FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Choi, EH
   Lee, DY
   Park, HS
   Shim, SM
AF Choi, Eun-Hye
   Lee, Da-Yeon
   Park, Hee-Sook
   Shim, Soon-Mi
TI Changes in the profiling of bioactive components with the roasting
   process in Lycium chinense leaves and the anti-obesity effect of
   its bioaccessible fractions
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE fresh-roasted Lycium chinense leaves; kaempferol-glycosides;
   bioaccessible; pancreatic lipase; adipocyte 3T3-L1
ID ANTIOXIDANT ACTIVITY; PHENOLIC-COMPOUNDS; PANCREATIC LIPASE; IN-VITRO;
   LIPID-ACCUMULATION; ALPHA-GLUCOSIDASE; CHLOROGENIC ACID; TEA
   POLYPHENOLS; KAEMPFEROL; OBESITY
AB BackgroundThis study aimed to investigate the profiles of bioactive components in roasted Lycium chinense leaves (LCLs) and its in vitro anti-obesity activity after digestion processes.
   ResultsChlorogenic acid, kaempferol-3-sophoroside-7-glucoside, kaempferol-3-sophoroside, and kaempferol-3-glucoside were discovered as bioactive components in various ratios of ethanol (EtOH) extract in LCLs by using ultra-performance liquid chromatography-electrospray ionization-mass spectrophotometry (UPLC-ESI-MS). The roasting process followed by a 30% EtOH extraction tended to decrease the content of chlorogenic acid and kaempferol-3-glucoside, and enhanced the content of kaempferol-3-sophoroside-7-glucoside. It effectively inhibited pancreatic lipase activity by 62.504.81%, which was approximately 1.71 percentage points higher than that of the dried-nonroasted LCL extract (60.79 +/- 3.75%). Its bioaccessible fraction obtained from in vitro digestion significantly and dose dependently reduced intracellular lipid accumulation by adipocyte 3T3-L1 compared with a 30% EtOH extraction. At a concentration of 200 mu gmL(-1), it inhibited lipid accumulation up to 29.55% in 3T3-L1 cells, which indicated that human digestive enzymes converted kaempferol-3-sophoroside-7-glucoside to kaempferol metabolites that have anti-obesity effects.
   ConclusionThis study suggests that the profiling of bioactive components by processing methods and a bioaccessible fraction could be crucial to improve the bioactivity of LCLs, and potentially be a natural anti-obesity ingredient after oral intake. (c) 2019 Society of Chemical Industry
C1 [Choi, Eun-Hye; Lee, Da-Yeon; Shim, Soon-Mi] Sejong Univ, Dept Food Sci & Biotechnol, 98 Gunja Dong, Seoul 05006, South Korea.
   [Choi, Eun-Hye] Sejongbiotech Corp, R&D Ctr, Seoul, South Korea.
   [Park, Hee-Sook] Korea Food Res Inst, Div Metab & Nutr, Wanju Gun, South Korea.
C3 Sejong University; Korea Food Research Institute (KFRI)
RP Shim, SM (corresponding author), Sejong Univ, Dept Food Sci & Biotechnol, 98 Gunja Dong, Seoul 05006, South Korea.
EM soonmishim@sejong.ac.kr
OI Lee, Da-Yeon/0000-0002-4085-0689
CR Ballinger A, 2002, EUR J PHARMACOL, V440, P109, DOI 10.1016/S0014-2999(02)01422-X
   Bhutani KK, 2007, NAT PROD COMMUN, V2, P331
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Boyer J, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-1
   Carmona M, 2007, FOOD CHEM, V100, P445, DOI 10.1016/j.foodchem.2005.09.065
   Chen J., 2004, Chinese medical herbology and pharmacology
   Chen W, 2017, SCI REP-UK, V7, DOI 10.1038/srep40514
   Choi EH, 2017, FOOD FUNCT, V8, P3664, DOI [10.1039/c7fo01173c, 10.1039/C7FO01173C]
   Choi JS, 2012, FOOD SCI BIOTECHNOL, V21, P19, DOI 10.1007/s10068-012-0003-7
   Christodoulou E, 2015, J PHARM PHARMACOL, V67, P1634, DOI 10.1111/jphp.12456
   Dong JZ, 2013, J SCI FOOD AGR, V93, P310, DOI 10.1002/jsfa.5758
   Ferreres F, 2005, J AGR FOOD CHEM, V53, P2901, DOI 10.1021/jf040441s
   Fiol M, 2013, FOOD CHEM, V138, P857, DOI 10.1016/j.foodchem.2012.10.101
   Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Hu DW, 2018, FOOD CHEM, V258, P43, DOI 10.1016/j.foodchem.2018.03.049
   Jaramillo-Flores ME, 2003, FOOD SCI TECHNOL INT, V9, P271, DOI 10.1177/108201303036093
   Jara-Palacios MJ, 2018, FOOD RES INT, V109, P433, DOI 10.1016/j.foodres.2018.04.060
   Jung M.Y, 1997, FOOD SCI TECHNOLOGY, V3, P210
   Kang MH, 2010, J MED FOOD, V13, P801, DOI 10.1089/jmf.2010.1032
   Kim HG, 2011, LWT-FOOD SCI TECHNOL, V44, P992, DOI 10.1016/j.lwt.2010.12.011
   Kim SN, 2009, PLANTA MED, V75, P596, DOI 10.1055/s-0029-1185358
   Kim SY, 1997, FOOD CHEM, V58, P297, DOI 10.1016/S0308-8146(96)00099-4
   Kleinman HK, 2018, APPL BIOL CHEM, V61, P703, DOI 10.1007/s13765-018-0400-6
   Klopsch R, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00322
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   Lee EH, 2018, APPL BIOL CHEM, V61, P441, DOI 10.1007/s13765-018-0378-0
   Lee M, 2018, MED TEACH, V1, P1
   Lee S, 2009, FOOD CHEM, V112, P316, DOI 10.1016/j.foodchem.2008.05.065
   Lee Won Jeong, 2012, Prev Nutr Food Sci, V17, P280, DOI 10.3746/pnf.2012.17.4.280
   Lee YJ, 2015, FOOD FUNCT, V6, P2824, DOI 10.1039/c5fo00481k
   Lin JT, 2016, FOOD CHEM, V190, P520, DOI 10.1016/j.foodchem.2015.06.004
   Liu SC, 2017, FOOD CHEM, V215, P284, DOI 10.1016/j.foodchem.2016.06.072
   Martins F, 2010, OBESITY, V18, P42, DOI 10.1038/oby.2009.189
   McDougall GJ, 2009, FOOD CHEM, V115, P193, DOI 10.1016/j.foodchem.2008.11.093
   Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m
   Mocan A, 2014, MOLECULES, V19, P10056, DOI 10.3390/molecules190710056
   Moon JK, 2009, J AGR FOOD CHEM, V57, P5365, DOI 10.1021/jf900012b
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Oliviero T, 2009, J AGR FOOD CHEM, V57, P147, DOI 10.1021/jf802250j
   Ortega N, 2011, FOOD CHEM, V124, P65, DOI 10.1016/j.foodchem.2010.05.105
   Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6
   Park HS, 2013, NAT PROD COMMUN, V8, P1579
   Peters CM, 2010, FOOD RES INT, V43, P95, DOI 10.1016/j.foodres.2009.08.016
   Potterat O, 2010, PLANTA MED, V76, P7, DOI 10.1055/s-0029-1186218
   Price KR, 1998, J AGR FOOD CHEM, V46, P4898, DOI 10.1021/jf980687v
   Moraga AR, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-109
   Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005
   Sergent T, 2012, FOOD CHEM, V135, P68, DOI 10.1016/j.foodchem.2012.04.074
   Son YR, 2016, FOOD FUNCT, V7, P861, DOI 10.1039/c5fo01258a
   Turkmen N, 2005, FOOD CHEM, V93, P713, DOI 10.1016/j.foodchem.2004.12.038
   Yeh YC, 2008, BIORESOURCE TECHNOL, V99, P1383, DOI 10.1016/j.biortech.2007.01.058
   You Q, 2012, LWT-FOOD SCI TECHNOL, V46, P164, DOI 10.1016/j.lwt.2011.10.011
   Zanatta L, 2008, J NAT PROD, V71, P532, DOI 10.1021/np070358+
   Zang YQ, 2015, FOOD FUNCT, V6, P834, DOI [10.1039/c4fo00844h, 10.1039/C4FO00844H]
   Zhang B, 2015, FOOD CHEM, V172, P862, DOI 10.1016/j.foodchem.2014.09.144
   Zhang DL, 2004, J FOOD AGRIC ENVIRON, V2, P95
   Zhang LX, 2017, FOOD CHEM, V230, P306, DOI 10.1016/j.foodchem.2017.03.045
NR 58
TC 10
Z9 11
U1 2
U2 56
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JUL
PY 2019
VL 99
IS 9
BP 4482
EP 4492
DI 10.1002/jsfa.9687
PG 11
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA IN9NE
UT WOS:000479004900036
PM 30868582
DA 2025-04-28
ER

PT J
AU Peng, SG
   Pang, YL
   Zhu, Q
   Kang, JH
   Liu, MX
   Wang, Z
AF Peng, Shu-guang
   Pang, Yi-lin
   Zhu, Qi
   Kang, Jing-he
   Liu, Ming-xin
   Wang, Zheng
TI Chlorogenic Acid Functions as a Novel Agonist of PPARγ2 during the
   Differentiation of Mouse 3T3-L1 Preadipocytes
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID PROLIFERATOR-ACTIVATED RECEPTOR; DIET-INDUCED OBESITY; PPAR-GAMMA;
   TRANSCRIPTION FACTORS; FAT ACCUMULATION; ADIPOCYTE DIFFERENTIATION;
   5-CAFFEOYLQUINIC ACID; INHIBIT ADIPOGENESIS; GENE-EXPRESSION;
   C/EBP-ALPHA
AB Rosiglitazone (RG) is a well-known activator of peroxisome proliferator-activated receptor-gamma (PPAR) and used to treat hyperglycemia and type 2 diabetes; however, its clinical application has been confounded by adverse side effects. Here, we assessed the roles of chlorogenic acid (CGA), a phenolic secondary metabolite found in many fruits and vegetables, on the differentiation and lipolysis of mouse 3T3-L1 preadipocytes. The results showed that CGA promoted differentiation in vitro according to oil red O staining and quantitative polymerase chain reaction assays. As a potential molecular mechanism, CGA downregulated mRNA levels of the adipocyte differentiation-inhibitor gene Pref1 and upregulated those of major adipogenic transcriptional factors (Cebpb and Srebp1). Additionally, CGA upregulated the expression of the differentiation-related transcriptional factor PPAR2 at both the mRNA and protein levels. However, following CGA intervention, the accumulation of intracellular triacylglycerides following preadipocyte differentiation was significantly lower than that in the RG group. Consistent with this, our data indicated that CGA treatment significantly upregulated the expression of lipogenic pathway-related genes Plin and Srebp1 during the differentiation stage, although the influence of CGA was weaker than that of RG. Notably, CGA upregulated the expression of the lipolysis-related gene Hsl, whereas it did not increase the expression of the lipid synthesis-related gene Dgat1. These results demonstrated that CGA might function as a potential PPAR agonist similar to RG; however, the impact of CGA on lipolysis in 3T3-L1 preadipocytes differed from that of RG.
C1 [Peng, Shu-guang; Pang, Yi-lin; Zhu, Qi; Liu, Ming-xin; Wang, Zheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
   [Peng, Shu-guang] Res Inst Hunan Tobacco Sci, Changsha 410007, Hunan, Peoples R China.
   [Peng, Shu-guang] Hunan Agr Univ, Coll Plant Protect, Changsha 410128, Hunan, Peoples R China.
   [Kang, Jing-he] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop, Changsha 410125, Hunan, Peoples R China.
C3 Hunan Agricultural University; China National Tobacco Corporation; Hunan
   Agricultural University; Chinese Academy of Sciences; Institute of
   Subtropical Agriculture, CAS
RP Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
EM zhengw@hunau.edu.cn
RI Pang, Yilin/MIJ-9943-2025; Zhu, Qi/KYR-6238-2024; Wang,
   Zheng/JNT-1898-2023
OI Wang, Zheng/0000-0001-9159-047X
FU National Natural Science Foundation of China [31071531]; Foundation of
   the Research Institute of Hunan Tobacco Science [15-17Aa04]
FX This study was supported by the National Natural Science Foundation of
   China (31071531) and the Foundation of the Research Institute of Hunan
   Tobacco Science (15-17Aa04).
CR Adedapo Adeolu Alex, 2015, Journal of Basic and Clinical Physiology and Pharmacology, V26, P327, DOI 10.1515/jbcpp-2014-0051
   Agrawal R, 2012, MINI-REV MED CHEM, V12, P87, DOI 10.2174/138955712798995048
   Ahuja S, 2011, J PHARM PHARMACOL, V63, P1604, DOI 10.1111/j.2042-7158.2011.01363.x
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2
   Cheong LY, 2015, J CELL BIOCHEM, V116, P1361, DOI 10.1002/jcb.25093
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593
   Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1126, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1126::AID-JSFA604>3.0.CO;2-0
   De Souza Marinho Do Nascimento D., 2017, MOLECULES, V22
   Deka SJ, 2017, CURR MOL MED, V17, P79, DOI 10.2174/1566524017666170209160619
   den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213
   Du WY, 2013, J ETHNOPHARMACOL, V147, P74, DOI 10.1016/j.jep.2013.01.042
   Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0
   Ghadieh HE, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0014-5
   Hakkou Z, 2017, BIOMED PHARMACOTHER, V93, P62, DOI 10.1016/j.biopha.2017.06.015
   HERRERA R, 1989, MOL CELL BIOL, V9, P5331, DOI 10.1128/MCB.9.12.5331
   HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Hudak C.S., 2013, Frontiers in Endocrinology vol, V4
   Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873
   Jang BC, 2016, BIOCHEM BIOPH RES CO, V474, P220, DOI 10.1016/j.bbrc.2016.04.109
   Jang J, 2018, J ETHNOPHARMACOL, V210, P10, DOI 10.1016/j.jep.2017.08.024
   Jiang RJ, 2016, J NUTR BIOCHEM, V27, P53, DOI 10.1016/j.jnutbio.2015.08.017
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Kowalska K, 2014, FOOD CHEM, V148, P246, DOI 10.1016/j.foodchem.2013.10.032
   Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1
   Lee H, 2000, CIRC RES, V87, P516
   Lee H, 2017, J GINSENG RES, V41, P257, DOI 10.1016/j.jgr.2016.04.004
   Li ZY, 2015, DIABETES, V64, P4011, DOI 10.2337/db15-0274
   Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056
   Liu SL, 2015, FOOD FUNCT, V6, P2779, DOI 10.1039/c5fo00626k
   Lu Y, 2015, J DIABETES INVEST, V6, P78, DOI 10.1111/jdi.12246
   Martínez G, 2017, PESTIC BIOCHEM PHYS, V140, P30, DOI 10.1016/j.pestbp.2017.05.012
   Mikami Y, 2015, LIFE SCI, V139, P69, DOI 10.1016/j.lfs.2015.08.005
   Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200
   Nathan DM, 2015, JAMA-J AM MED ASSOC, V314, P1052, DOI 10.1001/jama.2015.9536
   Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761
   Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102
   Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024
   Orchard TJ, 2006, DIABETES CARE, V29, P746, DOI 10.2337/diacare.29.03.06.dc05-2181
   Palócz O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166642
   Park JJ, 2015, CELL ONCOL, V38, P111, DOI 10.1007/s13402-014-0216-2
   Rashid AM, 2016, FOOD FUNCT, V7, P881, DOI [10.1039/C5FO01208B, 10.1039/c5fo01208b]
   Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802
   Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110
   Schreiber I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17595-5
   SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L
   Song X., 2015, SCI REPORTS, V5
   Sprott KM, 2002, BIOCHEM J, V365, P181, DOI 10.1042/BJ20020215
   Sul HS, 2000, INT J OBESITY, V24, pS15, DOI 10.1038/sj.ijo.0801494
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Toyota Y, 2017, BIOORG MED CHEM LETT, V27, P2776, DOI 10.1016/j.bmcl.2017.04.061
   Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879
   Wang G, 2005, METABOLISM, V54, P590, DOI 10.1016/j.metabol.2004.11.017
   Wang L., 2015, FRONTIERS MICROBIOLO, V6
   Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015
   Wu DH, 2015, J PHARMACOL SCI, V129, P177, DOI 10.1016/j.jphs.2015.10.005
   WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350
   Xue NN, 2017, SCI REP-UK, V7, DOI 10.1038/srep39011
   Ye HY, 2017, INFLAMMATION, V40, P523, DOI 10.1007/s10753-016-0498-9
   Ye JP, 2011, ACTA PHARM SIN B, V1, P137, DOI 10.1016/j.apsb.2011.06.011
   Zhang KH, 2010, J CLIN PHARMACOL, V50, P1022, DOI 10.1177/0091270009355159
   Zhang ZZ, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201601196
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zheng SQ, 2017, J GERONTOL A-BIOL, V72, P464, DOI 10.1093/gerona/glw105
NR 70
TC 25
Z9 26
U1 0
U2 15
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2018
VL 2018
AR 8594767
DI 10.1155/2018/8594767
PG 14
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA HE8YN
UT WOS:000453734000001
PM 30627576
OA Green Published, Green Submitted, hybrid
DA 2025-04-28
ER

PT J
AU Park, I
   Ochiai, R
   Ogata, H
   Kayaba, M
   Hari, S
   Hibi, M
   Katsuragi, Y
   Satoh, M
   Tokuyama, K
AF Park, Insung
   Ochiai, Ryuji
   Ogata, Hitomi
   Kayaba, Momoko
   Hari, Sayaka
   Hibi, Masanobu
   Katsuragi, Yoshihisa
   Satoh, Makoto
   Tokuyama, Kumpei
TI Effects of subacute ingestion of chlorogenic acids on sleep architecture
   and energy metabolism through activity of the autonomic nervous system:
   a randomised, placebo-controlled, double-blinded cross-over trial
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Chlorogenic acids; Energy metabolism; Sleep architecture; Autonomic
   nervous system
ID COFFEE CONSUMPTION; ENDOTHELIAL FUNCTION; CAFFEINE INGESTION;
   HEART-RATE; DURATION; OBESITY; RISK; METAANALYSIS; WAKEFULNESS;
   EXPENDITURE
AB Chlorogenic acids (CGA) are the most abundant polyphenols in coffee. Continuous consumption of CGA reduces body fat and body weight. Since energy metabolism and sleep are controlled by common regulatory factors, consumption of CGA might modulate sleep. Lack of sleep has been identified as a risk factor for obesity, hypertension and type 2 diabetes. The aim of this study was to determine the effects of ingesting CGA over 5 d on energy metabolism and sleep quality in humans. A total of nine healthy subjects (four male and five female) completed a placebo-controlled, double-blinded, cross-over intervention study. Subjects consumed a test beverage containing 0 or 600 mg of CGA for 5 d. On the fifth night, subjects stayed in a whole-room metabolic chamber to measure energy metabolism; sleep was evaluated using polysomnographic recording. It was found that CGA shortened sleep latency (9 ((SEM) 2) v. 16 ((SEM) 4) min, P< 0.05) compared with the control, whereas no effect on sleep architecture, such as slow-wave sleep, rapid eye movement or waking after sleep onset, was observed. Indirect calorimetry revealed that consumption of CGA increased fat oxidation (510 ((SEM) 84) kJ/8 h (122 ((SEM) 20) kcal/8 h) v. 331 ((SEM) 79) kJ/8 h (81 ((SEM) 19) kcal/8 h), P < 0.05) but did not affect energy expenditure during sleep. Consumption of CGA enhanced parasympathetic activity assessed from heart-rate variability during sleep (999 ((SEM) 77) v. 919 ((SEM) 54), P< 0.05). A period of 5-d CGA consumption significantly increased fat oxidation during sleep, suggesting that beverages containing CGA may be beneficial to reduce body fat and prevent obesity. Consumption of CGA shortened sleep latency and did not adversely affect sleep quality.
C1 [Park, Insung; Ogata, Hitomi; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Sports Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058574, Japan.
   [Ochiai, Ryuji; Hari, Sayaka; Hibi, Masanobu; Katsuragi, Yoshihisa] Kao Corp, Hlth Care Food Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
   [Kayaba, Momoko; Satoh, Makoto] Univ Tsukuba, Int Inst Integrat Sleep Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.
C3 University of Tsukuba; KAO Corporation; University of Tsukuba
RP Tokuyama, K (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Div Sports Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058574, Japan.
EM tokuyama@taiiku.tsukuba.ac.jp
RI Hibi, Masanobu/AAF-6115-2019; PARK, Insung/AFR-8117-2022; ochiai,
   ryuji/Q-7834-2019; ochiai, ryuji/T-3621-2018
OI PARK, Insung/0000-0001-6389-1937; Hibi, Masanobu/0000-0001-6791-3662;
   ochiai, ryuji/0000-0002-8306-7950
FU Grants-in-Aid for Scientific Research [16H01877] Funding Source: KAKEN
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 1976, BIOCHEM J
   [Anonymous], 2010, Dietary Reference Intakes for Calcium and Vitamin D
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Camfield DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082897
   Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cipolla-Neto J, 2014, J PINEAL RES, V56, P371, DOI 10.1111/jpi.12137
   CLIFFORD MN, 1976, J SCI FOOD AGR, V27, P73, DOI 10.1002/jsfa.2740270112
   DAMICIS A, 1993, CAFFEINE COFFEE HLTH, P1
   EDWARDS SJ, 1992, INT J PSYCHOPHYSIOL, V13, P97, DOI 10.1016/0167-8760(92)90048-G
   Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920
   FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hernán MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   Hirotsu C, 2015, SLEEP SCI, V8, P143, DOI 10.1016/j.slsci.2015.09.002
   Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491
   Jokura H, 2015, NUTR RES, V35, P873, DOI 10.1016/j.nutres.2015.07.005
   Júdice PB, 2013, APPL PHYSIOL NUTR ME, V38, P49, DOI 10.1139/apnm-2012-0145
   Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1
   Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001
   Lecoultre V, 2014, AM J CLIN NUTR, V99, P268, DOI 10.3945/ajcn.113.069526
   Matsui Y, 2007, J CHROMATOGR B, V858, P96, DOI 10.1016/j.jchromb.2007.08.013
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Nicolaidis S, 2006, METABOLISM, V55, pS24, DOI 10.1016/j.metabol.2006.07.009
   Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x
   Ochiai R, 2015, INT J FOOD SCI NUTR, V66, P350, DOI 10.3109/09637486.2015.1007453
   Ochiai R, 2014, NUTR RES, V34, P155, DOI 10.1016/j.nutres.2013.11.001
   Ota N, 2010, J HEALTH SCI, V56, P745, DOI 10.1248/jhs.56.745
   Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118
   Porciúncula LO, 2013, NEUROCHEM INT, V63, P594, DOI 10.1016/j.neuint.2013.09.009
   Rechtschaffen A, 1968, MANUAL STANDARDIZED
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Sakurai T, 2005, SLEEP MED REV, V9, P231, DOI 10.1016/j.smrv.2004.07.007
   Shinomiya K, 2004, EUR J PHARMACOL, V504, P185, DOI 10.1016/j.ejphar.2004.09.054
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008
   Tu Y, 2012, NEUROSCI LETT, V525, P95, DOI 10.1016/j.neulet.2012.07.068
   Tverdal A, 2003, ANN EPIDEMIOL, V13, P419, DOI 10.1016/S1047-2797(02)00462-3
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Zanzinger J, 1999, CARDIOVASC RES, V43, P639, DOI 10.1016/S0008-6363(99)00085-1
   Zhang L, 2008, CHEST, V133, P427, DOI 10.1378/chest.07-1190
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
NR 48
TC 47
Z9 54
U1 5
U2 23
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD APR
PY 2017
VL 117
IS 7
BP 979
EP 984
DI 10.1017/S0007114517000587
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EV8SM
UT WOS:000402053600007
PM 28412986
OA Green Submitted, Bronze
DA 2025-04-28
ER

PT J
AU Zaklos-Szyda, M
   Pietrzyk, N
   Szustak, M
   Podsedek, A
AF Zaklos-Szyda, Malgorzata
   Pietrzyk, Nina
   Szustak, Marcin
   Podsedek, Anna
TI Viburnum opulus L. Juice Phenolics Inhibit Mouse 3T3-L1 Cells
   Adipogenesis and Pancreatic Lipase Activity
SO NUTRIENTS
LA English
DT Article
DE Viburnum opulus; phenolic compounds; adipogenesis; PPAR gamma; lipase
   inhibition
ID ACTIVATED-RECEPTOR-GAMMA; PPAR-GAMMA; HEPATIC STEATOSIS; CHLOROGENIC
   ACID; INSULIN-RESISTANCE; ANTIOXIDANT; OBESITY; RUTIN; MICE;
   DIFFERENTIATION
AB Viburnum opulusL. fruit is a rich source of phenolic compounds that may be involved in the prevention of metabolic diseases. The purpose of this study was to determine the effects ofViburnum opulusfresh juice (FJ) and juice purified by solid-phase extraction (PJ) on the adipogenesis process with murine 3T3-L1 preadipocyte cell line and pancreatic lipase activity in triolein emulsion, as well as their phenolic profiles by UPLC/Q-TOF-MS. Decrease of lipids and triacylglycerol accumulation in differentiated 3T3-L1 cells were in concordance with downregulation of the expression of peroxisome proliferator-activated receptor-gamma (PPAR gamma), CCAAT/enhancer-binding protein alpha (C/EBP beta/alpha), and sterol regulatory element-binding protein 1c (SREBP-1c). Furthermore, regulation of PPAR gamma-mediated beta-lactamase expression byV. opuluscomponents in reporter gene assay, as well as their binding affinity to ligand-binding domain of PPAR gamma, were tested. In addition, the levels of enzymes involved in lipid metabolism, like fatty acid synthase (FAS) or acetyl-CoA carboxylase (ACC), were decreased, along with inflammatory cytokines, like tumor necrosis factor alpha (TNF alpha), interleukin-6 (Il-6) and leptin. Moreover, FJ and PJ were able to inhibit pancreatic lipase, which potentially could reduce the fat absorption from the intestinal lumen and the storage of body fat in the adipose tissues. Thirty-two phenolic compounds with chlorogenic acid as the dominant compound were identified in PJ which revealed significant biological activity. These data contribute to elucidateV. opulusjuice phenolic compounds' molecular mechanism in adipogenesis regulation in 3T3-L1 cells and dietary fat lipolysis.
C1 [Zaklos-Szyda, Malgorzata; Pietrzyk, Nina; Szustak, Marcin; Podsedek, Anna] Lodz Univ Technol, Inst Mol & Ind Biotechnol, Dept Biotechnol & Food Sci, PL-90924 Lodz, Poland.
C3 Lodz University of Technology
RP Zaklos-Szyda, M (corresponding author), Lodz Univ Technol, Inst Mol & Ind Biotechnol, Dept Biotechnol & Food Sci, PL-90924 Lodz, Poland.
EM malgorzata.zaklos-szyda@p.lodz.pl; nina.pietrzyk@dokt.p.lodz.pl;
   marcin.szustak@p.lodz.pl; anna.podsedek@p.lodz.pl
RI Szustak, Marcin/IAQ-2156-2023; Pietrzyk, Nina/AAD-5480-2019;
   Zaklos-Szyda, Malgorzata/M-5229-2019; Podsedek, Anna/M-4197-2018
OI Pietrzyk, Nina/0000-0002-3279-0612; Szustak, Marcin/0000-0003-2063-5241;
   Zaklos-Szyda, Malgorzata/0000-0001-8341-1654; Podsedek,
   Anna/0000-0001-6654-4818
FU National Science Centre, Poland [2016/23/B/NZ9/03629]
FX The research was supported by grant number 2016/23/B/NZ9/03629 from The
   National Science Centre, Poland.
CR [Anonymous], 2015, CURR TOP MED CHEM
   Aranaz P, 2019, MOLECULES, V24, DOI 10.3390/molecules24061045
   Austin David, 2018, Oncotarget, V9, P33912, DOI 10.18632/oncotarget.26089
   Cai Y, 2012, PLANTA MED, V78, P861, DOI 10.1055/s-0031-1298548
   Cataloguing W.L., 2016, GLOBAL REPORT DIABET, P6
   Cesoniene L., 2008, Biologija, V54, P93
   Cesoniene L, 2010, CENT EUR J BIOL, V5, P864, DOI 10.2478/s11535-010-0088-z
   Chem F., 2008, J AGR FOOD CHEM, V56, P642
   Choi I, 2006, BIOFACTORS, V26, P273, DOI 10.1002/biof.5520260405
   Chyau CC, 2018, MOLECULES, V23, DOI 10.3390/molecules23071780
   Crewe C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129397
   Fabroni S, 2016, J SCI FOOD AGR, V96, P4713, DOI 10.1002/jsfa.7708
   Fujisawa K, 2009, BIOCHEM BIOPH RES CO, V379, P43, DOI 10.1016/j.bbrc.2008.11.141
   Gao RF, 2018, MICROB PATHOGENESIS, V124, P178, DOI 10.1016/j.micpath.2018.07.030
   Gao Y, 2008, BIOL PHARM BULL, V31, P1716, DOI 10.1248/bpb.31.1716
   Gironés-Vilaplana A, 2013, INT J FOOD SCI NUTR, V64, P897, DOI 10.3109/09637486.2013.809406
   Graham MR, 2015, DIABET METAB SYND OB, V8, P455, DOI 10.2147/DMSO.S82629
   Guo HH, 2012, J NUTR BIOCHEM, V23, P349, DOI 10.1016/j.jnutbio.2010.12.013
   Hallenborg P, 2016, PROG LIPID RES, V61, P149, DOI 10.1016/j.plipres.2015.11.002
   Hiebl V, 2018, BIOTECHNOL ADV, V36, P1657, DOI 10.1016/j.biotechadv.2018.03.003
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Jang JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18274-1
   Ruiz-Ojeda FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071040
   Karaçelik AA, 2015, FOOD CHEM, V175, P106, DOI 10.1016/j.foodchem.2014.11.085
   Kern L, 2019, CANCERS, V11, DOI 10.3390/cancers11010024
   Kowalska K, 2014, FOOD CHEM, V148, P246, DOI 10.1016/j.foodchem.2013.10.032
   Kraujalyte V, 2013, FOOD CHEM, V141, P3695, DOI 10.1016/j.foodchem.2013.06.054
   Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Liberato MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036297
   Ma XR, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00473
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mahindroo N, 2006, J MED CHEM, V49, P1212, DOI 10.1021/jm0510373
   Maire A., 2019, CELLS, V8, P1392, DOI [10.3390/cells8111392, DOI 10.3390/CELLS8111392]
   Martens FMAC, 2002, DRUGS, V62, P1463, DOI 10.2165/00003495-200262100-00004
   McDougall GJ, 2009, FOOD CHEM, V115, P193, DOI 10.1016/j.foodchem.2008.11.093
   Medina-Gomez G, 2007, PUBLIC HEALTH NUTR, V10, P1132, DOI 10.1017/S1368980007000614
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nones K, 2009, BRIT J NUTR, V101, P169, DOI 10.1017/S0007114508009847
   Pascual-Serrano A, 2017, INT J OBESITY, V41, P1246, DOI 10.1038/ijo.2017.90
   Peng SG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8594767
   Perova IB, 2014, PHARM CHEM J+, V48, P332, DOI 10.1007/s11094-014-1105-8
   Pinent M, 2005, INT J OBESITY, V29, P934, DOI 10.1038/sj.ijo.0802988
   Plutzky J, 2011, CIRC RES, V108, P1002, DOI 10.1161/CIRCRESAHA.110.226860
   Ribeiro HV, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00011
   Rigano D, 2017, ACTA PHARMACOL SIN B, V7, P427, DOI 10.1016/j.apsb.2017.05.005
   Schneider H, 2014, ARCH BIOCHEM BIOPHYS, V546, P8, DOI 10.1016/j.abb.2014.01.025
   Siriwardhana N, 2013, J NUTR BIOCHEM, V24, P613, DOI 10.1016/j.jnutbio.2012.12.013
   Sosnowska D, 2018, J FUNCT FOODS, V49, P196, DOI 10.1016/j.jff.2018.08.029
   Stepien A., 2018, European Journal of Clinical and Experimental Medicine, V16, P47
   Sugiyama H, 2007, J AGR FOOD CHEM, V55, P4604, DOI 10.1021/jf070569k
   Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125
   Velioglu YS, 2006, INT J FOOD SCI TECH, V41, P1011, DOI [10.1111/j.1365-2621.2006.01142.x, 10.1111/j.1365-2621.2005.01142.x]
   Venkataraman B, 2020, PHYTOTHER RES, V34, P1530, DOI 10.1002/ptr.6625
   Villalpando-Arteaga EV, 2013, FOOD FUNCT, V4, P618, DOI 10.1039/c3fo30270a
   Weidner C, 2012, P NATL ACAD SCI USA, V109, P7257, DOI 10.1073/pnas.1116971109
   Worsztynowicz P, 2014, PROCESS BIOCHEM, V49, P1457, DOI 10.1016/j.procbio.2014.06.002
   Zaklos-Szyda M., 2019, Acta Innovations, P33
   Zaklos-Szyda M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050433
   Zaklos-Szyda M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080262
   Zaklos-Szyda M, 2018, ACTA BIOCHIM POL, V65, P67, DOI 10.18388/abp.2017_1604
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
   Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125667
   Zhang J, 2017, BIOMED PHARMACOTHER, V86, P292, DOI 10.1016/j.biopha.2016.12.019
   Zhang YX, 2018, P NATL ACAD SCI USA, V115, pE6039, DOI 10.1073/pnas.1806366115
   Zheng FP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101269
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zhu XJ, 2017, EXP THER MED, V13, P688, DOI 10.3892/etm.2016.3975
NR 70
TC 22
Z9 23
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUL
PY 2020
VL 12
IS 7
AR 2003
DI 10.3390/nu12072003
PG 29
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA MV6VR
UT WOS:000556493400001
PM 32640537
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Oben, J
   Enonchong, E
   Kuate, D
   Mbanya, D
   Thomas, TC
   Hildreth, DJ
   Ingolia, TD
   Tempesta, MS
AF Oben, Julius
   Enonchong, Ebangha
   Kuate, Dieudonne
   Mbanya, Dora
   Thomas, Tiffany C.
   Hildreth, DeWall J.
   Ingolia, Thomas D.
   Tempesta, Michael S.
TI The effects of ProAlgaZyme novel algae infusion on metabolic syndrome
   and markers of cardiovascular health
SO LIPIDS IN HEALTH AND DISEASE
LA English
DT Article
ID CATECHIN-POLYPHENOLS; DENSITY LIPOPROTEIN; GREEN TEA; OBESITY;
   OXIDATION; WINES; ANTIOXIDANTS; CHOLESTEROL; CAFFEINE; PLASMA
AB Background: Metabolic Syndrome, or Syndrome X, is characterized by a set of metabolic and lipid imbalances that greatly increases the risk of developing diabetes and cardiovascular disease. The syndrome is highly prevalent in the United States and worldwide, and treatments are in high demand. ProAlgaZyme, a novel and proprietary freshwater algae infusion in purified water, has been the subject of several animal studies and has demonstrated low toxicity even with chronic administration at elevated doses. The infusion has been used historically for the treatment of several inflammatory and immune disorders in humans and is considered well-tolerated. Here, the infusion is evaluated for its effects on the cardiovascular risk factors present in metabolic syndrome in a randomized double-blind placebo-controlled study involving 60 overweight and obese persons, ages 25-60. All participants received four daily oral doses (I fl oz) of ProAlgaZyme (N = 22) or water placebo (N = 30) for a total of 10 weeks, and were encouraged to maintain their normal levels of physical activity. Blood sampling and anthropometric measurements were taken at the beginning of the study period and after 4, 8 and 10 weeks of treatment. Eight participants did not complete the study.
   Results: ProAlgaZyme brought about statistically significant (p < 0.001) reductions in the following: weight, body fat, total cholesterol, LDL-cholesterol, triglycerides, C-reactive protein and fasting blood glucose levels, accompanied by a significant (p < 0.001) increase in HDL-cholesterol levels over the 10-week study period. The infusion was well-tolerated and no side effects were noted.
   Conclusion: ProAlgaZyme (4 fl oz daily) consumption resulted in significant reductions in weight and blood glucose levels, while significantly improving serum lipid profiles and reducing markers of inflammation, thus improving cardiovascular risk factors in overweight and obese subjects over a course of 10 weeks with an absence of adverse side effects.
   Trial Registration: US ClinicalTrials.gov NCT00489333.
C1 Univ Yaounde, Dept Biochem, Lab Nutr & Nutr Biochem, Yaounde, Cameroon.
   Hlth Enhancement Prod Inc, Scottsdale, AZ USA.
   Univ Yaounde, Fac Med & Biomed Sci, Yaounde, Cameroon.
C3 University of Yaounde I; University of Yaounde I
RP Oben, J (corresponding author), Univ Yaounde, Dept Biochem, Lab Nutr & Nutr Biochem, Yaounde, Cameroon.
EM juliusoben@hotmail.com; juliusoben@hotmail.com; juliusoben@hotmail.com;
   juliusoben@hotmail.com; tiffany@heponline.com; dochildreth@cox.net;
   tingolia@heponline.com; natprod@aol.com
CR AGBO GA, 2006, PAK J BIOL SCI
   Agbor GA, 2005, J AGR FOOD CHEM, V53, P6819, DOI 10.1021/jf050445c
   AGBOR GA, IN PRESS NUTR RES
   ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502
   BACHORIK PS, 1976, CLIN CHEM, V22, P1828
   BROWN RK, 1994, PEDIATR RES, V36, P487, DOI 10.1203/00006450-199410000-00013
   BUCOLO G, 1973, CLIN CHEM, V19, P476
   Combaret L, 2004, BIOCHEM J, V378, P239, DOI 10.1042/BJ20031660
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dupuy AM, 2003, CLIN CHEM LAB MED, V41, P948, DOI 10.1515/CCLM.2003.144
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   FRANKEL EN, 1995, J AGR FOOD CHEM, V43, P890, DOI 10.1021/jf00052a008
   Friedewald WT, 1972, CLIN CHEM, V18, P449
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI [10.1161/01.CIR.0000111245.75752.C6, 10.1161/01.CIR.0000112379.88385.67]
   Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   KANNER J, 1994, J AGR FOOD CHEM, V42, P64, DOI 10.1021/jf00037a010
   *KOR NAT STAT OFF, 2001, REP STAT MORT KOR
   Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x
   McGill HC, 2002, CIRCULATION, V105, P2712, DOI 10.1161/01.CIR.0000018121.67607.CE
   OBEN J, 2006, LIPIDS HLTH DIS, P5
   RICHMOND W, 1973, CLIN CHEM, V19, P476
   Ristig M, 2003, AIDS PATIENT CARE ST, V17, P439, DOI 10.1089/108729103322395456
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   *SPSS, 2001, SPSS WIND REL 11 01
   STEINBERG D, 1989, NEW ENGL J MED, V320, P915
   Teissedre PL, 1996, J SCI FOOD AGR, V70, P55, DOI 10.1002/(SICI)1097-0010(199601)70:1<55::AID-JSFA471>3.3.CO;2-O
   Trinder P., 1969, Journal of Clinical Pathology, V22, P158, DOI 10.1136/jcp.22.2.158
NR 30
TC 15
Z9 21
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-511X
J9 LIPIDS HEALTH DIS
JI Lipids Health Dis.
PD SEP 5
PY 2007
VL 6
AR 20
DI 10.1186/1476-511X-6-20
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 234AC
UT WOS:000251132000001
PM 17803818
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Alderete, E
   Bejarano, I
   Rodríguez, A
AF Alderete, E.
   Bejarano, I.
   Rodriguez, A.
TI Beverage intake and obesity in early childhood: evidence form primary
   health care clients in Northwest Argentina
SO JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE
LA English
DT Article
DE beverages; dietary sugar; latin America; pediatric obesity; water
ID BODY-MASS INDEX; SUGAR-SWEETENED BEVERAGES; INCOME PRESCHOOL-CHILDREN;
   SOFT DRINK CONSUMPTION; LATIN-AMERICA; JUICE INTAKE; OVERWEIGHT; WEIGHT;
   PREVALENCE; NUTRITION
AB Sugar sweetened beverages (SSB) are thought to play an important role in weight gain. We examined the relationship between the intake of caloric and noncaloric beverages (SSB and water) and the nutritional status of children. In 2014, we randomly selected 16 public health clinics in four cities of Northwest Argentina and conducted a survey among mothers of children 0-6 years of age. Children's beverage intake was ascertained by 24-h dietary recall provided by the mothers. Children's weight and height measures were obtained from clinic's registries. We calculated the body mass index using the International Obesity Task Force standards. The analysis included 562 children 25 months to 6 years of age with normal or above normal nutritional status. Children's beverage consumption was as follows, water 81.8%, carbonated soft drinks (CSD) 49.7%, coffee/tea/cocoa 44.0%, artificial fruit drinks 35.6%, flavored water 17.9%, natural fruit juice 14.5%. In multivariate logistic regression models the likelihood of being obese v. being overweight or having normal weight doubled with an intake of one to five glasses of CSD (OR = 2.2) and increased by more than three-fold with an intake of more than five glasses (OR = 3.5). Drinking more than five glasses of water decreased the likelihood of being obese by less than half (OR = 0.3). The percentage of children drinking more than five glasses of other beverages was low (3.3-0.9%) and regression models did not yield significant results. The study contributed evidence for reducing children's CSD intake and for promoting water consumption, together with the implementation of comprehensive regulatory public health policies.
C1 [Alderete, E.] Univ Nacl Jujuy, Fac Humanidades & Cs Sociales FHYCS UNJU, ICTER, CONICET, El Hornero 468, RA-4600 San Salvador De Jujuy, Jujuy, Argentina.
   [Bejarano, I.; Rodriguez, A.] Univ Nacl Jujuy, Fac Humanidades & Cs Sociales FHYCS UNJU, ICTER, San Salvador De Jujuy, Jujuy, Argentina.
C3 Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)
RP Alderete, E (corresponding author), Univ Nacl Jujuy, Fac Humanidades & Cs Sociales FHYCS UNJU, ICTER, CONICET, El Hornero 468, RA-4600 San Salvador De Jujuy, Jujuy, Argentina.
EM alderetew@gmail.com
RI Rodriguez, Alina/B-3541-2015; Bejarano, Ignacio/AAD-4314-2020
OI Rodriguez, Alina/0000-0003-1209-8802
FU Secretaria de Ciencia y Tecnica y Estudios Regionales, Universidad
   Nacional de Jujuy, Argentina, Resolucion CS [081/2015]; Salud Investiga,
   Ministerio de Salud de la Nacion Argentina, Becas de Investigacion
   Carrillo-Onativia
FX This study was funded by Secretaria de Ciencia y Tecnica y Estudios
   Regionales, Universidad Nacional de Jujuy, Argentina, Resolucion CS
   No081/2015; and by Salud Investiga, Ministerio de Salud de la Nacion
   Argentina, Becas de Investigacion Carrillo-Onativia 2013
   http://www.saludinvestiga.org.ar/ganadores_em_2013.asp.
CR Abeya Gilardon EO, 2009, EVALUACION ESTADO NU
   Albrecht SS, 2014, AM J HUM BIOL, V26, P627, DOI 10.1002/ajhb.22573
   Almiron-Roig E, 2003, Obes Rev, V4, P201, DOI 10.1046/j.1467-789X.2003.00112.x
   Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6
   [Anonymous], 2006, WHO Multicentre Growth Reference Study Group: WHO Child Growth Standards: Length/ Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development
   [Anonymous], POL ACT CANC PREV FO
   [Anonymous], 2000, GUIDE MEASURING HOUS
   [Anonymous], NHANES 3 REF MAN REP
   [Anonymous], 2005, DIET REF INT WAT POT
   Bachman CM, 2006, NUTR REV, V64, P153, DOI 10.1301/nr.2006.apr.153-174
   BARKER DJP, 1986, LANCET, V1, P1077
   Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974
   Bejarano Ignacio, 2005, Arch. argent. pediatr., V103, P101
   Bolzán Andrés, 2005, Arch. argent. pediatr., V103, P545
   Bray G.A., 2014, Handbook of obesity: Clinical applications, V2
   Centers for Disease Control and Prevention, The National Health and Nutrition Examination Survey
   Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582
   Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   de Onis M, 2000, AM J CLIN NUTR, V72, P1032
   de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Deckelbaum RJ, 2001, OBES RES, V9, p239S, DOI 10.1038/oby.2001.125
   Dennison BA, 1997, PEDIATRICS, V99, P15
   Dietz WH, 1998, J PEDIATR-US, V132, P191
   Dietz WH, 2009, MILBANK Q, V87, P215, DOI 10.1111/j.1468-0009.2009.00553.x
   Drewnowski A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-85
   Dubois L, 2007, J AM DIET ASSOC, V107, P924, DOI 10.1016/j.jada.2007.03.004
   Durán P, 2009, ARCH ARGENT PEDIATR, V107, P397, DOI 10.1590/S0325-00752009000500005
   Faith MS, 2006, PEDIATRICS, V118, P2066, DOI 10.1542/peds.2006-1117
   Fiorito LM, 2009, AM J CLIN NUTR, V90, P935, DOI 10.3945/ajcn.2009.27623
   Frazier CRM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003221
   Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Institute of Medicine of the National Academies, 2009, LOC GOV ACT PREV CHI
   Jimenez-Cruz A, 2010, ASIA PAC J CLIN NUTR, V19, P316
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Kain J, 2009, CAD SAUDE PUBLICA, V19, pS77
   King V, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-73
   Kral TVE, 2008, OBESITY, V16, P1802, DOI 10.1038/oby.2008.287
   Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738
   Lim S, 2009, OBESITY, V17, P1262, DOI 10.1038/oby.2008.656
   Lobstein BT, 2005, EU BRIEFING PAPER
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Meyer E, 2013, ARCH ARGENT PEDIATR, V111, P516, DOI [10.5546/aap.2013.516, 10.5546/aap.2013.eng.516]
   Muckelbauer R, 2014, OBESITY, V22, P2462, DOI 10.1002/oby.20911
   Muckelbauer R, 2009, PEDIATRICS, V123, pE661, DOI 10.1542/peds.2008-2186
   Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020
   O'Connor TM, 2006, PEDIATRICS, V118, pE1010, DOI 10.1542/peds.2005-2348
   O'Donnell A., 2003, ARCH ARGENT PEDIATR, V101, P57
   Padula G, 2008, ARCH LATINOAM NUTR, V58, P330
   PAHO/WHO, 2014, PLAN ACT PREV OB CHI
   Pérez-Morales E, 2013, NUTR HOSP, V28, P47, DOI 10.3305/nh.2013.28.1.6247
   Piernas C, 2014, AM J CLIN NUTR, V99, P567, DOI 10.3945/ajcn.113.072132
   Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1207, DOI 10.1136/bmj.39048.503750.BE
   Romaguera D, 2008, PUBLIC HEALTH NUTR, V11, P606, DOI 10.1017/S1368980007001061
   Skinner JD, 2001, J AM DIET ASSOC, V101, P432, DOI 10.1016/S0002-8223(01)00111-0
   Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S
   UNDP, 2014, HUMAN DEV REPORT 201
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Vio F, 2008, PUBLIC HEALTH NUTR, V11, P405, DOI 10.1017/S136898000700050X
   Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792
   Welsh JA, 2005, PEDIATRICS, V115, pE223, DOI 10.1542/peds.2004-1148
   WHO, 2014, REPORT OF THE FIRST
   WHO. World Health Statistics, 2014, THE WHO DOCUMENT PRO
   World Health Organization, 1998, OBESITY PREVENTING A
NR 71
TC 3
Z9 3
U1 0
U2 11
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 2040-1744
EI 2040-1752
J9 J DEV ORIG HLTH DIS
JI J. Dev. Orig. Health Dis.
PD JUN
PY 2016
VL 7
IS 3
BP 244
EP 252
DI 10.1017/S204017441500793X
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA DR3CT
UT WOS:000379780900005
PM 26639571
OA Green Published
DA 2025-04-28
ER

PT J
AU Etxeberria, U
   de la Garza, AL
   Martínez, JA
   Milagro, FI
AF Etxeberria, Usune
   Laura de la Garza, Ana
   Alfredo Martinez, J.
   Milagro, Fermin I.
TI Biocompounds Attenuating the Development of Obesity and Insulin
   Resistance Produced by a High-fat Sucrose Diet
SO NATURAL PRODUCT COMMUNICATIONS
LA English
DT Article
DE Curcumin; Chlorogenic acid; Coumaric acid; Naringin; Leucine;
   Anti-obesity
ID PHENOLIC-COMPOUNDS; GLUCOSE-TOLERANCE; RATS; LEUCINE; ACID; MANAGEMENT;
   MICE
AB The use of biocompounds as agents with potential anti-obesity effects might be a feasible alternative to the prescription of traditional drugs in the near future. The goal of the present study was to screen five different compounds in relation to their ability to prevent body weight gain and ameliorate obesity-associated metabolic impairments, namely insulin resistance. For this purpose, seventy Wistar rats were randomly assigned into seven experimental groups. A standard diet-fed control group (control, n=10); a high-fat, high-sucrose diet-fed group (BPS, n=10) and five experimental groups which were fed the I-IFS diet supplemented with one of the following biocompounds; curcumin (100 mg/kg bw, n=10), chlorogenic acid (50 mg/kg bw, n=10), coumaric acid (100 mg/kg bw, n=10), naringin (100 mg/kg bw, n=10) and leucine (1 % of diet, n=10). These results confirm the effectiveness of all the compounds to reduce significantly food efficiency, despite the significant higher food intake. Moreover, visceral fat mass percentage was significantly decreased after naringin and coumaric acid supplementation. In fact, this finding might be related to the considerable amelioration of HOMA-IR index detected in naringin-treated animals. A significant reduction in serum insulin levels and an improvement in the intraperitoneal glucose tolerance test and AUC were found in leucine- and coumaric acid-treated rats, respectively. In summary, the tested biocompounds, particularly naringin, coumaric acid and leucine, showed potential benefits in the prevention of obesity-related complications in rats, at least at the proved doses.
C1 [Etxeberria, Usune; Laura de la Garza, Ana; Alfredo Martinez, J.; Milagro, Fermin I.] Univ Navarra, Dept Nutr Food Sci & Physiol, Ctr Nutr Res, Pamplona 31008, Spain.
   [Alfredo Martinez, J.; Milagro, Fermin I.] Carlos III Hlth Res Inst, CIBERobn Physiopathol Obes & Nutr, Madrid, Spain.
C3 University of Navarra; CIBER - Centro de Investigacion Biomedica en Red;
   CIBEROBN
RP Martínez, JA (corresponding author), Univ Navarra, Dept Nutr Food Sci & Physiol, Ctr Nutr Res, C Irunlarrea 1, Pamplona 31008, Spain.
EM jalfmtz@unav.es
RI de la Garza, Ana Laura/GLU-6360-2022; Milagro, Fermin/F-2315-2015;
   Aranburu, Usune/ABG-9510-2020; Martínez, J./K-8709-2014
OI Milagro, Fermin I./0000-0002-3228-9916; Etxeberria,
   Usune/0000-0001-9554-0015
FU Linea Especial about Nutrition, Obesity and Health (University of
   Navarra, Spain); CIBERobn Physiopathology of Obesity and Nutrition;
   University of Navarra; Department of Education, Language policy and
   Culture from the Government of the Basque Country
FX The authors wish to acknowledge Linea Especial about Nutrition, Obesity
   and Health (University of Navarra LE/97, Spain) and CIBERobn
   Physiopathology of Obesity and Nutrition for the financial support. The
   authors also wish to thank Asociacion de Amigos from University of
   Navarra for the predoctoral grant given to A.L. de la Garza and the
   Department of Education, Language policy and Culture from the Government
   of the Basque Country for the predoctoral grant given to U. Etxeberria.
CR Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637
   Alves N. E. G., 2012, The Open Nutraceuticals Journal, V5, P193, DOI DOI 10.2174/1876396001205010193
   [Anonymous], 2015, OB OV
   Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x
   González-Castejón M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004
   Hoey H, 2014, P NUTR SOC, V73, P519, DOI 10.1017/S0029665114000652
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI [10.1002/mnfr.200890019, 10.1002/mnfr.200700393]
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   de la Garza AL, 2014, FOOD FUNCT, V5, P2120, DOI [10.1039/C4FO00154K, 10.1039/c4fo00154k]
   LECLERCQMEYER V, 1985, ENDOCRINOLOGY, V116, P1168, DOI 10.1210/endo-116-3-1168
   Lomba A, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-60
   Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Öner-Iyidogan Y, 2013, J PHYSIOL BIOCHEM, V69, P677, DOI 10.1007/s13105-013-0244-9
   Pu P, 2012, ARCH BIOCHEM BIOPHYS, V518, P61, DOI 10.1016/j.abb.2011.11.026
   TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152
   Torres-Leal FL, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-62
   van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107
   Vasudeva N, 2012, CHIN J INTEGR MED, V18, P473, DOI 10.1007/s11655-012-1120-0
   Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x
   Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123
NR 26
TC 7
Z9 7
U1 0
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1934-578X
EI 1555-9475
J9 NAT PROD COMMUN
JI Nat. Prod. Commun.
PD AUG
PY 2015
VL 10
IS 8
BP 1417
EP 1420
PG 4
WC Chemistry, Medicinal; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology
GA CO3XY
UT WOS:000359095800026
PM 26434131
DA 2025-04-28
ER

PT J
AU Otake, T
   Fukumoto, J
   Abe, M
   Takemura, S
   Mihn, PN
   Mizoue, T
   Kiyohara, C
AF Otake, Toshie
   Fukumoto, Jin
   Abe, Masao
   Takemura, Shigeki
   Pham Ngoc Mihn
   Mizoue, Tetsuya
   Kiyohara, Chikako
TI Linking lifestyle factors and insulin resistance, based on fasting
   plasma insulin and HOMA-IR in middle-aged Japanese men: A
   cross-sectional study
SO SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
LA English
DT Article
DE Insulin resistance (IR); homeostasis model assessment-estimated insulin
   resistance (HOMA-IR); fasting plasma insulin; lifestyle; obesity;
   alcohol; physical activity; coffee; green tea
ID HOMEOSTASIS MODEL ASSESSMENT; RANDOMIZED CONTROLLED-TRIAL;
   ALCOHOL-CONSUMPTION; CARDIOVASCULAR-DISEASE; GLUCOSE-METABOLISM; TEA
   CONSUMPTION; GLOBAL BURDEN; SENSITIVITY; POPULATION; SMOKING
AB Objective. Insulin resistance (IR) is regarded as one of the earliest features of many metabolic diseases, and major efforts are aimed at improving insulin function to confront this issue. The aim of this study was to investigate the relationship of body mass index (BMI), cigarette smoking, alcohol intake, physical activity, green tea and coffee consumption to IR. Methods. We performed a cross-sectional study of 1542 male self defense officials. IR was defined as the highest quartile of the fasting plasma insulin (>= 50 pmol/L) or the homeostasis model assessment-estimated IR (HOMA-IR >= 1.81). An unconditional logistic model was used to estimate the odds ratio (OR) and 95% confidence interval (CI) for the association between IR and influential factors. Stratified analysis by obesity status (BMI < 25 kg/m(2), non-obese; >= 25 kg/m(2), obese) was performed. Results. IR was significantly positively related to BMI and glucose tolerance, negatively related to alcohol use. Independent of obesity status, significant trends were observed between IR and alcohol use. Drinking 30 mL or more of ethanol per day reduced IR by less than 40%. Strong physical activity was associated with decreased risk of IR based on fasting plasma insulin only in the obese. Coffee consumption was inversely associated with the risk of IR based on HOMA-IR in the non-obese group. Conclusion. Higher coffee consumption may be protective against IR among only the non-obese. Further studies are warranted to examine the effect modification of the obesity status on the coffee-IR association.
C1 [Otake, Toshie; Abe, Masao] Self Def Forces Fukuoka Hosp, Kasuga, Fukuoka, Japan.
   [Otake, Toshie; Fukumoto, Jin; Abe, Masao; Kiyohara, Chikako] Kyushu Univ, Grad Sch Med Sci, Dept Prevent Med, Higashi Ku, Fukuoka 8128582, Japan.
   [Fukumoto, Jin; Takemura, Shigeki] Wakayama Med Univ, Sch Med, Dept Hyg, Wakayama, Japan.
   [Pham Ngoc Mihn; Mizoue, Tetsuya] Int Med Ctr Japan, Res Inst, Dept Epidemiol & Int Hlth, Shinjuku Ku, Tokyo, Japan.
C3 Kyushu University; Wakayama Medical University; Japan Institute for
   Health Security (JIHS); National Center for Global Health & Medicine -
   Japan
RP Kiyohara, C (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Prevent Med, Higashi Ku, Fukuoka 8128582, Japan.
EM chikako@phealth.med.kyushu-u.ac.jp
OI Kiyohara, Chikako/0000-0002-8825-9281
CR AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011
   Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320
   Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57
   Carrieri P, 2012, HEPATOLOGY, V56, P2010, DOI 10.1002/hep.25813
   Das UN, 2002, PROSTAG LEUKOTR ESS, V67, P1, DOI 10.1054/plef.2002.0374
   Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878
   ELIASSON B, 1994, ARTERIOSCLER THROMB, V14, P1946, DOI 10.1161/01.ATV.14.12.1946
   Esteghamati A, 2009, PREV MED, V49, P402, DOI 10.1016/j.ypmed.2009.09.005
   Fueki Y, 2007, CLIN CHIM ACTA, V382, P71, DOI 10.1016/j.cca.2007.03.027
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Fukumoto J, 2008, CANCER SCI, V99, P781, DOI 10.1111/j.1349-7006.2008.00745.x
   Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177
   Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809
   Kawamoto R, 2009, TOHOKU J EXP MED, V218, P331, DOI 10.1620/tjem.218.331
   Kiechl S, 1996, BRIT MED J, V313, P1040
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Komiya H, 2006, TOHOKU J EXP MED, V208, P123, DOI 10.1620/tjem.208.123
   Kono S, 1999, JPN J CANCER RES, V90, P805, DOI 10.1111/j.1349-7006.1999.tb00819.x
   Lazarus R, 1997, AM J EPIDEMIOL, V145, P909, DOI 10.1093/oxfordjournals.aje.a009050
   Lee KY, 2002, J NUTR SCI VITAMINOL, V48, P467, DOI 10.3177/jnsv.48.467
   Lee S, 2006, J KOREAN MED SCI, V21, P695
   Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191
   MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Perry IJ, 2002, P NUTR SOC, V61, P543, DOI 10.1079/PNS2002196
   Radikova Z, 2006, EXP CLIN ENDOCR DIAB, V114, P249, DOI 10.1055/s-2006-924233
   Reaven G, 2005, PANMINERVA MED, V47, P201
   Rebello SA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-61
   Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7
   Riegelman R. K., 2004, INTERPRETATION STUDY, P50
   Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X
   Taniyama M, 2008, NIPPON RINSHO, V66, P208
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wise S, 2006, DIABETIC MED, V23, P510, DOI 10.1111/j.1464-5491.2006.01836.x
   World Health Organization International Diabetes Federation, 2006, Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation
   Yang JY, 2012, DIABETES, V61, P1888, DOI 10.2337/db11-1393
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
NR 41
TC 6
Z9 6
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0036-5513
EI 1502-7686
J9 SCAND J CLIN LAB INV
JI Scand. J. Clin. Lab. Invest.
PD SEP
PY 2014
VL 74
IS 6
BP 536
EP 545
DI 10.3109/00365513.2014.913304
PG 10
WC Medical Laboratory Technology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology; Research & Experimental Medicine
GA AP4OE
UT WOS:000342056100011
PM 24830843
DA 2025-04-28
ER

PT J
AU Klebanoff, MA
   Keim, SA
AF Klebanoff, Mark A.
   Keim, Sarah A.
TI Maternal Serum Paraxanthine During Pregnancy and Offspring Body Mass
   Index at Ages 4 and 7 Years
SO EPIDEMIOLOGY
LA English
DT Article
ID CAFFEINE CONSUMPTION; UNITED-STATES; RISK; METABOLITES; EXPOSURE;
   SMOKING; OBESITY; TRENDS; WOMEN
AB Background: Obesity affects 18% of U. S. children. In a recent report, maternal consumption of >= 150 mg of caffeine per day during pregnancy was associated with increased odds for obesity in the offspring (odds ratio = 2.1 [95% confidence interval = 1.2-3.5]). If this association was causal, a considerable fraction of childhood obesity might be prevented by reduction of caffeine intake in pregnancy.
   Methods: We studied 1986 mother-child pairs who were controls from a case-control study of caffeine metabolites and spontaneous abortion nested within the Collaborative Perinatal Project. Women were pregnant during 1959-1966, and children were followed with visits at 48 and/or 84 months of age, when height and weight were measured according to a standardized protocol. Serum was drawn at <20 and >= 26 weeks' gestation and assayed for paraxanthine (caffeine's primary metabolite) by high-performance liquid chromatography. Relative risks of obesity (body mass index >= 95th percentile for age and sex) were estimated by log-binomial or Poisson regression and adjusted for maternal age, race, education, smoking, prepregnant weight, diabetes in pregnancy, and gestational age at blood draw.
   Results: Obesity prevalence was 11.7% at 48 months and 6.5% at 84 months. Associations of maternal serum paraxanthine and child obesity were nonlinear, and adjustment reduced the magnitude of all associations. The maximum relative risk (approximately 1.4) was for the association of paraxanthine drawn at <20 weeks with obesity at ages 48 and 84 months.
   Conclusion: This study does not support an increased risk of childhood obesity with increasing maternal caffeine consumption during pregnancy.
C1 Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA.
   Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens
   Hospital; Research Institute at Nationwide Children's Hospital;
   University System of Ohio; Ohio State University
RP Klebanoff, MA (corresponding author), Nationwide Childrens Hosp, Res Bldg 3,WB 5231,700 Childrens Dr, Columbus, OH 43215 USA.
EM mark.klebanoff@nationwidechildrens.org
RI Keim, Sarah/F-8929-2013
OI Keim, Sarah/0000-0003-3490-3649
CR ALDRIDGE A, 1981, SEMIN PERINATOL, V5, P310
   [Anonymous], 1985, MALFORMATIONS CHILDR
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Branum AM, 2011, AM J EPIDEMIOL, V174, P1159, DOI 10.1093/aje/kwr250
   Buscariollo DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087547
   Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841
   Diggle P, 1995, OXFORD STAT SCI SERI
   FDA, MED MY HOM CAFF YOUR
   Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Grosso LM, 2008, ANN EPIDEMIOL, V18, P172, DOI 10.1016/j.annepidem.2007.11.005
   Grosso LM, 2006, AM J EPIDEMIOL, V163, P1035, DOI 10.1093/aje/kwj125
   Hediger ML, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e60
   Hinkle S, 2014, BJOG, DOI 10.111/1471-0528.12930
   Hoyt AT, 2014, MATERN CHILD HLTH J, V18, P1540, DOI 10.1007/s10995-013-1397-4
   Klebanoff MA, 1999, NEW ENGL J MED, V341, P1639, DOI 10.1056/NEJM199911253412202
   Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32
   Klebanoff MA, 1998, ANN EPIDEMIOL, V8, P107, DOI 10.1016/S1047-2797(97)00125-7
   Lassmann FM, 1980, EARLY CORRELATES SPE
   LELO A, 1986, CLIN PHARMACOL THER, V39, P54, DOI 10.1038/clpt.1986.10
   Leviton A, 2002, FOOD CHEM TOXICOL, V40, P1271, DOI 10.1016/S0278-6915(02)00092-3
   Li D-K, 2014, SOC PED PER EP RES S
   Martin Joyce A, 2007, Natl Vital Stat Rep, V56, P1
   McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074
   Niswander KR, 1972, DHEW PUBLICATION
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   PARSONS WD, 1978, CLIN PHARMACOL THER, V24, P40
   Peck JD, 2010, FOOD CHEM TOXICOL, V48, P2549, DOI 10.1016/j.fct.2010.06.019
   Ribas-Fitó N, 2006, INT J EPIDEMIOL, V35, P853, DOI 10.1093/ije/dyl067
   Signorello LB, 2004, EPIDEMIOLOGY, V15, P229, DOI 10.1097/01.ede.0000112221.24237.0c
   Tong VT, 2013, MMWR SURVEILL SUMM, V62, P1
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 32
TC 10
Z9 12
U1 0
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1044-3983
EI 1531-5487
J9 EPIDEMIOLOGY
JI Epidemiology
PD MAR
PY 2015
VL 26
IS 2
BP 185
EP 191
DI 10.1097/EDE.0000000000000220
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA CB1PO
UT WOS:000349400300024
PM 25643099
OA Bronze
DA 2025-04-28
ER

PT J
AU Choi, JY
   Kim, YJ
   Ryu, R
   Cho, SJ
   Kwon, EY
   Choi, MS
AF Choi, Ji-Young
   Kim, Ye Jin
   Ryu, Ri
   Cho, Su-Jung
   Kwon, Eun-Young
   Choi, Myung-Sook
TI Effect of Green Tea Extract on Systemic Metabolic Homeostasis in
   Diet-Induced Obese Mice Determined via RNA-Seq Transcriptome Profiles
SO NUTRIENTS
LA English
DT Article
DE energy expenditure; green tea extract; obesity; RNA-seq; transcriptome
ID ACTIVATED PROTEIN-KINASE; AMINO-ACID CATABOLISM; INSULIN-RESISTANCE;
   ADIPOSE-TISSUE; ENERGY-EXPENDITURE; FAT OXIDATION; CAFFEINE; LIVER;
   (-)-EPIGALLOCATECHIN-3-GALLATE; SUPPLEMENTATION
AB Green tea (GT) has various health effects, including anti-obesity properties. However, the multiple molecular mechanisms of the effects have not been fully determined. The aim of this study was to elucidate the anti-obesity effects of GT via the analysis of its metabolic and transcriptional responses based on RNA-seq profiles. C57BL/6J mice were fed a normal, high-fat (60% energy as fat), or high-fat + 0.25% (w/w) GT diet for 12 weeks. The GT extract ameliorated obesity, hepatic steatosis, dyslipidemia, and insulin resistance in diet-induced obesity (DIO) mice. GT supplementation resulted in body weight gain reduction than mice fed high-fat through enhanced energy expenditure, and reduced adiposity. The transcriptome profiles of epididymal white adipose tissue (eWAT) suggested that GT augments transcriptional responses to the degradation of branched chain amino acids (BCAAs), as well as AMP-activated protein kinase (AMPK) signaling, which suggests enhanced energy homeostasis. Our findings provide some significant insights into the effects of GT for the prevention of obesity and its comorbidities. We demonstrated that the GT extract contributed to the regulation of systemic metabolic homeostasis via transcriptional responses to not only lipid and glucose metabolism, but also amino acid metabolism via BCAA degradation in the adipose tissue of DIO mice.
C1 [Choi, Ji-Young; Kim, Ye Jin; Ryu, Ri; Cho, Su-Jung; Kwon, Eun-Young; Choi, Myung-Sook] Kyungpook Natl Univ, Dept Food Sci & Nutr, 1370 Sankyuk Dong, Daegu 702701, South Korea.
   [Choi, Ji-Young; Kim, Ye Jin; Ryu, Ri; Cho, Su-Jung; Kwon, Eun-Young; Choi, Myung-Sook] Kyungpook Natl Univ, Ctr Food & Nutr Genom Res, 1370 Sankyuk Dong, Daegu 702701, South Korea.
C3 Kyungpook National University (KNU); Kyungpook National University (KNU)
RP Choi, MS (corresponding author), Kyungpook Natl Univ, Dept Food Sci & Nutr, 1370 Sankyuk Dong, Daegu 702701, South Korea.; Choi, MS (corresponding author), Kyungpook Natl Univ, Ctr Food & Nutr Genom Res, 1370 Sankyuk Dong, Daegu 702701, South Korea.
EM jyjy31@hanmail.net; freewilly59@hanmail.net; sangsang0119@gmail.com;
   chocrystalhihi@hanmail.net; savage20@naver.com; mschoi@knu.ac.kr
OI ri, ryu/0000-0003-3414-8399
FU Bio-Synergy Research Project of the Ministry of Science, ICT and Future
   Planning through the National Research Foundation of Korea
   [NRF-2012M3A9C4048818]; Science Research Center Project of the Ministry
   of Science, ICT and Future Planning through the National Research
   Foundation of Korea [NRF-2015R1A5A6001906]
FX This work was supported by the Bio-Synergy Research Project
   (NRF-2012M3A9C4048818) and the Science Research Center Project
   (NRF-2015R1A5A6001906) of the Ministry of Science, ICT and Future
   Planning through the National Research Foundation of Korea.
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Do GM, 2012, MOL NUTR FOOD RES, V56, P1282, DOI 10.1002/mnfr.201200067
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Forester SC, 2011, MOL NUTR FOOD RES, V55, P844, DOI 10.1002/mnfr.201000641
   Freudenberg A, 2013, AMINO ACIDS, V44, P519, DOI 10.1007/s00726-012-1363-2
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001
   Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428
   Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   Lian K, 2015, DIABETES, V64, P49, DOI 10.2337/db14-0312
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151
   Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171
   Mann DA, 2002, GUT, V50, P891, DOI 10.1136/gut.50.6.891
   MARKWELL MA, 1973, J BIOL CHEM, V248, P3426
   McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   OCHOA S, 1955, METHOD ENZYMOL, V1, P735, DOI 10.1016/0076-6879(55)01128-2
   Park HJ, 2011, J NUTR BIOCHEM, V22, P393, DOI 10.1016/j.jnutbio.2010.03.009
   Peng XL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06251
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Santamarina AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141227
   SEIFTER S, 1950, ARCH BIOCHEM, V25, P191
   SHAPIRO DJ, 1974, BIOCHIM BIOPHYS ACTA, V370, P369, DOI 10.1016/0005-2744(74)90098-9
   She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007
   Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Zhang ZF, 2010, PHYTOMEDICINE, V17, P14, DOI 10.1016/j.phymed.2009.09.007
NR 42
TC 17
Z9 20
U1 1
U2 24
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2016
VL 8
IS 10
AR 640
DI 10.3390/nu8100640
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA ED2HT
UT WOS:000388665300057
PM 27754422
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Serrano, J
   Casanova-Martí, A
   Gual, A
   Pérez-Vendrell, AM
   Blay, MT
   Terra, X
   Ardévol, A
   Pinent, M
AF Serrano, Joan
   Casanova-Marti, Angela
   Gual, Andreu
   Maria Perez-Vendrell, Anna
   Teresa Blay, M.
   Terra, Ximena
   Ardevol, Anna
   Pinent, Montserrat
TI A specific dose of grape seed-derived proanthocyanidins to inhibit body
   weight gain limits food intake and increases energy expenditure in rats
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Proanthocyanidin; Obesity; Food intake; Energy expenditure; Subcutaneous
   adipose tissue
ID GLUCAGON-LIKE PEPTIDE-1; DIETARY POLYPHENOLS; ADIPOSE-TISSUE; FAT
   OXIDATION; GREEN TEA; PROCYANIDINS; EXTRACTS; RICH; COMBINATION;
   CAFFEINE
AB Several studies have suggested that flavanols may have antiobesity effects; however, those effects clearly depend on the experimental conditions. In a previous study, we found that a single acute dose of grape seed proanthocyanidin extract (GSPE) has satiating effects. We therefore hypothesise that satiating doses of GSPE could be used to reduce body weight gain, and our present objective was to define the most effective dose.
   We assayed two GSPE doses in aged male Wistar rats. First we performed a subchronic (8-day) treatment by intragastric administration, which was repeated after a washout period. We measured body weight, energy intake and faeces composition; we performed indirect calorimetry; and we analysed the mRNA expression of genes involved in lipid metabolism to determine the target tissue for the GSPE.
   We observed that 0.5 g GSPE/kg BW significantly reduced food intake and thus the amount of energy absorbed. This dosage also increased lipid oxidation in subcutaneous adipose tissue, thus causing a higher total energy expenditure. These combined effects caused a decrease in body weight. Conversely, 1 g GSPE/kg BW, which also reduced energy absorption after the first treatment, had a rebound effect on body weight gain which resulted in a lower response to the proanthocyanidin extract. That is, after the second treatment, the GSPE did not reduce the energy absorbed or modify energy expenditure and body weight.
   GSPE at a dose of 0.5 g/kg can reduce body weight by limiting food intake and activating energy expenditure in subcutaneous adipose tissue.
C1 [Serrano, Joan; Casanova-Marti, Angela; Gual, Andreu; Teresa Blay, M.; Terra, Ximena; Ardevol, Anna; Pinent, Montserrat] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, C Marcel Li Domingo 1, E-43007 Tarragona, Spain.
   [Maria Perez-Vendrell, Anna] IRTA, Monogastr Nutr Ctr Mas de Bover, Ctra Reus El Morell Km 3-8, Constanti 43120, Spain.
C3 Universitat Rovira i Virgili; IRTA
RP Ardévol, A (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, C Marcel Li Domingo 1, E-43007 Tarragona, Spain.
EM anna.ardevol@urv.cat
RI Ardévol, Anna/AAO-6194-2021; Pinent, Montserrat/ABE-6178-2021;
   Pérez-Vendrell, Anna/J-8677-2017; Blay, M. Teresa/B-1680-2009; Terra,
   Ximena/K-3918-2014
OI Serrano, Joan/0000-0001-6002-116X; Blay, M. Teresa/0000-0002-6256-9847;
   Ardevol, Anna/0000-0003-0156-7538; Terra, Ximena/0000-0003-1043-5844;
   Gual-Grau, Andreu/0000-0002-8901-3582
FU Spanish government [AGL2014-55347-R]; Universitat Rovira i Virgili;
   Government of Catalonia
FX We would like to express our thanks to Niurka Llopiz for her technical
   support. We also thank the Technological Center of Nutrition and Health
   for the use of their animal facilities. This work has been supported by
   a Grant (AGL2014-55347-R) from the Spanish government. Angela Casanova
   received a grant for Ph.D. students from Universitat Rovira i Virgili.
   Joan Serrano received a pre-doctoral fellowship from the Government of
   Catalonia. Montserrat Pinent is a Serra Hunter fellow.
CR Ardévol A, 2013, FOOD CHEM, V141, P160, DOI 10.1016/j.foodchem.2013.02.104
   Assaad H, 2014, FRONT BIOSCI-LANDMRK, V19, P967, DOI 10.2741/4261
   Baiges I, 2010, MOL CELL PROTEOMICS, V9, P1499, DOI 10.1074/mcp.M000055-MCP201
   Bao L, 2014, FOOD FUNCT, V5, P1872, DOI 10.1039/c4fo00340c
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bladé C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476
   Caimari A, 2013, INT J OBESITY, V37, P576, DOI 10.1038/ijo.2012.75
   Casanova E, 2014, J NUTR BIOCHEM, V25, P1003, DOI 10.1016/j.jnutbio.2014.05.003
   Crescenti A, 2015, J NUTR BIOCHEM, V26, P912, DOI 10.1016/j.jnutbio.2015.03.003
   Da-Silva WS, 2007, DIABETES, V56, P767, DOI 10.2337/db06-1488
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Freedland Eric S, 2004, Nutr Metab (Lond), V1, P12, DOI 10.1186/1743-7075-1-12
   Gonçalves R, 2010, J AGR FOOD CHEM, V58, P11924, DOI 10.1021/jf1023356
   Gonçalves R, 2010, J AGR FOOD CHEM, V58, P11901, DOI 10.1021/jf103026x
   González-Abuín N, 2014, FOOD FUNCT, V5, P2357, DOI [10.1039/C4FO00447G, 10.1039/c4fo00447g]
   González-Abuín N, 2014, J AGR FOOD CHEM, V62, P1066, DOI 10.1021/jf405239p
   Gruendel S, 2006, J NUTR, V136, P1533, DOI 10.1093/jn/136.6.1533
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Salvadó MJ, 2015, FOOD FUNCT, V6, P1053, DOI 10.1039/c4fo01035c
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Landete JM, 2012, CRIT REV FOOD SCI, V52, P936, DOI 10.1080/10408398.2010.513779
   Lee YA, 2007, J NUTR SCI VITAMINOL, V53, P287, DOI 10.3177/jnsv.53.287
   Margalef M, 2015, J NUTR BIOCHEM, V26, P987, DOI 10.1016/j.jnutbio.2015.04.006
   McDougall GJ, 2005, BIOFACTORS, V23, P189, DOI 10.1002/biof.5520230403
   Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Pinent M, 2017, CRIT REV FOOD SCI, V57, P326, DOI 10.1080/10408398.2013.871221
   Quiñones M, 2013, FOOD RES INT, V51, P587, DOI 10.1016/j.foodres.2013.01.023
   Rondanelli M, 2013, J AM COLL NUTR, V32, P41, DOI 10.1080/07315724.2013.767667
   Serrano J, 2016, FOOD FUNCT, V7, P483, DOI [10.1039/C5FO00892A, 10.1039/c5fo00892a]
   Soares S, 2017, CRIT REV FOOD SCI, V57, P937, DOI 10.1080/10408398.2014.946468
   TEBIB K, 1994, ENZYME PROTEIN, V48, P51, DOI 10.1159/000474969
   Tebib K, 1996, NUTR RES, V16, P105, DOI 10.1016/0271-5317(95)02064-0
   Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697
   Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3
   Yilmazer-Musa M, 2012, J AGR FOOD CHEM, V60, P8924, DOI 10.1021/jf301147n
NR 37
TC 41
Z9 43
U1 1
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN
PY 2017
VL 56
IS 4
BP 1629
EP 1636
DI 10.1007/s00394-016-1209-x
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EX7ZU
UT WOS:000403469100022
PM 27039093
DA 2025-04-28
ER

PT J
AU Marty, L
   Evans, R
   Sheen, F
   Humphreys, G
   Jones, A
   Boyland, E
   Robinson, E
AF Marty, Lucile
   Evans, Rebecca
   Sheen, Florence
   Humphreys, Gabrielle
   Jones, Andrew
   Boyland, Emma
   Robinson, Eric
TI The energy and nutritional content of snacks sold at supermarkets and
   coffee shops in the UK
SO JOURNAL OF HUMAN NUTRITION AND DIETETICS
LA English
DT Article
DE coffee shop; energy content; nutritional quality; snacking; supermarket
ID DIETARY-INTAKE; OBESITY; MEAL; BEHAVIORS; DENSITY; COSTS
AB Background Snacking is associated with a higher daily energy intake and dietary guidelines recommend snacks of no more than 200 kcal for adults and 100 kcal for children. The present study examines the energy content, nutritional quality and price of single-serving snack food products sold by major supermarket and coffee shop chains in the UK.
   Methods Energy content, nutritional content and price of single-serving snack products were recorded in 2019 via the websites of 14 major chains (seven supermarkets; seven coffee shops).
   Results The mean energy content of all eligible snack products (n = 2283) was 186 kcal [95% confidence interval (CI) = 182-190]. The mean energy content of the snack products sold at coffee shops (n = 379; 282 kcal [95% CI = 269-295]) was significantly higher than the energy content of the snack products sold at supermarkets (n = 1904; 167 kcal [95% CI = 164-170]). Seventy nine % of supermarket snacks exceeded energy recommendations for children and 32% for adults. In coffee shops, 91% exceeded recommendations for children and 73% for adults. Forty one % of snacks were high in fat, 42% were high in saturated fat, 39% were high in sugar and 7% were high in salt. Cheaper snack products were more likely to be of lower nutritional quality.
   Conclusions The high proportion of snack products that do not meet public health recommendations for energy content may contribute to the association between snacking and increased energy intake. Public health measures to increase the availability and reduce the price of snack products that meet public health energy content recommendations may reduce population-level obesity.
C1 [Marty, Lucile; Evans, Rebecca; Sheen, Florence; Humphreys, Gabrielle; Jones, Andrew; Boyland, Emma; Robinson, Eric] Univ Liverpool, Dept Psychol, Eleanor Rathbone Bldg,Bedford St South, Liverpool L69 7ZA, Merseyside, England.
C3 University of Liverpool
RP Marty, L; Robinson, E (corresponding author), Univ Liverpool, Dept Psychol, Eleanor Rathbone Bldg,Bedford St South, Liverpool L69 7ZA, Merseyside, England.
EM lucile.marty@liv.ac.uk; eric.robinson@liv.ac.uk
RI Jones, Andy/ABB-9742-2021; Humphreys, Gabrielle/JFJ-8776-2023; Sheen,
   Florence/L-2486-2019
OI Sheen, Florence/0000-0001-6256-4395; Jones, Andrew/0000-0001-5951-889X;
   Robinson, Eric/0000-0003-3586-5533; Boyland, Emma/0000-0001-8384-4994;
   Humphreys, Gabrielle/0000-0002-0762-7864; Evans,
   Rebecca/0000-0001-8894-5938
CR Adams J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0210-8
   Amies-Cull B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1417
   [Anonymous], 2020, Public Health England Beyond the data: understanding the impact of Covid 19 on BAME groups
   [Anonymous], 2015, Sugar Reduction: from evidence to action
   [Anonymous], 2017, Salt Reduction Targets for 2017
   [Anonymous], 2018, Sugar reduction and wider reformulation programme: progress report towards 5% and next steps
   Askew K., 2019, FOOD NAVIGATOR
   Casazza K, 2015, CRIT REV FOOD SCI, V55, P2014, DOI 10.1080/10408398.2014.922044
   Chamontin A, 2003, APPETITE, V41, P21, DOI 10.1016/S0195-6663(03)00036-9
   Department of Health, 2016, Guide to creating a front of pack (FoP) nutrition label for pre-packed products sold through retail outlets
   Drewnowski A, 2005, J NUTR, V135, P900, DOI 10.1093/jn/135.4.900
   Drewnowski A, 2004, AM J CLIN NUTR, V79, P6
   Duffey KJ, 2013, EUR J CLIN NUTR, V67, P868, DOI 10.1038/ejcn.2013.60
   French SA, 2003, J NUTR, V133, p841S, DOI 10.1093/jn/133.3.841S
   Green H., 2017, Journal of Nutrition & Intermediary Metabolism, V9, P1, DOI 10.1016/j.jnim.2017.07.001
   Hassen WS, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0336-z
   Hollands GJ, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012573.pub3
   Jumpertz R, 2013, OBESITY, V21, P164, DOI 10.1002/oby.20185
   Kant AK, 2018, PHYSIOL BEHAV, V193, P270, DOI 10.1016/j.physbeh.2018.03.022
   Kant AK, 2015, J ACAD NUTR DIET, V115, P50, DOI 10.1016/j.jand.2014.06.354
   Kantar Worldpanel, 2019, GROCERY MARKET SHARE
   Kerver JM, 2006, J AM DIET ASSOC, V106, P46, DOI 10.1016/j.jada.2005.09.045
   Larson NI, 2016, J NUTR, V146, P1348, DOI 10.3945/jn.116.230334
   Maillot M, 2007, J NUTR, V137, P1815, DOI 10.1093/jn/137.7.1815
   Marshall D, 2003, FOOD QUAL PREFER, V14, P53, DOI 10.1016/S0950-3293(02)00015-0
   Marty L, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-0922-2
   Muc M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029679
   Murakami K, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0283-0
   Murakami K, 2016, BRIT J NUTR, V116, P1479, DOI 10.1017/S0007114516003573
   Ng M, 2014, LANCET, V384, P746
   Ovaskainen ML, 2006, EUR J CLIN NUTR, V60, P494, DOI 10.1038/sj.ejcn.1602343
   Piernas C, 2010, J NUTR, V140, P325, DOI 10.3945/jn.109.112763
   Robinson E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7017-5
   Robinson E, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4982
   Statista, 2019, MARKET SHARE GROCERY
   Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Theis DRZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222773
   Vandevijvere S, 2015, B WORLD HEALTH ORGAN, V93, P446, DOI 10.2471/BLT.14.150565
   Wadhera D, 2012, APPETITE, V58, P882, DOI 10.1016/j.appet.2012.02.006
NR 40
TC 4
Z9 4
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0952-3871
EI 1365-277X
J9 J HUM NUTR DIET
JI J. Hum. Nutr. Diet.
PD DEC
PY 2021
VL 34
IS 6
BP 1035
EP 1041
DI 10.1111/jhn.12880
EA APR 2021
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA WX8YQ
UT WOS:000643743900001
PM 33899984
DA 2025-04-28
ER

PT J
AU Zhu, ZJ
   Lin, ZY
   Jiang, HR
   Jiang, Y
   Zhao, MM
   Liu, XL
AF Zhu, Zhenjun
   Lin, Zhongyi
   Jiang, Hongrui
   Jiang, Yi
   Zhao, Mouming
   Liu, Xiaoling
TI Hypolipidemic effect of Youcha in hyperlipidemia rats induced by
   high-fat diet
SO FOOD & FUNCTION
LA English
DT Article
ID INDUCED OBESITY; INSULIN-RESISTANCE; METABOLIC SYNDROME;
   LIPID-METABOLISM; GREEN TEA; MICE; ANTIOBESITY; CHITOSAN; ENZYMES;
   LIPASE
AB Youcha is a novel tea drink from the northeast of Guangxi. This study aimed to investigate the hypolipidemic properties of Youcha in high-fat induced hyperlipidemic Sprague-Dawley (SD) rats. After designing the model, rats were randomly divided into six groups (n = 10): normal diet (NMD) group, high-fat diet (HFD) group, Xuezhikang (120 mg kg(-1) d(-1)) (HFD+P) group and Youcha (150, 750 or 1500 mg kg(-1) d(-1)) (HFD+L, HFD+M or HFD+H) groups. Youcha comprises tea polyphenols (1.51 g per 100 g), caffeine (34.80 mg per 100 g) and other functional compounds. To evaluate the lipid-lowering effects of Youcha, weight of the body, liver and fat, fat index, lipid metabolism, antioxidant properties and liver damage indices were examined. In addition, the activities of some enzymes in serum and liver tissue were examined to preliminarily study their possible mechanism. The results reveal that Youcha tends to reduce body weight, liver weight, fat index, total cholesterol (TC) and triglyceride (TG) contents, low-density lipoprotein cholesterol (LDL-C), atherogenic index (AI), malondialdehyde (MDA), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and increase high-density lipoprotein cholesterol (HDL-C), superoxide dismutase (SOD) and glutathione peroxidase (GPx) relative to the HFD group. The hypolipidemic effect was partly due to the regulation of fatty acid synthetase (FAS) and lipase (LPS) rather than lipoprotein lipase (LPL) to decrease TG markedly. These findings suggest that Youcha could be potentially used to remedy hyperlipidemia and is hence worthy of promotion as a tea drink.
C1 [Zhu, Zhenjun; Lin, Zhongyi; Jiang, Hongrui; Jiang, Yi; Zhao, Mouming; Liu, Xiaoling] Guangxi Univ, Coll Light Ind & Food Engn, Nanning 530004, Peoples R China.
C3 Guangxi University
RP Zhao, MM; Liu, XL (corresponding author), Guangxi Univ, Coll Light Ind & Food Engn, Nanning 530004, Peoples R China.
EM 1106133912@qq.com; 769375931@qq.com; 349360402@qq.com; 847702770@qq.com;
   zmmgxu@gxu.edu.cn; 1083183501@qq.com
RI Zhao, Mouming/KIK-7150-2024; Zhu, Zhenjun/U-2726-2019
OI Zhu, Zhenjun/0000-0003-0807-4525
FU "Guangxi Distinctive Agricultural Products Deep Processing and Safety
   Control" Key Laboratory Project; "Bagui Scholars Distinguished
   Professor" Special Project
FX This study was supported by the grants received from the "Guangxi
   Distinctive Agricultural Products Deep Processing and Safety Control"
   Key Laboratory Project and the "Bagui Scholars Distinguished Professor"
   Special Project.
CR Ban SJ, 2012, FOOD CHEM TOXICOL, V50, P130, DOI 10.1016/j.fct.2011.10.051
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007
   Hsu CL, 2011, FOOD CHEM, V127, P1146, DOI 10.1016/j.foodchem.2011.01.116
   Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013
   Kwon SH, 2007, J MED FOOD, V10, P552, DOI 10.1089/jmf.2006.147
   Lee HS, 2015, J MED FOOD, V18, P1095, DOI 10.1089/jmf.2014.3259
   Lei YF, 2011, FOOD CHEM TOXICOL, V49, P3206, DOI 10.1016/j.fct.2011.08.027
   Mao M., 2015, INTERPRETATION PING
   Mendis S, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0486-3
   Moon MK, 2012, FOOD SCI BIOTECHNOL, V21, P317, DOI 10.1007/s10068-012-0042-0
   Mukthamba P, 2016, FOOD BIOSCI, V14, P1, DOI 10.1016/j.fbio.2016.01.002
   Naidu PB, 2016, MOL CELL ENDOCRINOL, V419, P139, DOI 10.1016/j.mce.2015.10.007
   Pan HT, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.31137
   Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005
   Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200
   Saravanan G, 2014, J SCI FOOD AGR, V94, P2972, DOI 10.1002/jsfa.6642
   Shen LL, 2011, MOL BIOL REP, V38, P553, DOI 10.1007/s11033-010-0140-0
   Suzuki Y, 2005, J JPN SOC FOOD SCI, V52, P167, DOI 10.3136/nskkk.52.167
   Woo MN, 2009, FOOD CHEM TOXICOL, V47, P2076, DOI 10.1016/j.fct.2009.05.041
   Xia XC, 2013, J TRADIT CHIN MED, V33, P518, DOI 10.1016/S0254-6272(13)60158-2
   Xiong S., 2014, CURRENT GUANGXI, P52
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yang KT, 2014, FOOD CHEM, V160, P148, DOI 10.1016/j.foodchem.2014.03.052
   Yang XL, 2010, FOOD CHEM TOXICOL, V48, P2374, DOI 10.1016/j.fct.2010.05.074
   Zeng L, 2015, FOOD FUNCT, V6, P2008, DOI 10.1039/c5fo00362h
   Zhang HL, 2011, INT IMMUNOPHARMACOL, V11, P457, DOI 10.1016/j.intimp.2010.12.015
   Zhang JL, 2008, NUTR RES, V28, P383, DOI 10.1016/j.nutres.2007.12.013
   Zhang JL, 2012, INT J BIOL MACROMOL, V51, P504, DOI 10.1016/j.ijbiomac.2012.06.018
NR 30
TC 25
Z9 27
U1 1
U2 64
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD APR 1
PY 2017
VL 8
IS 4
BP 1680
EP 1687
DI 10.1039/c7fo00089h
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA ES8JY
UT WOS:000399804500030
PM 28379241
DA 2025-04-28
ER

PT J
AU Tsai, CH
   Chiu, WC
   Yang, NC
   Ouyang, CM
   Yen, YH
AF Tsai, Ch-Huing
   Chiu, Wan-Chen
   Yang, Nae-Cherng
   Ouyang, Chung-Mei
   Yen, Yue-Horng
TI A novel green tea meal replacement formula for weight loss among obese
   individuals: a randomized controlled clinical trial
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE Green tea; meal replacement; weight loss; fat mass; blood lipid
ID FOOD PROVISION; REDUCTION; EXTRACT; CHOLESTEROL; CAFFEINE; RISK; RICH;
   FAT
AB Objective To assess the efficacy and safety of a green tea meal replacement formula product for the treatment of obesity.
   Design A 12-week clinical trial was performed, in which 120 (25 male, 95 female) healthy, overweight and obese persons were included (each of them occupy one-third of the whole population). The green tea formula was provided in the treatment group and normal diet was provided as control.
   Results More weight loss was found in the treatment group than the control (6.8 versus 2.3 kg; P<0.001). Also, the treatment group had a greater changes in total cholesterol (185.2 versus 215.2 mg/dl; P = 0.011) and low-density lipoprotein cholesterol (106.7 versus 127.6 mg/dl; P<0.005). Among completers only, the treatment group again lost more weight (6.8 kg; n = 54 versus 0.8 kg; n = 56; P = 0.001) and had a greater reduced total body fat mass (7.6%; n = 37 versus 0.5%; P = 0.005).
   Conclusions This green tea meal replacement formula contributes to the lower body weight and reduced low-density lipoprotein cholesterol level.
C1 [Tsai, Ch-Huing; Chiu, Wan-Chen; Yen, Yue-Horng] DaYeh Univ, Dept BioInd Technol, Changhua, Taiwan.
   [Yang, Nae-Cherng] Chung Chou Inst Technol, Dept Nutr & Hlth Sci, Changhua, Taiwan.
   [Ouyang, Chung-Mei] Natl Taiwan Univ Hosp, Dept Dietet, Taipei, Taiwan.
C3 Da Yeh University; National Taiwan University; National Taiwan
   University Hospital
RP Yen, YH (corresponding author), DaYeh Univ, Dept BioInd Technol, Changhua, Taiwan.
EM d9414002@yahoo.com.tw
RI Yang, Nae-Cherng/ADE-3580-2022
OI Ouyang, Chung-Mei/0000-0002-1377-772X
CR Allison D. B., 1997, Overweight and weight management: the health professional's guide to understanding and practice., P557
   Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661
   *AM DIET ASS, 1995, EXCH LISTS WEIGHT MA
   Anderson JW, 2001, OBES RES, V9, p326S, DOI 10.1038/oby.2001.138
   Bray GA, 1999, ENDOCR REV, V20, P805, DOI 10.1210/er.20.6.805
   DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320
   Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235
   DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017
   DHURANDHAR N, 2000, EC NEUROSCI, V2, P42
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   EDLENNEZIN L, 1993, TRUTH CONSEQUENCES H
   FROHLICH E D, 1988, Hypertension (Dallas), V11, p210A
   Heymsfield SB, 1996, AM J CLIN NUTR, V64, P478, DOI 10.1093/ajcn/64.3.478S
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   JEFFERY RW, 1993, J CONSULT CLIN PSYCH, V61, P1038, DOI 10.1037/0022-006X.61.6.1038
   LOHMAN JAB, 1988, EXPERIENTIA, V44, P666, DOI 10.1007/BF01941027
   Maron DJ, 2003, ARCH INTERN MED, V163, P1448, DOI 10.1001/archinte.163.12.1448
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Pan WH, 2008, OBES REV, V9, P22, DOI 10.1111/j.1467-789X.2007.00434.x
   PETERSON L, 1982, J APPL BEHAV ANAL, V15, P477, DOI 10.1901/jaba.1982.15-477
   RAZDAN A, 1997, BR J NUTR, V76, P87
   Subramanian S, 2009, CURR OPIN LIPIDOL, V20, P39, DOI 10.1097/MOL.0b013e32831bef8b
   Vinson JA, 1989, COMP HUMAN BIOAVAILA, P125
   Wing RR, 1996, INT J OBESITY, V20, P56
   Zhong LT, 2006, AM J CLIN NUTR, V84, P551, DOI 10.1093/ajcn/84.3.551
NR 25
TC 18
Z9 18
U1 0
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PY 2009
VL 60
SU 6
BP 151
EP 159
DI 10.1080/09637480903136667
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 545IB
UT WOS:000273724600014
PM 19736596
DA 2025-04-28
ER

PT J
AU Keaver, L
   Gilpin, S
   da Silva, JCF
   Buckley, C
   Foley-Nolan, C
AF Keaver, Laura
   Gilpin, Susannah
   da Silva, Joana Caldeira Fernandes
   Buckley, Claire
   Foley-Nolan, Cliodina
TI Energy drinks available in Ireland: a description of caffeine and sugar
   content
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Energy drinks; Sugar; Island of Ireland; Obesity
ID SWEETENED BEVERAGES; WEIGHT-GAIN; CONSUMPTION; CHILDREN
AB Objective: To describe the caffeine and sugar content of all energy drinks available on the island of Ireland.
   Design: Two retail outlets were selected from each of: multinational, convenience and discount stores in Northern Ireland and the Republic of Ireland, and all available single-serve energy drinks were purchased. The cross-sectional survey was conducted in February 2015 and brand name, price, volume, caffeine and sugar content were recorded for each product. Descriptive analysis was performed.
   Results: Seventy-eight products were identified on the island of Ireland (regular, n 59; diet/sugar-free/light, n 19). Caffeine and sugar content was in the range of 14-35 mg and 2.9-15.6 g per 100 ml, respectively. Mean caffeine content of 102.2mg per serving represents 25.6% of the maximum intake advised for adults by the European Food Safety Authority. Per serving, mean sugar content of regular energy drinks was 37 g. This exceeds WHO recommendations for maximum daily sugar intake of <5% of total energy intake (25 g for adults consuming 8368 kJ (2000 kcal) diet). If displaying front-of-pack labelling, fifty-seven of the fifty-nine regular energy drinks would receive a Food Standards Agency 'red' colour-coded label for sugar.
   Conclusions: Energy drinks are freely available on the island of Ireland and all products surveyed can be defined as highly caffeinated products. This has potential health issues particularly for children and adolescents where safe limits of caffeine have not been determined. Energy drinks surveyed also contained high levels of sugar and could potentially contribute to weight gain and adverse dental health effects.
C1 [Keaver, Laura] Inst Technol Sligo, Dept Life Sci, Ash Lane, Sligo, Sligo, Ireland.
   [Keaver, Laura; Gilpin, Susannah; da Silva, Joana Caldeira Fernandes; Foley-Nolan, Cliodina] Safefood, Little Isl, Cork, Ireland.
   [Gilpin, Susannah] Ulster Univ, Sch Biomed Sci, Coleraine, Londonderry, North Ireland.
   [Buckley, Claire] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Cork, Ireland.
C3 Atlantic Technological University (ATU); Ulster University; University
   College Cork
RP Keaver, L (corresponding author), Inst Technol Sligo, Dept Life Sci, Ash Lane, Sligo, Sligo, Ireland.; Keaver, L (corresponding author), Safefood, Little Isl, Cork, Ireland.
EM lmkeaver@eircom.net
CR Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   [Anonymous], REV HLTH EFFECTS STI
   [Anonymous], HLTH WEIGHT IR OB PO
   [Anonymous], IR U NUTR ALL 2011
   [Anonymous], GUIF CREAT FRONT PAC
   [Anonymous], NUTR REV S1
   [Anonymous], EU AD ACT PLAN CHILD
   [Anonymous], EFSA J
   Bedi N, 2014, INDIAN PEDIATR, V51, P529, DOI 10.1007/s13312-014-0441-9
   Breda JJ, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00134
   DeBoer MD, 2013, PEDIATRICS, V132, P413, DOI 10.1542/peds.2013-0570
   Hasselkvist A, 2010, SWED DENT J, V34, P187
   Layte R., 2011, Growing up in Ireland - National Longitudinal Study of Children: Overweight and Obesity among 9-year-olds'
   Li HG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034566
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Marshall TA, 2003, PEDIATRICS, V112, pE184, DOI 10.1542/peds.112.3.e184
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E7492
NR 17
TC 6
Z9 8
U1 0
U2 13
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JUN
PY 2017
VL 20
IS 9
BP 1534
EP 1539
DI 10.1017/S1368980017000362
PG 6
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA GJ9NZ
UT WOS:000435731200002
PM 28438229
OA Green Published, Green Submitted, Bronze
DA 2025-04-28
ER

PT J
AU Corrêa, VG
   Tureck, C
   Locateli, G
   Peralta, RM
   Koehnlein, EA
AF Correa, Vanesa Gesser
   Tureck, Camila
   Locateli, Gelvani
   Peralta, Rosane Marina
   Koehnlein, Eloa Angelica
TI Estimate of consumption of phenolic compounds by Brazilian population
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Article
DE Antioxidants; Flavonoids; Food consumption; Phenolic compounds
ID MAJOR FOOD SOURCES; TOTAL ANTIOXIDANT CAPACITY; DIETARY-INTAKE; TEA
   CONSUMPTION; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; POLYPHENOLS;
   VEGETABLES; CANCER; FRUITS
AB Objective
   Estimate the intake of phenolic compounds by the Brazilian population.
   Methods
   To estimate the average per capita food consumption, micro data from the National Dietary Survey and from the Household Budget Survey from 2008 to 2009 was analyzed. The phenolic content in food was estimated from the base of Phenol-Explorer. It was chosen according to compatibility and variety of food items and usual method of preparation.
   Results
   The Brazilian population consumed, on average, 460.15 mg/day of total phenolic compounds, derived mainly from beverages (48.9%), especially coffee and legumes (19.5%). Since this analysis of classes of phenolics it was possible to observe an intake of 314 mg/day of phenolic acids, 138.92 mg/day of flavonoids and 7.16 mg/ day of other kinds of phenolics. Regarding the variables studied this present study shows that those men who live in the countryside and in the northeastern region of the country had a higher consumption of phenolic compounds. Besides, consumption was higher by adults and the elderly, the medium income classes, the population with incomplete and complete primary education and those with adequate nutrition and also overweight status.
   Conclusion
   The intake of phenolic compounds can be considered low, especially where consumption of fruit and vegetables is insufficient. We can conclude that coffee and black beans were the best contributors to phenolic intake.
C1 [Correa, Vanesa Gesser; Tureck, Camila; Locateli, Gelvani; Koehnlein, Eloa Angelica] Univ Fed Fronteira Sul, Curso Nutr, BR-85770000 Realeza, PR, Brazil.
   [Peralta, Rosane Marina] Univ Estadual Maringa, Curso Bioquim, Dept Bioquim, Maringa, Parana, Brazil.
C3 Universidade Federal da Fronteira Sul; Universidade Estadual de Maringa
RP Koehnlein, EA (corresponding author), Univ Fed Fronteira Sul, Curso Nutr, R Edmundo Gaievski 1000,Rodovia PR 182,Km 466, BR-85770000 Realeza, PR, Brazil.
EM eloa.koehnlein@uffs.edu.br
RI Koehnlein, Eloá/ABC-4548-2020; PERALTA, ROSANE MARINA/J-3912-2016
OI PERALTA, ROSANE MARINA/0000-0001-5749-0723
CR Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x
   [Anonymous], 2014, GUIA ALIMENTAR POPUL
   [Anonymous], 2011, COORD TRAB REND PESQ
   [Anonymous], 2002, DIET NUTR PREV CHRON
   [Anonymous], 2017, Annex 3-03, P4
   Arab L, 2013, AM J CLIN NUTR, V98, p1651S, DOI 10.3945/ajcn.113.059345
   Arabbi PR, 2004, J AGR FOOD CHEM, V52, P1124, DOI 10.1021/jf0499525
   Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059
   Biesaga M, 2009, J CHROMATOGR A, V1216, P6620, DOI 10.1016/j.chroma.2009.07.066
   Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021
   Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244
   Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176
   Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a
   de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Debette S, 2008, ARTERIOSCL THROM VAS, V28, P353, DOI 10.1161/ATVBAHA.107.151928
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Hayashi M, 2009, NEUROPATHOLOGY, V29, P1, DOI 10.1111/j.1440-1789.2008.00888.x
   Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881
   Hervert-Hernández D, 2011, FOOD RES INT, V44, P1182, DOI 10.1016/j.foodres.2010.09.021
   Koehnlein EA, 2014, INT J FOOD SCI NUTR, V65, P293, DOI 10.3109/09637486.2013.879285
   Faller ALK, 2009, REV SAUDE PUBL, V43, P211, DOI 10.1590/S0034-89102009005000010
   Lee HS, 2013, J ACAD NUTR DIET, V113, P1194, DOI 10.1016/j.jand.2013.04.022
   McKay DL, 2015, FOOD CHEM, V168, P233, DOI 10.1016/j.foodchem.2014.07.062
   Mullen W, 2013, J AGR FOOD CHEM, V61, P5298, DOI 10.1021/jf4003126
   Murphy MM, 2012, J ACAD NUTR DIET, V112, P222, DOI 10.1016/j.jada.2011.08.044
   Nardini M, 2004, FOOD CHEM, V84, P137, DOI 10.1016/S0308-8146(03)00257-7
   Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024
   Nutritional Screening Initiative, 1992, INT MAN PROF CAR OLD
   Ordoñez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024
   Ovaskainen ML, 2008, J NUTR, V138, P562
   Pérez-Jiménez J, 2010, EUR J CLIN NUTR, V64, pS112, DOI 10.1038/ejcn.2010.221
   Pérez-Jiménez J, 2008, FOOD RES INT, V41, P274, DOI 10.1016/j.foodres.2007.12.004
   Pérez-Jiménez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Quiñones M, 2013, PHARMACOL RES, V68, P125, DOI 10.1016/j.phrs.2012.10.018
   Rostagno MA, 2011, ANAL CHIM ACTA, V685, P204, DOI 10.1016/j.aca.2010.11.031
   Rothwell JA, 2015, MOL NUTR FOOD RES, V59, P160, DOI 10.1002/mnfr.201400494
   Sawaya AL, 1996, AM J CLIN NUTR, V63, P491, DOI 10.1093/ajcn/63.4.491
   Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005
   Stea TH, 2008, EUR J NUTR, V47, P201, DOI 10.1007/s00394-008-0714-y
   Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092
   Tomata Y, 2012, AM J CLIN NUTR, V95, P732, DOI 10.3945/ajcn.111.023200
   Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008
   Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Zamora-Ros R, 2013, BRIT J NUTR, V110, P1500, DOI 10.1017/S0007114513000688
   Zamora-Ros R, 2013, BRIT J NUTR, V109, P1498, DOI 10.1017/S0007114512003273
NR 48
TC 30
Z9 33
U1 0
U2 21
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO
   ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
J9 REV NUTR
JI Rev. Nutr.
PD MAR-APR
PY 2015
VL 28
IS 2
BP 185
EP 196
DI 10.1590/1415-52732015000200007
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CG3EI
UT WOS:000353160500007
OA gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Ohta, Y
   Funayama, M
   Seino, H
   Sami, M
   Kanda, T
   Shoji, T
   Ohtake, Y
   Osada, K
AF Ohta, Yutaka
   Funayama, Makoto
   Seino, Hirotake
   Sami, Manabu
   Kanda, Tomomasa
   Shoji, Toshihiko
   Ohtake, Yasuyuki
   Osada, Kyoichi
TI Apple polyphenol improves lipid metabolism and insulin independence in
   obese rats
SO JOURNAL OF THE JAPANESE SOCIETY FOR FOOD SCIENCE AND TECHNOLOGY-NIPPON
   SHOKUHIN KAGAKU KOGAKU KAISHI
LA English
DT Article
DE apple; procyanidins; obesity; Zucker fatty rat; insulin resistance
ID GREEN TEA CATECHINS; DIET-INDUCED OBESITY; MASS-SPECTROMETRY;
   CHLOROGENIC ACID; GENE-EXPRESSION; LIQUID-CHROMATOGRAPHY;
   GLUCOSE-HOMEOSTASIS; CAFFEIC ACID; PROCYANIDINS; CHOLESTEROL
AB We evaluated the effects of apple polyphenol (AP), of which the major components are procyanidins, on obesity and glucose tolerance using Zucker fatty rats (fa/fa). In this study, Zucker fatty rats were fed diets containing 0.2% or 1.0% apple polyphenol for 12 weeks. Visceral fat weight and triglyceride levels in blood and liver were reduced by AP intake. Glucose and insulin levels in blood also decreased, and the amount of fatty acids excreted into feces increased in dose-dependent manner. Furthermore, suppression of fatty acid synthase gene expression in the liver and increase of adiponectin gene expression in white adipose tissues were observed. These results indicate that AP improves lipid metabolism and insulin resistance.
C1 Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 036, Japan.
   Asahi Brewery Co Ltd, Fundamental Res Labs, Ibaraki 302, Japan.
C3 Hirosaki University; Asahi Group Holdings Ltd.
RP Ohta, Y (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, 3 Bunkyo-cho, Hirosaki, Aomori 036, Japan.
EM yutaka.ohta@asahibeer.co.jp
OI Shoji, Toshihiko/0000-0003-4241-2129
CR AKAZOME Y, 2005, JPN PHARMACOL THER, V33, P893
   ALLAIN CC, 1974, CLIN CHEM, V20, P470
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   DROR Y, 1970, CLIN CHIM ACTA, V28, P291, DOI 10.1016/0009-8981(70)90093-8
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Feng WY, 2006, CURR DRUG METAB, V7, P755, DOI 10.2174/138920006778520552
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI [10.1161/01.CIR.0000111245.75752.C6, 10.1161/01.CIR.0000112379.88385.67]
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   JEEJEEBHOY KN, 1970, CLIN BIOCHEM, V3, P157, DOI 10.1016/S0009--912(0()70)80021--2
   Kanda T, 1998, BIOSCI BIOTECH BIOCH, V62, P1284, DOI 10.1271/bbb.62.1284
   Kao Y, 2000, AM J CLIN NUTR, V72, P1232
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Li RW, 2006, LIFE SCI, V79, P365, DOI 10.1016/j.lfs.2006.01.023
   Li RW, 2006, J ETHNOPHARMACOL, V104, P24, DOI 10.1016/j.jep.2005.08.045
   Liu XM, 2004, DIABETES CARE, V27, P839, DOI 10.2337/diacare.27.3.839
   Masukawa Y, 2006, J CHROMATOGR B, V834, P26, DOI 10.1016/j.jchromb.2006.02.008
   Matsui N, 2005, NUTRITION, V21, P594, DOI 10.1016/j.nut.2004.10.008
   MATSUMOTO N, 1993, BIOSCI BIOTECH BIOCH, V57, P525, DOI 10.1271/bbb.57.525
   Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Nakamura Y, 2002, J HEALTH SCI, V48, P570, DOI 10.1248/jhs.48.570
   Nepokroeff C M, 1975, Methods Enzymol, V35, P37, DOI 10.1016/0076-6879(75)35136-7
   OhnishiKameyama M, 1997, RAPID COMMUN MASS SP, V11, P31, DOI 10.1002/(SICI)1097-0231(19970115)11:1<31::AID-RCM784>3.0.CO;2-T
   Ohta Y., 2006, Journal of Oleo Science, V55, P305
   Osada K, 1999, BBA-GEN SUBJECTS, V1427, P337, DOI 10.1016/S0304-4165(99)00039-2
   Osada K., 2006, Journal of Oleo Science, V55, P79
   Osada K, 2006, LIPIDS, V41, P133, DOI 10.1007/s11745-006-5081-y
   Schoenlau Frank, 2001, International Ophthalmology, V24, P161, DOI 10.1023/A:1021160924583
   Shoji T, 2006, J AGR FOOD CHEM, V54, P884, DOI 10.1021/jf052260b
   Shoji T, 2006, J CHROMATOGR A, V1102, P206, DOI 10.1016/j.chroma.2005.10.065
   Shoji T, 2004, FOOD CHEM TOXICOL, V42, P959, DOI 10.1016/j.fct.2004.02.008
   Shoji T, 2003, J AGR FOOD CHEM, V51, P3806, DOI 10.1021/jf0300184
   SUGIYAMA H, UNPUB J AGR FOOD CHE
   Tian WX, 2006, CURR MED CHEM, V13, P967, DOI 10.2174/092986706776361012
   Tsuda T, 1999, FEBS LETT, V449, P179, DOI 10.1016/S0014-5793(99)00407-X
   Tsuda T, 2005, BBA-MOL CELL BIOL L, V1733, P137, DOI 10.1016/j.bbalip.2004.12.014
   Tsuda T, 2006, BIOCHEM PHARMACOL, V71, P1184, DOI 10.1016/j.bcp.2005.12.042
   Tsuda T, 2004, BIOCHEM BIOPH RES CO, V316, P149, DOI 10.1016/j.bbrc.2004.02.031
   Wen X, 2006, DRUG METAB DISPOS, V34, P1786, DOI 10.1124/dmd.106.011122
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yanagida A, 2000, J CHROMATOGR A, V890, P251, DOI 10.1016/S0021-9673(00)00614-2
NR 52
TC 5
Z9 5
U1 0
U2 18
PU JAPAN SOC FOOD SCIENCE TECHNOLOGY
PI IBARAKI-KEN
PA 2-1-12 KANNONDAI TSUKUBA-SHI, IBARAKI-KEN, 305-8642, JAPAN
SN 1341-027X
J9 J JPN SOC FOOD SCI
JI J. Jpn. Soc. Food Sci. Technol.-Nippon Shokuhin Kagaku Kogaku Kaishi
PY 2007
VL 54
IS 6
BP 287
EP 294
PG 8
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 181FF
UT WOS:000247421600007
OA Bronze
DA 2025-04-28
ER

PT J
AU Lean, MEJ
   Te Morenga, L
AF Lean, Michael E. J.
   Te Morenga, Lisa
TI Sugar and Type 2 diabetes
SO BRITISH MEDICAL BULLETIN
LA English
DT Review
DE diet; soda; body mass index; diabetes; evidence; beliefs
ID SWEETENED BEVERAGE CONSUMPTION; LIFE-STYLE INTERVENTION; GLYCEMIC INDEX;
   FOOD-CONSUMPTION; VEGETARIAN DIETS; FRUCTOSE INTAKE; BLOOD-PRESSURE;
   WEIGHT-LOSS; RISK; GLUCOSE
AB Background: Consumption of sugar, specifically sugar-sweetened beverages, has been widely held responsible by the media for the global rise in Type 2 diabetes (T2DM).
   Sources of data: Systematic reviews and dietary guidelines relating dietary sugars to T2DM.
   Areas of agreement: Weight gain and T2DM incidence are associated with diet and lifestyle patterns characterized by high consumptions of any sweetened beverages. High sugar intakes impair risk factors for macrovascular complications of T2DM.
   Areas of controversy: Much of the association between sugars and T2DM is eliminated by adjusting data for body mass index (BMI). However, BMI adjustment does not fully account for adiposity (r(2)=0.65-0.75). Excess sugar can promote weight gain, thus T2DM, through extra calories, but has no unique diabetogenic effect at physiological levels.
   Growing points: Ethical concerns about caffeine added to sweetened beverages, undetectable by consumers, to increase consumption.
   Areas timely for developing research: Evidence needed for limiting dietary sugar below 10% energy intake.
C1 [Lean, Michael E. J.] Univ Glasgow, Dept Human Nutr, Sch Med, Glasgow Royal Infirm, Level 2,New Lister Bldg,10-16 Alexandra Parade, Glasgow G31 2ER, Lanark, Scotland.
   [Te Morenga, Lisa] Univ Otago, Dept Human Nutr, Dunedin 9016, New Zealand.
   [Te Morenga, Lisa] Univ Otago, Edgar Inst Diabet & Obes Res, Dunedin 9016, New Zealand.
C3 University of Glasgow; University of Otago; University of Otago
RP Lean, MEJ (corresponding author), Univ Glasgow, Dept Human Nutr, Sch Med, Glasgow Royal Infirm, Level 2,New Lister Bldg,10-16 Alexandra Parade, Glasgow G31 2ER, Lanark, Scotland.
EM Mike.Lean@glasgow.ac.uk
RI Morenga, Lisa/IZP-9606-2023; Te Morenga, Lisa/C-4459-2011
OI Te Morenga, Lisa/0000-0003-3526-0091
CR Al-Gindan YY, 2015, BRIT J NUTR, V114, P1852, DOI 10.1017/S0007114515003670
   [Anonymous], INT J EPIDEMIOL
   [Anonymous], 1998, LANCET
   BANTLE JP, 1983, NEW ENGL J MED, V309, P7, DOI 10.1056/NEJM198307073090102
   Barclay AW, 2007, DIABETES CARE, V30, P2811, DOI 10.2337/dc07-0784
   Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873
   Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158
   Cheungpasitporn W, 2014, NEPHROLOGY, V19, P791, DOI 10.1111/nep.12343
   de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5
   Franz MJ, 2015, J ACAD NUTR DIET, V115, P1447, DOI 10.1016/j.jand.2015.02.031
   Gardner C, 2012, DIABETES CARE, V35, P1798, DOI 10.2337/dc12-9002
   Ha V, 2012, HYPERTENSION, V59, P787, DOI 10.1161/HYPERTENSIONAHA.111.182311
   Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560
   Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701
   Huang C, 2014, ATHEROSCLEROSIS, V234, P11, DOI 10.1016/j.atherosclerosis.2014.01.037
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576
   Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033
   Karamanou M, 2014, HORM-INT J ENDOCRINO, V13, P296, DOI 10.1007/BF03401345
   Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
   Lara JJ, 2004, J HUM NUTR DIET, V17, P209, DOI 10.1111/j.1365-277X.2004.00520.x
   Lê KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336
   Lean M, 2011, CLIN OBES, V1, P41, DOI 10.1111/j.1758-8111.2010.00007.x
   Lean M E, 1985, Diabet Med, V2, P117
   Lindström J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230
   Livesey G, 2008, AM J CLIN NUTR, V88, P1419, DOI 10.3945/ajcn.2007.25700
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Meni ACS, 2015, DIABETOLOGIA, V58, P2455, DOI 10.1007/s00125-015-3694-5
   Merlotti C, 2014, DIABETES OBES METAB, V16, P719, DOI 10.1111/dom.12270
   Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094
   Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492
   OSEI K, 1989, DIABETIC MED, V6, P506, DOI 10.1111/j.1464-5491.1989.tb01218.x
   Raatz SK, 2015, J NUTR, V145, P2265, DOI 10.3945/jn.115.218016
   Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492
   Shridhar K, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-55
   Sievenpiper JL, 2009, DIABETES CARE, V32, P1930, DOI 10.2337/dc09-0619
   Sluijs I, 2010, AM J CLIN NUTR, V92, P905, DOI 10.3945/ajcn.2010.29620
   Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Tanamas SK, 2016, QJM-INT J MED, V109, P443, DOI 10.1093/qjmed/hcv201
   Tappy L, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0627-0
   Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521
   Tonstad S, 2013, NUTR METAB CARDIOVAS, V23, P292, DOI 10.1016/j.numecd.2011.07.004
   Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wang DD, 2012, J NUTR, V142, P916, DOI 10.3945/jn.111.151951
   WOLEVER TMS, 1995, AM J CLIN NUTR, V62, p212S, DOI 10.1093/ajcn/62.1.212S
   World Health Organization, 2015, GUID SUG INT AD CHIL
   Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563
NR 50
TC 47
Z9 54
U1 5
U2 67
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1420
EI 1471-8391
J9 BRIT MED BULL
JI Br. Med. Bull.
PD DEC
PY 2016
VL 120
IS 1
BP 43
EP 53
DI 10.1093/bmb/ldw037
PG 11
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA EI8CX
UT WOS:000392733700006
PM 27707695
OA Green Accepted, Bronze
DA 2025-04-28
ER

PT J
AU Otton, R
   Bolin, AP
   Ferreira, LT
   Marinovic, MP
   Rocha, ALS
   Mori, MA
AF Otton, Rosemari
   Bolin, Anaysa Paola
   Ferreira, Leticia Torres
   Marinovic, Marcelo Paradiso
   Silva Rocha, Andrea Livia
   Mori, Marcelo Alves
TI Polyphenol-rich green tea extract improves adipose tissue metabolism by
   down-regulating miR-335 expression and mitigating insulin resistance and
   inflammation
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Obesity; miR-155; Epigenetic; Energy expenditure; Metabolism; Adipose
   tissue
ID ENERGY-EXPENDITURE; FAT OXIDATION; KAPPA-B; ADIPONECTIN; OBESITY;
   EPIGALLOCATECHIN-3-GALLATE; SENSITIVITY; CAFFEINE; LEPTIN; ALPHA
AB Obesity leads to changes in miRNA expression in adipose tissue, and this modulation is linked to the pathophysiology of the disease. Green tea (GT) is a natural source of polyphenols that have been shown to confer health benefits, particularly preventing metabolic diseases. Here, we investigated if the beneficial effects of GT in obesity results from changes in the miRNA profile in white adipose tissue. GT treatment [500 mg/body weight (BW)/12 weeks] increased energy expenditure of high-fat diet-fed mice (16 weeks), leading to reduced weight gain, decreased adiposity, reduced inflammation and improved insulin sensitivity. These phenotypes were associated with a decrease in the expression of miR-335 in the adipose tissue. miR-335 was up-regulated by TNF-alpha in adipocytes and, in turn, down-regulated genes involved in insulin signaling and lipid metabolism. On the other hand, GT inhibited TNF-a effect. In conclusion, miR-335 serves as a link between inflammation and impaired metabolism in adipose tissue, providing an important mechanistic insight into the molecular basis underlying GT action during obesity. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Otton, Rosemari; Ferreira, Leticia Torres; Marinovic, Marcelo Paradiso] Univ Cruzeiro Sul, CBS, Interdisciplinary Postgrad Program Hlth Sci, BR-03342000 Sao Paulo, Brazil.
   [Bolin, Anaysa Paola] Univ Sao Paulo, Biomed Sci Inst, Dept Pharmacol, BR-05508000 Sao Paulo, Brazil.
   [Silva Rocha, Andrea Livia; Mori, Marcelo Alves] Univ Estadual Campinas, Dept Biochem & Tissue Biol, BR-13083862 Campinas, SP, Brazil.
C3 Universidade Cruzeiro do Sul; Universidade de Sao Paulo; Universidade
   Estadual de Campinas
RP Otton, R (corresponding author), Av Regente Feijo 1295, BR-03342000 Sao Paulo, SP, Brazil.
EM rosemariotton@hotmail.com
RI Bolin, Anaysa/AAG-2808-2019; Otton, Rosemari/C-6531-2012; Mori,
   Marcelo/R-2881-2018; Bolin, Anaysa/L-1199-2018
OI Otton, Rosemari/0000-0001-5503-3967; Rocha, Andrea/0000-0002-9044-980X;
   Mori, Marcelo/0000-0001-7112-5263; Bolin, Anaysa/0000-0003-0956-5801
FU Sao Paulo Research Foundation (FAPESP) [2013/22293-0, 2015/01316-7];
   National Council for Scientific and Technological Development (CNPq);
   Cruzeiro do Sul University; Formas [2015-01316] Funding Source: Formas;
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [15/01316-7, 13/22293-0] Funding Source: FAPESP
FX The authors are grateful for the technical assistance of Biju H.E.S.,
   Fernandes T., Lima M.S., Rodrigues A., Bondan E.F., Giannocco G.,
   Fernandes, P.A.C.M. and Camara, N.O.S. This research was supported by
   the Sao Paulo Research Foundation (FAPESP 2013/22293-0, and
   2015/01316-7), the National Council for Scientific and Technological
   Development (CNPq) and Cruzeiro do Sul University.
CR Ahmad N, 2000, ARCH BIOCHEM BIOPHYS, V376, P338, DOI 10.1006/abbi.2000.1742
   Albuquerque KFFS, 2016, EUR J NUTR, V55, P1261, DOI 10.1007/s00394-015-0940-z
   Amri EZ, 2017, MOL CELL ENDOCRINOL, V456, P87, DOI 10.1016/j.mce.2017.04.009
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Brandao BB, 2017, REDOX BIOL, V12, P82, DOI 10.1016/j.redox.2017.01.020
   Cai X, 2012, J MOL CELL BIOL, V4, P341, DOI 10.1093/jmcb/mjs044
   Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051
   Chan PC, 2010, TOXICOL PATHOL, V38, P1070, DOI 10.1177/0192623310382437
   Deiuliis JA, 2016, INT J OBESITY, V40, P88, DOI 10.1038/ijo.2015.170
   Douglass JD, 2017, MOL METAB, V6, P366, DOI 10.1016/j.molmet.2017.01.010
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437
   Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013
   Ferreira MA, 2016, OBES REV, V17, P1316, DOI 10.1111/obr.12452
   Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009
   Gaudet AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22862
   Gordon MW, 2015, MOL CARCINOGEN, V54, P1060, DOI 10.1002/mc.22175
   Halim U, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3213
   Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986
   Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004
   Jang JY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-421
   Kim ES, 2007, OBESITY, V15, P3023, DOI 10.1038/oby.2007.360
   Lambert JD, 2003, J NUTR, V133, P4172, DOI 10.1093/jn/133.12.4172
   Martel J, 2017, NAT REV ENDOCRINOL, V13, P149, DOI 10.1038/nrendo.2016.142
   Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058
   Ohishi Tomokazu, 2016, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V15, P74, DOI 10.2174/1871523015666160915154443
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011
   Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672
   Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001
   Yang ZH, 2015, ACTA PHARM SIN B, V5, P145, DOI 10.1016/j.apsb.2015.01.002
   Zhu L, 2014, CELL BIOCHEM BIOPHYS, V68, P283, DOI 10.1007/s12013-013-9708-3
NR 37
TC 71
Z9 75
U1 1
U2 43
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JUL
PY 2018
VL 57
BP 170
EP 179
DI 10.1016/j.jnutbio.2018.03.024
PG 10
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA GM5MJ
UT WOS:000438181200019
PM 29734116
DA 2025-04-28
ER

PT J
AU Beckford, K
   Grimes, CA
   Riddell, LJ
AF Beckford, Kelsey
   Grimes, Carley A.
   Riddell, Lynn J.
TI Australian children's consumption of caffeinated, formulated beverages:
   a cross-sectional analysis
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Caffeine; Dietary; Beverages; Dietary; Soft drink; Child; Adolescent;
   Australia
ID SUGAR-SWEETENED BEVERAGES; BODY-WEIGHT; INTERNATIONAL SURVEY; OBESITY;
   TRIAL; ADOLESCENTS; DRINKS; DIETS
AB Background: Caffeine is a common additive in formulated beverages, including sugar-sweetened beverages. Currently there are no data on the consumption of caffeinated formulated beverages in Australian children and adolescents. This study aimed to determine total intake and consumption patterns of CFBs in a nationally representative sample of Australian children aged 2-16 years and to determine contribution of CFBs to total caffeine intake. Consumption by day type, mealtime and location was also examined.
   Methods: Dietary data from one 24-hour recall collected in the 2007 Australian National Children's Nutrition and Physical Activity Survey were analysed. CFBs were defined as beverages to which caffeine has been added as an additive, including cola-type beverages and energy drinks. Socioeconomic status was based on the highest level of education attained by the participant's primary caregiver. Time of day of consumption was classified based on traditional mealtimes and type of day of consumption as either a school or non-school day. Location of consumption was defined by the participant during the survey.
   Results: On the day of the survey 15% (n = 642) of participants consumed CFBs. Older children and those of low socioeconomic background were more likely to consume CFBs (both P < 0.001). Amongst the 642 consumers mean (95% CI) intakes were 151 (115-187) g/day, 287 (252-321) g/day, 442 (400-484) g/day, and 555 (507-602) g/day for 2-3, 4-8, 9-13 and 14-16 year olds respectively. Consumers of CFBs had higher intakes of caffeine (mean (95% CI) 61 (55-67) mg vs. 11 (10-12) mg) and energy (mean (95% CI) 9,612 (9,247-9978) kJ vs. 8,186 (8,040-8,335) kJ) than non-consumers (both P < 0.001). CFBs contributed 69% of total daily caffeine intake. CFB intake was higher on non-school days compared with school days (P < 0.005) and consumption occurred predominantly at the place of residence (56%), within the "dinner" time bracket (17: 00-20: 30, 44%).
   Conclusions: The consumption of CFBs by all age groups within Australian children is of concern. Modifications to the permissibility of caffeine as a food additive may be an appropriate strategy to reduce the intake of caffeine in this age group. Additional areas for intervention include targeting parental influences over mealtime beverage choices.
C1 [Beckford, Kelsey; Grimes, Carley A.; Riddell, Lynn J.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Melbourne, Vic 3125, Australia.
C3 Deakin University
RP Riddell, LJ (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, 221 Burwood Highway, Melbourne, Vic 3125, Australia.
EM lynn.riddell@deakin.edu.au
RI Riddell, Lynn/P-4950-2016; Grimes, Carley/Q-9970-2018
OI Riddell, Lynn/0000-0002-0688-2134; Grimes, Carley/0000-0002-9123-1888;
   Beckford, Kelsey/0000-0002-3822-5147
CR [Anonymous], 2005, Principles of nutritional assessment
   [Anonymous], AUSTR FOOD SUPPL NUT
   [Anonymous], 2010, 2007 AUSTR NAT CHILD
   Armfield JM, 2013, AM J PUBLIC HEALTH, V103, P494, DOI 10.2105/AJPH.2012.300889
   Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Fitt E, 2013, FOOD CHEM, V140, P421, DOI 10.1016/j.foodchem.2012.07.092
   Food Standards Australia New Zealand, 2008, AUSNUT 2007 AUSTR FO
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   GRIFFITHS RR, 1988, PSYCHOPHARMACOLOGY, V94, P437, DOI 10.1007/BF00212836
   Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628
   Grimes CA, 2011, BRIT J NUTR, V105, P468, DOI 10.1017/S0007114510003673
   Hafekost K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-950
   Heatherley SV, 2005, PSYCHOPHARMACOLOGY, V178, P461, DOI 10.1007/s00213-005-2159-9
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   Keast RSJ, 2011, EUR J CLIN NUTR, V65, P1338, DOI 10.1038/ejcn.2011.123
   Keast RSJ, 2007, APPETITE, V49, P255, DOI 10.1016/j.appet.2006.11.003
   Keast RSJ, 2015, BRIT J NUTR, V113, P366, DOI 10.1017/S000711451400378X
   Knight CA, 2006, CAN J DIET PRACT RES, V67, P96, DOI 10.3148/67.2.2006.96
   Mitchell GL, 2013, APPETITE, V60, P85, DOI 10.1016/j.appet.2012.09.014
   Riddell LJ, 2012, FOOD NUTR COMPON FOC, V2, P22, DOI 10.1039/9781849734752-00022
   Spurrier NJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-31
   Whiting SJ, 2004, J NUTR, V134, p696S, DOI 10.1093/jn/134.3.696S
NR 27
TC 17
Z9 19
U1 0
U2 25
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 31
PY 2015
VL 15
AR 70
DI 10.1186/s12889-015-1443-9
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA CB1WN
UT WOS:000349418800035
PM 25636490
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Sikalidis, AK
   Kelleher, AH
   Maykish, A
   Kristo, AS
AF Sikalidis, Angelos K.
   Kelleher, Anita H.
   Maykish, Adeline
   Kristo, Aleksandra S.
TI Non-Alcoholic Beverages, Old and Novel, and Their Potential Effects on
   Human Health, with a Focus on Hydration and Cardiometabolic Health
SO MEDICINA-LITHUANIA
LA English
DT Review
DE non-alcoholic beverages; novel beverages; health; sparkling water; soft
   seltzer
ID SUGAR-SWEETENED BEVERAGES; TYPE-2 DIABETES-MELLITUS; ENERGY DRINKS; DIET
   SODA; ARTIFICIAL SWEETENERS; CARBONATED WATER; TEA CONSUMPTION; CAFFEINE
   INTAKE; GUT MICROBIOTA; RISK
AB The Beverage Guidance System has established dietary recommendations for daily intake of commonly consumed beverages including water, tea, coffee, milk, non-calorically sweetened beverages, and calorically sweetened beverages. As obesity in America continues to be a growing problem, this guidance becomes of increasing importance due to many beverages' potential links to Type 2 Diabetes Mellitus (T2DM), Cardiovascular disease (CVD), and numerous other harmful health effects. However, the growing popularity of "better for you" beverages is causing a shift in the market, with consumers pushing for healthier beverage alternatives. Beverages simultaneously present advantages while posing concerns that need to be evaluated and considered. In this review, health effects of nonalcoholic beverages are discussed including various aspects of consumption and current trends of the beverage market such as the novel Soft Seltzer category as an alternative to Hard Seltzer and various mashups. A variety of advisory boards and agencies responsible for dietary guidelines in various countries suggest drinking water as the preferred practice for hydration.
C1 [Sikalidis, Angelos K.; Kelleher, Anita H.; Maykish, Adeline; Kristo, Aleksandra S.] Calif Polytech State Univ San Luis Obispo, Dept Food Sci & Nutr, San Luis Obispo, CA 93407 USA.
C3 California State University System; California Polytechnic State
   University San Luis Obispo
RP Sikalidis, AK (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Food Sci & Nutr, San Luis Obispo, CA 93407 USA.
EM asikalid@calpoly.edu; ahkelleh@calpoly.edu; amaykish@calpoly.edu;
   akristo@calpoly.edu
RI Kristo, Aleksandra/AHC-3770-2022; Sikalidis, Angelos/L-4690-2019
OI Kelleher, Anita/0000-0003-0693-1028; Kristo, Aleksandra
   S./0000-0002-0733-4041; Sikalidis, Angelos/0000-0003-3487-4120
FU APC [FSN-382]
FX Support and APC coverage was through an FSN-382 grant awarded to Angelos
   K. Sikalidis.
CR Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021
   ANDERSON RL, 1980, FOOD COSMET TOXICOL, V18, P353, DOI 10.1016/0015-6264(80)90188-1
   [Anonymous], 2010, Obstet Gynecol, V116, P467, DOI 10.1097/AOG.0b013e3181eeb2a1
   Babey S.H, 2009, HLTH POLICY RES, P1
   Bandy LK, 2020, BMC MED, V18, DOI 10.1186/s12916-019-1477-4
   Battikh H, 2013, J FOOD BIOCHEM, V37, P231, DOI 10.1111/j.1745-4514.2011.00629.x
   Branum AM, 2014, PEDIATRICS, V133, P386, DOI 10.1542/peds.2013-2877
   Brown RJ, 2012, DIABETES CARE, V35, P959, DOI 10.2337/dc11-2424
   Chen L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020530
   Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055
   Coombes JS, 2000, SPORTS MED, V29, P181, DOI 10.2165/00007256-200029030-00004
   Criswell D, 1991, Int J Sport Nutr, V1, P178
   Cuomo R, 2002, EUR J GASTROEN HEPAT, V14, P991, DOI 10.1097/00042737-200209000-00010
   Dallosso HM, 2003, BJU INT, V92, P69, DOI 10.1046/j.1464-410X.2003.04271.x
   Di Rienzi SC, 2020, ADV NUTR, V11, P616, DOI 10.1093/advances/nmz118
   Ferruzzi MG, 2020, ADV NUTR, V11, P507, DOI 10.1093/advances/nmz115
   Fitch C, 2012, J ACAD NUTR DIET, V112, P739, DOI 10.1016/j.jand.2012.03.009
   Fried EJ, 2002, JAMA-J AM MED ASSOC, V288, P2181, DOI 10.1001/jama.288.17.2181
   Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235
   García-Conreras F, 2000, ARCH MED RES, V31, P360, DOI 10.1016/S0188-4409(00)00090-4
   Grotz VL, 2003, J AM DIET ASSOC, V103, P1607, DOI 10.1016/j.jada.2003.09.021
   Guyenet S, SUGAR CONSUMPTION US
   Heibati M, 2017, WATER RES, V125, P1, DOI 10.1016/j.watres.2017.08.020
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ruiz-Ojeda FJ, 2019, ADV NUTR, V10, pS31, DOI 10.1093/advances/nmy037
   Johnson RK, 2018, CIRCULATION, V138, pE126, DOI 10.1161/CIR.0000000000000569
   Jones AC, 2019, NUTR J, V18, DOI 10.1186/s12937-019-0488-5
   Kassaar O, 2017, SCI REP-UK, V7, DOI 10.1038/srep45417
   Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255
   Lang F, 2017, KIDNEY BLOOD PRESS R, V42, P483, DOI 10.1159/000479640
   Lemetais G, 2018, EUR J NUTR, V57, P1883, DOI 10.1007/s00394-017-1471-6
   Lobach AR, 2019, FOOD CHEM TOXICOL, V124, P385, DOI 10.1016/j.fct.2018.12.005
   Magnuson B, COUNCIL SPOKESPERSON
   Maksimovic Z, 2005, BIORESOURCE TECHNOL, V96, P873, DOI 10.1016/j.biortech.2004.09.006
   MAUGHAN RJ, 1994, EUR J APPL PHYSIOL O, V69, P209, DOI 10.1007/BF01094790
   Maykish A, 2020, J PERS MED, V10, DOI 10.3390/jpm10010019
   McGartland C, 2003, J BONE MINER RES, V18, P1563, DOI 10.1359/jbmr.2003.18.9.1563
   Mekonnen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081723
   Mezitis NHE, 1996, DIABETES CARE, V19, P1004, DOI 10.2337/diacare.19.9.1004
   Muscogiuri G, 2018, ENDOCRINE, V62, P292, DOI 10.1007/s12020-018-1680-7
   Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799
   Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487
   Patterson Mary E, 2018, J Nutr Intermed Metab, V14, P1, DOI 10.1016/j.jnim.2018.08.004
   Pearlman Michelle, 2017, Curr Gastroenterol Rep, V19, P64, DOI 10.1007/s11894-017-0602-9
   Perrier E, 2013, BRIT J NUTR, V109, P1678, DOI 10.1017/S0007114512003601
   Ponmurugan P., 2006, Journal of Plantation Crops, V34, P688
   Popkin BM, 2007, AM J CLIN NUTR, V86, P525
   Qian JJ, 2020, TRENDS ENDOCRIN MET, V31, P218, DOI 10.1016/j.tem.2019.11.004
   Qin L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040377
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Robertson Jennifer, 2003, Diabetes Technol Ther, V5, P201, DOI 10.1089/152091503321827867
   Sakurai M, 2014, EUR J NUTR, V53, P251, DOI 10.1007/s00394-013-0523-9
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Sharma A, 2016, INDIAN J PHARMACOL, V48, P237, DOI 10.4103/0253-7613.182888
   Sikalidis AK, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8010008
   Sikalidis AK, 2019, J AM COLL NUTR, V38, P84, DOI 10.1080/07315724.2018.1481797
   Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504
   Sreeramulu G, 2000, J AGR FOOD CHEM, V48, P2589, DOI 10.1021/jf991333m
   Stern D, 2019, J NUTR, V149, P795, DOI 10.1093/jn/nxy298
   Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793
   Swithers SE, 2017, NAT REV ENDOCRINOL, V13, P443, DOI 10.1038/nrendo.2017.71
   Tamez M, 2018, J NUTR, V148, P117, DOI 10.1093/jn/nxx021
   Tang NP, 2010, LUNG CANCER, V67, P17, DOI 10.1016/j.lungcan.2009.03.012
   Temple JL, 2019, J AM ACAD CHILD PSY, V58, P36, DOI 10.1016/j.jaac.2018.06.030
   THELLE DS, 1983, NEW ENGL J MED, V308, P1454, DOI 10.1056/NEJM198306163082405
   Thornton SN, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00018
   US Department of Health and Human Services, US DEP AGR 2015 2020
   USDA, CLOS LOOK CURR INT R
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x
   Vlajinac HD, 1997, AM J EPIDEMIOL, V145, P335, DOI 10.1093/oxfordjournals.aje.a009110
   W. H. O, 2003, WHO TECHN REP SER, V916, P34
   Wakisaka S, 2012, J NUTR SCI VITAMINOL, V58, P333, DOI 10.3177/jnsv.58.333
   Watso JC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081866
   Xi B, 2015, BRIT J NUTR, V113, P709, DOI 10.1017/S0007114514004383
   Xu P, 2016, FOOD FUNCT, V7, P294, DOI 10.1039/c5fo00828j
   Yang ZW, 2009, J SCI FOOD AGR, V89, P150, DOI 10.1002/jsfa.3422
   Young LR, 2003, J AM DIET ASSOC, V103, P231, DOI 10.1053/jada.2003.50027
   Zheng FF, 2018, DIABETOLOGIA, V61, P839, DOI 10.1007/s00125-017-4541-7
NR 82
TC 11
Z9 11
U1 4
U2 27
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1010-660X
EI 1648-9144
J9 MEDICINA-LITHUANIA
JI Med. Lith.
PD OCT
PY 2020
VL 56
IS 10
AR 490
DI 10.3390/medicina56100490
PG 21
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA OL4FS
UT WOS:000585298700001
PM 32977648
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Malinowska, AM
   Mlodzik-Czyzewska, MA
   Chmurzynska, A
AF Malinowska, Anna M.
   Mlodzik-Czyzewska, Monika A.
   Chmurzynska, Agata
TI Dietary patterns associated with obesity and overweight: When should
   misreporters be included in analysis?
SO NUTRITION
LA English
DT Article
DE Obesity; Misreporters; Western; Healthy; Dietary pattern; Dietary
   records
ID MULTIPLE-PASS METHOD; ENERGY-INTAKE; FOOD-INTAKE; RECALLS; WOMEN;
   QUESTIONNAIRE; MORTALITY; ADHERENCE; ACCURACY; CHILDREN
AB Objective: The aim of the study was to identify dietary patterns associated with overweight and obesity and to examine the effect of including and excluding misreporters on the analysis of these dietary patterns and on the associations between identified dietary patterns and anthropometric parameters.
   Methods: The study was carried out with adult participants in an observational case-control manner. The participants' diet was assessed using 3-d dietary records. To identify misreporters, the Goldberg and Black cutoff method was used. Dietary patterns were evaluated using factor analysis and dietary indices.
   Results: Among 410 participants, 100 were underreporters and 1 was an overreporter. The nutritional value of the diets and the relative intake of several groups of food products differed between those with normal and increased body weight. Excluding misreporters affected the differences between body weight groups in energy; dietary fiber; empty calories; cholesterol; sodium; magnesium; folate; vitamins C, PP, and A; groats; vegetables; coffee; and water intake. The Western diet (WD) factor correlated positively with the waist circumference and the amount of fat tissue, whereas the healthy diet (HD) factor correlated negatively with body weight, waist circumference, and the fat tissue amount. The coefficients of the correlation between the HD factor and the anthropometric parameters were stronger when misreporters were excluded, whereas those between the WD factor and the parameters did not change much after exclusion of misreporters.
   Conclusions: There is a positive relationship between the WD pattern and obesity. The exclusion of misreporters from the data set may positively affect the association between the HD pattern and anthropometric parameters. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Malinowska, Anna M.; Mlodzik-Czyzewska, Monika A.; Chmurzynska, Agata] Poznan Univ Life Sci, Inst Human Nutr & Dietet, Poznan, Poland.
C3 Poznan University of Life Sciences
RP Chmurzynska, A (corresponding author), Poznan Univ Life Sci, Inst Human Nutr & Dietet, Poznan, Poland.
EM agata.chmurzynska@up.poznan.pl
RI Mlodzik Czyzewska, Monika/MHQ-8132-2025; Malinowska, Anna/Q-6042-2019
OI Malinowska, Anna/0000-0002-7402-1328; Mlodzik-Czyzewska,
   Monika/0000-0001-6563-3640; Chmurzynska, Agata/0000-0002-2045-0709
FU National Science Center, Poland [2014/15/13/N29/02134]
FX This work was supported by the National Science Center, Poland. (grant
   no. 2014/15/13/N29/02134). AC was responsible for the conception and
   design of the study, as well as approval of the final version of the
   manuscript. AMM, MMC, and AC were responsible for the generation,
   collection, assembly, analysis, and interpretation of data. AM drafted
   and revised the manuscript. The authors have no conflicts of of interest
   to declare.
CR [Anonymous], NUTRIENTS
   Bailey RL, 2007, J AM DIET ASSOC, V107, P64, DOI 10.1016/j.jada.2006.10.009
   Banna JC, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00045
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Briefel RR, 1997, AM J CLIN NUTR, V65, P1203
   Chmurzynska A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111692
   Chmurzynska A, 2017, NUTR RES REV, V30, P106, DOI 10.1017/S0954422417000014
   Conway JM, 2004, J AM DIET ASSOC, V104, P595, DOI 10.1016/j.jada.2004.01.007
   Conway JM, 2003, AM J CLIN NUTR, V77, P1171, DOI 10.1093/ajcn/77.5.1171
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Czekajlo A, 2018, ANN AGR ENV MED, V25, P635, DOI 10.26444/aaem/76321
   European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3143
   Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409
   Funtikova AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127647
   GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13
   Jankovic N, 2014, AM J EPIDEMIOL, V180, P978, DOI 10.1093/aje/kwu229
   Jarosz M, Normy zywienia dla populacji Polski i ich zastosowanie
   Jessri M, 2016, BRIT J NUTR, V115, P147, DOI 10.1017/S0007114515004237
   Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476
   Krebs-Smith SM, 2000, EUR J CLIN NUTR, V54, P281, DOI 10.1038/sj.ejcn.1600936
   Krebs-Smith SM, 2018, J ACAD NUTR DIET, V118, P1591, DOI 10.1016/j.jand.2018.05.021
   Krieger JP, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010062
   Kye Seunghee, 2014, Osong Public Health Res Perspect, V5, P85, DOI 10.1016/j.phrp.2014.02.002
   Macdiarmid JI, 1997, EUR J CLIN NUTR, V51, P199, DOI 10.1038/sj.ejcn.1600380
   Markussen MS, 2016, BRIT J NUTR, V116, P547, DOI 10.1017/S000711451600218X
   Marques A, 2018, EUR J PUBLIC HEALTH, V28, P295, DOI 10.1093/eurpub/ckx143
   Mela DJ, 1997, J AM DIET ASSOC, V97, P791, DOI 10.1016/S0002-8223(97)00195-8
   Mendez MA, 2004, PUBLIC HEALTH NUTR, V7, P9, DOI 10.1079/PHN2003508
   Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380
   Mu M, 2017, IRAN J PUBLIC HEALTH, V46, P869
   Murakami K, 2015, BRIT J NUTR, V114, P1294, DOI 10.1017/S0007114515002706
   Ozen AE, 2015, PUBLIC HEALTH NUTR, V18, P659, DOI 10.1017/S1368980014000809
   Poppitt SD, 1998, INT J OBESITY, V22, P303, DOI 10.1038/sj.ijo.0800584
   Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602
   Rasmussen LB, 2007, PUBLIC HEALTH NUTR, V10, P230, DOI 10.1017/S136898000724666X
   Ravelli MN, 2018, REV NUTR, V31, P235
   Rezagholizadeh F, 2017, NUTR RES, V41, P1, DOI 10.1016/j.nutres.2017.01.006
   Rhee JJ, 2015, AM J EPIDEMIOL, V181, P225, DOI 10.1093/aje/kwu308
   Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z
   Rutayisire E, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2018.15
   Scagliusi FB, 2008, BRIT J NUTR, V100, P1060, DOI 10.1017/S0007114508971300
   Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5
   Schrijvers JK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080450
   Shaneshin M, 2014, J HEALTH POPUL NUTR, V32, P36
   Shin KO, 2007, BRIT J NUTR, V98, P416, DOI 10.1017/S0007114507720226
   Silveira BKS, 2018, CARDIOL RES PRACT, V2018, DOI 10.1155/2018/4585412
   Thomson JL, 2019, AM J CLIN NUTR, V109, P127, DOI 10.1093/ajcn/nqy284
   Tooze JA, 2012, EUR J CLIN NUTR, V66, P569, DOI 10.1038/ejcn.2011.198
   Voss S, 1998, EUR J CLIN NUTR, V52, P119, DOI 10.1038/sj.ejcn.1600525
   Widaman AM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030218
   Yang WY, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4010005
NR 53
TC 17
Z9 17
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD FEB
PY 2020
VL 70
AR 110605
DI 10.1016/j.nut.2019.110605
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KG3BX
UT WOS:000509818600010
PM 31743814
DA 2025-04-28
ER

PT J
AU Kent, LM
   Worsley, A
AF Kent, Lillian M.
   Worsley, Anthony
TI Trends in BMI, diet and lifestyle between 1976 and 2005 in North Sydney
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE BMI; diet; lifestyle; prudent lifestyle; Western lifestyle
ID BODY-MASS INDEX; ENERGY-EXPENDITURE; CHILDHOOD OBESITY;
   PHYSICAL-ACTIVITY; US CHILDREN; CONSUMPTION; PREVALENCE; OVERWEIGHT;
   PATTERN; DRINKS
AB Although the prevalence of overweight and obesity in Australia has increased during the past 30 years, little is known about the dietary and behavioural antecedents of body mass index (BMI). We examined changes in mean BMI, diet, and other lifestyle behaviours between 1976 and 2005 and described the cross-sectional associations between these factors and BMI. A series of biennial biomedical surveys by Sydney Adventist Hospital from 1976 to 2005 allowed examination of BMI trends, while the selection of three surveys enabled detailed examination of likely dietary and lifestyle associations. Subjects included in this study were: 384 men and 338 women in 1976: 160 men and 146 women in 1978; 166 men and 141 women in 1980. 164 men and 142 women in 1982; 177 men and 13 women in 1984; 239 men and 227 women in 1986; 210 men and 225 women in 1988; 165 men and 148 women in 1990; 138 men and 167 women in 1992 and 270 men and 62 women in 2005. Height and weight were measured by hospital staff. Mean BMI increased in the early 1990s. Salt, coffee, cola.. alcohol and meat consumption, dieting to lose weight and eating between meals were positively associated with BMI while physical activity, food variety, large breakfasts and consumption of spreads were negatively associated. Food consumption and daily activities have important associations with BMI, though their specific associations differ by sex. "Affluent" lifestyle patterns appear to contribute to higher BMI, while a more "prudent" lifestyle seems to protect from such increases.
C1 [Kent, Lillian M.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia.
   [Worsley, Anthony] Univ Wollongong, Sch Hlth Sci, Wollongong, NSW, Australia.
C3 Murdoch Children's Research Institute; University of Wollongong
RP Kent, LM (corresponding author), Murdoch Childrens Res Inst, Ctr Adolescent Hlth, 2 Gatehouse St, Parkville, Vic 3052, Australia.
EM lillian.kent@mcri.edu.au
OI Worsley, Anthony/0000-0002-4635-6059; Kent, Lillian/0000-0001-9518-7303
FU Deakin University, Melbourne, Australia; Sanitarium Health Food Company;
   Australian Research Council
FX Financial support was provided by Deakin University, Melbourne,
   Australia; the Sanitarium Health Food Company; and Australian Research
   Council grant awarded to A.W. The authors report no conflicts of
   interest.
CR *ABS, 1979, NEW S WAL YB
   *ABS, 2003, SOC IND AR AUSTR 200
   *ABS, 2004, OV OB AD AUSTR 2004
   *ABS, 2006, AUSTR HIST POP STAT
   *ABS, 2000, NAT NUTR SURV SEL HI
   Allman-Farinelli MA, 2008, EUR J CLIN NUTR, V62, P898, DOI 10.1038/sj.ejcn.1602769
   [Anonymous], 1997, Curr Ther
   [Anonymous], 2002, Diet, nutrition and the prevention of chronic diseases
   ARMSTRONG T, 2000, 10 AIHW CVD
   Barr E, 2006, AUSTR DIABETES OBESI
   Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x
   BORTNER RW, 1969, J CHRON DIS, V22, P87, DOI 10.1016/0021-9681(69)90061-7
   Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x
   CASHEL K, 2001, CHANGING PATTERNS EA
   Catford JC, 2003, MED J AUSTRALIA, V179, P577, DOI 10.5694/j.1326-5377.2003.tb05703.x
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   DECASTRO JM, 1995, PHYSIOL BEHAV, V57, P287, DOI 10.1016/0031-9384(94)00229-X
   Drewnowski A, 2004, AM J CLIN NUTR, V79, P6
   Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   Jahns L, 2001, J PEDIATR-US, V138, P493, DOI 10.1067/mpd.2001.112162
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   JENKINS CD, 1967, J CHRON DIS, V20, P371, DOI 10.1016/0021-9681(67)90010-0
   Kent LM, 2009, PUBLIC HEALTH NUTR, V12, P472, DOI 10.1017/S1368980008002334
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   McDevitt RM, 2000, AM J CLIN NUTR, V72, P369
   National Health and Medical Research Council, 2003, DIET GUID AUSTR AD
   *NSW, 2003, STAT FOOD NUTR NSW S
   Organisation mondiale de la sante, 1999, Obesity: preventing and managing the global epidemic, report of a WHO Consultaton
   PEETERS A, 2007, DIS TRENDS RES SUMM
   Quatromoni PA, 2002, J AM DIET ASSOC, V102, P1240
   Rippe JM, 1998, J AM DIET ASSOC, V98, pS31, DOI 10.1016/S0002-8223(98)00708-1
   RISING R, 1994, AM J CLIN NUTR, V59, P800, DOI 10.1093/ajcn/59.4.800
   Song WO, 2005, J AM DIET ASSOC, V105, P1373, DOI 10.1016/j.jada.2005.06.002
   Sorensen TIA, 1998, INT J OBESITY, V22, P73, DOI 10.1038/sj.ijo.0800548
   Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355
   Westenhoefer J, 1999, INT J EAT DISORDER, V26, P53, DOI 10.1002/(SICI)1098-108X(199907)26:1<53::AID-EAT7>3.0.CO;2-N
   Westerterp KR, 1997, INT J OBESITY, V21, P184, DOI 10.1038/sj.ijo.0800385
   Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S
   Zimmet P., 2000, The Asia-Pacific perspective: redefining obesity and its treatment
NR 40
TC 16
Z9 22
U1 0
U2 7
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI MCKINNON
PA PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA
SN 0964-7058
EI 1440-6047
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PY 2009
VL 18
IS 3
BP 453
EP 461
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 507FD
UT WOS:000270836300019
PM 19786395
DA 2025-04-28
ER

PT J
AU Baek, JH
   Kim, NJ
   Song, JK
   Chun, KH
AF Baek, Jung-Hwan
   Kim, Nam-Jun
   Song, Jun-Kyu
   Chun, Kyung-Hee
TI Kahweol inhibits lipid accumulation and induces Glucose-uptake through
   activation of AMP-activated protein kinase (AMPK)
SO BMB REPORTS
LA English
DT Article
DE Adipogenesis; AMPK; Coffee bean; Glucose-uptake; Kahweol
ID COLORECTAL-CANCER CELLS; ADIPOCYTE DIFFERENTIATION; WEIGHT-LOSS;
   STEM-CELLS; OBESITY; COFFEE; PHOSPHORYLATION; CAFESTOL; HEALTH;
   TRANSCRIPTION
AB Weight loss >= 5 percent is sufficient to significantly reduce health risks for obese people; therefore, development of novel weight loss compounds with reduced toxicity is urgently required. After screening of natural compounds with anti-adipogenesis properties in 3T3-L1 cells, we determined that kahweol, a coffee-specific diterpene, inhibited adipogenesis. Kahweol reduced lipid accumulation and expression levels of adipogenesis and lipid accumulation-related factors. Levels of phosphorylated AKT and phosphorylated JAK2, that induce lipid accumulation, decreased in kahweol-treated cells. Particularly, kahweol treatment significantly increased AMP-activated protein kinase (AMPK) activation. We revealed that depletion of AMPK alleviated reduction in lipid accumulation from kahweol treatment, suggesting that inhibition of lipid accumulation by kahweol is dependent on AMPK activation. We detected more rapid reduction in blood glucose levels in mice administrated kahweol than in control mice. We suggest that kahweol has anti-obesity effects and should be studied further for possible therapeutic applications.
C1 [Baek, Jung-Hwan; Kim, Nam-Jun; Song, Jun-Kyu; Chun, Kyung-Hee] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 03722, South Korea.
   [Baek, Jung-Hwan; Kim, Nam-Jun; Song, Jun-Kyu; Chun, Kyung-Hee] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University
RP Chun, KH (corresponding author), Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 03722, South Korea.; Chun, KH (corresponding author), Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea.
EM khchun@yuhs.ac
RI Kim, Yoon/J-2746-2012
OI Chun, Kyung-Hee/0000-0002-9867-7321; Baek, junghwan/0000-0002-2250-1557
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [NRF-2014R1A2A1A11050600]; Bio & Medical Technology Development Program
   of the NRF - Korean government, MSIP [NRF-2015M3A9B6073835, NRF-2015M3
   A9B6073833]; Basic Science Research Program through the National
   Research Foundation of Korea (NRF) - Ministry of Education
   [NRF-2014R1A1A2055009]; National Research Foundation of Korea (NRF) -
   Korean government (Ministry of Science, ICT and Future Planning)
   [NRF-2016R1A6A3A11935119]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP)
   (NRF-2014R1A2A1A11050600), the Bio & Medical Technology Development
   Program of the NRF funded by the Korean government, MSIP
   (NRF-2015M3A9B6073835, NRF-2015M3 A9B6073833), the Basic Science
   Research Program through the National Research Foundation of Korea (NRF)
   funded by the Ministry of Education (NRF-2014R1A1A2055009) and by the
   National Research Foundation of Korea (NRF) grants funded by the Korean
   government (Ministry of Science, ICT and Future Planning)
   (NRF-2016R1A6A3A11935119).
CR Apovian CM, 2015, J CLIN ENDOCR METAB, V100, P342, DOI 10.1210/jc.2014-3415
   Bray GA, 2013, OBESITY, V21, P893, DOI 10.1002/oby.20394
   Cardenas C, 2011, PLOS ONE, V2011, P6
   Cheung BMY, 2013, THER ADV DRUG SAF, V4, P171, DOI 10.1177/2042098613489721
   Choi DW, 2015, BIOMOL THER, V23, P128, DOI 10.4062/biomolther.2014.133
   Choi HY, 2015, BMB REP, V48, P68, DOI 10.5483/BMBRep.2015.48.2.250
   Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7
   Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313
   Fumimoto R, 2012, J PHARMACOL SCI, V118, P479, DOI 10.1254/jphs.11212FP
   GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397
   Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8
   Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484
   Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116
   Herrero-Martín G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81
   Kang H, 2015, BMB REP, V48, P319, DOI 10.5483/BMBRep.2015.48.6.206
   Khera R, 2016, JAMA-J AM MED ASSOC, V315, P2424, DOI 10.1001/jama.2016.7602
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim HG, 2009, TOXICOL LETT, V187, P28, DOI 10.1016/j.toxlet.2009.01.022
   Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.119
   Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012
   Liu XL, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.123
   Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843
   Moeenfard M, 2016, J CELL BIOCHEM, V117, P2748, DOI 10.1002/jcb.25573
   Morisco F, 2014, J CLIN GASTROENTEROL, V48, pS87, DOI 10.1097/MCG.0000000000000240
   Oh JH, 2009, APOPTOSIS, V14, P1378, DOI 10.1007/s10495-009-0407-x
   Park GH, 2016, FOOD CHEM TOXICOL, V95, P142, DOI 10.1016/j.fct.2016.07.008
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Rustan AC, 1997, ARTERIOSCL THROM VAS, V17, P2140, DOI 10.1161/01.ATV.17.10.2140
   Stoppani J, 2002, AM J PHYSIOL-ENDOC M, V283, pE1239, DOI 10.1152/ajpendo.00278.2002
   Xia Y, 2015, OBESITY, V23, P1721, DOI 10.1002/oby.21136
   Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
NR 34
TC 37
Z9 38
U1 1
U2 13
PU KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
PI SEOUL
PA KOREA SCIENCE & TECHNOLOGY CENTER, # 801,  635-4 , YEOKSAM-DONG,
   KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-6696
EI 1976-670X
J9 BMB REP
JI BMB Rep.
PD NOV
PY 2017
VL 50
IS 11
BP 566
EP 571
DI 10.5483/BMBRep.2017.50.11.031
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA FO8ZZ
UT WOS:000417178900007
PM 28602160
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Martinez-Saez, N
   García, AT
   Pérez, ID
   Rebollo-Hernanz, M
   Mesías, M
   Morales, FJ
   Martin-Cabrejas, MA
   del Castillo, MD
AF Martinez-Saez, Nuria
   Tamargo Garcia, Alba
   Dominguez Perez, Ines
   Rebollo-Hernanz, Miguel
   Mesias, Marta
   Morales, Francisco J.
   Martin-Cabrejas, Maria A.
   Dolores del Castillo, Maria
TI Use of spent coffee grounds as food ingredient in bakery products
SO FOOD CHEMISTRY
LA English
DT Article
DE Spent coffee grounds; Antioxidant dietary fibre; Food grade ingredient;
   Bakery products
ID MAILLARD REACTION-PRODUCTS; NATURAL ANTIOXIDANTS; SUGAR REPLACEMENT;
   EXTRACTION; GLYCATION
AB The present research aimed to evaluate the use of spent coffee grounds (SCG) from instant coffee as a food ingredient and its application in bakery products. Data on physicochemical characterization, thermal stability and food safety of SCG were acquired. Evaluation of feasibility as dietary fibre was also determined. Results showed SCG are natural source of antioxidant insoluble fibre, essential amino acids, low glycaemic sugars, resistant to thermal food processing and digestion process, and totally safe. In the present work, SCG were incorporated in biscuit formulations for the first time. Low-calorie sweeteners and oligofructose were also included in the food formulations. Nutritional quality, chemical (acrylamide, hydroxymethylfurfural and advanced glycation end products) and microbiological safety and sensory tests of the biscuits were carried out. Innovative biscuits were obtained according to consumers' preferences with high nutritional and sensorial quality and potential to reduce the risk of chronic diseases such as obesity and diabetes. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Martinez-Saez, Nuria; Tamargo Garcia, Alba; Dominguez Perez, Ines; Rebollo-Hernanz, Miguel; Martin-Cabrejas, Maria A.; Dolores del Castillo, Maria] UAM CSIC, Food Sci Res Inst, CIAL, Madrid 28049, Spain.
   [Mesias, Marta; Morales, Francisco J.] ICTAN CSIC, Inst Food Sci Technol & Nutr, Madrid 28040, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM -
   Instituto de Investigacion en Ciencias de la Alimentacion (CIAL);
   Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN)
RP del Castillo, MD (corresponding author), UAM CSIC, Food Sci Res Inst, CIAL, Madrid 28049, Spain.
EM mdolores.delcastillo@csic.es
RI Tamargo, Alba/JUV-2071-2023; Rebollo-Hernanz, Miguel/S-6539-2019;
   Martín-Cabrejas, María/L-6433-2014; Morales, Francisco/N-1941-2019; del
   Castillo, MD/J-6283-2012; Mesias, Marta/E-7280-2014
OI Martinez Saez, Nuria/0000-0003-0098-2537; del Castillo,
   MD/0000-0001-6309-5383; Morales, Francisco J./0000-0003-3984-7009;
   Tamargo, Alba/0000-0002-3447-9027; Rebollo-Hernanz,
   Miguel/0000-0003-1034-1290; Mesias, Marta/0000-0003-0905-1587
FU SUSCOFFEE project [AGL2014-57239-R]; JAE Intro fellowship
   [JAEINT_15_00086]; FPU predoctoral program of the Ministry of Education,
   Culture and Sports [FPU15/04238]
FX This study was funded by SUSCOFFEE (AGL2014-57239-R) project. The
   present research is part of the PhD. Thesis of Martinez-Saez, N.
   FPI-predoc fellow belongs to Autonomous University of Madrid (UAM),
   Spain. Rebollo-Hernanz, M. thanks the JAE Intro fellowship
   (JAEINT_15_00086) and the FPU predoctoral program of the Ministry of
   Education, Culture and Sports (FPU15/04238). Authors also thank Prosol
   for the spent coffee grounds and BENEO-ORAFTI for the FOS.
CR Açar ÖÇ, 2009, EUR FOOD RES TECHNOL, V229, P961, DOI 10.1007/s00217-009-1131-z
   [Anonymous], 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2592
   [Anonymous], 2005, EFSA Journal, P1
   Ballesteros LF, 2014, FOOD BIOPROCESS TECH, V7, P3493, DOI 10.1007/s11947-014-1349-z
   Bravo J, 2012, J AGR FOOD CHEM, V60, P12565, DOI 10.1021/jf3040594
   Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012
   Capuano E, 2011, LWT-FOOD SCI TECHNOL, V44, P793, DOI 10.1016/j.lwt.2010.11.002
   Codex Alimentarius, 2009, CAC RCP 69 2009
   Contini M, 2008, FOOD CHEM, V110, P659, DOI 10.1016/j.foodchem.2008.02.060
   Cruz R, 2012, J AGR FOOD CHEM, V60, P7777, DOI 10.1021/jf3018854
   Culetu A, 2016, FOOD CHEM, V197, P14, DOI 10.1016/j.foodchem.2015.10.097
   Del Castillo M. D., COFFEE CHEM QUALITY
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   del Castillo MD., 2014, PCTES2014070062
   Edwards AD, 2009, VACCINE, V27, P3897, DOI 10.1016/j.vaccine.2009.04.006
   Esfahani A, 2011, IUBMB LIFE, V63, P7, DOI 10.1002/iub.418
   European Commission, 2013, OFFICIAL J EUROPEA L, VL301
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547
   Fernandez-Gomez B, 2015, FOOD FUNCT, V6, P2081, DOI [10.1039/C5FO00194C, 10.1039/c5fo00194c]
   Garcia-Serna E, 2014, POL J FOOD NUTR SCI, V64, P243, DOI 10.2478/pjfns-2013-0024
   Hellfritsch C, 2012, J AGR FOOD CHEM, V60, P6782, DOI 10.1021/jf301297n
   Hollebeeck S, 2013, FOOD CHEM, V138, P1936, DOI 10.1016/j.foodchem.2012.11.041
   Ishikawa T, 2012, WORLD J GASTROENTERO, V18, P2005, DOI 10.3748/wjg.v18.i17.2005
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Kulthe AA, 2014, J FOOD SCI TECH MYS, V51, P153, DOI 10.1007/s13197-011-0465-2
   Lago R.A.R., 2001, CENTESIMAL COMPOSITI
   Mesías M, 2014, FOOD RES INT, V62, P1120, DOI 10.1016/j.foodres.2014.05.058
   Michalska A, 2008, J CEREAL SCI, V48, P123, DOI 10.1016/j.jcs.2007.08.012
   Murthy PS, 2012, FOOD BIOPROCESS TECH, V5, P897, DOI 10.1007/s11947-010-0363-z
   Murthy PS, 2012, RESOUR CONSERV RECY, V66, P45, DOI 10.1016/j.resconrec.2012.06.005
   Mussatto SI, 2011, FOOD BIOPROCESS TECH, V4, P661, DOI 10.1007/s11947-011-0565-z
   Mussatto SI, 2011, CARBOHYD POLYM, V83, P368, DOI 10.1016/j.carbpol.2010.07.063
   Oki T, 2006, FOOD SCI TECHNOL RES, V12, P156, DOI 10.3136/fstr.12.156
   Oomah BD, 2001, J SCI FOOD AGR, V81, P889, DOI 10.1002/jsfa.898
   Panusa A, 2013, J AGR FOOD CHEM, V61, P4162, DOI 10.1021/jf4005719
   Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052
   Pujol D, 2013, IND CROP PROD, V50, P423, DOI 10.1016/j.indcrop.2013.07.056
   Rufián-Henares JA, 2006, J AOAC INT, V89, P161
   Simoes J, 2013, CARBOHYD POLYM, V97, P81, DOI 10.1016/j.carbpol.2013.04.067
   Tamanna Nahid, 2015, Int J Food Sci, V2015, P526762, DOI 10.1155/2015/526762
   Vardon DR, 2013, ACS SUSTAIN CHEM ENG, V1, P1286, DOI 10.1021/sc400145w
   Vatankhah M, 2015, QUAL ASSUR SAF CROP, V7, P393, DOI 10.3920/QAS2014.0396
   Vlassopoulos A, 2013, FREE RADICAL BIO MED, V60, P318, DOI 10.1016/j.freeradbiomed.2013.03.010
   Zoulias EI, 2000, J SCI FOOD AGR, V80, P2049, DOI 10.1002/1097-0010(200011)80:14<2049::AID-JSFA735>3.0.CO;2-Q
NR 44
TC 162
Z9 167
U1 11
U2 422
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD FEB 1
PY 2017
VL 216
BP 114
EP 122
DI 10.1016/j.foodchem.2016.07.173
PG 9
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA DY0JO
UT WOS:000384783300015
PM 27596399
DA 2025-04-28
ER

PT J
AU John, CM
   Arockiasamy, S
AF John, Cordelia Mano
   Arockiasamy, Sumathy
TI Effect of Phenolic Acids and Flavonoids on Low Dose Caffeine-Induced
   Adipogenesis and Oxidative Stress in 3T3-L1 Adipocytes
SO PHARMACEUTICAL CHEMISTRY JOURNAL
LA English
DT Article
DE caffeine; syringic acid; sinapic acid; hesperidin; chrysin; adipogenesis
ID PPAR-GAMMA; DIFFERENTIATION; PROLIFERATION; EXPRESSION; RECEPTORS;
   MECHANISM; OBESITY
AB Obesity is characterised by an excessive build-up of lipids and triglycerides in adipocytes. Phenolic acids and flavonoids have previously been shown to inhibit body weight increase and fat buildup in mice. This study investigated the anti-obesity effect of phenolics, syringic (SYA) and sinapic acid (SIA) and flavonoids hesperidin (HD) and chrysin (CR) along with caffeine (CAF) on 3T3-L1 cells. Anti-obesity on 3T3-L1 adipocytes was evaluated by MTT assay, ORO staining, TG quantification and NBT assay. 100 mu mol CAF exhibited adipogenesis, lipogenesis and ROS accumulation which was reduced with combinations of SYA, SIA, HD and CR in a concentration-dependent manner. Moreover, CAF + SYA/SIA/HD/CR inhibited the mRNA expression of PPAR gamma, C/EBP alpha and SREBP-1c in mature adipocytes. Taken together, these preliminary data demonstrate that these phytocompounds prevent CAF-induced adipogenesis. These phytocompounds can be exploited further to study the in vitro and in vivo anti-adipogenic mechanism in combination with caffeine.
C1 [John, Cordelia Mano; Arockiasamy, Sumathy] Sri Ramachandra Inst Higher Educ & Res, Fac Biomed Sci & Technol, Dept Biomed Sci, Chennai 600116, Tamil Nadu, India.
C3 Sri Ramachandra Institute of Higher Education & Research
RP Arockiasamy, S (corresponding author), Sri Ramachandra Inst Higher Educ & Res, Fac Biomed Sci & Technol, Dept Biomed Sci, Chennai 600116, Tamil Nadu, India.
EM sumathyjoseph04@sriramachandra.edu.in
RI AROCKIASAMY, SUMATHY/HNP-7935-2023; JOHN, CORDELIA/KFS-4830-2024
FU Shri NPV Ramasamy Udayar Research Fellowship
FX Partial financial support was received from Shri NPV Ramasamy Udayar
   Research Fellowship for PhD program.
CR Aguirre L, 2014, MOLECULES, V19, P18632, DOI 10.3390/molecules191118632
   Akiba T, 2004, BIOCHEM PHARMACOL, V68, P1929, DOI 10.1016/j.bcp.2004.07.036
   Ambele MA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124283
   [Anonymous], 2020, NEWSR FACT SHEETS
   Azam Sonish, 2003, Med Sci Monit, V9, pBR325
   Beyer LA, 2018, FOOD CHEM TOXICOL, V118, P566, DOI 10.1016/j.fct.2018.06.002
   Guerra RC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/175080
   Chang E., 2019, MOLECULES, V24, P1
   Cheemanapalli S, 2018, BIOMED PHARMACOTHER, V108, P547, DOI 10.1016/j.biopha.2018.09.069
   Chen JX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62493-y
   CHOI OH, 1988, LIFE SCI, V43, P387, DOI 10.1016/0024-3205(88)90517-6
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Furukawa S., 2004, Journal of Clinical Investigation, V114, P1752, DOI 10.1172/JCI21625
   GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0
   Grygiel-Górniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17
   Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957
   Gusti AMT, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040595
   Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200
   Hassan M, 2007, BIOCHEM BIOPH RES CO, V361, P208, DOI 10.1016/j.bbrc.2007.07.021
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983
   Jiang L, 2008, BIOCHEM BIOPH RES CO, V371, P185, DOI 10.1016/j.bbrc.2008.03.129
   John C. M., 2019, NAT PROD RES, V34
   John CM., 2021, J AM COLL NUTR, V41, P1
   John CM, 2021, IN VITRO CELL DEV-AN, V57, P386, DOI 10.1007/s11626-021-00549-7
   Karri S, 2019, BIOMED PHARMACOTHER, V110, P224, DOI 10.1016/j.biopha.2018.11.076
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333
   Ko J, 2020, ENDOCR J, V67, P439, DOI 10.1507/endocrj.EJ19-0521
   Kong L, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13795
   Manach C, 2003, EUR J CLIN NUTR, V57, P235, DOI 10.1038/sj.ejcn.1601547
   Mani R, 2018, PHYTOCHEMISTRY, V145, P187, DOI 10.1016/j.phytochem.2017.09.016
   Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Niciforovic N, 2014, COMPR REV FOOD SCI F, V13, P34, DOI 10.1111/1541-4337.12041
   Pannala AS, 2001, BIOCHEM BIOPH RES CO, V282, P1161, DOI 10.1006/bbrc.2001.4705
   RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Sugiura C, 2020, J FOOD SCI, V85, P192, DOI 10.1111/1750-3841.14811
   Sun NN, 2016, MOLECULES, V21, DOI 10.3390/molecules21101351
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Tiwari KK, 2014, BIOCHEM BIOPH RES CO, V450, P1345, DOI 10.1016/j.bbrc.2014.06.132
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   World Health Organization, Obesity and overweight
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
   Zhao YS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1459497
   Zhu XJ, 2017, EXP THER MED, V13, P688, DOI 10.3892/etm.2016.3975
NR 52
TC 0
Z9 0
U1 3
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0091-150X
EI 1573-9031
J9 PHARM CHEM J+
JI Pharm. Chem. J.
PD FEB
PY 2024
VL 57
IS 11
BP 1768
EP 1777
DI 10.1007/s11094-024-03078-1
EA MAR 2024
PG 10
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA MX3X3
UT WOS:001186399600001
DA 2025-04-28
ER

PT J
AU Mellbye, FD
   Nguyen, MD
   Hermansen, K
   Jeppesen, PB
   Al-Mashhadi, ZK
   Ringgaard, S
   Gregersen, S
AF Mellbye, Fredrik D.
   Nguyen, Mi D.
   Hermansen, Kjeld
   Jeppesen, Per B.
   Al-Mashhadi, Zheer K.
   Ringgaard, Steffen
   Gregersen, Soren
TI Effects of 12-Week Supplementation with Coffee Diterpene Cafestol in
   Healthy Subjects with Increased Waist Circumference: A Randomized,
   Placebo-Controlled Trial
SO NUTRIENTS
LA English
DT Article
DE coffee; diabetes; obesity; cafestol; glucose; placebo; metabolism
ID GAMMA-GLUTAMYL-TRANSFERASE; CHOLESTEROL-RAISING FACTOR; MEDIATED
   GLUCOSE-UPTAKE; SERUM-LIPIDS; BIOACTIVE SUBSTANCE; INSULIN SUPPRESSION;
   WEIGHT-LOSS; KAHWEOL; RISK; CONSUMPTION
AB Background: Coffee consumption is inversely associated with type 2 diabetes. Cafestol, a bioactive compound in coffee, has demonstrated glucose-lowering and insulin-secretory properties in cell and animal studies. The acute effects of cafestol on glucose metabolism in humans have only been briefly investigated, and longer-term effects have not been explored. This study aimed to assess the effects of purified cafestol on insulin sensitivity and other metabolic parameters in healthy individuals with increased waist circumference at risk of developing type 2 diabetes. Methods: A 12-week randomized, placebo-controlled, parallel trial was conducted with 40 participants. Insulin suppression tests, mixed meal tests, and MRI scans were performed before and after the intervention. Results: Administering 6 mg of cafestol twice daily did not alter insulin sensitivity or glucose tolerance but led to significant reductions in body weight (2%), visceral fat volume (5%), and gamma-glutamyl transferase levels (15%) compared to the placebo. Conclusions: Cafestol may hold promise for weight and visceral fat reduction. Cafestol did not improve insulin sensitivity or glucose tolerance in this study but might still contribute to the observed inverse association between coffee consumption and type 2 diabetes. Future research should explore higher dosages and longer treatment durations, particularly in individuals with impaired glucose metabolism and type 2 diabetes.
C1 [Mellbye, Fredrik D.; Nguyen, Mi D.; Al-Mashhadi, Zheer K.; Gregersen, Soren] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, DK-8200 Aarhus, Denmark.
   [Mellbye, Fredrik D.; Hermansen, Kjeld; Jeppesen, Per B.; Al-Mashhadi, Zheer K.] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8200 Aarhus, Denmark.
   [Mellbye, Fredrik D.; Nguyen, Mi D.; Hermansen, Kjeld; Jeppesen, Per B.; Al-Mashhadi, Zheer K.; Gregersen, Soren] Aarhus Univ, Dept Clin Med, DK-8200 Aarhus, Denmark.
   [Ringgaard, Steffen] Aarhus Univ, MR Res Ctr, DK-8200 Aarhus, Denmark.
C3 Aarhus University; Aarhus University; Aarhus University; Aarhus
   University
RP Mellbye, FD (corresponding author), Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, DK-8200 Aarhus, Denmark.; Mellbye, FD (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8200 Aarhus, Denmark.; Mellbye, FD (corresponding author), Aarhus Univ, Dept Clin Med, DK-8200 Aarhus, Denmark.
EM fbmellbye@clin.au.dk; mi-nguyen@hotmail.com; kjeld.hermansen@dadlnet.dk;
   per.bendix.jeppesen@clin.au.dk; zhehus@rm.dk; steffen@clin.au.dk;
   soeren.gregersen@aarhus.rm.dk
RI hermansen, kjeld/AAY-4241-2021; Gregersen, Søren/HJZ-2527-2023;
   Al-Mashhadi, Zheer/ABA-2607-2020
OI Gregersen, Soren/0000-0002-1953-8631; Kejlberg Al-Mashhadi,
   Zheer/0000-0003-1201-199X; Jeppesen, Per Bendix/0000-0001-8042-7554
FU Aarhus University; Aarhus University, Steno Diabetes Center Aarhus,
   Helsefonden; Civilingenir Frode Nyegaard og Hustru's Fond
FX This research was funded by Aarhus University, Steno Diabetes Center
   Aarhus, Helsefonden, Laegefonden/A.P. M & oslash;ller Fonden and
   Civilingeni & oslash;r Frode Nyegaard og Hustru's Fond.
CR Alperet DJ, 2020, AM J CLIN NUTR, V111, P448, DOI 10.1093/ajcn/nqz306
   Battelino T, 2019, DIABETES CARE, V42, P1593, DOI 10.2337/dci19-0028
   Carlström M, 2018, NUTR REV, V76, P395, DOI 10.1093/nutrit/nuy014
   De Roos B, 1998, J INTERN MED, V244, P451, DOI 10.1111/j.1365-2796.1998.00386.x
   De Roos B, 2000, J INTERN MED, V248, P211, DOI 10.1046/j.1365-2796.2000.00728.x
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870
   Gorji Z, 2019, PHYTOMEDICINE, V63, DOI 10.1016/j.phymed.2019.153018
   Gross G, 1997, FOOD CHEM TOXICOL, V35, P547, DOI 10.1016/S0278-6915(96)00123-8
   IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23
   Knowles JW, 2013, METABOLISM, V62, P548, DOI 10.1016/j.metabol.2012.10.002
   Lee DH, 2004, J CLIN ENDOCR METAB, V89, P5410, DOI 10.1210/jc.2004-0505
   Magliano D J., 2021, IDF DIABETES ATLAS, V10th
   McLaughlin T, 2006, AM J CLIN NUTR, V84, P813, DOI 10.1093/ajcn/84.4.813
   McLaughlin T, 2011, METABOLISM, V60, P1741, DOI 10.1016/j.metabol.2011.05.008
   Mellbye FB, 2017, J NAT PROD, V80, P2353, DOI 10.1021/acs.jnatprod.7b00395
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Ohnaka Keizo, 2012, J Nutr Metab, V2012, P207426, DOI 10.1155/2012/207426
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Sirotkin AV, 2021, PHYSIOL RES, V70, P161, DOI 10.33549/physiolres.934674
   SU HY, 1995, AM J HYPERTENS, V8, P1067, DOI 10.1016/0895-7061(95)00330-R
   Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031
   URGERT R, 1995, J AGR FOOD CHEM, V43, P2167, DOI 10.1021/jf00056a039
   Urgert R, 1997, AM J CLIN NUTR, V65, P519, DOI 10.1093/ajcn/65.2.519
   Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305
   Urgert R, 1996, BRIT MED J, V313, P1362, DOI 10.1136/bmj.313.7069.1362
   URGERT R, 1995, AM J CLIN NUTR, V61, P149, DOI 10.1093/ajcn/61.1.149
   Uusitupa M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112611
   VANROOIJ J, 1995, AM J CLIN NUTR, V61, P1277, DOI 10.1093/ajcn/61.6.1277
   Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93
   WEUSTENVANDERWOUW MPME, 1994, J LIPID RES, V35, P721
   WHO, 2008, The World Health Report, P1
NR 35
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2024
VL 16
IS 19
AR 3232
DI 10.3390/nu16193232
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA I7M0U
UT WOS:001332051800001
PM 39408200
OA gold
DA 2025-04-28
ER

PT J
AU Gosselin, C
   Haman, F
AF Gosselin, Chantal
   Haman, Francois
TI Effects of green tea extracts on non-shivering thermogenesis during mild
   cold exposure in young men
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Epigallocatechin-3-gallate; Caffeine; Non-shivering thermogenesis
ID BROWN ADIPOSE-TISSUE; ENERGY-EXPENDITURE; FUEL SELECTION; MUSCLE
   GLYCOGEN; CARBOHYDRATE AVAILABILITY; CATECHIN-POLYPHENOLS;
   PLASMA-GLUCOSE; FAT OXIDATION; HUMANS; CAFFEINE
AB The effects of epigallocatechin-3-gallate (EGCG) and caffeine on non-shivering thermogenesis (NST) during cold exposure is unknown. The purpose of the present study was to quantify the effects of co-ingesting EGCG and caffeine on the thermogenic responses of a 3 h cold exposure. A total of eight healthy males were exposed to mild cold, using a liquid-conditioned suit perfused with 15 degrees C water, on two occasions and consumed a placebo or an extract of 1600 mg of EGCG and 600 mg of caffeine (Green tea). Thermic, metabolic and electromyographic measurements were monitored at baseline and during the cold exposure. Results showed that the AUC of shivering intensity over the cold exposure period was reduced by approximately 20% in the Green tea (266 (SEM 6)% maximal voluntary contraction (MVC) x min) compared with the Placebo (332 (SEM 69)% MVC x min) (P=0.01) treatments. In contrast, the total AUC for energy expenditure (EE) was approximately 10% higher in the Green tea (23.5 (SEM 1.4) kJ/kg x 180 min) compared with the Placebo (327 (SEM 74) kJ/kg 180 min) (P=0.007) treatments. The decrease in shivering activity combined with an increase in EE, following the ingestion of EGCG and caffeine during the cold exposure, indicates that NST pathways can be significantly stimulated in adult human subjects. The present study provides an experimental approach for human investigations into the potential role of diet and bioactive food ingredients in modulating NST during cold exposure. Stimulating NST pathways in such a manner may also provide important targets in the search of targets for the management of obesity and diabetes.
C1 [Gosselin, Chantal; Haman, Francois] Hop Montfort, Unite Rech Nutr & Metab, Ottawa, ON K1K 0T2, Canada.
   [Gosselin, Chantal; Haman, Francois] Univ Ottawa, Ottawa, ON K1N 6N5, Canada.
C3 University of Ottawa; University of Ottawa
RP Haman, F (corresponding author), Hop Montfort, Unite Rech Nutr & Metab, 713 Chemin Montreal, Ottawa, ON K1K 0T2, Canada.
EM fhaman@uottawa.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC
   Canada); Ontario Graduate Scholarship (OGS)
FX The authors would like to acknowledge the contribution and assistance
   provided by Marie-Andree Imbeault, Denis Blondin, Jean-Francois Mauger
   and Bernard Pinet. They would also like to thank the subjects of the
   present study for their participation. The present work was funded by
   grants and scholarships from the Natural Sciences and Engineering
   Research Council of Canada (NSERC Canada) to F. H. and C. G. as well as
   from Ontario Graduate Scholarship (OGS). C. G. conducted the
   experiments, analysis and participated in the writing of the present
   paper under the supervision of F. H. The authors have no conflict of
   interest in relation to the present study.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ASTRUP A, 1985, AM J PHYSIOL, V248, pE507, DOI 10.1152/ajpendo.1985.248.5.E507
   Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182
   Bartness TJ, 2005, P NUTR SOC, V64, P53, DOI 10.1079/PNS2004409
   BELL DG, 1992, J APPL PHYSIOL, V72, P2336, DOI 10.1152/jappl.1992.72.6.2336
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535
   Blondin DP, 2012, MED SCI SPORT EXER, V44, P1706, DOI 10.1249/MSS.0b013e318254e952
   Blondin DP, 2011, J APPL PHYSIOL, V111, P1014, DOI 10.1152/japplphysiol.00293.2011
   Blondin DP, 2010, J APPL PHYSIOL, V109, P654, DOI 10.1152/japplphysiol.00440.2010
   Blondin DP, 2010, EUR J APPL PHYSIOL, V108, P289, DOI 10.1007/s00421-009-1210-7
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   DULLOO AG, 1984, BRIT J NUTR, V52, P179, DOI 10.1079/BJN19840087
   ELIA M, 1991, AM J PHYSIOL, V260, pE75, DOI 10.1152/ajpendo.1991.260.1.E75
   Garofalo MAR, 1996, J AUTONOM NERV SYST, V60, P206, DOI 10.1016/0165-1838(96)00037-9
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Haman F, 2006, J APPL PHYSIOL, V100, P1702, DOI 10.1152/japplphysiol.01088.2005
   Haman F, 2005, J PHYSIOL-LONDON, V566, P247, DOI 10.1113/jphysiol.2005.086272
   Haman F, 2004, J PHYSIOL-LONDON, V556, P305, DOI 10.1113/jphysiol.2003.055152
   Haman F, 2004, J APPL PHYSIOL, V96, P41, DOI 10.1152/japplphysiol.00428.2003
   Haman F, 2004, J APPL PHYSIOL, V96, P32, DOI 10.1152/japplphysiol.00427.2003
   Haman F, 2002, J APPL PHYSIOL, V93, P77, DOI 10.1152/japplphysiol.00773.2001
   Hardy JD, 1938, J NUTR, V15, P461, DOI 10.1093/jn/15.5.461
   HETZLER RK, 1990, J APPL PHYSIOL, V68, P44, DOI 10.1152/jappl.1990.68.1.44
   JANSKY L, 1973, BIOL REV, V48, P85
   Kim J, 2008, J THEOR BIOL, V251, P523, DOI 10.1016/j.jtbi.2007.12.005
   Lichtenbelt WDV, 2003, CURR OPIN CLIN NUTR, V6, P469, DOI 10.1097/01.mco.0000078992.96795.5f
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   MACNAUGHTON KW, 1990, J APPL PHYSIOL, V68, P1889, DOI 10.1152/jappl.1990.68.5.1889
   Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677
   Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433
   PERONNET F, 1991, CAN J SPORT SCI, V16, P23
   Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   VALLERAND AL, 1989, J APPL PHYSIOL, V67, P438, DOI 10.1152/jappl.1989.67.1.438
   Vallerand AL, 1999, AVIAT SPACE ENVIR MD, V70, P42
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
NR 44
TC 38
Z9 40
U1 0
U2 37
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JUL 28
PY 2013
VL 110
IS 2
BP 282
EP 288
DI 10.1017/S0007114512005089
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 166HD
UT WOS:000320544400009
PM 23237788
OA Bronze
DA 2025-04-28
ER

PT J
AU Jurgens, TM
   Whelan, AM
   Killian, L
   Doucette, S
   Kirk, S
   Foy, E
AF Jurgens, Tannis M.
   Whelan, Anne Marie
   Killian, Lara
   Doucette, Steve
   Kirk, Sara
   Foy, Elizabeth
TI Green tea for weight loss and weight maintenance in overweight or obese
   adults
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID RANDOMIZED-CONTROLLED-TRIAL; BODY-WEIGHT; ENERGY-EXPENDITURE; FAT
   OXIDATION; DOUBLE-BLIND; INSULIN-RESISTANCE; ABDOMINAL FAT;
   RISK-FACTORS; CAFFEINE; CATECHINS
AB Background
   Preparations of green tea are used as aids in weight loss and weight maintenance. Catechins and caffeine, both contained in green tea, are each believed to have a role in increasing energy metabolism, which may lead to weight loss. A number of randomised controlled trials (RCTs) evaluating the role of green tea in weight loss have been published; however, the efficacy of green tea preparations in weight loss remains unclear.
   Objectives
   To assess the efficacy and safety of green tea preparations for weight loss and weight maintenance in overweight or obese adults.
   Search methods
   We searched the following databases from inception to specified date as well as reference lists of relevant articles: The Cochrane Library (Issue 12, 2011), MEDLINE (December 2011), EMBASE (December 2011), CINAHL (January 2012), AMED (January 2012), Biological Abstracts (January 2012), IBIDS (August 2010), Obesity+ (January 2012), IPA (January 2012) and Web of Science (December 2011). Current Controlled Trials with links to other databases of ongoing trials was also searched.
   Selection criteria
   RCTs of at least 12 weeks' duration comparing green tea preparations to a control in overweight or obese adults.
   Data collection and analysis
   Three authors independently extracted data, assessed studies for risk of bias and quality, with differences resolved by consensus. Heterogeneity of included studies was assessed visually using forest plots and quantified using the I-2 statistic. We synthesised data using meta-analysis and descriptive analysis as appropriate; subgroup and sensitivity analyses were conducted. Adverse effects reported in studies were recorded.
   Main results
   Due to the level of heterogeneity among studies, studies were divided into two groups; those conducted in Japan and those conducted outside Japan. Study length ranged between 12 and 13 weeks. Meta-analysis of six studies conducted outside Japan showed a mean difference (MD) in weight loss of -0.04 kg (95% CI -0.5 to 0.4; P = 0.88; I-2 = 18%; 532 participants). The eight studies conducted in Japan were not similar enough to allow pooling of results and MD in weight loss ranged from -0.2 kg to -3.5 kg (1030 participants) in favour of green tea preparations. Meta-analysis of studies measuring change in body mass index (BMI) conducted outside Japan showed a MD in BMI of -0.2 kg/m(2) (95% CI -0.5 to 0.1; P = 0.21; I-2 = 38%; 222 participants). Differences among the eight studies conducted in Japan did not allow pooling of results and showed a reduction in BMI ranging from no effect to -1.3 kg/m(2) (1030 participants), in favour of green tea preparations over control. Meta-analysis of five studies conducted outside Japan and measuring waist circumference reported a MD of -0.2 cm (95% CI -1.4 to 0.9; P = 0.70; I2 = 58%; 404 participants). Differences among the eight studies conducted in Japan did not allow pooling of results and showed effects on waist circumference ranging from a gain of 1 cm to a loss of 3.3 cm (1030 participants). Meta-analysis for three weight loss studies, conducted outside Japan, with waist-to-hip ratio data (144 participants) yielded no significant change (MD 0; 95% CI -0.02 to 0.01). Analysis of two studies conducted to determine if green tea could help to maintain weight after a period of weight loss (184 participants) showed a change in weight loss of 0.6 to -1.6 kg, a change in BMI from 0.2 to -0.5 kg/m(2) and a change in waist circumference from 0.3 to -1.7 cm. In the eight studies that recorded adverse events, four reported adverse events that were mild to moderate, with the exception of two (green tea preparations group) that required hospitalisation (reported as not associated with the intervention). Nine studies reported on compliance/adherence, one study assessed attitude towards eating as part of the health-related quality of life outcome. No studies reported on patient satisfaction, morbidity or cost.
   Authors' conclusions
   Green tea preparations appear to induce a small, statistically non-significant weight loss in overweight or obese adults. Because the amount of weight loss is small, it is not likely to be clinically important. Green tea had no significant effect on the maintenance of weight loss. Of those studies recording information on adverse events, only two identified an adverse event requiring hospitalisation. The remaining adverse events were judged to be mild to moderate.
C1 [Jurgens, Tannis M.; Whelan, Anne Marie; Foy, Elizabeth] Dalhousie Univ, Coll Pharm, Halifax, NS B3H 4R2, Canada.
   [Killian, Lara] Nova Scotia Cochrane Resource Ctr, Halifax, NS, Canada.
   [Doucette, Steve] Clin Res Ctr, Capital Hlth Res Serv, Dalhousie Dept Community Hlth & Epidemiol, Halifax, NS, Canada.
   [Kirk, Sara] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS B3H 4R2, Canada.
C3 Dalhousie University; Dalhousie University; Dalhousie University
   Hospital; Dalhousie University
RP Jurgens, TM (corresponding author), Dalhousie Univ, Coll Pharm, 5968 Coll St, Halifax, NS B3H 4R2, Canada.
EM tannis.jurgens@dal.ca
RI ; Kirk, Sara/E-2302-2011
OI Whelan, Anne Marie/0000-0002-4492-4980; Kirk, Sara/0000-0003-2146-4448;
   Killian, Lara/0000-0003-4160-7565; Jurgens, Tannis/0000-0003-4549-2603
FU Nova Scotia Health Research Foundation, Canada; Knowledge
   Transfer/Exchange Program
FX External sources Nova Scotia Health Research Foundation, Canada.
   Knowledge Transfer/Exchange Program
CR [Anonymous], PHARM J
   [Anonymous], GREE TEA CAM SIN
   [Anonymous], FOCUS ON ALTERNATIVE
   [Anonymous], FOCUS ALTERNATIVE CO
   [Anonymous], ALTERNATIVE COMPLEME
   [Anonymous], GREEN TEA
   [Anonymous], FOCUS ALTERNATIVE CO
   [Anonymous], PREVENTION WEIGHT GA
   [Anonymous], FOCUS ALTERNATIVE CO
   [Anonymous], 2008, JPN PHARMACOL THER
   [Anonymous], COCHRANE HDB SYSTEMA
   [Anonymous], FOCUS ALTERNATIVE CO
   [Anonymous], NATURAL MED COMPREHE
   [Anonymous], FOCUS ALTERNATIVE CO
   [Anonymous], COMP MON GREEN TEA
   [Anonymous], PROGR MED
   [Anonymous], FOCUS ALTERNATIVE CO
   [Anonymous], ZEITSCHRIFT FUR PHYT
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bakker GCM, 2010, AM J CLIN NUTR, V91, P1044, DOI 10.3945/ajcn.2009.28822
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bayés M, 2005, METHOD FIND EXP CLIN, V27, P411
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bolling BW, 2009, CURR OPIN CLIN NUTR, V12, P42, DOI 10.1097/MCO.0b013e32831b9c48
   Boon N, 2008, INT J VITAM NUTR RES, V78, P275, DOI 10.1024/0300-9831.78.6.275
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Busse W, 2000, DRUG INF J, V34, P15, DOI 10.1177/009286150003400102
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Clement Y, 2009, PREV MED, V49, P83, DOI 10.1016/j.ypmed.2009.05.005
   Dalbo VJ, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-6
   Di Pierro F, 2009, ALTERN MED REV, V14, P154
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eckel RH, 2008, NEW ENGL J MED, V358, P1941, DOI 10.1056/NEJMcp0801652
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Goto T, 1996, J CHROMATOGR A, V749, P295, DOI 10.1016/0021-9673(96)00456-6
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972
   Gupta J., 2008, IJP - International Journal of Pharmacology, V4, P314
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Jurgens T, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-11
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kataoka K., 2004, Progress in Medicine, V24, P3358
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kuhad A, 2008, DRUG FUTURE, V33, P249
   Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Batista GDP, 2009, ARQ BRAS CARDIOL, V93, P121
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rao A. V., 2006, Journal of Herbs, Spices & Medicinal Plants, V12, P67, DOI 10.1300/J044v12n03_05
   Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Schneider C, 2009, AM FAM PHYSICIAN, V79, P591
   Seeram NP, 2006, J AGR FOOD CHEM, V54, P1599, DOI 10.1021/jf052857r
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Sterne J.A., 2001, Systematic reviews in health care, P189, DOI 10.1002/9780470693926.ch11
   Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002
   Suzuki Y., 2009, Japanese Pharmacology and Therapeutics, V37, P521
   Takashima S., 2004, Progress in Medicine, V24, P3371
   Takeshita M, 2008, Jpn Pharmacol Ther, V36, P767
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   Tian WX, 2004, LIFE SCI, V74, P2389, DOI 10.1016/j.lfs.2003.09.064
   Tsai CH, 2009, INT J FOOD SCI NUTR, V60, P151, DOI 10.1080/09637480903136667
   tsuchida t., 2002, Prog med, V9, P2189
   Tucker LA, 2008, AM J HEALTH PROMOT, V23, P121, DOI 10.4278/ajhp.07051646
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wolfram S, 2007, J AM COLL NUTR, V26, p373S, DOI 10.1080/07315724.2007.10719626
   World Health Organization, Obesity and overweight
   Yoneda T, 2009, METAB SYNDR RELAT D, V7, P349, DOI 10.1089/met.2008.0061
NR 100
TC 88
Z9 98
U1 1
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2012
IS 12
AR CD008650
DI 10.1002/14651858.CD008650.pub2
PG 139
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 053EV
UT WOS:000312254600025
PM 23235664
OA Green Published
DA 2025-04-28
ER

PT J
AU Xu, Y
   Zhang, M
   Wu, T
   Dai, SD
   Xu, JL
   Zhou, ZK
AF Xu, Yan
   Zhang, Min
   Wu, Tao
   Dai, ShengDong
   Xu, Jinling
   Zhou, Zhongkai
TI The anti-obesity effect of green tea polysaccharides, polyphenols and
   caffeine in rats fed with a high-fat diet
SO FOOD & FUNCTION
LA English
DT Article
ID EPIGALLOCATECHIN GALLATE; ANTIOXIDANT PROPERTIES; LIPID-METABOLISM;
   BODY-FAT; OBESITY; CATECHINS; EXTRACT; SUPPLEMENTATION; OXIDATION;
   THEANINE
AB Beneficial effects of green tea (Camellia sinensis, Theaceae) extracts against obesity have been reported; however, the anti-obesity ability of the major components of green tea, polysaccharides, polyphenols and caffeine is not clear. Therefore, experiments with total green tea extracts, polyphenols, polysaccharides, caffeine, and a complex of polysaccharide and polyphenol at a dose of 400 or 800 mg kg(-1) were conducted on high-fat diet fed rats for 6 weeks to investigate their anti-obesity effects. The results indicated that polyphenols and polysaccharides were responsible for the suppressive effect of green tea extracts on body weight increase and fat accumulation. Moreover, polyphenols, polysaccharides, or caffeine can improve blood lipid and antioxidant levels, and effectively reduce rat serum leptin levels, inhibit the absorption of fatty acids, and markedly reduce the expression levels of the IL-6 and TNF-alpha gene. Furthermore, it was shown that polysaccharides and polyphenols were synergistic in reduction of serum leptin levels and in anti-inflammatory activity. These results suggest that the polysaccharide combination with polyphenols might be a potential therapy against obesity.
C1 [Xu, Yan; Zhang, Min; Wu, Tao; Dai, ShengDong; Xu, Jinling; Zhou, Zhongkai] Tianjin Univ Sci & Technol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
C3 Tianjin University Science & Technology
RP Zhang, M (corresponding author), Tianjin Univ Sci & Technol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
EM zm0102@tust.edu.cn
RI Zhou, Zhongkai/AAC-1412-2019; zhang, min/IYI-9869-2023; Wu,
   Tao/E-7769-2011
OI Wu, Tao/0000-0002-0629-8421
FU Ministry of Science and Technology of the People's Republic of China
   [2012BAD33B08]
FX The research was supported by the Project of the Ministry of Science and
   Technology of the People's Republic of China (no. 2012BAD33B08).
CR Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Colman E, 2012, NEW ENGL J MED, V367, P1577, DOI 10.1056/NEJMp1211277
   Dirinck E, 2011, OBESITY, V19, P709, DOI 10.1038/oby.2010.133
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585
   Friedrich M, 2012, INT J OBESITY, V36, P735, DOI 10.1038/ijo.2011.136
   Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972
   Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Huvaere K, 2011, J AGR FOOD CHEM, V59, P8718, DOI 10.1021/jf201139e
   Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049
   Imayama I, 2012, CANCER RES, V72, P2314, DOI 10.1158/0008-5472.CAN-11-3092
   Jordan M. A., 2013, DRUG DISCOV TODAY, P107, DOI DOI 10.5772/51145
   Jurgens TM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008650.pub2
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Lonac MC, 2011, OBESITY, V19, P298, DOI 10.1038/oby.2010.181
   Lu C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034833, 10.1371/journal.pone.0038332]
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Matsubara Y, 2009, ANN NUTR METAB, V54, P258, DOI 10.1159/000229506
   Mohamed G. A., 2014, Bulletin of the Faculty of Pharmacy, Cairo University, V52, P269, DOI 10.1016/j.bfopcu.2014.05.001
   Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI [10.1001/jama.2012.39, 10.1001/jama.2012.40]
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Polotsky M, 2012, J APPL PHYSIOL, V112, P1637, DOI 10.1152/japplphysiol.01222.2011
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sayama K, 2000, IN VIVO, V14, P481
   Senanayake SPJN, 2013, J FUNCT FOODS, V5, P1529, DOI 10.1016/j.jff.2013.08.011
   Shen C. L., 2011, FASEB J, P25
   Stimpson E, 2013, J HEART LUNG TRANSPL, V32, pS212, DOI 10.1016/j.healun.2013.01.531
   Tian C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053796
   Wang L, 2012, FOOD CHEM, V131, P1539, DOI 10.1016/j.foodchem.2011.09.129
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wu T, 2013, FOOD FUNCT, V4, P1654, DOI 10.1039/c3fo60251f
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
   Yang MH, 2001, J NUTR BIOCHEM, V12, P14, DOI 10.1016/S0955-2863(00)00140-6
   Zheng GD, 2004, IN VIVO, V18, P55
NR 39
TC 163
Z9 180
U1 16
U2 376
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PY 2015
VL 6
IS 1
BP 297
EP 304
DI 10.1039/c4fo00970c
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA AX9QB
UT WOS:000347235900029
PM 25431018
DA 2025-04-28
ER

PT J
AU Boschmann, M
   Thielecke, F
AF Boschmann, Michael
   Thielecke, Frank
TI The effects of epigallocatechin-3-gallate on thermogenesis and fat
   oxidation in obese men: A pilot study
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article; Proceedings Paper
CT 47th Annual Meeting of the American-College-of-Nutrition
CY OCT 05-08, 2006
CL Reno, NV
SP Amer Coll Nutr
DE epigallocatechin gallate; fat oxidation; energy expenditure
ID GREEN TEA; ENERGY-EXPENDITURE; METABOLIC-RATE; SUBSTRATE UTILIZATION;
   ADIPOSE-TISSUE; CAFFEINE; EPHEDRINE; WOMEN; CONSUMPTION; INHIBITION
AB Objectives: The development of obesity is characterized by an increase in adipose tissue mass and by concomitant and profound changes in almost all organ functions leading to diseases such as hypertension, diabetes mellitus and coronary heart disease. Recent data from human studies indicate that the consumption of green tea and green tea extracts may help reduce body weight, mainly body fat, by increasing postprandial thermogenesis and fat oxidation. However, human studies investigating the metabolic effects of the most predominant tea catechin, EGCG, alone are absent.
   Methods: In a randomized double blind, placebo-controlled, cross-over pilot study, six overweight men were given 300 mg EGCG/d for 2d. Fasting and postprandial changes in energy expenditure (EE) and substrate oxidation were assessed.
   Results: Resting EE did not differ significantly between EGCG and placebo treatments, although during the first postprandial monitoring phase, respiratory quotient (RQ) values were significantly lower with EGCG compared to the placebo.
   Conclusions: These findings suggest that EGCG alone has the potential to increase fat oxidation in men and may thereby contribute to the anti-obesity effects of green tea. However, more studies with a greater sample size and a broader range of age and BMI are needed to define the optimum dose.
C1 Univ Med Berlin, Franz Volhard Ctr Clin Res, D-13125 Berlin, Germany.
   HELIOS Clin Berlin Buch, Berlin, Germany.
   DSM Nutr Prod, Basel, Switzerland.
C3 Berlin Institute of Health; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; DSM NV
RP Boschmann, M (corresponding author), Univ Med Berlin, Franz Volhard Ctr Clin Res, Charite Campus Buch, D-13125 Berlin, Germany.
EM michael.boschmann@charite.de
RI Thielecke, Frank/AAJ-3422-2020
OI Thielecke, Frank/0000-0003-4975-5327
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   [Anonymous], Z PHYTOTHER
   Arch JRS, 1996, INT J OBESITY, V20, P191
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Boschmann M, 2005, HYPERTENSION, V46, P130, DOI 10.1161/01.HYP.0000171477.63859.b2
   Boschmann M, 2003, J CLIN ENDOCR METAB, V88, P6015, DOI 10.1210/jc.2003-030780
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   DULLOO AG, 1993, INT J OBESITY, V17, pS35
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dulloo AG, 1998, BRIT J NUTR, V80, P493, DOI 10.1017/S0007114598001573
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   DULLOO AG, 1993, NUTRITION, V9, P366
   FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165
   Horton TJ, 1996, INT J OBESITY, V20, P91
   Jordan J, 2000, CIRCULATION, V101, P504, DOI 10.1161/01.CIR.101.5.504
   Jordan J, 2004, CIRCULATION, V109, P1823, DOI 10.1161/01.CIR.0000126283.99195.37
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Landsteiner K, 1929, J IMMUNOL, V17, P1
   Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Ten S, 2004, J CLIN ENDOCR METAB, V89, P2526, DOI 10.1210/jc.2004-0276
   TOUBRO S, 1993, INT J OBESITY, V17, pS69
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Wei M, 1996, AM J EPIDEMIOL, V144, P1058, DOI 10.1093/oxfordjournals.aje.a008878
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409
   Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
NR 41
TC 137
Z9 150
U1 0
U2 35
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD AUG
PY 2007
VL 26
IS 4
BP 389S
EP 395S
DI 10.1080/07315724.2007.10719627
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 217PP
UT WOS:000249960100013
PM 17906192
DA 2025-04-28
ER

PT J
AU Ialongo, D
   Tudino, V
   Arpacioglu, M
   Messore, A
   Patacchini, E
   Costi, R
   Di Santo, R
   Madia, VN
AF Ialongo, Davide
   Tudino, Valeria
   Arpacioglu, Merve
   Messore, Antonella
   Patacchini, Elisa
   Costi, Roberta
   Di Santo, Roberto
   Madia, Valentina Noemi
TI Synergistic Effects of Caffeine in Combination with Conventional Drugs:
   Perspectives of a Drug That Never Ages
SO PHARMACEUTICALS
LA English
DT Review
DE caffeine; synergism; multidrug therapy; anti-inflammatory drugs;
   anticancer drugs; antimicrobial drugs; opioids; neurodegenerative
   diseases; antidiabetic drugs; anti-obesity drugs
ID FUNCTIONAL IMPAIRMENT MODEL; A(2A) RECEPTOR ANTAGONISTS; DOUBLE-BLIND;
   POTENTIATED CHEMOTHERAPY; COGNITIVE IMPAIRMENT; ANALGESIC ADJUVANT;
   ESCHERICHIA-COLI; NATURAL-PRODUCTS; IN-VITRO; INHIBITION
AB Plants have been known since ancient times for their healing properties, being used as preparations against human diseases of different etiologies. More recently, natural products have been studied and characterized, isolating the phytochemicals responsible for their bioactivity. Most certainly, there are currently numerous active compounds extracted from plants and used as drugs, dietary supplements, or sources of bioactive molecules that are useful in modern drug discovery. Furthermore, phytotherapeutics can modulate the clinical effects of co-administered conventional drugs. In the last few decades, the interest has increased even more in studying the positive synergistic effects between plant-derived bioactives and conventional drugs. Indeed, synergism is a process where multiple compounds act together to exert a merged effect that is greater than that of each of them summed together. The synergistic effects between phytotherapeutics and conventional drugs have been described in different therapeutic areas, and many drugs are based on synergistic interactions with plant derivatives. Among them, caffeine has shown positive synergistic effects with different conventional drugs. Indeed, in addition to their multiple pharmacological activities, a growing body of evidence highlights the synergistic effects of caffeine with different conventional drugs in various therapeutic fields. This review aims to provide an overview of the synergistic therapeutic effects of caffeine and conventional drugs, summarizing the progress reported to date.
C1 [Ialongo, Davide; Tudino, Valeria; Arpacioglu, Merve; Messore, Antonella; Patacchini, Elisa; Costi, Roberta; Di Santo, Roberto; Madia, Valentina Noemi] Sapienza Univ Roma, Fdn Cenci Bolognetti, Ist Pasteur, Dipartimento Chim & Tecnol Farmaco, Ple Aldo Moro 5, I-00185 Rome, Italy.
C3 Fondazione Cenci Bolognetti; Sapienza University Rome
RP Madia, VN (corresponding author), Sapienza Univ Roma, Fdn Cenci Bolognetti, Ist Pasteur, Dipartimento Chim & Tecnol Farmaco, Ple Aldo Moro 5, I-00185 Rome, Italy.
EM valentinanoemi.madia@uniroma1.it
RI Madia, Valentina Noemi/ACZ-3757-2022; Messore, Antonella/AAA-6574-2022
OI Di Santo, Roberto/0000-0002-4279-7666; Patacchini,
   Elisa/0000-0002-4531-3612; IALONGO, DAVIDE/0000-0002-4672-2936; Madia,
   Valentina Noemi/0000-0002-5724-612X; Messore,
   Antonella/0000-0003-0158-5816
CR Abe K, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5891-y
   Aboutabl M.E., 2021, B NATL RES CENT, V45, P219, DOI [10.1186/s42269-021-00678-9, DOI 10.1186/S42269-021-00678-9]
   Al-Majed A, 2016, Profiles Drug Subst Excip Relat Methodol, V41, P379, DOI 10.1016/bs.podrm.2015.11.002
   Alfaro TM, 2018, CLIN RESPIR J, V12, P1283, DOI 10.1111/crj.12662
   Alshabi AM, 2021, SAUDI MED J, V42, P151, DOI 10.15537/smj.2021.2.25695
   ANTTILA VJ, 1994, CLIN INFECT DIS, V18, P979, DOI 10.1093/clinids/18.6.979
   Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021
   Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087
   ARNOLD MA, 1982, LIFE SCI, V31, P1017, DOI 10.1016/0024-3205(82)90174-6
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   Bandookwala M, 2019, NEUROSCI LETT, V711, DOI 10.1016/j.neulet.2019.134438
   BERENBAUM MC, 1989, PHARMACOL REV, V41, P93
   BERKOWIT.BA, 1970, EUR J PHARMACOL, V10, P64, DOI 10.1016/0014-2999(70)90158-5
   Betoni JEC, 2006, MEM I OSWALDO CRUZ, V101, P387, DOI 10.1590/S0074-02762006000400007
   Bruno S, 2015, ONCOTARGET, V6, P22624, DOI 10.18632/oncotarget.4168
   Butterweck V, 2000, PLANTA MED, V66, P3, DOI 10.1055/s-2000-11119
   CASTANEDAHERNANDEZ G, 1994, CAN J PHYSIOL PHARM, V72, P1127, DOI 10.1139/y94-159
   Chung FL, 1998, CANCER RES, V58, P4096
   CORRODI H, 1972, J PHARM PHARMACOL, V24, P155, DOI 10.1111/j.2042-7158.1972.tb08952.x
   Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j
   Da Silva RS, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P355, DOI 10.1016/B978-0-12-382032-7.10027-X
   Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008
   Darwish RA, 2002, J ETHNOPHARMACOL, V79, P359, DOI 10.1016/S0378-8741(01)00411-1
   Diaz-Reval Maria Irene, 2008, Cir Cir, V76, P241
   Diener HC, 2005, CEPHALALGIA, V25, P776, DOI 10.1111/j.1468-2982.2005.00948.x
   Doepker C, 2016, ANNU REV FOOD SCI T, V7, P117, DOI 10.1146/annurev-food-041715-033243
   Doos L, 2014, FAM PRACT, V31, P654, DOI 10.1093/fampra/cmu056
   Durao P, 2018, TRENDS MICROBIOL, V26, P677, DOI 10.1016/j.tim.2018.01.005
   Dzobo K., Compr. Pharmacol, V2022, P408, DOI [10.1016/B978-0-12-820472-6.00041-4, DOI 10.1016/B978-0-12-820472-6.00041-4]
   Eichenwald EC, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3757
   Engelhardt G, 1997, ARZNEIMITTEL-FORSCH, V47, P917
   Esimone CO, 2008, TROP J PHARM RES, V7, P969
   Fabiani C, 2018, NEUROPHARMACOLOGY, V135, P464, DOI 10.1016/j.neuropharm.2018.03.041
   Faudone G, 2021, J MED CHEM, V64, P7156, DOI 10.1021/acs.jmedchem.1c00261
   Fehrholz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051575
   Ferri M, 2017, CRIT REV FOOD SCI, V57, P2857, DOI 10.1080/10408398.2015.1077192
   Flores-Ramos J.M., 2013, ISRN PAIN, V2013, P196429, DOI [10.1155/2013/196429, DOI 10.1155/2013/196429]
   Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149
   Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]
   Gasscht F, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0501-3
   GAYAWALI K, 1991, METHOD FIND EXP CLIN, V13, P529
   Golunski G, 2013, BIOORGAN MED CHEM, V21, P3280, DOI 10.1016/j.bmc.2013.03.043
   Granados-Soto V, 1999, J PHARMACOL TOX MET, V42, P67, DOI 10.1016/S1056-8719(00)00044-7
   GRANADOSSOTO V, 1993, J PHARM PHARMACOL, V45, P627, DOI 10.1111/j.2042-7158.1993.tb05666.x
   Greenway F L, 2001, Obes Rev, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   Gupta D, 2005, SUPPORT CARE CANCER, V13, P912, DOI 10.1007/s00520-005-0820-9
   Gururajanna B, 1999, INT J MOL MED, V4, P501
   Hashimoto T, 2004, CANCER RES, V64, P3344, DOI 10.1158/0008-5472.CAN-03-3453
   Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008
   Henderson-Smart DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000140.pub2
   Hong CT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061860
   Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x
   Ibrahim SA, 2006, FOOD CHEM, V99, P645, DOI 10.1016/j.foodchem.2005.08.026
   Igarashi K, 2016, ANTICANCER RES, V36, P4477, DOI 10.21873/anticanres.10992
   Ikram M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090902
   Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132
   Díaz-Reval MI, 2010, PHARMACOL BIOCHEM BE, V97, P357, DOI 10.1016/j.pbb.2010.09.004
   Izzo AA, 2012, MED PRIN PRACT, V21, P404, DOI 10.1159/000334488
   Jacobson KA, 2022, BRIT J PHARMACOL, V179, P3496, DOI 10.1111/bph.15103
   Kang NJ, 2011, CARCINOGENESIS, V32, P921, DOI 10.1093/carcin/bgr022
   Kang TNMZ, 2012, ANTIMICROB AGENTS CH, V56, P3216, DOI 10.1128/AAC.00066-12
   Karita M, 2008, ANTICANCER RES, V28, P1449
   Laurent C, 2016, MOL PSYCHIATR, V21, P97, DOI 10.1038/mp.2014.151
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Lipton RB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0806-2
   Liu AG, 2015, OBESITY, V23, P1830, DOI 10.1002/oby.21163
   Liu SH, 2012, J ETHNOPHARMACOL, V140, P614, DOI 10.1016/j.jep.2012.01.047
   MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G
   Mercadante S, 2001, J PAIN SYMPTOM MANAG, V21, P369, DOI 10.1016/S0885-3924(01)00249-4
   MISRA AL, 1985, BRIT J PHARMACOL, V84, P789, DOI 10.1111/j.1476-5381.1985.tb17372.x
   Mohammadrezaei FM, 2016, DRUG RES, V66, P450, DOI 10.1055/s-0042-109390
   Motegi T, 2013, RES VET SCI, V95, P600, DOI 10.1016/j.rvsc.2013.06.011
   Nakata H, 2015, ONCOL REP, V33, P1593, DOI 10.3892/or.2015.3761
   Nascimento GGF, 2000, BRAZ J MICROBIOL, V31, P247
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s
   Obodozie O.O., 2012, Readings in Advanced Pharmacokinetics-Theory, Methods and Applications, DOI DOI 10.5772/33699
   Oda Y, 2017, BIOL PHARM BULL, V40, P2005, DOI 10.1248/bpb.b17-00457
   Okubo S, 1991, Nihon Saikingaku Zasshi, V46, P509
   Ortiz MI, 2008, EUR J PAIN, V12, P233, DOI 10.1016/j.ejpain.2007.05.008
   Palaniappan K, 2010, INT J FOOD MICROBIOL, V140, P164, DOI 10.1016/j.ijfoodmicro.2010.04.001
   Pezzani R, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55040110
   Poch G., 1993, Combined effects of drugs and toxic agents: Modern evaluation in theory and practice
   Polski A, 2014, CURR ISS PHARM MED S, V27, P10, DOI 10.2478/cipms-2014-0003
   Popovic DJ, 2018, EUR REV MED PHARMACO, V22, P2461, DOI 10.26355/eurrev_201804_14840
   Rasool M, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/641597
   Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200
   Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3
   Roberts J.J., 1984, CAFFEINE, DOI [10.1007/978-3-642-69823-1_16, DOI 10.1007/978-3-642-69823-1_16]
   Robinson TP, 2016, LANCET, V387, pE1, DOI 10.1016/S0140-6736(15)00730-8
   Sawynok J, 1996, EUR J PHARMACOL, V298, P105, DOI 10.1016/0014-2999(95)00791-1
   Sawynok J, 1998, EUR J PHARMACOL, V347, P1, DOI 10.1016/S0014-2999(97)01605-1
   SAWYNOK J, 1993, PHARMACOL REV, V45, P43
   Sawynok J, 2011, PAIN, V152, P726, DOI 10.1016/j.pain.2010.10.011
   Schmidt B, 2008, NEONATOLOGY, V93, P284, DOI 10.1159/000121453
   Scott JR, 2017, J PAIN RES, V10, P1801, DOI 10.2147/JPR.S134421
   Shapiro RE, 2008, CURR PAIN HEADACHE R, V12, P311, DOI 10.1007/s11916-008-0052-z
   Shi D, 2003, CELL MOL NEUROBIOL, V23, P331, DOI 10.1023/A:1023688604792
   Silva AC, 2018, NEUROBIOL DIS, V117, P72, DOI 10.1016/j.nbd.2018.05.024
   Silva DM, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920180117
   Simola N., 2014, HDB NEUROTOXICITY, V1st ed., P2281
   Suh SY, 2013, J PAIN SYMPTOM MANAG, V46, P474, DOI 10.1016/j.jpainsymman.2012.10.232
   TOMITA K, 1989, CLIN THER, V11, P43
   Tsabar M, 2015, NUCLEIC ACIDS RES, V43, P6902, DOI 10.1093/nar/gkv525
   Tsuchiya H, 1998, ANTICANCER RES, V18, P3651
   Ulanowska K, 2005, BIOORG CHEM, V33, P402, DOI 10.1016/j.bioorg.2005.07.004
   van Gelder BM, 2007, EUR J CLIN NUTR, V61, P226, DOI 10.1038/sj.ejcn.1602495
   Vanden Bossche H, 1985, Curr Top Med Mycol, V1, P313
   VELDSTRA H, 1956, PHARMACOL REV, V8, P339
   Wang ZL, 2019, MED ONCOL, V36, DOI 10.1007/s12032-019-1323-8
   Weiser T, 2019, ADV THER, V36, P597, DOI 10.1007/s12325-019-0891-5
   Wilkinson SC, 2006, INT ARCH OCC ENV HEA, V79, P405, DOI 10.1007/s00420-005-0056-5
   Wink Michael, 2015, Medicines (Basel), V2, P251, DOI 10.3390/medicines2030251
   Wink M, 2008, CURR DRUG METAB, V9, P996, DOI 10.2174/138920008786927794
   Wostyn Peter, 2011, Int J Alzheimers Dis, V2011, P617420, DOI 10.4061/2011/617420
   Woziwodzka A, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15070872
   Woziwodzka A, 2013, CHEM RES TOXICOL, V26, P1660, DOI 10.1021/tx4002513
   Xu K, 2005, PHARMACOL THERAPEUT, V105, P267, DOI 10.1016/j.pharmthera.2004.10.007
NR 118
TC 13
Z9 13
U1 0
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD MAY 11
PY 2023
VL 16
IS 5
AR 730
DI 10.3390/ph16050730
PG 23
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA H7TA7
UT WOS:000997931100001
PM 37242514
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Ballard, SL
   Wellborn-Kim, JJ
   Clauson, KA
AF Ballard, Stephanie L.
   Wellborn-Kim, Jennifer J.
   Clauson, Kevin A.
TI Effects of Commercial Energy Drink Consumption on Athletic Performance
   and Body Composition
SO PHYSICIAN AND SPORTSMEDICINE
LA English
DT Article
DE energy drink; functional food; caffeine; taurine; athletic performance;
   weight loss
ID ACUTE HORMONAL RESPONSE; CAFFEINE INGESTION; THERMOGENIC DRINK; TAURINE;
   EXERCISE; SUPPLEMENTATION; OBESITY; SAFETY; RISK; MEN
AB Energy drinks are frequently marketed to individuals interested in athletics and an active lifestyle. From 2001 to 2008, estimates of energy drink use in adolescent to middle-aged populations ranged from 24% to 56%. Most energy drinks feature caffeine and a combination of other components, including taurine, sucrose, guarana, ginseng, niacin, pyridoxine, and cyanocobalamin. This article examines the evidence for 2 commonly purported uses of energy drinks: athletic performance enhancement and weight loss. Observed ergogenic benefits of energy drinks are likely attributable to caffeine and glucose content. There is conflicting evidence regarding the impact of energy drinks on weight loss, although some data suggest that combining energy drink use with exercise may enhance body fat reduction. As with any pharmacologically active substance, energy drinks are associated with adverse effects. Combining energy drinks with alcohol exacerbates safety concerns and is an increasingly common practice contributing to toxic jock identity among college-aged male athletes. Practitioners should monitor identified populations likely to consume these loosely regulated beverages.
C1 [Clauson, Kevin A.] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33328 USA.
   [Ballard, Stephanie L.; Wellborn-Kim, Jennifer J.] Nova SE Univ, Coll Pharm, W Palm Beach, FL USA.
C3 Nova Southeastern University; Nova Southeastern University
RP Clauson, KA (corresponding author), Nova SE Univ, Coll Pharm, 3200 S Univ Dr, Ft Lauderdale, FL 33328 USA.
EM clauson@nova.edu
OI Ballard, Stephanie/0000-0002-6648-4488
CR Acheson Kevin J., 2005, Metabolic Syndrome and Related Disorders, V3, P19, DOI 10.1089/met.2005.3.19
   Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021
   ARRIA AM, 2008, 136 ANN M EXP AM PUB
   Bahrke MS, 2009, INT J SPORT NUTR EXE, V19, P298, DOI 10.1123/ijsnem.19.3.298
   Ballistreri MC, 2008, REV LAT-AM ENFERM, V16, P558, DOI 10.1590/S0104-11692008000700009
   Barthel T, 2001, AMINO ACIDS, V20, P63, DOI 10.1007/s007260170066
   Baum M, 2001, AMINO ACIDS, V20, P75, DOI 10.1007/s007260170067
   Berger AJ, 2009, MED J AUSTRALIA, V190, P41, DOI 10.5694/j.1326-5377.2009.tb02263.x
   *BEV SPECTR, 2009 EN DRINK GUID
   Brons C, 2004, EUR J CLIN NUTR, V58, P1239, DOI 10.1038/sj.ejcn.1601955
   Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130
   Candow DG, 2009, J STRENGTH COND RES, V23, P1271, DOI 10.1519/JSC.0b013e3181a026c2
   Chapman Robert F, 2009, Phys Sportsmed, V37, P97, DOI 10.3810/psm.2009.12.1747
   Chelben J, 2008, GEN HOSP PSYCHIAT, V30, P187, DOI 10.1016/j.genhosppsych.2007.10.002
   Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055
   *COC COL CO, FULL THROTTL
   *COC COL CO, SOFT DRINK NUTR INF
   Dalbo VJ, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-6
   Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000
   Desbrow B, 2007, INT J SPORT NUTR EXE, V17, P328, DOI 10.1123/ijsnem.17.4.328
   Desbrow B, 2006, INT J SPORT NUTR EXE, V16, P545, DOI 10.1123/ijsnem.16.5.545
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x
   Ellender L, 2005, PRIMARY CARE, V32, P277, DOI 10.1016/j.pop.2004.11.008
   *EUR COMM HLTH CON, 2003, OP SCI COMM FOOD FUR
   *FAC, RED BULL
   *FAC, ROCKST EN DRINK US
   Finnegan D., 2003, Nutrition Bulletin, V28, P147, DOI 10.1046/j.1467-3010.2003.00345.x
   *FOODBEV, ANT TREND EM DRINKS
   Forbes SC, 2007, INT J SPORT NUTR EXE, V17, P433, DOI 10.1123/ijsnem.17.5.433
   Ganio MS, 2009, J STRENGTH COND RES, V23, P315, DOI 10.1519/JSC.0b013e31818b979a
   GEISS KR, 1994, AMINO ACIDS, V7, P45, DOI 10.1007/BF00808445
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Health Canada, 2009, CANADIAN ADVERSE REA, V19, P4
   Hoffman JR, 2008, J STRENGTH COND RES, V22, P874, DOI 10.1519/JSC.0b013e31816d5db6
   Ivy JL, 2009, INT J SPORT NUTR EXE, V19, P61, DOI 10.1123/ijsnem.19.1.61
   Iyadurai SJP, 2007, EPILEPSY BEHAV, V10, P504, DOI 10.1016/j.yebeh.2007.01.009
   Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566
   LOCKWOOD CM, J STRENGTH COND RES
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Machado-Vieira R, 2001, CAN J PSYCHIAT, V46, P454, DOI 10.1177/070674370104600524
   Malek MH, 2006, J STRENGTH COND RES, V20, P751
   Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35
   Masuda K, 2009, CLIN EXP DERMATOL, V34, pe263, DOI 10.1111/j.1365-2230.2008.03173.x
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490
   Nagajothi N, 2008, AM J MED, V121, pE3, DOI 10.1016/j.amjmed.2007.12.003
   National Collegiate Athletic Association, NCAA DRUG TEST PROGR
   O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   O'Dea JA, 2003, HEALTH EDUC RES, V18, P98, DOI 10.1093/her/18.1.98
   Oteri A, 2007, ALCOHOL CLIN EXP RES, V31, P1677, DOI 10.1111/j.1530-0277.2007.00464.x
   Petrie HJ, 2004, AM J CLIN NUTR, V80, P22
   Petróczi A, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-19
   Ratamess NA, 2007, INT J SPORT NUTR EXE, V17, P608, DOI 10.1123/ijsnem.17.6.608
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Roberts MD, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-19
   *ROCKST INC, ROCKST EN DRINK
   Röggla G, 2007, LANCET, V370, P220, DOI 10.1016/S0140-6736(07)61121-0
   Rush E, 2006, ASIA PAC J CLIN NUTR, V15, P242
   Schneiker KT, 2006, MED SCI SPORT EXER, V38, P578, DOI 10.1249/01.mss.0000188449.18968.62
   SEXSON B, 2009, NATL J CRIMINAL JUST, V4, P14
   SHERMAN WM, 1995, AM J CLIN NUTR, V62, p228S, DOI 10.1093/ajcn/62.1.228S
   Slater G, 2003, INT J SPORT NUTR EXE, V13, P320, DOI 10.1123/ijsnem.13.3.320
   SMITH N, 2007, EVID-BASED COMPL ALT, P1
   SOTANIEMI EA, 1995, DIABETES CARE, V18, P1373, DOI 10.2337/diacare.18.10.1373
   Steinke L, 2009, ANN PHARMACOTHER, V43, P596, DOI 10.1345/aph.1L614
   Stimulant Drinks Committee, 2002, REV HLTH EFF STIM DR
   Suliman ME, 2002, NEPHROL DIAL TRANSPL, V17, P528, DOI 10.1093/ndt/17.3.528
   Terlizzi R, 2008, CLIN AUTON RES, V18, P221, DOI 10.1007/s10286-008-0483-y
   *TWITT, RED BULL
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   *VEN EN, VEN REPR
   Vuksan V, 2000, DIABETES CARE, V23, P1221, DOI 10.2337/diacare.23.9.1221
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   WOLINSKY I, 1998, NUTR EXERCISE SPORTS, P183
   Woojae K., 2003, Nutrition Bytes, V9, P1
   Worrall BB, 2005, NEUROLOGY, V65, P1137, DOI 10.1212/01.wnl.0000178985.35765.e0
   Zhang M, 2004, AMINO ACIDS, V26, P203, DOI 10.1007/s00726-003-0002-3
   FIXX EXTREME ULTRA S
   2006, ESPN SOCCERNET  0309
   NATURAL MED COMPREHE
   BEVERAGE SPECTRUM MA
NR 83
TC 52
Z9 66
U1 2
U2 140
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0091-3847
EI 2326-3660
J9 PHYSICIAN SPORTSMED
JI Physician Sportsmed.
PD APR
PY 2010
VL 38
IS 1
BP 107
EP 117
DI 10.3810/psm.2010.04.1768
PG 11
WC Primary Health Care; Orthopedics; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC General & Internal Medicine; Orthopedics; Sport Sciences
GA 766SO
UT WOS:000290807000012
PM 20424408
DA 2025-04-28
ER

PT J
AU Hursel, R
   Westerterp-Plantenga, MS
AF Hursel, Rick
   Westerterp-Plantenga, Margriet S.
TI Catechin- and caffeine-rich teas for control of body weight in humans
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article; Proceedings Paper
CT 5th International Scientific Symposium on Tea and Human Health
CY SEP 19-19, 2012
CL Washington, DC
ID BROWN ADIPOSE-TISSUE; O-METHYLTRANSFERASE GENOTYPE; RANDOMIZED
   CONTROLLED-TRIAL; DIETARY-FAT OXIDATION; GREEN TEA; ENERGY-EXPENDITURE;
   EPIGALLOCATECHIN GALLATE; GUT MICROBIOTA; DOUBLE-BLIND; WHITE TEA
AB Maintaining the level of daily energy expenditure during weight loss and weight maintenance is as important as maintaining satiety while decreasing energy intake. In this context, different catechin- and caffeine-rich teas (CCRTs), such as green, oolong, and white teas, as well as caffeine have been proposed as tools for maintaining or enhancing energy expenditure and for increasing fat oxidation. Tea polyphenols have been proposed to counteract the decrease in metabolic rate that is usually present during weight loss. Their effects may be of particular importance during weight maintenance after weight loss. Although the thermogenic effect of CCRT has the potential to produce significant effects on these metabolic targets as well as on fat absorption and energy intake, possibly via its impact on the gut microbiota and gene expression, a clinically meaningful outcome also depends on compliance by the subjects. Limitations to this approach require further examination, including moderating factors such as genetic predisposition, habitual caffeine intake, and catechin composition and dose. Nevertheless, CCRTs may be useful agents that could help in preventing a positive energy balance and obesity.
C1 [Hursel, Rick; Westerterp-Plantenga, Margriet S.] Maastricht Univ, Dept Human Biol, Nutr & Toxicol Res Inst Maastricht NUTRIM, NL-6200 MD Maastricht, Netherlands.
C3 Maastricht University
RP Hursel, R (corresponding author), Maastricht Univ, Dept Human Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM rick.hursel@maastrichtuniversity.nl
FU Tea Council of the USA; American Cancer Society; American College of
   Nutrition; American Institute for Cancer Research; American Medical
   Women's Association; American Society for Nutrition; Linus Pauling
   Institute
FX Supported by the Tea Council of the USA.Presented at the conference
   "Fifth International Scientific Symposium on Tea and Human Health," held
   at the US Department of Agriculture, Washington, DC, 19 September 2012.
   The conference was organized by Jeffrey Blumberg, Tufts University,
   Boston, MA, and a Steering Committee including representatives from each
   of the symposium cosponsors: the American Cancer Society, the American
   College of Nutrition, the American Institute for Cancer Research, the
   American Medical Women's Association, the American Society for
   Nutrition, and the Linus Pauling Institute. The symposium was
   underwritten by the Tea Council of the USA. Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the Tea Council of the USA or the cosponsoring
   organizations.
CR Alcazar A, 2007, J AGR FOOD CHEM, V55, P5960, DOI 10.1021/jf070601a
   [Anonymous], APPETITE
   [Anonymous], PROGR MED
   Arts MJTJ, 2002, J AGR FOOD CHEM, V50, P1184, DOI 10.1021/jf010855a
   Arts MJTJ, 2001, FOOD CHEM TOXICOL, V39, P787, DOI 10.1016/S0278-6915(01)00020-5
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bäckhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Bajerska J., 2010, Pakistan Journal of Nutrition, V9, P696
   Bajzer M, 2006, NATURE, V444, P1009, DOI 10.1038/4441009a
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bodenmann S, 2010, SLEEP, V33, P1027, DOI 10.1093/sleep/33.8.1027
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BROWN PJ, 1963, J CHROMATOGR, V11, P504, DOI 10.1016/S0021-9673(01)80953-5
   Cabrera C, 2003, J AGR FOOD CHEM, V51, P4427, DOI 10.1021/jf0300801
   Cai ZJ, 1999, WHO TECH REP SER, V887, P1
   Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chen W., 1998, JPN J CLIN NUTR, V20, P83
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Conterno L, 2011, GENES NUTR, V6, P241, DOI 10.1007/s12263-011-0230-1
   Cornelis MC, 2007, AM J CLIN NUTR, V86, P240, DOI 10.1093/ajcn/86.1.240
   Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227
   Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146
   Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dridi S, 2009, J NUTR BIOCHEM, V20, P831, DOI 10.1016/j.jnutbio.2009.06.003
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1996, EUR J CLIN NUTR, V50, P152
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Egert S, 2013, EUR J NUTR, V52, P281, DOI 10.1007/s00394-012-0330-8
   Ferruzzi MG, 2012, PHYSIOL BEHAV, V107, P591, DOI 10.1016/j.physbeh.2012.02.020
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   Forester SC, 2012, MOL NUTR FOOD RES, V56, P1647, DOI 10.1002/mnfr.201200206
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637
   Gosselin C, 2013, BRIT J NUTR, V110, P282, DOI 10.1017/S0007114512005089
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   Hilal Y, 2007, J VERBRAUCH LEBENSM, V2, P414, DOI 10.1007/s00003-007-0250-3
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Himmerich H, 2010, PROTEIN PEPTIDE LETT, V17, P186, DOI 10.2174/092986610790225941
   Hodgson JM, 2006, BRIT J NUTR, V95, P14, DOI 10.1079/BJN20051621
   Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2011, NUTRIENTS, V3, P725, DOI 10.3390/nu3080725
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Inoue-Choi M, 2010, INT J MOL EPIDEMIOL, V1, P114
   Jakicic JM, 2012, NESTLE NUTR WORKS SE, V73, P21, DOI 10.1159/000341283
   Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x
   Jöbstl E, 2006, J AGR FOOD CHEM, V54, P4077, DOI 10.1021/jf053259f
   Josic J, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-63
   Josse AR, 2012, AM J CLIN NUTR, V96, P665, DOI 10.3945/ajcn.112.038794
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132
   Jurgens TM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008650.pub2
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kataoka K., 2004, Progress in Medicine, V24, P3358
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Krul C, 2001, MUTAT RES-FUND MOL M, V474, P71, DOI 10.1016/S0027-5107(00)00158-5
   Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P181, DOI 10.1080/09637480050029683
   Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240
   Lonac MC, 2011, OBESITY, V19, P298, DOI 10.1038/oby.2010.181
   Lorenz M, 2007, EUR HEART J, V28, P219, DOI 10.1093/eurheartj/ehl442
   Lu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038332
   Lu H, 2003, DRUG METAB DISPOS, V31, P452, DOI 10.1124/dmd.31.4.452
   Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572
   Lyon MR, 2011, ALTERN MED REV, V16, P348
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Männistö PT, 1999, PHARMACOL REV, V51, P593
   Maron DJ, 2003, ARCH INTERN MED, V163, P1448, DOI 10.1001/archinte.163.12.1448
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Miller RJ, 2012, MOL NUTR FOOD RES, V56, P966, DOI 10.1002/mnfr.201100726
   Miller RJ, 2012, EUR J NUTR, V51, P47, DOI 10.1007/s00394-011-0189-0
   Miller RJ, 2011, BRIT J NUTR, V105, P1138, DOI 10.1017/S0007114510004836
   Miyajima E, 2005, PROG MED TOKYO, V25, P831
   Mobbs CV, 2005, PHYSIOL BEHAV, V85, P3, DOI 10.1016/j.physbeh.2005.04.005
   Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Nagy TR, 1996, J APPL PHYSIOL, V80, P1743, DOI 10.1152/jappl.1996.80.5.1743
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   Otsuka K, 2002, JAPANESE J NUTR ASSE, V19, P365
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Pasman WJ, 1999, METABOLISM, V48, P15, DOI 10.1016/S0026-0495(99)90004-5
   Peters CM, 2010, FOOD RES INT, V43, P95, DOI 10.1016/j.foodres.2009.08.016
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Rastmanesh R, 2011, CHEM-BIOL INTERACT, V189, P1, DOI 10.1016/j.cbi.2010.10.002
   Richards JC, 2010, MED SCI SPORT EXER, V42, P739, DOI 10.1249/MSS.0b013e3181bcab6c
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Ryan L, 2010, NUTR RES, V30, P14, DOI 10.1016/j.nutres.2009.11.005
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Saito M, 2013, CURR OPIN LIPIDOL, V24, P71, DOI 10.1097/MOL.0b013e32835a4f40
   Santana-Rios G, 2001, MUTAT RES-GEN TOX EN, V495, P61, DOI 10.1016/S1383-5718(01)00200-5
   SCHUTZ Y, 1989, AM J CLIN NUTR, V50, P307, DOI 10.1093/ajcn/50.2.307
   Shishikura Y, 2006, J AGR FOOD CHEM, V54, P1906, DOI 10.1021/jf051988p
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Siebert KJ, 1996, J AGR FOOD CHEM, V44, P80, DOI 10.1021/jf9502459
   Söhle J, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-20
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Stunkard AJ, 1996, AM J MED, V100, P230, DOI 10.1016/S0002-9343(97)89464-8
   Takashima S., 2004, Progress in Medicine, V24, P3371
   Takeshita M, 2008, Jpn Pharmacol Ther, V36, P767
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   tsuchida t., 2002, Prog med, V9, P2189
   Tuohy KM, 2012, J AGR FOOD CHEM, V60, P8776, DOI 10.1021/jf2053959
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384
   Unachukwu UJ, 2010, J FOOD SCI, V75, pC541, DOI 10.1111/j.1750-3841.2010.01705.x
   Unno T, 2009, J NUTR SCI VITAMINOL, V55, P447, DOI 10.3177/jnsv.55.447
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288
   WADDEN TA, 1988, J CONSULT CLIN PSYCH, V56, P925, DOI 10.1037/0022-006X.56.6.925
   Walker J, 2012, FOOD CHEM TOXICOL, V50, P390, DOI 10.1016/j.fct.2011.09.041
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang S, 2006, J NUTR, V136, P2791, DOI 10.1093/jn/136.11.2791
   Weisburger JH, 1997, CANCER LETT, V114, P315, DOI 10.1016/S0304-3835(97)04691-0
   Westerterp KR, 2008, AM J CLIN NUTR, V87, P132, DOI 10.1093/ajcn/87.1.132
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Yang FJ, 2001, MOL PHARMACOL, V60, P528
   Yang FJ, 1998, J NUTR, V128, P2334, DOI 10.1093/jn/128.12.2334
   Yoneda T, 2009, METAB SYNDR RELAT D, V7, P349, DOI 10.1089/met.2008.0061
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
NR 160
TC 84
Z9 89
U1 4
U2 94
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD DEC
PY 2013
VL 98
IS 6
SU S
BP 1682S
EP 1693S
DI 10.3945/ajcn.113.058396
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 266DJ
UT WOS:000328002400010
PM 24172301
OA Bronze
DA 2025-04-28
ER

PT J
AU Ammatalli, NKR
   Kuricheti, SSSK
   Veeramachaneni, S
   Koo, YK
   Ramanathan, G
   Yalamanchi, A
AF Ammatalli, Nihal Kumar Reddy
   Kuricheti, Sesha Sai Siva Krishna
   Veeramachaneni, Sudipta
   Koo, Yean Kyoung
   Ramanathan, Guru
   Yalamanchi, Amulya
TI A combination of Citrus aurantifolia fruit rind and Theobroma cacao seed
   extracts supplementation enhances metabolic rates in overweight
   subjects: a randomized, placebo-controlled, cross-over study
SO FOOD & NUTRITION RESEARCH
LA English
DT Article
DE body fat mass; Citrus aurantifolia; fat and carbohydrate oxidation;
   resting energy expenditure; thermogenic botani- cal composition;
   Theobroma cacao
ID BROWN ADIPOSE-TISSUE; ENERGY-EXPENDITURE; WEIGHT-LOSS; OBESITY;
   THERMOGENESIS; DIET; ADIPOCYTES; OXIDATION; CAFFEINE
AB Background and objective: LN19183 is a proprietary, synergistic combination of Citrus aurantifolia fruit rind and Theobroma cacao seed extracts that increased resting energy expenditure (REE) in high-fat diet (HFD)fed obese rats. The objective of this study was to validate the thermogenic potential of LN19183 in obese Sprague Dawley (SD) rats and to assess its clinical efficacy in a proof-of-concept, randomized, placebo-controlled, cross-over human trial. Methods: : In the rat study, HFD-fed obese rats were supplemented with either HFD alone or with 45, 90, or 180 mg LN19183 per kg body weight (BW) for 28 days. In the human study, 60 overweight adults (male and female, aged 20-39 years) were randomized. Subjects took LN19183 (450 mg) or a matched placebo capsule on two consecutive days in phases one and two of the study, separated by a 10-day washout period. In each phase, on day 1, REE at pre-dose, 60-, 120-, and 180-min post-dose, and on day 2, metabolic rates at pre-dose and post-dose during and 20 min after exercise were measured using indirect calorimetry. Results: In rats, LN19183 significantly increased REE, reduced BW gain and fat masses, and increased fat and carbohydrate metabolism marker proteins including beta 3 adrenergic receptor (beta 3-AR), phospho-AMP-activated protein kinase (AMPK), glucagon-like peptide-1 receptor (GLP-1R) in the liver, and serum adiponectin levels. Furthermore, LN19183-supplemented human volunteers increased (P P < 0.05, vs. placebo) the metabolic rates at rest and with exercise; their fat oxidation was increased (P P < 0.05, vs. placebo) at rest and 20 min post-exercise. The groups' systolic and diastolic blood pressure (BP), heart rates (HR), and safety parameters were comparable. Conclusion:These observations suggest that LN19183 is a thermogenic botanical composition with no stimulatory effects on BP and HR.
C1 [Ammatalli, Nihal Kumar Reddy; Kuricheti, Sesha Sai Siva Krishna] Anu Hosp, Dept Gen Med, Vijayawada, India.
   [Veeramachaneni, Sudipta] SV Sci, Pittsburgh, PA USA.
   [Koo, Yean Kyoung] COSMAXBIO, Dept R&I Ctr, Seongnam, South Korea.
   [Ramanathan, Guru] Pennington Biomed Res Ctr, Pharmacol Based Clin Trials Lab, Baton Rouge, LA USA.
   [Yalamanchi, Amulya] Yalamanchi Hosp & Res Ctr, Dept Gen Med, Vijayawada 520002, Andhra Pradesh, India.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center
RP Yalamanchi, A (corresponding author), Yalamanchi Hosp & Res Ctr, Dept Gen Med, Vijayawada 520002, Andhra Pradesh, India.
EM yalamanchiamulya@gmail.com
OI Koo, Yeankyoung/0000-0003-1550-6824
FU Chemiloids Life Sciences Pvt. Ltd, Aswaraopet, Telangana, India
   [CLSOW1918320]
FX The authors thank Chemiloids Life Sciences Pvt. Ltd, Aswaraopet,
   Telangana, India (grant no. CLSOW1918320) , for funding the research and
   the clinical trial site monitors, the supporting staff, and the
   participants for their cooperation in completing the clinical study. The
   authors also thank the staff of the Pharmacology Department of Laila
   Nutraceuticals R&D Center, Vijayawada, India, for conducting the rat
   study.
CR Alshahrani SH, 2023, BMC ENDOCR DISORD, V23, DOI 10.1186/s12902-023-01477-1
   Arabi YM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020384
   Astrup A, 1999, PUBLIC HEALTH NUTR, V2, P341, DOI 10.1017/S1368980099000464
   Awasthi S, 2023, J NUTR SCI, V12, DOI 10.1017/jns.2023.83
   Baskin AS, 2018, DIABETES, V67, P2113, DOI 10.2337/db18-0462
   Blondin DP, 2020, CELL METAB, V32, P287, DOI 10.1016/j.cmet.2020.07.005
   Burke AC, 2018, J LIPID RES, V59, P1714, DOI 10.1194/jlr.M087387
   Campbell BI, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0125-z
   Church T, 2018, OBESITY, V26, P14, DOI 10.1002/oby.22072
   Cinti S, 2002, J ENDOCRINOL INVEST, V25, P823, DOI 10.1007/BF03344046
   Cuevas-Ramos D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00037
   Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009
   Danysz W, 2018, BBA-MOL BASIS DIS, V1864, P2972, DOI 10.1016/j.bbadis.2018.06.007
   De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814
   Finlin BS, 2020, J CLIN INVEST, V130, P2319, DOI 10.1172/JCI134892
   Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111
   Flippo KH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76593-2
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   Gandhi GR, 2020, NUTRIENTS, V12, DOI 10.3390/nu12102907
   Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001
   González-García I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143445
   Guest NS, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-020-00383-4
   Jang MH, 2018, BIOTECHNOL BIOPROC E, V23, P617, DOI 10.1007/s12257-018-0434-y
   Jimenez-Munoz CM, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14050435
   Kundimi S, 2024, J AM NUTR ASSOC, V43, P286, DOI 10.1080/27697061.2023.2280777
   Le TDV, 2023, MOL METAB, V72, DOI 10.1016/j.molmet.2023.101718
   LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001
   Maddahi NS, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05025-1
   Mund RA, 2013, CARDIOL REV, V21, P265, DOI 10.1097/CRD.0b013e31829cabff
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   Preza AM, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-61
   Rabadan-Chávez G, 2016, J FUNCT FOODS, V20, P54, DOI 10.1016/j.jff.2015.10.016
   Rachid TL, 2015, CELL BIOCHEM FUNCT, V33, P249, DOI 10.1002/cbf.3111
   Roberts AT, 2005, ALTERN MED REV, V10, P321
   Shabrova EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024634
   Shin EJ, 2013, FOOD CHEM, V141, P4115, DOI 10.1016/j.foodchem.2013.06.059
   Song NJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.70
   Stohs SJ, 2016, PHYTOTHER RES, V30, P732, DOI 10.1002/ptr.5583
   Tovar-Pérez EG, 2017, CYTA-J FOOD, V15, P489, DOI 10.1080/19476337.2017.1297963
   Wang JY, 2023, FRONT ENDOCRINOL, V14, DOI 10.3389/fendo.2023.1085799
   Wang XC, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/6620289
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493
   Zouhar P, 2021, MOL METAB, V53, DOI 10.1016/j.molmet.2021.101324
NR 46
TC 0
Z9 0
U1 0
U2 1
PU SWEDISH NUTRITION FOUNDATION-SNF
PI LUND
PA IDEON SCIENCE PARK, BESOK SCHEELEV 17 BETA 5, 3V, LUND, 223 70, SWEDEN
SN 1654-6628
EI 1654-661X
J9 FOOD NUTR RES
JI Food Nutr. Res.
PD AUG 1
PY 2024
VL 68
AR 10745
DI 10.29219/fnr.v68.10745
PG 14
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA F5N4V
UT WOS:001310284000001
PM 39113917
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Nelson, MC
   Neumark-Sztainer, D
   Hannan, PJ
   Story, M
AF Nelson, Melissa C.
   Neumark-Sztainer, Dianne
   Hannan, Peter J.
   Story, Mary
TI Five-Year Longitudinal and Secular Shifts in Adolescent Beverage Intake:
   Findings from Project EAT (Eating Among Teens)-II
SO JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
LA English
DT Article
ID FOOD FREQUENCY QUESTIONNAIRE; SOFT DRINK CONSUMPTION; UNITED-STATES;
   CHILDREN; TRENDS; OBESITY; PREVALENCE; OVERWEIGHT; ADULTHOOD; PATTERNS
AB Detailed research examining concurrent longitudinal and secular changes in adolescent beverage intake is not currently available, particularly since the year 2000. This study's objective was to evaluate these trends in beverage intake in a large, diverse adolescent cohort. Project EAT (Eating Among Teens)-II is a 5-year longitudinal study (n=2,516) including two cohorts, which allows for the observation of longitudinal changes from early to midadolescence (junior high to high school) and from mid- to late adolescence (high school to post high school). Project EAT-II also examined secular trends in adolescent health behavior from 1999-2004 in mid-adolescence. Daily beverage servings were assessed using the Youth and Adolescent Food Frequency Questionnaire. Longitudinal findings indicate that intake of soda and sugar-sweetened beverages (including soda, sweetened iced teas, and fruit drinks) increased significantly among younger males, and alcohol increased across all groups (P<0.01). Consumption of certain beverages decreased with age: fruit juice (among all males and older females, P <= 0.02), milk (older adolescents, P<0.01), other milk beverages (all females and older males, P<0.01), diet soda (younger adolescents, P<0.01), and coffee/tea (all males and younger females, P<0.01). Significant secular decreases were observed in fruit juice and coffee/tea for males and females (P <= 0.05). Overall, these findings reflect recent secular and longitudinal shifts in adolescent beverage consumption during the critical transition period from early to mid-adolescence and mid- to late adolescence. Although additional research is needed to better understand nuances in adolescent consumption patterns, registered dietitians and other health care practitioners working with adolescents should address the importance of limiting sugar-sweetened beverages with low nutrient density.
C1 [Nelson, Melissa C.; Neumark-Sztainer, Dianne; Hannan, Peter J.; Story, Mary] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities
RP Nelson, MC (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, 1300 S 2nd St,WBOB Suite 300, Minneapolis, MN 55454 USA.
EM nelson@epi.umn.edu
RI Neumark-Sztainer, Dianne/D-8574-2011
OI Laska, Melissa/0000-0002-3836-0269; Neumark-Sztainer,
   Dianne/0000-0001-9435-1669
FU Maternal and Child Health Bureau [R40 MC 00319]; Health Resources and
   Services Administration, Department of Health and Human Services;
   Obesity Prevention Center at the University of Minnesota
FX This study was supported by grant R40 MC 00319 from the Maternal and
   Child Health Bureau (Title V, Social Security Act), Health Resources and
   Services Administration, Department of Health and Human Services.
   Additional salary support was provided by the Obesity Prevention Center
   at the University of Minnesota.
CR [Anonymous], 2011, STEPS HLTH YOU
   [Anonymous], 2005, DIET GUID AM 2005
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Cavadini C, 2000, ARCH DIS CHILD, V83, P18, DOI 10.1136/adc.83.1.18
   Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026
   Diggle P. J., 2002, Analysis of Longitudinal Data, V2nd
   French SA, 2003, J AM DIET ASSOC, V103, P1326, DOI 10.1016/S0002-8223(03)01076-9
   Fulgoni V, 2007, J AM DIET ASSOC, V107, P256, DOI 10.1016/j.jada.2006.11.007
   Gamble M, 1999, AM J HEALTH BEHAV, V23, P261, DOI 10.5993/AJHB.23.4.3
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   Hawkes C., 2002, GLOBALIZATION DIETS
   Institute of Medicine (IOM), 2005, Public Health Nutrition, V9, P606
   Little R, 1986, INT STAT REV, V54, P137
   Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365
   Neumark-Sztainer D, 2006, J AM DIET ASSOC, V106, P559, DOI 10.1016/j.jada.2006.01.003
   Neumark-Sztainer D, 2002, AM J PUBLIC HEALTH, V92, P844, DOI 10.2105/AJPH.92.5.844
   Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Powell LM, 2007, AM J PREV MED, V33, pS251, DOI 10.1016/j.amepre.2007.07.009
   *QSR WEB, BEV TRENDS IMP QSR Q
   Rajeshwari R, 2005, J AM DIET ASSOC, V105, P208, DOI 10.1016/j.jada.2004.11.026
   Rampersaud GC, 2003, J AM DIET ASSOC, V103, P97, DOI 10.1053/jada.2003.50006
   ROCKETT HRH, 1995, J AM DIET ASSOC, V95, P336, DOI 10.1016/S0002-8223(95)00086-0
   Rockett HRH, 1997, PREV MED, V26, P808, DOI 10.1006/pmed.1997.0200
   Sichert-Hellert W, 2001, ACTA PAEDIATR, V90, P732, DOI 10.1080/080352501750315627
NR 27
TC 44
Z9 65
U1 0
U2 7
PU AMER DIETETIC ASSOC
PI CHICAGO
PA 216 W JACKSON BLVD #800, CHICAGO, IL 60606-6995 USA
SN 0002-8223
J9 J AM DIET ASSOC
JI J. Am. Diet. Assoc.
PD FEB
PY 2009
VL 109
IS 2
BP 308
EP 312
DI 10.1016/j.jada.2008.10.043
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 401CI
UT WOS:000262915500017
PM 19167959
DA 2025-04-28
ER

PT J
AU de Cosío-Barrón, ACG
   Hernández-Arriaga, AM
   Campos-Vega, R
AF Gonzalez de Cosio-Barron, Ana Cecilia
   Maria Hernandez-Arriaga, Angelica
   Campos-Vega, Rocio
TI Spent coffee (Coffea arabica L.) grounds positively modulate
   indicators of colonic microbial activity
SO INNOVATIVE FOOD SCIENCE & EMERGING TECHNOLOGIES
LA English
DT Article
DE Spent coffee grounds; Melanoidins; Oligosaccharides; In vitro colonic
   fermentation; Colonic enzymes; Short-chain fatty acids
ID CHAIN FATTY-ACIDS; DIETARY FIBER; GASTROINTESTINAL DIGESTION;
   CHEMICAL-CHARACTERIZATION; ANTIOXIDANT PROPERTIES; PHENOLIC-COMPOUNDS;
   FERMENTATION; MELANOIDINS; OLIGOSACCHARIDES; ABSORPTION
AB Spent coffee grounds (SCG; MR-medium and DR-dark-roasted) were submitted to an in vitro gastrointestinal digestion followed by a colonic fermentation using two microbiota communities (lean and overweight). The in vitro protective colonic effect of SCG was evaluated on colonic enzyme activities (beta-glucosidase, beta-glucuronidase, tryptophanase, and urease). The bioaccessibility of oligosaccharides and melanoidins, as well as colonic short-chain fatty acids (SCFAs) and ester production were determined and correlated with evaluated colonic enzymes. Melanoidins (8-17 mg/100 g) were highly correlated with antioxidant capacity (16-80 mu mol Trolox/g sample; r=-0.78, p=0.0001, ABTS), while raffinose was only detected during the colonic phase (1.22-4.23 mg/g) suggesting SCG use as human microbiota substrate. The extract obtained from MR-SCG colonic fermentation inhibited enzyme activity (up to 80%) at a rate similar to or even higher than inulin (used as a positive control during colonic fermentation). Using the same substrate (MR-SCG), microbial communities produced different amounts and SCFAs ester patterns, linked to the enzymatic inhibition effects. OW-microbiota produced the highest cumulative SCFAs (36 nmol/L; 55% more than L-microbiota). Molecular studies, and in vivo assays are needed to further elucidate the mechanisms exerted by SCG. Microbial communities need to be identified to determine the colonic effects of SCG and support their use as a functional food ingredient.
   Industrial relevance: Our results support the added value of this industrial by-product to be used as a nutraceutical or functional ingredient for food products. Reducing food losses and waste 'is essential' to improve the sustainability of food systems, and contribute to broader systemic changes, including nutrition and health. SCG are digested under in vitro human gastrointestinal condition, where nutraceutical compounds are released from the matrix exerting health benefits, including antioxidant capacity, and positively modulating indicators of colonic microbial activity.
C1 [Gonzalez de Cosio-Barron, Ana Cecilia; Maria Hernandez-Arriaga, Angelica; Campos-Vega, Rocio] Univ Autonoma Queretaro, Programa Posgrad Alimentos Ctr Republ PROPAC, Sch Chem, Res & Grad Studies Food Sci, Santiago De Queretaro 76010, Qro, Mexico.
C3 Universidad Autonoma de Queretaro
RP Campos-Vega, R (corresponding author), Univ Autonoma Queretaro, Programa Posgrad Alimentos Ctr Republ PROPAC, Sch Chem, Res & Grad Studies Food Sci, Santiago De Queretaro 76010, Qro, Mexico.
EM chio_cve@yahoo.com.mx
RI Campos-Vega, Rocio/JZC-8641-2024; Campos-Vega, Rocio/L-3151-2016
OI Hernandez-Arriaga, Angelica/0000-0002-9980-4695; Campos-Vega,
   Rocio/0000-0003-4054-1250
FU Consejo Nacional de Ciencia y Tecnologia (CONACyT) [FOMIX-QRO-279751];
   CONACyT [623269, 621898]
FX This study was supported by Consejo Nacional de Ciencia y Tecnologia
   (CONACyT) Grant CONACYT-Fondos Mixtos (FOMIX-QRO-279751). Ana Cecilia
   Gonzalez de Cosio-Barron and Angelica Maria Hernandez-Arriaga were
   supported by a scholarship from CONACyT [grants number 623269 and
   621898].
CR Alam MA, 2012, J PHARM PHARMACOL, V64, P326, DOI 10.1111/j.2042-7158.2011.01391.x
   Ames JM, 1999, BRIT J NUTR, V82, P489, DOI 10.1017/S0007114599001749
   An HM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-116
   AOAC (Association of Official Analytical Chemists), 2002, OFFICIAL METHODS ANA, V32
   Borrelli RC, 2002, J AGR FOOD CHEM, V50, P6527, DOI 10.1021/jf025686o
   Bryk G, 2016, EUR J NUTR, V55, P2445, DOI 10.1007/s00394-015-1052-5
   Campos-Vega R, 2015, FOOD RES INT, V77, P156, DOI 10.1016/j.foodres.2015.07.024
   Campos-Vega R, 2009, J FOOD SCI, V74, pT59, DOI 10.1111/j.1750-3841.2009.01292.x
   Campos-Vega R, 2017, FUNCT FOOD SCI TECHN, P123
   Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012
   Chong ESL, 2014, WORLD J MICROB BIOT, V30, P351, DOI 10.1007/s11274-013-1499-6
   Chong J, 2019, METABOLITES, V9, DOI 10.3390/metabo9030057
   Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480
   Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x
   Delgado-Andrade C, 2005, J AGR FOOD CHEM, V53, P7832, DOI 10.1021/jf0512353
   Delgado-Andrade C, 2018, ANNU REV FOOD SCI T, V9, P271, DOI 10.1146/annurev-food-030117-012441
   Díaz-Batalla L, 2006, J AGR FOOD CHEM, V54, P2045, DOI 10.1021/jf051706l
   Ferguson MJ, 2000, J SCI FOOD AGR, V80, P166, DOI 10.1002/(SICI)1097-0010(20000101)80:1<166::AID-JSFA512>3.0.CO;2-K
   Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w
   García-Gutiérrez N, 2017, J FUNCT FOODS, V30, P237, DOI 10.1016/j.jff.2017.01.014
   Gomes AC, 2018, GUT MICROBES, V9, P308, DOI 10.1080/19490976.2018.1465157
   Gråsten S, 2003, NUTR RES, V23, P1503, DOI 10.1016/S0271-5317(03)00164-7
   Hutkins RW, 2016, CURR OPIN BIOTECH, V37, P1, DOI 10.1016/j.copbio.2015.09.001
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Jeszka-Skowron M, 2016, EUR FOOD RES TECHNOL, V242, P1403, DOI 10.1007/s00217-016-2643-y
   Jiménez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Lassoued MA, 2011, J PHARM PHARM SCI, V14, P117, DOI 10.18433/J3GC7R
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lee DK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-21
   LEE IE, 1992, BIOSCI BIOTECH BIOCH, V56, P21, DOI 10.1271/bbb.56.21
   Luzardo-Ocampo I, 2017, FOOD RES INT, V100, P304, DOI 10.1016/j.foodres.2017.07.018
   Zamora-Gasga VM, 2015, LWT-FOOD SCI TECHNOL, V60, P766, DOI 10.1016/j.lwt.2014.10.032
   Hernández-Arriaga AM, 2017, FOOD RES INT, V97, P191, DOI 10.1016/j.foodres.2017.04.004
   López-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175
   Martínez-Villaluenga C, 2008, FOOD CHEM, V107, P258, DOI 10.1016/j.foodchem.2007.08.011
   Mora D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004472
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   NAIR BM, 1981, PROG FOOD NUTR SCI, V5, P217
   Nenadis N, 2004, J AGR FOOD CHEM, V52, P4669, DOI 10.1021/jf0400056
   Neyrinck AM, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0019-z
   Passos CP, 2013, CARBOHYD POLYM, V94, P626, DOI 10.1016/j.carbpol.2013.01.088
   Pérez-Burillo S, 2019, J AGR FOOD CHEM, V67, P2500, DOI 10.1021/acs.jafc.8b06604
   Rahat-Rozenbloom S, 2014, INT J OBESITY, V38, P1525, DOI 10.1038/ijo.2014.46
   Sales AL, 2019, COFFEE: CONSUMPTION AND HEALTH IMPLICATIONS, P286
   Saura-Calixto F, 2010, MOL NUTR FOOD RES, V54, P939, DOI 10.1002/mnfr.200900276
   Shiga TM, 2009, CARBOHYD POLYM, V76, P100, DOI 10.1016/j.carbpol.2008.09.035
   Tagliazucchi D, 2015, AMINO ACIDS, V47, P1077, DOI 10.1007/s00726-015-1951-z
   Tian T, 2017, J AGR FOOD CHEM, V65, P2784, DOI 10.1021/acs.jafc.6b04716
   Vázquez-Sánchez K, 2018, FOOD CHEM, V261, P253, DOI 10.1016/j.foodchem.2018.04.064
   Wagner KH, 2002, FOOD CHEM, V78, P375, DOI 10.1016/S0308-8146(02)00200-5
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089
   Yoshida Y, 2009, MICROBIOL-SGM, V155, P968, DOI 10.1099/mic.0.024174-0
   Zacarías MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200305
   Zamora-Gasga V., 2018, CEREAL CHEM, P1
NR 55
TC 21
Z9 21
U1 2
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1466-8564
EI 1878-5522
J9 INNOV FOOD SCI EMERG
JI Innov. Food Sci. Emerg. Technol.
PD MAR
PY 2020
VL 60
AR 102286
DI 10.1016/j.ifset.2019.102286
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA LF4DP
UT WOS:000527369800015
DA 2025-04-28
ER

PT J
AU Montenegro-Bethancourt, G
   Vossenaar, M
   Doak, CM
   Solomons, NW
AF Montenegro-Bethancourt, Gabriela
   Vossenaar, Marieke
   Doak, Colleen M.
   Solomons, Noel W.
TI Contribution of beverages to energy, macronutrient and micronutrient
   intake of third- and fourth-grade schoolchildren in Quetzaltenango,
   Guatemala
SO MATERNAL AND CHILD NUTRITION
LA English
DT Article
DE water; beverage; juice; milk; energy; micronutrients; schoolchildren;
   24-h food record; childhood nutrition; Guatemala
ID DISCONTINUING COFFEE INTAKE; SUGAR-SWEETENED BEVERAGES; DRINKING-WATER;
   CHILDHOOD OBESITY; CONSUMPTION; CHILDREN; WEIGHT; FOODS; GROWTH;
   ASSOCIATION
AB Beverages are selected based on availability, culture, taste preference, health, safety and social context. Beverages may be important to energy and to the macronutrient and micronutrient quality of overall intake. The aim of this study was to determine the contribution of beverages to the dietary energy and estimated macro- and micronutrient intake to the diet of young schoolchildren. We analyzed data from third- and fourth-grade urban Guatemalan school-children aged predominantly 8-10 years old. One-day pictorial registries of all beverages, foods and snacks consumed over a 24-h period were collected from children from private (n = 219) and public (n = 230) schools. Food composition nutrient values were assigned to the items consumed. Eleven main categories of beverages were identified. The contribution of each of the 11 beverage categories to energy, macro- and micronutrients was evaluated. The estimated intake of beverages was 475 300 mL, as reported by the 449 children. As a group, the beverage consumed in the greatest quantity was coffee (126 500 mL), followed by plain water (62 000 mL). Beverages represented a mean energy contribution of 418 +/- 26 kcal (21.5% of total dietary energy). The beverages varied in energy density from 0 (water) to 1.5 kcal mL-1 (thin gruels). Beverages contributed one-third of the dietary carbohydrate. Through the contribution of fortified drinks, beverages were important sources of vitamin A (55%), vitamin C (38%), zinc (21%) and calcium (19%). Milk was an important source for vitamin D (10%). These results show the importance of drinks to nutrition and the balance of concerns of overweight/obesity with micronutrient quality.
C1 [Montenegro-Bethancourt, Gabriela; Vossenaar, Marieke; Solomons, Noel W.] CeSSIAM, Guatemala City 01011, Guatemala.
   [Doak, Colleen M.] Vrije Univ Amsterdam, Inst Hlth Sci, Fac Earth & Life Sci, Amsterdam, Netherlands.
C3 Vrije Universiteit Amsterdam
RP Montenegro-Bethancourt, G (corresponding author), CeSSIAM, 17 Ave 16-89 Interior,Zona 11 Anillo Periferico, Guatemala City 01011, Guatemala.
EM cessiam@guate.net.gt
RI Doak, Colleen/R-4229-2019
OI Vossenaar, Marieke/0000-0002-2101-2620; Montenegro-Bethancourt,
   Gabriela/0009-0002-6724-4803
CR Allen L., 2006, Guidelines on Food Fortification with Micronutrients
   Avery AA, 1999, ENVIRON HEALTH PERSP, V107, P583, DOI 10.2307/3434401
   Baxter SD, 2006, NUTR RES, V26, P241, DOI 10.1016/j.nutres.2006.05.005
   Benton D, 2004, INT J OBESITY, V28, P858, DOI 10.1038/sj.ijo.0802532
   Blum JW, 2005, J AM COLL NUTR, V24, P93, DOI 10.1080/07315724.2005.10719449
   Cordain L, 1999, World Rev Nutr Diet, V84, P19
   CORDAIN L, 2002, STUDIES HLTH DIS, P144
   Cotton PA, 2004, J AM DIET ASSOC, V104, P921, DOI 10.1016/j.jada.2004.03.019
   Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S
   Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24
   Dennison BA, 1999, J AM COLL NUTR, V18, P346, DOI 10.1080/07315724.1999.10718874
   Dewey KG, 1997, J NUTR, V127, P306, DOI 10.1093/jn/127.2.306
   Dewey KG, 1997, AM J CLIN NUTR, V66, P168, DOI 10.1093/ajcn/66.1.168
   Dietz WH, 2006, J PEDIATR-US, V148, P152, DOI 10.1016/j.jpeds.2005.12.045
   Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011
   Engle PL, 1999, EARLY HUM DEV, V53, P251, DOI 10.1016/S0378-3782(98)00080-2
   Forshee RA, 2006, J AM COLL NUTR, V25, P108, DOI 10.1080/07315724.2006.10719520
   Forshee RA, 2003, INT J FOOD SCI NUTR, V54, P297, DOI [10.1080/09637480120092143, 10.1080/096374803766666175]
   Fulgoni VL, 2007, J AM COLL NUTR, V26, p588S, DOI 10.1080/07315724.2007.10719663
   GEBHARDT SE, 2004, USDA NUTR DAT STAND
   Gibson S, 2007, INT J FOOD SCI NUTR, V58, P445, DOI 10.1080/09637480701288363
   Gilbert Rachel, 2006, Nurs Times, V102, P55
   Gill TP, 2006, MED J AUSTRALIA, V184, P263, DOI 10.5694/j.1326-5377.2006.tb00233.x
   Groeneveld IF, 2007, REV PANAM SALUD PUBL, V22, P169, DOI 10.1590/S1020-49892007000800003
   Groeneveld IF, 2007, INT J PEDIATR OBES, V2, P114, DOI 10.1080/17477160601127426
   James J, 2005, INT J OBESITY, V29, pS54, DOI 10.1038/sj.ijo.0803062
   Johnson L, 2007, NUTRITION, V23, P557, DOI 10.1016/j.nut.2007.05.005
   Krause VM, 1998, J NUTR, V128, P860, DOI 10.1093/jn/128.5.860
   Kruawal K, 2005, SCI TOTAL ENVIRON, V340, P57, DOI 10.1016/j.scitotenv.2004.08.008
   Liang Jennifer L., 2006, Morbidity and Mortality Weekly Report, V55, P31
   Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Menchu M.T., 2000, Tabla de Composicion de Alimentos de Centroamerica
   Montenegro-Bethancourt G, 2009, REV PANAM SALUD PUBL, V25, P146, DOI 10.1590/S1020-49892009000200008
   Moore GF, 2007, EUR J CLIN NUTR, V61, P420, DOI 10.1038/sj.ejcn.1602531
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   O'Connor TM, 2006, PEDIATRICS, V118, pE1010, DOI 10.1542/peds.2005-2348
   Pizarro Fernando, 1999, Reviews on Environmental Health, V14, P231
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Popkin BM, 2005, OBES RES, V13, P2146, DOI 10.1038/oby.2005.266
   Pridmore P., 1995, HEALTH EDUC J, V54, P473, DOI [10.1177/001789699505400410, DOI 10.1177/001789699505400410]
   Ritz P, 2005, NUTR REV, V63, pS6, DOI 10.1111/j.1753-4887.2005.tb00155.x
   Rivera Juan A, 2008, Salud pública Méx, V50, P173
   Rolls BJ., 1982, THIRST
   Sanigorski AM, 2007, PUBLIC HEALTH NUTR, V10, P152, DOI 10.1017/S1368980007246634
   Shenkin Jonathan D, 2003, Gen Dent, V51, P30
   SIMOONS FJ, 1978, AM J DIGESTIVE DIS, V23, P363
   Solomons NW, 2009, NUTRITION, V25, P385, DOI 10.1016/j.nut.2008.09.013
   Stookey JD, 2001, EUR J CLIN NUTR, V55, P349, DOI 10.1038/sj.ejcn.1601163
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   VOSSENAAR M, 2008, PUBLIC HEALTH NUTR, V9, P1
NR 53
TC 7
Z9 8
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1740-8695
EI 1740-8709
J9 MATERN CHILD NUTR
JI Matern. Child Nutr.
PD APR
PY 2010
VL 6
IS 2
BP 174
EP 189
DI 10.1111/j.1740-8709.2009.00193.x
PG 16
WC Nutrition & Dietetics; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Pediatrics
GA 568OK
UT WOS:000275531800006
PM 20624213
OA Green Published
DA 2025-04-28
ER

PT J
AU Semiz, S
   Serdarevic, F
AF Semiz, Sabina
   Serdarevic, Fadila
TI Prevention and Management of Type 2 Diabetes and Metabolic Syndrome in
   the Time of COVID-19: Should We Add a Cup of Coffee?
SO FRONTIERS IN NUTRITION
LA English
DT Review
DE polyphenols; coffee; COVID-19; ACE2; type 2 diabetes; obesity; insulin
   resistance; physical activity
ID ANGIOTENSIN-CONVERTING ENZYME; GREEN TEA; CARDIOVASCULAR RISK; POLISH
   ARM; ACE2; CONSUMPTION; ASSOCIATION; EXPRESSION; METFORMIN; FAT
AB Recent evidence shows that COVID-19 patients with existing metabolic disorders, such as diabetes and metabolic syndrome, are exposed to a high risk of morbidity and mortality. At the same time, in order to manage the pandemic, the health authorities around the world are advising people to stay at home. This results in decreased physical activity and an increased consumption of an unhealthy diet, which often leads to an increase in body weight, risk for diabetes, insulin resistance, and metabolic syndrome, and thus, paradoxically, to a high risk of morbidity and mortality due to COVID-19 complications. Here we summarize the evidence demonstrating that the promotion of a healthy life style, including physical activity and a dietary intake of natural polyphenols present in coffee and tea, has the potential to improve the prevention and management of insulin resistance and diabetes in the time of COVID-19 pandemic. Particularly, it would be pertinent to evaluate further the potential positive effects of coffee beverages, rich in natural polyphenols, as an adjuvant therapy for COVID-19, which appear not to be studied sufficiently.
C1 [Semiz, Sabina] Khalifa Univ, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates.
   [Semiz, Sabina; Serdarevic, Fadila] Assoc South East European Network Med Res SOVE, Sarajevo, Bosnia & Herceg.
   [Serdarevic, Fadila] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands.
C3 Khalifa University of Science & Technology; Erasmus University
   Rotterdam; Erasmus MC
RP Semiz, S (corresponding author), Khalifa Univ, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates.; Semiz, S (corresponding author), Assoc South East European Network Med Res SOVE, Sarajevo, Bosnia & Herceg.
EM sabina.semiz@ku.ac.ae
RI Serdarevic, Fadila/X-4503-2019
OI Semiz, Sabina/0000-0003-2629-4660; Serdarevic,
   Fadila/0000-0002-5803-7979
CR Ali N, 2020, J INFECT PUBLIC HEAL, V13, P1373, DOI 10.1016/j.jiph.2020.06.021
   Almandoz J.P., 2020, CLIN OBES, V10, pe 12386, DOI [DOI 10.1111/cob.12386, 10.1111/cob.12386]
   Ammar A, 2020, NUTRIENTS, V12
   [Anonymous], 2020, row Transplant, V6, P43, DOI [10.1590/1413-7054201943029518, 10.1080/14766080802648631]
   [Anonymous], 2020, NUTRIENTS
   [Anonymous], 2018, LIPIDS HEALTH DIS
   [Anonymous], 2018, INT J MOL SCI
   [Anonymous], 2019, DIABETOL METAB SYNDR
   Batlle D, 2020, CLIN SCI, V134, P543, DOI 10.1042/CS20200163
   Bhardwaj VK, 2021, J BIOMOL STRUCT DYN, V39, P3449, DOI 10.1080/07391102.2020.1766572
   Cao H, 2019, CRIT REV FOOD SCI, V59, P3371, DOI 10.1080/10408398.2018.1492900
   Cao X, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1145-x
   Cao X, 2014, MOL CELL ENDOCRINOL, V393, P30, DOI 10.1016/j.mce.2014.05.024
   Carboni E, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109776
   Caro-Gómez E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030497
   Casal S, 2017, CURR MED CHEM, V24, P376, DOI 10.2174/0929867323666161003123717
   Chen C, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-24
   Chen Y, 2018, CHINESE MED J-PEKING, V131, P376, DOI 10.4103/0366-6999.223856
   Clark KJ, 1998, VET MICROBIOL, V63, P147, DOI 10.1016/S0378-1135(98)00242-9
   Constandt B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114144
   Cory H, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00087
   Dalan R, 2020, HORM METAB RES, V52, P257, DOI 10.1055/a-1155-0501
   Di Renzo L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02399-5
   Fan ZM, 2019, LIFE SCI, V225, P39, DOI 10.1016/j.lfs.2019.03.059
   Fernandes T, 2010, BRAZ J MED BIOL RES, V43, P837, DOI 10.1590/S0100-879X2010007500088
   Frantz ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067192
   Gao F, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0321-8
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Grosso G, 2017, BRIT J NUTR, V118, P60, DOI [10.1017/S0007114517001805, 10.1017/s0007114517001805]
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Guo Y, 2008, VIRUS RES, V133, P4, DOI 10.1016/j.virusres.2007.01.022
   Gupte M, 2008, AM J PHYSIOL-REG I, V295, pR781, DOI 10.1152/ajpregu.00183.2008
   Härdtner C, 2013, INT J MOL MED, V32, P795, DOI 10.3892/ijmm.2013.1469
   Higashi Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092104
   Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052
   Horne JR, 2020, AM J PHYSIOL-ENDOC M, V318, pE830, DOI 10.1152/ajpendo.00150.2020
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   Kawada T, 2018, BRIT J NUTR, V120, P240, DOI 10.1017/S0007114518001289
   Kim EN, 2018, ATHEROSCLEROSIS, V270, P123, DOI 10.1016/j.atherosclerosis.2018.01.043
   Kim Y, 2018, BRIT J NUTR, V120, P1279, DOI [10.1017/S0007114518002635, 10.1017/s0007114518002635]
   Kishor K, 2020, J PAK MED ASSOC, V70, pS77, DOI 10.5455/JPMA.14
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Kumar A, 2018, MOL CELL BIOCHEM, V438, P167, DOI 10.1007/s11010-017-3123-9
   Kuo CS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58361-4
   Leandro CG, 2020, NEUROIMMUNOMODULAT, V27, P75, DOI 10.1159/000508951
   Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9
   Li HW, 2011, PHYTOTHER RES, V25, P338, DOI 10.1002/ptr.3260
   Li XC, 2017, PHARMACOL RES, V125, P21, DOI 10.1016/j.phrs.2017.06.005
   Lin SC, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2253-8
   Liu C, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0771-3
   Liu FR, 2020, CLIN GASTROENTEROL H, V18, P2128, DOI 10.1016/j.cgh.2020.04.040
   Lukassen S, 2020, EMBO J, V39, DOI 10.15252/embj.20105114
   Luo P, 2020, AM J TROP MED HYG, V103, P69, DOI 10.4269/ajtmh.20-0375
   Magrone T, 2020, ENDOCR METAB IMMUNE, V20, P807, DOI 10.2174/1871530320666200427112902
   Mani JS, 2020, VIRUS RES, V284, DOI 10.1016/j.virusres.2020.197989
   Marinella MA, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13535
   Martinez-Ferran M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061549
   Menendez JA, 2020, AGING-US, V12, P8760, DOI 10.18632/aging.103347
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   Mizuiri S, 2008, AM J KIDNEY DIS, V51, P613, DOI 10.1053/j.ajkd.2007.11.022
   Mortensen E, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.congress-2018.PA2639
   Morvaridi M, 2020, J DIABETES METAB DIS, V19, P645, DOI 10.1007/s40200-020-00536-x
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagai E, 2019, PLANT FOOD HUM NUTR, V74, P538, DOI 10.1007/s11130-019-00773-3
   Nakagawa T, 2002, J AGR FOOD CHEM, V50, P2418, DOI 10.1021/jf011339n
   Narici M, 2021, EUR J SPORT SCI, V21, P614, DOI 10.1080/17461391.2020.1761076
   Nilsson PM, 2019, EUR J PREV CARDIOL, V26, P33, DOI 10.1177/2047487319886404
   O'Callaghan F, 2018, RISK MANAG HEALTHC P, V11, P263, DOI 10.2147/RMHP.S156404
   Orioli L, 2020, ANN ENDOCRINOL-PARIS, V81, P101, DOI 10.1016/j.ando.2020.05.001
   Pahlavani M, 2017, COMPR PHYSIOL, V7, P1137, DOI 10.1002/cphy.c160031
   Paizis G, 2005, GUT, V54, P1790, DOI 10.1136/gut.2004.062398
   Pal R, 2020, DIAB MET SYND CLIN R, V14, P513, DOI 10.1016/j.dsx.2020.04.049
   Park JY, 2017, J ENZYM INHIB MED CH, V32, P504, DOI 10.1080/14756366.2016.1265519
   Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298
   Pollak M, 2017, DIABETOLOGIA, V60, P1662, DOI 10.1007/s00125-017-4352-x
   Randazzo W, 2017, FOOD MICROBIOL, V66, P150, DOI 10.1016/j.fm.2017.04.018
   Rebollo-Hernanz M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080279
   Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497
   Reis CEG, 2019, J TRADIT COMPL MED, V9, P184, DOI 10.1016/j.jtcme.2018.01.001
   Reis CEG, 2018, BRIT J NUTR, V119, P1029, DOI 10.1017/S000711451800034X
   Ren HH, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01035-2
   Rhodes JM, 2020, ALIMENT PHARM THER, V51, P1434, DOI 10.1111/apt.15777
   Sacramento JF, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00262
   Sairro ST, 2007, J AGR FOOD CHEM, V55, P9409, DOI 10.1021/jf071796p
   Santos RA, 2014, HYPERTENSION, V63, P1138, DOI 10.1161/HYPERTENSIONAHA.113.01274
   Sergi Consolato, 2020, Arch Med Sci Atheroscler Dis, V5, pe98, DOI 10.5114/amsad.2020.95884
   Shi L, 2020, J INTERN MED, V287, P405, DOI 10.1111/joim.13009
   Shin S, 2019, APPL PHYSIOL NUTR ME, V44, P1371, DOI 10.1139/apnm-2018-0880
   Shin WJ, 2012, BIOSCI BIOTECH BIOCH, V76, P581, DOI 10.1271/bbb.110764
   Sinisi V, 2017, PLANTA MED, V83, P615, DOI 10.1055/s-0042-119449
   Suliga E, 2017, INT J FOOD SCI NUTR, V68, P507, DOI 10.1080/09637486.2016.1256381
   Sundararajan A, 2010, ANTIVIR RES, V88, P1, DOI 10.1016/j.antiviral.2010.06.014
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Takeda M, 2013, DIABETES, V62, P223, DOI 10.2337/db12-0177
   Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200
   Tomczynska M, 2016, CURR TOP MED CHEM, V16, P2223, DOI 10.2174/1568026616666160216152324
   Ursini F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01236
   Wahedi HM, 2021, J BIOMOL STRUCT DYN, V39, P3225, DOI 10.1080/07391102.2020.1762743
   Wallach JD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l7078
   Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065213
   Xuan XP, 2018, METABOLISM, V81, P83, DOI 10.1016/j.metabol.2017.12.003
   Yang J, 2012, FITOTERAPIA, V83, P348, DOI 10.1016/j.fitote.2011.11.016
   Yook HS, 2010, AM J CHINESE MED, V38, P937, DOI 10.1142/S0192415X10008366
   Zachary Z, 2020, OBES RES CLIN PRACT, V14, P210, DOI 10.1016/j.orcp.2020.05.004
   Zahedipour F, 2020, PHYTOTHER RES, V34, P2911, DOI 10.1002/ptr.6738
   Zbinden-Foncea H, 2020, OBESITY, V28, P1378, DOI 10.1002/oby.22849
   Zhang W, 2013, ANN HEPATOL, V12, P892, DOI 10.1016/S1665-2681(19)31294-3
   Zhong JC, 2008, BRIT J PHARMACOL, V153, P66, DOI 10.1038/sj.bjp.0707482
NR 108
TC 4
Z9 4
U1 0
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD OCT 6
PY 2020
VL 7
AR 581680
DI 10.3389/fnut.2020.581680
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA OC9JJ
UT WOS:000579470700001
PM 33123550
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Quarta, S
   Scoditti, E
   Carluccio, MA
   Calabriso, N
   Santarpino, G
   Damiano, F
   Siculella, L
   Wabitsch, M
   Verri, T
   Favari, C
   Del Rio, D
   Mena, P
   De Caterina, R
   Massaro, M
AF Quarta, Stefano
   Scoditti, Egeria
   Carluccio, Maria Annunziata
   Calabriso, Nadia
   Santarpino, Giuseppe
   Damiano, Fabrizio
   Siculella, Luisa
   Wabitsch, Martin
   Verri, Tiziano
   Favari, Claudia
   Del Rio, Daniele
   Mena, Pedro
   De Caterina, Raffaele
   Massaro, Marika
TI Coffee Bioactive N-Methylpyridinium Attenuates Tumor Necrosis
   Factor (TNF)-α-Mediated Insulin Resistance and Inflammation in Human
   Adipocytes
SO BIOMOLECULES
LA English
DT Article
DE coffee bioactives; N-methylpyridinium; adipocytes; inflammation; insulin
   resistance
ID PROLIFERATOR-ACTIVATED RECEPTORS; ADIPOSE TRIGLYCERIDE LIPASE;
   TNF-ALPHA; IN-VITRO; 3T3-L1 ADIPOCYTES; OXIDATIVE STRESS; TERMINAL
   KINASE; OBESITY; EXPRESSION; TISSUE
AB Although coffee consumption has been historically associated with negative health outcomes, recent evidence suggests a lower risk of metabolic syndrome, obesity and diabetes among regular coffee drinkers. Among the plethora of minor organic compounds assessed as potential mediators of coffee health benefits, trigonelline and its pyrolysis product N-methylpyridinium (NMP) were preliminary shown to promote glucose uptake and exert anti-adipogenic properties. Against this background, we aimed at characterizing the effects of trigonelline and NMP in inflamed and dysfunctional human adipocytes. Human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes were treated with NMP or, for comparison, trigonelline, for 5 h before stimulation with tumor necrosis factor (TNF)-alpha. NMP at concentrations as low as 1 mu mol/L reduced the stimulated expression of several pro-inflammatory mediators, including C-C Motif chemokine ligand (CCL)-2, C-X-C Motif chemokine ligand (CXCL)-10, and intercellular adhesion Molecule (ICAM)-1, but left the induction of prostaglandin G/H synthase (PTGS)2, interleukin (IL)-1 beta, and colony stimulating factor (CSF)1 unaffected. Furthermore, NMP restored the downregulated expression of adiponectin (ADIPOQ). These effects were functionally associated with downregulation of the adhesion of monocytes to inflamed adipocytes. Under the same conditions, NMP also reversed the TNF-alpha-mediated suppression of insulin-stimulated Ser473 Akt phosphorylation and attenuated the induction of TNF-alpha-stimulated lipolysis restoring cell fat content. In an attempt to preliminarily explore the underlying mechanisms of its action, we show that NMP restores the expression of the master regulator of adipocyte differentiation peroxisome proliferator-activated receptor (PPAR)gamma and downregulates activation of the pro-inflammatory mitogen-activated protein jun N-terminal kinase (JNK). In conclusion, NMP reduces adipose dysfunction in pro-inflammatory activated adipocytes. These data suggest that bioactive NMP in coffee may improve the inflammatory and dysmetabolic milieu associated with obesity.
C1 [Quarta, Stefano; Damiano, Fabrizio; Siculella, Luisa; Verri, Tiziano] Univ Salento, Dept Biol & Environm Sci & Technol DISTEBA, I-73100 Lecce, Italy.
   [Scoditti, Egeria; Carluccio, Maria Annunziata; Calabriso, Nadia; Massaro, Marika] Natl Res Council CNR, Inst Clin Physiol IFC, I-73100 Lecce, Italy.
   [Santarpino, Giuseppe] Paracelsus Med Univ, Cardiovasc Ctr, D-90471 Nurnberg, Germany.
   [Santarpino, Giuseppe] Citta di Lecce Hosp, GVM Care & Res, I-73100 Lecce, Italy.
   [Santarpino, Giuseppe] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Cardiac Surg Unit, I-88100 Catanzaro, Italy.
   [Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol Diabet & Obes, D-89075 Ulm, Germany.
   [Favari, Claudia; Del Rio, Daniele; Mena, Pedro] Univ Parma, Dept Food & Drugs, Human Nutr Unit, I-43125 Parma, Italy.
   [De Caterina, Raffaele] Pisa Univ Hosp, Cardiol Div, I-56126 Pisa, Italy.
   [De Caterina, Raffaele] Fdn Villa Serena Ric, I-65013 Pescara, Italy.
C3 University of Salento; Consiglio Nazionale delle Ricerche (CNR);
   Istituto di Fisiologia Clinica (IFC-CNR); Magna Graecia University of
   Catanzaro; Ulm University; University of Parma; University of Pisa;
   Azienda Ospedaliero Universitaria Pisana
RP Massaro, M (corresponding author), Natl Res Council CNR, Inst Clin Physiol IFC, I-73100 Lecce, Italy.; De Caterina, R (corresponding author), Pisa Univ Hosp, Cardiol Div, I-56126 Pisa, Italy.; De Caterina, R (corresponding author), Fdn Villa Serena Ric, I-65013 Pescara, Italy.
EM stefano.quarta3@unisalento.it; egeria.scoditti@ifc.cnr.it;
   maria.carluccio@ifc.cnr.it; nadia.calabriso@ifc.cnr.it;
   gsantarpino@gymnet.it; fabrizio.damiano@unisalento.it;
   luisa.siculella@unisalento.it; Martin.Wabitsch@uniklinik-ulm.de;
   tiziano.verri@unisalento.it; daudia.favari@unipr.it;
   daniele.delrio@unipr.it; pedromiguel.menaparreno@unipr.it;
   raffaele.decaterina@unipi.it; marika.massaro@ifc.cnr.it
RI Quarta, Stefano/AAC-9033-2021; Damiano, Fabrizio/AAF-9594-2020; Mena,
   Pedro/P-6353-2019; Carluccio, Maria/AAO-1683-2020; De Caterina,
   Raffaele/K-3857-2016; Santarpino, Giuseppe/H-8678-2013; Massaro,
   Marika/HNI-1375-2023; SCODITTI, EGERIA/J-8609-2016; Del Rio,
   Daniele/E-8696-2010; Verri, Tiziano/K-1442-2013
OI Damiano, Fabrizio/0000-0001-7828-9519; Quarta,
   Stefano/0000-0003-1589-4177; SCODITTI, EGERIA/0000-0003-2753-8487;
   Santarpino, Giuseppe/0000-0002-4913-9834; Del Rio,
   Daniele/0000-0001-5394-1259; Massaro, Marika/0000-0001-6124-5077;
   Favari, Claudia/0000-0003-0669-2223; Verri, Tiziano/0000-0003-4983-2767
CR Allott EH, 2012, CLIN TRANSL ONCOL, V14, P774, DOI 10.1007/s12094-012-0863-6
   Baek JH, 2017, BMB REP, V50, P566, DOI 10.5483/BMBRep.2017.50.11.031
   Barbato DL, 2014, CELL DEATH DIFFER, V21, P113, DOI 10.1038/cdd.2013.137
   Barbato DL, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/917698
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Boden Guenther, 2006, Curr Diab Rep, V6, P177, DOI 10.1007/s11892-006-0031-x
   Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09
   Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011
   Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002
   Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006
   Bresciani L, 2020, MOL NUTR FOOD RES, DOI 10.1002/mnfr.202000489
   Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003
   Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051
   Chacón MR, 2007, OBESITY, V15, P664, DOI 10.1038/oby.2007.578
   Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8
   Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z
   Czech MP, 2020, MOL METAB, V34, P27, DOI 10.1016/j.molmet.2019.12.014
   Dal Canto E, 2019, EUR J PREV CARDIOL, V26, P25, DOI 10.1177/2047487319878371
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Feng J, 2020, DIABET METAB SYND OB, V13, P1399, DOI 10.2147/DMSO.S236127
   Filip-Ciubotaru Florina, 2011, Rev Med Chir Soc Med Nat Iasi, V115, P477
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Gao P, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924334
   Good Manuela, 2006, Diab Vasc Dis Res, V3, P26, DOI 10.3132/dvdr.2006.003
   Grygiel-Górniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17
   Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439
   Hamden Khaled, 2013, Sci Pharm, V81, P233, DOI 10.3797/scipharm.1211-14
   Han CY, 2012, J BIOL CHEM, V287, P10379, DOI 10.1074/jbc.M111.304998
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Hurrle S, 2017, BIOMED J, V40, P257, DOI 10.1016/j.bj.2017.06.007
   Ishizuka K, 2007, ENDOCRINOLOGY, V148, P2994, DOI 10.1210/en.2006-1702
   Jeong Jun Hyun, 2015, J Exerc Nutrition Biochem, V19, P65, DOI 10.5717/jenb.2015.15060203
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jin D, 2014, CYTOKINE, V69, P196, DOI 10.1016/j.cyto.2014.06.005
   Kain V, 2015, SCI REP-UK, V5, DOI 10.1038/srep15197
   Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007
   Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005
   Kim K, 2005, BIOCHEM BIOPH RES CO, V327, P460, DOI 10.1016/j.bbrc.2004.12.026
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kumar Priti, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot095505
   Kurylowicz A, 2020, MOLECULES, V25, DOI 10.3390/molecules25092224
   Lang R, 2013, ANAL BIOANAL CHEM, V405, P8487, DOI 10.1007/s00216-013-7288-0
   Lang R, 2010, ANAL CHEM, V82, P1486, DOI 10.1021/ac902616k
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Lee MW, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060854
   Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200
   Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012
   Li YY, 2019, EXP THER MED, V18, P1331, DOI 10.3892/etm.2019.7698
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Massaro M, 2016, PHARMACOL RES, V107, P125, DOI 10.1016/j.phrs.2016.02.027
   Moreno-Viedma V, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0441-2
   Nandipati KC, 2017, MOL CELL BIOCHEM, V426, P27, DOI 10.1007/s11010-016-2878-8
   Ng ACT, 2021, NAT REV CARDIOL, V18, P291, DOI 10.1038/s41569-020-00465-5
   Pillon NJ, 2021, CELL, V184, P1530, DOI 10.1016/j.cell.2021.02.012
   Polvani S, 2016, WORLD J GASTROENTERO, V22, P2441, DOI 10.3748/wjg.v22.i8.2441
   Rebollo-Hernanz M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080279
   Rebollo-Hernanz M, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110672
   Riedel A, 2014, FOOD FUNCT, V5, P454, DOI 10.1039/c3fo60320b
   Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319
   Saeed M, 2019, CRIT REV FOOD SCI, V59, P3293, DOI 10.1080/10408398.2018.1489368
   Samoggia A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030653
   Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109
   Semen S, 2017, FOOD CHEM, V215, P92, DOI 10.1016/j.foodchem.2016.07.176
   Shahinfar H, 2021, NUTR METAB CARDIOVAS, V31, P2526, DOI 10.1016/j.numecd.2021.05.014
   Shimobayashi M, 2018, J CLIN INVEST, V128, P1538, DOI 10.1172/JCI96139
   Silakari O, 2021, Concepts and Experimental Protocols of Modelling and Informatics in Drug Design, P131, DOI DOI 10.1016/B978-0-12-820546-4.00006-4
   Solinas G, 2017, MOL METAB, V6, DOI 10.1016/j.molmet.2016.12.001
   Somoza V, 2003, J AGR FOOD CHEM, V51, P6861, DOI 10.1021/jf034750e
   Stadler RH, 2002, J AGR FOOD CHEM, V50, P1192, DOI 10.1021/jf011234k
   Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005
   Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13
   Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045
   Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Porto ACV, 2019, COFFEE: CONSUMPTION AND HEALTH IMPLICATIONS, P432
   Wei F., 2015, Coffee in Health and Disease Prevention, P149, DOI DOI 10.1016/B978-0-12-409517-5.00017-6
   Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229
NR 81
TC 12
Z9 12
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD OCT
PY 2021
VL 11
IS 10
AR 1545
DI 10.3390/biom11101545
PG 20
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA XI9RM
UT WOS:000726439000001
PM 34680177
OA gold, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Zheng, XX
   Xu, YL
   Li, SH
   Hui, RT
   Wu, YJ
   Huang, XH
AF Zheng, Xin-Xin
   Xu, Yan-Lu
   Li, Shao-Hua
   Hui, Rutai
   Wu, Yong-Jian
   Huang, Xiao-Hong
TI Effects of green tea catechins with or without caffeine on glycemic
   control in adults: a meta-analysis of randomized controlled trials
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; WEIGHT MAINTENANCE; FAT
   OXIDATION; DOUBLE-BLIND; BODY-WEIGHT; METABOLIC SYNDROME; GLUCOSE
   CONTROL; EXTRACT; OBESITY
AB Background: The effect of green tea catechins (GTCs) with or without caffeine on glycemic control is controversial.
   Objective: We aimed to identify and quantify the effects of GTCs or GTC-caffeine mixtures on glucose metabolism in adults.
   Design: A comprehensive literature search was conducted to identify relevant trials of GTCs with or without caffeine on markers of glycemic control [fasting blood glucose (FBG), fasting blood insulin (FBI), glycated hemoglobin (Hb A(1c)), and homeostatic model assessment of insulin resistance (HOMA-IR)]. Weighted mean differences were calculated for net changes by using fixed-effects models. Pre-specified subgroup analyses were performed to explore the influence of covariates on net changes in FBG and FBI concentrations.
   Results: Twenty-two eligible randomized controlled trials with 1584 subjects were identified. Pooled analyses showed that FBG (-1.48 mg/dL; 95% CI: -2.57, -0.40 mg/dL) decreased significantly with GTCs with or without caffeine, whereas FBI (0.04 mu U/mL; 95% CI: -0.36, 0.45 mu U/mL), Hb A(1c) (-0.04%; 95% CI: -0.15, 0.08%), and HOMA-IR (-0.05; 95% CI: -0.37, 0.26) did not. Subgroup analyses indicated that the glucose-lowering effect was apparent when the duration of follow-up was over a median of 12 wk. Overall, no significant heterogeneity was detected for FBG, FBI, Hb A(1c), or HOMA-IR.
   Conclusions: The meta-analysis showed that the administration of GTCs with or without caffeine resulted in a significant reduction in FBG. The limited data available on GTCs did not support a positive effect on FBI, Hb A(1c), or HOMA-IR. Thus, more large and well-designed trials are needed in the future. This trial was registered at http://www.crd.york.ac.uk/prospero as CRD42012002139. Am J Clin Nutr 2013;97:750-62.
C1 [Zheng, Xin-Xin; Xu, Yan-Lu; Hui, Rutai; Wu, Yong-Jian; Huang, Xiao-Hong] Chinese Acad Med Sci, Dept Cardiol, Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.
   [Zheng, Xin-Xin; Xu, Yan-Lu; Hui, Rutai; Wu, Yong-Jian; Huang, Xiao-Hong] Chinese Acad Med Sci, Key Lab Clin Cardiovasc Genet, Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.
   [Zheng, Xin-Xin; Xu, Yan-Lu; Hui, Rutai; Wu, Yong-Jian; Huang, Xiao-Hong] Chinese Acad Med Sci, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.
   [Zheng, Xin-Xin; Xu, Yan-Lu; Hui, Rutai; Wu, Yong-Jian; Huang, Xiao-Hong] Peking Union Med Coll, Beijing 100021, Peoples R China.
   [Li, Shao-Hua] Shandong Univ, Dept Cardiol, Prov Hosp, Jinan 250100, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College; Fu
   Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union
   Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese
   Academy of Medical Sciences - Peking Union Medical College; Peking Union
   Medical College; Shandong University
RP Huang, XH (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp, 167 Beilishi Rd, Beijing 100037, Peoples R China.
EM fuwaihospital@gmail.com; huangxhong12@gmail.com
RI wang, jian/HRB-9588-2023
OI Wu, Yongjian/0000-0002-5590-8396
FU Ministry of Science and Technology of China; National High-Rech Research
   and Development Program of China
FX Supported by the Ministry of Science and Technology of China with a
   grant from the National High-Rech Research and Development Program of
   China (to X-HH).
CR Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Basu A, 2011, NUTRITION, V27, P206, DOI 10.1016/j.nut.2010.01.015
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bonora E, 2002, DIABETES CARE, V25, P1135, DOI 10.2337/diacare.25.7.1135
   Broadhurst CL, 2000, J AGR FOOD CHEM, V48, P849, DOI 10.1021/jf9904517
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Dean S, 2009, INT J SPORT NUTR EXE, V19, P624, DOI 10.1123/ijsnem.19.6.624
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Di Pierro F, 2009, ALTERN MED REV, V14, P154
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   Frank J, 2009, J NUTR, V139, P58, DOI 10.3945/jn.108.096412
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014
   Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Higgins J., 2009, Cochrane Handbook for Systematic Reviews of Interventions
   Higgins JP, 2003, BMJ, V327, P557
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hsu Chung-Hua, 2011, Altern Med Rev, V16, P157
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Josic J, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-63
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kozuma K., 2005, Prog Med, V25, P1945
   LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, pS4, DOI 10.1055/s-2008-1081488
   MacKenzie T, 2007, METABOLISM, V56, P1340, DOI 10.1016/j.metabol.2007.05.018
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mann JI, 2006, NUTR REV, V64, P422, DOI 10.1111/j.1753-4887.2006.tb00227.x
   Maruyama K, 2009, J CLIN BIOCHEM NUTR, V44, P41, DOI 10.3164/jcbn.08-13
   Mirzaei K, 2009, DARU, V17, P38
   Mohammadi S., 2010, J Zanjan Univ Med Sci Health Services, V18, P44
   Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Naqshbandi M, 2008, DIABETES RES CLIN PR, V82, P1, DOI 10.1016/j.diabres.2008.07.017
   Panagiotakos DB, 2009, YONSEI MED J, V50, P31, DOI 10.3349/ymj.2009.50.1.31
   Penugonda K., 2009, The FASEB Journal, V23
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Roghani Mehrdad, 2010, Pathophysiology, V17, P55, DOI 10.1016/j.pathophys.2009.07.004
   Rondanelli M, 2009, BRIT J NUTR, V101, P457, DOI 10.1017/S0007114508024008
   Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001
   Sakurai N, 2009, NUTRITION, V25, P1047, DOI 10.1016/j.nut.2009.02.012
   Sano M, 2001, ANALYST, V126, P816, DOI 10.1039/b102541b
   Sone T, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.8326
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Takabayashi F, 2004, BIOFACTORS, V21, P335, DOI 10.1002/biof.552210165
   tsuchida t., 2002, Prog med, V9, P2189
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
NR 64
TC 111
Z9 117
U1 0
U2 61
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD APR
PY 2013
VL 97
IS 4
BP 750
EP 762
DI 10.3945/ajcn.111.032573
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 113CQ
UT WOS:000316644200011
PM 23426037
OA Bronze
DA 2025-04-28
ER

PT J
AU Milenkovic, D
   Morand, C
   Cassidy, A
   Konic-Ristic, A
   Tomás-Barberán, F
   Ordovas, JM
   Kroon, P
   De Caterina, R
   Rodriguez-Mateos, A
AF Milenkovic, Dragan
   Morand, Christine
   Cassidy, Aedin
   Konic-Ristic, Aleksandra
   Tomas-Barberan, Francisco
   Ordovas, Jose M.
   Kroon, Paul
   De Caterina, Raffaele
   Rodriguez-Mateos, Ana
TI Interindividual Variability in Biomarkers of Cardiometabolic Health
   after Consumption of Major Plant-Food Bioactive Compounds and the
   Determinants Involved
SO ADVANCES IN NUTRITION
LA English
DT Review
DE plant-food bioactives; interindividual variability; cardiometabolic
   health; determinants of interindividual variability; biological
   responsiveness
ID FLOW-MEDIATED DILATION; VASCULAR FUNCTION; BLOOD-PRESSURE; ARTERIAL
   STIFFNESS; CARDIOVASCULAR-DISEASE; INTESTINAL MICROBIOTA; ENDOTHELIAL
   FUNCTION; COFFEE CONSUMPTION; METABOLIC SYNDROME; CYP1A2 GENOTYPE
AB Cardiometabolic disease, comprising cardiovascular diseases, type 2 diabetes, and their associated risk factors including metabolic syndrome and obesity, is the leading cause of death worldwide. Plant foods are rich sources of different groups of bioactive compounds, which might not be essential throughout life but promote health and well-being by reducing the risk of age-related chronic diseases. However, heterogeneity in the responsiveness to bioactive compounds can obscure associations between their intakes and health outcomes, resulting in the hiding of health benefits for specific population groups and thereby limiting our knowledge of the exact role of the different bioactive compounds for health. The heterogeneity in response suggests that some individuals may benefit more than others from the health effects of these bioactive compounds. However, to date, this interindividual variation after habitual intake of plant bioactive compounds has been little explored. The aim of this review is to provide an overview of the existing research that has revealed interindividual variability in the responsiveness to plant-food bioactive compound consumption regarding cardiometabolic outcomes, focusing on polyphenols, caffeine and plant sterols, and the identified potential determinants involved.
C1 [Milenkovic, Dragan; Morand, Christine] Clermont Univ, Univ Auvergne, Unite Nutr Humaine, INRA,UMR 1019,UNH,CRNH Auvergne, Clermont Ferrand, France.
   [Cassidy, Aedin] Univ East Anglia, Norwich Med Sch, Dept Nutr & Prevent Med, Norwich, Norfolk, England.
   [Konic-Ristic, Aleksandra] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.
   [Tomas-Barberan, Francisco] CEBAS CSIC, Res Grp Qual Safety & Bioact Plant Foods, Campus Espinardo, Murcia, Spain.
   [Ordovas, Jose M.] Tufts Univ, Jean Mayer US Dept Agr Human Nutr, Res Ctr Aging, Nutr & Genom Lab, Boston, MA 02111 USA.
   [Ordovas, Jose M.] IMDEA Alimentac, Madrid, Spain.
   [Kroon, Paul] Inst Food Res, Food & Hlth Programme, Norwich Res Pk, Norwich, Norfolk, England.
   [De Caterina, Raffaele] CNR, Inst Clin Physiol, Lecce, Italy.
   [Rodriguez-Mateos, Ana] Univ Dusseldorf, Med Fac, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany.
C3 Universite Clermont Auvergne (UCA); INRAE; University of East Anglia;
   University of Leeds; Consejo Superior de Investigaciones Cientificas
   (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura
   (CEBAS); Tufts University; UK Research & Innovation (UKRI);
   Biotechnology and Biological Sciences Research Council (BBSRC); Quadram
   Institute; University of East Anglia; Consiglio Nazionale delle Ricerche
   (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Heinrich Heine
   University Dusseldorf
RP Milenkovic, D (corresponding author), Clermont Univ, Univ Auvergne, Unite Nutr Humaine, INRA,UMR 1019,UNH,CRNH Auvergne, Clermont Ferrand, France.
RI Konic Ristic, Aleksandra/KDM-9154-2024; Rodriguez-Mateos,
   Ana/ABE-1560-2020; De Caterina, Raffaele/K-3857-2016; Tomas-Barberan,
   Francisco/D-6686-2011; Konic Ristic, Aleksandra/D-7634-2014; MORAND,
   Christine/P-6988-2018; Kroon, Paul/H-5384-2013
OI Tomas-Barberan, Francisco/0000-0002-0790-1739; Konic Ristic,
   Aleksandra/0000-0002-1218-1190; Milenkovic, Dragan/0000-0001-6353-0912;
   MORAND, Christine/0000-0001-8128-1032; Rodriguez-Mateos,
   Ana/0000-0003-3242-402X; Kroon, Paul/0000-0002-9805-6947
FU COST (European Cooperation in Science and Technology); BBSRC
   [BBS/E/F/00044434] Funding Source: UKRI
FX We acknowledge networking support by the COST Action FA 1403 POSITIVe
   (interindividual variation in response to consumption of plant food
   bioactives and determinants involved), supported by COST (European
   Cooperation in Science and Technology). All authors read and approved
   the final manuscript.
CR AbuMweis SS, 2014, CAN J CARDIOL, V30, P1225, DOI 10.1016/j.cjca.2014.04.022
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Auclair Sylvain, 2009, Atherosclerosis, V204, pe21, DOI 10.1016/j.atherosclerosis.2008.12.007
   AVOLIO AP, 1985, CIRCULATION, V71, P202, DOI 10.1161/01.CIR.71.2.202
   Cai Y, 2012, BRIT J NUTR, V108, P1698, DOI 10.1017/S0007114511007331
   Espín JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/270418
   Castro JP, 2003, CURR HYPERTENS REP, V5, P393, DOI 10.1007/s11906-003-0085-y
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0
   Chanet A, 2012, J NUTR BIOCHEM, V23, P469, DOI 10.1016/j.jnutbio.2011.02.001
   Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400
   Clavel T, 2014, GUT MICROBES, V5, P544, DOI 10.4161/gmic.29331
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   De Castro-Orós I, 2011, CLIN NUTR, V30, P239, DOI 10.1016/j.clnu.2010.07.020
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Dellinger RW, 2014, DRUG METAB PHARMACOK, V29, P112, DOI 10.2133/dmpk.DMPK-13-RG-012
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528
   Fisher G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138853
   Fisher NDL, 2006, J HYPERTENS, V24, P1575, DOI 10.1097/01.hjh.0000239293.40507.2a
   Fox GP, 2013, J AGR FOOD CHEM, V61, P10772, DOI 10.1021/jf4011388
   Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869
   Guadamuro L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00777
   Habauzit V, 2012, THER ADV CHRONIC DIS, V3, P87, DOI 10.1177/2040622311430006
   Happonen P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000117
   Hazim S, 2016, AM J CLIN NUTR, V103, P694, DOI 10.3945/ajcn.115.125690
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Heiss C, 2007, J CARDIOVASC PHARM, V49, P74, DOI 10.1097/FJC.0b013e31802d0001
   Heiss C, 2015, AGE, V37, DOI 10.1007/s11357-015-9794-9
   Hollman PCH, 2011, J NUTR, V141, p989S, DOI 10.3945/jn.110.131490
   Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003
   Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38
   Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457
   Ibero-Baraibar I, 2014, NUTR METAB CARDIOVAS, V24, P416, DOI 10.1016/j.numecd.2013.09.017
   Kaya A, 2010, METAB SYNDR RELAT D, V8, P53, DOI 10.1089/met.2009.0004
   Khoo HE, 2011, MOLECULES, V16, P1710, DOI 10.3390/molecules16021710
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kreijkamp-Kaspers S, 2004, J HYPERTENS, V22, P1381, DOI 10.1097/01.hjh.0000125435.28861.d2
   Landete JM, 2015, CRIT REV FOOD SCI, V55, P1792, DOI 10.1080/10408398.2015.1016371
   Landete JM, 2012, CRIT REV FOOD SCI, V52, P936, DOI 10.1080/10408398.2010.513779
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Mackay DS, 2015, AM J CLIN NUTR, V101, P432, DOI 10.3945/ajcn.114.095356
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Manach C, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600557
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Miller RJ, 2012, MOL NUTR FOOD RES, V56, P966, DOI 10.1002/mnfr.201100726
   Miller RJ, 2011, BRIT J NUTR, V105, P1138, DOI 10.1017/S0007114510004836
   Mora-Cubillos X, 2015, MOL NUTR FOOD RES, V59, P2480, DOI 10.1002/mnfr.201500549
   Morand C, 2011, AM J CLIN NUTR, V93, P73, DOI 10.3945/ajcn.110.004945
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Ostertag LM, 2013, MOL NUTR FOOD RES, V57, P191, DOI 10.1002/mnfr.201200283
   Ostlund RE, 2002, ANNU REV NUTR, V22, P533, DOI 10.1146/annurev.nutr.22.020702.075220
   Palatini P, 2015, EUR J EPIDEMIOL, V30, P209, DOI 10.1007/s10654-015-9990-z
   Palatini P, 2009, J HYPERTENS, V27, P1594, DOI 10.1097/HJH.0b013e32832ba850
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Renda G, 2012, AM J CLIN NUTR, V95, P241, DOI 10.3945/ajcn.111.018267
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Rideout TC, 2010, AM J CLIN NUTR, V92, P41, DOI 10.3945/ajcn.2009.29073
   Rodriguez-Mateos A, 2015, MOL NUTR FOOD RES, V59, P1504, DOI 10.1002/mnfr.201500091
   Rodriguez-Mateos A, 2014, ARCH TOXICOL, V88, P1803, DOI 10.1007/s00204-014-1330-7
   Rodriguez-Mateos A, 2013, AM J CLIN NUTR, V98, P1179, DOI 10.3945/ajcn.113.066639
   Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x
   Sanchez-Muniz FJ, 2009, J NUTR, V139, P13, DOI 10.3945/jn.108.090969
   Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103
   Selma MV, 2016, FOOD FUNCT, V7, P1769, DOI [10.1039/c5fo01100k, 10.1039/C5FO01100K]
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S
   Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188
   Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776
   Strandhagen E, 2004, INT J MOL MED, V13, P811
   Strandhagen Elisabeth, 2004, Lipids Health Dis, V3, P26, DOI 10.1186/1476-511X-3-26
   Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010
   Tomás-Barberán FA, 2014, J AGR FOOD CHEM, V62, P6535, DOI 10.1021/jf5024615
   Usui T, 2013, CLIN ENDOCRINOL, V78, P365, DOI 10.1111/j.1365-2265.2012.04400.x
   Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3
   Welty FK, 2007, ARCH INTERN MED, V167, P1060, DOI 10.1001/archinte.167.10.1060
   West SG, 2014, BRIT J NUTR, V111, P653, DOI 10.1017/S0007114513002912
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   Wong JMW, 2012, AM J CLIN NUTR, V95, P564, DOI 10.3945/ajcn.111.017418
   Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051
   Zhao H, 2008, LIPIDS, V43, P1155, DOI 10.1007/s11745-008-3241-y
NR 86
TC 80
Z9 87
U1 0
U2 46
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2161-8313
EI 2156-5376
J9 ADV NUTR
JI Adv. Nutr.
PD JUL
PY 2017
VL 8
IS 4
BP 558
EP 570
DI 10.3945/an.116.013623
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FC0ZK
UT WOS:000406567000004
PM 28710143
OA Green Published, Green Accepted, hybrid, Green Submitted
DA 2025-04-28
ER

PT J
AU Watson, WL
   Piazza, S
   Wellard, L
   Hughes, C
   Chapman, K
AF Watson, Wendy L.
   Piazza, Sarah
   Wellard, Lyndal
   Hughes, Clare
   Chapman, Kathy
TI Energy and nutrient composition of menu items at Australian coffee
   chains
SO NUTRITION & DIETETICS
LA English
DT Article
DE Australia; fast food; food industry; menu labelling; nutrition
   information
ID BODY-MASS INDEX; FAST-FOOD; NUTRITION INFORMATION; CONSUMPTION;
   CHILDREN; OBESITY; CHOICES
AB AimWorldwide, there are concerns about the link between fast food and overall poor dietary quality and weight gain. Beverages and snack foods purchased from coffee chains may contribute excess energy and nutrients to the diet if they are consumed in addition to usual meals. The present study investigated the energy, saturated fat and sugar content of beverages and sweet snacks from major coffee chains and compared the nutrient content to daily intake (DI) reference values for adults.
   MethodsNutrition information per serve was sourced from the Australian websites of five coffee chains with the largest number of outlets in New South Wales and compared to DI reference values for adults for energy, saturated fat and sugars. Energy per serve was compared to 600kJ, the Australian Dietary Guidelines recommendation for one serve of a discretionary food.
   ResultsEighty-four per cent (n=238) of sweet snacks and 65% (n=79) of cold beverages provided more than two equivalent serves (1200kJ) of a discretionary food. Sixteen (13%) cold beverages and 47 (16%) sweet snacks provided over 50% DI of saturated fat. Sixty-six (54%) cold beverages and 47 (16%) sweet snacks had more than half the DI of sugars.
   ConclusionsFood and beverage items from coffee chains may contribute to excess intake of energy and other nutrients of public health concern if consumed in addition to meals. To assist consumers to make informed and healthier fast food choices, accessible detailed nutrition information should be available along with reductions in portion sizes and reformulation to more nutritious menu items.
C1 [Watson, Wendy L.; Wellard, Lyndal; Hughes, Clare; Chapman, Kathy] NSW Canc Council, Canc Programs Div, Sydney, NSW, Australia.
   [Piazza, Sarah] Univ Sydney, Sch Mol Biosci, Discipline Nutr & Dietet, Fac Sci, Sydney, NSW 2006, Australia.
C3 Cancer Council New South Wales; University of Sydney
RP Watson, WL (corresponding author), NSW Canc Council, Canc Programs Div, 153 Dowling St, Woolloomooloo, NSW 2011, Australia.
EM wendyw@nswcc.org.au
OI Hughes, Clare/0000-0002-7579-2722; Watson, Wendy/0000-0002-8906-4064;
   Wellard-Cole, Lyndal/0000-0003-1514-2135
CR [Anonymous], FIND US
   [Anonymous], 6530 0 HOUS EXP SURV
   [Anonymous], 2013, AUSTR DIET GUID
   [Anonymous], 8655 0 CAF REST CAT
   [Anonymous], 2012, 4364 0 055 001 AUSTR
   [Anonymous], FAST CHOIC EV EN PUR
   [Anonymous], MCDONALDS OUR STOR
   [Anonymous], AUSTR NZ FOOD STAT C
   [Anonymous], TOP 30 FAST GROW FRA
   [Anonymous], PUBL HLTH RESP DEAL
   [Anonymous], MICH PAT STOR LOC
   [Anonymous], GLOR JEANS STOR
   [Anonymous], 2014, Notice, V79
   [Anonymous], MUFF BREAK FIND CAD
   [Anonymous], RES REV JUN
   [Anonymous], COFF CLUB STORE
   [Anonymous], 2009, Australia: the Healthiest Country by 2020
   Australian Bureau of Statistics, 2014, 4364 0 55 007 AUSTR
   Bassett MT, 2008, AM J PUBLIC HEALTH, V98, P1457, DOI 10.2105/AJPH.2008.135020
   Bollinger B., 2010, Calorie posting in chain restaurants
   Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112
   Burns C, 2002, PUBLIC HEALTH NUTR, V5, P441, DOI 10.1079/PHN2001316
   Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973
   Dunn KI, 2008, APPETITE, V51, P331, DOI 10.1016/j.appet.2008.03.003
   ESPINEL P, 2010, APPARENT CONSUMPTION
   Fayet F, 2012, NUTR DIET, V69, P102, DOI 10.1111/j.1747-0080.2012.01582.x
   Kozup JC, 2003, J MARKETING, V67, P19, DOI 10.1509/jmkg.67.2.19.18608
   National Health & Medical Research Council, 2013, EAT HLTH EDUCATOR GU
   Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0
   Pulos E, 2010, AM J PUBLIC HEALTH, V100, P1035, DOI 10.2105/AJPH.2009.174839
   Rangan AM, 2009, EUR J CLIN NUTR, V63, P865, DOI 10.1038/ejcn.2008.51
   Sinclair SE, 2014, J ACAD NUTR DIET, V114, P1375, DOI 10.1016/j.jand.2014.05.014
   Tandon PS, 2010, PEDIATRICS, V125, P244, DOI 10.1542/peds.2009-1117
   Watson WL, 2013, PUBLIC HEALTH NUTR, V16, P409, DOI 10.1017/S1368980012000900
   WHO, 2013, GLOB ACT PLAN PREV C
   Young LR, 2012, AM J PREV MED, V43, P565, DOI 10.1016/j.amepre.2012.07.024
NR 36
TC 4
Z9 5
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1446-6368
EI 1747-0080
J9 NUTR DIET
JI Nutr. Diet.
PD FEB
PY 2016
VL 73
IS 1
BP 81
EP 87
DI 10.1111/1747-0080.12226
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DD3NT
UT WOS:000369829800011
DA 2025-04-28
ER

PT J
AU Hughes, LAE
   Arts, ICW
   Ambergen, T
   Brants, HAM
   Dagnelie, PC
   Goldbohm, RA
   van den Brandt, PA
   Weijenberg, MP
AF Hughes, Laura A. E.
   Arts, Ilja C. W.
   Ambergen, Ton
   Brants, Henny A. M.
   Dagnelie, Pieter C.
   Goldbohm, R. Alexandra
   van den Brandt, Piet A.
   Weijenberg, Matty P.
TI Higher dietary flavone, flavonol, and catechin intakes are associated
   with less of an increase in BMI over time in women: a longitudinal
   analysis from the Netherlands Cohort Study
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID SELF-REPORTED HEIGHT; POTENTIALLY ANTICARCINOGENIC FLAVONOIDS; SCALE
   PROSPECTIVE COHORT; GREEN TEA; FAT OXIDATION; CARDIOVASCULAR RISK;
   PREVENTS OBESITY; BODY-WEIGHT; CONSUMPTION; ANTHOCYANINS
AB Background: Dietary flavonoids are suggested to have antiobesity effects. Prospective evidence of an association between flavonoids and body mass index (BMI) is lacking in general populations.
   Objective: We assessed this association between 3 flavonoid subgroups and BMI over a 14-y period in 4280 men and women aged 55-69 y at baseline from the Netherlands Cohort Study.
   Design: Dietary intake was estimated at baseline (1986) by a validated food-frequency questionnaire. BMI was ascertained through self-reported height (in 1986) and weight (in 1986, 1992, and 2000). Analyses were based on sex-specific quintiles for the total intake of 6 catechins and of 3 flavonols/flavones. Linear mixed effect modeling was used to assess longitudinal associations in 3 adjusted models: age only, lifestyle (age, energy intake, physical activity, smoking status, alcohol intake, type 2 diabetes, and coffee consumption), and lifestyle and diet (vegetables, fruit, fiber, grains, sugar, dessert, and dieting habits).
   Results: After adjustment for age and confounders, the BMI(kg/m(2)) of women with the lowest intake of total flavonols/flavones and total catechins increased by 0.95 and 0.77, respectively, after 14 y. Women with the highest intake of total flavonols/flavones and total catechins experienced a significantly lower increase in BMI of 0.40 and 0.31, respectively (between group difference: P < 0.05). This difference remained after additional adjustment for dietary determinants and after stratification of median baseline BMI. In men, no significant differences in BMI change were observed over the quintiles of flavonoid intake after 14 y.
   Conclusion: Our results suggest that flavonoid intake may contribute to maintaining body weight in the general female population. Am J Clin Nutr 2008; 88: 1341-52.
C1 [Hughes, Laura A. E.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Epidemiol, Sch Oncol & Dev Biol GROW, NL-6200 MD Maastricht, Netherlands.
   [Arts, Ilja C. W.; Dagnelie, Pieter C.] Maastricht Univ, Nutr & Toxicol Res Inst, NUTRIM, Maastricht, Netherlands.
   [Ambergen, Ton] Univ Maastricht, Dept Methodol & Stat, Maastricht, Netherlands.
   [Brants, Henny A. M.] TNO Qual Life, Dept Food & Chem Risk Anal, Zeist, Netherlands.
   [Goldbohm, R. Alexandra] TNO Qual Life, Dept Prevent & Hlth, Zeist, Netherlands.
C3 Maastricht University; Maastricht University; Maastricht University;
   Netherlands Organization Applied Science Research; Netherlands
   Organization Applied Science Research
RP Hughes, LAE (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Dept Epidemiol, Sch Oncol & Dev Biol GROW, POB 616, NL-6200 MD Maastricht, Netherlands.
EM laura.hughes@epid.unimaas.nl.s
RI Arts, Ilja/C-6946-2008
OI van den Brandt, Piet/0000-0001-8781-8099; Arts, Ilja/0000-0001-6462-6692
FU Dutch Cancer Society; Netherlands Organization for Scientific
   Research-Earth and Life Sciences
FX Supported by the Dutch Cancer Society and by a VENI Innovational
   Research Grant from the Netherlands Organization for Scientific
   Research-Earth and Life Sciences.
CR Abidov M, 2006, Georgian Med News, P66
   Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643
   [Anonymous], FOOD NUTR PHYS ACT P
   Aron PM, 2008, MOL NUTR FOOD RES, V52, P79, DOI 10.1002/mnfr.200700137
   Arts ICW, 2000, J AGR FOOD CHEM, V48, P1746, DOI 10.1021/jf000025h
   Arts ICW, 2000, J AGR FOOD CHEM, V48, P1752, DOI 10.1021/jf000026+
   Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S
   Arts ICW, 2001, EUR J CLIN NUTR, V55, P76, DOI 10.1038/sj.ejcn.1601115
   Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Chang NS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-8
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Czernichow S, 2002, INT J OBESITY, V26, P1138, DOI 10.1038/sj.ijo.0802059
   de Boer VCJ, 2006, CELL MOL LIFE SCI, V63, P2847, DOI 10.1007/s00018-006-6316-z
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Finucane Mariel M, 2007, Epidemiol Perspect Innov, V4, P8, DOI 10.1186/1742-5573-4-8
   Frank T, 2003, CAN J PHYSIOL PHARM, V81, P423, DOI [10.1139/y03-038, 10.1139/Y03-038]
   Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014
   GOLDBOHM RA, 1995, EUR J CLIN NUTR, V49, P420
   GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253
   Goldbohm RA, 1997, POLYPHENOLS FOOD, P159
   Henning SM, 2004, AM J CLIN NUTR, V80, P1558
   HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267
   HERTOG MGL, 1992, J AGR FOOD CHEM, V40, P2379, DOI 10.1021/jf00024a011
   HERTOG MGL, 1993, J AGR FOOD CHEM, V41, P1242, DOI 10.1021/jf00032a015
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   HOLBROOK TL, 1989, INT J OBESITY, V13, P723
   Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4
   Holt RR, 2006, J CARDIOVASC PHARM, V47, pS187, DOI 10.1097/00005344-200606001-00014
   Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001
   Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049
   IMAI K, 1995, BRIT MED J, V310, P693, DOI 10.1136/bmj.310.6981.693
   Kono S, 1996, J Epidemiol, V6, P128
   Kwon SH, 2007, J MED FOOD, V10, P552, DOI 10.1089/jmf.2006.147
   MAZZA G, 2007, ANTHOCYANINS CARDIOV
   Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536
   Ong KC, 2000, LIFE SCI, V67, P1695, DOI 10.1016/S0024-3205(00)00758-X
   Palermo CM, 2003, CHEM RES TOXICOL, V16, P865, DOI 10.1021/tx025672c
   Panico S, 2008, PREV MED, V47, P53, DOI 10.1016/j.ypmed.2008.01.023
   Peterson J, 1998, NUTR RES, V18, P1995, DOI 10.1016/S0271-5317(98)00169-9
   Phillips SM, 2003, INT J OBESITY, V27, P1106, DOI 10.1038/sj.ijo.0802370
   Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246
   Prior RL, 2008, J AGR FOOD CHEM, V56, P647, DOI 10.1021/jf071993o
   Prior RL, 2006, FREE RADICAL RES, V40, P1014, DOI 10.1080/10715760600758522
   Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Sampson L, 2002, J AM DIET ASSOC, V102, P1414, DOI 10.1016/S0002-8223(02)90314-7
   Schmidt M, 2005, FOOD CHEM TOXICOL, V43, P307, DOI 10.1016/j.fct.2004.11.001
   Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023
   Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322
   Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703
   Tokunaga S, 2002, ANN EPIDEMIOL, V12, P157, DOI 10.1016/S1047-2797(01)00307-6
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125
   Tsuda T, 2008, J AGR FOOD CHEM, V56, P642, DOI 10.1021/jf073113b
   VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E
   Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   World Health Organization (WHO), 2005, EURO1305 WHO, V12
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Wu CH, 2002, ARCH INTERN MED, V162, P1001, DOI 10.1001/archinte.162.9.1001
NR 63
TC 88
Z9 95
U1 0
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD NOV 1
PY 2008
VL 88
IS 5
BP 1341
EP 1352
DI 10.3945/ajcn.2008.26058
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 370OD
UT WOS:000260770600023
PM 18996871
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Yahya, HM
   Day, A
   Lawton, C
   Myrissa, K
   Croden, F
   Dye, L
   Williamson, G
AF Yahya, Hanis Mastura
   Day, Andrea
   Lawton, Clare
   Myrissa, Kyriaki
   Croden, Fiona
   Dye, Louise
   Williamson, Gary
TI Dietary intake of 20 polyphenol subclasses in a cohort of UK women
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Polyphenols; Flavonoids; Phenolic acids; Food diary; Phenol-Explorer
ID MAJOR FOOD SOURCES; RECALL COHORT; CANCER; ADULTS; FLAVONOIDS;
   POPULATION; VEGETABLES; COUNTRIES; DISEASE; RISK
AB Establishing and linking the proposed health benefits of dietary polyphenols to their consumption requires measurement of polyphenol intake in appropriate samples and an understanding of factors that influence their intake in the general population.
   This study examined polyphenol intake estimated from 3- and 7-day food diaries in a sample of 246 UK women aged 18-50 years. Estimation of the intake of 20 polyphenol subclasses commonly present in foods consumed by the sample studied was done using Phenol-Explorer(A (R)) and USDA polyphenol databases. Women were participants in the Leeds Women's Wellbeing Study (LWW) (n = 143), a dietary intervention study aimed at overweight women (mean age 37.2 +/- 9.4 years; mean BMI 30.8 +/- 3.1 kg/m(2)), and the Diet and Health Study (DH) (n = 103) which aimed to examine the relationship between polyphenol intake and cognitive function (mean age 25.0 +/- 9.0 years; mean BMI 24.5 +/- 4.6 kg/m(2)).
   The estimated intake of polyphenol subclasses was significantly different between the two samples (p < 0.01) with consumption of 1292 +/- 844 and 808 +/- 680 mg/day for the LWW and DH groups, respectively. Flavanols and hydroxycinnamic acids were the most important contributors to the polyphenols consumed by both groups, owing to tea and coffee consumption. Other major polyphenol food sources included fruits, vegetables and processed foods.
   Older women consumed more polyphenol-containing foods and beverages, which was due to the higher coffee and tea consumption amongst the LWW participants.
C1 [Yahya, Hanis Mastura; Day, Andrea; Williamson, Gary] Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.
   [Yahya, Hanis Mastura] Univ Kebangsaan Malaysia, Sch Healthcare Sci, Fac Hlth Sci, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
   [Lawton, Clare; Myrissa, Kyriaki; Croden, Fiona; Dye, Louise] Univ Leeds, Sch Psychol, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England.
C3 University of Leeds; Universiti Kebangsaan Malaysia; University of Leeds
RP Williamson, G (corresponding author), Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.
EM hanis.yahya@ukm.edu.my; G.Williamson@leeds.ac.uk
RI ; Williamson, Gary/AAE-9665-2019
OI Peakall, Andrea/0000-0002-3949-8155; Myrissa,
   Kyriaki/0000-0003-1878-1645; Williamson, Gary/0000-0002-5624-6267
FU Ministry of Education Malaysia; Universiti Kebangsaan Malaysia;
   Kellogg's Sales and Marketing UK
FX This work was supported by funding from the Ministry of Education
   Malaysia and Universiti Kebangsaan Malaysia. The Leeds Women's Wellbeing
   Study was funded by Kellogg's Sales and Marketing UK.
CR Bhagwat S., 2011, USDA DATABASE FLAVON
   Cheyette C, 2010, CARBS CALS PROTEIN F
   Cieslik E, 2006, FOOD CHEM, V94, P135, DOI 10.1016/j.foodchem.2004.11.015
   Dummer Trevor J B, 2012, J Obes, V2012, P934895, DOI 10.1155/2012/934895
   GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569
   Hertog MGL, 1997, AM J CLIN NUTR, V65, P1489, DOI 10.1093/ajcn/65.5.1489
   Johnson CM, 2011, APPETITE, V57, P220, DOI 10.1016/j.appet.2011.04.025
   Kuhnert N, 2010, ARCH BIOCHEM BIOPHYS, V501, P37, DOI 10.1016/j.abb.2010.04.013
   Li GL, 2013, J ACAD NUTR DIET, V113, P786, DOI 10.1016/j.jand.2013.01.018
   Mahabir S, 2006, EUR J CLIN NUTR, V60, P561, DOI 10.1038/sj.ejcn.1602359
   Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024
   Oakes ME, 2005, APPETITE, V44, P317, DOI 10.1016/j.appet.2005.03.010
   Oakes ME, 2001, PSYCHOL HEALTH, V16, P57, DOI 10.1080/08870440108405489
   Ovaskainen ML, 2008, J NUTR, V138, P562
   Pérez-Jiménez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5
   Sohrab G, 2013, INT J FOOD SCI NUTR, V64, P661, DOI 10.3109/09637486.2013.787397
   Somerset SM, 2008, NUTR CANCER, V60, P442, DOI 10.1080/01635580802143836
   Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008
   Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050
   Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481
   Zamora-Ros R, 2013, EUR J CLIN NUTR, V67, P779, DOI 10.1038/ejcn.2013.89
   Zamora-Ros R, 2012, EUR J CLIN NUTR, V66, P932, DOI 10.1038/ejcn.2012.36
   Zamora-Ros R, 2013, BRIT J NUTR, V110, P1500, DOI 10.1017/S0007114513000688
   Zamora-Ros R, 2013, BREAST CANCER RES TR, V139, P163, DOI 10.1007/s10549-013-2483-4
   Zamora-Ros R, 2013, BRIT J NUTR, V109, P1498, DOI 10.1017/S0007114512003273
   Zamora-Ros R, 2011, BRIT J NUTR, V106, P1915, DOI 10.1017/S000711451100239X
   Zamora-Ros R, 2011, BRIT J NUTR, V106, P1090, DOI 10.1017/S0007114511001437
NR 28
TC 16
Z9 17
U1 0
U2 29
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD AUG
PY 2016
VL 55
IS 5
BP 1839
EP 1847
DI 10.1007/s00394-015-1001-3
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DR8CI
UT WOS:000380125600004
PM 26210882
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Cunha, PC
   Rodrigues, PRM
   Moreira, NF
   Gorgulho, BM
   Ferreira, MG
   Muraro, AP
AF Cunha, Paula Costa
   Melo Rodrigues, Paulo Rogerio
   Moreira, Naiara Ferraz
   Gorgulho, Bartira Mendes
   Ferreira, Marcia Goncalves
   Muraro, Ana Paula
TI Consumption of free sugars and dietary sources in the diet of university
   students according to socioeconomic and lifestyle factors
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Article
DE Eating; Sugars; Students; Universities
ID ASSOCIATION; BRAZIL
AB Objective To evaluate the consumption of free sugars and associated factors in the diet of university students entering full-time courses at a public university in Mato Grosso.Methods Cross-sectional study with students aged 16 to 26 years in the first semester of 2016, 2017, and 2018. Average sugar consumption was estimated using a 24-hour diet recall, evaluating the percentage of free sugars in total energy intake and the prevalence of consumption greater than 10.0% of total energy intake, according to socioeconomic and lifestyle variables, stratified by sex, and the foods that most contributed to its consumption.Results A total of 1,063 students were evaluated, the percentage of free sugars in the students' diet was on average 14.3% among men and 15.4% among women, with the prevalence of consumption above 10.0% also being higher among women (72.6 vs. 66.6%). There was a direct relationship between the participation of free sugars in the highest tertiles of energy intake, and the main food groups sources of sugar were desserts, juices, soft drinks, and coffee. There was a significant association between courses outside the health sciences, tobacco use, and unsatisfactory meal consumption profile with higher consumption of free sugars among women. Among men, sugar consumption was higher among those who were not overweight compared to those who were overweight.Conclusion The consumption of free sugars is high among university students, being associated with higher energy consumption, especially for sweetened beverages.
C1 [Cunha, Paula Costa; Melo Rodrigues, Paulo Rogerio; Gorgulho, Bartira Mendes; Ferreira, Marcia Goncalves] Univ Fed Mato Grosso, Fac Nutricao, Dept Alimentos & Nutricao Cuiaba, Cuiaba, MT, Brazil.
   [Moreira, Naiara Ferraz] Fundacao Univ Fed Grande Dourados, Dept Ciencias Saude Dourados, Dourados, MS, Brazil.
   [Muraro, Ana Paula] Univ Fed Mato Grosso, Dept Saude Colet Cuiaba, Inst Saude Colet, Cuiaba, MT, Brazil.
C3 Universidade Federal de Mato Grosso; Universidade Federal da Grande
   Dourados; Universidade Federal de Mato Grosso
RP Muraro, AP (corresponding author), Univ Fed Mato Grosso, Dept Saude Colet Cuiaba, Inst Saude Colet, Cuiaba, MT, Brazil.
EM muraroap@gmail.com
RI Rodrigues, Paulo/R-1441-2018; Muraro, Ana/X-8028-2019; Moreira,
   Naiara/AAG-1512-2019
CR Al-Qahtani MH, 2016, INT J HEALTH SCI-IJH, V10, P353
   [Anonymous], 2016, REV SAUDE PUBL
   [Anonymous], 2007, Growth reference data for 5-19 years
   Associacao Brasileira de Empresas de Pesquisa, 2015, CRIT BRAZ CRIT EC CL
   Atmarita, 2018, ASIA PAC J CLIN NUTR, V27, P47, DOI 10.6133/apjcn.042017.07
   Bailey CP, 2020, OBES SCI PRACT, V6, P694, DOI 10.1002/osp4.445
   Baker P, 2020, OBES REV, V21, DOI 10.1111/obr.13126
   Barufaldi Laura Augusta, 2016, Rev. bras. epidemiol., V19, P464, DOI 10.1590/1980-5497201600020020
   Bawadi H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051058
   Benaich S, 2021, NUTR HEALTH-UK, V27, P69, DOI 10.1177/0260106020960863
   Brace Andrea M., 2018, Nutrition and Health (Bicester), V24, P171, DOI 10.1177/0260106018785528
   Castelao-Naval O, 2019, ENFERM CLIN, V29, P280, DOI 10.1016/j.enfcli.2018.03.002
   Fernandes DPD, 2016, MUNDO SAUDE, V40, P94, DOI 10.15343/0104-7809.2016400194105
   Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011
   Du C, 2023, J AM COLL HEALTH, V71, P300, DOI 10.1080/07448481.2021.1891082
   Fagan MJ, 2020, PREV MED REP, V19, DOI 10.1016/j.pmedr.2020.101148
   Franca JQS, 2018, REV NUTR SCI ONLINE, V2, P37
   Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07
   Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1
   Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010
   Huang K, 2022, NUTRIENTS, V14, DOI 10.3390/nu14132740
   Instituto Brasileiro de Geografia e Estatistica, 2020, RES FAM BUDG POF 201
   Instituto Brasileiro de Geografia e Estatistica, 2016, NAT STUD HLTH SURV P
   Instituto Brasileiro de Geografia e Estatistica, 2011, HOUS BUDG SURV POF 2
   Kalbus A, 2021, PUBLIC HEALTH REV, V42, DOI 10.3389/phrs.2021.1603965
   Khandpur N, 2019, FOOD RES INT, V121, P854, DOI 10.1016/j.foodres.2019.01.008
   Khawaja AH, 2019, DIABETES METAB SYND, V13, P2579, DOI 10.1016/j.dsx.2019.06.031
   Lee YH, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050493
   Luger M, 2017, OBESITY FACTS, V10, P674, DOI 10.1159/000484566
   Malta DC, 2021, REV BRAS EPIDEMIOL, V24
   Matsudo V, 2001, ATIVIDADE FISICA SAU, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18
   Mendes M.L.M., 2016, Tempus, actas de saude colet, V10, P205
   Ministerio da Saude. Brasil, 2020, VIG BRAS 2019 SURV R
   Ministerio da Saude. Brasil, 2021, PLAN AC ESTR ENFR DO
   Nakhooda R, 2020, S AFR J CLIN NUTR, V33, P64, DOI 10.1080/16070658.2018.1553360
   Narciso J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214941
   Nogueira PS, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00145917, 10.1590/0102-311X00145917]
   Pereira RA, 2014, PUBLIC HEALTH NUTR, V17, P113, DOI 10.1017/S1368980012004892
   Perez PMP, 2016, CIENC SAUDE COLETIVA, V21, P531, DOI 10.1590/1413-81232015212.01732015
   Rauber F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050587
   Santin F, 2022, CAD SAUDE PUBLICA, V38, DOI [10.1590/0102-311X00118821, 10.1590/0102-311x00118821]
   Seferidi P, 2018, PEDIATR OBES, V13, P195, DOI 10.1111/ijpo.12194
   Senín-Calderón C, 2017, PSYCHIAT RES, V248, P121, DOI 10.1016/j.psychres.2016.12.003
   Sogari G, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121823
   Syed NK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238458
   Touma Sawaya R, 2020, J FAM MED PRIM CARE, V9, P3921, DOI 10.4103/jfmpc.jfmpc_340_20
   WHO, 1995, WHO PHYS STATUS USE
   World Cancer Research Found International, 2018, BUILD MOM LESS IMPL
   World Health Organization, 2016, TAX SUG DRINKS WHY D
   World Health Organization (WHO), 2015, Guideline: Sugars Intake for Adults and Children
   Yee AZH, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0501-3
NR 51
TC 0
Z9 0
U1 0
U2 2
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO
   ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
EI 1678-9865
J9 REV NUTR
JI Rev. Nutr.
PY 2023
VL 36
AR e210153
DI 10.1590/1678-9865202336e210153
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA H2FO1
UT WOS:000994176100001
DA 2025-04-28
ER

PT J
AU Arent, SM
   Walker, AJ
   Pellegrino, JK
   Sanders, DJ
   McFadden, BA
   Ziegenfuss, TN
   Lopez, HL
AF Arent, Shawn M.
   Walker, Alan J.
   Pellegrino, Joseph K.
   Sanders, David J.
   McFadden, Bridget A.
   Ziegenfuss, Tim N.
   Lopez, Hector L.
TI The Combined Effects of Exercise, Diet, and a Multi-Ingredient Dietary
   Supplement on Body Composition and Adipokine Changes in Overweight
   Adults
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE Dietary supplement; raspberry ketone; adipokine; body composition; fat
   loss; capsaicin
ID INSULIN-RESISTANCE; DOWN-REGULATION; ADIPOSE-TISSUE; LEPTIN LEVELS;
   WEIGHT-LOSS; FAT MASS; OBESITY; ADIPONECTIN; PROTEIN; CAPSAICIN
AB Background: Very few weight and fat loss supplements undergo finished-product research to examine efficacy. The purpose of this study was to determine the effects of an 8-week diet and exercise program on body composition, hip and waist girth, and adipokines and evaluate whether a dietary supplement containing raspberry ketone, capsaicin, caffeine, garlic, and Citrus aurantium enhanced outcomes.
   Methods: Overweight men and women completed this randomized, placebo-controlled, double-blind study. Participants consumed 4 capsules/d of supplement (EXP; n = 18) or placebo (PLA; n = 18). Participants underwent 8 weeks of daily supplementation, calorie restriction (500 kcal < RMR [resting metabolic rate] x 1.2), and supervised progressive exercise training 3 times a week. Body composition, girth, and adipokines were assessed at baseline and postintervention (T1 and T2).
   Results: Significant decreases in weight (-2.6 +/- 0.57 kg, p < 0.001), fat mass (-1.8 +/- 0.20 kg; p < 0.001), and percentage body fat (-3.7% +/- 0.29%, p < 0.001) and a significant increase in lean body mass (LBM; 1.5 +/- 0.26 kg; p < 0.001) were seen from T1 to T2 in both groups. For men, only those in the EXP group increased LBM from T1 to T2 (1.3 +/- 0.38 kg; p < 0.05). Hip girth was also reduced, with the women in the EXP group (-10.7 +/- 2.15 cm, p < 0.001) having a greater reduction. There was a time by group interaction, with significant decreases in leptin (p < 0.001) and significant increases in adiponectin (p < 0.05) in the EXP group.
   Conclusions: Significant improvements in adipokines and leptin support the utility of exercise, diet, and fat loss for impacting inflammatory biomarkers. The improvement in adiponectin with EXP may suggest a unique health mechanism.
C1 [Arent, Shawn M.; Walker, Alan J.; Pellegrino, Joseph K.; Sanders, David J.; McFadden, Bridget A.] Rutgers State Univ, Ctr Hlth & Human Performance, New Brunswick, NJ 08901 USA.
   [Ziegenfuss, Tim N.; Lopez, Hector L.] Ctr Appl Hlth Sci, Stow, OH USA.
C3 Rutgers University System; Rutgers University New Brunswick
RP Arent, SM (corresponding author), Rutgers State Univ, Ctr Hlth Human Performance, 61 Dudley Rd, New Brunswick, NJ 08901 USA.
EM shawn.arent@rutgers.edu
RI Sanders, David/AGT-9556-2022
CR Arciero PJ, 2014, J APPL PHYSIOL, V117, P1, DOI 10.1152/japplphysiol.00152.2014
   Ban JO, 2012, PHYTOTHER RES, V26, P1265, DOI 10.1002/ptr.3729
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bloomer RJ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-72
   Coppola A, 2009, INT J CARDIOL, V134, P414, DOI 10.1016/j.ijcard.2007.12.087
   Davitt PM, 2014, J STRENGTH COND RES, V28, P1937, DOI 10.1519/JSC.0000000000000355
   Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Díez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293
   Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008
   Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0
   Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3
   Ernsberger P, 2007, AM J HYPERTENS, V20, P866, DOI 10.1016/j.amjhyper.2007.02.015
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Hawley JA, 2009, APPL PHYSIOL NUTR ME, V34, P355, DOI 10.1139/H09-023
   Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032
   Hunter GR, 2010, OBESITY, V18, P690, DOI 10.1038/oby.2009.316
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Isa Y, 2008, BIOCHEM BIOPH RES CO, V373, P429, DOI 10.1016/j.bbrc.2008.06.046
   Josse AR, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-65
   Kazumi T, 2004, METABOLISM, V53, P589, DOI 10.1016/j.metabol.2003.12.008
   Keophiphath M, 2009, J NUTR, V139, P2055, DOI 10.3945/jn.109.105452
   Layman DK, 2005, J NUTR, V135, P1903, DOI 10.1093/jn/135.8.1903
   Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897
   Longland TM, 2016, AM J CLIN NUTR, V103, P738, DOI 10.3945/ajcn.115.119339
   Lopez HL, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-22
   Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142
   Melone M, 2012, J AM COLL CARDIOL, V59, P1697, DOI 10.1016/j.jacc.2011.11.064
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   Morimoto C, 2005, LIFE SCI, V77, P194, DOI 10.1016/j.lfs.2004.12.029
   Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33
   O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Park KS, 2010, PLANTA MED, V76, P1654, DOI 10.1055/s-0030-1249860
   Pasman WJ, 1998, AM J PHYSIOL-ENDOC M, V274, pE280, DOI 10.1152/ajpendo.1998.274.2.E280
   Perusse L, 1997, J APPL PHYSIOL, V83, P5, DOI 10.1152/jappl.1997.83.1.5
   Reseland JE, 2001, AM J CLIN NUTR, V73, P240
   Sahebkar A, 2011, WORLD J GASTROENTERO, V17, P271, DOI 10.3748/wjg.v17.i2.271
   Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036
   SNYDER SH, 1981, P NATL ACAD SCI-BIOL, V78, P3260, DOI 10.1073/pnas.78.5.3260
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Stohs SJ, 2012, INT J MED SCI, V9, P527, DOI 10.7150/ijms.4446
   Stohs SJ, 2011, INT J MED SCI, V8, P295, DOI 10.7150/ijms.8.295
   Strychar I, 2009, J AM DIET ASSOC, V109, P718, DOI 10.1016/j.jada.2008.12.026
   Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7
   Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3
   Wankhade UD, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2365609
   Whiting S, 2012, APPETITE, V59, P341, DOI 10.1016/j.appet.2012.05.015
   Willis LH, 2012, J APPL PHYSIOL, V113, P1831, DOI 10.1152/japplphysiol.01370.2011
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
   Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597
NR 52
TC 22
Z9 25
U1 0
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PY 2018
VL 37
IS 2
BP 111
EP 120
DI 10.1080/07315724.2017.1368039
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GA8LV
UT WOS:000428592600004
PM 29111889
DA 2025-04-28
ER

PT J
AU Van Schaik, L
   Kettle, C
   Green, R
   Wundersitz, D
   Gordon, B
   Irving, HRR
   Rathner, JAA
AF Van Schaik, Lachlan
   Kettle, Christine
   Green, Rod
   Wundersitz, Daniel
   Gordon, Brett
   Irving, Helen R. R.
   Rathner, Joseph A. A.
TI Both caffeine and Capsicum annuum fruit powder lower blood
   glucose levels and increase brown adipose tissue temperature in healthy
   adult males
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE thermogenesis; substrate utilisation; capsaicin; glucose use; infra-red
   thermography (IRT); energy expenditure (EE); randomized double-blind
   placebo and positive-controlled crossover trial
ID NON-PUNGENT CULTIVAR; DIET-INDUCED OBESITY; ENERGY-EXPENDITURE;
   RED-PEPPER; INSULIN SENSITIVITY; HEART-RATE; BODY-FAT; INFRARED
   THERMOGRAPHY; INDUCED THERMOGENESIS; CH-19 SWEET
AB Using a combination of respiratory gas exchange, infrared thermography, and blood glucose (BGL) analysis, we have investigated the impact of Capsicum annuum (C. annuum) fruit powder (475 mg) or caffeine (100 mg) on metabolic activity in a placebo controlled (lactose, 100 mg) double-blinded three-way cross-over-design experiment. Metabolic measurements were made on day 1 and day 7 of supplementation in eight adult male participants (22.2 +/- 2 years of age, BMI 23 +/- 2 kg/m(2), x(-) +/- SD). Participants arrived fasted overnight and were fed a high carbohydrate meal (90 g glucose), raising BGL from fasting baseline (4.4 +/- 0.3 mmol/L) to peak BGL (8.5 +/- 0.3 mmol/L) 45 min after the meal. Participants consumed the supplement 45 min after the meal, and both caffeine and C. annuum fruit powder restored BGL (F-(8,F-178) = 2.2, p = 0.02) to near fasting levels within 15 min of supplementation compared to placebo (120 min). In parallel both supplements increased energy expenditure (F-(2,F-21) = 175.6, p < 0.001) over the 120-min test period (caffeine = 50.74 +/- 2 kcal/kg/min, C. annuum fruit = 50.95 +/- 1 kcal/kg/min, placebo = 29.34 +/- 1 kcal/kg/min). Both caffeine and C. annuum fruit powder increased supraclavicular fossa temperature (F-(2,F-42) = 32, p < 0.001) on both day 1 and day 7 of testing over the 120-min test period. No statistical difference in core temperature or reference point temperature, mean arterial pressure or heart rate was observed due to supplementation nor was any statistical difference seen between day 1 and day 7 of intervention. This is important for implementing dietary ingredients as potential metabolism increasing supplements. Together the results imply that through dietary supplements such as caffeine and C. annuum, mechanisms for increasing metabolism can be potentially targeted to improve metabolic homeostasis in people.
C1 [Van Schaik, Lachlan; Kettle, Christine; Green, Rod; Irving, Helen R. R.; Rathner, Joseph A. A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Rural Clin Sci, Bendigo, Vic, Australia.
   [Wundersitz, Daniel; Gordon, Brett] La Trobe Univ, La Trobe Rural Hlth Sch, Dept Rural Allied Hlth, Holsworth Res Initiat, Bendigo, Vic, Australia.
   [Rathner, Joseph A. A.] Univ Melbourne, Sch Biomed Sci, Dept Anat & Physiol, Melbourne, Vic, Australia.
C3 La Trobe University; La Trobe University; University of Melbourne
RP Van Schaik, L (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Rural Clin Sci, Bendigo, Vic, Australia.
EM j.vanschaik@latrobe.edu.au
RI Gordon, Brett/AFV-9359-2022; Irving, Helen/B-4425-2019
OI Irving, Helen/0000-0002-1514-0909; Van Schaik,
   Lachlan/0000-0001-9589-661X; Kettle, Christine/0000-0003-3223-4090;
   Gordon, Brett/0000-0001-8864-2128; Wundersitz,
   Daniel/0000-0002-7316-6373
FU Holsworth Research Initiative; La Trobe University
FX This study was conducted with the support of the Holsworth Research
   Initiative, La Trobe University. The Defence Science Institute (DSI,
   Australia).
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Ahuja KDK, 2006, AM J CLIN NUTR, V84, P63, DOI 10.1093/ajcn/84.1.63
   Andersson J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48879-7
   Barnard ND, 2005, AM J MED, V118, P991, DOI 10.1016/j.amjmed.2005.03.039
   Barnard ND, 2009, AM J CLIN NUTR, V89, pS1588, DOI 10.3945/ajcn.2009.26736H
   Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297
   Baskaran P, 2017, INT J OBESITY, V41, P739, DOI 10.1038/ijo.2017.16
   Baskaran P, 2016, BRIT J PHARMACOL, V173, P2369, DOI 10.1111/bph.13514
   Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356
   Brasil S, 2020, REV ENDOCR METAB DIS, V21, P37, DOI 10.1007/s11154-020-09539-8
   Camm AJ, 1996, CIRCULATION, V93, P1043
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Chaiyasit Kamon, 2009, Journal of the Medical Association of Thailand, V92, P108
   Chen HY, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20102885
   Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213
   Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746
   CUNNINGHAM JJ, 1990, NUTRITION, V6, P222
   Dekker MJ, 2007, BRIT J NUTR, V98, P556, DOI 10.1017/S0007114507730738
   Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x
   Dunaief D. M., 2012, Open Journal of Preventive Medicine, V2, P364, DOI 10.4236/ojpm.2012.23053
   El Hadi H, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01954
   El Hadi H, 2016, PHYSIOL MEAS, V37, DOI 10.1088/0967-3334/37/12/N118
   Ernst G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00240
   Fuse S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092676
   Galgani JE, 2010, BRIT J NUTR, V103, P38, DOI 10.1017/S0007114509991358
   HAARBO J, 1991, CLIN PHYSIOL, V11, P331, DOI 10.1111/j.1475-097X.1991.tb00662.x
   Hachiya S, 2007, BIOSCI BIOTECH BIOCH, V71, P671, DOI 10.1271/bbb.60359
   Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891
   Hibi M, 2016, INT J OBESITY, V40, P1655, DOI 10.1038/ijo.2016.124
   Iwasaki Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2608, DOI 10.1271/bbb.80289
   Iwen KA, 2017, J CLIN ENDOCR METAB, V102, P4226, DOI 10.1210/jc.2017-01250
   Jang HH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77983-2
   Johnson W, 2007, INT J TOXICOL, V26, P3, DOI 10.1080/10915810601163939
   Kahleova H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091302
   Khedoe PPSJ, 2015, J LIPID RES, V56, P51, DOI 10.1194/jlr.M052746
   Koenig J., 2013, Journal of Caffeine Research, V3, P22, DOI 10.1089/jcr.2013.0009
   Kwak SG, 2017, KOREAN J ANESTHESIOL, V70, P144, DOI 10.4097/kjae.2017.70.2.144
   Law J, 2018, J NUCL MED, V59, P516, DOI 10.2967/jnumed.117.190546
   Lee E, 2015, FASEB J, V29, P3182, DOI 10.1096/fj.14-268300
   Lee P, 2013, INT J OBESITY, V37, P593, DOI 10.1038/ijo.2012.90
   Lee P, 2011, DIABETES OBES METAB, V13, P92, DOI 10.1111/j.1463-1326.2010.01318.x
   Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513
   Lejeune MPGM, 2003, BRIT J NUTR, V90, P651, DOI 10.1079/BJN2003938
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   Malik M, 1998, CURR OPIN CARDIOL, V13, P36, DOI 10.1097/00001573-199801000-00006
   Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206
   McCracken E, 2018, CLIN DERMATOL, V36, P14, DOI 10.1016/j.clindermatol.2017.09.004
   Najjar RS, 2018, CLIN CARDIOL, V41, P307, DOI 10.1002/clc.22863
   Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   O'Mara AE, 2020, J CLIN INVEST, V130, P2209, DOI 10.1172/JCI131126
   Ohnuki K, 2001, BIOSCI BIOTECH BIOCH, V65, P2033, DOI 10.1271/bbb.65.2033
   Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012
   Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433
   PERONNET F, 1991, CAN J SPORT SCI, V16, P23
   Poher AL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00004
   Rauh R, 2006, CLIN PHYSIOL FUNCT I, V26, P163, DOI 10.1111/j.1475-097X.2006.00663.x
   Roman S, 2015, TRANSL RES, V165, P464, DOI 10.1016/j.trsl.2014.11.002
   Saito M, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00222
   Saito Masayuki, 2015, Adv Food Nutr Res, V76, P1, DOI 10.1016/bs.afnr.2015.07.002
   Saito M, 2013, CURR OPIN LIPIDOL, V24, P71, DOI 10.1097/MOL.0b013e32835a4f40
   Salem V, 2016, DIABETES OBES METAB, V18, P72, DOI 10.1111/dom.12585
   Sievers W, 2019, OBES SCI PRACT, V5, P592, DOI 10.1002/osp4.368
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561
   Sullivan SJL, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99300-1
   Sun LJ, 2018, AM J CLIN NUTR, V107, P62, DOI 10.1093/ajcn/nqx025
   Symonds ME, 2012, J PEDIATR-US, V161, P892, DOI 10.1016/j.jpeds.2012.04.056
   Teran CG, 2012, CHILD CARE HLTH DEV, V38, P471, DOI 10.1111/j.1365-2214.2011.01264.x
   Ursino MG, 2009, PHARMACOL RES, V59, P221, DOI 10.1016/j.phrs.2009.01.002
   Pérez DIV, 2021, J THERM BIOL, V99, DOI 10.1016/j.jtherbio.2021.103000
   van der Lans AAJJ, 2014, AM J PHYSIOL-REG I, V307, pR103, DOI 10.1152/ajpregu.00021.2014
   Van Schaik L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80505-9
   Van Schaik L, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.621356
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Vilarim MM, 2011, EXPERT REV NEUROTHER, V11, P1185, DOI [10.1586/ern.11.83, 10.1586/ERN.11.83]
   Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503
   WATANABE T, 1987, BIOCHEM BIOPH RES CO, V142, P259, DOI 10.1016/0006-291X(87)90479-7
   Whittle A, 2013, TRENDS PHARMACOL SCI, V34, P347, DOI 10.1016/j.tips.2013.04.004
   Yoneshiro T, 2017, AM J CLIN NUTR, V105, P873, DOI 10.3945/ajcn.116.144972
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
   Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
   Zsiborás C, 2018, CRIT REV FOOD SCI, V58, P1419, DOI 10.1080/10408398.2016.1262324
NR 84
TC 9
Z9 9
U1 3
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD AUG 9
PY 2022
VL 13
AR 870154
DI 10.3389/fphys.2022.870154
PG 17
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 3Y6JO
UT WOS:000843829600001
PM 36017333
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Liu, AG
   Smith, SR
   Fujioka, K
   Greenway, FL
AF Liu, Ann G.
   Smith, Steven R.
   Fujioka, Ken
   Greenway, Frank L.
TI The Effect of Leptin, Caffeine/Ephedrine and their Combination Upon
   Visceral Fat Mass and Weight Loss
SO OBESITY
LA English
DT Article
ID ADIPOSE-TISSUE COMPARTMENTS; RECOMBINANT LEPTIN; OBESE SUBJECTS; RISK;
   EPHEDRINE; EFFICACY; PLACEBO; SAFETY; ADULTS
AB Objective: To evaluate the effects of combination caffeine/ephedrine and leptin A-200 on visceral fat mass and weight loss over 24 weeks.
   Design and Methods: In this randomized, double-blind, parallel-arm trial, 90 obese subjects received one of the three treatments for 24 weeks: 200 mg caffeine/20 mg ephedrine t.i.d. (CE), leptin A-200 (recombinant methionyl human Fc-leptin, 20 mg q.d.) (L), or combination leptin A-200 and caffeine/ephedrine (LCE). Outcomes included change in weight, visceral fat mass by computed tomography, lean mass and fat mass by dual energy X-ray absorptiometry.
   Results: Groups treated with CE and LCE lost significant amounts of weight (-5.9 +/- 1.2% and -6.5 +/- 1.1%, P < 0.05) and whole body fat mass (-9.6 +/- 2.4% and -12.4 +/- 2.3%, P < 0.05) compared to leptin only group. Only treatment with LCE significantly reduced visceral fat mass (-11.0 +/- 3.3%, P < 0.05). There were no differences in lean mass between treatment groups.
   Conclusions: Our study provides evidence that CE is a modestly effective weight loss agent and produces significant reductions in fat mass. Leptin A-200 was not effective in producing weight loss and did not have any significant additive or synergistic actions when combined with CE.
C1 [Liu, Ann G.; Greenway, Frank L.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.
   [Smith, Steven R.] Florida Hosp, Sanford Burnham Med Res Inst, Translat Res Inst Metab & Diabet, Orlando, FL USA.
   [Fujioka, Ken] Scripps Clin, La Jolla, CA 92037 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Sanford Burnham Prebys Medical
   Discovery Institute; Adventist Health Services; AdventHealth; Scripps
   Research Institute
RP Greenway, FL (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA USA.
EM Frank.Greenway@pbrc.edu
RI Greenway, Frank/N-1966-2017
OI Smith, Steven/0000-0002-5098-8147; Liu, Ann/0000-0002-4959-4933
FU Amgen Pharmaceuticals
FX This study was funded through an investigator-initiated grant from Amgen
   Pharmaceuticals to SRS and FLG.
CR Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204
   Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693
   Food and Drug Administration HHS, 2004, Fed Regist, V69, P6787
   Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355
   Greenway F L, 2001, Obes Rev, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   Hallas J, 2008, AM J EPIDEMIOL, V168, P966, DOI 10.1093/aje/kwn191
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   Hukshorn CJ, 2000, J CLIN ENDOCR METAB, V85, P4003, DOI 10.1210/jc.85.11.4003
   LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257
   Mittendorfer B, 2011, DIABETES, V60, P1474, DOI 10.2337/db10-1302
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   Moon HS, 2011, DIABETES, V60, P1647, DOI 10.2337/db10-1791
   Ravussin E, 2009, OBESITY, V17, P1736, DOI 10.1038/oby.2009.184
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693
   Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475
   Zelissen PMJ, 2005, DIABETES OBES METAB, V7, P755, DOI 10.1111/j.1463-1326.2005.00468.x
NR 20
TC 25
Z9 26
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD OCT
PY 2013
VL 21
IS 10
BP 1991
EP 1996
DI 10.1002/oby.20416
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 231OT
UT WOS:000325427300006
PM 23686786
DA 2025-04-28
ER

PT J
AU Pereira, DLM
   Juvanhol, LL
   Silva, DCG
   Longo, GZ
AF Pereira, Dayana L. M.
   Juvanhol, Leidjaira L.
   Silva, Danielle C. G.
   Longo, Giana Z.
TI Dietary patterns and metabolic phenotypes in Brazilian adults: a
   population-based cross-sectional study
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Food consumption; Changes in body weight; Eating behaviour; Feeding
   behaviour; Body size
ID CARDIOVASCULAR-DISEASE; HEALTHY OBESITY; RISK-FACTORS; FOOD-INTAKE;
   ADOLESCENTS; ASSOCIATION; INDEX; WOMEN; CITY
AB Objective: Dietary patterns have been pointed out as useful diet quality indicators, but evidence about their relationship to metabolic phenotypes is still scarce. Thus, the present study aimed to verify the relationship between dietary patterns and metabolic phenotypes in Brazilian adults. Design: Cross-sectional study. A food consumption frequency questionnaire assessed food consumption profiles. Metabolic phenotypes were defined based on the criteria of the National Health and Nutrition Examination Survey: overweight or normal weight and metabolically healthy (MHOW and MHNW) or unhealthy (MUOW and MUNW). Dietary patterns were established through exploratory factor analysis and principal component analysis. The associations were tested using multinomial logistic regression. Setting: Vicosa, Minas Gerais, Brazil. Participants: Individuals (n 896) aged 20-59 years of both sexes, selected using probabilistic sampling. Results: Three dietary patterns were identified: Unhealthy pattern (alcoholic beverages, oils and fats, condiments, soda and juice, sugars and sweets, snacks, and meat and derivatives), Traditional pattern (culinary preparations, beans, milk and dairy products, and coffee and tea) and Healthy pattern (vegetables and fruits, whole grains, chicken and fish, and skimmed milk). Unhealthy pattern was positively associated with the MHOW and MUOW phenotypes in the fourth quartile (OR = 1 center dot 84; 95 % CI 1 center dot 06, 3 center dot 22) and in the third (OR = 1 center dot 94; 95 % CI 1 center dot 11, 3 center dot 39) and fourth (OR = 2 center dot 56; 95 % CI 1 center dot 41, 4 center dot 64) quartiles of consumption, respectively. Healthy pattern was also associated with these phenotypes. Conclusions: Both the pattern comprising energy-dense foods and the healthier pattern were associated with overweight phenotypes among Brazilian adults.
C1 [Pereira, Dayana L. M.; Juvanhol, Leidjaira L.; Longo, Giana Z.] Univ Fed Vicosa, Dept Nutr & Saude, Programa Posgrad Ciencia Nutr, Campus Univ, BR-36570900 Vicosa, MG, Brazil.
   [Silva, Danielle C. G.] Univ Fed Oeste Bahia, Ctr Ciencias Biol & Saude, Barreiras, BA, Brazil.
C3 Universidade Federal de Vicosa; Universidade Federal do Oeste da Bahia
RP Pereira, DLM (corresponding author), Univ Fed Vicosa, Dept Nutr & Saude, Programa Posgrad Ciencia Nutr, Campus Univ, BR-36570900 Vicosa, MG, Brazil.
EM dayanalnut@gmail.com
RI Juvanhol, Leidjaira/AAW-5793-2020; LONGO, GIANA/AAX-6501-2020; da Silva
   de Oliveira, Danielle/O-5548-2015
OI Lopes Juvanhol, Leidjaira/0000-0001-8012-6006
FU Coordination for the Improvement of Higher Education Personnel (CAPES)
FX During the 24-month period of research data analysis, author D.L.M.P.
   received financial support from the Coordination for the Improvement of
   Higher Education Personnel (CAPES). CAPES had no additional role in the
   design, analysis or writing of this article.
CR Neumann AICP, 2007, REV PANAM SALUD PUBL, V22, P329, DOI 10.1590/S1020-49892007001000006
   da Silva DCG, 2018, J HUM NUTR DIET, V31, P85, DOI 10.1111/jhn.12497
   Silva DFD, 2016, CIENC SAUDE COLETIVA, V21, P1181, DOI 10.1590/1413-81232015214.08742015
   de Pinho L, 2014, J PEDIAT-BRAZIL, V90, P267, DOI 10.1016/j.jped.2013.04.006
   Fardet A, 2016, FOOD FUNCT, V7, P2338, DOI [10.1039/c6fo00107f, 10.1039/C6FO00107F]
   de Moraes ACF, 2012, APPETITE, V58, P1057, DOI 10.1016/j.appet.2012.01.024
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   Goday A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2921-4
   Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]
   Diniz MDHS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004010
   Hoffmann M, 2015, CIENC SAUDE COLETIVA, V20, P1564, DOI 10.1590/1413-81232015205.07942014
   Kimokoti RW, 2015, J NUTR, V145, P2551, DOI 10.3945/jn.115.221283
   Kimokoti RW, 2014, J NUTR, V144, P2018, DOI 10.3945/jn.114.198341
   Lissner L, 2000, BRIT J NUTR, V83, pS21
   Marchioni DM, 2011, PUBLIC HEALTH NUTR, V14, P1586, DOI 10.1017/S1368980011000486
   Moreira PL, 2014, REV ASSOC MED BRAS, V60, P457, DOI 10.1590/1806-9282.60.05.014
   Olinto M., 2007, Padroes alimentares: analise de componentes principai, P213
   Pardini R., 2001, Rev Bras Cien e Mov, V9, P45
   Perozzo G, 2008, CAD SAUDE PUBLICA, V24, P2427, DOI 10.1590/S0102-311X2008001000023
   Phillips CM, 2017, ANN NY ACAD SCI, V1391, P85, DOI 10.1111/nyas.13230
   Pomerleau J, 1999, EUR J EPIDEMIOL, V15, P553, DOI 10.1023/A:1007512420937
   Roberson L, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-121
   Rodrigues Paulo Rogério Melo, 2012, Rev. bras. epidemiol., V15, P662, DOI 10.1590/S1415-790X2012000300019
   Salvatti AG, 2011, REV NUTR, V24, P703, DOI 10.1590/S1415-52732011000500004
   Segheto W, 2015, NUTR HOSP, V32, P101, DOI 10.3305/nh.2015.32.1.8391
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Silva D, 2017, REV NUTRI, V30, P783
   WHO, 1995, World Health Organization technical report series, V854, P1
   Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617
   Xia LL, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040391
NR 30
TC 11
Z9 12
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD DEC
PY 2019
VL 22
IS 18
BP 3377
EP 3383
AR PII S1368980019002593
DI 10.1017/S1368980019002593
PG 7
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA JT9WP
UT WOS:000501332300008
PM 31571548
OA Bronze
DA 2025-04-28
ER

PT J
AU Takahashi, A
   Shimizu, H
   Okazaki, Y
   Sakaguchi, H
   Taira, T
   Suzuki, T
   Chiji, H
AF Takahashi, Azusa
   Shimizu, Hisae
   Okazaki, Yukako
   Sakaguchi, Hirohide
   Taira, Toshio
   Suzuki, Takashi
   Chiji, Hideyuki
TI Anthocyanin-rich Phytochemicals from Aronia Fruits Inhibit Visceral Fat
   Accumulation and Hyperglycemia in High-fat Diet-induced Dietary Obese
   Rats
SO JOURNAL OF OLEO SCIENCE
LA English
DT Article
DE Aronia; phytochemicals; anthocyanin; visceral fat accumulation;
   postprandial hyperlipidemia
ID AMELIORATES HYPERGLYCEMIA; ALPHA-GLUCOSIDASE; CHLOROGENIC ACID;
   ADIPOSE-TISSUE; MELANOCARPA; EXTRACT; INSULIN; SUPPLEMENTATION;
   METABOLISM; ACTIVATION
AB Aronia fruits (chokeberry: Aronia melanocarpa E.) containing phenolic phytochemicals, such as cyanidin 3-glycosides and chlorogenic acid, have attracted considerable attention because of their potential human health benefits in humans including antioxidant activities and ability to improved vision. In the present study, the effects of anthocyanin-rich phytochemicals from aronia fruits (aronia phytochemicals) on visceral fat accumulation and fasting hyperglycemia were examined in rats fed a high-fat diet (Experiment 1). Total visceral fat mass was significantly lower in rats fed aronia phytochemicals than that in both the control group and bilberry phytochemicals-supplemented rats (p < 0.05). Moreover, perirenal and epididymal adipose tissue mass in rats fed aronia phytochemicals was significantly lower than that in both the control and bilberry phytochemicals group. Additionally, the mesenteric adipose tissue mass in aronia phytochemicals-fed rats was significantly low (p < 0.05). Furthermore, the fasting blood glucose levels significantly decreased in rats fed aronia phytochemicals for 4 weeks compared to that in the control rats (p <0.05). Therefore, we investigated the effects of phytochemicals on postprandial hyperlipidemia after corn oil loading in rats, pancreatic lipase activity in vitro, and the plasma glycemic response after sucrose loading in order to elucidate the preventive factor of aronia phytochemical on visceral fat accumulation. In the oral corn oil tolerance tests (Experiment 2), aronia phytochemicals significantly inhibited the increases in plasma triglyceride levels, with a half-maximal inhibitory concentration (IC50) of 1.50 mg/mL. However, the inhibitory activity was similar to that of bilberry and tea catechins. In the sucrose tolerance tests (Experiment 3), aronia phytochemicals also significantly inhibited the increases in blood glucose levels that were observed in the control animals (p < 0.05). These results suggest that anthocyanin-rich phytochemicals in aronia fruits suppress visceral fat accumulation and hyperglycemia by inhibiting pancreatic lipase activity and/or intestinal lipid absorption.
C1 [Takahashi, Azusa; Suzuki, Takashi] Hokkaido Univ, Grad Sch Agr, Div Agrobiol, Kita Ku, Sapporo, Hokkaido 0608589, Japan.
   [Shimizu, Hisae; Chiji, Hideyuki] Fuji Womens Univ, Fac Human Life Sci, Dept Food Sci & Human Nutr, Ishikari, Hokkaido 0613204, Japan.
   [Okazaki, Yukako] Fuji Womens Univ, Fac Human Life Sci, Deprtment Human Life Sci, Ishikari, Hokkaido 0613204, Japan.
   [Sakaguchi, Hirohide] Nihonshinyaku Co Ltd, Minami Ku, Kyoto, Kyoto 6018550, Japan.
   [Taira, Toshio] COSMO BIO Co Ltd, Nishi Ku, Sapporo, Hokkaido 0630061, Japan.
C3 Hokkaido University
RP Chiji, H (corresponding author), Fuji Womens Univ, Fac Human Life Sci, Dept Food Sci & Human Nutr, 4-5-7 Hanakawa Minami, Ishikari, Hokkaido 0613204, Japan.
EM hchiji@fujijoshi.ac.jp
OI Suzuki, Takashi/0009-0000-4253-9280
FU  [25292017]
FX Some parts of this study were conducted with the grant of the
   Grant-in-Aid for Scientific Research B (Grant number 25292017).
CR Ardévol A, 2013, FOOD CHEM, V141, P160, DOI 10.1016/j.foodchem.2013.02.104
   Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701
   Chandra A, 2001, J AGR FOOD CHEM, V49, P3515, DOI 10.1021/jf010389p
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Han LK, 2005, YAKUGAKU ZASSHI, V125, P213, DOI 10.1248/yakushi.125.213
   Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23
   Kawasaki K, 2009, J JPN SOC FOOD SCI, V56, P545, DOI 10.3136/nskkk.56.545
   Krajka-Kuzniak V, 2009, J AGR FOOD CHEM, V57, P5071, DOI 10.1021/jf803973y
   Kristy L. W., 2003, J NUTR, V133, P2268
   Matsiu T, 2002, J AGR FOOD CHEM, V50, P7244, DOI 10.1021/jf025913m
   Matsumoto M, 2004, J AGR FOOD CHEM, V52, P2226, DOI 10.1021/jf034818q
   McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926
   McDougall GJ, 2009, FOOD CHEM, V115, P193, DOI 10.1016/j.foodchem.2008.11.093
   Noguchi A, 2011, NIPPON EIYO SHOKURYO, V64, P27
   Ohta Y, 2007, J JPN SOC FOOD SCI, V54, P287, DOI 10.3136/nskkk.54.287
   Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Rie S, 2007, BIOCHEM PHARMACOL, V74, P1619, DOI 10.1016/j.bcp.2007.08.008
   Seeram NP, 2006, J AGR FOOD CHEM, V54, P9329, DOI 10.1021/jf061750g
   Taira T., 2015, J CLIN BIOCHEM NUTR, V57, P1
   Takahashi A, 2015, J JPN SOC FOOD SCI, V62, P235, DOI 10.3136/nskkk.62.235
   Takahashi A, 2014, J OLEO SCI, V63, P201, DOI 10.5650/jos.ess13196
   Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216
   Tamura A, 2004, J NUTR SCI VITAMINOL, V50, P13, DOI 10.3177/jnsv.50.13
   Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125
   Valcheva-Kuzmanova S, 2004, EXP TOXICOL PATHOL, V56, P195, DOI 10.1016/j.etp.2004.04.012
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   Wang Y, 2012, J NUTR, V142, P1033, DOI 10.3945/jn.112.157701
   Xia XD, 2006, J NUTR, V136, P2220, DOI 10.1093/jn/136.8.2220
   You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v
NR 34
TC 39
Z9 43
U1 3
U2 47
PU JAPAN OIL CHEMISTS SOC
PI TOKYO
PA YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO,
   103-0027, JAPAN
SN 1345-8957
EI 1347-3352
J9 J OLEO SCI
JI J. Oleo Sci.
PD DEC
PY 2015
VL 64
IS 12
BP 1243
EP 1250
DI 10.5650/jos.ess15181
PG 8
WC Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology
GA CY2LQ
UT WOS:000366240600001
PM 26582155
OA gold
DA 2025-04-28
ER

PT J
AU Shields, DH
   Corrales, KM
   Metallinos-Katsaras, E
AF Shields, DH
   Corrales, KM
   Metallinos-Katsaras, E
TI Gourmet coffee beverage consumption among college women
SO JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
LA English
DT Article
ID UNITED-STATES; PORTION SIZES; ENERGY-INTAKE; US; OBESITY; ADOLESCENTS;
   TRENDS; FOODS; MEN; CONSEQUENCES
AB Gourmet coffee beverages (GCBs) are relatively new products in the foodservice industry that consist of high-energy coffee drinks. A descriptive study was conducted to evaluate the frequency of consumption of GCBs and their energy and fat contribution to overall dietary intake in college women using a beverage questionnaire and a 3-day food diary. A convenience sample of 165 undergraduate and graduate women attending Simmons College completed a beverage questionnaire, and a subsample of 41 women completed a 3-day food diary. Mean reported GCB consumption was 2.5 times/week for the entire sample and 7 times/week for the food diary subsample. A comparison of GCB consumers and nonconsumers indicated that GCB drinkers had a 206 kcal/day higher intake (P=.250) and a 32 g higher sugar intake than nonconsumers (P<.05). A significant percentage of college women consume GCBs, which contributes additional energy and fat to dietary intake. Over time, this could potentially affect weight status.
C1 Simmons Coll, Sch Hlth Studies, Dept Nutr, Boston, MA 02115 USA.
   Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   Childrens Hosp, Div Gastroenterol & Nutr, Boston, MA 02115 USA.
C3 Simmons University; Harvard University; Harvard University Medical
   Affiliates; Beth Israel Deaconess Medical Center; Harvard University;
   Harvard University Medical Affiliates; Boston Children's Hospital
RP Simmons Coll, Sch Hlth Studies, Dept Nutr, 300 Fenway, Boston, MA 02115 USA.
EM metallin@simmons.edu
CR *ALL DOM, CORP INF QUICK SERV
   Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356
   Bowman SA, 2002, J AM DIET ASSOC, V102, P1234, DOI 10.1016/S0002-8223(02)90273-7
   DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P1133, DOI 10.1016/0031-9384(93)90370-U
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429
   Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3
   Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   Jeffery RW, 1998, AM J PUBLIC HEALTH, V88, P277, DOI 10.2105/AJPH.88.2.277
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   McCrory MA, 1999, OBES RES, V7, P564, DOI 10.1002/j.1550-8528.1999.tb00715.x
   *NAT COFF ASS US I, 2002, NAT COFF DRINK TREND
   Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450
   Nielsen SJ, 2002, PREV MED, V35, P107, DOI 10.1006/pmed.2002.1037
   Nielsen SJ, 2002, OBES RES, V10, P370, DOI 10.1038/oby.2002.51
   NIELSEN SJ, 2003, JAMA-J AM MED ASSOC, V289, P1977
   Rolls BJ, 2000, J AM DIET ASSOC, V100, P232, DOI 10.1016/S0002-8223(00)00070-5
   ROLLS BJ, 1990, PHYSIOL BEHAV, V48, P19, DOI 10.1016/0031-9384(90)90254-2
   Rolls BJ, 2002, AM J CLIN NUTR, V76, P1207, DOI 10.1093/ajcn/76.6.1207
   Smiciklas-Wright H, 2003, J AM DIET ASSOC, V103, P41, DOI 10.1053/jada.2003.50000
   *STARB COFF CO, 2002, BEV RES MAN
   Troiano RP, 2000, AM J CLIN NUTR, V72, p1343S, DOI 10.1093/ajcn/72.5.1343s
   WEISBERG K, 2000, FOODSERVICE DIRECTOR, V13, P84
   WEISBERG K, 1999, FOODSERVICE DIRECTOR, V12, P84
   WILLETT W, 1998, NUTR EPIDEMIOLOGY, P246
   Young LR, 2003, J AM DIET ASSOC, V103, P231, DOI 10.1053/jada.2003.50027
NR 28
TC 21
Z9 26
U1 1
U2 14
PU AMER DIETETIC ASSOC
PI CHICAGO
PA 120 S RIVERSIDE PLZ, STE 2000, CHICAGO, IL 60606-6995 USA
SN 0002-8223
J9 J AM DIET ASSOC
JI J. Am. Diet. Assoc.
PD APR
PY 2004
VL 104
IS 4
BP 650
EP 653
DI 10.1016/j.jada.2004.01.015
PG 4
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 809KE
UT WOS:000220634800025
PM 15054352
DA 2025-04-28
ER

PT J
AU Lee, HS
   Jeon, YE
   Jung, JI
   Kim, SM
   Hong, SH
   Lee, J
   Hwang, JS
   Hwang, MO
   Kwon, K
   Kim, EJ
AF Lee, Hyun Sook
   Jeon, Young Eun
   Jung, Jae In
   Kim, So Mi
   Hong, Su Hee
   Lee, Jaehak
   Hwang, Jung Soon
   Hwang, Myeong Oh
   Kwon, Kisung
   Kim, Eun Ji
TI Anti-obesity effect of Cydonia oblonga Miller extract in high-fat
   diet-induced obese C57BL/6 mice
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Cydonia oblonga Miller; Chlorogenic acid; AMPK; Adipokine; Adipogenic
   transcription factor; High fat-induced obesity
ID ANTIOXIDANT PROPERTIES; HORMONE ADIPONECTIN; INSULIN-RESISTANCE;
   BLOOD-PRESSURE; LEAF EXTRACTS; COENZYME-A; QUINCE; FRUIT; GLUCOSE;
   CARBOXYLASE
AB effects and the mechanism involved. COME reduced body weight, fat mass, adipose tissue weight, and serum levels of insulin, triglyceride, and leptin, but increased the serum levels of adiponectin and high-density lipoprotein-cholesterol in high-fat diet (HFD)-induced obese C57BL/6 mice. COME increased AMPK activation. COME suppressed adipogenesis by decreasing CCAAT/enhancer binding protein a, peroxisome proliferator-activated receptor gamma,sterol regulatory element-binding protein-1c, acetyl-CoA carboxylase 1, ATP-citrate lyase, fatty acid synthase, and adipocyte protein 2 mRNA expression and enhanced lipolysis by increasing carnitine palmitoyl transferase 1 and hormone sensitive lipase mRNA expression. These results suggest that COME is potentially beneficial in inhibiting HFD-induced obesity by inducing AMPK activation and thereby, regulating several pathways involved in inhibiting adipogenesis, and promoting lipolysis and fatty acid oxidation. Our results suggest that COM may be used as an anti-obesity agent.
C1 [Lee, Hyun Sook] Dongseo Univ, Dept Food Sci & Nutr, Busan, South Korea.
   [Jeon, Young Eun; Jung, Jae In; Kim, So Mi; Hong, Su Hee; Kim, Eun Ji] Hallym Univ, Reg Strateg Ind Innovat Ctr, 1 Hallymdaehak Gil, Chunchon 24252, South Korea.
   [Lee, Jaehak] Kangwon Natl Univ, Dept Appl Anim Sci, Chunchon, South Korea.
   [Hwang, Jung Soon; Hwang, Myeong Oh] BnG Inc, Res Inst, Chunchon, South Korea.
   [Kwon, Kisung] Cha Univ, Dept Food Sci & Biotechnol, Pochon, South Korea.
C3 Dongseo University; Hallym University; Kangwon National University;
   Pochon Cha University
RP Kim, EJ (corresponding author), Hallym Univ, Reg Strateg Ind Innovat Ctr, 1 Hallymdaehak Gil, Chunchon 24252, South Korea.
EM myej4@hallym.ac.kr
RI Kim, Eun-Ji/HHN-4611-2022
CR Abliz A, 2014, J ETHNOPHARMACOL, V151, P970, DOI 10.1016/j.jep.2013.12.010
   Ashrafi H, 2013, AFR J TRADIT COMPLEM, V10, P277, DOI 10.4314/ajtcam.v10i2.12
   Aslam M, 2014, ADV PHARMACOL SCI, V2014, DOI 10.1155/2014/282698
   Aslan M, 2010, J ETHNOPHARMACOL, V128, P384, DOI 10.1016/j.jep.2010.01.040
   Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001
   Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838
   Bouret S, 2015, PHYSIOL REV, V95, P47, DOI 10.1152/physrev.00007.2014
   Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196
   Cano-Lamadrid M, 2018, J SCI FOOD AGR, V98, P5731, DOI 10.1002/jsfa.9120
   Carvalho M, 2010, J AGR FOOD CHEM, V58, P3366, DOI 10.1021/jf903836k
   Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cho HJ, 2003, AM J PHYSIOL-GASTR L, V284, pG996, DOI 10.1152/ajpgi.00347.2002
   Costa RM, 2009, FOOD CHEM TOXICOL, V47, P860, DOI 10.1016/j.fct.2009.01.019
   Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a
   Díez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293
   Din Ganaie M. U., 2020, Obesity Medicine, V18, DOI [10.1016/j.obmed.2020.100202, DOI 10.1016/J.OBMED.2020.100202]
   Essafi-Benkhadir K, 2012, BIOCHEM BIOPH RES CO, V418, P180, DOI 10.1016/j.bbrc.2012.01.003
   Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844
   Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200
   Hao JQ, 2018, CELL METAB, V28, P689, DOI 10.1016/j.cmet.2018.07.006
   He XY, 2021, J SCI FOOD AGR, V101, P631, DOI 10.1002/jsfa.10675
   Ho Chi-Tang, 2013, J Tradit Complement Med, V3, P139, DOI 10.4103/2225-4110.114892
   Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81
   Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002
   Karar MGE, 2014, FOOD RES INT, V65, P121, DOI 10.1016/j.foodres.2013.10.040
   Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411
   Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967
   Kültür S, 2007, J ETHNOPHARMACOL, V111, P341, DOI 10.1016/j.jep.2006.11.035
   Kumar R, 2020, CURR MOL PHARMACOL, V13, P7, DOI 10.2174/1874467212666190716145210
   Kurban M, 2004, J XINGJIANG NORMAL U, V60, P269
   Lee HS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102475
   Lim SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051190
   Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008
   Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Minaiyan M, 2012, RES PHARM SCI, V7, P103
   Mir SA, 2016, INT FOOD RES J, V23, P816
   Mirmohammadlu M, 2015, IRAN J PHARM RES, V14, P1207
   Naeimi M, 2019, COMPLEMENT THER MED, V45, P215, DOI 10.1016/j.ctim.2019.06.007
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Pacifico S, 2012, FOOD CHEM TOXICOL, V50, P4130, DOI 10.1016/j.fct.2012.07.061
   Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715
   Renaldi Olly, 2009, Acta Med Indones, V41, P20
   Schreurs M, 2010, OBES REV, V11, P380, DOI 10.1111/j.1467-789X.2009.00642.x
   Shinomiya F, 2009, BIOSCI BIOTECH BIOCH, V73, P1773, DOI 10.1271/bbb.90130
   Silva BM, 2005, J AGR FOOD CHEM, V53, P111, DOI 10.1021/jf040321k
   Sut S, 2019, J SCI FOOD AGR, V99, P1046, DOI 10.1002/jsfa.9271
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4
   Umar A, 2015, J ETHNOPHARMACOL, V169, P239, DOI 10.1016/j.jep.2015.04.038
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Wojdylo A, 2013, J AGR FOOD CHEM, V61, P2762, DOI 10.1021/jf304969b
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Zhou WT, 2014, J ETHNOPHARMACOL, V153, P635, DOI 10.1016/j.jep.2014.03.014
   Zhou W, 2014, J ETHNOPHARMACOL, V154, P163, DOI 10.1016/j.jep.2014.03.056
   Zhou WT, 2014, J ETHNOPHARMACOL, V152, P464, DOI 10.1016/j.jep.2014.01.018
NR 57
TC 13
Z9 13
U1 1
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD FEB
PY 2022
VL 89
AR 104945
DI 10.1016/j.jff.2022.104945
EA JAN 2022
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 1R0LC
UT WOS:000803069800004
OA gold
DA 2025-04-28
ER

PT J
AU Mielgo-Ayuso, J
   Barrenechea, L
   Alcorta, P
   Larrarte, E
   Margareto, J
   Labayen, I
AF Mielgo-Ayuso, Juan
   Barrenechea, Lurdes
   Alcorta, Pilar
   Larrarte, Eider
   Margareto, Javier
   Labayen, Idoia
TI Effects of dietary supplementation with epigallocatechin-3-gallate on
   weight loss, energy homeostasis, cardiometabolic risk factors and liver
   function in obese women: randomised, double-blind, placebo-controlled
   clinical trial
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Green tea; Epigallocatechin-3-gallate; Weight loss; Resting energy
   expenditure; Insulin resistance; Cholesterol
ID GREEN TEA-EXTRACT; RESTING METABOLIC-RATE; FAT OXIDATION; SUBSTRATE
   OXIDATION; INSULIN-RESISTANCE; CATECHINS; CAFFEINE; MAINTENANCE;
   EXPENDITURE; RESTRICTION
AB The aim of the present study was to examine the effects of green tea epigallocatechin-3-gallate (EGCG) on changes in body composition, energy and substrate metabolism, cardiometabolic risk factors and liver function enzymes after an energy-restricted diet intervention in obese women. In the present randomised, double-blind, placebo-controlled study, eighty-three obese (30 kg/m(2) > BMI < 40 kg/m(2)) premenopausal women consumed 300 mg/d of EGCG or placebo (lactose). We measured body weight and adiposity (dual-energy X-ray absorptiometry), energy expenditure and fat oxidation rates (indirect calorimetry), blood lipid levels (TAG, total cholesterol, LDL-cholesterol and HDL-cholesterol), insulin resistance, C-reactive protein and liver function markers (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, g-glutamyltransferase, urea, bilirubin and 2-keto[1-C-13] isocaproate oxidation) before and after the intervention in the EGCG and control groups. We did not find any significant difference in the changes in body weight (-0.3 kg, 95% CI -5.0, 4.3), fat mass (-0.7 kg, 95% CI -3.5, 2.1), energy (0.3 kJ/kg per d, 95% CI -3.1, 2.7) and fat (-0.1 g/min, 95% CI -0.03, 0.01) metabolism, homeostasis assessment model for insulin resistance (0.2, 95% CI -0.2, 0.7), total cholesterol (-0.21 mmol/l, 95% CI -0.55, 0.13), LDL-cholesterol (-0.15 mmol/l, 95% CI -0.50, 0.20), TAG (-0.14 mmol/l, 95% CI -0.56, 0.29) and liver function markers between the EGCG and control groups. In conclusion, the present results suggest that dietary supplementation with 300 mg/d of EGCG for 12 weeks did not enhance energy-restricted diet-induced adiposity reductions, and did not improve weight-loss-induced changes in cardiometabolic risk factors in obese Caucasian women. The intake of 300 mg/d of EGCG for 12 weeks did not cause any adverse effect on liver function biomarkers.
C1 [Mielgo-Ayuso, Juan; Labayen, Idoia] Univ Basque Country, Dept Nutr & Food Sci, UPV EHU, Vitoria, Spain.
   [Barrenechea, Lurdes] Univ Basque Country, Dept Med, Vitoria, Spain.
   [Alcorta, Pilar] Hosp Santiago Apostol, Dept Nucl Med, UPV EHU, Vitoria, Spain.
   [Larrarte, Eider; Margareto, Javier] Tecnalia, Biomed Res Area, Minano, Spain.
   [Larrarte, Eider] Tecnalia, Hlth & Qual Life Area, Minano, Spain.
C3 University of Basque Country; University of Basque Country; University
   of Basque Country
RP Labayen, I (corresponding author), Univ Basque Country, Dept Nutr & Food Sci, UPV EHU, Vitoria, Spain.
EM idoia.labayen@ehu.es
RI Mielgo-Ayuso, Juan/E-7525-2019; LABAYEN, IDOIA/C-7661-2009
OI LABAYEN, IDOIA/0000-0002-4334-3287; Mielgo Ayuso,
   Juan/0000-0002-6554-4602; BARRENECHEA, MARIA LOURDES/0000-0002-7724-9256
FU Department of Industry of the Government of the Basque Country
   [S-PE06LE04]
FX The present study was supported by the Department of Industry of the
   Government of the Basque Country (S-PE06LE04). The Department of
   Industry of the Government of the Basque Country had no role in the
   design, analyses or writing of this article.
CR Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009
   Davis NJ, 2006, DIABETES EDUCATOR, V32, P557, DOI 10.1177/0145721706290437
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x
   Frank J, 2009, J NUTR, V139, P58, DOI 10.3945/jn.108.096412
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Grattagliano I, 2010, EUR J CLIN INVEST, V40, P843, DOI 10.1111/j.1365-2362.2010.02331.x
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hsu Chung-Hua, 2011, Altern Med Rev, V16, P157
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Krishna YR, 2011, CAN J GASTROENTEROL, V25, P157
   Labayen I, 1999, EUR J NUTR, V38, P158, DOI 10.1007/s003940050057
   Labayen I, 2004, CLIN NUTR, V23, P571, DOI 10.1016/j.clnu.2003.10.004
   Martin CK, 2007, OBESITY, V15, P2964, DOI 10.1038/oby.2007.354
   Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7
   Moore RJ, 2009, BRIT J NUTR, V102, P1790, DOI 10.1017/S0007114509991218
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Parra D, 2003, METABOLISM, V52, P463, DOI 10.1053/meta.2003.50075
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Ruiz JR, 2012, NUTR METAB CARDIOVAS, V22, pE1, DOI 10.1016/j.numecd.2011.03.003
   Ruiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023759
   Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sarma DN, 2008, DRUG SAFETY, V31, P469, DOI 10.2165/00002018-200831060-00003
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Temme EHM, 2002, EUR J CLIN NUTR, V56, P379, DOI 10.1038/sj.ejcn.1601309
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wylie-Rosett J, 2007, J AM DIET ASSOC, V107, P1296, DOI 10.1016/j.jada.2007.05.009
   Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309
   Yang HY, 2012, BRIT J NUTR, V107, P749, DOI 10.1017/S0007114511005095
NR 45
TC 124
Z9 133
U1 1
U2 47
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD APR 14
PY 2014
VL 111
IS 7
BP 1263
EP 1271
DI 10.1017/S0007114513003784
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AZ2CJ
UT WOS:000348041900014
PM 24299662
OA Bronze
DA 2025-04-28
ER

PT J
AU Bashir, KMI
   Kim, JW
   Park, HR
   Lee, JK
   Choi, BR
   Choi, JS
   Ku, SK
AF Bashir, Khawaja Muhammad Imran
   Kim, Joo Wan
   Park, Hye-Rim
   Lee, Jae-Kyoung
   Choi, Beom-Rak
   Choi, Jae-Suk
   Ku, Sae-Kwang
TI Validating the Health Benefits of Coffee Berry Pulp Extracts in Mice
   with High-Fat Diet-Induced Obesity and Diabetes
SO ANTIOXIDANTS
LA English
DT Article
DE antioxidant; Coffea arabica L.; coffee berry pulp; diabetic obese mice;
   high-fat-diet; type 2 diabetes
ID ACTIVATED PROTEIN-KINASE; ANTIOXIDANT ACTIVITY; SUPEROXIDE-DISMUTASE;
   LIPID-PEROXIDATION; INSULIN-RESISTANCE; IN-VITRO;
   GLUTATHIONE-PEROXIDASE; BROWN RICE; GLUCOKINASE; CAPACITY
AB The effects of coffee (Coffea arabica L.) berry pulp extracts (CBP extracts) on the improvement of diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD) were evaluated using various in vitro antioxidant activity assays and through a high-fat diet-induced mild diabetic obese mouse model. After an 84-day oral administration of CBP extracts (400-100 mg/kg), bioactivities were evaluated. The in vitro analysis showed the highest DPPH center dot scavenging activity of 73.10 +/- 4.27%, ABTS(center dot) scavenging activity of 41.18 +/- 1.14%, and SOD activity of 56.24 +/- 2.81%, at a CBP extract concentration of 1000 mu g/mL. The in vivo analysis of the CBP extracts showed favorable and dose-dependent anti-obesity, anti-diabetic, NAFLD, nephropathy, and hyperlipidemia refinement effects through hepatic glucose enzyme activity, 5 '-AMP-activated protein kinase (AMPK) up-regulation, antioxidant activity, lipid metabolism-related gene expression, and pancreatic lipid digestion enzyme modulatory activities. This study shows that an appropriate oral dosage of CBP extracts could function as a potent herbal formulation for a refinement agent or medicinal food ingredient to control type 2 diabetes and related complications.
C1 [Bashir, Khawaja Muhammad Imran; Choi, Jae-Suk] Gyeongsang Natl Univ, Inst Marine Ind, Dept Seafood Sci & Technol, Tongyeong 53064, South Korea.
   [Bashir, Khawaja Muhammad Imran] German Engn Res & Dev Ctr Life Sci Technol Med & E, Busan 46742, South Korea.
   [Kim, Joo Wan] Daegu Haany Univ, Dept Compan Anim Hlth, Gyongsan 38610, South Korea.
   [Park, Hye-Rim; Choi, Beom-Rak] Nutracore Co Ltd, Suwon 16514, South Korea.
   [Park, Hye-Rim; Ku, Sae-Kwang] Daegu Haany Univ, Coll Korean Med, Dept Anat & Histol, Gyongsan 38610, South Korea.
   [Lee, Jae-Kyoung] CNS Pharm Korea Co Ltd, Seoul 04043, South Korea.
   [Lee, Jae-Kyoung] Korea Univ, Coll Sci & Technol, Dept Food Regulatory Sci, Sejong Campus, Sejong 30019, South Korea.
C3 Gyeongsang National University; Daegu Haany University; Daegu Haany
   University; Korea University
RP Choi, JS (corresponding author), Gyeongsang Natl Univ, Inst Marine Ind, Dept Seafood Sci & Technol, Tongyeong 53064, South Korea.; Ku, SK (corresponding author), Daegu Haany Univ, Coll Korean Med, Dept Anat & Histol, Gyongsan 38610, South Korea.
EM imran.bashir@lstme.org; jsc1008@gnu.ac.kr; gucci200@dhu.ac.kr
RI BASHIR, KHAWAJA MUHAMMAD IMRAN/J-9192-2018; Lee,
   Jae-Kyoung/AAG-8902-2020; Kim, Seung-Hyung/AAA-4707-2020; Jo,
   Cheorun/D-5724-2014
OI Choi, Jae-Suk/0000-0002-8151-6054; Ku, Sae-kwang/0000-0003-1269-3804;
   Bashir, Khawaja Muhammad Imran/0000-0002-6830-2588
CR Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   [Anonymous], 2005, Guidance for Industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteer
   Assady M, 2011, IRAN J PARASITOL, V6, P17
   Bashir KMI, 2023, METABOLITES, V13, DOI 10.3390/metabo13040501
   Bashir KMI, 2020, FOOD CHEM, V323, DOI 10.1016/j.foodchem.2020.126809
   Bashir KMI, 2018, J AQUAT FOOD PROD T, V27, P107, DOI 10.1080/10498850.2017.1407013
   Bertrand B, 2023, J SCI FOOD AGR, V103, P3602, DOI 10.1002/jsfa.12347
   Bolzan AD, 1997, CLIN BIOCHEM, V30, P449, DOI 10.1016/S0009-9120(97)00047-7
   BOOKCHIN RM, 1968, BIOCHEM BIOPH RES CO, V32, P86, DOI 10.1016/0006-291X(68)90430-0
   Carrera I, 2023, INT J MED SCI, V20, P292, DOI 10.7150/ijms.80727
   Chakniramol S, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11051021
   Chen CY, 2021, J CHEM-NY, V2021, DOI 10.1155/2021/8649618
   Chen HX, 2009, J FOOD SCI, V74, pC469, DOI 10.1111/j.1750-3841.2009.01231.x
   Chi PJ, 2022, INT J MED SCI, V19, P729, DOI 10.7150/ijms.69031
   Choi BR, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092837
   Choi EH, 2020, J FUNCT FOODS, V72, DOI 10.1016/j.jff.2020.104072
   Choi JS, 2017, INT J MOL MED, V39, P1437, DOI 10.3892/ijmm.2017.2967
   Chung SI, 2014, NUTRIENTS, V6, P4610, DOI 10.3390/nu6104610
   COMPORTI M, 1985, LAB INVEST, V53, P599
   Contreras-Oliva A, 2022, INT FOOD RES J, V29, P274
   Coope GJ, 2006, BRIT J PHARMACOL, V149, P328, DOI 10.1038/sj.bjp.0706848
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Ellulu MS, 2017, INFLAMMOPHARMACOLOGY, V25, P313, DOI 10.1007/s10787-017-0314-7
   Erejuwa OO, 2011, INT J MOL SCI, V12, P829, DOI 10.3390/ijms12010829
   Esa NM, 2013, FOOD CHEM, V141, P1306, DOI 10.1016/j.foodchem.2013.03.086
   Eswari R., 2021, IOSR J. Pharm. Biol. Sci, V16, P27
   Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724
   Floegel A, 2011, J FOOD COMPOS ANAL, V24, P1043, DOI 10.1016/j.jfca.2011.01.008
   Garg M C, 1997, Indian J Exp Biol, V35, P264
   George J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.747794
   Geremu M, 2016, CHEM BIOL TECHNOL AG, V3, DOI 10.1186/s40538-016-0077-1
   Goldstein BJ, 2002, AM J CARDIOL, V90, p3G
   Guo HY, 2018, EXP THER MED, V16, P333, DOI 10.3892/etm.2018.6178
   Haider K, 2020, EUR J MED CHEM, V204, DOI 10.1016/j.ejmech.2020.112607
   Handayani B.R., 2009, Ph.D. Dissertation, P1
   Heeger A, 2017, FOOD CHEM, V221, P969, DOI 10.1016/j.foodchem.2016.11.067
   Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360
   Jackson KMP, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601118
   JAMALL IS, 1985, TOXICOL APPL PHARM, V80, P33, DOI 10.1016/0041-008X(85)90098-5
   Jeong DW, 2018, J MICROBIOL BIOTECHN, V28, P1094, DOI 10.4014/jmb.1801.01013
   Junior M.P.F., 2023, Coffee Sci, V18, pe182101
   Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005
   Kang HG, 2022, MEDICINA-LITHUANIA, V58, DOI 10.3390/medicina58020189
   Kedare SB, 2011, J FOOD SCI TECH MYS, V48, P412, DOI 10.1007/s13197-011-0251-1
   KFDA, 2017, Standard for Toxicity Study of Pharmaceuticals
   Kim HJ, 2018, NUTR RES PRACT, V12, P503, DOI 10.4162/nrp.2018.12.6.503
   Kim JW, 2018, INT J MOL MED, V42, P3047, DOI 10.3892/ijmm.2018.3879
   Kim MR, 2017, INT J MOL MED, V40, P784, DOI 10.3892/ijmm.2017.3063
   Kim NY, 2015, J MICROBIOL BIOTECHN, V25, P1589, DOI 10.4014/jmb.1503.03080
   Kuda T, 2005, J FOOD COMPOS ANAL, V18, P625, DOI 10.1016/j.jfca.2004.06.015
   Kwon TH, 2013, J FOOD SCI, V78, pC679, DOI 10.1111/1750-3841.12109
   LARSEN ML, 1990, NEW ENGL J MED, V323, P1021, DOI 10.1056/NEJM199010113231503
   Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576
   Lin CH, 2014, INT J MOL SCI, V15, P20022, DOI 10.3390/ijms151120022
   Ma A, 2017, J LIPID RES, V58, P1536, DOI 10.1194/jlr.M073270
   Manasa V, 2021, WASTE MANAGE, V120, P762, DOI 10.1016/j.wasman.2020.10.045
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Mottillo EP, 2017, MOL METAB, V6, P471, DOI 10.1016/j.molmet.2017.04.001
   Noriega-López L, 2007, J BIOL CHEM, V282, P20657, DOI 10.1074/jbc.M701045200
   Ou BX, 2002, J AGR FOOD CHEM, V50, P3122, DOI 10.1021/jf0116606
   Park JE, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9060459
   Park SH, 2005, J ETHNOPHARMACOL, V102, P326, DOI 10.1016/j.jep.2005.06.041
   Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812
   Pieme CA, 2010, ENVIRON TOXICOL PHAR, V29, P223, DOI 10.1016/j.etap.2010.01.003
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Rustenbeck I, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.19
   Saewan N, 2022, COSMETICS-BASEL, V9, DOI 10.3390/cosmetics9030066
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000
   Shokouh P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010006
   Sodikoff C.H., 1995, Laboratory Profiles of Small Animal Diseases: A Guide to Laboratory Diagnosis, P1
   Sone H, 2001, TRENDS MOL MED, V7, P320, DOI 10.1016/S1471-4914(01)02041-X
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Sung YY, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1810-4
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645
   Terzo S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121857
   Thyagarajan A, 2018, INTEGR CANCER THER, V17, P210, DOI 10.1177/1534735416681639
   Torres-Valenzuela L.S., 2020, COFFEE PRODUCTION RE, P1
   Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513
   Wendel AA, 2008, J LIPID RES, V49, P98, DOI 10.1194/jlr.M700195-JLR200
   Wootton-Beard PC, 2011, FOOD RES INT, V44, P217, DOI 10.1016/j.foodres.2010.10.033
   Wu DD, 2015, MED GAS RES, V5, DOI 10.1186/s13618-014-0022-y
   Wu D, 2012, PHYTOMEDICINE, V19, P712, DOI 10.1016/j.phymed.2012.03.003
   Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w
   Yun SN, 2004, ARCH PHARM RES, V27, P790, DOI 10.1007/BF02980150
   Zhao MJ, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0472-z
   Zhao W, 2021, MOL MED REP, V24, DOI 10.3892/mmr.2021.12381
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 91
TC 2
Z9 2
U1 4
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD JAN
PY 2024
VL 13
IS 1
AR 10
DI 10.3390/antiox13010010
PG 25
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA GH7P5
UT WOS:001151846200001
PM 38275632
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU English, L
   Carmona, YR
   Peterson, KE
   Jansen, EC
   Rojo, MMT
   Olascoaga, LT
   Cantoral, A
AF English, Lindsey
   Carmona, Yanelli R.
   Peterson, Karen E.
   Jansen, Erica C.
   Tellez Rojo, Martha Maria
   Torres Olascoaga, Libni
   Cantoral, Alejandra
TI Changes in Sugar Sweetened Beverage Intake Are Associated with Changes
   in Body Composition in Mexican Adolescents: Findings from the ELEMENT
   Cohort
SO NUTRIENTS
LA English
DT Article
DE body mass index; waist circumference; body fat percentage; sugar intake;
   beverages; puberty
ID WAIST-CIRCUMFERENCE; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; GLYCEMIC
   INDEX; WEIGHT; CONSUMPTION; CHILDREN; SUCROSE; DRINKS; ENVIRONMENT
AB Changes in consumption of sugar sweetened beverage (SSBs) have been associated with increased body mass index (BMI), but little work has evaluated the effect on waist circumference (WC) and body fat percentage during adolescence, a period characterized by rapid growth and change in dietary behaviors. We examined the relationship of changes in SSB intake and changes in adiposity over two years in 464 Mexican adolescents. Food frequency questionnaires were used to sum intake of regular soda, coffee with sugar, tea with sugar, sweetened water with fruit, chocolate milk, corn atole, and a sweetened probiotic milk beverage. Linear regression models were used to estimate the associations of changes in SSBs with changes in BMI, body fat percentage, and WC, adjusting for sex, socioeconomic status, screen time, physical activity, age, and change in age. Adolescents who increased their daily SSB intake by >2 serving had a -2.72% higher body fat percentage (95% CI: 0.61, 4.82); a 1-2 serving increase was associated with a 2.49 cm increase (95% CI: 0.21, 4.76) in WC compared with those with no change in intake. Within an adolescent sample, changes in SSB intake were related to concomitant changes in body fat percentage and WC, but not BMI.
C1 [English, Lindsey] Univ North Dakota, Dept Nutr & Dietet, Grand Forks, ND 58202 USA.
   [Carmona, Yanelli R.; Peterson, Karen E.; Jansen, Erica C.] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA.
   [Peterson, Karen E.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   [Tellez Rojo, Martha Maria; Torres Olascoaga, Libni] Natl Inst Publ Hlth Mexico, Ctr Hlth & Nutr Res, Cuernavaca 62100, Morelos, Mexico.
   [Cantoral, Alejandra] Univ Iberoamer Ciudad Mexico, Dept Hlth, Mexico City 01219, DF, Mexico.
C3 University of North Dakota Grand Forks; University of Michigan System;
   University of Michigan; University of Michigan System; University of
   Michigan; Instituto Nacional de Salud Publica; Universidad
   Iberoamericana Ciudad de Mexico
RP Cantoral, A (corresponding author), Univ Iberoamer Ciudad Mexico, Dept Hlth, Mexico City 01219, DF, Mexico.
EM lindsey.english@und.edu; yanelli@umich.edu; karenep@umich.edu;
   janerica@umich.edu; mmtellez@insp.mx; libniavib@gmail.com;
   alejandra.cantoral@ibero.mx
RI /T-7248-2019; English, Lindsey/LIG-2230-2024; Cantoral,
   Alejandra/AAA-3615-2021
OI Tellez Rojo, Martha/0000-0003-3322-3334; Rodriguez-Carmona,
   Yanelli/0000-0001-6559-4776; CANTORAL, ALEJANDRA/0000-0002-1397-8476;
   Peterson, Karen/0000-0003-0471-1427; Torres-Olascoaga,
   Libni/0000-0002-9231-9937; English, Lindsey/0000-0002-0150-5292
FU US Environmental Protection Agency (US EPA) [RD83543601]; National
   Institute for Environmental Health Sciences (NIEHS) [PO1 ES 02284401,
   R24ES028502]; National Institute of Public Health/Ministry of Health of
   Mexico; National Heart, Lung, and Blood Institute [K01 HL151673];
   National Heart Lung and Blood Institute [K01HL151673] Funding Source:
   NIH RePORTER; National Institute of Environmental Health Sciences
   [R24ES028502, P30ES017885] Funding Source: NIH RePORTER
FX This work was supported by the US Environmental Protection Agency (US
   EPA) grant RD83543601, and National Institute for Environmental Health
   Sciences (NIEHS) grants, PO1 ES 02284401 and R24ES028502. This study was
   also supported and partially funded by the National Institute of Public
   Health/Ministry of Health of Mexico. Jansen reports funding from the
   National Heart, Lung, and Blood Institute (K01 HL151673).
CR Aceves-Martins M, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.29625
   Colchero MA, 2017, J NUTR, V147, P1552, DOI 10.3945/jn.117.251892
   Barrientos-Gutierrez T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176336
   Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94
   Cantoral A, 2016, PEDIATR OBES, V11, P68, DOI 10.1111/ijpo.12023
   Macedo-Ruíz EC, 2018, REV PERSPECT EMPERSA, V5, P83, DOI 10.16967/rpe.v5n2a6
   Chambers L, 2015, TRENDS FOOD SCI TECH, V41, P149, DOI 10.1016/j.tifs.2014.10.007
   Chavarro JE, 2017, J PEDIATR-US, V186, P172, DOI 10.1016/j.jpeds.2017.03.050
   Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240
   Clawson RC, 2019, PHYSIOL BEHAV, V201, P165, DOI 10.1016/j.physbeh.2018.11.026
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Gan WY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152785
   García-Chávez GC, 2018, PUBLIC HEALTH NUTR, V21, P702, DOI 10.1017/S1368980017003299
   Gibbs BB, 2012, J ACAD NUTR DIET, V112, P1347, DOI 10.1016/j.jand.2012.06.012
   Gómez EJ, 2019, HEALTH POLICY PLANN, V34, P520, DOI 10.1093/heapol/czz063
   Haslam DE, 2018, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00368
   He F, 2015, J CLIN DENSITOM, V18, P30, DOI 10.1016/j.jocd.2014.07.009
   Hernández B, 2000, SALUD PUBLICA MEXICO, V42, P315, DOI 10.1590/S0036-36342000000400006
   Laurson K, 2008, ACTA PAEDIATR, V97, P795, DOI 10.1111/j.1651-2227.2008.00713.x
   Laverty AA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0297-y
   Leal DB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101098
   Lennerz BS, 2013, AM J CLIN NUTR, V98, P641, DOI 10.3945/ajcn.113.064113
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414
   Ng SW, 2019, PUBLIC HEALTH NUTR, V22, P750, DOI [10.1017/S136898001800321X, 10.1017/s136898001800321x]
   OECD, 2017, Obesity Update 2017, DOI DOI 10.1007/S11428-017-0241-7
   Ortega-Avila AG, 2019, J PUBLIC HEALTH-HEID, V27, P791, DOI 10.1007/s10389-018-0993-6
   Perng W, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030427
   Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721
   Reid M, 2007, BRIT J NUTR, V97, P193, DOI 10.1017/S0007114507252705
   Roberts EFS, 2021, AM ANTHROPOL, DOI 10.1111/aman.13560
   Roberts EFS, 2015, BIOSOCIETIES, V10, P247, DOI 10.1057/biosoc.2015.18
   Romero-Martínez M, 2019, SALUD PUBLICA MEXICO, V61, P917
   Sánchez-Pimienta TG, 2016, J NUTR, V146, P1888, DOI 10.3945/jn.115.220301
   Sari CI, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01162
   Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264
   Sharma AK, 2015, PEDIATR RES, V78, P723, DOI 10.1038/pr.2015.160
   Soenen S, 2007, AM J CLIN NUTR, V86, P1586
   Stanhope KL, 2018, OBES REV, V19, P1205, DOI 10.1111/obr.12699
   Stern D, 2017, AM J PUBLIC HEALTH, V107, P1801, DOI [10.2105/AJPH.2017.304008, 10.2105/ajph.2017.304008]
   Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652
   Vanselow MS, 2009, AM J CLIN NUTR, V90, P1489, DOI 10.3945/ajcn.2009.27573
   Wisniewski AB, 2009, GENDER MED, V6, P76, DOI 10.1016/j.genm.2008.12.001
   Zeng Q, 2012, BRAZ J MED BIOL RES, V45, P591, DOI 10.1590/S0100-879X2012007500059
   Zheng M, 2014, EUR J CLIN NUTR, V68, P77, DOI 10.1038/ejcn.2013.243
   Zheng Y, 2016, AM J CLIN NUTR, V103, P1179, DOI 10.3945/ajcn.115.107177
NR 46
TC 7
Z9 7
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD FEB
PY 2022
VL 14
IS 3
AR 719
DI 10.3390/nu14030719
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA ZG3NQ
UT WOS:000760166000001
PM 35277078
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Uche, UI
   Suzuki, S
   Fulda, KG
   Zhou, ZY
AF Uche, Uloma Igara
   Suzuki, Sumihiro
   Fulda, Kimberly G.
   Zhou, Zhengyang
TI Environment-wide association study on childhood obesity in the US
SO ENVIRONMENTAL RESEARCH
LA English
DT Article
DE Environmental factors; Childhood obesity; EWAS; NHANES; Public health
ID POLYCYCLIC AROMATIC-HYDROCARBONS; BLOOD LEAD LEVELS; TOCOPHEROL-MEDIATED
   PEROXIDATION; VITAMIN-E; COFFEE CONSUMPTION; NATIONAL-HEALTH;
   CARDIOVASCULAR-DISEASE; CAFFEINE CONSUMPTION; OXIDATIVE STRESS; GLYCEMIC
   INDEX
AB Background: Childhood obesity is a national public health issue with increasing prevalence. It has been linked to diet, lack of physical activity, and genetic susceptibility, with more recent evidence that it could also result from environmental factors. Studies linking it to environmental factors are limited, unsystematic, incomprehensive, and inconclusive.
   Objective: To conduct an environment-wide association study (EWAS) to comprehensively investigate all the environmental factors available in a nationally representative sample of children to determine factors associated with childhood obesity.
   Methods: We utilized the 1999-2016 National Health and Nutrition Examination Survey (NHANES) datasets and included all children/adolescents (6-17 years). Obesity was measured using body mass index and waist to height ratio. A multinomial and binary logistic regression were used adjusting for age, sex, race/ethnicity, creatinine, calorie intake, physical activity, screen time, limitation to physical activities, and socioeconomic status. We then controlled for multiple hypothesis testing and validated our findings on a different cohort of children.
   Results: We found that metals such as beryllium (OR: 3.305 CI: 1.460-7.479) and platinum (OR: 1.346 CI: 1.107-1.636); vitamins such as gamma-tocopherol (OR: 8.297 CI: 5.683-12.114) and delta-tocopherol (OR: 1.841 CI:1.476-2.297); heterocyclic aromatic amines such as 2-Amino-9H-pyrido (2,3-b) indole (OR: 1.323 CI: 1.083-1.617) and 2-Amino-3-methyl-9H-pyriodo(2,3-b)indole (OR: 2.799 CI: 1.442-5.433); polycyclic aromatic amines such as 9 - fluorene (OR: 1.509 CI: 1.230-1.851) and 4-phenanthrene (OR: 2.828 CI: 1.632-4.899); and caffeine metabolites such as 1,3,7-trimethyluric acid (OR: 1.22 CI: 1.029-1.414) and 1,3,7-trimethylxanthine (OR: 1.258 CI: 1.075-1.473) were positively and significantly associated with childhood obesity.
   Conclusion: Following the unique concept of EWAS, certain environmental factors were associated with childhood obesity. Further studies are required to confirm these associations while investigating their mechanisms of action.
C1 [Uche, Uloma Igara; Suzuki, Sumihiro; Zhou, Zhengyang] Univ North Texas Hlth Sci Ctr, Dept Biostat & Epidemiol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.
   [Fulda, Kimberly G.] Univ North Texas Hlth Sci Ctr, North Texas Primary Care Practice Based Res Netwo, Dept Family Med & Osteopath Manipulat Med, Ft Worth, TX USA.
C3 University of North Texas System; University of North Texas Health
   Science Center
RP Uche, UI (corresponding author), Univ North Texas Hlth Sci Ctr, Dept Biostat & Epidemiol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.
EM ulomaucheigara@gmail.com
RI Zhang, Lin/L-5132-2019
OI Uche, Uloma/0000-0003-1887-3419; Zhou, Zhengyang/0000-0002-8039-418X;
   Fulda, Kimberly/0000-0002-5096-2983
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   [Anonymous], 2007, NAT HLTH NUTR EX SUR
   [Anonymous], 2016, GLOB STRAT DIET PHYS
   [Anonymous], 2009, Federal Register, V74, P4199
   Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Berkey CS, 2008, J PEDIATR, V153, P635, DOI 10.1016/j.jpeds.2008.04.072
   BOWRY VW, 1993, J AM CHEM SOC, V115, P6029, DOI 10.1021/ja00067a019
   BOWRY VW, 1995, J BIOL CHEM, V270, P5756, DOI 10.1074/jbc.270.11.5756
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Bracken MB, 2002, EPIDEMIOLOGY, V13, P165, DOI 10.1097/00001648-200203000-00011
   Brand-Miller J, 2009, J AM COLL NUTR, V28, p446S, DOI 10.1080/07315724.2009.10718110
   Bray G.A., 2014, Handbook of obesity, V2
   Burgalassi A, 2009, EAT WEIGHT DISORD-ST, V14, pE212, DOI 10.1007/BF03325119
   Burton GW, 1998, AM J CLIN NUTR, V67, P669, DOI 10.1093/ajcn/67.4.669
   Bushnik T, 2020, J DEV ORIG HLTH DIS, V11, P623, DOI 10.1017/S2040174419000825
   Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598
   Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641
   Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752
   Chew E.Y., 2005, Evidence-Based Eye Care, P88
   Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04
   Louzada MLD, 2015, PREV MED, V81, P9, DOI 10.1016/j.ypmed.2015.07.018
   Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24
   Dhooge W, 2010, ENVIRON INT, V36, P330, DOI 10.1016/j.envint.2010.01.005
   DONALD JM, 1988, TOXICOL LETT, V42, P137, DOI 10.1016/0378-4274(88)90071-9
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Fan Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020104
   Fang CC, 2019, J TRACE ELEM MED BIO, V52, P209, DOI 10.1016/j.jtemb.2018.12.017
   Finkelstein EA, 2003, HEALTH AFFAIR, V22, pW219
   Fortin MC, 2012, ENVIRON HEALTH PERSP, V120, P278, DOI 10.1289/ehp.1103873
   Freedman David S, 2007, MedGenMed, V9, P26
   GREER MA, 1966, ENDOCRINOLOGY, V79, P237, DOI 10.1210/endo-79-2-237
   Grün F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018
   Grundy SM, 1998, AM J CLIN NUTR, V67, p563S, DOI 10.1093/ajcn/67.3.563S
   Gu K., 2019, BIOL TRACE ELEMENT R, P1
   Gunanti IR, 2014, J NUTR, V144, P2027, DOI 10.3945/jn.114.201202
   Gyllenhammar I, 2018, ENVIRON INT, V111, P191, DOI 10.1016/j.envint.2017.12.002
   Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI [10.2147/DMSO.S7384, 10.2147/DMSOTT.S7384]
   HARRIS MW, 1989, FUND APPL TOXICOL, V12, P442, DOI 10.1016/0272-0590(89)90018-3
   Hauser R, 2008, ENVIRON HEALTH PERSP, V116, P976, DOI 10.1289/ehp.10516
   Health U.D.o. Services H., 2001, NAT REP HUM EXP ENV
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   HEYSSEL RM, 1966, AM J CLIN NUTR, V18, P176
   Higdon JV, 2003, ARTERIOSCL THROM VAS, V23, P365, DOI 10.1161/01.ATV.0000063608.43095.E2
   Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371
   Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106
   Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341
   Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210
   Huzior-Balajewicz A, 2001, Przegl Lek, V58, P315
   Jain RB, 2016, SCI TOTAL ENVIRON, V557, P221, DOI 10.1016/j.scitotenv.2016.03.064
   Jaksic M, 2019, J PEDIATR ENDOCR MET, V32, P951, DOI 10.1515/jpem-2019-0086
   Jiang Q, 2001, AM J CLIN NUTR, V74, P714
   Kamel Nahed M, 2003, J Egypt Public Health Assoc, V78, P1
   Karlsen M, 2017, REPROD TOXICOL, V68, P145, DOI 10.1016/j.reprotox.2016.08.002
   Kim HW, 2014, ENVIRON RES, V135, P354, DOI 10.1016/j.envres.2014.08.032
   KIM R, 1995, ENVIRON HEALTH PERSP, V103, P952, DOI 10.2307/3432741
   Kolnes AJ, 2010, ACTA PHYSIOL, V200, P65, DOI 10.1111/j.1748-1716.2010.02103.x
   Kreiss K, 2007, ANNU REV PUBL HEALTH, V28, P259, DOI 10.1146/annurev.publhealth.28.021406.144011
   Kun V., 1993, OUT BREATH CHILDRENS
   Kushi LH, 1996, NEW ENGL J MED, V334, P1156, DOI 10.1056/NEJM199605023341803
   Labrador-Rached CJ, 2018, J TOXICOL-US, V2018, DOI 10.1155/2018/1367801
   Lamb MR, 2008, ENVIRON RES, V106, P195, DOI 10.1016/j.envres.2007.09.012
   Lampi AM, 2002, FUN FO NUTR SERIES, P1
   Laurberg P, 2002, THYROID, V12, P897, DOI 10.1089/105072502761016520
   Leasure JL, 2008, ENVIRON HEALTH PERSP, V116, P355, DOI 10.1289/ehp.10862
   Leklem J. E., 2001, Handbook of vitamins, P339
   Leyh B, 2015, ONCOTARGET, V6, P39307, DOI 10.18632/oncotarget.5624
   Li DK, 2015, INT J OBESITY, V39, P658, DOI 10.1038/ijo.2014.196
   Lichtveld K, 2018, J EXPO SCI ENV EPID, V28, P1, DOI 10.1038/jes.2017.18
   Lilis R, 1981, Am J Ind Med, V2, P293, DOI 10.1002/ajim.4700020309
   Lin JL, 2006, KIDNEY INT, V69, P2049, DOI 10.1038/sj.ki.5001505
   Lind PM, 2013, ENVIRON INT, V55, P1, DOI 10.1016/j.envint.2013.01.017
   Little BB, 2009, ANN HUM BIOL, V36, P331, DOI 10.1080/03014460902806615
   Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002
   Liu Z, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1748065
   Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lopez-Garcia E, 2009, CIRCULATION, V119, P1116, DOI 10.1161/CIRCULATIONAHA.108.826164
   Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380
   Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414
   Luttrell WE, 2008, J CHEM HEALTH SAF, V15, P46, DOI 10.1016/j.jchas.2008.05.009
   MATHES EW, 1981, J HUMANIST PSYCHOL, V21, P69, DOI 10.1177/002216788102100406
   McGinnis DP, 2016, SCI REP-UK, V6, DOI 10.1038/srep30373
   MCLAUGHLIN PJ, 1979, J AM DIET ASSOC, V75, P647
   Mervish NA, 2016, ENVIRON HEALTH PERSP, V124, P542, DOI 10.1289/ehp.1409309
   Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110
   Morris CD, 2003, ANN INTERN MED, V139, P56, DOI 10.7326/0003-4819-139-1-200307010-00014
   Moya J, 2004, PEDIATRICS, V113, P996
   MURPHY SP, 1990, AM J CLIN NUTR, V52, P361, DOI 10.1093/ajcn/52.2.361
   Murray CW, 2008, J EXPO SCI ENV EPID, V18, P571, DOI 10.1038/sj.jes.7500648
   Nachtigal MC, 2005, J ALTERN COMPLEM MED, V11, P909, DOI 10.1089/acm.2005.11.909
   Nauwelaërs G, 2013, CHEM RES TOXICOL, V26, P1367, DOI 10.1021/tx4002226
   Nogaj E, 2014, ANN AGR ENV MED, V21, P267, DOI 10.5604/1232-1966.1108589
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI [10.1001/jama.2012.39, 10.1001/jama.2012.40]
   Ogden J, 2013, APPETITE, V62, P119, DOI 10.1016/j.appet.2012.11.023
   Ohta A, 2009, CURR OPIN PHARMACOL, V9, P501, DOI 10.1016/j.coph.2009.05.005
   Padilla MA, 2010, INT J ENV RES PUB HE, V7, P3332, DOI 10.3390/ijerph7093332
   Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746
   Pathak KV, 2015, J BIOL CHEM, V290, P16304, DOI 10.1074/jbc.M115.646539
   Pediatrics A.A.o., 2007, PEDIATRICS S4, V120
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Prevention C. f.D.C.a., 2019, GROWTH CHART TRAIN
   Proctor B., 2002, Current population reports, P60-219, Poverty in the United States: 2001
   Reinehr T, 2010, MOL CELL ENDOCRINOL, V316, P165, DOI 10.1016/j.mce.2009.06.005
   Resnick HE, 2006, J CLIN SLEEP MED, V2, P163
   ROBERTS HJ, 1981, JAMA-J AM MED ASSOC, V246, P129, DOI 10.1001/jama.246.2.129
   Rogers LJ, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0111-0
   Rogers PJ, 2010, NEUROPSYCHOPHARMACOL, V35, P1973, DOI 10.1038/npp.2010.71
   Rossi-George A, 2009, TOXICOL APPL PHARM, V234, P117, DOI 10.1016/j.taap.2008.10.003
   Sato R, 2002, CANCER EPIDEM BIOMAR, V11, P451
   Schober SE, 2006, ENVIRON HEALTH PERSP, V114, P1538, DOI 10.1289/ehp.9123
   Scinicariello F, 2014, ENVIRON HEALTH PERSP, V122, P299, DOI 10.1289/ehp.1307234
   Scinicariello F, 2013, TOXICOL APPL PHARM, V273, P516, DOI 10.1016/j.taap.2013.09.022
   Shahidi F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101745
   Shiue I, 2015, ENVIRON SCI POLLUT R, V22, P20306, DOI 10.1007/s11356-015-5546-8
   Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23
   Statistics N.C. f.H. Control and Prevention C. f.D., 2006, AN REP GUID NAT HLTH
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   Sun Y, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00771
   Tang-Péronard JL, 2011, OBES REV, V12, P622, DOI 10.1111/j.1467-789X.2011.00871.x
   Tonacchera M, 2004, THYROID, V14, P1012, DOI 10.1089/thy.2004.14.1012
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x
   Virgolini MB, 2005, TOXICOL SCI, V87, P469, DOI 10.1093/toxsci/kfi269
   Virtamo J, 1998, ARCH INTERN MED, V158, P668, DOI 10.1001/archinte.158.6.668
   Wagner KH, 2004, ANN NUTR METAB, V48, P169, DOI 10.1159/000079555
   Wang NJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18299
   Wang X, 2018, ENVIRON INT, V121, P683, DOI 10.1016/j.envint.2018.09.035
   Wang Y, 2016, ENVIRON HEALTH PERSP, V124, P1794, DOI 10.1289/ehp.1509998
   Weitzman P., 1987, BIOCH SOC S, V54, P1
   White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001
   Yu W., 1999, Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
   Zhong Y, 2016, ANN EPIDEMIOL, V26, P638, DOI 10.1016/j.annepidem.2016.07.005
   Zhu FH, 2019, ENVIRON INT, V133, DOI 10.1016/j.envint.2019.105191
   Zoeller R.T., 2008, SPECIFYING WEIGHTING
   Zoeller RT, 2007, THYROID, V17, P811, DOI 10.1089/thy.2007.0107
NR 139
TC 16
Z9 17
U1 1
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0013-9351
EI 1096-0953
J9 ENVIRON RES
JI Environ. Res.
PD DEC
PY 2020
VL 191
AR 110109
DI 10.1016/j.envres.2020.110109
PG 10
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA OP3GW
UT WOS:000587971600077
PM 32841636
DA 2025-04-28
ER

PT J
AU Serina, JJC
   Castilho, PCMF
AF Serina, Jose Joao Caires
   Castilho, Paula Cristina Machado Ferreira
TI Using polyphenols as a relevant therapy to diabetes and its
   complications, a review
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Complications; diabetes; polyphenols; risk factors
ID KEY ENZYMES RELEVANT; ACTIVITY IN-VITRO; ALPHA-GLUCOSIDASE INHIBITORS;
   GREEN TEA POLYPHENOLS; CHLOROGENIC ACID; CAFFEIC ACID; DIETARY
   POLYPHENOLS; PHENOLIC-COMPOUNDS; CARDIOVASCULAR-DISEASE; PERIPHERAL
   NEUROPATHY
AB Diabetes is currently a worldwide health concern. Hyperglycemia, hypertension, obesity, and oxidative stress are the major risk factors that inevitably lead to all the complications from diabetes. These complications severely impact the quality of life of patients, and they can be managed, reduced, or even reverted by several polyphenols, plant extracts and foods rich in these compounds. The goal of this review is to approach diabetes not as a single condition but rather an interconnected combination of risk factors and complications. This work shows that polyphenols have multi target action and effects and they have been systematically proven to be relevant in the reduction of each risk factor and improvement of associated complication.
C1 [Serina, Jose Joao Caires; Castilho, Paula Cristina Machado Ferreira] Univ Madeira, Ctr Quim Madeira, Campus Penteada, P-9020105 Madeira, Portugal.
C3 Universidade da Madeira
RP Castilho, PCMF (corresponding author), Univ Madeira, Ctr Quim Madeira, Campus Penteada, P-9020105 Madeira, Portugal.
EM pcastilho@staff.uma.pt
RI Serina, João/JFJ-4036-2023; Castilho, Paula/A-4412-2013
OI Serina, Joao/0000-0002-5738-3925; Castilho, Paula/0000-0002-8303-4286
FU FCT - Fundacao para a Ciencia e a Tecnologia through the CQM Base Fund
   [UIDB/00674/2020]; FCT - Fundacao para a Ciencia e a Tecnologia
   [UIDP/00674/2020, 2020.05328.bd]; ARDITI-Agencia Regional para o
   Desenvolvimento da Investigacao Tecnologia e Inovacao - Centro de
   Quimica da Madeira - CQMthorn (Madeira 14-20 Program)
   [M1420-01-0145-FEDER-000005]; Fundação para a Ciência e a Tecnologia
   [2020.05328.BD] Funding Source: FCT
FX This work was supported by FCT - Fundacao para a Ciencia e a Tecnologia
   through the CQM Base Fund UIDB/00674/2020, and Programmatic Fund -
   UIDP/00674/2020, and by ARDITI-Agencia Regional para o Desenvolvimento
   da Investigacao Tecnologia e Inovacao, through the project
   M1420-01-0145-FEDER-000005 - Centro de Quimica da Madeira - CQMthorn
   (Madeira 14-20 Program). Joao Serina would also like to acknowledge FCT
   - Fundacao para a Ciencia e a Tecnologia for the PhD grant
   2020.05328.bd.
CR Actis-Goretta L, 2006, J AGR FOOD CHEM, V54, P229, DOI 10.1021/jf052263o
   Addepalli V, 2018, BIOMED PHARMACOTHER, V108, P1517, DOI 10.1016/j.biopha.2018.09.179
   Adefegha SA, 2017, J FOOD BIOCHEM, V41, DOI 10.1111/jfbc.12309
   Adefegha SA, 2016, J TAIBAH UNIV SCI, V10, P521, DOI 10.1016/j.jtusci.2015.10.008
   Ademosun MT, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13324
   Adisakwattana S, 2009, J ENZYM INHIB MED CH, V24, P1194, DOI 10.1080/14756360902779326
   Agustinah W, 2016, J FOOD QUALITY, V39, P370, DOI 10.1111/jfq.12206
   Aires V, 2018, MOLECULES, V23, DOI 10.3390/molecules23010007
   Al Hroob AM, 2019, BIOMED PHARMACOTHER, V109, P2155, DOI 10.1016/j.biopha.2018.11.086
   Alagesan K., 2012, Int. J. Pharm. Life Sci, V3, P1407
   Alexiadou Kleopatra, 2012, Diabetes Ther, V3, P4, DOI 10.1007/s13300-012-0004-9
   Alharbi AMD, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.11991
   Almeida AAP, 2006, J AGR FOOD CHEM, V54, P8738, DOI 10.1021/jf0617317
   Alotaibi A, 2017, J EPIDEMIOL GLOB HEA, V7, P211, DOI 10.1016/j.jegh.2017.10.001
   Alramadan MJ, 2019, DIABETES METAB SYND, V13, P484, DOI 10.1016/j.dsx.2018.11.007
   Anjaneyulu M, 2004, CLIN EXP PHARMACOL P, V31, P244, DOI 10.1111/j.1440-1681.2004.03982.x
   [Anonymous], 1985, WHO TECH REP SER, P1
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   [Anonymous], 2019, DIABETES ATLAS, VNinth
   [Anonymous], 2020, HOUSING COVID 19 POL, P1, DOI [DOI 10.1787/82129230-EN, 10.1787/efb16d0b-en]
   Antunes A., 2008, ATIVIDADE INIBITORIA
   Aryaeian Naheed, 2017, Med J Islam Repub Iran, V31, P134, DOI 10.14196/mjiri.31.134
   Asgar MA, 2013, INT J FOOD PROP, V16, P91, DOI 10.1080/10942912.2011.595864
   Badescu L, 2014, J PHYSIOL BIOCHEM, V70, P355, DOI 10.1007/s13105-013-0309-9
   Bahadoran Z, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-43
   BALASURIYA BWN, 2011, DIABETES-METAB RES, V1, P172
   Bang CY, 2014, J PHARM PHARMACOL, V66, P875, DOI 10.1111/jphp.12211
   Barbosa M, 2020, MAR DRUGS, V18, DOI 10.3390/md18120654
   Bastin J, 2011, HUM MOL GENET, V20, P2048, DOI 10.1093/hmg/ddr089
   Bhattacharya S, 2014, DIABETES OBES METAB, V16, P602, DOI 10.1111/dom.12236
   Bhullar KS, 2014, EUR J PHARMACOL, V730, P125, DOI 10.1016/j.ejphar.2014.02.038
   Bin Ahmed I, 2018, INT J MED RES HEALTH, V7, P33
   Borges CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28282
   Boue SM, 2013, J AGR FOOD CHEM, V61, P8412, DOI 10.1021/jf4020087
   Buchholz T, 2015, PLANTA MED, V81, P771, DOI 10.1055/s-0035-1546173
   Cao H, 2019, CRIT REV FOOD SCI, V59, P3371, DOI 10.1080/10408398.2018.1492900
   Cao H, 2012, ANTI-CANCER AGENT ME, V12, P929, DOI 10.2174/187152012802650110
   Cao QJ, 2020, FOOD CHEM, V333, DOI 10.1016/j.foodchem.2020.127528
   Espín JC, 2007, PHYTOCHEMISTRY, V68, P2986, DOI 10.1016/j.phytochem.2007.09.014
   Centers for Disease Control and Prevention, 2020, National diabetes statistics report
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Chao CY, 2010, MOL NUTR FOOD RES, V54, P388, DOI 10.1002/mnfr.200900087
   Chen R, 2014, MOL VIS, V20, P242
   Cho ES, 2009, MUTAT RES-FUND MOL M, V661, P18, DOI 10.1016/j.mrfmmm.2008.10.021
   Clark M, 2004, PATIENT EDUC COUNS, V53, P277, DOI 10.1016/j.pec.2003.07.008
   Condliffe S, 2013, APPL ECON LETT, V20, P649, DOI 10.1080/13504851.2012.727966
   Crozier A, 2010, MOL ASPECTS MED, V31, P446, DOI 10.1016/j.mam.2010.09.007
   Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a
   Cui CB, 2009, J KOREAN SOC APPL BI, V52, P655, DOI 10.3839/jksabc.2009.109
   Alves JLD, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00448
   Cádiz-Gurrea MDLL, 2018, J FUNCT FOODS, V46, P514, DOI [10.1016/j.jff.2018.05.026, 10.1016/j.jff.2018.]
   de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101
   de la Monte SM, 2009, J ALZHEIMERS DIS, V17, P519, DOI 10.3233/JAD-2009-1070
   de Oliveira DM, 2011, QUIM NOVA, V34, P1051, DOI 10.1590/S0100-40422011000600023
   DeFronzo RA, 2011, DIABETES CARE, V34, pS202, DOI 10.2337/dc11-s221
   Dehdashtian E, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3336
   Dembinska-Kiec A, 2008, BRIT J NUTR, V99, pES109, DOI 10.1017/S000711450896579X
   Den Hartogh DJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071624
   Díaz-Gómez R, 2014, LWT-FOOD SCI TECHNOL, V59, P896, DOI 10.1016/j.lwt.2014.06.049
   Díaz-Gómez R, 2013, LWT-FOOD SCI TECHNOL, V54, P331, DOI 10.1016/j.lwt.2013.07.012
   Dib I, 2017, J ETHNOPHARMACOL, V206, P224, DOI 10.1016/j.jep.2017.05.036
   Ding KX, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061712
   Dureshahwar K, 2019, PHARMACOGN MAG, V15, P128, DOI 10.4103/pm.pm_553_18
   de Lima ME, 2018, J FUNCT FOODS, V44, P9, DOI 10.1016/j.jff.2018.02.024
   Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Eguchi T, 2013, PLOS ONE, V8
   El-Seedi HR, 2012, J AGR FOOD CHEM, V60, P10877, DOI 10.1021/jf301807g
   Elbe H, 2015, HUM EXP TOXICOL, V34, P100, DOI 10.1177/0960327114531995
   Fareed M, 2017, INT J MED RES HEALTH, V6, P125
   Fernando IPS, 2020, TRENDS FOOD SCI TECH, V97, P286, DOI 10.1016/j.tifs.2020.01.020
   Fujihara T, 2007, BIOSCI BIOTECH BIOCH, V71, P711, DOI 10.1271/bbb.60562
   Funke I, 2005, PHARMAZIE, V60, P796
   Gomes IBS, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-184
   Gómez-Guzmán M, 2018, MAR DRUGS, V16, DOI 10.3390/md16080250
   González I, 2020, FOOD RES INT, V129, DOI 10.1016/j.foodres.2019.108843
   Gowd V, 2019, TRENDS FOOD SCI TECH, V93, P81, DOI 10.1016/j.tifs.2019.09.005
   Grauslund J, 2009, DIABETOLOGIA, V52, P1829, DOI 10.1007/s00125-009-1450-4
   Grosso G, 2018, EUR J NUTR, V57, P1535, DOI 10.1007/s00394-017-1438-7
   Gu GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076109
   Gunathilaka TL, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/1230218
   Hakamata W, 2009, CURR TOP MED CHEM, V9, P3, DOI 10.2174/156802609787354306
   Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564
   Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368
   Hayashi D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68716-6
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Hossain MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040569
   Hostetler GL, 2017, ADV NUTR, V8, P423, DOI 10.3945/an.116.012948
   Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x
   International Diabetes Federation, 2000, DIAB ATL 2000
   International Diabetes Federation, 2019, US AM DIAB REP 2010
   Iwata S, 2019, FOOD SCI TECHNOL RES, V25, P295, DOI 10.3136/fstr.25.295
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kang MY, 2012, YONSEI MED J, V53, P138, DOI 10.3349/ymj.2012.53.1.138
   Kanlaya R, 2019, ADV NUTR, V10, P112, DOI 10.1093/advances/nmy077
   Kärvestedt L, 2011, J DIABETES COMPLICAT, V25, P97, DOI 10.1016/j.jdiacomp.2010.04.001
   Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0
   Khangholi S, 2016, PLANTA MED, V82, P32, DOI 10.1055/s-0035-1558086
   Kim CS, 2016, BIOMOL THER, V24, P178, DOI 10.4062/biomolther.2015.101
   Kim H, 2008, WOUND REPAIR REGEN, V16, P714, DOI 10.1111/j.1524-475X.2008.00422.x
   Kim M, 2019, ANAT SCI INT, V94, P285, DOI 10.1007/s12565-019-00486-2
   Kim YS, 2011, BIOL PHARM BULL, V34, P925, DOI 10.1248/bpb.34.925
   Kirakosyan A, 2018, FOOD CHEM, V252, P142, DOI 10.1016/j.foodchem.2018.01.084
   Kolluru GK, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/918267
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Kühn G, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00106
   Kulashekar M, 2018, J AM OSTEOPATH ASSOC, V118, P596, DOI 10.7556/jaoa.2018.133
   Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001
   Lambert K, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7406946
   Lambert K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21287-z
   Le Sage F, 2017, PHARMACOL RES, V119, P303, DOI 10.1016/j.phrs.2017.02.020
   Lee HS, 2014, MOLECULES, V19, P12150, DOI 10.3390/molecules190812150
   Lee SH, 2013, FITOTERAPIA, V86, P129, DOI 10.1016/j.fitote.2013.02.013
   Lee WC, 2009, J AGR FOOD CHEM, V57, P2206, DOI 10.1021/jf802993s
   Lee YS, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091204
   Les F, 2021, J PHYSIOL BIOCHEM, V77, P109, DOI 10.1007/s13105-020-00739-z
   Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843
   Lin XW, 2020, TROP J PHARM RES, V19, P829, DOI 10.4314/tjpr.v19i4.22
   Luna-Vital DA, 2019, J AGR FOOD CHEM, V67, P9148, DOI 10.1021/acs.jafc.8b06642
   Luna-Vital DA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200449
   Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532
   Ma CM, 2008, J MED CHEM, V51, P6188, DOI 10.1021/jm800621x
   Ma CT, 2016, FOOD FUNCT, V7, P1111, DOI 10.1039/c5fo01358e
   Maher P, 2005, INVEST OPHTH VIS SCI, V46, P4796, DOI 10.1167/iovs.05-0397
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   Manivannan A, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/434256
   MARATHE CS, 2013, J CHEM-NY, V44, P75
   Martinez-Gonzalez AI, 2017, FOOD TECHNOL BIOTECH, V55, P519, DOI 10.17113/ftb.55.04.17.5138
   MATEOS R, 2020, FOOD TECHNOL BIOTECH, V18, P501
   McCarty MF, 2005, MED HYPOTHESES, V64, P151, DOI 10.1016/j.mehy.2004.03.036
   Menati L, 2020, J RENAL INJ PREV, V9, DOI 10.34172/jrip.2020.09
   MIRANDA AM, 2016, MED HYPOTHESES, V11
   MOHTASHAMI R, 2019, PLOS ONE, V9, P44
   MOMTAZ S, 2019, AVICENNA J PHYTOMEDI, V56, P472
   MONTE SMD, 2009, CRIT REV CL LAB SCI, V42, P475
   MONTE SMD, 2006, BMB REP, V10, P89
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   MUNDIL D, 2012, J NUTR, V9, P95
   MURASE T., 2011, Agent useful for preventing andor treating seborrheic alopecia, seborrheic dermatitis and or diabetic nephropathy
   MURASE T, 2012, DIABETES VASC DIS RE, V107, P1757
   MURITALA HF, 2018, BRIT J NUTR, V6, P1676
   Murphy KJ, 2020, J CLIN EXP NEUROPSYC, V42, P881, DOI 10.1080/13803395.2020.1825633
   Murray M, 2018, CRIT REV FOOD SCI, V58, P1342, DOI 10.1080/10408398.2016.1259209
   NARITA Y, 2009, CRIT REV FOOD SCI, V57, P9218
   Naseri R, 2019, DARU, V27, P781, DOI 10.1007/s40199-019-00289-w
   Natarajan SB, 2017, ENVIRON TOXICOL PHAR, V50, P83, DOI 10.1016/j.etap.2016.12.004
   NATHER A, 2008, ENVIRON TOXICOL PHAR, V22, P126
   NAVARRO M, 2015, J DIABETES COMPLICAT, V175, P92
   NEVILLE SE, 2009, FOOD CHEM, V25, P705
   Nwosu F, 2011, FOOD CHEM, V126, P1006, DOI 10.1016/j.foodchem.2010.11.111
   Oboh G, 2012, J FUNCT FOODS, V4, P450, DOI 10.1016/j.jff.2012.02.003
   OCHIAI R, 2004, J FUNCT FOODS, V27, P731
   Olivares-Vicente M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122961
   OOI KL, 2011, QUIM NOVA, V135, P685
   PAN HZ, 2008, J ETHNOPHARMACOL, V92, P548
   PARI L, 2010, BRIT J OPHTHALMOL, V341, P109
   Park JB, 2009, J NUTR BIOCHEM, V20, P800, DOI 10.1016/j.jnutbio.2008.07.009
   Peng CH, 2014, J AGR FOOD CHEM, V62, P9736, DOI 10.1021/jf5024092
   PEREZVIZCAINO F, 2010, J AGR FOOD CHEM, V31, P478
   PERO RW, 2009, MOL ASPECTS MED, V23, P335
   Pinto J, 2017, FOOD RES INT, V100, P404, DOI 10.1016/j.foodres.2017.03.044
   Pradhan B, 2021, MOLECULES, V26, DOI 10.3390/molecules26041171
   Qin RX, 2013, INT J MOL SCI, V14, P1802, DOI 10.3390/ijms14011802
   Quintana G, 2020, J FOOD SCI TECH MYS, V57, P1061, DOI 10.1007/s13197-019-04140-7
   Rahim ATMA, 2015, FOOD RES INT, V75, P289, DOI 10.1016/j.foodres.2015.05.017
   RAPOSO D, 2015, INT J MOL SCI, V110, P68
   Rational Assessment of Drugs and Research, 2010, DIP PEPT 4 INH GLIPT
   RAY S, 2017, BRAIN RES BULL, V27, P580
   REDEUIL K, 2011, REV BRAS FARMACOGN, V1218, P4678
   Reid T, 2012, Clin Diabetes, V30, P3
   Ribu L, 2008, J DIABETES COMPLICAT, V22, P400, DOI 10.1016/j.jdiacomp.2007.06.006
   RUSSO B, 2019, J DIABETES COMPLICAT, V20, P2061
   RUSSO M, 2012, INT J MOL SCI, V83, P6
   Sakulnarmrat K, 2012, FOOD CHEM, V134, P1011, DOI 10.1016/j.foodchem.2012.02.217
   SALAZARMARTINEZ E, 2004, BIOCHEM PHARMACOL, V140, P1
   Salehi B, 2020, ACS OMEGA, V5, P11849, DOI 10.1021/acsomega.0c01818
   SAMADDAR S, 2019, ACS OMEGA, V5
   Samaddar S, 2019, PHARMACOGN MAG, V15, P468, DOI 10.4103/pm.pm_212_19
   SARRIA B, 2018, HELIYON, V57, P269
   Semega J, 2019, Income and Poverty in the United States: 2019
   SHAI L, 2011, EUR J NUTR, V5, P2863
   Shi Y, 2013, ACTA PHARMACOL SIN, V34, P1140, DOI 10.1038/aps.2013.59
   SHYANGDAN DS, 2010, ACTA PHARMACOL SIN, V10, P20
   SILVEIRA AC, 2019, BMC ENDOCR DISORD, V17, P590
   SMITH DM, 2010, CURR NEUROPHARMACOL, V3, P41
   SMITH DW, 2005, BMC MED GENOMICS, V59, P385
   SONG J, 2020, J PSYCHOSOM RES, V161, P5109
   SOSNOWSKA D, 2018, PHARMACOL RES, V49, P196
   Souza P., 2011, THESIS U BRASILIA
   SOVA M, 2020, J FUNCT FOODS, V12, P2190
   SOYALAN B, 2011, NUTRIENTS, V50, P135
   Spínola V, 2020, LWT-FOOD SCI TECHNOL, V118, DOI 10.1016/j.lwt.2019.108727
   Spínola V, 2019, FOOD RES INT, V122, P283, DOI 10.1016/j.foodres.2019.04.030
   Spínola V, 2018, FOOD CHEM, V259, P105, DOI 10.1016/j.foodchem.2018.03.112
   Stefek Milan, 2011, Interdiscip Toxicol, V4, P69, DOI 10.2478/v10102-011-0013-y
   STRIEN TV, 2007, LWT-FOOD SCI TECHNOL, V26, P105
   Sun CD, 2020, FOOD FRONTIERS, V1, P18, DOI 10.1002/fft2.15
   TARRIDE JE, 2010, HEALTH PSYCHOL, V28, P255
   THOM E, 2007, PHARMACOECONOMICS, V35, P900
   Toshima A, 2010, J SCI FOOD AGR, V90, P1545, DOI 10.1002/jsfa.3983
   TUCKER DMD, 2011, J SCI FOOD AGR, V5, P9
   TUNG TH, 2005, PRIM CARE DIABETES, V20, P317
   TUNNICLIFFE JM, 2008, EUR J EPIDEMIOL, V33, P1290
   *UKPDS GROUP, 1990, APPL PHYSIOL NUTR ME, V39, P905
   Unger Jeffrey R, 2011, Diabetes Ther, V2, P29, DOI 10.1007/s13300-010-0013-5
   URIOS P, 2014, METABOLISM, V105, P373
   Valentová K, 2007, J AGR FOOD CHEM, V55, P7726, DOI 10.1021/jf0712447
   Venkatesan J., 2019, Encyclopedia of Food Chemistry, DOI DOI 10.1016/B978-0-08-100596-5.22360-3
   VETTERLI L, 2011, DIABETES RES CLIN PR, V286, P6049
   VIGANO J, 2016, J BIOL CHEM, V85, P51
   VISWANATHAN V, 2012, FOOD RES INT, V136, P46
   VUPPUTURI S, 2011, INDIAN J MED RES, V91, P246
   WANG GG, 2011, DIABETES RES CLIN PR, V2011, P1
   WANG T, 2018, EVID-BASED COMPL ALT, V81, P74
   WHO, 2020, DENG CONTR FACT SHEE
   Williams LH, 2010, AM J MED, V123, P748, DOI 10.1016/j.amjmed.2010.01.023
   WILLIAMSON G, 2020, MOL NUTR FOOD RES, V12, P3135
   WILLIAMSON G, 2013, AM J MED, V57, P48
   WU X, 2017, NUTRIENTS, V38, P510
   XIAO J, 2015, J FUNCT FOODS, V55, P16
   YAMABE N, 2006, CRIT REV FOOD SCI, V319, P228
   YAMASHITA Y, 2016, J PHARMACOL EXP THER, V11
   Yang YS, 2013, J AGR FOOD CHEM, V61, P7545, DOI 10.1021/jf4020735
   Yeh WJ, 2017, J FOOD DRUG ANAL, V25, P84, DOI 10.1016/j.jfda.2016.10.017
   Yi RK, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9329356
   Yokozawa T, 2005, J PHARM PHARMACOL, V57, P773, DOI 10.1211/0022357056154
   YOON SP, 2014, J PHARM PHARMACOL, V116, P1210
   YOON SR, 2015, ACTA HISTOCHEM, V61, P158
   YUAN Y, 2019, LWT-FOOD SCI TECHNOL, V67, P12472
   Yuda N, 2012, J FOOD SCI, V77, pH254, DOI 10.1111/j.1750-3841.2012.02967.x
   ZANDER M, 2002, J FOOD SCI, V359, P824
   ZHANG Y, 2010, LANCET, V62, P1120
   Zhao P, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/6091923
   Zhong RZ, 2013, J ANIM PHYSIOL AN N, V97, P475, DOI 10.1111/j.1439-0396.2012.01288.x
   ZHU D, 2014, NUTR CANCER, V58, P2249
   ZOU J, 2014, MOL NUTR FOOD RES, V64, P231
NR 236
TC 22
Z9 22
U1 11
U2 67
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD NOV 7
PY 2022
VL 62
IS 30
BP 8355
EP 8387
DI 10.1080/10408398.2021.1927977
EA MAY 2021
PG 33
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 5X8MC
UT WOS:000653561000001
PM 34028316
OA Green Published
DA 2025-04-28
ER

PT J
AU Mendel, RW
   Hofheins, JE
AF Mendel, Ron W.
   Hofheins, Jennifer E.
TI Metabolic responses to the acute ingestion of two commercially available
   carbonated beverages: A pilot study
SO JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
LA English
DT Article
ID GREEN TEA; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; CATECHIN-POLYPHENOLS;
   CAFFEINE CONSUMPTION; BLOOD-PRESSURE; FAT OXIDATION; BODY-WEIGHT;
   OBESITY; COFFEE
AB Background: The purpose of this placebo-controlled, double-blind cross-over study was to compare the effects of two commercially available soft drinks on metabolic rate.
   Methods: After giving informed consent, twenty healthy men and women were randomly assigned to ingest 12 ounces of Celsius (TM) and, on a separate day, 12 ounces of Diet Coke (R). All subjects completed both trials using a randomized, counterbalanced design. Metabolic rate (via indirect calorimetry) and substrate oxidation (via respiratory exchange ratio) were measured at baseline (pre-ingestion) and at the end of each hour for 3 hours post-ingestion.
   Results: Two-way ANOVA revealed a significant interaction (p < 0.001) between trials in metabolic rate. Scheffe post-hoc testing indicated that metabolic rate increased by 13.8% (+ 0.6 L/min, p < 0.001) 1 hr post, 14.4% (+ 0.63 L/min, p < 0.001) 2 hr post, and 8.5% (+ 0.37 L/min, p < 0.004) 3 hr post Celsius (TM) ingestion. In contrast, small (similar to 4-6%) but statistically insignificant increases in metabolic rate were noted following Diet Coke (R) ingestion. No differences in respiratory exchange ratio were noted between trials.
   Conclusion: These preliminary findings indicate Celsius (TM) has thermogenic properties when ingested acutely. The effects of repeated, chronic ingestion of Celsius (TM) on body composition are unknown at this time.
C1 [Mendel, Ron W.; Hofheins, Jennifer E.] Wadsworth Vet Adm Med Ctr, Div Exercise Sci & Sports Nutr, Ohio Res Grp, Wadsworth, OH 44281 USA.
   [Mendel, Ron W.] Mt Union Coll, Dept Human Performance & Sport Management, Alliance, OH 44601 USA.
C3 University System of Ohio; University of Mount Union
RP Mendel, RW (corresponding author), Wadsworth Vet Adm Med Ctr, Div Exercise Sci & Sports Nutr, Ohio Res Grp, Wadsworth, OH 44281 USA.
EM ron@ohioresearchgroup.com; jennifer@ohioresearchgroup.com
FU EliteFx Technologies (Boynton Beach, FL)
FX This research was sponsored by a grant from EliteFx Technologies
   (Boynton Beach, FL). EliteFx Technologies had no role in the collection,
   analyses, or interpretation of the data. Tim Ziegenfuss, Ph.D., was
   instrumental in providing critically important intellectual content.
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Arciero PJ, 2000, METABOLISM, V49, P101, DOI 10.1016/S0026-0495(00)90888-6
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bensimhon DR, 2006, AM HEART J, V151, P598, DOI 10.1016/j.ahj.2005.03.005
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Catenacci VA, 2007, NAT CLIN PRACT ENDOC, V3, P518, DOI 10.1038/ncpendmet0554
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009
   DONELLY K, 1992, EUR J APPL PHYSIOL O, V65, P459, DOI 10.1007/BF00243514
   Drewnowski A, 2007, AM J CLIN NUTR, V85, P651, DOI 10.1093/ajcn/85.3.651
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Grzanna R, 2005, J MED FOOD, V8, P125, DOI 10.1089/jmf.2005.8.125
   HIATT HH, 1958, BIOCHIM BIOPHYS ACTA, V28, P645, DOI 10.1016/0006-3002(58)90536-5
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Lachance PA, 2005, ADV FOOD NUTR RES, V49, P1, DOI 10.1016/S1043-4526(05)49001-4
   Le Masurier GC, 2003, RES Q EXERCISE SPORT, V74, P389, DOI 10.1080/02701367.2003.10609109
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Sitzman Kathy, 2003, AAOHN J, V51, P404
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
NR 29
TC 7
Z9 7
U1 0
U2 17
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1550-2783
J9 J INT SOC SPORT NUTR
JI J. Int. Soc. Sport Nutr.
PD SEP
PY 2007
VL 4
AR 7
DI 10.1186/1550-2783-4-7
PG 5
WC Nutrition & Dietetics; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Sport Sciences
GA V17ZD
UT WOS:000207974200001
PM 17908290
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Popiolek-Kalisz, J
AF Popiolek-Kalisz, Joanna
TI The Impact of Dietary Flavonols on Central Obesity Parameters in Polish
   Adults
SO NUTRIENTS
LA English
DT Article
DE obesity; abdominal obesity; flavonols; quercetin; myricetin;
   isorhamnetin
ID BODY-MASS INDEX; ABDOMINAL OBESITY; CLINICAL-PRACTICE; OXIDATIVE STRESS;
   BLOOD-PRESSURE; QUERCETIN; ASSOCIATION; OVERWEIGHT; HEALTH; TEA
AB Background: Central obesity is defined as the excessive fat tissue located in abdominal region accompanied by systemic inflammation, which drives to cardiovascular disease. Flavonols are antioxidative agents present in food. The aim of this study was investigating the relationship between dietary flavonols intake and central obesity. Methods and results: 80 participants (40 central obese and 40 healthy controls) were administered a food frequency questionnaire dedicated to flavonols intake assessment. Body composition was measured with bioelectrical impedance analysis. The analysis showed significant differences between central obese participants and healthy controls in total flavonol (p = 0.005), quercetin (p = 0.003), kaempferol (p = 0.04) and isorhamnetin (p < 0.001) habitual intake. Among central obese participants, there was a moderate inverse correlation between fat mass (FM) and total flavonol (R = -0.378; 95% CI: -0.620 to -0.071; p = 0.02), quercetin (R = -0.352; 95% CI: -0.601 to -0.041; p = 0.03), kaempferol (R = -0.425; 95% CI: -0.653 to -0.127; p = 0.01) and myricetin intake (R = -0.352; 95% CI: -0.601 to -0.041; p = 0.03). BMI was inversely correlated with total flavonol (R = -0.330; 95% CI: -0.584 to -0.016; p = 0.04) and quercetin intake (R = -0.336; 95% CI: -0.589 to -0.023; p = 0.04). Waist circumference was inversely correlated with total flavonol (R = -0.328; 95% CI: -0.586 to -0.009; p = 0.04), quercetin (R = -0.322; 95% CI: -0.582 to -0.002; p = 0.048) and myricetin intake (R = -0.367; 95% CI: -0.615 to -0.054; p = 0.02). Among flavonols' dietary sources, there was an inverse correlation between black tea consumption and FM (R: -0.511; 95% CI: -0.712 to -0.233; p < 0.001) and between coffee and waist circumference (R: -0.352; 95% CI: -0.604 to -0.036; p = 0.03) in central obese participants. Conclusions: The higher flavonol intake could play a protective role in abdominal obesity development. What is more, total and selected flavonol dietary intakes are inversely correlated with the parameters used for obesity assessment in central obese participants. The habitual consumption of products rich in flavonols, mainly tea and coffee, could possibly have a preventive role in abdominal obesity development.
C1 [Popiolek-Kalisz, Joanna] Med Univ Lublin, Dept Bioanalyt, Clin Dietet Unit, ul Chodzki 7, PL-20093 Lublin, Poland.
   [Popiolek-Kalisz, Joanna] Cardinal Wyszynski Hosp Lublin, Dept Cardiol, al Krasnicka 100, PL-20718 Lublin, Poland.
C3 Medical University of Lublin
RP Popiolek-Kalisz, J (corresponding author), Med Univ Lublin, Dept Bioanalyt, Clin Dietet Unit, ul Chodzki 7, PL-20093 Lublin, Poland.; Popiolek-Kalisz, J (corresponding author), Cardinal Wyszynski Hosp Lublin, Dept Cardiol, al Krasnicka 100, PL-20718 Lublin, Poland.
EM joannapopiolekkalisz@umlub.pl
RI Popiolek-Kalisz, Joanna/CAI-4688-2022
OI Popiolek-Kalisz, Joanna/0000-0001-9108-8391
CR Akindehin S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121962
   Awad MA, 2000, SCI HORTIC-AMSTERDAM, V83, P249, DOI 10.1016/S0304-4238(99)00124-7
   Ben Lagha A, 2017, J PERIODONTAL RES, V52, P458, DOI 10.1111/jre.12411
   Bhagwat S., 2011, USDA DATABASE FLAVON
   Bian YF, 2022, J NUTR BIOCHEM, V99, DOI 10.1016/j.jnutbio.2021.108840
   Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783
   Cederholm T, 2017, CLIN NUTR, V36, P49, DOI 10.1016/j.clnu.2016.09.004
   Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110
   Costanzo G, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11020187
   Del Pino-García R, 2017, FOOD CHEM, V221, P1723, DOI 10.1016/j.foodchem.2016.10.113
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Dwyer JT, 2013, AM J CLIN NUTR, V98, p1611S, DOI 10.3945/ajcn.113.059584
   Egert S, 2010, J NUTR, V140, P278, DOI 10.3945/jn.109.117655
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   García-Macías P, 2007, J AGR FOOD CHEM, V55, P10168, DOI 10.1021/jf071570m
   Garvey WT, 2016, ENDOCR PRACT, V22, P1, DOI 10.4158/EP161365.GL
   Giuffrè AM, 2013, EUR FOOD RES TECHNOL, V237, P555, DOI 10.1007/s00217-013-2033-7
   Häkkinen SH, 2000, J AGR FOOD CHEM, V48, P2960, DOI 10.1021/jf991274c
   Häkkinen SH, 1999, J AGR FOOD CHEM, V47, P2274, DOI 10.1021/jf9811065
   Hibi M, 2018, NUTR RES, V55, P1, DOI 10.1016/j.nutres.2018.03.012
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Huber K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099325
   Jiang N, 2019, FRONT MED-PRC, V13, P314, DOI 10.1007/s11684-018-0625-0
   Kaur D, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13608
   Kawai T, 2021, AM J PHYSIOL-CELL PH, V320, pC375, DOI 10.1152/ajpcell.00379.2020
   Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11
   Khan N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010039
   Khorshidi M, 2018, PHYTOTHER RES, V32, P2282, DOI 10.1002/ptr.6166
   Kim SA, 2020, APPL PHYSIOL NUTR ME, V45, P203, DOI 10.1139/apnm-2019-0211
   Knab AM, 2011, APPL PHYSIOL NUTR ME, V36, P331, DOI [10.1139/h11-015, 10.1139/H11-015]
   Kudo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137809
   Kuti JO, 2004, J AGR FOOD CHEM, V52, P117, DOI 10.1021/jf030246y
   Lee A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061274
   Liaudanskas M, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9111611
   Liu BY, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n365
   Liu LX, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1333390
   Ma XY, 2016, FOOD CHEM, V200, P189, DOI 10.1016/j.foodchem.2016.01.036
   Maria GA, 2020, EMIR J FOOD AGR, V32, P522, DOI 10.9755/ejfa.2020.v32.i7.2128
   Nishimura M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010091
   Ohishi T, 2021, MOLECULES, V26, DOI 10.3390/molecules26020453
   Yuji OA, 2007, EXP MOL PATHOL, V83, P73, DOI 10.1016/j.yexmp.2007.02.007
   Olsen H, 2009, J AGR FOOD CHEM, V57, P2816, DOI 10.1021/jf803693t
   Pan HB, 2016, MOLECULES, V21, DOI 10.3390/molecules21121659
   Pan SS, 2018, MOL BIOL REP, V45, P689, DOI 10.1007/s11033-018-4205-9
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Pérez-Torres I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041786
   Popioek J., 2019, MEDICINA-LITHUANIA, V55, P671, DOI [10.3390/medicina55100671, DOI 10.3390/medicina55100671]
   Popiolek-Kalisz J, 2022, NUTRIENTS, V14, DOI 10.3390/nu14214586
   Popiolek-Kalisz J, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph191912546
   Popiolek-Kalisz J, 2022, CURR PROB CARDIOLOGY, V47, DOI 10.1016/j.cpcardiol.2022.101350
   Popiolek-Kalisz J, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091973
   Ramadan G, 2017, INT J RHEUM DIS, V20, P203, DOI 10.1111/1756-185X.12666
   Rodriguez-Mateos A, 2014, J AGR FOOD CHEM, V62, P3979, DOI 10.1021/jf403366q
   Rodríguez-Rodríguez C, 2015, FOOD FUNCT, V6, P805, DOI [10.1039/c4fo01092b, 10.1039/C4FO01092B]
   Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11
   Sagar NA, 2022, FOOD FRONTIERS, V3, P380, DOI 10.1002/fft2.135
   Sampson L, 2002, J AM DIET ASSOC, V102, P1414, DOI 10.1016/S0002-8223(02)90314-7
   Sharma A.K., 2018, ELS
   Shishikura Y, 2006, J AGR FOOD CHEM, V54, P1906, DOI 10.1021/jf051988p
   Slimestad R, 2008, J AGR FOOD CHEM, V56, P2436, DOI 10.1021/jf073434n
   Somerset SM, 2008, NUTR CANCER, V60, P442, DOI 10.1080/01635580802143836
   Stepaniak U, 2016, POL ARCH MED WEWN, V126, P662, DOI 10.20452/pamw.3499
   Sun YQ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l1042
   Tanaka T, 2020, CHEM PHARM BULL, V68, P1131, DOI 10.1248/cpb.c20-00295
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Visseren FLJ, 2021, EUR HEART J, V42, P3227, DOI 10.1093/eurheartj/ehab484
   W. H. Organization, 2017, WHO fact sheetsthe top 10 causes of death
   Wang TQ, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4532482
   Wannamethee SG, 2015, P NUTR SOC, V74, P405, DOI 10.1017/S002966511500169X
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0
   Wu XL, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01310
   Xu JL, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.202000353
   Yumuk V, 2015, OBESITY FACTS, V8, P402, DOI 10.1159/000442721
   Zamora-Ros R, 2011, BRIT J NUTR, V106, P1915, DOI 10.1017/S000711451100239X
   Zamora-Ros R, 2010, J AM DIET ASSOC, V110, P390, DOI 10.1016/j.jada.2009.11.024
   Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714
   Zhu L, 2012, INT J MOL SCI, V13, P3492, DOI 10.3390/ijms13033492
   Zivcak M, 2017, PLANTA, V245, P1215, DOI 10.1007/s00425-017-2676-x
NR 81
TC 13
Z9 13
U1 1
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD DEC
PY 2022
VL 14
IS 23
AR 5051
DI 10.3390/nu14235051
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 6X2SS
UT WOS:000896269800001
PM 36501081
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Brunkwall, L
   Almgren, P
   Hellstrand, S
   Orho-Melander, M
   Ericson, U
AF Brunkwall, Louise
   Almgren, Peter
   Hellstrand, Sophie
   Orho-Melander, Marju
   Ericson, Ulrika
TI Commonly consumed beverages associate with different lifestyle and
   dietary intakes
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE Sweetened beverages; juice; coffee; tea; dietary pattern; confounding
   and public health
ID SUGAR-SWEETENED BEVERAGES; CARDIOVASCULAR-DISEASE; MALMO FOOD; HISTORY
   METHOD; CONSUMPTION; OBESITY; RISK; CANCER; VALIDITY; FRUIT
AB Sugar sweetened beverages (SSB), artificially sweetened beverages (ASB), juice, coffee and tea has been associated with risk of metabolic disease. High consumption of these beverages may be associated with certain characteristics of the overall diet that would be important to take into account when analysing beverage-disease associations. Here, we investigate five beverages and their association with lifestyle and diet in 25,112 individuals from the Malmo Diet and Cancer Cohort. We observed that high consumption of SSB was associated with lower intakes of foods perceived as healthy. However, high consumption of both tea and juice was associated with higher intakes of foods perceived as healthy. Further, high consumption of ASB was associated with higher intakes of low-fat products. High consumption of coffee was associated with higher intakes of meat and high-fat margarine, and lower intake of breakfast cereals. We observe five beverages to associate with different lifestyle and dietary patterns.
C1 [Brunkwall, Louise; Almgren, Peter; Hellstrand, Sophie; Orho-Melander, Marju; Ericson, Ulrika] Lund Univ, Dept Clin Sci, Malmo, Sweden.
C3 Lund University
RP Brunkwall, L (corresponding author), Clin Res Ctr 60 013 26, Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden.
EM louise.brunkwall@med.lu.se
OI Ericson, Ulrika/0000-0003-4629-4318
FU Direktor Albert Pahlssons Stiftelse; Novo Nordisk UK Research
   Foundation; Region Skane ALF; Swedish Nutrition Foundation; Swedish
   Research Council
FX This work was funded by Direktor Albert Pahlssons Stiftelse; Novo
   Nordisk UK Research Foundation; Region Skane ALF; Swedish Nutrition
   Foundation; Swedish Research Council.
CR Barnes TL, 2015, J ACAD NUTR DIET, V115, P1117, DOI 10.1016/j.jand.2015.01.009
   Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y
   Brunkwall L, 2016, AM J CLIN NUTR, V104, P809, DOI 10.3945/ajcn.115.126052
   Crowe-White K, 2016, CRIT REV FOOD SCI, V56, P871, DOI 10.1080/10408398.2015.1061475
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Elmstahl S, 1996, EUR J CLIN NUTR, V50, P143
   Elmstahl S, 1996, EUR J CLIN NUTR, V50, P134
   Ericson U, 2017, DIETARY GENETI UNPUB
   Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997
   Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Larsson SC, 2014, J NUTR, V144, P856, DOI 10.3945/jn.114.190546
   Maki KC, 2014, ADV NUTR, V5, P7, DOI 10.3945/an.113.004929
   Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003
   Mullie P, 2012, EUR J CLIN NUTR, V66, P150, DOI 10.1038/ejcn.2011.138
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   O'Neil CE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-107
   Piernas C, 2014, AM J CLIN NUTR, V99, P567, DOI 10.3945/ajcn.113.072132
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rampersaud GC, 2017, CRIT REV FOOD SCI, V57, P129, DOI 10.1080/10408398.2013.862611
   Riboli E, 1997, INT J EPIDEMIOL, V26, pS161, DOI 10.1093/ije/26.suppl_1.S161
   Tarasuk VS, 1997, J NUTR, V127, P1847, DOI 10.1093/jn/127.9.1847
   Thiébaut ACM, 2008, CANCER INVEST, V26, P68, DOI 10.1080/07357900701527918
   Trumbo PR, 2014, NUTR REV, V72, P566, DOI 10.1111/nure.12128
   Vågstrand K, 2009, BRIT J NUTR, V101, P1541, DOI 10.1017/S0007114508083542
   Vuong QV, 2014, CRIT REV FOOD SCI, V54, P523, DOI 10.1080/10408398.2011.594184
   Willett W., 2017, Nutritional epidemiology
   Wirfält E, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20523
   Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325
NR 32
TC 7
Z9 8
U1 0
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD JAN 2
PY 2019
VL 70
IS 1
BP 88
EP 97
DI 10.1080/09637486.2018.1466272
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HF8RR
UT WOS:000454510400009
PM 29697292
OA Green Submitted, hybrid
DA 2025-04-28
ER

PT J
AU Walker, JM
   Mennella, I
   Ferracane, R
   Tagliamonte, S
   Holik, AK
   Hölz, K
   Somoza, MM
   Somoza, V
   Fogliano, V
   Vitaglione, P
AF Walker, Joel M.
   Mennella, Ilario
   Ferracane, Rosalia
   Tagliamonte, Silvia
   Holik, Ann-Katrin
   Hoelz, Kathrin
   Somoza, Mark M.
   Somoza, Veronika
   Fogliano, Vincenzo
   Vitaglione, Paola
TI Melanoidins from coffee and bread differently influence energy intake: A
   randomized controlled trial of food intake and gut-brain axis response
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Obesity; Dietary fibre; Diabetes; Processed foods; Clinical trial;
   Maillard reaction
ID CHEMICAL-CHARACTERIZATION; SATIETY RESPONSES; APPETITE; GHRELIN;
   MECHANISMS; HORMONES; DIETARY; POLYPHENOLS; SECRETION; PATHWAYS
AB Melanoidins are Maillard reaction products similar to dietary fiber but their effect on food intake was under-investigated. A randomized, crossover study of 14 healthy subjects investigated whether melanoidins modulated energy intake and affected the postprandial dynamics of 21 gut-brain modulators of appetite including gastrointestinal peptides, endocannabinoids, N-acylethanolamines and neuropeptides. At breakfast the subjects consumed a bread enriched with either 3 g coffee melanoidins (CM), 3 g bread melanoidins (BM), or a conventional bread (CT). Energy intakes at lunch and throughout the day were measured, while appetite sensations and blood samples were collected before and 30, 60, 120, and 180 min after breakfast. Compared to CT, CM significantly reduced daily energy intake by 26%. CM lowered blood glucose peak, insulin, alpha-melanocyte stimulating hormone, orexin-A, beta-endorphin, and blunted the response of three N-acylethanolamines versus BM. Coffee melanoidins at breakfast reduces daily energy intake and modulates postprandial glycemia and other biomarkers.
C1 [Walker, Joel M.; Mennella, Ilario; Ferracane, Rosalia; Tagliamonte, Silvia; Vitaglione, Paola] Univ Naples Federico II, Dept Agr Sci, Via Univ 100, I-80055 Portici, NA, Italy.
   [Holik, Ann-Katrin; Somoza, Veronika] Univ Vienna, Fac Chem, Dept Physiol Chem, Althanstr 14, A-1090 Vienna, Austria.
   [Hoelz, Kathrin; Somoza, Mark M.] Univ Vienna, Fac Chem, Dept Inorgan Chem, Althanstr 14, A-1090 Vienna, Austria.
   [Somoza, Veronika] Univ Vienna, Fac Chem, Christian Doppler Lab Bioact Aroma Cpds, Althanstr 14, A-1090 Vienna, Austria.
   [Fogliano, Vincenzo] Wageningen Univ & Res Ctr, Food Qual Design Grp, POB 8129, NL-6700 EV Wageningen, Netherlands.
C3 University of Naples Federico II; University of Vienna; University of
   Vienna; University of Vienna; Wageningen University & Research
RP Vitaglione, P (corresponding author), Univ Naples Federico II, Dept Agr Sci, Parco Gussone Ed 84, I-80055 Portici, NA, Italy.
EM paola.vitaglione@unina.it
RI Holik, Ann-Katrin/F-4233-2014; Somoza, Veronika/D-4141-2013;
   Tagliamonte, Silvia/ABA-4700-2021; fogliano, vincenzo/A-1419-2009;
   Vitaglione, Paola/B-2864-2010
OI Somoza, Veronika/0000-0003-2456-9245; Tagliamonte,
   Silvia/0000-0002-1176-4992; Walker, Joel Michael/0000-0002-8546-3578;
   fogliano, vincenzo/0000-0001-8786-9355; Holz,
   Kathrin/0000-0001-9089-2417; Vitaglione, Paola/0000-0002-6608-5209;
   Somoza, Mark/0000-0002-8039-1341
FU People Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme FP7 under REA [300815]
FX The research leading to these results has received funding from the
   People Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme FP7 under REA (grant number 300815).
CR Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067
   ALjahdali N, 2019, CRIT REV FOOD SCI, V59, P474, DOI 10.1080/10408398.2017.1378865
   Berthoud HR, 2011, CURR OPIN NEUROBIOL, V21, P888, DOI 10.1016/j.conb.2011.09.004
   Borrelli RC, 2003, FOOD CHEM TOXICOL, V41, P1367, DOI 10.1016/S0278-6915(03)00140-6
   Borrelli RC, 2002, J AGR FOOD CHEM, V50, P6527, DOI 10.1021/jf025686o
   Camilleri M, 2015, GASTROENTEROLOGY, V148, P1219, DOI 10.1053/j.gastro.2014.09.016
   Choi S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030363
   De Marco LM, 2011, J AGR FOOD CHEM, V59, P11417, DOI 10.1021/jf202778w
   Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457
   Di Marzo V, 2009, INT J OBESITY, V33, pS18, DOI 10.1038/ijo.2009.67
   DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108
   Edwards CMB, 1999, J ENDOCRINOL, V160, pR7, DOI 10.1677/joe.0.160R007
   Fetissov SO, 2017, NAT REV ENDOCRINOL, V13, P11, DOI 10.1038/nrendo.2016.150
   Fogliano V, 2011, FOOD FUNCT, V2, P117, DOI 10.1039/c0fo00156b
   Fu J, 2011, J NEUROSCI, V31, P5730, DOI 10.1523/JNEUROSCI.5668-10.2011
   Gatta-Cherifi B, 2012, INT J OBESITY, V36, P880, DOI 10.1038/ijo.2011.165
   Green SM, 1997, APPETITE, V29, P291, DOI 10.1006/appe.1997.0096
   Hall KD, 2019, CELL METAB, V30, P67, DOI 10.1016/j.cmet.2019.05.008
   Hansen HS, 2014, PHARMACOL RES, V86, P18, DOI 10.1016/j.phrs.2014.03.006
   Helou C, 2017, FOOD FUNCT, V8, P2722, DOI [10.1039/C7FO00430C, 10.1039/c7fo00430c]
   Helou C, 2015, FOOD FUNCT, V6, P3737, DOI [10.1039/C5FO00836K, 10.1039/c5fo00836k]
   Hoggard N, 2004, J MOL ENDOCRINOL, V32, P145, DOI 10.1677/jme.0.0320145
   Isaksson H, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-31
   Izaguirre M, 2016, ENDOCRINOLOGY, V157, P3391, DOI 10.1210/en.2016-1542
   Karagiannides I, 2008, GASTROENTEROLOGY, V134, P747, DOI 10.1053/j.gastro.2007.12.032
   Keesey RE, 2008, APPETITE, V51, P442, DOI 10.1016/j.appet.2008.06.009
   Keogh J, 2011, APPETITE, V57, P707, DOI 10.1016/j.appet.2011.08.015
   Levin F, 2006, J CLIN ENDOCR METAB, V91, P3296, DOI 10.1210/jc.2005-2638
   Mari A, 2002, DIABETES, V51, pS221, DOI 10.2337/diabetes.51.2007.S221
   Mari A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1159, DOI 10.1152/ajpendo.00093.2002
   Mennella I, 2016, BRIT J NUTR, V116, P1841, DOI 10.1017/S0007114516003858
   Mennella I, 2015, J NUTR, V145, P2169, DOI 10.3945/jn.114.207704
   Mennella I, 2015, FOOD FUNCT, V6, P204, DOI 10.1039/c4fo00697f
   Monteleone P, 2012, J CLIN ENDOCR METAB, V97, pE917, DOI 10.1210/jc.2011-3018
   Morales FJ, 2012, AMINO ACIDS, V42, P1097, DOI 10.1007/s00726-010-0774-1
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484
   Naughton SS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/361895
   Nunes FM, 2007, J AGR FOOD CHEM, V55, P3967, DOI 10.1021/jf063735h
   Pastoriza S, 2014, FOOD CHEM, V164, P438, DOI 10.1016/j.foodchem.2014.04.118
   Rigamonti AE, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1297553
   Rigamonti AE, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.29678
   Rosén LAH, 2011, J AGR FOOD CHEM, V59, P12139, DOI 10.1021/jf2019825
   Rosén LA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-7
   SINGH M, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/874610
   So M, 2018, J PHYSIOL SCI, V68, P129, DOI 10.1007/s12576-016-0517-5
   Sohn JW, 2015, BMB REP, V48, P229, DOI 10.5483/BMBRep.2015.48.4.272
   Suzuki K, 2010, ENDOCR J, V57, P359, DOI 10.1507/endocrj.K10E-077
   Tischmann L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102269
   Veening JG, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/2045-8118-12-3
   Vitaglione P, 2015, AM J CLIN NUTR, V101, P251, DOI 10.3945/ajcn.114.088120
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013
   Witkamp RF, 2018, MOL ASPECTS MED, V64, P45, DOI 10.1016/j.mam.2018.01.002
   WOLEVER TMS, 1988, AM J CLIN NUTR, V48, P1041, DOI 10.1093/ajcn/48.4.1041
   Zanchi D, 2017, NEUROSCI BIOBEHAV R, V80, P457, DOI 10.1016/j.neubiorev.2017.06.013
NR 56
TC 23
Z9 23
U1 2
U2 33
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD SEP
PY 2020
VL 72
AR 104063
DI 10.1016/j.jff.2020.104063
PG 11
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA MO7PA
UT WOS:000551711700028
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Vercammen, KA
   Koma, JW
   Bleich, SN
AF Vercammen, Kelsey A.
   Koma, J. Wyatt
   Bleich, Sara N.
TI Trends in Energy Drink Consumption Among US Adolescents and Adults,
   2003-2016
SO AMERICAN JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Article
ID CAFFEINE INTAKE; UNITED-STATES; HIGH-RISK; CHILDREN; PERFORMANCE;
   PREVALENCE; OBESITY
AB Introduction: Energy drinks refer to non-alcoholic beverages that contain caffeine, amino acids, herbs, and vitamins. Although energy drinks are marketed to reduce fatigue and improve physical/mental performance, frequent consumption of these beverages has been linked to negative health consequences. The purpose of this study is to provide timely, national estimates of the percentage of energy drink consumers in the U.S. and to analyze trends in energy drink intake between 2003 and 2016.
   Methods: A total of 9,911 adolescents (aged 12-19 years); 12,103 young adults (aged 20-39 years); and 11,245 middle-aged adults (aged 40-59 years) were assessed using dietary data from the 2003-2016 National Health and Nutrition Examination Surveys. For each age group (adolescents, young adults, and middle-aged adults), logistic regression was used to estimate the proportion of energy drink consumers, and negative binomial regression was used to estimate per capita energy drink consumption, adjusting for covariates. Differences in total caffeine intake between energy drink consumers and non-consumers were examined by pooling all survey years together and using negative binomial regression. Analyses were conducted in 2018.
   Results: From 2003 to 2016, the prevalence of energy drink consumption increased significantly for adolescents (0.2% to 1.4%, p=0.028); young adults (0.5% to 5.5%, p<0.001); and middle-aged adults (0.0% to 1.2%, p=0.006). Per capita consumption of energy drinks increased significantly from 2003 to 2016 only for young adults (1.1 to 9.7 calories, p<0.001). Pooled across years, energy drink consumers had significantly higher total caffeine intake compared with non-consumers for adolescents (227.0 mg vs 52.1 mg, p<0.001); young adults (278.7 mg vs 135.3 mg, p<0.001); and middle-aged adults (348.8 mg vs 219.0 mg, p<0.001).
   Conclusions: These findings indicate that consumption of energy drinks has grown substantially and that these drinks are a major source of caffeine among those who consume them. (C) 2019 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
C1 [Vercammen, Kelsey A.] Harvard TH Chan Sch Public Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.
   [Bleich, Sara N.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard T.H. Chan School of Public Health
RP Vercammen, KA (corresponding author), Harvard TH Chan Sch Public Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.
EM key266@mail.harvard.edu
CR Abian-Vicen J, 2014, AMINO ACIDS, V46, P1333, DOI 10.1007/s00726-014-1702-6
   Ahluwalia N, 2014, AM J CLIN NUTR, V100, P1124, DOI 10.3945/ajcn.113.082172
   Al-Shaar L, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00225
   [Anonymous], 2015, 2015 2020 DIET GUID
   [Anonymous], 2013, About the National Health and Nutrition Examination Survey
   Arria AM, 2011, JAMA-J AM MED ASSOC, V305, P600, DOI 10.1001/jama.2011.109
   Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019
   Bleich Sara N, 2018, BMC Obes, V5, P6, DOI 10.1186/s40608-017-0178-9
   Bleich SN, 2018, OBESITY, V26, P432, DOI 10.1002/oby.22056
   Branum AM, 2014, PEDIATRICS, V133, P386, DOI 10.1542/peds.2013-2877
   Breda JJ, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00134
   Gallo-Salazar C, 2015, INT J SPORT PHYSIOL, V10, P305, DOI 10.1123/ijspp.2014-0103
   Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35
   Marczinski CA, 2015, ADV NUTR, V6, P96, DOI 10.3945/an.114.007393
   O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Seifert SM, 2013, CLIN TOXICOL, V51, P566, DOI 10.3109/15563650.2013.820310
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Shah SA, 2016, ANN PHARMACOTHER, V50, P808, DOI 10.1177/1060028016656433
   Striley CW, 2014, CURR OPIN PSYCHIATR, V27, P263, DOI 10.1097/YCO.0000000000000070
   Zhang Q, 2009, ETHNIC HEALTH, V14, P439, DOI 10.1080/13557850802699155
NR 24
TC 65
Z9 68
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0749-3797
EI 1873-2607
J9 AM J PREV MED
JI Am. J. Prev. Med.
PD JUN
PY 2019
VL 56
IS 6
BP 827
EP 833
DI 10.1016/j.amepre.2018.12.007
PG 7
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA HY3OD
UT WOS:000468035100013
PM 31005465
DA 2025-04-28
ER

PT J
AU Imamura, F
   Schulze, MB
   Sharp, SJ
   Guevara, M
   Romaguera, D
   Bendinelli, B
   Salamanca-Fernández, E
   Ardanaz, E
   Arriola, L
   Aune, D
   Boeing, H
   Dow, C
   Fagherazzi, G
   Franks, PW
   Freisling, H
   Jakszyn, P
   Kaaks, R
   Khaw, KT
   Kühn, T
   Mancini, FR
   Masala, G
   Chirlaque, MD
   Nilsson, PM
   Overvad, K
   Pala, VM
   Panico, S
   Perez-Cornago, A
   Quirós, JR
   Ricceri, F
   Rodríguez-Barranco, M
   Rolandsson, O
   Sluijs, I
   Stepien, M
   Spijkerman, AMW
   Tjonneland, A
   Tong, TYN
   Tumino, R
   Vissers, LET
   Ward, HA
   Langenberg, C
   Riboli, E
   Forouhi, NG
   Wareham, NJ
AF Imamura, Fumiaki
   Schulze, Matthias B.
   Sharp, Stephen J.
   Guevara, Marcela
   Romaguera, Dora
   Bendinelli, Benedetta
   Salamanca-Fernandez, Elena
   Ardanaz, Eva
   Arriola, Larraitz
   Aune, Dagfinn
   Boeing, Heiner
   Dow, Courtney
   Fagherazzi, Guy
   Franks, Paul W.
   Freisling, Heinz
   Jakszyn, Paula
   Kaaks, Rudolf
   Khaw, Kay-Tee
   Kuehn, Tilman
   Mancini, Francesca R.
   Masala, Giovanna
   Chirlaque, Maria-Dolores
   Nilsson, Peter M.
   Overvad, Kim
   Pala, Valeria M.
   Panico, Salvatore
   Perez-Cornago, Aurora
   Quiros, Jose R.
   Ricceri, Fulvio
   Rodriguez-Barranco, Miguel
   Rolandsson, Olov
   Sluijs, Ivonne
   Stepien, Magdalena
   Spijkerman, Annemieke M. W.
   Tjonneland, Anne
   Tong, Tammy Y. N.
   Tumino, Rosario
   Vissers, Linda E. T.
   Ward, Heather A.
   Langenberg, Claudia
   Riboli, Elio
   Forouhi, Nita G.
   Wareham, Nick J.
TI Estimated Substitution of Tea or Coffee for Sugar-Sweetened Beverages
   Was Associated with Lower Type 2 Diabetes Incidence in Case-Cohort
   Analysis across 8 European Countries in the EPIC-InterAct Study
SO JOURNAL OF NUTRITION
LA English
DT Article
DE diabetes; epidemiology; dietary guidelines; beverages; sugar-sweetened
   beverages
ID CONSUMPTION PATTERNS; RISK; CANCER; MELLITUS; WATER; METAANALYSIS;
   PREVENTION; VALIDITY; PROJECT; OBESITY
AB Introduction: Beverage consumption is a modifiable risk factor for type 2 diabetes (T2D), but there is insufficient evidence to inform the suitability of substituting 1 type of beverage for another.
   Objective: The aim of this study was to estimate the risk of T2D when consumption of sugar-sweetened beverages (SSBs) was replaced with consumption of fruit juice, milk, coffee, or tea.
   Methods: In the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study of 8 European countries (n = 27,662, with 12,333 cases of incident T2D, 1992-2007), beverage consumption was estimated at baseline by dietary questionnaires. Using Prentice-weighted Cox regression adjusting for other beverages and potential confounders, we estimated associations of substituting 1 type of beverage for another on incident T2D.
   Results: Mean +/- SD of estimated consumption of SSB was 55 +/- 105 g/d. Means +/- SDs for the other beverages were as follows: fruit juice, 59 +/- 101 g/d; milk, 209 +/- 203 g/d; coffee, 381 +/- 372 g/d; and tea, 152 +/- 282 g/d. Substituting coffee for SSBs by 250 g/d was associated with a 21% lower incidence of T2D (95% CI: 12%, 29%). The rate difference was -12.0 (95% CI: -20.0, -5.0) per 10,000 person-years among adults consuming SSBs >= 250 g/d (absolute rate = 48.3/10,000). Substituting tea for SSBs was estimated to lower T2D incidence by 22% (95% CI: 15%, 28%) or -11.0 (95% CI:-20.0, -2.6) per 10,000 person-years, whereas substituting fruit juice or milk was estimated not to alter T2D risk significantly.
   Conclusions: These findings indicate a potential benefit of substituting coffee or tea for SSBs for the primary prevention of T2D and may help formulate public health recommendations on beverage consumption in different populations.
C1 [Imamura, Fumiaki; Sharp, Stephen J.; Langenberg, Claudia; Forouhi, Nita G.; Wareham, Nick J.] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England.
   [Schulze, Matthias B.; Boeing, Heiner] Germen Inst Human Nutr, Dept Mol Epidemiol, Potsdam, Germany.
   [Guevara, Marcela; Ardanaz, Eva] IDISNA Navarra Hlth Res Inst, Pamplona, Spain.
   [Guevara, Marcela; Salamanca-Fernandez, Elena; Ardanaz, Eva; Chirlaque, Maria-Dolores; Rodriguez-Barranco, Miguel] CIBER Epidemiol & Publ Hlth, Madrid, Spain.
   [Romaguera, Dora; Aune, Dagfinn; Ward, Heather A.; Riboli, Elio] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.
   [Romaguera, Dora] Hlth Res Inst Balearic Isl IdISBa, Palma De Mallorca, Spain.
   [Romaguera, Dora] CIBER Physiopathol Obes & Nutr, Madrid, Spain.
   [Bendinelli, Benedetta; Masala, Giovanna] Inst Canc Res Prevent & Clin Network ISPRO, Canc Risk Factors & Lifestyle Epidemiol Unit, Florence, Italy.
   [Salamanca-Fernandez, Elena; Rodriguez-Barranco, Miguel] Univ Granada, Andalusian Sch Publ Hlth, Inst Invest Inst Invest Biosanitaria Granada IbsG, Granada, Spain.
   [Arriola, Larraitz] CIBERESP, Publ Hlth Div Gipuzkoa, Inst BIOdonostia, Gipuzkoa, Spain.
   [Aune, Dagfinn] Bjorknes Univ Coll, Dept Nutr, Oslo, Norway.
   [Aune, Dagfinn] Oslo Univ Hosp Ulleval, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway.
   [Dow, Courtney; Fagherazzi, Guy; Mancini, Francesca R.] Gustave Roussy Inst, Villejuif, France.
   [Dow, Courtney; Fagherazzi, Guy; Mancini, Francesca R.] Univ Paris Saclay, Univ Versailles St Quentin, Univ Paris South, Fac Med, Villejuif, France.
   [Dow, Courtney; Fagherazzi, Guy; Mancini, Francesca R.] Natl Inst Hlth & Med Res INSERM, Ctr Res Epidemiol & Populat Hlth, Villejuif, France.
   [Franks, Paul W.; Rolandsson, Olov] Umea Univ, Dept Publ Hlth & Clin Med, Family Med, Umea, Sweden.
   [Franks, Paul W.; Nilsson, Peter M.] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden.
   [Freisling, Heinz; Stepien, Magdalena] Int Agcy Res Canc IARC WHO, Sect Nutr & Metab, Lyon, France.
   [Jakszyn, Paula] Catalan Inst Oncol, Barcelona, Spain.
   [Jakszyn, Paula] Univ Ramon Llull, FCS Blanquerna, Barcelona, Spain.
   [Kaaks, Rudolf; Kuehn, Tilman] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.
   [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Sch Clin Med, Cambridge, England.
   [Chirlaque, Maria-Dolores] IMIB Arrixaca, Dept Epidemiol, Reg Hlth Council, Murcia, Spain.
   [Chirlaque, Maria-Dolores] Univ Murcia, Dept Hlth & Social Sci, Murcia, Spain.
   [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aarhus, Denmark.
   [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark.
   [Pala, Valeria M.] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy.
   [Panico, Salvatore] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy.
   [Perez-Cornago, Aurora; Tong, Tammy Y. N.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.
   [Quiros, Jose R.] Publ Hlth Directorate, Asturias, Spain.
   [Ricceri, Fulvio] Univ Turin, Dept Clin & Biol Sci, Turin, Italy.
   [Ricceri, Fulvio] Reg Hlth Serv ASL TO3, Unit Epidemiol, Grugliasco, Italy.
   [Sluijs, Ivonne; Vissers, Linda E. T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Cardiovasc Epidemiol, Utrecht, Netherlands.
   [Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands.
   [Tjonneland, Anne] Danish Canc Soc Res Ctr, Copenhagen, Denmark.
   [Tumino, Rosario] Civ MP Arezzo Hosp, Canc Registry & Histopathol Dept, Ragusa, Italy.
C3 University of Cambridge; CIBER - Centro de Investigacion Biomedica en
   Red; CIBERESP; Imperial College London; Institut Investigacio Sanitaria
   Illes Balears (IdISBa); CIBER - Centro de Investigacion Biomedica en
   Red; CIBEROBN; University of Granada; Escuela Andaluza de Salud Publica;
   CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de
   Investigacion Sanitaria Biogipuzkoa; University of Oslo; UNICANCER;
   Gustave Roussy; Universite Paris Saclay; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Umea University; Lund University;
   Skane University Hospital; World Health Organization; International
   Agency for Research on Cancer (IARC); Institut Catala d'Oncologia;
   Universitat Ramon Llull; Helmholtz Association; German Cancer Research
   Center (DKFZ); University of Cambridge; Hospital Clinico Universitario
   Virgen de la Arrixaca; University of Murcia; Aalborg University; Aalborg
   University Hospital; Aarhus University; Fondazione IRCCS Istituto
   Nazionale Tumori Milan; University of Naples Federico II; University of
   Oxford; University of Turin; Utrecht University; Utrecht University
   Medical Center; Netherlands National Institute for Public Health & the
   Environment; Danish Cancer Society; Civile M.P. Arezzo Hospital
RP Imamura, F (corresponding author), Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England.
EM fumiaki.imamura@mrc-epid.cam.ac.uk
RI Tong, Tammy/I-8770-2019; Chirlaque, Maria-Dolores/KCL-3322-2024; Dow,
   Courtney/ABC-4038-2021; Pala, Valeria/K-4738-2016; Tjonneland,
   Anne/AGU-0320-2022; Panico, Salvatore/K-6506-2016; Khaw,
   Kay-Tee/AAZ-3209-2021; Forouhi, Nita/JAC-2361-2023; mancini, francesca
   romana/GRF-5129-2022; Kritchevsky, Stephen/JWP-7971-2024; Langenberg,
   Claudia/ABG-9067-2021; Aune, Dagfinn/AFP-4300-2022; Fagherazzi,
   Guy/ABB-2555-2020; Franks, Paul/AAA-3300-2020; Kühn,
   Tilman/JYP-5102-2024; Ricceri, Fulvio/I-9910-2018; Masala,
   Giovanna/AAC-5474-2022; Riboli, Elio/A-4357-2009; Romaguera,
   Dora/AAB-2852-2020; Guevara, Marcela/B-4473-2015; Salamanca-Fernandez,
   Elena/R-5943-2016; Jakszyn, Paula/K-1458-2016; Schulze, Matthias
   B./AAH-6906-2021; RODRIGUEZ-BARRANCO, MIGUEL/H-4541-2012; Mancini,
   Francesca Romana/H-3778-2018; Dow, Courtney/MIP-1135-2025; Imamura,
   Fumiaki/J-1038-2019; Perez-Cornago, Aurora/C-1097-2016
OI Forouhi, Nita/0000-0002-5041-248X; Romaguera, Dora/0000-0002-5762-8558;
   Tong, Tammy/0000-0002-0284-8959; Riboli, Elio/0000-0001-6795-6080;
   Guevara, Marcela/0000-0001-9242-6364; Salamanca-Fernandez,
   Elena/0000-0002-1795-2206; Jakszyn, Paula/0000-0003-0672-8847; Sharp,
   Stephen/0000-0003-2375-1440; Overvad, Kim/0000-0001-6429-7921; Schulze,
   Matthias B./0000-0002-0830-5277; Langenberg,
   Claudia/0000-0002-5017-7344; Bendinelli, Benedetta/0000-0002-4796-1517;
   Ward, Heather/0000-0002-2721-2404; RODRIGUEZ-BARRANCO,
   MIGUEL/0000-0002-9972-9779; Wareham, Nicholas/0000-0003-1422-2993;
   Franks, Paul/0000-0002-0520-7604; Mancini, Francesca
   Romana/0000-0003-2297-3869; Dow, Courtney/0000-0002-9925-8460; Ardanaz,
   Eva/0000-0001-8434-2013; Freisling, Heinz/0000-0001-8648-4998; Imamura,
   Fumiaki/0000-0002-6841-8396; Perez-Cornago, Aurora/0000-0002-5652-356X;
   Aune, Dagfinn/0000-0002-4533-1722; tumino, rosario/0000-0003-2666-414X
FU EU FP6 program [LSHM_CT_2006_037197]; Medical Research Council
   Epidemiology Unit Core Support [MC_UU_12015/1, MC_UU_12015/5]; National
   Institute for Health Research, Biomedical Research Centre Cambridge:
   Nutrition, Diet, and Lifestyle Research Theme [IS-BRC-1215-20014];
   German Federal Ministry of Education and Research; German Center for
   Diabetes Research; State of Brandenburg, Germany; Netherlands Agency
   grant [IGE05012]; Board of the University Medical Center Utrecht
   (Netherlands); Dutch Ministry of Public Health, Welfare, and Sports;
   Netherlands Cancer Registry; LK Research Funds; Dutch Prevention Funds;
   Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund;
   Statistics Netherlands; Swedish Research Council; Novo Nordisk; Swedish
   Heart Lung Foundation; Swedish Diabetes Association; Danish Cancer
   Society; Deutsche Krebshilfe; Associazione Italiana per la Ricerca sul
   Cancro; Asturias Regional Government; Navarra Regional Government,
   Health Research Fund of the Spanish Ministry of Health; CIBER
   Epidemiologia y Salud Publica, Spain; Murcia Regional Government [6236];
   AIRE-ONLUS Ragusa; AVIS-Ragusa; Sicilian Regional Government; MRC
   [MC_UU_12015/1, MR/N003284/1, MC_UU_12015/5] Funding Source: UKRI
FX The InterAct project was funded by the EU FP6 program
   (LSHM_CT_2006_037197). InterAct investigators acknowledge funding from
   the following agencies: Medical Research Council Epidemiology Unit Core
   Support (MC_UU_12015/1, MC_UU_12015/5); National Institute for Health
   Research, Biomedical Research Centre Cambridge: Nutrition, Diet, and
   Lifestyle Research Theme (IS-BRC-1215-20014); the German Federal
   Ministry of Education and Research, the German Center for Diabetes
   Research, the State of Brandenburg, Germany; Netherlands Agency grant
   IGE05012 and an Incentive Grant from the Board of the University Medical
   Center Utrecht (Netherlands); Dutch Ministry of Public Health, Welfare,
   and Sports, Netherlands Cancer Registry, LK Research Funds, Dutch
   Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer
   Research Fund, and Statistics Netherlands; Swedish Research Council,
   Novo Nordisk, Swedish Heart Lung Foundation, and Swedish Diabetes
   Association; Danish Cancer Society; Deutsche Krebshilfe; Associazione
   Italiana per la Ricerca sul Cancro; Asturias Regional Government;
   Navarra Regional Government, Health Research Fund of the Spanish
   Ministry of Health; CIBER Epidemiologia y Salud Publica, Spain; Murcia
   Regional Government (grant 6236); and AIRE-ONLUS Ragusa, AVIS-Ragusa,
   and Sicilian Regional Government.
CR [Anonymous], PASSP GLOB MARK INF
   [Anonymous], 2019, BMJ-BRIT MED J
   Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227
   Bernstein AM, 2012, AM J CLIN NUTR, V95, P1190, DOI 10.3945/ajcn.111.030205
   Beulens JWJ, 2012, J INTERN MED, V272, P358, DOI 10.1111/j.1365-2796.2012.02532.x
   Borges MC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002195
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   European Food Safety Authority, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2097
   Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9
   Gijsbers L, 2016, AM J CLIN NUTR, V103, P1111, DOI 10.3945/ajcn.115.123216
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9
   Langenberg C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001647
   Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9
   Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Margetts BM, 1997, INT J EPIDEMIOL, V26, pS1, DOI 10.1093/ije/26.suppl_1.S1
   Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380
   O'Connor L, 2015, DIABETOLOGIA, V58, P1474, DOI 10.1007/s00125-015-3572-1
   Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698
   Piernas C, 2013, AM J CLIN NUTR, V97, P604, DOI 10.3945/ajcn.112.048405
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   PRENTICE RL, 1986, BIOMETRIKA, V73, P1
   Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394
   Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8
   ROSNER B, 1992, AM J EPIDEMIOL, V136, P1400, DOI 10.1093/oxfordjournals.aje.a116453
   Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636
   Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679
   Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395
   Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907
   Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   van Woudenbergh GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036910
   Visioli F, 2014, ADV NUTR, V5, P131, DOI 10.3945/an.113.005025
   Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439
   Weaver CM, 2014, AM J CLIN NUTR, V99, p1217S, DOI 10.3945/ajcn.113.073007
   Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005632
   Zheng MB, 2015, J ACAD NUTR DIET, V115, P767, DOI 10.1016/j.jand.2015.01.006
   Zheng MB, 2015, NUTRITION, V31, P38, DOI 10.1016/j.nut.2014.04.017
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
NR 46
TC 29
Z9 29
U1 9
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD NOV
PY 2019
VL 149
IS 11
BP 1985
EP 1993
DI 10.1093/jn/nxz156
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA JY3NE
UT WOS:000504324800016
PM 31396627
OA Green Published, hybrid, Green Submitted
DA 2025-04-28
ER

PT J
AU Rudelle, S
   Ferruzzi, MG
   Cristiani, I
   Moulin, J
   Mace, K
   Acheson, KJ
   Tappy, L
AF Rudelle, Servane
   Ferruzzi, Mario G.
   Cristiani, Isabelle
   Moulin, Julie
   Mace, Katherine
   Acheson, Kevin J.
   Tappy, Luc
TI Effect of a thermogenic beverage on 24-hour energy metabolism in humans
SO OBESITY
LA English
DT Article
DE 24-hour energy expenditure; fat oxidation; green tea; caffeine;
   epigallocatechin gallate
ID FAT OXIDATION; GREEN TEA; CALCIUM INTAKE; CATECHIN-POLYPHENOLS; DIETARY
   CALCIUM; CAFFEINE; EXPENDITURE; WEIGHT; DAIRY; OBESITY
AB Objective: To test whether consumption of a beverage containing active ingredients will increase 24-hour energy metabolism in healthy, young, lean individuals.
   Research Method and Procedures: Thirty-one male and female subjects consumed 3 X 250-mL servings of a beverage containing green tea catechins, caffeine, and calcium for 3 days in a single-center, double-blind, placebo-controlled, cross-over design study. On the 3rd day, 23-hour energy metabolism, extrapolated to 24-hour, was measured in a calorimeter chamber. Blood pressure and heart rate were measured, and total day and night urines were analyzed for urea and catecholamine excretion.
   Results: Twenty-four-hour energy expenditure (EE) and 24-hour fat oxidation were lower in women than in men (p < 0.0001 and p < 0.015, respectively). Although there were no treatment or treatment/gender effects on substrate oxidation, treatment increased 24-hour EE by 106 +/- 31 kcal/24 hours (p = 0.002), equivalent to 4.7 +/- 1.6 kcal/h (day; p = 0.005) and 3.3 +/- 1.5 kcal/h (night; p = 0.04). No significant differences were observed in hemodynamic parameters.
   Discussion: The present study provides evidence that consumption of a beverage containing green tea catechins, caffeine, and calcium increases 24-hour EE by 4.6%, but the contribution of the individual ingredients cannot be distinguished. Although this increase is modest, the results are discussed in relation to proposed public health goals, indicating that such modifications are sufficient to prevent weight gain. When consumed regularly as part of a healthy diet and exercise regime, such a beverage may provide benefits for weight control.
C1 Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland.
   Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA.
   Nestle Res Ctr, CH-1000 Lausanne, Switzerland.
C3 University of Lausanne; Purdue University System; Purdue University;
   Nestle SA; Nestle Research Center
RP Tappy, L (corresponding author), Univ Lausanne, Dept Physiol, Rue du Bugnon 7, CH-1005 Lausanne, Switzerland.
EM Luc.Tappy@unil.ch
RI Tappy, Luc/A-8911-2017
OI Tappy, Luc/0000-0001-8469-4692; Ferruzzi, Mario/0000-0003-1384-2672
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Arch JRS, 1996, INT J OBESITY, V20, P191
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Barr SI, 2003, J NUTR, V133, p245S
   Benowitz NL, 1995, CLIN PHARMACOL THER, V58, P684, DOI 10.1016/0009-9236(95)90025-X
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Boothby WM, 1923, J PHARMACOL EXP THER, V22, P99
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Bray GA, 2000, NUTRITION, V16, P953, DOI 10.1016/S0899-9007(00)00424-X
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070
   Ferruzzi MG, 2006, FOOD CHEM, V99, P484, DOI 10.1016/j.foodchem.2005.08.010
   *GOT PUBL, INT C HARM TOP E6 GU
   Higgins HL, 1915, J PHARMACOL EXP THER, V7, P1
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   HURNI M, 1982, BRIT J NUTR, V47, P33, DOI 10.1079/BJN19820006
   Jacobsen R, 2005, INT J OBESITY, V29, P292, DOI 10.1038/sj.ijo.0802785
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   LIVESEY G, 1988, AM J CLIN NUTR, V47, P608, DOI 10.1093/ajcn/47.4.608
   Means JH, 1917, ARCH INTERN MED, V19, P832
   Melanson EL, 2003, INT J OBESITY, V27, P196, DOI 10.1038/sj.ijo.802202
   MILLER DS, 1974, P NUTR SOC, V33, pA28
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Silva AP, 2005, J NEUROCHEM, V93, P163, DOI 10.1111/j.1471-4159.2004.03005.x
   Teegarden D, 2003, J NUTR, V133, p249S, DOI 10.1093/jn/133.1.249S
   Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144
   Zemel MB, 2004, AM J CLIN NUTR, V79, P907
   Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132
   Zemel MB, 2004, NUTR REV, V62, P125, DOI [10.1301/nr.2004.apr.125–131, 10.1111/j.1753-4887.2004.tb00034.x]
   Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67
   Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212
NR 36
TC 84
Z9 93
U1 2
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD FEB
PY 2007
VL 15
IS 2
BP 349
EP 355
DI 10.1038/oby.2007.529
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 212OB
UT WOS:000249605600010
PM 17299107
OA Bronze
DA 2025-04-28
ER

PT J
AU Bernstein, AM
   de Koning, L
   Flint, AJ
   Rexrode, KM
   Willett, WC
AF Bernstein, Adam M.
   de Koning, Lawrence
   Flint, Alan J.
   Rexrode, Kathryn M.
   Willett, Walter C.
TI Soda consumption and the risk of stroke in men and women
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID SUGAR-SWEETENED BEVERAGES; CORONARY-HEART-DISEASE;
   CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; WEIGHT-GAIN; PRIMARY
   PREVENTION; LIFETIME RISK; DIET; OBESITY; COFFEE
AB Background: Consumption of sugar-sweetened soda has been associated with an increased risk of cardiometabolic disease. The relation with cerebrovascular disease has not yet been closely examined.
   Objective: Our objective was to examine patterns of soda consumption and substitution of alternative beverages for soda in relation to stroke risk.
   Design: The Nurses' Health Study, a prospective cohort study of 84,085 women followed for 28 y (1980-2008), and the Health Professionals Follow-Up Study, a prospective cohort study of 43,371 men followed for 22 y (1986-2008), provided data on soda consumption and incident stroke.
   Results: We documented 1416 strokes in men during 841,770 person-years of follow-up and 2938 strokes in women during 2,188,230 person-years of follow-up. The pooled RR of total stroke for >= 1 serving of sugar-sweetened soda/d, compared with none, was 1.16 (95% Cl: 1.00, 1.34). The pooled RR of total stroke for >= 1 serving of low-calorie soda/d, compared with none, was 1.16(95% CI: 1.05, 1.28), Compared with 1 serving of sugar-sweetened soda/d, 1 serving of decaffeinated coffee/d was associated with a 10% (95% Cl: 1%, 19%) lower risk of stroke and 1 serving of caffeinated coffee/d with a 9% (95% Cl: 0%, 17%) lower risk. Similar estimated reductions in risk were seen for substitution of caffeinated or decaffeinated coffee for low-calorie soda.
   Conclusions: Greater consumption of sugar-sweetened and low-calorie sodas was associated with a significantly higher risk of stroke. This risk may be reduced by substituting alternative beverages for soda. Am J Clin Nutr 2012;95:1190-9.
C1 [Bernstein, Adam M.] Cleveland Clin, Wellness Inst, Lyndhurst, OH 44124 USA.
   [Bernstein, Adam M.; de Koning, Lawrence; Flint, Alan J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Flint, Alan J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Flint, Alan J.; Willett, Walter C.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA.
   [Rexrode, Kathryn M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
C3 Cleveland Clinic Foundation; Harvard University; Harvard T.H. Chan
   School of Public Health; Harvard University; Harvard T.H. Chan School of
   Public Health; Harvard University; Harvard University Medical
   Affiliates; Brigham & Women's Hospital; Harvard University; Harvard
   University Medical Affiliates; Brigham & Women's Hospital; Harvard
   University; Harvard Medical School
RP Bernstein, AM (corresponding author), Cleveland Clin, Wellness Inst, 1950 Richmond Road,TR2-203, Lyndhurst, OH 44124 USA.
EM bernsta2@ccf.org
RI Willett, Walter/E-2352-2013; Rexrode, Kathryn/I-1177-2018
OI Rexrode, Kathryn/0000-0003-3387-8429
FU NIH, Department of Health and Human Services [P01CA087969, U19
   CA055075-20]; Harvard Human Nutrition Program
FX Supported by grants P01CA087969 and U19 CA055075-20 from the NIH,
   Department of Health and Human Services. AMB was supported through the
   Harvard Human Nutrition Program.
CR Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013
   [Anonymous], 1981, STROKE
   Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165
   Bray GA, 2007, AM J CLIN NUTR, V86, P895, DOI 10.1093/ajcn/86.4.895
   Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939
   Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Ding EL, 2006, SEMIN NEUROL, V26, P11, DOI 10.1055/s-2006-933305
   Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810
   Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238
   Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317
   Halton TL, 2006, AM J CLIN NUTR, V83, P284
   Hu FB, 1999, AM J CLIN NUTR, V70, P1001
   Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Johnson RJ, 2007, AM J CLIN NUTR, V86, P899
   Lin J, 2011, CLIN J AM SOC NEPHRO, V6, P160, DOI 10.2215/CJN.03260410
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Malik VS, 2009, AM J CLIN NUTR, V89, P438, DOI 10.3945/ajcn.2008.26980
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726
   Mostofsky E, 2010, NEUROLOGY, V75, P1583, DOI 10.1212/WNL.0b013e3181fb443d
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Mukamal KJ, 2004, AM HEART J, V147, P999, DOI 10.1016/j.ahj.2003.12.038
   Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75
   Preis SR, 2010, AM J CLIN NUTR, V91, P39, DOI 10.3945/ajcn.2009.28060
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2
   STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804
   Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
   WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
NR 42
TC 140
Z9 150
U1 3
U2 27
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD MAY
PY 2012
VL 95
IS 5
BP 1190
EP 1199
DI 10.3945/ajcn.111.030205
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 930LK
UT WOS:000303140700025
PM 22492378
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Eltahir, HM
   Alamri, G
   Alamri, A
   Aloufi, A
   Nazmy, M
   Bahashwan, S
   Elbadawy, HM
   Alahmadi, YM
   Abouzied, MM
AF Eltahir, Heba M.
   Alamri, Ghadi
   Alamri, Asmaa
   Aloufi, Asmaa
   Nazmy, Maiiada
   Bahashwan, Saleh
   Elbadawy, Hossein M.
   Alahmadi, Yaser M.
   Abouzied, Mekky M.
TI The metabolic disorders associated with chronic consumption of soft and
   energy drinks in rats
SO ACTA BIOCHIMICA POLONICA
LA English
DT Article
DE energy drinks; soft drinks; hyperglycemia; splenomegaly
ID CAFFEINE; PREVALENCE; STUDENTS; GLUCOSE; OBESITY
AB Background: Energy Drinks (EDs) and Soft Drinks (SDs) are widely consumed among adolescents and young adults. These drinks contain variable amounts of caffeine which is a central nervous system stimulator; in addition to sugar, taurine, vitamins and herbal extracts. Several adverse effects have been reported for the excessive consumption of caffeine and sugar. Aim: This work aimed at providing a comparison between the effect of chronic consumption of both drinks on metabolism biochemically as well as at the histopathological level. Methods: Adult albino rats were randomly divided into three groups and treated for 4 weeks. Animals received water (control, group 1), 12.5 ml/kg/day of either Pepsi degrees (SD, group 2) or Power Horse' (ED, group 3). All animals had free access to water and standard animal chow. Results: ED and SD groups showed a significant weight gain compared to control. ED animals showed a significant increase in serum urea, hyperlipidemia and hyperglycemia in comparison to control and SD groups. Serum uric acid significantly increased in ED and SD groups. ED group showed congestion and inflammation in their renal tissues in addition to splenomegaly and increased phagocyte infiltration. Conclusion: The high caffeine-sugar content in ED exerts a more significant influence on the metabolic pathways than SDs. Both increase the incidence of cardiovascular diseases and tissue inflammation due to their effect on lipid profile and blood glucose. The other ingredients in EDs may play a role in the observed metabolic disturbances. Chronic use of EDs should be especially discouraged to avoid these negative effects.
C1 [Eltahir, Heba M.; Abouzied, Mekky M.] Taibah Univ, Coll Pharm, Dept Pharmacol & Toxicol Subdiv Biochem, Medina, Saudi Arabia.
   [Alamri, Ghadi; Alamri, Asmaa; Aloufi, Asmaa] Taibah Univ, Coll Pharm, Medina, Saudi Arabia.
   [Nazmy, Maiiada; Abouzied, Mekky M.] Menia Univ, Fac Pharm, Dept Biochem, Al Minya, Egypt.
   [Bahashwan, Saleh; Elbadawy, Hossein M.] Taibah Univ, Coll Pharm, Dept Pharmacol & Toxicol, Medina, Saudi Arabia.
   [Alahmadi, Yaser M.] Taibah Univ, Dept Clin & Hosp Pharm, Coll Pharm, Medina, Saudi Arabia.
C3 Taibah University; Taibah University; Egyptian Knowledge Bank (EKB);
   Minia University; Taibah University; Taibah University
RP Eltahir, HM (corresponding author), Taibah Univ, Coll Pharm, Dept Pharmacol & Toxicol Subdiv Biochem, Medina, Saudi Arabia.
EM Heba_m.eltahir@yahoo.com
RI ALAHMADI, YASER/ABA-5186-2021; Eltahir, Heba/S-6533-2019; Elbadawy,
   Hossein/ABA-5272-2021
OI ALAMRI, ASMA/0009-0003-1692-1584; Abouzied, mekky/0000-0001-5309-3552;
   Elbadawy, Hossein Mostafa/0000-0001-8675-0838; Nazmy, Maiiada
   Hassan/0000-0002-5537-3432; ALAHMADI, YASER/0000-0001-6578-385X;
   eltahir, heba/0000-0003-3308-1137
CR Ali F, 2015, POSTGRAD MED, V127, P308, DOI 10.1080/00325481.2015.1001712
   Aljaloud O, 2016, AM J SPORTS SCI, V4, P6
   Altunkaynak BZ, 2007, SAUDI MED J, V28, P353
   Aluqmany R, 2013, J TAIBAH UNIV MED SC, V8, P60, DOI 10.1016/j.jtumed.2013.01.009
   Ayuob N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149191
   Boulton J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010330
   Champlin SE, 2016, J PRIM PREV, V37, P345, DOI 10.1007/s10935-016-0437-4
   Dwaidy J, 2018, HEALTH INF SCI SYST, V6, DOI 10.1007/s13755-018-0056-y
   Ebuehi O A T, 2011, Nig Q J Hosp Med, V21, P29
   Gheith I, 2017, LIFE SCI J, V14, P16
   González-Domínguez R, 2017, ELECTROPHORESIS, V38, P2313, DOI 10.1002/elps.201700044
   Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Horrigan LA, 2004, INT IMMUNOPHARMACOL, V4, P1409, DOI 10.1016/j.intimp.2004.06.005
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Ibrahim NK IR, 2014, J FOOD NUT RES, V2, P6
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576
   Kassab A.A., 2018, Egypt. J. Histol, V41, P11, DOI [10.21608/EJH.2018.7518, DOI 10.21608/EJH.2018.7518]
   Katib AA., 2018, J FOOD NUTR RES, V6, P531
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Khayyat L., 2012, The Journal of American Science, V8, P688
   Khayyat L., 2014, LIFE SCI J, V11, P1131
   Khayyat LI, 2014, J ENVIRON BIOL, V35, P883
   Macdonald IA, 2016, EUR J NUTR, V55, pS17, DOI 10.1007/s00394-016-1340-8
   Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35
   Mansy W, 2017, TROP J PHARM RES, V16, P2849, DOI 10.4314/tjpr.v16i12.8
   Mattioli AV, 2018, ANATOL J CARDIOL, V19, P422, DOI 10.14744/AnatolJCardiol.2018.25826
   Nagai R, 2014, J CLIN BIOCHEM NUTR, V55, P1, DOI 10.3164/jcbn.13-112
   Narain A, 2016, INT J CLIN PRACT, V70, P791, DOI 10.1111/ijcp.12841
   Nieradko-Iwanicka B, 2016, FAMILY MED PRIMARY C, V18, P4
   Nowak D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030544
   Nowak D, 2015, INT J ENV RES PUB HE, V12, P7910, DOI 10.3390/ijerph120707910
   Obochi G O, 2010, Niger J Physiol Sci, V25, P17
   Rahamathulla MP, 2017, PAK J MED SCI, V33, P347, DOI 10.12669/pjms.332.12084
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Sadowska J, 2012, ACTA SCI POLON-TECHN, V11, P311
   Schaefer EJ, 2009, J NUTR, V139, pS1257, DOI 10.3945/jn.108.098186
   Tofovic SP, 2007, RENAL FAILURE, V29, P891, DOI 10.1080/08860220701569846
   Ugwuja EI, 2014, ADV PHARM BULL, V4, P69, DOI 10.5681/apb.2014.011
   Unruh D, 2015, CIRCULATION, V132, P1898, DOI 10.1161/CIRCULATIONAHA.115.017313
   Zhou SS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-746
NR 41
TC 3
Z9 3
U1 1
U2 5
PU ACTA BIOCHIMICA POLONICA
PI WARSAW
PA PASTEURA 3, 02-093 WARSAW, POLAND
SN 0001-527X
EI 1734-154X
J9 ACTA BIOCHIM POL
JI Acta Biochim. Pol.
PY 2020
VL 67
IS 1
BP 79
EP 84
DI 10.18388/abp.2020_2914
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA KW0SM
UT WOS:000520883500011
PM 32191411
OA gold
DA 2025-04-28
ER

PT J
AU Crovesy, L
   Kaippert, VC
   Lopes, MCOD
   Magno, FCCM
   Fialho, E
   Rosado, EL
AF Crovesy, Louise
   Kaippert, Vanessa Chaia
   Oliveira dos Santos Lopes, Marcelly Cunha
   Carvalho Mattos Magno, Fernanda Cristina
   Fialho, Eliane
   Rosado, Eliane Lopes
TI Profile of polyphenol intake by women with different classes of obesity:
   Consumption of these compounds does not reflect healthy eating
SO NUTRITION
LA English
DT Article
DE Obesity; Polyphenol; Phenolic compounds; Food intake; Phenol-Explorer
ID DIETARY-INTAKE; POPULATION; OVERWEIGHT; SERUM
AB Objectives: The aim of this study was to evaluate polyphenol intake in women with different classes of obesity and identify which are consumed more frequently and what the food sources are.
   Methods: A cross-sectional study was conducted with 114 women with obesity. The study evaluated polyphenol intake via a 3-d food record using Phenol-Explorer. Anthropometric, biochemical, and dietetic variables were evaluated.
   Results: The women's habitual food intake was low calorie and adequate in macronutrients. Mean polyphenol intake by the group was 573 +/- 490, 614 +/- 475, and 379 +/- 25 mg/d for class I, class II, and class III obesity (P = 0.002), respectively. The most frequent food or beverage consumed by the group was coffee and caffeoylquinic acid, its phenolic compound. Fruits, vegetables, and nuts contributed the least to the intake of polyphenols.
   Conclusions: Although the diets of the study participants did include some food sources of polyphenols, they were not of sufficient quality to significantly contribute to a healthy diet; instead, they sometimes were foods may have that contributed to weight gain. Women with class III obesity consumed the most calories; however, they had low fruit, vegetable, and whole foods intake. (C) 2020 Elsevier Inc. All rights reserved.
C1 [Crovesy, Louise; Carvalho Mattos Magno, Fernanda Cristina; Rosado, Eliane Lopes] Univ Fed Rio Janeiro, Fundao Isl, Inst Nutr Josu de Castro, Dept Nutr & Dietet DND, Rio De Janeiro, Brazil.
   [Kaippert, Vanessa Chaia; Oliveira dos Santos Lopes, Marcelly Cunha] Univ Fed Rio de Janeiro, Nutr Assessment Lab, Inst Nutr Josu de Castro, Rio De Janeiro, Brazil.
   [Fialho, Eliane] Univ Fed Rio de Janeiro, Dept Basic & Expt Nutr DNBE, Inst Nutr Josu de Castro, Rio De Janeiro, Brazil.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de
   Janeiro
RP Crovesy, L (corresponding author), Univ Fed Rio Janeiro, Fundao Isl, Inst Nutr Josu de Castro, Dept Nutr & Dietet DND, Rio De Janeiro, Brazil.
EM louisecrovesy@yahoo.com.br
RI Mattos, Fernanda/J-6051-2017
OI Rosado, Eliane/0000-0003-0889-4662
FU Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de
   Janeiro; Coordcao de Aperfeicoamento de Pessoal de Nivel Superior ~
   Brasil (CAPES) [001]
FX This work was supported by the Fundaao de Amparo a Pesquisa Carlos
   Chagas Filho do Estado do Rio de Janeiro and the Coordenaao de
   Aperfeicoamento de Pessoal de Nivel Superior ~ Brasil (CAPES) ~ Finance
   code 001.The funders have no involvement in the study design,
   collection, analysis, and interpretation of data, writing of the report,
   or decision to submit the article for publication. All of the authors
   participated in the conception and design of the study, interpretation
   of the data, drafting the article and gave final approval of the version
   to be submitted. LCO was responsible for the acquisition and analysis of
   data.
CR Adriouch S, 2018, INT J OBESITY, V42, P310, DOI 10.1038/ijo.2017.227
   Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Amiot MJ, 2016, OBES REV, V17, P573, DOI 10.1111/obr.12409
   Associacao Brasileira para o Estudo da Obesidade e Sindrome Metabolica (Abeso), 2022, Obesidade e a gordofobia: Percepcoes 2022
   French National Institute for Agricultural Research (INRA), SIL PHEN EXPL DAT PO
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Karam J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191573
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   KOSTNER GM, 1979, CLIN CHEM, V25, P939
   Lee MS, 2018, MOLECULES, V23, DOI 10.3390/molecules23081853
   Liu SL, 2015, FOOD FUNCT, V6, P2779, DOI 10.1039/c5fo00626k
   LOTT JA, 1975, CLIN CHEM, V21, P1754
   MCGOWAN MW, 1983, CLIN CHEM, V29, P538
   Miranda AM, 2016, BRIT J NUTR, V115, P1061, DOI 10.1017/S0007114515005061
   Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231
   Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024
   Pérez-Jiménez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   RICHMOND W, 1973, CLIN CHEM, V19, P1350
   Schlesinger S, 2019, ADV NUTR, V10, P205, DOI 10.1093/advances/nmy092
   Sousa AG, 2015, BRIT J NUTR, V113, P1615, DOI 10.1017/S0007114515000835
   Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005
   THOMPSON FE, 1994, J NUTR, V124, pS2245, DOI 10.1093/jn/124.suppl_11.2245s
   Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008
   Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F
   WHO, 2022, LINGUIST INQ, DOI DOI 10.1162/ling_a_00422
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   World Health Organization, 2015, GUID SUG INT ADULTS, P51
   Zang YQ, 2015, FOOD FUNCT, V6, P834, DOI [10.1039/c4fo00844h, 10.1039/C4FO00844H]
NR 29
TC 5
Z9 5
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD FEB
PY 2021
VL 82
AR 111045
DI 10.1016/j.nut.2020.111045
EA JAN 2021
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA WH1LW
UT WOS:000707449600012
PM 33279359
OA Bronze
DA 2025-04-28
ER

PT J
AU Dostal, AM
   Samavat, H
   Espejo, L
   Arikawa, AY
   Stendell-Hollis, NR
   Kurzer, MS
AF Dostal, Allison M.
   Samavat, Hamed
   Espejo, Luis
   Arikawa, Andrea Y.
   Stendell-Hollis, Nicole R.
   Kurzer, Mindy S.
TI Green Tea Extract and Catechol-O-Methyltransferase Genotype
   Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a
   Randomized Controlled Trial of Overweight and Obese Postmenopausal Women
SO JOURNAL OF NUTRITION
LA English
DT Article
DE green tea extract; obesity; postmenopausal women; insulin; adiponectin
ID BREAST-CANCER; METABOLIC SYNDROME; BODY-WEIGHT; RISK; GLUCOSE; COMT;
   SUPPLEMENTATION; BIOMARKERS; PARAMETERS; RESISTANCE
AB Background: Green tea consumption has been associated with favorable changes in body weight and obesity-related hormones, although it is not known whether these changes result from green tea polyphenols or caffeine.
   Objective: We examined the impact of decaffeinated green tea extract (GTE) containing 843 mg of (-)-epigallocatechin-3-gallate on anthropometric variables, obesity-associated hormones, and glucose homeostasis.
   Methods: The Minnesota Green Tea Trial was a 12-mo randomized, double-blind, placebo-controlled clinical trial of 937 healthy postmenopausal women assigned to either decaffeinated GTE (1315 mg total catechins/d) or a placebo, stratified by catechol-O-amethyltransferase (COM7) genotype. This study was conducted in a subset of 237 overweight and obese participants [body mass index (BMI) >= 25 kg/m(2)].
   Results: No changes in energy intake, body weight, BMI, or waist circumference (WC) were observed over 12 mo in women taking GTE In = 117) or placebo In = 120). No differences were seen in circulating leptin, ghrelin, adiponectin, or glucose concentrations at month 12. Participants randomly assigned to GTE with baseline insulin >= 10 mu U/mL (n= 23) had a decrease in fasting serum insulin from baseline to month 12 (-1.43 +/- 0.59 plU/mL), whereas those randomly assigned to placebo with baseline insulin >= 10 mu IU/mL In = 19) had an increase in insulin over 12 mo (0.55 +/- 0.641.1 mu IU/mL, P< 0.01). Participants with the homozygous high-activity (G/G) form of COMT had significantly lower adiponectin (5.97 +/- 0.50 compared with 7.58 +/- 0.53 mu g/mL, P = 0.03) and greater insulin concentrations (7.63 +/- 0.53 compared with 6.18 +/- 0.36 mu lU/mL, P = 0.02) at month 12 compared with those with the low-activity (NA) genotype, regardless of treatment group.
   Conclusions: Decaffeinated GTE was not associated with reductions in body weight, BMI, or WC and did not alter energy intake or mean hormone concentrations in healthy postmenopausal women over 12 mo. GTE decreased fasting insulin concentrations in those with elevated baseline fasting concentrations. The high-activity form of the COMT enzyme may be associated with elevations in insulin and a reduction in adiponectin concentrations over time. This trial was registered at http://www.clinicaltrials.gov as NCT00917735.
C1 [Dostal, Allison M.; Samavat, Hamed; Espejo, Luis; Kurzer, Mindy S.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA.
   [Arikawa, Andrea Y.] Univ N Florida, Dept Nutr & Dietet, Jacksonville, FL USA.
   [Stendell-Hollis, Nicole R.] Cent Washington Univ, Dept Nutr Exercise & Hlth Sci, Ellensburg, WA USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   State University System of Florida; University of North Florida; Central
   Washington University
RP Kurzer, MS (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN 55108 USA.
EM mkurzer@umn.edu
RI Arikawa, Andrea/ABA-8106-2021
OI Dostal Webster, Allison/0000-0002-6467-8430; Samavat,
   Hamed/0000-0002-3545-1712
FU NIH/National Cancer Institute [R01 CA127236]; National Cancer Institute
   [T32CA132670]; Department of Defense/US Army Medical Research and
   Materiel Command [W81XWH-11-1-0013]; University of Minnesota graduate
   school doctoral dissertation fellowship; University of Minnesota
   Agricultural Experiment Station [MIN-18-103]; National Center for
   Advancing Translational Sciences of the NIH [UL1TR000114]
FX Supported by the NIH/National Cancer Institute grant R01 CA127236, award
   number T32CA132670 from the National Cancer Institute, the Department of
   Defense/US Army Medical Research and Materiel Command award number
   W81XWH-11-1-0013, the University of Minnesota graduate school doctoral
   dissertation fellowship, the University of Minnesota Agricultural
   Experiment Station project number MIN-18-103, and the National Center
   for Advancing Translational Sciences of the NIH award number
   UL1TR000114.
CR Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   [Anonymous], NATL HLTH STAT REP
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bhagwat S., 2014, USDA DATABASE FLAVON
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Dawling S, 2001, CANCER RES, V61, P6716
   Dostal AM, 2015, FOOD CHEM TOXICOL, V83, P26, DOI 10.1016/j.fct.2015.05.019
   Gao H, 2013, DIABETES, V62, P1338, DOI 10.2337/db12-0935
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Hsu Chung-Hua, 2011, Altern Med Rev, V16, P157
   Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Jurgens T.M., 2012, COCHRANE DB SYST REV, V12, P12
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   KARHUNEN T, 1994, J HISTOCHEM CYTOCHEM, V42, P1079, DOI 10.1177/42.8.8027527
   Kring SII, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006696
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Liu Y, 2007, J CLIN ENDOCR METAB, V92, P4313, DOI 10.1210/jc.2007-0890
   Mather KJ, 2014, BEST PRACT RES CL EN, V28, P107, DOI 10.1016/j.beem.2013.06.008
   Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7
   Narotzki B, 2013, J AM COLL NUTR, V32, P31, DOI 10.1080/07315724.2013.767661
   National Institutes of Health [NIH], 2007, DIET HIST QUEST VERS
   NIH, 2009, COMM TERM CRIT ADV E
   Ortsäter H, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-11
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975
   Samavat H, 2015, CANCER CAUSE CONTROL, V26, P1405, DOI 10.1007/s10552-015-0632-2
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Sarma DN, 2008, DRUG SAFETY, V31, P469, DOI 10.2165/00002018-200831060-00003
   Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534
   Shrubsole MJ, 2009, J NUTR, V139, P310, DOI 10.3945/jn.108.098699
   Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6
   Swarbrick Michael M., 2008, Metabolic Syndrome and Related Disorders, V6, P87, DOI 10.1089/met.2007.0029
   Syvanen AC, 1997, PHARMACOGENETICS, V7, P65
   U.S. Department of Agriculture (USDA 2000) Human Nutrition Research Center, 2000, CONT SURV FOOD INT I
   Vona-Davis L, 2007, OBES REV, V8, P395, DOI 10.1111/j.1467-789X.2007.00396.x
   Wang JP, 2002, CLIN EXP PHARMACOL P, V29, P419, DOI 10.1046/j.1440-1681.2002.03673.x
   Wannamethee SG, 2007, INT J OBESITY, V31, P1089, DOI 10.1038/sj.ijo.0803544
   Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu AH, 2003, CANCER RES, V63, P7526
   Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407
   Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005632
   Zamora-Ros R, 2014, J NUTR, V144, P335, DOI 10.3945/jn.113.184945
   Zhang M, 2007, CARCINOGENESIS, V28, P1074, DOI 10.1093/carcin/bgl252
NR 46
TC 66
Z9 66
U1 0
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD JAN
PY 2016
VL 146
IS 1
BP 38
EP 45
DI 10.3945/jn.115.222414
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DA3MF
UT WOS:000367701100006
PM 26581683
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Pimpley, VA
   Das, M
   Gurusiddhaiah, SK
   Murthy, PS
AF Pimpley, Vaibhavi A.
   Das, Moumita
   Gurusiddhaiah, Suresh Kumar
   Murthy, Pushpa S.
TI Modulatory effect of green coffee bioactives on high-fat diet-induced
   obesity in C57BL6 mice model
SO NUTRITION
LA English
DT Article
DE Green coffee; Polyphenols; Alkaloids; Antioxidants; Obesity; Prevention
ID BEAN EXTRACT
AB Objectives: The aim of the present study was to determine the efficacy of green coffee bioactives in ameliorating the effects of high-fat diet (HFD)-induced obesity through in vitro and in vivo assessments.
   Methods: Green coffee extract (GCE) was obtained by implementing a novel green extraction technique. The efficacy of GCE to inhibit in vitro pancreatic amylase and lipase was evaluated. Further, in vivo studies were conducted using a C57BL6 mice model grouped as starch-fed diet control, HFD control, HFD + positive control, HFD + GCE (100 mg/kg body weight), and HFD + GCE (200 mg/kg body weight). Animal body weight, diet intake, and fecal fat excretion were measured during the feeding period. On completion of the experiment, blood serum was collected for biochemical analysis, and organs were harvested for assessing the obesity-related biomarkers.
   Results: The obtained GCE was enriched with polyphenols and alkaloids. GCE led to significant (P < 0.05) in vitro inhibition of pancreatic amylase and lipase. GCE supplementation considerably prevented weight gain in treated groups post-consumption of HFD. It also led to increased fecal fat excretion and regulated the high-fat-mediated blood glucose levels. GCE effectively modulated the blood lipid profile, morphology of adipose and liver tissues, and liver antioxidant defense enzymes and resulted in hepatoprotective effects. It also downregulated the genes associated with lipid biosynthesis.
   Conclusions: GCE exhibits promising results in suppressing the consequences associated with HFD-induced obesity. It has the potential to be incorporated into food products benefiting consumer health and food industries. (c) 2023 Elsevier Inc. All rights reserved.
C1 [Pimpley, Vaibhavi A.; Murthy, Pushpa S.] CSIR, Cent Food Technol Res Inst, Dept Plantat Prod Spices & Flavour Technol, Mysore, India.
   [Pimpley, Vaibhavi A.; Das, Moumita; Gurusiddhaiah, Suresh Kumar; Murthy, Pushpa S.] Acad Scienti fi c & Innovat Res AcSIR, Ghaziabad 201002, India.
   [Gurusiddhaiah, Suresh Kumar] CSIR, Cent Food Technol Res Inst, Dept Biochem, Mysore, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Central Food Technological Research Institute (CFTRI); Council of
   Scientific & Industrial Research (CSIR) - India; CSIR - Central Food
   Technological Research Institute (CFTRI)
RP Murthy, PS (corresponding author), CSIR, Cent Food Technol Res Inst, Dept Plantat Prod Spices & Flavour Technol, Mysore, India.; Murthy, PS (corresponding author), Acad Scienti fi c & Innovat Res AcSIR, Ghaziabad 201002, India.
EM pushpa@cftri.res.in
RI Das, Moumita/JZD-6492-2024
OI Murthy, Pushpa/0000-0002-8643-1201; Das, Moumita/0009-0007-0831-2657
FU Science and Engineering Research Board (SERB) , Ministry of Food
   Processing Industries, Govt. of India [Q -11/15/2019- RD]; Department of
   Biotechnology, India
FX Authors express gratitude towards the Science and Engineering Research
   Board (SERB) , Ministry of Food Processing Industries, Govt. of India,
   grant no. Q -11/15/2019- R & D. for provision of funds to carry out the
   experiments. Ms. Vaibhavi Pimpley would like to thank Department of
   Biotechnology, India, for the award of a research fellowship. The
   authors also wish to thank the Central Instrumentation Facilities and
   Animal House Facilities, Central Food Technological Research Institute,
   for their kind help.
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Chen QP, 2014, J FUNCT FOODS, V9, P148, DOI 10.1016/j.jff.2014.03.034
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Das M, 2022, LIFE SCI, V305, DOI 10.1016/j.lfs.2022.120779
   Eo H, 2015, J AGR FOOD CHEM, V63, P349, DOI 10.1021/jf502830b
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Geetha V, 2022, J FOOD SCI TECH MYS, V59, P1649, DOI 10.1007/s13197-021-05178-2
   Johnson MH, 2016, J NUTR BIOCHEM, V31, P45, DOI 10.1016/j.jnutbio.2015.12.013
   Kumar ASM, 2022, J FOOD SCI TECH MYS, V59, P1299, DOI 10.1007/s13197-021-05138-w
   Kumar R, 2020, CURR MOL PHARMACOL, V13, P7, DOI 10.2174/1874467212666190716145210
   Mateos R, 2022, FOOD FUNCT, V13, P574, DOI [10.1039/d1fo02272e, 10.1039/D1FO02272E]
   McCue P, 2005, ASIA PAC J CLIN NUTR, V14, P145
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Pimpley V, 2020, PREP BIOCHEM BIOTECH, V50, P969, DOI 10.1080/10826068.2020.1786699
   Pimpley VA, 2021, FOOD BIOSCI, V43, DOI 10.1016/j.fbio.2021.101284
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Seliem EM, 2022, LIFE-BASEL, V12, DOI 10.3390/life12050693
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Talawar ST, 2020, J AGR FOOD RES, V2, DOI 10.1016/j.jafr.2020.100080
   Talawar ST, 2017, J AGR FOOD CHEM, V65, P9839, DOI 10.1021/acs.jafc.7b03440
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   Unuofin JO, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00810
   Valle-Martos R, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.629346
   Wu T, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4051232
   Yusni Y, 2022, Open Access Maced. J Med Sci, V10, P346
NR 26
TC 4
Z9 4
U1 2
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD NOV
PY 2023
VL 115
AR 112141
DI 10.1016/j.nut.2023.112141
EA AUG 2023
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA R3FK3
UT WOS:001063240200001
PM 37562077
DA 2025-04-28
ER

PT J
AU Peng, CH
   Liu, LK
   Chuang, CM
   Chyau, CC
   Huang, CN
   Wang, CJ
AF Peng, Chiung-Huei
   Liu, Li-Kaung
   Chuang, Chao-Ming
   Chyau, Charng-Cherng
   Huang, Chieng-Ning
   Wang, Chau-Jong
TI Mulberry Water Extracts Possess an Anti-obesity Effect and Ability To
   Inhibit Hepatic Lipogenesis and Promote Lipolysis
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Mulberry water extracts; anti-obese; hypolipidemic; lipogenesis;
   lipolysis
ID FREE FATTY-ACID; INSULIN-RESISTANCE; PHENOLIC-COMPOUNDS; ADIPOSE-TISSUE;
   OBESITY; ANTHOCYANINS; POLYPHENOL; METABOLISM; LIVER; DIET
AB Obesity plays a critical role in dyslipidemia and related disorders. Mulberry water extracts (MWEs) contain polyphenols, including gallic acid, chlorogenic acid, rutin, and anthocyanins. In this study, using 6-week-old male hamsters, we investigated the anti-obese effect of MWEs. After 12 weeks of treatment, MWEs lowered high-fat diet (HED)-induced body weight and visceral fat, accompanied with hypolipidemic effects by reducing serum triacylglycerol, cholesterol, free fatty acid, and the low-density lipoprotein (LDL)/high-density lipoprotein (HDL) ratio (n = 8 for each group). MWEs decreased hepatic lipids, thus protected livers from impairment. The hepatic peroxisome proliferator-activated receptor alpha and carnitine palmitoyltransferase-1 were elevated, while fatty acid synthase and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase were reduced by MWEs, indicating that MWEs regulated lipogenesis and lipolysis, which exerted the anti-obese and hypolipidemic effects. Noticeably, MWEs showed both efficacy and safety in vivo. In concluson, MWEs can be used to reduce body weight, serum, and liver lipids.
C1 [Liu, Li-Kaung; Wang, Chau-Jong] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung 402, Taiwan.
   [Peng, Chiung-Huei; Chuang, Chao-Ming] Hungkuang Univ, Div Basic Med Sci, Taichung 433, Shalu County, Taiwan.
   [Chyau, Charng-Cherng] Hungkuang Univ, Inst Biotechnol, Taichung 433, Shalu County, Taiwan.
   [Huang, Chieng-Ning] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung 402, Taiwan.
   [Wang, Chau-Jong] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 402, Taiwan.
C3 Chung Shan Medical University; Hungkuang University; Hungkuang
   University; Chung Shan Medical University; Chung Shan Medical University
   Hospital; Chung Shan Medical University; Chung Shan Medical University
   Hospital
RP Wang, CJ (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, 110 Sect 1,Chien Kuo N Rd, Taichung 402, Taiwan.
EM wcj@csmu.edu.tw
RI 陈, 文杰·/HHN-5495-2022
FU National Science Council (NSC), Taiwan [NSC 99-2321-B-040-001]
FX Funding for this research was provided by the National Science Council
   (NSC), Taiwan, under NSC 99-2321-B-040-001.
CR Agouni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005557
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501
   Carr MC, 2001, J CLIN ENDOCR METAB, V86, P2831, DOI 10.1210/jc.86.6.2831
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   de Jongh RT, 2004, DIABETES, V53, P2873, DOI 10.2337/diabetes.53.11.2873
   Després JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895
   Finck BN, 2002, J MOL CELL CARDIOL, V34, P1249, DOI 10.1006/jmcc.2002.2061
   Fruchart JC, 2006, DRUGS TODAY, V42, P39, DOI 10.1358/dot.2006.42.1.963528
   Gouni-Berthold I., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P513, DOI 10.2174/156800605774962022
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Huang HP, 2008, J AGR FOOD CHEM, V56, P9286, DOI 10.1021/jf8013102
   Jang A, 2008, CHEM-BIOL INTERACT, V174, P109, DOI 10.1016/j.cbi.2008.05.018
   Kang TH, 2006, NEUROSCI LETT, V391, P122, DOI 10.1016/j.neulet.2005.08.053
   Kim YW, 1999, J KOREAN MED SCI, V14, P539, DOI 10.3346/jkms.1999.14.5.539
   Koutsari C, 2006, J LIPID RES, V47, P1643, DOI 10.1194/jlr.R600011-JLR200
   La Torre GL, 2006, FOOD CHEM, V94, P640, DOI 10.1016/j.foodchem.2005.02.007
   Liu LK, 2008, J FOOD SCI, V73, pH113, DOI 10.1111/j.1750-3841.2008.00801.x
   Liu LK, 2009, J AGR FOOD CHEM, V57, P7605, DOI 10.1021/jf9014697
   MCGARRY JD, 1989, DIABETES METAB REV, V5, P271, DOI 10.1002/dmr.5610050305
   Mittendorfer B, 2009, OBESITY, V17, P1872, DOI 10.1038/oby.2009.224
   Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280
   Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812
   Prior RL, 2009, MOL NUTR FOOD RES, V53, P1406, DOI 10.1002/mnfr.200900026
   Shadid S, 2007, DIABETES, V56, P1369, DOI 10.2337/db06-1680
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Yang DJ, 2010, J AGR FOOD CHEM, V58, P2020, DOI 10.1021/jf903355q
   Yang MY, 2010, J AGR FOOD CHEM, V58, P850, DOI 10.1021/jf903209w
   Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65
   Zadernowski R, 2005, J AGR FOOD CHEM, V53, P2118, DOI 10.1021/jf040411p
NR 30
TC 163
Z9 174
U1 2
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAR 23
PY 2011
VL 59
IS 6
BP 2663
EP 2671
DI 10.1021/jf1043508
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 735GQ
UT WOS:000288401800067
PM 21361295
DA 2025-04-28
ER

PT J
AU Gan, WY
   Mohamed, SF
   Law, LS
AF Gan, Wan Ying
   Mohamed, Siti Fathiah
   Law, Leh Shii
TI Unhealthy Lifestyle Associated with Higher Intake of Sugar-Sweetened
   Beverages among Malaysian School-Aged Adolescents
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Sugar-sweetened beverages (SSBs); obesity; physical activity; screen
   time; sleep quality; fast food; Malaysian adolescents
ID PHYSICAL-ACTIVITY; SLEEP DURATION; ENERGY DRINKS; CONSUMPTION; PATTERNS;
   CHILDREN; OVERWEIGHT; DIETARY; HEALTH; ADULTS
AB High consumption of sugar-sweetened beverages (SSBs) among adolescents has turned into a global concern due to its negative impact on health. This cross-sectional study determined the amount of SSB consumption among adolescents and its associated factors. A total of 421 adolescents aged 13.3 +/- 1.3 years (41.8% males, 58.2% females) completed a self-administered questionnaire on sociodemographic characteristics, physical activity, screen-viewing behavior, sleep quality, frequency of eating at fast food restaurants, home food availability, peer social pressure, parenting practice, and SSB consumption. Weight and height were measured. Results showed that the mean daily consumption of SSBs among adolescents was 1038.15 +/- 725.55 mL. The most commonly consumed SSB was malted drink, while the least commonly consumed SSB was instant coffee. The multiple linear regression results revealed that younger age (beta = -0.204, p < 0.001), higher physical activity (beta = 0.125, p = 0.022), higher screen time (beta = 0.147, p = 0.007), poorer sleep quality (beta = 0.228, p < 0.001), and unhealthy home food availability (beta = 0.118, p = 0.032) were associated with a higher SSB intake. Therefore, promoting a healthy lifestyle may help to reduce the excessive consumption of SSBs among adolescents.
C1 [Gan, Wan Ying; Mohamed, Siti Fathiah; Law, Leh Shii] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Malaysia.
C3 Universiti Putra Malaysia
RP Gan, WY (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Malaysia.
EM wanying@upm.edu.my
RI Law, LehShii/Z-1798-2019; MOHAMED, SITI/AAD-1026-2020; Gan, Wan
   Ying/N-2445-2019
OI Law, Leh Shii/0000-0002-7526-9317; MOHAMED, SITI
   FATHIAH/0000-0002-4547-4977; Gan, Wan Ying/0000-0002-9016-3414
CR Ambrosini GL, 2013, AM J CLIN NUTR, V98, P327, DOI 10.3945/ajcn.112.051383
   Azian N.M.Z., 2016, INT J PUBLIC HLTH RE, V6, P670
   Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974
   Bleich Sara N, 2018, BMC Obes, V5, P6, DOI 10.1186/s40608-017-0178-9
   Bogart LM, 2013, ACAD PEDIATR, V13, P348, DOI 10.1016/j.acap.2013.02.009
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Dan S P Jr, 2007, Malays J Nutr, V13, P109
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Bibiloni MD, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070389
   Gebremariam MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171537
   Ha K, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010031
   Hardy LL, 2018, AUST NZ J PUBL HEAL, V42, P22, DOI 10.1111/1753-6405.12749
   Haughton CF, 2018, J PEDIATR-US, V202, P121, DOI 10.1016/j.jpeds.2018.06.046
   Institute for Public Health (IPH), 2012, NAT HLTH MORB SURV M
   Institute of Public Health (IPH), 2014, MAL AD NUTR SURV MAN, VII
   Institute of Public Health (IPH), 2011, NONC DIS, V2
   Kenney EL, 2017, J PEDIATR-US, V182, P144, DOI 10.1016/j.jpeds.2016.11.015
   Kowalski KC, 2004, PHYS ACTIVITY QUESTI
   Kremers S, 2013, CHILD OBES, V9, pS22, DOI 10.1089/chi.2013.0026
   Larson N, 2014, J NUTR EDUC BEHAV, V46, P181, DOI 10.1016/j.jneb.2014.02.008
   Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P222, DOI 10.1017/S1368980009990760
   Lee Haeng-Shin, 2013, Clin Nutr Res, V2, P135, DOI 10.7762/cnr.2013.2.2.135
   Loh DA, 2017, PEDIATR OBES, V12, pE1, DOI 10.1111/ijpo.12108
   Luszczynska A, 2013, J YOUTH ADOLESCENCE, V42, P1873, DOI 10.1007/s10964-013-9908-6
   Ma JT, 2014, J NUTR, V144, P1283, DOI 10.3945/jn.113.188599
   Mai BH, 2019, DIABETES METAB SYNDR, V12, P821, DOI 10.2147/DMSO.S198968
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Mesirow MSC, 2015, J ACAD NUTR DIET, V115, P559, DOI 10.1016/j.jand.2014.09.004
   Mohamed HJBJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2666-5
   Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536
   Pérez-Farinós N, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3962-4
   Prather AA, 2016, SLEEP HEALTH, V2, P272, DOI 10.1016/j.sleh.2016.09.007
   Qobadi M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030228
   Ranjit N, 2010, PEDIATRICS, V126, pE754, DOI 10.1542/peds.2010-1229
   Sampasa-Kanyinga H, 2018, NUTRITION, V48, P77, DOI 10.1016/j.nut.2017.11.013
   Tak NI, 2011, APPETITE, V56, P503, DOI 10.1016/j.appet.2011.01.013
   van Ansem WJC, 2014, BRIT J NUTR, V112, P467, DOI 10.1017/S0007114514001007
   van de Gaar VM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4095-0
   Wang H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021493
   Winpenny EM, 2017, OBES REV, V18, P1336, DOI 10.1111/obr.12588
   Xi B, 2015, BRIT J NUTR, V113, P709, DOI 10.1017/S0007114514004383
   Yang LL, 2017, AM J PUBLIC HEALTH, V107, P1095, DOI 10.2105/AJPH.2017.303762
   Yunus RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180222
NR 43
TC 32
Z9 32
U1 1
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG 1
PY 2019
VL 16
IS 15
AR 2785
DI 10.3390/ijerph16152785
PG 13
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA IS4MU
UT WOS:000482128400154
PM 31382672
OA Green Published, Green Accepted, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Imada, S
   Tanaka, A
   Nishiumi, S
   Ashida, H
AF Imada, Sayuri
   Tanaka, Akihito
   Nishiumi, Shin
   Ashida, Hitoshi
TI Concentration of Catechins and Caffeine in Black Tea Affects Suppression
   of Fat Accumulation and Hyperglycemia in High-fat Diet-fed Mice
SO FOOD SCIENCE AND TECHNOLOGY RESEARCH
LA English
DT Article
DE black tea; glucose transporter 4; insulin receptor-beta; high-fat diet
ID GLUT4 GLUCOSE-TRANSPORTER; GREEN TEA; INSULIN-RESISTANCE;
   SKELETAL-MUSCLE; (-)-EPIGALLOCATECHIN GALLATE; LIPID-ACCUMULATION;
   3T3-L1 CELLS; EXPRESSION; OBESITY; KINASE
AB In this study, we investigated preventive effects of black tea on obesity and hyperglycemia in C57BL/6 mice fed a high-fat diet for 14 weeks. During the feeding period, mice were given the following black teas: BT1 containing 3,000 mg/L total catechins and 864 mg/L caffeine; and BT2 containing 1,437 mg/L total catechins and 594 mg/L caffeine. Both BT1 and BT2 suppressed high-fat diet-caused body weight gain, deposition of white adipose tissue, and increases in plasma lipids and glucose. Moreover, both BT1 and BT2 counteracted the high-fat diet-caused decrease in the expression of insulin receptor (IR)-beta and glucose transporter 4 (GLUT4), markers for insulin resistance. Of these effects, BT2 were stronger than that of BT1. In conclusion, black tea prevents hyperglycemia and insulin resistance through maintenance of IR-beta and GLUT4 expression in high-fat diet-fed mice, with an appropriate concentration of tea producing maximal effectiveness.
C1 [Imada, Sayuri; Tanaka, Akihito; Nishiumi, Shin; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan.
   [Nishiumi, Shin] Kobe Univ, Grad Sch Med, Dept Internal Med, Chuo Ku, Kobe, Hyogo 6500017, Japan.
C3 Kobe University; Kobe University
RP Ashida, H (corresponding author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.
EM ashida@kobe-u.ac.jp
RI Nishiumi, Shin/ABD-5775-2020; Tanaka, Akihito/ABD-2596-2021
FU Creation of Innovation Centers for Advanced Interdisciplinary Research
   Areas (Innovative Bioproduction Kobe), MEXT, Japan
FX This study was supported by Special Coordination Funds for Promoting
   Science and Technology, Creation of Innovation Centers for Advanced
   Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT,
   Japan.
CR Akiba T, 2004, BIOCHEM PHARMACOL, V68, P1929, DOI 10.1016/j.bcp.2004.07.036
   Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   BARON AD, 1988, AM J PHYSIOL, V255, P768
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Bruno RS, 2008, J NUTR, V138, P323, DOI 10.1093/jn/138.2.323
   Choi Kangduk, 2010, Korean Journal of Internal Medicine, V25, P119, DOI 10.3904/kjim.2010.25.2.119
   DeFronzo RA, 1997, DIABETES REV, V5, P177
   Dey D, 2007, BIOCHEM BIOPH RES CO, V357, P474, DOI 10.1016/j.bbrc.2007.03.183
   Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Formiguera X, 2004, BEST PRACT RES CL GA, V18, P1125, DOI 10.1016/j.bpg.2004.06.030
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329
   Guo L, 2006, PHARMACOL THERAPEUT, V111, P145, DOI 10.1016/j.pharmthera.2005.10.009
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006
   Johansson SM, 2007, BIOCHEM PHARMACOL, V74, P1628, DOI 10.1016/j.bcp.2007.08.006
   KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Lapidot TM, 2002, J AGR FOOD CHEM, V50, P7220, DOI 10.1021/jf020615a
   León D, 2005, NEUROSCIENCE, V131, P481, DOI 10.1016/j.neuroscience.2004.11.028
   Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200
   Lin J, 2005, OBES RES, V13, P982, DOI 10.1038/oby.2005.115
   Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138
   Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   Nakagawa K, 2009, BIOSCI BIOTECH BIOCH, V73, P2014, DOI 10.1271/bbb.90195
   Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342
   Nishiumi S, 2010, J AGR FOOD CHEM, V58, P12916, DOI 10.1021/jf102840w
   Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939
   Robinson LE, 2004, J NUTR, V134, P2528, DOI 10.1093/jn/134.10.2528
   Ueda M, 2008, BIOCHEM BIOPH RES CO, V377, P286, DOI 10.1016/j.bbrc.2008.09.128
   VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172/JCI117104
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu BT, 2005, J AGR FOOD CHEM, V53, P5695, DOI 10.1021/jf050045p
   Xiao DM, 2000, J NEUROCHEM, V74, P392, DOI 10.1046/j.1471-4159.2000.0740392.x
   YOUNGS G, 1972, GUT, V13, P154, DOI 10.1136/gut.13.2.154
   Zorzano A, 2005, ACTA PHYSIOL SCAND, V183, P43, DOI 10.1111/j.1365-201X.2004.01380.x
NR 38
TC 6
Z9 6
U1 0
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1344-6606
J9 FOOD SCI TECHNOL RES
JI Food Sci. Technol. Res.
PD JUL
PY 2011
VL 17
IS 4
BP 353
EP 359
DI 10.3136/fstr.17.353
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 817CN
UT WOS:000294648500013
OA Bronze
DA 2025-04-28
ER

PT J
AU McMenamin, JP
   Tiglio, AD
AF McMenamin, Joseph P.
   Tiglio, Andrea D.
TI Not the next tobacco: Defenses to obesity claims
SO FOOD AND DRUG LAW JOURNAL
LA English
DT Review
ID BODY-MASS INDEX; NUTRITION EXAMINATION SURVEY; INCREASED DOPAMINE
   RELEASE; MEDIAL FOREBRAIN-BUNDLE; PLASMA GHRELIN LEVELS; HUMAN
   COFFEE-DRINKING; SEDENTARY LIFE-STYLE; FAT DIETARY PATTERN; INDUCED
   WEIGHT-GAIN; PHYSICAL-ACTIVITY
C1 McGuireWoods LLP, Richmond, VA USA.
   McGuireWoods LLP, Mclean, VA USA.
RP McMenamin, JP (corresponding author), McGuireWoods LLP, Richmond, VA USA.
CR Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197
   Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0
   Ahmed SH, 1997, PSYCHOPHARMACOLOGY, V132, P289, DOI 10.1007/s002130050347
   AHREN B, 1991, CELL TISSUE RES, V264, P263, DOI 10.1007/BF00313963
   Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179
   Alderman J, 2006, AM J PREV MED, V30, P82, DOI 10.1016/j.amepre.2005.08.036
   Allison DB, 1996, INT J OBESITY, V20, P501
   Allison DB, 2001, J CLIN PSYCHIAT, V62, P22
   *AM AC PED COUNC S, 1835, PEDIATRICS, V17, P1834
   [Anonymous], 2000, Diagnostic ans Statistical Manual of Mental Disorders, V4th, P191
   [Anonymous], 2002, FAST FOOD NATION DAR
   [Anonymous], 1997, WHO TECHN REP SER
   [Anonymous], HEART DIS STROK STAT
   [Anonymous], 1997, HIST PSYCHIAT
   [Anonymous], PREV CHILDH OB HLTH
   [Anonymous], WALL STREET J 1124
   [Anonymous], 2004, MMWR-MORBID MORTAL W, V53, P82
   Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206
   Arif AA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-126
   ASCHERIO A, 1999, T FATTY ACIDS CORONA, V340, P1933
   ASIMOV N, 2006, SAN FRANCISCO C 0608, pB1
   Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5
   Babey SH., 2005, Access to safe parks helps increase physical activity among teenagers, P1
   BADMAN MK, 2005, SCI, V307, P1904
   Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0
   BAKER DP, 1997, WASH POST       0531, pA3
   BALE J, 2005, LONDON TIMES    1219
   Balk EM, 2006, ATHEROSCLEROSIS, V184, P237, DOI 10.1016/j.atherosclerosis.2005.06.042
   BANZHAF J, 2003, COMMUNICATION   0619
   Baptista T, 2004, CURR DRUG TARGETS, V5, P279, DOI 10.2174/1389450043490514
   Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423
   Barnes P.M., 2003, Advanced data from vital and health statistics, V333, P1
   BARNES PM, 2003, ADV DATA VITAL HLTH, V333, P19
   Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519
   Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204
   Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151
   BELANGER A, 1988, FRAMINGHAM PUBLICATI
   BELL CG, 2004, RECENT PROG HORM RES, V59, P409
   BELL CG, 2003, OBES REV, V4, P139
   BELL CG, 2005, NATURE REV GENETICS, P221
   BENNETT WI, 1995, NEW ENGL J MED, V332, P673, DOI 10.1056/NEJM199503093321009
   Benoit SC, 2002, J NEUROSCI, V22, P9048
   Berg K, 2005, AM J HUM GENET, V77, P519
   Bernstein IM, 2005, OBSTET GYNECOL, V106, P986, DOI 10.1097/01.AOG.0000182580.78402.d2
   Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8
   BERTINO M, 1991, AM J PHYSIOL, V261, pR59, DOI 10.1152/ajpregu.1991.261.1.R59
   Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41
   BIRCH LL, 1980, CHILD DEV, V51, P489, DOI 10.2307/1129283
   Bjorntorp P, 1996, INT J OBESITY, V20, P291
   Björntorp P, 2001, LANCET, V358, P1006, DOI 10.1016/S0140-6736(01)06110-4
   BJORNTORP P, 1970, METABOLIS, V19, P631, DOI 10.1016/0026-0495(70)90020-X
   Blair SN, 2002, MAYO CLIN PROC, V77, P109
   Bloche MG, 2005, GEORGETOWN LAW J, V93, P1335
   BLOCHE MG, 2005, GEORGETOWN, V93, P1341
   Blum K, 1996, PHARMACOGENETICS, V6, P297, DOI 10.1097/00008571-199608000-00003
   Blum K, 1996, AM SCI, V84, P132
   BLUM K, 2000, PSYCHOACTIVE DRUGS S, V32, P1
   BLUNDELL J, 1991, TRENDS PHARMACOL SCI, V12, P147, DOI 10.1016/0165-6147(91)90532-W
   Blundell JE, 2000, BRIT J NUTR, V83, pS33
   Bolton R.N., 1983, CURRENT ISSUES RES A, P173
   BOLTON RN, 1983, CURRENT ISSUES RES A, V6, P187
   BORAHGIDDENS J, 1993, J NUTR EDUC, V25, P102
   BOUCHARD C, 1990, INT J OBESITY, V14, P57
   BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101
   Bouchard Claude., 1994, The Genetics of Obesity
   Branson R, 2003, NEW ENGL J MED, V348, P1096, DOI 10.1056/NEJMoa021971
   Breen FM, 2006, PHYSIOL BEHAV, V88, P443, DOI 10.1016/j.physbeh.2006.04.016
   Brooks GA, 2004, AM J CLIN NUTR, V79, P921
   BROWN D, 2002, WASH POST       0408, pA2
   BROWN ER, 2005, HALF CALIFORNIA ADUL, P1
   BURGESON CR, 2003, J PHYS ED REC DANCE, V174, P20
   BURGESON CR, 2001, J SCH HLTH, V71, P292
   BURNS DM, 1991, CLIN CHEST MED, V12, P631
   BURTZOS FM, 2004, COLO LAWYER, V33, P53
   Butler LM, 2004, AM J RESP CRIT CARE, V170, P279, DOI 10.1164/rccm.200306-789OC
   BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306
   BUTTERFIELD PS, 1988, ADDICT BEHAV, V13, P131, DOI 10.1016/0306-4603(88)90002-0
   CABANAC M, 1970, SCIENCE, V168, P496, DOI 10.1126/science.168.3930.496
   CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103
   Cannon CM, 2003, J NEUROSCI, V23, P10827
   Cannon CM, 2004, PHYSIOL BEHAV, V81, P741, DOI 10.1016/j.physbeh.2004.04.020
   CAPLAN PH, 1995, THEY SAY YOURE CRAZY, P85
   Carelli RM, 2000, J NEUROSCI, V20, P4255
   CARMONA RH, 2003, AM ENT I OB C WASH D
   Castañeda TR, 2005, J NUTR, V135, P1314, DOI 10.1093/jn/135.5.1314
   *CDC, 2002, MMWR-MORBID MORTAL W, V300, P51
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P785
   Challis BG, 2000, DIABETES, V49, P872, DOI 10.2337/diabetes.49.5.872
   Chandler KE, 2003, J MED GENET, V40, P233, DOI 10.1136/jmg.40.4.233
   Chaput JP, 2006, INT J OBESITY, V30, P1080, DOI 10.1038/sj.ijo.0803291
   Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489
   Chin-Chance C, 2000, J CLIN ENDOCR METAB, V85, P2685, DOI 10.1210/jc.85.8.2685
   Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003
   Christakis DA, 2004, J PEDIATR-US, V145, P652, DOI 10.1016/j.jpeds.2004.06.078
   Clément K, 1998, NATURE, V392, P398, DOI 10.1038/32911
   Clement Karine, 2002, Am J Pharmacogenomics, V2, P177, DOI 10.2165/00129785-200202030-00003
   Cochran RF., 2000, Pepp L Rev, V27, P701
   Cogan JC, 1999, J SOC ISSUES, V55, P187, DOI 10.1111/0022-4537.00112
   Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66
   COLEMAN DL, 1979, SCIENCE, V203, P663, DOI 10.1126/science.760211
   Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867
   COMMUZZIE A, 1997, NAT GENET, V15, P1
   Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273
   CONNELLY M, 2003, NY TIMES        0513, pF5
   Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527
   Coombes Rebecca., 2004, British Medical Journal, V328, P1572
   COOMBS R, 2001, TEX BAR J, V64, P166
   COOMBS R, 2001, TEX BAR J, V64, P171
   Crawford FranklinE., 2002, Ohio St LJ, V63, P1165
   Crespo CJ, 2001, ARCH PEDIAT ADOL MED, V155, P360, DOI 10.1001/archpedi.155.3.360
   CULTER DM, 2003, EC PERSP, V17, P97
   Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714
   Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908
   CUPP RL, 1998, U KAN L REV, V46, P465
   Curtis KM, 1997, AM J EPIDEMIOL, V146, P32, DOI 10.1093/oxfordjournals.aje.a009189
   CUSTOMS JE, 2003, BMJ-BRIT MED J, V326, P326
   Cutler DM, 2003, J ECON PERSPECT, V17, P93, DOI 10.1257/089533003769204371
   CUTLER DM, 2003, 9446 NAT BUR EC RES
   Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208
   Dansicker AndrewM., 2004, MD BJ, V37, P12
   Datar A, 2004, AM J PUBLIC HEALTH, V94, P1501, DOI 10.2105/AJPH.94.9.1501
   Davidson M, 2006, J ADV NURS, V54, P342, DOI 10.1111/j.1365-2648.2006.03812.x
   Davis C, 2004, APPETITE, V42, P131, DOI 10.1016/j.appet.2003.07.004
   DECASTRO JM, 1991, PHYSIOL BEHAV, V50, P729, DOI 10.1016/0031-9384(91)90010-L
   DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P777, DOI 10.1016/0031-9384(93)90188-L
   DECASTRO JM, 1993, PHYSIOL BEHAV, V54, P633, DOI 10.1016/0031-9384(93)90070-V
   DeCastro JM, 1996, NEUROSCI BIOBEHAV R, V20, P119, DOI 10.1016/0149-7634(95)00047-I
   DECASTRO JM, 1995, PHYSIOL BEHAV, V57, P439, DOI 10.1016/0031-9384(94)00232-T
   DECASTRO JM, 1991, PHYSIOL BEHAV, V50, P243, DOI 10.1016/0031-9384(91)90527-U
   DECASTRO JM, 1989, AM J CLIN NUTR, V50, P237, DOI 10.1093/ajcn/50.2.237
   DECASTRO JM, 1994, PHYSIOL BEHAV, V56, P445, DOI 10.1016/0031-9384(94)90286-0
   Dennison BA, 2002, PEDIATRICS, V109, P1028, DOI 10.1542/peds.109.6.1028
   DERTHICK MA, 2002, SMOKE LEGISLATION LI, P39
   Deshmukh R, 2003, CLEV CLIN J MED, V70, P614, DOI 10.3949/ccjm.70.7.614
   Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741
   DEVEREUX M, 2004, NZ HERALD       0717
   Dhurandhar NV, 2002, J NUTR, V132, P3155, DOI 10.1093/jn/131.10.3155
   Dietz WH, 1997, J NUTR, V127, pS1884, DOI 10.1093/jn/127.9.1884S
   DIETZ WH, 1985, PEDIATRICS, V75, P807
   DOLE VP, 1986, ALCOHOL CLIN EXP RES, V10, P361, DOI 10.1111/j.1530-0277.1986.tb05107.x
   Dorey G, 2001, Br J Nurs, V10, P455
   DUENWALD M, 2005, NY TIMES        0816, pF5
   Duggirala R, 1996, AM J HUM GENET, V59, P694
   DYR W, 1993, ALCOHOL, V10, P207, DOI 10.1016/0741-8329(93)90037-O
   DYRENFORTH SR, 1980, WOMANS CONFLICT SPEC
   EDELSTEIN EL, 1973, BRIT J ADDICT, V68, P365
   Eisenmann JC, 2002, OBES RES, V10, P379, DOI 10.1038/oby.2002.52
   Engell D., 1991, THIRST PHYSL PSYCHOL, P382
   Epstein LH, 2000, ARCH PEDIAT ADOL MED, V154, P220, DOI 10.1001/archpedi.154.3.220
   Epstein LH, 2005, AM J CLIN NUTR, V81, P361
   Epstein RA, 2005, GEORGETOWN LAW J, V93, P1361
   Eyny YS, 2003, J NEUROSCI, V23, P1584
   Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200
   Faivre L, 2002, J MED GENET, V39, P594, DOI 10.1136/jmg.39.8.594
   Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0
   Farooqi IS, 2005, BEST PRACT RES CL EN, V19, P359, DOI 10.1016/j.beem.2005.04.004
   Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204
   Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050
   Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693
   Farrell SW, 2002, OBES RES, V10, P417, DOI 10.1038/oby.2002.58
   Fava M, 2000, J CLIN PSYCHIAT, V61, P863, DOI 10.4088/JCP.v61n1109
   Fava M, 2000, J CLIN PSYCHIAT, V61, P37
   FELDER RA, 1989, AM J PHYSIOL, V257, pF315, DOI 10.1152/ajprenal.1989.257.3.F315
   Feldman DE, 2003, ARCH PEDIAT ADOL MED, V157, P797, DOI 10.1001/archpedi.157.8.797
   Fernández JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124
   Field AE, 2004, INT J OBESITY, V28, P1210, DOI 10.1038/sj.ijo.0802762
   FIELD J, 1980, METABOLISM, V29, P296, DOI 10.1016/0026-0495(80)90072-4
   Firestone A, 2005, MED J AUSTRALIA, V182, P652, DOI 10.5694/j.1326-5377.2005.tb06860.x
   Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407
   FLINT A, 2001, BOSTON GLOBE    1008, pB2
   Flynn MC, 1999, PHYSIOL BEHAV, V65, P901
   Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011
   FRENCH SA, 2001, ANNU REV PUBL HEALTH, V22, P319
   FRIEDMAN J, 2004, NAT MED, V10, P567
   Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563
   Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856
   Friedman SL, 2003, ARCH PEDIAT ADOL MED, V157, P185
   FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949
   GAESSER G, 2002, BIG FAT LIES TRUTH Y, P75
   Gale SM, 2004, J NUTR, V134, P295, DOI 10.1093/jn/134.2.295
   Gardner E, 1997, SUBSTANCE ABUSE COMP
   GARDNER EL, 1999, ADDICTION ENTRIES EX, P80
   GARDNER EL, 1999, ADDICTION ENTRIES EX, P59
   GARN SM, 1986, AM J CLIN NUTR, V43, P879, DOI 10.1093/ajcn/43.6.879
   GARN SM, 1985, AM J DIS CHILD, V139, P181, DOI 10.1001/archpedi.1985.02140040083033
   GARNER DW, 1977, EMORY LAW J, V26, P269
   GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673
   GERACI C, 2004, EDITOR PUBLISHE 0524
   Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461
   GILLMAN MW, 2003, PEDIATRICS, V111, P3
   Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0
   GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1
   Glazer G, 2001, ARCH INTERN MED, V161, P1814, DOI 10.1001/archinte.161.15.1814
   GOLD M, 2003, PSYCHIAT ANN, V33, P118
   Gold MS, 2003, PSYCHIAT ANN, V33, P117, DOI 10.3928/0048-5713-20030201-08
   GONUL AS, 2004, YENI S, V42, P139
   GOODRICH K, 1999, DRUGS SOC, V15, P124
   Gordon C.J., 1993, TEMPERATURE REGULATI
   Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003
   GRAHAM A, 1992, J CONTEMP PSYCHOTHER, V22, P28
   Graham A., 1992, Journal of Contemporary Psychotherapy, V22, P21, DOI [10.1007/BF00952339, DOI 10.1007/BF00952339]
   Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732
   GRATTON A, 1994, J NEUROSCI, V14, P4130
   Gratton A, 1996, J PSYCHIATR NEUROSCI, V21, P264
   GRAY S, 2004, WALL ST J       1214, pD1
   Greenway F, 2006, AM J PHYSIOL-REG I, V290, pR188, DOI 10.1152/ajpregu.00607.2005
   Guo SS, 2000, INT J OBESITY, V24, P1628, DOI 10.1038/sj.ijo.0801461
   Hackshaw AK, 1997, BMJ-BRIT MED J, V315, P980, DOI 10.1136/bmj.315.7114.980
   Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003
   Haney M, 1997, PSYCHOPHARMACOLOGY, V132, P311, DOI 10.1007/s002130050350
   HARDY SC, 1994, J PEDIATR-US, V125, pS69, DOI 10.1016/S0022-3476(06)80739-0
   HARPER LV, 1975, J EXP CHILD PSYCHOL, V20, P206, DOI 10.1016/0022-0965(75)90098-3
   Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008
   Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194
   HEDIGER ML, 2004, JAMA-J AM MED ASSOC, V285, P2453
   Hellström PM, 2004, BRIT J NUTR, V92, pS47, DOI 10.1079/BJN20041142
   Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779
   Hernán MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277
   HERNANDEZ L, 1990, BRAIN RES BULL, V25, P975, DOI 10.1016/0361-9230(90)90197-8
   HERNANDEZ L, 1988, PHYSIOL BEHAV, V44, P599, DOI 10.1016/0031-9384(88)90324-1
   HILL JO, 2003, SCI, V301, P598
   HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375
   Holder JL, 2000, HUM MOL GENET, V9, P101
   Howard BV, 1997, CIRCULATION, V95, P2591, DOI 10.1161/01.CIR.95.11.2591
   Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655
   Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785
   *I MED, 2001, DIET REF INT, P142
   *I MED, 2005, FOOD MARK CHILD YOUT
   IARC, 2002, IARC MON EV CARC RIS, V83
   JAFF D, 2004, CAT POL FOR JUN 7
   Jensen CL, 2002, CLIN PERINATOL, V29, P261, DOI 10.1016/S0095-5108(02)00010-6
   Jéquier E, 1999, AM J CLIN NUTR, V69, P173
   JOHNS E, 2004, STAR TRIB       0209, pA6
   JOHNSON SL, 1994, PEDIATRICS, V94, P653
   *KAIS FDN, 2000, ISS BRIEF ROL MED CH
   KALIVAS PW, 1993, J NEUROSCI, V13, P266
   KALRA SP, 1991, PHYSIOL BEHAV, V50, P5, DOI 10.1016/0031-9384(91)90490-F
   KALRA SP, 1991, P NATL ACAD SCI USA, V88, P10931, DOI 10.1073/pnas.88.23.10931
   Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092
   Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293
   Katsoulis S, 1996, SCAND J GASTROENTERO, V31, P446, DOI 10.3109/00365529609006763
   KATZENSTEIN AW, 1992, ENVIRON INT, V18, P341, DOI 10.1016/0160-4120(92)90064-B
   Kawachi I, 1999, J CLIN PSYCHIAT, V60, P5
   KEEFE KA, 1992, NEUROSCIENCE, V47, P325, DOI 10.1016/0306-4522(92)90248-Z
   KEESEY RE, 1984, EATING ITS DISORDERS, P87
   Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015
   Kimm SYS, 2005, LANCET, V366, P301, DOI 10.1016/S0140-6736(05)66837-7
   Kimmel HL, 2002, NEUROPEPTIDES, V36, P9, DOI 10.1054/npep.2002.0884
   King C, 2001, NEW ENGL J MED, V345, P504, DOI 10.1056/NEJMsa003149
   Kleiner KD, 2004, J ADDICT DIS, V23, P105, DOI 10.1300/J069v23n03_08
   Koeppen-Schomerus G, 2001, INT J OBESITY, V25, P838, DOI 10.1038/sj.ijo.0801589
   Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004
   KOOB GF, 1988, SCI, V4, P716
   Korner J, 2004, J CLIN ENDOCR METAB, V89, P2616, DOI 10.1210/jc.2004-0341
   KRAMER MS, 1985, J PEDIATR-US, V107, P104, DOI 10.1016/S0022-3476(85)80627-2
   Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94
   KRONDL M, 1982, J AM DIET ASSOC, V80, P523
   Kruk ZL, 1998, J NEUROSCI METH, V79, P9, DOI 10.1016/S0165-0270(97)00156-8
   KUNKEL D, 1992, J COMMUN, V42, P134, DOI 10.1111/j.1460-2466.1992.tb00803.x
   KWON HY, 1994, P NATL ACAD SCI USA, V91, P9760, DOI 10.1073/pnas.91.21.9760
   LAFETRA DJ, 2003, IND L REV, V36, P645
   LAKDAWALLA D, 2002, NBER WORKING PAPER, V8946, P2
   LAMARCHE B, 1992, METABOLISM, V41, P1249, DOI 10.1016/0026-0495(92)90017-5
   Lanza E, 2001, AM J CLIN NUTR, V74, P387
   Larsen TM, 2003, INT J OBESITY, V27, P147, DOI 10.1038/sj.ijo.802223
   Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973
   Lee CD, 1999, AM J CLIN NUTR, V69, P373
   LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001
   LEIBEL RL, 1990, WORLD REV NUTR DIET, V63, P90
   LEVINE HG, 1979, STUDIES ALCOHOL, V15, P493
   Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561
   Levine JA, 2003, P NUTR SOC, V62, P667, DOI 10.1079/PNS2003281
   Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227
   Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212
   Lichtenstein AH, 1998, NUTR REV, V56, pS3
   Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158
   Lipanovich A., 2005, Golden Gate L Rev, V35, P429
   Livingstone MBE, 2003, P NUTR SOC, V62, P681, DOI 10.1079/PNS2003291
   LONGMORE M, 2002, OXFORD HDB CLIN MED, P232
   Lowinson J.H., 1997, SUBSTANCE ABUSE COMP
   Lowry R, 2002, J SCHOOL HEALTH, V72, P413, DOI 10.1111/j.1746-1561.2002.tb03551.x
   LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0
   Ludwig DS, 2004, LANCET, V364, P226, DOI 10.1016/S0140-6736(04)16688-9
   MAGID B, 1995, J PSYCHOTHERAP PRAC, V4, P8
   Marchal-Victorion S, 2002, PHARMACOGENETICS, V12, P23, DOI 10.1097/00008571-200201000-00004
   MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374
   Marlett G. A., 1985, RELAPSE PREVENTION M
   Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706
   MARTIN M, 2003, CHICAGO TRIBUNE 1101, P9
   Martínez-González MA, 1999, INT J OBESITY, V23, P1192, DOI 10.1038/sj.ijo.0801049
   Masuzaki Hiroaki, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P255
   Matson CA, 2000, AM J PHYSIOL-REG I, V278, pR882, DOI 10.1152/ajpregu.2000.278.4.R882
   MCCARTY MF, 1995, MED HYPOTHESES, V45, P193, DOI 10.1016/0306-9877(95)90068-3
   MELCHIOR JC, 1991, PHYSIOL BEHAV, V49, P1217, DOI 10.1016/0031-9384(91)90354-Q
   Mello MM, 2003, HEALTH AFFAIR, V22, P207, DOI 10.1377/hlthaff.22.6.207
   Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39
   MILLER NS, 1993, PSYCHIAT CLIN N AM, V16, P105
   Miltenberger RJ, 1997, J NUTR, V127, pS1902, DOI 10.1093/jn/127.9.1902S
   MITTENBERGER RJ, 1997, J NUTR, V127, pS1902
   Mogenson G.J., 1982, The neural basis of feeding and reward, P275
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   Moore H, 1999, BIOL PSYCHIAT, V46, P40, DOI 10.1016/S0006-3223(99)00078-5
   MORRISEY S, 2004, ABA J EREPORT, P11
   MORSE RM, 1992, JAMA-J AM MED ASSOC, V268, P1012, DOI 10.1001/jama.268.8.1012
   Moyad M A, 2001, Semin Urol Oncol, V19, P247
   Munger LeeJ., 2004, Conn Pub Intl LJ, V3, P456
   MUNGER LJ, 2004, CONN PUB INT LJ, V3, P478
   Murphy KG, 2004, EXP PHYSIOL, V89, P507, DOI 10.1113/expphysiol.2004.027789
   Nagai K, 2003, EXP BIOL MED, V228, P1138, DOI 10.1177/153537020322801007
   Nagareda RA, 1998, MICH LAW REV, V96, P1121, DOI 10.2307/1290177
   *NCHS, 2001, PUB HLTH REP, V116, P274
   *NCHS, 2001, PUB HLTH REP, V116, P273
   NEEL JV, 1962, AM J HUM GENET, V14, P353
   Nemets H, 2006, AM J PSYCHIAT, V163, P1098, DOI 10.1176/appi.ajp.163.6.1098
   NETTER P, 1996, PLEASURE QUALITY LIF, P84
   Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450
   *NIH, 1998, NIH PUBL, pR11
   NOBLE EP, 1994, INT J EAT DISORDER, V15, P205, DOI 10.1002/1098-108X(199404)15:3<205::AID-EAT2260150303>3.0.CO;2-P
   Nussey S., ENDOCRINOLOGY INTEGR
   O'Rahilly S, 2003, ENDOCRINOLOGY, V144, P3757, DOI 10.1210/en.2003-0373
   Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861
   OLDS J, 1962, PHYSIOL REV, V42, P554, DOI 10.1152/physrev.1962.42.4.554
   OLDS ME, 1969, AM J PHYSIOL, V217, P1253, DOI 10.1152/ajplegacy.1969.217.5.1253
   OLIVER JE, 2006, FAT POLITICS REAL ST, P133
   Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316
   Olson RE, 2000, J AM DIET ASSOC, V100, P28, DOI 10.1016/S0002-8223(00)00012-2
   Oncken C, 2001, PSYCHOPHARMACOLOGY, V154, P397, DOI 10.1007/s002130000666
   Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436
   OWEN DG, 2000, MADDEN OWEN PRODUCTS, V1
   Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174
   Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x
   Phillips SM, 2004, OBES RES, V12, P461, DOI 10.1038/oby.2004.52
   Pietiläinen KH, 1999, INT J OBESITY, V23, P107, DOI 10.1038/sj.ijo.0800767
   Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008
   POLLOCK F, 1920, LAW TORTS, P455
   Pool R., 2001, Fat: Fighting the Obesity Epidemic
   PRENTICE AM, 1995, INT J OBESITY, V19, pS44
   PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437
   Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629
   Price GM, 2006, AM J CLIN NUTR, V84, P449
   PRINGLE H, 2004, MEDIA WEEK      0116
   Proctor MH, 2003, INT J OBESITY, V27, P827, DOI 10.1038/sj.ijo.0802294
   PROSSER W, 1971, HDB LAW TORTS, P240
   Putnam J., 1999, FoodReview, V22, P2
   Raben A, 2003, AM J CLIN NUTR, V77, P91, DOI 10.1093/ajcn/77.1.91
   RABIN RL, 1992, STANFORD LAW REV, V44, P853, DOI 10.2307/1229002
   RADHAKISHUN FS, 1988, NEUROSCI LETT, V85, P351, DOI 10.1016/0304-3940(88)90591-5
   RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701
   RAVUSSIN E, 1992, LANCET, V340, P404, DOI 10.1016/0140-6736(92)91480-V
   Ravussin E, 1999, SCIENCE, V283, P184, DOI 10.1126/science.283.5399.184
   RAVUSSIN E, 1992, American Journal of Clinical Nutrition, V55, p242S, DOI 10.1093/ajcn/55.1.242s
   Ravussin E, 2002, ANN ENDOCRINOL-PARIS, V63, P96
   REAVAN G, 2000, SYNDROME 10 SILENT K
   REDD M, 1992, PHYSIOL BEHAV, V52, P749, DOI 10.1016/0031-9384(92)90409-U
   REPACE JL, 1990, RISK ANAL, V10, P27, DOI 10.1111/j.1539-6924.1990.tb01017.x
   RICE D, 1990, EC COST ALCOHOL DRUG, P2
   ROBBINS TW, 1989, NEUROSCI BIOBEHAV R, V13, P155, DOI 10.1016/S0149-7634(89)80025-9
   Robbins TW., 1992, SEMIN NEUROSCI, V4, P119
   Robinson J.P., 1997, TIME LIFE
   ROBINSON JH, 1992, PSYCHOPHARMACOLOGY, V108, P411, DOI 10.1007/BF02247414
   Robinson TN, 2001, PEDIATR CLIN N AM, V48, P1017, DOI 10.1016/S0031-3955(05)70354-0
   Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561
   Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381
   ROGERS PJ, 1980, APPETITE, V1, P85
   Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0
   Rogers PJ, 1999, P NUTR SOC, V58, P59, DOI 10.1079/PNS19990009
   Rosenbaum M, 1988, Adv Pediatr, V35, P73
   Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424
   Rosenbaum M, 1998, PEDIATRICS, V101, P525
   ROSENBLOOM M, 2005, TOXICITY VITAMIN
   ROSS GL, 2003, CIGARETTES WHAT WARN
   Rotimi C, 1997, GENET EPIDEMIOL, V14, P255, DOI 10.1002/(SICI)1098-2272(1997)14:3<255::AID-GEPI4>3.0.CO;2-4
   Rozin P., 1996, Why we eat what we eat: The psychology of eating, P233, DOI DOI 10.1037/10291-009
   Sacks Oliver., 1998, The Man Who Mistook His Wife for a Hat, P43
   Saelens BE, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200206000-00001
   Sainsbury A, 2002, BEST PRACT RES CL EN, V16, P623, DOI 10.1053/beem.2002.0230
   Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6
   Sakurai Y, 1997, EUR J EPIDEMIOL, V13, P893, DOI 10.1023/A:1007416322031
   Saleens B.E., 2003, OBESITY, P217
   SALLIS JF, 1993, CRIT REV FOOD SCI, V33, P403, DOI 10.1080/10408399309527639
   SALSBERRY PJ, DYNAMICS EARLY CHILD, P1329
   SANJUR D, 1982, SOCIAL CULTURAL PERS, P336
   Saris WHM, 2003, CURR OPIN CLIN NUTR, V6, P609, DOI 10.1097/00075197-200311000-00001
   SCHAEF AW, 1987, SOC BECOMES ADDICT, P18
   SCHARF I, 1995, HOUS L REV, V32, P615
   Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409
   SCHULTZ SG, 1998, ESSENTIAL MED PHYSL
   SCHWARTZ A, 1989, VA LAW REV, V75, P509, DOI 10.2307/1073251
   Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232
   Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534
   SEBOK AJ, 2002, BIF FAT CLASS ACTION
   Segal-Lieberman G, 2003, P NATL ACAD SCI USA, V100, P10085, DOI 10.1073/pnas.1633636100
   SEID R, 1989, NEVER TOO LATE
   SEIDMAN DS, 1991, AM J DIS CHILD, V145, P782
   Shell E.R., 2002, The hungry gene: The science of fat and the future of thin
   SHLAES A, 2002, CHICAGO TRIBUNE 1127, P25
   SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2
   Smith G. P., 1992, MULTIPLE CHOLECYSTOK, P166
   Smith H E, 1985, Top Emerg Med, V7, P69
   SMITH L, 2005, LONDON TIMES    1217
   SMITH L, 2005, TIMES LONDON    1217
   Snitker S, 2001, INT J OBESITY, V25, P1481, DOI 10.1038/sj.ijo.0801746
   Snyder EE, 2004, OBES RES, V12, P369, DOI 10.1038/oby.2004.47
   Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699
   SORENSEN TIA, 1995, METABOLISM, V44, P4, DOI 10.1016/0026-0495(95)90310-0
   Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008
   SPITZER R, 1980, COMPREHENSIVE TXB PS, V3, P1053
   STEIGER WR, 2004, COMMUNICATION   0105
   Stein WE, 1999, APPL STOCH MODEL BUS, V15, P103, DOI 10.1002/(SICI)1526-4025(199904/06)15:2<103::AID-ASMB369>3.0.CO;2-C
   STERN JS, 1972, LANCET, V2, P948
   Stettler N, 2004, OBES RES, V12, P896, DOI 10.1038/oby.2004.109
   Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194
   Strauss RS, 1997, J PEDIATR-US, V130, P95, DOI 10.1016/S0022-3476(97)70316-0
   Strauss RS, 2001, ARCH PEDIAT ADOL MED, V155, P897, DOI 10.1001/archpedi.155.8.897
   Stricker EM, 2000, NUTRITION, V16, P821, DOI 10.1016/S0899-9007(00)00412-3
   STROBEL A, 1999, NAT GENET, V18, P213
   Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055
   STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51
   STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401
   STUNKARD AJ, 1959, PSYCHIAT QUART, V33, P284, DOI 10.1007/BF01575455
   STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102
   SUNSTEIN CR, 1986, U CHICAGO LAW REV, V53, P1129, DOI 10.2307/1599746
   SUNSTEIN CR, 1986, U CHICAGO LAW REV, V53, P1159
   SUTHERLAND L, 2003, FED AM SOC EXP BIOL
   SWANSON DW, 1970, ARCH GEN PSYCHIAT, V22, P120
   Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585
   Taber MT, 1997, NEUROSCIENCE, V76, P1105, DOI 10.1016/S0306-4522(96)00450-2
   Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062
   Talamini R, 2005, INT J CANCER, V115, P606, DOI 10.1002/ijc.20891
   TANGCHRISTENSEN M, 2003, P 85 ANN M END SOC P, V497, P93
   Tapson Victor F, 2005, Proc Am Thorac Soc, V2, P71, DOI 10.1513/pats.200407-038MS
   Taubes G, 2001, SCIENCE, V291, P2536, DOI 10.1126/science.291.5513.2536
   Taylor DM, 2000, ACTA PSYCHIAT SCAND, V101, P416, DOI 10.1034/j.1600-0447.2000.101006416.x
   THOMPSON PDR, 2005, PHYS DESK REFERENCE, P1746
   Tidey JW, 1997, PSYCHOPHARMACOLOGY, V130, P203, DOI 10.1007/s002130050230
   TOCOPHEROL A, 1994, NEW ENGL J MED, V330, P1029
   Troiano RP, 2000, AM J CLIN NUTR, V72, p1343S, DOI 10.1093/ajcn/72.5.1343s
   Tschöp M, 2000, NATURE, V407, P908, DOI 10.1038/35038090
   TSCHOP M, 2000, J ENDOCRINOL INVEST, V24, P19
   Turley J, 2000, HARVARD J LEGIS, V37, P433
   *U MAR SCH LAW REG, 2003, TOBACCO REG REV, V2, P616
   Uauy R, 2000, AM J CLIN NUTR, V72, p1354S, DOI 10.1093/ajcn/72.5.1354s
   Utter J, 2003, J AM DIET ASSOC, V103, P1298, DOI 10.1016/S0002-8223(03)01079-4
   van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029
   VANDALL FJ, 1999, VILL J REV, V44, P558
   Vandall FrankJ., 1999, VILLANOVA LAW REV, V44, P547
   VANHAASTEREN GAC, 1995, J ENDOCRINOL, V145, P143, DOI 10.1677/joe.0.1450143
   VARIYAM JN, 2001, FOOD REV         MAY, P18
   VARIYAM JN, 2001, FOOD REV         MAY, P20
   Velasco M, 1998, Am J Ther, V5, P37, DOI 10.1097/00045391-199801000-00007
   Vereecken CA, 2004, APPETITE, V43, P93, DOI 10.1016/j.appet.2004.04.002
   von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147
   WALLACE L, 1987, ARCH ENVIRON HEALTH, V42, P272, DOI 10.1080/00039896.1987.9935820
   Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026
   Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312
   Wardle J, 2003, EUR J CLIN NUTR, V57, P341, DOI 10.1038/sj.ejcn.1601541
   WEIGLE D, 2002, SCI, V88, P2462
   WELSH MJ, 1978, J CLIN INVEST, V61, P708, DOI 10.1172/JCI108983
   Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301
   Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6
   Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.2.e9
   WHITEAKER RC, 1996, OESS RES, V4, P215
   *WHO, 2002, OB PREV MAN GLOB EP, P116
   *WHO, 2006, WHO TECHN REP SER, V916
   *WHO IARC, 1986, IARC MON, V38, P421
   Widdowson PS, 1997, BRAIN RES, V774, P1, DOI 10.1016/S0006-8993(97)81680-0
   Wightman R. M., 1996, Society for Neuroscience Abstracts, V22, P832
   WILDING JPH, 1992, J ENDOCRINOL, V132, P299, DOI 10.1677/joe.0.1320299
   Williams G, 2000, P NUTR SOC, V59, P385, DOI 10.1017/S0029665100000434
   Wilmore J H., 1994, Physiology of sports and exercise
   WILMORE JH, 2004, PRESIDENTS COUNCIL P
   WILSON BD, 1995, HUM MOL GENET, V4, P223, DOI 10.1093/hmg/4.2.223
   WILSON GT, 1991, ADV BEHAV RES THER, V13, P27, DOI 10.1016/0146-6402(91)90013-Z
   WOO R, 1982, AM J CLIN NUTR, V36, P470, DOI 10.1093/ajcn/36.3.470
   WOODS SC, 1991, PSYCHOL REV, V98, P488, DOI 10.1037/0033-295X.98.4.488
   Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378
   Woods SC, 1996, NEUROSCI BIOBEHAV R, V20, P139, DOI 10.1016/0149-7634(95)00044-F
   Wortley KE, 2004, REGUL PEPTIDES, V117, P89, DOI 10.1016/j.regpep.2003.08.005
   YEARY J, 1987, J PSYCHOACTIVE DRUGS, V19, P303, DOI 10.1080/02791072.1987.10472417
   Yeomans MR, 1996, PHYSIOL BEHAV, V60, P439, DOI 10.1016/S0031-9384(96)80017-5
   Yeomans MR, 2002, NEUROSCI BIOBEHAV R, V26, P713, DOI 10.1016/S0149-7634(02)00041-6
   Yeomans MR, 2003, CURR OPIN CLIN NUTR, V6, P639, DOI 10.1097/00075197-200311000-00006
   YEOMANS MR, 2003, CURR OPIN NUTR METAB, V6, P640
   YEOMANS MR, 2003, CURR OPIN NUTR METAB, V6, P641
   York D, 2000, ENDOCRINE, V13, P143, DOI 10.1385/ENDO:13:2:143
   YOSHIDA M, 1992, NEUROSCI LETT, V139, P73, DOI 10.1016/0304-3940(92)90861-Z
   YOUNG AMJ, 1992, NEUROSCIENCE, V48, P871, DOI 10.1016/0306-4522(92)90275-7
   Young B., 1996, ROLE TELEVISION ADVE
   Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5
   Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255
   Zhang M, 1998, J PHARMACOL EXP THER, V285, P908
   ZHANG M, 1998, J PHARM EXPT THERAPE, V285, P914
   ZURLO F, 1990, AM J PHYSIOL, V259, pE650
   ZYWICKI TJ, 2004, GEO MASON L REV, V12, P1000
   1998, U TOL L REV, V29, P699
   2004, BMJ, V328, P1572
   2005, PR NEWSWIRE     0719
   1998, U TOL L REV, V29, P700
   2005, SCI DAILY       0127
   2006, PERSPECTIVES MARKETI, pR8
   ABELIN T, 1989, LANCET, V1, P7
   ABRAHAM SF, 1982, PSYCHOL MED, V12, P625, DOI 10.1017/S0033291700055732
   al'Absi M, 2002, PHARMACOL BIOCHEM BE, V72, P707, DOI 10.1016/S0091-3057(02)00739-6
   [Anonymous], BEHAV ANAL DRUG DEPE
   [Anonymous], TOB CONTROL S
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI [10.1001/jama.291.10.1199-b, 10.1001/jama.291.10.1199-a]
   ATKINSON RL, 1985, CLIN PHARMACOL THER, V38, P419, DOI 10.1038/clpt.1985.197
   Baird J Kevin, 2002, Methods Mol Med, V72, P13, DOI 10.1385/1-59259-271-6:13
   Baldessarini R., 1996, Goodman and Gilmans the pharmacological of the therapeutics, V9th, P431
   BANZHAF J, 2002, SAN FRANCISCO D 0104
   Baptista T, 1999, ACTA PSYCHIAT SCAND, V100, P3, DOI 10.1111/j.1600-0447.1999.tb10908.x
   BAPTISTA T, 1998, NEUROSCI ANN M, V24, P706
   BARNARD N, 2003, BREAKING FOOD SEDUCT, P51
   Benowitz NL, 1999, PRIMARY CARE, V26, P611, DOI 10.1016/S0095-4543(05)70120-2
   BENOWITZ NL, 1983, NEW ENGL J MED, V309, P139, DOI 10.1056/NEJM198307213090303
   BERKEN GH, 1984, J AFFECT DISORDERS, V7, P133, DOI 10.1016/0165-0327(84)90031-4
   BLASS EM, 1989, ANN NY ACAD SCI, V575, P292, DOI 10.1111/j.1749-6632.1989.tb53251.x
   BORYS DJ, 1988, VET HUM TOXICOL, V30, P20
   BOZARTH MA, 1985, JAMA-J AM MED ASSOC, V254, P81, DOI 10.1001/jama.254.1.81
   BRESLAU N, 1993, ARCH GEN PSYCHIAT, V50, P31
   Carchman SH, 1996, FOOD DRUG LAW J, V51, P85
   CARTER WR, 1984, SOC BEHAV MED, P40
   *CDC, 1995, MMWR-MORBID MORTAL W, V44, P830
   COHAN JA, 2003, WIDENER LJ, V12, P116
   Cohan JohnAlan., 2003, Widener LJ, V12, P103
   Cooper S.J., 1988, ENDORPHINS OPIATES B, P143
   Corcos M, 2000, ANN MED INTERNE, V151, pB53
   Croft H, 1999, CLIN THER, V21, P643, DOI 10.1016/S0149-2918(00)88317-4
   Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580
   Davis C, 1998, ADDICT BEHAV, V23, P463, DOI 10.1016/S0306-4603(98)00009-4
   DAVIS WM, 2006, DRUG TOPICS     0418, P128
   DAWBER TR, 1974, NEW ENGL J MED, V291, P871, DOI 10.1056/NEJM197410242911703
   *DHHS, 1988, DHH PUBL
   diTomaso E, 1996, NATURE, V382, P677, DOI 10.1038/382677a0
   DJORDJEVIC MV, 1995, CARCINOGENESIS, V16, P2627, DOI 10.1093/carcin/16.11.2627
   DREWNOWSKI A, 1992, PHYSIOL BEHAV, V51, P371, DOI 10.1016/0031-9384(92)90155-U
   Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237
   DREWNOWSKI A, 1987, AM J CLIN NUTR, V46, P703, DOI 10.1093/ajcn/46.4.703
   DREWNOWSKI A, 1995, AM J CLIN NUTR, V61, P1206, DOI 10.1093/ajcn/61.6.1206
   DREWNOWSKI A, 1990, ANN NY ACAD SCI, V575, P99
   Fairburn Christopher G., 1993, P317
   FERNO O, 1977, DHEW PUB
   Fingarette H., 1998, Heavy drinking
   Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244
   FOLTIN W, 1990, PHARM BIOCH BEHAV, V36, P873
   FOULDS J, 1992, PSYCHOPHARMACOLOGY, V106, P421, DOI 10.1007/BF02245429
   GARLAND EJ, 1988, J CLIN PSYCHOPHARM, V8, P323
   GARVEY AJ, 1992, ADDICT BEHAV, V17, P367, DOI 10.1016/0306-4603(92)90042-T
   Gattellari M, 1997, INT J EAT DISORDER, V21, P377, DOI 10.1002/(SICI)1098-108X(1997)21:4<377::AID-EAT11>3.0.CO;2-W
   Gibson EL, 1999, APPETITE, V32, P219, DOI 10.1006/appe.1998.0207
   Glassman AH, 1996, NATURE, V379, P677, DOI 10.1038/379677a0
   Goffman E., 1961, Asylums: Essays on the Social Situation of Mental Patients and Other Inmates, DOI [10.4324/9781351327763, DOI 10.4324/9781351327763]
   GOLDFEIN JA, 1993, INT J EAT DISORDER, V14, P427, DOI 10.1002/1098-108X(199312)14:4<427::AID-EAT2260140405>3.0.CO;2-H
   GOLDSTEIN A, 1965, J PHARMACOL EXP THER, V150, P146
   Gonzalez VMM, 2004, APPETITE, V43, P155, DOI 10.1016/j.appet.2004.03.006
   GREDEN JF, 1974, AM J PSYCHIAT, V131, P1089
   GRIFFITHS RR, 1986, J EXP ANAL BEHAV, V45, P133, DOI 10.1901/jeab.1986.45-133
   GRIFFITHS RR, 1976, PSYCHOPHARMACOLOGY, V50, P251, DOI 10.1007/BF00426841
   GRIFFITHS RR, 1988, PHARMACOL BIOCHEM BE, V29, P419, DOI 10.1016/0091-3057(88)90180-3
   GRIFFITHS RR, 1986, J PHARMACOL EXP THER, V239, P416
   GRIFFITHS RR, 2003, PRINCIPLES ADDICTION, P194
   GROTTA JC, 2003, STROKE, V34, P1242
   GRUNBERG N, 1999, BROWN U DIGEST ADDIC, V18
   HARRIE JR, 1970, J AMER MED ASSOC, V213, P628, DOI 10.1001/jama.1970.03170300072029
   Heishman S J, 1999, Nicotine Tob Res, V1 Suppl 2, pS143
   HEISHMAN SJ, 1994, PHARMACOPSYCHOECOLOG, V7, P127
   Henningfield Jack E., 1995, P1715
   HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T
   HENNINGFIELD JE, 1993, J CONSULT CLIN PSYCH, V61, P743, DOI 10.1037/0022-006X.61.5.743
   HENNINGFIELD JE, 1995, NEW ENGL J MED, V333, P1196, DOI 10.1056/NEJM199511023331807
   Henningfield JE, 1998, FOOD DRUG LAW J, V53, P75
   HEPPNER CC, 1986, PHARMACOL BIOCHEM BE, V24, P1555, DOI 10.1016/0091-3057(86)90484-3
   HETHERINGTON MM, 1991, PHARMACOL BIOCHEM BE, V40, P185, DOI 10.1016/0091-3057(91)90343-Z
   HETHERINGTON MM, 1993, APPETITE, V21, P233, DOI 10.1006/appe.1993.1042
   HETHERINGTON MM, 1991, APPETITE, V17, P199
   Heubner H.F., 1993, Endorphins, eating disorders and other addictive behaviors
   *HHS, 1988, HLTH CONS SMOK NIC A, P11
   Hughes J, 1994, DSM 4 SOURCEBOOK, P129
   HUGHES JR, 1992, AM J PSYCHIAT, V149, P33
   Hughes JR, 1999, JAMA-J AM MED ASSOC, V281, P72, DOI 10.1001/jama.281.1.72
   HUGHES JR, 1984, JAMA-J AM MED ASSOC, V252, P2855, DOI 10.1001/jama.252.20.2855
   HUGHES JR, 1994, ADDICTION, V89, P1461, DOI 10.1111/j.1360-0443.1994.tb03744.x
   HUGHES JR, 1999, JAMA-J AM MED ASSOC, V281, P75
   HUGHES JR, 1990, RECENT ADV ALCOHOL D, P10
   HURST WJ, 1981, ANALYST, V106, P394, DOI 10.1039/an9810600394
   HURST WJ, 1982, NUTR REP INT, V26, P1081
   Ibanez Angela, 2003, J Gambl Stud, V19, P11, DOI 10.1023/A:1021271029163
   JARVIS MJ, 1991, HDB ADDICTION BEHAV, P97
   KALES EF, 1990, PHYSIOL BEHAV, V48, P837, DOI 10.1016/0031-9384(90)90236-W
   KAROUM F, 1979, J NEUROCHEM, V33, P201, DOI 10.1111/j.1471-4159.1979.tb11722.x
   Kelder GrahamE., 1997, Stan L Poly Rev, V8, P63
   Kessler DA, 1996, NEW ENGL J MED, V335, P988, DOI 10.1056/NEJM199609263351321
   KOZLOWSKI LT, 1976, NATURE, V264, P354, DOI 10.1038/264354a0
   LAVOIE F W, 1991, Journal of Emergency Medicine, V9, P133, DOI 10.1016/0736-4679(91)90318-A
   LONDON WM, 2000, PRIORITIES HLTH, V12, P11
   Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664
   MACDIARMID JI, 1995, BRIT J CLIN PSYCHOL, V34, P129, DOI 10.1111/j.2044-8260.1995.tb01445.x
   MALCOLM R, 1985, INT J OBESITY, V9, P347
   Marley E, 1970, Adv Pharmacol Chemother, V8, P185
   MARRAZZI MA, 1986, INT J EAT DISORDER, V5, P191, DOI 10.1002/1098-108X(198602)5:2<191::AID-EAT2260050202>3.0.CO;2-I
   MARX V, 1973, LANCET, V301, P827
   MAX B, TRENDS PHARM SCI, V10, P390
   McNaughton L R, 1986, Br J Sports Med, V20, P109
   Meier Benjamin Mason, 2005, Yale J Health Policy Law Ethics, V5, P137
   MERTINO M, 1991, AM J PHYSIOL, V261, P59
   MICHENER W, 1994, PHYSIOL BEHAV, V56, P419, DOI 10.1016/0031-9384(94)90283-6
   MITCHELL JE, 1987, BIOL PSYCHIAT, V22, P35, DOI 10.1016/0006-3223(87)90127-2
   MONALTO NK, 1994, AM BD FAM PRACT, V7, P417
   NESBITT PD, 1973, J PERS SOC PSYCHOL, V25, P137, DOI 10.1037/h0034256
   PARROTT AC, 1995, INT J ADDICT, V30, P1509, DOI 10.3109/10826089509055846
   Parrott AC, 1998, ADDICTION, V93, P27, DOI 10.1046/j.1360-0443.1998.931274.x
   PARROTT AC, 1994, PSYCHOPHARMACOLOGY, V115, P389, DOI 10.1007/BF02245082
   Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518
   PEELE G, 1989, DIS AM, P79
   PERKINS KA, 1992, CLIN PHARMACOL THER, V52, P627, DOI 10.1038/clpt.1992.201
   PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P61, DOI 10.1001/jama.261.1.61
   RABIN RL, 2001, REGULATING TOBACCO, P201
   REIMANN HA, 1967, JAMA-J AM MED ASSOC, V202, P131
   RUSSELL M, 1995, WORLD HLTH F, V16, P19
   RUSSELL M, 1995, WORLD HLTH F, V16, P20
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   SAXENA K, 1985, VET HUM TOXICOL, V27, P495
   Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103
   SCHUSTER, 1969, ABUSE CENTRAL STIMUL, P339
   SHERWOOD N, 1993, HUM PSYCHOPHARM CLIN, V8, P155, DOI 10.1002/hup.470080303
   Singh T K, 2003, Compr Rev Food Sci Food Saf, V2, P166, DOI 10.1111/j.1541-4337.2003.tb00021.x
   SLADE J, 1995, JAMA-J AM MED ASSOC, V274, P225, DOI 10.1001/jama.274.3.225
   STERN KN, 1989, PSYCHOPHARMACOLOGY, V98, P81, DOI 10.1007/BF00442010
   Sussman S, 1999, SUBST USE MISUSE, V34, P1469, DOI 10.3109/10826089909039411
   THOMAS A, 1992, US PHARM S, P1
   THOMPSON WG, 1994, AM J MED SCI, V308, P49, DOI 10.1097/00000441-199407000-00011
   TONNESEN P, 1993, JAMA-J AM MED ASSOC, V269, P1268, DOI 10.1001/jama.269.10.1268
   Trotzky Arthur S, 2002, Int J Adolesc Med Health, V14, P269
   TURNER MS, 1991, PSYCHOL MED, V21, P123, DOI 10.1017/S0033291700014719
   VANDEREYCKEN W, 1990, INT J EAT DISORDER, V9, P95, DOI 10.1002/1098-108X(199001)9:1<95::AID-EAT2260090111>3.0.CO;2-Z
   VELEBER DM, 1984, J ABNORM PSYCHOL, V93, P120, DOI 10.1037/0021-843X.93.1.120
   Woolf A, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e4
   Yancey AK, 2006, OBESITY, V14, P980, DOI 10.1038/oby.2006.112
   YANOVSKI SZ, 1992, AM J CLIN NUTR, V56, P975, DOI 10.1093/ajcn/56.6.975
   YEOMANS MR, 1990, PSYCHOPHARMACOLOGY, V100, P426, DOI 10.1007/BF02244618
   ZIMMERS T, 1994, AM J EMERG MED, V12, P374, DOI 10.1016/0735-6757(94)90164-3
NR 641
TC 6
Z9 6
U1 0
U2 6
PU FOOD DRUG LAW INST
PI WASHINGTON
PA 1000 VERMONT AVE NW, SUITE 1200, WASHINGTON, DC 20005-4903 USA
SN 1064-590X
J9 FOOD DRUG LAW J
JI Food Drug Law J.
PY 2006
VL 61
IS 3
BP 445
EP 518
PG 74
WC Food Science & Technology; Law; Nutrition & Dietetics; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Food Science & Technology; Government & Law; Nutrition & Dietetics;
   Pharmacology & Pharmacy
GA 085KJ
UT WOS:000240602700002
PM 16989036
DA 2025-04-28
ER

PT J
AU Prather, JM
   Florez, CM
   Vargas, A
   Soto, B
   Harrison, A
   Willoughby, D
   Tinsley, G
   Taylor, L
AF Prather, Jessica M.
   Florez, Christine M.
   Vargas, Amie
   Soto, Bella
   Harrison, Abby
   Willoughby, Darryn
   Tinsley, Grant
   Taylor, Lem
TI The effects of a thermogenic supplement on metabolic and hemodynamic
   variables and subjective mood states
SO JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
LA English
DT Article
DE Thermogenic supplement; Fat burners; Supplements; Multi-ingredient
ID CONJUGATED LINOLEIC-ACID; BODY-FAT MASS; ENERGY-EXPENDITURE;
   P-SYNEPHRINE; DOUBLE-BLIND; WEIGHT-LOSS; CAFFEINE; OVERWEIGHT; EXERCISE;
   HUMANS
AB Background Thermogenic supplements are widely used in the general population to support attempted fat loss; however, the efficacy and safety of these supplements are questioned. Purpose To determine whether a thermogenic supplement affects metabolic rate, hemodynamic responses, and mood states. Methods In a randomized double-blind crossover design, 23 females (22.2 +/- 3.5 years; 164.8 +/- 6.4 cm; 73.5 +/- 6.9 kg) who were moderate caffeine consumers (<150 mg/day) reported to the lab after a 12 h fast for baseline assessments of resting energy expenditure (REE) via indirect calorimetry, heart rate (HR), blood pressure (SBP and DBP), blood variables, and hunger, satiety, and mood states. Thereafter, subjects ingested the assigned treatment (active treatment containing caffeine, micronutrients, and phytochemicals [TR] or placebo [PL]). All variables were reassessed at 30-, 60-, 120-, and 180 min post-ingestion. Subjects repeated the same protocol with ingestion of the opposite treatment on a separate day. All data were analyzed using a 2 x 5 ANOVA with repeated measures and significance was accepted a priori at p Results In the TR group, mean increases in REE of 121 to 166 kcal/d were observed at 30-, 60-, and 180 min post-ingestion (p < 0.01 for all). PL group mean decreases in REE of 72 to 91 kcal/day were observed at 60-, 120-, and 180 min (p < 0.05 for all). Respiratory quotient decreased at 120 and 180 min in both treatments. Slight increases in SBP of 3-4 mmHg were observed at 30, 120, and 180 min (p < 0.05 for all) post-ingestion of TR, while no effects were observed for DBP. Observed increases in SBP were within normal blood pressure ranges. TR decreased subjective fatigue with no other significant changes in mood states. Glycerol was maintained in TR, while there was a decrease at 30, 60, and 180 min (p < 0.05 for all) post-ingestion of PLA. Free fatty acids increased in TR at 60 and 180 min (p < 0.05) post-ingestion as well as a significant difference between treatments at 30 min post-ingestion indicating greater circulating free fatty acids levels in TR vs. PL (p < 0.01). Conclusion These findings indicate that ingestion of a specific thermogenic supplement formulation produces a sustained increase in metabolic rate and caloric expenditure and reduces fatigue over 3 h without producing adverse hemodynamic responses.
C1 [Prather, Jessica M.; Florez, Christine M.; Vargas, Amie; Soto, Bella; Harrison, Abby; Willoughby, Darryn; Taylor, Lem] Univ Mary Hardin Baylor, Sch Exercise & Sport Sci, Human Performance Lab, Belton, TX USA.
   [Tinsley, Grant] Texas Tech Univ, Dept Kinesiol & Sport Management, Energy Balance & Body Composit Lab, Lubbock, TX USA.
   [Taylor, Lem] Univ Mary Hardin Baylor, Sch Exercise & Sport Sci, Human Performance Lab, 900 Coll St UMHB 8023, Belton, TX 76513 USA.
C3 University Mary Hardin Baylor; Texas Tech University System; Texas Tech
   University; University Mary Hardin Baylor
RP Taylor, L (corresponding author), Univ Mary Hardin Baylor, Sch Exercise & Sport Sci, Human Performance Lab, 900 Coll St UMHB 8023, Belton, TX 76513 USA.
EM ltaylor@umhb.edu
RI Tinsley, Grant/S-4582-2019
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Astell KJ, 2013, COMPLEMENT THER MED, V21, P407, DOI 10.1016/j.ctim.2013.05.007
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Benjamim CJR, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.890388
   Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420
   Cameron M, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-017-0206-7
   Campbell BI., 2016, J INT SOC SPORT NUTR, V13, P1
   Campbell BI, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0123-1
   Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Ehrman J.K., 2018, Advanced Exercise Physiology: Essential Concepts and Applications
   Gaullier JM, 2005, J NUTR, V135, P778
   Gutiérrez-Hellín J, 2021, EUR J SPORT SCI, V21, P1273, DOI 10.1080/17461391.2020.1817154
   Gutiérrez-Hellín J, 2016, BRIT J CLIN PHARMACO, V82, P362, DOI 10.1111/bcp.12952
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3
   Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-1
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kamphuis MMJW, 2003, INT J OBESITY, V27, P840, DOI 10.1038/sj.ijo.0802304
   Kim JE, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-94
   La Monica M., 2022, J INT SOC SPORT NUTR, V5, DOI [10.53520/jen2022.103113, DOI 10.53520/JEN2022.103113]
   Larsen TM, 2006, AM J CLIN NUTR, V83, P606, DOI 10.1093/ajcn.83.3.606
   LEBLANC J, 1985, J APPL PHYSIOL, V59, P832, DOI 10.1152/jappl.1985.59.3.832
   Lee D, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11121764
   Lehnen TE, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0097-4
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Outlaw J, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-25
   POEHLMAN ET, 1985, MED SCI SPORT EXER, V17, P689, DOI 10.1249/00005768-198512000-00012
   Ramírez-Maldonado M, 2021, J INT SOC SPORT NUTR, V18, DOI 10.1186/s12970-020-00400-6
   Ratamess NA, 2018, PHYTOTHER RES, V32, P94, DOI 10.1002/ptr.5953
   Ratamess NA, 2016, J AM COLL NUTR, V35, P657, DOI 10.1080/07315724.2016.1150223
   Ruiz-Moreno C, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010233
   Ryan ED, 2009, J STRENGTH COND RES, V23, P807, DOI 10.1519/JSC.0b013e3181a30fb8
   Santos-Zago LF, 2008, REV NUTR, V21, P195, DOI 10.1590/S1415-52732008000200008
   Semwal RB, 2015, FITOTERAPIA, V102, P134, DOI 10.1016/j.fitote.2015.02.012
   Talenezhad N, 2020, CLIN NUTR ESPEN, V37, P9, DOI 10.1016/j.clnesp.2020.03.008
   Turnbull D, 2017, REGUL TOXICOL PHARM, V89, P165, DOI 10.1016/j.yrtph.2017.07.025
   Urbina S., 2012, J INT SOC SPORTS NUT, V9, P31
   vanSoeren M, 1996, J APPL PHYSIOL, V80, P999, DOI 10.1152/jappl.1996.80.3.999
   Vaughan Roger A, 2014, ISRN Nutr, V2014, P650264, DOI 10.1155/2014/650264
   Wilborn C, 2009, APPL PHYSIOL NUTR ME, V34, P1073, DOI 10.1139/H09-113
   Zambell KL, 2000, LIPIDS, V35, P777, DOI 10.1007/s11745-000-0585-z
   Ziegenfuss Tim N., 2017, Journal of Dietary Supplements, V14, P288, DOI 10.1080/19390211.2016.1215366
NR 47
TC 5
Z9 5
U1 0
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
EI 1550-2783
J9 J INT SOC SPORT NUTR
JI J. Int. Soc. Sport Nutr.
PD DEC 31
PY 2023
VL 20
IS 1
AR 2185538
DI 10.1080/15502783.2023.2185538
PG 19
WC Nutrition & Dietetics; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Sport Sciences
GA 9N0NH
UT WOS:000942616500001
PM 36862833
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Huang, LC
   Lyu, Q
   Zheng, WY
   Yang, Q
   Cao, G
AF Huang, Lichuang
   Lyu, Qiang
   Zheng, Wanying
   Yang, Qiao
   Cao, Gang
TI Traditional application and modern pharmacological research of
   Eucommia ulmoides Oliv.
SO CHINESE MEDICINE
LA English
DT Review
ID OVX-INDUCED OSTEOPOROSIS; NEURONAL CELL-DEATH; ANTIOXIDANT ACTIVITY;
   GENIPOSIDIC ACID; RAT PLASMA; HYPOLIPIDEMIC ACTION; ALZHEIMERS-DISEASE;
   OXIDATIVE STRESS; CHLOROGENIC ACID; ALDOSE REDUCTASE
AB As a Traditional Chinese Medicine, Eucommia ulmoides Oliv. has been used for the treatment of various diseases since ancient times, involving lumbar pain, knee pain, osteoporosis, hepatoprotection, paralysis, intestinal haemorrhoids, vaginal bleeding, abortion, spermatorrhoea, foot fungus, anti-aging etc. With the developing discovery of E. ulmoides extracts and its active components in various pharmacological activities, E. ulmoides has gained more and more attention. Up to now, E. ulmoides has been revealed to show remarkable therapeutic effects on hypertension, hyperglycemia, diabetes, obesity, osteoporosis, Parkinson's disease, Alzheimer's disease, sexual dysfunction. E. ulmoides has also been reported to possess antioxidant, anti-inflammatory, neuroprotective, anti-fatigue, anti-aging, anti-cancer and immunoregulation activities etc. Along these lines, this review summarizes the traditional application and modern pharmacological research of E. ulmoides, providing novel insights of E. ulmoides in the treatment of various diseases.
C1 [Huang, Lichuang; Lyu, Qiang; Zheng, Wanying; Yang, Qiao; Cao, Gang] Zhejiang Chinese Med Univ, Sch Pharm, 548 Binwen Rd, Hangzhou 310053, Peoples R China.
C3 Zhejiang Chinese Medical University
RP Cao, G (corresponding author), Zhejiang Chinese Med Univ, Sch Pharm, 548 Binwen Rd, Hangzhou 310053, Peoples R China.
EM caogang33@163.com
RI Cao, Gang/AGQ-9295-2022
OI Huang, LiChuang/0000-0002-5445-1988; Yang, Qiao/0000-0002-0480-6146
FU National Natural Science Foundation of China [81973481, 81922073];
   Traditional Chinese Medicine Key Scientific Research Fund Project of
   Zhejiang Province [Q2019J02, 2021ZZ009]; Program of China
   [2017YFE0191500]
FX This work was financially supported by the National Natural Science
   Foundation of China (Nos. 81973481 and 81922073), and the Traditional
   Chinese Medicine Key Scientific Research Fund Project of Zhejiang
   Province (Nos. Q2019J02 and 2021ZZ009). Program of China (No.
   2017YFE0191500).
CR Armstrong MJ, 2020, JAMA-J AM MED ASSOC, V323, P548, DOI 10.1001/jama.2019.22360
   Chen SY, 2019, NEUROCHEM RES, V44, P472, DOI 10.1007/s11064-018-2700-y
   Chen YS, 2021, J ETHNOPHARMACOL, V272, DOI 10.1016/j.jep.2021.113920
   Choi MS, 2008, AM J CHINESE MED, V36, P81, DOI 10.1142/S0192415X08005606
   Cuzzocrea S, 2001, PHARMACOL REV, V53, P135
   Dai XP, 2013, FOOD CHEM, V139, P563, DOI 10.1016/j.foodchem.2013.02.006
   Ding YX, 2015, J ASIAN NAT PROD RES, V17, P867, DOI 10.1080/10286020.2015.1039999
   Ding ZJ, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/6432173
   Do MH., 2018, NUTRIENTS, V10, P3
   Dotan Y, 2004, PROG LIPID RES, V43, P200, DOI 10.1016/j.plipres.2003.10.001
   Du KZ, 2020, J SEP SCI, V43, P799, DOI 10.1002/jssc.201900910
   Duan MX, 2019, J PHARMACOL EXP THER, V371, P348, DOI 10.1124/jpet.119.259069
   Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041
   Fu C, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106547
   Fu H, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/1782953
   Fujikawa T, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.12
   Fujikawa T, 2010, BRIT J NUTR, V104, P1868, DOI 10.1017/S0007114510002965
   Fujiwara A, 2016, PHYTOCHEMISTRY, V122, P139, DOI 10.1016/j.phytochem.2015.11.017
   Gao WD, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1860637
   González A, 2020, CELL METAB, V31, P472, DOI 10.1016/j.cmet.2020.01.015
   González-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34
   Goyal MM, 2010, PROTEIN CELL, V1, P888, DOI 10.1007/s13238-010-0113-z
   Gu JA, 2011, J ETHNOPHARMACOL, V133, P6, DOI 10.1016/j.jep.2010.08.055
   Guo H, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0675-7
   Ha H, 2003, ARCH PHARM RES, V26, P929, DOI 10.1007/BF02980202
   Habtemariam S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6020039
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   He TF, 2019, MOL MED REP, V20, P1499, DOI 10.3892/mmr.2019.10396
   He XR, 2014, J ETHNOPHARMACOL, V151, P78, DOI 10.1016/j.jep.2013.11.023
   Hirata T, 2011, BIOORG MED CHEM LETT, V21, P1786, DOI 10.1016/j.bmcl.2011.01.060
   Ho JN, 2005, BIOL PHARM BULL, V28, P1244, DOI 10.1248/bpb.28.1244
   Hong YK, 2013, CARBOHYD POLYM, V92, P1761, DOI 10.1016/j.carbpol.2012.11.015
   Horii Y, 2010, NEUROSCI LETT, V479, P181, DOI 10.1016/j.neulet.2010.05.030
   Hsieh CL, 2000, LIFE SCI, V66, P1387, DOI 10.1016/S0024-3205(00)00450-1
   Hu RZ, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-020-00492-9
   Hu WC, 2014, CHEM-BIOL INTERACT, V224, P108, DOI 10.1016/j.cbi.2014.10.011
   Hua HM, 2002, J ASIAN NAT PROD RES, V4, P201, DOI 10.1080/10286020290023997
   Huang Q, 2021, NAT PROD RES, V35, P3376, DOI 10.1080/14786419.2019.1700250
   Huang YX, 2014, CHIN J NAT MEDICINES, V12, P469, DOI 10.1016/S1875-5364(14)60073-X
   Hung MY, 2006, FOOD CHEM TOXICOL, V44, P1424, DOI 10.1016/j.fct.2006.03.009
   Hussain T, 2020, TOXICOL IN VITRO, V62, DOI 10.1016/j.tiv.2019.104674
   Jiang S, 2020, J ANIM PHYSIOL AN N, V104, P1085, DOI 10.1111/jpn.13235
   Jin CF, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/751854
   Jin X, 2010, J ETHNOPHARMACOL, V128, P672, DOI 10.1016/j.jep.2010.02.019
   Jing X, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/987973
   Kim JY, 2015, PHYTOTHER RES, V29, P148, DOI 10.1002/ptr.5195
   Kim MC, 2012, AM J CHINESE MED, V40, P135, DOI 10.1142/S0192415X12500115
   Koh W, 2017, J ETHNOPHARMACOL, V209, P255, DOI 10.1016/j.jep.2017.08.001
   Kwon SH, 2016, BIOMOL THER, V24, P268, DOI 10.4062/biomolther.2015.150
   Kwon SH, 2014, J ETHNOPHARMACOL, V152, P173, DOI 10.1016/j.jep.2013.12.048
   Kwon SH, 2012, J ETHNOPHARMACOL, V142, P337, DOI 10.1016/j.jep.2012.04.010
   Kwon SH, 2011, NEUROSCI LETT, V487, P123, DOI 10.1016/j.neulet.2010.10.042
   Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705
   Lee GH., 2019, NUTRIENTS, V11, P2
   Lee HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081349
   Lee MK, 2005, DIABETES RES CLIN PR, V67, P22, DOI 10.1016/j.diabres.2004.05.013
   Lee MK, 2005, J MED FOOD, V8, P86, DOI 10.1089/jmf.2005.8.86
   Lei S, 2021, PINORESINOL DIGLUCOS
   Li CX, 2019, EUR J PHARMACOL, V854, P224, DOI 10.1016/j.ejphar.2019.04.021
   Li CP, 2016, NEUROL SCI, V37, P755, DOI 10.1007/s10072-016-2491-3
   Li CJ, 2012, MOLECULES, V17, P13960, DOI 10.3390/molecules171213960
   Li L, 2012, J ETHNOPHARMACOL, V139, P454, DOI 10.1016/j.jep.2011.11.032
   Li N, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7480512
   Li N, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00854
   Li Q, 2017, BIOMATERIALS, V148, P54, DOI 10.1016/j.biomaterials.2017.09.028
   Li Q, 2017, CARBOHYD POLYM, V169, P304, DOI 10.1016/j.carbpol.2017.04.034
   Li Q, 2016, ACS MACRO LETT, V5, P617, DOI 10.1021/acsmacrolett.6b00182
   Li Y, 2011, PHYTOTHER RES, V25, P1895, DOI 10.1002/ptr.3543
   Li YM, 1999, BIOL PHARM BULL, V22, P941, DOI 10.1248/bpb.22.941
   Li YM, 1998, BIOL PHARM BULL, V21, P1306, DOI 10.1248/bpb.21.1306
   Li YM, 1999, BIOL PHARM BULL, V22, P582, DOI 10.1248/bpb.22.582
   Li YJ, 2016, EUR J DRUG METAB PH, V41, P595, DOI 10.1007/s13318-015-0282-5
   Li ZY, 2013, AM J CHINESE MED, V41, P801, DOI 10.1142/S0192415X13500547
   Lin J, 2011, J ZHEJIANG UNIV-SC B, V12, P47, DOI 10.1631/jzus.B1000057
   Liu B, 2016, CELL PHYSIOL BIOCHEM, V39, P2044, DOI 10.1159/000447900
   Liu C., 2020, CHINA J CHIN MAT MED, V45, P3
   Liu HW, 2018, ANIM SCI J, V89, P888, DOI 10.1111/asj.12998
   [刘攀峰 Liu Panfeng], 2020, [生态学报, Acta Ecologica Sinica], V40, P5674
   Liu WZ, 2015, REV NEUROSCIENCE, V26, P371, DOI 10.1515/revneuro-2015-0005
   Luo JY, 2009, J ENZYM INHIB MED CH, V24, P1280, DOI 10.3109/14756360902829741
   Luo LF, 2010, J ETHNOPHARMACOL, V129, P238, DOI 10.1016/j.jep.2010.03.019
   Luo XM, 2020, REGUL TOXICOL PHARM, V118, DOI 10.1016/j.yrtph.2020.104811
   Ma B, 2019, PHYTOMEDICINE, V64, DOI 10.1016/j.phymed.2019.153057
   Ma ZG, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6053727
   Ma ZG, 2016, BRIT J PHARMACOL, V173, P1502, DOI 10.1111/bph.13449
   Marini JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.52
   Meng YY, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7901735
   Nathan DM, 2015, JAMA-J AM MED ASSOC, V314, P1052, DOI 10.1001/jama.2015.9536
   Neri-Numa IA, 2020, FOOD RES INT, V134, DOI 10.1016/j.foodres.2020.109252
   Niu HS, 2016, DRUG DES DEV THER, V10, P971, DOI 10.2147/DDDT.S98558
   Niu YM, 2020, INT J BIOL MACROMOL, V155, P911, DOI 10.1016/j.ijbiomac.2019.11.049
   Pan YL, 2014, AM J CHINESE MED, V42, P143, DOI 10.1142/S0192415X14500104
   Park SA, 2006, J MED FOOD, V9, P474, DOI 10.1089/jmf.2006.9.474
   Park SA, 2006, J ETHNOPHARMACOL, V107, P412, DOI 10.1016/j.jep.2006.03.034
   Qi SS, 2019, BIOL TRACE ELEM RES, V187, P172, DOI 10.1007/s12011-018-1362-6
   Qiu YL, 2018, BIOMED PHARMACOTHER, V106, P192, DOI 10.1016/j.biopha.2018.05.070
   Ramasamy R, 2010, CIRC RES, V106, P1449, DOI 10.1161/CIRCRESAHA.109.213447
   Shan M., 2017, MOLECULES, V22, P10, DOI [10.14348/molcells.2017.2311, DOI 10.14348/MOLCELLS.2017.2311]
   Shao P, 2015, J FOOD SCI TECH MYS, V52, P4925, DOI 10.1007/s13197-014-1571-8
   Shchepotin B M, 1983, Vrach Delo, P30
   Shen BY, 2019, J CELL MOL MED, V23, P4063, DOI 10.1111/jcmm.14293
   Sheng CJ, 2019, EUR J PHARMACOL, V854, P28, DOI 10.1016/j.ejphar.2019.03.058
   Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296
   Sierksma A, 2020, SCIENCE, V370, P61, DOI 10.1126/science.abb8575
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   SIH CJ, 1976, J AM CHEM SOC, V98, P5412, DOI 10.1021/ja00433a070
   Taams LS, 2020, J EXP MED, V217, DOI 10.1084/jem.20192048
   Takamura C, 2007, J NAT PROD, V70, P1312, DOI 10.1021/np0780046
   Takeuchi Y, 2020, IMMUNOL REV, V294, P164, DOI 10.1111/imr.12841
   Wang H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01863-9
   Wang JL, 2012, J ETHNOPHARMACOL, V139, P337, DOI 10.1016/j.jep.2011.10.037
   Wang JY, 2019, CHINESE MED J-PEKING, V132, P319, DOI 10.1097/CM9.0000000000000066
   Wang JY, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/7379893
   Wang JY, 2016, J ETHNOPHARMACOL, V194, P609, DOI 10.1016/j.jep.2016.10.038
   Wang YS, 2019, ONCOTARGETS THER, V12, P5515, DOI 10.2147/OTT.S210497
   Wei XN, 2021, J AGR FOOD CHEM, V69, P3797, DOI 10.1021/acs.jafc.0c07560
   Wu D., 2018, MOLECULES, V23, P8
   Wu JM, 2016, MOLECULES, V21, DOI 10.3390/molecules21030260
   Wu QQ, 2018, BRIT J PHARMACOL, V175, P1548, DOI 10.1111/bph.14164
   Xiang Y, 2004, J STRUCT BIOL, V148, P86, DOI 10.1016/j.jsb.2004.04.002
   Xiao DF, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9719618
   Xiao Y, 2018, PLANTA MED, V84, P91, DOI [10.1055/s-0043-118663, 10.1055/s-0043-122577]
   Xu W, 2012, BIOMED CHROMATOGR, V26, P1066, DOI 10.1002/bmc.1748
   Xu ZS, 2010, J AGR FOOD CHEM, V58, P7289, DOI 10.1021/jf100304t
   Yan JK, 2019, NAT PROD RES, V33, P1162, DOI 10.1080/14786419.2018.1462181
   Yan JK, 2017, FITOTERAPIA, V116, P121, DOI 10.1016/j.fitote.2016.12.001
   Yan JK, 2017, J NAT MED-TOKYO, V71, P780, DOI 10.1007/s11418-017-1102-9
   Yang G, 2015, CHEM BIODIVERS, V12, P538, DOI 10.1002/cbdv.201400376
   Yang J, 2003, LIFE SCI, V73, P3245, DOI 10.1016/j.lfs.2003.06.011
   Yang Z, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4327901
   Yen GC, 1998, J AGR FOOD CHEM, V46, P3952, DOI 10.1021/jf9800458
   Yin F, 2010, BIOL PHARM BULL, V33, P1841, DOI 10.1248/bpb.33.1841
   Zeida A, 2019, CHEM REV, V119, P10829, DOI 10.1021/acs.chemrev.9b00371
   Zeng XC, 2020, FITOTERAPIA, V140, DOI 10.1016/j.fitote.2019.104443
   Zhang L, 2013, ASIAN PAC J TROP MED, V6, P673, DOI 10.1016/S1995-7645(13)60117-0
   Zhang Q, 2014, J BIOSCI BIOENG, V118, P45, DOI 10.1016/j.jbiosc.2013.12.009
   Zhang Q, 2013, MOLECULES, V18, P1857, DOI 10.3390/molecules18021857
   Zhang R, 2009, BONE, V45, P553, DOI 10.1016/j.bone.2008.08.127
   Zhang R, 2014, J ETHNOPHARMACOL, V155, P104, DOI 10.1016/j.jep.2014.04.031
   Zhang Wan-hong, 2005, Zhonghua Nan Ke Xue, V11, P309
   Zhang Wan-Hong, 2006, Zhonghua Nan Ke Xue, V12, P466
   Zhang WP, 2012, AM J CHINESE MED, V40, P735, DOI 10.1142/S0192415X12500553
   Zhao X, 2020, FOOD SCI NUTR, V8, P4897, DOI 10.1002/fsn3.1779
   Zhou YX, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/4925682
   Zhou YQ, 2009, ENVIRON TOXICOL PHAR, V28, P342, DOI 10.1016/j.etap.2009.05.012
   Zhou ZJZ, 2020, EUR J PHARMACOL, V869, DOI 10.1016/j.ejphar.2019.172857
   Zhua YL, 2018, NEUROREPORT, V29, P1075, DOI 10.1097/WNR.0000000000001075
NR 147
TC 68
Z9 75
U1 25
U2 168
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-8546
J9 CHIN MED-UK
JI Chin. Med.
PD AUG 6
PY 2021
VL 16
IS 1
AR 73
DI 10.1186/s13020-021-00482-7
PG 26
WC Integrative & Complementary Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; Pharmacology & Pharmacy
GA TY6NP
UT WOS:000683899400001
PM 34362420
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU de Araújo, FF
   Farias, DD
   Neri-Numa, IA
   Pastore, GM
AF de Araujo, Fabio Fernandes
   Farias, David de Paulo
   Neri-Numa, Iramaia Angelica
   Pastore, Glaucia Maria
TI Polyphenols and their applications: An approach in food chemistry and
   innovation potential
SO FOOD CHEMISTRY
LA English
DT Review
DE Phenolic compounds; Flavonoids; Phenolic acids; Anthocyanins; Tannins;
   Health benefits; Technological applications
ID CHLOROGENIC ACID; ANTIOXIDANT ACTIVITY; GALLIC ACID; IN-VITRO; CAFFEIC
   ACID; DIETARY POLYPHENOLS; PHENOLIC-COMPOUNDS; OXIDATIVE STRESS; GELATIN
   FILMS; ELLAGIC ACID
AB Polyphenols are compounds naturally present in fruits and vegetables that are gaining more and more attention due to their therapeutic effects and their potential technological applications. In this review, we intend to demonstrate the importance of some phenolic compounds, addressing their biological effects and potential for applications in various industrial fields. The intake of these compounds in appropriate concentrations can present promising effects in the prevention of diseases such as diabetes, obesity, Parkinson's, Alzheimer's, and others. They can also be used to improve the physicochemical properties of starch, in the preservation of foods, as natural dyes, prebiotic ingredients, hydrogels and nanocomplexes. In addition, these compounds have potential for innovation in the most diverse technological fields, including organic fine chemistry, basic materials chemistry, pharmaceuticals, food chemistry, chemical engineering, etc.
C1 [de Araujo, Fabio Fernandes; Farias, David de Paulo; Neri-Numa, Iramaia Angelica; Pastore, Glaucia Maria] Univ Estadual Campinas, Fac Food Engn, Dept Food Sci, Bioflavors & Bioact Cpds Lab, Rua Monteiro Lobato 80, BR-13083862 Campinas, SP, Brazil.
C3 Universidade Estadual de Campinas
RP de Araújo, FF; Farias, DD (corresponding author), Univ Estadual Campinas, Fac Food Engn, Dept Food Sci, Bioflavors & Bioact Cpds Lab, Rua Monteiro Lobato 80, BR-13083862 Campinas, SP, Brazil.
EM fabio.fernandesn18@gmail.com; farias.davidp@gmail.com
RI Farias, David/Y-7537-2019; Araújo, Fábio/ABD-5401-2020; Numa,
   Iramaia/T-7472-2019
OI Araujo, Fabio/0000-0001-5113-877X; Farias, David/0000-0003-0282-978X
FU National Council for Scientific and Technological Development,
   CNPq-Brazil [406820/2018-0]; Sao Paulo Research Foundation,
   FAPESP-Brazil [2015/50333-1]; Coordination for the Improvement of Higher
   Education Personnel, CAPES-Brazil [001]; CNPq [160639/2017-4]; Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [15/50333-1]
   Funding Source: FAPESP
FX The authors thanks the National Council for Scientific and Technological
   Development, CNPq-Brazil (grant number 406820/2018-0), Sao Paulo
   Research Foundation, FAPESP-Brazil (grant number 2015/50333-1) and
   Coordination for the Improvement of Higher Education Personnel,
   CAPES-Brazil (Finance Code 001) for their financial support. F.F.A
   (studentship 160639/2017-4) thanks the CNPq.
CR Adami R, 2019, J SUPERCRIT FLUID, V143, P82, DOI 10.1016/j.supflu.2018.07.020
   Addepalli V, 2018, BIOMED PHARMACOTHER, V108, P1517, DOI 10.1016/j.biopha.2018.09.179
   Agunloye OM, 2019, BIOMED PHARMACOTHER, V109, P450, DOI 10.1016/j.biopha.2018.10.044
   Ali F, 2019, NEUROSCI LETT, V692, P90, DOI 10.1016/j.neulet.2018.10.053
   [Anonymous], 2008, Official Journal of the European Union, V16
   Bakoyiannis I, 2019, BIOMED PHARMACOTHER, V109, P1488, DOI 10.1016/j.biopha.2018.10.086
   Barauna SC, 2018, METAB BRAIN DIS, V33, P1985, DOI 10.1007/s11011-018-0306-3
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Bener M, 2010, IND CROP PROD, V32, P499, DOI 10.1016/j.indcrop.2010.06.020
   Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Bondonno NP, 2020, CLIN NUTR, V39, P141, DOI 10.1016/j.clnu.2019.01.004
   Cano A, 2020, FOOD HYDROCOLLOID, V100, DOI 10.1016/j.foodhyd.2019.105443
   Cao Z, 2018, J CELL PHYSIOL, V233, P2332, DOI 10.1002/jcp.26105
   Carloni P, 2013, FOOD RES INT, V53, P900, DOI 10.1016/j.foodres.2012.07.057
   Cassidy A, 2018, MOL ASPECTS MED, V61, P76, DOI 10.1016/j.mam.2017.05.002
   Castello F, 2018, ARCH BIOCHEM BIOPHYS, V646, P1, DOI 10.1016/j.abb.2018.03.021
   Catroux P., 2001, [No title captured], Patent No. [ES2225548T3., 2225548T3]
   Chaitanya L. G., 2014, Research Journal of Chemical Sciences, V4, P87
   Chatham LA, 2020, FOOD CHEM, V310, DOI 10.1016/j.foodchem.2019.125734
   Chen GL, 2019, FOOD CHEM, V277, P706, DOI 10.1016/j.foodchem.2018.11.040
   Chen JY, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4231-y
   Chen L, 2019, TRENDS FOOD SCI TECH, V85, P149, DOI 10.1016/j.tifs.2018.11.026
   Chen TT, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801064
   Chen X, 2018, FOOD RES INT, V114, P30, DOI 10.1016/j.foodres.2018.07.062
   Cladis DP, 2020, FOOD CHEM TOXICOL, V139, DOI 10.1016/j.fct.2020.111254
   Czubinski J, 2019, FOOD RES INT, V116, P1126, DOI 10.1016/j.foodres.2018.09.057
   Dasgupta F., 2013, [No title captured], Patent No. [US8513374B2., 8513374]
   de Araújo FF, 2019, FOOD RES INT, V121, P57, DOI 10.1016/j.foodres.2019.03.018
   de la Rosa LA, 2019, POSTHARVEST PHYSIOLOGY AND BIOCHEMISTRY OF FRUITS AND VEGETABLES, P253, DOI 10.1016/B978-0-12-813278-4.00012-9
   Decker K. J., 2018, CAN POLYPHENOLS SERV
   Del Bo C, 2019, CHEM-BIOL INTERACT, V300, P49, DOI 10.1016/j.cbi.2019.01.002
   Ding XQ, 2019, BIOMED PHARMACOTHER, V110, P85, DOI 10.1016/j.biopha.2018.11.018
   Du J, 2019, INT J BIOL MACROMOL, V132, P1193, DOI 10.1016/j.ijbiomac.2019.04.046
   Ebrahimi I, 2016, COLOR TECHNOL, V132, P162, DOI 10.1111/cote.12204
   Edwards M, 2015, J AGR FOOD CHEM, V63, P2423, DOI 10.1021/jf5041993
   El SN, 2012, COMPR REV FOOD SCI F, V11, P2, DOI 10.1111/j.1541-4337.2011.00167.x
   Muñoz AE, 2020, LWT-FOOD SCI TECHNOL, V128, DOI 10.1016/j.lwt.2020.109457
   Fan SL, 2018, LIFE SCI, V207, P205, DOI 10.1016/j.lfs.2018.06.006
   Fang ZX, 2018, FOOD CHEM, V260, P90, DOI 10.1016/j.foodchem.2018.04.005
   Farias DD, 2019, TRENDS FOOD SCI TECH, V93, P23, DOI 10.1016/j.tifs.2019.09.004
   Farias DD, 2020, FOOD CHEM, V306, DOI 10.1016/j.foodchem.2019.125630
   Farrag Y, 2018, INT J BIOL MACROMOL, V118, P2201, DOI 10.1016/j.ijbiomac.2018.07.087
   Fei JL, 2019, BIOMED PHARMACOTHER, V109, P1586, DOI 10.1016/j.biopha.2018.09.161
   Ferreira LP, 2017, IND CROP PROD, V97, P599, DOI 10.1016/j.indcrop.2016.12.064
   Fikry EM, 2019, BIOMED PHARMACOTHER, V110, P878, DOI 10.1016/j.biopha.2018.12.041
   Frauches NS, 2016, BRIT J PHARM RES, V12, DOI 10.9734/BJPR/2016/26782
   Ganeshpurkar A, 2018, INT IMMUNOPHARMACOL, V54, P261, DOI 10.1016/j.intimp.2017.11.022
   Garrido EMPJ, 2018, FOOD CHEM, V254, P260, DOI 10.1016/j.foodchem.2018.02.007
   Ge J, 2018, FOOD HYDROCOLLOID, V74, P23, DOI 10.1016/j.foodhyd.2017.07.029
   Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75
   Gowd V, 2019, TRENDS FOOD SCI TECH, V93, P81, DOI 10.1016/j.tifs.2019.09.005
   Gu RX, 2018, BIOMED PHARMACOTHER, V105, P491, DOI 10.1016/j.biopha.2018.05.158
   Gunm L., 2018, GUT BOOSTING POTENTI
   Heleno SA, 2015, FOOD CHEM, V173, P501, DOI 10.1016/j.foodchem.2014.10.057
   Huang BX, 2018, J FUNCT FOODS, V45, P452, DOI 10.1016/j.jff.2018.04.018
   Hytti M, 2017, J NUTR BIOCHEM, V42, P37, DOI 10.1016/j.jnutbio.2016.12.014
   Iglesias-Carres L, 2019, FOOD CHEM, V299, DOI 10.1016/j.foodchem.2019.125092
   Jiang J, 2018, FOOD CHEM, V268, P334, DOI 10.1016/j.foodchem.2018.06.015
   Jiang L, 2020, MATER DESIGN, V192, DOI 10.1016/j.matdes.2020.108674
   Jiao XY, 2019, J NUTR BIOCHEM, V64, P88, DOI 10.1016/j.jnutbio.2018.07.008
   Kaewprachu P, 2018, FOOD PACKAGING SHELF, V18, P173, DOI 10.1016/j.fpsl.2018.10.011
   Kfoury M, 2019, FOOD CHEM, V278, P163, DOI 10.1016/j.foodchem.2018.11.055
   Khoo HE, 2017, FOOD NUTR RES, V61, P1, DOI 10.1080/16546628.2017.1361779
   Kumari M., 2012, RES J RECENT SCI, V1, P1
   Landete JM, 2011, FOOD RES INT, V44, P1150, DOI 10.1016/j.foodres.2011.04.027
   Li PP, 2019, FOOD HYDROCOLLOID, V92, P208, DOI 10.1016/j.foodhyd.2019.02.002
   Li XH, 2019, CARBOHYD POLYM, V207, P160, DOI 10.1016/j.carbpol.2018.11.084
   Links MR, 2015, J FUNCT FOODS, V12, P55, DOI 10.1016/j.jff.2014.11.003
   Liu B, 2017, DYES PIGMENTS, V142, P32, DOI 10.1016/j.dyepig.2017.03.023
   Liu J, 2018, INT J BIOL MACROMOL, V116, P1011, DOI 10.1016/j.ijbiomac.2018.05.149
   Liu J, 2018, INT J BIOL MACROMOL, V114, P130, DOI 10.1016/j.ijbiomac.2018.03.101
   Loi M, 2018, FOOD RES INT, V106, P763, DOI 10.1016/j.foodres.2018.01.050
   López CJ, 2019, FOOD CHEM, V275, P426, DOI 10.1016/j.foodchem.2018.09.099
   Neto ML, 2018, SPECTROCHIM ACTA A, V193, P249, DOI 10.1016/j.saa.2017.12.036
   Lukic I, 2019, FOOD CHEM, V300, DOI 10.1016/j.foodchem.2019.125251
   Mahobiya A, 2018, PHARMACOL REP, V70, P863, DOI 10.1016/j.pharep.2018.03.006
   Gómez-Caravaca AM, 2014, POLYPHENOLS IN PLANTS: ISOLATION, PURIFICATION AND EXTRACT PREPARATION, P37, DOI 10.1016/B978-0-12-397934-6.00003-6
   Mazed M. A., 2009, [No title captured], Patent No. [US8017147B2, 8017147]
   Mendoz J, 2018, DYES PIGMENTS, V151, P321, DOI 10.1016/j.dyepig.2018.01.007
   Mocciaro G, 2019, J FUNCT FOODS, V63, DOI 10.1016/j.jff.2019.103576
   Molino S, 2018, J FUNCT FOODS, V49, P188, DOI 10.1016/j.jff.2018.07.056
   Murakami A, 2014, ARCH BIOCHEM BIOPHYS, V557, P3, DOI 10.1016/j.abb.2014.04.018
   Netke S., 2008, [No title captured], Patent No. [AU2003235762B2., 2003235762]
   Oracz J, 2019, FOOD RES INT, V115, P135, DOI 10.1016/j.foodres.2018.08.028
   Orbit, 2020, QUEST NEW PORT PAT D
   Park S, 2019, J NUTR BIOCHEM, V63, P87, DOI 10.1016/j.jnutbio.2018.09.024
   Park YS, 2015, FOOD RES INT, V74, P37, DOI 10.1016/j.foodres.2015.04.021
   Phan K, 2020, DYES PIGMENTS, V176, DOI 10.1016/j.dyepig.2019.108180
   Rashid S, 2018, J MED FOOD, V21, P390, DOI 10.1089/jmf.2017.0078
   Rodriguez-Amaya DB, 2019, FOOD RES INT, V124, P200, DOI 10.1016/j.foodres.2018.05.028
   Rui LY, 2017, CARBOHYD POLYM, V170, P206, DOI 10.1016/j.carbpol.2017.04.076
   Santana AL, 2018, J FUNCT FOODS, V47, P457, DOI 10.1016/j.jff.2018.05.048
   Santos S., 2018, NUTR METAB CARDIOVAS, V28, P1188, DOI DOI 10.1016/J.NUMECD.2018.06.019
   Saulite L, 2019, PHYTOMEDICINE, V53, P86, DOI 10.1016/j.phymed.2018.09.029
   Sganzerla WG, 2020, INT J BIOL MACROMOL, V147, P295, DOI 10.1016/j.ijbiomac.2020.01.074
   Sharma D, 2019, BIOMED PHARMACOTHER, V109, P1610, DOI 10.1016/j.biopha.2018.10.195
   Shi J, 2020, IND CROP PROD, V145, DOI 10.1016/j.indcrop.2020.112130
   Shirmohammadli Y, 2018, IND CROP PROD, V126, P316, DOI 10.1016/j.indcrop.2018.10.034
   Singh S, 2019, PHYTOMEDICINE, V55, P92, DOI 10.1016/j.phymed.2018.07.009
   Skrovankova S, 2015, INT J MOL SCI, V16, P24673, DOI 10.3390/ijms161024673
   Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336
   Thilavech T, 2018, J FUNCT FOODS, V49, P258, DOI 10.1016/j.jff.2018.08.034
   Uranga J, 2018, FOOD HYDROCOLLOID, V84, P313, DOI 10.1016/j.foodhyd.2018.06.018
   Urbatzka R, 2018, EUR J MED CHEM, V151, P272, DOI 10.1016/j.ejmech.2018.03.036
   Vilela C, 2017, FOOD HYDROCOLLOID, V73, P120, DOI 10.1016/j.foodhyd.2017.06.037
   Vinha A.F., 2018, Polyphenols: Properties, Recovery, and Applications ed, P363, DOI 10.1016/B978-0-12-813572-3.00011-7
   Vuolo MM, 2019, BIOACTIVE COMPOUNDS: HEALTH BENEFITS AND POTENTIAL APPLICATIONS, P33, DOI 10.1016/B978-0-12-814774-0.00002-5
   Xing J, 2019, INT IMMUNOPHARMACOL, V66, P146, DOI 10.1016/j.intimp.2018.11.016
   Yang H, 2019, CHEM-BIOL INTERACT, V297, P44, DOI 10.1016/j.cbi.2018.10.016
   Yu M, 2019, NEUROBIOL DIS, V124, P67, DOI 10.1016/j.nbd.2018.11.009
   Zaitone SA, 2019, PHARMACOL REP, V71, P32, DOI 10.1016/j.pharep.2018.08.004
   Zhang JJ, 2019, FOOD CHEM, V272, P306, DOI 10.1016/j.foodchem.2018.08.041
   Zhang XK, 2018, FOOD RES INT, V106, P568, DOI 10.1016/j.foodres.2017.12.054
   Zhao YJ, 2019, J SUPERCRIT FLUID, V143, P97, DOI 10.1016/j.supflu.2018.07.025
   Zheleva-Dimitrova D, 2019, FOOD CHEM TOXICOL, V134, DOI 10.1016/j.fct.2019.110841
   Zhou BH, 2019, FOOD CHEM TOXICOL, V123, P16, DOI 10.1016/j.fct.2018.10.036
   Zhu L, 2019, INT IMMUNOPHARMACOL, V67, P129, DOI 10.1016/j.intimp.2018.11.049
   Zou B, 2014, J FUNCT FOODS, V11, P330, DOI 10.1016/j.jff.2014.10.016
NR 118
TC 287
Z9 293
U1 53
U2 899
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD FEB 15
PY 2021
VL 338
AR 127535
DI 10.1016/j.foodchem.2020.127535
PG 15
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA OE5GW
UT WOS:000580559700098
PM 32798817
OA hybrid
DA 2025-04-28
ER

PT J
AU Fujii, K
   Ota, Y
   Nishiyama, K
   Kunitake, H
   Yamasaki, Y
   Tari, H
   Araki, K
   Arakawa, T
   Yamasaki, M
AF Fujii, Kento
   Ota, Yuma
   Nishiyama, Kazuo
   Kunitake, Hisato
   Yamasaki, Yumi
   Tari, Hiroyuki
   Araki, Kaori
   Arakawa, Teruaki
   Yamasaki, Masao
TI Blueberry Leaf Polyphenols Prevent Body Fat Accumulation in Mice Fed
   High-fat, High-sucrose Diet
SO JOURNAL OF OLEO SCIENCE
LA English
DT Article
DE blueberry leaf; polyphenol; chlorogenic acid; proanthocyanidin; obesity
ID ASHEI-READE LEAVES; LIPID-METABOLISM; GREEN TEA; ANTIOXIDANT; RATS;
   INFLAMMATION; EXTRACT; OBESITY
AB Blueberry leaf is currently a popular dietary supplement. Effects of dietary blueberry leaf and its active components on body fat accumulation were examined. C57BL/6J mice were fed high-fat, high-sucrose diet with or without 3% blueberry leaf extract (BLEx) or 3% concentrated-polyphenolic BLEx (CP BLEx) for 8 weeks. Compared to mice fed a high-fat, high-sucrose diet without blueberry leaf, BLEx and CP BLEx significantly reduced body weight and adipose tissue weight gain. Adipocytes were also smaller and and liver lipid accumulatioin was significantly inhibited in mice fed either BLEx or CP BLEx. These effects tended to be more pronounced in mice fed CP BLEx compared to in mice fed BLEx. Together, results suggest that blueberry leaf inhibits body fat accumulation typically observed in mice fed a high-fat, high-sucrose diet, and that inhibition is attributable to polyphenolic components in leaf extracts.
C1 [Fujii, Kento; Ota, Yuma; Nishiyama, Kazuo; Kunitake, Hisato; Yamasaki, Masao] Univ Miyazaki, Fac Agr, Dept Biochem & Appl Biosci, 1-1 Gakuenkibanadai Nishi, Miyazaki 8892192, Japan.
   [Yamasaki, Yumi] Univ Miyazaki, Fac Reg Innovat, 1-1 Gakuenkibanadai Nishi, Miyazaki 8892192, Japan.
   [Tari, Hiroyuki; Araki, Kaori; Arakawa, Teruaki] Bizen Chem Co Ltd, 363 Tokudomi, Akaiwa 7090716, Japan.
C3 University of Miyazaki; University of Miyazaki
RP Yamasaki, M (corresponding author), Univ Miyazaki, Fac Agr, Dept Biochem & Appl Biosci, 1-1 Gakuenkibanadai Nishi, Miyazaki 8892192, Japan.
EM myamasaki@cc.miyazaki-u.ac.jp
CR Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321
   Bagchi D, 2014, MUTAT RES-FUND MOL M, V768, P69, DOI 10.1016/j.mrfmmm.2014.04.004
   Cha JW, 2014, BIOMOL THER, V22, P136, DOI 10.4062/biomolther.2014.006
   Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003
   da Costa GF, 2017, PHYTOTHER RES, V31, P1621, DOI 10.1002/ptr.5898
   Dai N, 2014, J MED FOOD, V17, P663, DOI 10.1089/jmf.2013.2834
   Ehlenfeldt MK, 2001, J AGR FOOD CHEM, V49, P2222, DOI 10.1021/jf0013656
   Elshorbagy AK, 2012, J NUTR BIOCHEM, V23, P332, DOI 10.1016/j.jnutbio.2010.12.009
   FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406
   Gil-Cardoso K, 2018, J NUTR BIOCHEM, V62, P35, DOI 10.1016/j.jnutbio.2018.07.012
   Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046
   Haczeyni F, 2018, OBES REV, V19, P406, DOI 10.1111/obr.12646
   Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007
   Inoue N, 2011, BIOSCI BIOTECH BIOCH, V75, P2304, DOI 10.1271/bbb.110451
   Koga K, 2013, J FOOD SCI, V78, pH105, DOI 10.1111/1750-3841.12001
   Nagao K, 2008, BIOSCI BIOTECH BIOCH, V72, P1619, DOI 10.1271/bbb.80036
   Neyrinck AM, 2017, J NUTR BIOCHEM, V49, P15, DOI 10.1016/j.jnutbio.2017.07.008
   Ozguven S, 2016, EUR J NUCL MED MOL I, V43, P355, DOI 10.1007/s00259-015-3166-7
   Park Su-Hui, 2008, Nutr Res Pract, V2, P227, DOI 10.4162/nrp.2008.2.4.227
   Pero RW, 2009, PHYTOTHER RES, V23, P335, DOI 10.1002/ptr.2628
   Sakaida H, 2007, BIOSCI BIOTECH BIOCH, V71, P2335, DOI 10.1271/bbb.70277
   SONG SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/718379
   Suzuki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02749
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077585
   Yamasaki M, 2015, FOOD SCI TECHNOL RES, V21, P827, DOI 10.3136/fstr.21.827
NR 29
TC 12
Z9 12
U1 1
U2 31
PU JAPAN OIL CHEMISTS SOC
PI TOKYO
PA YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO,
   103-0027, JAPAN
SN 1345-8957
EI 1347-3352
J9 J OLEO SCI
JI J. Oleo Sci.
PD MAY
PY 2019
VL 68
IS 5
BP 471
EP 479
DI 10.5650/jos.ess18226
PG 9
WC Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology
GA IA0GF
UT WOS:000469234200008
PM 30971641
OA gold
DA 2025-04-28
ER

PT J
AU Sousa, S
   de Morais, IL
   Albuquerque, G
   Gelormini, M
   Casal, S
   Pinho, O
   Motta, C
   Damasceno, A
   Moreira, P
   Breda, J
   Lunet, N
   Padrao, P
AF Sousa, Sofia
   de Morais, Ines Lanca
   Albuquerque, Gabriela
   Gelormini, Marcello
   Casal, Susana
   Pinho, Olivia
   Motta, Carla
   Damasceno, Albertino
   Moreira, Pedro
   Breda, Joao
   Lunet, Nuno
   Padrao, Patricia
TI A Cross-Sectional Study of the Street Foods Purchased by Customers in
   Urban Areas of Central Asia
SO NUTRIENTS
LA English
DT Article
DE street food; nutritional value; nutrition transition; central Asia
ID SUGAR-SWEETENED BEVERAGES; CARDIOVASCULAR-DISEASE; OBESITY; WEIGHT;
   SODIUM; MAPUTO; DIET
AB This study aimed to describe street food purchases in cities from Central Asia, considering customers' characteristics and the nutritional composition of the foods and beverages. Cross-sectional studies were conducted in 2016/2017 in Dushanbe (Tajikistan), Bishkek (Kyrgyzstan), Ashgabat (Turkmenistan) and Almaty (Kazakhstan). Direct observation was used to collect data on the purchases made by street food customers, selected by random and systematic sampling. Nutritional composition was estimated using data from chemical analyses, food composition tables or food labels. A total of 714 customers (56.6% females, 55.5% aged degrees 5 years, 23.3% overweight/obese) were observed, who bought 852 foods and beverages, the most frequent being savoury pastries/snacks (23.2%), main dishes (19.0%), sweet pastries/confectionery (17.9%), tea/coffee (11.3%) and soft drinks/juices (9.8%). Fruit was the least purchased food (1.1%). Nearly one-third of customers purchased industrial food items (31.9%). The median energy content of a street food purchase was 529 kcal/serving. Saturated and trans-fat median contents were 4.7 g/serving and 0.36 g/serving (21.4% and 16.5% of maximum daily intake recommendations, respectively). Median sodium and potassium contents were 745 mg/serving (37.3% of maximum recommendation) and 304 mg/serving (8.7% of minimum recommendation), respectively. In general, the purchases observed presented high contents of energy, saturated-fat, trans-fat and sodium, and low levels of potassium. Policies towards the improvement of these urban food environments should be encouraged.
C1 [Sousa, Sofia; Albuquerque, Gabriela; Casal, Susana; Damasceno, Albertino; Moreira, Pedro; Lunet, Nuno; Padrao, Patricia] Univ Porto, EPIUnit Inst Saude Publ, Rua Taipas 135, P-4050600 Porto, Portugal.
   [Sousa, Sofia; Albuquerque, Gabriela; Casal, Susana; Damasceno, Albertino; Moreira, Pedro; Lunet, Nuno; Padrao, Patricia] Lab Invest Integrat & Translac Saude Populac ITR, Rua Taipas 135, P-4050600 Porto, Portugal.
   [Sousa, Sofia; Pinho, Olivia; Moreira, Pedro; Padrao, Patricia] Univ Porto, Fac Ciencias Nutr & Alimentacao, Rua Campo Alegre 823, P-4150180 Porto, Portugal.
   [de Morais, Ines Lanca; Gelormini, Marcello] WHO, Nutr Phys Act & Obes Programme, Reg Off Europe, Div Noncommunicable Dis & Life Course, Marmorvej 51, DK-2100 Copenhagen, Denmark.
   [Casal, Susana; Pinho, Olivia] Univ Porto, Fac Farm, Lab Bromatol & Hidrol, REQUIMTE, Rua D Manuel II, P-4050313 Porto, Portugal.
   [Motta, Carla] Inst Nacl Saude Doutor Ricardo Jorge INSA, Dept Alimentacao & Nutr, Ave Padre Cruz, P-1649016 Lisbon, Portugal.
   [Damasceno, Albertino; Lunet, Nuno] Univ Porto, Dept Ciencias Saude Publ & Forenses & Educ Med, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.
   [Damasceno, Albertino] Univ Eduardo Mondlane, Fac Med, Ave Salvador Allende 702, Maputo 257, Mozambique.
   [Moreira, Pedro] Univ Porto, Ctr Invest Atividade Fis Saude & Lazer, Rua Dr Placido Costa 91, P-4200450 Porto, Portugal.
   [Breda, Joao] WHO, Reg Off Europe, Marmorvej 51, DK-2100 Copenhagen, Denmark.
C3 Universidade do Porto; Universidade do Porto; World Health Organization;
   Universidade do Porto; Instituto Nacional de Saude Dr. Ricardo Jorge;
   Universidade do Porto; Eduardo Mondlane University; Universidade do
   Porto; World Health Organization
RP Padrao, P (corresponding author), Univ Porto, EPIUnit Inst Saude Publ, Rua Taipas 135, P-4050600 Porto, Portugal.; Padrao, P (corresponding author), Lab Invest Integrat & Translac Saude Populac ITR, Rua Taipas 135, P-4050600 Porto, Portugal.; Padrao, P (corresponding author), Univ Porto, Fac Ciencias Nutr & Alimentacao, Rua Campo Alegre 823, P-4150180 Porto, Portugal.
EM sofia.sousa@ispup.up.pt; inesbolm@gmail.com;
   gabriela.albuquerque@ispup.up.pt; marcello.gelormini@gmail.com;
   sucasal@ff.up.pt; oliviapinho@fcna.up.pt; carla.motta@insa.min-saude.pt;
   tino_7117@hotmail.com; pedromoreira@fcna.up.pt;
   rodriguesdasilvabred@who.int; nlunet@med.up.pt;
   patriciapadrao@fcna.up.pt
RI Albuquerque, Gabriela/GPC-7658-2022; Pinho, Olivia/D-6989-2013; Moreira,
   Pedro/K-5456-2012; Albuquerque, Gabriela/D-9905-2018; Breda,
   Joao/J-9371-2014; Casal, Susana/D-6603-2011; Padrao,
   Patricia/K-8230-2012; Moreira, Pedro/U-3034-2019
OI Lunet, Nuno/0000-0003-1870-1430; Albuquerque,
   Gabriela/0000-0002-0212-6868; Motta, Carla/0000-0002-8382-312X; Pinho,
   Olivia/0000-0001-9477-8638; Azevedo de Sousa, Sofia/0000-0001-8389-1758;
   Breda, Joao/0000-0002-8177-4926; Casal, Susana/0000-0002-1686-3850;
   Padrao, Patricia/0000-0001-6310-4956; Moreira, Pedro/0000-0002-7035-7799
FU World Health Organization Europe [2015/591370-0, 2017/698514]; Ministry
   of Health of the Russian Federation; FCT (Fundacao para a Ciencia e
   Tecnologia-Ministerio da Ciencia, Tecnologia e Ensino Superior)
   [UID/QUI/50006/2020, UIDB/04750/2020]; FCT [SFRH/BD/130650/2017,
   SFRH/BD/118630/2016]; Human Capital Operational Programme of the
   European Social Fund (POCH/FSE); Fundação para a Ciência e a Tecnologia
   [SFRH/BD/130650/2017, UIDB/04750/2020] Funding Source: FCT
FX The FEEDCities project is funded by the World Health Organization Europe
   (WHO registration 2015/591370-0 and 2017/698514) and by the Ministry of
   Health of the Russian Federation. The EPIUnit-Instituto de Saude
   Publica, Universidade do Porto (Ref. UIDB/04750/2020) and the
   Investigation Unit LAQV/REQUIMTE (UID/QUI/50006/2020) are funded by
   Portuguese funds from FCT (Fundacao para a Ciencia e
   Tecnologia-Ministerio da Ciencia, Tecnologia e Ensino Superior).
   Individual grants attributed to SS (SFRH/BD/130650/2017) and GA
   (SFRH/BD/118630/2016) are funded by FCT and the Human Capital
   Operational Programme of the European Social Fund (POCH/FSE).
CR Abrahale K, 2019, J HUM NUTR DIET, V32, P152, DOI 10.1111/jhn.12604
   Albuquerque G, 2020, FOOD SCI NUTR, V8, P5309, DOI 10.1002/fsn3.1753
   Albuquerque G, 2019, BRIT J NUTR, V122, P1052, DOI 10.1017/S0007114519001892
   [Anonymous], 2019, Turkmenistan: Employment in agriculture
   [Anonymous], Noncommunicable diseases-key facts
   [Anonymous], 2018, Key facts
   [Anonymous], Wisconsin School Food Safety
   AOAC, 2000, OFF METH AN AOAC INT
   D'Elia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070
   Louzada MLD, 2018, PUBLIC HEALTH NUTR, V21, P94, DOI 10.1017/S1368980017001434
   de Morais IL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010098
   de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978
   Eurasian Economic Commission, 2011, 0242011 TP TC EUR EC
   Fellows P., 2012, SELLING STREET SNACK
   Food and Agriculture Organization, 2019, EUR CENTR AS REG OV
   Food and Agriculture Organization, 1989, 46 FAO
   Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x
   Gupta V, 2016, J NUTR EDUC BEHAV, V48, P269, DOI 10.1016/j.jneb.2015.11.006
   Harris CV, 2008, INT J OBESITY, V32, P336, DOI 10.1038/sj.ijo.0803704
   Hussain T., 2001, Food Composition Table for Pakistan
   Juul F, 2018, BRIT J NUTR, V120, P90, DOI [10.1017/S0007114518001046, 10.1017/s0007114518001046]
   Kelly M., 2016, Eating, Drinking: Surviving: The International Year of Global Understanding-IYGU, P83, DOI [DOI 10.1007/978-3-319-42468-29, 10.1007/978-3-319-42468-29, 10.1007/978-3-319-42468-2_9, DOI 10.1007/978-3-319-42468-2_9]
   Kurlansky Mark., 2003, SALT WORLD HIST
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Lunet N., 2019, FEEDcities project-A comprehensive characterization of the street food environment in cities
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Ministry of Food Agriculture and Livestock of Turkey, TURKOMP NAT FOOD COM
   Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107
   Nago ES, 2010, BRIT J NUTR, V103, P281, DOI 10.1017/S0007114509991668
   Namugumya BS, 2012, PUBLIC HEALTH NUTR, V15, P1503, DOI 10.1017/S1368980011002710
   Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Popkin BM, 2011, P NUTR SOC, V70, P82, DOI 10.1017/S0029665110003903
   Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7
   Poti JM, 2017, CURR OBES REP, V6, P420, DOI 10.1007/s13679-017-0285-4
   Rauber F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050587
   Sousa Sofia, 2019, Nutrition and Health (Bicester), V25, P37, DOI 10.1177/0260106018816427
   Sousa S, 2018, J PUBLIC HEALTH-UK, V40, P659, DOI 10.1093/pubmed/fdx113
   Steele EM, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0119-3
   Steyn NP, 2014, PUBLIC HEALTH NUTR, V17, P1363, DOI 10.1017/S1368980013001158
   Uauy R, 2009, EUR J CLIN NUTR, V63, pS68, DOI 10.1038/ejcn.2009.15
   United Nations, 2013, URB CENTR AS CHALL I
   Whelton PK, 2012, CIRCULATION, V126, P2880, DOI 10.1161/CIR.0b013e318279acbf
   WHO, 2003, WHO TECH REP SER, V916, P1
   WHO, 2012, Guideline: Sodium Intake for Adults and Children
   WHO Europe, 2020, TACKL NONC DIS UKR 2, V45, DOI DOI 10.2900/112339
   World Health Organization, 2015, EL T FATS EUR POL BR
   World Health Organization, 2019, FEEDCITIES PROJ FOOD
   World Health Organization, 2017, CRAVEN COUNTY PROFIL
   World Health Organization, 2012, Potassium intake for adults and children
NR 51
TC 6
Z9 7
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2021
VL 13
IS 10
AR 3651
DI 10.3390/nu13103651
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA WU2UK
UT WOS:000716405100001
PM 34684652
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Li, MW
   Liu, D
   Han, TT
   Li, J
   Chen, LB
   Li, DX
   Xie, ZW
AF Li, Mengwan
   Liu, Dan
   Han, Tingting
   Li, Juan
   Chen, Linbo
   Li, Daxiang
   Xie, Zhongwen
TI Comparative investigation of metabolite signatures and hypoadiposity
   effect between Dali tea and Yunkang tea
SO FOOD CHEMISTRY-X
LA English
DT Article
DE Camellia taliensis; Metabolomics; Characteristic compounds;
   Hypoadiposity
AB Dali tea (DLT) made by wild tea plant (Camellia taliensis) has been very popular in the market.However, the signature compounds and health benefits of DLT were not reported yet. To comprehensively understand metabolite signatures and potential health-function, the distinct metabolite signatures and hypoadiposity effect between DLT and Yunkang tea (YKT, made by Camellia sinensis var assamica cv. Yunkang 10) were comparative investigated. Our data found that catechins, and dimeric catechins were lower in DLT than YKT. In contrast, the levels of phenolic acid and amino acids were higher in DLT than YKT. An un-targeted metabolomics and a chemometric analysis indicated that flavonoid biosynthesis is a major pathway that distinguishes DLT from YKT. Additionally, chlorogenic acid, ellagic acid, arginine, tyrosine, and theanine were identified as characteristic metabolites of DLT. Furthermore, animal experiment showed that YKT performs better efficiency than DLT on alleviating hyperadiposity and renal damages in high-fat-diet induced obese mice.
C1 [Li, Mengwan; Liu, Dan; Han, Tingting; Li, Daxiang; Xie, Zhongwen] Anhui Agr Univ, Sch Tea & Food Sci & Technol, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Anhui, Peoples R China.
   [Li, Mengwan; Liu, Dan; Han, Tingting; Li, Daxiang; Xie, Zhongwen] Anhui Agr Univ, Joint Res Ctr Food Nutr & Hlth IHM, Hefei 230036, Anhui, Peoples R China.
   [Li, Juan] Anhui Agr Univ, Ctr Biotechnol, Hefei 230036, Anhui, Peoples R China.
   [Chen, Linbo] Yunnan Acad Agr Sci, Tea Res Inst, Menghai 666201, Yunnan, Peoples R China.
C3 Anhui Agricultural University; Anhui Agricultural University; Anhui
   Agricultural University; Yunnan Academy of Agricultural Sciences
RP Li, DX; Xie, ZW (corresponding author), Anhui Agr Univ, Sch Tea & Food Sci & Technol, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Anhui, Peoples R China.
EM dxli@ahau.edu.cn; zhongwenxie@ahau.edu.cn
RI Han, Tingting/AFL-9459-2022; li, daxiang/H-6815-2017; Xie,
   Zhongwen/I-7705-2019
FU National Key Research and Development Program of China [2021YFD1601102];
   Research Funds of Joint Research Center for Food Nutrition and Health of
   IHM [2023SJY02]; Earmarked Found for CARS [CARS-19]
FX This research was funded by the National Key Research and Development
   Program of China (2021YFD1601102) , Research Funds of Joint Research
   Center for Food Nutrition and Health of IHM (Grant numbers: 2023SJY02) ,
   and Earmarked Found for CARS (Grant numbers: CARS-19) .
CR Fang ZT, 2021, J FOOD COMPOS ANAL, V97, DOI 10.1016/j.jfca.2020.103772
   Gao DF, 2008, J AGR FOOD CHEM, V56, P7517, DOI 10.1021/jf800878m
   Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668
   Gu QY, 2022, J NUTR BIOCHEM, V108, DOI 10.1016/j.jnutbio.2022.109085
   Kim S, 2023, NUCLEIC ACIDS RES, V51, pD1373, DOI 10.1093/nar/gkac956
   Li DX, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051115
   Li MW, 2022, FOOD RES INT, V159, DOI 10.1016/j.foodres.2022.111639
   Li MW, 2021, FOODS, V10, DOI 10.3390/foods10051070
   Liang XJ, 2022, MOLECULES, V27, DOI 10.3390/molecules27051564
   Lim HJ, 2022, IN VIVO, V36, P1753, DOI 10.21873/invivo.12888
   Liu YJ, 2020, FOOD RES INT, V135, DOI 10.1016/j.foodres.2020.109276
   Liu Y, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-92
   Meng XH, 2019, J AGR FOOD CHEM, V67, P5318, DOI 10.1021/acs.jafc.8b05037
   Meyer RS, 2015, PHYTOCHEMISTRY, V115, P194, DOI 10.1016/j.phytochem.2015.02.006
   Ming T., 1992, Acta Bot Yunnanica, V14, P115
   Pang ZQ, 2022, NAT PROTOC, V17, P1735, DOI 10.1038/s41596-022-00710-w
   Patial V, 2023, LIFE SCI, V316, DOI 10.1016/j.lfs.2023.121437
   Pollastri S, 2011, ANN BOT-LONDON, V108, P1225, DOI 10.1093/aob/mcr234
   Shimamura Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1455, DOI 10.1271/bbb.130097
   Swaminathan S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212071
   Teng Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010075
   Tung YC, 2022, FOOD FUNCT, V13, P2846, DOI [10.1039/d1fo03356e, 10.1039/D1FO03356E]
   Wang LX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040833
   Wei K, 2012, FOOD CHEM, V130, P720, DOI 10.1016/j.foodchem.2011.07.092
   Wishart DS, 2022, NUCLEIC ACIDS RES, V50, pD622, DOI 10.1093/nar/gkab1062
   Wu GH, 2022, FOODS, V11, DOI 10.3390/foods11111638
   Xia EH, 2017, MOL PLANT, V10, P866, DOI 10.1016/j.molp.2017.04.002
   Xia XY, 2021, J ETHNOPHARMACOL, V272, DOI 10.1016/j.jep.2021.113919
   Xie ZW, 2015, J CLIN INVEST, V125, P324, DOI 10.1172/JCI76881
   Yan K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01563
   Yao J, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.917692
   Yue Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0243-1
   Zeng CZ, 2019, J FOOD SCI, V84, P1746, DOI 10.1111/1750-3841.14657
   Zhang HB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1494-4
   Zhang WY, 2020, PLANT J, V104, P613, DOI 10.1111/tpj.14950
   Zhang YZ, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-0433-9
   Zhao DW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-14
   Zhou J, 2019, J AGR FOOD CHEM, V67, P5306, DOI 10.1021/acs.jafc.8b05032
   Zhu LF, 2012, J AGR FOOD CHEM, V60, P12170, DOI 10.1021/jf302726t
NR 39
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2590-1575
J9 FOOD CHEM X
JI Food Chem. X
PD DEC 30
PY 2024
VL 24
AR 101989
DI 10.1016/j.fochx.2024.101989
EA NOV 2024
PG 13
WC Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology
GA M7P7R
UT WOS:001359423800001
PM 39629280
OA gold
DA 2025-04-28
ER

PT J
AU Liu, MY
   Zhang, YJ
   Ye, ZL
   Yang, SS
   Zhang, YY
   He, PP
   Zhou, C
   Hou, FF
   Qin, XH
AF Liu, Mengyi
   Zhang, Yanjun
   Ye, Ziliang
   Yang, Sisi
   Zhang, Yuanyuan
   He, Panpan
   Zhou, Chun
   Hou, Fan Fan
   Qin, Xianhui
TI Association of unsweetened and sweetened tea consumption with the risk
   of new-onset chronic kidney disease: Findings from UK Biobank and
   Coronary Artery Risk Development in Young Adults (CARDIA) study
SO JOURNAL OF GLOBAL HEALTH
LA English
DT Article
ID CYP1A2 GENOTYPE; COFFEE; OBESE
AB Background The association between tea consumption and chronic kidney disease (CKD) remained inconsistent. We aimed to evaluate the association of tea consumption with new-onset CKD and examine the effects of com-mon additives (milk and sweeteners) and genetic variations in caffeine me-tabolism on the association.Methods 176 038 and 3104 participants free of CKD at baseline in the Unit-ed Kingdom Biobank (UK Biobank) and Coronary Artery Risk Development in Young Adults (CARDIA) study were included, respectively. Dietary in-formation was collected using 24-hour dietary recall questionnaires. The study outcome was new-onset CKD.Results In the UK Biobank, during a median follow-up of 12.13 years, 3535 (2.01%) participants developed CKD. Compared with tea non-consumers, the risk of new-onset CKD was significantly lower in unsweetened tea con-sumers (hazard ratio (HR) = 0.84, 95% confidence interval (CI) = 0.76-0.93), but not in sweetened tea consumers (HR = 0.96, 95% CI = 0.85-1.08), regard-less of whether milk was added to tea. Accordingly, relative to tea non-con-sumers, the adjusted HRs (95% CIs) of new-onset CKD for participants who reported drinking unsweetened tea 1.5 or fewer, >1.5 to 2.5, >2.5 to 3.5, >3.5 to 4.5, and >4.5 drinks/d were HR = 0.86, 95% CI = 0.75-0.99; HR = 0.88, 95% CI = 0.78-1.00; HR = 0.83, 95% CI = 0.73-0.94; HR = 0.83, 95% CI = 0.72-0.95; and HR = 0.86, 95% CI = 0.75-0.99. Moreover, the as-sociation of unsweetened tea consumption with new-onset CKD was stron-ger among those with faster genetically predicted caffeine metabolism lev-els, although the interaction was insignificant (P-value interaction = 0.768). Consistently, in the CARDIA study, compared with tea non-consumers, a significantly lower risk of new-onset CKD was found in unsweetened tea consumers (HR = 0.80, 95% CI = 0.65-0.98) but not in sweetened tea con-sumers (HR = 0.97, 95% CI = 0.70-1.34).Conclusions Compared with tea non-consumers, consumption of unsweet-ened tea, but not sweetened tea, was significantly associated with a lower risk of new-onset CKD, regardless of whether milk was added.
C1 [Hou, Fan Fan; Qin, Xianhui] Southern Med Univ, Nanfang Hosp, Div Nephrol, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.
   [Hou, Fan Fan; Qin, Xianhui] Natl Clin Res Ctr Kidney Dis, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.
   [Hou, Fan Fan; Qin, Xianhui] State Key Lab Organ Failure Res, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.
   [Hou, Fan Fan; Qin, Xianhui] Guangdong Prov Inst Nephrol, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.
   [Hou, Fan Fan; Qin, Xianhui] Guangdong Prov Key Lab Renal Failure Res, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.
C3 Southern Medical University - China
RP Hou, FF; Qin, XH (corresponding author), Southern Med Univ, Nanfang Hosp, Div Nephrol, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.; Hou, FF; Qin, XH (corresponding author), Natl Clin Res Ctr Kidney Dis, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.; Hou, FF; Qin, XH (corresponding author), State Key Lab Organ Failure Res, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.; Hou, FF; Qin, XH (corresponding author), Guangdong Prov Inst Nephrol, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.; Hou, FF; Qin, XH (corresponding author), Guangdong Prov Key Lab Renal Failure Res, 1838 Guangzhou Ave North, Guangzhou, Peoples R China.
EM ffhouguangzhou@163.com; pharmaqin@126.com
RI Qin, XIan/JUU-4649-2023
FU National Natural Science Foundation of China [81973133, 81730019];
   National Key Research and Development Program [2022YFC2009600,
   2022YFC2009605]; Out-standing Youths Development Scheme of Nanfang
   Hospital, Southern Medical University [2017J009]; National Natural
   Science Foundation of China (Key Program) [82030022]; Program of
   Introducing Talents of Discipline to Universities; 111 Plan
   [2020B1111170013]; Guangdong Provincial Clinical Research Center for
   Kidney Disease [2023B1111030004]; Key Technologies R&D Program of
   Guangdong Province [D18005]
FX The study was supported by the National Natural Science Foundation of
   China (81973133, 81730019 to XHQ) ; the National Key Research and
   Development Program (2022YFC2009600, 2022YFC2009605 to XHQ) ;
   Outstanding Youths Development Scheme of Nanfang Hospital, Southern
   Medical University (2017J009 to XHQ) ; the National Natural Science
   Foundation of China (Key Program) (82030022 to FFH) ; the Program of
   Introducing Talents of Discipline to Universities, 111 Plan (D18005 to
   FFH) ; Guangdong Provincial Clinical Research Center for Kidney Disease
   (2020B1111170013 to FFH) ; Key Technologies R&D Program of Guangdong
   Province (2023B1111030004 to FFH) .
CR Abe SK, 2021, EUR J CLIN NUTR, V75, P865, DOI 10.1038/s41430-020-00710-7
   Andres-Hernando A, 2023, BIOMOLECULES, V13, DOI 10.3390/biom13050780
   Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3
   Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z
   Cao SY, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8060166
   Choudhary AK, 2017, NUTR REV, V75, P718, DOI 10.1093/nutrit/nux035
   Collins R, 2012, LANCET, V379, P1173, DOI [10.1016/S0140-6736(12)60404-8, 10.1016/S0140-6736(16)31357-5]
   Cornelis MC, 2020, J NUTR, V150, P2772, DOI 10.1093/jn/nxaa212
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Daenen K, 2019, PEDIATR NEPHROL, V34, P975, DOI 10.1007/s00467-018-4005-4
   Drew L, 2019, NATURE, V566, pS2, DOI 10.1038/d41586-019-00395-4
   Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276
   Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246
   Gaeini Z, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0355-6
   Herber-Gast GCM, 2016, AM J CLIN NUTR, V103, P1370, DOI 10.3945/ajcn.115.112755
   Inoue-Choi M, 2022, ANN INTERN MED, V175, P1201, DOI 10.7326/M22-0041
   Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X
   Khan N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010039
   Korir MW, 2014, FOOD CHEM, V145, P145, DOI 10.1016/j.foodchem.2013.08.016
   Lees JS, 2019, NAT MED, V25, P1753, DOI 10.1038/s41591-019-0627-8
   Lew QLJ, 2018, J NUTR, V148, P1315, DOI 10.1093/jn/nxy075
   Liu B, 2011, PUBLIC HEALTH NUTR, V14, P1998, DOI 10.1017/S1368980011000942
   Lo WC, 2021, J NEPHROL, V34, P1791, DOI 10.1007/s40620-020-00957-0
   Mihai S, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2180373
   Palatini P, 2009, J HYPERTENS, V27, P1594, DOI 10.1097/HJH.0b013e32832ba850
   Peluso I, 2017, BRIT J PHARMACOL, V174, P1195, DOI 10.1111/bph.13649
   Rebholz CM, 2019, CLIN J AM SOC NEPHRO, V14, P49, DOI 10.2215/CJN.06380518
   Reyes CM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111772
   Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Tofovic SP, 2002, KIDNEY INT, V61, P1433, DOI 10.1046/j.1523-1755.2002.00278.x
   Vuong QV, 2014, CRIT REV FOOD SCI, V54, P523, DOI 10.1080/10408398.2011.594184
   Wahl P, 2016, AM J PHYSIOL-RENAL, V310, pF433, DOI 10.1152/ajprenal.00375.2015
   Zhang YC, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.801591
   Zhou A, 2019, AM J CLIN NUTR, V109, P509, DOI 10.1093/ajcn/nqy297
NR 35
TC 1
Z9 1
U1 0
U2 8
PU INT SOC GLOBAL HEALTH
PI EDINBURGH
PA CALEDONIAN EXCHANGE, 19A CANNING ST, EDINBURGH, Lothian, ENGLAND
SN 2047-2978
EI 2047-2986
J9 J GLOB HEALTH
JI J. Glob. Health
PY 2023
VL 13
AR 04094
DI 10.7189/jogh.13.04094
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA W8JW8
UT WOS:001094046800001
PM 37856735
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Lopez, HL
   Ziegenfuss, TN
   Hofheins, JE
   Habowski, SM
   Arent, SM
   Weir, JP
   Ferrando, AA
AF Lopez, Hector L.
   Ziegenfuss, Tim N.
   Hofheins, Jennifer E.
   Habowski, Scott M.
   Arent, Shawn M.
   Weir, Joseph P.
   Ferrando, Arny A.
TI Eight weeks of supplementation with a multi-ingredient weight loss
   product enhances body composition, reduces hip and waist girth, and
   increases energy levels in overweight men and women
SO JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
LA English
DT Article
DE Dietary supplement; Raspberry ketone; Adipokine; Body composition; Fat
   loss; Capsaicin
ID FAT-FREE MASS; ADIPOSE-SPECIFIC PROTEIN; DOWN-REGULATION; EXPENDITURE;
   ADIPONECTIN; CAFFEINE; ASSOCIATION; CAPSAICIN; HYPOADIPONECTINEMIA;
   THERMOGENESIS
AB Background: Numerous natural products are marketed and sold claiming to decrease body weight and fat, but few undergo finished product-specific research demonstrating their safety and efficacy.
   Objective: To determine the safety and efficacy of a multi-ingredient supplement containing primarily raspberry ketone, caffeine, capsaicin, garlic, ginger and Citrus aurantium (Prograde Metabolism (TM) [METABO]) as an adjunct to an eight-week weight loss program.
   Methods: Using a randomized, placebo-controlled, double-blind design, 70 obese but otherwise healthy subjects were randomly assigned to METABO or a placebo and underwent 8 weeks of daily supplementation, a calorie restricted diet, and exercise training. Subjects were tested for changes in body composition, serum adipocytokines (adiponectin, resistin, leptin, TNF-alpha, IL-6) and markers of health including heart rate and blood pressure.
   Results: Of the 45 subjects who completed the study, significant differences were observed in: body weight (METABO -2.0% vs. placebo -0.5%, P < 0.01), fat mass (METABO -7.8 vs. placebo -2.8%, P < 0.001), lean mass (METABO +3.4% vs. placebo +0.8%, P < 0.03), waist girth (METABO -2.0% vs. placebo -0.2%, P < 0.0007), hip girth (METABO -1.7% vs. placebo -0.4%, P < 0.003), and energy levels per anchored visual analogue scale (VAS) (METABO +29.3% vs. placebo +5.1%, P < 0.04). During the first 4 weeks, effects/trends for maintaining elevated serum leptin (P < 0.03) and decreased serum resistin (P < 0.08) in the METABO group vs. placebo were also observed. No changes in systemic hemodynamics, clinical blood chemistries, adverse events, or dietary intake were noted between groups.
   Conclusions: METABO administration is a safe and effective adjunct to an eight-week diet and exercise weight loss program by augmenting improvements in body composition, waist and hip girth. Adherence to the eight-week weight loss program also led to beneficial changes in body fat in placebo. Ongoing studies to confirm these results and clarify the mechanisms (i.e., biochemical and neuroendocrine mediators) by which METABO exerts the observed salutary effects are being conducted.
C1 [Lopez, Hector L.; Ziegenfuss, Tim N.; Hofheins, Jennifer E.; Habowski, Scott M.] Ctr Appl Hlth Sci, Stow, OH 44224 USA.
   [Arent, Shawn M.] Rutgers State Univ, Dept Exercise Sci & Sport Studies, New Brunswick, NJ 08901 USA.
   [Weir, Joseph P.] Univ Kansas, Dept Hlth Sport & Exercise Sci, Lawrence, KS 66045 USA.
   [Ferrando, Arny A.] Univ Arkansas Med Sci, Ctr Translat Res Aging & Longev, Little Rock, AR 72205 USA.
C3 Rutgers University System; Rutgers University New Brunswick; University
   of Kansas; University of Arkansas System; University of Arkansas Medical
   Sciences
RP Lopez, HL (corresponding author), Ctr Appl Hlth Sci, 4302 Allen Rd,STE 120, Stow, OH 44224 USA.
EM hl@appliedhealthsciences.org
OI Weir, Joseph/0000-0003-0684-2930
FU Ultimate Wellness Systems Inc; Integrity Nutraceuticals Inc.; Ultimate
   Wellness Systems, Inc. (Lutz, FL)
FX HLL and TNZ have received research funding and/or acted as consultants
   to raw material suppliers, nutraceutical and dietary supplement
   companies, including Ultimate Wellness Systems Inc, and Integrity
   Nutraceuticals Inc.The authors would like to thank the subjects who
   participated in the study and Dr. Susan Reijntjes from Niche Science and
   Technology Ltd for providing editorial support during the preparation of
   this manuscript. The presentation of results of this study does not
   constitute endorsement by the any of the researchers, The Center for
   Applied Health Sciences, or the International Society of Sports
   Nutrition. The sponsor of this study, Ultimate Wellness Systems, Inc.
   (Lutz, FL), had no role in the collection, analyses, or interpretation
   of the data.
CR Ahnis A, 2012, PATIENT PREFER ADHER, V6, P165, DOI 10.2147/PPA.S28022
   Albarracini CA, 2008, DIABETES-METAB RES, V24, P41, DOI 10.1002/dmrr.755
   [Anonymous], AD OB FACTS
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104
   Ban JO, 2012, PHYTOTHER RES, V26, P1265, DOI 10.1002/ptr.3729
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   BLACK AE, 1993, J AM DIET ASSOC, V93, P572, DOI 10.1016/0002-8223(93)91820-G
   Bloomer RJ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-72
   Campbell WW, 2009, OBESITY, V17, P1332, DOI 10.1038/oby.2009.2
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008
   Ernsberger P, 2007, AM J HYPERTENS, V20, P866, DOI 10.1016/j.amjhyper.2007.02.015
   Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822
   Goldstein ER, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-5
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Hunter GR, 2008, OBESITY, V16, P1045, DOI 10.1038/oby.2008.38
   Hunter GR, 2010, OBESITY, V18, P690, DOI 10.1038/oby.2009.316
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Inelmen EM, 2005, INT J OBESITY, V29, P122, DOI 10.1038/sj.ijo.0802846
   Isa Y, 2008, BIOCHEM BIOPH RES CO, V373, P429, DOI 10.1016/j.bbrc.2008.06.046
   Josse AR, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-65
   Keophiphath M, 2009, J NUTR, V139, P2055, DOI 10.3945/jn.109.105452
   Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50
   Lohman T.G., 1991, Anthropometric Standardization Reference Manual
   Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100
   Maridakis V, 2009, INT J NEUROSCI, V119, P975, DOI 10.1080/00207450802333995
   Martin CK, 2008, APPETITE, V51, P324, DOI 10.1016/j.appet.2008.03.002
   MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241
   Morimoto C, 2005, LIFE SCI, V77, P194, DOI 10.1016/j.lfs.2004.12.029
   Okamoto M, 2011, J MED CHEM, V54, P6295, DOI 10.1021/jm200662c
   Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Park KS, 2010, PLANTA MED, V76, P1654, DOI 10.1055/s-0030-1249860
   Sadashiv, 2012, WORLD J DIABETES, V3, P135, DOI 10.4239/wjd.v3.i7.135
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sahebkar A, 2011, WORLD J GASTROENTERO, V17, P271, DOI 10.3748/wjg.v17.i2.271
   Scarpellini E, 2012, DIGEST DIS, V30, P148, DOI 10.1159/000336664
   Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036
   Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561
   Stohs SJ, 2012, INT J MED SCI, V9, P527, DOI 10.7150/ijms.4446
   Strychar I, 2009, J AM DIET ASSOC, V109, P718, DOI 10.1016/j.jada.2008.12.026
   Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x
   Valcour V, 2009, HIV MED, V10, P103, DOI 10.1111/j.1468-1293.2008.00658.x
   Wang LL, 2012, J MED FOOD, V15, P495, DOI 10.1089/jmf.2011.1717
   Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   Whiting S, 2012, APPETITE, V59, P341, DOI 10.1016/j.appet.2012.05.015
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
NR 50
TC 38
Z9 45
U1 0
U2 84
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1550-2783
J9 J INT SOC SPORT NUTR
JI J. Int. Soc. Sport Nutr.
PD APR 19
PY 2013
VL 10
AR 22
DI 10.1186/1550-2783-10-22
PG 14
WC Nutrition & Dietetics; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Sport Sciences
GA 139SK
UT WOS:000318604300001
PM 23601452
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU John, OD
   du Preez, R
   Panchal, SK
   Brown, L
AF John, Oliver D.
   du Preez, Ryan
   Panchal, Sunil K.
   Brown, Lindsay
TI Tropical foods as functional foods for metabolic syndrome
SO FOOD & FUNCTION
LA English
DT Article
ID BROWN SEAWEED SARGASSUM; GARCINIA-MANGOSTANA L.; SPENT COFFEE; BIOACTIVE
   COMPOUNDS; HYDROXYCITRIC ACID; ANTIOXIDANT ACTIVITY; DIETARY-PROTEIN;
   GENE-EXPRESSION; FAT DIET; WEIGHT
AB Tropical foods are an integral part of the traditional diet and form part of traditional medicine in many countries. This review examines the potential of tropical foods to treat signs of metabolic syndrome, defined as a chronic low-grade inflammation leading to obesity, hypertension, impaired glucose tolerance, insulin resistance, dyslipidaemia and fatty liver. It is a major risk factor for cardiovascular and metabolic disease as well as osteoarthritis and some cancers. Tropical foods such as seaweeds and tropical fruits including indigenous fruits such as Davidson's plums are effective in reducing these signs of metabolic syndrome in rats, as well as reducing degeneration of bone cartilage and altering gut microbiome. Further, waste products from tropical fruits including mangosteen rind, coffee pulp and spent coffee grounds provide further options to reduce metabolic syndrome. Production of local tropical foods and local recovery of food waste from these foods could allow the development of commercial, sustainable and cost-effective functional foods in tropical countries. The aim is to develop these functional foods to reduce the incidence of metabolic syndrome and decrease the risk of costly chronic cardiovascular and metabolic disorders locally and globally.
C1 [John, Oliver D.; du Preez, Ryan; Panchal, Sunil K.; Brown, Lindsay] Univ Southern Queensland, Funct Foods Res Grp, Toowoomba, Qld 4350, Australia.
   [du Preez, Ryan] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld 4701, Australia.
   [Panchal, Sunil K.] Western Sydney Univ, Sch Sci, Richmond, NSW 2753, Australia.
   [Brown, Lindsay] Univ Southern Queensland, Sch Hlth & Wellbeing, Ipswich, Qld 4305, Australia.
C3 University of Southern Queensland; Central Queensland University;
   Western Sydney University; University of Southern Queensland
RP Brown, L (corresponding author), Univ Southern Queensland, Funct Foods Res Grp, Toowoomba, Qld 4350, Australia.; Brown, L (corresponding author), Univ Southern Queensland, Sch Hlth & Wellbeing, Ipswich, Qld 4305, Australia.
EM Lind.say.Brown@usq.edu.au
RI John, Oliver/AAX-5651-2021
OI John, Oliver Dean/0000-0001-5035-1878; Panchal, Sunil
   K/0000-0001-5464-3376; du Preez, Ryan/0000-0003-2164-0819
CR Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x
   Abu Bakar MF, 2009, FOOD CHEM, V113, P479, DOI 10.1016/j.foodchem.2008.07.081
   Aekplakorn W, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/468759
   Agodi A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070898
   Altendorf S, 2018, MINOR TROPICAL FRUIT
   [Anonymous], 2018, EAT WEEDS OTHER THIN
   [Anonymous], 2016, CHEM COMPOSITION SEA
   [Anonymous], 2020, Food outlook: Biannual report on global food markets, DOI DOI 10.1044/LEADER.PPL.19102014.18
   [Anonymous], 2018, COMPLIANCE PRINCIPLE
   [Anonymous], 2017, Food and Agricultural Organization of the United States
   Antony B, 2004, INDIAN J PHARM SCI, V66, P208
   Asyifah MR, 2014, J AGR FOOD CHEM, V62, P3505, DOI 10.1021/jf5007352
   Ayyad SEN, 2011, PHARMACOGN RES, V3, P160, DOI 10.4103/0974-8490.85000
   Bhandarkar NS, 2020, FASEB J, V34, P4783, DOI 10.1096/fj.201902416RR
   Bhaswant M, 2015, PHARMACOL RES, V102, P208, DOI 10.1016/j.phrs.2015.10.006
   Bhatt P, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/320329
   Blunt JW, 2008, NAT PROD REP, V25, P35, DOI 10.1039/b701534h
   Brando C. H. J., 2008, COFFEE GROWING PRO 3, P604, DOI DOI 10.1002/
   Bravo J, 2013, FOOD CHEM TOXICOL, V60, P397, DOI 10.1016/j.fct.2013.08.002
   Brown EM, 2014, NUTR REV, V72, P205, DOI 10.1111/nure.12091
   Brown L, 2015, OBES REV, V16, P914, DOI 10.1111/obr.12313
   Burton-Freeman BM, 2017, FOOD FUNCT, V8, P3010, DOI [10.1039/C7FO00190H, 10.1039/c7fO00190h, 10.1039/c7fo00190h]
   Campos-Vega R, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13204
   Cardoso SM, 2015, MAR DRUGS, V13, P6838, DOI 10.3390/md13116838
   Chang SK, 2019, CRIT REV FOOD SCI, V59, P1580, DOI 10.1080/10408398.2017.1422111
   Chater PI, 2015, FOOD FUNCT, V6, P3420, DOI [10.1039/C5FO00293A, 10.1039/c5fo00293a]
   Chen XL, 2019, PEERJ, V7, DOI 10.7717/peerj.6118
   Cheok CY, 2018, CRIT REV FOOD SCI, V58, P335, DOI 10.1080/10408398.2016.1176009
   Choi B, 2017, FOOD SCI BIOTECHNOL, V26, P921, DOI 10.1007/s10068-017-0144-9
   Circuncisao AR, 2018, MAR DRUGS, V16, DOI 10.3390/md16110400
   Cooper W., 2013, Austrobaileya, V9, P1
   Costa ES, 2019, BRIT J NUTR, V121, P1365, DOI 10.1017/S0007114519000576
   D'Orazio N, 2012, MAR DRUGS, V10, P604, DOI 10.3390/md10030604
   Dar A, 2007, J EXP MAR BIOL ECOL, V351, P1, DOI 10.1016/j.jembe.2007.03.019
   Raposo MFD, 2016, MAR DRUGS, V14, DOI 10.3390/md14020027
   Decha-Dier Usawadee, 2008, Journal of Natural Remedies, V8, P151
   Devalaraja S, 2011, FOOD RES INT, V44, P1856, DOI 10.1016/j.foodres.2011.04.008
   Dhillon GS, 2013, RENEW SUST ENERG REV, V27, P789, DOI 10.1016/j.rser.2013.06.046
   Dorsey BM, 2017, HANDBOOK OF COFFEE PROCESSING BY-PRODUCTS: SUSTAINABLE APPLICATIONS, P27, DOI 10.1016/B978-0-12-811290-8.00002-5
   Doyle EFranks J., 2015, Sargassum Fact Sheet
   du Preez R, 2020, MAR DRUGS, V18, DOI 10.3390/md18020097
   Duarte O, 2011, WOODHEAD PUBL FOOD S, P48
   Edwiges T, 2020, ENVIRON TECHNOL, V41, P921, DOI 10.1080/09593330.2018.1515262
   El Khoury D, 2015, CRIT REV FOOD SCI, V55, P1406, DOI 10.1080/10408398.2012.700654
   Evans SF, 2017, NUTR METAB INSIGHTS, V10, DOI 10.1177/1178638817731770
   Evans SF, 2014, NUTR METAB INSIGHTS, V7, P77, DOI 10.4137/NMI.S17028
   Falcomer AL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061222
   Famà P, 2002, J PHYCOL, V38, P1040, DOI 10.1046/j.1529-8817.2002.t01-1-01237.x
   Fisgativa H, 2017, J ENVIRON MANAGE, V188, P95, DOI 10.1016/j.jenvman.2016.11.058
   Food and Agriculture Organization of the United Nations, 2020, BAN MARK REV PREL RE
   Garcia-Garcia G, 2019, J CLEAN PROD, V211, P1339, DOI 10.1016/j.jclepro.2018.11.269
   Gosch BJ, 2012, GCB BIOENERGY, V4, P919, DOI 10.1111/j.1757-1707.2012.01175.x
   Grasgruber P, 2016, ECON HUM BIOL, V21, P172, DOI 10.1016/j.ehb.2016.01.005
   Harakeh SM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00095
   Hayamizu K, 2003, CURR THER RES CLIN E, V64, P551, DOI 10.1016/j.curtheres.2003.08.006
   Hemshekhar M, 2011, PHYTOCHEM REV, V10, P325, DOI 10.1007/s11101-011-9207-3
   Hill AM, 2015, AM J CLIN NUTR, V102, P757, DOI 10.3945/ajcn.114.104026
   International Coffee Organization, 2020, Total production by all exporting countries (In thousand 60 kg bags)
   Jahurul MHA, 2019, FOOD RES INT, V115, P105, DOI 10.1016/j.foodres.2018.08.017
   Jakobsdottir G, 2014, NUTRITION, V30, P497, DOI 10.1016/j.nut.2013.08.013
   Jayeola CO, 2018, THERAPEUTIC, PROBIOTIC, AND UNCONVENTIONAL FOODS, P317, DOI 10.1016/B978-0-12-814625-5.00017-0
   John OD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010272
   John OD, 2019, NUTRACEUTICALS AND NATURAL PRODUCT DERIVATIVES: DISEASE PREVENTION & DRUG DISCOVERY, P39
   John OD, 2019, J FUNCT FOODS, V56, P204, DOI 10.1016/j.jff.2019.03.018
   John OD, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101425
   Johnstone AM, 2012, P NUTR SOC, V71, P339, DOI 10.1017/S0029665112000122
   Joseph KS, 2017, ERWERBS-OBSTBAU, V59, P195, DOI 10.1007/s10341-016-0311-9
   Kadam SU, 2015, MAR DRUGS, V13, P4270, DOI 10.3390/md13074270
   Khamthong N, 2017, NAT PROD COMMUN, V12, P453
   Khoo HE, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7591951
   Khoozani AA, 2019, J FOOD SCI TECH MYS, V56, P548, DOI 10.1007/s13197-018-03562-z
   Kidgell JT, 2019, ALGAL RES, V39, DOI 10.1016/j.algal.2019.101422
   Kim Su Il, 2007, Journal of Chitin and Chitosan, V12, P65
   Kim YJ, 2013, WORLD J GASTROENTERO, V19, P4689, DOI 10.3748/wjg.v19.i29.4689
   Konczak I., 2009, RIRDC PUB
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   Kovacs EMR, 2006, PHYSIOL BEHAV, V88, P371, DOI 10.1016/j.physbeh.2006.04.005
   Kraan S, 2008, J APPL PHYCOL, V20, P825, DOI 10.1007/s10811-007-9208-1
   Kraikruan W., 2017, Acta Horticulturae, P235, DOI [10.17660/actahortic.2017.1186.37, 10.17660/ActaHortic.2017.1186.37]
   Kumar SA, 2013, REV ENDOCR METAB DIS, V14, P299, DOI 10.1007/s11154-013-9254-8
   Kumoro AC, 2020, INT J FOOD SCI, V2020, DOI 10.1155/2020/4051475
   Laffoley Dd'A., 2011, The Protection and Management of the Sargasso Sea: The Golden Floating Rainforest of the Atlantic Ocean. Summary Science and Supporting Evidence Case. Sargasso Sea Alliance
   Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077344
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lim T. K., 2012, EDIBLE MED NONMEDICI, P59
   Lim TongKwee., 2012, Edible Medicinal and Non-Medicinal Plants (12-19), DOI DOI 10.1007/978-94-007-2534-8_14
   Lima RD, 2019, FOOD RES INT, V115, P451, DOI 10.1016/j.foodres.2018.10.053
   Liu CQ, 2015, CANCER LETT, V362, P8, DOI 10.1016/j.canlet.2015.03.019
   Liu D, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103605
   Liu L, 2012, J ETHNOPHARMACOL, V142, P591, DOI 10.1016/j.jep.2012.05.046
   Lordan S, 2011, MAR DRUGS, V9, P1056, DOI 10.3390/md9061056
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Lupatini AL, 2017, J SCI FOOD AGR, V97, P724, DOI 10.1002/jsfa.7987
   MacArtain P, 2007, NUTR REV, V65, P535, DOI 10.1111/j.1753-4887.2007.tb00278.x
   Magoni C, 2018, FOOD RES INT, V112, P129, DOI 10.1016/j.foodres.2018.06.026
   Maneesh A, 2017, INT J FOOD PROP, V20, P931, DOI 10.1080/10942912.2016.1189434
   López-Barrera DM, 2016, FOOD CHEM, V212, P282, DOI 10.1016/j.foodchem.2016.05.175
   Matanjun P, 2010, J MED FOOD, V13, P792, DOI 10.1089/jmf.2008.1212
   Matharu AS, 2016, BIORESOURCE TECHNOL, V215, P123, DOI 10.1016/j.biortech.2016.03.039
   Mattio L, 2011, BOT REV, V77, P31, DOI 10.1007/s12229-010-9060-x
   May-Lin BY, 2013, J APPL PHYCOL, V25, P805, DOI 10.1007/s10811-012-9963-5
   McHugh D.J., 2003, A guide to the seaweed industry
   Mesías M, 2017, CURR OPIN FOOD SCI, V14, P37, DOI 10.1016/j.cofs.2017.01.007
   Miyazaki T, 2016, ONCOTARGET, V7, P10448, DOI 10.18632/oncotarget.7249
   Moghadamtousi SZ, 2015, INT J MOL SCI, V16, P15625, DOI 10.3390/ijms160715625
   Mohamed S, 2012, TRENDS FOOD SCI TECH, V23, P83, DOI 10.1016/j.tifs.2011.09.001
   Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501
   Nakayama T, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.26
   Naylor J, 1976, PRODUCTION TRADE UTI
   Necas J, 2013, VET MED-CZECH, V58, P187, DOI 10.17221/6758-VETMED
   O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229
   Obolskiy D, 2009, PHYTOTHER RES, V23, P1047, DOI 10.1002/ptr.2730
   Ohia SE, 2002, MOL CELL BIOCHEM, V238, P89, DOI 10.1023/A:1019911205672
   Ontawong A, 2019, PHYTOMEDICINE, V52, P187, DOI 10.1016/j.phymed.2018.06.021
   Oseguera-Castro KY, 2019, FOOD FUNCT, V10, P4546, DOI [10.1039/C9FO01021A, 10.1039/c9fo01021a]
   Ovalle-Magallanes B, 2017, FOOD CHEM TOXICOL, V109, P102, DOI 10.1016/j.fct.2017.08.021
   Padam BS, 2014, J FOOD SCI TECH MYS, V51, P3527, DOI 10.1007/s13197-012-0861-2
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]
   Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982
   Paul JY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00558
   Paul N., 2013, GREEN CAVIAR SEA GRA
   Paun A, 2016, PEDIATR DIABETES, V17, P469, DOI 10.1111/pedi.12424
   Pereira A, 2015, J ETHNOPHARMACOL, V160, P149, DOI 10.1016/j.jep.2014.11.008
   Phang S M., 2010, Malays. J. Sci, V29, P214, DOI DOI 10.22452/MJS.VOL29NO3.4
   Piaggi P, 2019, OBESITY, V27, P691, DOI 10.1002/oby.22456
   Pierson JT, 2012, MOL NUTR FOOD RES, V56, P357, DOI 10.1002/mnfr.201100441
   Pinkaew D, 2012, AM J PHYSIOL-HEART C, V302, pH451, DOI 10.1152/ajpheart.00669.2011
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Radulovich R, 2015, AQUACULTURE, V436, P40, DOI 10.1016/j.aquaculture.2014.10.032
   Raghavendran HRB, 2004, J HEALTH SCI, V50, P42, DOI 10.1248/jhs.50.42
   Raihana ARN, 2015, INT J FOOD PROP, V18, P2380, DOI 10.1080/10942912.2014.980946
   Ramalakshmi K, 2009, FOOD CHEM, V115, P79, DOI 10.1016/j.foodchem.2008.11.063
   Ramirez-Higuera A, 2014, J APPL PHYCOL, V26, P597, DOI 10.1007/s10811-013-0134-0
   Ranjith D, 2011, CURR SCI INDIA, V100, P24
   Rebholz CM, 2012, AM J EPIDEMIOL, V176, pS27, DOI 10.1093/aje/kws245
   Rosemary T, 2019, MOLECULES, V24, DOI 10.3390/molecules24122225
   Roy S, 2003, GENE EXPRESSION, V11, P251, DOI 10.3727/000000003783992289
   Sagar NA, 2018, COMPR REV FOOD SCI F, V17, P512, DOI 10.1111/1541-4337.12330
   Santana LF, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071608
   Sardá FAH, 2016, J FUNCT FOODS, V24, P63, DOI 10.1016/j.jff.2016.04.001
   Schell JM, 2015, OCEANOGRAPHY, V28, P8, DOI 10.5670/oceanog.2015.70
   Semwal RB, 2015, FITOTERAPIA, V102, P134, DOI 10.1016/j.fitote.2015.02.012
   Serafini M, 2016, CURR PHARM DESIGN, V22, P6701, DOI 10.2174/1381612823666161123094235
   Sharifuddin Y, 2015, MAR DRUGS, V13, P5447, DOI 10.3390/md13085447
   Sharma BR, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0412-5
   Sharma H. K., 2017, FOOD PROCESSING BY P, V3, P27
   Shin JY, 2015, INT J FOOD SCI NUTR, V66, P416, DOI 10.3109/09637486.2015.1025716
   Shirosaki M, 2011, ADV FOOD NUTR RES, V64, P199, DOI 10.1016/B978-0-12-387669-0.00015-6
   Smit AJ, 2004, J APPL PHYCOL, V16, P245, DOI 10.1023/B:JAPH.0000047783.36600.ef
   Sripradha R, 2015, J CLIN DIAGN RES, V9, pBF1, DOI 10.7860/JCDR/2015/12045.5577
   Terakado S, 2012, CLIN EXP HYPERTENS, V34, P99, DOI 10.3109/10641963.2011.618196
   Terrazas PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076485
   Tharachand S.I., 2013, Int J Pharm Sci Rev Res, V19, P101
   The Seaweed Site: Information on marine algae, 2020, SEAWEED HUMAN FOOD
   Tjahjani S, 2014, PROCEDIA CHEM, V13, P198, DOI 10.1016/j.proche.2014.12.027
   van de Velde F, 2002, ADV SYNTH CATAL, V344, P815, DOI 10.1002/1615-4169(200209)344:8<815::AID-ADSC815>3.0.CO;2-H
   van Dixhoorn J., 2015, ERJ OPEN RES, V1, P00001, DOI [10.1183/23120541.00001-2015, DOI 10.1183/23120541.00001-2015]
   Vázquez-Sánchez K, 2018, FOOD CHEM, V261, P253, DOI 10.1016/j.foodchem.2018.04.064
   Virgolin LB, 2017, PESQUI AGROPECU BRAS, V52, P933, DOI [10.1590/s0100-204x2017001000013, 10.1590/S0100-204X2017001000013]
   Wang L, 2014, WASTE MANAGE, V34, P2627, DOI 10.1016/j.wasman.2014.08.005
   Wang R, 2013, FREE RADICAL BIO MED, V57, P141, DOI 10.1016/j.freeradbiomed.2012.12.019
   Wells ML, 2017, J APPL PHYCOL, V29, P949, DOI 10.1007/s10811-016-0974-5
   Westerterp-Plantenga M, 2002, INT J OBESITY, V26, P870, DOI 10.1038/sj.ijo.0801979
   Westerterp-Plantenga MS, 2012, BRIT J NUTR, V108, pS105, DOI 10.1017/S0007114512002589
   Womersley H. B. S., 1996, RHODOPHYTA 3A
   Xu SY, 2017, MAR DRUGS, V15, DOI 10.3390/md15120388
   Yende Subhash R, 2014, Pharmacogn Rev, V8, P1, DOI 10.4103/0973-7847.125514
   Yu PZ, 2003, PHARMACOL RES, V48, P543, DOI 10.1016/S1043-6618(03)00215-9
   Zhao Y, 2018, MAR DRUGS, V16, DOI 10.3390/md16090321
NR 169
TC 15
Z9 15
U1 0
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD AUG 1
PY 2020
VL 11
IS 8
BP 6946
EP 6960
DI 10.1039/d0fo01133a
PG 15
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA NB7EU
UT WOS:000560678100014
PM 32692322
DA 2025-04-28
ER

PT J
AU Nagao, T
   Hase, T
   Tokimitsu, I
AF Nagao, Tomonori
   Hase, Tadashi
   Tokimitsu, Ichiro
TI A green tea extract high in catechins reduces body fat and
   cardiovascular risks in humans
SO OBESITY
LA English
DT Article
DE tea polyphenol; adiposity; serum cholesterol; blood pressure; metabolic
   syndrome
ID METABOLIC SYNDROME; ENERGY-EXPENDITURE; POLYPHENOLS; ADIPONECTIN;
   OXIDATION; INGESTION; CAFFEINE; OBESITY; RICH; MEN
AB Objective: The body fat reducing effect and reduction of risks for cardiovascular disease by a green tea extract (GTE) high in catechins was investigated in humans with typical lifestyles.
   Research Methods and Procedures: Japanese women and men with visceral fat-type obesity were recruited for the trial. After a 2-week diet run-in period, a 12-week double-blind parallel multicenter trial was performed, in which the subjects ingested green tea containing 583 mg of catechins (catechin group) or 96 mg of catechins (control group) per day. Randomization was stratified by gender and body mass index at each medical institution. The subjects were instructed to maintain their usual dietary intake and normal physical activity.
   Results: Data were analyzed using per-protocol samples of 240 subjects (catechin group; n = 123, control group; n = 117). Decreases in body weight, body mass index, body fat ratio, body fat mass, waist circumference, hip circumference, visceral fat area, and subcutaneous fat area were found to be greater in the catechin group than in the control group. A greater decrease in systolic blood pressure (SBP) was found in the catechin group compared with the control group for subjects whose initial SBP was 130 mm Hg or higher. Low-density lipoprotein (LDL) cholesterol was also decreased to a greater extent in the catechin group. No adverse effect was found.
   Discussion: The continuous ingestion of a GTE high in catechins led to a reduction in body fat, SBP, and LDL cholesterol, suggesting that the ingestion of such an extract contributes to a decrease in obesity and cardiovascular disease risks.
C1 Kao Corp, Hlth Care Food Res Labs, Sumida Ku, Tokyo 1318501, Japan.
C3 KAO Corporation
RP Nagao, T (corresponding author), Kao Corp, Hlth Care Food Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
EM nagao.tomonori@kao.co.jp
OI HASE, TADASHI/0009-0003-3657-5332
CR Abe I, 2000, BIOCHEM BIOPH RES CO, V268, P767, DOI 10.1006/bbrc.2000.2217
   Ajay M, 2003, LIFE SCI, V74, P603, DOI 10.1016/j.lfs.2003.06.039
   Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210
   [Anonymous], 2001, GUID DOC US IN VITR
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Fujishima M, 2001, HYPERTENS RES, V24, P613
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683
   *JAP SOC CLIN CHEM, REC
   *KAG NUTR U PRESS, 2000, 4 REV STAND TABL FOO
   Kanno T., 1997, JPN J MED PHARM SCI, V37, P635
   Lin JK, 1998, J AGR FOOD CHEM, V46, P3635, DOI 10.1021/jf980223x
   Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF
   Matsuzawa Y, 2005, J JPN SOC INT MED, V94, P188, DOI [DOI 10.5551/JAT.12.301, 10.5551/jat.12.301]
   McKay DL, 2002, J AM COLL NUTR, V21, P1
   *MIN HLTH LAB WELF, 2004, NAT NUTR SURV JAP 20
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagaretani H, 2001, DIABETES CARE, V24, P2127, DOI 10.2337/diacare.24.12.2127
   Nozawa A, 2002, J NUTR FOOD, V5, P1
   TOKUNAGA K, 1983, INT J OBESITY, V7, P437
NR 24
TC 383
Z9 423
U1 3
U2 112
PU NORTH AMER ASSOC STUDY OBESITY
PI SILVER SPRING
PA 8630 FENTON ST, SUITE 918, SILVER SPRING, MD 20910 USA
SN 1930-7381
J9 OBESITY
JI Obesity
PD JUN
PY 2007
VL 15
IS 6
BP 1473
EP 1483
DI 10.1038/oby.2007.176
PG 11
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 180ZG
UT WOS:000247405900017
PM 17557985
OA Bronze
DA 2025-04-28
ER

PT J
AU Leal, DB
   de Assis, MAA
   Hinnig, PD
   Schmitt, J
   Lobo, AS
   Bellisle, F
   Di Pietro, PF
   Vieira, FK
   Araujo, PHD
   de Andrade, DF
AF Leal, Danielle Biazzi
   Altenburg de Assis, Maria Alice
   Hinnig, Patricia de Fragas
   Schmitt, Jeovani
   Lobo, Adriana Soares
   Bellisle, France
   Di Pietro, Patricia Faria
   Vieira, Francilene Kunradi
   de Moura Araujo, Pedro Henrique
   de Andrade, Dalton Francisco
TI Changes in Dietary Patterns from Childhood to Adolescence and Associated
   Body Adiposity Status
SO NUTRIENTS
LA English
DT Article
DE dietary patterns; tracking; children; adolescents; factor analysis
ID CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; EATING PATTERNS; FOOD PATTERNS;
   CHILDREN; OBESITY; TRACKING; SCHOOLCHILDREN; CONSUMPTION; ADULTHOOD
AB The aims of this study were to identify cross-sectional dietary patterns (DPs) in a representative sample of 7-10-year-old schoolchildren, to examine how scores for these DPs tracked over a time period of five years (from age 7-10 years to 12-15 years), and to investigate longitudinal associations between changes in DPs scores and changes in BMI (Body Mass Index) z-scores. Children aged 7-10-years were examined in 2007 (n = 1158) and a subset of the sample participated in a follow-up in 2012 (n = 458). Factor analysis (FA) was applied to derive DPs at baseline. The change in DP from childhood to adolescence was analyzed by comparing factor scores using the complete cases, in which factor loadings were the ones evaluated at baseline. Associations of BMI change with DP change were assessed by multivariate linear regression. At baseline, four DP were identified that explained 47.9% of the food intake variance. On average, the factor scores of DP II (salty snacks, French fries, fast-food, sugary beverages) decreased in follow-up, while no changes were observed for DP I (rice, cooked beans, beef/poultry, leafy vegetables), DP III (fruits, cooked and leafy vegetables, fruit juices, pasta, milk, cheese), and DP IV (milk, coffee with milk, cheese, breads/biscuits). No significant linear association was shown between changes in BMI z-scores and changes in DP scores from childhood to adolescence. In conclusion, three out of four DP scores identified at baseline tracked slightly in adolescence.
C1 [Leal, Danielle Biazzi; Altenburg de Assis, Maria Alice; Hinnig, Patricia de Fragas; Lobo, Adriana Soares; Di Pietro, Patricia Faria; Vieira, Francilene Kunradi] Univ Fed Santa Catarina, Hlth Sci Ctr, Post Grad Program Nutr, CCS,UFSC, Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
   [Leal, Danielle Biazzi; Altenburg de Assis, Maria Alice] Univ Fed Santa Catarina, Sports Ctr, Post Grad Program Phys Educ, CDS,UFSC, Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
   [Schmitt, Jeovani; de Moura Araujo, Pedro Henrique] Univ Fed Santa Catarina, Ctr Technol, Post Grad Program Prod Engn, Univ Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
   [Bellisle, France] Univ Paris 13, Ctr Rech Epidemiol & Stat, Equipe Rech Epidemiol Nutr, Inserm,U1153,Inra,U1125,Cnam,COMUE Sorbonne Paris, F-93017 Bobigny, France.
   [de Andrade, Dalton Francisco] Univ Fed Santa Catarina, Ctr Technol, Informat & Stat Dept, Univ Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
C3 Universidade Federal de Santa Catarina (UFSC); Universidade Federal de
   Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC);
   Universite Paris 13; Universite Paris Cite; heSam Universite;
   Conservatoire National Arts & Metiers (CNAM); Institut National de la
   Sante et de la Recherche Medicale (Inserm); INRAE; Universidade Federal
   de Santa Catarina (UFSC)
RP Leal, DB (corresponding author), Univ Fed Santa Catarina, Hlth Sci Ctr, Post Grad Program Nutr, CCS,UFSC, Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.; Leal, DB (corresponding author), Univ Fed Santa Catarina, Sports Ctr, Post Grad Program Phys Educ, CDS,UFSC, Campus Trindade, BR-88040900 Florianopolis, SC, Brazil.
EM danibiazzi@yahoo.com.br; malicedeassis@gmail.com; phinnig@yahoo.com.br;
   jeovani.schmitt@yahoo.com.br; adri_lobo@hotmail.com;
   bellisle@uren.smbh.univ-paris13.fr; fariadipietro@gmail.com;
   frankunradi@gmail.com; phma05@gmail.com; daltoncasa@hotmail.com
RI Kunradi Vieira, Francilene/KGK-8532-2024; Di Pietro,
   Patricia/G-6101-2015; Hinnig, Patricia/Q-4262-2018; Araújo,
   Pedro/Q-9549-2019; de Assis, Maria/B-8125-2009; Assis, Maria
   Alice/L-8489-2015
OI Assis, Maria Alice/0000-0002-5383-3714; Bellisle,
   France/0000-0002-6952-6890; Schmitt, Jeovani/0000-0003-4453-9035
FU Brazilian National Council for Scientific and Technological
   Development-CNPq [402322/2005-3, 483955/2011-6, 305148/2011-7,
   308352/2016-5]; Brazilian Federal Agency for the Improvement of Higher
   Education; Foundation of Research from Santa Catarina State
FX The survey was funded by the Brazilian National Council for Scientific
   and Technological Development-CNPq (grants 402322/2005-3 and
   483955/2011-6), (M.A.A.d.A. grants no. 305148/2011-7 and 308352/2016-5).
   D.B.L. and A.S.L. received a fellowship from the Brazilian Federal
   Agency for the Improvement of Higher Education and the Foundation of
   Research from Santa Catarina State, respectively. The funding sources
   had no role in the study design; collection, analysis, and
   interpretation of data; writing of the report; or the decision to submit
   the article for publication.
CR Alexy U, 2004, INT J OBESITY, V28, P1203, DOI 10.1038/sj.ijo.0802708
   Alexy U, 2011, EUR J CLIN NUTR, V65, P160, DOI 10.1038/ejcn.2010.254
   de Assis MAA, 2010, CAD SAUDE PUBLICA, V26, P1355, DOI 10.1590/S0102-311X2010000700014
   de Assis MAA, 2009, CAD SAUDE PUBLICA, V25, P1816, DOI 10.1590/S0102-311X2009000800018
   dos Santos NHA, 2014, CAD SAUDE PUBLICA, V30, P2235
   Ambrosini GL, 2014, P NUTR SOC, V73, P137, DOI 10.1017/S0029665113003765
   Ambrosini GL, 2014, OBESITY, V22, P458, DOI 10.1002/oby.20542
   BARANOWSKI T, 1994, AM J CLIN NUTR, V59, p212S, DOI 10.1093/ajcn/59.1.212S
   Bull CJ, 2016, PUBLIC HEALTH NUTR, V19, P3369, DOI 10.1017/S1368980016001592
   Cabral L. G. A., 2011, Rev Bras Ativ Fis Saude, V16, P100
   Cohen J., 1992, Current Directions in Psychological Science, V1, P98, DOI [DOI 10.1111/1467-8721.EP10768783, 10.1111/1467-8721.ep10768783]
   Craig LCA, 2010, BRIT J NUTR, V103, P319, DOI 10.1017/S0007114509991942
   Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005
   de Carvalho CA, 2016, CIENC SAUDE COLETIVA, V21, P143, DOI 10.1590/1413-81232015211.18962014
   de Jesus GM, 2016, REV BRAS MED ESPORTE, V22, P261, DOI 10.1590/1517-869220162204157067
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026
   Due P, 2011, SCAND J PUBLIC HEALT, V39, P62, DOI 10.1177/1403494810395989
   Emmett PM, 2015, NUTR REV, V73, P207, DOI 10.1093/nutrit/nuv055
   Harris C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2189-0
   Hawkes C., 2009, GLOBALIZATION HLTH P, P235
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541
   Kupek E, 2016, BRIT J NUTR, V116, P1954, DOI 10.1017/S0007114516004128
   Leal DB, 2015, PUBLIC HEALTH NUTR, V18, P2105, DOI 10.1017/S1368980014002857
   Ledoux TA, 2011, OBES REV, V12, pe143, DOI 10.1111/j.1467-789X.2010.00786.x
   Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169
   Lohman T.G., 1991, Anthropometric Standardization Reference Manual
   Lytle LA, 2000, AM J HEALTH PROMOT, V14, P222, DOI 10.4278/0890-1171-14.4.222
   Arruda SPM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-654
   Madruga SW, 2012, REV SAUDE PUBL, V46, P376, DOI 10.1590/S0034-89102012005000016
   Magarey A, 2009, INT J PEDIATR OBES, V4, P257, DOI 10.3109/17477160902846161
   Massarani FA, 2015, CAD SAUDE PUBLICA, V31, P2535, DOI 10.1590/0102-311X00090314
   de Pinho MGM, 2017, REV NUTR, V30, P377, DOI 10.1590/1678-98652017000300010
   McCarrey S, 2014, PERSPECTIVES ON THE PERFORMANCE OF FRENCH PIANO MUSIC, P1, DOI 10.1016/j.physbeh.2014.02.046
   Mikkilä V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418
   Moreira P, 2010, INT J ENV RES PUB HE, V7, P1121, DOI 10.3390/ijerph7031121
   Nascimento S, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-79
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Northstone K, 2008, BRIT J NUTR, V100, P1069, DOI 10.1017/S0007114508968264
   Northstone K, 2008, BRIT J NUTR, V99, P1099, DOI 10.1017/S0007114507842802
   Oellingrath IM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-106
   Pala V, 2013, EUR J CLIN NUTR, V67, P1042, DOI 10.1038/ejcn.2013.145
   Pate RR, 2013, OBES REV, V14, P645, DOI 10.1111/obr.12035
   Patterson E, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-91
   Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x
   R Core team, 2016, R: A Language and Environmental Statistical Computing, DOI DOI 10.1007/978-3-540-74686-7
   Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45
   Robinson S, 2007, BRIT J NUTR, V98, P1029, DOI 10.1017/S0007114507750936
   Rodrigues Paulo Rogério Melo, 2012, Rev. bras. epidemiol., V15, P662, DOI 10.1590/S1415-790X2012000300019
   Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x
   Rothausen BW, 2013, BRIT J NUTR, V109, P1704, DOI 10.1017/S0007114512003662
   Santos RD, 2015, BRIT J NUTR, V114, P822, DOI 10.1017/S0007114515002445
   Frainer DES, 2007, ARCH LATINOAM NUTR, V57, P335
   Shang L, 2014, APPL PHYSIOL NUTR ME, V39, P195, DOI 10.1139/apnm-2012-0392
   Shroff MR, 2014, PUBLIC HEALTH NUTR, V17, P1507, DOI 10.1017/S136898001300133X
   Smith ADAC, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.22769
   Svensson Å, 2014, EUR J CLIN NUTR, V68, P822, DOI 10.1038/ejcn.2014.87
   Thorpe MG, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0353-2
   Togo P, 2004, INT J OBESITY, V28, P583, DOI 10.1038/sj.ijo.0802598
   Totland TH, 2013, PUBLIC HEALTH NUTR, V16, P673, DOI 10.1017/S1368980012003060
   Twisk JWR., 2007, Applied longitudinal data analysis for epidemiology. A practical guide
   Verly E, 2010, CAD SAUDE PUBLICA, V26, P2129, DOI 10.1590/S0102-311X2010001100014
   Wilks DC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-48
NR 64
TC 30
Z9 34
U1 0
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2017
VL 9
IS 10
AR 1098
DI 10.3390/nu9101098
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FM0DM
UT WOS:000414629900054
PM 28984828
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Galbete, C
   Nicolaou, M
   Meeks, K
   Klipstein-Grobusch, K
   Aikins, AD
   Addo, J
   Amoah, SK
   Smeeth, L
   Owusu-Dabo, E
   Spranger, J
   Agyemang, C
   Mockenhaupt, FP
   Beune, E
   Stronks, K
   Schulze, MB
   Danquah, I
AF Galbete, Cecilia
   Nicolaou, Mary
   Meeks, Karlijn
   Klipstein-Grobusch, Kerstin
   Aikins, Ama de-Graft
   Addo, Juliet
   Amoah, Stephen K.
   Smeeth, Liam
   Owusu-Dabo, Ellis
   Spranger, Joachim
   Agyemang, Charles
   Mockenhaupt, Frank P.
   Beune, Erik
   Stronks, Karien
   Schulze, Matthias B.
   Danquah, Ina
TI Dietary patterns and type 2 diabetes among Ghanaian migrants in Europe
   and their compatriots in Ghana: the RODAM study
SO NUTRITION & DIABETES
LA English
DT Article
ID MEAT CONSUMPTION; PREVALENCE; METAANALYSIS; PREVENTION; MANAGEMENT; RISK
AB Background/objectives We aimed to study the associations of dietary patterns (DPs) with type 2 diabetes (T2D) among Ghanaian adults.
   Subjects/methods In the multi-centre, cross-sectional RODAM (Research on Obesity and Diabetes among African Migrants) study (n = 4543), three overall DPs ("mixed", "rice, pasta, meat and fish," and "roots, tubers and plantain") and two site-specific DPs per study site (rural Ghana, urban Ghana and Europe) were identified by principal component analysis. The DPs-T2D associations were calculated by logistic regression models.
   Results Higher adherence to the "rice, pasta, meat and fish" DP (characterized by legumes, rice/pasta, meat, fish, cakes/sweets, condiments) was associated with decreased odds of T2D, adjusted for socio-demographic factors, total energy intake and adiposity measures (odds ratio (OR) per 1 SD = 0.80; 95% confidence interval (CI) = 0.70-0.92). Similar DPs and T2D associations were discernible in urban Ghana and Europe. In the total study population, neither the "mixed" DP (whole grain cereals, sweet spreads, dairy products, potatoes, vegetables, poultry, coffee/tea, sodas/juices, olive oil) nor the "roots, tubers and plantain" DP (refined cereals, fruits, nuts/seeds, roots/tubers/plantain, fermented maize products, legumes, palm oil, condiments) was associated with T2D. Yet, after the exclusion of individuals with self-reported T2D, the "roots, tubers and plantain" DP was inversely associated with T2D (ORper 1 SD = 0.88; 95% CI = 0.69-1.12).
   Conclusion In this Ghanaian population, DPs characterized by the intake of legumes, fish, meat and confectionery were inversely associated with T2D. The effect of a traditional-oriented diet (typical staples, vegetables and legumes) remains unclear.
C1 [Galbete, Cecilia; Schulze, Matthias B.; Danquah, Ina] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Epidemiol, Nuthetal, Germany.
   [Nicolaou, Mary; Meeks, Karlijn; Agyemang, Charles; Beune, Erik; Stronks, Karien] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.
   [Klipstein-Grobusch, Kerstin] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.
   [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa.
   [Aikins, Ama de-Graft] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana.
   [Addo, Juliet; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Non Communicable Dis Epidemiol, London, England.
   [Amoah, Stephen K.; Mockenhaupt, Frank P.] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany.
   [Amoah, Stephen K.; Spranger, Joachim; Mockenhaupt, Frank P.; Danquah, Ina] Berlin Inst Hlth, Berlin, Germany.
   [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Dept Global & Int Hlth, Kumasi, Ghana.
   [Spranger, Joachim] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Endocrinol & Metab Dis, Berlin, Germany.
   [Danquah, Ina] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.
C3 Leibniz Association; Deutsches Institut fur Ernahrungsforschung
   Potsdam-Rehbrucke (DIfE); Vrije Universiteit Amsterdam; University of
   Amsterdam; Academic Medical Center Amsterdam; Utrecht University;
   Utrecht University Medical Center; University of Witwatersrand;
   University of Ghana; University of London; London School of Hygiene &
   Tropical Medicine; Berlin Institute of Health; Free University of
   Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Berlin Institute of Health; Kwame Nkrumah University Science &
   Technology; Berlin Institute of Health; Free University of Berlin;
   Humboldt University of Berlin; Charite Universitatsmedizin Berlin;
   Berlin Institute of Health; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin
RP Galbete, C (corresponding author), German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Epidemiol, Nuthetal, Germany.; Galbete, C (corresponding author), Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.
EM cecilia.galbete@dife.de
RI Sonestedt, Emily/I-3814-2016; Klipstein-Grobusch, Kerstin/F-5555-2016;
   Mockenhaupt, Frank/U-9824-2017; Smeeth, Liam/X-5862-2018; Schulze,
   Matthias B./AAH-6906-2021; Galbete, Cecilia/M-1276-2013
OI Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Mockenhaupt,
   Frank/0000-0002-8117-5421; Stronks, Karien/0000-0002-0921-2232; Meeks,
   Karlijn/0000-0003-3032-405X; Smeeth, Liam/0000-0002-9168-6022; Danquah,
   Ina/0000-0003-3222-3498; Schulze, Matthias B./0000-0002-0830-5277;
   Nicolaou, Mary/0000-0002-0419-5816; Galbete, Cecilia/0000-0002-2497-6791
FU European Commission under the 7th Framework Programme [278901];
   NutriAct-Competence Cluster Nutrition Research Berlin-Potsdam - Federal
   Ministry of Education and Research [FKZ: 01EA1408A-G]
FX This work was supported by the European Commission under the 7th
   Framework Programme (grant number: 278901). C.G. was financially
   supported by NutriAct-Competence Cluster Nutrition Research
   Berlin-Potsdam funded by the Federal Ministry of Education and Research
   (FKZ: 01EA1408A-G). The funders had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript. The authors are very grateful to the advisory board members
   for their valuable support in shaping the methods, to the research
   assistants, interviewers and other staff of the five research locations
   who have taken part in gathering the data and, most of all, to the
   Ghanaian volunteers participating in this project. We gratefully
   acknowledge Jan van Straalen from the Academic Medical Centre for his
   valuable support with standardization of the lab procedures and the AMC
   Biobank for support in biobank management and storage of collected
   samples.
CR Agyemang C, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0709-0
   Agyemang C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004877
   [Anonymous], 2015, WHO Calls on Countries to Reduce Sugars Intake among Adults and Children
   Ballotari P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1403-4
   Basu S, 2013, PUBLIC HEALTH NUTR, V16, P179, DOI 10.1017/S1368980012002881
   Becerra-Tomás N, 2018, CLIN NUTR, V37, P906, DOI 10.1016/j.clnu.2017.03.015
   Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y
   Danquah I, 2018, EUR J NUTR, V57, P2723, DOI 10.1007/s00394-017-1538-4
   FAO. FAOSTATS, 2017, FOOD BAL SHEETS FOOD
   Federation ID, 2015, IDF DIAB ATL INT DIA
   Frank LK, 2014, BRIT J NUTR, V112, P89, DOI 10.1017/S000711451400052X
   Galbete C, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1341809
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Jannasch F, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0286-x
   Jannasch F, 2017, J NUTR, V147, P1174, DOI 10.3945/jn.116.242552
   Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2826, DOI 10.1158/1055-9965.EPI-12-ED1
   Kröger J, 2014, CURR OPIN LIPIDOL, V25, DOI 10.1097/MOL.0000000000000078
   Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9
   Meeks KAC, 2016, INTERN EMERG MED, V11, P327, DOI 10.1007/s11739-015-1302-9
   Misra A, 2007, NUTRITION, V23, P696, DOI 10.1016/j.nut.2007.06.008
   Mlotha V, 2016, FOOD SCI NUTR, V4, P322, DOI 10.1002/fsn3.293
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Osei-Kwasi HA, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0412-8
   Palli D, 2013, DIABETOLOGIA, V56, P47, DOI 10.1007/s00125-012-2718-7
   Ros E, 2015, BRIT J NUTR, V113, pS111, DOI 10.1017/S0007114514003924
   Schwingshackl L, 2017, EUR J EPIDEMIOL, V32, P363, DOI 10.1007/s10654-017-0246-y
   WHO, 2006, DEF DIAGN DIABT MELL
   WHO, 2005, Report No.: 9241593830
   Wittenbecher C, 2015, AM J CLIN NUTR, V101, P1241, DOI 10.3945/ajcn.114.099150
NR 29
TC 25
Z9 27
U1 0
U2 11
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2044-4052
J9 NUTR DIABETES
JI Nutr. Diabetes
PD APR 25
PY 2018
VL 8
AR 25
DI 10.1038/s41387-018-0029-x
PG 12
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA GF1VF
UT WOS:000431723000008
PM 29695705
OA Green Published, gold, Green Accepted
DA 2025-04-28
ER

PT J
AU Santos, LP
   Ong, KK
   Santos, IS
   Matijasevich, A
   Barros, AJD
AF Santos, Leonardo Pozza
   Ong, Ken K.
   Santos, Ina S.
   Matijasevich, Alicia
   Barros, Aluisio J. D.
TI Effects of dietary intake patterns from 1 to 4years on BMI z-score and
   body shape at age of 6 years: a prospective birth cohort study from
   Brazil
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Diet; Food intake; Body mass index; Body shape
ID WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; MASS INDEX; CHILDREN;
   CHILDHOOD; ADIPOSITY; ASSOCIATION; ADOLESCENTS; OBESITY; FAT
AB PurposeTo assess the association between dietary intake patterns from 1 to 4years and BMI and body shape at age of 6years.MethodsThis longitudinalstudy was based on3374 Brazilian children from the 2004 Pelotas Birth Cohort Study. We used previously described dietary patterns from 1 to 4years as the main exposure. We defined body shape using scores for corpulence (a recently described body shape component measured by Photonic Scanner), and trunk and gynoid fat mass percentage from DXA. We run linear regression models to evaluate the associations between dietary patterns from 1 to 4years and BMI and body shape at 6years.ResultsSeveral apparent associations between dietary patterns and BMI or body shape were explained by sociodemographic factors. High adherence to snacks (positive loadings to coffee, bread and cookies) at 4years predicted lower BMI, but higher gynoid fat mass percentage at 6 years, while higher adherence to staple at 2years (positive loadings to rice and beans) predicted higher trunk fat mass and lower gynoid fat mass. Finally, higher scores on milks at 1year (positive loading to breast milk) predicted higher gynoid fat mass at 6years.ConclusionThere were inconsistent associations between dietary patterns in infancy and early childhood and BMI and body shape at 6years. In adjusted analyses, higher adherence to breast milk at 1year and to snacks at 4years appeared to be beneficial for body shape, associated with lower BMI, but higher peripheral fat.
C1 [Santos, Leonardo Pozza; Santos, Ina S.; Matijasevich, Alicia; Barros, Aluisio J. D.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.
   [Santos, Leonardo Pozza] Fed Univ Pampa, Nutr Sch, Luiz Joaquim de Sa Britto S-N, BR-97650000 Itaqui, Brazil.
   [Ong, Ken K.] MRC, Inst Metab Sci, Epidemiol Unit, Cambridge, England.
   [Matijasevich, Alicia] Univ Sao Paulo, Fac Med FMUSP, Dept Prevent Med, Sao Paulo, Brazil.
C3 Universidade Federal de Pelotas; Universidade Federal do Pampa;
   University of Cambridge; Universidade de Sao Paulo
RP Santos, LP (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.; Santos, LP (corresponding author), Fed Univ Pampa, Nutr Sch, Luiz Joaquim de Sa Britto S-N, BR-97650000 Itaqui, Brazil.
EM leonardo_pozza@yahoo.com.br; ken.ong@mrc-epid.cam.ac.uk;
   inasantos@uol.com.br; amatija@yahoo.com; abarros.epi@gmail.com
RI Barros, Aluisio/A-7417-2008; Matijasevich, Alicia/C-5576-2009; Santos,
   Leonardo Pozza dos/E-3460-2014
OI Matijasevich, Alicia/0000-0003-0060-1589; Santos, Leonardo Pozza
   dos/0000-0002-3993-3786
FU Wellcome Trust [086974/Z/08/Z]; World Health Organization [03014HNI];
   Brazilian National Research Council (CNPq) [481012-2009-5,
   484077-2010-4, 470965-2010-0, 481141-2007-3]; Brazilian Ministry of
   Health [25000.105293/2004-83]; 'Science without Borders' Brazilian
   scheme [201801/2014-0]; MRC [MC_UU_12015/2] Funding Source: UKRI
FX The 2004 birth cohort study is supported by the Wellcome Trust through
   the scheme called 'Major Awards for Latin America on Health Consequences
   of Population Change' (Grant number 086974/Z/08/Z). The World Health
   Organization (Grant number 03014HNI), Brazilian National Research
   Council (CNPq) (Grant numbers 481012-2009-5; 484077-2010-4;
   470965-2010-0; and 481141-2007-3), and Brazilian Ministry of Health
   (Grant number 25000.105293/2004-83) have supported the previous phase of
   the study. LPS was supported by 'Science without Borders' Brazilian
   scheme under the protocol number 201801/2014-0.
CR Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6
   [Anonymous], PESQ ORC FAM 2008 20
   Araujo Cora L, 2004, Food Nutr Bull, V25, pS53
   Barros AJD, 2005, REV SAUDE PUBL, V39, P523, DOI 10.1590/S0034-89102005000400002
   Barros AJD, 2006, REV SAUDE PUBL, V40, P402, DOI 10.1590/S0034-89102006000300007
   Bermudez Odilia I., 2003, Cad. Saúde Pública, V19, pS87, DOI 10.1590/S0102-311X2003000700010
   Burrows TL, 2013, CLIN NUTR, V32, P613, DOI 10.1016/j.clnu.2012.11.006
   Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011
   Craig LCA, 2010, BRIT J NUTR, V103, P319, DOI 10.1017/S0007114509991942
   Cutler GJ, 2012, BRIT J NUTR, V108, P349, DOI 10.1017/S0007114511005435
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453
   Gatica G, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-43
   Habicht J P, 1974, Bol Oficina Sanit Panam, V76, P375
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Jennings A, 2011, J NUTR, V141, P453, DOI 10.3945/jn.110.131441
   Lefebvre CM, 2014, J AM ASSOC NURSE PRA, V26, P386, DOI 10.1002/2327-6924.12036
   Lindsay RS, 2001, J CLIN ENDOCR METAB, V86, P4061, DOI 10.1210/jc.86.9.4061
   Lioret S, 2015, J NUTR, V145, P775, DOI 10.3945/jn.114.201988
   Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714
   Mikkilä V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418
   Northstone K, 2008, BRIT J NUTR, V100, P1069, DOI 10.1017/S0007114508968264
   O'Connor L, 2015, BRIT J NUTR, V114, P1286, DOI 10.1017/S000711451500269X
   Pala V, 2013, EUR J CLIN NUTR, V67, P1042, DOI 10.1038/ejcn.2013.145
   Pietrobelli A, 1998, J PEDIATR-US, V132, P204, DOI 10.1016/S0022-3476(98)70433-0
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S
   Robinson SM, 2009, J CLIN ENDOCR METAB, V94, P2799, DOI 10.1210/jc.2009-0030
   Sainani KL, 2009, PM&R, V1, P1098, DOI 10.1016/j.pmrj.2009.10.004
   Santos IS, 2014, INT J EPIDEMIOL, V43, P1437, DOI 10.1093/ije/dyu144
   Santos LP, 2016, INT J OBESITY, V40, P1012, DOI 10.1038/ijo.2016.30
   Santos LP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3725-2
   Shroff MR, 2014, PUBLIC HEALTH NUTR, V17, P1507, DOI 10.1017/S136898001300133X
   Smith ADAC, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.22769
   Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372
   Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7
   Varraso R, 2012, AM J CLIN NUTR, V96, P1079, DOI 10.3945/ajcn.112.038109
   Voortman T, 2016, EUR J EPIDEMIOL, V31, P775, DOI 10.1007/s10654-016-0179-x
   Wang J, 2006, AM J CLIN NUTR, V83, P3
   Wells JCK, 2010, INT J OBESITY, V34, P649, DOI 10.1038/ijo.2009.249
   Wells JCK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124193
   Yang M, 2016, ASIA PAC J CLIN NUTR, V25, P798, DOI 10.6133/apjcn.092015.35
NR 42
TC 2
Z9 3
U1 1
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN
PY 2019
VL 58
IS 4
BP 1723
EP 1734
DI 10.1007/s00394-018-1720-3
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IC8TZ
UT WOS:000471256100032
PM 29774385
OA hybrid, Green Published
DA 2025-04-28
ER

PT J
AU Beck, KL
   Jones, B
   Ullah, I
   McNaughton, SA
   Haslett, SJ
   Stonehouse, W
AF Beck, K. L.
   Jones, B.
   Ullah, I.
   McNaughton, S. A.
   Haslett, S. J.
   Stonehouse, W.
TI Associations between dietary patterns, socio-demographic factors and
   anthropometric measurements in adult New Zealanders: an analysis of data
   from the 2008/09 New Zealand Adult Nutrition Survey
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Dietary patterns; Factor analysis; Obesity; Socio-economic status
ID LIFE-STYLE FACTORS; BODY-MASS INDEX; FOOD SECURITY; ENERGY-INTAKE;
   HEALTH; PREDICTION; AGE
AB Purpose To investigate associations between dietary patterns, socio-demographic factors and anthropometric measurements in adult New Zealanders.
   Methods Dietary patterns were identified using factor analysis in adults 15 years plus (n = 4657) using 24-h diet recall data from the 2008/09 New Zealand Adult Nutrition Survey. Multivariate regression was used to investigate associations between dietary patterns and age, gender and ethnicity. After controlling for demographic factors, associations between dietary patterns and food insecurity, deprivation, education, and smoking were investigated. Associations between dietary patterns and body mass index and waist circumference were examined adjusting for demographic factors, smoking and energy intake.
   Results Two dietary patterns were identified. 'Healthy' was characterised by breakfast cereal, low fat milk, soy and rice milk, soup and stock, yoghurt, bananas, apples, other fruit and tea, and low intakes of pies and pastries, potato chips, white bread, takeaway foods, soft drinks, beer and wine. 'Traditional' was characterised by beef, starchy vegetables, green vegetables, carrots, tomatoes, savoury sauces, regular milk, cream, sugar, tea and coffee, and was low in takeaway foods. The 'healthy' pattern was positively associated with age, female gender, New Zealand European or other ethnicity, and a secondary school qualification, and inversely associated with smoking, food insecurity, area deprivation, BMI and waist circumference. The 'traditional' pattern was positively associated with age, male gender, smoking, food insecurity and inversely associated with a secondary school qualification.
   Conclusions A 'Healthy' dietary pattern was associated with higher socio-economic status and reduced adiposity, while the 'traditional' pattern was associated with lower socio-economic status.
C1 [Beck, K. L.] Massey Univ Auckland, Coll Hlth, Sch Food & Nutr, Private Bag 102904, Auckland 0745, New Zealand.
   [Jones, B.; Ullah, I.] Massey Univ Auckland, Coll Sci, Inst Nat & Math Sci, Private Bag 102904, Auckland 0745, New Zealand.
   [Ullah, I.] Queensland Univ Technol, Sci & Engn Fac, GPO Box 2434, Brisbane, Qld 4001, Australia.
   [McNaughton, S. A.] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, 221 Burwood Highway, Burwood, Vic 3125, Australia.
   [Haslett, S. J.] Massey Univ, Coll Sci, Inst Fundamental Sci Stat, Private Bag 11222, Palmerston North 4442, New Zealand.
   [Haslett, S. J.] Australian Natl Univ, Stat Consulting Unit, Acton, ACT 2601, Australia.
   [Stonehouse, W.] CSIRO, Food & Nutr Business Unit, POB 11060, Adelaide, SA 5001, Australia.
C3 Massey University; Massey University; Queensland University of
   Technology (QUT); Deakin University; Massey University; Australian
   National University; Commonwealth Scientific & Industrial Research
   Organisation (CSIRO)
RP Beck, KL (corresponding author), Massey Univ Auckland, Coll Hlth, Sch Food & Nutr, Private Bag 102904, Auckland 0745, New Zealand.
EM k.l.beck@massey.ac.nz
RI Haslett, Stephen/AAX-2672-2021; McNaughton, Sarah A/B-2075-2012;
   Stonehouse, Welma/H-2316-2013
OI Haslett, Stephen/0000-0002-2775-5468; McNaughton, Sarah
   A/0000-0001-5936-9820; Beck, Kathryn Louise/0000-0003-1825-1927;
   Stonehouse, Welma/0000-0002-2856-4962
FU Higher Education Commission of Pakistan; NHMRC Career Development
   Fellowship Level 2 [1104636]; ARC Future Fellowship [FT100100581]; New
   Zealand Ministry of Health; National Health and Medical Research Council
   of Australia [1104636] Funding Source: NHMRC
FX Insha Ullah was supported by a PhD scholarship from the Higher Education
   Commission of Pakistan. Sarah McNaughton is supported by an NHMRC Career
   Development Fellowship Level 2, ID1104636 and was previously supported
   by an ARC Future Fellowship (2011-2015, FT100100581). The New Zealand
   Ministry of Health funded the 2008/09 New Zealand Adult Nutrition
   Survey. The New Zealand Crown is the owner of the copyright for the
   survey data. The funder had no role in the design, analysis or writing
   of this article. The results presented in this paper are the work of the
   authors.
CR [Anonymous], 2012, FOC PAC NUTR FIND 20
   [Anonymous], 2013 CENS QUICKSTATS
   [Anonymous], 2012, FOC MAOR NUTR FIND 2
   [Anonymous], 2016, National Diet and Nutrition Survey
   Australian Bureau of Statistics, 2014, 4364 0 55 007 AUSTR
   Ax E, 2016, BRIT J NUTR, V115, P95, DOI 10.1017/S0007114515004110
   Bailey RL, 2007, J AM DIET ASSOC, V107, P64, DOI 10.1016/j.jada.2006.10.009
   Beck KL, 2013, EUR J NUTR, V52, P467, DOI 10.1007/s00394-012-0348-y
   Bell LK, 2015, NUTRIENTS, V7, P6491, DOI 10.3390/nu7085295
   Carrera PM, 2007, J AM DIET ASSOC, V107, P1735, DOI 10.1016/j.jada.2007.07.016
   DiBello JR, 2009, J NUTR, V139, P1933, DOI 10.3945/jn.109.107888
   Gemming L, 2014, EUR J CLIN NUTR, V68, P259, DOI 10.1038/ejcn.2013.242
   Hefford M, 2005, HEALTH POLICY, V72, P9, DOI 10.1016/j.healthpol.2004.06.005
   Hellton KH, 2014, SCAND J STAT, V41, P1051, DOI 10.1111/sjos.12083
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Kim HS, 2008, NUTRITION, V24, P1065, DOI 10.1016/j.nut.2008.05.008
   Knudsen VK, 2014, EUR J CLIN NUTR, V68, P736, DOI 10.1038/ejcn.2014.38
   Lehtonen R., 2003, Practical Methods for Design and Analysis of Complex Surveys, V2nd
   Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [DOI 10.18637/JSS.V009.I08, 10.18637/jss.v009.i08]
   Lumley T., 2014, survey: analysis of complex survey samples. R package version 3.30
   Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017
   Macdiarmid JI, 1997, EUR J CLIN NUTR, V51, P199, DOI 10.1038/sj.ejcn.1600380
   Martinez ME, 1998, AM J EPIDEMIOL, V148, P17, DOI 10.1093/oxfordjournals.aje.a009552
   Maskarinec G, 2000, J NUTR, V130, P3068, DOI 10.1093/jn/130.12.3068
   Mateo-Gallego R, 2012, NUTR RES, V32, P466, DOI 10.1016/j.nutres.2012.05.004
   McNaughton SA, 2005, EUR J CLIN NUTR, V59, P341, DOI 10.1038/sj.ejcn.1602079
   Ministry of health, 2015, Understanding excess body weight: New Zealand health survey
   Mishra G, 2002, EUR J CLIN NUTR, V56, P687, DOI 10.1038/sj.ejcn.1601391
   Mishra GD, 2010, EUR J CLIN NUTR, V64, P1125, DOI 10.1038/ejcn.2010.121
   National Health and Nutrition Examinations Survey (NHANES), 2016, NHANES RESP RAT POP
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504
   Park SY, 2005, J NUTR, V135, P843, DOI 10.1093/jn/135.4.843
   Parnell WR, 2001, NEW ZEAL MED J, V114, P141
   Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x
   Price GM, 1997, BRIT J NUTR, V77, P833, DOI 10.1079/BJN19970083
   Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929
   Salmond CE, 2012, CAN J PUBLIC HEALTH, V103, pS7
   Scagliusi FB, 2008, BRIT J NUTR, V100, P1060, DOI 10.1017/S0007114508971300
   Smith C, 2015, PUBLIC HEALTH NUTR, V18, P3249, DOI 10.1017/S1368980015000890
   Stanforth PR, 2004, INT J OBESITY, V28, P925, DOI 10.1038/sj.ijo.0802563
   Stefanogiannis N, 2005, PUBLIC HEALTH NUTR, V8, P395, DOI 10.1079/PHN2004694
   Thompson JMD, 2010, BRIT J NUTR, V103, P1665, DOI 10.1017/S0007114509993606
   Togo P, 2001, INT J OBESITY, V25, P1741, DOI 10.1038/sj.ijo.0801819
   Townsend MS, 2001, J NUTR, V131, P1738, DOI 10.1093/jn/131.6.1738
   Tucker KL, 2010, APPL PHYSIOL NUTR ME, V35, P211, DOI 10.1139/H10-010
   University of Otago and Ministry of Health, 2011, METH REP 2008 09 NZ
   Wall CR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050300
   Wilde PE, 2006, J NUTR, V136, P1395, DOI 10.1093/jn/136.5.1395
NR 49
TC 57
Z9 60
U1 0
U2 26
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN
PY 2018
VL 57
IS 4
BP 1421
EP 1433
DI 10.1007/s00394-017-1421-3
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GG4YU
UT WOS:000432703000012
PM 28378296
DA 2025-04-28
ER

PT J
AU Nagao, T
   Meguro, S
   Hase, T
   Otsuka, K
   Komikado, M
   Tokimitsu, I
   Yamamoto, T
   Yamamoto, K
AF Nagao, Tomonori
   Meguro, Shinichi
   Hase, Tadashi
   Otsuka, Kazuhiro
   Komikado, Masanori
   Tokimitsu, Ichiro
   Yamamoto, Takashi
   Yamamoto, Kunio
TI A Catechin-rich Beverage Improves Obesity and Blood Glucose Control in
   Patients With Type 2 Diabetes
SO OBESITY
LA English
DT Article
ID GREEN TEA; EPIGALLOCATECHIN GALLATE; FAT; POLYPHENOLS; CONSUMPTION;
   CAFFEINE; INSULIN; DISEASE; HUMANS; LEVEL
AB We investigated the effects of continuous ingestion of a catechin-rich beverage in patients with type 2 diabetes who were not receiving insulin (Ins) therapy in a double-blind controlled study. The participants ingested green tea containing either 582.8 mg of catechins (catechin group; n = 23) or 96.3 mg of catechins (control group; n = 20) per day for 12 weeks. At week 12, the decrease in waist circumference was significantly greater in the catechin group than in the control group. Adiponectin, which is negatively correlated with visceral adiposity, increased significantly only in the catechin group. Although the increase in Ins at week 12 was significantly greater in the catechin group than in the control group, no apparent difference was noted between the two groups in glucose and hemoglobin A(1c). In patients treated with insulinotropic agents, the increase in Ins at week 12 was significantly greater in the catechin group than in the control group. This significant increase in Ins levels was observed only in the catechin group. In the catechin group receiving other treatments, Ins levels remained unchanged. In addition, in patients treated with insulinotropic agents, the decrease in hemoglobin A(1c) at week 12 was significantly greater in the catechin group than in the control group. These results suggest that a catechin-rich beverage might have several therapeutic uses: in the prevention of obesity; in the recovery of Ins-secretory ability; and, as a way to maintain low hemoglobin A(1c) levels in type 2 diabetic patients who do not yet require Ins therapy.
C1 [Nagao, Tomonori; Otsuka, Kazuhiro; Komikado, Masanori; Tokimitsu, Ichiro] Kao Corp, Hlth Care Food Res Labs, Tokyo, Japan.
   [Meguro, Shinichi; Hase, Tadashi] Kao Corp, Biol Sci Res Labs, Tochigi, Japan.
   [Yamamoto, Takashi; Yamamoto, Kunio] Koshien Univ, Dept Nutr, Kobe, Hyogo, Japan.
C3 KAO Corporation; KAO Corporation
RP Nagao, T (corresponding author), Kao Corp, Hlth Care Food Res Labs, Tokyo, Japan.
EM nagao.tomonori@kao.co.jp
OI HASE, TADASHI/0009-0003-3657-5332; Meguro, Shinichi/0000-0002-3072-2632
FU Kao Corporation
FX We are grateful to Dr. Koji Isozaki of the Isozaki Clinic, Dr. Kazuhiro
   Nagao of the Yuwakai Nagao Clinic, Dr. Hitofumi Mizuno of the Mizuno
   Clinic, the clinic staff, and the Aiei Support Corporation for their
   cooperation and advice. This study was supported by Kao Corporation, and
   there was no other funding/outside support.
CR Abe I, 2000, BIOCHEM BIOPH RES CO, V268, P767, DOI 10.1006/bbrc.2000.2217
   Ajay M, 2003, LIFE SCI, V74, P603, DOI 10.1016/j.lfs.2003.06.039
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Duffy SJ, 2001, CIRCULATION, V104, P151, DOI 10.1161/01.CIR.104.2.151
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Han MK, 2003, EXP MOL MED, V35, P136, DOI 10.1038/emm.2003.19
   Hosokawa Kazuhiro, 2002, Nihon Rinsho, V60 Suppl 9, P167
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kitabchi AE, 2001, DIABETES CARE, V24, P131, DOI 10.2337/diacare.24.1.131
   Kurioka S, 2002, ENDOCR J, V49, P459, DOI 10.1507/endocrj.49.459
   MATSUMOTO N, 1993, BIOSCI BIOTECH BIOCH, V57, P525, DOI 10.1271/bbb.57.525
   Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987
   MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929
   Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975
   Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703
   Wolfram S, 2006, J NUTR, V136, P2512, DOI 10.1093/jn/136.10.2512
   YOSHINO K, 1994, BIOL PHARM BULL, V17, P146, DOI 10.1248/bpb.17.146
   2006, NUTR SURVEY JAPAN 20
NR 24
TC 220
Z9 237
U1 5
U2 51
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1930-7381
J9 OBESITY
JI Obesity
PD FEB
PY 2009
VL 17
IS 2
BP 310
EP 317
DI 10.1038/oby.2008.505
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 400VJ
UT WOS:000262897200016
PM 19008868
OA Bronze
DA 2025-04-28
ER

PT J
AU Alam, MA
   Subhan, N
   Hossain, H
   Hossain, M
   Reza, HM
   Rahman, MM
   Ullah, MO
AF Alam, Md Ashraful
   Subhan, Nusrat
   Hossain, Hemayet
   Hossain, Murad
   Reza, Hasan Mahmud
   Rahman, Md Mahbubur
   Ullah, M. Obayed
TI Hydroxycinnamic acid derivatives: a potential class of natural compounds
   for the management of lipid metabolism and obesity
SO NUTRITION & METABOLISM
LA English
DT Review
DE Hydroxycinnamic acid; Obesity; Diabetes; Dyslipidemia; Inflammation
ID ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; NECROSIS-FACTOR-ALPHA;
   PHENETHYL ESTER CAPE; NF-KAPPA-B; FERULIC ACID; CAFFEIC ACID;
   PPAR-GAMMA; CHLOROGENIC ACID; CINNAMIC ACID
AB Hydroxycinnamic acid derivatives are important class of polyphenolic compounds originated from the Mavolanate-Shikimate biosynthesis pathways in plants. Several simple phenolic compounds such as cinnamic acid, p-coumaric acid, ferulic acid, caffeic acid, chlorgenic acid, and rosmarinic acid belong to this class. These phenolic compounds possess potent antioxidant and anti-inflammatory properties. These compounds were also showed potential therapeutic benefit in experimental diabetes and hyperlipidemia. Recent evidences also suggest that they may serve as valuable molecule for the treatment of obesity related health complications. In adipose tissues, hydroxycinnamic acid derivatives inhibit macrophage infiltration and nuclear factor kappa B (NF-kappa B) activation in obese animals. Hydroxycinnamic acid derivatives also reduce the expression of the potent proinflammatory adipokines tumor necrosis factor-alpha (TNF alpha), monocyte chemoattractant protein-1 (MCP-1), and plasminogen activator inhibitor type-1 (PAI-1), and they increase the secretion of an anti-inflammatory agent adiponectin from adipocytes. Furthermore, hydroxycinnamic acid derivatives also prevent adipocyte differentiation and lower lipid profile in experimental animals. Through these diverse mechanisms hydroxycinnamic acid derivatives reduce obesity and curtail associated adverse health complications.
C1 [Alam, Md Ashraful; Hossain, Murad; Reza, Hasan Mahmud; Rahman, Md Mahbubur; Ullah, M. Obayed] North South Univ Bangladesh, Dept Pharmaceut Sci, Dhaka, Bangladesh.
   [Subhan, Nusrat] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia.
   [Hossain, Hemayet] Bangladesh Council Sci & Ind Res, BCSIR Labs, Dhaka, Bangladesh.
C3 North South University (NSU); Charles Sturt University; Bangladesh
   Council of Scientific & Industrial Research (BCSIR); BCSIR Laboratories
   Dhaka
RP Ullah, MO (corresponding author), North South Univ Bangladesh, Dept Pharmaceut Sci, Dhaka, Bangladesh.
EM obayed.obhi@yahoo.com
RI Ullah, M/AAR-7211-2020; hossain, hemayet/O-5996-2018; Alam,
   Ashraful/G-1964-2014; Reza, Hasan Mahmud/AFL-0151-2022
OI Hossain, Hemayet/0000-0001-8759-9279; Rahman, Md.
   Mahbubur/0000-0003-3027-0354; Alam, Md Ashraful/0000-0001-7596-5868;
   Reza, Hasan Mahmud/0000-0003-3287-942X; Hossain, Dr.
   Murad/0000-0002-3680-6511
CR [Anonymous], EVID BASED COMPLEMEN
   Ardiansyah, 2008, J AGR FOOD CHEM, V56, P2825, DOI 10.1021/jf072896y
   Ardiansyah, 2007, BRIT J NUTR, V97, P67, DOI 10.1017/S000711450721013X
   Arranz S, 2012, NUTRIENTS, V4, P759, DOI 10.3390/nu4070759
   Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440
   Balasubashini MS, 2003, ACTA DIABETOL, V40, P118, DOI 10.1007/s00592-003-0099-6
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052
   Bruno G, 2011, TRANSPL P, V43, P327, DOI 10.1016/j.transproceed.2010.09.098
   Cantó C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4
   Celik S, 2009, PHARMACOL RES, V60, P270, DOI 10.1016/j.phrs.2009.03.017
   Chao CY, 2010, MOL NUTR FOOD RES, V54, P388, DOI 10.1002/mnfr.200900087
   Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33
   CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289
   Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082
   Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005
   Da Cunha FM, 2004, FREE RADICAL RES, V38, P1241, DOI 10.1080/10715760400016139
   de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367
   de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Eid HM, 2012, PLANTA MED, V78, pD121
   El-Seedi HR, 2012, J AGR FOOD CHEM, V60, P10877, DOI 10.1021/jf301807g
   Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Ferdowsian HR, 2009, AM J CARDIOL, V104, P947, DOI 10.1016/j.amjcard.2009.05.032
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Fonseca V, 2003, AM J MED, V115, P42, DOI 10.1016/j.amjmed.2003.09.005
   Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200
   Garcia-Roves PM, 2008, J BIOL CHEM, V283, P35724, DOI 10.1074/jbc.M805078200
   Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994
   Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028
   Hansen AS, 2005, EUR J CLIN NUTR, V59, P449, DOI 10.1038/sj.ejcn.1602107
   Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116
   He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100
   Herman CP, 2011, SOC ISS POLICY REV, V5, P37, DOI 10.1111/j.1751-2409.2011.01025.x
   Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956
   Hey-Mogensen M, 2012, ACTA PHYSIOL, V204, P354, DOI 10.1111/j.1748-1716.2011.02347.x
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Hole AS, 2012, FOOD CHEM, V133, P969, DOI 10.1016/j.foodchem.2012.02.017
   Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442
   Huang DW, 2012, J FUNCT FOODS, V4, P358, DOI 10.1016/j.jff.2012.01.005
   Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x
   James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008
   Juman S, 2011, BIOL PHARM BULL, V34, P490, DOI 10.1248/bpb.34.490
   Jung EH, 2007, J AGR FOOD CHEM, V55, P9800, DOI 10.1021/jf0714463
   Jung KJ, 2009, J NUTR BIOCHEM, V20, P378, DOI 10.1016/j.jnutbio.2008.04.008
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Kasetti RB, 2012, FOOD CHEM TOXICOL, V50, P1425, DOI 10.1016/j.fct.2012.02.003
   Kim EO, 2012, FOOD CHEM TOXICOL, V50, P1309, DOI 10.1016/j.fct.2012.02.011
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Kopp C, 2014, INT J MOL SCI, V15, P2906, DOI 10.3390/ijms15022906
   Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5
   Kwon EY, 2010, FOOD CHEM TOXICOL, V48, P2298, DOI 10.1016/j.fct.2010.05.063
   Kwon EY, 2009, J MED FOOD, V12, P996, DOI 10.1089/jmf.2009.0105
   Lafay Sophie, 2008, Phytochemistry Reviews, V7, P301, DOI 10.1007/s11101-007-9077-x
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lazarou C, 2012, CRIT REV FOOD SCI, V52, P382, DOI 10.1080/10408398.2010.500258
   Lee MK, 2007, CHEM-BIOL INTERACT, V170, P9, DOI 10.1016/j.cbi.2007.06.037
   Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011
   LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953
   Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006
   Long YC, 2005, DIABETOLOGIA, V48, P2354, DOI 10.1007/s00125-005-1962-5
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Marinou K, 2010, INT J CARDIOL, V138, P3, DOI 10.1016/j.ijcard.2009.03.135
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031
   McGowan MP, 2009, CURR ATHEROSCLER REP, V11, P470, DOI 10.1007/s11883-009-0070-2
   Michaluart P, 1999, CANCER RES, V59, P2347
   Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538
   Mnafgui K, 2015, J FOOD SCI TECH MYS, V52, P4378, DOI 10.1007/s13197-014-1488-2
   Narasimhan A, 2015, EUR J PHARMACOL, V761, P391, DOI 10.1016/j.ejphar.2015.04.043
   Narasimhan A, 2015, APPL PHYSIOL NUTR ME, V40, P769, DOI 10.1139/apnm-2015-0002
   Bezerra RMN, 2012, METABOLISM, V61, P1606, DOI 10.1016/j.metabol.2012.04.006
   Nicolson GL, 2007, J CELL BIOCHEM, V100, P1352, DOI 10.1002/jcb.21247
   Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c
   Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305
   Ohnishi M, 2004, BIOFACTORS, V21, P315, DOI 10.1002/biof.552210161
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003
   Pahan K, 2006, CELL MOL LIFE SCI, V63, P1165, DOI 10.1007/s00018-005-5406-7
   Pignatelli P, 2006, ATHEROSCLEROSIS, V188, P77, DOI 10.1016/j.atherosclerosis.2005.10.025
   Pistollato F, 2014, TRENDS FOOD SCI TECH
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Poquet L, 2008, DRUG METAB DISPOS, V36, P190, DOI 10.1124/dmd.107.017558
   Pragasam S, 2012, INFLAMMATION, P1
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907
   Racette SB, 2003, PHYS THER, V83, P276, DOI 10.1093/ptj/83.3.276
   Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0
   Rodríguez-Hernández H, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/678159
   Sakai S, 1997, CYTOKINE, V9, P242, DOI 10.1006/cyto.1996.0160
   Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Shashirekha MN, 2015, CRIT REV FOOD SCI, V55, P1324, DOI 10.1080/10408398.2012.692736
   Son MJ, 2011, J FOOD SCI, V76, pH7, DOI 10.1111/j.1750-3841.2010.01907.x
   Son MJ, 2010, J CLIN BIOCHEM NUTR, V46, P150, DOI 10.3164/jcbn.09-98
   Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767
   Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003
   Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015
   TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI [10.1139/H11-072, 10.1139/h11-072]
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang YF, 2012, INT REV PSYCHIATR, V24, P176, DOI 10.3109/09540261.2012.688195
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wilson TA, 2007, J NUTR BIOCHEM, V18, P105, DOI 10.1016/j.jnutbio.2006.03.006
   WOLFFRAM S, 1995, J NUTR, V125, P1300
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z
   Yen GC, 2011, J AGR FOOD CHEM, V59, P546, DOI 10.1021/jf1036992
   Yilmaz HR, 2004, J BIOCHEM MOL TOXIC, V18, P234, DOI 10.1002/jbt.20028
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 132
TC 251
Z9 278
U1 17
U2 181
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD APR 11
PY 2016
VL 13
AR 27
DI 10.1186/s12986-016-0080-3
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DI7JK
UT WOS:000373675300001
PM 27069498
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Wilsgaard, T
   Jacobsen, BK
   Arnesen, E
AF Wilsgaard, T
   Jacobsen, BK
   Arnesen, E
TI Determining lifestyle correlates of body mass index using multilevel
   analyses: The Tromso study, 1979-2001
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE body mass index; longitudinal studies; obesity; population; sex
ID CARDIOVASCULAR RISK-FACTORS; MIDDLE-AGED MEN; NUTRITION EXAMINATION
   SURVEY; 3RD NATIONAL-HEALTH; INTERNATIONAL PERSPECTIVE; SOCIOECONOMIC
   DIFFERENCES; EDUCATIONAL-LEVEL; PHYSICAL-ACTIVITY; MONICA PROJECT;
   BLOOD-PRESSURE
AB Increases in overweight and obesity have been observed globally in both developed and developing countries. The authors assessed the relation between lifestyle factors and body mass index (BMI) (weight (kg)/height (m)(2)) in a population-based longitudinal study, using BMI and its subsequent change as responses in a multilevel model. The authors included 11,115 men and women aged 20-61 years at baseline who were living in the municipality of Tromso, Norway, and who participated in three or four consecutive health surveys between 1979-1980 and 2001. Baseline age, physical activity at work, coffee consumption, and desired BMI (i.e., the BMI that the subjects reported they would like to have) were positively associated with baseline BMI, whereas height, alcohol consumption, leisure-time physical activity, and level of education were inversely associated. Most relations were found to be stronger in women than in men. Clinically relevant effect sizes were observed for most of the significant associations, especially in women. For instance, on an ordinal scale, a one-category increase in educational level would decrease the mean baseline BMI among women by 0.30 kg/m(2). Significant associations between several lifestyle factors and subsequent BMI change revealed that observed baseline associations were strengthened over time, especially in women.
C1 Univ Tromso, Fac Med, Inst Community Med, N-9037 Tromso, Norway.
C3 UiT The Arctic University of Tromso
RP Wilsgaard, T (corresponding author), Univ Tromso, Fac Med, Inst Community Med, N-9037 Tromso, Norway.
EM tom.wilsgaard@ism.uit.no
CR [Anonymous], SAS STAT US GUID
   [Anonymous], 2003, WHO TECH REP SER, V916, P1
   [Anonymous], 2017, Annex 3-03, P4
   BONAA KH, 1991, CIRCULATION, V83, P1305, DOI 10.1161/01.CIR.83.4.1305
   BONAA KH, 1992, CIRCULATION, V86, P394
   Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Droyvold WB, 2004, INT J OBESITY, V28, P410, DOI 10.1038/sj.ijo.0802569
   FOSS OP, 1986, SCAND J CLIN LAB INV, V46, P245, DOI 10.3109/00365518609083666
   HUBERT HB, 1987, AM J EPIDEMIOL, V125, P812, DOI 10.1093/oxfordjournals.aje.a114598
   JACOBSEN BK, 1987, SCAND J SOC MED, V15, P41, DOI 10.1177/140349488701500107
   JACOBSEN BK, 1987, J CHRON DIS, V40, P795, DOI 10.1016/0021-9681(87)90131-7
   JEFFERY RW, 1989, INT J OBESITY, V13, P59
   Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372
   Kawada T, 2004, ARCH MED RES, V35, P181, DOI 10.1016/j.arcmed.2003.09.012
   Laaksonen M, 1998, PREV MED, V27, P431, DOI 10.1006/pmed.1998.0288
   Lahti-Koski M, 2000, AM J CLIN NUTR, V72, P1436
   LamonFava S, 1996, ARTERIOSCL THROM VAS, V16, P1509, DOI 10.1161/01.ATV.16.12.1509
   Lin YC, 2003, PREV MED, V37, P233, DOI 10.1016/S0091-7435(03)00119-1
   LOCHEN ML, 1992, J EPIDEMIOL COMMUNIT, V43, P103
   MACMAHON S, 1987, EUR HEART J, V8, P57, DOI 10.1093/eurheartj/8.suppl_B.57
   Marques-Vidal P, 2001, ATHEROSCLEROSIS, V157, P431, DOI 10.1016/S0021-9150(00)00734-6
   Martikainen PT, 1999, AM J CLIN NUTR, V69, P719
   Molarius A, 1997, J EPIDEMIOL COMMUN H, V51, P252, DOI 10.1136/jech.51.3.252
   Molarius A, 2000, AM J PUBLIC HEALTH, V90, P1260, DOI 10.2105/AJPH.90.8.1260
   Myllykangas M, 1995, INT J EPIDEMIOL, V24, P1110, DOI 10.1093/ije/24.6.1110
   Petersen L, 2004, INT J OBESITY, V28, P105, DOI 10.1038/sj.ijo.0802548
   Rasky E, 1996, INT J EPIDEMIOL, V25, P1208, DOI 10.1093/ije/25.6.1208
   Rothman KJ., 1998, Modern Epidemiology, V2
   Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X
   Singer D., 2003, APPL LONGITUDINAL DA, DOI DOI 10.1093/ACPROF:OSO/9780195152968.003.0015
   Stamler J, 1991, Ann Epidemiol, V1, P347, DOI 10.1016/1047-2797(91)90045-E
   Sundquist J, 1998, INT J EPIDEMIOL, V27, P57, DOI 10.1093/ije/27.1.57
   THELLE DS, 1976, ACTA MED SCAND, V200, P107
   Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312
   Wilhelmsen L, 1976, Adv Cardiol, V18, P217
   Wilsgaard T, 2000, ARCH INTERN MED, V160, P2847, DOI 10.1001/archinte.160.18.2847
   Wilsgaard T, 2004, ANN EPIDEMIOL, V14, P265, DOI 10.1016/j.annepidem.2003.08.004
   Wilsgaard T, 2001, AM J EPIDEMIOL, V154, P418, DOI 10.1093/aje/154.5.418
   Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356
NR 40
TC 40
Z9 45
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD DEC 15
PY 2005
VL 162
IS 12
BP 1179
EP 1188
DI 10.1093/aje/kwi328
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA 991YI
UT WOS:000233850400006
PM 16269586
DA 2025-04-28
ER

PT J
AU Agarwal, K
   Manza, P
   Tejeda, HA
   Courville, AB
   Volkow, ND
   Joseph, P
AF Agarwal, Khushbu
   Manza, Peter
   Tejeda, Hugo A.
   Courville, Amber B.
   Volkow, Nora D.
   Joseph, Paule, V
TI Prenatal Caffeine Exposure Is Linked to Elevated Sugar Intake and BMI,
   Altered Reward Sensitivity, and Aberrant Insular Thickness in
   Adolescents: An ABCD Investigation
SO NUTRIENTS
LA English
DT Article
DE prenatal caffeine exposure; total sugar intake; body mass index; reward
   sensitivity; taste processing
ID CORTICAL THICKNESS; LIFE-STYLE; CHILDREN; CONSUMPTION; PREGNANCY; TASTE;
   ASSOCIATION; BEVERAGES; COGNITION; BEHAVIOR
AB Prenatal caffeine exposure (PCE) has been positively associated with elevated body mass index (BMI) in children. Why this association occurs is unclear, but it is possible that PCE alters the in utero development of brain structures associated with food preference, leading to more total sugar intake (TSI, grams) later in childhood. To test this hypothesis, we investigated if PCE (daily/weekly/<weekly vs. no exposure) and elevated BMI are associated with increased TSI, neural activation during large reward anticipation (monetary incentive delay task-functional MRI) and structural changes (thickness, mm) in taste processing regions of children (n = 5534; 9-11 years) from the large-scale Adolescent Brain Cognitive Development (ABCD) study. Linear mixed-effect models, after covariate adjustments, identified a positive association (p < 0.05, all |beta s| > 0.01) of excessive PCE (vs. no exposure) with elevated BMI (daily/weekly/daily limit; consistent in boys and girls), increased TSI (daily) and insular thickness (daily/weekly), as well as low middle frontal cortex (MFC) activation (daily). Our sub-analysis revealed an association of daily/weekly PCE (vs. no exposure) with increased gram sugar intake from soft drinks. We also identified a positive relationship of excessive PCE with elevated TSI and increased insular thickness (a key gustatory region), while in a Sobel test, reward sensitivity (reduced brain reactivity to reward anticipation in MFC; tracks reward outcomes) mediated (Test statistic = 2.23; p = 0.02) the PCE-linked BMI changes in adolescents. Our findings suggest that excessive PCE might be detrimental to frontal lobe development and altered reward sensitivity to food, thereby increasing risk for elevated TSI and obesity. Our results support recommendations to limit caffeine intake during pregnancy.
C1 [Agarwal, Khushbu; Joseph, Paule, V] NIAAA, Sect Sensory Sci & Metab, NIH, Bethesda, MD 20892 USA.
   [Agarwal, Khushbu; Joseph, Paule, V] NINR, NIH, Bethesda, MD 20892 USA.
   [Manza, Peter; Volkow, Nora D.] NIAAA, Lab Neuroimaging, NIH, Bethesda, MD 20892 USA.
   [Tejeda, Hugo A.] NIMH, Unit Neuromodulat & Synapt Integrat, NIH, Bethesda, MD 20892 USA.
   [Courville, Amber B.] NIDDK, NIH, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH)
   - USA; NIH National Institute of Nursing Research (NINR); National
   Institutes of Health (NIH) - USA; NIH National Institute on Alcohol
   Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA;
   NIH National Institute of Mental Health (NIMH); National Institutes of
   Health (NIH) - USA; NIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK)
RP Joseph, P (corresponding author), NIAAA, Sect Sensory Sci & Metab, NIH, Bethesda, MD 20892 USA.; Joseph, P (corresponding author), NINR, NIH, Bethesda, MD 20892 USA.; Volkow, ND (corresponding author), NIAAA, Lab Neuroimaging, NIH, Bethesda, MD 20892 USA.
EM nvolkow@nida.nih.gov
RI Manza, Peter/AFR-2344-2022; Tejeda, Hugo/AAX-2529-2021; Joseph,
   Paule/N-2701-2013
OI Joseph, Paule/0000-0002-1198-9622; Courville, Amber/0000-0002-1419-3937
FU National Institute on Alcohol Abuse and Alcoholism [Z01AA000135,
   Y1AA-3009]; Nursing Research [1ZIANR000035-01]; Office of Work force
   Diversity; National Institutes of Health Distinguished Scholar Award at
   the National Institutes of Health; Rockefeller University Heilbrunn
   Nurse Scholar Award; National Institute of Mental Health Intramural
   Research Program; NARSAD Young Investigator Award; National Institute of
   Nursing Research [ZIANR000035] Funding Source: NIH RePORTER
FX P.V.J. is supported by the National Institute on Alcohol Abuse and
   Alcoholism (Z01AA000135) and Nursing Research (1ZIANR000035-01), the
   Office of Work force Diversity and the National Institutes of Health
   Distinguished Scholar Award at the National Institutes of Health and by
   the Rockefeller University Heilbrunn Nurse Scholar Award. N.D.V. and
   P.M. are supported by the National Institute on Alcohol Abuse and
   Alcoholism (Grant No. Y1AA-3009). K.A. received Intramural Research
   Training Awards, National Institute on Alcohol Abuse and Alcoholism,
   Center on Compulsive Behaviors, National Institutes of Health,
   Department of Health, and Human Services. HAT is supported by the
   National Institute of Mental Health Intramural Research Program and a
   NARSAD Young Investigator Award.
CR Aden Ulrika, 2011, Handb Exp Pharmacol, P373, DOI 10.1007/978-3-642-13443-2_14
   Barch DM, 2018, DEV COGN NEUROS-NETH, V32, P55, DOI 10.1016/j.dcn.2017.10.010
   Berglundh S, 2021, EUR J NUTR, V60, P791, DOI 10.1007/s00394-020-02280-7
   Bernard JY, 2016, AM J EPIDEMIOL, V183, P871, DOI 10.1093/aje/kww027
   Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8
   Carroll J.M., 1999, Review of General Psychology, V3, P14, DOI [10.1037/1089-2680.3.1.14, DOI 10.1037/1089-2680.3.1.14]
   Casey BJ, 2018, DEV COGN NEUROS-NETH, V32, P43, DOI 10.1016/j.dcn.2018.03.001
   Christensen ZP, 2021, NEUROPHARMACOLOGY, V186, DOI 10.1016/j.neuropharm.2021.108479
   Cobiac L., 2003, Nutrition & Dietetics, V60, P152
   Compton WM, 2019, JAMA PEDIATR, V173, P809, DOI 10.1001/jamapediatrics.2019.2081
   De Decker A, 2016, APPETITE, V100, P189, DOI 10.1016/j.appet.2016.02.028
   Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021
   Duerden EG, 2013, NEUROIMAGE, V78, P159, DOI 10.1016/j.neuroimage.2013.04.014
   EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4552
   Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]
   Frantsve-Hawley J, 2017, J PUBLIC HEALTH DENT, V77, pS43, DOI 10.1111/jphd.12222
   Frayer Natalie C, 2020, Int J MCH AIDS, V9, P364, DOI 10.21106/ijma.387
   Garavan H, 2018, DEV COGN NEUROS-NETH, V32, P16, DOI 10.1016/j.dcn.2018.04.004
   GOLDSTEIN A, 1962, BIOCHEM PHARMACOL, V11, P166, DOI 10.1016/0006-2952(62)90106-5
   Gómez-Miranda LM, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19116403
   Hagler DJ, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116091
   Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3
   Hunsberger M, 2015, MATERN CHILD NUTR, V11, P260, DOI 10.1111/j.1740-8709.2012.00446.x
   Kaiser L, 2008, J AM DIET ASSOC, V108, P553, DOI 10.1016/j.jada.2008.01.030
   Keller A, 2015, CHILD OBES, V11, P338, DOI 10.1089/chi.2014.0117
   Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1
   Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5
   KNUTTI R, 1981, EUR J CLIN PHARMACOL, V21, P121, DOI 10.1007/BF00637512
   Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z
   Lees B, 2020, AM J PSYCHIAT, V177, P1060, DOI 10.1176/appi.ajp.2020.20010086
   Li DK, 2015, INT J OBESITY, V39, P658, DOI 10.1038/ijo.2014.196
   Liberali R, 2020, CHILD OBES, V16, P70, DOI 10.1089/chi.2019.0059
   Lyall K, 2014, INT J EPIDEMIOL, V43, P443, DOI 10.1093/ije/dyt282
   McGuire S, 2012, ADV NUTR, V3, P534, DOI 10.3945/an.112.002279
   Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0
   Nansel TR, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00033
   Oken E, 2005, ENVIRON HEALTH PERSP, V113, P1376, DOI 10.1289/ehp.8041
   Papadopoulou E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018895
   Paquet C, 2010, AM J CLIN NUTR, V91, P771, DOI 10.3945/ajcn.2009.28648
   Park S, 2016, MMWR-MORBID MORTAL W, V65, P169, DOI 10.15585/mmwr.mm6507a1
   Parnell W, 2008, PUBLIC HEALTH NUTR, V11, P860, DOI 10.1017/S1368980007000948
   Parsons AG, 2008, BRIT J NUTR, V99, P1133, DOI 10.1017/S0007114507853359
   Paul SE, 2021, JAMA PSYCHIAT, V78, P64, DOI 10.1001/jamapsychiatry.2020.2902
   Rolls ET, 2019, HAND CLINIC, V164, P97, DOI 10.1016/B978-0-444-63855-7.00007-1
   Rosinger Asher, 2017, NCHS Data Brief, P1
   Schilling C, 2013, MOL PSYCHIATR, V18, P624, DOI 10.1038/mp.2012.56
   Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s
   Shah B, 2020, BMJ NUTR PREV HLTH, V3, P387, DOI DOI 10.1136/BMJNPH-2020-000074
   Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540
   Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513
   Small DM, 2006, ADV OTO-RHINO-LARYNG, V63, P191, DOI 10.1159/000093761
   Small DM, 2010, BRAIN STRUCT FUNCT, V214, P551, DOI 10.1007/s00429-010-0266-9
   Soellner DE, 2009, BEHAV BRAIN RES, V205, P191, DOI 10.1016/j.bbr.2009.08.012
   Tanabe J, 2013, AM J NEURORADIOL, V34, P1150, DOI 10.3174/ajnr.A3347
   Temple JL, 2017, J PSYCHOPHARMACOL, V31, P561, DOI 10.1177/0269881117691568
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Vennerod FFF, 2018, APPETITE, V127, P130, DOI 10.1016/j.appet.2018.04.027
   Ventura AK, 2011, CURR OPIN CLIN NUTR, V14, P379, DOI 10.1097/MCO.0b013e328346df65
   Weinstein AM, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00185
   Welsh J. A., 2017, Nutrition Today, V52, pS60, DOI [10.1097/nt.0000000000000193, 10.1097/NT.0000000000000193]
   Whittle S, 2014, AM J PSYCHIAT, V171, P564, DOI 10.1176/appi.ajp.2013.13070920
   Yamamoto T, 2008, JPN DENT SCI REV, V44, P91, DOI 10.1016/j.jdsr.2008.07.003
   Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053055
   Zhang R, 2022, J CHILD PSYCHOL PSYC, V63, P563, DOI 10.1111/jcpp.13495
NR 64
TC 4
Z9 4
U1 2
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2022
VL 14
IS 21
AR 4643
DI 10.3390/nu14214643
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 6F5TA
UT WOS:000884121700001
PM 36364905
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Asgary, S
   Rastqar, A
   Keshvari, M
AF Asgary, Sedigheh
   Rastqar, Ali
   Keshvari, Mahtab
TI Functional Food and Cardiovascular Disease Prevention and Treatment: A
   Review
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE Cardiovascular disease; functional foods; nutrition
ID CORONARY-HEART-DISEASE; POMEGRANATE JUICE CONSUMPTION; INTIMA-MEDIA
   THICKNESS; WHOLE-GRAIN INTAKE; AGED GARLIC EXTRACT; POSTPRANDIAL
   ENDOTHELIAL FUNCTION; CARDIOMETABOLIC RISK-FACTORS; RANDOMIZED
   CONTROLLED-TRIAL; DIASTOLIC BLOOD-PRESSURE; SAFFRON CROCUS-SATIVUS
AB Cardiovascular disease (CVD) is now the leading cause of death globally and is a growing health concern. Lifestyle factors, including nutrition, play an important role in the etiology and treatment of CVD. Functional foods based on their basic nutritional functions can decrease the risk of many chronic diseases and have some physiological benefits. They contain physiologically active components either from plant or animal sources, marketed with the claim of their ability to reduce heart disease risk, focusing primarily on established risk factors, which are hyperlipidemia, diabetes, metabolic syndrome, obesity/overweight, elevated lipoprotein A level, small dense low-density lipoprotein cholesterol (LDL-C), and elevated inflammatory marker levels. Functional foods are suspected to exert their cardioprotective effects mainly through blood lipid profile level and improve hypertension control, endothelial function, platelet aggregation, and antioxidant actions. Clinical and epidemiological observations indicate that vegetable and fruit fiber, nuts and seeds, sea foods, coffee, tea, and dark chocolate have cardioprotective potential in humans, as well whole-grain products containing intact grain kernels rich in fiber and trace nutrients. They are nutritionally more important because they contain phytoprotective substances that might work synergistically to reduce cardiovascular risk. This review will focus on the reciprocal interaction between functional foods and the potential link to cardiovascular health and the possible mechanisms of action.
C1 [Asgary, Sedigheh; Keshvari, Mahtab] Isfahan Univ Med Sci, Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran.
   [Rastqar, Ali] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada.
   [Rastqar, Ali] Univ Quebec, Mental Hlth Inst, Res Ctr, Quebec City, PQ, Canada.
C3 Isfahan University of Medical Sciences; Laval University; University of
   Quebec
RP Keshvari, M (corresponding author), Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Isfahan Cardiovasc Res Inst, Moshtagh Sevom St,POB 81465-1148, Esfahan, Iran.
EM Mahtabkeshvari87@yahoo.com
RI keshvari, mahtab/ABD-4038-2020
OI keshvari, mahtab/0000-0003-0919-4406
CR Abuajah CI, 2015, J FOOD SCI TECH MYS, V52, P2522, DOI 10.1007/s13197-014-1396-5
   Agh F, 2017, ARCH IRAN MED, V20, P28, DOI 0172001/AIM.007
   Ahmadi N, 2013, INT J CARDIOL, V168, P2310, DOI 10.1016/j.ijcard.2013.01.182
   Akram M., 2010, ROM J BIOL PLANT BIO, V55, P65
   Al-Khalaf M. I., 2013, Australian Journal of Basic and Applied Sciences, V7, P505
   Albert CM, 2002, ARCH INTERN MED, V162, P1382, DOI 10.1001/archinte.162.12.1382
   Alissa EM, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/569486
   Alobaidi Amina Hamed Ahmad, 2014, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V13, P68
   Alvarez-Suarez JM, 2014, J NUTR BIOCHEM, V25, P289, DOI 10.1016/j.jnutbio.2013.11.002
   [Anonymous], NUTR HOSP
   [Anonymous], GLOSSARY INDIAN MED
   [Anonymous], 2015, LIFESTYLE CHANGES EF
   [Anonymous], ZHONGGUO ZHONG YAO Z
   [Anonymous], EUROPEAN HEART J
   [Anonymous], PATHOPHYSIOLOGY H S1
   [Anonymous], CURCUMA LONGA REV TH
   [Anonymous], 2011, Pakistan Journal of Nutrition, DOI DOI 10.3923/PJN.2011.162.167
   [Anonymous], CRITICAL REV FOOD SC
   [Anonymous], 2010, J. Adv. Med. Biomed. Res
   [Anonymous], 2016, LIPIDS HEALTH DIS, DOI DOI 10.1186/s12944-016-0382-5
   [Anonymous], 2014, J SHAHREKORD U MED
   [Anonymous], AM HEART ASS
   [Anonymous], CHIN J CLIN REHABIL
   [Anonymous], J DIABETES METABOLIC
   [Anonymous], STUDY EFFECT NIGELLA
   [Anonymous], J PUBLIC HLTH
   [Anonymous], 2009, Early life nutrition and lifelong health
   [Anonymous], 2003, QUAL HLTH CLAIMS LET
   [Anonymous], QOM U MED SCI J
   [Anonymous], 1999, FED REGISTER, V64, P57699
   [Anonymous], J ISFAHAN MED SCH
   [Anonymous], CHEM PHARM B
   [Anonymous], AHA STAT UPDATE HEAR
   Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43
   Asgary S, 2016, J HUM HYPERTENS, V30, P627, DOI 10.1038/jhh.2016.34
   Asgary S, 2015, J ENDOCRINOL INVEST, V38, P1039, DOI 10.1007/s40618-015-0337-0
   Asgary S, 2009, J MED PLANTS RES, V3, P785
   Asgary Sedigheh, 2014, ISRN Nutr, V2014, P405867, DOI 10.1155/2014/405867
   Asgary S, 2013, ARYA ATHEROSCLER, V9, P326
   Asgary S, 2014, PHYTOTHER RES, V28, P193, DOI 10.1002/ptr.4977
   Asgary S, 2013, ARYA ATHEROSCLER, V9, P98
   Assimopoulou AN, 2005, PHYTOTHER RES, V19, P997, DOI 10.1002/ptr.1749
   Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2716
   Aviram M, 2004, CLIN NUTR, V23, P423, DOI 10.1016/j.clnu.2003.10.002
   Aviram M, 2001, ATHEROSCLEROSIS, V158, P195, DOI 10.1016/S0021-9150(01)00412-9
   Baba S, 2007, J NUTR, V137, P1436, DOI 10.1093/jn/137.6.1436
   BAKHIT RM, 1994, J NUTR, V124, P213, DOI 10.1093/jn/124.2.213
   Barnuud NN, 2014, INT J BIOMETEOROL, V58, P1279, DOI 10.1007/s00484-013-0724-1
   Barona J, 2012, NUTRIENTS, V4, P1945, DOI 10.3390/nu4121945
   Barona J, 2012, J NUTR, V142, P1626, DOI 10.3945/jn.112.162743
   Basu A, 2014, J NUTR, V144, P830, DOI 10.3945/jn.113.188169
   Bathaie SZ, 2010, CRIT REV FOOD SCI, V50, P761, DOI 10.1080/10408390902773003
   Battino M, 2009, NUTR REV, V67, pS145, DOI 10.1111/j.1753-4887.2009.00178.x
   Baum JA, 1998, AM J CLIN NUTR, V68, P545, DOI 10.1093/ajcn/68.3.545
   Bhandari Prasan R, 2015, J Tradit Complement Med, V5, P81, DOI 10.1016/j.jtcme.2014.10.009
   Bhatti I. U., 2009, World Applied Sciences Journal, V6, P1053
   Bjelakovic G, 2007, JNCI-J NATL CANCER I, V99, P742, DOI 10.1093/jnci/djk211
   Bloom DE, 2012, Program on the Global Demography of Aging
   Bolger AP, 2000, DRUGS, V60, P1245, DOI 10.2165/00003495-200060060-00002
   Bolling BW, 2011, NUTR RES REV, V24, P244, DOI 10.1017/S095442241100014X
   Bondonno CP, 2015, AM J CLIN NUTR, V102, P368, DOI 10.3945/ajcn.114.101188
   Bondonno CP, 2012, FREE RADICAL BIO MED, V52, P95, DOI 10.1016/j.freeradbiomed.2011.09.028
   Boscá AR, 2000, MECH AGEING DEV, V114, P207, DOI 10.1016/S0047-6374(00)00089-0
   Budoff M, 2006, J NUTR, V136, p741S, DOI 10.1093/jn/136.3.741S
   Burton-Freeman B, 2012, MOL NUTR FOOD RES, V56, P622, DOI 10.1002/mnfr.201100649
   Buscemi S, 2012, AM J CLIN NUTR, V95, P1089, DOI 10.3945/ajcn.111.031088
   Cao ZL, 2009, AM J PHYSIOL-HEART C, V297, pH1494, DOI 10.1152/ajpheart.01233.2008
   Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, pS21, DOI 10.1016/j.numecd.2011.01.009
   Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408
   Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u
   Chen JY, 2013, J MED FOOD, V16, P361, DOI 10.1089/jmf.2012.2682
   Chen LH, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00071
   Cheng AL, 2001, ANTICANCER RES, V21, P2895
   Chiva-Blanch G, 2012, J BERRY RES, V2, P63, DOI 10.3233/JBR-2012-028
   Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244
   Ciccone MM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/782137
   Ciftci M, 2010, ACTA VET BRNO, V79, P33, DOI 10.2754/avb201079010033
   Coggan AR, 2015, CIRC-HEART FAIL, V8, P914, DOI 10.1161/CIRCHEARTFAILURE.115.002141
   Conen D, 2010, AM J CLIN NUTR, V92, P509, DOI 10.3945/ajcn.2010.29627
   Cortés B, 2006, J AM COLL CARDIOL, V48, P1666, DOI 10.1016/j.jacc.2006.06.057
   Craig WJ, 1997, J AM DIET ASSOC, V97, pS199, DOI 10.1016/S0002-8223(97)00765-7
   Craig WJ, 1999, AM J CLIN NUTR, V70, p491S, DOI 10.1093/ajcn/70.3.491s
   Crouse JR, 1999, ARCH INTERN MED, V159, P2070, DOI 10.1001/archinte.159.17.2070
   Daosukho C, 2007, FREE RADICAL BIO MED, V42, P1818, DOI 10.1016/j.freeradbiomed.2007.03.007
   Darmadi-Blackberry I, 2004, ASIA PAC J CLIN NUTR, V13, P217
   Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588
   Davidson MH, 1998, J NUTR, V128, P1927, DOI 10.1093/jn/128.11.1927
   Davidson MH, 2009, AM J CARDIOL, V104, P936, DOI 10.1016/j.amjcard.2009.05.037
   Romero-Prado MMD, 2015, BASIC CLIN PHARMACOL, V117, P57, DOI 10.1111/bcpt.12360
   de Oliveira MC, 2003, NUTRITION, V19, P253, DOI 10.1016/S0899-9007(02)00850-X
   Dehkordi FR, 2008, FUND CLIN PHARMACOL, V22, P447, DOI 10.1111/j.1472-8206.2008.00607.x
   Desch S, 2010, AM J HYPERTENS, V23, P694, DOI 10.1038/ajh.2010.29
   Diep QN, 2004, CAN J PHYSIOL PHARM, V82, P976, DOI 10.1139/Y04-094
   Ding EL, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-2
   Dow CA, 2012, METABOLISM, V61, P1026, DOI 10.1016/j.metabol.2011.12.004
   Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544
   Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041
   Dyerberg J, 2004, EUR J CLIN NUTR, V58, P1062, DOI 10.1038/sj.ejcn.1601934
   El-Bassossy HM, 2011, FOOD CHEM TOXICOL, V49, P3007, DOI 10.1016/j.fct.2011.07.060
   Engelhard YN, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.05.008
   Esmaillzadeh A, 2006, INT J VITAM NUTR RES, V76, P147, DOI 10.1024/0300-9831.76.3.147
   Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303
   Flammer AJ, 2012, EUR HEART J, V33, P2172, DOI 10.1093/eurheartj/ehr448
   Biondo PBF, 2014, FOOD SCI TECH-BRAZIL, V34, P94, DOI 10.1590/S0101-20612014005000007
   Fu CL, 2006, PLANT FOOD HUM NUTR, V61, P73, DOI 10.1007/s11130-006-0016-6
   Fuchs D, 2007, AM J CLIN NUTR, V86, P1369, DOI 10.1093/ajcn/86.5.1369
   Gajendragadkar PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099070
   Galleano M, 2009, J CARDIOVASC PHARM, V54, P483, DOI 10.1097/FJC.0b013e3181b76787
   GANGOLLI SD, 1994, EUR J PHARM-ENVIRON, V292, P1, DOI 10.1016/0926-6917(94)90022-1
   Giacco R, 2014, NUTR METAB CARDIOVAS, V24, P837, DOI 10.1016/j.numecd.2014.01.007
   Giampieri F, 2013, NAT PROD RES, V27, P448, DOI 10.1080/14786419.2012.706294
   Gilchrist M, 2013, FREE RADICAL BIO MED, V60, P89, DOI 10.1016/j.freeradbiomed.2013.01.024
   Glew RH, 2006, PLANT FOOD HUM NUTR, V61, P51, DOI 10.1007/s11130-006-0010-z
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   Goetz ME, 2016, J NUTR, V146, P2233, DOI 10.3945/jn.116.230185
   Goldberg I., 2012, Functional foods: designer foods, pharmafoods, nutraceuticals
   González CA, 2006, BRIT J NUTR, V96, pS87, DOI 10.1017/BJN20061868
   Gossell-Williams M, 2011, CLIMACTERIC, V14, P558, DOI 10.3109/13697137.2011.563882
   Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70
   Grassi D, 2005, AM J CLIN NUTR, V81, P611
   Greenberg JA, 2007, AM J CLIN NUTR, V85, P392, DOI 10.1093/ajcn/85.2.392
   Gross M, 2004, PHARM BIOL, V42, P21, DOI 10.3109/13880200490893483
   Grosso G, 2015, AM J CLIN NUTR, V101, P783, DOI 10.3945/ajcn.114.099515
   Hammer A, 2015, CLIN HEMORHEOL MICRO, V59, P145, DOI 10.3233/CH-141817
   He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212
   He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B
   He SY, 2005, LIFE SCI, V77, P907, DOI 10.1016/j.lfs.2005.02.006
   Hirai DM, 2017, AM J PHYSIOL-REG I, V312, pR13, DOI 10.1152/ajpregu.00263.2016
   Hobbs DA, 2013, J NUTR, V143, P1399, DOI 10.3945/jn.113.175778
   Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457
   HUANG HC, 1992, EUR J PHARMACOL, V221, P381
   Huguenin GVB, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0043-y
   Huseini HF, 2013, PHYTOTHER RES, V27, P1849, DOI 10.1002/ptr.4944
   Hwa JS, 2012, J ETHNOPHARMACOL, V139, P605, DOI 10.1016/j.jep.2011.12.001
   Hyson D, 2000, J Med Food, V3, P159, DOI 10.1089/jmf.2000.3.159
   Imaeda N, 1999, J NUTR SCI VITAMINOL, V45, P519, DOI 10.3177/jnsv.45.519
   Jacobs DR, 2000, J AM COLL NUTR, V19, p326S, DOI 10.1080/07315724.2000.10718968
   Jacques PF, 2013, BRIT J NUTR, V110, P545, DOI 10.1017/S0007114512005417
   Jain NK, 2012, ACTA POL PHARM, V69, P945
   Jaskani MJ, 2005, EUPHYTICA, V145, P259, DOI 10.1007/s10681-005-1644-x
   Joris PJ, 2013, ATHEROSCLEROSIS, V231, P78, DOI 10.1016/j.atherosclerosis.2013.09.001
   Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233
   Joukar S, 2013, PHARM BIOL, V51, P836, DOI 10.3109/13880209.2013.767362
   Joukar S, 2010, CARDIOVASC TOXICOL, V10, P66, DOI 10.1007/s12012-010-9063-1
   Jurenka J, 2008, ALTERN MED REV, V13, P128
   Kahle K, 2005, MOL NUTR FOOD RES, V49, P1143, DOI 10.1002/mnfr.200500132
   Kapil V, 2010, HYPERTENSION, V56, P274, DOI 10.1161/HYPERTENSIONAHA.110.153536
   Kelly JH, 2006, BRIT J NUTR, V96, pS61, DOI 10.1017/BJN20061865
   Keshvari M, 2013, ARYA ATHEROSCLER, V9, P280
   Kianbakht S, 2014, PHYTOTHER RES, V28, P432, DOI 10.1002/ptr.5011
   Kim SH, 2006, J ETHNOPHARMACOL, V104, P119, DOI 10.1016/j.jep.2005.08.059
   Kirwan JP, 2016, J NUTR, V146, P2244, DOI 10.3945/jn.116.230508
   Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560
   KO FN, 1995, BRIT J PHARMACOL, V116, P1801, DOI 10.1111/j.1476-5381.1995.tb16666.x
   Kojuri J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-5
   Koli R, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0075-3
   Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94
   Kulkarni AP, 2007, J AGR FOOD CHEM, V55, P1491, DOI 10.1021/jf0626720
   Kurowska EM, 1997, CLIN INVEST MED, V20, P162
   LANE JD, 1989, PSYCHOSOM MED, V51, P373, DOI 10.1097/00006842-198907000-00001
   Lansky EP, 2007, J ETHNOPHARMACOL, V109, P177, DOI 10.1016/j.jep.2006.09.006
   Larijani VN, 2013, NUTRITION, V29, P71, DOI 10.1016/j.nut.2012.03.016
   Lauritzen L, 2016, BRIT J NUTR, V116, P2082, DOI 10.1017/S0007114516004293
   Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733
   Lee YP, 2009, AM J CLIN NUTR, V89, P766, DOI 10.3945/ajcn.2008.26708
   Lee YS, 2005, J NUTR BIOCHEM, V16, P213, DOI 10.1016/j.jnutbio.2004.09.006
   Liu XR, 2017, J NUTR, V147, P835, DOI 10.3945/jn.116.246785
   Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x
   Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, P156, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]
   Lutsey PL, 2007, BRIT J NUTR, V98, P397, DOI 10.1017/S0007114507700715
   Lynn A, 2012, PLANT FOOD HUM NUTR, V67, P309, DOI 10.1007/s11130-012-0295-z
   Ma YY, 2010, DIABETES CARE, V33, P227, DOI 10.2337/dc09-1156
   Mahdavi R, 2015, FOOD FUNCT, V6, P2041, DOI [10.1039/C5FO00316D, 10.1039/c5fo00316d]
   Mansour EH, 1999, ACTA ALIMENT HUNG, V28, P59
   Markey O, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-78
   Markowski Jaroslaw, 2006, Journal of Fruit and Ornamental Plant Research, V14, P133
   Martins JM, 2005, J LIPID RES, V46, P1539, DOI 10.1194/jlr.M500129-JLR200
   Mathew AS, 2012, PLANT FOOD HUM NUTR, V67, P351, DOI 10.1007/s11130-012-0318-9
   Matsui T, 1998, FETT-LIPID, V100, P51, DOI 10.1002/(SICI)1521-4133(199802)100:2<51::AID-LIPI51>3.0.CO;2-W
   McKeown NM, 2016, PUBLIC HEALTH NUTR, V19, P326, DOI 10.1017/S1368980015001123
   McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390
   Mehdizadeh R, 2013, IRAN J BASIC MED SCI, V16, P56
   Meisel H, 1998, INT DAIRY J, V8, P363, DOI 10.1016/S0958-6946(98)00059-4
   Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008
   Mellen PB, 2010, J AM COLL NUTR, V29, P469, DOI 10.1080/07315724.2010.10719883
   Melnyk JP, 2010, FOOD RES INT, V43, P1981, DOI 10.1016/j.foodres.2010.07.033
   Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   MORRIS JN, 1977, BMJ-BRIT MED J, V2, P1307, DOI 10.1136/bmj.2.6098.1307
   Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885
   Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735
   Mulero J, 2015, NUTR HOSP, V32, P1462, DOI 10.3305/nh.2015.32.4.9510
   Murkovic M, 2002, J FOOD COMPOS ANAL, V15, P633, DOI 10.1006/jfca.2002.1052
   Naderi G. A., 2005, Journal of Medicinal Plants, V4, P29
   Nagasako-Akazome Yoko, 2007, J Oleo Sci, V56, P417
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   NAQVI S A H, 1991, Fitoterapia, V62, P221
   Naz A, 2014, EXCLI J, V13, P650
   NERGIZ C, 1993, FOOD CHEM, V48, P259, DOI 10.1016/0308-8146(93)90137-5
   Niki E, 2011, J BERRY RES, V1, P169, DOI 10.3233/BR-2011-018
   Noad Rebecca L, 2016, Heart, V102, P1371, DOI 10.1136/heartjnl-2015-309218
   Nwofia G. E., 2012, Pakistan Journal of Nutrition, V11, P848
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Oben J, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-16
   Ohira T, 2013, CIRC J, V77, P1646, DOI 10.1253/circj.CJ-13-0702
   Omoni AO, 2005, TRENDS FOOD SCI TECH, V16, P344, DOI 10.1016/j.tifs.2005.02.002
   Onakpoya I, 2017, CRIT REV FOOD SCI, V57, P602, DOI 10.1080/10408398.2014.901292
   Padhi EMT, 2015, J NUTR, V145, P2665, DOI 10.3945/jn.115.219873
   Palozza P, 2012, ANN NUTR METAB, V61, P126, DOI 10.1159/000342077
   Panagiotakos DB, 2003, J NUTR, V133, P3228, DOI 10.1093/jn/133.10.3228
   Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019
   Panahi Y, 2014, COMPLEMENT THER MED, V22, P851, DOI 10.1016/j.ctim.2014.07.006
   Panth N., 2016, ADV MED, V2016, P1, DOI [10.1155/2016/9152732, DOI 10.1155/2016/9152732]
   Park E, 2016, BRIT J NUTR, V115, P226, DOI 10.1017/S0007114515004328
   PARKER TG, 1990, J CLIN INVEST, V85, P507, DOI 10.1172/JCI114466
   Peters U, 2001, AM J EPIDEMIOL, V154, P495, DOI 10.1093/aje/154.6.495
   Pezzuto JM, 2008, J AGR FOOD CHEM, V56, P6777, DOI 10.1021/jf800898p
   Phrommintikul A, 2006, INT J CARDIOL, V112, P142, DOI 10.1016/j.ijcard.2005.11.106
   Qidwai W, 2009, J ALTERN COMPLEM MED, V15, P639, DOI 10.1089/acm.2008.0367
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   Rahbar AR, 2015, FOOD FUNCT, V6, P1992, DOI 10.1039/c5fo00100e
   Rahman S., 2013, J ENAM MED COLL, V3, P94
   Rahmani S, 2016, PHYTOTHER RES, V30, P1540, DOI 10.1002/ptr.5659
   Rakic V, 1996, CLIN EXP PHARMACOL P, V23, P559, DOI 10.1111/j.1440-1681.1996.tb02779.x
   Rao AV, 1999, NUTR RES, V19, P305, DOI 10.1016/S0271-5317(98)00193-6
   Rao PV, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/642942
   Razavi BM, 2013, CHEM-BIOL INTERACT, V203, P547, DOI 10.1016/j.cbi.2013.03.010
   Rebholz CM, 2013, EUR J CLIN NUTR, V67, P58, DOI 10.1038/ejcn.2012.186
   Reis JF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1076-5
   Rendeiro C, 2016, BRIT J NUTR, V116, P1999, DOI 10.1017/S0007114516004219
   Riccardi G, 2005, CURR OPIN CLIN NUTR, V8, P630, DOI 10.1097/01.mco.0000171126.98783.0c
   Riccioni G, 2009, EUR J CARDIOV PREV R, V16, P351, DOI 10.1097/HJR.0b013e328325d807
   Richter CK, 2017, BRIT J NUTR, V117, P1403, DOI 10.1017/S000711451700143X
   Ried K, 2010, MATURITAS, V67, P144, DOI 10.1016/j.maturitas.2010.06.001
   Ros E, 2004, CIRCULATION, V109, P1609, DOI 10.1161/01.CIR.0000124477.91474.FF
   Ross SA, 2000, FITOTERAPIA, V71, P154, DOI 10.1016/S0367-326X(99)00131-8
   Sabaté J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79
   Sabaté J, 2009, AM J CLIN NUTR, V89, pS1643, DOI 10.3945/ajcn.2009.26736Q
   Safaei N, 2017, ANN CARD ANAESTH, V20, P45, DOI 10.4103/0971-9784.197834
   Samarghandian S, 2014, PHARMACOGN RES, V6, P99, DOI 10.4103/0974-8490.128963
   Samman S, 2003, J NUTR, V133, P2188, DOI 10.1093/jn/133.7.2188
   Sampson L, 2002, J AM DIET ASSOC, V102, P1414, DOI 10.1016/S0002-8223(02)90314-7
   Santulli G., 2013, J. Cardiovasc. Dis. Res., V1
   Saraf-Bank S, 2016, J AM COLL NUTR, V35, P31, DOI 10.1080/07315724.2014.931262
   Sasikumar B., 2005, Plant Genetic Resources Characterization and Utilization, V3, P230, DOI 10.1079/PGR200574
   Sauder KA, 2015, METABOLISM, V64, P1521, DOI 10.1016/j.metabol.2015.07.021
   Saxena A, 2004, J ALTERN COMPLEM MED, V10, P369, DOI 10.1089/107555304323062365
   Schoonderwoerd BA, 2008, EUROPACE, V10, P668, DOI 10.1093/europace/eun124
   Sedigheh A, 2011, AFR J PHARM PHARMACO, V5, P2620, DOI 10.5897/AJPP11.635
   SENANAYAKE UM, 1978, J AGR FOOD CHEM, V26, P822, DOI 10.1021/jf60218a031
   Sener G., 2002, Journal of Medicinal Food, V5, P37, DOI 10.1089/109662002753723205
   Setorki M., 2010, Qom University of Medical Sciences Journal, V3, pPe11
   Setorki M, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-39
   Seymour EM, 2008, J GERONTOL A-BIOL, V63, P1034, DOI 10.1093/gerona/63.10.1034
   Seymour EM, 2010, HYPERTENSION, V55, P1179, DOI 10.1161/HYPERTENSIONAHA.109.149393
   Shemshian Maryam, 2014, J Complement Integr Med, V11, P43, DOI 10.1515/jcim-2013-0047
   Siervo M, 2013, J NUTR, V143, P818, DOI 10.3945/jn.112.170233
   Singh G, 2007, FOOD CHEM TOXICOL, V45, P1650, DOI 10.1016/j.fct.2007.02.031
   Sobenin IA, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-119
   Sobenin IA, 2009, HYPERTENS RES, V32, P433, DOI 10.1038/hr.2009.36
   Song F, 2013, J ETHNOPHARMACOL, V150, P125, DOI 10.1016/j.jep.2013.08.019
   Soni K. B., 1992, Indian Journal of Physiology and Pharmacology, V36, P273
   SRIVASTAVA R, 1985, THROMB RES, V40, P413, DOI 10.1016/0049-3848(85)90276-2
   Steiner M, 2001, J NUTR, V131, p980S, DOI 10.1093/jn/131.3.980S
   Steptoe A, 2007, ATHEROSCLEROSIS, V193, P277, DOI 10.1016/j.atherosclerosis.2006.08.054
   Storniolo CE, 2017, EUR J NUTR, V56, P89, DOI 10.1007/s00394-015-1060-5
   Sumner MD, 2005, AM J CARDIOL, V96, P810, DOI 10.1016/j.amjcard.2005.05.026
   Sumpio BE, 2006, J AM COLL SURGEONS, V202, P813, DOI 10.1016/j.jamcollsurg.2006.01.018
   Szewczuk LM, 2004, J BIOL CHEM, V279, P22727, DOI 10.1074/jbc.M314302200
   Terauchi M, 2014, MENOPAUSE, V21, P990, DOI [10.1097/GME.0000000000000200, 10.1097/gme.0000000000000200]
   Testai L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050502
   Tey SL, 2017, EUR J NUTR, V56, P1025, DOI 10.1007/s00394-015-1150-4
   Threapleton DE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6879
   Tjelle TE, 2015, BRIT J NUTR, V114, P1054, DOI 10.1017/S0007114515000562
   Torres N, 2006, J NUTR BIOCHEM, V17, P365, DOI 10.1016/j.jnutbio.2005.11.005
   Tovar J, 2014, BRIT J NUTR, V111, P706, DOI 10.1017/S000711451300305X
   Tranche S, 2016, GYNECOL ENDOCRINOL, V32, P477, DOI 10.3109/09513590.2015.1132305
   Tricarico PM, 2014, INT J MOL SCI, V15, P6843, DOI 10.3390/ijms15046843
   Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054
   Ueeda M, 2008, CIRC J, V72, P1836, DOI 10.1253/circj.CJ-08-0249
   Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058
   Vafa MR, 2011, INT J PREVENTIVE MED, V2, P94
   Vahidi AR, 2007, PLANTA MED, V73, P995
   Vaisman N, 2015, INT J FOOD SCI NUTR, V66, P342, DOI 10.3109/09637486.2014.1000840
   Valderas-Martinez P, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030170
   Varshney R, 2016, J NUTR, V146, p416S, DOI 10.3945/jn.114.202333
   Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106
   Velmurugan S, 2016, AM J CLIN NUTR, V103, P25, DOI 10.3945/ajcn.115.116244
   Venkatesan N, 1998, BRIT J PHARMACOL, V124, P425, DOI 10.1038/sj.bjp.0701877
   Verma S K, 1998, Indian J Med Sci, V52, P205
   Vilahur G, 2015, TRANSL RES, V166, P44, DOI 10.1016/j.trsl.2014.11.004
   Vinson JA, 2001, J AGR FOOD CHEM, V49, P5315, DOI 10.1021/jf0009293
   Wainstein J, 2011, J MED FOOD, V14, P1505, DOI 10.1089/jmf.2010.0300
   Wang X, 2014, BRIT J NUTR, V111, P1, DOI 10.1017/S000711451300278X
   Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523
   Weisburger JH, 2002, EXP BIOL MED, V227, P924, DOI 10.1177/153537020222701014
   West SG, 2014, BRIT J NUTR, V111, P653, DOI 10.1017/S0007114513002912
   Wien MA, 2003, INT J OBESITY, V27, P1365, DOI 10.1038/sj.ijo.0802411
   Wolak T, 2013, VASC PHARMACOL, V59, P63, DOI 10.1016/j.vph.2013.07.006
   Wong M. C. Y., 2008, Inflammopharmacology, V16, P235, DOI 10.1007/s10787-008-8023-x
   Xaplanteris P, 2012, NUTR RES, V32, P390, DOI 10.1016/j.nutres.2012.03.011
   Xia T, 2006, FITOTERAPIA, V77, P530, DOI 10.1016/j.fitote.2006.06.008
   Yadav M, 2010, NUTR RES REV, V23, P184, DOI 10.1017/S0954422410000107
   Yamada T, 2011, J EPIDEMIOL, V21, P169, DOI 10.2188/jea.JE20100084
   Yang L, 2015, INT J CLIN EXP PATHO, V8, P14345
   Yang Z, 2014, MOL MED REP, V9, P1941, DOI 10.3892/mmr.2014.2002
   Yoshimoto N, 2015, PLANT J, V83, P941, DOI 10.1111/tpj.12954
   YOUNG VR, 1991, J AM DIET ASSOC, V91, P828
   Zarfeshany Aida, 2014, Adv Biomed Res, V3, P100, DOI 10.4103/2277-9175.129371
   Zeb Irfan, 2012, J Cardiovasc Dis Res, V3, P185, DOI 10.4103/0975-3583.98883
   Zeng YW, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/9402849
   Zern TL, 2005, J NUTR, V135, P1911, DOI 10.1093/jn/135.8.1911
   Zhang XH, 2001, BLOOD COAGUL FIBRIN, V12, P67, DOI 10.1097/00001721-200101000-00010
   Zhang XH, 2001, J NUTR, V131, P1471, DOI 10.1093/jn/131.5.1471
   Zhang YZ, 2014, J MOL CELL CARDIOL, V72, P85, DOI 10.1016/j.yjmcc.2014.02.012
   Zhang ZY, 2010, LIPIDS, V45, P765, DOI 10.1007/s11745-010-3463-7
   Zhou DH, 2014, AM J CLIN NUTR, V100, P270, DOI 10.3945/ajcn.113.079152
   Zou J, 2013, J NUTR BIOCHEM, V24, P1117, DOI 10.1016/j.jnutbio.2012.08.011
   Zou ZY, 2014, BRIT J NUTR, V111, P474, DOI 10.1017/S0007114513002730
   Zunino SJ, 2014, BRIT J NUTR, V112, P369, DOI 10.1017/S0007114514000890
NR 320
TC 70
Z9 74
U1 4
U2 99
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PY 2018
VL 37
IS 5
BP 429
EP 455
DI 10.1080/07315724.2017.1410867
PG 27
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GK3XG
UT WOS:000436083200009
PM 29528772
DA 2025-04-28
ER

PT J
AU Liu, SL
   Peng, BJ
   Zhong, YL
   Liu, YL
   Song, Z
   Wang, Z
AF Liu, Si-Le
   Peng, Bing-Jie
   Zhong, Ying-Li
   Liu, Yun-Long
   Song, Zhuo
   Wang, Zheng
TI Effect of 5-caffeoylquinic acid on the NF-κB signaling pathway,
   peroxisome proliferator-activated receptor gamma 2, and macrophage
   infiltration in high-fat diet-fed Sprague-Dawley rat adipose tissue
SO FOOD & FUNCTION
LA English
DT Article
ID CHLOROGENIC ACID; INSULIN-RESISTANCE; PPAR-GAMMA; CHRONIC INFLAMMATION;
   METABOLIC DISEASE; OBESITY; CELLS; MICE; TRANSCRIPTION; ACCUMULATION
AB Obesity, considered as a consequence of overnutrition, sustains a low-degree inflammatory state and results in insulin-resistance and type 2 diabetes. Here, we investigated the anti-inflammatory effects of 5-caffeoylquinic acid (5-CQA) in high-fat diet-induced obese rats. Serum interleukin (IL)-6, monocyte chemotactic protein 1 (MCP-1), tumor necrosis factor-alpha (TNF-alpha), total cholesterol (TC), triglyceride (TG), and free fatty acid (FFA) levels were determined. Expression of genes related to TG metabolism, macrophage biomarkers, and inflammation was assessed by real-time PCR. Protein expression of NF-kappa B, PPAR gamma 2, and phosphorylated I kappa B alpha was evaluated by western blotting, and the histology of adipose tissue was examined. Supplementation of the rat diet with 5-CQA reduced obesity development, macrophage infiltration, and steatosis. Additionally, 5-CQA decreased the expression of NF-kappa B and downstream inflammatory cytokines, but increased the expression of PPAR gamma 2, in a dose-dependent manner. Thus, 5-CQA improved obesity and obesity-related metabolic disturbances via PPAR gamma 2 and the NF-kappa B signaling pathway.
C1 [Liu, Si-Le; Peng, Bing-Jie; Zhong, Ying-Li; Liu, Yun-Long; Song, Zhuo; Wang, Zheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
C3 Hunan Agricultural University
RP Liu, SL (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
EM wz8918@163.com
RI zhang, yuhang/ISS-5685-2023; Wang, Zheng/JNT-1898-2023
OI Wang, Zheng/0000-0001-9159-047X
FU National Natural Science Foundation of China [31071531]; Scientific
   Research Fund of the Hunan Provincial Education Department [14A071]
FX This research was financially supported by the National Natural Science
   Foundation of China (31071531) and the Scientific Research Fund of the
   Hunan Provincial Education Department (14A071); this funding is
   gratefully acknowledged.
CR Bahalim A. N., 2011, LANCET, V377, P557
   Bajaj M, 2007, DIABETOLOGIA, V50, P1723, DOI 10.1007/s00125-007-0698-9
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Cortez M, 2013, INFLAMMATION, V36, P379, DOI 10.1007/s10753-012-9557-z
   Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13
   Du WY, 2013, J ETHNOPHARMACOL, V147, P74, DOI 10.1016/j.jep.2013.01.042
   Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Francisco V, 2013, J ETHNOPHARMACOL, V148, P126, DOI 10.1016/j.jep.2013.03.077
   Fujioka K, 2008, FOOD CHEM, V106, P217, DOI 10.1016/j.foodchem.2007.05.091
   Gordon-Larsen P, 2014, OBES REV, V15, P37, DOI 10.1111/obr.12121
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Hebeda CB, 2011, J ETHNOPHARMACOL, V135, P261, DOI 10.1016/j.jep.2011.02.033
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Huang J.H., 2004, Chin. J. Clin. Pharmacol. Ther, V9, P1069
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jernås M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje
   Kastorini CM, 2011, AM HEART J, V162, P717, DOI 10.1016/j.ahj.2011.07.012
   Kim JC, 2012, ARCH ORAL BIOL, V57, P392, DOI 10.1016/j.archoralbio.2011.09.009
   Lakhdari O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013092
   Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017
   Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026
   Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   McGown C, 2014, CLIN LIVER DIS, V18, P41, DOI 10.1016/j.cld.2013.09.012
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011
   Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003
   Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200
   Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Stienstra R, 2007, PPAR RES, V2007, DOI 10.1155/2007/95974
   Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767
   Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623
   Tsai YT, 2014, APPL MICROBIOL BIOT, V98, P1, DOI 10.1007/s00253-013-5346-3
   Wang Zheng, 2008, Yaoxue Xuebao, V43, P185
   Wang Z, 2008, FOOD CHEM, V108, P369, DOI 10.1016/j.foodchem.2007.10.083
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007
   Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004
NR 49
TC 23
Z9 25
U1 0
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PY 2015
VL 6
IS 8
BP 2779
EP 2786
DI 10.1039/c5fo00626k
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA CO4KD
UT WOS:000359128700037
PM 26158223
DA 2025-04-28
ER

PT J
AU Tsiga, E
   Panagopoulou, E
   Niakas, D
AF Tsiga, E.
   Panagopoulou, E.
   Niakas, D.
TI Health promotion across occupational groups: one size does not fit all
SO OCCUPATIONAL MEDICINE-OXFORD
LA English
DT Article
DE Health behaviours; health promotion; lifestyles; physical activity;
   smoking
ID BODY-MASS INDEX; WORKING-CONDITIONS; PHYSICAL-ACTIVITY; JOB STRESS;
   NURSES; RISK; MEN; BEHAVIORS; OBESITY; SAMPLE
AB Background Although several studies have examined the link between specific working conditions and health behaviours, very few have comparatively assessed the health behaviours of different occupational groups.
   Aims To compare protective and risky health behaviours among police officers, ambulance workers, hospital staff (doctors and nurses) and office workers, prompted by the need to identify key areas for interventions tailored to the needs of different occupational groups.
   Methods A cross-sectional postal survey using the Health Behaviours Inventory, assessing health behaviours which are risky (alcohol intake, smoking, coffee consumption, fast food meals and painkiller consumption) and protective (physical activity, eating breakfast and hours of sleep).
   Results The sample consisted of 1451 employees. Ambulance workers smoked the most cigarettes per day (F-(4,F-1405) = 8.63, P < 0.01), while doctors consumed twice as many fast food meals as any other occupational group (F-(4,F-1415) = 78.45, P < 0.01) and had the highest daily caffeine consumption (F-(4,F-1440) = 11.17, P < 0.01). Ambulance workers and doctors reported the highest frequency of alcohol consumption per week (F-(4,F-1421) = 10.13, P < 0.01). In regard to protective health behaviours, office workers reported the highest number of breakfast meals per week (F-(4,F-1431) = 5.7, P < 0.01) and sleeping hours per night (F-(4,F-1438) = 170.34, P < 0.01), while police officers and ambulance workers exercised more frequently (F-(4,F-1420) = 5.764, P < 0.01).
   Conclusions The results of the study highlight key priorities for health promotion for different occupational groups which need to be taken into consideration in policy making and developing workplace interventions.
C1 [Tsiga, E.; Panagopoulou, E.] Aristotle Univ Thessaloniki, Sch Hlth Sci, Dept Med, GR-4124 Thessaloniki, Greece.
   [Niakas, D.] Hellenic Open Univ, Sch Social Sci, GR-4124 Thessaloniki, Greece.
C3 Aristotle University of Thessaloniki
RP Panagopoulou, E (corresponding author), Aristotle Univ Thessaloniki, Sch Hlth Sci, Dept Med, Hyg Lab, 4th Floor, GR-4124 Thessaloniki, Greece.
EM efharis@the.forthnet.gr
OI Panagopoulou, Efharis/0000-0001-8708-7361; Niakas,
   Dimitris/0000-0003-0528-755X
CR Atkinson G, 2008, SPORTS MED, V38, P671, DOI 10.2165/00007256-200838080-00005
   Callaghan P, 1999, J ADV NURS, V29, P28
   Cares A, 2015, SUBST ABUS, V36, P59, DOI 10.1080/08897077.2014.933725
   Croezen S, 2009, EUR J CLIN NUTR, V63, P405, DOI 10.1038/sj.ejcn.1602950
   Dobson M, 2013, AM J IND MED, V56, P776, DOI 10.1002/ajim.22151
   Frank E, 2009, CAN FAM PHYSICIAN, V55, P810
   Hemmingsson T, 1997, INT J EPIDEMIOL, V26, P584, DOI 10.1093/ije/26.3.584
   IBM Corp, 2011, IBM SPSS Statistics
   JARVIS MJ, 1993, PSYCHOPHARMACOLOGY, V110, P45, DOI 10.1007/BF02246949
   Kageyama T, 1998, IND HEALTH, V36, P263, DOI 10.2486/indhealth.36.263
   Kirkcaldy BD, 1997, INT J STRESS MANAGE, V4, P79
   Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-24
   Kumlin L, 2001, J INTERN MED, V249, P315, DOI 10.1046/j.1365-2796.2001.00817.x
   Lallukka T, 2004, PREV MED, V38, P48, DOI 10.1016/j.ypmed.2003.09.027
   Mekary RA, 2012, AM J CLIN NUTR, V95, P1182, DOI 10.3945/ajcn.111.028209
   Morikawa Y, 2007, SCAND J WORK ENV HEA, V33, P45, DOI 10.5271/sjweh.1063
   Moustou I., 2010, OPEN OCCUP HLTH SAF, V2, P16, DOI [10.2174/1876216601002010016, DOI 10.2174/1876216601002010016]
   Mummery WK, 2005, AM J PREV MED, V29, P91, DOI 10.1016/j.amepre.2005.04.003
   NELSON DE, 1994, JAMA-J AM MED ASSOC, V271, P1273, DOI 10.1001/jama.271.16.1273
   Oreskovich MR, 2012, ARCH SURG-CHICAGO, V147, P168, DOI 10.1001/archsurg.2011.1481
   Ostry AS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-53
   Pappas NA, 2005, BMC NURS, V4, DOI 10.1186/1472-6955-4-8
   Pratt JP, 1970, HEALTH VALUES, V18, P41
   Proctor SP, 1996, SCAND J WORK ENV HEA, V22, P124, DOI 10.5271/sjweh.120
   Pyörälä M, 2000, DIABETES CARE, V23, P1097, DOI 10.2337/diacare.23.8.1097
   Richardson C, 2006, J CLIN NURS, V15, P1196, DOI 10.1111/j.1365-2702.2006.01456.x
   RICHMAN JA, 1992, ALCOHOL CLIN EXP RES, V16, P166, DOI 10.1111/j.1530-0277.1992.tb01360.x
   Sörensen L, 2005, OCCUP MED-OXFORD, V55, P136, DOI 10.1093/occmed/kqi036
   Wandel M, 2005, APPETITE, V44, P93, DOI 10.1016/j.appet.2004.08.002
   Winston James, 2008, BMC Res Notes, V1, P69, DOI 10.1186/1756-0500-1-69
NR 30
TC 15
Z9 15
U1 0
U2 47
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0962-7480
EI 1471-8405
J9 OCCUP MED-OXFORD
JI Occup. Med.-Oxf.
PD OCT
PY 2015
VL 65
IS 7
BP 552
EP 557
DI 10.1093/occmed/kqv097
PG 6
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA CU0CZ
UT WOS:000363184800009
PM 26209792
OA Bronze
DA 2025-04-28
ER

PT J
AU Dalbo, VJ
   Roberts, MD
   Stout, JR
   Kerksick, CM
AF Dalbo, Vincent J.
   Roberts, Michael D.
   Stout, Jeffrey R.
   Kerksick, Chad M.
TI Acute effects of ingesting a commercial thermogenic drink on changes in
   energy expenditure and markers of lipolysis
SO JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION
LA English
DT Article
ID CAFFEINE INGESTION; SUBSTRATE UTILIZATION; FOOD INGREDIENTS;
   METABOLIC-RATE; FAT OXIDATION; DOUBLE-BLIND; EXERCISE; OBESITY; WEIGHT;
   COFFEE
AB Background: To determine the acute effects of ingesting a thermogenic drink (Celsius, Delray Beach, FL) (TD) on changes in metabolism and lipolysis.
   Methods: Healthy college-aged male (23.2 +/- 4.0 y, 177.2 +/- 6.1 cm, 81.7 +/- 11.3 kg, 22.8 +/- 7.3% fat; n = 30) and female (23.4 +/- 3.1 y, 165.6 +/- 8.7 cm, 62.1 +/- 9.9 kg, 28.3 +/- 7.4% fat; n = 30) participants were matched according to height and weight to consume 336 ml of the TD or a non-caloric, non-caffeinated placebo (PLA). After a 12 h fast, participants reported for pre-consumption measures of height, weight, heart rate, blood pressure, resting energy expenditure (REE), respiratory exchange ratio (RER), glycerol and free-fatty acid (FFA) concentrations. REE and RER were determined at 60, 120, and 180 min post-consumption. Serum glycerol and FFA concentrations were determined at 30, 60, 120 and 180 min post-consumption.
   Results: When compared to PLA, TD significantly increased REE at 60, 120 and 180 min (p < 0.05). FFA concentrations were significantly greater in TD compared to PLA at 30, 60, 120 and 180 min post-consumption (p < 0.05). No between-group differences were found in RER.
   Conclusion: Acute TD ingestion significantly increased REE, FFA and glycerol appearance. If sustained, these changes may help to promote weight loss and improve body composition; however, these findings are currently unknown as are the general safety and efficacy of prolonged consumption.
C1 [Dalbo, Vincent J.; Roberts, Michael D.; Stout, Jeffrey R.; Kerksick, Chad M.] Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA.
C3 University of Oklahoma System; University of Oklahoma - Norman
RP Kerksick, CM (corresponding author), Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA.
EM vinnyjames@ou.edu; mike_roberts@ou.edu; jrstout@ou.edu;
   chad_kerksick@ou.edu
RI Stout, Jeffrey/F-5805-2014; Kerksick, Chad/G-9059-2013
OI Kerksick, Chad/0000-0003-0458-7294; Stout, Jeffrey/0000-0001-6114-1649;
   Dalbo, Vincent/0000-0002-5944-7558
FU Celsius Inc. (Delray Beach, FL)
FX We would like to thank the subjects who participated in this study as
   well as Chelsea Baker, Scott Hassell, Paul House, Jordan Moon, Abbie
   Smith, and Ashley Walter who assisted with data collection and analysis.
   Celsius Inc. (Delray Beach, FL) provided funding for this project, and
   all researchers involved independently collected, analyzed, and
   interpreted the results from this study. Furthermore, the researchers
   involved have no financial interests concerning the outcome of this
   investigation. The results from this study do not constitute endorsement
   by the authors and/or their institutions concerning the investigated
   nutritional supplements.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   [Anonymous], 2003, HLTH AFF MILLWOOD S
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   BANGSBO J, 1992, J APPL PHYSIOL, V72, P1297, DOI 10.1063/1.351736
   Baron M., 2004, HLTH CARE FOOD NUTR, V21, P5
   BEAVO JA, 1970, MOL PHARMACOL, V6, P597
   BELLET S, 1968, METABOLISM, V17, P702, DOI 10.1016/0026-0495(68)90054-1
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   COLLINS LC, 1994, INT J OBESITY, V18, P551
   Crewe HK, 2007, J CHROMATOGR B, V847, P296, DOI 10.1016/j.jchromb.2006.10.019
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Essig D., 1980, Int J Sports Med, V1, P86, DOI DOI 10.1055/S-2008-1034637
   Graham TE, 1998, J APPL PHYSIOL, V85, P883, DOI 10.1152/jappl.1998.85.3.883
   GRAHAM TE, 1994, CAN J APPL PHYSIOL, V19, P111, DOI 10.1139/h94-010
   Graham TE, 2000, J PHYSIOL-LONDON, V529, P837, DOI 10.1111/j.1469-7793.2000.00837.x
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hoffman Jay R, 2006, J Int Soc Sports Nutr, V3, P35, DOI 10.1186/1550-2783-3-1-35
   Jessen AB, 2003, AM J CLIN NUTR, V77, P1442, DOI 10.1093/ajcn/77.6.1442
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Knapik JJ., 1983, Biochem Exerc, V13, P514
   Kovacs EMR, 2006, OBES REV, V7, P59, DOI 10.1111/j.1467-789X.2006.00203.x
   LEBLANC J, 1985, J APPL PHYSIOL, V59, P832, DOI 10.1152/jappl.1985.59.3.832
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   POEHLMAN ET, 1985, MED SCI SPORT EXER, V17, P689, DOI 10.1249/00005768-198512000-00012
   POWERS SK, 1985, SPORTS MED, V2, P165, DOI 10.2165/00007256-198502030-00002
   POWERS SK, 1983, EUR J APPL PHYSIOL, V50, P301, DOI 10.1007/BF00423236
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Ryu S, 2001, J NUTR SCI VITAMINOL, V47, P139, DOI 10.3177/jnsv.47.139
   Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288
   TAYLOR LW, 2007, J INT SOC SPORTS NUT, V4
   vanSoeren M, 1996, J APPL PHYSIOL, V80, P999, DOI 10.1152/jappl.1996.80.3.999
   WOLF AM, 1994, PHARMACOECONOMICS, V5, P34, DOI 10.2165/00019053-199400051-00007
   Wolpoff M, 1998, EVOL ANTHROPOL, V7, P1
NR 42
TC 26
Z9 28
U1 0
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1550-2783
J9 J INT SOC SPORT NUTR
JI J. Int. Soc. Sport Nutr.
PD FEB 20
PY 2008
VL 5
AR 6
DI 10.1186/1550-2783-5-6
PG 7
WC Nutrition & Dietetics; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Sport Sciences
GA 486NS
UT WOS:000269204500001
PM 18289388
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Bray, GA
   Krauss, RM
   Sacks, FM
   Qi, L
AF Bray, George A.
   Krauss, Ronald M.
   Sacks, Frank M.
   Qi, Lu
TI Lessons Learned from the POUNDS Lost Study: Genetic, Metabolic, and
   Behavioral Factors Affecting Changes in Body Weight, Body Composition,
   and Cardiometabolic Risk
SO CURRENT OBESITY REPORTS
LA English
DT Article
DE Genetic markers; POUNDS Lost Clinical Trial; Behavioral markers;
   Metabolic markers; Demographic markers
ID LOSS DIET INTERVENTION; LOW-FAT DIET; LOW-CARBOHYDRATE-DIET; OBESE
   YOUNG-ADULTS; INSULIN-RESISTANCE; 2-YEAR CHANGES; RANDOMIZED-TRIAL; FTO
   GENOTYPE; COFFEE CONSUMPTION; WIDE ASSOCIATION
AB Purpose of ReviewThis paper reviews the genetic and non-genetic factors that provided predictions of, or were associated with, weight loss and other metabolic changes in the POUNDS Lost clinical trial of weight loss. This trial randomized 811 individuals who were overweight or obese to one of four diets that contained either 15% or 25% protein and 20% or 40% fat in a 2x2 factorial design. A standard behavioral weight loss program was available for all participants who were followed for 2years with an 80% completion rate.Recent FindingsNineteen genes and five genetic risk scores were used along with demographic, behavioral, endocrine, and metabolic measurements. Genetic variations in most of the genes were associated with weight loss, but this association often varied with the dietary assignment. A number of demographic and behavioral factors, including attendance at behavioral sessions and food cravings were predictive of weight changes. A high baseline level of free triiodothyronine or free thyroxine predicted the magnitude of weight loss. Several perfluoroakyl compounds predicted more rapid weight regain.SummaryGenetic evidence from POUNDS Lost provides guidance toward selection of a personalized weight loss diet and improvement in metabolic profile. There is still room for additional research into the predictors of weight loss.
C1 [Bray, George A.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
   [Bray, George A.; Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.
   [Sacks, Frank M.; Qi, Lu] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Qi, Lu] Tulane Univ, Sch Publ Hlth, New Orleans, LA 70118 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Children's Hospital Oakland
   Research Institute; University of California System; University of
   California San Francisco; UCSF Medical Center; UCSF Benioff Children's
   Hospital Oakland; Harvard University; Harvard T.H. Chan School of Public
   Health; Tulane University
RP Bray, GA (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.; Bray, GA (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.
EM George.bray@pbrc.edu; Rkrauss@chori.org; fsacks@hsph.harvard.edu;
   lq1@tulane.edu
RI Krauss, Ronald M./LTD-4078-2024
FU National Heart, Lung, and Blood Institute [HL071981, HL034594,
   HL126024]; National Institute of Diabetes and Digestive and Kidney
   Diseases [DK091718, DK100383, DK078616]
FX The study has been supported in part by grants from the National Heart,
   Lung, and Blood Institute (HL071981, HL034594, HL126024), the National
   Institute of Diabetes and Digestive and Kidney Diseases (DK091718,
   DK100383, DK078616).
CR [Anonymous], 2013, BRIT J NUTR, DOI DOI 10.1017/S0007114513000548
   [Anonymous], JAMA
   [Anonymous], GOOD CALORIES BAD CA
   [Anonymous], BMJ
   [Anonymous], OBESITY
   [Anonymous], DR ATKINSS NEW DIET
   Anton SD, 2012, EAT WEIGHT DISORD-ST, V17, pE101, DOI 10.1007/BF03325333
   Anton Stephen D, 2012, J Diabetes Sci Technol, V6, P1216
   Apolzan JW, 2017, OBESITY, V25, P1343, DOI 10.1002/oby.21895
   Avenell A, 2004, J HUM NUTR DIET, V17, P293, DOI 10.1111/j.1365-277X.2004.00530.x
   Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663
   Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551
   Bray GA, 2018, ENDOCR REV, V39, P79, DOI 10.1210/er.2017-00253
   Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480
   Brinkworth GD, 2009, AM J CLIN NUTR, V90, P23, DOI 10.3945/ajcn.2008.27326
   Dansinger ML, 2007, ANN INTERN MED, V147, P41, DOI 10.7326/0003-4819-147-1-200707030-00007
   Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43
   Delahanty LM, 2006, J AM DIET ASSOC, V106, P698, DOI 10.1016/j.jada.2006.02.011
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982
   Due A, 2005, DIABETES OBES METAB, V7, P223, DOI 10.1111/j.1463-1326.2004.00426.x
   Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092
   Ello-Martin JA, 2007, AM J CLIN NUTR, V85, P1465, DOI 10.1093/ajcn/85.6.1465
   Espeland MA, 2015, INT J GERIATR PSYCH, V30, P999, DOI 10.1002/gps.4253
   Espeland MA, 2009, ANN EPIDEMIOL, V19, P701, DOI 10.1016/j.annepidem.2009.06.001
   Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005
   Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207
   Ghosh S, 2017, NAT REV GENET, V18, P731, DOI 10.1038/nrg.2017.72
   Goni L, 2019, EUR J NUTR, V58, P1381, DOI 10.1007/s00394-018-1660-y
   Goni L, 2018, J LIPID RES, V59, P155, DOI 10.1194/jlr.P078634
   Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060
   Hall KD, 2018, JAMA INTERN MED, V178, P1103, DOI 10.1001/jamainternmed.2018.2920
   Hall KD, 2017, GASTROENTEROLOGY, V152, P1718, DOI 10.1053/j.gastro.2017.01.052
   Han LY, 2017, AM J CLIN NUTR, V106, P1321, DOI 10.3945/ajcn.117.156232
   He H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01517-6
   Heianza Y, 2019, ENDOCRINOLOGY, V160, P81, DOI 10.1210/en.2018-00591
   Heianza Y, 2019, GUT, V68, P263, DOI 10.1136/gutjnl-2018-316155
   Heianza Y, 2018, INT J OBESITY, V42, P1565, DOI 10.1038/s41366-018-0046-9
   Heianza Y, 2018, DIABETES CARE, V41, P413, DOI 10.2337/dc17-2108
   Heianza Y, 2017, DIABETES, V66, P2416, DOI 10.2337/db16-1482
   Heianza Y, 2016, DIABETES CARE, V39, P1909, DOI 10.2337/dc16-1111
   Hjorth MF, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030586
   Hooper L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7666
   Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39
   Huang T, 2018, DIABETES OBES METAB, V20, P1445, DOI 10.1111/dom.13250
   Huang T, 2017, J NUTR, V147, P439, DOI 10.3945/jn.116.242958
   Huang T, 2016, AM J CLIN NUTR, V104, P198, DOI 10.3945/ajcn.115.121186
   Huang T, 2015, DIABETES CARE, V38, P439, DOI 10.2337/dc14-0473
   Huang T, 2014, AM J CLIN NUTR, V99, P1126, DOI 10.3945/ajcn.113.082164
   Jensen MD, 2014, OBESITY, V22, pS5, DOI 10.1002/oby.20821
   Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397
   Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073
   Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137
   Layman DK, 2009, J NUTR, V139, P514, DOI 10.3945/jn.108.099440
   Lin XC, 2015, AM J CLIN NUTR, V102, P514, DOI 10.3945/ajcn.115.107276
   Liu G, 2017, INT J OBESITY, V41, P878, DOI 10.1038/ijo.2017.28
   Liu G, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002502
   Loos RJF, 2018, CURR OPIN GENET DEV, V50, P86, DOI 10.1016/j.gde.2018.02.009
   Ma W, 2016, INT J OBESITY, V40, P1723, DOI 10.1038/ijo.2016.128
   Ma WJ, 2017, J CLIN ENDOCR METAB, V102, P316, DOI 10.1210/jc.2016-2909
   Ma WJ, 2016, J CLIN ENDOCR METAB, V101, P2415, DOI 10.1210/jc.2016-1207
   Mattei J, 2012, AM J CLIN NUTR, V96, P1129, DOI 10.3945/ajcn.112.038125
   McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466
   Mirzaei K, 2014, AM J CLIN NUTR, V99, P392, DOI 10.3945/ajcn.113.072066
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Noakes M, 2005, AM J CLIN NUTR, V81, P1298
   Nordmann AJ, 2011, AM J MED, V124, P841, DOI 10.1016/j.amjmed.2011.04.024
   Ornish Dean., 1993, Eat More, Weigh Less
   Qi L, 2014, ANN MED, V46, P247, DOI 10.3109/07853890.2014.891802
   Qi QB, 2015, DIABETOLOGIA, V58, P2791, DOI 10.1007/s00125-015-3750-1
   Qi QB, 2015, J LIPID RES, V56, P713, DOI 10.1194/jlr.P055715
   Qi QB, 2013, DIABETES CARE, V36, P3442, DOI 10.2337/dc13-0018
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Qi QB, 2012, AM J CLIN NUTR, V95, P506, DOI 10.3945/ajcn.111.025270
   Qi QB, 2011, CIRCULATION, V124, P563, DOI 10.1161/CIRCULATIONAHA.111.025767
   Rauschert S, 2017, ANN NUTR METAB, V70, P201, DOI 10.1159/000459635
   RODIN J, 1977, INT J OBESITY, V1, P79
   Rohde K, 2019, METABOLISM, V92, P37, DOI 10.1016/j.metabol.2018.10.007
   Rosenbaum M, 2018, OBESITY, V26, pS25, DOI 10.1002/oby.22156
   Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748
   Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637
   Schwingshackl L, 2013, OBES REV, V14, P183, DOI 10.1111/j.1467-789X.2012.01060.x
   Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   Sun D, 2018, DIABETES OBES METAB, V20, P2298, DOI 10.1111/dom.13333
   Thomas DM, 2015, AM J CLIN NUTR, V101, P449, DOI 10.3945/ajcn.114.091520
   Unick JL, 2015, OBESITY, V23, P1353, DOI 10.1002/oby.21112
   Vadiveloo M, 2016, J NUTR, V146, P1552, DOI 10.3945/jn.115.224683
   Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230
   Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784
   Wang T, 2016, INT J OBESITY, V40, P1164, DOI 10.1038/ijo.2016.41
   Wang TG, 2018, FRONT MED-PRC, V12, P601, DOI 10.1007/s11684-018-0648-6
   Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056
   Westman EC, 2018, EXPERT REV ENDOCRINO, V13, P263, DOI 10.1080/17446651.2018.1523713
   Williamson DA, 2010, J BEHAV MED, V33, P305, DOI 10.1007/s10865-010-9253-0
   Williamson DA, 2010, J BEHAV MED, V33, P35, DOI 10.1007/s10865-009-9230-7
   Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321
   Xu M, 2015, J NUTR, V145, P1289, DOI 10.3945/jn.115.212514
   Xu M, 2013, CIRCULATION, V127, P1283, DOI 10.1161/CIRCULATIONAHA.112.000586
   Yancy WS, 2010, ANN INTERN MED, V153, P337, DOI 10.7326/0003-4819-153-5-201009070-00009
   Zhang XM, 2012, DIABETES, V61, P3005, DOI 10.2337/db11-1799
   Zhang XM, 2012, HYPERTENSION, V60, P1169, DOI 10.1161/HYPERTENSIONAHA.112.197855
   Zhang XM, 2012, AM J CLIN NUTR, V96, P917, DOI 10.3945/ajcn.112.040907
   Zheng Y, 2016, J CLIN ENDOCR METAB, V101, P3820, DOI 10.1210/jc.2016-1760
   Zheng Y, 2016, AM J CLIN NUTR, V103, P505, DOI 10.3945/ajcn.115.117689
   Zheng Y, 2015, J NUTR, V145, P977, DOI 10.3945/jn.115.210005
   Zhou T, 2018, AM J CLIN NUTR, V108, P1129, DOI 10.1093/ajcn/nqy197
NR 107
TC 32
Z9 34
U1 1
U2 14
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2162-4968
J9 CURR OBES REP
JI Curr. Obes. Rep.
PD SEP
PY 2019
VL 8
IS 3
BP 262
EP 283
DI 10.1007/s13679-019-00353-1
PG 22
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA IL9XI
UT WOS:000477637900007
PM 31214942
DA 2025-04-28
ER

PT J
AU Li, D
   Yang, YL
   Sun, LJ
   Fang, ZX
   Chen, L
   Zhao, PT
   Wang, ZC
   Guo, YR
AF Li, Dan
   Yang, Yongli
   Sun, Lijun
   Fang, Zhongxiang
   Chen, Lei
   Zhao, Pengtao
   Wang, Zichao
   Guo, Yurong
TI Effect of young apple (Malus domestica Borkh. cv.
   Red Fuji) polyphenols on alleviating insulin resistance
SO FOOD BIOSCIENCE
LA English
DT Article
DE Insulin resistance; Glycogen synthesis; Gluconeogenesis; Mitochondrial
   function; Young apple polyphenols; Fuji apples
ID INHIBITS HEPATIC GLUCONEOGENESIS; INCREASES GLYCOGEN-SYNTHESIS; PI3K/AKT
   PATHWAY; MITOCHONDRIAL-FUNCTION; SIGNALING PATHWAY; OXIDATIVE STRESS;
   LIPID-METABOLISM; GLUCOSE-UPTAKE; DIABETIC MICE; OBESITY
AB Insulin resistance (IR) has an important role in the development of type 2 diabetes (T2DM). This study aimed to investigate the effect of young apple (Malus domestica Borkh. cv. Red Fuji) polyphenols (YAP) on IR in HepG2 cells. It was found that YAP and its two main components, phlorizin and chlorogenic acid, could increase glucose uptake, glucose consumption and glycogen content. YAP and phlorizin activated the insulin receptor substrate 2/phosphatidylinositol 3-kinase/phosphorylation of the protein kinase B (IRS2/PI3K/AKT) signal pathway, as well as its downstream proteins glycogen synthase kinase-3 beta (GSK3 beta) and forkhead box protein O1 (FOXO1), which were further confirmed by application of the PI3K inhibitor LY294002. YAP and phlorizin also improved mitochondrial dysfunction by reducing mitochondrial reactive oxygen species (ROS) accumulation, restoring ATP production and the mitochondrial membrane potential (MMP). This study suggested that YAP has the potential to alleviate T2DM symptoms.
C1 [Li, Dan; Yang, Yongli; Sun, Lijun; Zhao, Pengtao; Wang, Zichao; Guo, Yurong] Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Xian 710062, Shaanxi, Peoples R China.
   [Guo, Yurong] Shaanxi Normal Univ, Engn Res Ctr High Value Utilizat Western Fruit Re, Minist Educ, Xian 710062, Shaanxi, Peoples R China.
   [Fang, Zhongxiang] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia.
   [Chen, Lei] Qingdao Univ, Inst Nutr & Hlth, Qingdao 266071, Shandong, Peoples R China.
C3 Shaanxi Normal University; Shaanxi Normal University; University of
   Melbourne; Qingdao University
RP Wang, ZC; Guo, YR (corresponding author), Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Xian 710062, Shaanxi, Peoples R China.
EM zichao.wang@snnu.edu.cn; yrguo730@snnu.edu.cn
RI Wang, Zichao/KHX-4954-2024; Fang, Zhongxiang/A-8988-2019; Li,
   Dan/AAL-2581-2020; Zhao, Pengtao/KYP-1110-2024; Guo,
   Yurong/AGI-4266-2022
OI Wang, Zi-Chao/0009-0004-8766-0550; Sun, Lijun/0000-0002-4814-6485; Zhao,
   Pengtao/0000-0003-2492-0445
FU China Agriculture Research System [CARS-27]; Ministry of Agriculture of
   the People's Republic of China
FX This study was supported by the China Agriculture Research System
   (CARS-27) from the Ministry of Agriculture of the People's Republic of
   China.
CR Abu Bakar MH, 2017, BIOMED PHARMACOTHER, V93, P903, DOI 10.1016/j.biopha.2017.07.021
   Abu Bakar MH, 2015, MOL BIOSYST, V11, P1742, DOI 10.1039/c5mb00158g
   Afrin S, 2018, FOOD FUNCT, V9, P2145, DOI [10.1039/c8fo00164b, 10.1039/C8FO00164B]
   Alvarez-Cilleros D, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700470
   Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S
   Bhuvaneswari S, 2012, CAN J PHYSIOL PHARM, V90, P1544, DOI 10.1139/y2012-119
   Bondonno N. P., 2017, Trends in Food Science & Technology, V69, P243, DOI 10.1016/j.tifs.2017.04.012
   Chen L, 2019, FOOD CHEM TOXICOL, V127, P182, DOI 10.1016/j.fct.2019.03.038
   Chen L, 2017, J FUNCT FOODS, V33, P396, DOI 10.1016/j.jff.2017.03.055
   Gao YF, 2015, J AGR FOOD CHEM, V63, P6019, DOI 10.1021/acs.jafc.5b01238
   Graf BA, 2005, J MED FOOD, V8, P281, DOI 10.1089/jmf.2005.8.281
   Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568
   Henagan TM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0451-1
   Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002
   Kolnes AJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE231, DOI 10.1152/ajpendo.00282.2014
   Lambertucci RH, 2008, J CELL PHYSIOL, V216, P796, DOI 10.1002/jcp.21463
   Landete JM, 2012, CRIT REV FOOD SCI, V52, P936, DOI 10.1080/10408398.2010.513779
   Lee KH, 2013, AM J PHYSIOL-LUNG C, V304, pL782, DOI 10.1152/ajplung.00348.2012
   Li CY, 2018, MED SCI MONIT BASIC, V24, P1, DOI 10.12659/MSMBR.907775
   Li D, 2019, J FUNCT FOODS, V56, P127, DOI 10.1016/j.jff.2019.03.009
   Liu TY, 2015, CLIN SCI, V129, P839, DOI 10.1042/CS20150009
   Luan GX, 2018, J AGR FOOD CHEM, V66, P3169, DOI 10.1021/acs.jafc.8b00179
   Madrigal-Santillán E, 2014, WORLD J GASTROENTERO, V20, P14787, DOI 10.3748/wjg.v20.i40.14787
   Manzano M, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0088-8
   Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462
   Maurya CK, 2015, FREE RADICAL BIO MED, V89, P158, DOI 10.1016/j.freeradbiomed.2015.07.154
   Nepstad I, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0050-0
   Nie JR, 2017, J AGR FOOD CHEM, V65, P9041, DOI 10.1021/acs.jafc.7b02880
   Pisonero-Vaquero S, 2015, MOL NUTR FOOD RES, V59, P879, DOI 10.1002/mnfr.201400913
   Ramalingam L, 2017, BBA-MOL BASIS DIS, V1863, P1106, DOI 10.1016/j.bbadis.2016.07.019
   Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7
   Ren ZH, 2018, FOOD FUNCT, V9, P2829, DOI 10.1039/c8fo00257f
   Schulze C, 2014, MOL NUTR FOOD RES, V58, P1795, DOI 10.1002/mnfr.201400016
   Sekine K, 2007, EMBO J, V26, P3607, DOI 10.1038/sj.emboj.7601784
   Shieh JM, 2009, J PINEAL RES, V47, P339, DOI 10.1111/j.1600-079X.2009.00720.x
   Santos LFS, 2017, J ARRYTHM, V33, P220, DOI 10.1016/j.joa.2016.09.004
   Sun LJ, 2013, FOOD CHEM, V136, P1022, DOI 10.1016/j.foodchem.2012.09.036
   Tian YY, 2006, LIFE SCI, V80, P193, DOI 10.1016/j.lfs.2006.09.010
   Tu Z, 2013, J AGR FOOD CHEM, V61, P2803, DOI 10.1021/jf400298c
   Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8
   Yan FJ, 2016, J NUTR BIOCHEM, V36, P68, DOI 10.1016/j.jnutbio.2016.07.004
   Yan H, 2018, J BIOSCIENCES, V43, P287, DOI 10.1007/s12038-018-9746-5
   Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059
   Zhang HH, 2016, BIOMED PHARMACOTHER, V81, P15, DOI 10.1016/j.biopha.2016.04.002
   Zhang WY, 2012, J AGR FOOD CHEM, V60, P7652, DOI 10.1021/jf300601z
   Zheng HZ, 2012, FOOD CHEM, V131, P106, DOI 10.1016/j.foodchem.2011.08.038
NR 46
TC 22
Z9 23
U1 6
U2 56
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-4292
EI 2212-4306
J9 FOOD BIOSCI
JI Food Biosci.
PD AUG
PY 2020
VL 36
AR 100637
DI 10.1016/j.fbio.2020.100637
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA MM1EG
UT WOS:000549901100022
DA 2025-04-28
ER

PT J
AU Ali, HS
   Mansour, AF
   Kamil, MM
   Hussein, AMS
AF Ali, Hatem S.
   Mansour, Amr Farouk
   Kamil, M. M.
   Hussein, Ahmed M. S.
TI Formulation of Nutraceutical Biscuits Based on Dried Spent Coffee
   Grounds
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Spent coffee grounds; nutraceutical biscuits; rheological properties;
   volatile compounds; sensory properties
ID CHEMICAL-COMPOSITION; SOY PROTEIN; QUALITY; VOLATILES; PRODUCTS;
   RESIDUES; STARCH; MOISTURE; INDUSTRY; ISOLATE
AB Background and Objective: Spent coffee grounds (SCGs) are the most abundant residual material (45%) obtained during the instant coffee production. Therefore, around 6 million tons of SCGs generated per year. The purposes of the present study consisted in evaluating the use of SCGs as innovative functional food ingredient in bakery products and study the effect of SCGs and their chemical constituents on the sensory properties, volatile constituents and rheological properties of the final product. Materials and Methods: Effect of mixing wheat flour with 2, 4 and 6% SCGs on rheological properties of the obtained dough was evaluated, then chemical, texture profile and sensory properties of the final product were studied. Results: Rheological properties of mixed wheat flour with SCGs dough was affected slightly with the higher dietary fiber content. Moisture content of SCGs reached to 58.98%, therefore, was dried to reach 7.47% to control the microbial activity. Protein, ash, crude fiber and total carbohydrate of SCGs were 8.97, 2.77, 51.86 and 78.5%, respectively. Also, SCGs is good source of lipids (13.89%). Chemical composition of biscuit indicated that increasing mixing level of SCGs (2-6%) has shown good enhancement in fiber and ashes compared to control sample. Volatile sensory active compounds of biscuits and its supplemented mix with SCGs was evaluated. Thirty-eight volatile compounds was separated and identified in the biscuit samples by using SPME/GC-MS analysis. Hunter color parameter of produced biscuit indicated that whiteness (L*) of control sample reached to 71.17, while mixing SCGs with wheat flour at levels 2, 4 and 6% decreased L* to 66.31, 54.88 and 43.88, respectively. Also, redness degree (a*) was lower in wheat flour (0.45) than SCGs (3.57). Therefore, a* value of biscuit increased with increasing mixing level of SCGs. Sensory properties of biscuits showed that increasing SCGs level decreased significantly the color score but overall acceptability not affected significantly. Conclusion: Spent coffee grounds contains sufficient amounts from dietary insoluble fibers, protein, lipids, ashes and lower glycaemic sugars. Mixing wheat flour with SCGs affected slightly the rheological properties of dough and overall acceptability of the final product. Therefore, the obtained biscuit could be recommended to patients with obesity-related diseases and diabetes in addition to people looking for foods intake with reduced energy.
C1 [Ali, Hatem S.; Kamil, M. M.; Hussein, Ahmed M. S.] Natl Res Ctr, Dept Food Technol, Giza, Egypt.
   [Mansour, Amr Farouk] Natl Res Ctr, Dept Flavor & Aromat Chem, Giza, Egypt.
   [Ali, Hatem S.] King Saud Univ, Dept Food Sci & Nutr, Coll Food Sci & Agr, Riyadh, Saudi Arabia.
C3 Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian
   Knowledge Bank (EKB); National Research Centre (NRC); King Saud
   University
RP Hussein, AMS (corresponding author), Natl Res Ctr, Dept Food Technol, Giza, Egypt.
RI mansour, amr/ABH-5533-2020; Ali, Hatem/GZG-9665-2022
OI Ali, Hatem Salama/0000-0002-7306-3454; Farouk, Amr/0000-0002-5261-2397;
   Kamil, Mohie/0000-0001-8219-3093
CR AACC, 2009, Approved Methods of the American Association of Cereal Chemistry
   Adams RP., 1995, Identification of essential oil components by gas chromatography/mass spectrometry, P469
   Annor G. A, 2006, P 13 WORLD C FOOD SC
   [Anonymous], 2009, FOOD CHEM
   [Anonymous], INT J CURRENT RES
   Ballesteros LF, 2014, FOOD BIOPROCESS TECH, V7, P3493, DOI 10.1007/s11947-014-1349-z
   Batey IL, 2000, CEREAL CHEM, V77, P754, DOI 10.1094/CCHEM.2000.77.6.754
   Bredie WLP, 2002, J AGR FOOD CHEM, V50, P1118, DOI 10.1021/jf0111662
   Cruz R, 2012, J AGR FOOD CHEM, V60, P7777, DOI 10.1021/jf3018854
   El-Shebini S. M., 2013, Journal of Applied Sciences Research, V9, P1940
   Esfahani A, 2011, IUBMB LIFE, V63, P7, DOI 10.1002/iub.418
   Farouk A, 2016, J ESSENT OIL BEAR PL, V19, P1119, DOI 10.1080/0972060X.2016.1149112
   Flament I., 1991, VOLATILE COMPOUNDS F, P617
   Fortuna T, 2000, INT J FOOD SCI TECH, V35, P285, DOI 10.1046/j.1365-2621.2000.00368.x
   GIVENS DI, 1986, AGR WASTES, V18, P69, DOI 10.1016/0141-4607(86)90108-3
   Hussein A.M.S., 2006, Minufiya J. Agric. Res, V31, P877
   Hussein AS, 2010, CZECH J FOOD SCI, V28, P225, DOI 10.17221/97/2009-CJFS
   International Coffee Organization (ICO), 2017, COFF MARK REP
   JANE J, 1992, CEREAL CHEM, V69, P405
   Kim Y.S., 1997, Korean J. Food Sci. Technol., V29, P502
   Kondamudi N, 2008, J AGR FOOD CHEM, V56, P11757, DOI 10.1021/jf802487s
   Lago R., 2001, P 2 S PESQ CAF BRAS, P1473
   LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653
   Mansour A. F., 2001, Czech Journal of Food Sciences, V19, P24
   Martinez-Saez N, 2017, FOOD CHEM, V216, P114, DOI 10.1016/j.foodchem.2016.07.173
   McClave JT, 1991, Statistical for business and economics, P272
   Menjivar J.A., 1994, The science of cookie and cracker production, P283
   Mohsen SM, 2009, INT J FOOD SCI TECH, V44, P1705, DOI 10.1111/j.1365-2621.2009.01978.x
   Murthy PS, 2012, RESOUR CONSERV RECY, V66, P45, DOI 10.1016/j.resconrec.2012.06.005
   Mussatto SI, 2011, FOOD BIOPROCESS TECH, V4, P661, DOI 10.1007/s11947-011-0565-z
   Mussatto SI, 2011, CARBOHYD POLYM, V83, P368, DOI 10.1016/j.carbpol.2010.07.063
   Nabais JMV, 2008, FUEL PROCESS TECHNOL, V89, P262, DOI 10.1016/j.fuproc.2007.11.030
   Oliveira LS, 2006, LWT-FOOD SCI TECHNOL, V39, P235, DOI 10.1016/j.lwt.2005.01.011
   Ötles S, 2014, ACTA SCI POLON-TECHN, V13, P191, DOI 10.17306/J.AFS.2014.2.8
   Pasqualone A, 2014, FOOD RES INT, V65, P385, DOI 10.1016/j.foodres.2014.07.014
   Pozo-Bayón MA, 2006, FOOD REV INT, V22, P335, DOI 10.1080/87559120600864829
   Ratti C, 2009, CONTEMP FOOD ENG, P1
   Scully Damhan S., 2016, Bioengineering-Basel, V3, P33, DOI 10.3390/bioengineering3040033
   Sherwin CP, 2003, J FOOD SCI, V68, P588, DOI 10.1111/j.1365-2621.2003.tb05715.x
   Shibanuma Y, 1996, CARBOHYD POLYM, V29, P253, DOI 10.1016/0144-8617(96)00026-4
   Silva MA, 1998, BIOMASS BIOENERG, V14, P457, DOI 10.1016/S0961-9534(97)10034-4
   Solina M, 2005, FOOD CHEM, V90, P861, DOI 10.1016/j.foodchem.2004.06.005
   Sudha ML, 2007, J FOOD ENG, V80, P922, DOI 10.1016/j.jfoodeng.2006.08.006
   TESTER RF, 1990, CEREAL CHEM, V67, P558
   Urooj A, 1998, INT J FOOD SCI NUTR, V49, P265, DOI 10.3109/09637489809089397
   Vardon DR, 2013, ACS SUSTAIN CHEM ENG, V1, P1286, DOI 10.1021/sc400145w
   Whistler L, 1997, CARBOHYDRATES CHEM F
   WHITFIELD FB, 1992, CRIT REV FOOD SCI, V31, P1, DOI 10.1080/10408399209527560
   [William HorwitzW. AOAC International AOAC International], 2000, Official methods of analysis of AOAC International, VI.
   Wong CW, 2015, FOOD ENG SER, P41, DOI 10.1007/978-1-4939-2578-0_4
NR 50
TC 14
Z9 15
U1 7
U2 32
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PY 2018
VL 14
IS 4
BP 584
EP 594
DI 10.3923/ijp.2018.584.594
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA GD0FT
UT WOS:000430176800017
OA Bronze
DA 2025-04-28
ER

PT J
AU Arçari, DP
   Santos, JC
   Gambero, A
   Ribeiro, ML
AF Arcari, Demetrius Paiva
   Santos, Juliana Carvalho
   Gambero, Alessandra
   Ribeiro, Marcelo Lima
TI The in vitro and in vivo effects of yerba mate
   (Ilex paraguariensis) extract on adipogenesis
SO FOOD CHEMISTRY
LA English
DT Article
DE Yerba mate; Obesity; Gene expression; Wnt pathway
ID OXIDATIVE STRESS BIOMARKERS; ACTIVATED-RECEPTOR-GAMMA; TRANSCRIPTION
   FACTORS; GENE-EXPRESSION; POTENTIAL ROLE; PPAR-GAMMA; INSULIN; TEA;
   PROTEIN; DIET
AB The aim of this study was to evaluate the effects of yerba mate extract and its principal bioactive compounds on adipogenesis. The anti-adipogenic effects of yerba mate, chlorogenic acid, quercetin and rutin were evaluated in 3T3-L1 cells using a PCR array. The results obtained in vitro were validated in vivo in a high-fat diet-induced model of obesity. The in vitro and in vivo results demonstrated that yerba mate extract down-regulated the expression of genes that regulate adipogenesis, such as Creb-1 and C/EBP alpha, and the extract up-regulated the expression of genes related to the inhibition of adipogenesis, including Dlk1, Gata2, Gata3, Klf2, Lrp5, Ppar gamma 2, Sfrp1, Tcf7l2, Wnt10b, and Wnt3a. In summary, it was demonstrated that yerba mate and its bioactive compounds regulate the expression of genes related to in vitro adipogenesis. Furthermore, yerba mate might regulate adipogenesis through the Wnt pathway. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Arcari, Demetrius Paiva; Santos, Juliana Carvalho; Gambero, Alessandra; Ribeiro, Marcelo Lima] Univ Sao Francisco, Unidade Integrada Farmacol & Gastroenterol, BR-12900000 Braganca Paulista, SP, Brazil.
   [Arcari, Demetrius Paiva; Santos, Juliana Carvalho; Ribeiro, Marcelo Lima] Univ Estadual Campinas, Programa Pos Grad Genet & Biol Mol, Campinas, SP, Brazil.
C3 Universidade Sao Francisco; Universidade Estadual de Campinas
RP Ribeiro, ML (corresponding author), Univ Sao Francisco, Unidade Integrada Farmacol & Gastroenterol, Av Sao Francisco de Assis,218 Jd Sao Jose, BR-12900000 Braganca Paulista, SP, Brazil.
EM marcelo.ribeiro@usf.edu.br
RI Ribeiro, Marcelo/H-8856-2013; Gambero, Alessandra/G-5792-2013; Carvalho
   Santos, Juliana/R-5893-2016
OI Gambero, Alessandra/0000-0002-4862-4328; /0000-0003-4529-7832; Carvalho
   Santos, Juliana/0000-0003-4148-9570
FU FAPESP; CNPq
FX We would like to thank FAPESP and CNPq for financial support.
CR Arçari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Arçari DP, 2011, J FUNCT FOODS, V3, P190, DOI 10.1016/j.jff.2011.04.001
   Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200
   Bastos DHM., 2007, Med Aromat Plant Sci Biotechnol, V1, P37
   Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34
   Boaventura BCB, 2012, NUTRITION, V28, P657, DOI 10.1016/j.nut.2011.10.017
   Davis KE, 2004, J BIOL CHEM, V279, P42453, DOI 10.1074/jbc.M402197200
   Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5
   Fernandes ES, 2012, NUTRITION, V28, P1157, DOI 10.1016/j.nut.2012.04.011
   Fox KE, 2006, J BIOL CHEM, V281, P40341, DOI 10.1074/jbc.M605077200
   Gosmann G, 2012, PLANT FOOD HUM NUTR, V67, P156, DOI 10.1007/s11130-012-0289-x
   Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732
   Gronning LM, 2002, MOL ENDOCRINOL, V16, P873, DOI 10.1210/me.16.4.873
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Hu Y, 2009, PHYTOMEDICINE, V16, P864, DOI 10.1016/j.phymed.2009.03.002
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206
   Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340
   Kang Young-Rye, 2012, Lab Anim Res, V28, P23, DOI 10.5625/lar.2012.28.1.23
   Klemm DJ, 1998, J BIOL CHEM, V273, P917, DOI 10.1074/jbc.273.2.917
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3
   Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367
   Miranda DDC, 2008, MUTAGENESIS, V23, P261, DOI 10.1093/mutage/gen011
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pereira DF, 2012, PHYTOMEDICINE, V19, P868, DOI 10.1016/j.phymed.2012.05.008
   Pimentel G. D., 2012, J NUTR BIOCH, V24, P809
   Pomilio AB, 2002, PHYTOCHEM ANALYSIS, V13, P235, DOI 10.1002/pca.647
   Puangpraphant S, 2011, MOL NUTR FOOD RES, V55, P1509, DOI 10.1002/mnfr.201100128
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000
   Rodríguez E, 2004, OBES RES, V12, P1455, DOI 10.1038/oby.2004.182
   Rosen ED, 2000, GENE DEV, V14, P1293
   Santos Ana Paula, 2010, Recent Pat Food Nutr Agric, V2, P195, DOI 10.2174/1876142911002030195
   Shen YN, 2009, BMB REP, V42, P691, DOI 10.5483/BMBRep.2009.42.10.691
   Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507
   Stein FLP, 2005, BIOL RES NURS, V7, P146, DOI 10.1177/1099800405280521
   Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005
   Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045
   Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005
   Tong Q, 2003, DRUG NEWS PERSPECT, V16, P585, DOI 10.1358/dnp.2003.16.9.829340
   Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259
   Venugopal J, 2007, J CELL BIOCHEM, V101, P369, DOI 10.1002/jcb.21173
   Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953
   Waxman A, 2005, WORLD REV NUTR DIET, V95, P162, DOI 10.1159/000088302
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972
   Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200
NR 52
TC 54
Z9 58
U1 3
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD NOV 15
PY 2013
VL 141
IS 2
BP 809
EP 815
DI 10.1016/j.foodchem.2013.04.062
PG 7
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 183GW
UT WOS:000321803500021
PM 23790851
DA 2025-04-28
ER

PT J
AU Wang, X
   Wang, J
   Wei, L
   Hu, CY
   Deng, H
   Guo, YR
   Meng, YH
AF Wang, Xue
   Wang, Juan
   Wei, Lina
   Hu, Ching Yuan
   Deng, Hong
   Guo, Yurong
   Meng, Yong Hong
TI Apple phlorizin oxidation product 2 inhibits proliferation and
   differentiation of 3T3-L1 preadipocytes
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Phlorizin; Phlorizin oxidation product; Apple; 3T3-L1 preadipocytes;
   Differentiation
ID ADIPOCYTE DIFFERENTIATION; SIMULTANEOUS SEPARATION; ANTIOXIDANT
   ACTIVITIES; SCAVENGING ACTIVITY; CHLOROGENIC ACID; ADIPOGENESIS; CELLS;
   PURIFICATION; POLYPHENOLS; OBESITY
AB Phlorizin is a natural polyphenol with many bioactivities, however, its low water solubility limits its application. Phlorizin oxidation product 2 (POP2) has higher water solubility than phlorizin. However, reaction velocity and conversion rate of POP2 are low, and its bioactivity has not been elucidated. Thus, we have established a new method for preparation of POP2 with a purity of 96.8%, and the inhibitory activity of POP2 on 3T3-L1 pre-adipocytes was investigated. POP2 decreased adipocyte viability and inhibited the accumulation of intracellular triglycerides (TG). Furthermore, POP2 suppressed transcription of fatty acid synthase (FAS) and glucose transporter 4 (GLUT-4), led to reduce lipid accumulation. Also, POP2 down-regulated transcription and expression of PPAR gamma, C/EBP alpha, and FAS, led to inhibition of adipocyte differentiation. An efficient method to produce POP2 was developed, and we demonstrated that POP2 reduced lipid accretion. These results are useful for potential applications of phlorizin in the food and pharmaceutical industries.
C1 [Wang, Xue; Wang, Juan; Hu, Ching Yuan; Deng, Hong; Guo, Yurong; Meng, Yong Hong] Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Shaanxi Engn Lab Green Food Proc & Secur Control, Natl Res & Dev Ctr Apple Proc Technol, 620 West Changan Ave, Xian 710119, Shaanxi, Peoples R China.
   [Wei, Lina] Shaanxi Univ Sci & Technol, Coll Food & Bioengn, 6 Xuefu Rd, Xian 710021, Shaanxi, Peoples R China.
   [Hu, Ching Yuan] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Human Nutr Food & Anim Sci, 1955 East West Rd,AgSci 415J, Honolulu, HI 96822 USA.
C3 Shaanxi Normal University; Shaanxi University of Science & Technology;
   University of Hawaii System; University of Hawaii Manoa
RP Meng, YH (corresponding author), Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Shaanxi Engn Lab Green Food Proc & Secur Control, Natl Res & Dev Ctr Apple Proc Technol, 620 West Changan Ave, Xian 710119, Shaanxi, Peoples R China.
EM mengyonghong@snnu.edu.cn
RI Guo, Yurong/AGI-4266-2022; Wei, Lina/AAR-3347-2020; Hu,
   Ching/KDM-7972-2024
OI Wang, Zi-Chao/0000-0002-6409-1621
FU National Key Research and Development Program of China
   [2017YFD0400702-3]; Natural Science Foundation of China (NSFC)
   [31701562]
FX This research was supported by the National Key Research and Development
   Program of China (Project No. 2017YFD0400702-3), and the Natural Science
   Foundation of China (NSFC) (Project No. 31701562).
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Barros L, 2008, FOOD CHEM, V111, P61, DOI 10.1016/j.foodchem.2008.03.033
   Camp HS, 2002, TRENDS MOL MED, V8, P442, DOI 10.1016/S1471-4914(02)02396-1
   Choi RY, 2018, BIOMED PHARMACOTHER, V106, P355, DOI 10.1016/j.biopha.2018.06.140
   Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532
   Fernández-Agulló A, 2013, IND CROP PROD, V42, P126, DOI 10.1016/j.indcrop.2012.05.021
   Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Gosch C, 2010, PHYTOCHEMISTRY, V71, P838, DOI 10.1016/j.phytochem.2010.03.003
   Gulcin I, 2008, INT J FOOD PROP, V11, P450, DOI 10.1080/10942910701567364
   Guyot S, 2007, INNOV FOOD SCI EMERG, V8, P443, DOI 10.1016/j.ifset.2007.03.021
   Hashimoto T, 2013, BIOCHEM BIOPH RES CO, V440, P43, DOI 10.1016/j.bbrc.2013.09.034
   Hatia S, 2014, FREE RADICAL RES, V48, P387, DOI 10.3109/10715762.2013.879985
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Huang WC, 2013, MOL NUTR FOOD RES, V57, P1803, DOI 10.1002/mnfr.201300001
   Jiao Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020102
   Kassotis CD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42104
   Kim Y, 2015, J FUNCT FOODS, V12, P509, DOI 10.1016/j.jff.2014.12.004
   Kioumourtzoglou D, 2015, J CELL SCI, V128, P2423, DOI 10.1242/jcs.166561
   Ko HJ, 2015, J FUNCT FOODS, V17, P271, DOI 10.1016/j.jff.2015.05.033
   Kraus A, 2015, INT J CONSUM STUD, V39, P2, DOI 10.1111/ijcs.12144
   Le Bourvellec C, 2004, J AGR FOOD CHEM, V52, P122, DOI 10.1021/jf034461q
   Le Guernevé C, 2004, TETRAHEDRON LETT, V45, P6673, DOI 10.1016/j.tetlet.2004.06.096
   Lee S. L., 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1016/J.M0LCEL.2015.01.015
   Li X, 2012, J SCI FOOD AGR, V92, P292, DOI 10.1002/jsfa.4574
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MOUSTAID N, 1991, J BIOL CHEM, V266, P18550
   Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z
   Nenadis N, 2004, J AGR FOOD CHEM, V52, P4669, DOI 10.1021/jf0400056
   Obregon MJ, 2008, THYROID, V18, P185, DOI 10.1089/thy.2007.0254
   Onsa GH, 2000, J AGR FOOD CHEM, V48, P5041, DOI 10.1021/jf9909454
   RAA J, 1968, Netherlands Journal of Plant Pathology, V74, P37, DOI 10.1007/BF01977511
   Ramos FA, 2006, J AGR FOOD CHEM, V54, P3551, DOI 10.1021/jf060251c
   Rhyu J, 2014, NUTR RES PRACT, V8, P33, DOI 10.4162/nrp.2014.8.1.33
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Sharma BR, 2017, NUTR RES, V47, P44, DOI 10.1016/j.nutres.2017.09.002
   Shen YX, 2014, FOOD CHEM, V157, P553, DOI 10.1016/j.foodchem.2014.02.039
   Shingai Y, 2011, J AGR FOOD CHEM, V59, P8180, DOI 10.1021/jf202561p
   Shon MY, 2003, FOOD CHEM, V82, P593, DOI 10.1016/S0308-8146(03)00015-3
   Siersbæk R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010
   Sprott KM, 2002, BIOCHEM J, V365, P181, DOI 10.1042/BJ20020215
   Sun LJ, 2017, FOOD CHEM, V230, P362, DOI 10.1016/j.foodchem.2017.03.065
   Sun LJ, 2013, FOOD CHEM, V136, P1022, DOI 10.1016/j.foodchem.2012.09.036
   Tong ZG, 2012, MOL BIOTECHNOL, V50, P229, DOI 10.1007/s12033-011-9433-3
   Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200
   Wang Juan Wang Juan, 2018, Scientia Agricultura Sinica, V51, P182
   Yuan X, 2016, J FUNCT FOODS, V27, P429, DOI 10.1016/j.jff.2016.09.022
   Zhang J, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.13062
NR 48
TC 12
Z9 12
U1 2
U2 33
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD NOV
PY 2019
VL 62
AR 103525
DI 10.1016/j.jff.2019.103525
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA JF2HW
UT WOS:000491207500015
DA 2025-04-28
ER

PT J
AU Spano, M
   Di Matteo, G
   Carradori, S
   Locatelli, M
   Zengin, G
   Mannina, L
   Sobolev, AP
AF Spano, Mattia
   Di Matteo, Giacomo
   Carradori, Simone
   Locatelli, Marcello
   Zengin, Gokhan
   Mannina, Luisa
   Sobolev, Anatoly Petrovich
TI NMR Metabolite Profiling and Antioxidant Properties of Spartan, Jewels,
   Misty, and Camelia Blueberries
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE blueberry cultivars; NMR; antioxidant properties; anthocyanins;
   metabolomics; enzyme inhibition
ID FRUIT; OBESE; ACIDS; RISK; MEN
AB The health-promoting properties of blueberries are widely recognized and are mainly attributed to anthocyanins. However, fruit's chemical composition includes also other components and strongly depends on varieties and climatic conditions. Here, H-1 NMR metabolite profiling and biological activity of four blueberry cultivars (Spartan, Jewels, Misty, Camelia) grown in Central Italy over two years were reported. Untargeted and targeted NMR analyses allowed the quantification of sugars, organic acids, amino acids, anthocyanins, lipids, and other compounds. Spectrophotometric assays evaluated total phenolic and flavonoid content, antioxidant activity, and enzyme inhibitory activity toward cholinesterase, alpha-amylase, alpha-glucosidase, and tyrosinase. Statistical analysis showed a correlation between chemical composition and biological activity, revealing markers specific to blueberry cultivars (quinic acid, quercitrin, myo-inositol, myrtillin, and petunidin-3-O-glucoside). Almost all antioxidant assays were correlated with the chlorogenic acid levels. A strong effect of harvesting on chemical composition and biological activities was observed, with Misty cultivar having the highest antioxidant activity.
C1 [Spano, Mattia; Di Matteo, Giacomo; Mannina, Luisa] Sapienza Univ Rome, Dept Chem & Technol Drugs, Food Chem Lab, I-00185 Rome, Italy.
   [Carradori, Simone; Locatelli, Marcello] G Annunzio Univ Chieti Pescara, Dept Pharm, I-66100 Chieti, Italy.
   [Zengin, Gokhan] Selcuk Univ, Sci Fac, Dept Biol, TR-42130 Konya, Turkiye.
   [Sobolev, Anatoly Petrovich] CNR, Inst Biol Syst, Magnet Resonance Lab Segre Capitani, I-00015 Monterotondo, Italy.
C3 Sapienza University Rome; G d'Annunzio University of Chieti-Pescara;
   Selcuk University; Consiglio Nazionale delle Ricerche (CNR); Istituto
   per i Sistemi Biologici (ISB-CNR)
RP Mannina, L (corresponding author), Sapienza Univ Rome, Dept Chem & Technol Drugs, Food Chem Lab, I-00185 Rome, Italy.
EM luisa.mannina@uniroma1.it
RI Spano, Mattia/AGY-1673-2022; Di Matteo, Giacomo/GYU-6307-2022;
   Locatelli, Marcello/K-8569-2016; Mannina, Luisa/AGY-1694-2022; Sobolev,
   Anatoly/AAX-1170-2020; Carradori, Simone/S-4776-2019; Zengin,
   Gokhan/K-9393-2015
OI Di Matteo, Giacomo/0000-0002-0110-5010; Carradori,
   Simone/0000-0002-8698-9440; SPANO, MATTIA/0000-0001-5035-0971; Mannina,
   Luisa/0000-0001-8659-5890; Zengin, Gokhan/0000-0001-6548-7823
FU National Recovery and Resilience Plan (NRRP) of the Italian Ministry of
   University and Research - European Union-NextGenerationEU [341]; Italian
   Ministry of University and Research [PE00000003, 1550, CUP
   D93C22000890001]; Ministero Italiano della Salute, "Mediterranean Diet
   for Human Health Lab" project (MeDiHealthLab) [T5-AN-07 (POS5) CUP:
   B83C22005580006]
FX This project was partially funded under the National Recovery and
   Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3-Call for
   proposals No. 341 of 15 March 2022 of the Italian Ministry of University
   and Research funded by the European Union-NextGenerationEU. Award
   Number: Project code PE00000003, Concession Decree No. 1550 of 11
   October 2022 adopted by the Italian Ministry of University and Research,
   CUP D93C22000890001, Project title "ON Foods-Research and innovation
   network on food and nutrition Sustainability, Safety and
   Security-Working ON Foods". Ministero Italiano della Salute,
   "Mediterranean Diet for Human Health Lab" project (MeDiHealthLab)-No.
   T5-AN-07 (POS5) CUP: B83C22005580006.
CR Andres-Lacueva C, 2005, NUTR NEUROSCI, V8, P111, DOI 10.1080/10284150500078117
   [Anonymous], 2019, US DEP AGR
   [Anonymous], Phenol-Explorer
   arsial, SIARL SERVIZIO INTEG
   Balli D, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030238
   Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701
   Bett-Garber KL, 2015, J FOOD SCI, V80, pS818, DOI 10.1111/1750-3841.12821
   Biais B, 2009, ANAL CHEM, V81, P2884, DOI 10.1021/ac9001996
   Capitani D, 2014, ELECTROPHORESIS, V35, P1615, DOI 10.1002/elps.201300629
   Capitani D, 2013, J AGR FOOD CHEM, V61, P1727, DOI 10.1021/jf3028864
   Cásedas G, 2017, FOOD FUNCT, V8, P4187, DOI [10.1039/c7fo01205e, 10.1039/C7FO01205E]
   da Franca LG, 2021, J FOOD MEAS CHARACT, V15, P416, DOI 10.1007/s11694-020-00649-0
   Das PR, 2022, FOOD CHEM, V374, DOI 10.1016/j.foodchem.2021.131632
   Gallo V, 2014, J FOOD COMPOS ANAL, V35, P44, DOI 10.1016/j.jfca.2014.04.004
   Gil AM, 2000, J AGR FOOD CHEM, V48, P1524, DOI 10.1021/jf9911287
   González-Gallego J, 2010, BRIT J NUTR, V104, pS15, DOI 10.1017/S0007114510003910
   Hwang H, 2020, FOODS, V9, DOI 10.3390/foods9060690
   Jackson DM, 2015, SYNTHETIC COMMUN, V45, P2691, DOI 10.1080/00397911.2015.1100745
   Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010
   Lee S, 2014, J AGR FOOD CHEM, V62, P2126, DOI 10.1021/jf405272b
   Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005
   Menghini L, 2018, FOOD RES INT, V109, P91, DOI 10.1016/j.foodres.2018.04.028
   Mishra P, 2019, BIOORGAN MED CHEM, V27, P895, DOI 10.1016/j.bmc.2019.01.025
   Mollica A, 2016, J ENZYM INHIB MED CH, V31, P1, DOI 10.1080/14756366.2016.1214951
   Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Okan OT, 2018, NOT BOT HORTI AGROBO, V46, P639, DOI 10.15835/nbha46211120
   Pereira GE, 2006, J AGR FOOD CHEM, V54, P6765, DOI 10.1021/jf061013k
   Pertuzatti PB, 2021, FOOD CHEM, V340, DOI 10.1016/j.foodchem.2020.127958
   Roch L, 2020, J EXP BOT, V71, P5823, DOI 10.1093/jxb/eraa302
   Seeram NP, 2008, J AGR FOOD CHEM, V56, P630, DOI 10.1021/jf072504n
   Shi M, 2017, J FUNCT FOODS, V30, P16, DOI 10.1016/j.jff.2016.12.036
   Silva S, 2020, CRIT REV FOOD SCI, V60, P181, DOI 10.1080/10408398.2018.1518895
   Skrede G, 2012, ACTA AGR SCAND B-S P, V62, P193, DOI 10.1080/09064710.2011.598543
   Sobolev AP, 2022, MOLECULES, V27, DOI 10.3390/molecules27227906
   Spano M, 2022, FOODS, V11, DOI 10.3390/foods11223658
   Spano M, 2021, MOLECULES, V26, DOI 10.3390/molecules26175412
   Spano M, 2021, MOLECULES, V26, DOI 10.3390/molecules26102912
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   Wyzgoski FJ, 2010, J AGR FOOD CHEM, V58, P3407, DOI 10.1021/jf904401j
   Xu Y, 2019, CHEM COMMUN, V55, P39, DOI 10.1039/c8cc07985d
NR 41
TC 0
Z9 0
U1 6
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD SEP 30
PY 2024
VL 72
IS 40
BP 22258
EP 22268
DI 10.1021/acs.jafc.4c01442
EA SEP 2024
PG 11
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA I3E5I
UT WOS:001325617800001
PM 39348468
DA 2025-04-28
ER

PT J
AU Jang, YS
   Wang, ZQ
   Lee, JM
   Lee, JY
   Lim, SS
AF Jang, Young Soo
   Wang, Zhiqiang
   Lee, Jeong-Min
   Lee, Jae-Young
   Lim, Soon Sung
TI Screening of Korean Natural Products for Anti-Adipogenesis Properties
   and Isolation of Kaempferol-3-O-rutinoside as a Potent Anti-Adipogenetic
   Compound from Solidago virgaurea
SO MOLECULES
LA English
DT Article
DE obesity; screening; Solidago virgaurea; kaempferol-3-O-rutinoside
ID FATTY LIVER-DISEASE; 3T3-L1 ADIPOCYTES; PPAR-GAMMA; INHIBITORY-ACTIVITY;
   CHLOROGENIC ACID; OBESITY; EXTRACT; CELLS; IDENTIFICATION; ANTIOXIDANT
AB In this study, the anti-adipogenetic activity of 300 plant extracts was investigated using an Oil Red O staining assay in a 3T3-L1 cell line. Our results indicate that three plants, including the stem and leaf of Physalis angulata, the whole grass of Solidago virgaurea, and the root of Dioscorea nipponica, produced over 90% inhibition of adipogenesis. Kaempferol-3-O-rutinoside, which demonstrated a 48.2% inhibitory effect on adipogenesis without cytotoxicity, was isolated from the butanol layer of a water extract of S. virgaurea guided by the anti-adipogenesis assay in 3T3-L1. PPAR- and C/EBP expression levels were determined using western blot, and our results indicate that kaempferol-3-O-rutinoside has a strong anti-adipogenic effect in 3T3-L1 cells through the suppression of increases in PPAR- and C/EBP expression.
C1 [Jang, Young Soo; Wang, Zhiqiang; Lim, Soon Sung] Hallym Univ, Dept Food Sci & Nutr, Chunchon 200702, Gangwon Do, South Korea.
   [Lee, Jeong-Min; Lee, Jae-Young] Hallym Univ, Dept Boichem, Sch Med, Chunchon 200702, Gangwon Do, South Korea.
   [Lee, Jae-Young; Lim, Soon Sung] Hallym Univ, Inst Nat Med, Chunchon 200702, Gangwon Do, South Korea.
C3 Hallym University; Hallym University; Hallym University
RP Lim, SS (corresponding author), Hallym Univ, Dept Food Sci & Nutr, Chunchon 200702, Gangwon Do, South Korea.; Lim, SS (corresponding author), Hallym Univ, Inst Nat Med, Chunchon 200702, Gangwon Do, South Korea.
EM ggaeby77@gmail.com; wangwq01234@gmail.com; sindelela99@nate.com;
   jyolee@hallym.ac.kr; limss@hallym.ac.kr
RI Kim, Soon Hee/GXF-6736-2022; Lee, Jae-Young/GWZ-2558-2022
OI Wang, Zhiqiang/0000-0003-3637-8286; Soon Sung, Lim/0000-0003-4548-1285
FU Korea Institute of Planning and Evaluation for Technology in Food,
   Agriculture, Forestry and Fisheries (IPET) through (Agri-Bioindustry
   Technology Development Program) - Ministry of Agriculture, Food and
   Rural Affairs (MAFRA) [114066-3]; Priority Research Centers Program
   through the National Research Foundation of Korea (NRF) - Ministry of
   Education, Science and Technology [NRF-2009-0094071]; Hallym University
   Specialization Fund [HRF-S-13]; Academy of Finland (AKA) [114066]
   Funding Source: Academy of Finland (AKA)
FX This work was supported by Korea Institute of Planning and Evaluation
   for Technology in Food, Agriculture, Forestry and Fisheries (IPET)
   through (Agri-Bioindustry Technology Development Program), funded by
   Ministry of Agriculture, Food and Rural Affairs (MAFRA) (114066-3) and
   Priority Research Centers Program through the National Research
   Foundation of Korea (NRF) funded by the Ministry of Education, Science
   and Technology (NRF-2009-0094071), Hallym University Specialization Fund
   (HRF-S-13).
CR Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544
   Calderón-Montaño JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335
   CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538
   Christensen KB, 2010, PHYTOTHER RES, V24, pS129, DOI 10.1002/ptr.3005
   Demir H, 2009, AFR J BIOTECHNOL, V8, P274
   El-Tantawy WH, 2014, J PHYSIOL BIOCHEM, V70, P33, DOI 10.1007/s13105-013-0277-0
   Finelli C, 2013, WORLD J GASTROENTERO, V19, P802, DOI 10.3748/wjg.v19.i6.802
   Finelli C, 2012, J GASTROINTEST LIVER, V21, P293
   Vázquez-Vela MEF, 2008, ARCH MED RES, V39, P715, DOI 10.1016/j.arcmed.2008.09.005
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Habtemariam S, 2011, NAT PROD COMMUN, V6, P201
   Jafari S, 2013, DARU, V21, DOI 10.1186/2008-2231-21-37
   Jung HA, 1999, ARCH PHARM RES, V22, P213, DOI 10.1007/BF02976549
   KIM HW, 1996, THESIS PUSAN NATL U
   Kong CS, 2009, FOOD CHEM TOXICOL, V47, P2401, DOI 10.1016/j.fct.2009.06.010
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Kwon CS, 2003, BIOSCI BIOTECH BIOCH, V67, P1451, DOI 10.1271/bbb.67.1451
   Lahrita L, 2015, J ETHNOPHARMACOL, V168, P229, DOI 10.1016/j.jep.2015.03.082
   Lee J., 2004, THESIS KEIMYUNG U DA
   Lee JC, 2004, FOOD CHEM TOXICOL, V42, P1383, DOI 10.1016/j.fct.2004.03.012
   Lee T. B., 1979, ILLUSTRATED FLORA KO
   Lee YJ, 2015, FOOD FUNCT, V6, P2824, DOI 10.1039/c5fo00481k
   Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131
   LEUSCHNER J, 1995, ARZNEIMITTELFORSCH, V45-1, P165
   Li S., 2003, COMPENDIUM MAT MEDIC, DOI DOI 10.1016/j.cmpb.2011.01.006
   Reilly SM, 2008, FEBS LETT, V582, P26, DOI 10.1016/j.febslet.2007.11.040
   RONCARI DAK, 1981, METABOLISM, V30, P425, DOI 10.1016/0026-0495(81)90174-8
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Scazzocchio B, 2011, DIABETES, V60, P2234, DOI 10.2337/db10-1461
   Seo JB, 2011, EXP MOL MED, V43, P205, DOI 10.3858/emm.2011.43.4.025
   Takemura T, 2005, ACTA HORTIC, P487, DOI 10.17660/ActaHortic.2005.673.64
   Tarantino G, 2007, WORLD J GASTROENTERO, V13, P4669, DOI 10.3748/wjg.v13.i35.4669
   Watanabe M, 2003, BIOCHEM BIOPH RES CO, V300, P429, DOI 10.1016/S0006-291X(02)02860-7
   Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003
NR 34
TC 38
Z9 42
U1 1
U2 28
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD FEB
PY 2016
VL 21
IS 2
AR 226
DI 10.3390/molecules21020226
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA DG2KN
UT WOS:000371895900043
PM 26901177
OA gold, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Tek, NA
   Sentüre, SA
   Ersoy, N
AF Tek, Nilufer Acar
   Senture, Serife Akpinar
   Ersoy, Nursena
TI Is Propolis a Potential Anti-Obesogenic Agent for Obesity?
SO CURRENT NUTRITION REPORTS
LA English
DT Review
DE Propolis; UCP-1; Creatinine kinase; Thermogenesis
ID BROWN ADIPOSE-TISSUE; GREEN TEA; ENERGY-EXPENDITURE; BODY-FAT;
   ANTIOXIDANT ACTIVITY; PHENOLIC-COMPOUNDS; C57BL/6J MICE; DOUBLE-BLIND;
   CATECHIN; BEIGE
AB Purpose of ReviewPropolis is a bee product that has been used for thousands of years. The chemical composition and biological activity of propolis, which has been investigated in the twentieth century, may vary according to location. Propolis polyphenols can induce thermogenesis in brown and beige fat tissue via the uncoupled protein-1 and creatinine kinase metabolic pathways. This review provides a comprehensive investigation of the structural and biological properties of propolis and provides insights into their promising potential strategies in body weight management.Recent FindingsBy raising overall energy expenditure, it might lead to body weight management. Furthermore, the phenolic components artepillin C, quercetin, catechin, and chlorogenic acid found in its composition may have anti-obesogenic effect by stimulating the sympathetic nervous system, enhancing browning in white adipose tissue, and triggering AMP-activated protein kinase activation and mitochondrial biogenesis.SummaryPropolis, a natural product, is effective in preventing obesity which is a contemporary pandemic.
C1 [Tek, Nilufer Acar; Senture, Serife Akpinar] Gazi Univ, Dept Nutr & Dietet, Fac Hlth Sci, Emek,Biskek Main St 6 St, TR-06490 Ankara, Turkiye.
   [Ersoy, Nursena] Ankara Univ, Fac Hlth Sci, Dept Nutr & Dietet, Fatih St 197, TR-06290 Ankara, Turkiye.
C3 Gazi University; Ankara University
RP Sentüre, SA (corresponding author), Gazi Univ, Dept Nutr & Dietet, Fac Hlth Sci, Emek,Biskek Main St 6 St, TR-06490 Ankara, Turkiye.
EM ntek@gazi.edu.tr; serifeakpinar@gazi.edu.tr; nsersoy@ankara.edu.tr
RI Tek, Nilüfer/AAN-9250-2021; Ersoy, Nursena/KLD-7593-2024; Akpınar
   Şentüre, Şerife/AGK-6682-2022
OI Acar Tek, Nilufer/0000-0002-8772-9608; Akpinar Senture,
   Serife/0000-0003-2516-4071
FU Gazi University
FX No Statement Available
CR Acar-Tek N, 2018, J AM COLL NUTR, V37, P691, DOI 10.1080/07315724.2018.1461147
   Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1810
   Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077
   Ahn MR, 2004, J AGR FOOD CHEM, V52, P7286, DOI 10.1021/jf048726s
   Ali AM, 2021, MOLECULES, V26, DOI 10.3390/molecules26051232
   Anjum SI, 2019, SAUDI J BIOL SCI, V26, P1695, DOI 10.1016/j.sjbs.2018.08.013
   Archer E, 2018, PROG CARDIOVASC DIS, V61, P89, DOI 10.1016/j.pcad.2018.06.002
   BANKOVA V, 1992, APIDOLOGIE, V23, P79, DOI 10.1051/apido:19920109
   Barth SW, 2012, EUR J NUTR, V51, P841, DOI 10.1007/s00394-011-0264-6
   Beserra FP, 2021, PHYTOTHER RES, V35, P2274, DOI 10.1002/ptr.6875
   Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Boccellino M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165642
   Bosy-Westphal A, 2021, OBES REV, V22, DOI 10.1111/obr.13190
   Braakhuis A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112705
   Cardinault N, 2020, MOL NUTR FOOD RES, DOI 10.1002/mnfr.202000275
   Choi Y, 2021, PHARM RES-DORDR, V38, P549, DOI 10.1007/s11095-021-03027-7
   Crozier A., 2008, Plant secondary metabolites: occurrence, structure and role in the human diet
   Da Villa G, 2014, J BIOL REG HOMEOS AG, V28, P141
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Erdogan S, 2011, FOOD CHEM TOXICOL, V49, P1592, DOI 10.1016/j.fct.2011.04.006
   Farkli SS., 2008, ERCIYES U FEN BILIML, V24, P120
   Fonseca D. C., 2018, Clinical Nutrition Experimental, V20, P55, DOI 10.1016/j.yclnex.2018.04.001
   Fruh SM, 2017, J AM ASSOC NURSE PRA, V29, pS3, DOI 10.1002/2327-6924.12510
   Ghadieh HE, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0014-5
   Quinhoneiro DCG, 2018, INT J FOOD SCI NUTR, V69, P995, DOI 10.1080/09637486.2018.1442819
   Hamasaka T, 2004, FOOD SCI TECHNOL RES, V10, P86, DOI 10.3136/fstr.10.86
   Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   He XY, 2021, J SCI FOOD AGR, V101, P631, DOI 10.1002/jsfa.10675
   Ikeda R, 2011, BBA-GEN SUBJECTS, V1810, P695, DOI 10.1016/j.bbagen.2011.04.007
   Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816
   Kartal M, 2002, Z NATURFORSCH C, V57, P905
   Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035
   Kitamura S, 2014, CHRONOBIOL INT, V31, P845, DOI 10.3109/07420528.2014.914035
   Koya-Miyata S, 2009, BIOL PHARM BULL, V32, P2022, DOI 10.1248/bpb.32.2022
   Kuropatnicki AK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/964149
   Lee JS, 2016, NUTR RES PRACT, V10, P175, DOI 10.4162/nrp.2016.10.2.175
   Lee MS, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1325307
   Mele L, 2017, ADV NUTR, V8, P694, DOI 10.3945/an.117.015792
   Kadar NNMA, 2021, MOLECULES, V26, DOI 10.3390/molecules26185490
   Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009
   Nishikawa S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162512
   Ota N, 2010, J HEALTH SCI, V56, P745, DOI 10.1248/jhs.56.745
   Park I, 2017, BRIT J NUTR, V117, P979, DOI 10.1017/S0007114517000587
   Pfeuffer M, 2013, NUTR METAB CARDIOVAS, V23, P403, DOI 10.1016/j.numecd.2011.08.010
   Popova MP, 2009, PHYTOCHEMISTRY, V70, P1262, DOI 10.1016/j.phytochem.2009.07.025
   Rahbani JF, 2021, NATURE, V590, DOI 10.1038/s41586-021-03221-y
   Ricquier Daniel, 2011, Front Endocrinol (Lausanne), V2, P85, DOI 10.3389/fendo.2011.00085
   Sae-Tan S, 2015, J FUNCT FOODS, V14, P210, DOI 10.1016/j.jff.2015.01.036
   Sahinler N, 2005, NAT PROD RES, V19, P183, DOI 10.1080/14786410410001704877
   Salazar J, 2020, CURR PHARM DESIGN, V26, P4444, DOI 10.2174/1381612826666200701211422
   Santos LM, 2020, J SCI FOOD AGR, V100, P1369, DOI 10.1002/jsfa.10024
   Sarma S, 2021, DIABETES OBES METAB, V23, P3, DOI 10.1111/dom.14290
   Shinde AB, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.651763
   Silici S, 2005, J ETHNOPHARMACOL, V99, P69, DOI 10.1016/j.jep.2005.01.046
   Silvester AJ, 2019, J NUTR BIOCHEM, V64, P1, DOI 10.1016/j.jnutbio.2018.09.028
   Soga S, 2013, BIOSCI BIOTECH BIOCH, V77, P1633, DOI 10.1271/bbb.130147
   Stewart LK, 2008, METABOLISM, V57, pS39, DOI 10.1016/j.metabol.2008.03.003
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Sun YZ, 2021, NATURE, V593, P580, DOI 10.1038/s41586-021-03533-z
   Tsuda T, 2021, J AGR FOOD CHEM, V69, P15484, DOI 10.1021/acs.jafc.1c06194
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672
   Vardar-Ünlü G, 2008, WORLD J MICROB BIOT, V24, P1011, DOI 10.1007/s11274-007-9566-5
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846
   Wang SY, 2019, FOOD FUNCT, V10, P1263, DOI [10.1039/C8FO02154F, 10.1039/c8fo02154f]
   Wang ZC, 2021, FEBS J, V288, P3647, DOI 10.1111/febs.16015
   Watanabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071617
   Yamaguchi T., 2007, PROG MED, V27, P683
   Yan JQ, 2013, SCI CHINA LIFE SCI, V56, P804, DOI 10.1007/s11427-013-4512-2
   Yang Yoon-Kwon, 2013, [The Korean Society of Sports Science, 한국체육과학회지], V22, P955
   Yoneshiro T, 2017, AM J CLIN NUTR, V105, P873, DOI 10.3945/ajcn.116.144972
   Zhang WW, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13296
   Zhang Y, 2012, J FUNCT FOODS, V4, P315, DOI 10.1016/j.jff.2011.12.010
   Zhao YS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1459497
   Zhou JH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111681
   Zhu LY, 2023, FRONT NUTR, V10, DOI 10.3389/fnut.2023.1066789
NR 79
TC 1
Z9 1
U1 4
U2 14
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2161-3311
J9 CURR NUTR REP
JI Curr. Nutr. Rep.
PD JUN
PY 2024
VL 13
IS 2
BP 186
EP 193
DI 10.1007/s13668-024-00524-0
EA MAR 2024
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA TX1H0
UT WOS:001173355900001
PM 38436884
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Imai, M
   Yamane, T
   Kozuka, M
   Takenaka, S
   Sakamoto, T
   Ishida, T
   Nakagaki, T
   Nakano, Y
   Inui, H
AF Imai, Momoko
   Yamane, Takuya
   Kozuka, Miyuki
   Takenaka, Shigeo
   Sakamoto, Tatsuji
   Ishida, Tetsuo
   Nakagaki, Takenori
   Nakano, Yoshihisa
   Inui, Hiroshi
TI Caffeoylquinic acids from aronia juice inhibit both dipeptidyl peptidase
   IV and α-glucosidase activities
SO LWT-FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Aronia melanocarpa; Caffeoylquinic acids; DPP IV; alpha-Glucosidase
ID CHLOROGENIC ACID; BLOOD-GLUCOSE; MELANOCARPA; CHOKEBERRY; ANTIOXIDANT;
   POLYPHENOLS; EXTRACT
AB Aronia (Aronia melanocarpa) contains many polyphenols including cyanidin-3,5-diglucoside, and these polyphenols have beneficial effects on lifestyle-related diseases such as type 2 diabetes and obesity. In type 2 diabetes and obesity model KKA(y) mice, drinking water supplemented with aronia juice reduced blood glucose levels partly through inhibition of dipeptidyl peptidase IV (DPP IV) activity by cyanidin-3,5-diglucoside. The objective of this study was to find alpha-glucosidase inhibitors in aronia juice. Polyphenols in aronia juice were first separated using flash chromatography on a reversed-phase column. The fraction with inhibitory activity was further separated using reversed-phase HPLC. Two peak fractions showed inhibitory activity. LC-MS/MS analysis of the fractions indicated that they contained 3-caffeoylquinic acid (3-CQA) and 4-caffeoylquinic acid (4-CQA), respectively. Both CQAs also inhibited DPP IV activity. The results suggest that caffeoylquinic acids in aronia juice are important for the amelioration of type 2 diabetes by the juice.
C1 [Imai, Momoko; Takenaka, Shigeo] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Dept Nutr, Habikino, Osaka 5838555, Japan.
   [Imai, Momoko; Inui, Hiroshi] Soai Univ, Fac Human Dev, Dept Food & Nutr Management Studies, Osaka, Osaka 5590033, Japan.
   [Yamane, Takuya; Sakamoto, Tatsuji; Nakano, Yoshihisa; Inui, Hiroshi] Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Org Res Promot, Sakai, Osaka 5998570, Japan.
   [Yamane, Takuya; Sakamoto, Tatsuji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Appl Life Sci, Sakai, Osaka 5998531, Japan.
   [Yamane, Takuya; Nakagaki, Takenori] Nakagaki Consulting Engineer & Co Ltd, Inst Food Sci, Nishi Ku, Sakai, Osaka 5938328, Japan.
   [Kozuka, Miyuki] Hokkaido Bunkyo Univ, Fac Human Sci, Dept Hlth & Nutr, Eniwa, Hokkaido 0611449, Japan.
   [Ishida, Tetsuo] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan.
C3 Osaka Metropolitan University; Osaka Metropolitan University; Osaka
   Metropolitan University; University of the Ryukyus
RP Yamane, T (corresponding author), Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Org Res Promot, Sakai, Osaka 5998570, Japan.
EM tyt29194@osakafu-u.ac.jp
OI Yamane, Takuya/0000-0002-0408-6425
FU Nutrition and Food Science Fund of Japan Society of Nutrition and Food
   Science
FX This research is supported by the Nutrition and Food Science Fund of
   Japan Society of Nutrition and Food Science.
CR Banjari I, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00053
   Bhaswant M, 2017, NUTRITION, V41, P24, DOI 10.1016/j.nut.2016.12.009
   Bower AM, 2014, J AGR FOOD CHEM, V62, P6147, DOI 10.1021/jf500639f
   Duchnowicz P, 2012, MED SCI MONITOR, V18, pCR569, DOI 10.12659/MSM.883353
   Durazzo A, 2019, PHYTOTHER RES, V33, P2221, DOI 10.1002/ptr.6419
   Fang NB, 2002, J AGR FOOD CHEM, V50, P3579, DOI 10.1021/jf0201327
   International Diabetes Federation, 2017, IDF diabetes atlas, V8th
   Jakobek Lidija, 2007, Agriculturae Conspectus Scientificus, V72, P301
   Kalhotra P, 2018, MOLECULES, V23, DOI 10.3390/molecules23061368
   Kokotkiewicz A, 2010, J MED FOOD, V13, P255, DOI 10.1089/jmf.2009.0062
   Kozuka M, 2015, BIOCHEM BIOPH RES CO, V465, P433, DOI 10.1016/j.bbrc.2015.08.031
   Kulling SE, 2008, PLANTA MED, V74, P1625, DOI 10.1055/s-0028-1088306
   McDougall GJ, 2017, P NUTR SOC, V76, P163, DOI 10.1017/S0029665116000835
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Ncube EN, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0066-z
   Nyambe-Silavwe H, 2018, FOOD RES INT, V113, P452, DOI 10.1016/j.foodres.2018.07.038
   OHKUBO I, 1994, J BIOCHEM-TOKYO, V116, P1182, DOI 10.1093/oxfordjournals.jbchem.a124647
   Oprea E, 2014, FARMACIA, V62, P254
   Pyner A, 2017, J AGR FOOD CHEM, V65, P8643, DOI 10.1021/acs.jafc.7b03678
   Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X
   Rahmani J, 2019, PHYTOTHER RES, V33, P1981, DOI 10.1002/ptr.6398
   Santini A, 2017, FOODS, V6, DOI 10.3390/foods6090074
   Santini A, 2017, EUR J PHARM SCI, V96, P53, DOI 10.1016/j.ejps.2016.09.003
   Sidor A, 2019, MOLECULES, V24, DOI [10.3390/molecu, 10.3390/molecules24203710]
   Simeonov Simeon B, 2002, Folia Med (Plovdiv), V44, P20
   Sterrett JJ, 2016, AM J MED SCI, V351, P342, DOI 10.1016/j.amjms.2016.01.019
   Tasyurek HM, 2014, DIABETES-METAB RES, V30, P354, DOI 10.1002/dmrr.2501
   Tian Y, 2017, FOOD CHEM, V220, P266, DOI 10.1016/j.foodchem.2016.09.145
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI [10.1139/H11-072, 10.1139/h11-072]
   Valcheva-Kuzmanova S, 2007, METHOD FIND EXP CLIN, V29, P101, DOI 10.1358/mf.2007.29.2.1075349
   Vieira R, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12040152
   Xie C, 2011, J AGR FOOD CHEM, V59, P11078, DOI 10.1021/jf203104k
   Xu DL, 2015, J AGR FOOD CHEM, V63, P3694, DOI 10.1021/acs.jafc.5b00420
   Yamane T., 2017, Clinical Nutrition Experimental, V12, P20, DOI 10.1016/j.yclnex.2017.01.002
   Yamane T., 2016, Functional Foods in Health and Disease, V6, P144
   Yamane T., 2017, FUNCTIONAL FOOD HLTH, V7, P144
   Yamane T., 2018, STUD NAT PROD CHEM, V58, P245
   Yamane T, 2019, J FUNCT FOODS, V58, P21, DOI 10.1016/j.jff.2019.04.038
   Yamane T, 2016, J NUTR BIOCHEM, V31, P106, DOI 10.1016/j.jnutbio.2016.02.004
NR 39
TC 19
Z9 19
U1 2
U2 45
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0023-6438
EI 1096-1127
J9 LWT-FOOD SCI TECHNOL
JI LWT-Food Sci. Technol.
PD JUL
PY 2020
VL 129
AR 109544
DI 10.1016/j.lwt.2020.109544
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA LY9WN
UT WOS:000540878500037
DA 2025-04-28
ER

PT J
AU Kim, SJ
   Choung, SY
AF Kim, Sa-Jic
   Choung, Se-Young
TI Inhibitory effects of Aster spathulifolius extract on
   adipogenesis and lipid accumulation in 3T3-L1 preadipocytes
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article
DE 3T3-L1 cells; adipogenesis; AMPK alpha; Aster spathulifolius maxim;
   PPAR-gamma
ID ACTIVATED PROTEIN-KINASE; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION
   FACTORS; CHLOROGENIC ACID; DOWN-REGULATION; AERIAL PARTS; OBESITY; DIET;
   PHYTOCHEMICALS; ISOQUERCITRIN
AB ObjectivesAster spathulifolius Maxim (AS), known for its anti-viral and anti-allergic activity, is also known to reduce body weight gain in high fat diet-induced obese rats. But its molecular mechanism of the anti-obesity effects is still unclear. So, we investigated the inhibitory effect of AS extract (ASE) on adipogenesis and lipid accumulation to determine the underlying cellular molecular mechanism.
   MethodsTo perform this study, the contents of intracellular triglyceride were analysed. Real-time polymerase chain reaction and Western blotting were carried out to investigate the expression of adipogenic transcriptional factors.
   Key findingsASE showed the suppression of adipogenic differentiation and the considerable reduction of the lipid accumulation in 3T3-L1 cells. Especially, ASE inhibited the early stage of differentiation via the downregulation of C/EBP- and C/EBP-, which are early adipogenic factors. Major adipogenic factors, such as PPAR- and C/EBP-, were also subsequently inhibited. These findings were supported by Oil Red O staining and intracellular triglyceride levels. A molecular mechanism liking the effect of ASE was identified through the activation of AMPK pathway. ASE increased protein levels of phosphorylated AMPK and phosphorylated ACC.
   ConclusionsASE showed anti-adipogenic and anti-lipogenic effects through the regulation of adipogenic factors and AMPK pathway.
C1 [Kim, Sa-Jic; Choung, Se-Young] Kyung Hee Univ, Coll Pharm, Dept Life & Nanopharmaceut Sci Pharm, Seoul, South Korea.
   [Choung, Se-Young] Kyung Hee Univ, Coll Pharm, Dept Prevent Pharm & Toxicol, Seoul, South Korea.
C3 Kyung Hee University; Kyung Hee University
RP Choung, SY (corresponding author), Kyung Hee Univ, Coll Pharm, Dept Life & Nanopharmaceut Sci Pharm, Seoul, South Korea.
EM sychoung@khu.ac.kr
RI Choung, Young/HSE-1870-2023
OI Choung, Se Young/0000-0001-7619-6263
FU Kyung Hee University [KHU-20050434]; Industrial Strategic Technology
   Development Program - Ministry of Trade, Industry & Energy (MI, Korea)
   [10045257]
FX This work was supported by a grant from both Kyung Hee University in
   2005 (KHU-20050434) and the Industrial Strategic Technology Development
   Program (10045257, development of functional food product for improving
   metabolic syndrome using natural resources and extending global market)
   funded by the Ministry of Trade, Industry & Energy (MI, Korea).
CR Akowuah GA, 2004, FOOD CHEM, V87, P559, DOI 10.1016/j.foodchem.2004.01.008
   Bang CY, 2014, J PHARM PHARMACOL, V66, P875, DOI 10.1111/jphp.12211
   Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701
   Choi HS, 2014, BIOCHIMIE, V104, P127, DOI 10.1016/j.biochi.2014.06.010
   Davaatseren M, 2013, FOOD CHEM TOXICOL, V58, P30, DOI 10.1016/j.fct.2013.04.023
   Eberlé D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325
   González-Castejón M, 2014, PHYTOTHER RES, V28, P745, DOI 10.1002/ptr.5059
   González-Castejón M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI [10.1002/mnfr.200890019, 10.1002/mnfr.200700393]
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Hwang JW, 2015, J FUNCT FOODS, V15, P516, DOI 10.1016/j.jff.2015.04.002
   Jang HS, 2006, THESIS KYUNG HEE U S
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kang YJ, 2008, DIABETES RES CLIN PR, V82, P25, DOI 10.1016/j.diabres.2008.06.012
   Kessler RC, 2001, ANN INTERN MED, V135, P262, DOI 10.7326/0003-4819-135-4-200108210-00011
   Kim H, 2012, J MED FOOD, V15, P811, DOI 10.1089/jmf.2011.2126
   Kim M.J., 2015, Am. J. Mol. Biol, V5, P32, DOI [10.4236/ajmb.2015.52004, DOI 10.4236/AJMB.2015.52004]
   Kim NM, 2000, ARCH PHARM RES, V23, P237, DOI 10.1007/BF02976451
   Ko SC, 2013, ENVIRON TOXICOL PHAR, V36, P1253, DOI 10.1016/j.etap.2013.10.011
   Kong CS, 2015, J FOOD BIOCHEM, V39, P1, DOI 10.1111/jfbc.12093
   Kwak DH, 2014, MOL CELL BIOCHEM, V385, P257, DOI 10.1007/s11010-013-1834-0
   Lee E, 2013, J ETHNOPHARMACOL, V149, P148, DOI 10.1016/j.jep.2013.06.014
   Lee H, 2015, BASIC CLIN PHARMACOL, V116, P222, DOI 10.1111/bcpt.12308
   Lee JH, 2008, CLIN EXP ALLERGY, V38, P794, DOI 10.1111/j.1365-2222.2008.02936.x
   Lee SH, 2011, PHYTOTHER RES, V25, P1629, DOI 10.1002/ptr.3469
   Lee SO, 2006, ARCH PHARM RES, V29, P845, DOI 10.1007/BF02973904
   Leite CE, 2009, PHARMACOL REP, V61, P217, DOI 10.1016/S1734-1140(09)70025-8
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Lim DW, 2013, MOLECULES, V18, P9241, DOI 10.3390/molecules18089241
   Lin LZ, 2008, J AGR FOOD CHEM, V56, P10105, DOI 10.1021/jf802412m
   Lin LZ, 2010, FOOD CHEM, V120, P319, DOI 10.1016/j.foodchem.2009.09.083
   Lü H, 2009, PHYTOMEDICINE, V16, P967, DOI 10.1016/j.phymed.2009.03.024
   Luque CA, 1999, ANN PHARMACOTHER, V33, P968, DOI 10.1345/aph.18319
   Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1
   Mokdad A. H., 2003, JAMA, Journal of the American Medical Association, V289, P76, DOI 10.1001/jama.289.1.76
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Rogerio AP, 2007, INFLAMM RES, V56, P402, DOI 10.1007/s00011-007-7005-6
   Rosen ED, 2000, GENE DEV, V14, P1293
   Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   ROSS SE, 2000, SCIENCE, V289, P950, DOI DOI 10.1126/SCIENCE.289.5481.950
   Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Seo CR, 2014, FOOD CHEM TOXICOL, V64, P217, DOI 10.1016/j.fct.2013.11.040
   Shimoda H, 2003, BIOORG MED CHEM LETT, V13, P223, DOI 10.1016/S0960-894X(02)00889-2
   Singla P, 2010, WORLD J DIABETES, V1, P76, DOI 10.4239/wjd.v1.i3.76
   Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8
   Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8
   Swain T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Wan Y, 2014, EXP THER MED, V8, P79, DOI 10.3892/etm.2014.1698
   Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7
   Won JN, 2013, J MICROBIOL BIOTECHN, V23, P125, DOI 10.4014/jmb.1210.10074
   Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031
   Yang L, 2012, PHYTOTHER RES, V26, P438, DOI 10.1002/ptr.3604
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
NR 66
TC 11
Z9 11
U1 1
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD JAN
PY 2016
VL 68
IS 1
BP 107
EP 118
DI 10.1111/jphp.12485
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA DB9JH
UT WOS:000368831700011
PM 26471469
OA Bronze
DA 2025-04-28
ER

PT J
AU Riksen, NP
   Bosselaar, M
   Bakker, SJL
   Heine, RJ
   Rongen, GA
   Tack, CJ
   Smits, P
AF Riksen, Niels P.
   Bosselaar, Marlies
   Bakker, Stephan J. L.
   Heine, Robert J.
   Rongen, Gerard A.
   Tack, Cees J.
   Smits, Paul
TI Acute elevation of plasma non-esterified fatty acids increases pulse
   wave velocity and induces peripheral vasodilation in humans in
   vivo
SO CLINICAL SCIENCE
LA English
DT Article
DE adenosine; non-esterified fatty acid (NEFA); arterial compliance; blood
   flow; autonomic nervous system
ID INSULIN-RESISTANCE SYNDROME; AUTONOMIC NERVOUS-SYSTEM; HYPERDYNAMIC
   CIRCULATION; NOREPINEPHRINE SPILLOVER; ADENOSINE; INFUSION; ADOLESCENTS;
   ACTIVATION; MECHANISM; CHILDREN
AB Plasma NEFA (non-esterified fatty acid) concentrations are elevated in patients with obesity. In the present study we first aimed to provide an integral haemodynamic profile of elevated plasma NEFAs by the simultaneous assessment of blood pressure, pulse wave velocity, FBF (forearm blood flow) and sympathetic nervous system activity during acute elevation of NEFAs. Secondly, we hypothesized that NEFA-induced vasodilation is mediated by adenosine receptor stimulation. In a randomized cross-over trial in healthy subjects, Intralipid((R)) was infused for 2 h to elevate plasma NEFAs. Glycerol was administered as the Control infusion. We assessed blood pressure, pulse wave velocity, FBF (using venous occlusion plethysmography) and sympathetic nervous system activity by measurement of noradrenaline and adrenaline. During the last 15 min of Intralipid((R))/Control infusion, the adenosine receptor antagonist caffeine (90 mu g . min(-1) . dl(-1)) was administered into the brachial artery of the non-dominant arm. Compared with Control infusion, lntralipid((R))) increased pulse wave velocity, SBP (systolic blood pressure) and pulse pressure, as well as FBF (from 1.8 +/- 0.2 to 2.7 +/- 0.6 and from 2.3 +/- 0.2 to 2.7 +/- 0.6 ml . min-1 . dl(-1) for Intralipid((R)) compared with Control infusion; P < 0.05, n = 9). Although in a positive control study caffeine attenuated adenosine-induced forearm vasodilation (P < 0.0 1, n = 6), caffeine had no effect on Intralipid((R))-induced vasodilation (P = 0.5). In conclusion, elevation of plasma NEFA levels increased pulse wave velocity, SBP and pulse pressure. FBF was also increased, either by baroreflex-mediated inhibition of the sympathetic nervous system or by a direct vasodilating effect of NEFAs. As the adenosine receptor antagonist caffeine could not antagonize the vasodilator response, this response is not mediated by adenosine receptor stimulation.
C1 Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol Toxicol, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands.
   Univ Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands.
   Univ Groningen, Med Ctr, NL-9700 RB Groningen, Netherlands.
   Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, NL-1007 MB Amsterdam, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; University of
   Groningen; University of Groningen; Vrije Universiteit Amsterdam
RP Riksen, NP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol Toxicol, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM N.Riksen@aig.umcn.nl
RI Riksen, Niels/G-8260-2015; Smits, P.A.B.M./E-2889-2015; Rongen,
   Gerard/C-1578-2018; Tack, Cees/A-2368-2014; Bakker, Stephan/J-4023-2015
OI riksen, niels/0000-0001-9197-8124; Bakker, Stephan/0000-0003-3356-6791
CR Bakker SJL, 2001, ATHEROSCLEROSIS, V155, P283, DOI 10.1016/S0021-9150(00)00745-0
   Balakrishnan VS, 1996, AM J PHYSIOL-RENAL, V271, pF374, DOI 10.1152/ajprenal.1996.271.2.F374
   BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252
   CHANG PC, 1991, HYPERTENSION, V18, P56, DOI 10.1161/01.HYP.18.1.56
   CHUA BH, 1977, J BIOL CHEM, V252, P6711
   Ciapaite J, 2005, DIABETES, V54, P944, DOI 10.2337/diabetes.54.4.944
   de Kreutzenberg SV, 2000, J CLIN ENDOCR METAB, V85, P793, DOI 10.1210/jc.85.2.793
   Deussen A, 1999, CIRCULATION, V99, P2041, DOI 10.1161/01.CIR.99.15.2041
   Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001
   Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Fugmann A, 2003, CLIN SCI, V105, P715, DOI 10.1042/CS20030036
   Gadegbeku CA, 2002, AM J HYPERTENS, V15, P479, DOI 10.1016/S0895-7061(02)02275-6
   Gokce N, 2001, AM J CARDIOL, V88, P153, DOI 10.1016/S0002-9149(01)01610-1
   GREKIN RJ, 1995, HYPERTENSION, V26, P193, DOI 10.1161/01.HYP.26.1.193
   Grekin RJ, 2005, AM J HYPERTENS, V18, P422, DOI 10.1016/j.amjhyper.2004.10.013
   Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372
   Heptulla R, 2001, J CLIN ENDOCR METAB, V86, P90, DOI 10.1210/jc.86.1.90
   Huggett RJ, 2004, HYPERTENSION, V44, P847, DOI 10.1161/01.HYP.0000147893.08533.d8
   JIANG XZ, 1995, CIRCULATION, V91, P1101, DOI 10.1161/01.CIR.91.4.1101
   Kearney MT, 2002, CLIN SCI, V102, P495, DOI 10.1042/cs1020495
   Krebs M, 2001, J CLIN ENDOCR METAB, V86, P2153, DOI 10.1210/jc.86.5.2153
   Lind L, 2000, CLIN SCI, V99, P169, DOI 10.1042/cs0990169
   Magnan C, 1999, J CLIN INVEST, V103, P413, DOI 10.1172/JCI3883
   Manzella D, 2001, J CLIN ENDOCR METAB, V86, P2769, DOI 10.1210/jc.86.6.2769
   MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799
   Palatini P, 1999, HYPERTENSION, V33, P769, DOI 10.1161/01.HYP.33.3.769
   Paolisso G, 1998, DIABETOLOGIA, V41, P1127, DOI 10.1007/s001250051041
   Paolisso G, 2000, AM J CLIN NUTR, V72, P723
   Riksen NP, 2005, ARTERIOSCL THROM VAS, V25, P109, DOI 10.1161/01.ATV.0000150651.85907.69
   Rongen GA, 2000, CLIN SCI, V99, P363, DOI 10.1042/CS20000084
   Rongen GA, 1996, EUR J CLIN INVEST, V26, P192, DOI 10.1046/j.1365-2362.1996.110264.x
   Rongen GA, 1997, CLIN SCI, V92, P13, DOI 10.1042/cs0920013
   SCOTT MJ, 1989, J CARDIOVASC PHARM, V13, P125
   Shaltout HA, 2005, J PHARMACOL EXP THER, V314, P1328, DOI 10.1124/jpet.105.086314
   Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636
   STERN MP, 1992, HYPERTENSION, V20, P802, DOI 10.1161/01.HYP.20.6.802
   Stojiljkovic MP, 2001, AM J PHYSIOL-REG I, V280, pR1674, DOI 10.1152/ajpregu.2001.280.6.R1674
   Tack CJJ, 1996, HYPERTENSION, V28, P426, DOI 10.1161/01.HYP.28.3.426
   Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4
   van Popele NM, 2000, DIABETOLOGIA, V43, P665, DOI 10.1007/s001250051356
   WILLEMSEN JJ, 1995, CLIN CHEM, V41, P1455
NR 42
TC 9
Z9 9
U1 0
U2 1
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD JUL
PY 2007
VL 113
IS 1-2
BP 33
EP 40
DI 10.1042/CS20060365
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 199EM
UT WOS:000248679000004
PM 17309447
OA Green Published
DA 2025-04-28
ER

PT J
AU Sylvetsky, AC
   Visek, AJ
   Turvey, C
   Halberg, S
   Weisenberg, JR
   Lora, K
   Sacheck, J
AF Sylvetsky, Allison C.
   Visek, Amanda J.
   Turvey, Catherine
   Halberg, Sabrina
   Weisenberg, Jamie R.
   Lora, Karina
   Sacheck, Jennifer
TI Parental Concerns about Child and Adolescent Caffeinated Sugar-Sweetened
   Beverage Intake and Perceived Barriers to Reducing Consumption
SO NUTRIENTS
LA English
DT Article
DE sugar; caffeine; childhood obesity; beverage consumption; soda
ID FAST-FOOD RESTAURANTS; OBESITY; PREVENTION; BEHAVIORS; SCHOOLS; DRINKS
AB Sugar-sweetened beverage (SSB) consumption contributes to obesity and chronic disease. SSB intake in children and adolescents remains well above recommendations and reducing intake is challenging. In addition to high sugar content, SSBs are the predominant source of caffeine among youth. However, whether caffeine in SSBs presents unique barriers to reducing consumption is unknown. Herein, we examine parental concerns about child caffeinated-SSB (CSSB) intake and describe parent-reported barriers to lowering their child's consumption. In-depth qualitative interviews were conducted with 21 parents of children and adolescents 8-17 years of age. Interviews were audio-recorded and transcribed verbatim. Transcripts were coded using Nvivo (TM), and key themes were identified. Most parents expressed concern about child CSSB consumption, primarily with regard to dietary (e.g., excess sugar), health (e.g., obesity, diabetes) and/or behavioral (e.g., hyperactivity) consequences of frequent intake. Several key barriers to CSSB restriction were reported, encompassing six emergent themes: widespread availability and accessibility; child non-compliance when asked not to drink CSSBs; peer and cultural influences; negative child response to CSSB restriction; family eating behaviors; and, child preferences for CSSBs versus other beverages. Consideration of these barriers, along with the development of novel approaches to address these challenges, will likely bolster success in interventions aimed at reducing CSSB intake among children and adolescents.
C1 [Sylvetsky, Allison C.; Visek, Amanda J.; Turvey, Catherine; Halberg, Sabrina; Weisenberg, Jamie R.; Lora, Karina; Sacheck, Jennifer] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, 950 New Hampshire Ave NW, Washington, DC 20052 USA.
   [Sylvetsky, Allison C.] GeorgeWashington Univ, Milken Inst Sch Publ Hlth, Sumner M Redstone Global Ctr Prevent & Wellness, 950 New Hampshire Ave NW, Washington, DC 20052 USA.
C3 George Washington University
RP Sylvetsky, AC (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Dept Exercise & Nutr Sci, 950 New Hampshire Ave NW, Washington, DC 20052 USA.; Sylvetsky, AC (corresponding author), GeorgeWashington Univ, Milken Inst Sch Publ Hlth, Sumner M Redstone Global Ctr Prevent & Wellness, 950 New Hampshire Ave NW, Washington, DC 20052 USA.
EM asylvets@gwu.edu; avisek@gwu.edu; cturvey@gwmail.gwu.edu;
   halbergs@gwmail.gwu.edu; jrweisen@syr.edu; klora@email.gwu.edu;
   jsacheck25@email.gwu.edu
FU Cross-Disciplinary Research Fund Award from The George Washington
   University; NIH National Center for Advancing Translational Sciences
   [UL1TR001876, KL2TR001877]
FX This research was supported, in part, by a Cross-Disciplinary Research
   Fund Award (PI: Sylvetsky) from The George Washington University. This
   research was also supported, in part, by Award Numbers UL1TR001876 and
   KL2TR001877 from the NIH National Center for Advancing Translational
   Sciences. Its contents are solely the responsibility of the authors and
   do not necessarily represent the official views of the National Center
   for Advancing Translational Sciences or the National Institutes of
   Health. The APC was also funded by the above listed sources.
CR Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019
   Bogart LM, 2013, ACAD PEDIATR, V13, P348, DOI 10.1016/j.acap.2013.02.009
   Boles M, 2014, PREV MED, V67, pS40, DOI 10.1016/j.ypmed.2014.07.023
   Centers for Disease Control and Prevention, GET FACTS SUG SWEET
   Chung SJ, 2017, J PEDIATR NURS, V36, P44, DOI 10.1016/j.pedn.2017.04.010
   Cooksey-Stowers K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111366
   Creswell J.W., 2012, Educational Research, VFourth, DOI DOI 10.1017/CBO9781107415324.004
   Daniels SR, 2015, PEDIATRICS, V136, pE275, DOI 10.1542/peds.2015-1558
   Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638
   Dohnke B, 2011, ADDICT BEHAV, V36, P286, DOI 10.1016/j.addbeh.2010.11.001
   Doolen J, 2009, J AM ACAD NURSE PRAC, V21, P160, DOI 10.1111/j.1745-7599.2008.00382.x
   Drewnowski A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030154
   Eck KM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091232
   Gittelsohn J, 2017, NUTR REV, V75, P62, DOI 10.1093/nutrit/nuw038
   Glanz K, 2012, AM J PREV MED, V42, P503, DOI 10.1016/j.amepre.2012.01.013
   Grier SA, 2008, AM J PUBLIC HEALTH, V98, P1616, DOI 10.2105/AJPH.2007.115626
   Higgs S, 2015, APPETITE, V86, P38, DOI 10.1016/j.appet.2014.10.021
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Keast RSJ, 2015, BRIT J NUTR, V113, P366, DOI 10.1017/S000711451400378X
   Kirkpatrick SI, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081036
   Klassen KM, 2018, J MED INTERNET RES, V20, DOI 10.2196/10227
   Lopez NV, 2012, J ACAD NUTR DIET, V112, P541, DOI 10.1016/j.jand.2011.11.013
   Mahoney CR, 2019, CLIN NUTR, V38, P668, DOI 10.1016/j.clnu.2018.04.004
   Malik VS, 2017, CURR OPIN CARDIOL, V32, P572, DOI 10.1097/HCO.0000000000000439
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Park S, 2019, AM J HEALTH PROMOT, V33, P39, DOI 10.1177/0890117118774206
   Park S, 2012, J PUBLIC HEALTH-UK, V34, P228, DOI 10.1093/pubmed/fdr071
   Poti JM, 2014, J ACAD NUTR DIET, V114, P908, DOI 10.1016/j.jand.2013.08.012
   Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI [10.3945/ajcn.114.100925, 10.3945/ajcn.113.071928]
   Scaglioni S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060706
   Scharf RJ, 2016, ANNU REV PUBL HEALTH, V37, P273, DOI 10.1146/annurev-publhealth-032315-021528
   Striley Catherine L W, 2011, J Caffeine Res, V1, P219, DOI 10.1089/jcr.2011.0029
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Tipton JA, 2014, J PEDIATR NURS, V29, P47, DOI 10.1016/j.pedn.2013.06.006
   Tyler DO, 2008, J AM ACAD NURSE PRAC, V20, P194, DOI 10.1111/j.1745-7599.2007.00298.x
   Vargas-Garcia EJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0008-4
   Ventura AK, 2011, CURR OPIN CLIN NUTR, V14, P379, DOI 10.1097/MCO.0b013e328346df65
   Wiggers D, 2017, AM J PREV MED, V53, P866, DOI 10.1016/j.amepre.2017.05.021
   Zahid A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080929
NR 40
TC 18
Z9 18
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR
PY 2020
VL 12
IS 4
AR 885
DI 10.3390/nu12040885
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA LL8VE
UT WOS:000531831300005
PM 32218117
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Yu, HY
   Lee, SJ
   Lee, SY
   Lee, SK
   Hur, SJ
AF Yu, Hao Yang
   Lee, Seung-Jae
   Lee, Seung Yun
   Lee, Si Kyung
   Hur, Sun Jin
TI Effect of dietary bioactive compounds and biopolymer encapsulated lipids
   on metabolism of lipids in high fat diet-fed mice
SO EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Bioactive components; Biopolymers encapsulation; Lipid digestion; Lipid
   metabolism; Obese mice
ID SERUM LEPTIN CONCENTRATION; BODY-WEIGHT; ENERGY-EXPENDITURE;
   FOOD-INTAKE; FIBER; CHOLESTEROL; DIGESTION; CAFFEINE; EXTRACT;
   DIGESTIBILITY
AB Wedeterminedthe effects of dietarybioactivecomponentsandbiopolymer encapsulationonlipids'metabolism in obesemice. Six randomgroups of 60 obese mice were fed the following diets for 95 days: Basal diet; cellulose encapsulated lipids; pectinandchitosanencapsulatedlipids(EPC); Camellia sinensisandCoix lacrymaenhanced diet; C. sinensisandC. lacrymadiet plus pectin andchitosan encapsulated lipids; hydroxycitric acid, caffeine, and vitamin C enhanced diet plus pectin and chitosan encapsulated lipids (HCVEPC). The HCVEPC groupusually presented lower body and to taladipose tissueweight comparedtootherdiet groups. Intestine lengthwas not significantly different among all dietary groups. Serum leptin, triglycerides, and cholesterol were significantly lower in EPC and HCVEPC compared to other groups. However, serum glucose was not significantly different among groups. Our results indicate that bioactive compounds and biopolymers' encapsulation act synergistically in the reduction of body and adipose tissue weight.
C1 [Yu, Hao Yang; Lee, Si Kyung] Konkuk Univ, Dept Bioresources & Food Sci, Seoul, South Korea.
   [Lee, Seung-Jae] KRIBB, Nat Prod Res Ctr, Jeongeup, South Korea.
   [Lee, Seung Yun; Hur, Sun Jin] Chung Ang Univ, Dept Anim Sci & Technol, Anseong 17546, South Korea.
C3 Konkuk University; Korea Research Institute of Bioscience &
   Biotechnology (KRIBB); Chung Ang University
RP Hur, SJ (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong 17546, South Korea.
EM hursj@cau.ac.kr
RI lee, yeo/AAG-4342-2020; Lee, Jeong-Hoon/Q-1055-2018
OI Hur, Sun Jin/0000-0001-9386-5852
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2055131]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education (NRF-2014R1A1A2055131).
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Adisakwattana S, 2011, EUR REV MED PHARMACO, V15, P803
   Beysseriat M, 2006, FOOD HYDROCOLLOID, V20, P800, DOI 10.1016/j.foodhyd.2005.08.001
   Bray GA, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801269
   Chakrabarti R, 2009, EXPERT OPIN THER TAR, V13, P195, DOI [10.1517/14728220802637063, 10.1517/14728220802637063 ]
   Choi HS, 2016, KOREAN J FOOD SCI AN, V36, P131, DOI 10.5851/kosfa.2016.36.1.131
   Gallaher CM, 2000, J NUTR, V130, P2753, DOI 10.1093/jn/130.11.2753
   Hongu N, 2000, J NUTR, V130, P152, DOI 10.1093/jn/130.2.152
   Hur SJ, 2009, J FOOD SCI, V74, pC653, DOI 10.1111/j.1750-3841.2009.01344.x
   Hur SJ, 2014, FOOD BIOPROCESS TECH, V7, P2198, DOI 10.1007/s11947-014-1320-z
   Hur SJ, 2015, FOOD CHEM, V166, P254, DOI 10.1016/j.foodchem.2014.06.009
   Hur SJ, 2013, INT J MOL SCI, V14, P6848, DOI 10.3390/ijms14046848
   Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   KROMHOUT D, 1983, AM J CLIN NUTR, V38, P591, DOI 10.1093/ajcn/38.4.591
   Lairon D, 2007, J NUTR BIOCHEM, V18, P217, DOI 10.1016/j.jnutbio.2006.08.001
   Leonhardt M, 2001, PHYSIOL BEHAV, V74, P191, DOI 10.1016/S0031-9384(01)00547-9
   Li C. M., 2004, CHINA PUBLIC HLTH, V20, P721
   McDougall GJ, 2008, BIOFACTORS, V34, P73, DOI 10.1002/biof.5520340108
   Murakami K, 2007, NUTRITION, V23, P461, DOI 10.1016/j.nut.2007.04.006
   NOPPA H, 1980, AM J EPIDEMIOL, V111, P693, DOI 10.1093/oxfordjournals.aje.a112947
   Palafox-Carlos H, 2011, J FOOD SCI, V76, pR6, DOI 10.1111/j.1750-3841.2010.01957.x
   Preuss H., 2003, J MED, V35, P33
   Preuss HG, 2004, DIABETES OBES METAB, V6, P171, DOI 10.1111/j.1462-8902.2004.00328.x
   RACOTTA IS, 1994, PHARMACOL BIOCHEM BE, V48, P887, DOI 10.1016/0091-3057(94)90196-1
   Ramsey JJ, 1998, AM J CLIN NUTR, V68, P42, DOI 10.1093/ajcn/68.1.42
   SEIDELL JC, 1995, OBES RES, V3, pS89, DOI 10.1002/j.1550-8528.1995.tb00451.x
   Vasselli JR, 1998, FASEB J, V12, pA505
   Wielinga P. Y., 2003, APPETITE, V40, P369
NR 29
TC 1
Z9 1
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1438-7697
EI 1438-9312
J9 EUR J LIPID SCI TECH
JI Eur. J. Lipid Sci. Technol.
PD JUL
PY 2017
VL 119
IS 7
AR 1600310
DI 10.1002/ejlt.201600310
PG 6
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA FC7PU
UT WOS:000407034700017
DA 2025-04-28
ER

PT J
AU Murase, T
   Misawa, K
   Minegishi, Y
   Aoki, M
   Ominami, H
   Suzuki, Y
   Shibuya, Y
   Hase, T
AF Murase, Takatoshi
   Misawa, Koichi
   Minegishi, Yoshihiko
   Aoki, Masafumi
   Ominami, Hideo
   Suzuki, Yasuto
   Shibuya, Yusuke
   Hase, Tadashi
TI Coffee polyphenols suppress diet-induced body fat accumulation by
   downregulating SREBP-1c and related molecules in C57BL/6J mice
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE obesity; metabolic syndrome; energy metabolism; caffeoyl quinic acid;
   acetyl-coenzyme A carboxylase; sterol regulatory element-binding
   protein-1c
ID ANTISENSE OLIGONUCLEOTIDE INHIBITORS; SPONTANEOUSLY HYPERTENSIVE-RATS;
   STEAROYL-COA DESATURASE-1; TYPE-2 DIABETES-MELLITUS; ACTIVATED
   PROTEIN-KINASE; METABOLIC SYNDROME; INSULIN-RESISTANCE; HEPATIC
   STEATOSIS; LIPID-METABOLISM; INDUCED OBESITY
AB Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, Shibuya Y, Hase T. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab 300: E122-E133, 2011. First published October 13, 2010; doi:10.1152/ajpendo.00441.2010.-The prevalence of obesity is increasing globally, and obesity is a major risk factor for type 2 diabetes and cardiovascular disease. We investigated the effects of coffee polyphenols (CPP), which are abundant in coffee and consumed worldwide, on diet-induced body fat accumulation. C57BL/6J mice were fed either a control diet, a high-fat diet, or a high-fat diet supplemented with 0.5 to 1.0% CPP for 2-15 wk. Supplementation with CPP significantly reduced body weight gain, abdominal and liver fat accumulation, and infiltration of macrophages into adipose tissues. Energy expenditure evaluated by indirect calorimetry was significantly increased in CPP-fed mice. The mRNA levels of sterol regulatory element-binding protein (SREBP)-1c, acetyl-CoA carboxylase-1 and -2, stearoyl-CoA desaturase-1, and pyruvate dehydrogenase kinase-4 in the liver were significantly lower in CPP-fed mice than in high-fat control mice. Similarly, CPP suppressed the expression of these molecules in Hepa 1-6 cells, concomitant with an increase in microRNA-122. Structure-activity relationship studies of nine quinic acid derivatives isolated from CPP in Hepa 1-6 cells suggested that mono-or di-caffeoyl quinic acids (CQA) are active substances in the beneficial effects of CPP. Furthermore, CPP and 5-CQA decreased the nuclear active form of SREBP-1, acetyl-CoA carboxylase activity, and cellular malonyl-CoA levels. These findings indicate that CPP enhances energy metabolism and reduces lipogenesis by downregulating SREBP-1c and related molecules, which leads to the suppression of body fat accumulation.
C1 [Murase, Takatoshi; Misawa, Koichi; Minegishi, Yoshihiko; Aoki, Masafumi; Ominami, Hideo; Suzuki, Yasuto; Shibuya, Yusuke; Hase, Tadashi] Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan.
C3 KAO Corporation
RP Murase, T (corresponding author), Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
EM murase.takatoshi@kao.co.jp
OI Misawa, Koichi/0000-0002-0317-0609; Minegishi,
   Yoshihiko/0009-0000-3215-3528; HASE, TADASHI/0009-0003-3657-5332
CR Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100
   Cheung O, 2008, J HEPATOL, V48, pS47, DOI 10.1016/S0168-8278(08)60107-5
   Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005
   DEMOZ A, 1995, J CHROMATOGR B, V667, P148, DOI 10.1016/0378-4347(94)00595-V
   Dobrzyn A, 2004, TRENDS CARDIOVAS MED, V14, P77, DOI 10.1016/j.tcm.2003.12.005
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005
   Ferré P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019
   Harwood HJ, 2005, EXPERT OPIN THER TAR, V9, P267, DOI 10.1517/14728222.9.2.267
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hwahng SH, 2009, HEPATOLOGY, V49, P1913, DOI 10.1002/hep.22887
   Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812
   Inoue M, 2005, JNCI-J NATL CANCER I, V97, P293, DOI 10.1093/jnci/dji040
   JEEJEEBHOY KN, 1970, CLIN BIOCHEM, V3, P157, DOI 10.1016/S0009--912(0()70)80021--2
   Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962
   Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061
   Kusunoki J, 2006, ENDOCRINE, V29, P91, DOI 10.1385/ENDO:29:1:91
   Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Murase T, 2008, AM J PHYSIOL-REG I, V295, pR281, DOI 10.1152/ajpregu.00880.2007
   Murase T, 2010, AM J PHYSIOL-ENDOC M, V299, pE266, DOI 10.1152/ajpendo.00774.2009
   Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699
   Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976
   Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674
   Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gastro.2005.08.056
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300
   Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x
   Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002
   SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   Suzuki A, 2007, AM J HYPERTENS, V20, P508, DOI 10.1016/j.amjhyper.2006.11.008
   Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743
   Tanabe T, 1981, Methods Enzymol, V71 Pt C, P5
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
NR 47
TC 176
Z9 188
U1 1
U2 39
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JAN
PY 2011
VL 300
IS 1
BP E122
EP E133
DI 10.1152/ajpendo.00441.2010
PG 12
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 700CU
UT WOS:000285711200015
PM 20943752
DA 2025-04-28
ER

PT J
AU Wisnuwardani, RW
   De Henauw, S
   Forsner, M
   Gottrand, F
   Huybrechts, I
   Knaze, V
   Kersting, M
   Le Donne, C
   Manios, Y
   Marcos, A
   Molnár, D
   Rothwell, JA
   Scalbert, A
   Sjostrom, M
   Widhalm, K
   Moreno, LA
   Michels, N
AF Wisnuwardani, Ratih Wirapuspita
   De Henauw, Stefaan
   Forsner, Maria
   Gottrand, Frederic
   Huybrechts, Inge
   Knaze, Viktoria
   Kersting, Mathilde
   Le Donne, Cinzia
   Manios, Yannis
   Marcos, Ascension
   Molnar, Denes
   Rothwell, Joseph A.
   Scalbert, Augustin
   Sjostrom, Michael
   Widhalm, Kurt
   Moreno, Luis A.
   Michels, Nathalie
TI Polyphenol intake and metabolic syndrome risk in European adolescents:
   the HELENA study
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Risk factor; Polyphenol; Flavonoid; Youth; Obesity; Cholesterol
ID TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; CARDIOVASCULAR RISK; DIETARY
   POLYPHENOLS; COFFEE CONSUMPTION; ASSOCIATION; OBESITY; CHILDREN; WEIGHT;
   PLASMA
AB Purpose The role of polyphenol intake during adolescence to prevent metabolic syndrome (MetS) is little explored. This study aimed to evaluate the association between intake of total polyphenols, polyphenol classes and the 10 most consumed individual polyphenols with MetS risk in European adolescents. Methods Of the cross-sectional HELENA study, 657 adolescents (54% girls; 14.8% overweight; 12.5-17.5 year) had a fasting blood sample and polyphenol intake data from two non-consecutive 24-h recalls matched with the Phenol-Explorer database. MetS was defined via the pediatric American Heart Association definition. Multilevel linear regressions examined the associations of polyphenol quartiles with MetS components, while logistic regression examined the associations with MetS risk. Results After adjusting for all potential confounders (socio-demographics and nine nutrients), total polyphenol intake, polyphenol classes and individual polyphenols were not associated with MetS risk. From all MetS components, only BMI z-score was modestly inversely associated with total polyphenol intake. Further sub analyses on polyphenol classes revealed that flavonoid intake was significantly associated with higher diastolic blood pressure and lower BMI, and phenolic acid intake was associated with higher low-density cholesterol. For individual polyphenols, the above BMI findings were often confirmed (not independent from dietary intake) and a few associations were found with insulin resistance. Conclusion Higher intakes of total polyphenols and flavonoids were inversely associated with BMI. No consistent associations were found for other MetS components.
C1 [Wisnuwardani, Ratih Wirapuspita; De Henauw, Stefaan; Huybrechts, Inge; Michels, Nathalie] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, C Heymanslaan 10-4K3, B-9000 Ghent, Belgium.
   [Wisnuwardani, Ratih Wirapuspita] Mulawarman Univ, Fac Publ Hlth, Dept Publ Hlth Nutr, Samarinda, East Kalimantan, Indonesia.
   [Forsner, Maria] Umea Univ, Dept Nursing, Umea, Sweden.
   [Forsner, Maria] Dalarna Univ, Sch Educ Hlth & Social Sci, Falun, Sweden.
   [Gottrand, Frederic] Univ Lille, Inserm, CHU Lille, U995, Lille, France.
   [Huybrechts, Inge; Knaze, Viktoria; Rothwell, Joseph A.; Scalbert, Augustin] Int Agcy Res Canc, WHO, 150 Cours Albert Thomas, F-69372 Lyon, France.
   [Kersting, Mathilde] Ruhr Univ Bochum, Pediat Univ Clin Bochum, Res Dept Child Nutr, Bochum, Germany.
   [Le Donne, Cinzia] CREA Res Ctr Food & Nutr, Via Ardeatina 546, I-00178 Rome, Italy.
   [Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece.
   [Marcos, Ascension] Inst Food Sci Technol & Nutr, Dept Metab & Nutr, Immunonutr Res Grp, Madrid, Spain.
   [Molnar, Denes] Univ Pecs, Dept Pediat, Pecs, Hungary.
   [Sjostrom, Michael] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.
   [Widhalm, Kurt] Med Univ Vienna, Dept Pediat, Div Clin Nutr, Vienna, Austria.
   [Moreno, Luis A.] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Fac Hlth Sci, Edificio SAI,C Pedro Cerbuna S-N, E-50009 Zaragoza, Spain.
C3 Ghent University; Ghent University Hospital; Universitas Mulawarman;
   Umea University; Dalarna University; Institut National de la Sante et de
   la Recherche Medicale (Inserm); Universite de Lille; CHU Lille; World
   Health Organization; International Agency for Research on Cancer (IARC);
   Ruhr University Bochum; Consiglio per la Ricerca in Agricoltura e
   L'analisi Dell'economia Agraria (CREA); Harokopio University Athens;
   Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); University of
   Pecs; Karolinska Institutet; Medical University of Vienna; University of
   Zaragoza
RP Wisnuwardani, RW (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, C Heymanslaan 10-4K3, B-9000 Ghent, Belgium.; Wisnuwardani, RW (corresponding author), Mulawarman Univ, Fac Publ Hlth, Dept Publ Hlth Nutr, Samarinda, East Kalimantan, Indonesia.
EM ratihwirapuspita.wisnuwardani@ugent.be
RI Michels, Nathalie/C-2819-2012; Molnár, Dénes/AAB-6820-2022; Huybrechts,
   Inge/ITT-7052-2023; Rothwell, Joseph/AAN-1413-2021; Scalbert,
   Augustin/AAX-8160-2021; Moreno, Luis/S-1780-2019; Wisnuwardani, Ratih
   Wirapuspita/AAE-9877-2021; Sanchez, Ascension/K-4965-2014; Kengne,
   Andre/ABB-3696-2020; Chillon, Palma/E-5634-2014; Manios,
   Yannis/AAM-8953-2021; gottrand, frederic/G-7370-2015
OI Moreno Aznar, Luis A./0000-0003-0454-653X; Wisnuwardani, Ratih
   Wirapuspita/0000-0002-6050-2980; gottrand, frederic/0000-0002-5290-0436;
   Michels, Nathalie/0000-0002-3069-7254; Forsner,
   Maria/0000-0003-1169-2172; Rothwell, Joseph/0000-0002-6927-3360; Manios,
   Yannis/0000-0001-6486-114X
CR Adriouch S, 2018, INT J OBESITY, V42, P310, DOI 10.1038/ijo.2017.227
   Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Amiot MJ, 2016, OBES REV, V17, P573, DOI 10.1111/obr.12409
   [Anonymous], 1992, J AM OSTEOPATH ASS
   Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016
   Carrera-Quintanar L, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9734845
   Chiva-Blanch G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5812401
   COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25
   Cornish SM, 2009, APPL PHYSIOL NUTR ME, V34, P89, DOI 10.1139/H08-142
   Cremonini E, 2016, ARCH BIOCHEM BIOPHYS, V599, P13, DOI 10.1016/j.abb.2016.03.006
   Cuenca-García M, 2014, NUTRITION, V30, P236, DOI 10.1016/j.nut.2013.07.011
   Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024
   de Melo TS, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20165630, 10.1590/1414-431x20165630]
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Edmands WMB, 2015, AM J CLIN NUTR, V102, P905, DOI 10.3945/ajcn.114.101881
   Farhat G, 2017, PHYTOTHER RES, V31, P1005, DOI 10.1002/ptr.5830
   Flynn JT, 2017, PEDIATRICS, V140, DOI [10.1542/peds.2017-3035, 10.1542/peds.2017-1904]
   Grosso G, 2017, EUR J NUTR, V56, P1409, DOI 10.1007/s00394-016-1187-z
   Heiss C, 2015, AGE, V37, DOI 10.1007/s11357-015-9794-9
   Hossain MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040569
   Hurt Ryan T., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P269, DOI 10.1080/21551197.2012.698222
   Iliescu C, 2008, INT J OBESITY, V32, pS19, DOI 10.1038/ijo.2008.178
   Salvadó MJ, 2015, FOOD FUNCT, V6, P1053, DOI 10.1039/c4fo01035c
   Karabudak E, 2015, EXP THER MED, V9, P1841, DOI 10.3892/etm.2015.2342
   Luo JM, 2018, FOOD FUNCT, V9, P2962, DOI 10.1039/c8fo00035b
   Magnussen CG, 2010, CIRCULATION, V122, P1604, DOI 10.1161/CIRCULATIONAHA.110.940809
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Matsumoto C, 2018, CURR PHARM DESIGN, V24, P140, DOI 10.2174/1381612823666171115095720
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Medina-Remón A, 2015, NUTR METAB CARDIOVAS, V25, P60, DOI 10.1016/j.numecd.2014.09.001
   Miranda AM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030276
   Moreno LA, 2008, INT J OBESITY, V32, pS4, DOI 10.1038/ijo.2008.177
   Morrison JA, 2008, J PEDIATR-US, V152, P201, DOI 10.1016/j.jpeds.2007.09.010
   Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231
   Nagy E, 2008, INT J OBESITY, V32, pS58, DOI 10.1038/ijo.2008.184
   Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024
   Pacifico L, 2011, NUTR METAB CARDIOVAS, V21, P455, DOI 10.1016/j.numecd.2011.01.011
   Panagiotakos DB, 2003, J NUTR, V133, P3228, DOI 10.1093/jn/133.10.3228
   Penczynski KJ, 2019, EUR J NUTR, V58, P1159, DOI 10.1007/s00394-018-1631-3
   Penczynski KJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040488
   Pistollato F, 2014, TRENDS FOOD SCI TECH, V40, P62, DOI 10.1016/j.tifs.2014.07.012
   Rienks J, 2018, AM J CLIN NUTR, V108, P49, DOI 10.1093/ajcn/nqy083
   Rienks J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040415
   Sano T, 2017, NUTR METAB CARDIOVAS, V27, P249, DOI 10.1016/j.numecd.2016.11.008
   Sohrab G, 2018, METAB SYNDR RELAT D, V16, P274, DOI 10.1089/met.2017.0140
   TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170
   Tresserra-Rimbau A, 2014, NUTR METAB CARDIOVAS, V24, P639, DOI 10.1016/j.numecd.2013.12.014
   Tresserra-Rimbau A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-77
   Vanlancker T, 2017, EUR J PEDIATR, V176, P241, DOI 10.1007/s00431-016-2831-6
   Vereecken CA, 2008, INT J OBESITY, V32, pS26, DOI 10.1038/ijo.2008.180
   Vetrani C, 2018, ACTA DIABETOL, V55, P149, DOI 10.1007/s00592-017-1075-x
   Villani A, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-017-0700-4
   Vitale M, 2017, CLIN NUTR, V36, P1686, DOI 10.1016/j.clnu.2016.11.002
   Vlachojannis J, 2016, PHYTOTHER RES, V30, P1641, DOI 10.1002/ptr.5665
   Wisnuwardani RW, 2019, EUR J NUTR, V58, P2345, DOI 10.1007/s00394-018-1787-x
   Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743
   Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x
NR 57
TC 26
Z9 28
U1 1
U2 29
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD MAR
PY 2020
VL 59
IS 2
BP 801
EP 812
DI 10.1007/s00394-019-01946-1
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KS7LG
UT WOS:000518487600031
PM 30903362
DA 2025-04-28
ER

PT J
AU Jayawardena, R
   Sooriyaarachchi, P
   Ranasinghe, P
   Perera, A
   Hills, AP
AF Jayawardena, Ranil
   Sooriyaarachchi, Piumika
   Ranasinghe, Priyanga
   Perera, Amila
   Hills, Andrew P.
TI Availability and composition of weight-loss supplements in Sri Lanka
SO NUTRITION & DIETETICS
LA English
DT Article
DE dietary supplements; obesity; Sri Lanka; weight-loss products
ID GREEN TEA; HYDROXYCITRIC ACID; LOSS PRODUCTS; OBESITY; REDUCTION;
   SAFETY; MEDICATION; OVERWEIGHT; CATECHINS; EXTRACT
AB Aim The present study aims to investigate the composition and availability of weight-loss supplements in Sri Lanka and explore the evidence for their effectiveness.
   Methods Data were collected by visiting drug stores, searching the Internet for websites and referring to advertisements in national newspapers and magazines from August to October 2017.
   Results A total of 100 weight-loss products were identified of which the majority (n = 57) were available from drug stores. Most commonly, products were available in capsule form (36.0%). The number of active ingredients in products varied from 1 to a maximum of 22 with a total of 155 different active ingredients distinguished. The ingredients mainly originated from plants (77.4%) while green tea (Camellia sinensis), garcinia (Garcinia cambogia) and caffeine anhydrous were the three most common. At least one of the top 10 ingredients was included in 75 of the products sourced. Directions for use were specified in only 72 products, while a further 6 products lacked any information on ingredients. Literature predicted positive weight-loss effects for green tea and ginger while garcinia was reported for both positive and negative effects.
   Conclusions The ingredients are reported to have both beneficial and adverse effects. Many consumers may find it challenging to make informed purchase decisions as a number of products failed to provide adequate nutritional information and safety measures. Government regulatory authorities should pay closer attention to the availability and provision of products sold to the general public.
C1 [Jayawardena, Ranil] Univ Colombo, Fac Med, Dept Physiol, Colombo, Sri Lanka.
   [Jayawardena, Ranil; Sooriyaarachchi, Piumika] Univ Colombo, Fac Med, Dept Hlth & Wellness Unit, Colombo, Sri Lanka.
   [Ranasinghe, Priyanga] Univ Colombo, Fac Med, Dept Pharmacol, Colombo, Sri Lanka.
   [Perera, Amila] Med Res Inst, Dept Nutr, Colombo, Sri Lanka.
   [Hills, Andrew P.] Univ Tasmania, Coll Hlth & Med, Launceston, Tas, Australia.
C3 University of Colombo; University of Colombo; University of Colombo;
   Medical Research Institute Sri Lanka (MRI); University of Tasmania
RP Jayawardena, R (corresponding author), Univ Colombo, Fac Med, Dept Physiol, Colombo, Sri Lanka.
EM ranil@physiol.cmb.ac.lk
RI Ranasinghe, Priyanga/C-9772-2011; Hills, Andrew/ABE-6408-2020;
   Sooriyaarachchi, Piumika/IUP-0422-2023; Hills, Andrew/M-3199-2014;
   Jayawardena, Ranil/D-8693-2016
OI Hills, Andrew/0000-0002-7787-7201; Jayawardena,
   Ranil/0000-0002-7352-9365; Sooriyaarachchi, Piumika/0000-0001-9570-2344;
   Ranasinghe, Priyanga/0000-0002-1522-9276
CR [Anonymous], PROGR MED
   [Anonymous], 2014, GLOBAL EPIDEMIC OBES, DOI DOI 10.7243/2052-5966-2-2
   [Anonymous], 2009, INT J PHARM PRACT, DOI DOI 10.1211/ijpp/17.06.0003
   [Anonymous], 1999, Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity
   Blanck HM, 2001, JAMA-J AM MED ASSOC, V286, P930, DOI 10.1001/jama.286.8.930
   Campos P, 2006, INT J EPIDEMIOL, V35, P55, DOI 10.1093/ije/dyi254
   Cawley J, 2015, PHARMACOECONOMICS, V33, P707, DOI 10.1007/s40273-014-0230-2
   Christian JG, 2010, INT J OBESITY, V34, P207, DOI 10.1038/ijo.2009.213
   Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326
   Gamage P, 2007, ELECTRON LIBR, V25, P693, DOI 10.1108/02640470710837128
   Glandt M, 2011, J OBES, V2011, DOI 10.1155/2011/636181
   Heber D, 2003, PRIMARY CARE, V30, P441, DOI 10.1016/S0095-4543(03)00015-0
   Heymsfield SB, 1998, JAMA-J AM MED ASSOC, V280, P1596, DOI 10.1001/jama.280.18.1596
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Jayawardena R, 2015, ASIA-PAC J PUBLIC HE, V27
   Jordan MA, 2007, J ALTERN COMPLEM MED, V13, P1035, DOI 10.1089/acm.2007.7197
   Jurgens TM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008650.pub2
   Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13
   Katulanda P, 2010, OBES REV, V11, P751, DOI 10.1111/j.1467-789X.2010.00746.x
   Kaukua J, 2003, INT J OBESITY, V27, P1233, DOI 10.1038/sj.ijo.0802379
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kim JK, 2007, FREE RADICAL RES, V41, P603, DOI 10.1080/10715760701209896
   Lanka NMRAS, 2018, DEF BORD PROD ACC NM
   Low WY, 2015, INT J OCCUP MED ENV, V28, P20, DOI 10.2478/s13382-014-0326-0
   Maharlouei N, 2019, CRIT REV FOOD SCI, V59, P1753, DOI 10.1080/10408398.2018.1427044
   Márquez F, 2012, CRIT REV FOOD SCI, V52, P585, DOI 10.1080/10408398.2010.500551
   Metlay JP, 2005, J AM GERIATR SOC, V53, P976, DOI 10.1111/j.1532-5415.2005.53308.x
   Morris LA, 1997, MED CARE, V35, P996, DOI 10.1097/00005650-199710000-00002
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0553-2
   Patel D, 2015, METABOLISM, V64, P1376, DOI 10.1016/j.metabol.2015.08.001
   Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Sano M, 2001, ANALYST, V126, P816, DOI 10.1039/b102541b
   Sharpe PA, 2006, J AM DIET ASSOC, V106, P2045, DOI 10.1016/j.jada.2006.09.014
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Vermaak I, 2011, NAT PROD REP, V28, P1493, DOI 10.1039/c1np00035g
   Vitalone A, 2011, EUR J CLIN PHARMACOL, V67, P215, DOI 10.1007/s00228-010-0981-4
   Weidner MS, 2000, J ETHNOPHARMACOL, V73, P513, DOI 10.1016/S0378-8741(00)00340-8
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
NR 41
TC 7
Z9 7
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1446-6368
EI 1747-0080
J9 NUTR DIET
JI Nutr. Diet.
PD APR
PY 2020
VL 77
IS 2
BP 247
EP 252
DI 10.1111/1747-0080.12501
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KY5OT
UT WOS:000522619200010
PM 30515956
DA 2025-04-28
ER

PT J
AU Basora, J
   Villalobos, F
   Pallejà-Millán, M
   Babio, N
   Goday, A
   Zomeño, MD
   Pintó, X
   Sacanella, E
   Salas-Salvadó, J
AF Basora, Josep
   Villalobos, Felipe
   Palleja-Millan, Meritxell
   Babio, Nancy
   Goday, Albert
   Dolores Zomeno, Maria
   Pinto, Xavier
   Sacanella, Emilio
   Salas-Salvado, Jordi
TI Deprivation Index and Lifestyle: Baseline Cross-Sectional Analysis of
   the PREDIMED-Plus Catalonia Study
SO NUTRIENTS
LA English
DT Article
DE deprivation index; lifestyle; diet; physical activity
ID PHYSICAL-ACTIVITY QUESTIONNAIRE; MEDITERRANEAN DIET ADHERENCE;
   SOCIOECONOMIC DEPRIVATION; PATTERNS; HEALTH; ASSOCIATIONS; POPULATION;
   VALIDATION; INEQUALITIES; VALIDITY
AB This baseline cross-sectional analysis from data acquired in a sub-sample of the PREDIMED-Plus study participants aimed to evaluate the relation between the Composite Socioeconomic Index (CSI) and lifestyle (diet and physical activity). This study involved 1512 participants (759 (52.2%) women) between 55 and 80 years with overweight/obesity and metabolic syndrome assigned to 137 primary healthcare centers in Catalonia, Spain. CSI and lifestyle (diet and physical activity) were assessed. Multiple linear regression or multinomial regression were applied to the data. Cluster analysis was performed to identify dietary patterns. The multiple linear regression model showed that a high deprivation index was related to a higher consumption of refined cereals (11.98 g/d, p-value = 0.001) and potatoes (6.68 g/d, p-value = 0.001), and to a lower consumption of fruits (-17.52 g/d, p-value = 0.036), and coffee and tea (-8.03 g/d, p-value = 0.013). Two a posteriori dietary patterns were identified by cluster analysis and labeled as "healthy " and "unhealthy ". In addition, the multinomial regression model showed that a high deprivation index was related to an unhealthy dietary pattern and low physical activity (OR 1.42 [95% CI 1.06-1.89]; p-value < 0.05). In conclusion, a high deprivation index was related to an unhealthy lifestyle (diet and physical activity) in PREDIMED-Plus study participants.</p>
C1 [Basora, Josep] Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona 08007, Spain.
   [Basora, Josep; Babio, Nancy; Salas-Salvado, Jordi] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus 43201, Spain.
   [Basora, Josep; Babio, Nancy; Goday, Albert; Dolores Zomeno, Maria; Pinto, Xavier; Sacanella, Emilio; Salas-Salvado, Jordi] Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid 28029, Spain.
   [Villalobos, Felipe; Palleja-Millan, Meritxell] Fundacio Inst Univ Recerca Atencio Primaria Salut, Unitat Suport Recerca Tarragona Reus, Reus 43202, Spain.
   [Babio, Nancy; Salas-Salvado, Jordi] Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere & Virgili IISPV, Reus 43204, Spain.
   [Goday, Albert] Hosp Mar, Serv Endocrinol, Barcelona 08003, Spain.
   [Goday, Albert; Dolores Zomeno, Maria] Hosp Mar Med Res Inst IMIM, Cardiovasc Risk & Nutr Res Grp, Barcelona 08003, Spain.
   [Goday, Albert] Univ Autonoma Barcelona, Dept Med, Barcelona 08193, Spain.
   [Dolores Zomeno, Maria] Univ Ramon Llull, Nutr Humana & Dietet, Fac Ciencies Salut Blanquerna, Barcelona 08022, Spain.
   [Pinto, Xavier] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Internal Med, Lipid Unit, Lhospitalet De Llobregat 08908, Spain.
   [Sacanella, Emilio] Hosp Clin Barcelona, Dept Internal Med, Barcelona 08036, Spain.
   [Sacanella, Emilio] Univ Barcelona, Sch Med, Barcelona 08036, Spain.
C3 Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut
   d'Investigacio Sanitaria Pere Virgili (IISPV); Hospital del Mar Research
   Institute; Hospital del Mar; Hospital del Mar Research Institute;
   Hospital del Mar; Autonomous University of Barcelona; Universitat Ramon
   Llull; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL);
   Bellvitge University Hospital; University of Barcelona; Hospital Clinic
   de Barcelona; University of Barcelona
RP Basora, J (corresponding author), Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona 08007, Spain.; Basora, J; Babio, N (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Unitat Nutr Humana, Reus 43201, Spain.; Basora, J; Babio, N (corresponding author), Inst Salud Carlos III ISCIII, MP Fisiopatol Obesidad & Nutr CIBERObn, Consorcio CIBER, Madrid 28029, Spain.; Babio, N (corresponding author), Hosp Univ San Joan Reus, Inst Invest Sanitaria Pere & Virgili IISPV, Reus 43204, Spain.
EM jbasora@idiapjgol.org; fvillalobos@idiapjgol.info;
   mpalleja@idiapjgol.info; nancy.babio@urv.cat; agoday@parcdesalutmar.cat;
   mzomeno@imim.es; xpinto@bellvitgehospital.cat; esacane@clinic.cat;
   jordi.salas@urv.cat
RI Pintó, Xavier/AGI-4297-2022; Villalobos, Felipe/X-5457-2019; Babio,
   Nancy/AAN-2715-2020; Pallejà, Meritxell/AAB-2144-2021; Salas-Salvado,
   Jordi/C-7229-2017
OI Zomeno, M. Dolores/0000-0003-1280-7680; Villalobos,
   Felipe/0000-0002-6907-8354; BABIO SANCHEZ, NANCY/0000-0003-3527-5277;
   Salas-Salvado, Jordi/0000-0003-2700-7459; Pinto Sala,
   Xavier/0000-0002-2216-2444; Palleja, Meritxell/0000-0003-1985-8894;
   Basora, Josep/0000-0003-0278-1149
FU Strategic Plan of Research and Innovation in Health (PERIS) [P17/084];
   official Spanish Institutions for funding scientific biomedical
   research; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERObn);
   Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion para la
   Salud (FIS) [PI13/01123, PI17/00215, PI13/00233, PI13/02184, PI14/00728,
   PI16/01094, PI16/00501, PI16/00381, PI19/01226, P119/00017, PI19/00576,
   PI19/01032, PI20/00339]; Especial Action Project entitled Implementacion
   y evaluacion de una intervencion intensiva sobre la actividad fisica;
   European Research Council [340918]; Recercaixa [2013ACUP00194]; ICREA
FX Funding This work was supported by the 2017 call for proposals within
   the Strategic Plan of Research and Innovation in Health (PERIS) 20162020
   for Primary Care Research Projects from the Health Department of the
   Generalitat de Catalunya, with reference P17/084, and the official
   Spanish Institutions for funding scientific biomedical research, CIBER
   Fisiopatologia de la Obesidad y Nutricion (CIBERObn) and Instituto de
   Salud Carlos III (ISCIII), through the Fondo de Investigacion para la
   Salud (FIS), which is cofunded by the European Regional Development Fund
   (four coordinated FIS projects led by J.S.-S., including the following
   projects: PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI14/00728,
   PI16/01094, PI16/00501, PI16/00381, PI17/00215, PI19/01226, P119/00017,
   PI19/00576, PI19/01032 and PI20/00339), the Especial Action Project
   entitled Implementacion y evaluacion de una intervencion intensiva sobre
   la actividad fisica, Cohorte PREDIMED-Plus grant to J.S.-S.; the
   European Research Council (Advanced Research Grant 2014-2019; agreement
   #340918); the Recercaixa (number 2013ACUP00194) grant to J.S.-S. This
   work is partially supported by ICREA under the ICREA Academia program.
   None of the funding sources took part in the design, collection,
   analysis, interpretation of the data, or the writing of the report, or
   in the decision to submit the manuscript for publication.
CR Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8
   Algren MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139297
   Beaulac J, 2009, PREV CHRONIC DIS, V6
   Beck KL, 2018, EUR J NUTR, V57, P1421, DOI 10.1007/s00394-017-1421-3
   Black JL, 2008, NUTR REV, V66, P2, DOI 10.1111/j.1753-4887.2007.00001.x
   CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162
   Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006
   Chastin SFM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0292-3
   Ciprián D, 2013, NUTR HOSP, V28, P1741, DOI 10.3305/nh.2013.28.5.6758
   COCKERHAM WC, 1993, SOCIOL QUART, V34, P413, DOI 10.1111/j.1533-8525.1993.tb00119.x
   Colls C, 2020, GAC SANIT, V34, P44, DOI 10.1016/j.gaceta.2018.07.015
   Contoyannis P, 2004, J HEALTH ECON, V23, P965, DOI 10.1016/j.jhealeco.2004.02.001
   Darin-Mattsson A, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0670-3
   Ek S, 2015, HEALTH PROMOT INT, V30, P736, DOI 10.1093/heapro/dat063
   ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966
   Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011
   Fernández-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837
   Foster HME, 2018, LANCET PUBLIC HEALTH, V3, pE576, DOI 10.1016/S2468-2667(18)30200-7
   García-Altés A, 2018, J EPIDEMIOL COMMUN H, V72, P871, DOI 10.1136/jech-2018-210817
   Groth MV, 2001, EUR J CLIN NUTR, V55, P959, DOI 10.1038/sj.ejcn.1601251
   Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI [10.1016/S2214-109X(18)30357-7, 10.1016/s2214-109x(18)30357-7]
   Jones A, 2009, PREV MED, V49, P500, DOI 10.1016/j.ypmed.2009.10.012
   Kesse-Guyot E, 2009, EUR J CLIN NUTR, V63, P521, DOI 10.1038/sj.ejcn.1602978
   Kurotani K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092194
   Lachowycz K, 2014, SOC SCI MED, V107, P9, DOI 10.1016/j.socscimed.2014.02.023
   Lakshman R, 2011, J PUBLIC HEALTH-UK, V33, P234, DOI 10.1093/pubmed/fdq072
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519
   Maksimov S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010328
   Marques-Vidal P, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5045-1
   Martinez-Beneito MA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18115664
   Martínez-González MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745
   Martínez-González MA, 2019, INT J EPIDEMIOL, V48, P387, DOI 10.1093/ije/dyy225
   Martinez-Lacoba R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227620
   Mumme K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113425
   Northstone K, 2010, EUR J CLIN NUTR, V64, P978, DOI 10.1038/ejcn.2010.102
   Ochieng Bertha M N, 2006, Br J Community Nurs, V11, P78
   Papier K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111173
   Pérez-Tepayo S, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00568-2
   Sánchez-Villegas A, 2003, EUR J CLIN NUTR, V57, P285, DOI 10.1038/sj.ejcn.1601528
   Schröder H, 2021, CLIN NUTR, V40, P4971, DOI 10.1016/j.clnu.2021.06.030
   Schröder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566
   TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341
   van Lenthe FJ, 2005, SOC SCI MED, V60, P763, DOI 10.1016/j.socscimed.2004.06.013
   Wang J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020281
   Wardle J, 2004, ANN BEHAV MED, V27, P107, DOI 10.1207/s15324796abm2702_5
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
   Willett W.C., 2013, Nutritional Epidemiology
   Xiao Q, 2018, PREV MED, V111, P14, DOI 10.1016/j.ypmed.2018.02.011
NR 48
TC 7
Z9 8
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2021
VL 13
IS 10
AR 3408
DI 10.3390/nu13103408
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA WN0MO
UT WOS:000711471200001
PM 34684409
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Celec, P
   Behuliak, M
AF Celec, P.
   Behuliak, M.
TI Behavioural and endocrine effects of chronic cola intake
SO JOURNAL OF PSYCHOPHARMACOLOGY
LA English
DT Article
DE Coca cola; Kofola; oxidative stress; Pepsi cola; steroids
ID FORCED SWIMMING TEST; EXPLORATORY-BEHAVIOR; OXIDATIVE STRESS; CAFFEINE;
   MICE; BEVERAGES; RATS; ANXIETY
AB Consumption of cola beverages is very high worldwide. The health effects of cola intake are not clear, although epidemiological studies point toward associations with obesity, kidney diseases and osteoporosis. Experimental studies are surprisingly rare. In this study, we substituted drinking water of adult male Wistar rats with three different cola beverages for 3 months. Behavioural phenotyping, measurement of sex steroids in plasma and oxidative stress in testes were performed at the end of the study. A light-dark box showed increased locomotor activity and anxiety in all groups with cola intake. A subtle anti-depressive effect was seen in the forced swim test. Chronic cola intake increased both oestradiol and testosterone levels suggesting an additional mechanism of action beyond the known effects of caffeine on adenosine receptors.
C1 [Celec, P.] Comenius Univ, Dept Mol Biol, Inst Mol Biomed, Bratislava 81108, Slovakia.
   [Celec, P.; Behuliak, M.] Comenius Univ, Inst Pathophysiol, Bratislava 81108, Slovakia.
C3 Comenius University Bratislava; Comenius University Bratislava
RP Celec, P (corresponding author), Comenius Univ, Dept Mol Biol, Inst Mol Biomed, Sasinkova 4, Bratislava 81108, Slovakia.
EM petercelec@gmail.com
RI Behuliak, Michal/B-7166-2012; Celec, Peter/I-7103-2012
OI Celec, Peter/0000-0001-5883-3580; Behuliak, Michal/0000-0003-2266-7829
CR Abrams JK, 2005, NEUROSCIENCE, V133, P983, DOI 10.1016/j.neuroscience.2005.03.025
   Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838
   Chou KH, 2007, J FOOD SCI, V72, pC337, DOI 10.1111/j.1750-3841.2007.00414.x
   CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2
   El-Seweidy MM, 2008, J PHARM PHARMACOL, V60, P1237, DOI 10.1211/jpp.60.9.0017
   Enríquez-Castillo A, 2008, PHYSIOL BEHAV, V94, P501, DOI 10.1016/j.physbeh.2008.03.004
   Ettarh RR, 2000, PHARM BIOL, V38, P281, DOI 10.1076/1388-0209(200009)3841-AFT281
   Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975
   Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965
   Hascoët M, 1998, PHARMACOL BIOCHEM BE, V60, P645, DOI 10.1016/S0091-3057(98)00031-8
   Iivonen S, 2006, NEUROSCIENCE, V137, P1143, DOI 10.1016/j.neuroscience.2005.10.023
   Kaur P, 2004, J BIOMED SCI, V11, P391, DOI 10.1159/000077108
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   Pena A, 2005, FOOD ADDIT CONTAM, V22, P91, DOI 10.1080/02652030500037886
   POLLARD I, 1988, J ENDOCRINOL, V119, P275, DOI 10.1677/joe.0.1190275
   PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8
   Vieira C, 2008, NEUROSCI LETT, V445, P170, DOI 10.1016/j.neulet.2008.09.001
NR 18
TC 15
Z9 18
U1 0
U2 30
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0269-8811
J9 J PSYCHOPHARMACOL
JI J. Psychopharmacol.
PD OCT
PY 2010
VL 24
IS 10
BP 1569
EP 1572
DI 10.1177/0269881109105401
PG 4
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 662PA
UT WOS:000282822500018
PM 19423611
DA 2025-04-28
ER

PT J
AU Sanchis-Gomar, F
   Lavie, CJ
   Lippi, G
AF Sanchis-Gomar, Fabian
   Lavie, Carl J.
   Lippi, Giuseppe
TI Strict regulations on energy drinks to protect Minors' health in Europe
   - It is never too late to set things right at home
SO PREVENTIVE MEDICINE
LA English
DT Article
DE Energy drinks; Minors; Health risks; Caffeine; Psychoactive; Stimulant
   effects
AB The consumption of energy drinks poses significant risks to minors' health, and strict regulations are urgently needed to protect them. The high caffeine, high sugar, and high caloric content of energy drinks have drawn concern from health professionals. The consumption of energy drinks has been linked to unhealthy dietary behaviors, obesity, and mental health problems in adolescents. The psychoactive and stimulant effects of energy drinks are particularly worrisome, and the marketing of these drinks on social media platforms is also a cause for alarm. In light of these concerns, we strongly recommend policy measures, such as restrictions on the sale of energy drinks to minors, to prevent their health risks. The evidence clearly suggests that energy drinks pose significant risks to minors' health and well-being, and regulatory standards must be implemented without further delay.
C1 [Sanchis-Gomar, Fabian] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.
   [Lavie, Carl J.] Univ Queensland, Sch Med, John Ochsner Heart & Vasc Inst, Ochsner Clin Sch, New Orleans, LA USA.
   [Lippi, Giuseppe] Univ Verona, Sch Med, Sect Clin Biochem, Verona, Italy.
   [Sanchis-Gomar, Fabian] Stanford Univ, Dept Med, Med Ctr, Div Cardiovasc Med Cardiac Electrophysiol & Arrhyt, 453 Quarry Rd MC 5687, Stanford, CA 94304 USA.
C3 Stanford University; Ochsner Health System; University of Queensland;
   University of Verona; Stanford University
RP Sanchis-Gomar, F (corresponding author), Stanford Univ, Dept Med, Med Ctr, Div Cardiovasc Med Cardiac Electrophysiol & Arrhyt, 453 Quarry Rd MC 5687, Stanford, CA 94304 USA.
EM fabian.sanchis@uv.es
RI Lavie, Carl/AEW-0639-2022; Lippi, Giuseppe/X-7198-2018; Sanchis-Gomar,
   Fabian/R-4045-2019
OI Sanchis-Gomar, Fabian/0000-0003-0424-4208
CR Ayalde J, 2023, J ADOLESCENT HEALTH, V72, P633, DOI 10.1016/j.jadohealth.2022.10.025
   Cao DX, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.679105
   Caruso J, 2023, HEALTH PROMOT J AUST, V34, P100, DOI 10.1002/hpja.655
   Milazzo NA, 2021, MIL MED, V186, pE143, DOI 10.1093/milmed/usaa362
   Nuss T, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00719-z
   Oberhoffer FS, 2023, PEDIATR RES, V94, P1172, DOI 10.1038/s41390-023-02598-y
   Puupponen M, 2023, BMC PUBLIC HEALTH, V23, DOI 10.1186/s12889-023-15055-6
   Puupponen M, 2021, INT J PUBLIC HEALTH, V66, DOI 10.3389/ijph.2021.620268
   Sanchis-Gomar F, 2015, CAN J CARDIOL, V31, P572, DOI 10.1016/j.cjca.2014.12.019
NR 10
TC 3
Z9 3
U1 5
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-7435
EI 1096-0260
J9 PREV MED
JI Prev. Med.
PD MAR
PY 2024
VL 180
AR 107889
DI 10.1016/j.ypmed.2024.107889
EA FEB 2024
PG 2
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA KU0V0
UT WOS:001182368500001
PM 38325607
DA 2025-04-28
ER

PT J
AU Khalifa, I
   Zhu, W
   Li, KK
   Li, CM
AF Khalifa, Ibrahim
   Zhu, Wei
   Li, Kai-kai
   Li, Chun-mei
TI Polyphenols of mulberry fruits as multifaceted compounds: Compositions,
   metabolism, health benefits, and stability-A structural review
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Health benefits; Metabolism; Mulberry fruit; Polyphenols; Stability
ID MORUS-ALBA-L.; HIGH-PRESSURE HOMOGENIZATION; RADICAL-SCAVENGING
   ACTIVITY; HIGH HYDROSTATIC-PRESSURE; ANTIOXIDANT ACTIVITY; IN-VITRO;
   NIGRA L.; CHEMICAL-COMPOSITION; INHIBITORY-ACTIVITIES;
   PHENOLIC-COMPOUNDS
AB Mulberry (Moms sp.) fruits provide high levels of anthocyanins, quercetin glycoside, and chlorogenic acid. Recently, mulberry's polyphenols and their functionalities are spotlighted in different ex vivo and in vivo studies. Meanwhile, the deficiency of systematic knowledge on the health effects and polyphenols composition greatly hinders the development of mulberry as a sustainable fruit. This review briefly summarises the polyphenol compositions, metabolism, health benefits, and their stability in different mulberry production steps. These claimed health effects include anti-oxidative, anti-cancer, anti-diabetes, anti-obesity, and other related effects. However, although the current evidence is promising, further clinical studies are needed to evaluate the role of mulberries' polyphenols to support human health. Besides, the mechanisms by which they confer the health benefits, the bioavailability studies on mulberry's polyphenols are also scarce. We compile the research findings from the available literatures within the last two decades, and we also suggest some future perspectives in this review.
C1 [Khalifa, Ibrahim; Zhu, Wei; Li, Kai-kai; Li, Chun-mei] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan 430070, Hubei, Peoples R China.
   [Li, Chun-mei] Huazhong Agr Univ, Minist Educ China, Key Lab Environm Correlat Food Sci, Wuhan, Hubei, Peoples R China.
   [Khalifa, Ibrahim] Benha Univ, Fac Agr, Food Technol Dept, Moshtohor 13736, Egypt.
C3 Huazhong Agricultural University; Huazhong Agricultural University;
   Egyptian Knowledge Bank (EKB); Benha University
RP Li, CM (corresponding author), Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan 430070, Hubei, Peoples R China.
EM lichmyl@mail.hzau.edu.cn
RI Li, Kaikai/JZE-4530-2024; Khalifa, Ibrahim/H-8916-2019; Zhu,
   Wei/AFK-0930-2022
OI Zhu, Wei/0000-0002-7957-7843; Khalifa, Ibrahim/0000-0002-7648-2961
FU National Natural Science Foundation of China [31571839]; Chinese
   Scholarships Council Foundation [2016GXZ745]
FX The authors gratefully acknowledge for the National Natural Science
   Foundation of China (No. 31571839) and the financial support from the
   Chinese Scholarships Council Foundation (No. 2016GXZ745).
CR Akin M., 2016, ACTA SCI POLONORUM H, V15
   [Anonymous], 2013, PLOS ONE
   Bae SH, 2007, LWT-FOOD SCI TECHNOL, V40, P955, DOI 10.1016/j.lwt.2006.06.007
   Bao T, 2016, J FUNCT FOODS, V25, P537, DOI 10.1016/j.jff.2016.07.001
   BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309
   BOUTIN JA, 1993, DRUG METAB DISPOS, V21, P1157
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
   Buchanan CJ, 1996, J SCI FOOD AGR, V71, P459, DOI 10.1002/(SICI)1097-0010(199608)71:4<459::AID-JSFA602>3.0.CO;2-H
   Butkhup L, 2013, INT J FOOD SCI TECH, V48, P934, DOI 10.1111/ijfs.12044
   Calín-Sánchez A, 2013, PLANT FOOD HUM NUTR, V68, P370, DOI 10.1007/s11130-013-0382-9
   Cavalcanti RN, 2011, FOOD RES INT, V44, P499, DOI 10.1016/j.foodres.2010.12.007
   Chen CC, 2005, FOOD CHEM, V91, P601, DOI 10.1016/j.foodchem.2004.06.039
   Chen HJ, 2016, SCI HORTIC-AMSTERDAM, V213, P186, DOI 10.1016/j.scienta.2016.10.036
   Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033
   Chen QQ, 2017, LWT-FOOD SCI TECHNOL, V80, P178, DOI 10.1016/j.lwt.2017.02.017
   Cheng JR, 2016, FOOD CHEM, V213, P721, DOI 10.1016/j.foodchem.2016.07.032
   Choi KH, 2016, J MED FOOD, V19, P737, DOI 10.1089/jmf.2016.3665
   Chon SU, 2009, EUR FOOD RES TECHNOL, V230, P231, DOI 10.1007/s00217-009-1165-2
   Donno D, 2015, FOOD RES INT, V69, P179, DOI 10.1016/j.foodres.2014.12.020
   Du Q, 2008, J FOOD COMPOS ANAL, V21, P390, DOI 10.1016/j.jfca.2008.02.007
   Engmann FN, 2015, J FOOD PROCESS PRES, V39, P854, DOI 10.1111/jfpp.12296
   Engmann FN, 2014, J SCI FOOD AGR, V94, P2345, DOI 10.1002/jsfa.6612
   Ercisli S., 2010, FOOD TECHNOLOGY BIOT, V48
   Ercisli S, 2008, SCI HORTIC-AMSTERDAM, V116, P41, DOI 10.1016/j.scienta.2007.10.021
   Ercisli S, 2007, FOOD CHEM, V103, P1380, DOI 10.1016/j.foodchem.2006.10.054
   Eyduran S. P., 2015, FOOD TECHNOLOGY BIOT, V88
   Fazaeli M, 2013, FOOD BIOPROCESS TECH, V6, P585, DOI 10.1007/s11947-011-0648-x
   Fazaeli M, 2012, INT J FOOD ENG, V8, DOI 10.1515/1556-3758.2023
   Gerasopoulos D, 1997, J SCI FOOD AGR, V73, P261, DOI 10.1002/(SICI)1097-0010(199702)73:2<261::AID-JSFA724>3.3.CO;2-J
   Gu PS, 2017, J NUTR BIOCHEM, V39, P15, DOI 10.1016/j.jnutbio.2016.08.014
   Gundogdu M, 2011, SCI HORTIC-AMSTERDAM, V132, P37, DOI 10.1016/j.scienta.2011.09.035
   Halvorsen BL, 2002, J NUTR, V132, P461, DOI 10.1093/jn/132.3.461
   Hassimotto NMA, 2008, NUTR RES, V28, P198, DOI 10.1016/j.nutres.2007.12.012
   Hassimotto NMA, 2005, J AGR FOOD CHEM, V53, P2928, DOI 10.1021/jf047894h
   He H, 2013, J AGR FOOD CHEM, V61, P8110, DOI 10.1021/jf4019323
   Hojjatpanah G, 2011, INT J FOOD SCI TECH, V46, P956, DOI 10.1111/j.1365-2621.2011.02573.x
   HOLLMAN PCH, 1995, AM J CLIN NUTR, V62, P1276, DOI 10.1093/ajcn/62.6.1276
   Hsieh YS, 2007, J AGR FOOD CHEM, V55, P10437, DOI 10.1021/jf071868c
   Hsu LS, 2012, FOOD CHEM TOXICOL, V50, P3086, DOI 10.1016/j.fct.2012.05.055
   Huang HP, 2011, FOOD CHEM, V129, P1703, DOI 10.1016/j.foodchem.2011.06.035
   Huo Y., 2002, FAO Animal Prod. Health Paper, V147, P11
   Imran M, 2010, J ZHEJIANG UNIV-SC B, V11, P973, DOI 10.1631/jzus.B1000173
   Isabelile M, 2008, J AGR FOOD CHEM, V56, P9410, DOI 10.1021/jf801527a
   Iturralde M, 2005, APOPTOSIS, V10, P1369, DOI 10.1007/s10495-005-1511-1
   Jeong JC, 2010, NUTR CANCER, V62, P402, DOI 10.1080/01635580903441287
   Jiang DQ, 2013, FOOD CHEM TOXICOL, V59, P1, DOI 10.1016/j.fct.2013.05.023
   Jiang Y, 2015, FOOD CHEM, V174, P460, DOI 10.1016/j.foodchem.2014.11.083
   Jin Q, 2015, J FOOD SCI, V80, pC2440, DOI 10.1111/1750-3841.13099
   Kang TH, 2006, NEUROSCI LETT, V391, P122, DOI 10.1016/j.neulet.2005.08.053
   Kang WY, 2011, MED CHEM RES, V20, P809, DOI 10.1007/s00044-010-9391-5
   Kawamori R, 2009, LANCET, V373, P1607, DOI 10.1016/S0140-6736(09)60222-1
   Kim AJ, 2006, J MED FOOD, V9, P431, DOI 10.1089/jmf.2006.9.431
   Kim HG, 2010, BRIT J NUTR, V104, P8, DOI 10.1017/S0007114510000218
   이정애, 2011, Culinary Science & Hospitality Research, V17, P285, DOI 10.20878/cshr.2011.17.4.020
   Lee JS, 2013, INT IMMUNOPHARMACOL, V17, P858, DOI 10.1016/j.intimp.2013.09.019
   Lee Joonhee, 2009, Preventive Nutrition and Food Science, V14, P188
   Lee JY, 2004, FOOD SCI BIOTECHNOL, V13, P176
   Lee KM, 2016, FOOD SCI BIOTECHNOL, V25, P1035, DOI 10.1007/s10068-016-0167-7
   Li FH, 2016, FOOD BIOPROCESS TECH, V9, P1233, DOI 10.1007/s11947-016-1715-0
   Li J, 2014, BIOL PLANTARUM, V58, P618, DOI 10.1007/s10535-014-0450-5
   Liang LH, 2012, PHARMACOGN MAG, V8, P215, DOI 10.4103/0973-1296.99287
   Liang LH, 2012, FOOD RES INT, V46, P76, DOI 10.1016/j.foodres.2011.11.024
   Lin JY, 2007, FOOD CHEM, V101, P140, DOI 10.1016/j.foodchem.2006.01.014
   Liu LK, 2008, J FOOD SCI, V73, pH113, DOI 10.1111/j.1750-3841.2008.00801.x
   Liu LK, 2009, J AGR FOOD CHEM, V57, P7605, DOI 10.1021/jf9014697
   Liu XM, 2004, J BIOMED BIOTECHNOL, P326, DOI 10.1155/S1110724304403052
   Lucia K, 2016, J BERRY RES, V6, P333, DOI 10.3233/JBR-160141
   Marinova EM, 2009, FOOD CHEM, V114, P1498, DOI 10.1016/j.foodchem.2008.11.045
   Medina-Torres L, 2013, LWT-FOOD SCI TECHNOL, V50, P642, DOI 10.1016/j.lwt.2012.07.038
   Memon A.A., 2010, Polish J. Food Nutr. Sci, V60
   Mena P., 2016, FOOD RES
   Minhas MA, 2016, PAK J ZOOL, V48, P1381
   Moser P, 2017, FOOD CHEM, V214, P308, DOI 10.1016/j.foodchem.2016.07.081
   Natic MM, 2015, FOOD CHEM, V171, P128, DOI 10.1016/j.foodchem.2014.08.101
   Nikkhah E., 2007, Journal of Biological Sciences, V7, P1412
   Oki T, 2006, J FOOD SCI, V71, pC18, DOI 10.1111/j.1365-2621.2006.tb12382.x
   Özgen M, 2009, SCI HORTIC-AMSTERDAM, V119, P275, DOI 10.1016/j.scienta.2008.08.007
   Pawlowska AM, 2008, J AGR FOOD CHEM, V56, P3377, DOI 10.1021/jf703709r
   Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508
   Pérez-Gregorio MR, 2011, LWT-FOOD SCI TECHNOL, V44, P1793, DOI 10.1016/j.lwt.2011.03.007
   Qian ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17348
   Qin CG, 2010, CZECH J FOOD SCI, V28, P117, DOI 10.17221/228/2008-CJFS
   Radojkovic MM, 2012, HEM IND, V66, P545, DOI 10.2298/HEMIND111111002R
   Sakagami H, 2007, IN VIVO, V21, P499
   Sánchez-Salcedo EM, 2015, J FUNCT FOODS, V12, P399, DOI 10.1016/j.jff.2014.12.010
   Sarikaphuti A, 2013, EXP THER MED, V6, P689, DOI 10.3892/etm.2013.1203
   Sato D, 2014, BIOSCI BIOTECH BIOCH, V78, P1123, DOI 10.1080/09168451.2014.921551
   Sengül M, 2005, FOOD CONTROL, V16, P73, DOI 10.1016/j.foodcont.2003.11.010
   Shih PH, 2010, J NUTR BIOCHEM, V21, P598, DOI 10.1016/j.jnutbio.2009.03.008
   Singh KP., 1997, INDIAN DRUGS, V34, P488
   Singhal Brij Kishore, 2010, Journal of Fruit and Ornamental Plant Research, V18, P83
   Song N, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/150617
   Song W, 2009, J AGR FOOD CHEM, V57, P9133, DOI 10.1021/jf9022228
   Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z
   Suh HJ, 2003, NAHRUNG, V47, P132, DOI 10.1002/food.200390024
   Tan J, 1999, BRAIN RES BULL, V50, P143, DOI 10.1016/S0361-9230(99)00122-7
   [唐翠明 TANG CuiMing], 2008, [蚕业科学, Acta Sericologica Sinica], V34, P24
   Targhi RG, 2017, RADIAT PHYS CHEM, V130, P297, DOI 10.1016/j.radphyschem.2016.08.030
   Tomas M., 2016, J SCI FOOD AGR
   Tomas M, 2015, FOOD CHEM, V186, P277, DOI 10.1016/j.foodchem.2014.11.151
   Toydemir G, 2013, J FUNCT FOODS, V5, P1402, DOI 10.1016/j.jff.2013.05.008
   Trivellini A, 2016, IND CROP PROD, V83, P241, DOI 10.1016/j.indcrop.2015.12.039
   Tsujimoto Y., 2007, J BIOCH
   Valentino L, 1984, CLSU CENTRAL LUZON S
   Veberic R, 2015, LWT-FOOD SCI TECHNOL, V60, P509, DOI 10.1016/j.lwt.2014.08.033
   Wang F., 2016, FOOD SCI TECHNOLOGY
   Wang H, 1997, J AGR FOOD CHEM, V45, P304, DOI 10.1021/jf960421t
   Wang RJ, 2011, INT J FOOD PROP, V14, P1, DOI 10.1080/10942910903580900
   Wu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077585
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
   Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w
   Yamamoto J, 2006, PLATELETS, V17, P555, DOI 10.1080/09537100600759295
   Yan FJ, 2016, FOOD FUNCT, V7, P425, DOI 10.1039/c5fo00841g
   Yan JJ, 2004, BIOL PHARM BULL, V27, P2024, DOI 10.1248/bpb.27.2024
   Yang XL, 2010, FOOD CHEM TOXICOL, V48, P2374, DOI 10.1016/j.fct.2010.05.074
   You YL, 2015, FOOD FUNCT, V6, P401, DOI 10.1039/c4fo00719k
   Yu YS, 2016, J FOOD SCI, V81, pM702, DOI 10.1111/1750-3841.13213
   Yu YS, 2014, FOOD CHEM, V153, P114, DOI 10.1016/j.foodchem.2013.12.038
   Zadernowski R, 2005, J AGR FOOD CHEM, V53, P2118, DOI 10.1021/jf040411p
   Zhang W, 2008, J FOOD SCI, V73, pC512, DOI 10.1111/j.1750-3841.2008.00854.x
   Zhao Y., 2007, BERRY FRUIT VALUE AD
   Zou H, 2016, FOOD BIOPROCESS TECH, V9, P217, DOI 10.1007/s11947-015-1606-9
NR 123
TC 108
Z9 119
U1 12
U2 220
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN
PY 2018
VL 40
BP 28
EP 43
DI 10.1016/j.jff.2017.10.041
PG 16
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GA0LW
UT WOS:000428005500004
DA 2025-04-28
ER

PT J
AU Zheng, MB
   Sui, ZX
   Li, ZR
   Rangan, A
AF Zheng, Miaobing
   Sui, Zhixian
   Li, Zhangrong
   Rangan, Anna
TI A modeling study of beverage substitution and obesity outcomes among
   Australian adults
SO NUTRITION
LA English
DT Article
DE Sugar-sweetened beverage; Substitution; Obesity; Waist circumference
ID SUGAR-SWEETENED BEVERAGES; CARDIOMETABOLIC RISK-FACTORS; SOFT DRINK
   CONSUMPTION; MIDDLE-AGED ADULTS; ENERGY-INTAKE; WEIGHT-GAIN; METABOLIC
   SYNDROME; BODY-WEIGHT; WATER; CHILDREN
AB Objective: The aim of this study was to investigate the cross-sectional associations among sugar sweetened beverage (SSB) consumption, its substitution with beverage alternatives, and obesity outcomes in an Australian population.
   Methods: We used data from 9341 adults ages >= 19 y from the 2011-2012 Australian National Nutrition and Physical Activity Survey. Multivariate linear regression with adjustment for covariates was used to examine the associations between SSB consumption and body mass index (BMI) and waist circumference (WC). Substitution modeling was used to simulate the effect of replacing SSB with water, coffee/tea, fruit juice, and milk.
   Results: SSB intake (100 g/d) was associated with higher BMI (beta = 0.06 kg/m(2); P = 0.001) and WC (beta = 0.19 cm; P < 0.001). A linear trend with BMI and WC also was seen when SSB intake was examined as categories of servings per day (P-trend <= 0.001). Replacing SSB with water, coffee/tea, or milk was inversely associated with BMI (beta= -0.07 to -0.09 kg/m(2); P < 0.001) and WC (beta= -0.25 to -0.28 cm; P < 0.001).
   Conclusions: The results of the present study suggested that SSB intake is associated with obesity and that coffee/tea, water, and milk may be good alternatives for SSB. Further longitudinal and intervention studies are warranted to examine the effects of beverage substitution on obesity. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Zheng, Miaobing; Sui, Zhixian; Li, Zhangrong; Rangan, Anna] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW, Australia.
C3 University of Sydney
RP Zheng, MB (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW, Australia.
EM Miaobing.zheng@sydney.edu.au
RI Rangan, Anna/AFS-4449-2022
OI Rangan, Anna/0000-0003-1815-844X
CR Ambrosini GL, 2013, AM J CLIN NUTR, V98, P327, DOI 10.3945/ajcn.112.051383
   [Anonymous], 2011, The Global Health Observatory
   Australian Bureau of Statistics, 2013, Australian Health Survey: Users' Guide, 2011-13
   Australian Institute of Health and Welfare (AIHW), 2014, AIHW AUSTR HLTH SER, V14
   Bachman CM, 2006, NUTR REV, V64, P153, DOI 10.1301/nr.2006.apr.153-174
   Bes-Rastrollo M, 2006, AM J CLIN NUTR, V83, P362
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Boggs DA, 2013, ETHNIC DIS, V23, P445
   Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085
   Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437
   Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240
   Dennis EA, 2009, EAT BEHAV, V10, P237, DOI 10.1016/j.eatbeh.2009.07.006
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Dougkas A, 2011, NUTR RES REV, V24, P72, DOI 10.1017/S095442241000034X
   Drewnowski A, 2007, AM J CLIN NUTR, V85, P651, DOI 10.1093/ajcn/85.3.651
   Duffey KJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070395
   Funtikova AN, 2015, J NUTR, V145, P328, DOI 10.3945/jn.114.205229
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396
   Kaikkonen JE, 2015, SCAND J CLIN LAB INV, V75, P133, DOI 10.3109/00365513.2014.992945
   Kvaavik E, 2005, PUBLIC HEALTH NUTR, V8, P149, DOI 10.1079/PHN2004669
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Mattei J, 2012, J NUTR, V142, P1081, DOI 10.3945/jn.111.149344
   Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492
   Muckelbauer R, 2013, AM J CLIN NUTR, V98, P282, DOI 10.3945/ajcn.112.055061
   Pan A, 2013, INT J OBESITY, V37, P1378, DOI 10.1038/ijo.2012.225
   Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Stookey JD, 2008, OBESITY, V16, P2481, DOI 10.1038/oby.2008.409
   Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278
   Thomson JL, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.7304
   Thomson JL, 2011, FASEB J, V25
   Wang YC, 2009, ARCH PEDIAT ADOL MED, V163, P336, DOI 10.1001/archpediatrics.2009.23
   Wijlens AGM, 2012, OBESITY, V20, P2226, DOI 10.1038/oby.2012.131
   Willett WC, 2013, NUTR EPIDEMIOLOGY
   Zheng M, 2015, J HUM NUTR DIET, V28, P70, DOI 10.1111/jhn.12223
   Zheng M, 2014, EUR J CLIN NUTR, V68, P77, DOI 10.1038/ejcn.2013.243
   Zheng M, 2015, ASS SUGAR SWEETENED
   Zheng MB, 2015, BRIT J NUTR, V114, P1448, DOI 10.1017/S0007114515002974
   Zheng MB, 2015, J ACAD NUTR DIET, V115, P767, DOI 10.1016/j.jand.2015.01.006
NR 41
TC 3
Z9 4
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD JUL-AUG
PY 2017
VL 39-40
BP 71
EP 75
DI 10.1016/j.nut.2017.03.010
PG 5
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EY6JE
UT WOS:000404087900011
PM 28606573
DA 2025-04-28
ER

PT J
AU Kadar, NNMA
   Ahmad, F
   Teoh, SL
   Yahaya, MF
AF Muhammad Abdul Kadar, Nellysha Namela
   Ahmad, Fairus
   Teoh, Seong Lin
   Yahaya, Mohamad Fairuz
TI Caffeic Acid on Metabolic Syndrome: A Review
SO MOLECULES
LA English
DT Review
DE caffeic acid; metabolic syndrome; phenolic compound; obesity;
   dyslipidemia; hyperglycemia; hypertension
ID OXIDATIVE STRESS; PHENETHYL ESTER; ANTIOXIDANT PROPERTIES;
   PHENOLIC-ACIDS; INSULIN-RESISTANCE; CHLOROGENIC ACID; ELLAGIC ACID;
   IN-VITRO; PROPOLIS; MICE
AB Metabolic syndrome (MetS) is a constellation of risk factors that may lead to a more sinister disease. Raised blood pressure, dyslipidemia in the form of elevated triglycerides and lowered high-density lipoprotein cholesterol, raised fasting glucose, and central obesity are the risk factors that could lead to full-blown diabetes, heart disease, and many others. With increasing sedentary lifestyles, coupled with the current COVID-19 pandemic, the numbers of people affected with MetS will be expected to grow in the coming years. While keeping these factors checked with the polypharmacy available currently, there is no single strategy that can halt or minimize the effect of MetS to patients. This opens the door for a more natural way of controlling the disease. Caffeic acid (CA) is a phytonutrient belonging to the flavonoids that can be found in abundance in plants, fruits, and vegetables. CA possesses a wide range of beneficial properties from antioxidant, immunomodulatory, antimicrobial, neuroprotective, antianxiolytic, antiproliferative, and anti-inflammatory activities. This review discusses the current discovery of the effect of CA against MetS.
C1 [Muhammad Abdul Kadar, Nellysha Namela; Ahmad, Fairus; Teoh, Seong Lin; Yahaya, Mohamad Fairuz] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Anat, Kuala Lumpur 56000, Malaysia.
   [Muhammad Abdul Kadar, Nellysha Namela] Univ Malaysia Sabah, Fac Med & Hlth Sci, Dept Biomed Sci & Therapeut, Kota Kinabalu 88400, Sabah, Malaysia.
C3 Universiti Kebangsaan Malaysia; Universiti Malaysia Sabah
RP Yahaya, MF (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Anat, Kuala Lumpur 56000, Malaysia.
EM nellysha.namela@ums.edu.my; fairusahmad@ukm.edu.my;
   teohseonglin@ukm.edu.my; mfairuzy@ukm.edu.my
RI Yahaya, Mohamad/K-7614-2019; Teoh, Seong Lin/P-3950-2017
OI Teoh, Seong Lin/0000-0001-9733-8072; Ahmad, Fairus/0000-0002-2452-6459;
   Yahaya, Mohamad Fairuz/0000-0001-7155-2636
FU PPUKM Fundamental Grant [FF-2019-014]
FX This research was funded by PPUKM Fundamental Grant, grant number
   FF-2019-014.
CR Agunloye OM, 2018, J FOOD BIOCHEM, V42, DOI 10.1111/jfbc.12604
   Agunloye OM, 2018, J FOOD BIOCHEM, V42, DOI 10.1111/jfbc.12541
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Ando K, 2009, FREE RADICAL BIO MED, V47, P213, DOI 10.1016/j.freeradbiomed.2009.04.030
   Armutcu F, 2015, EXP THER MED, V9, P1582, DOI 10.3892/etm.2015.2346
   Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q
   Bhullar KS, 2014, EUR J PHARMACOL, V730, P125, DOI 10.1016/j.ejphar.2014.02.038
   Bocco BM, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20155003
   Boulangé CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Chait A, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00022
   Chao CY, 2010, MOL NUTR FOOD RES, V54, P388, DOI 10.1002/mnfr.200900087
   Choudhary S, 2016, INFLAMMOPHARMACOLOGY, V24, P347, DOI 10.1007/s10787-016-0287-y
   Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024
   Dantas M. B., 2018, African Journal of Pharmacy and Pharmacology, V12, P263, DOI 10.5897/ajpp2018.4937
   Dueñas M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/850902
   Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3
   Eid HM, 2017, PHARM BIOL, V55, P2026, DOI 10.1080/13880209.2017.1345952
   El-Denshary E.-E.-D.S., 2015, INT J SCI RES PUBL, V5, P1
   Engin AB, 2017, ADV EXP MED BIOL, V960, P327, DOI 10.1007/978-3-319-48382-5_14
   Etchegoyen M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00196
   Feldman F, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020672
   Feng Y, 2020, NUTR DIABETES, V10, DOI 10.1038/s41387-020-0107-8
   Filipe HAL, 2018, FREE RADICAL BIO MED, V115, P215, DOI 10.1016/j.freeradbiomed.2017.12.002
   Freeman A.M., 2021, STATPEARLS
   Göçer H, 2011, INT J FOOD SCI NUTR, V62, P821, DOI 10.3109/09637486.2011.585963
   Gonna H, 2019, DIABETES OBES METAB, V21, P6, DOI 10.1111/dom.13691
   Gülçin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011
   Gun A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3419479
   Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120
   Hashim KN, 2021, MOLECULES, V26, DOI 10.3390/molecules26040808
   Hassan NA, 2014, CHEM-BIOL INTERACT, V213, P28, DOI 10.1016/j.cbi.2014.01.019
   Honecker J, 2021, INT J OBESITY, V45, P2108, DOI 10.1038/s41366-021-00883-6
   Ibitoye OB, 2018, ARCH PHYSIOL BIOCHEM, V124, P410, DOI 10.1080/13813455.2017.1415938
   Jayarathne Shasika, 2017, Prev Nutr Food Sci, V22, P251
   Jensen MD, 2020, ENDOCRIN METAB CLIN, V49, P229, DOI 10.1016/j.ecl.2020.02.002
   Jimenez V, 2021, DEV PSYCHOBIOL, V63, DOI 10.1002/dev.22127
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Kasprzak-Drozd K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073715
   Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48
   Kassim M, 2010, NUTR RES, V30, P650, DOI 10.1016/j.nutres.2010.08.008
   Kepa M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7413504
   Kim HM, 2018, NUTRITION, V55-56, P63, DOI 10.1016/j.nut.2018.03.010
   Kim YH, 2014, J EXERC REHABIL, V10, P209, DOI 10.12965/jer.140145
   Koga M, 2019, TISSUE CELL, V60, P14, DOI 10.1016/j.tice.2019.07.006
   Kolgazi M, 2021, CHEM-BIOL INTERACT, V334, DOI 10.1016/j.cbi.2020.109351
   Korac B, 2021, REDOX BIOL, V42, DOI 10.1016/j.redox.2021.101887
   Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750
   Kumar SR, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/9752826
   Lee DH, 2014, J ATHEROSCLER THROMB, V21, P23
   Leonard W, 2021, COMPR REV FOOD SCI F, V20, P710, DOI 10.1111/1541-4337.12663
   Li AX, 2022, HEART FAIL REV, V27, P1387, DOI 10.1007/s10741-021-10109-6
   Li PG, 2005, HYPERTENS RES, V28, P369, DOI 10.1291/hypres.28.369
   Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942
   Lu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13824
   Manaf MRA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87248-1
   Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058
   Martinez-Ferran M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061549
   Matboli M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02320-z
   Mendoza MF, 2020, CURR OPIN CARDIOL, V35, P389, DOI 10.1097/HCO.0000000000000749
   Monserrat-Mesquida M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030236
   Mu HN, 2021, FOOD RES INT, V143, DOI 10.1016/j.foodres.2021.110240
   Nam GS, 2018, BIOTECHNOL BIOPROC E, V23, P641, DOI 10.1007/s12257-018-0424-0
   Nie JR, 2017, J AGR FOOD CHEM, V65, P9041, DOI 10.1021/acs.jafc.7b02880
   Nolan CJ, 2015, DIABETES, V64, P673, DOI 10.2337/db14-0694
   Oboh G, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13384
   Orsolic N, 2021, MOLECULES, V26, DOI 10.3390/molecules26113262
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Pappan N., 2021, StatPearls
   Parekh PJ, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00047
   Pereira P, 2006, BASIC CLIN PHARMACOL, V99, P374, DOI 10.1111/j.1742-7843.2006.pto_533.x
   Piazzon A, 2012, J AGR FOOD CHEM, V60, P12312, DOI 10.1021/jf304076z
   Poplawski J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69866-3
   Putteeraj M, 2018, CURR DRUG TARGETS, V19, P1710, DOI 10.2174/1389450119666180326125252
   Quinn KJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.167
   Ramli NZ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16244987
   Ranasinghe P, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4041-1
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Saibabu V, 2015, ADV PHARMACOL SCI, V2015, DOI 10.1155/2015/823539
   Salmas RE, 2017, CELL BIOCHEM FUNCT, V35, P304, DOI 10.1002/cbf.3277
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Shin EJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123055
   Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3
   Surikow S., 2019, HEART LUNG CIRC, V28, pS132, DOI [10.1016/j.hlc.2019.06.004, DOI 10.1016/J.HLC.2019.06.004]
   Taher M.A., 2015, IRAQI J PHARM SCI, V24, P18
   Touyz RM, 2020, CAN J CARDIOL, V36, P659, DOI 10.1016/j.cjca.2020.02.081
   Vanella L, 2016, PPAR RES, V2016, DOI 10.1155/2016/7359521
   Castro MFV, 2021, LIFE SCI, V277, DOI 10.1016/j.lfs.2021.119421
   Vinayagam R, 2016, PHYTOTHER RES, V30, P184, DOI 10.1002/ptr.5528
   Weng YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/984780
   Wu H, 2021, J HYPERTENS, V39, pE248
   Xu J, 2020, J FUNCT FOODS, V74, DOI 10.1016/j.jff.2020.104061
   Xu WG, 2020, TROP J PHARM RES, V19, P1227, DOI 10.4314/tjpr.v19i6.17
   Zhang Z, 2016, ONCOTARGET, V7, P31790, DOI 10.18632/oncotarget.9306
NR 94
TC 73
Z9 73
U1 5
U2 50
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD SEP
PY 2021
VL 26
IS 18
AR 5490
DI 10.3390/molecules26185490
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA UZ1FR
UT WOS:000701958200001
PM 34576959
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Furrer, AN
   Chegeni, M
   Ferruzzi, MG
AF Furrer, Amber N.
   Chegeni, Mohammad
   Ferruzzi, Mario G.
TI Impact of potato processing on nutrients, phytochemicals, and human
   health
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Potatoes; nutritional quality; processing; phytochemicals
ID SOLANUM-TUBEROSUM L.; FLESHED SWEET-POTATO; IN-VITRO BIOACCESSIBILITY;
   GLYCEMIC LOAD VALUES; RESISTANT STARCH; BETA-CAROTENE;
   PHENOLIC-COMPOUNDS; CHLOROGENIC ACID; ACRYLAMIDE FORMATION;
   IPOMOEA-BATATAS
AB Potatoes (Solanum tuberosum) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition, food security and disease prevention to issues of overnutrition including obesity, diabetes, heart disease. Processed potato products are typically categorized as high fat and sodium foods, as well as being classified as a significant source of carbohydrate, in the form of starch. Conversely, potato products are less known for their contribution of key micronutrients (vitamin C, potassium, magnesium), fiber, and phytochemicals (phenolics and carotenoids). More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes. This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in-home and common commercial processing on nutritional quality and potential impacts on human health.
C1 [Furrer, Amber N.; Chegeni, Mohammad] Purdue Univ, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA.
   [Ferruzzi, Mario G.] North Carolina State Univ, Plants Human Hlth Inst, Laureate Way, Kannapolis, NC 28081 USA.
C3 Purdue University System; Purdue University; North Carolina State
   University
RP Ferruzzi, MG (corresponding author), North Carolina State Univ, Plants Human Hlth Inst, 600 Laureate Way, Kannapolis, NC 28081 USA.
EM mferruz@ncsu.edu
OI Ferruzzi, Mario/0000-0003-1384-2672
FU PepsiCo Global RD
FX This manuscript was supported, in part, by an unrestricted grant from
   PepsiCo Global R&D. The views expressed in this manuscript are those of
   the author(s) and do not necessarily reflect the position or policy of
   PepsiCo Inc. Dr. Mario G. Ferruzzi is an advisory board member of the
   Alliance for Potato Research and Education.
CR Aguilera JM, 2000, J FOOD SCI, V65, P476, DOI 10.1111/j.1365-2621.2000.tb16031.x
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Amrein TM, 2003, J AGR FOOD CHEM, V51, P5556, DOI 10.1021/jf034344v
   Andre CM, 2007, J AGR FOOD CHEM, V55, P10839, DOI 10.1021/jf0726583
   Andre CM, 2007, J AGR FOOD CHEM, V55, P366, DOI 10.1021/jf062740i
   Andrikopoulos NK, 2002, INT J FOOD SCI NUTR, V53, P351, DOI 10.1080/09637480220138098
   [Anonymous], National Accuracy Clearinghouse (NAC) Evaluation: Final Report
   Antolovich M, 2000, ANALYST, V125, P989, DOI 10.1039/b000080i
   Arvanitoyannis IS, 2008, CRIT REV FOOD SCI, V48, P799, DOI 10.1080/10408390701691059
   Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239
   AUGUSTIN J, 1975, J FOOD SCI, V40, P1295, DOI 10.1111/j.1365-2621.1975.tb01076.x
   AUGUSTIN J, 1978, AM POTATO J, V55, P653, DOI 10.1007/BF02852138
   Barros F, 2012, J AGR FOOD CHEM, V60, P11609, DOI 10.1021/jf3034539
   Bassaganya-Riera J, 2011, J NUTR, V141, P1318, DOI 10.3945/jn.111.139022
   Beecher GR, 2003, J NUTR, V133, p3248S
   Bengtsson A, 2009, J AGR FOOD CHEM, V57, P9693, DOI 10.1021/jf901692r
   Berger KG, 2005, J AM OIL CHEM SOC, V82, P775, DOI 10.1007/s11746-005-1143-9
   Berni P, 2015, PLANT FOOD HUM NUTR, V70, P1, DOI 10.1007/s11130-014-0458-1
   Bertoft E, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, P83, DOI 10.1016/B978-0-12-374349-7.00004-0
   Blessington T, 2010, AM J POTATO RES, V87, P479, DOI 10.1007/s12230-010-9150-7
   Bogani P, 2007, ATHEROSCLEROSIS, V190, P181, DOI 10.1016/j.atherosclerosis.2006.01.011
   Bond J., 2013, VGS353 US DEP AGR
   Bordenave N, 2014, FOOD FUNCT, V5, P18, DOI 10.1039/c3fo60263j
   Bouchon P, 2003, J FOOD SCI, V68, P2711, DOI 10.1111/j.1365-2621.2003.tb05793.x
   Bouchon P, 2009, ADV FOOD NUTR RES, V57, P209, DOI 10.1016/S1043-4526(09)57005-2
   Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7
   Bradshaw JE, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, P1, DOI 10.1016/B978-0-12-374349-7.00001-5
   Bradshaw JE, 2010, HANDB PLANT BREED, V7, P1, DOI 10.1007/978-0-387-92765-7_1
   Bradshaw John E., 2007, P157
   BRAND JC, 1985, AM J CLIN NUTR, V42, P1192, DOI 10.1093/ajcn/42.6.1192
   Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368
   Breithaupt DE, 2002, J AGR FOOD CHEM, V50, P7175, DOI 10.1021/jf0257953
   Brierley ER, 1996, J SCI FOOD AGR, V70, P515, DOI 10.1002/(SICI)1097-0010(199604)70:4<515::AID-JSFA529>3.0.CO;2-P
   Brown C., 2005, P WASH STAT POT C MO
   Brown CR, 2005, AM J POTATO RES, V82, P163, DOI 10.1007/BF02853654
   Brown CR, 2003, AM J POTATO RES, V80, P241, DOI 10.1007/BF02855360
   Burgos G, 2013, PLANT FOOD HUM NUTR, V68, P385, DOI 10.1007/s11130-013-0381-x
   Burton W. G., 1989, The potato, V3rd ed, P286
   BUSHWAY RJ, 1987, AM POTATO J, V64, P409, DOI 10.1007/BF02853703
   Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996
   Chen YY, 2013, J NUTR SCI VITAMINOL, V59, P272, DOI 10.3177/jnsv.59.272
   Chun J, 2006, J FOOD COMPOS ANAL, V19, P196, DOI 10.1016/j.jfca.2005.08.001
   Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176
   Cohen R, 2011, J AGR FOOD CHEM, V59, P7932, DOI 10.1021/jf2013277
   Cotton PA, 2004, J AM DIET ASSOC, V104, P921, DOI 10.1016/j.jada.2004.03.019
   Crowell EF, 2008, TRANSGENIC RES, V17, P205, DOI 10.1007/s11248-007-9091-1
   Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a
   Dale MFB, 2003, J AGR FOOD CHEM, V51, P244, DOI 10.1021/jf020547s
   Daniel DR, 2005, J AM DIET ASSOC, V105, P1927, DOI 10.1016/j.jada.2005.09.029
   DAO L, 1992, J AGR FOOD CHEM, V40, P2152, DOI 10.1021/jf00023a022
   De Wilde T, 2005, J AGR FOOD CHEM, V53, P6550, DOI 10.1021/jf050650s
   Decker EA, 2013, ADV NUTR, V4, p345S, DOI 10.3945/an.112.003574
   Del Rio D, 2010, BRIT J NUTR, V104, pS67, DOI 10.1017/S0007114510003958
   DESBOROUGH SL, 1981, QUAL PLANT, V31, P11, DOI 10.1007/BF01093884
   DESHPANDE SS, 1982, J FOOD SCI, V47, P2080, DOI 10.1111/j.1365-2621.1982.tb12956.x
   Deusser H, 2012, FOOD CHEM, V135, P2814, DOI 10.1016/j.foodchem.2012.07.028
   Dietary Guidelines Advisory Committee, 2010, SCI REP DIET GUID AD
   Dilworth LL, 2007, BIOMETALS, V20, P37, DOI 10.1007/s10534-006-9012-4
   Dörmann P, 2007, PLANTA, V225, P269, DOI 10.1007/s00425-006-0438-2
   Donado-Pestana CM, 2012, PLANT FOOD HUM NUTR, V67, P262, DOI 10.1007/s11130-012-0298-9
   Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016
   DuPont Andrew W, 2011, Nat Rev Gastroenterol Hepatol, V8, P523, DOI 10.1038/nrgastro.2011.133
   Eichhorn S, 2005, FOOD RES INT, V38, P943, DOI 10.1016/j.foodres.2005.03.011
   Ek KL, 2012, FOOD CHEM, V133, P1230, DOI 10.1016/j.foodchem.2011.09.004
   ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33
   ENGLYST HN, 1987, AM J CLIN NUTR, V45, P423, DOI 10.1093/ajcn/45.2.423
   Erdmann J, 2007, EUR J NUTR, V46, P196, DOI 10.1007/s00394-007-0649-8
   Ereifej KI, 1998, J FOOD SCI TECH MYS, V35, P55
   Erk T, 2012, MOL NUTR FOOD RES, V56, P1488, DOI 10.1002/mnfr.201200222
   Ezekiel R, 2013, FOOD RES INT, V50, P487, DOI 10.1016/j.foodres.2011.04.025
   Failla ML, 2014, FOOD FUNCT, V5, P1101, DOI 10.1039/c3fo60599j
   Failla ML, 2009, J AGR FOOD CHEM, V57, P10922, DOI 10.1021/jf900415g
   Falk J, 2010, J EXP BOT, V61, P1549, DOI 10.1093/jxb/erq030
   Fan MZ, 2012, J ANIM SCI, V90, P278, DOI 10.2527/jas.54006
   FAO Trade and Markets Division, 2008, INT YEAR POT EC INT
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farhoosh R, 2008, JAOCS, V86, P71
   Faria A., 2013, Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes, P2465
   Farrell TL, 2013, BIOFACTORS, V39, P448, DOI 10.1002/biof.1090
   Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192
   Fernandes G, 2005, J AM DIET ASSOC, V105, P557, DOI 10.1016/j.jada.2005.01.003
   Fillion L, 1998, INT J FOOD SCI NUTR, V49, P157, DOI 10.3109/09637489809089395
   Food and Agriculture Organization of the United Nations, 2008, INT YEAR POT POT WOR
   Food and Agriculture Organization of the United Nations, 2008, INT YEAR POT POT
   Foot RJ, 2007, FOOD ADDIT CONTAM A, V24, P37, DOI 10.1080/02652030701439543
   Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5
   Friedman M, 1997, CRIT REV PLANT SCI, V16, P55, DOI 10.1080/713608144
   Friedman M, 2008, J AGR FOOD CHEM, V56, P6113, DOI 10.1021/jf0730486
   Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t
   Frossard E, 2000, J SCI FOOD AGR, V80, P861, DOI 10.1002/(SICI)1097-0010(20000515)80:7<861::AID-JSFA601>3.0.CO;2-P
   Gahlawat P, 1998, PLANT FOOD HUM NUTR, V52, P151, DOI 10.1023/A:1008045023304
   GALLIARD T, 1973, J SCI FOOD AGR, V24, P617, DOI 10.1002/jsfa.2740240515
   Garcia M. A., 2002, Innovative Food Science & Emerging Technologies, V3, P391, DOI 10.1016/S1466-8564(02)00050-4
   García-Alonso A, 2000, NAHRUNG, V44, P19, DOI 10.1002/(SICI)1521-3803(20000101)44:1<19::AID-FOOD19>3.3.CO;2-5
   Garrett DA, 2000, J NUTR BIOCHEM, V11, P574, DOI 10.1016/S0955-2863(00)00122-4
   Ghosh D, 2007, ASIA PAC J CLIN NUTR, V16, P200
   Giusti MM, 1996, J FOOD SCI, V61, P688, DOI 10.1111/j.1365-2621.1996.tb12182.x
   Giusti MM, 2003, BIOCHEM ENG J, V14, P217, DOI 10.1016/S1369-703X(02)00221-8
   Golaszewska B., 2001, POLISH J FOOD NUTR S, V10/51, P59
   Goltz S.R., 2013, Carotenoids and Human Health, Nutrition and Health, P111
   Goni I, 1997, FOOD CHEM, V59, P269, DOI 10.1016/S0308-8146(96)00275-0
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   GORDON MH, 1995, J SCI FOOD AGR, V68, P347, DOI 10.1002/jsfa.2740680314
   Govindakrishan PM., 2006, Handbook of potato production, improvement, and postharvestmanagement, P179
   Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002
   Halton TL, 2006, AM J CLIN NUTR, V83, P284
   Han JS, 2004, J AGR FOOD CHEM, V52, P6516, DOI 10.1021/jf0493270
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Harada K, 2004, BIOSCI BIOTECH BIOCH, V68, P1500, DOI 10.1271/bbb.68.1500
   He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754
   Hoover R, 2001, CARBOHYD POLYM, V45, P253, DOI 10.1016/S0144-8617(00)00260-5
   Huang CJ, 2000, J NUTR, V130, P534, DOI 10.1093/jn/130.3.534
   Huo T, 2007, J AGR FOOD CHEM, V55, P8950, DOI 10.1021/jf071687a
   Iablokov V, 2010, DIGEST DIS SCI, V55, P3078, DOI 10.1007/s10620-010-1158-9
   Im HW, 2008, J AGR FOOD CHEM, V56, P3341, DOI 10.1021/jf073476b
   Institute of Medicine (US), 2005, PAN MICR DIET REF IN
   Jansen G, 2006, GENET RESOUR CROP EV, V53, P1321, DOI 10.1007/s10722-005-3880-2
   Jansky S, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, P27, DOI 10.1016/B978-0-12-374349-7.00002-7
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362
   Jiao J, 2015, INT J FOOD SCI NUTR, V66, P114, DOI 10.3109/09637486.2014.959898
   Kanan W., 1998, Indian Journal of Physiology and Pharmacology, V42, P81
   Kärenlampi SO, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, P99, DOI 10.1016/B978-0-12-374349-7.00005-2
   Kaspar KL, 2011, J NUTR, V141, P108, DOI 10.3945/jn.110.128074
   Katan MB, 2006, ATHEROSCLEROSIS SUPP, V7, P63, DOI 10.1016/j.atherosclerosissup.2006.04.013
   Kean EG, 2008, J AGR FOOD CHEM, V56, P9918, DOI 10.1021/jf8018613
   Keijbets MJH, 2008, POTATO RES, V51, P271, DOI 10.1007/s11540-008-9104-3
   KELLER C, 1990, Mitteilungen aus dem Gebiete der Lebensmitteluntersuchung und Hygiene, V81, P68
   Kenny OM, 2013, LIFE SCI, V92, P775, DOI 10.1016/j.lfs.2013.02.006
   KEUKENS EAJ, 1992, BIOCHIM BIOPHYS ACTA, V1110, P127, DOI 10.1016/0005-2736(92)90349-Q
   KHANBARI OS, 1993, POTATO RES, V36, P359, DOI 10.1007/BF02361803
   Khosravi-Boroujeni H, 2012, INT J FOOD SCI NUTR, V63, P913, DOI 10.3109/09637486.2012.690024
   King JC, 2013, ADV NUTR, V4, p393S, DOI 10.3945/an.112.003525
   Kirkman Michael A., 2007, P27
   KOLASA KM, 1993, AM POTATO J, V70, P375, DOI 10.1007/BF02849118
   Kondo Y, 2014, J AGR FOOD CHEM, V62, P9286, DOI 10.1021/jf502587j
   Kondo Y, 2012, BRIT J NUTR, V107, P885, DOI 10.1017/S0007114511003643
   Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x
   Kurilich AC, 2005, J AGR FOOD CHEM, V53, P6537, DOI 10.1021/jf050570o
   Lachman J, 2005, PLANT SOIL ENVIRON, V51, P477, DOI 10.17221/3620-PSE
   Lachman J, 2013, FOOD CHEM, V138, P1189, DOI 10.1016/j.foodchem.2012.11.114
   Le Blay GM, 2003, J APPL MICROBIOL, V94, P312, DOI 10.1046/j.1365-2672.2003.01836.x
   Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d
   Lee SJ, 2014, FOOD CHEM TOXICOL, V63, P53, DOI 10.1016/j.fct.2013.10.040
   Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2
   Leeman AM, 2005, J SCI FOOD AGR, V85, P751, DOI 10.1002/jsfa.2035
   Leo L, 2008, J AGR FOOD CHEM, V56, P4154, DOI 10.1021/jf073322w
   Lewis CE, 1998, J SCI FOOD AGR, V77, P45, DOI 10.1002/(SICI)1097-0010(199805)77:1<45::AID-JSFA1>3.0.CO;2-S
   LINNEMANN AR, 1985, POTATO RES, V28, P271, DOI 10.1007/BF02357581
   Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517
   Lloyd BJ, 2004, J FOOD PROCESS PRES, V28, P460, DOI 10.1111/j.1745-4549.2004.23075.x
   Love SL, 2004, HORTSCIENCE, V39, P156, DOI 10.21273/HORTSCI.39.1.156
   LUNETTA M, 1995, DIABETES NUTR METAB, V8, P49
   Mäder J, 2009, J AGR FOOD CHEM, V57, P6292, DOI 10.1021/jf901066k
   Maiani G, 2009, MOL NUTR FOOD RES, V53, pS194, DOI 10.1002/mnfr.200800053
   Man YBC, 1999, J FOOD LIPIDS, V6, P181, DOI 10.1111/j.1745-4522.1999.tb00142.x
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Manach C, 2005, CURR OPIN LIPIDOL, V16, P77, DOI 10.1097/00041433-200502000-00013
   Martinez-Puig D, 2003, J NUTR, V133, P134, DOI 10.1093/jn/133.1.134
   Matthäus B, 2006, EUR J LIPID SCI TECH, V108, P200, DOI 10.1002/ejlt.200500249
   Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007
   MAZZA G, 1983, CAN I FOOD SC TECH J, V16, P39, DOI 10.1016/S0315-5463(83)72017-1
   McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092
   McGill CR, 2013, ANN MED, V45, P467, DOI 10.3109/07853890.2013.813633
   Mehta U, 2001, CRIT REV FOOD SCI, V41, P133, DOI 10.1080/20014091091788
   Mellema M, 2003, TRENDS FOOD SCI TECH, V14, P364, DOI 10.1016/S0924-2244(03)00050-5
   Mendez CDV, 2004, J AGR FOOD CHEM, V52, P1323, DOI 10.1021/jf0345595
   Mercier C., 2013, Polysaccharides in Food, P153
   Miller PE, 2010, NUTR CANCER, V62, P413, DOI 10.1080/01635580903407114
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Mills JP, 2009, J NUTR, V139, P44, DOI 10.3945/jn.108.098947
   Miranda L, 2013, FOOD FUNCT, V4, P1595, DOI 10.1039/c3fo60194c
   Miranda ML, 2006, FOOD REV INT, V22, P173, DOI 10.1080/87559120600574584
   Monro J, 2009, J FOOD COMPOS ANAL, V22, P539, DOI 10.1016/j.jfca.2008.11.008
   Monteleone E, 1997, APPETITE, V28, P255, DOI 10.1006/appe.1996.0081
   Morales F, 2008, ANN NY ACAD SCI, V1126, P89, DOI 10.1196/annals.1433.051
   Mori K, 2015, BREEDING SCI, V65, P3, DOI 10.1270/jsbbs.65.3
   Muttucumaru N, 2008, J AGR FOOD CHEM, V56, P6167, DOI 10.1021/jf800279d
   Navarre DA, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, P395
   Navarre DA, 2013, PLANT PHYSIOL BIOCH, V65, P89, DOI 10.1016/j.plaphy.2013.01.007
   Navarre DA, 2011, FOOD CHEM, V127, P34, DOI 10.1016/j.foodchem.2010.12.080
   Navarre DA, 2010, AM J POTATO RES, V87, P350, DOI 10.1007/s12230-010-9141-8
   Nayak B, 2014, FOOD RES INT, V56, P35, DOI 10.1016/j.foodres.2013.12.020
   Neilson AP, 2010, J AGR FOOD CHEM, V58, P6685, DOI 10.1021/jf1005353
   Noda T, 2008, FOOD CHEM, V110, P465, DOI 10.1016/j.foodchem.2008.02.027
   Nugent AP, 2005, NUTR BULL, V30, P27, DOI 10.1111/j.1467-3010.2005.00481.x
   O'Connor CJ, 2001, J FOOD SCI, V66, P903, DOI 10.1111/j.1365-2621.2001.tb15194.x
   Oakes ME, 2004, APPETITE, V42, P273, DOI 10.1016/j.appet.2003.10.004
   Oki T, 2006, BIOSCI BIOTECH BIOCH, V70, P2540, DOI 10.1271/bbb.60187
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Papathanasiou F, 1998, POTATO RES, V41, P117, DOI 10.1007/BF02358434
   Payyavula RS, 2015, PLANT BIOTECHNOL J, V13, P551, DOI 10.1111/pbi.12280
   Payyavula RS, 2013, J AGR FOOD CHEM, V61, P7357, DOI 10.1021/jf401522k
   Pedreschi F, 2008, J FOOD ENG, V87, P200, DOI 10.1016/j.jfoodeng.2007.11.031
   Pedreschi F, 2014, J SCI FOOD AGR, V94, P9, DOI 10.1002/jsfa.6349
   Peters CM, 2010, FOOD RES INT, V43, P95, DOI 10.1016/j.foodres.2009.08.016
   Raigond P, 2015, J SCI FOOD AGR, V95, P1968, DOI 10.1002/jsfa.6966
   Ramdath DD, 2014, FOOD FUNCT, V5, P909, DOI 10.1039/c3fo60395d
   Reboul E, 2006, J AGR FOOD CHEM, V54, P8749, DOI 10.1021/jf061818s
   Reddivari L, 2007, AM J POTATO RES, V84, P275, DOI 10.1007/BF02986239
   Reyes LF, 2004, AM J POTATO RES, V81, P187, DOI 10.1007/BF02871748
   Robert L, 2006, EUR J NUTR, V45, P267, DOI 10.1007/s00394-006-0594-y
   Robert L, 2008, J AM COLL NUTR, V27, P109, DOI 10.1080/07315724.2008.10719682
   Rodriguez-Saona LE, 1998, J FOOD SCI, V63, P458, DOI 10.1111/j.1365-2621.1998.tb15764.x
   Rommens CM, 2006, J AGR FOOD CHEM, V54, P9882, DOI 10.1021/jf062477l
   Rommens CM, 2008, PLANT BIOTECHNOL J, V6, P843, DOI 10.1111/j.1467-7652.2008.00363.x
   Rossi M, 2007, FOOD CHEM, V102, P812, DOI 10.1016/j.foodchem.2006.06.016
   Ruiz GM, 1999, J AM OIL CHEM SOC, V76, P421, DOI 10.1007/s11746-999-0019-1
   Rusinovci I, 2012, ACTA HORTIC, V960, P289, DOI 10.17660/ActaHortic.2012.960.41
   RYAN GB, 1977, AM J PATHOL, V86, P183
   Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x
   Salaman R.N., 1926, Potato Varieties
   Schramm DD, 2003, LIFE SCI, V73, P857, DOI 10.1016/S0024-3205(03)00373-4
   SHALLENBERGER RS, 1959, J AGR FOOD CHEM, V7, P274, DOI 10.1021/jf60098a010
   Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084
   Shikany JM, 2000, SOUTH MED J, V93, P1138, DOI 10.1097/00007611-200093120-00001
   Singh J, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, P273, DOI 10.1016/B978-0-12-374349-7.00010-6
   Slavin JL, 2013, ADV NUTR, V4, p351S, DOI 10.3945/an.112.003491
   Soh NL, 1999, EUR J CLIN NUTR, V53, P249, DOI 10.1038/sj.ejcn.1600713
   Sowokinos JR, 2001, AM J POTATO RES, V78, P221, DOI 10.1007/BF02883548
   SPYCHALLA JP, 1990, PLANT PHYSIOL, V94, P1214, DOI 10.1104/pp.94.3.1214
   Stalmach A, 2014, FOOD FUNCT, V5, P1727, DOI [10.1039/c4fo00316k, 10.1039/C4FO00316K]
   STOCKIGT J, 1974, FEBS LETT, V42, P131, DOI 10.1016/0014-5793(74)80769-6
   Storey ML, 2013, ADV NUTR, V4, p335S, DOI 10.3945/an.112.003541
   Storey Michael, 2007, P441, DOI 10.1016/B978-044451018-1/50063-4
   Stubenitsky K, 2000, BRIT J NUTR, V83, P277, DOI 10.1017/S0007114500000350
   Suda I, 2002, J AGR FOOD CHEM, V50, P1672, DOI 10.1021/jf011162x
   Tahvonen R, 2006, J FOOD COMPOS ANAL, V19, P372, DOI 10.1016/j.jfca.2005.10.008
   Tarazona-Díaz MP, 2013, FOOD SCI TECHNOL INT, V19, P439, DOI 10.1177/1082013212455346
   Tareke E, 2000, CHEM RES TOXICOL, V13, P517, DOI 10.1021/tx9901938
   THED ST, 1995, FOOD CHEM, V52, P301, DOI 10.1016/0308-8146(95)92828-8
   THOMPSON LU, 1984, AM J CLIN NUTR, V39, P745, DOI 10.1093/ajcn/39.5.745
   TOMA RB, 1979, J FOOD SCI, V44, P1403, DOI 10.1111/j.1365-2621.1979.tb06448.x
   TRUE RH, 1979, AM POTATO J, V56, P339, DOI 10.1007/BF02853849
   Tudela JA, 2002, POSTHARVEST BIOL TEC, V26, P75, DOI 10.1016/S0925-5214(02)00002-9
   Tudela JA, 2002, J AGR FOOD CHEM, V50, P5925, DOI 10.1021/jf020330y
   U.S. Department of Agriculture Agricultural Research Service, 2014, USDA NAT NUTR DAT ST
   U. S. Food and Drug Administration, 2015, 00141 US FDA
   United States Department of Agriculture, 2015, WHAT COUNTS CUP VEG
   United States Potato Board, 2007, CHIP STOCK POT
   United States Potato Board, 2007, TABL STOCK POT
   USDA Economic Research Service, 2014, USDA EC RES SERV POT
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881
   Veitch NC, 2008, NAT PROD REP, V25, P555, DOI 10.1039/b718040n
   Vinha AF, 2015, FOOD FUNCT, V6, P1157, DOI [10.1039/C4FO01209G, 10.1039/c4fo01209g]
   Vitaglione P, 2015, AM J CLIN NUTR, V101, P251, DOI 10.3945/ajcn.114.088120
   Vreugdenhil D., 2007, POTATO BIOL BIOTECHN, DOI DOI 10.1016/B978-044451018-1/50048-8
   Wang DJ, 2013, J SCI FOOD AGR, V93, P276, DOI 10.1002/jsfa.5753
   Watada A. E., 1955, American Potato Journal, V32, P132, DOI 10.1007/BF02851208
   Watanabe K, 2015, BREEDING SCI, V65, P53, DOI 10.1270/jsbbs.65.53
   White PJ, 2009, HORTSCIENCE, V44, P6, DOI 10.21273/HORTSCI.44.1.6
   WILSON AM, 1981, J FOOD SCI, V46, P300, DOI 10.1111/j.1365-2621.1981.tb14589.x
   Wszelaki AL, 2005, J SCI FOOD AGR, V85, P720, DOI 10.1002/jsfa.2051
   Xu XY, 2009, J AGR FOOD CHEM, V57, P10231, DOI 10.1021/jf902532q
   Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002
   Zaheer K, 2016, CRIT REV FOOD SCI, V56, P711, DOI 10.1080/10408398.2012.724479
   Zhang Y, 2007, CRIT REV FOOD SCI, V47, P521, DOI 10.1080/10408390600920070
   Zhu F, 2010, J SCI FOOD AGR, V90, P2254, DOI 10.1002/jsfa.4079
NR 260
TC 76
Z9 83
U1 8
U2 123
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PY 2018
VL 58
IS 1
BP 146
EP 168
DI 10.1080/10408398.2016.1139542
PG 23
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA FY5WF
UT WOS:000426907600009
PM 26852789
DA 2025-04-28
ER

PT J
AU Pfinder, M
   Heise, TL
   Boon, MH
   Pega, F
   Fenton, C
   Griebler, U
   Gartlehner, G
   Sommer, I
   Katikireddi, SV
   Lhachimi, SK
AF Pfinder, Manuela
   Heise, Thomas L.
   Boon, Michele Hilton
   Pega, Frank
   Fenton, Candida
   Griebler, Ursula
   Gartlehner, Gerald
   Sommer, Isolde
   Katikireddi, Srinivasa Vittal
   Lhachimi, Stefan K.
TI Taxation of unprocessed sugar or sugar-added foods for reducing their
   consumption and preventing obesity or other adverse health outcomes
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
AB Background
   Global prevalence of overweight and obesity are alarming. For tackling this public health problem, preventive public health and policy actions are urgently needed. Some countries implemented food taxes in the past and some were subsequently abolished. Some countries, such as Norway, Hungary, Denmark, Bermuda, Dominica, St. Vincent and the Grenadines, and the Navajo Nation (USA), specifically implemented taxes on unprocessed sugar and sugar-added foods. These taxes on unprocessed sugar and sugar-added foods are fiscal policy interventions, implemented to decrease their consumption and in turn reduce adverse health-related, economic and social effects associated with these food products.
   Objectives
   To assess the effects of taxation of unprocessed sugar or sugar-added foods in the general population on the consumption of unprocessed sugar or sugar-added foods, the prevalence and incidence of overweight and obesity, and the prevalence and incidence of other diet-related health outcomes.
   Search methods
   We searched CENTRAL, Cochrane Database of Systematic Reviews, MEDLINE, Embase and 15 other databases and trials registers on 12 September 2019. We handsearched the reference list of all records of included studies, searched websites of international organisations and institutions, and contacted review advisory group members to identify planned, ongoing or unpublished studies.
   Selection criteria
   We included studies with the following populations: children (0 to 17 years) and adults (18 years or older) from any country and setting. Exclusion applied to studies with specific subgroups, such as people with any disease who were overweight or obese as a side-effect of the disease. The review included studies with taxes on or artificial increases of selling prices for unprocessed sugar or food products that contain added sugar (e.g. sweets, ice cream, confectionery, and bakery products), or both, as intervention, regardless of the taxation level or price increase. In line with Cochrane Effective Practice and Organisation of Care (EPOC) criteria, we included randomised controlled trials (RCTs), cluster-randomised controlled trials (cRCTs), non-randomised controlled trials (nRCTs), controlled before-after (CBA) studies, and interrupted time series (ITS) studies. We included controlled studies with more than one intervention or control site and ITS studies with a clearly defined intervention time and at least three data points before and three after the intervention. Our primary outcomes were consumption of unprocessed sugar or sugar-added foods, energy intake, overweight, and obesity. Our secondary outcomes were substitution and diet, expenditure, demand, and other health outcomes.
   Data collection and analysis
   Two review authors independently screened all eligible records for inclusion, assessed the risk of bias, and performed data extraction.Two review authors independently assessed the certainty of the evidence using the GRADE approach.
   Main results
   We retrieved a total of 24,454 records. After deduplicating records, 18,767 records remained for title and abstract screeni ng. Of 11 potentially relevant studies, we included one ITS study with 40,210 household-level observations from the Hungarian Household Budget and Living Conditions Survey. The baseline ranged from January 2008 to August 2011, the intervention was implemented on September 2011, and follow-up was until December 2012 (16 months). The intervention was a tax-the so-called 'Hungarian public health product tax'- on sugar-added foods, including selected foods exceeding a specific sugar threshold value. The intervention includes co-interventions: the taxation of sugar-sweetened beverages (SSBs) and of foods high in salt or caffeine.
   The study provides evidence on the effect of taxing foods exceeding a specific sugar threshold value on the consumption of sugar-added foods. After implementation of the Hungarian public health product tax, the mean consumption of taxed sugar-added foods (measured in units of kg) decreased by 4.0% (standardised mean difference (SMD) -0.040, 95% confidence interval (CI) -0.07 to-0.01; very low-certainty evidence).
   The study was at low risk of bias in terms of performance bias, detection bias and reporting bias, with the shape of effect pre-specified and the intervention unlikely to have any effect on data collection. The study was at unclear risk of attrition bias and at high risk in terms of other bias and the independence of the intervention. We rated the certainty of the evidence as very low for the primary and secondary outcomes.
   The Hungarian public health product tax included a tax on sugar-added foods but did not include a tax on unprocessed sugar. We did not find eligible studies reporting on the taxation of unprocessed sugar. No studies reported on the primary outcomes of consumption of unprocessed sugar, energy intake, overweight, and obesity. No studies reported on the secondary outcomes of substitution and diet, demand, and other health outcomes. No studies reported on differential effects across population subgroups.
   We could not perform meta-analyses or pool study results.
   Authors' conclusions
   There was very limited evidence and the certainty of the evidence was very tow. Despite the reported reduction in consumption of taxed sugar-added foods, we are uncertain whether taxing unprocessed sugar or sugar-added foods has an effect on reducing their consumption and preventing obesity or other adverse health outcomes. Further robustly conducted studies are required to draw concrete conclusions on the effectiveness of taxing unprocessed sugar or sugar-added foods for reducing their consumption and preventing obesity or other adverse health outcomes.
C1 [Pfinder, Manuela] AOK Baden Wurttemberg, Dept Hlth Promot, Presselstr 19, Stuttgart 70191, Baden Wurttembe, Germany.
   [Pfinder, Manuela] Heidelberg Univ, Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.
   [Pfinder, Manuela; Heise, Thomas L.] Univ Bremen, Hlth Sci Bremen, Inst Publ Hlth & Nursing Res, Bremen, Germany.
   [Heise, Thomas L.; Lhachimi, Stefan K.] Leibniz Inst Prevent Res & Epidemiol, Res Grp Evidence Based Publ Hlth, Bremen, Germany.
   [Boon, Michele Hilton; Katikireddi, Srinivasa Vittal] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.
   [Pega, Frank] Univ Otago, Publ Hlth, Wellington, New Zealand.
   [Fenton, Candida] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.
   [Griebler, Ursula; Gartlehner, Gerald; Sommer, Isolde] Danube Univ Krems, Dept Evidence Based Med & Evaluat, Cochrane Austria, Krems, Austria.
   [Lhachimi, Stefan K.] Univ Bremen, Inst Publ Hlth & Nursing Res, Dept Hlth Serv Res, Hlth Sci Bremen, Bremen, Germany.
C3 Ruprecht Karls University Heidelberg; University of Bremen; Leibniz
   Association; Leibniz Institute for Prevention Research & Epidemiology
   (BIPS); University of Glasgow; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES
   UNIT; University of Otago; University of Edinburgh; Danube University
   Krems; University of Bremen
RP Pfinder, M (corresponding author), AOK Baden Wurttemberg, Dept Hlth Promot, Presselstr 19, Stuttgart 70191, Baden Wurttembe, Germany.
EM Dr.Manuela.Pfinder@bw.aok.de
RI Gartlehner, Gerald/AAY-2801-2021; sommer, iris/D-1190-2014; Bombana,
   Manuela/IVV-6649-2023; Fenton, Candida/JOZ-1797-2023; Lhachimi,
   Stefan/D-9227-2014; Boon, Michele/AAB-8745-2021
OI Heise, Thomas/0000-0003-0482-7657; Hilton Boon,
   Michele/0000-0002-2240-7923; Griebler, Ursula/0000-0002-9958-3714;
   Katikireddi, Srinivasa/0000-0001-6593-9092; Sommer,
   Isolde/0000-0003-3592-1507; Fenton, Candida/0000-0003-2516-9956;
   Gartlehner, Gerald/0000-0001-5531-3678
FU Senior Clinical Fellowship [SCAF/15/02]; Medical Research Council
   [MC_UU_12017/13, MC_UU_12017/15]; Scottish Government Chief Scientist
   OKice [SPHSU13, SPHSU15]; Cochrane Review Support Programme 2019; MRC
   [MC_UU_12017/13, MC_UU_12017/15, MC_UU_00022/2] Funding Source: UKRI
FX Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council
   (MC_UU_12017/13 & MC_UU_12017/15) and the Scottish Government Chief
   Scientist OKice (SPHSU13 & SPHSU15).`Michele Hilton Boon acknowledges
   funding from the Medical Research Council (MC_UU_12017/15) and the
   Scottish Government of Chief Scientist OKice (SPHSU15).Manuela Pfinder
   acknowledges funding from the Cochrane Review Support Programme 2019.
NR 0
TC 51
Z9 53
U1 6
U2 46
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2020
IS 4
AR CD012333
DI 10.1002/14651858.CD012333.pub2
PG 74
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA LJ0LV
UT WOS:000529866800015
PM 32270494
OA Green Published, Green Accepted
DA 2025-04-28
ER

PT J
AU Suzuki, T
   Ohishi, T
   Tanabe, H
   Miyoshi, N
   Nakamura, Y
AF Suzuki, Takuji
   Ohishi, Tomokazu
   Tanabe, Hiroki
   Miyoshi, Noriyuki
   Nakamura, Yoriyuki
TI Anti-Inflammatory Effects of Dietary Polyphenols through Inhibitory
   Activity against Metalloproteinases
SO MOLECULES
LA English
DT Review
DE inflammatory diseases; matrix metalloproteinases; dietary polyphenols;
   chlorogenic acid; curcumin; EGCG; genistein; quercetin; resveratrol;
   molecular docking analysis
ID GREEN TEA CATECHINS; NECROSIS-FACTOR-ALPHA; MATRIX METALLOPROTEINASES;
   RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; REGULATES EXPRESSION; INDUCED
   INFLAMMATION; ALZHEIMERS-DISEASE; MOLECULAR DOCKING; TISSUE INHIBITORS
AB Matrix metalloproteinases (MMPs) are zinc-dependent metalloproteinases that play important roles in a variety of diseases, including cancer, cardiovascular disease, diabetes, obesity, and brain diseases. Dietary polyphenols are thought to have a variety of beneficial effects on these diseases characterized by inflammation. Clinical studies have demonstrated that MMPs are in most cases upregulated in various inflammatory diseases, including osteoarthritis, rheumatoid arthritis, inflammatory bowel disease, and Alzheimer's disease. Studies using patient-derived human samples, animal studies, and cellular experiments have suggested that polyphenols may be beneficial against inflammatory diseases by suppressing MMP gene expression and enzyme activity. One important mechanism by which polyphenols exert their activity is the downregulation of reactive oxygen species that promote MMP expression. Another important mechanism is the direct binding of polyphenols to MMPs and their inhibition of enzyme activity. Molecular docking analyses have provided a structural basis for the interaction between polyphenols and MMPs and will help to explore new polyphenol-based drugs with anti-inflammatory properties.
C1 [Suzuki, Takuji] Doshisha Womens Coll Liberal Arts, Fac Human Life & Sci, Dept Food Sci & Nutr, Kamigyo ku, Kyoto 6020893, Japan.
   [Ohishi, Tomokazu] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Lab Oncol, Shinagawa, Tokyo 1410021, Japan.
   [Ohishi, Tomokazu] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Numazu, Shizuoka 4100301, Japan.
   [Tanabe, Hiroki] Nayoro City Univ, Fac Hlth & Welf Sci, Dept Nutr Sci, Nayoro, Hokkaido 0968641, Japan.
   [Miyoshi, Noriyuki] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Suruga ku, Shizuoka 4228526, Japan.
   [Nakamura, Yoriyuki] Univ Shizuoka, Tea Sci Ctr, Suruga ku, Shizuoka 4228526, Japan.
C3 University of Shizuoka; University of Shizuoka
RP Suzuki, T (corresponding author), Doshisha Womens Coll Liberal Arts, Fac Human Life & Sci, Dept Food Sci & Nutr, Kamigyo ku, Kyoto 6020893, Japan.; Miyoshi, N (corresponding author), Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Suruga ku, Shizuoka 4228526, Japan.; Nakamura, Y (corresponding author), Univ Shizuoka, Tea Sci Ctr, Suruga ku, Shizuoka 4228526, Japan.
EM tasuzuki@dwc.doshisha.ac.jp; ohishit@bikaken.or.jp;
   htanabe@nayoro.ac.jp; miyoshin@u-shizuoka-ken.ac.jp;
   yori.naka222@u-shizuoka-ken.ac.jp
RI Miyoshi, Noriyuki/F-4554-2010
OI Suzuki, Takuji/0000-0002-7257-6792; Ohishi,
   Tomokazu/0000-0002-9039-4474; Miyoshi, Noriyuki/0000-0002-4233-4282
FU Japan Society for the Promotion of Science (JSPS) [22K06783];
   Grants-in-Aid for Scientific Research [22K06783] Funding Source: KAKEN
FX This research was funded in part by the Japan Society for the Promotion
   of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) under
   grant number 22K06783 (T.O.).
CR Abenavoli L, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020494
   Ahmad A, 2015, AM J TRANSL RES, V7, P298
   Ahmed S, 2008, P NATL ACAD SCI USA, V105, P14692, DOI 10.1073/pnas.0802675105
   Ahmed S, 2006, ARTHRITIS RHEUM-US, V54, P2393, DOI 10.1002/art.22023
   BAIMA Júlio Pinheiro, 2022, Arq. Gastroenterol., V59, P51, DOI [10.1590/S0004-2803.2022005S1-03, 10.1590/s0004-2803.2022005s1-03]
   Baruah I, 2022, ACS OMEGA, DOI 10.1021/acsomega.2c00336
   Behera AK, 2005, INFECT IMMUN, V73, P126, DOI 10.1128/IAI.73.1.126-134.2005
   Boström G, 2021, J ALZHEIMERS DIS, V81, P629, DOI 10.3233/JAD-201565
   Buchbender M, 2022, CLIN ORAL INVEST, V26, P1217, DOI 10.1007/s00784-021-04093-2
   Chang WS, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13666
   Chauhan PS, 2017, INFLAMMATION, V40, P248, DOI 10.1007/s10753-016-0475-3
   Chen WP, 2011, INT IMMUNOPHARMACOL, V11, P23, DOI 10.1016/j.intimp.2010.09.021
   Chen XH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02121
   Cheng SC, 2019, CYTOKINE, V116, P48, DOI 10.1016/j.cyto.2019.01.001
   Cheng XJ, 2021, APPL PHYSIOL NUTR ME, V46, P1331, DOI 10.1139/apnm-2020-0958
   Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740
   Choi YS, 2014, RHINOLOGY, V52, P406, DOI [10.4193/Rhin13.189, 10.4193/Rhino13.189]
   Chong YH, 2001, J BIOL CHEM, V276, P23511, DOI 10.1074/jbc.M009466200
   Chowdhury A, 2017, MOL CELL BIOCHEM, V427, P111, DOI 10.1007/s11010-016-2903-y
   Cichocki M, 2014, NUTR CANCER, V66, P308, DOI 10.1080/01635581.2014.864419
   Coufal S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070719
   Crowley JT, 2016, J AUTOIMMUN, V69, P24, DOI 10.1016/j.jaut.2016.02.005
   Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850
   D'Abadia PL, 2020, AN ACAD BRAS CIENC, V92, DOI 10.1590/0001-3765202020190107
   Dai QD, 2018, DRUG DES DEV THER, V12, P4095, DOI 10.2147/DDDT.S175763
   Dave M, 2008, ARTHRITIS RHEUM, V58, P2786, DOI 10.1002/art.23799
   De Caridi G, 2016, CURR VASC PHARMACOL, V14, P382, DOI 10.2174/1570161114666160303111355
   Díaz-Chávez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064378
   Djerir D, 2018, BIOPHYS CHEM, V234, P34, DOI 10.1016/j.bpc.2018.01.002
   Duits FH, 2015, J ALZHEIMERS DIS, V48, P711, DOI 10.3233/JAD-143186
   EASTGATE JA, 1988, LANCET, V2, P706
   Elayyan J, 2017, FASEB J, V31, P3116, DOI 10.1096/fj.201601253R
   Epstein J, 2010, BRIT J NUTR, V103, P824, DOI 10.1017/S0007114509992510
   Erusappan T, 2021, J MOL MODEL, V27, DOI 10.1007/s00894-020-04651-7
   Fang CY, 2015, INT J MOL SCI, V16, P2530, DOI 10.3390/ijms16022530
   Fechtner S, 2017, TOXICOL APPL PHARM, V329, P112, DOI 10.1016/j.taap.2017.05.016
   Fontani F, 2014, EXP CELL RES, V323, P77, DOI 10.1016/j.yexcr.2014.02.019
   Fukutomi R, 2021, MOLECULES, V26, DOI 10.3390/molecules26020415
   Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x
   Gao WY, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6769789
   Gu DM, 2020, ANN CLIN TRANSL NEUR, V7, P1681, DOI 10.1002/acn3.51155
   Hao L, 2017, MOL MED REP, V16, P5099, DOI 10.3892/mmr.2017.7299
   Hayakawa S, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11122352
   Heitman E, 2017, NUTR NEUROSCI, V20, P32, DOI 10.1179/1476830514Y.0000000146
   Hosseini ES, 2023, BIOL RES, V56, DOI 10.1186/s40659-023-00412-x
   Hu XP, 2021, STEM CELLS DEV, V30, P641, DOI 10.1089/scd.2020.0193
   Hu Y, 2019, FREE RADICAL BIO MED, V145, P146, DOI 10.1016/j.freeradbiomed.2019.09.024
   Huh JE, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-256
   Huynh CB, 2023, EYE CONTACT LENS, V49, P193, DOI 10.1097/ICL.0000000000000982
   Hwang MK, 2009, INT J BIOCHEM CELL B, V41, P1592, DOI 10.1016/j.biocel.2009.01.014
   Im HJ, 2012, J CELL PHYSIOL, V227, P3488, DOI 10.1002/jcp.24049
   Ingale D, 2021, GENES-BASEL, V12, DOI 10.3390/genes12070989
   Islam R, 2022, CYTOKINE, V149, DOI 10.1016/j.cyto.2021.155720
   Jerah A, 2015, BIOINFORMATION, V11, P387, DOI 10.6026/97320630011387
   Keyszer G, 1999, J RHEUMATOL, V26, P251
   Khanna D, 2007, CURR OPIN PHARMACOL, V7, P344, DOI 10.1016/j.coph.2007.03.002
   Kim SH, 2006, FEBS LETT, V580, P1883, DOI 10.1016/j.febslet.2006.02.052
   Kim YS, 2012, MOL BIOL REP, V39, P8709, DOI 10.1007/s11033-012-1728-3
   Kumar L, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10102477
   Kumari A, 2019, INFLAMMOPHARMACOLOGY, V27, P731, DOI 10.1007/s10787-018-0544-3
   Lakatos G, 2012, DIGEST DIS, V30, P289, DOI 10.1159/000336995
   Lee RH, 2015, DRUG DEVELOP RES, V76, P9, DOI 10.1002/ddr.21235
   Leong Daniel J, 2014, Arthritis Res Ther, V16, P508, DOI 10.1186/s13075-014-0508-y
   Li FF, 2022, CHIN MED-UK, V17, DOI 10.1186/s13020-022-00597-5
   Li RL, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.1046810
   Li W, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/9978651
   Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0
   Liang YM, 2019, PHYTOMEDICINE, V58, DOI 10.1016/j.phymed.2018.11.028
   Liu CC, 2017, MOL MED REP, V16, P1369, DOI 10.3892/mmr.2017.6698
   Liu FC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051180
   Liu FC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3127
   Liu QL, 2014, ACTA BIOCH BIOPH SIN, V46, P31, DOI 10.1093/abbs/gmt128
   Liu T, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9635
   Mahmoud Randa K, 2005, Ital J Biochem, V54, P248
   Majrashi TA, 2023, NUTRIENTS, V15, DOI 10.3390/nu15071704
   Majster M, 2020, INFLAMM BOWEL DIS, V26, P1588, DOI 10.1093/ibd/izaa190
   Mäkitalo L, 2009, INT J COLORECTAL DIS, V24, P1157, DOI 10.1007/s00384-009-0756-5
   Martinez-Castillo M, 2021, WORLD J HEPATOL, V13, P218, DOI 10.4254/wjh.v13.i2.218
   Mirgani MT, 2014, INT J NANOMED, V9, P403, DOI 10.2147/IJN.S48136
   Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220
   Miyamoto N, 2000, CELL IMMUNOL, V204, P105, DOI 10.1006/cimm.2000.1696
   Mohamadian M, 2022, NUTR CANCER, V74, P2713, DOI 10.1080/01635581.2022.2049321
   Moon MH, 2013, OSTEOARTHR CARTILAGE, V21, P470, DOI 10.1016/j.joca.2012.11.017
   Moslehi A, 2023, IRAN J BASIC MED SCI, V26, P478, DOI 10.22038/IJBMS.2023.66827.14659
   Motawi TK, 2012, J PHYSIOL BIOCHEM, V68, P529, DOI 10.1007/s13105-012-0168-9
   Moussa C, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0779-0
   Murata M, 2023, BIOSCI MICROB FOOD H, V42, P87, DOI 10.12938/bmfh.2022-056
   Nabavi SF, 2015, CURR TOP MED CHEM, V15, P1714, DOI 10.2174/1568026615666150427122709
   Oh C, 2023, ACS NANO, V17, P4327, DOI 10.1021/acsnano.2c08898
   Ohishi T, 2022, MOLECULES, V27, DOI 10.3390/molecules27248899
   Ohishi T, 2023, CRIT REV FOOD SCI, V63, P7148, DOI 10.1080/10408398.2022.2038540
   Oka Y, 2012, J PHARMACOL SCI, V118, P55, DOI 10.1254/jphs.11082FP
   Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444
   Pandey AK, 2012, MED HYPOTHESES, V79, P76, DOI 10.1016/j.mehy.2012.04.005
   Poole AR, 2004, J IMMUNOL METHODS, V294, P145, DOI 10.1016/j.jim.2004.09.005
   Rasheed Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2700
   Ren YK, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.873699
   Roy Anup Jyoti, 2023, Current Drug Discovery Technologies, V20, pe121222211869, DOI 10.2174/1570163820666221212142221
   Sang DP, 2014, ACTA PHARMACOL SIN, V35, P832, DOI 10.1038/aps.2014.22
   Saragusti AC, 2010, EUR J PHARMACOL, V644, P138, DOI 10.1016/j.ejphar.2010.07.001
   Sarawi WS, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10091414
   Sarkar J, 2016, BIOMED PHARMACOTHER, V84, P340, DOI 10.1016/j.biopha.2016.09.049
   Sarkar S, 2022, NEUROBIOL DIS, V174, DOI 10.1016/j.nbd.2022.105861
   Sazuka M, 1997, BIOSCI BIOTECH BIOCH, V61, P1504, DOI 10.1271/bbb.61.1504
   Shahwan M, 2022, INT J BIOL MACROMOL, V206, P567, DOI 10.1016/j.ijbiomac.2022.03.004
   Shamsi A, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1245875
   Shamsi Farwa Batool, 2022, J Ayub Med Coll Abbottabad, V34, P12, DOI 10.55519/JAMC-01-8189
   Priya VS, 2021, J BIOMOL STRUCT DYN, V39, P7274, DOI 10.1080/07391102.2020.1810776
   Sieghart D, 2015, J CELL MOL MED, V19, P187, DOI 10.1111/jcmm.12405
   Soomro S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24235-0
   Sorrentino S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052780
   Srinivasan E, 2018, J COMPUT AID MOL DES, V32, P1347, DOI 10.1007/s10822-018-0175-1
   Sung MS, 2012, INFLAMMATION, V35, P1585, DOI 10.1007/s10753-012-9473-2
   Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200
   Syarifah-Noratiqah SB, 2018, CURR DRUG TARGETS, V19, P927, DOI 10.2174/1389450118666170328122527
   Tan SR, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.552020
   Tanabe H, 2023, MOLECULES, V28, DOI 10.3390/molecules28020525
   Tchetverikov I, 2003, ANN RHEUM DIS, V62, P1094, DOI 10.1136/ard.62.11.1094
   Testa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096795
   Tikoo K, 2008, BRIT J PHARMACOL, V153, P1225, DOI 10.1038/sj.bjp.0707666
   Tsuchiya A, 2022, BIOORGAN MED CHEM, V68, DOI 10.1016/j.bmc.2022.116854
   Vicentini FTMC, 2011, J DERMATOL SCI, V61, P162, DOI 10.1016/j.jdermsci.2011.01.002
   Videmark AN, 2023, CANCER MED-US, V12, P6675, DOI 10.1002/cam4.5455
   Wada H, 2022, CANCER SCI, V113, P4374, DOI 10.1111/cas.15576
   Wang CS, 2015, J ALLERGY CLIN IMMUN, V135, P922, DOI 10.1016/j.jaci.2014.10.018
   Wang Dong, 2022, Ann Transl Med, V10, P1227, DOI 10.21037/atm-22-4603
   Wang HY, 2023, J CELL MOL MED, V27, P515, DOI 10.1111/jcmm.17672
   Wang SD, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-26
   Wang XX, 2019, MOL MED REP, V20, P2703, DOI 10.3892/mmr.2019.10499
   Waszczykowski M, 2020, POSTEP DERM ALERGOL, V37, P1001, DOI 10.5114/ada.2020.94903
   Wiecek K, 2022, J IMMUNOL RES, V2022, DOI 10.1155/2022/1208970
   Wolk K, 2021, BRIT J DERMATOL, V185, P164, DOI 10.1111/bjd.19795
   Xiao JW, 2022, COMB CHEM HIGH T SCR, V25, P2153, DOI 10.2174/1386207325666220207105559
   Xie CF, 2023, J NUTR BIOCHEM, V112, DOI 10.1016/j.jnutbio.2022.109211
   Xu JM, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/7490279
   Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861
   Yang D, 2010, ACTA PHARMACOL SIN, V31, P1401, DOI 10.1038/aps.2010.75
   Yang D, 2022, PHARM BIOL, V60, P589, DOI 10.1080/13880209.2022.2039722
   Ye GY, 2021, J PAIN RES, V14, P1289, DOI 10.2147/JPR.S298727
   Yeh CC, 2015, ANTICANCER RES, V35, P3167
   Yi H, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01944-8
   Yu JW, 2022, CHEM BIOL DRUG DES, V100, P515, DOI 10.1111/cbdd.14117
   Yu ZY, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/7150605
   Yun HJ, 2008, RHEUMATOL INT, V29, P23, DOI 10.1007/s00296-008-0597-5
   Zeng GQ, 2015, GENET MOL RES, V14, P14811, DOI 10.4238/2015.November.18.46
   Zeng JJ, 2019, ORTHOP SURG, V11, P117, DOI 10.1111/os.12412
   Zeng KH, 2017, MOL NEUROBIOL, V54, P4000, DOI 10.1007/s12035-016-9972-5
   Zhang YJ, 2012, INFLAMMATION, V35, P377, DOI 10.1007/s10753-011-9365-x
   Zhang ZY, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923327
   Zhao HF, 2015, NEUROSCIENCE, V310, P641, DOI 10.1016/j.neuroscience.2015.10.006
   Zhong HZ, 2011, ACS MED CHEM LETT, V2, P455, DOI 10.1021/ml200031m
   Zhou JY, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012879
   Zhou L, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1449-z
NR 153
TC 11
Z9 11
U1 5
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JUL
PY 2023
VL 28
IS 14
AR 5426
DI 10.3390/molecules28145426
PG 32
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA N3VM0
UT WOS:001036328200001
PM 37513300
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Vinknes, KJ
   Elshorbagy, AK
   Nurk, E
   Drevon, CA
   Gjesdal, CG
   Tell, GS
   Nygård, O
   Vollset, SE
   Refsum, H
AF Vinknes, Kathrine J.
   Elshorbagy, Amany K.
   Nurk, Eha
   Drevon, Christian A.
   Gjesdal, Clara G.
   Tell, Grethe S.
   Nygard, Ottar
   Vollset, Stein E.
   Refsum, Helga
TI Plasma Stearoyl-CoA Desaturase Indices: Association with Lifestyle,
   Diet, and Body Composition
SO OBESITY
LA English
DT Article
ID FATTY-ACID-COMPOSITION; ADIPOSE-TISSUE; HORDALAND HOMOCYSTEINE; MASS
   INDEX; OBESITY; ALCOHOL; SERUM; DISEASE; MEN; CHOLESTEROL
AB Objective: Stearoyl-coenzyme A desaturase-1 (SCD1) is a key enzyme in fatty acid and energy metabolism. Increased hepatic SCD1 activity is associated with obesity and obesity-related diseases. We examined the relations of two plasma SCD activity indices (16:1n-7/16:0, 18:1n-9/18:0) with body composition, and the association of lifestyle and dietary variables with the plasma SCD indices.
   Design and Methods: This population-based, cross-sectional study of 2021 elderly (71-74 y) men and women from the Hordaland Health Study in Western Norway was conducted using a validated food frequency questionnaire, body composition measurements by dual-energy X-ray absorptiometry and determination of the plasma fatty acid profile.
   Results: In multivariate regression analyses, plasma SCD indices were positively associated with BMI and body fat (P<0.001 for both). From the 2.5th to 97.5th percentiles of plasma SCD-16 and SCD-18 indices, fat mass differed by about 8 kg and 5 kg, respectively. Intake of polyunsaturated fatty acids were negatively associated with SCD-16 (partial r = -0.30) and SCD-18 (partial r = -0.24) (P<0.001 for both). Alcohol intake was positively associated with SCD-16 (partial r = 0.26) and SCD-18 (partial r = 0.16) (P<0.001 for both), whereas coffee consumption and physical activity were inversely associated with SCD-16 (P = 0.026 and P = 0.006, respectively) and SCD-18 (P = 0.001 and P = 0.022, respectively).
   Conclusions: In this elderly population, plasma markers of SCD1 activity are associated with increased adiposity. Furthermore, modifiable dietary habits and lifestyle are associated with plasma SCD indices. These results suggest that SCD1 activity may be a promising target for weight control.
C1 [Vinknes, Kathrine J.; Nurk, Eha; Drevon, Christian A.; Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Fac Med, Oslo, Norway.
   [Elshorbagy, Amany K.; Refsum, Helga] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England.
   [Elshorbagy, Amany K.] Univ Alexandria, Dept Physiol, Fac Med, Alexandria, Egypt.
   [Nurk, Eha] Natl Inst Hlth Dev, Dept Surveillance & Evaluat, Tallinn, Estonia.
   [Gjesdal, Clara G.] Univ Bergen, Dept Med, Bergen, Norway.
   [Gjesdal, Clara G.] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway.
   [Tell, Grethe S.; Vollset, Stein E.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.
   [Nygard, Ottar] Univ Bergen, Inst Med, Cardiol Sect, Bergen, Norway.
   [Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway.
   [Vollset, Stein E.] Norwegian Inst Publ Hlth, Oslo, Norway.
C3 University of Oslo; University of Oxford; Egyptian Knowledge Bank (EKB);
   Alexandria University; National Institute for Health Development -
   Estonia; University of Bergen; University of Bergen; Haukeland
   University Hospital; University of Bergen; University of Bergen;
   University of Bergen; Haukeland University Hospital; Norwegian Institute
   of Public Health (NIPH)
RP Vinknes, KJ (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Nutr, Fac Med, Oslo, Norway.
EM kathrine.vinknes@medisin.uio.no
RI Elshorbagy, Amany/A-4117-2015; Tell, Grethe/G-5639-2015; Violante,
   Francesco/A-6934-2009; Drevon, Christian/F-6012-2010; Refsum,
   Helga/A-4073-2010; Vinknes, Kathrine/I-3979-2017
OI Vinknes, Kathrine/0000-0002-0756-5042; Elshorbagy,
   Amany/0000-0002-8624-860X
FU Advanced Research Programme of Norway; Research Council of Norway;
   Norwegian Rheumatism Association; Johan Throne Holst Foundation for
   Nutrition Research; University of Oslo, Norway
FX Funding Agencies: This study has received support from the Advanced
   Research Programme of Norway, The Research Council of Norway, Norwegian
   Rheumatism Association, The Johan Throne Holst Foundation for Nutrition
   Research, and University of Oslo, Norway.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Andersen LF, 1999, AM J EPIDEMIOL, V150, P75, DOI 10.1093/oxfordjournals.aje.a009921
   [Anonymous], NORD NUTR REC NNR 20
   Bjermo H, 2010, CURR OPIN CLIN NUTR, V13, P703, DOI 10.1097/MCO.0b013e32833ec41b
   Buckley JD, 2009, OBES REV, V10, P648, DOI 10.1111/j.1467-789X.2009.00584.x
   Caterson ID, 2004, CIRCULATION, V110, pE476, DOI 10.1161/01.CIR.0000140114.83145.59
   Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817
   Czernichow S, 2010, BRIT J NUTR, V104, P788, DOI 10.1017/S0007114510002096
   de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367
   Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215
   ENSER M, 1975, BIOCHEM J, V148, P551, DOI 10.1042/bj1480551
   Flowers MT, 2009, CLIN CHEM, V55, P2071, DOI 10.1373/clinchem.2009.135152
   Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694
   Gong JA, 2011, AM J CLIN NUTR, V93, P186, DOI 10.3945/ajcn.110.006502
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003
   Houston DK, 2009, J AM DIET ASSOC, V109, P1886, DOI 10.1016/j.jada.2009.08.014
   Lieber CS, 2000, ANNU REV NUTR, V20, P395, DOI 10.1146/annurev.nutr.20.1.395
   Mougios V, 2003, J APPL PHYSIOL, V94, P476, DOI 10.1152/japplphysiol.00624.2002
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Murase T, 2011, AM J PHYSIOL-ENDOC M, P300
   Nikolaidis MG, 2004, SPORTS MED, V34, P1051, DOI 10.2165/00007256-200434150-00004
   Ntambi JM, 1999, J LIPID RES, V40, P1549
   Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0
   Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699
   Nurk E, 2007, AM J CLIN NUTR, V86, P1470, DOI 10.1093/ajcn/86.5.1470
   NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526
   Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017
   Peter A, 2009, CLIN CHEM, V55, P2113, DOI 10.1373/clinchem.2009.127274
   Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941, DOI 10.1152/ajpendo.1996.271.6.E941
   Poudyal Hemant, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P217
   Refsum H, 2006, J NUTR, V136, p1731S, DOI 10.1093/jn/136.6.1731S
   Saadatian-Elahi M, 2009, AM J CLIN NUTR, V89, P331, DOI 10.3945/ajcn.2008.26834
   Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200
   Simon JA, 1996, AM J EPIDEMIOL, V144, P325, DOI 10.1093/oxfordjournals.aje.a008933
   SUTER PM, 1992, NEW ENGL J MED, V326, P983, DOI 10.1056/NEJM199204093261503
   Warensjö E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001
   Warensjö E, 2008, NUTR METAB CARDIOVAS, V18, P683, DOI 10.1016/j.numecd.2007.11.002
   WARNET JM, 1985, BMJ-BRIT MED J, V290, P1859, DOI 10.1136/bmj.290.6485.1859
   Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012
NR 40
TC 42
Z9 44
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
J9 OBESITY
JI Obesity
PD MAR
PY 2013
VL 21
IS 3
BP E294
EP E302
DI 10.1002/oby.20011
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 187AK
UT WOS:000322087600016
PM 23404690
DA 2025-04-28
ER

PT J
AU Marrelli, M
   Loizzo, MR
   Nicoletti, M
   Menichini, F
   Conforti, F
AF Marrelli, Mariangela
   Loizzo, Monica Rosa
   Nicoletti, Marcello
   Menichini, Francesco
   Conforti, Filomena
TI Inhibition of Key Enzymes Linked to Obesity by Preparations From
   Mediterranean Dietary Plants: Effects on α-Amylase and Pancreatic Lipase
   Activities
SO PLANT FOODS FOR HUMAN NUTRITION
LA English
DT Article
DE Wild edible plants; Pancreatic lipase; alpha-amylase; Inhibitors;
   Phenolic composition; Lipophilic composition
ID GLUCOSIDASE INHIBITORS
AB One of the most important strategy in the treatment of obesity includes the development of nutrient digestion and absorption inhibitors. Inhibition of digestive enzymes is one of the most widely studied mechanisms used to determine the potential efficacy of natural products as hypolipidemic and hypoglycaemic agents. In vitro studies here reported were performed to evaluate the inhibitory activity of five species (as hydroalcoholic extracts) of edible plants from Calabria region (Italy) on amylase and lipase by monitoring the hydrolysis of p-NPC and the hydrolysis of glycoside bonds in digestible carbohydrate foods. The formulation obtained from Clematis vitalba L. exhibited the strongest inhibitory effect on pancreatic lipase (IC50 = 0.99 mg/ml) and on alpha-amylase (IC50 = 31.52 mu g/ml). In order to explore metabolome production HPTLC analysis of the extracts was performed, revealing the predominance of (+/-)-catechin, caffeic acid and chlorogenic acid in C. vitalba formulation at concentration of 23.18 +/- 3.14, 13.63 +/- 0.65 and 18.88 +/- 0.76 mg/g, respectively. GC/MS analysis was used to identify fatty acids and terpene composition.
C1 [Marrelli, Mariangela; Loizzo, Monica Rosa; Menichini, Francesco; Conforti, Filomena] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-8736 Arcavacata Di Rende, CS, Italy.
   [Nicoletti, Marcello] Univ Roma La Sapienza, Dept Environm Biol, I-00185 Rome, Italy.
C3 University of Calabria; Sapienza University Rome
RP Conforti, F (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-8736 Arcavacata Di Rende, CS, Italy.
EM filomena.conforti@unical.it
RI Conforti, filomena/P-8191-2015
OI Marrelli, Mariangela/0000-0002-3741-4261; Menichini,
   Francesco/0000-0002-4584-4405; Loizzo, Monica Rosa/0000-0002-6050-9357;
   Conforti, Filomena/0000-0001-6699-005X
CR Adisakwattana S, 2013, PLANT FOOD HUM NUTR, V66, P143
   Barrett ML, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-24
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Chen XL, 2006, CURR MED CHEM, V13, P109, DOI 10.2174/092986706789803035
   CHIASSON JL, 2006, TRIAL END PRACT, V1, P25
   Conforti F, 2008, FOOD CHEM TOXICOL, V46, P3325, DOI 10.1016/j.fct.2008.08.004
   Conforti F, 2012, PHYTOTHER RES, V26, P600, DOI 10.1002/ptr.3603
   Elkhayat ES, 2008, J ASIAN NAT PROD RES, V10, P1039, DOI 10.1080/10286020802320590
   Glensk M, 1999, J NAT PROD, V62, P717, DOI 10.1021/np980505r
   Loizzo MR, 2008, J MED FOOD, V11, P184, DOI 10.1089/jmf.2007.638
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   Morikawa T, 2010, YAKUGAKU ZASSHI, V130, P673, DOI 10.1248/yakushi.130.673
   MULIMANI VH, 1993, PLANT FOOD HUM NUTR, V44, P181, DOI 10.1007/BF01088383
   Nair SindhuS., 2013, EUR J EXP BIOL, V3, P128
   Nicoletti M, 2011, REV BRAS FARMACOGN, V21, P818, DOI 10.1590/S0102-695X2011005000131
   Piccin A., 2012, NUTRAfoods, V11, P29
   Rekha MR, 2002, PLANT FOOD HUM NUTR, V57, P285, DOI 10.1023/A:1021837115267
   Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023
   Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007
NR 19
TC 52
Z9 53
U1 2
U2 57
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-9668
EI 1573-9104
J9 PLANT FOOD HUM NUTR
JI Plant Food Hum. Nutr.
PD DEC
PY 2013
VL 68
IS 4
BP 340
EP 346
DI 10.1007/s11130-013-0390-9
PG 7
WC Plant Sciences; Chemistry, Applied; Food Science & Technology; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Chemistry; Food Science & Technology; Nutrition &
   Dietetics
GA 253JS
UT WOS:000327081800002
PM 24122547
DA 2025-04-28
ER

PT J
AU Barragán-Zarate, GS
   Alexander-Aguilera, A
   Lagunez-Rivera, L
   Solano, R
   Soto-Rodríguez, I
AF Barragan-Zarate, Gabriela Soledad
   Alexander-Aguilera, Alfonso
   Lagunez-Rivera, Luicita
   Solano, Rodolfo
   Soto-Rodriguez, Ida
TI Bioactive compounds from Prosthechea karwinskii decrease obesity,
   insulin resistance, pro-inflammatory status, and cardiovascular risk in
   Wistar rats with metabolic syndrome
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Orchid; UPLC-ESI-qTOF-MS/MS; Hypotriglyceridemic; HS-CRP; Adiponectin;
   TNF-alpha; HOMA-IR
ID C-REACTIVE PROTEIN; OXIDATIVE STRESS; CHLOROGENIC ACID; ADIPOSE-TISSUE;
   ADIPONECTIN; ASSOCIATION; SENSITIVITY; EMBELIN; FAT; MECHANISMS
AB Ethnopharmacological relevance: The orchid Prosthechea karwinskii is a species endemic to Mexico, which is used in traditional medicine to lower glucose levels in patients with diabetes, and to treat inflammation-related problems. Recent studies have shown that this orchids can reduce glucose, cholesterol, and triglyceride levels in Wistar rats, which were previously induced to have metabolic syndrome (MS).
   Aim of the study: To evaluate the effect of P. karwinskii leaves extract on the components of metabolic syndrome: obesity, insulin resistance, pro-inflammatory status, and cardiovascular risk in a Wistar rat model, and to identify the bioactive compounds in the extract.
   Materials and methods: UPLC-ESI-qTOF-MS/MS was used to identify the compounds present in the extract. MS was induced in Wistar rats through administration of a 40% sucrose diet for 20 weeks. The rats were divided into five groups that received different treatments for 4 weeks: one group without any treatment, one group receiving metformin (200 mg/kg p.o.), and three groups receiving different doses of P. karwinskii leaves extract (100, 200, and 300 mg/kg p.o.). The animals' body weights were recorded weekly, and at the end of the experiment, they were sacrificed after fasting for 18 h to determine the levels of glucose, insulin, insulin resistance index, total cholesterol, triglycerides, and adiponectin in the serum, as well as levels of TNF-alpha and HS-CRP in the serum and liver homogenates. The abdominal and pericardial fat weights were also recorded.
   Results: The main bioactive compounds of the extract were quinic acid, neochlorogenic acid, chlorogenic acid, rutin, kaempferol-3-o-beta-rutinoside, and embelin, known to exhibit MS-related bioactivity. Oral administration of P. karwinskii leaves extract at a dose of 300 mg/kg decreased weight gain, abdominal and pericardial fat deposits, and insulin resistance. At the end of the treatment, levels of triglycerides, TNF-alpha, HS-CRP, and adiponectin returned to levels similar to normal.
   Conclusion: P. karwinskii extract (300 mg/kg) had an anti-obesity effect, decreased insulin resistance, pro inflammatory status, and cardiovascular risk in rats with induced MS by increasing adiponectin levels and decreasing TNF-alpha and HS-CRP levels. The compounds identified in the extract could be responsible for these effects, acting alone or in synergy, as several compounds in the extract are known to have MS-related bioactivity. The foliar extract of P. karwinskii has potential as an effective alternative to a cocktail of drugs used to treat problems associated with MS.
C1 [Barragan-Zarate, Gabriela Soledad; Lagunez-Rivera, Luicita; Solano, Rodolfo] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Lab Extracc & Anal Prod Nat Vegetales, Hornos 1003 Santa Cruz Xoxocotlan, Oaxaca 71230, Oaxaca, Mexico.
   [Alexander-Aguilera, Alfonso; Soto-Rodriguez, Ida] Univ Veracruzana, Fac Bioanal, Carmen Serdan S-N,Flores Magon, Veracruz 91700, Veracruz, Mexico.
   [Alexander-Aguilera, Alfonso] Univ Cristobal Colon, Escuela Med, Carretera Veracruz Medellin S-N,Col Puente Moreno, Boca Del Rio 94271, Veracruz, Mexico.
C3 Instituto Politecnico Nacional - Mexico; Universidad Veracruzana
RP Lagunez-Rivera, L (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Lab Extracc & Anal Prod Nat Vegetales, Hornos 1003 Santa Cruz Xoxocotlan, Oaxaca 71230, Oaxaca, Mexico.
EM gabybarraganzarate@hotmail.com; aalexander_2000@yahoo.com;
   llagunez@ipn.mx; solanogo@yahoo.com.mx; isoto@uv.mx
RI Alexander-Aguilera, Alfonso/AAH-9203-2019; Barragán Zarate,
   Gabriela/AAC-3480-2021; LAGUNEZ RIVERA, LUICITA/HZH-8241-2023;
   Solano-Gomez, Rodolfo/F-1183-2018
OI Barragan Zarate, Gabriela Soledad/0000-0001-7046-4001; LAGUNEZ RIVERA,
   LUICITA/0000-0001-9870-971X; Solano-Gomez, Rodolfo/0000-0002-0355-5496
FU CONACYT (Consejo Nacional de Ciencia y Tecnologia) [270428]; Instituto
   Politecnico Nacional (IPN) [SIP20161270, SIP-2016RE/50, SIP-20170263,
   SIP-20180451, SIP20180382]
FX We would like to thank CONACYT (Consejo Nacional de Ciencia y
   Tecnologia) for financial support to project 270428 and the Instituto
   Polit ' ecnico Nacional (IPN) for the financial support to projects
   SIP20161270, SIP-2016RE/50, SIP-20170263, SIP-20180451, and SIP20180382.
   The grants were awarded to Ph.D. students. The committee organized the
   Easter celebrations of the Villa de Zaachila in Oaxaca, Mexico, who
   facilitated the recuperation of the exemplars from the churches.
CR Ajmal Masihur Rehman, 2014, Indian Heart J, V66, P574, DOI 10.1016/j.ihj.2014.08.006
   Alexander-Aguilera A, 2011, J PHYSIOL BIOCHEM, V67, P595, DOI 10.1007/s13105-011-0106-2
   Anhê FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142
   [Anonymous], 2016, J CIM
   Ballak DB, 2015, CYTOKINE, V75, P280, DOI 10.1016/j.cyto.2015.05.005
   Calle MC, 2012, DIABETES METAB, V38, P183, DOI 10.1016/j.diabet.2011.11.006
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z
   Garcia GC, 2014, REV BRAS FARMACOGN, V24, P153
   El-Shiekh RA, 2019, J ETHNOPHARMACOL, V238, DOI 10.1016/j.jep.2019.111893
   Fuentes E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090699
   Gallagher EJ, 2011, MED CLIN N AM, V95, P855, DOI 10.1016/j.mcna.2011.06.001
   Ghadge AA, 2018, CYTOKINE GROWTH F R, V39, P151, DOI 10.1016/j.cytogfr.2018.01.004
   Ghorbani A, 2017, BIOMED PHARMACOTHER, V96, P305, DOI 10.1016/j.biopha.2017.10.001
   Gupta R, 2012, J DIABETES, V4, P248, DOI 10.1111/j.1753-0407.2012.00187.x
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jang SA, 2017, BIOMED PHARMACOTHER, V96, P563, DOI 10.1016/j.biopha.2017.10.021
   Jang YS, 2016, MOLECULES, V21, DOI 10.3390/molecules21020226
   Joo N. -S., 2017, MATURITAS, P184, DOI [10.1016/j.maturitas.2017.03.220, DOI 10.1016/J.MATURITAS.2017.03.220]
   Kahl KG, 2017, PROG NEURO-PSYCHOPH, V72, P30, DOI 10.1016/j.pnpbp.2016.08.005
   Kim M, 2015, NEUROCHEM RES, V40, P1792, DOI 10.1007/s11064-015-1659-1
   Kulabas SS, 2018, J ETHNOPHARMACOL, V223, P88, DOI 10.1016/j.jep.2018.04.043
   Kumar GK, 2011, EUR J PHARMACOL, V662, P63, DOI 10.1016/j.ejphar.2011.04.037
   Louis JM, 2020, CYTOKINE, V125, DOI 10.1016/j.cyto.2019.154815
   Villaseñor JL, 2016, REV MEX BIODIVERS, V87, P559, DOI 10.1016/j.rmb.2016.06.017
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McCracken E, 2018, CLIN DERMATOL, V36, P14, DOI 10.1016/j.clindermatol.2017.09.004
   Micháliková D, 2019, SAUDI PHARM J, V27, P1196, DOI 10.1016/j.jsps.2019.10.002
   Mirhafez SR, 2016, EUR J CLIN NUTR, V70, P1298, DOI 10.1038/ejcn.2016.111
   Naik SR, 2013, PHYTOMEDICINE, V20, P797, DOI 10.1016/j.phymed.2013.03.003
   Nakamura Y, 2004, HEART, V90, P528, DOI 10.1136/hrt.2003.011114
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3
   Park SY, 2018, ENVIRON TOXICOL PHAR, V62, P1, DOI 10.1016/j.etap.2018.06.001
   Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730
   Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011
   Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251
   Rojas-Olivos A, 2017, ALEX J MED, V53, P311, DOI 10.1016/j.ajme.2016.11.004
   Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z
   Shah RV, 2017, JACC-CARDIOVASC IMAG, V10, P1016, DOI 10.1016/j.jcmg.2016.10.024
   Solano R., 2020, Data Base SNIB-CONABIO, Project KT005
   Barragán-Zarate GS, 2020, J ETHNOPHARMACOL, V253, DOI 10.1016/j.jep.2020.112632
   Srikanthan K, 2016, INT J MED SCI, V13, P25, DOI 10.7150/ijms.13800
   Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676
   Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239
   Voils SA, 2014, DIABETES METAB SYND, V8, P88, DOI 10.1016/j.dsx.2014.04.021
   Wang SW, 2012, NEUROTOXICOLOGY, V33, P482, DOI 10.1016/j.neuro.2012.03.003
   Yeh CH, 2014, FREE RADICAL BIO MED, V69, P249, DOI 10.1016/j.freeradbiomed.2014.01.028
   Yoon K, 2018, DIABETES METAB SYND, V12, P977, DOI 10.1016/j.dsx.2018.06.008
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zheng JP, 2020, J ETHNOPHARMACOL, V246, DOI 10.1016/j.jep.2019.112225
NR 53
TC 8
Z9 8
U1 1
U2 23
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD OCT 28
PY 2021
VL 279
AR 114376
DI 10.1016/j.jep.2021.114376
EA JUL 2021
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA UA4FL
UT WOS:000685116600004
PM 34181956
DA 2025-04-28
ER

PT J
AU Lee, D
   Kim, JY
   Qi, Y
   Park, S
   Lee, HL
   Yamabe, N
   Kim, H
   Jang, DS
   Kang, KS
AF Lee, Dahae
   Kim, Ji-Young
   Qi, Yutong
   Park, Sangsu
   Lee, Hye Lim
   Yamabe, Noriko
   Kim, Hocheol
   Jang, Dae Sik
   Kang, Ki Sung
TI Phytochemicals from the flowers of Prunus persica (L.) Batsch:
   Anti-adipogenic effect of mandelamide on 3T3-L1 preadipocytes
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Prunus persica (L.) Batsch; Mandelamide; Adipocytes; Adipogenesis
ID DIET-INDUCED OBESITY; ADIPOCYTE DIFFERENTIATION; P38MAPK; CELLS; ACID;
   MICE
AB Flowers of Prunus persica (L.) Batsch (Rosaceae), known as peach blossoms, have been reported to exert anti-obesity effects by improving hepatic lipid metabolism in obese mice. However, little is known regarding the anti-adipogenic effects of the phenolic compounds isolated from P. persica flowers. This study investigated the inhibitory effects of compounds extracted from P. persica flowers (PPF) on adipogenesis in 3T3-L1 murine preadipocytes using adipogenic differentiation assays. Additionally, we compared the anti-adipogenic effects of the phenolic compounds isolated from PPF, such as prunasin amide (1), amygdalin amide (2), prunasin acid (3), mandelamide (4), methyl caffeate (5), ferulic acid (6), chlorogenic acid (7), benzyl alpha-L-xylpyranosyl-(1 -> 6)-beta-D- glucopyranoside (8), prunin (9), naringenin (10), nicotiflorin (11), astragalin (12), afzelin (13), and uridine (14), on adipogenesis in 3T3-L1 murine preadipocytes. PPF and compounds 4-7 and 10 significantly inhibited adipogenesis. Among them, mandelamide (4) exhibited the maximum inhibitory activity with an IC50 of 36.04 +/- 1.82 mu M. Additionally, mandelamide downregulated the expression of key adipogenic markers, such as extra cellular signal-regulated kinase, c-Jun-N-terminal kinase, P38, CCAAT/enhancer-binding protein alpha, CCAAT/enhancer-binding protein beta, peroxisome proliferator activated receptor gamma, and glucocorticoid receptor. These results indicate that mandelamide is an active ingredient of PPF possessing anti-obesity properties.
C1 [Lee, Dahae; Yamabe, Noriko; Kang, Ki Sung] Gachon Univ, Coll Korean Med, Seongnam 13120, South Korea.
   [Kim, Ji-Young; Qi, Yutong; Jang, Dae Sik] Kyung Hee Univ, Grad Sch, Dept Life & Nanopharmaceut Sci, Seoul 02447, South Korea.
   [Park, Sangsu] Kyung Hee Univ, Grad Sch, Dept Fundamental Pharmaceut Sci, Seoul 02447, South Korea.
   [Lee, Hye Lim] Daejeon Univ, Dept Pediat, Coll Korean Med, Daejeon, South Korea.
   [Kim, Hocheol] Kyung Hee Univ, Dept Herbal Pharmacol, Coll Korean Med, Seoul 02447, South Korea.
C3 Gachon University; Kyung Hee University; Kyung Hee University; Daejeon
   University; Kyung Hee University
RP Kang, KS (corresponding author), Gachon Univ, Coll Korean Med, Seongnam 13120, South Korea.; Jang, DS (corresponding author), Kyung Hee Univ, Grad Sch, Dept Life & Nanopharmaceut Sci, Seoul 02447, South Korea.
EM dsjang@khu.ac.kr; kkang@gachon.ac.kr
RI Jang, Dae/AAI-4526-2020; Kim, Ji-Young/HJA-5494-2022; Kim, Sung
   Hwan/GQQ-1731-2022; Kim, Cheol-Hee/F-6278-2013
FU National Research Foundation of Korea (NRF) - Ministry of Science and
   ICT (MSIT) , Korea [NRF-2019R1A2C1083945]; Basic Science Research
   Program through the NRF [2019R1F1A1059173]
FX This research was supported by a grant (No. NRF-2019R1A2C1083945) from
   the National Research Foundation of Korea (NRF) , funded by the Ministry
   of Science and ICT (MSIT) , Korea. The study was also supported by funds
   from the Basic Science Research Program through the NRF (grant number:
   2019R1F1A1059173).
CR Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963
   Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018
   Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392
   Chang E, 2019, MOLECULES, V24, DOI 10.3390/molecules24061157
   Giuffrida D, 2013, FRUITS, V68, P39, DOI 10.1051/fruits/2012049
   Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957
   Halder D, 2014, J FOOD BIOCHEM, V38, P216, DOI 10.1111/jfbc.12040
   Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213
   Ilavenil S, 2017, J FUNCT FOODS, V37, P293, DOI 10.1016/j.jff.2017.08.002
   Koh EJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22050745
   Kusuyama J, 2016, J LIPID RES, V57, P1806, DOI 10.1194/jlr.M067207
   Kwak CS, 2018, NUTR RES PRACT, V12, P29, DOI 10.4162/nrp.2018.12.1.29
   Lee D, BIOMOLECULES, V11
   Lim H, 2015, NUTR RES PRACT, V9, P599, DOI 10.4162/nrp.2015.9.6.599
   Madsen MS, 2014, MOL CELL BIOL, V34, P939, DOI 10.1128/MCB.01344-13
   Marcelin G, 2010, CURR OPIN PHARMACOL, V10, P588, DOI 10.1016/j.coph.2010.05.008
   Matsushita K, 2017, LAB INVEST, V97, P1158, DOI 10.1038/labinvest.2017.42
   Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S
   Ou CY, 2014, J BIOL CHEM, V289, P17078, DOI 10.1074/jbc.M114.548081
   Peng SG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8594767
   Richard AJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/549750
   Song J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092176
   Sweeney G, 1999, J BIOL CHEM, V274, P10071, DOI 10.1074/jbc.274.15.10071
   Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718
   Vasileva LV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249740
   Verhoog N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110702
   Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218
   Wu HT, 2020, FASEB J, V34, P2958, DOI 10.1096/fj.201901925R
   Yazid NSM, 2019, MALAYS J FUNDAM APPL, V15, P561
NR 29
TC 10
Z9 10
U1 5
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD OCT 1
PY 2021
VL 49
AR 128326
DI 10.1016/j.bmcl.2021.128326
EA AUG 2021
PG 6
WC Chemistry, Medicinal; Chemistry, Organic
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Chemistry
GA UR3AQ
UT WOS:000696625300008
PM 34403725
DA 2025-04-28
ER

PT J
AU Ghattamaneni, NKR
   Brown, L
AF Ghattamaneni, Naga K. R.
   Brown, Lindsay
TI Functional foods from the tropics to relieve chronic normobaric hypoxia
SO RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
LA English
DT Article
DE Obesity; Inflammatory bowel disease; Chronic hypoxia; Tropical foods
ID INDUCED METABOLIC SYNDROME; SODIUM-INDUCED COLITIS;
   INFLAMMATORY-BOWEL-DISEASE; JABOTICABA PEEL POWDER; HIGH-CARBOHYDRATE;
   ANTIOXIDANT ACTIVITY; CHLOROGENIC ACID; INSULIN-RESISTANCE; INDUCIBLE
   FACTOR; ADIPOSE-TISSUE
AB Functional foods with antioxidant and anti-inflammatory properties are regarded as a complementary therapy to improve chronic diseases such as obesity and inflammatory bowel disease (IBD). Obesity is a chronic low-grade inflammatory state leading to organ damage with increased risk of common diseases including cardiovascular and metabolic disease, non-alcoholic fatty liver disease, osteoarthritis and some cancers. IBD is a chronic intestinal inflammation categorised as Crohn's disease and ulcerative colitis depending on the location of inflammation. These inflammatory states are characterised by normobaric hypoxia in adipose and intestinal tissues, respectively. Tropical foods especially from Australia and South America are discussed in this review to show their potential in attenuation of these chronic diseases. The phytochemicals from these foods have antioxidant and anti-inflammatory activities to reduce chronic normobaric hypoxia in the tissues. These health benefits of the tropical foods are relevant not only for health economy but also in providing a global solution by improving the sustainability of their cultivation and assisting the local economies.
C1 [Ghattamaneni, Naga K. R.; Brown, Lindsay] Univ Southern Queensland, Funct Foods Res Grp, Ipswich, Qld 4305, Australia.
   [Ghattamaneni, Naga K. R.; Brown, Lindsay] Univ Southern Queensland, Sch Hlth & Wellbeing, Ipswich, Qld 4305, Australia.
C3 University of Southern Queensland; University of Southern Queensland
RP Brown, L (corresponding author), Univ Southern Queensland, Sch Hlth & Wellbeing, Ipswich, Qld 4305, Australia.
EM lindsaybrown1952@gmail.com
RI Ghattamaneni, Naga/AAL-3746-2020
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Ahluwalia B, 2018, SCAND J GASTROENTERO, V53, P379, DOI 10.1080/00365521.2018.1447597
   Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603
   Alam MA, 2013, NUTRIENTS, V5, P637, DOI 10.3390/nu5030637
   Arias-Reyes C, 2020, RESP PHYSIOL NEUROBI, V277, DOI 10.1016/j.resp.2020.103443
   Azuma T, 2013, J NUTR, V143, P827, DOI 10.3945/jn.113.174508
   Bagattoli PCD, 2016, INDIAN J PHARM SCI, V78, P34, DOI 10.4103/0250-474X.180239
   Barreca D, 2017, BIOFACTORS, V43, P495, DOI 10.1002/biof.1363
   Barthel C, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0070-8
   Bhandarkar NS, 2020, FASEB J, V34, P4783, DOI 10.1096/fj.201902416RR
   Bhandarkar NS, 2019, J FUNCT FOODS, V57, P141, DOI 10.1016/j.jff.2019.04.003
   Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Bhaswant M, 2019, J FUNCT FOODS, V56, P119, DOI 10.1016/j.jff.2019.03.011
   Bhaswant M, 2015, PHARMACOL RES, V102, P208, DOI 10.1016/j.phrs.2015.10.006
   Mariano LNB, 2016, PHARM BIOL, V54, P1697, DOI 10.3109/13880209.2015.1123279
   Bonacorsi C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/851621
   Brown E, 2018, J PHYSIOL-LONDON, V596, P2985, DOI 10.1113/JP274350
   Brown L, 2015, OBES REV, V16, P914, DOI 10.1111/obr.12313
   Bumrungpert A, 2010, J NUTR, V140, P842, DOI 10.3945/jn.109.120022
   Burke AC, 2018, J LIPID RES, V59, P1714, DOI 10.1194/jlr.M087387
   Moura MHC, 2018, FOOD RES INT, V107, P48, DOI 10.1016/j.foodres.2018.01.071
   Carvalho DV, 2019, FOOD FUNCT, V10, P1671, DOI [10.1039/C8FO01575A, 10.1039/c8fo01575a]
   Cazarin CBB, 2014, EXP BIOL MED, V239, P542, DOI 10.1177/1535370214525306
   Chae HS, 2017, J MED FOOD, V20, P727, DOI 10.1089/jmf.2017.3944
   Chaen Y, 2019, NUTR RES, V64, P82, DOI 10.1016/j.nutres.2019.01.004
   Chen PS, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00658-7
   Chowdhury R, 2012, CHEM RES TOXICOL, V25, P2194, DOI 10.1021/tx300274a
   Comín-Anduix B, 2002, J BIOL CHEM, V277, P46408, DOI 10.1074/jbc.M206150200
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   da Silva-Maia JK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112776
   De Leo M, 2020, PLANTA MED, V86, P180, DOI 10.1055/a-1070-9325
   de Rosso VV, 2008, J FOOD COMPOS ANAL, V21, P291, DOI 10.1016/j.jfca.2008.01.001
   Dias FM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-24
   Dragano NRV, 2013, BRIT J NUTR, V110, P447, DOI 10.1017/S0007114512005090
   du Preez R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040931
   Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283
   Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554
   Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]
   Fang HY, 2012, FOOD CHEM TOXICOL, V50, P4042, DOI 10.1016/j.fct.2012.08.037
   Fanning KJ, 2014, J SCI FOOD AGR, V94, P2137, DOI 10.1002/jsfa.6591
   Flück K, 2016, MUCOSAL IMMUNOL, V9, P379, DOI 10.1038/mi.2015.67
   Garcia JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113510
   Garzón GA, 2009, J FOOD SCI, V74, pC227, DOI 10.1111/j.1750-3841.2009.01092.x
   Geserick M, 2018, NEW ENGL J MED, V379, P1303, DOI 10.1056/NEJMoa1803527
   Ghattamaneni NKR, 2020, EUR J NUTR, V59, P2905, DOI 10.1007/s00394-019-02130-1
   Ghattamaneni NKR, 2019, J FUNCT FOODS, V56, P194, DOI 10.1016/j.jff.2019.01.028
   Ghattamaneni NKR, 2019, PHARMACOL REP, V71, P149, DOI 10.1016/j.pharep.2018.10.006
   Glover LE, 2017, ANN AM THORAC SOC, V14, pS233, DOI 10.1513/AnnalsATS.201608-610MG
   Goossens GH, 2012, CURR OPIN CLIN NUTR, V15, P539, DOI 10.1097/MCO.0b013e328358fa87
   Gutierrez-Orozco F, 2014, MOL NUTR FOOD RES, V58, P1226, DOI 10.1002/mnfr.201300771
   Gutierrez-Orozco F, 2013, J AGR FOOD CHEM, V61, P3891, DOI 10.1021/jf4004434
   Hellwig-Bürgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567
   Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009
   Impellizzeri D, 2015, CLIN NUTR, V34, P1146, DOI 10.1016/j.clnu.2014.11.012
   International Coffee Organization, 2020, Total production by all exporting countries (In thousand 60 kg bags)
   John OD, 2020, FOOD FUNCT, V11, P6946, DOI [10.1039/D0FO01133A, 10.1039/d0fo01133a]
   John OD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010272
   John OD, 2019, J FUNCT FOODS, V56, P204, DOI 10.1016/j.jff.2019.03.018
   John OD, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101425
   Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108
   Karczewski J, 2018, EUR CYTOKINE NETW, V29, P83, DOI 10.1684/ecn.2018.0415
   Ke ZL, 2020, J NUTR BIOCHEM, V83, DOI 10.1016/j.jnutbio.2020.108426
   Khamthong N, 2017, NAT PROD COMMUN, V12, P453
   Kim DH, 2015, INT J ONCOL, V47, P2226, DOI 10.3892/ijo.2015.3200
   Konczak I., 2009, Health Benefits of Australian Native Foods: An evaluation of health-enhancing properties
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012
   Lenquiste SA, 2019, FOOD RES INT, V120, P880, DOI 10.1016/j.foodres.2018.11.053
   Li QY, 2015, EUR J PHARMACOL, V751, P81, DOI 10.1016/j.ejphar.2015.01.046
   Lim V, 2020, METABOLITES, V10, DOI 10.3390/metabo10030114
   Lisk C, 2013, FREE RADICAL BIO MED, V63, P264, DOI 10.1016/j.freeradbiomed.2013.05.024
   Liu CQ, 2015, CANCER LETT, V362, P8, DOI 10.1016/j.canlet.2015.03.019
   Losso JN, 2005, J AGR FOOD CHEM, V53, P3751, DOI 10.1021/jf0479719
   Lu Y, 2018, BRIT J PHARMACOL, V175, P1085, DOI 10.1111/bph.14150
   Magee EA, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-7
   Matafome P, 2015, CURR MED CHEM, V22, P2417, DOI 10.2174/0929867322666150209155633
   McGarry T, 2018, FREE RADICAL BIO MED, V125, P15, DOI 10.1016/j.freeradbiomed.2018.03.042
   Mehl F, 2014, FOOD CHEM, V143, P325, DOI 10.1016/j.foodchem.2013.07.125
   Morrow NM, 2020, J LIPID RES, V61, P387, DOI 10.1194/jlr.RA119000542
   Musumeci L, 2020, NAT PROD RES, V34, P122, DOI 10.1080/14786419.2019.1601196
   Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501
   Nangaku M, 2008, CHINESE MED J-PEKING, V121, P257
   Netzel M, 2006, J AGR FOOD CHEM, V54, P9820, DOI 10.1021/jf0622735
   Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0
   O'Neil CE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-107
   Omidi-Ardali H, 2019, INFLAMMOPHARMACOLOGY, V27, P1265, DOI 10.1007/s10787-019-00581-w
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Panchal SK, 2011, J NUTR, V141, P1062, DOI 10.3945/jn.111.137877
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]
   Panelli MF, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7090120
   Parhiz H, 2015, PHYTOTHER RES, V29, P323, DOI 10.1002/ptr.5256
   Pierson JT, 2012, MOL NUTR FOOD RES, V56, P357, DOI 10.1002/mnfr.201100441
   Poole R, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5024
   Rajendran P, 2014, CLIN CHIM ACTA, V436, P332, DOI 10.1016/j.cca.2014.06.004
   Rangel-Huerta OD, 2015, J NUTR, V145, P1808, DOI 10.3945/jn.115.213660
   Richard NA, 2012, AVIAT SPACE ENVIR MD, V83, P677, DOI 10.3357/ASEM.3182.2012
   San Martin R, 2017, OBESITY FACTS, V10, P363, DOI 10.1159/000477461
   Sato M, 2019, J NUTR SCI VITAMINOL, V65, P19, DOI 10.3177/jnsv.65.19
   Shah Yatrik M, 2016, Mol Cell Pediatr, V3, P1, DOI 10.1186/s40348-016-0030-1
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Siracusa R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030834
   Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Teixeira N, 2019, FOOD RES INT, V119, P325, DOI 10.1016/j.foodres.2019.01.058
   Terrazas PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076485
   Titto M, 2020, RESP PHYSIOL NEUROBI, V274, DOI 10.1016/j.resp.2019.103336
   Treml B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145239
   Tsai ML, 2014, MOL NUTR FOOD RES, V58, P1820, DOI 10.1002/mnfr.201400149
   Villafuerte FC, 2016, HIGH ALT MED BIOL, V17, P61, DOI 10.1089/ham.2016.0031
   Vukelic I, 2018, FOOD CHEM TOXICOL, V121, P140, DOI 10.1016/j.fct.2018.08.061
   Ward ZJ, 2019, NEW ENGL J MED, V381, P2440, DOI 10.1056/NEJMsa1909301
   West JB, 2017, NEW ENGL J MED, V376, P1965, DOI 10.1056/NEJMra1612008
   Wilkins MR, 2015, CIRCULATION, V131, P582, DOI 10.1161/CIRCULATIONAHA.114.006977
   Wright EK, 2018, MED J AUSTRALIA, V209, P318, DOI 10.5694/mja17.01001
   Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010
   Yang YH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015795
   Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007
   Zhang ZR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060588
   Zimna A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/549412
   Zou Z, 2016, FOOD CHEM, V196, P885, DOI 10.1016/j.foodchem.2015.09.072
   Zubieta-Calleja G., 2017, BLDE University Journal of Health Sciences, V2, P80
NR 123
TC 2
Z9 2
U1 1
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1569-9048
EI 1878-1519
J9 RESP PHYSIOL NEUROBI
JI Respir. Physiol. Neuro.
PD APR
PY 2021
VL 286
AR 103599
DI 10.1016/j.resp.2020.103599
PG 9
WC Physiology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Respiratory System
GA TT7CX
UT WOS:000680503600008
PM 33333240
DA 2025-04-28
ER

PT J
AU Olivares-Vicente, M
   Sánchez-Marzo, N
   Herranz-López, M
   Micol, V
AF Olivares-Vicente, Marilo
   Sanchez-Marzo, Noelia
   Herranz-Lopez, Maria
   Micol, Vicente
TI Analysis of Lemon Verbena Polyphenol Metabolome and Its Correlation with
   Oxidative Stress under Glucotoxic Conditions in Adipocyte
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE cellular uptake; lemon verbena metabolite; adipocyte; oxidative stress;
   glucotoxicity; cellular metabolism
ID LIPPIA-CITRIODORA POLYPHENOLS; SMOOTH-MUSCLE-CELLS; OLIVE OIL;
   TRANSEPITHELIAL TRANSPORT; FERULIC ACID; UDP-GLUCURONOSYLTRANSFERASES;
   LIQUID-CHROMATOGRAPHY; ANTIOXIDANT ACTIVITY; BETA-GLUCURONIDASE;
   CHLOROGENIC ACID
AB Lemon verbena has been shown to ameliorate obesity-related oxidative stress, but the intracellular final effectors underlying its antioxidant activity are still unknown. The purpose of this study was to correlate the antioxidant capacity of plasma metabolites of lemon verbena (verbascoside, isoverbascoside, hydroxytyrosol, caffeic acid, ferulic acid, homoprotocatechuic acid, and luteolin-7-diglucuronide) with their uptake and intracellular metabolism in hypertrophic adipocytes under glucotoxic conditions. To this end, intracellular ROS levels were measured, and the intracellular metabolites were identified and quantified by high-performance liquid chromatography with a diode array detector coupled to mass spectrometry (HPLC-DAD-MS). The results showed that the plasma metabolites of lemon verbena are absorbed by adipocytes and metabolized through phase II reactions and that the intracellular appearance of these metabolites correlates with the decrease in the level of glucotoxicity-induced oxidative stress. It is postulated that the biotransformation and accumulation of these metabolites in adipocytes contribute to the long-term antioxidant activity of the extract.
C1 [Olivares-Vicente, Marilo; Sanchez-Marzo, Noelia; Herranz-Lopez, Maria; Micol, Vicente] Univ Miguel Hernandez UMH, Inst Investigac Desarrollo & Innovac Biotecnol San, Elche 03202, Spain.
   [Micol, Vicente] Inst Salud Carlos III ISCIII, CIBEROBN, CIBER Fisiopatol Obesidad & Nutr CB12 03 30038, Madrid 28029, Spain.
C3 Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion
   Biomedica en Red; CIBEROBN
RP Herranz-López, M (corresponding author), Univ Miguel Hernandez UMH, Inst Investigac Desarrollo & Innovac Biotecnol San, Elche 03202, Spain.
RI Micol, Vicente/K-6841-2014; Herranz-Lopez, Maria/AAB-1933-2020
OI Olivares-Vicente, Marilo/0000-0002-2792-9181
FU Spanish Ministry of Economy and Competitiveness [PID2021-125188OB-C32];
   Generalitat Valenciana [PROMETEO/2021/059]; CIBER (Fisiopatologia de la
   Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III)
   [CB12/03/30038]; Requalification of the Spanish University System;
   PLANTAGING Project of the "Programa de Ayudas para la Investigacion del
   Envejecimiento de la Fundacion ICAR, call 2023"
FX This researchwas funded by the Spanish Ministry of Economy
   andCompetitiveness (PID2021-125188OB-C32), Generalitat
   Valenciana(PROMETEO/2021/059), and CIBER (CB12/03/30038, Fisiopatologia
   de laObesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos
   III).M.H.-L. has also been supported by the Requalification of the
   SpanishUniversity System for 2021/2023 grant (Next Generation).
   PLANTAGINGProject of the "Programa de Ayudas para la Investigaciondel
   Envejecimiento de la Fundacion ICAR, call 2023".
CR Agulló V, 2020, MOLECULES, V25, DOI 10.3390/molecules25020371
   Andrés CMC, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24031841
   Martín MA, 2010, MOL NUTR FOOD RES, V54, P956, DOI 10.1002/mnfr.200900159
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438
   Baj T, 2017, OPEN CHEM, V15, P380, DOI 10.1515/chem-2017-0042
   Cao YJ, 2015, INT IMMUNOPHARMACOL, V28, P1018, DOI 10.1016/j.intimp.2015.07.037
   Carrera-Quintanar L, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9121242
   Chae S, 2005, J TOXICOL ENV HEAL A, V68, P389, DOI 10.1080/15287390590900750
   D'Imperio M, 2014, FOOD RES INT, V66, P373, DOI 10.1016/j.foodres.2014.09.037
   de Heredia FP, 2010, PFLUG ARCH EUR J PHY, V459, P509, DOI 10.1007/s00424-009-0750-3
   Cádiz-Gurrea MDLL, 2018, J FUNCT FOODS, V46, P514, DOI [10.1016/j.jff.2018.05.026, 10.1016/j.jff.2018.]
   Deiana M, 2011, CHEM-BIOL INTERACT, V193, P232, DOI 10.1016/j.cbi.2011.07.002
   Deng DW, 2006, FEBS LETT, V580, P5247, DOI 10.1016/j.febslet.2006.08.051
   Domínguez-Perles R, 2017, EUR J NUTR, V56, P215, DOI 10.1007/s00394-015-1071-2
   Felgines C, 2014, BRIT J NUTR, V111, P1773, DOI 10.1017/S0007114514000026
   Funes L, 2009, FOOD CHEM, V117, P589, DOI 10.1016/j.foodchem.2009.04.059
   Funes L, 2010, CHEM PHYS LIPIDS, V163, P190, DOI 10.1016/j.chemphyslip.2009.11.004
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Gülçin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011
   Han CY, 2012, J BIOL CHEM, V287, P10379, DOI 10.1074/jbc.M111.304998
   Hennebelle T, 2008, PHYTOTHER RES, V22, P256, DOI 10.1002/ptr.2266
   Herranz-López M, 2020, FOOD CHEM TOXICOL, V144, DOI 10.1016/j.fct.2020.111606
   Herranz-López M, 2017, PHYTOMEDICINE, V25, P25, DOI 10.1016/j.phymed.2016.12.008
   Herranz-López M, 2015, PHYTOMEDICINE, V22, P605, DOI 10.1016/j.phymed.2015.03.015
   Hussain Tarique, 2016, Oxid Med Cell Longev, V2016, P7432797
   Jia P, 2016, ANALYST, V141, P1112, DOI 10.1039/c5an01970b
   Khymenets O, 2010, DRUG METAB DISPOS, V38, P1417, DOI 10.1124/dmd.110.032821
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Konishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2014, DOI 10.1271/bbb.67.2014
   Konishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P856, DOI 10.1271/bbb.67.856
   Kuppusamy P, 2021, MOLECULES, V26, DOI 10.3390/molecules26071984
   de las Hazas MC, 2016, J FUNCT FOODS, V22, P52, DOI 10.1016/j.jff.2016.01.030
   Managò A, 2015, ANTIOXID REDOX SIGN, V22, P1097, DOI 10.1089/ars.2014.5979
   Manna C, 2000, FEBS LETT, V470, P341, DOI 10.1016/S0014-5793(00)01350-8
   Mateos R, 2005, J AGR FOOD CHEM, V53, P9897, DOI 10.1021/jf051721q
   Mateos R, 2006, J AGR FOOD CHEM, V54, P8724, DOI 10.1021/jf061664g
   Ning BB, 2017, ACTA PHARMACOL SIN, V38, P331, DOI 10.1038/aps.2016.142
   O'Leary KA, 2003, BIOCHEM PHARMACOL, V65, P479, DOI 10.1016/S0006-2952(02)01510-1
   Olivares-Vicente M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122961
   Olivares-Vicente M, 2018, CURR DRUG METAB, V19, P351, DOI 10.2174/1389200219666180220095236
   Paiva-Martins F, 2013, J AGR FOOD CHEM, V61, P6636, DOI 10.1021/jf4016202
   Passamonti S, 2009, CURR DRUG METAB, V10, P369, DOI 10.2174/138920009788498950
   Peiró C, 2001, BRIT J PHARMACOL, V133, P967, DOI 10.1038/sj.bjp.0704184
   Petersen C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13298-z
   Peyrol J, 2018, J NUTR BIOCHEM, V51, P8, DOI 10.1016/j.jnutbio.2017.09.009
   Pick A, 2011, BIOORGAN MED CHEM, V19, P2090, DOI 10.1016/j.bmc.2010.12.043
   Poquet L, 2008, DRUG METAB DISPOS, V36, P190, DOI 10.1124/dmd.107.017558
   Quirantes-Piné R, 2013, PHYTOMEDICINE, V20, P1112, DOI 10.1016/j.phymed.2013.05.007
   Reid AM, 2019, MOLECULES, V24, DOI 10.3390/molecules24112191
   Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019
   Rubió L, 2014, FOOD RES INT, V65, P59, DOI 10.1016/j.foodres.2014.05.009
   Sánchez-Marzo N, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080324
   Shi FG, 2018, J SEP SCI, V41, P3830, DOI 10.1002/jssc.201800585
   Shi YT, 2013, J PHARMACEUT BIOMED, V75, P239, DOI 10.1016/j.jpba.2012.11.038
   Shimoi K, 2001, DRUG METAB DISPOS, V29, P1521
   Stevens JF, 2018, ANTIOXID REDOX SIGN, V29, P1589, DOI 10.1089/ars.2017.7404
   Su D, 2016, FITOTERAPIA, V112, P45, DOI 10.1016/j.fitote.2016.05.004
   Tang L, 2014, PHARM RES-DORDR, V31, P847, DOI 10.1007/s11095-013-1207-0
   Tang Y, 2016, FOOD RES INT, V89, P716, DOI 10.1016/j.foodres.2016.09.034
   Tsikas D, 2017, ANAL BIOCHEM, V524, P13, DOI 10.1016/j.ab.2016.10.021
   Tuck KL, 2002, J AGR FOOD CHEM, V50, P2404, DOI 10.1021/jf011264n
   Vermot A, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060890
   Walle UK, 2002, DRUG METAB DISPOS, V30, P564, DOI 10.1124/dmd.30.5.564
   Wang LP, 2017, DRUG METAB DISPOS, V45, P306, DOI 10.1124/dmd.116.073619
   Wu XL, 2009, MOL NUTR FOOD RES, V53, pS76, DOI 10.1002/mnfr.200800231
   Yang SY, 2019, BMC COMPLEM ALTERN M, V19, DOI [10.1186/s12870-019-1872-1, 10.1186/s12906-019-2551-3]
   Yin R, 2013, J PHARMACEUT BIOMED, V72, P127, DOI 10.1016/j.jpba.2012.09.028
   Zdunska K, 2018, SKIN PHARMACOL PHYS, V31, P332, DOI 10.1159/000491755
   Zhi H, 2020, J AGR FOOD CHEM, V68, P2063, DOI 10.1021/acs.jafc.9b06954
   Zhou F, 2018, J AGR FOOD CHEM, V66, P4630, DOI 10.1021/acs.jafc.8b01307
NR 70
TC 3
Z9 3
U1 4
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD APR 17
PY 2024
VL 72
IS 17
BP 9768
EP 9781
DI 10.1021/acs.jafc.3c06309
EA APR 2024
PG 14
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA TG7V1
UT WOS:001204952900001
PM 38629896
OA hybrid
DA 2025-04-28
ER

PT J
AU Jeszka-Skowron, M
   Flaczyk, E
   Jeszka, J
   Krejpcio, Z
   Król, E
   Buchowski, MS
AF Jeszka-Skowron, Magdalena
   Flaczyk, Ewa
   Jeszka, Jan
   Krejpcio, Zbigniew
   Krol, Ewelina
   Buchowski, Maciej S.
TI Mulberry leaf extract intake reduces hyperglycaemia in streptozotocin
   (STZ)-induced diabetic rats fed high-fat diet
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Mulberry; Diabetic rats; Carbohydrate metabolism; Antioxidant activity;
   Phenolics; High-fat diet
ID MORUS-ALBA L.; POSTPRANDIAL BLOOD-GLUCOSE; ANTIOXIDANT ACTIVITY;
   FLAVONOL GLYCOSIDES; OXIDATIVE STRESS; PHENOLIC-ACIDS; LEAVES;
   1-DEOXYNOJIRIMYCIN; METABOLISM; INHIBITION
AB This study evaluated the antioxidant activity and anti-diabetic effect of mulberry (Morus alba L. wielkolistna zolwinska) leaf extracts in diabetic rats fed a high-fat diet. After initial 4-week high-fat diet, streptozotocin was injected in Wistar rats to induce non-obese type 2 diabetes. After confirmation of diabetes, animals were treated with mulberry dried leaves, leaf-derived ethanol or acetone extracts added to high-fat diet for 4 weeks. Mulberry ethanol extract with higher level of phenolics - chlorogenic acid and flavonol glucosides was more effective than acetone extract or dry leaves in the lowering of blood glucose, increasing insulin level and markers of antioxidant activity. The results confirm key mechanisms related to the effect of mulberry and its bioactive components on modulation of glucose metabolism through correcting hyperglycaemia, increasing insulin secretion, and improving antioxidant status in STZ-induced non-obese diabetic rat model. Antidiabetic effects exerted by mulberry leaves might depend on the extraction process. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Jeszka-Skowron, Magdalena] Poznan Univ Tech, Dept Chem & Tech Electrochem, PL-60965 Poznan, Poland.
   [Flaczyk, Ewa] Poznan Univ Life Sci, Dept Food Serv & Catering, PL-60624 Poznan, Poland.
   [Jeszka, Jan; Krejpcio, Zbigniew; Krol, Ewelina] Poznan Univ Life Sci, Dept Human Nutr & Hyg, PL-60624 Poznan, Poland.
   [Buchowski, Maciej S.] Vanderbilt Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37072 USA.
C3 Poznan University of Technology; Poznan University of Life Sciences;
   Poznan University of Life Sciences; Vanderbilt University
RP Jeszka-Skowron, M (corresponding author), Poznan Univ Tech, Dept Chem & Tech Electrochem, Piotrowo 3, PL-60965 Poznan, Poland.
EM magdalena.jeszka-skowron@put.poznan.pl
RI Jeszka-Skowron, Magdalena/M-1489-2014; Krejpcio, Zbigiew/B-7584-2009;
   Król, Ewelina/AFG-9083-2022
OI Flaczyk, Ewa/0000-0002-7173-3223; KREJPCIO,
   ZBIGNIEW/0000-0002-4399-7459; Buchowski, Maciej/0000-0002-0566-1743;
   Krol, Ewelina/0000-0002-9942-1328
FU EU Project POIG [01.01.02.-00-061/09]; Polish Ministry of Science and
   Higher Education [NN312209138]
FX We thank Malgorzata Tubacka (University of Life Sciences, Poznan Poland)
   for her assistance with animal study and Rafal Wojciak (University of
   Life Sciences, Poznan Poland) for insulin determination. This research
   was supported by the EU Project POIG no. 01.01.02.-00-061/09 and Polish
   Ministry of Science and Higher Education grant No. NN312209138.
CR Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102
   Amarowicz R, 2000, NAHRUNG, V44, P60, DOI 10.1002/(SICI)1521-3803(20000101)44:1<60::AID-FOOD60>3.3.CO;2-C
   [Anonymous], 2011, PROGRAM PREVENTION T
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Buege J A, 1978, Methods Enzymol, V52, P302
   Ceriello A, 2012, VASC PHARMACOL, V57, P133, DOI 10.1016/j.vph.2012.05.005
   Chan YK, 2012, LAB ANIM-UK, V46, P142, DOI 10.1258/la.2011.011136
   Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3
   Chung HI, 2013, J FUNCT FOODS, V5, P1502, DOI 10.1016/j.jff.2013.04.015
   Davis N, 2009, MT SINAI J MED, V76, P257, DOI 10.1002/msj.20118
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   HANOZET G, 1981, J BIOL CHEM, V256, P3703
   Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359
   Janaszewska A, 2002, SCAND J CLIN LAB INV, V62, P231, DOI 10.1080/003655102317475498
   Jeszka-Skowron M, 2009, BROMATOLOGIA CHEM TO, V42, P2791
   Jeszka-Skowron M., 2014, FOOD SCI TECHNOLOGY, V91, P15
   Katsube T, 2006, FOOD CHEM, V97, P25, DOI 10.1016/j.foodchem.2005.03.019
   Katsube T, 2009, FOOD CHEM, V113, P964, DOI 10.1016/j.foodchem.2008.08.041
   Katsube T, 2010, J SCI FOOD AGR, V90, P2386, DOI 10.1002/jsfa.4096
   Khan Muhammad Ali, 2013, BMC Res Notes, V6, P24, DOI 10.1186/1756-0500-6-24
   Kimura T, 2004, BIOFACTORS, V22, P341, DOI 10.1002/biof.5520220167
   Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g
   Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392
   Król E, 2010, FOOD CHEM TOXICOL, V48, P2791, DOI 10.1016/j.fct.2010.07.008
   Kwon HJ, 2011, J AGR FOOD CHEM, V59, P3014, DOI 10.1021/jf103463f
   Lee CY, 2007, NUTR RES, V27, P492, DOI 10.1016/j.nutres.2007.06.004
   Lee J, 2008, J ETHNOPHARMACOL, V115, P263, DOI 10.1016/j.jep.2007.09.029
   Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006
   Memon Ayaz Ali, 2010, Polish Journal of Food and Nutrition Sciences, V60, P25
   Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844
   Mohammadi J, 2008, INDIAN J PHARMACOL, V40, P15, DOI 10.4103/0253-7613.40483
   Nakamura M, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-29
   Naowaboot J, 2009, PLANT FOOD HUM NUTR, V64, P116, DOI 10.1007/s11130-009-0112-5
   Ong KW, 2011, J ETHNOPHARMACOL, V133, P598, DOI 10.1016/j.jep.2010.10.046
   Park E, 2013, J FUNCT FOODS, V5, P178, DOI 10.1016/j.jff.2012.10.002
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Reuter T., 2007, DRUG DISCOV TODAY, V4, P1
   Rodríguez-Sánchez S, 2013, J AGR FOOD CHEM, V61, P4539, DOI 10.1021/jf305049k
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Singa ANB, 2005, J ETHNOPHARMACOL, V100, P333, DOI 10.1016/j.jep.2005.03.013
   Song W, 2009, J AGR FOOD CHEM, V57, P9133, DOI 10.1021/jf9022228
   Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004
   Srivastava S, 2006, INT J FOOD SCI NUTR, V57, P305, DOI 10.1080/09637480600801837
   Sunil C, 2011, J ETHNOPHARMACOL, V134, P298, DOI 10.1016/j.jep.2010.12.018
   Thabti I, 2012, J FUNCT FOODS, V4, P367, DOI 10.1016/j.jff.2012.01.006
   Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288
   Wu CH, 2013, J FUNCT FOODS, V5, P1620, DOI 10.1016/j.jff.2013.07.004
   Zeni ALB, 2010, REV BRAS FARMACOGN, V20, P130, DOI 10.1590/S0102-695X2010000100025
   Zhang L, 2010, J ETHNOPHARMACOL, V132, P518, DOI 10.1016/j.jep.2010.08.053
NR 51
TC 93
Z9 102
U1 3
U2 115
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD MAY
PY 2014
VL 8
BP 9
EP 17
DI 10.1016/j.jff.2014.02.018
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA AI5DH
UT WOS:000336885100002
DA 2025-04-28
ER

PT J
AU Lee, KW
   Kang, MS
   Lee, SJ
   Kim, HR
   Jang, KA
   Shin, D
AF Lee, Kyung Won
   Kang, Min-Sook
   Lee, Seung Jae
   Kim, Haeng-Ran
   Jang, Kyeong-A
   Shin, Dayeon
TI Prospective Associations between Dietary Patterns and Abdominal Obesity
   in Middle-Aged and Older Korean Adults
SO FOODS
LA English
DT Article
DE dietary pattern; factor analysis; abdominal obesity; KoGES; Korean
   adults
ID METABOLIC SYNDROME; COFFEE CONSUMPTION; CLUSTER-ANALYSIS; RISK-FACTORS;
   WEIGHT; PREVENTION; QUALITY; HEALTH; INDEX
AB This study aimed to identify major dietary patterns associated with abdominal obesity in middle-aged and older Korean adults. Data from the Korean Genome and Epidemiology Study were used. A total of 48,037 Korean adults aged >40 years without abdominal obesity at baseline were followed-up. Dietary assessment was conducted using a validated 106-item food-frequency questionnaire, and dietary patterns were identified using factor analysis. Abdominal obesity was defined as a waist circumference of >90 cm for men and >85 cm for women, according to the Korean Society for the Study of Obesity. Multivariable Cox proportional-hazards models were used to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the future risk of abdominal obesity for each dietary pattern after adjusting for potential covariates. After an average follow-up of 4.89 years, we reported 5878 cases (1932 men and 3946 women) of abdominal obesity.Based on factor analysis, three major dietary patterns were identified in both men and women: the "healthy", "coffee and sweets", and "multi-grain" patterns. In the fully adjusted model, the "healthy" pattern was inversely associated with the incidence of abdominal obesity (HR for fourth vs. first quartile: 0.86; 95% CI: 0.75-0.98; p for trend = 0.0358 for men; HR for fourth vs. first quartile: 0.90; 95% CI: 0.83-0.99; p for trend = 0.0188 for women), whereas the "coffee and sweets" pattern was positively associated with it (HR for fourth vs. first quartile: 1.23; 95% CI: 1.08-1.40; p for trend = 0.0495 for men; HR for fourth vs. first quartile: 1.14; 95% CI: 1.04-1.25; p for trend = 0.0096 for women). In contrast, the "multi-grain" pattern in men and women showed no significant association with the incidence of abdominal obesity. Diets rich in colorful vegetables, seaweeds, mushrooms, tubers, fruits, soy products, and fish and low in coffee, sweets, and oils/fats might be favorable for reducing the future risk of abdominal obesity, particularly in middle-aged and older Korean adults.
C1 [Lee, Kyung Won] Korea Natl Univ Educ, Dept Home Econ Educ, Cheongju 28173, South Korea.
   [Kang, Min-Sook; Kim, Haeng-Ran; Jang, Kyeong-A] Dept Agrofood Resources, Rural Dev Adm, Natl Inst Agr Sci, Wonju 55365, South Korea.
   [Lee, Seung Jae] Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul 03760, South Korea.
   [Shin, Dayeon] Inha Univ, Dept Food & Nutr, Incheon 22212, South Korea.
C3 Korea National University of Education; National Institute of
   Agricultural Sciences; Rural Development Administration (RDA), Republic
   of Korea; Ewha Womans University; Inha University
RP Lee, KW (corresponding author), Korea Natl Univ Educ, Dept Home Econ Educ, Cheongju 28173, South Korea.; Shin, D (corresponding author), Inha Univ, Dept Food & Nutr, Incheon 22212, South Korea.
EM kwlee@knue.ac.kr; dyshin@inha.ac.kr
RI KIM, JEONGSEON/AAA-4643-2022; Shin, Dayeon/GMX-2004-2022
OI Shin, Dayeon/0000-0003-0828-184X
FU Cooperative Research Program for Agriculture, Science, and Technology
   Development of the Rural Development Administration, Republic of Korea
   [PJ016762]
FX This work was carried out with the support of the Cooperative Research
   Program for Agriculture, Science, and Technology Development (Project
   No. PJ016762) of the Rural Development Administration, Republic of
   Korea.
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   Ahn YounJhin Ahn YounJhin, 2007, Korean Journal of Nutrition, V40, P259
   Asghari G, 2017, BRIT J NUTR, V117, P1055, DOI 10.1017/S0007114517000915
   Bahadoran Z, 2013, J HUM NUTR DIET, V26, P145, DOI 10.1111/jhn.12048
   Basiri MG, 2015, INT J VITAM NUTR RES, V85, P145, DOI 10.1024/0300-9831/a000233
   Brauchla M, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/736258
   Chiva-Blanch G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5812401
   Choi K.P., 2014, FOOD IND NUTR, V19, P1
   Couillard C, 2005, J CLIN ENDOCR METAB, V90, P6454, DOI 10.1210/jc.2004-2438
   Dinh QN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406960
   Fang HJ, 2018, CURR OPIN CLIN NUTR, V21, P360, DOI 10.1097/MCO.0000000000000485
   Garcia-Diaz DF, 2014, J NUTR SCI VITAMINOL, V60, P367, DOI 10.3177/jnsv.60.367
   Gavrieli A, 2013, OBESITY, V21, P1127, DOI 10.1002/oby.20190
   Goodwin K, 2015, J NUTRIGENET NUTRIGE, V8, P164, DOI 10.1159/000442090
   Hajhashemy Z, 2021, OBES REV, V22, DOI 10.1111/obr.13134
   Hodge AM, 2021, PUBLIC HEALTH NUTR, V24, P6157, DOI 10.1017/S1368980021001713
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Hyundai Research Institute, 5 TRENDS PROSP COFF
   Im J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082312
   Ito T, 2019, NUTRITION, V58, P149, DOI 10.1016/j.nut.2018.05.029
   Jia XJ, 2019, MEDICINE, V98, DOI [10.1097/md.0000000000014469, 10.1097/MD.0000000000014469]
   Kim BY, 2021, J OBES METAB SYNDR, V30, P81, DOI 10.7570/jomes21022
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim J, 2015, NUTRIENTS, V7, P4154, DOI 10.3390/nu7064154
   Kim JH, 2012, J ACAD NUTR DIET, V112, P1550, DOI 10.1016/j.jand.2012.06.369
   Kim SA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122992
   Kim Y, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv316
   Korea Health Industry Development Institute, KOR NAT NUTR STAT
   Korean Society for the Study of Obesity, 2021, Obesity fact sheet
   LaRowe TL, 2007, J AM DIET ASSOC, V107, P1124, DOI 10.1016/j.jada.2007.04.013
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593
   Lee HA, 2019, J NUTR, V149, P323, DOI 10.1093/jn/nxy274
   Lee KW, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081801
   Lee KW, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060630
   Lim M, 2020, EUR J NUTR, V59, P1667, DOI 10.1007/s00394-019-02021-5
   Moreira PL, 2014, REV ASSOC MED BRAS, V60, P457, DOI 10.1590/1806-9282.60.05.014
   남정혜, 2006, [The Korean Journal of Food and Nutrition, 한국식품영양학회지], V19, P70
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Nicklas TA, 2012, J NUTR, V142, P2112, DOI 10.3945/jn.112.164889
   Rezagholizadeh F, 2017, NUTR RES, V41, P1, DOI 10.1016/j.nutres.2017.01.006
   Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005
   Rodriguez-Ramirez S, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.891609
   Rural Development Administration National Institute of Agricultural Sciences, KOR FOOD COMP DAT
   Sacks Frank M., 1995, Annals of Epidemiology, V5, P108, DOI 10.1016/1047-2797(94)00055-X
   Salinardi TC, 2010, J NUTR, V140, P1943, DOI 10.3945/jn.110.128207
   Sandoval-Insausti H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082368
   SCHWERIN HS, 1981, AM J CLIN NUTR, V34, P568, DOI 10.1093/ajcn/34.4.568
   Song S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020252
   Suliga E, 2017, INT J FOOD SCI NUTR, V68, P507, DOI 10.1080/09637486.2016.1256381
   Tande DL, 2010, PUBLIC HEALTH NUTR, V13, P208, DOI 10.1017/S1368980009990723
   Weickert MO, 2008, J NUTR, V138, P439, DOI 10.1093/jn/138.3.439
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
   Wirfalt AKE, 1997, J AM DIET ASSOC, V97, P272, DOI 10.1016/S0002-8223(97)00071-0
   Xue Y, 2022, BRIT J NUTR, V128, P762, DOI 10.1017/S0007114521003640
   Yin XY, 2020, NUTR DIABETES, V10, DOI 10.1038/s41387-020-0120-y
   Yu ZM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018060
   Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714
   Zhang Q, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111080
NR 59
TC 2
Z9 2
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD MAY 26
PY 2023
VL 12
IS 11
AR 2148
DI 10.3390/foods12112148
PG 14
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA I8VW6
UT WOS:001005515700001
PM 37297392
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Flores, G
   Lin, H
AF Flores, G.
   Lin, H.
TI Factors predicting severe childhood obesity in kindergarteners
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE overweight; children; early childhood; recursive partitioning analysis
ID BODY-MASS INDEX; BEVERAGE CONSUMPTION; CARDIOVASCULAR RISK;
   PHYSICAL-ACTIVITY; WEIGHT STATUS; LIFE-STYLE; CHILDREN; OVERWEIGHT;
   CARE; BMI
AB BACKGROUND: Severe obesity has increased >300% in US children since 1976, and is associated with multiple cardiovascular risk factors and high adult obesity rates.
   OBJECTIVE: The objective of this study was to identify predictors of severe obesity in kindergarteners.
   METHODS: Multivariable logistic regression and recursive partitioning analysis (RPA) were used to identify prenatal/pregnancy, infant, and early childhood predictors of severe kindergarten obesity (body mass index (BMI) >= 99th percentile) in the Early Childhood Longitudinal Study Birth Cohort, a nationally representative longitudinal study that followed children from birth through kindergarten.
   RESULTS: For the 6800 children, the severe kindergarten obesity prevalence was 5.7%, with higher adjusted odds for crossing the 85th percentile of BMI at 2 years old (odds ratio (OR), 8.0; 95% confidence interval (CI), 4.1-15.7), preschool age (OR, 7.9; 95% CI, 4.9-12.8) and 9 months old (OR, 1.8; 95% CI, 1.2-2.6); maternal severe obesity (OR, 3.4; 95% CI, 1.9-5.8) and gestational diabetes (OR, 2.9; 95% CI, 1.5-5.5); drinking tea or coffee between meals/before bedtime at 2 years old (OR, 3.3; 95% CI, 1.3-8.5); Latino (OR, 2.3; 95% CI, 1.4-3.7) and multiracial (OR, 2.3; 95% CI, 1.1-4.8) race/ethnicity; and drinking sugary beverages at kindergarten age at least weekly (OR, 2.3; 95% CI, 1.4-3.7). Ever-attending center-based daycare (OR, 0.3; 95% CI, 0.1-0.9), eating fruit at least weekly at kindergarten age (OR, 0.3; 95% CI, 0.1-0.7), and maternal history of a prior newborn birth weight >= 4000 g (OR, 0.1; 95% CI, 0.02-0.6) were associated with reduced odds of severe obesity. RPA identified low severe obesity prevalence (1.9%) for non-85th BMI-percentile preschool crossers and high severe obesity (56-80%) for predictor clusters which included crossing the 85th BMI percentile at earlier ages, low parental education, specific maternal age cutoffs, preschooler bedtime rules, and outside walking/play frequency for 9-month-olds.
   CONCLUSIONS: Certain parental, prenatal/pregnancy, infant, and early childhood factors, both alone and in combination, are potent predictors of severe obesity in kindergarteners. International Journal of Obesity (2013) 37, 31-39; doi: 10.1038/ijo.2012.168; published online 13 November 2012
C1 [Flores, G.; Lin, H.] UT SW Med Ctr, Dept Pediat, Div Gen Pediat, Dallas, TX 75390 USA.
   [Flores, G.] Childrens Med Ctr, Dallas, TX 75235 USA.
C3 University of Texas System; University of Texas Southwestern Medical
   Center Dallas
RP Flores, G (corresponding author), UT SW Med Ctr, Dept Pediat, Div Gen Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
EM glenn.flores@utsouthwestern.edu
CR Ambalavanan N, 2011, PEDIATRICS, V128, pE1216, DOI 10.1542/peds.2011-1142
   [Anonymous], US PROC MULTT PERF M
   [Anonymous], 2007, 2007084 NCES US DEP
   [Anonymous], 2000 CDC GROWTH CHAR
   [Anonymous], 2010, 2010009 NCES US DEP
   Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C
   Benjamin SE, 2009, PEDIATRICS, V124, P555, DOI 10.1542/peds.2008-2857
   Burke V, 2001, INT J OBESITY, V25, P147, DOI 10.1038/sj.ijo.0801538
   Dennison BA, 2006, OBESITY, V14, P491, DOI 10.1038/oby.2006.64
   Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Ekelund U, 2006, AM J CLIN NUTR, V83, P324
   Feinstein A. R., 1996, Multivariable Analysis: an Introduction
   Flores G, 2008, PEDIATRICS, V121, pE286, DOI 10.1542/peds.2007-1243
   Flores G, 2012, J ACAD NUTR DIET, V112, P81, DOI 10.1016/j.jada.2011.08.041
   Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042
   Freedman DS, 2006, OBESITY, V14, P301, DOI 10.1038/oby.2006.39
   Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E
   Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361
   Hui LL, 2008, ARCH PEDIAT ADOL MED, V162, P212, DOI 10.1001/archpediatrics.2007.62
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308
   KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295
   Koleilat M, 2012, MATERN CHILD HLTH J, V16, P706, DOI 10.1007/s10995-011-0774-0
   Lumeng JC, 2005, INT J OBESITY, V29, P60, DOI 10.1038/sj.ijo.0802848
   Maffeis C, 1998, INT J OBESITY, V22, P758, DOI 10.1038/sj.ijo.0800655
   Maher EJ, 2008, PEDIATRICS, V122, P322, DOI 10.1542/peds.2007-2233
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Mårild S, 2004, ACTA PAEDIATR, V93, P1588, DOI 10.1080/08035250410018265
   Moraeus L, 2012, INT J OBESITY, V36, P969, DOI 10.1038/ijo.2012.79
   Neuman MI, 2011, PEDIATRICS, V128, P246, DOI 10.1542/peds.2010-3367
   Ortega H, 2012, J ASTHMA, V49, P158, DOI 10.3109/02770903.2011.649872
   Philipps LH, 2011, DIABETOLOGIA, V54, P1957, DOI 10.1007/s00125-011-2180-y
   Rappaport EB, 2011, J SCHOOL HEALTH, V81, P341, DOI 10.1111/j.1746-1561.2011.00599.x
   Rolls BJ, 2004, NUTR REV, V62, P1, DOI [10.1301/nr.2004.jan.1–17, 10.1301/nr.2004.jan.1-17, 10.1111/j.1753-4887.2004.tb00001.x]
   Scott JG, 2012, CANCER-AM CANCER SOC, V118, P5595, DOI 10.1002/cncr.27570
   Semmler C, 2009, OBESITY, V17, P814, DOI 10.1038/oby.2008.621
   Silverwood RJ, 2009, INT J OBESITY, V33, P929, DOI 10.1038/ijo.2009.108
   Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005
   Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182
   Skinner AC, 2009, PEDIATRICS, V124, pE905, DOI 10.1542/peds.2009-0179
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Storey ML, 2006, J AM DIET ASSOC, V106, P1992, DOI 10.1016/j.jada.2006.09.009
   Tandon PS, 2012, J NUTR EDUC BEHAV, V44, P355, DOI 10.1016/j.jneb.2011.10.009
   Taveras EM, 2009, PEDIATRICS, V123, P1177, DOI 10.1542/peds.2008-1149
   Therneau T.M., 1997, INTRO RECURSIVE PART, P1
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301
   Zask A, 2012, HEALTH PROMOT J AUST, V23, P10, DOI 10.1071/HE12010
   Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690
NR 50
TC 49
Z9 63
U1 0
U2 67
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD JAN
PY 2013
VL 37
IS 1
BP 31
EP 39
DI 10.1038/ijo.2012.168
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 068HW
UT WOS:000313358100004
PM 23147114
DA 2025-04-28
ER

PT J
AU Zheng, YL
   Choi, YH
   Lee, JH
   Lee, SY
   Kang, IJ
AF Zheng, Yulong
   Choi, Yoon-Hee
   Lee, Ji-Hyun
   Lee, So-Yeon
   Kang, Il-Jun
TI Anti-Obesity Effect of Erigeron annuus (L.) Pers. Extract
   Containing Phenolic Acids
SO FOODS
LA English
DT Article
DE C57BL/6J mice; high-fat diet; anti-obesity; AMPK pathway; phenolic acid;
   Erigeron annuus (L.) Pers
ID ACTIVATED PROTEIN-KINASE; AMPK ACTIVATION; ANTIOXIDANT PROPERTIES; RED
   GINSENG; METABOLISM; IDENTIFICATION; GLYCATION; FLOWERS; OBESITY; TARGET
AB Erigeron annuus (L.) Pers. water extract (EAW) was investigated for its anti-obesity effects in C57BL/6J mice on a high-fat diet. Mice were divided into groups fed normal and high-fat diets (ND and HFD, respectively), and HFD mice were treated with EAW (50, 100, and 200 mg/kg/day) for 8 weeks. Inhibition of HFD-induced obesity by EAW was evaluated using biochemical parameters, immunohistochemistry, real-time PCR, and immunoblot assay. EAW supplementation significantly diminished the final body weight, adipose tissue size, and epididymal adipose tissue volume compared with mice with obesity induced by HFD (p < 0.05 for all). EAW also decreased serum triglyceride (TG) and LDL-cholesterol (LDL-c) levels in obese mice. EAW attenuated HFD-induced obesity by down-regulating C/EBP alpha, PPAR gamma, and SREBP-1c to suppress adipogenesis. Moreover, this study indicated that EAW activates the AMPK pathway and increases ACC phosphorylation and downstream CPT1 expression in HFD-induced obese mice. Furthermore, several phenolic acids with anti-obesity properties have been identified in EAW, including quinic acid, caffeic acid, chlorogenic acid, and 3,4-dicaffeoylquinic acid. Based on these data, EAW has anti-obesity effects in vivo, which indicates that it is an excellent candidate for the development of anti-obesity functional foods.
C1 [Zheng, Yulong; Lee, Ji-Hyun; Lee, So-Yeon; Kang, Il-Jun] Hallym Univ, Dept Food Sci & Nutr, Chunchon 24252, South Korea.
   [Zheng, Yulong; Lee, Ji-Hyun; Lee, So-Yeon; Kang, Il-Jun] Hallym Univ, Korean Inst Nutr, Chunchon 24252, South Korea.
   [Choi, Yoon-Hee] Hallym Polytech Univ, Dept Food & Nutr, Chunchon 24210, South Korea.
C3 Hallym University; Hallym University
RP Kang, IJ (corresponding author), Hallym Univ, Dept Food Sci & Nutr, Chunchon 24252, South Korea.; Kang, IJ (corresponding author), Hallym Univ, Korean Inst Nutr, Chunchon 24252, South Korea.
EM zyl1994@naver.com; cyh@hsc.ac.kr; leejihyun@hallym.ac.kr;
   syeon300@hallym.ac.kr; ijkang@hallym.ac.kr
RI 郑, 禹龙/KIG-3817-2024; KANG, IL-JUN/AAN-9277-2020; choi,
   Yoon/AAK-5172-2021
OI Kang, Il-Jun/0000-0003-0314-5195
FU Hallym University Research Fund [HRF-202010-003]
FX This research was supported by Hallym University Research Fund, 2020
   (HRF-202010-003).
CR Ahmad B, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00076
   Bertrand L, 2006, AM J PHYSIOL-HEART C, V291, pH239, DOI 10.1152/ajpheart.01269.2005
   Coughlan KA, 2014, DIABET METAB SYND OB, V7, P241, DOI 10.2147/DMSO.S43731
   Duangjai Acharaporn, 2018, Kobe J Med Sci, V64, pE84
   Durazzo A, 2017, FOODS, V6, DOI 10.3390/foods6030017
   Fathoni A, 2017, AIP CONF PROC, V1862, DOI 10.1063/1.4991183
   Felipe DF, 2014, MOLECULES, V19, P15720, DOI 10.3390/molecules191015720
   Foretz M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092826
   Ha JH, 2016, INT J MOL MED, V37, P816, DOI 10.3892/ijmm.2016.2484
   Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Jang DS, 2008, ARCH PHARM RES, V31, P900, DOI 10.1007/s12272-001-1244-z
   Jeong CH, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-25
   Jo MJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/297427
   Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13
   Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159990
   Kim Y, 2018, J AM SOC NEPHROL, V29, P1108, DOI 10.1681/ASN.2017060627
   Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218
   Lee HJ, 2006, BIOTECHNOL BIOPROC E, V11, P13, DOI 10.1007/BF02931862
   Li SS, 2016, J CHROMATOGR SCI, V54, P1225, DOI 10.1093/chromsci/bmw055
   Liao CC, 2013, J AGR FOOD CHEM, V61, P11082, DOI 10.1021/jf4026647
   Lindholm CR, 2013, J PHYSIOL BIOCHEM, V69, P165, DOI 10.1007/s13105-012-0199-2
   Liu YF, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8943059
   Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358
   Nazaruk J, 2009, MOLECULES, V14, P2458, DOI 10.3390/molecules14072458
   Nigro E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/658913
   Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Qu Q, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.132
   Randy A, 2016, J FUNCT FOODS, V27, P1, DOI 10.1016/j.jff.2016.08.050
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Simirgiotis MJ, 2015, MOLECULES, V20, P11490, DOI 10.3390/molecules200611490
   Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882
   Sudhakar M, 2020, J FUNCT FOODS, V74, DOI 10.1016/j.jff.2020.104161
   Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x
   Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523
   Yoo NH, 2008, J NAT PROD, V71, P713, DOI 10.1021/np070489a
   Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505
   Zheng YL, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092744
   Zheng Y, 2020, J MED FOOD, V23, P215, DOI 10.1089/jmf.2019.4660
NR 40
TC 11
Z9 12
U1 5
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD JUN
PY 2021
VL 10
IS 6
AR 1266
DI 10.3390/foods10061266
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA TA0SJ
UT WOS:000666964900001
PM 34199426
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Zyzelewicz, D
   Kulbat-Warycha, K
   Oracz, J
   Zyelewicz, K
AF Zyzelewicz, Dorota
   Kulbat-Warycha, Kamila
   Oracz, Joanna
   Zyelewicz, Kacper
TI Polyphenols and Other Bioactive Compounds ofSideritisPlants and
   Their Potential Biological Activity
SO MOLECULES
LA English
DT Review
DE Sideritis scardica; polyphenols; biological active compounds; gut
   microbiota; antioxidant; anti-inflammatory and neuroprotective
   properties
ID ACTIVATED PROTEIN-KINASE; SIDERITIS-SCARDICA GRISEB.; OXIDATIVE
   DNA-DAMAGE; P-COUMARIC ACID; ANTIOXIDANT ACTIVITY; PHENYLETHANOID
   GLYCOSIDES; CHLOROGENIC ACID; CYCLOOXYGENASE-2 EXPRESSION;
   CHEMICAL-COMPOSITION; LIPID-PEROXIDATION
AB Due to the growing problem of obesity associated with type 2 diabetes and cardiovascular diseases, causes of obesity are extensively investigated. In addition to a high caloric diet and low physical activity, gut microbiota disturbance may have a potential impact on excessive weight gain. Some reports indicate differences in the composition of the intestinal microflora of obese people in comparison to lean. Bioactive compounds of natural origin with beneficial and multifaceted effects on the body are more frequently used in prevention and treatment of many metabolic diseases including obesity.Sideritis scardicais traditionally consumed as mountain tea in the Balkans to strengthen the body and improve mood. Many reports indicate a positive effect on digestive system, weight loss, and prevention of insulin resistance. Additionally, it exhibits antioxidant activity and anti-inflammatory effects. The positive effect ofSideritis scardicaextracts on memory and general cognitive abilities is indicated as well. The multilevel positive effect on the body appears to originate from the abundant occurrence of phenolic compounds, especially phenolic acids inSideritis scardicaextracts. However, mechanisms underlying their action require careful discussion and further research. Therefore, the objective of this review is to summarize the available knowledge on the role and mechanism of action of biologically active compounds ofSideritis scardicaand other related species from the genusSideritis.
C1 [Zyzelewicz, Dorota; Kulbat-Warycha, Kamila; Oracz, Joanna] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Food Technol & Anal, PL-90924 Lodz, Poland.
   [Zyelewicz, Kacper] Med Univ Lodz, Fac Hlth Sci, PL-90647 Lodz, Poland.
C3 Lodz University of Technology; Medical University Lodz
RP Zyzelewicz, D (corresponding author), Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Food Technol & Anal, PL-90924 Lodz, Poland.
EM dorota.zyzelewicz@p.lodz.pl; kamila.kulbat-warycha@p.lodz.pl;
   joanna.oracz@p.lodz.pl; kaczyze@gmail.com
RI ; Oracz, Joanna/M-3099-2018; Zyzelewicz, Dorota/M-3397-2018
OI Kulbat-Warycha, Kamila/0000-0002-6094-9942; Oracz,
   Joanna/0000-0003-2469-3369; Zyzelewicz, Dorota/0000-0003-0989-0671
CR Akcos Y, 1999, PHARM BIOL, V37, P118, DOI 10.1076/phbi.37.2.118.6081
   Ali F, 2017, INT J FOOD PROP, V20, P1197, DOI 10.1080/10942912.2016.1207188
   [Anonymous], MATTER
   [Anonymous], 1988, PHYTOTHER RES, DOI DOI 10.1002/PTR.2650020208
   [Anonymous], 2011, J BAEKJE STUDY, DOI DOI 10.1186/1753-6561-5-S8-P20
   Axiotis E, 2020, MOLECULES, V25, DOI 10.3390/molecules25092022
   Balez R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31450
   Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005
   Bașer K. H. C., 1997, Journal of Essential Oil Research, V9, P205
   Behrendt I., 2016, Int. J. Phytomed, V8, P95
   Caltagirone S, 2000, INT J CANCER, V87, P595, DOI 10.1002/1097-0215(20000815)87:4<595::AID-IJC21>3.0.CO;2-5
   Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001
   Casalini C, 1999, EUR J NUTR, V38, P190, DOI 10.1007/s003940050061
   Charami MT, 2008, PHYTOTHER RES, V22, P450, DOI 10.1002/ptr.2333
   Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028
   Cheng HY, 2010, PHYTOTHER RES, V24, pS102, DOI 10.1002/ptr.2940
   Couteau D, 2001, J APPL MICROBIOL, V90, P873, DOI 10.1046/j.1365-2672.2001.01316.x
   Cui QL, 2018, J AGR FOOD CHEM, V66, P2660, DOI 10.1021/acs.jafc.7b04650
   Barros HRD, 2016, J FUNCT FOODS, V22, P477, DOI 10.1016/j.jff.2016.02.009
   Del Rio D, 2010, NUTRIENTS, V2, P820, DOI 10.3390/nu2080820
   El-Askary H, 2019, REV BRAS FARMACOGN, V29, P213, DOI 10.1016/j.bjp.2018.10.001
   Farid MM, 2019, BIOCATAL AGR BIOTECH, V22, DOI 10.1016/j.bcab.2019.101431
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   González-Burgos E, 2011, J ETHNOPHARMACOL, V135, P209, DOI 10.1016/j.jep.2011.03.014
   Guven M, 2015, INFLAMMATION, V38, P2124, DOI 10.1007/s10753-015-0195-0
   Guven M, 2015, INFLAMMATION, V38, P1986, DOI 10.1007/s10753-015-0179-0
   Guven M, 2015, IRAN J BASIC MED SCI, V18, P356
   Güvenç A, 2005, PHARM BIOL, V43, P173, DOI 10.1080/13880200590919528
   Hanske L, 2009, J NUTR, V139, P1095, DOI 10.3945/jn.108.102814
   Harris GK, 2006, J NUTR, V136, P1517, DOI 10.1093/jn/136.6.1517
   Heiner F, 2018, PEERJ, V6, DOI 10.7717/peerj.4683
   Hofrichter J, 2016, J ALZHEIMERS DIS, V53, P967, DOI 10.3233/JAD-160301
   Hostetler GL, 2017, ADV NUTR, V8, P423, DOI 10.3945/an.116.012948
   Hur JY, 2001, BIOL PHARM BULL, V24, P921, DOI 10.1248/bpb.24.921
   Ibraliu A., 2015, European Journal of Medicinal Plants, V5, P328, DOI 10.9734/EJMP/2015/14389
   Irakli M, 2018, J APPL RES MED AROMA, V8, P67, DOI 10.1016/j.jarmap.2017.12.001
   Iwai K, 2004, J AGR FOOD CHEM, V52, P4893, DOI 10.1021/jf040048m
   Jeremic I, 2019, PLANTA MED, V85, P465, DOI 10.1055/a-0835-6622
   JIMENEZ C, 1994, NAT PROD REP, V11, P591, DOI 10.1039/np9941100591
   Jung WW, 2014, INT J MOL MED, V33, P1327, DOI 10.3892/ijmm.2014.1666
   Kang KA, 2017, INT J ONCOL, V51, P1169, DOI 10.3892/ijo.2017.4091
   Karmakar S, 2009, BIOCHEM BIOPH RES CO, V388, P705, DOI 10.1016/j.bbrc.2009.08.071
   Karpinski TM, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010103
   Kassi E, 2013, CLIN LIPIDOL, V8, P627, DOI 10.2217/clp.13.64
   Kiliç I, 2013, SPECTROCHIM ACTA A, V115, P719, DOI 10.1016/j.saa.2013.06.110
   Kloukina Charalampia, 2019, Natural Volatiles & Essential Oils, V6, P16
   Knörle R, 2012, J NEURAL TRANSM, V119, P1477, DOI 10.1007/s00702-012-0824-9
   Koh Phil-Ok, 2012, Lab Anim Res, V28, P273, DOI 10.5625/lar.2012.28.4.273
   Korkina L.G., 2007, CELL MOL BIOL, V53, P78
   Kostyuk VA, 2011, EUR J PHARMACOL, V658, P248, DOI 10.1016/j.ejphar.2011.02.022
   Koutsaviti A, 2013, REC NAT PROD, V7, P6
   Lee JH, 2007, ARCH PHARM RES, V30, P1318, DOI 10.1007/BF02980273
   Li Y, 2016, J PHARMACEUT BIOMED, V118, P167, DOI 10.1016/j.jpba.2015.10.038
   Li YJ, 2014, J PHARMACEUT BIOMED, V89, P251, DOI 10.1016/j.jpba.2013.11.014
   Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015
   Liu R, 2009, NEUROSCIENCE, V162, P1232, DOI 10.1016/j.neuroscience.2009.05.009
   Liu R, 2011, J ALZHEIMERS DIS, V24, P85, DOI 10.3233/JAD-2010-101593
   Liu Rui, 2010, Chinese Journal of Natural Medicines, V8, P223, DOI 10.3724/SP.J.1009.2010.00223
   Lodovici M, 2000, FOOD CHEM TOXICOL, V38, P1085, DOI 10.1016/S0278-6915(00)00109-5
   Marín L, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/905215
   Mazzon E, 2009, N-S ARCH PHARMACOL, V380, P79, DOI 10.1007/s00210-009-0400-5
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Myhrstad MCW, 2002, FREE RADICAL BIO MED, V32, P386, DOI 10.1016/S0891-5849(01)00812-7
   Nakajima Y, 2007, LIFE SCI, V80, P370, DOI 10.1016/j.lfs.2006.09.017
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Panda S, 2007, J PHARM PHARMACOL, V59, P1543, DOI 10.1211/jpp.59.11.0012
   Patil SP, 2014, NEUROPHARMACOLOGY, V86, P192, DOI 10.1016/j.neuropharm.2014.07.012
   Petreska J, 2011, FOOD CHEM, V125, P13, DOI 10.1016/j.foodchem.2010.08.019
   Petreska J, 2011, NAT PROD COMMUN, V6, P21
   Qi M, 2013, J CHROMATOGR B, V940, P77, DOI 10.1016/j.jchromb.2013.09.023
   Quirantes-Piné R, 2013, PHYTOMEDICINE, V20, P1112, DOI 10.1016/j.phymed.2013.05.007
   Raafat KM, 2019, AVICENNA J PHYTOMEDI, V9, P221, DOI 10.22038/AJP.2019.12218
   da Silva ACR, 2012, MOLECULES, V17, P6305, DOI 10.3390/molecules17066305
   Rosa LD, 2018, MOLECULES, V23, DOI 10.3390/molecules23102569
   Sagdic O, 2008, INNOV FOOD SCI EMERG, V9, P80, DOI 10.1016/j.ifset.2007.06.001
   Sarikurkcu C, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01642
   Sarnowska E, 2013, POSTEP HIG MED DOSW, V67, P750
   Savtschenko A., 2013, Z. Phytother, V34, P25, DOI [DOI 10.1055/S-0033-1338227, 10.1055/s-0033-1338227]
   Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6
   Schoefer L, 2003, APPL ENVIRON MICROB, V69, P5849, DOI 10.1128/AEM.69.10.5849-5854.2003
   Seo HS, 2012, MOL CELL BIOCHEM, V366, P319, DOI 10.1007/s11010-012-1310-2
   Shailasree S, 2015, MOL NEUROBIOL, V51, P119, DOI 10.1007/s12035-014-8700-2
   Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0
   Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7
   Simons AL, 2005, J AGR FOOD CHEM, V53, P4258, DOI 10.1021/jf0500177
   Singh JPV, 2004, PHYTOMEDICINE, V11, P309, DOI 10.1078/0944711041495254
   Speranza L, 2010, PHYTOTHER RES, V24, P1398, DOI 10.1002/ptr.3173
   Stanoeva JP, 2015, BIOCHEM SYST ECOL, V61, P477, DOI 10.1016/j.bse.2015.07.008
   Stanoeva JP, 2013, J AGR FOOD CHEM, V61, P10488, DOI 10.1021/jf403052w
   Tadic V.M., 2007, PLANTA MED, V73, P2683, DOI [10.1055/s-2007-986880, DOI 10.1055/S-2007-986880]
   Tadic V, 2012, MOLECULES, V17, P2683, DOI 10.3390/molecules17032683
   Tadic VM, 2012, PLANTA MED, V78, P415, DOI 10.1055/s-0031-1298172
   Todorova M, 2014, J ETHNOPHARMACOL, V152, P256, DOI 10.1016/j.jep.2014.01.022
   Ugur A, 2005, PHARM BIOL, V43, P47, DOI 10.1080/13880200590903354
   Vasilopoulou CG, 2013, EUR J NUTR, V52, P107, DOI 10.1007/s00394-011-0292-2
   Vertuani S, 2011, MOLECULES, V16, P7068, DOI 10.3390/molecules16087068
   VILLAR A, 1984, J PHARM PHARMACOL, V36, P820, DOI 10.1111/j.2042-7158.1984.tb04884.x
   VIOLA H, 1995, PLANTA MED, V61, P213, DOI 10.1055/s-2006-958058
   Wang MQ, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7010467
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wightman EL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080955
   Wu YT, 2006, J CHROMATOGR B, V844, P89, DOI 10.1016/j.jchromb.2006.07.011
   Xagorari A, 2001, J PHARMACOL EXP THER, V296, P181
   Yaneva I., 2013, Bulgarian Journal of Public Health, V5, P48
   Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188
   Zhang F, 2014, NEUROL SCI, V35, P583, DOI 10.1007/s10072-013-1566-7
   Zhao G, 2010, NEUROCHEM INT, V56, P168, DOI 10.1016/j.neuint.2009.09.015
   Zhao L, 2013, MOLECULES, V18, P9949, DOI 10.3390/molecules18089949
   Zhao M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-104
   Zhou F, 2018, J AGR FOOD CHEM, V66, P4630, DOI 10.1021/acs.jafc.8b01307
   Zhou G, 2009, ACTA PHYSIOL, V196, P175, DOI 10.1111/j.1748-1716.2009.01967.x
   Zhou W, 2014, PHYTOMEDICINE, V21, P1549, DOI 10.1016/j.phymed.2014.06.016
   Zhu M, 2010, INT J SPORTS MED, V31, P537, DOI 10.1055/s-0030-1254115
NR 113
TC 46
Z9 48
U1 7
U2 39
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD AUG
PY 2020
VL 25
IS 16
AR 3763
DI 10.3390/molecules25163763
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA OA4YA
UT WOS:000577791500001
PM 32824863
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Podsedek, A
   Zaklos-Szyda, M
   Polka, D
   Sosnowska, D
AF Podsedek, Anna
   Zaklos-Szyda, Malgorzata
   Polka, Dominika
   Sosnowska, Dorota
TI Effects of Viburnum opulus fruit extracts on adipogenesis of
   3T3-L1 cells and lipase activity
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Viburnum opulus fruit; Adipocytes; Lipase activity; Phenolic compounds
ID INHIBIT PANCREATIC LIPASE; ANTIOXIDANT PROPERTIES; DIETARY POLYPHENOLS;
   ALPHA-GLUCOSIDASE; L.; COMPONENTS; LEGUMES; OBESITY; PROFILE; ACIDS
AB In this study, the anti-obesity effect and mechanism of action of Viburnim opulus fruit crude extract (CE) and semi-purified phenolic extract (SPPE) in 3T3-L1 cells were studied. In addition, inhibitory activity of extracts against pancreatic lipase in triolein emulsion was estimated, as well as their phenolic profiles by UPLC/Q-TOF-MS. Twenty four phenolic compounds were identified in both extracts with chlorogenic acid as the dominant compound. The inhibition mode of extracts against lipase was competitive and SPPE demonstrated synergistic action with orlistat. Both extracts had the ability to inhibit adipogenesis process in a dose-dependent manner. Cells treatment with extracts at 75 mu g/mL concentration was not only sufficient to inhibit lipids accumulation at almost 20%, but also influenced the size of lipid droplets. CE and SPPE reduced intracellular reactive oxygen species production by 20% and leptin level by 21-30%. They did not affect the peroxisome proliferator-activated receptor-gamma and adiponectin protein expression levels.
C1 [Podsedek, Anna; Zaklos-Szyda, Malgorzata; Polka, Dominika; Sosnowska, Dorota] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Mol & Ind Biotechnol, Stefanowskiego 4-10, PL-90924 Lodz, Poland.
C3 Lodz University of Technology
RP Podsedek, A (corresponding author), Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Mol & Ind Biotechnol, Stefanowskiego 4-10, PL-90924 Lodz, Poland.
EM anna.podsedek@p.lodz.pl
RI Dorota, Sosnowska/M-4286-2018; Podsędek, Anna/M-4197-2018; Kajszczak,
   Dominika/KQU-5772-2024; Zaklos-Szyda, Malgorzata/M-5229-2019
OI Zaklos-Szyda, Malgorzata/0000-0001-8341-1654; Kajszczak,
   Dominika/0000-0002-3122-0685
FU National Science Centre, Poland [2016/23/B/NZ9/03629]
FX This research study was supported by grant number 2016/23/B/NZ9/03629
   from The National Science Centre, Poland.
CR Alinia S, 2009, OBES REV, V10, P639, DOI 10.1111/j.1467-789X.2009.00582.x
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Barak TH, 2019, IND CROP PROD, V131, P62, DOI 10.1016/j.indcrop.2019.01.037
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Boath A. S., 2012, Food Digestion, V3, P1
   Cai SB, 2012, J AGR FOOD CHEM, V60, P7245, DOI 10.1021/jf3009958
   Cesoniene L, 2010, CENT EUR J BIOL, V5, P864, DOI 10.2478/s11535-010-0088-z
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi WG, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10030143
   Fabroni S, 2016, J SCI FOOD AGR, V96, P4713, DOI 10.1002/jsfa.7708
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Fu CH, 2016, J AGR FOOD CHEM, V64, P9571, DOI 10.1021/acs.jafc.6b04468
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Gadde KM, 2018, CLIN CHEM, V64, P118, DOI 10.1373/clinchem.2017.272815
   Gironés-Vilaplana A, 2014, J FUNCT FOODS, V7, P599, DOI 10.1016/j.jff.2013.12.025
   Gosmann G, 2012, PLANT FOOD HUM NUTR, V67, P156, DOI 10.1007/s11130-012-0289-x
   Gu YY, 2011, J AGR FOOD CHEM, V59, P5305, DOI 10.1021/jf200180n
   Hu B, 2015, INT J BIOL MACROMOL, V80, P529, DOI 10.1016/j.ijbiomac.2015.07.031
   Jin Q, 2015, J FOOD SCI, V80, pC2440, DOI 10.1111/1750-3841.13099
   Salvadó MJ, 2015, FOOD FUNCT, V6, P1053, DOI 10.1039/c4fo01035c
   Karaçelik AA, 2015, FOOD CHEM, V175, P106, DOI 10.1016/j.foodchem.2014.11.085
   Kraujalyte V, 2013, FOOD CHEM, V141, P3695, DOI 10.1016/j.foodchem.2013.06.054
   Li KG, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-304
   Li YQ, 2011, EUR FOOD RES TECHNOL, V233, P63, DOI 10.1007/s00217-011-1491-z
   McDougall GJ, 2009, FOOD CHEM, V115, P193, DOI 10.1016/j.foodchem.2008.11.093
   McSweeney M, 2015, CRIT REV FOOD SCI, V55, P660, DOI 10.1080/10408398.2012.670673
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   Mouls L, 2015, TETRAHEDRON, V71, P3012, DOI 10.1016/j.tet.2015.01.038
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Perova IB, 2014, PHARM CHEM J+, V48, P332, DOI 10.1007/s11094-014-1105-8
   Polka D, 2019, PLANT FOOD HUM NUTR, V74, P436, DOI 10.1007/s11130-019-00759-1
   Rodríguez-Pérez C, 2019, CRIT REV FOOD SCI, V59, P1212, DOI 10.1080/10408398.2017.1399859
   Rop O, 2010, MOLECULES, V15, P4467, DOI 10.3390/molecules15064467
   Salminen JP, 2005, J CHROMATOGR A, V1077, P170, DOI 10.1016/j.chroma.2005.04.073
   Sharma SP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100633
   Sosnowska D, 2018, J FUNCT FOODS, V49, P196, DOI 10.1016/j.jff.2018.08.029
   Spínola V, 2018, J FUNCT FOODS, V40, P595, DOI 10.1016/j.jff.2017.12.002
   Sugiyama H, 2007, J AGR FOOD CHEM, V55, P4604, DOI 10.1021/jf070569k
   Sun NN, 2016, MOLECULES, V21, DOI 10.3390/molecules21101351
   Tan YQ, 2017, FOOD CHEM, V214, P259, DOI 10.1016/j.foodchem.2016.06.100
   Teng H, 2019, CRIT REV FOOD SCI, V59, P2040, DOI 10.1080/10408398.2018.1437023
   Tsuda T, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5020013
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Wojdylo A, 2013, J AGR FOOD CHEM, V61, P2762, DOI 10.1021/jf304969b
   Wojnicz D, 2012, UROL RES, V40, P683, DOI 10.1007/s00240-012-0499-6
   Xu H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010128
   Yu C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00793
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
   Zaklos-Szyda M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080262
   Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005
   Zhang YX, 2018, P NATL ACAD SCI USA, V115, pE6039, DOI 10.1073/pnas.1806366115
   Zielinska-Blizniewska H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184556
NR 54
TC 21
Z9 22
U1 2
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD OCT
PY 2020
VL 73
AR 104111
DI 10.1016/j.jff.2020.104111
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA OC9UN
UT WOS:000579501700019
OA gold
DA 2025-04-28
ER

PT J
AU Fujii, TMD
   Jacob, PS
   Yamada, M
   Borges, MC
   Norde, MM
   Pantaleao, LC
   de Oliveira, DM
   Tirapegui, J
   de Castro, IA
   Borelli, P
   Fock, RA
   Rogero, MM
AF de Meneses Fujii, Tatiane Mieko
   Jacob, Patricia Silva
   Yamada, Monica
   Borges, Maria Carolina
   Norde, Marina Maintinguer
   Pantaleao, Lucas Carminatti
   de Oliveira, Daniela Moura
   Tirapegui, Julio
   de Castro, Inar Alves
   Borelli, Primavera
   Fock, Ricardo Ambrosio
   Rogero, Marcelo Macedo
TI Yerba Mate (Ilex paraguariensis) modulates NF-kappaB pathway and AKT
   expression in the liver of rats fed on a high-fat diet
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE High-fat diet; inflammation; insulin resistance; tea extract
ID INSULIN-RESISTANCE; CHLOROGENIC ACID; AQUEOUS EXTRACT;
   INTESTINAL-ABSORPTION; METABOLIC-DISORDERS; INDUCED OBESITY; CAFFEIC
   ACID; GLUCOSE; PLASMA; CHOLESTEROL
AB To investigate the effect of Yerba Mate (YM) aqueous extract intake on the NF-kB pathway and AKT expression in the liver, muscle, and adipose tissue of rats submitted to a high-fat diet (HFD). Male Wistar rats were fed a control (CON) (n = 24) or a HFD (n = 24) for 12 weeks. Afterwards, rats received YM daily (1 g/kg body weight) for 4 weeks. Intake of YM aqueous extract reduced body weight gain (p<0.05) and total blood cholesterol (p<0.05) in the HFD group in comparison to the non-treated HFD group. HFD group demonstrated an increased glycemic response at 5 and 10 min after insulin injection. YM decreased the ratio between phosphorylated and total kinase inhibitor of kappa B (IKK), increased the ratio of phosphorylated to total form of protein kinase B (AKT) and reduced NF-kappa B phosphorylation in the liver of the HFD group. Our data suggest a beneficial role of YM in improving metabolic dysfunctions induced by HFD.
C1 [de Meneses Fujii, Tatiane Mieko; Jacob, Patricia Silva; Yamada, Monica; Borges, Maria Carolina; Norde, Marina Maintinguer; de Oliveira, Daniela Moura; Rogero, Marcelo Macedo] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, Brazil.
   [Pantaleao, Lucas Carminatti] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol, BR-01246904 Sao Paulo, Brazil.
   [Tirapegui, Julio; de Castro, Inar Alves] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, BR-01246904 Sao Paulo, Brazil.
   [Borelli, Primavera; Fock, Ricardo Ambrosio] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Analyzes, BR-01246904 Sao Paulo, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de
   Sao Paulo; Universidade de Sao Paulo
RP Rogero, MM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Av Doutor Arnaldo 715, BR-01246904 Sao Paulo, Brazil.
EM mmrogero@usp.br
RI Castro, Inar/C-4923-2012; Tirapegui, Julio/I-4363-2012; Fock,
   Ricardo/C-6105-2012; Rogero, Marcelo/T-9025-2019; Borelli,
   Primavera/G-3422-2012; Norde, Marina/ABB-7135-2020; Borges, Maria
   Carolina/F-1980-2014
OI Fock, Ricardo/0000-0002-7964-5973; Moura de Oliveira Beltrame,
   Daniela/0000-0003-2989-3589; Norde, Marina/0000-0001-7666-3052; Macedo
   Rogero, Marcelo/0000-0003-0517-1645; Borges, Maria
   Carolina/0000-0001-7785-4547
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2009/54395-0]; FAPESP [2010/14609-9, 2009/12790-0, 2010/14164-7];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [09/12790-0, 10/14164-7, 10/14609-9] Funding Source: FAPESP
FX This work was financially supported by Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) (2009/54395-0). T. M. M. F., P. S. J., and
   M. Y. were supported by a fellowship from FAPESP (2010/14609-9,
   2009/12790-0 and 2010/14164-7). There are no conflicts of interest to
   declare.
CR Arçari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q
   Bastos DHM, 2007, MOLECULES, V12, P423, DOI 10.3390/12030423
   Bastos DHM., 2007, Med Aromat Plant Sci Biotechnol, V1, P37
   Ble-Castillo JL, 2012, INT J ENV RES PUB HE, V9, P1663, DOI 10.3390/ijerph9051663
   Bok SH, 2002, INT J VITAM NUTR RES, V72, P161, DOI 10.1024/0300-9831.72.3.161
   BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374
   BONORA E, 1987, DIABETES METAB, V13, P116
   Borges MC, 2013, INT J FOOD SCI NUTR, V64, P561, DOI 10.3109/09637486.2012.759188
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Crozier A, 2010, MOL ASPECTS MED, V31, P446, DOI 10.1016/j.mam.2010.09.007
   de Resende PE, 2012, J ETHNOPHARMACOL, V144, P735, DOI 10.1016/j.jep.2012.10.023
   Ferreira F, 1997, PHYTOTHER RES, V11, P79, DOI 10.1002/(SICI)1099-1573(199702)11:1<79::AID-PTR34>3.3.CO;2-I
   Gao HL, 2013, EXP GERONTOL, V48, P572, DOI 10.1016/j.exger.2013.03.008
   Gosmann G, 2012, PLANT FOOD HUM NUTR, V67, P156, DOI 10.1007/s11130-012-0289-x
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Gugliucci A, 2009, FITOTERAPIA, V80, P339, DOI 10.1016/j.fitote.2009.04.007
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   Jacob PS, 2013, CELL BIOCHEM FUNCT, V31, P244, DOI 10.1002/cbf.2894
   Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402
   Kishino E, 2006, J NUTR, V136, P433, DOI 10.1093/jn/136.2.433
   Konishi Y, 2006, J AGR FOOD CHEM, V54, P7539, DOI 10.1021/jf061554+
   Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lima ND, 2014, EUR J NUTR, V53, P73, DOI 10.1007/s00394-013-0500-3
   Martins F, 2010, OBESITY, V18, P42, DOI 10.1038/oby.2009.189
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Michalany J, 1979, AMB Rev Assoc Med Bras, V25, P44
   Miranda DDC, 2008, MUTAGENESIS, V23, P261, DOI 10.1093/mutage/gen011
   Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pearse AGE., 1968, Histochemistry: Theoretical and Applied, VI.
   Perez-Echarri N, 2007, J PHYSIOL BIOCHEM, V63, P317, DOI 10.1007/BF03165763
   Pimentel GD, 2013, J NUTR BIOCHEM, V24, P809, DOI 10.1016/j.jnutbio.2012.04.016
   Puangpraphant S, 2009, J AGR FOOD CHEM, V57, P8873, DOI 10.1021/jf902255h
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Rivelli DP, 2011, J AGR FOOD CHEM, V59, P8901, DOI 10.1021/jf201665t
   Rogero MM, 2008, J NUTR, V138, P1343, DOI 10.1093/jn/138.7.1343
   Safwat GM, 2009, NUTRITION, V25, P1157, DOI 10.1016/j.nut.2009.02.009
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Schinella G, 2005, CLIN NUTR, V24, P360, DOI 10.1016/j.clnu.2004.11.013
   Schinella GR, 2000, BIOCHEM BIOPH RES CO, V269, P357, DOI 10.1006/bbrc.2000.2293
   Shirai N, 2005, ANAL BIOCHEM, V343, P48, DOI 10.1016/j.ab.2005.04.037
   Silva RD, 2011, FITOTERAPIA, V82, P818, DOI 10.1016/j.fitote.2011.04.011
   Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340
   Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641
   Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007
   Wang S, 2006, J NUTR, V136, P2791, DOI 10.1093/jn/136.11.2791
NR 55
TC 6
Z9 11
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD DEC
PY 2014
VL 65
IS 8
BP 967
EP 976
DI 10.3109/09637486.2014.945153
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA AU0YB
UT WOS:000345347000008
PM 25088791
DA 2025-04-28
ER

PT J
AU Goyal, A
   Dubey, N
   Agrawal, A
   Sharma, R
   Verma, A
AF Goyal, Ahsas
   Dubey, Nandini
   Agrawal, Anant
   Sharma, Rashmi
   Verma, Aanchal
TI An Insight into the Promising Therapeutic Potential of Chicoric Acid
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Review
DE Chicoric acid; hydroxycinnamic acid; chicory; cancer; inflammation;
   oxidative stress
ID CICHORIUM-INTYBUS L.; ACUTE KIDNEY INJURY; OXIDATIVE STRESS;
   ECHINACEA-PURPUREA; MICROGLIAL CELLS; CHLOROGENIC ACID; LEAF EXTRACTS;
   CAFFEIC ACID; CANCER; LIPOPOLYSACCHARIDE
AB The pharmacological treatments that are now recommended for the therapy of chronic illnesses are examined in a great number of studies to determine whether or not they are both safe and effective. Therefore, it is important to investigate various alternative therapeutic assistance, such as natural remedies derived from medicinal plants. In this context, chicoric acid, classified as a hydroxycinnamic acid, has been documented to exhibit a range of health advantages. These include antiviral, antioxidant, anti-inflammatory, obesity-preventing, and neuroprotective effects. Due to its considerable pharmacological properties, chicoric acid has found extensive applications in food, pharmaceuticals, animal husbandry, and various other commercial sectors. This article provides a comprehensive overview of in vitro and in vivo investigations on chicoric acid, highlighting its beneficial effects and therapeutic activity when used as a preventative and management aid for public health conditions, including diabetes, cardiovascular disease, and hepatic illnesses like non-alcoholic steatohepatitis. Moreover, further investigation of this compound can lead to its development as a potential phytopharmaceutical candidate.
C1 [Goyal, Ahsas; Dubey, Nandini; Agrawal, Anant; Sharma, Rashmi; Verma, Aanchal] GLA Univ, Inst Pharmaceut Res, Mathura, Uttar Pradesh, India.
C3 GLA University
RP Goyal, A (corresponding author), GLA Univ, Inst Pharmaceut Res, Mathura, Uttar Pradesh, India.
EM ahsasgoyal1990@gmail.com
RI Goyal, Ahsas/L-4212-2014
OI Goyal, Ahsas/0000-0003-0110-9238; Verma, Aanchal/0000-0002-4250-2282
CR Abd El-Twab SM, 2019, INFLAMM RES, V68, P511, DOI 10.1007/s00011-019-01241-z
   Agatonovic-Kustrin S, 2013, PHYTOCHEM ANALYSIS, V24, P303, DOI 10.1002/pca.2411
   Ahn HR, 2014, J AGR FOOD CHEM, V62, P1310, DOI 10.1021/jf4046232
   Arab Sadeghabadi Zahra, 2018, J Basic Clin Physiol Pharmacol, V29, P463, DOI 10.1515/jbcpp-2017-0079
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Azay-Milhau J, 2013, J ETHNOPHARMACOL, V150, P755, DOI 10.1016/j.jep.2013.09.046
   Barrett B, 2003, PHYTOMEDICINE, V10, P66, DOI 10.1078/094471103321648692
   Bauer R., 1999, IMMUNOMODULATORY AGE, P41, DOI DOI 10.1007/978-3-0348-8763-22
   Baum BR, 2001, PHYTOCHEMISTRY, V56, P543, DOI 10.1016/S0031-9422(00)00425-8
   Birt DF, 2008, AM J CLIN NUTR, V87, p488S, DOI 10.1093/ajcn/87.2.488S
   Casanova LM, 2016, CHEM BIODIVERS, V13, P686, DOI 10.1002/cbdv.201500180
   Chang XW, 2021, J AGR FOOD CHEM, V69, P2179, DOI 10.1021/acs.jafc.0c07521
   Ding XQ, 2022, J AGR FOOD CHEM, V70, P2923, DOI 10.1021/acs.jafc.1c07795
   Ding XQ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9734560
   Garabadu D, 2020, NEUROMOL MED, V22, P314, DOI 10.1007/s12017-019-08590-2
   Garabadu D, 2019, BEHAV PHARMACOL, V30, P641, DOI 10.1097/FBP.0000000000000505
   Goyal A, 2023, CHEM BIOL DRUG DES, V101, P1229, DOI 10.1111/cbdd.14210
   Guo R, 2018, J AGR FOOD CHEM, V66, P9667, DOI 10.1021/acs.jafc.8b02147
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Hsu FL, 2000, PLANTA MED, V66, P228, DOI 10.1055/s-2000-8561
   Hussein OE, 2020, ENVIRON SCI POLLUT R, V27, P20725, DOI 10.1007/s11356-020-08557-y
   Jia LW, 2018, EXP THER MED, V15, P1640, DOI 10.3892/etm.2017.5598
   Jiang L, 2014, AM J CHINESE MED, V42, P679, DOI 10.1142/S0192415X1450044X
   Juskiewicz J, 2011, BRIT J NUTR, V105, P710, DOI 10.1017/S0007114510004344
   Kim JS, 2018, BIOSCI BIOTECH BIOCH, V82, P1197, DOI 10.1080/09168451.2018.1451742
   Kim M, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600632
   Kour K, 2011, PHARMACOL BIOCHEM BE, V99, P342, DOI 10.1016/j.pbb.2011.05.008
   Landmann M, 2014, NUTRITION, V30, P882, DOI 10.1016/j.nut.2013.11.015
   Lee J, 2013, FRONT CHEM, V1, DOI 10.3389/fchem.2013.00040
   Li Z, 2020, J CELL MOL MED, V24, P3022, DOI 10.1111/jcmm.14935
   Liu Q, 2019, FOOD FUNCT, V10, P6157, DOI 10.1039/c9fo01417a
   Liu Q, 2017, J AGR FOOD CHEM, V65, P338, DOI 10.1021/acs.jafc.6b04873
   Liu ZR, 2022, MOLECULES, V27, DOI 10.3390/molecules27092632
   Lu QB, 2018, REDOX BIOL, V14, P656, DOI 10.1016/j.redox.2017.11.012
   Ma J, 2018, BIOMED PHARMACOTHER, V104, P679, DOI 10.1016/j.biopha.2018.05.081
   Ma XJ, 2021, J RECEPT SIG TRANSD, V41, P378, DOI 10.1080/10799893.2020.1817076
   Mancek B, 2005, TALANTA, V66, P1094, DOI 10.1016/j.talanta.2005.01.028
   Mohammadi M, 2023, ARCH PHYSIOL BIOCHEM, V129, P1, DOI 10.1080/13813455.2020.1789881
   Mohseni R, 2019, NANOSCALE RES LETT, V14, DOI 10.1186/s11671-019-3042-7
   Mu Y, 2019, ECOTOX ENVIRON SAFE, V180, P396, DOI 10.1016/j.ecoenv.2019.05.040
   Nandagopal S., 2007, Advanced in Biological Research, V1, P17
   NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y
   National Center for Biotechnology Information, 2023, PubChem compound summary for CID 997, phenylpyruvic acid
   Nuissier G, 2010, FOOD CHEM, V120, P783, DOI 10.1016/j.foodchem.2009.11.010
   Peng Y, 2019, J MED FOOD, V22, P645, DOI 10.1089/jmf.2018.0211
   Peng Y, 2019, J AGR FOOD CHEM, V67, P9178, DOI 10.1021/acs.jafc.9b00705
   Qu YH, 2022, INT IMMUNOPHARMACOL, V111, DOI 10.1016/j.intimp.2022.109129
   Ritota M, 2013, J SCI FOOD AGR, V93, P1665, DOI 10.1002/jsfa.5947
   Roy PS, 2016, INDIAN J CANCER, V53, P441, DOI 10.4103/0019-509X.200658
   Sadeghabadi ZA, 2023, J DIABETES METAB DIS, V22, P307, DOI 10.1007/s40200-022-01134-9
   Sadeghabadi ZA, 2019, CYTOKINE, V116, P106, DOI 10.1016/j.cyto.2018.12.012
   Sanz AB, 2013, EXPERT OPIN DRUG DIS, V8, P879, DOI 10.1517/17460441.2013.793667
   Sanzini E, 2011, FOOD FUNCT, V2, P740, DOI 10.1039/c1fo10112a
   Schlernitzauer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078788
   Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293
   Street RA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/579319
   Sun XL, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109144
   Tousch D, 2008, BIOCHEM BIOPH RES CO, V377, P131, DOI 10.1016/j.bbrc.2008.09.088
   Tsai KL, 2017, ONCOTARGET, V8, P29600, DOI 10.18632/oncotarget.16768
   Tsai YL, 2012, J ETHNOPHARMACOL, V143, P914, DOI 10.1016/j.jep.2012.08.032
   Verma A, 2022, REV BRAS FARMACOGN, V32, P563, DOI 10.1007/s43450-022-00277-3
   Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406
   Wang JJ, 2018, EUR REV MED PHARMACO, V22, P3855, DOI 10.26355/eurrev_201806_15270
   Wang N, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23042031
   Wang N, 2022, FOOD FUNCT, V13, P2019, DOI [10.1039/d1fo02216d, 10.1039/D1FO02216D]
   Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022
   Wu H, 2018, AM J CHINESE MED, V46, P339, DOI 10.1142/S0192415X18500179
   Zhang WW, 2023, AM J CHINESE MED, DOI 10.1142/S0192415X23500659
   Zhang YL, 2011, IND CROP PROD, V34, P873, DOI 10.1016/j.indcrop.2011.02.010
   Zhu D, 2017, FOOD CHEM TOXICOL, V107, P138, DOI 10.1016/j.fct.2017.06.041
   Zhu D, 2015, J AGR FOOD CHEM, V63, P10903, DOI 10.1021/acs.jafc.5b04533
NR 71
TC 1
Z9 1
U1 3
U2 9
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
EI 1873-4316
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PY 2024
VL 25
IS 13
BP 1708
EP 1718
DI 10.2174/0113892010280616231127075921
PG 11
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA A6B1M
UT WOS:001283357400008
PM 38083896
DA 2025-04-28
ER

PT J
AU Kim, J
   Kim, J
   Shim, J
   Lee, CY
   Lee, KW
   Lee, HJ
AF Kim, Jiyoung
   Kim, Jaekyoon
   Shim, Jaesung
   Lee, Chang Yong
   Lee, Ki Won
   Lee, Hyong Joo
TI Cocoa Phytochemicals: Recent Advances in Molecular Mechanisms on Health
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Cocoa; cardiovascular diseases; cancer; neurodegeneration; obesity and
   diabetes; skin aging
ID FLAVANOL-RICH COCOA; CACAO LIQUOR PROANTHOCYANIDINS;
   LOW-DENSITY-LIPOPROTEIN; IMPROVES ENDOTHELIAL FUNCTION; LDL OXIDATIVE
   SUSCEPTIBILITY; CORONARY-HEART-DISEASE; NF-KAPPA-B; DARK CHOCOLATE;
   THEOBROMA-CACAO; BLOOD-PRESSURE
AB Recent reports on cocoa are appealing in that a food commonly consumed for pure pleasure might also bring tangible benefits for human health. Cocoa consumption is correlated with reduced health risks of cardiovascular diseases, hypertension, atherosclerosis, and cancer, and the health-promoting effects of cocoa are mediated by cocoa-driven phytochemicals. Cocoa is rich in procyanidins, theobromine, (-)-epicatechin, catechins, and caffeine. Among the phytochemicals present in consumed cocoa, theobromine is most available in human plasma, followed by caffeine, (-)-epicatechin, catechin, and procyanidins. It has been reported that cocoa phytochemicals specifically modulate or interact with specific molecular targets linked to the pathogenesis of chronic human diseases, including cardiovascular diseases, cancer, neurodegenerative diseases, obesity, diabetes, and skin aging. This review summarizes comprehensive recent findings on the beneficial actions of cocoa-driven phytochemicals in molecular mechanisms of human health.
C1 [Kim, Jiyoung; Kim, Jaekyoon; Shim, Jaesung; Lee, Ki Won; Lee, Hyong Joo] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea.
   [Kim, Jiyoung; Lee, Ki Won; Lee, Hyong Joo] Seoul Natl Univ, Ctr Food & Bioconvergence Technol, Seoul 151921, South Korea.
   [Kim, Jiyoung; Lee, Ki Won; Lee, Hyong Joo] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, Gyeonggi Do, South Korea.
   [Lee, Chang Yong] Cornell Univ, Dept Food Sci, Geneva, NY 14456 USA.
   [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Res Inst Bio Food Ind, Pyeongchang 232916, South Korea.
C3 Seoul National University (SNU); Seoul National University (SNU); Seoul
   National University (SNU); Cornell University; Seoul National University
   (SNU)
RP Lee, HJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 151742, South Korea.
EM kiwon@snu.ac.kr; leehyjo@snu.ac.kr
RI Lee, Jonghwa/LMP-5481-2024; Lee, Ki/M-4114-2018; Kim,
   Jiyoung/A-9934-2014
OI Kim, Jaekyoon/0000-0002-5518-2388; Kim, Jiyoung/0000-0002-2999-3320
FU National Research Foundation, Ministry of Education, Science and
   Technology, Republic of Korea [2010-0029233]; Ministry of Trade,
   Industry and Energy/Korea Institute for the Advancement of Technology,
   Republic of Korea [N0000697]
FX This work was supported by the National Leap Research Program
   (2010-0029233), National Research Foundation, Ministry of Education,
   Science and Technology, Republic of Korea. This work was also supported
   by the R&D program-Establishment of Infra Structure for Anti-aging
   Industry Support (N0000697), Ministry of Trade, Industry and
   Energy/Korea Institute for the Advancement of Technology, Republic of
   Korea.
CR Abd El Mohsen MM, 2002, FREE RADICAL BIO MED, V33, P1693, DOI 10.1016/S0891-5849(02)01137-1
   Andres-Lacueva C, 2008, J AGR FOOD CHEM, V56, P3111, DOI 10.1021/jf0728754
   Arteel GE, 2000, J NUTR, V130, p2100S, DOI 10.1093/jn/130.8.2100S
   Baba S, 2000, FREE RADICAL RES, V33, P635, DOI 10.1080/10715760000301151
   Baba S, 2007, J NUTR, V137, P1436, DOI 10.1093/jn/137.6.1436
   Baba S, 2007, AM J CLIN NUTR, V85, P709, DOI 10.1093/ajcn/85.3.709
   Barcz E, 1998, ONCOL REP, V5, P517
   Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6
   Biessels GJ, 2010, J ALZHEIMERS DIS, V20, pS143, DOI 10.3233/JAD-2010-091228
   Bisson JF, 2008, BRIT J NUTR, V100, P94, DOI 10.1017/S0007114507886375
   Brothers HM, 2010, NEUROSCI LETT, V480, P97, DOI 10.1016/j.neulet.2010.06.013
   Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411
   Caligiani A, 2007, CHIRALITY, V19, P329, DOI 10.1002/chir.20380
   Carnésecchi S, 2002, CANCER LETT, V175, P147, DOI 10.1016/S0304-3835(01)00731-5
   Chavez-Valdez R, 2009, PEDIATR RES, V65, P203, DOI 10.1203/PDR.0b013e31818d66b1
   Chen XS, 2010, J ALZHEIMERS DIS, V20, pS127, DOI 10.3233/JAD-2010-1376
   Cho ES, 2008, MUTAT RES-FUND MOL M, V640, P123, DOI 10.1016/j.mrfmmm.2007.12.012
   Cho ES, 2009, FREE RADICAL BIO MED, V46, P1319, DOI 10.1016/j.freeradbiomed.2009.02.010
   Cooper KA, 2008, BRIT J NUTR, V99, P1, DOI 10.1017/S0007114507795296
   Cooper KA, 2007, J AGR FOOD CHEM, V55, P2841, DOI 10.1021/jf063277c
   Corti R, 2009, CIRCULATION, V119, P1433, DOI 10.1161/CIRCULATIONAHA.108.827022
   Counet C, 2006, FOOD CHEM, V98, P649, DOI 10.1016/j.foodchem.2005.06.030
   Cuevas E, 2009, EUR J PHARMACOL, V616, P122, DOI 10.1016/j.ejphar.2009.06.013
   de Mendonça A, 2010, J ALZHEIMERS DIS, V20, pS1, DOI [10.3233/JAD-2010-1420, 10.3233/JAD-2010-01420]
   Déprez S, 2000, J NUTR, V130, P2733, DOI 10.1093/jn/130.11.2733
   Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503
   Dillinger TL, 2000, J NUTR, V130, p2057S, DOI 10.1093/jn/130.8.2057S
   Donovan JL, 2002, BRIT J NUTR, V87, P299, DOI 10.1079/BJN2001517
   Dray C, 2007, J PHYSIOL BIOCHEM, V63, P329, DOI 10.1007/BF03165764
   Echeverri D, 2010, INT J VASC MED, V2010, DOI 10.1155/2010/834060
   Engler MB, 2004, J AM COLL NUTR, V23, P197, DOI 10.1080/07315724.2004.10719361
   Engler MB, 2006, NUTR REV, V64, P109, DOI 10.1111/j.1753-4887.2006.tb00194.x
   Eskelinen MH, 2010, J ALZHEIMERS DIS, V20, pS167, DOI 10.3233/JAD-2010-1404
   Fisher NDL, 2006, J HYPERTENS, V24, P1575, DOI 10.1097/01.hjh.0000239293.40507.2a
   Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/00004872-200312000-00016
   FORSYTH WGC, 1952, BIOCHEM J, V51, P511, DOI 10.1042/bj0510511
   Fraga Cesar G, 2005, Clin Dev Immunol, V12, P11, DOI 10.1080/10446670410001722159
   Francis ST, 2006, J CARDIOVASC PHARM, V47, pS215, DOI 10.1097/00005344-200606001-00018
   Gasser P., 2008, International Journal of Cosmetic Science, V30, P339, DOI 10.1111/j.1468-2494.2008.00457.x
   GIL M, 1993, FOLIA BIOL-PRAGUE, V39, P63
   GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8
   Gotti R, 2006, J CHROMATOGR A, V1112, P345, DOI 10.1016/j.chroma.2005.11.058
   Grassi D, 2005, AM J CLIN NUTR, V81, P611
   Gu LW, 2006, J AGR FOOD CHEM, V54, P4057, DOI 10.1021/jf060360r
   Heinrich U, 2006, J NUTR, V136, P1565, DOI 10.1093/jn/136.6.1565
   Heiss C, 2005, J AM COLL CARDIOL, V46, P1276, DOI 10.1016/j.jacc.2005.06.055
   Heiss C, 2003, JAMA-J AM MED ASSOC, V290, P1030, DOI 10.1001/jama.290.8.1030
   Heiss C., 2006, J CARDIOVASC PHARM, V47, pS172
   Heiss C, 2007, J CARDIOVASC PHARM, V49, P74, DOI 10.1097/FJC.0b013e31802d0001
   Heiss C, 2006, J CARDIOVASC PHARM, V47, pS128, DOI 10.1097/00005344-200606001-00007
   Heptinstall S, 2006, J CARDIOVASC PHARM, V47, pS197, DOI 10.1097/00005344-200606001-00015
   Hermann F, 2006, HEART, V92, P119, DOI 10.1136/hrt.2005.063362
   Hollenberg NK, 1997, HYPERTENSION, V29, P171, DOI 10.1161/01.HYP.29.1.171
   Holt RR, 2002, AM J CLIN NUTR, V76, P798, DOI 10.1093/ajcn/76.4.798
   Innes AJ, 2003, PLATELETS, V14, P325, DOI 10.1080/0953710031000123681
   Jourdain C, 2006, EUR J CANCER PREV, V15, P353, DOI 10.1097/00008469-200608000-00009
   Kang NJ, 2008, J BIOL CHEM, V283, P20664, DOI 10.1074/jbc.M800263200
   Kang SS, 2010, CANCER RES, V70, P1173, DOI 10.1158/0008-5472.CAN-09-2886
   KENNY D, 1994, AM HEART J, V127, P1456, DOI 10.1016/0002-8703(94)90370-0
   Kenny TP, 2004, EXP BIOL MED, V229, P255, DOI 10.1177/153537020422900306
   Kim JE, 2010, BRIT J NUTR, V104, P957, DOI 10.1017/S0007114510001704
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Kostyuk VA, 2003, FEBS LETT, V537, P146, DOI 10.1016/S0014-5793(03)00113-3
   Kraemer T, 2004, BIOL CHEM, V385, P809, DOI 10.1515/BC.2004.106
   Ku BM, 2011, MOL CELLS, V31, P275, DOI 10.1007/s10059-011-0027-5
   Lee C, 2000, CLIN CHIM ACTA, V295, P141, DOI 10.1016/S0009-8981(00)00201-1
   Lee DE, 2010, J NUTR BIOCHEM, V21, P680, DOI 10.1016/j.jnutbio.2009.03.014
   Lee KW, 2008, CARDIOVASC RES, V79, P34, DOI 10.1093/cvr/cvn056
   Lee KW, 2003, J AGR FOOD CHEM, V51, P7292, DOI 10.1021/jf0344385
   Lee KW, 2006, J NUTR, V136, P1150, DOI 10.1093/jn/136.5.1150
   Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032
   Liuzzo G, 2001, Rays, V26, P221
   Loke WM, 2008, AM J CLIN NUTR, V88, P1018, DOI 10.1093/ajcn/88.4.1018
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lv XW, 2010, INFLAMM RES, V59, P635, DOI 10.1007/s00011-010-0176-6
   Mackenzie GG, 2006, FREE RADICAL RES, V40, P1086, DOI 10.1080/10715760600788396
   Mackenzie GG, 2004, FASEB J, V18, P167, DOI 10.1096/fj.03-0402fje
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mao T, 2000, J NUTR, V130, p2093S, DOI 10.1093/jn/130.8.2093S
   Mao T K, 2002, Dev Immunol, V9, P135
   Mao TK, 2003, EXP BIOL MED, V228, P93, DOI 10.1177/153537020322800113
   Merighi S, 2007, MOL PHARMACOL, V72, P395, DOI 10.1124/mol.106.032920
   Miller KB, 2006, J AGR FOOD CHEM, V54, P4062, DOI 10.1021/jf060290o
   Miller KB, 2009, J AGR FOOD CHEM, V57, P9169, DOI 10.1021/jf901821x
   Mumford GK, 1996, EUR J CLIN PHARMACOL, V51, P319, DOI 10.1007/s002280050205
   Muniyappa R, 2008, AM J CLIN NUTR, V88, P1685, DOI 10.3945/ajcn.2008.26457
   Murphy KJ, 2003, AM J CLIN NUTR, V77, P1466, DOI 10.1093/ajcn/77.6.1466
   Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002
   Naik JP, 2001, J AGR FOOD CHEM, V49, P3579, DOI [10.1021/jf000728z, 10.1021/jf.000728z]
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Natsume M, 2003, FREE RADICAL BIO MED, V34, P840, DOI 10.1016/S0891-5849(02)01434-X
   Nazaruddin R, 2006, IND CROP PROD, V24, P87, DOI 10.1016/j.indcrop.2006.03.013
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x
   Osakabe N, 2001, FREE RADICAL RES, V34, P93, DOI 10.1080/10715760100300091
   Osakabe N, 1998, J NUTR SCI VITAMINOL, V44, P313, DOI 10.3177/jnsv.44.313
   Ottaviani JI, 2002, ARCH BIOCHEM BIOPHYS, V406, P203, DOI 10.1016/S0003-9861(02)00455-1
   Pan TH, 2003, DRUG AGING, V20, P711, DOI 10.2165/00002512-200320100-00001
   Pearson DA, 2002, THROMB RES, V106, P191, DOI 10.1016/S0049-3848(02)00128-7
   Peng L, 2010, PHARM RES-DORDR, V27, P1128, DOI 10.1007/s11095-010-0052-7
   PETTIPHER GL, 1986, J SCI FOOD AGR, V37, P289, DOI 10.1002/jsfa.2740370314
   Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X
   Prediger RDS, 2010, J ALZHEIMERS DIS, V20, pS205, DOI 10.3233/JAD-2010-091459
   Ptolemy AS, 2010, J CHROMATOGR B, V878, P409, DOI 10.1016/j.jchromb.2009.12.019
   Ramiro E, 2005, J AGR FOOD CHEM, V53, P8506, DOI 10.1021/jf0511042
   Ramiro-Puig E, 2009, BRIT J NUTR, V101, P931, DOI 10.1017/S0007114508169896
   Rein D, 2000, J NUTR, V130, p2109S, DOI 10.1093/jn/130.8.2109S
   Richelle M, 1999, EUR J CLIN NUTR, V53, P22, DOI 10.1038/sj.ejcn.1600673
   Rios LY, 2003, AM J CLIN NUTR, V77, P912, DOI 10.1093/ajcn/77.4.912
   Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c
   Ruzaidi A, 2005, J ETHNOPHARMACOL, V98, P55, DOI 10.1016/j.jep.2004.12.018
   Schewe T, 2008, ARCH BIOCHEM BIOPHYS, V476, P102, DOI 10.1016/j.abb.2008.03.004
   Scholey AB, 2010, J PSYCHOPHARMACOL, V24, P1505, DOI 10.1177/0269881109106923
   Schramm DD, 2003, LIFE SCI, V73, P857, DOI 10.1016/S0024-3205(03)00373-4
   Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103
   Schroeter H, 2000, FREE RADICAL BIO MED, V29, P1222, DOI 10.1016/S0891-5849(00)00415-9
   Seimi C, 2008, MOL NUTR FOOD RES, V52, P1340, DOI 10.1002/mnfr.200700435
   Selmi C, 2006, J CARDIOVASC PHARM, V47, pS163, DOI 10.1097/00005344-200606001-00010
   SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
   Sies H, 2005, AM J CLIN NUTR, V81, p304S, DOI 10.1093/ajcn/81.1.304S
   Skopinska-Rózewska E, 1998, INT J MOL MED, V2, P649
   Smit HJ, 2000, PSYCHOPHARMACOLOGY, V152, P167, DOI 10.1007/s002130000506
   Smit HJ, 2005, PSYCHOPHARMACOLOGY, V181, P101, DOI 10.1007/s00213-005-2209-3
   Smit HJ, 2004, PSYCHOPHARMACOLOGY, V176, P412, DOI 10.1007/s00213-004-1898-3
   Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3
   STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823
   Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028
   TARKA SM, 1982, CRC CR REV TOXICOL, V9, P275, DOI 10.3109/10408448209037495
   Taubert D, 2007, ARCH INTERN MED, V167, P626, DOI 10.1001/archinte.167.7.626
   Tomaru M, 2007, NUTRITION, V23, P351, DOI 10.1016/j.nut.2007.01.007
   Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058
   van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007
   Vlachopoulos C, 2005, AM J HYPERTENS, V18, P785, DOI 10.1016/j.amjhyper.2004.12.008
   Wan Y, 2001, AM J CLIN NUTR, V74, P596
   Wang JF, 2000, J NUTR, V130, p2115S, DOI 10.1093/jn/130.8.2115S
   Wang-Polagruto JF, 2006, J CARDIOVASC PHARM, V47, pS177, DOI 10.1097/00005344-200606001-00013
   Waterhouse AL, 1996, LANCET, V348, P834, DOI 10.1016/S0140-6736(05)65262-2
   Weisburger JH, 2001, EXP BIOL MED, V226, P891, DOI 10.1177/153537020122601003
   Wollgast J, 2000, FOOD RES INT, V33, P423, DOI 10.1016/S0963-9969(00)00068-5
   Yamade T, 2009, J NUTR BIOCHEM, V20, P948, DOI 10.1016/j.jnutbio.2008.08.007
   Yamagishi M, 2003, CANCER LETT, V191, P49, DOI 10.1016/S0304-3835(02)00629-8
   Yamagishi M, 2002, CANCER LETT, V185, P123, DOI 10.1016/S0304-3835(02)00276-8
   Yamagishi M, 2001, LIPIDS, V36, P67, DOI 10.1007/s11745-001-0669-9
   Yang HY, 2004, CLIN EXP METASTAS, V21, P719, DOI 10.1007/s10585-004-8251-4
   Yasuda A, 2008, BIOFACTORS, V33, P211, DOI 10.1002/biof.5520330307
NR 146
TC 67
Z9 71
U1 1
U2 368
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD NOV 2
PY 2014
VL 54
IS 11
BP 1458
EP 1472
DI 10.1080/10408398.2011.641041
PG 15
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA AH2DS
UT WOS:000335931500004
PM 24580540
DA 2025-04-28
ER

PT J
AU Inoue, N
   Nagao, K
   Nomura, S
   Shirouchi, B
   Inafuku, M
   Hirabaru, H
   Nakahara, N
   Nishizono, S
   Tanaka, T
   Yanagita, T
AF Inoue, Nao
   Nagao, Koji
   Nomura, Saori
   Shirouchi, Bungo
   Inafuku, Masashi
   Hirabaru, Hideaki
   Nakahara, Noriaki
   Nishizono, Shoko
   Tanaka, Takashi
   Yanagita, Teruyoshi
TI Effect of Vaccinium ashei reade Leaf Extracts on Lipid Metabolism
   in Obese OLETF Rats
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE blueberry leaf; flavonol glycoside; proanthocyanidin; lipid metabolism;
   Otsuka Long-Evans Tokushima Fatty rat
ID C-REACTIVE PROTEIN; BLUEBERRY; LEAVES; PROANTHOCYANIDINS; CONSUMPTION;
   OXIDATION; CAPACITY; DISEASES; TANNINS; ENZYME
AB The effects of a hot water extract and fractional extracts from rabbiteye blueberry (Vaccinium ashei reade) leaves (BBL) on lipid metabolism were studied in obese Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Feeding the hot water extract and fractional extracts from BBL alleviated hepatic triglyceride accumulation in the rats. Additionally, feeding with the flavonol glycoside (FG) and proanthocyanidin (PA) fractions lowered serum cholesterol levels in the obese rats. The results from measurements of the hepatic enzyme activity indicate that the hypolipidemic effects of the hot water extract and the PA fraction might be attributable to enhanced lipolysis in the liver. The reduced serum levels of C-reactive protein, an inflammatory cytokine, by the chlorogenic acid + rutin fraction and FG fraction might be associated with alleviating the metabolic abnormalities in obese rats. These results indicate that the BBL extracts, and especially FG and PA, exerted hypolipidemic effects on obese OLETF rats and suggest that an infusion of BBL can be useful as a dietary hypolipidemic component.
C1 [Inoue, Nao; Nagao, Koji; Nomura, Saori; Shirouchi, Bungo; Inafuku, Masashi; Yanagita, Teruyoshi] Saga Univ, Dept Appl Biochem & Food Sci, Saga 8408502, Japan.
   [Inoue, Nao] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.
   [Hirabaru, Hideaki; Nakahara, Noriaki] Unkai Shuzo Co Ltd, Res Inst, Miyazaki 8801303, Japan.
   [Nishizono, Shoko] Miyazaki Univ, Cooperat Res Ctr, Miyazaki 8801303, Japan.
   [Tanaka, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan.
C3 Saga University; Tohoku University; University of Miyazaki; Nagasaki
   University
RP Yanagita, T (corresponding author), Saga Univ, Dept Appl Biochem & Food Sci, Saga 8408502, Japan.
EM yanagitt@cc.saga-u.ac.jp
RI INOUE, Nao/GLV-5671-2022; Shirouchi, Bungo/J-4849-2019; Nagao,
   Koji/F-5281-2011
OI Inoue, Nao/0000-0001-5428-844X; Tanaka, Takashi/0000-0001-7762-7432
FU Japanese Ministry of Education, Culture, Sports, Science, and
   Technology; Grants-in-Aid for Scientific Research [23700899, 23580173]
   Funding Source: KAKEN
FX This work was supported by research grants from the Japanese Ministry of
   Education, Culture, Sports, Science, and Technology.
CR Bisoendial RJ, 2007, ATHEROSCLEROSIS, V195, pE10, DOI 10.1016/j.atherosclerosis.2007.04.053
   Bladé C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476
   Cignarella A, 1996, THROMB RES, V84, P311, DOI 10.1016/S0049-3848(96)00195-8
   Del Bas JM, 2008, MOL NUTR FOOD RES, V52, P1172, DOI 10.1002/mnfr.200800054
   Fernandez ML, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-17
   FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Formiguera X, 2004, BEST PRACT RES CL GA, V18, P1125, DOI 10.1016/j.bpg.2004.06.030
   Fukuda N, 2011, J NUTR SCI VITAMINOL, V57, P144, DOI 10.3177/jnsv.57.144
   KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422
   KELLEY DS, 1986, BIOCHEM J, V235, P87, DOI 10.1042/bj2350087
   KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761
   Li RW, 2006, J ETHNOPHARMACOL, V104, P24, DOI 10.1016/j.jep.2005.08.045
   Li XC, 2002, J NAT PROD, V65, P1909, DOI 10.1021/np020289t
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKWELL MAK, 1973, J BIOL CHEM, V248, P3433
   Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005
   Matsuo Y, 2010, FOOD CHEM, V121, P1073, DOI 10.1016/j.foodchem.2010.01.052
   Mizrahi A, 2009, BRIT J NUTR, V102, P1075, DOI 10.1017/S0007114509359097
   Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094
   Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Nagao K, 2008, BIOSCI BIOTECH BIOCH, V72, P1619, DOI 10.1271/bbb.80036
   Nagao K, 2008, PROG LIPID RES, V47, P127, DOI 10.1016/j.plipres.2007.12.002
   Nanri A, 2007, ASIAN PAC J CANCER P, V8, P167
   Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279
   OCHOA S, 1955, METHOD ENZYMOL, V1, P739, DOI 10.1016/0076-6879(55)01129-4
   Piljac-Zegarac J, 2009, J MED FOOD, V12, P608, DOI 10.1089/jmf.2008.0081
   Sakaida H, 2007, BIOSCI BIOTECH BIOCH, V71, P2335, DOI 10.1271/bbb.70277
   Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039
   SPERRY WM, 1950, J BIOL CHEM, V187, P97
   Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945
   TANAKA T, 1994, J CHEM SOC PERK T 1, P3013, DOI 10.1039/p19940003013
   Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002
NR 35
TC 21
Z9 22
U1 0
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD DEC
PY 2011
VL 75
IS 12
BP 2304
EP 2308
DI 10.1271/bbb.110451
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 871YX
UT WOS:000298774700007
PM 22146710
OA Bronze
DA 2025-04-28
ER

PT J
AU Bracesco, N
   Sanchez, AG
   Contreras, V
   Menini, T
   Gugliucci, A
AF Bracesco, N.
   Sanchez, A. G.
   Contreras, V.
   Menini, T.
   Gugliucci, A.
TI Recent advances on Ilex paraguariensis research: Minireview
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Review
DE Ilex paraguariensis; Obesity; Inflammation; Oxidative stress;
   Hypercholesterolemia; Antimutagenesis
ID DENSITY-LIPOPROTEIN; CHLOROGENIC ACIDS; ESOPHAGEAL CANCER; MATE
   CONSUMPTION; AQUEOUS EXTRACT; BLACK TOBACCO; TEA; LEAVES; EXPRESSION;
   INHIBITORS
AB Ilex paraguariensis dried and minced leaves are made into a brewed tea, prepared in a sui generis manner by large populations in South America, having evolved from a tea drunk by the Guarani ethnic group to a beverage that has a social and almost ritualistic role in some South American modern societies. It is used both as a source of caffeine, in lieu or in parallel with tea and coffee, but also as a therapeutic agent for its alleged pharmacological properties. Although with some exceptions, research on biomedical properties of this herb has had a late start and strongly lags behind the impressive amount of literature on green tea and coffee. However, in the past 15 years, there was a several-fold increase in the literature studying Ilex paraguariensis properties showing effects such as antioxidant properties in chemical models and ex vivo lipoprotein studies, vaso-dilating and lipid reduction properties, antimutagenic effects, controversial association with oropharyngeal cancer, anti-glycation effects and weight reduction properties. Lately, promising results from human intervention studies have surfaced and the literature offers several developments on this area. The aim of this review is to provide a concise summary of the research published in the past three years, with an emphasis on translational studies, inflammation and lipid metabolism. Ilex paraguariensis reduces LDL-cholesterol levels in humans with Ilex paraguariensis dyslipoproteinemia and the effect is synergic with that of statins. Plasma antioxidant capacity as well as expression of antioxidant enzymes is positively modulated by intervention with Ilex paraguariensis in human cohorts. A review on the evidence implicating Ilex paraguariensis heavy consumption with some neoplasias show data that are inconclusive but indicate that contamination with alkylating agents during the drying process of the leaves should be avoided. On the other hand, several new studies confirm the antimutagenic effects of Ilex paraguariensis in different models, from DNA double breaks in cell culture models to mice studies. Novel interesting work has emerged showing significant effect on weight reduction both in mice and in rat models. Some mechanisms involved are inhibition of pancreatic lipase, activation of AMPK and uncoupling of electron transport. Intervention studies in animals have provided strong evidence of anti-inflammatory effects of Ilex paraguariensis, notably protecting cigarette-induced lung inflammation acting on macrophage migration and inactivating matrix-metalloproteinase. Research on the effects of Ilex paraguariensis in health and disease has confirmed its antioxidant, anti-inflammatory, antimutagenic and lipid-lowering activities. Although we are still waiting for the double-blind, randomized prospective clinical trial, the evidence seems to provide support for beneficial effects of mate drinking on chronic diseases with inflammatory component and lipid metabolism disorders. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Menini, T.; Gugliucci, A.] Touro Univ Calif, Glycat Oxidat & Dis Lab, Vallejo, CA 94592 USA.
   [Bracesco, N.; Sanchez, A. G.; Contreras, V.] Univ Republica, Fac Med & Ciencias, Lab Radiobiol Dpt Biofis, Montevideo, Uruguay.
C3 Touro University California; Universidad de la Republica, Uruguay
RP Gugliucci, A (corresponding author), Touro Univ Calif, Glycat Oxidat & Dis Lab, 1310 Johnson Lane, Vallejo, CA 94592 USA.
EM alejandro.gugliucci@tu.edu
RI Bracesco, Nelson/Y-3919-2019; Sanchez, Adrian/KLD-6450-2024
OI Sanchez, Ana G./0000-0003-1779-6394
FU ANII (Agencia Nacional Para la Investigacion y la Innovacion -Uruguay)
FX The authors are grateful to ANII (Agencia Nacional Para la Investigacion
   y la Innovacion -Uruguay) for funding and to Florencia Pamparato for her
   invaluable help in the writing of the manuscript.
CR Actis-Goretta L, 2002, ANN NY ACAD SCI, V957, P279, DOI 10.1111/j.1749-6632.2002.tb02925.x
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Bastos DHM., 2007, Med Aromat Plant Sci Biotechnol, V1, P37
   Bracesco N, 2003, J ALTERN COMPLEM MED, V9, P379, DOI 10.1089/107555303765551606
   Bracesco N., 2003, THESIS FM CIENCIAS
   Clifford MN, 2004, PLANTA MED, V70, P1103, DOI 10.1055/s-2004-835835
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   de Morais EC, 2009, J AGR FOOD CHEM, V57, P8316, DOI 10.1021/jf901660g
   DESTEFANI E, 1991, CANCER-AM CANCER SOC, V67, P536, DOI 10.1002/1097-0142(19910115)67:2<536::AID-CNCR2820670236>3.0.CO;2-8
   DESTEFANI E, 1988, REV EPIDEMIOL SANTE, V36, P389
   Dickel ML, 2007, J ETHNOPHARMACOL, V109, P60, DOI 10.1016/j.jep.2006.07.003
   Filip R, 2010, RECENT ADV PHYTOCHEM, V1, P113
   Filip R, 2010, PHYTOTHER RES, V24, P715, DOI 10.1002/ptr.3004
   Garcia RV, 1997, ARCH LATINOAM NUTR, V47, P77
   Gnoatto SCB, 2008, BIOORGAN MED CHEM, V16, P771, DOI 10.1016/j.bmc.2007.10.031
   GUGLIUCCI A, 1995, BIOCHEM MOL BIOL INT, V35, P47
   Gugliucci A, 1996, BIOCHEM BIOPH RES CO, V224, P338, DOI 10.1006/bbrc.1996.1030
   Gugliucci A, 2002, LIFE SCI, V71, P693, DOI 10.1016/S0024-3205(02)01734-4
   Gugliucci A, 2009, FITOTERAPIA, V80, P339, DOI 10.1016/j.fitote.2009.04.007
   Gugliucci A, 2009, FITOTERAPIA, V80, P138, DOI 10.1016/j.fitote.2009.01.001
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Heck CI, 2008, J AGR FOOD CHEM, V56, P8394, DOI 10.1021/jf801748s
   HSU CK, 1995, ARCH INTERN MED, V155, P2245, DOI 10.1001/archinte.155.20.2245
   Jacques RA, 2007, J AGR FOOD CHEM, V55, P10081, DOI 10.1021/jf071544o
   Jaiswal R, 2010, J AGR FOOD CHEM, V58, P5471, DOI 10.1021/jf904537z
   Kamangar F, 2008, CANCER EPIDEM BIOMAR, V17, P1262, DOI 10.1158/1055-9965.EPI-08-0025
   Lanzetti M, 2008, NUTRITION, V24, P375, DOI 10.1016/j.nut.2008.01.002
   Lee Richard, 2007, Harv Heart Lett, V18, P8
   LEITAO AC, 1994, BRAZ J MED BIOL RES, V27, P1517
   Loria D, 2009, REV PANAM SALUD PUBL, V25, P530, DOI 10.1590/S1020-49892009000600010
   Martinet A, 1999, PHYTOMEDICINE, V6, P231, DOI 10.1016/S0944-7113(99)80014-2
   Martinet A, 2001, PHYTOCHEM ANALYSIS, V12, P48, DOI 10.1002/1099-1565(200101/02)12:1<48::AID-PCA560>3.0.CO;2-#
   Martins F, 2010, OBESITY, V18, P42, DOI 10.1038/oby.2009.189
   Martins F, 2009, BRIT J NUTR, V101, P527, DOI 10.1017/S000711450802504X
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Menini T, 2007, PLANTA MED, V73, P1141, DOI 10.1055/s-2007-981585
   Miranda DDC, 2008, MUTAGENESIS, V23, P261, DOI 10.1093/mutage/gen011
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   PINTOS J, 1994, EPIDEMIOLOGY, V5, P583, DOI 10.1097/00001648-199411000-00005
   Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x
   Puangpraphant S, 2009, J AGR FOOD CHEM, V57, P8873, DOI 10.1021/jf902255h
   Ramirez-Mares MV, 2004, MUTAT RES-FUND MOL M, V554, P53, DOI 10.1016/j.mrfmmm.2004.03.002
   SANZ MDT, 1991, ARCH LATINOAM NUTR, V41, P441
   Schinella G, 2005, CLIN NUTR, V24, P360, DOI 10.1016/j.clnu.2004.11.013
   Schubert A, 2007, PHARMAZIE, V62, P876, DOI 10.1691/ph.2007.11.7052
   Sewram V, 2003, CANCER EPIDEM BIOMAR, V12, P508
   Stein FLP, 2005, BIOL RES NURS, V7, P146, DOI 10.1177/1099800405280521
   Strassmann BB, 2008, J AGR FOOD CHEM, V56, P8348, DOI 10.1021/jf801041f
   Sugimoto S, 2009, CHEM PHARM BULL, V57, P257, DOI 10.1248/cpb.57.257
   Taketa ATC, 2004, J NAT PROD, V67, P1697, DOI 10.1021/np040059+
   Alves RJV, 2008, TOXICOL IN VITRO, V22, P695, DOI 10.1016/j.tiv.2007.11.005
   VASSALLO A, 1985, JNCI-J NATL CANCER I, V75, P1005
   Vieira MA, 2008, J AGR FOOD CHEM, V56, P4637, DOI 10.1021/jf8011085
   Warnakulasuriya S, 2009, BRIT DENT J, V207, P471, DOI 10.1038/sj.bdj.2009.1009
   Wnuk M, 2009, MUTAT RES-GEN TOX EN, V679, P18, DOI 10.1016/j.mrgentox.2009.07.017
   Wróbel K, 2000, BIOL TRACE ELEM RES, V78, P271, DOI 10.1385/BTER:78:1-3:271
   Xu GH, 2009, ARCH PHARM RES, V32, P1215, DOI 10.1007/s12272-009-1905-7
   Zanoelo EF, 2009, J AGR FOOD CHEM, V57, P11564, DOI 10.1021/jf903388a
   Zuin WG, 2005, J CHROMATOGR A, V1091, P2, DOI 10.1016/j.chroma.2005.07.057
NR 63
TC 312
Z9 334
U1 3
U2 116
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JUL 14
PY 2011
VL 136
IS 3
SI SI
BP 378
EP 384
DI 10.1016/j.jep.2010.06.032
PG 7
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 802AR
UT WOS:000293482200002
PM 20599603
DA 2025-04-28
ER

PT J
AU Chen, YL
   Li, W
   Qiu, SH
   Vladmir, C
   Xu, XH
   Wang, XL
   Nian, X
   Chen, QY
   Wang, Q
   Tu, P
   Zhang, LH
   Yan, SJ
   Li, KL
   Chen, J
   Wu, H
   Wang, XY
   Wang, XH
   Liu, JB
   Cai, M
   Wang, ZY
   Wang, B
   Sun, ZL
AF Chen, Yaling
   Li, Wei
   Qiu, Shanhu
   Vladmir, Carvalho
   Xu, Xiaohan
   Wang, Xinling
   Nian, Xin
   Chen, Qingyun
   Wang, Qing
   Tu, Ping
   Zhang, Lihui
   Yan, Sunjie
   Li, Kaili
   Chen, Juan
   Wu, Hang
   Wang, Xuyi
   Wang, Xiaohang
   Liu, Jingbao
   Cai, Min
   Wang, Zhiyao
   Wang, Bei
   Sun, Zilin
TI Tea consumption and risk of diabetes in the Chinese population: a
   multi-centre, cross-sectional study
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Tea consumption; Lifestyle; Diabetes mellitus; Risk
ID GREEN TEA; BLACK TEA; OOLONG TEA; COFFEE; METAANALYSIS; CAFFEINE;
   POLYSACCHARIDES; ANTIOXIDANT; PREVALENCE; BIOMARKERS
AB The aim of the present study was to explore the influence of tea consumption on diabetes mellitus in the Chinese population. This multi-centre, cross-sectional study was conducted in eight sites from south, east, north, west and middle regions in China by enrolling 12 017 subjects aged 20-70 years. Socio-demographic and general information was collected by a standardised questionnaire. A standard procedure was used to measure anthropometric characteristics and to obtain blood samples. The diagnosis of diabetes was determined using a standard 75-g oral glucose tolerance test. In the final analysis, 10 825 participants were included and multiple logistic models and interaction effect analysis were applied for assessing the association between tea drinking with diabetes. Compared with non-tea drinkers, the multivariable-adjusted OR for newly diagnosed diabetes were 0 center dot 80 (95 % CI 0 center dot 67, 0 center dot 97), 0 center dot 88 (95 % CI 0 center dot 71, 1 center dot 09) and 0 center dot 86 (95 % CI 0 center dot 67, 1 center dot 11) for daily tea drinkers, occasional tea drinkers and seldom tea drinkers, respectively. Furthermore, drinking tea daily was related to decreased risk of diabetes in females by 32 %, elderly (>45 years) by 24 % and obese (BMI > 30 kg/m(2)) by 34 %. Moreover, drinking dark tea was associated with reduced risk of diabetes by 45 % (OR 0 center dot 55; 95 % CI 0 center dot 42, 0 center dot 72; P < 0 center dot 01). The results imply that drinking tea daily was negatively related to risk of diabetes in female, elderly and obese people. In addition, drinking dark tea was associated with decreased risk of type 2 diabetes mellitus.
C1 [Chen, Yaling; Li, Wei; Qiu, Shanhu; Vladmir, Carvalho; Xu, Xiaohan; Chen, Juan; Wu, Hang; Wang, Xuyi; Wang, Xiaohang; Liu, Jingbao; Cai, Min; Sun, Zilin] Southeast Univ, Zhongda Hosp, Sch Med, Inst Diabet,Dept Endocrinol, Nanjing 210009, Peoples R China.
   [Wang, Xinling] Peoples Hosp Xinjiang Uygbur Autonomous Reg, Dept Endocrinol, Urumqi 830001, Peoples R China.
   [Nian, Xin] Kunming Med Univ, Affiliated Hosp 1, Dept Endocrinol, Kunming 650032, Yunnan, Peoples R China.
   [Chen, Qingyun] Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanning 530021, Peoples R China.
   [Wang, Qing] Jilin Univ, China Japan Union Hosp, Dept Endocrinol, Changchun 130031, Peoples R China.
   [Tu, Ping] Third Hosp Nanchang, Dept Endocrinol, Nanchang 330009, Jiangxi, Peoples R China.
   [Zhang, Lihui] Hebei Med Univ, Hosp 2, Dept Endocrinol, Shijiazhuang 050035, Hebei, Peoples R China.
   [Yan, Sunjie] Fujian Med Univ, Diabet Res Inst Fujian Prov, Affiliated Hosp 1, Dept Endocrinol, Fuzhou 350005, Peoples R China.
   [Li, Kaili] Xinjiang Uygur Autonomous Reg Hosp Tradit Chinese, Dept Endocrinol, Urumqi 830006, Peoples R China.
   [Wang, Zhiyao] Suzhou MetroHlth Med Technol Co Ltd, Suzhou 215101, Peoples R China.
   [Wang, Bei] Southeast Univ, Sch Publ Hlth, Nanjing 210009, Peoples R China.
C3 Southeast University - China; Kunming Medical University; Guangxi
   Medical University; Jilin University; Hebei Medical University; Fujian
   Medical University; Southeast University - China
RP Sun, ZL (corresponding author), Southeast Univ, Zhongda Hosp, Sch Med, Inst Diabet,Dept Endocrinol, Nanjing 210009, Peoples R China.
EM sunzilin1963@126.com
RI chen, yaling/HOH-6338-2023; Liu, Jinbao/W-4889-2017
OI Xu, Xiaohan/0000-0003-0950-9615
FU National Key R&D Program of China [2016YFC1305700]; National Key
   Scientific Instrument and Equipment Development Project of China [51 627
   808]; Excellence Project of Southeast University [SJCX17_0072]
FX The present study was supported by the National Key R&D Program of China
   (no. 2016YFC1305700), the National Key Scientific Instrument and
   Equipment Development Project of China (no. 51 627 808) and the grants
   from the Excellence Project of Southeast University (no. SJCX17_0072).
CR Akter S, 2017, J EPIDEMIOL, V27, P553, DOI 10.1016/j.je.2016.12.017
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Chan EWC, 2011, PHARMACOGN RES, V3, P266, DOI 10.4103/0974-8490.89748
   Chen HX, 2009, J FOOD SCI, V74, pC469, DOI 10.1111/j.1750-3841.2009.01231.x
   Deng YT, 2015, FOOD FUNCT, V6, P1539, DOI [10.1039/C4FO01025F, 10.1039/c4fo01025f]
   Drouin P, 1999, DIABETES METAB, V25, P72
   Farag YMK, 2011, NEPHROL DIAL TRANSPL, V26, P28, DOI 10.1093/ndt/gfq576
   Fu QY, 2017, MOLECULES, V22, DOI 10.3390/molecules22050849
   Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Han K, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070408
   Hayashino Y, 2011, DIABETIC MED, V28, P805, DOI 10.1111/j.1464-5491.2011.03239.x
   Jing YL, 2009, J GEN INTERN MED, V24, P557, DOI 10.1007/s11606-009-0929-5
   Kolb H, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0901-x
   Kongpichitchoke T, 2016, MOLECULES, V21, DOI 10.3390/molecules21101346
   Li W, 2018, EBIOMEDICINE, V35, P307, DOI 10.1016/j.ebiom.2018.08.009
   Liu XN, 2018, INT J EPIDEMIOL, V47, P1887, DOI 10.1093/ije/dyy173
   Mahmoud F, 2016, PHYTOTHER RES, V30, P454, DOI 10.1002/ptr.5548
   Mao JT, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P33, DOI 10.1016/B978-0-12-384937-3.00003-3
   Montgomery MP, 2008, AM J EPIDEMIOL, V167, P1235, DOI 10.1093/aje/kwn028
   Neyestani TR, 2010, ANN NUTR METAB, V57, P40, DOI 10.1159/000312666
   O'Connor L, 2015, DIABETOLOGIA, V58, P1474, DOI 10.1007/s00125-015-3572-1
   Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Özyurt H, 2016, FOOD FUNCT, V7, P1390, DOI [10.1039/c5fo01525a, 10.1039/C5FO01525A]
   Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537
   Sanlier N, 2018, TRENDS FOOD SCI TECH, V78, P95, DOI 10.1016/j.tifs.2018.05.026
   Siddiqui FJ, 2015, DIABETES RES CLIN PR, V107, P148, DOI 10.1016/j.diabres.2014.09.025
   Son HK, 2010, ENVIRON INT, V36, P410, DOI 10.1016/j.envint.2010.02.012
   Striegel Lisa, 2015, Front Nutr, V2, P3, DOI 10.3389/fnut.2015.00003
   Suguitan Jr AL, 2011, PLOS ONE, V6
   Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596
   Wu LY, 2004, J AGR FOOD CHEM, V52, P643, DOI 10.1021/jf030365d
   Yajima H., 2014, POLYPHENOLS HUMAN HL, P135, DOI [10.1016/b978-0-12-398456-2.00012-8, DOI 10.1016/B978-0-12-398456-2.00012-8]
   Yang WS, 2014, BRIT J NUTR, V111, P1329, DOI 10.1017/S0007114513003887
   Yao ZX, 2019, EUR J NUTR, V58, P819, DOI 10.1007/s00394-018-1713-2
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
NR 38
TC 22
Z9 24
U1 5
U2 55
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD FEB 28
PY 2020
VL 123
IS 4
BP 428
EP 436
AR PII S000711451900299X
DI 10.1017/S000711451900299X
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KH6NU
UT WOS:000510769000008
PM 31760957
OA Bronze
DA 2025-04-28
ER

PT J
AU Fisman, EZ
   Tenenbaum, A
AF Fisman, Enrique Z.
   Tenenbaum, Alexander
TI Adiponectin: a manifold therapeutic target for metabolic syndrome,
   diabetes, and coronary disease?
SO CARDIOVASCULAR DIABETOLOGY
LA English
DT Review
DE Adipokines; Adiponectin; Atherosclerosis; Coronary artery disease;
   Diabetes mellitus; Metabolic syndrome; Obesity; T-cadherin
ID CARDIOVASCULAR RISK-FACTORS; ADIPOSE-SPECIFIC PROTEIN; PROGENITOR-CELL
   FUNCTION; LIFE-STYLE INTERVENTION; INSULIN-RESISTANCE; ARTERY-DISEASE;
   T-CADHERIN; PLASMA-PROTEIN; INFLAMMATORY MARKERS; SERUM-LEVELS
AB Adiponectin is the most abundant peptide secreted by adipocytes, being a key component in the interrelationship between adiposity, insulin resistance and inflammation. Central obesity accompanied by insulin resistance is a key factor in the development of metabolic syndrome (MS) and future macrovascular complications. Moreover, the remarkable correlation between coronary artery disease (CAD) and alterations in glucose metabolism has raised the likelihood that atherosclerosis and type 2 diabetes mellitus (T2DM) may share a common biological background. We summarize here the current knowledge about the influence of adiponectin on insulin sensitivity and endothelial function, discussing its forthcoming prospects and potential role as a therapeutic target for MS, T2DM, and cardiovascular disease. Adiponectin is present in the circulation as a dimer, trimer or protein complex of high molecular weight hexamers, >400 kDa. AdipoR1 and AdipoR2 are its major receptors in vivo mediating the metabolic actions. Adiponectin stimulates phosphorylation and AMP (adenosin mono phosphate) kinase activation, exerting direct effects on vascular endothelium, diminishing the inflammatory response to mechanical injury and enhancing endothelium protection in cases of apolipoprotein E deficiency. Hypoadiponectinemia is consistently associated with obesity, MS, atherosclerosis, CAD, T2DM. Lifestyle correction helps to favorably modify plasma adiponectin levels. Low adiponectinemia in obese patients is raised via continued weight loss programs in both diabetic and nondiabetic individuals and is also accompanied by reductions in pro-inflammatory factors. Diet modifications, like intake of fish, omega-3 supplementation, adherence to a Mediterranean dietary pattern and coffee consumption also increase adiponectin levels. Antidiabetic and cardiovascular pharmacological agents, like glitazones, glimepiride, angiotensin converting enzyme inhibitors and angiotensin receptor blockers are also able to improve adiponectin concentration. Fibric acid derivatives, like bezafibrate and fenofibrate, have been reported to enhance adiponectin levels as well. T-cadherin, a membrane-associated adiponectin-binding protein lacking intracellular domain seems to be a main mediator of the antiatherogenic adiponectin actions. The finding of novel pharmacologic agents proficient to improve adiponectin plasma levels should be target of exhaustive research. Interesting future approaches could be the development of adiponectin-targeted drugs chemically designed to induce the activaton of its receptors and/or postreceptor signaling pathways, or the development of specific adiponectin agonists.
C1 [Fisman, Enrique Z.; Tenenbaum, Alexander] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
   [Fisman, Enrique Z.; Tenenbaum, Alexander] Cardiovasc Diabetol Res Fdn, IL-58484 Holon, Israel.
   [Tenenbaum, Alexander] Chaim Sheba Med Ctr, Cardiac Rehabil Inst, IL-52621 Tel Hashomer, Israel.
C3 Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical
   Center
RP Fisman, EZ (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
EM zfisman@post.tau.ac.il
RI Fisman, Enrique/ABV-2830-2022
OI Fisman, Enrique/0000-0001-7055-4488
FU Cardiovascular Diabetology Research Foundation, Holon, Israel [RA
   58-040-684-1]
FX This work was supported in part by the Cardiovascular Diabetology
   Research Foundation (RA 58-040-684-1), Holon, Israel.
CR Abdelgadir M, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-15
   Al-Attas OS, 2013, J ATHEROSCLER THROMB, V20, P313, DOI 10.5551/jat.14837
   Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010
   Baars T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-12
   Balagopal P, 2005, J CLIN ENDOCR METAB, V90, P6192, DOI 10.1210/jc.2004-2427
   Baldasseroni S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-151
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192
   Brooks NL, 2007, DIABETES OBES METAB, V9, P246, DOI 10.1111/j.1463-1326.2006.00596.x
   Caselli C, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-143
   Cesari M, 2007, J CLIN ENDOCR METAB, V92, P3082, DOI 10.1210/jc.2007-0403
   Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z
   Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321
   Curti MLR, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-49
   Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607
   Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464
   Díez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293
   Dominguez Reyes C., 2007, REV ENDOCRINOLOGIA N, V15, P149
   Elkayam A, 2013, ISR MED ASSOC J, V15, P170
   Fava C, 2011, AM J CARDIOL, V108, P1432, DOI 10.1016/j.amjcard.2011.06.068
   Fisman EZ, 2008, ADV CARDIOL, V45, P44, DOI 10.1159/000115187
   Fisman EZ, 2006, AM J CARDIOL, V98, P14, DOI 10.1016/j.amjcard.2006.01.045
   Fisman EZ, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-11
   Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E
   Gallagher AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028157
   Ghaffari S, 2013, CARDIOL J, V20, P261, DOI 10.5603/CJ.2013.0071
   Gil JS, 2013, CLINICS, V68, P1495, DOI 10.6061/clinics/2013(12)04
   Grundy SM, 2002, CIRCULATION, V105, P2696, DOI 10.1161/01.CIR.0000020650.86137.84
   Guo ZX, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-94
   Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387
   Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367
   Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061
   Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536
   Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801
   Hiuge A, 2007, ARTERIOSCL THROM VAS, V27, P635, DOI 10.1161/01.ATV.0000256469.06782.d5
   Hoffstedt J, 2004, J CLIN ENDOCR METAB, V89, P1391, DOI 10.1210/jc.2003-031458
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697
   Huang PH, 2011, J MOL CELL CARDIOL, V51, P109, DOI 10.1016/j.yjmcc.2011.03.008
   Hug C, 2005, SCIENCE, V307, P366, DOI 10.1126/science.1106933
   Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x
   Issan Y, 2012, CAN J CARDIOL, V28, P728, DOI 10.1016/j.cjca.2012.01.013
   Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b
   Jeon WS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-137
   Jung CH, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-24
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kaser S, 2008, EUR J CLIN INVEST, V38, P827, DOI 10.1111/j.1365-2362.2008.02028.x
   KATO M, 1985, LANCET, V2, P270
   Kawano Jordan, 2009, J Cardiometab Syndr, V4, P44, DOI 10.1111/j.1559-4572.2008.00030.x
   Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042
   Kim JY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-140
   Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478
   Koh KK, 2006, INT J CARDIOL, V108, P96, DOI 10.1016/j.ijcard.2005.07.040
   Kolattukudy PE, 1998, AM J PATHOL, V152, P101
   Kostopoulos CG, 2014, CARDIOVASC PATHOL, V23, P131, DOI 10.1016/j.carpath.2014.02.003
   Kriketos AD, 2004, DIABETES CARE, V27, P629, DOI 10.2337/diacare.27.2.629
   Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200
   Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50
   Lacquemant C, 2004, DIABETIC MED, V21, P776, DOI 10.1111/j.1464-5491.2004.01224.x
   Leguisamo NM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-100
   Lima Marcos Miguel, 2009, Rev. Venez. Endocrinol. Metab., V7, P3
   Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127
   Liu PH, 2008, TWIN RES HUM GENET, V11, P495, DOI 10.1375/twin.11.5.495
   Liu Y, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-25
   Lu CJ, 2013, CEREBROVASC DIS, V36, P145, DOI 10.1159/000353679
   Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587
   Maia-Fernandes Teresa, 2008, Rev Port Cardiol, V27, P1431
   Mamali I, 2012, PEPTIDES, V33, P120, DOI 10.1016/j.peptides.2011.11.007
   Mantzoros CS, 2006, AM J CLIN NUTR, V84, P328
   Matsubara M, 2004, ENDOCR J, V51, P587, DOI 10.1507/endocrj.51.587
   Matsuzawa Y, 2003, HORM RES, V60, P56, DOI 10.1159/000074502
   Milewicz A, 2005, GYNECOL ENDOCRINOL, V20, P68, DOI 10.1080/09513590400020989
   Monzillo LU, 2003, OBES RES, V11, P1048, DOI 10.1038/oby.2003.144
   Moreno-Aliaga MJ, 2008, REV ESP OBES, V6, P205
   Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652
   Ogawa Y, 2005, HYPERTENS RES, V28, P51, DOI 10.1291/hypres.28.51
   Ohashi K, 2004, J AM COLL CARDIOL, V43, P1195, DOI 10.1016/j.jacc.2003.10.049
   Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656
   Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19
   Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182
   Okamoto Y, 2000, HORM METAB RES, V32, P47, DOI 10.1055/s-2007-978586
   Oranskiy SP, 2012, CROAT MED J, V53, P350, DOI 10.3325/cmj.2012.53.350
   Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8
   Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296
   Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057
   Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473
   Ozeki N, 2009, METABOLISM, V58, P1470, DOI 10.1016/j.metabol.2009.04.042
   Parker-Duffen JL, 2014, BEST PRACT RES CL EN, V28, P81, DOI 10.1016/j.beem.2013.09.001
   Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835
   Peake PW, 2005, EUR J ENDOCRINOL, V153, P409, DOI 10.1530/eje.1.01978
   Philippova M, 2012, CARDIOVASC RES, V93, P498, DOI 10.1093/cvr/cvs004
   Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730
   Ranheim T, 2004, ACTA OBSTET GYN SCAN, V83, P341, DOI 10.1111/j.0001-6349.2004.00413.x
   Robinson K, 2011, CRIT CARE, V15, DOI 10.1186/cc10021
   Sahebkar A, 2013, ATHEROSCLEROSIS, V230, P110, DOI 10.1016/j.atherosclerosis.2013.06.026
   Sarkanen JR, 2012, TISSUE ENG PT A, V18, P17, DOI [10.1089/ten.tea.2010.0712, 10.1089/ten.TEA.2010.0712]
   SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746
   Schmid PM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-46
   Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65
   Shargorodsky M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-61
   Sharma AM, 2002, HYPERTENSION, V40, P609, DOI 10.1161/01.HYP.0000036448.44066.53
   Shuldiner AR, 2001, NEW ENGL J MED, V345, P1345, DOI 10.1056/NEJM200111013451814
   Silva FM, 2011, NUTR REV, V69, P599, DOI 10.1111/j.1753-4887.2011.00414.x
   Silva TE, 2014, DIABETES METAB, V40, P95, DOI 10.1016/j.diabet.2013.11.004
   Silva-Nunes J, 2013, OBESITY FACTS, V6, P124, DOI 10.1159/000350664
   STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369
   Stumvoll M, 2002, DIABETES, V51, P37, DOI 10.2337/diabetes.51.1.37
   Sulistyoningrum DC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-170
   Suzuki H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-71
   Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69
   Tenenbaum A, 2006, ARCH INTERN MED, V166, P737, DOI 10.1001/archinte.166.7.737
   Tenenbaum A, 2004, INT J CARDIOL, V97, P167, DOI 10.1016/j.ijcard.2003.07.033
   Tenenbaum H, 2007, ATHEROSCLEROSIS, V194, P265, DOI 10.1016/j.atherosclerosis.2006.08.005
   Thanakun S, 2013, PEPTIDES, V47, P60, DOI 10.1016/j.peptides.2013.06.010
   Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001
   Toldo S, 2014, AM J PHYSIOL-HEART C, V306, pH1025, DOI 10.1152/ajpheart.00795.2013
   Tong GX, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-67
   Tremblay M, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-4
   Tripathy D, 2014, DIABETES CARE
   Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x
   Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239
   Tsunekawa T, 2003, DIABETES CARE, V26, P285, DOI 10.2337/diacare.26.2.285
   Tuñón J, 2014, AM J CARDIOL, V113, P434, DOI 10.1016/j.amjcard.2013.10.012
   Tvarijonaviciute A, 2010, CAN J VET RES, V74, P279
   Tyrberg B, 2011, ISLETS, V3, P327, DOI 10.4161/isl.3.6.17705
   Valsamakis G, 2003, DIABETES OBES METAB, V5, P131, DOI 10.1046/j.1463-1326.2003.00254.x
   Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607
   Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200
   Weiss R, 2003, J CLIN ENDOCR METAB, V88, P2014, DOI 10.1210/jc.2002-021711
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Xu AM, 2010, ADV PHARMACOL, V60, P229, DOI [10.1016/S1054-3589(10)60002-6, 10.1016/B978-0-12-385061-4.00008-8]
   Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999
   Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557
   Yamauchi T, 2014, BEST PRACT RES CL EN, V28, P15, DOI 10.1016/j.beem.2013.09.003
   Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968
   Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081
NR 140
TC 181
Z9 194
U1 2
U2 40
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2840
J9 CARDIOVASC DIABETOL
JI Cardiovasc. Diabetol.
PD JUN 23
PY 2014
VL 13
AR 103
DI 10.1186/1475-2840-13-103
PG 10
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism
GA AO2AV
UT WOS:000341118200001
PM 24957699
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Schreiner, T
   Eggerstorfer, NM
   Morlock, GE
AF Schreiner, Tamara
   Eggerstorfer, Naila Margot
   Morlock, Gertrud Elisabeth
TI Ten-dimensional hyphenation including simulated static gastro-intestinal
   digestion on the adsorbent surface, planar assays, and bioactivity
   evaluation for meal replacement products
SO FOOD & FUNCTION
LA English
DT Article
ID ACETYLCHOLINESTERASE ACTIVITY; DIETARY-INTAKE; FOOD; TRENDS; BURDEN;
   IMPACT; MODEL
AB Meal replacement products are normally consumed in weight-loss interventions and the treatment of obesity and diabetes. Changing lifestyles and eating habits made meal replacement products in the forms of shakes and bars a good alternative as To-go-meals, promoted as balanced in its composition and thus healthier compared to other ready-to-eat meals. This study aimed to evaluate the bioactivity of six differently flavoured powdered meal replacement products. Their analysis was made by a ten-dimensional hyphenation composed of digestion on the adsorbent surface, followed by normal-phase high-performance thin-layer chromatographic separation, multi-imaging, and planar assay application (effect-directed analysis), and then heart-cut elution/transfer of bioactive compound zones to reversed-phase high-performance liquid chromatography, diode array detection, and high-resolution tandem mass spectrometry. The on-surface digestion of saccharides, fats, and proteins through intestinal enzymatic activity revealed new breakdown products. These exhibited bioactivity in their different effect-profiles obtained by the Gram-negative Aliivibrio fischeri bioassay as well as alpha-/beta-glucosidase and acetyl-/butyrylcholinesterease inhibition assays. The main bioactive compounds arising through simulated static pancreatic digestion were saturated and unsaturated free fatty acids. The synthetic sweetener sucralose was not influenced by simulated static intestinal digestion, but showed antimicrobial activity. In the prepared drinking meals with coffee and choco flavour, the acetylcholinesterase-inhibiting methylxanthines caffeine and theobromine were identified as bioactive compounds. Some other bioactive constituents could not be assigned to specific molecules and require further analyses. Although the studied meal replacement products showed health-beneficial properties through antimicrobial properties or inhibition of enzymes involved in the expression of the civilisation diseases, such as diabetes and Alzheimer's disease, plant foods, herbs and spices have been shown to be even richer and more versatile in bioactive compounds.
C1 [Schreiner, Tamara; Eggerstorfer, Naila Margot; Morlock, Gertrud Elisabeth] Justus Liebig Univ Giessen, Inst Nutr Sci, Chair Food Sci, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.
C3 Justus Liebig University Giessen
RP Morlock, GE (corresponding author), Justus Liebig Univ Giessen, Inst Nutr Sci, Chair Food Sci, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.
RI Eggerstorfer, Naila/JTU-8037-2023; Morlock, Gertrud/E-6343-2013
OI Morlock, Gertrud/0000-0001-9406-0351
FU Deutsche Forschungsgemeinschaft [INST 162/536-1 FUGG, INST 162/471-1
   FUGG]
FX We thank Merck, Darmstadt, for supply of plates. Instrumentation was
   partially funded by the Deutsche Forschungsgemeinschaft (INST 162/536-1
   FUGG and INST 162/471-1 FUGG).
CR Balfegó M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0245-0
   Bollmann N., STORY YFOOD
   Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349
   Brunhofer G, 2012, BIOORGAN MED CHEM, V20, P6669, DOI 10.1016/j.bmc.2012.09.040
   Casillas-Vargas G, 2021, PROG LIPID RES, V82, DOI 10.1016/j.plipres.2021.101093
   Chandana NGASS, 2021, FOOD CHEM, V357, DOI 10.1016/j.foodchem.2021.129135
   Correa-Betanzo J, 2014, FOOD CHEM, V165, P522, DOI 10.1016/j.foodchem.2014.05.135
   Costantini L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122645
   de la Monte SM, 2009, J ALZHEIMERS DIS, V17, P817, DOI 10.3233/JAD-2009-1098
   European Committee for Standardization, 2009, WAT QUAL DET INH EFF
   Gallier S, 2013, FOOD CHEM, V141, P3273, DOI 10.1016/j.foodchem.2013.06.020
   Gómez MI, 2013, FOOD POLICY, V42, P129, DOI 10.1016/j.foodpol.2013.06.009
   Hartmann C, 2016, APPETITE, V105, P775, DOI 10.1016/j.appet.2016.07.013
   Ketnawa S, 2020, FOOD CHEM, V311, DOI 10.1016/j.foodchem.2019.125885
   Li YP, 2017, DIABETES CARE, V40, P1685, DOI 10.2337/dc17-0571
   Liu XJ, 2021, LWT-FOOD SCI TECHNOL, V138, DOI 10.1016/j.lwt.2020.110782
   Mehl Annabel, 2021, J Chromatogr A, V1651, P462334, DOI 10.1016/j.chroma.2021.462334
   Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j
   Mohr AE, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082469
   Moreno LA, 2010, CRIT REV FOOD SCI, V50, P106, DOI 10.1080/10408390903467480
   Morlock G.E., 2023, FOOD CHEM
   Morlock GE, 2021, ANAL CHIM ACTA, V1154, DOI 10.1016/j.aca.2021.338307
   Morlock GE, 2014, J LIQ CHROMATOGR R T, V37, P2892, DOI 10.1080/10739149.2014.907000
   Muller I, VALIDATION QUANTIFIC
   Orsavova J, 2015, INT J MOL SCI, V16, P12871, DOI 10.3390/ijms160612871
   Peng JH, 2019, BRIT J NUTR, V121, P560, DOI 10.1017/S0007114518003628
   Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI [10.3945/ajcn.114.100925, 10.3945/ajcn.113.071928]
   Qiao X, 2011, J CHROMATOGR A, V1218, P107, DOI 10.1016/j.chroma.2010.10.116
   Rothacker DQ, 2001, J AM DIET ASSOC, V101, P345, DOI 10.1016/S0002-8223(01)00089-X
   Sammugam L, 2019, CRIT REV FOOD SCI, V59, P2746, DOI 10.1080/10408398.2018.1468729
   Schreiner T., EFFECTS GASTRO UNPUB
   Schreiner T, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.755941
   Sollano-Mendieta XC, 2021, FOODS, V10, DOI 10.3390/foods10091995
   Sommano S, 2014, ADVANCES IN FOOD SCIENCE AND NUTRITION, P361
   Souza AC, 2015, BRAIN RES, V1595, P10, DOI 10.1016/j.brainres.2014.10.039
   Vellas B, 2005, J NUTR HEALTH AGING, V9, P75
   Wang QP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199080
   Yip I, 2001, OBES RES, V9, p341S, DOI 10.1038/oby.2001.140
   Zugno AI, 2015, LIFE SCI, V121, P65, DOI 10.1016/j.lfs.2014.11.025
NR 39
TC 7
Z9 7
U1 2
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD JAN 3
PY 2023
VL 14
IS 1
BP 344
EP 353
DI 10.1039/d2fo02610d
EA NOV 2022
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 7I4MU
UT WOS:000897868000001
PM 36511163
DA 2025-04-28
ER

PT J
AU Wee, JH
   Min, C
   Park, MW
   Park, IS
   Park, B
   Choi, HG
AF Wee, Jee Hye
   Min, Chanyang
   Park, Min Woo
   Park, Il-Seok
   Park, Bumjung
   Choi, Hyo Geun
TI Energy-drink consumption is associated with asthma, allergic rhinitis,
   and atopic dermatitis in Korean adolescents
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID CAFFEINE INTAKE; URIC-ACID; SUGAR; HEALTH; EXERCISE; SODIUM; COFFEE
AB Background/objectives Few studies have evaluated the effects of energy drinks on allergic diseases. The purpose of this investigation was to evaluate the association between energy drinks and various allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis, in a large representative Korean adolescent population. Subjects/methods This cross-sectional study used data from the Korea Youth Risk Behavior Web-based Survey collected from 2015 to 2016. A total of 129,809 participants (n = 67,056 for males; n = 62,753 for females) aged 12-18 years were included and were asked about their frequency of consumption of energy drinks such as Hot6(R), Redbull(R), and Bacchus(R). Their history of asthma, allergic rhinitis, and atopic dermatitis throughout life and in the last 12 months were obtained. The association between the frequency of energy-drink consumption and allergic diseases was analyzed using multiple logistic regression with adjustment for various covariates. Results Age, sex, physical activity, obesity, region of residence, economic level, paternal and maternal educational level, smoking, and alcohol consumption differed significantly according to the frequency of energy-drink consumption (each P < 0.001). Frequent energy-drink consumption (>= 7 times a week) was significantly associated with asthma throughout life (odds ratio [OR] = 1.30, 95% confidence interval (CI) = 1.03-1.64, P = 0.025), asthma within the last 12 months (OR = 1.65, 95% CI = 1.16-2.35, P = 0.006), allergic rhinitis within the last 12 months (OR = 1.21, 95% CI = 1.02-1.44, P = 0.030), and atopic dermatitis within the last 12 months (OR = 1.49, 95% CI = 1.17-1.90, P = 0.001) compared to no energy-drink consumption in the full-adjusted model. Conclusions Frequent energy-drink consumption is associated with allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis, in Korean adolescents.
C1 [Wee, Jee Hye; Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Sacred Heart Hosp, Anyang, South Korea.
   [Min, Chanyang; Choi, Hyo Geun] Hallym Univ, Hallym Data Sci Lab, Coll Med, Anyang, South Korea.
   [Min, Chanyang] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.
   [Park, Min Woo] Kangdong Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.
   [Park, Il-Seok] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Dongtan Sacred Heart Hosp, Dongtan, South Korea.
C3 Hallym University; Hallym University; Seoul National University (SNU);
   Hallym University
RP Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Sacred Heart Hosp, Anyang, South Korea.; Choi, HG (corresponding author), Hallym Univ, Hallym Data Sci Lab, Coll Med, Anyang, South Korea.
EM pupen@naver.com
RI Choi, Hyo/K-4461-2019; Wee, Jee/AAV-7053-2021
OI Wee, Jee Hye/0000-0002-6513-7011; Choi, Hyo Geun/0000-0003-1655-9549
FU National Research Foundation [NRF-2018-R1D1A1A02085328,
   NRF-2020-R1G1A1005390]; Hallym University Research Fund [HURF 2019-31]
FX This work was supported by the National Research Foundation (HGC, Grant
   number NRF-2018-R1D1A1A02085328) (JHW, grant number
   NRF-2020-R1G1A1005390); and Hallym University Research Fund (HGC, Grant
   number HURF 2019-31). The National Research Foundation and Hallym
   University Research Fund had no role in the design, analysis or writing
   of this article.
CR Aeberli I, 2011, AM J CLIN NUTR, V94, P479, DOI 10.3945/ajcn.111.013540
   Al-Zalabani AH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029046
   Alfaro TM, 2018, CLIN RESPIR J, V12, P1283, DOI 10.1111/crj.12662
   Ali F, 2015, POSTGRAD MED, V127, P308, DOI 10.1080/00325481.2015.1001712
   Asero R, 2006, ALLERGY, V61, P1240, DOI 10.1111/j.1398-9995.2006.01154.x
   Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403
   Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396
   Berentzen NE, 2015, EUR J CLIN NUTR, V69, P303, DOI 10.1038/ejcn.2014.153
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Centers for Disease Control and Prevention, 2018, CHILDR TEEN BMI
   Cho SI, 2020, EUR J NUTR, V59, P3171, DOI 10.1007/s00394-019-02157-4
   COHEN S, 1975, NEW ENGL J MED, V293, P897, DOI 10.1056/NEJM197510302931803
   DeChristopher LR, 2018, BRIT J NUTR, V119, P1157, DOI 10.1017/S0007114518000417
   Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST
   Ellwood P, 2013, THORAX, V68, P351, DOI 10.1136/thoraxjnl-2012-202285
   Eltahir HM, 2020, ACTA BIOCHIM POL, V67, P79, DOI 10.18388/abp.2020_2914
   Euromonitor International, 2016, EN DRINKS S KOR
   Gupta S, 2018, INDIAN J PEDIATR, V85, P887, DOI 10.1007/s12098-017-2484-0
   Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x
   Jin MJ, 2016, KOREAN J FAM MED, V37, P111, DOI 10.4082/kjfm.2016.37.2.111
   Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814
   Kauffmann F, 2012, J ALLERGY CLIN IMMUN, V130, P1229, DOI 10.1016/j.jaci.2012.10.038
   Kim KB, 2019, J EXERC REHABIL, V15, P647, DOI 10.12965/jer.1938470.235
   Kim M.S., 2015, Health and Welfare Policy Forum, V220, P14, DOI [10.23062/2015.02.3, DOI 10.23062/2015.02.3]
   Kim S, 2007, STUDY ESTABLISHMENT, P18
   Kim SY, 2020, PEDIATR RES, V88, P320, DOI 10.1038/s41390-020-0749-1
   Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187759
   Koivusilta L, 2016, INT J PUBLIC HEALTH, V61, P299, DOI 10.1007/s00038-016-0797-9
   Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015
   Korea Centers for Disease Control and Prevention, 2015, KOR YOUTH RISK BEH W
   Korea Centers for Disease Control and Prevention, 2012, 5 KOR NAT HLTH NUTR
   Kwon JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072507
   Larson N, 2014, J NUTR EDUC BEHAV, V46, P181, DOI 10.1016/j.jneb.2014.02.008
   Lee KS, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0549-2
   Li L, 2014, ASIAN PAC J ALLERGY, V32, P93, DOI 10.12932/AP0337.32.1.2014
   Meltzer LJ, 2015, PEDIATR PULM, V50, P1360, DOI 10.1002/ppul.23179
   문진수, 2008, Clinical and Experimental Pediatrics, V51, P1
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nordt SP, 2017, PEDIATR EMERG CARE, V33, P770, DOI 10.1097/PEC.0000000000000644
   Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014
   Oren E, 2017, J ALLER CL IMM-PRACT, V5, P427, DOI 10.1016/j.jaip.2016.09.019
   Pacor ML, 2004, ALLERGY, V59, P192, DOI 10.1046/j.1398-9995.2003.00380.x
   Park S, 2016, PREV MED, V91, P58, DOI 10.1016/j.ypmed.2016.08.004
   Poulos NS, 2015, PERSPECT PUBLIC HEAL, V135, P316, DOI 10.1177/1757913914565388
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Research S, 2018, GLOB EN DRINKS SOFT
   Rhee CS, 2014, AM J RHINOL ALLERGY, V28, pE107, DOI 10.2500/ajra.2014.28.4040
   Ruxton CHS, 2008, NUTR BULL, V33, P15, DOI 10.1111/j.1467-3010.2007.00665.x
   Sanchez Sixto E, 2013, Health (Irvine Calif), V5, P26
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Temple JL, 2014, PEDIATRICS, V134, pE112, DOI 10.1542/peds.2013-3962
   The International Study of Asthma and Allergies in Children (ISSAC), 2017, ISSAC MAN
   Visness CM, 2010, J ASTHMA, V47, P822, DOI 10.3109/02770903.2010.489388
   Walker GJ, 2007, MED SCI SPORT EXER, V39, P1554, DOI 10.1249/mss.0b013e3180a74228
   Wang CS, 2018, RESPIROLOGY, V23, P901, DOI 10.1111/resp.13339
   Wang W, 2015, CHINESE MED J-PEKING, V128, P2242, DOI 10.4103/0366-6999.162494
   Welsh EJ, 2010, COCHRANE DB SYST REV, V2010
   Williams RD, 2017, AM J HEALTH BEHAV, V41, P454, DOI 10.5993/AJHB.41.4.10
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   Zhang Y, 2015, J SCI MED SPORT, V18, P569, DOI 10.1016/j.jsams.2014.07.017
   Zucconi S., 2013, Supporting Publications EN-394, DOI [DOI 10.2903/SP.EFSA.2013.EN, 10.2903/sp.efsa.2013.EN-394, DOI 10.2903/SP.EFSA.2013.EN-394]
NR 61
TC 8
Z9 9
U1 2
U2 11
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD JUL
PY 2021
VL 75
IS 7
BP 1077
EP 1087
DI 10.1038/s41430-020-00812-2
EA NOV 2020
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA TG4AQ
UT WOS:000594792700001
PM 33257845
DA 2025-04-28
ER

PT J
AU Haaz, S
   Fontaine, KR
   Cutter, G
   Limdi, N
   Perumean-Chaney, S
   Allison, DB
AF Haaz, S
   Fontaine, KR
   Cutter, G
   Limdi, N
   Perumean-Chaney, S
   Allison, DB
TI Citrus aurantium and synephrine alkaloids in the treatment of
   overweight and obesity:: an update
SO OBESITY REVIEWS
LA English
DT Review
DE bitter orange; Citrus aurantium; herbal supplements; synephrine
ID SEVILLE ORANGE JUICE; SPINAL-ANESTHESIA; BETA(3)-ADRENOCEPTOR AGONISTS;
   GRAPEFRUIT JUICE; EPHEDRA-FREE; BODY-WEIGHT; PHENYLEPHRINE; CAFFEINE;
   ADULTS; DRUGS
AB Obesity is a major health problem facing the developed and developing world. Efforts by individuals, health professionals, educators, and policy makers to combat the escalating trend of growing obesity prevalence have been multifaceted and mixed in outcome. Various dietary supplements have been marketed to reduce obesity. These products have been suggested to accomplish this by decreasing energy intake and energy absorption, and/or increasing metabolic rate. Ephedra, one such supplement, was banned from sale in the US market because of concerns about adverse events. Another substance, Citrus aurantium, which contains several compounds including synephrine alkaloids, has been suggested as a safe alternative. This review examines the evidence for safety and efficacy of C. aurantium and synephrine alkaloids as examined in animal studies, clinical weight loss trials, acute physiologic studies and case reports. Although at least three reviews of C. aurantium have been published, our review expands upon these by: (i) distinguishing and evaluating the efficacy of C. aurantium and related compounds; (ii) including results from previously unreviewed research; (iii) incorporating recent case reports that serve to highlight, in an anecdotal way, potential adverse events related to the use of C. aurantium and related compounds; and (iv) offering recommendations to guide the design of future trials to evaluate the safety and efficacy of C. aurantium. While some evidence is promising, we conclude that larger and more rigorous clinical trials are necessary to draw adequate conclusions regarding the safety and efficacy of C. aurantium and synephrine alkaloids for promoting weight loss.
C1 Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.
   Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA.
   Univ Alabama Birmingham, Nutr Res Ctr, Birmingham, AL 35294 USA.
   Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA.
C3 University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham; Johns
   Hopkins University
RP Univ Alabama Birmingham, Dept Biostat, Ryals Publ Hlth Bldg,1665 Univ Blvd, Birmingham, AL 35294 USA.
EM Dallison@ms.soph.uab.edu
RI Cutter, Gary/AAY-5392-2021
OI Allison, David/0000-0003-3566-9399; Cutter, Gary/0000-0002-8455-980X
FU NIAMS NIH HHS [AR49720-01A1] Funding Source: Medline; NIDDK NIH HHS
   [P30DK056336] Funding Source: Medline
CR Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530
   Allison DB, 2005, INT J OBESITY, V29, P443, DOI 10.1038/sj.ijo.0802879
   Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194
   [Anonymous], 2004, CLARKES ANAL DRUGS P, V3rd
   [Anonymous], 2004, Martindale: The complete drug reference
   [Anonymous], 2017, Annex 3-03, P4
   Antipatis V. J., 2001, International textbook of obesity, P3
   Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8
   Armstrong W.J., 2001, Journal of Exercise Physiology Online, V4, P28
   Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207
   ASTRUP A, 1993, INT J OBESITY, V17, pS41
   ATKINSON RL, 1994, JAMA-J AM MED ASSOC, V272, P1196, DOI 10.1001/jama.272.15.1196
   Ayyad C, 2000, Obes Rev, V1, P113, DOI 10.1046/j.1467-789x.2000.00019.x
   Barnes J, 2003, BRIT J CLIN PHARMACO, V55, P331, DOI 10.1046/j.1365-2125.2003.01811.x
   Billington C J, 2000, J Am Board Fam Pract, V13, P222
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BRADLEY JG, 1991, POSTGRAD MED, V89, P195
   Bray GA, 1999, ENDOCR REV, V20, P805, DOI 10.1210/er.20.6.805
   BROWN CM, 1988, BRIT J PHARMACOL, V93, P417, DOI 10.1111/j.1476-5381.1988.tb11449.x
   Calapai G, 1999, FITOTERAPIA, V70, P586, DOI 10.1016/S0367-326X(99)00093-3
   *CANT HLTH SCI INT, 2000, SAF ASS DET TOL LIM
   Cantu C, 2003, STROKE, V34, P1667, DOI 10.1161/01.STR.0000075293.45936.FA
   COLDITZ GA, 1992, AM J CLIN NUTR, V55, P503
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   Cooper DW, 2002, ANESTHESIOLOGY, V97, P1582, DOI 10.1097/00000542-200212000-00034
   DESFAITS AC, 1995, LIFE SCI, V57, P705, DOI 10.1016/0024-3205(95)00322-W
   Di Marco MP, 2002, LIFE SCI, V71, P1149, DOI 10.1016/S0024-3205(02)01799-X
   DITTRICH A, 1991, J UROLOGY, V146, P323, DOI 10.1016/S0022-5347(17)37781-9
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Eyeson-Annan ML, 1998, OPHTHALMOLOGY, V105, P726, DOI 10.1016/S0161-6420(98)94030-1
   *FDA, 2001, OV DIET SUPPL
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187
   Fontaine KR, 2000, INT J EAT DISORDER, V27, P101, DOI 10.1002/(SICI)1098-108X(200001)27:1<101::AID-EAT12>3.0.CO;2-D
   Food and Drug Administration HHS, 2004, Fed Regist, V69, P6787
   Freedman MR, 2001, OBES RES, V9, p1S, DOI 10.1038/oby.2001.113
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   Geyer H, 2004, INT J SPORTS MED, V25, P124, DOI 10.1055/s-2004-819955
   Gurley BJ, 2000, AM J HEALTH-SYST PH, V57, P963, DOI 10.1093/ajhp/57.10.963
   Halpern A, 2003, Obes Rev, V4, P25, DOI 10.1046/j.1467-789X.2003.00083.x
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   HEDREI P, 1997, THERMOGENIC EFFECT B
   HELLMICH N, 2002, USA TODAY       0120
   Heo M, 1998, MECH AGEING DEV, V102, P45, DOI 10.1016/S0047-6374(98)00010-4
   Iaccarino G, 1998, AM J PHYSIOL-HEART C, V275, pH1298, DOI 10.1152/ajpheart.1998.275.4.H1298
   IBRAHIM KE, 1984, ANAL CHEM, V56, P1695, DOI 10.1021/ac00273a037
   JONES D, 2001, Patent No. 6224873
   JORDAN R, 1987, J PHARM PHARMACOL, V39, P752, DOI 10.1111/j.2042-7158.1987.tb06986.x
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Kim KW, 2001, N-S ARCH PHARMACOL, V364, P21, DOI 10.1007/s002100100416
   Lee A, 2002, ANESTH ANALG, V94, P920, DOI 10.1097/00000539-200204000-00028
   Malhotra S, 2001, CLIN PHARMACOL THER, V69, P14, DOI 10.1067/mcp.2001.113185
   Marcus DM, 2003, SCIENCE, V301, P1669
   Markus CR, 2003, PHARMACOL BIOCHEM BE, V76, P487, DOI 10.1016/j.pbb.2003.09.002
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   MOONEY RA, 1984, INT J BIOCHEM, V16, P55, DOI 10.1016/0020-711X(84)90050-8
   MORO CO, 2002, FITOTERAPIA S1, V71, pS73
   Nasir JM, 2004, MAYO CLIN PROC, V79, P1059, DOI 10.4065/79.8.1059
   *NAT TOX PROGR, 1987, NATL TOX PROGR TECH, V322, P1
   National Taxicology Program, 1986, Natl. Toxicol. Progr. Tech. Rep, V307, P1
   Newton Gail D, 2004, J Am Pharm Assoc (2003), V44, P211, DOI 10.1331/154434504773062636
   Nykamp DL, 2004, ANN PHARMACOTHER, V38, P812, DOI 10.1345/aph.1D473
   PATHAK B, 1999, CURRENT THERAPEUTIC, V60, P145
   Pellati F, 2002, J PHARMACEUT BIOMED, V29, P1113, DOI 10.1016/S0731-7085(02)00153-X
   Penzak SR, 2001, J CLIN PHARMACOL, V41, P1059, DOI 10.1177/00912700122012652
   Preuss Harry G., 2002, Journal of Medicine (Westbury), V33, P247
   RADACK K, 1986, ANN ALLERGY, V56, P396
   Rados C., 2004, FDA CONSUMER MAG MAR
   REDFEARN S, 2003, WASHINGTON POST 0113
   Sahu D., 2003, INDIAN J ANAESTH, V47, P125
   SCHUMER C, 2004, NEW US EPHEDRA BAN D
   SHUGARMAN AE, 2004, MED SCI SPORTS EXERC, V31, pS1646
   Spurlock ME, 1996, PHYSIOL BEHAV, V60, P1217, DOI 10.1016/S0031-9384(96)00219-3
   Starke K, 1998, N-S ARCH PHARMACOL, V358, P1, DOI 10.1007/PL00005229
   STRICKER EM, 1991, BRAIN RES BULL, V27, P299, DOI 10.1016/0361-9230(91)90115-Z
   Thomas DG, 1996, BRIT J ANAESTH, V76, P61, DOI 10.1093/bja/76.1.61
   THOMAS SHL, 1991, BRIT J CLIN PHARMACO, V32, P705
   *US FDA, 2003, WHIT PAP EV SAF EFF
   Weyer C, 1999, DIABETES METAB, V25, P11
   WHO, 1997, WHO CONS OB
   Xie JT, 2002, PHYTOMEDICINE, V9, P254, DOI 10.1078/0944-7113-00106
   Yeh SY, 1999, PHYSIOL BEHAV, V68, P227, DOI 10.1016/S0031-9384(99)00180-8
   YOSHIDA T, 1994, INT J OBESITY, V18, P345
   2004, DANGEROUS SUPPLEMENT
NR 85
TC 156
Z9 170
U1 0
U2 66
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7881
EI 1467-789X
J9 OBES REV
JI Obes. Rev.
PD FEB
PY 2006
VL 7
IS 1
BP 79
EP 88
DI 10.1111/j.1467-789X.2006.00195.x
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 007QC
UT WOS:000234983400008
PM 16436104
DA 2025-04-28
ER

PT J
AU Gomes, KEPD
   Costa, MCO
   Vieira, TD
   Matos, SMA
   Vieira, GO
AF Peixoto de Souza Gomes, Karina Emanuella
   Oliveira Costa, Maria Conceicao
   Vieira, Tatiana de Oliveira
   Alvim Matos, Sheila Maria
   Vieira, Graciete Oliveira
TI Food consumption pattern and obesity in preschool children in Feira
   de Santana, Bahia, Brazil
SO REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION
LA English
DT Article
DE Child, preschool; Factor analysis, statistical; Feeding behavior;
   Obesity
ID DIETARY; OVERWEIGHT; YOUTH
AB Objective
   To evaluate the association between food consumption patterns and obesity in preschool children in Feira de Santana, Bahia, Brazil.
   Methods
   Cross-sectional, population-based nested within a live-birth cohort study of 813 children, which has started in 2004 in Feira de Santana, Bahia. The anthropometric status among children under four years of age was evaluated based on their body mass index; obesity/severe obesity was defined as a Z-score >+2. The Food Frequency Questionnaire was used to identify dietary patterns using principal components analysis. The association between obesity and food consumption patterns was assessed using Pearson's Chi-squared test and logistic regression, adopting p<0.05 to denote statistical significance.
   Results
   Obesity was detected in 12.7% of the children investigated. Four food consumption patterns were identified: dietary pattern 1 (milk and other dairy products, vegetables and tubers, cereals, legumes, fruits, and fish); dietary pattern 2 (deep-fried or baked snacks, soft drinks/artificial fruit juices, oils and fats, sweets, and coffee/tea); dietary pattern 3 (encased meats, fast food, ketchup/mayonnaise, and eggs); and, dietary pattern 4 (chicken and red meats). Obesity was statistically associated with high adherence to the dietary pattern 3 (OR=1.92; 95% CI=1.01-3.66).
   Conclusion
   The results obtained showed that the high intake of energy-dense foods (dietary pattern 3) was a contributing factor to childhood obesity. These data reinforce the need for public policies and food education programs in health units and schools, aiming to change children's eating habits, significant predictors of nutritional problems.
C1 [Peixoto de Souza Gomes, Karina Emanuella; Oliveira Costa, Maria Conceicao; Vieira, Tatiana de Oliveira; Vieira, Graciete Oliveira] Univ Estadual Feira de Santana, Dept Saude, Programa Posgrad Saude Colet, Av Transnordestina S-N,Ctr Posgrad Saude Colet, BR-44036900 Feira De Santana, BA, Brazil.
   [Alvim Matos, Sheila Maria] Univ Fed Bahia, Inst Saude Colet, Programa Posgrad Saude Colet, Salvador, BA, Brazil.
C3 Universidade Estadual de Feira de Santana; Universidade Federal da Bahia
RP Gomes, KEPD (corresponding author), Univ Estadual Feira de Santana, Dept Saude, Programa Posgrad Saude Colet, Av Transnordestina S-N,Ctr Posgrad Saude Colet, BR-44036900 Feira De Santana, BA, Brazil.
EM souzakep@gmail.com
RI da Conceição Lopes Costa, Maria/AAL-1461-2021
CR ANDERSON MA, 1995, B WORLD HEALTH ORGAN, V73, P165
   [Anonymous], 2010, R LANG ENV STAT COMP
   [Anonymous], 2000, STAT PACKAGE SOCIAL
   Baker JL, 2010, OBESITY FACTS, V3, P131, DOI 10.1159/000295112
   D'Innocenzo Silvana, 2011, Rev. Bras. Saude Mater. Infant., V11, P41, DOI 10.1590/S1519-38292011000100005
   D'Innocenzo S, 2014, CAD SAUDE PUBLICA, V30, P1849
   de Carvalho CA, 2016, CIENC SAUDE COLETIVA, V21, P143, DOI 10.1590/1413-81232015211.18962014
   de Jesus GM, 2010, J PEDIAT-BRAZIL, V86, P311, DOI [10.2223/JPED.2009, 10.1590/S0021-75572010000400011]
   Ford CN, 2013, J ACAD NUTR DIET, V113, P35, DOI 10.1016/j.jand.2012.08.022
   Hair J.F., 2009, AN LISE MULTIVARIADA, V6a
   Instituto Brasileiro de Geografia e Estatistica Diretoria de Pesquisas Coordenacao de Trabalho e Rendimento, 2010, PESQ ORC FAM 2008 20
   Levy DT, 2013, AM J COMMUN PSYCHOL, V51, P299, DOI 10.1007/s10464-012-9535-5
   Lo K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124753
   Nobre LN, 2012, J PEDIAT-BRAZIL, V88, P129, DOI 10.2223/JPED.2169
   Olinto M., 2007, Padroes alimentares: analise de componentes principai, P213
   Oliveira Ana Mayra A. de, 2003, Arq Bras Endocrinol Metab, V47, P144, DOI 10.1590/S0004-27302003000200006
   Shiu LKC, 2012, ASIA PAC J CLIN NUTR, V21, P144
   Sotero Andrea Marques, 2015, Rev Paul Pediatr, V33, P445, DOI 10.1016/j.rpped.2015.03.006
   Souza R, 2013, Cad Saude Publica, V29, P2416, DOI [10.1590/0102-311x00156412, DOI 10.1590/0102-311X00156412]
   Sune FR, 2007, CAD SAUDE PUBLICA, V23, P1361, DOI 10.1590/S0102-311X2007000600011
   Vieira GO, 2010, J PEDIAT-BRAZIL, V86, P441, DOI 10.2223/JPED.2010
   WHO & FAO of the United Nations, 1998, WHO TECH REP SER
   Zaghloul S, 2013, PUBLIC HEALTH NUTR, V16, P596, DOI 10.1017/S1368980012003941
   [No title captured]
NR 24
TC 2
Z9 2
U1 1
U2 8
PU PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS
PI CAMPINAS
PA NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO
   ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL
SN 1415-5273
J9 REV NUTR
JI Rev. Nutr.
PD SEP-OCT
PY 2017
VL 30
IS 5
BP 639
EP 650
DI 10.1590/1678-98652017000500009
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FQ6TP
UT WOS:000418497200009
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Santos, HO
   Tinsley, GM
AF Santos, Heitor O.
   Tinsley, Grant M.
TI Is breakfast consumption detrimental, unnecessary, or an opportunity for
   health promotion? A review of cardiometabolic outcomes and functional
   food choices
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Review
DE breakfast consumption; breakfast skipping; cardiovascular disease;
   cardiovascular events; intermittent fasting
ID DOSE-RESPONSE METAANALYSIS; ALL-CAUSE MORTALITY;
   CARDIOVASCULAR-DISEASES; DAIRY CONSUMPTION; NUT CONSUMPTION;
   BLOOD-PRESSURE; ENERGY-INTAKE; WHEY-PROTEIN; RISK-FACTORS; WEIGHT-LOSS
AB Breakfast consumption is generally considered a health-promoting habit for cardiometabolism, particularly with regard to chrononutrition. Glucose uptake is enhanced by proper insulin secretion triggered by the pancreatic clock, averting metabolic dysregulation related to insulin resistance. Breakfast skipping, in turn, is often considered a behaviour detrimental to health, in part due to putative inverse metabolic actions compared to breakfast consumption, such that breakfast skipping may promote circadian desynchrony. However, most ill health concerns about breakfast skipping are inferred from observational research, and recent well-controlled randomized clinical trials have shown benefits of breakfast skipping for cardiovascular risk factors. Accordingly, this review describes the effects of breakfast consumption versus breakfast skipping on cardiovascular risk factors (blood pressure and glycaemic and lipid indices). In addition, the view of breakfast consumption as an opportunity for functional food ingestion is considered to provide further insights into decision-making practice. Collectively, both breakfast consumption and breakfast skipping can be considered viable habits, but they depend on individual preferences, planning, and the specific foods being consumed or omitted. When consumed, breakfast should consist primarily of functional foods typical for this meal (e.g., eggs, dairy products, nuts, fruits, whole grains, coffee, tea, etc.). While breakfast consumption aligns with chrononutrition principles, breakfast skipping can contribute to a calorie deficit over time, which has the potential for widespread cardiometabolic benefits for patients with overweight/obesity. The concepts and practical considerations discussed in the present review may aid health care personnel in personalising breakfast consumption recommendations for diverse patient populations.
C1 [Santos, Heitor O.] Fed Univ Uberlandia UFU, Sch Med, Uberlandia, MG, Brazil.
   [Tinsley, Grant M.] Texas Tech Univ, Dept Kinesiol & Sport Management, Lubbock, TX USA.
   [Santos, Heitor O.] Fed Univ Uberlandia UFU, Sch Med, Para St, 1720,Umuarama,Block 2H, BR-38400902 Uberlandia, MG, Brazil.
C3 Universidade Federal de Uberlandia; Texas Tech University System; Texas
   Tech University
RP Santos, HO (corresponding author), Fed Univ Uberlandia UFU, Sch Med, Para St, 1720,Umuarama,Block 2H, BR-38400902 Uberlandia, MG, Brazil.
EM heitoroliveirasantos@gmail.com
RI Tinsley, Grant/S-4582-2019
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)-Brazil
FX & nbsp;HOS has been supported by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)-Brazil.
CR Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Aune Dagfinn, 2017, Int J Epidemiol, V46, P1029, DOI 10.1093/ije/dyw319
   Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2716
   Becerra-Tomás N, 2021, AM J CLIN NUTR, V113, P960, DOI 10.1093/ajcn/nqaa358
   Bonnet JP, 2020, OBESITY, V28, P1098, DOI 10.1002/oby.22791
   Chen GC, 2017, FOOD FUNCT, V8, P3893, DOI [10.1039/C7FO00915A, 10.1039/c7fo00915a]
   Chung M, 2020, ADV NUTR, V11, P790, DOI 10.1093/advances/nmaa010
   Chungchunlam SMS, 2016, BRIT J NUTR, V116, P1666, DOI 10.1017/S0007114516003767
   Curtis PJ, 2022, CLIN NUTR, V41, P165, DOI 10.1016/j.clnu.2021.11.030
   D'Elia L, 2021, EUR J NUTR, V60, P2449, DOI 10.1007/s00394-020-02426-7
   Da Silva MS, 2015, MOL NUTR FOOD RES, V59, P1249, DOI 10.1002/mnfr.201400569
   Del Gobbo LC, 2015, AM J CLIN NUTR, V102, P1347, DOI 10.3945/ajcn.115.110965
   DiMarco DM, 2017, J NUTR, V147, P323, DOI 10.3945/jn.116.241877
   Drouin-Chartier JP, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m513
   Frid AH, 2005, AM J CLIN NUTR, V82, P69, DOI 10.1093/ajcn/82.1.69
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Guo J, 2017, EUR J EPIDEMIOL, V32, P269, DOI 10.1007/s10654-017-0243-1
   Guo K, 2015, J DIABETES, V7, P202, DOI 10.1111/1753-0407.12173
   Hasler CM, 2009, J AM DIET ASSOC, V109, P735, DOI 10.1016/j.jada.2009.02.023
   Henry CJ, 2010, EUR J CLIN NUTR, V64, P657, DOI 10.1038/ejcn.2010.101
   Hidayat K, 2017, HYPERTENS RES, V40, P264, DOI 10.1038/hr.2016.135
   Hou QT, 2015, NUTRIENTS, V7, P10369, DOI 10.3390/nu7125536
   Hui SC, 2019, EUR J NUTR, V58, P2779, DOI 10.1007/s00394-018-1827-6
   Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460
   Jówko E, 2015, ANTIOXIDANTS IN SPORT NUTRITION, P123
   Kahleova H, 2017, J NUTR, V147, P1722, DOI 10.3945/jn.116.244749
   Lari A, 2021, NUTR METAB CARDIOVAS, V31, P2766, DOI 10.1016/j.numecd.2021.05.030
   LeCheminant GM, 2017, APPETITE, V112, P44, DOI 10.1016/j.appet.2016.12.041
   Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566
   Lee SH, 2022, MMWR-MORBID MORTAL W, V71, P1, DOI 10.15585/mmwr.mm7101a1
   Li ZP, 2013, FOOD FUNCT, V4, P384, DOI 10.1039/c2fo30226h
   Loftfield E, 2018, JAMA INTERN MED, V178, P1086, DOI 10.1001/jamainternmed.2018.2425
   Loureiro LMR, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103335
   Mahdavi-Roshan M, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102430
   McGregor RA, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-46
   McRae MP, 2017, J CHIROPR MED, V16, P10, DOI 10.1016/j.jcm.2016.08.008
   Moosavian SP, 2020, NUTR METAB CARDIOVAS, V30, P872, DOI 10.1016/j.numecd.2020.01.011
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Park HA, 2021, KOREAN J FAM MED, V42, P9, DOI 10.4082/kjfm.20.0225
   Paudel D, 2021, FOODS, V10, DOI 10.3390/foods10112591
   Peou S, 2016, J CLIN LIPIDOL, V10, P161, DOI 10.1016/j.jacl.2015.10.011
   Pot GK, 2014, INT J OBESITY, V38, P1518, DOI 10.1038/ijo.2014.51
   Rahmani S, 2020, ADV NUTR, V11, P52, DOI 10.1093/advances/nmz063
   Rakhra Varundeep, 2020, Mo Med, V117, P536
   Rasane P, 2015, J FOOD SCI TECH MYS, V52, P662, DOI 10.1007/s13197-013-1072-1
   Ros E, 2013, CIRCULATION, V128, P553, DOI 10.1161/CIRCULATIONAHA.112.001119
   Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010
   Rouhani MH, 2018, J AM COLL NUTR, V37, P99, DOI 10.1080/07315724.2017.1366878
   Ruddick-Collins LC, 2022, CELL METAB, V34, P1472, DOI 10.1016/j.cmet.2022.08.001
   Sakamoto FL, 2019, PHARMACOL RES, V147, DOI 10.1016/j.phrs.2019.104395
   Santos H. O., 2018, INT J CARDIOVASC SCI, V32, P190, DOI [10.5935/2359-4802.20180077, DOI 10.5935/2359-4802.20180077]
   Santos HO, 2022, AM J CLIN NUTR, V115, P991, DOI 10.1093/ajcn/nqab433
   Santos HO, 2021, INT J SPORT NUTR EXE, V31, P514, DOI 10.1123/ijsnem.2021-0086
   Santos HO, 2021, CLIN NUTR ESPEN, V42, P90, DOI 10.1016/j.clnesp.2021.01.033
   Santos HO, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103159
   Santos HO, 2022, CRIT REV FOOD SCI, V62, P466, DOI 10.1080/10408398.2020.1819768
   Santos HO, 2020, PROG CARDIOVASC DIS, V63, P503, DOI 10.1016/j.pcad.2020.04.009
   Santos HO, 2021, CRIT REV FOOD SCI, V61, P417, DOI 10.1080/10408398.2020.1734912
   Santos HO, 2019, CLIN THER, V41, P1780, DOI 10.1016/j.clinthera.2019.06.002
   Santos HO, 2018, CLIN NUTR ESPEN, V27, P10, DOI 10.1016/j.clnesp.2018.06.001
   Santos HO, 2018, CLIN NUTR ESPEN, V27, P1, DOI 10.1016/j.clnesp.2018.07.011
   Santos HO, 2018, ARQ BRAS CARDIOL, V110, P585, DOI 10.5935/abc.20180092
   Serafini M., 2011, Herbal Medicine: Biomolecular and Clinical Aspects, DOI DOI 10.1201/B10787-13
   Sievert K, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l42
   Soedamah-Muthu SS, 2012, HYPERTENSION, V60, P1131, DOI 10.1161/HYPERTENSIONAHA.112.195206
   St-Onge MP, 2017, CIRCULATION, V135, pE96, DOI 10.1161/CIR.0000000000000476
   Sun YB, 2023, J ACAD NUTR DIET, V123, DOI 10.1016/j.jand.2022.08.119
   Teixeira FJ, 2019, PHARMACOL RES, V144, P245, DOI 10.1016/j.phrs.2019.04.019
   Townsend N, 2022, NAT REV CARDIOL, V19, P133, DOI 10.1038/s41569-021-00607-3
   Tsao CW, 2022, CIRCULATION, V145, pE153, DOI 10.1161/CIR.0000000000001052
   Wallace TC, 2020, CRIT REV FOOD SCI, V60, P2174, DOI 10.1080/10408398.2019.1632258
   Wang P, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2020.102358
   Wehrli F, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082560
   Whitehead A, 2014, AM J CLIN NUTR, V100, P1413, DOI 10.3945/ajcn.114.086108
   Xie ZB, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28662-5
   Xu RF, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00557-5
   Yu JY, 2017, DIABETES METAB J, V41, P251
   Zhang L, 2022, CLIN THER, V44, P482, DOI 10.1016/j.clinthera.2022.02.012
   Zhu CY, 2020, COMPLEMENT THER MED, V53, DOI 10.1016/j.ctim.2020.102517
NR 79
TC 10
Z9 10
U1 9
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-7552
EI 1520-7560
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD FEB
PY 2024
VL 40
IS 2
DI 10.1002/dmrr.3684
EA JUL 2023
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA MP3Y0
UT WOS:001020574800001
PM 37395322
DA 2025-04-28
ER

PT J
AU Kent, LM
   Worsley, A
AF Kent, Lillian M.
   Worsley, Anthony
TI Does the prescriptive lifestyle of Seventh-day Adventists provide
   'immunity' from the secular effects of changes in BMI?
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Lifestyle; Diet; Body mass index; Seventh-day Adventist; Physical
   activity
ID SELF-REPORTED HEIGHT; CARDIOVASCULAR-DISEASE; PORTION SIZES;
   RISK-FACTORS; BODY-MASS; OBESITY; OVERWEIGHT; MORTALITY; WEIGHT
AB Objective.. To examine the effect of Seventh-day Adventist (SDA) membership on 'immunity' to the secular effects of changes in BMI.
   Design: Three independent, cross-sectional, screening surveys conducted by Sydney Adventist Hospital in 1976, 1986 and 1988 and a survey conducted among residents of Melbourne in 2006.
   Subjects: Two hundred and fifty-two SDA and 464 non-SDA in 1976; 166 SDA and 291 non-SDA in 1986; 120 SDA and 300-non SDA in 1988; and 251 SDA and 294 non-SDA in 2006.
   Measurements: Height and weight measured by hospital staff in 1976, 1986 and 1988; self-reported by respondents in 2006.
   Results: The mean BMI of non-SDA men increased between 1986 and 2006 (P< 0-001) but did not change for SDA men or non-SDA women. Despite small increases in SDA women's mean BMI (P= 0-030) between 1988 and 2006, this was no different to that of SDA men and non-SDA women in 2006. The diet and eating patterns of SDA men and women were more 'prudent' than those of non-SDA men and women, including more fruit, vegetables, grains, nuts and legumes, and less alcohol, meat, sweetened drinks and coffee. Many of these factors were found to be predictors of lower BMI.
   Conclusion: The 'prudent' dietary and lifestyle prescriptions of SDA men appear to have 'immunised' them to the secular effects of changes that occurred among non-SDA men's BMI. The dietary and lifestyle trends of SDA women did not reflect the increase in their BMI observed in 2006
C1 [Kent, Lillian M.] Deakin Univ, Sch Exercise & Nutr Sci, Fac Hlth & Behav Sci, Melbourne, Vic 3125, Australia.
   [Worsley, Anthony] VicHealth, Melbourne, Vic, Australia.
C3 Deakin University
RP Kent, LM (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Fac Hlth & Behav Sci, 221 Burwood Highway, Melbourne, Vic 3125, Australia.
EM lkent@deakin.edu.au
OI Kent, Lillian/0000-0001-9518-7303; Worsley, Anthony/0000-0002-4635-6059
FU Deakin University, Melbourne, Australia; Sanitarium Health Food Company,
   Australia; Australian Research Council
FX Financial support was provided by Deakin University, Melbourne,
   Australia; the Sanitarium Health Food Company, Australia; and Australian
   Research Council grants awarded to A.W. Statistical assistance was
   provided by Professor Kai Lo. There were no conflicts of interest to
   report. L.M.K. was I PhD student conducting the research under the
   supervision of A.W. Both authors contributed to the manuscript.
CR Alexander H, 1999, J AM COLL NUTR, V18, P127, DOI 10.1080/07315724.1999.10718840
   [Anonymous], 1998, AUSTR GUIDE HLTH EAT
   *AUSTR BUR STAT, 2003, SOC IND AR AUSTR 200
   Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143
   Bryant R, 2005, J CONSUM AFF, V39, P399, DOI 10.1111/j.1745-6606.2005.00021.x
   CALKINS B M, 1984, American Journal of Clinical Nutrition, V40, P887, DOI 10.1093/ajcn/40.4.887
   Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x
   *COMM DEP HLTH AG, 1999, NAT PHYS ACT SURV
   Flood V, 2000, AUST NZ J PUBL HEAL, V24, P96, DOI 10.1111/j.1467-842X.2000.tb00733.x
   FONNEBO V, 1992, AM J EPIDEMIOL, V135, P504, DOI 10.1093/oxfordjournals.aje.a116317
   Fraser G.E., 2003, DIET LIFE EXPECTANCY
   Haddad EH, 1999, AM J CLIN NUTR, V70, p586S, DOI 10.1093/ajcn/70.3.586s
   Hebert JR, 2008, J NUTR, V138, p226S, DOI 10.1093/jn/138.1.226S
   Kristal AR, 1998, J AM DIET ASSOC, V98, P40, DOI 10.1016/S0002-8223(98)00012-1
   LINDSTED K, 1991, INT J OBESITY, V15, P397
   Lindsted KD, 1998, INT J OBESITY, V22, P544, DOI 10.1038/sj.ijo.0800623
   MELBY CL, 1993, J AM COLL NUTR, V12, P262
   *MIN ASS, 1988, MIN ASS GEN C 7 DAY
   National Health and Medical Research Council, 2003, DIET GUID AUSTR AD
   Nestle M, 2003, J AM DIET ASSOC, V103, P39, DOI 10.1053/jada.2003.50007
   Organisation mondiale de la sante, 1999, Obesity: preventing and managing the global epidemic, report of a WHO Consultaton
   Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322
   VENN AJ, 1985, MED J AUSTRALIA, V186, P458
   WHO, 2003, WHO TECHN REP SER
   Willett WC, 1999, AM J CLIN NUTR, V70, p434S, DOI 10.1093/ajcn/70.3.434s
   Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246
NR 26
TC 8
Z9 9
U1 4
U2 18
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD APR
PY 2009
VL 12
IS 4
BP 472
EP 480
DI 10.1017/S1368980008002334
PG 9
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 423UU
UT WOS:000264522000006
PM 18457602
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Imamura, F
   Sharp, SJ
   Koulman, A
   Schulze, MB
   Kröger, J
   Griffin, JL
   Huerta, JM
   Guevara, M
   Sluijs, I
   Agudo, A
   Ardanaz, E
   Balkau, B
   Boeing, H
   Chajes, V
   Dahm, CC
   Dow, C
   Fagherazzi, G
   Feskens, EJM
   Franks, PW
   Gavrila, D
   Gunter, M
   Kaaks, R
   Key, TJ
   Khaw, KT
   Kühn, T
   Melander, O
   Molina-Portillo, E
   Nilsson, PM
   Olsen, A
   Overvad, K
   Palli, D
   Panico, S
   Rolandsson, O
   Sieri, S
   Sacerdote, C
   Slimani, N
   Spijkerman, AMW
   Tjonneland, A
   Tumino, R
   van der Schouw, YT
   Langenberg, C
   Riboli, E
   Forouhi, NG
   Wareham, NJ
AF Imamura, Fumiaki
   Sharp, Stephen J.
   Koulman, Albert
   Schulze, Matthias B.
   Kroeger, Janine
   Griffin, Julian L.
   Huerta, Jose M.
   Guevara, Marcela
   Sluijs, Ivonne
   Agudo, Antonio
   Ardanaz, Eva
   Balkau, Beverley
   Boeing, Heiner
   Chajes, Veronique
   Dahm, Christina C.
   Dow, Courtney
   Fagherazzi, Guy
   Feskens, Edith J. M.
   Franks, Paul W.
   Gavrila, Diana
   Gunter, Marc
   Kaaks, Rudolf
   Key, Timothy J.
   Khaw, Kay-Tee
   Kuehn, Tilman
   Melander, Olle
   Molina-Portillo, Elena
   Nilsson, Peter M.
   Olsen, Anja
   Overvad, Kim
   Palli, Domenico
   Panico, Salvatore
   Rolandsson, Olov
   Sieri, Sabina
   Sacerdote, Carlotta
   Slimani, Nadia
   Spijkerman, Annemieke M. W.
   Tjonneland, Anne
   Tumino, Rosario
   van der Schouw, Yvonne T.
   Langenberg, Claudia
   Riboli, Elio
   Forouhi, Nita G.
   Wareham, Nick J.
TI A combination of plasma phospholipid fatty acids and its association
   with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study
SO PLOS MEDICINE
LA English
DT Article
ID CARDIOVASCULAR-DISEASE; COFFEE CONSUMPTION; INSULIN-RESISTANCE; RISK;
   BIOMARKER; INDEX; DIET; METAANALYSIS; ERYTHROCYTE; VALIDITY
AB Background
   Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated.
   Methods and findings
   We measured plasma phospholipid fatty acids by gas chromatography in 27,296 adults, including 12,132 incident cases of T2D, over the follow-up period between baseline (1991-1998) and 31 December 2007 in 8 European countries in EPIC-InterAct, a nested casecohort study. The first principal component derived by principal component analysis of 27 individual fatty acids (mole percentage) was the main exposure (subsequently called the fatty acid pattern score [FA-pattern score]). The FA-pattern score was partly characterised by high concentrations of linoleic acid, stearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrations of.-linolenic acid, palmitic acid, and long-chain monounsaturated fatty acids, and it explained 16.1% of the overall variability of the 27 fatty acids. Based on country-specific Prentice-weighted Cox regression and random-effects meta-analysis, the FA-pattern score was associated with lower incident T2D. Comparing the top to the bottom fifth of the score, the hazard ratio of incident T2D was 0.23 (95% CI 0.19-0.29) adjusted for potential confounders and 0.37 (95% CI 0.27-0.50) further adjusted for metabolic risk factors. The association changed little after adjustment for individual fatty acids or fatty acid subclasses. In cross-sectional analyses relating the FA-pattern score to metabolic, genetic, and dietary factors, the FA-pattern score was inversely associated with adiposity, triglycerides, liver enzymes, C-reactive protein, a genetic score representing insulin resistance, and dietary intakes of soft drinks and alcohol and was positively associated with high-density-lipoprotein cholesterol and intakes of polyunsaturated fat, dietary fibre, and coffee (p < 0.05 each). Limitations include potential measurement error in the fatty acids and other model covariates and possible residual confounding.
   Conclusions
   A combination of individual fatty acids, characterised by high concentrations of linoleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower incidence of T2D. The specific fatty acid pattern may be influenced by metabolic, genetic, and dietary factors.
C1 [Imamura, Fumiaki; Sharp, Stephen J.; Langenberg, Claudia; Forouhi, Nita G.; Wareham, Nick J.] Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England.
   [Koulman, Albert] Univ Cambridge, Addenbrookes Hosp, Natl Inst Hlth Res Biomed Res Ctr Core Nutr Bioma, Cambridge, England.
   [Koulman, Albert] Univ Cambridge, Addenbrookes Hosp, Natl Inst Hlth Res Biomed Res Ctr Core Metabol &, Cambridge, England.
   [Koulman, Albert; Griffin, Julian L.] Elsie Widdowson Lab, Med Res Council Epidemiol Unit, Cambridge, England.
   [Schulze, Matthias B.; Kroeger, Janine; Boeing, Heiner] German Inst Human Nutr, Dept Mol Epidemiol, Potsdam, Germany.
   [Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge, England.
   [Huerta, Jose M.] CIBER Epidemiol & Salud Publ, Consejeria Sanidad & Polit Social, Dept Epidemiol, Murcia, Spain.
   [Huerta, Jose M.; Guevara, Marcela; Ardanaz, Eva; Gavrila, Diana; Molina-Portillo, Elena] CIBER Epidemiol & Salud Publ, Madrid, Spain.
   [Guevara, Marcela; Ardanaz, Eva] Navarre Publ Hlth Inst Pamplona, Navarra Inst Hlth Res IdiSNA, Pamplona, Spain.
   [Sluijs, Ivonne; van der Schouw, Yvonne T.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Agudo, Antonio] Catalan Inst Oncol, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain.
   [Balkau, Beverley; Dow, Courtney; Fagherazzi, Guy] Paris Saclay Univ, Univ Versailles Saint Quentinen En Yvelines, Paris Sud Univ, Ctr Res Epidemiol & Populat Hlth,Inserm U1018, Villejuif, France.
   [Chajes, Veronique; Slimani, Nadia] Int Agcy Res Canc, Lyon, France.
   [Dahm, Christina C.; Gunter, Marc; Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark.
   [Dow, Courtney; Fagherazzi, Guy] Gustave Roussy Inst, Villejuif, France.
   [Feskens, Edith J. M.] Wageningen Univ, Dept Agrotechnol & Food Sci, Wageningen, Netherlands.
   [Franks, Paul W.; Rolandsson, Olov] Umea Univ, Dept Publ Hlth & Clin Med, Family Med, Umea, Sweden.
   [Franks, Paul W.; Melander, Olle] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden.
   [Gavrila, Diana] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain.
   [Gavrila, Diana] Hosp Virgen Arrixaca, Murcia BioHealth Res Inst, Murcia, Spain.
   [Kaaks, Rudolf; Kuehn, Tilman] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.
   [Key, Timothy J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.
   [Khaw, Kay-Tee; Nilsson, Peter M.] Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England.
   [Molina-Portillo, Elena] Univ Granada, Hosp Univ Granada, Inst Invest Biosanitaria ibs GRANADA, Escuela Andaluza Salud Publ, Granada, Spain.
   [Olsen, Anja; Tjonneland, Anne] Danish Canc Soc Res Ctr, Copenhagen, Denmark.
   [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aarhus, Denmark.
   [Palli, Domenico] Canc Res & Prevent Inst, Canc Risk Factors & Lifestyle Epidemiol Unit, Florence, Italy.
   [Panico, Salvatore] Univ Federico II Naples, Dipartimento Med Clin & Chirurgia, Naples, Italy.
   [Sieri, Sabina] Fdn IRCCS, Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy.
   [Sacerdote, Carlotta] Univ Turin, Citta Salute Sci Hosp, Unit Canc Epidemiol, Turin, Italy.
   [Sacerdote, Carlotta] Ctr Canc Prevent, Turin, Italy.
   [Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands.
   [Tumino, Rosario] Azienda Sanitaria Prov Ragusa, Affiliat Canc Registry, Dept Prevent, Ragusa, Italy.
   [Riboli, Elio] Imperial Coll London, Sch Publ Hlth, London, England.
C3 UK Research & Innovation (UKRI); Medical Research Council UK (MRC);
   University of Cambridge; University of Cambridge; Cambridge University
   Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cambridge
   University Hospitals NHS Foundation Trust; Addenbrooke's Hospital;
   University of Cambridge; UK Research & Innovation (UKRI); Medical
   Research Council UK (MRC); Leibniz Association; Deutsches Institut fur
   Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Cambridge;
   CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERESP; Utrecht University;
   Utrecht University Medical Center; Institut Catala d'Oncologia; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Universite
   Paris Saclay; World Health Organization; International Agency for
   Research on Cancer (IARC); Aarhus University; UNICANCER; Gustave Roussy;
   Wageningen University & Research; Umea University; Lund University;
   Skane University Hospital; Murcia Regional Health Council; Hospital
   Clinico Universitario Virgen de la Arrixaca; Helmholtz Association;
   German Cancer Research Center (DKFZ); University of Oxford; University
   of Cambridge; Escuela Andaluza de Salud Publica; Instituto de
   Investigacion Biosanitaria IBS Granada; University of Granada; Danish
   Cancer Society; Aalborg University; Aalborg University Hospital;
   University of Naples Federico II; Fondazione IRCCS Istituto Nazionale
   Tumori Milan; A.O.U. Citta della Salute e della Scienza di Torino;
   University of Turin; Netherlands National Institute for Public Health &
   the Environment; Imperial College London
RP Imamura, F (corresponding author), Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England.
EM fumiaki.imamura@mrc-epid.cam.ac.uk
RI van der Schouw, Yvonne/F-8327-2014; Bonnet, Fabrice/G-4255-2017;
   Kritchevsky, Stephen/JWP-7971-2024; Franks, Paul/AAA-3300-2020;
   Fagherazzi, Guy/ABB-2555-2020; Khaw, Kay-Tee/AAZ-3209-2021; Kühn,
   Tilman/JYP-5102-2024; Gunter, Marc/AAP-8621-2020; Koulman,
   Albert/B-2967-2009; Forouhi, Nita/JAC-2361-2023; MOLINA PORTILLO,
   ELENA/ABA-3364-2021; Tjonneland, Anne/AGU-0320-2022; Langenberg,
   Claudia/ABG-9067-2021; Feskens, Edith/ABI-1446-2020; Dow,
   Courtney/ABC-4038-2021; Gil-Agudo, Ángel/ABD-3065-2021; Sacerdote,
   Carlotta/K-3611-2018; Riboli, Elio/A-4357-2009; Guevara,
   Marcela/B-4473-2015; Dahm, Christina/G-9787-2014; Imamura,
   Fumiaki/J-1038-2019; Dow, Courtney/MIP-1135-2025; Sieri,
   Sabina/K-4667-2016; Fagherazzi, Guy/P-3534-2017; Schulze, Matthias
   B./AAH-6906-2021; Huerta, Jose Maria/N-8654-2015
OI Guevara, Marcela/0000-0001-9242-6364; Langenberg,
   Claudia/0000-0002-5017-7344; Tjonneland, Anne/0000-0003-4385-2097; Dahm,
   Christina/0000-0003-0481-2893; Imamura, Fumiaki/0000-0002-6841-8396;
   Sharp, Stephen/0000-0003-2375-1440; Melander, Olle/0000-0002-2581-484X;
   Franks, Paul/0000-0002-0520-7604; Ardanaz, Eva/0000-0001-8434-2013; Dow,
   Courtney/0000-0002-9925-8460; Sieri, Sabina/0000-0001-5201-172X;
   Koulman, Albert/0000-0001-9998-051X; Chajes,
   Veronique/0000-0003-1297-3064; Overvad, Kim/0000-0001-6429-7921;
   Forouhi, Nita/0000-0002-5041-248X; Olsen, Anja/0000-0003-4788-503X;
   Fagherazzi, Guy/0000-0001-5033-5966; Riboli, Elio/0000-0001-6795-6080;
   Schulze, Matthias B./0000-0002-0830-5277; Huerta, Jose
   Maria/0000-0002-9637-3869; MOLINA PORTILLO, ELENA/0000-0002-9955-3080;
   tumino, rosario/0000-0003-2666-414X; Gunter, Marc/0000-0001-5472-6761;
   Sacerdote, Carlotta/0000-0002-8008-5096
FU EU FP6 programme [LSHM_CT_2006_037197]; MRC Epidemiology Unit
   [MC_UU_12015/1, MC_UU_12015/5]; National Institute for Health Research
   Biomedical Research Centre Cambridge [IS-BRC1215-20014]; MRC Elsie
   Widdowson Laboratory [MC_UD99999906]; Cambridge Lipidomics Biomarker
   Research Initiative [G0800783]; MRC [MR/M012190/1]; Cancer Research UK
   [C8221/19170]; the German Federal Ministry of Education and Research;
   German Center for Diabetes Research; State of Brandenburg; Health
   Research Fund of the Spanish Ministry of Health; Murcia Regional
   Government [6236]; Regional Government of Navarre and Institute de Salud
   Carlos III [PIE14/00045]; Dutch Ministry of Public Health, Welfare and
   Sports, Netherlands Cancer Registry; LK Research Funds; Dutch Prevention
   Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund;
   Statistics Netherlands; Netherlands Agency [IGE05012]; UMC Utrecht;
   Swedish Research Council; Novo Nordisk; Swedish Diabetes Association;
   Swedish Heart-Lung Foundation; German Cancer Aid; German Ministry of
   Research; MRC UK; Cancer Research UK; Danish Cancer Society; The
   Vasterboten County Council; AlRE-ONLUS Ragusa, AVIS-Ragusa, Sicilian
   Regional Government; Imperial College Biomedical Research Centre; MRC
   [MC_PC_13030, MR/P01836X/1, MC_UP_A090_1006, MC_UU_12015/1,
   MR/N003284/1, MC_UU_12015/5, MR/P011705/1, MC_EX_G0800783] Funding
   Source: UKRI
FX The InterAct project was funded by the EU FP6 programme (grant number
   LSHM_CT_2006_037197). InterAct investigators acknowledge funding from
   the following sources: FI, SJS, CL, NGF, NJW: MRC Epidemiology Unit
   MC_UU_12015/1, MC_UU_12015/5; NGF, AK, NJW: National Institute for
   Health Research Biomedical Research Centre Cambridge (IS-BRC1215-20014);
   AK, JLG: MRC Elsie Widdowson Laboratory MC_UD99999906 and Cambridge
   Lipidomics Biomarker Research Initiative G0800783; TJK: MRC
   (MR/M012190/1) and Cancer Research UK (C8221/19170); MBS: the German
   Federal Ministry of Education and Research, the German Center for
   Diabetes Research, and the State of Brandenburg; JMH: Health Research
   Fund of the Spanish Ministry of Health; Murcia Regional Government (No
   6236); MEG, EA: Regional Government of Navarre and Institute de Salud
   Carlos III (PIE14/00045); IS, AMWS, IS, YTvdS: Dutch Ministry of Public
   Health, Welfare and Sports, Netherlands Cancer Registry, LK Research
   Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland),
   World Cancer Research Fund, Statistics Netherlands; Verification of
   diabetes cases in EPIC-Netherlands was additionally funded by the
   Netherlands Agency grant IGE05012 and an Incentive Grant from the Board
   of the UMC Utrecht; PWF: Swedish Research Council, Novo Nordisk, Swedish
   Diabetes Association, Swedish Heart-Lung Foundation; RK: German Cancer
   Aid, German Ministry of Research; KTK: MRC UK, Cancer Research UK; PMN:
   Swedish Research Council; KO and AT: Danish Cancer Society; OR: The
   Vasterboten County Council; RT: AlRE-ONLUS Ragusa, AVIS-Ragusa, Sicilian
   Regional Government; ER: Imperial College Biomedical Research Centre.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abdullah MMH, 2015, BRIT J NUTR, V113, P435, DOI 10.1017/S0007114514003894
   Anderson SG, 2009, HYPERTENSION, V53, P839, DOI 10.1161/HYPERTENSIONAHA.108.123885
   [Anonymous], INTRO BOOTSTRAP
   [Anonymous], 1962, SOME QUESTIONS FACTO
   Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627
   Baylin A, 2006, CURR OPIN LIPIDOL, V17, P22, DOI 10.1097/01.mol.0000199814.46720.83
   BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404
   Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182
   Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027
   Dahm CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022587
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504
   Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4
   Forouhi NG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002094
   Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9
   Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007
   Grösch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001
   Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003
   Imamura F, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002087
   Imamura F, 2012, AM J CLIN NUTR, V96, P1252, DOI 10.3945/ajcn.112.039990
   Jacobs S, 2014, AM J CLIN NUTR, V100, P891, DOI 10.3945/ajcn.113.080317
   Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, pE517, DOI 10.1152/ajpendo.00045.2005
   Jenkins BJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44845
   Jump DB, 2013, ANNU REV NUTR, V33, P249, DOI 10.1146/annurev-nutr-071812-161139
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   King IB, 2006, AM J CLIN NUTR, V83, P227
   Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005
   Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9
   Lemaitre RN, 2014, PROSTAG LEUKOTR ESS, V91, P149, DOI 10.1016/j.plefa.2014.07.010
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Lotta L.A., 2016, Jama, V316, P1383
   MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813
   Margetts BM, 1997, INT J EPIDEMIOL, V26, pS1, DOI 10.1093/ije/26.suppl_1.S1
   Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023
   Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006
   PRENTICE RL, 1986, BIOMETRIKA, V73, P1
   Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442
   Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549
   Scott RA, 2014, DIABETES, V63, P4378, DOI 10.2337/db14-0319
   Sevastianova K, 2012, AM J CLIN NUTR, V96, P727, DOI 10.3945/ajcn.112.038695
   Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679
   Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   VESSBY B, 1990, ATHEROSCLEROSIS, V82, P137, DOI 10.1016/0021-9150(90)90152-9
   Vigneau E, 2003, COMMUN STAT-SIMUL C, V32, P1131, DOI 10.1081/SAC-120023882
   Vinknes KJ, 2013, OBESITY, V21, pE294, DOI 10.1002/oby.20011
   Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001
   Wang LY, 2013, GENOME MED, V5, DOI 10.1186/gm443
   Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439
   Warensjö E, 2006, AM J CLIN NUTR, V84, P442
   Weitkunat K, 2017, AM J CLIN NUTR, V105, P1544, DOI 10.3945/ajcn.117.152702
NR 53
TC 56
Z9 59
U1 1
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD OCT
PY 2017
VL 14
IS 10
AR e1002409
DI 10.1371/journal.pmed.1002409
PG 19
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA FL2QR
UT WOS:000414064100013
PM 29020051
OA Green Submitted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Moubarac, JC
   Receveur, O
   Cargo, M
   Daniel, M
AF Moubarac, Jean-Claude
   Receveur, Olivier
   Cargo, Margaret
   Daniel, Mark
TI Consumption patterns of sweetened food and drink products in a Catholic
   Middle Eastern Canadian community
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Sweet products; Ultra-processed; Public health nutrition; Middle Eastern
   Canadian; Arab Canadian
ID WEIGHT-GAIN; LIFE-STYLE; PROCESSED FOODS; OBESITY; BEVERAGES; HEALTH;
   SCHOOLCHILDREN; OVERWEIGHT; NUTRITION; IMPACT
AB Objective: The present study describes the consumption patterns of sweetened food and drink products in a Catholic Middle Eastern Canadian community and examines its associations with physical activity, sedentary behaviours and BMI. Design: A two-stage cross-sectional design was used. In Stage 1 (n 42), 24 h recalls enabled the identification of sweetened products. In Stage 2 (n 192), an FFQ was administered to measure the daily consumption of these products and to collect sociodemographic and behavioural data. Sweetened products were defined as processed culinary ingredients and ultra-processed products for which total sugar content exceeded 20 % of total energy. Setting: Three Catholic Middle Eastern churches located in Montreal, Canada. Subjects: Normoglycaemic men and women (18-60 years old). Results: Twenty-six sweetened products represented an average consumption of 75.4 g total sugars/d or 15.1 % of daily energy intake (n 190, 56 % women). Soft drinks, juices, sweetened coffee, chocolate, cookies, cakes and muffins were the main sources of consumption and mostly consumed between meals. Age (exp (beta) = 0.99; P < 0.01), physical activity (exp (beta) = 1.08; P < 0.01) and recreational computer use (exp (beta) = 1.17; P < 0.01) were independently associated with sweetened product consumption. The association between sweetened product consumption and physical activity was U-shaped. BMI was not significantly associated with sweetened product consumption but all participants regardless of BMI were above the WHO recommendation for free sugars. Conclusions: Being physically active and spending less time using a computer may favour a reduced consumption of sweetened products. Very active individuals may, however, overconsume such products.
C1 [Moubarac, Jean-Claude] Univ Sao Paulo, Nucleo Pesquisas Epidemiol Nutr & Saude, BR-01255000 Sao Paulo, Brazil.
   [Moubarac, Jean-Claude] Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada.
   [Receveur, Olivier] Univ Montreal, Dept Nutr, Montreal, PQ, Canada.
   [Cargo, Margaret; Daniel, Mark] Univ S Australia, Sch Hlth Sci, Adelaide, SA 5001, Australia.
C3 Universidade de Sao Paulo; Universite de Montreal; Universite de
   Montreal; University of South Australia
RP Moubarac, JC (corresponding author), Univ Sao Paulo, Nucleo Pesquisas Epidemiol Nutr & Saude, Av Dr Arnaldo 715, BR-01255000 Sao Paulo, Brazil.
EM jcmoubarac@gmail.com
RI Daniel, Mark/A-1151-2009; Cargo, Margaret/B-2141-2010; Moubarac,
   Jean-Claude/ABE-6439-2020
OI Daniel, Mark/0000-0001-9112-134X
CR Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI [10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc10-S011, 10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc12-s011, 10.2337/dc13-S067, 10.2337/dc11-S062, 10.2337/dc14-S081]
   Andersen LF, 2005, SCAND J PUBLIC HEALT, V33, P99, DOI 10.1080/140349404100410019172
   [Anonymous], TECHN FOC CHOL GDX S
   [Anonymous], 84 FAO
   [Anonymous], 2012, CAN NUTR FIL
   [Anonymous], PUBLIC HLTH NUTR
   [Anonymous], AR COMM
   [Anonymous], DIET REF INT
   [Anonymous], QUEST CYCL 2 1
   [Anonymous], PUBLIC HLTH NUTR
   Asfaw A, 2011, HEALTH ECON, V20, P184, DOI 10.1002/hec.1579
   Bandini LG, 1999, OBES RES, V7, P438, DOI 10.1002/j.1550-8528.1999.tb00431.x
   Blanchet C., 2009, La consommation alimentaire et les apports nutritionnels des adultes quebecois. Rapport de l'Enquete sur la sante dans les collectivites canadiennes (Cycle 2.2)
   Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2
   Bryan SN, 2006, CAN J PUBLIC HEALTH, V97, P271, DOI 10.1007/BF03405602
   Chapelot D, 2011, J NUTR, V141, P158, DOI 10.3945/jn.109.114330
   Cummings JH, 2007, EUR J CLIN NUTR, V61, pS5, DOI 10.1038/sj.ejcn.1602936
   Deldicque L, 2008, CURR OPIN CLIN NUTR, V11, P774, DOI 10.1097/MCO.0b013e3283139489
   Dogra Shilpa, 2010, Int J Behav Nutr Phys Act, V7, P75, DOI 10.1186/1479-5868-7-75
   Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286
   Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3
   Hassan-Wassef H, 2004, East Mediterr Health J, V10, P898
   Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Issa C, 2009, INT J FOOD SCI NUTR, V60, P285, DOI 10.1080/09637480903107700
   Jaghasi I., 2012, Eastern Mediterranean Health Journal, V18, P358
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Liu Richard, 2010, Open Med, V4, pe143
   Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a
   Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   McDonald JT, 2005, SOC SCI MED, V61, P2469, DOI 10.1016/j.socscimed.2005.05.004
   Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252
   Monteiro CA, 2010, AM J PUBLIC HEALTH, V100, P975, DOI 10.2105/AJPH.2009.187666
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005
   Moubarac JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044738
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Mullie P, 2012, EUR J CLIN NUTR, V66, P150, DOI 10.1038/ejcn.2011.138
   Musaiger AO, 2012, INT J GEN MED, V5, P199, DOI 10.2147/IJGM.S29663
   Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064
   Nakanishi S, 2004, BIOMED PHARMACOTHER, V58, P571, DOI 10.1016/j.biopha.2004.10.001
   Nasreddine L, 2006, PUBLIC HEALTH NUTR, V9, P194, DOI 10.1079/PHN2005855
   Nickles H.G., 1975, La cuisine au Moyen-Orient
   O'Loughlin J, 2007, ETHNIC DIS, V17, P657
   Pi-Sunyer FX, 2000, P NUTR SOC, V59, P505, DOI 10.1017/S0029665100000732
   Rehm CD, 2008, J URBAN HEALTH, V85, P375, DOI 10.1007/s11524-008-9269-8
   Sabaté J, 2004, BRIT J NUTR, V92, P199, DOI 10.1079/BJN20041229
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Shi L, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-52
   Tremblay Mark S, 2005, Health Rep, V16, P23
   Vallianatos H., 2008, Food, Culture & Society, V11, P355, DOI 10.2752/175174408X347900
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   WHO, 2003, WHO TECHN REP SER
NR 54
TC 4
Z9 5
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD FEB
PY 2014
VL 17
IS 2
BP 471
EP 478
DI 10.1017/S1368980012005460
PG 8
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA AD0XN
UT WOS:000332957800027
PM 23286218
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Hill, EB
   Siebert, JC
   Yazza, DN
   Ostendorf, DM
   Bing, K
   Wayland, L
   Scorsone, JJ
   Bessesen, DH
   MacLean, PS
   Melanson, EL
   Catenacci, VA
   Borengasser, SJ
AF Hill, Emily B.
   Siebert, Janet C.
   Yazza, Deaunabah N.
   Ostendorf, Danielle M.
   Bing, Kristen
   Wayland, Liza
   Scorsone, Jared J.
   Bessesen, Daniel H.
   MacLean, Paul S.
   Melanson, Edward L.
   Catenacci, Victoria A.
   Borengasser, Sarah J.
TI Proteomics, dietary intake, and changes in cardiometabolic health within
   a behavioral weight-loss intervention: A pilot study
SO OBESITY
LA English
DT Article
ID BINDING-PROTEIN 4; RISK PREDICTION; EATING INDEX; OBESITY; METAANALYSIS;
   MORTALITY; WHOLE; INDIVIDUALS; OVERWEIGHT; BIOMARKERS
AB Objective Identifying associations among circulating proteins, dietary intakes, and clinically relevant indicators of cardiometabolic health during weight loss may elucidate biologically relevant pathways affected by diet, allowing for an incorporation of precision nutrition approaches when designing future interventions. This study hypothesized that plasma proteins would be associated with diet and cardiometabolic health indicators within a behavioral weight-loss intervention. Methods This secondary data analysis included participants (n = 20, mean [SD], age: 40.1 [9.5] years, BMI: 34.2 [4.0] kg/m(2)) who completed a 1-year behavioral weight-loss intervention. Cardiovascular disease-related plasma proteins, diet, and cardiometabolic health indicators were evaluated at baseline and 3 months. Associations were determined via linear regression and integrated networks created using Visualization Of LineAr Regression Elements (VOLARE). Results A total of 16 plasma proteins were associated with >= 1 diet or health indicator at baseline (p < 0.001); changes in 42 proteins were associated with changes in diet or health indicators from baseline to 3 months (p < 0.005). Baseline tumor necrosis factor receptor superfamily member 10C (TNFRSF10C) was associated with intakes of dark green vegetables (r = -0.712), and fatty acid-binding protein 4 (FABP4) was associated with intakes of unsweetened coffee (r = -0.689). Changes in refined-grain intakes were associated with changes in scavenger receptor cysteine-rich type 1 protein M130 (CD163; r = 0.725), interleukin-1 receptor type 1 (IL1R-T1; r = 0.624), insulin (r = 0.656), and triglycerides (r = 0.648). Conclusions Circulating cardiovascular disease-related proteins were associated with diet and cardiometabolic health indicators prior to and in response to weight loss.
C1 [Hill, Emily B.; Yazza, Deaunabah N.; Borengasser, Sarah J.] Univ Colorado, Sect Nutr, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Siebert, Janet C.] CytoAnalytics, Denver, CO USA.
   [Ostendorf, Danielle M.; Bing, Kristen; Wayland, Liza; Bessesen, Daniel H.; MacLean, Paul S.; Melanson, Edward L.; Catenacci, Victoria A.] Univ Colorado, Dept Med, Div Endocrinol Metab & Diabet, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Ostendorf, Danielle M.; Bing, Kristen; Wayland, Liza; Scorsone, Jared J.; Catenacci, Victoria A.] Univ Colorado, Dept Med, Anschutz Hlth & Wellness Ctr, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Melanson, Edward L.] Univ Colorado, Dept Med, Div Geriatr Med, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Melanson, Edward L.] Eastern Colorado Vet Affairs Geriatr Res Educ & C, Denver, CO USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado System; University of Colorado Anschutz
   Medical Campus; University of Colorado System; University of Colorado
   Anschutz Medical Campus; University of Colorado System; University of
   Colorado Anschutz Medical Campus; Geriatric Research Education &
   Clinical Center
RP Borengasser, SJ (corresponding author), Univ Colorado, Anschutz Med Campus,12631 E 17th Ave, Aurora, CO 80045 USA.
EM vicki.catenacci@cuanschutz.edu; sarah.borengasser@cuanschutz.edu
RI MacLean, Paul/A-7887-2008; Ostendorf, Danielle/AGR-5612-2022; Melanson,
   Edward/AAY-9224-2021
OI Melanson, Edward L./0000-0001-9151-9745; Hill, Emily/0000-0002-0308-5666
FU American Heart Association [18IPA34170317]; National Center for
   Advancing Translational Sciences [UL1TR002535]; National Institute of
   Diabetes and Digestive and Kidney Diseases [F32DK122652, P30DK048520,
   R01DK111622, T32DK007658]; National Institutes of Health [U54AG062319];
   Olink Proteomics; University of Colorado Anschutz Medical Campus
   Genomics and Microarray Core; National Center for Advancing
   Translational Sciences [UL1TR002535] Funding Source: NIH RePORTER;
   National Institute of Diabetes and Digestive and Kidney Diseases
   [F32DK122652, R01DK111622, T32DK007658] Funding Source: NIH RePORTER;
   American Heart Association (AHA) [18IPA34170317] Funding Source:
   American Heart Association (AHA)
FX American Heart Association, Grant/Award Number: 18IPA34170317; National
   Center for Advancing Translational Sciences, Grant/Award Number:
   UL1TR002535; National Institute of Diabetes and Digestive and Kidney
   Diseases, Grant/Award Numbers: F32DK122652, P30DK048520, R01DK111622,
   T32DK007658; National Institutes of Health, Grant/Award Number:
   U54AG062319; Olink Proteomics and the University of Colorado Anschutz
   Medical Campus Genomics and Microarray Core
CR Aleksandrova K, 2018, CLIN CHEM, V64, P142, DOI 10.1373/clinchem.2017.275172
   [Anonymous], 2004, HUMAN ENERGY REQUIRE
   Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192
   Bruderer R, 2019, MOL CELL PROTEOMICS, V18, P1242, DOI 10.1074/mcp.RA118.001288
   Ceccarini G, 2019, ENDOCRINE, V65, P86, DOI 10.1007/s12020-019-01915-y
   Figarska SM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64636-7
   Furuhashi M, 2014, CLIN MED INSIGHTS-CA, V8, P23, DOI 10.4137/CMC.S17067
   Geyer PE, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167357
   Giacco R, 2014, NUTR METAB CARDIOVAS, V24, P837, DOI 10.1016/j.numecd.2014.01.007
   Grams J, 2015, CURR OBES REP, V4, P287, DOI 10.1007/s13679-015-0155-x
   Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1
   Haywood NJ, 2019, MOL METAB, V19, P86, DOI 10.1016/j.molmet.2018.10.008
   Herrmann SD, 2015, OBESITY, V23, P1539, DOI 10.1002/oby.21073
   Höbaus C, 2018, ANGIOLOGY, V69, P424, DOI 10.1177/0003319717728226
   Hoogeveen RM, 2020, EUR HEART J, V41, P3998, DOI 10.1093/eurheartj/ehaa648
   Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee
   Kameji H, 2010, NUTRITION, V26, P1151, DOI 10.1016/j.nut.2009.09.006
   Klimczak-Tomaniak D, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-06698-3
   Krebs-Smith SM, 2018, J ACAD NUTR DIET, V118, P1591, DOI 10.1016/j.jand.2018.05.021
   Lemming EW, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011860
   Levy E, 2007, CURR OPIN LIPIDOL, V18, P310, DOI 10.1097/MOL.0b013e32813fa2e2
   Lichtenstein AH, 2021, CIRCULATION, V144, pE472, DOI 10.1161/CIR.0000000000001031
   Liese AD, 2015, J NUTR, V145, P393, DOI 10.3945/jn.114.205336
   Liu G, 2016, ARTERIOSCL THROM VAS, V36, P2259, DOI 10.1161/ATVBAHA.116.308320
   Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424
   Ma CH, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4849
   Marshall S, 2020, J ACAD NUTR DIET, V120, P1859, DOI 10.1016/j.jand.2020.06.021
   Nurmohamed NS, 2022, EUR HEART J, V43, P1569, DOI 10.1093/eurheartj/ehac055
   Onvani S, 2017, J HUM NUTR DIET, V30, P216, DOI 10.1111/jhn.12415
   Ostendorf DM, 2022, TRIALS, V23, DOI 10.1186/s13063-022-06523-2
   Raynor HA, 2016, J ACAD NUTR DIET, V116, P129, DOI 10.1016/j.jand.2015.10.031
   Sawicki CM, 2021, J NUTR, V151, P2790, DOI 10.1093/jn/nxab177
   Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005
   Shah RV, 2019, ARTERIOSCL THROM VAS, V39, P107, DOI 10.1161/ATVBAHA.118.311928
   Siebert JC, 2021, OBESITY, V29, P859, DOI 10.1002/oby.23127
   Siebert JC, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3021-0
   Spence JD, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.017066
   Stefan N, 2018, LANCET DIABETES ENDO, V6, P249, DOI 10.1016/S2213-8587(17)30292-9
   Stojanovic SD, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00520
   Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388
   Wang DD, 2021, CIRCULATION, V143, P1642, DOI 10.1161/CIRCULATIONAHA.120.048996
NR 41
TC 4
Z9 4
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD NOV
PY 2022
VL 30
IS 11
BP 2134
EP 2145
DI 10.1002/oby.23574
PG 12
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 5V8RA
UT WOS:000877490600009
PM 36321274
OA Green Accepted
DA 2025-04-28
ER

PT J
AU de Castro, JM
AF de Castro, John M.
TI When, how much and what foods are eaten are related to total daily food
   intake
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Eating; Meal times; Diurnal rhythms; Energy density; Breakfast
ID DIETARY ENERGY DENSITY; BODY-MASS INDEX; MEAL PATTERNS; CEREAL
   CONSUMPTION; NUTRIENT INTAKE; BREAKFAST CONSUMPTION; SOCIAL
   FACILITATION; OBESITY EPIDEMIC; UNITED-STATES; WEIGHT-LOSS
AB Intake in the morning is associated with a reduction in the total intake for the day, while intake at night is associated with greater overall daily intake. These associations are macronutrient specific, with morning carbohydrate intake associated with reduced daily carbohydrate intake, morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake. Since different types of foods contain differing proportions of macronutrients, the present study investigated the associations of different types of foods ingested at various times of day with total daily and macronutrient intakes. The intakes of 388 male and 621 female free-living individuals reported in 7d diet diaries were reanalysed. The intakes of twenty-four different types of foods and seven different drinks occurring during the morning (04.00-10.29 hours), afternoon (10.30-16.59 hours) and evening (17.00-02.00 hours) were identified and related to overall daily intakes. Dairy foods, ice cream, beef, other meats, potatoes, pastry, nuts, chips and snacks, condiments, alcohol and soda were significantly associated with higher total intake over the day, while fruit, soup, breakfast cereal, pasta, pizza, water, coffee/tea and diet soda were either not associated or were associated with lower overall intake. Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake. This suggests that eating low-density foods in the morning and avoiding high-density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity.
C1 Sam Houston State Univ, Coll Humanities & Social Sci, Huntsville, TX 77341 USA.
C3 Texas State University System; Sam Houston State University
RP de Castro, JM (corresponding author), Sam Houston State Univ, Coll Humanities & Social Sci, Huntsville, TX 77341 USA.
EM jdecastro@shsu.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [R01-DK39881]
FX The analysis of the data was supported by a grant from the General Mills
   Corporation. The data collection was supported in part by grant
   R01-DK39881 from the National Institute of Diabetes and Digestive and
   Kidney Diseases.
CR ADLESON SF, 1960, J AM DIET ASSOC, V36, P453
   Affenito SG, 2005, J AM DIET ASSOC, V105, P938, DOI 10.1016/j.jada.2005.03.003
   *AHA, 2003, 43 ANN C CARD DIS EP
   Albertson A, 2003, J AM DIET ASSOC, V103, P1613, DOI 10.1016/j.jada.2003.09.020
   BANDINI LG, 1990, AM J CLIN NUTR, V52, P421, DOI 10.1093/ajcn/52.3.421
   Barton BA, 2005, J AM DIET ASSOC, V105, P1383, DOI 10.1016/j.jada.2005.06.003
   Bazzano LA, 2005, OBES RES, V13, P1952, DOI 10.1038/oby.2005.240
   Bell EA, 2001, AM J CLIN NUTR, V73, P1010
   Boutelle K, 2002, J PEDIATR PSYCHOL, V27, P531, DOI 10.1093/jpepsy/27.6.531
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   de Castro JM, 2000, PHYSIOL BEHAV, V70, P343, DOI 10.1016/S0031-9384(00)00264-X
   de Castro JM, 2006, J NUTR, V136, P1382, DOI 10.1093/jn/136.5.1382
   de Castro JM, 2004, J NUTR, V134, P104, DOI 10.1093/jn/134.1.104
   de Castro JM, 1998, J NUTR, V128, P61, DOI 10.1093/jn/128.1.61
   de Castro JM, 2004, J NUTR, V134, P335, DOI 10.1093/jn/134.2.335
   de Castro JM, 2001, NUTRITION, V17, P713, DOI 10.1016/S0899-9007(01)00611-6
   de Castro JM, 1999, PROG OBES R, P215
   de Castro JM., 2000, NEURAL CONTROL MACRO, P43
   De Castro JM, 2007, BRIT J NUTR, V98, P1077, DOI 10.1017/S0007114507754296
   DECASTRO JM, 1991, PHYSIOL BEHAV, V50, P729, DOI 10.1016/0031-9384(91)90010-L
   DECASTRO JM, 1993, PHYSIOL BEHAV, V54, P677, DOI 10.1016/0031-9384(93)90076-R
   DECASTRO JM, 1994, APPETITE, V23, P57, DOI 10.1006/appe.1994.1034
   DECASTRO JM, 1987, PHYSIOL BEHAV, V40, P437, DOI 10.1016/0031-9384(87)90028-X
   DECASTRO JM, 1992, PHYSIOL BEHAV, V51, P121, DOI 10.1016/0031-9384(92)90212-K
   DECASTRO JM, 1989, AM J CLIN NUTR, V50, P237, DOI 10.1093/ajcn/50.2.237
   DECASTRO JM, 1994, PHYSIOL BEHAV, V56, P445, DOI 10.1016/0031-9384(94)90286-0
   DECASTRO JM, 1986, PHYSIOL BEHAV, V38, P25, DOI 10.1016/0031-9384(86)90128-9
   deCastro JM, 1997, NUTR RES, V17, P807, DOI 10.1016/S0271-5317(97)00050-X
   DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P1133, DOI 10.1016/0031-9384(93)90370-U
   DECASTRO JM, 1994, APPETITE, V23, P179, DOI 10.1006/appe.1994.1045
   Flegal KM, 1999, MED SCI SPORT EXER, V31, pS509, DOI 10.1097/00005768-199911001-00004
   Forslund HB, 2002, EUR J CLIN NUTR, V56, P740, DOI 10.1038/sj.ejcn.1601387
   GERSOVITZ M, 1978, J AM DIET ASSOC, V73, P48
   GIBSON SA, 1995, J ROY SOC HEALTH, V115, P366, DOI 10.1177/146642409511500608
   GORAN MI, 1992, METABOLISM, V41, P744, DOI 10.1016/0026-0495(92)90315-2
   Haines PS, 1996, J AM DIET ASSOC, V96, P464, DOI 10.1016/S0002-8223(96)00130-7
   HEADY JA, 1961, J R STAT SOC SER A-G, V124, P336, DOI 10.2307/2343242
   JUDD CM, 1981, EVALUATION REV, V5, P602, DOI 10.1177/0193841X8100500502
   Kral TVE, 2002, APPETITE, V39, P137, DOI 10.1006/appe.2002.0498
   KRANTZLER NJ, 1982, AM J CLIN NUTR, V36, P1234, DOI 10.1093/ajcn/36.6.1234
   LIVINGSTONE MBE, 1992, AM J CLIN NUTR, V56, P29, DOI 10.1093/ajcn/56.1.29
   LIVINGSTONE MBE, 1990, BMJ-BRIT MED J, V300, P708, DOI 10.1136/bmj.300.6726.708
   LUNNEBORD CE, 1983, ELEMENTARY MULTIVARI
   Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117
   Mattes RD, 2002, J AM COLL NUTR, V21, P570, DOI 10.1080/07315724.2002.10719257
   Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519
   Nicklas TA, 2004, J AM DIET ASSOC, V104, P753, DOI 10.1016/j.jada.2004.02.030
   Poppitt SD, 1998, INT J OBESITY, V22, P1024, DOI 10.1038/sj.ijo.0800726
   Prentice AM, 1998, AM J CLIN NUTR, V67, p535S, DOI 10.1093/ajcn/67.3.535S
   Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007
   REDD M, 1992, PHYSIOL BEHAV, V52, P749, DOI 10.1016/0031-9384(92)90409-U
   Rolls BJ, 1999, AM J CLIN NUTR, V70, P448
   Rolls BJ, 2000, AM J CLIN NUTR, V72, P361
   Siega-Riz AM, 1998, AM J CLIN NUTR, V67, p748S, DOI 10.1093/ajcn/67.4.748S
   Siega-Riz AM, 2000, PREV MED, V30, P415, DOI 10.1006/pmed.2000.0651
   SINGLETON N, 1982, J SCHOOL HEALTH, V52, P529, DOI 10.1111/j.1746-1561.1982.tb04033.x
   STJEOR ST, 1983, J AM DIET ASSOC, V83, P155
   Stubbs RJ, 1998, INT J OBESITY, V22, P980, DOI 10.1038/sj.ijo.0800715
   Stubbs RJ, 1996, INT J OBESITY, V20, P651
   Thompson OM, 2006, INT J OBESITY, V30, P176, DOI 10.1038/sj.ijo.0803072
   Vanelli Maurizio, 2005, Acta Biomed, V76, P79
   Waller SM, 2004, J AM COLL NUTR, V23, P316, DOI 10.1080/07315724.2004.10719374
   Wyatt HR, 2002, OBES RES, V10, P78, DOI 10.1038/oby.2002.13
   Yao MJ, 2001, NUTR REV, V59, P247
NR 64
TC 78
Z9 82
U1 1
U2 25
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD OCT 28
PY 2009
VL 102
IS 8
BP 1228
EP 1237
DI 10.1017/S0007114509371640
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 513TX
UT WOS:000271347800016
PM 19650955
OA Bronze
DA 2025-04-28
ER

PT J
AU Bertoia, ML
   Rimm, EB
   Mukamal, KJ
   Hu, FB
   Willett, WC
   Cassidy, A
AF Bertoia, Monica L.
   Rimm, Eric B.
   Mukamal, Kenneth J.
   Hu, Frank B.
   Willett, Walter C.
   Cassidy, Aedin
TI Dietary flavonoid intake and weight maintenance: three prospective
   cohorts of 124 086 US men and women followed for up to 24 years
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID HIGH-FAT DIET; GREEN TEA; BODY-WEIGHT; GLUCOSE-UPTAKE; RISK;
   SUPPLEMENTATION; CONSUMPTION; OVERWEIGHT; CAFFEINE; GAIN
AB OBJECTIVE
   To examine whether dietary intake of specific flavonoid subclasses (including flavonols, flavones, flavanones, flavan-3-ols, anthocyanins, and flavonoid polymers) is associated with weight change over time.
   DESIGN
   Three prospective cohort studies.
   SETTING
   Health professionals in the United States.
   PARTICIPANTS
   124 086 men and women participating in the Health Professionals Follow-up Study (HPFS), Nurses' Health Study (NHS), and Nurses' Health Study II (NHS II).
   MAIN OUTCOME MEASURE
   Self reported change in weight over multiple four year time intervals between 1986 and 2011.
   RESULTS
   Increased consumption of most flavonoid subclasses, including flavonols, flavan-3-ols, anthocyanins, and flavonoid polymers, was inversely associated with weight change over four year time intervals, after adjustment for simultaneous changes in other lifestyle factors including other aspects of diet, smoking status, and physical activity. In the pooled results, the greatest magnitude of association was observed for anthocyanins (-0.23 (95% confidence interval -0.30 to -0.15) lbs per additional standard deviation/day, 10 mg), flavonoid polymers (-0.18 (-0.28 to -0.08) lbs per additional SD/day, 138 mg), and flavonols (-0.16 (-0.26 to -0.06) lbs per additional SD/day, 7 mg). After additional adjustment for fiber intake, associations remained significant for anthocyanins, proanthocyanidins, and total flavonoid polymers but were attenuated and no longer statistically significant for other subclasses.
   CONCLUSIONS
   Higher intake of foods rich in flavonols, flavan-3-ols, anthocyanins, and flavonoid polymers may contribute to weight maintenance in adulthood and may help to refine dietary recommendations for the prevention of obesity and its potential consequences.
C1 [Bertoia, Monica L.; Rimm, Eric B.; Mukamal, Kenneth J.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, 655 Huntington Ave, Boston, MA 02115 USA.
   [Bertoia, Monica L.; Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Bertoia, Monica L.; Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.
   [Cassidy, Aedin] Univ E Anglia, Norwich Med Sch, Dept Nutr, Norwich NR4 7TJ, Norfolk, England.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard University Medical Affiliates; Brigham & Women's
   Hospital; Harvard University; Harvard Medical School; Harvard
   University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard University Medical Affiliates; Beth Israel Deaconess
   Medical Center; University of East Anglia
RP Bertoia, ML (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, 655 Huntington Ave, Boston, MA 02115 USA.
EM mbertoia@hsph.harvard.edu
RI Hu, Frank/C-1919-2013; Willett, Walter/E-2352-2013; Mukamal,
   Kenneth/GVR-7978-2022
FU National Institutes of Health [P01 CA87969, R01 CA49449, R01 HL034594,
   R01 HL088521, UM1 CA176726, R01 CA67262, UM1 CA167552, R01 HL35464, UM1
   CA186107]; Biotechnology, Biological Sciences Research Council (BBSRC),
   UK [BB/J004545/1]; Danish Council for Strategic Research (Innovation
   Fund Denmark) [0603-00488B]; project "Diet and prevention of ischemic
   heart disease: a translational approach" (DIPI)
FX This study was supported by grants P01 CA87969, R01 CA49449, R01
   HL034594, R01 HL088521, UM1 CA176726, R01 CA67262, UM1 CA167552, R01
   HL35464, and UM1 CA186107 from the National Institutes of Health; the
   Biotechnology, Biological Sciences Research Council (BBSRC), UK
   (reference BB/J004545/1); and the project "Diet and prevention of
   ischemic heart disease: a translational approach" (DIPI, www.dipi.dk),
   which is supported by the Danish Council for Strategic Research (today,
   Innovation Fund Denmark) (contract 0603-00488B). AC is a Royal Society
   Wolfson Research Merit Award holder. The funders played no role in the
   study design, data collection, analysis and interpretation of data,
   writing of the manuscript, or the decision to submit the article for
   publication.
CR Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643
   [Anonymous], 2004, USDA DAT PROANTH CON
   [Anonymous], 2010, Dietary Guidelines for Americans
   Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Badshah H, 2013, NEUROPEPTIDES, V47, P347, DOI 10.1016/j.npep.2013.06.001
   Bertoia ML, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001878
   Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015
   Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Czernichow S, 2002, INT J OBESITY, V26, P1138, DOI 10.1038/sj.ijo.0802059
   de Kleijn MJJ, 2001, J NUTR, V131, P1826
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   HOLBROOK TL, 1989, INT J OBESITY, V13, P723
   Hsu Chung-Hua, 2011, Altern Med Rev, V16, P157
   Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Josic J, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-63
   Kimmons Joel, 2009, Medscape J Med, V11, P26
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Moon J, 2013, FOOD CHEM TOXICOL, V58, P347, DOI 10.1016/j.fct.2013.05.006
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Panico S, 2008, PREV MED, V47, P53, DOI 10.1016/j.ypmed.2008.01.023
   Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X
   Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009
   RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211
   RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W
   Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S
   Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078
   Stendell-Hollis NR, 2010, J HUM NUTR DIET, V23, P590, DOI 10.1111/j.1365-277X.2010.01078.x
   Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703
   US Departament of Agriculture, 2007, USDA DAT FLAV CONT S
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   WILLETT WC, 1987, NEW ENGL J MED, V316, P22, DOI 10.1056/NEJM198701013160105
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
NR 39
TC 140
Z9 148
U1 1
U2 18
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0959-535X
EI 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JAN 28
PY 2016
VL 352
AR i17
DI 10.1136/bmj.i17
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA DC6EX
UT WOS:000369313700002
PM 26823518
OA Green Published, Green Accepted, hybrid
DA 2025-04-28
ER

PT J
AU Guo, JY
   Luo, SY
   Su, Z
   Fu, JH
   Ma, J
   Zhong, XX
   Zeng, CZ
   Huang, J
   Zhang, WW
   Zhang, ZB
   Zhu, HL
   Li, Y
AF Guo, Jiaying
   Luo, Shiyun
   Su, Zheng
   Fu, Jinhan
   Ma, Jie
   Zhong, Xuexin
   Zeng, Chunzi
   Huang, Jie
   Zhang, Weiwei
   Zhang, Zhoubin
   Zhu, Huilian
   Li, Yan
TI Consumption Patterns of Sugar-Sweetened Beverages and Association with
   Undernutrition among Children Aged 9-17 Years in Guangzhou, China: A
   Cross-Sectional Study
SO NUTRIENTS
LA English
DT Article
DE sugar-sweetened beverages consumption patterns; undernutrition;
   children; China
ID FOOD-INTAKE; NORMAL-WEIGHT; GROWTH; APPETITE; OBESITY; LIFE
AB Globally, the high consumption levels of sugar-sweetened beverages (SSBs) and their effect on health have drawn significant attention. This study aimed to identify the consumption patterns of SSBs among children in rural areas of Guangzhou, China, and explore their association with undernutrition. A total of 1864 children aged 9-17 years old were included in this study. Demographics, lifestyle behaviors, and anthropometric and dietary information were collected. Factor analysis was used to identify patterns of SSBs, while nutritional status was assessed using Body Mass Index (BMI). Latent class analysis was used to establish dietary preference models. Log-binomial regression analysis was used to analyze the association between SSBs consumption patterns and undernutrition. The undernutrition prevalence in children was 14.54-19.94% in boys and 9.07% in girls. Three SSB consumption patterns were identified, including the plant protein pattern, dairy-containing pattern, and coffee pattern. Both medium-high (Q3) and the highest (Q4) scores in the dairy-containing pattern were positively associated with the risk of undernutrition, especially in boys. Furthermore, the highest scores in the plant protein pattern and coffee pattern were positively associated with the risk of undernutrition in children aged 9-10 years old. The dairy-containing pattern was a risk factor for undernutrition in children, especially for boys; the plant protein patterns and coffee patterns were risk factors for undernutrition in children aged 9-10 years old. The findings of the study can provide scientific evidence and policy recommendations for improving children's health conditions.
C1 [Guo, Jiaying; Fu, Jinhan; Zhong, Xuexin; Zhu, Huilian] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Peoples R China.
   [Guo, Jiaying; Luo, Shiyun; Zeng, Chunzi; Huang, Jie; Zhang, Weiwei; Zhang, Zhoubin; Li, Yan] Guangzhou Ctr Dis Control & Prevent, Dept Foodborne Dis & Food Safety Risk Surveillance, Guangzhou 510440, Peoples R China.
   [Su, Zheng; Ma, Jie] Southern Med Univ, Sch Publ Hlth, Guangzhou 510515, Peoples R China.
C3 Sun Yat Sen University; Southern Medical University - China
RP Li, Y (corresponding author), Guangzhou Ctr Dis Control & Prevent, Dept Foodborne Dis & Food Safety Risk Surveillance, Guangzhou 510440, Peoples R China.
EM guojy78@mail2.sysu.edu.cn; luoshy25@mail3.sysu.edu.cn;
   sue1995@smu.edu.cn; fujh6@mail2.sysu.edu.cn; jasmine225@smu.edu.cn;
   zhongxx27@mail2.sysu.edu.cn; gzcdc_zengcz@gz.gov.cn;
   huangjie1026@126.com; gzcdczhangww@foxmail.com; gzcdczzb@gzcdc.org.cn;
   zhuhl@mail.sysu.edu.cn; gzcdcliy@foxmail.com
RI Zhu, Huilian/V-1040-2019
OI Huang, Jie/0000-0003-4851-4660
FU Guangzhou Municipal Science and Technology Bureau [2023A03J0451,
   2023A03J0940]; Guangzhou Municipal Health Commission [20221A010040]
FX This work was supported by the Guangzhou Municipal Science and
   Technology Bureau(grant numbers 2023A03J0451 and 2023A03J0940) and the
   Guangzhou Municipal Health Commission(grant numbers 20221A010040).
CR Anderson GH, 2016, ADV NUTR, V7, p232S, DOI 10.3945/an.115.009357
   [Anonymous], 2014, Screening Standard for Malnutrition in School-age Children and Adolescents
   [Anonymous], 2008, GB/T 21732-2008
   [Anonymous], 2015, GB/T 10789-2015
   [Anonymous], 2013, WST 424-2013
   Bailey RL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010102
   Bellisle F, 2012, J NUTR, V142, p1149S, DOI 10.3945/jn.111.149583
   Bellissimo N, 2008, INT J OBESITY, V32, P362, DOI 10.1038/sj.ijo.0803709
   Bhutta ZA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.67
   Boozari B, 2021, SLEEP BREATH, V25, P649, DOI 10.1007/s11325-020-02155-5
   Bragança MLBM, 2023, NUTRIENTS, V15, DOI 10.3390/nu15020324
   Cecil JE, 2005, AM J CLIN NUTR, V82, P302, DOI 10.1093/ajcn/82.2.302
   Chaput JP, 2018, PUBLIC HEALTH NUTR, V21, P2385, DOI 10.1017/S1368980018000976
   Chen M X, 2022, Zhonghua Yu Fang Yi Xue Za Zhi, V56, P139, DOI 10.3760/cma.j.cn112150-20210615-00577
   Chen X, 2022, INT J FOOD SCI NUTR, V73, P82, DOI 10.1080/09637486.2021.1913102
   chinanutri, Chronic Disease and Nutrition Monitoring Work Plan for Chinese Residents (Trial)
   Chiu S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020405
   [《中国人群身体活动指南》编写委员会 Composing And Editorial Board of Physical Activity Guidelines for Chinese], 2022, [中国公共卫生, China Journal of Public Health], V38, P129
   Duchaine CS, 2014, NUTRIENTS, V6, P2987, DOI 10.3390/nu6082987
   Ebbeling CB, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015668
   Farhangi MA, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02511-9
   FDA, Spilling the Beans: how much caffeine is too much?
   Ferguson K, 2023, NUTRIENTS, V15, DOI 10.3390/nu15092171
   Francis LA, 2018, PEDIATRIC FOOD PREFERENCES AND EATING BEHAVIORS, P183, DOI 10.1016/B978-0-12-811716-3.00010-5
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
   Galler JR, 2021, NEUROIMAGE, V231, DOI 10.1016/j.neuroimage.2021.117828
   Grey K, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-003161
   Händel MN, 2015, AM J CLIN NUTR, V102, P1182, DOI 10.3945/ajcn.115.108456
   Hu Xiao, 2023, Wei Sheng Yan Jiu, V52, P27, DOI 10.19813/j.cnki.weishengyanjiu.2023.01.005
   Institute of Nutrition and Health Chinese Center for Disease Control and Prevention, 2020, Monitoring Report on Student Nutrition and Health Status (2012-2017)
   Jiang YR, 2014, WORLD J PEDIATR, V10, P245, DOI 10.1007/s12519-014-0500-2
   Johnson RJ, 2017, ADV NUTR, V8, P412, DOI 10.3945/an.116.014654
   Li Sheng-ping, 2022, Chinese Journal of School Health, V43, P41, DOI 10.16835/j.cnki.1000-9817.2022.01.010
   Liu J., 2023, Chin. J. Prev. Med, V57, P27
   Liu W., 2022, China Youth Study, V06, P92, DOI [10.19633/j.cnki.11-2579/d.2022.0083, DOI 10.19633/J.CNKI.11-2579/D.2022.0083]
   Lu DY., 2022, Mod. Prev. Med, V17, P3123, DOI [10.20043/j.cnki.MPM.202202333, DOI 10.20043/J.CNKI.MPM.202202333]
   Lu S., 2020, Mod. Prev. Med, V47, P3313
   Luhovyy BL, 2007, J AM COLL NUTR, V26, p704S, DOI 10.1080/07315724.2007.10719651
   Ma J, 2023, NUTRIENTS, V15, DOI 10.3390/nu15194133
   Malik VS, 2022, NAT REV ENDOCRINOL, V18, P205, DOI 10.1038/s41574-021-00627-6
   Mäntyselkä A, 2018, CLIN ENDOCRINOL, V88, P234, DOI 10.1111/cen.13511
   Million More People Pushed into Hunger, Since 2019 Due to Multiple Crises, Reveals UN Report
   Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585
   Murray CJL, 2020, LANCET, V396, P1223, DOI [10.1016/S0140-6736(20)30752-2, 10.1016/S0140-6736(20)30925-9]
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   [潘峰 Pan Feng], 2020, [中国食品卫生杂志, Chinese Journal of Food Hygiene], V32, P316
   Poirier KL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020270
   Pries AM, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12729
   SASSIN JF, 1969, SCIENCE, V165, P513, DOI 10.1126/science.165.3892.513
   Shearrer GE, 2016, APPETITE, V97, P43, DOI 10.1016/j.appet.2015.11.015
   Shen Li-ping, 2023, Journal of Environmental & Occupational Medicine, V40, P769
   Shomaker LB, 2010, AM J CLIN NUTR, V92, P123, DOI 10.3945/ajcn.2010.29383
   Soos R, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182312389
   Sun Zhuo, 2023, Journal of Environmental & Occupational Medicine, V40, P737
   Ten Year Health Monitoring, Witnessing Nutritional Improvement Changes in Nutritional Health Status of Rural Compulsory Education Students under the Nutrition Improvement Program (2012-2022)
   Utriainen P, 2015, HORM RES PAEDIAT, V83, P221, DOI 10.1159/000369458
   Van Engelen M, 2014, EUR J CLIN NUTR, V68, P773, DOI 10.1038/ejcn.2014.33
   Victora CG, 2021, LANCET, V397, P1388, DOI 10.1016/S0140-6736(21)00394-9
   von Philipsborn P, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012292.pub2
   Wang B., 2014, Sociol. Stud, V29, P220
   Wang M., 2023, Latent Variable Modeling and Mplus Application (Advanced Part)
   Wong THT, 2019, EUR J NUTR, V58, P2485, DOI 10.1007/s00394-018-1801-3
   Wu M., 2022, Sci. Technol. Cereals Oils Foods, V30, P212
   Xiu Li, 2022, Chinese Journal of School Health, V43, P1729, DOI 10.16835/j.cnki.1000-9817.2022.11.031
   Zhan S., 2017, Epidemiology National Health and Family Planning Commission's 13th Five Year Plan Textbook for Preventive Medicine Majors
   Zhang CQ, 2019, APPETITE, V141, DOI 10.1016/j.appet.2019.104332
   Zhou X., 2021, Occup. Health Damage, V36, P310
NR 67
TC 2
Z9 2
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAR
PY 2024
VL 16
IS 5
AR 650
DI 10.3390/nu16050650
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KW3Y2
UT WOS:001182971900001
PM 38474778
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Tapper, K
   Yarrow, K
   Farrar, ST
   Mandeville, KL
AF Tapper, Katy
   Yarrow, Kielan
   Farrar, Stephanie T.
   Mandeville, Kate L.
TI Effects of calorie labelling and contextual factors on hypothetical
   coffee shop menu choices
SO APPETITE
LA English
DT Article
DE Calorie labelling; Menu labelling; Habits; Reflective motivation;
   Obesity; Policy
ID BEHAVIOR; IMPACT; HABIT; FOOD
AB This study examined the effects of calorie labelling and two key contextual factors (reflective motivation and habits) on the calorie content of hypothetical coffee-shop menu choices. In one exploratory (n = 70) and one preregistered (n = 300) laboratory study (Studies 1 and 2 respectively), participants viewed a hypothetical calorie-labelled or non calorie-labelled menuboard and selected their preferred item(s). Coffee shop drinking habits were measured using the Self-Report Habit Index, and reflective motivation (relating to calorie intake) was assessed with three items asking about watching weight, eating healthily, and reading calorie labels. In Study 2, participants also estimated calories contained in a subset of the menuboard drinks. Results of both studies showed that labelling did not significantly affect the total calorie content of items selected. However, in Study 2, as predicted, there was a trend toward moderation by reflective motivation (p = .056) with less motivated participants showing relatively greater calorie selection when exposed to labelling. Participants with weaker habits took longer to select items (p = .002) but, contrary to predictions, were not more influenced by labelling. Higher reflective motivation was associated with selecting fewer calories (p = .002), correctly recalling the presence/ absence of labelling (p = .016) and better estimating calorie content (p < .001). Overall, participants significantly underestimated calories in higher calorie drinks but overestimated calories in lower calorie drinks. The results highlight the importance of contextual factors such as habits and reflective motivation for obesity interventions and are relevant for the UK's introduction of selective mandatory calorie labelling. In some instances, labelling may actually increase intake among those less motivated by health and weight concerns, but further research is needed to substantiate this concern.
C1 [Tapper, Katy; Yarrow, Kielan; Farrar, Stephanie T.] City Univ London, Dept Psychol, Whiskin St, London EC1R 0JD, England.
   [Mandeville, Kate L.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England.
C3 City St Georges, University of London; City, University of London;
   University of London; London School of Hygiene & Tropical Medicine
RP Tapper, K (corresponding author), City Univ London, Dept Psychol, Whiskin St, London EC1R 0JD, England.
EM Katy.tapper.1@city.ac.uk
RI Tapper, Katy/ABE-2814-2021
OI Yarrow, Kielan/0000-0003-0666-2163; Mandeville,
   Kate/0000-0002-5525-1574; Tapper, Katy/0000-0001-9097-6311
CR Aarts H., 1999, Eur. Rev. Soc. Psychol, V10, P101, DOI [10.1080/14792779943000035, DOI 10.1080/14792779943000035]
   Allan JL, 2015, HEALTH PSYCHOL, V34, P750, DOI 10.1037/hea0000173
   Bleich SN, 2017, OBESITY, V25, P2018, DOI 10.1002/oby.21940
   Bollinger B, 2011, AM ECON J-ECON POLIC, V3, P91, DOI 10.1257/pol.3.1.91
   Brennan L, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00946-3
   Butland B., 2007, TACKLING OBESITIES F, V10, P17
   Crocketta RA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009315.pub2
   DEPARTMENT OF HEALTH AND SOCIAL CARE, 2020, Tackling obesity: empowering adults and children to live healthier lives
   Feng WH, 2018, APPETITE, V128, P223, DOI 10.1016/j.appet.2018.06.015
   Gardner B, 2020, SOC PERSONAL PSYCHOL, V14, DOI 10.1111/spc3.12553
   Gardner B, 2015, HEALTH PSYCHOL REV, V9, P277, DOI 10.1080/17437199.2013.876238
   Gardner B, 2016, BRIT J HEALTH PSYCH, V21, P613, DOI 10.1111/bjhp.12189
   Gardner B, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-102
   Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1
   Hayes A. F., 2013, INTRO MEDIATION MODE
   Lems E, 2019, HEALTH EXPECT, V22, P1040, DOI 10.1111/hex.12913
   Marty L., 2021, BMC PUBLIC HEALTH, V21, P1
   Marty L, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-0922-2
   Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42
   Moghimi E, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16244939
   Nettle D, 2017, BEHAV BRAIN SCI, V40, DOI [10.1017/S0140525X16002041, 10.1017/S0140525X16000947]
   Petimar J, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0865-7
   Petimar J, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5837
   Robertson DA, 2020, APPETITE, V144, DOI 10.1016/j.appet.2019.104446
   Sarink D, 2016, APPETITE, V99, P59, DOI 10.1016/j.appet.2015.12.022
   Starbucks, 2021, NUTR ALL GUID SUMM A
   Statista, 2021, NUMB COFF SHOPS UK
   STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061
   Stribitcaia E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69504-y
   Theis DRZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222773
   van der Heijden A, 2021, APPETITE, V161, DOI 10.1016/j.appet.2021.105135
   Vasiljevic M, 2019, APPETITE, V141, DOI 10.1016/j.appet.2019.05.035
   Vasiljevic M, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0671-7
   Verhoeven AAC, 2012, BRIT J HEALTH PSYCH, V17, P758, DOI 10.1111/j.2044-8287.2012.02070.x
   Verplanken B, 1997, EUR J SOC PSYCHOL, V27, P539, DOI 10.1002/(SICI)1099-0992(199709/10)27:5<539::AID-EJSP831>3.0.CO;2-A
   Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x
   Wellard-Cole L, 2018, PUBLIC HEALTH NUTR, V21, P1194, DOI [10.1017/S1368980017003706, 10.1017/s1368980017003706]
   Zlatevska N, 2018, J RETAILING, V94, P89, DOI 10.1016/j.jretai.2017.09.007
NR 38
TC 3
Z9 3
U1 2
U2 7
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6663
EI 1095-8304
J9 APPETITE
JI Appetite
PD MAY 1
PY 2022
VL 172
AR 105963
DI 10.1016/j.appet.2022.105963
EA FEB 2022
PG 8
WC Behavioral Sciences; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Nutrition & Dietetics
GA 2S6ED
UT WOS:000821882300016
PM 35131387
OA hybrid, Green Accepted, Green Submitted
DA 2025-04-28
ER

PT J
AU Kim, J
   Jo, I
   Joung, H
AF Kim, Jihye
   Jo, Inho
   Joung, Hyojee
TI A Rice-Based Traditional Dietary Pattern Is Associated with Obesity in
   Korean Adults
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
ID BODY-MASS INDEX; CORONARY-HEART-DISEASE; FOOD-INTAKE PATTERNS; WAIST
   CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME;
   NATIONAL-HEALTH; WEIGHT CHANGE; LIFE-STYLE; WOMEN
AB Background Dietary patterns are critical in the prevention of chronic disease. The relationship between specific dietary patterns and obesity has not been evaluated in a Korean adult population.
   Objective This study examined whether specific dietary patterns are associated with obesity using survey data of the largest, nationally representative, general Korean population.
   Design The cross-sectional study was comprised of 10,089 Korean adults (19 years or older) who participated in the second and third Korean National Health and Nutrition Examination Surveys conducted in 2001 and 2005, respectively. Dietary data were assessed by 24-hour recall method. Obesity was defined as body mass index (calculated as kg/m(2)) >= 25 which is the cutoff point for adults in the Asian and Pacific regions.
   Results Four dietary patterns were derived using factor analysis (white rice and kimchi pattern; high-fat, sweets, and coffee pattern; meat and alcohol pattern; and grains, vegetables, and fish pattern). Each dietary pattern explained 8.6%, 6.7%, 5.7%, and 5.7% of the variation in food intake, respectively. The white rice and kimchi pattern (P for trend=0.0039) and the high-fat, sweets, and coffee pattern (P for trend=0.0054) were positively associated with obesity after adjustments for age, sex, energy intake, alcohol intake, smoking status, physical activity, and chronic diseases. No significant association was found among the meat and alcohol pattern; the grains, vegetables, and fish pattern; and obesity.
   Conclusions Specific dietary patterns, which include the white rice and kimchi and high-fat, sweets, and coffee patterns, may be independently associated with obesity in Korean adults. J Acad Nutr Diet. 2012;112:246-253.
C1 [Joung, Hyojee] Seoul Natl Univ, Grad Sch Publ Hlth, Sch Publ Hlth, Seoul 151742, South Korea.
   [Kim, Jihye] Daegu Univ, Dept Food & Nutr, Gyongsan, Gyeongbuk, South Korea.
   [Jo, Inho] Ewha Womans Univ, Dept Mol Med, Sch Med, Seoul, South Korea.
C3 Seoul National University (SNU); Daegu University; Ewha Womans
   University
RP Joung, H (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Sch Publ Hlth, Seoul 151742, South Korea.
EM hjjoung@snu.ac.kr
RI Kim, Jihye/AAI-7341-2020; Jo, Inho/R-3581-2019; Joung,
   Hyojee/AAU-9502-2020
OI Jo, Inho/0000-0001-6060-6416; Kim, Jihye/0000-0002-3280-7381; Joung,
   Hyojee/0000-0003-1182-7786
FU Daegu University
FX The research was supported by a 2010 Daegu University Research Grant.
CR [Anonymous], 2003, Statistics for epidemiology
   [Anonymous], 2000, ASIA PACIFIC PERSPEC
   Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Dougkas A, 2011, NUTR RES REV, V24, P72, DOI 10.1017/S095442241000034X
   FRENCH SA, 1994, INT J OBESITY, V18, P145
   Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857
   Harnden KE, 2010, J HUM NUTR DIET, V23, P3, DOI 10.1111/j.1365-277X.2009.01007.x
   Hu FB, 2000, AM J CLIN NUTR, V72, P912
   Kent LM, 2009, ASIA PAC J CLIN NUTR, V18, P453
   Kim J, 2010, EUR J CLIN NUTR, V64, P169, DOI 10.1038/ejcn.2009.131
   Kim J-O., 1978, Factor analysis: statistical methods and practical issues
   Kim JA, 2007, DIABETES CARE, V30, P1904, DOI 10.2337/dc06-2591
   Kim J, 2011, J AM DIET ASSOC, V111, P1141, DOI 10.1016/j.jada.2011.05.001
   Kimokoti RW, 2010, J NUTR, V140, P1287, DOI 10.3945/jn.109.120808
   *KOR NUTR SOC, 2005, DIET REF INT KOR
   Lin H, 2003, J NUTR, V133, P3651, DOI 10.1093/jn/133.11.3651
   LISSNER L, 1995, EUR J CLIN NUTR, V49, P79
   Macdiarmid JI, 1998, INT J OBESITY, V22, P1053, DOI 10.1038/sj.ijo.0800724
   Martinez ME, 1998, AM J EPIDEMIOL, V148, P17, DOI 10.1093/oxfordjournals.aje.a009552
   Maskarinec G, 2000, J NUTR, V130, P3068, DOI 10.1093/jn/130.12.3068
   McNaughton SA, 2008, J NUTR, V138, P364, DOI 10.1093/jn/138.2.364
   McNaughton SA, 2007, J NUTR, V137, P99, DOI 10.1093/jn/137.1.99
   Millen BE, 2004, J AM DIET ASSOC, V104, P208, DOI 10.1016/j.jada.2003.11.007
   Ministry of Health and Welfare, 2005, NAT HLTH NUTR EX SUR
   Mittendorfer B, 2001, AM J CLIN NUTR, V73, P892
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Newby PK, 2006, J NUTR, V136, P2580, DOI 10.1093/jn/136.10.2580
   Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504
   Okubo H, 2008, INT J OBESITY, V32, P541, DOI 10.1038/sj.ijo.0803737
   Park SH, 2010, INT J CARDIOL, V139, P234, DOI 10.1016/j.ijcard.2008.10.011
   Park SY, 2005, J NUTR, V135, P843, DOI 10.1093/jn/135.4.843
   Rumawas ME, 2009, AM J CLIN NUTR, V90, P1608, DOI 10.3945/ajcn.2009.27908
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Togo P, 2004, INT J OBESITY, V28, P583, DOI 10.1038/sj.ijo.0802598
   Togo P, 2001, INT J OBESITY, V25, P1741, DOI 10.1038/sj.ijo.0801819
   van Dam RM, 2003, AM J CLIN NUTR, V77, P1156, DOI 10.1093/ajcn/77.5.1156
   van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008
NR 38
TC 70
Z9 73
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 2212-2672
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD FEB
PY 2012
VL 112
IS 2
BP 246
EP 253
DI 10.1016/j.jada.2011.10.005
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 897MV
UT WOS:000300655700006
PM 22732459
DA 2025-04-28
ER

PT J
AU Anton-Paduraru, DT
   Gotca, I
   Mocanu, V
   Popescu, V
   Iliescu, ML
   Miftode, EG
   Boiculese, VL
AF Anton-Paduraru, Dana-Teodora
   Gotca, Ioan
   Mocanu, Veronica
   Popescu, Veronica
   Iliescu, Maria-Liliana
   Miftode, Egidia-Gabriela
   Boiculese, Vasile-Lucian
TI Assessment of Eating Habits and Perceived Benefits of Physical Activity
   and Body Attractiveness among Adolescents from Northeastern Romania
SO APPLIED SCIENCES-BASEL
LA English
DT Article
DE adolescent; eating habits; perceived benefits of physical activity;
   perceived body attractiveness
ID SCHOOL-AGED CHILDREN; NUTRITIONAL-STATUS; DIETARY HABITS; BEHAVIOR;
   VALIDITY
AB The purpose of this paper was to present the results of the evaluation of 1320 adolescents from 4 high schools in Iasi, Romania regarding their eating habits and perceived benefits of physical activity and body attractiveness after they completed an anonymous questionnaire. The data analysis was performed using IBM SPSS version 18. The analysis of the nutritional status showed that over 70% of adolescents were of a normal weight. Most of them (63.56%) consumed 3-4 meals/day, with breakfast being the most skipped meal (60.53%). Compared with the boys, the girls consumed fewer whole grains, dairy products, and meat, but the girls consumed fruits and vegetables in approximately the same percentage. The adolescents studied consumed more fruits than vegetables, but the servings of fruits and vegetables consumed were not sufficient in the diets of many adolescents (39.31%). Among the adolescents, 5.68% consumed at least 2 alcoholic drinks daily, and 37.87% consumed caffeine products one or more times per week. Among the boys, 95.20% practiced regular physical activity, and 97.20% of the girls considered that the right nutrition plays a role in the prevention of obesity. The study of the self-perception profile showed that 89.8% of boys and 79.5% of girls considered that they had attractive bodies. According to the BMI, 86.7% of normal-weight adolescents and 84.8% of underweight adolescents considered themselves as having attractive bodies, while this was only considered by 73.5% of overweight and 56.7% of obese adolescents. It is necessary to introduce nutritional education in schools for the improvement of eating habits in children and adolescents. More studies are needed to appreciate the social behaviors (e.g., food intake, physical activity, and recreation time) and then develop interventions and national health programs to promote a healthy lifestyle, particularly healthy eating habits.
C1 [Anton-Paduraru, Dana-Teodora] Grigore T Popa Univ Med & Pharm, Dept Mother & Child Med, 16 Univ St, Iasi 700115, Romania.
   [Gotca, Ioan; Mocanu, Veronica] Grigore T Popa Univ Med & Pharm, Dept Morphofunct Sci 2, 16 Univ St, Iasi 700115, Romania.
   [Popescu, Veronica] Alexandru Ioan Cuza Univ, Fac Phys Educ & Sport, Iasi 700554, Romania.
   [Iliescu, Maria-Liliana; Boiculese, Vasile-Lucian] Grigore T Popa Univ Med & Pharm, Dept Prevent Med & Interdisciplinar, 16 Univ St, Iasi 700115, Romania.
   [Miftode, Egidia-Gabriela] Grigore T Popa Univ Med & Pharm, Dept Med Sci 2, 16 Univ St, Iasi 700115, Romania.
C3 Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa
   University of Medicine & Pharmacy; Alexandru Ioan Cuza University;
   Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa
   University of Medicine & Pharmacy
RP Gotca, I; Mocanu, V (corresponding author), Grigore T Popa Univ Med & Pharm, Dept Morphofunct Sci 2, 16 Univ St, Iasi 700115, Romania.
EM dana.anton@umfiasi.ro; ioan.gotca@umfiasi.ro;
   veronica.mocanu@umfiasi.ro; veronica.popescu@uaic.ro;
   maria.iliescu@umfiasi.ro; egidia.miftode@umfiasi.ro;
   vasile.boiculese@umfiasi.ro
RI Popescu, Veronica/LRU-0790-2024; Mocanu, Veronica/AAQ-6285-2020;
   BOICULESE, Vasile Lucian/MSW-2525-2025; Anton-Paduraru,
   Dana-Teodora/IYS-1710-2023; Miftode, Egidia/JQW-2941-2023; ANTON
   PADURARU, DANA TEODORA/C-9742-2015
OI ANTON PADURARU, DANA TEODORA/0000-0001-8657-378X; Mocanu,
   Veronica/0000-0002-9330-1691
CR Agofure O, 2021, PAN AFR MED J, V38, DOI 10.11604/pamj.2021.38.32.15824
   Amos PM, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012468140
   [Anonymous], 2010, Dietary Guidelines for Americans
   Baric IC, 2000, FOOD TECHNOL BIOTECH, V38, P217
   Bazhan M., 2013, J PARAMED SCI, V4, P93
   Castaneda-Sanchez O., 2008, ARCHIVOS MEDICINA FA, V10, P7
   Citozi R., 2013, Journal of Human Sport and Exercise, V8, pS192
   Drenowatz C., 2018, ANN CLIN NUTR, V2, P1010
   Fortes LD, 2013, REV NUTR, V26, P529, DOI 10.1590/S1415-52732013000500004
   Gill F, 2016, Int J Nutr Food Sci, V4, P304, DOI [10.11648/j.ijnfs.20160504.21, DOI 10.11648/J.IJNFS.20160504.21]
   Graur M., 2006, ROMANIAN GUIDE HLTH
   Ilas S, 2016, STATUS NUTR ED PRESC
   Lago R.R., 2016, ADOLESCENCIA SAUDE, V13, P98
   Lestari S., 2018, P INT C SCI TECHN EN
   Lindwall M, 2011, PSYCHOL HEALTH MED, V16, P115, DOI 10.1080/13548506.2010.521567
   Rodrigues PRM, 2017, NUTRITION, V42, P114, DOI 10.1016/j.nut.2017.03.011
   Mizia S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18083996
   Musaiger AO, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.7122
   Onyiriuka A., 2013, Sri Lanka J Child Health, V42, P20
   Pérez-Rodrigo C, 2015, NUTR HOSP, V31, P76, DOI 10.3305/nh.2015.31.sup3.8755
   Roura E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159962
   Samuelson G, 2000, EUR J CLIN NUTR, V54, pS21, DOI 10.1038/sj.ejcn.1600980
   Sarkar M., 2015, IOSR J DENT MED SCI, V14, P6
   Schröder H, 2012, PUBLIC HEALTH NUTR, V15, P618, DOI 10.1017/S1368980011001923
   Silva FA, 2017, J PEDIAT-BRAZIL, V93, P79, DOI [10.1016/j.jped.2016.04.008, 10.1016/j.jpedp.2016.07.007]
   Stoian AP, 2018, J MIND MED SCI, V5, P85, DOI 10.22543/7674.51.P8592
   Story M., 2005, Guidelines Adolesc Nutr Serv, V9, P19
   Vereecken CA, 2005, BRIT J NUTR, V94, P423, DOI 10.1079/BJN20051513
   Vizbaraite D., 2011, Baltic J Sport Health Sci, V2, P52, DOI [10.33607/bjshs.v2i81.331, DOI 10.33607/BJSHS.V2I81.331]
   World Health Organization, AD DIET HAB FACT SHE
   zkan B.A., 2020, PROG NUTR, V22
NR 31
TC 5
Z9 5
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD NOV
PY 2021
VL 11
IS 22
AR 11042
DI 10.3390/app112211042
PG 10
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials
   Science, Multidisciplinary; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Engineering; Materials Science; Physics
GA XF2VZ
UT WOS:000723935100001
OA gold
DA 2025-04-28
ER

PT J
AU Kim, J
   Jang, JY
   Cai, J
   Kim, Y
   Shin, K
   Choi, EK
   Lee, SP
   Kim, JC
   Kim, TS
   Jeong, HS
   Kim, YB
AF Kim, Jihyun
   Jang, Ja Young
   Cai, Jingmei
   Kim, Youngeun
   Shin, Kyungha
   Choi, Ehn-Kyoung
   Lee, Sung-Pyo
   Kim, Jong-Choon
   Kim, Tae-Su
   Jeong, Heon-Sang
   Kim, Yun-Bae
TI Ethanol extracts of unroasted Coffea canephora robusta beans
   suppress adipogenesis in preadipocytes and fat accumulation in rats fed
   a high-fat diet
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE green coffee bean extract; adiopogenesis; obesity; hyperlipidemia
ID WEIGHT-GAIN; BODY-FAT; OBESITY; MORTALITY; LEPTIN
AB Anti-adipogenic and anti-obesity effects of a green coffee been extract (GCE) from unroasted Coffea canephora Robusta beans were investigated in vitro and in vivo. Insulin-induced adipogenesis in 3T3-L1 preadipocytes was inhibited by 25.6 and 87.9% following treatment with 100 and 500 mu g/mL GCE, respectively. Expression of adipogenesis-specific genes was down-regulated. Body weight gains of C57BL/6 mice fed a high-fat diet (HFD) were suppressed in a concentration-dependent manner using GCE (0.3 or 1% in the diet), exhibiting a marked lower gain in 1% GCE-fed mice than in normal diet-fed animals. Decreases in body fat weights and the size of adipocytes were confirmed. GCE supplementation reduced concentrations of blood lipids and leptin, and attenuated hepatic steatosis. GCE inhibits adipogenesis by modulating cell signaling and improves dietary obesity by reducing lipid accumulation and the size of adipocytes.
C1 [Kim, Jihyun; Jang, Ja Young; Cai, Jingmei; Kim, Youngeun; Shin, Kyungha; Choi, Ehn-Kyoung; Kim, Yun-Bae] Chungbuk Natl Univ, Coll Vet Med, Cheongju 362763, Chungbuk, South Korea.
   [Lee, Sung-Pyo; Kim, Tae-Su] Misuba RTech Co Ltd, Asan 336795, Chungnam, South Korea.
   [Kim, Jong-Choon] Chonnam Natl Univ, Coll Vet Med, Kwangju 500757, South Korea.
   [Jeong, Heon-Sang] Chungbuk Natl Univ, Dept Food Sci & Biotechnol, Cheongju 362763, Chungbuk, South Korea.
C3 Chungbuk National University; Chonnam National University; Chungbuk
   National University
RP Kim, YB (corresponding author), Chungbuk Natl Univ, Coll Vet Med, Cheongju 362763, Chungbuk, South Korea.
EM solar93@cbu.ac.kr
RI Kim, Kwang Pyo/AAG-1815-2020; Park, Hong-Gyu/C-6000-2008
FU Province of Chungcheongnam-do; Chungcheong Institute for Regional
   Program Evaluation (CIRPE) through Research and Development fund for
   Regional Industry
FX This research was financially supported by the Province of
   Chungcheongnam-do and the Chungcheong Institute for Regional Program
   Evaluation (CIRPE) through the Research and Development fund for
   Regional Industry.
CR Ahrén B, 1998, EUR J ENDOCRINOL, V139, P461, DOI 10.1530/eje.0.1390461
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   BELLET S, 1968, METABOLISM, V17, P702, DOI 10.1016/0026-0495(68)90054-1
   BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001
   del Castillo MD, 2002, J AGR FOOD CHEM, V50, P3698, DOI 10.1021/jf011702q
   Despres J P, 1998, Obes Res, V6 Suppl 1, p8S
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   HART RW, 1995, FUND APPL TOXICOL, V25, P184, DOI 10.1006/faat.1995.1054
   Hill JO, 2007, CLIN PHARMACOL THER, V81, P772, DOI 10.1038/sj.clpt.6100107
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Lee Myung-Yul, 2006, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V35, P335
   Lee SH, 2012, EUR J NUTR, V51, P1011, DOI 10.1007/s00394-011-0280-6
   Levy JR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1088, DOI 10.1152/ajpendo.2000.279.5.E1088
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101
   Mercer JG, 2000, CNS DRUGS, V14, P413, DOI 10.2165/00023210-200014060-00001
   Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128
   Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Nicklas BJ, 2003, DIABETES CARE, V26, P1413, DOI 10.2337/diacare.26.5.1413
   Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Prineas R J, 1993, Ann Epidemiol, V3, P35, DOI 10.1016/1047-2797(93)90007-Q
   ROTHWELL NJ, 1984, CLIN ENDOCRINOL META, V13, P437, DOI 10.1016/S0300-595X(84)80032-8
   최용민, 2010, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V39, P927
   Tanaka K, 2009, FOOD SCI TECHNOL RES, V15, P147, DOI 10.3136/fstr.15.147
   Vasselli JR, 2005, OBES RES, V13, P693, DOI 10.1038/oby.2005.78
   Visscher TLS, 2001, ANNU REV PUBL HEALTH, V22, P355, DOI 10.1146/annurev.publhealth.22.1.355
   Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081
   Yang G, 2011, FOOD SCI BIOTECHNOL, V20, P1649, DOI 10.1007/s10068-011-0227-y
NR 33
TC 8
Z9 8
U1 0
U2 12
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1226-7708
EI 2092-6456
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD DEC
PY 2014
VL 23
IS 6
BP 2029
EP 2035
DI 10.1007/s10068-014-0276-0
PG 7
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA AS5RE
UT WOS:000344326600040
DA 2025-04-28
ER

PT J
AU Schulze, MB
   Hu, FB
AF Schulze, MB
   Hu, FB
TI Primary prevention of diabetes: What can be done and how much can be
   prevented?
SO ANNUAL REVIEW OF PUBLIC HEALTH
SE Annual Review of Public Health
LA English
DT Review; Book Chapter
ID IMPAIRED GLUCOSE-TOLERANCE; CORONARY-HEART-DISEASE; TIME
   PHYSICAL-ACTIVITY; BODY-FAT DISTRIBUTION; DIETARY FIBER INTAKE; MODERATE
   ALCOHOL-CONSUMPTION; FRUCTOSE CORN SYRUP; WHOLE-GRAIN INTAKE; 20-YEAR
   FOLLOW-UP; AGED FINNISH MEN
AB Although it is widely believed that type 2 diabetes mellitus is the result of a complex interplay between genetic and environmental factors, compelling evidence from epidemiologic studies indicates that the current worldwide diabetes epidemic is largely due to changes in diet and lifestyle. Prospective cohort studies and randomized clinical trials have demonstrated that type 2 diabetes can be prevented largely through moderate diet and lifestyle modifications. Excess adiposity is the most important risk factor for diabetes, and thus, maintaining a healthy body weight and avoiding weight gain during adulthood is the cornerstone of diabetes prevention. Increasing physical activity and reducing sedentary behaviors such as prolonged TV watching are important both for maintaining body weight and improving insulin sensitivity. There is increasing evidence that the quality of fat and carbohydrate plays a more important role than does the quantity, and thus, public health strategies should emphasize replacing saturated and trans fats with unsaturated fats and replacing refined grain products with whole grains. Recent studies have also suggested a potential role for coffee, dairy, nuts, magnesium, and calcium in preventing diabetes. Overall, a healthy diet, together with regular physical activity, maintenance of a healthy weight, moderate alcohol consumption, and avoidance of sedentary behaviors and smoking, could nearly eliminate type 2 diabetes. However, there is still a wide gap between what we know and what we practice in the field of public health; how to narrow that gap remains a major public health challenge.
C1 Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard University Medical Affiliates; Brigham & Women's
   Hospital; Harvard University; Harvard Medical School
RP Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
EM mschulze@mail.dife.de; frank.hu@channing.harvard.edu
RI Hu, Frank/C-1919-2013; Schulze, Matthias B./AAH-6906-2021
OI Schulze, Matthias B./0000-0002-0830-5277
CR Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025
   [Anonymous], 2003, WORLD HLTH REP 2002
   [Anonymous], WHO TECH REP SER
   BALKAU B, 1985, AM J EPIDEMIOL, V122, P594, DOI 10.1093/oxfordjournals.aje.a114139
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796
   BUTLER WJ, 1982, AM J EPIDEMIOL, V116, P971, DOI 10.1093/oxfordjournals.aje.a113499
   Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158
   Carlsson S, 2003, DIABETES CARE, V26, P2785, DOI 10.2337/diacare.26.10.2785
   Chandalia M, 2000, NEW ENGL J MED, V342, P1392, DOI 10.1056/NEJM200005113421903
   Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5
   Christiansen E, 1997, DIABETES CARE, V20, P881, DOI 10.2337/diacare.20.5.881
   COLDITZ GA, 1992, AM J CLIN NUTR, V55, P1018, DOI 10.1093/ajcn/55.5.1018
   COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001
   COLLINS VR, 1994, DIABETES CARE, V17, P288, DOI 10.2337/diacare.17.4.288
   Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390
   Cordain L, 2000, METABOLISM, V49, P1473, DOI 10.1053/meta.2000.17672
   Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559
   de Vegt F, 2002, DIABETES RES CLIN PR, V57, P53, DOI 10.1016/S0168-8227(02)00013-X
   Duncan GE, 2003, DIABETES CARE, V26, P557, DOI 10.2337/diacare.26.3.557
   Eliasson B, 1997, EUR J CLIN INVEST, V27, P450, DOI 10.1046/j.1365-2362.1997.1330680.x
   Eliasson M, 2004, J INTERN MED, V256, P101, DOI 10.1111/j.1365-2796.2004.01344.x
   FESKENS EJM, 1989, AM J EPIDEMIOL, V130, P1101, DOI 10.1093/oxfordjournals.aje.a115437
   FESKENS EJM, 1995, DIABETES CARE, V18, P1104, DOI 10.2337/diacare.18.8.1104
   Field AE, 2004, OBES RES, V12, P267, DOI 10.1038/oby.2004.34
   Flanagan DEH, 2002, EUR J CLIN INVEST, V32, P187, DOI 10.1046/j.1365-2362.2002.00970.x
   Ford ES, 2001, PREV MED, V32, P33, DOI 10.1006/pmed.2000.0772
   Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207
   Freeman DJ, 2001, CIRCULATION, V103, P357
   FUKAGAWA NK, 1990, AM J CLIN NUTR, V52, P524, DOI 10.1093/ajcn/52.3.524
   Fung TT, 2002, AM J CLIN NUTR, V76, P535, DOI 10.1093/ajcn/76.3.535
   FUNG TT, 2004, IN PRESS ARCH INTERN
   GOHDES D, 1993, DIABETES CARE, V16, P239, DOI 10.2337/diacare.16.1.239
   GURWITZ JH, 1994, J AM GERIATR SOC, V42, P1235, DOI 10.1111/j.1532-5415.1994.tb06503.x
   Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739
   Harding AH, 2004, AM J EPIDEMIOL, V159, P73, DOI 10.1093/aje/kwh004
   HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302
   Herman WH, 2003, DIABETES CARE, V26, P36
   HODGE AM, 1993, AM J EPIDEMIOL, V137, P178, DOI 10.1093/oxfordjournals.aje.a116658
   HODGE AM, 1994, INT J OBESITY, V18, P419
   HOLBROOK TL, 1990, AM J EPIDEMIOL, V132, P902, DOI 10.1093/oxfordjournals.aje.a115733
   Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433
   Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547
   Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785
   Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542
   Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892
   Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x
   JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362
   Jéquier E, 2002, AM J MED, V113, P41, DOI 10.1016/S0002-9343(01)00991-3
   Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711
   Jiang R, 2004, AM J CLIN NUTR, V79, P70
   Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554
   Juntunen KS, 2003, AM J CLIN NUTR, V77, P385
   Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151
   Kao WHL, 2001, AM J EPIDEMIOL, V154, P748, DOI 10.1093/aje/154.8.748
   Kawakami N, 1997, AM J EPIDEMIOL, V145, P103
   KAYE SA, 1991, J CLIN EPIDEMIOL, V44, P329, DOI 10.1016/0895-4356(91)90044-A
   Keenan Joseph M, 2002, J Fam Pract, V51, P369
   Klonoff DC, 2000, DIABETES CARE, V23, P390, DOI 10.2337/diacare.23.3.390
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/nejmoa012512
   Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167
   Kriska AM, 2003, AM J EPIDEMIOL, V158, P669, DOI 10.1093/aje/kwg191
   Lee DH, 2004, DIABETOLOGIA, V47, P185, DOI 10.1007/s00125-003-1307-1
   Lichtenstein AH, 2003, ATHEROSCLEROSIS, V171, P97, DOI 10.1016/j.atherosclerosis.2003.07.005
   Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3
   Lindholm LH, 2002, J HYPERTENS, V20, P1879, DOI 10.1097/00004872-200209000-00035
   Liu SM, 2002, J AM COLL NUTR, V21, P298, DOI 10.1080/07315724.2002.10719227
   Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409
   Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134
   Louheranta AM, 1999, METABOLISM, V48, P870, DOI 10.1016/S0026-0495(99)90221-4
   Lovejoy JC, 2002, DIABETES CARE, V25, P1283, DOI 10.2337/diacare.25.8.1283
   Lu WQ, 2003, METABOLISM, V52, P129, DOI 10.1053/meta.2003.50020
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   LUNDGREN H, 1989, INT J OBESITY, V13, P413
   MANSON JE, 1994, AM J PREV MED, V10, P172, DOI 10.1016/S0749-3797(18)30615-9
   MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B
   MARSHALL JA, 1994, DIABETES CARE, V17, P50, DOI 10.2337/diacare.17.1.50
   Mayer-Davis EJ, 1998, JAMA-J AM MED ASSOC, V279, P669, DOI 10.1001/jama.279.9.669
   MCPHILLIPS JB, 1990, AM J EPIDEMIOL, V131, P443, DOI 10.1093/oxfordjournals.aje.a115519
   MEDALIE JH, 1975, ARCH INTERN MED, V135, P811, DOI 10.1001/archinte.135.6.811
   Meyer KA, 2000, AM J CLIN NUTR, V71, P921
   Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528
   MONTERROSA AE, 1995, DIABETES CARE, V18, P448, DOI 10.2337/diacare.18.4.448
   Montonen J, 2003, AM J CLIN NUTR, V77, P622, DOI 10.1093/ajcn/77.3.622
   Nakanishi N, 2003, DIABETES CARE, V26, P48, DOI 10.2337/diacare.26.1.48
   NEEL JV, 1962, AM J HUM GENET, V14, P353
   OHLSON LO, 1988, DIABETOLOGIA, V31, P798
   OHLSON LO, 1985, DIABETES, V34, P1055, DOI 10.2337/diabetes.34.10.1055
   Okada K, 2000, DIABETIC MED, V17, P53, DOI 10.1046/j.1464-5491.2000.00229.x
   PAFFENBARGER RS, 1973, AM J EPIDEMIOL, V97, P314, DOI 10.1093/oxfordjournals.aje.a121511
   Palmer AJ, 2004, CLIN THER, V26, P304, DOI 10.1016/S0149-2918(04)90029-X
   Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537
   Paolisso G, 1997, AM J HYPERTENS, V10, P346, DOI 10.1016/S0895-7061(96)00342-1
   Parikh SJ, 2003, AM J CLIN NUTR, V77, P281, DOI 10.1093/ajcn/77.2.281
   Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081
   Pereira MA, 2002, AM J CLIN NUTR, V75, P848, DOI 10.1093/ajcn/75.5.848
   Pereira MA, 2001, PEDIATR CLIN N AM, V48, P969, DOI 10.1016/S0031-3955(05)70351-5
   Perry IJ, 2001, INT J EPIDEMIOL, V30, P554, DOI 10.1093/ije/30.3.554
   Petersen M, 2003, DIABETES CARE, V26, P917
   Pi-Sunyer FX, 1998, OBES RES, V6, p51S
   Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721
   RIMM EB, 1993, AM J PUBLIC HEALTH, V83, P211, DOI 10.2105/AJPH.83.2.211
   RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Sairenchi T, 2004, AM J EPIDEMIOL, V160, P158, DOI 10.1093/aje/kwh183
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472
   Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545
   Salmerón J, 2001, AM J CLIN NUTR, V73, P1019
   Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637
   Saremi A, 2003, DIABETES CARE, V26, P2211, DOI 10.2337/diacare.26.7.2211
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348
   Schulze MB, 2003, DIABETOLOGIA, V46, P1465, DOI 10.1007/s00125-003-1220-7
   Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184
   Slattery M L, 2000, Semin Gastrointest Dis, V11, P142
   Song Y, 2004, DIABETES CARE, V27, P2108, DOI 10.2337/diacare.27.9.2108
   Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59
   STAMPFER MJ, 1988, AM J EPIDEMIOL, V128, P549, DOI 10.1093/oxfordjournals.aje.a115002
   Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103
   Steven J, 2002, DIABETES CARE, V25, P1715, DOI 10.2337/diacare.25.10.1715
   Stumvoll M, 2002, ANN MED, V34, P217, DOI 10.1080/713782132
   Sugimori H, 1998, J Med Syst, V22, P27, DOI 10.1023/A:1022650305109
   Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3
   THORBURN A, 1993, METABOLISM, V42, P780, DOI 10.1016/0026-0495(93)90249-N
   TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963
   Tosiello L, 1996, ARCH INTERN MED, V156, P1143, DOI 10.1001/archinte.156.11.1143
   Tsumura K, 1999, DIABETES CARE, V22, P1432, DOI 10.2337/diacare.22.9.1432
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   van Dam RM, 2003, EUR J EPIDEMIOL, V18, P1115
   van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008
   Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620
   Wannamethee SG, 2003, ARCH INTERN MED, V163, P1329, DOI 10.1001/archinte.163.11.1329
   Wannamethee SG, 2002, J EPIDEMIOL COMMUN H, V56, P542, DOI 10.1136/jech.56.7.542
   Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590
   Wannamethee SG, 2000, ARCH INTERN MED, V160, P2108, DOI 10.1001/archinte.160.14.2108
   Watanabe M, 2002, DIABETES RES CLIN PR, V57, P191, DOI 10.1016/S0168-8227(02)00083-9
   Wei M, 2000, DIABETES CARE, V23, P18, DOI 10.2337/diacare.23.1.18
   Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x
   Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540
   Willemsen R, 2002, NEUE RUNDSCH, V113, P9
   Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004
   WILSON PWF, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90532-2
   Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882
   Zilkens RR, 2003, DIABETES CARE, V26, P608, DOI 10.2337/diacare.26.3.608
NR 152
TC 211
Z9 247
U1 2
U2 40
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0163-7525
EI 1545-2093
J9 ANNU REV PUBL HEALTH
JI Annu. Rev. Public Health
PY 2005
VL 26
BP 445
EP 467
DI 10.1146/annurev.publhealth.26.021304.144532
PG 23
WC Public, Environmental & Occupational Health
WE Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA 924LY
UT WOS:000228981500020
PM 15760297
OA Bronze
DA 2025-04-28
ER

PT J
AU Li, R
   Zhu, QB
   Wang, XY
   Wang, HY
AF Li, Rui
   Zhu, Qubo
   Wang, Xiaoyan
   Wang, Haiyan
TI Mulberry leaf polyphenols alleviated high-fat diet-induced obesity in
   mice
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE mulberry leaf polyphenols; mice; obesity; fatty acid composition;
   adipose tissue browning
ID EXTRACT; THERMOGENESIS; LEAVES
AB Mulberry leaf is an important medicinal food plant, which is rich in polyphenol compounds. Mulberry leaf polyphenols (MLP) possess significant lipid-lowering and antioxidant effects, and healthcare functions. In this study, the polyphenol content of mulberry leaf ethanol extract was measured using HPLC. The analysis of mulberry leaf extract resulted in the identification of 14 compounds, of which Chlorogenic acid and Quercitrin were the highest. A high-fat diet (HFD)-induced obese mouse model was developed and treated with MLP for 12 weeks to explore their effect on lipid metabolism in HFD-induced obese mice. The results showed that the MLP could inhibit the weight gain and fat cell volume increase in the HFD-induced obese mice in a dose-dependent manner. Further analysis revealed that the MLP decelerated the fatty acid composition in the adipose tissues of HFD-induced obese mice, and significantly increased the polyunsaturated-to-saturated fatty acid (PUFA/SFA) ratio. The real-time quantitative PCR (RT-qPCR) results indicated that the MLP significantly inhibited the down regulation of uncoupling protein (UCP) 1 (UCP1), UCP3, and PR domain zinc finger protein 16 (PRDM16) caused by the HFD. These beneficial effects of MLP on HFD-induced obese mice might be attributed to their ability to change the fatty acid composition of adipose tissue and increase the expression of thermogenesis genes. Overall, the study results suggested that the MLP could serve as potential lipid-lowering and weight-loss functional food and healthcare products.
C1 [Li, Rui; Wang, Xiaoyan; Wang, Haiyan] Chongqing Acad Anim Sci, Chongqing, Peoples R China.
   [Zhu, Qubo] Southwest Univ, Chongqing, Peoples R China.
   [Zhu, Qubo] Natl Ctr Technol Innovat Pigs, Chongqing, Peoples R China.
C3 Chongqing Academy of Animal Sciences; Southwest University - China
RP Wang, HY (corresponding author), Chongqing Acad Anim Sci, Chongqing, Peoples R China.
EM whydetian@163.com
RI Wang, Xiaoyan/IVV-5727-2023
FU Key R&D Project in Agriculture and Animal Husbandry of Rongchang;
   General Project of Chongqing Natural Science Foundation; 
   [cstc2019ngzx0006];  [cstc2019jcyj-msxmx0090]
FX Funding This project was funded by The Key R&D Project in Agriculture
   and Animal Husbandry of Rongchang (Grant cstc2019ngzx0006) and General
   Project of Chongqing Natural Science Foundation (Grant
   cstc2019jcyj-msxmx0090).
CR Al Alwan I, 2013, INT J HEALTH SCI-IJH, V7, P3, DOI 10.12816/0006015
   Alberca RW, 2021, CRIT REV FOOD SCI, V61, P2262, DOI 10.1080/10408398.2020.1775546
   Alfaia CMM, 2007, MEAT SCI, V75, P44, DOI 10.1016/j.meatsci.2006.06.013
   Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001
   Bird JK, 2017, ADV NUTR, V8, P839, DOI 10.3945/an.117.016568
   Bray G., 2020, DIABETES OBES METAB, V23, P1, DOI 10.101111/dom.14200
   Cai LingKai Cai LingKai, 2018, Acta Nutrimenta Sinica, V40, P583
   Correa-Betanzo J, 2014, FOOD CHEM, V165, P522, DOI 10.1016/j.foodchem.2014.05.135
   Curtin Carol, 2005, BMC Pediatr, V5, P48, DOI 10.1186/1471-2431-5-48
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Fenwick PH, 2019, CRIT REV FOOD SCI, V59, P2028, DOI 10.1080/10408398.2018.1437022
   Gan ML, 2020, FOOD FUNCT, V11, P2418, DOI [10.1039/c9fo00861f, 10.1039/C9FO00861F]
   Gan ML, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9121080
   Gong ES, 2022, J SCI FOOD AGR, V102, P984, DOI 10.1002/jsfa.11432
   Guo XX, 2017, EMIR J FOOD AGR, V29, P532, DOI 10.9755/ejfa.2017-05-1067
   Gupta SV, 2000, J NUTR, V130, P1217, DOI 10.1093/jn/130.5.1217
   Jimenez-Sanchez G, 2008, GENOME RES, V18, P1191, DOI 10.1101/gr.065359.107
   Landete JM, 2013, CRIT REV FOOD SCI, V53, P706, DOI 10.1080/10408398.2011.555018
   [李先佳 Li Xianjia], 2005, [食品科学, Food Science], V26, P159
   Lim HH, 2013, EXP BIOL MED, V238, P1160, DOI 10.1177/1535370213498982
   McSweeney M, 2015, CRIT REV FOOD SCI, V55, P660, DOI 10.1080/10408398.2012.670673
   Monnard CR, 2021, OBES REV, V22, DOI 10.1111/obr.13197
   Nankam PAN, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061619
   Neamat-Allah ANF, 2021, FISH SHELLFISH IMMUN, V108, P147, DOI 10.1016/j.fsi.2020.11.028
   Oh KS, 2009, J ETHNOPHARMACOL, V122, P216, DOI 10.1016/j.jep.2009.01.020
   Palmer BF, 2017, OBES REV, V18, P819, DOI 10.1111/obr.12563
   Pan MH, 2019, J AGR FOOD CHEM, V67, P13605, DOI 10.1021/acs.jafc.9b05963
   Satin LS, 2015, MOL ASPECTS MED, V42, P61, DOI 10.1016/j.mam.2015.01.003
   [沈维治 Shen Weizhi], 2015, [蚕业科学, Acta Sericologica Sinica], V41, P342
   Sheng Y, 2019, FOOD FUNCT, V10, P4771, DOI [10.1039/C9FO00883G, 10.1039/c9fo00883g]
   Siri-Tarino PW, 2015, ANNU REV NUTR, V35, P517, DOI 10.1146/annurev-nutr-071714-034449
   Tang J, 2019, J CLIN LIPIDOL, V13, P70, DOI 10.1016/j.jacl.2018.09.013
   Tao FF, 2018, CRIT REV FOOD SCI, V58, P1565, DOI 10.1080/10408398.2016.1261332
   [韦芳媚 Wei Fangmei], 2018, [食品工业科技, Science & Technology of Food Industry], V39, P299
   Wu ZC, 2020, NAT PROD REP, V37, P1511, DOI 10.1039/d0np00060d
   Xu XJ, 2019, FOOD FUNCT, V10, P7426, DOI 10.1039/c9fo01304k
   Yang MY, 2011, J AGR FOOD CHEM, V59, P1985, DOI 10.1021/jf103661v
   Yang SJ, 2014, NUTR RES PRACT, V8, P613, DOI 10.4162/nrp.2014.8.6.613
   Yang Y K, 2003, Obes Rev, V4, P239, DOI 10.1046/j.1467-789X.2003.00104.x
   Ying Z, 2011, FOOD CHEM, V127, P1273, DOI 10.1016/j.foodchem.2011.01.083
   Zhu YP., 2017, FOOD SCI, V38, P163, DOI [10.7506/spkx1002-6630-201709026, DOI 10.7506/SPKX1002-6630-201709026]
NR 41
TC 23
Z9 24
U1 9
U2 52
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD SEP 15
PY 2022
VL 9
AR 979058
DI 10.3389/fnut.2022.979058
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 4Z3LC
UT WOS:000862113800001
PM 36185673
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Ma, LY
   Sun, ZH
   Zeng, YW
   Luo, MC
   Yang, JZ
AF Ma, Luyao
   Sun, Zhenghai
   Zeng, Yawen
   Luo, Mingcan
   Yang, Jiazhen
TI Molecular Mechanism and Health Role of Functional Ingredients in
   Blueberry for Chronic Disease in Human Beings
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE blueberry; functional ingredients; chronic disease; functional food
ID INDUCED OXIDATIVE STRESS; VACCINIUM-CORYMBOSUM L.; FREEZE-DRIED
   STRAWBERRY; KILLER-CELL COUNTS; ANTIOXIDANT ACTIVITY;
   INSULIN-RESISTANCE; BIOACTIVE COMPOUNDS; ARTERIAL STIFFNESS;
   ALPHA-GLUCOSIDASE; GUT MICROBIOTA
AB Functional ingredients in blueberry have the best health benefits. To obtain a better understanding of the health role of blueberry in chronic disease, we conducted systematic preventive strategies for functional ingredients in blueberry, based on comprehensive databases, especially PubMed, ISI Web of Science, and CNKI for the period 2008-2018. Blueberry is rich in flavonoids (mainly anthocyanidins), polyphenols (procyanidin), phenolic acids, pyruvic acid, chlorogenic acid, and others, which have anticancer, anti-obesity, prevent degenerative diseases, anti-inflammation, protective properties for vision and liver, prevent heart diseases, antidiabetes, improve brain function, protective lung properties, strong bones, enhance immunity, prevent cardiovascular diseases, and improve cognitive decline. The anthocyanins and polyphenols in blueberry are major functional ingredients for preventive chronic disease. These results support findings that blueberry may be one of the best functional fruits, and further reveals the mechanisms of anthocyanins and polyphenols in the health role of blueberry for chronic disease. This paper may be used as scientific evidence for developing functional foods, nutraceuticals, and novel drugs of blueberry for preventive chronic diseases.
C1 [Ma, Luyao; Sun, Zhenghai] Southwest Forestry Univ, Econ & Management Coll, Kunming 650224, Yunnan, Peoples R China.
   [Ma, Luyao; Sun, Zhenghai; Luo, Mingcan] Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilisat Sou, Minist Educ, Kunming 650224, Yunnan, Peoples R China.
   [Zeng, Yawen; Yang, Jiazhen] Yunnan Acad Agr Sci, Biotechnol & Germplasm Resources Inst, Kunming 650205, Yunnan, Peoples R China.
C3 Southwest Forestry University - China; Southwest Forestry University -
   China; Yunnan Academy of Agricultural Sciences
RP Sun, ZH (corresponding author), Southwest Forestry Univ, Econ & Management Coll, Kunming 650224, Yunnan, Peoples R China.; Sun, ZH (corresponding author), Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilisat Sou, Minist Educ, Kunming 650224, Yunnan, Peoples R China.; Zeng, YW (corresponding author), Yunnan Acad Agr Sci, Biotechnol & Germplasm Resources Inst, Kunming 650205, Yunnan, Peoples R China.
EM ma403294928@163.com; sunzhenghai1978@163.com; zengyw1967@126.com;
   lmc1961@sohu.com; yangjiazhen415@163.com
RI Ma, Luyao/L-8087-2013
OI Zeng, Yawen/0000-0001-7616-9177; jiazhen, yang/0000-0003-2201-3059
FU Science and Technology to Benefit the People from Yunnan Provincial
   Scientific and Technology Department [2014RA060]; scientific research
   foundation of Yunnan Provincial Department of Education [2017YJS091];
   China Agriculture Research System [CARS-05]
FX This research was funded by the Science and Technology to Benefit the
   People from Yunnan Provincial Scientific and Technology Department
   (2014RA060), the scientific research foundation of Yunnan Provincial
   Department of Education (2017YJS091), and China Agriculture Research
   System (CARS-05).
CR Adams LS, 2010, CANCER RES, V70, P3594, DOI 10.1158/0008-5472.CAN-09-3565
   Ahrén IL, 2015, CLIN NUTR, V34, P719, DOI 10.1016/j.clnu.2014.08.009
   [Anonymous], 2017, NUTR NEUROSCI
   Aranaz P, 2017, FOOD FUNCT, V8, P3999, DOI [10.1039/c7fo00996h, 10.1039/C7FO00996H]
   Ayoub M, 2016, FOOD CHEM, V197, P221, DOI 10.1016/j.foodchem.2015.10.107
   Baba AB, 2017, FOOD CHEM TOXICOL, V109, P534, DOI 10.1016/j.fct.2017.09.054
   Bell L, 2017, FOOD FUNCT, V8, P3104, DOI [10.1039/c7fo00724h, 10.1039/c7fO00724h]
   Ben Lagha A, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-017-2072-x
   Ben Lagha A, 2015, J AGR FOOD CHEM, V63, P6999, DOI 10.1021/acs.jafc.5b01525
   Bensalem J, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2018.10
   Bobinaite R, 2015, J FOOD SCI TECH MYS, V52, P5898, DOI 10.1007/s13197-014-1668-0
   Bowtell JL, 2017, APPL PHYSIOL NUTR ME, V42, P773, DOI 10.1139/apnm-2016-0550
   Bunea A, 2013, PHYTOCHEMISTRY, V95, P436, DOI 10.1016/j.phytochem.2013.06.018
   Cásedas G, 2018, FOOD CHEM TOXICOL, V118, P572, DOI 10.1016/j.fct.2018.05.066
   Cásedas G, 2017, FOOD FUNCT, V8, P4187, DOI [10.1039/c7fo01205e, 10.1039/C7FO01205E]
   Chen Chieh-fu, 2010, Yaoxue Xuebao, V45, P422
   Chen GG, 2017, ONCOL REP, V38, P488, DOI 10.3892/or.2017.5675
   Chen Qi, 2014, Yichuan, V36, P566, DOI 10.3724/SP.J.1005.2014.0566
   Chen YL, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4196572
   Ciric A, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4150
   Çoban J, 2015, METAB BRAIN DIS, V30, P793, DOI 10.1007/s11011-014-9643-z
   Cocetta G, 2015, PHYSIOL PLANTARUM, V153, P269, DOI 10.1111/ppl.12243
   Correa-Betanzo J, 2014, FOOD CHEM, V165, P522, DOI 10.1016/j.foodchem.2014.05.135
   Cortez R, 2017, COMPR REV FOOD SCI F, V16, P180, DOI 10.1111/1541-4337.12244
   Cuevas A, 2013, NUTRIENTS, V5, P2314, DOI 10.3390/nu5072314
   Cutler BR, 2018, INT J CARDIOL, V261, P155, DOI 10.1016/j.ijcard.2018.03.027
   Davidson KT, 2018, PATHOL ONCOL RES, V24, P733, DOI 10.1007/s12253-017-0376-2
   DeFuria J, 2009, J NUTR, V139, P1510, DOI 10.3945/jn.109.105155
   Del Bo C, 2017, FOOD FUNCT, V8, P4108, DOI 10.1039/c7fo00861a
   Devareddy L, 2008, J NUTR BIOCHEM, V19, P694, DOI 10.1016/j.jnutbio.2007.09.004
   Diaconeasa Z, 2015, INT J MOL SCI, V16, P2352, DOI 10.3390/ijms16022352
   Elks CM, 2015, OBESITY, V23, P573, DOI 10.1002/oby.20926
   Faria A, 2010, PHYTOTHER RES, V24, P1862, DOI 10.1002/ptr.3213
   Ferlemi AV, 2015, NEUROCHEM RES, V40, P2280, DOI 10.1007/s11064-015-1718-7
   Fragua V, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.33
   Garcia-Diaz DF, 2015, J MED FOOD, V18, P489, DOI 10.1089/jmf.2014.0039
   Gong P, 2014, ENVIRON TOXICOL PHAR, V37, P1015, DOI 10.1016/j.etap.2014.03.017
   Håkansson Å, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033510
   Hong SM, 2018, J AGR FOOD CHEM, V66, P99, DOI 10.1021/acs.jafc.7b03965
   Huang WF, 2018, DIABET METAB SYND OB, V11, P357, DOI 10.2147/DMSO.S166728
   Huang WY, 2018, J AGR FOOD CHEM, V66, P1638, DOI 10.1021/acs.jafc.7b06135
   Huang WY, 2014, MOLECULES, V19, P12827, DOI 10.3390/molecules190812827
   Huang WY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1862462
   Ishida Y, 2014, WORLD J HEPATOL, V6, P870, DOI 10.4254/wjh.v6.i12.870
   Jeong HR, 2013, J MED FOOD, V16, P968, DOI 10.1089/jmf.2013.2881
   Johnson MH, 2011, J AGR FOOD CHEM, V59, P8923, DOI 10.1021/jf201720z
   Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001
   Kalt W, 2014, J AGR FOOD CHEM, V62, P11180, DOI 10.1021/jf503689c
   Kang J, 2015, PLANT FOOD HUM NUTR, V70, P56, DOI 10.1007/s11130-014-0461-6
   Kausar H, 2012, CANCER LETT, V325, P54, DOI 10.1016/j.canlet.2012.05.029
   Khanal RC, 2009, J FOOD SCI, V74, pH52, DOI 10.1111/j.1750-3841.2009.01063.x
   Kim JG, 2013, J ZHEJIANG UNIV-SC B, V14, P793, DOI 10.1631/jzus.B1300012
   Kim M, 2017, J CANCER PREV, V22, P174, DOI 10.15430/JCP.2017.22.3.174
   Koupy D., 2015, CES SLOV FARM, V64, P3
   Kraujalyte V, 2015, FOOD CHEM, V188, P583, DOI 10.1016/j.foodchem.2015.05.031
   Krikorian R, 2010, J AGR FOOD CHEM, V58, P3996, DOI 10.1021/jf9029332
   Lasekan O, 2014, CURR OPIN CLIN NUTR, V17, P589, DOI 10.1097/MCO.0000000000000109
   Lee In-Chul, 2014, J Cancer Prev, V19, P209, DOI 10.15430/JCP.2014.19.3.209
   Lee SG, 2015, PLANT FOOD HUM NUTR, V70, P427, DOI 10.1007/s11130-015-0514-5
   Lee SG, 2015, J MED FOOD, V18, P476, DOI 10.1089/jmf.2013.0182
   Lee S, 2018, J NUTR, V148, P209, DOI 10.1093/jn/nxx027
   Lee YM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101089
   Lewis ED, 2018, BRIT J NUTR, V119, P1393, DOI 10.1017/S0007114518001034
   Li B, 2015, J FOOD SCI TECH MYS, V52, P5228, DOI 10.1007/s13197-014-1611-4
   Li CY, 2013, J AGR FOOD CHEM, V61, P523, DOI 10.1021/jf3046158
   Li HQ, 2020, NUTR NEUROSCI, V23, P75, DOI 10.1080/1028415X.2018.1471251
   Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021
   Lin WM, 2017, ONCOL LETT, V13, P4897, DOI 10.3892/ol.2017.6094
   Lin Z, 2016, FOOD CHEM, V194, P986, DOI 10.1016/j.foodchem.2015.08.113
   Liu FH, 2015, FOOD CHEM, V188, P399, DOI 10.1016/j.foodchem.2015.05.036
   Liu J, 2015, J FOOD SCI TECH MYS, V52, P3022, DOI 10.1007/s13197-014-1379-6
   Liu YX, 2015, J AGR FOOD CHEM, V63, P9295, DOI 10.1021/acs.jafc.5b04341
   Liu YX, 2011, J AGR FOOD CHEM, V59, P12254, DOI 10.1021/jf203136j
   Liu YX, 2011, J AGR FOOD CHEM, V59, P356, DOI 10.1021/jf103852s
   Liu YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127813
   Louis XL, 2014, FOOD FUNCT, V5, P1785, DOI [10.1039/c3fo60588d, 10.1039/C3FO60588D]
   Lu Shuang, 2012, Zhonghua Gan Zang Bing Za Zhi, V20, P497, DOI 10.3760/cma.j.issn.1007-3418.2012.07.004
   Ma H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020461
   Marhuenda J, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/5194901
   Maulik M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26905-4
   McAnulty LS, 2014, NUTR RES, V34, P577, DOI 10.1016/j.nutres.2014.07.002
   McAnulty LS, 2011, APPL PHYSIOL NUTR ME, V36, P976, DOI [10.1139/H11-120, 10.1139/h11-120]
   McGill C.M., 2018, Int. J. Biopharm. Sci, V1
   McNamara RK, 2018, NEUROBIOL AGING, V64, P147, DOI 10.1016/j.neurobiolaging.2017.12.003
   Milbury PE, 2010, J AGR FOOD CHEM, V58, P3950, DOI 10.1021/jf903529m
   Miller MG, 2018, EUR J NUTR, V57, P1169, DOI 10.1007/s00394-017-1400-8
   Minker C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/154164
   Moghe SS, 2012, J MED FOOD, V15, P448, DOI 10.1089/jmf.2011.0234
   Nair AR, 2017, FOOD FUNCT, V8, P4118, DOI [10.1039/C7FO00815E, 10.1039/c7fo00815e]
   Nair AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111976
   Nair AR, 2014, FREE RADICAL BIO MED, V71, P16, DOI 10.1016/j.freeradbiomed.2014.03.012
   Nemes-Nagy E, 2008, ACTA PHYSIOL HUNG, V95, P383, DOI 10.1556/APhysiol.95.2008.4.5
   Oh DR, 2018, AM J CHINESE MED, V46, P357, DOI [10.1142/S0192415X18500180, 10.1142/s0192415x18500180]
   Ozcelik E, 2014, PHARMACOGN MAG, V10, P217, DOI 10.4103/0973-1296.133234
   Pertuzatti PB, 2014, FOOD CHEM, V164, P81, DOI 10.1016/j.foodchem.2014.04.114
   Poulose SM, 2014, BRAIN RES, V1593, P9, DOI 10.1016/j.brainres.2014.10.028
   Rahal OM, 2013, CARCINOGENESIS, V34, P464, DOI 10.1093/carcin/bgs353
   Ravoori S, 2012, J AGR FOOD CHEM, V60, P5547, DOI 10.1021/jf205325p
   Ren TT, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/469059
   Reyes-Farias M, 2015, J MED FOOD, V18, P601, DOI 10.1089/jmf.2014.0031
   Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46
   Senevirathne M, 2010, NUTR RES PRACT, V4, P183, DOI 10.4162/nrp.2010.4.3.183
   Shi DZ, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/5476903
   Skrovankova S, 2015, INT J MOL SCI, V16, P24673, DOI 10.3390/ijms161024673
   Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069925
   Srovnalova A, 2014, J AGR FOOD CHEM, V62, P789, DOI 10.1021/jf404643w
   Sun JC, 2018, FOOD CHEM TOXICOL, V120, P491, DOI 10.1016/j.fct.2018.07.048
   Sun XY, 2015, MOLECULES, V20, P3841, DOI 10.3390/molecules20033841
   Tan L, 2014, BIOMED ENVIRON SCI, V27, P186, DOI 10.3967/bes2014.007
   Uysal U, 2013, CURR PHARM DESIGN, V19, P6094, DOI 10.2174/1381612811319340004
   Vendrame S, 2015, J MED FOOD, V18, P619, DOI 10.1089/jmf.2014.0065
   Vendrame S, 2014, BRIT J NUTR, V111, P194, DOI 10.1017/S0007114513002390
   Vendrame S, 2013, J NUTR BIOCHEM, V24, P1508, DOI 10.1016/j.jnutbio.2012.12.010
   Wang EL, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1325308
   Wang Y, 2015, J SCI FOOD AGR, V95, P936, DOI 10.1002/jsfa.6765
   Wang YP, 2010, HEPATOB PANCREAT DIS, V9, P164
   Whyte AR, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060660
   Williams CM, 2008, FREE RADICAL BIO MED, V45, P295, DOI 10.1016/j.freeradbiomed.2008.04.008
   Wiseman W, 2011, CAN J PHYSIOL PHARM, V89, P67, DOI [10.1139/Y10-101, 10.1139/y10-101]
   Wu T, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4051232
   Wu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077585
   Wu Y, 2017, FOOD RES INT, V100, P312, DOI 10.1016/j.foodres.2017.07.004
   Xu N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00853
   Yan XR, 2015, J SURG RES, V199, P592, DOI 10.1016/j.jss.2015.06.013
   Zeng YW, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3232080
   Zeng YW, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/9402849
   Zeng YW, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/497934
   Zhan W, 2017, ONCOTARGET, V8, P96761, DOI 10.18632/oncotarget.17842
   Zhang CY, 2017, J HORTIC SCI BIOTECH, V92, P57, DOI 10.1080/14620316.2016.1224604
   Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024486
   Zhao MY, 2015, FOOD FUNCT, V6, P3006, DOI [10.1039/c5fo00408j, 10.1039/C5FO00408J]
   Zhao MY, 2015, J FOOD SCI, V80, pH869, DOI 10.1111/1750-3841.12815
   Zhou F, 2018, FOOD RES INT, V107, P509, DOI 10.1016/j.foodres.2018.02.071
   Zhu Juan-Juan, 2017, Sichuan Da Xue Xue Bao Yi Xue Ban, V48, P203
   Zu XY, 2010, CHINESE MED J-PEKING, V123, P2714, DOI 10.3760/cma.j.issn.0366-6999.2010.19.018
   [No title captured]
   [No title captured]
   [No title captured]
   [No title captured]
NR 139
TC 102
Z9 107
U1 15
U2 115
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2018
VL 19
IS 9
AR 2785
DI 10.3390/ijms19092785
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA HA1OU
UT WOS:000449988100321
PM 30223619
OA Green Submitted, gold, Green Published
DA 2025-04-28
ER

PT J
AU Rasheed, H
   Ahmad, D
   Bao, JS
AF Rasheed, Haroon
   Ahmad, Daraz
   Bao, Jinsong
TI Genetic Diversity and Health Properties of Polyphenols in Potato
SO ANTIOXIDANTS
LA English
DT Review
DE potato; polyphenol; health properties
ID PURPLE-FLESHED POTATOES; ANTIOXIDANT ACTIVITY; SOLANUM-TUBEROSUM;
   COOKING METHODS; CHLOROGENIC ACID; PHENOLIC CONTENT; BIOACTIVE
   COMPOUNDS; DOMESTIC COOKING; GUT MICROBIOTA; GLYCEMIC INDEX
AB Polyphenol is one of the most essential phytochemicals with various health benefits. Potato (Solanum tuberosum L.) is known as a potential source of polyphenols, and also has health benefits in which phenolic acids, such as chlorogenic, ferulic acid, caffeic acid, and flavonoids, such as anthocyanins, sustainably play the most significant role. Almost every polyphenol contributes to various biological activities. In this review, we collected comprehensive information concerning the diversity of polyphenols in potatoes, and the effects of post-harvest processing and different cooking methods on the bioavailability of polyphenols. To achieve maximum health benefits, the selection of potato cultivars is necessary by choosing their colors, but various cooking methods are also very important in obtaining the maximum concentration of polyphenolic compounds. The health properties including major biological activities of polyphenols, such as antioxidant activity, anticarcinogenic activity, anti-inflammatory activity, anti-obesity activity, and antidiabetic activity, have also been summarized. All these biological activities of polyphenols in potatoes might be helpful for breeders in the design of new varieties with many health benefits, and are expected to play a vital role in both pharmaceutical and nutraceutical industries.
C1 [Rasheed, Haroon; Ahmad, Daraz; Bao, Jinsong] Zhejiang Univ, Inst Nucl Agr Sci, Coll Agr & Biotechnol, Key Lab Nucl Agr Sci,Minist Agr & Zhejiang Prov, Hangzhou 310058, Peoples R China.
C3 Zhejiang University
RP Bao, JS (corresponding author), Zhejiang Univ, Inst Nucl Agr Sci, Coll Agr & Biotechnol, Key Lab Nucl Agr Sci,Minist Agr & Zhejiang Prov, Hangzhou 310058, Peoples R China.
EM haroonzju@zju.edu.cn; 11916123@zju.edu.cn; jsbao@zju.edu.cn
RI Rasheed, Haroon/E-9299-2018; Ahmad, Daraz/IQV-9166-2023; Bao,
   Jinsong/A-7413-2008
OI Rasheed, Haroon/0009-0004-1887-0060; Ahmad, Daraz/0000-0002-3168-5298;
   Bao, Jinsong/0000-0002-9606-6615
FU Starry Night Science Fund of Zhejiang University Shanghai Institute for
   Advanced Study [SN-ZJU-SIAS-0012]
FX This research is supported by the Starry Night Science Fund of Zhejiang
   University Shanghai Institute for Advanced Study, grant No.
   SN-ZJU-SIAS-0012.
CR Afsar U.AHMED, 2011, [Frontiers in Biology, 生物学前沿], V6, P274
   Akyol H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060835
   Al-Weshahy A, 2009, FOOD RES INT, V42, P1062, DOI 10.1016/j.foodres.2009.05.011
   Albishi T, 2013, J FUNCT FOODS, V5, P930, DOI 10.1016/j.jff.2013.02.005
   Aleti G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02314-x
   Andersen SSH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111726
   Andre CM, 2007, J AGR FOOD CHEM, V55, P10839, DOI 10.1021/jf0726583
   Aregbe AY, 2019, FOOD CHEM, V290, P125, DOI 10.1016/j.foodchem.2019.03.100
   Valiñas MA, 2017, FOOD CHEM, V229, P837, DOI 10.1016/j.foodchem.2017.02.150
   Arun KB, 2015, FOOD BIOSCI, V9, P36, DOI 10.1016/j.fbio.2014.10.003
   Åsli LA, 2018, BRIT J NUTR, V119, P1408, DOI 10.1017/S0007114518000788
   Aversano R, 2017, PHYTOCHEMISTRY, V137, P42, DOI 10.1016/j.phytochem.2017.02.011
   Basilicata MG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236087
   Bibi S, 2019, AM J POTATO RES, V96, P170, DOI 10.1007/s12230-018-09706-3
   Blessington T, 2010, AM J POTATO RES, V87, P479, DOI 10.1007/s12230-010-9150-7
   Borch D, 2016, AM J CLIN NUTR, V104, P489, DOI 10.3945/ajcn.116.132332
   Briguglio Giusi., 2020, International Journal of Functional Nutrition, V1, P1, DOI [DOI 10.3892/IJFN.2020.9, 10.3892/IJFN.2020.9]
   Brown CR, 2008, AM J POTATO RES, V85, P298, DOI 10.1007/s12230-008-9028-0
   Brown CR, 2008, POTATO RES, V51, P259, DOI 10.1007/s11540-008-9115-0
   Brown CR, 2005, J AM SOC HORTIC SCI, V130, P174, DOI 10.21273/JASHS.130.2.174
   Brown CR, 2003, AM J POTATO RES, V80, P241, DOI 10.1007/BF02855360
   Burgos G., 2014, CONCENTRACION BIOACC
   Burgos G, 2020, POTATO CROP: ITS AGRICULTURAL, NUTRITIONAL AND SOCIAL CONTRIBUTION TO HUMANKIND, P37, DOI 10.1007/978-3-030-28683-5_2
   Burgos G, 2013, J FOOD COMPOS ANAL, V30, P6, DOI 10.1016/j.jfca.2012.12.001
   Burmeister A, 2011, J FOOD COMPOS ANAL, V24, P865, DOI 10.1016/j.jfca.2011.03.006
   Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996
   Campos H, 2020, POTATO CROP: ITS AGRICULTURAL, NUTRITIONAL AND SOCIAL CONTRIBUTION TO HUMANKIND, pVII
   Silveira AC, 2017, POSTHARVEST BIOL TEC, V128, P1, DOI 10.1016/j.postharvbio.2017.01.011
   Cepeda AM, 2015, NUTRIENTS, V7, P5098, DOI 10.3390/nu7075098
   Charepalli V, 2015, J NUTR BIOCHEM, V26, P1641, DOI 10.1016/j.jnutbio.2015.08.005
   Chen K, 2020, J AGR FOOD CHEM, V68, P9436, DOI 10.1021/acs.jafc.0c04125
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi E, 2005, FOOD AGR IMMUNOL, V16, P29, DOI 10.1080/09540100500064320
   Choi MK, 2013, FOOD SCI BIOTECHNOL, V22, P1415, DOI 10.1007/s10068-013-0231-5
   Chouhan S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02259
   Dalamu, 2015, INDIAN J HORTIC, V72, P447, DOI 10.5958/0974-0112.2015.00090.0
   Das A, 2018, PREHARVEST MODULATION OF POSTHARVEST FRUIT AND VEGETABLE QUALITY, P381, DOI 10.1016/B978-0-12-809807-3.00014-7
   De Masi L, 2020, MOLECULES, V25, DOI 10.3390/molecules25010233
   Deusser H, 2012, FOOD CHEM, V135, P2814, DOI 10.1016/j.foodchem.2012.07.028
   Hunjek DD, 2021, J FOOD SCI, V86, P1656, DOI 10.1111/1750-3841.15712
   Dutt S., 2020, POTATO, DOI [DOI 10.1007/978-981-15-7662-1_4, 10.1007/978-981-15-7662-1_4]
   Ek KL, 2014, BRIT J NUTR, V111, P699, DOI 10.1017/S0007114513003048
   Ercoli S, 2021, LWT-FOOD SCI TECHNOL, V136, DOI 10.1016/j.lwt.2020.110370
   Ezekiel R, 2013, FOOD RES INT, V50, P487, DOI 10.1016/j.foodres.2011.04.025
   Faller ALK, 2009, FOOD RES INT, V42, P210, DOI 10.1016/j.foodres.2008.10.009
   Farhadnejad H, 2018, CAN J DIABETES, V42, P613, DOI 10.1016/j.jcjd.2018.02.010
   Finotti E, 2006, FOOD CHEM, V99, P698, DOI 10.1016/j.foodchem.2005.08.046
   Furrer A, 2017, FOOD CHEM, V218, P47, DOI 10.1016/j.foodchem.2016.08.126
   Galani JHY, 2017, HORTIC PLANT J, V3, P73, DOI 10.1016/j.hpj.2017.07.004
   Giusti MM, 2014, J AGR FOOD CHEM, V62, P4408, DOI 10.1021/jf500655n
   Gu T, 2021, TOXINS, V13, DOI 10.3390/toxins13030210
   Hamouz K, 2007, HORTIC SCI, V34, P132, DOI 10.17221/1894-HORTSCI
   Han KH, 2007, BRIT J NUTR, V98, P914, DOI 10.1017/S0007114507761792
   Hayashi K, 2006, FOOD SCI TECHNOL RES, V12, P22, DOI 10.3136/fstr.12.22
   Jayanty SS, 2019, AM J POTATO RES, V96, P183, DOI 10.1007/s12230-018-09704-5
   Jokioja J, 2020, FOOD CHEM, V310, DOI 10.1016/j.foodchem.2019.125797
   Kalita D., 2014, Journal of Food Processing and Technology, V5, P358
   Kalita D, 2017, CURR RES NUTR FOOD S, V5, P75, DOI 10.12944/CRNFSJ.5.2.04
   Kaspar KL, 2011, J NUTR, V141, P108, DOI 10.3945/jn.110.128074
   Kent K, 2017, J HUM NUTR DIET, V30, P260, DOI 10.1111/jhn.12431
   Kita A, 2015, LWT-FOOD SCI TECHNOL, V62, P525, DOI 10.1016/j.lwt.2014.03.026
   Kita A, 2013, J FOOD COMPOS ANAL, V32, P169, DOI 10.1016/j.jfca.2013.09.006
   Ku SK, 2016, EXP THER MED, V12, P354, DOI 10.3892/etm.2016.3256
   Kubow S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090953
   Kubow S, 2014, MOL NUTR FOOD RES, V58, P2235, DOI 10.1002/mnfr.201400013
   Kulasari S., 2019, J. Pharmacogn. Phytochem., V8, P3344
   Külen O, 2013, J SCI FOOD AGR, V93, P2437, DOI 10.1002/jsfa.6053
   Lachman J, 2013, FOOD CHEM, V138, P1189, DOI 10.1016/j.foodchem.2012.11.114
   Lachman J, 2012, FOOD CHEM, V133, P1107, DOI 10.1016/j.foodchem.2011.07.077
   Lal MK, 2021, FOOD CHEM, V359, DOI 10.1016/j.foodchem.2021.129939
   Lemos MA, 2015, FOOD CHEM, V173, P462, DOI 10.1016/j.foodchem.2014.10.064
   Leo L, 2008, J AGR FOOD CHEM, V56, P4154, DOI 10.1021/jf073322w
   Lingling C., 2018, Grain Oil Sci Technol, V1, P145, DOI [10.3724/SP.J.1447.GOST.2018.18037, DOI 10.3724/SP.J.1447.GOST.2018.18037]
   Lippert E, 2017, DIGESTION, V95, P275, DOI 10.1159/000475524
   Madiwale GP, 2011, J AGR FOOD CHEM, V59, P8155, DOI 10.1021/jf201073g
   Mäder J, 2009, J AGR FOOD CHEM, V57, P6292, DOI 10.1021/jf901066k
   Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007
   Moser S, 2018, NUTR RES, V52, P57, DOI 10.1016/j.nutres.2018.02.001
   Müller L, 2016, CRIT REV FOOD SCI, V56, P1868, DOI 10.1080/10408398.2013.801827
   Mulinacci N, 2008, J AGR FOOD CHEM, V56, P11830, DOI 10.1021/jf801521e
   Navarre DA, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, P395
   Navarre DA, 2010, AM J POTATO RES, V87, P350, DOI 10.1007/s12230-010-9141-8
   Ndungutse V., 2019, Annals Food Science and Technology, V20, P393
   Nzaramba MN, 2009, J AGR FOOD CHEM, V57, P8308, DOI 10.1021/jf901567k
   Oertel A, 2017, PLANTA, V246, P281, DOI 10.1007/s00425-017-2718-4
   Ombra MN, 2015, NAT PROD RES, V29, P1087, DOI 10.1080/14786419.2014.981183
   Patras A, 2010, TRENDS FOOD SCI TECH, V21, P3, DOI 10.1016/j.tifs.2009.07.004
   Perla V, 2012, LWT-FOOD SCI TECHNOL, V45, P161, DOI 10.1016/j.lwt.2011.08.005
   Piñeros-Niño C, 2017, FOOD SCI NUTR, V5, P380, DOI 10.1002/fsn3.403
   Raigond P, 2020, Potato: Nutrition and Food Security, P213, DOI [10.1007/978-981-15-7662-1, DOI 10.1007/978-981-15-7662-1]
   Raigond P, 2018, J FOOD COMPOS ANAL, V74, P82, DOI 10.1016/j.jfca.2018.09.001
   Ramadan MF, 2016, J OLEO SCI, V65, P459, DOI 10.5650/jos.ess16015
   Ramdath DD, 2014, FOOD FUNCT, V5, P909, DOI 10.1039/c3fo60395d
   Reddivari L, 2007, CARCINOGENESIS, V28, P2227, DOI 10.1093/carcin/bgm117
   Reddivari L, 2007, AM J POTATO RES, V84, P275, DOI 10.1007/BF02986239
   Reddivari L, 2019, AM J POTATO RES, V96, P164, DOI 10.1007/s12230-018-09699-z
   Reddivari L, 2010, NUTR CANCER, V62, P601, DOI 10.1080/01635580903532358
   Amado IR, 2014, FOOD CHEM, V165, P290, DOI 10.1016/j.foodchem.2014.05.103
   Ru WD, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100419
   Rytel E, 2014, FOOD CHEM, V161, P224, DOI 10.1016/j.foodchem.2014.04.002
   Samaniego I, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9070815
   Sepelev I., 2015, RES RURAL DEV, P131
   Shakya R, 2006, J AGR FOOD CHEM, V54, P5253, DOI 10.1021/jf0605300
   Stankov S. V., 2012, Open Inflamm. J, V5, P1, DOI [10.2174/1875041901205010001, DOI 10.2174/1875041901205010001]
   Sulc M, 2017, FOOD CHEM, V237, P981, DOI 10.1016/j.foodchem.2017.05.155
   Sun HW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/805926
   Sun XF, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700536
   Swer TL, 2019, LWT-FOOD SCI TECHNOL, V114, DOI 10.1016/j.lwt.2019.108360
   Tian JH, 2016, FOOD CHEM, V202, P165, DOI 10.1016/j.foodchem.2016.01.120
   Tian JH, 2016, FOOD CHEM, V197, P1264, DOI 10.1016/j.foodchem.2015.11.049
   Tierno R, 2015, J FOOD COMPOS ANAL, V41, P58, DOI 10.1016/j.jfca.2015.01.013
   Tsang C., 2017, P 2 INT C OB BARC SP
   Tudela JA, 2002, J AGR FOOD CHEM, V50, P5925, DOI 10.1021/jf020330y
   Vanamala JKP, 2019, AM J POTATO RES, V96, P177, DOI 10.1007/s12230-018-09700-9
   Visvanathan R, 2016, J SCI FOOD AGR, V96, P4850, DOI 10.1002/jsfa.7848
   Wahyudi Ivan Arie, 2020, Indonesian Journal of Cancer Chemoprevention, V11, P30, DOI 10.14499/indonesianjcanchemoprev11iss1pp30-35
   Wang QY, 2011, NUTR CANCER, V63, P1044, DOI 10.1080/01635581.2011.597538
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Yang YL, 2016, J SCI FOOD AGR, V96, P413, DOI 10.1002/jsfa.7104
   Yoon SS, 2008, J ETHNOPHARMACOL, V118, P396, DOI 10.1016/j.jep.2008.05.014
   Zeng H, 2016, LWT-FOOD SCI TECHNOL, V73, P425, DOI 10.1016/j.lwt.2016.06.052
   Zhang H, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600928
   Zhang H, 2016, J FUNCT FOODS, V22, P363, DOI 10.1016/j.jff.2016.01.004
   Zhang YM, 2018, IRAN J PUBLIC HEALTH, V47, P1627
NR 124
TC 31
Z9 32
U1 7
U2 44
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD APR
PY 2022
VL 11
IS 4
AR 603
DI 10.3390/antiox11040603
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 0U2MP
UT WOS:000787489300001
PM 35453288
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Finicelli, M
   Squillaro, T
   Di Cristo, F
   Di Salle, A
   Melone, MAB
   Galderisi, U
   Peluso, G
AF Finicelli, Mauro
   Squillaro, Tiziana
   Di Cristo, Francesca
   Di Salle, Anna
   Melone, Mariarosa Anna Beatrice
   Galderisi, Umberto
   Peluso, Gianfranco
TI Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and
   perspectives
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Review
DE Mediterranean diet; metabolic syndrome; olive oil; polyphenols;
   resveratrol
ID VIRGIN OLIVE OIL; OXIDATIVE STRESS; INSULIN-RESISTANCE; ADIPOSE-TISSUE;
   CHLOROGENIC ACID; FATTY-ACIDS; ENDOTHELIAL DYSFUNCTION;
   MITOCHONDRIAL-FUNCTION; MYOCARDIAL-INFARCTION; POSSIBLE INVOLVEMENT
AB Metabolic syndrome (MetS) is defined as the co-occurrence of metabolic risk factors that includes insulin resistance, hyperinsulinemia, impaired glucose tolerance, type 2 diabetes mellitus, dyslipidemia, and visceral obesity. The clinical significance of MetS consists of identifying a subgroup of patients sharing a common physiopathological state predisposing to chronic diseases. Clinical and scientific studies pinpoint lifestyle modification as an effective strategy aiming to reduce several features accountable for the risk of MetS onset. Among the healthy dietary patterns, the Mediterranean diet (MedDiet) emerges in terms of beneficial properties associated with longevity. Current evidence highlights the protective effect exerted by MedDiet on the different components of MetS. Interestingly, the effect exerted by polyphenols contained within the representative MedDiet components (i.e., olive oil, red wine, and nuts) seems to be accountable for the beneficial properties associated to this dietary pattern. In this review, we aim to summarize the principal evidence regarding the effectiveness of MedDiet-polyphenols in preventing or delaying the physiopathological components accountable for MetS onset. These findings may provide useful insights concerning the health properties of MedDiet-polyphenols as well as the novel targets destined to a tailored approach to MetS.
C1 [Finicelli, Mauro; Di Salle, Anna; Peluso, Gianfranco] CNR, Inst Agrienvironm Biol & Forestry IBAF, Via P Castellino 111, I-80131 Naples, Italy.
   [Squillaro, Tiziana; Melone, Mariarosa Anna Beatrice] Univ Campania Luigi Vanvitelli, Dept Med Surg Neurol Metab Sci & Aging, Div Neurol 2, Ctr Rare Dis, Naples, Italy.
   [Squillaro, Tiziana; Melone, Mariarosa Anna Beatrice] Univ Campania Luigi Vanvitelli, InterUniv Ctr Res Neurosci, Naples, Italy.
   [Di Cristo, Francesca] Elleva Pharma Srl, Via S Fancesco dAssisi, Naples, Italy.
   [Galderisi, Umberto] Univ Campania Luigi Vanvitelli, Dept Expt Med, Biotechnol & Mol Biol Sect, Naples, Italy.
   [Melone, Mariarosa Anna Beatrice; Galderisi, Umberto] Temple Univ, Dept Biol, Coll Sci & Technol, Sbarro Inst Canc Res & Mol Med,Ctr Biotechnol, Philadelphia, PA 19122 USA.
C3 Consiglio Nazionale delle Ricerche (CNR); Universita della Campania
   Vanvitelli; Universita della Campania Vanvitelli; Universita della
   Campania Vanvitelli; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); Temple University
RP Peluso, G (corresponding author), CNR, Inst Agrienvironm Biol & Forestry IBAF, Via P Castellino 111, I-80131 Naples, Italy.
EM gianfranco.peluso@ibaf.cnr.it
RI Di Cristo, Francesca/AEN-6072-2022; Di Salle, A/AAF-5416-2019;
   Finicelli, Mauro/ABC-1392-2020; Melone, Mariarosa AB/N-6788-2015
OI Finicelli, Mauro/0000-0003-2289-0916; Di Cristo,
   Francesca/0000-0002-4544-6837; Di Salle, Anna/0000-0001-6763-3636;
   Melone, Mariarosa AB/0000-0002-7213-9277
FU PO FESR 2014-2020 - Regione Campania, Asse 1 - obiettivo specifico 1.2,
   Progetto "Sviluppo di nanotecnologie Orientate alla Rigenerazione e
   Ricostruzione tissutale, Implantologia e Sensoristica in Odontoiatria"
   oculistica (SORRISO)" [pdt1-000410]; Project " Studio di fattibilita per
   la progettazione di sistemi di rilascio nanoparticellari a base di
   idrossidi doppi lamellari (layered double hyroxide-LDH) in grado di
   veicolare, in modo controllato e prolungato nel tempo, molecole
   biologicamente attive [N. 0000836/2018]; PON IAMP;C 2014-2020 FESR
   progetto "Micro/nanoformulati innovativi per la valorizzazione di
   molecole bioattive, utili per la salute e il benessere delle
   popolazione, ottenute da prodotti di scarto della filiera ittica
   (FORTUNA)" [F/050347/03IX32]
FX PO FESR 2014-2020 - Regione Campania, Asse 1 - obiettivo specifico 1.2,
   Progetto "Sviluppo di nanotecnologie Orientate alla Rigenerazione e
   Ricostruzione tissutale, Implantologia e Sensoristica in Odontoiatria"
   oculistica (SORRISO)", Grant/Award Number: pdt1-000410; Project " Studio
   di fattibilita per la progettazione di sistemi di rilascio
   nanoparticellari a base di idrossidi doppi lamellari (layered double
   hyroxide-LDH) in grado di veicolare, in modo controllato e prolungato
   nel tempo, molecole biologicamente attive tipo Ca e/o F", Grant/Award
   Number: Prot. N. 0000836/2018; PON I&C 2014-2020 FESR progetto
   "Micro/nanoformulati innovativi per la valorizzazione di molecole
   bioattive, utili per la salute e il benessere delle popolazione,
   ottenute da prodotti di scarto della filiera ittica (FORTUNA)",
   Grant/Award Number: F/050347/03IX32
CR Abe R, 2011, EUR J VASC ENDOVASC, V41, P814, DOI 10.1016/j.ejvs.2010.12.021
   Abe-Higuchi N, 2016, BIOL PSYCHIAT, V80, P815, DOI 10.1016/j.biopsych.2016.01.009
   Abete I, 2011, NUTR METAB CARDIOVAS, V21, pB1, DOI 10.1016/j.numecd.2011.05.001
   Alberti KGMM, 1998, DIABETIC MED, V15, P535, DOI 10.1002/(SICI)1096-9136(199807)15:7<535::AID-DIA670>3.3.CO;2-H
   Albiero M, 2015, METAB SYNDR RELAT D, V13, P161, DOI 10.1089/met.2015.0005
   Albracht-Schulte K, 2018, J NUTR BIOCHEM, V58, P1, DOI 10.1016/j.jnutbio.2018.02.012
   Alcalá M, 2015, OBESITY, V23, P1598, DOI 10.1002/oby.21135
   Alirezaei M., 2014, Comparative Clinical Pathology, V23, P1359, DOI 10.1007/s00580-013-1791-8
   Allard JS, 2009, MOL CELL ENDOCRINOL, V299, P58, DOI 10.1016/j.mce.2008.10.018
   Amiot MJ, 2016, OBES REV, V17, P573, DOI 10.1111/obr.12409
   Ando K, 2009, FREE RADICAL BIO MED, V47, P213, DOI 10.1016/j.freeradbiomed.2009.04.030
   [Anonymous], 2015, The Mediterranean Diet: An Evidence-Based Approach, DOI DOI 10.1016/B978-0-12-407849-9.00029-4
   Babio N, 2014, CAN MED ASSOC J, V186, pE649, DOI 10.1503/cmaj.140764
   Babio N, 2009, PUBLIC HEALTH NUTR, V12, P1607, DOI 10.1017/S1368980009990449
   Balkau B, 1999, DIABETIC MED, V16, P442
   Barone D, 2018, J CELL PHYSIOL, V233, P1266, DOI 10.1002/jcp.25995
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bayram B, 2012, REJUV RES, V15, P71, DOI 10.1089/rej.2011.1245
   Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343
   Blüher M, 2013, BEST PRACT RES CL EN, V27, P163, DOI 10.1016/j.beem.2013.02.005
   Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x
   Camargo A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-253
   Cao K, 2014, FREE RADICAL BIO MED, V67, P396, DOI 10.1016/j.freeradbiomed.2013.11.029
   Carluccio M.A., 2015, MEDITERRANEAN DIET, P291, DOI [10.1016/B978-0-12-407849-9.00027-0, DOI 10.1016/B978-0-12-407849-9.00027-0]
   Carluccio MA, 2003, ARTERIOSCL THROM VAS, V23, P622, DOI 10.1161/01.ATV.0000062884.69432.A0
   Chiva-Blanch G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5812401
   Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003
   Covas MI, 2006, ANN INTERN MED, V145, P333, DOI 10.7326/0003-4819-145-5-200609050-00006
   Dalle Grave R, 2010, DIABET METAB SYND OB, V3, P373, DOI 10.2147/DMSOTT.S13860
   Davinelli S, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0070-3
   DeFuria J, 2009, J NUTR, V139, P1510, DOI 10.3945/jn.109.105155
   Devaraj S, 2008, FREE RADICAL BIO MED, V44, P1203, DOI 10.1016/j.freeradbiomed.2007.12.018
   Di Daniele N, 2017, ONCOTARGET, V8, P8947, DOI 10.18632/oncotarget.13553
   Di Renzo L, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/681318
   Dragan S, 2015, CURR MED CHEM, V22, P14
   Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440
   Esposito T, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070783
   Fenni S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601083
   Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008
   Ge JF, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00044
   Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636
   Godos J, 2018, MOLECULES, V23, DOI 10.3390/molecules23050999
   Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018
   Gregório BM, 2016, CURR PHARM DESIGN, V22, P859, DOI 10.2174/1381612822666151209152352
   Gronbæk M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008
   Grosso G, 2014, CURR PHARM DESIGN, V20, P5039, DOI 10.2174/1381612819666131206112144
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Guasch-Ferré M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6723931
   Hadley CW, 2003, J NUTR, V133, P727, DOI 10.1093/jn/133.3.727
   Hao JJ, 2010, J NUTR BIOCHEM, V21, P634, DOI 10.1016/j.jnutbio.2009.03.012
   Harper Charles R, 2003, Prev Cardiol, V6, P136, DOI 10.1111/j.1520-037X.2003.1332.x
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104
   Hirabara SM, 2007, J CELL PHYSIOL, V210, P7, DOI 10.1002/jcp.20811
   Hitomi H, 2007, CURR OPIN CARDIOL, V22, P311, DOI 10.1097/HCO.0b013e3281532b53
   Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180
   León-Pedroza JI, 2015, CIR CIR, V83, P543, DOI 10.1016/j.circir.2015.05.041
   Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001
   Juhan-Vague I, 2003, J THROMB HAEMOST, V1, P2322, DOI 10.1046/j.1538-7836.2003.00458.x
   Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213
   Kim SR, 2014, ARCH PHARM RES, V37, P539, DOI 10.1007/s12272-013-0211-6
   Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921
   Konstantinidou V, 2010, FASEB J, V24, P2546, DOI 10.1096/fj.09-148452
   Koponen H, 2008, J CLIN PSYCHIAT, V69, P178, DOI 10.4088/JCP.v69n0202
   Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z
   Kuwabara A, 2014, J NUTR SCI VITAMINOL, V60, P239, DOI 10.3177/jnsv.60.239
   Kwon EY, 2015, DIABETES, V64, P1658, DOI 10.2337/db14-0631
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108
   Lim S, 2014, REV ENDOCR METAB DIS, V15, P329, DOI 10.1007/s11154-014-9298-4
   Liu Ling, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P89, DOI 10.2174/187153008784534385
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   López-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007
   Mabalirajan Ulaganathan, 2013, J Allergy (Cairo), V2013, P340476, DOI 10.1155/2013/340476
   Maes Michael, 2012, Inflammopharmacology, V20, P127, DOI 10.1007/s10787-011-0111-7
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Manjunath C N, 2013, Indian J Endocrinol Metab, V17, P969, DOI 10.4103/2230-8210.122600
   Martínez-González MA, 2013, REV ENDOCR METAB DIS, V14, P265, DOI 10.1007/s11154-013-9264-6
   Medina-Remón A, 2017, BRIT J CLIN PHARMACO, V83, P114, DOI 10.1111/bcp.12986
   Medina-Remón A, 2013, MINI-REV MED CHEM, V13, P1137, DOI 10.2174/1389557511313080002
   Méndez-del Villar M, 2014, METAB SYNDR RELAT D, V12, P497, DOI 10.1089/met.2014.0082
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645
   Montserrat-de la Paz S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600824
   Mora-Cubillos X, 2015, MOL NUTR FOOD RES, V59, P2480, DOI 10.1002/mnfr.201500549
   Mucerino S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41824
   Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1
   Ndiaye M, 2004, BRIT J PHARMACOL, V142, P1131, DOI 10.1038/sj.bjp.0705774
   Ng F, 2013, J CELL PHYSIOL, V228, P2262, DOI 10.1002/jcp.24399
   Nolan Paul B, 2017, Prev Med Rep, V7, P211, DOI 10.1016/j.pmedr.2017.07.004
   Oak MH, 2003, ARTERIOSCL THROM VAS, V23, P1001, DOI 10.1161/01.ATV.0000070101.70534.38
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Opie LH, 2007, EUR HEART J, V28, P1683, DOI 10.1093/eurheartj/ehm149
   Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055
   Panagiotakos DB, 2004, AM HEART J, V147, P106, DOI 10.1016/S0002-8703(03)00442-3
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Papoutsi Z, 2008, BRIT J NUTR, V99, P715, DOI 10.1017/S0007114507837421
   Pérez-Martínez P, 2017, NUTR REV, V75, P307, DOI 10.1093/nutrit/nux014
   Peyrol J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030306
   Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730
   Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059
   Reboredo-Rodríguez P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030668
   Riccitiello F, 2018, EUR POLYM J, V99, P289, DOI 10.1016/j.eurpolymj.2017.12.035
   Rietjens SJ, 2007, AM J PHYSIOL-HEART C, V292, pH1931, DOI 10.1152/ajpheart.00755.2006
   Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379
   Ros E, 2010, NUTRIENTS, V2, P652, DOI 10.3390/nu2070652
   Rumawas ME, 2009, AM J CLIN NUTR, V90, P1608, DOI 10.3945/ajcn.2009.27908
   Saibandith B, 2017, MOLECULES, V22, DOI 10.3390/molecules22071082
   Saija A, 1998, Int J Cosmet Sci, V20, P331, DOI 10.1046/j.1467-2494.1998.177057.x
   Salas-Salvadó J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449
   Sánchez-González C, 2017, CRIT REV FOOD SCI, V57, P3373, DOI 10.1080/10408398.2015.1126218
   Scapagnini G, 2012, CNS DRUGS, V26, P477, DOI 10.2165/11633190-000000000-00000
   Scoditti E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128218
   Servili M, 2004, J CHROMATOGR A, V1054, P113, DOI [10.1016/j.chroma.2004.08.070, 10.1016/S0021-9673(04)01423-2]
   Shamim U, 2012, J CELL PHYSIOL, V227, P1493, DOI 10.1002/jcp.22865
   Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211
   Soleas GJ, 2001, METHOD ENZYMOL, V335, P130
   Spencer M, 2013, DIABETES, V62, P1709, DOI 10.2337/db12-1042
   Squillaro T, 2018, J CELL PHYSIOL, V233, P3955, DOI 10.1002/jcp.26170
   Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014
   Suzuki A, 2007, AM J HYPERTENS, V20, P508, DOI 10.1016/j.amjhyper.2006.11.008
   Takeda Y, 2014, BIOCHEM BIOPH RES CO, V446, P1225, DOI 10.1016/j.bbrc.2014.03.094
   Tangvarasittichai S, 2016, INDIAN J CLIN BIOCHE, V31, P446, DOI 10.1007/s12291-016-0553-1
   Torrens-Mas M, 2018, J CELL PHYSIOL, V233, P6067, DOI 10.1002/jcp.26443
   Tortosa A, 2007, DIABETES CARE, V30, P2957, DOI 10.2337/dc07-1231
   Ukropcova B, 2007, DIABETES, V56, P720, DOI 10.2337/db06-0521
   Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010
   Valentino A, 2017, ONCOGENE, V36, P6030, DOI 10.1038/onc.2017.216
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   van Zwieten P A, 2006, Neth Heart J, V14, P301
   Vanecková I, 2014, J ENDOCRINOL, V223, pR63, DOI 10.1530/JOE-14-0368
   Villarroya J, 2013, AM J PHYSIOL-ENDOC M, V305, pE567, DOI 10.1152/ajpendo.00250.2013
   Vinson JA, 2012, FOOD FUNCT, V3, P134, DOI 10.1039/c2fo10152a
   Wallerath T, 2003, J AM COLL CARDIOL, V41, P471, DOI 10.1016/S0735-1097(02)02826-7
   Wang B, 2014, J FOOD SCI, V79, pH1823, DOI 10.1111/1750-3841.12555
   Weiss R, 2013, ANN NY ACAD SCI, V1281, P123, DOI 10.1111/nyas.12030
   Winand J, 2014, FOOD FUNCT, V5, P310, DOI 10.1039/c3fo60443h
   Wong SK, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00444
   Yu YM, 2005, J NUTR BIOCHEM, V16, P675, DOI 10.1016/j.jnutbio.2005.03.013
   Zaghini I, 2002, J BIOL CHEM, V277, P1324, DOI 10.1074/jbc.M106375200
   Zhang XM, 2009, N-S ARCH PHARMACOL, V379, P581, DOI 10.1007/s00210-009-0399-7
   Zheng A, 2015, J NUTR BIOCHEM, V26, P190, DOI 10.1016/j.jnutbio.2014.10.006
   Zhu XY, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0217-z
   Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295
NR 149
TC 135
Z9 141
U1 3
U2 128
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD MAY
PY 2019
VL 234
IS 5
BP 5807
EP 5826
DI 10.1002/jcp.27506
PG 20
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA HK7AQ
UT WOS:000458138600041
PM 30317573
DA 2025-04-28
ER

PT J
AU Hirata, T
   Kobayashi, T
   Wada, A
   Ueda, T
   Fujikawa, T
   Miyashita, H
   Ikeda, T
   Tsukamoto, S
   Nohara, T
AF Hirata, T.
   Kobayashi, T.
   Wada, A.
   Ueda, T.
   Fujikawa, T.
   Miyashita, H.
   Ikeda, T.
   Tsukamoto, S.
   Nohara, T.
TI Anti-obesity compounds in green leaves of Eucommia ulmoides
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Eucommia ulmoides Oliv.; Anti-obesity; Iridoid; Asperuloside; Chronic
   high-dose administration
ID INSULIN-RESISTANCE; LEAF EXTRACT; ADIPONECTIN; ACID; RATS
AB The anti-hypertensive effect of Eucommia leaves has been confirmed clinically,(1a,b) and the study of their anti-obesity properties has advanced. 2 However, the compounds involved in their anti-obesity effect have not been fully elucidated. In this Letter, we examined the anti-obesity effect of Eucommia green leaf extract (EGLE) divided into five fractions with high porous polystyrene gel and of the compounds isolated, geniposidic acid, asperuloside and chlorogenic acid, respectively. A metabolic syndrome-like clinical model in mice was generated by feeding a 40% high-fat diet to examine the anti-obesity effects of chronic administration of test substance. After 4 weeks, body weight, white adipose tissue weight, plasma triglyceride levels and total cholesterol levels in the model mice were significantly inhibited by the 30% MeOH fraction (containing much higher levels of asperuloside than the other fractions), and these effects were similar to those of EGLE. Chronic administration of isolated asperuloside in Eucommia leaves suppressed increases in model mouse body weight, white adipose tissue weight, plasma triglyceride levels and free fatty acids levels. These results suggest that asperuloside in Eucommia leaves has important anti-obesity effects. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Hirata, T.; Kobayashi, T.; Wada, A.; Ueda, T.] Kobayashi Pharmaceut Co Ltd, R&D Ctr, Osaka 5670057, Japan.
   [Fujikawa, T.] Suzuka Univ Med Sci, Dept Pharm, Lab Mol Prophylaxis & Pharmacol, Susuka, Mie 5138670, Japan.
   [Fujikawa, T.] Mie Univ, Grad Sch Med, Dept Biochem & Prote, Tsu, Mie 5148507, Japan.
   [Miyashita, H.; Nohara, T.] Sojo Univ, Fac Med & Pharmaceut Sci, Kumamoto 8620082, Japan.
   [Ikeda, T.; Tsukamoto, S.] Kumamoto Univ, Fac Med & Pharmaceut Sci, Kumamoto 8620973, Japan.
C3 Kobayashi Pharmaceutical Co Ltd; Mie University; Sojo University;
   Kumamoto University
RP Hirata, T (corresponding author), Kobayashi Pharmaceut Co Ltd, R&D Ctr, 1-30-3 Toyokawa, Osaka 5670057, Japan.
EM t.hirata@kobayashi.co.jp; tikeda@gpo.kumamoto-u.ac.jp
RI tsukamoto, sachiko/HGE-7770-2022
OI Hirata, Tetsuya/0000-0003-4560-0387; Ikeda,
   Tsuyoshi/0000-0002-1504-1636; Tsukamoto, Sachiko/0000-0002-7993-381X
FU Grants-in-Aid for Scientific Research [22406001, 23590010, 22310138]
   Funding Source: KAKEN
CR [Anonymous], 2007, INT S EUCOMMIA ULMOI, DOI DOI 10.3387/ISEU.1.63
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi MS, 2008, AM J CHINESE MED, V36, P81, DOI 10.1142/S0192415X08005606
   Fujikawa T, 2010, BRIT J NUTR, V104, P1868, DOI 10.1017/S0007114510002965
   Jiangsu New Medical College, 1977, CHIN MAT MED DICT, P1031
   Jin X, 2010, J ETHNOPHARMACOL, V128, P672, DOI 10.1016/j.jep.2010.02.019
   KAWASAKI K, 2000, J HEALTH SCI, V22, P29
   Li H, 2005, ULTRASON SONOCHEM, V12, P295, DOI 10.1016/j.ultsonch.2004.01.033
   Matsuzawa Y, 2005, ATHEROSCLEROSIS SUPP, V6, P7, DOI 10.1016/j.atherosclerosissup.2005.02.003
   METORI K, 1994, BIOL PHARM BULL, V17, P917
   Nakamura Takanori, 1997, Natural Medicines, V51, P275
   Nakazawa Yoshihisa, 1997, Natural Medicines, V51, P392
   Namba T., 1986, J TRAD MED, V3, P89
   NOMURA Y, 1986, J TRAD MED, V3, P328
   Takamura C, 2007, J NAT PROD, V70, P1312, DOI 10.1021/np0780046
   Takamura C, 2007, J NAT MED-TOKYO, V61, P220, DOI 10.1007/s11418-006-0027-5
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
NR 19
TC 86
Z9 109
U1 5
U2 57
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD MAR 15
PY 2011
VL 21
IS 6
BP 1786
EP 1791
DI 10.1016/j.bmcl.2011.01.060
PG 6
WC Chemistry, Medicinal; Chemistry, Organic
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Chemistry
GA 730DM
UT WOS:000288012800047
PM 21324693
DA 2025-04-28
ER

PT J
AU Marrelli, M
   Loizzo, MR
   Nicoletti, M
   Menichini, F
   Conforti, F
AF Marrelli, Mariangela
   Loizzo, Monica Rosa
   Nicoletti, Marcello
   Menichini, Francesco
   Conforti, Filomena
TI In vitro investigation of the potential health benefits of wild
   Mediterranean dietary plants as anti-obesity agents with α-amylase and
   pancreatic lipase inhibitory activities
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE wild edible plants; pancreatic lipase; alpha-amylase; inhibitors;
   chemical composition
ID OBESITY; GLUCOSIDASE; ANTIOXIDANT; PREVALENCE; FLAVONOIDS; SAPONIN
AB BACKGROUND: Inhibition of digestive enzymes is one of the most widely studied mechanisms used to determine the potential efficacy of natural products as anti-obesity agents. In vitro studies reported here were performed to evaluate the inhibitory activity of formulations of edible plants from Italy on amylase and lipase by monitoring the hydrolysis of nitrophenyl caprilate and the hydrolysis of glycoside bonds in digestible carbohydrate foods.
   RESULTS: The formulation obtained from Capparis sicula exhibited the strongest inhibitory effect on pancreatic lipase (IC50 = 0.53 mg mL(-1)) while the Borago officinalis formulation exhibited the strongest inhibitory effect on alpha-amylase (IC50 = 31.61 mu g mL(-1)). In order to characterise the extracts, high-performance thin-layer chromatography analysis of the formulations was performed, revealing the predominance of (+/-)-catechin in Mentha aquatica formulation, rutin in C. sicula, and caffeic acid and chlorogenic acid in Echium vulgare.
   CONCLUSION: The results obtained indicated that the extracts of C. sicula and B. officinalis could be good candidates for further studies to isolate pancreatic lipase and alpha-amylase inhibitors, respectively. (C) 2013 Society of Chemical Industry
C1 [Marrelli, Mariangela; Loizzo, Monica Rosa; Menichini, Francesco; Conforti, Filomena] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, CS, Italy.
   [Nicoletti, Marcello] Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy.
C3 University of Calabria; Sapienza University Rome
RP Conforti, F (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, CS, Italy.
EM filomena.conforti@unical.it
RI Conforti, filomena/P-8191-2015
OI Menichini, Francesco/0000-0002-4584-4405; Conforti,
   Filomena/0000-0001-6699-005X; Loizzo, Monica Rosa/0000-0002-6050-9357;
   Marrelli, Mariangela/0000-0002-3741-4261
CR Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Bustanji Y, 2011, J ENZYM INHIB MED CH, V26, P453, DOI 10.3109/14756366.2010.525509
   Carek PJ, 1999, DRUGS, V57, P883, DOI 10.2165/00003495-199957060-00005
   Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033
   Chiasson Jean-Louis, 2006, Endocr Pract, V12 Suppl 1, P25
   Conforti F, 2008, FOOD CHEM TOXICOL, V46, P3325, DOI 10.1016/j.fct.2008.08.004
   Conforti F, 2012, PHYTOTHER RES, V26, P600, DOI 10.1002/ptr.3603
   de Sales PM, 2012, J PHARM PHARM SCI, V15, P141
   Elkhayat ES, 2008, J ASIAN NAT PROD RES, V10, P1039, DOI 10.1080/10286020802320590
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861
   Funke I, 2005, PHARMAZIE, V60, P796
   Galhardo J, 2010, ARCH DIS CHILD, V95, P856, DOI 10.1136/adc.2010.190959
   Glensk M, 1999, J NAT PROD, V62, P717, DOI 10.1021/np980505r
   Grussu D, 2011, J AGR FOOD CHEM, V59, P2324, DOI 10.1021/jf1045359
   Karu N, 2007, J AGR FOOD CHEM, V55, P2824, DOI 10.1021/jf0628025
   Kim YS, 2010, J ETHNOPHARMACOL, V130, P621, DOI 10.1016/j.jep.2010.05.053
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   Lee YM, 2012, PHYTOTHER RES, V26, P778, DOI 10.1002/ptr.3644
   Li MF, 2009, BRIT J CLIN PHARMACO, V68, P804, DOI 10.1111/j.1365-2125.2009.03453.x
   Loizzo MR, 2008, J MED FOOD, V11, P184, DOI 10.1089/jmf.2007.638
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   Marrelli M, 2013, PLANT FOOD HUM NUTR, V68, P340, DOI 10.1007/s11130-013-0390-9
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238
   Morikawa T, 2010, YAKUGAKU ZASSHI, V130, P673, DOI 10.1248/yakushi.130.673
   Nagai T., 2012, Food and Nutrition Sciences, V3, P614, DOI 10.4236/fns.2012.35084
   Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s
   Nicoletti M, 2012, STUD NAT PROD CHEM, V37, P217, DOI 10.1016/B978-0-444-59514-0.00008-0
   Nicoletti M, 2011, REV BRAS FARMACOGN, V21, P818, DOI 10.1590/S0102-695X2011005000131
   Piccin A., 2012, NUTRAfoods, V11, P29
   Qian JY, 2004, FOOD CHEM, V87, P283, DOI 10.1016/j.foodchem.2003.11.008
   Sales PMD., 2012, Journal of Pharmacology and Pharmaceutical Sciences, V15, P141, DOI [DOI 10.18433/J35S3K, 10.18433/j35s3k]
   Schnee DM, 2006, CURR MED RES OPIN, V22, P1463, DOI 10.1185/030079906X115496
   Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023
   Sreerama YN, 2012, J FOOD SCI, V77, pC927, DOI 10.1111/j.1750-3841.2012.02848.x
   Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007
   Vetter ML, 2010, NAT REV ENDOCRINOL, V6, P578, DOI 10.1038/nrendo.2010.121
   Wang HY, 2013, ADV FOOD NUTR RES, V70, P103, DOI 10.1016/B978-0-12-416555-7.00003-5
   Youdim KA, 2002, J NUTR BIOCHEM, V13, P282, DOI 10.1016/S0955-2863(01)00221-2
   Yuda N, 2012, J FOOD SCI, V77, pH254, DOI 10.1111/j.1750-3841.2012.02967.x
   Zia-Ul-Haq M, 2011, INT J MOL SCI, V12, P8846, DOI 10.3390/ijms12128846
NR 42
TC 65
Z9 69
U1 1
U2 78
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD AUG
PY 2014
VL 94
IS 11
BP 2217
EP 2224
DI 10.1002/jsfa.6544
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA AL3BA
UT WOS:000338998700010
PM 24535986
DA 2025-04-28
ER

PT J
AU Piccinini, A
   Oliveira, MP
   Silva, MR
   Bett, GS
   Becker, IB
   Mendes, TF
   Salla, DH
   Silva, LE
   Vilela, TC
   Moraes, FM
   Moterle, D
   Damiani, AP
   Dagostin, LS
   Tietbohl, LT
   Bittencourt, JVS
   Biehl, E
   Denicol, TL
   Bonfante, SR
   Andrade, VM
   Silveira, PCL
   Prophiro, JS
   Ferreira, GK
   Petronilho, F
   Kanis, LA
   Rezin, GT
AF Piccinini, Alexandre
   Oliveira, Mariana Pacheco
   Silva, Mariella Reinol
   Bett, Gabriela Souza
   Becker, Isabel Borges
   Mendes, Talita Farias
   Salla, Daniele Hendler
   Silva, Larissa Espindola
   Vilela, Thais Cereser
   Moraes, Fernanda Mendes
   Moterle, Diego
   Damiani, Adriani Paganini
   Dagostin, Ligia Salvan
   Tietbohl, Lariani Tamires
   Silvano Bittencourt, Joao Vitor
   Biehl, Erica
   Denicol, Tais Luise
   Bonfante, Sandra Regina
   Andrade, Vanessa Moraes
   Lock Silveira, Paulo Cesar
   Prophiro, Josiane Somariva
   Ferreira, Gabriela Kozuchovski
   Petronilho, Fabricia
   Kanis, Luiz Alberto
   Rezin, Gislaine Tezza
TI Effects of Ethanolic Extract of Cynara cardunculus (Artichoke)
   Leaves on Neuroinflammatory and Neurochemical Parameters in a
   Diet-Induced Mice Obesity Model
SO NEUROCHEMICAL RESEARCH
LA English
DT Article
DE Obesity; Cynara cardunculus; Inflammation; Oxidative stress
ID OXIDATIVE STRESS; LEAF EXTRACT; SCOLYMUS L.; CHLOROGENIC ACID;
   PROTECTIVE PROPERTIES; PHENOLIC-COMPOUNDS; DNA-DAMAGE; INFLAMMATION;
   DYSFUNCTION; METABOLISM
AB This study aimed to evaluate the effect of Cynara cardunculus leaf ethanol extract on inflammatory and oxidative stress parameters in the hypothalamus, prefrontal cortex, hippocampus, striatum, cerebral cortex and liver of high-fat diet-induced obese mice. Food intake, body weight, visceral fat weight, and liver weight were also evaluated. Male Swiss mice were divided into control (low-fat purified diet) and obese (high-fat purified diet) groups. After 6 weeks, mice were divided into control + saline, control + C. cardunculus leaf ethanol extract, obese + saline, obese + C. cardunculus leaf ethanol extract. Cynara cardunculus leaf ethanol extract (1600 mg/kg/day) or saline was administered orally for 4 weeks. Brain structures (hypothalamus, hippocampus, prefrontal cortex, striatum and cerebral cortex) and liver were removed. Treatment with C. cardunculus leaf ethanol extract did not affect body weight but did reduce visceral fat. Obesity can cause inflammation and oxidative stress and increase the activity of antioxidant enzymes in brain structures. Treatment with ethanolic extract of C. cardunculus leaves partially reversed the changes in inflammatory damage parameters and oxidative damage parameters and attenuated changes in the antioxidant defense. The C. cardunculus leaf ethanol extract benefited from the brains of obese animals by partially reversing the changes caused by the consumption of a high-fat diet and the consequent obesity. These results corroborate those of studies indicating that the C. cardunculus leaf ethanol extract can contribute to the treatment of obesity.
C1 [Piccinini, Alexandre; Oliveira, Mariana Pacheco; Silva, Mariella Reinol; Bett, Gabriela Souza; Becker, Isabel Borges; Mendes, Talita Farias; Salla, Daniele Hendler; Silva, Larissa Espindola; Vilela, Thais Cereser; Biehl, Erica; Denicol, Tais Luise; Bonfante, Sandra Regina; Petronilho, Fabricia; Rezin, Gislaine Tezza] Univ Southern Santa Catarina, Lab Neurobiol Inflammatory & Metab Proc, Postgrad Program Hlth Sci, Tubarao, SC, Brazil.
   [Moraes, Fernanda Mendes; Moterle, Diego; Kanis, Luiz Alberto] Univ Southern Santa Catarina, Postgrad Program Environm Sci, Pharmaceut Technol Grp, Tubarao, SC, Brazil.
   [Damiani, Adriani Paganini; Dagostin, Ligia Salvan; Andrade, Vanessa Moraes] Univ Extremo Sul Catarinense, Lab Biomed Translat, Postgrad Program Hlth Sci, Criciuma, SC, Brazil.
   [Tietbohl, Lariani Tamires; Silvano Bittencourt, Joao Vitor; Lock Silveira, Paulo Cesar] Univ Extremo Sul Catarinense, Lab Expt Phisiopatol, Postgrad Program Hlth Sci, Criciuma, SC, Brazil.
   [Prophiro, Josiane Somariva] Univ Southern Santa Catarina, Postgrad Program Hlth Sci, Immunoparasitol Res Grp, Tubarao, SC, Brazil.
   [Prophiro, Josiane Somariva] Univ Southern Santa Catarina, Postgrad Program Environm Sci, Tubarao, SC, Brazil.
   [Ferreira, Gabriela Kozuchovski] Educ Soc Santa Catarina, Joinville, SC, Brazil.
C3 Universidade do Sul de Santa Catarina; Universidade do Sul de Santa
   Catarina; Universidade do Extremo Sul Catarinense; Universidade do
   Extremo Sul Catarinense; Universidade do Sul de Santa Catarina;
   Universidade do Sul de Santa Catarina
RP Rezin, GT (corresponding author), Univ Southern Santa Catarina, Lab Neurobiol Inflammatory & Metab Proc, Postgrad Program Hlth Sci, Tubarao, SC, Brazil.
EM gitezza@hotmail.com
RI Prophiro, Josiane/CAI-1653-2022; Andrade, Vanessa/F-9623-2012; Moraes,
   Fernanda/KMA-3054-2024; Damiani, Adriani/N-8007-2018; Bonfante, Sandra
   Regina/MGW-4785-2025; Kanis, Luiz/O-5406-2018; Petronilho,
   Fabricia/D-8822-2013
OI Witt Tietbohl, Lariani Tamires/0000-0001-5691-4301; Oliveira, Mariana
   Pacheco/0000-0002-2046-2101; Vilela, Thais Cereser/0000-0002-2986-1715;
   Petronilho, Fabricia/0000-0003-3240-2808; da Silva,
   Larissa/0000-0001-7514-6272
CR ABESO, BRAZ ASS STUD OB MET
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Aksenov MY, 2001, NEUROSCI LETT, V302, P141, DOI 10.1016/S0304-3940(01)01636-6
   Alzoubi KH, 2018, PHYSIOL BEHAV, V196, P1, DOI 10.1016/j.physbeh.2018.08.011
   Badimon L, 2017, CARDIOVASC RES, V113, P1064, DOI 10.1093/cvr/cvx096
   BANNISTER JV, 1987, METHOD BIOCHEM ANAL, V32, P279
   Bogavac-Stanojevic N, 2018, PHARM BIOL, V56, P138, DOI 10.1080/13880209.2018.1434549
   Bruce-Keller AJ, 2009, BBA-MOL BASIS DIS, V1792, P395, DOI 10.1016/j.bbadis.2008.10.004
   Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431
   Caimari A, 2010, J NUTR BIOCHEM, V21, P1127, DOI 10.1016/j.jnutbio.2009.10.001
   Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178
   Castro AI, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101348
   Chen KHE, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02183-2
   Chusyd DE, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00010
   D'Antuono I, 2018, MOLECULES, V23, DOI 10.3390/molecules23112729
   de Mello AH, 2019, MOL NEUROBIOL, V56, P513, DOI 10.1007/s12035-018-1097-6
   de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978
   DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
   FangFang, 2017, METAB BRAIN DIS, V32, P385, DOI 10.1007/s11011-016-9921-z
   Fernández-Sánchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117
   Fetrow CW., 2000, MANUAL MED ALTERNATI, P743
   FISCHER JC, 1985, CLIN CHIM ACTA, V145, P89, DOI 10.1016/0009-8981(85)90022-1
   Gebhardt R, 1997, TOXICOL APPL PHARM, V144, P279, DOI 10.1006/taap.1997.8130
   Gebhardt R, 1998, J PHARMACOL EXP THER, V286, P1122
   Gómez-Apo E, 2021, J OBES, V2021, DOI 10.1155/2021/6613385
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Guillemot-Legris O, 2017, TRENDS NEUROSCI, V40, P237, DOI 10.1016/j.tins.2017.02.005
   Gul Z, 2016, NEUROCHEM RES, V41, P2075, DOI 10.1007/s11064-016-1919-8
   Guo YJ, 2015, LIFE SCI, V127, P12, DOI 10.1016/j.lfs.2015.01.036
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594
   Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264
   Janssen I, 2004, AM J CLIN NUTR, V79, P379
   Jiménez-Escrig A, 2003, J AGR FOOD CHEM, V51, P5540, DOI 10.1021/jf030047e
   Juzyszyn Z, 2010, PHYTOTHER RES, V24, pS123, DOI 10.1002/ptr.2995
   Klöting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0
   Kraft K, 1997, PHYTOMEDICINE, V4, P369, DOI 10.1016/S0944-7113(97)80049-9
   Kumar A, 2010, Pharmacogn Rev, V4, P147, DOI 10.4103/0973-7847.70908
   Kwon EY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080979
   Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001
   Landeiro FM., 2012, REV CIENC MED BIOL, V10, P236
   Lattanzio V, 2009, J FUNCT FOODS, V1, P131, DOI 10.1016/j.jff.2009.01.002
   Le Thuc O, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00197
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Magielse J, 2014, MOL NUTR FOOD RES, V58, P211, DOI 10.1002/mnfr.201300282
   Maiuolo J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13072158
   Mallik SB, 2016, NEUROSCI LETT, V632, P218, DOI 10.1016/j.neulet.2016.08.044
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Moreno B, 2016, ENDOCRINE, V54, P681, DOI 10.1007/s12020-016-1050-2
   Oppedisano F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051435
   Panahi Y, 2018, PHYTOTHER RES, V32, P1382, DOI 10.1002/ptr.6073
   Pérez-García F, 2000, FREE RADICAL RES, V33, P661, DOI 10.1080/10715760000301171
   Pigott Beatrice M, 2016, Front Synaptic Neurosci, V8, P17, DOI 10.3389/fnsyn.2016.00017
   Rahman SO, 2019, BIOMED PHARMACOTHER, V110, P47, DOI 10.1016/j.biopha.2018.11.043
   Ribeiro G, 2013, REV PORT ENDOCRINOL, V8, P82, DOI 10.1016/j.rpedm.2013.09.001
   Rizi EP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191609
   Santos HO, 2018, PHARMACOL RES, V137, P170, DOI 10.1016/j.phrs.2018.10.007
   Schraiber RD, 2019, METAB BRAIN DIS, V34, P565, DOI 10.1007/s11011-018-0337-9
   Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Tang XC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091000
   van de Sande-Lee S, 2011, DIABETES, V60, P1699, DOI 10.2337/db10-1614
   Vitkovic L, 2001, NEUROIMMUNOMODULAT, V9, P295, DOI 10.1159/000059387
   Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0
   Wang JM, 2018, PHARM BIOL, V56, P626, DOI 10.1080/13880209.2018.1527370
   Wang MF, 2003, J AGR FOOD CHEM, V51, P601, DOI 10.1021/jf020792b
   Wlodarczyk M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051146
   Wlodarczyk M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050578
   Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206
   World Health Organization, 2021, Obesity and overweight
   Yadav UCS, 2011, CHEM-BIOL INTERACT, V191, P339, DOI 10.1016/j.cbi.2011.02.014
   Zapolska-Downar D, 2002, LIFE SCI, V71, P2897, DOI 10.1016/S0024-3205(02)02136-7
   Zhu XF, 2004, J AGR FOOD CHEM, V52, P7272, DOI 10.1021/jf0490192
NR 75
TC 4
Z9 4
U1 1
U2 8
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-3190
EI 1573-6903
J9 NEUROCHEM RES
JI Neurochem. Res.
PD JUL
PY 2022
VL 47
IS 7
BP 1888
EP 1903
DI 10.1007/s11064-022-03572-6
EA APR 2022
PG 16
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 2I1IV
UT WOS:000782724900001
PM 35426598
DA 2025-04-28
ER

PT J
AU Choi, JH
   Kim, KM
   Park, SE
   Kim, MK
   Kim, S
AF Choi, Jun-Hui
   Kim, Ki-Man
   Park, Se-Eun
   Kim, Myung-Kon
   Kim, Seung
TI Short-Term Effects of PJE Administration on Metabolic Parameters in
   Diet-Induced Obesity Mice
SO FOODS
LA English
DT Article
DE Petasites japonicus (Siebold & Zucc; ) Maxim; diet-induced obesity;
   metabolic parameter; fat accumulation; anti-obesity
ID PETASITES-JAPONICUS; ANTIOXIDANT ACTIVITY; ACCUMULATION; DISEASES
AB The study investigated the effects of Petasites japonicus (Siebold & Zucc.) Maxim. extract (PJE) and fenofibrate on diet-induced obesity (DIO) in mice. PJE was found to contain various bio-active polyphenolic compounds, including kaempferol, p-hydroxybenzoic acid, ferulic acid, gallic acid, chlorogenic acid, 3,4-dicaffeoylquinic acid, caffeic acid, quercetin, rutin, protocatechuic acid, 3,5-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid, p-coumaric acid, apigenin, and 1,3-dicaffeoylquinic acid. The results showed that PJE treatment up to 1000 mu g/mL did not affect the viability of 3T3-L1 cell line, and it reduced the feed efficiency ratio in DIO mice. PJE administration also resulted in a significant reduction in body weight gain and fat accumulation in the liver compared to the DIO control group. Additionally, PJE administration improved the levels of lipid and related parameters, including total cholesterol, triacylglycerol, low-density lipoprotein, very low-density lipoprotein, glucose, insulin, insulin resistance, leptin, and atherogenic or cardiac indexes compared to the DIO control group. The study suggested that PJE may have a beneficial effect on insulin resistance, lipid profiles, atherogenesis, adipokines, and cardiac risk associated with diet-induced obesity.
C1 [Choi, Jun-Hui; Kim, Ki-Man; Park, Se-Eun; Kim, Seung] Gwangju Univ, Dept Hlth Funct Food, Gwangju 61743, South Korea.
   [Kim, Myung-Kon] Chonbuk Natl Univ, Dept Food Sci & Technol, Iksan 54596, South Korea.
C3 Gwangju University; Jeonbuk National University
RP Kim, S (corresponding author), Gwangju Univ, Dept Hlth Funct Food, Gwangju 61743, South Korea.
EM sekai0572@naver.com; kmkim@gwangju.ac.kr; seungk@gwangju.ac.kr
RI Choi, Jun-Hui/AGS-2406-2022
OI Choi, Jun-Hui/0000-0001-6725-381X; Kim, Seung/0000-0001-6249-8156
FU Korea Forest Service [2021381D10-2323-BD02]
FX This research was funded by Korea Forest Service (2021381D10-2323-BD02).
CR Afnan, 2022, MOLECULES, V27, DOI 10.3390/molecules27217286
   Ahn EM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051261
   Al-Khayri JM, 2022, MOLECULES, V27, DOI 10.3390/molecules27092901
   Arfaoui L, 2021, MOLECULES, V26, DOI 10.3390/molecules26102959
   Badimon L, 2019, CURR MED CHEM, V26, P3639, DOI 10.2174/0929867324666170428103206
   Cardel MI, 2020, JAMA PEDIATR, V174, P609, DOI 10.1001/jamapediatrics.2020.0085
   Carrasco-Pozo C, 2019, J MED FOOD, V22, P753
   Chae Hyunju, 2019, Korean J Women Health Nurs, V25, P129, DOI 10.4069/kjwhn.2019.25.2.129
   Choi EM, 2007, FOOD SCI BIOTECHNOL, V16, P710
   Choi HJ, 2010, FOOD CHEM, V119, P437, DOI 10.1016/j.foodchem.2009.06.039
   Choi JH, 2022, MOLECULES, V27, DOI 10.3390/molecules27113496
   Choi JH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78166-9
   Choi JH, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13110
   Choi JH, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22004
   Choi JH, 2017, INT J MED MUSHROOMS, V19, P107, DOI 10.1615/IntJMedMushrooms.v19.i2.20
   Choi JH, 2015, BIOCHIMIE, V115, P177, DOI 10.1016/j.biochi.2015.06.001
   Danino O, 2009, FOOD RES INT, V42, P1273, DOI 10.1016/j.foodres.2009.03.023
   Debelo H, 2020, CURR OPIN FOOD SCI, V32, P90, DOI 10.1016/j.cofs.2020.03.001
   Deepika, 2022, MOLECULES, V27, DOI 10.3390/molecules27082498
   Di Lorenzo C, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010273
   Entezari M, 2022, BIOMED PHARMACOTHER, V146, DOI 10.1016/j.biopha.2021.112563
   Eom Hyun-Ju, 2021, 한국식품저장유통학회지, V28, P915
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gowd V, 2019, TRENDS FOOD SCI TECH, V93, P81, DOI 10.1016/j.tifs.2019.09.005
   Guo L, 2020, FOOD FUNCT, V11, P5664, DOI [10.1039/D0FO00594K, 10.1039/d0fo00594k]
   Guo L, 2019, FOOD FUNCT, V10, P4396, DOI [10.1039/c9fo00549h, 10.1039/C9FO00549H]
   Hall KD, 2022, AM J CLIN NUTR, V115, P1243, DOI 10.1093/ajcn/nqac031
   유근형, 2015, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V44, P1431
   Hiemori-Kondo M, 2020, J CLIN BIOCHEM NUTR, V67, P10, DOI 10.3164/jcbn.20-58
   Hiemori-Kondo M, 2020, BIOSCI BIOTECH BIOCH, V84, P621, DOI 10.1080/09168451.2019.1691913
   Hu ZM, 2022, MOL NUTR FOOD RES, V66, DOI 10.1002/mnfr.202100732
   Ikewuch CJ, 2009, Biokemistri, V21, P71, DOI [10.4314/biokem.v21i2.56473, DOI 10.4314/BIOKEM.V21I2.56473]
   Jakobek L, 2019, TRENDS FOOD SCI TECH, V83, P235, DOI 10.1016/j.tifs.2018.11.024
   Jan R, 2022, PLANTS-BASEL, V11, DOI 10.3390/plants11192623
   Kamarauskaite J, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10091405
   Kim Eun Jin, 2020, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V49, P289
   Kojta I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051305
   Lavefve L, 2020, FOOD FUNCT, V11, P45, DOI [10.1039/C9FO01634A, 10.1039/c9fo01634a]
   Lee Myung-Yul, 2007, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V36, P298
   NAYA K, 1968, TETRAHEDRON LETT, P629
   Park CH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134620
   Park JH, 2019, J MED FOOD, V22, P374, DOI 10.1089/jmf.2018.4248
   Pérez-Torres I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041786
   Randy A, 2016, J FUNCT FOODS, V27, P1, DOI 10.1016/j.jff.2016.08.050
   Schoeler M, 2019, REV ENDOCR METAB DIS, V20, P461, DOI 10.1007/s11154-019-09512-0
   Sharma M, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01329
   우연정, 2017, 한국식품저장유통학회지, V24, P1113
   Sotoudeheian M., 2023, PREPRINTS, DOI [10.20944/preprints202301.0528.v1, DOI 10.20944/PREPRINTS202301.0528.V1]
   Stimac D, 2020, DIGEST DIS, V38, P150, DOI 10.1159/000505394
   Stromsnes K, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9081074
   Truzzi F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115514
   Uesugi S, 2022, FITOTERAPIA, V157, DOI 10.1016/j.fitote.2022.105130
   Vinola Selvanathan M J, 2021, J Conserv Dent, V24, P539, DOI 10.4103/jcd.jcd_433_21
   Vogeser M, 2007, CLIN BIOCHEM, V40, P964, DOI 10.1016/j.clinbiochem.2007.05.009
   Watanabe T, 2010, BIOSCI BIOTECH BIOCH, V74, P499, DOI 10.1271/bbb.90684
   Williams DM, 2020, DIABETES THER, V11, P1199, DOI 10.1007/s13300-020-00816-y
NR 56
TC 2
Z9 2
U1 2
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD APR
PY 2023
VL 12
IS 8
AR 1675
DI 10.3390/foods12081675
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA F0WA2
UT WOS:000979624000001
PM 37107470
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Kumaraguru, G
   Ramalingam, A
   Shanmugam, G
   Kumar, AKK
   Muthusamy, S
   Malaiyandi, J
AF Kumaraguru, Gowtham
   Ramalingam, Arulmathi
   Shanmugam, Girija
   Krishna Kumar, Ashok Kumar
   Muthusamy, Suganthi
   Malaiyandi, Jayanthi
TI Investigating antioxidant, anti-obesity, and anticancer potential in raw
   and processed flour extracts of barnyard millets
SO JOURNAL OF FOOD MEASUREMENT AND CHARACTERIZATION
LA English
DT Article
DE Barnyard millet; Anti-diabetic; Region; Alpha-amylase; Anti-nutrient;
   Processing
ID PHYTOCHEMICALS; INHIBITORS; CAPACITY; SORGHUM
AB Barnyard millet (Echinochloa frumantacea L.) is a traditional South Indian dietary staple known for its short grain ripening period of 45 days. Various processing methods are employed to enhance its nutrient quality, aid digestion, and improve bioavailability by reducing anti-nutrients. This study aimed to compare the nutritional properties of barnyard millet processed through different methods, including whole flour, de-husked flour, and roasted flour. Samples were collected from different regions in Tamil Nadu, namely Chennai, Kovilpatti, and Virudhunagar. Subsequently, they underwent maceration extraction using methanol to evaluate their nutritional, antioxidant, and anti-nutritional properties. Phytochemical analysis revealed elevated levels of selected compounds in all samples, with processing methods resulting in a reduction of anti-nutrient content. Notably, the roasted sample from Chennai exhibited significant antioxidant activity, while de-husked flour from Chennai and Kovilpatti regions demonstrated inhibition of in vitro anti-obesity activity. RP-HPLC analysis identified major metabolites, and molecular docking against oxidoreductase proteins highlighted the efficacy of Chlorogenic acid and Gallic acid. These findings suggest the potential for developing novel therapeutic drugs for diabetes and anti-cancer health benefits associated with specific barnyard millet processing methods.
C1 [Kumaraguru, Gowtham; Shanmugam, Girija] Bharathiar Univ, Dept Biotechnol, Plant Biotechnonol Lab, Coimbatore 641046, Tamil Nadu, India.
   [Ramalingam, Arulmathi; Krishna Kumar, Ashok Kumar; Muthusamy, Suganthi; Malaiyandi, Jayanthi] Vels Inst Sci Technol, Dept Biotechnol, Chennai 600015, Tamil Nadu, India.
C3 Bharathiar University; Vels Institute of Science, Technology & Advanced
   Studies
RP Malaiyandi, J (corresponding author), Vels Inst Sci Technol, Dept Biotechnol, Chennai 600015, Tamil Nadu, India.
EM girijabiotech@yahoo.co.in; rsjaya24@gmail.com
OI , Gowtham/0000-0002-0130-0588
CR Adewale IO, 2006, CARBOHYD POLYM, V66, P71, DOI 10.1016/j.carbpol.2006.02.022
   AISONI J. E., 2018, Greener Journal of Biological Sciences, V8, P014, DOI [10.15580/GJBS.2018.2.032018048, DOI 10.15580/GJBS.2018.2.032018048]
   Al-Sheddi ES, 2018, BIOINORG CHEM APPL, V2018, DOI 10.1155/2018/9390784
   Alkhalaf MI, 2021, J KING SAUD UNIV SCI, V33, DOI 10.1016/j.jksus.2020.10.007
   Alzandi AA, 2022, J GASTROINTEST CANC, V53, P211, DOI 10.1007/s12029-020-00561-2
   Azad MOK, 2019, FOODS, V8, DOI 10.3390/foods8070230
   Badau M. H., 2006, Journal of Applied Glycoscience, V53, P1
   Bajpai P, 2018, BIERMANN'S HANDBOOK OF PULP AND PAPER: PAPER AND BOARD MAKING, VOL2, 3RD EDITION, P363, DOI 10.1016/B978-0-12-814238-7.00017-9
   BARNES H, 1973, Journal of Experimental Marine Biology and Ecology, V12, P103, DOI 10.1016/0022-0981(73)90040-3
   BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8
   Chandrasekara A, 2011, J FUNCT FOODS, V3, P159, DOI 10.1016/j.jff.2011.03.008
   CHANDRASEKHER G, 1981, J SCI FOOD AGR, V32, P9, DOI 10.1002/jsfa.2740320103
   Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503
   Devi RS., 2016, J FOOD PROCESS TE-US, DOI [10.4172/2157-7110.1000595, DOI 10.4172/2157-7110.1000595]
   DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485
   Fadhil S., 2007, Res. J. Phytochem, V1, P79, DOI [10.3923/RJPHYTO.2007.79.82, DOI 10.3923/RJPHYTO.2007.79.82]
   Fei H., 2018, INT J FOOD ENG, DOI [10.18178/ijfe.4.2.110-116, DOI 10.18178/IJFE.4.2.110-116]
   Goel Krati, 2021, Asian Journal of Dairy and Food Research, V40, P55, DOI 10.18805/ajdfr.DR-1588
   Guo XX, 2018, J FOOD SCI TECH MYS, V55, P1010, DOI 10.1007/s13197-017-3014-9
   Hua F, 2018, FOOD FUNCT, V9, P4173, DOI 10.1039/c8fo00562a
   Iqbal J, 2022, RSC ADV, V12, P14069, DOI 10.1039/d2ra01929a
   Kabir MSH, 2016, J YOUNG PHARM, V8, P391, DOI 10.5530/jyp.2016.4.15
   Kim JY, 2011, FOOD SCI BIOTECHNOL, V20, P461, DOI 10.1007/s10068-011-0064-z
   Kom YD., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3532486, DOI 10.2139/SSRN.3532486]
   Krishna Muralidharan Krishna Muralidharan, 2018, African Journal of Biotechnology, V17, P1021, DOI 10.5897/ajb2018.16561
   Kubola J, 2008, FOOD CHEM, V110, P881, DOI 10.1016/j.foodchem.2008.02.076
   Kulla S, 2021, ANN PHYTOMEDICINE, V10, P178, DOI 10.21276/ap.2021.10.1.18
   Kumar G, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1927-x
   Kumari D, 2017, FOOD SCI NUTR, V5, P474, DOI 10.1002/fsn3.415
   Li Guifeng, 2018, IOP Conference Series: Materials Science and Engineering, V392, DOI 10.1088/1757-899X/392/5/052023
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lyzu C, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/3190496
   Ma Q, 2023, FOOD RES INT, V171, DOI 10.1016/j.foodres.2023.113066
   Mahajan M, 2024, J FOOD PROCESS ENG, V47, DOI 10.1111/jfpe.14313
   Mahmud Zobaer Al, 2017, BMC Res Notes, V10, P245, DOI 10.1186/s13104-017-2503-2
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Mounika D., 2022, INDIAN J APPL PURE B, V37, P810
   Muzammil S, 2022, MOLECULES, V27, DOI 10.3390/molecules27196263
   OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307
   PANDEY S., 2021, Pharm Innov., V10, P379
   Patel A., 2010, Int. J. Pharm. Sci. Res., V1, P66
   Pradeep PM, 2015, FOOD CHEM, V169, P455, DOI 10.1016/j.foodchem.2014.08.010
   Pradeep SR, 2011, FOOD CHEM, V126, P1643, DOI 10.1016/j.foodchem.2010.12.047
   Pulido R, 2000, J AGR FOOD CHEM, V48, P3396, DOI 10.1021/jf9913458
   Pushparaj F. S., 2011, Food and Nutrition Sciences, V2, P895, DOI 10.4236/fns.2011.28122
   Rajeswari N, 2021, CURR RES NUTR FOOD S, V9, P1067, DOI 10.12944/CRNFSJ.9.3.31
   Sachdev N, 2023, APPL FOOD RES, V3, DOI 10.1016/j.afres.2023.100288
   Sasipriya G, 2012, FOOD CHEM TOXICOL, V50, P2864, DOI 10.1016/j.fct.2012.05.048
   Shahidi F, 2015, Processing and impact on active components in food, P345, DOI [10.1016/B978-0-12-404699-3.00041-X, DOI 10.1016/B978-0-12-404699-3.00041-X]
   Shankaramurthy K. N., 2019, Indian Journal of Health Sciences and Biomedical Research KLEU, V12, P228, DOI 10.4103/kleuhsj.kleuhsj_32_19
   Sharma N, 2018, J CEREAL SCI, V83, P162, DOI 10.1016/j.jcs.2018.08.013
   Shunmugapriya K., 2020, Int. J. Biochem. Res, V29, P39, DOI [10.9734/ijbcrr/2020/v29i430184, DOI 10.9734/IJBCRR/2020/V29I430184]
   Simon C, 2000, ARCH BIOCHEM BIOPHYS, V373, P418, DOI 10.1006/abbi.1999.1560
   Singh A., 2022, J. Pharm. Innov., V11, P115
   Singh S., 2021, WORLD J ADV RES REV, V11, P23, DOI [10.30574/wjarr.2021.11.3.0415, DOI 10.30574/WJARR.2021.11.3.0415]
   Singleton VL, 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5
   Surekha N., 2013, IOSR J ENV SCI TOXIC, V7, P1, DOI [10.9790/2402-0730110, DOI 10.9790/2402-0730110]
   Taylor JRN, 2015, J SCI FOOD AGR, V95, P225, DOI 10.1002/jsfa.6713
   Tripathi B, 2011, FOOD CHEM, V126, P537, DOI 10.1016/j.foodchem.2010.11.039
   Uddin Md Zia, 2019, J Complement Integr Med, V17, DOI 10.1515/jcim-2019-0102
   Ullah I, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1215395
   Wang H, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.780499
   Wang SY, 2000, J AGR FOOD CHEM, V48, P5677, DOI 10.1021/jf000766i
   Watanabe M, 1999, J AGR FOOD CHEM, V47, P4500, DOI 10.1021/jf990498s
   Workman RL., 1957, ACAD MED, V32, P315, DOI [10.1097/00001888-195704000-00025, DOI 10.1097/00001888-195704000-00025]
   Wu MX, 2021, FOOD BIOSCI, V43, DOI 10.1016/j.fbio.2021.101224
   Wu YL, 2024, CHEM PAP, V78, P221, DOI 10.1007/s11696-023-03066-x
   Yadav CB, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.599649
   Yadav GP, 2022, J FOOD PROCESS ENG, V45, DOI 10.1111/jfpe.14106
   Zhang HL, 2022, LWT-FOOD SCI TECHNOL, V170, DOI 10.1016/j.lwt.2022.114082
   Zhang LY, 2017, J FOOD QUALITY, DOI 10.1155/2017/8372854
   Zheng BL, 2022, LWT-FOOD SCI TECHNOL, V154, DOI 10.1016/j.lwt.2021.112740
   Zielinski H, 2006, MOL NUTR FOOD RES, V50, P824, DOI 10.1002/mnfr.200500258
NR 73
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2193-4126
EI 2193-4134
J9 J FOOD MEAS CHARACT
JI J. Food Meas. Charact.
PD JUL
PY 2024
VL 18
IS 7
BP 6124
EP 6144
DI 10.1007/s11694-024-02633-4
EA JUN 2024
PG 21
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA A2N9C
UT WOS:001238567300001
DA 2025-04-28
ER

PT J
AU Ziegler, AM
   Temple, JL
AF Ziegler, Amanda M.
   Temple, Jennifer L.
TI Soda Consumption is Associated with Risk-Taking Behaviors in Adolescents
SO AMERICAN JOURNAL OF HEALTH BEHAVIOR
LA English
DT Article
DE risk taking; adolescents; caffeine; sugar sweetened beverages; soda
ID ENERGY DRINK CONSUMPTION; SWEETENED BEVERAGE CONSUMPTION; UNITED-STATES;
   SUBSTANCE USE; REINFORCEMENT SENSITIVITY; SENSATION SEEKING;
   BRAIN-DEVELOPMENT; CAFFEINE INTAKE; ALCOHOL-USE; TRAJECTORIES
AB Objectives: Soda consumption is on the rise among children and adolescents. The purpose of this study was to test the hypothesis that increased soda consumption predicts risk-taking behavior among high school students. Methods: To test this hypothesis, we used data from the 2011 Youth Risk Behavior Surveillance System to compare the odds of engaging in a series of risk-taking behaviors among students who reported no soda consumption, occasional soda consumption (1 - 6 times per week), and daily soda consumption (>= 7 times per week). Results: Daily soda consumption was associated with increased odds of engaging in 90% of the risk behaviors analyzed. In addition, there were sex differences in the magnitude of the relationships for many of these behaviors. Conclusions: These data suggest that in addition to increased risk of obesity, dental caries, and reduced sleep quality, soda consumption is associated with increased risk-taking behavior.
C1 [Ziegler, Amanda M.; Temple, Jennifer L.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.
   [Temple, Jennifer L.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA.
C3 State University of New York (SUNY) System; University at Buffalo, SUNY;
   State University of New York (SUNY) System; University at Buffalo, SUNY
RP Temple, JL (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.
EM jltemple@buffalo.edu
OI Ziegler, Amanda/0000-0001-8052-0134
FU  [RO1 DA030386]
FX JLT and AMZ are supported by RO1 DA030386.
CR Ahluwalia N, 2015, ADV NUTR, V6, P102, DOI 10.3945/an.114.007401
   Ahluwalia N, 2014, AM J CLIN NUTR, V100, P1124, DOI 10.3945/ajcn.113.082172
   Arcan C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-263
   Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019
   Balconi M, 2014, J ADDICT MED, V8, P399, DOI 10.1097/ADM.0000000000000065
   Brener Nancy D., 2004, Morbidity and Mortality Weekly Report, V53, P1
   Burrows T, 2013, NUTR REV, V71, P135, DOI 10.1111/nure.12005
   Chen TJH, 2005, MED HYPOTHESES, V65, P703, DOI 10.1016/j.mehy.2005.04.037
   Colder CR, 2002, J CONSULT CLIN PSYCH, V70, P976, DOI 10.1037/0022-006X.70.4.976
   Colder CR, 2001, HEALTH PSYCHOL, V20, P127, DOI 10.1037/0278-6133.20.2.127
   Colder CR, 2013, J RES ADOLESCENCE, V23, P345, DOI 10.1111/jora.12001
   Collado A, 2014, ADDICT BEHAV, V39, P1580, DOI 10.1016/j.addbeh.2014.01.024
   Dayan J, 2010, J PHYSIOL-PARIS, V104, P279, DOI 10.1016/j.jphysparis.2010.08.007
   Dickin KL, 2014, J ACAD NUTR DIET, V114, P945, DOI 10.1016/j.jand.2013.09.029
   Eaton DK, 2013, J ACAD NUTR DIET, V113, P1165, DOI 10.1016/j.jand.2013.05.013
   Emond JA, 2014, J PEDIATR-US, V165, P1194, DOI 10.1016/j.jpeds.2014.08.050
   Fagan AA, 2013, J QUANT CRIMINOL, V29, P347, DOI 10.1007/s10940-012-9183-9
   Fite PJ, 2006, ADDICT BEHAV, V31, P1454, DOI 10.1016/j.addbeh.2005.09.015
   Gage Julia C, 2005, J Adolesc Health, V37, P517, DOI 10.1016/j.jadohealth.2004.12.012
   Galvan A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.006.2010
   Ginsburg KR, 2009, PEDIATRICS, V124, P1040, DOI 10.1542/peds.2008-3037
   Hamilton HA, 2013, CAN J PUBLIC HEALTH, V104, pE496, DOI 10.17269/cjph.104.3998
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Harrington S, 2008, J SCH NURS, V24, P3, DOI 10.1622/1059-8405(2008)024[0003:TROSBC]2.0.CO;2
   Haszard JJ, 2015, PUBLIC HEALTH NUTR, V18, P1036, DOI 10.1017/S1368980014001256
   Kann L, 2014, MMWR SURVEILL SUMM, V63, P1
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Konrad K, 2013, DTSCH ARZTEBL INT, V110, P425, DOI 10.3238/arztebl.2013.0425
   Kuznetsova VB, 2015, PERSONAL MENT HEALTH, V9, P44, DOI 10.1002/pmh.1280
   Laghi F, 2015, EAT BEHAV, V17, P119, DOI 10.1016/j.eatbeh.2015.01.011
   Larson N, 2015, PUBLIC HEALTH NUTR, P1
   Larson N, 2014, J NUTR EDUC BEHAV, V46, P181, DOI 10.1016/j.jneb.2014.02.008
   Lopez NV, 2012, J ACAD NUTR DIET, V112, P541, DOI 10.1016/j.jand.2011.11.013
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Marczinski CA, 2015, ADV NUTR, V6, P96, DOI 10.3945/an.114.007393
   Marczinski CA, 2013, ALCOHOL CLIN EXP RES, V37, P276, DOI 10.1111/j.1530-0277.2012.01868.x
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490
   Moreno-López L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185
   Park S, 2013, AM J HEALTH BEHAV, V37, P414, DOI 10.5993/AJHB.37.3.14
   Scalese Marco, 2014, J Addict, V2014, P962178, DOI 10.1155/2014/962178
   Sleet DA, 2010, ANNU REV PUBL HEALTH, V31, P195, DOI 10.1146/annurev.publhealth.012809.103616
   Snipes DJ, 2015, ADDICT BEHAV, V41, P136, DOI 10.1016/j.addbeh.2014.10.010
   Temple JL, 2014, PEDIATRICS, V134, pE112, DOI 10.1542/peds.2013-3962
   Temple Jennifer L, 2011, J Caffeine Res, V1, P41, DOI 10.1089/jcr.2011.0005
   Temple JL, 2009, BEHAV PHARMACOL, V20, P731, DOI 10.1097/FBP.0b013e328333b27c
   Terry-McElrath YM, 2014, J ADDICT MED, V8, P6, DOI 10.1097/01.ADM.0000435322.07020.53
   Trapp GSA, 2014, DRUG ALCOHOL DEPEN, V134, P30, DOI 10.1016/j.drugalcdep.2013.09.006
   Trucco EM, 2011, ADDICT BEHAV, V36, P729, DOI 10.1016/j.addbeh.2011.02.008
   Vara AS, 2014, DEV COGN NEUROS-NETH, V10, P129, DOI 10.1016/j.dcn.2014.08.009
   Wang B, 2013, SOC SCI MED, V97, P161, DOI 10.1016/j.socscimed.2013.08.013
NR 51
TC 8
Z9 11
U1 0
U2 22
PU PNG PUBLICATIONS
PI OAK RIDGE
PA 2205-K OAK RIDGE RD, #115, OAK RIDGE, NC 27310 USA
SN 1945-7359
J9 AM J HEALTH BEHAV
JI Am. J. Health Behav.
PD NOV
PY 2015
VL 39
IS 6
BP 761
EP 771
DI 10.5993/AJHB.39.6.3
PG 11
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA DB1JN
UT WOS:000368264600003
PM 26450543
DA 2025-04-28
ER

PT J
AU Higgins, JP
   Tuttle, TD
   Higgins, CL
AF Higgins, John P.
   Tuttle, Troy D.
   Higgins, Christopher L.
TI Energy Beverages: Content and Safety
SO MAYO CLINIC PROCEEDINGS
LA English
DT Review
ID DRINK CONSUMPTION; L-CARNITINE; CAFFEINE; PERFORMANCE; METABOLISM;
   NUTRITION; FLUID; SUPPLEMENTATION; CARBOHYDRATE; ASSOCIATION
AB Exercise is making a resurgence in many countries, given its benefits for fitness as well as prevention of obesity This trend has spawned many supplements that purport to aid performance, muscle growth, and recovery initially, sports drinks were developed to provide electrolyte and carbohydrate replacement Subsequently, energy beverages (EBs) containing stimulants and additives have appeared in most gyms and grocery stores and are being used in creasingly by "weekend warriors" and those seeking an edge In an endurance event Long term exposure to the various components of EBs may result in significant alterations in the cardiovascular system, and the safety of EBs has not been fully established For this review, we searched the MEDLINE and EMBASE databases from 1976 through May 2010, using the following keywords energy beverage, energy drink, power drink, exercise, caffeine, red bull, bitter orange, glucose, ginseng, guarana, and taurine Evidence regarding the effects of EBs is summarized, and practical recommendations are made to help in answering the patient who asks, "Is it safe for me to drink an energy beverage when I exercise?"
C1 [Higgins, John P.] Univ Texas Med Sch Houston, Lyndon B Johnson Gen Hosp, Div Cardiol, Houston, TX 77026 USA.
   [Higgins, John P.] Univ Texas Med Sch Houston, Mem Hermann Sports Med Inst, Houston, TX 77026 USA.
   [Tuttle, Troy D.] Univ Texas Hlth Sci Ctr, Noninvas Cardiovasc Lab, Houston, TX USA.
   [Higgins, Christopher L.] Univ Queensland, Sch Human Movements Studies, St Lucia, Qld, Australia.
C3 University of Texas System; University of Texas Health Science Center
   Houston; University of Texas System; University of Texas Health Science
   Center Houston; University of Texas System; University of Texas Health
   Science Center Houston; University of Queensland
RP Higgins, JP (corresponding author), Univ Texas Med Sch Houston, Lyndon B Johnson Gen Hosp, Div Cardiol, 5656 Kelley St,UT Annex Room 104, Houston, TX 77026 USA.
CR [Anonymous], CBC NEWS
   Armstrong LE, 2005, INT J SPORT NUTR EXE, V15, P252, DOI 10.1123/ijsnem.15.3.252
   Bâ A, 2008, CELL MOL NEUROBIOL, V28, P923, DOI 10.1007/s10571-008-9297-7
   Bahrke MS, 2009, INT J SPORT NUTR EXE, V19, P298, DOI 10.1123/ijsnem.19.3.298
   Bain MA, 2006, J CLIN PHARMACOL, V46, P1163, DOI 10.1177/0091270006292851
   Balla T, 2009, CELL CALCIUM, V45, P527, DOI 10.1016/j.ceca.2009.03.013
   Ballard SL, 2010, PHYSICIAN SPORTSMED, V38, P107, DOI 10.3810/psm.2010.04.1768
   Baum M, 2001, AMINO ACIDS, V20, P75, DOI 10.1007/s007260170067
   Berger AJ, 2009, MED J AUSTRALIA, V190, P41, DOI 10.5694/j.1326-5377.2009.tb02263.x
   BERTHOLD BN, 1997, ANN NUTR METAB, V41, P29
   BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933
   Bryce DJ, 2007, HARVARD BUS REV, V85, P84
   Burke LM, 2007, J SPORT SCI, V25, pS29, DOI 10.1080/02640410701607239
   Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641
   Candow DG, 2009, J STRENGTH COND RES, V23, P1271, DOI 10.1519/JSC.0b013e3181a026c2
   CBCNEWS RED, 2003, HEART DA, V5, P253
   Clarkson PM, 1996, SPORTS MED, V21, P393, DOI 10.2165/00007256-199621060-00001
   Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055
   Curry K, 2009, HUM PSYCHOPHARM CLIN, V24, P473, DOI 10.1002/hup.1045
   DAVIS JM, 1988, EUR J APPL PHYSIOL, V57, P563, DOI 10.1007/BF00418463
   Depeint F, 2006, CHEM-BIOL INTERACT, V163, P94, DOI 10.1016/j.cbi.2006.04.014
   ElSayed MS, 1997, COMP BIOCHEM PHYS A, V118, P789, DOI 10.1016/S0300-9629(97)00064-9
   FISHER SM, 1986, INT J SPORTS MED, V7, P276, DOI 10.1055/s-2008-1025774
   Frishman William H, 2003, Heart Dis, V5, P253, DOI 10.1097/01.hdx.0000080713.09303.a6
   Ganio MS, 2009, J STRENGTH COND RES, V23, P315, DOI 10.1519/JSC.0b013e31818b979a
   GAULL GE, 1989, PEDIATRICS, V83, P433
   Hew-Butler T, 2006, CLIN J SPORT MED, V16, P283, DOI 10.1097/00042752-200607000-00001
   Howarth KR, 2009, J APPL PHYSIOL, V106, P1394, DOI 10.1152/japplphysiol.90333.2008
   Ivy JL, 2009, INT J SPORT NUTR EXE, V19, P61, DOI 10.1123/ijsnem.19.1.61
   Jeukendrup AE, 2005, SPORTS MED, V35, P163, DOI 10.2165/00007256-200535020-00005
   JONES B, 2009, US TODAY        0708
   Jones G, 2008, ESSAYS BIOCHEM, V44, P109, DOI 10.1042/BSE0440109
   Karlic H, 2004, NUTRITION, V20, P709, DOI 10.1016/j.nut.2004.04.003
   Lakshmi AV, 1998, INDIAN J MED RES, V108, P182
   Laurent D, 2000, J CLIN ENDOCR METAB, V85, P2170, DOI 10.1210/jc.85.6.2170
   Lourenco R, 2002, Nutr Hosp, V17, P262
   Mahmud A, 2001, HYPERTENSION, V38, P227, DOI 10.1161/01.HYP.38.2.227
   Margaritis I, 2008, NUTR RES REV, V21, P3, DOI 10.1017/S0954422408018076
   Masuda K, 2009, CLIN EXP DERMATOL, V34, pe263, DOI 10.1111/j.1365-2230.2008.03173.x
   Maughan RJ, 2003, J HUM NUTR DIET, V16, P411, DOI 10.1046/j.1365-277X.2003.00477.x
   *MAYO CLIN STAFF, NUTR HLTH EAT CAFF M
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   Miranda VD, 2009, J ALTERN COMPLEM MED, V15, P431, DOI 10.1089/acm.2008.0324
   Nagajothi N, 2008, AM J MED, V121, pE3, DOI 10.1016/j.amjmed.2007.12.003
   Nicolaï SPA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006888.pub2
   Oteri A, 2007, ALCOHOL CLIN EXP RES, V31, P1677, DOI 10.1111/j.1530-0277.2007.00464.x
   Peake JM, 2007, J NUTR BIOCHEM, V18, P357, DOI 10.1016/j.jnutbio.2006.10.005
   Piirainen H, 2011, BBA-BIOMEMBRANES, V1808, P1233, DOI 10.1016/j.bbamem.2010.05.021
   Ragsdale FR, 2010, AMINO ACIDS, V38, P1193, DOI 10.1007/s00726-009-0330-z
   Rashti SL, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-57
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Riesenhuber A, 2006, AMINO ACIDS, V31, P81, DOI 10.1007/s00726-006-0363-5
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Sato S., 2003, Foods Food Ingredients Journal of Japan, V208, P133
   SATTARI MG, 2010, J AMINO ACIDS, P10
   Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758
   Smith N, 2010, EVID-BASED COMPL ALT, V7, P279, DOI 10.1093/ecam/nem162
   Sökmen B, 2008, J STRENGTH COND RES, V22, P978, DOI 10.1519/JSC.0b013e3181660cec
   Spinneker A, 2007, NUTR HOSP, V22, P7
   Steinke L, 2009, ANN PHARMACOTHER, V43, P596, DOI 10.1345/aph.1L614
   Sudano Isabella, 2005, Prog Cardiovasc Nurs, V20, P65, DOI 10.1111/j.0889-7204.2005.02477.x
   Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014
   Terlizzi R, 2008, CLIN AUTON RES, V18, P221, DOI 10.1007/s10286-008-0483-y
   Thombs DL, 2010, ADDICT BEHAV, V35, P325, DOI 10.1016/j.addbeh.2009.11.004
   WEISE E, 2008, US TODAY        1022
   Wiklund U, 2009, CLIN PHYSIOL FUNCT I, V29, P74, DOI 10.1111/j.1475-097X.2008.00837.x
   Williams SL, 2006, NUTR REV, V64, P93, DOI 10.1111/j.1753-4887.2006.tb00193.x
   Zhou W, 2004, CARDIOVASC DRUG REV, V22, P309
   Zóltaszek R, 2008, POSTEP HIG MED DOSW, V62, P451
   2007, INDEPENDENT IE RED B
NR 70
TC 259
Z9 284
U1 0
U2 118
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD NOV
PY 2010
VL 85
IS 11
BP 1033
EP 1041
DI 10.4065/mcp.2010.0381
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 680AN
UT WOS:000284202500009
PM 21037046
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Lee, LS
   Choi, JH
   Sung, MJ
   Hur, JY
   Hur, HJ
   Park, JD
   Kim, YC
   Gu, EJ
   Min, B
   Kim, HJ
AF Lee, Lan-Sook
   Choi, Ji Hea
   Sung, Mi Jeong
   Hur, Jin-Young
   Hur, Haeng Jeon
   Park, Jong-Dae
   Kim, Young-Chan
   Gu, Eun-Ji
   Min, Byungjin
   Kim, Hyun-Jin
TI Green tea changes serum and liver metabolomic profiles in mice with
   high-fat diet-induced obesity
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Acetyl-CoA acyltransferase 2; Fatty acid beta-oxidation; Green tea;
   Metabolomics; Obesity
ID MITOCHONDRIAL BETA-OXIDATION; WEIGHT MAINTENANCE; SKELETAL-MUSCLE; LIPID
   OXIDATION; CATECHINS; POLYPHENOLS; METAANALYSIS; CAFFEINE; ACID; RATS
AB Scope: Green tea (GT) consumption helps to prevent and control obesity by stimulating hepatic lipid metabolism. However, GT-induced changes in serum and liver metabolomes associated with the anti-obesity effects are not clearly understood. The aim of this study was to identify and validate metabolomic profiles in the livers and sera of GT-fed obese mice to elucidate the relationship between GT consumption and obesity prevention.
   Methods and results: Serum and liver metabolites were analyzed in mice fed normal diet, high-fat diet (HFD), HFD with GT, and HFD with crude catechins, using LC-quadrupole TOF MS. The addition of 1% GT to HFD reduced adipose tissue and the levels of blood triglycerides, glucose, insulin, and leptin elevated in HFD-fed mice. We proposed an HFD-induced obesity pathway and validated it by investigating the key regulatory enzymes of mitochondrial beta-oxidation: carnitine palmitoyltransferase-1 and -2, acyl-coenzyme A dehydrogenase, and acetylcoenzyme A acyltransferase. The results showed that HFD-induced abnormal mitochondrial beta-oxidation was moderated by the consumption of caffeine-and theanine-enriched GT.
   Conclusion: Results of LC/MS-based metabolomic analysis of obese mice showed changes associated with abnormal lipid and energy metabolism, which were alleviated by GT intake, indicating the mechanism underlying the anti-obesity effects of GT.
C1 [Lee, Lan-Sook; Choi, Ji Hea; Sung, Mi Jeong; Hur, Jin-Young; Hur, Haeng Jeon; Park, Jong-Dae; Kim, Young-Chan] Korea Food Res Inst, Songnam, Gyeonggi, South Korea.
   [Choi, Ji Hea] Univ Sci & Technol, Dept Food Biotechnol, Daejeon, South Korea.
   [Gu, Eun-Ji; Kim, Hyun-Jin] Gyeongsang Natl Univ, Dept Food Sci & Technol, Div Appl Life Sci Plus BK21, Jinju, Gyeongsang, South Korea.
   [Gu, Eun-Ji; Kim, Hyun-Jin] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, Gyeongsang, South Korea.
   [Min, Byungjin] Tuskegee Univ, Coll Agr Environm & Nutr Sci, Dept Food & Nutr Sci, Tuskegee, AL 36088 USA.
C3 Korea Food Research Institute (KFRI); University of Science & Technology
   (UST); Gyeongsang National University; Gyeongsang National University;
   Tuskegee University
RP Kim, HJ (corresponding author), Gyeongsang Natl Univ, 501 Jinjudaero, Jinju, Gyeongsang, South Korea.
EM hyunjkim@gnu.ac.kr
RI Park, Donghyun/I-5849-2019; Kim, Jeong-ah/Q-2453-2016
OI Kim, Hyun-Jin/0000-0002-7284-3547
FU High Value-added Food Technology Development Program, Ministry of
   Agriculture, Food and Rural Affairs; Korea Food Research Institute;
   Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of
   Korea [2014R1A2A2A01006774]; BK21 Plus Program, Ministry of Education,
   Republic of Korea
FX This research was supported by the High Value-added Food Technology
   Development Program, Ministry of Agriculture, Food and Rural Affairs and
   by research grants from the Korea Food Research Institute and by Basic
   Science Research Program through the National Research Foundation of
   Korea (NRF) funded by the Ministry of Science, ICT & Future Planning
   (grant #2014R1A2A2A01006774), Republic of Korea. Eun-Ji Gu was supported
   by a scholarship from the BK21 Plus Program, Ministry of Education,
   Republic of Korea.
CR An YP, 2013, J PROTEOME RES, V12, P3755, DOI 10.1021/pr400398b
   Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104
   Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345
   Fu CW, 2011, J PHARMACEUT BIOMED, V55, P1067, DOI 10.1016/j.jpba.2011.03.011
   Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022
   Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006
   Girillo P, 2006, J AM SOC NEPHROL, V17, pS165, DOI 10.1681/ASN.2006080909
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Khaodhiar L, 1999, Clin Cornerstone, V2, P17, DOI 10.1016/S1098-3597(99)90002-9
   Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r
   Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p
   Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Lee LS, 2013, J AGR FOOD CHEM, V61, P332, DOI 10.1021/jf304161y
   Li TP, 2013, J AGR FOOD CHEM, V61, P7599, DOI 10.1021/jf400283w
   Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138
   Lu KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093135
   Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258
   McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Ogura R, 2008, FOOD CHEM TOXICOL, V46, P2190, DOI 10.1016/j.fct.2008.02.016
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Richard D, 2009, PHARMACOL RES, V59, P351, DOI 10.1016/j.phrs.2009.01.015
   Rogge MM, 2009, BIOL RES NURS, V10, P356, DOI 10.1177/1099800408329408
   Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Xie GX, 2012, J PROTEOME RES, V11, P3449, DOI 10.1021/pr300318m
   Xie GX, 2009, J AGR FOOD CHEM, V57, P3046, DOI 10.1021/jf804000y
   Zheng GD, 2004, IN VIVO, V18, P55
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
NR 35
TC 55
Z9 59
U1 2
U2 113
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD APR
PY 2015
VL 59
IS 4
BP 784
EP 794
DI 10.1002/mnfr.201400470
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA CF8CK
UT WOS:000352782800016
PM 25631872
DA 2025-04-28
ER

PT J
AU Teixeira, CD
   Barbosa, PO
   de Souza, MO
AF Teixeira, Clecia Dias
   Barbosa, Priscila Oliveira
   de Souza, Melina Oliveira
TI Effects of guarana (Paullinia cupana) powder on
   obesity-associated diseases in animal models: A systematic review
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Bioactive compounds; Caffeine; Guarana; Paullinia cupana; Polyphenols;
   Obesity
ID GREEN TEA; METHYLXANTHINES; CATECHINS; CAFFEINE; PERFORMANCE;
   METABOLISM; IMPROVES
AB Obesity, a public health problem and a risk factor for numerous comorbidities, has stimulated a growing interest in bioactive-rich foods, such as guarana (Paullinia cupana). This systematic review examined the impact of guarana on obesity-related diseases using animal models from January 1990 and November 2023. Seven articles were included in this review, examining guarana's impact on hyperlipidemia, diabetes, hypercholesterolemia, and obesity. The studies used powdered guarana, provided by orogastric gavage or incorporated into the diet, with doses ranging from 12.5 mg/kg to 2 g/kg. Compelling evidence from our systematic review suggests that guarana powder positively affects biometric parameters, energy metabolism, and biochemical and inflammatory biomarkers, indicating its potential for addressing obesity-related conditions. However, due to the limited number of studies, additional research, including human, clinical trials, is needed to confirm the applicability of these findings to human health and to clarify the mechanisms of action of guarana's bioactive compounds.
C1 [Teixeira, Clecia Dias; de Souza, Melina Oliveira] Univ Fed Ouro Preto, Nutr Sch, Postgrad Program Hlth & Nutr PPGSN, Ouro Preto, Brazil.
   [Barbosa, Priscila Oliveira] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil.
   [Barbosa, Priscila Oliveira] Robert Gordon Univ, Ctr Obes Res & Educ CORE, Sch Pharm & Life Sci, Aberdeen, Scotland.
   [de Souza, Melina Oliveira] Univ Fed Ouro Preto, Sch Nutr, Dept Food Sci, Lab Nutr Biochem & Mol Biol, BR-35400000 Ouro Preto, Brazil.
C3 Universidade Federal de Ouro Preto; Universidade de Sao Paulo; Robert
   Gordon University; Universidade Federal de Ouro Preto
RP de Souza, MO (corresponding author), Univ Fed Ouro Preto, Sch Nutr, Dept Food Sci, Lab Nutr Biochem & Mol Biol, BR-35400000 Ouro Preto, Brazil.
EM melina@ufop.edu.br
RI Barbosa, Priscila/IUN-5145-2023
OI Oliveira Barbosa, Priscila/0000-0001-5270-6345; Dias Teixeira,
   Clecia/0009-0008-7399-5308
CR Abboud RD, 2020, NUTR HOSP, V37, P343, DOI 10.20960/nh.02759
   Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529
   Bjornstad P, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1101-6
   Bortolin RC, 2019, PHYTOTHER RES, V33, P1394, DOI 10.1002/ptr.6330
   Pinaffi ACD, 2020, MOLECULES, V25, DOI 10.3390/molecules25030679
   dos Santos TW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092757
   Edwards HGM, 2005, ANAL CHIM ACTA, V532, P177, DOI 10.1016/j.aca.2004.10.055
   EMBRAPA, 2005, Cultura do guaranazeiro no Amazonas
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Farias-Pereira R, 2019, FOOD SCI BIOTECHNOL, V28, P1287, DOI 10.1007/s10068-019-00662-0
   Guan CC, 2022, BIOMED PHARMACOTHER, V156, DOI 10.1016/j.biopha.2022.113951
   Hall Philip, 2012, Ulster Med J, V81, P30
   Haskell CF, 2007, J PSYCHOPHARMACOL, V21, P65, DOI 10.1177/0269881106063815
   Hooijmans CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0187271
   Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43
   Kawai T, 2021, AM J PHYSIOL-CELL PH, V320, pC375, DOI 10.1152/ajpcell.00379.2020
   Kennedy DO, 2022, SPORTS MED, V52, P69, DOI 10.1007/s40279-022-01796-8
   Krewer CD, 2014, EUR FOOD RES TECHNOL, V239, P49, DOI 10.1007/s00217-014-2182-3
   Krewer CD, 2011, PHYTOTHER RES, V25, P1367, DOI 10.1002/ptr.3437
   Lima ND, 2019, EUR J NUTR, V58, P765, DOI 10.1007/s00394-018-1686-1
   Lima ND, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020165
   Lima ND, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060635
   Lin XH, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.706978
   Machado AK, 2015, FOOD RES INT, V67, P426, DOI 10.1016/j.foodres.2014.11.056
   Machado KN, 2021, FOOD CHEM, V355, DOI 10.1016/j.foodchem.2021.129563
   Machado KN, 2018, FOOD CHEM, V239, P180, DOI 10.1016/j.foodchem.2017.06.089
   Martyn JAJ, 2008, ANESTHESIOLOGY, V109, P137, DOI 10.1097/ALN.0b013e3181799d45
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Mendes TMN, 2019, J FUNCT FOODS, V55, P352, DOI 10.1016/j.jff.2019.02.026
   Pagliarussi RS, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070254
   Patrick M, 2019, J AGR FOOD CHEM, V67, P11281, DOI 10.1021/acs.jafc.9b03781
   Penna EM, 2024, INT J SPORT NUTR EXE, V34, P30, DOI 10.1123/ijsnem.2023-0148
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Reverte-Salisa L, 2019, HANDB EXP PHARMACOL, V251, P161, DOI 10.1007/164_2018_117
   Roggia I, 2020, J FOOD COMPOS ANAL, V94, DOI 10.1016/j.jfca.2020.103629
   Roncon CM, 2011, PLANTA MED, V77, P236, DOI 10.1055/s-0030-1250315
   Ruchel JB, 2016, PHYTOTHER RES, V30, P49, DOI 10.1002/ptr.5499
   Ruchel JB, 2021, DRUG CHEM TOXICOL, V44, P524, DOI 10.1080/01480545.2019.1624767
   Ruchel JB, 2017, PHYSIOL BEHAV, V168, P11, DOI 10.1016/j.physbeh.2016.10.003
   Russo S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.746151
   Santana AL, 2018, J FUNCT FOODS, V47, P457, DOI 10.1016/j.jff.2018.05.048
   Schimpl FC, 2013, J ETHNOPHARMACOL, V150, P14, DOI 10.1016/j.jep.2013.08.023
   Shabalala SC, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110785
   Silva C. P., 2019, J Food Bioact, V6, P1, DOI [10.31665/JFB.2019.6182, DOI 10.31665/JFB.2019.6182]
   Singh M, 2020, FUTURE FOODS, V1-2, DOI 10.1016/j.fufo.2020.100002
   Siriwardhana N, 2013, J NUTR BIOCHEM, V24, P613, DOI 10.1016/j.jnutbio.2012.12.013
   Sousa SA, 2010, REV BRAS FARMACOGN, V20, P866, DOI 10.1590/S0102-695X2011005000001
   Dinh TC, 2019, DIAB MET SYND CLIN R, V13, P1667, DOI 10.1016/j.dsx.2019.03.021
   Torres EAFS, 2022, COMPR REV FOOD SCI F, V21, P272, DOI 10.1111/1541-4337.12862
   Tozzi M, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00878
   van der Vaart JI, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051122
   Van Schaik L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80505-9
   Van Schaik L, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.621356
   World Health Organization, 2021, Obeisty and Overweight
   Wu LF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15904
   Yonekura L, 2016, FOOD FUNCT, V7, P2970, DOI [10.1039/C6FO00513F, 10.1039/c6fo00513f]
NR 57
TC 3
Z9 3
U1 3
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN
PY 2024
VL 112
AR 105944
DI 10.1016/j.jff.2023.105944
EA DEC 2023
PG 12
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HL8Y1
UT WOS:001159764800001
OA gold
DA 2025-04-28
ER

PT J
AU Torres, A
   Noriega, LG
   Delgadillo-Puga, C
   Tovar, AR
   Navarro-Ocaña, A
AF Torres, Andrea
   Noriega, Lilia G.
   Delgadillo-Puga, Claudia
   Tovar, Armando R.
   Navarro-Ocana, Arturo
TI Caffeoylquinic Acid Derivatives of Purple Sweet Potato as Modulators of
   Mitochondrial Function in Mouse Primary Hepatocytes
SO MOLECULES
LA English
DT Article
DE purple sweet potato; CQA-derivatives; maximal respiration; glycolysis;
   hepatic steatosis
ID FATTY LIVER-DISEASE; ANTIOXIDANT ACTIVITY; HEPATIC STEATOSIS; FLESHED
   POTATOES; CHLOROGENIC ACID; ANTHOCYANIN; OBESITY; INHIBITION;
   METABOLISM; EXTRACTION
AB Owing to their antioxidant properties, caffeoylquinic acid (CQA)-derivatives could potentially improve the impaired metabolism in hepatic cells, however, their effect on mitochondrial function has not been demonstrated yet. Here, we evaluated the impact of three CQA-derivatives extracted from purple sweet potato, namely 5-CQA, 3,4- and 4,5-diCQA, on mitochondrial activity in primary hepatocytes using an extracellular flux analyzer. Notably, an increase of maximal respiration and spare respiratory capacity were observed when 5-CQA and 3,4-diCQA were added to the system indicating the improved mitochondrial function. Moreover, 3,4-diCQA was shown to considerably increase glycolytic reserve which is a measure of cell capability to respond to an energy demand through glycolysis. Conversely, 4,5-diCQA did not modify mitochondrial activity but increased glycolysis at low concentration in primary hepatocytes. All compounds tested improved cellular capacity to oxidize fatty acids. Overall, our results demonstrated the potential of test CQA-derivatives to modify mitochondrial function in hepatic cells. It is especially relevant in case of dysfunctional mitochondria in hepatocytes linked to hepatic steatosis during obesity, diabetes, and metabolic syndrome.
C1 [Torres, Andrea; Navarro-Ocana, Arturo] Univ Nacl Autonoma Mexico, Fac Quim, Dept Alimentos & Biotecnol, Mexico City 04529, DF, Mexico.
   [Noriega, Lilia G.; Tovar, Armando R.] Inst Nacl Ciencias Med Nutr Salvador Zubiran, Dept Fisiol Nutr, Mexico City 14080, DF, Mexico.
   [Delgadillo-Puga, Claudia] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nutr Anim Dr Fernando Perez Gil Romo, Mexico City 14080, DF, Mexico.
C3 Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias
   Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de
   Ciencias Medicas y Nutricion Salvador Zubiran - Mexico
RP Navarro-Ocaña, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Alimentos & Biotecnol, Mexico City 04529, DF, Mexico.
EM andrea_ta5@hotmail.com; lgnoriegal@gmail.com;
   claudia.delgadillop@incmnsz.mx; armando.tovarp@incmnsz.mx;
   arturono@unam.mx
RI Torres, Andrea/HLP-6166-2023; Noriega, Lilia/ABF-4876-2020; Delgadillo,
   Claudia/M-4487-2019; Delgadillo, Claudia/M-7308-2013
OI Navarro Ocana, ARTURO/0000-0002-8538-3631; Delgadillo,
   Claudia/0000-0003-3506-754X; Noriega, Lilia G./0000-0003-2156-9872
FU CONACYT [308249]; project PAPIIT-UNAM [IT202318]
FX The authors would like to thank the CONACYT doctoral scholarship of
   Andrea Torres (scholarship number: 308249), the project
   PAPIIT-UNAM-IT202318, the members of the Fisiologia de la Nutricion
   department for discussion and the technical support of Margarita Guzman
   and Sandra Tobon-Cornejo.
CR BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Burgos G, 2013, J FOOD COMPOS ANAL, V30, P6, DOI 10.1016/j.jfca.2012.12.001
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Che YY, 2016, MOLECULES, V21, DOI 10.3390/molecules21121728
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   Erk T, 2014, EUR J NUTR, V53, P159, DOI 10.1007/s00394-013-0512-z
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Fan SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051007
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Huang WF, 2018, DIABET METAB SYND OB, V11, P357, DOI 10.2147/DMSO.S166728
   Jackson KMP, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601118
   Jiang XW, 2017, CELL MOL NEUROBIOL, V37, P499, DOI 10.1007/s10571-016-0387-7
   Kita A, 2013, J FOOD COMPOS ANAL, V32, P169, DOI 10.1016/j.jfca.2013.09.006
   Liu T, 2018, MOLECULES, V23, DOI 10.3390/molecules23081988
   Loebenstein G., 2009, P9, DOI 10.1007/978-1-4020-9475-0_2
   MAHMOOD N, 1993, ANTIVIR CHEM CHEMOTH, V4, P235, DOI 10.1177/095632029300400406
   Leal-Díaz AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34242
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Meng XJ, 2019, INT J FOOD SCI TECH, V54, P2887, DOI 10.1111/ijfs.14153
   Mu TH, 2017, SWEET POTATO PROCESSING TECHNOLOGY, P357, DOI 10.1016/B978-0-12-812871-8.00007-6
   Nicolson GL, 2014, ALTERN THER HEALTH M, V20, P18
   Nugroho A, 2009, ARCH PHARM RES, V32, P1361, DOI 10.1007/s12272-009-2003-6
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Palacios-González B, 2019, J NUTR BIOCHEM, V68, P59, DOI 10.1016/j.jnutbio.2019.03.012
   Pereira AD, 2003, Z NATURFORSCH C, V58, P590
   Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Scarano A, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8070102
   Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304
   Spínola V, 2017, PHYTOCHEMISTRY, V143, P29, DOI 10.1016/j.phytochem.2017.07.006
   TAGA MS, 1984, J AM OIL CHEM SOC, V61, P928, DOI 10.1007/BF02542169
   Tominaga Kunihiko, 2009, Environmental Health and Preventive Medicine, V14, P142, DOI 10.1007/s12199-008-0074-5
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Van den Bossche J, 2015, JOVE-J VIS EXP, DOI 10.3791/53424
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang AM, 2018, FOOD CHEM, V260, P124, DOI 10.1016/j.foodchem.2018.03.125
   Wang HL, 2020, INT J BIOL MACROMOL, V148, P324, DOI 10.1016/j.ijbiomac.2020.01.146
   Wianowska D, 2019, PHYTOCHEM REV, V18, P273, DOI 10.1007/s11101-018-9592-y
   Xie MH, 2019, J AGR FOOD CHEM, V67, P171, DOI 10.1021/acs.jafc.8b05444
   Yoshimoto M, 2002, BIOSCI BIOTECH BIOCH, V66, P2336, DOI 10.1271/bbb.66.2336
   Zamora-López K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71878-y
   Zhang H, 2016, J FUNCT FOODS, V22, P363, DOI 10.1016/j.jff.2016.01.004
   Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053931, 10.1371/journal.pone.0053995, 10.1371/journal.pone.0057805]
   Zhao JG, 2014, FOOD CHEM, V161, P22, DOI 10.1016/j.foodchem.2014.03.079
NR 47
TC 11
Z9 12
U1 1
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN
PY 2021
VL 26
IS 2
AR 319
DI 10.3390/molecules26020319
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA PX6FW
UT WOS:000611451000001
PM 33435516
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Ogura, K
   Ogura, M
   Shoji, T
   Sato, Y
   Tahara, Y
   Yamano, G
   Sato, H
   Sugizaki, K
   Fujita, N
   Tatsuoka, H
   Usui, R
   Muka, E
   Fujimoto, S
   Inagaki, N
   Nagashima, K
AF Ogura, Kasane
   Ogura, Masahito
   Shoji, Toshihiko
   Sato, Yuichi
   Tahara, Yumiko
   Yamano, Gen
   Sato, Hiroki
   Sugizaki, Kazu
   Fujita, Naotaka
   Tatsuoka, Hisato
   Usui, Ryota
   Muka, Eri
   Fujimoto, Shimpei
   Inagaki, Nobuya
   Nagashima, Kazuaki
TI Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance
   via Suppression of Pro-Inflammatory Cytokine Expression in Liver of
   Diabetic ob/ob Mice
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE apple procyanidins; insulin resistance; inflammation; ob/ob mouse
ID BETA-CELL FUNCTION; HIGH-FAT; GLUCOSE-PRODUCTION; OXIDATIVE STRESS;
   CHLOROGENIC ACID; GENE-EXPRESSION; DISEASE; MECHANISMS; OBESITY; RATS
AB Procyanidins, the main ingredient of apple polyphenols, are known to possess antioxidative and anti-inflammatory effects associated closely with the pathophysiology of insulin resistance and type 2 diabetes. We investigated the effects of orally administered apple procyanidins (APCs) on glucose metabolism using diabetic ob/ob mice. We found no difference in body weight or body composition between mice treated with APCs and untreated mice. A 4 week oral administration of APCs containing water [0.5% (w/v)] ameliorated glucose tolerance, insulin resistance, and hepatic gluconeogenesis in ob/ob mice. APCs also suppressed the increase in the level of the pancreatic beta-cell. Insulin-stimulated Akt phosphorylation was significantly enhanced; pro-inflammatory cytokine expression levels were significantly decreased, and c-Jun N-terminal kinase phosphorylation was downregulated in the liver of those mice treated with APCs. In conclusion, APCs ameliorate insulin resistance by improving hepatic insulin signaling through suppression Of hepatic inflammation in ob/ob mice, which may be a mechanism with possible beneficial health effects of APCs in disturbed glucose metabolism.
C1 [Ogura, Kasane; Ogura, Masahito; Sato, Yuichi; Tahara, Yumiko; Yamano, Gen; Sato, Hiroki; Sugizaki, Kazu; Fujita, Naotaka; Tatsuoka, Hisato; Usui, Ryota; Inagaki, Nobuya; Nagashima, Kazuaki] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Shogoinkawahara Cho, Kyoto 6068507, Japan.
   [Shoji, Toshihiko] NARO, Inst Fruit Tree & Tea Sci, 2-1 Fujimoto, Tsukuba, Ibaraki 3058605, Japan.
   [Muka, Eri] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Lab Med Physiol & Metab, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.
   [Fujimoto, Shimpei] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, 185-1 Kohasu,Oko Cho, Nankoku, Kochi 7838505, Japan.
C3 Kyoto University; National Agriculture & Food Research Organization -
   Japan; Ritsumeikan University; Kochi University
RP Nagashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Shogoinkawahara Cho, Kyoto 6068507, Japan.
EM nagasima@kuhp.kyoto-u.ac.jp
RI Inagaki, Nobuya/IVV-3659-2023; Tatsuoka, Hisato/JLL-5299-2023; Sato,
   Hiroki/IRZ-1683-2023
OI Usui, Ryota/0000-0002-4641-0158; Inagaki, Nobuya/0000-0001-8261-2593;
   Tatsuoka, Hisato/0000-0002-0669-6825; Shoji,
   Toshihiko/0000-0003-4241-2129
FU Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of
   Education, Culture, Sports, Science and Technology of Japan
FX This work was supported by grants for research project (Development of
   Fundamental Technology for Analysis and Evaluation of Functional
   Agricultural Products and Functional Foods and Development of
   Agricultural Products and Foods with Health-promoting Benefits) from the
   Ministry of Agriculture, Forestry and Fisheries of Japan and scientific
   research grants from the Ministry of Education, Culture, Sports, Science
   and Technology of Japan.
CR Akiyama H, 2005, FEBS LETT, V579, P4485, DOI 10.1016/j.febslet.2005.07.019
   Bagdas D, 2015, FOOD CHEM TOXICOL, V81, P54, DOI 10.1016/j.fct.2015.04.001
   Baratta JL, 2009, HISTOCHEM CELL BIOL, V131, P713, DOI 10.1007/s00418-009-0577-1
   Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006
   Corssmit EPM, 2001, METABOLISM, V50, P742, DOI 10.1053/meta.2001.24195
   de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057
   Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026
   Espley RV, 2014, J NUTR, V144, P146, DOI 10.3945/jn.113.182659
   Floyel T, 2014, P NATL ACAD SCI USA, V111, P10305, DOI 10.1073/pnas.1402571111
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296
   Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004
   Jung M, 2009, MOL NUTR FOOD RES, V53, P1263, DOI 10.1002/mnfr.200800575
   KAHN BB, 1991, J CLIN INVEST, V87, P561, DOI 10.1172/JCI115031
   Konrad D, 2007, DIABETOLOGIA, V50, P833, DOI 10.1007/s00125-007-0596-1
   Kuroda N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092884
   Lapidot T, 2002, J AGR FOOD CHEM, V50, P3156, DOI 10.1021/jf011522g
   Lee YA, 2007, J AGR FOOD CHEM, V55, P9395, DOI 10.1021/jf071523u
   Leontowicz H, 2002, J NUTR BIOCHEM, V13, P603, DOI 10.1016/S0955-2863(02)00206-1
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   Masumoto S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31208
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mezza T, 2014, DIABETES, V63, P994, DOI 10.2337/db13-1013
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Mlinar B, 2007, CLIN CHIM ACTA, V375, P20, DOI 10.1016/j.cca.2006.07.005
   Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001
   Nasteska D, 2014, DIABETES, V63, P2332, DOI 10.2337/db13-1563
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ou KQ, 2014, MOL NUTR FOOD RES, V58, P2196, DOI 10.1002/mnfr.201400243
   Perseghin G, 2009, DIABETES CARE, V32, pS164, DOI 10.2337/dc09-S303
   Qin Bolin, 2010, J Diabetes Sci Technol, V4, P685
   Robertson K, 2008, AM J PHYSIOL-ENDOC M, V294, pE928, DOI 10.1152/ajpendo.00606.2007
   Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005
   Shoji T, 2003, J AGR FOOD CHEM, V51, P3806, DOI 10.1021/jf0300184
   Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200
   Sugiyama H, 2007, J AGR FOOD CHEM, V55, P4604, DOI 10.1021/jf070569k
   Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006
   Vayndorf EM, 2013, J FUNCT FOODS, V5, P1235, DOI 10.1016/j.jff.2013.04.006
   Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806
   Yamashita Y, 2013, BIOSCI BIOTECH BIOCH, V77, P888, DOI 10.1271/bbb.130095
   Yanagida A, 2000, J CHROMATOGR A, V890, P251, DOI 10.1016/S0021-9673(00)00614-2
   Yoshioka Y, 2008, INT IMMUNOPHARMACOL, V8, P1802, DOI 10.1016/j.intimp.2008.08.021
NR 45
TC 46
Z9 56
U1 1
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD NOV 23
PY 2016
VL 64
IS 46
BP 8857
EP 8865
DI 10.1021/acs.jafc.6b03424
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA ED5SU
UT WOS:000388913400017
PM 27792335
DA 2025-04-28
ER

PT J
AU Hu, B
   Cui, FC
   Yin, FP
   Zeng, XX
   Sun, Y
   Li, YQ
AF Hu, Bing
   Cui, Fengchao
   Yin, Fangping
   Zeng, Xiaoxiong
   Sun, Yi
   Li, Yunqi
TI Caffeoylquinic acids competitively inhibit pancreatic lipase through
   binding to the catalytic triad
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chlorogenic acids; Pancreatic lipase; Ligand-protein complex
ID DENSITY-FUNCTIONAL THERMOCHEMISTRY; AUTODOCK VINA; GREEN TEA; COFFEE;
   POLYPHENOLS; OBESITY; ENZYMES
AB Caffeoylquinic acid and its isomers inhibited porcine Pancreatic Lipase (PL) activity according to a competitive mode where binding and interaction with the catalytic triad of Ser153, His264 and Asp177 simultaneously occurred. The IC50 values under which 3-caffeoylquinic acid (CQA) and its isomers 4-, 5-CQA, 3,4-, 3,5- and 4,5-diCQA inhibited half of the porcine PL activity were 1.10, 1.23, 1.24, 0.252, 0.591 and 0.502 mM, respectively. The binding affinities in the range from -8.4 to -9.5 kCal/mol were well predicted from docking, which showed a high linear correlation coefficient of 0.893 and Spearman correlation of 1.0 with log(IC50) values. Caffeoylquinic acid and its isomers were stabilized by hydrogen bond and hydrophobic interaction in the binding pocket. This finding provided molecular mechanism of coffee and other natural food or drink containing caffeoylquinic acid and its isomers against lipase activity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Hu, Bing; Yin, Fangping; Zeng, Xiaoxiong; Sun, Yi] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.
   [Cui, Fengchao; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China.
   [Cui, Fengchao; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, Changchun 130022, Peoples R China.
C3 Nanjing Agricultural University; Chinese Academy of Sciences; Changchun
   Institute of Applied Chemistry, CAS; Chinese Academy of Sciences;
   Changchun Institute of Applied Chemistry, CAS
RP Sun, Y (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.
EM sunyi01@njau.edu.cn; yunqi@ciac.ac.cn
RI Zeng, Xiaoxiong/LYP-2646-2024; Li, Yunqi/C-8372-2016
OI Li, Yunqi/0000-0002-5190-3037; Zeng, Xiaoxiong/0000-0003-2954-3896
FU National Natural Science Foundation of China [31171666, 21374117];
   Natural Science Foundation of Jiangsu Province, China [BK2012367];
   Specialized Research Fund for the Doctoral Program of Higher Education
   of China [20120097120001]; Priority Academic Program Development of
   Jiangsu Higher Education Institutions
FX This work was supported by National Natural Science Foundation of China
   (31171666, 21374117), Natural Science Foundation of Jiangsu Province,
   China (BK2012367), Specialized Research Fund for the Doctoral Program of
   Higher Education of China (No. 20120097120001), and Project Funded by
   the Priority Academic Program Development of Jiangsu Higher Education
   Institutions.
CR Bandyopadhyay P, 2012, FOOD FUNCT, V3, P592, DOI 10.1039/c2fo00006g
   BAXTER J, 1981, J OPER RES SOC, V32, P815, DOI 10.2307/2581397
   Becke A. D., 1993, Journal of Chemical Physics, V98, P5648, DOI 10.1063/1.464913
   BECKE AD, 1992, J CHEM PHYS, V97, P9173, DOI 10.1063/1.463343
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Christian B., 2008, HYBRID METAHEURISTIC
   Cui FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125848
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Frisch J., 2009, GAUSSIAN 16 REVISION
   Gilham D, 2005, METHODS, V36, P139, DOI 10.1016/j.ymeth.2004.11.003
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Hermoso J, 1996, J BIOL CHEM, V271, P18007, DOI 10.1074/jbc.271.30.18007
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   Jöbstl E, 2004, BIOMACROMOLECULES, V5, P942, DOI 10.1021/bm0345110
   Kukol A, 2011, EUR J MED CHEM, V46, P4661, DOI 10.1016/j.ejmech.2011.05.026
   LaBute MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106298
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lehner R, 1997, BIOCHEMISTRY-US, V36, P1861, DOI 10.1021/bi962186d
   Liang L, 2008, BIOMACROMOLECULES, V9, P50, DOI 10.1021/bm700728k
   Little TJ, 2007, AM J CLIN NUTR, V86, P531, DOI 10.1093/ajcn/86.3.531
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3
   Murase T, 2012, BRIT J NUTR, V107, P1757, DOI 10.1017/S0007114511005083
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Perryman AL, 2014, J COMPUT AID MOL DES, V28, P429, DOI 10.1007/s10822-014-9709-3
   Sakulnarmrat K, 2012, FOOD CHEM, V134, P1011, DOI 10.1016/j.foodchem.2012.02.217
   Sengupta B, 2012, INT J BIOL MACROMOL, V51, P250, DOI 10.1016/j.ijbiomac.2012.05.013
   Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469
   Singh H, 2009, PROG LIPID RES, V48, P92, DOI 10.1016/j.plipres.2008.12.001
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529
   Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x
   Wilde PJ, 2011, ADV COLLOID INTERFAC, V165, P14, DOI 10.1016/j.cis.2011.02.004
   Wu XL, 2013, J AGR FOOD CHEM, V61, P8829, DOI 10.1021/jf401779z
   Xiang L, 2015, J MOL STRUCT, V1086, P207, DOI 10.1016/j.molstruc.2015.01.021
   Xiao JB, 2012, CRIT REV FOOD SCI, V52, P85, DOI 10.1080/10408398.2010.499017
   You Q, 2012, LWT-FOOD SCI TECHNOL, V46, P164, DOI 10.1016/j.lwt.2011.10.011
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
NR 46
TC 57
Z9 60
U1 8
U2 75
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP
PY 2015
VL 80
BP 529
EP 535
DI 10.1016/j.ijbiomac.2015.07.031
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA CR3RO
UT WOS:000361251000063
PM 26193679
DA 2025-04-28
ER

PT J
AU Greenway, FL
   de Jonge, L
   Blanchard, D
   Frisard, M
   Smith, SR
AF Greenway, FL
   de Jonge, L
   Blanchard, D
   Frisard, M
   Smith, SR
TI Effect of a dietary herbal supplement containing caffeine and ephedra on
   weight, metabolic rate, and body composition
SO OBESITY RESEARCH
LA English
DT Article
DE ephedra; caffeine; metabolic rate; body composition; herbal dietary
   supplement
ID CATECHIN-POLYPHENOLS; ENERGY-EXPENDITURE; OBESE WOMEN; GREEN TEA;
   EFFICACY; SAFETY; THERMOGENESIS; EXERCISE
AB Objective: To evaluate the effect of a dietary supplement containing herbal caffeine (70 mg/dose) and ephedra (24 mg/dose; C&E) on metabolic rate, weight loss, body composition, and safety parameters.
   Research Methods and Procedures: In phase 1, 12 healthy subjects with a BMI of 25 to 35 kg/m 2 had resting metabolic rate (RMR) measured for 2 hours after ingesting C&E or a placebo on two occasions I week apart, followed by a 1-week washout before phase II. In phase 11, these 12 and 28 additional subjects were randomized to a 12-week, double-blind trial comparing C&E (3 times/day) to placebo. In phase III, the C&E group was given open-label C&E for 3 months, and the placebo group was given C&E for 6 months.
   Results: In phase 1, C&E gave an average 8 +/- 0.1% (SE) rise, in RMR over 2 hours compared with placebo (p < 0.01). In phase 11, weight loss at 12 weeks was 3.5 +/- 0.6 kg with C&E compared with 0.8 +/- 0.5 kg with placebo (p < 0.02). The percentage fat lost, shown by DXA, was 7.9 +/- 2.9% with C&E and 1.9 +/- 1.1% with placebo (p < 0.05). Pulse decreased more. in the placebo group that in the CE group (p < 0.03). There were no differences in lipid levels or blood pressure. In phase 111, there was a 6-month loss of 7.3% and 7.8% of initial body weight for the groups on placebo and C&E during phase 11, respectively. There were no serious adverse events.
   Discussion: C&E increased RMR significantly by 8% compared with placebo, promoted more weight and fat loss than placebo, and was well tolerated.
C1 Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center
RP Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM greenwfl@pbrc.edu
RI Greenway, Frank/N-1966-2017
OI de Jonge, Lilian/0000-0001-5900-0695; Smith, Steven/0000-0002-5098-8147
CR ASTRUP A, 1992, INT J OBESITY, V16, P269
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   Dowling EA, 1996, MED SCI SPORT EXER, V28, P482, DOI 10.1097/00005768-199604000-00013
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   *FDC, 2000, FDC REP
   Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541
   GOODMAN L, 1985, PHARMACOL BASIS THER, P595
   Greenway F L, 2001, Obes Rev, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   HAGAN RD, 1982, INT J SPORTS MED, V3, P177, DOI 10.1055/s-2008-1026085
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Hoeger WWK, 1998, ADV THER, V15, P305
   JAEDIG S, 1994, MINER ELECTROL METAB, V20, P147
   LIU YL, 1995, INT J OBESITY, V19, P678
   MALCHOWMOLLER A, 1981, INT J OBESITY, V5, P183
   Pi-Sunyer FX, 1998, OBES RES, V6, p51S
   ROGERS PJ, 1994, PHYSIOL BEHAV, V56, P247, DOI 10.1016/0031-9384(94)90191-0
   SCHECHTER PJ, 1979, AM J CLIN NUTR, V32, P1011, DOI 10.1093/ajcn/32.5.1011
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Umeta M, 2000, LANCET, V355, P2021, DOI 10.1016/S0140-6736(00)02348-5
   Vansal SS, 1999, BIOCHEM PHARMACOL, V58, P807, DOI 10.1016/S0006-2952(99)00152-5
   Volpe SL, 2001, J AM COLL NUTR, V20, P293, DOI 10.1080/07315724.2001.10719050
NR 23
TC 53
Z9 59
U1 0
U2 19
PU NORTH AMER ASSOC STUDY OBESITY
PI SILVER SPRING
PA 8630 FENTON ST, SUITE 918, SILVER SPRING, MD 20910 USA
SN 1071-7323
J9 OBES RES
JI Obes. Res.
PD JUL
PY 2004
VL 12
IS 7
BP 1152
EP 1157
DI 10.1038/oby.2004.144
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 844KY
UT WOS:000223158300015
PM 15292480
DA 2025-04-28
ER

PT J
AU Wan, CJ
   Lin, LY
   Yu, TH
   Sheu, WHH
AF Wan, Chu-Jen
   Lin, Li-Yun
   Yu, Tung-Hsi
   Sheu, Wayne H-H
TI Metabolic syndrome associated with habitual indulgence and dietary
   behavior in middle-aged health-care professionals
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Article
DE Health-care professionals; Habitual indulgence; Metabolic syndrome
ID ALCOHOL-CONSUMPTION; COFFEE CONSUMPTION; INSULIN-RESISTANCE; DAIRY
   CONSUMPTION; TEA CONSUMPTION; BLOOD-PRESSURE; RISK-FACTORS; GREEN TEA;
   PREVALENCE; OBESITY
AB Aims/Introduction: Few studies, especially in Asia, have examined the relevance between metabolic syndrome (MetS), habitual indulgence and dietary behaviors in health-care professionals. The present study evaluates metabolic syndrome rate and its association with habitual indulgence (coffee, tea, alcohol and cigarette smoking) and diet behavior in health-care professionals.
   Materials and Methods: Information was collected from 514 health-care professionals (147 men, 367 women) who underwent routine physical examinations at a medical center in central Taiwan.
   Results: Mean age was 48 +/- 5 years for men and 45 +/- 4 years for women. Mean body mass index was 25.2 +/- 4.0 kg/m(2) for men and 22.5 +/- 3.4 kg/m(2) for women. The age-adjusted MetS rate among subjects was 24.8-11.7% in men and 7.8-5.4% in women, using two different definitions, respectively. The MetS rate among those who occasionally or frequently consumed tea was higher than among those who never consumed tea (P < 0.05). Although the proportion of subjects who had MetS differed among those with differing alcohol drinking habits (never, quit and current; P < 0.05), a posteriori comparisons showed no significant differences between the two groups. Compared with those who had never smoked, the rate was higher in former smokers and current smokers (P < 0.001). No significant association with coffee consumption was found. People with MetS often consumed sweetened beverages (P < 0.05), rarely read nutrition labels and seldom consumed dairy products.
   Conclusions: Health-care professionals who regularly consume tea, smoke, frequently have sweetened drinks, rarely read nutrition labels or rarely consume dairy products are at higher risk of suffering from MetS. (J Diabetes Invest, doi:10.1111/j.2040-1124.2010.00055.x, 2010)
C1 [Sheu, Wayne H-H] Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan.
   [Wan, Chu-Jen] Taichung Vet Gen Hosp, Dept Dietet, Taichung, Taiwan.
   [Wan, Chu-Jen; Lin, Li-Yun] Hungkuang Univ, Dept Food Sci & Appl Biotechnol, Taichung, Taiwan.
   [Yu, Tung-Hsi] Hungkuang Univ, Dept Hotel & Restaurant Management, Taichung, Taiwan.
   [Sheu, Wayne H-H] Natl Chung Hsing Univ, Inst Med Technol, Taichung 40227, Taiwan.
   [Sheu, Wayne H-H] Natl Yang Ming Univ, Coll Med, Taipei 112, Taiwan.
C3 Taichung Veterans General Hospital; Taichung Veterans General Hospital;
   Hungkuang University; Hungkuang University; National Chung Hsing
   University; National Yang Ming Chiao Tung University
RP Sheu, WHH (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan.
EM whhsheu@vghtc.gov.tw
CR Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Azadbakht L, 2005, AM J CLIN NUTR, V82, P523, DOI 10.1093/ajcn/82.3.523
   Boisaubin EV, 2001, AM J MED SCI, V322, P31, DOI 10.1097/00000441-200107000-00006
   Brooke D, 1996, ADDICTION, V91, P317, DOI 10.1111/j.1360-0443.1996.tb02281.x
   CAPLAN RP, 1994, BRIT MED J, V309, P1261, DOI 10.1136/bmj.309.6964.1261
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Djoussé L, 2004, OBES RES, V12, P1375, DOI 10.1038/oby.2004.174
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   Fraser ML, 2007, COMPLEMENT THER MED, V15, P46, DOI 10.1016/j.ctim.2006.07.002
   Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Harris A, 2007, PSYCHONEUROENDOCRINO, V32, P322, DOI 10.1016/j.psyneuen.2007.01.003
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hodgson JM, 2006, CLIN EXP PHARMACOL P, V33, P838, DOI 10.1111/j.1440-1681.2006.04450.x
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3
   Ishizaka N, 2005, ATHEROSCLEROSIS, V181, P381, DOI 10.1016/j.atherosclerosis.2005.01.026
   Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647
   Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353
   John U, 2005, OBES RES, V13, P101, DOI 10.1038/oby.2005.13
   Kim SY, 2000, J AGR RESOUR ECON, V25, P215
   Kreuter MW, 1997, AM J PREV MED, V13, P277, DOI 10.1016/S0749-3797(18)30175-2
   Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006
   Lin CC, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-12
   Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X
   McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538
   Mennen LI, 2000, NUTR RES, V20, P335, DOI 10.1016/S0271-5317(00)00127-5
   Neuhouser ML, 1999, J AM DIET ASSOC, V99, P45, DOI 10.1016/S0002-8223(99)00013-9
   Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081
   ROMELSJO A, 1992, BRIT J ADDICT, V87, P1173
   Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0
   Shimada K, 2004, DIABETES RES CLIN PR, V65, P227, DOI 10.1016/j.diabres.2004.01.003
   Smith DR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-115
NR 34
TC 9
Z9 9
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1116
EI 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD DEC
PY 2010
VL 1
IS 6
BP 259
EP 265
DI 10.1111/j.2040-1124.2010.00055.x
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 755DR
UT WOS:000289907400006
PM 24843441
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Gemesi, K
   Holzmann, SL
   Kaiser, B
   Wintergerst, M
   Lurz, M
   Groh, G
   Böhm, M
   Krcmar, H
   Gedrich, K
   Hauner, H
   Holzapfel, C
AF Gemesi, Kathrin
   Holzmann, Sophie Laura
   Kaiser, Birgit
   Wintergerst, Monika
   Lurz, Martin
   Groh, Georg
   Boehm, Markus
   Krcmar, Helmut
   Gedrich, Kurt
   Hauner, Hans
   Holzapfel, Christina
TI Stress eating: an online survey of eating behaviours, comfort foods, and
   healthy food substitutes in German adults
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Stress; Nutrition; Chocolate; Coffee; Obesity
ID SELECTION; CHOICES
AB Background: In many people, stress is associated with changes in eating behaviour. Food products consumed during stress (comfort foods) are often unhealthy. It is rather unknown what comfort foods are consumed in Germany and what healthier food products are considered as alternatives to support stress-eaters in making healthier food choices.
   Methods: This online survey was conducted in spring 2021 throughout Germany. Participants were digitally recruited by newsletters, homepages, social media, and mailing lists. The survey included a standardized questionnaire with items concerning e.g. sociodemography, stress, and nutrition. Comfort foods were pre-selected through literature search and food substitutes were defined and discussed by experts. Analyses examined comfort food consumption and substitute preferences dependent on sex, age, body mass index (BMI), and being a self-identified stress-eater. The statistical analysis was performed using R.
   Results: Survey participants were mostly female (80.6%, 994/1234), had a mean age of 31.4 +/- 12.8 years and a mean BMI of 23.4 +/- 4.3 kg/m(2). Participants stated, that the two favourite comfort foods were chocolate (consumed often/very often by 48.3%, 596/1234) and coffee (consumed often/very often by 45.9%, 566/1234). Regarding food substitutes, the most frequently named alternative food for chocolate and cookies was fresh fruits (for chocolate: 74.4%, 815/1096, for cookies: 62.6%, 565/902). Tea without added sugar (64.4%, 541/840) was the preferred substitute for coffee. Almost 50% of participants (48.1%, 594/1234) identified themselves as stress-eaters, of which 68.9% (408/592) stated to eat (very) often more than usual in subjective stress situations.
   Conclusions: The results from this work suggest that specific comfort foods and substitutes are preferred by the participants in stressful situations. This knowledge about food choices and substitutes should be investigated in further studies to improve eating behaviour in stressful situations.
C1 [Gemesi, Kathrin; Holzmann, Sophie Laura; Hauner, Hans; Holzapfel, Christina] Tech Univ Munich, Sch Med, Inst Nutr Med, Georg Brauchle Ring 62, D-80992 Munich, Germany.
   [Kaiser, Birgit; Gedrich, Kurt] Tech Univ Munich, ZIEL Inst Food & Hlth, Res Grp Publ Hlth Nutr, Freising Weihenstephan, Germany.
   [Wintergerst, Monika; Groh, Georg] Tech Univ Munich, Dept Informat, Res Grp Social Comp, Garching, Germany.
   [Lurz, Martin; Boehm, Markus; Krcmar, Helmut] Tech Univ Munich, Dept Informat, Krcmar Lab, Garching, Germany.
   [Boehm, Markus] Univ Appl Sci Landshut, Dept Informat, Landshut, Germany.
   [Hauner, Hans] Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, Sch Life Sci, Freising Weihenstephan, Germany.
C3 Technical University of Munich; Technical University of Munich;
   Technical University of Munich; Technical University of Munich;
   Technical University of Munich
RP Holzapfel, C (corresponding author), Tech Univ Munich, Sch Med, Inst Nutr Med, Georg Brauchle Ring 62, D-80992 Munich, Germany.
EM christina.holzapfel@tum.de
RI Gedrich, Kurt/I-2312-2019; Böhm, Markus/AAF-3762-2020; Krcmar,
   Helmut/AAA-8434-2020; Holzapfel, Christina/AAO-5928-2020
OI Gemesi, Kathrin/0000-0002-5179-6366; Gedrich, Kurt/0000-0001-7321-2555
FU German Federal Ministry of Education and Research (Bundesministerium fur
   Bildung und Forschung, BMBF) [01EA1807H, 01EA1807A]; Projekt DEAL
FX Open Access funding enabled and organized by Projekt DEAL. This work was
   supported by the enable competence cluster, an interdisciplinary cluster
   of nutrition research, funded by the German Federal Ministry of
   Education and Research (Bundesministerium fur Bildung und Forschung,
   BMBF; grant number: 01EA1807H, 01EA1807A). The enable publication number
   is 78.
CR Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011
   [Anonymous], 2007, STRESS MAJ HLTH PROB
   Broers VJV, 2017, EUR J PUBLIC HEALTH, V27, P912, DOI 10.1093/eurpub/ckx085
   Bucher T, 2016, BRIT J NUTR, V115, P2252, DOI 10.1017/S0007114516001653
   Choi J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051241
   Dubé L, 2005, PHYSIOL BEHAV, V86, P559, DOI 10.1016/j.physbeh.2005.08.023
   Errisuriz VL, 2016, EAT BEHAV, V22, P211, DOI 10.1016/j.eatbeh.2016.06.008
   Hapke U, 2013, BUNDESGESUNDHEITSBLA, V56, P749, DOI 10.1007/s00103-013-1690-9
   Janssen M, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.635859
   Kaiser B., 2020, Ernaehrungs-Umschau, V67, P98
   Kaiser B, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-021-12488-9
   Kandiah J, 2006, NUTR RES, V26, P118, DOI 10.1016/j.nutres.2005.11.010
   Khaled K, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00609-w
   Klatzkin RR, 2019, PHYSIOL BEHAV, V210, DOI 10.1016/j.physbeh.2019.112639
   Laitinen J, 2002, PREV MED, V34, P29, DOI 10.1006/pmed.2001.0948
   Ling JY, 2021, APPETITE, V163, DOI 10.1016/j.appet.2021.105215
   Mikolajczyk RT, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-31
   Mohamed BA, 2020, PSYCHOL RES BEHAV MA, V13, P211, DOI 10.2147/PRBM.S236953
   Oliver G, 1999, PHYSIOL BEHAV, V66, P511, DOI 10.1016/S0031-9384(98)00322-9
   Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016
   Richardson AS, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0110-4
   Rutters F, 2009, OBESITY, V17, P72, DOI 10.1038/oby.2008.493
   Spence C, 2017, INT J GASTRON FOOD S, V9, P105, DOI 10.1016/j.ijgfs.2017.07.001
   Tomiyama AJ, 2019, ANNU REV PSYCHOL, V70, P703, DOI 10.1146/annurev-psych-010418-102936
   Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008
   Tsenkova V, 2013, APPETITE, V69, P151, DOI 10.1016/j.appet.2013.05.020
   Van Blyderveen S, 2016, EAT BEHAV, V23, P76, DOI 10.1016/j.eatbeh.2016.07.009
   Wagner HS, 2014, HEALTH PSYCHOL, V33, P1552, DOI 10.1037/hea0000068
   Weinstein SE, 1997, APPETITE, V28, P7, DOI 10.1006/appe.1996.0056
   Westermann S, 2015, EAT BEHAV, V17, P74, DOI 10.1016/j.eatbeh.2015.01.001
   Zellner DA, 2006, PHYSIOL BEHAV, V87, P789, DOI 10.1016/j.physbeh.2006.01.014
NR 31
TC 8
Z9 8
U1 1
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 24
PY 2022
VL 22
IS 1
AR 391
DI 10.1186/s12889-022-12787-9
PG 12
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ZH5DG
UT WOS:000760958900004
PM 35209876
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Gyntelberg, F
   Hein, HO
   Suadicani, P
AF Gyntelberg, Finn
   Hein, Hans Ole
   Suadicani, Poul
TI Determinants of Obesity Among Men with the Lewis Double-Negative Blood
   Group: A Genetic Marker of Obesity-The Copenhagen Male Study
SO METABOLIC SYNDROME AND RELATED DISORDERS
LA English
DT Article
ID COFFEE CONSUMPTION; GLUCOSE-TOLERANCE; RISK
AB Objective: Middle-aged and elderly men with the Lewis blood group phenotype Le(a-b-), have a two-fold higher prevalence of obesity than others. We investigated if the association could be ascribed to differences in lifestyle, or if obesity determinants had a different impact in this group.
   Method: This was a cross-sectional study of 3,290 men aged 53-74 years with a mean of 63 years drawn from the Copenhagen Male Study. The main outcome measure was prevalence of obesity [body mass index (BMI) >= 30 (kg/m(2))].
   Results: Among men with the Le(a-b-) phenotype (n = 315), the prevalence of obesity was 15.6%; it was 8.1% among men with other phenotypes (n = 2,975, p<0.001). Obesity-related life style habits did not differ between Le(a-b-) and other men. In multiple logistic regression analyses, the role of obesity covariates was conspicuously different between men with the Le(a-b-) phenotype and men with other Lewis phenotypes. However, among Le(a-b-) men, a much stronger inverse association was found between high coffee consumption (>7 cups/day vs. less) and obesity, and between lacking fat avoidance and obesity; the odds ratio [95% confidence interval (CI)] for high coffee consumption was 0.2(0.1-0.7) and for avoidance of fatty foods 2.0(1.04-3.7). The association of obesity with leisure time physical activity, smoking, alcohol use, use of sugar in hot beverages, and tea consumption, did not differ between Le(a-b-) men and others.
   Conclusions: Our findings suggests a gene-environment interaction between lifestyle and obesity. Because some ethnic groups have up to 40% with the Le(a-b-) phenotype, the above observations may be of significant public health interest.
C1 [Gyntelberg, Finn; Hein, Hans Ole; Suadicani, Poul] Univ Copenhagen, Bispebjerg Hosp, Epidemiol Res Unit, Dept Occupat & Environm Med, DK-2400 Copenhagen NV, Denmark.
   [Hein, Hans Ole] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.
C3 University of Copenhagen; Bispebjerg Hospital; Copenhagen University
   Hospital; University of Copenhagen; Copenhagen University Hospital
RP Gyntelberg, F (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Epidemiol Res Unit, Dept Occupat & Environm Med, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.
EM fgyn0001@bbhregionh.dk
CR Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   [Anonymous], 1998, OB PREV MAN GLOB EP
   GYNTELBERG F, 1973, DAN MED BULL, V20, P1
   GYNTELBERG F, 1975, DAN MED BULL, V22, P81
   HEIN HO, 1992, J INTERN MED, V232, P481, DOI 10.1111/j.1365-2796.1992.tb00620.x
   Hein HO, 2005, INT J OBESITY, V29, P540, DOI 10.1038/sj.ijo.0802923
   Hosmer D, 1989, APPL LOGISTIC REGRES
   KLEINBAUM DG, 1982, EPIDEMIOLOGICAL RES, pCH19
   Mourant AE, 1976, DISTRIBUTION HUMAN B
   NORUSIS M, 1997, SPSS WINDOWS PROFESS
   NORUSIS MJ, 1997, SPSS WINDOWS BASE SY
   Omvik Per, 1996, Blood Pressure, V5, P71, DOI 10.3109/08037059609062111
   Petrie HJ, 2004, AM J CLIN NUTR, V80, P22
   Suadicani P, 2005, EUR J CARDIOV PREV R, V12, P236, DOI 10.1097/00149831-200506000-00009
   SUADICANI P, 1994, INT J EPIDEMIOL, V23, P293, DOI 10.1093/ije/23.2.293
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
NR 16
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-4196
EI 1557-8518
J9 METAB SYNDR RELAT D
JI Metab. Syndr. Relat. Disord.
PD APR
PY 2011
VL 9
IS 2
BP 99
EP 103
DI 10.1089/met.2010.0044
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 741EY
UT WOS:000288847200004
PM 21117959
DA 2025-04-28
ER

PT J
AU Greenberg, JA
   Neuhouser, ML
   Tinker, LF
   Lane, DS
   Paskett, ED
   Van Horn, LV
   Wassertheil-Smoller, S
   Shikany, JM
   Qi, LH
   Sealy-Jefferson, S
   Manson, JE
AF Greenberg, James A.
   Neuhouser, Marian L.
   Tinker, Lesley F.
   Lane, Dorothy S.
   Paskett, Electra D.
   Van Horn, Linda V.
   Wassertheil-Smoller, Sylvia
   Shikany, James M.
   Qi, Lihong
   Sealy-Jefferson, Shawnita
   Manson, JoAnn E.
TI Chocolate Candy and Incident Invasive Cancer Risk in the Women's Health
   Initiative: An Observational Prospective Analysis
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
DE Women's Health Initiative; Chocolate consumption; Invasive cancer;
   Invasive colorectal cancer; Obesity
ID CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; COCOA; CONSUMPTION;
   FLAVONOIDS; COFFEE; FOODS; FAT
AB Background Laboratory and animal studies suggest an inverse association between chocolate consumption and the risk of cancer. Epidemiological studies have yielded inconsistent evidence.
   Objective To assess the association of chocolate candy consumption with incident, invasive total, breast, colorectal, and lung cancers in a large cohort of postmenopausal American women.
   Design Prospective cohort study with a mean 14.8-year follow-up. Chocolate candy intake was assessed by food frequency questionnaire. Invasive cancer events were assessed by physician adjudication.
   Participants/setting The Women's Health Initiative Study enrolled 161,808 postmenopausal women at 40 clinical centers nationwide between 1993 and 1998. Of these women, 114,281 with plausible food frequency or biometric data and no missing data on chocolate candy exposure were selected for analysis.
   Main outcome measures Cancer risk in quartiles of chocolate candy consumption with the first quartile as referent.
   Statistical analyses Multivariable Cox regression was used to calculate hazard ratios and 95% confidence intervals.
   Results There were 16,164 documented incident invasive cancers, representing an incidence rate of 17.0 per 100 participants and 12.3 per 1000 person years during follow-up among participants without any preexisting cancers or missing outcome data. There were no statistically significant associations for total invasive cancer (P-linear = .47, P-curvature = .14), or invasive breast cancer (P-linear = .77, P-curvature = .26). For colorectal cancer P-linear was .02, P-curvature was .03, and compared with women eating a 1 oz (28.4 g) chocolate candy serving <1 time per month, the hazard ratio for >= 1.5 times/ wk was 1.18 (95% confidence interval: 1.04-1.35). This result may be attributable to the excess adiposity associated with frequent chocolate candy consumption.
   Conclusions In the Women's Health Initiative, there was no significant association between chocolate candy consumption and invasive total or breast cancer. There was a modest 18% higher risk of invasive colorectal cancer for women who ate chocolate candy at least 1.5 times/wk. These results require confirmation.
C1 [Greenberg, James A.] CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, 2900 Bedford Ave, Brooklyn, NY 11210 USA.
   [Neuhouser, Marian L.; Tinker, Lesley F.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA.
   [Lane, Dorothy S.] SUNY Stony Brook, Sch Med, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA.
   [Paskett, Electra D.] Ohio State Univ, Canc Res, Dept Internal Med, Div Canc Prevent & Control,Coll Med,Comprehens Ca, Columbus, OH 43210 USA.
   [Sealy-Jefferson, Shawnita] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA.
   [Van Horn, Linda V.] Northwestern Univ, Nutr, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.
   [Shikany, James M.] Univ Alabama Birmingham, Cardiovasc Dis, Div Prevent Med, Sch Med, Birmingham, AL USA.
   [Shikany, James M.] Univ Alabama Birmingham, Sch Med, Div Prevent Med, Res, Birmingham, AL USA.
   [Qi, Lihong] Univ Calif Davis, Dept Publ Hlth Sci, Sch Med, Davis, CA 95616 USA.
   [Manson, JoAnn E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.
C3 City University of New York (CUNY) System; Brooklyn College (CUNY); Fred
   Hutchinson Cancer Center; State University of New York (SUNY) System;
   Stony Brook University; University System of Ohio; Ohio State
   University; University System of Ohio; Ohio State University;
   Northwestern University; Feinberg School of Medicine; Yeshiva
   University; Montefiore Medical Center; Albert Einstein College of
   Medicine; University of Alabama System; University of Alabama
   Birmingham; University of Alabama System; University of Alabama
   Birmingham; University of California System; University of California
   Davis; Harvard University; Harvard Medical School; Harvard University
   Medical Affiliates; Brigham & Women's Hospital
RP Greenberg, JA (corresponding author), CUNY Brooklyn Coll, Dept Hlth & Nutr Sci, 2900 Bedford Ave, Brooklyn, NY 11210 USA.
EM jamesg@brooklyn.cuny.edu
RI Sealy-Jefferson, Shawnita/AAS-8992-2020; Smoller, Sylvia/JWO-5822-2024;
   Manson, JoAnn/JOZ-3576-2023
FU National Institutes of Health (NIH)/National Heart, Lung, and Blood
   Institute (NHLBI), US Department of Health and Human Services
   [HHSN268201600018C, HHSN268201600001C, HHSN268201600002C,
   HHSN268201600003C, HHSN268201600004C, HHSN268201100001C]; NIH/NHLBI, the
   Women's Health Initiative program [HHSN268201100001C]; Mars
   Symbioscience; NIH/NHLBI, US Department of Health and Human Services
   [HHSN268201100046C]; Stony Brook WHI Center grant, NHLBI [NO1-WH-42115]
FX The Women's Health Initiative (WHI) program is funded by National
   Institutes of Health (NIH)/National Heart, Lung, and Blood Institute
   (NHLBI), US Department of Health and Human Services through contracts
   HHSN268201600018C, HHSN268201600001C, HHSN268201600002C,
   HHSN268201600003C, and HHSN268201600004C. In addition, the following
   authors had funding related to this project: J. E. Manson had partial
   support from HHSN268201100001C from NIH/NHLBI, the Women's Health
   Initiative program. J. E. Manson and colleagues at Brigham and Women's
   Hospital, Harvard Medical School are recipients of funding from Mars
   Symbioscience for an investigator-initiated randomized trial of cocoa
   flavanols and chronic disease outcomes. L. F. Tinker and M. L. Neuhouser
   received support from NIH/NHLBI, US Department of Health and Human
   Services contract HHSN268201100046C. D. S. Lane received support from
   Stony Brook WHI Center grant, NHLBI contract no. NO1-WH-42115.
CR Allison, 2010, SURVIVAL ANAL USING, P175
   Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
   Martin MA, 2013, FOOD CHEM TOXICOL, V56, P336, DOI 10.1016/j.fct.2013.02.020
   Martín MA, 2010, J NUTR BIOCHEM, V21, P196, DOI 10.1016/j.jnutbio.2008.10.009
   [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373, DOI 10.1001/jama.2013.281053
   Arts ICW, 2001, INT J CANCER, V92, P298, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1187>3.0.CO;2-8
   Bayard Vicente, 2007, Int J Med Sci, V4, P53
   Boutron-Ruault MC, 1999, EUR J CANCER PREV, V8, P229, DOI 10.1097/00008469-199906000-00011
   Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222
   Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6
   Ellinger S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060321
   Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829
   Giannandrea F, 2009, INT J ENV RES PUB HE, V6, P568, DOI 10.3390/ijerph6020578
   Greenberg JA, 2015, OBESITY, V23, P677, DOI 10.1002/oby.20983
   Gu YY, 2014, EUR J NUTR, V53, P149, DOI 10.1007/s00394-013-0510-1
   Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7
   Heiss C, 2010, EUR HEART J, V31, P2583, DOI 10.1093/eurheartj/ehq332
   Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5
   Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849
   Knuiman MW, 1998, ANN EPIDEMIOL, V8, P56, DOI 10.1016/S1047-2797(97)00107-5
   Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4
   Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602
   Lemeshow L, 1999, APPL SURVIVAL ANAL R, P205
   Maskarinec G, 2009, NUTR CANCER, V61, P573, DOI 10.1080/01635580902825662
   McKelvey W, 2000, EPIDEMIOLOGY, V11, P469, DOI 10.1097/00001648-200007000-00018
   PANNELLI F, 1989, EUR J EPIDEMIOL, V5, P392, DOI 10.1007/BF00144843
   Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6
   Ramiro E, 2005, BRIT J NUTR, V93, P859, DOI 10.1079/BJN20051443
   Rodríguez-Ramiro I, 2011, MOL NUTR FOOD RES, V55, P1895, DOI 10.1002/mnfr.201100363
   SELIGSON FH, 1994, AM J CLIN NUTR, V60, p1060S, DOI 10.1093/ajcn/60.6.1060S
   Spadafranca A, 2010, BRIT J NUTR, V103, P1008, DOI 10.1017/S0007114509992698
   Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159
   Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120
   Zhou A, 2019, AM J CLIN NUTR, V109, P509, DOI 10.1093/ajcn/nqy297
NR 35
TC 6
Z9 6
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2212-2672
EI 2212-2680
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD FEB
PY 2021
VL 121
IS 2
BP 314
EP +
DI 10.1016/j.jand.2020.06.014
EA JAN 2021
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA PW1EK
UT WOS:000610419300014
PM 32763064
DA 2025-04-28
ER

PT J
AU Sui, ZX
   Zheng, MB
   Zhang, M
   Rangan, A
AF Sui, Zhixian
   Zheng, Miaobing
   Zhang, Man
   Rangan, Anna
TI Water and Beverage Consumption: Analysis of the Australian 2011-2012
   National Nutrition and Physical Activity Survey
SO NUTRIENTS
LA English
DT Article
DE water intake; dietary pattern; drinking water; diet quality; adults;
   children
ID SUGAR-SWEETENED BEVERAGES; DIETARY ENERGY DENSITY; HYDRATION BIOMARKERS;
   PLAIN WATER; CHILDREN; OBESITY; DEHYDRATION; PERFORMANCE; QUALITY;
   HEALTH
AB Background: Water consumption as a vital component of the human diet is under-researched in dietary surveys and nutrition studies. Aim: To assess total water and fluid intakes and examine demographic, anthropometric, and dietary factors associated with water consumption in the Australian population. Methods: Dietary intake data from the 2011 to 2012 National Nutrition and Physical Activity Survey were used. Usual water, fluid and food and nutrient intakes were estimated from two days of dietary recalls. Total water includes plain drinking water and moisture from all food and beverage sources; total fluids include plain drinking water and other beverages, but not food moisture. Results: The mean (SD) daily total water intakes for children and adolescents aged 2-18 years were 1.7 (0.6) L for males and 1.5 (0.4) L for females, and for adults aged 19 years and over were 2.6 (0.9) L for males and 2.3 (0.7) L for females. The majority of the population failed to meet the Adequate Intake (AI) values for total water intake (82%) and total fluids intake (78%) with the elderly at highest risk (90%-95%). The contributions of plain drinking water, other beverages and food moisture to total water intake were 44%, 27%, and 29%, respectively, among children and adolescents, and 37%, 37% and 25% among adults. The main sources of other beverages were full-fat plain milk and regular soft drinks for children and adolescents, and tea, coffee, and alcoholic drinks for adults. For adults, higher total water intake was associated with lower percent energy from fat, saturated fat, and free sugars, lower sodium and energy-dense nutrient poor food intakes but higher dietary fibre, fruit, vegetable, caffeine, and alcohol intakes. No associations were found between total water consumption and body mass index (BMI) for adults and BMI z-score for children and adolescents. Conclusion: Reported water consumption was below recommendations. Higher water intakes were suggestive of better diet quality.
C1 [Sui, Zhixian; Zheng, Miaobing; Zhang, Man; Rangan, Anna] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia.
C3 University of Sydney
RP Sui, ZX (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW 2006, Australia.
EM zhixian.sui@sydney.edu.au; miaobing.zheng@sydney.edu.au;
   mzha7338@uni.sydney.edu.au; anna.rangan@sydney.edu.au
RI Rangan, Anna/AFS-4449-2022
OI Rangan, Anna/0000-0003-1815-844X
CR Ali A, 2015, INT J SPORTS MED, V36, P433, DOI 10.1055/s-0034-1398580
   An R, 2016, J HUM NUTR DIET, V29, P624, DOI 10.1111/jhn.12368
   An RP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050263
   [Anonymous], DRI DIET REF INT WAT
   [Anonymous], AUSTR HTLH SURV NUTR
   [Anonymous], 2013, AUSTR GUID HLTH EAT
   [Anonymous], 2014, Australian Food, Supplement and Nutrient Database (AUSNUT) 2011-13: Food Recipe File
   [Anonymous], WAT HLTH WHO GUID DR
   Armstrong LE, 2012, NUTR REV, V70, pS121, DOI 10.1111/j.1753-4887.2012.00539.x
   Australian Bureau of Statistics, 2013, Australian Health Survey: Users' Guide, 2011-13
   Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971
   Börnhorst C, 2014, CLIN NUTR, V33, P79, DOI 10.1016/j.clnu.2013.03.018
   Drewnowski A., 2013, Nutr J, V12
   Drewnowski A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1068
   Frangeskou M, 2015, J NUTR HEALTH AGING, V19, P619, DOI 10.1007/s12603-015-0491-2
   Gemming L, 2014, EUR J CLIN NUTR, V68, P259, DOI 10.1038/ejcn.2013.242
   Harttig U, 2011, EUR J CLIN NUTR, V65, pS87, DOI 10.1038/ejcn.2011.92
   Jayalath VH, 2015, AM J CLIN NUTR, V102, P914, DOI 10.3945/ajcn.115.107243
   Jéquier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111
   Kant AK, 2009, AM J CLIN NUTR, V90, P655, DOI 10.3945/ajcn.2009.27749
   Keller A, 2015, CHILD OBES, V11, P338, DOI 10.1089/chi.2014.0117
   Masento NA, 2014, BRIT J NUTR, V111, P1841, DOI 10.1017/S0007114513004455
   Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188
   Millar L, 2014, OBESITY, V22, pE96, DOI 10.1002/oby.20665
   National Health and Medical Research Council, 2013, EAT HEALTHEDUCATOR G
   O'Connor L, 2014, J HUM NUTR DIET, V27, P550, DOI 10.1111/jhn.12189
   Owens JA, 2014, NUTR REV, V72, P65, DOI 10.1111/nure.12150
   Perrier E, 2013, EUR J CLIN NUTR, V67, P939, DOI 10.1038/ejcn.2013.93
   Perrier E, 2013, BRIT J NUTR, V109, P1678, DOI 10.1017/S0007114512003601
   Rangan A, 2014, J HUM NUTR DIET, V27, P450, DOI 10.1111/jhn.12182
   Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086
   Stookey JD, 2007, OBESITY, V15, P3013, DOI 10.1038/oby.2007.359
   Tooze JA, 2006, J AM DIET ASSOC, V106, P1575, DOI 10.1016/j.jada.2006.07.003
   Vanrullen IB, 2014, BRIT J NUTR, V111, P1292, DOI 10.1017/S0007114513003759
   Vieux F, 2016, PUBLIC HEALTH NUTR, V19, P2305, DOI 10.1017/S1368980015003614
   Wang J, 2008, DIABETES CARE, V31, P2120, DOI 10.2337/dc08-1085
   WHO, 2006, LENGTH HEIGHT AG WEI
   Zheng MB, 2015, BRIT J NUTR, V114, P1448, DOI 10.1017/S0007114515002974
   Zheng MB, 2015, NUTRITION, V31, P38, DOI 10.1016/j.nut.2014.04.017
NR 39
TC 41
Z9 43
U1 0
U2 19
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2016
VL 8
IS 11
AR 678
DI 10.3390/nu8110678
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA ED2IE
UT WOS:000388666400014
PM 27792184
OA Green Submitted, gold, Green Published
DA 2025-04-28
ER

PT J
AU Al-Zalabani, AH
   Wesselius, A
   Yu, EYW
   van den Brandt, P
   Grant, EJ
   White, E
   Skeie, G
   Liedberg, F
   Weiderpass, E
   Zeegers, MP
AF Al-Zalabani, Abdulmohsen H.
   Wesselius, Anke
   Yu, Evan Yi-Wen
   van den Brandt, Piet
   Grant, Eric J.
   White, Emily
   Skeie, Guri
   Liedberg, Fredrik
   Weiderpass, Elisabete
   Zeegers, Maurice P.
TI Tea consumption and risk of bladder cancer in the Bladder Cancer
   Epidemiology and Nutritional Determinants (BLEND) Study: Pooled analysis
   of 12 international cohort studies
SO CLINICAL NUTRITION
LA English
DT Article
DE Urinary bladder cancer; Tea; Smoking; Dose-response analysis; Cohort
   studies; Epidemiology
ID GREEN TEA; OXIDATIVE STRESS; FLUID INTAKE; BLACK TEA; DESIGN;
   CARCINOGENESIS; CAFFEINE; SMOKERS; COFFEE; INHIBITION
AB Background & aims: Tea has been shown to be associated with reduced risk of several diseases including cardiovascular diseases, stroke, metabolic syndrome, and obesity. However, the results on the relation-ship between tea consumption and bladder cancer are conflicting. This research aimed to assess the association between tea consumption and risk of bladder cancer using a pooled analysis of prospective cohort data. Methods: Individual data from 532,949 participants in 12 cohort studies, were pooled for analyses. Cox regression models stratified by study centre was used to estimate hazard ratios (HR) and corresponding 95% CIs. Fractional polynomial regression models were used to examine the dose-response relationship. Results: A higher level of tea consumption was associated with lower risk of bladder cancer incidence (compared with no tea consumption: HR = 0.87, 95% C.I. = 0.77-0.98 for low consumption; HR = 0.86, 95% C.I. = 0.77-0.96 for moderate consumption; HR = 0.84, 95% C.I. = 0.75-0.95 for high consumption). When stratified by sex and smoking status, this reduced risk was statistically significant among men and current and former smokers. In addition, dose-response analyses showed a lower bladder cancer risk with increment of 100 ml of tea consumption per day (HR-increment = 0.97; 95% CI = 0.96-0.98). A similar inverse association was found among males, current and former smokers while never smokers and females showed non-significant results, suggesting potential sex-dependent effect. Conclusions: Higher consumption of tea is associated with reduced risk of bladder cancer with potential interaction with sex and smoking status. Further studies are needed to clarify the mechanisms for a protective effect of tea (e.g. inhibition of the survival and proliferation of cancer cells and antiinflammatory mechanisms) and its interaction with smoking and sex. (c) 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Al-Zalabani, Abdulmohsen H.] Taibah Univ, Coll Med, Dept Family & Community Med, Madinah 41541, Saudi Arabia.
   [Wesselius, Anke; Zeegers, Maurice P.] Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Epidemiol, Univ Singel 40,Room C5-570, NL-6229 ER Maastricht, Netherlands.
   [Yu, Evan Yi-Wen] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Key Lab Environm Med & Engn,Minist Educ, Nanjing, Peoples R China.
   [Yu, Evan Yi-Wen] Maastricht Univ, Sch Nutr & Translat Res Metab, CAPHRI Care & Publ Hlth Res Inst, Dept Epidemiol, Maastricht, Netherlands.
   [van den Brandt, Piet] Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands.
   [van den Brandt, Piet] Maastricht Univ Med Ctr, Sch Publ Hlth, Dept Epidemiol, Maastricht, Netherlands.
   [van den Brandt, Piet] Maastricht Univ Med Ctr, Sch Primary Care, Dept Epidemiol, Maastricht, Netherlands.
   [Grant, Eric J.] Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima, Japan.
   [White, Emily] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   [Skeie, Guri] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.
   [Liedberg, Fredrik] Lund Univ, Inst Translat Med, Malmo, Sweden.
   [Weiderpass, Elisabete] World Hlth Org, Int Agcy Res Canc, Lyon, France.
   [Zeegers, Maurice P.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands.
C3 Taibah University; Maastricht University; Southeast University - China;
   Maastricht University; Maastricht University; Maastricht University
   Medical Centre (MUMC); Maastricht University; Maastricht University
   Medical Centre (MUMC); Maastricht University; Maastricht University
   Medical Centre (MUMC); Radiation Effects Research Foundation - Japan;
   Fred Hutchinson Cancer Center; UiT The Arctic University of Tromso; Lund
   University; World Health Organization; International Agency for Research
   on Cancer (IARC); Maastricht University
RP Wesselius, A (corresponding author), Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Epidemiol, Univ Singel 40,Room C5-570, NL-6229 ER Maastricht, Netherlands.
EM anke.wesselius@maastrichtuniversity.nl
RI Al-Zalabani, Abdulmohsen/E-9869-2013; Weiderpass, Elisabete/M-4029-2016
OI Liedberg, Fredrik/0000-0001-8193-0370; van den Brandt,
   Piet/0000-0001-8781-8099; Skeie, Guri/0000-0003-2476-4251; Weiderpass,
   Elisabete/0000-0003-2237-0128; Wesselius, Anke/0000-0003-4474-9665
FU World Cancer Research Fund International [WCRF 2012/590]; European
   Commission [FP7-PEOPLE-618308]; Dutch Cancer Society; US Department of
   Energy (DOE); DOE [DEHS0000031]; RERF [RP-A5-12]; National Cancer
   Institute [R01CA74846]; Radiation Effects Research Foundation (RERF),
   Hiroshima and Nagasaki, Japan, a public interest foundation - Japanese
   Ministry of Health, Labour and Welfare (MHLW); "Europe Against Cancer"
   Programme of the European Commission (SANCO); Ligue contre le Cancer
   (France); Societe 3 M (France); Mutuelle Generale de l'Education
   Nationale; Institut National de la Sante et de la Recherche Medicale
   (INSERM); Institute Gustave Roussy; German Cancer Aid; German Cancer
   Research Centre; German Federal Ministry of Education and Research;
   Danish Cancer Society; Health Research Fund (FIS) of the Spanish
   Ministry of Health; Spanish Regional Government of Andalucia; Spanish
   Regional Government of Asturias; Spanish Regional Government of Basque
   Country; Spanish Regional Government of Murcia; Spanish Regional
   Government of Navarra; Cancer Research UK; Medical Research Council, UK;
   Stroke Association, UK; British Heart Foundation; Department of Health,
   UK; Food Standards Agency, UK; Wellcome Trust, UK; Italian Association
   for Research on Cancer; Italian National Research Council; Dutch
   Ministry of Public Health, Welfare and Sports; Dutch Prevention Funds;
   LK Research Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer
   Research Fund; Swedish Cancer Society; Swedish Scientific Council;
   Regional Government of Skane, Sweden; Norwegian Cancer Society;
   Norwegian Research Council; Centre de Recherche etd'In-formation
   Nutritionnelles (CERIN)
FX This work was partly funded by the World Cancer Research Fund
   International (WCRF 2012/590) and European Commission
   (FP7-PEOPLE-618308) . The Netherlands Cohort Study on diet and can-cer
   was supported by the Dutch Cancer Society. The RERF atomic bomb
   survivors Study was supported by The Radiation Effects Research
   Foundation (RERF) , Hiroshima and Nagasaki, Japan, a public interest
   foundation funded by the Japanese Ministry of Health, Labour and Welfare
   (MHLW) and the US Department of Energy (DOE) . The research was also
   funded in part through DOE award DEHS0000031 to the National Academy of
   Sciences. This publication was supported by RERF Research Protocol
   RP-A5-12. The VITamins and Lifestyle Study (VITAL) was supported by a
   grant (R01CA74846) from the National Cancer Institute. The Euro-pean
   Prospective Investigation into Cancer and Nutrition (EPIC) was carried
   out with financial support of the "Europe Against Cancer" Programme of
   the European Commission (SANCO) ; Ligue contre le Cancer (France) ;
   Societe 3 M (France) ; Mutuelle Generale de l'Education Nationale;
   Institut National de la Sante et de la Recherche M?edicale (INSERM) ;
   Institute Gustave Roussy; German Cancer Aid; German Cancer Research
   Centre; German Federal Ministry of Education and Research; Danish Cancer
   Society; Health Research Fund (FIS) of the Spanish Ministry of Health;
   the Spanish Regional Governments of Andalucia, Asturias, Basque Country,
   Murcia and Navarra; Cancer Research UK; Medical Research Council, UK;
   Stroke Association, UK; British Heart Foundation; Department of Health,
   UK; Food Standards Agency, UK; Wellcome Trust, UK; Italian Association
   for Research on Cancer; Italian National Research Council; Dutch
   Ministry of Public Health, Welfare and Sports; Dutch Prevention Funds;
   LK Research Funds; Dutch ZON (Zorg Onderzoek Nederland) ; World Cancer
   Research Fund; Swedish Cancer Society; Swedish Scientific Council;
   Regional Government of Skane, Sweden; Norwegian Cancer Society;Norwegian
   Research Council. Partial support for the publication this supplement
   was provided by the Centre de Recherche etd'In-formation Nutritionnelles
   (CERIN) .
CR Abualhasan MN, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/7631562
   Al-Zalabani AH, 2016, EUR J EPIDEMIOL, V31, P811, DOI 10.1007/s10654-016-0138-6
   Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217
   Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787
   Chen LX, 2017, J NUTR BIOCHEM, V40, P1, DOI 10.1016/j.jnutbio.2016.05.005
   Chung FL, 1998, CANCER RES, V58, P4096
   Chung M, 2020, ADV NUTR, V11, P790, DOI 10.1093/advances/nmaa010
   Clavel-Chapelon F, 1997, EUR J CANCER PREV, V6, P473, DOI 10.1097/00008469-199710000-00007
   Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430
   Day N, 1999, BRIT J CANCER, V80, P95
   Fan XQ, 2021, IUBMB LIFE, V73, P328, DOI 10.1002/iub.2445
   Ferlay J E.M., 2020, Global Cancer Observatory: Cancer Today, DOI DOI 10.32455/LC2020
   Goossens ME, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0140-1
   Hakim IA, 2003, J NUTR, V133, p3303S, DOI 10.1093/jn/133.10.3303S
   Hashemian M, 2019, ANN EPIDEMIOL, V34, P33, DOI 10.1016/j.annepidem.2019.03.014
   Hashibe M, 2015, BRIT J CANCER, V113, P809, DOI 10.1038/bjc.2015.276
   Hassler E, 2021, ANTIOXIDANTS-BASEL, P10
   Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515
   Jochems SHJ, 2020, INT J CANCER, V147, P2091, DOI 10.1002/ijc.33008
   Kim TL, 2020, ADV NUTR, V11, P1437, DOI 10.1093/advances/nmaa077
   Klaunig JE, 1999, P SOC EXP BIOL MED, V220, P249, DOI 10.1046/j.1525-1373.1999.d01-43.x
   KOHLMEIER L, 1992, EUR J CLIN NUTR, V46, pS25
   Kurahashi N, 2009, CANCER SCI, V100, P284, DOI 10.1111/j.1349-7006.2008.01027.x
   Lenis AT, 2020, JAMA-J AM MED ASSOC, V324, P1980, DOI [10.1001/jama.2020.17598, 10.1001/jama.2020.17601]
   Lin Y, 2020, PHYTOTHER RES, V34, P2459, DOI 10.1002/ptr.6697
   Lipunova N, 2020, TRANSL ANDROL UROL, V9, P1329, DOI 10.21037/tau-19-523
   Liu W, 2020, PHYTOTHER RES, V34, P2857, DOI 10.1002/ptr.6731
   Mania Monika, 2014, Rocz Panstw Zakl Hig, V65, P281
   Misra A, 2003, J NUTR, V133, P2622, DOI 10.1093/jn/133.8.2622
   Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1
   PANICO S, 1992, EUR J EPIDEMIOL, V8, P601, DOI 10.1007/BF00146383
   Peluso I, 2017, BRIT J PHARMACOL, V174, P1195, DOI 10.1111/bph.13649
   Regelson Spencer, 2021, Gen Dent, V69, P17
   Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394
   Richters A, 2020, WORLD J UROL, V38, P1895, DOI 10.1007/s00345-019-02984-4
   Ros MM, 2011, INT J CANCER, V128, P2695, DOI 10.1002/ijc.25592
   Saginala K., 2020, Med Sci (Basel), V8, P15, DOI 10.3390/medsci8010015
   SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239
   Schwartz JL, 2005, MOL NUTR FOOD RES, V49, P43, DOI 10.1002/mnfr.200400031
   Seow WJ, 2020, EUR J NUTR, V59, P3083, DOI 10.1007/s00394-019-02146-7
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986
   van Osch FHM, 2019, EUR J CANCER PREV, V28, P40, DOI 10.1097/CEJ.0000000000000404
   Wang J, 2013, BRIT J CANCER, V108, P2372, DOI 10.1038/bjc.2013.190
   Wang ST, 2020, WORLD J GASTROENTERO, V26, P562, DOI 10.3748/wjg.v26.i6.562
   Watanabe D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72245-7
   White E, 2004, AM J EPIDEMIOL, V159, P83, DOI 10.1093/aje/kwh010
   World Cancer Research Fund/American Institute for Cancer Research, Continuous update project expert report 2018. physical activity and the risk of cancer
   Xu XY, 2020, CRIT REV FOOD SCI, V60, P1693, DOI 10.1080/10408398.2019.1588223
   XU Y, 1992, CANCER RES, V52, P3875
   Yang CS, 2016, MOLECULES, V21, DOI 10.3390/molecules21121679
   Yasuda T, 2018, IN VIVO, V32, P721, DOI 10.21873/invivo.11300
   Yu EYW, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01931-8
   Yuan JM, 2013, AM J CLIN NUTR, V98, p1676S, DOI 10.3945/ajcn.113.058271
   Zamora-Ros R, 2014, BRIT J CANCER, V111, P1870, DOI 10.1038/bjc.2014.459
   Zeegers MPA, 2001, BRIT J CANCER, V85, P977, DOI [10.1038/sj.bjc.6691968, 10.1054/bjoc.2001.1968]
   Zeegers MPA, 2001, CANCER CAUSE CONTROL, V12, P231, DOI 10.1023/A:1011245627593
   Zhao LG, 2021, ADV NUTR, V12, P402, DOI 10.1093/advances/nmaa117
   Zhou JC, 2014, INT J CANCER, V135, P1229, DOI 10.1002/ijc.28764
NR 60
TC 15
Z9 15
U1 2
U2 11
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD MAY
PY 2022
VL 41
IS 5
BP 1122
EP 1130
DI 10.1016/j.clnu.2022.03.020
EA APR 2022
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 0V1DR
UT WOS:000788086300013
PM 35413574
OA Green Submitted, hybrid, Green Published
DA 2025-04-28
ER

PT S
AU Savica, V
   Bellinghieri, G
   Kopple, JD
AF Savica, Vincenzo
   Bellinghieri, Guido
   Kopple, Joel D.
BE Cousins, RJ
TI The Effect of Nutrition on Blood Pressure
SO ANNUAL REVIEW OF NUTRITION, VOL 30
SE Annual Review of Nutrition
LA English
DT Review; Book Chapter
DE diet; obesity; salt; hypertension; dietary compliance; public health
ID OBSTRUCTIVE SLEEP-APNEA; COFFEE BEAN EXTRACT; LIFE-STYLE MODIFICATION;
   CORONARY-HEART-DISEASE; BODY-MASS INDEX; OBESITY-ASSOCIATED
   HYPERTENSION; CARDIOVASCULAR RISK-FACTORS; RANDOMIZED CONTROLLED-TRIAL;
   ATRIAL-NATRIURETIC-PEPTIDE; SYMPATHETIC-NERVE ACTIVITY
AB The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients. Excessive energy intake and obesity arc major causes of hypertension. Obesity is associated with increased activity of the renin-angiotensin-aldosterone and sympathetic nervous systems, possibly other mineralcorticoid activity, insulin resistance, salt-sensitive hypertension and excess salt intake, and reduced kidney function. High sodium chloride intake strongly predisposes to hypertension. Increased alcohol consumption may acutely elevate blood pressure. High intakes of potassium, polyunsaturated fatty acids, and protein, along with exercise and possibly vitamin D, may reduce blood pressure. Less-conclusive studies suggest that amino acids, tea, green coffee bean extract, dark chocolate, and foods high in nitrates may reduce blood pressure. Short-term studies indicate that specialized diets may prevent or ameliorate mild hypertension; most notable are the Dietary Approaches to Stop Hypertension (DASH) diet, which is high in fruits, vegetables, and low-fat dairy products, and the DASH low-sodium diet. Long-term compliance to these diets remains a major concern.
C1 [Savica, Vincenzo] Univ Messina, Nephrol Unit, I-98168 Messina, Italy.
   [Savica, Vincenzo] Univ Messina, Unit Dialysis, Papardo Hosp, I-98168 Messina, Italy.
   [Kopple, Joel D.] Univ Calif Los Angeles, Los Angeles Biomed Res Inst, Harbor UCLA Med Ctr, David Geffen Sch Med, Torrance, CA 90501 USA.
   [Kopple, Joel D.] Univ Calif Los Angeles, Sch Publ Hlth, Torrance, CA 90501 USA.
   [Savica, Vincenzo; Bellinghieri, Guido] Univ Messina, Polyclin, I-98168 Messina, Italy.
C3 University of Messina; University of Messina; Lundquist Institute;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of Messina
RP Savica, V (corresponding author), Univ Messina, Nephrol Unit, I-98168 Messina, Italy.
EM jkopple@labiomed.org
CR Allender PS, 1996, ANN INTERN MED, V124, P825, DOI 10.7326/0003-4819-124-9-199605010-00007
   Almeida OP, 2009, AM J GERIAT PSYCHIAT, V17, P889, DOI 10.1097/JGP.0b013e3181b047e3
   ALTURA BM, 1984, SCIENCE, V223, P1315, DOI 10.1126/science.6701524
   [Anonymous], 1990, Arch Intern Med, V150, P153, DOI 10.1001/archinte.150.1.153
   [Anonymous], 2004, DIET REF INT WAT POT
   [Anonymous], 2005, Dietary guidelines for Americans
   Antonios TFT, 1996, LANCET, V348, P250, DOI 10.1016/S0140-6736(96)01463-8
   Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6
   APPEL LJ, 1993, ARCH INTERN MED, V153, P1429, DOI 10.1001/archinte.153.12.1429
   Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823
   Baguet JP, 2006, J HYPERTENS, V24, P205, DOI 10.1097/01.hjh.0000198039.39504.63
   BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x
   Barri YM, 1997, AM J MED SCI, V314, P37, DOI 10.1097/00000441-199707000-00008
   Beltowski J, 2006, J HYPERTENS, V24, P789
   Blaine B, 2008, J HEALTH PSYCHOL, V13, P1190, DOI 10.1177/1359105308095977
   Bouillon R, 2009, AM J HYPERTENS, V22, P816, DOI 10.1038/ajh.2009.105
   Brancati FL, 1996, ARCH INTERN MED, V156, P61, DOI 10.1001/archinte.156.1.61
   Brook RD, 2001, AM J CARDIOL, V88, P1264, DOI 10.1016/S0002-9149(01)02088-4
   Bucher HC, 1996, JAMA-J AM MED ASSOC, V275, P1016, DOI 10.1001/jama.275.13.1016
   Burke V, 2005, J HYPERTENS, V23, P1241, DOI 10.1097/01.hjh.0000170388.61579.4f
   Burke V, 2001, HYPERTENSION, V38, P821, DOI 10.1161/hy1001.092614
   Burke V, 2008, NUTR METAB CARDIOVAS, V18, P198, DOI 10.1016/j.numecd.2006.10.004
   Burke V, 2008, HEALTH EDUC RES, V23, P202, DOI 10.1093/her/cym017
   Cakir H, 2006, WESTERN J NURS RES, V28, P190, DOI 10.1177/0193945905283367
   Canoy D, 2004, J HYPERTENS, V22, P2067, DOI 10.1097/00004872-200411000-00007
   CAPPUCCIO FP, 1995, AM J EPIDEMIOL, V142, P935, DOI 10.1093/oxfordjournals.aje.a117741
   CAPPUCCIO FP, 1991, J HYPERTENS, V9, P465, DOI 10.1097/00004872-199105000-00011
   CAPPUCCIO FP, 1985, BMJ-BRIT MED J, V291, P235, DOI 10.1136/bmj.291.6490.235
   Chamarthi B, 2007, J CLIN ENDOCR METAB, V92, P1340, DOI 10.1210/jc.2006-2093
   Chen ZY, 2009, J AGR FOOD CHEM, V57, P4485, DOI 10.1021/jf900803r
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Collier SR, 2008, J HUM HYPERTENS, V22, P678, DOI 10.1038/jhh.2008.36
   Cooper R, 1997, J HUM HYPERTENS, V11, P107, DOI 10.1038/sj.jhh.1000391
   Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A
   Cottrell EC, 2007, P NUTR SOC, V66, P198, DOI 10.1017/S0029665107005447
   Curhan GC, 1998, J AM SOC NEPHROL, V9, P1645
   Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S
   CUTLER JA, 1991, HYPERTENSION, V17, pI27, DOI 10.1161/01.HYP.17.1_Suppl.I27
   Danoviz ME, 2006, CLIN EXP PHARMACOL P, V33, P248, DOI 10.1111/j.1440-1681.2006.04353.x
   Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588
   de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205
   De Nicola L, 2005, SEMIN NEPHROL, V25, P425, DOI 10.1016/j.semnephrol.2005.05.014
   Dengel DR, 2007, PHYSIOL RES, V56, P393, DOI 10.33549/physiolres.931002
   DEPERGOLA G, 1994, INT J OBESITY, V18, P93
   Dessì-Fulgheri P, 1997, J HYPERTENS, V15, P1695, DOI 10.1097/00004872-199715120-00074
   DORNFELD LP, 1987, KIDNEY INT, V32, pS254
   DORNFELD LP, 1985, INT J OBESITY, V9, P381
   Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007
   Engler MB, 2004, J AM COLL NUTR, V23, P197, DOI 10.1080/07315724.2004.10719361
   Eriksson J, 2000, HYPERTENSION, V36, P790, DOI 10.1161/01.HYP.36.5.790
   Esposito K, 2006, DIABETES CARE, V29, P954, DOI 10.2337/diacare.29.04.06.dc05-2541
   Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885
   Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924
   Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42
   Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/00004872-200312000-00016
   Folsom AR, 2007, AM J HYPERTENS, V20, P225, DOI 10.1016/j.amjhyper.2006.09.003
   Ford ES, 2008, AM J HYPERTENS, V21, P1124, DOI 10.1038/ajh.2008.246
   Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060
   Friedrich MJ, 2002, JAMA-J AM MED ASSOC, V287, P1382, DOI 10.1001/jama.287.11.1382
   Fuchs FD, 2001, HYPERTENSION, V37, P1242, DOI 10.1161/01.HYP.37.5.1242
   Fujita T, 2008, CURR HYPERTENS REP, V10, P421, DOI 10.1007/s11906-008-0078-y
   Fujita T, 2008, J MOL MED, V86, P729, DOI 10.1007/s00109-008-0343-1
   Funatsu K, 2005, HYPERTENS RES, V28, P521, DOI 10.1291/hypres.28.521
   Funk KL, 2008, HEALTH PROMOT PRACT, V9, P271, DOI 10.1177/1524839906289035
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Gallen IW, 1998, AM J KIDNEY DIS, V31, P19, DOI 10.1053/ajkd.1998.v31.pm9428447
   Gao SK, 2009, ARCH INTERN MED, V169, P702, DOI 10.1001/archinternmed.2009.17
   Govindarajan G, 2005, AM J MED SCI, V330, P311, DOI 10.1097/00000441-200512000-00009
   Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70
   Grassi D, 2005, AM J CLIN NUTR, V81, P611
   Grassi G, 2008, J NEUROENDOCRINOL, V20, P63, DOI 10.1111/j.1365-2826.2008.01688.x
   Grassi G, 2005, HYPERTENSION, V46, P321, DOI 10.1161/01.HYP.0000174243.39897.6c
   Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383
   Griffith LE, 1999, AM J HYPERTENS, V12, P84, DOI 10.1016/S0895-7061(98)00224-6
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Hafidh S, 2005, AM J MED SCI, V330, P343, DOI 10.1097/00000441-200512000-00013
   Hamano S, 2005, INT J UROL, V12, P859, DOI 10.1111/j.1442-2042.2005.01160.x
   HARIHARAN S, 1991, J LAB CLIN MED, V117, P423
   Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532
   He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459
   He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0
   He J, 2005, ANN INTERN MED, V143, P1, DOI 10.7326/0003-4819-143-1-200507050-00004
   Hebert Patricia R., 1995, Annals of Epidemiology, V5, P130, DOI 10.1016/1047-2797(94)00057-Z
   HENSON LC, 1987, AM J CLIN NUTR, V46, P893, DOI 10.1093/ajcn/46.6.893
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   HISHIKAWA K, 1992, JPN HEART J, V33, P41
   Hodgson JM, 2006, CLIN EXP PHARMACOL P, V33, P838, DOI 10.1111/j.1440-1681.2006.04450.x
   Hodgson JM, 2005, J HYPERTENS, V23, P47, DOI 10.1097/00004872-200501000-00012
   Hodgson JM, 2002, CLIN SCI, V102, P195, DOI 10.1042/CS20010120
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131
   Horvath K, 2008, ARCH INTERN MED, V168, P571, DOI 10.1001/archinte.168.6.571
   Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655
   Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102
   Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x
   Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001
   Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464
   Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647
   Jee SH, 2002, AM J HYPERTENS, V15, P691, DOI 10.1016/S0895-7061(02)02964-3
   Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5
   Johnson AG, 2001, J HYPERTENS, V19, P1053, DOI 10.1097/00004872-200106000-00009
   Johnson RJ, 2002, NEW ENGL J MED, V346, P913, DOI 10.1056/NEJMra011078
   Jones-Burton C, 2006, AM J NEPHROL, V26, P268, DOI 10.1159/000093833
   Kaaja RJ, 2006, J HYPERTENS, V24, P131, DOI 10.1097/01.hjh.0000194121.19851.e5
   Kabir AA, 2006, AM J HYPERTENS, V19, P639, DOI 10.1016/j.amjhyper.2005.10.026
   Kahn R, 2005, LANCET, V366, P1921, DOI 10.1016/S0140-6736(05)67778-1
   KATZEFF HL, 1990, P SOC EXP BIOL MED, V194, P198, DOI 10.3181/00379727-194-43078
   Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kennedy RL, 2005, DIABETIC MED, V22, P821, DOI 10.1111/j.1464-5491.2005.01594.x
   Khan NA, 2006, CAN J CARDIOL, V22, P583, DOI 10.1016/S0828-282X(06)70280-X
   King DE, 2009, AM J MED, V122, P528, DOI 10.1016/j.amjmed.2008.11.013
   KIYOHARA Y, 1995, STROKE, V26, P368, DOI 10.1161/01.STR.26.3.368
   Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103
   Klag MJ, 2002, ARCH INTERN MED, V162, P657, DOI 10.1001/archinte.162.6.657
   Kojuri Javad, 2007, BMC Cardiovasc Disord, V7, P34
   Kotchen TA, 1998, CIRCULATION, V98, P613, DOI 10.1161/01.CIR.98.6.613
   Kotchen TA, 2009, AM J HYPERTENS, V22, P350, DOI 10.1038/ajh.2009.15
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   KRISHNA GG, 1987, J LAB CLIN MED, V109, P724
   Kuchel O, 1998, AM J PHYSIOL-REG I, V275, pR1164, DOI 10.1152/ajpregu.1998.275.4.R1164
   Kuhlmann A, 2004, AM J PHYSIOL-RENAL, V286, pF526, DOI 10.1152/ajprenal.00316.2003
   Kumanyika SK, 2005, J HUM HYPERTENS, V19, P33, DOI 10.1038/sj.jhh.1001774
   Kurukulasuriya LR, 2008, ENDOCRIN METAB CLIN, V37, P647, DOI 10.1016/j.ecl.2008.06.002
   Landsberg L, 2001, J HYPERTENS, V19, P523, DOI 10.1097/00004872-200103001-00001
   Lavigne C, 2000, AM J PHYSIOL-ENDOC M, V278, pE491, DOI 10.1152/ajpendo.2000.278.3.E491
   LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819
   Leuenberger V, 2006, Rev Med Suisse, V2, P2041
   LEUENBERGER V, 2006, REV MED SUISSE, V2, P2044
   Lien LF, 2007, HYPERTENSION, V50, P609, DOI 10.1161/HYPERTENSIONAHA.107.089458
   Logan AG, 2007, AM J HYPERTENS, V20, P223, DOI 10.1016/j.amjhyper.2006.10.006
   Lopez L, 2009, AM J HYPERTENS, V22, P325, DOI 10.1038/ajh.2008.348
   MacGregor G A, 1999, Nutr Metab Cardiovasc Dis, V9, P6
   MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9
   Mann M, 2008, AM J CARDIOL, V101, P1518, DOI 10.1016/j.amjcard.2007.12.041
   Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991
   Mark AL, 2007, CURR HYPERTENS REP, V9, P368, DOI 10.1007/s11906-007-0068-5
   McCall DO, 2009, CIRCULATION, V119, P2153, DOI 10.1161/CIRCULATIONAHA.108.831297
   MCCARRON DA, 1991, CONTRIB NEPHROL, V90, P2
   McCarron DA, 2001, AM J HYPERTENS, V14, p206S, DOI 10.1016/S0895-7061(01)02090-8
   MCCARRON DA, 1989, HOSP PRACT, V24, P229
   McCarron DA, 1998, AM J CLIN NUTR, V68, P517, DOI 10.1093/ajcn/68.3.517
   Melander O, 2007, J HYPERTENS, V25, P619, DOI 10.1097/HJH.0b013e328013cd50
   Mellen PB, 2008, ARCH INTERN MED, V168, P308, DOI 10.1001/archinternmed.2007.119
   Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590
   MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776
   Moreira LB, 1998, J HYPERTENS, V16, P175, DOI 10.1097/00004872-199816020-00007
   MORRIS MC, 1993, CIRCULATION, V88, P523, DOI 10.1161/01.CIR.88.2.523
   Morris RC, 1999, HYPERTENSION, V33, P18, DOI 10.1161/01.HYP.33.1.18
   Mu Jian-jun, 2003, Zhonghua Yufang Yixue Zazhi, V37, P90
   Naismith DJ, 2003, BRIT J NUTR, V90, P53, DOI 10.1079/BJN2003861
   NAKAKI T, 1990, LANCET, V336, P696, DOI 10.1016/0140-6736(90)92196-O
   Narkiewicz K, 1999, CIRCULATION, V100, P2332, DOI 10.1161/01.CIR.100.23.2332
   Narkiewicz K, 2006, OBES REV, V7, P155, DOI 10.1111/j.1467-789X.2006.00226.x
   Nowson CA, 2003, J NUTR, V133, P4118, DOI 10.1093/jn/133.12.4118
   Nuttall FQ, 2006, AM J PHYSIOL-ENDOC M, V291, pE786, DOI 10.1152/ajpendo.00011.2006
   Obarzanek E, 1996, JAMA-J AM MED ASSOC, V275, P1598, DOI 10.1001/jama.275.20.1598
   Obligado SH, 2008, AM J HYPERTENS, V21, P257, DOI 10.1038/ajh.2007.62
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Olsen MH, 2005, HYPERTENSION, V46, P660, DOI 10.1161/01.HYP.0000179575.13739.72
   Papaioannou TG, 2006, CLIN MED RES, V4, P114, DOI 10.3121/cmr.4.2.114
   Patel SB, 2008, CURR HYPERTENS REP, V10, P131, DOI 10.1007/s11906-008-0025-y
   Pausova Z, 2006, CURR OPIN NEPHROL HY, V15, P173, DOI 10.1097/01.mnh.0000214775.42103.a5
   Pausova Z, 2005, HYPERTENSION, V46, P1280, DOI 10.1161/01.HYP.0000188049.23233.fb
   Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901
   Pere AK, 2000, KIDNEY INT, V58, P2462, DOI 10.1046/j.1523-1755.2000.00429.x
   Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633
   Phillips BG, 2000, AM J PHYSIOL-HEART C, V279, pH234, DOI 10.1152/ajpheart.2000.279.1.H234
   Pierce GL, 2008, HYPERTENSION, V52, P72, DOI 10.1161/HYPERTENSIONAHA.108.111427
   Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135
   Pinar R, 2006, WESTERN J NURS RES, V28, P214, DOI 10.1177/0193945905283413
   Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298
   Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183
   REISIN E, 1978, NEW ENGL J MED, V298, P1, DOI 10.1056/NEJM197801052980101
   RESNICK LM, 1986, ANN INTERN MED, V105, P649, DOI 10.7326/0003-4819-105-5-649
   RICH GM, 1991, AM J HYPERTENS, V4, pS642, DOI 10.1093/ajh/4.11S.642S
   ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905
   Rohrer JE, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-212
   Rossi GP, 2008, J CLIN ENDOCR METAB, V93, P2566, DOI 10.1210/jc.2008-0251
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   SAITO K, 1989, HYPERTENSION, V13, P219, DOI 10.1161/01.HYP.13.3.219
   Saito T, 2008, ADV EXP MED BIOL, V606, P295, DOI 10.1007/978-0-387-74087-4_12
   Sanders PW, 2007, SEMIN DIALYSIS, V20, P408, DOI 10.1111/j.1525-139X.2007.00316.x
   Sarzani R, 2008, J HYPERTENS, V26, P831, DOI 10.1097/HJH.0b013e3282f624a0
   Satterfield S, 1991, Ann Epidemiol, V1, P455
   SCHERRER U, 1994, CIRCULATION, V89, P2634, DOI 10.1161/01.CIR.89.6.2634
   Schulz M, 2005, J HUM HYPERTENS, V19, P61, DOI 10.1038/sj.jhh.1001776
   SCIARRONE SEG, 1990, CLIN EXP PHARMACOL P, V17, P197, DOI 10.1111/j.1440-1681.1990.tb01305.x
   Shah M, 2007, AM J CLIN NUTR, V85, P1251, DOI 10.1093/ajcn/85.5.1251
   Shaldon S, 2006, CLIN NEPHROL, V66, P1
   Shaldon S, 2002, NEPHROL DIAL TRANSPL, V17, P1163, DOI 10.1093/ndt/17.7.1163
   Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906
   Sharma A M, 2001, Curr Hypertens Rep, V3, P152, DOI 10.1007/s11906-001-0030-x
   Sharma AM, 2002, INT J OBESITY, V26, pS5, DOI 10.1038/sj.ijo.0802210
   Siebenhofer A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007654.pub3
   Sjöström L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622
   St Peter JV, 2006, CLIN CHEM, V52, P680, DOI 10.1373/clinchem.2005.062562
   STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598
   Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S
   Stamler J, 2009, CIRCULATION, V120, P221, DOI 10.1161/CIRCULATIONAHA.108.839241
   Steffens AA, 2006, J HYPERTENS, V24, P1489, DOI 10.1097/01.hjh.0000239282.27938.0f
   Stein AD, 2006, EUR J EPIDEMIOL, V21, P759, DOI 10.1007/s10654-006-9065-2
   Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007
   Streppel MT, 2005, ARCH INTERN MED, V165, P150, DOI 10.1001/archinte.165.2.150
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   Talmor Y, 2008, EUR J CLIN INVEST, V38, P548, DOI 10.1111/j.1365-2362.2008.01977.x
   Taubert D, 2003, JAMA-J AM MED ASSOC, V290, P1029, DOI 10.1001/jama.290.8.1029
   Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455
   Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x
   Taylor EN, 2006, AM J KIDNEY DIS, V48, P905, DOI 10.1053/j.ajkd.2006.09.004
   Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d
   Tuan NT, 2008, J NUTR, V138, P1377, DOI 10.1093/jn/138.7.1377
   Viera AJ, 2008, J CLIN HYPERTENS, V10, P105, DOI 10.1111/j.1751-7176.2008.07577.x
   Vollmer WM, 2001, ANN INTERN MED, V135, P1019, DOI 10.7326/0003-4819-135-12-200112180-00005
   Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523
   WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028
   Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657
   Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624
   Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882
   Whelton SP, 2005, J HYPERTENS, V23, P475, DOI 10.1097/01.hjh.0000160199.51158.cf
   Wildman RP, 2005, J HYPERTENS, V23, P737, DOI 10.1097/01.hjh.0000163141.82212.5f
   WILLIAMS M, 1986, J CLIN INVEST, V78, P1687, DOI 10.1172/JCI112763
   Winkelmayer WC, 2005, JAMA-J AM MED ASSOC, V294, P2330, DOI 10.1001/jama.294.18.2330
   WITTEMAN JCM, 1989, CIRCULATION, V80, P1320, DOI 10.1161/01.CIR.80.5.1320
   Wofford MR, 2004, CURR PHARM DESIGN, V10, P3621, DOI 10.2174/1381612043382855
   Wu GR, 2006, CLIN EXP HYPERTENS, V28, P489, DOI 10.1080/10641960600798705
   Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004
   Yang CS, 2004, J NUTR, V134, p3181S, DOI 10.1093/jn/134.11.3181S
   Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200
   Yung L. M., 2008, Inflammopharmacology, V16, P230, DOI 10.1007/s10787-008-8022-y
   ZEMEL MB, 1986, J HYPERTENS, V4, pS343
   Zheng YN, 2005, J AM SOC NEPHROL, V16, P2288, DOI 10.1681/ASN.2005020193
   Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101
   Zilkens RR, 2005, HYPERTENSION, V45, P874, DOI 10.1161/01.HYP.0000164639.83623.76
   1947, ARCH INTERN MED, V157, P2413
   2003, BMJ, V297, P319
NR 240
TC 160
Z9 181
U1 2
U2 92
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0199-9885
EI 1545-4312
BN 978-0-8243-2830-6
J9 ANNU REV NUTR
JI Annu. Rev. Nutr.
PY 2010
VL 30
BP 365
EP 401
DI 10.1146/annurev-nutr-010510-103954
PG 37
WC Nutrition & Dietetics
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA BRN63
UT WOS:000283182500018
PM 20645853
DA 2025-04-28
ER

PT J
AU Marrelli, M
   Menichini, F
   Conforti, F
AF Marrelli, Mariangela
   Menichini, Francesco
   Conforti, Filomena
TI Hypolipidemic and Antioxidant Properties of Hot Pepper Flower
   (Capsicum annuum L.)
SO PLANT FOODS FOR HUMAN NUTRITION
LA English
DT Article
DE Capsicum annuum; Pancreatic lipase; Phenolic composition; Antioxidant;
   Obesity
ID DIETARY PLANTS; LIPASE; INHIBITION; OBESITY; FRUITS; CELLS
AB At present, the various medical treatments of obesity involve side effects. The aim of the research is therefore to find natural compounds that have anti-obesity activity with minimum disadvantages. In this study, the hypolipidemic effect of hydroalcoholic extract of flowers from Capsicum annuum L. was examined through the evaluation of inhibition of pancreatic lipase. Antioxidant activity was assessed using different tests: 2,2-diphenyl-1-picrylhydrazyl (DPPH), nitric oxide ((NO)-N-center dot) and lipid peroxidation inhibition assays. Phytochemical analysis indicated that total phenolic and flavonoid content in the extract was 128.7 +/- 4.5 mg chlorogenic acid equivalent/g of crude extract and 17.66 +/- 0.11 mg of quercetin equivalent/g of crude extract, respectively. The extract inhibited pancreatic lipase with IC50 value equal to 3.54 +/- 0.18 mg/ml. It also inhibited lipid peroxidation with IC50 value of 27.61 +/- 2.25 mu g/ml after 30 min of incubation and 41.69 +/- 1.13 mu g/ml after 60 min of incubation. The IC50 value of radical scavenging activity was 51.90 +/- 2.03 mu g/ml. The extract was also able to inhibit NO production (IC50 = of 264.3 +/- 7.98 mu g/ml) without showing any cytotoxic effect.
C1 [Marrelli, Mariangela; Menichini, Francesco; Conforti, Filomena] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-8736 Arcavacata Di Rende, CS, Italy.
C3 University of Calabria
RP Conforti, F (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-8736 Arcavacata Di Rende, CS, Italy.
EM filomena.conforti@unical.it
RI Conforti, filomena/P-8191-2015
OI Marrelli, Mariangela/0000-0002-3741-4261; Conforti,
   Filomena/0000-0001-6699-005X
CR Araniti F, 2014, PHYTOCHEM LETT, V8, P179, DOI 10.1016/j.phytol.2013.08.019
   Araniti F, 2013, NAT PROD RES, V27, P880, DOI 10.1080/14786419.2012.691491
   Bray MS, 2000, J APPL PHYSIOL, V88, P788, DOI 10.1152/jappl.2000.88.2.788
   Conforti F, 2007, FOOD CHEM, V102, P1096, DOI 10.1016/j.foodchem.2006.06.047
   Conforti F, 2012, NAT PROD RES, V26, P1594, DOI 10.1080/14786419.2011.585988
   Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882
   Heo M, 2011, OBESITY FACTS, V4, P449, DOI 10.1159/000335279
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   Marrelli M, 2015, FOOD CHEM TOXICOL, V86, P16, DOI 10.1016/j.fct.2015.09.011
   Marrelli M, 2013, PLANT FOOD HUM NUTR, V68, P340, DOI 10.1007/s11130-013-0390-9
   Marrelli M, 2012, FOOD CHEM TOXICOL, V50, P726, DOI 10.1016/j.fct.2011.12.025
   Menichini G, 2013, CELL PROLIFERAT, V46, P193, DOI 10.1111/cpr.12020
   Menichini G, 2012, ANTI-CANCER AGENT ME, V12, P959, DOI 10.2174/187152012802649987
   Sosnowska D, 2015, PLANT FOOD HUM NUTR, V70, P344, DOI 10.1007/s11130-015-0501-x
   Szajdek A, 2008, PLANT FOOD HUM NUTR, V63, P147, DOI 10.1007/s11130-008-0097-5
   Zhang WL, 2014, OBES REV, V15, P957, DOI 10.1111/obr.12228
NR 16
TC 25
Z9 25
U1 1
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-9668
EI 1573-9104
J9 PLANT FOOD HUM NUTR
JI Plant Food Hum. Nutr.
PD SEP
PY 2016
VL 71
IS 3
BP 301
EP 306
DI 10.1007/s11130-016-0560-7
PG 6
WC Plant Sciences; Chemistry, Applied; Food Science & Technology; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Chemistry; Food Science & Technology; Nutrition &
   Dietetics
GA EA8MA
UT WOS:000386887700012
PM 27372805
DA 2025-04-28
ER

PT J
AU Li, L
   Su, CP
   Chen, XY
   Wang, Q
   Jiao, WC
   Luo, H
   Tang, JY
   Wang, W
   Li, S
   Guo, SZ
AF Li, Lin
   Su, Congping
   Chen, Xiangyang
   Wang, Qing
   Jiao, Wenchao
   Luo, Hui
   Tang, Jiayang
   Wang, Wei
   Li, Sen
   Guo, Shuzhen
TI Chlorogenic Acids in Cardiovascular Disease: A Review of Dietary
   Consumption, Pharmacology, and Pharmacokinetics
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Review
DE chlorogenic acids; hypertension; atherosclerosis; heart failure;
   myocardial infarction
ID PROLIFERATOR-ACTIVATED RECEPTOR; COFFEE BEAN EXTRACT;
   HIGH-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; OXIDATIVE STRESS; CAFFEIC
   ACID; IN-VITRO; CARDIAC-HYPERTROPHY; NITRIC-OXIDE; MYOCARDIAL-INFARCTION
AB Chlorogenic acids (CGAs) have gained considerable attention as pervasive human dietary constituents with potential cardiovascular-preserving effects. The main sources include coffee, yerba mate, Eucommia ulmodies leaves, and Lonicerae Japonicae Flos. CGA consumption can reduce the risks of hypertension, atherosclerosis, heart failure, myocardial infarction, and other factors associated with cardiovascular risk, such as obesity and type 2 diabetes. This review recapitulates recent advances of CGAs in the cardiovascular-preserving effects, pharmacokinetics, sources, and safety. Emerging evidence indicates that CGAs exhibit circulatory guarding properties through the suppression of oxidative stress, leukocyte infiltration, platelet aggregation, platelet-leukocyte interactions, vascular remodeling, and apoptosis as well as the regulation of glucose and lipid metabolism and vasodilatory action in the cardiovascular system. CGAs exert these effects by acting on complex signaling networks, but the global mechanisms are still not clear. The oral bioavailability of CGA is poor, and there is a potential sensitization concern about CGA. The bioactive metabolites, systematic toxicity, and optimized structure are needed for further identification.
C1 [Li, Lin; Su, Congping; Wang, Qing; Jiao, Wenchao; Luo, Hui; Tang, Jiayang; Wang, Wei; Guo, Shuzhen] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing 100029, Peoples R China.
   [Li, Sen] Beijing Univ Chinese Med, Sch Life Sci, Beijing 100029, Peoples R China.
   [Chen, Xiangyang] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing 102488, Peoples R China.
C3 Beijing University of Chinese Medicine; Beijing University of Chinese
   Medicine; Beijing University of Chinese Medicine
RP Wang, W; Guo, SZ (corresponding author), Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing 100029, Peoples R China.; Li, S (corresponding author), Beijing Univ Chinese Med, Sch Life Sci, Beijing 100029, Peoples R China.
EM senli@bucm.edu.cn; guoshz@bucm.edu.cn
RI wang, zhe/G-6938-2011; Chen, Xiangyang/AAH-6086-2020
FU National Natural Science Foundation of China [81874387, 81774101]
FX This work was supported by the National Natural Science Foundation of
   China (Grants 81874387 and 81774101).
CR Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Agunloye OM, 2019, BIOMED PHARMACOTHER, V109, P450, DOI 10.1016/j.biopha.2018.10.044
   Akila P, 2017, BIOMED PHARMACOTHER, V85, P582, DOI 10.1016/j.biopha.2016.11.067
   Akila P, 2016, BIOMED PHARMACOTHER, V84, P208, DOI 10.1016/j.biopha.2016.09.028
   Al-Rasheed NM, 2014, SAUDI J BIOL SCI, V21, P265, DOI 10.1016/j.sjbs.2013.09.006
   Amato A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050492
   Amin RP, 2013, J COMPLEMENT INTEGR, V10, P1
   Andreasen MF, 2001, J AGR FOOD CHEM, V49, P5679, DOI 10.1021/jf010668c
   [Anonymous], SHANGHAI J TRADITION
   [Anonymous], 2019, Encyclopedia of Food Chemistry, DOI DOI 10.1016/B978-0-08-100596-5.22395-0
   Ardiansyah, 2008, J AGR FOOD CHEM, V56, P2825, DOI 10.1021/jf072896y
   Aviram M, 2006, PATHOPHYSIOL HAEMO T, V35, P146, DOI 10.1159/000093558
   Azuma K, 2000, J AGR FOOD CHEM, V48, P5496, DOI 10.1021/jf000483q
   Baeza G, 2017, FOOD FUNCT, V8, P1333, DOI [10.1039/c6fo01404f, 10.1039/C6FO01404F]
   Balzan S, 2013, FITOTERAPIA, V86, P115, DOI 10.1016/j.fitote.2013.02.008
   Benz PM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0144-z
   Bhandarkar NS, 2019, NUTR RES, V62, P78, DOI 10.1016/j.nutres.2018.11.002
   Bhattacharyya S, 2014, J PHOTOCH PHOTOBIO B, V130, P293, DOI 10.1016/j.jphotobiol.2013.11.020
   Budryn G, 2015, FOOD CHEM, V168, P276, DOI 10.1016/j.foodchem.2014.07.056
   Bumrungpert A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060713
   Calinoiu LF, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111615
   Chang WC, 2010, EUR J NUTR, V49, P267, DOI 10.1007/s00394-009-0083-1
   Chaowuttikul C, 2017, PHARMACOGN RES, V9, P128, DOI 10.4103/pr.pr_117_16
   Che YY, 2016, MOLECULES, V21, DOI 10.3390/molecules21121728
   Chen JL, 2019, APPL MICROBIOL BIOT, V103, P8157, DOI 10.1007/s00253-019-10025-8
   Chen L, 2017, EUR J PHARM SCI, V100, P102, DOI 10.1016/j.ejps.2017.01.011
   Chen ZY, 2009, J AGR FOOD CHEM, V57, P4485, DOI 10.1021/jf900803r
   Chlopcíková S, 2004, PHYTOTHER RES, V18, P408, DOI 10.1002/ptr.1461
   Cho HJ, 2012, BLOOD COAGUL FIBRIN, V23, P629, DOI 10.1097/MBC.0b013e3283570846
   Choi JH, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22004
   Choudhury R, 1999, FREE RADICAL BIO MED, V27, P278, DOI 10.1016/S0891-5849(99)00054-4
   Chowdhury S, 2016, FOOD CHEM TOXICOL, V97, P187, DOI 10.1016/j.fct.2016.09.011
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   Clifford MN, 2006, J AGR FOOD CHEM, V54, P1957, DOI 10.1021/jf0601665
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Coppieters KT, 2014, MOL METAB, V3, P275, DOI 10.1016/j.molmet.2013.12.005
   Couteau D, 2001, J APPL MICROBIOL, V90, P873, DOI 10.1046/j.1365-2672.2001.01316.x
   Cui T, 2006, J AGR FOOD CHEM, V54, P4574, DOI 10.1021/jf060310m
   Dewanto V, 2002, J AGR FOOD CHEM, V50, P4959, DOI 10.1021/jf0255937
   Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021
   Du WY, 2013, J ETHNOPHARMACOL, V147, P74, DOI 10.1016/j.jep.2013.01.042
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farrell TL, 2012, MOL NUTR FOOD RES, V56, P1413, DOI 10.1002/mnfr.201200021
   Feng YS, 2016, INT J PHARMACEUT, V501, P342, DOI 10.1016/j.ijpharm.2016.01.081
   FREEDMAN SO, 1961, NATURE, V192, P241, DOI 10.1038/192241a0
   FREEDMAN SO, 1962, T ASSOC AM PHYSICIAN, V75, P99
   FREEDMAN SO, 1964, J ALLERGY, V35, P108, DOI 10.1016/0021-8707(64)90024-3
   Fuentes E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090699
   Gebara KS, 2017, J AGR FOOD CHEM, V65, P10093, DOI 10.1021/acs.jafc.7b04093
   Ghosh S, 2017, FOOD CHEM TOXICOL, V103, P41, DOI 10.1016/j.fct.2017.02.028
   Glezeva N, 2016, J CARDIOVASC PHARM T, V21, P245, DOI 10.1177/1074248415609436
   Godar RJ, 2015, AUTOPHAGY, V11, P1537, DOI 10.1080/15548627.2015.1063768
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928
   Gordon MH, 2010, J AGR FOOD CHEM, V58, P5828, DOI 10.1021/jf100106e
   Gordts PLSM, 2018, MATRIX BIOL, V71-72, P262, DOI 10.1016/j.matbio.2018.05.010
   GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141
   Gugliucci A, 2009, FITOTERAPIA, V80, P138, DOI 10.1016/j.fitote.2009.01.001
   Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17
   [贺文凤 He Wenfeng], 2014, [临床心血管病杂志, Journal of Clinical Cardiology], V30, P725
   Hebeda CB, 2011, J ETHNOPHARMACOL, V135, P261, DOI 10.1016/j.jep.2011.02.033
   Hilfiker-Klemer D, 2006, J AM COLL CARDIOL, V48, pA56, DOI 10.1016/j.jacc.2006.07.007
   Hong Q, 2016, EUR J PHARMACOL, V777, P1, DOI 10.1016/j.ejphar.2016.01.005
   Hosseinzadeh A, 2019, LIFE SCI, V217, P91, DOI 10.1016/j.lfs.2018.11.050
   Hou YZ, 2004, EUR J PHARMACOL, V499, P85, DOI 10.1016/j.ejphar.2004.07.107
   Irukayama-Tomobe Y, 2004, CIRCULATION, V109, P904, DOI 10.1161/01.CIR.0000112596.06954.00
   Ishiguro K, 2007, J AGR FOOD CHEM, V55, P10773, DOI 10.1021/jf072256v
   Jaganath IB, 2006, FREE RADICAL RES, V40, P1035, DOI 10.1080/10715760600771400
   Jaiswal R, 2012, FOOD FUNCT, V3, P976, DOI 10.1039/c2fo10260a
   Jaiswal R, 2011, J MASS SPECTROM, V46, P933, DOI 10.1002/jms.1972
   Jamshidi Y, 2002, CIRCULATION, V105, P950, DOI 10.1161/hc0802.104535
   Jeon JS, 2019, J ADV RES, V17, P85, DOI 10.1016/j.jare.2019.01.002
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jonnalagadda SS, 2011, J NUTR, V141, p1011S, DOI 10.3945/jn.110.132944
   JORIS I, 1983, AM J PATHOL, V113, P341
   Jung HJ, 2017, BMB REP, V50, P323, DOI 10.5483/BMBRep.2017.50.6.182
   Jung JW, 2014, XENOBIOTICA, V44, P635, DOI 10.3109/00498254.2013.874610
   Kang N, 2015, ENVIRON TOXICOL PHAR, V39, P764, DOI 10.1016/j.etap.2015.02.006
   Kanno Y, 2013, INT HEART J, V54, P176, DOI 10.1536/ihj.54.176
   Kashef F, 2012, J BIOL CHEM, V287, P30268, DOI 10.1074/jbc.M112.368415
   Kellogg DL, 2005, J APPL PHYSIOL, V98, P629, DOI 10.1152/japplphysiol.00728.2004
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Krga I, 2018, ARCH BIOCHEM BIOPHYS, V645, P34, DOI 10.1016/j.abb.2018.03.016
   Kunyan L., 2014, CHINAS HLTH IND, V11, P87
   Ky CL, 1997, J AGR FOOD CHEM, V45, P786, DOI 10.1021/jf9605254
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Lan X., 2009, CHIN AGR SCI BULLET, V25, P86
   Lassègue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972
   Layton L. L., 2004, INT ARCH ALLERGY IMM, V33, P417
   Layton L. L., 2004, INT ARCH ALLERGY IMM, V23, P225
   LAYTON LL, 1966, J ALLERGY, V38, P268, DOI 10.1016/0021-8707(66)90020-7
   Lee SJ, 2018, J CLIN INVEST, V128, P5018, DOI 10.1172/JCI99659
   Lee SM, 2013, NUTR RES, V33, P136, DOI 10.1016/j.nutres.2012.11.010
   Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001
   Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10
   Li Q., 2014, CHIN J MOD APPL PHAR, V26, P555
   Li QY, 2015, EUR J PHARMACOL, V751, P81, DOI 10.1016/j.ejphar.2015.01.046
   Li YF, 2014, TOXICOL LETT, V226, P257, DOI 10.1016/j.toxlet.2014.02.016
   Li Y, 2018, PHARMACOL RES, V130, P110, DOI 10.1016/j.phrs.2018.01.006
   Lindsey ML, 2018, AM J PHYSIOL-HEART C, V314, pH812, DOI 10.1152/ajpheart.00335.2017
   Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517
   Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687
   Lu FH, 2013, CELL PHYSIOL BIOCHEM, V31, P728, DOI 10.1159/000350091
   Ludwig IA, 2013, BIOFACTORS, V39, P623, DOI 10.1002/biof.1124
   Luo YY, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00692
   Marinova GV, 2008, J PHARMACOL SCI, V106, P385, DOI 10.1254/jphs.FP0072275
   Martins PD, 2004, ARTERIOSCL THROM VAS, V24, P193, DOI 10.1161/01.ATV.0000106320.40933.E5
   Marx C, 2019, BLOOD, V134, P1859, DOI 10.1182/blood.2019000518
   McClements DJ, 2015, ADV COLLOID INTERFAC, V219, P27, DOI 10.1016/j.cis.2015.02.002
   Meinhart AD, 2019, FOOD CHEM, V286, P51, DOI 10.1016/j.foodchem.2019.02.004
   Meinhart AD, 2017, FOOD RES INT, V99, P522, DOI 10.1016/j.foodres.2017.06.017
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Mullen W, 2006, BRIT J NUTR, V96, P107, DOI 10.1079/BJN20061809
   Nallamuthu I, 2015, ASIAN J PHARM SCI, V10, P203, DOI 10.1016/j.ajps.2014.09.005
   Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547
   NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y
   Natella F, 2007, AM J CLIN NUTR, V86, P604, DOI 10.1093/ajcn/86.3.604
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526
   Obermayer G, 2018, J THROMB HAEMOST, V16, P418, DOI 10.1111/jth.13925
   Ochiai R, 2009, HYPERTENS RES, V32, P969, DOI 10.1038/hr.2009.132
   Olthof MR, 2001, AM J CLIN NUTR, V73, P532
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Ong SB, 2018, PHARMACOL THERAPEUT, V186, P73, DOI 10.1016/j.pharmthera.2018.01.001
   Ostertag LM, 2011, MOL NUTR FOOD RES, V55, P1624, DOI 10.1002/mnfr.201100135
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Park ES, 2014, J ETHNOPHARMACOL, V153, P552, DOI 10.1016/j.jep.2014.02.019
   Park JJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-81
   Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009
   Patel SS, 2011, PHARMACOGN RES, V3, P239, DOI 10.4103/0974-8490.89743
   Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577
   Pretorius L, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0783-z
   Priscilla DH, 2009, CHEM-BIOL INTERACT, V179, P118, DOI 10.1016/j.cbi.2008.12.012
   Rani MRP, 2018, BIOMED PHARMACOTHER, V100, P467, DOI 10.1016/j.biopha.2018.02.027
   Redeuil K, 2011, J CHROMATOGR A, V1218, P4678, DOI 10.1016/j.chroma.2011.05.050
   Renouf M, 2014, MOL NUTR FOOD RES, V58, P301, DOI 10.1002/mnfr.201300349
   Roland A, 2001, ARTERIOSCL THROM VAS, V21, P594, DOI 10.1161/01.ATV.21.4.594
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Scivittaro V, 2000, AM J PHYSIOL-RENAL, V278, pF676, DOI 10.1152/ajprenal.2000.278.4.F676
   Seal CJ, 2015, P NUTR SOC, V74, P313, DOI 10.1017/S0029665115002104
   Shyu KG, 2005, J BIOMED SCI, V12, P409, DOI 10.1007/s11373-005-3008-x
   Song Y, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.30323
   Sookoian S, 2011, CURR HYPERTENS REP, V13, P149, DOI 10.1007/s11906-010-0164-9
   Stalmach A, 2014, FOOD FUNCT, V5, P1727, DOI [10.1039/c4fo00316k, 10.1039/C4FO00316K]
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Steinbacher P, 2015, BIOMOLECULES, V5, P356, DOI 10.3390/biom5020356
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   Suzuki A, 2019, INT J FOOD SCI NUTR, V70, P901, DOI 10.1080/09637486.2019.1585763
   Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890
   Tian G, 2016, THESIS
   Tian L, 2019, J CELL MOL MED, V23, P4666, DOI 10.1111/jcmm.14351
   Tom ENL, 2016, PHYTOMEDICINE, V23, P1037, DOI 10.1016/j.phymed.2016.06.012
   Tsai KL, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700928
   Tsai KL, 2014, BIOCHEM PHARMACOL, V88, P189, DOI 10.1016/j.bcp.2013.12.005
   Upadhyay R, 2013, CRIT REV FOOD SCI, V53, P968, DOI 10.1080/10408398.2011.576319
   Uto-Kondo H, 2010, CIRC RES, V106, P779, DOI 10.1161/CIRCRESAHA.109.206615
   van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Wang C, 2016, IRAN J BASIC MED SCI, V19, P97
   Wang DD, 2019, PHARMACOL REV, V71, P596, DOI 10.1124/pr.118.017178
   Wang JS, 2016, MOL MED REP, V14, P4063, DOI 10.3892/mmr.2016.5743
   Wang M, 2013, ATHEROSCLEROSIS, V229, P62, DOI 10.1016/j.atherosclerosis.2013.01.017
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548
   Wu Y, 2018, INT J FOOD SCI NUTR, V69, P566, DOI 10.1080/09637486.2017.1394449
   Xi L.S., 2014, Acta Agric. Nucl. Sin, V28, P292
   Xie LP, 2016, DIABETES, V65, P3171, DOI 10.2337/db16-0020
   Yago T, 2018, BLOOD, V132, P1426, DOI 10.1182/blood-2018-05-850859
   Yamaguchi T, 2008, NUTR METAB CARDIOVAS, V18, P408, DOI 10.1016/j.numecd.2007.03.004
   Yamamoto Y, 2007, J ORG CHEM, V72, P7817, DOI 10.1021/jo070579k
   Yiming B., 2019, THESIS
   Yu BW, 2016, ACTA PHARMACOL SIN, V37, P1413, DOI 10.1038/aps.2016.79
   Yu XH, 2019, PROG LIPID RES, V73, P65, DOI 10.1016/j.plipres.2018.12.002
   Yukawa GS, 2004, BIOCHEMISTRY-MOSCOW+, V69, P70, DOI 10.1023/B:BIRY.0000016354.05438.0f
   Zhang B, 2018, EUR J CLIN NUTR, V72, P57, DOI 10.1038/ejcn.2017.149
   Zhang JY, 2013, J ETHNOPHARMACOL, V148, P563, DOI 10.1016/j.jep.2013.04.053
   Zhang ZF, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7961940
   Zhuang T, 2019, CIRC RES, V125, P590, DOI 10.1161/CIRCRESAHA.118.314402
NR 187
TC 73
Z9 77
U1 5
U2 93
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUN 17
PY 2020
VL 68
IS 24
BP 6464
EP 6484
DI 10.1021/acs.jafc.0c01554
PG 21
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA MB9PT
UT WOS:000542930300002
PM 32441927
DA 2025-04-28
ER

PT J
AU Chen, TG
   Li, YY
   Zhang, LW
AF Chen, Tinggui
   Li, Yayun
   Zhang, Liwei
TI Nine Different Chemical Species and Action Mechanisms of Pancreatic
   Lipase Ligands Screened Out from Forsythia suspensa Leaves All at
   One Time
SO MOLECULES
LA English
DT Article
DE Forsythia suspensa leaves; affinity screening; pancreatic lipase
   inhibitor; obesity
ID NATURAL INHIBITORS; PORCINE PANCREAS; TEA; IDENTIFICATION; POLYPHENOLS;
   EXTRACTS
AB It is difficult to screen out as many active components as possible from natural plants all at one time. In this study, subfractions of Forsythia suspensa leaves were firstly prepared; then, their inhibitive abilities on pancreatic lipase were tested; finally, the highest inhibiting subfraction was screened by self-made immobilized pancreatic lipase. Results showed that nine ligands, including eight inhibitors and one promotor, were screened out all at one time. They were three flavonoids (rutin, IC50: 149 +/- 6.0 mu mol/L; hesperidin, 52.4 mu mol/L; kaempferol-3-O-rutinoside, isolated from F. suspensa leaves for the first time, IC50 notably reached 2.9 +/- 0.5 mu mol/L), two polyphenols (chlorogenic acid, 3150 +/- 120 mu mol/L; caffeic acid, 1394 +/- 52 mu mol/L), two lignans (phillyrin, promoter; arctigenin, 2129 +/- 10.5 mu mol/L), and two phenethyl alcohol (forsythiaside A, 2155 +/- 8.5 mu mol/L; its isomer). Their action mechanisms included competitive inhibition, competitive promotion, noncompetitive inhibition, and uncompetitive inhibition. In sum, using the appropriate methods, more active ingredients can be simply and quickly screened out all at one time from a complex natural product system. In addition, F. suspensa leaves contain numerous inhibitors of pancreatic lipase.
C1 [Chen, Tinggui; Li, Yayun; Zhang, Liwei] Shanxi Univ, Inst Mol Sci, Key Lab Chem Biol & Mol Engn, Minist Educ, Taiyuan 030006, Peoples R China.
C3 Shanxi University
RP Chen, TG (corresponding author), Shanxi Univ, Inst Mol Sci, Key Lab Chem Biol & Mol Engn, Minist Educ, Taiyuan 030006, Peoples R China.
EM chentg@sxu.edu.cn; lisf@sxu.edu.cn; lwzhang@sxu.edu.cn
OI Chen, Tinggui/0000-0001-8455-1317
FU Key Technology Research of Traditional Chinese Medicine Modernization of
   Shanxi Province (Zhendong Special) [2014ZD0304]
FX This work was supported by the Key Technology Research of Traditional
   Chinese Medicine Modernization of Shanxi Province (Zhendong Special)
   (2014ZD0304).
CR Baretic M, 2012, DIGEST DIS, V30, P168, DOI 10.1159/000336672
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Cai SB, 2012, J AGR FOOD CHEM, V60, P7245, DOI 10.1021/jf3009958
   [陈廷贵 Chen Tinggui], 2017, [天然产物研究与开发, Natural Product Research and Development], V29, P198
   Dai SJ, 2009, PLANTA MED, V75, P375, DOI 10.1055/s-0028-1112204
   del Castillo-Santaella T, 2015, J AGR FOOD CHEM, V63, P10333, DOI 10.1021/acs.jafc.5b04550
   Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326
   Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6
   Habtemariam S, 2013, PHYTOTHER RES, V27, P152, DOI 10.1002/ptr.4711
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Kang WY, 2010, MED CHEM RES, V19, P617, DOI 10.1007/s00044-009-9217-5
   Kawaguchi K, 1997, BIOSCI BIOTECH BIOCH, V61, P102, DOI 10.1271/bbb.61.102
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Qu HH, 2008, J PHARM PHARMACOL, V60, P261, DOI 10.1211/jpp.60.2.0016
   Roh C, 2012, INT J MOL SCI, V13, P1710, DOI 10.3390/ijms13021710
   Tao Y, 2013, BIOMED CHROMATOGR, V27, P148, DOI 10.1002/bmc.2761
   World Health Organization (WHO), 2000, REP WHO CONS OB PREV
   Wu XL, 2013, J AGR FOOD CHEM, V61, P8829, DOI 10.1021/jf401779z
   Yuda N, 2012, J FOOD SCI, V77, pH254, DOI 10.1111/j.1750-3841.2012.02967.x
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
   Zhang Guo-Gang, 2002, Journal of Herbal Pharmacotherapy, V2, P35, DOI 10.1080/J157v02n03_04
NR 23
TC 19
Z9 21
U1 5
U2 48
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD MAY
PY 2017
VL 22
IS 5
AR 795
DI 10.3390/molecules22050795
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA EZ2EP
UT WOS:000404522900116
PM 28498356
OA Green Published, Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Liu, MT
   Qin, J
   Cong, J
   Yang, YB
AF Liu, Mengting
   Qin, Jian
   Cong, Jing
   Yang, Yubin
TI Chlorogenic Acids Inhibit Adipogenesis: Implications of
   Wnt/β-Catenin Signaling Pathway
SO INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID 3T3-L1 CELL-DIFFERENTIATION; METABOLISM; ACCUMULATION; OBESITY
AB In our previous in vitro study, we found that chlorogenic acid (CGA) inhibited adipocyte differentiation and triglyceride (TG) accumulation, but the underlying mechanism is still unclear. Accumulative genetic evidence supports that canonical Wnt signaling is a key modulator on adipogenesis. Methods. In this study, 3T3-L1 cells were induced adipogenic differentiation and then treated with CGA. We investigate the effect of CGA in inhibiting adipogenesis and evaluate its role in modulating Wnt10b (wingless integration1 10b), beta-catenin, glycogen synthase kinase-3 beta (GSK-3 beta), and peroxisome proliferator-activated receptor gamma (PPAR-gamma) involved in the Wnt (wingless integration1)/beta-catenin signaling pathway. Results. The result showed that after CGA treatment, lipid accumulation and TG level decreased significantly in 3T3-L1 cells, indicating that CGA could inhibit adipogenesis. In addition, CGA repressed the induction of adipocyte differentiation biomarkers as PPAR-gamma, adipocyte protein 2 (aP2), fatty acid synthase (FAS), and lipoprotein lipase (LPL), and the secretion of GSK-3 beta in a dose-dependent manner upregulated the expression of beta-catenin and Wnt10b both in gene and protein levels. Moreover, CGA induced phosphorylation of GSK-3 beta and promoted the accumulation of free cytosolic beta-catenin in 3T3-L1 adipocytes. Conclusion. Overall, these findings gave us the implications that CGA inhibits adipogenesis via the canonical Wnt signaling pathway.
C1 [Liu, Mengting; Yang, Yubin] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Guangzhou 510080, Peoples R China.
   [Qin, Jian] Sun Yat Sen Univ, Affiliated Hosp 7, Shenzhen 518000, Peoples R China.
   [Cong, Jing] Giant Praise HK Pharmaceut Grp Ltd, Acad Dept, Changchun 130033, Peoples R China.
C3 Guangdong Pharmaceutical University; Sun Yat Sen University
RP Yang, YB (corresponding author), Guangdong Pharmaceut Univ, Affiliated Hosp 1, Guangzhou 510080, Peoples R China.
EM liuying120660@163.com; qingq1997813@163.com; vsb989@163.com;
   yybin@mail.sysu.edu.cn
FU CGA monomer; Giant Praise (HK) Pharmaceutical Group Limited; Guangdong
   Provincial Administration of Traditional Chinese Medicine Project
   [20181052]; Guangdong Natural Science Fund Project [2018A030313411];
   Chinese National Natural Science Foundation [82104716]
FX The CGA monomer for this research was sponsored by Giant Praise (HK)
   Pharmaceutical Group Limited. This study was supported in part by grants
   from Guangdong Provincial Administration of Traditional Chinese Medicine
   Project (20181052) Guangdong Natural Science Fund Project
   (2018A030313411), and Chinese National Natural Science Foundation
   (82104716).
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Ahn J, 2010, AM J PHYSIOL-CELL PH, V298, pC1510, DOI 10.1152/ajpcell.00369.2009
   Ambele MA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124283
   Bahmad HF, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102326
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Bessesen DH, 2018, LANCET DIABETES ENDO, V6, P237, DOI 10.1016/S2213-8587(17)30236-X
   Chang E, 2019, MOLECULES, V24, DOI 10.3390/molecules24061157
   Chen H, 2014, CELL SIGNAL, V26, P2583, DOI 10.1016/j.cellsig.2014.07.017
   Chen JL, 2018, J NUTR BIOCHEM, V59, P84, DOI 10.1016/j.jnutbio.2018.06.005
   Chen N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00792
   Chi YY, 2016, FOOD SCI BIOTECHNOL, V25, P1147, DOI 10.1007/s10068-016-0183-7
   de Sá PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022
   Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]
   Feng S, 2016, MOLECULES, V21, DOI 10.3390/molecules21101278
   Gong XJ, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.4008
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3
   Ji E, 2014, INT J OBESITY, V38, P1035, DOI 10.1038/ijo.2013.202
   Kong L, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13795
   Ma LY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092785
   MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016
   Martínez-López S, 2019, EUR J NUTR, V58, P865, DOI 10.1007/s00394-018-1726-x
   Moorer MC, 2018, ENDOCRINOL METAB, V33, P318, DOI 10.3803/EnM.2018.33.3.318
   Nijhawan P, 2020, MOL BIOL REP, V47, P8091, DOI 10.1007/s11033-020-05784-x
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Smith KB, 2016, PRIMARY CARE, V43, P121, DOI 10.1016/j.pop.2015.10.001
   Son JW, 2020, DIABETES METAB J, V44, P802, DOI 10.4093/dmj.2020.0258
   Song Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060554
   Tang LJ, 2015, CELL PHYSIOL BIOCHEM, V37, P143, DOI 10.1159/000430340
   Tian YY, 2016, FOOD SCI BIOTECHNOL, V25, P1753, DOI 10.1007/s10068-016-0267-4
NR 32
TC 14
Z9 15
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1687-8337
EI 1687-8345
J9 INT J ENDOCRINOL
JI Int. J. Endocrinol.
PD NOV 20
PY 2021
VL 2021
AR 2215274
DI 10.1155/2021/2215274
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA XT7KG
UT WOS:000733761200001
PM 34845409
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Kubot, K
   Sumi, S
   Tojo, H
   Sumi-Inoue, Y
   I-Chin, H
   Oi, Y
   Fujita, H
   Urata, H
AF Kubot, Kazumitsu
   Sumi, Shunichiro
   Tojo, Hideaki
   Sumi-Inoue, Yukiko
   I-chin, Hou
   Oi, Yasuyuki
   Fujita, Hiroyuki
   Urata, Hidenori
TI Improvements of mean body mass index and body weight in preobese and
   overweight Japanese adults with black Chinese tea (Pu-Erh) water extract
SO NUTRITION RESEARCH
LA English
DT Article
DE Black Chinese tea; Obesity; Visceral fat area; Pu-Erh; Metabolic
   syndrome; Food for Specified Health Uses: Human
ID DOUBLE-BLIND; GALLIC ACID; FAT; OBESITY; ACCUMULATION; CHOLESTEROL;
   BORDERLINE; CATECHINS; CAFFEINE; HEALTHY
AB Water-soluble black Chinese (Pu-Erh) tea extract (BTE), which contains high gallic acid content, has been demonstrated to elicit antiobese effects in animals. Because gallic acid is related with the reduction of visceral fat and cholesterol contents and improvement of obesity in animals, we investigated the effects of BTE intake on 36 preobese Japanese adults (body mass index [BMI], >25-<30 kg/m(2)) in a 12-week double-blind, randomized, placebo-controlled group comparison study using powdered barley tea with or without (placebo) BTE. A follow-up 4-week period after BTE intake termination was monitored to observe the withdrawal effect. All subjects ingested barley tea with or without BTE (333 mg) before each of the 3 daily meals. In the BTE-treated group, the mean pretreament values of body weight and BMI significantly decreased after intake and after BTE withdrawal. However, the corresponding values scored significant differences only from 8 weeks after intake (vs the placebo-treated group). The mean values of the waist circumference indicated a similar tendency. Furthermore, coronal navel section (same anatomical position) images of computed tomography of all BTE- and non BTE-treated subjects revealed that the visceral fat areas (cm(2)) were significantly (P < .05) less in the former 12 weeks after BTE ingestion. Measured biochemical parameters did not indicate significant differences, and BTE-treated subjects did not complain of any adverse effects (abdominal distension, etc). Ingestion of BTE exhibited significant effects in reducing the mean waist circumference, BMI, and visceral fat values and might be useful for weight control and prevention of obesity development (or metabolic syndrome) in humans. Crown Copyright (C) 2011 Published by Elsevier Inc. All rights reserved.
C1 [I-chin, Hou; Oi, Yasuyuki; Fujita, Hiroyuki] Nippon Supplement Inc, Dept Res & Dev, Kita Ku, Osaka 5300013, Japan.
   [Kubot, Kazumitsu; Sumi, Shunichiro; Tojo, Hideaki; Sumi-Inoue, Yukiko; Urata, Hidenori] Fukuoka Univ, Chikushi Hosp, Dept Cardiovasc Dis, Fukuoka 8188502, Japan.
C3 Fukuoka University
RP Fujita, H (corresponding author), Nippon Supplement Inc, Dept Res & Dev, Kita Ku, 19-19 Chayamachi, Osaka 5300013, Japan.
EM fujita@nippon-sapuri.co.jp
FU R&D division of Nippon Supplement, Inc.
FX We thank Harumi Ide for great technical help and Narumi Yamauchi in the
   Department of Radiology of Fukuoka University Chikushi Hospital for her
   expertise in performing CT scanning of the participants. This study is
   funded by the R&D division of Nippon Supplement, Inc. Thanks are also
   due to Anthony Foong of Kyoto Pharmaceutical University, Kyoto, for
   reading the manuscript.
CR [Anonymous], 2017, Annex 3-03, P4
   Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13
   Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581
   Fujita H, 2000, J FOOD SCI, V65, P564, DOI 10.1111/j.1365-2621.2000.tb16049.x
   Fujita H, 2001, J NUTR, V131, P2105, DOI 10.1093/jn/131.8.2105
   Fujita H, 2008, PHYTOTHER RES, V22, P1275, DOI 10.1002/ptr.2477
   Fujita H, 2008, ANN NUTR METAB, V53, P33, DOI 10.1159/000153006
   Fujita H, 2008, NUTR RES, V28, P450, DOI 10.1016/j.nutres.2008.04.005
   GARY DM, 2006, OBESITY, V139, P1219
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Hosokawa M, 2010, ARCH BIOCHEM BIOPHYS, V504, P17, DOI 10.1016/j.abb.2010.05.031
   Hsu CL, 2007, BRIT J NUTR, V98, P727, DOI 10.1017/S000711450774686X
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245
   KEY TJ, 2002, LANCET, V288, P1723
   Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353
   Kuo KL, 2005, J AGR FOOD CHEM, V53, P480, DOI 10.1021/jf049375k
   Lin JK, 1998, J AGR FOOD CHEM, V46, P3635, DOI 10.1021/jf980223x
   Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   MARIEPIERRE SO, 2008, J CLIN NUTR, V87, P621
   Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987
   Nagao T, 2000, J NUTR, V130, P792, DOI 10.1093/jn/130.4.792
   Najm W, 2010, PRIMARY CARE, V37, P237, DOI 10.1016/j.pop.2010.02.008
   TORIS T, 2007, NIPPON NOUGEIKAGAK S, P261
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Tsuji H, 2001, J NUTR, V131, P2853, DOI 10.1093/jn/131.11.2853
   Way TD, 2009, J AGR FOOD CHEM, V57, P5257, DOI 10.1021/jf900730e
   Yang TTC, 1997, PHARMACOL RES, V35, P505, DOI 10.1006/phrs.1997.0176
   Yoo HJ, 2010, J KOREAN MED SCI, V25, P49, DOI 10.3346/jkms.2010.25.1.49
NR 32
TC 61
Z9 72
U1 1
U2 32
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
J9 NUTR RES
JI Nutr. Res.
PD JUN
PY 2011
VL 31
IS 6
BP 421
EP 428
DI 10.1016/j.nutres.2011.05.004
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 795AQ
UT WOS:000292944300002
PM 21745623
DA 2025-04-28
ER

PT J
AU Opala, T
   Rzymski, P
   Pischel, I
   Wilczak, M
   Wozniak, J
AF Opala, T.
   Rzymski, P.
   Pischel, I.
   Wilczak, M.
   Wozniak, J.
TI Efficacy of 12 weeks supplementation of a botanical extract-based weight
   loss formula on body weight, body composition and blood chemistry in
   healthy, overweight subjects - A randomised double-blind
   placebo-controlled clinical trial
SO EUROPEAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
DE dietary supplement; weight reduction; obesity; body composition
ID ENERGY-EXPENDITURE; FAT OXIDATION; FOOD-INTAKE; OBESITY; ORLISTAT;
   (-)-HYDROXYCITRATE; TRIGLYCERIDES; CAFFEINE; SATIETY; HUMANS
AB Objective: The aim of this study was to evaluate the efficacy and safety of composite extracts in reducing weight, as the main outcome measure. Secondary measures of the study were body composition change. Design: Randomised, double blind, placebo-controlled clinical trial. Setting: Tertiary university clinic. Subjects: hundred and five subjects, 5 of them withdrawn consent, 2 drop-outs not related to study preparation. Intervention: two tablet per meal concept supposed to generate a "psychological" therapy-like approach during 12 weeks supported by measured physical activity. The tablets 1 (one hour before meals, comprises extracts of Asparagus, Green tea, Black tea, Guarana, Mate and Kidney beans) and 2 (taken half an hour after meals, comprises extracts of Kidney bean pods, Garcinia cambogia, and Chromium yeast) are taken twice daily with two main meals. Results: A significant change of the Body Composition Improvement Index (BCI) was observed in the active extract group compared to placebo (p = 0.012). Weight, BMI, waist-to-hip ratio was not statistically different between groups. Body fat loss was greater in active group (p = 0.011) compared to placebo. A weight loss parameter corrected for exercise was introduced and found to be higher in active group (p = 0.046) than in placebo, meaning that the formula was more efficacious, due to a concurrently performed exercise program - a recommended strategy for life style modification. Conclusions: A significant change of the Body Composition Improvement Index and the decrease in body fat was statistically significant in active extract subjects compared to placebo. A change in some outcome measures like: weight, BMI failed to produce significant difference between groups.
C1 Poznan Univ Med Sci, Dept Mothers & Childs Hlth, Poznan, Poland.
   Finzelberg GmbH & Co KG, Andernach, Germany.
   Poznan Univ Med Sci, Dept Educ Med, Poznan, Poland.
C3 Poznan University of Medical Sciences; Poznan University of Medical
   Sciences
RP Rzymski, P (corresponding author), Poznan Univ Med Sci, Dept Mothers & Childs Hlth, Polna St 33, Poznan, Poland.
EM parzymsk@gpsk.am.poznan.pl
RI Rzymski, Pawel/JRW-4350-2023
OI Wilczak, Maciej/0000-0002-0941-9970; Rzymski, Pawel/0000-0001-9911-2448
CR Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   Campbell ML, 2001, AM J HEALTH-SYST PH, V58, P1301, DOI 10.1093/ajhp/58.14.1301
   Chanoine JP, 2005, JAMA-J AM MED ASSOC, V293, P2873, DOI 10.1001/jama.293.23.2873
   Coffey CS, 2004, INT J OBESITY, V28, P1411, DOI 10.1038/sj.ijo.0802784
   Colak R, 2004, PHYSIOL RES, V53, P53, DOI 10.33549/physiolres.930279
   Doucet E, 1997, EUR J CLIN NUTR, V51, P846, DOI 10.1038/sj.ejcn.1600497
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581
   Greenway F L, 2001, Obes Rev, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   Heymsfield SB, 1998, JAMA-J AM MED ASSOC, V280, P1596, DOI 10.1001/jama.280.18.1596
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kelley DE, 2004, DIABETES CARE, V27, P33, DOI 10.2337/diacare.27.1.33
   Koukiekolo R, 1999, EUR J BIOCHEM, V265, P20, DOI 10.1046/j.1432-1327.1999.00611.x
   Kovacs EMR, 2001, INT J OBESITY, V25, P1087, DOI 10.1038/sj.ijo.0801605
   LEBERREANTON V, RECENT ADV RES ANTIN, V93, P131
   Lenz Thomas L, 2004, J Am Pharm Assoc (2003), V44, P59, DOI 10.1331/154434504322713246
   Mathus-Vliegen E M, 1998, Ned Tijdschr Geneeskd, V142, P1982
   Moro CO, 2000, FITOTERAPIA, V71, pS73, DOI 10.1016/S0367-326X(00)00177-5
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Pittler MH, 2003, INT J OBESITY, V27, P522, DOI 10.1038/sj.ijo.0802262
   Rippe JM, 1998, J AM DIET ASSOC, V98, pS9, DOI 10.1016/S0002-8223(98)00704-4
   Soni MG, 2004, FOOD CHEM TOXICOL, V42, P1513, DOI 10.1016/j.fct.2004.04.014
   Westerterp-Plantenga M, 2002, INT J OBESITY, V26, P870, DOI 10.1038/sj.ijo.0801979
NR 25
TC 48
Z9 51
U1 0
U2 21
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0949-2321
EI 2047-783X
J9 EUR J MED RES
JI Eur. J. Med. Res.
PD AUG 30
PY 2006
VL 11
IS 8
BP 343
EP 350
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 087FR
UT WOS:000240728800005
PM 17052970
DA 2025-04-28
ER

PT J
AU Mariadoss, AVA
   Vinyagam, R
   Rajamanickam, V
   Sankaran, V
   Venkatesan, S
   David, E
AF Mariadoss, Arokia V. A.
   Vinyagam, Ramachandran
   Rajamanickam, Vinothkumar
   Sankaran, Vijayalakshmi
   Venkatesan, Sathish
   David, Ernest
TI Pharmacological Aspects and Potential Use of Phloretin: A Systemic
   Review
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Phloretin; antioxidant; anti-inflammatory; anti-microbial;
   anti-allergic; anti-carcinogenic; anti-thrombotic
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; DIET-INDUCED OBESITY; CANCER
   CELL-GROWTH; MELANOMA 4A5 CELLS; NF-KAPPA-B; INDUCED APOPTOSIS;
   IN-VITRO; ENDOTHELIAL DYSFUNCTION; ANTIOXIDANT ACTIVITY; BIOACTIVE
   COMPOUNDS
AB Over the past two decades, many researchers have concluded that a diet rich in polyphenolic compounds plays an important therapeutic role in reducing the risk of cancer, cardiovascular disease, inflammation, diabetes, and other degenerative diseases. Polyphenolic compounds have been reported to be involved in neutralization of reactive oxygen species and charged radicals, and have anti-carcinogenic effects, hepatoprotective effects, low-glycaemic response, and other benefits. The benefits of fruits and vegetables may be partly attributable to polyphenolic compounds, which have antioxidant and free radical scavenging properties. Fruits such as apples contain a variety of phytochemicals, including (+)-catechin and (-)-epicatechin, phlorizin, phloretin quercetin, cyanidin-3-Ogalactoside, chlorogenic acid, and p-coumaric acid, all of which are strong antioxidants. Phloretin, a natural phenolic compound, is a dihydrochalcone, which is present in the apple. It exhibits a wide variety of activities such as antioxidative, anti-inflammatory, anti-microbial, anti-allergic, anticarcinogenic, anti-thrombotic, and hepatoprotective, besides being involved in the activation of apoptotic associated gene expression and signal transduction in molecular pathways. Despite a multitude of clinical studies, new efforts are needed in clinical research to determine the complete therapeutic potential of phloretin.
C1 [Mariadoss, Arokia V. A.; Vinyagam, Ramachandran; Sankaran, Vijayalakshmi; Venkatesan, Sathish; David, Ernest] Thiruvalluvar Univ, Dept Biotechnol, Vellore 632115, Tamil Nadu, India.
   [Rajamanickam, Vinothkumar] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China.
C3 Thiruvalluvar University; Wenzhou Medical University
RP Mariadoss, AVA; David, E (corresponding author), Thiruvalluvar Univ, Dept Biotechnol, Vellore 632115, Tamil Nadu, India.
EM mavijaibt@gmail.com; ernestdavid2009@gmail.com
RI M, Arokia Vijaya Anand/AAA-7033-2020; Vinayagam,
   Ramachandran/AAX-9725-2020
OI Vinayagam, Ramachandran/0000-0003-3568-2358
FU University Grant Commission, Government of India [BL/15-16/0424]
FX The authors wish to acknowledge the financial support from the
   University Grant Commission, Government of India through the UGC-DSK
   Postdoctoral progamme (Ref No: BL/15-16/0424).
CR Abkin SV, 2016, CANCER IMMUNOL IMMUN, V65, P83, DOI 10.1007/s00262-015-1778-1
   Aliomrani M, 2016, DARU, V24, DOI 10.1186/s40199-016-0154-9
   Alsanea S, 2017, AAPS J, V19, P797, DOI 10.1208/s12248-017-0053-0
   An RB, 2007, ARCH PHARM RES, V30, P674, DOI 10.1007/BF02977626
   Anand M Arokia Vijaya, 2014, Toxicol Int, V21, P179, DOI 10.4103/0971-6580.139805
   [Anonymous], ALTERNAT MED
   [Anonymous], FUSION GENES CANC
   [Anonymous], IRAN J PHARM RES
   [Anonymous], 2010, J. Chromatogr. Sep. Technol, DOI [10.4172/2157-7064.1000101, DOI 10.4172/2157-7064.1000101]
   [Anonymous], BIOL ACTIONS PHENOLI
   [Anonymous], J CHEM PHARM RES
   Auner BG, 2005, INT J PHARMACEUT, V294, P149, DOI 10.1016/j.ijpharm.2005.01.031
   Barreca D, 2017, BIOFACTORS, V43, P549, DOI 10.1002/biof.1358
   Barreca D, 2014, FOOD CHEM, V160, P292, DOI 10.1016/j.foodchem.2014.03.118
   Chang WT, 2012, FOOD CHEM, V134, P972, DOI 10.1016/j.foodchem.2012.03.002
   Choi BM, 2011, PHARMACOL REP, V63, P708, DOI 10.1016/S1734-1140(11)70582-5
   Crespy V, 2001, J NUTR, V131, P3227, DOI 10.1093/jn/131.12.3227
   DEVI MA, 1993, CANCER LETT, V69, P191, DOI 10.1016/0304-3835(93)90174-8
   Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148
   Escarpa A, 1998, J CHROMATOGR A, V823, P331, DOI 10.1016/S0021-9673(98)00294-5
   Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413
   Fordham JB, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/938712
   Gosch C, 2010, PHYTOCHEMISTRY, V71, P838, DOI 10.1016/j.phytochem.2010.03.003
   Huang WC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00134
   Huang WC, 2016, INT IMMUNOPHARMACOL, V40, P98, DOI 10.1016/j.intimp.2016.08.035
   Huang WC, 2015, INT IMMUNOPHARMACOL, V27, P32, DOI 10.1016/j.intimp.2015.04.024
   Jeon D, 2017, MOLECULES, V22, DOI 10.3390/molecules22010183
   Kobori M, 1997, CANCER LETT, V119, P207, DOI 10.1016/S0304-3835(97)00271-1
   Kobori M, 1999, BIOSCI BIOTECH BIOCH, V63, P719, DOI 10.1271/bbb.63.719
   Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0
   Lattanzio V, 2001, J AGR FOOD CHEM, V49, P5817, DOI 10.1021/jf010255b
   Lee JH, 2011, INFECT IMMUN, V79, P4819, DOI 10.1128/IAI.05580-11
   Leu SJ, 2006, BIOL PHARM BULL, V29, P740, DOI 10.1248/bpb.29.740
   Lin ST, 2016, J AGR FOOD CHEM, V64, P6826, DOI 10.1021/acs.jafc.6b02861
   Liu SY, 2017, J CELL MOL MED, V21, P2553, DOI 10.1111/jcmm.13176
   Liu YY, 2016, J NEURO-ONCOL, V128, P217, DOI 10.1007/s11060-016-2107-z
   Lu MQ, 2015, TROP J PHARM RES, V14, P27, DOI 10.4314/tjpr.v14i1.5
   Lu Xiao-yu, 2009, Yaoxue Xuebao, V44, P480
   Ma JY, 2012, FOOD FUNCT, V3, P178, DOI 10.1039/c1fo10124b
   Ma LJ, 2016, INT J ONCOL, V48, P843, DOI 10.3892/ijo.2015.3304
   Malekova L, 2007, PFLUG ARCH EUR J PHY, V455, P349, DOI 10.1007/s00424-007-0300-9
   McInnes IB, 2017, LANCET, V389, P2328, DOI 10.1016/S0140-6736(17)31472-1
   Nakamura Y, 2003, J AGR FOOD CHEM, V51, P3309, DOI 10.1021/jf0341060
   NELSON JAS, 1993, ANTICANCER RES, V13, P2293
   Oresajo Christian, 2008, J Cosmet Dermatol, V7, P290, DOI 10.1111/j.1473-2165.2008.00408.x
   Park SY, 2007, J MED FOOD, V10, P581, DOI 10.1089/jmf.2007.116
   Przybylska Katarzyna, 2007, Polish Journal of Food and Nutrition Sciences, V57, P307
   Ren DY, 2016, FOOD CHEM TOXICOL, V94, P203, DOI 10.1016/j.fct.2016.06.004
   Sampath C, 2017, FOOD CHEM, V226, P79, DOI 10.1016/j.foodchem.2017.01.056
   Shen X, 2017, DRUG DES DEV THER, V11, P313, DOI 10.2147/DDDT.S127010
   Shin S, 2014, INT J MOL SCI, V15, P18919, DOI 10.3390/ijms151018919
   Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI 10.3322/caac.21590
   Stangl V, 2005, J NUTR, V135, P172, DOI 10.1093/jn/135.2.172
   Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298
   Üllen A, 2012, FREE RADICAL BIO MED, V53, P1770, DOI 10.1016/j.freeradbiomed.2012.08.575
   Wang G, 2017, NUTR CANCER, V69, P534, DOI 10.1080/01635581.2017.1295090
   Wang H, 2012, AFR J PHARM PHARMACO, V6, P648, DOI 10.5897/AJPP11.869
   Wang JF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00009
   Wei YQ, 2017, J MOL LIQ, V236, P68, DOI 10.1016/j.molliq.2017.03.098
   WHO, 2005, Report No.: 9241593830
   Wu CH, 2009, INT J CANCER, V124, P2210, DOI 10.1002/ijc.24189
   Wu SC, 2016, ANTON LEEUW INT J G, V109, P1503, DOI 10.1007/s10482-016-0752-z
   Yang KC, 2009, MOL CARCINOGEN, V48, P420, DOI 10.1002/mc.20480
   Zhang L, 2007, MOL PHARMACEUT, V4, P833, DOI 10.1021/mp700077z
   Zhang SH, 2003, J PHARMACOL EXP THER, V304, P1258, DOI 10.1124/jpet.102.044412
   Zhou M, 2018, ONCOL LETT, V15, P1985, DOI 10.3892/ol.2017.7480
   Zhu SP, 2013, INT IMMUNOPHARMACOL, V15, P6, DOI 10.1016/j.intimp.2012.11.001
   Zuo AR, 2014, J CHIN MED ASSOC, V77, P290, DOI 10.1016/j.jcma.2014.01.007
NR 68
TC 87
Z9 93
U1 7
U2 109
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PY 2019
VL 19
IS 13
BP 1060
EP 1067
DI 10.2174/1389557519666190311154425
PG 8
WC Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA IS5IX
UT WOS:000482187100004
PM 30864525
DA 2025-04-28
ER

PT J
AU Dwyer, JT
   Allison, DB
   Coates, PM
AF Dwyer, JT
   Allison, DB
   Coates, PM
TI Dietary supplements in weight reduction
SO JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
LA English
DT Article
ID BODY-WEIGHT; CALCIUM INTAKE; BONE TURNOVER; FAT LOSS; OVERWEIGHT;
   EFFICACY; SAFETY; RESTRICTION; OBESITY; ADULTS
AB We summarize evidence on the role of dietary supplements in weight reduction, with particular attention to their safety and benefits. Dietary supplements are used for two purposes in weight reduction: (a) providing nutrients that may be inadequate in calorie-restricted diets and (b) for their potential benefits in stimulating weight loss. The goal in planning weight-reduction diets is that total intake from food and supplements should meet recommended dietary allowance/adequate intake levels without greatly exceeding them for all nutrients, except energy. If nutrient amounts from food sources in the reducing diet fall short, dietary supplements containing a single nutrient/element or a multivitamin-mineral combination may be helpful. On hypocaloric diets, the addition of dietary supplements providing nutrients at a level equal to or below recommended dietary allowance/adequate intake levels or 100% daily value, as stated in a supplement's facts box on the label, may help dieters to achieve nutrient adequacy and maintain electrolyte balance while avoiding the risk of excessive nutrient intakes. Many botanical and other types of dietary supplements are purported to be useful for stimulating or enhancing weight loss. Evidence of their efficacy in stimulating weight loss is inconclusive at present. Although there are few examples of safety concerns related to products that are legal and on the market for this purpose, there is also a paucity of evidence on safety for this intended use. Ephedra and ephedrine-containing supplements, with or without caffeine, have been singled out in recent alerts from the Food and Drug Administration because of safety concerns, and use of products containing these substances cannot be recommended. Dietitians should periodically check the Food and Drug Administration Web site (http://www.cfsan.fda.gov) for updates and warnings and alert patients/clients to safety concerns. Dietetics professionals should also consult authoritative sources for new data on efficacy as it becomes available (ods.od.nih.gov).
C1 NIH, Off Dietary Supplements, Bethesda, MD 20892 USA.
   Univ Alabama Birmingham, Sect Stat Genet, Dept Biostat, Birmingham, AL USA.
   Univ Alabama Birmingham, Clin Nutr Res Ctr, Dept Nutr Sci, Birmingham, AL USA.
C3 National Institutes of Health (NIH) - USA; University of Alabama System;
   University of Alabama Birmingham; University of Alabama System;
   University of Alabama Birmingham
RP NIH, Off Dietary Supplements, 6100 Execut Blvd,Room 3B01 MSC 7517, Bethesda, MD 20892 USA.
EM DwyerJ1@od.nih.gov
RI Dwyer, Johanna/AAI-5027-2020
OI Dwyer, Johanna/0000-0002-0783-1769; Allison, David/0000-0003-3566-9399
CR Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661
   Barr SI, 2003, J NUTR, V133, p245S
   Bent S, 2004, AM J CARDIOL, V94, P1359, DOI 10.1016/j.amjcard.2004.07.137
   Black A, 2001, J GERONTOL A-BIOL, V56, pB98, DOI 10.1093/gerona/56.3.B98
   Bowen J, 2004, J NUTR, V134, P568, DOI 10.1093/jn/134.3.568
   BREUM L, 1994, INT J OBESITY, V2, P99
   Chamberlain A., 2004, NUTR CLIN CARE, V7, P19
   Cifuentes MC, 2004, AM J CLIN NUTR, V80, P123
   COLKER CM, 2004, J STRENGTH COND RES, V16, P1
   *COMM FRAM EV SAF, 2004, FOOD NUTR BOARD BOAR
   *CORP, 1993, JAMA-J AM MED ASSOC, V270, P967
   Crawford V, 1999, DIABETES OBES METAB, V1, P331, DOI 10.1046/j.1463-1326.1999.00055.x
   Egger G, 1999, MED J AUSTRALIA, V171, P604, DOI 10.5694/j.1326-5377.1999.tb123817.x
   FLIER J, 2004, HARRISONS PRINCIPLES, P422
   Food and Drug Administration HHS, 2004, Fed Regist, V69, P6787
   [Food and Nutrition Board Institute of Medicine], 2004, DIET REF INT WAT POT
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   Goode LR, 2004, OBES RES, V12, P40, DOI 10.1038/oby.2004.7
   Gurley BJ, 2004, CLIN PHARMACOL THER, V75, pP35, DOI 10.1016/j.clpt.2003.11.134
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   Hunt J, 2001, J AM DIET ASSOC, V101, P115, DOI 10.1016/S0002-8223(01)00026-8
   Kroll DJ, 2004, AM J HEALTH-SYST PH, V61, P1707, DOI 10.1093/ajhp/61.16.1707
   Larsen TM, 2003, J LIPID RES, V44, P2234, DOI 10.1194/jlr.R300011-JLR200
   Lenz Thomas L, 2004, J Am Pharm Assoc (2003), V44, P59, DOI 10.1331/154434504322713246
   *MASS DEP PUBL HLT, EX REP EXP PAN PAT S
   Mhurchu CN, 2004, INT J OBESITY, V28, P1149, DOI 10.1038/sj.ijo.0802693
   *NAT I HLTH, 2004, NIH STRAT PLAN OB RE
   Pi-Sunyer FX, 1998, OBES RES, V6, p51S
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Pittler MH, 2003, INT J OBESITY, V27, P522, DOI 10.1038/sj.ijo.0802262
   Risérus U, 2004, AM J CLIN NUTR, V79, p1146S
   Shapses SA, 2004, J CLIN ENDOCR METAB, V89, P632, DOI 10.1210/jc.2002-021136
   Shapses SA, 2001, J BONE MINER RES, V16, P1329, DOI 10.1359/jbmr.2001.16.7.1329
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   SQUIRES RD, 1959, J CLIN INVEST, V38, P1134, DOI 10.1172/JCI103890
   Thomson C, 2002, J AM DIET ASSOC, V102, P1158, DOI 10.1016/S0002-8223(02)90257-9
   Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67
   ZEMEL MB, 2004, IN PRESS OBES RES
   2004, NUTR BUSINESS J SPOR
NR 39
TC 66
Z9 79
U1 0
U2 23
PU AMER DIETETIC ASSOC
PI CHICAGO
PA 120 S RIVERSIDE PLZ, STE 2000, CHICAGO, IL 60606-6995 USA
SN 0002-8223
J9 J AM DIET ASSOC
JI J. Am. Diet. Assoc.
PD MAY
PY 2005
VL 105
IS 5
SU 1
BP S80
EP S86
DI 10.1016/j.jada.2005.02.028
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 927VL
UT WOS:000229228500014
PM 15867902
DA 2025-04-28
ER

PT J
AU do Nascimento, DDM
   Oliveira, RM
   Camara, RBG
   Gomes, DL
   Monte, JFS
   Costa, MSSP
   Fernandes, JM
   Langassner, SMZ
   Rocha, HAO
AF Marinho do Nascimento, Daniele de Souza
   Oliveira, Ruth Medeiros
   Gomes Camara, Rafael Barros
   Gomes, Dayanne Lopes
   Santiago Monte, Jessika Fernanda
   Santos Pereira Costa, Mariana Santana
   Fernandes, Julia Moraes
   Zucolotto Langassner, Silvana Maria
   Oliveira Rocha, Hugo Alexandre
TI Baccharis trimera (Less.) DC Exhibits an Anti-Adipogenic Effect
   by Inhibiting the Expression of Proteins Involved in Adipocyte
   Differentiation
SO MOLECULES
LA English
DT Article
DE adipogenesis; antioxidant; chlorogenic acid
ID HIGH-FAT DIET; OXIDATIVE STRESS; MEDICINAL-PLANTS; IN-VITRO;
   ANTIOXIDANT; OBESITY; EXTRACTS; ADIPONECTIN; FLAVONOIDS; IRON
AB Baccharis trimera (Less.) DC (gorse) is a plant popularly used for the treatment of obesity. In this study, we prepared three B.trimera extracts aqueous extract (AE), decoction (AE-D), and methanol extract (ME) and investigated their antioxidant effects in six different tests and their anti-adipogenic effect in 3T3-L1 cells. The extracts showed a dose-dependent antioxidant activity in all tests. AE was the most potent antioxidant in copper and ferric ion chelation assays, whereas AE-D was the most potent in superoxide and hydroxyl radical scavenging assays, reducing power assay, and total antioxidant capacity analysis. Only ME showed a cytotoxic effect against 3T3-L1 cells. Lipid accumulation decreased in 3T3-L1 adipocytes in the presence of AE and AE-D extracts (0.5 to 1.0 mg/mL). In addition, the extracts dramatically attenuated the levels of adipogenic transcriptional factors, including CCAAT enhancer-binding protein alpha (C/EBP alpha), CCAAT enhancer-binding protein fi (C/EBP fi), and gamma receptors by peroxisome proliferators (PPAR gamma), during adipogenesis. AE-D (1.0 mg/mL) caused an approximately 90% reduction in the levels of these molecules. We propose that B. trimera has an anti-adipogenic effect and could be used in the development of functional foods.
C1 [Marinho do Nascimento, Daniele de Souza; Gomes, Dayanne Lopes; Zucolotto Langassner, Silvana Maria; Oliveira Rocha, Hugo Alexandre] Univ Fed Rio Grande do Norte, UFRN, Ctr Ciencias Saude, Programa Posgrad Ciencias Saude, R Gen Gustavo Cordeiro Farias S-N, BR-59012570 Natal, RN, Brazil.
   [Marinho do Nascimento, Daniele de Souza; Oliveira, Ruth Medeiros; Gomes Camara, Rafael Barros; Gomes, Dayanne Lopes; Santiago Monte, Jessika Fernanda; Santos Pereira Costa, Mariana Santana; Oliveira Rocha, Hugo Alexandre] Univ Fed Rio Grande do Norte, UFRN, Ctr Biociencias, Dept Bioquim, Ave Salgado Filho 3000, BR-59078970 Natal, RN, Brazil.
   [Oliveira, Ruth Medeiros] Inst Fed Educ Ciencia Tecnol Rio Grande Norte IFR, Rodovia RN-288,S-N Nova Caic, BR-59300000 Caico, RN, Brazil.
   [Gomes Camara, Rafael Barros] Univ Fed Rio Grande do Norte, UFRN, Escola Multicampi Ciencias Med Rio Grande Norte, EMCM,RN, Ave Cel Martiniano 354, BR-59300000 Caico, RN, Brazil.
   [Santos Pereira Costa, Mariana Santana] Inst Fed Educ Ciencia Tecnol Rio Grande Norte IFR, Rua Margaridas,300 Conjunto COHAB, BR-59500000 Macau, RN, Brazil.
   [Fernandes, Julia Moraes; Zucolotto Langassner, Silvana Maria] Univ Fed Rio Grande do Norte, UFRN, Ctr Ciencias Saude, Dept Farm, Rua Gen Gustavo Cordeiro de Farias S-N, BR-59012570 Natal, RN, Brazil.
C3 Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio
   Grande do Norte; Universidade Federal do Rio Grande do Norte;
   Universidade Federal do Rio Grande do Norte
RP Rocha, HAO (corresponding author), Univ Fed Rio Grande do Norte, UFRN, Ctr Ciencias Saude, Programa Posgrad Ciencias Saude, R Gen Gustavo Cordeiro Farias S-N, BR-59012570 Natal, RN, Brazil.; Rocha, HAO (corresponding author), Univ Fed Rio Grande do Norte, UFRN, Ctr Biociencias, Dept Bioquim, Ave Salgado Filho 3000, BR-59078970 Natal, RN, Brazil.
EM danysmari@yahoo.com.br; rmo_85@hotmail.com; rafael_bec@yahoo.com.br;
   dayanne_gomes@hotmail.com; jessika.monte@gmail.com;
   mariana.costa@ifrn.edu.br; fernandesjm@outlook.com;
   szucolotto@hotmail.com; hugo@cb.ufrn.br
RI Câmara, Rafael/X-7416-2019; Zucolotto, Silvana/A-8557-2014; de Oliveira
   Rocha, Hugo/I-5130-2019; Fernandes, Júlia/AAM-2962-2020
OI Barros Gomes da Camara, Rafael/0000-0001-5109-1991; Fernandes, Julia
   Morais/0000-0001-9769-5352; Rocha, Hugo Alexandre/0000-0003-2252-1221;
   Nascimento, Daniele/0000-0002-3932-4411; Zucolotto,
   Silvana/0000-0002-2768-0793
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Ministerio de Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC-the
   Science and Technology Ministry in Brazil); CAPES
FX We thank the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), and the Ministerio de Ciencia, Tecnologia,
   Inovacoes e Comunicacoes (MCTIC-the Science and Technology Ministry in
   Brazil) for their financial support in the form of grants and
   scholarships. Rafael Camara and Ruth Oliveira and Dayanne Gomes thank
   the PhD scholarship from CAPES. Hugo A. O. Rocha is a CNPq fellowship
   honored researcher. This research was presented at Programa de
   Pos-Graduacao em Ciencias da Saude at Universidade Federal do Rio Grande
   do Norte, as part of the M.Sc dissertation of Daniele Nascimento.
CR Agyare C, 2016, J ETHNOPHARMACOL, V177, P85, DOI 10.1016/j.jep.2015.11.008
   [Anonymous], REV BRAS FARM
   Arçari DP, 2013, FOOD CHEM, V141, P809, DOI 10.1016/j.foodchem.2013.04.062
   Cercato LM, 2015, J ETHNOPHARMACOL, V176, P286, DOI 10.1016/j.jep.2015.10.038
   Charradi K, 2013, J PHYSIOL SCI, V63, P445, DOI 10.1007/s12576-013-0283-6
   Chen BY, 2006, BIOCHEM BIOPH RES CO, V341, P549, DOI 10.1016/j.bbrc.2006.01.004
   Alves MGDF, 2016, J APPL PHYCOL, V28, P1931, DOI 10.1007/s10811-015-0705-3
   de Oliveira CB, 2012, MOLECULES, V17, P1113, DOI 10.3390/molecules17011113
   de Souza SP, 2011, REV BRAS FARMACOGN, V21, P450, DOI 10.1590/S0102-695X2011005000049
   Nobre LTDB, 2013, CARBOHYD POLYM, V98, P224, DOI 10.1016/j.carbpol.2013.05.040
   Fabri R.L, 2011, Rev. bras. plantas med., V13, P183, DOI 10.1590/S1516-05722011000200009
   Fève B, 2005, BEST PRACT RES CL EN, V19, P483, DOI 10.1016/j.beem.2005.07.007
   Finelli C, 2013, WORLD J GASTROENTERO, V19, P802, DOI 10.3748/wjg.v19.i6.802
   Gene RM, 1996, PLANTA MED, V62, P232, DOI 10.1055/s-2006-957866
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Liu Guei-Sheung, 2012, Cells, V1, P976, DOI 10.3390/cells1040976
   McMurray F, 2016, OBESITY, V24, P2301, DOI 10.1002/oby.21654
   Melo-Silveira RF, 2014, MOLECULES, V19, P5360, DOI 10.3390/molecules19045360
   Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463
   Oliveira ACP, 2005, J ETHNOPHARMACOL, V102, P465, DOI 10.1016/j.jep.2005.06.025
   Oliveira S. Q, 2004, ACTA FARM BONAER, V23, P365
   Palatty Princy Louis, 2012, J Assoc Physicians India, V60, P34
   Ríha M, 2014, RSC ADV, V4, P32628, DOI 10.1039/c4ra04575k
   Ristow M, 2013, EMBO MOL MED, V5, P1147, DOI 10.1002/emmm.201303094
   Ross MG, 2013, CLIN OBSTET GYNECOL, V56, P529, DOI 10.1097/GRF.0b013e318299c39d
   Sahreen S, 2010, FOOD CHEM, V122, P1205, DOI 10.1016/j.foodchem.2010.03.120
   Siersbæk R, 2011, COLD SH Q B, V76, P247, DOI 10.1101/sqb.2011.76.010512
   Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001
   Simao A. A., 2012, Journal of Medicinal Plants Research, V6, P5826
   Simoes-Pires CA, 2005, PHYTOCHEM ANALYSIS, V16, P307, DOI 10.1002/pca.826
   SOICKE H, 1987, PLANTA MED, P37
   Melo KRT, 2013, MOLECULES, V18, P14543, DOI 10.3390/molecules181214543
   Tinkov AA, 2013, BIOMETALS, V26, P447, DOI 10.1007/s10534-013-9630-6
   Vieira TO, 2011, REV BRAS FARMACOGN, V21, P601, DOI 10.1590/S0102-695X2011005000091
NR 34
TC 11
Z9 11
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD JUN
PY 2017
VL 22
IS 6
AR 972
DI 10.3390/molecules22060972
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA EZ3WQ
UT WOS:000404642100117
PM 28604636
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Hassan, BK
   Cunha, DB
   Santos, RD
   Baltar, VT
AF Hassan, Bruna Kulik
   Cunha, Diana Barbosa
   Santos, Roberta de Oliveira
   Baltar, Valeria Troncoso
TI Breakfast patterns and weight status among adolescents: a study on the
   Brazilian National Dietary Survey 2008-2009
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Adolescent; BMI; Breakfast; Dietary pattern; Population-based
ID RANDOMIZED CONTROLLED-TRIAL; CAUSAL ROLE; NUTRIENT INTAKE;
   ENERGY-BALANCE; BODY-WEIGHT; OBESITY; CONSUMPTION; CHILDREN; HEALTH;
   ASSOCIATION
AB Examining the composition of breakfast concerning weight status is essential for evaluating adolescent health and understanding this gap. This study aimed to identify breakfast patterns and investigate the relationship with weight status among Brazilian adolescents. We used a subsample of 7425 adolescents aged 10-19 years from the 2008-2009 Brazilian Household Budget Survey. Breakfast eaters were those with intake of at least 50 kcal (209 center dot 2 kJ) between 05.00 and 10.00 hours. Breakfast dietary patterns were derived by principal component factor analysis with varimax rotation. We performed logistic regression analyses between breakfast patterns and weight status, considering the complexity of the survey sample design. Three breakfast patterns were identified explaining 44 center dot 8 % of data variability: (1) the Cereal, protein, fruit beverages and Northern/Northeastern pattern, characterised by high consumption of cookies, meats, dairy products, preparations with maize, eggs, fruit juices/fruit drinks/soya-based drinks, tubers/roots/potatoes and cereals, and negative adherence to cold cut meat and savoury snacks/crackers; (2) the Protein-based pattern, characterised by positive loadings for cold cut meat, milk and cheese, and negative for cookies, fruit juices/fruit drinks/soya-based drinks, tubers/roots/potatoes and cereals; and (3) the Mixed pattern, with positive loadings for cakes, coffee/tea, bread, fruit juices/fruit drinks/soya-based drinks, chocolate/desserts and savoury snacks/crackers. No association was found between skipping and weight status. Overweight adolescents had lower adherence to the Cereal, protein, fruit beverages and Northern/Northeastern pattern (OR = 0 center dot 67; 95 % CI 0 center dot 47, 0 center dot 96). This is the first study to address dietary patterns at the meal level with adolescent population-based data, which requires further investigation.
C1 [Hassan, Bruna Kulik; Baltar, Valeria Troncoso] Fluminense Fed Univ, Inst Collect Hlth, Dept Epidemiol & Biostat, Rio De Janeiro, Brazil.
   [Cunha, Diana Barbosa] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, Brazil.
   [Santos, Roberta de Oliveira] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.
C3 Universidade Federal Fluminense; Universidade do Estado do Rio de
   Janeiro; Universidade de Sao Paulo
RP Hassan, BK (corresponding author), Fluminense Fed Univ, Inst Collect Hlth, Dept Epidemiol & Biostat, Rio De Janeiro, Brazil.
EM bruna_hassan@id.uff.br
RI de Oliveira Santos, Roberta/AAN-2098-2020; Baltar, Valeria/AFM-7189-2022
OI Hassan, Bruna/0000-0001-5484-4880; Barbosa Cunha,
   Diana/0000-0003-0900-5628; Troncoso Baltar, Valeria/0000-0002-8152-8565
FU Brazilian National Council for Scientific and Technological Development
   (CNPq) [42446320180]; Coordination for the Improvement of Higher
   Education Personnel [88882306180201801]
FX This work was supported by The Brazilian National Council for Scientific
   and Technological Development (CNPq, grant number 42446320180) and The
   Coordination for the Improvement of Higher Education Personnel (B.K.H.,
   grant number 88882306180201801).
CR Affinita A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-44
   Ahmed S, 2019, FRONT SUSTAIN FOOD S, V3, DOI 10.3389/fsufs.2019.00076
   Alves MD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00153818, 10.1590/0102-311x00153818]
   Anyaegbu G., 2010, Economic & Labour Market Review, V4, P49, DOI [DOI 10.1057/ELMR.2010.9, https://doi.org/10.1057/elmr.2010.9]
   Araki Erica Lie, 2011, Rev. paul. pediatr., V29, P164
   Azeredo CM, 2015, PUBLIC HEALTH NUTR, V18, P1215, DOI 10.1017/S1368980014001463
   Baltar VT, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00111917, 10.1590/0102-311X00111917]
   Betts JA, 2014, AM J CLIN NUTR, V100, P539, DOI 10.3945/ajcn.114.083402
   Bloch Katia Vergetti, 2016, Rev. Saúde Pública, V50, p9s, DOI [10.1590/S01518-8787.2016050006685, 10.1590/S01518-8787.201605000SUPL1AP]
   Blondin SA, 2016, PEDIATR OBES, V11, P333, DOI 10.1111/ijpo.12082
   Brazil Ministry of Health of Brazil, 2015, Dietary Guidelines for the Brazilian Population
   Brazilian Institute of Geography and Statistics, 2011, Pesquisa de orcamentos familiares 2008-2009: analise do consumo alimentar pessoal no Brasil / IBGE, Coordenacao de Trabalho e Rendimento
   Brown AW, 2013, AM J CLIN NUTR, V98, P1298, DOI 10.3945/ajcn.113.064410
   Castro MA, 2016, BRIT J NUTR, V2, P1
   Chatelan A, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0752-7
   Chowdhury EA, 2016, AM J CLIN NUTR, V103, P747, DOI 10.3945/ajcn.115.122044
   Cunha DB, 2018, APPETITE, V120, P374, DOI 10.1016/j.appet.2017.09.028
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   de Onis Mercedes, 2007, Bull World Health Organ, V85, P660, DOI 10.2471/BLT.07.043497
   Deshmukh-Taskar PR, 2010, J AM DIET ASSOC, V110, P869, DOI 10.1016/j.jada.2010.03.023
   Dialektakou KD, 2008, J AM DIET ASSOC, V108, P1517, DOI 10.1016/j.jada.2008.06.435
   Coelho SEDC, 2015, REV NUTR, V28, P555, DOI 10.1590/1415-52732015000500010
   Food and Agriculture Organization of the United Nations (FAO) & The University of Oxford, 2016, FOOD CLIMATE RES NET
   Fritzell J, 2015, INT J PUBLIC HEALTH, V60, P101, DOI 10.1007/s00038-014-0614-2
   Hassan BK, 2019, J ACAD NUTR DIET, V119, P944, DOI 10.1016/j.jand.2018.11.014
   Hassan BK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200587
   Horsfield G., 2013, EQUIVALISED INCOME
   Howarth NC, 2001, NUTR REV, V59, P129, DOI 10.1111/j.1753-4887.2001.tb07001.x
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Instituto Brasileiro de Geografia e Estatistica Diretoria de Pesquisas Coordenacao de Trabalho e Rendimento, 2010, PESQ ORC FAM 2008 20
   Johnson RA., 1992, Applied multivariate statistical analysis, V3rd edn
   Latzer Y, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-7
   Lazarou C, 2015, PUBLIC HEALTH NUTR, V18, P1308, DOI 10.1017/S1368980014001967
   Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262
   Leidy HJ, 2016, ADV NUTR, V7, p563S, DOI 10.3945/an.115.010223
   Lobstein T.B., 2019, Hannah Atlas of Childhood Obesity Report
   Meera S., 2020, HUMAN DEV PERSPECTIV
   Mesas AE, 2012, OBES REV, V13, P106, DOI 10.1111/j.1467-789X.2011.00936.x
   Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107
   Monteiro LS, 2017, REV NUTR, V30, P463, DOI 10.1590/1678-98652017000400006
   Monzani A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020387
   Murrieta Rui Sérgio Sereni, 2008, Rev. Nutr., V21, p123s
   Murrieta RSS, 2004, ECOL FOOD NUTR, V43, P231, DOI 10.1080/03670240490447550
   Naja F, 2015, BRIT J NUTR, V114, P1909, DOI 10.1017/S0007114515003657
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Organisation for Economic Co-operation and Development, 2019, HEAV BURD OB EC PREV
   Organization for Economic Cooperation and Development, 2018, WHAT AR EQ SCAL PROJ
   Pont SJ, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-3034
   Power C, 2011, DIABETES CARE, V34, P1986, DOI 10.2337/dc10-1482
   Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1
   Santos RD, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4582-3
   Santos RD, 2015, BRIT J NUTR, V114, P822, DOI 10.1017/S0007114515002445
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Simmonds M, 2016, OBES REV, V17, P95, DOI 10.1111/obr.12334
   Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018
   Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005
   Souza Amanda de Moura, 2016, Rev. Saúde Pública, V50, p5s, DOI [10.1590/S01518-8787.2016050006698, 10.1590/s01518-8787.2016050006698]
   Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514
   Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P2679, DOI [10.1590/0102-311X00016814, 10.1590/0102-311x00016814]
   Tooze JA, 2006, J AM DIET ASSOC, V106, P1575, DOI 10.1016/j.jada.2006.07.003
   Umer A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4691-z
   Willett W., 1990, IMPLICATIONS TOTAL E
   World Bank, 2018, MEAS POV
   World Health Organization, 2010, WHO ANTHR PERS COMP
   World Health Organization, The Global Health Observatory-Body Mass Index
   Zhang LJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040384
NR 66
TC 7
Z9 7
U1 1
U2 4
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD MAY 28
PY 2022
VL 127
IS 10
BP 1549
EP 1556
AR PII S0007114521002403
DI 10.1017/S0007114521002403
EA JUN 2021
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA 0T8UG
UT WOS:000744723600001
PM 34180382
DA 2025-04-28
ER

PT J
AU Stajic, D
   Popovic, B
   Cpajak, M
   Ribaric, S
   Djonovic, N
AF Stajic, Dalibor
   Popovic, Bojana
   Cpajak, Mijan
   Ribaric, Senka
   Djonovic, Nela
TI Is there an association between nutritional status an d intellectual
   capabilities of adolescents?
SO PROGRESS IN NUTRITION
LA English
DT Article
DE adolescents; eating habits; nutritional status; intellectual
   capabilities; academic achievement
ID BODY-MASS INDEX; PHYSICAL-ACTIVITY; LIFE-STYLE; METABOLIC SYNDROME;
   ACADEMIC-ACHIEVEMENT; SEDENTARY BEHAVIOR; DIETARY HABITS; EATING HABITS;
   INTELLIGENCE; WEIGHT
AB The aim of this study was to investigate the correlations among lifestyles, eating habits, nutritional status and intellectual capabilities of adolescents. A cross-sectional study was carried out using anthropometric measurements and standardized food questionnaire. The sample consisted of 151 adolescents attending a secondary school in central Serbia. Academic achievement was estimated through grade point average (GPA) in the previous academic year. Intellectual capabilities were expressed through intelligence quotient (IQ) determined by Cybernetic battery of intelligence (KOG 3). Totally, 14.5% of students were categorized as overweight or obese. No strong correlation was found between specific dietary habits and nutritional status of adolescents. The percentage of respondents with IQ>110 was higher in the group with increased body mass index (BMI percentile>85) compared to that in the group with normal body weight or underweight (38.5% vs. 15.7%). Besides, 16.7% of students with BMI percentile<85 and only 7.7% of students with BMI percentile>85 had IQ<90. However, Spearman con-elation coefficient indicated no strong correlation between IQ test results and students' BMI (rho=0.144). On the other hand, students with lower academic performance (GPA<3.5) were more prone to certain dietary habits such as frequent consumptions of coffee (p=0.002) and fast food (p=0.044). On the contrary, sedentary lifestyles were rather typical for adolescents with better academic achievements GPA>3.5 (p=0.009). A significant correlation was found between students' IQ and height (Spearman's p=0.352). Although there was no strong correlation between intellectual capabilities and nutritional status of adolescents, certain eating habits and lifestyles might be associated with intellectual performance.
C1 [Stajic, Dalibor] Univ Kragujevac, Fac Med Sci, Dept Hyg & Ecol, Svetozara Markovica 69, Kragujevac 34000, Serbia.
   [Popovic, Bojana] First Tech Sch, Kragujevac, Serbia.
   [Cpajak, Mijan] Inst Neonatol, Belgrade, Serbia.
   [Ribaric, Senka] Clin Ctr Kragujevac, Kragujevac, Serbia.
   [Djonovic, Nela] Inst Publ Hlth, Kragujevac, Serbia.
C3 University of Kragujevac
RP Stajic, D (corresponding author), Univ Kragujevac, Fac Med Sci, Dept Hyg & Ecol, Svetozara Markovica 69, Kragujevac 34000, Serbia.
EM stajicdalibor@yahoo.com
RI Djonovic, Nela/A-6598-2010
OI Djonovic, Nela/0000-0002-8426-012X; Stajic, Dalibor/0000-0002-7887-5347
CR Adesina AF, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-31
   [Anonymous], 2007, Growth Reference Data for 5-19 years
   Ayranci U, 2010, NUTRITION, V26, P772, DOI 10.1016/j.nut.2009.07.007
   Beauchamp JP, 2011, BEHAV GENET, V41, P242, DOI 10.1007/s10519-010-9376-7
   Burrows T, 2017, J HUM NUTR DIET, V30, P117, DOI 10.1111/jhn.12407
   Calderon LL, 2004, J AM DIET ASSOC, V104, P1369, DOI 10.1016/j.jada.2004.06.017
   Correa-Burrows P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050433
   Cournot M, 2006, NEUROLOGY, V67, P1208, DOI 10.1212/01.wnl.0000238082.13860.50
   Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24
   Dziemidok P, 2011, ANN AGR ENV MED, V18, P318
   Freidl EK, 2013, SURG OBES RELAT DIS, V9, P991, DOI 10.1016/j.soard.2013.04.018
   Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694
   Garcia-Continente X, 2015, AN PEDIATR, V83, P3, DOI 10.1016/j.anpedi.2014.07.006
   Harris MA, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0340-0
   Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296
   Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488
   Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x
   Janszky I, 2011, ANN AGR ENV MED, V18, P270
   Kanazawa S, 2014, CURR OPIN ENDOCRINOL, V21, P339, DOI 10.1097/MED.0000000000000091
   Kanazawa S, 2009, AM J PSYCHOL, V122, P527
   Kapka-Skrzypczak L, 2012, ANN AGR ENV MED, V19, P299
   Karmakar T, 2016, AM J ED RES, V4, P1145
   KARP R, 1992, CLIN PEDIATR, V31, P336, DOI 10.1177/000992289203100604
   Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618
   Krupp D, 2015, EUR J NUTR, V54, P1269, DOI 10.1007/s00394-014-0804-y
   Leitzmann M, 2015, CANCER EPIDEMIOL, V39, pS46, DOI 10.1016/j.canep.2015.03.009
   León-Latre M, 2014, REV ESP CARDIOL, V67, P449, DOI [10.1016/j.rec.2013.10.015, 10.1016/j.recesp.2013.10.017]
   LI X, 1995, INT J OBESITY, V19, P355
   Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x
   MacCann C, 2013, INT J OBESITY, V37, P40, DOI 10.1038/ijo.2012.47
   Marioni RE, 2014, BEHAV GENET, V44, P91, DOI 10.1007/s10519-014-9644-z
   Maruf Fatai A, 2013, Tanzan J Health Res, V15, P247
   McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232
   Monneuse MO, 1997, EUR J CLIN NUTR, V51, P46, DOI 10.1038/sj.ejcn.1600361
   Musaiger AO, 2014, ANN AGR ENV MED, V21, P416, DOI 10.5604/1232-1966.1108616
   Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064
   Nield L, 2016, J HUM NUTR DIET, V29, P669, DOI 10.1111/jhn.12392
   Nikolic M, 2015, BRIT J GEN PRACT, V65, P451, DOI 10.3399/bjgp15X686449
   Ogechi U. P., 2007, Pakistan Journal of Nutrition, V6, P641
   Phan TLT, 2013, SURG OBES RELAT DIS, V9, P574, DOI 10.1016/j.soard.2012.08.009
   Radjen SD, 2011, AVIAT SPACE ENVIR MD, V82, P622, DOI 10.3357/ASEM.2981.2011
   Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007
   Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8
   Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514
   Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4
   Timlin MT, 2008, PEDIATRICS, V121, pE638, DOI 10.1542/peds.2007-1035
   Vereecken CA, 2005, BRIT J NUTR, V94, P423, DOI 10.1079/BJN20051513
   WILLIAMS CL, 1995, PEDIATRICS, V96, P985
   Wing RR, 1999, MED SCI SPORT EXER, V31, pS547, DOI 10.1097/00005768-199911001-00010
   Wolf B., 1992, KOG 3 - Baterija testova inteligencije
   World Health Organization, 2015, FACT SHEET 5 CHILDH
   World Health Organization/ UNICEF, 1995, PICT HLTH REV ANN BI
   Yates KF, 2012, ARTERIOSCL THROM VAS, V32, P2060, DOI 10.1161/ATVBAHA.112.252759
   Yu ZB, 2010, OBES REV, V11, P656, DOI 10.1111/j.1467-789X.2009.00656.x
   Zametkin AJ, 2004, J AM ACAD CHILD PSY, V43, P134, DOI 10.1097/00004583-200402000-00008
   2012, EUR J EPIDEMIOL, V27, P647, DOI DOI 10.1007/S10654-012-9713-7
NR 56
TC 0
Z9 0
U1 0
U2 3
PU MATTIOLI 1885
PI FIDENZA
PA VIA DELLA LODESANA 649-SX, FIDENZA, 43046 PR, ITALY
SN 1129-8723
J9 PROG NUTR
JI Prog. Nutr.
PD DEC
PY 2018
VL 20
SU 2
BP 279
EP 289
DI 10.23751/pn.v20i2-S.6166
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HY0RW
UT WOS:000467821100033
DA 2025-04-28
ER

PT J
AU Elfaki, FA
   Chandika, RM
   Kahlani, SH
   Hakami, HH
   Hakami, AS
   Alsayegh, AA
   Dighriri, AY
   Khalafalla, HE
AF Elfaki, Fatima A.
   Chandika, Rama M.
   Kahlani, Saleha H.
   Hakami, Huda H.
   Hakami, Ahlam Sh.
   Alsayegh, Abdulrahman A.
   Dighriri, Abdulrahim Y.
   Khalafalla, Husameldin E.
TI Dietary patterns and their associations with glycemic control among type
   2 diabetic patients in Jazan, Saudi Arabia: A cross-sectional study
SO MEDICINE
LA English
DT Article
DE dietary patterns; glycated hemoglobin; glycemic control; HbA1c; Jazan;
   Saudi Arabia; type 2 diabetes
ID NUTRITION; ADULTS; RISK
AB Diabetes is an important global health concern. According to the World Health Organization, the Kingdom of Saudi Arabia (KSA) has 2.8 to 4.3 million diabetic patients between the ages of 27 to 60 in the year 2022. Medical nutrition therapy an essential component of diabetes management, helps improve diabetes outcomes by assisting patients in achieving a target glycated hemoglobin (HbA1c) level of <7. This study aimed to describe the pattern of food consumption in the study population and determine its association with glycemic control. This was a cross-sectional study among health facility attendees at the Endocrinology and Diabetes Center (EDC) in Jazan, KSA. A total of 315 patients with type 2 diabetes (T2D) were enrolled using a systematic random sampling technique. Sociodemographic and dietary habit information gathered through face-to-face interviews, anthropometric measurements, and HbA1c were collected from medical records. Participants were mostly females (55.6%), and more than half of them were above 50 years of age. More than 90% of the patients had poor HbA1c levels, and 2-thirds of the patients were overweight and obese (43.8% and 37.1%, respectively). The most consumed foods were bread (8 times/week) and coffee/tea and vegetables (7 times per week), and the least consumed was soda beverages (once/week). Multivariate logistic regression revealed that the consumption of fruits (consumed 5 times/week) significantly decreased HbA1c, while the consumption of pastries/pizza (consumed twice/week) significantly increased it. The pattern of consumption of fruits and vegetables in the study population conformed to the recommended levels, and that of fruits showed a statistically significant association with the control of HbA1c. Another food item that has a significant negative effect on HbA1c is pastries/pizza. Further studies that include more potentially confounding variables, such as treatment type, are needed.
C1 [Elfaki, Fatima A.; Chandika, Rama M.; Kahlani, Saleha H.; Hakami, Huda H.; Hakami, Ahlam Sh.; Alsayegh, Abdulrahman A.] Jazan Univ, Coll Appl Med Sci, Dept Clin Nutr, Jazan 45142, Saudi Arabia.
   [Dighriri, Abdulrahim Y.] Endocrinol & Diabet Ctr, Jazan, Saudi Arabia.
   [Khalafalla, Husameldin E.] Jazan Univ, Coll Med, Dept Family & Community Med, Jazan, Saudi Arabia.
C3 Jazan University; Jazan University
RP Elfaki, FA (corresponding author), Jazan Univ, Coll Appl Med Sci, Dept Clin Nutr, Jazan 45142, Saudi Arabia.
EM famohamed@jazanu.edu.sa; rchandika@jazanu.edu.sa; weeew342@gmail.com;
   ahlam310h@gmail.com; ahlam310h@gmail.com; aalsayegh@jazanu.edu.sa;
   aydagreri@moh.gov.sa; hkhalafalla@jazanu.edu.sa
RI Elfaki, Fatima/KIK-5269-2024; CHANDIKA, RAMA/GQP-2060-2022; Khalafalla,
   Husam/G-2961-2012
OI CHANDIKA, RAMA/0000-0001-7095-1248; Elfaki, Fatima
   A./0000-0003-3103-6690
CR Afshin A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006385
   Al Dawish MA, 2016, CURR DIABETES REV, V12, P359, DOI 10.2174/1573399811666150724095130
   Alaradi M, 2021, PUBLIC HEALTH NUTR, V24, P4506, DOI 10.1017/S1368980020003572
   Aljahdali AA, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0267977
   Alramadan MJ, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0292-9
   Alsayegh AA, 2022, J FAM MED PRIM CARE, V11, P2774, DOI 10.4103/jfmpc.jfmpc_1924_21
   American Diabetes Association, 2017, Clin Diabetes, V35, P5, DOI 10.2337/cd16-0067
   Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x
   Boushey C., 2020, Dietary Patterns and All-Cause Mortality: A Systematic Review [Internet]
   Breen C, 2015, BRIT J NUTR, V114, P439, DOI 10.1017/S0007114515002068
   Colles Susan L, 2013, Indian J Endocrinol Metab, V17, P1066, DOI 10.4103/2230-8210.122626
   Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388
   ElSayed NA, 2023, DIABETES CARE, V46, pS1, DOI [10.2337/dc23-Sint, 10.2337/dc23-SINT]
   Frank LK, 2014, BRIT J NUTR, V112, P89, DOI 10.1017/S000711451400052X
   Franz MJ, 2017, J ACAD NUTR DIET, V117, P1659, DOI 10.1016/j.jand.2017.03.022
   Halawani R., 2019, CURR DEV NUTR, V3, pnzz050.P16
   International Diabetes Federation, 2015, IDF diabetes atlas, V7th
   Lee KL, 2012, KOREAN J FAM MED, V33, P280, DOI 10.4082/kjfm.2012.33.5.280
   Studart EPM, 2018, REV NUTR, V31, P1, DOI 10.1590/1678-98652018000100001
   Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947
   Naeem Z, 2015, INT J HEALTH SCI-IJH, V9, pV
   Papamichou D, 2019, NUTR METAB CARDIOVAS, V29, P531, DOI 10.1016/j.numecd.2019.02.004
   Sadiya A, 2019, DIABETES METAB SYNDR, V12, P1143, DOI 10.2147/DMSO.S209320
   Sami W, 2020, PROG NUTR, V22, P521, DOI 10.23751/pn.v22i2.9239
   Shu L, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0303-0
   Slattery ML, 2010, APPL PHYSIOL NUTR ME, V35, P207, DOI 10.1139/H10-006
   Sluijs I, 2010, DIABETES CARE, V33, P43, DOI 10.2337/dc09-1321
   Tatoli R, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22062193
   Vitale M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010101
   Weir CB, 2023, StatPearls
   World Health Organization, 2022, DIAB FACT SHEETS
   Yang X, 2020, DIABETES METAB, V46, P345, DOI 10.1016/j.diabet.2020.03.004
   Zaroudi M, 2016, ARCH IRAN MED, V19, P166, DOI 0161903/AIM.003
NR 33
TC 2
Z9 2
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JUL 14
PY 2023
VL 102
IS 28
DI 10.1097/MD.0000000000034296
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA M4EJ3
UT WOS:001029742100038
PM 37443467
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Stacewicz-Sapuntzakis, M
AF Stacewicz-Sapuntzakis, M.
TI Dried Plums and Their Products: Composition and Health Effects-An
   Updated Review
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Prunes; prune juice; sorbitol; chlorogenic acids; quinic acid; laxation
ID PRUNUS-DOMESTICA L.; COLON-CANCER RISK; CHLOROGENIC ACID; IN-VITRO;
   PHENOLIC-ACIDS; ANTIOXIDANT CAPACITY; COMMON FOODS; URINARY-EXCRETION;
   BONE-RESORPTION; CRANBERRY JUICE
AB This paper describes composition of dried plums and their products (prune juice and dried plum powder) with special attention to possibly bioactive compounds. Dried plums contain significant amounts of sorbitol, quinic acid, chlorogenic acids, vitamin K1, boron, copper, and potassium. Synergistic action of these and other compounds, which are also present in dried plums in less conspicuous amounts, may have beneficial health effects when dried plums are regularly consumed. Snacking on dried plums may increase satiety and reduce the subsequent intake of food, helping to control obesity, diabetes, and related cardiovascular diseases. Despite their sweet taste, dried plums do not cause large postprandial rise in blood glucose and insulin. Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer. The characteristic phenolic compounds and their metabolites may also act as antibacterial agents in both gastrointestinal and urinary tracts. The indirect salutary effects on bone turnover are supported by numerous laboratory studies with animals and cell cultures. Further investigation of phenolic compounds in dried plums, particularly of high molecular weight polymers, their metabolism and biological actions, alone and in synergy with other dried plum constituents, is necessary to elucidate the observed health effects and to indicate other benefits.
C1 Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60612 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Stacewicz-Sapuntzakis, M (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, 1919 West Taylor St, Chicago, IL 60612 USA.
EM msapuntz@uic.edu
FU California Dried Plum Board, Sacramento, CA
FX Supported by a grant from California Dried Plum Board, Sacramento, CA.
CR Amakura Y, 2000, J CHROMATOGR A, V891, P183, DOI 10.1016/S0021-9673(00)00625-7
   Anderson David L., 1994, Journal of Food Composition and Analysis, V7, P59, DOI 10.1006/jfca.1994.1006
   [Anonymous], 2007, Database for the Flavonoid Content of Selected Foods
   [Anonymous], 2000, Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids
   [Anonymous], INTERENT J NUTR WELL
   [Anonymous], DAT PROANTH CONT SEL
   Arjmandi BH, 2007, J BONE MINER RES, V22, pS214
   Arjmandi B.H., 2001, JANA, V4, P50
   Arjmandi BH, 2002, J WOMEN HEALTH GEN-B, V11, P61, DOI 10.1089/152460902753473471
   Attaluri A, 2011, ALIMENT PHARM THER, V33, P822, DOI 10.1111/j.1365-2036.2011.04594.x
   Badary OA, 2006, WORLD J GASTROENTERO, V12, P5363, DOI 10.3748/wjg.v12.i33.5363
   BAUER LL, 2004, CHEM COMPOSITION SEL
   Bennett LE, 2011, CRIT REV FOOD SCI, V51, P38, DOI 10.1080/10408390903044552
   Blatherwick NR, 1914, ARCH INTERN MED, V14, P409
   Blatherwick NR, 1923, J BIOL CHEM, V57, P815
   Boateng J, 2007, FOOD CHEM TOXICOL, V45, P725, DOI 10.1016/j.fct.2006.10.019
   Boato F, 2002, J AGR FOOD CHEM, V50, P6935, DOI 10.1021/jf025832q
   BODEL PT, 1959, J LAB CLIN MED, V54, P881
   Bodet C, 2006, J ANTIMICROB CHEMOTH, V57, P685, DOI 10.1093/jac/dkl031
   Bouayed J, 2007, J NEUROL SCI, V262, P77, DOI 10.1016/j.jns.2007.06.028
   Bu SY, 2007, OSTEOPOROSIS INT, V18, P931, DOI 10.1007/s00198-007-0335-y
   Bu SY, 2008, CALCIFIED TISSUE INT, V82, P475, DOI 10.1007/s00223-008-9139-0
   Bu SY, 2009, J NUTR BIOCHEM, V20, P35, DOI 10.1016/j.jnutbio.2007.11.012
   Burger O, 2002, CRIT REV FOOD SCI, V42, P279, DOI 10.1080/10408390209351916
   Burt BA, 2006, J AM DENT ASSOC, V137, P190, DOI 10.14219/jada.archive.2006.0144
   CATHCARTRAKE W, 1975, AM J CLIN NUTR, V28, P1110, DOI 10.1093/ajcn/28.10.1110
   Chen JR, 2010, J BONE MINER RES, V25, P2399, DOI 10.1002/jbmr.137
   *CHIN I NUTR FOOD, 2005, 200503024 CHIN I NUT
   *CHIN I NUTR FOOD, 2006, 200503024 CHIN I NUT
   Chun OK, 2004, FOOD RES INT, V37, P337, DOI 10.1016/j.foodres.2004.02.001
   CLEMENTS RS, 1980, AM J CLIN NUTR, V33, P1954, DOI 10.1093/ajcn/33.9.1954
   COHEN S, 1975, NEW ENGL J MED, V293, P897, DOI 10.1056/NEJM197510302931803
   Cremin P, 2001, J AGR FOOD CHEM, V49, P1747, DOI 10.1021/jf000764y
   CUMMINGS JH, 1992, GASTROENTEROLOGY, V103, P1783, DOI 10.1016/0016-5085(92)91435-7
   CZOK G, 1961, ARZNEIMITTEL-FORSCH, V11, P545
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Del Caro A, 2004, J AGR FOOD CHEM, V52, P4780, DOI 10.1021/jf049889j
   Devirian TA, 2003, CRIT REV FOOD SCI, V43, P219, DOI 10.1080/10408690390826491
   Deyhim F, 2005, MENOPAUSE, V12, P755, DOI 10.1097/01.gme.0000185486.55758.5b
   Dikeman CL, 2004, J AGR FOOD CHEM, V52, P853, DOI 10.1021/jf034858u
   Dismore ML, 2003, J AM DIET ASSOC, V103, P1650, DOI 10.1016/j.jada.2003.09.028
   Druzic Jasmina, 2007, Agriculturae Conspectus Scientificus, V72, P307
   Durand P J, 1991, Can Nurse, V87, P35
   Edenharder R, 2002, MUTAT RES-GEN TOX EN, V521, P57, DOI 10.1016/S1383-5718(02)00212-7
   Ertekin C, 2006, J FOOD ENG, V75, P508, DOI 10.1016/j.jfoodeng.2005.04.034
   Fang NB, 2002, J AGR FOOD CHEM, V50, P3579, DOI 10.1021/jf0201327
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farajian P, 2010, EAT BEHAV, V11, P201, DOI 10.1016/j.eatbeh.2010.02.004
   Fatimi A, 2007, SCI ALIMENT, V27, P423, DOI 10.3166/sda.27.423-430
   FDA, 2001, Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Report of the Panel on Micronutrients
   FELDMAN JM, 1985, AM J CLIN NUTR, V42, P639, DOI 10.1093/ajcn/42.4.639
   FERRER FP, 1955, AM J DIG DIS, V22, P272
   Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5
   Franklin M, 2006, BONE, V39, P1331, DOI 10.1016/j.bone.2006.05.024
   Fujii T, 2006, J NUTR SCI VITAMINOL, V52, P389, DOI 10.3177/jnsv.52.389
   Fung D.Y.C., 2009, Int. Rev. Food Sci. Technol, V1, P80
   FUNG DYC, 2001, EFFECTS DRIED PLUMS
   Furchner-Evanson A, 2010, APPETITE, V54, P564, DOI 10.1016/j.appet.2010.02.015
   Gallaher CM, 2009, BRIT J NUTR, V101, P233, DOI 10.1017/S0007114508995684
   *GLYC IND TEST INC, 2004, DET GI PRUN PRUN JUI
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   Grabitske H, 2009, CRIT REV FOOD SCI, V49, P327, DOI 10.1080/10408390802067126
   Gu LW, 2004, J NUTR, V134, P613, DOI 10.1093/jn/134.3.613
   HAGL S, 2011, MOL NUTR FOOD RES, V54, P1781
   Halloran BP, 2010, J NUTR, V140, P1781, DOI 10.3945/jn.110.124198
   Hönow R, 2002, FOOD CHEM, V78, P511, DOI 10.1016/S0308-8146(02)00212-1
   Hooshmand S., 2014, Br J Nutr
   HOOSHMAND S, 2008, J BONE MINER RES, V23
   Hooshmand S, 2009, AGEING RES REV, V8, P122, DOI 10.1016/j.arr.2009.01.002
   Howarth L, 2010, J AM DIET ASSOC, V110, P1322, DOI 10.1016/j.jada.2010.06.002
   Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038
   HUGHES DA, 2004, DIET HUMAN IMMUNE FU
   Hushmendy S, 2009, NUTR RES, V29, P568, DOI 10.1016/j.nutres.2009.08.003
   Institute of Medicine, 1997, Phosphorus
   Institute of Medicine Food and Nutrition Board, 2005, DIET REF INT EN CARB, DOI DOI 10.17226/10490
   Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate Other B Vitamins and Choline, 1998, DIET REF INT THAIM R
   Jiang Y, 2000, PHYTOMEDICINE, V7, P483, DOI 10.1016/S0944-7113(00)80034-3
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Joseph JA, 2004, J ALZHEIMERS DIS, V6, P403
   Kahlon TS, 2007, FOOD CHEM, V100, P1182, DOI 10.1016/j.foodchem.2005.10.066
   KAMKAR L, 2006, J BONE MINER RES, V21, pM199
   Kamkar LL, 2005, J BONE MINER RES, V20, pS246
   Kaper S, 2010, FASEB J, V24
   Karakaya S, 2001, INT J FOOD SCI NUTR, V52, P501, DOI 10.1080/713671810
   Kasai H, 2000, FOOD CHEM TOXICOL, V38, P467, DOI 10.1016/S0278-6915(00)00014-4
   Kasim-Karakas SE, 2002, AM J CLIN NUTR, V76, P1422, DOI 10.1093/ajcn/76.6.1422
   Kayano S, 2004, BIOSCI BIOTECH BIOCH, V68, P942, DOI 10.1271/bbb.68.942
   Kayano S, 2003, J AGR FOOD CHEM, V51, P1480, DOI 10.1021/jf025929c
   Kayano S, 2002, J AGR FOOD CHEM, V50, P3708, DOI 10.1021/jf0200164
   KAYANO S, 2003, ITE LETT, V4, P639
   Kayano SI, 2004, BIOFACTORS, V21, P309, DOI 10.1002/biof.552210160
   KEAST DR, 2009, FASEB J, V23, pLB511
   Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x
   Kikuzaki H, 2004, J AGR FOOD CHEM, V52, P344, DOI 10.1021/jf034954v
   Kimura Y, 2008, BIOSCI BIOTECH BIOCH, V72, P1615, DOI 10.1271/bbb.70823
   KINNEY AB, 1979, NURS RES, V28, P287
   KNUUTTILA M, 1989, BONE MINER, V6, P25, DOI 10.1016/0169-6009(89)90020-2
   Koontz JL, 2005, J AOAC INT, V88, P805
   Kravetz RE, 2002, AM J GASTROENTEROL, V97, P2914
   Kumar Ajay, 2009, FASEB JOURNAL, V23
   Lam S, 2006, CANCER EPIDEM BIOMAR, V15, P1526, DOI 10.1158/1055-9965.EPI-06-0128
   Lee SH, 2008, COMP IMMUNOL MICROB, V31, P389, DOI 10.1016/j.cimid.2007.06.005
   Levine J, 1997, EUR NEUROPSYCHOPHARM, V7, P147, DOI 10.1016/S0924-977X(97)00409-4
   LIM YF, 2009, FASEB J, V23
   Lin JY, 2007, FOOD CHEM, V101, P140, DOI 10.1016/j.foodchem.2006.01.014
   Livesey G, 2003, NUTR RES REV, V16, P163, DOI 10.1079/NRR200371
   Livesey G, 2001, BRIT J NUTR, V85, pS7, DOI 10.1079/BJN2000253
   Los Jadwiga, 2000, Polish Journal of Food and Nutrition Sciences, V9, P35
   Lucas E. A., 2004, Journal of Applied Research, V4, P37
   Lugasi A, 2003, NAHRUNG, V47, P79, DOI 10.1002/food.200390031
   Lundberg A, 1984, Vardfacket, V8, P46
   Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019
   Mattila PT, 1996, J NUTR, V126, P1865
   McRorie J, 2000, REGUL TOXICOL PHARM, V31, P59, DOI 10.1006/rtph.1999.1368
   MORGAN TB, 1957, NATURE, V180, P543, DOI 10.1038/180543a0
   Mozaffarian D, 2010, JAMA-J AM MED ASSOC, V304, P681, DOI 10.1001/jama.2010.1116
   Mühlbauer RC, 2003, J NUTR, V133, P3592, DOI 10.1093/jn/133.11.3592
   Müller-Lissner SA, 2005, EUR J GASTROEN HEPAT, V17, P109
   Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s
   *NDS R, 2008, NUTR TOT REP
   Negishi H, 2007, CLIN EXP PHARMACOL P, V34, pS47, DOI 10.1111/j.1440-1681.2007.04775.x
   Nicklas TA, 2009, J AM COLL NUTR, V28, p73S, DOI 10.1080/07315724.2009.10719807
   Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m
   Nunes C, 2008, J AGR FOOD CHEM, V56, P5188, DOI 10.1021/jf8006135
   Olsson ME, 2004, J AGR FOOD CHEM, V52, P7264, DOI 10.1021/jf030479p
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Pellegrini N, 2006, MOL NUTR FOOD RES, V50, P1030, DOI 10.1002/mnfr.200600067
   PEPPLER E, 1960, J NUTR, V71, P91, DOI 10.1093/jn/71.1.91
   Piga A, 2003, J AGR FOOD CHEM, V51, P3675, DOI 10.1021/jf021207+
   Piirainen L, 2007, NUTR RES, V27, P511, DOI 10.1016/j.nutres.2007.06.008
   Prior RL, 2002, FASEB J, V16, pA980
   Prior RL, 2005, PHYTOCHEMISTRY, V66, P2264, DOI 10.1016/j.phytochem.2005.03.025
   Prior RL, 2007, J AM COLL NUTR, V26, P170, DOI 10.1080/07315724.2007.10719599
   RAYNAL J, 1989, J AGR FOOD CHEM, V37, P1046, DOI 10.1021/jf00088a050
   REELE SB, 1985, INT J CLIN PHARM TH, V23, P403
   RENDINA E, 2009, FASEB J, V23, P563
   Rios LY, 2003, AM J CLIN NUTR, V77, P912, DOI 10.1093/ajcn/77.4.912
   Rocha BS, 2009, TOXICOLOGY, V265, P41, DOI 10.1016/j.tox.2009.09.008
   Rop O, 2009, SCI HORTIC-AMSTERDAM, V122, P545, DOI 10.1016/j.scienta.2009.06.036
   Sabarez HT, 2000, J AGR FOOD CHEM, V48, P1838, DOI 10.1021/jf990553x
   Sairanen U, 2007, EUR J CLIN NUTR, V61, P1423, DOI 10.1038/sj.ejcn.1602670
   Salvador MT, 2000, CAN J PHYSIOL PHARM, V78, P359, DOI 10.1139/cjpp-78-5-359
   Sanz ML, 2001, J AGR FOOD CHEM, V49, P5228, DOI 10.1021/jf010580z
   Shahidi F, 2010, PHYTOCHEM REV, V9, P147, DOI 10.1007/s11101-009-9142-8
   Sherry CL, 2010, BRAIN BEHAV IMMUN, V24, P631, DOI 10.1016/j.bbi.2010.01.015
   Shukitt-Hale B, 2009, NUTRITION, V25, P567, DOI 10.1016/j.nut.2008.10.018
   Smith BJ, 2003, J BONE MINER RES, V18, pS277
   SOBOTA AE, 1984, J UROLOGY, V131, P1013, DOI 10.1016/S0022-5347(17)50751-X
   Somogyi L.P., 2005, Processing fruits: Science and technology, V2nd, P513
   Stacewicz-Sapuntzakis M, 2001, CRIT REV FOOD SCI, V41, P251, DOI 10.1080/20014091091814
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   STERN FH, 1966, J AM GERIATR SOC, V14, P1153, DOI 10.1111/j.1532-5415.1966.tb02869.x
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Townsley ED, 2009, FASEB J, V23
   *USDA, 2007, OXYG RAD ABS CAP ORA
   *USDA, 1987, SUG CONT SEL FOODS I
   USDA, 2008, Database for the Choline Content of Common Foods
   *USDA, 2010, SR 25 PAG REP
   Utsunomiya H, 2002, LIFE SCI, V72, P659, DOI 10.1016/S0024-3205(02)02300-7
   Utsunomiya H, 2005, BIOMED RES-TOKYO, V26, P193, DOI 10.2220/biomedres.26.193
   VANGORSEL H, 1992, J AGR FOOD CHEM, V40, P784, DOI 10.1021/jf00017a016
   VAUGHAN OW, 1960, J NUTR, V71, P10, DOI 10.1093/jn/71.1.10
   Viani R., 1988, COFFEE, V3, P1
   Vinson JA, 2005, J AM COLL NUTR, V24, P44, DOI 10.1080/07315724.2005.10719442
   Vinson JA, 1999, J AGR FOOD CHEM, V47, P2502, DOI 10.1021/jf9902393
   Walkowiak-Tomczak Dorota, 2008, Polish Journal of Food and Nutrition Sciences, V58, P401
   Walkowiak-Tomczak Dorota, 2008, Bromatologia i Chemia Toksykologiczna, V41, P562
   Wu HY, 2003, AM J CLIN NUTR, V78, P1085, DOI 10.1093/ajcn/78.6.1085
   Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w
   Yang YQ, 2005, NUTR CANCER, V53, P117, DOI 10.1207/s15327914nc5301_14
   Yu MH, 2007, INT J FOOD SCI NUTR, V58, P42, DOI 10.1080/09637480601121938
   ZAREMBSKI PM, 1962, BRIT J NUTR, V16, P627, DOI 10.1079/BJN19620061
   Zittermann A, 2001, CURR OPIN CLIN NUTR, V4, P483, DOI 10.1097/00075197-200111000-00003
NR 174
TC 75
Z9 88
U1 0
U2 98
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD JAN 1
PY 2013
VL 53
IS 12
BP 1277
EP 1302
DI 10.1080/10408398.2011.563880
PG 26
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 227OW
UT WOS:000325124200003
PM 24090144
DA 2025-04-28
ER

PT J
AU Guerrero-López, CM
   Unar-Munguía, M
   Colchero, MA
AF Guerrero-Lopez, Carlos M.
   Unar-Munguia, Mishel
   Arantxa Colchero, M.
TI Price elasticity of the demand for soft drinks, other sugar-sweetened
   beverages and energy dense food in Chile
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Price elasticity; Soft drinks; Sugar sweetened beverages; High energy
   density foods; Chile
ID CONSUMPTION; WEIGHT; TAXES; PRODUCTS; HEALTH; IMPACT; INDEX; RISK
AB Background: Chile is the second world's largest per capita consumer of caloric beverages. Caloric beverages are associated with overweight, obesity and other chronic diseases. The objective of this study is to estimate the price elasticity of demand for soft drinks, other sugar-sweetened beverages and high-energy dense foods in urban areas in Chile in order to evaluate the potential response of households' consumption to changes in prices.
   Methods: We used microdata from the VII Family Budget Survey 2012-2013, which collects information on expenditures made by Chilean urban households on items such as beverages and foods. We estimated a Linear Approximation of an Almost Ideal Demand System Model to derive own and cross price elasticities of milk, coffee, tea and other infusions, plain water, soft drinks, other flavored beverages, sweet snacks, sugar and honey, and desserts. We considered the censored nature of the data and included the Inverse Mills Ratio in each equation of the demand system. We estimated a Quadratic Almost Ideal Demand System and a two-part model as sensitivity analysis.
   Results: We found an own price-elasticity of -1.37 for soft drinks. This implies that a price increase of 10% is associated with a reduction in consumption of 13.7%. We found that the rest of food and beverages included in the demand system behave as substitutes for soft drinks. For instance, plain water showed a cross-price elasticity of 0.63: a 10% increase in price of soft drinks could lead to an increase of 6.3% of plain water. Own and cross price elasticities were similar between models.
   Conclusions: The demand of soft drinks is price sensitive among Chilean households. An incentive system such as subsidies to non-sweetened beverages and tax to soft drinks could lead to increases in the substitutions for other healthier beverages.
C1 [Guerrero-Lopez, Carlos M.; Arantxa Colchero, M.] Inst Nacl Salud Publ, Ctr Hlth Syst Res, Univ 655 Colonia Santa Maria Ahuacatitlan, Cuernavaca 62100, Morelos, Mexico.
   [Unar-Munguia, Mishel] Inst Nacl Salud Publ, Nutr & Hlth Res Ctr, Univ 655 Colonia Santa Maria Ahuacatitlan, Cuernavaca 62100, Morelos, Mexico.
C3 Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica
RP Colchero, MA (corresponding author), Inst Nacl Salud Publ, Ctr Hlth Syst Res, Univ 655 Colonia Santa Maria Ahuacatitlan, Cuernavaca 62100, Morelos, Mexico.
EM acolchero@insp.mx
RI Munguia, Mishel/P-7134-2019
OI Guerrero-Lopez, Carlos Manuel/0000-0002-6405-5217; Unar Munguia,
   Mishel/0000-0002-1156-9337
FU Pan American Health Organization [SCON2016-00287]
FX The publication is based on findings of a research financed by the Pan
   American Health Organization (letter of agreement SCON2016-00287). The
   Pan American Health Organization had no role in the study design or the
   analysis and interpretation of the data and did not participate in the
   elaboration of this publication. The authors alone are responsible for
   the views expressed in this publication.
CR Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   [Anonymous], 2014, Plan of action for the prevention of obesity in children and adolescents
   [Anonymous], LANCET DIABETES ENDO
   Araneda J, 2015, SALUD PUBLICA MEXICO, V57, P128
   Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704
   Asfaw A, 2011, HEALTH ECON, V20, P184, DOI 10.1002/hec.1579
   Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015
   Blecher E, 2015, SOC SCI MED, V136, P175, DOI 10.1016/j.socscimed.2015.05.022
   Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723
   Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007
   Crovetto M, 2014, REV MED CHILE, V142, P1530, DOI 10.4067/S0034-98872014001200006
   Crovetto M, 2014, REV MED CHILE, V142, P850, DOI 10.4067/S0034-98872014000700005
   Crovetto M, 2012, REV MED CHILE, V140, P305, DOI 10.4067/S0034-98872012000300004
   DEATON A, 1980, AM ECON REV, V70, P312
   DEATON A, 1990, J ECONOMETRICS, V44, P281, DOI 10.1016/0304-4076(90)90060-7
   Deaton A., 2019, The Analysis of Household Surveys: A Microeconometric Approach to Development Policy
   Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072
   Fletcher JM, 2010, J PUBLIC ECON, V94, P967, DOI 10.1016/j.jpubeco.2010.09.005
   HEIEN D, 1990, J BUS ECON STAT, V8, P365, DOI 10.2307/1391973
   Instituto Nacional de Estadistica de Chile, 2013, 7  ENC PRES FAM MET
   Jensen JD, 2016, PUBLIC HEALTH NUTR, V19, P3085, DOI 10.1017/S1368980015002360
   Jou J, 2012, HEALTH POLICY, V107, P83, DOI 10.1016/j.healthpol.2012.05.011
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Meyer S, 2011, AGR APPL EC ASS 2011
   Ministry of Health, 2010, ENC NAC SAL ENS CHIL
   Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492
   MOSCHINI G, 1995, AM J AGR ECON, V77, P63, DOI 10.2307/1243889
   Organisation for Economic Co-operation and Development (OECD), 2014, OB UPD
   Paraje G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152260
   Poi BP, 2012, STATA J, V12, P433, DOI 10.1177/1536867X1201200306
   Ross H, 2003, HEALTH ECON, V12, P217, DOI 10.1002/hec.709
   Silva P, 2014, REV CHIL NUTR, V41, P90, DOI 10.4067/S0717-75182014000100013
   Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571
   Teruel G, 2005, ESCALAS EQUIVALENCIA, V23
   Unar M, 2013, EFFECT FOOD BEVERAGE
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wooldridge J. M., 2002, ECONOMETRIC ANAL CRO
   Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049
NR 41
TC 60
Z9 68
U1 2
U2 45
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 10
PY 2017
VL 17
AR 180
DI 10.1186/s12889-017-4098-x
PG 8
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA EL0LP
UT WOS:000394314200001
PM 28183287
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Thompson, OM
   Ballew, C
   Resnicow, K
   Must, A
   Bandini, LG
   Cyr, H
   Dietz, WH
AF Thompson, OM
   Ballew, C
   Resnicow, K
   Must, A
   Bandini, LG
   Cyr, H
   Dietz, WH
TI Food purchased away from home as a predictor of change in BMI z-score
   among girls
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE children; adolescents; quick-service food; BMI; overweight
ID BODY-MASS INDEX; OBESITY; EPIDEMIC; CHILDREN; DIETARY; WOMEN
AB OBJECTIVES: To assess the relationship between eating food purchased away from home (FAH) and longitudinal change in body mass index (BMI) z-score among girls, and to assess the longitudinal tracking of eating FAH from childhood through adolescence.
   DESIGN: Participants kept 7-day dietary records at two points in time. The records included the place and time for all foods consumed. We recorded how often participants ate FAH, calculated the percent of total energy derived from FAH, and classified foods as quick-service food, coffee-shop food, or restaurant food.
   PARTICIPANTS: Healthy girls (n = 101) between the ages of 8 and 12 y at baseline and 11 and 19 y at follow-up participated in a longitudinal study of growth and development at the Massachusetts Institute of Technology.
   STATISTICAL ANALYSES: Analysis of variance was used to assess the relationship between change in BMI z-score and both the frequency of eating FAH and energy derived from eating FAH. The participants' baseline BMI z-score was a significant covariate and was controlled for in both models. We used the kappa coefficient to assess FAH tracking from childhood through adolescence.
   RESULTS: The frequency of eating quick-service food at baseline was positively associated with change in BMI z-score (F = 6.49, P < 0.01). Participants who ate quick-service food twice a week or more at baseline had the greatest mean increase in BMI z-score compared to those who ate quick-service food once a week or not at all. Quick-service food eating tracked slightly from childhood through adolescence (k = 0.17, P < 0.05).
   DISCUSSION: Adolescent girls who eat quick-service food twice a week or more are likely to increase their relative BMI over time.
C1 Univ Washington, Dept Nutr Sci, Seattle, WA 98195 USA.
   Alaska Nat Epidemiol Ctr, Anchorage, AK USA.
   Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA.
   Tufts Univ, Sch Med, Dept Family Med & Community Hlth, Boston, MA 02111 USA.
   Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.
   UMASS, Sch Med, Eunice Kennedy Shriver Ctr, Waltham, MA USA.
   MIT, Clin Res Ctr, Cambridge, MA 02139 USA.
   Ctr Dis Control & Prevent, Div Nutr & Phys Act, Atlanta, GA USA.
C3 University of Washington; University of Washington Seattle; University
   of Michigan System; University of Michigan; Tufts University; Boston
   University; Eunice Kennedy Shriver Center; Massachusetts Institute of
   Technology (MIT); Centers for Disease Control & Prevention - USA
RP Univ Washington, Dept Nutr Sci, 305 Raitt Hall,Box 353410, Seattle, WA 98195 USA.
EM omt@u.washington.edu
FU NCRR NIH HHS [M01-RR-00088] Funding Source: Medline; NIDDK NIH HHS
   [DK46200, R01-DK50537] Funding Source: Medline
CR [Anonymous], CLIN GUID ID EV TREA
   [Anonymous], PREV OV OB AD US
   BANDINI LG, 1995, AM J CLIN NUTR, V62, P711, DOI 10.1093/ajcn/62.4.711
   Baranowski T, 2000, PREV MED, V31, pS1, DOI 10.1006/pmed.2000.0686
   Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356
   BORRUD L, 1996, FOOD REV         SEP, P14
   CHOU SY, CTR DIS CONTR PREV 0
   Clauson A., 1999, FoodReview, V22, P20
   Dietz WH, 1999, AM J CLIN NUTR, V70, p123S
   FREEDMAN DS, IN PRESS NESTLE NUTR, V49
   French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309
   French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429
   Glantz SA., 1997, Primer of biostatistics
   Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371
   Jeffery RW, 1998, AM J PUBLIC HEALTH, V88, P277, DOI 10.2105/AJPH.88.2.277
   Jekanowski M. D., 1999, FoodReview, V22, P11
   LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786
   LIN BH, 1999, AGR INFORMATION B US, V749
   McCrory MA, 1999, OBES RES, V7, P564, DOI 10.1002/j.1550-8528.1999.tb00715.x
   Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852
   MUST A, 1991, AM J CLIN NUTR, V53, P839, DOI 10.1093/ajcn/53.4.839
   National Center for Health Statistics, CDC GROWTH CHARTS US
   Nestle M, 2000, PUBLIC HEALTH REP, V115, P12, DOI 10.1093/phr/115.1.12
   Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728
   PENNINGTON JA, 1997, BOWES CHURCHDS FOOD
   SAS Institute Inc, 1999, SAS STAT US GUID VER
   US Department of Health and Human Services, HLTH PEOPL 2010 NUTR
   Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246
NR 28
TC 155
Z9 212
U1 0
U2 8
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD FEB
PY 2004
VL 28
IS 2
BP 282
EP 289
DI 10.1038/sj.ijo.0802538
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 765VH
UT WOS:000188304700014
PM 14647177
DA 2025-04-28
ER

PT J
AU Haselgrübler, R
   Stadlbauer, V
   Stübl, F
   Schwarzinger, B
   Rudzionyte, I
   Himmelsbach, M
   Iken, M
   Weghuber, J
AF Haselgruebler, Renate
   Stadlbauer, Verena
   Stuebl, Flora
   Schwarzinger, Bettina
   Rudzionyte, Ieva
   Himmelsbach, Markus
   Iken, Marcus
   Weghuber, Julian
TI Insulin Mimetic Properties of Extracts Prepared from Bellis
   perennis
SO MOLECULES
LA English
DT Article
DE Bellis perennis extract; insulin mimetic property; GLUT4 translocation;
   glucose uptake; hens egg test-chorioallantoic membrane (HET-CAM) assay;
   type 2 diabetes
ID GLUCOSE-UPTAKE; TRITERPENE SAPONINS; GLUCOSE-TRANSPORTER-4
   TRANSLOCATION; GLUT4 TRANSLOCATION; FLOWERS; DIFFERENTIATION; TRANSPORT;
   OBESITY; CACO-2; PLASMA
AB Diabetes mellitus (DM) and consequential cardiovascular diseases lead to millions of deaths worldwide each year; 90% of all people suffering from DM are classified as Type 2 DM (T2DM) patients. T2DM is linked to insulin resistance and a loss of insulin sensitivity. It leads to a reduced uptake of glucose mediated by glucose transporter 4 (GLUT4) in muscle and adipose tissue, and finally hyperglycemia. Using a fluorescence microscopy-based screening assay we searched for herbal extracts that induce GLUT4 translocation in the absence of insulin, and confirmed their activity in chick embryos. We found that extracts prepared from Bellis perennis (common daisy) are efficient inducers of GLUT4 translocation in the applied in vitro cell system. In addition, these extracts also led to reduced blood glucose levels in chicken embryos (in ovo), confirming their activity in a living organism. Using high-performance liquid chromtaography (HPLC) analysis, we identified and quantified numerous polyphenolic compounds including apigenin glycosides, quercitrin and chlorogenic acid, which potentially contribute to the induction of GLUT4 translocation. In conclusion, Bellis perennis extracts reduce blood glucose levels and are therefore suitable candidates for application in food supplements for the prevention and accompanying therapy of T2DM.
C1 [Haselgruebler, Renate; Stadlbauer, Verena; Stuebl, Flora; Schwarzinger, Bettina; Rudzionyte, Ieva; Weghuber, Julian] Univ Appl Sci Upper Austria, Sch Engn, Stelzhamerstr 23, A-4600 Wels, Austria.
   [Stadlbauer, Verena; Schwarzinger, Bettina; Weghuber, Julian] Austrian Competence Ctr Feed & Food Qual Safety &, A-4600 Wels, Austria.
   [Himmelsbach, Markus] Johannes Kepler Univ Linz, Inst Analyt Chem, A-4040 Linz, Austria.
   [Iken, Marcus] PM Int AG, L-5445 Schengen, Luxembourg.
C3 Johannes Kepler University Linz
RP Stadlbauer, V; Weghuber, J (corresponding author), Univ Appl Sci Upper Austria, Sch Engn, Stelzhamerstr 23, A-4600 Wels, Austria.; Stadlbauer, V; Weghuber, J (corresponding author), Austrian Competence Ctr Feed & Food Qual Safety &, A-4600 Wels, Austria.
EM renate.haselgruebler@fh-wels.at; verena.stadlbauer@fh-wels.at;
   flora.stuebl@fh-wels.at; bettina.schwarzinger@fh-wels.at;
   ieva.rudzionyte@fh-wels.at; markus.himmelsbach@jku.at;
   marcus.iken@pm-international.de; julian.weghuber@fh-wels.at
RI Schwarzinger, Bettina/ABI-1039-2020; Himmelsbach, Markus/N-7803-2019;
   Himmelsbach, Markus/L-2182-2016
OI Stadlbauer, Verena/0009-0003-4875-3239; Himmelsbach,
   Markus/0000-0002-0489-3534; Schwarzinger, Bettina/0000-0002-8273-8679;
   Weghuber, Julian/0000-0001-6312-4666
FU Austrian Research Promotion Agency (FFG) [850681]; University of Applied
   Sciences Upper Austria Basic Funding initiative
FX This work was funded by the Austrian Research Promotion Agency (FFG;
   project number 850681) and the University of Applied Sciences Upper
   Austria Basic Funding initiative (project GlucoSTAR).
CR Alemán-González-Duhart D, 2016, PPAR RES, V2016, DOI 10.1155/2016/7614270
   [Anonymous], GLOB REP DIAB
   Arakaki RF, 2016, POSTGRAD MED, V128, P409, DOI 10.1080/00325481.2016.1167570
   Bommer C, 2018, DIABETES CARE, V41, P963, DOI 10.2337/dc17-1962
   Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140
   Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782
   Cakilcioglu U, 2010, J ETHNOPHARMACOL, V132, P165, DOI 10.1016/j.jep.2010.08.017
   Cohen FJ, 2003, DIABETES CARE, V26, P1847, DOI 10.2337/diacare.26.6.1847
   Marques THC, 2013, BIOL RES, V46, P231, DOI 10.4067/S0716-97602013000300002
   Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D
   Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Eid HM, 2017, PHARM BIOL, V55, P2026, DOI 10.1080/13880209.2017.1345952
   Filipova E, 2017, DIABETES THER, V8, P705, DOI 10.1007/s13300-017-0273-4
   Haselgrubler R., 2018, JOVE-J VIS EXP, V134, P57237
   Haselgrübler R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182788
   Huang D, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7839101
   Huang M, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00288
   Iqbal Z, 2018, CLIN THER, V40, P828, DOI 10.1016/j.clinthera.2018.04.001
   Kadan S, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8294320
   Karakas FP, 2016, AFR J TRADIT COMPLEM, V13, P34, DOI 10.21010/ajtcam.v13i4.6
   Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009
   Krishnamoorthy RM, 2017, CHEM-BIOL INTERACT, V275, P95, DOI 10.1016/j.cbi.2017.07.016
   Lanzerstorfer P, 2015, FEBS J, V282, P987, DOI 10.1111/febs.13213
   Lanzerstorfer P, 2014, BRIT J PHARMACOL, V171, P5237, DOI 10.1111/bph.12845
   Lanzerstorfer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092151
   List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863
   Liu XQ, 2005, J NUTR, V135, P165, DOI 10.1093/jn/135.2.165
   Malematja RO, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/5101656
   Martel J, 2017, NAT REV ENDOCRINOL, V13, P149, DOI 10.1038/nrendo.2016.142
   MEUNIER V, 1995, CELL BIOL TOXICOL, V11, P187, DOI 10.1007/BF00756522
   Minakawa M, 2012, BIOCHEM BIOPH RES CO, V422, P469, DOI 10.1016/j.bbrc.2012.05.017
   Mitich LW, 1997, WEED TECHNOL, V11, P626, DOI 10.1017/S0890037X00045541
   Morikawa T, 2008, J NAT PROD, V71, P828, DOI 10.1021/np8000333
   Morikawa T, 2015, PHYTOCHEMISTRY, V116, P203, DOI 10.1016/j.phytochem.2015.05.011
   Morikawa T, 2011, CHEM PHARM BULL, V59, P889, DOI 10.1248/cpb.59.889
   MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x
   Mueckler M, 2001, J CLIN INVEST, V107, P1211, DOI 10.1172/JCI13020
   Müller U, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201701012
   Naowaboot J, 2012, AM J CHINESE MED, V40, P163, DOI 10.1142/S0192415X12500139
   Nazaruk J, 2001, Acta Pol Pharm, V58, P401
   Nazaruk J., 2000, L ACTA POL PHARM, V57, P129
   Onur S., 2013, Journal of Food Research, V2, P101
   Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582
   Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092
   Rózanska D, 2018, ADV CLIN EXP MED, V27, P135, DOI 10.17219/acem/64983
   Sayem AM, 2018, MOLECULES, V23, DOI 10.3390/molecules23020258
   Scheen AJ, 2012, DIABETES RES CLIN PR, V98, P175, DOI 10.1016/j.diabres.2012.09.001
   SCHOPKE T, 1992, PHYTOCHEMISTRY, V31, P2555, DOI 10.1016/0031-9422(92)83328-V
   Siatka T, 2010, MOLECULES, V15, P9450, DOI 10.3390/molecules15129450
   Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75
   Spielmann H, 1995, Methods Mol Biol, V43, P199
   Stadlbauer V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148109
   Torabi S, 2016, EXP BIOL MED, V241, P1776, DOI 10.1177/1535370216645213
   Uysal I., 2010, Biol Divers Conserv, V3, P15
   Uzun E, 2004, J ETHNOPHARMACOL, V95, P287, DOI 10.1016/j.jep.2004.07.013
   Volpe DA, 2011, FUTURE MED CHEM, V3, P2063, DOI [10.4155/FMC.11.149, 10.4155/fmc.11.149]
   Xu ML, 2014, MOL NUTR FOOD RES, V58, P931, DOI 10.1002/mnfr.201300510
   Yoshikawa M, 2008, CHEM PHARM BULL, V56, P559, DOI 10.1248/cpb.56.559
   Yoshitomi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183988
   Yoshiyama Y, 2005, BIOL PHARM BULL, V28, P1986, DOI 10.1248/bpb.28.1986
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
   Ziegler D, 2015, J DIABETES COMPLICAT, V29, P146, DOI 10.1016/j.jdiacomp.2014.08.008
NR 63
TC 24
Z9 26
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD OCT
PY 2018
VL 23
IS 10
AR 2605
DI 10.3390/molecules23102605
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA HB6SF
UT WOS:000451201400201
PM 30314325
OA gold, Green Submitted, Green Published
DA 2025-04-28
ER

PT J
AU Huang, K
   Liang, XC
   Zhong, YL
   He, WY
   Wang, Z
AF Huang, Kang
   Liang, Xiu-ci
   Zhong, Ying-li
   He, Wan-yan
   Wang, Zheng
TI 5-Caffeoylquinic acid decreases diet-induced obesity in rats by
   modulating PPAR and LXR transcription
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE CGA; 5-CQA; PPAR; LXR; obesity; lipid metabolism
ID ACTIVATED RECEPTOR-ALPHA; LIVER-X-RECEPTOR; HIGH-FAT DIET; CHLOROGENIC
   ACID; OXYSTEROL RECEPTORS; METABOLIC SYNDROME; HDL-CHOLESTEROL; BINDING
   PROTEIN; MICE LACKING; IN-VITRO
AB BackgroundChlorogenic acids (CGAs) are widely distributed in plant material, including foods and beverages. 5-Caffeoylquinic acid (5-CQA) is the most studied CGA, but the mechanism of its hypolipidaemic effect remains unclear. This study aimed to determine the effect of 5-CQA on lipid metabolism in the liver of Sprague-Dawley rats fed a high-fat diet (HFD).
   Results5-CQA suppressed HFD-induced increases in body weight and visceral fat-pad weight, serum lipid levels, and serum and hepatic free fatty acids in a dose-dependent manner. Real-time polymerase chain reaction revealed that 5-CQA altered the mRNA expression of the transcription factors peroxisome proliferator-activated receptor (PPAR) and liver X receptor (LXR) and target genes involved in hepatic fatty acid uptake, -oxidation, fatty acid synthesis, and cholesterol synthesis. Moreover, hepatic tissue sections from HFD-fed rats showed many empty vacuoles, suggesting that liver cells were filled with more fat droplets. However, 5-CQA significantly ameliorated this effect.
   Conclusion5-CQA may improve lipid metabolism disorders by altering the expression of PPAR and LXR, which are involved in multiple intracellular signalling pathways. (c) 2014 Society of Chemical Industry
C1 [Huang, Kang; Liang, Xiu-ci; Zhong, Ying-li; He, Wan-yan; Wang, Zheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
C3 Hunan Agricultural University
RP Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
EM wz8918@163.com
RI zhang, yuhang/ISS-5685-2023; Wang, Zheng/JNT-1898-2023
OI Wang, Zheng/0000-0001-9159-047X
FU National Natural Science Foundation of China [31071531]; Scientific
   Research Fund of Hunan Provincial Education Department [14A071]
FX The financial support for this research from the National Natural
   Science Foundation of China (31071531) and the Scientific Research Fund
   of Hunan Provincial Education Department (14A071) is gratefully
   acknowledged. The authors thank Professor M.N. Clifford for helpful
   suggestions and assistance with presentation.
CR [Anonymous], SCI WORLD J
   [Anonymous], EUROP J BIOCH, DOI DOI 10.1111/J.1432-1033.1968.TB00328.X
   [Anonymous], J OBESITY, DOI DOI 10.1155/2013/269038
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Berge RK, 2005, BIOCHIMIE, V87, P15, DOI 10.1016/j.biochi.2004.11.011
   Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11
   Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cho KW, 2011, EUR J NUTR, V50, P81, DOI 10.1007/s00394-010-0117-8
   Crook MA, 2000, J CLIN PATHOL, V53, P796, DOI 10.1136/jcp.53.10.796
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Du WY, 2013, J ETHNOPHARMACOL, V147, P74, DOI 10.1016/j.jep.2013.01.042
   Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498
   Gong LX, 2014, NUTRIENTS, V6, P1635, DOI 10.3390/nu6041635
   Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638
   Gutschi LM, 2006, ANN PHARMACOTHER, V40, P1672, DOI 10.1345/aph.1H020
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Huang J.H., 2004, Chin. J. Clin. Pharmacol. Ther, V9, P1069
   Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200
   Kampe K, 2014, AM J PHYSIOL-RENAL, V306, pF401, DOI 10.1152/ajprenal.00454.2013
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Kasai H, 2000, FOOD CHEM TOXICOL, V38, P467, DOI 10.1016/S0278-6915(00)00014-4
   Kastorini CM, 2011, AM HEART J, V162, P717, DOI 10.1016/j.ahj.2011.07.012
   Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013
   Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076
   Marques V, 2009, FOOD CHEM, V113, P1370, DOI 10.1016/j.foodchem.2008.08.086
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Nicholls SJ, 2012, DIABETES VASC DIS RE, V9, P89, DOI 10.1177/1479164112441477
   Ohnaka K, 2012, J NUTR METAB, V2012, P9
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Panchal SK, 2011, J BIOMED BIOTECHNOL, V2011, P14
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Ravikumar B, 2005, AM J PHYSIOL-ENDOC M, V288, pE789, DOI 10.1152/ajpendo.00557.2004
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400
   Shimoda H, 2006, BMC COMPLEM ALTERN M, DOI [10. 1186/472-6882-6-9, DOI 10.1186/472-6882-6-9]
   Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200
   Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388
   Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200
   Wang Z, 2008, FOOD CHEM, V108, P369, DOI 10.1016/j.foodchem.2007.10.083
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190
   Yue LD, 2005, PROTEIN SCI, V14, P812, DOI 10.1110/ps.04951405
   Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200
NR 53
TC 102
Z9 109
U1 0
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JUL
PY 2015
VL 95
IS 9
BP 1903
EP 1910
DI 10.1002/jsfa.6896
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA CJ6UQ
UT WOS:000355630400017
PM 25186103
DA 2025-04-28
ER

PT J
AU Boon, N
AF Boon, Niels
TI Health Potential for Functional Green Teas?
SO INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
LA English
DT Article; Proceedings Paper
CT 17th International ISFE Symposium
CY DEC 04-05, 2008
CL Como, ITALY
DE Green tea; catechins; health benefits
ID RANDOMIZED CONTROLLED-TRIAL; BLOOD-GLUCOSE LEVELS; BODY-WEIGHT LOSS; FAT
   OXIDATION; BLACK TEA; ENDOTHELIAL FUNCTION; ENERGY-EXPENDITURE;
   INSULIN-RESISTANCE; CATECHIN-POLYPHENOLS; CAFFEINE INTAKE
AB Obesity is a major health problem in the developed and developing world. Many "functional" foods and ingredients are advocated for their effects on body composition but few have consistent scientific support for their efficacy. However, an increasing amount of mechanistic and clinical evidence is building for green tea. The tea plant is naturally rich in a group of antioxidants known as catechins. Unlike black tea, green tea production involves little processing and fermentation and therefore, green tea brews are rich in catechins.
   Green tea has been suggested to have a number of potential health benefits in areas such as cardiovascular disease, cancer prevention, glucose homeostasis and dental health. Although there is some promising evidence in all of these areas, more data from human intervention trials are needed.
   A lot of attention has lately been focused on the beneficial effects of green tea on body composition and particularly visceral fat, which has been shown to have a strong link with different components of the metabolic syndrome such as cardiovascular disease and type 2 diabetes. Most, but not all, of the positive results come from a number Asian studies, in which overweight subjects (men and women) consumed green tea for approximately 12 weeks. Finally, green tea may also have measurable acute effects oil energy metabolism and fat oxidation and in particular during physical activity, as evidenced by other studies specifically looking at these endpoints. Small cumulative effects on energy metabolism could also be responsible for the longer-tem effects of green tea on body composition, and these long-term effects may also be most apparent in the context of moderate physical activity. However, more research is needed to further clarify the exact mechanisms of action and to extrapolate these findings to non-Asian populations.
C1 [Boon, Niels] Unilever Res Labs, Vlaardingen, Netherlands.
   [Boon, Niels] Lipton Inst Tea, Vlaardingen, Netherlands.
C3 Unilever
RP Boon, N (corresponding author), Unilever Res Labs, Vlaardingen, Netherlands.
EM niels.boon@unilever.com
CR Alexopoulos N, 2008, EUR J CARDIOV PREV R, V15, P300, DOI 10.1097/HJR.0b013e3282f4832f
   Astill C, 2001, J AGR FOOD CHEM, V49, P5340, DOI 10.1021/jf010759+
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   *FOOD STAND AG, 2001, COMM TOX CHEM FOOD C
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Gardner EJ, 2007, EUR J CLIN NUTR, V61, P3, DOI 10.1038/sj.ejcn.1602489
   Hamilton-Miller JMT, 2001, J MED MICROBIOL, V50, P299, DOI 10.1099/0022-1317-50-4-299
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hirasawa M, 2006, CARIES RES, V40, P265, DOI 10.1159/000092236
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Jochmann N, 2008, BRIT J NUTR, V99, P863, DOI 10.1017/S0007114507838992
   Jones C, 1999, COMMUNITY DENT HLTH, V16, P68
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kataoka K., 2004, Progress in Medicine, V24, P3358
   Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636
   Kim W, 2006, CIRC J, V70, P1052, DOI 10.1253/circj.70.1052
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Liu T, 2000, Zhonghua Kou Qiang Yi Xue Za Zhi, V35, P383
   MacKenzie T, 2007, METABOLISM, V56, P1340, DOI 10.1016/j.metabol.2007.05.018
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Moon HS, 2007, CHEM-BIOL INTERACT, V167, P85, DOI 10.1016/j.cbi.2007.02.008
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   *NHS CRD, 2000, 18 NHS CRD U YORK CT
   OOSHIMA T, 1994, CARIES RES, V28, P146, DOI 10.1159/000261636
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   Polychronopoulos E, 2008, EUR J NUTR, V47, P10, DOI 10.1007/s00394-007-0690-7
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Ryu OH, 2006, DIABETES RES CLIN PR, V71, P356, DOI 10.1016/j.diabres.2005.08.001
   SARIS WHM, 1995, INT J OBESITY, V19, pS17
   Song YQ, 2005, J AM COLL NUTR, V24, P376, DOI 10.1080/07315724.2005.10719488
   Stangl V, 2006, MOL NUTR FOOD RES, V50, P218, DOI 10.1002/mnfr.200500118
   Takashima S., 2004, Progress in Medicine, V24, P3371
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   Tsuneki Hiroshi, 2004, BMC Pharmacology, V4, P18, DOI 10.1186/1471-2210-4-18
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Vermeer MA, 2008, J AGR FOOD CHEM, V56, P12031, DOI 10.1021/jf8022035
   WANG M, 2007, 4 AS OC C OB, V115
   WEI SHY, 1989, NUTRITION, V5, P237
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Widlansky ME, 2007, J AM COLL NUTR, V26, P95, DOI 10.1080/07315724.2007.10719590
   Wolfram S, 2007, J AM COLL NUTR, V26, p373S, DOI 10.1080/07315724.2007.10719626
   Wu CD, 2002, NUTRITION, V18, P443, DOI 10.1016/S0899-9007(02)00763-3
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Yang CS, 2007, TOXICOL APPL PHARM, V224, P265, DOI 10.1016/j.taap.2006.11.024
   You S.Q., 1993, CHUNG HUA KOU CHIANG, V28, P197
   YU H, 1995, J DENT, V23, P101, DOI 10.1016/0300-5712(95)98975-9
NR 65
TC 12
Z9 13
U1 3
U2 72
PU VERLAG HANS HUBER
PI BERN 9
PA LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND
SN 0300-9831
EI 1664-2821
J9 INT J VITAM NUTR RES
JI Int. J. Vitam. Nutr. Res.
PD DEC
PY 2008
VL 78
IS 6
SI SI
BP 275
EP 281
DI 10.1024/0300-9831.78.6.275
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 484IR
UT WOS:000269038400005
PM 19685436
DA 2025-04-28
ER

PT J
AU Lee, HS
   Park, S
   Kim, MH
AF Lee, Haeng-Shin
   Park, Sohyun
   Kim, Mi-Hyun
TI Factors associated with low water intake among South Korean adolescents
   - Korea National Health and Nutrition Examination Survey, 2007-2010
SO NUTRITION RESEARCH AND PRACTICE
LA English
DT Article
DE Plain water; adolescents; behaviors; demographics; beverages
ID SUGAR-SWEETENED BEVERAGES; YOUTH PHYSICAL-ACTIVITY; DRINKING-WATER;
   ENERGY-INTAKE; WEIGHT; CONSUMPTION; CHILDREN; IMPACT; TRIAL
AB Water is essential for life and plain water instead of sugar-sweetened beverages is one approach for decreasing energy intake. Due to limited data on characteristics associated with water intake among Korean adolescents, this study examined associations of demographic and behavioral characteristics with plain water intake by using nationally representative sample of South Korean adolescents. The data (2007-2010 Korea National Health and Nutrition Examination Survey) for 1,288 high school-aged adolescents (15-18 years) were used. Multivariable logistic regression was used to calculate adjusted odds ratios (OR) for factors associated with low water intake (<4 cups/day) and very low water intake (<2.5 cups/day). Nationwide, 38.4% and 19.0% of adolescents reported drinking water <4.0 cups/day and <2.5 cups/day, respectively. The mean plain water intake was 5.7 cups/day for males and 4.1 cups/day for females. Females had significantly higher odds for drinking water <2.5 cups/day (OR = 2.2) than males, whereas adolescents with low milk consumption had significantly lower odds for drinking water <2.5 cups/day (OR = 0.7). Factors significantly associated with a greater odds for drinking water <4 cups/daywere being female (OR = 2.8) and not meeting physical activity recommendations 20 min/day on <3 days/week) (OR = 1.6). Being underweight, overweight, and obese were significantly associated with reduced odds for drinking water <4 cups/day (OR = 0.7, 0.4 and 0.5, respectively). However, intake of soda, coffee drinks, fruits, vegetables, and sodium and eating out were not significantly associated with low or very low water intake. These findings may be used to target intervention efforts to increase plain water intake as part of a healty lifestyle.
C1 [Lee, Haeng-Shin] Korea Hlth Ind Dev Inst, Nutr Management Serv & Policy Team, Chungbuk 363700, South Korea.
   [Park, Sohyun] Ctr Dis Control & Prevent, Div Nutr Phys Activ & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
   [Kim, Mi-Hyun] Korea Natl Univ Transportat, Dept Food & Nutr, Chungbuk 368701, South Korea.
C3 Centers for Disease Control & Prevention - USA; Korea National
   University of Transportation
RP Kim, MH (corresponding author), Korea Natl Univ Transportat, Dept Food & Nutr, 61 Daehak Ro, Chungbuk 368701, South Korea.
EM mhkim1129@ut.ac.kr
RI Lee, Yun-Sik/GMU-0783-2022
OI Park, Sohyun/0000-0002-8192-7048
CR [Anonymous], 2007, KOREAN J PEDIAT, DOI DOI 10.3345/KJP.2008.51.1.1
   [Anonymous], 2011, REV UPD CURR WHO REC
   Armfield JM, 2013, AM J PUBLIC HEALTH, V103, P494, DOI 10.2105/AJPH.2012.300889
   Brener Nancy D., 2011, Morbidity and Mortality Weekly Report, V60, P778
   Daniels MC, 2010, NUTR REV, V68, P505, DOI 10.1111/j.1753-4887.2010.00311.x
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Isasi CR, 2006, DIABETES EDUCATOR, V32, P415, DOI 10.1177/0145721706288763
   Kant AK, 2010, AM J CLIN NUTR, V92, P887, DOI 10.3945/ajcn.2010.29708
   Korea Centers for Disease Control and Prevention; Korean Pediatric Society; Establishing Commission for Growth Curve of Children and Adolescents, 2007, 2007 KOR NAT GROWTH
   Korea Centers for Disease Control & Prevention, 2011, Korea National Health and Nutrition Examination Survey (KNHANES VII1), V2
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2011, AN GUID KOR NAT HLTH
   Muckelbauer R, 2009, PEDIATRICS, V123, pE661, DOI 10.1542/peds.2008-2186
   Park MK, 2009, SPORT SCI, V9, P2
   Park S, 2012, J ACAD NUTR DIET, V112, P1421, DOI 10.1016/j.jand.2012.04.014
   Park S, 2012, J ACAD NUTR DIET, V112, P125, DOI 10.1016/j.jada.2011.08.045
   Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536
   Park S, 2011, J AM DIET ASSOC, V111, P1211, DOI 10.1016/j.jada.2011.05.006
   Rural Development Administration (KR), 2006, FOOD COMP TABL KOR
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Sebastian R.S., 2011, Drinking Water Intake in the United States
   Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278
   The Korean Nutrition Society, 2010, DIEAT REF INT KOR 20
   Wang YC, 2009, ARCH PEDIAT ADOL MED, V163, P336, DOI 10.1001/archpediatrics.2009.23
   WHO, 2003, WHO TECHN REP SER
NR 28
TC 6
Z9 7
U1 1
U2 12
PU KOREAN NUTRITION SOC
PI SEOUL
PA 804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-1457
EI 2005-6168
J9 NUTR RES PRACT
JI Nutr. Res. Pract.
PD FEB
PY 2014
VL 8
IS 1
BP 74
EP 80
DI 10.4162/nrp.2014.8.1.74
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AA0WW
UT WOS:000330819100011
PM 24611109
OA Green Published
DA 2025-04-28
ER

PT J
AU Vanselow, MS
   Pereira, MA
   Neumark-Sztainer, D
   Raatz, SK
AF Vanselow, Michelle S.
   Pereira, Mark A.
   Neumark-Sztainer, Dianne
   Raatz, Susan K.
TI Adolescent beverage habits and changes in weight over time: findings
   from Project EAT
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID BODY-MASS INDEX; SUGAR-SWEETENED BEVERAGES; FOOD FREQUENCY
   QUESTIONNAIRE; EARLY SEXUAL-MATURATION; US CHILDREN; METABOLIC SYNDROME;
   DRINK CONSUMPTION; CHILDHOOD OBESITY; OVERWEIGHT STATUS; RISK-FACTORS
AB Background: Obesity in adolescence has been increasing in the past several decades. Beverage habits among adolescents include increased consumption of sugar-sweetened beverages and decreased consumption of milk.
   Objective: This study aimed to examine the association between beverage consumption and 5-y body weight change in 2294 adolescents.
   Design: Project EAT (Eating Among Teens) is a 5-y longitudinal study of eating patterns among adolescents. Surveys were completed in 1998-1999 (time 1) and in 2003-2004 (time 2). Multivariable linear regression was used to examine the association between beverage consumption at time 2 and change in body mass index from time 1 to time 2, with adjustments for age, socioeconomic status, race, cohort, physical activity, sedentary behavior, coffee, tea, time 1 body mass index, and beverage variables.
   Results: In prospective analyses, consumption of beverages was not associated with weight gain, except for consumption of low-calorie soft drinks (positive association, P = 0.002) and white milk (inverse association, P = 0.03), but these associations did not appear to be a monotonic linear dose-response relation. The positive association with low-calorie soft drinks was no longer present after adjustment for dieting and parental weight-related concerns, which suggests that the use of low-calorie soft drinks is a marker for more general dietary behaviors and weight concerns.
   Conclusions: We showed no association between sugar-sweetened beverage consumption, juice consumption, and adolescent weight gain over a 5-y period. A direct association between diet beverages and weight gain appeared to be explained by dieting practices. Adolescents who consumed little or no white milk gained significantly more weight than their peers who consumed white milk. Future research that examines beverage habits and weight among adolescents should address portion sizes, adolescent maturation, and dieting behaviors. Am J Clin Nutr 2009;90:1489-95.
C1 [Vanselow, Michelle S.; Pereira, Mark A.; Neumark-Sztainer, Dianne] Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, Minneapolis, MN 55454 USA.
   [Raatz, Susan K.] Univ Minnesota, Div Endocrinol & Diabet, Dept Med, Minneapolis, MN 55454 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities
RP Pereira, MA (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, Sch Publ Hlth, 1300 S 2nd St,Suite 300, Minneapolis, MN 55454 USA.
EM map@umn.edu
RI Neumark-Sztainer, Dianne/D-8574-2011
OI Neumark-Sztainer, Dianne/0000-0001-9435-1669; Pereira,
   Mark/0000-0002-6704-5276
FU PHS HHS [R40 MC 00319] Funding Source: Medline
CR Ackard DM, 2003, PEDIATRICS, V111, P67, DOI 10.1542/peds.111.1.67
   [Anonymous], WHAT WE EAT AM USDA
   Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94
   Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543
   Cadogan J, 1997, BMJ-BRIT MED J, V315, P1255, DOI 10.1136/bmj.315.7118.1255
   CHAN GM, 1995, J PEDIATR-US, V126, P551, DOI 10.1016/S0022-3476(95)70348-9
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Field AE, 2003, PEDIATRICS, V112, P900, DOI 10.1542/peds.112.4.900
   Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662
   Forshee RA, 2009, AM J CLIN NUTR, V89, P439, DOI 10.3945/ajcn.2008.27089
   GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141
   Godin G., 1997, MED SCI SPORTS EXERC, pS36
   Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409
   Haines J, 2006, PEDIATRICS, V117, pE209, DOI 10.1542/peds.2005-1242
   Haines J, 2007, OBESITY, V15, P2748, DOI 10.1038/oby.2007.327
   Harper A, 2007, BRIT J NUTR, V97, P579, DOI 10.1017/S0007114507339846
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   Himes JH, 2005, ANN EPIDEMIOL, V15, P272, DOI 10.1016/j.annepidem.2004.08.010
   Himes JH, 2004, OBES RES, V12, p64S, DOI 10.1038/oby.2004.270
   Hoffman WH, 2005, OBES RES, V13, P2195, DOI 10.1038/oby.2005.272
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   Koplan JP, 1999, JAMA-J AM MED ASSOC, V282, P1579, DOI 10.1001/jama.282.16.1579
   Libuda L, 2008, BRIT J NUTR, V99, P1370, DOI 10.1017/S0007114507862362
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Malik VS, 2009, AM J CLIN NUTR, V89, P438, DOI 10.3945/ajcn.2008.26980
   Merrilees MJ, 2000, EUR J NUTR, V39, P256, DOI 10.1007/s003940070004
   Mrdjenovic G, 2003, J PEDIATR-US, V142, P604, DOI 10.1067/mpd.2003.200
   MUST A, 1991, AM J CLIN NUTR, V54, P773, DOI 10.1093/ajcn/54.5.773
   MUST A, 1991, AM J CLIN NUTR, V53, P839, DOI 10.1093/ajcn/53.4.839
   Neumark-Sztainer D, 2003, PREV MED, V37, P198, DOI 10.1016/S0091-7435(03)00114-2
   Neumark-Sztainer D, 2006, J AM DIET ASSOC, V106, P559, DOI 10.1016/j.jada.2006.01.003
   Neumark-Sztainer D, 2002, AM J PUBLIC HEALTH, V92, P844, DOI 10.2105/AJPH.92.5.844
   Neumark-Sztainer D, 2002, J PSYCHOSOM RES, V53, P963, DOI 10.1016/S0022-3999(02)00486-5
   Neumark-Sztainer D, 2006, PREV MED, V43, P52, DOI 10.1016/j.ypmed.2006.03.014
   Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728
   Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401
   Phillips SM, 2004, OBES RES, V12, P461, DOI 10.1038/oby.2004.52
   RESNICK MD, 1993, J PAEDIATR CHILD H, V29, pS3, DOI 10.1111/j.1440-1754.1993.tb02257.x
   ROCKETT HRH, 1995, J AM DIET ASSOC, V95, P336, DOI 10.1016/S0002-8223(95)00086-0
   Rockett HRH, 1997, PREV MED, V26, P808, DOI 10.1006/pmed.1997.0200
   Stice E, 2005, J CONSULT CLIN PSYCH, V73, P195, DOI 10.1037/0022-006X.73.2.195
   Stice E, 1999, J CONSULT CLIN PSYCH, V67, P967, DOI 10.1037/0022-006X.67.6.967
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   Wang YF, 2002, PEDIATRICS, V110, P903, DOI 10.1542/peds.110.5.903
NR 47
TC 83
Z9 99
U1 0
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD DEC 1
PY 2009
VL 90
IS 6
BP 1489
EP 1495
DI 10.3945/ajcn.2009.27573
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 522XZ
UT WOS:000272034900008
PM 19864412
DA 2025-04-28
ER

PT J
AU Siri, G
   Nikrad, N
   Keshavari, S
   Jamshidi, S
   Fayyazishishavan, E
   Ardekani, AM
   Farhangi, MA
   Jafarzadeh, F
AF Siri, Goli
   Nikrad, Negin
   Keshavari, Sheida
   Jamshidi, Saideh
   Fayyazishishavan, Ehsan
   Ardekani, Abnoos Mokhtari
   Farhangi, Mahdieh Abbasalizad
   Jafarzadeh, Faria
TI A high Diabetes Risk Reduction Score (DRRS) is associated with a better
   cardio-metabolic profile among obese individuals
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Diabetes risk reduction; Metabolic syndrome; Obesity; Metabolic
   parameters; Diabetes
ID TRANS-FATTY-ACIDS; QUALITY-OF-LIFE; MEDITERRANEAN DIET; DASH DIET;
   CARDIOVASCULAR HEALTH; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; METAANALYSIS;
   OVERWEIGHT; WEIGHT
AB BackgroundDietary indices and scores are valuable predictive markers against chronic diseases. Several previous studies have revealed the beneficial effects of diabetes risk reduction score (DRRS) against diabetes and cancer incidence. However, its association with metabolic abnormalities among obese individuals have not been revealed before. In the current study, we aimed to investigate the association between DRRS and metabolic risk factors among obese individuals.MethodsIn the current cross-sectional study, 342 obese individuals [Body mass index (BMI) >= 30 kg/m(2)] aged 20-50 years were included. Dietary intake was assessed by a validated semi-quantitative food frequency questionnaire (FFQ) of 168 food items and DRRS was calculated. Metabolic syndrome (MetS) was defined based on the guidelines of the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III). Enzymatic methods were used to assess serum lipids, glucose, and insulin concentrations. Blood pressure was measured by a sphygmomanometer and body composition with bioelectrical impedance analysis (BIA).ResultsThose with a higher adherence to DRRS had a significantly higher intake of energy, fiber, and lower protein compared with those in the lower quartiles. Moreover, lower intakes of trans fats, meat, sugar sweetened beverages (SSB), and glycemic index (GI) with higher intakes of fruits, cereal fiber, polyunsaturated fatty acids/ saturated fatty acids (PUFA/ SFA) ratio, coffee, and nuts were observed in the highest versus lowest DRRS categories. Lower systolic blood pressure, diastolic blood pressure, triglyceride and, higher high-density lipoprotein values were observed in higher DRRS categories. Logistic regression analysis showed that hypertension was significantly associated with adherence to DRRS among obese individuals, the odds ratio (OR) was 0.686 (95% confidence interval [CI], 0.26-0.84) after adjustment for potential confounders. But the risk of other components of MetS was not significantly associated with higher quartiles of adherence to DRRS. Also, a non-significantly lower prevalence of MetS was observed in the higher quartile of DRRS.ConclusionsAccording to the results of the current study, higher DRRS was associated with lower blood pressure, modified serum lipids, and lower Mets prevalence. Further studies in different populations are warranted for better generalization of the obtained findings.
C1 [Siri, Goli] Univ Tehran Med Sci, Amir Alam Hosp, Dept Internal Med, Tehran, Iran.
   [Nikrad, Negin] Tabriz Univ Med Sci, Fac Nutr, Dept Community Nutr, Tabriz, Iran.
   [Keshavari, Sheida; Jamshidi, Saideh] Iran Univ Med Sci, Echocardiog Res Ctr, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran.
   [Fayyazishishavan, Ehsan] Univ Texas Hlth Sci Ctr Houston UTHealth, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA.
   [Ardekani, Abnoos Mokhtari] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran.
   [Ardekani, Abnoos Mokhtari] Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran.
   [Farhangi, Mahdieh Abbasalizad] Tabriz Univ Med Sci, Drug Appl Res Ctr, Daneshgah Blvd, Tabriz, Iran.
   [Jafarzadeh, Faria] North Khorasan Univ Med Sci, Sch Med, Dept Internal Med, Bojnourd, Iran.
C3 Tehran University of Medical Sciences; Amir Alam Hospital; Tabriz
   University of Medical Science; Iran University of Medical Sciences;
   University of Texas System; University of Texas Health Science Center
   Houston; University of Texas School Public Health; Kerman University of
   Medical Sciences; Kerman University of Medical Sciences; Tabriz
   University of Medical Science; North Khorasan University of Medical
   Sciences
RP Farhangi, MA (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Daneshgah Blvd, Tabriz, Iran.; Jafarzadeh, F (corresponding author), North Khorasan Univ Med Sci, Sch Med, Dept Internal Med, Bojnourd, Iran.
EM abbasalizad_m@yahoo.com; f.Jafarzadeh@nkums.ac.ir
RI jamshidi, saideh/JZT-1819-2024; Mokhtari, Abnoos/GYV-5829-2022;
   jafarzadeh, faria/E-1413-2018; Farhangi, Mahdieh/AAC-6758-2019; Nikrad,
   Negin/JZD-3883-2024; Fayyazishishavan, Ehsan/GRY-2545-2022
OI Fayyazishishavan, Ehsan/0000-0002-9548-6028; JAFARZADEH,
   FARIA/0009-0003-5883-098X; Siri, Goli/0009-0008-0271-0416
FU Tabriz University of Medical Sciences [IR.TBZMED.REC.1398.460,
   TBZMED.REC.1396.768]
FX Present study has been financially supported by a grant from Tabriz
   University of Medical Sciences. (registration code:
   IR.TBZMED.REC.1398.460 and IR. TBZMED.REC.1396.768). The funders had no
   role in hypothesis generation, recruiting and designing the study. Their
   role was only financial supporting.
CR Aghajani R, 2020, J. Chem. Health Risks, V10, P117
   Aminianfar A, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00531-1
   Arliny Y, 2021, DIAGNOSTIC PREDICTOR, V1, P2
   Aro A, 1997, AM J CLIN NUTR, V65, P1419, DOI 10.1093/ajcn/65.5.1419
   Ascherio A, 2006, ATHEROSCLEROSIS SUPP, V7, P25, DOI 10.1016/j.atherosclerosissup.2006.04.018
   Asghari G, 2020, ASS DIETARY DIABETES
   Babio N, 2009, PUBLIC HEALTH NUTR, V12, P1607, DOI 10.1017/S1368980009990449
   Baldini G, 2019, J ENDOCRINOL, V241, pR1, DOI [10.1530/JOE-18-0596, 10.1530/joe-18-0596]
   Bendsen NT, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2010.4
   Besagil PS, 2020, NIGER J CLIN PRACT, V23, P481, DOI 10.4103/njcp.njcp_212_19
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Buckland G, 2008, OBES REV, V9, P582, DOI 10.1111/j.1467-789X.2008.00503.x
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Chiu S, 2016, AM J CLIN NUTR, V103, P341, DOI 10.3945/ajcn.115.123281
   Corrêa TAF, 2013, NUTRITION, V29, P977, DOI 10.1016/j.nut.2013.01.003
   de Zwaan M, 2009, PSYCHOSOMATICS, V50, P474, DOI 10.1176/appi.psy.50.5.474
   Donohoe F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041241
   Dowaidar M, 2021, DISCOVERIES GENE ENV
   Erstad BL, 2021, ANN PHARMACOTHER, V55, P80, DOI 10.1177/1060028020935580
   Farhangi MA, 2020, LIFESTYLE GENOM, V13, P1, DOI 10.1159/000503789
   Farhangi MA, 2020, EAT WEIGHT DISORD-ST, V25, P1049, DOI 10.1007/s40519-019-00729-1
   Farhangi MA, 2017, EAT WEIGHT DISORD-ST, V22, P451, DOI 10.1007/s40519-016-0288-2
   Farias G, 2018, NEUROPEPTIDES, V69, P60, DOI 10.1016/j.npep.2018.04.005
   Fernández-Garcia JC, 2013, CURR VASC PHARMACOL, V11, P906, DOI 10.2174/15701611113116660175
   Gasmi A, 2021, Arch Razi Inst, V76, P707, DOI 10.22092/ari.2021.356057.1768
   Ghaffarpour M., 1999, TEHRAN NASHRE OLUME, V7, P42
   Ghanbari E., 2022, INT J BODY MIND CULT, DOI 10.22122/ijbmc.v9i2.295
   Ghanim H, 2017, J CLIN ENDOCR METAB, V102, P858, DOI 10.1210/jc.2016-2669
   Ghorabi S, 2019, DIABETES METAB SYND, V13, P1699, DOI 10.1016/j.dsx.2019.03.039
   Giugliano D, 2005, ANN NY ACAD SCI, V1056, P253, DOI 10.1196/annals.1352.012
   Goswami B., 2021, J NATURAL SCI BIOL M, V12, P207
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Guerra ZC, 2022, AM J HEALTH BEHAV, V46, P324, DOI 10.5993/AJHB.46.3.11
   Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4
   Holt RIG, 2009, DIABETES OBES METAB, V11, P665, DOI 10.1111/j.1463-1326.2009.01038.x
   Huang Y, 2021, CLIN NUTR, V40, P5595, DOI 10.1016/j.clnu.2021.09.037
   Jakicic JM, 2001, MED SCI SPORT EXER, V33, P2145, DOI 10.1097/00005768-200112000-00026
   Jasim O H, 2022, Arch Razi Inst, V77, P277, DOI [10.22092/ari.2021.356465.1846, 10.22092/ARI.2021.356465.1846]
   Jayawardena R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-314
   Jenkins DJA, 1997, METABOLISM, V46, P530, DOI 10.1016/S0026-0495(97)90190-6
   Kadam I, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103555
   Kang JH, 2020, AM J CLIN NUTR, V112, P1492, DOI 10.1093/ajcn/nqaa268
   Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073
   Khodarahmi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219193
   Kjaergaard AD, 2022, CLIN CHEM, V68, P461, DOI 10.1093/clinchem/hvab249
   Kourlaba G, 2009, MATURITAS, V62, P1, DOI 10.1016/j.maturitas.2008.11.021
   Lajous M, 2014, AM J CLIN NUTR, V100, P948, DOI 10.3945/ajcn.113.080598
   Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s
   Lega IC, 2020, ENDOCR REV, V41, P33, DOI 10.1210/endrev/bnz014
   Liese AD, 2011, CIRCULATION, V123, P1410, DOI 10.1161/CIRCULATIONAHA.110.955922
   Luo X, 2019, AM J GASTROENTEROL, V114, P1870, DOI 10.14309/ajg.0000000000000450
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   Lutz M, 2021, ARCH CLIN PSYCHIAT, V48, DOI 10.15761/0101-60830000000290
   Masala G, 2008, J HYPERTENS, V26, P2112, DOI 10.1097/HJH.0b013e32830ef75c
   Minhas M, 2021, ADDICTION, V116, P2870, DOI 10.1111/add.15446
   Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698
   Musaiger AO, 2016, ENVIRON HEALTH PREV, V21, P224, DOI 10.1007/s12199-016-0515-5
   Norrman E, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003723
   Paul R., 2020, J NAT SCI BIOL MED, V11, P111
   Pavlos S, 2021, J COMPL MED RES, V12, P244, DOI 10.5455/jcmr.2021.12.04.36
   Payab M, 2022, J DIABETES METAB DIS, V21, P889, DOI 10.1007/s40200-021-00917-w
   Ramli NNS, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57090957
   Rhee JJ, 2015, DIABETES CARE, V38, P596, DOI 10.2337/dc14-1986
   Ros E, 2014, ADV NUTR, V5, p330S, DOI 10.3945/an.113.005389
   Rosengren A, 2021, EUR HEART J, V42, P3404, DOI 10.1093/eurheartj/ehab518
   Ruhm CJ, 2007, FORUM HLTH EC POLICY
   Salehi-Abargouei A, 2016, EUR J CLIN NUTR, V70, P1, DOI 10.1038/ejcn.2015.118
   Saneei P, 2015, EUR J NUTR, V54, P421, DOI 10.1007/s00394-014-0723-y
   Sarwer DB, 2002, OBESITY BODY IMAGE D
   Satija A, 2012, CURR ATHEROSCLER REP, V14, P505, DOI 10.1007/s11883-012-0275-7
   Scarlett JM, 2008, ENDOCRINOLOGY, V149, P4837, DOI 10.1210/en.2007-1680
   Schroeder K, 2020, AM J HEALTH BEHAV, V44, P756, DOI 10.5993/AJHB.44.6.2
   Siervo M, 2015, BRIT J NUTR, V113, P1, DOI 10.1017/S0007114514003341
   Silveira EA, 2021, OBES REV, V22, DOI 10.1111/obr.13088
   Singh AK, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140989
   Storz MA, 2020, J POPUL THER CLIN PH, V27, pE22, DOI 10.15586/jptcp.v27SP2.744
   Tang DS, 2020, AM J HEALTH BEHAV, V44, P780, DOI 10.5993/AJHB.44.6.4
   Teper Y, 2020, CANCERS, V12, DOI 10.3390/cancers12071946
   Teymoori F., 2021, BMC ENDOCR DISORD, V21, P1
   Titolo D, 2006, MOL ENDOCRINOL, V20, P2080, DOI 10.1210/me.2006-0027
   Turati F, 2022, EUR J CANCER PREV, V31, P339, DOI 10.1097/CEJ.0000000000000709
   Varkaneh HK, 2018, NUTR FOOD SCI, V48, P702, DOI 10.1108/NFS-09-2017-0203
   Wang ZH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051369
   Washburn RA, 2000, RES Q EXERCISE SPORT, V71, pS79, DOI 10.1080/02701367.2000.11082790
   Wei BZ, 2018, CLIN NUTR, V37, P1935, DOI 10.1016/j.clnu.2017.10.019
   Wilson RE, 2011, OBESITY BODY IMAGE A
   Wong JC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245436
   Zelenovic M, 2022, REV PSICOL DEPORTE, V31, P1
   Zhang N, 2022, BRIT J NUTR, V128, P1137, DOI 10.1017/S0007114521004013
   Zhao CN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060598
NR 90
TC 2
Z9 2
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD FEB 3
PY 2023
VL 23
IS 1
AR 31
DI 10.1186/s12902-023-01279-5
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 8L8JM
UT WOS:000924026300002
PM 36737726
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Gong, M
   Su, CF
   Fan, MZ
   Wang, P
   Cui, BD
   Guo, ZY
   Liang, SJ
   Yang, LH
   Liu, XQ
   Dai, LP
   Wang, ZM
AF Gong, Man
   Su, Chengfu
   Fan, Mengzhe
   Wang, Ping
   Cui, Bingdi
   Guo, Zhongyuan
   Liang, Shaojia
   Yang, Lianhe
   Liu, Xiaoqian
   Dai, Liping
   Wang, Zhimin
TI Mechanism by which Eucommia ulmoides leaves Regulate
   Nonalcoholic fatty liver disease based on system pharmacology
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Eucommia ulmoides leaves; Nonalcoholic fatty liver disease; Nuclear
   receptors; Autophagy; Flavonoids; Phenolics
ID HEPATIC LIPID-ACCUMULATION; CHLOROGENIC ACID; EXTRACT; AUTOPHAGY;
   METABOLISM; MODULATION; FLAVONOIDS
AB Ethnopharmacological relevance: Eucommia ulmoides (E. ulmoides) leaves are included in the Chinese Pharmacopoeia, and are traditionally used to treat hypertension, obesity, diabetes, and other diseases. Numerous pharmacological studies have shown that E. ulmoides has a good effect on lowering blood lipids and can improve obesity and nonalcoholic fatty liver. Aim: To study the mechanism of E. ulmoides leaves in regulating nonalcoholic fatty liver disease by combining prediction and validation. Methods: Using network pharmacology, and molecular docking to predict E. ulmoides in regulating the action mechanism and potential active ingredients of nonalcoholic fatty liver, large hole adsorption resin enrichment active sites, in vitro experiments were performed to verify its fat-lowering effect and mechanism. Results: The major components of E. ulmoides leaves exhibited good combination with lipid metabolismregulating core proteins, particularly flavonoids. EUL 50 significantly reduced lipid accumulation, and increased PPAR gamma. Compared with the control group, the autophagy level increased after the administration of EUL 50. PPAR gamma decreased significantly after the addition of chloroquine (CQ, autophagy inhibitor). Conclusion: The active ingredients in E. ulmoides leaves regulating nonalcoholic fatty liver disease are mainly flavonoids and phenolics. EUL 50 may play a role in lowering lipids by regulating PPAR gamma expression through inducing autophagy.
C1 [Gong, Man; Su, Chengfu; Fan, Mengzhe; Wang, Ping; Cui, Bingdi; Yang, Lianhe; Dai, Liping; Wang, Zhimin] Henan Univ Chinese Med, Zhengzhou 450046, Henan, Peoples R China.
   [Gong, Man; Wang, Ping; Cui, Bingdi; Dai, Liping; Wang, Zhimin] Engn Technol Res Ctr Comprehens Dev & Utilizat Au, Zhengzhou 450046, Henan, Peoples R China.
   [Dai, Liping] Henan Zhongjing Key Lab Prescript, Zhengzhou 450046, Henan, Peoples R China.
   [Liang, Shaojia] Henan Golden Eucommia Agr Technol Co Ltd, Xuchang 461000, Henan, Peoples R China.
   [Guo, Zhongyuan; Liu, Xiaoqian; Wang, Zhimin] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China.
   [Su, Chengfu] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong 999077, Peoples R China.
C3 Henan University of Traditional Chinese Medicine; China Academy of
   Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS;
   Hong Kong Baptist University
RP Dai, LP; Wang, ZM (corresponding author), Henan Univ Chinese Med, Zhengzhou 450046, Henan, Peoples R China.; Dai, LP; Wang, ZM (corresponding author), Engn Technol Res Ctr Comprehens Dev & Utilizat Au, Zhengzhou 450046, Henan, Peoples R China.
EM liping_dai@hactcm.edu.cn; zhmw123@163.com
RI SU, CHENGFU/KHC-6775-2024; WANG, ZHIMIN/AAJ-8452-2021
OI Fan, Mengzhe/0000-0002-0624-8467; CHENGFU, SU/0000-0001-6479-3271
CR Akhlaghi M, 2016, PHYTOTHER RES, V30, P1559, DOI 10.1002/ptr.5667
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Caiozzi G, 2012, CELL BIOCHEM FUNCT, V30, P531, DOI 10.1002/cbf.2842
   Cao H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236093
   China C. f.t.P.o.P, 2020, PHARM PR CHIN 1, P154
   Chu Q, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4825949
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Filipovic B, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/2097435
   Fuchs CD, 2016, SEMIN LIVER DIS, V36, P69, DOI 10.1055/s-0036-1571296
   Gao LJ, 2020, DRUG DES DEV THER, V14, P1705, DOI 10.2147/DDDT.S235969
   Greenway F, 2011, ALTERN MED REV, V16, P338
   Han L, 2017, FUTUR CARDIOL, V13, DOI 10.2217/fca-2017-0019
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   Hassan K, 2014, WORLD J GASTROENTERO, V20, P12082, DOI 10.3748/wjg.v20.i34.12082
   He XR, 2014, J ETHNOPHARMACOL, V151, P78, DOI 10.1016/j.jep.2013.11.023
   Hosoo S, 2017, HYPERTENS RES, V40, P546, DOI 10.1038/hr.2016.189
   Jiao XY, 2021, COMPUT BIOL CHEM, V90, DOI 10.1016/j.compbiolchem.2020.107402
   Jin X, 2010, J ETHNOPHARMACOL, V128, P672, DOI 10.1016/j.jep.2010.02.019
   Khambu Bilon, 2018, Liver Res, V2, P112, DOI 10.1016/j.livres.2018.09.004
   Kim HY, 2004, J ETHNOPHARMACOL, V93, P227, DOI 10.1016/j.jep.2004.03.047
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Kobayashi Y, 2012, J SCI FOOD AGR, V92, P358, DOI 10.1002/jsfa.4586
   Kumar DP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66458-z
   Lascala A, 2018, J NUTR BIOCHEM, V58, P119, DOI 10.1016/j.jnutbio.2018.04.005
   Lee GH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020426
   Lee GH, 2018, BIOMED PHARMACOTHER, V97, P1164, DOI 10.1016/j.biopha.2017.11.035
   Liu J., 1980, SHAANXI TRADITIONAL, P27
   Pisonero-Vaquero S, 2015, CURR MED CHEM, V22, P2991, DOI 10.2174/0929867322666150805094940
   Qiu Bo, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1912
   Song MJ, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.107401
   Sun JH, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.109900
   Swamy GM, 2022, ARCH PHYSIOL BIOCHEM, V128, P938, DOI 10.1080/13813455.2020.1740742
   Tardelli M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061777
   Tian Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24050964
   Varshney R, 2017, MOL CELL ENDOCRINOL, V448, P1, DOI 10.1016/j.mce.2017.02.033
   Yang BY, 2019, CURR PHARM BIOTECHNO, V20, P293, DOI 10.2174/1389201020666190328115411
   Yang SM, 2017, ENDOCRINOLOGY, V158, P2799, DOI 10.1210/en.2016-1479
   Zhang RZ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00123
   Zhou JH, 2019, WORLD J GASTROENTERO, V25, P1307, DOI 10.3748/wjg.v25.i11.1307
   Zhu MO, 2018, J AGR FOOD CHEM, V66, P5433, DOI 10.1021/acs.jafc.8b01312
NR 40
TC 22
Z9 26
U1 5
U2 76
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JAN 10
PY 2022
VL 282
AR 114603
DI 10.1016/j.jep.2021.114603
EA SEP 2021
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA WK4KK
UT WOS:000709695800005
PM 34496264
OA hybrid
DA 2025-04-28
ER

PT J
AU Friis, K
   Lyng, JI
   Lasgaard, M
   Larsen, FB
AF Friis, Karina
   Lyng, Jeppe I.
   Lasgaard, Mathias
   Larsen, Finn B.
TI Energy drink consumption and the relation to socio-demographic factors
   and health behaviour among young adults in Denmark. A population-based
   study
SO EUROPEAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID SWEETENED BEVERAGE CONSUMPTION; JOCK IDENTITY; ALCOHOL; RISK; PATTERNS;
   MASCULINITY; ASSOCIATION; CAFFEINE; WEIGHT; SPORTS
AB Background: The objective of this study is to estimate the prevalence of energy drink consumption and examine the associations of socio-demographic factors and health behaviour with energy drink consumption among young adults in Denmark. Methods: The study is based on a public health survey from 2010 (n= 3923). Multiple logistic regression analyses were used to analyse the association between weekly consumption of energy drink and the potential explanatory factors of interest. Results: In total, 15.8 % of the young adults drink energy drinks on a weekly basis. Men have higher odds of weekly energy drink consumption than women. The study also shows that young age, being employed and having a low educational level are associated with weekly energy drink consumption. According to health behaviour, daily smoking, high amounts of alcohol consumption, alcoholic binge drinking and being overweight are associated with weekly energy drink consumption. Conclusion: Compared with other European countries the prevalence of energy drink consumption is relatively low in Denmark. In Denmark energy drink consumption is typically a male phenomenon and there is a clear social gradient in the prevalence of energy drink consumption where the intake is far more common among people with low levels of education than among people with higher levels of education. This study also shows that there is some kind of 'add on' effect of energy drinks, meaning that people who also use other stimulants-such as alcohol and cigarettes-are more inclined to consume energy drinks.
C1 [Friis, Karina; Lasgaard, Mathias; Larsen, Finn B.] Cent Denmark Reg, Publ Hlth & Qual Improvement, Aarhus, Denmark.
   [Lyng, Jeppe I.] Ctr Sociol Anal, Aalborg, Denmark.
   [Lasgaard, Mathias] Univ Southern Denmark, Odense, Denmark.
C3 University of Southern Denmark
RP Friis, K (corresponding author), Reg House Aarhus, Olof Palmes Alle 15, DK-8200 Aarhus N, Denmark.
EM karina.friis@stab.rm.dk
OI Lasgaard, Mathias/0000-0001-5808-8883; Friis, Karina/0000-0001-5967-2723
FU Central Denmark Region
FX Central Denmark Region
CR Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x
   Arria AM, 2010, J ADDICT MED, V4, P74, DOI 10.1097/ADM.0b013e3181aa8dd4
   Attila S, 2011, NUTRITION, V27, P316, DOI 10.1016/j.nut.2010.02.008
   Ballistreri MC, 2008, REV LAT-AM ENFERM, V16, P558, DOI 10.1590/S0104-11692008000700009
   Berger LK, 2011, ADDICT BEHAV, V36, P516, DOI 10.1016/j.addbeh.2010.12.027
   Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003
   Brasel SA, 2011, J CONSUM PSYCHOL, V21, P57, DOI 10.1016/j.jcps.2010.09.008
   Burrows T, 2013, NUTR REV, V71, P135, DOI 10.1111/nure.12005
   Burt BA, 2006, CARIES RES, V40, P473, DOI 10.1159/000095645
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Christensen AI, 2012, SCAND J PUBLIC HEALT, V40, P391, DOI 10.1177/1403494812451412
   Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055
   Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1
   Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   Iyadurai SJP, 2007, EPILEPSY BEHAV, V10, P504, DOI 10.1016/j.yebeh.2007.01.009
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35
   Marczinski CA, 2013, ALCOHOL CLIN EXP RES, V37, P276, DOI 10.1111/j.1530-0277.2012.01868.x
   Marczinski CA, 2011, INT J ENV RES PUB HE, V8, P3232, DOI 10.3390/ijerph8083232
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490
   Miller K, 2009, AM PHILOS QUART, V46, P1
   O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   Park S, 2013, J ACAD NUTR DIET, V113, P112, DOI 10.1016/j.jand.2012.09.019
   Peacock A, 2013, APPETITE, V64, P1, DOI 10.1016/j.appet.2012.12.021
   Price SR, 2010, DRUG ALCOHOL REV, V29, P331, DOI 10.1111/j.1465-3362.2009.00163.x
   Ríos JL, 2013, P R HEALTH SCI J, V32, P95
   SARNDAL CE, 2005, WILEY, P1
   Sindal H, 2013, POLITIKKEN      0125
   Venables MC, 2005, MED SCI SPORT EXER, V37, P39, DOI 10.1249/01.MSS.0000150017.74892.F5
   Wimer DJ, 2013, AM J MENS HEALTH, V7, P317, DOI 10.1177/1557988312474034
   Worthley MI, 2010, AM J MED, V123, P184, DOI 10.1016/j.amjmed.2009.09.013
   Zucconi S., 2013, Gathering Consumption Data on Specific Consumer Groups of Energy Drinks, DOI [10.2903/sp.efsa.2013.EN-394, DOI 10.2903/SP.EFSA.2013.EN-394]
NR 37
TC 32
Z9 34
U1 1
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1101-1262
EI 1464-360X
J9 EUR J PUBLIC HEALTH
JI Eur. J. Public Health
PD OCT
PY 2014
VL 24
IS 5
BP 840
EP 844
DI 10.1093/eurpub/cku003
PG 5
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA AR1EQ
UT WOS:000343326900025
PM 24532566
OA Bronze
DA 2025-04-28
ER

PT J
AU Persky, AM
   Berry, NS
   Pollack, GM
   Brouwer, KLR
AF Persky, AM
   Berry, NS
   Pollack, GM
   Brouwer, KLR
TI Modelling the cardiovascular effects of ephedrine
SO BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
LA English
DT Article
DE adverse events; ephedra; safety; tolerance; weight-loss
ID WEIGHT-LOSS; MA-HUANG; PHARMACOKINETICS; TOLERANCE; CAFFEINE; RECEPTOR;
   SAFETY; PHARMACODYNAMICS; DESENSITIZATION; SUPPLEMENTS
AB Aims
   Recent reports have called into question the safety of ephedra supplements especially with regards to their cardiovascular effects. The purpose of this analysis was to characterize, via pharmacokinetic/pharmacodynamic modelling, the cardiovascular effects of ephedrine, the main active ingredient of ephedra, in apparently healthy, overweight volunteers.
   Methods
   In a randomized, double-blind, crossover, placebo-controlled study, eight subjects received either placebo, 0.25, 0.5 or 1.0 mg kg(-1) ephedrine sulphate by mouth with a 7-day washout between treatments. Plasma ephedrine concentrations, heart rate and blood pressure were determined for 8 h postdose.
   Results
   The pharmacokinetics of ephedrine were best described by a one-compartment model with first-order absorption and elimination. The percentage change in heart rate was described by a linear model with a resulting slope of 0.14%.l mug(-1) (CV = 59%). The percentage change in systolic blood pressure demonstrated clockwise hysteresis, and a sigmoidal tolerance model was used to describe the data. The mean maximum predicted effect (E-max) was 53.7% (CV = 41%) with an EC50 of 107 mug-l(-1) (CV = 65%) and an inhibitory maximum (I-max) of 39.8% (CV = 60%). Tolerance developed with a mean half-life of 15 min (range 6-140 min).
   Conclusions
   This is the first study to apply a comprehensive pharmacokinetic/pharmacodynamic model to the cardiovascular effects of orally administered ephedrine. Although systolic blood pressure increases quickly after administration, the increase is nearly abolished by compensatory mechanisms.
C1 Univ N Carolina, Div Drug Delivery & Disposit, Sch Pharm, Chapel Hill, NC 27599 USA.
C3 University of North Carolina; University of North Carolina Chapel Hill
RP Univ N Carolina, Div Drug Delivery & Disposit, Sch Pharm, Kerr Hall,CB 7360, Chapel Hill, NC 27599 USA.
EM apersky@nc.rr.com
RI Persky, Adam/E-2341-2016
OI Brouwer, Kim/0000-0003-1945-4929; Persky, Adam/0000-0001-5583-9450
FU NCRR NIH HHS [M01 RR000046, RR00046] Funding Source: Medline
CR ASTRUP A, 1993, INT J OBESITY, V17, pS41
   BAUER JA, 1994, PHARM RES-DORDR, V11, P816, DOI 10.1023/A:1018917522072
   Bent S, 2003, ANN INTERN MED, V138, P468, DOI 10.7326/0003-4819-138-6-200303180-00010
   Berlin I, 2001, EUR J CLIN PHARMACOL, V57, P447, DOI 10.1007/s002280100317
   Blanck HM, 2001, JAMA-J AM MED ASSOC, V286, P930, DOI 10.1001/jama.286.8.930
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   Bouchard R, 2002, CLIN J SPORT MED, V12, P209, DOI 10.1097/00042752-200207000-00003
   Broadley KJ, 1999, J AUTON PHARMACOL, V19, P335, DOI 10.1111/j.1365-2680.1999.tb00006.x
   CHOW MJ, 1985, CLIN PHARMACOL THER, V38, P318, DOI 10.1038/clpt.1985.179
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Curtis BM, 2002, MAYO CLIN PROC, V77, P45, DOI 10.4065/77.1.45
   Deedwania Prakash C., 1996, Cardiology Clinics, V14, P229
   Dingemanse J, 1996, J CARDIOVASC PHARM, V28, P856, DOI 10.1097/00005344-199612000-00017
   Fattinger K, 1997, J PHARMACOL EXP THER, V281, P1238
   Green GA, 2001, CLIN J SPORT MED, V11, P51, DOI 10.1097/00042752-200101000-00009
   Gurley BJ, 1998, THER DRUG MONIT, V20, P439, DOI 10.1097/00007691-199808000-00015
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Haller CA, 2002, CLIN PHARMACOL THER, V71, P421, DOI 10.1067/mcp.2002.124523
   HUTCHINSON TA, DRUGDEX SYSTEM
   Jacobs I, 2003, MED SCI SPORT EXER, V35, P987, DOI 10.1249/01.MSS.0000069916.49903.70
   January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871
   Kalman D, 2002, INT J OBESITY, V26, P1363, DOI 10.1038/sj.ijo.0802061
   Kanayama G, 2001, PSYCHOTHER PSYCHOSOM, V70, P137, DOI 10.1159/000056238
   KLEINJAN KJ, CARDIOVASCULAR EFFEC, P48
   LIU YL, 1995, INT J OBESITY, V19, P678
   Ouellet DMC, 1995, J PHARMACOKINET BIOP, V23, P531, DOI 10.1007/BF02353460
   PERSKY AM, IN PRESS INT J CLIN
   PICKUP ME, 1976, BRIT J CLIN PHARMACO, V3, P123, DOI 10.1111/j.1365-2125.1976.tb00579.x
   Samenuk D, 2002, MAYO CLIN PROC, V77, P12, DOI 10.4065/77.1.12
   Shannon JR, 1999, CLIN SCI, V96, P483, DOI 10.1042/CS19980206
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   SHI J, 1993, CLIN PHARMACOL THER, V53, P6, DOI 10.1038/clpt.1993.3
   Vansal SS, 1999, BIOCHEM PHARMACOL, V58, P807, DOI 10.1016/S0006-2952(99)00152-5
   White LM, 1997, J CLIN PHARMACOL, V37, P116, DOI 10.1002/j.1552-4604.1997.tb04769.x
   WILKINSON GR, 1968, J PHARM SCI-US, V57, P1933, DOI 10.1002/jps.2600571122
   Williams BR, 2000, MOL PHARMACOL, V58, P421, DOI 10.1124/mol.58.2.421
NR 37
TC 36
Z9 39
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0306-5251
EI 1365-2125
J9 BRIT J CLIN PHARMACO
JI Br. J. Clin. Pharmacol.
PD MAY
PY 2004
VL 57
IS 5
BP 552
EP 562
DI 10.1111/j.1365-2125.2003.02062.x
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 817HW
UT WOS:000221169600005
PM 15089807
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Akram, A
   Jamshed, A
   Anwaar, M
   Rasheed, HMF
   Haider, SI
   Aslam, N
   Jabeen, Q
AF Akram, Adnan
   Jamshed, Ayesha
   Anwaar, Mariya
   Rasheed, Hafiz Muhammad Farhan
   Haider, Syed Ihtisham
   Aslam, Naveed
   Jabeen, Qaiser
TI Evaluation of Caralluma edulis for its Potential Against Obesity,
   Atherosclerosis and Hypertension
SO DOSE-RESPONSE
LA English
DT Article
DE Caralluma edulis; high-fat diet; obesity; hyperlipidemia; hypertension;
   atherosclerosis
ID OXIDATIVE STRESS; EXTRACT; PLANT; ANTIOXIDANT; CHOLESTEROL; MANAGEMENT;
   HEALTH; RATS
AB Obesity, a chronic metabolic condition, is an increase in fat mass and blood lipid levels mainly causing atherosclerosis and hypertension, which further lead to cardiovascular complications. The objective of the study was to investigate the crude extract of Caralluma edulis (CE.Cr) for its potential against high-fat diet (HFD)-induced obesity and its related complications. Hyperlipidemia was induced in Wistar albino rats with HFD (1% cholesterol + 0.5% cholic acid) for 28 days. Treatment groups were administered with different doses of CE.Cr (100, 300 and 500 mg/Kg, p.o.) and the standard group received atorvastatin. At the end of study, sera were analyzed for biochemical markers and the aorta was dissected for microscopic examination. Antioxidant potential was evaluated and high-performance liquid chromatography (HPLC) analysis was performed. The hypotensive potential of CE.Cr was evaluated through an invasive technique. HPLC analysis of CE.Cr showed the presence of chlorogenic acid, caffeic acid, apigenin and naringenin. Histological examination of the aorta section showed anti-atherosclerotic effects which were also evident from decrease in serum total cholesterol, triglycerides and low-density lipoproteins levels. CE.Cr decreased mean arterial blood pressure and evoked significant hypotensive effects. The crude extract of C. edulis showed anti-obesity, antihypertensive, anti-atherosclerotic and antioxidant potential.
C1 [Akram, Adnan; Jamshed, Ayesha; Anwaar, Mariya; Rasheed, Hafiz Muhammad Farhan; Haider, Syed Ihtisham; Jabeen, Qaiser] Islamia Univ, Fac Pharm, Dept Pharmacol, Bahawalpur, Pakistan.
   [Akram, Adnan; Rasheed, Hafiz Muhammad Farhan; Aslam, Naveed] Govt Punjab, Dept Primary & Secondary Healthcare, Lahore, Pakistan.
   [Jamshed, Ayesha; Jabeen, Qaiser] Islamia Univ Bahawalpur, Fac Pharm, Dept Pharmacol, Bahawalpur 63100, Pakistan.
C3 Islamia University of Bahawalpur
RP Jamshed, A; Jabeen, Q (corresponding author), Islamia Univ Bahawalpur, Fac Pharm, Dept Pharmacol, Bahawalpur 63100, Pakistan.
EM ayesha13jamshad@gmail.com; qaiser.jabeen@iub.edu.pk
RI Jabeen, Qaiser/IZE-0630-2023; Anwaar, Mariya/KVY-9467-2024
OI Jabeen, Qaiser/0000-0002-6346-860X; Rasheed, Hafiz Muhammad
   Farhan/0000-0003-2516-7387
CR Adnan M, 2014, J PHARM PHARMACOL, V66, P1351, DOI 10.1111/jphp.12265
   Ahmad M, 2009, PAK J BOT, V41, P2777
   Akram A, 2022, TROP J PHARM RES, V21, P563, DOI 10.4314/tjpr.v21i3.16
   Ali H, 2011, J MED PLANTS RES, V5, P4676
   Ansari B, 2022, CURR TOP MED CHEM, V22, P1501, DOI 10.2174/1568026622666220527092825
   Ashfaq A, 2017, TROP J PHARM RES, V16, P2417, DOI 10.4314/tjpr.v16i10.15
   Aslam N, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2740-0
   Barter P, 2005, EUR HEART J SUPPL, V7, pF4, DOI 10.1093/eurheartj/sui036
   Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6
   Bubb KJ, 2022, EXPERT REV CARDIOVAS, V20, P185, DOI 10.1080/14779072.2022.2058489
   Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909
   Cai XQ, 2021, FOOD FUNCT, V12, P9922, DOI [10.1039/d1fo01966j, 10.1039/D1FO01966J]
   Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726
   Chedea VS, 2022, MOLECULES, V27, DOI 10.3390/molecules27206826
   Cheng YC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8526438
   Choi HJ, 2007, BIOCHEM BIOPH RES CO, V359, P419, DOI 10.1016/j.bbrc.2007.05.107
   Duan YJ, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01125-5
   Elahi MM, 2009, OXID MED CELL LONGEV, V2, P259, DOI 10.4161/oxim.2.5.9441
   Firdoos S, 2017, SAINS MALAYS, V46, P1859, DOI 10.17576/jsm-2017-4610-24
   Gul H, 2022, DOSE-RESPONSE, V20, DOI 10.1177/15593258221127566
   Haider SI, 2022, INFLAMMOPHARMACOLOGY, V30, P621, DOI 10.1007/s10787-022-00949-5
   Jabeen Q, 2021, BANGL J PHARMACOL, V16, P103, DOI 10.3329/bjp.v16i3.54174
   Jabeen Q, 2013, IRAN J PHARM RES, V12, P769
   Jamshed A, 2022, DOSE-RESPONSE, V20, DOI 10.1177/15593258211073087
   Jamshed A, 2021, PAK J PHARM SCI, V34, P1867, DOI 10.36721/PJPS.2021.34.5.SUP.1867-1872.1
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Khan TJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19013-2
   Kolodgie FD, 1999, APOPTOSIS, V4, P5, DOI 10.1023/A:1009645730270
   Krakoff LR, 2005, CIRCULATION, V112, pE127, DOI 10.1161/CIRCULATIONAHA.105.570192
   Lee Eunyoung, 2021, Food Nutr Res, V65, DOI 10.29219/fnr.v65.7587
   Lei SZ, 2023, FOOD CHEM, V404, DOI 10.1016/j.foodchem.2022.134599
   Leontowicz M, 2016, NUTR RES, V36, P1231, DOI 10.1016/j.nutres.2016.09.010
   Malik S, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0018-2
   Morikawa T, 2009, PHYTOCHEMISTRY, V70, P1166, DOI 10.1016/j.phytochem.2009.06.015
   NISHINA PM, 1993, J LIPID RES, V34, P1413
   Ntchapda F, 2015, ASIAN PAC J TROP MED, V8, P359, DOI 10.1016/S1995-7645(14)60344-8
   Patel AK, 2014, SCI HORTIC-AMSTERDAM, V165, P175, DOI 10.1016/j.scienta.2013.10.039
   Rasheed HMF, 2016, J ETHNOPHARMACOL, V186, P244, DOI 10.1016/j.jep.2016.03.039
   Rowicka G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5621989
   Sayantan R., 2012, NSHM J PHARM HEALTHC, V3, P76
   Shad AA, 2016, PAK J PHARM SCI, V29, P2039
   Shrivastava AK, 2021, FOOD FRONTIERS, V2, P527, DOI 10.1002/fft2.91
   Sinaga E, 2021, BIOMED PHARMACOTHER, V142, DOI 10.1016/j.biopha.2021.111996
   Surveswaran S, 2010, NAT PROD RES, V24, P206, DOI 10.1080/14786410802228827
   Vellasamy DM, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232113059
   Watanabe Y, 2022, PHARMACOLOGY, V107, P188, DOI 10.1159/000520982
   Wickramasinghe ASD, 2022, J PHARMACOL TOX MET, V113, DOI 10.1016/j.vascn.2021.107144
   Xiong C., 2019, J BIOSCI MED, V7, P120, DOI [10.4236/jbm.2019.72010, DOI 10.4236/JBM.2019.72010]
   Xu Y., 2022, CHEM BIODIVERS, V19, pe202200870
   Yaseen G, 2015, J ETHNOPHARMACOL, V174, P91, DOI 10.1016/j.jep.2015.07.041
   Yokozawa T, 2003, PHYTOMEDICINE, V10, P17, DOI 10.1078/094471103321648610
   Zobeiri M, 2018, CURR PHARM BIOTECHNO, V19, P196, DOI 10.2174/1389201019666180514170122
NR 52
TC 2
Z9 2
U1 1
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1559-3258
J9 DOSE-RESPONSE
JI Dose-Response
PD JAN
PY 2023
VL 21
IS 1
AR 15593258231152112
DI 10.1177/15593258231152112
PG 12
WC Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging;
   Toxicology
GA H8ZM9
UT WOS:000998777500001
PM 36655145
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Bondia-Pons, I
   Aura, AM
   Vuorela, S
   Kolehmainen, M
   Mykkänen, H
   Poutanen, K
AF Bondia-Pons, Isabel
   Aura, Anna-Marja
   Vuorela, Satu
   Kolehmainen, Marjukka
   Mykkanen, Hannu
   Poutanen, Kaisa
TI Rye phenolics in nutrition and health
SO JOURNAL OF CEREAL SCIENCE
LA English
DT Review
DE Rye; Health; Phenolic; Phytochemical; Antioxidant
ID WHOLE-GRAIN WHEAT; FERULIC ACID DEHYDRODIMERS; MAMMALIAN LIGNANS
   ENTEROLACTONE; VITRO ANTIOXIDANT ACTIVITY; MASS-SPECTROMETRIC METHOD;
   HUMAN FECAL MICROBIOTA; IN-VITRO; CEREAL ALKYLRESORCINOLS; CHLOROGENIC
   ACID; DIETARY-FIBER
AB Dietary intake of whole-grain foods is associated with a decreased risk of chronic diseases such as diabetes, obesity and heart disease. In addition to dietary fibre, various phytochemicals have been suggested to contribute to the health effects of whole grain products. This review focuses on phenolic compounds in rye (Secale cereale L.), which is one of the major bread grains in Europe. Data on phenolic concentrations in rye grain and foods, their bioavailability to tissues and effects in vivo, and their potential contributions to health are presented. Phenolic compounds in rye, such as phenolic acids, alkylresorcinols and lignans, are concentrated in the outer layers of the grain. Phenolic acids are the major phenolic compounds in whole grain rye (103-300 mg/100 g grain), ferulic acid being the most abundant. Rye lignans are present at concentrations of 2 mg/100 g grain and had been shown to be converted by the intestinal microflora to the mammalian lignans enterodiol and enterolactone in human intervention studies. Alkylresorcinols (36-320 mg/100 g grain), which have been found to be incorporated into human erythrocyte membranes, are of particular interest due to their potential use as biomarkers of the intake of rye and wheat. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Bondia-Pons, Isabel; Kolehmainen, Marjukka; Mykkanen, Hannu; Poutanen, Kaisa] Univ Kuopio, Dept Clin Nutr, Food & Hlth Res Ctr, FIN-70211 Kuopio, Finland.
   [Aura, Anna-Marja; Vuorela, Satu; Poutanen, Kaisa] VIT Tech Res Ctr Finland, FIN-02044 Espoo, Finland.
C3 University of Eastern Finland; VTT Technical Research Center Finland
RP Poutanen, K (corresponding author), Univ Kuopio, Dept Clin Nutr, Food & Hlth Res Ctr, POB 1627, FIN-70211 Kuopio, Finland.
EM kaisa.poutanen@vtt.fi
RI Vuorela, Satu/KBA-2504-2024; Kolehmainen, Marjukka/JFS-1563-2023
OI Vuorela, Satu/0000-0002-3757-3465; Kolehmainen,
   Marjukka/0000-0002-3770-2538; Aura, Anna-Marja/0000-0002-8926-4744
FU Fundacion Alfonso Martin Escudero; Academy of Finland [209445]; Academy
   of Finland (AKA) [209445] Funding Source: Academy of Finland (AKA)
FX Isabel Bondia-Pons is grateful to the Fundacion Alfonso Martin Escudero,
   for her postdoctoral grant and Marjukka Kolehmainen to the Academy of
   Finland for her grant 209445.
CR ADLERCREUTZ H, 1995, J STEROID BIOCHEM, V52, P97, DOI 10.1016/0960-0760(94)00146-D
   Adlercreutz H, 2007, CRIT REV CL LAB SCI, V44, P483, DOI 10.1080/10408360701612942
   Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099
   Andreasen MF, 2001, FREE RADICAL BIO MED, V31, P304, DOI 10.1016/S0891-5849(01)00585-8
   Andreasen MF, 2001, J AGR FOOD CHEM, V49, P5679, DOI 10.1021/jf010668c
   Andreasen MF, 2001, J AGR FOOD CHEM, V49, P4090, DOI 10.1021/jf0101758
   Andreasen MF, 2000, J AGR FOOD CHEM, V48, P2837, DOI 10.1021/jf991266w
   Andreasen MF, 2000, J CEREAL SCI, V31, P303, DOI 10.1006/jcrs.1999.0296
   Aura AM, 2006, EUR J NUTR, V45, P45, DOI 10.1007/s00394-005-0561-z
   Aura AM, 2005, J SCI FOOD AGR, V85, P2085, DOI 10.1002/jsfa.2229
   AXELSON M, 1981, FEBS LETT, V123, P337, DOI 10.1016/0014-5793(81)80322-5
   Barron C, 2007, J CEREAL SCI, V45, P88, DOI 10.1016/j.jcs.2006.07.004
   Basly JP, 2005, PLANTA MED, V71, P287, DOI 10.1055/s-2005-864092
   Begum AN, 2004, J NUTR, V134, P120, DOI 10.1093/jn/134.1.120
   Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191
   Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S
   BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25
   Bylund A, 2000, PROSTATE, V42, P304, DOI 10.1002/(SICI)1097-0045(20000301)42:4<304::AID-PROS8>3.0.CO;2-Z
   Cassidy A, 2000, J SCI FOOD AGR, V80, P1044, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1044::AID-JSFA586>3.3.CO;2-E
   Chen JH, 1997, J AGR FOOD CHEM, V45, P2374, DOI 10.1021/jf970055t
   Chen Y, 2004, J AGR FOOD CHEM, V52, P8242, DOI 10.1021/jf049726v
   Chesson A, 1999, J SCI FOOD AGR, V79, P373, DOI 10.1002/(SICI)1097-0010(19990301)79:3<373::AID-JSFA257>3.0.CO;2-6
   Couteau D, 2001, J APPL MICROBIOL, V90, P873, DOI 10.1046/j.1365-2672.2001.01316.x
   Cyran MR, 2007, J AGR FOOD CHEM, V55, P2329, DOI 10.1021/jf062473g
   de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261
   Deszcz L., 1997, CELL MOL BIOL LETT, V2, P213
   DEWICK PM, 2001, NAT PROD REP, V18, P334
   Frankel EN, 2000, J SCI FOOD AGR, V80, P1925, DOI 10.1002/1097-0010(200010)80:13<1925::AID-JSFA714>3.0.CO;2-4
   Gallardo C, 2006, FOOD CHEM, V99, P455, DOI 10.1016/j.foodchem.2005.07.053
   Gasiorowski K, 1996, CANCER LETT, V106, P109, DOI 10.1016/0304-3835(96)04294-2
   Gasiorowski K, 2001, CELL MOL BIOL LETT, V6, P141
   Glitso LV, 2000, BRIT J NUTR, V84, P429
   Glitso LV, 1999, J CEREAL SCI, V29, P89, DOI 10.1006/jcrs.1998.0214
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Hall C, 2006, ADV FOOD NUTR RES, V51, P1, DOI 10.1016/S1043-4526(06)51001-0
   Harder H, 2004, EUR J NUTR, V43, P230, DOI 10.1007/s00394-004-0463-5
   Heiniö RL, 2008, J CEREAL SCI, V47, P566, DOI 10.1016/j.jcs.2007.06.018
   Heiniö RL, 2003, LEBENSM-WISS TECHNOL, V36, P533, DOI 10.1016/S0023-6438(03)00057-4
   Heinonen S, 2001, J AGR FOOD CHEM, V49, P3178, DOI 10.1021/jf010038a
   HENGTRAKUL P, 1991, J NUTR BIOCHEM, V2, P20, DOI 10.1016/0955-2863(91)90044-6
   Jacobs DR, 2007, AM J CLIN NUTR, V85, P1606, DOI 10.1093/ajcn/85.6.1606
   Jacobs E, 1999, J STEROID BIOCHEM, V68, P211, DOI 10.1016/S0960-0760(99)00033-3
   Jensen MK, 2006, AM J CLIN NUTR, V83, P275
   Ji XF, 2008, PHYTOCHEMISTRY, V69, P1197, DOI 10.1016/j.phytochem.2007.12.008
   Johnsen NF, 2004, J NUTR, V134, P2691, DOI 10.1093/jn/134.10.2691
   Juntunen KS, 2000, BRIT J NUTR, V84, P839
   KANGAS L, 2002, EUROPEAN J CANC P S2, V11, pS1
   Kariluoto S, 2006, J AGR FOOD CHEM, V54, P9522, DOI 10.1021/jf061734j
   Karppinen S, 2000, J SCI FOOD AGR, V80, P1469, DOI 10.1002/1097-0010(200008)80:10<1469::AID-JSFA675>3.0.CO;2-A
   Katcher HI, 2008, AM J CLIN NUTR, V87, P79, DOI 10.1093/ajcn/87.1.79
   Katina K, 2007, J CEREAL SCI, V46, P348, DOI 10.1016/j.jcs.2007.07.006
   Katina K, 2007, FOOD MICROBIOL, V24, P175, DOI 10.1016/j.fm.2006.07.012
   Katina K, 2006, LWT-FOOD SCI TECHNOL, V39, P479, DOI 10.1016/j.lwt.2005.03.013
   Kaukovirta-Norja A, 2004, AGR FOOD SCI, V13, P100, DOI 10.2137/1239099041838049
   Kern SM, 2003, J AGR FOOD CHEM, V51, P7884, DOI 10.1021/jf030470n
   Kilkkinen A, 2003, J NUTR, V133, P1830, DOI 10.1093/jn/133.6.1830
   Kilkkinen A, 2001, AM J CLIN NUTR, V73, P1094
   Kitts DD, 1999, MOL CELL BIOCHEM, V202, P91, DOI 10.1023/A:1007022329660
   Knudsen KEB, 2003, J NUTR, V133, P1368
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P6418, DOI 10.1021/jf049560y
   KOZUBEK A, 1992, Z NATURFORSCH C, V47, P608
   Kozubek A, 1999, CHEM REV, V99, P1, DOI 10.1021/cr970464o
   KOZUBEK A, 1995, ACTA BIOCHIM POL, V42, P247
   KOZUBEK A, 1989, ACTA U WRATISL, V868, P27
   Kroon PA, 1997, J AGR FOOD CHEM, V45, P661, DOI 10.1021/jf9604403
   Kuijsten A, 2005, J NUTR, V135, P795, DOI 10.1093/jn/135.4.795
   Lampe JW, 2003, J NUTR, V133, p956S, DOI 10.1093/jn/133.3.956S
   Landberg R, 2008, AM J CLIN NUTR, V87, P832, DOI 10.1093/ajcn/87.4.832
   Landberg R, 2006, J NUTR, V136, P2760, DOI 10.1093/jn/136.11.2760
   Liggins J, 2000, ANAL BIOCHEM, V287, P102, DOI 10.1006/abio.2000.4811
   Linko AM, 2006, BRIT J NUTR, V95, P282, DOI 10.1079/BJN20051642
   Linko AM, 2005, J NUTR, V135, P580, DOI 10.1093/jn/135.3.580
   Linko AM, 2002, ANAL BIOCHEM, V308, P307, DOI 10.1016/S0003-2697(02)00226-9
   Linko-Parvinen AM, 2007, J NUTR, V137, P1137, DOI 10.1093/jn/137.5.1137
   Liukkonen KH, 2003, P NUTR SOC, V62, P117, DOI 10.1079/PNS2002218
   Lof M, 2006, NUTR RES, V26, P609, DOI 10.1016/j.nutres.2006.09.020
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Manach C, 2005, CURR OPIN LIPIDOL, V16, P77, DOI 10.1097/00041433-200502000-00013
   Mattila P, 2005, J AGR FOOD CHEM, V53, P8290, DOI 10.1021/jf051437z
   Mazur W, 1998, PURE APPL CHEM, V70, P1759, DOI 10.1351/pac199870091759
   Mazur W, 1996, ANAL BIOCHEM, V233, P169, DOI 10.1006/abio.1996.0025
   Mazur W., 2000, THESIS
   Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008
   Mellen PB, 2007, AM J CLIN NUTR, V85, P1495, DOI 10.1093/ajcn/85.6.1495
   Meyer AS, 1998, J AGR FOOD CHEM, V46, P1783, DOI 10.1021/jf9708960
   Michalska A, 2007, J AGR FOOD CHEM, V55, P734, DOI 10.1021/jf062425w
   Milder IEJ, 2005, BRIT J NUTR, V93, P393, DOI 10.1079/BJN20051371
   Milder IEJ, 2004, J AGR FOOD CHEM, V52, P4643, DOI 10.1021/jf0497556
   Milder IEJ, 2007, J NUTR, V137, P1266, DOI 10.1093/jn/137.5.1266
   Morelló JR, 2005, J AGR FOOD CHEM, V53, P2002, DOI 10.1021/jf048386a
   Natella F, 1999, J AGR FOOD CHEM, V47, P1453, DOI 10.1021/jf980737w
   Niemeyer HB, 2003, J FOOD ENG, V56, P255, DOI 10.1016/S0260-8774(02)00263-7
   Nienartowicz Barbara, 1993, Polish Journal of Food and Nutrition Sciences, V2, P51
   Nilsson M, 1997, J SCI FOOD AGR, V73, P143, DOI 10.1002/(SICI)1097-0010(199702)73:2<143::AID-JSFA698>3.0.CO;2-H
   Nyström L, 2005, J AGR FOOD CHEM, V53, P2503, DOI 10.1021/jf048051t
   NYSTROM L, 2007, OCURRENCE PROPERTIES, P1
   Nyström L, 2008, J AGR FOOD CHEM, V56, P9758, DOI 10.1021/jf801065r
   Ohta T, 1997, BIOSCI BIOTECH BIOCH, V61, P1942, DOI 10.1271/bbb.61.1942
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Ovaskainen ML, 2008, J NUTR, V138, P562
   Parikka K, 2006, J AGR FOOD CHEM, V54, P1646, DOI 10.1021/jf052486e
   Pekkarinen SS, 1999, J AGR FOOD CHEM, V47, P3036, DOI 10.1021/jf9813236
   Peñalvo JL, 2005, J AGR FOOD CHEM, V53, P9342, DOI 10.1021/jf051488w
   Plumb GW, 1999, J SCI FOOD AGR, V79, P390, DOI 10.1002/(SICI)1097-0010(19990301)79:3<390::AID-JSFA258>3.0.CO;2-0
   Rejman J, 2004, J AGR FOOD CHEM, V52, P246, DOI 10.1021/jf034745a
   REJMAN J, 1997, CELL MOL BIOL LETT, V2, P411
   Rickard SE, 1996, J NUTR, V126, P2012
   Roberts MS, 2002, CLIN PHARMACOKINET, V41, P751, DOI 10.2165/00003088-200241100-00005
   Rondini L, 2004, J AGR FOOD CHEM, V52, P4338, DOI 10.1021/jf0348323
   Rondini L, 2002, J AGR FOOD CHEM, V50, P3037, DOI 10.1021/jf011295i
   Ross AB, 2005, BRIT J NUTR, V94, P496, DOI 10.1079/BJN20051511
   Ross AB, 2004, NUTR REV, V62, P81, DOI 10.1301/nr.2004.mar.81-95
   Ross AB, 2004, J CHROMATOGR B, V809, P125, DOI 10.1016/j.jchromb.2004.06.015
   Ross AB, 2004, J NUTR, V134, P506, DOI 10.1093/jn/134.3.506
   Ross AB, 2003, BRIT J NUTR, V90, P787, DOI 10.1079/BJN2003965
   Ross AB, 2003, J NUTR, V133, P2222, DOI 10.1093/jn/133.7.2222
   Ross AB, 2003, J AGR FOOD CHEM, V51, P4111, DOI 10.1021/jf0340456
   Ross AB, 2001, J SCI FOOD AGR, V81, P1405, DOI 10.1002/jsfa.956
   Rowland I, 2003, BRIT J NUTR, V89, pS45, DOI 10.1079/BJN2002796
   RYBKA K, 1993, CEREAL CHEM, V70, P55
   Saarinen NM, 2000, NUTR CANCER, V36, P207, DOI 10.1207/S15327914NC3602_10
   Saarinen NM, 2002, J CHROMATOGR B, V777, P311, DOI 10.1016/S1570-0232(02)00339-2
   Salmenkallio-Marttila M, 2001, CEREAL CHEM, V78, P429, DOI 10.1094/CCHEM.2001.78.4.429
   Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6
   SEITZ LM, 1992, J AGR FOOD CHEM, V40, P1541, DOI 10.1021/jf00021a014
   SETCHELL KDR, 1981, LANCET, V2, P4
   Singh M, 2008, J AGR FOOD CHEM, V56, P4855, DOI 10.1021/jf0735073
   Slavin J, 2003, P NUTR SOC, V62, P129, DOI 10.1079/PNS2002221
   Smeds AI, 2007, J AGR FOOD CHEM, V55, P1337, DOI 10.1021/jf0629134
   Stasiuk M, 2008, FOOD CHEM, V108, P996, DOI 10.1016/j.foodchem.2007.12.011
   TLUSCIK F, 1990, Acta Alimentaria Polonica, V16, P119
   Touillaud MS, 2007, JNCI-J NATL CANCER I, V99, P475, DOI 10.1093/jnci/djk096
   Vanharanta M, 1999, LANCET, V354, P2112, DOI 10.1016/S0140-6736(99)05031-X
   Vuorela S, 2005, J AGR FOOD CHEM, V53, P5922, DOI 10.1021/jf050554r
   Vuorela S, 2004, J AGR FOOD CHEM, V52, P8202, DOI 10.1021/jf0487046
   Wang LQ, 2000, CHEM PHARM BULL, V48, P1606, DOI 10.1248/cpb.48.1606
   Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381
   Zhao ZH, 2004, J NUTR, V134, P3083, DOI 10.1093/jn/134.11.3083
   Zielinski H, 2007, FOOD CHEM, V104, P980, DOI 10.1016/j.foodchem.2007.01.002
NR 140
TC 112
Z9 117
U1 2
U2 82
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0733-5210
EI 1095-9963
J9 J CEREAL SCI
JI J. Cereal Sci.
PD MAY
PY 2009
VL 49
IS 3
BP 323
EP 336
DI 10.1016/j.jcs.2009.01.007
PG 14
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 458DW
UT WOS:000266995600001
DA 2025-04-28
ER

PT J
AU Hervert-Hernández, D
   Goñi, I
AF Hervert-Hernandez, Deisy
   Goni, Isabel
TI Contribution of beverages to the intake of polyphenols and antioxidant
   capacity in obese women from rural Mexico
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Polyphenols; Antioxidant activity; Obesity; Beverages; Mexican diet
ID SUGAR-SWEETENED BEVERAGES; CONSUMPTION; ADOLESCENTS; NUTRITION; RISK
AB Objective: The aims of the present work were to study beverage consumption among obese women from rural communities in Mexico and to estimate daily polyphenol intake and dietary antioxidant capacity from beverages.
   Design: A cross-sectional study was used to analyse the beverage intake of 139 premenopausal obese women estimated through repeated 24 h food recalls. Total polyphenol content and antioxidant capacity were determined in eighteen beverages, representing 71% of total beverage consumption, in order to estimate the intake of polyphenols (mg/person per cl) and the dietary antioxidant capacity (mu mol Trolox equivalents/person per d) from beverages.
   Setting: Five rural communities located in Queretaro State, Mexico, in 2008.
   Subjects: A total of 139 premenopausal women identified as obese (BMI 35.0 (SE 0.4) kg/m(2)), aged 25-45 years.
   Results: The contribution of beverages to dietary energy was 1369 kJ/d (18% of total energy intake). Soft drinks were consumed the most (283 (SE 17) ml/d), followed by coffee and fresh fruit beverages. Polyphenol intake and dietary antioxidant capacity from beverages was 180.9 (SE 12.5) mg/person per d and >1000 mu mol Trolox equivalents/person per cl, respectively. The items that contributed most to this intake were coffee, roselle chink, peach and guava juices and infusions.
   Conclusions: There is an urgent need to reduce the consumption of sugar-sweetened beverages among obese women from rural Mexico. Low-sugar beverages rich in polyphenols and antioxidants may be healthier options to replace sweetened drinks and increase the intake of bioactive compounds. Nutritional advice on this topic could be a viable strategy to tackle obesity in rural areas in Mexico.
C1 [Hervert-Hernandez, Deisy; Goni, Isabel] Univ Complutense Madrid, Fac Pharm, Dept Nutr & Bromatol 1, Nutr & Gastrointestinal Hlth Unit, E-28040 Madrid, Spain.
C3 Complutense University of Madrid
RP Goñi, I (corresponding author), Univ Complutense Madrid, Fac Pharm, Dept Nutr & Bromatol 1, Nutr & Gastrointestinal Hlth Unit, E-28040 Madrid, Spain.
EM igonic@farm.ucm.es
RI Goni, Isabel/F-1361-2016
OI Goni, Isabel/0000-0003-4184-3971
FU Spanish Ministry of Science and Innovation [AGL-2008-01633]; Mexican
   institutions, National Council on Science and Technology and Secretariat
   of Public Education; National Program of I + D
FX The study was supported by the Spanish Ministry of Science and
   Innovation, National Program of I + D, AGL-2008-01633. D.H.-H. received
   predoctoral fellowships from the Mexican institutions, National Council
   on Science and Technology and Secretariat of Public Education.
CR Almajano MP, 2008, FOOD CHEM, V108, P55, DOI 10.1016/j.foodchem.2007.10.040
   Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163
   Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701
   Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368
   Chen LW, 2010, CIRCULATION, V121, P2398, DOI 10.1161/CIRCULATIONAHA.109.911164
   Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240
   Dennis EA, 2009, EAT BEHAV, V10, P237, DOI 10.1016/j.eatbeh.2009.07.006
   Denova-Gutiérrez E, 2010, PUBLIC HEALTH NUTR, V13, P835, DOI 10.1017/S1368980009991145
   Dolara P, 2005, MUTAT RES-FUND MOL M, V591, P237, DOI 10.1016/j.mrfmmm.2005.04.022
   Ferk F, 2010, MUTAT RES-FUND MOL M, V691, P17, DOI 10.1016/j.mrfmmm.2010.06.006
   Ferruzzi MG, 2010, PHYSIOL BEHAV, V100, P33, DOI 10.1016/j.physbeh.2010.01.035
   Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662
   Hervert-Hernández D, 2011, FOOD RES INT, V44, P1182, DOI 10.1016/j.foodres.2010.09.021
   Hofmann SM, 2009, J CLIN INVEST, V119, P1089, DOI 10.1172/JCI39332
   Ibarra-Alvarado C, 2010, PHARM BIOL, V48, P732, DOI 10.3109/13880200903271280
   Jimenez-Aguilar A, 2009, SALUD PUBLICA MEX S4, V51, pS604
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Montreau F., 1972, CONNAIS VIGNE VIN, V24, P397, DOI DOI 10.20870/OENO-ONE.1972.6.4.2071
   Neufeld LM, 2008, OBESITY, V16, P714, DOI 10.1038/oby.2007.119
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Pérez-Jiménez J, 2008, FOOD RES INT, V41, P274, DOI 10.1016/j.foodres.2007.12.004
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Rivera JA, 2004, NUTR REV, V62, pS149, DOI 10.1111/j.1753-4887.2004.tb00086.x
   Rivera JA, 2008, SALUD PUBLICA MEXICO, V50, P173, DOI 10.1590/S0036-36342008000200011
   Saura-Calixto F, 2006, FOOD CHEM, V94, P442, DOI 10.1016/j.foodchem.2004.11.033
   Saura-Calixto F, 2007, FOOD CHEM, V101, P492, DOI 10.1016/j.foodchem.2006.02.006
   Sayago-Ayerdi SG, 2007, J AGR FOOD CHEM, V55, P7886, DOI 10.1021/jf070485b
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Woodward-Lopez G, 2010, PUBLIC HLTH NUTR
NR 29
TC 14
Z9 15
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JAN
PY 2012
VL 15
IS 1
BP 6
EP 12
DI 10.1017/S1368980011001753
PG 7
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 882WK
UT WOS:000299594400003
PM 21806865
OA Bronze
DA 2025-04-28
ER

PT J
AU Laque, A
   Wagner, GE
   Matzeu, A
   De Ness, GL
   Kerr, TM
   Carroll, AM
   De Guglielmo, G
   Nedelescu, H
   Buczynski, MW
   Gregus, AM
   Jhou, TC
   Zorrilla, EP
   Martin-Fardon, R
   Koya, E
   Ritter, RC
   Weiss, F
   Suto, N
AF Laque, Amanda
   Wagner, Grant E.
   Matzeu, Alessandra
   De Ness, Genna L.
   Kerr, Tony M.
   Carroll, Ayla M.
   de Guglielmo, Giordano
   Nedelescu, Hermina
   Buczynski, Matthew W.
   Gregus, Ann M.
   Jhou, Thomas C.
   Zorrilla, Eric P.
   Martin-Fardon, Remi
   Koya, Eisuke
   Ritter, Robert C.
   Weiss, Friedbert
   Suto, Nobuyoshi
TI Linking drug and food addiction via compulsive appetite
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE eating disorders; food addiction; substance use disorders
ID HELPS INFORM; HIGH-FAT; COCAINE; BEHAVIOR; SEEKING; RATS; SENSITIZATION;
   NEUROBIOLOGY; WITHDRAWAL; DISEASE
AB Background and Purpose 'Food addiction' is the subject of intense public and research interest. However, this nosology based on neurobehavioural similarities among obese individuals, patients with eating disorders and those with substance use disorders (drug addiction) remains controversial. We thus sought to determine which aspects of disordered eating are causally linked to preclinical models of drug addiction. We hypothesized that extensive drug histories, known to cause addiction-like brain changes and drug motivation in rats, would also cause addiction-like food motivation. Experimental Approach Rats underwent extensive cocaine, alcohol, caffeine or obesogenic diet histories and were subsequently tested for punishment-resistant food self-administration or 'compulsive appetite', as a measure of addiction-like food motivation. Key Results Extensive cocaine and alcohol (but not caffeine) histories caused compulsive appetite that persisted long after the last drug exposure. Extensive obesogenic diet histories also caused compulsive appetite, although neither cocaine nor alcohol histories caused excess calorie intake and bodyweight during abstinence. Hence, compulsive appetite and obesity appear to be dissociable, with the former sharing common mechanisms with preclinical drug addiction models. Conclusion and Implications Compulsive appetite, as seen in subsets of obese individuals and patients with binge-eating disorder and bulimia nervosa (eating disorders that do not necessarily result in obesity), appears to epitomize 'food addiction'. Because different drug and obesogenic diet histories caused compulsive appetite, overlapping dysregulations in the reward circuits, which control drug and food motivation independently of energy homeostasis, may offer common therapeutic targets for treating addictive behaviours across drug addiction, eating disorders and obesity.
C1 [Laque, Amanda; Wagner, Grant E.; De Ness, Genna L.; Kerr, Tony M.; Carroll, Ayla M.; de Guglielmo, Giordano; Nedelescu, Hermina; Buczynski, Matthew W.; Weiss, Friedbert; Suto, Nobuyoshi] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA.
   [Matzeu, Alessandra; Zorrilla, Eric P.; Martin-Fardon, Remi] Scripps Res Inst, Dept Mol Med, La Jolla, CA USA.
   [Kerr, Tony M.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.
   [de Guglielmo, Giordano] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   [Buczynski, Matthew W.; Gregus, Ann M.] Virginia Polytech Inst & State Univ, Sch Neurosci, Blacksburg, VA 24061 USA.
   [Jhou, Thomas C.] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA.
   [Koya, Eisuke] Univ Sussex, Sch Psychol, Sussex Neurosci, Falmer, England.
   [Ritter, Robert C.] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA.
C3 Scripps Research Institute; Scripps Research Institute; University of
   Texas System; University of Texas Austin; University of California
   System; University of California San Diego; Virginia Polytechnic
   Institute & State University; Medical University of South Carolina;
   University of Sussex; Washington State University
RP Weiss, F; Suto, N (corresponding author), Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA.
EM bweiss@scripps.edu; nsuto@scripps.edu
RI Martin-Fardon, R/ABB-7865-2020; de Guglielmo, Giordano/IWD-6906-2023;
   Jhou, Thomas/JJC-7763-2023; de Guglielmo, Giordano/AAX-6289-2021
OI Nedelescu, Hermina/0000-0003-1300-672X; Martin-Fardon,
   Remi/0000-0002-7470-5885; Gregus, Ann/0000-0001-6851-1382; Kerr,
   Tony/0000-0002-8962-6215; Carroll, Ayla/0000-0001-8068-9693; de
   Guglielmo, Giordano/0000-0002-4782-7430; Koya,
   Eisuke/0000-0002-5039-4875; Matzeu, Alessandra/0000-0002-7654-4149
FU National Institute on Drug Abuse [K99/R00DA035865, R01DA037294,
   R01DA08467]; National Institute on Alcohol Abuse and Alcoholism
   [R01AA021549, R01AA023183, T32AA007456]; National Institute of Mental
   Health [R21MH124036] Funding Source: NIH RePORTER; National Institute on
   Drug Abuse [R21DA046865] Funding Source: NIH RePORTER
FX National Institute on Drug Abuse, Grant/Award Numbers: K99/R00DA035865,
   R01DA037294, R01DA08467; National Institute on Alcohol Abuse and
   Alcoholism, Grant/Award Numbers: R01AA021549, R01AA023183, T32AA007456
CR Ahmed SH, 2012, NEUROSCIENCE, V211, P107, DOI 10.1016/j.neuroscience.2011.08.014
   Alaux-Cantin S, 2021, ADDICT BIOL, V26, DOI 10.1111/adb.13023
   Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS1, DOI 10.1111/bph.14747
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V280
   Avena Nicole M, 2011, Curr Drug Abuse Rev, V4, P133
   Berthoud HR, 2006, OBESITY, V14, P197
   Billing L, 2015, AM J DRUG ALCOHOL AB, V41, P115, DOI 10.3109/00952990.2014.966196
   Boswell RG, 2021, CLIN THER, V43, P50, DOI 10.1016/j.clinthera.2020.10.014
   Chao AM, 2016, EAT BEHAV, V21, P41, DOI 10.1016/j.eatbeh.2015.12.007
   Clemens KJ, 2018, PROG NEURO-PSYCHOPH, V87, P48, DOI 10.1016/j.pnpbp.2017.11.011
   Cowan J, 2008, APPETITE, V50, P33, DOI 10.1016/j.appet.2007.05.006
   Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153
   de Araujo IE, 2020, ANNU REV PSYCHOL, V71, P139, DOI 10.1146/annurev-psych-122216-011643
   Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020
   Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104
   du Sert NP, 2020, BRIT J PHARMACOL, V177, P3617, DOI [10.1111/bph.15193, 10.1136/bmjos-2020-100115]
   Edwards S, 2012, NEUROPHARMACOLOGY, V62, P1142, DOI 10.1016/j.neuropharm.2011.11.006
   Ersche KD, 2013, APPETITE, V71, P75, DOI 10.1016/j.appet.2013.07.011
   Everitt BJ, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0027
   Fletcher PC, 2018, NEUROPSYCHOPHARMACOL, V43, P2506, DOI 10.1038/s41386-018-0203-9
   Gearhardt AN, 2021, AM J CLIN NUTR, V113, P263, DOI 10.1093/ajcn/nqaa343
   Gearhardt AN, 2021, AM J CLIN NUTR, V113, P274, DOI 10.1093/ajcn/nqaa345
   Gearhardt AN, 2016, PSYCHOL ADDICT BEHAV, V30, P113, DOI 10.1037/adb0000136
   Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P201
   Heckman MA, 2010, J FOOD SCI, V75, pR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x
   Hodgkins Candace, 2007, J Addict Dis, V26 Suppl 1, P41, DOI 10.1300/J069v26S01_05
   Holtrup B, 2017, ADIPOCYTE, V6, P224, DOI 10.1080/21623945.2017.1349042
   HORSAGER C, 2021, EAT WEIGHT DISORD-ST
   Jean-Richard-Dit-Bressel P, 2021, ELIFE, V10, DOI 10.7554/eLife.69594
   Jean-Richard-dit-Bressel P, 2019, ELIFE, V8, DOI 10.7554/eLife.52765
   Jiménez-Murcia S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112633
   Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519
   Kirpich IA, 2011, J NUTR BIOCHEM, V22, P38, DOI 10.1016/j.jnutbio.2009.11.009
   Klein ED, 2007, LEARN MOTIV, V38, P44, DOI 10.1016/j.lmot.2006.07.004
   Laque A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11799-1
   LeSage MG, 2006, PHARMACOL BIOCHEM BE, V83, P585, DOI 10.1016/j.pbb.2006.03.021
   Li YY, 2017, PSYCHOPHARMACOLOGY, V234, P1277, DOI 10.1007/s00213-017-4565-1
   Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x
   Lilley E, 2020, BRIT J PHARMACOL, V177, P3611, DOI 10.1111/bph.15178
   Lucantonio F, 2014, NAT NEUROSCI, V17, P1092, DOI 10.1038/nn.3763
   McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40
   Minhas M, 2021, ADDICTION, V116, P2870, DOI 10.1111/add.15446
   Munn-Chernoff MA, 2021, ADDICT BIOL, V26, DOI 10.1111/adb.12880
   Pelloux Y, 2007, PSYCHOPHARMACOLOGY, V194, P127, DOI 10.1007/s00213-007-0805-0
   Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0
   Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093
   Rossetti C, 2014, ADDICT BIOL, V19, P975, DOI 10.1111/adb.12065
   Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216
   Schoenbaum G, 2004, EUR J NEUROSCI, V19, P1997, DOI 10.1111/j.1460-9568.2004.03274.x
   Serafine KM, 2021, NEUROPHARMACOLOGY, V196, DOI 10.1016/j.neuropharm.2021.108556
   Serrano A, 2018, NEUROPSYCHOPHARMACOL, V43, P1840, DOI 10.1038/s41386-018-0055-3
   Shoaib M, 1999, PSYCHOPHARMACOLOGY, V142, P327, DOI 10.1007/s002130050896
   Singer BF, 2018, J NEUROSCI, V38, P60, DOI 10.1523/JNEUROSCI.2458-17.2017
   Small DM, 2019, SCIENCE, V363, P346, DOI 10.1126/science.aav0556
   Spierling S, 2020, NEUROPSYCHOPHARMACOL, V45, P579, DOI 10.1038/s41386-019-0538-x
   Udo T, 2018, BIOL PSYCHIAT, V84, P345, DOI 10.1016/j.biopsych.2018.03.014
   Uriarte G, 2013, J PHYSIOL BIOCHEM, V69, P601, DOI 10.1007/s13105-012-0231-6
   Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975
   Vanderschuren LJMJ, 2021, CSH PERSPECT MED, V11, DOI 10.1101/cshperspect.a040287
   Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452
   Volkow ND, 2016, NEW ENGL J MED, V374, P363, DOI 10.1056/NEJMra1511480
   Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
   Wiss DA, 2017, APPETITE, V115, P19, DOI 10.1016/j.appet.2016.12.019
NR 64
TC 4
Z9 5
U1 7
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD JUN
PY 2022
VL 179
IS 11
BP 2589
EP 2609
DI 10.1111/bph.15797
EA MAR 2022
PG 21
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Pharmacology & Pharmacy
GA 0Z1ED
UT WOS:000765273500001
PM 35023154
OA Green Accepted, Green Submitted, Bronze
DA 2025-04-28
ER

PT J
AU Finlay, A
   Boyland, E
   Jones, A
   Witkam, R
   Robinson, E
AF Finlay, Amy
   Boyland, Emma
   Jones, Andrew
   Witkam, Rozemarijn
   Robinson, Eric
TI The impact of calorie labelling and proportional pricing on out of home
   food orders: a randomised controlled trial study using a virtual food
   and drink delivery app
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE Calorie labelling; Proportional pricing; Food ordering; Out-of-home
   food; Food delivery apps
ID CONSUMPTION; CHOICE
AB BackgroundMandatory calorie labelling in the out-of-home food sector was introduced in England in 2022, and menu pricing strategies that ensure cost is equivalent to portion size (proportional pricing) have been proposed as a policy to reduce obesity. Food delivery app-based platforms now contribute significantly to diet, and evidence suggests that those at a socioeconomic disadvantage may have greater exposure to unhealthy options on these platforms. However, public health policies to improve nutritional quality of food ordered from food delivery apps has received limited examination.ObjectiveThis experimental study assessed the impact of calorie labelling and proportional pricing on item and meal size selection, calories ordered, and money spent when selecting food and drinks from three outlet types on a virtual delivery app.MethodsUK adult participants (N = 1126, 49% female), stratified by gender and education level completed an online study where they ordered items from three branded food and beverage outlets (coffee shop, sandwich outlet, fast food outlet) using a virtual delivery app. Participants were presented food and beverage options with vs. without calorie labels and with value (larger portions are proportionally cheaper) vs. proportional pricing.ResultsCalorie labelling did not influence portion size selection for any outlets, but significantly reduced calories ordered from the coffee shop (-18.95kcals, 95% CI -33.07 to -4.84) and fast food outlet (-54.19kcals, 95% CI -86.04 to -22.33). Proportional pricing reduced the likelihood of choosing a larger beverage from the coffee shop (OR = 0.58, 95% CI 0.45 to 0.75), but was associated with increased calories ordered from the fast food outlet (51.25kcals, 95% CI 19.59 to 82.90). No consistent interactions were observed with participant characteristics, suggesting that effects of calorie labelling and pricing on outcomes were similar across sociodemographic groups.ConclusionsCalorie labelling on food delivery platforms may effectively reduce calories ordered. Proportional pricing may be useful in prompting consumers to select smaller portion sizes, although further research in real-world settings will now be valuable.
C1 [Finlay, Amy; Boyland, Emma; Witkam, Rozemarijn; Robinson, Eric] Univ Liverpool, Dept Psychol, Liverpool L69 7ZA, England.
   [Jones, Andrew] Liverpool John Moores Univ, Dept Psychol, Liverpool L3 3AF, England.
C3 University of Liverpool; University of Liverpool; Liverpool John Moores
   University
RP Finlay, A (corresponding author), Univ Liverpool, Dept Psychol, Liverpool L69 7ZA, England.
EM afinlay@liverpool.ac.uk
RI Jones, Andy/ABB-9742-2021; Finlay, Amy/ISV-0073-2023
OI Boyland, Emma/0000-0001-8384-4994; Robinson, Eric/0000-0003-3586-5533;
   Finlay, Amy/0000-0002-7509-4772
FU ESRC [ES/P000665/1, 803194]; European Research Council (ERC) under the
   European Union [ES/W007932/1]; National Institute for Health and Care
   Research (NIHR) Oxford Health Biomedical Research Centre (BRC); ESRC
   [ES/W007932/1] Funding Source: UKRI
FX The first author (AF) is funded by an ESRC case studentship, grant no:
   ES/P000665/1, with a contribution from the Obesity Health Alliance. ER
   is funded by the European Research Council (ERC) under the European
   Union's Horizon 2020 research and innovation programme (Grant reference:
   PIDS, 803194) and the National Institute for Health and Care Research
   (NIHR) Oxford Health Biomedical Research Centre (BRC). The views
   expressed are those of the author(s) and not necessarily those of the
   NIHR or the Department of Health and Social Care. The research is also
   supported by ESRC grant ES/W007932/1.
CR Abdul G, 2022, The GuardianApril 6
   [Anonymous], 2017, Strategies for encouraging healthier 'Out of Home'Food Provision: a toolkit for local councils working with small food businesses
   Aquino Jdescr, 2021, Descriptive Statistics: R package version 1.1.5
   Arrazat L, 2023, INT J BEHAV NUTR PHY, V20, DOI 10.1186/s12966-023-01410-8
   Blair Graeme, 2024, CRAN, DOI 10.32614/CRAN.package.estimatr
   Bleich SN, 2017, OBESITY, V25, P2018, DOI 10.1002/oby.21940
   Coppola D., 2023, Number of downloads of leading food delivery and takeout apps in the United Kingdom (UK) in 2022
   Curry D, Uber Eats revenue and usage statistics2021
   Curry D., 2021, Food Delivery App Revenue and Usage Statistics 2021
   Department of Health and Social Care, 2021, CAL LAB OUT HOM SECT
   Department of Health and Social Care, 2022, NEW CAL LAB RUL COM
   Dobson PW, 2017, J BUS RES, V75, P185, DOI 10.1016/j.jbusres.2016.07.017
   Dumanovsky T, 2011, BMJ, V343
   Feng WH, 2018, APPETITE, V128, P223, DOI 10.1016/j.appet.2018.06.015
   Finlay A, 2022, Value vs proportional pricing OSF
   Gardner B, 2015, HEALTH PSYCHOL REV, V9, P277, DOI 10.1080/17437199.2013.876238
   Gill T, 2022, APPETITE, V169, DOI 10.1016/j.appet.2021.105830
   Goffe L, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0589-5
   Gollust SE, 2018, PUBLIC HEALTH NUTR, V21, P2518, DOI 10.1017/S1368980018001143
   Gollust SE, 2014, PREV MED, V63, P52, DOI 10.1016/j.ypmed.2014.03.002
   Haws KL, 2020, J CONSUM PSYCHOL, V30, P392, DOI 10.1002/jcpy.1129
   Haws KL, 2013, J MARKETING, V77, P48, DOI 10.1509/jm.11.0261
   Jansen L, 2021, INT J BEHAV NUTR PHY, V18, DOI 10.1186/s12966-021-01222-8
   Jaworowska A, 2014, Nutritional composition of takeaway food in the UK
   Keeble M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145190
   Kunst A, 2019, Methods of using food delivery services in the United Kingdom (UK) 2017, by age
   Lillico HG, 2015, PUBLIC HEALTH, V129, P732, DOI 10.1016/j.puhe.2015.03.005
   Ludecke D., 2021, J OPEN SOURCE SOFTW, V6, P3139, DOI [DOI 10.21105/JOSS.03139, 10.21105/joss.03139]
   Muc M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029679
   Nguyen BT, 2014, PUBLIC HEALTH NUTR, V17, P2445, DOI 10.1017/S1368980014001153
   Obesity Health Alliance, 2021, TURN TID 10 YEAR HLT
   Office for National Statistics, 2021, Education and training statistics for the UK UK
   Office for National Statistics, Equivalised income. Compendium: Family Spending in the UK
   Operario D, 2004, PSYCHOL HEALTH, V19, P237, DOI 10.1080/08870440310001638098
   Polden M, 2022, Assessing public perception and awareness of UK mandatory calorie labelling in the out-of-home sector. using Twitter and Google trends data
   Prolific, 2022, Conduct your best research
   Raats M. M., 1992, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D
   Reynolds P, 2019, SOC SCI MED, V236, DOI 10.1016/j.socscimed.2019.112395
   Robinson E, 2023, APPETITE, V182, DOI 10.1016/j.appet.2023.106451
   Robinson E, 2022, INT J BEHAV NUTR PHY, V19, DOI 10.1186/s12966-022-01287-z
   Robinson E, 2021, OBES REV, V22, DOI 10.1111/obr.13198
   Robinson E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n40
   Robinson E, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4982
   STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061
   van't Riet J, 2011, APPETITE, V57, P585, DOI 10.1016/j.appet.2011.07.010
   Vercammen KA, 2020, PUBLIC HEALTH NUTR, V23, P348, DOI 10.1017/S1368980019003410
   Vermeer WM, 2010, EUR J PUBLIC HEALTH, V20, P65, DOI 10.1093/eurpub/ckp092
   Waterlander WE, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3774
NR 48
TC 4
Z9 4
U1 4
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5868
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD SEP 19
PY 2023
VL 20
IS 1
AR 112
DI 10.1186/s12966-023-01513-2
PG 15
WC Nutrition & Dietetics; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Physiology
GA S6BF1
UT WOS:001071989300001
PM 37726788
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Browning, HF
   Laxer, RE
   Janssen, I
AF Browning, H. Frances
   Laxer, Rachel E.
   Janssen, Ian
TI Food and Eating Environments In Canadian Schools
SO CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH
LA English
DT Article
AB Purpose: This national study was conducted to examine healthy eating programs, healthy eating education, and the food retail environments of schools.
   Methods: A total of 436 Canadian schools were studied. Administrators completed a questionnaire designed to assess school healthy eating programs, healthy eating education, and food retail environment. The number of chain fast food restaurants, chain cafes/coffee shops, and convenience stores within 1 km of schools was measured using geographic information systems food retailer measures from DMTI Spatial Inc. and the Yellow Pages.
   Results: During the preceding year, 67% of schools had initiated healthy eating lunch programs while 18% had junk food-free days. The majority of schools offered cooking classes (59%) and healthy eating media literacy education (67%), while a minority offered gardening activities (15%) and field trips to farmers' markets (27%) and grocery stores (36%). Fifty-three percent had a school cafeteria, and most had a school tuck shop (75%) and pop/juice vending machines (76%). Fifty percent had a chain fast food restaurant, 33% had a chain cafe/coffee shop, and 41% had a convenience store within 1 km.
   Conclusions: An important aspect of addressing childhood obesity will be improving the food environments of schools and their surrounding neighbourhoods, and providing healthy eating education for all students.
C1 [Browning, H. Frances; Laxer, Rachel E.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.
   [Janssen, Ian] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada.
C3 Queens University - Canada; Queens University - Canada
RP Browning, HF (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.
RI ; Janssen, Ian/B-7700-2009
OI Laxer, Rachel/0000-0002-9043-5264; Janssen, Ian/0000-0003-2159-3012
FU Canadian Institutes of Health Research [MOP 9762, PCR 101415]; Heart and
   Stroke Foundation of Canada; Public Health Agency of Canada and Health
   Canada; Canada Research Chair position
FX This study was supported by research grants from the Canadian Institutes
   of Health Research (operating grants MOP 9762 and PCR 101415) and the
   Heart and Stroke Foundation of Canada. The Health Behaviour in
   School-aged Children Survey (HBSC), a World Health Organization European
   Region collaborative study, was funded in Canada by the Public Health
   Agency of Canada and Health Canada. The international coordinator of the
   HBSC is Candace Currie (University of Edinburgh). The principal
   investigators of the 2009/2010 Canadian HBSC are John Freeman and
   William Pickett. Ian Janssen was supported by a Canada Research Chair
   position.
CR BC Healthy Living Alliance, 2007, BC HLTH LIV ALL HLTH
   Bergen D, 2006, J AM DIET ASSOC, V106, P1866, DOI 10.1016/j.jada.2006.08.002
   Buscher LA, 2001, J AM DIET ASSOC, V101, P909, DOI 10.1016/S0002-8223(01)00223-1
   Campbell D, 2010, TAKEWAY BAN NEAR SCH
   Cummins S, 2007, INT J EPIDEMIOL, V36, P355, DOI 10.1093/ije/dym033
   De Niet JE, 2011, MINERVA PEDIATR, V63, P491
   Finkelstein DM, 2008, PEDIATRICS, V122, pE251, DOI 10.1542/peds.2007-2814
   Garriguet D., 2004, OVERVIEW CANADIANS E
   Héroux M, 2012, HEALTH PLACE, V18, P1240, DOI 10.1016/j.healthplace.2012.09.004
   Institute of Medicine, 2005, PREVENTING CHILDHOOD
   Kubik MY, 2005, ARCH PEDIAT ADOL MED, V159, P1111, DOI 10.1001/archpedi.159.12.1111
   Ledrou Ingird, 2005, Health Rep, V16, P47
   Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852
   Neumark-Sztainer Dianne, 2005, Int J Behav Nutr Phys Act, V2, P14, DOI 10.1186/1479-5868-2-14
   Public Health Agency of Canada, 2011, ACT TAK FUT DIR 2011
   Public Health Agency of Canada, 2011, CURB CHILDH OB FED P
   Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813
   Seliske L, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-19
   Seliske L, 2012, INT J ENV RES PUB HE, V9, P2715, DOI 10.3390/ijerph9082715
   Seliske LM, 2009, HEALTH PLACE, V15, P903, DOI 10.1016/j.healthplace.2008.11.001
   Simon PA, 2008, PREV MED, V47, P284, DOI 10.1016/j.ypmed.2008.02.021
   Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x
   Tremblay Mark S, 2010, Health Rep, V21, P7
   Vanasse A, 2006, INT J OBESITY, V30, P677, DOI 10.1038/sj.ijo.0803168
NR 24
TC 21
Z9 25
U1 1
U2 20
PU DIETITIANS CANADA
PI TORONTO
PA 480 UNIV AVE, SUITE 604, TORONTO, ONTARIO M5G 1V2, CANADA
SN 1486-3847
EI 2292-9592
J9 CAN J DIET PRACT RES
JI Can. J. Diet. Pract. Res.
PD DEC
PY 2013
VL 74
IS 4
BP 160
EP 166
DI 10.3148/74.4.2013.160
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA V36RB
UT WOS:000209227400003
PM 24472163
DA 2025-04-28
ER

PT J
AU Grandner, MA
   Knutson, KL
   Troxel, W
   Hale, L
   Jean-Louis, G
   Miller, KE
AF Grandner, Michael A.
   Knutson, Kristen L.
   Troxel, Wendy
   Hale, Lauren
   Jean-Louis, Girardin
   Miller, Kathleen E.
TI Implications of sleep and energy drink use for health disparities
SO NUTRITION REVIEWS
LA English
DT Review
DE caffeine; energy drinks; health disparities; sleep; sugar-sweetened
   beverages
ID PROTECTIVE BEHAVIORAL STRATEGIES; ALCOHOL-RELATED CONSEQUENCES;
   COLLEGE-STUDENTS; SOCIOECONOMIC-STATUS; DRUG-USE; OBESITY EPIDEMIC;
   BLOOD-PRESSURE; CHRONIC STRESS; UNITED-STATES; RISK-TAKING
AB The popularity of energy drinks has increased rapidly in the past decade. One of the main reasons people use energy drinks is to counteract effects of insufficient sleep or sleepiness. Risks associated with energy drink use, including those related to sleep loss, may be disproportionately borne by racial minorities and those of lower socioeconomic status. In this review, a brief introduction to the issue of health disparities is provided, population-level disparities and inequalities in sleep are described, and the social-ecological model of sleep and health is presented. Social and demographic patterns of energy drink use are then presented, followed by discussion of the potential ways in which energy drink use may contribute to health disparities, including the following: 1) effects of excessive caffeine in energy drinks, 2) effects of energy drinks as sugar-sweetened beverages, 3) association between energy drinks and risk-taking behaviors when mixed with alcohol, 4) association between energy drink use and short sleep duration, and 5) role of energy drinks in cardiometabolic disease. The review concludes with a research agenda of critical unanswered questions. (C) 2014 International Life Sciences Institute
C1 [Grandner, Michael A.] Univ Penn, Perelman Sch Med, Dept Psychiat, Behav Sleep Med Program, Philadelphia, PA 19104 USA.
   [Grandner, Michael A.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA.
   [Knutson, Kristen L.] Univ Chicago, Dept Med, Sect Pulm Crit Care, Chicago, IL 60637 USA.
   [Troxel, Wendy] RAND Corp, Pittsburgh, PA USA.
   [Hale, Lauren] SUNY Stony Brook, Program Publ Hlth, Stony Brook, NY 11794 USA.
   [Jean-Louis, Girardin] NYU, Sch Med, Dept Populat Hlth, New York, NY USA.
   [Jean-Louis, Girardin] NYU, Sch Med, Dept Psychiat, New York, NY USA.
   [Miller, Kathleen E.] SUNY Buffalo, Res Inst, Buffalo, NY 14260 USA.
C3 University of Pennsylvania; University of Pennsylvania; University of
   Chicago; RAND Corporation; State University of New York (SUNY) System;
   Stony Brook University; New York University; New York University; State
   University of New York (SUNY) System; University at Buffalo, SUNY
RP Grandner, MA (corresponding author), Behav Sleep Med Program, 3535 Market St,Suite 670, Philadelphia, PA 19104 USA.
EM grandner@upenn.edu
OI Grandner, Michael/0000-0002-4626-754X; Knutson,
   Kristen/0000-0002-2751-6168; Hale, Lauren/0000-0002-7530-2519;
   Jean-Louis, Girardin/0000-0001-6777-2724
FU National Heart, Lung and Blood Institute [K23HL110216]; National
   Institute of Environmental Health Science [R21ES022931]; University of
   Pennsylvania CTSA [UL1RR024134]; National Institute of Diabetes and
   Digestive and Kidney Diseases [R01DK095207, R21DK089414s]; National
   Heart, Lung, and Blood Institute [K23HL093220]; Eunice Kennedy Shriver
   National Institute of Child Health and Human Development [R01HD073352];
   National Institute of Diabetes and Digestive and Kidney Diseases;
   National Institute on Alcohol Abuse and Alcoholism [R01AA021395]
FX This work was supported by the following grants: MG: K23HL110216
   (National Heart, Lung and Blood Institute), R21ES022931 (National
   Institute of Environmental Health Science), UL1RR024134 (University of
   Pennsylvania CTSA); KK: R01DK095207 (National Institute of Diabetes and
   Digestive and Kidney Diseases); WT: K23HL093220 (National Heart, Lung,
   and Blood Institute); LH: R01HD073352 (Eunice Kennedy Shriver National
   Institute of Child Health and Human Development), R21DK089414s (National
   Institute of Diabetes and Digestive and Kidney Diseases); and KM:
   R01AA021395 (National Institute on Alcohol Abuse and Alcoholism).
CR Abbey A, 2004, AGGRESS VIOLENT BEH, V9, P271, DOI 10.1016/S1359-1789(03)00011-9
   Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852
   Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243
   Andreyeva T, 2012, AM J PREV MED, V43, P411, DOI 10.1016/j.amepre.2012.06.015
   [Anonymous], 2005, MONITORING FUTURE NA
   [Anonymous], Weekly US influenza surveillance report (FluView)
   Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x
   Arria AM, 2010, J ADDICT MED, V4, P74, DOI 10.1097/ADM.0b013e3181aa8dd4
   Bailey RL, 2014, NUTR REV, V72, P9, DOI 10.1111/nure.12138
   Berger LK, 2011, ADDICT BEHAV, V36, P516, DOI 10.1016/j.addbeh.2010.12.027
   Bogle K.A., 2008, HOOKING SEX DATING R
   Borden LA, 2011, PSYCHOL ADDICT BEHAV, V25, P346, DOI 10.1037/a0022678
   Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003
   Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641
   Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055
   Cornelius L J, 1991, J Health Care Poor Underserved, V2, P374
   Crabtree VM, 2005, SLEEP MED, V6, P319, DOI 10.1016/j.sleep.2005.02.001
   Curry K, 2009, HUM PSYCHOPHARM CLIN, V24, P473, DOI 10.1002/hup.1045
   de Leon CFM, 2005, J GERONTOL B-PSYCHOL, V60, pS263, DOI 10.1093/geronb/60.5.S263
   Fillmore MT, 1996, J STUD ALCOHOL, V57, P598, DOI 10.15288/jsa.1996.57.598
   Finch BK, 2010, HEALTH PLACE, V16, P1058, DOI 10.1016/j.healthplace.2010.05.009
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   French SA, 2003, J AM DIET ASSOC, V103, P1326, DOI 10.1016/S0002-8223(03)01076-9
   Friedman EM, 2005, P NATL ACAD SCI USA, V102, P18757, DOI 10.1073/pnas.0509281102
   Gallimberti L, 2013, EUR J PEDIATR, V172, P1335, DOI 10.1007/s00431-013-2036-1
   Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10
   Gellis LA, 2005, J ABNORM PSYCHOL, V114, P111, DOI 10.1037/0021-843X.114.1.111
   Geroldi C, 1996, GERONTOLOGY, V42, P163
   Grandner MA, 2013, J CLIN SLEEP MED, V9, P897, DOI 10.5664/jcsm.2990
   Grandner MA, 2010, SLEEP MED, V11, P470, DOI 10.1016/j.sleep.2009.10.006
   Gunes A, 2008, PHARMACOGENOMICS, V9, P625, DOI 10.2217/14622416.9.5.625
   Hale L, 2007, SLEEP, V30, P1096, DOI 10.1093/sleep/30.9.1096
   Hall MH, 2009, SLEEP, V32, P73
   Harris JL, 2011, EVALUATING SURG DRIN
   Ishak Waguih William, 2012, Innov Clin Neurosci, V9, P25
   Jackson JS, 2011, INT HANDB POPUL, V2, P311, DOI 10.1007/978-90-481-9996-9_15
   Jackson JS, 2010, AM J PUBLIC HEALTH, V100, P933, DOI 10.2105/AJPH.2008.143446
   Jean-Louis G, 2000, BIOL PSYCHIAT, V47, P921, DOI 10.1016/S0006-3223(99)00169-9
   Jones SC, 2012, DRUG ALCOHOL REV, V31, P281, DOI 10.1111/j.1465-3362.2011.00319.x
   Killgore WDS, 2012, CHRONOBIOL INT, V29, P43, DOI 10.3109/07420528.2011.635230
   Kozak PJ, 2011, SLEEP, V34, pA9
   LaBrie JW, 2011, ADDICT BEHAV, V36, P354, DOI 10.1016/j.addbeh.2010.12.013
   Lauderdale DS, 2006, AM J EPIDEMIOL, V164, P5, DOI 10.1093/aje/kwj199
   Lewis MA, 2010, PSYCHOL ADDICT BEHAV, V24, P229, DOI 10.1037/a0018361
   Locatelli D, 2012, REV BRAS PSIQUIATR, V34, P193, DOI 10.1590/S1516-44462012000200012
   Maia Q, 2013, ACCIDENT ANAL PREV, V59, P618, DOI 10.1016/j.aap.2013.07.028
   Marczinski CA, 2005, PSYCHOPHARMACOLOGY, V181, P337, DOI 10.1007/s00213-005-2269-4
   Marczinski CA, 2011, INT J ENV RES PUB HE, V8, P3232, DOI 10.3390/ijerph8083232
   Marczinski CA, 2011, ALCOHOL CLIN EXP RES, V35, P1282, DOI 10.1111/j.1530-0277.2011.01464.x
   Martens MP, 2004, PSYCHOL ADDICT BEHAV, V18, P390, DOI 10.1037/0893-164X.18.4.390
   Mezick EJ, 2008, PSYCHOSOM MED, V70, P410, DOI 10.1097/PSY.0b013e31816fdf21
   Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003
   Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490
   Miller Kathleen E, 2012, J Caffeine Res, V2, P62, DOI 10.1089/jcr.2012.0015
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Nolen-Hoeksema S, 2006, J GEN PSYCHOL, V133, P357, DOI 10.3200/GENP.133.4.357-374
   Nomura K, 2010, J PSYCHOSOM RES, V69, P435, DOI 10.1016/j.jpsychores.2010.04.014
   O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401
   Ogden Cynthia L, 2011, NCHS Data Brief, P1
   Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014
   Oteri A, 2007, ALCOHOL CLIN EXP RES, V31, P1677, DOI 10.1111/j.1530-0277.2007.00464.x
   Park S, 2013, J ACAD NUTR DIET, V113, P112, DOI 10.1016/j.jand.2012.09.019
   Patel NP, 2010, SLEEP, V33, pA307
   Peacock A, 2012, ALCOHOL CLIN EXP RES, V36, P2008, DOI 10.1111/j.1530-0277.2012.01820.x
   Pollak CP, 2003, PEDIATRICS, V111, P42, DOI 10.1542/peds.111.1.42
   Pomeranz JL, 2013, J PUBLIC HEALTH POL, V34, P254, DOI 10.1057/jphp.2013.6
   Price SR, 2010, DRUG ALCOHOL REV, V29, P331, DOI 10.1111/j.1465-3362.2009.00163.x
   Putnam JudithJ., 1999, FOOD CONSUMPTION PRI
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Ríos JL, 2013, P R HEALTH SCI J, V32, P95
   Roberts RE, 2000, AM J PSYCHIAT, V157, P81, DOI 10.1176/ajp.157.1.81
   Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004
   Ruiter ME, 2011, SLEEP MED, V12, P209, DOI 10.1016/j.sleep.2010.12.010
   Rush E, 2006, ASIA PAC J CLIN NUTR, V15, P242
   Savoca MR, 2005, AM J HYPERTENS, V18, P116, DOI 10.1016/j.amjhyper.2004.08.011
   Savoca MR, 2004, ARCH PEDIAT ADOL MED, V158, P473, DOI 10.1001/archpedi.158.5.473
   Sharwood LN, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1140
   Smedley B. D., 2003, UNEQUAL TREATMENT CO, DOI [10.17226/12875, DOI 10.17226/12875]
   Smith G, 2009, INT J SEX HEALTH, V21, P119, DOI 10.1080/19317610902973241
   Snipes DJ, 2013, ADDICT BEHAV, V38, P1418, DOI 10.1016/j.addbeh.2012.07.011
   Stamatakis KA, 2007, ANN EPIDEMIOL, V17, P948, DOI 10.1016/j.annepidem.2007.07.096
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Thombs DL, 2010, ADDICT BEHAV, V35, P325, DOI 10.1016/j.addbeh.2009.11.004
   Toblin Robin L., 2012, Morbidity and Mortality Weekly Report, V61, P895
   Tomfohr LM, 2010, BEHAV SLEEP MED, V8, P219, DOI 10.1080/15402002.2010.509236
   Velazquez CE, 2012, DRUG ALCOHOL DEPEN, V123, P167, DOI 10.1016/j.drugalcdep.2011.11.006
   Walia HK, 2012, SLEEP BREATH, V16, P543, DOI 10.1007/s11325-011-0540-y
   Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007
   Wells BE, 2013, AM J DRUG ALCOHOL AB, V39, P8, DOI 10.3109/00952990.2012.720320
   Whinnery J, 2014, SLEEP, V37, P601, DOI 10.5665/sleep.3508
   Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979
   Woods D, 2012, J PRIM HEALTH CARE, V4, P163, DOI 10.1071/HC12163
   Worthley MI, 2010, AM J MED, V123, P184, DOI 10.1016/j.amjmed.2009.09.013
NR 95
TC 28
Z9 32
U1 4
U2 53
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0029-6643
EI 1753-4887
J9 NUTR REV
JI Nutr. Rev.
PD OCT
PY 2014
VL 72
SU 1
SI SI
BP 14
EP 22
DI 10.1111/nure.12137
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA CB9PR
UT WOS:000349964500003
PM 25293540
OA Bronze, Green Accepted
DA 2025-04-28
ER

PT J
AU Khedr, NF
   Zahran, ES
   Ebeid, AM
   Melek, ST
   Werida, RH
AF Khedr, Naglaa F.
   Zahran, Enas S.
   Ebeid, Abla M.
   Melek, Samuel T.
   Werida, Rehab H.
TI Effect of green coffee on miR-133a, miR-155 and inflammatory biomarkers
   in obese individuals
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Adiponectin; Green coffee; Metabolic syndrome; miR-133a; miR-155;
   Resistin
ID DENSITY-LIPOPROTEIN CHOLESTEROL; INSULIN-RESISTANCE; METABOLIC SYNDROME;
   GLUCOSE; PLASMA; ALPHA; MIRNA; ACID
AB ObjectivesMetabolic syndrome is a cluster of conditions that increases the risk of atherosclerotic cardiovascular diseases. The current study was a randomized, double blind, placebo-controlled study that aimed to determine the impact of green coffee (GC) in obese patients with metabolic syndrome through analysis of miRNA-155, miRNA-133a and the inflammatory biomarkers such as resistin, TNF-alpha, total sialic acid, homocysteine, high sensitivity C-reactive protein (hs-CRP), and the anti-inflammatory cytokine, adiponectin.MethodsOne hundred-sixty obese patients were randomly supplemented either with GC capsules (800 mg) or placebo daily for six months. Both groups were advised to take a balanced diet. Blood samples were collected at baseline and after six months of supplementation.ResultsGC supplementation for 6 months reduced BMI (p = 0.002), waist circumference (p = 0.038), blood glucose (p = 0.002), HbA1c% (p = 0.000), Insulin (p = 0.000), systolic blood pressure (p = 0.005), diastolic BP (p = 0.001) compared with placebo. GC significantly decreased total cholesterol (TC, p = 0.000), LDL-C (p = 0.001), triglycerides (TG, p = 0.002) and increased HDL-C (p = 0.008) compared with placebo group. In addition, GC significantly (p <= 0.005) reduced total sialic acid, homocysteine, resistin, TNF-alpha, hs-CRP and the oxidative stress marker malondialdehyde (MDA), but increased serum adiponectin (p = 0.000) compared to placebo group. There was a significant reduction in the gene expression of miR-133a (p = 0.000) in GC group as compared with baseline levels and with the control placebo group (p = 0.001) after 6 months.ConclusionGC administration modulated metabolic syndrome by decreasing BMI, high BP, blood glucose, dyslipidemia, miRNA-133a and inflammatory biomarkers that constitute risk factors for cardiovascular diseases.ClinicalTrials.gov registration No. is NCT05688917.ConclusionGC administration modulated metabolic syndrome by decreasing BMI, high BP, blood glucose, dyslipidemia, miRNA-133a and inflammatory biomarkers that constitute risk factors for cardiovascular diseases.ClinicalTrials.gov registration No. is NCT05688917.
C1 [Khedr, Naglaa F.] Tanta Univ, Fac Pharm, Biochem Dept, Med Complex, Al Baher St, Tanta 31527, Egypt.
   [Zahran, Enas S.] Menoufia Univ, Fac Med, Internal Med Dept, Shibin Al Kawm, Egypt.
   [Ebeid, Abla M.] AL Delta Univ, Fac Pharm, Clin Pharm Dept, Gamasa, Egypt.
   [Melek, Samuel T.] Natl Org Drug Control & Res NODCAR, Dept Parasitol & Blood Res, Cairo 12654, Egypt.
   [Werida, Rehab H.] Damanhour Univ, Fac Pharm, Clin Pharm Dept, Damanhour, Egypt.
C3 Egyptian Knowledge Bank (EKB); Tanta University; Egyptian Knowledge Bank
   (EKB); Menofia University; Delta University for Science & Technology;
   National Organization for Drug Control & Research (NODCAR); Egyptian
   Knowledge Bank (EKB); Damanhour University
RP Khedr, NF (corresponding author), Tanta Univ, Fac Pharm, Biochem Dept, Med Complex, Al Baher St, Tanta 31527, Egypt.; Werida, RH (corresponding author), Damanhour Univ, Fac Pharm, Clin Pharm Dept, Damanhour, Egypt.
EM naglaa.khedr@pharm.tanta.edu.eg; rehabwrieda@pharm.dmu.edu.eg
RI Werida, Rehab/AAU-2278-2021
OI khedr, naglaa/0000-0003-4539-8940
FU Tanta University; Faculty of Pharmacy, Tanta University
FX The authors thank medical staff members of the Internal Medicine
   Department, Faculty of Medicine, Menoufia University, Egypt, for helping
   in the recruitment of participants. Authors also thank the Faculty of
   Pharmacy, Tanta University and the Faculty of Pharmacy, at Damanhour and
   Delta University for supporting the research.
CR Agbu P, 2021, NAT REV MOL CELL BIO, V22, P425, DOI 10.1038/s41580-021-00354-w
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   ALLAIN CC, 1974, CLIN CHEM, V20, P470
   Asbaghi O, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00587-z
   AUBREELECAT A, 1989, ANAL BIOCHEM, V178, P427, DOI 10.1016/0003-2697(89)90665-9
   BUCOLO G, 1973, CLIN CHEM, V19, P476
   Caro-Gómez E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030497
   Cerda A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031468
   Chakraborty C, 2014, WIRES RNA, V5, P697, DOI 10.1002/wrna.1240
   Chen H, 2020, COMPLEMENT THER MED, V52, DOI 10.1016/j.ctim.2020.102498
   Corp I., 2023, IBM SPSS Statistics for windows
   Daily ZA, 2023, BMC ORAL HEALTH, V23, DOI 10.1186/s12903-023-03584-w
   de Gonzalo-Calvo D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00070-6
   DURRINGTON PN, 1982, CRC CR REV CL LAB SC, V18, P31, DOI 10.3109/10408368209082589
   DWEK RA, 1993, ANNU REV BIOCHEM, V62, P65, DOI 10.1146/annurev.bi.62.070193.000433
   El-Kersh DM, 2023, FOOD CHEM TOXICOL, V179, DOI 10.1016/j.fct.2023.113971
   Ellulu MS, 2017, ARCH MED SCI, V13, P851, DOI 10.5114/aoms.2016.58928
   Engin A, 2017, ADV EXP MED BIOL, V960, P1, DOI 10.1007/978-3-319-48382-5_1
   Fodor A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126337
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Grzelczyk J, 2020, J THERM ANAL CALORIM, V142, P877, DOI 10.1007/s10973-020-09801-w
   Heyn GS, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.563816
   Huang JH, 2023, FRONT PHARMACOL, V14, DOI 10.3389/fphar.2023.1218015
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Jeszka-Skowron M, 2016, EUR FOOD RES TECHNOL, V242, P1403, DOI 10.1007/s00217-016-2643-y
   Johnson C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01297
   Khalili-Moghadam S, 2023, FRONT NUTR, V10, DOI 10.3389/fnut.2023.1241844
   Kim H., 2017, FASEB J, V31, P3, DOI [10.1096/fasebj.31.1supplement.46.3, DOI 10.1096/FASEBJ.31.1SUPPLEMENT.46.3]
   Kim NH, 2020, CLIN NUTR, V39, P910, DOI 10.1016/j.clnu.2019.03.033
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Lukitasari M, 2020, J ADV PHARM TECHNOL, V11, P81, DOI 10.4103/japtr.JAPTR_116_19
   Maitrias P, 2017, ARTERIOSCL THROM VAS, V37, P1608, DOI 10.1161/ATVBAHA.117.309233
   Malo E, 2011, METAB SYNDR RELAT D, V9, P203, DOI 10.1089/met.2010.0106
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Meuth VML, 2023, OBESITIES-BASEL, V3, P243, DOI 10.3390/obesities3030020
   Morvaridi M, 2020, J DIABETES METAB DIS, V19, P645, DOI 10.1007/s40200-020-00536-x
   Nikpayam O, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0489-8
   Nugroho DA., 2017, Asian J Pharmaceutical Clin Res, V10, P279, DOI [10.2159/ajpcr.2017.v10i9.19329, DOI 10.2159/AJPCR.2017.V10I9.19329, 10.12688/f1000research.55470.1, DOI 10.22159/AJPCR.2017.V10I9.19329]
   Ochiai R, 2004, HYPERTENS RES, V27, P731, DOI 10.1291/hypres.27.731
   Ohishi T, 2021, MOLECULES, V26, DOI 10.3390/molecules26020453
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Panyathep A, 2023, FOODS, V12, DOI 10.3390/foods12142648
   Patel H, 2015, CURR RES NUTR FOOD S, V3, P263, DOI 10.12944/CRNFSJ.3.3.10
   Qureshi R, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S14
   Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089
   Rohman MS, 2023, BENI-SUEF U J BASIC, V12, DOI 10.1186/s43088-023-00381-w
   Roshan H, 2018, BRIT J NUTR, V119, P250, DOI 10.1017/S0007114517003439
   Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z
   Salamat S, 2019, EUR J INTEGR MED, V28, P109, DOI 10.1016/j.eujim.2019.05.001
   Sánchez-Margalet V, 2002, J NUTR BIOCHEM, V13, P75, DOI 10.1016/S0955-2863(01)00197-8
   Seliem EM, 2022, LIFE-BASEL, V12, DOI 10.3390/life12050693
   Shokouh P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092074
   Sudeep HV, 2021, SAGE OPEN MED, V9, DOI 10.1177/20503121211002590
   Summerhill VI, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143561
   Sun L, 2015, MOL MED REP, V11, P4039, DOI 10.3892/mmr.2015.3246
   Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203
   Verma N, 2024, J AM NUTR ASSOC, V43, P315, DOI 10.1080/27697061.2023.2284994
   Wang L, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.943911
   WHO, 2003, WHO TECH REP SER, V916, P1
   Yang XM, 2022, BMC WOMENS HEALTH, V22, DOI 10.1186/s12905-022-01994-6
   Yung JHM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030706
   Zhang C, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1113-5
   Zhou Y, 2022, CARDIOL J, V29, P284, DOI 10.5603/CJ.a2020.0034
NR 64
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD OCT 28
PY 2024
VL 16
IS 1
AR 256
DI 10.1186/s13098-024-01478-7
PG 16
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA K5R4N
UT WOS:001344442100001
PM 39468643
OA gold, Green Accepted
DA 2025-04-28
ER

PT J
AU Türközü, D
   Sanlier, N
AF Turkozu, Duygu
   Sanlier, Nevin
TI L-theanine, unique amino acid of tea, and its metabolism, health
   effects, and safety
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Tea; theanine; health; safety
ID GREEN TEA; CAMELLIA-SINENSIS; BLOOD-PRESSURE; DOUBLE-BLIND; PU-ERH;
   CAFFEINE; RATS; COMPONENTS; ATTENTION; LEAVES
AB Tea has been a very popular beverage around the world for centuries. The reason that it is delicious, enabling hydration, showing warming and relaxing effect can be mentioned why it is consumed so much in addition to its prominent health effects. Although the catechins and caffeine are the primary bioactive components that are related with the health effects of the tea, the health effects of theanine amino acid, which is a nonproteinic amino acid special to tea, has become prominent in recent years. It has been known that the theanine amino acid in tea has positive effects especially on relaxing, cognitive performance, emotional status, sleep quality, cancer, cardiovascular diseases, obesity, and common cold. The results of acute and chronic toxicity tests conducted on the safety of theanine express that L-theanine is reliable in general even if it is consumed too much with diet. However, it has not revealed a clear evidence-based result yet regarding theanine metabolism, health effects, and its safety. Within this frame, chemical structure of theanine, its biosynthesis, dietary sources, metabolism, health effects, and safety are discussed in present study.
C1 [Turkozu, Duygu; Sanlier, Nevin] Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.
C3 Gazi University
RP Sanlier, N (corresponding author), Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Muammer Yasar Bostanci Caddesi,16, TR-06500 Besevler, Turkey.
EM nevintekgul@gmail.com
RI Sanlier, Nevin/W-7657-2018; Ağagündüz, Duygu/AAS-9583-2020
CR Alcazar A, 2007, J AGR FOOD CHEM, V55, P5960, DOI 10.1021/jf070601a
   [Anonymous], 2013, WORLD TEA NEWS MARKE
   Borzelleca JF, 2006, FOOD CHEM TOXICOL, V44, P1158, DOI 10.1016/j.fct.2006.03.014
   Bryan J, 2008, NUTR REV, V66, P82, DOI 10.1111/j.1753-4887.2007.00011.x
   Bukowski JF, 2008, NUTR REV, V66, P96, DOI 10.1111/j.1753-4887.2007.00013.x
   Camfield DA, 2014, NUTR REV, V72, P507, DOI 10.1111/nure.12120
   Chu D.C., 1997, CHEM APPL GREEN TEA, P1
   Deng WW, 2008, PHYTOCHEM LETT, V1, P115, DOI 10.1016/j.phytol.2008.06.002
   Desai MJ, 2005, CHIRALITY, V17, P154, DOI 10.1002/chir.20144
   EkborgOtt KH, 1997, J AGR FOOD CHEM, V45, P353, DOI 10.1021/jf960432m
   Fraser ML, 2007, COMPLEMENT THER MED, V15, P46, DOI 10.1016/j.ctim.2006.07.002
   Friedman M, 2007, J AGR FOOD CHEM, V55, P243, DOI 10.1021/jf062276h
   Fujii S, 2008, FOOD CHEM, V110, P643, DOI 10.1016/j.foodchem.2008.02.052
   Gomez-Ramirez M, 2007, CLIN NEUROPHARMACOL, V30, P25, DOI 10.1097/01.WNF.0000240940.13876.17
   Haskell CF, 2008, BIOL PSYCHOL, V77, P113, DOI 10.1016/j.biopsycho.2007.09.008
   Hilal Y, 2007, J VERBRAUCH LEBENSM, V2, P414, DOI 10.1007/s00003-007-0250-3
   Jain A, 2013, TOXICOL LETT, V220, P82, DOI 10.1016/j.toxlet.2013.04.010
   Jang HS, 2012, PHARMACOL BIOCHEM BE, V101, P217, DOI 10.1016/j.pbb.2012.01.011
   Juneja LR, 1999, TRENDS FOOD SCI TECH, V10, P425, DOI 10.1016/S0924-2244(00)00031-5
   Kakuda T, 2011, PHARMACOL RES, V64, P162, DOI 10.1016/j.phrs.2011.03.010
   Keenan EK, 2011, FOOD CHEM, V125, P588, DOI 10.1016/j.foodchem.2010.08.071
   Kelly SP, 2008, J NUTR, V138, P1572
   Kim TI, 2009, FREE RADICAL BIO MED, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008
   Kimura K, 2007, BIOL PSYCHOL, V74, P39, DOI 10.1016/j.biopsycho.2006.06.006
   Kobayashi K, 1998, NIPPON NOGEIK KAISHI, V72, P153
   Kobayashi M, 2014, Polyphenols in human health and disease, P625
   Kurihara S., 2010, J AMINO ACIDS, V2010, P1
   Kurihara S, 2007, J VET MED SCI, V69, P1263, DOI 10.1292/jvms.69.1263
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Liu Q, 2009, CYTOTECHNOLOGY, V59, P211, DOI 10.1007/s10616-009-9223-y
   Lu K, 2004, HUM PSYCHOPHARM CLIN, V19, P457, DOI 10.1002/hup.611
   Lyon MR, 2011, ALTERN MED REV, V16, P348
   Matsumoto K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-15
   Nagai K., 2013, Biomedicine & Preventive Nutrition, V3, P197
   Nantz MP, 2009, NUTRITION, V25, P147, DOI 10.1016/j.nut.2008.07.018
   Narukawa M, 2014, AMINO ACIDS, V46, P1583, DOI 10.1007/s00726-014-1713-3
   Pinto MD, 2013, FOOD RES INT, V53, P558, DOI 10.1016/j.foodres.2013.01.038
   Sakato Y., 1949, Journal of Agricultural and Food Chemistry, V23, P262, DOI [10.1271/nogeikagaku1924.23.262, DOI 10.1271/NOGEIKAGAKU1924.23.262]
   Sayama K, 2000, IN VIVO, V14, P481
   Siamwala JH, 2013, J NUTR BIOCHEM, V24, P595, DOI 10.1016/j.jnutbio.2012.02.016
   Song ChanHee Song ChanHee, 2003, Korean Journal of Nutrition, V36, P918
   Sugiyama T, 2004, CANCER LETT, V212, P177, DOI 10.1016/j.canlet.2004.03.040
   The Republic of Turkey Ministry of Health and Hacettepe University Nutrition and Dietetics Department. Turkey Nutrition and Health Survey, 2010, USITC PUBL, VSB-SAG-2014/0
   Unno T, 1999, J AGR FOOD CHEM, V47, P1593, DOI 10.1021/jf981113t
   van der Pijl PC, 2010, J FUNCT FOODS, V2, P239, DOI 10.1016/j.jff.2010.08.001
   Vuong QV, 2014, CRIT REV FOOD SCI, V54, P523, DOI 10.1080/10408398.2011.594184
   Vuong QV, 2011, J SCI FOOD AGR, V91, P1931, DOI 10.1002/jsfa.4373
   Yamada T, 2008, BIOSCI BIOTECH BIOCH, V72, P1352, DOI 10.1271/bbb.70668
   Yamada T, 2007, LIFE SCI, V81, P1247, DOI 10.1016/j.lfs.2007.08.023
   Ying Y, 2005, J LIQ CHROMATOGR R T, V28, P727, DOI 10.1081/JLC-200048894
   YOKOGOSHI H, 1995, BIOSCI BIOTECH BIOCH, V59, P615, DOI 10.1271/bbb.59.615
   Yokozawa T, 1997, EXP TOXICOL PATHOL, V49, P329, DOI 10.1016/S0940-2993(97)80096-6
   YOKOZAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P2134, DOI 10.1271/bbb.59.2134
   Yoto A, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-28
   Zhang L, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P425, DOI 10.1016/B978-0-12-384937-3.00035-5
   Zhao M, 2011, J AGR FOOD CHEM, V59, P3641, DOI 10.1021/jf104601v
   Zheng GD, 2004, IN VIVO, V18, P55
NR 57
TC 145
Z9 153
U1 19
U2 251
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PY 2017
VL 57
IS 8
BP 1681
EP 1687
DI 10.1080/10408398.2015.1016141
PG 7
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA EO6BU
UT WOS:000396777500013
PM 26192072
DA 2025-04-28
ER

PT J
AU Richard, D
   Kefi, K
   Barbe, U
   Poli, A
   Bausero, P
   Visioli, F
AF Richard, Doriane
   Kefi, Kaouthar
   Barbe, Ullah
   Poli, Andrea
   Bausero, Pedro
   Visioli, Francesco
TI Weight and plasma lipid control by decaffeinated green tea
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Green tea; Obesity; Polyphenols; Diet; Decaffeinated
ID CATECHIN-POLYPHENOLS; HEPATIC STEATOSIS; WHITE TEA; BODY-FAT; CAFFEINE;
   OBESITY; MICE; SYSTEM; RATS; (-)-EPIGALLOCATECHIN-3-GALLATE
AB We investigated whether regular decaffeinated green tea intake could modulate body weight in an experimental model of obesity. Male leptin-deficient (ob/ob) mice and their C57BL/6J lean littermates (4 weeks of age; n 20/genotype) were assigned randomly to receive either decaffeinated green tea or vehicle, for 6 weeks. Body weights were recorded weekly and fluid intake was measured at each replacement. Blood was collected from the heart into collection tubes, with Li(+)-heparin as the anticoagulant. Administration of decaffeinated green tea to ob/ob mice significantly slowed their rate of weight gain, as compared with animals that were fed buffer alone. This effect is apparent after only 1 week of supplementation. No significant difference was recorded between C57BL/6J lean mice administrated decaffeinated green tea and those given buffer alone. Decaffeinated green tea consumption by ob/ob mice was also associated with significantly lower cholesterolemia, triglyceridemia, and adiponectin concentration. Fecal lipids did not change significantly throughout the experiment. In conclusion, administration of decaffeinated green tea might contribute to weight control and provides an opportunity for through-the-day consumption, without the excitatory effects of caffeine. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Richard, Doriane; Kefi, Kaouthar; Barbe, Ullah; Bausero, Pedro; Visioli, Francesco] Univ Paris 06, UR4, Lab Micronutrients & Cardiovasc Dis, F-75252 Paris 5, France.
   [Poli, Andrea] Nutr Fdn Italy, Milan, Italy.
C3 Sorbonne Universite
RP Richard, D (corresponding author), Univ Paris 06, UR4, Lab Micronutrients & Cardiovasc Dis, Bat A 5 Etage,Case Courrier 256,7 Quai St Bernard, F-75252 Paris 5, France.
EM doriane.richard@upmc.fr
RI Visioli, Francesco/J-9356-2013
OI Visioli, Francesco/0000-0002-1756-1723; Bausero,
   Pedro/0000-0002-5915-0228
FU Nutrition Foundation of Italy
FX This study was supported by the Nutrition Foundation of Italy. Drs.
   Angelique Stalmach and Alan Crozier performed tea analysis. Dr. John
   Doucet edited the manuscript. We thank Drs. Rod H. Dashwood and Gayle
   Orner for helpful advice.
CR [Anonymous], 2002, WHO LIB CAT IN PUBL
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Babu PVA, 2007, PHARMACOL RES, V55, P433, DOI 10.1016/j.phrs.2007.01.019
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Bruno RS, 2008, J NUTR, V138, P323, DOI 10.1093/jn/138.2.323
   Carter O, 2007, NUTR CANCER, V58, P60, DOI 10.1080/01635580701308182
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Deitel M, 2002, OBES SURG, V12, P613, DOI 10.1381/096089202321019558
   Delporte ML, 2004, AM J PHYSIOL-ENDOC M, V287, pE446, DOI 10.1152/ajpendo.00488.2003
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Fiorini RN, 2005, LIVER TRANSPLANT, V11, P298, DOI 10.1002/lt.20348
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Galani C, 2007, INT J PUBLIC HEALTH, V52, P348, DOI 10.1007/s00038-007-7015-8
   Giannessi D, 2007, PHARMACOL RES, V56, P459, DOI 10.1016/j.phrs.2007.09.014
   Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464
   James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x
   Jin JY, 2007, PHARMACOL RES, V56, P237, DOI 10.1016/j.phrs.2007.06.004
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Koo MWL, 2004, EUR J PHARMACOL, V500, P177, DOI 10.1016/j.ejphar.2004.07.023
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Shishikura Y, 2006, J AGR FOOD CHEM, V54, P1906, DOI 10.1021/jf051988p
   Visioli F, 2007, BRIT J NUTR, V98, P1101, DOI 10.1017/S0007114507853475
   Visioli F, 2007, PHARMACOL RES, V55, P199, DOI 10.1016/j.phrs.2007.01.008
   Wang R, 2008, CARCINOGENESIS, V29, P834, DOI 10.1093/carcin/bgn051
   WHO, 2000, WHO TECHN REP SER, V894
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
NR 32
TC 41
Z9 47
U1 0
U2 17
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
J9 PHARMACOL RES
JI Pharmacol. Res.
PD MAY
PY 2009
VL 59
IS 5
BP 351
EP 354
DI 10.1016/j.phrs.2009.01.015
PG 4
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 442DU
UT WOS:000265821000009
PM 19416635
DA 2025-04-28
ER

PT J
AU Yamamoto, T
   Takahashi, H
   Suzuki, K
   Hirano, A
   Kamei, M
   Goto, T
   Takahashi, N
   Kawada, T
AF Yamamoto, Takayuki
   Takahashi, Haruya
   Suzuki, Koichiro
   Hirano, Akira
   Kamei, Masanori
   Goto, Tsuyoshi
   Takahashi, Nobuyuki
   Kawada, Teruo
TI Theobromine enhances absorption of cacao polyphenol in rats
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE absorption; rat; theobromine; Caco-2; cacao polyphenol
ID (-)-EPICATECHIN METABOLITES; MASS-SPECTROMETRY; ORAL INGESTION; COCOA;
   TRANSPORT; HUMANS; PLASMA; CAFFEINE; OBESITY; CELLS
AB Several concentrations of theobromine (TB) and (-)-epicatechin (EC) were coadministered to rats, and plasma EC and its metabolites were determined using ultra-high-performance liquid chromatography-tandem mass spectrometry. It has been demonstrated that TB increases the absorption of EC in a dose-dependent manner. Cocoa powder had a similar effect, and the mechanism involved is not thought to depend on tight junctions.
C1 [Yamamoto, Takayuki; Takahashi, Haruya; Goto, Tsuyoshi; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto, Japan.
   [Yamamoto, Takayuki; Suzuki, Koichiro; Hirano, Akira; Kamei, Masanori] Morinaga & Co Ltd, Res Inst, Yokohama, Kanagawa, Japan.
C3 Kyoto University; Morinaga & Company, Ltd.
RP Yamamoto, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto, Japan.
EM t-yamamoto-jc@morinaga.co.jp
RI Takahashi, Nobuyuki/AAX-8671-2021; Goto, Tsuyoshi/AAY-2344-2020
OI Goto, Tsuyoshi/0000-0003-1283-147X; Takahashi,
   Nobuyuki/0000-0002-9705-662X
CR Abd El Mohsen MM, 2002, FREE RADICAL BIO MED, V33, P1693, DOI 10.1016/S0891-5849(02)01137-1
   CEREIJIDO M, 1993, J CELL SCI, P127
   CRAIG WJ, 1984, J FOOD SCI, V49, P302, DOI 10.1111/j.1365-2621.1984.tb13737.x
   Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503
   Donovan JL, 2001, J NUTR, V131, P1753, DOI 10.1093/jn/131.6.1753
   GANS JH, 1980, TOXICOL APPL PHARM, V53, P481, DOI 10.1016/0041-008X(80)90360-9
   Hammerstone JF, 1999, J AGR FOOD CHEM, V47, P490, DOI 10.1021/jf980760h
   Kadowaki M, 2008, J PHARM PHARMACOL, V60, P1189, DOI 10.1211/jpp.60.9.0011
   Kosinska A, 2012, FOOD CHEM, V135, P999, DOI 10.1016/j.foodchem.2012.05.101
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Matsui N, 2005, NUTRITION, V21, P594, DOI 10.1016/j.nut.2004.10.008
   Nakagawa K, 2009, BIOSCI BIOTECH BIOCH, V73, P2014, DOI 10.1271/bbb.90195
   Natsume M, 2003, FREE RADICAL BIO MED, V34, P840, DOI 10.1016/S0891-5849(02)01434-X
   Ortega N, 2008, J AGR FOOD CHEM, V56, P9621, DOI 10.1021/jf8014415
   Ottaviani JI, 2012, FREE RADICAL BIO MED, V52, P1403, DOI 10.1016/j.freeradbiomed.2011.12.010
   Piskula MK, 1998, J NUTR, V128, P1172, DOI 10.1093/jn/128.7.1172
   Roelofsen H, 1998, J CELL SCI, V111, P1137
   Roura E, 2005, J AGR FOOD CHEM, V53, P6190, DOI 10.1021/jf050377u
   Salucci M, 2002, BRIT J CANCER, V86, P1645, DOI 10.1038/sj.bjc.6600295
   Sánchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395
   Suzuki K, 2013, BIOSCI BIOTECH BIOCH, V77, P1792, DOI 10.1271/bbb.130380
   Vaidyanathan JB, 2001, PHARMACEUT RES, V18, P1420, DOI 10.1023/A:1012200805593
   Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018
   Zomer E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3657
NR 24
TC 9
Z9 9
U1 0
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD DEC 2
PY 2014
VL 78
IS 12
BP 2059
EP 2063
DI 10.1080/09168451.2014.942252
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA AU3HZ
UT WOS:000345504400012
PM 25079983
OA Bronze
DA 2025-04-28
ER

PT J
AU Shaheen, S
   Shorbagi, M
   Lorenzo, JM
   Farag, MA
AF Shaheen, Sherif
   Shorbagi, Mohamed
   Lorenzo, Jose M.
   Farag, Mohamed A.
TI Dissecting dietary melanoidins: formation mechanisms, gut interactions
   and functional properties
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Melanoidins; Maillard reaction; dietary sources; metabolism; gut
   microbiota; functional properties
ID MAILLARD REACTION-PRODUCTS; TRADITIONAL BALSAMIC VINEGAR; SIMULATED
   GASTRIC DIGESTION; BIOLOGICAL-PROPERTIES; CHEMICAL-CHARACTERIZATION;
   HETEROCYCLIC AMINES; LIPID-PEROXIDATION; COFFEE MELANOIDINS;
   END-PRODUCTS; HEPG2 CELLS
AB Dietary melanoidins are late stage Maillard reaction products (MRPs), browning colorants and predominantly high molecular weight (HMW) chemicals. They originate through polycondensation reactions of reducing sugars and proteins or amino acids upon thermal processing. Their presence in several daily food and beverages (i.e. coffee, beer, honey, bakery products, chocolate, grilled meat) contribute to food sensory characters (i.e. color, aroma, and flavor). Additionally, melanoidins exhibit many biological attributes (i.e. antioxidant, anti-obesity, antibacterial activity and impact on gut microbiota as prebiotics). However, dissecting melanoidins specific biological and functional characteristics in relation to their metabolism and gut interaction with link to their chemical structures has yet to be reported in literature. For a better understanding of melanoidins benefits and flavor properties in processed foods, this review represents a state of the art comprehensive insight of its formation mechanism and chemistry in relation to their functionalities and health effects. Further, a compile of the factors affecting melanoidins production to optimize for the best flavor attributes while minimizing hazardous compounds is presented. This study presents the first analysis of melanoidins gut interaction in context to its different action mechanisms.
C1 [Shaheen, Sherif] Univ Coll Dublin, UCD Sch Agr & Food Sci, Belfield, Ireland.
   [Shaheen, Sherif] TEAGASC, Meat Chem Dept, Food Res Ctr, Dublin 15, Ireland.
   [Shorbagi, Mohamed] Benha Univ, Fac Sci, Dept Special Chem, Al Qalyubia Governorate, Egypt.
   [Lorenzo, Jose M.] Meat Technol Ctr Galicia CTC, Orense, Spain.
   [Lorenzo, Jose M.] Univ Vigo, Fac Sci Ourense, Food Technol Dept, Orense, Spain.
   [Farag, Mohamed A.] Cairo Univ, Coll Pharm, Pharmacognosy Dept, Cairo, Egypt.
   [Farag, Mohamed A.] Amer Univ Cairo, Sch Sci & Engn, Dept Chem, New Cairo, Egypt.
C3 University College Dublin; Teagasc; Egyptian Knowledge Bank (EKB); Benha
   University; Universidade de Vigo; Centre de Recerca en Agrotecnologia
   (Agrotecnio); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian
   Knowledge Bank (EKB); American University Cairo
RP Farag, MA (corresponding author), Cairo Univ, Coll Pharm, Pharmacognosy Dept, Cairo, Egypt.; Farag, MA (corresponding author), Amer Univ Cairo, Sch Sci & Engn, Dept Chem, New Cairo, Egypt.
EM Mohamed.Farag@pharma.cu.edu.eg
RI Elseedi, Hesham/KGK-5692-2024; Lorenzo Rodriguez, Jose
   Manuel/K-6375-2014
OI Shorbagi, Mohamed/0000-0001-5314-3230; Shaheen,
   Sherif/0000-0003-0718-7704; Lorenzo Rodriguez, Jose
   Manuel/0000-0002-7725-9294
FU Alexander von Humboldt foundation; GAIN (Axencia Galega de Innovacion)
   [IN607A2019/01]
FX Dr. Mohamed Farag thanks the Alexander von Humboldt foundation for
   supporting his laboratory at Cairo University. Thanks to GAIN (Axencia
   Galega de Innovacion) for supporting this review (grant number
   IN607A2019/01).
CR Adams A, 2005, J AGR FOOD CHEM, V53, P4136, DOI 10.1021/jf047903m
   Adams A, 2010, FOOD RES INT, V43, P1517, DOI 10.1016/j.foodres.2010.04.033
   Aktag IG, 2019, J FOOD COMPOS ANAL, V84, DOI 10.1016/j.jfca.2019.103308
   Aljahdali N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010241
   Alves G, 2020, J FOOD SCI TECH MYS, V57, P3119, DOI 10.1007/s13197-020-04346-0
   Ames JM, 1999, BRIT J NUTR, V82, P489, DOI 10.1017/S0007114599001749
   Martin MA, 2009, J AGR FOOD CHEM, V57, P7250, DOI 10.1021/jf9006032
   [Anonymous], 1997, BROWNING COMPOSITION
   [Anonymous], 2019, CHELATING COMPLEX ME
   [Anonymous], 2015, PROCESS PREPARING FO
   [Anonymous], 2011, SUBSTRATE ANTIMICROB
   [Anonymous], 2007, COSMETIC COMPOSITION
   [Anonymous], 2020, HAIR COSMETIC COMPOS
   [Anonymous], 2016, PREPARATION METHOD C
   [Anonymous], 2009, ANTIOXIDANT BREAD CO
   [Anonymous], 2009, ENHANCER INDIGO DYEI
   [Anonymous], 2020, SYSTEM METHOD SELECT
   [Anonymous], 2017, OXIDATION RESISTANT
   [Anonymous], 2018, INDIGESTIBLE MAT MAN
   [Anonymous], 2014, ANTIOXIDANT ANTIOXID
   [Anonymous], 1992, MICROWAVE OVEN COOKE
   Argirova MD, 2013, FOOD FUNCT, V4, P1204, DOI 10.1039/c3fo60025d
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P7138, DOI 10.1021/jf800999a
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P2055, DOI 10.1021/jf073157k
   Bharagava RN, 2009, WORLD J MICROB BIOT, V25, P737, DOI 10.1007/s11274-008-9944-7
   Borrelli RC, 2002, J AGR FOOD CHEM, V50, P6527, DOI 10.1021/jf025686o
   Brudzynski K, 2011, FOOD CHEM, V127, P1023, DOI 10.1016/j.foodchem.2011.01.075
   Brudzynski K, 2011, FOOD CHEM, V125, P570, DOI 10.1016/j.foodchem.2010.09.049
   CAMMERER B, 1995, FOOD CHEM, V53, P55, DOI 10.1016/0308-8146(95)95786-6
   Cani PD, 2016, NAT REV ENDOCRINOL, V12, P133, DOI 10.1038/nrendo.2015.211
   Chandra R, 2008, BIORESOURCE TECHNOL, V99, P4648, DOI 10.1016/j.biortech.2007.09.057
   CULVER CA, 1989, J DAIRY SCI, V72, P2916, DOI 10.3168/jds.S0022-0302(89)79442-X
   Delgado-Andrade C, 2018, ANNU REV FOOD SCI T, V9, P271, DOI 10.1146/annurev-food-030117-012441
   Diaz-Morales N, 2021, FOOD CHEM, V343, DOI 10.1016/j.foodchem.2020.128405
   Diez-Simon C, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1493-6
   Echavarría AP, 2014, FOOD SCI TECHNOL INT, V20, P119, DOI 10.1177/1082013213476071
   Echavarría AP, 2012, FOOD ENG REV, V4, P203, DOI 10.1007/s12393-012-9057-9
   Elshahed MS, 2021, CARBOHYD POLYM, V255, DOI 10.1016/j.carbpol.2020.117388
   Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156
   Fogliano V, 2011, FOOD FUNCT, V2, P117, DOI 10.1039/c0fo00156b
   Goya L, 2007, MOL NUTR FOOD RES, V51, P536, DOI 10.1002/mnfr.200600228
   Helou C, 2015, FOOD FUNCT, V6, P3737, DOI [10.1039/C5FO00836K, 10.1039/c5fo00836k]
   HIRANO M, 1994, BIOSCI BIOTECH BIOCH, V58, P940, DOI 10.1271/bbb.58.940
   Hofmann T, 2002, J AGR FOOD CHEM, V50, P319, DOI 10.1021/jf010823n
   Iriondo-DeHond A, 2020, FOODS, V9, DOI 10.3390/foods9050620
   Jakszyn P, 2004, J NUTR, V134, P2011, DOI 10.1093/jn/134.8.2011
   JOHANSSON MAE, 1995, CARCINOGENESIS, V16, P2553, DOI 10.1093/carcin/16.10.2553
   Knol JJ, 2010, FOOD CHEM, V120, P1047, DOI 10.1016/j.foodchem.2009.11.049
   Kuntcheva RJ, 1996, Z LEBENSM UNTERS FOR, V202, P238
   Langner E, 2014, INT J FOOD PROP, V17, P344, DOI 10.1080/10942912.2011.631253
   Laukaleja I, 2019, FOODBALT, P7, DOI 10.22616/FoodBalt.2019.002
   Machate DJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114093
   Marhuenda-Muñoz M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112725
   Martinez-Gomez A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030400
   Mesías M, 2017, CURR OPIN FOOD SCI, V14, P37, DOI 10.1016/j.cofs.2017.01.007
   Mohsin GF, 2020, FOOD CHEM, V305, DOI 10.1016/j.foodchem.2019.125459
   Morales FJ, 2005, FOOD CHEM, V90, P821, DOI 10.1016/j.foodchem.2004.05.030
   Morales FJ, 2012, AMINO ACIDS, V42, P1097, DOI 10.1007/s00726-010-0774-1
   Mundt S, 2003, J AGR FOOD CHEM, V51, P3651, DOI 10.1021/jf026027e
   Nooshkam M, 2020, FOOD RES INT, V131, DOI 10.1016/j.foodres.2020.109003
   Nunes FM, 2007, J AGR FOOD CHEM, V55, P3967, DOI 10.1021/jf063735h
   OBRETENOV TD, 1993, J AGR FOOD CHEM, V41, P653, DOI 10.1021/jf00028a028
   Ogutu Benrick, 2017, Prev Nutr Food Sci, V22, P211, DOI 10.3746/pnf.2017.22.3.211
   Oracz J, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110560
   Oracz J, 2019, FOOD RES INT, V115, P135, DOI 10.1016/j.foodres.2018.08.028
   Pastoriza S, 2014, FOOD CHEM, V164, P438, DOI 10.1016/j.foodchem.2014.04.118
   Pastoriza S, 2012, LWT-FOOD SCI TECHNOL, V45, P198, DOI 10.1016/j.lwt.2011.08.004
   Pérez-Burillo S, 2020, FOOD CHEM, V316, DOI 10.1016/j.foodchem.2020.126309
   Ripper B, 2020, J FOOD COMPOS ANAL, V87, DOI 10.1016/j.jfca.2019.103399
   Rodríguez A, 2019, MOLECULES, V24, DOI 10.3390/molecules24224163
   Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8
   Rufián-Henares JA, 2008, FOOD CHEM, V111, P1069, DOI 10.1016/j.foodchem.2008.05.027
   Rufián-Henares JA, 2007, FOOD RES INT, V40, P995, DOI 10.1016/j.foodres.2007.05.002
   Santal A.R., 2013, Biodegradation of Hazardous and Special Products, P71, DOI [10.5772/56252, DOI 10.5772/56252]
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Silván JM, 2006, J PHARMACEUT BIOMED, V41, P1543, DOI 10.1016/j.jpba.2006.04.004
   Somoza V, 2005, MOL NUTR FOOD RES, V49, P663, DOI 10.1002/mnfr.200500034
   Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504
   Tagliazucchi D, 2015, AMINO ACIDS, V47, P1077, DOI 10.1007/s00726-015-1951-z
   Tagliazucchi D, 2010, J FOOD BIOCHEM, V34, P1061, DOI 10.1111/j.1745-4514.2010.00349.x
   Tagliazucchi D, 2010, J AGR FOOD CHEM, V58, P2513, DOI 10.1021/jf903701h
   Takahama U, 2008, J AGR FOOD CHEM, V56, P4736, DOI 10.1021/jf703660k
   Tuohy KM, 2006, MOL NUTR FOOD RES, V50, P847, DOI 10.1002/mnfr.200500126
   Verzelloni E, 2010, FOOD CHEM TOXICOL, V48, P2097, DOI 10.1016/j.fct.2010.05.010
   Walker JM, 2020, J FUNCT FOODS, V72, DOI 10.1016/j.jff.2020.104063
   Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075
   Wang ZS, 2021, FOOD CHEM, V355, DOI 10.1016/j.foodchem.2021.129444
   Wu JF, 2020, FOOD FUNCT, V11, P9585, DOI [10.1039/d0fo02379e, 10.1039/D0FO02379E]
   Zhang H, 2021, FOOD CHEM, V345, DOI 10.1016/j.foodchem.2020.128827
   Zhao YM, 2021, FOOD CHEM, V337, DOI 10.1016/j.foodchem.2020.127790
NR 90
TC 35
Z9 36
U1 11
U2 120
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD NOV 14
PY 2022
VL 62
IS 32
BP 8954
EP 8971
DI 10.1080/10408398.2021.1937509
EA JUN 2021
PG 18
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 6E2FH
UT WOS:000662763200001
PM 34137312
DA 2025-04-28
ER

PT J
AU Mokhtari, I
   Mokhtari, C
   Moumou, M
   Harnafi, M
   Milenkovic, D
   Amrani, S
   Hakmaoui, A
   Harnafi, H
AF Mokhtari, Imane
   Mokhtari, Chakib
   Moumou, Mohammadine
   Harnafi, Mohamed
   Milenkovic, Dragan
   Amrani, Souliman
   Hakmaoui, Abdelmalek
   Harnafi, Hicham
TI Polyphenol-rich extract from loquat fruit peel prevents hyperlipidemia
   and hepato-nephrotoxicity in mice: in vivo study and in
   silico prediction of possible mechanisms involving identified
   polyphenols and/or their circulating metabolites
SO FOOD & FUNCTION
LA English
DT Article
ID FATTY LIVER-DISEASE; ERIOBOTRYA-JAPONICA; OXIDATIVE STRESS; NONALCOHOLIC
   STEATOHEPATITIS; ANTIOXIDANT ACTIVITY; DIETARY POLYPHENOLS;
   LIPID-METABOLISM; LIPOTOXICITY; HYPERTENSION; PATHOGENESIS
AB Hyperlipidemia is the most well-known cause of metabolic complications and tissue toxicity such as liver steatosis, atherosclerosis and obesity. This study aims to evaluate the preventive effect of loquat fruit peel extract (PE) against tyloxapol-induced hyperlipidemia and related tissue lipotoxicity in mice. The in vivo study was conducted on mice injected daily with tyloxapol at 100 mg per kg B.W. and treated simultaneously with the PE at concentrations of 100 and 200 mg kg(-1) or fenofibrate for 28 days. Plasma and tissue lipid biochemical analyses were undertaken using enzymatic methods. The antioxidative stress was revealed by measuring the malondialdehyde content and activities of superoxide dismutase and catalase as well as the scavenging activity against lipoperoxyl radicals. The PE significantly prevented oxidative stress and restored lipid metabolism, plasma glucose, body weight, organ relative mass and biomarkers of hepato-nephrotoxicity as well as the histological structure of the liver and kidneys. It contains five major polyphenols, namely, ferulic acid, caffeic acid, neochlorogenic acid, chlorogenic acid and quercetin. According to molecular docking analysis, these compounds and their circulating metabolites could interact with major proteins implicated in lipid metabolism and oxidative stress. Overall, the study suggests that PE could prevent hyperlipidemia and related toxic tissue complications.
C1 [Mokhtari, Imane; Moumou, Mohammadine; Harnafi, Mohamed; Amrani, Souliman; Harnafi, Hicham] Univ Mohamed I, Fac Sci, Lab Bioresources Biotechnol Ethnopharmacol & Hlth, Oujda 60000, Morocco.
   [Mokhtari, Chakib] Univ Mohamed I, Fac Sci, Lab Appl Chem & Environm ECOMP, Oujda 60000, Morocco.
   [Milenkovic, Dragan] Univ Calif Davis, Coll Agr & Environm Sci, Dept Nutr, Davis, CA 95616 USA.
   [Hakmaoui, Abdelmalek] Univ Hosp Mohamed VI, Ctr Clin Res, Lab Biopathol, Marrakech, Morocco.
C3 Mohammed First University of Oujda; Mohammed First University of Oujda;
   University of California System; University of California Davis; Cadi
   Ayyad University of Marrakech; Mohammed VI University Hospital Center of
   Marrakech
RP Harnafi, H (corresponding author), Univ Mohamed I, Fac Sci, Lab Bioresources Biotechnol Ethnopharmacol & Hlth, Oujda 60000, Morocco.; Milenkovic, D (corresponding author), Univ Calif Davis, Coll Agr & Environm Sci, Dept Nutr, Davis, CA 95616 USA.
EM dmilenkovic@ucdavis.edu; h.harnafi@ump.ac.ma
RI HARNAFI, Hicham/GVR-7673-2022; AMRANI, Souliman/AAK-7617-2020
OI Milenkovic, Dragan/0000-0001-6353-0912
FU ANPMA (Agence Nationale des Plantes Medicinales et Aromatiques,
   Morocco); CNRST (Centre National pour la Recherche Scientifique et
   Technique, Morocco); UMP (Universite Mohamed Premier. Oujda, Morocco)
   [PMA2020/2]; CNRST
FX This work is part of the project funded by the ANPMA (Agence Nationale
   des Plantes Medicinales et Aromatiques, Morocco), the CNRST (Centre
   National pour la Recherche Scientifique et Technique, Morocco) and the
   UMP (Universite Mohamed Premier. Oujda, Morocco), Grant number:
   PMA2020/2. We acknowledge support from CNRST for a PhD fellowship to
   Imane Mokhtari.
CR Abdelrahman ZR, 2023, PHARMACOGN MAG, V19, P56, DOI 10.1177/09731296221137432
   Abdou HM, 2018, J BASIC APPL ZOOL, V79, DOI 10.1186/s41936-018-0065-z
   Ahmed SSZ, 2019, CHIN HERB MED, V11, P326, DOI 10.1016/j.chmed.2019.05.006
   Akhter S, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/356729
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438
   Babashamsi MM, 2019, DIABETES METAB SYND, V13, P1529, DOI 10.1016/j.dsx.2019.03.004
   Bae JW, 2015, J ETHNOPHARMACOL, V162, P1, DOI 10.1016/j.jep.2014.12.023
   Balarini CM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-220
   Barradas V, 2021, REPROD FERTIL, V2, P141, DOI 10.1530/RAF-20-0048
   Benedict M, 2017, WORLD J HEPATOL, V9, P715, DOI 10.4254/wjh.v9.i16.715
   Bin-Jumah MN, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3914384
   Bo MS, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/7027624
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Buege J A, 1978, Methods Enzymol, V52, P302
   Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025
   Chiva-Blanch G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5812401
   Cory H, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00087
   Delfanian M, 2015, FOOD SCI NUTR, V3, P179, DOI [10.1002/fsn3.201, 10.1002/fsn3.320]
   Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028
   dos Santos RR, 2015, ULTRASON SONOCHEM, V22, P95, DOI 10.1016/j.ultsonch.2014.05.015
   Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148
   Ferreres F, 2009, FOOD CHEM, V114, P1019, DOI 10.1016/j.foodchem.2008.10.065
   GOLDFARB S, 1978, J LIPID RES, V19, P489
   Gyebi L, 2012, CURR HYPERTENS REP, V14, P177, DOI 10.1007/s11906-012-0250-2
   Hamada A, 2004, BIOL PHARM BULL, V27, P1961, DOI 10.1248/bpb.27.1961
   Heck SO, 2020, TOXICOL MECH METHOD, V30, P73, DOI 10.1080/15376516.2019.1669240
   Iftikhar N, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11112240
   Izquierdo-Lahuerta A, 2016, J NEPHROL, V29, P603, DOI 10.1007/s40620-016-0278-5
   Jawed A, 2019, S AFR J BOT, V120, P25, DOI 10.1016/j.sajb.2018.04.004
   Jian TY, 2017, BIOMED PHARMACOTHER, V91, P229, DOI 10.1016/j.biopha.2017.04.056
   김아라, 2011, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V40, P673
   Khlifi R, 2019, REGUL TOXICOL PHARM, V107, DOI 10.1016/j.yrtph.2019.104404
   Koba K, 2007, FOOD CHEM, V104, P308, DOI 10.1016/j.foodchem.2006.11.043
   Kuo JHS, 2006, PHARM RES, V23, P1509, DOI 10.1007/s11095-006-0281-y
   Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114
   Lin CH, 2018, J FUNCT FOODS, V49, P122, DOI 10.1016/j.jff.2018.08.005
   Lin Y, 2012, LAB INVEST, V92, P265, DOI 10.1038/labinvest.2011.159
   Liu HuiLing Liu HuiLing, 2013, Journal of Applied Pharmaceutical Science, V3, P16
   Liu Q, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-42
   Ma J, 2020, ANIM NUTR, V6, P404, DOI 10.1016/j.aninu.2020.08.002
   MAKKAR HPS, 1993, J SCI FOOD AGR, V61, P161, DOI 10.1002/jsfa.2740610205
   Marra F, 2018, J HEPATOL, V68, P280, DOI 10.1016/j.jhep.2017.11.014
   Mattes RD, 2005, PHYSIOL BEHAV, V86, P691, DOI 10.1016/j.physbeh.2005.08.058
   Mokhtari I, 2022, J FOOD QUALITY, V2022, DOI 10.1155/2022/9142395
   Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719
   Nickavar B, 2012, J ACUPUNCT MERIDIAN, V5, P119, DOI 10.1016/j.jams.2012.03.003
   OTWAY S, 1967, J PHYSIOL-LONDON, V190, P309, DOI 10.1113/jphysiol.1967.sp008210
   Pingili RB, 2019, CHEM-BIOL INTERACT, V308, P51, DOI 10.1016/j.cbi.2019.05.010
   Prata MF, 2022, EUR J LIPID SCI TECH, V124, DOI 10.1002/ejlt.202100017
   Ramos LPA, 2021, BIOMED PHARMACOTHER, V142, DOI 10.1016/j.biopha.2021.112049
   SAZUKA Y, 1989, JPN J CANCER RES, V80, P89, DOI 10.1111/j.1349-7006.1989.tb02250.x
   Shafi S., 2013, EUR SCI J, V9, P1
   Shahat AA, 2018, EVID-BASED COMPL ALT, V2018, P1
   Sheik Samreen M., 2023, Journal of Applied Pharmaceutical Science, V13, P154, DOI 10.7324/JAPS.2023.130217
   Sodipo O.A., 2011, Afr. J. Med. Med. Sci., V3, P93, DOI [10.9790/3013-0230464474, DOI 10.9790/3013-0230464474]
   Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2
   Tacherfiout M, 2018, BIOMED PHARMACOTHER, V101, P501, DOI 10.1016/j.biopha.2018.02.106
   Upadhyay G, 2010, CHEM-BIOL INTERACT, V183, P333, DOI 10.1016/j.cbi.2009.11.028
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Yang M, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9101405
   Yaribeygi H., 2019, COMP CLIN PATHOL, V28, P203, DOI [10.1007/s00580-018-2816-0, DOI 10.1007/s00580-018-2816-0]
   Zámbó V, 2013, WORLD J HEPATOL, V5, P550, DOI 10.4254/wjh.v5.i10.550
   Zhou Jun-Xian, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6020043
   Ziyyat A, 1997, J ETHNOPHARMACOL, V58, P45, DOI 10.1016/S0378-8741(97)00077-9
NR 64
TC 13
Z9 13
U1 3
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD AUG 14
PY 2023
VL 14
IS 16
BP 7489
EP 7505
DI 10.1039/d3fo01992f
EA JUL 2023
PG 17
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA O7UM7
UT WOS:001037027200001
PM 37498560
DA 2025-04-28
ER

PT J
AU Zhao, Y
   Tan, DC
   Peng, B
   Yang, L
   Zhang, SY
   Shi, RP
   Chong, CM
   Zhong, ZF
   Wang, SP
   Liang, QL
   Wang, YT
AF Zhao, Yi
   Tan, De-Chao
   Peng, Bo
   Yang, Lin
   Zhang, Si-Yuan
   Shi, Rui-Peng
   Chong, Cheong-Meng
   Zhong, Zhang-Feng
   Wang, Sheng-Peng
   Liang, Qiong-Lin
   Wang, Yi-Tao
TI Neuroendocrine-Immune Regulatory Network of Eucommia ulmoides
   Oliver
SO MOLECULES
LA English
DT Review
DE Eucommia ulmoides Oliver (E; ulmoides); neuroendocrine-immune; cancer;
   network pharmacology; natural products
ID CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; NEURONAL
   CELL-DEATH; ANGIOTENSIN-II; KAPPA-B; ANTIINFLAMMATORY ACTIVITY;
   ENDOTHELIAL DYSFUNCTION; CHEMICAL-CONSTITUENTS; INSULIN-RESISTANCE;
   CHLOROGENIC ACID
AB Eucommia ulmoides Oliver (E. ulmoides) is a popular medicinal herb and health supplement in China, Japan, and Korea, and has a variety of pharmaceutical properties. The neuroendocrine-immune (NEI) network is crucial in maintaining homeostasis and physical or psychological functions at a holistic level, consistent with the regulatory theory of natural medicine. This review aims to systematically summarize the chemical compositions, biological roles, and pharmacological properties of E. ulmoides to build a bridge between it and NEI-associated diseases and to provide a perspective for the development of its new clinical applications. After a review of the literature, we found that E. ulmoides has effects on NEI-related diseases including cancer, neurodegenerative disease, hyperlipidemia, osteoporosis, insomnia, hypertension, diabetes mellitus, and obesity. However, clinical studies on E. ulmoides were scarce. In addition, E. ulmoides derivatives are diverse in China, and they are mainly used to enhance immunity, improve hepatic damage, strengthen bones, and lower blood pressure. Through network pharmacological analysis, we uncovered the possibility that E. ulmoides is involved in functional interactions with cancer development, insulin resistance, NAFLD, and various inflammatory pathways associated with NEI diseases. Overall, this review suggests that E. ulmoides has a wide range of applications for NEI-related diseases and provides a direction for its future research and development.
C1 [Zhao, Yi; Tan, De-Chao; Peng, Bo; Yang, Lin; Zhang, Si-Yuan; Shi, Rui-Peng; Chong, Cheong-Meng; Zhong, Zhang-Feng; Wang, Sheng-Peng; Wang, Yi-Tao] Univ Macau, Macau Ctr Res & Dev Chinese Med, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China.
   [Liang, Qiong-Lin] Tsinghua Univ, Ctr Synthet & Syst Biol, Dept Chem,Beijing Key Lab Microanalyt Methods & I, MOE Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.
C3 University of Macau; Tsinghua University
RP Wang, YT (corresponding author), Univ Macau, Macau Ctr Res & Dev Chinese Med, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China.; Liang, QL (corresponding author), Tsinghua Univ, Ctr Synthet & Syst Biol, Dept Chem,Beijing Key Lab Microanalyt Methods & I, MOE Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.
EM mc05809@umac.mo; yc07549@umac.mo; bopengtcm@gmail.com;
   mb95803@um.edu.mo; yb97506@um.edu.mo; mc05808@umac.mo;
   cmchong@um.edu.mo; zhangfengzhong@um.edu.mo; swang@um.edu.mo;
   liangql@tsinghua.edu.cn; ytwang@um.edu.mo
RI Wang, Shengpeng/HRA-8956-2023; Peng, Boyang/MCK-2075-2025; wang,
   xueting/JPY-2782-2023; Siyuan, Zhang/JFA-6923-2023; Tan,
   Dechao/AAM-8251-2020; Liang, Qionglin/A-2407-2011
OI ZHAO, YI/0000-0003-2555-2154
FU Macao Science and Technology Development Fund [FDCT 007/2020/ALC,
   0006/2020/AKP]; Shenzhen-Hong Kong-Macau S&T Program (Category C)
   [SGDX2020110309420200]; Research Fund of University of Macau
   [CPG2022-00005-ICMS]
FX This work was supported by the Macao Science and Technology Development
   Fund (FDCT 007/2020/ALC and 0006/2020/AKP), Shenzhen-Hong Kong-Macau S&T
   Program (Category C) (SGDX2020110309420200), and the Research Fund of
   University of Macau (CPG2022-00005-ICMS).
CR Ahn HY, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018318
   Allen M J., 2022, Physiology, adrenocorticotropic hormone (ACTH)
   Anderson W.R., 1982, Brittonia, V34, P268, DOI [10.2307/2806386, DOI 10.2307/2806386]
   Ashley NT, 2017, HORM BEHAV, V87, P25, DOI 10.1016/j.yhbeh.2016.10.004
   Bai MM, 2015, J AGR FOOD CHEM, V63, P2198, DOI 10.1021/acs.jafc.5b00055
   Baracos VE, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.105
   Beauquis J, 2010, EXP NEUROL, V222, P125, DOI 10.1016/j.expneurol.2009.12.022
   Bellavance MA, 2012, IMMUNOL REV, V248, P36, DOI 10.1111/j.1600-065X.2012.01129.x
   Bilbo SD, 2012, HORM BEHAV, V62, P187, DOI 10.1016/j.yhbeh.2012.06.005
   BORN J, 1989, J CLIN ENDOCR METAB, V68, P904, DOI 10.1210/jcem-68-5-904
   Bozec A, 2017, CURR OSTEOPOROS REP, V15, P121, DOI 10.1007/s11914-017-0356-1
   Cabral MD, 2011, CLINICS, V66, P1321, DOI 10.1590/S1807-59322011000800003
   Canalis E, 2002, ANN NY ACAD SCI, V966, P73, DOI 10.1111/j.1749-6632.2002.tb04204.x
   CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885
   Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029
   Caplan A, 2017, J AM ACAD DERMATOL, V76, P11, DOI 10.1016/j.jaad.2016.02.1239
   [陈林攀 Chen Linpan], 2014, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V25, P2845
   Chen L, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1125-2
   Cho S, 2018, J ETHNOPHARMACOL, V213, P328, DOI 10.1016/j.jep.2017.10.008
   Chong CM, 2019, CHIN MED-UK, V14, DOI 10.1186/s13020-019-0242-0
   Cruz-Topete D, 2015, NEUROIMMUNOMODULAT, V22, P20, DOI 10.1159/000362724
   Dalbeth N, 2005, RHEUMATOLOGY, V44, P24, DOI 10.1093/rheumatology/keh398
   De Pablo-Fernández E, 2017, J NEUROL NEUROSUR PS, V88, P176, DOI 10.1136/jnnp-2016-314601
   Deckx N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/705232
   Delany AM, 2001, MOL ENDOCRINOL, V15, P1781, DOI 10.1210/me.15.10.1781
   den Uyl D, 2011, CURR RHEUMATOL REP, V13, P233, DOI 10.1007/s11926-011-0173-y
   Ding ZJ, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/6432173
   Do MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030265
   Du H.Y., 2015, GREEN BOOK EUCOMMIA
   Fan SS, 2020, J ETHNOPHARMACOL, V260, DOI 10.1016/j.jep.2020.113016
   [冯晗 Feng Han], 2015, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V20, P713
   Fisher RE, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/792934
   Forouhi N.G., 2010, MEDICINE, V38, P602, DOI DOI 10.1016/J.MPMED.2010.08.007
   FREDRICKSON DS, 1971, ANN INTERN MED, V75, P471, DOI 10.7326/0003-4819-75-3-471
   Freimark D, 2004, AM HEART J, V148, P878, DOI 10.1016/j.ahj.2004.04.013
   Fujikawa T, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.12
   Fujikawa T, 2010, BRIT J NUTR, V104, P1868, DOI 10.1017/S0007114510002965
   Fujiwara A, 2016, PHYTOCHEMISTRY, V122, P139, DOI 10.1016/j.phytochem.2015.11.017
   Gálvez I, 2017, ENDOCR METAB IMMUNE, V17, P78, DOI 10.2174/1871530317666170320113613
   Geng CH, 2017, PEPTIDES, V97, P8, DOI 10.1016/j.peptides.2017.09.002
   Guerrini MM, 2014, ARCH BIOCHEM BIOPHYS, V561, P118, DOI 10.1016/j.abb.2014.06.003
   Guo FF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00049
   Guo H, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0675-7
   Hao L, 2011, INT J ENDOCRINOL MET, V31, P368, DOI 10.3760/cma.j.issn.1673-4157.2011.06.003
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   Harding JL, 2019, DIABETOLOGIA, V62, P3, DOI 10.1007/s00125-018-4711-2
   Hayashi R, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00379
   He K, 2011, J ETHNOPHARMACOL, V137, P1135, DOI 10.1016/j.jep.2011.07.033
   He XR, 2014, J ETHNOPHARMACOL, V151, P78, DOI 10.1016/j.jep.2013.11.023
   Herhaus B, 2018, OBESITY FACTS, V11, P491, DOI 10.1159/000493533
   Hill M F., 2022, Hyperlipidemia
   Hirata T, 2011, BIOORG MED CHEM LETT, V21, P1786, DOI 10.1016/j.bmcl.2011.01.060
   Hofbauer LC, 2009, MOL ENDOCRINOL, V23, P1525, DOI 10.1210/me.2009-0069
   HOLSBOER F, 1988, NEUROENDOCRINOLOGY, V48, P32, DOI 10.1159/000124986
   Hosoo S, 2017, HYPERTENS RES, V40, P546, DOI 10.1038/hr.2016.189
   Hou XM, 2018, RSC ADV, V8, P40941, DOI 10.1039/c8ra07491g
   Hu RZ, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-020-00492-9
   Hu WC, 2014, CHEM-BIOL INTERACT, V224, P108, DOI 10.1016/j.cbi.2014.10.011
   Huang AG, 2020, AQUACULTURE, V528, DOI 10.1016/j.aquaculture.2020.735533
   In Man-Jin, 2018, Journal of Applied Biological Chemistry, V61, P119, DOI 10.3839/jabc.2018.017
   Jara LJ, 2017, IMMUNOL RES, V65, P512, DOI 10.1007/s12026-016-8891-x
   Jia CF, 2020, FOOD SCI BIOTECHNOL, V29, P657, DOI 10.1007/s10068-019-00712-7
   Jiang SH, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.586757
   Jiang SH, 2017, GASTROENTEROLOGY, V153, P277, DOI 10.1053/j.gastro.2017.03.008
   Jin CF, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/751854
   Jung FU, 2020, COGN AFFECT BEHAV NE, V20, P49, DOI 10.3758/s13415-019-00750-y
   Kerage D, 2019, J NEUROIMMUNOL, V332, P99, DOI 10.1016/j.jneuroim.2019.04.006
   Kim JY, 2015, PHYTOTHER RES, V29, P148, DOI 10.1002/ptr.5195
   KITAZONO T, 1995, CIRCULATION, V91, P1129, DOI 10.1161/01.CIR.91.4.1129
   Kobayashi Y., 2010, Journal of Traditional Medicines, V27, P225
   Kranzhöfer R, 1999, BIOCHEM BIOPH RES CO, V257, P826, DOI 10.1006/bbrc.1999.0543
   Kwon SH, 2016, BIOMOL THER, V24, P268, DOI 10.4062/biomolther.2015.150
   Kwon SH, 2014, J ETHNOPHARMACOL, V152, P173, DOI 10.1016/j.jep.2013.12.048
   Kwon SH, 2013, BIOMOL THER, V21, P462, DOI 10.4062/biomolther.2013.074
   Kwon SH, 2012, J ETHNOPHARMACOL, V142, P337, DOI 10.1016/j.jep.2012.04.010
   Lai LL, 2021, HUM EXP TOXICOL, V40, P661, DOI 10.1177/0960327120954521
   Lee GH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020426
   Lee GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088017
   Lee HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081349
   Lee SK, 2012, KOREAN J PHYSIOL PHA, V16, P199, DOI 10.4196/kjpp.2012.16.3.199
   [雷燕妮 Lei Yanni], 2015, [西北大学学报. 自然科学版, Journal of Northwest University. Natural Science Edition], V45, P777
   Lenna S, 2014, IUBMB LIFE, V66, P530, DOI 10.1002/iub.1292
   Li H., 2018, Practical J. Cancer, V33, P1045, DOI [10.3969/j.issn.1001-5930.2018.07.001, DOI 10.3969/J.ISSN.1001-5930.2018.07.001]
   Li JW, 2020, BIOMED CHROMATOGR, V34, DOI 10.1002/bmc.4741
   Li J, 2014, J HEPATOL, V60, P1225, DOI 10.1016/j.jhep.2014.02.025
   Li ManXiang Li ManXiang, 2010, Zhongguo Yufang Shouyi Xuebao / Chinese Journal of Preventive Veterinary Medicine, V32, P205
   Li Q, 2017, BIOMATERIALS, V148, P54, DOI 10.1016/j.biomaterials.2017.09.028
   Li Q, 2017, CARBOHYD POLYM, V169, P304, DOI 10.1016/j.carbpol.2017.04.034
   Li Q, 2016, ACS MACRO LETT, V5, P617, DOI 10.1021/acsmacrolett.6b00182
   Li S., 2010, THESIS NW U XIAN CHI
   Li X.H., 2018, LIAONING J TRADIT CH, V45, P1019
   Li XZ, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6362094
   Li X, 2017, NAT PROD RES, V31, P2072, DOI 10.1080/14786419.2016.1272108
   Li X, 2013, NAT PROD RES, V27, P1657, DOI 10.1080/14786419.2012.746343
   [李欣 Li Xin], 2012, [食品工业科技, Science & Technology of Food Industry], V33, P378
   [李欣 LI Xin], 2011, [食品科学, Food Science], V32, P296
   Li ZY, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-8
   Limmer A, 2017, Z ORTHOP UNFALLCHIR, V155, P273, DOI 10.1055/s-0043-100100
   Lin J, 2011, J ZHEJIANG UNIV-SC B, V12, P47, DOI 10.1631/jzus.B1000057
   Lin Q., 2019, Journal of Liaoning University of Traditional Chinese Medicine, V21, P26, DOI [10.13194/j.issn.1673-842x.2019.02.007, DOI 10.13194/J.ISSN.1673-842X.2019.02.007]
   Liu B, 2016, CELL PHYSIOL BIOCHEM, V39, P2044, DOI 10.1159/000447900
   Liu Cong, 2020, Zhongguo Zhong Yao Za Zhi, V45, P497, DOI 10.19540/j.cnki.cjcmm.20191108.201
   Liu M., 2017, SHAANXI J TRADIT CHI, V38, P226
   Liu ZQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26396
   Luo D, 2014, ACS CHEM NEUROSCI, V5, P855, DOI 10.1021/cn5001205
   [罗伟 Luo Wei], 2016, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V21, P1434
   Maseroli E, 2020, J MOL ENDOCRINOL, V65, P109, DOI 10.1530/JME-20-0147
   Miranda RA, 2016, J ENDOCRINOL, V230, P27, DOI 10.1530/JOE-15-0467
   Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje
   Nakamura A, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101522
   Nakazawa Y., 1995, MED AROMATIC PLANTS, P215
   National Pharmacopoeia Commission, 2020, CHINESE PHARMACOPOEI, V1
   Nie HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061678
   Niu HS, 2016, DRUG DES DEV THER, V10, P971, DOI 10.2147/DDDT.S98558
   Oglodek E, 2014, PHARMACOL REP, V66, P776, DOI 10.1016/j.pharep.2014.04.009
   Oikawa H, 2021, CURR MOL PHARMACOL, V14, P234, DOI 10.2174/1874467213666200505094631
   Okamura A, 1999, J HYPERTENS, V17, P537, DOI 10.1097/00004872-199917040-00012
   Padro CJ, 2014, SEMIN IMMUNOL, V26, P357, DOI 10.1016/j.smim.2014.01.003
   Park SB, 2013, EUR J PHARMACOL, V721, P70, DOI 10.1016/j.ejphar.2013.09.052
   Pasquali R, 2000, HORM METAB RES, V32, P521, DOI 10.1055/s-2007-978680
   Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012
   Peng MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223002
   Peng S., 2011, THESIS JISHOU U JISH
   Picchi A, 2006, CIRC RES, V99, P69, DOI 10.1161/01.RES.0000229685.37402.80
   Priyanka HP, 2019, TURK J IMMUNOL, V7, pS99, DOI 10.25002/tji.2019.1027
   Procaccini C, 2017, DEV COMP IMMUNOL, V66, P120, DOI 10.1016/j.dci.2016.06.006
   Procaccini C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00143
   Prpic-Krizevac I, 2012, WIEN KLIN WOCHENSCHR, V124, P403, DOI 10.1007/s00508-012-0191-4
   Qi YZ, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4261485
   [钱文丹 Qian Wendan], 2019, [中成药, Chinese Traditional Patent Medicine], V41, P1059
   Richardson GS, 2001, J CLIN PSYCHIAT, V62, P39
   Rovet JF, 2014, ENDOCR DEV, V26, P26, DOI 10.1159/000363153
   Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13
   Sagawa K, 2005, ARTHRITIS RHEUM-US, V52, P1920, DOI 10.1002/art.21040
   Sánchez-Lemus E, 2009, BRAIN BEHAV IMMUN, V23, P945, DOI 10.1016/j.bbi.2009.04.012
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao P, 2015, J FOOD SCI TECH MYS, V52, P4925, DOI 10.1007/s13197-014-1571-8
   Silverman MN, 2010, PM&R, V2, P338, DOI 10.1016/j.pmrj.2010.04.008
   Straub RH, 2010, J INTERN MED, V267, P543, DOI 10.1111/j.1365-2796.2010.02218.x
   Sturmberg JP, 2017, J EVAL CLIN PRACT, V23, P199, DOI 10.1111/jep.12587
   Sugawa H, 2016, FOOD FUNCT, V7, P2566, DOI [10.1039/C5FO01563D, 10.1039/c5fo01563d]
   Sun LJ, 2017, ONCOTARGET, V8, P40065, DOI 10.18632/oncotarget.16990
   Syzon Оrysya, 2017, Wiad Lek, V70, P205
   Szabó C, 2004, MOL MED, V10, P28, DOI 10.2119/2004-00001.Szabo
   Tagawa N, 2013, J ENDOCRINOL, V218, P311, DOI 10.1530/JOE-13-0066
   Taiwan Ministry of Health and Welfare, 2022, Taiwan health and welfare report
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217
   Tan XL, 2014, NAT PROD COMMUN, V9, P529
   Triggianese P, 2015, AM J REPROD IMMUNOL, V73, P56, DOI 10.1111/aji.12335
   van den Bergh JP, 2012, NAT REV RHEUMATOL, V8, P163, DOI 10.1038/nrrheum.2011.217
   Verburg-van Kemenade BML, 2017, DEV COMP IMMUNOL, V66, P2, DOI 10.1016/j.dci.2016.05.015
   Villa A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15224
   Wan P, 2014, WORLD J GASTROENTERO, V20, P14099, DOI 10.3748/wjg.v20.i39.14099
   Wang CY, 2019, AM J CHINESE MED, V47, P259, DOI 10.1142/S0192415X19500137
   Wang H, 2011, FOOD CHEM, V129, P408, DOI 10.1016/j.foodchem.2011.04.092
   [王娟娟 Wang Juanjuan], 2017, [中草药, Chinese Traditional and Herbal Drugs], V48, P3228
   Wang YS, 2019, ONCOTARGETS THER, V12, P5515, DOI 10.2147/OTT.S210497
   Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799
   Weitzmann MN, 2016, NAT REV ENDOCRINOL, V12, P518, DOI 10.1038/nrendo.2016.91
   Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
   Wilbert-Lampen U, 2006, J PSYCHOSOM RES, V61, P453, DOI 10.1016/j.jpsychores.2006.07.001
   World Health Organization, Obesity and overweight
   Wu D, 2018, MOLECULES, V23, DOI 10.3390/molecules23081898
   Xing YF, 2019, FOOD SCI HUM WELL, V8, P177, DOI 10.1016/j.fshw.2019.03.013
   Yan JK, 2017, FITOTERAPIA, V116, P121, DOI 10.1016/j.fitote.2016.12.001
   Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263
   Yu X., 2015, J MOD MED HLTH, V31, P187
   Yuan DX, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10111998
   [袁带秀 Yuan Daixiu], 2014, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V19, P1332
   Zeng ZY, 2017, PHARMACOGN MAG, V13, P498, DOI 10.4103/pm.pm_256_16
   [张立超 Zhang Lichao], 2013, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V19, P217
   Zhang Q, 2013, MOLECULES, V18, P1857, DOI 10.3390/molecules18021857
   Zhang R, 2009, BONE, V45, P553, DOI 10.1016/j.bone.2008.08.127
   Zhang R, 2014, J ETHNOPHARMACOL, V155, P104, DOI 10.1016/j.jep.2014.04.031
   Zhang S., 2018, CHIN ARCH TRADIT CHI, V36, P284
   Zhang SS, 2020, FOOD FUNCT, V11, P1425, DOI [10.1039/c9fo02288k, 10.1039/C9FO02288K]
   [张贤 Zhang Xian], 2012, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V16, P8520
   [赵继荣 Zhao Jirong], 2020, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V26, P1868
   熊伟, 2016, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V27, P2623
   Zhao LD, 2016, SCI CHINA LIFE SCI, V59, P1241, DOI 10.1007/s11427-016-5105-7
   Zhou ZJZ, 2020, EUR J PHARMACOL, V869, DOI 10.1016/j.ejphar.2019.172857
   Zhu MO, 2018, J AGR FOOD CHEM, V66, P5433, DOI 10.1021/acs.jafc.8b01312
NR 184
TC 16
Z9 16
U1 12
U2 85
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JUN
PY 2022
VL 27
IS 12
AR 3697
DI 10.3390/molecules27123697
PG 38
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 2K5AZ
UT WOS:000816349800001
PM 35744822
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Gerhauser, C
AF Gerhauser, Clarissa
TI Cancer Chemopreventive Potential of Apples, Apple juice, and Apple
   Components
SO PLANTA MEDICA
LA English
DT Review
DE apples; Malus sp.; Rosaceae; cancer chemoprevention; oligomeric
   procyanidins; polyphenols
ID PLASMA ANTIOXIDANT CAPACITY; POMACE EXTRACTION JUICES; GROWTH-FACTOR
   RECEPTOR; KAPPA-B ACTIVATION; DNA-DAMAGE; HYDROGEN-PEROXIDE; CHLOROGENIC
   ACID; MALUS-PUMILA; IN-VITRO; ANTIPROLIFERATIVE ACTIVITY
AB Apples (Malus sp., Rosaceae) are a rich source of nutrient as well as non-nutrient components and contain high levels of polyphenols and other phytochemicals. Main structural classes of apple constituents include hydroxycinnamic acids, di-hydrochalcones, flavonols (quercetin glycosides), catechins and oligomeric procyaniclins, as well as triterpenoids in apple peel and anthocyanins in red apples. Several lines of evidence suggest that apples and apple products possess a wide range of biological activities which may contribute to health beneficial effects against cardiovascular disease, asthma and pulmonary dysfunction, diabetes, obesity, and cancer (reviewed by Boyer and Liu, Nutr J 2004). The present review will summarize the current knowledge on potential cancer preventive effects of apples, apple juice and apple extracts (jointly designated as apple products). In brief, apple extracts and components, especially oligomeric procyanidins, have been shown to influence multiple mechanisms relevant for cancer prevention in in vitro studies. These include antimutagenic activity, modulation of carcinogen metabolism, antioxidant activity, anti-inflammatory mechanisms, modulation of signal transduction pathways, antiproliferative and apoptosis-inducing activity, as well as novel mechanisms on epigenetic events and innate immunity. Apple products have been shown to prevent skin, mammary and colon carcinogenesis in animal models. Epidemiological observations indicate that regular consumption of one or more apples a day may reduce the risk for lung and colon cancer.
C1 German Canc Res Ctr, Div Toxicol & Canc Risk Factors, D-9120 Heidelberg, Germany.
C3 Helmholtz Association; German Cancer Research Center (DKFZ)
RP Gerhauser, C (corresponding author), German Canc Res Ctr, Div Toxicol & Canc Risk Factors, Neuenheimer Feld 280, D-9120 Heidelberg, Germany.
EM c.gerhauser@dkfz.de
OI Gerhauser, Clarissa/0000-0002-5792-3901
CR Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009
   Ahn KS, 2007, CURR MOL MED, V7, P619, DOI 10.2174/156652407782564363
   Akazome Y, 2004, BIOFACTORS, V22, P311, DOI 10.1002/biof.5520220161
   Akiyama H, 2005, FEBS LETT, V579, P4485, DOI 10.1016/j.febslet.2005.07.019
   Alonso-Salces RM, 2004, J AGR FOOD CHEM, V52, P2938, DOI 10.1021/jf035416l
   [Anonymous], FLUSSIGES OBST
   Aprikian O, 2003, J NUTR, V133, P1860, DOI 10.1093/jn/133.6.1860
   Aron PM, 2008, MOL NUTR FOOD RES, V52, P79, DOI 10.1002/mnfr.200700137
   Arts ICW, 2001, INT J CANCER, V92, P298, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1187>3.0.CO;2-8
   Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647
   Barth SW, 2007, J AGR FOOD CHEM, V55, P1181, DOI 10.1021/jf063078t
   Barth SW, 2005, CARCINOGENESIS, V26, P1414, DOI 10.1093/carcin/bgi082
   Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5
   Briviba K, 2007, J AGR FOOD CHEM, V55, P7716, DOI 10.1021/jf0710534
   Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m
   Chen D, 2008, HISTOL HISTOPATHOL, V23, P487, DOI 10.14670/HH-23.487
   Chen MS, 2004, IN VIVO, V18, P73
   Chinnici F, 2004, J AGR FOOD CHEM, V52, P4684, DOI 10.1021/jf049770a
   Chrzczanowicz J, 2008, CLIN CHEM LAB MED, V46, P342, DOI 10.1515/CCLM.2008.062
   Crespy V, 2001, J NUTR, V131, P3227, DOI 10.1093/jn/131.12.3227
   Crespy V, 2001, J NUTR, V131, P2109, DOI 10.1093/jn/131.8.2109
   D'Angelo S, 2007, J AGR FOOD CHEM, V55, P9977, DOI 10.1021/jf071773a
   Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S
   Davis PA, 2006, EXP BIOL MED, V231, P594
   De Flora S, 2005, MUTAT RES-FUND MOL M, V591, P8, DOI 10.1016/j.mrfmmm.2005.02.029
   DeneoPellegrini H, 1996, NUTR CANCER, V25, P297, DOI 10.1080/01635589609514453
   Déprez S, 2000, J NUTR, V130, P2733, DOI 10.1093/jn/130.11.2733
   Ding M, 2004, J BIOL CHEM, V279, P10670, DOI 10.1074/jbc.M311465200
   Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148
   Ellinger W., 2007, ZMP MARKTBILANZ OBST
   Fang MZ, 2007, J NUTR, V137, p223S, DOI 10.1093/jn/137.1.223S
   FERGUSON LR, 1994, MUTAT RES, V307, P395, DOI 10.1016/0027-5107(94)90313-1
   Ferguson LR, 2003, FOOD CHEM TOXICOL, V41, P785, DOI 10.1016/S0278-6915(03)00012-7
   Feskanich D, 2000, JNCI-J NATL CANCER I, V92, P1812, DOI 10.1093/jnci/92.22.1812
   Fini L, 2007, J NUTR, V137, P2622, DOI 10.1093/jn/137.12.2622
   Fridrich D, 2007, MOL NUTR FOOD RES, V51, P594, DOI 10.1002/mnfr.200600189
   Frighetto RTS, 2008, FOOD CHEM, V106, P767, DOI 10.1016/j.foodchem.2007.06.003
   Gallus S, 2005, ANN ONCOL, V16, P1841, DOI 10.1093/annonc/mdi361
   Gerhäuser C, 2008, EJC SUPPL, V6, P50, DOI 10.1016/S1359-6349(08)70258-1
   Gerhäuser C, 2003, MUTAT RES-FUND MOL M, V523, P163, DOI 10.1016/S0027-5107(02)00332-9
   GERHAUSER C, 2007, FORUM DTSCH KREBSGES, P5
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Goodlad RA, 2007, NUTRITION, V23, P434, DOI 10.1016/j.nut.2006.10.010
   Gossé F, 2005, CARCINOGENESIS, V26, P1291, DOI 10.1093/carcin/bgi074
   Gossé F, 2006, INT J ONCOL, V29, P423
   Graff JC, 2007, J LEUKOCYTE BIOL, V82, P603, DOI 10.1189/jlb.0207125
   Gu LW, 2004, J NUTR, V134, P613, DOI 10.1093/jn/134.3.613
   Guyot S, 2003, J AGR FOOD CHEM, V51, P6240, DOI 10.1021/jf0301798
   Guyot S, 2001, J AGR FOOD CHEM, V49, P14, DOI 10.1021/jf000814z
   Guyot S, 1998, J AGR FOOD CHEM, V46, P1698, DOI 10.1021/jf970832p
   He XJ, 2007, J AGR FOOD CHEM, V55, P4366, DOI 10.1021/jf063563o
   Hensel A, 1999, PLANTA MED, V65, P395, DOI 10.1055/s-1999-14013
   Hibasami H, 2004, INT J MOL MED, V13, P795
   Hoffmann Raymond G., 2007, V404, P19, DOI 10.1007/978-1-59745-530-5_2
   Holderness J, 2007, J IMMUNOL, V179, P6468, DOI 10.4049/jimmunol.179.10.6468
   Huemmer Wolfgang, 2008, Biotechnol J, V3, P234, DOI 10.1002/biot.200700116
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Kahle K, 2005, MOL NUTR FOOD RES, V49, P1143, DOI 10.1002/mnfr.200500132
   Kahle K, 2005, MOL NUTR FOOD RES, V49, P797, DOI 10.1002/mnfr.200500064
   Kahle K, 2007, J AGR FOOD CHEM, V55, P10605, DOI 10.1021/jf071942r
   Kang NJ, 2004, BIOFACTORS, V21, P361, DOI 10.1002/biof.552210169
   Kelloff GJ, 2006, CLIN CANCER RES, V12, P3661, DOI 10.1158/1078-0432.CCR-06-1104
   Kern M, 2005, MOL NUTR FOOD RES, V49, P317, DOI 10.1002/mnfr.200400086
   Kern M, 2007, J AGR FOOD CHEM, V55, P4999, DOI 10.1021/jf063158x
   Kern M, 2006, J AGR FOOD CHEM, V54, P7041, DOI 10.1021/jf0606611
   Kestell P, 2004, J CHROMATOGR B, V802, P201, DOI 10.1016/j.jchromb.2003.10.046
   Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4
   Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560
   Ko SH, 2005, J MED FOOD, V8, P41, DOI 10.1089/jmf.2005.8.41
   Köhle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009
   Lapidot T, 2002, J AGR FOOD CHEM, V50, P3156, DOI 10.1021/jf011522g
   Lata B, 2005, J AGR FOOD CHEM, V53, P8970, DOI 10.1021/jf051503x
   Lata B, 2007, J AGR FOOD CHEM, V55, P10795, DOI 10.1021/jf072035p
   Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154
   Lee KW, 2003, J AGR FOOD CHEM, V51, P6516, DOI 10.1021/jf034475w
   Lee Se Young, 2005, Korean J Gastroenterol, V45, P23
   Lindblad P, 1997, CANCER EPIDEM BIOMAR, V6, P215
   Liu RH, 2005, J AGR FOOD CHEM, V53, P2341, DOI 10.1021/jf058010c
   Liu RH, 2003, J AGR FOOD CHEM, V51, P1718, DOI 10.1021/jf026162r
   Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895
   Lotito SB, 2004, FREE RADICAL BIO MED, V36, P201
   Lotito SB, 2004, FREE RADICAL BIO MED, V37, P251, DOI 10.1016/j.freeradbiomed.2004.04.019
   Lotito SB, 2006, FREE RADICAL BIO MED, V41, P1727, DOI 10.1016/j.freeradbiomed.2006.04.033
   Maffei F, 2007, BRIT J NUTR, V97, P921, DOI 10.1017/S0007114507665192
   Maldonado-Celis ME, 2008, CELL MOL LIFE SCI, V65, P1425, DOI 10.1007/s00018-008-8023-4
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   MANDIR N, 2008, BR J NUTR, P1
   Mangas JJ, 1997, J AGR FOOD CHEM, V45, P4777, DOI 10.1021/jf970262t
   Mayer B, 2001, ANAL BIOCHEM, V297, P144, DOI 10.1006/abio.2001.5333
   McCann MJ, 2007, FOOD CHEM TOXICOL, V45, P1224, DOI 10.1016/j.fct.2007.01.003
   McGhie TK, 2005, J AGR FOOD CHEM, V53, P3065, DOI 10.1021/jf047832r
   Mehrländer K, 2002, J AGR FOOD CHEM, V50, P1230, DOI 10.1021/jf011007i
   Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734
   Michels KB, 2006, CANCER RES, V66, P3942, DOI 10.1158/0008-5472.CAN-05-3637
   Milner JA, 2006, NUTR CANCER, V56, P216, DOI 10.1207/s15327914nc5602_13
   Miura D, 2007, BIOSCI BIOTECH BIOCH, V71, P2743, DOI 10.1271/bbb.70359
   Miura T, 2008, CARCINOGENESIS, V29, P585, DOI 10.1093/carcin/bgm198
   MULERONAVARRO S, 2008, CRIT REV ONCOL HEMAT, DOI DOI 10.1016/J.CRI-TREVONC.2008.03.001
   OHKAMI H, 1995, JPN J CANCER RES, V86, P523, DOI 10.1111/j.1349-7006.1995.tb02429.x
   OhnishiKameyama M, 1997, RAPID COMMUN MASS SP, V11, P31, DOI 10.1002/(SICI)1097-0231(19970115)11:1<31::AID-RCM784>3.0.CO;2-T
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Oszmianski J, 2007, J SCI FOOD AGR, V87, P573, DOI 10.1002/jsfa.2707
   Ovesná Z, 2004, NEOPLASMA, V51, P327
   OWEN R W, 1987, Nutrition and Cancer, V9, P67
   Pan L, 2005, CANCER EPIDEM BIOMAR, V14, p2715S
   Park SY, 2007, J MED FOOD, V10, P581, DOI 10.1089/jmf.2007.116
   Pearson DA, 1999, LIFE SCI, V64, P1913, DOI 10.1016/S0024-3205(99)00137-X
   Percival SS, 2008, J NUTR, V138, P1
   Pohl C, 2006, J AGR FOOD CHEM, V54, P10262, DOI 10.1021/jf061791c
   Prior RL, 2005, PHYTOCHEMISTRY, V66, P2264, DOI 10.1016/j.phytochem.2005.03.025
   Ramos S, 2008, MOL NUTR FOOD RES, V52, P507, DOI 10.1002/mnfr.200700326
   Rios LY, 2002, AM J CLIN NUTR, V76, P1106, DOI 10.1093/ajcn/76.5.1106
   Sanoner P, 1999, J AGR FOOD CHEM, V47, P4847, DOI 10.1021/jf990563y
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Schaefer S, 2006, MOL NUTR FOOD RES, V50, P24, DOI 10.1002/mnfr.200500136
   Schmitz-Eiberger M, 2003, J APPL BOT-ANGEW BOT, V77, P167
   Sembries S, 2004, J NUTR BIOCHEM, V15, P296, DOI 10.1016/j.jnutbio.2003.12.005
   Sembries S, 2003, BRIT J NUTR, V90, P607, DOI 10.1079/BJN2003925
   Sembries S, 2006, J AGR FOOD CHEM, V54, P10269, DOI 10.1021/jf0618168
   Sengupta S, 2006, J GASTROEN HEPATOL, V21, P209, DOI 10.1111/j.1440-1746.2006.04213.x
   Shi David, 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P233
   Shibusawa Y, 2001, J CHROMATOGR A, V915, P253, DOI 10.1016/S0021-9673(01)00575-1
   Shimizu J, 1996, J NUTR SCI VITAMINOL, V42, P527, DOI 10.3177/jnsv.42.527
   Shoji T, 2006, J CHROMATOGR A, V1102, P206, DOI 10.1016/j.chroma.2005.10.065
   Shoji T, 2004, FOOD CHEM TOXICOL, V42, P959, DOI 10.1016/j.fct.2004.02.008
   Souci S.W., 2005, FOOD COMPOSITION NUT
   Spencer JPE, 2001, ANTIOXID REDOX SIGN, V3, P1023, DOI 10.1089/152308601317203558
   SPORN MB, 1979, FED PROC, V38, P2528
   Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189
   Theodoratou E, 2007, CANCER EPIDEM BIOMAR, V16, P684, DOI 10.1158/1055-9965.EPI-06-0785
   Thielen C, 2004, DEUT LEBENSM-RUNDSCH, V100, P389
   Trosko JE, 2006, CONTRIB MICROBIOL, V13, P45, DOI 10.1159/000092965
   Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298
   Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Van Buren J., 1970, The biochemistry of fruits and their products, vol, V1, P269
   van der Sluis AA, 2000, J AGR FOOD CHEM, V48, P4116, DOI 10.1021/jf000156i
   Vanzani P, 2005, J AGR FOOD CHEM, V53, P3377, DOI 10.1021/jf040482o
   Veeriah S, 2006, MOL CARCINOGEN, V45, P164, DOI 10.1002/mc.20158
   Veeriah S, 2008, INT J CANCER, V122, P2647, DOI 10.1002/ijc.23440
   Veeriah S, 2007, J AGR FOOD CHEM, V55, P2892, DOI 10.1021/jf063386r
   Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x
   Vrhovsek U, 2004, J AGR FOOD CHEM, V52, P6532, DOI 10.1021/jf049317z
   Waldecker M, 2008, NUTRITION, V24, P366, DOI 10.1016/j.nut.2007.12.013
   Walle T, 2000, J NUTR, V130, P2658, DOI 10.1093/jn/130.11.2658
   Walle Thomas, 2001, Journal of Nutrition, V131, P2648
   Will F, 2000, EUR FOOD RES TECHNOL, V211, P291, DOI 10.1007/s002170000171
   Wilms LC, 2005, MUTAT RES-GEN TOX EN, V582, P155, DOI 10.1016/j.mrgentox.2005.01.006
   Wilms LC, 2007, CARCINOGENESIS, V28, P1800, DOI 10.1093/carcin/bgm145
   *WIRTSCH ALK GETR, 2008, PROKOPF VERBR ALK GE
   Wolfe KL, 2003, J AGR FOOD CHEM, V51, P1676, DOI 10.1021/jf025916z
   Yanagida A, 1999, J CHROMATOGR A, V855, P181, DOI 10.1016/S0021-9673(99)00684-6
   Yanagida A, 2000, J CHROMATOGR A, V890, P251, DOI 10.1016/S0021-9673(00)00614-2
   Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381
   Yang GY, 1998, CARCINOGENESIS, V19, P611, DOI 10.1093/carcin/19.4.611
   Yoon H, 2007, J AGR FOOD CHEM, V55, P3167, DOI 10.1021/jf0632379
   Zessner H, 2008, MOL NUTR FOOD RES, V52, pS28, DOI 10.1002/mnfr.200700317
NR 158
TC 196
Z9 219
U1 9
U2 104
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0032-0943
EI 1439-0221
J9 PLANTA MED
JI Planta Med.
PD OCT
PY 2008
VL 74
IS 13
BP 1608
EP 1624
DI 10.1055/s-0028-1088300
PG 17
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 370RT
UT WOS:000260781300010
PM 18855307
OA Bronze
DA 2025-04-28
ER

PT J
AU dos Santos, DC
   de Oliveira, JG
   de Sousa, TL
   Ribeiro, CB
   Egea, MB
AF dos Santos, Daiane Costa
   de Oliveira Filho, Josemar Goncalves
   de Sousa, Tainara Leal
   Ribeiro, Carolina Barbosa
   Egea, Mariana Buranelo
TI Ameliorating effects of metabolic syndrome with the consumption of
   rich-bioactive compounds fruits from Brazilian Cerrado: a narrative
   review
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Brazilian native fruits; diabetes; dyslipidemia; functional foods;
   obesity
ID EUGENIA-DYSENTERICA DC.; DIPTERYX-ALATA VOG.; ANACARDIUM-OCCIDENTALE L.;
   VITAMIN-C; CARYOCAR-BRASILIENSE; PHENOLIC-COMPOUNDS; CHLOROGENIC ACID;
   HIGH-FAT; OXIDATIVE STRESS; TROPICAL FRUITS
AB Evidence suggests that bioactive compounds present in fruits and vegetables, including carotenoids, polyphenols, and phytosterols, may have beneficial effects against the development of obesity and other diseases. The fruits of the Brazilian Cerrado are rich in biologically active compounds but are underexplored by the population being used only locally dietary consumption. The objective of this review is to direct attention to the bioactive compounds already elucidated for the fruits of "Cerrado" cashew (Anacadium othanianum Rizz.), baru almond (Dipteryx alata Vogel), cagaita (Eugenia dysenterica DC.), "Cerrado" pear (Eugenia klotzschiana Berg), mangaba (Hancornia speciosa), and pequi (Caryocar brasiliense Camb), demonstrating possible metabolic effects of the consumption of these fruits on the metabolic syndrome and its risk factors. Studies have shown that Cerrado native fruits have a high content of bioactive compounds such as phenolic compounds, which also demonstrate high antioxidant capacity and may be related to the protective effect in metabolic syndrome-related diseases by act as inhibitors in various processes in lipid metabolism and glucose transport. Although more scientific evidence is still needed, the consumption of native fruits from the Cerrado seems to be a promising strategy which -along with other strategies such as nutritional therapy- can ameliorate the effects of the metabolic syndrome.
C1 [dos Santos, Daiane Costa] Goias Fed Univ UFG, IPTSP UFG, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.
   [dos Santos, Daiane Costa; Ribeiro, Carolina Barbosa] Unibras Coll Rio Verde, Sch Nutr, Rio Verde, Go, Brazil.
   [de Oliveira Filho, Josemar Goncalves] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Araraquara, SP, Brazil.
   [de Sousa, Tainara Leal; Egea, Mariana Buranelo] Goias Fed Univ UFG, Dept Agron, Goiania, Go, Brazil.
   [Egea, Mariana Buranelo] Goiano Fed Inst Educ Sci & Technol, Rio Verde, Go, Brazil.
C3 Universidade Estadual Paulista; Instituto Federal de Goias (IFG)
RP Egea, MB (corresponding author), Goiano Fed Inst, Rio Verde, Go, Brazil.
EM mariana.egea@ifgoiano.edu.br
RI Egea, Mariana/B-1889-2014; Sousa, Tainara/ABA-9324-2020; de Oliveira
   Filho, Josemar/AAU-5158-2020
OI Goncalves de Oliveira Filho, Josemar/0000-0001-9755-7128
FU CNPq [426479/2016-5, 203394/2019-4, 308489/2020-9]; FAPEG; CAPES [001];
   IF Goiano
FX The authors acknowledge the financial support of CNPq (Processes no.
   426479/2016-5, no. 203394/2019-4, and no. 308489/2020-9), FAPEG, CAPES
   (001), and IF Goiano.
CR Abbaspour N, 2014, J RES MED SCI, V19, P164
   Ahrens MJ, 2013, J MED FOOD, V16, P211, DOI 10.1089/jmf.2012.0069
   Alkhatib A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121310
   Alves AM, 2017, FOOD SCI TECH-BRAZIL, V37, P564, DOI [10.1590/1678-457x.26716, 10.1590/1678-457X.26716]
   ALVES AM, 2010, AGR RES TROPICS, V20, P266
   Stefanello MÉA, 2011, CHEM BIODIVERS, V8, P73, DOI 10.1002/cbdv.201000098
   Assumpcao CF, 2014, CIENC RURAL, V44, P1297, DOI 10.1590/0103-8478cr20130855
   Assunçao RB, 2003, FOOD CHEM, V81, P495, DOI 10.1016/S0308-8146(02)00477-6
   ATALA Alex., 2003, Por uma Gastronomia Brasileira
   Azevedo-Meleiro CH, 2004, J FOOD COMPOS ANAL, V17, P385, DOI 10.1016/j.jfca.2004.02.004
   Azzi A, 2004, BIOL CHEM, V385, P585, DOI 10.1515/BC.2004.072
   Balisteiro DM, 2017, FOOD RES INT, V100, P196, DOI 10.1016/j.foodres.2017.08.044
   Benedict M, 2017, WORLD J HEPATOL, V9, P715, DOI 10.4254/wjh.v9.i16.715
   Bento APN, 2014, NUTR METAB CARDIOVAS, V24, P1330, DOI 10.1016/j.numecd.2014.07.002
   Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34
   Almeida MMB, 2011, FOOD RES INT, V44, P2155, DOI 10.1016/j.foodres.2011.03.051
   Bilbeisi, 2019, CLIN NUTR EXP, V26, P23, DOI [10.1016/j.yclnex.2019.05.003, DOI 10.1016/J.YCLNEX.2019.05.003]
   Birch CS, 2019, INT J FOOD SCI TECH, V54, P1467, DOI 10.1111/ijfs.14060
   Lemos MRB, 2012, FOOD RES INT, V48, P592, DOI 10.1016/j.foodres.2012.05.027
   Bortolotto IM, 2017, REG ENVIRON CHANGE, V17, P1329, DOI 10.1007/s10113-016-1088-y
   Botezelli L., 2015, CERNE, V6, P9
   Carneiro NS, 2017, AN ACAD BRAS CIENC, V89, P1907, DOI 10.1590/0001-3765201720160652
   Carneiro NS, 2019, BRAZ ARCH BIOL TECHN, V62, DOI 10.1590/1678-4324-2019170562
   CARR A, 2020, CRIT REV FOOD SCI, V61, P1
   Carvalho DV, 2019, FOOD FUNCT, V10, P1671, DOI [10.1039/C8FO01575A, 10.1039/c8fo01575a]
   Chen X, 2001, HYPERTENSION, V38, P606, DOI 10.1161/hy09t1.094005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cho Y, 2015, ANN LAB MED, V35, P586, DOI 10.3343/alm.2015.35.6.586
   Cohen K.D.O., 2010, PARAMETROS FISICO QU
   Costa CF, 2017, BIOCHEM SYST ECOL, V72, P63, DOI 10.1016/j.bse.2017.03.001
   Cynober L., 2000, NUTR CLIN METABOL S1, V14, P3, DOI [10.1016/S0985-0562(00)80002-3, DOI 10.1016/S0985-0562(00)80002-3]
   Czeder L. P., 2012, Agricultural Sciences, V3, P745
   da Cunha PLR, 2009, QUIM NOVA, V32, P649, DOI 10.1590/S0100-40422009000300009
   Neves GAD, 2021, J SCI FOOD AGR, V101, P2855, DOI 10.1002/jsfa.10916
   da Silva D.X, 2020, BRAZILIAN J DEV, V6, P21951, DOI [10.34117/bjdv6n4-385, DOI 10.34117/BJDV6N4-385]
   Damasco G., 2018, Frontiers for Young Minds, V6, P1, DOI [10.3389/frym.2018.00022, DOI 10.3389/FRYM.2018.00022]
   Das UN, 2019, ARCH MED RES, V50, P11, DOI 10.1016/j.arcmed.2019.05.004
   Daza LD, 2017, FOOD BIOSCI, V18, P15, DOI 10.1016/j.fbio.2017.03.003
   de Almeida AB, 2019, NUTR FOOD SCI, V49, P381, DOI 10.1108/NFS-07-2018-0199
   Siqueira EMD, 2012, FOOD RES INT, V45, P427, DOI 10.1016/j.foodres.2011.11.005
   De Ancos B, 2020, FOOD RES INT, V132, DOI 10.1016/j.foodres.2020.109105
   Silva CAD, 2016, FOOD SCI BIOTECHNOL, V25, P1225, DOI 10.1007/s10068-016-0195-3
   de Araújo FF, 2019, FOOD RES INT, V121, P57, DOI 10.1016/j.foodres.2019.03.018
   De Lima A, 2007, REV BRAS FRUTIC, V29, P695, DOI 10.1590/S0100-29452007000300052
   de Lima TM, 2021, LWT-FOOD SCI TECHNOL, V135, DOI 10.1016/j.lwt.2020.110030
   Sousa AGD, 2011, FOOD RES INT, V44, P2319, DOI 10.1016/j.foodres.2011.02.013
   de Sousa E.R., 2018, EXOTIC FRUITS, P77, DOI DOI 10.1016/B978-0-12-803138-4.00011-3
   de Souzaz FG, 2007, CIENC AGROTEC, V31, P1449, DOI 10.1590/S1413-70542007000500027
   Dedehou E., 2016, African Journal of Biotechnology, V15, P2637
   Dionisio AP, 2015, FOOD RES INT, V77, P171, DOI 10.1016/j.foodres.2015.07.020
   Donado-Pestana CM, 2018, CURR OPIN FOOD SCI, V19, P42, DOI 10.1016/j.cofs.2018.01.001
   Donado-Pestana CM, 2018, FOOD RES INT, V103, P40, DOI 10.1016/j.foodres.2017.10.011
   Donado-Pestana CM, 2015, FOOD RES INT, V77, P177, DOI 10.1016/j.foodres.2015.06.044
   Egea M.B., 2020, CURR DEV NUTR, V4, P373, DOI [10.1093/cdn/nzaa045_006, DOI 10.1093/CDN/NZAA045_006]
   Egea M.B., 2020, Bioactive Compounds in Underutilized Fruits and Nuts, P289, DOI [DOI 10.1007/978-3-030-30182-8_17, 10.1007/978-3-030-30182-817]
   Ellis GR, 2000, J AM COLL CARDIOL, V36, P1474, DOI 10.1016/S0735-1097(00)00916-5
   Emanuela F, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/476380
   Schiassi MCEV, 2018, FOOD CHEM, V245, P305, DOI 10.1016/j.foodchem.2017.10.104
   Fåk F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127252
   Fernandes DC, 2010, J SCI FOOD AGR, V90, P1650, DOI 10.1002/jsfa.3997
   Fernandes Pricilla Regina Oliveira Fernandes, 2011, Arq. Bras. Cardiol., V96, P490
   Araujo ACF, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20151337
   Fonteles TV, 2017, FOOD BIOPROCESS TECH, V10, P1854, DOI 10.1007/s11947-017-1960-x
   Forouhi NG, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2139
   FREI B, 1990, ADV EXP MED BIOL, V264, P155
   Galli F, 2017, FREE RADICAL BIO MED, V102, P16, DOI 10.1016/j.freeradbiomed.2016.09.017
   Gharibzahedi SMT, 2017, TRENDS FOOD SCI TECH, V62, P119, DOI 10.1016/j.tifs.2017.02.017
   Godoy-Matos AF, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00570-y
   Granger M, 2018, ADV FOOD NUTR RES, V83, P281, DOI 10.1016/bs.afnr.2017.11.006
   Greenfield DM, 2019, EBMT HANDBOOK: HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CELLULAR THERAPIES, P415, DOI 10.1007/978-3-030-02278-5_55
   Gregório BM, 2016, CURR PHARM DESIGN, V22, P859, DOI 10.2174/1381612822666151209152352
   Gullón B, 2017, TRENDS FOOD SCI TECH, V67, P220, DOI 10.1016/j.tifs.2017.07.008
   Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122
   Hopps E, 2010, NUTR METAB CARDIOVAS, V20, P72, DOI 10.1016/j.numecd.2009.06.002
   Horenstein A, 2018, CLIN PSYCHOL-SCI PR, V25, DOI 10.1111/cpsp.12248
   Hosono Akio., 2016, Development for Sustainable Agriculture: The Brazilian Cerrado
   Samamad NTI, 2018, SCI HORTIC-AMSTERDAM, V238, P363, DOI 10.1016/j.scienta.2018.05.007
   Ishida I.B, 2017, WORLD J PHARM RES, V8, P10
   Jakobek L, 2015, FOOD CHEM, V175, P556, DOI 10.1016/j.foodchem.2014.12.013
   Jesch Elliot D, 2017, Prev Nutr Food Sci, V22, P67, DOI 10.3746/pnf.2017.22.2.67
   Johner JCF, 2018, J SUPERCRIT FLUID, V137, P34, DOI 10.1016/j.supflu.2018.03.005
   Justino AB, 2020, FOOD BIOSCI, V35, DOI 10.1016/j.fbio.2020.100573
   Kamalakkannan N, 2006, MOL CELL BIOCHEM, V293, P211, DOI 10.1007/s11010-006-9244-1
   Kanwar P, 2016, CLIN LIVER DIS, V20, P225, DOI 10.1016/j.cld.2015.10.002
   Kaprasob R, 2019, PROCESS BIOCHEM, V82, P40, DOI 10.1016/j.procbio.2019.05.005
   Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23
   Kaul D, 2005, EUR J CLIN NUTR, V59, P978, DOI 10.1038/sj.ejcn.1602203
   Kaur C, 2001, INT J FOOD SCI TECH, V36, P703, DOI 10.1046/j.1365-2621.2001.00513.x
   Kelley DE, 2004, DIABETES CARE, V27, P33, DOI 10.2337/diacare.27.1.33
   Kieffer DA, 2016, J NUTR, V146, P2476, DOI 10.3945/jn.116.238931
   Kumar S., 2017, Journal of Disability Management Special Education, V1, P1
   LEE CY, 1982, J FOOD SCI, V47, P961, DOI 10.1111/j.1365-2621.1982.tb12755.x
   Lee J, 2013, FRONT CHEM, V1, DOI 10.3389/fchem.2013.00040
   de Figueiredo PRL, 2016, J ETHNOPHARMACOL, V191, P87, DOI 10.1016/j.jep.2016.06.038
   Lemes AC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060950
   Silva ALLE, 2020, J FUNCT FOODS, V69, DOI 10.1016/j.jff.2020.103950
   Lima TB, 2010, PEPTIDES, V31, P1426, DOI 10.1016/j.peptides.2010.05.003
   Lin DR, 2016, MOLECULES, V21, DOI 10.3390/molecules21101374
   Liu CQ, 2020, CLIN NUTR, V39, P198, DOI 10.1016/j.clnu.2019.01.015
   Lobanco C., 2003, REV I FLORESTAL, V15, P33
   Lopes M.B, 2011, CADERNOS AGROECOLOGI, V6, P1
   Bailao EFLC, 2015, INT J MOL SCI, V16, P23760, DOI 10.3390/ijms161023760
   de Souza RGM, 2018, NUTRITION, V55-56, P154, DOI 10.1016/j.nut.2018.06.001
   Magalhaes FD, 2018, FOOD BIOPROD PROCESS, V108, P105, DOI 10.1016/j.fbp.2018.02.003
   Magalhaes FD, 2019, J FOOD ENG, V257, P26, DOI 10.1016/j.jfoodeng.2019.03.025
   Mariano A.P.X., 2020, RES SOC DEV, V9, DOI [DOI 10.33448/RSD-V9I9.8219, 10.33448/rsdv9i98219]
   Martinez-Gonzalez AI, 2017, MOLECULES, V22, DOI 10.3390/molecules22040669
   Mason SA, 2019, DIABETES OBES METAB, V21, P674, DOI 10.1111/dom.13571
   Mazuti Silva S.M., 2015, Infarma, V27, P49, DOI [10.14450/2318-9312.v27.e1.a2015.pp49-95, DOI 10.14450/2318-9312.V27.E1.A2015.PP49-95]
   Minatel IO., 2017, Phenolic Compounds - Biological Activity, DOI DOI 10.5772/66368
   Miranda-Vilela AL, 2016, GENET MOL BIOL, V39, P554, DOI 10.1590/1678-4685-GMB-2015-0299
   Mitchell JohnD., 1987, MEMOIRS NEW YORK BOT, V42, P1
   Pinto MRMR, 2018, POWDER TECHNOL, V339, P939, DOI 10.1016/j.powtec.2018.08.076
   Mohammadi M, 2017, REP BIOCHEM MOL BIOL, V6, P74
   Monachino Joseph, 1945, LILLOA, V11, P19
   Moraes F.P., 2006, Revista electronica de Farmacia, V3, P109
   Murtaza G, 2019, PROG CARDIOVASC DIS, V62, P315, DOI 10.1016/j.pcad.2019.03.003
   Narain N., 2018, EXOTIC FRUITS, P305, DOI DOI 10.1016/B978-0-12-803138-4.00040
   Naves, 2015, J FOOD RES, V4, P38, DOI [10.5539/jfr.v4n4p38, DOI 10.5539/JFR.V4N4P38]
   NIH, 2011, NAT I HLTH DIET REF
   NIH, 2020, METABOLIC SYNDROME
   Bitencourt MAO, 2019, TOXICON, V164, P1, DOI 10.1016/j.toxicon.2019.03.018
   Oliveira D., 2008, REMEA REV ELETRONICA, V21
   Oliveira Maria Neudes Sousa de, 2006, Rev. Bras. Frutic., V28, P380, DOI 10.1590/S0100-29452006000300010
   Oliveira VF, 2019, J SCI FOOD AGR, V99, P6199, DOI 10.1002/jsfa.9892
   Oliveira VB, 2012, FOOD RES INT, V48, P170, DOI 10.1016/j.foodres.2012.03.011
   Ombredane AS, 2020, J DRUG DELIV SCI TEC, V58, DOI 10.1016/j.jddst.2020.101819
   Ommati MM, 2020, BIOLOGIA, V75, P1221, DOI 10.2478/s11756-020-00429-7
   Packard CJ, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00252
   Pianovski AR, 2008, REV BRAS CIENC FARM, V44, P249, DOI 10.1590/S1516-93322008000200010
   Pirola Luciano, 2017, World J Biol Chem, V8, P120, DOI 10.4331/wjbc.v8.i2.120
   Ramos M. I. L., 2001, Boletim do Centro de Pesquisa e Processamento de Alimentos, V19, P23
   Reis Amanda Figueiredo, 2019, Braz. J. Food Technol., V22, pe2017150, DOI 10.1590/1981-6723.15017
   Rincon-Leon F., 2003, Encyclopedia of Food Sciences and Nutrition, P2827, DOI DOI 10.1016/B0-12-227055-X/01328-6
   Rocha WS, 2011, REV BRAS FRUTIC, V33, P1215, DOI 10.1590/S0100-29452011000400021
   Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379
   Rodrigues EB, 2016, GENETICA, V144, P139, DOI 10.1007/s10709-016-9884-3
   Nascimento-Silva NRR, 2020, J BIOENERGY FOOD SCI, V7, DOI 10.18067/jbfs.v7i2.281
   Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037
   Saklani R, 2016, MOL CELL BIOCHEM, V420, P65, DOI 10.1007/s11010-016-2767-1
   Sano S.M., 2004, BARU BIOL USO EMBRAP
   Santana RV, 2020, LWT-FOOD SCI TECHNOL, V128, DOI 10.1016/j.lwt.2020.109319
   Santos UP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163225
   Sartori, 2006, FRUTAS BRASILEIRAS E, P640
   Schweiggert RM, 2016, FOOD CHEM, V200, P274, DOI 10.1016/j.foodchem.2016.01.038
   Silva MR, 2008, CIENC RURAL, V38, P1790, DOI 10.1590/S0103-84782008000600051
   Siqueira APS, 2015, FOOD SCI TECH-BRAZIL, V35, P127, DOI 10.1590/1678-457X.6532
   Silveira Tatiana Feitoza Vianna da, 2009, Physis, V19, P1189
   Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417
   Sousa JN, 2020, EXP GERONTOL, V134, DOI 10.1016/j.exger.2020.110881
   Souza PLC, 2015, J FOOD SCI TECH MYS, V52, P1712, DOI 10.1007/s13197-013-1134-4
   Sugizaki CSA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111645
   Tamiello-Rosa CS, 2019, CARBOHYD RES, V483, DOI 10.1016/j.carres.2019.107752
   Teixeira T. N., 2013, Journal of Medicinal Plants Research, V7, P963
   Torres LRO, 2018, GRASAS ACEITES, V69, DOI 10.3989/gya.1222172
   Torres-Rêgo M, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1259-x
   Valli M, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920190208
   Valli M, 2018, AN ACAD BRAS CIENC, V90, P763, DOI 10.1590/0001-3765201820170653
   van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207
   Vera R, 2009, REV BRAS FRUTIC, V31, P112, DOI 10.1590/S0100-29452009000100017
   Vieira R., 2018, EMBRAPA RECURSOS GEN
   Vulcani V.A.S., 2019, ENCICLOPEDIA BIOSFER, V16, P229, DOI [10.18677/EnciBio_2019A16, DOI 10.18677/ENCIBIO_2019A16]
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   WEBSTER DH, 1981, CAN J PLANT SCI, V61, P73, DOI 10.4141/cjps81-010
   WHO, 2019, RAIS CHOL
   World Health Organization, 2020, OB OV
   Yamashita FD, 2020, TOXICON, V179, P42, DOI 10.1016/j.toxicon.2020.02.025
   Yanai H, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-10
   Yang JX, 2008, LWT-FOOD SCI TECHNOL, V41, P1060, DOI 10.1016/j.lwt.2007.06.010
   Zuin V., 2020, BIOMASS BURNING SUBS, P143, DOI DOI 10.1007/978-94-007-0808-2_11
NR 170
TC 18
Z9 18
U1 6
U2 41
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD SEP 22
PY 2022
VL 62
IS 27
BP 7632
EP 7649
DI 10.1080/10408398.2021.1916430
EA APR 2021
PG 18
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 4W4XB
UT WOS:000649594900001
PM 33977838
DA 2025-04-28
ER

PT J
AU Akhter, NN
   Mumtaz, MW
   Akhtar, MT
AF Akhter, Nadia Noreen
   Mumtaz, Muhammad Waseem
   Akhtar, Muhammad Tayyab
TI Dodonaea viscosa; AEnzyme Inhibitory Potential Towards
   Obesity/Diabetes Management and UHPLC-QTOF-MS/MS Based Metabolite
   Profiling
SO IRANIAN JOURNAL OF CHEMISTRY & CHEMICAL ENGINEERING-INTERNATIONAL
   ENGLISH EDITION
LA English
DT Article
DE Dodonaea viscosa; Antioxidant; Anti-obesity; Anti-diabetic activity;
   UHPLC- QTOF-MS/MS metabolic profiling
ID ANTIOXIDANT ACTIVITY; IN-VITRO; ACID; EXTRACTS; PHYTOCHEMICALS;
   EPICATECHIN; OBESITY; L.
AB Obesity and diabetes mellitus are generalized under Diabesity, a concerning epidemic condition that affects mankind diversely. The medicinal flora has been used as a natural remedy for controlling metabolic disorders like diabesity. Dodonaea viscosat (from the Potohar region of Pakistan) has been evaluated as a potential source for the treatment of obesity/diabetes. Different solvent compositions (DVL@100%PEE, DVL@80%HEE, DVL@60%HEE, DVL@40%HEE, DVL@20%HEE & DVL@PAE) were investigated for anti-oxidant, anti-obesity and antidiabetic activities. Among all compositions, DVL@60% HEE ethanolic leaves extract showed highest TFC (89 + 1.94 mgRE/g DE), TPC (144 + 1.37 mgGAE/g DE), DPPH scavenging potential (IC50 = 33.75 + 0.86 mu g/mL), TAP (131.59 +1.30 mg/gAAE), pancreatic lipase inhibition (70.82 + 0.94%) and alpha-glycosidase inhibition (IC50 = 43.52 + 0.80 mu g/mL). Numerous active metabolites have been identified by the highly sensitive UHPLC-QTOF-MS/MS analytical technique including Shikimic acid, Cryptomerin B, Menisdaurin, 4-O-Caffeoylquinic acid, Chlorogenic acid, cis-Caffeic acid, Quinic acid, 4-Hydroxymethyl-2-furfural, Epicatechin, Cnidimol F, 3-Hydroxynaringenin, Asaricin, cis-Anethole, E-p-Coumatic acid, Methyl 3-Oferuloylquinate, Lappaol D, Isolariciresinol, and Urolignoside, etc that might be responsible for the substantial anti-obesity/anti diabetic attributes of D. viscosa leaves extracts.
C1 [Akhter, Nadia Noreen; Mumtaz, Muhammad Waseem] Univ Gujrat, Fac Sci, Dept Chem, Gujrat, Pakistan.
   [Akhtar, Muhammad Tayyab] Govt Coll Univ, Inst Ind Biotechnol, Lahore, Pakistan.
C3 University of Gujrat; Government College University Lahore
RP Mumtaz, MW (corresponding author), Univ Gujrat, Fac Sci, Dept Chem, Gujrat, Pakistan.
EM muhammad.waseem@uog.edu.pk
RI Mumtaz, Muhammad/MCY-0921-2025
CR Abbas ZK, 2015, SAUDI J BIOL SCI, V22, P322, DOI 10.1016/j.sjbs.2014.11.015
   Abdulkhaleq LA, 2017, VET WORLD, V10, P869, DOI 10.14202/vetworld.2017.869-872
   Ahmad M, 2012, PAK VET J, V32, P50
   Ahmed M., 2011, Pak. Vet. J., V32, P1
   Ahn SJ, 2022, FOOD ADDIT CONTAM A, V39, P1195, DOI 10.1080/19440049.2022.2069291
   Al-Malki AL, 2019, INT J BIOL MACROMOL, V122, P1212, DOI 10.1016/j.ijbiomac.2018.09.072
   Al-Snafi P.D.A.E., 2017, J. Pharm., V7, P10
   Almarfadi OM, 2022, OPEN CHEM, V20, P559, DOI 10.1515/chem-2022-0181
   Alomari AA, 2020, ORIENT J CHEM, V36, P179, DOI 10.13005/ojc/360124
   Altemimi A, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6040042
   Aras A, 2018, IRAN J CHEM CHEM ENG, V37, P209
   Arfan M, 2018, PAK J PHARM SCI, V31, P2697
   Avula B, 2009, CHROMATOGRAPHIA, V69, P307, DOI 10.1365/s10337-008-0884-z
   Ayari J, 2020, IRAN J CHEM CHEM ENG, V39, P217, DOI 10.30492/IJCCE.2020.39791
   Ferrare K, 2018, J ETHNOPHARMACOL, V215, P241, DOI 10.1016/j.jep.2017.12.035
   Fozia F, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/1904874
   Grauzdyte D, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020218
   Hao S, 2016, PHARM BIOL, V54, P251, DOI 10.3109/13880209.2015.1029054
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Hussain AI, 2013, IND CROP PROD, V45, P416, DOI 10.1016/j.indcrop.2013.01.002
   Karar M.G. E., 2015, Journal of Chemical Biology Therapeutics, V1, DOI DOI 10.4172/2572-0406.1000102
   Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5
   Kitts DD, 2012, J AGR FOOD CHEM, V60, P6718, DOI 10.1021/jf2044636
   Knispel N, 2013, MOLECULES, V18, P7686, DOI 10.3390/molecules18077686
   Konidala SK, 2021, ARAB J CHEM, V14, DOI 10.1016/j.arabjc.2021.103154
   Kumar N, 2017, FUNCT FOODS HEALTH D, V7, P1
   Malik MN, 2022, ARAB J CHEM, V15, DOI 10.1016/j.arabjc.2022.103688
   Malode L.L., 2021, GSC Advanc. Res. Reviews, V9, P149
   Nadeem M., 2019, Biologia (Pakistan), V61, P65
   Nadeem M, 2020, INT J FOOD PROP, V23, P918, DOI 10.1080/10942912.2020.1764578
   Nadeem M, 2020, IND CROP PROD, V152, DOI 10.1016/j.indcrop.2020.112445
   Nadeem M, 2019, J FOOD MEAS CHARACT, V13, P3206, DOI 10.1007/s11694-019-00243-z
   Niemann B, 2017, J AM COLL CARDIOL, V70, P230, DOI 10.1016/j.jacc.2017.05.043
   Oguntibeju Oluwafemi Omoniyi, 2019, Int J Physiol Pathophysiol Pharmacol, V11, P45
   Park YS, 2008, FOOD CHEM, V107, P640, DOI 10.1016/j.foodchem.2007.08.070
   Rahmoune B., 2017, Int J Pharm Pharm Sci, V9, P150, DOI [10.22159/ijpps.2017v9i7.15946, DOI 10.22159/IJPPS.2017V9I7.15946]
   Ravichandran Harini Ravichandran Harini, 2012, Journal of Pharmacy Research, V5, P3227
   Riaz T, 2012, J SERB CHEM SOC, V77, P423, DOI 10.2298/JSC110621183R
   Ruan JY, 2019, MOLECULES, V24, DOI 10.3390/molecules24152784
   Sadeghi M., 2024, J. Chem. Chem. Eng. (IJCCE), DOI 10.30492/IJCCE.2024.2002119.6026
   Sayed M, 2019, J FOOD MEAS CHARACT, V13, P707, DOI 10.1007/s11694-018-9983-1
   Sohail A, 2022, BIOMED RES INT, V2022, DOI 10.1155/2022/2323078
   Song XC, 2021, J AGR FOOD CHEM, V69, P10856, DOI 10.1021/acs.jafc.1c02845
   Stöggl WM, 2004, J SEP SCI, V27, P524, DOI 10.1002/jssc.200301694
   Sun H, 2022, DIABETES RES CLIN PR, V183, DOI 10.1016/j.diabres.2021.109119
   Toplak H, 2019, WIEN KLIN WOCHENSCHR, V131, P71, DOI 10.1007/s00508-018-1418-9
   Tsai KL, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700928
   Ul Aabideen Z, 2022, ASIAN PAC J TROP BIO, V12, P164, DOI 10.4103/2221-1691.340561
   Ul Aabideen Z, 2020, MOLECULES, V25, DOI 10.3390/molecules25214935
   Umamaheswari M, 2008, AFR J TRADIT COMPLEM, V5, P61
   Vellapandian C, 2022, J DIABETES METAB DIS, V21, P1557, DOI 10.1007/s40200-022-01101-4
   Willems JL, 2016, ANAL CHIM ACTA, V933, P164, DOI 10.1016/j.aca.2016.05.041
   Xie JC, 2022, BMJ-BRIT MED J, V379, DOI 10.1136/bmj-2022-072385
   Yamada P, 2011, PLANTA MED, V77, P434, DOI 10.1055/s-0030-1250402
   Yao YF, 2019, MOLECULES, V24, DOI 10.3390/molecules24010071
   Zhao L, 2013, J AGR FOOD CHEM, V61, P10604, DOI 10.1021/jf403098y
   Zheng XY, 2019, MOLECULES, V24, DOI 10.3390/molecules24071403
   Zhu JF, 2017, J CHROMATOGR B, V1060, P262, DOI 10.1016/j.jchromb.2017.06.022
NR 58
TC 1
Z9 1
U1 0
U2 0
PU JIHAD DANESHGAHI
PI TEHRAN
PA PO BOX 13145-1494, TEHRAN, 00000, IRAN
SN 1021-9986
J9 IRAN J CHEM CHEM ENG
JI Iran J. Chem. Chem. Eng.-Int. Engl. Ed.
PD JUN
PY 2024
VL 43
IS 6
BP 2500
EP 2517
PG 18
WC Chemistry, Multidisciplinary; Engineering, Chemical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Engineering
GA Q0M0T
UT WOS:001381724300001
DA 2025-04-28
ER

PT J
AU Shahidi, F
   Danielski, R
AF Shahidi, Fereidoon
   Danielski, Renan
TI Review on the Role of Polyphenols in Preventing and Treating Type 2
   Diabetes: Evidence from In Vitro and In Vivo Studies
SO NUTRIENTS
LA English
DT Review
DE enzymatic inhibition; cholesterol-lowering; gut microbiota;
   inflammation; oxidative stress
ID DIETARY PHENOLIC-COMPOUNDS; INSULIN-SECRETION; INFLAMMATION;
   ANTIOXIDANT; INHIBIT; OBESITY; JUICE; ACID
AB Type 2 diabetes (T2D) is one of the leading causes of death globally. There was a 70% increase in diabetes-related deaths between 2000 and 2020, particularly among males. This non-communicable disease is characterized by increased insulin resistance, leading to elevated blood sugar levels and, if untreated, resulting in complications such as nerve damage, kidney disease, blindness, and poor wound healing. T2D management includes dietary intervention, physical exercise, and the administration of blood sugar-lowering medication. However, these medications often have side effects related to intestinal discomfort. Therefore, natural alternatives to standard diabetes medications are being sought to improve the quality of life for individuals with this condition. Polyphenols, which are naturally occurring plant metabolites, have emerged as strong candidates for T2D control. Various phenolic acids (e.g., chlorogenic acid), flavonoids (e.g., quercetin), proanthocyanidins (e.g., procyanidin B2), gallotannins (e.g., monogalloyl hexoside), and ellagitannins (e.g., ellagic acid hexoside) can enhance insulin sensitivity in tissues, reduce chronic inflammation, scavenge free radicals, improve insulin secretion, inhibit enzymes involved in carbohydrate digestion, regulate glucose transport across cell membranes, and modulate gut microbiota. This contribution compiles up-to-date evidence from in vitro and in vivo studies on the role of polyphenols in the prevention and management of T2D, emphasizing the mechanisms of action underlying these effects.
C1 [Shahidi, Fereidoon; Danielski, Renan] Mem Univ Newfoundland, Dept Biochem, St John, NF A1C 5S7, Canada.
C3 Memorial University Newfoundland
RP Shahidi, F (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF A1C 5S7, Canada.
EM fshahidi@mun.ca; rdanielski@mun.ca
OI Shahidi, Fereidoon/0000-0002-9912-0330
FU Natural Sciences and Engineering Research Council (NSERC) of Canada; 
   [RGPIN-2016-04468]
FX This work was funded by Natural Sciences and Engineering Research
   Council (NSERC) of Canada, RGPIN-2016-04468.
CR Abdel-Moneim A, 2018, BIOMED PHARMACOTHER, V105, P1091, DOI 10.1016/j.biopha.2018.06.096
   Abdelli I, 2021, J BIOMOL STRUCT DYN, V39, P816, DOI 10.1080/07391102.2020.1718553
   Afonso AF, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090814
   Ahmad E, 2022, LANCET, V400, P1803, DOI 10.1016/S0140-6736(22)01655-5
   Albishi T., 2020, J FOOD BIOACTIVES, V8, P92, DOI [10.31665/JFB.2019.8211, DOI 10.31665/JFB.2019.8211]
   Aleixandre A, 2022, FOOD CHEM, V372, DOI 10.1016/j.foodchem.2021.131231
   Alongi M, 2021, FOOD CHEM, V342, DOI 10.1016/j.foodchem.2020.128289
   Asgar MA, 2013, INT J FOOD PROP, V16, P91, DOI 10.1080/10942912.2011.595864
   Ashour M. A., 2023, J GLOBAL SCI RES, V8, P3157
   Aslam N, 2022, TOXICOL RES-UK, V11, P920, DOI 10.1093/toxres/tfac070
   Chen L, 2018, CRIT REV FOOD SCI, V58, P2908, DOI 10.1080/10408398.2017.1345853
   Pinaffi ACD, 2020, MOLECULES, V25, DOI 10.3390/molecules25030679
   Danielski R, 2024, J AGR FOOD CHEM, V72, P4035, DOI 10.1021/acs.jafc.3c06350
   DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19
   Dias TR, 2017, CURR MED CHEM, V24, P334, DOI 10.2174/0929867323666160905150419
   DiMeglio LA, 2018, LANCET, V391, P2449, DOI 10.1016/S0140-6736(18)31320-5
   Du X, 2018, FOOD FUNCT, V9, P2998, DOI 10.1039/c8fo00250a
   Ehrmann D, 2020, LANCET DIABETES ENDO, V8, P436, DOI 10.1016/S2213-8587(20)30042-5
   Ellulu MS, 2017, ARCH MED SCI, V13, P851, DOI 10.5114/aoms.2016.58928
   Ezeako EC, 2023, FUTUR J PHARM SCI, V9, DOI 10.1186/s43094-023-00527-8
   Girard D, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.991716
   Gu I, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090871
   Halim M, 2019, DIABETES METAB SYND, V13, P1165, DOI 10.1016/j.dsx.2019.01.040
   Higashi Y, 2023, CELLS-BASEL, V12, DOI 10.3390/cells12091293
   Hybertson Brooks M, 2022, OBM Integr Compliment Med, V7, DOI 10.21926/obm.icm.2201002
   Ju ZR, 2022, ACTA PHARM SIN B, V12, P2790, DOI 10.1016/j.apsb.2022.01.002
   Kasprzak-Drozd K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073715
   Kawakami Y, 2021, NUTRITION, V85, DOI 10.1016/j.nut.2020.111128
   Li H, 2020, NUTR RES, V73, P83, DOI 10.1016/j.nutres.2019.09.005
   Li XX, 2022, LWT-FOOD SCI TECHNOL, V153, DOI 10.1016/j.lwt.2021.112455
   Li YJ, 2023, MICROBIOL SPECTR, V11, DOI 10.1128/spectrum.03796-22
   Lin LK, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000429
   Liu HC, 2020, FOOD FUNCT, V11, P5749, DOI [10.1039/D0FO00855A, 10.1039/d0fo00855a]
   Liu SW, 2021, FOOD RES INT, V142, DOI 10.1016/j.foodres.2021.110239
   Mahendra VP, 2019, J FUNCT FOODS, V56, P110, DOI 10.1016/j.jff.2019.02.047
   Mansour HMM, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12061275
   Manzano M, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0088-8
   Martin SS, 2012, MED CLIN N AM, V96, P13, DOI 10.1016/j.mcna.2012.01.009
   Miller N, 2022, PLANTA MED, V88, P1078, DOI 10.1055/a-1557-7379
   Mohamedshah Z, 2020, FOOD FUNCT, V11, P6433, DOI [10.1039/d0fo00792g, 10.1039/D0FO00792G]
   Ozyel B, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000777
   Peng H, 2022, J AGR FOOD CHEM, V70, P9227, DOI 10.1021/acs.jafc.2c03086
   Rabiee A, 2018, CELL SIGNAL, V47, P1, DOI 10.1016/j.cellsig.2018.03.003
   Rakshe PS, 2024, AGEING RES REV, V96, DOI 10.1016/j.arr.2024.102255
   Ren JN, 2024, FOOD FUNCT, V15, P5596, DOI [10.1039/D3FO05456J, 10.1039/d3fo05456j]
   Riyaphan J, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11121877
   Romani A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081776
   Saji N, 2020, FOODS, V9, DOI 10.3390/foods9060829
   Salahuddin MAH, 2020, FOOD CHEM, V331, DOI 10.1016/j.foodchem.2020.127240
   Sarkar A, 2024, PHARMACEUTICALS-BASE, V17, DOI 10.3390/ph17070968
   Sarriá B, 2020, PEERJ, V8, DOI 10.7717/peerj.9953
   Sergent T, 2010, CHEM-BIOL INTERACT, V188, P659, DOI 10.1016/j.cbi.2010.08.007
   Shahidi F., 2018, Journal of Food Bioactives, V4, P11, DOI [DOI 10.31665/JFB.2018.4162, 10.31665/jfb.2018, DOI 10.31665/JFB.2018, 10.31665/jfb.2018.4162]
   Shahidi F, 2022, PLANTS-BASEL, V11, DOI 10.3390/plants11233283
   Shahidi F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061573
   Simsek M, 2015, J AGR FOOD CHEM, V63, P3873, DOI 10.1021/jf505425d
   Singh AK, 2021, COMPUT BIOL MED, V134, DOI 10.1016/j.compbiomed.2021.104462
   Son TH, 2022, VIETNAM J FOOD CONTR, V5, P553
   Sun LJ, 2020, TRENDS FOOD SCI TECH, V104, P190, DOI 10.1016/j.tifs.2020.08.003
   Tabák AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9
   Tanase DM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123719
   Tshivhase AM, 2024, SCI REP-UK, V14, DOI 10.1038/s41598-023-50084-6
   Wojdylo A, 2016, J FUNCT FOODS, V25, P421, DOI 10.1016/j.jff.2016.06.015
   Wu CH, 2010, FOOD CHEM, V121, P639, DOI 10.1016/j.foodchem.2010.02.008
   Xepapadaki E, 2021, DIABETOLOGIA, V64, P1917, DOI 10.1007/s00125-021-05509-0
   Xia T, 2022, FOOD CHEM, V393, DOI 10.1016/j.foodchem.2022.133443
   Xiang YY, 2023, MOL NUTR FOOD RES, V67, DOI 10.1002/mnfr.202200244
   Yang K, 2021, MOLECULES, V26, DOI 10.3390/molecules26082285
   Yang K, 2020, ACS OMEGA, V5, P8596, DOI 10.1021/acsomega.9b04478
   Yeo J., 2020, J. Food Bioact, V12, P122, DOI [10.31665/JFB.2020.12250, DOI 10.31665/JFB.2020.12250]
   Youl E, 2010, BRIT J PHARMACOL, V161, P799, DOI 10.1111/j.1476-5381.2010.00910.x
   Yu C, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6635460
   Yu MH, 2024, FOOD CHEM, V435, DOI 10.1016/j.foodchem.2023.137499
   Yuan L., 2023, Phytomedicine, V116, P154945
   Zafar A., 2021, CURRENT PHARM REPORT, V7, P107, DOI 10.1007/s40495-021-00255-8
   Zatterale F, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01607
   Zeb A, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13394
   Zhang H, 2016, J FUNCT FOODS, V22, P363, DOI 10.1016/j.jff.2016.01.004
   Zhao QN, 2024, FOOD RES INT, V175, DOI 10.1016/j.foodres.2023.113689
   Zhu JZ, 2020, CRIT REV FOOD SCI, V60, P695, DOI 10.1080/10408398.2018.1548428
   Ziolkowska S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222011128
NR 81
TC 7
Z9 7
U1 11
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2024
VL 16
IS 18
AR 3159
DI 10.3390/nu16183159
PG 23
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA H5D9Q
UT WOS:001323656900001
PM 39339759
OA gold
DA 2025-04-28
ER

PT J
AU Ma, R
   Weng, HB
   Liang, JY
AF Ma, Rui
   Weng, Hongbo
   Liang, Jianying
TI Screening of lipase inhibitors in Folium Mori with lipase-linked
   magnetic microspheres by high-performance liquid chromatography and
   evaluation in diabetic mice
SO JOURNAL OF SEPARATION SCIENCE
LA English
DT Article
DE Astragalin; Folium Mori; High-performance liquid chromatography;
   Immobilized enzymes; Lipase inhibitors
ID MULBERRY LEAF; MASS-SPECTROMETRY; MELLITUS; EXTRACT; COMPLICATIONS;
   TYPE-2; RUTIN; RATS; OBESITY
AB A new method for the screening of compounds with hypoglycemic effect from traditional Chinese medicines employing high-performance liquid chromatography and lipase-linked magnetic microspheres has been proposed. We hypothesized that the interaction of traditional Chinese medicine extracts with lipase-linked magnetic microspheres should decrease the concentration of compounds with hypoglycemic effect. Using this approach, the potential lipase inhibitors in Folium Mori extract were investigated. First, lipase was immobilized on magnetic microspheres by a chemical method. Then, by comparing the chromatograms of samples before and after the interaction with lipase-linked magnetic microspheres, seven compounds of Folium Mori extract were identified. It was found that protocatechuic acid, chlorogenic acid, protocatechualdehyde, rutin, isoquercitrin, astragalin, and dicaffeoylquinic acid B had evident combination with lipase-linked magnetic microspheres. Their hypoglycemic effects were verified in streptozocin-induced diabetic mice. In the present study, astragalin was verified to improve the glucose tolerance and lower the level of glucose in streptozocin-induced diabetic mice, which indicated that astragalin might be a new highly efficient lipase inhibitor. Based on these significant results, this method could be a convenient approach to screen potential lipase inhibitors from traditional Chinese medicines. Meanwhile, it also could be expanded to screen other active compounds in traditional Chinese medicines.
C1 [Ma, Rui; Liang, Jianying] Fudan Univ, Sch Pharm, Dept Pharmaceut Anal, Lecturer Room 521,Res Bldg,826 Zhangheng Rd, Shanghai 201203, Peoples R China.
   [Weng, Hongbo] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.
C3 Fudan University; Fudan University
RP Liang, JY (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmaceut Anal, Lecturer Room 521,Res Bldg,826 Zhangheng Rd, Shanghai 201203, Peoples R China.; Weng, HB (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.
EM hbweng@fudan.edu.cn; jyliang@shmu.edu.cn
FU Shanghai Committee of Science and Technology, China [14431904900]
FX This work was financially supported by Shanghai Committee of Science and
   Technology, China (Grant no. 14431904900).
CR Amutha A, 2016, J DIABETES COMPLICAT, V30, P951, DOI 10.1016/j.jdiacomp.2016.02.009
   [Anonymous], J PHARM PHARM
   Araujo CM, 2015, FOOD FUNCT, V6, P3490, DOI [10.1039/c5fo00474h, 10.1039/C5FO00474H]
   Arrellano-Valdez F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-549
   Buchholz T, 2016, PHYTOTHER RES, V30, P260, DOI 10.1002/ptr.5525
   Ding D, 2015, DIABETES RES CLIN PR, V108, P306, DOI 10.1016/j.diabres.2015.02.002
   Dugo P, 2009, J SEP SCI, V32, P3627, DOI 10.1002/jssc.200900348
   Foster-Schubert KE, 2006, ENDOCR REV, V27, P779, DOI 10.1210/er.2006-0041
   Habtemariam S, 2015, MINI-REV MED CHEM, V15, P524, DOI 10.2174/138955751507150424103721
   Hsu CY, 2014, MOL NUTR FOOD RES, V58, P1168, DOI 10.1002/mnfr.201300691
   Hu FL, 2008, J AM SOC MASS SPECTR, V19, P865, DOI 10.1016/j.jasms.2008.02.016
   Huang Shiang-Suo, 2014, J Tradit Complement Med, V4, P162, DOI 10.4103/2225-4110.131639
   Hunyadi A, 2013, PHYTOTHER RES, V27, P847, DOI 10.1002/ptr.4803
   Hunyadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050619
   Kim JY, 2015, J MED FOOD, V18, P306, DOI 10.1089/jmf.2014.3160
   Kimura T, 2004, J AGR FOOD CHEM, V52, P1415, DOI 10.1021/jf0306901
   Kowluru R. A., 2007, EXP DIABETES RES ANN
   Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y
   Niture NT, 2014, INDIAN J EXP BIOL, V52, P720
   Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586
   Pan LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133212
   Pitocco D, 2013, INT J MOL SCI, V14, P21525, DOI 10.3390/ijms141121525
   Pospiskova K, 2013, CARBOHYD POLYM, V96, P545, DOI 10.1016/j.carbpol.2013.04.014
   Sayyid RK, 2016, TRENDS ENDOCRIN MET, V27, P249, DOI 10.1016/j.tem.2016.02.006
   Shaefer C, 2016, CURR MED RES OPIN, V32, P1479, DOI 10.1185/03007995.2016.1163255
   Sharma SB, 2010, J PHARM PHARMACOL, V62, P247, DOI [10.1211.jpp/62.02.0013, 10.1211/jpp/62.02.0013]
   Van Gaal L, 2015, DIABETES CARE, V38, P1161, DOI 10.2337/dc14-1630
   Yang L, 2016, J SEP SCI, V39, P38, DOI 10.1002/jssc.201500899
   Yang SJ, 2014, NUTR RES PRACT, V8, P613, DOI 10.4162/nrp.2014.8.6.613
   Zhang LL, 2014, J SEP SCI, V37, P1265, DOI 10.1002/jssc.201301267
NR 30
TC 14
Z9 16
U1 2
U2 39
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1615-9306
EI 1615-9314
J9 J SEP SCI
JI J. Sep. Sci.
PD DEC
PY 2016
VL 39
IS 23
BP 4474
EP 4483
DI 10.1002/jssc.201600924
PG 10
WC Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA EJ2HG
UT WOS:000393030100002
PM 27687881
DA 2025-04-28
ER

PT J
AU Wang, X
   Li, B
   Liu, DY
   Guo, Y
   Zhang, JX
   Li, WY
   Peng, TT
   Ma, QH
   Shi, XF
AF Wang, Xin
   Li, Bin
   Liu, Dongyan
   Guo, Yuer
   Zhang, Jiaxu
   Li, Wanyu
   Peng, Tengteng
   Ma, Quhuan
   Shi, Xiaofeng
TI Isolation, characterization, and LC MS/MS determination of anti-obesity
   components from pine needles of Cedrus deodara (Roxb.) G. Don
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE Cedrus deodara (Roxb.) G. Don; needle leaves; anti-obesity ingredients;
   phenolic acids; UPLC-QQQ-MS/MS
ID PHENOLIC-ACID PROFILES; CHEMICAL-CONSTITUENTS; PURIFICATION; LOUD.; MICE
AB Objective: This study aimed to isolate and analyze the components in cedar pine needles (needle leaves of Cedrus deodara (Roxb.) G. Don) that exhibit anti-obesity effects, as determined through animal experiments. Methods: The extract of cedar pine needles was separated into four fractions of different polarities using a macroporous resin column. The fraction that retained anti-obesity activity was evaluated based on the results of animal experiments. Monomeric compounds were structurally characterized and isolated from the active fraction using a preparative liquid chromatography system. Combined with subsequent glucose gel chromatographic separation. The content of the separated components was determined using ultrahigh performance liquid chromatography coupled with triple quadrupole mass spectrometry (UPLC-QQQ-MS/MS). Results: The water-washed fraction retained anti-obesity activity of the cedar pine needles more effectively. A total of 16 compounds were separated from this fraction, and the contents of 14 of these compounds were determined to be present in cedar pine needles. Conclusion: Nine components, namely p-hydroxy benzyl alcohol, chlorogenic acid, vanillic acid, syringic acid, P-coumaric acid, sinapic acid, benzoic acid, phenylacetic acid, salicylic acid, were characterized and determined for the first time in cedar pine needles. The components with anti-obesity activity in the pine needles of Cedrus are mainly derived from phenolic acids.
C1 [Wang, Xin; Li, Bin; Zhang, Jiaxu; Li, Wanyu; Shi, Xiaofeng] Gansu Univ Tradit Chinese Med, Coll Pharm, Lanzhou, Peoples R China.
   [Liu, Dongyan; Ma, Quhuan; Shi, Xiaofeng] Gansu Acad Med Sci, Inst Pharmaceut Res, Lanzhou, Peoples R China.
   [Guo, Yuer] Lanzhou Univ Technol, Coll Biomed, Lanzhou, Peoples R China.
   [Peng, Tengteng] Northwest Normal Univ, Coll Life Sci, Lanzhou, Peoples R China.
C3 Gansu University of Chinese Medicine; Lanzhou University of Technology;
   Northwest Normal University - China
RP Shi, XF (corresponding author), Gansu Univ Tradit Chinese Med, Coll Pharm, Lanzhou, Peoples R China.; Ma, QH; Shi, XF (corresponding author), Gansu Acad Med Sci, Inst Pharmaceut Res, Lanzhou, Peoples R China.
EM 641907083@qq.com; teamocuier@163.com
RI Shi, Xiaofeng/B-8700-2011; Zhang, Jiaxu/HMU-8539-2023
FU Gansu Province Science and Technology Program Grant Project
   [23CXGA0038]; Natural Science Foundation of Gansu Province [23JRRA1802]
FX The author(s) declare financial support was received for the research,
   authorship, and/or publication of this article. The authors acknowledged
   financial support from the Gansu Province Science and Technology Program
   Grant Project (No. 23CXGA0038) and the Natural Science Foundation of
   Gansu Province (No. 23JRRA1802).
CR Bisht A, 2021, J ETHNOPHARMACOL, V279, DOI 10.1016/j.jep.2021.114361
   Chaudhary A. K., 2011, Pharmacognosy Journal, V3, P12, DOI 10.5530/pj.2011.23.2
   CHAUDHARY AK, 2014, INT J PHARM PHARM SC, V6, P587
   Chaudhary AK, 2014, J NAT MED-TOKYO, V68, P274, DOI 10.1007/s11418-013-0775-y
   Chu LL, 2019, INT J BIOL MACROMOL, V125, P445, DOI 10.1016/j.ijbiomac.2018.12.082
   Clark SP, 2014, PHYTOTHER RES, V28, P252, DOI 10.1002/ptr.4991
   Ishii M, 2010, INT IMMUNOPHARMACOL, V10, P1041, DOI 10.1016/j.intimp.2010.06.003
   KAR K, 1975, J PHARM SCI-US, V64, P258, DOI 10.1002/jps.2600640213
   Kim EA, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10050837
   [刘东彦 Liu Dongyan], 2017, [中草药, Chinese Traditional and Herbal Drugs], V48, P5136
   [龙国清 Long Guoqing], 2022, [中草药, Chinese Traditional and Herbal Drugs], V53, P978
   [马翠霞 Ma Cuixia], 2019, [中国药学杂志, Chinese Pharmaceutical Journal], V54, P1557
   Peng D., 2021, Zhongnan Med, V19, P870, DOI [10.7539/j.issn.1672-2981.2021.05.014, DOI 10.7539/J.ISSN.1672-2981.2021.05.014]
   Puratchikody A., 2011, Journal of Phytology, V3, P31
   Sharma A., 2018, Asian J Pharm Res Dev, V6, P71, DOI [10.22270/ajprd.v6i2.348, DOI 10.22270/AJPRD.V6I2.348]
   Shi J., 2018, Chin Pharm J, V53, P178
   Shi XF, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2682-6
   [石晓峰 Shi Xiaofeng], 2016, [天然产物研究与开发, Natural Product Research and Development], V28, P1325
   Shinde UA, 1999, J ETHNOPHARMACOL, V65, P21, DOI 10.1016/S0378-8741(98)00150-0
   [司金光 Si Jinguang], 2018, [中国药学杂志, Chinese Pharmaceutical Journal], V53, P178
   Tian T., 2020, Zhongcaoyao, V51, P3131
   Wang Y., 2023, Farm Prod Process, V10, P56, DOI [10.16693/j.cnki.1671-9646(X).2023.10.013, DOI 10.16693/J.CNKI.1671-9646(X).2023.10.013]
   Wang YT, 2014, J FOOD SCI, V79, pC1100, DOI 10.1111/1750-3841.12483
   Yadav JP, 2010, FITOTERAPIA, V81, P223, DOI 10.1016/j.fitote.2009.09.008
   Yang W, 2010, FOOD CHEM, V120, P886, DOI 10.1016/j.foodchem.2009.10.063
   Yao T., 2022, China Pharmacist, V25, P1076, DOI [10.19962/j.cnki.issn1008-049X, DOI 10.19962/J.CNKI.ISSN1008-049X, 10.19962/j.cnki.issn1008-049X.2022.06.030, DOI 10.19962/J.CNKI.ISSN1008-049X.2022.06.030]
   张军民, 2009, [中成药, Chinese Traditional Patent Medicine], V31, P928
   Zhang LQ, 2019, FOOD CHEM, V276, P538, DOI 10.1016/j.foodchem.2018.10.074
   [张旭 Zhang Xu], 2023, [中草药, Chinese Traditional and Herbal Drugs], V54, P2373
   Zhang YingJie Zhang YingJie, 2017, Food Research and Development, V38, P20
   Zhang Y, 2012, J CEREAL SCI, V56, P629, DOI 10.1016/j.jcs.2012.07.006
NR 31
TC 0
Z9 0
U1 7
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD AUG 1
PY 2024
VL 11
AR 1448908
DI 10.3389/fnut.2024.1448908
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA C8D3Q
UT WOS:001291616400001
PM 39149547
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Tavares, WR
   Seca, AML
AF Tavares, Wilson R.
   Seca, Ana M. L.
TI Inula L. Secondary Metabolites against Oxidative Stress-Related Human
   Diseases
SO ANTIOXIDANTS
LA English
DT Review
DE Inula; oxidative stress; ROS; secondary metabolites; inflammation;
   diabetes; neurologicaldamage; cancer; sesquiterpene lactones
ID NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; IN-VITRO; ALZHEIMERS-DISEASE;
   INSULIN-RESISTANCE; CANCER PREVENTION; CHLOROGENIC ACID; ESSENTIAL OIL;
   ALANTOLACTONE; ANTIOXIDANT
AB An imbalance in the production of reactive oxygen species in the body can cause an increase of oxidative stress that leads to oxidative damage to cells and tissues, which culminates in the development or aggravation of some chronic diseases, such as inflammation, diabetes mellitus, cancer, cardiovascular disease, and obesity. Secondary metabolites from Inula species can play an important role in the prevention and treatment of the oxidative stress-related diseases mentioned above. The databases Scopus, PubMed, and Web of Science and the combining terms Inula, antioxidant and secondary metabolites were used in the research for this review. More than 120 articles are reviewed, highlighting the most active compounds with special emphasis on the elucidation of their antioxidative-stress mechanism of action, which increases the knowledge about their potential in the fight against inflammation, cancer, neurodegeneration, and diabetes. Alantolactone is the most polyvalent compound, reporting interesting EC50 values for several bioactivities, while 1-O-acetylbritannilactone can be pointed out as a promising lead compound for the development of analogues with interesting properties. The Inula genus is a good bet as source of structurally diverse compounds with antioxidant activity that can act via different mechanisms to fight several oxidative stress-related human diseases, being useful for development of new drugs.
C1 [Tavares, Wilson R.] Univ Azores, Fac Sci & Technol, P-9501801 Ponta Delgada, Portugal.
   [Seca, Ana M. L.] cE3c, Azorean Biodivers Grp, Rua Mae Deus, P-9501801 Ponta Delgada, Portugal.
   [Seca, Ana M. L.] Univ Azores, Rua Mae Deus, P-9501801 Ponta Delgada, Portugal.
   [Seca, Ana M. L.] Univ Aveiro, QOPNA, P-3810193 Aveiro, Portugal.
   [Seca, Ana M. L.] Univ Aveiro, LAQV REQUIMTE, P-3810193 Aveiro, Portugal.
C3 Universidade dos Acores; Universidade dos Acores; Universidade de
   Aveiro; Universidade de Aveiro
RP Seca, AML (corresponding author), cE3c, Azorean Biodivers Grp, Rua Mae Deus, P-9501801 Ponta Delgada, Portugal.; Seca, AML (corresponding author), Univ Azores, Rua Mae Deus, P-9501801 Ponta Delgada, Portugal.; Seca, AML (corresponding author), Univ Aveiro, QOPNA, P-3810193 Aveiro, Portugal.; Seca, AML (corresponding author), Univ Aveiro, LAQV REQUIMTE, P-3810193 Aveiro, Portugal.
EM wrt-94@hotmail.com; ana.ml.seca@uac.pt
RI Tavares, Wilson/LZH-6736-2025; Seca, Ana/E-5475-2013
OI Tavares, Wilson/0000-0001-9817-2756; Seca, Ana/0000-0002-7709-2375
FU FCT/MCT [UID/BIA/00329/2013, UID/BIA/00329/2019, FCT
   UID/QUI/00062/2019]; FEDER, within the PT2020 Partnership Agreement
FX This research was funded by FCT/MCT, by financial support to the cE3c
   centre (FCT Unit, UID/BIA/00329/2013, 2015-2018, and
   UID/BIA/00329/2019), and to the QOPNA research Unit (FCT
   UID/QUI/00062/2019) through national founds and, where applicable,
   co-financed by the FEDER, within the PT2020 Partnership Agreement, and
   to the Portuguese NMR Network.
CR Al-Rifai A, 2018, S AFR J BOT, V116, P238, DOI 10.1016/j.sajb.2018.04.007
   Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002
   Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120
   [Anonymous], 2015, EVID BASED COMPL ALT
   [Anonymous], PLOS ONE
   [Anonymous], ACTA MED MARISIENSIS
   Badarinath AV., 2010, Intl J Pharm Tech Res, V2, P1276
   Cébe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3
   Chan SMH, 2013, DIABETES, V62, P2095, DOI 10.2337/db12-1397
   Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   Chauhan G, 2019, NEUROPHARMACOLOGY, V146, P138, DOI 10.1016/j.neuropharm.2018.11.026
   Chen L, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/508409
   Chen QS, 2018, BRIT J PHARMACOL, V175, P1279, DOI 10.1111/bph.13828
   Choi JS, 2014, ARCH PHARM RES, V37, P1354
   Chun J, 2012, INT IMMUNOPHARMACOL, V14, P375, DOI 10.1016/j.intimp.2012.08.011
   Cui L, 2018, ARCH PHARM RES, V41, P299, DOI 10.1007/s12272-017-0990-2
   Dahham SS, 2015, MOLECULES, V20, P11808, DOI 10.3390/molecules200711808
   Danino O, 2009, FOOD RES INT, V42, P1273, DOI 10.1016/j.foodres.2009.03.023
   Deacon CF, 2012, DIABETES OBES METAB, V14, P762, DOI 10.1111/j.1463-1326.2012.01603.x
   Ding YH, 2019, BIOORG CHEM, V86, P363, DOI 10.1016/j.bioorg.2019.01.055
   Ding YH, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0327-5
   Dong S, 2014, EUR J MED CHEM, V80, P71, DOI 10.1016/j.ejmech.2014.04.028
   Fang XM, 2011, ONCOL REP, V26, P1181, DOI 10.3892/or.2011.1411
   Fontanella C, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.14
   Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401
   Garayev E, 2018, J ETHNOPHARMACOL, V226, P176, DOI 10.1016/j.jep.2018.08.005
   Geng HM, 2007, CHROMATOGRAPHIA, V66, P271, DOI 10.1365/s10337-007-0285-8
   Goradel NH, 2019, J CELL PHYSIOL, V234, P5683, DOI 10.1002/jcp.27411
   He ZF, 2015, BIOCHEM BIOPH RES CO, V464, P422, DOI 10.1016/j.bbrc.2015.06.126
   Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5
   Hu XJ, 2011, HELV CHIM ACTA, V94, P306, DOI 10.1002/hlca.201000195
   Huang SH, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800955
   Huang XL, 2017, ONCOTARGET, V8, P101545, DOI 10.18632/oncotarget.21074
   Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001
   Ighodaro OM, 2018, BIOMED PHARMACOTHER, V108, P656, DOI 10.1016/j.biopha.2018.09.058
   Ivanova V, 2017, NAT PROD COMMUN, V12, P153
   Jayasinghe C, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0162-5
   Jeelani SM, 2018, J APPL RES MED AROMA, V8, P10, DOI 10.1016/j.jarmap.2017.11.001
   Jiang Y, 2016, ONCOL LETT, V11, P4203, DOI 10.3892/ol.2016.4511
   Jin Q, 2018, PHYTOCHEMISTRY, V155, P107, DOI 10.1016/j.phytochem.2018.07.008
   Kedare SB, 2011, J FOOD SCI TECH MYS, V48, P412, DOI 10.1007/s13197-011-0251-1
   Khan AL, 2010, MOLECULES, V15, P1562, DOI 10.3390/molecules15031562
   Kharroubi AT, 2015, WORLD J DIABETES, V6, P850, DOI 10.4239/wjd.v6.i6.850
   Kim HN, 2014, CANCER LETT, V351, P41, DOI 10.1016/j.canlet.2014.03.037
   Kim JJ, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/212563
   Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.119
   Kim M, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00405
   Kim TH, 2013, ACTA DIABETOL, V50, P189, DOI 10.1007/s00592-011-0259-z
   Klaunig James E., 2018, Current Opinion in Toxicology, V7, P116, DOI 10.1016/j.cotox.2017.11.014
   Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028
   Knoops L, 2008, ONCOGENE, V27, P1511, DOI 10.1038/sj.onc.1210800
   Kohnert KD, 2012, CURR DIABETES REV, V8, P345, DOI 10.2174/157339912802083513
   Kumari S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918755391
   Lee SG, 2016, TROP J PHARM RES, V15, P521, DOI 10.4314/tjpr.v15i3.13
   Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210
   Li M, 2018, BIOCHEM PHARMACOL, V150, P189, DOI 10.1016/j.bcp.2018.02.017
   Li MY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42176
   Li XC, 2016, MOLECULES, V21, DOI 10.3390/molecules21091246
   Lind M, 2017, BIOMED PHARMACOTHER, V93, P370, DOI 10.1016/j.biopha.2017.06.036
   Liu B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.64
   Liu B, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2475
   Liu F, 2018, BIOORG CHEM, V77, P168, DOI 10.1016/j.bioorg.2018.01.009
   Liu HY, 2018, ONCOTARGET, V9, P2887, DOI [10.18632/oncotarget.23208, 10.18632/oncotarget.20812]
   Liu YR, 2018, PHYTOTHER RES, V32, P643, DOI 10.1002/ptr.6004
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Maier ME, 2015, ORG BIOMOL CHEM, V13, P5302, DOI 10.1039/c5ob00169b
   Manoharan S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8590578
   McGarry T, 2018, FREE RADICAL BIO MED, V125, P15, DOI 10.1016/j.freeradbiomed.2018.03.042
   Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006
   Nimse SB, 2015, RSC ADV, V5, P27986, DOI 10.1039/c4ra13315c
   Volpe CMO, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0135-z
   Olszowy M, 2018, CHEM PAP, V72, P393, DOI 10.1007/s11696-017-0288-3
   Park SH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010017
   Priydarshi R, 2016, J ESSENT OIL RES, V28, P172, DOI 10.1080/10412905.2015.1090935
   Rajabi M, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5020034
   Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449
   Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200
   Seca AML, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010263
   Seca AML, 2015, CHEM BIODIVERS, V12, P859, DOI 10.1002/cbdv.201400080
   Seca AML, 2014, J ETHNOPHARMACOL, V154, P286, DOI 10.1016/j.jep.2014.04.010
   Sennino B, 2012, NAT REV CANCER, V12, P699, DOI 10.1038/nrc3366
   Seo JY, 2017, PHYTOTHER RES, V31, P801, DOI 10.1002/ptr.5804
   Shadfar S, 2015, ARCH PHARM RES, V38, P2106, DOI 10.1007/s12272-015-0648-x
   Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   Palmieri MGS, 2018, BIOCATAL AGR BIOTECH, V16, P43, DOI 10.1016/j.bcab.2018.07.011
   Stojakowska A, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2069-y
   Stojakowska A, 2010, BIOCHEM SYST ECOL, V38, P232, DOI 10.1016/j.bse.2009.12.011
   Straub RH, 2016, EVOL MED PUBLIC HLTH, P37, DOI 10.1093/emph/eow001
   Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160
   Suzuki T, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0215-2
   Szymanska R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2068370
   Tafani M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3907147
   Tai YY, 2019, REDOX BIOL, V20, P451, DOI 10.1016/j.redox.2018.10.024
   Tanaka T., 2013, Journal of Experimental and Clinical Medicine, V5, P203
   Tang JJ, 2014, MEDCHEMCOMM, V5, P1584, DOI 10.1039/c4md00209a
   Thomas C, 2009, REDOX REP, V14, P102, DOI 10.1179/135100009X392566
   Todoric J, 2016, CANCER PREV RES, V9, P895, DOI 10.1158/1940-6207.CAPR-16-0209
   Vara D, 2014, CURR MOL MED, V14, P1103, DOI 10.2174/1566524014666140603114010
   Wang F, 2015, MOL MED REP, V12, P5568, DOI 10.3892/mmr.2015.4042
   Wang GW, 2014, EXPERT OPIN INV DRUG, V23, P317, DOI 10.1517/13543784.2014.868882
   Wang J, 2015, J CHROMATOGR SCI, V53, P526, DOI 10.1093/chromsci/bmu079
   Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111
   Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503
   Wang QS, 2005, NEUROCHEM RES, V30, P1387, DOI 10.1007/s11064-005-8391-1
   Wang Q, 2018, PHYTOMEDICINE, V46, P78, DOI 10.1016/j.phymed.2018.04.036
   Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976
   Wang X, 2018, AM J TRANSL RES, V10, P368
   Wang X, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0563-8
   Wei XP, 2017, PHYTOCHEM LETT, V19, P248, DOI 10.1016/j.phytol.2017.02.003
   Wright GD, 2019, MICROB BIOTECHNOL, V12, P55, DOI 10.1111/1751-7915.13351
   Wu ZJ, 2010, CHEM NAT COMPD+, V46, P298, DOI 10.1007/s10600-010-9595-4
   Yu NJ, 2006, J ASIAN NAT PROD RES, V8, P385, DOI 10.1080/10286020500034832
   Zeng GZ, 2009, PHYTOTHER RES, V23, P885, DOI 10.1002/ptr.2671
   Zhang HH, 2015, ACTA PHARMACOL SIN, V36, P507, DOI 10.1038/aps.2014.143
   Zhang JM, 2016, BIOCHEM PHARMACOL, V102, P34, DOI 10.1016/j.bcp.2015.12.004
   Zhang L, 2018, RSC ADV, V8, P14967, DOI 10.1039/c8ra00675j
   Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003
   Zhang SD, 2012, PLANTA MED, V78, P166, DOI 10.1055/s-0031-1280294
   Zuñiga LY, 2018, J MED FOOD, V21, P469, DOI 10.1089/jmf.2017.0110
NR 121
TC 39
Z9 40
U1 2
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD MAY
PY 2019
VL 8
IS 5
AR 122
DI 10.3390/antiox8050122
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA IC5PO
UT WOS:000471020500012
PM 31064136
OA gold, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Gebremariam, LW
   Aoyama, A
   Kahsay, AB
   Hirakawa, Y
   Chiang, CF
   Yatsuya, H
   Matsuyama, A
AF Gebremariam, Lemlem Weldegerima
   Aoyama, Atsuko
   Kahsay, Alemayehu Bayray
   Hirakawa, Yoshihisa
   Chiang, Chifa
   Yatsuya, Hiroshi
   Matsuyama, Akiko
TI Perception and practice of 'healthy' diet in relation to noncommunicable
   diseases among the urban and rural people in northern Ethiopia: a
   community-based qualitative study
SO NAGOYA JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE noncornmunicable diseases; Northern Ethiopia; dietary habit; habitual
   practice; qualitative study
ID ADDIS-ABABA; CONSUMPTION; NUTRITION; BARRIERS; OVERWEIGHT; PREVENTION;
   BURDEN
AB Dietary habits are related to the risks of noncommunicable diseases (NCDs). such as cardiovascular disease and diabetes, of which burdens are increasing in low-income countries including Ethiopia. Although several epidemiological studies of NCD risk factors were conducted in Ethiopia, qualitative studies on people's dietary habit in relation to NCDs have not been conducted yet. This study aims to describe people's perception and practice of 'healthy' diet, and barriers to practice 'healthy' diet, paying attention to the dynamics between the perception and practice. We conducted 16 key informant interviews and eight focus group discussions in an urban and a rural areas in northern Ethiopia between November 2014 and January 2016. Audio-records in local language were transcribed word-for-word, and translated into English. English text data were analyzed qualitatively, through constant comparative analysis following the principles of the grounded theory. Three themes have emerged: (1) dietary habit perceived as 'good' or 'bad' for health; (2) reasons for continuing current 'unhealthy' dietary habit; and (3) current dietary habit perceived as 'traditional.' People's practice was mostly consistent with their perception, while they sometimes practiced contrary to the perception because of personal preference and physical or financial obstacles. People were often indifferent of health implications of their habitual dietary practice, such as drinking a lot of sweet coffee. We showed dynamics between perception and practice of 'healthy' diet among people in northern Ethiopia. It is needed to increase awareness of NCDs both among the urban and rural people and to improve the social environment for removing the obstacles.
C1 [Gebremariam, Lemlem Weldegerima; Aoyama, Atsuko; Hirakawa, Yoshihisa; Chiang, Chifa; Yatsuya, Hiroshi; Matsuyama, Akiko] Nagoya Univ, Sch Med, Dept Publ Hlth & Hlth Syst, Nagoya, Aichi, Japan.
   [Kahsay, Alemayehu Bayray] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia.
   [Yatsuya, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi, Japan.
C3 Nagoya University; Mekelle University; Fujita Health University
RP Aoyama, A (corresponding author), Nagoya Univ, Sch Med, Dept Publ Hlth & Hlth Syst, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.
EM atsukoa@med.nagoya-u.ac.jp
RI Aoyama, Atsuko/M-4826-2014; HIRAKAWA, Yoshihisa/E-4452-2015; Yatsuya,
   Hiroshi/L-4213-2016
FU Tigray Provincial Health Bureau; Japan Society for the Promotion of
   Science [26293147]; Japan Agency for Medical Research and Development
   [16jk0110008h0102]; Mekelle University College of Health Sciences;
   Grants-in-Aid for Scientific Research [26293147] Funding Source: KAKEN
FX The authors wish to thank Tigray Provincial Health Bureau, Mekelle
   University College of Health Sciences, and staff members of Department
   of Public Health and Health Systems, Nagoya University School of
   Medicine, for their valuable advice and support throughout the study. We
   also would like to thank people in Mekelle city and Kilte Awlaelo
   district, and members of the field study for assistance in data
   collection and valuable advice. This work was supported by Grant-in-Aid
   for Scientific Research (KAKENHI) from Japan Society for the Promotion
   of Science [B, 26293147 to AA], and in part by Sciences Research Grant
   for Research on Global Health Issues from Japan Agency for Medical
   Research and Development [16jk0110008h0102 to AA]. The funders had no
   roles in the study design, data collection, data analysis, preparation
   of the manuscript, and the decision to submit it for publication.
CR Abebe SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125210
   Alemseged F, 2012, ETHIOP J HEALTH SCI, V22, P19
   [Anonymous], 2013, NAT NUTR PROGR JUN 2
   [Anonymous], 2008, Summary and Statistical Report of the 2007 Population and Housing Census-Population Size by Age and Sex
   [Anonymous], 2017, World Development Indicators 2017, DOI DOI 10.1596/26447
   [Anonymous], STAT REP 2014 URB EM
   [Anonymous], NAT STRAT ACT PLAN N
   [Anonymous], 2014, INT J INNOV PHARM SC
   Asgary R, 2014, AM J TROP MED HYG, V90, P153, DOI 10.4269/ajtmh.13-0215
   Barsness R.E., 2018, CORE COMPETENCIES RE, V1st
   Block JP, 2013, J ADOLESCENT HEALTH, V52, P702, DOI 10.1016/j.jadohealth.2012.11.017
   Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486
   Burton S, 2015, J BUS RES, V68, P2067, DOI 10.1016/j.jbusres.2015.03.004
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   Daivadanam M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1880-5
   Dito BB, 2015, FEM ECON, V21, P168, DOI 10.1080/13545701.2015.1007073
   Ethiopian Public Health Institute, 2016, Ethiopia STEPS report on risk factors for noncommunicable diseases and prevalence of selected NCDs
   Farahmand M, 2015, APPETITE, V89, P291, DOI 10.1016/j.appet.2015.02.025
   Ferzacca S, 2013, APPETITE, V69, P156, DOI 10.1016/j.appet.2013.05.021
   Glaser BG., 2002, INT J QUAL METHODS, V1, P23, DOI DOI 10.1177/160940690200100203
   Land MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3064-3
   Langdon EJ, 2010, REV LAT-AM ENFERM, V18, P459, DOI 10.1590/S0104-11692010000300023
   Lazarou C, 2010, INT J FOOD SCI NUTR, V61, P739, DOI 10.3109/09637481003769782
   Maher D, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-14
   Matenge S. T. P., 2012, African Journal of Agricultural Research, V7, P2243
   Metta E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1504-0
   Mook K, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150402
   Morcos N Y., 2013, International Journal of Nutrition, Pharmacology, Neurological Diseases, V3, P375, DOI DOI 10.4103/2231-0738.119853
   Moser A, 2017, EUR J GEN PRACT, V24, DOI 10.1080/13814788.2017.1375091
   Mukherjea A, 2013, FAM COMMUNITY HEALTH, V36, P311, DOI 10.1097/FCH.0b013e31829d2549
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61729-2
   Nakagawa Hideaki, 2004, Environ Health Prev Med, V9, P123, DOI 10.1007/BF02898090
   Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135
   Oli N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24023
   Persynaki A, 2017, NUTRITION, V35, P14, DOI 10.1016/j.nut.2016.10.005
   Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587
   Scott A, 2013, HEALTH PROMOT INT, V28, P4, DOI 10.1093/heapro/das038
   Stead M, 2011, SOC SCI MED, V72, P1131, DOI 10.1016/j.socscimed.2010.12.029
   Tebekaw Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1126
   Townsend N, 2017, HEALTH PROMOT INT, V32, P91, DOI 10.1093/heapro/dav056
   Trepanowski JF, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-57
   Wagner MG, 2016, APPETITE, V100, P94, DOI 10.1016/j.appet.2016.02.002
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   World Health Organization, STEPwise approach to surveillance (STEPS).
   World Health Organization (WHO), 2014, Uganda 2014 Report
   Yalew E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-975
   Yilmaz B., 2017, Journal of Ethnic Foods, V4, P213, DOI 10.1016/j.jef.2017.11.003
   Zhang Y, 2016, NAGOYA J MED SCI, V78, P163
NR 48
TC 13
Z9 13
U1 0
U2 7
PU NAGOYA UNIV, SCH MED
PI NAGOYA
PA EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU,
   NAGOYA, 466-8550, JAPAN
SN 2186-3326
EI 0027-7622
J9 NAGOYA J MED SCI
JI Nagoya J. Med. Sci.
PD NOV
PY 2018
VL 80
IS 4
BP 451
EP 464
DI 10.18999/nagjms.80.4.451
PG 14
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA HC5QE
UT WOS:000451856700002
PM 30587860
DA 2025-04-28
ER

PT J
AU Iftikhar, N
   Hussain, AI
   Kamal, GM
   Manzoor, S
   Fatima, T
   Alswailmi, FK
   Ahmad, A
   Alsuwayt, B
   Alnasser, SMA
AF Iftikhar, Neelam
   Hussain, Abdullah Ijaz
   Kamal, Ghulam Mustafa
   Manzoor, Sidra
   Fatima, Tabinda
   Alswailmi, Farhan Khashim
   Ahmad, Ashfaq
   Alsuwayt, Bader
   Abdullah Alnasser, Sulaiman Mohammed
TI Antioxidant, Anti-Obesity, and Hypolipidemic Effects of Polyphenol Rich
   Star Anise (Illicium verum) Tea in High-Fat-Sugar Diet-Induced
   Obesity Rat Model
SO ANTIOXIDANTS
LA English
DT Article
DE BMI; VLDL; HDL; kidney index; liver index; high-fat diet; DPPH radical
   scavenging activity; phenolic acids and flavonoids
ID SERUM BILIRUBIN LEVELS; ZINGIBER-OFFICINALE; METABOLIC SYNDROME;
   EXTRACT; PROFILE; LIPASE; L.
AB Star anise (Illicium verum Hook. fil.) is commonly utilized as a culinary and medicinal fruit and is most famous in indigenous systems of medicine. The present research work aims to appraise and validate the potential of polyphenol-rich star anise tea (SAT) on oxidative stress, obesity and related biochemical parameters in high-fat-sugar-diet (HFSD)-induced obesity model in rats. SAT was prepared using the traditional method in warm water. The Reverse Phase High Pressure Liquid Chromatography (RP-HPLC) analysis was performed for the simultaneous determination of phenolic acids and flavonoids in SAT. Two doses (250 and 500 mg/kg body weight) were selected to investigate the anti-obesity potential of SAT using HFSD-induced obese rat model. Major (>5 mg/100 mL) phenolic acids in SAT were p-coumeric acid, gallic aid, cinamic acid, chlorogenic acid and ferulic acid while catechin and rutin were the major flavonoids detected in the SAT. SAT exhibited 51.3% DPPH radical scavenging activity. In vivo study showed that higher doses of SAT (500 mg/kg body weight) significantly reduced the body weight increase (74.82%) and BMI (0.64 g/cm(2)). Moreover, significant reductions in the levels of serum total cholesterol, triglyceride, LDL and VLDL were recorded in all the treatment groups in comparison to the HFSDC group. Furthermore, SAT reduced the alterations in MDA, SOD and GSH levels of experimental groups thus showing the potential against oxidative stress. The SAT-500 group showed a significant decrease in the elevated kidney and liver weights and atherogenic index in comparison to the HFSDC group. The present study proved that SAT exhibited strong protective effects against obesity and oxidative stress, especially at higher doses.
C1 [Iftikhar, Neelam; Hussain, Abdullah Ijaz; Manzoor, Sidra] Govt Coll Univ Faisalabad, Dept Chem, Nat Prod & Synthet Chem NPSC Lab, Faisalabad 38000, Pakistan.
   [Hussain, Abdullah Ijaz] Govt Coll Univ Faisalabad, Cent Hitech Lab, Faisalabad 38000, Pakistan.
   [Kamal, Ghulam Mustafa] Khwaja Fareed Univ Engn & Informat Technol, Inst Chem, Rahim Yar Khan 64200, Pakistan.
   [Fatima, Tabinda] Univ Hafr Al Batin, Coll Pharm, Dept Pharmaceut Chem, Hafar al Batin 39524, Saudi Arabia.
   [Alswailmi, Farhan Khashim; Ahmad, Ashfaq; Alsuwayt, Bader] Univ Hafr Al Batin, Coll Pharm, Dept Pharm Practice, Hafar al Batin 39524, Saudi Arabia.
   [Abdullah Alnasser, Sulaiman Mohammed] Qassim Univ, Unaizah Coll Pharm, Dept Pharmacol & Toxicol, Buraydah 51452, Saudi Arabia.
C3 Government College University Faisalabad; Government College University
   Faisalabad; Khwaja Fareed University of Engineering & Information
   Technology, Pakistan; Hafr Albatin University; Hafr Albatin University;
   Qassim University
RP Hussain, AI (corresponding author), Govt Coll Univ Faisalabad, Dept Chem, Nat Prod & Synthet Chem NPSC Lab, Faisalabad 38000, Pakistan.; Hussain, AI (corresponding author), Govt Coll Univ Faisalabad, Cent Hitech Lab, Faisalabad 38000, Pakistan.; Alnasser, SMA (corresponding author), Qassim Univ, Unaizah Coll Pharm, Dept Pharmacol & Toxicol, Buraydah 51452, Saudi Arabia.
EM abdullahijaz@gcuf.edu.pk; sm.alnasser@qu.edu.sa
RI Alsuwayt, Bader/HSG-7114-2023; Ahmad, Ashfaq/IUM-8419-2023; Kamal,
   Ghulam/AAP-2325-2021; ALSWAILMI, FARHAN/ABM-1370-2022; Hussain,
   Abdullah/AGI-0192-2022
OI Hussain, Abdullah Ijaz/0000-0001-7862-8859; Ahmad,
   Ashfaq/0000-0002-9185-4639; Alnasser, Sulaiman/0000-0001-8678-5029;
   Kamal, Ghulam Mustafa/0000-0003-1323-2364
CR Alberca RW, 2021, CRIT REV FOOD SCI, V61, P2262, DOI 10.1080/10408398.2020.1775546
   Aly S. E., 2016, Journal of the Saudi Society of Agricultural Sciences, V15, P20, DOI 10.1016/j.jssas.2014.05.003
   Boccellino M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165642
   Cai M, 2013, INT J FOOD SCI TECH, V48, P2324, DOI 10.1111/ijfs.12221
   Cuenca MC, 2019, NEUROLOGIA, V34, P211, DOI 10.1016/j.nrl.2017.05.006
   Chang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037241
   Chien MY, 2016, J FOOD DRUG ANAL, V24, P594, DOI 10.1016/j.jfda.2016.01.012
   Chung Hai-Jung, 2009, Preventive Nutrition and Food Science, V14, P195
   Ezzat SM, 2020, J ETHNOPHARMACOL, V251, DOI 10.1016/j.jep.2020.112541
   FAE Ghozy S., 2017, 2017 IEEE INT C PROG, V2017, P593, DOI [10.21608/mbse.2017.139078, DOI 10.21608/MBSE.2017.139078]
   Goyal RK, 2006, FITOTERAPIA, V77, P160, DOI 10.1016/j.fitote.2006.01.005
   Haque RA, 2013, J COORD CHEM, V66, P3211, DOI 10.1080/00958972.2013.831406
   Hasani-Ranjbar S, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-28
   Hernández-Saavedra D, 2016, MED CHEM RES, V25, P163, DOI 10.1007/s00044-015-1454-1
   Hosen MB, 2015, INT J REPROD BIOMED, V13, P525
   Hussain AI, 2013, IND CROP PROD, V45, P416, DOI 10.1016/j.indcrop.2013.01.002
   Iftikhar N, 2022, FOOD SCI NUTR, V10, P698, DOI 10.1002/fsn3.2695
   Islam MT, 2020, PHYTOTHER RES, V34, P1216, DOI 10.1002/ptr.6602
   Jabri MA, 2017, BIOMED PHARMACOTHER, V87, P153, DOI 10.1016/j.biopha.2016.12.043
   Jenko-Praznikar Z, 2013, METABOLISM, V62, P976, DOI 10.1016/j.metabol.2013.01.011
   Kamoun J, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06717
   Kanatt SR, 2014, FOOD BIOSCI, V6, P24, DOI 10.1016/j.fbio.2014.03.002
   Kang NL, 2021, VASC HEALTH RISK MAN, V17, P371, DOI 10.2147/VHRM.S316108
   Karadag F, 2017, CLIN PSYCHOPHARM NEU, V15, P153, DOI 10.9758/cpn.2017.15.2.153
   Kwok S, 2020, CLIN OBES, V10, DOI 10.1111/cob.12403
   Mahmoud RH, 2013, EUR REV MED PHARMACO, V17, P75
   MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407
   Nammi S, 2009, BASIC CLIN PHARMACOL, V104, P366, DOI 10.1111/j.1742-7843.2008.00362.x
   Nuutila AM, 2002, FOOD CHEM, V76, P519, DOI 10.1016/S0308-8146(01)00305-3
   Oh J, 2013, FOOD CONTROL, V31, P403, DOI 10.1016/j.foodcont.2012.10.021
   RiceEvans C, 1997, PROSTAG LEUKOTR ESS, V57, P499, DOI 10.1016/S0952-3278(97)90435-X
   Rodríguez-Pérez C, 2019, CRIT REV FOOD SCI, V59, P1212, DOI 10.1080/10408398.2017.1399859
   Rufino AT, 2021, MED RES REV, V41, P556, DOI 10.1002/med.21740
   Salem MA, 2021, INFECT DRUG RESIST, V14, P33, DOI 10.2147/IDR.S285940
   Saravanan G, 2014, J SCI FOOD AGR, V94, P2972, DOI 10.1002/jsfa.6642
   Sarikahya NB, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11102075
   Sattar N, 2021, CURR OBES REP, V10, P282, DOI 10.1007/s13679-021-00448-8
   Shahrajabian Mohamad Hesam, 2021, Pharmacognosy Communications, V11, P31, DOI 10.5530/pc.2021.1.7
   Shang AO, 2021, CRIT REV FOOD SCI, V61, P2061, DOI 10.1080/10408398.2020.1769548
   Shi Y, 2021, FOOD CHEM, V342, DOI 10.1016/j.foodchem.2020.128359
   Takahashi Y, 2014, WORLD J GASTROENTERO, V20, P15539, DOI 10.3748/wjg.v20.i42.15539
   Vamanu E, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00492
   Velez-Carrasco W, 2008, J NUTR BIOCHEM, V19, P362, DOI 10.1016/j.jnutbio.2007.05.005
   Wang CM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2473081
   Wang GW, 2011, J ETHNOPHARMACOL, V136, P10, DOI 10.1016/j.jep.2011.04.051
   Wang Y, 2021, J SCI FOOD AGR, V101, P287, DOI 10.1002/jsfa.10642
NR 46
TC 17
Z9 17
U1 5
U2 32
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD NOV
PY 2022
VL 11
IS 11
AR 2240
DI 10.3390/antiox11112240
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 8U0PB
UT WOS:000929652300001
PM 36421427
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Cai, CL
   Li, HY
   Zhang, LJ
   Li, JQ
   Duan, SQ
   Fang, ZF
   Li, C
   Chen, H
   Alharbi, M
   Ye, L
   Liu, YT
   Zeng, Z
AF Cai, Chenglin
   Li, Hongyu
   Zhang, Lijia
   Li, Junqi
   Duan, Songqi
   Fang, Zhengfeng
   Li, Cheng
   Chen, Hong
   Alharbi, Metab
   Ye, Lin
   Liu, Yuntao
   Zeng, Zhen
TI Machine Learning Identification of Nutrient Intake Variations across Age
   Groups in Metabolic Syndrome and Healthy Populations
SO NUTRIENTS
LA English
DT Article
DE machine learning; XGBoost; Cox; metabolic syndrome; diet nutrition; age
ID VITAMIN-A; PREVALENCE; DISEASE; TESTOSTERONE; SENSITIVITY; MANAGEMENT;
   HORMONES; OBESITY; TRENDS; MEN
AB This study undertakes a comprehensive examination of the intricate link between diet nutrition, age, and metabolic syndrome (MetS), utilizing advanced artificial intelligence methodologies. Data from the National Health and Nutrition Examination Survey (NHANES) spanning from 1999 to 2018 were meticulously analyzed using machine learning (ML) techniques, specifically extreme gradient boosting (XGBoost) and the proportional hazards model (COX). Using these analytic methods, we elucidated a significant correlation between age and MetS incidence and revealed the impact of age-specific dietary patterns on MetS. The study delineated how the consumption of certain dietary components, namely retinol, beta-cryptoxanthin, vitamin C, theobromine, caffeine, lycopene, and alcohol, variably affects MetS across different age demographics. Furthermore, it was revealed that identical nutritional intakes pose diverse pathogenic risks for MetS across varying age brackets, with substances such as cholesterol, caffeine, and theobromine exhibiting differential risks contingent on age. Importantly, this investigation succeeded in developing a predictive model of high accuracy, distinguishing individuals with MetS from healthy controls, thereby highlighting the potential for precision in dietary interventions and MetS management strategies tailored to specific age groups. These findings underscore the importance of age-specific nutritional guidance and lay the foundation for future research in this area.
C1 [Cai, Chenglin; Li, Hongyu; Zhang, Lijia; Li, Junqi; Duan, Songqi; Fang, Zhengfeng; Li, Cheng; Chen, Hong; Liu, Yuntao; Zeng, Zhen] Sichuan Agr Univ, Coll Food Sci, Yaan 625014, Peoples R China.
   [Cai, Chenglin] Sichuan Agr Univ, Coll Informat Engn, Yaan 625014, Peoples R China.
   [Alharbi, Metab] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, POB 2455, Riyadh 11451, Saudi Arabia.
   [Ye, Lin] Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu 611130, Peoples R China.
C3 Sichuan Agricultural University; Sichuan Agricultural University; King
   Saud University; Sichuan Agricultural University
RP Liu, YT; Zeng, Z (corresponding author), Sichuan Agr Univ, Coll Food Sci, Yaan 625014, Peoples R China.
EM caichengl@163.com; liuyt@sicau.edu.cn; zengzhen201304@163.com
RI Alharbi, Metab/AAF-3351-2019; yuntao, liu/AAO-6411-2020; zeng,
   zhen/HTM-4886-2023
OI /0000-0002-8320-8725; Duan, Songqi/0000-0002-0822-5883; Fang,
   Zhengfeng/0000-0003-1844-194X; Cai, Chenglin/0009-0006-5376-1657
FU King Saud University
FX No Statement Available
CR Abete I, 2011, NUTR METAB CARDIOVAS, V21, pB1, DOI 10.1016/j.numecd.2011.05.001
   Ahmad OB., 2001, Age standardization of rates: a new WHO standard, V9, P1
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Amengual J, 2010, CELL PHYSIOL BIOCHEM, V25, P657, DOI 10.1159/000315085
   Azam Sonish, 2003, Med Sci Monit, V9, pBR325
   Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Castro-Barquero S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12102983
   Chen M, 2017, IEEE ACCESS, V5, P8869, DOI 10.1109/ACCESS.2017.2694446
   Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785
   Desroches S, 2007, APPL PHYSIOL NUTR ME, V32, P23, DOI [10.1139/H06-095, 10.1139/h06-095]
   Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5
   Ervin R Bethene, 2009, Natl Health Stat Report, P1
   Feldeisen SE, 2007, APPL PHYSIOL NUTR ME, V32, P46, DOI [10.1139/H06-101, 10.1139/h06-101]
   Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589
   Ferrini RL, 1998, AM J EPIDEMIOL, V147, P750
   Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444
   Patro SGK, 2015, Arxiv, DOI [arXiv:1503.06462, DOI 10.17148/IARJSET.2015.2305, 10.48550/arxiv.1503.06462]
   GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016, DOI 10.1210/jcem-73-5-1016
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Hirode G, 2020, JAMA-J AM MED ASSOC, V323, P2526, DOI 10.1001/jama.2020.4501
   Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50
   Ivanovic D, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0601-7
   James PT, 2001, OBES RES, V9, p228S, DOI 10.1038/oby.2001.123
   James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010
   Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48
   KREISBERG RA, 1987, AM J MED, V82, P54, DOI 10.1016/0002-9343(87)90272-5
   LaValley MP, 2008, CIRCULATION, V117, P2395, DOI 10.1161/CIRCULATIONAHA.106.682658
   Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703
   Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x
   Lv K, 2023, BMC MED, V21, DOI 10.1186/s12916-023-03045-9
   Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565
   Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595
   Park S, 2015, NUTRITION, V31, P111, DOI 10.1016/j.nut.2014.05.011
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Ponce O., 2019, Journal of Nutrition & Intermediary Metabolism, V17, P100101
   Reifen R, 2002, P NUTR SOC, V61, P397, DOI 10.1079/PNS2002172
   Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006
   Riccardi G, 2000, BRIT J NUTR, V83, pS143
   Salas-Salvadó J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449
   Therneau TM., 2000, The cox model
   Trigka M, 2023, COMPUTATION, V11, DOI 10.3390/computation11090170
   Wolf JE, 2002, ADV THER, V19, P109, DOI 10.1007/BF02850266
   Wong SK, 2020, INT J MED SCI, V17, P1625, DOI 10.7150/ijms.47103
   Wu F, 2022, J ACAD NUTR DIET, V122, P758, DOI 10.1016/j.jand.2021.09.010
   Wu FF, 2019, SPECTROCHIM ACTA A, V215, P354, DOI 10.1016/j.saa.2019.03.001
   Xu H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010128
   Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711
NR 48
TC 4
Z9 4
U1 7
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2024
VL 16
IS 11
AR 1659
DI 10.3390/nu16111659
PG 24
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA UB3L3
UT WOS:001245562100001
PM 38892592
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Torres, A
   Quintanilla, F
   Barnafi, E
   Sánchez, C
   Acevedo, F
   Walbaum, B
   Merino, T
AF Torres, Alvaro
   Quintanilla, Francisca
   Barnafi, Esteban
   Sanchez, Cesar
   Acevedo, Francisco
   Walbaum, Benjamin
   Merino, Tomas
TI Dietary Interventions for Cancer Prevention: An Update to ACS
   International Guidelines
SO NUTRIENTS
LA English
DT Review
DE diet; nutrition; cancer; risk; prevention; Mediterranean diet; dairy;
   vitamin D; diet quality; carbohydrates
ID HEALTH; RISK; QUALITY; OBESITY; CALCIUM; INDEXES
AB Cancer, the second leading cause of death worldwide, demands the identification of modifiable risk factors to optimize its prevention. Diet has emerged as a pivotal focus in current research efforts. This literature review aims to enhance the ACS guidelines on diet and cancer by integrating the latest findings and addressing unresolved questions. The methodology involved an advanced PubMed search with specific filters relevant to the research topic. Topics covered include time-restricted diet, diet quality, acid load, counseling, exercise and diet combination, Mediterranean diet, vegetarian and pescetarian diets, weight loss, dairy consumption, coffee and tea, iron, carbohydrates, meat, fruits and vegetables, heavy metals, micronutrients, and phytoestrogens. The review highlights the benefits of the Mediterranean diet in reducing cancer risk. Adherence to overnight fasting or carbohydrate consumption may contribute to cancer prevention, but excessive fasting may harm patients' quality of life. A vegetarian/pescetarian diet is associated with lower risks of general and colorectal cancer compared to a carnivorous diet. High heme and total iron intake are linked to increased lung cancer risk, while phytoestrogen intake is associated with reduced risk. Coffee and tea have a neutral impact on cancer risk. Finally, the roles of several preventive micronutrients and carcinogenic heavy metals are discussed.
C1 [Torres, Alvaro; Quintanilla, Francisca; Barnafi, Esteban] Pontificia Univ Catolica Chile, Fac Med, Sch Med, Santiago 8331150, Chile.
   [Sanchez, Cesar; Acevedo, Francisco; Walbaum, Benjamin] Pontificia Univ Catolica Chile, Fac Med, Dept Hematol Oncol, Santiago 8330077, Chile.
   [Merino, Tomas] Red Salud Christus UC, Canc Ctr UC, Santiago 8330032, Chile.
C3 Pontificia Universidad Catolica de Chile; Pontificia Universidad
   Catolica de Chile
RP Merino, T (corresponding author), Red Salud Christus UC, Canc Ctr UC, Santiago 8330032, Chile.
EM astorres1@uc.cl; fran.quintanilla@uc.cl; estebanandres@barnafi.com;
   csanchez@med.puc.cl; fnaceved@uc.cl; bvwalbau@uc.cl; tmerino@med.puc.cl
RI Merino, Tomas/AAE-4664-2022
OI Merino, Tomas/0000-0003-3661-9123; Walbaum, Benjamin/0000-0003-2314-5360
FX This research received no external funding.
CR [Anonymous], 1982, DIET NUTR CANC
   Aune D, 2017, INT J EPIDEMIOL, V46, P1029, DOI 10.1093/ije/dyw319
   Berthy F, 2022, AM J CLIN NUTR, V116, P980, DOI 10.1093/ajcn/nqac208
   Bikle Daniel D, 2009, Curr Osteoporos Rep, V7, P58
   Botteri E, 2018, J INTERN MED, V284, P282, DOI 10.1111/joim.12765
   Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1
   Cai HL, 2022, CANCER SCI, V113, P744, DOI 10.1111/cas.15215
   Dowlati M, 2021, TRENDS FOOD SCI TECH, V109, P527, DOI 10.1016/j.tifs.2021.01.064
   Feingold K., 2021, Endotext [Internet]
   Filippini T, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105879
   Gatarek P, 2021, EXCLI J, V20, P301, DOI 10.17179/excli2020-3239
   Griffin LE, 2019, FOOD FUNCT, V10, P2138, DOI [10.1039/C9FO00333A, 10.1039/c9fo00333a]
   Hawrysz I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123788
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   International Atomic Energy Agency, 2018, Diet Quality
   Kim TH, 2023, J GASTRIC CANCER, V23, P3, DOI 10.5230/jgc.2023.23.e11
   Kourlaba G, 2009, MATURITAS, V62, P1, DOI 10.1016/j.maturitas.2008.11.021
   Liu L, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.838762
   Lubinski J, 2023, NUTRIENTS, V15, DOI 10.3390/nu15112611
   Ma JF, 2020, J HAZARD MATER, V399, DOI 10.1016/j.jhazmat.2020.123095
   Malik V.S., 2017, Cardiovascular, Respiratory, and Related Disorders, V3rd ed., P5
   Männistö S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95773-2
   Matuszczak M, 2024, ANTIOXIDANTS-BASEL, V13, DOI 10.3390/antiox13070841
   Matuszczak M, 2024, ANTIOXIDANTS-BASEL, V13, DOI 10.3390/antiox13050609
   Mitra S, 2022, MOLECULES, V27, DOI 10.3390/molecules27020555
   Myneni AA, 2021, J NUTR, V151, P1618, DOI 10.1093/jn/nxab033
   Palomar-Cros A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082662
   Park SY, 2021, NUTRIENTS, V13, DOI 10.3390/nu13051614
   Parra-Soto S, 2022, BMC MED, V20, DOI 10.1186/s12916-022-02257-9
   Pietrzak S, 2024, NUTRIENTS, V16, DOI 10.3390/nu16040527
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Qin H, 2022, MEDICINE, V101, DOI 10.1097/MD.0000000000029879
   Rock CL, 2022, CA-CANCER J CLIN, V72, P230, DOI 10.3322/caac.21719
   Rock CL, 2020, CA-CANCER J CLIN, V70, P245, DOI 10.3322/caac.21591
   Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z
   Ronco A.L., 2019, Multidiscip. Cancer Investig, V3, P20, DOI [10.30699/acadpub.mci.3.3.20, DOI 10.30699/ACADPUB.MCI.3.3.20]
   Ronco Alvaro L, 2021, Cancer Treat Res Commun, V28, P100382, DOI 10.1016/j.ctarc.2021.100382
   Roy S., 2019, Nutrition and Immunity
   Sadeghi A, 2022, NUTR CANCER, V74, P2859, DOI 10.1080/01635581.2022.2036770
   Schwingshackl L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101063
   Sen A, 2019, INT J CANCER, V144, P240, DOI 10.1002/ijc.31634
   Shah SA, 2023, EUR J CLIN NUTR, V77, P596, DOI 10.1038/s41430-023-01267-x
   Su LJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5080843
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Tolipoulos IK, 2011, INDIAN J EXP BIOL, V49, P904
   Turati F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030326
   Virtanen JK, 2022, AM J CLIN NUTR, V115, P1300, DOI 10.1093/ajcn/nqab419
   Wang Q, 2021, CARCINOGENESIS, V42, P1250, DOI 10.1093/carcin/bgab072
   Wang Q, 2021, CANCER CAUSE CONTROL, V32, P493, DOI 10.1007/s10552-021-01400-w
   Ward HA, 2019, EUR J CLIN NUTR, V73, P1122, DOI 10.1038/s41430-018-0271-2
   Wei XX, 2021, AM J CLIN NUTR, V114, P2043, DOI 10.1093/ajcn/nqab298
   Willemsen RF, 2022, EUR J CLIN NUTR, V76, P360, DOI 10.1038/s41430-021-00958-7
   Willett WC, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P833
   Wu Y, 2021, AM J CLIN NUTR, V114, P450, DOI 10.1093/ajcn/nqab097
   Yang BY, 2014, J CLIN ONCOL, V32, P2335, DOI 10.1200/JCO.2014.55.3024
   Zambrana Luis E., 2021, CURR DEV NUTR, V5, pnzab101, DOI [10.1093/cdn/nzab101, DOI 10.1093/CDN/NZAB101]
NR 56
TC 1
Z9 1
U1 9
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2024
VL 16
IS 17
AR 2897
DI 10.3390/nu16172897
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA F6O0I
UT WOS:001310979800001
PM 39275213
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Merlotti, C
   Morabito, A
   Pontiroli, AE
AF Merlotti, C.
   Morabito, A.
   Pontiroli, A. E.
TI Prevention of type 2 diabetes; a systematic review and meta-analysis of
   different intervention strategies
SO DIABETES OBESITY & METABOLISM
LA English
DT Article
DE bariatric surgery; lifestyle modifications; meta-analysis; prevention;
   type 2 diabetes
ID IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; RENIN-ANGIOTENSIN
   SYSTEM; LIPID-LOWERING TREATMENT; BETA-CELL FUNCTION;
   CARDIOVASCULAR-DISEASE; BARIATRIC SURGERY; FASTING GLUCOSE;
   DOUBLE-BLIND; ALCOHOL-CONSUMPTION
AB Aim: Different intervention strategies can prevent type 2 diabetes (T2DM). Aim of the present systematic review and meta-analysis was to evaluate the effectiveness of different strategies.
   Methods: Studies were grouped into 15 different strategies: 1: diet plus physical activity; 2: physical activity; 3-6: anti-diabetic drugs [glitazones, metformin, beta-cell stimulating drugs (sulphanylureas, glinides), alfa-glucosidase inhibitors]; 7-8: cardiovascular drugs (ACE inhibitors, ARB, calcium antagonists); 9-14 [diets, lipid-affecting drugs (orlistat, bezafibrate), vitamins, micronutrients, estrogens, alcohol, coffee]; 15: bariatric surgery. Only controlled studies were included in the analysis, whether randomized, non-randomized, observational studies, whether primarily designed to assess incident cases of diabetes, or performed with other purposes, such as control of hypertension, of ischemic heart disease or prevention of cardiovascular events. Appropriate methodology [preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement] was used. Seventy-one studies (490 813 subjects), published as full papers, were analysed to identify predictors of new cases of T2DM, and were included in a meta-analysis (random-effects model) to study the effect of different strategies. Intervention effect (new cases of diabetes) was expressed as odds ratio (OR), with 95% confidence intervals (C. I. s). Publication bias was formally assessed.
   Results: Body mass index was in the overweight range for 13 groups, obese or morbidly obese in lipid-affecting drugs and in bariatric surgery. Non-surgical strategies, except for beta-cell stimulating drugs, estrogens and vitamins, were able to prevent T2DM, with different effectiveness, from 0.37 (C. I. 0.26-0.52) to 0.85 (C. I. 0.77-0.93); the most effective strategy was bariatric surgery in morbidly obese subjects [0.16 (C. I. 0.11,0.24)]. At meta-regression analysis, age of subjects and amount of weight lost were associated with effectiveness of intervention.
   Conclusions: These data indicate that several strategies prevent T2DM, making it possible to make a choice for the individual subject.
C1 Univ Milan, Cattedra Med Interna, Dipartimento Sci Salute, I-20142 Milan, Italy.
   Univ Milan, Cattedra Stat Med & Biometria, Dipartimento Sci Salute, I-20142 Milan, Italy.
   Dipartimento Sci Clin & Comunita, Milan, Italy.
C3 University of Milan; University of Milan
RP Pontiroli, AE (corresponding author), Univ Milan, Osped San Paolo, Dipartimento Sci Salute, Via Antonio di Rudini 8, I-20142 Milan, Italy.
EM antonio.pontiroli@unimi.it
RI pontiroli, antonio/AAI-5575-2020
CR Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051
   Abuissa H, 2008, DIABETES OBES METAB, V10, P1157, DOI 10.1111/j.1463-1326.2008.00898.x
   Anderson DC Jr, 2005, ANN PHARMACOTHER, V39, P102, DOI 10.1345/aph.1E081
   Andraws R, 2007, AM J CARDIOL, V99, P1006, DOI 10.1016/j.amjcard.2006.10.068
   [Anonymous], TOT PREV DIAB PRED
   [Anonymous], BMJ
   [Anonymous], International, DOI DOI 10.2337/dc10-S011
   [Anonymous], VITAMIN D SUPPLEMENT
   Arterburn DE, 2013, OBES SURG, V23, P93, DOI 10.1007/s11695-012-0802-1
   Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191
   Bennett SMA, 2004, DIABETIC MED, V21, P415, DOI 10.1111/j.1464-5491.2004.01155.x
   Black HR, 2008, DIABETES CARE, V31, P353, DOI 10.2337/dc07-1452
   Bo S, 2007, J GEN INTERN MED, V22, P1695, DOI 10.1007/s11606-007-0399-6
   Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0
   Bosch J, 2005, CIRCULATION, V112, P1339, DOI 10.1161/CIRCULATIONAHA.105.548461
   Bosch J, 2006, NEW ENGL J MED, V355, P1551
   Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4
   Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796
   Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041
   Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082
   Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5
   Cooper-DeHoff R, 2006, AM J CARDIOL, V98, P890, DOI 10.1016/j.amjcard.2006.04.030
   Dahlöf B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3
   Dahlöf B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1
   de Boer IH, 2008, DIABETES CARE, V31, P701, DOI 10.2337/dc07-1829
   de Vegt F, 2002, DIABETES RES CLIN PR, V57, P53, DOI 10.1016/S0168-8227(02)00013-X
   DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Diabetes Prevention Progam, 2005, DIABETES, V54, P1150
   Djoussé L, 2007, OBESITY, V15, P1758, DOI 10.1038/oby.2007.209
   Durbin RJ, 2004, DIABETES OBES METAB, V6, P280, DOI 10.1111/j.1462-8902.2004.0348.x
   EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y
   Eriksson JG, 2006, J INTERN MED, V259, P553, DOI 10.1111/j.1365-2796.2006.01633.x
   ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196
   Flory JH, 2009, DIABETES CARE, V32, P547, DOI 10.2337/dc08-1809
   Fossum E, 2007, J INTERN MED, V262, P439, DOI 10.1111/j.1365-2796.2007.01808.x
   Garber Alan J, 2008, Endocr Pract, V14, P933
   Gerstein HC, 2011, DIABETOLOGIA, V54, P487, DOI 10.1007/s00125-010-1985-4
   Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8
   Haffner SM, 2000, CIRCULATION, V101, P975, DOI 10.1161/01.CIR.101.9.975
   Harbord RM, 2009, STATA J, V9, P197, DOI 10.1177/1536867X0900900202
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hirai FE, 2008, DIABETES CARE, V31, P493, DOI 10.2337/dc07-1161
   Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122
   Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129
   Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   JARRETT RJ, 1979, DIABETOLOGIA, V16, P25, DOI 10.1007/BF00423146
   Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005
   Kataja-Tuomola M, 2008, DIABETOLOGIA, V51, P47, DOI 10.1007/s00125-007-0864-0
   Kawahara T, 2008, DIABETES CARE, V31, P1949, DOI 10.2337/dc07-2272
   Kawamori R, 2009, LANCET, V373, P1607, DOI 10.1016/S0140-6736(09)60222-1
   Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006
   Kjeldsen SE, 2006, J HYPERTENS, V24, P1405, DOI 10.1097/01.hjh.0000234122.55895.5b
   Knowler WC, 2003, DIABETES CARE, V26, P977
   Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
   Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010
   Li CL, 1999, DIABETIC MED, V16, P477, DOI 10.1046/j.1464-5491.1999.00090.x
   Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7
   Liao D, 2002, DIABETES CARE, V25, P1504, DOI 10.2337/diacare.25.9.1504
   Liu SM, 2006, DIABETES, V55, P2856, DOI 10.2337/db06-0456
   Lloret-Linares C, 2008, DIABETIC MED, V25, P1142, DOI 10.1111/j.1464-5491.2008.02550.x
   LONG SD, 1994, DIABETES CARE, V17, P372, DOI 10.2337/diacare.17.5.372
   Mancia G, 2003, HYPERTENSION, V41, P431, DOI 10.1161/01.HYP.0000057420.27692.AD
   Mayer-Davis EJ, 2002, DIABETES CARE, V25, P2172, DOI 10.2337/diacare.25.12.2172
   McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700]
   Norris SL, 2005, AM J PREV MED, V28, P126, DOI 10.1016/j.amepre.2004.08.006
   Oldroyd JC, 2006, DIABETES RES CLIN PR, V72, P117, DOI 10.1016/j.diabres.2005.09.018
   Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736
   Pan CY, 2003, DIABETES RES CLIN PR, V61, P183, DOI 10.1016/S0168-8227(03)00117-7
   Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537
   Penn L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-342
   Phung OJ, 2011, DIABETIC MED, V28, P948, DOI 10.1111/j.1464-5491.2011.03303.x
   Pontiroli AE, 2012, NUTR METAB CARDIOVAS, V22, pE24, DOI 10.1016/j.numecd.2012.05.012
   Pontiroli AE, 2005, DIABETES CARE, V28, P2703, DOI 10.2337/diacare.28.11.2703
   Qiao Q, 2003, DIABETES CARE, V26, P688
   Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z
   Ramachandran A, 2009, DIABETOLOGIA, V52, P1019, DOI 10.1007/s00125-009-1315-x
   Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772
   Rossi R, 2004, DIABETES CARE, V27, P645, DOI 10.2337/diacare.27.3.645
   Roumen C, 2008, DIABETIC MED, V25, P597, DOI 10.1111/j.1464-5491.2008.02417.x
   Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275
   Salas-Salvadó J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288
   SARTOR G, 1980, DIABETES, V29, P41, DOI 10.2337/diabetes.29.1.41
   Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6
   Scheen AJ, 2007, DIABETES METAB, V33, P3, DOI 10.1016/j.diabet.2006.11.005
   Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007
   Simmons D, 2004, DIABETIC MED, V21, P122, DOI 10.1111/j.1464-5491.2004.01020.x
   Sjöström L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622
   Smith GD, 2005, ANN INTERN MED, V142, P313, DOI 10.7326/0003-4819-142-5-200503010-00006
   Southwood RL, 2010, AM J THER, V17, P201, DOI 10.1097/MJT.0b013e3181b64aa1
   Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175
   Tenenbaum A, 2005, EUR HEART J, V26, P2032, DOI 10.1093/eurheartj/ehi310
   Tenenbaum A, 2004, CIRCULATION, V109, P2197, DOI 10.1161/01.CIR.0000126824.12785.B6
   Tenenbaum A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035298
   Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155
   Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801
   Wein P, 1999, AUST NZ J OBSTET GYN, V39, P162, DOI 10.1111/j.1479-828X.1999.tb03363.x
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066
   Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780
   Yates T, 2007, DIABETOLOGIA, V50, P1116, DOI 10.1007/s00125-007-0638-8
   Yusuf S, 2005, CIRCULATION, V112, P48, DOI 10.1161/CIRCULATIONAHA.104.528166
   Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882
   Zanolla L, 2007, J CARDIOVASC MED, V8, P473, DOI 10.2459/01.JCM.0000278445.04613.27
   Zinman B, 2010, LANCET, V376, P103, DOI 10.1016/S0140-6736(10)60746-5
NR 107
TC 113
Z9 122
U1 2
U2 57
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-8902
EI 1463-1326
J9 DIABETES OBES METAB
JI Diabetes Obes. Metab.
PD AUG
PY 2014
VL 16
IS 8
BP 719
EP 727
DI 10.1111/dom.12270
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AN5EH
UT WOS:000340612400006
PM 24476122
OA Bronze
DA 2025-04-28
ER

PT J
AU Lee, SR
   Schriefer, JM
   Gunnels, TA
   Harvey, IC
   Bloomer, RJ
AF Lee, Sang-Rok
   Schriefer, JohnHenry M.
   Gunnels, Trint A.
   Harvey, Innocence C.
   Bloomer, Richard J.
TI Acute oral intake of a higenamine-based dietary supplement increases
   circulating free fatty acids and energy expenditure in human subjects
SO LIPIDS IN HEALTH AND DISEASE
LA English
DT Article
DE Lipolysis; Thermogenesis; Fat mobilization; Weight loss; Nutritional
   supplements
ID SYMPATHETIC-NERVE ACTIVITY; LIPID MOBILIZATION; METABOLIC-RATE; OBESE
   WOMEN; CAFFEINE; YOHIMBINE; MEN; OXIDATION; LIPOLYSIS; MICE
AB Background: Higenamine, also known as norcoclaurine, is an herbal constituent thought to act as a beta-2 adrenergic receptor agonist-possibly stimulating lipolysis. It was the purpose of this study to determine the impact of a higenamine-based dietary supplement on plasma free fatty acids and energy expenditure following acute oral ingestion.
   Methods: Sixteen healthy subjects (8 men; 26.1 +/- 2.5 yrs; 8 women 22.4 +/- 3.1 yrs) ingested a dietary supplement containing a combination of higenamine, caffeine (270 mg), and yohimbe bark extract or a placebo, on two separate occasions in a double-blind, randomized, cross-over design, separated by 6-8 days. Blood samples were collected immediately before ingestion, and at 30, 60, 120, and 180 minutes post ingestion, and analyzed for plasma free fatty acids (FFA) and glycerol. Breath samples were collected at the same times for a measure of kilocalorie expenditure and respiratory exchange ratio (RER) using indirect calorimetry. Heart rate and blood pressure were recorded at all times. Data collection occurred in the morning following a 10 hour overnight fast.
   Results: A condition effect was noted for both FFA (p < 0.0001) and kilocalorie expenditure (p = 0.001), with values higher for supplement compared to placebo at 60, 120, and 180 minutes post ingestion. No statistically significant effects were noted for glycerol or RER (p > 0.05). A condition effect was noted for heart rate (p = 0.03) and systolic blood pressure (p < 0.0001), with values higher for supplement compared to placebo.
   Conclusion: Ingestion of a higenamine-based dietary supplement stimulates lipolysis and energy expenditure, as evidenced by a significant increase in circulating FFA and kilocalorie expenditure. The same supplement results in a moderate increase in heart rate (similar to 3 bpm) and systolic blood pressure (similar to 12 mmHg), which is consistent with previous studies evaluating moderate doses of caffeine and yohimbine, suggesting that higenamine contributes little to the increase in these hemodynamic variables. These findings are in reference to young, healthy and active men and women.
C1 [Lee, Sang-Rok; Schriefer, JohnHenry M.; Gunnels, Trint A.; Harvey, Innocence C.; Bloomer, Richard J.] Univ Memphis, Dept Hlth & Sport Sci, Cardioresp Metab Lab, Memphis, TN 38152 USA.
C3 University of Memphis
RP Bloomer, RJ (corresponding author), Univ Memphis, Dept Hlth & Sport Sci, Cardioresp Metab Lab, 106 Roane Field House, Memphis, TN 38152 USA.
EM rbloomer@memphis.edu
FU USPlabs, LLC; University of Memphis
FX Funding for this work was provided in part by USPlabs, LLC and the
   University of Memphis.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   [Anonymous], 2009, NCHS DATA BRIEF, DOI DOI 10.CDC/NCHS
   BERLAN M, 1991, INT J OBESITY, V15, P305
   Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-32
   Bloomer RJ, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-10
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BUTCHER RW, 1968, J BIOL CHEM, V243, P1705
   Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Feng S, 2012, ACTA PHARMACOL SIN, V33, P1353, DOI 10.1038/aps.2012.114
   GALITZKY J, 1988, EUR J CLIN INVEST, V18, P587, DOI 10.1111/j.1365-2362.1988.tb01272.x
   GALITZKY J, 1991, BRIT J PHARMACOL, V104, P514, DOI 10.1111/j.1476-5381.1991.tb12460.x
   GOLDSTEIN DS, 1991, HYPERTENSION, V18, pS40
   GROSSMAN E, 1991, AM J PHYSIOL, V260, pR142, DOI 10.1152/ajpregu.1991.260.1.R142
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   Hartley TR, 2004, AM J CARDIOL, V93, P1022, DOI 10.1016/j.amjcard.2003.12.057
   Hashimoto T, 2013, J APPL PHYSIOL, V115, P260, DOI 10.1152/japplphysiol.00427.2013
   LANE JD, 1983, PSYCHOSOM MED, V45, P447, DOI 10.1097/00006842-198310000-00008
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   LITOSCH I, 1982, MOL PHARMACOL, V22, P109
   Lo CF, 1997, PLANTA MED, V63, P95, DOI 10.1055/s-2006-957619
   Major GC, 2008, BRIT J NUTR, V99, P1157, DOI 10.1017/S0007114507853335
   Outlaw J, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-25
   PARIS R, 1958, Ann Pharm Fr, V16, P15
   Pasman WJ, 1997, APPETITE, V29, P77, DOI 10.1006/appe.1997.0091
   Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   SAX L, 1991, INT J OBESITY, V15, P561
   Stewart LK, 2008, METABOLISM, V57, pS39, DOI 10.1016/j.metabol.2008.03.003
   Tam SW, 2001, PHARMACOL THERAPEUT, V91, P215, DOI 10.1016/S0163-7258(01)00156-5
   Tambalis KD, 2013, J PAEDIATR CHILD H, V49, P769, DOI 10.1111/jpc.12253
   Zhou Su-juan, 2003, Zhongguo Zhongyao Zazhi, V28, P910
NR 34
TC 28
Z9 29
U1 1
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-511X
J9 LIPIDS HEALTH DIS
JI Lipids Health Dis.
PD OCT 21
PY 2013
VL 12
AR 148
DI 10.1186/1476-511X-12-148
PG 8
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 245BX
UT WOS:000326435000001
PM 24139127
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Wang, H
   Jeong, H
   Kim, NH
   Kang, Y
   Hwang, K
   Lee, H
   Hong, JH
   Oh, KS
AF Wang, Hyewon
   Jeong, HaYoung
   Kim, Na-Hui
   Kang, YoonJung
   Hwang, Kyungmi
   Lee, HwaJung
   Hong, Jin-Hwan
   Oh, Keum-Soon
TI Association between beverage intake and obesity in children: The Korea
   National Health and Nutrition Examination Survey (KNHANES) 2013-2015
SO NUTRITION RESEARCH AND PRACTICE
LA English
DT Article
DE Obesity; child; sugars; beverages; carbonated beverages
ID SUGAR-SWEETENED BEVERAGES; CHILDHOOD OBESITY; WEIGHT-GAIN; DIETARY
   PATTERNS; UNITED-STATES; CONSUMPTION; ADOLESCENTS; OVERWEIGHT; RISK;
   CONSEQUENCES
AB BACKGROUND/OBJECTIVES: Numerous researches have studied the association between sugar intake and obesity of children in many countries. This study was undertaken to investigate the association between beverage intake and obesity of children by reviewing a database for total sugar contents established in all foods and presented in a nutrition survey by the Korea National Health and Nutrition Examination Survey (KNHANES).
   SUBJECTS/METHODS: Data of 1,520 children aged 6-11 years in the 6th KNHANES (2013-2015) were analyzed for this study. A database for total sugar intake comprises the total sugar contents of all foods included in the results of a nutrition survey using the 24-hour recall method of 6th KNHANES. Beverages were categorized into carbonated beverages, fruit & vegetable drinks, other drinks, tea, and coffee.
   RESULTS: The average daily beverage intake of all children was 131.75 g/day, and the average daily total sugar intake in beverages was 13.76 g/day. Carbonated beverages had the highest intake rate (58.85 g/day) and also ranked highest for sugar intake (6.36 g/day). After adjusting for confounding variables, the odds ratio for obesity in children with beverage intake of >= 200 mL/day significantly increased by 1.83 times (95% CI, 1.11-3.00) as compared to children with beverage intake of < 200 mL/day. Also, a significant increase was observed in the odds ratio for obesity in total children (2.41 times; 95% CI, 1.35-4.33) and boys (3.15 times; 95% CI, 1.53-6.49) with carbonated beverage intake of < 200 mL/day when compared with children who consumed >= 200 mL/day.
   CONCLUSION: A positive association is observed between beverage intake and obesity in Korean children. In particular, an intake of carbonated beverages has a positive correlation with childhood obesity in boys. This study can therefore be used as scientific evidence for reducing sugar, and for the continuous management and research on beverages.
C1 [Wang, Hyewon; Jeong, HaYoung; Kim, Na-Hui; Kang, YoonJung; Hwang, Kyungmi; Lee, HwaJung; Hong, Jin-Hwan; Oh, Keum-Soon] Natl Inst Food & Drug Safety Evaluat, Nutr & Funct Food Res Team, Cheongju 28159, Chungbuk, South Korea.
C3 Ministry of Food & Drug Safety (MFDS), Republic of Korea; National
   Institute of Food & Drug Safety Evaluation
RP Oh, KS (corresponding author), Natl Inst Food & Drug Safety Evaluat, Nutr & Funct Food Res Team, Cheongju 28159, Chungbuk, South Korea.
EM gs9705@korea.kr
RI Lee, Hye Ah/ABC-8131-2021
OI Hwa Jung, Lee/0000-0002-0176-231X; Yoon Jung, Kang/0000-0002-8400-5110
FU Ministry of Food and Drug Safety [17161MFDS081]
FX This research was supported by a grant in 2017 (17161MFDS081) from the
   Ministry of Food and Drug Safety.
CR [Anonymous], 2015, DIET REF INT KOR
   Bishop J., 2005, ASPE Research Brief: Childhood obesity
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437
   Charlotte MB, 2011, DIABETES CARE, V34, P1986
   Collison KS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-234
   Committee of Clinical Practice Guidelines Korean Society for the Study of Obesity, 2014, CLIN PRACT GUID OV O
   Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10
   Dietz WH, 1998, J NUTR, V128, p411S, DOI 10.1093/jn/128.2.411S
   Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911
   Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458
   Flodmark CE, 2004, INT J OBESITY, V28, P1189, DOI 10.1038/sj.ijo.0802787
   Gibson S, 2007, INT J FOOD SCI NUTR, V58, P445, DOI 10.1080/09637480701288363
   Ha K, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010031
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968
   Hursti UK, 2014, NORDIC NUTR RECOMMEN
   Jackson-Leach R, 2006, INT J PEDIATR OBES, V1, P26, DOI 10.1080/17477160600586614
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   Keller A, 2015, CHILD OBES, V11, P338, DOI 10.1089/chi.2014.0117
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kim HM, 2006, AM J EPIDEMIOL, V164, P787, DOI 10.1093/aje/kwj251
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Koplan JP, 1999, JAMA-J AM MED ASSOC, V282, P1579, DOI 10.1001/jama.282.16.1579
   Korea Health Industry Development Institute, 2013, FOOD IND AN REP
   Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424
   Langlois Kellie, 2011, Health Rep, V22, P23
   Lee Haeng-Shin, 2013, Clin Nutr Res, V2, P135, DOI 10.7762/cnr.2013.2.2.135
   Lee HaengShin Lee HaengShin, 2014, Journal of Nutrition and Health, V47, P268, DOI 10.4163/jnh.2014.47.4.268
   Lobstein T., 2004, OBES REV, V5, P4, DOI 10.1111/j.1467-789X.2004.00133.x
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   McCrindle BW, 2015, CAN J CARDIOL, V31, DOI 10.1016/j.cjca.2014.08.017
   Mikkilä V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418
   Millar L, 2014, OBESITY, V22, pE96, DOI 10.1002/oby.20665
   Ministry of Food and Drug Safety, 2016, MON TOT SUG SOD CONT
   Ministry of Food and Drug Safety Korea Health Industry Development Institute, 2015, SUG DAT COMP COMM CO
   Ministry of Health and Welfare, 2016, KOR HLTH STAT 2015 K
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Newens KJ, 2016, J HUM NUTR DIET, V29, P225, DOI 10.1111/jhn.12338
   Olsen NJ, 2012, OBESITY FACTS, V5, P506, DOI 10.1159/000341631
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010
   Sánchez-Cruz JJ, 2013, REV ESP CARDIOL, V66, P371, DOI [10.1016/j.recesp.2012.10.016, 10.1016/j.rec.2012.10.012]
   Song Y, 2010, INT J OBESITY, V34, P48, DOI 10.1038/ijo.2009.203
   United States Department of Agriculture, DIET GUID AM 2015 20
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
   World Health Organization (WHO), 2015, Guideline: Sugars Intake for Adults and Children
NR 51
TC 18
Z9 18
U1 0
U2 14
PU KOREAN NUTRITION SOC
PI SEOUL
PA 804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-1457
EI 2005-6168
J9 NUTR RES PRACT
JI Nutr. Res. Pract.
PD AUG
PY 2018
VL 12
IS 4
BP 307
EP 314
DI 10.4162/nrp.2018.12.4.307
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GQ2JG
UT WOS:000441480700005
PM 30090168
OA Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Chellan, N
   Muller, CJF
   de Beer, D
   Joubert, E
   Page, BJ
   Louw, J
AF Chellan, N.
   Muller, C. J. F.
   de Beer, D.
   Joubert, E.
   Page, B. J.
   Louw, J.
TI An in vitro assessment of the effect of Athrixia
   phylicoides DC. aqueous extract on glucose metabolism
SO PHYTOMEDICINE
LA English
DT Article
DE Athrixia phylicoides; Diabetes; Glucose metabolism; Bush tea;
   Polyphenols
ID INSULIN-RESISTANCE; ANTIOXIDANT ACTIVITY; DIABETES-MELLITUS;
   SOUTH-AFRICA; BETA-CELLS; FLAVONOIDS; ACID; MICE; POLYPHENOLS;
   HOMEOSTASIS
AB Athrixia phylicoides DC. is an aromatic shrub indigenous to the eastern parts of Southern Africa. Indigenous communities brew "bush tea" from dried twigs and leaves of A. phylicoides, which is consumed as a beverage and used for its medicinal properties. Plant polyphenols have been shown to be beneficial to Type 2 diabetes mellitus (T2D) and obesity. Aqueous extracts of the plant have been shown to be rich in polyphenols, in particular phenolic acids, which may enhance glucose uptake and metabolism. The aim of this study was to determine the phenolic composition of a hot water A. phylicoides extract and assess its in vitro effect on cellular glucose utilisation. The most abundant phenolic compounds in the extract were 6-hydroxyluteolin-7-O-glucoside, chlorogenic acid, protocatechuic acid, a di-caffeoylquinic acid and a methoxy-flavonol derivative. The extract increased glucose uptake in C2C12, Chang and 3T3-L1 cells, respectively. Intracellular glucose was utilised by both oxidation (C2C12 myocytes and Chang cells; p < 0.01 and p < 0.05, respectively) and by increased glycogen storage (Chang cells; p < 0.05). No cytotoxicity was observed in Chang cells at the concentrations tested. The effects of the extract were not dose-dependent. A. phylicoides aqueous extract stimulated in vitro glucose uptake and metabolism, suggesting that consumption of this phenolic-rich extract could potentially ameliorate metabolic disorders related to obesity and T2D. (C) 2012 Elsevier GmbH. All rights reserved.
C1 [Chellan, N.; Muller, C. J. F.; Louw, J.] MRC, ZA-7505 Tygerberg, South Africa.
   [de Beer, D.; Joubert, E.] Agr Res Council ARC Infruitec Nietvoorbij, Postharvest & Wine Technol Div, ZA-7599 Stellenbosch, South Africa.
   [Chellan, N.; Page, B. J.] Univ Stellenbosch, Fac Hlth Sci, ZA-7602 Matieland, South Africa.
   [Joubert, E.] Univ Stellenbosch, Dept Food Sci, ZA-7602 Matieland, South Africa.
C3 Agricultural Research Council of South Africa; Stellenbosch University;
   Stellenbosch University
RP Chellan, N (corresponding author), MRC, POB 19070, ZA-7505 Parow Valley, South Africa.
EM nchellan@mrc.ac.za
RI Chellan, Nireshni/M-3037-2013; De Beer, Dalene/E-8831-2010
OI Muller, Christo/0000-0001-6821-2120; Joubert,
   Elizabeth/0000-0002-9717-9769; Louw, Johan/0000-0002-9023-1659; Chellan,
   Nireshni/0000-0001-9968-0998; De Beer, Dalene/0000-0002-3680-142X
FU Agricultural Research Council, SA; Diabetes Discovery Platform (Medical
   Research Council, SA)
FX The Agricultural Research Council, SA and Diabetes Discovery Platform
   (Medical Research Council, SA) for funding.
CR Arthur H, 2011, FOOD CHEM, V127, P581, DOI 10.1016/j.foodchem.2011.01.044
   Beltrán-Debón R, 2011, PHYTOMEDICINE, V18, P414, DOI 10.1016/j.phymed.2010.11.008
   Bowen R., 2009, ENDOCRINE PANCREAS I
   Cazzolli R, 2002, AM J PHYSIOL-ENDOC M, V282, pE1204, DOI 10.1152/ajpendo.00487.2001
   Chellan N, 2008, HUM EXP TOXICOL, V27, P819, DOI 10.1177/0960327108099537
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399
   de Beer D, 2011, J CHROMATOGR A, V1218, P6179, DOI 10.1016/j.chroma.2010.12.096
   DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013
   Deutschländer MS, 2009, J ETHNOPHARMACOL, V124, P619, DOI 10.1016/j.jep.2009.04.052
   Fernandez-Panchon MS, 2008, CRIT REV FOOD SCI, V48, P649, DOI 10.1080/10408390701761845
   Gray AM, 1998, J ENDOCRINOL, V157, P259, DOI 10.1677/joe.0.1570259
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Harini Ranganathan, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P79
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   HUIJING F, 1970, CLIN CHIM ACTA, V30, P567, DOI 10.1016/0009-8981(70)90246-9
   Jensen TC, 2000, J BIOL CHEM, V275, P40148, DOI 10.1074/jbc.M004902200
   Joubert E., 2011, PHENOLIC ACIDS COMPO
   Jung EH, 2007, J AGR FOOD CHEM, V55, P9800, DOI 10.1021/jf0714463
   Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224
   Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071
   Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002
   Mashimbye MJ, 2006, S AFR J CHEM-S-AFR T, V59, P1
   Mathews C. K., 2000, BIOCHEMISTRY-US, P831
   Matsuda H, 2011, BIOORGAN MED CHEM, V19, P2835, DOI 10.1016/j.bmc.2011.03.040
   Mavundza EJ, 2010, J MED PLANTS RES, V4, P2584
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Pan MH, 2010, FOOD FUNCT, V1, P15, DOI 10.1039/c0fo00103a
   Pari L, 2010, MOL CELL BIOCHEM, V341, P109, DOI 10.1007/s11010-010-0442-5
   PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166
   Prabhakar PK, 2009, PHYTOMEDICINE, V16, P1119, DOI 10.1016/j.phymed.2009.05.021
   Rampedi I., 2005, Acta Academica, V37, P165
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI [10.1172/JCI29069, 10.1016/j.febslet.2007.11.057]
   Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van de Venter M, 2008, J ETHNOPHARMACOL, V119, P81, DOI 10.1016/j.jep.2008.05.031
   Van Wyk B E, 2000, PEOPLES PLANTS GUIDE, P102
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711
   Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 43
TC 13
Z9 15
U1 0
U2 18
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0944-7113
J9 PHYTOMEDICINE
JI Phytomedicine
PD JUN 15
PY 2012
VL 19
IS 8-9
BP 730
EP 736
DI 10.1016/j.phymed.2012.03.006
PG 7
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 983OF
UT WOS:000307127900012
PM 22516895
DA 2025-04-28
ER

PT J
AU Liu, TG
   Xie, QT
   Zhang, M
   Gu, J
   Huang, DJ
   Cao, QH
AF Liu, Tiange
   Xie, Qingtong
   Zhang, Min
   Gu, Jia
   Huang, Dejian
   Cao, Qinghe
TI Reclaiming Agriceuticals from Sweetpotato (Ipomoea batatas [L.]
   Lam.) By-Products
SO FOODS
LA English
DT Review
DE sweetpotato by-products; functional properties; bioactive ingredients;
   extraction technology; polyphenols; dietary fibres
ID RESPONSE-SURFACE METHODOLOGY; WASTE-WATER; PHYSICOCHEMICAL PROPERTIES;
   ANTIOXIDANT ACTIVITIES; FUNCTIONAL-PROPERTIES; PHENOLICS EXTRACTION;
   BIOACTIVE COMPOUNDS; ACID; OPTIMIZATION; STARCH
AB Sweetpotato (SP, Ipomoea batatas [L.] Lam.) is a globally significant food crop known for its high nutritional and functional values. Although the contents and compositions of bioactive constituents vary among SP varieties, sweetpotato by-products (SPBs), including aerial parts, storage root peels, and wastes generated from starch processing, are considered as excellent sources of polyphenols (e.g., chlorogenic acid, caffeoylquinic acid, and dicaffeoylquinic acid), lutein, functional carbohydrates (e.g., pectin, polysaccharides, and resin glycosides) or proteins (e.g., polyphenol oxidase, beta-amylase, and sporamins). This review summarises the health benefits of these ingredients specifically derived from SPBs in vitro and/or in vivo, such as anti-obesity, anti-cancer, antioxidant, cardioprotective, and anti-diabetic, evidencing their potential to regenerate value-added bio-products in the fields of food and nutraceutical. Accordingly, conventional and novel technologies have been developed and sometimes combined for the pretreatment and extraction processes aimed at optimising the recovery efficiency of bioactive ingredients from SPBs while ensuring sustainability. However, so far, advanced extraction technologies have not been extensively applied for recovering bioactive compounds from SPBs except for SP leaves. Furthermore, the incorporation of reclaimed bioactive ingredients from SPBs into foods or other healthcare products remains limited. This review also briefly discusses current challenges faced by the SPB recycling industry while suggesting that more efforts should be made to facilitate the transition from scientific advances to commercialisation for reutilising and valorising SPBs.
C1 [Liu, Tiange; Zhang, Min; Gu, Jia; Huang, Dejian] Natl Univ Singapore Suzhou, Res Inst, 377 Linquan St, Suzhou 215123, Peoples R China.
   [Xie, Qingtong; Huang, Dejian] Natl Univ Singapore, Dept Food Sci & Technol, 2 Sci Dr 2, Singapore 117542, Singapore.
   [Cao, Qinghe] Xuzhou Inst Agr Sci Jiangsu Xuhuai Dist, Xuzhou 221131, Peoples R China.
   [Cao, Qinghe] Minist Agr & Rural Affairs, Key Lab Biol & Genet Breeding Sweetpotato, Xuzhou 221131, Peoples R China.
C3 National University of Singapore; Ministry of Agriculture & Rural
   Affairs
RP Liu, TG (corresponding author), Natl Univ Singapore Suzhou, Res Inst, 377 Linquan St, Suzhou 215123, Peoples R China.
EM tiange.liu@nusri.cn; e0966402@u.nus.edu; min.zhang@nusri.cn;
   jia.gu@nusri.cn; dejian@nus.edu.sg; caoqinghe@jaas.ac.cn
RI 庆彤, 谢/GXV-2557-2022; Huang, Dejian/ABC-3721-2021
OI Xie, Qingtong/0009-0006-5254-0051
FU Singapore MOE grant; National University of Singapore (Suzhou) Research
   Institute, China; National University of Singapore, Singapore
FX The authors gratefully acknowledge the National University of Singapore
   (Suzhou) Research Institute, China, and National University of
   Singapore, Singapore, for their support of the study.
CR Akoetey W, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20160610
   Al-Maqtari QA, 2024, FOOD BIOPROCESS TECH, V17, P1, DOI 10.1007/s11947-023-03086-1
   Alam MK, 2021, TRENDS FOOD SCI TECH, V115, P512, DOI 10.1016/j.tifs.2021.07.001
   Alexandre EMC, 2017, FOOD ENG REV, V9, P190, DOI 10.1007/s12393-016-9154-2
   Althwab S. A., 2019, Food and Nutrition Sciences, V10, P503
   Alves EG, 2020, ULTRASON SONOCHEM, V63, DOI 10.1016/j.ultsonch.2019.104911
   Anastácio A, 2016, J FOOD SCI TECH MYS, V53, P4117, DOI 10.1007/s13197-016-2354-1
   Anastacio A, 2013, IND CROP PROD, V43, P99, DOI 10.1016/j.indcrop.2012.07.011
   Angoy A, 2020, INNOV FOOD SCI EMERG, V61, DOI 10.1016/j.ifset.2020.102338
   [Anonymous], Food and Agriculture Organization of the United Nations: FAOSTAT - Inputs/Pesticides Use
   Bai CL, 2023, INT J BIOL MACROMOL, V247, DOI 10.1016/j.ijbiomac.2023.125730
   Bin Hisamuddin ASD, 2023, FRONT PHARMACOL, V14, DOI 10.3389/fphar.2023.1175907
   Bodjrenou DM, 2023, INT J BIOL MACROMOL, V225, P13, DOI 10.1016/j.ijbiomac.2022.12.002
   Bovell-Benjamin A.C., 2007, Preparation and Characterization of Sweetpotato Peels for Use as Dietary Fiber Enhancement in Space Foods
   Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7
   Boyadzhiev L, 2006, CHEM ENG SCI, V61, P4126, DOI 10.1016/j.ces.2006.01.032
   Cao Y, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.986667
   Cervantes-Flores JC, 2011, MOL BREEDING, V28, P201, DOI 10.1007/s11032-010-9474-5
   Cevallos-Casals BA, 2002, ACTA HORTIC, P195, DOI 10.17660/ActaHortic.2002.583.22
   Chen HJ, 2015, J PLANT PHYSIOL, V186, P39, DOI 10.1016/j.jplph.2015.08.004
   Chen J., 2016, Functional Carbohydrates: Development, Characterization, and Biomanufacture, V1st ed., DOI [10.1201/9781315371061, DOI 10.1201/9781315371061]
   Chen Y, 2017, INT J FOOD SCI TECH, V52, P1131, DOI 10.1111/ijfs.13377
   Cheng S, 2015, APPL MICROBIOL BIOT, V99, P1745, DOI 10.1007/s00253-014-6034-7
   Cheng ZY, 2016, J CHROMATOGR SCI, V54, P246, DOI 10.1093/chromsci/bmv116
   Cipriano PD, 2022, FOOD CHEM, V374, DOI 10.1016/j.foodchem.2021.131076
   Dereje B, 2020, INT J FOOD PROP, V23, P1639, DOI 10.1080/10942912.2020.1818776
   Dziedzoave NT, 2010, FOOD CONTROL, V21, P162, DOI 10.1016/j.foodcont.2009.05.005
   El Sheikha AF, 2017, CRIT REV FOOD SCI, V57, P455, DOI 10.1080/10408398.2014.960909
   Escobar-Puentes AA, 2022, FOODS, V11, DOI 10.3390/foods11071058
   Fu ZF, 2016, FOOD BIOSCI, V15, P11, DOI 10.1016/j.fbio.2016.04.004
   Hannoufa A, 2012, BIOCATAL AGR BIOTECH, V1, P198, DOI 10.1016/j.bcab.2012.03.004
   He J, 2006, NUTR CANCER, V54, P3, DOI 10.1207/s15327914nc5401_2
   Hisamuddin ASDB, 2023, FRONT PHARMACOL, V14, DOI 10.3389/fphar.2023.1132087
   Hong JY, 2020, FOOD SCI NUTR, V8, P4086, DOI 10.1002/fsn3.1675
   Hou WC, 1997, PLANT SCI, V128, P151, DOI 10.1016/S0168-9452(97)00153-2
   Hu N, 2019, SEP PURIF TECHNOL, V209, P392, DOI 10.1016/j.seppur.2018.07.064
   Huang GJ, 2007, BOT STUD, V48, P133
   Huang XQ, 2013, FOOD BIOPROD PROCESS, V91, P1, DOI 10.1016/j.fbp.2012.07.006
   International Potato Center, Sweet Potato
   Ishida H, 2000, FOOD CHEM, V68, P359, DOI 10.1016/S0308-8146(99)00206-X
   Jeng TL, 2015, J FOOD DRUG ANAL, V23, P701, DOI 10.1016/j.jfda.2014.07.002
   Jha AK, 2022, TRENDS FOOD SCI TECH, V119, P579, DOI 10.1016/j.tifs.2021.11.019
   Ji Hua Ji Hua, 2015, Food and Nutrition Sciences, V6, P161, DOI 10.4236/fns.2015.61017
   Jia RX, 2022, MOLECULES, V27, DOI 10.3390/molecules27103117
   Johnson EJ, 2004, FOOD REV INT, V20, P1, DOI 10.1081/FRI-120028826
   Johnson M, 2010, NUTR REV, V68, P604, DOI 10.1111/j.1753-4887.2010.00320.x
   Kaur M, 2016, TROPICAL ROOTS AND TUBERS: PRODUCTION, PROCESSING AND TECHNOLOGY, P479
   Krishna T.U., 2018, Drug Invent. Today, V10, P2618
   Li GL, 2019, MOLECULES, V24, DOI 10.3390/molecules24203743
   Li M, 2017, FOOD SCI BIOTECHNOL, V26, P97, DOI 10.1007/s10068-017-0013-6
   Li QR, 2018, FOOD CHEM, V245, P854, DOI 10.1016/j.foodchem.2017.11.095
   Liao WC, 2011, FOOD CHEM, V127, P1224, DOI 10.1016/j.foodchem.2011.01.131
   Liu M, 2021, FOOD RES INT, V150, DOI 10.1016/j.foodres.2021.110761
   Liu M, 2020, FOOD FUNCT, V11, P689, DOI [10.1039/C9FO01009B, 10.1039/c9fo01009b]
   Liu TE, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.1016020
   Liu W, 2019, FOOD BIOPROD PROCESS, V115, P1, DOI 10.1016/j.fbp.2019.02.003
   Lu GQ, 2011, FLOUR AND BREADS AND THEIR FORTIFICATION IN HEALTH AND DISEASE PREVENTION, P407, DOI 10.1016/B978-0-12-380886-8.10037-6
   Lu HJ, 2013, FOOD RES INT, V50, P121, DOI 10.1016/j.foodres.2012.10.013
   Lu XF, 2019, J PHARMACEUT BIOMED, V169, P245, DOI 10.1016/j.jpba.2019.03.003
   Luo D, 2021, FOOD BIOSCI, V39, DOI 10.1016/j.fbio.2020.100801
   Makori SI, 2020, NAT PROD COMMUN, V15, DOI 10.1177/1934578X20936931
   Maloney KP, 2014, FOOD SCI NUTR, V2, P351, DOI 10.1002/fsn3.110
   Maloney KP, 2012, J FOOD SCI, V77, pE307, DOI 10.1111/j.1750-3841.2012.02921.x
   Maoka T, 2020, J NAT MED-TOKYO, V74, P1, DOI 10.1007/s11418-019-01364-x
   Mei X, 2010, J AGR FOOD CHEM, V58, P7305, DOI 10.1021/jf101021s
   Meng FT, 2023, FOODS, V12, DOI 10.3390/foods12213910
   Meng FT, 2023, J AGR FOOD CHEM, V71, P15073, DOI 10.1021/acs.jafc.3c03710
   Mosha TC, 1995, PLANT FOOD HUM NUTR, V48, P235, DOI 10.1007/BF01088445
   Mu T.-H., 2019, Polyphenols in Plants, VSecond, P365, DOI [10.1016/B978-0-12-813768-0.00022-0, DOI 10.1016/B978-0-12-813768-0.00022-0]
   Mu TH, 2009, FOOD CHEM, V112, P1002, DOI 10.1016/j.foodchem.2008.07.012
   Mu TH, 2014, SEP SCI TECHNOL, V49, P2255, DOI 10.1080/01496395.2014.911324
   Becerra MO, 2020, J FUNCT FOODS, V66, DOI 10.1016/j.jff.2019.103771
   Oliveira ÉR, 2019, FOOD BIOPROD PROCESS, V115, P47, DOI 10.1016/j.fbp.2019.02.005
   Oluyori AP, 2016, NUTR CANCER, V68, P1330, DOI 10.1080/01635581.2016.1225107
   Ou SJL, 2022, FOOD CHEM, V374, DOI 10.1016/j.foodchem.2021.131744
   Phomkaivon N, 2022, FOOD SCI TECHNOL RES, V28, P275, DOI 10.3136/fstr.FSTR-D-21-00268
   Qiao HZ, 2021, FOOD CHEM, V335, DOI 10.1016/j.foodchem.2020.127522
   Qin DY, 2021, TRENDS FOOD SCI TECH, V112, P581, DOI 10.1016/j.tifs.2021.04.025
   Qin YX, 2022, FOOD BIOSCI, V50, DOI 10.1016/j.fbio.2022.102208
   Rodriguez-Mena A., 2023, Food Chem. Adv., V3, DOI [DOI 10.1016/J.FOCHA.2023.100358, 10.1016]
   Sandmann G, 2015, ADV BIOCHEM ENG BIOT, V148, P449, DOI 10.1007/10_2014_277
   Sasaki K, 2015, BIOSCI BIOTECH BIOCH, V79, P1308, DOI 10.1080/09168451.2015.1025032
   García-Pérez JS, 2019, J ENVIRON MANAGE, V232, P796, DOI 10.1016/j.jenvman.2018.11.117
   Seczyk L, 2017, FOOD CHEM, V223, P1, DOI 10.1016/j.foodchem.2016.12.020
   Seregelj V, 2020, FOOD TECHNOL BIOTECH, V58, P314, DOI 10.17113/ftb.58.03.20.6557
   Shaari N, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11050872
   Su XY, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01964
   Sun HN, 2017, INT J FOOD PROP, V20, P318, DOI 10.1080/10942912.2016.1160410
   Sun HN, 2014, FOOD CHEM, V156, P380, DOI 10.1016/j.foodchem.2014.01.079
   Sun MJ, 2012, J FOOD COMPOS ANAL, V26, P104, DOI 10.1016/j.jfca.2012.03.008
   Taira J, 2013, J FOOD COMPOS ANAL, V29, P117, DOI 10.1016/j.jfca.2012.10.007
   Tharanathan RN, 2002, CRIT REV BIOTECHNOL, V22, P65, DOI 10.1080/07388550290789469
   Toy JYH, 2022, FOOD FUNCT, V13, P5353, DOI [10.1039/D2FO00555G, 10.1039/d2fo00555g]
   Toy JYH, 2022, FOOD CHEM, V385, DOI 10.1016/j.foodchem.2022.132684
   Truong VD, 2007, J FOOD SCI, V72, pC343, DOI 10.1111/j.1750-3841.2007.00415.x
   Tsao R, 2004, J CHROMATOGR A, V1045, P65, DOI 10.1016/j.chroma.2004.06.020
   Vishnu VR, 2019, J AGR FOOD CHEM, V67, P2467, DOI 10.1021/acs.jafc.8b05473
   Vithu P, 2020, J FOOD MEAS CHARACT, V14, P1520, DOI 10.1007/s11694-020-00401-8
   Vithu P, 2019, FOOD REV INT, V35, P726, DOI 10.1080/87559129.2019.1600540
   Wang SN, 2016, FOOD RES INT, V89, P90, DOI 10.1016/j.foodres.2016.08.032
   Wang TL, 2017, INT J FOOD SCI TECH, V52, P741, DOI 10.1111/ijfs.13329
   Weber CT, 2020, J CLEAN PROD, V268, DOI 10.1016/j.jclepro.2020.121788
   Xu WQ, 2010, J FOOD COMPOS ANAL, V23, P599, DOI 10.1016/j.jfca.2009.12.008
   Yang SN, 2022, J FOOD SCI, V87, P339, DOI 10.1111/1750-3841.16017
   Yanling J., 2021, J Agric, V11, P98
   Zhang CP, 2011, INT J FOOD SCI TECH, V46, P2274, DOI 10.1111/j.1365-2621.2011.02746.x
   Zhang M, 2019, PLANT FOOD HUM NUTR, V74, P225, DOI 10.1007/s11130-019-00724-y
   Zhang YY, 2013, INT J FOOD SCI TECH, V48, P778, DOI 10.1111/ijfs.12026
   Zhang Y, 2018, J FOOD BIOCHEM, V42, DOI 10.1111/jfbc.12513
   Zhao DL, 2022, J AGR FOOD CHEM, V70, P2574, DOI 10.1021/acs.jafc.1c05388
   Zhu F, 2011, STARCH-STARKE, V63, P249, DOI 10.1002/star.201000134
   Zhu LL, 2022, FOOD CHEM, V374, DOI 10.1016/j.foodchem.2021.131500
NR 112
TC 2
Z9 3
U1 16
U2 27
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD APR
PY 2024
VL 13
IS 8
AR 1180
DI 10.3390/foods13081180
PG 20
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA QF4D9
UT WOS:001219441700001
PM 38672853
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Zych, M
   Folwarczna, J
   Trzeciak, HI
AF Zych, Maria
   Folwarczna, Joanna
   Trzeciak, Henryk I.
TI Natural phenolic acids may increase serum estradiol level in
   ovariectomized rats
SO ACTA BIOCHIMICA POLONICA
LA English
DT Article
DE ferulic acid; caffeic acid; p-coumaric acid; chlorogenic acid;
   estradiol; body mass; rat
ID P-COUMARIC ACID; FERULIC ACID; BONE LOSS; ESTROGEN; RECEPTOR; LEPTIN
AB Natural phenolic acids are commonly present in plants consumed in the diet. Recently we have observed that different natural phenolic acids exert differential effects on the body mass gain in ovariectomized and non-ovariectomized female rats. The aim of the present study was to investigate the effects of ferulic, caffeic, p-coumaric and chlorogenic acids on serum estradiol and total cholesterol levels in ovariectomized and non-ovariectomized rats. The experiments were carried out on 3-month old female Wistar Cmd:(WI)WU rats, divided into following groups (n=8 in each group): non-ovariectomized control rats and non-ovariectomized rats receiving ferulic, caffeic, p-coumaric or chlorogenic acids, sham-operated control rats, ovariectomized control rats and ovariectomized rats receiving the same phenolic acids. The phenolic acids were administered at a dose of 10 mg/kg p.o. daily for 4 weeks. Serum estradiol and total cholesterol levels on the next day after the last administration of the phenolic acids were examined. The phenolic acids did not affect serum estradiol or total cholesterol levels in non-ovariectomized rats. In ovariectomized rats, caffeic acid and to a lesser extent p-coumaric acid increased serum estradiol level, which effect correlated with a decreased body mass gain. All the phenolic acids decreased serum cholesterol level in ovariectomized rats. Concluding, the anti-obesity activity of some phenolic acids may be, at least partially, connected with estrogenic pathways.
C1 [Folwarczna, Joanna; Trzeciak, Henryk I.] Med Univ Silesia, Dept Pharmacol, PL-41200 Katowice, Sosnowiec, Poland.
   [Zych, Maria] Med Univ Silesia, Dept Pharmacognosy & Phytochem, PL-41200 Katowice, Sosnowiec, Poland.
C3 Medical University Silesia; Medical University Silesia
RP Folwarczna, J (corresponding author), Med Univ Silesia, Dept Pharmacol, Jagiellonska 4, PL-41200 Katowice, Sosnowiec, Poland.
EM jfolwarczna@sum.edu.pl
OI Zych, Maria/0000-0002-7231-0505; Folwarczna, Joanna/0000-0002-4376-2748
CR Ardiansyah, 2008, J AGR FOOD CHEM, V56, P2825, DOI 10.1021/jf072896y
   Balasubashini MS, 2003, ACTA DIABETOL, V40, P118, DOI 10.1007/s00592-003-0099-6
   Chang CJ, 2006, EUR J CLIN INVEST, V36, P588, DOI 10.1111/j.1365-2362.2006.01676.x
   Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339
   Folwarczna J, 2009, PLANTA MED, V75, P1567, DOI 10.1055/s-0029-1185904
   Hany J, 1999, TOXICOL APPL PHARM, V158, P231, DOI 10.1006/taap.1999.8710
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI [10.1002/mnfr.200890019, 10.1002/mnfr.200700393]
   Innocenti G, 2007, PHYTOMEDICINE, V14, P147, DOI 10.1016/j.phymed.2006.05.005
   Jung EH, 2007, J AGR FOOD CHEM, V55, P9800, DOI 10.1021/jf0714463
   Kim HK, 2003, CLIN CHIM ACTA, V327, P129, DOI 10.1016/S0009-8981(02)00344-3
   Lafay S, 2005, INT J VITAM NUTR RES, V75, P119, DOI 10.1024/0300-9831.75.2.119
   Lee JS, 2003, ANN NUTR METAB, V47, P144, DOI 10.1159/000070037
   Lee JS, 2001, CLIN CHIM ACTA, V314, P221, DOI 10.1016/S0009-8981(01)00700-8
   Liang YQ, 2002, INT J OBESITY, V26, P1103, DOI 10.1038/sj.ijo.0802054
   Meli R, 2004, ENDOCRINOLOGY, V145, P3115, DOI 10.1210/en.2004-0129
   PAKRASHI A, 1979, EXPERIENTIA, V35, P843, DOI 10.1007/BF01968287
   Sassa S, 2003, IN VIVO, V17, P277
   Setchell KDR, 2003, AM J CLIN NUTR, V78, p593S, DOI 10.1093/ajcn/78.3.593S
   SHARMA RD, 1979, LIPIDS, V14, P535, DOI 10.1007/BF02533528
   Stalikas CD, 2007, J SEP SCI, V30, P3268, DOI 10.1002/jssc.200700261
   Stromeier S, 2005, PLANTA MED, V71, P495, DOI 10.1055/s-2005-864148
   Yamaguchi M, 2008, MOL CELL BIOCHEM, V311, P31, DOI 10.1007/s11010-007-9689-x
   Zang LY, 2000, AM J PHYSIOL-CELL PH, V279, pC954, DOI 10.1152/ajpcell.2000.279.4.C954
   ZYCH M, 2009, ADM CAFFEIC AC UNPUB
NR 24
TC 24
Z9 25
U1 0
U2 10
PU ACTA BIOCHIMICA POLONICA
PI WARSAW
PA PASTEURA 3, 02-093 WARSAW, POLAND
SN 0001-527X
EI 1734-154X
J9 ACTA BIOCHIM POL
JI Acta Biochim. Pol.
PY 2009
VL 56
IS 3
BP 503
EP 507
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 505AR
UT WOS:000270660500017
PM 19753332
DA 2025-04-28
ER

PT J
AU Bustos, AS
   Håkansson, A
   Linares-Pastén, JA
   Penarrieta, JM
   Nilsson, L
AF Bustos, Atma-Sol
   Hakansson, Andreas
   Linares-Pasten, Javier A.
   Penarrieta, Jose M.
   Nilsson, Lars
TI Interaction Between Phenolic Compounds and Lipase: The Influence of
   Solubility and Presence of Particles in the IC50 Value
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE inhibition; lipase; particles; phenols; reproducibility
ID PANCREATIC LIPASE; TEA POLYPHENOLS; IN-VITRO; INHIBITORY-ACTIVITIES;
   GREEN TEA; WATER; FLAVONOIDS; BEHAVIOR; OBESITY
AB Obesity is one of the principal human health problems and one of the main treatments against it is the inhibition of pancreatic lipase, the main responsible enzyme of lipid digestion. For that purpose, previous studies have tested several phenolic compounds against lipase, without considering their aggregation behavior in aqueous solutions. Because of this, the present study focuses on understanding how the solubility and the presence of particles affect the IC50 value of the interaction between lipase and phenolic compounds present in beverages like fruit juices and teas. Therefore, the inhibitory capacity against pancreatic lipase and the aggregate formation of 9 phenolic compounds (quercetin, rutin, myricetin, catechin, epigallocatechin gallate, cyanidin, caffeic acid, chlorogenic acid, and vanillic acid) were analyzed. The results obtained together with the solubility data from literature were treated by principal component analysis and indicate that the IC50 value does not correlate with the solubility or aggregate formation of the phenolic compounds. However, the IC50 values of phenolic compounds which aggregate during the assay conditions have low reproducibility. This study shows that the aggregate formation of phenolic compounds plays an important role during in vitro assays for pancreatic lipase inhibition and should be considered in future experiments as it can lead to false positive results. In terms of particle formation, the flavonoids investigated in this study are more prone to aggregation compared to the phenolic acids.
C1 [Bustos, Atma-Sol; Hakansson, Andreas; Nilsson, Lars] Lund Univ, Fac Engn LTH, Food Technol, POB 124, S-22100 Lund, Sweden.
   [Bustos, Atma-Sol; Penarrieta, Jose M.] Univ Mayor San Andres, Fac Pure & Nat Sci, Sch Chem, POB 303, La Paz, Bolivia.
   [Hakansson, Andreas] Kristianstad Univ, Food & Meal Sci, POB 15, S-29181 Kristianstad, Sweden.
   [Linares-Pasten, Javier A.] Lund Univ, Fac Engn LTH, Biotechnol, POB 117, S-22100 Lund, Sweden.
C3 Lund University; Universidad Mayor de San Andres; Kristianstad
   University; Lund University
RP Bustos, AS (corresponding author), Lund Univ, Fac Engn LTH, Food Technol, POB 124, S-22100 Lund, Sweden.; Bustos, AS (corresponding author), Univ Mayor San Andres, Fac Pure & Nat Sci, Sch Chem, POB 303, La Paz, Bolivia.
EM atma-sol.bustos@food.lth.se
RI Hakansson, Anders/H-8190-2014; Linares-Pasten, Javier/N-8450-2018;
   Penarrieta, J. Mauricio/ABB-4331-2021
OI Nilsson, Lars/0000-0002-6769-2641; Linares-Pasten,
   Javier/0000-0001-6999-6334; Hakansson, Andreas/0000-0002-0002-661X;
   Bustos Zenteno, Atma-Sol/0000-0002-7691-8622; Penarrieta, J.
   Mauricio/0000-0002-0958-3092
FU Swedish Int. Development Agency (SIDA)
FX The present work is supported by Swedish Int. Development Agency (SIDA):
   a collaboration project between Univ. Mayor de San Andres (Bolivia) and
   Lund Univ. (Sweden). SOLVE Research & Consultancy AB, Lund, Sweden is
   acknowledged for the loan of the dynamic light scattering instrument.
CR [Anonymous], 2014, OB OV
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Buchholz T, 2015, PLANTA MED, V81, P771, DOI 10.1055/s-0035-1546173
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Guerciolini R, 1997, INT J OBESITY, V21, pS12
   Haminiuk CharlesW.I., 2012, Food Science and Technology - 47, P2023
   HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381
   Hong C, 2014, INT J PHARMACEUT, V477, P251, DOI 10.1016/j.ijpharm.2014.10.044
   Kfoury M, 2016, FOOD CHEM, V196, P518, DOI 10.1016/j.foodchem.2015.09.078
   Li YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34387
   Lunagariya NA, 2014, EXCLI J, V13, P897
   McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Noubigh A, 2007, J CHEM THERMODYN, V39, P297, DOI 10.1016/j.jct.2006.06.014
   OLEFSKY J, 1974, J CLIN INVEST, V53, P64, DOI 10.1172/JCI107560
   Peng B, 2009, J CHEM ENG DATA, V54, P1378, DOI 10.1021/je800816f
   Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774
   Sergent T, 2012, FOOD CHEM, V135, P68, DOI 10.1016/j.foodchem.2012.04.074
   Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469
   SHIMURA S, 1994, J JPN SOC FOOD SCI, V41, P847
   Sigma Aldrich, 2017, EP GALL
   Srinivas K, 2010, J CHEM ENG DATA, V55, P3101, DOI 10.1021/je901097n
   Sugiyama H, 2007, J AGR FOOD CHEM, V55, P4604, DOI 10.1021/jf070569k
   Wu XL, 2013, J AGR FOOD CHEM, V61, P8829, DOI 10.1021/jf401779z
   Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7
   You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v
   Yuda N, 2012, J FOOD SCI, V77, pH254, DOI 10.1111/j.1750-3841.2012.02967.x
   Zhang CT, 2018, J FUNCT FOODS, V40, P729, DOI 10.1016/j.jff.2017.12.019
   Zhang KX, 2016, FITOTERAPIA, V113, P102, DOI 10.1016/j.fitote.2016.07.008
NR 29
TC 23
Z9 27
U1 2
U2 45
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD AUG
PY 2018
VL 83
IS 8
BP 2071
EP 2076
DI 10.1111/1750-3841.14217
PG 6
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA GQ0EV
UT WOS:000441290500008
PM 30020550
DA 2025-04-28
ER

PT J
AU Yousef, GG
   Brown, AF
   Funakoshi, Y
   Mbeunkui, F
   Grace, MH
   Ballington, JR
   Loraine, A
   Lila, MA
AF Yousef, Gad G.
   Brown, Allan F.
   Funakoshi, Yayoi
   Mbeunkui, Flaubert
   Grace, Mary H.
   Ballington, James R.
   Loraine, Ann
   Lila, Mary A.
TI Efficient Quantification of the Health-Relevant Anthocyanin and Phenolic
   Acid Profiles in Commercial Cultivars and Breeding Selections of
   Blueberries (Vaccinium spp.)
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE anthocyanins; chlorogenic acid; blueberry; HPLC-DAD-MS; Vaccinium spp.;
   freeze-drying; health benefits
ID ANTIOXIDANT CAPACITY; STORAGE; IDENTIFICATION; HPLC; ABSORPTION;
   EXTRACTION; FLAVONOIDS; OBESE; FRUIT; MEN
AB Anthocyanins and phenolic acids are major secondary metabolites in blueberry with important implications for human health maintenance. An improved protocol was developed for the accurate, efficient, and rapid comparative screening for large blueberry sample sets. Triplicates of six commercial cultivars and four breeding selections were analyzed using the new method. The compound recoveries ranged from 94.2 to 97.5 +/- 5.3% when samples were spiked with commercial standards prior to extraction. Eighteen anthocyanins and 4 phenolic acids were quantified in frozen and freeze-dried fruits. Large variations for individual and total anthocyanins, ranging from 201.4 to 402.8 mg/100 g, were assayed in frozen fruits. The total phenolic acid content ranged from 23.6 to 61.7 mg/100 g in frozen fruits. Across all genotypes, freeze-drying resulted in minor reductions in anthocyanin concentration (3.9%) compared to anthocyanins in frozen fruits. However, phenolic acids increased by an average of 1.9-fold (+/- 0.3) in the freeze-dried fruit. Different genotypes frequently had comparable overall levels of total anthocyanins and phenolic acids, but differed dramatically in individual profiles of compounds. Three of the genotypes contained markedly higher concentrations of delphinidin 3-O-glucoside, cyanidin 3-O-glucoside, and malvidin 3-0-glucoside, which have previously been implicated as bioactive principles in this fruit The implications of these findings for human health benefits are discussed.
C1 [Yousef, Gad G.; Brown, Allan F.] N Carolina State Univ, Dept Hort Sci, Kannapolis, NC 28081 USA.
   [Yousef, Gad G.; Funakoshi, Yayoi; Mbeunkui, Flaubert; Grace, Mary H.; Lila, Mary A.] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Plants Human Hlth Inst, Kannapolis, NC 28081 USA.
   [Ballington, James R.] N Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA.
   [Loraine, Ann] N Carolina State Univ, Dept Bioinformat & Genom, Kannapolis, NC 28081 USA.
C3 North Carolina State University; North Carolina State University; North
   Carolina State University; North Carolina State University
RP Lila, MA (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Plants Human Hlth Inst, North Carolina Res Campus, Kannapolis, NC 28081 USA.
EM mlila@ncsu.edu
RI Grace, Mary/AAE-4629-2021
OI Funakoshi, Yayoi/0000-0002-3409-4813; Grace, Mary/0000-0002-8536-4211;
   Lila, Mary Ann/0000-0002-4928-3836; Loraine, Ann/0000-0002-8365-0177
FU North Carolina Blueberry Council [50407]; University of North Carolina
   General Administration Special Allocation for Collaborative Research at
   the NCRC
FX We thank the North Carolina Blueberry Council for Grant 50407 and the
   University of North Carolina General Administration Special Allocation
   for Collaborative Research at the NCRC for their support of this
   research. We also thank the North Carolina Department of Agriculture,
   Piedmont Research Station in Salisbury, NC.
CR Barnes JS, 2009, J CHROMATOGR A, V1216, P4728, DOI 10.1016/j.chroma.2009.04.032
   Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701
   Blanck Heidi Michels, 2008, Prev Chronic Dis, V5, pA35
   Brownmiller C, 2008, J FOOD SCI, V73, pH72, DOI 10.1111/j.1750-3841.2008.00761.x
   Buckow R, 2010, J AGR FOOD CHEM, V58, P10076, DOI 10.1021/jf1015347
   Connor AM, 2002, J AGR FOOD CHEM, V50, P893, DOI 10.1021/jf011212y
   Connor AM, 2002, ACTA HORTIC, P209, DOI 10.17660/ActaHortic.2002.574.31
   de Groot H, 1998, FUND CLIN PHARMACOL, V12, P249
   Garcia-Viguera C, 1998, PHYTOCHEM ANALYSIS, V9, P274, DOI 10.1002/(SICI)1099-1565(199811/12)9:6<274::AID-PCA416>3.0.CO;2-G
   Gavrilova V, 2011, J AGR FOOD CHEM, V59, P4009, DOI 10.1021/jf104565y
   González-Gallego J, 2010, BRIT J NUTR, V104, pS15, DOI 10.1017/S0007114510003910
   Grace MH, 2012, J FOOD SCI, V77, pH176, DOI 10.1111/j.1750-3841.2012.02788.x
   Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018
   Gustafson SJ, 2012, J BERRY RES, V2, P215, DOI 10.3233/JBR-2012-041
   Guzman I, 2012, J AGR FOOD CHEM, V60, P7238, DOI 10.1021/jf302475d
   Häkkinen S, 1999, FOOD RES INT, V32, P345, DOI 10.1016/S0963-9969(99)00095-2
   HASEGAWA S, 1966, J AGR FOOD CHEM, V14, P165, DOI 10.1021/jf60144a020
   Ishiguro K, 2007, J AGR FOOD CHEM, V55, P10773, DOI 10.1021/jf072256v
   JACKMAN RL, 1987, J FOOD BIOCHEM, V11, P201, DOI 10.1111/j.1745-4514.1987.tb00123.x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kader F, 1996, FOOD CHEM, V55, P35, DOI 10.1016/0308-8146(95)00068-2
   Kalt W, 1996, J AM SOC HORTIC SCI, V121, P142, DOI 10.21273/JASHS.121.1.142
   Kalt W, 1999, CAN J PLANT SCI, V79, P617, DOI 10.4141/P99-009
   Kalt W, 2001, J AGR FOOD CHEM, V49, P4761, DOI 10.1021/jf010653e
   Kalt W, 2008, J AGR FOOD CHEM, V56, P705, DOI 10.1021/jf071998l
   Kellogg J, 2010, J AGR FOOD CHEM, V58, P3884, DOI 10.1021/jf902693r
   Klopotek Y, 2005, J AGR FOOD CHEM, V53, P5640, DOI 10.1021/jf047947v
   Lee J, 2008, FOOD CHEM, V110, P782, DOI 10.1016/j.foodchem.2008.03.010
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   Martin C, 2011, PLANT CELL, V23, P1685, DOI 10.1105/tpc.111.083279
   Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005
   McGhie TK, 2003, J AGR FOOD CHEM, V51, P4539, DOI 10.1021/jf026206w
   McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092
   Padda MS, 2008, SCI HORTIC-AMSTERDAM, V119, P17, DOI 10.1016/j.scienta.2008.07.008
   Prior R.L., 1999, J. Am. Nutrient Assoc, V2, P46
   Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d
   Prior RL, 2001, J AGR FOOD CHEM, V49, P1270, DOI 10.1021/jf001211q
   Prior RL, 2006, FREE RADICAL RES, V40, P1014, DOI 10.1080/10715760600758522
   Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e
   Serafini M, 1998, J NUTR, V128, P1003, DOI 10.1093/jn/128.6.1003
   SHI ZL, 1992, J FOOD SCI, V57, P755, DOI 10.1111/j.1365-2621.1992.tb08088.x
   Srivastava A, 2007, J AGR FOOD CHEM, V55, P2705, DOI 10.1021/jf062914w
   Stevenson D, 2012, J BERRY RES, V2, P179, DOI 10.3233/JBR-2012-038
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   Wojdylo A, 2009, J AGR FOOD CHEM, V57, P1337, DOI 10.1021/jf802507j
   Wu XL, 2005, J AGR FOOD CHEM, V53, P2589, DOI 10.1021/jf048068b
   Yi WG, 2006, J AGR FOOD CHEM, V54, P5651, DOI 10.1021/jf0531959
NR 47
TC 95
Z9 105
U1 4
U2 113
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 22
PY 2013
VL 61
IS 20
BP 4806
EP 4815
DI 10.1021/jf400823s
PG 10
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 152SL
UT WOS:000319551300017
PM 23635035
DA 2025-04-28
ER

PT J
AU Yu, HS
   Kim, WJ
   Bae, WY
   Lee, NK
   Paik, HD
AF Yu, Hyung-Seok
   Kim, Won-Ju
   Bae, Won-Young
   Lee, Na-Kyoung
   Paik, Hyun-Dong
TI Inula britannica Inhibits Adipogenesis of 3T3-L1 Preadipocytes
   via Modulation of Mitotic Clonal Expansion Involving ERK 1/2 and Akt
   Signaling Pathways
SO NUTRIENTS
LA English
DT Article
DE Inula britannica; anti-obesity; adipogenesis; lipogenesis; mitotic
   clonal expansion; ERK 1; 2 signaling pathways; Akt signaling pathways
ID C/EBP-ALPHA; LIPID-ACCUMULATION; PHENOLIC-COMPOUNDS; EARLY-STAGE;
   PPAR-GAMMA; DIFFERENTIATION; OBESITY; KINASE; FAT; ANTIOXIDANT
AB The flower of Inula britannica contains various phenolic compounds with prophylactic properties. This study aimed to determine the anti-adipogenic effect of an I. britannica flower aqueous extract (IAE) and its underlying mechanisms in the 3T3-L1 preadipocytes and to identify the phenolic compounds in the extract. Treatment with IAE inhibited the adipogenesis of 3T3-L1 preadipocytes by showing a dose-dependently suppressed intracellular lipid accumulation and significantly mitigated expression levels of lipogenesis- and adipogenesis-associated biomarkers including transcription factors. IAE exerted an anti-adipogenic effect through the modulation of the early phases of adipogenesis including mitotic clonal expansion (MCE). Treatment with IAE inhibited MCE by arresting the cell cycle at the G0/G1 phase and suppressing the activation of MCE-related transcription factors. Furthermore, IAE inhibited adipogenesis by regulating the extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Protocatechuic acid, chlorogenic acid, kaempferol-3-O-glucoside, and 6-methoxyluteolin, which are reported to exhibit anti-adipogenic properties, were detected in IAE. Therefore, modulation of early phases of adipogenesis, especially MCE, is a key mechanism underlying the anti-adipogenic activity of IAE. In summary, the anti-obesity effects of IAE can be attributed to its phenolic compounds, and hence, IAE can be used for the development of anti-obesity products.
C1 [Yu, Hyung-Seok; Kim, Won-Ju; Bae, Won-Young; Lee, Na-Kyoung; Paik, Hyun-Dong] Konkuk Univ, Dept Food Sci & Biotechnol Anim Resources, Seoul 05029, South Korea.
C3 Konkuk University
RP Paik, HD (corresponding author), Konkuk Univ, Dept Food Sci & Biotechnol Anim Resources, Seoul 05029, South Korea.
EM hyungseok_yu@naver.com; jootopaz22@naver.com; won5483101@naver.com;
   lnk11@konkuk.ac.kr; hdpaik@konkuk.ac.kr
RI Bae, Won-Young/AAS-2512-2020; Paik, Hyun-Dong/D-5226-2011
OI Kim, Won-Ju/0000-0003-3554-8984; Awad Mohamed, Dina Abdelrazik
   Bayoumi/0000-0003-1115-4219; Paik, Hyun-Dong/0000-0001-9891-7703
CR Abood S, 2018, PHYTOTHER RES, V32, P1583, DOI 10.1002/ptr.6089
   Apovian Caroline M, 2016, Am J Manag Care, V22, ps176
   Bae WY, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2670-x
   Bae WY, 2019, MOL BIOL REP, V46, P6053, DOI 10.1007/s11033-019-05040-x
   Bae WY, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12785
   Bai NS, 2005, J FOOD LIPIDS, V12, P141, DOI 10.1111/j.1745-4522.2005.00012.x
   Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402
   Cabiati M, 2012, J MOL ENDOCRINOL, V48, P251, DOI 10.1530/JME-12-0024
   Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047
   Chae SY, 2015, J FUNCT FOODS, V19, P700, DOI 10.1016/j.jff.2015.09.060
   Chang E, 2019, MOLECULES, V24, DOI 10.3390/molecules24061157
   Chayaratanasin P, 2019, MOLECULES, V24, DOI 10.3390/molecules24101894
   Chen Q, 2017, CELL REP, V18, P3155, DOI 10.1016/j.celrep.2017.03.006
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198
   DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7
   Feng S, 2016, MOLECULES, V21, DOI 10.3390/molecules21101278
   Ferguson Bradley S, 2016, Biochem Biophys Rep, V5, P16, DOI 10.1016/j.bbrep.2015.11.014
   Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026
   Gao D, 2016, J ETHNOPHARMACOL, V191, P379, DOI 10.1016/j.jep.2016.06.059
   Gao Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3656
   Graham MR, 2015, DIABET METAB SYND OB, V8, P455, DOI 10.2147/DMSO.S82629
   Granato D, 2020, TRENDS FOOD SCI TECH, V98, P162, DOI 10.1016/j.tifs.2020.01.010
   GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3
   Guo L, 2012, CELL DEATH DIFFER, V19, P1917, DOI 10.1038/cdd.2012.75
   Hales Craig M, 2017, NCHS Data Brief, P1
   Hong T, 2012, INT J BIOL MACROMOL, V51, P550, DOI 10.1016/j.ijbiomac.2012.06.021
   Jang YJ, 2015, FOOD FUNCT, V6, P2365, DOI 10.1039/c5fo00397k
   Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102
   Kang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061411
   Khan AL, 2010, MOLECULES, V15, P1562, DOI 10.3390/molecules15031562
   Kim CY, 2020, FOOD SCI BIOTECHNOL, V29, P431, DOI 10.1007/s10068-019-00672-y
   Kim HY, 2020, FOOD SCI BIOTECHNOL, V29, P569, DOI 10.1007/s10068-019-00690-w
   Kim HS, 2018, FOOD SCI BIOTECHNOL, V27, P451, DOI 10.1007/s10068-017-0253-5
   Kim SJ, 2016, J PHARM PHARMACOL, V68, P107, DOI 10.1111/jphp.12485
   Konige M, 2014, BBA-MOL BASIS DIS, V1842, P393, DOI 10.1016/j.bbadis.2013.05.007
   Lee JH, 2018, J ETHNOPHARMACOL, V222, P61, DOI 10.1016/j.jep.2018.04.020
   Lee YJ, 2015, FOOD FUNCT, V6, P2824, DOI 10.1039/c5fo00481k
   Maki C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173264
   Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792
   Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124
   Park SH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010017
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Qiu ZL, 2001, J BIOL CHEM, V276, P11988, DOI 10.1074/jbc.M011729200
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Ross SE, 1999, MOL CELL BIOL, V19, P8433
   Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100
   Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200
   Yu HS, 2019, J MICROBIOL BIOTECHN, V29, P1022, DOI 10.4014/jmb.1903.03014
   Zaklos-Szyda M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072003
   Zhang H, 2016, CURR OPIN FOOD SCI, V8, P33, DOI 10.1016/j.cofs.2016.02.002
   Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101
NR 55
TC 27
Z9 27
U1 3
U2 12
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2020
VL 12
IS 10
AR 3037
DI 10.3390/nu12103037
PG 21
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA OL1HB
UT WOS:000585091300001
PM 33023055
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Worsztynowicz, P
   Napierala, M
   Bialas, W
   Grajek, W
   Olkowicz, M
AF Worsztynowicz, Paulina
   Napierala, Marta
   Bialas, Wojciech
   Grajek, Wlodzimierz
   Olkowicz, Mariola
TI Pancreatic α-amylase and lipase inhibitory activity of polyphenolic
   compounds present in the extract of black chokeberry (Aronia
   melanocarpa L.)
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Chokeberry; Obesity; Amylase; Lipase; Enzyme inhibition
ID TEA POLYPHENOLS; ANTHOCYANINS; GLUCOSIDASE; OBESITY; METABOLISM;
   ABSORPTION; CYANIDIN; ENZYMES
AB The aim of this study was to investigate the effect of black chokeberry (Aronia melanoccopa L.) extract on the activity of porcine pancreatic alpha-amylase and lipase. An in vitro study demonstrated that three kinds of chokeberry extracts: methanolic, water and acetic caused inhibition of alpha-amylase and lipase. The methanolic and acetic extracts exhibited the highest inhibitory activities against alpha-amylase with the IC50 values of 10.31 +/- 0.04 mg/ml and pancreatic lipase 83.45 +/- 0.50 mg/ml, respectively. In order to identify the compounds which may be the potential inhibitors of alpha-amylase and lipase, chokeberry extract was analyzed by preparative reverse phase chromatography and high performance liquid chromatography-mass spectrometry (HPLC-MS). These studies have shown that both anthocyanins and phenolic acids are compounds which inhibit the ability of the reaction catalyzed by alpha-amylase and lipase. The most effective inhibitor of pancreatic alpha-amylase was chlorogenic acid (IC50= 0.57 +/- 0.16 mg/ml). In the group of anthocyanins the most potent inhibitor of alpha-amylase was cyanidin-3-glucoside (IC50= 1.74 +/- 0.04 mg/ml), which also showed an ability to inhibit the reaction catalyzed by pancreatic lipase(IC50 = 1.17 +/- 0.05 mg/ml). These findings seem to indicate the use of chokeberry as a functional food component, contributing to its anti-obesity activities. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Worsztynowicz, Paulina; Napierala, Marta; Bialas, Wojciech; Grajek, Wlodzimierz; Olkowicz, Mariola] Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, PL-60627 Poznan, Poland.
   [Napierala, Marta] Poznan Univ Med Sci, Environm Res Lab, Dept Toxicol, PL-60631 Poznan, Poland.
C3 Poznan University of Life Sciences; Poznan University of Medical
   Sciences
RP Worsztynowicz, P (corresponding author), Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, Wojska Polskiego 48, PL-60627 Poznan, Poland.
EM paulina.worsztynowicz@up.poznan.pl; martan@ump.edu.pl;
   wbialas@up.poznan.pl; grajek@up.poznan.pl; mariola.olkowicz@up.poznan.pl
RI Olkowicz, Mariola/ABF-1182-2020; Bialas, Wojciech/F-8058-2015; Szukalska
   (Napierala), Marta/C-8113-2019
OI Bialas, Wojciech/0000-0002-6095-3167; Szukalska (Napierala),
   Marta/0000-0002-3295-2546; Worsztynowicz, Paulina/0000-0001-8218-0188
FU  [POIG 01.01.02-00-061/09]
FX The work was financially supported by the grant POIG 01.01.02-00-061/09
   "Bioactive food" implemented within the Programme Innovative Economy
   2007-2013.
CR Akkarachiyasit S, 2010, INT J MOL SCI, V11, P3387, DOI 10.3390/ijms11093387
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Asai A, 2014, AM J PHYSL GASTROINT
   Barrett ML, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-24
   Bräunlich M, 2013, NUTRIENTS, V5, P663, DOI 10.3390/nu5030663
   Cai ZJ, 1999, WHO TECH REP SER, V887, P1
   Griffiths D W, 1986, Adv Exp Med Biol, V199, P509
   Grussu D, 2011, J AGR FOOD CHEM, V59, P2324, DOI 10.1021/jf1045359
   Gu YY, 2011, J AGR FOOD CHEM, V59, P5305, DOI 10.1021/jf200180n
   Han LK, 2001, INT J OBESITY, V25, P1459, DOI 10.1038/sj.ijo.0801747
   Huang JB, 2013, J AGR FOOD CHEM, V61, P8565, DOI 10.1021/jf402004x
   Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004
   Kim HK, 2012, NUTR RES, V32, P770, DOI 10.1016/j.nutres.2012.06.008
   de la Garza AL, 2013, J AGR FOOD CHEM, V61, P12012, DOI 10.1021/jf4021569
   Matsui T, 2004, BIOSCI BIOTECH BIOCH, V68, P2239, DOI 10.1271/bbb.68.2239
   Matsui T, 2001, J AGR FOOD CHEM, V49, P1948, DOI 10.1021/jf001251u
   McDougall GJ, 2008, BIOFACTORS, V34, P73, DOI 10.1002/biof.5520340108
   Moreno DA, 2003, NUTRITION, V19, P876, DOI 10.1016/S0899-9007(03)00167-9
   Moreno DA, 2006, LIFE SCI, V78, P2797, DOI 10.1016/j.lfs.2005.11.012
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Narita Y, 2011, FOOD CHEM, V127, P1532, DOI 10.1016/j.foodchem.2011.02.013
   Narita Y, 2009, J AGR FOOD CHEM, V57, P9218, DOI 10.1021/jf9017383
   Ono Y, 2006, J ETHNOPHARMACOL, V106, P238, DOI 10.1016/j.jep.2005.12.036
   Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X
   SATOUCHI K, 1974, AGR BIOL CHEM TOKYO, V38, P97, DOI 10.1080/00021369.1974.10861113
   Sikora J, 2012, EUR J NUTR, V51, P549, DOI 10.1007/s00394-011-0238-8
   Slimestad R, 2005, J FOOD COMPOS ANAL, V18, P61, DOI 10.1016/j.jfca.2003.12.003
   Somogyi M., 1952, J BIOL CHEM, V200, P245
   Sousa BA, 2012, BRAZ J CHEM ENG, V29, P25, DOI 10.1590/S0104-66322012000100003
   TANI H, 1995, J AGR FOOD CHEM, V43, P2796, DOI 10.1021/jf00059a003
   Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979
   Wu XL, 2004, J AGR FOOD CHEM, V52, P7846, DOI 10.1021/jf0486850
   Yao SL, 2013, FOOD FUNCT, V4, P1602, DOI 10.1039/c3fo60196j
   You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v
   Zielinska-Przyjemska M, 2009, PHYTOTHER RES, V23, P49, DOI 10.1002/ptr.2535
NR 37
TC 84
Z9 96
U1 3
U2 110
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD SEP
PY 2014
VL 49
IS 9
BP 1457
EP 1463
DI 10.1016/j.procbio.2014.06.002
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA AO7RF
UT WOS:000341549600011
DA 2025-04-28
ER

PT J
AU Lee, YH
   Wang, Z
   Chiang, TC
   Liu, CT
AF Lee, Yen-Han
   Wang, Zhi
   Chiang, Timothy C.
   Liu, Ching-Ti
TI Beverage Intake, Smoking Behavior, and Alcohol Consumption in
   Contemporary China-A Cross-Sectional Analysis from the 2011 China Health
   and Nutrition Survey
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE China; beverage intake; smoking; alcohol consumption; Westernization;
   health behavior
ID SUGAR-SWEETENED BEVERAGES; CIGARETTE-SMOKING; TOBACCO SMOKING; DISEASE
   BURDEN; OBESITY; RISK; DRINKING; PATHWAYS; HISTORY; COFFEE
AB Chinese residents enjoy various types of beverages in their daily life. With the rapid Westernization of contemporary China, several adverse health concerns-such as diabetes linked to sweetened beverages-have emerged. Until now, no research that examines associations between beverage consumption and smoking/drinking behaviors has been made available, despite the large Chinese populations partaking in such activities. We conducted a cross-sectional study to explore the association between beverage intake frequencies and smoking/drinking behaviors in 12,634 adult respondents who participated in the latest wave (2011) of the China Health and Nutrition Survey (CHNS). Further, we applied Tukey's Honest Significance test for pairwise comparisons. We defined the consumption categories as daily (at least one serving per day), weekly (less than one serving per day, at least one serving per week), monthly (less than one serving per week, at least one serving per month), and less than monthly or none-for sweetened beverage, water, tea, and coffee consumptions. The data showed that both tea and sweetened beverages are associated with smoking/drinking behaviors. Compared to respondents who consume tea and sweetened beverages daily, the odds of smoking behaviors are lower for those who consume such beverages less frequently. Further policy implications are discussed, including higher taxes on sweetened beverages and lessons from other countries.
C1 [Lee, Yen-Han; Wang, Zhi] Indiana Univ, Sch Publ Hlth, Dept Appl Hlth Sci, Bloomington, IN 47405 USA.
   [Chiang, Timothy C.] Penn State Univ, Coll Med, Hershey, PA 17033 USA.
   [Liu, Ching-Ti] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA.
C3 Indiana University System; Indiana University Bloomington; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Pennsylvania State
   University; Penn State Health; Boston University
RP Lee, YH (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Appl Hlth Sci, Bloomington, IN 47405 USA.
EM yil5050@bu.edu; zw34@indiana.edu; tchiang@hmc.psu.edu; ctliu@bu.edu
RI Liu, Li-Ping/ADB-6833-2022
OI Liu, Ching-Ti/0000-0002-0703-0742
FU National Institute of Nutrition and Food Safety; China Center for
   Disease Control and Prevention; Carolina Population Center; University
   of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350,
   R01-HD38700]; National Institutes of Health Fogarty International Center
FX We sincerely thank two anonymous reviewers who provided valuable
   comments to this present study. We also thank the National Institute of
   Nutrition and Food Safety, the China Center for Disease Control and
   Prevention, the Carolina Population Center, the University of North
   Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, and
   R01-HD38700), and the National Institutes of Health Fogarty
   International Center for financial support for CHNS data collection and
   analysis files from 1989 to 2006, plus the China-Japan Friendship
   Hospital, Ministry of Health for support of CHNS 2009 and future
   surveys.
CR [Anonymous], 2016, LANCET, V388, P1851, DOI 10.1016/S0140-6736(16)31842-6
   Bai J., CHEM INTERPRETATION
   Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974
   Burkitt L., 2017, WALL STREET J
   Cheng H, 2010, INT J PUBLIC HEALTH, V55, P645, DOI 10.1007/s00038-010-0127-6
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072
   Feng L, 2012, J NUTR HEALTH AGING, V16, P754, DOI 10.1007/s12603-012-0077-1
   Fortuna JL, 2010, J PSYCHOACTIVE DRUGS, V42, P147, DOI 10.1080/02791072.2010.10400687
   Hsiao W, HLTH CARE CHINA DESP
   Hu FB, 2011, OBES REV, V12, P552, DOI 10.1111/j.1467-789X.2011.00863.x
   Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   International Coffee Organization, COFF IN CHIN
   Jiang H, 2015, LANCET GLOB HEALTH, V3, pE190, DOI 10.1016/S2214-109X(15)70017-3
   Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636
   Kleiman S, 2012, OBES REV, V13, P258, DOI 10.1111/j.1467-789X.2011.00949.x
   Kottasova I, UK CHARGE SODA TAX S
   Larsson SC, 2008, STROKE, V39, P1681, DOI 10.1161/STROKEAHA.107.504183
   Lee CG, 2015, INT J BEHAV MED, V22, P481, DOI 10.1007/s12529-014-9452-0
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Marquez P.V., CHINAS 2015 TOBACCO
   Méndez D, 2013, TOB CONTROL, V22, P46, DOI 10.1136/tobaccocontrol-2011-050147
   Mullen J., 2016, CNN Money
   Niu Bolin, 2011, Yale Journal of Biology and Medicine, V84, P155
   Park S, 2014, PREV CHRONIC DIS
   Park S, 2016, J ACAD NUTR DIET, V116, P1589, DOI 10.1016/j.jand.2016.04.012
   Pepino MY, 2007, ALCOHOL CLIN EXP RES, V31, P1891, DOI 10.1111/j.1530-0277.2007.00519.x
   Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x
   Salín-Pascual RJ, 2006, SLEEP MED, V7, P141, DOI 10.1016/j.sleep.2005.06.008
   Sato K, 2002, ACTA OTO-LARYNGOL, V122, P74, DOI 10.1080/00016480260046445
   Smith DR, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-14
   Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88
   Tang YL, 2013, B WORLD HEALTH ORGAN, V91, P270, DOI 10.2471/BLT.12.107318
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Yi Z., MERIT TIMES
   Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119
   Zhang J, 2011, RESPIROLOGY, V16, P1165, DOI 10.1111/j.1440-1843.2011.02062.x
NR 38
TC 34
Z9 35
U1 4
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY
PY 2017
VL 14
IS 5
AR 493
DI 10.3390/ijerph14050493
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA EY6PT
UT WOS:000404106400041
PM 28481283
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Nowotny, B
   Zahiragic, L
   Bierwagen, A
   Kabisch, S
   Groener, JB
   Nowotny, PJ
   Fleitmann, AK
   Herder, C
   Pacini, G
   Erlund, I
   Landberg, R
   Haering, HU
   Pfeiffer, AFH
   Nawroth, PP
   Roden, M
AF Nowotny, Bettina
   Zahiragic, Lejla
   Bierwagen, Alessandra
   Kabisch, Stefan
   Groener, Jan B.
   Nowotny, Peter J.
   Fleitmann, Ann Kristin
   Herder, Christian
   Pacini, Giovanni
   Erlund, Iris
   Landberg, Rikard
   Haering, Hans-Ulrich
   Pfeiffer, Andreas F. H.
   Nawroth, Peter P.
   Roden, Michael
TI Low-energy diets differing in fibre, red meat and coffee intake equally
   improve insulin sensitivity in type 2 diabetes: a randomised feasibility
   trial
SO DIABETOLOGIA
LA English
DT Article
DE Diet; Inflammation; Insulin sensitivity; Type 2 diabetes; Weight loss
ID LIFE-STYLE INTERVENTION; BETA-CELL FUNCTION; POSTMENOPAUSAL WOMEN;
   SKELETAL-MUSCLE; CEREAL FIBER; AMINO-ACIDS; RISK; RESISTANCE; HUMANS;
   CONSUMPTION
AB Epidemiological studies have found that a diet high in fibre and coffee, but low in red meat, reduces the risk for type 2 diabetes. We tested the hypothesis that these nutritional modifications differentially improve whole-body insulin sensitivity (primary outcome) and secretion.
   Inclusion criteria were: age 18-69 years, BMI a parts per thousand yen30 kg/m(2), type 2 diabetes treated with diet, metformin or acarbose and known disease duration of a parts per thousand currency sign5 years. Exclusion criteria were: HbA(1c) > 75 mmol/mol (9.0%), type 1 or secondary diabetes types and acute or chronic diseases including cancer. Patients taking any medication affecting the immune system or insulin sensitivity, other than metformin, were also excluded. Of 59 patients (randomised using randomisation blocks [four or six patients] with consecutive numbers), 37 (54% female) obese type 2 diabetic patients completed this controlled parallel-group 8-week low-energy dietary intervention. The participants consumed either a diet high in cereal fibre (whole grain wheat/rye: 30-50 g/day) and coffee (a parts per thousand yen5 cups/day), and free of red meat (L-RISK, n = 17) or a diet low in fibre (a parts per thousand currency sign10 g/day), coffee-free and high in red meat (a parts per thousand yen150 g/day) diet (H-RISK, n = 20). Insulin sensitivity and secretion were assessed by hyperinsulinaemic-euglycaemic clamp and intravenous glucose tolerance tests with isotope dilution. Whole-body and organ fat contents were measured by magnetic resonance imaging and spectroscopy.
   Whole-body insulin sensitivity increased in both groups (mean [95% CI]) (H-RISK vs L-RISK: 0.8 [0.2, 1.4] vs 1.0 [0.4, 1.7] mg kg(-1) min(-1), p = 0.59), while body weight decreased (-4.8% [-6.1%, -3.5%] vs -4.6% [-6.0%, -3.3%], respectively). Hepatic insulin sensitivity remained unchanged, whereas hepatocellular lipid content fell in both groups (-7.0% [-9.6%, -4.5%] vs -6.7% [-9.5%, -3.9%]). Subcutaneous fat mass (-1,553 [-2,767, -340] cm(3) vs -751 [-2,047; 546] cm(3), respectively) visceral fat mass (-206 [-783, 371] cm(3) vs -241 [-856, 373] cm(3), respectively) and muscle fat content (-0.09% [-0.16%, -0.02%] vs -0.02% [-0.10%, 0.05%], respectively) decreased similarly. Insulin secretion remained unchanged, while the proinflammatory marker IL-18 decreased only after the L-RISK diet.
   No evidence of a difference between both low-energy diets was identified. Thus, energy restriction per se seems to be key for improving insulin action in phases of active weight loss in obese type 2 diabetic patients, with a potential improvement of subclinical inflammation with the L-RISK diet.
   Trial Registration: Clinicaltrials.gov NCT01409330
   Funding: This study was supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW), the German Federal Ministry of Health (BMG), the Federal Ministry for Research (BMBF) to the Center for Diabetes Research (DZD e.V.) and the Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases (ICEMED).
C1 [Nowotny, Bettina; Zahiragic, Lejla; Bierwagen, Alessandra; Nowotny, Peter J.; Fleitmann, Ann Kristin; Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany.
   [Nowotny, Bettina; Zahiragic, Lejla; Bierwagen, Alessandra; Nowotny, Peter J.; Fleitmann, Ann Kristin; Herder, Christian; Roden, Michael] Partner Dusseldorf, German Ctr Diabet Res, Dusseldorf, Germany.
   [Nowotny, Bettina; Zahiragic, Lejla; Roden, Michael] Univ Dusseldorf, Dept Endocrinol & Diabetol, D-40225 Dusseldorf, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] German Inst Nutr Res DIfE Potsdam, Dept Clin Nutr, Bergholz Rehbrucke, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] Partner Berlin, German Ctr Diabet Res, Berlin, Germany.
   [Groener, Jan B.; Nawroth, Peter P.] Univ Clin Heidelberg, Dept Internal Med 1, Heidelberg, Germany.
   [Pacini, Giovanni] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy.
   [Erlund, Iris] Natl Publ Hlth Inst, Dept Hlth & Funct Capac, Helsinki, Finland.
   [Landberg, Rikard] Swedish Univ Agr Sci, Dept Food Sci, Uppsala, Sweden.
   [Landberg, Rikard] Karolinska Inst, Inst Environm Med, Nutr Epidemiol Unit, S-10401 Stockholm, Sweden.
   [Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Tubingen, Germany.
   [Haering, Hans-Ulrich] Univ Tubingen Hosp, Inst Diabet Res & Metab Dis, Tubingen, Germany.
   [Haering, Hans-Ulrich] Partner Tubingen Neuherberg, German Ctr Diabet Res, Tubingen, Germany.
C3 Leibniz Association; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine
   University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz
   Association; Deutsches Institut fur Ernahrungsforschung
   Potsdam-Rehbrucke (DIfE); Berlin Institute of Health; Free University of
   Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Ruprecht Karls University Heidelberg; Consiglio Nazionale delle
   Ricerche (CNR); Finland National Institute for Health & Welfare; Swedish
   University of Agricultural Sciences; Karolinska Institutet; Eberhard
   Karls University of Tubingen; Eberhard Karls University Hospital;
   Eberhard Karls University of Tubingen; Eberhard Karls University
   Hospital
RP Roden, M (corresponding author), Univ Dusseldorf, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
EM michael.roden@ddz.uni-duesseldorf.de
RI Roden, Michael/AAD-3843-2019; Bierwagen, Alessandra/T-6163-2017; Erlund,
   Iris/AAA-4108-2019; Pfeiffer, Andreas/AAJ-2311-2020; Kabisch,
   Stefan/C-5106-2013
OI Nowotny, Bettina/0000-0002-0671-9644; Roden,
   Michael/0000-0001-8200-6382; Pfeiffer, Andreas F.
   H./0000-0002-6887-0016; Erlund, Iris/0000-0002-0083-1256; Kabisch,
   Stefan/0000-0003-1792-1757
CR Andersson A, 2007, J NUTR, V137, P1401, DOI 10.1093/jn/137.6.1401
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   Cho SS, 2013, AM J CLIN NUTR, V98, P594, DOI 10.3945/ajcn.113.067629
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Giacco R, 2013, CLIN NUTR, V32, P941, DOI 10.1016/j.clnu.2013.01.016
   Herder C, 2013, DIABETES CARE, V36, P3663, DOI 10.2337/dc13-0382
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Juntunen KS, 2003, AM J CLIN NUTR, V77, P385
   Kahl S, 2014, DIABETOLOGIA, V57, P2094, DOI 10.1007/s00125-014-3328-3
   Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Krebs M, 2003, DIABETOLOGIA, V46, P917, DOI 10.1007/s00125-003-1129-1
   Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213
   Laufs A, 2014, MAGN RESON MED, V71, P1670, DOI 10.1002/mrm.24835
   Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7
   Lindström J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162
   Machann J, 2010, RADIOLOGY, V257, P353, DOI 10.1148/radiol.10092284
   Marklund M, 2010, J CHROMATOGR B, V878, P888, DOI 10.1016/j.jchromb.2010.02.007
   Martínez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104
   Moazzami AA, 2014, J NUTR, V144, P807, DOI 10.3945/jn.113.188912
   Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024
   Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163
   Nowotny B, 2012, DIABETIC MED, V29, P260, DOI 10.1111/j.1464-5491.2011.03406.x
   Nowotny B, 2013, DIABETES, V62, P2240, DOI 10.2337/db12-1179
   Pacini G, 2003, BEST PRACT RES CL EN, V17, P305, DOI 10.1016/S1521-690X(03)00042-3
   Pan A, 2013, JAMA INTERN MED, V173, P1328, DOI 10.1001/jamainternmed.2013.6633
   Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Schadewaldt P, 2013, AM J CLIN NUTR, V97, P763, DOI 10.3945/ajcn.112.035014
   Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089
   Sharma N, 2012, BBA-MOL BASIS DIS, V1822, P1735, DOI 10.1016/j.bbadis.2012.07.012
   Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007
   Stefan N, 2014, LANCET DIABETES ENDO, V2, P406, DOI 10.1016/S2213-8587(13)70170-0
   Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674
   Weickert MO, 2011, AM J CLIN NUTR, V94, P459, DOI 10.3945/ajcn.110.004374
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
NR 37
TC 35
Z9 37
U1 0
U2 57
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD FEB
PY 2015
VL 58
IS 2
BP 255
EP 264
DI 10.1007/s00125-014-3457-8
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AY6SY
UT WOS:000347697000006
PM 25425219
OA Bronze
DA 2025-04-28
ER

PT J
AU Tupper, T
   Gopalakrishnan, G
AF Tupper, Traci
   Gopalakrishnan, Geetha
TI Prevention of diabetes development in those with the metabolic syndrome
SO MEDICAL CLINICS OF NORTH AMERICA
LA English
DT Article
ID LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; BETA-CELL FUNCTION;
   CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; FOLLOW-UP; POSTMENOPAUSAL WOMEN;
   INSULIN SENSITIVITY; COFFEE CONSUMPTION; PROSPECTIVE COHORT
AB Metabolic syndrome is characterized by abnormal glucose levels, central obesity, hypertension, elevated triglycerides, and low HDL cholesterol. This article reviews available data regarding the impact of lifestyle modification and drug therapies on the progression to diabetes in high risk individuals, such as those with hypertension, dyslipidemia, obesity, and prediabetes. Lifestyle and pharmaco-logical interventions may alter metabolic parameters and impact progression to diabetes. However, the cost-effectiveness of these interventions are unclear.
C1 Brown Univ, Warren Alpert Med Sch, Providence, RI 02860 USA.
C3 Brown University
RP Gopalakrishnan, G (corresponding author), Brown Univ, Warren Alpert Med Sch, 1 Hoppin St,Suite 200, Providence, RI 02860 USA.
EM ggopala@lifespan.org
CR Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   *AM COLL END TASK, 2003, ENDOCR PRACT, V9, P236
   Balkau B, 1999, DIABETIC MED, V16, P442
   Bosch J, 2006, NEW ENGL J MED, V355, P1551
   Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796
   Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Collins R, 2003, LANCET, V361, P2005
   Dahlöf B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3
   Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559
   Diabetes Prevention Progam, 2005, DIABETES, V54, P1150
   *DPP, 2002, DIABETES CARE, V259, P2165
   Durbin RJ, 2004, DIABETES OBES METAB, V6, P280, DOI 10.1111/j.1462-8902.2004.0348.x
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006
   ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196
   Fontbonne A, 1996, DIABETES CARE, V19, P920, DOI 10.2337/diacare.19.9.920
   Frati AC, 1996, DIABETES CARE, V19, P112, DOI 10.2337/diacare.19.2.112
   Freeman DJ, 2001, CIRCULATION, V103, P357
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   Genuth S, 2003, DIABETES CARE, V26, P3160
   Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8
   Gillespie EL, 2005, DIABETES CARE, V28, P2261, DOI 10.2337/diacare.28.9.2261
   American Heart Association, 2005, Cardiol Rev, V13, P322
   Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560
   Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120
   HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302
   Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007
   Heymsfield SB, 2000, ARCH INTERN MED, V160, P1321, DOI 10.1001/archinte.160.9.1321
   Houston TK, 2006, BMJ-BRIT MED J, V332, P1064, DOI 10.1136/bmj.38779.584028.55
   Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433
   Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   JAING R, 2002, JAMA-J AM MED ASSOC, V345, P790
   JANZON L, 1983, DIABETOLOGIA, V25, P86
   Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005
   Keech A, 2003, DIABETES CARE, V26, P2713, DOI 10.2337/diacare.26.10.2713
   Keen H., 1973, Advances in Metabolic Disorders, P521
   Kirkman MS, 2006, DIABETES CARE, V29, P2095, DOI 10.2337/dc06-0061
   Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404
   Klein BEK, 2002, DIABETES CARE, V25, P1790, DOI 10.2337/diacare.25.10.1790
   Knowler WC, 2003, DIABETES CARE, V26, P977
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/nejmoa012512
   Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719
   Li CL, 1999, DIABETIC MED, V16, P477, DOI 10.1046/j.1464-5491.1999.00090.x
   Lindström J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8
   LONG SD, 1994, DIABETES CARE, V17, P372, DOI 10.2337/diacare.17.5.372
   Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307
   Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4
   Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x
   Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736
   Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081
   RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555
   SARTOR G, 1980, DIABETES, V29, P41, DOI 10.2337/diabetes.29.1.41
   Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94
   Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956
   Sever PS, 2004, DRUGS, V64, P43, DOI 10.2165/00003495-200464002-00005
   Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057
   SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169
   Smith B, 2006, DIABETES CARE, V29, P2385, DOI 10.2337/dc06-1084
   STAMPFER MJ, 1988, AM J EPIDEMIOL, V128, P549, DOI 10.1093/oxfordjournals.aje.a115002
   Tenenbaum A, 2004, CIRCULATION, V109, P2197, DOI 10.1161/01.CIR.0000126824.12785.B6
   The ALLHAT Officers Coordinators for the ALLHAT Collaborative Research Group, 2002, JAMA, V288, P2981, DOI [10.1001/jama, DOI 10.1001/JAMA.288.23.2981]
   Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417
   van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008
   Vermes E, 2003, CIRCULATION, V107, P1291, DOI 10.1161/01.CIR.0000054611.89228.92
   Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590
   Weickert MO, 2006, DIABETES CARE, V29, P775, DOI 10.2337/diacare.29.04.06.dc05-2374
   Wing RR, 1998, DIABETES CARE, V21, P350, DOI 10.2337/diacare.21.3.350
   Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066
   Yang W, 2001, CHIN J ENDOCRINOL ME, V17, P131
   Yusuf S, 2005, CIRCULATION, V112, P48, DOI 10.1161/CIRCULATIONAHA.104.528166
   Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882
NR 79
TC 5
Z9 6
U1 0
U2 4
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0025-7125
EI 1557-9859
J9 MED CLIN N AM
JI Med. Clin. N. Am.
PD NOV
PY 2007
VL 91
IS 6
BP 1091
EP +
DI 10.1016/j.mcna.2007.06.006
PG 17
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 235HO
UT WOS:000251224600007
PM 17964911
DA 2025-04-28
ER

PT J
AU Gregg, EW
   Cadwell, BL
   Cheng, YJ
   Cowie, CC
   Williams, DE
   Geiss, L
   Engelgau, MM
   Vinicor, F
AF Gregg, EW
   Cadwell, BL
   Cheng, YJ
   Cowie, CC
   Williams, DE
   Geiss, L
   Engelgau, MM
   Vinicor, F
TI Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes
   according to obesity levels in the U.S
SO DIABETES CARE
LA English
DT Article
ID NUTRITION EXAMINATION SURVEY; IMPAIRED GLUCOSE-TOLERANCE; US ADULTS;
   COFFEE CONSUMPTION; NATIONAL-HEALTH; RISK-FACTOR; MELLITUS
AB OBJECTIVE - To examine trends in the prevalence of diagnosed and undiagnosed diabetes and the proportion of total cases previously diagnosed, according to obesity status in the U.S. over the past 40 years.
   RESEARCH DESIGN AND METHODS - We assembled data from five consecutive cross-sectional national surveys: National Health Examination Survey I (1960-1962), National Health and Nutrition Examination Survey (NHANES) I (1971-1974), NHANES II (1976-1980), NHANES III (1988-1994), and NHANES 1999-2000. Diagnosed diabetes was ascertained, and height and weight were measured in adults aged 20-74 years in all surveys. In NHANES II, NHANES III, and NHANES 1999-2000, a fasting glucose level greater than or equal to126 mg/dl was used to identify cases among individuals not reporting diabetes. Design-based analyses and Bayesian models estimate the probability that prevalence of diabetes increased within four BMI groups (<25, 25-29, 30-34, and greater than or equal to35 kg/m(2)).
   RESULTS - In the U.S. population aged 20-74 years between 1976-1980 and 1999-2000,, significant increases in the prevalence of diagnosed diabetes (3.3-5.8%, probability >99.9%) were accompanied by nonsignificant increases in undiagnosed diabetes (2.0-2.4%, 66.6%). This resulted in an increase in total diabetes (5.3 8.2%, >99.9%) and a modest nonsignificant increase in the proportion of cases that were diagnosed (62-70%, 62.4%). However, these trends varied considerably by BMI level. In individuals with BMI greater than or equal to35 kg/m(2), diagnosed diabetes increased markedly (from 4.9% in 1960, to 8.6% during 1976-1980, to 15.1% in 1999-2000; probability >99.9%), whereas undiagnosed diabetes declined considerably (12.5% during 1976-1980 to 3.2% in 1999-2000, probability of increase 4.5%) Therefore, the proportion of total diabetes cases that were diagnosed increased from 41 to 83% (probability 99.9%) among individuals with BMI greater than or equal to35 kg/m(2). By comparison, changes in prevalence within BMI strata <35 kg/m(2) were modest and there was no increase in the percent of total cases that were diagnosed.
   CONCLUSIONS - National surveys over the last several decades have found large increases in diagnosed diabetes, particularly in overweight and obese individuals, but this has been accompanied by large decreases in undiagnosed diabetes only among individuals with BMI greater than or equal to35 kg/m(2). This suggests that improvements in diabetes awareness and detection are most prominent among this subgroup.
C1 CDCP, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, Atlanta, GA 30341 USA.
   Northrop Grumman, Div Informat Technol, Atlanta, GA USA.
   NIDDK, NIH, Bethesda, MD USA.
C3 Centers for Disease Control & Prevention - USA; National Institutes of
   Health (NIH) - USA; NIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK)
RP CDCP, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, 4770 Buford Hwy,NE Mailstop K-10, Atlanta, GA 30341 USA.
EM edg7@cdc.gov
RI Cheng, Yiling/A-6547-2009
OI Cheng, Yiling/0000-0002-5053-0814; Gregg, Edward/0000-0003-2381-6822
CR [Anonymous], MMWR MORB MORTAL WKL
   [Anonymous], CLIN DIABETES MELLIT
   Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371
   *CDCP, 2003, PREV DIAGN DIAB AG U
   *CDCP, 1997, DIAB SURV
   COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001
   Desai Jay, 2003, J Public Health Manag Pract, VSuppl, pS44
   Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141
   FLEGAL KM, 1991, DIABETES CARE, V14, P628, DOI 10.2337/diacare.14.7.628
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256
   Freid V.M., 2003, Chartbook on trends in the health of Americans. Health
   Gelman A, 1995, BAYESIAN DATA ANAL
   HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523
   Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518
   Hu FB, 1999, AM J CLIN NUTR, V70, P1001
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232
   Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554
   Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409
   Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4
   MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63
   MCDOWELL A, 1981, VITAL HLTH STAT, V1, P15
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278
   *MRC BIOST UN, 2003, WINBUGS
   *NAT CTR HLTH STAT, 2001, NHANES 1999 2000 DAT
   *NAT CTR HLTH STAT, 1973, VITAL HLTH STAT 1, V10, P1
   *NAT CTR HLTH STAT, 1965, VITAL HLTH STAT, V4, P1
   Pi-Sunyer FX, 1998, OBES RES, V6, p51S
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   *SAS I, 1999, SAS PROC GUID
   Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016
   SHAH B, 1999, SUDAAN USERS MANUAL
   STAMPFER MJ, 1988, AM J EPIDEMIOL, V128, P549, DOI 10.1093/oxfordjournals.aje.a115002
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
   1994, VIT HLTH STAT 1, V32, P1
NR 38
TC 249
Z9 295
U1 0
U2 9
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD DEC
PY 2004
VL 27
IS 12
BP 2806
EP 2812
DI 10.2337/diacare.27.12.2806
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 874DU
UT WOS:000225331900006
PM 15562189
OA Bronze
DA 2025-04-28
ER

PT J
AU Sakboonyarat, B
   Pornpongsawad, C
   Sangkool, T
   Phanmanas, C
   Kesonphaet, N
   Tangthongtawi, N
   Limsakul, A
   Assavapisitkul, R
   Thangthai, T
   Janenopparkarnjana, P
   Varodomvitaya, P
   Dachoviboon, W
   Laohasara, J
   Kruthakool, N
   Limprasert, S
   Mungthin, M
   Hatthachote, P
   Rangsin, R
AF Sakboonyarat, Boonsub
   Pornpongsawad, Chanyut
   Sangkool, Tanatip
   Phanmanas, Chidapha
   Kesonphaet, Nithitchaya
   Tangthongtawi, Nirutti
   Limsakul, Ammiga
   Assavapisitkul, Ramita
   Thangthai, Titipatara
   Janenopparkarnjana, Patcha
   Varodomvitaya, Pijitra
   Dachoviboon, Wichayada
   Laohasara, Janepoj
   Kruthakool, Naphat
   Limprasert, Sarawuth
   Mungthin, Mathirut
   Hatthachote, Panadda
   Rangsin, Ram
TI Trends, prevalence and associated factors of obesity among adults in a
   rural community in Thailand: serial cross-sectional surveys, 2012 and
   2018
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Obesity; Trends; Rural community; Instant coffee-mix; Urine Na level
ID SUGAR-SWEETENED BEVERAGES; CORONARY-HEART-DISEASE; METABOLIC SYNDROME;
   COFFEE CONSUMPTION; DIETARY-SODIUM; RISK-FACTORS; WEIGHT-GAIN;
   HYPERTENSION; SMOKING; HEALTH
AB BackgroundObesity is one principle risk factor increasing the risk of noncommunicable diseases including diabetes, hypertension and atherosclerosis. In Thailand, a 2014 study reported obesity (BMI >= 25kg/m(2)) in a Thai population aged >= 15years was 37.5, 32.9 and 41.8% overall and among males and females, respectively. The study aimed to determine trends in the prevalence of obesity among adults residing in a Thai rural community between 2012 and 2018 and investigate the associations between obesity and behavioral factors.MethodsSerial cross-sectional studies were conducted in 2012 and 2018 among adults in Na-Ngam rural community. In 2012 and 2018, all 635 and 627 individuals, respectively, were interviewed using structured questionnaires related to demographics, risk behaviors, comorbidities and arthrometric measurement. Spot urine was collected by participants and obesity was defined as BMI >= 25kg/m(2). The risk factors for obesity were analyzed in the 2018 survey.ResultsA total of 1262 adults in Na-Ngam rural community were included in the study. The prevalence of obesity was 33.9% in 2012 and 44.8% in 2018 (P <0.001). The average BMI increased from 23.94.2kg/m(2) in 2012 to 25.0<plus/minus>4.52kg/m(2) in 2018 (P <0.001). Obesity was associated with higher age (AOR 0.99; 95%CI 0.97-0.99), smoking (AOR 0.52; 95%CI 0.28-0.94), instant coffee-mix consumption >1 cup/week (AOR 1.44; 95%CI 1.02-2.04), higher number of chronic diseases (>= 1 disease AOR 1.82; 95%CI 1.01-2.68, >2 diseases AOR 2.15; 95%CI 1.32-3.50), and higher spot urine sodium level (AOR 1.002; 95%CI 0.99-1.01).Conclusion p id=Par Our data emphasized that obesity constituted a serious problem among adults residing in a rural community. A trend in significant increase was found regarding the prevalence of obesity and average BMI in the rural community over 6years. Effective public health interventions should be provided at the community level to reduce BMI. Moreover, modifiable risk factors for obesity should be attenuated to inhibit the progression of metabolic syndrome, noncommunicable diseases and their complications.
C1 [Sakboonyarat, Boonsub; Rangsin, Ram] Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok 10400, Thailand.
   [Pornpongsawad, Chanyut; Sangkool, Tanatip; Phanmanas, Chidapha; Kesonphaet, Nithitchaya; Tangthongtawi, Nirutti; Limsakul, Ammiga; Assavapisitkul, Ramita; Thangthai, Titipatara; Janenopparkarnjana, Patcha; Varodomvitaya, Pijitra; Dachoviboon, Wichayada; Laohasara, Janepoj; Kruthakool, Naphat] Phramongkutklao Coll Med, Bangkok 10400, Thailand.
   [Limprasert, Sarawuth] Phramongkutklao Coll Med, Dept Internal Med, Bangkok 10400, Thailand.
   [Mungthin, Mathirut] Phramongkutklao Coll Med, Dept Pharmacol, Bangkok 10400, Thailand.
   [Hatthachote, Panadda] Phramongkutklao Coll Med, Dept Physiol, Bangkok 10400, Thailand.
C3 Phramongkutklao College of Medicine; Phramongkutklao College of
   Medicine; Phramongkutklao College of Medicine; Phramongkutklao College
   of Medicine; Phramongkutklao College of Medicine
RP Sakboonyarat, B (corresponding author), Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok 10400, Thailand.
EM countryside.physician@gmail.com
RI Rangsin, Ram/AAW-9527-2020; Sakboonyarat, Boonsub/ISU-4684-2023
OI Limprasert, Sarawuth/0000-0002-9506-6525; Sakboonyarat,
   Boonsub/0000-0003-0577-0699
CR Aekplakorn W, 2014, J OBES, V2014, DOI 10.1155/2014/410259
   Akil L, 2011, J HEALTH CARE POOR U, V22, P61, DOI 10.1353/hpu.2011.0166
   Antonios TFT, 1996, LANCET, V348, P250, DOI 10.1016/S0140-6736(96)01463-8
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Canale MP, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/865965
   CfDCa P, 2019, AD TOB US INF 2019
   Chan TF, 2014, NUTRIENTS, V6, P2088, DOI 10.3390/nu6052088
   Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470
   Dare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123579
   DeMarco VG, 2014, NAT REV ENDOCRINOL, V10, P364, DOI 10.1038/nrendo.2014.44
   DIVISION UNDP, 2018, WORLD URB PROSP 2018
   dos Santos EM, 2018, RENAL FAILURE, V40, P22, DOI 10.1080/0886022X.2017.1419967
   Drenowatz C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04928
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Fonseca-Alaniz MH, 2007, OBESITY, V15, P2200, DOI 10.1038/oby.2007.261
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697
   Hatthachote P, 2019, MILITARY MED RES, V6, DOI 10.1186/s40779-019-0201-1
   HODDINOTT SN, 1986, CAN FAM PHYSICIAN, V32, P2366
   Hostmark AT, 2010, APPL PHYSIOL NUTR ME, V35, P635, DOI 10.1139/H10-059
   Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
   HSR. I, 2014, THAI NAT HLTH EX 5 N
   Hu LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170238
   Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2
   Inoue S, 2000, AS PAC PERSP RED OB
   Izci T, 2018, TRANSPLANTATION, V102, pS524, DOI 10.1097/01.tp.0000543363.16096.fb
   Jain N, 2014, AM J CLIN NUTR, V99, P992, DOI 10.3945/ajcn.113.077362
   김경윤, 2017, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V46, P630
   Jitnarin Nattinee, 2008, Journal of the Medical Association of Thailand, V91, P1109
   Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147
   Kearns K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-143
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Li ZL, 2012, ARTERIOSCL THROM VAS, V32, P1132, DOI 10.1161/ATVBAHA.111.244061
   Ma Y, 2015, HYPERTENSION, V66, P843, DOI 10.1161/HYPERTENSIONAHA.115.05948
   Namgung SD, 2018, ADV ELECTRON MATER, V4, DOI 10.1002/aelm.201800046
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Patel SA, 2016, GLOB HEART, V11, P71, DOI 10.1016/j.gheart.2016.01.003
   Pengpid S, 2020, EAT WEIGHT DISORD-ST, V25, P265, DOI 10.1007/s40519-018-0571-5
   PERKINS KA, 1993, J CONSULT CLIN PSYCH, V61, P768, DOI 10.1037/0022-006X.61.5.768
   Rachmi CN, 2017, PUBLIC HEALTH, V147, P20, DOI 10.1016/j.puhe.2017.02.002
   Rautela Yashneel Singh, 2018, J Family Med Prim Care, V7, P809, DOI 10.4103/jfmpc.jfmpc_161_17
   Rigotti Nancy A., 1996, Cardiology Clinics, V14, P51
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Shin HY, 2017, J EPIDEMIOL, V27, P413, DOI 10.1016/j.je.2016.08.014
   Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990
   Stelmach-Mardas M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040229
   Taylor A, 2016, TRENDS ADULT BODY MA
   Wang R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010828
   Watanabe T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148926
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
   Zhao Y, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0406-z
   Zhu HD, 2014, PEDIATRICS, V133, pE635, DOI 10.1542/peds.2013-1794
NR 53
TC 25
Z9 25
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUN 3
PY 2020
VL 20
IS 1
DI 10.1186/s12889-020-09004-w
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA LY1CB
UT WOS:000540259000016
PM 32493314
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Lee, KW
   Shin, D
AF Lee, Kyung Won
   Shin, Dayeon
TI A Healthy Beverage Consumption Pattern Is Inversely Associated with the
   Risk of Obesity and Metabolic Abnormalities in Korean Adults
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE beverage consumption pattern; factor analysis;
   healthy beverage; Korean adults;
   metabolic syndrome; obesity
ID SUGAR-SWEETENED BEVERAGES; SOFT DRINK CONSUMPTION; NATIONAL-HEALTH;
   COFFEE CONSUMPTION; DIETARY PATTERNS; CALORIC BEVERAGES; PREVALENCE;
   CHILDREN; MECHANISMS; COMPONENTS
AB As the use of beverages in diets is increasing, several studies have examined the effect of beverage consumption in human health. Thus, we aimed at identifying specific beverage patterns and determining their associations with obesity and metabolic syndrome (MetS) risk factors in Korean adults. Based on the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2012 data, 19,800 Korean adults (20 years) with a single 24-h dietary recall and health examination data were investigated. All beverage items consumed by participants were categorized into 15 beverage groups based on the KNHANES coding system. Three major beverage consumption patterns were identified according to factor analysis: (1) the healthy beverage (high intake of dairy products, 100% fruit/vegetable juices and low intake of alcoholic beverages); (2) the sugar-sweetened beverage (high intake of soda, sweetened coffee/tea, and fruit drink); and (3) the unsweetened beverage (high intake of unsweetened coffee) patterns. Multivariable logistic regression analyses were conducted to determine the odds of obesity (body mass index 25kg/m(2)) and MetS (defined by National Cholesterol Education Program III [NCEP III]) for each beverage pattern after controlling for covariates. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) for associations of the healthy beverage pattern with risks of obesity, abdominal obesity, and elevated triglycerides, fasting blood glucose (FBG), and blood pressure (BP) were 0.88 (0.79-0.98), 0.83 (0.74-0.92), 0.88 (0.78-0.99), 0.85 (0.79-0.98), and 0.81 (0.72-0.92), respectively. AORs (95% CIs) of associations of the sugar-sweetened beverage pattern with risks of abdominal obesity, elevated FBG and BP were 1.15 (1.03-1.30), 1.14 (1.01-1.29), and 1.18 (1.04-1.33), respectively. However, no associations were found between the unsweetened beverage pattern and any parameters examined. Intake of healthy beverages should be encouraged to reduce risks of obesity and metabolic abnormalities; however, individuals who consume sugar-sweetened beverages should be advised on the adverse effects of those beverages on the risk of obesity and MetS.
C1 [Lee, Kyung Won] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.
   [Lee, Kyung Won] Korea Ctr Dis Control & Prevent, Div Epidemiol & Hlth Index, Ctr Genome Sci, Korea Natl Inst Hlth, Cheongju, Chungcheongbuk, South Korea.
   [Shin, Dayeon] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, 552 White Hall, Syracuse, NY 13244 USA.
C3 Michigan State University; Korea Disease Control & Prevention Agency
   (KDCA); Korea National Institute of Health (KNIH); Korea CDC Center for
   Genome Science; Syracuse University
RP Shin, D (corresponding author), Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, 552 White Hall, Syracuse, NY 13244 USA.
EM dshin03@syr.edu
RI Shin, Dayeon/GMX-2004-2022
OI Shin, Dayeon/0000-0003-0828-184X; Lee, Kyung Won/0000-0003-4430-3241
CR Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260
   Ahluwalia N, 2013, DIABETES METAB, V39, P99, DOI 10.1016/j.diabet.2012.08.007
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   [Anonymous], 2000, ASIA PACIFIC PERSPEC
   Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455
   Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163
   Tran BT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3936-6
   Cho YA, 2011, NUTR METAB CARDIOVAS, V21, P893, DOI 10.1016/j.numecd.2010.02.018
   Chung S, 2015, METABOLISM, V64, P1477, DOI 10.1016/j.metabol.2015.07.012
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Danyliw AD, 2011, PUBLIC HEALTH NUTR, V14, P1961, DOI 10.1017/S1368980011001091
   Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008
   Drewnowski A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1068
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Duffey KJ, 2012, EUR J CLIN NUTR, V66, P244, DOI 10.1038/ejcn.2011.166
   Duffey KJ, 2006, J NUTR, V136, P2901, DOI 10.1093/jn/136.11.2901
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910
   Falahi E, 2016, INT DAIRY J, V61, P85, DOI 10.1016/j.idairyj.2016.04.008
   Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Han E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-195
   Hostmark AT, 2010, APPL PHYSIOL NUTR ME, V35, P635, DOI 10.1139/H10-059
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   김경윤, 2017, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V46, P630
   Kang Y, 2017, BRIT J NUTR, V117, P315, DOI 10.1017/S0007114517000046
   Kim D, 2017, BRIT J NUTR, V117, P148, DOI [10.1017/S000711451600444X, 10.1017/s000711451600444x]
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   *KOR CTR DIS CONTR, 2016, US GUID 4 KOR NAT HL, DOI DOI 10.1016/J.NIMB.2005.04.002
   *KOR HLTH IND DEV, 2014, FOOD IND AN REP 2014, DOI DOI 10.1186/1743-7075-8-65
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee JE, 2011, NUTRITION, V27, P26, DOI 10.1016/j.nut.2009.10.011
   LEE KW, 2016, NUTRIENTS, V8, DOI DOI 10.3390/NU8100617
   LEE KW, 2017, NUTRIENTS, V9, DOI DOI 10.3390/NU9060630
   Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Mesirow MSC, 2015, J ACAD NUTR DIET, V115, P559, DOI 10.1016/j.jand.2014.09.004
   Ministry of Health and Welfare, 2016, KOR HLTH STAT 2015 K
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2013, KOR HLTH STAT 2012 K
   *NAT HLTH INS SERV, 2015, SOC IMP HLTH RISK FA
   Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504
   Pereira MA, 2010, J AM COLL NUTR, V29, P625, DOI 10.1080/07315724.2010.10719901
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Shin D, 2015, NUTRIENTS, V7, P9369, DOI 10.3390/nu7115472
   Song F., 2016, NFS Journal, V4, P9
   Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
NR 52
TC 10
Z9 10
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD SEP
PY 2018
VL 21
IS 9
BP 935
EP 945
DI 10.1089/jmf.2017.0119
EA MAR 2018
PG 11
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA GT7FT
UT WOS:000428437800001
PM 29569988
DA 2025-04-28
ER

PT J
AU Murosaki, S
   Lee, TR
   Muroyama, K
   Shin, ES
   Cho, SY
   Yamamoto, Y
   Lee, SJ
AF Murosaki, Shinji
   Lee, Tae Ryong
   Muroyama, Koutarou
   Shin, Eui Seok
   Cho, Si Young
   Yamamoto, Yoshihiro
   Lee, Sang Jun
TI A combination of caffeine, arginine, soy lsoflavones, and L-carnitine
   enhances both upolysis and fatty acid oxidation in 3T3-L1 and HepG2
   cells in vitro and in KK mice in vivo
SO JOURNAL OF NUTRITION
LA English
DT Article
ID INSULIN-RESISTANCE; CITRIC-ACID; BODY-FAT; OBESITY; PROTEIN; LIPOLYSIS;
   EXERCISE; ASSOCIATION; ADIPONECTIN; CLEARANCE
AB To develop an anti-obesity agent containing dietary components, we focused on the mechanisms that enhance both lipolysis and fatty acid oxidation. Caffeine and arginine (CA), a nonselective adenosine-receptor antagonist and an inducer of lipolytic hormone, respectively, were used to stimulate lipolysis. Soy isoflavones and L-camiline (SL), stimulators of carnitine palmitoyl transferase 1A and a cofactor for P-oxidation of fatty acids, respectively, were used to enhance fatty acid oxidation. Effects of a combination of CA and SL (CASL) on lipid metabolism were studied in vitro and in vivo. During 3T3-L1 differentiation, lipid accumulation was significantly lower in cells treated with CASL (50 mu mol/L, 1 mmol/L, 1 mu mol/L, and 1 mmol/L, respectively) compared with each alone. Lipolysis was also significantly greater in 3T3-L1 adipocytes treated with CASL (50 mu mol/L, I mmol/L, 10 mu mol/L and 0.5 mmol/L, respectively) compared with each alone. In addition, treatment with higher concentrations of CASL (2 mmol/L, 1 mmol/L, 10 mu mol/L, and 1 mmol/L, respectively) significantly enhanced beta-oxiclation in HepG2 cells. The effects of CASL-containing diets (250 mg, 6 g, 200 mg, and 1.5 g/kg diet, respectively) were studied in vivo. When KK mice were food deprived for 48 In and subsequently refed a fat-free diet for 72 h, hepatic triglyceride (TG) accumulation was significantly lower in mice fed CASL compared with the control mice. In addition, after obese KK mice were fed a low-fat diet for 2 wk, adipose tissue weights were significantly lower in those fed CASL, but not CA or SL alone, compared with the control mice. Plasma and liver TG levels were also lower in mice fed CASL than in the control mice. These results suggest that CASL is effective for controlling obesity.
C1 House Wellness Foods Corp, Dept Res & Dev, Itami, Hyogo 6640011, Japan.
   AmorePacific Corp, R&D Ctr, Yongin 449729, Gyeonggi Do, South Korea.
C3 Samsung
RP Murosaki, S (corresponding author), House Wellness Foods Corp, Dept Res & Dev, Itami, Hyogo 6640011, Japan.
EM Murosaki_Shinji@house-wf.co.jp
OI Lee, Tae Ryong/0000-0002-6914-1237
CR Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408
   DODD SL, 1993, SPORTS MED, V15, P14, DOI 10.2165/00007256-199315010-00003
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   HARPER AE, 1959, J NUTR, V68, P405, DOI 10.1093/jn/68.3.405
   Horowitz JF, 2000, AM J PHYSIOL-ENDOC M, V278, pE1144, DOI 10.1152/ajpendo.2000.278.6.E1144
   IRITANI N, 1986, J NUTR, V116, P190, DOI 10.1093/jn/116.2.190
   Jocken JWE, 2007, INT J OBESITY, V31, P813, DOI 10.1038/sj.ijo.0803499
   KALKHOFF RK, 1973, NEW ENGL J MED, V289, P465, DOI 10.1056/NEJM197308302890907
   Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011
   Koutsari C, 2006, J LIPID RES, V47, P1643, DOI 10.1194/jlr.R600011-JLR200
   Kuhajda FP, 2005, TRENDS PHARMACOL SCI, V26, P541, DOI 10.1016/j.tips.2005.09.002
   Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009
   Mannino DM, 2006, INT J OBESITY, V30, P6, DOI 10.1038/sj.ijo.0803145
   McCarthy MF, 2004, MED HYPOTHESES, V63, P1065, DOI 10.1016/j.mehy.2002.11.002
   Mittendorfer B, 2004, AM J PHYSIOL-ENDOC M, V286, pE354, DOI 10.1152/ajpendo.00301.2003
   Muroyama K, 2003, J NUTR SCI VITAMINOL, V49, P56, DOI 10.3177/jnsv.49.56
   Muroyama K, 2003, BIOSCI BIOTECH BIOCH, V67, P2325, DOI 10.1271/bbb.67.2325
   NURJHAN N, 1988, METABOLISM, V37, P386, DOI 10.1016/0026-0495(88)90140-0
   Park HyunWoo Park HyunWoo, 2006, Nutritional Sciences, V9, P179
   Parks EJ, 1999, J CLIN INVEST, V104, P1087, DOI 10.1172/JCI6572
   Schiffelers SLH, 2001, J CLIN ENDOCR METAB, V86, P2191, DOI 10.1210/jc.86.5.2191
   Shin ES, 2006, EUR J NUTR, V45, P159, DOI 10.1007/s00394-005-0576-5
   Shin ES, 2007, J NUTR, V137, P1127, DOI 10.1093/jn/137.5.1127
   Statnick M A, 2000, Int J Exp Diabetes Res, V1, P81, DOI 10.1155/EDR.2000.81
   Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899
   van Baak MA, 1999, INT J OBESITY, V23, pS11, DOI 10.1038/sj.ijo.0800879
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
NR 33
TC 49
Z9 56
U1 0
U2 8
PU AMER SOC NUTRITION-ASN
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD OCT
PY 2007
VL 137
IS 10
BP 2252
EP 2257
DI 10.1093/jn/137.10.2252
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 213XU
UT WOS:000249701400014
PM 17885007
OA Bronze
DA 2025-04-28
ER

PT J
AU Hughes, TA
   Stentz, F
   Gettys, T
   Smith, SR
AF Hughes, TA
   Stentz, F
   Gettys, T
   Smith, SR
TI Combining β-adrenergic and peroxisome proliferator-activated receptor 7
   stimulation improves lipoprotein composition in healthy moderately obese
   subjects
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
ID LOW-DENSITY-LIPOPROTEIN; GENE-EXPRESSION; PPAR-GAMMA; LIPASE ACTIVITY;
   HEPATIC LIPASE; SR-BI; RECEPTOR; PLASMA; METABOLISM; RAT
AB Current pharmacological regimens for hypertriglyceridemia and low high-density lipoprotein (HDL) are limited to the peroxisome proliferator-activated receptor (PPAR) alpha activating fibrates, niacin, and statins. This pilot study examined the impact of simultaneous stimulation of cyclic adenosine monophosphate with a beta-adrenergic agonist and PPAR gamma with pioglitazone (PIO) on lipoprotein composition in moderately obese, healthy subjects. Subjects were treated with PIO (45 mg) to stimulate PPAR or a combination of ephedrine (25 mg TID), a beta-agonist, with caffeine (200 mg TID), a phosphodiesterase inhibitor (ephedrine plus caffeine), or both for 16 weeks. Lipoproteins were separated by gradient ultracentrifugation into very low-density lipoprotein (VLDL), intermediate-density lipoprotein, low-density lipoprotein (LDL), and 3 HDL (L, M, and D) subfractions. Apolipoproteins were measured by high-performance liquid chromatography. PIO alone reduced the core triglyceride (TG) content relative to cholesterol ester (CE) in VLDL (-40%), IDL (-25%), and HDL-M (-38%). Ephedrine plus caffeine alone reduced LDL CE (-13%), phospholipids (-9%), and apolipoprotein (apo) B (-13%); increased HDL-M LpA-I (HDL containing apoA-I without apoA-II, 28%), CE/TG (23%), and CE/apoA-I (8%) while reducing apoA-II (-10%); and increased HDL-L LpA-I (29%). Combination therapy reduced total plasma TG (-28%), LDL cholesterol (LDL-C, -10%), apoB (-16%), apoB/apoA-I ratio (-21%) while increasing HDL cholesterol (HDL-C, 21%), total plasma apoA-I (12%), LpA-1 (43%), and apoC-I (26%). It also reduced VLDL total mass (-34%) and apoC-III (-39%), LDL CE (-13%), apoB (-13%), and total mass (-11%). Combination therapy increased HDL-L CE/TG (32%), apoC-I (30%), apoA-I (56%), and LpA-I (70%), as well as HDL-M CE (35%), phospholipids (24%), total mass (19%), apoC-I (25%), apoA-I (18%), and LpA-I (56%). In conclusion, simultaneous beta-adrenergic and PPAR gamma activation produced beneficial effects on VLDL, LDL, HDL-L, and HDL-M. Perhaps the most important impact of combination therapy was dramatic increases in LpA-I and apoC-I in HDL-L and HDL-M, which were much greater than the sum of the monotherapies. Because LpA-1 appears to be the most efficient mediator of reverse-cholesterol transport and a major negative risk factor for cardiovascular disease, this combination therapy may provide very effective treatment of atherosclerosis. (c) 2005 Elsevier Inc. All fights reserved.
C1 Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.
   Pennington Biomed Res Ctr, Mol Endocrinol Lab, Baton Rouge, LA 70808 USA.
   Pennington Biomed Res Ctr, Adipose Tissue Signaling Lab, Baton Rouge, LA 70808 USA.
C3 University of Tennessee System; University of Tennessee Health Science
   Center; Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Louisiana State University
   System; Louisiana State University; Pennington Biomedical Research
   Center
RP Hughes, TA (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.
EM thughes303@aol.com
OI Smith, Steven/0000-0002-5098-8147
FU NCRR NIH HHS [P20 RR021945] Funding Source: Medline; NIDDK NIH HHS [R01
   DK074772, P30 DK072476, R01 DK074772-01A1] Funding Source: Medline;
   NIGMS NIH HHS [P30 GM118430] Funding Source: Medline
CR AIRAYYES O, 1998, DIABETES, V47, P1193
   ARNER P, 1993, ARTERIOSCLER THROMB, V13, P967, DOI 10.1161/01.ATV.13.7.967
   Ballart X, 2003, BIOCHIMIE, V85, P971, DOI 10.1016/j.biochi.2003.09.001
   BJORNSSON OG, 1994, EUR J CLIN INVEST, V24, P137, DOI 10.1111/j.1365-2362.1994.tb00979.x
   Blaak EE, 2003, P NUTR SOC, V62, P753, DOI 10.1079/PNS2003290
   Boquist S, 1998, ATHEROSCLEROSIS, V137, P391, DOI 10.1016/S0021-9150(97)00278-5
   Conde-Knape K, 2002, J LIPID RES, V43, P2136, DOI 10.1194/jlr.M200210-JLR200
   de Beer MC, 2004, J LIPID RES, V45, P706, DOI 10.1194/jlr.M300417-JLR200
   DESHAIES Y, 1993, HORM METAB RES, V25, P13, DOI 10.1055/s-2007-1002036
   Duriez P, 1999, CLIN CHIM ACTA, V286, P97, DOI 10.1016/S0009-8981(99)00096-0
   Duvillard L, 2003, DIABETES CARE, V26, P1540, DOI 10.2337/diacare.26.5.1540
   EGUSA G, 1983, J LIPID RES, V24, P1261
   Fredenrich A, 1998, DIABETES METAB, V24, P490
   Gautier T, 2002, J BIOL CHEM, V277, P31354, DOI 10.1074/jbc.M203151200
   Gautier T, 2000, J BIOL CHEM, V275, P37504, DOI 10.1074/jbc.M007210200
   GOLDBERG RB, 2005, IN PRESS DIABETES CA
   Haidar B, 2002, J LIPID RES, V43, P2087, DOI 10.1194/jlr.M200235-JLR200
   Hodgkinson CP, 2003, BIOCHEM BIOPH RES CO, V308, P505, DOI 10.1016/S0006-291X(03)01416-5
   HOLMQUIST L, 1978, ANAL BIOCHEM, V88, P457, DOI 10.1016/0003-2697(78)90444-X
   Hsueh WA, 2001, ARTERIOSCL THROM VAS, V21, P1891, DOI 10.1161/hq1201.100261
   HUGHES TA, 1988, J LIPID RES, V29, P363
   HUGHES TA, 1991, THER DRUG MONIT, V13, P289, DOI 10.1097/00007691-199107000-00002
   Kageyama H, 2003, BIOCHEM BIOPH RES CO, V305, P22, DOI 10.1016/S0006-291X(03)00663-6
   Kuusela P, 1997, BIOCHEM J, V321, P759, DOI 10.1042/bj3210759
   Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291
   Lefebvre AM, 1997, ARTERIOSCL THROM VAS, V17, P1756, DOI 10.1161/01.ATV.17.9.1756
   Liu JQ, 2000, EUR J ENDOCRINOL, V142, P677, DOI 10.1530/eje.0.1420677
   Liu JW, 2000, J BIOL CHEM, V275, P5214, DOI 10.1074/jbc.275.7.5214
   Maki KC, 1996, METABOLISM, V45, P712, DOI 10.1016/S0026-0495(96)90136-5
   Neve BP, 1998, BIOCHEM J, V330, P701
   Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200
   RABKIN SW, 1994, HYPERTENSION, V24, P241, DOI 10.1161/01.HYP.24.2.241
   Rinninger F, 2003, ATHEROSCLEROSIS, V166, P31, DOI 10.1016/S0021-9150(02)00311-8
   SHEN MMS, 1981, J LIPID RES, V22, P236
   Tan MH, 2000, EXP CLIN ENDOCR DIAB, V108, pS224
NR 35
TC 10
Z9 12
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0026-0495
J9 METABOLISM
JI Metab.-Clin. Exp.
PD JAN
PY 2006
VL 55
IS 1
BP 26
EP 34
DI 10.1016/j.metabol.2005.06.022
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 995KE
UT WOS:000234098400005
PM 16324916
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Hussain, A
   Cho, JS
   Kim, JS
   Lee, YI
AF Hussain, Ahtesham
   Cho, Jin Sook
   Kim, Jong-Seok
   Lee, Young Ik
TI Protective Effects of Polyphenol Enriched Complex Plants Extract on
   Metabolic Dysfunctions Associated with Obesity and Related Nonalcoholic
   Fatty Liver Diseases in High Fat Diet-Induced C57BL/6 Mice
SO MOLECULES
LA English
DT Article
DE plants extract; Rubus crataegifolius; Crataegus pinnatifida Bunge;
   Cinnamomum cassia; obesity; metabolic dysfunctions; NAFLD; HFD-induced
   mouse model
AB Background: Currently, obesity is a global health challenge due to its increasing prevalence and associated health risk. It is associated with various metabolic diseases, including diabetes, hypertension, cardiovascular disease, stroke, certain forms of cancer, and non-alcoholic liver diseases (NAFLD). Objective: The aim of this study to evaluate the effects of polyphenol enriched herbal complex (Rubus crataegifolius/ellagic acid, Crataegus pinnatifida Bunge/vitexin, chlorogenic acid, Cinnamomum cassiaa/cinnamic acid) on obesity and obesity induced NAFLD in the high-fat diet (HFD)-induced obese mouse model. Methods: Obesity was induced in male C57BL/6 mice using HFD. After 8 weeks, the mice were treated with HFD+ plants extract for 8 weeks. Body weight, food intake weekly, and blood sugar level were measured. After sacrifice, changes in the treated group's liver weight, fat weight, serum biochemical parameters, hormone levels, and enzyme levels were measured. For histological analysis, tissues were stained with hematoxylin-eosin (H&E) and Oil Red-O. Results: Our results showed that the herbal complex ameliorated body weight and liver weight gain, and decreased total body fat in HFD-fed animals. Post prandial blood glucose (PBG) and fasting blood glucose (FBG) were lower in the herbal complex-treated group than in the HFD control group. Additionally, herbal formulation treatment significantly increased HDL levels in serum and decreased TC, TG, AST, ALT, deposition of fat droplets in the liver, and intima media thickness (IMT) in the aorta. Herbal complex increased serum adiponectin and decreased serum leptin. Herbal complex also increased carnitine palmityl transferase (CPT) activity and significantly decreased enzyme activity of beta-hydroxy beta methyl glutamyl-CoA (HMG-CoA) reductase, and fatty acid synthase (FAS). Conclusions: The results of this study demonstrated that the herbal complex is an effective herbal formulation in the attenuation of obesity and obesity-induced metabolic dysfunction including NAFLD in HFD-induced mouse model.
C1 [Hussain, Ahtesham; Cho, Jin Sook; Lee, Young Ik] Lees Biotech Co Ltd, 416,C Dong,17 Techno 4 Ro, Daejeon 34013, South Korea.
   [Kim, Jong-Seok] Konyang Univ, Myunggok Med Res Inst, Coll Med, Daejeon 35365, South Korea.
C3 Konyang University
RP Lee, YI (corresponding author), Lees Biotech Co Ltd, 416,C Dong,17 Techno 4 Ro, Daejeon 34013, South Korea.
EM ahtsham07@gmail.com; nabucco1@hanmail.net; jskim7488@konyang.ac.kr;
   yilee@kribb.re.kr
RI Lee, Su Hwan/R-6161-2019
OI kim, Jong-Seok/0000-0002-0998-5569; Hussain,
   Ahtesham/0000-0002-2524-5341
FU Small and Medium Business Administration and Lee's Biotech Company,
   Republic of Korea
FX This work was financially supported by Small and Medium Business
   Administration and Lee's Biotech Company, Republic of Korea. The role of
   founder were designing of the study, collection, selection of
   candidates, interpretation of data and revised the manuscript.
CR [Anonymous], 2015, J MED BIOENG, DOI DOI 10.12720/JOMB.4.5.342-349
   [Anonymous], 1991, CONSTITUENTS USES ME
   Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8
   Azab KS, 2011, ECOTOX ENVIRON SAFE, V74, P2324, DOI 10.1016/j.ecoenv.2011.06.016
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Chang Q, 2002, J CLIN PHARMACOL, V42, P605, DOI 10.1177/00970002042006003
   Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004
   Choe SS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00030
   Dahmer S, 2010, AM FAM PHYSICIAN, V81, P465
   Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88
   Han K, 2015, FOOD FUNCT, V6, P2684, DOI 10.1039/c5fo00232j
   Hoffman KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042866
   HULCHER FH, 1973, J LIPID RES, V14, P625
   Hussain A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165483
   Jeon SK, 2007, J LIFE SCI, V17, P1723
   Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324
   Jung KA, 2007, J MED FOOD, V10, P689, DOI 10.1089/jmf.2006.006
   Kim S, 2013, J ETHNOPHARMACOL, V146, P515, DOI 10.1016/j.jep.2013.01.016
   Kuo DH, 2009, J ETHNOPHARMACOL, V124, P544, DOI 10.1016/j.jep.2009.05.005
   Lee SC, 2013, J AGR FOOD CHEM, V61, P4905, DOI 10.1021/jf401039z
   Lee SJ, 2014, CLIN NUTR, V33, P973, DOI 10.1016/j.clnu.2013.12.006
   Lim JW, 2012, J AGR FOOD CHEM, V60, P5121, DOI 10.1021/jf205350k
   Luo M, 2016, J FOOD SCI, V81, pC1102, DOI 10.1111/1750-3841.13291
   Mang B, 2006, EUR J CLIN INVEST, V36, P340, DOI 10.1111/j.1365-2362.2006.01629.x
   Markwell M.A.K., 1973, ARCH BIOCH BIOPHYSIO, V176, P497
   Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004
   Moselhy SS, 2009, BIOL RES, V42, P93, DOI /S0716-97602009000100009
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Pichiah PBT, 2012, NUTR RES, V32, P856, DOI 10.1016/j.nutres.2012.09.015
   Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347
   Qian WB, 2016, YONAGO ACTA MED, V59, P149
   Qin B, 2004, HORM METAB RES, V36, P119, DOI 10.1055/s-2004-814223
   Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6
   Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178
   Shatwan IA, 2013, J MED FOOD, V16, P656, DOI 10.1089/jmf.2012.0083
   Vafa M, 2012, INT J PREVENTIVE MED, V3, P531
   Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086117
   Wang JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08391
   Wang XA, 2013, ENDOCRINOLOGY, V154, P685, DOI 10.1210/en.2012-1911
   Yoo JH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050283
NR 40
TC 19
Z9 20
U1 5
U2 34
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JAN
PY 2021
VL 26
IS 2
AR 302
DI 10.3390/molecules26020302
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA PX6HA
UT WOS:000611454000001
PM 33435558
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Yao, D
   Xie, LY
   Du, K
   Yao, XY
   Shen, XH
AF Yao, Die
   Xie, Luyao
   Du, Kun
   Yao, Xinyuan
   Shen, Xiuhua
TI Decaffeinated green tea polyphenols supplementation had no adverse
   health effects in girls with obesity: a randomized controlled trial
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE decaffeinated green tea polyphenols; safety; children; obesity;
   randomized controlled trial
ID CAFFEINE CONSUMPTION; BLACK TEA; WOMEN; EXERCISE
AB Background and Objectives: While the health promoting effects of green tea polyphenols have been identified among adult, research on children is scarce probably due to safety concerns about caffeine. This study aims to evaluate the safety of decaffeinated green tea polyphenols (DGTP) supplementation in girls with obesity and lay the foundation for its application in children population. Methods and Study Design: This 12 -week randomized, double -blinded, parallel -controlled trial was performed among 62 girls with obesity aged 6 to 10 years old. Participants were allocated to take 400 mg/d DGTP (DGTP group, n = 31) or isodose placebo (Control group, n = 31) at random. Anthropometric measurements and biochemical parameters including hepatic and renal function indicators, serum minerals concentrations, and routine blood parameters, were measured at baseline and the end of this trial. DGTP intake diary was required for each participant to record any abnormal reactions. Results: After the 12 -week supplementation, compared to Control group, the uric acid concentration in DGTP group showed a significant decrease (-48.0 +/- 83.2 vs -0.01 +/- 69.1, mu mol/L), within the normal range. Regarding other biochemical indicators, there were no significant differences in changed values between the two groups. Throughout the trial, no adverse effects were reported in either group. Conclusions: This study indicated that the supplementation of 400 mg/d DGTP for 12 weeks had no adverse health effects in girls with obesity, providing evidence for the DGTP adoption in children research.
C1 [Yao, Die; Xie, Luyao; Yao, Xinyuan; Shen, Xiuhua] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai, Peoples R China.
   [Yao, Die; Xie, Luyao; Yao, Xinyuan; Shen, Xiuhua] Shanghai Jiao Tong Univ, Coll Hlth Sci & Technol, Sch Med, Dept Clin Nutr, Shanghai, Peoples R China.
   [Du, Kun] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Clin Lab Med, Shanghai, Peoples R China.
   [Shen, Xiuhua] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Clin Nutr, R320,25 Bldg,1665 Kong Jiang Rd, Shanghai 200092, Peoples R China.
   [Shen, Xiuhua] Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai
   Jiao Tong University; Shanghai Jiao Tong University
RP Shen, XH (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Clin Nutr, R320,25 Bldg,1665 Kong Jiang Rd, Shanghai 200092, Peoples R China.
EM srachel@126.com
RI shen, Rachel/LCL-2708-2024; Xie, Luyao/HSD-1878-2023
CR [Anonymous], 2004, Chin J Epid, V25, P97, DOI [10.3760/j.issn:0254-6450.2004.02.003, DOI 10.3760/J.ISSN:0254-6450.2004.02.003]
   Bedrood Z, 2018, PHYTOTHER RES, V32, P1163, DOI 10.1002/ptr.6063
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   de Souza RFV, 2005, SPECTROCHIM ACTA A, V61, P1985, DOI 10.1016/j.saa.2004.07.029
   Fuzi SFA, 2017, AM J CLIN NUTR, V106, P1413, DOI 10.3945/ajcn.117.161364
   Hayat K, 2015, CRIT REV FOOD SCI, V55, P939, DOI 10.1080/10408398.2012.678949
   Henning SM, 2015, PROSTATE, V75, P550, DOI 10.1002/pros.22943
   Kanlaya R, 2019, ADV NUTR, V10, P112, DOI 10.1093/advances/nmy077
   Khan N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010039
   Kim EY, 2011, J AGR FOOD CHEM, V59, P3606, DOI 10.1021/jf104260j
   Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030
   Li F, 2018, EXPERT OPIN DRUG DIS, V13, P643, DOI 10.1080/17460441.2018.1465923
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Miyata Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24010193
   Neyestani TR, 2022, NUTR METAB CARDIOVAS, V32, P2026, DOI 10.1016/j.numecd.2022.05.021
   Pang J, 2016, INT J CARDIOL, V202, P967, DOI 10.1016/j.ijcard.2014.12.176
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Prasanth MI, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020474
   Record IR, 1996, BIOL TRACE ELEM RES, V53, P27, DOI 10.1007/BF02784542
   Richards G, 2015, J PSYCHOPHARMACOL, V29, P1236, DOI 10.1177/0269881115612404
   Saeed M, 2017, BIOMED PHARMACOTHER, V95, P1260, DOI 10.1016/j.biopha.2017.09.024
   Samavat H, 2016, AM J CLIN NUTR, V104, P1671, DOI 10.3945/ajcn.116.137075
   Turley KR, 2007, PEDIATR EXERC SCI, V19, P481, DOI 10.1123/pes.19.4.481
   Wang DX, 2019, FOOD FUNCT, V10, P3898, DOI [10.1039/c9fo00572b, 10.1039/C9FO00572B]
   Watson EJ, 2017, J CLIN SLEEP MED, V13, P533, DOI 10.5664/jcsm.6536
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Xie LY, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.736724
   Xing LJ, 2019, J AGR FOOD CHEM, V67, P1029, DOI 10.1021/acs.jafc.8b06146
   Zhao HX, 2015, RADIOTHER ONCOL, V114, P351, DOI 10.1016/j.radonc.2015.02.014
NR 30
TC 2
Z9 2
U1 5
U2 7
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI MCKINNON
PA PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA
SN 0964-7058
EI 1440-6047
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PD MAR
PY 2024
VL 33
IS 1
BP 111
EP 117
DI 10.6133/apjcn.202403_33(1).0012
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA LQ4G9
UT WOS:001188249400011
PM 38494693
DA 2025-04-28
ER

PT J
AU Al-Basher, GI
   Aljabal, H
   Almeer, RS
   Allam, AA
   Mahmoud, AM
AF Al-Basher, Gadh I.
   Aljabal, Hanan
   Almeer, Rafa S.
   Allam, Ahmed A.
   Mahmoud, Ayman M.
TI Perinatal exposure to energy drink induces oxidative damage in the
   liver, kidney and brain, and behavioral alterations in mice offspring
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Energy drinks; Oxidative stress; Liver injury; Caffeine; Taurine
ID CAFFEINE CONSUMPTION; RED-BULL; STRESS; TAURINE; ANXIETY; HEALTH;
   PERFORMANCE; OBESE; RISK
AB The worldwide consumption of energy drinks (EDs) has increased in recent years. EDs have several side effects and can be linked to liver injury, kidney damage and risk-seeking behavior. The impact of perinatal consumption of EDs on the newborns has not been previously investigated. In this study, we evaluated the effects of perinatal exposure to a caffeinated ED on the liver, kidney, brain, locomotor activity and anxiety in mice newborns. Pregnant mice received 2.5 or 5 ml ED by oral gavage from the first day of pregnancy until day 15 after birth. Perinatal exposure to the ED induced a significant increase in lipid peroxidation and declined antioxidant defenses in the liver, kidney, cerebrum, cerebellum and medulla oblongata of the newborns at days 21 and 35 after birth. ED induced several histological alterations, including vacuolations and lipid infiltration of hepatocytes, developing and degenerated glomeruli and dilated urinary spaces in the renal cortex, pyknosis and chromatolysis of the cerebral and medullary neurons, and degenerated and abnormal Purkinje cells in the cerebellum. In addition, ED increased the locomotion and induced anxiety-like behavior in mice newborns. In conclusion, perinatal exposure to EDs induces oxidative stress, tissue injury and behavioral alterations in the mice newborns. Therefore, the consumption of EDs during pregnancy and lactation has a negative impact on the newborns and should be treated as a significant health problem that warrants attention.
C1 [Al-Basher, Gadh I.; Aljabal, Hanan; Almeer, Rafa S.] King Saud Univ, Zool Dept, Coll Sci, Riyadh, Saudi Arabia.
   [Allam, Ahmed A.; Mahmoud, Ayman M.] Beni Suef Univ, Zool Dept, Fac Sci, Bani Suwayf, Egypt.
C3 King Saud University; Egyptian Knowledge Bank (EKB); Beni Suef
   University
RP Mahmoud, AM (corresponding author), Beni Suef Univ, Physiol Div, Zool Dept, Fac Sci, Salah Salim St, Bani Suwayf 62514, Egypt.
EM ayman.mahmoud@science.bsu.edu.eg
RI Allam, Ahmed/AAE-6047-2022; Mahmoud, Ayman/S-2613-2016; Allam,
   Ahmed/K-9931-2017
OI Mahmoud, Ayman/0000-0003-0279-6500; Allam, Ahmed/0000-0003-0702-8025
FU Deanship of Scientific Research at King Saud University, College of
   Science Research Center
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at King Saud University, College of
   Science Research Center for its funding of this research.
CR a. N. I. o. D. a. D. a. K. D United States National Library of Medicine, 2017, LIVERTOX CLIN RES IN
   Abd El-Twab SM, 2016, CAN J PHYSIOL PHARM, V94, P651, DOI 10.1139/cjpp-2015-0503
   Abreu RV, 2011, PHARMACOL BIOCHEM BE, V99, P659, DOI 10.1016/j.pbb.2011.06.010
   Abu-Taweel GM, 2012, INDIAN J EXP BIOL, V50, P696
   Ajarem JS, 1998, PHARMACOL BIOCHEM BE, V59, P313, DOI 10.1016/S0091-3057(97)00408-5
   Al-Shaar L, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00225
   Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Bichler A, 2006, AMINO ACIDS, V31, P471, DOI 10.1007/s00726-005-0302-x
   Bouayed J, 2009, OXID MED CELL LONGEV, V2, P63, DOI 10.4161/oxim.2.2.7944
   Buege J A, 1978, Methods Enzymol, V52, P302
   Childs E, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12148
   COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7
   Díaz A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8725354
   Grasser EK, 2014, EUR J NUTR, V53, P1561, DOI 10.1007/s00394-014-0661-8
   Greene E, 2014, ANN PHARMACOTHER, V48, P1366, DOI 10.1177/1060028014541997
   Harb Jennifer Nicole, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-216612
   Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x
   Holubcikova J, 2017, EUR J PEDIATR, V176, P599, DOI 10.1007/s00431-017-2881-4
   Howard MA, 2010, EXP CLIN PSYCHOPHARM, V18, P553, DOI 10.1037/a0021740
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Khayyat L., 2014, LIFE SCI J, V11, P1131
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Marshall TA, 2003, PEDIATRICS, V112, pE184, DOI 10.1542/peds.112.3.e184
   Noschang CG, 2009, NEUROCHEM RES, V34, P1568, DOI 10.1007/s11064-009-9945-4
   Oliveira MWS, 2010, PHARMACOL REP, V62, P185, DOI 10.1016/S1734-1140(10)70256-5
   Pennay Amy, 2012, BMC Res Notes, V5, P369, DOI 10.1186/1756-0500-5-369
   Reis R, 2017, J FOOD SCI, V82, P1037, DOI 10.1111/1750-3841.13662
   Richards Gareth, 2016, Journal of Caffeine Research, V6, P49, DOI 10.1089/jcr.2015.0033
   Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006
   Schöffl I, 2011, PEDIATRICS, V128, pE227, DOI 10.1542/peds.2010-2677
   Seifert SM, 2013, CLIN TOXICOL, V51, P566, DOI 10.3109/15563650.2013.820310
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Souza DB, 2017, EUR J NUTR, V56, P13, DOI 10.1007/s00394-016-1331-9
   Tofovic SP, 2002, KIDNEY INT, V61, P1433, DOI 10.1046/j.1523-1755.2002.00278.x
   Tofovic SP, 2007, RENAL FAILURE, V29, P891, DOI 10.1080/08860220701569846
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Valle M. T. C., 2017, EUR J NUTR, DOI [10.1007/s00394-00017-01522-z, DOI 10.1007/S00394-00017-01522-Z]
   Vivekanandarajah Abhirami, 2011, J Med Case Rep, V5, P227, DOI 10.1186/1752-1947-5-227
   Wall PM, 2001, NEUROSCI BIOBEHAV R, V25, P275, DOI 10.1016/S0149-7634(01)00013-6
   Zeidán-Chuliá F, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/791795
NR 41
TC 17
Z9 18
U1 4
U2 17
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUN
PY 2018
VL 102
BP 798
EP 811
DI 10.1016/j.biopha.2018.03.139
PG 14
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA GG3HV
UT WOS:000432583800093
PM 29605768
DA 2025-04-28
ER

PT J
AU Yen, C
   Huang, YL
   Chung, M
   Chen, YC
AF Yen, Chieh
   Huang, Ya-Li
   Chung, Mei
   Chen, Yi-Chun
TI Sugar Content and Warning Criteria Evaluation for Popular
   Sugar-Sweetened Beverages in Taipei, Taiwan
SO NUTRIENTS
LA English
DT Article
DE sugar-sweetened beverage; energy; sugar content; Chilean warning label
   system; WHO guideline
ID SERVING SIZE; PROCESSED FOODS; DAIRY FOODS; CONSUMPTION; OBESITY;
   COFFEE; ADOLESCENTS; CHILDRENS; DISEASE; HEALTH
AB Sugar intake may increase the risk of obesity, cardiovascular disease, diabetes, and dental caries. In Taiwan, people frequently consume sugar-sweetened beverages (SSBs). This study explored the energy and sugar content of Taiwanese SSBs and evaluated them using the Chilean warning label system (>70 kcal/100 mL and >5 g sugar/100 mL) and the World Health Organization (WHO) sugar guideline (<= 25 g sugar). A total of 341 SSBs with volumes <= 600 mL were analyzed. No significant differences were observed in sugar per serving among different types of SSBs, but a great variation in portion size (i.e., package size for individual consumption) was noted. The energy and sugar ratios per serving were lower in soft drinks and coffee and tea containing >1 serving than in those containing only one serving. The calorie and sugar ratios per portion were higher in all types of SSBs containing >1 serving per portion than in those containing exactly one serving. Approximately 70.0% of Taiwanese SSBs were classified as high sugar according to the Chilean criteria, and 41.6% of SSBs exceeded the WHO guideline. Moreover, 40.8% of SSBs that were not considered as high sugar according to the Chilean criteria contained >25 g sugar per portion. For individual consumption, it is more clear that nutrition labeling is based on portion rather than serving. Evaluating SSBs on sugar/portion rather than sugar/100 mL will help consumers make better choices.
C1 [Yen, Chieh; Chen, Yi-Chun] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei 110, Taiwan.
   [Yen, Chieh] Far Eastern Mem Hosp, Nutr Div, New Taipei 220, Taiwan.
   [Huang, Ya-Li] Taipei Med Univ, Sch Med, Coll Med, Dept Publ Hlth, Taipei 110, Taiwan.
   [Huang, Ya-Li] Taipei Med Univ, Coll Publ Hlth, Sch Publ Hlth, Taipei 110, Taiwan.
   [Chung, Mei] Tuft Univ, Friedman Sch Nutr Sci & Policy, Medford, MA 02115 USA.
C3 Taipei Medical University; Far Eastern Memorial Hospital; Taipei Medical
   University; Taipei Medical University
RP Chen, YC (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei 110, Taiwan.
EM yichun@tmu.edu.tw
RI Chen, Chun-Jung/A-6880-2011; Huang, yali/GWR-3654-2022
OI Chung, Mei/0000-0002-5583-2870; Chen, Yi Chun/0000-0002-6930-1712
FU Ministry of Science and Technology; MOST [107-2511-H-038-001-MY2, MOST
   110-2511-H-038-001]
FX This work was supported by the Ministry of Science and Technology (grant
   no. MOST 107-2511-H-038-001-MY2 and no. MOST 110-2511-H-038-001).
CR Almiron-Roig E, 2020, NUTR REV, V78, P91, DOI 10.1093/nutrit/nuz047
   [Anonymous], 1996, MIN HLTH AM SUPR DEC
   [Anonymous], 2015, TECHN M NUTR LAB PRO
   Ashdown-Franks G, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0796-3
   Auerbach BJ, 2018, ADV NUTR, V9, P78, DOI 10.1093/advances/nmx006
   Australian Bureau of Statistics, 2015, NUTR 1 RES FOOD NUTR
   Brownbill AL, 2018, PUBLIC HEALTH NUTR, V21, P3335, DOI 10.1017/S1368980018002392
   bsmi, MINISTRY EC AFFAIRS
   Chen MC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010174
   Chepulis L, 2018, PUBLIC HEALTH NUTR, V21, P2507, DOI 10.1017/S1368980017004128
   Chepulis L, 2017, AUST NZ J PUBL HEAL, V41, P321, DOI 10.1111/1753-6405.12638
   Collin LJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3121
   Comerford KB, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.671999
   Corvalán C, 2019, OBES REV, V20, P367, DOI 10.1111/obr.12802
   Crino M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090983
   D'Elia L, 2021, EUR J NUTR, V60, P2449, DOI 10.1007/s00394-020-02426-7
   Department of Health, HLTH STAR RAT STY GU
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Elwood PC, 2010, LIPIDS, V45, P925, DOI 10.1007/s11745-010-3412-5
   Essman M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111767
   European Food Information Council, GLOBL UPD NUTR LAB
   fda, MINISTRY HLTH WELFAR
   Global Food Research Program, U N CAR CHAP HILL FR
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Guasch-Ferré M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3109
   Guelinckx I, 2015, EUR J NUTR, V54, P69, DOI 10.1007/s00394-015-0955-5
   Hashem KM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010874
   Haskelberg H, 2016, BRIT J NUTR, V115, P1810, DOI 10.1017/S0007114516000799
   Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1
   Health Canada, FOOD LAB CHANG
   Heyman MB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0967
   hpa, MINISTRY HLTH WELFAR
   Jacobs A., SWEEPING WAR OBESITY
   Kanter R, 2019, OBES REV, V20, P129, DOI 10.1111/obr.12870
   Khan N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010039
   Khandpur N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060688
   leginfo, CALIFORNIA STATE LEG
   Lythgoe A, 2013, PUBLIC HEALTH NUTR, V16, P2221, DOI 10.1017/S1368980013000943
   Mahato DK, 2020, FOODS, V9, DOI 10.3390/foods9101400
   Mhurchu CN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080918
   Ministry of Health and Welfare, REC FOOD SERV SIZ
   Ministry of Health and Welfare, 2019, Act governing food safety and sanitation
   Ministry of Health and Welfare, NUTR HLTH SURV TAIW
   moea, MINISTRY EC AFFAIRS
   Morrison H, 2019, NUTR DIET, V76, P296, DOI 10.1111/1747-0080.12486
   Mozaffarian D, 2018, CIRC RES, V122, P369, DOI 10.1161/CIRCRESAHA.117.309008
   Ng SW, 2017, AM J CLIN NUTR, V106, P179, DOI 10.3945/ajcn.117.153858
   Nilson EAF, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070742
   Özen AE, 2015, J HUM NUTR DIET, V28, P417, DOI 10.1111/jhn.12250
   Paraje G, 2021, FOOD POLICY, V100, DOI 10.1016/j.foodpol.2020.102016
   Parker CE, 2012, NUTRIENTS, V4, P1794, DOI 10.3390/nu4121794
   Patel AI, 2018, PREV MED, V111, P151, DOI 10.1016/j.ypmed.2018.02.031
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Reyes M, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003220
   Rippin HL, 2019, APPETITE, V134, P193, DOI 10.1016/j.appet.2018.12.018
   Roberto CA, 2014, INT J OBESITY, V38, pS25, DOI 10.1038/ijo.2014.86
   Scarborough P, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003025
   Scrinis G, 2018, PUBLIC HEALTH NUTR, V21, P247, DOI 10.1017/S1368980017001392
   Shih YH, 2020, J NUTR SCI, V9, DOI 10.1017/jns.2020.2
   Shih YH, 2019, ASIA PAC J CLIN NUTR, V28, P371, DOI 10.6133/apjcn.201906_28(2).0020
   Sim J, 2005, PHYS THER, V85, P257
   Smith NR, 2020, AM J PREV MED, V59, pE135, DOI 10.1016/j.amepre.2020.02.021
   Taillie LS, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020569
   Tedstone A., 2015, CARB HLTH
   Thomson RK, 2016, PUBLIC HEALTH NUTR, V19, P2949, DOI 10.1017/S1368980016001208
   Turck D, 2022, EFSA J, V20, DOI 10.2903/j.efsa.2022.7074
   U.S. Food & Drug Administration, CHANG NUTR FACTS LAB
   Vanderlee L, 2012, CAN J PUBLIC HEALTH, V103, pE327, DOI 10.1007/BF03404435
   Vyth EL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-65
   Wartella E., 2010, Front-of-Package Nutrition Rating Systems and Symbols: Phase I Report, DOI DOI 10.17226/12957
   Wen J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124297
   WHO Guideline, SUG INT AD CHILDR
   World Cancer Research Fund International, 2022, NOURISHING Policy Database: Nutrition label standards and regulations on the use of claims and implied claims on food
   Yi MS, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900389
   Zhang YT, 2016, AM J HEALTH PROMOT, V30, P181, DOI 10.4278/ajhp.130117-QUAN-30
NR 75
TC 4
Z9 4
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2022
VL 14
IS 16
AR 3339
DI 10.3390/nu14163339
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 4B5FZ
UT WOS:000845804400001
PM 36014844
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Myszkowska-Ryciak, J
   Harton, A
AF Myszkowska-Ryciak, Joanna
   Harton, Anna
TI Do Preschools Offer Healthy Beverages to Children? A Nationwide Study in
   Poland
SO NUTRIENTS
LA English
DT Article
DE preschool; nutrition recommendation; beverages; sugars; dietary
   prevention; preschool children
ID SUGAR-SWEETENED BEVERAGES; ADULT METABOLIC SYNDROME; CHILDHOOD OBESITY;
   CARE CENTERS; BODY-WEIGHT; NUTRITION PRACTICES; DRINK CONSUMPTION;
   VITAMIN-C; ADOLESCENTS; CALCIUM
AB Background: Children's beverage consumption patterns have received increased attention in light of the obesity epidemic in this group. In day care centers (DCCs), children spend up to 10 h a day, and typically consume half to three quarters of their daily food intake. The purpose of the study was to investigate what beverages are typically served to children in preschools in Poland, and to evaluate the practices associated with adding sugar and other sweetening agents to beverages. Methods: Direct interviews with preschools staff were conducted with a questionnaire regarding offered beverages and adding sugar and other sweetening agents. The menu of 10 consecutive days and inventory reports were analyzed to verify information. Results: A total of 720 preschools were included in the study. Cocoa and milk coffee substitute were served in 95% of preschools, followed by compote (92%), tea (84%), fruit/herbal tea (73%) and water (69%). Water was the only beverage available between meals (93% DCCs). 86% of preschools added sugar to tea/cocoa/coffee substitute drinks, and 74% to compote. Conclusions: In the majority of preschools, beverages which are not recommended were offered. Such an assortment of beverages and common practice of sweetening can increase the amount of added sugar in a children diet. Nutrition education and legal regulations concerning the assortment of beverages served in preschools are urgently needed.
C1 [Myszkowska-Ryciak, Joanna; Harton, Anna] WULS, Dept Dietet, Fac Human Nutr & Consumer Sci, 159C Nowoursynowska Str, PL-02776 Warsaw, Poland.
C3 Warsaw University of Life Sciences
RP Myszkowska-Ryciak, J (corresponding author), WULS, Dept Dietet, Fac Human Nutr & Consumer Sci, 159C Nowoursynowska Str, PL-02776 Warsaw, Poland.
EM joanna_myszkowska_ryciak@sggw.pl; anna_harton@sggw.pl
RI Harton, Anna/AAB-5994-2019; Myszkowska-Ryciak, Joanna/U-8478-2019
OI Myszkowska-Ryciak, Joanna/0000-0001-7167-1993; Harton,
   Anna/0000-0001-5805-6996
FU Danone Ecosysteme research and education grant
FX This research was financed by Danone Ecosysteme research and education
   grant within the program Eating healthy, growing healthy. The authors of
   this publication want to express their gratitude to the Nutricia
   Foundation and partners of Eating healthy, growing healthy program: The
   Comenius Foundation for Child Development, The Institute of Mother and
   Child, The Academic Business Incubators and Educators involved in the
   project.
CR [Anonymous], 2015, USDA NAT NUTR DAT ST
   [Anonymous], 2005, J AM DIET ASSOC, V105, P970
   [Anonymous], PROBL HIG EPIDEMIOL
   Ball SC, 2008, J AM DIET ASSOC, V108, P718, DOI 10.1016/j.jada.2008.01.014
   Benton D, 2004, INT J OBESITY, V28, P858, DOI 10.1038/sj.ijo.0802532
   Bertenshaw EJ, 2008, PHYSIOL BEHAV, V93, P427, DOI 10.1016/j.physbeh.2007.09.014
   Bes-Rastrollo M, 2016, OBESITY, V24, P1410, DOI 10.1002/oby.21535
   Briefel RR, 2013, J ACAD NUTR DIET, V113, P269, DOI 10.1016/j.jand.2012.10.016
   Centers for Disease Control and Pre- vention, 2014, INCR ACC DRINK WAT O
   Copeland KA, 2013, CHILD OBES, V9, P223, DOI 10.1089/chi.2012.0138
   Cunningham SA, 2014, NEW ENGL J MED, V370, P1660, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]
   Daniels MC, 2010, NUTR REV, V68, P505, DOI 10.1111/j.1753-4887.2010.00311.x
   de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786
   DeBoer MD, 2013, PEDIATRICS, V132, P413, DOI 10.1542/peds.2013-0570
   Dev DA, 2013, J ACAD NUTR DIET, V113, P1346, DOI 10.1016/j.jand.2013.05.023
   Dunford LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186
   Erinosho T, 2011, J AM DIET ASSOC, V111, P1391, DOI 10.1016/j.jada.2011.06.001
   Farhat AG, 2010, NUTR FOOD SCI, V40, P504, DOI 10.1108/00346651011077018
   Feldens CA, 2007, COMMUNITY DENT ORAL, V35, P215, DOI 10.1111/j.1600-0528.2006.00337.x
   Fijakowska A., 2017, COSI STUD P C RED CH
   Fisher JO, 2004, AM J CLIN NUTR, V79, P698
   Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662
   Heyman MB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0967
   Ismail AI, 2009, J DENT RES, V88, P270, DOI 10.1177/0022034508331011
   Jimenez-Cruz A, 2010, ASIA PAC J CLIN NUTR, V19, P316
   Jones RE, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00058
   Katzmarzyk PT, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120770
   Kedzior A, 2017, ENDOKRYNOL PED, V1, P41, DOI DOI 10.18544/EP-01.16.01.1662
   Keller A, 2015, CHILD OBES, V11, P338, DOI 10.1089/chi.2014.0117
   Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151
   Kunachowicz H., 2005, DATA BASE TABLES NUT
   Larson N, 2011, J AM DIET ASSOC, V111, P1343, DOI 10.1016/j.jada.2011.06.007
   Le Bodo Y., 2016, Em Taxing Soda for Public Health, P35, DOI [10.1007/978-3-319-33648-0_2, DOI 10.1007/978-3-319-33648-0_2]
   Libuda L, 2009, CURR OPIN CLIN NUTR, V12, P596, DOI 10.1097/MCO.0b013e32833189f6
   Maalouf J, 2013, CHILD OBES, V9, P437, DOI 10.1089/chi.2013.0018
   Marcinek Katarzyna, 2016, Rocz Panstw Zakl Hig, V67, P169
   McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855
   Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88
   Merkiel S, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0050-4
   Mrdjenovic G, 2003, J PEDIATR-US, V142, P604, DOI 10.1067/mpd.2003.200
   Neelon SEB, 2013, PUBLIC HEALTH NUTR, V16, P2014, DOI 10.1017/S1368980012004387
   Neelon SEB, 2010, J AM DIET ASSOC, V110, P1890, DOI 10.1016/j.jada.2010.09.012
   Nelson M, 2004, J HUM NUTR DIET, V17, P43, DOI 10.1046/j.1365-277X.2003.00497.x
   Nicklas TA, 2009, J AM COLL NUTR, V28, p73S, DOI 10.1080/07315724.2009.10719807
   Orkusz A., 2014, Nauki Inz Technol, V1, P72, DOI DOI 10.15611/nit.2014.1.05
   Patel AI, 2011, AM J PUBLIC HEALTH, V101, P1370, DOI 10.2105/AJPH.2011.300142
   Pérez-Morales E, 2013, NUTR HOSP, V28, P47, DOI 10.3305/nh.2013.28.1.6247
   Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007
   Salamoun MM, 2005, EUR J CLIN NUTR, V59, P177, DOI 10.1038/sj.ejcn.1602056
   Sisson SB, 2012, J ACAD NUTR DIET, V112, P1230, DOI 10.1016/j.jand.2012.05.009
   Skinner JD, 2002, J NUTR EDUC BEHAV, V34, P310, DOI 10.1016/S1499-4046(06)60113-9
   Sun SS, 2008, J PEDIATR-US, V152, P191, DOI 10.1016/j.jpeds.2007.07.055
   US Department of Health and Human Services and US Department of Agriculture, 2015 2020 DIET GUID
   Van Lippevelde W, 2013, APPETITE, V61, P59, DOI 10.1016/j.appet.2012.10.019
   Wardle J, 2008, BRIT J NUTR, V99, pS15, DOI 10.1017/S000711450889246X
   Watt RG, 2000, J HUM NUTR DIET, V13, P13, DOI 10.1046/j.1365-277X.2000.00212.x
   World Health Organization, 2016, CONS EV CHILDH OB CO
   World Health Organization (WHO), 2015, Guideline: Sugars Intake for Adults and Children
   Zijp IM, 2000, CRIT REV FOOD SCI, V40, P371, DOI 10.1080/10408690091189194
NR 59
TC 9
Z9 9
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2017
VL 9
IS 11
AR 1167
DI 10.3390/nu9111167
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FO1TH
UT WOS:000416547200005
PM 29072604
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Sung, YY
   Kim, DS
   Kim, HK
AF Sung, Yoon-Young
   Kim, Dong-Seon
   Kim, Ho Kyoung
TI Akebia quinata extract exerts anti-obesity and hypolipidemic effects in
   high-fat diet-fed mice and 3T3-L1 adipocytes
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Adipogenesis; Adipose tissue; Akebia quinata; AMP-activated protein
   kinase; Fatty acid oxidation
ID ACTIVATED PROTEIN-KINASE; INDUCED OBESITY; ADIPOSE-TISSUE;
   ENERGY-BALANCE; WHITE ADIPOSE; PPAR-ALPHA; EXPRESSION; ADIPONECTIN;
   METABOLISM; MASS
AB Ethnopharmacological relevance: The dry ripe fruit of the Akebia quinata (A. quinata) plant is used as an analgesic, an antiphlogistic, and a diuretic in traditional medicine. A. quinata has also been used in Korea as a crude drug for treating obesity. The aim of the study was to determine the anti-obesity and hypolipidemic effects of A. quinata extract (AQE) in mice consuming a high-fat diet and in 3T3-L1 adipocytes.
   Materials and methods: We measured obesity-related physiological parameters, gene expression, and protein phosphorylation in mice consuming a high-fat diet supplemented with AQE (400 mg/kg/day) for 6.5 weeks.
   Results: AQE reduced gain in body weight, adipose tissue weight, and serum lipid levels in mice consuming a high-fat diet. AQE supplementation reduced expression of genes related to adipogenesis and increased expression of PPAR alpha, acetyl-CoA oxidase, and adiponectin in the epididymal adipose tissue. Furthermore, AQE increased phospholylation of adenosine monophosphate-activated protein kinase (AMPK) and acetyl-CoA carboxylase, both of which are related to fatty acid oxidation, in vivo. HPLC analysis revealed that AQE contained chlorogenic acid, isochlorogenic acid A, and isochlorogenic acid C. AQE and all of these constituents inhibited differentiation of 3T3-L1 cells and enhanced AMPK phosphorylation.
   Conclusions: These results suggest the AQE exerted anti-obesity and hypolipidemic effects in mice consuming a high-fat diet by regulating adipogenesis and fatty acid oxidation via AMPK activation. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Sung, Yoon-Young; Kim, Ho Kyoung] Korea Inst Oriental Med, Mibyeong Res Ctr, Taejon 305811, South Korea.
   [Kim, Dong-Seon] Korea Inst Oriental Med, KM Convergence Res Div, Taejon 305811, South Korea.
C3 Korea Institute of Oriental Medicine (KIOM); Korea Institute of Oriental
   Medicine (KIOM)
RP Kim, HK (corresponding author), Korea Inst Oriental Med, Mibyeong Res Ctr, 1672 Yuseong Daero, Taejon 305811, South Korea.
EM yysung@kiom.re.kr; dskim@kiom.re.kr; hkkim@kiom.re.kr
FU Korea Institute of Oriental Medicine, South Korea [K15200]; National
   Research Foundation (NRF) - Ministry of Science, ICT & Future Planning,
   South Korea [NRF-2014M3A9D7034335]
FX This research was supported by the research program of Korea Institute
   of Oriental Medicine, South Korea (K15200). This research was also
   supported by the Bio & Medical Technology Development Program of the
   National Research Foundation (NRF) funded by the Ministry of Science,
   ICT & Future Planning, South Korea (NRF-2014M3A9D7034335).
CR [Anonymous], KOREAN J LAB ANIMAL
   [Anonymous], J KOREAN MED
   Arçari DP, 2013, FOOD CHEM, V141, P809, DOI 10.1016/j.foodchem.2013.04.062
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Bray G A, 2001, Rev Endocr Metab Disord, V2, P403, DOI 10.1023/A:1011808701117
   Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi HJ, 2007, BIOCHEM BIOPH RES CO, V359, P419, DOI 10.1016/j.bbrc.2007.05.107
   Choi J, 2005, J MED FOOD, V8, P78, DOI 10.1089/jmf.2005.8.78
   Dulloo AG, 2004, PHYSIOL BEHAV, V83, P587, DOI 10.1016/j.physbeh.2004.07.028
   Fasshauer M, 2003, DIABETOLOGIA, V46, P1594, DOI 10.1007/s00125-003-1228-z
   Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116
   전용섭, 2014, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V43, P200
   Hsu CY, 2007, BIOL RES, V40, P13
   Hsu SC, 2006, J NUTR, V136, P1779, DOI 10.1093/jn/136.7.1779
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kawata Jyunichi, 2007, J Oleo Sci, V56, P59
   Kim SK, 2010, CHEM-BIOL INTERACT, V186, P24, DOI 10.1016/j.cbi.2010.04.003
   Kim SJ, 2008, BIOL PHARM BULL, V31, P1415, DOI 10.1248/bpb.31.1415
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899
   Lei F, 2007, INT J OBESITY, V31, P1023, DOI 10.1038/sj.ijo.0803502
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Rim A-Ram, 2006, Preventive Nutrition and Food Science, V11, P84
   Rohrer J., 2007, BMC HEALTH SERV RES, V7, P1
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Schnell MA, 2002, HUM GENE THER, V13, P155, DOI 10.1089/10430340152712700
   Song MY, 2009, J MED FOOD, V12, P304, DOI 10.1089/jmf.2008.1010
   Sung YY, 2011, MOL MED REP, V4, P431, DOI 10.3892/mmr.2011.451
   Tang W, 1992, CHINESE DRUGS PLANT, P59
   Tzeng TF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/781812
   Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355
   Yamamoto Y, 2002, CLIN SCI, V103, P137, DOI 10.1042/CS20010336
   Zhou Y, 2009, BIOL PHARM BULL, V32, P993, DOI 10.1248/bpb.32.993
NR 35
TC 41
Z9 44
U1 2
U2 49
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JUN 20
PY 2015
VL 168
BP 17
EP 24
DI 10.1016/j.jep.2015.03.051
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA CK9JG
UT WOS:000356555800002
PM 25835369
DA 2025-04-28
ER

PT J
AU Jones-Smith, JC
   Walkinshaw, LP
   Oddo, VM
   Knox, M
   Neuhouser, ML
   Hurvitz, PM
   Saelens, BE
   Chan, N
AF Jones-Smith, Jessica C.
   Walkinshaw, Lina Pinero
   Oddo, Vanessa M.
   Knox, Melissa
   Neuhouser, Marian L.
   Hurvitz, Philip M.
   Saelens, Brian E.
   Chan, Nadine
TI Impact of a sweetened beverage tax on beverage prices in Seattle, WA
SO ECONOMICS & HUMAN BIOLOGY
LA English
DT Article
DE Soda taxes; Food policy; Health policy; Beverage taxes; Obesity
ID RETAIL-PRICES; BERKELEY; FOOD
AB Seattle's Sweetened Beverage Tax is an excise tax of 1.75 cents per ounce on sugar-sweetened beverages and is one of the highest beverage taxes in the U.S. This study examined the impact of Seattle's tax on the prices of beverages. We conducted audits of 407 retail food stores and eating places (quick service restaurants and coffee shops) before and 6 months after the tax was implemented in Seattle and in a comparison area. Ordinary least squares difference-in-differences models with store fixed effects were used to estimate the effect of the tax on prices, stratified by beverage type and store type. In secondary analyses, we assessed the effect of the tax on the price of non-taxed beverages and foods. Results from the adjusted difference-in-differences models indicated the tax was associated with an average increase of 1.58 cents per ounce among Seattle retailers, representing 90 % of the price of the tax. By store type, price increases were highest in smaller grocery stores and drug stores. By beverage type, price increases were highest for energy beverages and soda and lowest for bottled coffee and juice drinks. Prices of some nontaxed beverages also increased while the prices of select healthy foods generally did not. The sweetened beverage tax in Seattle is higher than beverage taxes in most other cities, and nearly the full cost of the tax is being passed through to consumers for many beverage types and stores types. (c) 2020 Published by Elsevier B.V.
C1 [Jones-Smith, Jessica C.; Walkinshaw, Lina Pinero; Oddo, Vanessa M.] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA.
   [Jones-Smith, Jessica C.; Chan, Nadine] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.
   [Knox, Melissa] Univ Washington, Dept Econ, Seattle, WA 98195 USA.
   [Neuhouser, Marian L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.
   [Hurvitz, Philip M.] Univ Washington, Urban Form Lab, Dept Urban Design & Planning, Seattle, WA 98195 USA.
   [Hurvitz, Philip M.] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA.
   [Saelens, Brian E.] Seattle Childrens Res Inst, Seattle, WA USA.
   [Saelens, Brian E.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA.
   [Chan, Nadine] Publ Hlth Seattle & King Cty, Assessment Policy Dev & Evaluat Div, Seattle, WA USA.
C3 University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle; University of
   Washington; University of Washington Seattle; Fred Hutchinson Cancer
   Center; University of Washington; University of Washington Seattle;
   University of Washington; University of Washington Seattle; Seattle
   Children's Hospital; University of Washington; University of Washington
   Seattle
RP Jones-Smith, JC (corresponding author), Univ Washington, Sch Publ Hlth, Box 353410, Seattle, WA 98195 USA.
EM jjoness@uw.edu
RI Knox, Melissa/AAN-3457-2021
OI Walkinshaw, Lina/0000-0002-7042-7558; Saelens,
   Brian/0000-0001-6998-6339; Knox, Melissa/0000-0001-7525-0854
FU City of Seattle Sweetened Beverage Tax
FX Funding for this study came from the City of Seattle Sweetened Beverage
   Tax. A review team consisting of City Councilmember staffers, City
   budget office staff, the Office of the City auditor, and City Finance
   and Administrative Services reviewed and approved our evaluation plans.
   They also reviewed draft reports of our findings. The scientific
   evaluation team answered questions on methods, interpretation, and
   findings for the City Review team. The City of Seattle and the review
   team did not influence analyses, interpretation, or writing of this
   manuscript. Deidentified data are available upon request from the
   corresponding author.
CR Allison P.D., 2009, Fixed effect regression models
   [Anonymous], 2018, DEV RELIABILITY TEST
   Bleich SN, 2018, OBESITY, V26, P432, DOI 10.1002/oby.22056
   Brand N, 2018, FACT CHECK I 1634 YE
   Cawley J., 2018, SSRN ELECT J, DOI [10.2139/ssrn.3247248, DOI 10.2139/SSRN.3247248]
   Cawley J., 2018, 25050 NBER
   Cawley J, 2020, ECON HUM BIOL, V37, DOI 10.1016/j.ehb.2020.100865
   Cawley J, 2019, J HEALTH ECON, V67, DOI 10.1016/j.jhealeco.2019.102225
   Cawley J, 2017, J POLICY ANAL MANAG, V36, P303, DOI 10.1002/pam.21960
   Chan Nadine, 2018, The Evaluation of Seattles Sweetened Beverage Tax
   Change Lab Solutions & Healthy Food America, 2016, BEST PRACTICES DESIG
   Falbe J, 2015, AM J PUBLIC HEALTH, V105, P2194, DOI 10.2105/AJPH.2015.302881
   Grogger J, 2017, AM J AGR ECON, V99, P481, DOI 10.1093/ajae/aax024
   Healthy Food America, COMP TAX POL
   Moudon AV, 2013, PUBLIC HEALTH NUTR, V16, P1238, DOI 10.1017/S1368980013000773
   Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002
   Powell LM, 2020, ECON HUM BIOL, V37, DOI 10.1016/j.ehb.2020.100856
   Powell LM, 2020, ECON HUM BIOL, V37, DOI 10.1016/j.ehb.2020.100855
   Roberto CA, 2019, JAMA-J AM MED ASSOC, V321, P1799, DOI 10.1001/jama.2019.4249
   Silver LD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002283
NR 20
TC 24
Z9 28
U1 0
U2 17
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1570-677X
EI 1873-6130
J9 ECON HUM BIOL
JI Econ. Hum. Biol.
PD DEC
PY 2020
VL 39
AR 100917
DI 10.1016/j.ehb.2020.100917
PG 8
WC Economics; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Business & Economics; Public, Environmental & Occupational Health
GA PB7YJ
UT WOS:000596531900023
PM 32801099
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Choi, YE
   Choi, SI
   Han, XG
   Men, X
   Jang, GW
   Kwon, HY
   Kang, SR
   Han, JS
   Lee, OH
AF Choi, Ye-Eun
   Choi, Sun-Il
   Han, Xionggao
   Men, Xiao
   Jang, Gill-Woong
   Kwon, Hee-Yeon
   Kang, Seong-Ran
   Han, Jin-Soo
   Lee, Ok-Hwan
TI Radical Scavenging-Linked Anti-Adipogenic Activity of Aster
   scaber Ethanolic Extract and Its Bioactive Compound
SO ANTIOXIDANTS
LA English
DT Article
DE anti-oxidant; reactive oxygen species; anti-obesity; Aster scaber
ID ACTIVATED PROTEIN-KINASE; HORMONE-SENSITIVE LIPASE; OXIDATIVE STRESS;
   ANTIOXIDANT ACTIVITY; SUPEROXIDE-DISMUTASE; PHENOLIC-COMPOUNDS;
   GENE-EXPRESSION; PPAR-GAMMA; ACID; DIFFERENTIATION
AB Aster scaber is a wild vegetable cultivated in Korea and is known to contain phytochemicals with various biological activities. The potential antioxidant and anti-obesity effects of A. scaber and their mechanism are yet to be reported. We evaluated the total phenolic, flavonoid, and proanthocyanidin contents and oxygen radical absorbance capacity of A. scaber ethanolic extract (ASE), and analyzed the major phenolic compounds of ASE. Antioxidant activity was measured at the chemical level through 2,2-diphenyl-1-picrylhydrazyl (DPPH), reducing power assay, 2,2 '-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS), and fluorescence recovery after photobleaching (FRAP) assay. In addition, it was measured in vitro through inhibition of Reactive oxygen species (ROS) production in 3T3-L1 adipocyte, and inhibition of lipid accumulation was also evaluated. ASE reduced the expression of enzymes involved in the production of ROS and increased the expression of antioxidant enzymes that reduce increased ROS levels. They also reduced the expression of adipogenesis transcription factors that regulate adipocyte differentiation in relation to ROS production, inhibited the expression of lipogenesis-related genes related to fat accumulation through AMP-activated protein kinase (AMPK) activity, and increased expression of lipolysis-related genes. Thus, ASE containing CGA (chlorogenic acid) inhibits ROS production in 3T3-L1 adipocytes, owing to its strong antioxidant activity, and inhibits lipid accumulation caused by oxidative stress. The extract can be used as a potential functional food material for reducing oxidative stress and obesity.
C1 [Choi, Ye-Eun; Choi, Sun-Il; Han, Xionggao; Men, Xiao; Jang, Gill-Woong; Kwon, Hee-Yeon; Lee, Ok-Hwan] Kangwon Natl Univ, Dept Food Sci & Biotechnol, Chunchon 24341, South Korea.
   [Kang, Seong-Ran; Han, Jin-Soo] Food Ind Promot Agcy Korea, Iksan 54576, South Korea.
C3 Kangwon National University
RP Lee, OH (corresponding author), Kangwon Natl Univ, Dept Food Sci & Biotechnol, Chunchon 24341, South Korea.
EM ye0538@hanmail.net; docgotack89@hanmail.net; xionggao414@hotmail.com;
   menxiaodonglei@naver.com; jkw5235@naver.com; sosakwonl@naver.com;
   srkang0817@foodpoils.kr; jinsoo07@foodpoils.kr; loh99@kangwon.ac.kr
OI choi, ye eun/0000-0001-8298-248X; Lee, Ok-Hwan/0000-0001-6855-3136
CR Adachi T, 2009, REDOX REP, V14, P34, DOI 10.1179/135100009X392467
   An YT, 2011, FITOTERAPIA, V82, P595, DOI 10.1016/j.fitote.2011.01.010
   [Anonymous], 1997, ILL BOOK EM PLANTS, P221
   Anthony NM, 2009, OBESITY, V17, P1312, DOI 10.1038/oby.2008.645
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bjorntorp P., 1974, HORM METAB RES HORM, V77, P83
   Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437
   Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014
   CHUNG TY, 1993, J AGR FOOD CHEM, V41, P1693, DOI 10.1021/jf00034a033
   Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028
   Esposito K, 2006, J ENDOCRINOL INVEST, V29, P791, DOI 10.1007/BF03347372
   Fernández-Sánchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117
   Ferreira ICFR, 2007, FOOD CHEM, V100, P1511, DOI 10.1016/j.foodchem.2005.11.043
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Gaidhu MP, 2006, J BIOL CHEM, V281, P25956, DOI 10.1074/jbc.M602992200
   GARTON AJ, 1989, EUR J BIOCHEM, V179, P249, DOI 10.1111/j.1432-1033.1989.tb14548.x
   GUTFINGER T, 1981, J AM OIL CHEM SOC, V58, P966, DOI 10.1007/BF02659771
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X
   He L, 2017, CELL PHYSIOL BIOCHEM, V44, P532, DOI 10.1159/000485089
   Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5
   Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365
   Hotamisligil GS, 2015, NAT REV ENDOCRINOL, V11, P592, DOI 10.1038/nrendo.2015.122
   Huang CJ, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0031-y
   Hur JY, 2004, BIOCHEM BIOPH RES CO, V313, P948, DOI 10.1016/j.bbrc.2003.11.178
   Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2
   Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2
   Jung CM, 2001, CHEM PHARM BULL, V49, P912, DOI 10.1248/cpb.49.912
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Kwon HC, 2000, CHEM PHARM BULL, V48, P1796, DOI 10.1248/cpb.48.1796
   Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200
   Lee YJ, 2013, MOLECULES, V18, P12937, DOI 10.3390/molecules181012937
   LOOMIS WD, 1966, PHYTOCHEMISTRY, V5, P423, DOI 10.1016/S0031-9422(00)82157-3
   MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021
   MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8
   Mensor LL, 2001, PHYTOTHER RES, V15, P127, DOI 10.1002/ptr.687
   Mitsunaga T, 1998, J WOOD SCI, V44, P125, DOI 10.1007/BF00526257
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423
   Ng CF, 2007, FREE RADICAL RES, V41, P1201, DOI 10.1080/10715760701625075
   Nugroho A, 2009, ARCH PHARM RES, V32, P1361, DOI 10.1007/s12272-009-2003-6
   Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052
   Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o
   OYAIZU M, 1988, J JPN SOC FOOD SCI, V35, P771
   Park HJ, 2010, ARCH PHARM RES, V33, P1703, DOI 10.1007/s12272-010-1101-9
   Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254
   Roby MHH, 2013, IND CROP PROD, V43, P827, DOI 10.1016/j.indcrop.2012.08.029
   Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562
   Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024
   Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023
   Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   THURMAN RG, 1972, EUR J BIOCHEM, V25, P420, DOI 10.1111/j.1432-1033.1972.tb01711.x
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wu DF, 2003, ALCOHOL RES HEALTH, V27, P277
   WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350
NR 61
TC 16
Z9 16
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD DEC
PY 2020
VL 9
IS 12
AR 1290
DI 10.3390/antiox9121290
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA PJ6GN
UT WOS:000601863700001
PM 33339396
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Godin, KM
   Hammond, D
   Chaurasia, A
   Leatherdale, ST
AF Godin, Katelyn M.
   Hammond, David
   Chaurasia, Ashok
   Leatherdale, Scott T.
TI Examining changes in school vending machine beverage availability and
   sugar-sweetened beverage intake among Canadian adolescents participating
   in the COMPASS study: a longitudinal assessment of provincial school
   nutrition policy compliance and effectiveness
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE School nutrition policy; Sugar-sweetened beverages; Canada; Adolescents;
   Schools; Vending machines; Longitudinal study; Dietary assessment
ID FOOD ENVIRONMENT; SOFT DRINK; CONSUMPTION; CHILDREN; ASSOCIATIONS;
   CAFFEINE; OBESITY; RISK; INTERVENTIONS; BEHAVIORS
AB BackgroundSchool nutrition policies can encourage restrictions in sugar-sweetened beverage (SSB) availability in school food outlets in order to discourage students' SSB intake. The main objective was to examine how beverage availability in school vending machines changes over three school years across schools in distinct school nutrition policy contexts. Secondary objectives were to examine how students' weekday SSB intake varies with time and identify longitudinal associations between beverage availability and SSB intake.MethodsThis longitudinal study used data from the COMPASS study (2013/14-2015/16), representing 7679 students from 78 Canadian secondary schools and three provincial school nutrition policy contexts (Alberta - voluntary guidelines, Ontario public - mandatory guidelines, and Ontario private schools - no guidelines). We assessed availability of 10 beverage categories in schools' vending machines via the COMPASS School Environment Application and participants' intake of three SSB varieties (soft drinks, sweetened coffees/teas, and energy drinks) via a questionnaire. Hierarchical regression models were used to examine whether: i) progression of time and policy group were associated with beverage availability; and, ii) beverage availability was associated with students' SSB intake.ResultsOntario public schools were significantly less likely than the other policy groups to serve SSBs in their vending machines, with the exception of flavoured milks. Vending machine beverage availability was consistent over time. Participants' overall SSB intake remained relatively stable; reductions in soft drink intake were partially offset by increased sweetened coffee/tea consumption. Relative to Ontario public schools, attending school in Alberta was associated with more frequent energy drink intake and overall SSB intake whereas attending an Ontario private school was associated with less frequent soft drink intake, with no differences in overall SSB intake. Few beverage availability variables were significantly associated with participants' SSB intake.ConclusionsMandatory provincial school nutrition policies were predictive of more limited SSB availability in school vending machines. SSB intake was significantly lower in Ontario public and private schools, although we did not detect a direct association between SSB consumption and availability. The findings provide support for mandatory school nutrition policies, as well as the need for comprehensive school- and broader population-level efforts to reduce SSB intake.
C1 [Godin, Katelyn M.; Hammond, David; Chaurasia, Ashok; Leatherdale, Scott T.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
C3 University of Waterloo
RP Godin, KM (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
EM kmgodin@uwaterloo.ca
RI Hammond, David/JPW-9267-2023; Leatherdale, Scott/AAE-4515-2022
FU Canadian Institutes of Health Research (CIHR) Institute of Nutrition,
   Metabolism and Diabetes [OOP-110788]; CIHR Institute of Population and
   Public Health (IPPH) [MOP-114875]; Public Health Agency of Canada; CIHR
   Institute of Neurosciences, Mental Health and Addiction; IPPH
FX The COMPASS study is supported by a bridge grant from the Canadian
   Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism
   and Diabetes through the "Obesity - Interventions to Prevent or Treat"
   priority funding awards (OOP-110788; grant awarded to STL) and an
   operating grant from the CIHR Institute of Population and Public Health
   (IPPH) (MOP-114875; grant awarded to STL). STL and DH are Chairs in
   Applied Public Health, funded by the Public Health Agency of Canada in
   partnership with CIHR Institute of Neurosciences, Mental Health and
   Addiction and IPPH. The funders had no role in the design, analysis or
   writing of this article.
CR Ambrosini GL, 2013, AM J CLIN NUTR, V98, P327, DOI 10.3945/ajcn.112.051383
   [Anonymous], 2018, CANMAP ROUT ENH POIN
   [Anonymous], GROWTH REF 5 19 YEAR
   [Anonymous], 2006, GUID SUPP SUCC TRANS
   Apparicio P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-4
   Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341
   Berman ER, 2015, AM J PUBLIC HEALTH, V105, P1404, DOI 10.2105/AJPH.2015.302593
   Branum AM, 2014, PEDIATRICS, V133, P386, DOI 10.1542/peds.2013-2877
   Bremer AA, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/196476
   Brown RJ, 2010, INT J PEDIATR OBES, V5, P305, DOI 10.3109/17477160903497027
   Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005
   Driessen CE, 2014, OBES REV, V15, P968, DOI 10.1111/obr.12224
   Finkelstein E, 2004, AM J PREV MED, V27, P163, DOI 10.1016/j.amepre.2004.06.017
   Frary CD, 2004, J ADOLESCENT HEALTH, V34, P56, DOI 10.1016/S1054-139X(03)00248-9
   Fung C, 2013, PREV MED, V57, P934, DOI 10.1016/j.ypmed.2013.07.016
   Garriguet Didier, 2008, Health Rep, V19, P17
   Godin KM, 2019, PUBLIC HEALTH NUTR, V22, P1928, DOI 10.1017/S1368980018001246
   Godin KM, 2017, PUBLIC HEALTH NUTR, V20, P2980, DOI 10.1017/S1368980017001926
   Godin KM, 2017, CAN J DIET PRACT RES, V78, P92, DOI 10.3148/cjdpr-2016-037
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Huang C, 2009, PREV CHRONIC DIS, V6
   Imamura F, 2016, BRIT J SPORT MED, V50, P496, DOI 10.1136/bjsports-2016-h3576rep
   Jones AC, 2017, HLTH EC IMPACTS TAX
   Jones NR, 2010, HEALTH PLACE, V16, P776, DOI 10.1016/j.healthplace.2010.04.002
   Leatherdale S. T., 2014, RELIABILITY VALIDITY, V2
   Leatherdale ST, 2014, MEASUREMENT, V50, P331, DOI 10.1016/j.measurement.2014.01.008
   Leatherdale ST, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-42
   Lebel A, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/1416384
   Levy DT, 2011, ADV NUTR, V2, p182S, DOI 10.3945/an.111.000356
   Lien N, 2014, HEALTH PLACE, V30, P28, DOI 10.1016/j.healthplace.2014.07.013
   Lo E, 2008, NUTR RES, V28, P144, DOI 10.1016/j.nutres.2008.01.005
   Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mâsse LC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-29
   Mâsse LC, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-26
   McKenna ML, 2010, CAN J PUBLIC HEALTH, V101, pS14, DOI 10.1007/BF03405619
   Minaker LM, 2011, PUBLIC HEALTH NUTR, V14, P1350, DOI 10.1017/S1368980011000449
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E7492
   Mullally ML, 2010, CAN J PUBLIC HEALTH, V101, P40, DOI 10.1007/BF03405560
   Nelson MC, 2009, J AM DIET ASSOC, V109, P308, DOI 10.1016/j.jada.2008.10.043
   Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465
   Ontario Ministry of Education, HLTH SCH NEW SCH FOO
   Orava T, 2016, CAN J PUBLIC HEALTH, V107, pE417, DOI [10.17269/cjph.107.5326, 10.17269/CJPH.107.5326]
   Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536
   Pikora TJ, 2002, AM J PREV MED, V23, P187, DOI 10.1016/S0749-3797(02)00498-1
   Qian W, 2015, COMPASS TECHNICAL RE, V3
   Shankar P, 2013, NUTRITION, V29, P1293, DOI 10.1016/j.nut.2013.03.024
   Statistics Canada, 2013, SEM PROF FSA BAS 201
   Statistics Canada, 2015, URB AR POP CTR
   Story M, 2009, MILBANK Q, V87, P71, DOI 10.1111/j.1468-0009.2009.00548.x
   Taber DR, 2012, ARCH PEDIAT ADOL MED, V166, P256, DOI 10.1001/archpediatrics.2011.200
   Turner L, 2012, J ACAD NUTR DIET, V112, P1380, DOI 10.1016/j.jand.2012.04.017
   Turton P, 2016, J NUTR EDUC BEHAV, V48, P181, DOI 10.1016/j.jneb.2015.12.004
   Valaitis R, 2016, FASEB J, V30
   van der Horst K, 2008, AM J PREV MED, V35, P217, DOI 10.1016/j.amepre.2008.05.022
   Vanderlee L, 2014, J SCHOOL HEALTH, V84, P168, DOI 10.1111/josh.12139
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Vecchiarelli S, 2006, J SCHOOL HEALTH, V76, P525, DOI 10.1111/j.1746-1561.2006.00153.x
   Vézina-Im LA, 2017, PUBLIC HEALTH NUTR, V20, P2416, DOI [10.1017/S1368980017000076, 10.1017/s1368980017000076]
   Vine MM, 2017, CAN J PUBLIC HEALTH, V108, pE43, DOI [10.17269/cjph.108.5701, 10.17269/CJPH.108.5701]
   Vine MM, 2014, CAN J DIET PRACT RES, V75, P118, DOI 10.3148/cjdpr-2014-003
   Vine MM, 2014, PUBLIC HEALTH NUTR, V17, P1290, DOI 10.1017/S1368980013002516
   Watts AW, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-50
NR 65
TC 16
Z9 17
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5868
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD NOV 27
PY 2018
VL 15
AR 121
DI 10.1186/s12966-018-0754-5
PG 17
WC Nutrition & Dietetics; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics; Physiology
GA HB9RE
UT WOS:000451428900001
PM 30482211
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Herranz-López, M
   Olivares-Vicente, M
   Gallego, ER
   Encinar, JA
   Pérez-Sánchez, A
   Ruiz-Torres, V
   Joven, J
   Roche, E
   Micol, V
AF Herranz-Lopez, Maria
   Olivares-Vicente, Marilo
   Rodriguez Gallego, Esther
   Antonio Encinar, Jose
   Perez-Sanchez, Almudena
   Ruiz-Torres, Veronica
   Joven, Jorge
   Roche, Enrique
   Micol, Vicente
TI Quercetin metabolites from Hibiscus sabdariffa contribute to
   alleviate glucolipotoxicity-induced metabolic stress in vitro
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Glucolipotoxicity; Hibiscus sabdariffa; Polyphenols; Quercetin
   derivatives; AMPK; Mitochondrial remodeling; Molecular docking
   simulations
ID PLANT-DERIVED POLYPHENOLS; ACTIVATED PROTEIN-KINASE; MONOCYTE
   CHEMOATTRACTANT PROTEIN-1; MITOCHONDRIAL DYSFUNCTION;
   INSULIN-RESISTANCE; OXIDATIVE STRESS; AQUEOUS EXTRACT; GENE-EXPRESSION;
   ADIPOSE-TISSUE; FATTY-ACIDS
AB Polyphenols from Hibiscus sabdariffa (HS) alleviate obesity-related metabolic complications but the metabolites responsible for such effects are unknown. We aimed to elucidate which of the potential plasma metabolites from a polyphenol-enriched HS (PEHS) extract contributed for the reversion of glucolipotoxicity-induced metabolic stress using 3T3-L1 adipocyte and INS 832/13 pancreatic beta-cell models under glucolipotoxic conditions.
   PEHS extract, quercetin (Q) and quercetin-3-O-glucuronide (Q3GA) showed stronger capacity to decrease glucolipotoxicity-induced ROS generation than ascorbic acid or chlorogenic acid. PEHS extract, Q and Q3GA decreased secretion of cytokines (leptin, THE-alpha, IGF-1, IL-6, VEGF, IL-1 alpha, IL-1 beta and CCL2) and reduced CCL2 expression at transcriptional level. In addition, PEHS extract, Q and Q3GA reduced triglyceride accumulation, which occurred through fatty acid synthase (FASN) downregulation, AMPK activation and mitochondrial mass and biogenesis restoration via PPAR alpha upregulation. Electron microscopy confirmed that PEHS extract and Q3GA decreased mitochondrial remodeling and mitophagy. Virtual screening leads us to postulate that Q and Q3GA might act as agonists of these protein targets at specific sites.
   These data suggest that Q and Q3GA may be the main responsible compounds for the capacity of PEHS extract to revert glucolipotoxicity-induced metabolic stress through AMPK-mediated decrease in fat storage and increase in fatty acid oxidation, though other compounds of the extract may contribute to this capacity.
C1 [Herranz-Lopez, Maria; Olivares-Vicente, Marilo; Antonio Encinar, Jose; Perez-Sanchez, Almudena; Ruiz-Torres, Veronica; Micol, Vicente] Miguel Hernandez Univ UMH, Inst Invest Desarrollo & Innovac Biotecnol Sanita, Alicante 03202, Spain.
   [Herranz-Lopez, Maria; Olivares-Vicente, Marilo; Antonio Encinar, Jose; Perez-Sanchez, Almudena; Ruiz-Torres, Veronica; Micol, Vicente] Miguel Hernandez Univ UMH, Inst Biol Mol & Celular IBMC, Alicante 03202, Spain.
   [Rodriguez Gallego, Esther] Univ Rovira & Virgili, Hosp Univ Tarragona Joan XXIII, Inst Invest Sanitaria Pere Virgili, Tarragona 43007, Spain.
   [Joven, Jorge] Univ Rovira & Virgili, Dept Cirurgia & Med, Unitat Recerca Biomed, Tarragona 43201, Spain.
   [Joven, Jorge] Inst Invest Sanitaria Pere Virgili IISPV, Reus 43204, Spain.
   [Roche, Enrique] Univ Miguel Hernandez, Alicante Inst Hlth & Biomed Res ISABIAL, Inst Bioengn, Alicante, Spain.
   [Roche, Enrique] Univ Miguel Hernandez, Alicante Inst Hlth & Biomed Res ISABIAL, Dept Appl Biol Nutr, Alicante, Spain.
   [Roche, Enrique; Micol, Vicente] Inst Salud Carlos III CB12 03 30038, CIBERobn, Fisiopatol Obesidad & Nutr, CIBER, Madrid 28220, Spain.
C3 Universitat Rovira i Virgili; Hospital Universitari De Tarragona Joan
   XXIII; Institut d'Investigacio Sanitaria Pere Virgili (IISPV);
   Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut
   d'Investigacio Sanitaria Pere Virgili (IISPV); General University
   Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat
   d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante
   (ISABIAL); General University Hospital of Alicante; Universidad Miguel
   Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion
   Sanitaria y Biomedica de Alicante (ISABIAL); CIBER - Centro de
   Investigacion Biomedica en Red; CIBEROBN
RP Herranz-López, M (corresponding author), Miguel Hernandez Univ UMH, Inst Invest Desarrollo & Innovac Biotecnol Sanita, Alicante 03202, Spain.; Herranz-López, M (corresponding author), Miguel Hernandez Univ UMH, Inst Biol Mol & Celular IBMC, Alicante 03202, Spain.
EM mherranz@umh.es
RI Encinar, José/AAE-9141-2020; Joven, Jorge/B-3360-2016; Roche,
   Enrique/V-5738-2017; Micol, Vicente/K-6841-2014; Rodriguez-Gallego,
   Esther/B-6581-2016; Encinar, Jose Antonio/F-2946-2013
OI Olivares-Vicente, Marilo/0000-0002-2792-9181; Herranz-Lopez,
   Maria/0000-0002-1819-7978; Rodriguez-Gallego,
   Esther/0000-0002-6363-2510; Micol, Vicente/0000-0001-8089-0696; Encinar,
   Jose Antonio/0000-0002-7219-3863
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [AGL2015-67995-C3-1-R, RTI2018-096724-B-C21]; Generalitat Valenciana
   [PROMETEO/2016/006, APOSTD/2017/023, APOSTD/2018/097, ACIF/2016/230];
   CIBER (Fisiopatologia de la Obesidad y la Nutricion, CIBERobn, Instituto
   de Salud Carlos III) [CB12/03/30038]
FX We thank grants AGL2015-67995-C3-1-R and RTI2018-096724-B-C21 from the
   Spanish Ministry of Economy and Competitiveness (MINECO);
   PROMETEO/2016/006, APOSTD/2017/023, APOSTD/2018/097 and ACIF/2016/230
   from Generalitat Valenciana; CIBER (CB12/03/30038, Fisiopatologia de la
   Obesidad y la Nutricion, CIBERobn, Instituto de Salud Carlos III). We
   are grateful to the Cluster of Scientific Computing (http://ccc.umh.es/)
   of the Miguel Hernandez University (UMH) and the Centro de
   Supercomputacion (ALHAMBRA-CSIRC) of the University of Granada for
   supporting supercomputing facilities.
CR Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054
   Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077
   Alarcon-Aguilar FJ, 2007, J ETHNOPHARMACOL, V114, P66, DOI 10.1016/j.jep.2007.07.020
   [Anonymous], 2018, MOLECULES
   Encinar JA, 2015, DRUG DES DEV THER, V9, P5877, DOI 10.2147/DDDT.S93449
   Barrajón-Catalán E, 2014, ADV EXP MED BIOL, V824, P141, DOI 10.1007/978-3-319-07320-0_11
   Beltrán-Debón R, 2010, PHYTOMEDICINE, V17, P186, DOI 10.1016/j.phymed.2009.08.006
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Borrás-Linares I, 2015, INT J MOL SCI, V16, P18396, DOI 10.3390/ijms160818396
   Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x
   Chambial S, 2013, INDIAN J CLIN BIOCHE, V28, P314, DOI 10.1007/s12291-013-0375-3
   Chang HC, 2014, FOOD FUNCT, V5, P734, DOI 10.1039/c3fo60495k
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786
   El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238
   Fernández-Arroyo S, 2012, MOL NUTR FOOD RES, V56, P1590, DOI 10.1002/mnfr.201200091
   Fernández-Arroyo S, 2011, FOOD RES INT, V44, P1490, DOI 10.1016/j.foodres.2011.03.040
   Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039
   GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2
   Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218
   Han CY, 2016, DIABETES METAB J, V40, P272
   Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925
   Herranz-López M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080907
   Herranz-López M, 2017, PHYTOMEDICINE, V25, P25, DOI 10.1016/j.phymed.2016.12.008
   Herranz-López M, 2012, PHYTOMEDICINE, V19, P253, DOI 10.1016/j.phymed.2011.12.001
   Hopkins AL, 2013, FITOTERAPIA, V85, P84, DOI 10.1016/j.fitote.2013.01.003
   Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005
   Imessaoudene A, 2016, J NUTR BIOCHEM, V29, P107, DOI 10.1016/j.jnutbio.2015.11.011
   Indra Mochamad Rasjad, 2013, BMC Res Notes, V6, P275, DOI 10.1186/1756-0500-6-275
   Jokinen R, 2017, REDOX BIOL, V12, P246, DOI 10.1016/j.redox.2017.02.011
   Joven J, 2013, FOOD CHEM TOXICOL, V51, P267, DOI 10.1016/j.fct.2012.10.004
   Joven J, 2014, CRIT REV FOOD SCI, V54, P985, DOI 10.1080/10408398.2011.621772
   Joven J, 2012, BBA-GEN SUBJECTS, V1820, P894, DOI 10.1016/j.bbagen.2012.03.020
   Jung CH, 2013, PHYTOTHER RES, V27, P139, DOI 10.1002/ptr.4687
   Kim JK, 2007, J ETHNOPHARMACOL, V114, P260, DOI 10.1016/j.jep.2007.08.028
   Kim TK, 2015, CYTOKINE, V76, P368, DOI 10.1016/j.cyto.2015.05.015
   Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392
   Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251
   Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426
   Langendorf CG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10912
   Li C, 2016, REDOX BIOL, V9, P104, DOI 10.1016/j.redox.2016.06.006
   Luna-Luna M, 2015, ARCH MED RES, V46, P392, DOI 10.1016/j.arcmed.2015.05.007
   Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282
   Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239
   Makris DP, 2001, J AGR FOOD CHEM, V49, P3370, DOI 10.1021/jf010107l
   Menendez JA, 2009, CLIN CHEM, V55, P425, DOI 10.1373/clinchem.2008.115352
   Mittra S, 2008, DRUG DISCOV TODAY, V13, P211, DOI 10.1016/j.drudis.2008.01.006
   Miyake H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209448
   Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24
   Nabavi SM, 2012, FOOD CHEM, V132, P931, DOI 10.1016/j.foodchem.2011.11.070
   Nemeth K, 2007, CRIT REV FOOD SCI, V47, P397, DOI 10.1080/10408390600846291
   Nisha VM, 2014, APPL BIOCHEM BIOTECH, V174, P1365, DOI 10.1007/s12010-014-1129-2
   O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229
   Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656
   Olivares-Vicente M, 2018, CURR DRUG METAB, V19, P351, DOI 10.2174/1389200219666180220095236
   Overman A, 2011, INT J OBESITY, V35, P1165, DOI 10.1038/ijo.2010.272
   Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263
   Roche M, 2009, CELL BIOL TOXICOL, V25, P635, DOI 10.1007/s10565-008-9118-2
   Rodríguez-Medina IC, 2009, J SEP SCI, V32, P3441, DOI 10.1002/jssc.200900298
   Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036
   Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315
   Sánchez-Reus MI, 2007, NEUROPHARMACOLOGY, V52, P606, DOI 10.1016/j.neuropharm.2006.09.003
   Sesink ALA, 2001, J NUTR, V131, P1938, DOI 10.1093/jn/131.7.1938
   Tanis RM, 2015, BBA-MOL CELL RES, V1853, P213, DOI 10.1016/j.bbamcr.2014.10.012
   Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092
   Vankoningsloo S, 2005, J LIPID RES, V46, P1133, DOI 10.1194/jlr.M400464-JLR200
   Vidyashankar S, 2013, TOXICOL IN VITRO, V27, P945, DOI 10.1016/j.tiv.2013.01.014
   Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133
   Yang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35460
   Ying HZ, 2013, FOOD CHEM TOXICOL, V52, P53, DOI 10.1016/j.fct.2012.10.030
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 71
TC 16
Z9 16
U1 0
U2 26
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD OCT
PY 2020
VL 144
AR 111606
DI 10.1016/j.fct.2020.111606
PG 14
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA NK6AX
UT WOS:000566815000021
PM 32738368
DA 2025-04-28
ER

PT J
AU Hursel, R
   Westerterp-Plantenga, MS
AF Hursel, R.
   Westerterp-Plantenga, M. S.
TI Thermogenic ingredients and body weight regulation
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Review
DE body weight; thermogenic; fat oxidation; energy expenditure; energy
   intake
ID GREEN TEA EXTRACT; CATECHOL-O-METHYLTRANSFERASE; DIET-INDUCED OBESITY;
   ENERGY-EXPENDITURE; FAT OXIDATION; RED-PEPPER; SUBSTRATE UTILIZATION;
   DOUBLE-BLIND; WHITE TEA; CAFFEINE CONSUMPTION
AB The global prevalence of obesity has increased considerably in the last decade. Tools for obesity management, including consumption of caffeine, capsaicin and different teas such as green, white and oolong tea, have been proposed as strategies for weight loss and weight maintenance, as they may increase energy expenditure (4-5%), fat oxidation (10-16%) and have been proposed to counteract the decrease in metabolic rate that is present during weight loss. Daily increases in thermogenesis of approximately 300-400 kJ can eventually lead to substantial weight loss. However, it becomes clearer that certain conditions have to be met before thermogenic ingredients yield an effect, as intra-variability with respect to body weight regulation has been shown between subjects. Furthermore, the sympathetic nervous system is involved in the regulation of lipolysis, and the sympathetic innervation of white adipose tissue may have an important role in the regulation of total body fat in general. Taken together, these functional ingredients have the potential to produce significant effects on metabolic targets such as satiety, thermogenesis and fat oxidation. A significant clinical outcome may sometimes appear straightforward and may also depend very strongly on full compliance of subjects. Nevertheless, thermogenic ingredients may be considered as functional agents that could help in preventing a positive energy balance and obesity. International Journal of Obesity (2010) 34, 659-669; doi: 10.1038/ijo.2009.299; published online 9 February 2010
C1 [Hursel, R.; Westerterp-Plantenga, M. S.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Human Biol, Maastricht, Netherlands.
C3 Maastricht University
RP Westerterp-Plantenga, MS (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Dept Human Biol, Maastricht, Netherlands.
EM m.westerterp@hb.unimaas.nl
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Alcazar A, 2007, J AGR FOOD CHEM, V55, P5960, DOI 10.1021/jf070601a
   [Anonymous], PROGR MED
   ARCIERO PJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1192, DOI 10.1152/ajpendo.1995.268.6.E1192
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BROWN PJ, 1963, J CHROMATOGR, V11, P504, DOI 10.1016/S0021-9673(01)80953-5
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chen W., 1998, JPN J CLIN NUTR, V20, P83
   Cornelis MC, 2007, AM J CLIN NUTR, V86, P240, DOI 10.1093/ajcn/86.1.240
   CURATOLO PW, 1983, ANN INTERN MED, V98, P641, DOI 10.7326/0003-4819-98-5-641
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Faraut B, 2007, AM J PHYSIOL-ENDOC M, V292, pE1474, DOI 10.1152/ajpendo.00292.2006
   Galgani JE, 2010, BRIT J NUTR, V103, P38, DOI 10.1017/S0007114509991358
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   Hertog MGL, 1997, AM J CLIN NUTR, V65, P1489, DOI 10.1093/ajcn/65.5.1489
   Hilal Y, 2007, J VERBRAUCH LEBENSM, V2, P414, DOI 10.1007/s00003-007-0250-3
   Hodgson JM, 2006, BRIT J NUTR, V95, P14, DOI 10.1079/BJN20051621
   HOLLANDS MA, 1981, AM J CLIN NUTR, V34, P2291, DOI 10.1093/ajcn/34.10.2291
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Jöbstl E, 2006, J AGR FOOD CHEM, V54, P4077, DOI 10.1021/jf053259f
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kao Y, 2000, AM J CLIN NUTR, V72, P1232
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Komatsu Tatsushi, 2003, Journal of Medical Investigation, V50, P170
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Lejeune MPGM, 2003, BRIT J NUTR, V90, P651, DOI 10.1079/BJN2003938
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lorenz M, 2007, EUR HEART J, V28, P219, DOI 10.1093/eurheartj/ehl442
   Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527
   Masuda Y, 2003, J APPL PHYSIOL, V95, P2408, DOI 10.1152/japplphysiol.00828.2002
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Obesity, 2000, World Health Organ Tech Rep Ser, V894, P1, DOI DOI 10.1016/J.BBI.2016.02.019
   Ohnuki K, 2001, BIOSCI BIOTECH BIOCH, V65, P2033, DOI 10.1271/bbb.65.2033
   Otsuka K, 2002, JAPANESE J NUTR ASSE, V19, P365
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Pasman WJ, 1997, INT J OBESITY, V21, P1143, DOI 10.1038/sj.ijo.0800528
   Pasman WJ, 1999, METABOLISM, V48, P15, DOI 10.1016/S0026-0495(99)90004-5
   Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010
   ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Santana-Rios G, 2001, MUTAT RES-GEN TOX EN, V495, P61, DOI 10.1016/S1383-5718(01)00200-5
   Serafini M, 1996, EUR J CLIN NUTR, V50, P28
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Smeets AJ, 2009, EUR J NUTR, V48, P229, DOI 10.1007/s00394-009-0006-1
   Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561
   Söhle J, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-20
   Stunkard AJ, 1996, AM J MED, V100, P230, DOI 10.1016/S0002-9343(97)89464-8
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   TSUCHIDA T, 2002, PROGR MED, V22, P2189
   WADDEN TA, 1988, J CONSULT CLIN PSYCH, V56, P925, DOI 10.1037/0022-006X.56.6.925
   Wang H, 2009, OBESITY SILVER SPRIN
   Weisburger JH, 1997, CANCER LETT, V114, P315, DOI 10.1016/S0304-3835(97)04691-0
   Westerterp-Plantenga MS, 2005, INT J OBESITY, V29, P682, DOI 10.1038/sj.ijo.0802862
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Yang FJ, 2001, MOL PHARMACOL, V60, P528
   Yoshioka M, 1995, J NUTR SCI VITAMINOL, V41, P647, DOI 10.3177/jnsv.41.647
   Yoshioka M, 1999, BRIT J NUTR, V82, P115, DOI 10.1017/S0007114599001269
   Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
NR 85
TC 101
Z9 112
U1 0
U2 41
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD APR
PY 2010
VL 34
IS 4
BP 659
EP 669
DI 10.1038/ijo.2009.299
PG 11
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 580WQ
UT WOS:000276481700009
PM 20142827
DA 2025-04-28
ER

PT J
AU Jalil, AMM
   Ismail, A
   Chong, PP
   Hamid, M
   Kamaruddin, SHS
AF Jalil, Abbe Maleyki Mhd
   Ismail, Amin
   Chong, Pei Pei
   Hamid, Muhajir
   Kamaruddin, Syed Hasbullah Syed
TI Effects of cocoa extract containing polyphenols and methylxanthines on
   biochemical parameters of obese-diabetic rats
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE cocoa extract; obese-diabetic (Ob-db); lipid profiles; insulin
   sensitivity
ID INSULIN SECRETORY DYSFUNCTION; CAFFEINE INGESTION; HDL-CHOLESTEROL;
   GLUCOSE-UPTAKE; CHOCOLATE; MODEL; FAT; ANTIOXIDANT; RESISTANCE;
   EXPRESSION
AB BACKGROUND: Previous studies have indicated that cocoa extract possesses hypoglycaemic and hypocholesterolaemic properties in streptozotocin-induced diabetic rats. However, there has been limited research on the effects of cocoa extract on obese-diabetic (Ob-db) rats that mimic human diabetes syndrome. Hence this study was initiated to determine the effect of cocoa extract containing polyphenols and methylxanthines on several biochemical parameters, namely glucose level, insulin sensitivity and lipid profiles of Ob-db rats.
   RESULTS: Intake of cocoa extract supplemented with polyphenols (2.17 mg epicatechin, 1.52 mg catechin, 0.25 mg dimer and 0.13 mg trimer g(-1) cocoa extract) and methylxanthines (3.55 mg caffeine and 2.22 mg theobromine g(-1) cocoa extract) for 4 weeks significantly (P < 0.05) reduced the plasma total cholesterol, triglycerides and low-density lipoprotein cholesterol of obese-diabetic rats (Ob-db + cocoa) compared with non-supplemented animals (Ob-db). Short-term (acute) supplementation of cocoa extract significantly (P < 0.05) reduced the plasma glucose level at 60 and 90 min compared with untreated rats as assessed by the oral glucose tolerance test. However, no significant differences were observed in plasma glucose level, insulin level and insulin sensitivity after chronic (4 weeks) cocoa extract supplementation.
   CONCLUSION: The results of this study suggest that cocoa extract possesses hypocholesterolaemic properties and can exert a transient glucose-lowering effect but not long-term glucose control. (C) 2008 Society of Chemical Industry
C1 [Jalil, Abbe Maleyki Mhd; Ismail, Amin; Kamaruddin, Syed Hasbullah Syed] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Selangor, Malaysia.
   [Chong, Pei Pei] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Selangor, Malaysia.
   [Hamid, Muhajir] Univ Putra Malaysia, Fac Biotechnol & Mol Sci, Dept Microbiol, Serdang 43400, Selangor, Malaysia.
C3 Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra
   Malaysia
RP Ismail, A (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Selangor, Malaysia.
EM amin@medic.upm.edu.my
RI Chong, Pei/AAP-4227-2021; Ismail, Amin/J-8725-2015; Mhd Jalil, Abbe
   Maleyki/Y-3659-2018; Chong, Pei Pei/G-1367-2018
OI Hamid, Muhajir/0000-0002-2475-7628; Ismail, Amin/0000-0002-9427-2028;
   Mhd Jalil, Abbe Maleyki/0000-0002-0051-4533; Chong, Pei
   Pei/0000-0002-8229-3593
CR Adamson GE, 1999, J AGR FOOD CHEM, V47, P4184, DOI 10.1021/jf990317m
   Amin I., 2004, Nutrition & Food Science, V34, P116, DOI 10.1108/00346650410536737
   Amin I, 2004, J MED FOOD, V7, P7, DOI 10.1089/109662004322984635
   Baba S, 2007, J NUTR, V137, P1436, DOI 10.1093/jn/137.6.1436
   Baba S, 2007, AM J CLIN NUTR, V85, P709, DOI 10.1093/ajcn/85.3.709
   Brand-Miller J, 2003, J NUTR, V133, P3149, DOI 10.1093/jn/133.10.3149
   Buchanan Thomas A., 2003, Clinical Therapeutics, V25, pB32, DOI 10.1016/S0149-2918(03)80241-2
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Cooper KA, 2008, BRIT J NUTR, V99, P1, DOI 10.1017/S0007114507795296
   Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y
   Heiss C, 2007, J CARDIOVASC PHARM, V49, P74, DOI 10.1097/FJC.0b013e31802d0001
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099
   Kelm MA, 2006, J AGR FOOD CHEM, V54, P1571, DOI 10.1021/jf0525941
   Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832
   Lee S, 2005, DIABETES CARE, V28, P566, DOI 10.2337/diacare.28.3.566
   Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200
   Matteucci E, 2008, J ETHNOPHARMACOL, V115, P163, DOI 10.1016/j.jep.2007.08.040
   Najjar N, 2004, NUTR RES, V24, P993, DOI 10.1016/j.nutres.2004.09.002
   Neukam K, 2007, EUR J NUTR, V46, P53, DOI 10.1007/s00394-006-0627-6
   Pal S, 2003, J NUTR, V133, P700, DOI 10.1093/jn/133.3.700
   Purintrapiban J, 2006, BIOL PHARM BULL, V29, P1995, DOI 10.1248/bpb.29.1995
   Ramljak D, 2005, MOL CANCER THER, V4, P537, DOI 10.1158/1535-7163.MCT-04-0286
   Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721
   Rein D, 2000, J NUTR, V130, p2109S, DOI 10.1093/jn/130.8.2109S
   Rensen PCN, 1996, J BIOL CHEM, V271, P14791, DOI 10.1074/jbc.271.25.14791
   Rios LY, 2003, AM J CLIN NUTR, V77, P912, DOI 10.1093/ajcn/77.4.912
   Ruzaidi A, 2005, J ETHNOPHARMACOL, V98, P55, DOI 10.1016/j.jep.2004.12.018
   Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004
   Tomaru M, 2007, NUTRITION, V23, P351, DOI 10.1016/j.nut.2007.01.007
   Tomas-Barberán FA, 2007, J AGR FOOD CHEM, V55, P3926, DOI 10.1021/jf070121j
   Vinson JA, 1999, J AGR FOOD CHEM, V47, P4821, DOI 10.1021/jf990312p
   Vinson JA, 2006, J AGR FOOD CHEM, V54, P8071, DOI 10.1021/jf062175j
   Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231
   Weyer C, 2001, DIABETES CARE, V24, P89, DOI 10.2337/diacare.24.1.89
   Wilcox LJ, 2001, J LIPID RES, V42, P725
   Zeggwagh NA, 2006, J ETHNOPHARMACOL, V108, P223, DOI 10.1016/j.jep.2006.05.005
   Zhang FL, 2003, EXP ANIM TOKYO, V52, P401, DOI 10.1538/expanim.52.401
   Ziai SA, 2005, J ETHNOPHARMACOL, V102, P202, DOI 10.1016/j.jep.2005.06.042
NR 41
TC 31
Z9 36
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JAN 15
PY 2009
VL 89
IS 1
BP 130
EP 137
DI 10.1002/jsfa.3419
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 384VY
UT WOS:000261773500017
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Törrönen, R
   Sarkkinen, E
   Tapola, N
   Hautaniemi, E
   Kilpi, K
   Niskanen, L
AF Torronen, Riitta
   Sarkkinen, Essi
   Tapola, Niina
   Hautaniemi, Elina
   Kilpi, Kyllikki
   Niskanen, Leo
TI Berries modify the postprandial plasma glucose response to sucrose in
   healthy subjects
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Berries; Polyphenols; Sucrose; Glucose response
ID BORDER-MEMBRANE-VESICLES; GASTROINTESTINAL HORMONE-SECRETION; EMARGINATA
   DC. FRUIT; ALPHA-GLUCOSIDASE; PHENOLIC-COMPOUNDS; INHIBITORY-ACTIVITY;
   CHLOROGENIC ACID; OAT GUM; POLYPHENOLS; INSULIN
AB Sucrose increases postprandial blood glucose concentrations, and diets with a high glycaemic response may be associated with increased risk of obesity, type 2 diabetes and CVD. Previous studies have suggested that polyphenols may influence carbohydrate digestion and absorption and thereby postprandial glycaemia. Berries are rich sources of various polyphenols and berry products are typically consumed with sucrose. We investigated the glycaemic effect of a berry puree made of bilberries, blackcurrants, cranberries and strawberries, and sweetened with sucrose, in comparison to sucrose with adjustment of available carbohydrates. A total of twelve healthy subjects (eleven women and one man, aged 25-69 years) with normal fasting plasma glucose ingested 150 g of the berry puree with 35 g sucrose or a control sucrose load in a randomised, controlled cross-over design. After consumption of the berry meal, the plasma glucose concentrations were significantly lower at 15 and 30 min (P<0.05, P<0.01, respectively) and significantly higher at 150 min (P<0.05) compared with the control meal. The peak glucose concentration was reached at 45 min after the berry meal and at 30 min after the control meal. The peak increase from the baseline was 1.0 mmol/l smaller (P=0.002) after ingestion of the berry meal. There was no statistically significant difference in the 3 h area under the glucose response curve. These results show that berries rich in polyphenols decrease the postprandial glucose response of sucrose in healthy subjects. The delayed and attenuated glycaemic response indicates reduced digestion and/or absorption of sucrose from the berry meal.
C1 [Torronen, Riitta] Univ Kuopio, Food & Hlth Res Ctr, Dept Clin Nutr, FI-70211 Kuopio, Finland.
   [Sarkkinen, Essi; Tapola, Niina; Hautaniemi, Elina] Foodfiles Ltd, Kuopio, Finland.
   [Kilpi, Kyllikki] Finnsugar Ltd, Kantvik, Finland.
   [Niskanen, Leo] Kuopio Univ Hosp, Inst Med, SF-70210 Kuopio, Finland.
C3 University of Eastern Finland; Kuopio University Hospital; University of
   Eastern Finland; University of Eastern Finland Hospital
RP Törrönen, R (corresponding author), Univ Kuopio, Food & Hlth Res Ctr, Dept Clin Nutr, POB 1627, FI-70211 Kuopio, Finland.
EM riitta.torronen@uku.fi
FU Finnsugar Ltd.
FX The study was funded by Finnsugar Ltd.
CR Adisakwattana S, 2004, J ENZYM INHIB MED CH, V19, P313, DOI 10.1080/14756360409162443
   Adisakwattana S, 2009, J ENZYM INHIB MED CH, V24, P65, DOI [10.1080/14756360801906947, 10.1080/14756360801906947 ]
   BRAATEN JT, 1991, AM J CLIN NUTR, V53, P1425, DOI 10.1093/ajcn/53.6.1425
   Buchert J, 2005, J SCI FOOD AGR, V85, P2548, DOI 10.1002/jsfa.2284
   Cermak R, 2004, BRIT J NUTR, V91, P849, DOI 10.1079/BJN20041128
   Fineli, 2004, FINN FOOD COMP DAT
   Hanamura T, 2005, BIOSCI BIOTECH BIOCH, V69, P280, DOI 10.1271/bbb.69.280
   Hanamura T, 2006, BIOSCI BIOTECH BIOCH, V70, P1813, DOI 10.1271/bbb.50592
   Iwai K, 2006, J AGR FOOD CHEM, V54, P4588, DOI 10.1021/jf0606353
   Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Johnston KL, 2002, J SCI FOOD AGR, V82, P1800, DOI 10.1002/jsfa.1264
   Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832
   Koponen JM, 2007, J AGR FOOD CHEM, V55, P1612, DOI 10.1021/jf062897a
   LEVIN RJ, 1994, AM J CLIN NUTR, V59, p690S, DOI 10.1093/ajcn/59.3.690S
   Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414
   Määttä-Riihinen KR, 2004, J AGR FOOD CHEM, V52, P4477, DOI 10.1021/jf049595y
   Määttä-Riihinen KR, 2004, J AGR FOOD CHEM, V52, P6178, DOI 10.1021/jf049450r
   Matsiu T, 2002, J AGR FOOD CHEM, V50, P7244, DOI 10.1021/jf025913m
   Matsui T, 2001, J AGR FOOD CHEM, V49, P1952, DOI 10.1021/jf0012502
   Matsui T, 2007, J AGR FOOD CHEM, V55, P99, DOI 10.1021/jf0627672
   Mattila P, 2006, J AGR FOOD CHEM, V54, P7193, DOI 10.1021/jf0615247
   McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926
   Ovaskainen ML, 2008, J NUTR, V138, P562
   Pinto MDS, 2008, J AGR FOOD CHEM, V56, P4386, DOI 10.1021/jf0732758
   Schäfer A, 2007, DIABETES RES CLIN PR, V77, P41, DOI 10.1016/j.diabres.2006.10.011
   Song J, 2002, J BIOL CHEM, V277, P15252, DOI 10.1074/jbc.M110496200
   Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149
   Tappy L, 1996, DIABETES CARE, V19, P831, DOI 10.2337/diacare.19.8.831
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   WELSCH CA, 1989, J NUTR, V119, P1737, DOI 10.1093/jn/119.11.1737
   WELSCH CA, 1989, J NUTR, V119, P1698, DOI 10.1093/jn/119.11.1698
   Wilson T, 2008, J MED FOOD, V11, P46, DOI 10.1089/jmf.2007.531
   Wood PJ, 2007, J CEREAL SCI, V46, P230, DOI 10.1016/j.jcs.2007.06.012
   WOOD PJ, 1994, BRIT J NUTR, V72, P731, DOI 10.1079/BJN19940075
NR 35
TC 126
Z9 138
U1 4
U2 53
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
J9 BRIT J NUTR
JI Br. J. Nutr.
PD APR 28
PY 2010
VL 103
IS 8
BP 1094
EP 1097
DI 10.1017/S0007114509992868
PG 4
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 590ST
UT WOS:000277248800002
PM 19930765
OA Bronze
DA 2025-04-28
ER

PT J
AU Nwakiban, APA
   Sokeng, AJ
   Dell'Agli, M
   Bossi, L
   Beretta, G
   Gelmini, F
   Tchamgoue, AD
   Agbor, GA
   Kuiaté, JR
   Daglia, M
   Magni, P
AF Nwakiban, Achille Parfait Atchan
   Sokeng, Arold Jorel
   Dell'Agli, Mario
   Bossi, Lorenzo
   Beretta, Giangiacomo
   Gelmini, Fabrizio
   Tchamgoue, Armelle Deutou
   Agbor, Gabriel Agbor
   Kuiate, Jules-Roger
   Daglia, Maria
   Magni, Paolo
TI Hydroethanolic plant extracts from Cameroon positively modulate enzymes
   relevant to carbohydrate/lipid digestion and cardio-metabolic diseases
SO FOOD & FUNCTION
LA English
DT Article
ID INHIBITORY-ACTIVITIES; PANCREATIC LIPASE; IN-VITRO; ANGIOTENSIN;
   PEPTIDES; MODERATE; SYSTEM
AB Cardiovascular diseases are the greatest cause of death globally and are frequently associated with type 2 diabetes mellitus and metabolic syndrome, a condition including visceral obesity, hypertension, elevated triglycerides and low HDL cholesterol and hyperglycaemia. Several medicinal plants, including spices, are used in Cameroon as herbal medicines and are traditionally employed for the treatment of several ailments such as diabetes and related diseases. In this study, we chemically characterized eleven Cameroonian spice extracts and evaluated their effects on some enzyme activities relevant to carbohydrate and lipid digestion and cardio-metabolic diseases. Hydroethanolic spice extracts were characterized by GC-MS analysis and screened for their ability to modulate the activity of alpha-glucosidase, alpha-amylase, pancreatic lipase, 3-hydroxy-3-methylglutaryl-coenzyme A reductase and angiotensin-converting enzyme (ACE). Among the spice extracts tested, those from Xylopia parviflora showed the widest inhibitory spectrum, with a relevant effect on all enzyme activities. Dichrostachys glomerata and Aframomum citratum extracts were more selective. The selected and strong activity of some plants, such as that of Aframomum citratum on pancreatic lipase and that of Xylopia aethiopica on ACE, suggests their specific use in obesity and hypertension, respectively. Chemical analysis indicated that for some spice extracts such as Xylopia parviflora and Aframomum citratum their secondary metabolites (chlorogenic acid, pimaric acid, and catechin and its derivatives) could potentially justify the biological properties observed. Our findings clearly show significant inhibition of cardio-metabolic enzymes by hydroethanolic Cameroonian spice extracts, suggesting the potential usefulness of nutraceuticals derived from these plants to develop novel management strategies for obesity and diabetes complications.
C1 [Nwakiban, Achille Parfait Atchan; Kuiate, Jules-Roger] Univ Dschang, Fac Sci, Dept Biochem, Dschang, Cameroon.
   [Sokeng, Arold Jorel; Daglia, Maria] Univ Napoli Federico II, Dipartimento Farm, Naples, Italy.
   [Dell'Agli, Mario; Bossi, Lorenzo; Magni, Paolo] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.
   [Beretta, Giangiacomo; Gelmini, Fabrizio] Univ Milan, Dept Environm Sci & Policy, Milan, Italy.
   [Tchamgoue, Armelle Deutou; Agbor, Gabriel Agbor] Inst Med Res & Med Plants Studies IMPM, Yaounde, Cameroon.
   [Daglia, Maria] Jiangsu Univ, Int Res Ctr Food Nutr & Safety, Zhenjiang, Jiangsu, Peoples R China.
   [Magni, Paolo] IRCCS MultiMed, Sesto San Giovanni, Italy.
C3 Universite de Dschang; University of Naples Federico II; University of
   Milan; University of Milan; Jiangsu University; IRCCS Multimedica
RP Daglia, M (corresponding author), Univ Napoli Federico II, Dipartimento Farm, Naples, Italy.; Magni, P (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.; Daglia, M (corresponding author), Jiangsu Univ, Int Res Ctr Food Nutr & Safety, Zhenjiang, Jiangsu, Peoples R China.; Magni, P (corresponding author), IRCCS MultiMed, Sesto San Giovanni, Italy.
EM maria.daglia@unina.it; paolo.magni@unimi.it
RI Magni, Paolo/AAC-2918-2019; Agbor, Gabriel/AAZ-7990-2020; beretta,
   giangiacomo/D-3861-2011; Mario, Dellagli/E-5253-2011; Kuiate,
   Jules-Roger/U-9881-2019; Daglia, Maria/AAC-9498-2019; NWAKIBAN ATCHAN,
   Achille Parfait/AAX-6396-2021; Agbor, Gabriel/J-8377-2013
OI Daglia, Maria/0000-0002-4870-7713; MAGNI, PAOLO/0000-0002-2254-8881;
   NWAKIBAN ATCHAN, Achille Parfait/0000-0003-1660-7125; Dell'Agli,
   Mario/0000-0001-5378-402X; Agbor, Gabriel/0000-0001-5860-9853; Beretta,
   Giangiacomo/0000-0003-0987-0857
FU Italian Ministry of Foreign Affairs and International Cooperation
   (MAECI)
FX A. P. A. N. is the recipient of a research fellowship from the Italian
   Ministry of Foreign Affairs and International Cooperation (MAECI), for
   which the authors are grateful. This work was funded by internal funds
   to P. M. and M. D.
CR Adefegha Stephen A, 2016, Pathophysiology, V23, P191, DOI 10.1016/j.pathophys.2016.05.005
   Adefegha Stephen A., 2012, Journal of Basic and Clinical Physiology and Pharmacology, V23, P153, DOI 10.1515/jbcpp-2012-0029
   Ananya D., 2015, ASIAN PAC J TROP BIO, V5, P1042
   Baskaran G, 2015, DRUG DES DEV THER, V9, P509, DOI 10.2147/DDDT.S75056
   Beretta G, 2011, J PHARMACEUT BIOMED, V55, P1255, DOI 10.1016/j.jpba.2011.03.026
   Brewer Rachel A, 2016, Nutr Healthy Aging, V4, P31, DOI 10.3233/NHA-160007
   Butterweck V, 2012, PLANTA MED, V78, P747, DOI 10.1055/s-0031-1298434
   Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005
   Carey RM, 2003, ENDOCR REV, V24, P261, DOI 10.1210/er.2003-0001
   Catapano AL, 2016, ATHEROSCLEROSIS, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018
   Dzoyem JP, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-58
   Ekanem AP, 2007, PHYTOTHER RES, V21, P1253, DOI 10.1002/ptr.2239
   Fankam AG, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-104
   Hou WC, 2003, J AGR FOOD CHEM, V51, P1706, DOI 10.1021/jf0260242
   Isganaitis E, 2005, ARTERIOSCL THROM VAS, V25, P2451, DOI 10.1161/01.ATV.0000186208.06964.91
   Jimenez-Ferrer E, 2010, J ETHNOPHARMACOL, V130, P340, DOI 10.1016/j.jep.2010.05.013
   Ko MM, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014543
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Laurent S, 2017, PHARMACOL RES, V124, P116, DOI 10.1016/j.phrs.2017.07.026
   Soares RAM, 2015, INT J MOL SCI, V16, P4150, DOI 10.3390/ijms16024150
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Oliveira VB, 2018, FOOD RES INT, V105, P989, DOI 10.1016/j.foodres.2017.11.079
   Pilitsi E, 2019, METABOLISM, V92, P170, DOI 10.1016/j.metabol.2018.10.010
   Pinto MD, 2009, BIORESOURCE TECHNOL, V100, P6599, DOI 10.1016/j.biortech.2009.07.021
   Pradhan R, 2002, J DIABETES COMPLICAT, V16, P377, DOI 10.1016/S1056-8727(02)00188-5
   Roh C, 2012, INT J MOL SCI, V13, P1710, DOI 10.3390/ijms13021710
   Ruscica M, 2018, EUR J NUTR, V57, P499, DOI 10.1007/s00394-016-1333-7
   Ruscica M, 2014, J CLIN LIPIDOL, V8, P61, DOI 10.1016/j.jacl.2013.11.003
   Ryden L., 2013, EUR HEART J, V34
   Singla RK, 2016, CURR TOP MED CHEM, V16, P2625, DOI 10.2174/1568026616666160414123500
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644
   Worthington V., 1993, Worthington Enzyme Manual
   Wu TT, 2011, J ETHNOPHARMACOL, V136, P305, DOI 10.1016/j.jep.2011.04.059
   Zheng CD, 2010, J CHIN MED ASSOC, V73, P319, DOI 10.1016/S1726-4901(10)70068-X
NR 34
TC 16
Z9 16
U1 1
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD OCT 1
PY 2019
VL 10
IS 10
BP 6533
EP 6542
DI 10.1039/c9fo01664c
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA JE9BP
UT WOS:000490983800024
PM 31539010
DA 2025-04-28
ER

PT J
AU Jang, YS
   Kim, HY
   Zuo, G
   Lee, EH
   Kang, SK
   Lim, SS
AF Jang, Young Soo
   Kim, Hyun-Yong
   Zuo, Guanglei
   Lee, Eun Hee
   Kang, Sung Kwon
   Lim, Soon Sung
TI Constituents from Solidago virgaurea var. gigantea and
   their inhibitory effect on lipid accumulation
SO FITOTERAPIA
LA English
DT Article
DE Solidago viraurea var. gigantean (Nakai); Anti-adipogenic activity;
   Lipid accumulation; (1R,2S,3S,5R,7S)-methyl 7-((cinnamoyloxy)
   methyl)-2,3-dihydroxy-6,8-dioxabicyclo[3.2.1]; octane-5-carboxylate
ID ACID; EXTRACT; OBESITY
AB In this study, the anti-adipogenic activities of compounds isolated from Solidago viraurea var. gigantea (SG) extracts were investigated using Oil Red O staining in the 3T3-L1 cell line. Four known compounds including 3,5-di-O-caffeoylquinic acid (5), protocatechuic acid (6), chlorogenic acid (7), and kaempferol-3-O-rutinoside (8), and four undescribed compounds including (1R,2S,3S,5R,7S)-methyl 7-((cinnamoyloxy)methyl)-2,3-dihydroxy-6,8-dioxabicyclo[3.2.1]-octane-5-carboxylate (1), (1R,2S,3S,5R,7S)-methyl 2,3-dihydroxy-7-((((Z)-3-phenylacryloyl)oxy)methyl)-6,8-dioxabicyclo[3.2.1]-octane-5-carboxylate (2), (1R,2S,3S,5R,7S)-2,3-dihydroxy-7((((Z)-3-phenylacryloyl)oxy)methyl)-6,8-dioxabicyclo[3.2.1]-octane-5-carboxylic acid (3), and (1R,2S,3S,5R,7S)7-((cinnamoyloxy)methyl)-2,3-dihydroxy-6,8-dioxabicyclo-[3.2.1]-octane-5-carboxylic acid (4) were isolated from S. viraurea var. gigantea. The structures of the compounds were first identified by comparing their H-1 NMR spectra with spectral data from the literature and a more detailed identification was then performed using 2D NMR (Correlated spectroscopy (COSY), heteronuclear single quantum correlation (HSQC), heteronuclear multiple bond correlation (HMBC), and nuclear overhauser spectroscopy (NOESY)), and X-ray crystallography analyses. The anti-adipogenic activities of all compounds were evaluated by MTT assay and Oil Red O staining in 3T3-L1 cells. 3,5-di-O-caffeoylquinic acid was found to inhibit lipid accumulation more potently than the other tested compounds.
C1 [Jang, Young Soo; Kim, Hyun-Yong; Zuo, Guanglei; Lim, Soon Sung] Hallym Univ, Dept Food Sci & Nutr, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
   [Lee, Eun Hee] Korea Univ, Coll Pharm, 2511 Sejong Ro, Sejong 339700, South Korea.
   [Kang, Sung Kwon] Chungnam Natl Univ, Dept Chem, 99 Daehak Ro, Daejeon 305746, South Korea.
   [Lim, Soon Sung] Hallym Univ, Inst Korean Nutr, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
   [Lim, Soon Sung] Hallym Univ, Inst Nat Med, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
C3 Hallym University; Korea University; Chungnam National University;
   Hallym University; Hallym University
RP Lim, SS (corresponding author), Hallym Univ, Dept Food Sci & Nutr, 1 Hallymdeahak Gil, Chunchon 24252, South Korea.
EM limss@hallym.ac.kr
RI Kim, Soon Hee/GXF-6736-2022; Kim, Soo-Jin/P-2677-2014; Zuo,
   Guanglei/AAG-8172-2021
OI Lee, Eun Hee/0000-0003-2289-8520; Zuo, Guanglei/0000-0003-4052-2543
FU Hallym University Research Fund [HRF-201908-009]
FX This research was supported by Hallym University Research Fund
   (HRF-201908-009).
CR Amen YM, 2015, NAT PROD RES, V29, P511, DOI 10.1080/14786419.2014.952233
   Back CG, 2014, MYCOBIOLOGY, V42, P79, DOI 10.5941/MYCO.2014.42.1.79
   Bhattarai BR, 2010, BIOORG MED CHEM LETT, V20, P6758, DOI 10.1016/j.bmcl.2010.08.130
   Choi SZ, 2004, ARCH PHARM RES, V27, P164, DOI 10.1007/BF02980100
   Gutzeit D, 2007, CHROMATOGRAPHIA, V65, P1, DOI 10.1365/s10337-006-0105-6
   Hu XQ, 2016, J FUNCT FOODS, V21, P372, DOI 10.1016/j.jff.2015.12.006
   Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927
   Hwang SH, 2017, J ANAL METHODS CHEM, V2017, DOI 10.1155/2017/3047408
   Jang YS, 2016, MOLECULES, V21, DOI 10.3390/molecules21020226
   Kim H. S., 1996, THESIS
   Lee J., 2004, THESIS
   Lee T. B., 1979, ILLUSTRATED FLORA KO
   Lei F, 2007, INT J OBESITY, V31, P1023, DOI 10.1038/sj.ijo.0803502
   LEUSCHNER J, 1995, ARZNEIMITTELFORSCH, V45-1, P165
   Lim S.S., 2016, KO patent, Patent No. 1020160093055
   Ono Y, 2006, J ETHNOPHARMACOL, V106, P238, DOI 10.1016/j.jep.2005.12.036
   Sajiki H., 2008, SYNFACTS, V2008, P890
   SAKUSHIMA A, 1985, PHYTOCHEMISTRY, V24, P325, DOI 10.1016/S0031-9422(00)83545-1
   Sergent T, 2012, FOOD CHEM, V135, P68, DOI 10.1016/j.foodchem.2012.04.074
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   Tong J, 2015, J AGR FOOD CHEM, V63, P10791, DOI 10.1021/acs.jafc.5b04552
   Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118
   Wang ZQ, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2016.1273479
   Williams DJ, 2013, FOOD RES INT, V52, P323, DOI 10.1016/j.foodres.2013.03.015
NR 24
TC 3
Z9 4
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0367-326X
EI 1873-6971
J9 FITOTERAPIA
JI Fitoterapia
PD OCT
PY 2020
VL 146
AR 104683
DI 10.1016/j.fitote.2020.104683
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA OE3IF
UT WOS:000580427700029
PM 32634454
DA 2025-04-28
ER

PT J
AU Hameed, S
   Arshad, MS
   Ahmad, RS
   Hussain, G
   Imran, M
   Arshad, MU
   Ahmed, A
   Imran, M
   Imran, A
AF Hameed, Saleeha
   Arshad, Muhammad Sajid
   Ahmad, Rabia Shabir
   Hussain, Ghulam
   Imran, Muhammad
   Arshad, Muhammad Umair
   Ahmed, Aftab
   Imran, Muhammad
   Imran, Ali
TI Potential preventive and protective perspectives of different spice
   powders and their mixtures in rat model
SO LIPIDS IN HEALTH AND DISEASE
LA English
DT Article
DE Fenugreek seeds; Black cumin seeds; Efficacy trial; Physical parameters;
   Lipid profile; Hyperglycemia
ID TRIGONELLA-FOENUM-GRAECUM; ANTIOXIDANT ACTIVITY; SODIUM-ORTHOVANADATE;
   NUTRITIONAL-VALUE; FENUGREEK SEEDS; THYMOQUINONE; ALPHA; L.; CAPACITY;
   EXTRACTS
AB Background The spices based dietary interventions are in lime light among the scientific community owing to their promising therapeutic perspective. The bioactive components in spices can be used to exert various health promoting functions in human body such as prompting weight loss, inhibit diet-induced obesity, hypercholesterolemia, hyperglycemia, allergies and various other maladies. In current study extraction and in vitro characterization of coriander seed (CS), black cumin seed (BCS) and fenugreek seed (FS) polyphenols was conducted for further development of dietary intervention against lipid and glycemia related abnormalities in experimental Sprague Dowley rats fed with control and different spice powder supplemented diets. Methods Purposely, extraction of Coriander (CS), Black cumin (BCS) and Fenugreek seeds (FS) were carried out by using water and aqueous methanol (70:30 v/v). Afterwards, the resultant extracts were thoroughly investigated for their antioxidant potential through different indices like TPC, TFC, FRAP and beta Carotene Bleaching Assay and ABTS. Furthermore, HPLC quantification were also conducted with special reference to thymoquinone, disogenin, chlorogenic acid, caffeic acid and kaempferol alongside in vitro pancreatic lipase inhibitory activity estimation. Bio-evaluation trial was consisting of three modules i.e. study-I (normal diet), study-II (high cholesterol diet) and study-III (high sucrose diet). Furthermore, rats were sub-divided in five groups in each module on the basis of diet provision including T-0 (control), T-1 (Diet containing CS), T-2 (Diet containing BCS), T-3 (Diet containing FS) and T-4 (Diet containing CSP + BCSP + FSP). At the beginning of trial, some rats were dissected to evaluate the baseline values whilst rest of the rats was killed at the termination (56th day). Feed and drink intakes were quantified on daily bases whereas, body weight was calculated weekly. Cholesterol level, serum low density lipoproteins (LDL), high density lipoproteins (HDL), triglycerides, glucose concentration and insulin level of collected sera was measured by standard procedures. Results The in vitro characterization showed better extraction of spices antioxidant through aqueous methanol as compared to water. Among the spices, Black cumin seed alone or in combination revealed highest antioxidant activity in T2 (BCS) followed by T4 (CS + BCS), T7 (CS + BCS + FS), T1 (CS), T6 (BCS + FS), T5 (CS + FS) and lowest in T3 (FS). Likewise, the HPLC characterization showed the presence of thymoquinone in BCS, Dosignienin FGS and chlorogenic acid, caffeic acid and kaempferol in the other treatments. Furthermore, all the treatments showed dose dependent inhibition in Pancreatic lipase activity and order of inhibition was BCS > CS + BCS > CS + BCS + FS > CS > BCS + FC > CS + FS > FS. The maximum feed intake, drink intake and weight gain was observed in T0 (control) trailed by T1, T2, T3 and T4 group in experimental study I, II and III, respectively. The resultant diet T4 enhanced the high density lipoprotein from T0 (58.58 +/- 2.51) to 61.71 +/- 1.62 (T4) in hypercholesterolemia rats whereas in hyperglycaemia rats the HDL was varied from 38.77 +/- 1.2 to 40.02 +/- 0.99 in T0 and T4, respectively. Similarly, T2 significantly lowered the low density lipoprotein from 62.53 +/- 1.22 (T1) & 46.53 +/- 0.99 to 54.88 +/- 0.52 & 40.94 +/- 1.99 (T2) in hypercholesteraemic and diabetic rats.
   Moreover, T4 treatment showed maximum reduction as 10.01 & 11.53% in respective studies.
   Conclusions The diet prepared from the different combination of spices has been proven effective against Oxidative stress related physiological malfunctioning.
C1 [Hameed, Saleeha; Arshad, Muhammad Sajid; Ahmad, Rabia Shabir; Imran, Muhammad; Arshad, Muhammad Umair; Ahmed, Aftab; Imran, Ali] Govt Coll Univ, Inst Home & Food Sci, Fac Life Sci, Faisalabad, Pakistan.
   [Hussain, Ghulam] Govt Coll Univ, Fac Life Sci, Dept Physiol, Faisalabad, Pakistan.
   [Imran, Muhammad] Univ Lahore Pakistan, Univ Inst Diet & Nutr Sci, Fac Allied Hlth Sci, Lahore, Pakistan.
C3 Government College University Faisalabad; Government College University
   Faisalabad
RP Imran, A (corresponding author), Govt Coll Univ, Inst Home & Food Sci, Fac Life Sci, Faisalabad, Pakistan.
EM aliimran.ft@gmail.com
RI Arshad, Muhammad Umair/JGE-1765-2023; HUSSAIN, Ghulam/LLM-1486-2024;
   imran, muhammad/AAZ-4199-2021; Imran, Ali/J-1316-2019; Arshad,
   Muhammad/AAR-4975-2020; Ahmad, Rabia/AAW-9737-2021; Ahmed,
   Aftab/AFO-5670-2022; Imran, Muhammad/ABG-5094-2021; Imran,
   Muhammad/B-1724-2010
OI Ahmad, Rabia Shabir/0000-0003-2946-3626; Ahmed,
   Aftab/0000-0003-0912-7596; Imran, Muhammad/0000-0002-2363-5039
FU Higher Education Commission of Pakistan
FX Financial assistance for this study was provided by Higher Education
   Commission of Pakistan.
CR Al Haj M., 2011, J MED SCI, V4, P73, DOI [10.2174/1996327001104020073, DOI 10.2174/1996327001104020073]
   Al-Ghamdi MS, 2001, J ETHNOPHARMACOL, V76, P45, DOI 10.1016/S0378-8741(01)00216-1
   Al-Habori M, 2001, PHARM PROPERTIES FEN, P163
   Al-Saleh IA, 2006, J FOOD COMPOS ANAL, V19, P167, DOI 10.1016/j.jfca.2005.04.011
   ALAM P, 2013, ASIAN PAC J TROP DIS, V3, P467, DOI DOI 10.1016/S2222-1808(13)60102-4
   Alshatwi AA, 2010, NUTR RES, V30, P66, DOI 10.1016/j.nutres.2009.12.002
   Anfenan M. L. K., 2014, World Applied Sciences Journal, V30, P1504
   [Anonymous], 2011, Pakistan Journal of Nutrition, DOI DOI 10.3923/PJN.2011.162.167
   [Anonymous], 2012, International Journal of Pharmacological Science
   Badary OA, 2000, TOXICOLOGY, V143, P219, DOI 10.1016/S0300-483X(99)00179-1
   Badary OA, 2003, DRUG CHEM TOXICOL, V26, P87, DOI 10.1081/DCT-120020404
   Billaud C, 2001, SCI ALIMENT, V21, P3, DOI 10.3166/sda.21.3-26
   Bohm V, 2002, J AGR FOOD CHEM, V50, P221, DOI 10.1021/jf010888q
   Burits M, 2000, PHYTOTHER RES, V14, P323, DOI 10.1002/1099-1573(200008)14:5<323::AID-PTR621>3.0.CO;2-Q
   Butt MS, 2010, CRIT REV FOOD SCI, V50, P654, DOI 10.1080/10408390902768797
   Caduff A, 2011, DIABETOLOGIA, V10, P2210
   Carlsen MH, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-37
   Danladi J., 2013, IOSR J DENT MED SCI, V4, P56, DOI [DOI 10.9790/0853-0435662, 10.9790/0853-0435662]
   Dhanapakiam P, 2008, J ENVIRON BIOL, V29, P53
   Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028
   El Rahman A. M. A., 2014, WORLD APPL SCI J, V29, p[7, 835]
   Huang CS, 2011, FOOD CHEM TOXICOL, V49, P2189, DOI 10.1016/j.fct.2011.05.032
   Imran A, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0808-3
   Inove M, 1987, J PROTEIN CHEM, V36, P169
   Iqbal M, 2013, ASIAN PAC J TROP DIS, V3, P467
   Jaworski J, 2003, CURR OPIN PLANT BIOL, V6, P178, DOI 10.1016/S1369-5266(03)00013-X
   Kaleem M., 2006, Indian Journal of Experimental Biology, V44, P745
   Kankana Das Kankana Das, 2015, Journal of Advanced Pharmacy Education and Research, V5, P44
   Kawabata T, 2011, PLANTA MED, V77, P705, DOI 10.1055/s-0030-1250477
   Khole S, 2014, J FUNCT FOODS, V6, P270, DOI 10.1016/j.jff.2013.10.016
   Kim JY, 2011, ATHEROSCLEROSIS, V215, P189, DOI 10.1016/j.atherosclerosis.2010.11.036
   Kubde MS, 2010, REPORT OPINION, V2, P91, DOI DOI 10.7537/MARSROJ021210.01
   Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852
   Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013
   Mohammad S, 2006, CAN J PHYSIOL PHARM, V84, P647, DOI 10.1139/Y05-164
   Müller L, 2011, FOOD CHEM, V129, P139, DOI 10.1016/j.foodchem.2011.04.045
   Norziah MH, 2015, INT FOOD RES J, V22, P1261
   Ok-Kim D, 2002, CURR PROTOC FOOD ANA, V3, pI131
   Padhye Subhash, 2008, Cancer Ther, V6, P495
   Patel K, 2002, NAHRUNG, V46, P394, DOI [10.1002/1521-3803(20021101)46:6<394::AID-FOOD394>3.0.CO;2-D, DOI 10.1002/1521-3803(20021101)46:6<394::AID-FOOD394>3.0.CO;2-D]
   Pellegrini N, 2006, MOL NUTR FOOD RES, V50, P1030, DOI 10.1002/mnfr.200600067
   Rubio CP, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0792-7
   Preet A, 2006, MOL CELL BIOCHEM, V289, P137, DOI 10.1007/s11010-006-9156-0
   Ramadan MF, 2007, INT J FOOD SCI TECH, V42, P1208, DOI 10.1111/j.1365-2621.2006.01417.x
   Sharma MM, 1999, CORIANDER HDB HERBS, P1
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   SOLIMAN G., 2012, Med. J. Cairo Univ., V80, P191
   Souri E, 2008, DARU, V16, P83
   Srinivasan K, 2006, FOOD REV INT, V22, P203, DOI 10.1080/87559120600586315
   Steele R.G.D., 1997, PRINCIPLES PROCEDURE, V3rd
   Sultan MT, 2011, FUNCT FOODS HEALTH D, V1, P516, DOI 10.31989/ffhd.v1i12.109
   TAGA MS, 1984, J AM OIL CHEM SOC, V61, P928, DOI 10.1007/BF02542169
   Ulbricht Catherine, 2008, Journal of Herbal Pharmacotherapy, V7, P143, DOI 10.1080/15228940802142852
   Wu R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170003
   Yadav UCS, 2004, J BIOSCIENCES, V29, P81, DOI 10.1007/BF02702565
   Yuan YH, 2003, LANGMUIR, V19, P3705, DOI 10.1021/la026368m
   Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n
   Zou YP, 2004, J AGR FOOD CHEM, V52, P5032, DOI 10.1021/jf049571r
NR 58
TC 5
Z9 5
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1476-511X
J9 LIPIDS HEALTH DIS
JI Lipids Health Dis.
PD APR 23
PY 2020
VL 19
IS 1
AR 78
DI 10.1186/s12944-020-01223-9
PG 14
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA LJ4KB
UT WOS:000530134100001
PM 32326942
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Wei, YF
   An, Q
   Li, JY
   Song, H
   Ji, XD
   Yang, YJ
   Yue, GR
AF Wei, Yangfei
   An, Qiong
   Li, Jianyin
   Song, Hai
   Ji, Xiangdong
   Yang, Yongjian
   Yue, Guoren
TI Fingerprint and multicomponent quantitative analysis for the quality
   evaluation of Sibiraea angustata leaves by HPLC-DAD and
   HPLC-ESI-MS/MS combined with chemometrics
SO JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
LA English
DT Article
DE Fingerprint; HPLC-DAD; HPLC-ESI-MS/MS; multicomponent quantitative
   analysis; quality evaluation; Sibiraea angustata leaves
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; MEDICINE; SAMPLES
AB Sibiraea angustata leaves, known as a traditional Tibetan medicine, have been specially used in the treatment of indigestion and obesity. In the study, a simple and sensitive high-performance liquid chromatography (HPLC) method with a diode array detector (DAD) was established to solve the problem of lacking quality standard of S. angustata leaves, including the fingerprint analysis and quantification of six characteristic components. The analytical method was validated for linearity, repeatability, stability, recovery, and specificity. Seventeen raw samples and 1 processed sample of S. angustata leaves were collected from different locations of China to establish the fingerprint. The chemometric methods, including similarity analysis (SA), principal component analysis (PCA), and hierarchical clustering analysis (HCA), were applied to distinguish the 18 batches of S. angustata samples. The results successfully sorted these samples into five clusters and kept in line with each other. According to the result of the fingerprint analysis, 21 peaks were extracted to be the common peaks and most of them were identified by mass spectrometry (MS) with electron-spray ionization (ESI) in the negative mode. Meanwhile, the loading plot of PCA further indicated that the peaks of neochlorogenic acid, chlorogenic acid, ferulic acid, rutin, hyperin, and isoquercitrin played a greater role in the discrimination among the 21 peaks. So the six components mentioned above were investigated as index constituents to evaluate the quality of S. angustata leaves from different locations. The study demonstrated that the developed new method was a beneficial approach for authentication and quality evaluation of S. angustata leaves.
C1 [Wei, Yangfei; Song, Hai; Ji, Xiangdong; Yue, Guoren] Hexi Univ, Key Lab Hexi Corridor Resources Utilizat Gansu, Zhangye 734000, Peoples R China.
   [An, Qiong] Hexi Univ, Inst Integrat Tradit Chinese & Western Med, Zhangye, Peoples R China.
   [Li, Jianyin; Yang, Yongjian] Lanzhou Univ, Coll Pharm, Lanzhou, Peoples R China.
C3 Hexi University; Hexi University; Lanzhou University
RP Song, H (corresponding author), Hexi Univ, Key Lab Hexi Corridor Resources Utilizat Gansu, Zhangye 734000, Peoples R China.
EM wyfhxxy@163.com
FU Funds of Young Teacher for Hexi University [QN2014-15]; Principal Funds
   of Scientific Research Innovation for Hexi University [XZ2015-20];
   Second Five-Year Plan to develop education scientific planning project
   for the Gansu Province [GS[2014]GHB0305]
FX This work was supported by the Funds of Young Teacher for Hexi
   University (No. QN2014-15), the Principal Funds of Scientific Research
   Innovation for Hexi University (No. XZ2015-20), and the Second Five-Year
   Plan to develop education scientific planning project for the Gansu
   Province in 2014 (No. GS[2014]GHB0305).
CR Ablajan K, 2006, J MASS SPECTROM, V41, P352, DOI 10.1002/jms.995
   [Anonymous], 2011, TRADITIONAL CHINESE
   Cui LL, 2016, IND CROP PROD, V85, P29, DOI 10.1016/j.indcrop.2016.02.043
   Ding XX, 2015, ANAL METHODS-UK, V7, P961, DOI [10.1039/C4AY02115K, 10.1039/c4ay02115k]
   Duan Bowen, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1466
   Ju L., 2016, ASIA PAC TRADIT MED, V12, P45
   Li B, 2015, PHYTOCHEM LETT, V13, P319, DOI 10.1016/j.phytol.2015.07.009
   Li Dan, 2014, Zhongguo Zhong Yao Za Zhi, V39, P2305
   [刘昕 Liu Xin], 2003, [中国病理生理杂志, Chinese Journal of Pathophysiology], V19, P253
   Ni YNA, 2012, ANAL METHODS-UK, V4, P171, DOI 10.1039/c1ay05661a
   Ni YN, 2009, ANAL CHIM ACTA, V647, P149, DOI 10.1016/j.aca.2009.06.021
   Ren Biao Ren Biao, 2014, Journal of Chinese Pharmaceutical Sciences, V23, P642
   Sharma DK, 2016, J CHROMATOGR SCI, V54, P536, DOI 10.1093/chromsci/bmv182
   Shi L., 2009, LISHIZHEN MED MAT ME, V20, P2091
   Wang J.B., 2010, TRADITIONAL CHINESE, V21, P176
   Wang Zhang-wei, 2014, Zhong Yao Cai, V37, P57
   Wang ZW, 2013, PHYTOCHEM LETT, V6, P461, DOI 10.1016/j.phytol.2013.05.016
   Xia Miao, 2011, Zhong Yao Cai, V34, P922
   Xiao L, 2010, EXP BIOL MED, V235, P1442, DOI 10.1258/ebm.2010.010167
   Xie PS, 2009, J CHROMATOGR A, V1216, P1933, DOI 10.1016/j.chroma.2008.08.045
   [闫志慧 Yan Zhihui], 2014, [应用化学, Chinese Journal of Applied Chemistry], V31, P237
   Yang Mei Yang Mei, 2004, Chinese Journal of Natural Medicines, V2, P301
   Yao L., 2009, CHIN J INTEGR TRAD W, V17, P376
   [姚莉 YAO Li], 2010, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V30, P483
   Zhai HL, 2014, FOOD CHEM, V145, P625, DOI 10.1016/j.foodchem.2013.08.112
   Zhang DL, 2015, J SEP SCI, V38, P3337, DOI 10.1002/jssc.201500451
   Zhao RN., 2004, The Gansu herbal medicine resource records, P31
   Zhao Yuan, 2012, Journal of Beijing Normal University (Natural Science), V48, P621
   Zhou YanLin Zhou YanLin, 2013, China Journal of Traditional Chinese Medicine and Pharmacy, V28, P1392
NR 29
TC 4
Z9 5
U1 0
U2 16
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1082-6076
EI 1520-572X
J9 J LIQ CHROMATOGR R T
JI J. Liq. Chromatogr. Relat. Technol.
PY 2017
VL 40
IS 9
BP 449
EP 458
DI 10.1080/10826076.2017.1320290
PG 10
WC Biochemical Research Methods; Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA FA5LQ
UT WOS:000405485200003
DA 2025-04-28
ER

PT J
AU Lee, YJ
   Yu, SY
   Lee, JS
   Kim, MD
   Lee, DW
   Kim, KJ
   Lee, OH
AF Lee, Young-Jun
   Yu, Seok-Yeong
   Lee, Jong Seok
   Kim, Myoung-Dong
   Lee, Dae-Won
   Kim, Kui-Jin
   Lee, Ok-Hwan
TI Anti-Adipogenic and Anti-Oxidant Activities of Mugwort and Pine Needles
   Fermented Using Leuconostoc mesenteroides 1076
SO FOOD BIOTECHNOLOGY
LA English
DT Article
DE fermentation; pine needle; lipid accumulation; mugwort; anti-oxidant
   activities
ID HYPERTONIC SALINE; LIPID-METABOLISM; FLAVONOIDS; MANNITOL;
   DIFFERENTIATION; POLYPHENOLS; ADIPOCYTES; INHIBITION; VEGETABLES;
   RECEPTOR
AB In this study, we investigated the antioxidant and anti-adipogenic activities of aqueous extracts of mugwort and pine needles fermented by Leuconostoc mesenteroides 1076. We also evaluated the phenolic composition, total phenolic content and flavonoid contents of both the fermented mugwort extract (FME) and fermented pine needle extract (FPE). The antioxidant potentials of the FME and FPE were assessed using various antioxidant assays, including the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical assay, the 2,2-azino-bis-(3-ethylenebenzothiozoline-6-sulfonic acid) (ABTS) radical scavenging assay, the ferric-reducing antioxidant power (FRAP) assay, and the reducing power assay. In addition, the anti-adipogenic effects of the FME and FPE were investigated during the adipogenesis of 3T3-L1 cells. Our results showed that the total phenolic contents of the FME and FPE were 182 +/- 4 and 116 +/- 5 mg GAE/g, respectively. Among the phenolic compounds, chlorogenic acid was found to be the major phenolic acid in the FPE, whereas hesperetin was found to be the major phenolic acid in the FME. The antioxidant activities of the FME and FPE increased in a dose-dependent manner. The FME exhibited higher antioxidant activities than the FPE. Furthermore, both the FME and FPE inhibited lipid accumulation and reactive oxygen species (ROS) production, which involved the down-regulation of peroxisome proliferator-activated receptor gamma (PPAR gamma), adipocyte protein 2 (aP2) and NADPH oxidase 4 (NOX4) mRNA expression. These results indicated that the FPE and FME could be useful in the treatment of obesity and as natural sources of antioxidants.
C1 [Lee, Young-Jun; Yu, Seok-Yeong; Lee, Jong Seok; Kim, Myoung-Dong; Lee, Ok-Hwan] Kangwon Natl Univ, Dept Food Sci & Biotechnol, Chunchon 200701, South Korea.
   [Lee, Dae-Won] Jeongseon Yaccho Co Ltd, Jeongseon, South Korea.
   [Kim, Kui-Jin] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.
C3 Kangwon National University; University System of Maryland; University
   of Maryland College Park
RP Lee, OH (corresponding author), Kangwon Natl Univ, Dept Food Sci & Biotechnol, Chunchon 200701, South Korea.
EM loh99@kangwon.ac.kr
RI Lee, Youngjun/JMQ-1570-2023; Lee, Ho-jeong/S-4934-2019; LEE,
   Daewon/GWZ-8418-2022; Kim, Jeong-ah/Q-2453-2016
OI Lee, Ok-Hwan/0000-0001-6855-3136
FU Small and Medium Business Administration [C1008390-01-02,
   C-1008143-01-01]
FX This study was supported by a 2011 Research Grant from the Small and
   Medium Business Administration (C1008390-01-02 & C-1008143-01-01).
CR Amro B, 2002, FITOTERAPIA, V73, P456, DOI 10.1016/S0367-326X(02)00173-9
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200
   Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047
   Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936
   Cao FL, 2012, POULTRY SCI, V91, P1210, DOI 10.3382/ps.2011-01886
   Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6
   Choi M. Y., 1997, KOREAN J APPL MICROB, V25, P293
   Chu YH, 2000, J SCI FOOD AGR, V80, P561, DOI 10.1002/(SICI)1097-0010(200004)80:5<561::AID-JSFA574>3.0.CO;2-#
   Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009
   Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200
   Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   GUTFINGER T, 1981, J AM OIL CHEM SOC, V58, P966, DOI 10.1007/BF02659771
   HANASAKI Y, 1994, FREE RADICAL BIO MED, V16, P845, DOI 10.1016/0891-5849(94)90202-X
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Hunaefi D, 2013, FOOD BIOTECHNOL, V27, P66, DOI 10.1080/08905436.2012.755694
   Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184
   Lee Hyogee, 2002, [Korean Journal of Food and Cookery Science, 한국식품조리과학회지], V18, P164
   Lee OH, 2012, PHYTOTHER RES, V26, P403, DOI 10.1002/ptr.3568
   Lee OH, 2011, PHYTOTHER RES, V25, P106, DOI 10.1002/ptr.3236
   Lee YL, 2008, FOOD CHEM, V106, P1128, DOI 10.1016/j.foodchem.2007.07.047
   김소윤, 2013, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V42, P325
   Liu Q, 2011, J ASIAN NAT PROD RES, V13, P714, DOI 10.1080/10286020.2011.586341
   Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x
   MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8
   MEISTER A, 1988, J BIOL CHEM, V263, P17205
   Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883
   Moreno MIN, 2000, J ETHNOPHARMACOL, V71, P109, DOI 10.1016/S0378-8741(99)00189-0
   Moure A, 2001, FOOD CHEM, V72, P145, DOI 10.1016/S0308-8146(00)00223-5
   Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596
   Ou BX, 2002, J AGR FOOD CHEM, V50, P3122, DOI 10.1021/jf0116606
   OYAIZU M, 1988, J JPN SOC FOOD SCI, V35, P771
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Roginsky V, 2005, FOOD CHEM, V92, P235, DOI 10.1016/j.foodchem.2004.08.004
   Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145
   Shafi G, 2012, MOL BIOL REP, V39, P7373, DOI 10.1007/s11033-012-1569-0
   Shi Ham Seung, 2005, 한국식품저장유통학회지, V12, P179
   Soetaert W, 1999, METH BIOTEC, V10, P261
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Tan RX, 1998, PLANTA MED, V64, P295, DOI 10.1055/s-2006-957438
   Tiwari AK, 2001, J AGR FOOD CHEM, V49, P4642, DOI 10.1021/jf010573a
   Toda S, 2004, J MED FOOD, V7, P52, DOI 10.1089/109662004322984707
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Wang CY, 2011, J SCI FOOD AGR, V91, P2271, DOI 10.1002/jsfa.4450
   Yamamoto N, 2010, BIOSCI BIOTECH BIOCH, V74, P2036, DOI 10.1271/bbb.100305
   Zeng WC, 2012, INT J FOOD MICROBIOL, V153, P78, DOI 10.1016/j.ijfoodmicro.2011.10.019
NR 50
TC 5
Z9 6
U1 0
U2 16
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0890-5436
EI 1532-4249
J9 FOOD BIOTECHNOL
JI Food Biotechnol.
PD APR 3
PY 2014
VL 28
IS 2
BP 79
EP 95
DI 10.1080/08905436.2014.895945
PG 17
WC Biotechnology & Applied Microbiology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA AG1SZ
UT WOS:000335197700001
DA 2025-04-28
ER

PT J
AU Aryal, D
   Joshi, S
   Thapa, NK
   Chaudhary, P
   Basaula, S
   Joshi, U
   Bhandari, D
   Rogers, HM
   Bhattarai, S
   Sharma, KR
   Regmi, BP
   Parajuli, N
AF Aryal, Dipa
   Joshi, Soniya
   Thapa, Nabin Kumar
   Chaudhary, Pratiksha
   Basaula, Sirjana
   Joshi, Usha
   Bhandari, Damodar
   Rogers, Hannah M.
   Bhattarai, Salyan
   Sharma, Khaga Raj
   Regmi, Bishnu P.
   Parajuli, Niranjan
TI Dietary phenolic compounds as promising therapeutic agents for diabetes
   and its complications: A comprehensive review
SO FOOD SCIENCE & NUTRITION
LA English
DT Review
DE Anti-obesity; Enzyme Inhibition; Medicinal Plants; alpha-Amylase;
   alpha-Glucosidase
ID ALPHA-GLUCOSIDASE; AMELIORATES HYPERGLYCEMIA; INSULIN SENSITIVITY;
   OXIDATIVE STRESS; NATURAL-PRODUCTS; INHIBITORY-ACTIVITY; CANCER
   PREVENTION; MORINGA-OLEIFERA; ROSMARINIC ACID; BLOOD-GLUCOSE
AB In the middle of an ever-changing landscape of diabetes care, precision medicine, and lifestyle therapies are becoming increasingly important. Dietary polyphenols are like hidden allies found in our everyday meals. These biomolecules, found commonly in fruits, vegetables, and various plant-based sources, hold revolutionary potential within their molecular structure in the way we approach diabetes and its intimidating consequences. There are currently numerous types of diabetes medications, but they are not appropriate for all patients due to limitations in dosages, side effects, drug resistance, a lack of efficacy, and ethnicity. Currently, there has been increased interest in practicing herbal remedies to manage diabetes and its related complications. This article aims to summarize the potential of dietary polyphenols as a foundation in the treatment of diabetes and its associated consequences. We found that most polyphenols inhibit enzymes linked to diabetes. This review outlines the potential benefits of selected molecules, including kaempferol, catechins, rosmarinic acid, apigenin, chlorogenic acid, and caffeic acid, in managing diabetes mellitus as these compounds have exhibited promising results in in vitro, in vivo, in silico, and some preclinical trials study. This encompassing exploration reveals the multifaceted impact of polyphenols not only in mitigating diabetes but also in addressing associated conditions like inflammation, obesity, and even cancer. Their mechanisms involve antioxidant functions, immune modulation, and proinflammatory enzyme regulation. Furthermore, these molecules exhibit anti-tumor activities, influence cellular pathways, and activate AMPK pathways, offering a less toxic, cost-effective, and sustainable approach to addressing diabetes and its complications.
C1 [Aryal, Dipa; Joshi, Soniya; Thapa, Nabin Kumar; Chaudhary, Pratiksha; Basaula, Sirjana; Joshi, Usha; Bhandari, Damodar; Sharma, Khaga Raj; Parajuli, Niranjan] Tribhuvan Univ, Cent Dept Chem, Biol Chem Lab, Kathmandu, Nepal.
   [Rogers, Hannah M.; Regmi, Bishnu P.] Florida A&M Univ, Dept Chem Engn, Tallahassee, FL USA.
   [Bhattarai, Salyan] Paraza Pharma Inc, Montreal, PQ, Canada.
   [Parajuli, Niranjan] Tribhuvan Univ, Cent Dept Chem, Biol Chem Lab, Kathmandu 44618, Nepal.
C3 Tribhuvan University; State University System of Florida; Florida A&M
   University; Tribhuvan University
RP Parajuli, N (corresponding author), Tribhuvan Univ, Cent Dept Chem, Biol Chem Lab, Kathmandu 44618, Nepal.
EM niranjan.parajuli@cdc.tu.edu.np
RI Sharma, Khaga/AAT-9805-2020; Parajuli, Niranjan/HZI-4045-2023; Aryal,
   Dipa/IXD-8356-2023; Joshi, Soniya/JDV-8663-2023; REGMI,
   BISHNU/H-6810-2019
OI Thapa, Nabin kumar/0009-0009-6281-8899; Joshi,
   Soniya/0009-0005-0165-0181; Aryal, Dipa/0000-0002-3586-0655; Bhandari,
   Damodar/0009-0004-7051-2463; Basaula, Sirjana/0009-0004-9397-357X;
   Joshi, Usha/0009-0009-3238-601X; Chaudhary,
   Pratiksha/0000-0002-9731-6698
FU University Grants Commission- Nepal; Office of Undergraduate Research,
   Division of Academic Affairs at Florida AM University
FX Hannah M. Rogers is thankful to the Office of Undergraduate Research,
   Division of Academic Affairs at Florida A&M University for the support.
CR Addepalli V, 2018, BIOMED PHARMACOTHER, V108, P1517, DOI 10.1016/j.biopha.2018.09.179
   Adisakwattana S, 2009, J ENZYM INHIB MED CH, V24, P1194, DOI 10.1080/14756360902779326
   Afrin S, 2020, BIOTECHNOL ADV, V38, DOI 10.1016/j.biotechadv.2018.11.011
   Ahmadieh Hala, 2013, ISRN Endocrinol, V2013, P181240, DOI 10.1155/2013/181240
   Ahmed S, 2022, MOLECULES, V27, DOI 10.3390/molecules27144526
   Ajiboye B. O., 2023, Informatics in Medicine Unlocked, DOI 10.1016/j.imu.2022.101126
   Akhtar MT, 2020, TROP J PHARM RES, V19, P283, DOI 10.4314/tjpr.v19i2.10
   Al-Numair KS, 2015, REDOX REP, V20, P198, DOI 10.1179/1351000214Y.0000000117
   Al-Salahi R, 2018, FUTURE MED CHEM, V10, P1889, DOI 10.4155/fmc-2018-0141
   Alam S, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.800714
   Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x
   Aleixandre A, 2022, FOOD CHEM, V372, DOI 10.1016/j.foodchem.2021.131231
   Alkhalidy H, 2018, J NUTR BIOCHEM, V58, P90, DOI 10.1016/j.jnutbio.2018.04.014
   Aloo SO, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12020416
   Amoah SKS, 2016, PLANTA MED, V82, P388, DOI 10.1055/s-0035-1568274
   Annapurna HV, 2013, J MOL GRAPH MODEL, V39, P87, DOI 10.1016/j.jmgm.2012.10.009
   [Anonymous], 2023, GLOB DIAB CAS SOAR 5
   Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174
   Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x
   Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f
   BAK JF, 1992, DIABETOLOGIA, V35, P777
   Balez R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31450
   Barky A.R.E., 2020, Int J. Clin. Case Rep. Rev., V3, P32, DOI 10.31579/2690-4861/03
   Barrett EJ, 2017, J CLIN ENDOCR METAB, V102, P4343, DOI 10.1210/jc.2017-01922
   Bellik Y, 2013, MOLECULES, V18, P322, DOI 10.3390/molecules18010322
   Bello M, 2021, BIOCATAL AGR BIOTECH, V36, DOI 10.1016/j.bcab.2021.102111
   Bishayee A, 2016, SEMIN CANCER BIOL, V40-41, P1, DOI 10.1016/j.semcancer.2016.08.006
   Calvo MB, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/205357
   BompardGilles C, 1996, STRUCTURE, V4, P1441, DOI 10.1016/S0969-2126(96)00151-7
   Bontpart T, 2016, J EXP BOT, V67, P3537, DOI 10.1093/jxb/erw184
   Cardullo N, 2019, J NAT PROD, V82, P573, DOI 10.1021/acs.jnatprod.8b01002
   Chen AY, 2013, FOOD CHEM, V138, P2099, DOI 10.1016/j.foodchem.2012.11.139
   Chen J, 2018, CELL PHYSIOL BIOCHEM, V48, P1164, DOI 10.1159/000491983
   Chen LY, 2022, FOOD RES INT, V151, DOI 10.1016/j.foodres.2022.111202
   Choi MS, 2008, DIABETES-METAB RES, V24, P74, DOI 10.1002/dmrr.780
   Ciumarnean L, 2020, MOLECULES, V25, DOI 10.3390/molecules25184320
   Cole JB, 2020, NAT REV NEPHROL, V16, P377, DOI 10.1038/s41581-020-0278-5
   Cremonini E, 2019, FREE RADICAL BIO MED, V130, P478, DOI 10.1016/j.freeradbiomed.2018.11.010
   Davalli P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/984219
   Den Hartogh DJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010058
   Deng YL, 2023, NUTRIENTS, V15, DOI 10.3390/nu15224820
   Devi KP, 2015, PHARMACOL RES, V99, P1, DOI 10.1016/j.phrs.2015.05.002
   Dey G, 2002, J IND MICROBIOL BIOT, V28, P193, DOI 10.1038/sj.jim.7000220
   Diabetes, 2023, About us
   Dogan A, 2019, MOL BIOL REP, V46, P3049, DOI 10.1007/s11033-019-04741-7
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Dong WW, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.971213
   Dudonné S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r
   Ebrahimi E, 2017, JUNDISHAPUR J NAT PH, V12, DOI 10.5812/jjnpp.31657
   Eketunde AO, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8010
   Ellulu MS, 2022, BMC ENDOCR DISORD, V22, DOI 10.1186/s12902-021-00925-0
   Emiliani G, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-7
   Fabricant DS, 2001, ENVIRON HEALTH PERSP, V109, P69, DOI 10.2307/3434847
   Farrell TL, 2011, DRUG METAB DISPOS, V39, P2338, DOI 10.1124/dmd.111.040147
   Feng H, 2017, PLANTA MED, V83, P837, DOI 10.1055/s-0043-103415
   Focaccetti C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071714
   Fraser Christopher M, 2011, Arabidopsis Book, V9, pe0152, DOI 10.1199/tab.0152
   Gupta SK, 2013, J OCUL PHARMACOL TH, V29, P419, DOI 10.1089/jop.2012.0089
   Hanalp HC, 2023, Z NATURFORSCH C, V78, P189, DOI 10.1515/znc-2022-0082
   Hassan A, 2022, J CHEM-NY, V2022, DOI 10.1155/2022/9046780
   Hausenblas HA, 2015, MOL NUTR FOOD RES, V59, P147, DOI 10.1002/mnfr.201400173
   Hedrington MS, 2019, EXPERT OPIN PHARMACO, V20, P2229, DOI 10.1080/14656566.2019.1672660
   HERMANS MMP, 1991, J BIOL CHEM, V266, P13507
   Hossain U, 2020, FOOD CHEM TOXICOL, V145, DOI 10.1016/j.fct.2020.111738
   Ibitoye OB, 2018, J FOOD BIOCHEM, V42, DOI 10.1111/jfbc.12479
   Iqbal Z, 2018, CLIN THER, V40, P828, DOI 10.1016/j.clinthera.2018.04.001
   Islam F, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/5649156
   Kato M, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8608497
   Kaur P, 2023, S AFR J BOT, V162, P519, DOI 10.1016/j.sajb.2023.09.040
   Kawaguchi H, 2017, BIORESOURCE TECHNOL, V245, P1664, DOI 10.1016/j.biortech.2017.06.135
   Kazeem MI, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/527570
   Keshari AK, 2016, J ETHNOPHARMACOL, V181, P252, DOI 10.1016/j.jep.2016.02.004
   Kim M, 2020, NUTR RES PRACT, V14, P252, DOI 10.4162/nrp.2020.14.3.252
   Kong MJ, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.110975
   Kooti Wesam, 2016, Electron Physician, V8, P1832, DOI 10.19082/1832
   Lee YJ, 2015, FOOD FUNCT, V6, P2824, DOI 10.1039/c5fo00481k
   Li H, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020215
   Li H, 2023, FOOD CHEM, V420, DOI 10.1016/j.foodchem.2023.136113
   Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629
   Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172
   Liu HJ, 2017, MOL CELL BIOCHEM, V428, P9, DOI 10.1007/s11010-016-2913-9
   Liu J, 2018, ACS APPL MATER INTER, V10, P16315, DOI 10.1021/acsami.8b03868
   Lo Piparo E, 2008, J MED CHEM, V51, P3555, DOI 10.1021/jm800115x
   Lu CC, 2015, CURR OPIN FOOD SCI, V2, P1, DOI 10.1016/j.cofs.2014.11.002
   Lucier J., 2023, StatPearls
   Macciò A, 2011, THESCIENTIFICWORLDJO, V11, P2020, DOI 10.1100/2011/806787
   Maradesha T, 2022, MOLECULES, V27, DOI 10.3390/molecules27061888
   Mathew S, 2015, J FOOD SCI TECH MYS, V52, P5790, DOI 10.1007/s13197-014-1704-0
   McIntyre HD, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0098-8
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Mensah M.L., 2019, Herbal Medicine, P63, DOI DOI 10.5772/INTECHOPEN.72437
   Miao M, 2014, FOOD HYDROCOLLOID, V38, P180, DOI 10.1016/j.foodhyd.2013.12.006
   Mohamed G. A., 2014, Bulletin of the Faculty of Pharmacy, Cairo University, V52, P269, DOI 10.1016/j.bfopcu.2014.05.001
   Espíndola KMM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00541
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Naz R, 2023, MOLECULES, V28, DOI 10.3390/molecules28103996
   Nazir N, 2021, MOLECULES, V26, DOI 10.3390/molecules26010137
   Nikinmaa M, 2014, INTRODUCTION TO AQUATIC TOXICOLOGY, P111, DOI 10.1016/B978-0-12-411574-3.00011-6
   Nowotny K, 2015, BIOMOLECULES, V5, P194, DOI 10.3390/biom5010194
   Okutan H, 2005, CLIN BIOCHEM, V38, P191, DOI 10.1016/j.clinbiochem.2004.10.003
   Orsolic N, 2021, MOLECULES, V26, DOI 10.3390/molecules26113262
   Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P320, DOI 10.1016/S2221-1691(12)60032-X
   Patil VM, 2019, STUD NAT PROD CHEM, V59, P401, DOI 10.1016/B978-0-444-64179-3.00012-8
   Patwardhan B., 2012, AYURVEDA METABOLIC D, DOI [10.13140/RG.2.1.1204.6563, DOI 10.13140/RG.2.1.1204.6563]
   Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515
   Peng CH, 2020, FOOD FUNCT, V11, P483, DOI [10.1039/c9fo02240f, 10.1039/C9FO02240F]
   Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7
   Proença C, 2019, J ENZYM INHIB MED CH, V34, P577, DOI 10.1080/14756366.2018.1558221
   Sun Q, 2014, WORLD J DIABETES, V5, P89, DOI 10.4239/wjd.v5.i2.89
   Ramalingam S, 2020, ALL LIFE, V13, P120, DOI 10.1080/26895293.2020.1733104
   Rehman K, 2019, J CELL BIOCHEM, V120, P425, DOI 10.1002/jcb.27398
   Ren B, 2016, EUR J PHARMACOL, V773, P13, DOI 10.1016/j.ejphar.2016.01.002
   Roy A, 2022, BIOMED RES INT, V2022, DOI 10.1155/2022/5445291
   Runtuwene J, 2016, DRUG DES DEV THER, V10, P2193, DOI 10.2147/DDDT.S108539
   Sagoo MK, 2020, METHODS MOL BIOL, V2067, P3, DOI 10.1007/978-1-4939-9841-8_1
   Salahuddin P, 2021, INT J BIOL MACROMOL, V186, P580, DOI 10.1016/j.ijbiomac.2021.07.056
   Salem AM, 2019, INDIAN J CLIN BIOCHE, V34, P296, DOI 10.1007/s12291-018-0743-0
   Salleh NH, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/5570939
   Samarghandian S, 2017, DOSE-RESPONSE, V15, DOI 10.1177/1559325817691158
   Samec D, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10010118
   Santos-Sanchez N.F., 2019, Plant Physiol. Aspects of Phenolic Compounds, P1, DOI DOI 10.5772/INTECHOPEN.83815
   Rie S, 2007, BIOCHEM PHARMACOL, V74, P1619, DOI 10.1016/j.bcp.2007.08.008
   Schmidt RE, 2002, INT REV NEUROBIOL, V50, P257
   Seo YG, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/5850879
   Serna A, 2022, EUR J NUTR, V61, P825, DOI 10.1007/s00394-021-02678-x
   Shahwan M, 2022, INT J BIOL MACROMOL, V206, P567, DOI 10.1016/j.ijbiomac.2022.03.004
   Shanak S, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/5515775
   Sharma P, 2020, J ETHNOPHARMACOL, V248, DOI 10.1016/j.jep.2019.112268
   Sheng ZW, 2018, INT J FOOD SCI TECH, V53, P755, DOI 10.1111/ijfs.13579
   Shi HT, 2016, CLIN NUTR, V35, P1366, DOI 10.1016/j.clnu.2016.03.002
   Shin SA, 2020, MOLECULES, V25, DOI 10.3390/molecules25245932
   Siddiqui S, 2023, INT J BIOL MACROMOL, V245, DOI 10.1016/j.ijbiomac.2023.125497
   Silveira AC, 2019, CURR NEUROPHARMACOL, V17, P590, DOI 10.2174/1570159X16666180803162059
   Singh M, 2020, FUTURE FOODS, V1-2, DOI 10.1016/j.fufo.2020.100002
   Singh S, 2022, J DIABETES METAB DIS, V21, P941, DOI 10.1007/s40200-021-00943-8
   Su H, 2020, INT J BIOL MACROMOL, V150, P31, DOI 10.1016/j.ijbiomac.2020.02.027
   Sun CD, 2020, FOOD FRONTIERS, V1, P18, DOI 10.1002/fft2.15
   Sun G, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/708183
   Sun LJ, 2021, FOOD FUNCT, V12, P215, DOI [10.1039/d0fo02689a, 10.1039/D0FO02689A]
   Sun LJ, 2020, TRENDS FOOD SCI TECH, V104, P190, DOI 10.1016/j.tifs.2020.08.003
   Sun LJ, 2019, TRENDS FOOD SCI TECH, V91, P262, DOI 10.1016/j.tifs.2019.07.009
   Sur R, 2008, ARCH DERMATOL RES, V300, P569, DOI 10.1007/s00403-008-0858-x
   Tang L, 2023, NEURAL REGEN RES, V18, P976, DOI 10.4103/1673-5374.355743
   Taylor SI, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142243
   Tebbe C, 2014, ONCOTARGET, V5, P4746, DOI 10.18632/oncotarget.2012
   Terra W.R., 2005, Biochemistry and Molecular Biology, P171
   Tolmie M, 2021, J DIABETES, V13, P779, DOI 10.1111/1753-0407.13163
   TRUSCHEIT E, 1981, ANGEW CHEM INT EDIT, V20, P744, DOI 10.1002/anie.198107441
   Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007
   Ullah A, 2016, SAUDI PHARM J, V24, P547, DOI 10.1016/j.jsps.2015.03.013
   Venkatakrishnan K, 2018, FOOD FUNCT, V9, P1205, DOI 10.1039/c7fo01449j
   Vennos C., 2019, BIOACTIVE FOOD DIETA, P309, DOI [10.1016/B978-0-12-813822-9.00020-5, DOI 10.1016/B978-0-12-813822-9.00020-5]
   Verma RR, 2004, CHEMBIOCHEM, V5, P1188, DOI 10.1002/cbic.200400094
   Vincent AM, 2002, ANN NY ACAD SCI, V959, P368, DOI 10.1111/j.1749-6632.2002.tb02108.x
   Vlavcheski F, 2017, MOLECULES, V22, DOI 10.3390/molecules22101669
   Wang GR, 2020, FOOD CHEM, V304, DOI 10.1016/j.foodchem.2019.125446
   Wang QQ, 2014, BIOORGAN MED CHEM, V22, P1515, DOI 10.1016/j.bmc.2014.01.038
   Wang Y, 2022, FRONT ONCOL, V12, DOI 10.3389/fonc.2022.836058
   Wang Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0114792, 10.1371/journal.pone.0113603, 10.1371/journal.pone.0097907]
   Wen LH, 2022, NUTRIENTS, V14, DOI 10.3390/nu14214681
   Xie MG, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/3456542
   Xie T, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.796565
   Yan YW, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1042044
   Yan YW, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/9680508
   Yang Y, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.990299
   Yilmazer-Musa M, 2012, J AGR FOOD CHEM, V60, P8924, DOI 10.1021/jf301147n
   Yuan JM, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00949-4
   Yusni Y, 2018, SAUDI MED J, V39, P154, DOI 10.15537/smj.2018.2.21238
   Zeng L, 2016, J AGR FOOD CHEM, V64, P6939, DOI 10.1021/acs.jafc.6b02314
   Zhang HM, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/747982
   Zhang JF, 2022, FOOD RES INT, V157, DOI 10.1016/j.foodres.2022.111210
   Zhao L, 2020, NEUROSCI LETT, V716, DOI 10.1016/j.neulet.2019.134633
NR 172
TC 13
Z9 13
U1 11
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD MAY
PY 2024
VL 12
IS 5
BP 3025
EP 3045
DI 10.1002/fsn3.3983
EA JAN 2024
PG 21
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA PR0F4
UT WOS:001154077900001
PM 38726403
OA hybrid, Green Published
DA 2025-04-28
ER

PT J
AU Checkouri, E
   Reignier, F
   Robert-Da Silva, C
   Meilhac, O
AF Checkouri, Eloise
   Reignier, Franck
   Robert-Da Silva, Christine
   Meilhac, Olivier
TI Evaluation of Polyphenol Content and Antioxidant Capacity of Aqueous
   Extracts from Eight Medicinal Plants from Reunion Island: Protection
   against Oxidative Stress in Red Blood Cells and Preadipocytes
SO ANTIOXIDANTS
LA English
DT Article
DE antioxidant; medicinal plants; polyphenols; infusions; decoctions;
   pharmacopeia
ID PHENOLIC COMPOSITION; DIETARY POLYPHENOLS; LDL OXIDATION; FOOD SOURCES;
   BIOAVAILABILITY; ERYTHROCYTE; TEMPERATURE; MANGIFERIN; FLAVONOIDS;
   OBESITY
AB Background-Medicinal plants are traditionally used as infusions or decoctions for their antioxidant, anti-inflammatory, hypolipidemic and anti-diabetic properties. Purpose-The aim of the study was to define the polyphenol composition and to assess the antioxidant capacity of eight medicinal plants from Reunion Island referred to in the French Pharmacopeia, namely Aphloia theiformis, Ayapana triplinervis, Dodonaea viscosa, Hubertia ambavilla, Hypericum lanceolatum, Pelargonium x graveolens, Psiloxylon mauritianum and Syzygium cumini. Methods-Polyphenol content was assessed by biochemical assay and liquid chromatography coupled to mass spectrometry. Antioxidant capacity was assessed by measuring DPPH reduction and studying the protective effects of herbal preparation on red blood cells or preadipocytes exposed to oxidative stress. Results-Polyphenol content ranged from 25 to 143 mg gallic acid equivalent (GAE)/L for infusions and 35 to 205 mg GAE/L for decoctions. Liquid chromatography coupled to mass spectrometry analysis showed the presence of major bioactive polyphenols, such as quercetin, chlorogenic acid, procyanidin and mangiferin. Antioxidant capacity assessed by different tests, including DPPH and Human red blood cell (RBC) hemolysis of herbal preparations, demonstrated a dose-dependent effect whatever the extraction procedure. Our data suggest that decoction slightly improved polyphenol extraction as well as antioxidant capacity relative to the infusion mode of extraction (DPPH test). However, infusions displayed a better protective effect against oxidative stress-induced RBC hemolysis. Conclusion-Traditional preparations of medicinal plant aqueous extracts (infusions and decoctions) display antioxidant properties that limit oxidative stress in preadipocytes and red blood cells, supporting their use in the context of metabolic disease prevention and treatment.
C1 [Checkouri, Eloise; Robert-Da Silva, Christine; Meilhac, Olivier] Univ La Reunion, INSERM, UMR 1188 Diabete Aatherothombose Reunion Ocean In, F-97490 St Clotilde, La Reunion, France.
   [Checkouri, Eloise; Reignier, Franck] Habemus Papam, Food Ind, F-97470 St Benoit, La Reunion, France.
   [Meilhac, Olivier] CHU La Reunion, CIC 1410, F-97410 St Pierre, La Reunion, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   University of La Reunion; CHU Reunion; Institut National de la Sante et
   de la Recherche Medicale (Inserm)
RP Meilhac, O (corresponding author), Univ La Reunion, INSERM, UMR 1188 Diabete Aatherothombose Reunion Ocean In, F-97490 St Clotilde, La Reunion, France.; Meilhac, O (corresponding author), CHU La Reunion, CIC 1410, F-97410 St Pierre, La Reunion, France.
EM eloise.checkouri@gmail.com; dg.asbethleem@outlook.fr;
   christine.robert@univ-reunion.fr; olivier.meilhac@inserm.fr
RI Meilhac, Olivier/N-4385-2017
OI Meilhac, Olivier/0000-0002-3740-7539
FU EU-Region Reunion-French State national counterpart [FEDER RE0001897];
   BIOST Federation
FX This research was funded by FEDER RE0001897 (EU-Region Reunion-French
   State national counterpart), as well as the BIOST Federation.
CR [Anonymous], 2014, MED MALADIES METABOL, DOI DOI 10.1016/S1957-2557(14)70860-0
   [Anonymous], 2013, INT J PHARM SCI INVE
   Arya VS, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13369
   Becatti M, 2017, THROMB HAEMOSTASIS, V117, P2334, DOI 10.1160/TH17-05-0356
   Bonarska-Kujawa D, 2014, J MEMBRANE BIOL, V247, P611, DOI 10.1007/s00232-014-9677-5
   Brima EI, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101209
   Callcott ET, 2018, J APPL BIOMED, V16, P255, DOI 10.1016/j.jab.2018.03.001
   Carnat A, 2004, FITOTERAPIA, V75, P32, DOI 10.1016/j.fitote.2003.07.007
   Ciccone L, 2020, J ENZYM INHIB MED CH, V35, P1145, DOI 10.1080/14756366.2020.1760262
   D'Angelo C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9091932
   D'Archivio M, 2012, EUR J CLIN INVEST, V42, P70, DOI 10.1111/j.1365-2362.2011.02558.x
   Dai F, 2006, LIFE SCI, V78, P2488, DOI 10.1016/j.lfs.2005.10.009
   Dai J, 2010, MOLECULES, V15, P7313, DOI 10.3390/molecules15107313
   Danthu P, 2010, CHEM BIODIVERS, V7, P140, DOI 10.1002/cbdv.200900199
   Tavares IMD, 2016, FOOD RES INT, V82, P1, DOI 10.1016/j.foodres.2016.01.014
   de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156
   Delveaux J., ANTIRHEA BORBONICA A
   Dludla PV, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010023
   dos Santos MM, 2018, J ETHNOPHARMACOL, V210, P69, DOI 10.1016/j.jep.2017.08.033
   El Gharras H, 2009, INT J FOOD SCI TECH, V44, P2512, DOI 10.1111/j.1365-2621.2009.02077.x
   Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1
   Gangwar M., 2014, Scientific World Journal, DOI 10.1155/2014/279451
   Gauvin-Bialecki A, 2008, BIOCHEM SYST ECOL, V36, P853, DOI 10.1016/j.bse.2008.09.006
   Ghorbani A, 2017, BIOMED PHARMACOTHER, V96, P305, DOI 10.1016/j.biopha.2017.10.001
   Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Hatia S, 2014, FREE RADICAL RES, V48, P387, DOI 10.3109/10715762.2013.879985
   Heleno SA, 2015, FOOD CHEM, V173, P501, DOI 10.1016/j.foodchem.2014.10.057
   Vallejo MJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4586068
   Kang MR, 2015, INT IMMUNOPHARMACOL, V29, P914, DOI 10.1016/j.intimp.2015.10.020
   Kulkarni Vrushali M., 2018, Agriculture and Natural Resources, V52, P155, DOI 10.1016/j.anres.2018.07.001
   Kumarappan CT, 2012, SAUDI J BIOL SCI, V19, DOI 10.1016/j.sjbs.2012.04.004
   Lavergne R., 1989, THESIS
   Li XW, 2018, MOLECULES, V23, DOI 10.3390/molecules23123245
   Lobo FA, 2017, FOOD CHEM, V221, P258, DOI 10.1016/j.foodchem.2016.10.080
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mothana RAA, 2010, EVID-BASED COMPL ALT, V7, P323, DOI 10.1093/ecam/nen004
   Neergheen-Bhujun VS, 2014, J HERB MED, V4, P1, DOI 10.1016/j.hermed.2013.11.002
   Nimse SB, 2015, RSC ADV, V5, P27986, DOI 10.1039/c4ra13315c
   Nowicka A, 2019, FOOD CHEM, V270, P32, DOI 10.1016/j.foodchem.2018.07.015
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Pavan V, 2017, NAT PROD RES, V31, P632, DOI 10.1080/14786419.2016.1214830
   Pérez-Burillo S, 2018, FOOD CHEM, V248, P111, DOI 10.1016/j.foodchem.2017.12.056
   Pérez-Jiménez J, 2010, EUR J CLIN NUTR, V64, pS112, DOI 10.1038/ejcn.2010.221
   Rangasamy O, 2014, S AFR J BOT, V93, P198, DOI 10.1016/j.sajb.2014.03.017
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Santhakumar AB, 2018, FOOD CHEM TOXICOL, V113, P49, DOI 10.1016/j.fct.2018.01.022
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Septembre-Malaterre A, 2016, FOOD CHEM, V212, P225, DOI 10.1016/j.foodchem.2016.05.147
   Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035
   Sung YY, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2152-6
   Tresserra-Rimbau A, 2018, BIOCHEM PHARMACOL, V156, P186, DOI 10.1016/j.bcp.2018.07.050
   Villaño D, 2007, TALANTA, V71, P230, DOI 10.1016/j.talanta.2006.03.050
   Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x
   Wan L, 2018, J FUNCT FOODS, V44, P283, DOI 10.1016/j.jff.2018.03.015
   Wang TY, 2018, ASIAN J PHARM SCI, V13, P12, DOI 10.1016/j.ajps.2017.08.004
   Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234
   Yang QQ, 2019, J BIOMECH, V95, DOI 10.1016/j.jbiomech.2019.07.045
   Zanforlin E, 2017, CURR MED CHEM, V24, P3749, DOI 10.2174/0929867324666170712161829
   Zou Y, 2017, J CHROMATOGR B, V1060, P443, DOI 10.1016/j.jchromb.2017.06.026
NR 62
TC 22
Z9 24
U1 3
U2 22
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD OCT
PY 2020
VL 9
IS 10
AR 959
DI 10.3390/antiox9100959
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA OJ6VB
UT WOS:000584095200001
PM 33036442
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Monteiro-Alfredo, T
   Oliveira, S
   Amaro, A
   Rosendo-Silva, D
   Antunes, K
   Pires, AS
   Teixo, R
   Abrantes, AM
   Botelho, MF
   Castelo-Branco, M
   Seiça, R
   Silva, S
   Souza, KD
   Matafome, P
AF Monteiro-Alfredo, Tamaeh
   Oliveira, Sara
   Amaro, Andreia
   Rosendo-Silva, Daniela
   Antunes, Katia
   Pires, Ana Salome
   Teixo, Ricardo
   Abrantes, Ana Margarida
   Botelho, Maria Filomena
   Castelo-Branco, Miguel
   Seica, Raquel
   Silva, Sonia
   de Picoli Souza, Kely
   Matafome, Paulo
TI Hypoglycaemic and Antioxidant Properties of Acrocomia aculeata
   (Jacq.) Lodd Ex Mart. Extract Are Associated with Better Vascular
   Function of Type 2 Diabetic Rats
SO NUTRIENTS
LA English
DT Article
DE diabetes; macauba; bocaiuva; vascular function; polyphenols
ID INSULIN-RESISTANCE; OXIDATIVE STRESS; FERULIC ACID; CAFFEIC ACID;
   CORONARY-ARTERIES; CHLOROGENIC ACID; COCOS-NUCIFERA; TRIGLYCERIDES;
   QUERCETIN; COMPLICATIONS
AB Oxidative stress is involved in the metabolic dysregulation of type 2 diabetes (DM2). Acrocomia aculeata (Aa) fruit pulp has been described for the treatment of several diseases, and recently we have proved that its leaves have phenolic compounds with a marked antioxidant effect. We aimed to assess whether they can improve metabolic, redox and vascular functions in DM2. Control Wistar (W-Ctrl) and non-obese type 2 diabetic Goto-Kakizaki (GK-Ctrl) rats were treated for 30 days with 200 mg.kg(-1) aqueous extract of Aa (EA-Aa) (Wistar, W-EA-Aa/GK, GK-EA-Aa). EA-Aa was able to reduce fasting glycaemia and triglycerides of GK-EA-Aa by improving proteins related to glucose and lipid metabolism, such as GLUT-4, PPAR gamma, AMPK, and IR, when compared to GK-Ctrl. It also improved viability of 3T3-L1 pre-adipocytes exposed by H2O2. EA-Aa also increased the levels of catalase in the aorta and kidney, reduced oxidative stress and increased relaxation of the aorta in GK-treated rats in relation to GK-Ctrl, in addition to the protective effect against oxidative stress in HMVec-D cells. We proved the direct antioxidant potential of the chemical compounds of EA-Aa, the increase in antioxidant defences in a tissue-specific manner and hypoglycaemic properties, improving vascular function in type 2 diabetes. EA-Aa and its constituents may have a therapeutic potential for the treatment of DM2 complications.
C1 [Monteiro-Alfredo, Tamaeh; Oliveira, Sara; Amaro, Andreia; Rosendo-Silva, Daniela; Seica, Raquel; Matafome, Paulo] Univ Coimbra, Inst Physiol, Fac Med, P-3000548 Coimbra, Portugal.
   [Monteiro-Alfredo, Tamaeh; Oliveira, Sara; Amaro, Andreia; Rosendo-Silva, Daniela; Pires, Ana Salome; Teixo, Ricardo; Abrantes, Ana Margarida; Botelho, Maria Filomena; Silva, Sonia; Matafome, Paulo] Univ Coimbra, Ctr Innovat Biomed & Biotechnol CIBB, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, P-3000548 Coimbra, Portugal.
   [Monteiro-Alfredo, Tamaeh; Oliveira, Sara; Amaro, Andreia; Rosendo-Silva, Daniela; Pires, Ana Salome; Teixo, Ricardo; Abrantes, Ana Margarida; Botelho, Maria Filomena; Matafome, Paulo] Clin Acad Ctr Coimbra, P-3000548 Coimbra, Portugal.
   [Monteiro-Alfredo, Tamaeh; Antunes, Katia; de Picoli Souza, Kely] Fed Univ Grande Dourados, Res Grp Biotechnol & Bioprospecting Appl Metab GE, BR-79825070 Dourados, MS, Brazil.
   [Pires, Ana Salome; Teixo, Ricardo; Abrantes, Ana Margarida; Botelho, Maria Filomena] Univ Coimbra, Inst Biophys, Fac Med, P-3000548 Coimbra, Portugal.
   [Castelo-Branco, Miguel] Univ Coimbra, Inst Biomed Imaging & Life Sci IBILI, Visual Neurosci Lab, Fac Med, P-3000548 Coimbra, Portugal.
   [Castelo-Branco, Miguel] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, IBILI, P-3000548 Coimbra, Portugal.
   [Castelo-Branco, Miguel] Univ Coimbra, Inst Nucl Sci Appl Hlth ICNAS, P-3000548 Coimbra, Portugal.
   [Castelo-Branco, Miguel] Univ Coimbra, Lab Bioestat Med, Fac Med, P-3000548 Coimbra, Portugal.
   [Silva, Sonia] Univ Coimbra, Inst Pharmacol & Expt Therapeut, Fac Med, P-3000548 Coimbra, Portugal.
   [Matafome, Paulo] Inst Politecn Coimbra, Coimbra Hlth Sch ESTeSC, Dept Complementary Sci, P-3000548 Coimbra, Portugal.
C3 Universidade de Coimbra; Universidade de Coimbra; Universidade de
   Coimbra; Universidade Federal da Grande Dourados; Universidade de
   Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade
   de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Instituto
   Politecnico de Coimbra (IPC)
RP Matafome, P (corresponding author), Univ Coimbra, Inst Physiol, Fac Med, P-3000548 Coimbra, Portugal.; Matafome, P (corresponding author), Univ Coimbra, Ctr Innovat Biomed & Biotechnol CIBB, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, P-3000548 Coimbra, Portugal.; Matafome, P (corresponding author), Clin Acad Ctr Coimbra, P-3000548 Coimbra, Portugal.; Matafome, P (corresponding author), Inst Politecn Coimbra, Coimbra Hlth Sch ESTeSC, Dept Complementary Sci, P-3000548 Coimbra, Portugal.
EM tamaehamonteiro@hotmail.com; sara.1996.oliveira@hotmail.com;
   andreia.amaro15@hotmail.com; daniela.silva26@hotmail.com;
   avilacatia@hotmail.com; a.salome.pires@gmail.com;
   ricardo.teixo@gmail.com; margaridaabrantes@gmail.com;
   mfbotelho@fmed.uc.pt; mcbranco@fmed.uc.pt; rseica@fmed.uc.pt;
   sonias@ci.uc.pt; kelypicoli@gmail.com; paulo.matafome@uc.pt
RI de Picoli Souza, Kely/AAU-5978-2020; Teixo, Ricardo/HCH-7611-2022;
   Silva, Sónia/AAX-9056-2020; Abrantes, Ana Margarida/GZG-9457-2022;
   Rosendo-Silva, Daniela/ISV-1704-2023; Oliveira, Sara/AAX-6715-2021;
   Matafome, Paulo/AAQ-4113-2020; Monteiro Alfredo, Tamaeh/G-5134-2018;
   Pires, Salome/H-6010-2018; Marreiros Amaro, Andreia/KJL-5260-2024; de
   Picoli Souza, Kely/I-1248-2015; Castelo-Branco, Miguel/F-3866-2019;
   Botelho, Maria Filomena/G-1860-2011; Abrantes, Ana M/G-6913-2018
OI Pires, Salome/0000-0001-7994-4650; Matafome, Paulo/0000-0002-3422-290X;
   Monteiro Alfredo, Tamaeh/0000-0001-5514-0797; Marreiros Amaro,
   Andreia/0000-0002-0959-6571; Silva, Sonia/0000-0001-9869-8651;
   Rosendo-Silva, Daniela/0000-0002-4276-5920; Marques Teixo, Ricardo
   Jorge/0000-0002-1317-3352; Oliveira, Sara/0000-0002-0423-7959; de Picoli
   Souza, Kely/0000-0001-5764-2125; Castelo-Branco,
   Miguel/0000-0003-4364-6373; Botelho, Maria Filomena/0000-0001-7202-1650;
   Abrantes, Ana M/0000-0003-4185-7871
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Foundation for Science and Technology (FCT), Portugal [PEst
   UID/NEU/04539/2013, UID/NEU/04539/2019, PEst UIDB/04539/2020,
   UIDP/04539/2020]
FX This work was supported by grants from Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES). This work was also supported by
   Foundation for Science and Technology (FCT), Portugal (PEst
   UID/NEU/04539/2013 and UID/NEU/04539/2019: CNC.IBILI; PEst
   UIDB/04539/2020 and UIDP/04539/2020: CIBB)).
CR Abdelaziz DHA, 2015, PHARM BIOL, V53, P792, DOI 10.3109/13880209.2014.942790
   Agostini-Costa TD, 2018, J ETHNOPHARMACOL, V224, P202, DOI 10.1016/j.jep.2018.05.035
   Akuodor GC, 2014, J ACUTE DIS, V3, P99, DOI 10.1016/S2221-6189(14)60025-1
   AL-Ishaq RK, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090430
   Nonato CDA, 2018, PEERJ, V6, DOI 10.7717/peerj.5991
   [Anonymous], 2012, THESIS U FEDERAL GRA
   [Anonymous], IDF DIABETES ATLAS W
   Appeldoorn MM, 2009, J AGR FOOD CHEM, V57, P7693, DOI 10.1021/jf901381x
   Chen L, 2019, TRENDS FOOD SCI TECH, V85, P149, DOI 10.1016/j.tifs.2018.11.026
   Choi S, 2012, KIDNEY RES CLIN PRAC, V31, P227, DOI 10.1016/j.krcp.2012.09.001
   da Silva PVB, 2019, NAT PROD RES, V33, P2413, DOI 10.1080/14786419.2018.1446006
   de Oliveira LM, 2016, VASC PHARMACOL, V81, P69, DOI 10.1016/j.vph.2015.10.010
   Aquino DFD, 2020, J ETHNOPHARMACOL, V253, DOI 10.1016/j.jep.2020.112648
   de Souza FG, 2020, FOOD RES INT, V138, DOI 10.1016/j.foodres.2020.109690
   Egawa T., 2017, Phenolic Compounds, V169, DOI [10.5772/65968, DOI 10.5772/65968]
   Eid HM, 2010, BIOCHEM PHARMACOL, V79, P444, DOI 10.1016/j.bcp.2009.08.026
   Fusi F, 2003, EUR J NUTR, V42, P10, DOI 10.1007/s00394-003-0395-5
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005
   Huang DW, 2016, NUTR RES, V36, P150, DOI 10.1016/j.nutres.2015.10.001
   Huang DD, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2019.109767
   Ighodaro OM, 2018, BIOMED PHARMACOTHER, V108, P656, DOI 10.1016/j.biopha.2018.09.058
   Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005
   Khursheed R, 2019, EUR J PHARMACOL, V862, DOI 10.1016/j.ejphar.2019.172625
   King GL, 1996, ENDOCRIN METAB CLIN, V25, P255, DOI 10.1016/S0889-8529(05)70324-8
   Koyama K, 1997, AM J PHYSIOL-ENDOC M, V273, pE708, DOI 10.1152/ajpendo.1997.273.4.E708
   Kraegen EW, 2001, EXP CLIN ENDOCR DIAB, V109, pS516
   Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714
   Matafome P, 2012, ARCH PHYSIOL BIOCHEM, V118, P58, DOI 10.3109/13813455.2012.658065
   Monteiro-Alfredo T., ACROCOMIA ACULEATA J
   Nunes AA, 2018, PLANT FOOD HUM NUTR, V73, P61, DOI 10.1007/s11130-017-0648-8
   Nunes AA, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104295
   Papatheodorou K, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3086167
   Pashikanti S, 2010, FREE RADICAL BIO MED, V48, P656, DOI 10.1016/j.freeradbiomed.2009.11.019
   Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092
   Preetha PP, 2013, REV BRAS FARMACOGN, V23, P481, DOI 10.1590/S0102-695X2013005000027
   Renjith RS, 2013, ASIAN PAC J TROP MED, V6, P804, DOI 10.1016/S1995-7645(13)60142-X
   Ribeiro DA, 2014, J ETHNOPHARMACOL, V155, P1522, DOI 10.1016/j.jep.2014.07.042
   Ribeiro JA, 2020, J ETHNOPHARMACOL, V260, DOI 10.1016/j.jep.2020.112547
   Rodrigues T, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105198
   Santos RX, 2009, J FOOD SCI, V74, pH8, DOI 10.1111/j.1750-3841.2008.00982.x
   Sena CM, 2014, PHYSIOL RES, V63, P189, DOI 10.33549/physiolres.932554
   Shabab S, 2021, J ETHNOPHARMACOL, V265, DOI 10.1016/j.jep.2020.113328
   Shi GJ, 2019, BIOMED PHARMACOTHER, V109, P1085, DOI 10.1016/j.biopha.2018.10.130
   Soares J, 2017, MOL ONCOL, V11, P612, DOI 10.1002/1878-0261.12051
   Sova M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082190
   Taubert D, 2002, J CARDIOVASC PHARM, V40, P701, DOI 10.1097/00005344-200211000-00008
   Topakas E, 2003, LEBENSM-WISS TECHNOL, V36, P561, DOI 10.1016/S0023-6438(03)00060-4
   Traka MH, 2011, PLANT CELL, V23, P2483, DOI 10.1105/tpc.111.087916
   Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001
   Winterbone MS, 2009, ATHEROSCLEROSIS, V202, P431, DOI 10.1016/j.atherosclerosis.2008.04.040
   Wu WC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41606
   Yang K, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.580208
   Zhou ZY, 2017, EUR J PHARMACOL, V815, P26, DOI 10.1016/j.ejphar.2017.10.008
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
NR 55
TC 11
Z9 11
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2021
VL 13
IS 8
AR 2856
DI 10.3390/nu13082856
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA UH6JE
UT WOS:000690033800001
PM 34445015
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Abiri, B
   Valizadeh, M
   Nasreddine, L
   Hosseinpanah, F
AF Abiri, Behnaz
   Valizadeh, Majid
   Nasreddine, Lara
   Hosseinpanah, Farhad
TI Dietary determinants of healthy/unhealthy metabolic phenotype in
   individuals with normal weight or overweight/obesity: a systematic
   review
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE metabolic phenotypes; dietary intake; metabolically healthy obesity;
   metabolically unhealthy obesity; metabolically unhealthy normal weight
ID HEALTHY OBESITY; MEDITERRANEAN DIET; VITAMIN-D; UNHEALTHY OBESITY;
   FOOD-INTAKE; RISK; CONSUMPTION; ASSOCIATION; PREVALENCE; PATTERNS
AB Objectives: Nutritional factors are amongst the major determinants in the onset and development of obesity and metabolic complications. Nevertheless, the dietary determinants of metabolic health are not completely elucidated. The aim of this systematic review is to investigate nutritional and dietary factors that may contribute to metabolic heterogeneity in individuals with obesity or normal weight. Methods: A literature search was performed in PubMed, Scopus, EMBASE, and google scholar databases until August 2021, to locate studies that examined metabolic health and its association with intakes of specific foods or food groups, nutrient intakes or status, as well as adherence to certain dietary patterns. Two researchers had independently screened titles and abstracts, examined full-text studies, conducted data extraction, and evaluated their quality using the Newcastle-Ottawa Scale. Results: Twenty-seven studies, with a total of 39518 subjects, were included. Of these studies, 11 articles evaluated the association between different dietary patterns and metabolic phenotypes, while 15 had investigated the association of single food/nutrients intakes or nutrient status with metabolic phenotype, and one paper evaluated the association of dietary inflammatory index with metabolic health. The findings of these studies propose that healthy dietary patterns such as the Mediterranean pattern, Dietary Approaches to Stop Hypertension, and population-derived patterns (such as the "Healthy" and "Fruit and vegetable" patterns) were associated with higher odds of the metabolically healthy phenotype. Higher intakes of fruits, vegetables, dairy products, coffee/tea, vitamin D, magnesium, and flavonoids, were suggested to lower the risk of developing metabolically unhealthy phenotype, while, higher consumption of saturated fat, carbohydrate and sugar-sweetened beverages, fast foods, organ meats, and a pro-inflammatory diet increased the risk. Conclusion: Results from published studies, which were mostly cross-sectional, suggest that higher adherence to unhealthier dietary patterns, characterized by the consumption of refined and processed foods, was associated with a lower likelihood of having a healthy metabolic phenotype, while the opposite was observed for healthier dietary patterns. Findings may be used in developing nutritional strategies aimed at improving metabolic health in the population.
C1 [Abiri, Behnaz; Valizadeh, Majid; Hosseinpanah, Farhad] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.
   [Nasreddine, Lara] Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut, Lebanon.
C3 Shahid Beheshti University Medical Sciences; American University of
   Beirut
RP Hosseinpanah, F (corresponding author), Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.
EM fhospanah@endocrine.ac.ir
RI Valizadeh, Majid/AAD-9338-2022; Abiri, Behnaz/AAE-6684-2022;
   hosseinpanah, farhad/AAM-7277-2020
CR Abdurahman AA, 2019, NUTR DIET, V76, P192, DOI 10.1111/1747-0080.12482
   Ahmed SH, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0699-3
   Aldhoon-Hainerová I, 2017, NUTR METAB CARDIOVAS, V27, P703, DOI 10.1016/j.numecd.2017.05.002
   Arenaza L, 2019, EUR J NUTR, V58, P2615, DOI [10.1007/s00394-018-1809-8, 10.1007/s00394]
   Azadbakht L, 2005, AM J CLIN NUTR, V82, P523, DOI 10.1093/ajcn/82.3.523
   Baik I, 2010, J AM DIET ASSOC, V110, P1018, DOI 10.1016/j.jada.2010.04.013
   Bell LK, 2015, NUTRIENTS, V7, P6491, DOI 10.3390/nu7085295
   Boonchaya-Anant P, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0441-1
   Cai XL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040183
   Camhi SM, 2015, PREV MED, V77, P23, DOI 10.1016/j.ypmed.2015.04.023
   Carughi A, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0142-4
   Choi J, 2012, NUTR METAB CARDIOVAS, V22, P567, DOI 10.1016/j.numecd.2010.09.001
   Cordeiro A, 2020, DIABET METAB SYND OB, V13, P4131, DOI 10.2147/DMSO.S256132
   Dibaba DT, 2014, DIABETIC MED, V31, P1301, DOI 10.1111/dme.12537
   Suárez-Ortegón MF, 2019, OBESITY, V27, P636, DOI 10.1002/oby.22425
   Farhadnejad H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55285-6
   Hankinson AL, 2013, OBESITY, V21, P637, DOI 10.1002/oby.20257
   Hjelmgren O, 2020, J OBES METAB SYNDR, V29, P39, DOI 10.7570/jomes19078
   Hung TKW, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123701
   Hwang YC, 2015, INT J OBESITY, V39, P1365, DOI 10.1038/ijo.2015.75
   Jung CH, 2017, KOREAN J INTERN MED, V32, P611, DOI 10.3904/kjim.2016.259
   Kelishadi R, 2008, J AM DIET ASSOC, V108, P82, DOI 10.1016/j.jada.2007.10.013
   Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim Y, 2018, BRIT J NUTR, V120, P1279, DOI [10.1017/S0007114518002635, 10.1017/s0007114518002635]
   Kim Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040390
   Kimokoti RW, 2015, J NUTR, V145, P2551, DOI 10.3945/jn.115.221283
   Kimokoti RW, 2014, J NUTR, V144, P2018, DOI 10.3945/jn.114.198341
   Lai YHL, 2013, CLIN NUTR, V32, P966, DOI 10.1016/j.clnu.2013.05.002
   Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280
   Li LJ, 2016, J CLIN ENDOCR METAB, V101, P1816, DOI 10.1210/jc.2015-3760
   Liu S, 2005, DIABETES CARE, V28, P2926, DOI 10.2337/diacare.28.12.2926
   Lowe G, 2003, J CLIN EPIDEMIOL, V56, P694, DOI 10.1016/S0895-4356(03)00086-6
   Lydakis C, 2012, EUR J PEDIATR, V171, P1373, DOI 10.1007/s00431-012-1735-3
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Matta J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070432
   Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977
   Millar CL, 2017, ADV NUTR, V8, P226, DOI 10.3945/an.116.014050
   Mirmiran P, 2020, INT J FOOD SCI NUTR, V71, P891, DOI 10.1080/09637486.2020.1746955
   Mirzababaei A, 2019, DIABETES METAB SYND, V13, P322, DOI 10.1016/j.dsx.2018.09.012
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700]
   Moslehi N, 2020, FOOD FUNCT, V11, P3451, DOI [10.1039/c9fo02852h, 10.1039/C9FO02852H]
   Most MM, 2004, J AM DIET ASSOC, V104, P1725, DOI 10.1016/j.jada.2004.08.001
   Naja F, 2020, EUR J NUTR, V59, P2145, DOI 10.1007/s00394-019-02063-9
   Nasreddine L, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1247-z
   Nerurkar PV, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041348
   Neufcourt L, 2015, NUTR METAB CARDIOVAS, V25, P988, DOI 10.1016/j.numecd.2015.09.002
   Nikniaz L, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0455-3
   Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754
   Papathanasopoulos A, 2010, GASTROENTEROLOGY, V138, P65, DOI 10.1053/j.gastro.2009.11.045
   Park YM, 2016, INT J OBESITY, V40, P1541, DOI 10.1038/ijo.2016.114
   Park YMM, 2017, CLIN NUTR, V36, P1301, DOI 10.1016/j.clnu.2016.08.018
   Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076188
   Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038
   Qorbani M, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00617-0
   Rahimi H, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00631-y
   Ramos-Lopez O, 2019, THER ADV ENDOCRINOL, V10, DOI 10.1177/2042018819877303
   Roberge JB, 2019, J PEDIATR-US, V204, P46, DOI 10.1016/j.jpeds.2018.08.063
   Shin JY, 2015, INT J FOOD SCI NUTR, V66, P416, DOI 10.3109/09637486.2015.1025716
   Slagter SN, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0319-0
   Sohrab G, 2018, METAB SYNDR RELAT D, V16, P274, DOI 10.1089/met.2017.0140
   Soltani S, 2018, INT J ENDOCRINOL MET, V16, DOI 10.5812/ijem.60048
   Soriguer F, 2013, J CLIN ENDOCR METAB, V98, P2318, DOI 10.1210/jc.2012-4253
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039
   van Meijl LEC, 2008, NUTR RES REV, V21, P148, DOI 10.1017/S0954422408116997
   Velázquez-López L, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-175
   Viscogliosi G, 2013, METAB SYNDR RELAT D, V11, P210, DOI 10.1089/met.2012.0168
   Wannamethee SG, 2006, AM J CLIN NUTR, V83, P567, DOI 10.1093/ajcn.83.3.567
   Wellington N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102407
   Wells G., 2012, The Newcastle -Ottawa Scale (NOS) for assessing the quality of non -randomised studies in meta -analyses
   WHO, 2017, OB OV FACTSH
   Widmer RJ, 2015, AM J MED, V128, P229, DOI 10.1016/j.amjmed.2014.10.014
   Zuñiga YLM, 2014, BRIT J NUTR, V111, P1118, DOI 10.1017/S0007114513003486
NR 73
TC 21
Z9 22
U1 4
U2 19
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD AUG 29
PY 2023
VL 63
IS 22
BP 5856
EP 5873
DI 10.1080/10408398.2021.2025036
EA JAN 2022
PG 18
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA R3WT5
UT WOS:000740912400001
PM 35001754
DA 2025-04-28
ER

PT J
AU Salwathura, A
   Ahmed, F
AF Salwathura, Ayesha
   Ahmed, Faruk
TI Dietary Pattern, Nutrition-Related Knowledge and Attitudes of Working
   Women in Western Province, Sri Lanka
SO NUTRIENTS
LA English
DT Article
DE dietary pattern; dietary diversity score; nutrition knowledge; nutrition
   attitudes
ID HEALTH-BENEFITS; CONSUMPTION; BEHAVIOR
AB Healthy eating behaviour of women is critical not only for their health but also for their children's health and well-being. The present study examined the dietary pattern, nutrition-related knowledge, and attitudes of working women in Western Province, Sri Lanka. In addition, this study identified the factors associated with dietary diversity score (DDS). A cross-sectional study was conducted among 300 working women, aged 20-60 years, in Western Province, Sri Lanka. The data on socio-demography, dietary patterns, and nutrition-related knowledge and attitudes were collected. Overall, 38% of the women were overweight and 13% were obese. The median frequency of intake of chicken, fish, eggs, milk and milk products, green leafy vegetables, and fruits were 2, 5, 2, 9, 5, and 10 respectively, per week. A large majority of the women (70%) had tea/coffee with sugar and snacks (60%) at least four times a week. Only a third of the women met the minimum DDS, while more than half of the women had good nutrition-related knowledge and attitudes. Women with good nutrition-related knowledge were more frequent consumers of roots/tubers, shellfish, vegetables, fruit, fruit juice, nuts and oils, and fast food. Women with good nutrition-related attitudes had a significantly lower frequency of consumption of soya meat, while having a higher frequency of consumption of fast food. Multiple regression analysis showed that age and household income were significantly independently related to DDS, while attitudes were negatively associated. While there was a trend, the association of nutrition-related knowledge with DDS was not statistically significant (p = 0.057). The overall F ratio (8.46) was highly significant (p = 0.001) and the adjusted R-2 was 0.093. The results demonstrate that a significant proportion of working women have good basic nutrition-related knowledge and attitudes, while two-thirds of them do not meet the minimum DDS. Furthermore, age, family income, and knowledge were positively associated with DDS, while attitudes were negatively associated. Before designing any intervention, further research is needed using a qualitative approach to understand how nutrition knowledge and eating behaviour are related in this population group.
C1 [Salwathura, Ayesha] Sri Lanka Stand Inst, 17 Victoria Pl, Elvitigala Mawatha 00800, Colombo, Sri Lanka.
   [Ahmed, Faruk] Griffith Univ, Sch Med & Dent, Publ Hlth, Gold Coast Campus, Gold Coast, Qld 4220, Australia.
C3 Griffith University; Griffith University - Gold Coast Campus
RP Ahmed, F (corresponding author), Griffith Univ, Sch Med & Dent, Publ Hlth, Gold Coast Campus, Gold Coast, Qld 4220, Australia.
EM arsalwathura@gmail.com; f.ahmed@griffith.edu.au
CR Abeywickrama HM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010150
   Adebawo O, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-14
   [Anonymous], 2010, A healthy lifestyle-WHO recommendations
   Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414
   Aykan Nuri Faruk, 2015, Oncol Rev, V9, P288, DOI 10.4081/oncol.2015.288
   Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873
   Beydoun MA, 2008, PREV MED, V46, P145, DOI 10.1016/j.ypmed.2007.06.016
   Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(13)60937-X
   Briggs MA, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5020029
   Damania H., 2014, INT J INNOV RES DEV, V3, P398
   Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53
   Department of Census and Statistics (DCS) and Ministry of Health Nutrition and Indigenous Medicine, 2017, SRI LANK DEM HLTH SU
   Department of Consensus and Statistics, 2021, SRI LANK LAB FORC SU
   Department of Consensus and Statistics, 2014, NAT SURV SELF REP HL
   Dickson-Spillmann M, 2011, APPETITE, V56, P617, DOI 10.1016/j.appet.2011.01.034
   Elshibly EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-244
   FAO FHI 360, 2016, MIN DIET DIV SCOR WO
   FMoH UNICEF EU, 2016, SIT AN NUTR SECT ETH
   Fuhrman J, 2018, AM J LIFESTYLE MED, V12, P375, DOI 10.1177/1559827618766483
   Heshmat Ramin, 2016, Med J Islam Repub Iran, V30, P426
   Idris IB, 2021, IND HEALTH, V59, P146, DOI 10.2486/indhealth.2020-0204
   Jayatissa R, 2019, National nutrition and micronutrient survey among school adolescents aged 10-18 years in Sri Lanka 2017
   Kim KyungHee Kim KyungHee, 2003, Korean Journal of Community Nutrition, V8, P181
   Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94
   Krishna K.U.P., 2022, INT J CLIN BIOCH RES, V9, P79, DOI DOI 10.18231/J.IJCBR.2022.016
   Liu HY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040615
   Martínez-González MA, 2011, PUBLIC HEALTH NUTR, V14, P2309, DOI 10.1017/S1368980011002564
   Mirmiran P, 2007, PUBLIC HEALTH NUTR, V10, P897, DOI 10.1017/S1368980007246701
   Mudryj AN, 2014, APPL PHYSIOL NUTR ME, V39, P1197, DOI 10.1139/apnm-2013-0557
   Olsen NJ, 2009, OBES REV, V10, P68, DOI 10.1111/j.1467-789X.2008.00523.x
   Onarheim KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150120
   Oniango R., 2002, Nutrition: A Foundation for Development
   Pallavi R., 2020, J Food Process Technol, V11, P841, DOI [10.35248/2157-7110.20.11.841, DOI 10.35248/2157-7110.20.11.841]
   Priyadarshini V., 2016, ASIAN J HOME SCI, V11, P320, DOI DOI 10.15740/HAS/AJHS/11.2/320-326
   Ratajczak AE, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041329
   Reethesh S R, 2019, Indian J Endocrinol Metab, V23, P102, DOI 10.4103/ijem.IJEM_487_18
   Rizzoli R, 2022, AGING CLIN EXP RES, V34, P9, DOI 10.1007/s40520-021-01970-4
   Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154
   Spronk I, 2014, BRIT J NUTR, V111, P1713, DOI 10.1017/S0007114514000087
   Tiwari S., 2018, GLOB J ENG SCI RES, V5, P62, DOI DOI 10.5281/ZENODO.1250300
   Triches RM, 2005, REV SAUDE PUBL, V39, P541, DOI 10.1590/S0034-89102005000400004
   Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311
   Weerasekara PC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113985
   WHO, 2003, WHO TECH REP SER, V916, P1
   Xie Z. F., 2017, Chinese Journal of Health Education, V33, P544
NR 45
TC 0
Z9 0
U1 1
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUL
PY 2023
VL 15
IS 13
AR 3007
DI 10.3390/nu15133007
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA M2BF2
UT WOS:001028279300001
PM 37447332
OA gold, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Smith, AE
   Lockwood, CM
   Moon, JR
   Kendall, KL
   Fukuda, DH
   Tobkin, SE
   Cramer, JT
   Stout, JR
AF Smith, Abbie E.
   Lockwood, Christopher M.
   Moon, Jordan R.
   Kendall, Kristina L.
   Fukuda, David H.
   Tobkin, Sarah E.
   Cramer, Joel T.
   Stout, Jeffrey R.
TI Physiological effects of caffeine, epigallocatechin-3-gallate, and
   exercise in overweight and obese women
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM
LA English
DT Article
ID GREEN TEA EXTRACT; BODY-WEIGHT LOSS; ENERGY-EXPENDITURE; DOUBLE-BLIND;
   INTESTINAL-ABSORPTION; THERMOGENIC DRINK; FAT OXIDATION; HUMANS; RATS;
   METABOLISM
AB Cette etude se propose d'analyser les effets combines d'un programme d'exercices de 10 semaines et de la consommation de cafeine additionnee d'epigallocatechine-3-gallate (EGCG) sur la composition corporelle, la condition physique cardiovasculaire et la force chez des femmes presentant un surplus de poids et des femmes obeses. Selon un devis experimental a double insu, des femmes presentant un surpoids et des femmes obeses (n = 27) sont assignees aleatoirement dans 4 groupes : un groupe avec supplementation et exercice (EX-Act), un groupe placebo, soit sans supplementation, mais avec exercice (EX-PL), un groupe avec supplementation, mais sans exercice (NEX-Act) et un autre groupe placebo, soit sans supplementation ni exercice (NEX-PL). Toutes les participantes consomment une boisson par jour durant 10 semaines; les groupes EX-Act et EX-PL participent a un programme combine d'endurance et de force. Les variations de composition corporelle sont evaluees en fonction d'un modele a quatre compartiments. Les variations de la masse musculaire (MM) sont determinees au moyen d'une equation determinant la masse maigre des tissus mous appendiculaires obtenue par DXA. On observe une interaction significative traitement temps en ce qui concerne la MM (p = 0,026) et la concentration totale de cholesterol (TC) (p = 0,047); on observe aussi une interaction significative traitement temps en ce qui concerne le consommation d'oxygene de pointe (p = 0,046) et la force du haut et du bas du corps (p < 0,05). En outre, on observe des differences significatives entre les groupes EX et NEX en ce qui concerne les variations en pourcentage de la MM, du le consommation d'oxygene de pointe et de la force du haut et du bas du corps. Les marqueurs cliniques des fonctions hepatique et renale ne revelent aucun effet indesirable. La TC diminue significativement dans les groupes recevant des supplements (EX-Act, NEX-Act). Cette etude indique que boire un breuvage contenant de la cafeine et du EGCG avant l'exercice dans un programme d'entrainement physique contribue a l'amelioration de la masse musculaire, de la condition physique et du bilan lipidique chez des femmes presentant un surpoids et des femmes obeses.
C1 [Smith, Abbie E.; Lockwood, Christopher M.; Kendall, Kristina L.; Fukuda, David H.; Cramer, Joel T.; Stout, Jeffrey R.] Univ Oklahoma, Dept Hlth & Exercise Sci, Norman, OK 73019 USA.
   [Moon, Jordan R.] United States Sports Acad, Dept Sports Fitness & Hlth, Daphne, AL 36526 USA.
   [Tobkin, Sarah E.] Univ Oklahoma Hlth Sci Ctr, Coll Med, Oklahoma City, OK 73126 USA.
C3 University of Oklahoma System; University of Oklahoma - Norman;
   University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP Stout, JR (corresponding author), Univ Oklahoma, Metab & Body Composit Lab, Norman, OK 73019 USA.
EM jrstout@ou.edu
RI smith, abbie/JVP-3804-2024; Stout, Jeffrey/F-5805-2014; Fukuda,
   David/F-4507-2014; Kendall, Kristina/L-2148-2017; Lockwood,
   Christopher/A-8136-2018; Cramer, Joel/H-8530-2013
OI Fukuda, David/0000-0002-4299-7764; Kendall,
   Kristina/0000-0001-6872-7335; Kendall, Kristina/0000-0003-3029-0435;
   Stout, Jeffrey/0000-0001-6114-1649; Lockwood,
   Christopher/0000-0002-4002-4301; Cramer, Joel/0000-0002-5270-9359;
   Smith-Ryan, Abbie/0000-0002-5405-304X
FU Celsius Inc. (Delray Beach, Fla.)
FX We thank Celsius Inc. (Delray Beach, Fla.) for funding this study; and
   Ashley Walter, Jason DeFreitas, and Pablo Costa for their assistance in
   subject training. We declare no competing interests.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   Beck TW, 2008, J STRENGTH COND RES, V22, P1654, DOI 10.1519/JSC.0b013e318181ff2c
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Benowitz NL, 1995, CLIN PHARMACOL THER, V58, P684, DOI 10.1016/0009-9236(95)90025-X
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155
   Dalbo VJ, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-6
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   DULLOO AG, 1994, AM J PHYSIOL-ENDOC M, V267, pE801, DOI 10.1152/ajpendo.1994.267.5.E801
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dulloo AG, 1998, BRIT J NUTR, V80, P493, DOI 10.1017/S0007114598001573
   Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4
   Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694
   Hackman RM, 2006, INT J OBESITY, V30, P1545, DOI 10.1038/sj.ijo.0803283
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   LANDSBERG L, 1984, AM J PHYSIOL, V247, pE181, DOI 10.1152/ajpendo.1984.247.2.E181
   Lockwood CM, 2010, J STRENGTH COND RES, V24, P2227, DOI 10.1519/JSC.0b013e3181aeb0cf
   Moon JR, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-16
   Moon JR, 2009, EUR J APPL PHYSIOL, V105, P119, DOI 10.1007/s00421-008-0881-9
   MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Roberts MD, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-19
   Rossiter HB, 2006, J APPL PHYSIOL, V100, P764, DOI 10.1152/japplphysiol.00932.2005
   TSCHIDA T, 2002, PROG MED, V22, P2189
   VANNUCCI SJ, 1989, AM J PHYSIOL, V257, pE871, DOI 10.1152/ajpendo.1989.257.6.E871
   Wang ZM, 1998, INT J OBESITY, V22, P329, DOI 10.1038/sj.ijo.0800590
   Wang ZM, 2002, AM J CLIN NUTR, V76, P968, DOI 10.1093/ajcn/76.5.968
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wilkins L.W., 2010, ACSM GUID EX TEST, V8th
   WONG WW, 1987, AM J CLIN NUTR, V45, P905, DOI 10.1093/ajcn/45.5.905
   YOKO K, 2000, J AGR FOOD CHEM, V48, P5618
NR 48
TC 15
Z9 18
U1 1
U2 48
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 1715-5312
EI 1715-5320
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD OCT
PY 2010
VL 35
IS 5
BP 607
EP 616
DI 10.1139/H10-056
PG 10
WC Nutrition & Dietetics; Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA 668WD
UT WOS:000283303100005
PM 20962916
DA 2025-04-28
ER

PT J
AU Haddock, CK
   Poston, WSC
   LaGrotte, C
   Klotz, AA
   Oliver, TL
   Vander Veur, SS
   Foster, GD
   Jebb, SA
   Moore, C
   Roberts, SA
   Reeves, RS
   Bolton, MP
   Foreyt, JP
AF Haddock, C. Keith
   Poston, Walker S. C.
   LaGrotte, Caitlin
   Klotz, Alicia A.
   Oliver, Tracy L.
   Vander Veur, Stephanie S.
   Foster, Gary D.
   Jebb, Susan A.
   Moore, Carmel
   Roberts, Susan A.
   Reeves, Rebecca S.
   Bolton, Mary Pat
   Foreyt, John P.
TI Findings from an online behavioural weight management programme provided
   with or without a fortified diet beverage
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Internet; Obesity; Weight loss; Online behavioural modification
   programmes
ID GREEN TEA; ENERGY-EXPENDITURE; FAT OXIDATION; PRIMARY-CARE; BODY-WEIGHT;
   INTERNET; MAINTENANCE; WEB; CAFFEINE; ADULTS
AB The present multi-centre randomised weight-loss trial evaluated the efficacy of a low-intensity 12-week online behavioural modification programme, with or without a fortified diet beverage using a 2x2 factorial design. A total of 572 participants were randomised to: (1) an online basic lifestyle information (OBLI) intervention, consisting of one online informational class about tips for weight management; (2) an online behavioural weight management (OBWM) intervention, entailing 12 weekly online classes focused on weight-loss behaviour modification; (3) an OBLI intervention plus a fortified diet cola beverage (BEV) containing green tea extract (total catechin 167mg), soluble fibre dextrin (10g) and caffeine (100mg) (OBLI+BEV); (4) OBWM+BEV. Assessments included height, weight, dual-energy X-ray absorptiometry-derived body composition, and waist circumference (WC). Attrition was 15 center dot 7%. Intention-to-treat (ITT) models demonstrated a main effect for type of Internet programme, with those assigned to the OBWM condition losing significantly more weight (F=7 center dot 174; P=0 center dot 008) and fat mass (F=4 center dot 491; P=0 center dot 035) than those assigned to the OBLI condition. However, there was no significant main effect for the OBWM condition on body fat percentage (F=2 center dot 906; P=0 center dot 089) or WC (F=3 center dot 351; P=0 center dot 068), and no significant main effect for beverage use or significant interactions between factors in ITT models. A 12-week, low-intensity behaviourally based online programme produced a greater weight loss than a basic information website. The addition of a fortified diet beverage had no additional impact.
C1 [Haddock, C. Keith; Poston, Walker S. C.] Natl Dev & Res Inst Inc, Inst Biobehav Hlth Res, Leawood, KS 66224 USA.
   [LaGrotte, Caitlin; Klotz, Alicia A.; Oliver, Tracy L.; Vander Veur, Stephanie S.; Foster, Gary D.] Temple Univ, Philadelphia, PA 19122 USA.
   [Jebb, Susan A.; Moore, Carmel] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England.
   [Roberts, Susan A.] Coca Cola Co, Global Sci & Regulatory Affairs, Atlanta, GA USA.
   [Reeves, Rebecca S.; Bolton, Mary Pat; Foreyt, John P.] Baylor Coll Med, Behav Med Res Ctr, Houston, TX 77030 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple
   University; UK Research & Innovation (UKRI); Medical Research Council UK
   (MRC); MRC Human Nutrition Research; The Coca-Cola Company; Baylor
   College of Medicine
RP Poston, WSC (corresponding author), Natl Dev & Res Inst Inc, Inst Biobehav Hlth Res, 1920 West 143rd St,Suite 120, Leawood, KS 66224 USA.
EM carlosposton@hopehri.com
OI Jebb, Susan/0000-0001-9190-2920
FU Coca-Cola Company; MRC [MC_U105960389] Funding Source: UKRI
FX The study was funded by The Coca-Cola Company. As an employee of the
   Coca-Cola Company, S. A. R was involved in the study origination and
   design, data interpretation and critical revision of the manuscript.
CR Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x
   [Anonymous], 2009, OPEN MED-WARSAW
   Arem H, 2011, OBES REV, V12, pe236, DOI 10.1111/j.1467-789X.2010.00787.x
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bennett GG, 2010, OBESITY, V18, P308, DOI 10.1038/oby.2009.242
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Gold B, 2007, ANN BEHAV MED, V33, P49, DOI 10.1207/s15324796abm3301_6
   Gold BC, 2007, OBESITY, V15, P155, DOI 10.1038/oby.2007.520
   Guérin-Deremaux L, 2011, NUTR RES, V31, P665, DOI 10.1016/j.nutres.2011.09.004
   Guerin-Deremaux L, 2011, INT J FOOD SCI NUTR, V62, P628, DOI 10.3109/09637486.2011.569492
   Harvey-Berino J, 2002, BEHAV MODIF, V26, P103, DOI 10.1177/0145445502026001006
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Hunter CM, 2008, AM J PREV MED, V34, P119, DOI 10.1016/j.amepre.2007.09.026
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5
   MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Organisation for Economic Co-operation and Development (OECD), 2011, OECD HLTH DAT 2010 F
   Pasman W, 2006, EUR J CLIN NUTR, V60, P1024, DOI 10.1038/sj.ejcn.1602418
   Pritchard JE, 1997, J AM DIET ASSOC, V97, P37, DOI 10.1016/S0002-8223(97)00015-1
   Rothert K, 2006, OBESITY, V14, P266, DOI 10.1038/oby.2006.34
   Rowe S, 2009, AM J CLIN NUTR, V89, P1285, DOI 10.3945/ajcn.2009.27604
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Smith CE, 2011, NUTR RES REV, V24, P118, DOI 10.1017/S0954422411000023
   Tate DF, 2001, JAMA-J AM MED ASSOC, V285, P1172, DOI 10.1001/jama.285.9.1172
   Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833
   Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Williamson D A, 2005, Eat Weight Disord, V10, P193
   Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883
   Womble LG, 2004, OBES RES, V12, P1011, DOI 10.1038/oby.2004.124
NR 36
TC 9
Z9 10
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JAN 28
PY 2014
VL 111
IS 2
BP 372
EP 379
DI 10.1017/S0007114513002377
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AD0UX
UT WOS:000332950700022
PM 23920353
OA Bronze
DA 2025-04-28
ER

PT J
AU Duffey, KJ
   Popkin, BM
AF Duffey, Kiyah J.
   Popkin, Barry M.
TI Adults with healthier dietary patterns have healthier beverage patterns
SO JOURNAL OF NUTRITION
LA English
DT Article
ID US ADULTS; FOOD-CONSUMPTION; BODY-WEIGHT; TRENDS; CARBOHYDRATE;
   CHILDREN; OBESITY; YOUNG; RISK; MEN
AB There is an absence of research examining associations between food and beverage intake patterns and most research has centered on soft drinks, whereas research on overall beverage patterns is absent. Using data from the National Health and Nutrition Examination Survey 99-02 for adults aged 19 y and older, we independently examined beverage and food intake patterns, as well as their interrelations. Cluster analysis generated mutually exclusive intake patterns for beverages and foods. Multinomial logistic regression models provided the odds of a given beverage pattern for each food pattern; we then compared the probability of a given beverage pattern for each food pattern. Six beverage and 6 food patterns emerged. Beverage patterns revealed that calorically sweetened, noncaloric, and diet beverages tended to be consumed independently of one another. Being in the Snacks and High-Fat Foods cluster increased the odds of being in the Coffee and Soda (odds ratio (OR): 1.62 [95% CI: 1.27-2.06]) or Nutrients and Soda (OR: 1.51 [95% CI: 1.14-2.00]) beverage clusters and decreased the odds of being in the Water and Tea (OR: 0.51 [95% CI: 0.52-0.97]) cluster relative to the odds of being in the Water, Coffee, and Tea cluster. The opposite was true for the Vegetable pattern. Furthermore, persons who had a healthier food pattern had a higher probability of having a noncaloric beverage pattern than persons who did not. Increasing awareness of both the contribution of calorie-containing beverages to overall energy intake and dietary patterns associated with these beverages helps inform policies targeted at reducing energy intake in the population.
C1 Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27516 USA.
C3 University of North Carolina; University of North Carolina Chapel Hill
RP Popkin, BM (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27516 USA.
EM popkin@unc.edu
RI Duffey, Kiyah/MXL-8423-2025; Popkin, Barry/T-6633-2019
OI popkin, barry/0000-0001-9495-9324
FU NCI NIH HHS [R01-CA121152, R01-CA109831] Funding Source: Medline
CR DellaValle DM, 2005, APPETITE, V44, P187, DOI 10.1016/j.appet.2004.11.003
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Forshee RA, 2003, INT J FOOD SCI NUTR, V54, P297, DOI [10.1080/09637480120092143, 10.1080/096374803766666175]
   Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235
   Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3
   HULSHOF T, 1993, APPETITE, V21, P273, DOI 10.1006/appe.1993.1045
   Knol LL, 2005, J AM DIET ASSOC, V105, P1765, DOI 10.1016/j.jada.2005.08.012
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   MAINS P, 1992, J AM DIET ASSOC, V92, P704
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   Millen BE, 2005, J AM DIET ASSOC, V105, P1723, DOI 10.1016/j.jada.2005.08.007
   Montonen J, 2005, AM J EPIDEMIOL, V161, P219, DOI 10.1093/aje/kwi039
   Nelson MC, 2005, AM J PREV MED, V28, P259, DOI 10.1016/j.amepre.2004.12.006
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Nielsen SJ, 2002, OBES RES, V10, P370, DOI 10.1038/oby.2002.51
   Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1
   *PAN DIET REF INT, 2002, DIET REF INT EN CARB
   *PAN IET REF INT E, 2004, DIET REF INT WAT POT
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Popkin BM, 2005, OBES RES, V13, P2146, DOI 10.1038/oby.2005.266
   Popkin BM, 1999, APPETITE, V32, P8, DOI 10.1006/appe.1998.0190
   Quatromoni PA, 2002, J AM DIET ASSOC, V102, P1240
   RABEN A, 1994, AM J CLIN NUTR, V60, P544, DOI 10.1093/ajcn/60.4.544
   Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721
   Rajeshwari R, 2005, J AM DIET ASSOC, V105, P208, DOI 10.1016/j.jada.2004.11.026
   Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2005, DIET GUID AM 2005
   *US DEP HHS USDA, 2005, DIET GUID ADV COMM R
   USDA, 2004, USDA FOOD NUTR DAT D
   Villegas R, 2004, PUBLIC HEALTH NUTR, V7, P1017, DOI 10.1079/PHN2004638
   2004, DIET REFERENCE INTAK
NR 35
TC 99
Z9 108
U1 0
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD NOV
PY 2006
VL 136
IS 11
BP 2901
EP 2907
DI 10.1093/jn/136.11.2901
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 100DY
UT WOS:000241649000031
PM 17056820
OA Bronze
DA 2025-04-28
ER

PT J
AU Nilsson, LM
   Winkvist, A
   Brustad, M
   Jansson, JH
   Johansson, I
   Lenner, P
   Lindahl, B
   Van Guelpen, B
AF Nilsson, Lena Maria
   Winkvist, Anna
   Brustad, Magritt
   Jansson, Jan-Hakan
   Johansson, Ingegerd
   Lenner, Per
   Lindahl, Bernt
   Van Guelpen, Bethany
TI A traditional Sami diet score as a determinant of mortality in a general
   northern Swedish population
SO INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH
LA English
DT Article
DE the VIP cohort; Sami, traditional food; traditional lifestyle; mortality
ID LIFE-STYLE; MYOCARDIAL-INFARCTION; ENERGY-INTAKE; HEALTH; DISEASE;
   SWEDEN; CANCER; COFFEE; FOOD; CONSUMPTION
AB Objectives. To examine the relationship between "traditional Sami" dietary pattern and mortality in a general northern Swedish population.
   Study design. Population-based cohort study.
   Methods. We examined 77,319 subjects from the Vasterbotten Intervention Program (VIP) cohort. A traditional Sami diet score was constructed by adding 1 point for intake above the median level of red meat, fatty fish, total fat, berries and boiled coffee, and 1 point for intake below the median of vegetables, bread and fibre. Hazard ratios (HR) for mortality were calculated by Cox regression.
   Results. Increasing traditional Sami diet scores were associated with slightly elevated all-cause mortality in men [Multivariate HR per 1-point increase in score 1.04 (95% CI 1.01-1.07), p = 0.018], but not for women [Multivariate HR 1.03 (95% CI 0.99-1.07), p = 0.130]. This increased risk was approximately equally attributable to cardiovascular disease and cancer, though somewhat more apparent for cardiovascular disease mortality in men free from diabetes, hypertension and obesity at baseline [Multivariate HR 1.10 (95% CI 1.01 1.20), p = 0.023].
   Conclusions. A weak increased all-cause mortality was observed in men with higher traditional Sami diet scores. However, due to the complexity in defining a "traditional Sami" diet, and the limitations of our questionnaire for this purpose, the study should be considered exploratory, a first attempt to relate a "traditional Sami" dietary pattern to health endpoints. Further investigation of cohorts with more detailed information on dietary and lifestyle items relevant for traditional Sami culture is warranted.
C1 [Nilsson, Lena Maria; Jansson, Jan-Hakan; Lindahl, Bernt] Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.
   [Winkvist, Anna] Univ Gothenburg, Dept Internal Med & Clin Nutr, Sahlgrenska Acad, Gothenburg, Sweden.
   [Brustad, Magritt] Univ Tromso, Ctr Sami Hlth Res, Dept Community Med, Tromso, Norway.
   [Jansson, Jan-Hakan] Skelleftea Hosp, Dept Med, Skelleftea, Sweden.
   [Johansson, Ingegerd] Umea Univ, Dept Odontol, SE-90185 Umea, Sweden.
   [Lenner, Per] Umea Univ, Dept Oncol & Radiat Sci, Ctr Oncol, SE-90185 Umea, Sweden.
   [Van Guelpen, Bethany] Umea Univ, Dept Med Biosci, SE-90185 Umea, Sweden.
C3 Umea University; University of Gothenburg; UiT The Arctic University of
   Tromso; Umea University; Umea University; Umea University
RP Nilsson, LM (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.
EM lena.nilsson@nutrires.umu.se
RI Winkvist, Anna/AAC-6178-2021; Van Guelpen, Bethany/J-8159-2015
OI Winkvist, Anna/0000-0001-9122-7240; Van Guelpen,
   Bethany/0000-0002-9692-101X; Nilsson, Lena Maria/0000-0002-2354-7258
FU HELGA/Nordforsk; Joint Committee of Northern Sweden Healthcare Region;
   Vasterbotten County Council; Swedish Research Council; Swedish Council
   for Working Life and Social Research
FX This work was supported by HELGA/Nordforsk. The Vasterbotten
   Intervention Project cohort was supported by the Joint Committee of
   Northern Sweden Healthcare Region, Vasterbotten County Council, and The
   Swedish Research Council, The Swedish Council for Working Life and
   Social Research. The authors would like to thank the participants in the
   Vasterbotten Intervention Program for their contribution to health
   research, as well as Professor Peter Skold, Center for Sami Research,
   CESAM, Umea University, Sweden, for valuable advice.
CR [Anonymous], HUM NUTR CLIN NUT S1
   [Anonymous], 1983, KUNGLIGA SKYTTEANSKA
   Bere E, 2007, EUR J CLIN NUTR, V61, P431, DOI 10.1038/sj.ejcn.1602512
   Bere E, 2009, PUBLIC HEALTH NUTR, V12, P91, DOI 10.1017/S1368980008001985
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Brustad M, 2008, INT J CIRCUMPOL HEAL, V67, P82
   Chung N, 2008, INT J CLIN PRACT, V62, P1306, DOI 10.1111/j.1742-1241.2008.01838.x
   Downward G, 2011, THESIS UMEA U UMEA
   Drake S., 1918, VASTERBOTTENSLAPPARN
   Elenius L, 2006, NATIONALSTAT MINORIT, P212
   Fjellstrom P., 1985, Samernas samhalle i tradition och nutid Lappish Society in Tradition and the Present Day
   Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4
   Haglin L, 1991, Arctic Med Res, VSuppl, P741
   Hammar N, 2003, J INTERN MED, V253, P653, DOI 10.1046/j.1365-2796.2003.01142.x
   Haraldson S., 1962, LAKARTIDNINGEN, V59, P2829
   Hassan AA, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18187
   Hassler S, 2005, INT J EPIDEMIOL, V34, P623, DOI 10.1093/ije/dyi027
   Hassler S, 2008, INT J CIRCUMPOL HEAL, V67, P421, DOI 10.3402/ijch.v67i5.18351
   Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569
   Johansson G, 2008, INT J OBESITY, V32, P1031, DOI 10.1038/ijo.2008.42
   Johansson H, 1975, FORSKARE BEFOLKNINGS
   Johansson I, 2010, EUR J CLIN NUTR, V64, P905, DOI 10.1038/ejcn.2010.80
   Johansson I, 2002, PUBLIC HEALTH NUTR, V5, P487, DOI 10.1079/PHN2001315
   Kozlov A, 1997, ANTHROPOL ANZ, V55, P293
   Kozlov A, 2008, INT J CIRCUMPOL HEAL, V67, P56
   Michels KB, 2003, INT J EPIDEMIOL, V32, P486, DOI 10.1093/ije/dyg216
   MIETTINEN J. K., 1964, RADIOL HLTH DATA, V5, P83
   Morkenstam U, 2000, KOMPLEXA KONTINENTEN, P267
   Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885
   Naqshbandi M, 2008, DIABETES RES CLIN PR, V82, P1, DOI 10.1016/j.diabres.2008.07.017
   Nilsson LM, 2010, NUTR METAB CARDIOVAS, V20, P527, DOI 10.1016/j.numecd.2009.05.004
   Nilsson LM, 2011, INT J CIRCUMPOL HEAL, V70, P301, DOI 10.3402/ijch.v70i3.17831
   Nilsson LM, 2010, CANCER CAUSE CONTROL, V21, P1533, DOI 10.1007/s10552-010-9582-x
   Nystad T, 2010, PUBLIC HEALTH NUTR, V13, P1818, DOI 10.1017/S1368980010000376
   ODIN M, 1934, SOCIALHYGIENISK UN 2, P8
   Olsen A, 2011, J NUTR, V141, P639, DOI 10.3945/jn.110.131375
   Pukkala E, 2007, ACTA ONCOL, V46, P286, DOI 10.1080/02841860701203545
   Ross AB, 2006, CROAT MED J, V47, P553
   Ross AB, 2009, INT J CIRCUMPOL HEAL, V68, P372, DOI 10.3402/ijch.v68i4.17371
   Sjolander P, 2011, GLOB HLTH ACTION, V4, P1
   Sjölander P, 2008, SCAND J PUBLIC HEALT, V36, P84, DOI 10.1177/1403494807085305
   Sköold P, 2008, INT J CIRCUMPOL HEAL, V67, P27
   Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344
   Turi J, 1987, BOK SAMERNAS LIV MUI
   Weinehall L, 1998, SCAND J PRIM HEALTH, V16, P171
   Wennberg M, 2011, AM J CLIN NUTR, V93, P27, DOI 10.3945/ajcn.2010.29408
   Wennberg M, 2009, PUBLIC HEALTH NUTR, V12, P1477, DOI 10.1017/S1368980008004503
   Wiklund K, 1991, Arctic Med Res, V50, P3
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
   Winkvist A, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-12
   World Cancer Research Fund, 2007, FOOD NUTR PHYS ACT P, P63
NR 51
TC 23
Z9 25
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1239-9736
EI 2242-3982
J9 INT J CIRCUMPOL HEAL
JI Int. J. Circumpolar Health
PY 2012
VL 71
AR 18537
DI 10.3402/ijch.v71i0.18537
PG 12
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA 998JC
UT WOS:000308232900001
PM 22584519
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Haller, CA
   Jacob, P
   Benowitz, NL
AF Haller, CA
   Jacob, P
   Benowitz, NL
TI Short-term metabolic and hemodynamic effects of ephedra and guarana
   combinations
SO CLINICAL PHARMACOLOGY & THERAPEUTICS
LA English
DT Article
ID DIETARY-SUPPLEMENT; MA-HUANG; HEALTHY-VOLUNTEERS; CAFFEINE;
   PHARMACOKINETICS; MULTICOMPONENT; PHARMACOLOGY; ALKALOIDS; SINICA
AB Objective: Serious adverse health events have been reported with the use of dietary supplements containing ephedra and guarana. We sought to determine whether repeated dosing and multi-ingredient formulations contribute to the adverse effects of these supplements.
   Methods. In this study, 16 healthy adults (8 women) took 2 doses each of ephedra-guarana alone, Xenadrine RFA, a multicomponent dietary supplement containing 25 mg ephedra alkaloids and 200 mg caffeine, or placebo 5 hours apart in a randomized, double-blind, 3-arm crossover study.
   Results. Peak plasma ephedrine levels averaged 130 to 140 ng/mL. Compared with placebo, Xenadrine and ephedra-guarana significantly increased heart rate (maximum increase, 9.4 +/- 8.6 beats/min; P = .002), blood pressure (maximum increase in systolic and diastolic pressure, 11.5 +/- 10.7 min Hg and 7.3 +/- 7.4 min Hg, respectively; P = .015), postprandial glucose concentration (maximum change, 41.0 +/- 18.8 mg/dL; P < .0001), and insulin concentration (maximum change, 41.2 +/- 47.8 mu IU/mL; P = .005). Serum potassium concentrations were significantly decreased by both treatments. Hemodynamic and metabolic changes were observed after both the first and second doses. However, plasma free fatty acid concentrations increased after the first dose only. Xenadrine RFA produced higher increases in glucose concentration than ephedra-guarana, but no other pharmacodynamic differences between the treatments were found.
   Conclusions: Consumption of 2 doses of ephedra and guarana supplements, per supplement label recommendations, results in persistent increases in heart rate and blood pressure and unfavorable actions on glucose and potassium homeostasis. Such effects could be detrimental in persons with hypertension, atherosclerosis, or glucose intolerance, conditions that are strongly associated with obesity.
C1 Univ Calif San Francisco, Dept Med, Div Clin Pharmacol, San Francisco, CA 94143 USA.
C3 University of California System; University of California San Francisco
RP Haller, CA (corresponding author), Univ Calif San Francisco, Dept Med, Div Clin Pharmacol, Box 1220, San Francisco, CA 94143 USA.
EM dchaller@worldnet.att.net
FU NCCIH NIH HHS [K23AT00069-04] Funding Source: Medline; NCRR NIH HHS
   [M01RR00083-41] Funding Source: Medline; NIDA NIH HHS [DA12393] Funding
   Source: Medline; National Institute on Drug Abuse [P30DA012393] Funding
   Source: NIH RePORTER
CR ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   ASTRUP A, 1986, Acta Endocrinologica Supplementum, V112, P1
   BYE C, 1975, EUR J CLIN PHARMACOL, V8, P47, DOI 10.1007/BF00616414
   COSTELLO JF, 1975, BRIT J CLIN PHARMACO, V2, pP180
   DICKERSON J, 1978, EUR J CLIN PHARMACOL, V14, P253, DOI 10.1007/BF00560458
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   *FDA US, QUEST ANSW FDAS ACT
   Gardner SF, 2003, AM J CARDIOL, V91, P1510, DOI 10.1016/S0002-9149(03)00413-2
   Gurley BJ, 1998, THER DRUG MONIT, V20, P439, DOI 10.1097/00007691-199808000-00015
   HALL J, EPHEDRINE BAN HAS HO
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Haller CA, 2004, CLIN PHARMACOL THER, V75, P259, DOI 10.1016/j.clpt.2003.11.375
   Haller CA, 2002, CLIN PHARMACOL THER, V71, P421, DOI 10.1067/mcp.2002.124523
   Horton TJ, 1996, INT J OBESITY, V20, P91
   Jacob P, 2004, J ANAL TOXICOL, V28, P152, DOI 10.1093/jat/28.3.152
   Kockler DR, 2001, PHARMACOTHERAPY, V21, P647, DOI 10.1592/phco.21.6.647.34542
   LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442
   Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201
   McBride BF, 2004, JAMA-J AM MED ASSOC, V291, P216, DOI 10.1001/jama.291.2.216
   PATIL PN, 1965, J PHARMACOL EXP THER, V148, P158
   PENTEL P, 1984, JAMA-J AM MED ASSOC, V252, P1898, DOI 10.1001/jama.252.14.1898
   SACCA L, 1983, AM J PHYSIOL, V245, pE294, DOI 10.1152/ajpendo.1983.245.3.E294
   Samenuk D, 2002, MAYO CLIN PROC, V77, P12, DOI 10.4065/77.1.12
   SAWYNOK J, 1993, PHARMACOL REV, V45, P43
   Schier JG, 2003, J TOXICOL-CLIN TOXIC, V41, P849, DOI 10.1081/CLT-120025350
   Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537
   Vahedi K, 2000, J NEUROL NEUROSUR PS, V68, P112, DOI 10.1136/jnnp.68.1.112
   White LM, 1997, J CLIN PHARMACOL, V37, P116, DOI 10.1002/j.1552-4604.1997.tb04769.x
NR 28
TC 43
Z9 49
U1 0
U2 11
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0009-9236
J9 CLIN PHARMACOL THER
JI Clin. Pharmacol. Ther.
PD JUN
PY 2005
VL 77
IS 6
BP 560
EP 571
DI 10.1016/j.clpt.2005.01.023
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 935EU
UT WOS:000229763200012
PM 15961987
DA 2025-04-28
ER

PT J
AU Grasser, EK
   Yepuri, G
   Dulloo, AG
   Montani, JP
AF Grasser, Erik K.
   Yepuri, Gayathri
   Dulloo, Abdul G.
   Montani, Jean-Pierre
TI Cardio- and cerebrovascular responses to the energy drink Red
   Bull in young adults: a randomized cross-over study
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Energy drink; Blood pressure; Cerebral blood flow velocity;
   Microvascular endothelial dysfunction; Hemodynamics; Risk factor
ID BLOOD-FLOW; CONSUMPTION; CAFFEINE; PARAMETERS; TAURINE; BIOIMPEDANCE
AB Energy drinks are beverages containing vasoactive metabolites, usually a combination of caffeine, taurine, glucuronolactone and sugars. There are concerns about the safety of energy drinks with some countries banning their sales. We determined the acute effects of a popular energy drink, Red Bull, on cardiovascular and hemodynamic variables, cerebrovascular parameters and microvascular endothelial function.
   Twenty-five young non-obese and healthy subjects attended two experimental sessions on separate days according to a randomized crossover study design. During each session, primary measurements included beat-to-beat blood pressure measurements, impedance cardiography and transcranial Doppler measurements for at least 20 min baseline and for 2 h following the ingestion of either 355 mL of the energy drink or 355 mL of tap water; the endothelial function test was performed before and two hours after either drink.
   Unlike the water control load, Red Bull consumption led to increases in both systolic and diastolic blood pressure (p < 0.005), associated with increased heart rate and cardiac output (p < 0.05), with no significant changes in total peripheral resistance and without diminished endothelial response to acetylcholine; consequently, double product (reflecting myocardial load) was increased (p < 0.005). Red Bull consumption also led to increases in cerebrovascular resistance and breathing frequency (p < 0.005), as well as to decreases in cerebral blood flow velocity (p < 0.005) and end-tidal carbon dioxide (p < 0.005).
   Our results show an overall negative hemodynamic profile in response to ingestion of the energy drink Red Bull, in particular an elevated blood pressure and double product and a lower cerebral blood flow velocity.
C1 [Grasser, Erik K.; Yepuri, Gayathri; Dulloo, Abdul G.; Montani, Jean-Pierre] Univ Fribourg, Div Physiol, Dept Med, Lab Integrat Cardiovasc & Metab Physiol, CH-1700 Fribourg, Switzerland.
C3 University of Fribourg
RP Grasser, EK (corresponding author), Univ Fribourg, Div Physiol, Dept Med, Lab Integrat Cardiovasc & Metab Physiol, Chemin Musee 5, CH-1700 Fribourg, Switzerland.
EM erikkonrad.grasser@unifr.ch
OI DULLOO, Abdul/0000-0003-3877-6149
FU Swiss National Science Foundation [3200B0-122554]
FX Research related to this paper was funded in part by the Swiss National
   Science Foundation (Project 3200B0-122554 to JPM).
CR Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021
   Baum M, 2001, AMINO ACIDS, V20, P75, DOI 10.1007/s007260170067
   Berger AJ, 2009, MED J AUSTRALIA, V190, P41, DOI 10.5694/j.1326-5377.2009.tb02263.x
   Bichler A, 2006, AMINO ACIDS, V31, P471, DOI 10.1007/s00726-005-0302-x
   Brown CM, 2005, AM J PHYSIOL-REG I, V289, pR1687, DOI 10.1152/ajpregu.00205.2005
   de Jongh RT, 2004, DIABETOLOGIA, V47, P978, DOI 10.1007/s00125-004-1412-9
   Fennessy FM, 2003, CIRCULATION, V107, P410, DOI 10.1161/01.CIR.0000046447.72402.47
   Fortin J, 2006, COMPUT BIOL MED, V36, P1185, DOI 10.1016/j.compbiomed.2005.06.001
   Franks AM, 2012, ANN PHARMACOTHER, V46, P192, DOI 10.1345/aph.1Q555
   Grasser EK, 2009, PHYSIOL RES, V58, P817, DOI 10.33549/physiolres.931591
   Gratze G, 1998, COMPUT BIOL MED, V28, P121, DOI 10.1016/S0010-4825(98)00005-5
   Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x
   Higgins JP, 2013, INT J CARDIOL, V168, pE47, DOI 10.1016/j.ijcard.2013.06.114
   Higgins JP, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.12.023
   Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381
   KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995
   KUBICEK WG, 1970, ANN NY ACAD SCI, V170, P724, DOI 10.1111/j.1749-6632.1970.tb17735.x
   Lal GG, 2007, FOOD TECHNOL-CHICAGO, V61, P24
   MATHEW RJ, 1985, STROKE, V16, P814, DOI 10.1161/01.STR.16.5.814
   Morris SJ, 1996, J PHYSIOL-LONDON, V496, P531, DOI 10.1113/jphysiol.1996.sp021704
   Nienhueser J., 2011, INT J EXERC SCI, V4, P321
   Ragsdale FR, 2010, AMINO ACIDS, V38, P1193, DOI 10.1007/s00726-009-0330-z
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   REIVICH M, 1964, AM J PHYSIOL, V206, P25, DOI 10.1152/ajplegacy.1964.206.1.25
   Rottlaender D, 2011, INT J CARDIOL, V158, P51
   Steinke L, 2009, ANN PHARMACOTHER, V43, P596, DOI 10.1345/aph.1L614
   Trabulo D, 2011, EMERG MED J, V28, P712, DOI [10.1136/emj.09.2010.3322rep, 10.1136/bcr.09.2010.3322]
   Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058
   Van Vliet BN, 1999, AM J PHYSIOL-HEART C, V277, pH1679, DOI 10.1152/ajpheart.1999.277.5.H1679
   WEINHOLD C, 1993, J HEART LUNG TRANSPL, V12, P832
   Worthley MI, 2010, AM J MED, V123, P184, DOI 10.1016/j.amjmed.2009.09.013
NR 31
TC 93
Z9 102
U1 2
U2 109
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT
PY 2014
VL 53
IS 7
BP 1561
EP 1571
DI 10.1007/s00394-014-0661-8
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AP9UV
UT WOS:000342426800012
PM 24474552
OA Green Published, Green Submitted, hybrid
DA 2025-04-28
ER

PT J
AU Marakis, G
   Kontopoulou, L
   Garofalakis, G
   Vasara, E
   Vasiliadis, G
   Grammatikopoulou, MG
AF Marakis, Georgios
   Kontopoulou, Lamprini
   Garofalakis, Gorgias
   Vasara, Eleni
   Vasiliadis, Georgios
   Grammatikopoulou, Maria G.
TI Development and relative validity of a self-administered
   semi-quantitative drinks frequency questionnaire, validated in a
   population of university students
SO NUTRITION & DIETETICS
LA English
DT Article
DE beverage; diet; food frequency; nutrition; nutritional epidemiology;
   validation
ID SUGAR-SWEETENED BEVERAGES; WATER-INTAKE; PRESCHOOL-CHILDREN; DIETARY
   ASSESSMENT; FOOD; CONSUMPTION; REPRODUCIBILITY; ADOLESCENTS; OBESITY;
   AGREEMENT
AB Aim Drinks can contribute to energy as well as micro- and macro-nutrient intake. Drink-specific, validated, quick and easy to administer questionnaires are needed to monitor secular trends in beverage consumption for different populations. The aim of the present cross-sectional study was to develop and validate a drink-specific questionnaire for the Greek population. Methods A 41-item semi-quantitative drinks frequency questionnaire (DFQ) was developed and validated against 7-day weighed food records, among young Greek adults. Wilcoxon ranks tests, Kendall tau-b correlations and Bland-Altman plot were used to compare the two methods. Fifty-nine Greek University students (28 males, 31 females) completed both methods. Results No difference was observed in total drinks intake between the two methods. The Bland-Altman plot showed that the two methods are likely to agree concerning the total drinks intake. Wilcoxon's rank test showed no significant differences between the two methods, except for the 'whiskey/vodka/gin' intake (P < 0.001). 'Good' agreement (tau-b > 0.61) was observed for most DFQ items, including low-fat and chocolate milk, hot chocolate, Greek/espresso coffee, commercial tea, packaged fruit juices, wine, alcohol-free beer, light cola-type drinks and water (tap/bottled/sparkling). 'Low' agreement (<0.30) was noted for filtered/instant/iced coffee, freshly squeezed orange juice and some alcoholic drinks (beer/whiskey/vodka/gin). Conclusions The DFQ appears to be an overall valid means of estimating the habitual intake of drinks in large-scale epidemiological surveys. The study supports the use of DFQ for assessing drinks consumption patterns and secular trends.
C1 [Marakis, Georgios; Garofalakis, Gorgias] Hellen Food Author, Nutr Policy & Res Directorate, Athens, Greece.
   [Kontopoulou, Lamprini] Technol Educ Inst Thessaly, Dept Nutr & Dietet, Kardhitsa, Greece.
   [Vasara, Eleni] Aristotle Univ Thessaloniki, Dept Biol, Fac Hlth Sci, Thessaloniki, Greece.
   [Grammatikopoulou, Maria G.] Aristotle Univ Thessaloniki, Fac Hlth Sci, Dept Med, Thessaloniki, Greece.
   [Grammatikopoulou, Maria G.] Alexander Technol Educ Inst, Dept Nutr & Dietet, Thessaloniki, Greece.
   [Vasiliadis, Georgios] Technol Educ Inst Western Macedonia, Dept Informat Engn, Kastoria, Greece.
C3 Aristotle University of Thessaloniki; Aristotle University of
   Thessaloniki; International Hellenic University
RP Grammatikopoulou, MG (corresponding author), Alexander Technol Educ Inst, Dept Nutr & Dietet, POB 141, Sindos, Greece.
EM maria@nutr.teithe.gr
RI Garofalakis, Gorgias/HOF-6374-2023
OI Vasiliadis, Georgios/0009-0001-3675-8513; KONTOPOULOU,
   LAMPRINI/0009-0005-4745-2586; Marakis, Georgios/0000-0003-3468-5100
CR Al-Dlaigan YH, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0307-9
   Athanasatou A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090559
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   Brunner E, 2001, BRIT J NUTR, V86, P405, DOI 10.1079/BJN2001414
   Buch-Andersen T, 2016, PUBLIC HEALTH NUTR, V19, P1184, DOI 10.1017/S136898001500275X
   Byers T, 2001, AM J EPIDEMIOL, V154, P1087, DOI 10.1093/aje/154.12.1087
   Byrne R, 2018, NUTR DIET, V75, P159, DOI 10.1111/1747-0080.12409
   Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318
   Dawodu A, 2017, J CHILD HEALTH CARE, V21, P446, DOI 10.1177/1367493517731948
   Deshpande G, 2017, J ENDOCR SOC, V1, P1372, DOI 10.1210/js.2017-00262
   Edmonds CJ, 2018, PHYSIOL BEHAV, V194, P233, DOI 10.1016/j.physbeh.2018.06.004
   Edmonds CJ, 2017, APPETITE, V108, P464, DOI 10.1016/j.appet.2016.11.011
   Ferreira-Pego Cintia, 2016, Nutrients, V8, DOI 10.3390/nu8080475
   Franks B, 2017, APPETITE, V116, P205, DOI 10.1016/j.appet.2017.04.019
   Fresán U, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110688
   Fung TT, 2014, AM J CLIN NUTR, V100, P953, DOI 10.3945/ajcn.114.083352
   Glabska D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121574
   Grammatikopoulou MG, 2014, CLIN OBES, V4, P303, DOI 10.1111/cob.12070
   Grammatikopoulou M. G, 2016, OBESITY MED, V2, P31
   Hedrick VE, 2013, EAT BEHAV, V14, P90, DOI 10.1016/j.eatbeh.2012.10.011
   Hedrick VE, 2012, J ACAD NUTR DIET, V112, P840, DOI 10.1016/j.jand.2012.01.023
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226
   Kiwanuka SN, 2006, COMMUNITY DENT ORAL, V34, P372, DOI 10.1111/j.1600-0528.2006.00287.x
   Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2826, DOI 10.1158/1055-9965.EPI-12-ED1
   Leventakou V, 2015, PUBLIC HEALTH NUTR, V18, P421, DOI 10.1017/S1368980014000445
   Lin WT, 2016, J PEDIATR-US, V171, P90, DOI 10.1016/j.jpeds.2015.12.061
   LIVINGSTONE MBE, 1990, BMJ-BRIT MED J, V300, P708, DOI 10.1136/bmj.300.6726.708
   Malisova O, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040204
   Marshall TA, 2003, J AM DIET ASSOC, V103, P714, DOI 10.1053/jada.2003.50137
   Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214
   Naska Androniki, 2017, F1000Res, V6, P926, DOI 10.12688/f1000research.10703.1
   Neuhouser ML, 2009, J AM DIET ASSOC, V109, P1587, DOI 10.1016/j.jada.2009.06.365
   Papandreou D, 2013, HIPPOKRATIA, V17, P42
   Patsopoulou A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010083
   Poulimeneas Dimitrios, 2017, Int J Adolesc Med Health, V31, DOI 10.1515/ijamh-2017-0019
   Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264
   Shrestha A, 2017, INT J FOOD SCI NUTR, V68, P605, DOI 10.1080/09637486.2016.1268099
   Steinemann N, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1305193
   Streppel MT, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-75
   Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089
   Theodoridis X, 2018, NUTR METAB CARDIOVAS, V28, P477, DOI 10.1016/j.numecd.2018.02.007
   Thomson CA, 2003, AM J EPIDEMIOL, V157, P754, DOI 10.1093/aje/kwg025
   Van Diepen S, 2011, NUTR METAB CARDIOVAS, V21, P534, DOI 10.1016/j.numecd.2009.11.006
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Watson EJ, 2017, INT J FOOD SCI NUTR, V68, P617, DOI 10.1080/09637486.2016.1268102
NR 46
TC 4
Z9 4
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1446-6368
EI 1747-0080
J9 NUTR DIET
JI Nutr. Diet.
PD NOV
PY 2019
VL 76
IS 5
BP 532
EP 538
DI 10.1111/1747-0080.12494
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA JP2XO
UT WOS:000498132700006
PM 30353963
DA 2025-04-28
ER

PT J
AU Miller, J
   Lee, A
   Obersky, N
   Edwards, R
AF Miller, Jane
   Lee, Amanda
   Obersky, Natalie
   Edwards, Rachael
TI Implementation of A Better Choice Healthy Food and Drink Supply Strategy
   for staff and visitors in government-owned health facilities in
   Queensland, Australia
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Food supply; Hospitals; Health centres; Health facilities; Obesity;
   Australia
ID OBESITY PREVENTION; INTERVENTIONS; ENVIRONMENT; PROMOTION; NUTRITION;
   PROGRAM; SCHOOLS
AB Objective: The present paper reports on a quality improvement activity examining implementation of A Better Choice Healthy Food and Drink Supply Strategy for Queensland Health Facilities (A Better Choice). A Better Choice is a policy to increase supply and promotion of healthy foods and drinks and decrease supply and promotion of energy-dense, nutrient-poor choices in all food supply areas including food outlets, staff dining rooms, vending machines, tea trolleys, coffee carts, leased premises, catering, fundraising, promotion and advertising.
   Design: An online survey targeted 278 facility managers to collect self-reported quantitative and qualitative data. Telephone interviews were sought concurrently with the twenty-five A Better Choice district contact officers to gather qualitative information.
   Setting: Public sector-owned and -operated health facilities in Queensland, Australia.
   Subjects:One hundred and thirty-four facility managers and twenty-four district contact officers participated with response rates of 48.2 % and 96.0 %, respectively.
   Results: Of facility managers, 78.4 % reported implementation of more than half of the A Better Choice requirements including 24.6 % who reported full strategy implementation. Reported implementation was highest in food outlets, staff dining rooms, tea trolleys, coffee carts, internal catering and drink vending machines. Reported implementation was more problematic in snack vending machines, external catering, leased premises and fundraising.
   Conclusions: Despite methodological challenges, the study suggests that policy approaches to improve the food and drink supply can be implemented successfully in public-sector health facilities, although results can be limited in some areas. A Better Choice may provide a model for improving food supply in other health and workplace settings.
C1 [Miller, Jane; Obersky, Natalie; Edwards, Rachael] Queensland Hlth, Prevent Hlth Unit, Fortitude Valley Bc, Qld 4006, Australia.
   [Lee, Amanda] Queensland Univ Technol, Fac Hlth, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia.
   [Lee, Amanda] Queensland Univ Technol, Sch Exercise & Nutr Sci, Kelvin Grove, Qld, Australia.
C3 Queensland Health; Queensland University of Technology (QUT); Queensland
   University of Technology (QUT)
RP Miller, J (corresponding author), Queensland Hlth, Prevent Hlth Unit, POB 2368, Fortitude Valley Bc, Qld 4006, Australia.
EM janemiller.au@gmail.com
OI Lee, Amanda/0000-0001-6887-5426
FU Queensland Health
FX This activity was funded by Queensland Health. Staff from Queensland
   Health contributed to the study design and conduct, interpretation of
   the findings and preparation of the manuscript.
CR Anderson LM, 2009, AM J PREV MED, V37, P340, DOI 10.1016/j.amepre.2009.07.003
   [Anonymous], AUSTR DIET GUID INC
   Australian Bureau of Statistics, 2012, 2011 CENS QUICKST QU
   Devine CM, 2007, OBESITY, V15, p57S, DOI 10.1038/oby.2007.388
   Dick M, 2012, EUR J CLIN NUTR, V66, P1124, DOI 10.1038/ejcn.2012.108
   Engbers LH, 2005, AM J PREV MED, V29, P61, DOI 10.1016/j.amepre.2005.03.001
   Franco L, 2005, AUST NZ J PUBL HEAL, V29, P189, DOI 10.1111/j.1467-842X.2005.tb00074.x
   Goetzel RZ, 2009, J OCCUP ENVIRON MED, V51, P125, DOI 10.1097/JOM.0b013e3181954b03
   Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5
   Healthy Fundraising Australia, 2012, SCH FUNDR ID
   Heinen L, 2009, MILBANK Q, V87, P101, DOI 10.1111/j.1468-0009.2009.00549.x
   Kelly B, 2012, HEALTH PROMOT J AUST, V23, P73, DOI 10.1071/HE12073
   Kelly B, 2011, HEALTH PROMOT INT, V26, P188, DOI 10.1093/heapro/daq061
   Kelly B, 2010, AUST NZ J PUBL HEAL, V34, P583, DOI 10.1111/j.1753-6405.2010.00619.x
   Lawrence S, 2009, PEDIATRICS, V123, pS287, DOI 10.1542/peds.2008-2780G
   Living Fundraisers, 2012, SMART HEALTH MOR PRO
   Nutrition Australia, 2011, FUNDR ID HLTH KIDS
   Pratt CA, 2007, OBESITY, V15, P2171, DOI 10.1038/oby.2007.258
   Public Service Commission, 2011, QUEENSL PUBL SERV WO
   Queensland Association of School Tuckshops Inc, 2005, FRESH ID FUNDR
   Queensland Government, 2011, INT FACTS QUEENSL
   Queensland Government, 2010, HLTH CHOIC CAT
   Queensland Health, 2011, A BETT CHOIC
   Queensland Health, 2007, BETT CHOIC HLTH FOOD
   Queensland Health, 2011, QUEENSL HLTH STRAT P
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Wharton CM, 2008, J SCHOOL HEALTH, V78, P245, DOI 10.1111/j.1746-1561.2008.00296.x
   Whitehead D, 2004, HEALTH PROMOT INT, V19, P259, DOI 10.1093/heapro/dah213
   [No title captured]
NR 29
TC 20
Z9 20
U1 2
U2 18
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JUN
PY 2015
VL 18
IS 9
BP 1602
EP 1609
DI 10.1017/S1368980013003455
PG 8
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA CJ1UZ
UT WOS:000355271400013
PM 24476797
OA Green Published, Green Submitted, Bronze
DA 2025-04-28
ER

PT J
AU Wilson, T
   Bendich, A
AF Wilson, Ted
   Bendich, Adrianne
TI Nutrition Guidelines for Improved Clinical Care
SO MEDICAL CLINICS OF NORTH AMERICA
LA English
DT Article
DE Diet; Nutrition; Essential nutrients; Hydration; Alcohol
ID ALL-CAUSE MORTALITY; COFFEE CONSUMPTION; ALCOHOL-CONSUMPTION; COVID-19
   INFECTION; HEART-DISEASE; UNITED-STATES; GREEN TEA; RISK; PATTERNS;
   DRINKING
AB Approximately 80% of the major chronic diseases, such as obesity, diabetes, hyper-tension, and diet-related cancers, are at least partly preventable with better nutrition. Unfortunately, medical training and practice is focused on the treatment of these con-ditions after their diagnosis. It is critically important that both the clinician and the pa-tient understand that humans are required to consume a varied diet that contains sufficient liquids and the essential vitamins, mineral, fats, and amino acids necessary for life. General fluency with respect to the health effects of water, tea, coffee, SSBs is also an area of intense patient interest and clinical significance. An improved under-standing of the governmental organizations responsible for nutrition recommenda-tions and the use of NFLs on food products can improve health outcomes. Growth charts, BMI, and caloric need calculations are also important clinical nutrition consid-erations. Finally, the complications to food availability, delivery, and nutrition assess-ment in relation to the ongoing COVID pandemic will continue to stress our ability to provide the most data-driven recommendations concerning nutrition for health, dis-ease prevention, and treatment. It is clear that much needs to be done to avoid a continuation of the increase in deaths associated with many different diet-based pre-ventable conditions. It is true that the scientific basis of nutrition recommendations is constantly changing, as is true for all science/research-based fields. This article can help the clinician understand the changes that have led to the current diet recommen-dations and can remind the patient that as more nutrition research is done, the recom-mendations will further improve their nutrition and overall health.
C1 [Wilson, Ted] Winona State Univ, Dept Biol, Rm 232,Pasteur Hall, Winona, MN 55987 USA.
   [Bendich, Adrianne] Springer, Nat Nutr & Hlth Book Series, 8765 Via Brilliante, Wellington, FL 33411 USA.
C3 Minnesota State Colleges & Universities; Winona State University;
   Springer Nature
RP Wilson, T (corresponding author), Winona State Univ, Dept Biol, Winona, MN 55987 USA.
EM twilson@winona.edu
CR Adams KM, 2010, ACAD MED, V85, P1537, DOI 10.1097/ACM.0b013e3181eab71b
   Alicandro G, 2017, EUR J CANCER PREV, V26, P424, DOI [10.1097/CEJ.0000000000000341, 10.1097/cej.0000000000000341]
   [Anonymous], MYPLATE
   [Anonymous], DEF DEP WILL HELP RE
   [Anonymous], 1989, Report of the Committee on Diet and Health, Food and Nutrition Board, P750
   [Anonymous], 2005, DIETARY REFERENCE IN, P73, DOI [10.17226/10925, DOI 10.17226/10925]
   [Anonymous], 1980, Dietary Guidelines for Americans
   [Anonymous], 2008, DEV DRIS 1994 2004 L, DOI [10.17226/12086, DOI 10.17226/12086]
   [Anonymous], 2004, DIETARY REFERENCE IN
   [Anonymous], 2009, HEALTH REP
   [Anonymous], 2013, About the National Health and Nutrition Examination Survey
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002
   Basu A, 2007, NUTR REV, V65, P361, DOI 10.1111/j.1753-4887.2007.tb00314.x
   Bellinger DC, 2016, NEW ENGL J MED, V374, P1101, DOI 10.1056/NEJMp1601013
   Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238
   Carlson JR, 2007, MAYO CLIN PROC, V82, P725
   Catov JM, 2011, AM J CLIN NUTR, V94, P906, DOI 10.3945/ajcn.111.012393
   Cereda G, 2022, ADV NUTR, V13, P66, DOI 10.1093/advances/nmab110
   Choi SL, 2021, PUBLIC HEALTH, V200, P7, DOI 10.1016/j.puhe.2021.09.002
   Chromium, 2001, DIETARY REFERENCE IN, P197
   Collard Kalyn M, 2021, Acad Pediatr, V21, P1067, DOI 10.1016/j.acap.2020.12.007
   Craig WJ, 2021, NUTRIENTS
   Czeizel AE, 2015, EUR J OBSTET GYN R B, V193, P34, DOI 10.1016/j.ejogrb.2015.06.024
   Dana LM, 2021, PUBLIC HEALTH NUTR, V24, P5704, DOI 10.1017/S1368980021001294
   Devries S, 2019, JAMA-J AM MED ASSOC, V321, P1351, DOI 10.1001/jama.2019.1581
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   DiNicolantonio JJ, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000444
   Dong X, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030840
   FAO/WHO, 1989, National Research Council Recommended Dietary 626 Allowances, V10th, DOI [10.17226/1349, DOI 10.17226/1349]
   Fiorino S, 2020, AGING CLIN EXP RES, V32, P2115, DOI 10.1007/s40520-020-01669-y
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Gaby S.K, 1991, VITAMIN INTAKE HLTH, P1
   Good Food Institute, US RET MARK DAT PLAN
   Gosdin LK, 2022, MMWR-MORBID MORTAL W, V71, P10, DOI 10.15585/mmwr.mm7101a2
   Keeble M, 2021, APPL GEOGR, V133, DOI 10.1016/j.apgeog.2021.102498
   Kim EJ, 2021, AM J HEALTH PROMOT, V35, P648, DOI 10.1177/0890117120983128
   Lands W.E.M., 1991, MICRONUTRIENTS HLTH, P9
   Lee SH, 2022, MMWR-MORBID MORTAL W, V71, P1, DOI 10.15585/mmwr.mm7101a1
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947
   MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241
   Mignogna C, 2021, ADV NUTR
   Miranda AM, 2021, CLIN NUTR, V40, P542, DOI 10.1016/j.clnu.2020.05.052
   Moser U, 1991, HDB VITAMINS, P196
   Mukamal KJ, 2005, CIRCULATION, V112, P1406, DOI 10.1161/CIRCULATIONAHA.105.537704
   National Center for Health Statistics, GROWTH CHARTS CTR DI
   National Institute of Standards and Technology, YOU KNOW YOUR FOODS
   National Research Council, 1941, Recommended Dietary Allowances, DOI [10.17226/13286, DOI 10.17226/13286]
   National Research Council (U.S). Food and nutrition board, 1968, REC DIET ALL REP FOO
   Nguyen NT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0417
   Olsen JA, 1991, HDB VITAMINS, V2nd, P2
   Popkin BM, 2010, PHYSIOL BEHAV, V100, P4, DOI 10.1016/j.physbeh.2009.12.022
   Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11
   ROSE WC, 1951, J BIOL CHEM, V193, P605
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Schulz R, 2021, ADV NUTR, V12, P1108, DOI 10.1093/advances/nmab050
   Soedamah-Muthu SS, 2011, AM J CLIN NUTR, V93, P158, DOI 10.3945/ajcn.2010.29866
   Stephenson T, 2022, HUMAN NUTR SCI HLTH
   Teramoto M, 2021, STROKE, V52, P957, DOI 10.1161/STROKEAHA.120.032273
   Thibault R, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03159-z
   U.S. DEPARTMENT OF AGRICULTURE, FOOD LAB EC RES SERV
   United States Department of Agriculture, 1980, US DEP HLTH HUM SERV
   Vivanti AP, 2012, EUR J CLIN NUTR, V66, P1282, DOI 10.1038/ejcn.2012.157
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Wierdsma NJ, 2021, CLIN NUTR ESPEN, V43, P369, DOI 10.1016/j.clnesp.2021.03.021
   Willett WC, 2015, PREVENTIVE NUTR, V5th, P25
   Wilson T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092201
   Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X
   Yisak H, 2021, RISK MANAG HEALTHC P, V14, P31, DOI 10.2147/RMHP.S291584
   Zafar MI, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.647600
NR 71
TC 4
Z9 4
U1 0
U2 4
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0025-7125
EI 1557-9859
J9 MED CLIN N AM
JI Med. Clin. N. Am.
PD SEP
PY 2022
VL 106
IS 5
BP 819
EP 836
DI 10.1016/j.mcna.2022.04.007
EA SEP 2022
PG 18
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 6S6CS
UT WOS:000893073200007
PM 36154702
OA Green Published
DA 2025-04-28
ER

PT J
AU Zhang, XL
   Li, XA
   Chen, FR
   Cao, XS
   Wang, CX
   Jiao, LY
   Yue, L
   Wang, ZY
AF Zhang, Xiaoli
   Li, Xiaona
   Chen, Feiran
   Cao, Xuesong
   Wang, Chuanxi
   Jiao, Liya
   Yue, Le
   Wang, Zhenyu
TI Selenium Nanomaterials Enhance the Nutrients and Functional Components
   of Fuding Dabai Tea
SO NANOMATERIALS
LA English
DT Article
DE selenium nanomaterials; theanine; tea polyphenols; regulatory mechanism
ID IMPACT; SOIL; TRANSLOCATION; NANOPARTICLES; POLYPHENOLS; BACTERIA;
   QUALITY; OBESITY; NITRATE; HEALTH
AB Theanine, polyphenols, and caffeine not only affect the flavor of tea, but also play an important role in human health benefits. However, the specific regulatory mechanism of Se NMs on fat-reducing components is still unclear. In this study, the synthesis of fat-reducing components in Fuding Dabai (FDDB) tea was investigated. The results indicated that the 100-bud weight, theanine, EGCG, total catechin, and caffeine contents of tea buds were optimally promoted by 10 mg<middle dot>L-1 Se NMs in the range of 24.3%, 36.2%, 53.9%, 67.1%, and 30.9%, respectively. Mechanically, Se NMs promoted photosynthesis in tea plants, increased the soluble sugar content in tea leaves (30.3%), and provided energy for the metabolic processes, including the TCA cycle, pyruvate metabolism, amino acid metabolism, and the glutamine/glutamic acid cycle, ultimately increasing the content of amino acids and antioxidant substances (catechins) in tea buds; the relative expressions of key genes for catechin synthesis, CsPAL, CsC4H, CsCHI, CsDFR, CsANS, CsANR, CsLAR, and UGGT, were significantly upregulated by 45.1-619.1%. The expressions of theanine synthesis genes CsTs, CsGs, and CsGOGAT were upregulated by 138.8-693.7%. Moreover, Se NMs promoted more sucrose transfer to the roots, with the upregulations of CsSUT1, CsSUT2, CsSUT3, and CsSWEET1a by 125.8-560.5%. Correspondingly, Se NMs enriched the beneficial rhizosphere microbiota (Roseiarcus, Acidothermus, Acidibacter, Conexicter, and Pedosphaeraceae), enhancing the absorption and utilization of ammonium nitrogen by tea plants, contributing to the accumulation of theanine. This study provides compelling evidence supporting the application of Se NMs in promoting the lipid-reducing components of tea by enhancing its nitrogen metabolism.
C1 [Zhang, Xiaoli; Li, Xiaona; Chen, Feiran; Cao, Xuesong; Wang, Chuanxi; Jiao, Liya; Yue, Le; Wang, Zhenyu] Jiangnan Univ, Inst Environm Proc & Pollut Control, Sch Environm & Ecol, Wuxi 214122, Peoples R China.
   [Zhang, Xiaoli; Li, Xiaona; Chen, Feiran; Cao, Xuesong; Wang, Chuanxi; Jiao, Liya; Yue, Le; Wang, Zhenyu] Jiangsu Engn Lab Biomass Energy & Carbon Reduct Te, Wuxi 214122, Peoples R China.
C3 Jiangnan University
RP Yue, L (corresponding author), Jiangnan Univ, Inst Environm Proc & Pollut Control, Sch Environm & Ecol, Wuxi 214122, Peoples R China.; Yue, L (corresponding author), Jiangsu Engn Lab Biomass Energy & Carbon Reduct Te, Wuxi 214122, Peoples R China.
EM leyue@jiangnan.edu.cn
RI 张, 丽/HNR-1093-2023; Wang, Chuanxi/AAE-6782-2021; Wang,
   Zhenyu/IVU-7687-2023; Jiao, Liya/AAY-2854-2021; Yue, Le/MSZ-6117-2025;
   Cao, Xuesong/HNJ-6507-2023; Chen, Feiran/HIA-0017-2022; Li,
   Xiaona/AGZ-8131-2022
OI Li, Xiaona/0000-0002-0767-3609
FU the National Natural Science Foundation of China [41820104009, 42277225,
   41807378]; National Natural Science Foundation of China
FX Financial support from the National Natural Science Foundation of China
   (41820104009, 42277225, and 41807378) is gratefully acknowledged.
CR Abdallah WA, 2005, J MATER SCI, V40, P2679, DOI 10.1007/s10853-005-2104-7
   Anderson MR, 2021, CHEST, V160, P2135, DOI 10.1016/j.chest.2021.08.001
   Arnoriaga-Rodríguez M, 2020, CELL METAB, V32, P548, DOI 10.1016/j.cmet.2020.09.002
   Arvind G, 2011, J MICROBIOL BIOTECHN, V21, P545, DOI 10.4014/jmb.1012.12022
   Avellan A, 2021, ENVIRON SCI TECHNOL, V55, P13417, DOI 10.1021/acs.est.1c00178
   Avellan A, 2019, ACS NANO, V13, P5291, DOI 10.1021/acsnano.8b09781
   Bag S, 2022, FOOD CHEM, V371, DOI 10.1016/j.foodchem.2021.131098
   Cai L, 2020, J HAZARD MATER, V393, DOI 10.1016/j.jhazmat.2020.122415
   Morales-Espinoza MC, 2019, MOLECULES, V24, DOI 10.3390/molecules24173030
   Chen N, 2021, FOOD BIOSCI, V40, DOI 10.1016/j.fbio.2020.100875
   Chen WC, 2021, APPL SOIL ECOL, V157, DOI 10.1016/j.apsoil.2020.103762
   Dechorgnat J, 2011, J EXP BOT, V62, P1349, DOI 10.1093/jxb/erq409
   Dong CX, 2020, PLANT J, V101, P57, DOI 10.1111/tpj.14517
   Doornbos RF, 2012, AGRON SUSTAIN DEV, V32, P227, DOI 10.1007/s13593-011-0028-y
   Fan K, 2020, J PLANT NUTR SOIL SC, V183, P180, DOI 10.1002/jpln.201900268
   Fu HP, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13052967
   Galili G, 2016, ANNU REV PLANT BIOL, V67, P153, DOI 10.1146/annurev-arplant-043015-112213
   Ghafariyan MH, 2013, ENVIRON SCI TECHNOL, V47, P10645, DOI 10.1021/es402249b
   Glass ADM, 2002, J EXP BOT, V53, P855, DOI 10.1093/jexbot/53.370.855
   Gudkov SV, 2023, MATERIALS, V16, DOI 10.3390/ma16145164
   Handa N, 2019, ENVIRON EXP BOT, V161, P180, DOI 10.1016/j.envexpbot.2018.11.009
   Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007
   Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1
   Huang S, 2021, J AGR FOOD CHEM, V69, P1242, DOI 10.1021/acs.jafc.0c06284
   Lee SD, 2017, INT J SYST EVOL MICR, V67, P3214, DOI 10.1099/ijsem.0.002083
   Li D, 2021, ENVIRON POLLUT, V273, DOI 10.1016/j.envpol.2021.116503
   Li JX, 2021, HORTSCIENCE, V56, P753, DOI 10.21273/HORTSCI15658-20
   Li Q, 2013, J SCI FOOD AGR, V93, P1310, DOI 10.1002/jsfa.5887
   Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138
   Liu KH, 2021, ENVIRON EXP BOT, V188, DOI 10.1016/j.envexpbot.2021.104475
   Liu MY, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2027-0
   Liu SH, 2021, TRENDS FOOD SCI TECH, V114, P540, DOI 10.1016/j.tifs.2021.06.006
   Lu ZW, 2014, PLANT PHYSIOL BIOCH, V80, P328, DOI 10.1016/j.plaphy.2014.04.016
   Mikula K, 2020, SCI TOTAL ENVIRON, V712, DOI 10.1016/j.scitotenv.2019.136365
   Nair R, 2010, PLANT SCI, V179, P154, DOI 10.1016/j.plantsci.2010.04.012
   Prasad R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01014
   Ruan JY, 2013, J PLANT NUTR SOIL SC, V176, P450, DOI 10.1002/jpln.201200175
   Ruan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep38370
   Sanchez-Arcos C, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00188
   Serov DA, 2023, MATERIALS, V16, DOI 10.3390/ma16155363
   Sharma G, 2014, MOLECULES, V19, P2761, DOI 10.3390/molecules19032761
   Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002
   Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9
   Tang S, 2021, SCI TOTAL ENVIRON, V778, DOI 10.1016/j.scitotenv.2021.146328
   Vuong QV, 2011, J SCI FOOD AGR, V91, P1931, DOI 10.1002/jsfa.4373
   Wang J, 2022, ACS NANO, V16, P21047, DOI 10.1021/acsnano.2c08753
   Wang ZY, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105831
   Xia SM, 2016, ENVIRON TECHNOL, V37, P795, DOI 10.1080/09593330.2015.1085099
   Xie SW, 2019, ENVIRON SCI POLLUT R, V26, P2464, DOI 10.1007/s11356-018-3732-1
   Xin W, 2024, CURR BIOL, V34, DOI 10.1016/j.cub.2024.01.044
   Yan ZM, 2020, ANIM NUTR, V6, P115, DOI 10.1016/j.aninu.2020.01.001
   Yang XD, 2018, AGR ECOSYST ENVIRON, V252, P74, DOI 10.1016/j.agee.2017.10.004
   Yao LN, 2020, PLANT CELL PHYSIOL, V61, P1669, DOI 10.1093/pcp/pcaa091
   Yu F, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00347
   Yue L, 2023, SCI TOTAL ENVIRON, V901, DOI 10.1016/j.scitotenv.2023.166500
   Zhalnina K, 2018, NAT MICROBIOL, V3, P470, DOI 10.1038/s41564-018-0129-3
   Zhan XH, 2015, ENVIRON SCI POLLUT R, V22, P6280, DOI 10.1007/s11356-014-3834-3
NR 57
TC 2
Z9 2
U1 18
U2 37
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-4991
J9 NANOMATERIALS-BASEL
JI Nanomaterials
PD APR
PY 2024
VL 14
IS 8
AR 681
DI 10.3390/nano14080681
PG 15
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA OW7B6
UT WOS:001210368900001
PM 38668175
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Samanta, S
AF Samanta, Saptadip
TI Potential Bioactive Components and Health Promotional Benefits of Tea
   (Camellia sinensis)
SO JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION
LA English
DT Review
DE Tea; Camellia sinensis; epicatechins; theaflavins; theanine; health
   benefits
ID HUMAN PROSTATE-CANCER; NF-KAPPA-B; CELL-CYCLE ARREST; GREEN TEA;
   BLACK-TEA; BREAST-CANCER; EPIGALLOCATECHIN GALLATE; GROWTH-INHIBITION;
   L-THEANINE; HEPATOCELLULAR-CARCINOMA
AB Tea is prepared from the young leaves, buds, stalks of the plant Camellia sinensis. The cultivation process of tea plants and the habit of tea drinking were initiated in China from ancient times. Now, the consumption of tea is very popular throughout the world and it is an integral part of our social culture. Tea contains polyphenolic compounds (catechins and epicatechins), theaflavins, flavonol glycosides, L-theanine, caffeine, theobromine, and volatile organic substances. These bioactive components are responsible for the astringency, flavor, aroma, and taste of the tea as well as its health beneficial effects. Moreover, tea has several medicinal values. The phytochemical components are involved in the prevention and cure of many illnesses like cardiovascular diseases, malignancy, digestive dysfunction, and metabolic disorders like obesity, diabetes. Tea flavonoids show strong antioxidant properties. Caffeine and other methylxanthine regulate the intracellular second messenger levels. Additionally, catechins exhibit anti-inflammatory effects. All these multidimensional actions make some positive attributes in favor of neuroprotection, cardioprotection, and cancer prevention. Various approaches are also taken to use tea ingredients as an adjuvant in cancer therapy. This review emphasizes the importance of bioactive components, and their health promotional activities. KEY TEACHING POINTS
   Origin and brief history of tea.
   Processing steps and characteristics of different types of teas.
   Bioactive components of teas (green and black tea), their biochemical characteristics and health promotional effects.
   Role of different bioactive components to control the various physiological and metabolic disorders.
   Possibilities of use of tea component in cancer therapy.
C1 [Samanta, Saptadip] Midnapore Coll, Dept Physiol, Midnapore 721101, W Bengal, India.
C3 Midnapore College
RP Samanta, S (corresponding author), Midnapore Coll, Dept Physiol, Midnapore 721101, W Bengal, India.
EM saptadip174@gmail.com
OI Samanta, Saptadip/0000-0001-6741-699X
CR Abd-Elbaset M, 2020, N-S ARCH PHARMACOL, V393, P1611, DOI 10.1007/s00210-020-01863-9
   Abdel-Rahman A, 2011, TOXICOL SCI, V123, P333, DOI 10.1093/toxsci/kfr198
   Adak M., 2011, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V2, P645
   Adhami VM, 2007, CLIN CANCER RES, V13, P1611, DOI 10.1158/1078-0432.CCR-06-2269
   Adhikary R, 2017, ASIAN PAC J TROP BIO, V7, P842, DOI 10.1016/j.apjtb.2017.08.005
   Agarwal R, 2000, BIOCHEM PHARMACOL, V60, P1051, DOI 10.1016/S0006-2952(00)00385-3
   Ajiboye TO, 2016, CHEM-BIOL INTERACT, V258, P276, DOI 10.1016/j.cbi.2016.09.010
   Alshatwi AA, 2016, CHEM-BIOL INTERACT, V247, P1, DOI 10.1016/j.cbi.2016.01.012
   Amine LS, 2014, J ISLAMIC MARK, V5, P71, DOI 10.1108/JIMA-02-2013-0012
   Bag Arundhati, 2018, J Nat Sci Biol Med, V9, P2, DOI 10.4103/jnsbm.JNSBM_46_17
   Baggott MJ, 2013, PSYCHOPHARMACOLOGY, V228, P109, DOI 10.1007/s00213-013-3021-0
   Bahorun T, 2012, PREV MED, V54, pS98, DOI 10.1016/j.ypmed.2011.12.009
   Balasubramanian S, 2006, J BIOL CHEM, V281, P36162, DOI 10.1074/jbc.M605368200
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010
   Benn JA., 2015, TEA CHINA RELIG CULT
   BERKOWITZ JE, 1971, PHYTOCHEMISTRY, V10, P2271, DOI 10.1016/S0031-9422(00)89866-0
   Bernatoniene J, 2018, MOLECULES, V23, DOI 10.3390/molecules23040965
   Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145
   Boggs DA, 2010, CANCER CAUSE CONTROL, V21, P1941, DOI 10.1007/s10552-010-9622-6
   Boyanova L, 2015, DIAGN MICR INFEC DIS, V82, P85, DOI 10.1016/j.diagmicrobio.2015.03.001
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Casanova E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030532
   Cascella M, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0145-6
   Chaturvedula VSP, 2011, J MED PLANTS RES, V5, P2110
   Cheang WS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10340
   Chen HX, 2005, FOOD CHEM, V90, P17, DOI 10.1016/j.foodchem.2004.03.001
   Chen JJ, 2004, BJU INT, V93, P1082, DOI 10.1111/j.1464-410X.2004.04785.x
   Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085771
   Chen QC, 2019, FOOD CHEM, V274, P915, DOI 10.1016/j.foodchem.2018.09.072
   Chen ST, 2019, MOLECULES, V24, DOI 10.3390/molecules24010156
   Chisholm K, 2004, ANTI-CANCER DRUG, V15, P889, DOI 10.1097/00001813-200410000-00010
   Chu SL, 2011, CHIN J INTEGR MED, V17, P492, DOI 10.1007/s11655-011-0781-4
   Chung JY, 1999, CANCER RES, V59, P4610
   Chung LY, 2001, LIFE SCI, V68, P1207, DOI 10.1016/S0024-3205(00)01020-1
   Clifford MN, 2007, J AGR FOOD CHEM, V55, P2797, DOI 10.1021/jf063533l
   Costa J, 2010, J ALZHEIMERS DIS, V20, pS221, DOI 10.3233/JAD-2010-091525
   Coyle CH, 2008, LIFE SCI, V83, P12, DOI 10.1016/j.lfs.2008.04.010
   de Mejia EG, 2009, BRAIN BEHAV IMMUN, V23, P721, DOI 10.1016/j.bbi.2009.02.013
   Di Leo N, 2017, EUR J PHARM BIOPHARM, V114, P1, DOI 10.1016/j.ejpb.2016.12.024
   Di X, 2010, NEUROSCIENCE, V168, P778, DOI 10.1016/j.neuroscience.2010.04.019
   Díaz-Gómez R, 2013, LWT-FOOD SCI TECHNOL, V54, P331, DOI 10.1016/j.lwt.2013.07.012
   Dong HW, 2013, ARCH TOXICOL, V87, P1797, DOI 10.1007/s00204-013-1041-5
   Duffy SJ, 2001, CIRCULATION, V104, P151, DOI 10.1161/01.CIR.104.2.151
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Echeverri D, 2010, INT J VASC MED, V2010, DOI 10.1155/2010/834060
   Eisenstein M, 2019, NATURE, V566, pS6, DOI 10.1038/d41586-019-00397-2
   Esmaeili Mohammad Ali, 2016, Journal of Chemical Biology, V9, P41, DOI 10.1007/s12154-015-0144-2
   Fan FY, 2016, FOOD CHEM, V196, P347, DOI 10.1016/j.foodchem.2015.09.056
   Farkas O, 2004, MOLECULES, V9, P1079, DOI 10.3390/91201079
   Fatima M, 2015, NATL ACAD SCI LETT, V38, P25, DOI 10.1007/s40009-014-0285-9
   Fiori J, 2018, J CHROMATOGR A, V1562, P115, DOI 10.1016/j.chroma.2018.05.063
   Forester SC, 2011, MOL NUTR FOOD RES, V55, P844, DOI 10.1002/mnfr.201000641
   Franco R, 2013, NUTRIENTS, V5, P4159, DOI 10.3390/nu5104159
   Fujiki H, 2018, MOL CELLS, V41, P73, DOI 10.14348/molcells.2018.2227
   Fujiki Hirota, 2015, J Cancer Prev, V20, P1
   Fung KF, 2003, ENVIRON GEOCHEM HLTH, V25, P219, DOI 10.1023/A:1023233226620
   Gao Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24040673
   Gao Y, 2016, ANTICANCER RES, V36, P643
   Gosslau A, 2011, MOL NUTR FOOD RES, V55, P198, DOI 10.1002/mnfr.201000165
   Grassi D, 2015, NUTRIENTS, V7, P1037, DOI 10.3390/nu7021037
   Greyling A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103247
   GUO WF, 1993, PHYTOCHEMISTRY, V33, P1373, DOI 10.1016/0031-9422(93)85093-7
   Guo XY, 2018, FOOD CHEM, V263, P18, DOI 10.1016/j.foodchem.2018.04.117
   Guo YM, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006426, 10.1097/md.0000000000006426]
   Gupta S, 2000, TOXICOL APPL PHARM, V164, P82, DOI 10.1006/taap.1999.8885
   Gupta S, 2003, ARCH BIOCHEM BIOPHYS, V410, P177, DOI 10.1016/S0003-9861(02)00668-9
   Guth H., 1993, Flavour and Fragrance Journal, V8, P173, DOI 10.1002/ffj.2730080402
   Hajiboland R, 2017, FOLIA HORTIC, V29, P199, DOI 10.1515/fhort-2017-0019
   HARA Y, 1995, FOOD REV INT, V11, P371, DOI [10.1080/87559129509541054, 10.1080/87559129509541053, 10.1080/87559129509541056, 10.1080/87559129509541052]
   Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154
   Hastak K, 2003, ONCOGENE, V22, P4851, DOI 10.1038/sj.onc.1206708
   Hayashino Y, 2011, DIABETIC MED, V28, P805, DOI 10.1111/j.1464-5491.2011.03239.x
   He HF, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1344521
   Hegarty VM, 2000, AM J CLIN NUTR, V71, P1003
   Heiss M.L., 2007, STORY TEA CULTURE HI, P4
   Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102
   Horinaka M, 2006, MOL CANCER THER, V5, P945, DOI 10.1158/1535-7163.MCT-05-0431
   Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002
   Hosoda K, 2003, DIABETES CARE, V26, P1714, DOI 10.2337/diacare.26.6.1714
   Huang HC, 2020, FOOD CHEM TOXICOL, V137, DOI 10.1016/j.fct.2020.111165
   Huang YJ, 2011, IEEE VLSI TEST SYMP, P20, DOI 10.1109/VTS.2011.5783749
   Hung WL, 2017, FOOD FUNCT, V8, P3276, DOI 10.1039/c7fo00700k
   Ibrahim SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117516
   Ide K, 2018, MOLECULES, V23, DOI 10.3390/molecules23092357
   Ikeda A, 2018, ATHEROSCLEROSIS, V277, P90, DOI 10.1016/j.atherosclerosis.2018.08.001
   Isemura M, 2019, MOLECULES, V24, DOI 10.3390/molecules24030528
   Iwasaki M, 2010, BREAST CANCER RES TR, V124, P827, DOI 10.1007/s10549-010-0916-x
   Javed H, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0293-4
   Jensen GS, 2016, CLIN INTERV AGING, V11, P367, DOI 10.2147/CIA.S94881
   Jo M, 2011, BIOMOL THER, V19, P288, DOI 10.4062/biomolther.2011.19.3.288
   Kakuda T, 2002, BIOSCI BIOTECH BIOCH, V66, P2683, DOI 10.1271/bbb.66.2683
   Kakuda T, 2002, BIOL PHARM BULL, V25, P1513, DOI 10.1248/bpb.25.1513
   Kakuda T, 2011, PHARMACOL RES, V64, P162, DOI 10.1016/j.phrs.2011.03.010
   Kaneko S, 2006, J AGR FOOD CHEM, V54, P2688, DOI 10.1021/jf0525232
   Khalesi S, 2014, EUR J NUTR, V53, P1299, DOI 10.1007/s00394-014-0720-1
   Khan N, 2012, NUTR METAB CARDIOVAS, V22, P1046, DOI 10.1016/j.numecd.2011.02.001
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Khan N, 2013, CURR PHARM DESIGN, V19, P6141, DOI 10.2174/1381612811319340008
   Khurana N, 2018, CANCERS, V10, DOI 10.3390/cancers10100352
   Kidist Teshome Kidist Teshome, 2019, Journal of Horticulture and Forestry, V11, P84
   Kobayashi M, 2009, J AGR FOOD CHEM, V57, P7131, DOI 10.1021/jf900855v
   Koch W., 2020, Handbook of dietary phytochemicals, V1, P975
   Konariková K, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0871-4
   Kong LX, 2015, ARCH ORAL BIOL, V60, P12, DOI 10.1016/j.archoralbio.2014.08.019
   Kudo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137809
   Kumazawa K, 2002, J AGR FOOD CHEM, V50, P5660, DOI 10.1021/jf020498j
   Kundu T, 2005, CANCER LETT, V230, P111, DOI 10.1016/j.canlet.2004.12.035
   Kurita I, 2010, J AGR FOOD CHEM, V58, P1903, DOI 10.1021/jf904335g
   Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x
   Lambert JD, 2005, AM J CLIN NUTR, V81, p284S, DOI 10.1093/ajcn/81.1.284S
   Lee LS, 2016, FOOD SCI BIOTECHNOL, V25, P1523, DOI 10.1007/s10068-016-0236-y
   Lee LS, 2014, MOLECULES, V19, P9173, DOI 10.3390/molecules19079173
   Lee YH, 2012, INT J MOL MED, V30, P69, DOI 10.3892/ijmm.2012.966
   Leung LK, 2001, J NUTR, V131, P2248, DOI 10.1093/jn/131.9.2248
   Li F, 2018, EXPERT OPIN DRUG DIS, V13, P643, DOI 10.1080/17460441.2018.1465923
   Li SM, 2013, FOOD FUNCT, V4, P10, DOI 10.1039/c2fo30093a
   Li Y, 2020, J NAT MED-TOKYO, V74, P238, DOI 10.1007/s11418-019-01333-4
   Liang G, 2010, INT J ONCOL, V37, P111, DOI 10.3892/ijo_00000659
   Liang YC, 1999, CARCINOGENESIS, V20, P733, DOI 10.1093/carcin/20.4.733
   LIAO SS, 1995, CANCER LETT, V96, P239, DOI 10.1016/0304-3835(95)03948-V
   Liao YY, 2019, FOOD CHEM, V292, P204, DOI 10.1016/j.foodchem.2019.04.055
   Lin CL, 2009, NEUROBIOL AGING, V30, P81, DOI 10.1016/j.neurobiolaging.2007.05.012
   Liu JN, 2016, EUR J PHARMACOL, V791, P297, DOI 10.1016/j.ejphar.2016.09.007
   Liu Q, 2009, CYTOTECHNOLOGY, V59, P211, DOI 10.1007/s10616-009-9223-y
   Liu SM, 2015, J FUNCT FOODS, V18, P1095, DOI 10.1016/j.jff.2014.08.023
   Logar DB, 2007, J BONE MINER METAB, V25, P219, DOI 10.1007/s00774-007-0753-0
   Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687
   Lorenz M, 2009, BASIC RES CARDIOL, V104, P100, DOI 10.1007/s00395-008-0759-3
   Lu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18955
   Luczaj W, 2009, ACTA POL PHARM, V66, P617
   Luo KW, 2017, J NUTR BIOCHEM, V41, P56, DOI 10.1016/j.jnutbio.2016.12.004
   Lv HP, 2012, FOOD CHEM, V130, P1074, DOI 10.1016/j.foodchem.2011.07.135
   Ma HJ, 2011, J PHYSIOL SCI, V61, P337, DOI 10.1007/s12576-011-0148-9
   Maia L, 2002, EUR J NEUROL, V9, P377, DOI 10.1046/j.1468-1331.2002.00421.x
   Mair VH, 2009, TRUE HIST TEA
   Mangels DR, 2017, ARTERIOSCL THROM VAS, V37, P757, DOI 10.1161/ATVBAHA.117.309048
   Mao AJ, 2018, INT J FOOD SCI TECH, V53, P2586, DOI 10.1111/ijfs.13853
   Marinovic MP, 2015, TOXICOL IN VITRO, V29, P1766, DOI 10.1016/j.tiv.2015.07.014
   Martin LC., 2007, TEA DRINK CHANGED WO
   Martínez-Pinilla E, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00030
   Mathivha PL, 2020, HERBAL MEDICINE IN INDIA: INDIGENOUS KNOWLEDGE, PRACTICE, INNOVATION AND ITS VALUE, P281, DOI 10.1007/978-981-13-7248-3_20
   Matsui T, 2007, J AGR FOOD CHEM, V55, P99, DOI 10.1021/jf0627672
   Mazumder MEH, 2012, ANTICANCER RES, V32, P4851
   Meng Q, 2019, J AGR FOOD CHEM, V67, P5379, DOI 10.1021/acs.jafc.8b05917
   Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004
   Mirkov S, 2007, DRUG METAB DISPOS, V35, P228, DOI 10.1124/dmd.106.012047
   Miyata Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24010193
   Mizukami Y, 2008, J AGR FOOD CHEM, V56, P2154, DOI 10.1021/jf0731806
   Mondal T. K., 2007, Transgenic Crops V, P519
   Monobe M, 2015, FOOD SCI TECHNOL RES, V21, P333, DOI 10.3136/fstr.21.333
   Mukherjee S, 2014, J INFLAMM RES, V7, P89, DOI 10.2147/JIR.S61365
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Nagasaki T, 1997, PROC INT CONF DOC, P16, DOI 10.1109/ICDAR.1997.619806
   Nantz MP, 2009, NUTRITION, V25, P147, DOI 10.1016/j.nut.2008.07.018
   Narukawa M, 2014, AMINO ACIDS, V46, P1583, DOI 10.1007/s00726-014-1713-3
   Naveed M, 2018, BIOMED PHARMACOTHER, V100, P521, DOI 10.1016/j.biopha.2018.02.048
   Nguyen MM, 2012, CANCER PREV RES, V5, P290, DOI 10.1158/1940-6207.CAPR-11-0306
   Ni J, 2018, MOLECULES, V23, DOI 10.3390/molecules23040788
   Nishikawa K, 2015, NAT MED, V21, P281, DOI 10.1038/nm.3774
   Nobre AC, 2008, ASIA PAC J CLIN N S1, V17
   Neto JDN, 2013, NEUROCHEM RES, V38, P1861, DOI 10.1007/s11064-013-1092-2
   Noh MK, 2013, EXP THER MED, V6, P847, DOI 10.3892/etm.2013.1222
   NONAKA GI, 1984, PHYTOCHEMISTRY, V23, P1753, DOI 10.1016/S0031-9422(00)83484-6
   OBANDA M, 1995, J SCI FOOD AGR, V69, P529, DOI 10.1002/jsfa.2740690418
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Ogunleye AA, 2010, BREAST CANCER RES TR, V119, P477, DOI 10.1007/s10549-009-0415-0
   Oka Y, 2012, J PHARMACOL SCI, V118, P55, DOI 10.1254/jphs.11082FP
   Pan HB, 2018, J FUNCT FOODS, V46, P1, DOI 10.1016/j.jff.2018.04.037
   Pan M.H., 2013, Food Sci. Hum. Wellness, V2, P12, DOI [DOI 10.1016/J.FSHW.2013.03.004, 10.1016/j.fshw.2013.03.004]
   Pan MH, 2000, J AGR FOOD CHEM, V48, P6337, DOI 10.1021/jf000777b
   Pan SS, 2018, MOL BIOL REP, V45, P689, DOI 10.1007/s11033-018-4205-9
   Pan ZF, 2018, INT IMMUNOPHARMACOL, V61, P241, DOI 10.1016/j.intimp.2018.06.011
   Pastoriza S, 2017, FOOD FUNCT, V8, P2650, DOI [10.1039/c7fo00611j, 10.1039/C7FO00611J]
   Patel BS, 2016, AM J RESP CELL MOL, V54, P792, DOI 10.1165/rcmb.2015-0308OC
   Pekal A, 2011, EUR J NUTR, V50, P681, DOI 10.1007/s00394-011-0179-2
   Peng C, 2014, SCI REP-UK, V4, DOI [10.1038/srep06001, 10.1038/srep06251]
   Periasamy VS, 2013, BASIC CLIN PHARMACOL, V112, P374, DOI 10.1111/bcpt.12035
   Prasanth MI, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020474
   Qi DD, 2018, FOOD CHEM, V265, P189, DOI 10.1016/j.foodchem.2018.05.080
   Qi GY, 2017, FOOD CHEM TOXICOL, V110, P189, DOI 10.1016/j.fct.2017.10.031
   Qin J, 2007, BIOCHEM BIOPH RES CO, V354, P852, DOI 10.1016/j.bbrc.2007.01.003
   Qin JH, 2012, J AGR FOOD CHEM, V60, P1213, DOI 10.1021/jf204844g
   Rakshit S., 2018, J Pharm Chem Biol Sci, V6, P218
   Ramalingam S, 2020, INDIAN J CLIN BIOCHE, V35, P322, DOI 10.1007/s12291-019-00831-2
   Rana A., 2020, Chemistry, pharmacology and therapeutic delivery of major tea constituents, V43, P113
   Rao DN, 2002, INT J CANCER, V99, P727, DOI 10.1002/ijc.10339
   Reyes CM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111772
   Robertson A., 1992, TEA CULTIVATION CONS, P553
   Roomi MW, 2006, INT J UROL, V13, P415, DOI 10.1111/j.1442-2042.2006.01309.x
   Rothenberg DO, 2018, MOLECULES, V23, DOI 10.3390/molecules23051176
   Rothwell JA, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0607-5
   Sadzuka Y, 2006, FOOD CHEM TOXICOL, V44, P286, DOI 10.1016/j.fct.2005.07.010
   Sae-tan S, 2016, J HEALTH RES, V30, P451, DOI 10.14456/jhr.2016.59
   Saeed NM, 2015, BIOCHEM PHARMACOL, V95, P145, DOI [10.1016/j.bcp.2015.02.006, 10.1016/j.bcp.2015.02.00]
   Sasaki T, 2017, FOOD CHEM, V220, P177, DOI 10.1016/j.foodchem.2016.09.208
   Scoparo CT, 2012, J CHROMATOGR A, V1222, P29, DOI 10.1016/j.chroma.2011.11.038
   Senanayake SPJN, 2013, J FUNCT FOODS, V5, P1529, DOI 10.1016/j.jff.2013.08.011
   Setiawan VW, 2001, INT J CANCER, V92, P600, DOI 10.1002/ijc.1231
   She Gai-Mei, 2005, Acta Botanica Yunnanica, V27, P572
   Shin CM, 2018, CLIN NUTR, V37, P452, DOI 10.1016/j.clnu.2017.01.014
   Shrubsole MJ, 2009, J NUTR, V139, P310, DOI 10.3945/jn.108.098699
   Shu WS, 2003, CHEMOSPHERE, V52, P1475, DOI 10.1016/S0045-6535(03)00485-5
   Siddiqui IA, 2006, CARCINOGENESIS, V27, P833, DOI 10.1093/carcin/bgi323
   Siddiqui IA, 2004, J CELL BIOCHEM, V91, P232, DOI 10.1002/jcb.10737
   Siddiqui IA, 2008, PHARM RES-DORDR, V25, P2135, DOI 10.1007/s11095-008-9553-z
   Gomes FMS, 2018, MICROB PATHOGENESIS, V115, P175, DOI 10.1016/j.micpath.2017.12.058
   Staal J, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090122
   Stearns ME, 2011, TRANSL ONCOL, V4, P147, DOI 10.1593/tlo.10286
   Stuart EC, 2006, LIFE SCI, V79, P2329, DOI 10.1016/j.lfs.2006.07.036
   Suganuma M, 2011, CANCER SCI, V102, P317, DOI 10.1111/j.1349-7006.2010.01805.x
   Suganuma M, 2006, INT J CANCER, V119, P33, DOI 10.1002/ijc.21809
   Sugiyama T, 2004, CANCER LETT, V212, P177, DOI 10.1016/j.canlet.2004.03.040
   Sugiyama T, 2003, BBA-REV CANCER, V1653, P47, DOI 10.1016/S0304-419X(03)00031-3
   Sugiyama T, 1999, JPN J CANCER RES, V90, P775, DOI 10.1111/j.1349-7006.1999.tb00814.x
   Sumathi T, 2015, DRUG CHEM TOXICOL, V38, P22, DOI 10.3109/01480545.2014.900068
   Sun SL, 2013, ONCOL REP, V30, P763, DOI 10.3892/or.2013.2504
   Takeda A, 2012, CELL MOL NEUROBIOL, V32, P41, DOI 10.1007/s10571-011-9732-z
   Takemoto M, 2018, MOLECULES, V23, DOI 10.3390/molecules23040918
   Tamano H, 2013, BRAIN RES BULL, V95, P1, DOI 10.1016/j.brainresbull.2013.02.005
   Tanaka T, 2002, J NAT PROD, V65, P1582, DOI 10.1021/np020245k
   Tazzeo T, 2012, AM J PHYSIOL-LUNG C, V303, pL334, DOI 10.1152/ajplung.00103.2012
   Thangarajan S, 2014, INT J NEUROSCI, V124, P673, DOI 10.3109/00207454.2013.872642
   Thomas F, 2009, PROSTATE, V69, P219, DOI 10.1002/pros.20873
   Tong T, 2019, MOLECULES, V24, DOI 10.3390/molecules24162917
   Unachukwu UJ, 2010, J FOOD SCI, V75, pC541, DOI 10.1111/j.1750-3841.2010.01705.x
   Vargo MA, 2006, BIOCHEM PHARMACOL, V72, P681, DOI 10.1016/j.bcp.2006.06.010
   Vayalil PK, 2004, PROSTATE, V59, P33, DOI 10.1002/pros.10352
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Vergote D, 2002, BREAST CANCER RES TR, V76, P195, DOI 10.1023/A:1020833410523
   Wakabayashi C, 2012, PSYCHOPHARMACOLOGY, V219, P1099, DOI 10.1007/s00213-011-2440-z
   Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c
   Wang YF, 2012, CARBOHYD POLYM, V88, P146, DOI 10.1016/j.carbpol.2011.11.083
   Way TD, 2004, EUR J CANCER, V40, P2165, DOI 10.1016/j.ejca.2004.06.018
   Weber P, 2004, AGRO FOOD IND HI TEC, V15, P20
   WEERAWATANAKORN M., 2015, Food Science and Human Wellness, V4, P133, DOI [10.1016/J.FSHW.2015.10.002, DOI 10.1016/J.FSHW.2015.10.002, 10.1016/j.fshw.2015.10.002]
   Weerawatanakorn M, 2015, FOOD FUNCT, V6, P1832, DOI [10.1039/c5fo00126a, 10.1039/C5FO00126A]
   Wei CL, 2018, P NATL ACAD SCI USA, V115, pE4151, DOI 10.1073/pnas.1719622115
   Wei JCC, 2016, EUR J PHARMACOL, V770, P16, DOI 10.1016/j.ejphar.2015.11.048
   Weinberg BA, 2001, WORLD CAFFEINE SCI C
   Williams JL, 2020, PLANT FOOD HUM NUTR, V75, P12, DOI 10.1007/s11130-019-00771-5
   Wu CD, 2002, NUTRITION, V18, P443, DOI 10.1016/S0899-9007(02)00763-3
   Xia EH, 2017, MOL PLANT, V10, P866, DOI 10.1016/j.molp.2017.04.002
   Yamada T, 2009, AMINO ACIDS, V36, P21, DOI 10.1007/s00726-007-0020-7
   Yang C. S., 2020, NATURAL PRODUCTS CAN, P241
   Yang G, 2011, CARCINOGENESIS, V32, P1684, DOI 10.1093/carcin/bgr186
   Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005632
   Yang XW, 2012, HEPATOL RES, V42, P494, DOI 10.1111/j.1872-034X.2011.00947.x
   Yang ZY, 2008, TOXICOL IN VITRO, V22, P1250, DOI 10.1016/j.tiv.2008.04.007
   Ye YL, 2018, J FOOD COMPOS ANAL, V66, P98, DOI 10.1016/j.jfca.2017.12.008
   Yi T, 2015, LWT-FOOD SCI TECHNOL, V62, P194, DOI 10.1016/j.lwt.2015.01.003
   Yiannakopoulou EC, 2014, ANTI-CANCER AGENT ME, V14, P290, DOI 10.2174/18715206113136660339
   Yilmaz Y, 2006, TRENDS FOOD SCI TECH, V17, P64, DOI 10.1016/j.tifs.2005.10.005
   Yin JY, 2017, J NUTR HEALTH AGING, V21, P1151, DOI 10.1007/s12603-016-0829-4
   You HL, 2018, J CHIN MED ASSOC, V81, P458, DOI 10.1016/j.jcma.2017.11.007
   Yu JY, 2017, DIABETES METAB J, V41, P251
   Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006
   Zhang GY, 2014, ONCOTARGET, V5, P8528, DOI 10.18632/oncotarget.2336
   Zhang L, 2019, COMPR REV FOOD SCI F, V18, P1474, DOI 10.1111/1541-4337.12479
   Zhang XB, 2018, RSC ADV, V8, P11305, DOI 10.1039/c8ra00151k
   Zhao YM, 2015, CLIN NUTR, V34, P612, DOI 10.1016/j.clnu.2014.06.003
   Zhen Y.S., 2002, Tea: Bioactivity and Therapeutic Potential
   Zhou H, 2017, FOOD CHEM, V235, P227, DOI 10.1016/j.foodchem.2017.05.034
   Zhou JY, 2006, J COMPUT, V1, P41
   Zhou Y, 2016, TUMOR BIOL, V37, P8555, DOI 10.1007/s13277-015-4719-x
   Zhu JC, 2015, J AGR FOOD CHEM, V63, P7499, DOI 10.1021/acs.jafc.5b02358
   Zhu JA, 2010, MOL BIOL REP, V37, P2653, DOI 10.1007/s11033-009-9793-y
NR 267
TC 89
Z9 90
U1 23
U2 47
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 2769-7061
EI 2769-707X
J9 J AM NUTR ASSOC
JI J. Am. Nutr. Assoc.
PD FEB 3
PY 2022
VL 41
IS 1
BP 65
EP 93
DI 10.1080/07315724.2020.1827082
EA OCT 2020
PG 29
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 2L6IG
UT WOS:000591268900001
PM 33216711
DA 2025-04-28
ER

PT J
AU Gutiérrez-Esparza, GO
   Ramírez-delReal, TA
   Martínez-García, M
   Vázquez, OI
   Vallejo, M
   Hernández-Torruco, J
AF Gutierrez-Esparza, Guadalupe O.
   Ramirez-delReal, Tania A.
   Martinez-Garcia, Mireya
   Vazquez, Oscar Infante
   Vallejo, Maite
   Hernandez-Torruco, Jose
TI Machine and Deep Learning Applied to Predict Metabolic Syndrome without
   a Blood Screening
SO APPLIED SCIENCES-BASEL
LA English
DT Article
DE metabolic syndrome; features selection; health parameters; random
   forest; deep neural networks; C4.5; Mexico City; tlalpan 2020 cohort
ID ALCOHOL-CONSUMPTION; FOOD PATTERNS; OBESITY; RISK; DEFINITION;
   CLASSIFICATION; ASSOCIATION; COMPONENTS; DIAGNOSIS; HEALTH
AB The exponential increase of metabolic syndrome and its association with the risk impact of morbidity and mortality has propitiated the development of tools to diagnose this syndrome early. This work presents a model that is based on prognostic variables to classify Mexicans with metabolic syndrome without blood screening applying machine and deep learning. The data that were used in this study contain health parameters related to anthropometric measurements, dietary information, smoking habit, alcohol consumption, quality of sleep, and physical activity from 2289 participants of the Mexico City Tlalpan 2020 cohort. We use accuracy, balanced accuracy, positive predictive value, and negative predictive value criteria to evaluate the performance and validate different models. The models were separated by gender due to the shared features and different habits. Finally, the highest performance model in women found that the most relevant features were: waist circumference, age, body mass index, waist to height ratio, height, sleepy manner that is associated with snoring, dietary habits related with coffee, cola soda, whole milk, and Oaxaca cheese and diastolic and systolic blood pressure. Men's features were similar to women's; the variations were in dietary habits, especially in relation to coffee, cola soda, flavored sweetened water, and corn tortilla consumption. The positive predictive value obtained was 84.7% for women and 92.29% for men. With these models, we offer a tool that supports Mexicans to prevent metabolic syndrome by gender; it also lays the foundation for monitoring the patient and recommending change habits.
C1 [Gutierrez-Esparza, Guadalupe O.; Ramirez-delReal, Tania A.] Catedra CONACYT Consejo Nacl Ciencia, Ciudad De Mexico 08400, Mexico.
   [Gutierrez-Esparza, Guadalupe O.; Martinez-Garcia, Mireya; Vazquez, Oscar Infante; Vallejo, Maite] Inst Nacl Cardiol Ignacio Chavez, Ciudad De Mexico 14080, Mexico.
   [Ramirez-delReal, Tania A.] Ctr Invest Ciencias Informac Geoespacial, Circuito Tecnopolo Norte 107, Aguascalientes 20313, Aguascalientes, Mexico.
   [Hernandez-Torruco, Jose] Univ Juarez Autonoma Tabasco, Div Acad Ciencias & Tecnol Informac, Cunduacan 86690, Tabasco, Mexico.
C3 National Institute of Cardiology - Mexico; Universidad Juarez Autonoma
   de Tabasco
RP Vallejo, M (corresponding author), Inst Nacl Cardiol Ignacio Chavez, Ciudad De Mexico 14080, Mexico.; Hernández-Torruco, J (corresponding author), Univ Juarez Autonoma Tabasco, Div Acad Ciencias & Tecnol Informac, Cunduacan 86690, Tabasco, Mexico.
EM ggutierreze@conacyt.mx; tramirez@centrogeo.edu.mx;
   mireya.martinez@cardiologia.org.mx; osinfa@yahoo.com;
   maite.vallejo@cardiologia.org.mx; jose.hernandezt@ujat.mx
RI Ramirez-delReal, Tania Aglae/ISS-4817-2023; Martínez-García,
   Mireya/AAU-6797-2020; Hernández-Torruco, José/AFL-8743-2022
OI Ramirez-delReal, Tania Aglae/0000-0002-1638-5086; Hernandez-Torruco,
   Jose/0000-0003-3146-9349; Martinez-Garcia, Mireya/0000-0002-2876-8500
FU National Council of Science and Technology (CONACYT, Mexico), Catedras
   CONACYT [1591]
FX This research was supported by the National Council of Science and
   Technology (CONACYT, Mexico), Catedras CONACYT 1591.
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Alley DE, 2010, J GERONTOL A-BIOL, V65, P111, DOI 10.1093/gerona/glp177
   [Anonymous], 1983, BIOESTADISTICA BASE
   [Anonymous], 2003, Manual de Usuario. SNUT Sistema de Evaluacion de Habitos Nutricionales y Consumo de Nutrimentos
   Barrios M, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9040192
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI [10.1039/c7fo00388a, 10.1039/C7FO00388A]
   Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974
   Bobadilla J, 2012, INFORM PROCESS MANAG, V48, P204, DOI 10.1016/j.ipm.2011.03.007
   Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324
   Chen Z, 2018, GENOM PROTEOM BIOINF, V16, P451, DOI 10.1016/j.gpb.2018.08.004
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Choe Eun Kyung, 2018, Genomics & Informatics, V16, pe31
   Chollet F., 2015, Keras
   Cohen I., 2009, Speech Process, P1, DOI DOI 10.1007/978-3-642-00296-05
   Colín-Ramírez E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016773
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Elmadhun NY, 2013, CLIN LIPIDOL, V8, P5, DOI 10.2217/CLP.12.82
   Fernandez-Mendoza J, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005479
   Foster KR, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-94
   GECCO, 2003, P GEN EVO COMP C
   Gertner D, 2018, THUNDERBIRD INT BUS, V60, P161, DOI 10.1002/tie.21888
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI [10.1161/01.CIR.0000111245.75752.C6, 10.1161/01.CIR.0000112379.88385.67]
   Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527
   Ho JS, 2008, AM J CARDIOL, V102, P689, DOI 10.1016/j.amjcard.2008.05.010
   Hostmark AT, 2010, APPL PHYSIOL NUTR ME, V35, P635, DOI 10.1139/H10-059
   Hsu C.-W., 2003, A Practical Guide to Support Vector Classification
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Ivanovic D, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0601-7
   Jain D, 2018, EGYPT INFORM J, V19, P179, DOI 10.1016/j.eij.2018.03.002
   Jia WP, 2013, BIOMED ENVIRON SCI, V26, P947, DOI 10.3967/bes2013.029
   Karegowda AG., 2010, International Journal of Information Technology and Knowledge Management, V2, P271
   Gutiérrez-Solis AL, 2018, METAB SYNDR RELAT D, V16, P395, DOI 10.1089/met.2017.0157
   Liu Xiaoxuan, 2019, Lancet Digit Health, V1, pe271, DOI 10.1016/S2589-7500(19)30123-2
   Maity NG, 2017, AEROSP CONF PROC
   Marfell-Jones MJ, 2012, International Standards for Anthropometric Assessment
   Milei J, 2011, WORLD J CARDIOL, V3, P111, DOI 10.4330/wjc.v3.i4.111
   Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287
   Murguia-Romero Miguel, 2013, Advances in Artificial Intelligence and Its Applications. 12th Mexican International Conference on Artificial Intelligence, MICAI 2013. Proceedings: LNCS 8265, P464, DOI 10.1007/978-3-642-45114-0_36
   Nambiar L., 2014, J SCI MED SPORT, V18, pE117, DOI [10.1016/j.jsams.2014.11.080, DOI 10.1016/J.JSAMS.2014.11.080]
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Oh Eui-Geum, 2007, Taehan Kanho Hakhoe Chi, V37, P790
   Panagiotakos DB, 2007, J AM DIET ASSOC, V107, P979, DOI 10.1016/j.jada.2007.03.006
   Porchia LM, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.9
   Quinlan JR., 1993, C4.5: Programs for machine learning
   Raats M. M., 1992, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D
   Salas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105581
   Salazar N.A.S., 2018, REV EXP MED HOSP REG, V4, P56
   Sarebanhassanabadi M, 2018, PUBLIC HEALTH NUTR, V21, P1139, DOI [10.1017/S1368980017003627, 10.1017/s1368980017003627]
   Sethi P, 2010, COMM COM INF SC, V54, P392
   SPRITZER K., 2003, MOS Sleep Scale: A Manual for Use and Scoring, P1
   Stewart A. L., 1992, MEASURING FUNCTIONIN, DOI DOI 10.7249/CB361
   Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307
   Sun K, 2014, CLIN NUTR, V33, P596, DOI 10.1016/j.clnu.2013.10.003
   Troxel WM, 2010, SLEEP, V33, P1633, DOI 10.1093/sleep/33.12.1633
   Tsai SS, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0358-x
   Vrbaski D, 2019, ARTIF INTELL MED, V101, DOI 10.1016/j.artmed.2019.101708
   Wirfält E, 2001, AM J EPIDEMIOL, V154, P1150, DOI 10.1093/aje/154.12.1150
   Worachartcheewan Apilak, 2015, ScientificWorldJournal, V2015, P581501, DOI 10.1155/2015/581501
   Wu WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130279
   Yahia N, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-111
   Zheng Z., 2004, ACM SIGKDD Explor Newsl, V6, P80, DOI [DOI 10.1145/1007730.1007741, 10.1145/1007730.1007741]
   Zou JJ, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/9578391
NR 65
TC 5
Z9 5
U1 2
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD MAY
PY 2021
VL 11
IS 10
AR 4334
DI 10.3390/app11104334
PG 18
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials
   Science, Multidisciplinary; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Chemistry; Engineering; Materials Science; Physics
GA ST7EE
UT WOS:000662602100001
OA gold
DA 2025-04-28
ER

PT J
AU Friedman, M
   Levin, CE
   Choi, SH
   Kozukue, E
   Kozukue, N
AF Friedman, Mendel
   Levin, Carol E.
   Choi, Suk-Hyun
   Kozukue, Etsuko
   Kozukue, Nobuyuki
TI HPLC analysis of catechins, theaflavins, and alkaloids in commercial
   teas and green tea dietary supplements: Comparison of water and 80%
   ethanol/water extracts
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE alkaloids; dietary supplements; flavonoids; HPLC; tea leaves
ID BRAN EXTRACTS; MEDICINAL BENEFITS; CAFFEINE; POLYPHENOLS; BLACK;
   CONSUMPTION; OBESITY; HERBS
AB To help meet the needs of consumers, producers of dietary tea supplements, and researchers for information on health-promoting tea compounds, we compared the following conditions for the extraction of tea leaves and green tea-containing dietary supplements: 80% ethanol/water at 60 degrees C for 15 min and boiled water for 5 min. The following 7 catechins, 4 theaflavins, and 3 alkaloids were seperated in a 70-min single HPLC analysis(-)-epigallocatechin, (-)catechin, (+)-epicatechin, (-)-epigallocatechin-3-gallate, (-)gallocatechin-3-gallate, (-)-epicatechin-3-gallate, (-)-catechin-3-gallate, theaflavin-3'-gallate, theaflavin-3,3'-digallate, caffeine, theobromine, and theophylline. The following ranges of concentrations of flavonoids (catechins plus theaflavins) in the tea leaves extracted with 80% ethanol were observed (in mg/g): in 32 black teas, 19.8 to 115.1; in 24 green teas, 12.3 to 136.3; in 14 speciality teas, 4.9 to 118.5; in 7 herbal teas, 0 to 46.0. Total alkaloids in all teas ranged from 0 to 32.6 mg/g. Significantly greater amounts of flavonoids were extracted from the tea leaves with aqueous ethanol than with boiled water. Levels of tea catechins in 10 capsules sold as dietary supplements were about 50 to 75% lower than the amounts listed on the labels. Catechin content of 4 commercial green tea extracts ranged from 96 to 696 mg/g. The results make it possible to maximize the extraction of tea compounds to better relate the flavonoid and alkaloid content of teas and dietary tea supplements to their health-promoting effects.
C1 USDA, ARS, Western Reg Res Ctr, Albany, CA 94710 USA.
   Dept Food Serv Ind, Gyeongju 780713, Gyongbuk, South Korea.
C3 United States Department of Agriculture (USDA)
RP Friedman, M (corresponding author), USDA, ARS, Western Reg Res Ctr, Albany, CA 94710 USA.
EM mfried@pw.usda.gov
OI Friedman, Mendel/0000-0003-2582-7517; Levin, Carol/0000-0001-6522-6156
CR Astill C, 2001, J AGR FOOD CHEM, V49, P5340, DOI 10.1021/jf010759+
   Aucamp JP, 2000, J CHROMATOGR A, V876, P235, DOI 10.1016/S0021-9673(00)00145-X
   Barnes PJ, 2006, BRIT J PHARMACOL, V147, pS297, DOI 10.1038/sj.bjp.0706437
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145
   Bonoli M, 2003, J AGR FOOD CHEM, V51, P1141, DOI 10.1021/jf020907b
   Brown MS, 1999, J AGR FOOD CHEM, V47, P2331, DOI 10.1021/jf981124m
   Cabrera C, 2003, J AGR FOOD CHEM, V51, P4427, DOI 10.1021/jf0300801
   Camouse MM, 2005, EXPERT REV ANTICANC, V5, P1061, DOI 10.1586/14737140.5.6.1061
   Choe E, 2005, J FOOD SCI, V70, pR142, DOI 10.1111/j.1365-2621.2005.tb08329.x
   Cooper R, 2005, J ALTERN COMPLEM MED, V11, P639, DOI 10.1089/acm.2005.11.639
   Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521
   Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   Fernández PL, 2002, J AGR FOOD CHEM, V50, P1833, DOI 10.1021/jf0114435
   Ferrara L, 2001, FARMACO, V56, P397, DOI 10.1016/S0014-827X(01)01104-1
   Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s
   Friedman M, 2006, J FOOD PROTECT, V69, P354, DOI 10.4315/0362-028X-69.2.354
   Friedman M, 2005, J FOOD SCI, V70, pC550, DOI 10.1111/j.1365-2621.2005.tb08304.x
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Goldstein J, 2005, HEADACHE, V45, P973, DOI 10.1111/j.1526-4610.2005.05177.x
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Khokhar S, 2002, J AGR FOOD CHEM, V50, P565, DOI 10.1021/jf010153l
   Lai PK, 2004, CURR MED CHEM, V11, P1451, DOI 10.2174/0929867043365107
   Lee BL, 2000, J CHROMATOGR A, V881, P439, DOI 10.1016/S0021-9673(00)00215-6
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Manning Jared, 2003, Journal of Herbal Pharmacotherapy, V3, P19, DOI 10.1080/J157v03n03_03
   Maron DJ, 2003, ARCH INTERN MED, V163, P1448, DOI 10.1001/archinte.163.12.1448
   McLellan TM, 2005, AVIAT SPACE ENVIR MD, V76, P647
   Menet MC, 2004, J AGR FOOD CHEM, V52, P2455, DOI 10.1021/jf035427e
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Nam SH, 2006, FOOD CHEM, V94, P613, DOI 10.1016/j.foodchem.2004.12.010
   Nam SH, 2005, FOOD CHEM TOXICOL, V43, P741, DOI 10.1016/j.fct.2005.01.014
   Nam SH, 2005, J AGR FOOD CHEM, V53, P816, DOI 10.1021/jf0490293
   Piñeiro Z, 2004, J CHROMATOGR A, V1026, P19, DOI 10.1016/j.chroma.2003.10.096
   Rao A, 2005, NUTR NEUROSCI, V8, P141, DOI 10.1080/10284150500096994
   Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gastro.2005.08.056
   Sakakibara H, 2003, J AGR FOOD CHEM, V51, P571, DOI 10.1021/jf020926l
   *SAS I, 2000, REL 9 1 3
   Schmidt B, 2005, BIOL NEONATE, V88, P208, DOI 10.1159/000087584
   Schulz-Stübner S, 2005, ANESTH ANALG, V101, P1809, DOI 10.1213/01.ANE.0000184203.52747.7D
   Seely Dugald, 2005, Integr Cancer Ther, V4, P144, DOI 10.1177/1534735405276420
   Thornfeldt C, 2005, DERMATOL SURG, V31, P873
   Wang LF, 2000, J AGR FOOD CHEM, V48, P4227, DOI 10.1021/jf0003597
   Xu JZ, 2004, BRIT J NUTR, V91, P873, DOI 10.1079/BJN20041132
   Yang CS, 2005, EXP LUNG RES, V31, P135, DOI 10.1080/01902140490495525
NR 46
TC 108
Z9 113
U1 2
U2 93
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD AUG
PY 2006
VL 71
IS 6
BP C328
EP C337
DI 10.1111/j.1750-3841.2006.00090.x
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 080ZK
UT WOS:000240286800004
DA 2025-04-28
ER

PT J
AU Rajeshwari, R
   Yang, SJ
   Nicklas, TA
   Berenson, GS
AF Rajeshwari, R
   Yang, SJ
   Nicklas, TA
   Berenson, GS
TI Secular trends in children's sweetened-beverage consumption (1973 to
   1994): The Bogalusa heart study
SO JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
LA English
DT Article
ID BODY-MASS INDEX; NUTRITION EXAMINATION SURVEYS; ENERGY-INTAKE;
   NATIONAL-HEALTH; FOOD-INTAKE; YOUNG ADULTHOOD; UNITED-STATES;
   RISK-FACTORS; OBESITY; ADOLESCENTS
AB Objective To determine whether children's sweetened-beverage consumption has changed over a 21-year period (1973 to 1994) in Bogalusa, LA, and whether trends in energy intake, milk consumption, and body mass index (BMI) varied among the sweetened-beverage consumption groups.
   Design Information on food and nutrient intake was derived from a single 24-hour dietary recall collected from children who participated in one of seven cross-sectional surveys.
   Subjects/Setting A total of 1,548 10-year-old children (65% white, 35% African American; 51% female, 49% male) were randomly selected to participate in the study.
   Statistical Analyses The Cochran-Armitage Trend test was applied to examine the trends in sweetened-beverage consumption by 10-year-old children over a 21-year period. A general linear model was used to examine the trend in milk consumption, energy intake, and BMI among the sweetened-beverage consumption groups.
   Results The percentage of children consuming sweetened beverages significantly decreased from 83% (1973) to 81% (1994) (P<.05), particularly consumption of soft drinks (P<.01) and coffee with sugar (P<.0001). However, the mean gram amount of tea with sugar consumed significantly increased (P<.0001), with no changes in the mean gram amount of fruit drinks, soft drinks, and coffee with sugar consumed. When comparing tertiles of sweetened-beverage consumption over time, the mean gram consumption significantly increased from 1973 to 1994 for those children who were in the medium (P<.001) to high (P<.0001) tertiles. The mean BMI significantly increased (P<.001) from 1973 to 1994 in children within all of the sweetened-beverage consumption groups; however, there were no significant differences in total BMI across the sweetened-beverage consumption groups. The total gram amount of milk consumption was significantly lower in the medium to high sweetened-beverage consumption groups compared with the lower to no sweetened-beverage consumption groups. Total energy intake remained unchanged from 1973 to 1994 within all four sweetened-beverage consumption groups. Total energy intake was significantly higher in the high sweetened-beverage consumption group compared with the other three sweetened-beverage consumption groups.
   Conclusions Children's sweetened-beverage consumption has changed over a 21-year period. The percentage of children consuming sweetened beverages decreased from 1973 to 1994, particularly consumption of soft drinks and coffee with sugar. Data suggest that there was no linear relationship between sweetened-beverage consumption and BMI and total energy intake. However, total milk consumption was lower in the medium to high sweetened-beverage consumption groups compared with the low to no consumption groups. More studies are needed to confirm these regional findings, which may not be reflective of national trends.
C1 Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA.
   Tulane Ctr Cardiovasc Hlth, Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA.
C3 Baylor College of Medicine; Tulane University; Tulane University
   Hospital
RP Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, 1100 Bates Ave, Houston, TX 77030 USA.
EM tnicklas@bcm.tmc.edu
FU NHLBI NIH HHS [R01 HL38844] Funding Source: Medline; NIA NIH HHS
   [AG16592] Funding Source: Medline
CR [Anonymous], WHAT WE EAT AM USDA
   Ariza AJ, 2004, J URBAN HEALTH, V81, P150, DOI 10.1093/jurban/jth091
   Ballew C, 2000, ARCH PEDIAT ADOL MED, V154, P1148, DOI 10.1001/archpedi.154.11.1148
   Berenson G.S., 1986, CAUSATION CARDIOVASC
   Berenson GS., 1980, Cardiovascular risk factors in children: The early natural history of atherosclerosis and essential hypertension
   Bowman S.A., 1999, FAMILY EC NUTR REV, V12, P31
   Bowman SA, 2002, J AM DIET ASSOC, V102, P1234, DOI 10.1016/S0002-8223(02)90273-7
   Braam LAJLM, 1998, AM J EPIDEMIOL, V147, P1081, DOI 10.1093/oxfordjournals.aje.a009402
   Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157
   Briefel RR, 1997, AM J CLIN NUTR, V65, P1203
   Cavadini C, 2000, ARCH DIS CHILD, V83, P18, DOI 10.1136/adc.83.1.18
   Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026
   Farris R., 1993, TXB PEDIAT NUTR, V2nd, P505
   Ferraro KF, 2003, J GERONTOL B-PSYCHOL, V58, pS110, DOI 10.1093/geronb/58.2.S110
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   FLEMING KH, 1994, J NUTR, V124, pS1426, DOI 10.1093/jn/124.suppl_8.1426S
   Forshee RA, 2003, INT J FOOD SCI NUTR, V54, P297, DOI [10.1080/09637480120092143, 10.1080/096374803766666175]
   FRANK GC, 1977, J AM DIET ASSOC, V71, P26
   Freedman DS, 1997, PEDIATRICS, V99, P420, DOI 10.1542/peds.99.3.420
   FREEDMAN DS, 1987, AM J PUBLIC HEALTH, V77, P588, DOI 10.2105/AJPH.77.5.588
   GERRIOR S, 1998, FOOD REV, V21, P29
   Gibson SA, 1996, INT J FOOD SCI NUTR, V47, P405, DOI 10.3109/09637489609006954
   GIDDING SS, 1995, J PEDIATR-US, V127, P868, DOI 10.1016/S0022-3476(95)70020-X
   GUO SS, 1994, AM J CLIN NUTR, V59, P810, DOI 10.1093/ajcn/59.4.810
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   Heerstrass DW, 1998, INT J EPIDEMIOL, V27, P186, DOI 10.1093/ije/27.2.186
   Johansson G, 2001, PUBLIC HEALTH NUTR, V4, P919, DOI 10.1079/PHN2001124
   Johnson RK, 1998, J AM DIET ASSOC, V98, P1136, DOI 10.1016/S0002-8223(98)00263-6
   Johnson RK, 2002, J AM DIET ASSOC, V102, P853, DOI 10.1016/S0002-8223(02)90192-6
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Macdiarmid JI, 1998, INT J OBESITY, V22, P1053, DOI 10.1038/sj.ijo.0800724
   Moore M.C., 1982, EXTENDED TABLE NUTR
   Nicklas TA, 2003, AM J PREV MED, V25, P9, DOI 10.1016/S0749-3797(03)00098-9
   Overby NC, 2004, PUBLIC HEALTH NUTR, V7, P285, DOI 10.1079/PHN2003515
   Rampersaud GC, 2003, J AM DIET ASSOC, V103, P97, DOI 10.1053/jada.2003.50006
   Roberts SB, 2002, J AM COLL NUTR, V21, p140S, DOI 10.1080/07315724.2002.10719211
   SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014
   Storey ML, 2003, INT J FOOD SCI NUTR, V54, P491, DOI 10.1080/09637480310001622350
   Thompson B, 1999, J AM DIET ASSOC, V99, P1241, DOI 10.1016/S0002-8223(99)00306-5
   THOMPSON FE, 1994, J NUTR, V124, pS2245, DOI 10.1093/jn/124.suppl_11.2245s
   TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963
   TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005
   Troiano RP, 2000, AM J CLIN NUTR, V72, p1343S, DOI 10.1093/ajcn/72.5.1343s
   WEBBER LS, 1986, J CHRON DIS, V39, P91, DOI 10.1016/0021-9681(86)90065-2
   WILSON JAW, DATA TABLES COMBINED
   Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132
   1996, WHAT WHERE OUR CHILD
NR 47
TC 73
Z9 88
U1 0
U2 7
PU AMER DIETETIC ASSOC
PI CHICAGO
PA 120 S RIVERSIDE PLZ, STE 2000, CHICAGO, IL 60606-6995 USA
SN 0002-8223
J9 J AM DIET ASSOC
JI J. Am. Diet. Assoc.
PD FEB
PY 2005
VL 105
IS 2
BP 208
EP 214
DI 10.1016/j.jada.2004.11.026
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 893QA
UT WOS:000226733100009
PM 15668676
DA 2025-04-28
ER

PT J
AU Wang, DQ
   Hawley, NL
   Thompson, AA
   Lameko, V
   Reupena, MS
   McGarvey, ST
   Baylin, A
AF Wang, Dongqing
   Hawley, Nicola L.
   Thompson, Avery A.
   Lameko, Viali
   Reupena, Muagatutia Sefuiva
   McGarvey, Stephen T.
   Baylin, Ana
TI Dietary Patterns Are Associated with Metabolic Outcomes among Adult
   Samoans in a Cross-Sectional Study
SO JOURNAL OF NUTRITION
LA English
DT Article
DE Samoa; dietary pattern; eating pattern; metabolic syndrome; nutrition
   transition; principal component analysis; nutritional epidemiology
ID RED MEAT CONSUMPTION; CORONARY-HEART-DISEASE; ACUTE
   MYOCARDIAL-INFARCTION; COCONUT OIL; MODERNIZING SAMOANS;
   CLUSTER-ANALYSIS; RISK-FACTORS; MORTALITY; ADIPOSITY; VALIDITY
AB Background: The Samoan population has been undergoing a nutrition transition toward more imported and processed foods and a more sedentary lifestyle.
   Objectives: We aimed to identify dietary patterns in Samoa and to evaluate their associations with metabolic outcomes.
   Methods: The sample of this cross-sectional study includes 2774 Samoan adults recruited in 2010 (1104 with metabolic syndrome compared with 1670 without). Principal component analysis on food items from a 104-item food-frequency questionnaire was used to identify dietary patterns. Adjusted least squares means of each component of metabolic syndrome were estimated by quintiles of factor scores for each dietary pattern. Metabolic syndrome status was regressed on quintiles of scores by using log-binomial models to obtain prevalence ratios.
   Results: We identified a modern pattern, a mixed-traditional pattern, and a mixed-modern pattern. The modern pattern included a high intake of imported and processed foods, including pizza, cheeseburgers, margarine, sugary drinks, desserts, snacks, egg products, noodles, nuts, breads, and cakes and a low intake of traditional agricultural products and fish. The mixed-traditional pattern had a high intake of neotraditional foods, including fruits, vegetables, soup, poultry, and fish, and imported and processed foods, including dairy products, breads, and cakes. The mixed-modern pattern was loaded with imported and processed foods, including pizza, cheeseburgers, red meat, egg products, noodles, and grains, but also with neotraditional foods, such as seafood and coconut. It also included a low intake of fish, tea, coffee, soup, and traditional agricultural staples. Higher adherence to the mixed-modern pattern was associated with lower abdominal circumference (P-trend < 0.0001), lower serum triglycerides (P-trend = 0.03), and higher serum HDL cholesterol (P-trend = 0.0003). The mixed-modern pattern was inversely associated with prevalence of metabolic syndrome (the highest quintile: prevalence ratio = 0.79; 95% CI: 0.69, 0.91; P-trend = 0.006).
   Conclusion: Mixed dietary patterns containing healthier foods, rather than a largely imported and processed modern diet, may help prevent metabolic syndrome in Samoa.
C1 [Wang, Dongqing; Baylin, Ana] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Baylin, Ana] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA.
   [Hawley, Nicola L.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA.
   [Thompson, Avery A.] Yale Univ, Yale Coll, New Haven, CT USA.
   [Lameko, Viali] Oceania Univ Med, Apia, Samoa.
   [Reupena, Muagatutia Sefuiva] Samoa Bur Stat, Apia, Samoa.
   [McGarvey, Stephen T.] Brown Univ, Int Hlth Inst, Providence, RI 02912 USA.
   [McGarvey, Stephen T.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; Yale University; Yale
   University; Brown University; Brown University
RP Baylin, A (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.; Baylin, A (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA.
EM abaylin@umich.edu
RI Wang, Dongqing/X-2777-2019; McGarvey, Stephen/I-1788-2014
OI Hawley, Nicola/0000-0002-2601-3454; Wang, Dongqing/0000-0003-3369-5972
FU NIH [R01-HL093093]
FX Supported by NIH R01-HL093093 (to STM).
CR Aekplakorn W, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/468759
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Araya MR, 2004, REV PANAM SALUD PUBL, V16, P295, DOI 10.1590/S1020-49892004001100001
   Ashaye A, 2011, NUTR METAB CARDIOVAS, V21, P941, DOI 10.1016/j.numecd.2010.03.009
   Assunçao ML, 2009, LIPIDS, V44, P593, DOI 10.1007/s11745-009-3306-6
   Baylin A, 2013, EUR J CLIN NUTR, V67, P101, DOI 10.1038/ejcn.2012.124
   Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165
   BOLLAND JE, 1990, J AM DIET ASSOC, V90, P1402
   CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10
   Cleland CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1255
   Colón-Ramos U, 2007, PUBLIC HEALTH NUTR, V10, P1214, DOI 10.1017/S1368980007699571
   Denova-Gutiérrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671
   Devlin UM, 2012, P NUTR SOC, V71, P599, DOI 10.1017/S0029665112000729
   DiBello JR, 2009, J NUTR, V139, P1933, DOI 10.3945/jn.109.107888
   DiBello JR, 2008, AM J EPIDEMIOL, V168, P1433, DOI 10.1093/aje/kwn274
   Feranil AB, 2011, ASIA PAC J CLIN NUTR, V20, P190
   GALANIS DJ, 1995, INT J OBESITY, V19, P731
   Galanis DJ, 1995, J CLIN EPIDEMIOL, V48, P1485, DOI 10.1016/0895-4356(95)00060-7
   Galanis DJ, 1999, J AM DIET ASSOC, V99, P184, DOI 10.1016/S0002-8223(99)00044-9
   GARROW J, 1995, EUR J CLIN NUTR, V49, P231
   Hawley NL, 2014, AM J HUM BIOL, V26, P491, DOI 10.1002/ajhb.22553
   Hodge AM, 1997, INT J EPIDEMIOL, V26, P297, DOI 10.1093/ije/26.2.297
   Hoffmann K, 2004, AM J CLIN NUTR, V80, P633
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   Kabagambe EK, 2005, J NUTR, V135, P2674, DOI 10.1093/jn/135.11.2674
   Kaluza J, 2014, CIRC-HEART FAIL, V7, P552, DOI 10.1161/CIRCHEARTFAILURE.113.000921
   Kant AK, 1996, J AM DIET ASSOC, V96, P785, DOI 10.1016/S0002-8223(96)00217-9
   Keighley ED, 2006, AM J HUM BIOL, V18, P112, DOI 10.1002/ajhb.20469
   Keighley ED, 2007, CAM S BIO EVOL ANTHR, V52, P147, DOI 10.1017/CBO9780511542510.008
   Lajous M, 2014, AM J CLIN NUTR, V100, P948, DOI 10.3945/ajcn.113.080598
   Lee JE, 2013, AM J CLIN NUTR, V98, P1032, DOI 10.3945/ajcn.113.062638
   McGarvey S T, 2001, Pac Health Dialog, V8, P157
   MCGARVEY ST, 1979, HUM BIOL, V51, P461
   Micha R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-136
   Nagao M, 2012, EUR J CLIN NUTR, V66, P687, DOI 10.1038/ejcn.2012.6
   Nevin KG, 2004, CLIN BIOCHEM, V37, P830, DOI 10.1016/j.clinbiochem.2004.04.010
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287
   Rumawas ME, 2009, AM J CLIN NUTR, V90, P1608, DOI 10.3945/ajcn.2009.27908
   Schulze MB, 2006, BRIT J NUTR, V95, P860, DOI 10.1079/BJN20061731
   Seiden A, 2012, AM J HUM BIOL, V24, P286, DOI 10.1002/ajhb.22237
   Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6
   Song Y, 2012, NUTR METAB CARDIOVAS, V22, P456, DOI 10.1016/j.numecd.2010.09.002
   Takata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056963
   TAYLOR R, 1989, INT J EPIDEMIOL, V18, P634, DOI 10.1093/ije/18.3.634
   Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7
   Tsai HJ, 2001, AM J HUM GENET, V69, P1236, DOI 10.1086/324646
   Weikert C, 2005, J NUTR, V135, P1981, DOI 10.1093/jn/135.8.1981
   WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
NR 51
TC 26
Z9 29
U1 1
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD APR
PY 2017
VL 147
IS 4
BP 628
EP 635
DI 10.3945/jn.116.243733
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EV7VV
UT WOS:000401990600020
PM 28202634
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Yazici-Tutunis, S
   Gurel-Gurevin, E
   Ustunova, S
   Demirci-Tansel, C
   Mericli, F
AF Yazici-Tutunis, Secil
   Gurel-Gurevin, Ebru
   Ustunova, Savas
   Demirci-Tansel, Cihan
   Mericli, Filiz
TI Possible effects of Phillyrea latifolia on weight loss in rats
   fed a high-energy diet
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE High-density lipoprotein; leptin; liver; low-density lipoprotein;
   obesity; small intestine; total cholesterol
ID HIGH-FAT DIET; SMALL-INTESTINE; LIPID-METABOLISM; OBESITY; EXTRACT;
   ACIDS; CONSTITUENTS; LEAVES
AB Context Phillyrea latifolia L. (Oleaceae), commonly found in the Mediterranean region in Turkey, is used as medicinal teas for weight loss and hyperglycaemia in folk medicine.
   Objective The study investigated the possible effects of P. latifolia leaves aqueous extract's on weight loss and biochemical-histological changes in the rats fed a high-energy diet (HED), also isolated and determined the main phenolic compounds.
   Materials and methods Twenty-four male Wistar albino rats were divided into four equal groups such as the HED group fed a HED, the PLE group given only the extract of P. latifolia leaves (220 mg/kg), the HED + PLE group administrated with the extract of leaves ( 220 mg/kg) after being fed with HED and a control group fed with standard pellet diet.
   Results PLE administration caused a remarkable decrement of body weight in the HED + PLE group (p < 0.05). PLE showed an improved effect on structural integrity and decreased leukocyte infiltration in liver and small intestinal tissues. The blood glucose (117.3 mmol/L), leptin (5.6 ng/mL), total cholesterol (61.8 mg/dL) and LDL (9.3 mmol/L) levels were significantly increased in the HED group. PLE administration in the HED group decreased these levels. The levels of HDL (26.8 mmol/L) in the HED + PLE group were higher than both control and HED groups. Chemical composition was investigated and luteolin 7-O-glucoside and chlorogenic acid were determined for the first time in Turkish sample from the EtOAc extract of leaves.
   Discussion and conclusion Phillyrea latifolia leaves may have beneficial effects on obesity related cellular problems and may become a good source of antidiabetic medication.
C1 [Yazici-Tutunis, Secil] Istanbul Univ, Fac Pharm, Dept Pharmacognosy, TR-34116 Istanbul, Turkey.
   [Gurel-Gurevin, Ebru; Demirci-Tansel, Cihan] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey.
   [Ustunova, Savas] Bezmialem Vakf Univ, Fac Med, Dept Physiol, Bezmialem, Turkey.
   [Mericli, Filiz] Near East Univ, Fac Pharm, Dept Pharmacognosy & Phytopharm Phytotherapy, Nicosia, Trnc Mersin, Turkey.
C3 Istanbul University; Istanbul University; Bezmialem Vakif University;
   Near East University
RP Yazici-Tutunis, S (corresponding author), Istanbul Univ, Fac Pharm, Dept Pharmacognosy, TR-34116 Istanbul, Turkey.
EM secilyaz@istanbul.edu.tr
RI Gurevin, Ebru/AAC-7921-2020; Üstünova, Savaş/CAJ-4395-2022;
   Demirci-Tansel, Cihan/AAC-4534-2020; YAZICI TUTUNIS, SECiL/O-3335-2018
OI Ustunova, Savas/0000-0003-1870-229X; YAZICI TUTUNIS,
   SECiL/0000-0003-4237-9939
FU Research Found of the University of Istanbul [6387]
FX This work was supported by The Research Found of the University of
   Istanbul (Project no. 6387).
CR Altunkaynak Z, 2005, EUR J GEN MED, V2, P100, DOI 10.29333/ejgm/82319
   Ayranci E, 2013, MOLECULES, V18, P1798, DOI 10.3390/molecules18021798
   Bray GA, 2002, J NUTR, V132, P2488, DOI 10.1093/jn/132.9.2488
   Choi HJ, 2007, BIOCHEM BIOPH RES CO, V359, P419, DOI 10.1016/j.bbrc.2007.05.107
   Davis P H., 1978, Flora of Turkey and the East Aegean Islands, Vol, V6, P145
   de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028
   Díaz AM, 2000, BIOL PHARM BULL, V23, P1307, DOI 10.1248/bpb.23.1307
   Estadella D, 2004, NUTRITION, V20, P218, DOI 10.1016/j.nut.2003.10.008
   ESTORNELL E, 1995, J NUTR, V125, P1309
   Henning B, 2001, J AM COLL NUTR, V20, P97, DOI 10.1080/07315724.2001.10719021
   Janakat S, 2002, J ETHNOPHARMACOL, V83, P135, DOI 10.1016/S0378-8741(02)00241-6
   Lanza AMD, 2001, PLANTA MED, V67, P219, DOI 10.1055/s-2001-12004
   Meriçli AH, 2006, PHARM BIOL, V44, P643, DOI 10.1080/13880200601006830
   Milagro FI, 2009, J PHYSIOL BIOCHEM, V65, P1, DOI 10.1007/BF03165964
   Mozes S, 2004, PHYSIOL RES, V53, P177, DOI 10.33549/physiolres.930388
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Pieroni A, 2000, J ETHNOPHARMACOL, V70, P213, DOI 10.1016/S0378-8741(99)00169-5
   PUGALENDHI KV, 1990, INDIAN J EXP BIOL, V28, P895
   Reuter TY., 2007, Drug Discov. Today Dis. Models, V4, P3, DOI [10.1016/j.ddmod.2007.09.004, DOI 10.1016/J.DDMOD.2007.09.004, 10.1016/J.DDMOD.2007.09.004]
   Sefcíková Z, 2008, PHYSIOL RES, V57, P467, DOI 10.33549/physiolres.931117
   Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059
   Szer U., 2006, SCI PHARM, V74, P203, DOI 10.3797/scipharm.2006.74.203
   Tomkin GeealdH., 2012, Open atherosclerosis and thrombosis journal, V5, P13, DOI [DOI 10.2174/1876506801205010013, 10.2174/1876506801205010013]
   Tuzlac E., 2007, IstanbulJPharm, V39, P39, DOI [10.16883/JFPIU.37197, DOI 10.16883/JFPIU.37197]
NR 24
TC 5
Z9 6
U1 1
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PY 2016
VL 54
IS 10
BP 1991
EP 1997
DI 10.3109/13880209.2015.1137952
PG 7
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA DZ7JP
UT WOS:000386041500006
PM 26850900
OA Bronze
DA 2025-04-28
ER

PT J
AU Karinchai, J
   Buacheen, P
   Rodthayoy, D
   Yodweerapong, T
   Imsumran, A
   Wongnoppavich, A
   Chantarasuwan, B
   Suttisansanee, U
   Temviriyanukul, P
   Pitchakarn, P
AF Karinchai, Jirarat
   Buacheen, Pensiri
   Rodthayoy, Daraphan
   Yodweerapong, Tanpitcha
   Imsumran, Arisa
   Wongnoppavich, Ariyaphong
   Chantarasuwan, Bhanumas
   Suttisansanee, Uthaiwan
   Temviriyanukul, Piya
   Pitchakarn, Pornsiri
TI Anti-Inflammatory and Anti-Adipocyte Dysfunction Effects of Ficus
   lindsayana Latex and Root Extracts
SO PHARMACEUTICALS
LA English
DT Article
DE Ficus lindsayana; adipogenesis; insulin resistance; chronic
   inflammation; metabolic diseases
ID PPAR-GAMMA; ANTIOXIDANT ACTIVITIES; FLAVONOID CONTENTS; CHLOROGENIC
   ACID; NITRIC-OXIDE; GALLIC ACID; C/EBP-ALPHA; CARICA L.; IN-VITRO;
   INFLAMMATION
AB Low-grade chronic inflammation and adipocyte dysfunction are prominent risk factors of insulin resistance and type 2 diabetes mellitus (T2DM) in obesity. Thus, prevention of inflammation and adipocyte dysfunction could be one possible approach to mitigate T2DM development. Several Ficus species have been used in traditional medicine for ameliorating inflammation and T2DM. Our previous studies reported biological effects of Ficus lindsayana including antioxidant, anti-cancer, and anti-alpha-glucosidase activities. Further, this study therefore investigated whether F. lindsayana latex (FLLE) and root (FLRE) extracts inhibit inflammation-stimulated insulin resistance in adipocytes and inflammation in macrophages. FLLE and FLRE (200 mu g/mL) had no significant cytotoxicity for macrophages, adipocytes, and blood cells (PBMCs and RBCs). FLRE had a total flavonoid content about three times higher than FLLE, while both had similar levels of total phenolic content. FLRE showed higher abilities than FLLE in suppressing inflammation in both macrophages and adipocytes and reversing the inflammation-induced insulin resistance in adipocytes. In TNF-alpha-induced adipocytes, FLRE significantly improved insulin-induced glucose uptake and insulin-suppressed lipolysis, while FLLE only significantly improved glucose uptake. Moreover, FLRE and FLLE remarkably reduced chemoattractant (MCP-1) but improved adipogenic (PPAR gamma and CEBP alpha) gene expression, leading to the promotion of adipogenesis and the suppression of insulin resistance. In LPS-induced macrophages, FLRE, but not FLLE, significantly inhibited LPS-induced NO production. Moreover, FLRE significantly reduced LPS-stimulated iNOS, COX-2, IL-1 beta, IL-6, and TNF-alpha gene expression. These results may provide the potential data for the development of this plant, especially the root part, as an alternative medicine, functional ingredient, or food supplement for the prevention of inflammation and obesity-associated insulin resistance, as well as T2DM.
C1 [Karinchai, Jirarat; Buacheen, Pensiri; Rodthayoy, Daraphan; Yodweerapong, Tanpitcha; Imsumran, Arisa; Wongnoppavich, Ariyaphong; Pitchakarn, Pornsiri] Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50200, Thailand.
   [Chantarasuwan, Bhanumas] Natl Sci Museum, Thailand Nat Hist Museum, Khlong 5, Khlong Laung 12120, Pathum Thani, Thailand.
   [Suttisansanee, Uthaiwan; Temviriyanukul, Piya] Mahidol Univ, Inst Nutr, Nakhon Pathom 73170, Thailand.
C3 Chiang Mai University; Mahidol University
RP Pitchakarn, P (corresponding author), Chiang Mai Univ, Fac Med, Dept Biochem, Chiang Mai 50200, Thailand.
EM jirarat.ka@cmu.ac.th; pensiri.bc@gmail.com; daraphanr@gmail.com;
   tanpitcha.y@hotmail.com; arisa.bonness@cmu.ac.th;
   ariyaphong.w@cmu.ac.th; b.chantarasuwan@gmail.com;
   uthaiwan.sut@mahidol.ac.th; piya.tem@mahidol.ac.th; pornsiri.p@cmu.ac.th
RI Wongnopavich, Ariyaphong/AAE-2938-2020; Bonness, Arisa/J-1769-2019;
   Pitchakarn, Pornsiri/AEB-6331-2022; Suttisansanee,
   Uthaiwan/JCE-4100-2023
OI Bonness, Arisa/0000-0002-2787-2461; Suttisansanee,
   Uthaiwan/0000-0001-5887-6329; Wongnoppavich,
   Ariyaphong/0000-0002-9238-0447; Temviriyanukul,
   Piya/0000-0002-7590-7024; Buacheen, Pensiri/0000-0001-6764-0801;
   Karinchai, Jirarat/0000-0002-1629-2808
FU Agricultural Research Development Agency (Public Organization), Thailand
FX This manuscript was proofread by Ruth Leatherman, RN, native English
   Proofreader, Research Administration Section, Faculty of Medicine,
   Chiang Mai University, Chiang Mai, 50200 Thailand.
CR Adam Z, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/632763
   Ahmed F, 2010, PHARM BIOL, V48, P672, DOI 10.3109/13880200903241861
   Ali B, 2012, NAT PROD RES, V26, P460, DOI 10.1080/14786419.2010.488236
   Aziz F. M., 2012, Jordan Journal of Biological Sciences (JJBS), V5, P175
   Baba SA, 2015, J TAIBAH UNIV SCI, V9, P449, DOI 10.1016/j.jtusci.2014.11.001
   Batra P, 2013, 3 BIOTECH, V3, P439, DOI 10.1007/s13205-013-0117-5
   Beentje H. J., 2021, Gardens' Bulletin (Singapore), V73, P307, DOI 10.26492/gbs73(2).2021-07
   Bittersohl H, 2016, PERSONALIZED IMMUNOSUPPRESSION IN TRANSPLANTATION: ROLE OF BIOMARKER MONITORING AND THERAPEUTIC DRUG MONITORING, P199, DOI 10.1016/B978-0-12-800885-0.00009-6
   Buacheen P, 2023, NANOMATERIALS-BASEL, V13, DOI 10.3390/nano13202804
   Budluang P, 2017, FOOD SCI NUTR, V5, P486, DOI 10.1002/fsn3.416
   Chandrashekhar CH, 2008, Int. J. Green Pharm, V2, P100, DOI DOI 10.4103/0973-8258.41180
   Chansriniyom C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96261-3
   Chantarasuwan B., 2006, Thai Forest Bulletin (Botany), P25
   Chatthongpisut R, 2015, FOOD CHEM, V188, P99, DOI 10.1016/j.foodchem.2015.04.074
   Chen L, 2019, FOOD CHEM TOXICOL, V127, P182, DOI 10.1016/j.fct.2019.03.038
   Cheng JX, 2020, J ETHNOPHARMACOL, V248, DOI 10.1016/j.jep.2019.112204
   Chupeerach C, 2022, FOODS, V11, DOI 10.3390/foods11233905
   Craig AP, 2016, TALANTA, V154, P481, DOI 10.1016/j.talanta.2016.03.101
   de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057
   Deepa P, 2018, J ETHNOPHARMACOL, V215, P210, DOI 10.1016/j.jep.2017.12.045
   Elisha IL, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1301-z
   Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006
   Feng XJ, 2016, EBIOMEDICINE, V9, P61, DOI 10.1016/j.ebiom.2016.06.017
   Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x
   Gupta D, 2008, J ETHNOPHARMACOL, V115, P361, DOI 10.1016/j.jep.2007.10.018
   Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387
   Han MS, 2020, P NATL ACAD SCI USA, V117, P2751, DOI 10.1073/pnas.1920004117
   Hu RT, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-19843-9
   Hu RT, 2022, CANCERS, V14, DOI 10.3390/cancers14112665
   Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x
   Huang FY, 2013, INT J CLIN EXP PATHO, V6, P2129
   Hunter P, 2012, EMBO REP, V13, P968, DOI 10.1038/embor.2012.142
   Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4
   Ibraheim Z.Z., 2015, Am. J. Chem, V5, P23
   Jasmine R., 2015, African Journal of Biotechnology, V14, P634
   Jeong JB, 2010, FOOD CHEM TOXICOL, V48, P2148, DOI 10.1016/j.fct.2010.05.020
   Ji CB, 2011, J BIOENERG BIOMEMBR, V43, P367, DOI 10.1007/s10863-011-9361-8
   Ji GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053101
   Jung HW, 2008, PHYTOTHER RES, V22, P1064, DOI 10.1002/ptr.2442
   Jung UJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050305
   Kern L, 2019, CANCERS, V11, DOI 10.3390/cancers11010024
   Keshari AK, 2016, J ETHNOPHARMACOL, V181, P252, DOI 10.1016/j.jep.2016.02.004
   Khanna R D., 2014, Microinflammation, V1, P109, DOI DOI 10.4172/2381-8727.1000109
   Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021
   Kong L, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13795
   Lansky EP, 2008, J ETHNOPHARMACOL, V119, P195, DOI 10.1016/j.jep.2008.06.025
   Liao CC, 2013, J AGR FOOD CHEM, V61, P11082, DOI 10.1021/jf4026647
   Lu QQ, 2014, OBESITY, V22, P1623, DOI 10.1002/oby.20705
   Mahmoudi S, 2016, ASIAN PAC J TROP BIO, V6, P239, DOI 10.1016/j.apjtb.2015.12.010
   McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052
   Misbah H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-118
   Mollace V, 2005, PHARMACOL REV, V57, P217, DOI 10.1124/pr.57.2.1
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Nworu CS, 2013, J IMMUNOTOXICOL, V10, P302, DOI 10.3109/1547691X.2012.732121
   Olaokun OO, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1087-z
   Osafo N., Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
   Panday DR, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1413-5
   Park CH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134620
   Ramchoun M, 2009, PHARMACOGN RES, V1, P106
   Ramos-Zavala MG, 2011, DIABETES CARE, V34, P1591, DOI 10.2337/dc11-0357
   Rebollo-Hernanz M, 2019, FOOD CHEM TOXICOL, V132, DOI 10.1016/j.fct.2019.110672
   Santiago LA, 2017, INT FOOD RES J, V24, P2050
   Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100
   Schröter D, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030571
   Seo CS, 2016, PHARMACOGN MAG, V12, P104, DOI 10.4103/0973-1296.177908
   Shi YX, 2018, J ETHNOPHARMACOL, V226, P185, DOI 10.1016/j.jep.2018.07.027
   Sirichai P, 2022, PLANTS-BASEL, V11, DOI 10.3390/plants11030294
   Suganthy N, 2018, REGUL TOXICOL PHARM, V92, P347, DOI 10.1016/j.yrtph.2017.12.019
   Suttisansanee U., 2021, J. Pharm. Res. Int, V32, P84
   Suttisansanee U, 2021, FOOD SCI NUTR, V9, P2269, DOI 10.1002/fsn3.2205
   Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274
   Tian CL, 2021, S AFR J BOT, V137, P257, DOI 10.1016/j.sajb.2020.10.022
   Tolosa L, 2015, METHODS MOL BIOL, V1250, P333, DOI 10.1007/978-1-4939-2074-7_26
   Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179
   Vinayagam R, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0057-7
   Wang HF, 2008, J COSMET SCI, V59, P509
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wongrakpanich S, 2018, AGING DIS, V9, P143, DOI 10.14336/AD.2017.0306
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244
   Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457
   Zhang Q, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00071
   Zhang QZ, 2020, J FUNCT FOODS, V69, DOI 10.1016/j.jff.2020.103972
NR 83
TC 1
Z9 1
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD MAR
PY 2024
VL 17
IS 3
AR 287
DI 10.3390/ph17030287
PG 19
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA MJ9X0
UT WOS:001193382000001
PM 38543073
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Mihaylova, D
   Desseva, I
   Popova, A
   Dincheva, I
   Vrancheva, R
   Lante, A
   Krastanov, A
AF Mihaylova, Dasha
   Desseva, Ivelina
   Popova, Aneta
   Dincheva, Ivayla
   Vrancheva, Radka
   Lante, Anna
   Krastanov, Albert
TI GC-MS Metabolic Profile and α-Glucosidase-, α-Amylase-, Lipase-, and
   Acetylcholinesterase-Inhibitory Activities of Eight Peach Varieties
SO MOLECULES
LA English
DT Article
DE peach; amylase; glucosidase; lipase; acetylcholinesterase; enzyme
   inhibitory activities; GC-MS; principal component analysis; hierarchical
   cluster analysis
ID ANTIOXIDANT PROPERTIES; VEGETABLE CONSUMPTION; DIFFERENT SENSITIVITY;
   INSULIN-RESISTANCE; PHENOLIC-COMPOUNDS; CHLOROGENIC ACID; FRUIT;
   CAROTENOIDS; NECTARINE; QUALITY
AB The inhibition of certain digestive enzymes by target food matrices represents a new approach in the treatment of socially significant diseases. Proving the ability of fruits to inhibit such enzymes can support the inclusion of specific varieties in the daily diets of patients with diabetes, obesity, Alzheimer's disease, etc., providing them with much more than just valuable micro- and macromolecules. The current study aimed atidentifying and comparing the GC-MS metabolic profiles of eight peach varieties ("Filina", "Ufo 4, "Gergana", "Laskava", "July Lady", "Flat Queen", "Evmolpiya", and "Morsiani 90") grown in Bulgaria (local and introduced) and to evaluate the inhibitory potential of their extracts towards alpha-glucosidase, alpha-amylase, lipase, and acetylcholinesterase. In order to confirm samples' differences or similarities, principal component analysis (PCA) and hierarchical cluster analysis (HCA) were also applied to the identified metabolites. The results provide important insights into the metabolomic profiles of the eight peach varieties and represent a first attempt to characterize the peels of the peach varieties with respect to alpha-glucosidase-, alpha-amylase-, lipase-, and acetylcholinesterase-inhibitory activities. All of the studied peach extracts displayed inhibitory activity towards alpha-glucosidase (IC50: 125-757 mg/mL) and acetylcholinesterase (IC50: 60-739 mg/mL), but none of them affected alpha-amylase activity. Five of the eight varieties showed inhibitory activity towards porcine pancreatic lipase (IC50: 24-167 mg/mL). The obtained results validate the usefulness of peaches and nectarines as valuable sources of natural agents beneficial for human health, although further detailed investigation should be performed in order to thoroughly identify the enzyme inhibitors responsible for each activity.
C1 [Mihaylova, Dasha; Krastanov, Albert] Univ Food Technol, Fac Technol, Dept Biotechnol, Plovdiv 4002, Bulgaria.
   [Desseva, Ivelina; Vrancheva, Radka] Univ Food Technol, Fac Technol, Dept Analyt Chem & Phys Chem, Plovdiv 4002, Bulgaria.
   [Popova, Aneta] Univ Food Technol, Fac Econ, Dept Catering & Tourism, Plovdiv 4002, Bulgaria.
   [Dincheva, Ivayla] Agricultural Acad, AgroBioInst, 8 Dr Tsankov Blvd, Sofia 1164, Bulgaria.
   [Lante, Anna] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, I-35020 Legnaro, Italy.
C3 University of Food Technology - Bulgaria; University of Food Technology
   - Bulgaria; University of Food Technology - Bulgaria; Agricultural
   Academy - Bulgaria; University of Padua
RP Mihaylova, D (corresponding author), Univ Food Technol, Fac Technol, Dept Biotechnol, Plovdiv 4002, Bulgaria.; Desseva, I (corresponding author), Univ Food Technol, Fac Technol, Dept Analyt Chem & Phys Chem, Plovdiv 4002, Bulgaria.
EM dashamihaylova@yahoo.com; ivelina_hristova_vn@abv.bg;
   popova_aneta@yahoo.com; ivadincheva@yahoo.com;
   radka_vrancheva@yahoo.com; anna.lante@unipd.it;
   a_krastanov@uft-plovdiv.bg
RI Popova, Aneta/K-8823-2016; Krastanov, Albert/JAC-5626-2023; Deseva,
   Ivelina/M-1256-2016; Dincheva, Ivayla/K-8250-2013; Mihaylova,
   Dasha/L-8364-2016
OI Dincheva, Ivayla/0000-0003-0276-4170; LANTE, ANNA/0000-0003-4709-9311;
   Mihaylova, Dasha/0000-0002-6144-9640
FU Ministry of Education and Science Scientific Research Fund, Bulgaria [K
   P-06-H37/23-2019]
FX This research was funded by the Ministry of Education and Science
   Scientific Research Fund, Bulgaria, grant number K P-06-H37/23-2019.
CR Adefegha Stephen A., 2012, Journal of Basic and Clinical Physiology and Pharmacology, V23, P153, DOI 10.1515/jbcpp-2012-0029
   Akhatou I, 2016, PLANT PHYSIOL BIOCH, V101, P14, DOI 10.1016/j.plaphy.2016.01.016
   [Anonymous], 2018, NAT PROD COMMUN
   [Anonymous], 2019, Increasing fruit and vegetable consumption to reduce the risk of noncommunicable diseases
   Aseervatham GSB, 2016, BIOMED PHARMACOTHER, V82, P54, DOI 10.1016/j.biopha.2016.04.066
   Assaad HI, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-474
   Atta-ur-Rahman, 2001, PURE APPL CHEM, V73, P555, DOI 10.1351/pac200173030555
   Bagdas D, 2020, CURR NEUROPHARMACOL, V18, P216, DOI 10.2174/1570159X17666191021111809
   Omena CMB, 2012, FOOD RES INT, V49, P334, DOI 10.1016/j.foodres.2012.07.010
   Becerra-Tomás N, 2021, NUTR METAB CARDIOVAS, V31, P1702, DOI 10.1016/j.numecd.2021.02.007
   Bento C, 2022, FOOD REV INT, V38, P1703, DOI 10.1080/87559129.2020.1837861
   Bento C, 2018, J FUNCT FOODS, V43, P224, DOI 10.1016/j.jff.2018.02.018
   Berger K, 2020, MOLECULES, V25, DOI 10.3390/molecules25225224
   Berkov S, 2018, REF SER PHYTOCHEM, P67, DOI 10.1007/978-3-319-54600-1_12
   Berkov S, 2011, TALANTA, V83, P1455, DOI 10.1016/j.talanta.2010.11.029
   Bhadra S., 2015, CHAPTER 13 EVALUATIO, P273
   Bontpart T, 2016, J EXP BOT, V67, P3537, DOI 10.1093/jxb/erw184
   Bostock RM, 1999, PHYSIOL MOL PLANT P, V54, P37, DOI 10.1006/pmpp.1998.0189
   Bourgaud F, 2001, PLANT SCI, V161, P839, DOI 10.1016/S0168-9452(01)00490-3
   Brown AF, 2014, J AM SOC HORTIC SCI, V139, P676, DOI 10.21273/JASHS.139.6.676
   Budreviciute A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.574111
   Byrne DH, 2009, ACTA HORTIC, V841, P267, DOI 10.17660/ActaHortic.2009.841.32
   Cao SF, 2017, FOOD CHEM, V214, P137, DOI 10.1016/j.foodchem.2016.07.085
   Cevallos-Cevallos JM, 2012, PLANT PHYSIOL BIOCH, V53, P69, DOI 10.1016/j.plaphy.2012.01.010
   Colaric M, 2005, J SCI FOOD AGR, V85, P2611, DOI 10.1002/jsfa.2316
   Commisso M, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10050380
   Dabbou S, 2017, PLANT FOOD HUM NUTR, V72, P103, DOI 10.1007/s11130-016-0585-y
   Dobrev G, 2015, BIOCATAL AGRIC BIOTE, V4, P77, DOI 10.1016/j.bcab.2014.09.011
   Duan YX, 2013, ACTA PHYSIOL PLANT, V35, P707, DOI 10.1007/s11738-012-1111-y
   Famiani F, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.572601
   Ferreira J, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/3825629
   Food and Agriculture Organization, 2003, INCR FRUIT VEG CONS INCR FRUIT VEG CONS
   Guo CT, 2020, INT J FOOD PROP, V23, P1272, DOI 10.1080/10942912.2020.1797782
   Habtemariam S, 2019, MOLECULES, V24, DOI 10.3390/molecules24081519
   Hamade Y, 2013, METABOLISM, V62, P734, DOI 10.1016/j.metabol.2012.10.015
   Ikram MMM, 2020, METABOLITES, V10, DOI 10.3390/metabo10040134
   Infante R, 2011, CHIL J AGR RES, V71, P445, DOI 10.4067/S0718-58392011000300016
   Ingkaninan K, 2003, J ETHNOPHARMACOL, V89, P261, DOI 10.1016/j.jep.2003.08.008
   Iwasaki Y, 2012, METABOLITES, V2, P496, DOI 10.3390/metabo2030496
   Jocken JWE, 2016, INT J OBESITY, V40, P507, DOI 10.1038/ijo.2015.211
   Johnson Elizabeth J, 2002, Nutr Clin Care, V5, P56, DOI 10.1046/j.1523-5408.2002.00004.x
   Kabir MT, 2019, CURR PHARM DESIGN, V25, P3519, DOI 10.2174/1381612825666191008103141
   Kazeem MI, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/527570
   Keutgen AJ, 2008, FOOD CHEM, V107, P1413, DOI 10.1016/j.foodchem.2007.09.071
   Kopka J, 2006, J BIOTECHNOL, V124, P312, DOI 10.1016/j.jbiotec.2005.12.012
   Lara MV, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.562252
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Lillo-Carmona V, 2020, METABOLITES, V10, DOI 10.3390/metabo10040154
   Liu H, 2018, J FOOD PROCESS PRES, V42, DOI 10.1111/jfpp.13624
   Liu H, 2015, LWT-FOOD SCI TECHNOL, V63, P1042, DOI 10.1016/j.lwt.2015.04.052
   Liu YJ, 2013, MOL MED REP, V8, P1106, DOI 10.3892/mmr.2013.1652
   Lobbens ESB, 2017, J ETHNOPHARMACOL, V200, P66, DOI 10.1016/j.jep.2017.02.020
   Lombardo VA, 2011, PLANT PHYSIOL, V157, P1696, DOI 10.1104/pp.111.186064
   Martinez-Gonzalez AI, 2017, MOLECULES, V22, DOI 10.3390/molecules22040669
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Michailidis M, 2021, HORTICULTURAE, V7, DOI 10.3390/horticulturae7040085
   Mihaylova D, 2021, MOLECULES, V26, DOI 10.3390/molecules26092818
   Mihaylova D, 2021, FOODS, V10, DOI 10.3390/foods10010164
   Mirmiran P, 2009, METABOLISM, V58, P460, DOI 10.1016/j.metabol.2008.11.002
   Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001
   Nakajima K, 2016, WORLD J DIABETES, V7, P112, DOI 10.4239/wjd.v7.i6.112
   Quan NV, 2019, MOLECULES, V24, DOI 10.3390/molecules24030482
   Noori T, 2021, EUR J PHARMACOL, V898, DOI 10.1016/j.ejphar.2021.173974
   Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m
   Nowicka P, 2018, PLANT FOOD HUM NUTR, V73, P314, DOI 10.1007/s11130-018-0688-8
   Nowicka P, 2016, J FUNCT FOODS, V25, P397, DOI 10.1016/j.jff.2016.06.024
   Oboh G, 2013, NEUROCHEM RES, V38, P413, DOI 10.1007/s11064-012-0935-6
   Oguntibeju O.O., 2013, DIABETES MELLITUS IN, V3, P180
   Olatona FA, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0152-2
   Parashar A, 2010, INT J FRUIT SCI, V10, P425, DOI 10.1080/15538362.2010.530129
   ROBERTSON JA, 1988, HORTSCIENCE, V23, P1032
   Rodríguez-Solana R, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110563
   RYUGO KAY, 1959, PROC AMER SOC HORT SCI, V74, P130
   Saifuddin N, 2008, E-J CHEM, V5, P864, DOI 10.1155/2008/920408
   Saini RK, 2015, FOOD RES INT, V76, P735, DOI 10.1016/j.foodres.2015.07.047
   Santana-Gálvez J, 2017, MOLECULES, V22, DOI 10.3390/molecules22030358
   Santin M, 2018, POSTHARVEST BIOL TEC, V139, P127, DOI 10.1016/j.postharvbio.2018.02.001
   Sasaki K, 2010, FOOD CHEM, V118, P830, DOI 10.1016/j.foodchem.2009.05.070
   Sochor J, 2011, MOLECULES, V16, P7428, DOI 10.3390/molecules16097428
   Statistical M., FUNCTIONAL INTEGRATI
   Suh SJ, 2006, J MOL NEUROSCI, V29, P101, DOI 10.1385/JMN:29:2:101
   Sultana R, 2020, FOODS, V9, DOI 10.3390/foods9070844
   Sun LJ, 2020, CRIT REV FOOD SCI, V60, P541, DOI 10.1080/10408398.2018.1544883
   Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149
   Tian Y, 2018, PUBLIC HEALTH NUTR, V21, P756, DOI 10.1017/S136898001700310X
   Torras-Claveria L, 2010, PHYTOCHEM ANALYSIS, V21, P80, DOI 10.1002/pca.1158
   Uriarte-Pueyo I, 2011, CURR MED CHEM, V18, P5289, DOI 10.2174/092986711798184325
   Vendrame S, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5040034
   Volpe SL, 2019, ACSMS HEALTH FIT J, V23, P30, DOI 10.1249/FIT.0000000000000474
   Vrancheva R, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10010094
   Vrancheva RZ, 2020, Z NATURFORSCH C, V75, P451, DOI 10.1515/znc-2020-0058
   Wagner C, 2003, PHYTOCHEMISTRY, V62, P887, DOI 10.1016/S0031-9422(02)00703-3
   Walker R., 2018, HORTICULTURAL REV, P371
   Wang XB, 2020, RSC MED CHEM, V11, P225, DOI 10.1039/c9md00441f
   Watanabe J, 1997, BIOSCI BIOTECH BIOCH, V61, P177, DOI 10.1271/bbb.61.127
   Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b
   World Health Organisation, 2020, NONC DIS PROGR MON 2
   Wu BH, 2012, J AGR SCI-CAMBRIDGE, V150, P53, DOI 10.1017/S0021859611000438
   Yoshioka T, 2004, Z NATURFORSCH C, V59, P509
   Zhang XA, 2019, MOLECULES, V24, DOI 10.3390/molecules24101968
   Zhao CN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060598
   Zheleva-Dimitrova DZ, 2013, PHARMACOGN MAG, V9, P109, DOI 10.4103/0973-1296.111251
NR 102
TC 19
Z9 20
U1 5
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JUL
PY 2021
VL 26
IS 14
AR 4183
DI 10.3390/molecules26144183
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA TO1DR
UT WOS:000676662200001
PM 34299456
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU El Azab, EF
   Alakilli, SYM
   Saleh, AM
   Alhassan, HH
   Alanazi, HH
   Ghanem, HB
   Yousif, SO
   Alrub, HA
   Anber, N
   Elfaki, EM
   Hamza, A
   Abdulmalek, S
AF El Azab, Eman Fawzy
   Alakilli, Saleha Y. M.
   Saleh, Abdulrahman M.
   Alhassan, Hassan H.
   Alanazi, Hamad H.
   Ghanem, Heba Bassiony
   Yousif, Sara Osman
   Alrub, Heba Abu
   Anber, Nahla
   Elfaki, Elyasa Mustafa
   Hamza, Alneil
   Abdulmalek, Shaymaa
TI Actinidia deliciosa Extract as a Promising Supplemental Agent for
   Hepatic and Renal Complication-Associated Type 2 Diabetes (In Vivo and
   In Silico-Based Studies)
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Actinidia deliciosa; adipocytokines; insulin resistance; mTOR; SIRT-1
   pathway; PTEN; caffeic acid; melezitose
ID GLUTATHIONE-REDUCTASE; INSULIN-RESISTANCE; EXPRESSION; MODEL
AB Type 2 diabetes (T2D) is a chronic metabolic condition associated with obesity, oxidative stress-mediated inflammation, apoptosis, and impaired insulin signaling. The utilization of phytochemical therapy generated from plants has emerged as a promising approach for the treatment of diabetes and its complications. Kiwifruit is recognized for its substantial content of antioxidative phenolics. Therefore, this work aimed to examine the effect of Actinidia deliciosa (kiwi fruit) on hepatorenal damage in a high-fat diet (HFD) and streptozotocin (STZ)-induced T2D in rats using in vivo and in silico analyses. An increase in hepatic and renal lipid peroxidation was observed in diabetic rats accompanied by a decrease in antioxidant status. Furthermore, it is important to highlight that there were observable inflammatory and apoptotic responses in the hepatic and renal organs of rats with diabetes, along with a dysregulation of the phosphorylation levels of mammalian target of rapamycin (mTOR), protein kinase B (Akt), and phosphoinositide 3-kinase (PI3K) signaling proteins. However, the administration of kiwi extract to diabetic rats alleviated hepatorenal dysfunction, inflammatory processes, oxidative injury, and apoptotic events with activation of the insulin signaling pathway. Furthermore, molecular docking and dynamic simulation studies revealed quercetin, chlorogenic acid, and melezitose as components of kiwi extract that docked well with potential as effective natural products for activating the silent information regulator 1(SIRT-1) pathway. Furthermore, phenolic acids in kiwi extract, especially syringic acid, P-coumaric acid, caffeic acid, and ferulic acid, have the ability to inhibit the phosphatase and tensin homolog (PTEN) active site. In conclusion, it can be argued that kiwi extract may present a potentially beneficial adjunctive therapy approach for the treatment of diabetic hepatorenal complications.
C1 [El Azab, Eman Fawzy; Alanazi, Hamad H.; Yousif, Sara Osman; Alrub, Heba Abu; Elfaki, Elyasa Mustafa; Hamza, Alneil] Jouf Univ, Coll Appl Med Sci Al Qurayyat, Dept Clin Lab Sci, Al Qurayyat 77454, Saudi Arabia.
   [Alakilli, Saleha Y. M.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah 23761, Saudi Arabia.
   [Saleh, Abdulrahman M.] Al Azhar Univ, Fac Pharm Boys, Pharmaceut Med Chem & Drug Design Dept, Cairo 11884, Egypt.
   [Alhassan, Hassan H.; Ghanem, Heba Bassiony] Jouf Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Sakaka 72341, Saudi Arabia.
   [Ghanem, Heba Bassiony] Tanta Univ, Fac Med, Med Biochem Dept, Tanta 31527, Egypt.
   [Yousif, Sara Osman] Sudan Univ Sci & Technol, Fac Med Lab Sci, Dept Clin Chem, Khartoum 13311, Sudan.
   [Anber, Nahla] Mansoura Univ, Emergency Hosp, Mansoura 35516, Egypt.
   [Abdulmalek, Shaymaa] Alexandria Univ, Fac Sci, Biochem Dept, Alexandria 21511, Egypt.
C3 Al Jouf University; King Abdulaziz University; Egyptian Knowledge Bank
   (EKB); Al Azhar University; Al Jouf University; Egyptian Knowledge Bank
   (EKB); Tanta University; Egyptian Knowledge Bank (EKB); Mansoura
   University; Egyptian Knowledge Bank (EKB); Alexandria University
RP El Azab, EF (corresponding author), Jouf Univ, Coll Appl Med Sci Al Qurayyat, Dept Clin Lab Sci, Al Qurayyat 77454, Saudi Arabia.
EM efelazab@ju.edu.sa; salakilli@kau.edu.sa; abdo.saleh240@azhar.edu.eg;
   h.alhasan@ju.edu.sa; hhalanzi@ju.edu.sa; hbghanem@ju.edu.sa;
   soyousif@ju.edu.sa; htaburub@ju.edu.sa; nahlaamedanber@mans.edu.eg;
   eelfaki@ju.edu.sa; aahamza@ju.edu.sa; shaymaa.abdulmalek@alexu.edu.eg
RI Ghanem, Heba/HNP-6935-2023; Elfaki, Elyasa/AAC-3116-2022; yousif,
   Sara/JMC-0962-2023; El Azab, Eman/ACZ-1925-2022; Alanazi,
   Hamad/HPG-9717-2023; Anber, Nahla/AAM-9830-2021; saleh,
   Abdulrahman/JTT-4389-2023; Alhassan, Hassan/GSN-1926-2022; Hamza,
   Alneil/Y-8332-2019
OI El Azab, Eman/0000-0001-9463-5506; M. Saleh,
   Abdulrahman/0000-0002-5153-7399; Hamza, Alneil/0000-0002-6792-0704;
   Alhassan, Dr. Hassan/0000-0002-7174-9831
FU Deanship of Scientific Research Foundation of Jouf University, KSA
   [DSR-2021-01-03182]
FX This work was supported by the Deanship of Scientific Research
   Foundation of Jouf University, KSA, grant number (DSR-2021-01-03182).
CR Abdulmalek S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-00108-w
   Al-Dabet MM, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32477-9
   AlAmri OD, 2020, J FUNCT FOODS, V71, DOI 10.1016/j.jff.2020.103996
   Aleid IS, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103499
   Sani MA, 2022, J OBES, V2022, DOI 10.1155/2022/1015669
   Bancroft J.D., 2008, Theory and practice of histological techniques, V6th
   Baraskar K, 2023, J DIABETES METAB DIS, V22, P721, DOI 10.1007/s40200-023-01194-5
   Bhatti JS, 2022, FREE RADICAL BIO MED, V184, P114, DOI 10.1016/j.freeradbiomed.2022.03.019
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   Buzanovskii V.A., 2015, Rev. J. Chem, V5, P143, DOI [10.1134/S2079978015020028, DOI 10.1134/S2079978015020028]
   Cao R, 2023, MEDCOMM, V4, DOI 10.1002/mco2.283
   Cho GW, 2016, BBA-MOL BASIS DIS, V1862, P763, DOI 10.1016/j.bbadis.2016.01.011
   CRIBB AE, 1989, ANAL BIOCHEM, V183, P195, DOI 10.1016/0003-2697(89)90188-7
   Czech MP, 2013, DIABETOLOGIA, V56, P949, DOI 10.1007/s00125-013-2869-1
   DasNandy A, 2023, J INTEGR MED-JIM, V21, P226, DOI 10.1016/j.joim.2023.02.003
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Dinic S, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1006376
   Duttaroy AK, 2013, ADV FOOD NUTR RES, V68, P273, DOI 10.1016/B978-0-12-394294-4.00015-8
   El Azab EF, 2022, J FOOD BIOCHEM, V46, DOI 10.1111/jfbc.14142
   El Azab EF, 2022, FOOD SCI TECH-BRAZIL, V42, DOI 10.1590/fst.06021
   El-Demerdash FM, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/1499510
   Escamilla-Ramírez A, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13070156
   Gao RM, 1998, BIOELECTROCH BIOENER, V45, P41, DOI 10.1016/S0302-4598(98)00072-5
   Gothai S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080461
   Goyal SN, 2016, CHEM-BIOL INTERACT, V244, P49, DOI 10.1016/j.cbi.2015.11.032
   Hesp AC, 2020, KIDNEY INT, V98, P579, DOI 10.1016/j.kint.2020.02.041
   Hunter Denise C., 2016, P239, DOI 10.1016/B978-0-12-802972-5.00012-3
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   Laleethambika N., 2019, SN COMPREHENSIVE CLI, V1, P49, DOI [10.1007/s42399-018-0012-9, DOI 10.1007/S42399-018-0012-9]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mohseni AH, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1886844
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   Mueller S, 1997, ANAL BIOCHEM, V245, P55, DOI 10.1006/abio.1996.9939
   Othman MS, 2021, BIOMED PHARMACOTHER, V144, DOI 10.1016/j.biopha.2021.112287
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Ramalingam S, 2020, ALL LIFE, V13, P120, DOI 10.1080/26895293.2020.1733104
   Reza ASMA, 2023, J FUNCT FOODS, V106, DOI 10.1016/j.jff.2023.105610
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   Roy JR, 2023, TOXICS, V11, DOI 10.3390/toxics11030240
   Roy JR, 2023, CURR ISSUES MOL BIOL, V45, P852, DOI 10.3390/cimb45020056
   Sah SP, 2016, PHARMACOL REP, V68, P1165, DOI 10.1016/j.pharep.2016.07.010
   Sarkar T, 2023, CRIT REV FOOD SCI, V63, P6491, DOI 10.1080/10408398.2022.2033953
   Satpal D, 2021, J FOOD PROCESS PRES, V45, DOI 10.1111/jfpp.15588
   Schüttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   Shokouh P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092074
   Singh R, 2014, PHARMACOL RES, V80, P21, DOI 10.1016/j.phrs.2013.12.005
   Türkan F, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22205
   Wang KL, 2022, NUTRIENTS, V14, DOI 10.3390/nu14163369
   Yang Hsin-Yi, 2020, J Nutr Sci Vitaminol (Tokyo), V66, pS356, DOI 10.3177/jnsv.66.S356
   Zhou JY, 2023, J NUTR BIOCHEM, V119, DOI 10.1016/j.jnutbio.2023.109404
NR 52
TC 9
Z9 9
U1 3
U2 5
PU MDPI
PI BASEL
PA MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2023
VL 24
IS 18
AR 13759
DI 10.3390/ijms241813759
PG 41
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA T2TS2
UT WOS:001076565700001
PM 37762060
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Han, E
   Kim, TH
   Powell, LM
AF Han, Euna
   Kim, Tae Hyun
   Powell, Lisa M.
TI Beverage consumption and individual-level associations in South Korea
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Beverage consumption; Individual-level associations; Two-part regression
   model; South Korea
ID SUGAR-SWEETENED BEVERAGES; SOFT DRINK CONSUMPTION; NUTRITION TRANSITION;
   DIETARY PATTERNS; UNITED-STATES; US CHILDREN; OBESITY; ADOLESCENTS;
   PREVALENCE; OVERWEIGHT
AB Background: Few previous studies investigated consumption distributions of sugar-sweetened beverages (SSBs) over time and individual-level associations in Asia despite the recent interest in SSBs regarding obesity control. This study aimed to provide recent evidence on beverage consumption trends from 2001 to 2009 for overall and subtypes of SSBs and for milk as a comparable healthy beverage in South Korea, as well as associations with individual-level socioeconomic status (SES).
   Methods: The Korean National Health and Nutrition Examination Surveys from 2001 to 2009 were used. Consumption prevalence and average caloric intake by SSB type were examined. Associations of SES with consumption were assessed in a multivariate logistic regression model (consumption prevalence) and in a multivariate two-part regression model (overall caloric intake adjusting for consumption probability).
   Results: SSB consumption prevalence increased to 38%, 69%, 70%, and 50% by 2009 up from 31%, 66%, 63%, and 32% in 2001 among adolescents, young adults, adults, and the elderly, respectively. Miscellaneous SSBs (sports/energy drinks, coffee/tea products, flavored milk, and others) were the most prevalent and their prevalence increased among adults (from 62% to 69%) and the elderly (from 30% to 47%) between 2001 and 2009. Adolescents consumed the most calories from miscellaneous SSBs among all beverage types although its prevalence was lower than regular soda and milk in both 2001 and 2009. Women (top-income group only) and men in higher income groups showed higher odds of consuming total SSBs (OR = 1.18-1.25), soda (OR = 1.18, men only), fruit drinks (OR = 1.18, the top-income only for both genders), and miscellaneous SSBs (OR = 1.1-1.2). Men with higher-education showed higher odds of total SSB consumption (OR = 1.14-1.20), and all subtypes of SSBs (OR = 1.18, 1.29, 1.19 for soda, fruit drinks, and miscellaneous SSBs, respectively for the top-education group only). There were statistically significant but minimal differences in the overall amount of caloric intake from SSBs by individual SES for both genders.
   Conclusions: South Korea is following the global nutrition transition toward greater consumption of SSBs. However, unlike other developed countries, SSB consumption prevalence was higher among high-SES individuals, particularly for fruit drinks and miscellaneous SSBs. Further research is needed to build the international evidence base.
C1 [Han, Euna] Gachon Univ, Coll Pharm, Dept Pharm, Inchon 406799, South Korea.
   [Han, Euna] Gachon Univ, Gachon Inst Pharmaceut Sci, Inchon 406799, South Korea.
   [Kim, Tae Hyun] Yonsei Univ, Sch Publ Hlth, Seoul 120749, South Korea.
   [Kim, Tae Hyun] Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea.
   [Powell, Lisa M.] Univ Illinois, Sch Publ Hlth, Dept Hlth Policy & Adm, Chicago, IL USA.
   [Powell, Lisa M.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL USA.
C3 Gachon University; Gachon University; Yonsei University; Yonsei
   University; University of Illinois System; University of Illinois
   Chicago; University of Illinois Chicago Hospital; University of Illinois
   System; University of Illinois Chicago; University of Illinois Chicago
   Hospital
RP Kim, TH (corresponding author), Yonsei Univ, Sch Publ Hlth, 50 Yonsei Ro, Seoul 120749, South Korea.
EM thkim@yuhs.ac
RI Kim, Juewon/ABH-3314-2020; Han, Euna/KFA-2394-2024
OI Han, Euna/0000-0003-2656-7059; Kim, Tae Hyun/0000-0003-1053-8958
FU Korea National Research Foundation [NRF-2012007096]
FX Funding from Korea National Research Foundation (NRF-2012007096) was
   greatly appreciated (Han and Kim). All authors have no conflict of
   interest to disclose. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   Korea National Research Foundation. No financial disclosures were
   reported by the authors of this paper.
CR Ambrosini GL, 2009, PUBLIC HEALTH NUTR, V12, P1807, DOI 10.1017/S1368980008004618
   [Anonymous], 2002, GLOBALIZATION DIETS
   Arcan C, 2009, J AM DIET ASSOC, V109, P823, DOI 10.1016/j.jada.2009.02.001
   Bleich SN, 2011, DIABETES CARE, V34, P551, DOI 10.2337/dc10-1687
   Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007
   Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392
   Center for Science in the Public Interest, 2009, LIQ CAND WHY TAX SOF
   Dennis EA, 2009, EAT BEHAV, V10, P237, DOI 10.1016/j.eatbeh.2009.07.006
   Ehlen LA, 2008, NUTR RES, V28, P299, DOI 10.1016/j.nutres.2008.03.001
   Eisenmann JC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-607
   Evans AE, 2010, J AM COLL NUTR, V29, P387, DOI 10.1080/07315724.2010.10719856
   Ezendam NPM, 2010, BRIT J NUTR, V103, P768, DOI 10.1017/S0007114509992297
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Hafekost K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-950
   Han E, 2005, J MENT HEALTH POLICY, V8, P131
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6
   HARRIS SS, 1994, AM J CLIN NUTR, V60, P573, DOI 10.1093/ajcn/60.4.573
   International Monetary Fund, 2010, WORLD EC OUTL DAT
   Kim E, 2005, OBES RES, V13, P1510, DOI 10.1038/oby.2005.183
   Kim S, 2000, AM J CLIN NUTR, V71, P44
   Korea Food and Drug Administration, SUG CONS LEV KOR
   Korean Center of Disease and Control, 2011, US GUID KOR NAT HLTH
   Korean Statistical Information Service, 2009, MIN MAN SURV C2008
   Lee HS, 2012, ASIA PAC J CLIN NUTR, V21, P618
   Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294
   Lee SK, 2003, PUBLIC HEALTH NUTR, V6, P665, DOI 10.1079/PHN2003485
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   MANNING WG, 1987, J ECONOMETRICS, V35, P59, DOI 10.1016/0304-4076(87)90081-9
   McKinley J, 2007, NY TIMES
   Ministry of Health and Welfare, HLTH EAT STYL KOR AD
   Moon HK, 1994, KOREAN J NUTR, V27, P509
   New York State Division of Budget, 2009 2010 EX BUDG BR
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Park M.H., 2003, CULTURAL LIFE KOREA
   Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536
   Patrick DL, 2009, FY2010 HOUSE BUDGET
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]
   Putnam JudithJ., 1999, FOOD CONSUMPTION PRI
   Rehm CD, 2008, J URBAN HEALTH, V85, P375, DOI 10.1007/s11524-008-9269-8
   Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1, DOI 10.1542/peds.2018-0939
   Song Y, 2005, BRIT J NUTR, V93, P943, DOI 10.1079/BJN20051435
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   World Health Organization, 2003, INF SHEET OB OV
   Zoellner J, 2011, J AM DIET ASSOC, V111, P1012, DOI 10.1016/j.jada.2011.04.010
NR 49
TC 33
Z9 35
U1 1
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAR 6
PY 2013
VL 13
AR 195
DI 10.1186/1471-2458-13-195
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA 128JQ
UT WOS:000317765700001
PM 23497024
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Andreazzi, AE
   Grassiolli, S
   Marangon, PB
   Martins, AG
   de Oliveira, JC
   Torrezan, R
   Gravena, C
   Garcia, RMG
   Mathias, PCD
AF Andreazzi, Ana Eliza
   Grassiolli, Sabrina
   Marangon, Paula Beatriz
   Martins, Adriana Gallego
   de Oliveira, Julio Cezar
   Torrezan, Rosana
   Gravena, Clarice
   Gonzalez Garcia, Raul Marcel
   de Freitas Mathias, Paulo Cezar
TI Impaired Sympathoadrenal Axis Function Contributes to Enhanced Insulin
   Secretion in Prediabetic Obese Rats
SO EXPERIMENTAL DIABETES RESEARCH
LA English
DT Article
ID SYMPATHETIC-NERVOUS-SYSTEM; MONOSODIUM-L-GLUTAMATE; ADRENAL CHROMAFFIN
   CELLS; REDUCED NOREPINEPHRINE TURNOVER; BROWN ADIPOSE-TISSUE;
   MSG-TREATED-RATS; PROTEIN-KINASE-C; ENERGY HOMEOSTASIS;
   PANCREATIC-ISLETS; BETA-CELL
AB The involvement of sympathoadrenal axis activity in obesity onset was investigated using the experimental model of treating neonatal rats with monosodium L-glutamate. To access general sympathetic nervous system activity, we recorded the firing rates of sympathetic superior cervical ganglion nerves in animals. Catecholamine content and secretion from isolated adrenal medulla were measured. Intravenous glucose tolerance test was performed, and isolated pancreatic islets were stimulated with glucose and adrenergic agonists. The nerve firing rate of obese rats was decreased compared to the rate for lean rats. Basal catecholamine secretion decreased whereas catecholamine secretion induced by carbachol, elevated extracellular potassium, and caffeine in the isolated adrenal medulla were all increased in obese rats compared to control. Both glucose intolerance and hyperinsulinaemia were observed in obese rats. Adrenaline strongly inhibited glucose-induced insulin secretion in obese animals. These findings suggest that low sympathoadrenal activity contributes to impaired glycaemic control in prediabetic obese rats.
C1 [Andreazzi, Ana Eliza] Univ Fed Juiz de Fora, Dept Physiol, Physiol Lab, BR-36036900 Juiz De Fora, MG, Brazil.
   [Grassiolli, Sabrina; Marangon, Paula Beatriz; Martins, Adriana Gallego; de Oliveira, Julio Cezar; Torrezan, Rosana; Gravena, Clarice; de Freitas Mathias, Paulo Cezar] Univ Estadual Maringa, Dept Cell Biol & Genet, Lab Secret Cell Biol, BR-87020900 Maringa, Parana, Brazil.
   [Gonzalez Garcia, Raul Marcel] Univ Fed Juiz de Fora, Dept Biol, Cell Biol Lab, BR-36036900 Juiz De Fora, MG, Brazil.
C3 Universidade Federal de Juiz de Fora; Universidade Estadual de Maringa;
   Universidade Federal de Juiz de Fora
RP Andreazzi, AE (corresponding author), Univ Fed Juiz de Fora, Dept Physiol, Physiol Lab, BR-36036900 Juiz De Fora, MG, Brazil.
EM anaeliza.andreazzi@ufjf.edu.br
RI DE FREITAS MATHIAS, PAULO/AAQ-9682-2021; de Oliveira, Júlio/G-8527-2012;
   Grassiolli, Sabrina/AAP-5934-2020
OI de Freitas Mathias, Paulo Cezar/0000-0001-6994-4585; de Oliveira,
   Julio/0000-0002-6489-9348; Grassiolli, Sabrina/0000-0001-5647-7877
FU Brazilian Science Foundation CNPq; Brazilian Science Foundation CAPES;
   Brazilian Science Foundation Fundacao Araucaria
FX This research was supported by the Brazilian Science Foundations CNPq,
   CAPES, and Fundacao Araucaria.
CR Abizaid A, 2008, REGUL PEPTIDES, V149, P3, DOI 10.1016/j.regpep.2007.10.006
   AKAIKE A, 1993, JPN J PHARMACOL, V61, P145, DOI 10.1254/jjp.61.145
   ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P7713, DOI 10.1073/pnas.81.24.7713
   Andreazzi AE, 2009, J ENDOCRINOL, V201, P351, DOI 10.1677/JOE-08-0312
   ASTRUP A, 1995, INT J OBESITY, V19, pS24
   Balbo SL, 2007, ENDOCRINE, V31, P142, DOI 10.1007/s12020-007-0021-z
   Balbo SL, 2000, RES COMMUN MOL PATH, V108, P291
   BERNARDIS LL, 1968, J ENDOCRINOL, V40, P527, DOI 10.1677/joe.0.0400527
   Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRAY GA, 1991, J NUTR, V121, P1146, DOI 10.1093/jn/121.8.1146
   Bray GA., 1989, VITAM HORM, V45, P1
   BUNYAN J, 1976, BRIT J NUTR, V35, P25, DOI 10.1079/BJN19760005
   Campbell RK, 2009, J AM PHARM ASSOC, V49, pS10, DOI 10.1331/JAPhA.2009.09076
   CAWTHORN EG, 1991, MOL CELL ENDOCRINOL, V75, P197, DOI 10.1016/0303-7207(91)90161-K
   Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46
   Cruciani-Guglielmacci C, 2005, AM J PHYSIOL-ENDOC M, V288, pE148, DOI 10.1152/ajpendo.00225.2004
   Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024
   Davy KP, 2004, AM J PHYSIOL-REG I, V286, pR803, DOI 10.1152/ajpregu.00707.2003
   de Andrade IS, 2006, NEUROSCI LETT, V398, P6, DOI 10.1016/j.neulet.2005.12.043
   De Flines J, 2010, ACTA GASTRO-ENT BELG, V73, P261
   Díaz-Flores L, 2008, ACTA PHYSIOL, V192, P145, DOI 10.1111/j.1748-1716.2007.01811.x
   Dolnikoff M, 2001, INT J OBESITY, V25, P426, DOI 10.1038/sj.ijo.0801517
   Gao Q, 2008, FEBS LETT, V582, P132, DOI 10.1016/j.febslet.2007.11.063
   Grassiolli S, 2007, EUR J PHARMACOL, V556, P223, DOI 10.1016/j.ejphar.2006.11.022
   Grassiolli S, 2006, ENDOCRINE, V30, P191, DOI 10.1385/ENDO:30:2:191
   HERMANS MP, 1987, ENDOCRINOLOGY, V120, P1765, DOI 10.1210/endo-120-5-1765
   Hirata AE, 1997, BRAZ J MED BIOL RES, V30, P671, DOI 10.1590/S0100-879X1997000500016
   Jeanrenaud B, 1986, Int J Vitam Nutr Res Suppl, V29, P41
   Jocken JWE, 2008, PHYSIOL BEHAV, V94, P219, DOI 10.1016/j.physbeh.2008.01.002
   Kalra SP, 2010, PROG BRAIN RES, V181, P17, DOI 10.1016/S0079-6123(08)81002-3
   KELNER KL, 1985, NEUROCHEM INT, V7, P373, DOI 10.1016/0197-0186(85)90128-7
   Kim YW, 1999, J KOREAN MED SCI, V14, P539, DOI 10.3346/jkms.1999.14.5.539
   KRSTULOVIC AM, 1982, J CHROMATOGR, V229, P1, DOI 10.1016/S0378-4347(00)86033-8
   Kumer SC, 1996, J NEUROCHEM, V67, P443
   Lee M, 2009, PITUITARY, V12, P87, DOI 10.1007/s11102-008-0096-4
   LEIGH FSM, 1992, INT J OBESITY, V16, P597
   Leon-Quinto T, 1998, ENDOCRINOLOGY, V139, P3382, DOI 10.1210/en.139.8.3382
   LEVIN BE, 1995, AM J PHYSIOL-REG I, V268, pR389, DOI 10.1152/ajpregu.1995.268.2.R389
   Macho L, 2000, PHYSIOL RES, V49, pS79
   MAITER D, 1991, ENDOCRINOLOGY, V128, P1100
   Marçal AC, 2006, ENDOCRINE, V29, P445, DOI 10.1385/ENDO:29:3:445
   Martins ACP, 2004, LIFE SCI, V74, P3211, DOI 10.1016/j.lfs.2003.10.034
   Martins ACP, 2001, NEUROSCI RES COMMUN, V28, P49, DOI 10.1002/1520-6769(200101/02)28:1<49::AID-NRC6>3.0.CO;2-L
   Mitrani P, 2007, AM J PHYSIOL-ENDOC M, V292, pE1364, DOI 10.1152/ajpendo.00672.2006
   Nolan CJ, 2006, DIABETOLOGIA, V49, P2120, DOI 10.1007/s00125-006-0305-5
   Obici S, 2009, ENDOCRINOLOGY, V150, P2512, DOI 10.1210/en.2009-0409
   OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719
   Ravussin E, 1996, P NUTR SOC, V55, P793, DOI 10.1079/PNS19960079
   Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155
   SAAD MF, 1991, AM J PHYSIOL, V261, pE789, DOI 10.1152/ajpendo.1991.261.6.E789
   Sala F, 2008, ACTA PHYSIOL, V192, P203, DOI 10.1111/j.1748-1716.2007.01804.x
   Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260
   Scomparin DX, 2006, LIFE SCI, V79, P2151, DOI 10.1016/j.lfs.2006.07.012
   SCOTT AM, 1981, DIABETOLOGIA, V21, P470
   Sieg A, 2004, AM J PHYSIOL-ENDOC M, V286, pE463, DOI 10.1152/ajpendo.00365.2003
   Silva JE, 2008, THYROID, V18, P157, DOI 10.1089/thy.2007.0252
   TASSAVA TM, 1992, AM J PHYSIOL, V262, pE338, DOI 10.1152/ajpendo.1992.262.3.E338
   Teff KL, 2008, JPEN-PARENTER ENTER, V32, P569, DOI 10.1177/0148607108321705
   Tentolouris N, 2008, NEUROMOL MED, V10, P169, DOI 10.1007/s12017-008-8022-5
   Thirone ACP, 2004, ENDOCRINOLOGY, V145, P281, DOI 10.1210/en.2003-0575
   Vernochet C, 2009, FEBS J, V276, P5729, DOI 10.1111/j.1742-4658.2009.07302.x
   Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6
   YOSHIDA T, 1990, J NUTR SCI VITAMINOL, V36, P123, DOI 10.3177/jnsv.36.123
   YOSHIDA T, 1985, LIFE SCI, V36, P931, DOI 10.1016/0024-3205(85)90388-1
   YOSHIMATSU H, 1993, BRAIN RES, V601, P121, DOI 10.1016/0006-8993(93)91702-T
   Young JB, 2006, INT J OBESITY, V30, pS41, DOI 10.1038/sj.ijo.0803518
   YOUNG JB, 1992, INT J OBESITY, V16, P959
   Young JB, 2002, TRENDS ENDOCRIN MET, V13, P381, DOI 10.1016/S1043-2760(02)00661-6
   YOUNG JB, 1983, AM J PHYSIOL, V245, pE148, DOI 10.1152/ajpendo.1983.245.2.E148
NR 70
TC 16
Z9 17
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-5214
EI 1687-5303
J9 EXP DIABETES RES
JI Exp. Diabetes Res.
PY 2011
AR 947917
DI 10.1155/2011/947917
PG 11
WC Endocrinology & Metabolism; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA 830DY
UT WOS:000295638800001
PM 21860615
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Bajerska, J
   Mildner-Szkudlarz, S
   Walkowiak, J
AF Bajerska, Joanna
   Mildner-Szkudlarz, Sylwia
   Walkowiak, Jaroslaw
TI Effects of Rye Bread Enriched with Green Tea Extract on Weight
   Maintenance and the Characteristics of Metabolic Syndrome Following
   Weight Loss: A Pilot Study
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE metabolic syndrome; rye bread; functional foods; body-weight
   maintenance; green tea extract
ID BLOOD-PRESSURE; CAFFEINE INTAKE; POLYPHENOLS; CONSUMPTION; GUIDELINES;
   MANAGEMENT; ABSORPTION; CATECHINS; CONSUMER
AB We examined whether the incorporation of green tea extract enriched rye bread (GTRB) into the diet can improve weight loss (WL) maintenance and control of abnormalities linked to metabolic syndrome (MS). A total of 55 obese men and women (mean age: 53.0 +/- 7.0 years, body mass index: 35.0 +/- 5.5 kg m(-2)) were recruited. The study had a single-blind randomized study design and consisted of an 8-week WL phase with low-energy calorie diet, followed by a 12-week weight maintenance (WM) phase. During the WM phase, the subjects were randomized into two groups, receiving either the control rye bread (control group) or the GTRB (intervention group). The ingestion of 280 and 360 g GTRB provided daily totals of 123.2 and 158.4 mg caffeine, and 188.3 and 242.1 mg of epigallocatechin gallate, for women and men, respectively. After the WL phase, subjects lost 7.3 +/- 3.1 kg of their baseline body weight. GTRB intake did not significantly influence the maintenance of WL, high-density lipoprotein-cholesterol, triglycerides, and glucose concentrations. Although, it resulted in significant differences (mean difference [95% confidence interval]) between the treatment groups in the maintenance of waist circumference (-1.22 cm [-2.4, -0.02; P=.04]), the results were not clinically meaningful. Nevertheless, the ingestion of GTRB led to the maintenance of lower blood pressure (BP), also the proportion of subjects fulfilling the criteria of MS after the WM phase was lower in the intervention group than in the control group. Although GTRB consumption did not improve significantly the WL maintenance, it resulted in a better control of BP.
C1 [Bajerska, Joanna; Walkowiak, Jaroslaw] Poznan Univ Life Sci, Fac Food Sci & Nutr, Dept Human Nutr & Hyg, PL-60624 Poznan, Poland.
   [Mildner-Szkudlarz, Sylwia] Poznan Univ Life Sci, Inst Food Technol Plant Origin, PL-60624 Poznan, Poland.
   [Walkowiak, Jaroslaw] Pozna Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, Poznan, Poland.
C3 Poznan University of Life Sciences; Poznan University of Life Sciences
RP Bajerska, J (corresponding author), Poznan Univ Life Sci, Fac Food Sci & Nutr, Dept Human Nutr & Hyg, Wojska Polskiego 31, PL-60624 Poznan, Poland.
EM joanna.bajerska@up.poznan.pl
OI Mildner-Szkudlarz, Sylwia/0000-0002-6319-5285; Walkowiak,
   Jaroslaw/0000-0001-5813-5707; Bajerska, Joanna/0000-0002-2268-9326
FU Polish Ministry of Sciences and Higher Education [NN312331635]
FX This work was supported by a grant from the Polish Ministry of Sciences
   and Higher Education (NN312331635).
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Alldrick AJ, BAKERY POTENTIAL LEA
   Bajerska J, 2010, J FOOD NUTR RES-SLOV, V49, P104
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Fogelholm M, 2000, ARCH INTERN MED, V160, P2177, DOI 10.1001/archinte.160.14.2177
   Harsha DW, 2008, HYPERTENSION, V51, P1420, DOI 10.1161/HYPERTENSIONAHA.107.094011
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kunachowicz H, 2010, PRINCIPLES HUMAN NUT
   LUKASKI HC, 1985, AM J CLIN NUTR, V41, P810, DOI 10.1093/ajcn/41.4.810
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   Nakagawa K, 2009, BIOSCI BIOTECH BIOCH, V73, P2014, DOI 10.1271/bbb.90195
   Ogden Cynthia L, 2012, NCHS Data Brief, P1
   Phelan S, 2003, AM J CLIN NUTR, V78, P1079, DOI 10.1093/ajcn/78.6.1079
   Sacks DB, 2002, CLIN CHEM, V48, P436, DOI 10.2337/dc11-9998
   Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731
   Schramm DD, 2003, LIFE SCI, V73, P857, DOI 10.1016/S0024-3205(03)00373-4
   Siró I, 2008, APPETITE, V51, P456, DOI 10.1016/j.appet.2008.05.060
   STENSVOLD I, 1992, PREV MED, V21, P546, DOI 10.1016/0091-7435(92)90062-M
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   Szponar L, 2000, PHOTOGRAPHIC ALBUM F
   Wang R, 2004, J AGR FOOD CHEM, V52, P8224, DOI 10.1021/jf048655x
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323
   Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534
   Yoto A, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-28
NR 32
TC 24
Z9 25
U1 0
U2 45
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD JUN 1
PY 2015
VL 18
IS 6
BP 698
EP 705
DI 10.1089/jmf.2014.0032
PG 8
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA CQ3VI
UT WOS:000360531500012
PM 25494205
DA 2025-04-28
ER

PT J
AU Sheehy, T
   Kolandooz, F
   Roache, C
   Sharma, S
AF Sheehy, Tony
   Kolandooz, Fariba
   Roache, Cindy
   Sharma, Sangita
TI Changing dietary patterns in the Canadian Arctic: Frequency of
   consumption of foods and beverages by Inuit in three Nunavut communities
SO FOOD AND NUTRITION BULLETIN
LA English
DT Article
DE Food and beverage consumption; food frequency; Inuit; Nunavut
ID IMPAIRED GLUCOSE-TOLERANCE; NUTRITION TRANSITION; LIFE-STYLE;
   SOCIOECONOMIC INDICATORS; INTERVENTION PROGRAM; POPULATION; OBESITY;
   INUVIALUIT; HEALTH; ADULTS
AB Background. Inuit in Arctic regions are experiencing a rapid diet and lifestyle transition. There are limited data on food consumption patterns among this unique population, raising concerns about assessing the risk for the development of diet-related chronic diseases. Objective. To assess the current frequency of consumption of foods and beverages among Inuit in Nunavut, Arctic Canada.
   Methods. A cross-sectional dietary study was conducted among randomly selected Inuit adults from three communities in Nunavut using a validated quantitative food frequency questionnaire. The participants were 175 women and 36 men with median (IQR) ages of 41.0(32.5-48.5) and 40.1 (30.0-50.0) years, respectively. The mean and median frequencies of consumption over a 30-day period were computed for 147 individual food items and grouped as foods or beverages.
   Results. The 30 most frequently consumed foods were identified. Non-nutrient-dense foods (i.e., high-fat and high-sugar foods) were the most frequently consumed food group (median intake, 3.4 times/day), followed by grains (2.0 times/day) and traditional meats (1.7 times/day). The frequency of consumption of fruits (0.7 times/day) and vegetables (0.4 times/day) was low The median values for the three most frequently consumed food items were sugar or honey (once/day), butter (0.71 times/day), and Coffee-mate (0.71 times/day). Apart from water, coffee, and tea, the most frequently consumed beverages were sweetened juices (0.71 times/day) and regular pop (soft drinks) (0.36 times/day).This study showed that non-nutrient-dense foods are consumed most frequently in these Inuit communities.
   Conclusions. The results have implications for dietary quality and provide useful information on current dietary practices to guide nutritional intervention programs.
C1 [Sheehy, Tony] Natl Univ Ireland Univ Coll Cork, Cork, Ireland.
   [Kolandooz, Fariba; Roache, Cindy; Sharma, Sangita] Univ Alberta, Dept Med, Fac Med & Dent, Aboriginal & Global Hlth Res Grp, Edmonton, AB T6G 2T4, Canada.
C3 University College Cork; University of Alberta
RP Sharma, S (corresponding author), Univ Alberta, Dept Med, Fac Med & Dent, Aboriginal & Global Hlth Res Grp, Unit 5-10 Univ Terrace,8303 112 St, Edmonton, AB T6G 2T4, Canada.
EM gita.sharma@ualberta.ca
OI Sharma, Sangita/0000-0002-4995-0010
FU American Diabetes Association Clinical Research award [1-08-CR-57];
   Department of Health and Social Services (HSS) of the Government of
   Nunavut; Health Canada; Health Canada through the Aboriginal Diabetes
   Initiative and First Nations; Inuit Health Branch
FX The study was supported by an American Diabetes Association Clinical
   Research award (1-08-CR-57), the Department of Health and Social
   Services (HSS) of the Government of Nunavut, and Health Canada.
   Additional funds were contributed by Health Canada through the
   Aboriginal Diabetes Initiative and First Nations and Inuit Health
   Branch. We would like to acknowledge Mr. James Howard, Ms. Nora
   Niptanatiak, Ms. Julia Ogina, Ms. Rhonda Reid, and the communities for
   their incredible assistance, support, and participation. We also want to
   recognize the invaluable help we received from Ms. Rahabi Kamookak and
   Ms. Annie Buchan.
CR Blanchet C, 2000, CAN J DIET PRACT RES, V61, P50
   CHATEAUDEGAT ML, 2010, CAN J CARDIOL, V26, P190, DOI DOI 10.1016/S0828-282X(10)70398-6
   Deering KN, 2009, CAN J PUBLIC HEALTH, V100, P14, DOI 10.1007/BF03405485
   Drewnowski A., 2010, Fat Detection: Taste, Texture, and Post Ingestive Effects, P265
   Ebbesson SOK, 1998, DIABETES CARE, V21, P563, DOI 10.2337/diacare.21.4.563
   Egeland GM, 2011, J NUTR, V141, P1746, DOI 10.3945/jn.111.139006
   Erber E, 2010, J HUM NUTR DIET, V23, P35, DOI 10.1111/j.1365-277X.2010.01098.x
   Erber E, 2010, J HUM NUTR DIET, V23, P59, DOI 10.1111/j.1365-277X.2010.01097.x
   Friborg JT, 2008, LANCET ONCOL, V9, P892, DOI 10.1016/S1470-2045(08)70231-6
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Healey GK, 2007, INT J CIRCUMPOL HEAL, V66, P199, DOI 10.3402/ijch.v66i3.18256
   Health Canada, DIS HLTH COND
   Hopping BN, 2010, J HUM NUTR DIET, V23, P51, DOI 10.1111/j.1365-277X.2010.01100.x
   Hopping BN, 2010, J HUM NUTR DIET, V23, P27, DOI 10.1111/j.1365-277X.2010.01099.x
   Huet C, 2012, J NUTR, V142, P541, DOI 10.3945/jn.111.149278
   Jorgensen ME, 2002, DIABETES CARE, V25, P1766, DOI 10.2337/diacare.25.10.1766
   Kuhnlein HV, 2004, J NUTR, V134, P1447, DOI 10.1093/jn/134.6.1447
   LARDINOIS CK, 1987, MED HYPOTHESES, V24, P243, DOI 10.1016/0306-9877(87)90071-5
   McLaughlin J, 2005, ATHEROSCLEROSIS, V181, P353, DOI 10.1016/j.atherosclerosis.2005.01.019
   Mead E, 2010, J HUM NUTR DIET, V23, P18, DOI 10.1111/j.1365-277X.2010.01102.x
   Mendoza JA, 2007, DIABETES CARE, V30, P974, DOI 10.2337/dc06-2188
   Pakseresht M, 2010, J HUM NUTR DIET, V23, P67, DOI 10.1111/j.1365-277X.2010.01104.x
   Popkin BM, 2011, P NUTR SOC, V70, P82, DOI 10.1017/S0029665110003903
   Sharma S, 2010, J HUM NUTR DIET, V23, P120, DOI 10.1111/j.1365-277X.2010.01107.x
   Sharma S, 2010, J HUM NUTR DIET, V23, P5, DOI 10.1111/j.1365-277X.2010.01093.x
   Sharma S, 2010, BRIT J NUTR, V103, P749, DOI 10.1017/S0007114509992224
   Sheikh N, 2011, INT J CIRCUMPOL HEAL, V70, P511, DOI 10.3402/ijch.v70i5.17863
   *STAT CAN, 2006, COMM PROF 2006 CENS
   Statistics Canada, 2012, HLTH IND PROF AG STA
   Statistics Canada, AG SEX STRUCT CAN PR
   Statistics Canada, TABLE 103 0553 NEW C
   Varela-Moreiras G, 2006, INT J VITAM NUTR RES, V76, P262, DOI 10.1024/0300-9831.76.4.262
   Young TK, 2007, AM J PUBLIC HEALTH, V97, P691, DOI 10.2105/AJPH.2005.080614
   Zienczuk N, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-73
NR 34
TC 3
Z9 3
U1 0
U2 28
PU INT NUTRITION FOUNDATION
PI BOSTON
PA 150 HARRISON AVE, BOSTON, MA 02111 USA
SN 0379-5721
EI 1564-8265
J9 FOOD NUTR BULL
JI Food Nutr. Bull.
PD JUN
PY 2014
VL 35
IS 2
BP 244
EP 252
DI 10.1177/156482651403500211
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Food Science & Technology; Nutrition & Dietetics
GA CA7YU
UT WOS:000349134500011
PM 25076772
OA Bronze
DA 2025-04-28
ER

PT J
AU Seliske, L
   Pickett, W
   Rosu, A
   Janssen, I
AF Seliske, Laura
   Pickett, William
   Rosu, Andrei
   Janssen, Ian
TI The number and type of food retailers surrounding schools and their
   association with lunchtime eating behaviours in students
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE Eating behaviours; Youth; Food retail environment; Schools
ID DIETARY BEHAVIORS; PHYSICAL-ACTIVITY; NUTRIENT INTAKE; US CHILDREN;
   ADOLESCENTS; OBESITY; ENVIRONMENTS; CONSUMPTION; RESTAURANTS; OVERWEIGHT
AB Background: The primary study objective was to examine whether the presence of food retailers surrounding schools was associated with students' lunchtime eating behaviours. The secondary objective was to determine whether measures of the food retail environment around schools captured using road network or circular buffers were more strongly related to eating behaviours while at school.
   Methods: Grade 9 and 10 students (N=6,971) who participated in the 2009/10 Canadian Health Behaviour in School Aged Children Survey were included in this study. The outcome was determined by students' self-reports of where they typically ate their lunch during school days. Circular and road network-based buffers were created for a 1 km distance surrounding 158 schools participating in the HBSC. The addresses of fast food restaurants, convenience stores and coffee/donut shops were mapped within the buffers. Multilevel logistic regression was used to determine whether there was a relationship between the presence of food retailers near schools and students regularly eating their lunch at a fast food restaurant, snack-bar or cafe. The Akaike Information Criteria (AIC) value, a measure of goodness-of-fit, was used to determine the optimal buffer type.
   Results: For the 1 km circular buffers, students with 1-2 (OR=1.10, 95% CI: 0.57-2.11), 3-4 (OR=1.45, 95% CI: 0.75-2.82) and >= 5 nearby food retailers (OR=2.94, 95% CI: 1.71-5.09) were more likely to eat lunch at a food retailer compared to students with no nearby food retailers. The relationships were slightly stronger when assessed via 1 km road network buffers, with a greater likelihood of eating at a food retailer for 1-2 (OR=1.20, 95% CI: 0.74-1.95), 3-4 (OR=3.19, 95% CI: 1.66-6.13) and >= 5 nearby food retailers (OR=3.54, 95% CI: 2.08-6.02). Road network buffers appeared to provide a better measure of the food retail environment, as indicated by a lower AIC value (3332 vs. 3346).
   Conclusions: There was a strong relationship between the presence of food retailers near schools and students' lunchtime eating behaviours. Results from the goodness of fit analysis suggests that road network buffers provide a more optimal measure of school neighbourhood food environments relative to circular buffers.
C1 [Seliske, Laura; Pickett, William; Janssen, Ian] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON K7L 3N6, Canada.
   [Pickett, William] Kingston Gen Hosp, Dept Emergency Med, Kingston, ON K7L 2V7, Canada.
   [Rosu, Andrei; Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON K7L 3N6, Canada.
C3 Queens University - Canada; Queens University - Canada; Queens
   University Hospital; Queens University - Canada
RP Janssen, I (corresponding author), Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON K7L 3N6, Canada.
EM ian.janssen@queensu.ca
RI Janssen, Ian/B-7700-2009
OI Janssen, Ian/0000-0003-2159-3012
FU Public Health Agency of Canada; Canadian Institutes of Health Research
   [MOP 97962]; Health Canada; Heart and Stroke Foundation of Canada [PCR
   101415]; Frederick Banting and Charles Best Doctoral Research Award from
   the Canadian Institutes of Health Research; Canada Research Chair;
   Ontario Ministry of Research and Innovation
FX The authors of this study would like to thank Mariane Heroux, Rachel
   Laxer and Hoda Gharib for their assistance in the collection of the food
   retailer addresses. The 2009/10 Health Behaviour in School-aged Children
   Survey (HBSC), a World Health Organization/European Region collaborative
   study, was funded in Canada by the Public Health Agency of Canada and
   Health Canada. This study was funded by an operating grant from the
   Canadian Institutes of Health Research (MOP 97962), and a second
   operating grant co-funded by the Canadian Institutes of Health Research
   and the Heart and Stroke Foundation of Canada (PCR 101415). In addition,
   Laura Seliske was supported by a Frederick Banting and Charles Best
   Doctoral Research Award from the Canadian Institutes of Health Research.
   Ian Janssen was supported by a Canada Research Chair and an investigator
   award from the Ontario Ministry of Research and Innovation. The
   principal investigators of the 2009/10 Canadian HBSC were John Freeman
   and William Pickett, and the HBSC is coordinated internationally by
   Candace Currie (University of Edinburgh).
CR Alter DA, 2005, CAN J PUBLIC HEALTH, V96, P173, DOI 10.1007/BF03403684
   Anderson D. R., 2002, MODEL SELECTION MULT
   Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341
   Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94
   Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112
   Bradlee ML, 2010, PUBLIC HEALTH NUTR, V13, P797, DOI 10.1017/S1368980009991546
   Briefel RR, 2009, J AM DIET ASSOC, V109, pS91, DOI 10.1016/j.jada.2008.10.059
   Campbell K, 2002, ASIA PAC J CLIN NUTR, V11, pS553, DOI 10.1046/j.0964-7058.2002.00346.x
   Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
   Crawford DA, 2008, INT J PEDIATR OBES, V3, P249, DOI 10.1080/17477160802113225
   Currie C., 2010, Health Behav. School-aged Child. (HBSC) Study: Intern. Report
   Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024
   Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638
   Day PL, 2011, AM J PREV MED, V40, P113, DOI 10.1016/j.amepre.2010.10.018
   French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820
   Gordis L., 2004, EPIDEMIOLOGY, V3rd
   Holt EM, 2009, J AM DIET ASSOC, V109, P414, DOI 10.1016/j.jada.2008.11.036
   Kubik MY, 2003, AM J PUBLIC HEALTH, V93, P1168, DOI 10.2105/AJPH.93.7.1168
   Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1757, DOI 10.1017/S1368980010001564
   Leatherdale ST, 2011, INT J PUBLIC HEALTH, V56, P237, DOI 10.1007/s00038-010-0206-8
   Lindquist CH, 2000, AM J CLIN NUTR, V71, P725, DOI 10.1093/ajcn/71.3.725
   McNaughton SA, 2008, J NUTR, V138, P364, DOI 10.1093/jn/138.2.364
   Motulsky H., 2003, Fitting Models to Biological Data Using Linear and Non-linear Regression: A Practical Guide to Curve Fitting, DOI [10.5206/mase/10847, DOI 10.1007/BF02441170]
   Oliver LN, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-41
   Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1
   Park S, 2010, J AM DIET ASSOC, V110, P1532, DOI 10.1016/j.jada.2010.07.003
   Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0
   Piernas C, 2010, HEALTH AFFAIR, V29, P398, DOI 10.1377/hlthaff.2009.0666
   Pikora TJ, 2002, AM J PREV MED, V23, P187, DOI 10.1016/S0749-3797(02)00498-1
   Seliske L, 2012, INT J ENV RES PUB HE, V9, P2601, DOI 10.3390/ijerph9082601
   Sturm R, 2009, HEALTH AFFAIR, V28, pW1088, DOI 10.1377/hlthaff.28.6.w1088
   Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732
   Technomic, 2010, TECHN TOP 200 CAN CH
   van der Horst K, 2008, AM J PREV MED, V35, P217, DOI 10.1016/j.amepre.2008.05.022
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Wrigley N, 2003, ENVIRON PLANN A, V35, P151, DOI 10.1068/a35150
NR 36
TC 38
Z9 45
U1 0
U2 33
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5868
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD FEB 7
PY 2013
VL 10
AR 19
DI 10.1186/1479-5868-10-19
PG 9
WC Nutrition & Dietetics; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics; Physiology
GA 096EI
UT WOS:000315386600001
PM 23391296
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Leverrier, A
   Daguet, D
   Calame, W
   Dhoye, P
   Kodimule, SP
AF Leverrier, Aurelie
   Daguet, David
   Calame, Wim
   Dhoye, Pierre
   Kodimule, Shyam Prasad
TI Helianthus annuus Seed Extract Affects Weight and Body Composition of
   Healthy Obese Adults during 12 Weeks of Consumption: A Randomized,
   Double-Blind, Placebo-Controlled Pilot Study
SO NUTRIENTS
LA English
DT Article
DE sunflower seeds; chlorogenic acids; weight loss; BMI reduction; fat mass
   reduction; cholesterol
ID GREEN COFFEE EXTRACT
AB The aim of this pilot study was to evaluate the effects of a sunflower (Helianthus annuus) seed extract, standardized for 40% chlorogenic acids on weight and body composition of obese adults. Fifty subjects were randomly assigned to sunflower extract or isocaloric placebo groups, receiving respectively 500 mg/day of treatment for 12 weeks. At the end of the intervention, a significant decrease in body weight, Body Mass Index (BMI), and waist circumference was observed, especially for obese female subjects above 30 years. Those changes were associated with modified body composition related to fat mass loss. A decrease in blood cholesterol was also observed, supporting the potential action of sunflower extract on lipid metabolism. It was concluded that consumption of sunflower extract has a beneficial effect on body weight, fat mass, and lipid profile, providing evidence for its use as a natural anti-obesity herbal extract.
C1 [Leverrier, Aurelie; Daguet, David; Dhoye, Pierre; Kodimule, Shyam Prasad] Vidya Europe SAS, 7 Ave Norvege, F-91140 Villebon Sur Yvette, France.
   [Calame, Wim] StatistiCal BV, Strandwal 148, NL-2241 MN Wassenaar, Netherlands.
   [Kodimule, Shyam Prasad] Vidya Herbs Pvt Ltd, R&D Ctr Excellence, 14A Jigani 1 Phase, Bangalore 560105, Karnataka, India.
RP Daguet, D (corresponding author), Vidya Europe SAS, 7 Ave Norvege, F-91140 Villebon Sur Yvette, France.
EM aurelie@vidyaeurope.eu; david@vidyaeurope.eu; w.calame@kpnplanet.nl;
   pierre@vidyaeurope.eu; shyamprasad@vidyaherbs.com
RI Daguet, David/AAJ-2110-2020
FU Vidya Herbs (P) Ltd, India
FX This research was funded by Vidya Herbs (P) Ltd, India.
CR [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Aqeel Z., 2012, CHLOROGENIC ACIDS GR
   Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379
   Castelli WP, 1996, ATHEROSCLEROSIS, V124, pS1, DOI 10.1016/0021-9150(96)05851-0
   Daneschvar HL, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.009
   Dellalibera O., 2006, Phytotherapie (Paris), V4, P194, DOI 10.1007/s10298-006-0181-7
   EMA (Eur. Med. Agency), 2016, Guideline on clinical evaluation of medicinal products used in weight management
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Gouthamchandra K, 2017, FOOD SCI HUM WELL, V6, P147, DOI 10.1016/j.fshw.2017.06.001
   Guo SS, 2017, CHEM CENT J, V11, DOI 10.1186/s13065-017-0328-7
   Kakkar AK, 2015, EUR J INTERN MED, V26, P89, DOI 10.1016/j.ejim.2015.01.005
   Mahnaz Kazemipoor Mahnaz Kazemipoor, 2012, International Journal of Chemical Engineering and Applications, V3, P288
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Pi-Sunyer X, 2009, POSTGRAD MED, V121, P21, DOI 10.3810/pgm.2009.11.2074
   Saini S., 2013, INT J PHARM PHARM SC, V5, P382
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Weisz GM, 2009, FOOD CHEM, V115, P758, DOI 10.1016/j.foodchem.2008.12.074
   World Health Organization, Obesity and overweight
   Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011
NR 20
TC 13
Z9 13
U1 1
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAY
PY 2019
VL 11
IS 5
AR 1080
DI 10.3390/nu11051080
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IC5PY
UT WOS:000471021600140
PM 31096648
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Sofianou, A
   Fung, TT
   Tucker, KL
AF Sofianou, Anastasia
   Fung, Teresa T.
   Tucker, Katherine L.
TI Differences in Diet Pattern Adherence by Nativity and Duration of US
   Residence in the Mexican-American Population
SO JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
LA English
DT Article
ID FOOD-FREQUENCY QUESTIONNAIRE; CARDIOVASCULAR-DISEASE RISK;
   UNITED-STATES; EATING PATTERNS; OLDER-ADULTS; WOMEN; ASSOCIATION;
   OBESITY; HABITS; HEALTH
AB Literature on the diet of the Mexican-American population suggests that food consumption differs by nativity and duration of residence in the United States. However, no studies have used dietary pattern analysis to investigate these differences. To create dietary patterns, we used principal components analysis on food frequency questionnaire data for all adult respondents of the National Health and Nutrition Examination Survey years 2003-2006. Four dietary patterns were identified: Western, Healthy, Tomato/Tortilla, and Coffee/Sugar. Least squares means regression was used to test differences in adjusted mean dietary adherence scores among Mexico-born Mexican-American adults residing in the United States for <15 years (n=302), Mexico-born Mexican-American adults residing in the United States for a 15 years (n=234), US-born Mexican-American adults (n= 509), and US-born non-Hispanic whites (n=2,530) aged 18 to 69 years. Mean score for each diet pattern did not differ significantly by duration of US residence category in the Mexico-born Mexican-American population. However, in comparison to all Mexico-born Mexican Americans, US-born Mexican Americans had significantly lower score for the Tomato/Tortilla pattern, and significantly higher score for the Western pattern. Scores for the Healthy pattern were relatively low in all Mexican-American subgroups, indicating low adherence to the Healthy diet. However, Healthy diet scores of Mexico-born Mexican Americans among those aged :541 years appeared more similar to those of US-born non-Hispanic whites than US-born Mexican Americans. Education and policy action promoting healthy food access in Hispanic neighborhoods could help limit consumption of Western and Coffee/Sugar diet patterns and promote healthier choices in the Mexican-American population. J Am Diet Assoc. 2011;111:1563-1569.
C1 [Sofianou, Anastasia; Tucker, Katherine L.] Northeastern Univ, Dept Hlth Sci, Boston Puerto Rican Hlth Study, Boston, MA 02115 USA.
   [Fung, Teresa T.] Simmons Coll, Boston, MA 02115 USA.
   [Fung, Teresa T.] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA.
C3 Northeastern University; Simmons University; Harvard University; Harvard
   T.H. Chan School of Public Health
RP Tucker, KL (corresponding author), Northeastern Univ, Dept Hlth Sci, Boston Puerto Rican Hlth Study, 316 Robinson Hall,360 Huntington Aye, Boston, MA 02115 USA.
EM kl.tucker@neu.edu
RI Tucker, Katherine/A-4545-2010
OI Tucker, Katherine/0000-0001-7640-662X
CR [Anonymous], NATL HLTH NUTR SURVE
   [Anonymous], National Health and Nutrition Examination Survey (NHANES) 2005-2006
   Arsenault LN, 2009, AM J EPIDEMIOL, V170, P95, DOI 10.1093/aje/kwp089
   Bermúdez OI, 2000, J AM DIET ASSOC, V100, P665, DOI 10.1016/S0002-8223(00)00195-4
   Carrera PM, 2007, J AM DIET ASSOC, V107, P1735, DOI 10.1016/j.jada.2007.07.016
   CHAVEZ N, 1994, J NUTR EDUC, V26, P79
   Dixon LB, 2000, AM J EPIDEMIOL, V152, P548, DOI 10.1093/aje/152.6.548
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   GUENDELMAN S, 1995, AM J PUBLIC HEALTH, V85, P20, DOI 10.2105/AJPH.85.1.20
   Harley K, 2005, PAEDIATR PERINAT EP, V19, P125, DOI 10.1111/j.1365-3016.2005.00640.x
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   Hu FB, 2008, CIRCULATION, V118, P1913, DOI 10.1161/CIRCULATIONAHA.108.808493
   Jacques PF, 2001, AM J CLIN NUTR, V73, P1, DOI 10.1093/ajcn/73.1.1
   Johansson L, 1999, BRIT J NUTR, V81, P211, DOI 10.1017/S0007114599000409
   Kaiser L, 2009, J AM DIET ASSOC, V109, P1997, DOI 10.1016/j.jada.2009.09.007
   Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010
   Kerver JM, 2003, AM J CLIN NUTR, V78, P1103, DOI 10.1093/ajcn/78.6.1103
   Lallukka T, 2007, EUR J CLIN NUTR, V61, P701, DOI 10.1038/sj.ejcn.1602583
   Montez JK, 2008, J AM DIET ASSOC, V108, P473, DOI 10.1016/j.jada.2007.12.008
   Morland KB, 2009, HEALTH PLACE, V15, P491, DOI 10.1016/j.healthplace.2008.09.004
   Murtaugh MA, 2007, J AM DIET ASSOC, V107, P1311, DOI 10.1016/j.jada.2007.05.008
   Newby PK, 2006, J NUTR, V136, P2580, DOI 10.1093/jn/136.10.2580
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504
   Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008
   Schulze MB, 2006, OBESITY, V14, P1444, DOI 10.1038/oby.2006.164
   Slattery ML, 2008, AM J CLIN NUTR, V88, P14, DOI 10.1093/ajcn/88.1.14
   Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a
   Tucker KL, 2002, AM J CLIN NUTR, V76, P245, DOI 10.1093/ajcn/76.1.245
   Vlismas Konstantinos, 2009, Central European Journal of Public Health, V17, P55
   Willett W., 1990, NUTR EPIDEMIOLOGY, P396
NR 31
TC 42
Z9 56
U1 0
U2 3
PU AMER DIETETIC ASSOC
PI CHICAGO
PA 120 S RIVERSIDE PLZ, STE 2000, CHICAGO, IL 60606-6995 USA
SN 0002-8223
J9 J AM DIET ASSOC
JI J. Am. Diet. Assoc.
PD OCT
PY 2011
VL 111
IS 10
BP 1563
EP 1569
DI 10.1016/j.jada.2011.07.005
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 833TF
UT WOS:000295907100020
PM 21963024
DA 2025-04-28
ER

PT J
AU Wang, Y
   Nakagawa, Y
   Liu, L
   Wang, W
   Ren, X
   Anghel, A
   Lutfy, K
   Friedman, TC
   Liu, Y
AF Wang, Y.
   Nakagawa, Y.
   Liu, L.
   Wang, W.
   Ren, X.
   Anghel, A.
   Lutfy, K.
   Friedman, T. C.
   Liu, Y.
TI Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and
   glucose-6-phosphate transporter production in db/db mice as a model of
   type 2 diabetes
SO DIABETOLOGIA
LA English
DT Article
DE 11 beta-HSD1; G6PT; G6PT inhibitor; H6PDH; H6PDH siRNA; Insulin
   resistance; NADPH; Type 2 diabetes
ID BETA-HYDROXYSTEROID DEHYDROGENASE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE;
   GLUCOCORTICOID-RECEPTOR; ENDOPLASMIC-RETICULUM; INSULIN-RESISTANCE;
   ADIPOSE-TISSUE; OBESITY; HEPATOCYTES; EXPRESSION; HYPERGLYCEMIA
AB Tissue-specific amplification of glucocorticoid action through 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) affects the development of the metabolic syndrome. Hexose-6-phosphate dehydrogenase (H6PDH) mediates intracellular NADPH availability for 11 beta-HSD1 and depends on the glucose-6-phosphate transporter (G6PT). Little is known about the tissue-specific alterations of H6PDH and G6PT and their contributions to local glucocorticoid action in db/db mice.
   We characterised the role of H6PDH and G6PT in pre-receptor metabolism of glucocorticoids by examining the production of the hepatic 11 beta-HSD1-H6PDH-G6PT system in db/db mice.
   We observed that increased production of hepatic H6PDH in db/db mice was paralleled by upregulation of hepatic G6PT production and responded to elevated circulating levels of corticosterone. Treatment of db/db mice with the glucocorticoid antagonist RU486 markedly reduced production of both H6PDH and 11 beta-HSD1 and improved hyperglycaemia and insulin resistance. The reduction of H6PDH and 11 beta-HSD1 production by RU486 was accompanied by RU486-induced suppression of hepatic G6pt (also known as Slc37a4) mRNA. Incubation of mouse primary hepatocytes with corticosterone enhanced G6PT and H6PDH production with corresponding activation of 11 beta-HSD1 and PEPCK: effects that were blocked by RU486. Knockdown of H6pd by small interfering RNA showed effects comparable with those of RU486 for attenuating the corticosterone-induced H6PDH production and 11-HSD1 reductase activity in these intact cells. Addition of the G6PT inhibitor chlorogenic acid to primary hepatocytes suppressed H6PDH production.
   These findings suggest that increased hepatic H6PDH and G6PT production contribute to 11 beta-HSD1 upregulation of local glucocorticoid action that may be related to the development of type 2 diabetes.
C1 [Wang, Y.; Wang, W.; Ren, X.; Anghel, A.; Lutfy, K.; Friedman, T. C.; Liu, Y.] Univ Calif Los Angeles, Sch Med, Charles Drew Univ Med & Sci, Div Endocrinol Metab & Mol Med, Los Angeles, CA 90059 USA.
   [Nakagawa, Y.] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan.
   [Liu, L.] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai 200030, Peoples R China.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; Charles R. Drew University of Medicine & Science;
   Hamamatsu University School of Medicine; Shanghai Jiao Tong University
RP Liu, Y (corresponding author), Univ Calif Los Angeles, Sch Med, Charles Drew Univ Med & Sci, Div Endocrinol Metab & Mol Med, 1731 E 120th St, Los Angeles, CA 90059 USA.
EM dryanjunliu@hotmail.com
RI Lutfy, Kabirullah/H-9995-2019; Anghel, Adrian/M-6512-2019; Anghel,
   Adrian/C-1932-2013
OI Anghel, Adrian/0000-0002-4526-5913
FU NIH [KO1 DK073272, SC1DK087655, R01 DA14659, K21 DA00276]; 
   [S21MD000103-NIH/NCMHD]
FX Y. Liu is supported by NIH grants KO1 DK073272 and SC1DK087655. T. C.
   Friedman is supported by NIH grants R01 DA14659, K21 DA00276 and an
   endowment grant S21MD000103-NIH/NCMHD.
CR Alberts P, 2002, DIABETOLOGIA, V45, P1528, DOI 10.1007/s00125-002-0959-6
   Andrews RC, 2003, J CLIN ENDOCR METAB, V88, P285, DOI 10.1210/jc.2002-021194
   Atanasov AG, 2004, FEBS LETT, V571, P129, DOI 10.1016/j.febslet.2004.06.065
   Balachandran A, 2008, ENDOCRINOLOGY, V149, P4069, DOI 10.1210/en.2008-0088
   Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245
   Bánhegyi G, 2004, J BIOL CHEM, V279, P27017, DOI 10.1074/jbc.M404159200
   Belkaid A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-7
   Björntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6
   Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8
   Chou Janice Yang, 2002, Current Molecular Medicine (Hilversum), V2, P121, DOI 10.2174/1566524024605798
   Draper N, 2003, NAT GENET, V34, P434, DOI 10.1038/ng1214
   Friedman JE, 1997, J BIOL CHEM, V272, P31475, DOI 10.1074/jbc.272.50.31475
   Havel PJ, 1996, AM J PHYSIOL-REG I, V271, pR710, DOI 10.1152/ajpregu.1996.271.3.R710
   Hewitt KN, 2005, ENDOCRINOLOGY, V146, P2539, DOI 10.1210/en.2005-0117
   Hiraiwa H, 1999, J BIOL CHEM, V274, P5532, DOI 10.1074/jbc.274.9.5532
   Hiraiwa H, 2001, DNA CELL BIOL, V20, P447, DOI 10.1089/104454901316976073
   Hsu CL, 2006, J AGR FOOD CHEM, V54, P4191, DOI 10.1021/jf0609882
   JAMIESON PM, 1995, ENDOCRINOLOGY, V136, P4754, DOI 10.1210/en.136.11.4754
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924
   Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200
   Liu YJ, 2008, J MOL ENDOCRINOL, V41, P53, DOI 10.1677/JME-08-0004
   Liu YJ, 2006, ENDOCRINOLOGY, V147, P5061, DOI 10.1210/en.2006-0243
   Liu YJ, 2005, DIABETES, V54, P32, DOI 10.2337/diabetes.54.1.32
   Liu YJ, 2003, DIABETES, V52, P1409, DOI 10.2337/diabetes.52.6.1409
   Marcolongo P, 2008, BIOCHEM PHARMACOL, V76, P382, DOI 10.1016/j.bcp.2008.05.027
   Marcolongo P, 2007, ENDOCRINOLOGY, V148, P2487, DOI 10.1210/en.2006-1472
   Mason PJ, 1999, BLOOD CELL MOL DIS, V25, P30, DOI 10.1006/bcmd.1999.0224
   Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285
   McCormick KL, 2006, J BIOL CHEM, V281, P341, DOI 10.1074/jbc.M506026200
   Mziaut H, 1999, J BIOL CHEM, V274, P14122, DOI 10.1074/jbc.274.20.14122
   Nakano S, 2007, AM J PHYSIOL-ENDOC M, V292, pE1213, DOI 10.1152/ajpendo.00340.2006
   Nammi S, 2007, AM J PHYSIOL-REG I, V292, pR1101, DOI 10.1152/ajpregu.00255.2006
   Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8
   NIEMAN LK, 1985, J CLIN ENDOCR METAB, V61, P536, DOI 10.1210/jcem-61-3-536
   Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762
   Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283
   OZOLS J, 1993, P NATL ACAD SCI USA, V90, P5302, DOI 10.1073/pnas.90.11.5302
   Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101
   Piccirella S, 2006, J BIOL CHEM, V281, P4671, DOI 10.1074/jbc.M509406200
   Rajan V, 1996, J NEUROSCI, V16, P65
   RIZZA RA, 1982, J CLIN ENDOCR METAB, V54, P131, DOI 10.1210/jcem-54-1-131
   Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371
   SHIMOMURA Y, 1987, HORM METAB RES, V19, P295, DOI 10.1055/s-2007-1011804
   Stewart PM, 1999, J CLIN ENDOCR METAB, V84, P1022, DOI 10.1210/jc.84.3.1022
   Taylor AI, 2009, HORM METAB RES, V41, P899, DOI 10.1055/s-0029-1234071
   Tiosano D, 2003, J CLIN ENDOCR METAB, V88, P379, DOI 10.1210/jc.2002-020511
   Üçkaya G, 2008, DIABETES RES CLIN PR, V82, pS135, DOI 10.1016/j.diabres.2008.09.022
   Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513
   Walker EA, 2007, J BIOL CHEM, V282, P27030, DOI 10.1074/jbc.M704144200
   Wang SJY, 2006, DIABETOLOGIA, V49, P1333, DOI 10.1007/s00125-006-0239-y
NR 51
TC 22
Z9 23
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD FEB
PY 2011
VL 54
IS 2
BP 440
EP 450
DI 10.1007/s00125-010-1956-9
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 703SO
UT WOS:000286001800030
PM 21052977
OA Bronze, Green Accepted
DA 2025-04-28
ER

PT J
AU Halberg, SE
   Visek, AJ
   Blake, EF
   Essel, KD
   Sacheck, J
   Sylvetsky, AC
AF Halberg, Sabrina E.
   Visek, Amanda J.
   Blake, Emily F.
   Essel, Kofi D.
   Sacheck, Jennifer
   Sylvetsky, Allison C.
TI SODA MAPS: A Framework for Understanding Caffeinated Sugary Drink
   Consumption Among Children
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE youth; sugar-sweetened beverages; diet; caffeine; obesity; concept
   mapping
ID SWEETENED BEVERAGE CONSUMPTION; HOME FOOD ENVIRONMENT; CHILDHOOD
   OBESITY; BODY-WEIGHT; ADOLESCENTS; ACCESS; DISPARITIES; TRENDS; PARENT;
   SCHOOL
AB Excess sugary drink (SD) consumption is associated with childhood obesity and development of cardiometabolic disease. In addition to having high added sugar content, many SDs also contain caffeine, which may further encourage excess SD consumption among children. The objective of this study was to develop a conceptual framework of children's caffeinated SD consumption using group concept mapping, an applied social research multimethodology that collectively harnesses qualitative and quantitative data from participants to generate a visual representation of their ideas and input. Children, 8-14 years old, who reported consuming >= 12 ounces of caffeinated SDs (e.g., sodas, sweet teas) per day were recruited throughout Washington, D.C. and invited to participate. Concept mapping included three participant-driven activities: (1) brainstorming (n = 51), during which children reported reasons for their SD consumption, from which 58 unique reasons were identified; (2) sorting (n = 70), during which children sorted each of the reported reasons into categories and named each category; and (3) rating (n = 74), during which children rated the influence of each reason on their own caffeinated SD consumption. Similarity matrices, multidimensional scaling, and hierarchical cluster analysis were used to generate concept maps (hereafter "SODA MAPS"), which display the 58 reasons organized within eight overarching clusters. Among these eight clusters, Taste and Feel, Something to Do, and Energy were rated as particularly influential. Children's caffeinated SD consumption is encouraged not only by the palatable taste and reported preferences for these beverages (e.g., Taste and Feel), but also by psychological (e.g., Mood and Focus), biological (e.g., Energy), social (e.g., Something to Do) and environmental reasons (e.g., Nothing Better Available). Thus, the SODA MAPS can inform the development of tailored, multi-level SD reduction interventions that incorporate strategies to address important and currently overlooked reasons for caffeinated SD consumption among children.
C1 [Halberg, Sabrina E.; Visek, Amanda J.; Blake, Emily F.; Sacheck, Jennifer; Sylvetsky, Allison C.] George Washington Univ, Dept Exercise & Nutr Sci, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
   [Blake, Emily F.] Univ Maryland, Dept Kinesiol, Sch Publ Hlth, College Pk, MD 20742 USA.
   [Essel, Kofi D.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.
   [Essel, Kofi D.] Childrens Natl Hosp, Div Gen & Community Pediat, Washington, DC USA.
C3 George Washington University; University System of Maryland; University
   of Maryland College Park; George Washington University; Children's
   National Health System
RP Sylvetsky, AC (corresponding author), George Washington Univ, Dept Exercise & Nutr Sci, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
EM asylvets@gwu.edu
OI Blake, Emily/0000-0003-1838-8245
FU National Institutes of Health's (NIH) National Center for Advancing
   Translational Sciences (NCATS) [UL1TR001876, KL2TR00187]
FX This project was supported by the National Institutes of Health's (NIH)
   National Center for Advancing Translational Sciences (NCATS) [parent
   award numbers UL1TR001876, KL2TR00187] as part of a KL2 Career
   Development Award (PI: Sylvetsky). Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the NIH or NCATS.
CR Ahluwalia N, 2015, ADV NUTR, V6, P102, DOI 10.3945/an.114.007401
   Algert SJ, 2006, AM J PREV MED, V30, P365, DOI 10.1016/j.amepre.2006.01.009
   [Anonymous], Sugars Intake for Adults and Children
   Bleich SN, 2015, OBESITY, V23, P1039, DOI 10.1002/oby.21050
   Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007
   Bobowski N, 2017, CHILD OBES, V13, P369, DOI 10.1089/chi.2017.0023
   Bogart LM, 2013, ACAD PEDIATR, V13, P348, DOI 10.1016/j.acap.2013.02.009
   Bradbury KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223912
   Brown CL, 2015, PEDIATR CLIN N AM, V62, P1241, DOI 10.1016/j.pcl.2015.05.013
   Brownell KD, 2009, J ADOLESCENT HEALTH, V45, pS8, DOI 10.1016/j.jadohealth.2009.03.004
   Bruening M, 2014, J NUTR EDUC BEHAV, V46, P277, DOI 10.1016/j.jneb.2014.02.009
   Burke MV, 2015, PHYSIOL BEHAV, V152, P381, DOI 10.1016/j.physbeh.2015.05.036
   Chi Donald L, 2019, Dent Clin North Am, V63, P17, DOI 10.1016/j.cden.2018.08.003
   Chung SJ, 2017, J PEDIATR NURS, V36, P44, DOI 10.1016/j.pedn.2017.04.010
   Couch SC, 2014, J ACAD NUTR DIET, V114, P1569, DOI 10.1016/j.jand.2014.05.015
   Cruz ML, 2005, ANNU REV NUTR, V25, P435, DOI 10.1146/annurev.nutr.25.050304.092625
   Davis JN, 2010, AM J CLIN NUTR, V92, P1522, DOI 10.3945/ajcn.2010.30185
   DESOR JA, 1975, SCIENCE, V190, P686, DOI 10.1126/science.1188365
   DESOR JA, 1987, PHYSIOL BEHAV, V39, P639, DOI 10.1016/0031-9384(87)90166-1
   Dohnke B, 2011, ADDICT BEHAV, V36, P286, DOI 10.1016/j.addbeh.2010.11.001
   Drewnowski A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030154
   Eck KM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091232
   Falbe J, 2019, APPETITE, V133, P130, DOI 10.1016/j.appet.2018.10.032
   Fulkerson JA, 2018, J ACAD NUTR DIET, V118, P240, DOI 10.1016/j.jand.2017.04.006
   Gearhardt AN, 2012, INT J EAT DISORDER, V45, P657, DOI 10.1002/eat.20957
   Guerrero AD, 2016, J RACIAL ETHN HEALTH, V3, P129, DOI 10.1007/s40615-015-0122-y
   Hebebrand J, 2009, CHILD ADOL PSYCH CL, V18, P49, DOI 10.1016/j.chc.2008.08.002
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x
   Kane M., 2007, Concept mapping for planning and evaluation, DOI [10.4135/9781412983730, DOI 10.4135/9781412983730]
   Kiess W, 2001, Obes Rev, V2, P29, DOI 10.1046/j.1467-789x.2001.00017.x
   Klassen KM, 2018, J MED INTERNET RES, V20, DOI 10.2196/10227
   Kwate NOA, 2010, PREV MED, V51, P153, DOI 10.1016/j.ypmed.2010.04.020
   Lopez NV, 2012, J ACAD NUTR DIET, V112, P541, DOI 10.1016/j.jand.2011.11.013
   Ludden AB, 2010, HEALTH EDUC BEHAV, V37, P330, DOI 10.1177/1090198109341783
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Maller O, 1973, Symp Oral Sens Percept, P279
   Martin KB, 2021, J SLEEP RES, V30, DOI 10.1111/jsr.13130
   Mendez MA, 2019, AM J CLIN NUTR, V109, P79, DOI 10.1093/ajcn/nqy123
   Meredith Steven E, 2013, J Caffeine Res, V3, P114, DOI 10.1089/jcr.2013.0016
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Owens JA, 2014, NUTR REV, V72, P65, DOI 10.1111/nure.12150
   Patel AI, 2011, AM J PUBLIC HEALTH, V101, P1370, DOI 10.2105/AJPH.2011.300142
   Puder JJ, 2010, INT J OBESITY, V34, pS37, DOI 10.1038/ijo.2010.238
   Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557
   Pulgarón ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014
   Rosas SR, 2012, EVAL PROGRAM PLANN, V35, P236, DOI 10.1016/j.evalprogplan.2011.10.003
   Rosinger Asher, 2017, NCHS Data Brief, P1
   Scaglioni S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060706
   Scharf RJ, 2016, ANNU REV PUBL HEALTH, V37, P273, DOI 10.1146/annurev-publhealth-032315-021528
   Schulte EM, 2016, PROG BRAIN RES, V223, P329, DOI 10.1016/bs.pbr.2015.07.011
   Schulte EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117959
   Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578
   Stead M, 2011, SOC SCI MED, V72, P1131, DOI 10.1016/j.socscimed.2010.12.029
   Striley Catherine L W, 2011, J Caffeine Res, V1, P219, DOI 10.1089/jcr.2011.0029
   Sturrock K, 2000, Field Methods, V12, P49, DOI DOI 10.1177/1525822X0001200104
   Sylvetsky AC, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.594513
   Sylvetsky AC, 2020, APPETITE, V155, DOI 10.1016/j.appet.2020.104826
   Sylvetsky AC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040885
   Tipton JA, 2014, J PEDIATR NURS, V29, P47, DOI 10.1016/j.pedn.2013.06.006
   Trochim W, 2005, INT J QUAL HEALTH C, V17, P187, DOI 10.1093/intqhc/mzi038
   Trochim WM, 2017, EVAL PROGRAM PLANN, V60, P166, DOI 10.1016/j.evalprogplan.2016.10.006
   U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2015, 2015 2020 DIET GUID, V8
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   Visek AJ, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzy103
   Visek AJ, 2015, J PHYS ACT HEALTH, V12, P424, DOI 10.1123/jpah.2013-0180
   Vos MB, 2017, GASTROENTEROLOGY, V153, P642, DOI 10.1053/j.gastro.2017.07.029
   Vos MB, 2017, CIRCULATION, V135, pE1017, DOI 10.1161/CIR.0000000000000439
   Watts AW, 2018, EAT BEHAV, V30, P42, DOI 10.1016/j.eatbeh.2018.04.003
   Zahid A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080929
   Zenk SN, 2006, ETHNIC DIS, V16, P275
   Zytnick D, 2016, AM J HEALTH PROMOT, V30, pE110, DOI 10.4278/ajhp.140103-QUAN-8
NR 72
TC 5
Z9 6
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD MAR 10
PY 2021
VL 8
AR 640531
DI 10.3389/fnut.2021.640531
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA RB0YK
UT WOS:000631843300001
PM 33777993
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Halkjær, J
   Sorensen, TIA
   Tjonneland, A
   Togo, P
   Holst, C
   Heitmann, BL
AF Halkjær, J
   Sorensen, TIA
   Tjonneland, A
   Togo, P
   Holst, C
   Heitmann, BL
TI Food and drinking patterns as predictors of 6-year BMI-adjusted changes
   in waist circumference
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE abdominal obesity; food patterns; prospective study; waist circumference
ID BODY-MASS INDEX; TO-HIP RATIO; CORONARY-HEART-DISEASE; ADIPOSE-TISSUE
   DISTRIBUTION; LIFE-STYLE FACTORS; WHOLE-GRAIN INTAKE; MIDDLE-AGED MEN;
   DIETARY PATTERNS; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE
AB Few studies have investigated the prospective associations between diet or drinking patterns and abdominal obesity; we therefore investigated whether food and beverage groups or patterns predicted 6-year changes in waist circumference (WC) and whether these associations were independent of concurrent changes in BMI as a measure of general obesity. The subjects were 2300 middle-aged men and women with repeated measurements of dietary intake, BMI and WC from 1982 to 1993. Intakes from ten food groups and from coffee, tea, wine, beer and spirits were assessed; gender-specific food factors were identified by factor analyses. Multiple linear regression analyses were done before and after adjustment for concurrent changes in BMI. A high intake of potatoes seemed to prevent gain in WC for men, while a high intake of refined bread was associated with gain in WC for women. The association persisted for refined bread, but not for potatoes, after adjustment for concurrent BMI changes. Among women, but not men, high intakes of beer and spirits were associated with gain in WC in both models. A high intake of coffee for women and moderate to high intake of tea for men were associated with gain in WC, but the associations were weakened, especially for women, after adjustment for BMI changes. None of the food factors was associated with WC changes. Based on the present study, we conclude that very few food items and no food patterns seem to predict changes in WC, whereas high intakes of beer and spirits among women, and moderate to high tea intake among men, may promote gain in WC.
C1 Copenhagen Univ Hosp, Danish Epidemiol Sci Ctr, Inst Prevent Med, Copenhagen, Denmark.
   Copenhagen Univ Hosp, Res Unit Dietary Studies, Inst Prevent Med, Copenhagen, Denmark.
   Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.
   Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark.
C3 University of Copenhagen; Copenhagen University Hospital; Aarhus
   University; University of Copenhagen; Copenhagen University Hospital;
   University of Copenhagen; Copenhagen University Hospital; Danish Cancer
   Society
RP Copenhagen Univ Hosp, Danish Epidemiol Sci Ctr, Inst Prevent Med, Copenhagen, Denmark.
EM jh@ipm.hosp.dk
RI Heitmann, Berit/JBJ-6043-2023; Tjonneland, Anne/AGU-0320-2022
OI Tjonneland, Anne/0000-0003-4385-2097; Heitmann, Berit
   Lilienthal/0000-0002-6809-4504
CR BAECKE JAH, 1983, INT J OBESITY, V7, P13
   Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123
   Bjorntorp P, 1996, INT J OBESITY, V20, P291
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Brand-Miller JC, 2002, AM J CLIN NUTR, V76, p281S, DOI 10.1093/ajcn/76.1.281S
   Carey DGP, 1996, INT J OBESITY, V20, P722
   Chan DC, 2003, QJM-INT J MED, V96, P441, DOI 10.1093/qjmed/hcg069
   CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961
   COLDITZ GA, 1990, AM J CLIN NUTR, V51, P1100, DOI 10.1093/ajcn/51.6.1100
   Dallongeville J, 1998, INT J OBESITY, V22, P1178, DOI 10.1038/sj/ijo/0800744
   Delvaux K, 1999, INT J OBESITY, V23, P1233, DOI 10.1038/sj.ijo.0801052
   Dobbelsteyn CJ, 2001, INT J OBESITY, V25, P652, DOI 10.1038/sj.ijo.0801582
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   DUNCAN BB, 1995, AM J EPIDEMIOL, V142, P1034, DOI 10.1093/oxfordjournals.aje.a117556
   Ebbeling C B, 2001, Adv Pediatr, V48, P179
   ECK LH, 1995, INT J OBESITY, V19, P765
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   GEORGE V, 1990, INT J OBESITY, V14, P1085
   Greenwood DC, 2000, EUR J CLIN NUTR, V54, P314, DOI 10.1038/sj.ejcn.1600941
   GRINKER JA, 1995, OBES RES, V3, P435, DOI 10.1002/j.1550-8528.1995.tb00173.x
   Han TS, 1998, INT J EPIDEMIOL, V27, P422, DOI 10.1093/ije/27.3.422
   Haveman-Nies A, 2001, EUR J CLIN NUTR, V55, P870, DOI 10.1038/sj.ejcn.1601232
   Heitmann BL, 2000, INT J OBESITY, V24, P435, DOI 10.1038/sj.ijo.0801176
   HEITMANN BL, 1995, BRIT MED J, V311, P986
   Hu FB, 2000, AM J CLIN NUTR, V72, P912
   Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248
   JACOBSEN BK, 1987, J CHRON DIS, V40, P795, DOI 10.1016/0021-9681(87)90131-7
   Johansen D, 2003, ALCOHOL, V31, P11, DOI 10.1016/j.alcohol.2003.04.001
   Kahn HS, 1997, AM J PUBLIC HEALTH, V87, P747, DOI 10.2105/AJPH.87.5.747
   Kamycheva E, 2003, J NUTR, V133, P102, DOI 10.1093/jn/133.1.102
   KAYE SA, 1990, INT J OBESITY, V14, P583
   Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719
   KROMHOUT D, 1988, AM J CLIN NUTR, V47, P668, DOI 10.1093/ajcn/47.4.668
   Lakka HM, 2002, EUR HEART J, V23, P706, DOI 10.1053/euhj.2001.2889
   LAPIDUS L, 1989, APPETITE, V13, P25, DOI 10.1016/0195-6663(89)90024-X
   Larson DE, 1996, AM J CLIN NUTR, V64, P677, DOI 10.1093/ajcn/64.5.677
   LAWS A, 1990, AM J PUBLIC HEALTH, V80, P1358, DOI 10.2105/AJPH.80.11.1358
   LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158
   Lemieux S, 1997, INT J OBESITY, V21, P831, DOI 10.1038/sj.ijo.0800488
   Liebman M, 2003, INT J OBESITY, V27, P684, DOI 10.1038/sj.ijo.0802277
   Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85
   Lissner L, 2000, BRIT J NUTR, V83, pS21
   Ludwig DS, 2000, J NUTR, V130, p280S, DOI 10.1093/jn/130.2.280S
   Ludwig DS, 1999, JAMA-J AM MED ASSOC, V282, P1539, DOI 10.1001/jama.282.16.1539
   McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390
   MERKUS MP, 1995, J EPIDEMIOL COMMUN H, V49, P22, DOI 10.1136/jech.49.1.22
   Meyer KA, 2000, AM J CLIN NUTR, V71, P921
   Morris KL, 1999, NUTR REV, V57, P273
   Nelson TL, 1999, INT J OBESITY, V23, P449, DOI 10.1038/sj.ijo.0800840
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Osler M, 1996, INT J EPIDEMIOL, V25, P1023, DOI 10.1093/ije/25.5.1023
   Osler M, 2002, EUR J CLIN NUTR, V56, P568, DOI 10.1038/sj.ejcn.1601360
   Osler M, 2001, BRIT J NUTR, V85, P219, DOI 10.1079/BJN2000240
   Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843
   Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615
   Rosell MS, 2003, AM J CLIN NUTR, V78, P84, DOI 10.1093/ajcn/78.1.84
   Sakurai Y, 1997, EUR J EPIDEMIOL, V13, P893, DOI 10.1023/A:1007416322031
   Singh RB, 1996, J AM COLL NUTR, V15, P592, DOI 10.1080/07315724.1996.10718635
   SLATTERY ML, 1992, AM J CLIN NUTR, V55, P943, DOI 10.1093/ajcn/55.5.943
   Stookey JD, 2001, J NUTR, V131, p2433S, DOI 10.1093/jn/131.9.2433S
   TAVANI A, 1994, INT J OBESITY, V18, P497
   Toeller M, 2001, INT J OBESITY, V25, P1815, DOI 10.1038/sj.ijo.0801816
   Togo P, 2004, INT J OBESITY, V28, P583, DOI 10.1038/sj.ijo.0802598
   Togo P, 2003, BRIT J NUTR, V90, P667, DOI 10.1079/BJN2003943
   Trichopoulou A, 2001, AM J CLIN NUTR, V74, P574
   TROISI RJ, 1991, AM J CLIN NUTR, V53, P1104, DOI 10.1093/ajcn/53.5.1104
   TUCKER KL, 1992, J AM DIET ASSOC, V92, P1487
   Vadstrup ES, 2003, INT J OBESITY, V27, P238, DOI 10.1038/sj.ijo.802203
   van Lenthe FJ, 1998, AM J CLIN NUTR, V67, P846, DOI 10.1093/ajcn/67.5.846
   Van Pelt RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1023, DOI 10.1152/ajpendo.00467.2001
   Walker SP, 1996, AM J EPIDEMIOL, V144, P1143, DOI 10.1093/oxfordjournals.aje.a008892
   Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312
   Willett WC, 1998, NUTR EPIDEMIOLOGY
   Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337
   WILLIAMSON DF, 1987, AM J PUBLIC HEALTH, V77, P1324, DOI 10.2105/AJPH.77.10.1324
   Wirfalt AKE, 1997, J AM DIET ASSOC, V97, P272, DOI 10.1016/S0002-8223(97)00071-0
   Wirfält E, 2001, AM J EPIDEMIOL, V154, P1150, DOI 10.1093/aje/154.12.1150
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
NR 78
TC 73
Z9 81
U1 0
U2 15
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD OCT
PY 2004
VL 92
IS 4
BP 735
EP 748
DI 10.1079/BJN20041246
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 864NJ
UT WOS:000224639900021
PM 15522143
OA Bronze
DA 2025-04-28
ER

PT J
AU Quinhoneiro, DCG
   Nicoletti, CF
   Pinhel, MAS
   Noronha, NY
   Braga, CBM
   Oliveira, BAP
   Cortes-Oliveira, C
   Oliveira, WP
   Salgado, W
   Marchini, JS
   Nonino, CB
AF Gomes Quinhoneiro, Driele Cristina
   Nicoletti, Carolina Ferreira
   Souza Pinhel, Marcela Augusta
   Noronha, Natalia Yumi
   Moreno Braga, Camila Bitu
   Parenti Oliveira, Bruno Affonso
   Cortes-Oliveira, Cristiana
   Oliveira, Wanderley Pereira
   Salgado Junior, Wilson
   Marchini, Julio Sergio
   Nonino, Carla Barbosa
TI Green tea supplementation upregulates uncoupling protein 3 expression in
   severe obese women adipose tissue but does not promote weight loss
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE Catechin; green tea; UCP3; obesity; nutrigenomics
ID DIET-INDUCED OBESITY; FAT OXIDATION; BODY-COMPOSITION;
   CATECHIN-POLYPHENOLS; ENERGY-EXPENDITURE; GENE-EXPRESSION;
   MESSENGER-RNA; EXTRACT; CAFFEINE; CONSUMPTION
AB This study aims (i) to verify expression of the UCPs, PLIN1, PPARG2, and ADRB3 genes in the abdominal subcutaneous adipose tissue of obese women at baseline and after 8 weeks of supplementation with decaffeinated green tea extract, and (ii) to associate findings with clinical parameters. This is a longitudinal study during which 11 women with obesity grade III were submitted to supplementation with 450 mg of (-)-epigallocatechin gallate (EGCG) (intervention group); the control group consisted of 10 eutrophic women. Anthropometric parameters [weight, height, and body mass index (BMI)], resting metabolic rate (RMR, measured by indirect calorimetry), and gene expression (measured by real-time PCR, RT-qPCR) were determined before and after supplementation. After 8 weeks, clinical parameters and UCP1, PLIN1, PPARG2, and ADRB3 expression remained unaltered in the intervention group (p > .05). Genetic analysis also showed that the UCP3 gene was upregulated (p = .026), but its upregulation did not promote weight loss.
C1 [Gomes Quinhoneiro, Driele Cristina; Nicoletti, Carolina Ferreira; Souza Pinhel, Marcela Augusta; Noronha, Natalia Yumi; Moreno Braga, Camila Bitu; Parenti Oliveira, Bruno Affonso; Cortes-Oliveira, Cristiana; Marchini, Julio Sergio; Nonino, Carla Barbosa] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, SP, Brazil.
   [Oliveira, Wanderley Pereira] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, Ribeirao Preto, Brazil.
   [Salgado Junior, Wilson] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Ribeirao Preto, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de
   Sao Paulo
RP Nonino, CB (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, SP, Brazil.; Nonino, CB (corresponding author), Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM carla@fmrp.usp.br
RI Salgado, Wilson/L-1470-2016; Braga, Camila/K-6241-2015; Noronha,
   Natalia/AAQ-6468-2020; Marchini, Julio/K-1992-2016; Noronha,
   Natalia/T-7080-2018; Nonino, Carla Barbosa/D-4637-2012; OLIVEIRA,
   WANDERLEY/A-4602-2008; Diosa-Astaiza, Jesus Evelio/LMQ-0131-2024
OI Noronha, Natalia/0000-0001-9589-8586; Nonino, Carla
   Barbosa/0000-0001-8559-0772; Salgado Jr., Wilson/0000-0001-9796-0339;
   OLIVEIRA, WANDERLEY/0000-0003-4356-2508; Oliveira,
   Bruno/0000-0002-4233-5517; Diosa-Astaiza, Jesus
   Evelio/0000-0002-1919-1922
FU Sao Paulo Research Foundation (FAPESP) [2014/00669-0, 2013/08916-4];
   Vinnova [2014-00669] Funding Source: Vinnova; Swedish Research Council
   [2013-08916] Funding Source: Swedish Research Council; Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [14/00669-0] Funding
   Source: FAPESP
FX The authors wish to thank the Sao Paulo Research Foundation (FAPESP),
   grants #2014/00669-0 and #2013/08916-4. They also thank Wilson A Silva
   Junior for expert assistance.
CR Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Baladia E, 2014, NUTR HOSP, V29, P479, DOI [10.3305/nh.2014.29.3.7118, 10.3305/NH.2014.29.3.7118]
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bouchard C, 1997, HUM MOL GENET, V6, P1887, DOI 10.1093/hmg/6.11.1887
   Brown JC, 2016, J CLIN ONCOL, V34, P4217, DOI 10.1200/JCO.2016.66.8699
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cermak R, 2006, CURR DRUG METAB, V7, P729, DOI 10.2174/138920006778520570
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Clifford M.N., 2001, CRC CR REV FOOD SCI, V41, P393
   Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521
   Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dulloo AG, 2001, BIOCHEM SOC T, V29, P785, DOI 10.1042/BST0290785
   Flatt JP, 1998, HDB OBESITY, P513
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   Frood S, 2013, CURR OBES REP, V2, P320, DOI 10.1007/s13679-013-0072-9
   Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018
   Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261
   Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   Hasler CM, 2002, J NUTR, V132, P3772, DOI 10.1093/jn/132.12.3772
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Hosseini A, 2010, J ANIM PHYSIOL AN N, V94, pe178, DOI 10.1111/j.1439-0396.2010.01002.x
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Janssens PLHR, 2016, PHYSIOL BEHAV, V162, P83, DOI 10.1016/j.physbeh.2016.01.044
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Lee Mak-Soon, 2016, Prev Nutr Food Sci, V21, P62, DOI [10.3746/pnf.2016.21.1.62, 10.3746/pnf.2016.21.1.57]
   Mazon JN, 2017, LIFE SCI, V182, P22, DOI 10.1016/j.lfs.2017.06.002
   Millet L, 1997, J CLIN INVEST, V100, P2665, DOI 10.1172/JCI119811
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022
   Schrauwen P, 2001, FASEB J, V15, P2497, DOI 10.1096/fj.01-0400hyp
   SCHUTZ Y, 1992, AM J CLIN NUTR, V55, P670, DOI 10.1093/ajcn/55.3.670
   Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341
   Sueoka N, 2001, ANN NY ACAD SCI, V928, P274
   Toda C, 2014, BEST PRACT RES CL EN, V28, P757, DOI 10.1016/j.beem.2014.02.006
   Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Weijs PJM, 2010, CLIN NUTR, V29, P347, DOI 10.1016/j.clnu.2009.09.009
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wulan SN, 2010, MATURITAS, V65, P315, DOI 10.1016/j.maturitas.2009.12.012
   Yan JQ, 2013, SCI CHINA LIFE SCI, V56, P804, DOI 10.1007/s11427-013-4512-2
   Zhang M, 2004, INT J CANCER, V112, P465, DOI 10.1002/ijc.20456
NR 52
TC 17
Z9 17
U1 0
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD NOV 17
PY 2018
VL 69
IS 8
BP 995
EP 1002
DI 10.1080/09637486.2018.1442819
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GW9JR
UT WOS:000447302200013
PM 29482377
DA 2025-04-28
ER

PT J
AU Esfahani, FH
   Asghari, G
   Mirmiran, P
   Azizi, F
AF Esfahani, Firoozeh Hosseini
   Asghari, Golaleh
   Mirmiran, Parvin
   Azizi, Fereidoun
TI Reproducibility and Relative Validity of Food Group Intake in a Food
   Frequency Questionnaire Developed for the Tehran Lipid and Glucose Study
SO JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE food frequency questionnaire; validity and reproducibility; food group;
   Tehran
ID DIETARY QUESTIONNAIRE; NONCOMMUNICABLE DISEASE; NUTRIENT ADEQUACY; PILOT
   PHASE; VALIDATION; OBESITY; PREVENTION; COHORT; POPULATION; CANCER
AB Objective: To examine the validity and reproducibility of food groups in the semi-quantitative food frequency questionnaire (FFQ) developed for the Tehran Lipid and Glucose Study (TLGS).
   Methods: To evaluate the reproducibility of food groups included in the FFQ, 132 Subjects (61 men and 71 women) aged 20 years or older twice completed a 168-item FFQ (FFQ1, FFQ2), with a 14-month interval between FFQ1 and FFQ2. Over the 1-year interval, 12 dietary recalls (DRs) were collected (1 each month) to assess the validity of the FFQ. Seventeen food groups were derived front the FFQ based on methods described in previous studies. Age-adjusted and deattenuated Spearman correlation coefficients were used to assess the validity of the FFQ.
   Results: The mean (SD) age and body mass index of subjects were 35.5 (16.8) years and 25.5 (5.2)kg/m(2), respectively. Validity correlation coefficients ranged from 0.03 (liquid oil) to 0.77 (simple Sugars) in men (median, 0.44), and from 0.12 (snacks) to 0.79 (simple Sugars) in women (median, 0.37). The energy-adjusted intraclass correlation coefficient, which reflects the reproducibility of the FFQ, was 0.51 in men and was highest for tea and coffee (0.91); in women it vas 0.59 and was highest for simple sugars (0.74). The highest percentage of complete agreement and disagreement was observed for snacks and desserts (60.6%) and potatoes and dairy products (12.8%), respectively, in men, and tea and coffee (62.9%) and legumes (15.7%) in women.
   Conclusions: The FFQ that was designed for the TLGS was found to be reliable and valid for assessing the intake of several food groups.
C1 [Esfahani, Firoozeh Hosseini; Asghari, Golaleh; Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran 193954763, Iran.
   [Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Dept Human Nutr, Fac Nutr & Food Technol, Natl Nutr & Food Technol Inst, Tehran 193954763, Iran.
   [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran 193954763, Iran.
C3 Shahid Beheshti University Medical Sciences; Shahid Beheshti University
   Medical Sciences; Shahid Beheshti University Medical Sciences
RP Mirmiran, P (corresponding author), Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, 24 Parvaneh St,Yemen Ave, Tehran 193954763, Iran.
EM mirmiran@endocrine.ac.ir
RI Mirmiran, Parvin/V-1433-2019; asghari, golaleh/N-4521-2013; Azizi,
   Fereidoun/ABD-4136-2021; Hosseini-Esfahani, Firoozeh/K-9532-2017
OI Mirmiran, Parvin/0000-0003-2391-4924; Azizi,
   Fereidoun/0000-0002-6470-2517; Hosseini-Esfahani,
   Firoozeh/0000-0002-9697-0081
FU Research Institute or Endocrine Sciences, Shahid Beheshti University of
   Medical Sciences, I.R. Iran [098]
FX The authors would like to thank the subjects who participated in this
   study. We are grateful to the staff of the Nutrition Center for the
   dietary interviews. This study was part of the Tehran Lipid and Glucose
   Study and was Supported by grant no. 098 from the Research Institute or
   Endocrine Sciences, Shahid Beheshti University of Medical Sciences, I.R.
   Iran. F.H., G.A. and P.M. designed the study, collected and analyzed
   data, and wrote the manuscript. F.A. supervised the Study. None of the
   authors has any personal or financial conflicts of interest.
CR [Anonymous], 1997, Int J Epidemiol, V26 Suppl 1, pS91
   Azadbakht L, 2005, EUR J CLIN NUTR, V59, P1233, DOI 10.1038/sj.ejcn.1602234
   Azar M, Food composition table of Iran: National Nutrition and food research institute
   Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008
   Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5
   BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS59, DOI 10.1093/ije/26.suppl_1.S59
   Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318
   Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062
   Date C, 2005, J EPIDEMIOL, V15, pS9, DOI 10.2188/jea.15.S9
   Ebrahimpour Pantea, 2006, Metabolic Syndrome and Related Disorders, V4, P172, DOI 10.1089/met.2006.4.172
   Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Ghafarpour M., 1999, The manual for household measures, cooking yields factors and edible portion of foods
   Gill Tim, 2006, Asia Pac J Clin Nutr, V15 Suppl, P3
   GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   Johansson I, 2002, PUBLIC HEALTH NUTR, V5, P487, DOI 10.1079/PHN2001315
   Kaaks R, 1997, INT J EPIDEMIOL, V26, pS26, DOI 10.1093/ije/26.suppl_1.S26
   Kelishadi R, 2008, PUBLIC HEALTH NUTR, V11, P246, DOI 10.1017/S1368980007000262
   Kimiagar M, 1995, NATL FOOD CONSUMPTIO
   Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091
   Larsen L, 2006, J AM ACAD NURSE PRAC, V18, P70, DOI 10.1111/j.1745-7599.2006.00105.x
   Malekshah AF, 2006, EUR J CLIN NUTR, V60, P971, DOI 10.1038/sj.ejcn.1602407
   Marks GC, 2006, J NUTR, V136, P459, DOI 10.1093/jn/136.2.459
   McCullough ML, 2003, CANCER CAUSE CONTROL, V14, P959, DOI 10.1023/B:CACO.0000007983.16045.a1
   Mirmiran P, 2006, J AM COLL NUTR, V25, P354, DOI 10.1080/07315724.2006.10719546
   Nagel G, 2007, BRIT J NUTR, V98, P194, DOI 10.1017/S0007114507691636
   Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37
   Ocke MC, 1997, AM J CLIN NUTR, V65, P1240
   Pisani P, 1997, INT J EPIDEMIOL, V26, pS152, DOI 10.1093/ije/26.suppl_1.S152
   ROSNER B, 1988, AM J EPIDEMIOL, V127, P377, DOI 10.1093/oxfordjournals.aje.a114811
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264
   Schröder H, 2004, J NUTR, V134, P3355, DOI 10.1093/jn/134.12.3355
   Sturm R, 2008, PUBLIC HEALTH, V122, P739, DOI 10.1016/j.puhe.2008.01.004
   Willett WC, 1998, NUTR EPIDEMIOLOGY
NR 36
TC 623
Z9 632
U1 0
U2 12
PU JAPAN EPIDEMIOLOGICAL ASSOC
PI FUKUOKA
PA FUKUOKA INST HEALTH & ENVIRONMENTAL SCIENCES, MUKAIZANO 39, DAZAIFU,
   FUKUOKA, 818-0135, JAPAN
SN 0917-5040
J9 J EPIDEMIOL
JI J. Epidemiol.
PD MAR
PY 2010
VL 20
IS 2
BP 150
EP 158
DI 10.2188/jea.JE20090083
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA 568BR
UT WOS:000275497300010
PM 20154450
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Nakamura, R
   Pechey, R
   Suhrcke, M
   Jebb, SA
   Marteau, TM
AF Nakamura, Ryota
   Pechey, Rachel
   Suhrcke, Marc
   Jebb, Susan A.
   Marteau, Theresa M.
TI Sales impact of displaying alcoholic and non-alcoholic beverages in
   end-of-aisle locations: An observational study
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE United Kingdom; Alcohol; Non-alcoholic beverages; End-of-aisle display;
   Grocery store; Primary prevention
ID SUPERMARKET; BEHAVIOR; OBESITY; FOODS
AB In-store product placement is perceived to be a factor underpinning impulsive food purchasing but empirical evidence is limited. In this study we present the first in-depth estimate of the effect of end-of-aisle display on sales, focussing on alcohol. Data on store layout and product-level sales during 2010-11 were obtained for one UK grocery store, comprising detailed information on shelf space, price, price promotion and weekly sales volume in three alcohol categories (beer, wine, spirits) and three non-alcohol categories (carbonated drinks, coffee, tea). Multiple regression techniques were used to estimate the effect of end-of-aisle display on sales, controlling for price, price promotion, and the number of display locations for each product. End-of-aisle display increased sales volumes in all three alcohol categories: by 23.2% (p = 0.005) for beer, 33.6% (p < 0.001) for wine, and 46.1% (p < 0.001) for spirits, and for three non-alcohol beverage categories: by 51.7% (p < 0.001) for carbonated drinks, 73.5% (p < 0.001) for coffee, and 113.8% (p < 0.001) for tea. The effect size was equivalent to a decrease in price of between 4% and 9% per volume for alcohol categories, and a decrease in price of between 22% and 62% per volume for non-alcohol categories. End-of-aisle displays appear to have a large impact on sales of alcohol and non-alcoholic beverages. Restricting the use of aisle ends for alcohol and other less healthy products might be a promising option to encourage healthier in-store purchases, without affecting availability or cost of products. (c) 2014 The Authors. Published by Elsevier Ltd.
C1 [Nakamura, Ryota; Pechey, Rachel; Suhrcke, Marc; Jebb, Susan A.; Marteau, Theresa M.] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge CB2 1TN, England.
   [Nakamura, Ryota; Suhrcke, Marc] Univ E Anglia, Norwich Med Sch, Hlth Econ Grp, Norwich NR4 7TJ, Norfolk, England.
   [Jebb, Susan A.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England.
C3 University of Cambridge; University of East Anglia; UK Research &
   Innovation (UKRI); Medical Research Council UK (MRC); MRC Human
   Nutrition Research
RP Marteau, TM (corresponding author), Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge CB2 1TN, England.
EM tm388@cam.ac.uk
RI Suhrcke, Marc/AAE-9024-2019
OI Jebb, Susan/0000-0001-9190-2920; Suhrcke, Marc/0000-0001-7263-8626;
   Nakamura, Ryota/0000-0002-3217-6452; Marteau,
   Theresa/0000-0003-3025-1129; Pechey, Rachel/0000-0002-6558-388X
FU MRC [MC_U105960389] Funding Source: UKRI
CR BEMMAOR AC, 1991, J MARKETING RES, V28, P202, DOI 10.2307/3172808
   CHEVALIER M, 1975, J MARKETING RES, V12, P426, DOI 10.2307/3151091
   Chintagunta P, 2005, MANAGE SCI, V51, P832, DOI 10.1287/mnsc.1040.0323
   Cohen DA, 2012, OBES REV, V13, P766, DOI 10.1111/j.1467-789X.2012.01001.x
   Cohen DA, 2012, NEW ENGL J MED, V367, P1381, DOI 10.1056/NEJMp1209443
   Competition Commission, 2000, BACKGR CHAPT, V2
   CURHAN RC, 1974, J MARKETING RES, V11, P286, DOI 10.2307/3151144
   Erdem T, 1999, J ECONOMETRICS, V89, P177
   FRANK RE, 1970, J MARKETING RES, V7, P59, DOI 10.2307/3149508
   Glanz K, 2012, AM J PREV MED, V42, P503, DOI 10.1016/j.amepre.2012.01.013
   HONORE BE, 1992, ECONOMETRICA, V60, P533, DOI 10.2307/2951583
   Klein B, 2007, J LAW ECON, V50, P421, DOI 10.1086/524125
   Lee A, 2013, OBES REV, V14, P82, DOI 10.1111/obr.12078
   Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918
   Mhurchu CN, 2013, OBES REV, V14, P108, DOI 10.1111/obr.12080
   Nevo A, 2001, ECONOMETRICA, V69, P307, DOI 10.1111/1468-0262.00194
   PARK CW, 1989, J CONSUM RES, V15, P422, DOI 10.1086/209182
   Sigurdsson V, 2011, SERV IND J, V31, P2543, DOI [10.1080/02642069.2011.531127, 10.1080/02642069.2011.531126]
   Sorensen H, 2003, MARK RES, V15, P30
   Sorensen H, 2008, J ADVERTISING RES, V48, P329, DOI 10.2501/S0021849908080380
   Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001209, 10.1371/journal.pmed.1001242]
   USDA Foreign Agricultural Service, 2011, UK SUP CHAIN PROF GA
   Waterlander WE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-589
   Wilkie WL, 2002, J PUBLIC POLICY MARK, V21, P275, DOI 10.1509/jppm.21.2.275.17591
   WILKINSON JB, 1982, J MARKETING RES, V19, P72, DOI 10.2307/3151532
NR 25
TC 58
Z9 65
U1 3
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
EI 1873-5347
J9 SOC SCI MED
JI Soc. Sci. Med.
PD MAY
PY 2014
VL 108
SI SI
BP 68
EP 73
DI 10.1016/j.socscimed.2014.02.032
PG 6
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA AH4PE
UT WOS:000336109700008
PM 24632050
OA hybrid, Green Published, Green Submitted
DA 2025-04-28
ER

PT J
AU Hu, G
   Jousilahti, P
   Tuomilehto, J
   Antikainen, R
   Sundvall, J
   Salomaa, V
AF Hu, Gang
   Jousilahti, Pekka
   Tuomilehto, Jaakko
   Antikainen, Riitta
   Sundvall, Jouko
   Salomaa, Veikko
TI Association of Serum C-Reactive Protein Level with Sex-Specific Type 2
   Diabetes Risk: A Prospective Finnish Study
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID TIME PHYSICAL-ACTIVITY; CORONARY-HEART-DISEASE; MIDDLE-AGED MEN;
   LEISURE-TIME; COFFEE CONSUMPTION; INFLAMMATORY MARKERS; POSTMENOPAUSAL
   WOMEN; INSULIN-RESISTANCE; METABOLIC SYNDROME; MELLITUS
AB Objective: Our objective was to assess whether the association of serum C-reactive protein (CRP) with type 2 diabetes risk is modified by sex.
   Design and Subjects: We prospectively followed 12,861 Finnish men and women who were 35-74 yr of age, and free of diabetes, coronary heart disease, stroke, and cancer at baseline. Hazard ratios of type 2 diabetes were estimated for different levels of serum CRP.
   Results: During the follow-up, 208 men and 113 women developed diabetes. The multivariable-adjusted (age, physical activity, education, smoking, alcohol and coffee drinking, family history of diabetes, use of antihypertensive drugs, cholesterol-lowering agents, and hormone replacement therapy in women, systolic blood pressure, serum high-density lipoprotein cholesterol, serum triglycerides, and body mass index) hazard ratios of diabetes at three different levels of CRP (0.05-0.99, 1.0-2.99, and >= 3.0 mg/liter) based on the recommendation by Centers for Disease Control and the American Heart Association were 1.00, 1.46, and 1.85 (P for trend = 0.006) in men, and 1.00, 3.83, and 8.37 (P for trend <0.001) in women, respectively. CRP had a stronger association with diabetes risk in women than men (P for interaction: chi(2) = 6.42; 1 df; P < 0.025). This positive association between CRP and diabetes risk did not change when participants were stratified by age group, smoking status, level of obesity, alcohol drinking habit, or family history of diabetes.
   Conclusions: High baseline level of serum CRP was associated with an increased risk of diabetes among both men and women, but this association was stronger in women than men. (J Clin Endocrinol Metab 94: 2099-2105, 2009)
C1 [Hu, Gang] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA 70808 USA.
   [Hu, Gang; Jousilahti, Pekka; Tuomilehto, Jaakko; Salomaa, Veikko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FIN-00300 Helsinki, Finland.
   [Sundvall, Jouko] Natl Publ Hlth Inst, Dept Hlth & Funct Capac, FIN-00300 Helsinki, Finland.
   [Hu, Gang; Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland.
   [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland.
   [Antikainen, Riitta] Oulu City Hosp, Oulu 90015, Finland.
   [Antikainen, Riitta] Univ London Imperial Coll Sci Technol & Med, Div Med, London W12 0NN, England.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Finland National Institute for
   Health & Welfare; Finland National Institute for Health & Welfare;
   University of Helsinki; Imperial College London
RP Hu, G (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM gang.hu@pbrc.edu
RI Hu, Gang/V-7947-2019; Salomaa, Veikko/AEO-8209-2022; tuomilehto,
   jaakko/E-6504-2011; Hu, Gang/N-1971-2017
OI Hu, Gang/0000-0002-6172-8017
FU Finnish Academy [108297, 119681]; Finnish Foundation for Cardiovascular
   Research; Special Research Funds of the Social Welfare and Health Board,
   City of Oulu; Academy of Finland (AKA) [119681] Funding Source: Academy
   of Finland (AKA)
FX Disclosure Summary: The authors have nothing to disclose.
CR [Anonymous], 1999, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation-Part 1: Diagnosis and Classification of Diabetes Mellitus
   Bidel S, 2008, EUR J CLIN NUTR, V62, P178, DOI 10.1038/sj.ejcn.1602712
   COX DR, 1972, J R STAT SOC B, V187, P220
   Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288
   Doi Y, 2005, DIABETES CARE, V28, P2497, DOI 10.2337/diacare.28.10.2497
   Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799
   Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42
   Folsom AR, 2005, EUR J EPIDEMIOL, V20, P1015, DOI 10.1007/s10654-005-3657-0
   Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596
   Han TS, 2002, DIABETES CARE, V25, P2016, DOI 10.2337/diacare.25.11.2016
   Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693
   Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341
   Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892
   Hu G, 2003, DIABETOLOGIA, V46, P322, DOI 10.1007/s00125-003-1031-x
   Hu G, 2004, CIRCULATION, V110, P666, DOI 10.1161/01.CIR.0000138102.23783.94
   Hu G, 2005, STROKE, V36, P1994, DOI 10.1161/01.STR.0000177868.89946.0c
   Hu G, 2007, ATHEROSCLEROSIS, V194, P490, DOI 10.1016/j.atherosclerosis.2006.08.051
   Hu G, 2007, EUR HEART J, V28, P492, DOI 10.1093/eurheartj/ehl475
   Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x
   Liu S, 2007, ARCH INTERN MED, V167, P1676, DOI 10.1001/archinte.167.15.1676
   Nakanishi S, 2003, DIABETES CARE, V26, P2754, DOI 10.2337/diacare.26.10.2754
   PAJAK A, 1988, World Health Statistics Quarterly, V41, P115
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Snijder MB, 2003, DIABETES CARE, V26, P1656, DOI 10.2337/diacare.26.5.1656
   Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93
   Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49
   Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972
NR 30
TC 48
Z9 51
U1 0
U2 1
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0021-972X
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD JUN
PY 2009
VL 94
IS 6
BP 2099
EP 2105
DI 10.1210/jc.2008-2260
PG 7
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 453CM
UT WOS:000266587800038
PM 19318443
DA 2025-04-28
ER

PT J
AU Rurik, I
AF Rurik, I
TI Nutritional differences between elderly men and women - Primary care
   evaluation in Hungary
SO ANNALS OF NUTRITION AND METABOLISM
LA English
DT Article
DE elderly, nutritional differences; gender, nutritional habits;
   nutritional habits; Hungary, nutritional habits
ID GENDER-DIFFERENCES; DIETARY; FOOD; PATTERNS; HABITS; POPULATION;
   BREAKFAST; PEOPLE; ADULTS; OLDER
AB Background: Many differences exist between the two genders, i.e., biological, sociological, and also behavioral, which often depend on age. Objectives: The aim of this study was to find characteristic differences between nutritional habits of elderly men and women. Methods: 266 elderly people (109 men >65 years, and 157 women >60 years) were consecutively selected from primary care patients, in Budapest, Hungary. A self-managed questionnaire was filled in on lifestyle and eating habits, including a food frequency questionnaire. Medical checkup, registration of anthropometrical parameters, and laboratory tests were also performed. 53 subjects were also involved in a 3-day dietary recall. Results: The meal frequency was increased during aging in both genders, especially in men. Lunch was preferred by most of the women as a principal meal, but one quarter of the men had a filling dinner instead of lunch. Alcoholic beverages were consumed more and frequently by men. The fluid intake was low, especially in women. Milk and diary products, fresh fruit, bread, biscuits, chocolate, coffee and vitamin supplements were consumed more frequently by women. Almost all types of meat, eggs, and vegetables were more preferred by men and their energy intake was also higher (9.75 vs. 8.78 MJ). In both genders, fat represented a higher ratio (39%) of energy intake than recommended. The increase of body weight from youth to elderly was greater in women (14.04 vs. 10.65 kg). Prices had a higher impact on food purchases by women. Conclusion: High energy intake over decades led to overweight in both genders (BMI > 27 kg/m(2)). It seemed that the eating habits and food choices of women were closer to healthy ones and recent recommendations, although due to metabolic reasons and to the lower energy expenditure, they gained more weight. The elderly are the target population on every level of medical care. Further evaluations are needed to determine the differences in nutrition and to promote better administration of drugs and to establish public health suggestions. Copyright (C) 2006 S. Karger AG, Basel.
C1 Primary Care Off, Budapest, Hungary.
   Hungarian Inst Food Safety & Nutr, Budapest, Hungary.
RP Vorosmarty 5-7, HU-1201 Budapest, Hungary.
EM rurik.dr@axelero.hu
CR Antal M, 1997, INT J VITAM NUTR RES, V67, P115
   BARONCOHEN S, 2004, ESSENTIAL DIFFERENCE, P271
   BARTOSHUK LM, 1986, J GERONTOL, V41, P51, DOI 10.1093/geronj/41.1.51
   Bates CJ, 1999, EUR J CLIN NUTR, V53, P694, DOI 10.1038/sj.ejcn.1600834
   Beaufrère B, 2000, EUR J CLIN NUTR, V54, pS162, DOI 10.1038/sj.ejcn.1601040
   Biro G, 1996, EUR J CLIN NUTR, V50, P201
   Burger J, 2000, ENVIRON RES, V83, P140, DOI 10.1006/enrs.2000.4060
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Davis MA, 2000, J NUTR, V130, P2256, DOI 10.1093/jn/130.9.2256
   del Pozo S, 2003, Nutr Hosp, V18, P348
   DESOR JA, 1975, SCIENCE, V190, P686, DOI 10.1126/science.1188365
   Dynesen AW, 2003, EUR J CLIN NUTR, V57, P1586, DOI 10.1038/sj.ejcn.1601728
   Fagerli RA, 1999, APPETITE, V32, P171, DOI 10.1006/appe.1998.0188
   FODOR GJ, 2004, J MENT HLTH GENDER, V1, P32
   GOODWIN JS, 1989, AM J CLIN NUTR, V50, P1201, DOI 10.1093/ajcn/50.5.1201
   Gregory J., 1990, DIETARY NUTR SURVEY
   Grumbach M., 2004, Journal of Mens Health and Gender, V1, P12
   Gy Biro., 1994, Nepegeszsegugy, V75, P129
   HAUTVAST JGAJ, 1991, EUR J CLIN NUTR, V45, P3
   *HUNG CENTR STAT O, 2001, YB HLTH STAT 2000
   Leite MLC, 2003, EUR J CLIN NUTR, V57, P1522, DOI 10.1038/sj.ejcn.1601720
   Moore AA, 1999, J AM GERIATR SOC, V47, P412, DOI 10.1111/j.1532-5415.1999.tb07232.x
   MORO NH, 1989, NUTR AGING ELDERLY, P75
   MURPHY C, 1989, NUTR AGING ELDERLY, P79
   NES M, 1991, EUR J CLIN NUTR, V45, P97
   Rurik I, 2003, ACTA ALIMENT HUNG, V32, P363, DOI 10.1556/AAlim.32.2003.4.4
   Rurik I, 2003, ACTA ALIMENT HUNG, V32, P77, DOI 10.1556/AAlim.32.2003.1.9
   Schafer RB, 1999, SOC SCI MED, V48, P787, DOI 10.1016/S0277-9536(98)00377-3
   Shatenstein B, 2004, J Nutr Health Aging, V8, P83
   Siega-Riz AM, 2000, PREV MED, V30, P415, DOI 10.1006/pmed.2000.0651
   THIERNEY LM, 1999, CURRENT MED DIAGNOSI
   THOMPSON FE, 1994, J NUTR, V124, pS2245, DOI 10.1093/jn/124.suppl_11.2245s
   1992, 5943 A NUTR SCREEN I, P1
NR 33
TC 17
Z9 20
U1 0
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-6807
EI 1421-9697
J9 ANN NUTR METAB
JI Ann. Nutr. Metab.
PY 2006
VL 50
IS 1
BP 45
EP 50
DI 10.1159/000089564
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 003ZB
UT WOS:000234720700008
PM 16276075
DA 2025-04-28
ER

PT J
AU Kim, HS
   Jae-Hak, M
   Kim, YM
   Huh, JY
AF Kim, Hae-Soo
   Jae-Hak, Moon
   Kim, Young-Min
   Huh, Joo-Young
TI Epigallocatechin Exerts Anti-Obesity Effect in Brown Adipose Tissue
SO CHEMISTRY & BIODIVERSITY
LA English
DT Article
DE anti-obesity; (-)-epigallocatechin; (-)-epigallocatechin gallate; gallic
   acid
ID OBESITY; EXPRESSION; (-)-EPIGALLOCATECHIN-3-GALLATE; DIFFERENTIATION;
   ADIPOGENESIS; CATECHINS; CAFFEINE; GENE; FAT
AB Catechins in green tea are well-known to be effective in reducing the risk of obesity. The purpose of this study was to elucidate the effects of catechins present in green tea on adipocyte differentiation and mature adipocyte metabolism. Treatment of 3T3-L1 mouse adipocyte during differentiation adipocytes with (-)-epigallocatechin (EGC) and gallic acid (GA) resulted in dose-dependent inhibition of adipogenesis. Specifically, EGC increased adiponectin and uncoupling protein 1 (UCP1) transcription in mature adipocytes. Transcription levels of adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) were not significantly impacted by either of the compounds. These results suggest that the EGC is the most effective catechin having anti-obesity activity. Finally, EGC is an attractive candidate component for remodeling obesity.
C1 [Kim, Hae-Soo; Jae-Hak, Moon; Kim, Young-Min] Chonnam Natl Univ, Dept Food Sci & Technol, Gwangju 61186, South Korea.
   [Huh, Joo-Young] Chonnam Natl Univ, Coll Pharm, Gwangju 61186, South Korea.
C3 Chonnam National University; Chonnam National University
RP Kim, YM (corresponding author), Chonnam Natl Univ, Dept Food Sci & Technol, Gwangju 61186, South Korea.; Huh, JY (corresponding author), Chonnam Natl Univ, Coll Pharm, Gwangju 61186, South Korea.
EM u9897854@jnu.ac.kr; jooyhuh@jnu.ac.kr
OI KIM, YoungMin/0000-0002-2559-9182
FU 'Cooperative Research Program for Agriculture Science and Technology
   Development', Rural Development Administration, Republic of Korea
   [PJ012565]
FX This research was supported by the support of 'Cooperative Research
   Program for Agriculture Science and Technology Development (Project No.
   PJ012565)', Rural Development Administration, Republic of Korea.
CR Beemelmanns C, 2017, ORG LETT, V19, P1000, DOI 10.1021/acs.orglett.6b03831
   Chen ZY, 2001, J AGR FOOD CHEM, V49, P477, DOI 10.1021/jf000877h
   Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Fruh SM, 2017, J AM ASSOC NURSE PRA, V29, pS3, DOI 10.1002/2327-6924.12510
   Goto T, 1996, J CHROMATOGR A, V749, P295, DOI 10.1016/0021-9673(96)00456-6
   Huh JY, 2018, J ENZYM INHIB MED CH, V33, P1167, DOI 10.1080/14756366.2018.1491846
   Huh JY, 2017, BIOCHEM BIOPH RES CO, V491, P890, DOI 10.1016/j.bbrc.2017.07.132
   Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324
   Jou PC, 2010, J AGR FOOD CHEM, V58, P12703, DOI 10.1021/jf103121c
   Klaus S, 1997, BIOESSAYS, V19, P215, DOI 10.1002/bies.950190307
   Kopalli SR, 2016, J GINSENG RES, V40, P185, DOI 10.1016/j.jgr.2015.08.005
   Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363
   Lee M. S., 2017, FOOD RES, V61
   Lin J, 2005, OBES RES, V13, P982, DOI 10.1038/oby.2005.115
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263
   Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044
   Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200
   SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243
   Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75
   Sung HY, 2010, N-S ARCH PHARMACOL, V382, P303, DOI 10.1007/s00210-010-0547-0
   Tipoe George L., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P135
   Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033
   Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487
   Zhang YN, 2016, FOOD CHEM, V192, P470, DOI 10.1016/j.foodchem.2015.07.046
NR 26
TC 13
Z9 14
U1 5
U2 40
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1612-1872
EI 1612-1880
J9 CHEM BIODIVERS
JI Chem. Biodivers.
PD OCT
PY 2019
VL 16
IS 10
DI 10.1002/cbdv.201900347
EA SEP 2019
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA JF4KW
UT WOS:000486831300001
PM 31532890
DA 2025-04-28
ER

PT J
AU Seliske, LM
   Pickett, W
   Boyce, WF
   Janssen, I
AF Seliske, Laura M.
   Pickett, William
   Boyce, William F.
   Janssen, Ian
TI Density and type of food retailers surrounding Canadian schools:
   Variations across socioeconomic status
SO HEALTH & PLACE
LA English
DT Article
DE Food; Residence characteristics; Social class; Schools
ID BODY-MASS INDEX; NEIGHBORHOOD CHARACTERISTICS; UNITED-STATES;
   RESTAURANTS; CHILDREN; OBESITY; SUPERMARKETS; AVAILABILITY;
   ASSOCIATIONS; ENVIRONMENTS
AB Lower socioeconomic status (SES) neighbourhoods may have differential access to food retailers, potentially explaining the varying area-level obesity rates. The food retail environment around 188 schools across Canada was examined, including full-service restaurants, fast food restaurants, sub/sandwich retailers, donut/coffee shops, convenience stores, and grocery stores. School addresses were linked to census data to obtain area-level SES measures. Access to food retailers was generally not associated with the neighbourhood SES in the immediate proximity. Within the broader neighbourhood, lower SES neighbourhoods had access to fewer food retailers of all types. This effect was diminished after taking population density into account. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON K7L 3N6, Canada.
   [Pickett, William] Queens Univ, Dept Emergency Med, Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada.
   [Boyce, William F.] Queens Univ, Social Program, Evaluat Grp, Fac Educ, Kingston, ON K7L 3N6, Canada.
   [Seliske, Laura M.; Pickett, William; Boyce, William F.; Janssen, Ian] Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON K7L 3N6, Canada.
C3 Queens University - Canada; Queens University - Canada; Queens
   University Hospital; Queens University - Canada; Queens University -
   Canada
RP Janssen, I (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON K7L 3N6, Canada.
EM ian.janssen@queensu.ca
RI Janssen, Ian/B-7700-2009
OI Janssen, Ian/0000-0003-2159-3012
CR Apparicio P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-4
   Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341
   Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007
   Boone JE, 2008, ANN EPIDEMIOL, V18, P371, DOI 10.1016/j.annepidem.2007.11.008
   Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112
   Burdette HL, 2004, PREV MED, V38, P57, DOI 10.1016/j.ypmed.2003.09.029
   CHANDON P, 2007, J CONSUMER RES, V34
   Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276
   Cummins SCJ, 2005, AM J PREV MED, V29, P308, DOI 10.1016/j.amepre.2005.06.011
   Janssen I, 2006, AM J CLIN NUTR, V83, P139
   JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133
   Macintyre Sally, 2005, Int J Behav Nutr Phys Act, V2, P16, DOI 10.1186/1479-5868-2-16
   Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040
   Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003
   Oliver LN, 2005, CAN J PUBLIC HEALTH, V96, P415, DOI 10.1007/BF03405180
   Powell LA, 2007, AM J PREV MED, V33, pS240, DOI 10.1016/j.amepre.2007.07.005
   Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008
   Reidpath DD, 2002, HEALTH PLACE, V8, P141, DOI 10.1016/S1353-8292(01)00028-4
   Shields Margot, 2006, Health Rep, V17, P27
   Smoyer-Tomic KE, 2008, HEALTH PLACE, V14, P740, DOI 10.1016/j.healthplace.2007.12.001
   Sturm R, 2005, PUBLIC HEALTH, V119, P1059, DOI 10.1016/j.puhe.2005.05.007
   Terpstra TJ, 1952, INDAGATIONES MATHEMA, V14, P327, DOI [DOI 10.1016/S1385-7258(52)50043-X, 10.1016/s1385-7258(52)50043-x, 10.1016/S1385-7258(52)50043-X]
   Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680
NR 23
TC 32
Z9 35
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1353-8292
EI 1873-2054
J9 HEALTH PLACE
JI Health Place
PD SEP
PY 2009
VL 15
IS 3
BP 903
EP 907
DI 10.1016/j.healthplace.2008.11.001
PG 5
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA 460JI
UT WOS:000267183600030
PM 19121973
DA 2025-04-28
ER

PT J
AU Engin, AB
   Tsatsakis, AM
   Tsoukalas, D
   Engin, A
AF Engin, Ayse Basak
   Tsatsakis, Aristidis M.
   Tsoukalas, Dimitris
   Engin, Atilla
TI Do flavanols-rich natural products relieve obesity-related insulin
   resistance?
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Review
DE Insulin resistance; Obesity; Polyphenols; Cocoa; Coffee; G
   protein-coupled estrogen receptor
ID NONALCOHOLIC FATTY LIVER; DIET-INDUCED OBESITY; PROTEIN-KINASE-C;
   ADIPOSE-TISSUE; MITOCHONDRIAL DYSFUNCTION; ENDOTHELIAL FUNCTION;
   BLOOD-PRESSURE; METABOLIC SYNDROME; OXIDATIVE STRESS; DARK CHOCOLATE
AB Growing evidence support that insulin resistance may occur as a severe problem due to chronic energetic overfeeding and subsequent obesity. When an abundance of glucose and saturated fat enter the cell, impaired blood flow, hypoxia, inflammation and macrophage infiltration in obese adipose tissue may induce oxidative stress and insulin resistance. Excessive circulating saturated fatty acids ectopically accumulate in insulin-sensitive tissues and impair insulin action. In this context, excessive hepatic lipid accumulation may play a central, pathogenic role in insulin resistance. It is thought that dietary polyphenols may ameliorate obesity-related insulin resistance by attenuating inflammatory responses and oxidative stress. The most often occurring natural polyphenolic compounds are flavonoids. In this review, the possible mechanistic effect of flavonoid-rich natural products on insulin resistance-related metabolic pathways is discussed. Polyphenol intake can prevent high-fat diet-induced insulin resistance via cell surface G protein-coupled estrogen receptors by upregulating the expression of related genes, and their pathways, which are responsible for the insulin sensitivity.
C1 [Engin, Ayse Basak] Gazi Univ, Fac Pharm, Dept Toxicol, TR-06330 Ankara, Turkey.
   [Tsatsakis, Aristidis M.] Univ Crete, Med Sch, Lab Toxicol & Forens, Iraklion, Crete, Greece.
   [Tsoukalas, Dimitris] Univ Crete, Med Sch, Lab Toxicol, Iraklion, Crete, Greece.
   [Engin, Atilla] Gazi Univ, Fac Med, Dept Gen Surg, Ankara, Turkey.
C3 Gazi University; University of Crete; University of Crete; Gazi
   University
RP Engin, AB (corresponding author), Gazi Univ, Fac Pharm, Dept Toxicol, TR-06330 Ankara, Turkey.
EM abengin@gmail.com
RI TSOUKALAS, DIMITRIS/JNS-3199-2023; TSATSAKIS, ARISTIDIS/H-2890-2013
OI Engin, Ayse Basak/0000-0003-1300-4644; TSATSAKIS,
   ARISTIDIS/0000-0003-3824-2462; Tsoukalas, Dimitris/0000-0001-6885-6209
CR Adamson GE, 1999, J AGR FOOD CHEM, V47, P4184, DOI 10.1021/jf990317m
   Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200
   Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047
   Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603
   Ali MM, 2004, Z NATURFORSCH C, V59, P726
   Alunad F., 1997, J CLIN INVEST, V100, P449
   Baeza G, 2016, J AGR FOOD CHEM, V64, P9663, DOI 10.1021/acs.jafc.6b04022
   Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351
   Banks WA, 2008, CURR PHARM DESIGN, V14, P1606, DOI 10.2174/138161208784705496
   Beaudoin MS, 2013, APPL PHYSIOL NUTR ME, V38, P140, DOI 10.1139/apnm-2012-0201
   Bloch-Damti A, 2006, DIABETOLOGIA, V49, P2463, DOI 10.1007/s00125-006-0349-6
   Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008
   Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411
   Buijsse B, 2010, EUR HEART J, V31, P1616, DOI 10.1093/eurheartj/ehq068
   Calabrò P, 2009, INTERN EMERG MED, V4, P25, DOI 10.1007/s11739-008-0207-2
   Caprioli G, 2015, INT J FOOD SCI NUTR, V66, P505, DOI 10.3109/09637486.2015.1064871
   Caprioli G, 2014, INT J FOOD SCI NUTR, V65, P465, DOI 10.3109/09637486.2013.873890
   Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003
   Carr AC, 2000, ARTERIOSCL THROM VAS, V20, P1716, DOI 10.1161/01.ATV.20.7.1716
   Cavia-Saiz M, 2010, J SCI FOOD AGR, V90, P1238, DOI 10.1002/jsfa.3959
   Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634
   Chan CY, 2011, LIFE SCI, V89, P779, DOI 10.1016/j.lfs.2011.09.006
   Chin JM, 2008, J ANAL TOXICOL, V32, P702, DOI 10.1093/jat/32.8.702
   Chiva-Blanch G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5812401
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9
   Costa C, 2017, FOOD CHEM TOXICOL, V110, P286, DOI 10.1016/j.fct.2017.10.023
   Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198
   Croft KD, 1998, ANN NY ACAD SCI, V854, P435, DOI 10.1111/j.1749-6632.1998.tb09922.x
   Curtis PJ, 2012, DIABETES CARE, V35, P226, DOI 10.2337/dc11-1443
   Davison K, 2008, INT J OBESITY, V32, P1289, DOI 10.1038/ijo.2008.66
   DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173
   Di Girolamo FG, 2016, NUTRITION, V32, P928, DOI 10.1016/j.nut.2016.02.001
   Dorenkott MR, 2014, J AGR FOOD CHEM, V62, P2216, DOI 10.1021/jf500333y
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Engin A, 2017, ADV EXP MED BIOL, V960, P1, DOI 10.1007/978-3-319-48382-5_1
   Engin AB, 2015, WORLD J GASTROENTERO, V21, P3636, DOI 10.3748/wjg.v21.i12.3636
   Engin AB, 2011, CURR DRUG METAB, V12, P891
   Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516
   Faridi Z, 2008, AM J CLIN NUTR, V88, P58, DOI 10.1093/ajcn/88.1.58
   Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42
   Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002
   Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/00004872-200312000-00016
   Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200
   Fukuchi Y, 2008, J CLIN BIOCHEM NUTR, V43, P201, DOI 10.3164/jcbn.2008066
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   García-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313
   Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010
   Gopinath K, 2012, NEUROSCIENCE, V227, P134, DOI 10.1016/j.neuroscience.2012.07.060
   Gorjanovic S, 2017, J FOOD SCI TECH MYS, V54, P2324, DOI 10.1007/s13197-017-2672-y
   Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70
   Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671
   Grassi D, 2013, CURR OPIN CLIN NUTR, V16, P662, DOI 10.1097/MCO.0b013e3283659a51
   Guarino MP, 2013, AGE, V35, P1755, DOI 10.1007/s11357-012-9475-x
   Guasch-Ferré M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6723931
   Guimaraes R, 2010, FOOD CHEM TOXICOL, V48, P99, DOI 10.1016/j.fct.2009.09.022
   Hajduch E, 2008, BIOCHEM J, V410, P369, DOI 10.1042/BJ20070936
   Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hassan RH, 2014, WORLD J DIABETES, V5, P244, DOI 10.4239/wjd.v5.i3.244
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Holt RR, 2002, AM J CLIN NUTR, V76, P798, DOI 10.1093/ajcn/76.4.798
   Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005
   Jain M, 2011, INFLAMM RES, V60, P483, DOI 10.1007/s00011-010-0295-0
   Janszky I, 2009, J INTERN MED, V266, P248, DOI 10.1111/j.1365-2796.2009.02088.x
   Jennings A, 2014, J NUTR, V144, P202, DOI 10.3945/jn.113.184358
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kalmijn S, 2000, ARTERIOSCL THROM VAS, V20, P2255, DOI 10.1161/01.ATV.20.10.2255
   Karim M, 2000, J NUTR, V130, p2105S, DOI 10.1093/jn/130.8.2105S
   Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11
   Keaver L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079827
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Kris-Etherton PM, 2002, CURR OPIN LIPIDOL, V13, P41, DOI 10.1097/00041433-200202000-00007
   Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P181, DOI 10.1080/09637480050029683
   Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213
   Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200
   Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200
   Lee Y, 2017, J MED FOOD, V20, P610, DOI 10.1089/jmf.2016.3911
   Li Y, 2011, DIABETES RES CLIN PR, V93, P205, DOI 10.1016/j.diabres.2011.03.036
   Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Lorenz M, 2007, EUR HEART J, V28, P219, DOI 10.1093/eurheartj/ehl442
   Lu NH, 2011, TOXICOL IN VITRO, V25, P833, DOI 10.1016/j.tiv.2011.02.003
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI [10.1039/C4FO00042K, 10.1039/c4fo00042k]
   Ma LN, 2015, CLIN CHIM ACTA, V444, P18, DOI 10.1016/j.cca.2015.01.027
   Mack E, 2008, DIABETES-METAB RES, V24, P577, DOI 10.1002/dmrr.881
   Mackenzie GG, 2004, FASEB J, V18, P167, DOI 10.1096/fj.03-0402fje
   Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI 10.1093/ajcn/81.1.230S
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mao T., 2000, Journal of Medicinal Food, V3, P107
   Mao T K, 2002, Dev Immunol, V9, P135
   Mao TK, 2000, LIFE SCI, V66, P1377, DOI 10.1016/S0024-3205(00)00449-5
   Matsui N, 2005, NUTRITION, V21, P594, DOI 10.1016/j.nut.2004.10.008
   Moller DE, 2003, INT J OBESITY, V27, pS17, DOI 10.1038/sj.ijo.0802494
   Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883
   Moreno-Ulloa A, 2015, PHARMACOL RES, V100, P309, DOI 10.1016/j.phrs.2015.08.014
   Moreno-Ulloa A, 2014, BIOORG MED CHEM LETT, V24, P2749, DOI 10.1016/j.bmcl.2014.04.038
   Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024
   Nakagami H, 2005, CURR DIABETES REV, V1, P59, DOI 10.2174/1573399052952550
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Njike VY, 2011, INT J CARDIOL, V149, P83, DOI 10.1016/j.ijcard.2009.12.010
   Oberhauser F, 2012, HORM METAB RES, V44, P465, DOI 10.1055/s-0032-1306341
   Ogura K, 2016, J AGR FOOD CHEM, V64, P8857, DOI 10.1021/acs.jafc.6b03424
   Osakabe N, 1998, BIOSCI BIOTECH BIOCH, V62, P1535, DOI 10.1271/bbb.62.1535
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Park S, 2007, METABOLISM, V56, P599, DOI 10.1016/j.metabol.2006.12.004
   Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24
   Peng YH, 2016, J NEUROCHEM, V137, P701, DOI 10.1111/jnc.13563
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Pérez-Jiménez J, 2010, EUR J CLIN NUTR, V64, pS112, DOI 10.1038/ejcn.2010.221
   Perseghin G, 2009, DIABETES CARE, V32, pS164, DOI 10.2337/dc09-S303
   Pessayre D, 2004, EUR J GASTROEN HEPAT, V16, P1095, DOI 10.1097/00042737-200411000-00003
   Potashnik R, 2003, DIABETOLOGIA, V46, P639, DOI 10.1007/s00125-003-1097-5
   Punithavathi VR, 2008, J APPL TOXICOL, V28, P806, DOI 10.1002/jat.1343
   Rabinovitch RC, 2017, CELL REP, V21, P1, DOI 10.1016/j.celrep.2017.09.026
   Rakvaag E, 2016, EUR J NUTR, V55, P2221, DOI 10.1007/s00394-015-1032-9
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Rimbach G, 2009, INT J MOL SCI, V10, P4290, DOI 10.3390/ijms10104290
   Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062
   Rowley TJ, 2017, J NUTR BIOCHEM, V49, P30, DOI 10.1016/j.jnutbio.2017.07.015
   Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934
   Russo A, 2000, CELL BIOL TOXICOL, V16, P91, DOI 10.1023/A:1007685909018
   Sacramento JF, 2015, EUR J PHARM SCI, V70, P107, DOI 10.1016/j.ejps.2015.01.011
   Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400
   Sanbongi C, 1997, CELL IMMUNOL, V177, P129, DOI 10.1006/cimm.1997.1109
   Sano T, 2017, NUTR METAB CARDIOVAS, V27, P249, DOI 10.1016/j.numecd.2016.11.008
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096
   Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263
   Schewe T, 2001, BIOL CHEM, V382, P1687, DOI 10.1515/BC.2001.204
   Shamseddeen H, 2011, SURG CLIN N AM, V91, P1163, DOI 10.1016/j.suc.2011.08.001
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Shrime MG, 2011, J NUTR, V141, P1982, DOI 10.3945/jn.111.145482
   Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987
   Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011
   Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170
   Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   Tajiri Y, 2005, OBES RES, V13, P1810, DOI 10.1038/oby.2005.220
   Takahashi K, 2017, AGING-US, V9, P1863, DOI 10.18632/aging.101287
   Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003
   Tresserra-Rimbau A, 2016, J NUTR, V146, P767, DOI 10.3945/jn.115.223610
   Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054
   Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022
   Wang P, 2004, CELL MOL LIFE SCI, V61, P2405, DOI 10.1007/s00018-004-4256-z
   Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang Y, 2009, J ENDOCRINOL, V203, P65, DOI 10.1677/JOE-09-0026
   Watanabe S, 2017, METAB SYNDR RELAT D, V15, P170, DOI 10.1089/met.2016.0114
   Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685
   Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894
   Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335
   West SG, 2014, BRIT J NUTR, V111, P653, DOI 10.1017/S0007114513002912
   Wree A, 2011, DIGESTION, V83, P124, DOI 10.1159/000318741
   Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711
   Yeh TC, 2014, HYPERTENSION, V63, P535, DOI 10.1161/HYPERTENSIONAHA.113.02272
   Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104
   Zhang PW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000758
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
NR 170
TC 20
Z9 23
U1 0
U2 47
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD FEB
PY 2018
VL 112
BP 157
EP 167
DI 10.1016/j.fct.2017.12.055
PG 11
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA FW8GN
UT WOS:000425568900018
PM 29288757
DA 2025-04-28
ER

PT J
AU Zhou, JH
   Lin, HY
   Xu, P
   Yao, LY
   Xie, QY
   Mao, LM
   Wang, YF
AF Zhou, Jihong
   Lin, Haiyu
   Xu, Ping
   Yao, Liyun
   Xie, Qingyi
   Mao, Limin
   Wang, Yuefei
TI Matcha green tea prevents obesity-induced hypothalamic
   inflammationviasuppressing the JAK2/STAT3 signaling pathway
SO FOOD & FUNCTION
LA English
DT Article
ID INFLAMMATION; INHIBITION; DEFICIENCY; MICROGLIA; CAFFEINE; DISEASE;
   HEALTH; GROWTH; CANCER; MICE
AB Obesity is an increasingly severe global health problem, leading to chronic inflammation and metabolic disorders in both peripheral tissues and the central nervous system. Matcha is a powdered green tea, and it is very popular in recent years as a beverage and food additive. Matcha green tea has been reported to have outstanding potential in regulating obesity-related metabolic syndrome. However, there are few studies on the regulation mechanism of matcha green tea on the central nervous system. In this study, we established a high-fat diet-induced obese mouse model. The results showed that dietary supplementation with matcha could effectively inhibit the weight gain, fat accumulation, glycemia and lipidemia increase, and excessive activation of microglia in the arcuate nucleus of the hypothalamus. Furthermore, we used different concentrations (100%, 80%, 60%, 40%, and 20%, v/v) of ethanol solution to prepare matcha ethanol extracts, and investigated their effects on palmitic acid-induced inflammation of microglial BV-2 cells. The results showed that matcha ethanol extracts could significantly reduce the release of inflammatory cytokines and the expression and phosphorylation of JAK2 and STAT3.
C1 [Zhou, Jihong; Lin, Haiyu; Xu, Ping; Yao, Liyun; Xie, Qingyi; Mao, Limin; Wang, Yuefei] Zhejiang Univ, Tea Res Inst, Zijingang Campus, Hangzhou 310058, Peoples R China.
   [Mao, Limin] Zhejiang Tea Grp Co Ltd, Hangzhou 310058, Peoples R China.
C3 Zhejiang University
RP Wang, YF (corresponding author), Zhejiang Univ, Tea Res Inst, Zijingang Campus, Hangzhou 310058, Peoples R China.
EM zdcy@zju.edu.cn
RI wang, yue/ISA-4119-2023; Zhou, Jihong/AAQ-9034-2021
CR Ades PA, 2017, PREV MED, V104, P117, DOI 10.1016/j.ypmed.2017.04.013
   Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Al-Massri KF, 2018, NEUROCHEM INT, V120, P164, DOI 10.1016/j.neuint.2018.08.007
   Arnold M, 2016, CANCER EPIDEMIOL, V41, P8, DOI 10.1016/j.canep.2016.01.003
   Bae J, 2019, J NUTR BIOCHEM, V64, P152, DOI 10.1016/j.jnutbio.2018.10.014
   Bhagat AR, 2019, J AOAC INT, V102, P1365, DOI [10.5740/jaoacint.19-0129, 10.1093/jaoac/102.5.1365]
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551
   Butler MJ, 2020, HORM BEHAV, V120, DOI 10.1016/j.yhbeh.2020.104675
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Chowdhury A, 2016, BIOMED PHARMACOTHER, V78, P50, DOI 10.1016/j.biopha.2015.12.013
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S
   Ranilla LG, 2010, BIORESOURCE TECHNOL, V101, P4676, DOI 10.1016/j.biortech.2010.01.093
   Hyun P. J., 2018, NUTR RES, V70, P40
   Lee LS, 2014, MOLECULES, V19, P9173, DOI 10.3390/molecules19079173
   Lei ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091394
   Mao LM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205081
   Mutsnaini L, 2019, INFLAMM RES, V68, P351, DOI 10.1007/s00011-019-01222-2
   Park BS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121609
   Sun SW, 2006, J FOOD COMPOS ANAL, V19, P112, DOI 10.1016/j.jfca.2005.04.006
   Terrien J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56051-4
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Tsunekawa T, 2017, EBIOMEDICINE, V16, P172, DOI 10.1016/j.ebiom.2017.01.007
   Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018
   Wang Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040791
   Wang Z, 2012, BRIT J NUTR, V107, P229, DOI 10.1017/S0007114511002868
   Weng LH, 2017, INT IMMUNOPHARMACOL, V44, P1, DOI 10.1016/j.intimp.2016.12.018
   Wisse BE, 2009, CELL METAB, V10, P241, DOI 10.1016/j.cmet.2009.09.003
   Xu P, 2016, FOOD FUNCT, V7, P294, DOI 10.1039/c5fo00828j
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yamabe N, 2009, J MED FOOD, V12, P714, DOI 10.1089/jmf.2008.1282
   Ying L, 2018, J ZHEJIANG UNIV-SC B, V19, P199, DOI 10.1631/jzus.B1700162
   You PT, 2018, N-S ARCH PHARMACOL, V391, P743, DOI 10.1007/s00210-018-1503-7
   Yu XL, 2017, SPECTROSC SPECT ANAL, V37, P1908, DOI 10.3964/j.issn.1000-0593(2017)06-1908-04
   Zhao Y, 2017, EUR J NUTR, V56, P2309, DOI 10.1007/s00394-016-1271-4
   Zhou JH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111681
   Zhou KC, 2019, PHYTOMEDICINE, V59, DOI 10.1016/j.phymed.2019.152922
NR 38
TC 16
Z9 17
U1 3
U2 48
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD OCT 1
PY 2020
VL 11
IS 10
BP 8987
EP 8995
DI 10.1039/d0fo01500h
PG 9
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA OE6VW
UT WOS:000580667100044
PM 33001081
DA 2025-04-28
ER

PT J
AU Siqueira, JH
   Santana, NMT
   Pereira, TSS
   Moreira, AD
   Benseñor, IM
   Barreto, SM
   Velasquez-Melendez, G
   Molina, MDB
AF Siqueira, Jordana Herzog
   Teixeira Santana, Nathalia Miguel
   Silva Pereira, Taisa Sabrina
   Moreira, Alexandra Dias
   Bensenor, Isabela Martins
   Barreto, Sandhi Maria
   Velasquez-Melendez, Gustavo
   Bisi Molina, Maria del Carmen
TI Consumption of alcoholic and non-alcoholic beverages: ELSA-Brasil
   results
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Soft Drinks; Fruit Juices; Artificial Sweeteners; Alcoholic Beverages
ID SWEETENED BEVERAGES; GLYCEMIC LOAD; RISK; FOOD; OBESITY; DISEASE;
   HEALTH; METAANALYSIS; MORTALITY; WINE
AB The study aims to describe the consumption of alcoholic and non-alcoholic beverages according to sociodemographic, health and location variables. Cross-sectional study with ELSA-Brasil data (2008-2010). A questionnaire was used to collect sociodemographic, food, health data and anthropometry. Descriptive analysis and association with variables of interest were carried out. In the sample, 8% of the total caloric value comes from non-alcoholic beverages (5.6%: sugary drinks), and 4% from alcoholic beverages (2.7%: beer). Consumers of unsweetened and artificially sweetened beverages reported moderate/strong physical activity, former smokers and higher education. The opposite was true for sugary drinks. Eutrophic people reported higher consumption of sugary drinks and those obese, artificially sweetened and beer. Alcohol consumption varied with age (young: beer; elderly: wine/spirits) and education (low education: beer/spirits; higher education: wine). Coffee, natural juice and soda were the most consumed non-alcoholic beverages and beer was the most prevalent alcoholic beverage. Consumption variation was observed according to geographic location. The consumption of sugary and alcoholic beverages is high in Brazil and public health strategies are required.
C1 [Siqueira, Jordana Herzog; Bisi Molina, Maria del Carmen] Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29047105 Vitoria, ES, Brazil.
   [Teixeira Santana, Nathalia Miguel] Inst Fed Educ Ciencia & Tecnol Espirito Santo, Campus Santa Teresa, ES, Brazil.
   [Silva Pereira, Taisa Sabrina] Univ Amer Puebla, Dept Ciencias Saude, San Andres Cholula, Cholula, Brazil.
   [Moreira, Alexandra Dias; Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Dept Enfermagem Maternoinfantil & Saude Publ, Escola Enfermagem, Belo Horizonte, MG, Brazil.
   [Bensenor, Isabela Martins] Univ Sao Paulo, Fac Med, Dept Clin Med, Sao Paulo, SP, Brazil.
   [Barreto, Sandhi Maria] Univ Fed Minas Gerais, Fac Med, Dept Med Prevent & Social, Belo Horizonte, MG, Brazil.
C3 Universidade Federal do Espirito Santo; Instituto Federal do Espirito
   Santo (IFES); Universidade Federal de Minas Gerais; Universidade de Sao
   Paulo; Universidade Federal de Minas Gerais
RP Siqueira, JH (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Saude Colet, Av Marechal Campos 1468, BR-29047105 Vitoria, ES, Brazil.
EM jordana.herzog@gmail.com
RI Velasquez-Melendez, Gustavo/ACO-7729-2022; Bensenor,
   Isabela/L-3306-2017; Miguel Teixeira Santana, Nathália/HSF-6844-2023;
   Pereira, Taísa/AAB-3715-2021; Herzog Siqueira, Jordana/JAC-8661-2023;
   VELASQUEZ-MELENDEZ, GUSTAVO/A-5089-2008; Barreto, Sandhi/D-2855-2014
OI Silva Pereira, Taisa Sabrina/0000-0002-5922-7424; Miguel Teixeira
   Santana, Nathalia/0000-0003-0160-7659; VELASQUEZ-MELENDEZ,
   GUSTAVO/0000-0001-8349-5042; MOREIRA, ALEXANDRA/0000-0002-4477-5241;
   Bensenor, Isabela/0000-0002-6723-5678; Barreto,
   Sandhi/0000-0001-7383-7811; Molina, Maria del
   Carmen/0000-0002-8614-988X; Herzog Siqueira, Jordana/0000-0003-0116-7411
CR Aguiar DRD, 2009, STRUCTURAL CHANGES F, P151
   [Anonymous], 2025, Use of lower-sodium salt substitutes2025
   [Anonymous], 2010, EC BRAS PERSP
   [Anonymous], 2010, PESQ ORC FAM 2008 20
   Bezerra Ilana Nogueira, 2013, Rev Saude Publica, V47 Suppl 1, p200S, DOI 10.1590/S0034-89102013000700006
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968
   Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007
   Claro RM, 2012, AM J PUBLIC HEALTH, V102, P178, DOI 10.2105/AJPH.2011.300313
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Fernandes I, 2017, MOLECULES, V22, DOI 10.3390/molecules22020292
   Figueiredo N, 2018, PUBLIC HEALTH NUTR, V21, P3307, DOI 10.1017/S1368980018002161
   Fitzpatrick L, 2003, J BONE MINER RES, V18, P1570, DOI 10.1359/jbmr.2003.18.9.1570
   Griswold MG, 2018, Lancet, V392, P1015, DOI [DOI 10.1016/S0140-6736(18)31310-2, 10.1016/S0140-6736(18)31310-2]
   Haseeb S, 2017, CIRCULATION, V136, P1434, DOI 10.1161/CIRCULATIONAHA.117.030387
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576
   Institute for Health Metrics and Evaluation, 2013, GLOBAL BURDEN DIS CO
   Interministerial Food and Nutrition Security Chamber, 2015, BRAZ COMM UN DEC ACT
   Johnson RK, 2018, CIRCULATION, V138, pE126, DOI 10.1161/CIR.0000000000000569
   Knott CS, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h384, 10.1136/bmj.h384]
   Krenz M, 2012, J MOL CELL CARDIOL, V52, P93, DOI 10.1016/j.yjmcc.2011.10.011
   Levy-Costa RB, 2005, REV SAUDE PUBL, V39, P530, DOI 10.1590/S0034-89102005000400003
   Livesey G, 2013, AM J CLIN NUTR, V97, P584, DOI 10.3945/ajcn.112.041467
   Machado Ie, 2018, REV BRAS EPIDEMIOL, V20, P408
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Matsudo V., 2011, ATIVIDADE FISICA SAU, V6, P5
   Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
   Molina Maria Del Carmen Bisi, 2013, Cad Saude Publica, V29, P379, DOI 10.1590/S0102-311X2013000600024
   Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252
   Monteiro CA, 2008, REV SAUDE PUBL, V42, P582, DOI 10.1590/S0034-89102008000400002
   Mossavar-Rahmani Y, 2019, STROKE, V50, P555, DOI 10.1161/STROKEAHA.118.023100
   Muhlack E, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5948-x
   Mukamal KJ, 2005, CIRCULATION, V112, P1406, DOI 10.1161/CIRCULATIONAHA.105.537704
   Neves Alice Cristina Medeiros das, 2010, Cad. Saúde Pública, V26, P2379, DOI 10.1590/S0102-311X2010001200016
   Pan American Health Organization (PAHO), 2015, Regional Status Report on Alcohol and Health in the Americas
   Pearlman Michelle, 2017, Curr Gastroenterol Rep, V19, P64, DOI 10.1007/s11894-017-0602-9
   Pereira RA, 2015, PUBLIC HEALTH NUTR, V18, P1164, DOI 10.1017/S1368980014001657
   Pereira RA, 2014, PUBLIC HEALTH NUTR, V17, P113, DOI 10.1017/S1368980012004892
   Piano MR, 2017, ALCOHOL RES-CURR REV, V38, P219
   Rivera JA, 2008, SALUD PUBLICA MEXICO, V50, P173, DOI 10.1590/S0036-36342008000200011
   Roerecke M, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008202
   Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
   Shearer J, 2016, REV ENDOCR METAB DIS, V17, P179, DOI 10.1007/s11154-016-9372-1
   Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005
   Stanhope KL, 2012, ANNU REV MED, V63, P329, DOI 10.1146/annurev-med-042010-113026
   Stockwell T., 2000, INT GUID MON ALC CON
   Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185
   Temple NJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010039
   Traversy G, 2015, CURR OBES REP, V4, P122, DOI 10.1007/s13679-014-0129-4
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S
NR 52
TC 3
Z9 3
U1 2
U2 22
PU ABRASCO -  Brazilian Association of Collective Health
PI RIO DE JANEIRO
PA Ave Brasil 4365, Campus da Fundacao Oswaldo Cruz (Fiocruz)  Predio do
   CEPI  DSS  Manguinhos, RIO DE JANEIRO, Rio de Janeiro, BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD AUG
PY 2021
VL 26
SU 2
BP 3825
EP 3837
DI 10.1590/1413-81232021269.2.30682019
PG 13
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA UK3PE
UT WOS:000691884100041
PM 34468676
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU An, RP
AF An, Ruopeng
TI Beverage Consumption in Relation to Discretionary Food Intake and Diet
   Quality among US Adults, 2003 to 2012
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
DE Beverages; Snacks; Energy intake; Diet quality; 24-Hour dietary recall
ID SUGAR-SWEETENED BEVERAGES; BODY-WEIGHT; METABOLIC SYNDROME; SNACKING;
   PATTERNS; ENERGY; RISK; METAANALYSIS; AMERICANS; CHILDREN
AB Background A majority of Americans consume beverages and discretionary foods - foods that are typically low in nutrient value but high in sugar, sodium, fats, and cholesterol-as part of their daily diet, which profoundly impacts their energy balance and nutritional status.
   Objective This study examined consumption of different types of beverages in relation to discretionary food intake and diet quality among US adults.
   Methods Nationally representative sample of 22,513 adults from the National Health and Nutrition Examination Survey 2003 to 2012 waves were analyzed. The discretionary food category identifies energy-dense, nutrient-poor food products that do not necessarily provide essential nutrients that the human body needs, but can add variety. First-difference estimator addressed confounding bias from time-invariant unobservables (eg, eating habits, taste preferences) by using within-individual variations in diet and beverage consumption between 2 nonconsecutive 24-hour dietary recalls.
   Results Approximately 21.7%, 42.9%, 52.8%, 26.3%, and 22.2% of study participants consumed diet beverage, sugar-sweetened beverage (SSB), coffee, tea, and alcohol, respectively, and 90.1% consumed discretionary foods on any given day. Across beverage types, alcohol (384.8 kcal) and SSB (226.2 kcal) consumption was associated with the largest increase in daily total calorie intake; coffee (60.7 kcal) and diet-beverage (48.8 kcal) consumption was associated with the largest increase in daily calorie intake from discretionary foods, and SSB consumption was associated with the largest reduction in daily overall diet quality measured by the Healthy Eating Index 2010. The impact of beverage consumption on daily calorie intake (overall and from discretionary foods) and diet quality differed across individual sociodemographics and body-weight status. The incremental daily calorie intake from discretionary foods associated with diet-beverage consumption was highest in obese adults, and that associated with SSB was highest in normal-weight adults.
   Conclusions Interventions to promote healthy eating should assess beverage consumption in the context of overall dietary behavior.
C1 [An, Ruopeng] Univ Illinois, Coll Appl Hlth Sci, Dept Kinesiol & Community Hlth, Champaign, IL 61820 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign
RP An, RP (corresponding author), Univ Illinois, Coll Appl Hlth Sci, Dept Kinesiol & Community Hlth, 1206 South 4th St, Champaign, IL 61820 USA.
EM ran5@illinois.edu
OI An, Ruopeng/0000-0001-9632-0209
CR [Anonymous], HLTH EAT IND
   [Anonymous], 2013, AUSTR DIET GUID
   [Anonymous], 2010, Dietary Guidelines for Americans
   Appleton KM, 2001, APPETITE, V37, P225, DOI 10.1006/appe.2001.0435
   Bellisle F, 2007, EUR J CLIN NUTR, V61, P691, DOI 10.1038/sj.ejcn.1602649
   Binkley J, 2007, APPETITE, V49, P561, DOI 10.1016/j.appet.2007.03.225
   Bleich SN, 2014, AM J PUBLIC HEALTH, V104, pE72, DOI 10.2105/AJPH.2013.301556
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007
   Bowman S.A., 2008, MYPYRAMID EQUIVALENT
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Drummond S, 1996, EUR J CLIN NUTR, V50, P779
   Fakhouri Tala H I, 2012, NCHS Data Brief, P1
   FDA (Food and Drug Administration), 2013, GUID IND FOOD LAB GU, P127
   Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016
   Hampl JS, 2003, J HUM NUTR DIET, V16, P3, DOI 10.1046/j.1365-277X.2003.00417.x
   Holt SHA, 2000, INT J FOOD SCI NUTR, V51, P59, DOI 10.1080/096374800100912
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Keast DR, 2010, AM J CLIN NUTR, V92, P428, DOI 10.3945/ajcn.2009.28421
   Kerver JM, 2006, J AM DIET ASSOC, V106, P46, DOI 10.1016/j.jada.2005.09.045
   Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826
   Larson MR, 2000, INT J OBESITY, V24, P663, DOI 10.1038/sj.ijo.0801233
   Leblanc V, 2015, J HUM NUTR DIET, V28, P37, DOI 10.1111/jhn.12213
   Lucan SC, 2010, AM J PUBLIC HEALTH, V100, P631, DOI 10.2105/AJPH.2009.172692
   Malik AH, 2014, AM J CARDIOL, V113, P1574, DOI 10.1016/j.amjcard.2014.01.437
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mattes RD, 2011, OBES REV, V12, P346, DOI 10.1111/j.1467-789X.2010.00755.x
   Morley JE, 2001, J GERONTOL A-BIOL, V56, P81, DOI 10.1093/gerona/56.suppl_2.81
   National Cancer Institute, 2014, HEI TOOLS RES
   Ogden Cynthia L, 2011, NCHS Data Brief, P1
   Park S, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130304
   Piernas C, 2010, HEALTH AFFAIR, V29, P398, DOI 10.1377/hlthaff.2009.0666
   Rehm CD, 2008, J URBAN HEALTH, V85, P375, DOI 10.1007/s11524-008-9269-8
   US National Cancer Institute, 2005, SOURC BEV INT US POP
NR 35
TC 57
Z9 61
U1 0
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 2212-2672
EI 2212-2680
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD JAN
PY 2016
VL 116
IS 1
BP 28
EP 37
DI 10.1016/j.jand.2015.08.009
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA CZ3MV
UT WOS:000367009100005
PM 26372338
DA 2025-04-28
ER

PT J
AU O'Connor, L
   Imamura, F
   Brage, S
   Griffin, SJ
   Wareham, NJ
   Forouhi, NG
AF O'Connor, Laura
   Imamura, Fumiaki
   Brage, Soren
   Griffin, Simon J.
   Wareham, Nicholas J.
   Forouhi, Nita G.
TI Intakes and sources of dietary sugars and their association with
   metabolic and inflammatory markers
SO CLINICAL NUTRITION
LA English
DT Article
DE Sugars; Free sugar; Metabolic; Inflammation; Glycaemia
ID SWEETENED BEVERAGE CONSUMPTION; DAIRY PRODUCT INTAKE; PHYSICAL-ACTIVITY;
   RISK; OBESITY; MORTALITY; CANCER; YOUTH; YOUNG
AB Background & aims: Associations of dietary sugars with metabolic and inflammatory markers may vary according to the source of the sugars. The aim of this study was to examine the association of dietary sugars from different sources [beverages (liquids), foods (solids), extrinsic (free) or intrinsic (non-free)] with metabolic and inflammatory markers.
   Methods: Population-based cross-sectional study of adults in the East of England (n = 9678). Sugar intakes were estimated using food frequency questionnaires. Fasting glycated haemoglobin, glucose, insulin, and C-Reactive Protein (CRP) were measured and indices of metabolic risk were derived (homeostatic model of insulin resistance, HOMA-IR and metabolic risk z-score).
   Results: In multiple linear regression analyses adjusted for potential confounders including BMI and TEI, sugars from liquids were positively associated with In-CRP [b-coefficient (95%CI), 0.14 (0.05,0.22) per 10% TEI] and metabolic risk z-score [0.13 (0.07,0.18)]. Free sugars were positively associated with In-HOMA-IR [0.05 (0.03,0.08)] and metabolic risk z-score [0.09 (0.06,0.12)]. Sugars from solids were not associated with any outcome. Among major dietary contributors to intakes (g/d), sugars in fruit, vegetables, dairy products/egg dishes, cakes/biscuits/confectionary and squash/juice drinks were not associated, but sugar added to tea, coffee, cereal was significantly positively associated with all outcomes. Sugars in 100% juice [0.16 (0.06,0.25) per 10%TEI] and other non-alcoholic beverages [0.13 (0.03,0.23)] were positively associated with metabolic risk z-score.
   Conclusion: Higher intakes of sugars from non-alcoholic beverages and sugar added to tea, coffee, cereal were associated with glycaemia and inflammatory markers. Sugars from solids were not associated, irrespective of whether they were intrinsic or extrinsic. Positive associations of free sugars were largely explained by contribution of beverages to intake. (C) 2017 The Author(s). Published by Elsevier Ltd.
C1 [O'Connor, Laura; Imamura, Fumiaki; Brage, Soren; Griffin, Simon J.; Wareham, Nicholas J.; Forouhi, Nita G.] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Inst Metab Sci, Cambridge Biomed Campus,POB 285, Cambridge CB2 0QQ, England.
   [O'Connor, Laura] Manchester Metropolitan Univ, Fac Hlth Psychol & Social Care, Dept Hlth Profess, Manchester, Lancs, England.
   [Griffin, Simon J.] Univ Cambridge, Primary Care Unit, Dept Publ Hlth & Primary Care, Sch Clin Med,Inst Publ Hlth, Cambridge Biomed Campus, Cambridge, England.
C3 University of Cambridge; Manchester Metropolitan University; University
   of Cambridge
RP O'Connor, L; Forouhi, NG (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Inst Metab Sci, Cambridge Biomed Campus,POB 285, Cambridge CB2 0QQ, England.
EM laura.oconnor@mmu.ac.uk; nita.forouhi@mrc-epid.cam.ac.uk
RI Forouhi, Nita/JAC-2361-2023; Timpson, Nicholas/O-7548-2015; O'Connor,
   Laura/ABD-7999-2021; Imamura, Fumiaki/J-1038-2019; Griffin,
   Simon/K-3106-2013; Brage, Soren/C-6415-2013
OI Imamura, Fumiaki/0000-0002-6841-8396; Forouhi, Nita/0000-0002-5041-248X;
   Keyes, Laura/0000-0002-6022-2022; Griffin, Simon/0000-0002-2157-4797;
   Brage, Soren/0000-0002-1265-7355
FU Wellcome Trust; Medical Research Council [MC_UU_12015/1, MC_UU_12015/5];
   MRC [MC_U106179473, MC_UU_12015/5, MC_UU_12015/3, MC_UU_12015/1,
   MC_UU_12015/4, MC_PC_13046] Funding Source: UKRI
FX The Fenland Study is funded by the Wellcome Trust and the Medical
   Research Council. Support from Medical Research Council programmes
   MC_UU_12015/1 and MC_UU_12015/5 is acknowledged.
CR Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432
   Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137
   Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102
   Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141
   Brage S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137206
   Chen M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0215-1
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997
   Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Kelly SA, 2003, PLOS ONE, V16, P9
   Kelly SAM, 2003, J HUM NUTR DIET, V16, P27, DOI 10.1046/j.1365-277X.2003.00414.x
   Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3
   Ma JT, 2014, J NUTR, V144, P1283, DOI 10.3945/jn.113.188599
   Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E7492
   Mulligan AA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004503
   Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001
   O'Connor L, 2015, DIABETOLOGIA, V58, P1474, DOI 10.1007/s00125-015-3572-1
   O'Connor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1
   Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698
   Richelsen B, 2013, CURR OPIN CLIN NUTR, V16, P478, DOI 10.1097/MCO.0b013e328361c53e
   Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907
   Tasevska N, 2014, AM J CLIN NUTR, V99, P1077, DOI 10.3945/ajcn.113.069369
   Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521
   The Scientific Advisory Committee on Nutrition (SACN), 2016, SCI CONS DRAFT SACN
   van Buul VJ, 2014, NUTR RES REV, V27, P119, DOI 10.1017/S0954422414000067
   WALKER ARP, 1977, S AFR MED J, V51, P842
   Wang JW, 2014, J NUTR, V144, P81, DOI 10.3945/jn.113.182519
   Willet W., 2012, Nutritional Epidemiology, V3rd
   Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563
NR 36
TC 60
Z9 64
U1 0
U2 21
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD AUG
PY 2018
VL 37
IS 4
BP 1313
EP 1322
DI 10.1016/j.clnu.2017.05.030
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GK5GZ
UT WOS:000436204200030
PM 28711418
OA Green Published, Green Accepted, hybrid
DA 2025-04-28
ER

PT J
AU Faris, ME
   Al Gharaibeh, F
   Islam, MR
   Abdelrahim, D
   Saif, ER
   Turki, EA
   Al-Kitbi, MK
   Abu-Qiyas, S
   Zeb, F
   Hasan, H
   Hashim, MS
   Osaili, TM
   Radwan, H
   Ismail, LC
   Naja, F
   Bettayeb, FZ
   Obaid, RS
AF Faris, MoezAlIslam E.
   Al Gharaibeh, Fakir
   Islam, M. Rezaul
   Abdelrahim, Dana
   Saif, Eman Rashid
   Turki, Eman Ali
   Al-Kitbi, Mahra Khalfan
   Abu-Qiyas, Salma
   Zeb, Falak
   Hasan, Hayder
   Hashim, Mona S.
   Osaili, Tareq M.
   Radwan, Hadia
   Cheikh Ismail, Leila
   Naja, Farah
   Bettayeb, Fatima Zohra
   Obaid, Reyad Shaker
TI Caffeinated energy drink consumption among Emirati adolescents is
   associated with a cluster of poor physical and mental health, and
   unhealthy dietary and lifestyle behaviors: a cross-sectional study
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE adolescents; schoolchildren; energy drinks; caffeine; health behaviors;
   diet; health practice; lifestyle behaviors
ID SLEEP QUALITY; SCHOOL-CHILDREN; RISK BEHAVIORS; PATTERNS; STUDENTS;
   BEVERAGES; PREVALENCE; UNIVERSITY; SAMPLE
AB Background: Consumption of caffeinated energy drinks (CED) has escalated during the last few years, especially among schoolchildren, with evident adverse health sequelae in this critical age group.
   Objective: This study examined the prevalence of CED consumption and its associations with sleep, physical and mental health, and dietary and lifestyle habits among schoolchildren in the United Arab Emirates (UAE).
   Method: A structured self-administered online questionnaire was developed and disseminated among schoolchildren aged 14-18 years, selected from schools of the seven emirates of the UAE.
   Results: More than 4,500 (N= 4,648) responses received. A relatively low prevalence of CED consumption (20%) was found among schoolchildren in the UAE. However, those who reported CED consumption were more likely to report unhealthy dietary (skipping breakfast, frequent snacking, and eating fast foods, low fruit, and vegetable intake) and lifestyle behaviors (long screen time, poor sleep health), in addition to poor self-reported mental and physical health than non-users. CED consumption was significantly and variably associated with multiple sociodemographic factors such as students' nationality, parental companionship, sex, school type, education level (children's and parents'), daily allowance, academic performance, screen time, sleep quality parameters, self-reported physical and mental health, and parents' employment. Sources of knowledge about CED were social media (55%), friends/ schoolmates (52%), and family members (52%). Students believed that CED constitute sugar (87%), caffeine (69%), artificial flavors (67%) sweeteners (54%), and stimulating components (43%). The majority (70%) of students reported that CED consumption increases the risks for heart disease, diabetes, high blood sugar (65%), addiction (64%), high blood pressure (59%), and obesity (57%).
   Conclusion: These results offer important insights for health professionals, child health specialists, policymakers, and parents in the UAE regarding adolescents' attitudes, knowledge and behaviors toward CED consumption.
C1 [Faris, MoezAlIslam E.; Abu-Qiyas, Salma; Hasan, Hayder; Hashim, Mona S.; Osaili, Tareq M.; Radwan, Hadia; Cheikh Ismail, Leila; Naja, Farah; Obaid, Reyad Shaker] Univ Sharjah, Coll Hlth Sci, Dept Clin Nutr & Dietet, Sharjah, U Arab Emirates.
   [Faris, MoezAlIslam E.; Abdelrahim, Dana; Zeb, Falak; Hasan, Hayder; Hashim, Mona S.; Osaili, Tareq M.; Radwan, Hadia; Cheikh Ismail, Leila; Naja, Farah; Obaid, Reyad Shaker] Univ Sharjah, Res Inst Med & Hlth Res RIMHS, Sharjah, U Arab Emirates.
   [Al Gharaibeh, Fakir; Islam, M. Rezaul; Bettayeb, Fatima Zohra] Univ Sharjah, Res Inst Humanities & Social Sci, Sharjah, U Arab Emirates.
   [Saif, Eman Rashid; Turki, Eman Ali; Al-Kitbi, Mahra Khalfan] Supreme Council Family Affairs, Hlth Promot Dept, Sharjah 27272, U Arab Emirates.
   [Osaili, Tareq M.] Jordan Univ Sci & Technol, Fac Agr, Dept Nutr & Food Technol, Irbid, Jordan.
C3 University of Sharjah; University of Sharjah; University of Sharjah;
   Jordan University of Science & Technology
RP Faris, ME (corresponding author), Univ Sharjah, Coll Hlth Sci, Dept Clin Nutr & Dietet, Sharjah, U Arab Emirates.; Faris, ME (corresponding author), Univ Sharjah, Res Inst Med & Hlth Res RIMHS, Sharjah, U Arab Emirates.
EM mfaris@sharjah.ac.ae
RI Abu Qiyas, Salma/HNQ-0353-2023; Radwan, Hadia/B-7955-2016; Hasan,
   Hayder/J-4620-2019; Zeb, Falak/AAP-2095-2020; Faris,
   MoezAlIslam/M-9682-2017
OI Hasan, Hayder/0000-0001-5580-1911; Abu Qiyas, Salma/0000-0001-9208-8385;
   Hashim, Mona/0000-0002-3494-4718; Faris, MoezAlIslam/0000-0002-7970-2616
FU The author(s) declare that no financial support was received for the
   research, authorship, and/or publication of this article.
FX The author(s) declare that no financial support was received for the
   research, authorship, and/or publication of this article.
CR Al Gharaibeh F, 2022, COMMUNITY DEV J, V57, P404, DOI 10.1093/cdj/bsab045
   Al-Shaar L, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00225
   Alafif N, 2021, SAUDI J BIOL SCI, V28, P4511, DOI 10.1016/j.sjbs.2021.04.050
   Alhyas Layla, 2016, JRSM Open, V7, p2054270415593717, DOI 10.1177/2054270415593717
   Almulla AA, 2020, ASIA-PAC J PUBLIC HE, V32, P266, DOI 10.1177/1010539520931351
   Alsunni AA, 2015, INT J HEALTH SCI-IJH, V9, P468, DOI 10.12816/0031237
   Arria AM, 2014, NUTR REV, V72, P87, DOI 10.1111/nure.12129
   Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019
   Berenbaum SA, 2016, CURR OPIN BEHAV SCI, V7, P53, DOI 10.1016/j.cobeha.2015.11.011
   Bradbury KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223912
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Cadoni C, 2023, FRONT BEHAV NEUROSCI, V17, DOI 10.3389/fnbeh.2023.1080963
   Champlin SE, 2016, J PRIM PREV, V37, P345, DOI 10.1007/s10935-016-0437-4
   Chu J.Y., 2005, MEN MASC, V8, P93, DOI [DOI 10.1177/1097184X03257453, 10.1177/1097184X03257453]
   Degirmenci N, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6236-5
   Dillon Pamela, 2019, Journal of Caffeine and Adenosine Research, V9, P12, DOI 10.1089/caff.2018.0008
   Dubai Schools Ban Energy Drinks, Why such beverages are harmful for children
   Emond JA, 2014, J PEDIATR-US, V165, P1194, DOI 10.1016/j.jpeds.2014.08.050
   Jovel CAE, 2017, NEUROLOGIA, V32, P394, DOI 10.1016/j.nrl.2014.12.016
   Evren C, 2015, ASIAN J PSYCHIATR, V15, P44, DOI 10.1016/j.ajp.2015.05.001
   Faris MA, 2015, INT J CHILD HEALTH N, V4, P1
   Faris E, 2017, NUTR DIET, V74, P268, DOI 10.1111/1747-0080.12289
   Frayon S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214420
   Galemore Cynthia A, 2011, NASN Sch Nurse, V26, P320
   Galimov A, 2019, APPETITE, V139, P172, DOI 10.1016/j.appet.2019.04.016
   Gallimberti L, 2013, EUR J PEDIATR, V172, P1335, DOI 10.1007/s00431-013-2036-1
   Gambon DL, 2011, INT DENT J, V61, P247, DOI 10.1111/j.1875-595X.2011.00067.x
   Garg A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.12298
   Ghozayel M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232199
   Girán J, 2023, HELIYON, V9, DOI 10.1016/j.heliyon.2023.e15954
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Halldorsson TI, 2021, FOOD CHEM TOXICOL, V157, DOI 10.1016/j.fct.2021.112549
   Holubcikova J, 2017, EUR J PEDIATR, V176, P599, DOI 10.1007/s00431-017-2881-4
   Islam MR, 2023, ASIAN SOC WORK POLIC, V17, P39, DOI 10.1111/aswp.12270
   Kaldenbach S, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-049284
   Khan MS, 2017, ANN ABBASI SHAHEED H, V22, P179
   Khouja C, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2020-047746
   Kuhangana TC, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147617
   Larson N, 2014, J NUTR EDUC BEHAV, V46, P181, DOI 10.1016/j.jneb.2014.02.008
   Lebacq T, 2020, PUBLIC HEALTH, V185, P182, DOI 10.1016/j.puhe.2020.05.040
   Levant RF, 2015, HEALTH PSYCHOL, V34, P1100, DOI 10.1037/hea0000214
   Li PZ, 2023, NUTRIENTS, V15, DOI 10.3390/nu15112537
   Liu KSN, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113717
   Lohsoonthorn V, 2013, SLEEP BREATH, V17, P1017, DOI 10.1007/s11325-012-0792-1
   Ludden AB, 2010, HEALTH EDUC BEHAV, V37, P330, DOI 10.1177/1090198109341783
   Marinoni M, 2022, EUR J PEDIATR, V181, P889, DOI 10.1007/s00431-021-04321-7
   Masengo L, 2020, J AFFECT DISORDERS, V268, P102, DOI 10.1016/j.jad.2020.03.004
   McLellan TM, 2016, NEUROSCI BIOBEHAV R, V71, P294, DOI 10.1016/j.neubiorev.2016.09.001
   Miller KE, 2018, PSYCHOL ADDICT BEHAV, V32, P647, DOI 10.1037/adb0000389
   Musaiger Abdulrahman, 2013, Glob J Health Sci, V6, P42, DOI 10.5539/gjhs.v6n2p42
   Nuss T, 2021, NUTR J, V20, DOI 10.1186/s12937-021-00719-z
   Oddy WH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5268
   Pletzer B, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00240
   Puupponen M, 2023, BMC PUBLIC HEALTH, V23, DOI 10.1186/s12889-023-15055-6
   Puupponen M, 2021, INT J PUBLIC HEALTH, V66, DOI 10.3389/ijph.2021.620268
   Rawlins E, 2013, J HUM NUTR DIET, V26, P132, DOI 10.1111/j.1365-277X.2012.01280.x
   Richards G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00106
   Sampasa-Kanyinga H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093110
   Sampasa-Kanyinga H, 2018, NUTRITION, V48, P77, DOI 10.1016/j.nut.2017.11.013
   Scalese M, 2021, DRUG ALCOHOL DEPEN, V228, DOI 10.1016/j.drugalcdep.2021.109061
   Scalese M, 2017, ADDICT BEHAV, V72, P93, DOI 10.1016/j.addbeh.2017.03.016
   sleepfoundation, How blue light affects kids' sleep?
   The National, Doctors and parents back Dubai school's prime energy drink warning
   Thomas PA, 2017, INNOV AGING, V1, DOI 10.1093/geroni/igx025
   Tóth A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041290
   Trapp G, 2021, J HUM NUTR DIET, V34, P300, DOI 10.1111/jhn.12789
   UAE, Supermarkets take action on energy drink sales
   Utter J, 2018, J PAEDIATR CHILD H, V54, P279, DOI 10.1111/jpc.13708
   Veselska ZD, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18116055
   Visram S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010380
   von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
   Watson EJ, 2017, J CLIN SLEEP MED, V13, P533, DOI 10.5664/jcsm.6536
NR 72
TC 3
Z9 3
U1 2
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD OCT 16
PY 2023
VL 11
AR 1259109
DI 10.3389/fpubh.2023.1259109
PG 15
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA W8GB6
UT WOS:001093946000001
PM 37908686
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Orfanos, P
   Naska, A
   Trichopoulos, D
   Slimani, N
   Ferrari, P
   van Bakel, M
   Deharveng, G
   Overvad, K
   Tionneland, A
   Halkjær, J
   de Magistris, MS
   Tumino, R
   Pala, V
   Sacerdote, C
   Masala, G
   Skeie, G
   Engeset, D
   Lund, E
   Jakszyn, P
   Barricarte, A
   Chirlaque, MD
   Martinez-Garcia, C
   Amiano, P
   Quiros, JR
   Bingham, S
   Welch, A
   Spencer, EA
   Key, TJ
   Rohrmann, S
   Linseisen, J
   Ray, J
   Boeing, H
   Peeters, PH
   Bueno-De-Mesquita, HB
   Ocke, M
   Johansson, I
   Johansson, G
   Berglund, G
   Manjer, J
   Boutron-Ruault, MC
   Touvier, M
   Clavel-Chapelon, F
   Trichopoulou, A
AF Orfanos, Philippos
   Naska, Androniki
   Trichopoulos, Dimitrios
   Slimani, Nadia
   Ferrari, Pietro
   van Bakel, Marit
   Deharveng, Genevieve
   Overvad, Kim
   Tionneland, Anne
   Halkjaer, Jytte
   de Magistris, Maria Santucci
   Tumino, Rosario
   Pala, Valeria
   Sacerdote, Carlotta
   Masala, Giovanna
   Skeie, Guri
   Engeset, Dagrun
   Lund, Eiliv
   Jakszyn, Paula
   Barricarte, Aurelio
   Chirlaque, Maria-Dolores
   Martinez-Garcia, Carmen
   Amiano, Pilar
   Quiros, J. Ramon
   Bingham, Sheila
   Welch, Ailsa
   Spencer, Elizabeth A.
   Key, Timothy J.
   Rohrmann, Sabine
   Linseisen, Jakob
   Ray, Jennifer
   Boeing, Heiner
   Peeters, Petra H.
   Bueno-De-Mesquita, H. Bas
   Ocke, Marga
   Johansson, Ingegerd
   Johansson, Gerd
   Berglund, Goran
   Manjer, Jonas
   Boutron-Ruault, Marie-Christine
   Touvier, Mathilde
   Clavel-Chapelon, Francoise
   Trichopoulou, Antonia
TI Eating out of home and its correlates in 10 European countries.: The
   European Prospective Investigation into Cancer and Nutrition (EPIC)
   study
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE eating out of home; diet; energy intake; eating locations; 24-hour
   dietary recall; adults; EPIC
ID BODY-MASS INDEX; UNITED-STATES; ENERGY-INTAKE; YOUNG-ADULTS; FOOD;
   OBESITY; TRENDS; DIET; ASSOCIATION; CONSUMPTION
AB Objective: To compare the average out-of-home (OH) consumption of foods and beverages, as well as energy intake, among populations from 10 European countries and to describe the characteristics of substantial OH caters, as defined for the purpose of the present study, in comparison to other individuals.
   Design: Cross-sectional study. Dietary data were collected through single 24-hour dietary recalls, in which the place of consumption was recorded. For the present study, substantial OH eaters were defined as those who consumed more than 25% of total daily energy intake at locations other than the household premises. Mean dietary intakes and the proportion of substantial OH eaters are presented by food group and country. Logistic regression analyses were used to estimate the odds of being a substantial OH eater in comparison to not being one, using mutually adjusted possible non-dietary determinants.
   Setting: Ten European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC).
   Subjects: The subjects were 34 270 individuals, 12 537 men and 21733 women, aged 35-74 years.
   Results: The fraction of energy intake during OH eating was generally higher in northern European countries than in the southern ones. Among the food and beverage groups, those selectively consumed outside the home were coffee/tea/waters and sweets and, to a lesser extent, cereals, meats, added lipids and vegetables. Substantial OH eating was positively associated with energy intake and inversely associated with age and physical activity. Substantial OH eating was less common among the less educated compared with the more educated, and more common during weekdays in central and north Europe and during the weekend in south Europe.
   Conclusions: Eating outside the home was associated with sedentary lifestyle and increased energy intake; it was more common among the young and concerned in particular coffee/tea/waters and sweets.
C1 [Orfanos, Philippos; Naska, Androniki; Trichopoulou, Antonia] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens 11527, Greece.
   [Slimani, Nadia; Ferrari, Pietro; van Bakel, Marit; Deharveng, Genevieve] Int Agcy Res Canc, Nutr Hormones Grp, F-69372 Lyon, France.
   [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.
   [Tionneland, Anne; Halkjaer, Jytte] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark.
   [de Magistris, Maria Santucci] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy.
   [Tumino, Rosario] Azienda Osped Civile MP Arezzo, Canc Registry, Ragusa, Italy.
   [Pala, Valeria] Natl Canc Inst, Nutr Epidemiol Unit, I-20133 Milan, Italy.
   [Sacerdote, Carlotta] CPO Piemonte, Turin, Italy.
   [Masala, Giovanna] CSPO Sci Inst Tuscany, Mol & Nutrit Epidemiol Unit, Florence, Italy.
   [Skeie, Guri; Engeset, Dagrun; Lund, Eiliv] Univ Tromso, Inst Community Med, N-9001 Tromso, Norway.
   [Jakszyn, Paula] Catalan Inst Oncol, Dept Epidemiol, Barcelona, Spain.
   [Jakszyn, Paula] Catalan Inst Oncol, Canc Registry, Barcelona, Spain.
   [Barricarte, Aurelio] Publ Hlth Inst Navarra, Pamplona, Spain.
   [Chirlaque, Maria-Dolores] Murcia Hlth Council, Dept Epidemiol, Murcia, Spain.
   [Martinez-Garcia, Carmen] Andalusian Sch Publ Hlth, Granada, Spain.
   [Amiano, Pilar] Dept Publ Hlth Gipuzkoa, Donostia San Sebastian, Spain.
   [Quiros, J. Ramon] Publ Hlth & Hlth Planning Directorate, Asturias, Spain.
   [Bingham, Sheila; Welch, Ailsa] MRC Dunn Human Nutr Unit, Cambridge, England.
   [Bingham, Sheila; Welch, Ailsa] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC Ctr Nutrit Epidemiol Canc Prevent & Survival, Cambridge CB2 1TN, England.
   [Spencer, Elizabeth A.; Key, Timothy J.] Univ Oxford, Canc Res UK Epidemiol Unit, Oxford, England.
   [Rohrmann, Sabine; Linseisen, Jakob] German Canc Res Ctr, Div Clin Epidemiol, D-6900 Heidelberg, Germany.
   [Ray, Jennifer; Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany.
   [Peeters, Petra H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Bueno-De-Mesquita, H. Bas; Ocke, Marga] Natl Inst Publ Hlth & Environm, Canc Epidemiol Ctr Nutr & Hlth, NL-3720 BA Bilthoven, Netherlands.
   [Johansson, Ingegerd] Umea Univ, Dept Odontol, Cardiol Sect, S-90187 Umea, Sweden.
   [Johansson, Ingegerd] Umea Univ, Dept Publ Hlth & Med, Sect Nutrit Res, S-90187 Umea, Sweden.
   [Johansson, Gerd] Umea Univ, Dept Publ Hlth & Med, Sect Nutrit Res, S-90187 Umea, Sweden.
   [Berglund, Goran; Manjer, Jonas] Univ Hosp, Malmo Diet & Canc Study, Malmo, Sweden.
   [Boutron-Ruault, Marie-Christine; Touvier, Mathilde; Clavel-Chapelon, Francoise] Inst Gustave Roussy, INSERM, E3N EPIC Grp, F-94805 Villejuif, France.
C3 National & Kapodistrian University of Athens; Athens Medical School;
   World Health Organization; International Agency for Research on Cancer
   (IARC); Aalborg University; Aalborg University Hospital; Aarhus
   University; Danish Cancer Society; University of Naples Federico II;
   Civile M.P. Arezzo Hospital; Fondazione IRCCS Istituto Nazionale Tumori
   Milan; Centro di Riferimento per Epidemiologia e la Prevenzione
   Oncologica in Piemonte; UiT The Arctic University of Tromso; Institut
   Catala d'Oncologia; Institut Catala d'Oncologia; Public Health Institute
   of Navarra; Murcia Regional Health Council; Escuela Andaluza de Salud
   Publica; UK Research & Innovation (UKRI); Medical Research Council UK
   (MRC); MRC Human Nutrition Research; University of Cambridge; University
   of Oxford; Cancer Research UK; Helmholtz Association; German Cancer
   Research Center (DKFZ); Leibniz Association; Deutsches Institut fur
   Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Utrecht University;
   Utrecht University Medical Center; Netherlands National Institute for
   Public Health & the Environment; Umea University; Umea University; Umea
   University; Lund University; Skane University Hospital; Institut
   National de la Sante et de la Recherche Medicale (Inserm); UNICANCER;
   Gustave Roussy
RP Trichopoulou, A (corresponding author), Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens 11527, Greece.
EM antonia@nut.uoa.gr
RI Tjonneland, Anne/AGU-0320-2022; Sacerdote, Carlotta/K-3611-2018;
   TRICHOPOULOU, ANTONIA/ABF-8727-2021; Chirlaque,
   Maria-Dolores/KCL-3322-2024; Spencer, Elizabeth/AAE-7409-2022;
   Boutron-Ruault, Marie-Christine/H-3936-2014; Rohrmann,
   Sabine/D-2113-2012; Clavel-Chapelon, Francoise/G-6733-2014; Masala,
   Giovanna/AAC-5474-2022; Touvier, Mathilde/E-8817-2017; Martínez-García,
   Carmen/GLT-3905-2022; Orfanos, Philippos/AAL-2606-2021; Trichopoulos,
   Dimitrios/G-6825-2012; Engeset, Dagrun/A-4508-2008; Welch,
   Ailsa/A-4850-2008; Jakszyn, Paula/K-1458-2016; Pala,
   Valeria/K-4738-2016; Touvier, Mathilde/GLT-6939-2022; Linseisen,
   Jakob/B-5353-2014
OI Rohrmann, Sabine/0000-0002-2215-1200; Masala,
   Giovanna/0000-0002-5758-9069; Orfanos, Philippos/0000-0002-9949-3137;
   Jakszyn, Paula/0000-0003-0672-8847; Pala, Valeria/0000-0001-5438-970X;
   tumino, rosario/0000-0003-2666-414X; Touvier,
   Mathilde/0000-0002-8322-8857; Tjonneland, Anne/0000-0003-4385-2097;
   Skeie, Guri/0000-0003-2476-4251; Linseisen, Jakob/0000-0002-9386-382X;
   Engeset, Dagrun/0000-0001-6946-2949; Spencer,
   Elizabeth/0000-0002-9079-8006; Sacerdote, Carlotta/0000-0002-8008-5096;
   Lund, Eiliv/0000-0002-8071-8711
CR Agudo A, 2002, PUBLIC HEALTH NUTR, V5, P1179, DOI 10.1079/PHN2002398
   Armitage P., 2001, STAT METHODS MED RES, V4th
   Bell AC, 2004, EUR J CLIN NUTR, V58, P258, DOI 10.1038/sj.ejcn.1601775
   Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356
   Burns C, 2002, PUBLIC HEALTH NUTR, V5, P441, DOI 10.1079/PHN2001316
   Buzzard M., 1998, Nutritional Epidemiology, VSecond, P50
   Charrondiere UR, 2002, J FOOD COMPOS ANAL, V15, P435, DOI 10.1006/jfca.2002.1089
   Clemens LHE, 1999, J AM DIET ASSOC, V99, P442, DOI 10.1016/S0002-8223(99)00107-8
   Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409
   French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429
   Gillis LJ, 2003, J AM COLL NUTR, V22, P539, DOI 10.1080/07315724.2003.10719333
   GREGORY J, 1990, DIETARY NUTR SURVEY, P218
   Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3
   Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1163, DOI 10.1079/PHN2002397
   HAINES PS, 1992, J AM DIET ASSOC, V92, P698
   Harnack LJ, 2000, AM J CLIN NUTR, V71, P1478
   Heitmann BL, 2000, INT J OBESITY, V24, P435, DOI 10.1038/sj.ijo.0801176
   Jabs J, 2006, APPETITE, V47, P196, DOI 10.1016/j.appet.2006.02.014
   Jahns L, 2001, J PEDIATR-US, V138, P493, DOI 10.1067/mpd.2001.112162
   James WilliamP. T., 1990, HUMAN ENERGY REQUIRE
   Jeffery RW, 1998, AM J PUBLIC HEALTH, V88, P277, DOI 10.2105/AJPH.88.2.277
   Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004
   Kearney JM, 2001, PUBLIC HEALTH NUTR, V4, P1117, DOI 10.1079/PHN2001193
   Lafay L, 1997, INT J OBESITY, V21, P567, DOI 10.1038/sj.ijo.0800443
   LeFrancois P, 1996, EUR J CLIN NUTR, V50, P826
   LIN BH, 1999, AGR INFORM B, V749, P1
   LUTKEPOHL H, 1991, INTRO MULTIPLE TIMES, pCH4
   Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117
   McCrory MA, 1999, OBES RES, V7, P564, DOI 10.1002/j.1550-8528.1999.tb00715.x
   Nielsen AJ, 2003, JAMA-J AM MED ASSOC, V289, P450
   Nielsen SJ, 2002, PREV MED, V35, P107, DOI 10.1006/pmed.2002.1037
   Nielsen SJ, 2002, OBES RES, V10, P370, DOI 10.1038/oby.2002.51
   Popkin BM, 1999, APPETITE, V32, P8, DOI 10.1006/appe.1998.0190
   *REG GEN ENGL WAL, 1978, OPCS SERIES, V1
   Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394
   Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6
   Roos E, 2004, PUBLIC HEALTH NUTR, V7, P53, DOI 10.1079/PHN2003511
   *SHRAPN BIS, 1995, FAST FOOD AUSTR 1995
   Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395
   Slimani N, 1999, COMPUT METH PROG BIO, V58, P251, DOI 10.1016/S0169-2607(98)00088-1
   SLIMANI N, 2007, IN PRESS EUROPEAN J
   Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732
   Willett W., 1998, Nutritional epidemiology, P302, DOI [10.1093/acprof:oso/9780199754038.001.0001, DOI 10.1093/ACPROF:OSO/9780199754038.001.0001]
   Willett W., 1998, Nutritional epidemiology, P33
   World Health Organization Expert Committee, 1995, Physical status: the use and interpretation of anthropometry
   Zizza C, 2001, PREV MED, V32, P303, DOI 10.1006/pmed.2000.0817
NR 46
TC 136
Z9 155
U1 0
U2 24
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD DEC
PY 2007
VL 10
IS 12
BP 1515
EP 1525
DI 10.1017/S1368980007000171
PG 11
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 245UC
UT WOS:000251963300015
PM 17582244
OA Green Submitted, Bronze
DA 2025-04-28
ER

PT J
AU Bansal, S
   Syan, N
   Mathur, P
   Choudhary, S
AF Bansal, Sumit
   Syan, Navneet
   Mathur, Pooja
   Choudhary, Shivani
TI Pharmacological profile of green tea and its polyphenols: a review
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Review
DE Catechins; Epigallocatechin-3-gallate (EGCG); Green Tea; Polyphenols
ID EPIGALLOCATECHIN GALLATE; (-)-EPIGALLOCATECHIN GALLATE;
   OXIDATIVE-STRESS; ANTIOXIDANT ACTIVITY; PRECURSOR PROTEIN; INDUCED
   GASTRITIS; BLOOD-PRESSURE; CANCER RISK; BLACK TEA; CATECHINS
AB Tea (Camellia sinensis, Theaceae) is the second most consumed beverages in the world, next to water in terms of worldwide popularity. The chemical components of green tea chiefly include polyphenols, caffeine, and amino acids. Green tea is rich in catechins, of which (-)-epigallocatechin-3-gallate is the most abundant. As described in literature, green tea and its polyphenols are beneficial in curing a wide variety of diseases like cancer, diabetes, cardiovascular disease, obesity, etc. It also has antimicrobial activity, protects from solar radiations, and possesses neuroprotective properties. The current review article focuses on pharmacological profile associated with Green tea and its polyphenols. We hope that this review will expose areas for further study and encourage research on important public health issue.
C1 [Bansal, Sumit; Syan, Navneet; Mathur, Pooja] Ganpati Inst Pharm, Dept Pharmaceut Chem, Yamunanagar 135102, Haryana, India.
   [Choudhary, Shivani] Doon Valley Inst Pharm & Med, Karnal 132001, Haryana, India.
RP Bansal, S (corresponding author), Ganpati Inst Pharm, Dept Pharmaceut Chem, Yamunanagar 135102, Haryana, India.
EM bansalsumit50@gmail.com
RI Bansal, Sumit/AAC-9138-2022; Mathur, Pooja/AAU-7858-2021
CR Abdel-Raheem IT, 2010, PAK J PHARM SCI, V23, P21
   Akgün H, 2009, TURK J CHEM, V33, P107, DOI 10.3906/kim-0807-25
   Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794
   Al-Attar Atef M, 2010, Saudi J Biol Sci, V17, P295, DOI 10.1016/j.sjbs.2010.05.007
   Atoui AK, 2005, FOOD CHEM, V89, P27, DOI 10.1016/j.foodchem.2004.01.075
   Bisht GS, 2007, BIOORG MED CHEM LETT, V17, P4343, DOI 10.1016/j.bmcl.2007.05.015
   Blanco AR, 2005, ANTIMICROB AGENTS CH, V49, P4339, DOI 10.1128/AAC.49.10.4339-4343.2005
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518
   Carlson JR, 2007, MAYO CLIN PROC, V82, P725
   Carvalho M, 2010, FOOD CHEM, V122, P49, DOI 10.1016/j.foodchem.2010.02.014
   Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13
   Chan CM, 2010, MOL VIS, V16, P586
   Chan CM, 2008, MOL VIS, V14, P2528
   Chen AP, 2002, BIOCHEM J, V368, P695, DOI 10.1042/BJ20020894
   Chen XQ, 2010, CARBOHYD POLYM, V82, P28, DOI 10.1016/j.carbpol.2010.04.017
   Cheng TO, 2006, INT J CARDIOL, V108, P301, DOI 10.1016/j.ijcard.2005.05.038
   Chrostek L, 2005, Rocz Akad Med Bialymst, V50, P220
   Chyu KY, 2004, CIRCULATION, V109, P2448, DOI 10.1161/01.CIR.0000128034.70732.C2
   Clement Y, 2009, PREV MED, V49, P83, DOI 10.1016/j.ypmed.2009.05.005
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210
   El-Shahat AE, 2009, INT J MORPHOL, V27, P757
   Finkel R, 2009, PHARMACOLOGY, P215
   Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S
   Gordon NC, 2010, INT J ANTIMICROB AG, V36, P129, DOI 10.1016/j.ijantimicag.2010.03.025
   Hao J, 2007, J VET SCI, V8, P121, DOI 10.4142/jvs.2007.8.2.121
   Hara-Kudo Y, 2005, J SCI FOOD AGR, V85, P2354, DOI 10.1002/jsfa.2259
   Hauber I, 2009, P NATL ACAD SCI USA, V106, P9033, DOI 10.1073/pnas.0811827106
   Hirasawa M, 2004, J ANTIMICROB CHEMOTH, V53, P225, DOI 10.1093/jac/dkh046
   Hirasawa M, 2002, J PERIODONTAL RES, V37, P433, DOI 10.1034/j.1600-0765.2002.01640.x
   Hofmann CS, 2003, FASEB J, V17, P702, DOI 10.1096/fj.02-0665fje
   Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177
   Imanishi N, 2002, MICROBIOL IMMUNOL, V46, P491, DOI 10.1111/j.1348-0421.2002.tb02724.x
   Joshi S, 2010, BBA-BIOMEMBRANES, V1798, P1864, DOI 10.1016/j.bbamem.2010.06.016
   Juneja VK, 2007, J FOOD PROTECT, V70, P1429, DOI 10.4315/0362-028X-70.6.1429
   Kang KW, 2010, FOOD CHEM, V121, P1089, DOI 10.1016/j.foodchem.2010.01.055
   Karaca T, 2010, J ANIM VET ADV, V9, P102
   Kaszkin M, 2004, MOL PHARMACOL, V65, P15, DOI 10.1124/mol.65.1.15
   Katiyar SK, 2001, CARCINOGENESIS, V22, P287, DOI 10.1093/carcin/22.2.287
   Katiyar SK, 2001, J LEUKOCYTE BIOL, V69, P719
   Kim S. H., 2008, J WOMENS MED, V1, P27
   Kim Yong Wook, 2004, Cancer Res Treat, V36, P315, DOI 10.4143/crt.2004.36.5.315
   Koizumi Y, 2003, CANCER EPIDEM BIOMAR, V12, P472
   Kuriyama S, 2006, AM J CLIN NUTR, V83, P355
   Lee MJ, 2004, CANCER EPIDEM BIOMAR, V13, P132, DOI 10.1158/1055-9965.EPI-03-0040
   Leung LK, 2001, J NUTR, V131, P2248, DOI 10.1093/jn/131.9.2248
   Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200
   Maeta K, 2007, APPL ENVIRON MICROB, V73, P572, DOI 10.1128/AEM.01963-06
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Maruyama K, 2009, J CLIN BIOCHEM NUTR, V44, P41, DOI 10.3164/jcbn.08-13
   Matsubara S, 2003, BIOCHEM BIOPH RES CO, V310, P715, DOI 10.1016/j.bbrc.2003.09.066
   McNaught J.G., 1906, J. R. Army Med. Corps, V7, P372
   Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354
   Mildner-Szkudlarz S, 2009, J FOOD SCI, V74, pS362, DOI 10.1111/j.1750-3841.2009.01313.x
   Mimoto J, 2000, CARCINOGENESIS, V21, P915, DOI 10.1093/carcin/21.5.915
   Miura T, 2005, J HEALTH SCI, V51, P708, DOI 10.1248/jhs.51.708
   Mughal T., 2010, J APP PHARM, V2, P60
   Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Navarro-Martínez MD, 2005, ANTIMICROB AGENTS CH, V49, P2914, DOI 10.1128/AAC.49.7.2914-2920.2005
   Negishi H, 2004, J NUTR, V134, P38, DOI 10.1093/jn/134.1.38
   Ng TP, 2008, AM J CLIN NUTR, V88, P224, DOI 10.1093/ajcn/88.1.224
   Papparella I, 2008, J NUTR, V138, P1596, DOI 10.1093/jn/138.9.1596
   Park JH, 2009, J PHYSIOL PHARMACOL, V60, P101
   Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005
   Rietveld A, 2003, J NUTR, V133, p3285S, DOI 10.1093/jn/133.10.3285S
   Roy AM, 2005, MOL CANCER THER, V4, P81
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Ruggiero P, 2007, WORLD J GASTROENTERO, V13, P349, DOI 10.3748/wjg.v13.i3.349
   Sakanaka S, 2000, J BIOSCI BIOENG, V90, P81, DOI 10.1016/S1389-1723(00)80038-9
   Sartippour MR, 2006, CARCINOGENESIS, V27, P2424, DOI 10.1093/carcin/bgl066
   Sharangi AB, 2009, FOOD RES INT, V42, P529, DOI 10.1016/j.foodres.2009.01.007
   Sinha D, 2010, FOOD CHEM TOXICOL, V48, P1032, DOI 10.1016/j.fct.2010.01.016
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Stapleton PD, 2006, INT J FOOD MICROBIOL, V111, P276, DOI 10.1016/j.ijfoodmicro.2006.06.005
   Stoicov C, 2009, INT J ANTIMICROB AG, V33, P473, DOI 10.1016/j.ijantimicag.2008.10.032
   Suganuma M, 1999, CANCER RES, V59, P44
   Sutherland BA, 2004, FASEB J, V18, P258, DOI 10.1096/fj.04-2806fje
   Tanaka T, 2011, FREE RADICAL BIO MED, V50, P1324, DOI 10.1016/j.freeradbiomed.2011.01.024
   Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184
   Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903
   Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200
   USDA, USDA DAT FLAV CONT S
   Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200
   West P. W. J., 2001, Journal of Nutritional and Environmental Medicine (Abingdon), V11, P263, DOI 10.1080/13590840120103102
   Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016
   Wolfram S, 2006, J NUTR, V136, P2512, DOI 10.1093/jn/136.10.2512
   Xu JZ, 2004, BRIT J NUTR, V91, P873, DOI 10.1079/BJN20041132
   Yang G, 2007, CANCER EPIDEM BIOMAR, V16, P1219, DOI 10.1158/1055-9965.EPI-07-0097
   Yao K, 2008, MOL VIS, V14, P217
   Yee YK, 2000, ALIMENT PHARM THER, V14, P635, DOI 10.1046/j.1365-2036.2000.00747.x
   Yi SM, 2010, INT J FOOD MICROBIOL, V144, P111, DOI 10.1016/j.ijfoodmicro.2010.09.005
   Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176
   Yuan JM, 2005, CARCINOGENESIS, V26, P1389, DOI 10.1093/carcin/bgi080
   Zapora E, 2009, B VET I PULAWY, V53, P139
   Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006
   Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200
   Zhang ZF, 2010, PHYTOMEDICINE, V17, P14, DOI 10.1016/j.phymed.2009.09.007
   Zheng GD, 2004, IN VIVO, V18, P55
NR 105
TC 43
Z9 55
U1 4
U2 169
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD NOV
PY 2012
VL 21
IS 11
BP 3347
EP 3360
DI 10.1007/s00044-011-9800-4
PG 14
WC Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 014AY
UT WOS:000309348600003
DA 2025-04-28
ER

PT J
AU Ito, Y
   Ichikawa, T
   Morohosh, Y
   Nakamura, T
   Saegusa, Y
   Ishihara, K
AF Ito, Yuko
   Ichikawa, Takafumi
   Morohosh, Yasuo
   Nakamura, Takeshi
   Saegusa, Yoichi
   Ishihara, Kazuhiko
TI Effect of tea catechins on body fat accumulation in rats fed a normal
   diet
SO BIOMEDICAL RESEARCH-TOKYO
LA English
DT Article
ID CHOLESTEROL-FED RATS; GREEN TEA; ENERGY-EXPENDITURE; LIPID-METABOLISM;
   ADIPOSE-TISSUE; CAFFEINE; THERMOGENESIS; POLYPHENOLS; ACTIVATION;
   EXTRACTS
AB Although it is known that tea catechins exert potent effects in obese subjects, there is scant information concerning these effects on body weight gain and body fat accumulation in the non-obese. We studied normal rats fed a normal diet and water containing either 0.1% or 0.5% tea catechins to examine the effects on body fat content and serum cholesterol levels, as well as evaluating whether the effect is related to bile acids, which in recent years have emerged as an inducer of energy expenditure. The administration of 0.5% catechins decreased the accumulation of body fat and the serum levels of cholesterol and bile acids. These results indicate that tea catechins modulate lipid metabolism not only in obese subjects, but also in the non-obese.
C1 [Ito, Yuko; Ishihara, Kazuhiko] Kitasato Univ, Sch Allied Hlth Sci, Dept Biochem, Sagamihara, Kanagawa 2288555, Japan.
   [Ichikawa, Takafumi] Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 2288555, Japan.
   [Morohosh, Yasuo] Kitasato Univ, Sch Med, Dept Lab Anim Sci, Sagamihara, Kanagawa 2288555, Japan.
   [Nakamura, Takeshi] Kitasato Univ, Sch Med, Dept Parasitol, Sagamihara, Kanagawa 2288555, Japan.
   [Saegusa, Yoichi] Kitasato Univ, Sch Med, Dept Internal Med, Sagamihara, Kanagawa 2288555, Japan.
C3 Kitasato University; Kitasato University; Kitasato University; Kitasato
   University; Kitasato University
RP Ishihara, K (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Dept Biochem, 1-15-1 kitasato, Sagamihara, Kanagawa 2288555, Japan.
EM yukodietitian@yahoo.co.jp
RI Ichikawa, Takafumi/LQJ-1255-2024
CR Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087
   CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X
   Chen ZY, 2001, J AGR FOOD CHEM, V49, P477, DOI 10.1021/jf000877h
   Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   FOLCH J, 1963, BIOL CHEM, V226, P497
   FRIED SK, 1987, INT J OBESITY, V11, P129
   Hasegawa N, 2003, PHYTOTHER RES, V17, P477, DOI 10.1002/ptr.1177
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   IKEMOTO S, 1997, J AM PHYSL, V273, pE37
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Lin JK, 1998, J AGR FOOD CHEM, V46, P3635, DOI 10.1021/jf980223x
   MURAMATSU K, 1986, J NUTR SCI VITAMINOL, V32, P613, DOI 10.3177/jnsv.32.613
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   REBUFFESCRIVE M, 1989, METABOLISM, V38, P453, DOI 10.1016/0026-0495(89)90198-4
   Sano J, 2004, CIRC J, V68, P665, DOI 10.1253/circj.68.665
   Sato H, 2002, J GASTROENTEROL, V37, P106, DOI 10.1007/s005350200004
   Sayama K, 2000, IN VIVO, V14, P481
   Seto R, 1997, BIOSCI BIOTECH BIOCH, V61, P1434, DOI 10.1271/bbb.61.1434
   Suzuki Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1288, DOI 10.1271/bbb.69.1288
   Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330
   Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409
   Yang MH, 2001, J NUTR BIOCHEM, V12, P14, DOI 10.1016/S0955-2863(00)00140-6
   Yang TTC, 1999, LIFE SCI, V66, P411, DOI 10.1016/S0024-3205(99)00607-4
   Yokozawa T, 2002, J AGR FOOD CHEM, V50, P3549, DOI 10.1021/jf020029h
   Zheng GD, 2004, IN VIVO, V18, P55
NR 28
TC 39
Z9 42
U1 0
U2 6
PU BIOMEDICAL RESEARCH PRESS LTD
PI SAPPORO
PA HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA
   15-NISHI 7, SAPPORO, 060-8638, JAPAN
SN 0388-6107
EI 1880-313X
J9 BIOMED RES-TOKYO
JI Biomed. Res.
PD FEB
PY 2008
VL 29
IS 1
BP 27
EP 32
DI 10.2220/biomedres.29.27
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 273JQ
UT WOS:000253926600004
PM 18344595
OA Bronze
DA 2025-04-28
ER

PT J
AU Imamura, F
   Fretts, AM
   Marklund, M
   Ardisson Korat, AV
   Yang, WS
   Lankinen, M
   Qureshi, W
   Helmer, C
   Chen, TA
   Virtanen, JK
   Wong, K
   Bassett, JK
   Murphy, R
   Tintle, N
   Yu, CI
   Brouwer, IA
   Chien, KL
   Chen, Yy
   Wood, AC
   del Gobbo, LC
   Djousse, L
   Geleijnse, JM
   Giles, GG
   de Goede, J
   Gudnason, V
   Harris, WS
   Hodge, A
   Hu, F
   Koulman, A
   Laakso, M
   Lind, L
   Lin, HJ
   McKnight, B
   Rajaobelina, K
   Riserus, U
   Robinson, JG
   Samieri, C
   Senn, M
   Siscovick, DS
   Soedamah-Muthu, SS
   Sotoodehnia, N
   Sun, Q
   Tsai, MY
   Tuomainen, TP
   Uusitupa, M
   Wagenknecht, LE
   Wareham, NJ
   Wu, JHY
   Micha, R
   Lemaitre, RN
   Mozaffarian, D
   Forouhi, NG
AF Imamura, Fumiaki
   Fretts, Amanda M.
   Marklund, Matti
   Ardisson Korat, Andres V.
   Yang, Wei-Sin
   Lankinen, Maria
   Qureshi, Waqas
   Helmer, Catherine
   Chen, Tzu-An
   Virtanen, Jyrki K.
   Wong, Kerry
   Bassett, Julie K.
   Murphy, Rachel
   Tintle, Nathan
   Yu, Chaoyu Ian
   Brouwer, Ingeborg A.
   Chien, Kuo-Liong
   Chen, Yun-yu
   Wood, Alexis C.
   del Gobbo, Liana C.
   Djousse, Luc
   Geleijnse, Johanna M.
   Giles, Graham G.
   de Goede, Janette
   Gudnason, Vilmundur
   Harris, William S.
   Hodge, Allison
   Hu, Frank
   Koulman, Albert
   Laakso, Markku
   Lind, Lars
   Lin, Hung-Ju
   McKnight, Barbara
   Rajaobelina, Kalina
   Riserus, Ulf
   Robinson, Jennifer G.
   Samieri, Cecilia
   Senn, Mackenzie
   Siscovick, David S.
   Soedamah-Muthu, Sabita S.
   Sotoodehnia, Nona
   Sun, Qi
   Tsai, Michael Y.
   Tuomainen, Tomi-Pekka
   Uusitupa, Matti
   Wagenknecht, Lynne E.
   Wareham, Nick J.
   Wu, Jason H. Y.
   Micha, Renata
   Lemaitre, Rozenn N.
   Mozaffarian, Dariush
   Forouhi, Nita G.
CA InterAct Consortium
TI Fatty acids in the de novo lipogenesis pathway and incidence of type 2
   diabetes: A pooled analysis of prospective cohort studies
SO PLOS MEDICINE
LA English
DT Article
ID CORONARY-HEART-DISEASE; BETA-CELL TURNOVER; ADIPOSE-TISSUE; COFFEE
   CONSUMPTION; PLASMA; RISK; ASSOCIATION; BIOMARKERS; CANCER;
   PHOSPHOLIPIDS
AB Background
   De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D).
   Methods and findings
   Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970-1973 to 2006-2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3-75.5 years; % women = 20.4%62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-varianceweighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41-1.66; p< 0.001) for 16:0, 1.40 (1.33-1.48; p< 0.001) for 16:1n-7, 1.14 (1.05-1.22; p = 0.001) for 18:0, and 1.16 (1.07-1.25; p< 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I-2 = 51.1%-73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94-1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors.
   Conclusions
   Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D.
C1 [Imamura, Fumiaki; Koulman, Albert; Wareham, Nick J.; Forouhi, Nita G.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.
   [Fretts, Amanda M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.
   [Marklund, Matti; Riserus, Ulf] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden.
   [Marklund, Matti; Wu, Jason H. Y.] Univ New South Wales, George Inst Global Hlth, Fac Med, Sydney, NSW, Australia.
   [Marklund, Matti; Micha, Renata; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
   [Ardisson Korat, Andres V.; Hu, Frank] Harvard TH Chan Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA USA.
   [Ardisson Korat, Andres V.; Hu, Frank; Sun, Qi] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Ardisson Korat, Andres V.; Djousse, Luc; Hu, Frank; Sun, Qi] Harvard Med Sch, Boston, MA 02115 USA.
   [Yang, Wei-Sin; Chien, Kuo-Liong; Chen, Yun-yu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan.
   [Lankinen, Maria; Virtanen, Jyrki K.; Tuomainen, Tomi-Pekka; Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
   [Qureshi, Waqas] Wake Forest Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, Winston Salem, NC 27101 USA.
   [Helmer, Catherine; Rajaobelina, Kalina; Samieri, Cecilia] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France.
   [Chen, Tzu-An; Wood, Alexis C.; Senn, Mackenzie] USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Baylor Coll Med, Houston, TX USA.
   [Wong, Kerry; Bassett, Julie K.; Giles, Graham G.; Hodge, Allison] Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia.
   [Murphy, Rachel] Univ British Columbia, Sch Populat Publ & Hlth, Ctr Excellence Canc Prevent, Fac Med, Vancouver, BC, Canada.
   [Tintle, Nathan] Dordt Univ, Dept Math & Stat, Sioux Ctr, IA USA.
   [Yu, Chaoyu Ian; McKnight, Barbara] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA.
   [Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Hlth Sci, Fac Sci, Amsterdam, Netherlands.
   [Chien, Kuo-Liong; Chen, Yun-yu] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.
   [del Gobbo, Liana C.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.
   [Djousse, Luc] Brigham & Womens Hosp, Dept Med, Div Aging, 75 Francis St, Boston, MA 02115 USA.
   [Geleijnse, Johanna M.; de Goede, Janette; Soedamah-Muthu, Sabita S.] Wageningen Univ, Div Human Nutr & Hlth, Wageningen, Netherlands.
   [Giles, Graham G.; Hodge, Allison] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia.
   [Giles, Graham G.] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic, Australia.
   [Gudnason, Vilmundur] Iceland Heart Assoc Res Inst, Kopavogur, Iceland.
   [Harris, William S.] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD USA.
   [Harris, William S.] OmegaQuant Analyt, Sioux Falls, SD USA.
   [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Nutr Biomarker Lab, Cambridge, England.
   [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Metabol & Lipid Lab, Cambridge, England.
   [Koulman, Albert] MRC, Elsie Widdowson Lab, Cambridge, England.
   [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland.
   [Laakso, Markku] Kuopio Univ Hosp, Dept Med, Kuopio, Finland.
   [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden.
   [Lin, Hung-Ju] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.
   [Robinson, Jennifer G.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Prevent Intervent Ctr, Iowa City, IA USA.
   [Siscovick, David S.] New York Acad Med, New York, NY USA.
   [Soedamah-Muthu, Sabita S.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders, Tilburg, Netherlands.
   [Soedamah-Muthu, Sabita S.] Univ Reading, Inst Food Nutr & Hlth, Reading, Berks, England.
   [Sotoodehnia, Nona; Lemaitre, Rozenn N.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA.
   [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.
   [Wagenknecht, Lynne E.] Wake Forest Sch Med, Publ Hlth Sci, Winston Salem, NC 27101 USA.
C3 University of Cambridge; University of Washington; University of
   Washington Seattle; Uppsala University; University of New South Wales
   Sydney; George Institute for Global Health; Tufts University; Harvard
   University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard University Medical Affiliates; Brigham & Women's
   Hospital; Harvard University; Harvard Medical School; National Taiwan
   University; University of Eastern Finland; Wake Forest University;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite de Bordeaux; Baylor College of Medicine; United States
   Department of Agriculture (USDA); Cancer Council Victoria; University of
   British Columbia; University of Washington; University of Washington
   Seattle; Vrije Universiteit Amsterdam; Taipei Veterans General Hospital;
   Stanford University; Harvard University; Harvard University Medical
   Affiliates; Brigham & Women's Hospital; Wageningen University &
   Research; University of Melbourne; Monash University; Icelandic Heart
   Association; University of South Dakota; OmegaQuant, LLC; Cambridge
   University Hospitals NHS Foundation Trust; Addenbrooke's Hospital;
   University of Cambridge; University of Cambridge; Cambridge University
   Hospitals NHS Foundation Trust; Addenbrooke's Hospital; UK Research &
   Innovation (UKRI); Medical Research Council UK (MRC); MRC Human
   Nutrition Research; University of Eastern Finland; University of Eastern
   Finland; University of Eastern Finland Hospital; Kuopio University
   Hospital; Uppsala University; National Taiwan University; National
   Taiwan University Hospital; University of Iowa; New York Academy of
   Medicine; Tilburg University; University of Reading; University of
   Washington; University of Washington Seattle; University of Minnesota
   System; University of Minnesota Twin Cities; Wake Forest University
RP Imamura, F (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.
EM fumiaki.imamura@mrc-epid.cam.ac.uk
RI Uusitupa, Matti/AAX-4929-2020; Chen, Yun-Yu/IXO-3895-2023; Degenhardt,
   Louisa/D-4515-2012; Sun, Qi/KHT-5120-2024; Forouhi, Nita/JAC-2361-2023;
   Lind, Lars/KAM-1968-2024; Micha, Renata/LSL-6826-2024; Marklund,
   Matti/ABC-3674-2021; Wood, Alexis/B-8053-2010; HELMER,
   Catherine/AAG-5126-2021; Djousse, Luc/F-5033-2017; Gudnason,
   Vilmundur/AAE-7126-2019; Harris, William/T-1674-2019; Soedamah-Muthu,
   Sabita/A-8166-2014; Boncoraglio, Giorgio/B-8647-2011; Brouwer,
   Inge/K-8455-2013; Chen, Pei-Lung/A-3520-2010; , Jennifer/AAD-8336-2019;
   Koulman, Albert/B-2967-2009; Virtanen, Jyrki/G-5149-2013; Lin,
   Chih-Feng/KRQ-9587-2024; Hu, Frank/C-1919-2013; Giles,
   Graham/LCD-5671-2024; Wu, Jason/J-2936-2019; Samieri,
   Cecilia/T-3267-2019; Imamura, Fumiaki/J-1038-2019; Geleijnse, Johanna
   Marianna/B-5749-2012; HELMER, Catherine/I-6581-2015; Gudnason,
   Vilmundur/K-6885-2015
OI Forouhi, Nita/0000-0002-5041-248X; Murphy, Rachel/0000-0003-4383-5641;
   Lankinen, Maria/0000-0002-9158-283X; Wu, Jason/0000-0003-2073-3562; de
   Goede, Janette/0000-0002-6174-0681; Samieri,
   Cecilia/0000-0001-9809-7506; Imamura, Fumiaki/0000-0002-6841-8396;
   Geleijnse, Johanna Marianna/0000-0001-7638-0589; Brouwer,
   Ingeborg/0000-0002-8762-382X; Tintle, Nathan/0000-0003-1447-9107;
   Ardisson Korat, Andres/0000-0003-4599-2245; Wareham,
   Nicholas/0000-0003-1422-2993; HELMER, Catherine/0000-0002-5169-7421;
   Gudnason, Vilmundur/0000-0001-5696-0084; Marklund,
   Matti/0000-0002-3320-796X
FU United Kingdom Medical Research Council Epidemiology Unit core grant
   [MC_UU_12015/5, MC_UU_12015/1]; National Institute for Health Research
   (NIHR) Biomedical Research Centre Cambridge [IS-BRC-1215-20014]; Dutch
   Scientific Organization (ZonMW); Foundation Plan Alzheimer; NIH
   [3T32DK007703, T32CA009001, UM1 CA167552, R01 HL35464, AA11181, HL35464,
   CA55075, HL60712, P30 DK46200, M01-RR-43, CA186107, CA87969, CA49449,
   HL34594, CA167552, HL088521]; Netherlands Heart Foundation [2000T401];
   NIH (NIH/National Heart, Lung, and Blood Institute [NHLBI]); NIH (ODS)
   [R01HL-076200]; Unilever RD, Vlaardingen; United States National
   Institute of Health (NIH) [N01-AG012100]; National Institute of Aging
   (NIA) Intramural Research Program; Hjartavernd (the Icelandic Heart
   Association); Althingi (the Icelandic Parliament); Michael Smith
   Foundation for Medical Research [17644]; Canadian Cancer Society
   [704735]; Ministry of Science and Technology; National Taiwan
   University, Taiwan [MOST 103-2314-B-002 -135-MY3, NSC 100-2314-B-002
   -113 -MY3, NTUH 105-S3120, NTUH 106-S3453]; National Institute of
   Neurological Disorders and Stroke (NINDS); NIA [R01AG023629]; NHLBI;
   Boston University [N01-HC25195]; EU FP6 programme [LSHM_CT_2006_037197];
   Academy of Finland; VicHealth; Cancer Council Victoria; Australia's
   National Health and Medical Research Council [209057, 126403]; NCRR
   [UL1-TR000040, UL1-TR-001079]; European Union; Juselius Foundation;
   Uppsala University Hospital; Swedish Research Council for Health,
   Working Life and Welfare; Agence Nationale de la Recherche [COGINUT
   ANR-06-PNRA-005]; Fondation Plan Alzheimer [FCS 2009-2012]; Uppsala City
   Council; Swedish Research Council; Swedish Diabetes Foundation (UR);
   NHLBI, NIH, U.S. Department of Health and Human Services
   [HHSN268201600018C, HHSN268201600001C, HHSN268201600002C,
   HHSN268201600003C, HHSN268201600004C]; Fondation pour la Recherche
   Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction
   Generale de la Sante; MGEN; Institut de la Longevite; Conseils Regionaux
   d'Aquitaine et Bourgogne; Fondation de France; Ministry of
   Research-Institut National de la Sante; Caisse Nationale pour la
   Solidarite et l'Autonomie; NHLBI [HHSN268201200036C, HHSN268200800007C,
   HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081,
   N01HC85082, N01HC85083, N01HC85086, R01-HL-085710, U01HL080295,
   U01HL130114, U01-HL-47892, U01-HL-47902, N01-HC-95161, N01-HC-95162,
   N01-HC95163, N01-HC-95164, N01-HC-95165, N01-HC95166, N01-HC-95167,
   N01-HC-95168, N01HC-95169];  [DK-29867];  [R01-58329];  [DK-079888]; 
   [HHSN268201500003I];  [N01-HC-95159];  [N01-HC95160]; MRC
   [MC_UU_00006/3, MC_UU_12015/5, MC_UU_00014/5, MC_UU_12015/1] Funding
   Source: UKRI
FX No specific funding was received for this study. This manuscript does
   not reflect opinions or conclusions of any funding agency. No funding
   bodies had any role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. FI, NGF, and NJW
   were funded by the United Kingdom Medical Research Council Epidemiology
   Unit core grant (MC_UU_12015/5 and MC_UU_12015/1); NJW, NGF and AK
   acknowledge National Institute for Health Research (NIHR) Biomedical
   Research Centre Cambridge (IS-BRC-1215-20014); NJW is an NIHR Senior
   Investigator; IAB, by the European Union (FP7 and Horizon2020) and the
   Dutch Scientific Organization (ZonMW); CS, by the Foundation Plan
   Alzheimer; and AAK, by the NIH training grant (3T32DK007703 and
   T32CA009001). Alpha Omega Cohort was funded by the Netherlands Heart
   Foundation (grant 2000T401), the NIH (NIH/National Heart, Lung, and
   Blood Institute [NHLBI], and ODS, grant R01HL-076200), and Unilever R&D,
   Vlaardingen (margarine production and distribution). The authors
   acknowledge Kamalita Pertiwi, Wageningen University, the Netherlands,
   for analyses of data from the Alpha Omega Cohort. Age, Gene/Environment
   Susceptibility Study Reykjavik was funded by Office of Dietary
   Supplements, the United States National Institute of Health (NIH)
   contract N01-AG012100, the National Institute of Aging (NIA) Intramural
   Research Program, Hjartavernd (the Icelandic Heart Association), and the
   Althingi (the Icelandic Parliament). Additional support was provided by
   the Michael Smith Foundation for Medical Research (#17644) and the
   Canadian Cancer Society (grant #704735). Chin-Shan Community
   Cardiovascular Study was funded by Ministry of Science and Technology
   and National Taiwan University, Taiwan (MOST 103-2314-B-002 -135-MY3,
   NSC 100-2314-B-002 -113 -MY3, NTUH 105-S3120, NTUH 106-S3453). The
   Cardiovascular Health Study (CHS) was supported by contracts
   HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222,
   N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086,
   and grants R01-HL-085710, U01HL080295 and U01HL130114 from the NHLBI,
   with additional contribution from the National Institute of Neurological
   Disorders and Stroke (NINDS). Additional support was provided by
   R01AG023629 from NIA. The Framingham Heart Study was supported by the
   NHLBI in collaboration with Boston University (Contract No.
   N01-HC25195). The Health Professionals Follow-up Study was funded by UM1
   CA167552, R01 HL35464, AA11181, HL35464, CA55075, HL60712, and P30
   DK46200 from the NIH. The Insulin Resistance Atherosclerosis Study was
   funded by grants U01-HL-47892, U01-HL-47902, DK-29867, R01-58329, and
   DK-079888 from NHLBI and grant M01-RR-43 from the NIH. The InterAct
   project was funded by the EU FP6 programme (grant no.
   LSHM_CT_2006_037197). The Kuopio Ischaemic Heart Disease Risk Factor
   Study was supported mainly by the funding from the Academy of Finland to
   Jukka T. Salonen. The Melbourne Collaborative Cohort Study was funded by
   VicHealth and Cancer Council Victoria; and by grants 209057 and 126403
   from Australia's National Health and Medical Research Council and by
   infrastructure provided by Cancer Council Victoria. Multi-ethnic Study
   of Atherosclerosis was funded by contracts HHSN268201500003I,
   N01-HC-95159, N01-HC95160, N01-HC-95161, N01-HC-95162, N01-HC95163,
   N01-HC-95164, N01-HC-95165, N01-HC95166, N01-HC-95167, N01-HC-95168 and
   N01HC-95169 from the NHLBI and by grants UL1-TR000040 and UL1-TR-001079
   from NCRR. The Metabolic Syndrome in Men Study was funded by the grants
   from the European Union, the Academy of Finland, and the Juselius
   Foundation. The Nurses' Health Study was funded by the NIH (CA186107,
   CA87969, CA49449, HL34594, HL35464, CA167552, HL60712, and HL088521).
   Prospective Investigation of the Vasculature in Uppsala Seniors was
   supported by Uppsala University Hospital and the Swedish Research
   Council for Health, Working Life and Welfare. The Tree City Study was
   conducted under a partnership agreement between the Institut National de
   la Sante et de la Recherche Medicale, the University Bordeaux 2 Victor
   Segalen, and Sanofi; and funded by the Fondation pour la Recherche
   Medicale, the Caisse Nationale Maladie des Travailleurs Salaries,
   Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils
   Regionaux d'Aquitaine et Bourgogne, Fondation de France, Ministry of
   Research-Institut National de la Sante and de la Recherche Medicale
   Programme Cohortes, grant COGINUT ANR-06-PNRA-005 from the Agence
   Nationale de la Recherche, grant FCS 2009-2012 from the Fondation Plan
   Alzheimer, and the Caisse Nationale pour la Solidarite et l'Autonomie.
   The Uppsala Longitudinal Studies of Adult Men 50 and 70 were funded by
   the Swedish Research Council for Health, Working Life and Welfare,
   Uppsala City Council, Swedish Research Council, and Swedish Diabetes
   Foundation (UR). The Women's Health Initiative was funded by the NHLBI,
   NIH, U.S. Department of Health and Human Services through contracts
   HHSN268201600018C, HHSN268201600001C, HHSN268201600002C,
   HHSN268201600003C, and HHSN268201600004C. A full listing of each of CHS,
   MESA, and WHI investigators can be found at http://www.CHS-NHLBI.org,
   http://www.mesanhlbi.org, and http://www.whi.org/researchers/,
   respectively. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Alsharari ZD, 2020, EUR J NUTR, V59, P2089, DOI 10.1007/s00394-019-02058-6
   Ameer F, 2014, METABOLISM, V63, P895, DOI 10.1016/j.metabol.2014.04.003
   Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182
   Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048
   Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771
   Del Gobbo LC, 2016, JAMA INTERN MED, V176, P1155, DOI 10.1001/jamainternmed.2016.2925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2
   Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537
   Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400
   Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9
   Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7
   Harris WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147894
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hla T, 2014, CELL METAB, V20, P703, DOI 10.1016/j.cmet.2014.10.017
   Hodge AM, 2007, AM J CLIN NUTR, V86, P189, DOI 10.1093/ajcn/86.1.189
   Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003
   Hodson L, 2020, P NUTR SOC, V79, P30, DOI 10.1017/S0029665119000569
   Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002
   Iggman D, 2016, JAMA CARDIOL, V1, P745, DOI 10.1001/jamacardio.2016.2259
   Imamura F, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002670
   Imamura F, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002087
   Jacobs S, 2014, AM J CLIN NUTR, V100, P891, DOI 10.3945/ajcn.113.080317
   Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a
   Katan MB, 1997, J LIPID RES, V38, P2012
   King IB, 2006, AM J CLIN NUTR, V83, P227
   Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005
   Kröger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447
   Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603
   Lankinen MA, 2015, DIABETOLOGIA, V58, P2533, DOI 10.1007/s00125-015-3730-5
   Livesey G, 2013, AM J CLIN NUTR, V97, P584, DOI 10.3945/ajcn.112.041467
   Lodhi IJ, 2011, TRENDS ENDOCRIN MET, V22, P1, DOI 10.1016/j.tem.2010.09.002
   Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35
   Luukkonen PK, 2018, DIABETES CARE, V41, P1732, DOI 10.2337/dc18-0071
   Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726
   Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69
   Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182
   Rosqvist F, 2019, J CLIN ENDOCR METAB, V104, P6207, DOI 10.1210/jc.2019-00160
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Skeaff CM, 2006, J NUTR, V136, P565, DOI 10.1093/jn/136.3.565
   Song XL, 2017, AM J CLIN NUTR, V105, P1272, DOI 10.3945/ajcn.117.153072
   Stanhope KL, 2012, ANNU REV MED, V63, P329, DOI 10.1146/annurev-med-042010-113026
   Wang L, 2003, AM J CLIN NUTR, V78, P91
   Wu JHY, 2017, LANCET DIABETES ENDO, V5, P965, DOI [10.1016/S2213-8587(17)30307-8, 10.1016/s2213-8587(17)30307-8]
   Wu JHY, 2013, CIRC-CARDIOVASC GENE, V6, P171, DOI 10.1161/CIRCGENETICS.112.964619
   Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690
   Zheng JS, 2019, AM J CLIN NUTR, V109, P1527, DOI 10.1093/ajcn/nqz030
NR 47
TC 40
Z9 42
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD JUN
PY 2020
VL 17
IS 6
AR e1003102
DI 10.1371/journal.pmed.1003102
PG 17
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA NA3PI
UT WOS:000559724500001
PM 32530938
OA Green Published, gold, Green Accepted
DA 2025-04-28
ER

PT J
AU Nascimento, GO
   Marques, SPD
   Maia, CEG
   de Sousa, AF
   Cunha, RL
   Malta, MR
   Owen, RW
   Ferreira, MKA
   da Silva, AW
   Rebouças, EL
   de Menezes, JESA
   Marinho, MM
   Marinho, ES
   dos Santos, HS
   Saliba, ASMC
   Massarioli, AP
   Alencar, SM
   Sartori, AGO
   Trevisan, MTS
AF Nascimento, G. O.
   Marques, S. P. D.
   Maia, C. E. G.
   de Sousa, A. F.
   Cunha, R. L.
   Malta, M. R.
   Owen, R. W.
   Ferreira, M. K. A.
   da Silva, A. W.
   Reboucas, E. L.
   de Menezes, J. E. S. A.
   Marinho, M. M.
   Marinho, E. S.
   dos Santos, H. S.
   Saliba, A. S. M. C.
   Massarioli, A. P.
   Alencar, S. M.
   Sartori, A. G. O.
   Trevisan, M. T. S.
TI Hypoglycemic effect of Coffea arabica leaf extracts and major
   bioactive constituents
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article
DE alpha-glucosidase; antioxidant; pancreatic lipase; polyphenolics;
   zebrafish
ID ALPHA-GLUCOSIDASE; IN-VITRO; OPTIMIZATION; PERFORMANCE; PRODUCTS;
   DOCKING; CELLS
AB The present study focused on investigating the antioxidant, antiglycation activity, digestive enzymes inhibition, bioaccessibility and hypoglycemic effect of C. arabica leaves extracts. The extracts deactivated the O-2(-), ROO? , H2O2, HOCl reactive oxygen species. Coffee leaves showed strong inhibition of alpha-glucosidase (IC50 = 40.30 mu g mL(-1)) greater than the isolated metabolites and acarbose. There was also inhibition of pancreatic lipase (IC50 = 56.43 mu g mL(-1)) in addition to a hypoglycemic effect in zebrafish similar to acarbose and metformin. With the exception of rutin, all biocompounds were detected at all stages of in vitro digestion. Finally, these results suggest that C. arabica leaf extracts possess antidiabetic and anti-obesity properties that can be attributed to the main metabolites and the synergistic action between them.
C1 [Nascimento, G. O.; Maia, C. E. G.; de Sousa, A. F.; Owen, R. W.; Trevisan, M. T. S.] Univ Fed Ceara, Dept Quim Organ & Inorgan, Fortaleza, CE, Brazil.
   [Marques, S. P. D.] Inst Fed Educ Ciencia & Tecnol Ceara, Dept Quim, Quixada, CE, Brazil.
   [Cunha, R. L.; Malta, M. R.] Empresa Pesquisa Agr Minas Gerais EPAMIG, Belo Horizonte, MG, Brazil.
   [Ferreira, M. K. A.] Univ Estadual Ceara, Postgrad Program Nat Sci, Fortaleza, Ceara, Brazil.
   [Ferreira, M. K. A.; da Silva, A. W.; de Menezes, J. E. S. A.] State Univ Ceara Sci & Technol Ctr CCT, Lab Nat Prod Chem LQPN S, Itaperi Campus, Fortaleza, Ceara, Brazil.
   [da Silva, A. W.; Reboucas, E. L.] Univ Estadual Ceara, Grad Program Biotechnol, Northeast Biotechnol Network, Fortaleza, Ceara, Brazil.
   [Marinho, M. M.; Marinho, E. S.] Univ Estadual Ceara, Grp Theoret Chem & Electrochem GQTE, Limoeiro Do Norte, CE, Brazil.
   [dos Santos, H. S.] Vale do Acarau State Univ, Ctr Exact Sci & Technol, Sobral, CE, Brazil.
   [Saliba, A. S. M. C.; Massarioli, A. P.; Alencar, S. M.; Sartori, A. G. O.; Trevisan, M. T. S.] Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil.
C3 Universidade Federal do Ceara; Instituto Federal do Ceara (IFCE);
   Universidade Estadual do Ceara; Universidade Estadual do Ceara;
   Universidade Estadual do Ceara
RP Nascimento, GO (corresponding author), Univ Fed Ceara, Dept Quim Organ & Inorgan, Fortaleza, CE, Brazil.
EM gerlan@alu.ufc.br
RI Massarioli, Adna/I-4840-2013; Nascimento, Gerlan/HTM-6483-2023;
   Trevisan, Maria/AAJ-7236-2021; Menezes, Jane/AAW-3991-2020; Marinho,
   Marcia/AAB-9706-2022; Dos Santos, Helcio Silva/Y-7947-2019; Malta,
   Marcelo/AIE-9400-2022; Matias de Alencar, Severino/B-7743-2012;
   Giovanini de Oliveira Sartori, Alan/E-7493-2012; Marinho, Emmanuel
   Silva/F-1525-2018; Martelli Chaib Saliba, Ana Sofia/HTM-8067-2023
OI Matias de Alencar, Severino/0000-0002-6637-7973; Nascimento,
   Gerlan/0000-0003-0772-2498; Giovanini de Oliveira Sartori,
   Alan/0000-0002-6782-5379; Marinho, Emmanuel Silva/0000-0002-4774-8775;
   Martelli Chaib Saliba, Ana Sofia/0000-0002-5570-2822
FU Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico
   (Funcap) through the project CAPES/PROEX [88887.372227/2019-00];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   through the project CAPES/PROEX [88887.372227/2019-00]
FX The authors are grateful to Fundacao Cearense de Apoio ao
   Desenvolvimento Cientifico e Tecnologico (Funcap) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for financial
   support through the project CAPES/PROEX process: 88887.372227/2019-00.
CR Abreu L. L. d C., 2021, RES SOC DEV, V10, pe321101119603, DOI [https://doi.org/10.33448/rsd-v10i11.19603, DOI 10.33448/RSD-V10I11.19603]
   Aghajari E., 2020, AFR J PRIM HEALTH CA, V9, pe97284, DOI [https://doi.org/10.5812/jjcdc.97284, DOI 10.5812/JJCDC.97284]
   Ahangarpour A, 2019, DIABETES METAB SYND, V13, P854, DOI 10.1016/j.dsx.2018.11.051
   Alkadi Hourieh, 2020, Infectious Disorders - Drug Targets, V20, P16, DOI 10.2174/1871526518666180628124323
   Andres C.M. C., Stresses, V2022, P256, DOI [10.3390/stresses2030019, DOI 10.3390/STRESSES2030019]
   [Anonymous], 2020, DIABETES CARE, V43, pS1, DOI [10.2337/dc20-Sint, 10.2337/dc20-SINT, 10.2337/dc16-S001, 10.2337/dc19-Sint01, 10.2337/dc19-SINT01]
   Aranda-Rivera AK, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11101854
   da Silva WMB, 2020, NEUROTOX RES, V37, P893, DOI 10.1007/s12640-019-00142-7
   Biovia D.S., 2017, Dassault Systemes
   Campos-Florián J, 2013, EMIR J FOOD AGR, V25, P772, DOI 10.9755/ejfa.v25i10.16409
   Capiotti KM, 2014, COMP BIOCHEM PHYS B, V171, P58, DOI 10.1016/j.cbpb.2014.03.005
   Chisté Renan Campos, 2011, Acta Amaz., V41, P279, DOI 10.1590/S0044-59672011000200013
   Csizmadia P., 1999, MarvinSketch and MarvinView: molecule applets for the World Wide Web, DOI [DOI 10.3390/ECSOC-3-01775, 10.3390/ecsoc-3-01775]
   de Almeida R., 2014, ASS SCI INF COFF C, V1, P42
   de Almeida RF, 2019, FOOD RES INT, V115, P493, DOI 10.1016/j.foodres.2018.10.006
   de Lima JP, 2021, J ETHNOPHARMACOL, V268, DOI 10.1016/j.jep.2020.113667
   DeLano W.L., 2008, PYMOL MOL GRAPHICS S
   Dinda B, 2020, ADV PROTEIN CHEM STR, V120, P159, DOI 10.1016/bs.apcsb.2019.08.006
   de Franco EPD, 2020, J ENZYM INHIB MED CH, V35, P42, DOI 10.1080/14756366.2019.1681989
   Duangjai A., 2020, Biomed. Res., V31, P59
   Dumanovic J, 2021, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.552969
   Duong TH, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127359
   Franco RR, 2020, J ETHNOPHARMACOL, V261, DOI 10.1016/j.jep.2020.113132
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X
   Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17
   Hauner H., 2016, TXB DIABETES
   Huey R. G. M., 2012, USING AUTODOCK 4 AUT
   IMBERTY A, 1991, Glycobiology, V1, P631, DOI 10.1093/glycob/1.6.631
   Jaradat N, 2017, MARMARA PHARM J, V21, P828, DOI 10.12991/mpj.2017.9
   Kachmar MR, 2019, FOOD CHEM, V278, P424, DOI 10.1016/j.foodchem.2018.11.082
   Kadela-Tomanek M, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13060781
   Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033
   Kong LN, 2022, INT J NURS STUD, V126, DOI 10.1016/j.ijnurstu.2021.104156
   Korac B, 2021, REDOX BIOL, V42, DOI 10.1016/j.redox.2021.101887
   Kumar A, 2021, LIFE SCI, V271, DOI 10.1016/j.lfs.2021.119115
   Loetchutinat C, 2005, RADIAT PHYS CHEM, V72, P323, DOI 10.1016/j.radphyschem.2004.06.011
   Lourenço SC, 2019, MOLECULES, V24, DOI 10.3390/molecules24224132
   Marinho EM, 2020, MICROB PATHOGENESIS, V148, DOI 10.1016/j.micpath.2020.104365
   Marques S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6030088
   Martina D, 2021, PALLIATIVE MED, V35, P1776, DOI 10.1177/02692163211042530
   Massarioli AP, 2022, FOODS, V11, DOI 10.3390/foods11030449
   Melo PS, 2015, FOOD CHEM, V181, P160, DOI 10.1016/j.foodchem.2015.02.087
   Meza JC, 2010, WIRES COMPUT STAT, V2, P719, DOI 10.1002/wics.117
   Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j
   Monteiro A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9010006
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Morris TP, 2019, STAT MED, V38, P2074, DOI 10.1002/sim.8086
   Msopa E, 2019, DIABETES METAB SYND, V13, P1497, DOI 10.1016/j.dsx.2018.11.062
   Music Miralem, 2015, Med Arch, V69, P251, DOI 10.5455/medarh.2015.69.251-255
   Naveed M, 2018, BIOMED PHARMACOTHER, V97, P67, DOI 10.1016/j.biopha.2017.10.064
   Neha K, 2019, EUR J MED CHEM, V178, P687, DOI 10.1016/j.ejmech.2019.06.010
   Nguyen DD, 2017, J CHEM INF MODEL, V57, P1715, DOI 10.1021/acs.jcim.7b00226
   Ontawong A, 2021, J HERB MED, V29, DOI 10.1016/j.hermed.2021.100465
   Ontawong A, 2019, PHYTOMEDICINE, V52, P187, DOI 10.1016/j.phymed.2018.06.021
   Otterbach S, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105368
   Owen RW, 2000, EUR J CANCER, V36, P1235, DOI 10.1016/S0959-8049(00)00103-9
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Patay ÉB, 2016, ASIAN PAC J TROP MED, V9, P1127, DOI 10.1016/j.apjtm.2016.11.008
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pinheiro FD, 2021, FOOD CHEM, V336, DOI 10.1016/j.foodchem.2020.127701
   Barbosa JHP, 2016, QUIM NOVA, V39, P608, DOI 10.5935/0100-4042.20160048
   Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3
   Santos CMM, 2018, EUR J MED CHEM, V157, P1460, DOI 10.1016/j.ejmech.2018.07.073
   Sekar V, 2019, S AFR J BOT, V120, P129, DOI 10.1016/j.sajb.2018.02.001
   Shinde J, 2008, CARBOHYD RES, V343, P1278, DOI 10.1016/j.carres.2008.03.003
   Shityakov Sergey, 2014, Adv Appl Bioinform Chem, V7, P23, DOI 10.2147/AABC.S63749
   Shokouh P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092074
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Snoussi C, 2014, J NUTR BIOCHEM, V25, P557, DOI 10.1016/j.jnutbio.2014.01.006
   SOARES LV, 2017, Bread: Consumption, Cultural Significance and Health Effects, P125
   Swain SK, 2020, J ETHNOPHARMACOL, V247, DOI 10.1016/j.jep.2019.112257
   Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529
   Tseng YC, 2009, AM J PHYSIOL-REG I, V297, pR275, DOI 10.1152/ajpregu.00180.2009
   Tvrda Eva., 2020, Pathology, P3, DOI DOI 10.1016/B978-0-12-815972-9.00001-9
   Vissotto LC, 2013, FOOD SCI TECH-BRAZIL, V33, P57, DOI 10.1590/S0101-20612013000500010
   Watanabe K, 2019, NAT GENET, V51, P1339, DOI 10.1038/s41588-019-0481-0
   Wojtunik-Kulesza K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051401
   Yaman S.O., 2021, Accenting Lipid Peroxidation, P1, DOI [10.5772/intechopen.95802, DOI 10.5772/INTECHOPEN.95802]
   Yan JK, 2014, INT J BIOL MACROMOL, V64, P213, DOI 10.1016/j.ijbiomac.2013.12.007
   Ye MZ, 2022, NAT NANOTECHNOL, V17, P880, DOI 10.1038/s41565-022-01137-w
   Yu L. L., 2014, FOOD SAFETY CHEM TOX
   Yusuf D, 2008, J CHEM INF MODEL, V48, P1411, DOI 10.1021/ci800084x
   Zheng YX, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103587
NR 83
TC 11
Z9 11
U1 6
U2 30
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
PD DEC 29
PY 2023
VL 41
IS 24
BP 14871
EP 14886
DI 10.1080/07391102.2023.2188421
EA MAR 2023
PG 16
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA DL0E1
UT WOS:000954439300001
PM 36927332
DA 2025-04-28
ER

PT J
AU Lecour, S
   Lamont, KT
AF Lecour, S.
   Lamont, K. T.
TI Natural Polyphenols and Cardioprotection
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Cardioprotection; cocoa; natural polyphenols; prosurvival signaling
   pathways; tea-wine
ID RED WINE POLYPHENOLS; NITRIC-OXIDE SYNTHASE; GRAPE SEED
   PROANTHOCYANIDIN; INHIBIT PLATELET-FUNCTION; LOW-DENSITY-LIPOPROTEIN;
   GREEN TEA; REPERFUSION INJURY; BLOOD-PRESSURE; TNF-ALPHA; BLACK TEA
AB With more than 8000 polyphenols found in food (mainly, wine, tea, coffee, cocoa, vegetables and cereals), many epidemiological studies suggest that the intake of polyphenol-rich foods has a beneficial effect on a large number of cardiovascular risk factors, such as high blood pressure, high blood cholesterol, obesity, diabetes and smoking. The mechanisms involved in the cardioprotective effects of polyphenols are numerous and include antioxidant, vasodilator, anti-inflammatory, anti-fibrotic, antiapoptotic and metabolic. Most importantly, recent experimental data demonstrate that polyphenols can exert its cardioprotective effect via the activation of several powerful prosurvival cellular pathways that involve metabolic intermediates, microRNAs, sirtuins and mediators of the recently described reperfusion injury salvage kinases (RISK) and survivor activating factor enhancement (SAFE) pathways.
C1 [Lecour, S.; Lamont, K. T.] Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Cardiovasc Res Inst, ZA-7925 Observatory, South Africa.
C3 University of Cape Town
RP Lecour, S (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Cardiovasc Res Inst, Chris Barnard Bldg,Anzio Rd, ZA-7925 Observatory, South Africa.
EM Sandrine.lecour@uct.ac.za
FU Medical Research Council of South Africa; National Research Foundation;
   University of Cape Town
FX The research of S.L. is partly funded via grants from the Medical
   Research Council of South Africa, the National Research Foundation. K.L
   is funded via a grant from the Medical Research Council of South Africa
   and the University of Cape Town.
CR Agrawal M, 2011, EUR J PHARMACOL, V666, P5, DOI 10.1016/j.ejphar.2011.05.015
   Akhlaghi M, 2009, J MOL CELL CARDIOL, V46, P309, DOI 10.1016/j.yjmcc.2008.12.003
   Al-Awwadi NA, 2005, J AGR FOOD CHEM, V53, P151, DOI 10.1021/jf048919f
   Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440
   Aviram M, 1998, ARTERIOSCL THROM VAS, V18, P1617, DOI 10.1161/01.ATV.18.10.1617
   Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649
   Aviram M, 2000, AM J CLIN NUTR, V71, P1062
   Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X
   Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bhat KPL, 2001, ANTIOXID REDOX SIGN, V3, P1041, DOI 10.1089/152308601317203567
   Bhatt SR, 2011, EUR J PHARMACOL, V667, P258, DOI 10.1016/j.ejphar.2011.05.026
   Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783
   Conklin Kenneth A, 2005, Integr Cancer Ther, V4, P110, DOI 10.1177/1534735405276191
   Cruz MN, 2006, AM J PHYSIOL-HEART C, V290, pH1969, DOI 10.1152/ajpheart.01065.2005
   Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008
   Dal-Ros S, 2011, BIOCHEM BIOPH RES CO, V404, P743, DOI 10.1016/j.bbrc.2010.12.060
   Dao TMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020700
   Das DK, 2006, MOL INTERV, V6, P36, DOI 10.1124/mi.6.1.7
   Davies MJ, 2003, J NUTR, V133, p3298S, DOI 10.1093/jn/133.10.3298S
   Dell'Agli M, 2008, BRIT J NUTR, V99, P945, DOI 10.1017/S0007114507837470
   DEMROW HS, 1995, CIRCULATION, V91, P1182, DOI 10.1161/01.CIR.91.4.1182
   Deuchar GA, 2007, LIFE SCI, V80, P1686, DOI 10.1016/j.lfs.2007.01.040
   Di Santo A, 2003, J THROMB HAEMOST, V1, P1089, DOI 10.1046/j.1538-7836.2003.00217.x
   Dohadwala MM, 2011, AM J CLIN NUTR, V93, P934, DOI 10.3945/ajcn.110.004242
   DRESDALE AR, 1982, AM J CLIN ONCOL-CANC, V5, P657, DOI 10.1097/00000421-198212000-00015
   Eaton S., 1997, EVOLUTION DIET HLTH
   Estruch R, 2004, ATHEROSCLEROSIS, V175, P117, DOI 10.1016/j.atherosclerosis.2004.03.006
   Falchi M, 2006, J AGR FOOD CHEM, V54, P6613, DOI 10.1021/jf061048k
   Faller ALK, 2010, J FOOD COMPOS ANAL, V23, P561, DOI 10.1016/j.jfca.2010.01.003
   Fernandez MT, 2002, J INORG BIOCHEM, V92, P105, DOI 10.1016/S0162-0134(02)00511-1
   Fischer UM, 2003, EUR J CARDIO-THORAC, V23, P984, DOI 10.1016/S1010-7940(03)00113-1
   Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792
   Fuglesteg BN, 2008, BASIC RES CARDIOL, V103, P444, DOI 10.1007/s00395-008-0728-x
   Fuhrman B, 2005, J NUTR, V135, P722, DOI 10.1093/jn/135.4.722
   Gurusamy N, 2010, J CELL MOL MED, V14, P2235, DOI 10.1111/j.1582-4934.2010.01140.x
   Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384
   HANASAKI Y, 1994, FREE RADICAL BIO MED, V16, P845, DOI 10.1016/0891-5849(94)90202-X
   Hattori R, 2002, AM J PHYSIOL-HEART C, V282, pH1988, DOI 10.1152/ajpheart.01012.2001
   Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360
   Hirata K, 2004, AM J CARDIOL, V93, P1384, DOI 10.1016/j.amjcard.2004.02.035
   Hodgson JM, 2006, CLIN EXP PHARMACOL P, V33, P838, DOI 10.1111/j.1440-1681.2006.04450.x
   Hodgson JM, 2001, EUR J CLIN NUTR, V55, P881, DOI 10.1038/sj.ejcn.1601231
   Hodgson JM, 1999, J HYPERTENS, V17, P457, DOI 10.1097/00004872-199917040-00002
   Hollenberg NK, 2006, J CARDIOVASC PHARM, V47, pS119, DOI 10.1097/00005344-200606001-00005
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Huang Y, 1998, LIFE SCI, V63, P275, DOI 10.1016/S0024-3205(98)00273-2
   Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005
   Imamura G, 2002, AM J PHYSIOL-HEART C, V282, pH1996, DOI 10.1152/ajpheart.01013.2001
   Kelly RF, 2010, BASIC RES CARDIOL, V105, P763, DOI 10.1007/s00395-010-0125-0
   Khan N, 2011, NUTR METAB CARDIOVAS
   Kim Jeong-A., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P82, DOI 10.2174/187153008784534349
   Kimura Y, 2010, FOOD CHEM TOXICOL, V48, P429, DOI 10.1016/j.fct.2009.10.041
   Kostyuk VA, 2003, FEBS LETT, V537, P146, DOI 10.1016/S0014-5793(03)00113-3
   Lacerda L, 2010, CARDIOVASC RES, V87, pS126
   Lacerda L, 2009, CARDIOVASC RES, V84, P201, DOI 10.1093/cvr/cvp274
   Lamont KT, 2011, J PINEAL RES, V50, P374, DOI 10.1111/j.1600-079X.2010.00853.x
   Lazzè MC, 2006, MOL NUTR FOOD RES, V50, P44, DOI 10.1002/mnfr.200500134
   Lecour S, 2005, CIRCULATION, V112, P3911, DOI 10.1161/CIRCULATIONAHA.105.581058
   Lecour S, 2005, CARDIOVASC RES, V65, P239, DOI 10.1016/j.cardiores.2004.10.003
   Lecour S, 2002, J MOL CELL CARDIOL, V34, P509, DOI 10.1006/jmcc.2002.1533
   Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019
   Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43
   Lekli I, 2010, J CELL MOL MED, V14, P2506, DOI 10.1111/j.1582-4934.2009.00921.x
   Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105
   Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705
   Löest HB, 2002, J NUTR, V132, P1282, DOI 10.1093/jn/132.6.1282
   Loke WM, 2008, AM J CLIN NUTR, V88, P1018, DOI 10.1093/ajcn/88.4.1018
   Loke WM, 2008, BIOCHEM PHARMACOL, V75, P1045, DOI 10.1016/j.bcp.2007.11.002
   Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200
   Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   McCullough ML, 2006, J CARDIOVASC PHARM, V47, pS103, DOI 10.1097/00005344-200606001-00003
   Monagas M, 2009, AM J CLIN NUTR, V90, P1144, DOI 10.3945/ajcn.2009.27716
   Mosca L, 2000, J AGR FOOD CHEM, V48, P297, DOI 10.1021/jf990556+
   Mukamal KJ, 2002, CIRCULATION, V105, P2476, DOI 10.1161/01.CIR.0000017201.88994.F7
   Mukhopadhyay P, 2011, ANN NY ACAD SCI, V1215, P109, DOI 10.1111/j.1749-6632.2010.05866.x
   Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705
   Murase T, 1999, ARTERIOSCL THROM VAS, V19, P1412, DOI 10.1161/01.ATV.19.6.1412
   Mursu J, 2008, BRIT J NUTR, V100, P890, DOI 10.1017/S0007114508945694
   Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418
   Nishizuka T, 2011, P JPN ACAD B-PHYS, V87, P104, DOI 10.2183/pjab.87.104
   Oak MH, 2004, CIRCULATION, V110, P1861, DOI 10.1161/01.CIR.0000142617.52881.F4
   Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004
   Opie LH, 2007, EUR HEART J, V28, P1683, DOI 10.1093/eurheartj/ehm149
   Osakabe N, 2002, EXP BIOL MED, V227, P51, DOI 10.1177/153537020222700109
   Panneerselvam M, 2010, AM J PHYSIOL-HEART C, V299, pH1604, DOI 10.1152/ajpheart.00073.2010
   Pataki T, 2002, AM J CLIN NUTR, V75, P894, DOI 10.1093/ajcn/75.5.894
   Pellegatta F, 2003, AM J CLIN NUTR, V77, P1220, DOI 10.1093/ajcn/77.5.1220
   Rein D, 2000, J NUTR, V130, p2109S, DOI 10.1093/jn/130.8.2109S
   Relja B., 2011, EUR J NUTR IN PRESS
   RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F
   Robich MP, 2010, CIRCULATION, V122, pS142, DOI 10.1161/CIRCULATIONAHA.109.920132
   Santos Marta R, 2004, Free Radic Res, V38, P1011, DOI 10.1080/10715760400003384
   Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022
   Sato M, 1999, J MOL CELL CARDIOL, V31, P1289, DOI 10.1006/jmcc.1999.0961
   Sato M, 2002, ANN NY ACAD SCI, V957, P122, DOI 10.1111/j.1749-6632.2002.tb02911.x
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097
   Soares PR, 2011, ARQ BRAS CARDIOL, V96, P277, DOI 10.1590/S0066-782X2011005000020
   Song DK, 2010, J KOREAN MED SCI, V25, P380, DOI 10.3346/jkms.2010.25.3.380
   Soucek P, 2011, ANTI-CANCER DRUG, V22, P176, DOI 10.1097/CAD.0b013e328341a17b
   Stein JH, 1999, CIRCULATION, V100, P1050, DOI 10.1161/01.CIR.100.10.1050
   Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Thirunavukkarasu M, 2008, J AGR FOOD CHEM, V56, P6733, DOI 10.1021/jf801473v
   Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881
   Visioli F, 1998, NUTR REV, V56, P142
   Vitseva O, 2005, J CARDIOVASC PHARM, V46, P445, DOI 10.1097/01.fjc.0000176727.67066.1c
   Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C
   Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X
   Wollgast J, 2001, J CHROMATOGR A, V926, P211, DOI 10.1016/S0021-9673(01)00994-3
   Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051
   Xi JK, 2009, EUR J PHARMACOL, V604, P111, DOI 10.1016/j.ejphar.2008.12.024
   Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667
   Yamazaki KG, 2010, J AM COLL CARDIOL, V55, P2869, DOI 10.1016/j.jacc.2010.01.055
   Yasuda A, 2011, J AGR FOOD CHEM, V59, P1470, DOI 10.1021/jf103820b
   Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9
   Yung L. M., 2008, Inflammopharmacology, V16, P230, DOI 10.1007/s10787-008-8022-y
   Zern TL, 2003, J NUTR, V133, P2268, DOI 10.1093/jn/133.7.2268
   Zhou HB, 2005, WORLD J GASTROENTERO, V11, P280, DOI 10.3748/wjg.v11.i2.280
   Zykova TA, 2008, MOL CARCINOGEN, V47, P797, DOI 10.1002/mc.20437
NR 124
TC 79
Z9 84
U1 2
U2 81
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PD DEC
PY 2011
VL 11
IS 14
BP 1191
EP 1199
PG 9
WC Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 869YH
UT WOS:000298635800003
PM 22070680
DA 2025-04-28
ER

PT J
AU Aslan, DT
   Göktas, Z
AF Aslan, Dilem Tugal
   Goktas, Zeynep
TI The Therapeutic Potential of Theobromine in Obesity: A Comprehensive
   Review
SO NUTRITION REVIEWS
LA English
DT Review; Early Access
DE theobromine; obesity; browning; anti-inflammatory; antioxidant
ID BROWN ADIPOSE-TISSUE; OXIDATIVE STRESS; BLOOD-PRESSURE; IN-VITRO; COCOA;
   ADIPOGENESIS; INFLAMMATION; ADIPOCYTES; HEALTHY; MACROPHAGES
AB Obesity, characterized by chronic low-grade inflammation, is a significant health concern. Phytochemicals found in plants are being explored for therapeutic use, particularly in combating obesity. Among these, theobromine, commonly found in cocoa and chocolate, shows promise. Although not as extensively studied as caffeine, theobromine exhibits positive effects on human health. It improves lipid profiles, aids in asthma treatment, lowers blood pressure, regulates gut microbiota, reduces tumor formation, moderates blood glucose levels, and acts as a neuroprotective agent. Studies demonstrate its anti-obesity effects through mechanisms such as browning of white adipose tissue, activation of brown adipose tissue, anti-inflammatory properties, and reduction of oxidative stress. This study aims to suggest theobromine as a potential therapeutic agent against obesity-related complications.
C1 [Aslan, Dilem Tugal; Goktas, Zeynep] Hacettepe Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-06100 Ankara, Turkiye.
C3 Hacettepe University
RP Göktas, Z (corresponding author), Hacettepe Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-06100 Ankara, Turkiye.
OI Tugal Aslan, Dilem/0000-0003-1761-1919
CR Akil L, 2011, J HEALTH CARE POOR U, V22, P61, DOI 10.1353/hpu.2011.0166
   Aldiss P, 2018, METABOLISM, V81, P63, DOI 10.1016/j.metabol.2017.11.009
   Almoosawi S, 2012, FOOD FUNCT, V3, P1035, DOI 10.1039/c2fo30060e
   Aranaz P, 2019, FOOD FUNCT, V10, P4811, DOI [10.1039/C9FO00918C, 10.1039/c9fo00918c]
   Azam Sonish, 2003, Med Sci Monit, V9, pBR325
   Azhar Y, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0150-6
   Baggott MJ, 2013, PSYCHOPHARMACOLOGY, V228, P109, DOI 10.1007/s00213-013-3021-0
   Bhat JA, 2022, METAB BRAIN DIS, V37, P1787, DOI 10.1007/s11011-022-00995-6
   Bhat JA, 2021, BIOCHEM BIOPH RES CO, V571, P74, DOI 10.1016/j.bbrc.2021.07.051
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002
   Boutari Chrysoula, 2022, Metabolism, V133, P155217, DOI 10.1016/j.metabol.2022.155217
   Camps-Bossacoma M, 2019, J AGR FOOD CHEM, V67, P3605, DOI 10.1021/acs.jafc.8b07248
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Carrageta DF, 2018, J FUNCT FOODS, V43, P84, DOI 10.1016/j.jff.2018.02.001
   Castro JP, 2016, BIOL CHEM, V397, P709, DOI 10.1515/hsz-2015-0305
   Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071
   de Mello AH, 2018, LIFE SCI, V192, P26, DOI 10.1016/j.lfs.2017.11.019
   Fuggetta MP, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/1515621
   Glueck CJ, 2019, METABOLISM, V92, P108, DOI 10.1016/j.metabol.2018.11.002
   Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671
   Gu RH, 2020, INT IMMUNOPHARMACOL, V82, DOI 10.1016/j.intimp.2020.106226
   Gu YY, 2014, EUR J NUTR, V53, P149, DOI 10.1007/s00394-013-0510-1
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Iaia N, 2020, ARCH BIOCHEM BIOPHYS, V694, DOI 10.1016/j.abb.2020.108591
   Jang MH, 2020, EUR J NUTR, V59, P3503, DOI 10.1007/s00394-020-02184-6
   Jang MH, 2018, BIOTECHNOL BIOPROC E, V23, P617, DOI 10.1007/s12257-018-0434-y
   Jang YJ, 2015, FOOD FUNCT, V6, P2365, DOI 10.1039/c5fo00397k
   Jiang SZ, 2016, EXP THER MED, V12, P2395, DOI 10.3892/etm.2016.3667
   Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x
   Klein S, 2022, CELL METAB, V34, P11, DOI 10.1016/j.cmet.2021.12.012
   Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508
   Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218
   Kumar V, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/6852276
   Kurylowicz A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176241
   Lane M.D., 2013, Encyclopedia of Biological Chemistry, VSecond
   Lee HW, 2022, CURR ISSUES MOL BIOL, V44, P4216, DOI 10.3390/cimb44090289
   Liu C, 2023, J FUNCT FOODS, V108, DOI 10.1016/j.jff.2023.105702
   Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23
   Lobstein T, 2023, World Obesity Atlas 2023
   Bargut TCL, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2016-0051
   Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
   Manna P, 2015, METAB SYNDR RELAT D, V13, P423, DOI 10.1089/met.2015.0095
   Martín-Peláez S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700238
   Martínez-Pinilla E, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00030
   Maskarinec G, 2009, NUTR CANCER, V61, P573, DOI 10.1080/01635580902825662
   McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010
   Mehrabani S, 2020, COMPLEMENT THER MED, V48, DOI 10.1016/j.ctim.2019.102240
   Mendiola-Precoma J, 2017, J ALZHEIMERS DIS, V55, P1273, DOI 10.3233/JAD-160569
   Min SY, 2013, INT J OBESITY, V37, P584, DOI 10.1038/ijo.2012.85
   Mitani T, 2017, BBA-MOL CELL RES, V1864, P2438, DOI 10.1016/j.bbamcr.2017.09.017
   Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005
   Olusi SO, 2002, INT J OBESITY, V26, P1159, DOI 10.1038/sj.ijo.0802066
   Papadimitriou A, 2015, AM J PHYSIOL-RENAL, V308, pF209, DOI 10.1152/ajprenal.00252.2014
   Pati S, 2023, CANCERS, V15, DOI 10.3390/cancers15020485
   Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0
   Pizzino G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8416763
   Polyzos SA, 2019, METABOLISM, V92, P1, DOI 10.1016/j.metabol.2018.12.011
   Polyzos SA, 2019, METABOLISM, V92, P82, DOI 10.1016/j.metabol.2018.11.014
   Prasad R, 2022, CUREUS J MED SCIENCE, V14, DOI 10.7759/cureus.30535
   León-Carmona JR, 2012, INT J QUANTUM CHEM, V112, P3472, DOI 10.1002/qua.24084
   Ramiro-Puig E, 2009, EUR J NUTR, V48, P54, DOI 10.1007/s00394-008-0761-4
   Seo MH, 2018, J OBES METAB SYNDR, V27, P46, DOI 10.7570/jomes.2018.27.1.46
   Sharifi-Zahabi Elham, 2023, Food Funct, V14, P8431, DOI [10.1039/D3FO00555K, 10.1039/d3fo00555k]
   Shojaei-Zarghani S, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104293
   Smolders L, 2018, CLIN NUTR, V37, P719, DOI 10.1016/j.clnu.2017.06.007
   Smolders L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20068-y
   Smolders L, 2017, NUTR RES, V40, P85, DOI 10.1016/j.nutres.2017.03.007
   Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767
   Sugimoto N, 2019, BASIC CLIN PHARMACOL, V124, P575, DOI 10.1111/bcpt.13175
   Tanaka E, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108898
   Tun S, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01234
   van den Bogaard B, 2010, HYPERTENSION, V56, P839, DOI 10.1161/HYPERTENSIONAHA.110.158139
   Varela CE, 2017, EUR J PHARMACOL, V811, P48, DOI 10.1016/j.ejphar.2017.05.051
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Watanabe N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-64
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wu FF, 2019, SPECTROCHIM ACTA A, V215, P354, DOI 10.1016/j.saa.2019.03.001
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4
NR 82
TC 0
Z9 0
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0029-6643
EI 1753-4887
J9 NUTR REV
JI Nutr. Rev.
PD 2024 SEP 13
PY 2024
DI 10.1093/nutrit/nuae122
EA SEP 2024
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA F7W5M
UT WOS:001311877200001
PM 39271172
OA hybrid
DA 2025-04-28
ER

PT J
AU Pérez-Ramírez, IF
   González-Dávalos, ML
   Mora, O
   Silva, I
   Gallegos-Corona, MA
   Guzmán-Maldonado, SH
   Reynoso-Camacho, R
AF Perez-Ramirez, Iza F.
   Gonzalez-Davalos, Maria L.
   Mora, Ofelia
   Silva, Isaac
   Gallegos-Corona, Marco A.
   Guzman-Maldonado, Salvador H.
   Reynoso-Camacho, Rosalia
TI Cardiac Lipid Metabolism Is Modulated by Casimiroa edulis and
   Crataegus pubescens Aqueous Extracts in High Fat and Fructose
   (HFF) Diet-Fed Obese Rats
SO EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
LA English
DT Article
DE cardiac lipotoxicity; herbal extracts; inflammation; lipid metabolism;
   obese rats; oxidative stress
ID SERINE PALMITOYLTRANSFERASE; ACID; ANTIOXIDANTS; QUANTITATION;
   PEROXIDATION; HYPERTROPHY; INHIBITION; PRODUCTS; PLASMA
AB This study aim to evaluate the effect of Casimiroa edulis and Crataegus pubescens aqueous extracts on cardiac lipotoxicity in obese rats. Both extracts decrease cardiac hypertrophy and steatosis in high fat and fructose (HFF)-diet-fed obese rats. C. pubescens decreases the cardiac content of 16 and 18 carbon-length fatty acids, whereas C. edulis extract does not alter the fatty acid profile. Regarding lipotoxic compounds, C. pubescens reduces the cardiac content of 16 and 18 carbon-length ceramides and diacylglycerols, whereas C. edulis extract reduces >= 20 carbon-length lipotoxic compounds. Both extracts down-regulate fatty acid synthase (Fasn) and acetyl-CoA carboxylase (Acaca) (lipogenesis), glyceril-3-phosphate acyltransferase (Gpat) (diacylglycerol synthesis) and serine palmitoyltransferase 1 (Spt1) (ceramide synthesis), and up-regulate carnitine palmitoyltransferase 1 (Cpt1) and acyl-CoA dehydrogenase (Acadm) (beta-oxidation), and the greatest effect is observed with C. pubescens. In addition, C. edulis exerts the greatest cardiac anti-inflammatory activity, whereas C. pubescens shows the highest cardiac antioxidant activity. The cardioprotective effect of C. pubescens may be associated with its content of (-)-epigallocatechin gallate, (+)-catechin, chlorogenic acid, caffeic acid, and beta-campesterol, whereas the beneficial effect of C. edulis may be related to its high content of steroidal saponins and alkaloids. Therefore, these results demonstrate that both herbal aqueous extracts ameliorate cardiac lipotoxicity in HFF-diet-fed rats, and C. pubescens exerts a greater beneficial effect. Practical Applications: This study proposes the characterization of fatty acids and lipotoxic compounds (ceramides and diacylglycerols) of cardiac tissue in combination with the determination of the expression of specific genes related to lipid metabolism to identify the mechanisms associated with the cardioprotective effects of herbal extracts. The results obtained in this study demonstrate the cardioprotective potential of Casimiroa edulis and Crataegus pubescens aqueous extracts through the modulation of cardiac lipid metabolism in high fat and fructose diet fed obese rats. Therefore, these herbs can be used for the development of functional beverages or the extraction of bioactive compounds with cardioprotective effect.
C1 [Perez-Ramirez, Iza F.; Reynoso-Camacho, Rosalia] Univ Autonoma Queretaro, Fac Quim, Queretaro 76010, Mexico.
   [Gonzalez-Davalos, Maria L.; Mora, Ofelia] Univ Nacl Autonoma Mexico, Inst Neurobiol, Lab Rumiol & Metabolismo Nutr RuMeN, Queretaro 76230, Mexico.
   [Silva, Isaac] Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro 76230, Mexico.
   [Gallegos-Corona, Marco A.] Univ Autonoma Queretaro, Fac Med, Queretaro 76140, Mexico.
   [Gallegos-Corona, Marco A.; Guzman-Maldonado, Salvador H.] INIFAP, Unidad Biotecnol, Celaya 38110, Guanajuato, Mexico.
C3 Universidad Autonoma de Queretaro; Universidad Nacional Autonoma de
   Mexico; Universidad Autonoma de Queretaro; Universidad Autonoma de
   Queretaro
RP Reynoso-Camacho, R (corresponding author), Univ Autonoma Queretaro, Fac Quim, Queretaro 76010, Mexico.
EM rrcamachomx@yahoo.com.mx
RI Silva, Isaac/HCH-8608-2022; Perez-Ramirez, Iza/G-9275-2019
OI Reynoso-Camacho, Rosalia/0000-0002-7223-0062; Mora,
   Ofelia/0000-0002-7073-7740; Perez-Ramirez, Iza/0000-0001-7606-0892
CR Alexander J K, 1993, Heart Dis Stroke, V2, P317
   Amaya-Cruz DM, 2015, J FUNCT FOODS, V17, P93, DOI 10.1016/j.jff.2015.04.051
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choudhary SP, 2011, CURR MED CHEM, V18, P4557
   DeMarco VG, 2013, ENDOCRINOLOGY, V154, P159, DOI 10.1210/en.2012-1835
   Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004
   Drosatos Konstantinos, 2013, Curr Heart Fail Rep, V10, P109, DOI 10.1007/s11897-013-0133-0
   Du Y, 2007, J AGR FOOD CHEM, V55, P1695, DOI 10.1021/jf063071b
   Duda MK, 2009, CARDIOVASC RES, V84, P33, DOI 10.1093/cvr/cvp169
   Figueroa-Pérez MG, 2015, FOOD FUNCT, V6, P1865, DOI [10.1039/c5fo00160a, 10.1039/C5FO00160A, 10.1039/C5FO00160a]
   de Mejía EG, 2010, J FUNCT FOODS, V2, P23, DOI 10.1016/j.jff.2009.12.003
   Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372
   Guzzardi Maria A, 2011, Rev Diabet Stud, V8, P403, DOI 10.1900/RDS.2011.8.403
   Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3
   Huang JB, 2015, J ANIM PHYSIOL AN N, V99, P719, DOI 10.1111/jpn.12276
   KATES M, 1972, LAB TECHNIQUES BIOCH, P281
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   LENZ AG, 1989, ANAL BIOCHEM, V177, P419, DOI 10.1016/0003-2697(89)90077-8
   Okere IC, 2007, CLIN EXP PHARMACOL P, V34, P113, DOI 10.1111/j.1440-1681.2007.04545.x
   Pari L, 2010, MOL CELL BIOCHEM, V341, P109, DOI 10.1007/s11010-010-0442-5
   Priscilla DH, 2009, CHEM-BIOL INTERACT, V179, P118, DOI 10.1016/j.cbi.2008.12.012
   Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270
   Sugiura C, 2012, J OBES, V2012, DOI 10.1155/2012/520510
   Suresh P, 2012, INFLAMMATION, V35, P1314, DOI 10.1007/s10753-012-9444-7
   Suzuki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02749
   Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026
   van de Weijer T, 2011, CARDIOVASC RES, V92, P10, DOI 10.1093/cvr/cvr212
   VAZQUEZCRUZ B, 2009, PHARMACOLOGYONLINE, V3, P73
   Vessby B, 2003, CURR OPIN LIPIDOL, V14, P15, DOI 10.1097/00041433-200302000-00004
   Vincent HK, 2001, INT J OBESITY, V25, P378, DOI 10.1038/sj.ijo.0801536
   WRIGHT JR, 1981, ARCH BIOCHEM BIOPHYS, V206, P296, DOI 10.1016/0003-9861(81)90095-3
   Yi LZ, 2006, FEBS LETT, V580, P6837, DOI 10.1016/j.febslet.2006.11.043
   Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI [10.1093/cvr/cvq182, 10.1093/cvr/cvq266]
   Zhang YM, 2011, HYPERTENSION, V57, P148, DOI 10.1161/HYPERTENSIONAHA.110.164178
   Zhao HL, 2005, INT J OBESITY, V29, P983, DOI 10.1038/sj.ijo.0802948
NR 36
TC 1
Z9 1
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1438-7697
EI 1438-9312
J9 EUR J LIPID SCI TECH
JI Eur. J. Lipid Sci. Technol.
PD NOV
PY 2019
VL 121
IS 11
AR 1900157
DI 10.1002/ejlt.201900157
EA SEP 2019
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA JK4EY
UT WOS:000486791300001
DA 2025-04-28
ER

PT J
AU Sanz-Lamora, H
   Marrero, PF
   Haro, D
   Relat, J
AF Sanz-Lamora, Hector
   Marrero, Pedro F.
   Haro, Diego
   Relat, Joana
TI A Mixture of Pure, Isolated Polyphenols Worsens the Insulin Resistance
   and Induces Kidney and Liver Fibrosis Markers in Diet-Induced Obese Mice
SO ANTIOXIDANTS
LA English
DT Article
DE antioxidants; food matrix; insulin resistance; kidney disease; obesity;
   polyphenols
ID HIGH-FAT DIET; INJURY MOLECULE-1 EXPRESSION; METABOLIC SYNDROME; RENAL
   INJURY; FOOD SOURCES; LIPOCALIN 2; DISEASE; BIOACCESSIBILITY;
   ANTIOXIDANTS; MATRIX
AB Obesity is a worldwide epidemic with severe metabolic consequences. Polyphenols are secondary metabolites in plants and the most abundant dietary antioxidants, which possess a wide range of health effects. The most relevant food sources are fruit and vegetables, red wine, black and green tea, coffee, virgin olive oil, and chocolate, as well as nuts, seeds, herbs, and spices. The aim of this work was to evaluate the ability of a pure, isolated polyphenol supplementation to counteract the pernicious metabolic effects of a high-fat diet (HFD). Our results indicated that the administration of pure, isolated polyphenols under HFD conditions for 26 weeks worsened the glucose metabolism in diet-induced obese mice. The data showed that the main target organ for these undesirable effects were the kidneys, where we observed fibrotic, oxidative, and kidney-disease markers. This work led us to conclude that the administration of pure polyphenols as a food supplement would not be advisable. Instead, the ingestion of complete "whole" foods would be the best way to get the health effects of bioactive compounds such as polyphenols.
C1 [Sanz-Lamora, Hector; Marrero, Pedro F.; Haro, Diego; Relat, Joana] Univ Barcelona, Sch Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Food Torribera Campus, E-08921 Santa Coloma Gramenet, Spain.
   [Sanz-Lamora, Hector; Relat, Joana] Univ Barcelona INSA UB, Inst Nutr & Food Safety Res, E-08921 Santa Coloma Gramenet, Spain.
   [Marrero, Pedro F.; Haro, Diego] Univ Barcelona IBUB, Inst Biomed, E-08028 Barcelona, Spain.
   [Marrero, Pedro F.; Haro, Diego; Relat, Joana] Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBER OBN, E-28029 Madrid, Spain.
C3 University of Barcelona; University of Barcelona; Instituto de Salud
   Carlos III
RP Haro, D; Relat, J (corresponding author), Univ Barcelona, Sch Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Food Torribera Campus, E-08921 Santa Coloma Gramenet, Spain.; Relat, J (corresponding author), Univ Barcelona INSA UB, Inst Nutr & Food Safety Res, E-08921 Santa Coloma Gramenet, Spain.; Haro, D (corresponding author), Univ Barcelona IBUB, Inst Biomed, E-08028 Barcelona, Spain.; Haro, D; Relat, J (corresponding author), Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBER OBN, E-28029 Madrid, Spain.
EM h.sanz.lamora@ub.edu; pedromarrero@ub.edu; dharo@ub.edu; jrelat@ub.edu
RI Marrero, Pedro/I-1919-2015; Relat, Joana/I-5473-2015; Haro,
   Diego/I-4623-2015
OI Relat, Joana/0000-0001-8974-1785; Haro, Diego/0000-0001-9147-0486
FU ERDF: A way of making Europe; Generalitat de Catalunya (the Government
   of Catalonia) [2017SGR683]; University of Barcelona;  [AGL2017-82417-R];
    [MCIN/AEI/10.13039/501100011033]
FX This study was supported by the grant AGL2017-82417-R to P.F.M. and D.H.
   was funded by MCIN/AEI/10.13039/501100011033 and by "ERDF: A way of
   making Europe", and the Generalitat de Catalunya (the Government of
   Catalonia, grant 2017SGR683 to D.H.). APC was funded by the University
   of Barcelona.
CR Alfadda AA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/936486
   Sanahuja AB, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110551
   Bohn T, 2014, NUTR REV, V72, P429, DOI 10.1111/nure.12114
   Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001
   Carobbio S, 2017, ADV EXP MED BIOL, V960, P161, DOI 10.1007/978-3-319-48382-5_7
   Chandramohan R, 2021, TOXICOL MECH METHOD, V31, P507, DOI 10.1080/15376516.2021.1926030
   Cory H, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00087
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Dufour C, 2018, FOOD CHEM, V240, P314, DOI 10.1016/j.foodchem.2017.07.104
   Eker ME, 2020, FOODS, V9, DOI 10.3390/foods9010002
   Fraga CG, 2019, FOOD FUNCT, V10, P514, DOI [10.1039/C8FO01997E, 10.1039/c8fo01997e]
   Geng JW, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02776-8
   Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361
   Jakobek L, 2019, TRENDS FOOD SCI TECH, V83, P235, DOI 10.1016/j.tifs.2018.11.024
   Jiang WH, 2021, NEFROLOGIA, V41, P165, DOI 10.1016/j.nefro.2020.06.007
   Kanda J, 2015, CLIN EXP NEPHROL, V19, P99, DOI 10.1007/s10157-014-0952-7
   Karmakova TA, 2021, SOVREM TEHNOL MED, V13, P64, DOI 10.17691/stm2021.13.3.08
   Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181
   Kim Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010017
   Lavefve L, 2020, FOOD FUNCT, V11, P45, DOI [10.1039/C9FO01634A, 10.1039/c9fo01634a]
   Li S, 2019, NUTR DIABETES, V9, DOI 10.1038/s41387-019-0095-8
   Lin QZ, 2014, AM J PHYSIOL-RENAL, V306, pF885, DOI 10.1152/ajprenal.00331.2013
   Lousa I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010043
   Mahbub AA, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.43
   Mahbub A, 2017, ONCOTARGET, V8, P104877, DOI 10.18632/oncotarget.20501
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mandalari G, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090568
   Masuzaki R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144906
   Mende CW, 2019, ENDOCR PRACT, V25, P854, DOI 10.4158/EP-2018-0568
   Mertens C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207527
   Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45
   Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6
   Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e
   Monari S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256703
   Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Jiménez-Uribe AP, 2021, CELL SIGNAL, V87, DOI 10.1016/j.cellsig.2021.110123
   Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477
   Peng P, 2021, EXP THER MED, V21, DOI 10.3892/etm.2020.9485
   Pineda-Vadillo C, 2016, FOOD RES INT, V88, P284, DOI 10.1016/j.foodres.2016.01.029
   Prasatthong P, 2021, EUR J NUTR, V60, P833, DOI 10.1007/s00394-020-02291-4
   PRYOR WA, 1991, AM J CLIN NUTR, V53, pS391, DOI 10.1093/ajcn/53.1.391S
   Przybycinski J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249375
   Rayego-Mateos S, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/8739473
   de Alvarenga JFR, 2019, J SCI FOOD AGR, V99, P6535, DOI 10.1002/jsfa.9934
   de Alvarenga JFR, 2019, MOLECULES, V24, DOI 10.3390/molecules24081555
   Roden M, 2019, NATURE, V576, P51, DOI 10.1038/s41586-019-1797-8
   Samaniego-Sánchez C, 2021, FOODS, V10, DOI 10.3390/foods10081790
   Sanders FWB, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1439-8
   Sandoval V, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10050637
   Sandoval V, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082393
   Sandoval V, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090360
   Santos L, 2022, EUR J INTERN MED, V97, P18, DOI 10.1016/j.ejim.2021.09.020
   Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970
   Schön C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111720
   Sharma A, 2018, CURR MED CHEM, V25, P4740, DOI 10.2174/0929867324666171006144208
   Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009
   Sun Q, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081176
   Sun WY, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120196
   Tanaka T, 2021, MENOPAUSE, V28, P1340, DOI 10.1097/GME.0000000000001853
   Tang RX, 2022, FOOD CHEM, V371, DOI 10.1016/j.foodchem.2021.131065
   Tarko T, 2020, J AGR FOOD CHEM, V68, P1315, DOI 10.1021/acs.jafc.9b07680
   Tressera-Rimbau A, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7467962
   Tresserra-Rimbau A, 2013, NUTR METAB CARDIOVAS, V23, P953, DOI 10.1016/j.numecd.2012.10.008
   Tresserra-Rimbau A, 2016, J NUTR, V146, P767, DOI 10.3945/jn.115.223610
   Tüccar TB, 2023, INT J VITAM NUTR RES, V93, P319, DOI 10.1024/0300-9831/a000734
   Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006
   Urbschat A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062038
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004
   Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006
   Wojtunik-Kulesza K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051401
   Yang P, 2017, J LIPID RES, V58, P1417, DOI 10.1194/jlr.M076216
   Zha DQ, 2017, ENDOCRINOLOGY, V158, P2022, DOI 10.1210/en.2016-1765
   Zhang W, 2017, EUR REV MED PHARMACO, V21, P42
   Zheng B, 2022, APPL ENVIRON MICROB, V88, DOI [10.1128/aem.01851-21, 10.1128/AEM.01851-21]
   Zhu QZ, 2018, NAT REV NEPHROL, V14, P105, DOI 10.1038/nrneph.2017.157
NR 81
TC 4
Z9 5
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD JAN
PY 2022
VL 11
IS 1
AR 120
DI 10.3390/antiox11010120
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA YM4AE
UT WOS:000746518100001
PM 35052623
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Di Pierro, F
   Menghi, AB
   Barreca, A
   Lucarelli, M
   Calandrelli, A
AF Di Pierro, Francesco
   Menghi, Anna Borsetto
   Barreca, Angela
   Lucarelli, Maurizio
   Calandrelli, Andrea
TI GreenSelect® Phytosome as an Adjunct to a Low-Calorie Diet for Treatment
   of Obesity: A Clinical Trial
SO ALTERNATIVE MEDICINE REVIEW
LA English
DT Article
ID GREEN TEA EXTRACT; EPIGALLOCATECHIN GALLATE; ENERGY-EXPENDITURE;
   NERVOUS-SYSTEM; THERMOGENESIS; INHIBITION; POLYPHENOLS; CAFFEINE;
   TYROSINE; SILYBIN
AB A recently developed oral formulation in the form of coated tablets (Monoselect Camellia (R)) (MonCam) containing highly bioavailable green tea extract (GreenSelect (R) Phytosome) was tested in obese subjects (n=100) of both genders on a hypocaloric diet. Fifty subjects were assigned to the green tea extract plus hypocaloric diet, while the other 50 subjects followed the hypocaloric diet only. After 90 days of treatment, significant weight loss and decreased body mass index (BMI) were observed in the group taking the herbal extract (14-kg loss in the green tea group compared to a 5-kg loss in the diet-only group); waistline was reduced only in male subjects. Besides the effect on weight and BMI, biochemical parameters (LDL-, HDL-, and total cholesterol, triglycerides, growth hormone, insulin-like growth factor-1, insulin, and cortisol) were improved in both groups, Leptin, not tested in the diet-only group, was reduced in patients taking MonCam. Taking into consideration the high safety profile of the product and the total absence of adverse effects observed during and after the trial, MonCam appears to be a safe and effective tool for weight loss. (Altern Med Rev 2009;14(2):154-160)
C1 [Di Pierro, Francesco] Velleja Res, I-29010 Pontenure, Piacenza, Italy.
   [Barreca, Angela] Ctr Polispecialist Ric, Rome, Italy.
   [Lucarelli, Maurizio] Terme Fontecchio Hosp, Citta Di Castello, PG, Italy.
   [Calandrelli, Andrea] Univ Cattolica Sacro Cuore, Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Di Pierro, F (corresponding author), Velleja Res, Via G Natta 28, I-29010 Pontenure, Piacenza, Italy.
EM f.dipierro@vellejaresearch.com
CR ABDULLAH AR, 2008, METAB SYNDR REL 1124
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Chen D, 2008, HISTOL HISTOPATHOL, V23, P487, DOI 10.14670/HH-23.487
   Claessens M, 2007, METABOLISM, V56, P1051, DOI 10.1016/j.metabol.2007.04.001
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Filburn CR, 2007, J VET PHARMACOL THER, V30, P132, DOI 10.1111/j.1365-2885.2007.00834.x
   Giacomelli S, 2002, LIFE SCI, V70, P1447, DOI 10.1016/S0024-3205(01)01511-9
   Hassani Alireza Shoae, 2008, Pak J Biol Sci, V11, P1336, DOI 10.3923/pjbs.2008.1336.1341
   Hoffman Jay R, 2006, J Int Soc Sports Nutr, V3, P35, DOI 10.1186/1550-2783-3-1-35
   LIAO SS, 1995, BIOCHEM BIOPH RES CO, V214, P833, DOI 10.1006/bbrc.1995.2362
   Hermsdorff HHM, 2007, ARCH LATINOAM NUTR, V57, P33
   Monda M, 2008, PEPTIDES, V29, P120, DOI 10.1016/j.peptides.2007.10.016
   Moon HS, 2007, CHEM-BIOL INTERACT, V167, P85, DOI 10.1016/j.cbi.2007.02.008
   Nagle DG, 2006, PHYTOCHEMISTRY, V67, P1849, DOI 10.1016/j.phytochem.2006.06.020
   Pietta P, 1998, BIOCHEM MOL BIOL INT, V46, P895
   Seevaratnam N, 2007, DIABETES OBES METAB, V9, P669, DOI 10.1111/j.1463-1326.2006.00646.x
   Shin KO, 2007, J NUTR SCI VITAMINOL, V53, P145, DOI 10.3177/jnsv.53.145
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Smeets AJ, 2008, J NUTR, V138, P698, DOI 10.1093/jn/138.4.698
   van Baak MA, 2008, PHYSIOL BEHAV, V94, P178, DOI 10.1016/j.physbeh.2007.12.020
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yanagawa Y, 2003, CURR MICROBIOL, V47, P244, DOI 10.1007/s00284-002-3956-6
   Zhu BT, 2008, XENOBIOTICA, V38, P130, DOI [10.1080/00498250701744641, 10.1080/00498250701744641 ]
NR 23
TC 68
Z9 71
U1 0
U2 11
PU ALTERNATIVE MEDICINE REVIEW, LLC
PI DOVER
PA PO BOX 555, DOVER, ID 83825 USA
SN 1089-5159
J9 ALTERN MED REV
JI Altern. Med. Rev.
PD JUN
PY 2009
VL 14
IS 2
BP 154
EP 160
PG 7
WC Integrative & Complementary Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; Pharmacology & Pharmacy
GA 474DU
UT WOS:000268263500012
PM 19594224
DA 2025-04-28
ER

PT J
AU Tung, YC
   Hsieh, TH
   Yang, MJ
   Hung, WL
   Ho, CT
   Pan, MH
AF Tung, Yen-Chen
   Hsieh, Tsung-Hai
   Yang, Meei-Ju
   Hung, Wei-Lun
   Ho, Chi-Tang
   Pan, Min-Hsiung
TI The effects of the extract of oolong tea and its metabolites from
   Andraca theae in high fat diet induced obese Wistar rat
SO FOOD SCIENCE AND HUMAN WELLNESS
LA English
DT Article
DE Tea; Andraca theae; High fat diet; Obesity
ID GREEN TEA; (-)-EPIGALLOCATECHIN-3-GALLATE; MICROBIOTA; EXPRESSION;
   ADIPOCYTE; DISEASE; WEIGHT; BLACK
AB Obesity is a critical health issue worldwide. For a long time, the concept of drinking tea for health and pleasure is widely accepted. The strain of Andraca theae lives on the tea leaf and the bioactivity of its metabolites in the feces is unknown yet. Thus, the objective of this study was to investigate whether the extract of tea (Taiwan Tea Experiment Station No.12 (TE)) and its metabolites from Andraca theae (TME) could prevent obesity in the high fat diet-induced obese rats. Our results showed that TE had higher concentrations of epigallocatechin gallate (EGCG) and caffeine than that from TME. TE significantly decreased abdominal adipose tissue, especially epididymal fat via increasing preadipocyte factor 1 (Pref-1), SRY (sex determining region Y)-box 9 (SOX-9) and decreasing peroxisome proliferator-activated receptor gamma (PPAR gamma), CCAAT/enhancer binding protein (C/EBP)beta, C/EBP alpha and C/EBP gamma protein expression. Taken together, these results suggest that the content of tea polyphenols in TE play an important role for alleviating abdominal fat. (C) 2018 "Society information". Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
C1 [Tung, Yen-Chen; Hsieh, Tsung-Hai; Pan, Min-Hsiung] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 106, Taiwan.
   [Yang, Meei-Ju] Tea Res & Extens Stn, Taoyuan 326, Taiwan.
   [Hung, Wei-Lun] Univ Florida, Dept Food Sci & Human Nutr, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA.
   [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
C3 National Taiwan University; State University System of Florida;
   University of Florida; Rutgers University System; Rutgers University New
   Brunswick
RP Pan, MH (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, 1,Sect 4,Roosevelt Rd, Taipei 10617, Taiwan.
EM mhpan@ntu.edu.tw
RI Ho, Chi-Tang/B-5629-2012; Pan, Min-Hsiung/AAT-8865-2021; Tung,
   Yen-Chen/K-4460-2019; Hung, Wei-Lun/V-2107-2018
CR Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001
   Bonora E, 2012, NAT REV GASTRO HEPAT, V9, P372, DOI 10.1038/nrgastro.2012.79
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chou TY, 2018, J FOOD DRUG ANAL, V26, P41, DOI 10.1016/j.jfda.2016.11.011
   Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079
   Jéquier E, 2002, INT J OBESITY, V26, pS12, DOI 10.1038/sj.ijo.0802123
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kuo KL, 2005, J AGR FOOD CHEM, V53, P480, DOI 10.1021/jf049375k
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Mohamed G. A., 2014, Bulletin of the Faculty of Pharmacy, Cairo University, V52, P269, DOI 10.1016/j.bfopcu.2014.05.001
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Shah Meera, 2017, Curr Gastroenterol Rep, V19, P55, DOI 10.1007/s11894-017-0598-1
   Shi MG, 2013, TRADIT CHIN DRUG RES, V4, P1
   SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L
   STALLONE DD, 1991, INT J OBESITY, V15, P775
   Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160
   Tea Research and Extension Station, TAIW TEA CLASS
   Unno T, 2014, J NUTR SCI VITAMINOL, V60, P213, DOI 10.3177/jnsv.60.213
   van't Slot G, 2009, J AGR FOOD CHEM, V57, P8041, DOI 10.1021/jf900458e
   Yuan ED, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020187
NR 22
TC 10
Z9 10
U1 1
U2 10
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717,
   PEOPLES R CHINA
EI 2213-4530
J9 FOOD SCI HUM WELL
JI Food Sci. Human Wellness
PD JUN
PY 2018
VL 7
IS 2
BP 120
EP 124
DI 10.1016/j.fshw.2018.05.001
PG 5
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA JH4VT
UT WOS:000492769100002
OA gold
DA 2025-04-28
ER

PT J
AU Truthmann, J
   Mensink, GBM
   Richter, A
AF Truthmann, Julia
   Mensink, Gert B. M.
   Richter, Almut
TI Relative validation of the KiGGS Food Frequency Questionnaire among
   adolescents in Germany
SO NUTRITION JOURNAL
LA English
DT Article
DE adolescents; dietary surveys; nutrition assessment; Germany; population
   characteristics; epidemiology
ID DIETARY ASSESSMENT; HEALTH INTERVIEW; VALIDITY; REPRODUCIBILITY;
   CHILDREN; RELIABILITY; AGREEMENT; DESIGN; QUALITY; ENERGY
AB Background: The aim of this study was to determine the relative validity of the self-administered Food Frequency Questionnaire (FFQ) "What do you eat?", which was used in the German National Health Interview and Examination Survey for Children and Adolescents (KiGGS 2003-2006).
   Methods: The validation was conducted in the EsKiMo Nutrition Module, a subsample of KiGGS. The study population included 1,213 adolescents aged between 12 and 17. A modified diet history interview DISHES (Dietary Interview Software for Health Examination Studies) was used as the reference method. In order to compare the food groups, the data assessed with both instruments were aggregated to 40 similar food groups. The statistical analysis included calculating and comparing Spearman's correlation coefficients, calculating the mean difference between both methods, and ranking participants (quartiles) according to food group consumption, including weighted kappa coefficients. Correlations were also evaluated for relative body weight and socioeconomic status subgroups.
   Results: In the total study population the Spearman correlation coefficients ranged from 0.22 for pasta/rice to 0.69 for margarine; most values were 0.50 and higher. The mean difference ranged between 1.4% for milk and 100.3% for pasta/rice. The 2.5 percentiles and 97.5 percentiles indicated a wide range of differences. Classifications in the same and adjacent quartile varied between 70.1% for pasta/rice and 90.8% for coffee. For most groups, Cohen's weighted kappa showed values between 0.21 and 0.60. Only for white bread and pasta/rice were values less than 0.20. Most of the 40 food groups showed acceptable to good correlations in all investigated subgroups concerning age, sex, body weight and socio-economic status.
   Conclusions: The KiGGS FFQ showed fair to moderate ranking validity except for pasta/rice and white bread. However, the ability to assess absolute intakes is limited. The correlation coefficients for most food items were similar for normal weight and overweight as well as for different socio-economic status groups. Overall, the results of the relative validity were comparable to FFQs from the current literature.
C1 [Mensink, Gert B. M.; Richter, Almut] Robert Koch Inst, Dept Epidemiol & Hlth Reporting, D-13302 Berlin, Germany.
   [Truthmann, Julia] Tech Univ Munich, Sch Management Mkt & Consumer Res, D-85350 Freising Weihenstephan, Germany.
C3 Robert Koch Institute; Technical University of Munich
RP Richter, A (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Reporting, Post Box 65 02 61, D-13302 Berlin, Germany.
EM RichterA@rki.de
RI Truthmann, Julia/Q-5911-2019; Mensink, Gert/B-2447-2009
OI Truthmann, Julia/0000-0002-2849-7608; Mensink, Gert/0000-0001-6268-5998
FU German Research Foundation; German Ministry of Health; Ministry of
   Education and Research; Robert Koch Institute; German Federal Ministry
   of Food, Agriculture and Consumer Protection
FX This study was supported by the German Research Foundation. KiGGS was
   funded by the German Ministry of Health, the Ministry of Education and
   Research and the Robert Koch Institute. EsKiMo was funded by the German
   Federal Ministry of Food, Agriculture and Consumer Protection. We would
   like to thank the families who participated in KiGGS and EsKiMo.
CR Ambrosini GL, 2009, EUR J CLIN NUTR, V63, P1251, DOI 10.1038/ejcn.2009.44
   Ambrosini GL, 2001, PUBLIC HEALTH NUTR, V4, P255, DOI 10.1079/PHN200062
   [Anonymous], GESUNDHEITSWESEN
   Araujo MC, 2010, J AM DIET ASSOC, V110, P1170, DOI 10.1016/j.jada.2010.05.008
   Bandini LG, 1997, AM J CLIN NUTR, V65, P1138
   BEATON GH, 1994, AM J CLIN NUTR, V59, p253S, DOI 10.1093/ajcn/59.1.253S
   BELLACH B, 1993, EUR J CLIN NUTR, V47, pS42
   Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   Boschi V, 2003, ANN NUTR METAB, V47, P284, DOI 10.1159/000072401
   Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318
   Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370
   Cullen KW, 2004, J AM DIET ASSOC, V104, P1415, DOI 10.1016/j.jada.2004.06.022
   Fink A, 2007, HDB EPIDEMIOLOGY
   Haftenberger M, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-36
   Hartmann BM, 2006, ERNAHRUNGS UMSCHAU, V53, P124
   Hong TK, 2010, PUBLIC HEALTH NUTR, V13, P368, DOI [10.1017/S136898000999125X, 10.1109/ICEMI.2009.5274817]
   Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9
   Kesse-Guyot E, 2011, ANN NUTR METAB, V57, P153, DOI 10.1159/000321680
   Krems C, 2006, ERNAHRUNGS-UMSCHAU, V53, P44
   Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2826, DOI 10.1158/1055-9965.EPI-12-ED1
   Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107
   Kurth BM, 2007, BUNDESGESUNDHEITSBLA, V50, P533, DOI 10.1007/s00103-007-0214-x
   Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lange M, 2007, BUNDESGESUNDHEITSBLA, V50, P578, DOI 10.1007/s00103-007-0219-5
   Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169
   Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318
   Marks GC, 2006, J NUTR, V136, P459, DOI 10.1093/jn/136.2.459
   Matthys C, 2007, J AM DIET ASSOC, V107, P605, DOI 10.1016/j.jada.2007.01.005
   Mensink GBM, 2007, BUNDESGESUNDHEITSBLA, V50, P902, DOI 10.1007/s00103-007-0254-2
   Mensink G B M, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P219, DOI 10.1007/s00103-003-0794-z
   Mensink GBM, 2001, EUR J CLIN NUTR, V55, P409, DOI 10.1038/sj.ejcn.1601174
   Moore GF, 2007, EUR J CLIN NUTR, V61, P420, DOI 10.1038/sj.ejcn.1602531
   Papadopoulou SK, 2008, INT J FOOD SCI NUTR, V59, P148, DOI 10.1080/09637480701530004
   Price GM, 1997, BRIT J NUTR, V77, P833, DOI 10.1079/BJN19970083
   Rockett HRH, 2005, J AM DIET ASSOC, V105, P1867, DOI 10.1016/j.jada.2005.10.007
   Rockett HRH, 2003, CURR OPIN CLIN NUTR, V6, P557, DOI 10.1097/00075197-200309000-00009
   Serra-Majem L, 2009, BRIT J NUTR, V102, pS3, DOI 10.1017/S0007114509993114
   Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738
   Slater B, 2003, EUR J CLIN NUTR, V57, P629, DOI 10.1038/sj.ejcn.1601588
   Stallone DD, 1997, EUR J CLIN NUTR, V51, P815, DOI 10.1038/sj.ejcn.1600491
   Van Kappel A., 1994, EPIC-SOFT Picture Book for Estimation of Food Portion sizes
   Villegas R, 2007, BRIT J NUTR, V97, P993, DOI 10.1017/S0007114507669189
   WARDLE J, 1990, J PSYCHOSOM RES, V34, P377, DOI 10.1016/0022-3999(90)90061-8
   Watson JF, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-62
   WHO, 2003, WHO TECHN REP SER
   Willet W, 1998, NUTR EPIDEMIOLOGY, P47, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.06
   Willett W., 1998, nutritional epidemiology, V2nd, P74, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001]
   Winkler J., 1999, GESUNDHEITSWESEN, V61, P178
NR 50
TC 57
Z9 57
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD DEC 7
PY 2011
VL 10
AR 133
DI 10.1186/1475-2891-10-133
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 878NQ
UT WOS:000299264200001
PM 22152115
OA Green Published
DA 2025-04-28
ER

PT J
AU Contreras-Manzano, A
   Cruz-Casarrubias, C
   Munguía, A
   Jáuregui, A
   Vargas-Meza, J
   Nieto, C
   Tolentino-Mayo, L
   Barquera, S
AF Contreras-Manzano, Alejandra
   Cruz-Casarrubias, Carlos
   Munguia, Ana
   Jauregui, Alejandra
   Vargas-Meza, Jorge
   Nieto, Claudia
   Tolentino-Mayo, Lizbeth
   Barquera, Simon
TI Evaluation of the Mexican warning label nutrient profile on food
   products marketed in Mexico in 2016 and 2017: A cross-sectional analysis
SO PLOS MEDICINE
LA English
DT Article
ID CONSUMPTION; NUTRITION; CHILDREN; RECOMMENDATIONS; EPIDEMIOLOGY;
   PREVENTION; BEVERAGES; CAFFEINE; DISEASES; MODELS
AB BackgroundDifferent nutrient profiles (NPs) have been developed in Latin America to assess the nutritional quality of packaged food products. Recently, the Mexican NP was developed as part of the new warning label regulation implemented in 2020, considering 5 warning octagons (calories, sugar, sodium, saturated fats, and trans fats) and 2 warning rectangles (caffeine and non-nutritive sweeteners). The objective of this cross-sectional study was to evaluate the Mexican NP and other NPs proposed or used in Latin America against the Pan American Health Organization (PAHO) model. Methods and findingsNutrition content data of 38,872 packaged food products available in the Mexican market were collected in 2016 and 2017. The evaluation of the Mexican NP, including its 3 implementation phases of increasing stringency (2020, 2023, and 2025), was conducted by comparing the percentage of products classified as "healthy" (without warnings) or "less healthy" (with 1 or more warnings), as well as the number and type of warnings assigned to food products, against the PAHO NP. Using the calibration method, we compared the classifications produced by the PAHO model against those produced by the NP models of Ecuador, Chile (3 phases), Peru (2 phases), Uruguay, and Brazil. Kappa coefficients and Pearson correlations were estimated, and proportion tests were performed. We found that the 3 implementation phases of the Mexican NP had near to perfect agreement in the classification of healthy foods (Mexico NP models: 19.1% to 23.8%; PAHO model: 19.7%) and a strong correlation (>91.9%) with the PAHO model. Other NPs with high agreement with the PAHO model were the Ecuador (89.8%), Uruguay (82.5%), Chile Phase 3 (82.3%), and Peru Phase 2 (84.2%) NPs. In contrast, the Peru Phase 1, Brazil, and Chile Phase 1 NP models had the highest percentage of foods classified as healthy (49.2%, 47.1%, and 46.5%, respectively) and the lowest agreement with the PAHO model (69.9%, 69.3%, and 73%, respectively). Study limitations include that warnings considered by the Mexican NP models were evaluated as if all the warnings were octagon seals, while 2 out of the 7 were rectangular warnings (caffeine and non-nutritive sweeteners), and that our data are limited by the quality of the information reported in the list of ingredients and the nutrition facts table of the products. ConclusionsThe 3 implementation phases of the Mexican NP were useful to identify healthy food products. In contrast, the Peru Phase 1, Brazil, and Chile Phase 1 NP models may have limited usefulness for the classification of foods according to the content of ingredients of concern. The results of this study may inform countries seeking to adapt and evaluate existing NP models for use in population-specific applications.
   Author summary Why was this study done? Nutrient profile models that reflect the nutritional quality of food products are needed to help governments and decision-makers seeking to adapt simplified front-of-package labeling systems in their countries.The calibration of a nutrient profile aims to determine whether the nutrient profile model classifies foods correctly against reference methods, increasing the evidence supporting the model and improving its confidence. The Pan American Health Organization (PAHO) has developed a model that may work as a reference for Latin American countries.Several nutrient profiles have been developed and implemented in Latin America, with scarce evidence about their performance using representative databases of products of in the market.Even though the PAHO model was created for Latin American countries, it is relevant to adapt a nutrient profile model to local nutrition policies and epidemiology contexts. Recently, Mexico developed its own nutrient profile model based on the PAHO and Chile Phase 3 models, nutritional scientific population-based recommendations, and a feasibility analysis of products sold in the Mexican market. What did the researchers do and find? We compared the classification of a sample of more than 38,000 unique food products available in the Mexican market according to nutrient profile models from 6 countries (Mexico, Ecuador, Chile, Peru, Uruguay, and Brazil) against the PAHO model.According to the PAHO model, the Mexican Phase 3 nutrient profile performed best in identifying unhealthy products based on their content of energy, sugar, saturated fat, trans fat, sodium, non-nutritive sweeteners, and caffeine. This model had a strong correlation with the PAHO model (>91.9%). What do these findings mean? Our findings add support to the relevance of using the Mexican nutrient profile to evaluate the nutritional quality of food products as a basis for the prevention of obesity and chronic diseases related to diet.Our study has some limitations related to the quality of the information reported on the packages of the products included.
C1 [Contreras-Manzano, Alejandra; Cruz-Casarrubias, Carlos; Munguia, Ana; Jauregui, Alejandra; Vargas-Meza, Jorge; Nieto, Claudia; Tolentino-Mayo, Lizbeth; Barquera, Simon] Natl Inst Publ Hlth, Ctr Res Nutr & Hlth, Cuernavaca, Morelos, Mexico.
C3 Instituto Nacional de Salud Publica
RP Jáuregui, A (corresponding author), Natl Inst Publ Hlth, Ctr Res Nutr & Hlth, Cuernavaca, Morelos, Mexico.
EM alejandra.jauregui@insp.mx
RI Nieto, Claudia/AAJ-9880-2020; Munguía, Ana/KBA-6387-2024; Contreras,
   Alejandra/ITU-2625-2023
OI Nieto, Claudia/0000-0003-0091-8703; Barquera, Simon/0000-0003-1854-4615;
   Cruz-Casarrubias, Carlos/0000-0002-9972-4302; Tolentino-Mayo,
   Lizbeth/0000-0003-2400-8675; Munguia, Ana/0000-0002-3962-4617; Contreras
   Manzano, Alejandra/0000-0003-1576-5922; Jauregui,
   Alejandra/0000-0001-9158-2007; Vargas Meza, Jorge
   Luis/0000-0002-6099-2895
FU Bloomberg philantrophies [43003]
FX This work was funded by Bloomberg philantrophies [grant number #43003].
   (S.B). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Agncia Nacional de Vigilncia Sanitria, 2020, ANV APR NORM ROT NUT
   Ahuja Jaspreet K C, 2015, Prev Med Rep, V2, P962, DOI 10.1016/j.pmedr.2015.11.003
   Díaz AA, 2017, REV PANAM SALUD PUBL, V41
   [Anonymous], 2019, MINS PON MIR ED QUE
   [Anonymous], 2020, CURS AV IN NOM 051 E
   [Anonymous], 2015, MEXICO NEWS DAI 0129
   [Anonymous], 2016, PAN AM HLTH ORG NUTR
   [Anonymous], 2019, Instituto Brasileiro de Geografia e Estatistica
   Ares G, 2018, FOOD RES INT, V107, P669, DOI 10.1016/j.foodres.2018.03.021
   Arrúa A, 2017, APPETITE, V116, P139, DOI 10.1016/j.appet.2017.04.012
   Brasil, 2018, AG NAC VIG SAN ANVIS
   Braverman-Bronstein A, 2020, INT J OBESITY, V44, P1341, DOI 10.1038/s41366-019-0506-x
   Cooper SL, 2016, APPETITE, V100, P26, DOI 10.1016/j.appet.2016.02.001
   Correa T, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0781-x
   Diario Oficial de la Repblica de Chile, 2015, MOD DECR SUPR N 977
   Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x
   Agüero SD, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4806534
   Duran AC, 2021, PUBLIC HEALTH NUTR, V24, P1514, DOI 10.1017/S1368980019005056
   Figueroa M, 2017, SEMINARIO OBESIDAD P
   Freire Wilma B, 2017, Rev. perú. med. exp. salud publica, V34, P11, DOI 10.17843/rpmesp.2017.341.2762
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Holub CK, 2013, AM J PREV MED, V44, P529, DOI 10.1016/j.amepre.2013.01.023
   Internet, 2019, Aprueban Manual de Advertencias Publicitarias en el marco de lo establecido en la Ley N 30021, Ley de promocion de la alimentacion saludable para ninos, ninas y adolescentes, y su Reglamento aprobado por Decreto Supremo N 017-2017-SA
   Jesus TS, 2020, PHYSIOTHER CAN, V72, P122, DOI 10.3138/ptc-2018-0065
   Kanter R, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.001016
   Labonté MÉ, 2018, ADV NUTR, V9, P741, DOI 10.1093/advances/nmy045
   Manufactura, 2019, IND LCTEA PEL NUEV E
   Ministerio de Industria y Mineria, 2020, DECR NO 272 018 CRIT
   Ministerio de Salud de Chile, 2018, INF EV IMPL LEY COMP
   Ministerio de Salud de Chile, 2015, DIR VIG FISC COMP NU
   Ministerio de Salud de Uruguay, 2018, ANUARIO ESTADISTICA
   Monteiro, 2016, WORLD NUTR, V7, P28, DOI DOI 10.1186/1479-5868-9-43
   National Institute of Statistics and Geography, 2021, DENUE EST DIR
   National Institute of Statistics and Geography, 2021, 2010 CENS POP HOUS U
   Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592
   Pan American Health Organization, 2020, FRONT OF PACKAGE LAB
   Pan American Health Organization, 2021, ET FRONT ADV ARG
   RAPOPORT JL, 1984, ARCH GEN PSYCHIAT, V41, P1073
   Rayner M., 2017, INFORMAS protocol: food labelling module, DOI [10.17608/k6.auckland.5673643.v1, DOI 10.17608/K6.AUCKLAND.5673643.V1]
   Rayner M, 2017, P NUTR SOC, V76, P230, DOI 10.1017/S0029665117000362
   Rivera JA, 2008, SALUD PUBLICA MEXICO, V50, P173, DOI 10.1590/S0036-36342008000200011
   Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8
   Rosentreter SC, 2013, AUST NZ J PUBL HEAL, V37, P278, DOI 10.1111/1753-6405.12071
   Secretara de Economa, 2020, MODIFICACIN NORM OF
   Shamah-Levy Teresa, 2020, Salud pública Méx, V62, P614
   Spink J, 2011, PACKAG TECHNOL SCI, V24, P469, DOI 10.1002/pts.947
   Stockley L., 2007, NUTR PROFILES USE RE
   Subsecretara de Salud Pblica, 2015, MOD DS N 977 1996 MI
   Swinburn B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12087
   Sylvetsky A, 2011, PEDIATR CLIN N AM, V58, P1467, DOI 10.1016/j.pcl.2011.09.007
   Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001
   Townsend MS, 2010, AM J CLIN NUTR, V91, p1109S, DOI 10.3945/ajcn.2010.28450F
   U.S. Department of Agriculture, 2022, FOODDATA CENTR
   US Department of Agriculture Foreign Agricultural Service, 2017, PER PUBL WARN MAN PR
   Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511
   White M, 2020, HEALTH SYST REFORM, V6, DOI 10.1080/23288604.2020.1752063
   World Cancer Research Fund American Institution for Cancer Research, 2007, 2 AICR WORLD CANC RE
   World Health Organization, 2015, WHO CALLS COUNTR RED
   World Health Organization, 2011, NUTR PROF REP WHO IA
   World Health Organization, 2015, GUID SUG INT AD CHIL
   World Health Organization, 2022, WHO EUR REG OB REP 2
   World Health Organization, 2019, Guiding principles and framework manual for front-of-pack labelling for promoting healthy diet
   Zacarias I., 2011, PROPUESTA DE CRITERIOS Y RECOMENDACION DE LIMITES MAXIMOS DE NUTRIENTES CRITICOS PARA LA IMPLEMENTACION DE LA LEY DE COMPOSICION DE ALIMENTOS Y SU PUBLICIDAD
NR 63
TC 11
Z9 11
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD APR
PY 2022
VL 19
IS 4
AR e1003968
DI 10.1371/journal.pmed.1003968
PG 20
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 1K8HI
UT WOS:000798836600001
PM 35442949
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Stern, D
   Piernas, C
   Barquera, S
   Rivera, JA
   Popkin, BM
AF Stern, Dalia
   Piernas, Carmen
   Barquera, Simon
   Rivera, Juan A.
   Popkin, Barry M.
TI Caloric Beverages Were Major Sources of Energy among Children and Adults
   in Mexico, 1999-2012
SO JOURNAL OF NUTRITION
LA English
DT Article
ID SUGAR-SWEETENED BEVERAGES; NATIONAL-HEALTH; BODY-WEIGHT; FOOD;
   CONSUMPTION; OBESITY; CARBOHYDRATE; DEMAND; PRICES; TRENDS
AB Mexico, with 1 of the highest obesity prevalences in the world, instituted a 10% excise tax for any sugar-sweetened beverage (SSB) starting on 1 January 2014. Understanding the recent patterns and trends in beverage intake and sales in Mexico provides both background and baseline data for the importance of SSBs and other beverages in the Mexican diet. We analyzed a single 24-h dietary recall from 2 nationally representative surveys: the Mexican Nutrition Survey 1999 (n = 6049) and the National Health and Nutrition Survey 2012 (n = 10,343). To describe trends and patterns in beverages, we calculated the volume and energy intake per capita and per consumer and the proportion of consumers of each beverage group in each survey. A commercial sales dataset was used to describe beverage sales trends from 1999 to 2012. From 1999 to 2012, total daily energy from beverages increased among children aged 5-11 y (+45.3 kcal), females aged 12-19 y (+57.3 kcal), and adult females aged 20-49 y (+96.4 kcal) (P < 0.05). Over the same period, intake of beverages with added sugars increased, specifically flavored milk, agua fresca (fruit water made in stalls or at home, usually with added sugars), and fruit drinks among children aged 5-11 y and females aged 12-19 y and caloric coffee/tea, soda, and agua fresca among adult females aged 20-49 y. In 2012, beverages represented 17.5% (325 kcal) and 19.0% (382 kcal) of the total daily energy intake per capita in children aged 1-19 y and adults aged >= 20 y, respectively. In 2012, flavored milk beverages, caloric soda, and high-fat milk were the top 3 major contributors to total daily energy intake per capita in all children aged 1-19 y. Caloric soda, caloric coffee/tea, and agua fresca were the top 3 major energy contributors in adults aged >= 20 y. From 1999 to 2012, sales of soda, fruit-flavored drinks, and flavored waters increased. In conclusion, consumption of several beverages with added sugars increased among children and adult females in Mexico. Because caloric soda is currently 1 of the top beverages consumed, a 10% tax on SSBs might help to significantly reduce added sugars intake in Mexico.
C1 [Stern, Dalia; Piernas, Carmen; Popkin, Barry M.] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.
   [Barquera, Simon; Rivera, Juan A.] Natl Inst Publ Hlth, Nutr & Hlth Res Ctr, Cuernavaca, Morelos, Mexico.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   Instituto Nacional de Salud Publica
RP Popkin, BM (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.
EM popkin@unc.edu
RI Popkin, Barry/T-6633-2019; Rivera, Juan/AGG-2060-2022; Stern,
   Dalia/AAX-6676-2020; Piernas, Carmen/AAT-8276-2020
OI Stern, Dalia/0000-0003-3779-6543; Piernas, Carmen/0000-0002-7536-922X;
   Rivera, Juan A./0000-0003-2586-4908; popkin, barry/0000-0001-9495-9324
FU Mexican National Council of Science and Technology Scholarship (CONACyT)
   [309902]; Carolina Population Center [5 R24 HD050924]
FX Supported by Mexican National Council of Science and Technology
   Scholarship (CONACyT) 309902 and Carolina Population Center grant 5 R24
   HD050924.
CR Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013
   Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   [Anonymous], 2008, USDA NAT NUTR DAT ST
   Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163
   Barquera S, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-47
   Batis C, 2011, J NUTR, V141, P1898, DOI 10.3945/jn.111.141473
   Block JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5947
   Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189
   BRONFMAN M, 1988, ARCH INVEST MED, V19, P351
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   Drewnowski A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-85
   Duffey KJ, 2008, AM J CLIN NUTR, V88, p1722S, DOI 10.3945/ajcn.2008.25825C
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Euromonitor International, SOFT DRINKS
   Ford ES, 2013, AM J CLIN NUTR, V97, P848, DOI 10.3945/ajcn.112.052662
   Gibson R.S., 2005, PRINCIPLES NUTR ASSE
   Gutierrez JP., 2012, NATL HLTH NUTR SURVE
   Igumbor EU, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001253
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1
   Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3
   Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667
   Ng SW, 2014, AM J CLIN NUTR, V99, P609, DOI 10.3945/ajcn.113.072892
   Gutiérrez JP, 2013, SALUD PUBLICA MEXICO, V55, pS341, DOI 10.21149/spm.v55s2.5133
   Piernas C, 2013, PEDIATR OBES, V8, P294, DOI 10.1111/j.2047-6310.2013.00153.x
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002
   Resano-Pérez E, 2003, SALUD PUBLICA MEXICO, V45, pS558
   Rivera Juan A, 2008, Salud pública Méx, V50, P173
   Rivera-Dommarco J, 2001, NATL HLTH NUTR SURVE
   Romero-Martínez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132
   Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001209, 10.1371/journal.pmed.1001242]
NR 35
TC 126
Z9 143
U1 0
U2 58
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD JUN
PY 2014
VL 144
IS 6
BP 949
EP 956
DI 10.3945/jn.114.190652
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AH9LZ
UT WOS:000336465200023
PM 24744311
OA Green Submitted, Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Kurihara, H
   Shibata, H
   Fukui, Y
   Kiso, Y
   Xu, JK
   Yao, XS
   Fukami, H
AF Kurihara, Hiroshi
   Shibata, Hiroshi
   Fukui, Yuko
   Kiso, Yoshinobu
   Xu, Jie-Kun
   Yao, Xin-Sheng
   Fukami, Harukazu
TI Evaluation of the hypolipemic property of Camellia sinensis var.
   ptilophylla on postprandial hypertriglyceridemia
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Camellia sinensis var. ptilophylla; cocoa tea; triglyceride (TG);
   pancreatic lipase
ID LIPID ABSORPTION; TEA CATECHINS; HEALTH; CAFFEINE; OBESITY; SERUM;
   POLYPHENOLS; INHIBITION; RATS; RICH
AB A naturally decaffeinated tea, Camellia sinensis var. ptilophylla (cocoa tea), has long been popular in southern China as a healthy beverage. Our experiments indicate that a single oral administration of 500 mg/kg of cocoa tea extract suppresses increases in plasma triacylgycerol (TG) levels when fed with 5 mL/kg of olive or lard oil in mice and that the inhibition rates are 22.9% and 31.5%, respectively, compared with controls. Under the same condition, cocoa tea extract did not affect the level of plasma free fatty acid. Likewise, the extract reduced the lymphatic absorption of lipids at 250 and 500 mg/kg. Also, cocoa tea extract and polyphenols isolated from cocoa tea inhibit pancreatic lipase. These findings suggest that cocoa tea has hypolipemic activity, which may be due to the suppression of digestive lipase activity by the polyphenols contained within the tea.
C1 Kyotogakuen Univ, Fac Bioenvironm Sci, Dept Biosci & Biotechnol, Kameoka City, Kyoto 6218555, Japan.
   Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Guangzhou 510632, Guangdong, Peoples R China.
   Suntory Ltd, Inst Hlth Care Sci, Technol Dev Ctr, Shimamoto, Osaka 6180001, Japan.
C3 Jinan University; Suntory Holdings Ltd
RP Fukami, H (corresponding author), Kyotogakuen Univ, Fac Bioenvironm Sci, Dept Biosci & Biotechnol, 1-1 Nanjo, Kameoka City, Kyoto 6218555, Japan.
EM fukami@kyotogakuen.ac.jp
RI Kiso, Yoshinobu/D-5424-2012; Katoh-Fukui, Yuko/Y-5383-2019
CR Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413
   Ashihara H, 2001, TRENDS PLANT SCI, V6, P407, DOI 10.1016/S1360-1385(01)02055-6
   Ashihara H, 1998, J PLANT RES, V111, P599, DOI 10.1007/BF02507798
   Benzie IFF, 1999, J AGR FOOD CHEM, V47, P633, DOI 10.1021/jf9807768
   Bitou N, 1999, LIPIDS, V34, P441, DOI 10.1007/s11745-999-0383-7
   CHANG H, 1988, ACTA SCI NATUR U SUN, V27, P131
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Fujiki H, 1998, MUTAT RES-FUND MOL M, V402, P307, DOI 10.1016/S0027-5107(97)00310-2
   GROSSMAN SH, 1976, CLIN CHEM, V22, P1310
   GRUNDY SM, 1990, J LIPID RES, V31, P1149
   Hashimoto F, 1996, BIOORG MED CHEM LETT, V6, P695, DOI 10.1016/0960-894X(96)00095-9
   Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l
   IKEDA I, 1994, J NUTR SCI VITAMINOL, V40, P275, DOI 10.3177/jnsv.40.275
   JAMES JE, 1994, ADDICTION, V89, P1595, DOI 10.1111/j.1360-0443.1994.tb03760.x
   Lakenbrink C, 2000, J AGR FOOD CHEM, V48, P2848, DOI 10.1021/jf9908042
   Lowe ME, 1997, J NUTR, V127, P549, DOI 10.1093/jn/127.4.549
   Matsuzawa Y, 2001, Nihon Rinsho, V59, P188
   McKay DL, 2002, J AM COLL NUTR, V21, P1
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   OKABE H, 1980, CLIN CHEM, V26, P1540
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   SENIOR JR, 1964, J LIPID RES, V5, P495
   Silvarolla MB, 2004, NATURE, V429, P826, DOI 10.1038/429826a
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Suzuki K, 2001, BIOL PHARM BULL, V24, P1088, DOI 10.1248/bpb.24.1088
   Thomson ABR, 1997, METHOD ENZYMOL, V286, P3
   Weisburger JH, 1997, CANCER LETT, V114, P315, DOI 10.1016/S0304-3835(97)04691-0
   Wu CD, 2002, NUTRITION, V18, P443, DOI 10.1016/S0899-9007(02)00763-3
   XIE B, 1993, LIFE SCI, V17, P77
   Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409
   YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007
NR 32
TC 34
Z9 40
U1 0
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUL 12
PY 2006
VL 54
IS 14
BP 4977
EP 4981
DI 10.1021/jf0603681
PG 5
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 059IW
UT WOS:000238727500010
PM 16819905
DA 2025-04-28
ER

PT J
AU Mika, M
   Wikiera, A
   Zyla, K
AF Mika, Magdalena
   Wikiera, Agnieszka
   Zyla, Krzysztof
TI Effects of non-fermented tea extracts on in vitro digestive hydrolysis
   of lipids and on cholesterol precipitation
SO EUROPEAN FOOD RESEARCH AND TECHNOLOGY
LA English
DT Article
DE green tea; cholesterol; lipids; in vitro digestibility; catechin
   gallates
ID DIET-INDUCED OBESITY; GREEN TEA; EPIGALLOCATECHIN GALLATE;
   CATECHIN-POLYPHENOLS; INVITRO METHOD; FAT OXIDATION; RATS; ABSORPTION;
   CAFFEINE; ACID
AB Extracts of non-fermented teas precipitated cholesterol and decreased dialysability of lipids in an in vitro model that simulated digestion in humans. The efficiency of tea extracts was affected by catechins and mainly by EGCG, ECG, GCG and CG. Total amounts and concentrations of individual catechins in extracts depended strongly on the tea brands. There were significant relationships between amounts of dialysable products of triglyceride hydrolysis, amounts of precipitated cholesterol, and concentrations of individual catechin gallates in tea brews. Dialysability of lipids was effectively reduced by tea extracts high in GCG and CG. Dialysability of lipids was strongly correlated with the sum of GCG and CG (R-2=84.64%) whereas precipitation of cholesterol was highly correlated with total amounts of catechin gallates in the tea extracts (R-2=89.59%).
C1 [Mika, Magdalena; Wikiera, Agnieszka; Zyla, Krzysztof] Agr Univ Krakow, Fac Food Technol, Dept Food Biotechnol, PL-31149 Krakow, Poland.
C3 University of Agriculture in Krakow
RP Mika, M (corresponding author), Agr Univ Krakow, Fac Food Technol, Dept Food Biotechnol, Ul 122 Balicka, PL-31149 Krakow, Poland.
EM mmika@ar.krakow.pl
RI Mika, Magdalena/I-5124-2012
CR ALLAIN CC, 1974, CLIN CHEM, V20, P475
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   FOSSATI P, 1982, CLIN CHEM, V28, P2077
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Khokhar S, 2002, J AGR FOOD CHEM, V50, P565, DOI 10.1021/jf010153l
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kobayashi M, 2005, BIOSCI BIOTECH BIOCH, V69, P2455, DOI 10.1271/bbb.69.2455
   Lin JK, 1998, J AGR FOOD CHEM, V46, P3635, DOI 10.1021/jf980223x
   Lin YL, 1996, J AGR FOOD CHEM, V44, P1387, DOI 10.1021/jf950652k
   Löest HB, 2002, J NUTR, V132, P1282, DOI 10.1093/jn/132.6.1282
   MILLER DD, 1981, AM J CLIN NUTR, V34, P2248, DOI 10.1093/ajcn/34.10.2248
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nakamura Y, 2001, J HEALTH SCI, V47, P107, DOI 10.1248/jhs.47.107
   Peterson J, 2005, J FOOD COMPOS ANAL, V18, P487, DOI 10.1016/j.jfca.2004.05.006
   WIERZEJEWSKA R, 2004, ZYWIENIE CZLOWIEKA M, V3, P274
   Witkowska A., 2003, BROMATOLOGIA CHEM S, P401
   WOLTERS MGE, 1993, BRIT J NUTR, V69, P849, DOI 10.1079/BJN19930085
   Yang TTC, 1997, PHARMACOL RES, V35, P505, DOI 10.1006/phrs.1997.0176
   ZYLA K, 1995, BRIT J NUTR, V74, P3, DOI 10.1079/BJN19950102
NR 26
TC 6
Z9 6
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1438-2377
J9 EUR FOOD RES TECHNOL
JI Eur. Food Res. Technol.
PD FEB
PY 2008
VL 226
IS 4
BP 731
EP 736
DI 10.1007/s00217-007-0584-1
PG 6
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 253TH
UT WOS:000252540000012
DA 2025-04-28
ER

PT J
AU Tanida, M
   Tsuruoka, N
   Shen, J
   Kiso, Y
   Nagai, K
AF Tanida, Mamoru
   Tsuruoka, Nobuo
   Shen, Jiao
   Kiso, Yoshinobu
   Nagai, Katsuya
TI Effects of oolong tea on renal sympathetic nerve activity and
   spontaneous hypertension in rats
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
ID URETHANE-ANESTHETIZED RATS; BLOOD-PRESSURE; BRAIN HISTAMINE; VAGAL
   NERVE; LEPTIN; GHRELIN; REFLEX; STIMULATION; RESPONSES; NUCLEUS
AB In a previous study, evidence was presented that oolong tea (OT) reduced abdominal fat accumulation in diet-induced obese mice. In the study presented here, we examined the sympathetic and cardiovascular effects of intraduodenal injection of OT in urethane-anesthetized rats and found that it suppressed renal sympathetic nerve activity (RSNA) and blood pressure (BP). In addition, pretreatment with the histaminergic H3-receptor antagonist thioperamide or bilateral subdiaphragmatic vagotomy eliminated the effects of OT on RSNA and BP. Furthermore, OT drinking for 14 weeks reduced BP elevation in spontaneously hypertensive rats. These results thus suggest that OT may exert its hypotensive action through changes in autonomic neurotransmission via an afferent neural mechanism. Moreover, we found that intraduodenal injection of decaffeinated OT lowered RSNA and BP as well as OT, indicating that substances other than caffeine contained in OT may function as effective modulators of RSNA and BP. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Tanida, Mamoru; Shen, Jiao; Nagai, Katsuya] ANBAS Corp, Kita Ku, Osaka 5310072, Japan.
   [Tanida, Mamoru; Shen, Jiao; Nagai, Katsuya] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan.
   [Kiso, Yoshinobu] Suntory Ltd, Inst Hlth Care Sci, Osaka 6180012, Japan.
C3 The University of Osaka; Suntory Holdings Ltd
RP Tanida, M (corresponding author), ANBAS Corp, Kita Ku, Osaka 5310072, Japan.
EM mtanida@anbas.co.jp
RI Kiso, Yoshinobu/D-5424-2012
CR ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0
   Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3
   Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   HANDA RK, 1985, J PHYSIOL-LONDON, V369, P311, DOI 10.1113/jphysiol.1985.sp015903
   Haynes WG, 2005, EXP PHYSIOL, V90, P683, DOI 10.1113/expphysiol.2005.031237
   Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266
   Lembo G, 2000, DIABETES, V49, P293, DOI 10.2337/diabetes.49.2.293
   Lin JK, 1998, J AGR FOOD CHEM, V46, P3635, DOI 10.1021/jf980223x
   Matsumura K, 2002, HYPERTENSION, V40, P694, DOI 10.1161/01.HYP.0000035395.51441.10
   Mutoh T, 2000, AM J PHYSIOL-REG I, V279, pR1215, DOI 10.1152/ajpregu.2000.279.4.R1215
   Nagai N, 1996, ENDOCRINOLOGY, V137, P504, DOI 10.1210/en.137.2.504
   Niijima A, 1998, J AUTONOM NERV SYST, V73, P19, DOI 10.1016/S0165-1838(98)00109-X
   NUMAO Y, 1975, JPN HEART J, V16, P719
   Osaka T, 2002, J PHYSIOL-LONDON, V540, P665, DOI 10.1113/jphysiol.2001.013475
   SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008
   Tanida M, 2005, BRAIN RES, V1058, P44, DOI 10.1016/j.brainres.2005.07.048
   Tanida M, 2005, NEUROSCI LETT, V389, P109, DOI 10.1016/j.neulet.2005.07.036
   Tanida M, 2005, AM J PHYSIOL-REG I, V288, pR447, DOI 10.1152/ajpregu.00275.2004
   Tanida M, 2007, NEUROSCI LETT, V413, P88, DOI 10.1016/j.neulet.2006.11.035
   Yang MH, 2001, J NUTR BIOCHEM, V12, P14, DOI 10.1016/S0955-2863(00)00140-6
NR 21
TC 19
Z9 26
U1 0
U2 11
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
J9 METABOLISM
JI Metab.-Clin. Exp.
PD APR
PY 2008
VL 57
IS 4
BP 526
EP 534
DI 10.1016/j.metabol.2007.11.016
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 275VJ
UT WOS:000254099900015
PM 18328356
DA 2025-04-28
ER

PT J
AU Ong, CB
   Annuar, MSM
AF Ong, Chong-Boon
   Annuar, Mohamad Suffian Mohamad
TI Potentialities of Tannase-Treated Green Tea Extract in Nutraceutical and
   Therapeutic Applications
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Review
DE Antioxidant; Biotransformation; Catechins; Green tea; Tannase
ID EPIGALLOCATECHIN GALLATE; ANTIOXIDANT ACTIVITY; BLACK TEA; CATECHINS;
   BIOTRANSFORMATION; OOLONG; POLYPHENOLS; EXPRESSION; INCREASES; CAFFEINE
AB Green tea has garnered widespread interest in the past decades due to its content of health-beneficial polyphenols and catechins, besides reportedly exhibiting activities for the prevention, and possibly treatment, of many modern-life-associated afflictions. Hence, the functional food potential of health-beneficial beverages such as green tea is widely and commercially promoted. Biotransformation of green tea extract using enzymes such as tannase ostensibly enhances its beneficial well-being properties and disease-preventing functionalities. The tannase-treated green tea catechins may exhibit enhanced, amongst others, antioxidant, anti-tumour, anti-wrinkle, anti-inflammatory, anti-obesity and anti-sarcopenia properties compared to native green tea extract. Nonetheless, the health benefits and therapeutic and toxicological effects associated with these compounds, before and after tannase treatment, present a scientific gap for detailed studies. Accordingly, the review surveys the literature from the late twentieth century until the year 2023 related to the aforementioned important aspects.
C1 [Ong, Chong-Boon] Int Univ Malaya Wales, Fac Arts & Sci, Sch Sci & Psychol, Kuala Lumpur 50480, Malaysia.
   [Annuar, Mohamad Suffian Mohamad] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
C3 Universiti Malaya; Universiti Malaya
RP Ong, CB (corresponding author), Int Univ Malaya Wales, Fac Arts & Sci, Sch Sci & Psychol, Kuala Lumpur 50480, Malaysia.
EM ongchongboon@yahoo.com
RI MOHAMAD ANNUAR, MOHAMAD SUFFIAN/B-9031-2010; Ong, Chong-Boon/F-7758-2014
OI Ong, Chong-Boon/0000-0003-4564-6043
CR Adhikary PP, 2021, PHARMACOL THERAPEUT, V217, DOI 10.1016/j.pharmthera.2020.107648
   Aharwar A, 2023, BIOMASS CONVERS BIOR, V13, P261, DOI 10.1007/s13399-020-01162-6
   Ahmad R, 2023, ULTRASON SONOCHEM, V94, DOI 10.1016/j.ultsonch.2023.106337
   Al Zahrani NA, 2020, EUR J MED CHEM, V204, DOI 10.1016/j.ejmech.2020.112609
   Alhafez M, 2022, RESULTS CHEM, V4, DOI 10.1016/j.rechem.2022.100638
   Anggraini T, 2021, IOP C SER EARTH ENV, V709, DOI 10.1088/1755-1315/709/1/012017
   Baik JH, 2015, J SCI FOOD AGR, V95, P2337, DOI 10.1002/jsfa.6955
   Baik JH, 2014, J BIOSCI BIOENG, V118, P546, DOI 10.1016/j.jbiosc.2014.04.012
   Battestin V, 2008, FOOD CHEM, V108, P228, DOI 10.1016/j.foodchem.2007.10.068
   Bernatoniene J, 2018, MOLECULES, V23, DOI 10.3390/molecules23040965
   Cai ZY, 2018, MOLECULES, V23, DOI 10.3390/molecules23092346
   Cao QQ, 2019, FOOD CHEM, V277, P432, DOI 10.1016/j.foodchem.2018.10.146
   Chan EWC, 2010, J FOOD COMPOS ANAL, V23, P185, DOI 10.1016/j.jfca.2009.10.002
   Chen JL, 2021, CLIN NUTR, V40, P4830, DOI 10.1016/j.clnu.2021.06.031
   Cherrak SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165575
   Choung MG, 2011, FOOD SCI BIOTECHNOL, V20, P327, DOI 10.1007/s10068-011-0046-1
   Chu KO, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.899271
   Curylofo-Zotti FA, 2023, LASER MED SCI, V38, DOI 10.1007/s10103-023-03707-3
   Czaja AJ, 2017, HANDB SYST AUTOIMMUN, V13, P19, DOI 10.1016/B978-0-444-63707-9.00002-7
   Darwish DBE., 2017, EGYPT J EXP BIOL BOT, V13, P1, DOI DOI 10.5455/EGYJEBB.20170114092419
   Debnath B, 2021, J ENVIRON CHEM ENG, V9, DOI 10.1016/j.jece.2021.106179
   Deng SJ, 2022, FOOD RES INT, V157, DOI 10.1016/j.foodres.2022.111262
   Di Meo Sergio, 2016, Oxid Med Cell Longev, V2016, P1245049, DOI 10.1155/2016/1245049
   Farhan M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231810713
   Food and Agriculture Organization of the United Nations, 2022, INT TEA MARK MARK SI
   Fuster JJ, 2016, CIRC RES, V118, P1786, DOI 10.1161/CIRCRESAHA.115.306885
   He JT, 2018, MED SCI MONITOR, V24, P8198, DOI 10.12659/MSM.911175
   Hong KB, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/4319398
   Hong KB, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-020-2827-7
   Honga YH, 2014, INTEGR MED RES, V3, P25, DOI 10.1016/j.imr.2013.12.003
   Hong YH, 2013, J COSMET DERMATOL-US, V12, P137, DOI 10.1111/jocd.12038
   Hong YH, 2013, BIOSCI BIOTECH BIOCH, V77, P22, DOI 10.1271/bbb.120373
   Hong YH, 2012, APPL BIOCHEM BIOTECH, V166, P165, DOI 10.1007/s12010-011-9413-x
   Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
   Huang XY, 2022, CONTRAST MEDIA MOL I, V2022, DOI 10.1155/2022/8639139
   Hwang Y, 2019, ARCH DERMATOL RES, V311, P109, DOI 10.1007/s00403-018-01886-6
   Imokawa G, 2015, INT J MOL SCI, V16, P7776, DOI 10.3390/ijms16047776
   Islam SN, 2018, INT J FOOD SCI TECH, V53, P182, DOI 10.1111/ijfs.13572
   Jiang HY, 2015, FOOD CHEM, V183, P30, DOI 10.1016/j.foodchem.2015.03.024
   Jin Yinzhe, 2006, Biotechnology Journal, V1, P209, DOI 10.1002/biot.200500019
   Johnson AA, 2022, AGING CELL, V21, DOI 10.1111/acel.13664
   Kapoor M.P., 2013, Green tea polyphenols: Nutraceuticals of modern life, P1
   Karavasilis M., 2019, Emerg. Sci. J, V3, P344, DOI DOI 10.28991/ESJ-2019-01197
   Karen EB., 2020, PLAST AESTHET RES, V7, P59
   Kaur A, 2019, CURR NUTR FOOD SCI, V15, P415, DOI 10.2174/1573401313666171016162310
   Kim HS, 2020, ENZYME MICROB TECH, V135, DOI 10.1016/j.enzmictec.2019.109496
   Kim M, 2022, FOOD SCI BIOTECHNOL, V31, P539, DOI 10.1007/s10068-022-01063-6
   Kim TE, 2018, DRUG DES DEV THER, V12, DOI 10.2147/DDDT.S148257
   Liu SY, 2017, FOOD CHEM, V234, P168, DOI 10.1016/j.foodchem.2017.04.151
   Liu Y., 2022, Am. J. Biochem. Biotechnol., V18, P41, DOI [10.3844/ajbbsp.2022.41.48, DOI 10.3844/AJBBSP.2022.41.48]
   Liu ZW, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00477
   López-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   Lu MJ, 2009, LWT-FOOD SCI TECHNOL, V42, P338, DOI 10.1016/j.lwt.2008.05.015
   Lu MJ, 2008, FOOD RES INT, V41, P130, DOI 10.1016/j.foodres.2007.10.012
   Lu MJ, 2007, PROCESS BIOCHEM, V42, P1285, DOI 10.1016/j.procbio.2007.06.003
   Macedo JA, 2012, FOOD CHEM, V133, P358, DOI 10.1016/j.foodchem.2012.01.041
   Macedo JA, 2011, FOOD CHEM, V126, P491, DOI 10.1016/j.foodchem.2010.11.026
   Ladeira LCM, 2021, J ETHNOPHARMACOL, V274, DOI 10.1016/j.jep.2021.114032
   Lorenzo JM, 2016, ASIAN PAC J TROP BIO, V6, P709, DOI 10.1016/j.apjtb.2016.06.010
   Matsuura R, 2022, MICROORGANISMS, V10, DOI 10.3390/microorganisms10091796
   Murtiastutik D., 2020, INDIAN J FORENSIC ME, V15, P1021
   Nain CW, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11091844
   Ni H, 2015, LWT-FOOD SCI TECHNOL, V60, P1206, DOI 10.1016/j.lwt.2014.09.010
   Noh DO, 2014, PROCESS BIOCHEM, V49, P271, DOI 10.1016/j.procbio.2013.11.001
   Olson KR, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101731
   Ong CB, 2017, INT J FOOD SCI TECH, V52, P748, DOI 10.1111/ijfs.13331
   Panzella L, 2019, COSMETICS-BASEL, V6, DOI 10.3390/cosmetics6040057
   Park R, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13122533
   Parvez MAK, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02126
   Platzer M, 2021, MOLECULES, V26, DOI 10.3390/molecules26051244
   Rady I., 2018, Egyptian Journal of Basic and Applied Sciences, V5, P1, DOI DOI 10.1016/J.EJBAS.2017.12.001
   Rahim AA, 2014, FOOD CHEM, V147, P262, DOI 10.1016/j.foodchem.2013.09.131
   Rashidinejad A, 2021, FOOD RES INT, V142, DOI 10.1016/j.foodres.2021.110186
   Reto M, 2007, PLANT FOOD HUM NUTR, V62, P139, DOI 10.1007/s11130-007-0054-8
   Rha CS, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080278
   Rondanelli M, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/5970367
   Roy S, 2017, 3 BIOTECH, V8, DOI 10.1007/s13205-017-1055-4
   Roychoudhury S, 2017, REPROD BIOMED ONLINE, V34, P487, DOI 10.1016/j.rbmo.2017.02.006
   Mozumder NHMR, 2020, APPL BIOL CHEM, V63
   Safari F, 2022, J TRADIT CHIN MED, V42, P681, DOI 10.19852/j.cnki.jtcm.2022.05.002
   Salman S, 2022, FOOD BIOSCI, V49, DOI 10.1016/j.fbio.2022.101884
   Sanlier N, 2018, TRENDS FOOD SCI TECH, V78, P95, DOI 10.1016/j.tifs.2018.05.026
   Seo H, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10071026
   Shahwan M, 2022, INT J BIOL MACROMOL, V206, P567, DOI 10.1016/j.ijbiomac.2022.03.004
   Shariare MH, 2020, MOLECULES, V25, DOI 10.3390/molecules25225453
   Liu TPSL, 2017, INT J FOOD SCI TECH, V52, P652, DOI 10.1111/ijfs.13318
   Singh NA, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0179-4
   Sivanesan I, 2022, SEPARATIONS, V9, DOI 10.3390/separations9080209
   Song HD, 2022, FOOD CHEM, V388, DOI 10.1016/j.foodchem.2022.132903
   Sordon S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8070210
   Sousa CPB, 2023, CHEM-BIOL INTERACT, V378, DOI 10.1016/j.cbi.2023.110465
   Sun LL, 2020, NAT PROD COMMUN, V15, DOI 10.1177/1934578X20945505
   Tang GY, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10071076
   Thiyonila B, 2020, BIOCATAL AGR BIOTECH, V27, DOI 10.1016/j.bcab.2020.101675
   Traub M., 2020, TXB NATURAL MED, P1149, DOI [10.1016/B978-0-323-43044-9.00150-3, DOI 10.1016/B978-0-323-43044-9.00150-3]
   Truong VL, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22179109
   Vastrad J. V., 2022, PHENOLIC COMPOUNDS C
   Wan CP, 2023, J FUNCT FOODS, V104, DOI 10.1016/j.jff.2023.105506
   Wang QM, 2018, KARDIOL POL, V76, P1263, DOI 10.5603/KP.a2018.0114
   Wang QF, 2022, ECOTOX ENVIRON SAFE, V232, DOI 10.1016/j.ecoenv.2022.113279
   Xia GB, 2014, FOOD CHEM, V151, P380, DOI 10.1016/j.foodchem.2013.11.090
   Yin P, 2022, TRENDS FOOD SCI TECH, V129, P221, DOI 10.1016/j.tifs.2022.09.013
   Younes M, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5239
   Zhang F. M., 2021, EUROPEAN J SURG ONCO, V48, P541
   Zhang H, 2019, FOOD BIOSCI, V29, P55, DOI 10.1016/j.fbio.2019.03.009
   Zhao TT, 2022, MOLECULES, V27, DOI 10.3390/molecules27123909
   Zhao Y, 2011, FOOD CHEM, V126, P1269, DOI 10.1016/j.foodchem.2010.11.055
NR 107
TC 3
Z9 3
U1 14
U2 21
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD OCT
PY 2024
VL 196
IS 10
BP 7534
EP 7553
DI 10.1007/s12010-024-04946-y
EA MAY 2024
PG 20
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA M7D8K
UT WOS:001215354200001
PM 38713339
DA 2025-04-28
ER

PT J
AU Bezerra, IN
   Goldman, J
   Rhodes, DG
   Hoy, MK
   Souza, AD
   Chester, DN
   Martin, CL
   Sebastian, RS
   Ahuja, JK
   Sichieri, R
   Moshfegh, AJ
AF Bezerra, Ilana Nogueira
   Goldman, Joseph
   Rhodes, Donna G.
   Hoy, Mary Katherine
   Souza, Amanda de Moura
   Chester, Deirdra N.
   Martin, Carrie L.
   Sebastian, Rhonda S.
   Ahuja, Jaspreet K.
   Sichieri, Rosely
   Moshfegh, Alanna J.
TI Difference in adult food group intake by sex and age groups comparing
   Brazil and United States nationwide surveys
SO NUTRITION JOURNAL
LA English
DT Article
DE Diet; Food groups; Dietary surveys; Brazilian and American diet; Food
   habits
ID DIETARY PATTERNS; ENERGY-INTAKE; NUTRITIONAL-STATUS; CONSUMPTION;
   TRENDS; US; AVAILABILITY; VARIETY; OBESITY; SUGAR
AB Background: International comparisons of dietary intake are an important source of information to better understand food habits and their relationship to nutrition related diseases. The objective of this study is to compare food intake of Brazilian adults with American adults identifying possible dietary factors associated with the increase in obesity in Brazil.
   Methods: This research used cross-national analyses between the United States and Brazil, including 5,420 adults in the 2007-2008 What We Eat In America, National Health and Nutrition Examination Survey and 26,390 adults in the 2008-2009 Brazilian Household Budget Survey, Individual Food Intake. Dietary data were collected through 24 h recalls in the U. S. and through food records in Brazil. Foods and beverages were combined into 25 food categories. Food intake means and percentage of energy contribution by food categories to the population's total energy intake were compared between the countries.
   Results: Higher frequencies of intake were reported in the United States compared to Brazil for the majority of food categories except for meat, rice and rice dishes; beans and legumes; spreads; and coffee and tea. In either country, young adults (20-39 yrs) had greater reports of meat, poultry and fish mixed dishes; pizza and pasta; and soft drinks compared to older adults (60 + yrs). Meat, poultry and fish mixed dishes (13%), breads (11%), sweets and confections (8%), pizza and pasta (7%), and dairy products (6%) were the top five food category sources of energy intake among American adults. The top five food categories in Brazil were rice and rice dishes (13%), meat (11%), beans and legumes (10%), breads (10%), and coffee and tea (6%). Thus, traditional plant-based foods such as rice and beans were important contributors in the Brazilian diet.
   Conclusion: Although young adults had higher reports of high-calorie and nutrient-poor foods than older adults in both countries, Brazilian young adults did not consume a diet similar to Americans, indicating that it is still possible to reverse the current trends of incorporating Western dietary habits in Brazil.
C1 [Bezerra, Ilana Nogueira] Univ Fortaleza UNIFOR, Curso Nutr, Ctr Ciencias Saude, Fortaleza, Ceara, Brazil.
   [Goldman, Joseph; Rhodes, Donna G.; Hoy, Mary Katherine; Martin, Carrie L.; Sebastian, Rhonda S.; Ahuja, Jaspreet K.; Moshfegh, Alanna J.] ARS, Food Surveys Res Grp, Beltsville Human Nutr Res Ctr, USDA,BARC West, Beltsville, MD 20705 USA.
   [Souza, Amanda de Moura; Sichieri, Rosely] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, BR-20550012 Rio De Janeiro, RJ, Brazil.
   [Chester, Deirdra N.] USDA, Natl Inst Food & Agr, Washington, DC 20250 USA.
C3 Universidade Fortaleza; United States Department of Agriculture (USDA);
   Universidade do Estado do Rio de Janeiro; United States Department of
   Agriculture (USDA)
RP Bezerra, IN (corresponding author), Univ Fortaleza UNIFOR, Curso Nutr, Ctr Ciencias Saude, Av Washington Soares 1321,Sala C04 Edson Queiroz, Fortaleza, Ceara, Brazil.
EM ilana.bezerra@yahoo.com.br
RI Bezerra, Ilana/ACD-4132-2022; Brito, Flavia/ADC-5052-2022
OI Ahuja, Jaspreet/0000-0001-9212-9394; Bezerra, Ilana/0000-0002-2072-0123
FU Brazilian Ministry of Health; Brazilian Federal Agency for the
   Improvement of Higher Education (CAPES) [6748-10-4]
FX The Brazilian survey was funding by the Brazilian Ministry of Health.
   INB received a fellowship from the Brazilian Federal Agency for the
   Improvement of Higher Education (CAPES) - Process n.6748-10-4.
CR [Anonymous], CONS EXP SURV 2008 2
   Araujo MC, 2013, PUBLIC HLTH NUTR
   Bezerra IN, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-22
   Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007
   Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968
   Brazil. Ministry of Health:, 2013, VIG BRAS 2012 VIG FA
   Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752
   Chun OK, 2010, NUTRIENTS, V2, P834, DOI 10.3390/nu2080834
   Cuevas Ada, 2009, Expert Rev Cardiovasc Ther, V7, P281, DOI 10.1586/14779072.7.3.281
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026
   Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Foote JA, 2004, J NUTR, V134, P1779
   Hatloy A, 2000, PUBLIC HEALTH NUTR, V3, P57, DOI 10.1017/S1368980000000628
   Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881
   IBGE, 2004, NAT HOUS BUDG SURV 2
   IBGE, 2010, CONS EXP SURV 2008 2
   Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476
   Levy-Costa RB, 2005, REV SAUDE PUBL, V39, P530, DOI 10.1590/S0034-89102005000400003
   Marchioni DM, 2011, PUBLIC HEALTH NUTR, V14, P1586, DOI 10.1017/S1368980011000486
   McCrory MA, 2000, J NUTR, V130, p276S, DOI 10.1093/jn/130.2.276S
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Nascimento S, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-79
   National Diabetes Fact Sheet, 2011, DIAGN UND DIAB US AG
   Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365
   Olinto MTA, 2012, EUR J NUTR, V51, P281, DOI 10.1007/s00394-011-0213-4
   Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X
   Pereira RA, 2014, PUBLIC HEALTH NUTR, V17, P113, DOI 10.1017/S1368980012004892
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Sichieri R, 2010, CAD SAUDE PUBLICA, V26, P2050, DOI 10.1590/S0102-311X2010001100006
   Sun J, 2004, INT J ENV RES PUB HE, V11, P3956
   WHO, 2011, WHO FOR TECHN M IT W
   Willett WC, 1998, NUTR EPIDEMIOLOGY
NR 36
TC 49
Z9 51
U1 0
U2 24
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2891
J9 NUTR J
JI Nutr. J.
PD JUL 21
PY 2014
VL 13
AR 74
DI 10.1186/1475-2891-13-74
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AM2HJ
UT WOS:000339670900001
PM 25047421
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Metsovitis, T
   Bernardi, M
   Bruckert, E
   Fogacci, F
   Cicero, A
   Garcia-Zamora, S
   Spadafora, L
   Angoulvant, D
   Biondi-Zoccai, G
   Sabouret, P
AF Metsovitis, Theodora
   Bernardi, Marco
   Bruckert, Eric
   Fogacci, Federica
   Cicero, Arrigo
   Garcia-Zamora, Sebastian
   Spadafora, Luigi
   Angoulvant, Denis
   Biondi-Zoccai, Giuseppe
   Sabouret, Pierre
TI Role of nutrition and healthy lifestyle, for individuals in primary
   prevention: recent data, gaps in evidence and future directions
SO ARCHIVES OF MEDICAL SCIENCE
LA English
DT Article
DE lifestyle; nutrition; diet; physical activity; sleep duration
ID CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; MEDITERRANEAN DIET;
   VITAMIN-D; NUT CONSUMPTION; BLOOD-PRESSURE; 25-HYDROXYVITAMIN D; COFFEE
   CONSUMPTION; METABOLIC SYNDROME; SKELETAL-MUSCLE
AB All recent guidelines on cardiovascular prevention have highlighted the role of a healthy diet and lifestyle advocating an holistic approach to reduce the cardiovascular burden among the population. Despite these efforts, registries have reported that only a minority of healthcare professionals provide advice on diet and lifestyle, and, in most cases, counseling is suboptimal for several reasons. Cardiovascular benefits linked to lifestyle and nutrition seem to be underestimated by many patients and doctors. This overview aims to summarize well-established benefits related to lifestyle and nutrition, discuss the current debates in this field in order to improve awareness among the medical community and promote better implementation of non-pharmaceutical measures to prevent the occurrence of atherothrombotic events, by reducing cardiovascular risk factors such as hypertension, diabetes, dyslipidemia, and obesity.
C1 Catholic Univ, Rome, Italy.
   [Bernardi, Marco] Sapienza Univ, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy.
   Ctr Univ Paris, Paris, France.
   Alma Mater Studiorum Univ Bologna, Hypertens & Cardiovasc Risk Res Ctr, Med & Surg Sci Dept, Bologna, Italy.
   Delta Clin, Rosario, Argentina.
   [Angoulvant, Denis] CHRU Tours, Serv Cardiol, Tours, France.
   Fac Med Tours, Tours, France.
   [Angoulvant, Denis] Univ Tours, Transplantat Immun Inflammat, EA4245, Tours, France.
   [Biondi-Zoccai, Giuseppe] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Latina, Italy.
   [Biondi-Zoccai, Giuseppe] Mediterranea Cardioctr, Naples, Italy.
   [Sabouret, Pierre] CHU Pitie Salpetriere Paris, ACTION Study Grp, Heart Inst, Blvd Hop, Paris, France.
   [Sabouret, Pierre] Coll Natl Cardiologues Francais CNCF, Paris, France.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   Sapienza University Rome; Universite Paris Cite; University of Bologna;
   CHU Tours; Universite de Tours; Sapienza University Rome; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere
   - APHP
RP Bernardi, M (corresponding author), Sapienza Univ, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy.
EM marco.bernardi23@gmail.com
RI Spadafora, Luigi/AAA-9541-2022; Marco, Bernardi/ABZ-8626-2022; Fogacci,
   Federica/R-5931-2016; Sabouret, Pierre/AAE-3459-2020
OI Bernardi, Marco/0000-0001-9269-8829; SPADAFORA,
   LUIGI/0000-0001-6443-4121; Cicero, Arrigo Francesco
   Giuseppe/0000-0002-4367-3884
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x
   Martínez-González MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250
   Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.010]
   Aune D, 2019, ADV NUTR, V10, pS404, DOI 10.1093/advances/nmz042
   BAK AAA, 1989, NEW ENGL J MED, V321, P1432, DOI 10.1056/NEJM198911233212103
   Banach M, 2023, EUR J PREV CARDIOL, V30, P1975, DOI 10.1093/eurjpc/zwad229
   Barbarawi M, 2019, JAMA CARDIOL, V4, P765, DOI 10.1001/jamacardio.2019.1870
   Berryman CE, 2011, NUTR REV, V69, P171, DOI 10.1111/j.1753-4887.2011.00383.x
   Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591
   Bielecka-Dabrowa A, 2022, J PERS MED, V12, DOI 10.3390/jpm12101583
   Bitok E, 2018, PROG CARDIOVASC DIS, V61, P33, DOI 10.1016/j.pcad.2018.05.003
   Blesso CN, 2013, J CLIN LIPIDOL, V7, P463, DOI 10.1016/j.jacl.2013.03.008
   Blomhoff R, 2005, CURR OPIN LIPIDOL, V16, P47, DOI 10.1097/00041433-200502000-00009
   Buil-Cosiales P, 2014, AM J CLIN NUTR, V100, P1498, DOI 10.3945/ajcn.114.093757
   Cacciatore S, 2023, NUTRIENTS, V15, DOI 10.3390/nu15041026
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Calder PC, 2015, JPEN-PARENTER ENTER, V39, p18S, DOI 10.1177/0148607115595980
   Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471
   Chiavaroli L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020338
   Chieng D, 2022, TRENDS CARDIOVAS MED, V32, P399, DOI 10.1016/j.tcm.2021.08.004
   Cicero AFG, 2023, ARCH MED SCI, V19, P1169, DOI 10.5114/aoms/167969
   Clayton ZS, 2017, NUTRITION, V37, P79, DOI 10.1016/j.nut.2016.12.014
   Clifton PM, 2017, NUTR METAB CARDIOVAS, V27, P1060, DOI 10.1016/j.numecd.2017.10.010
   Couto E, 2011, BRIT J CANCER, V104, P1493, DOI 10.1038/bjc.2011.106
   Danziger J, 2015, CLIN J AM SOC NEPHRO, V10, P852, DOI 10.2215/CJN.10741013
   Dashti HM, 2021, MED PRIN PRACT, V30, P223, DOI 10.1159/000512142
   Davis C, 2015, NUTRIENTS, V7, P9139, DOI 10.3390/nu7115459
   de Lorgeril M, 2002, CARDIOVASC RES, V54, P503, DOI 10.1016/S0008-6363(01)00545-4
   Del Giorno R, 2022, INT J FOOD SCI NUTR, V73, P106, DOI 10.1080/09637486.2021.1926935
   Delzenne NM, 2005, CURR OPIN CLIN NUTR, V8, P636, DOI 10.1097/01.mco.0000171124.06408.71
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Dinu M, 2017, CRIT REV FOOD SCI, V57, P3640, DOI 10.1080/10408398.2016.1138447
   Dobrowolski P, METABOLIC SYNDROME N
   Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824
   Elagizi A, 2020, CURR OBES REP, V9, P571, DOI 10.1007/s13679-020-00403-z
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Filippou CD, 2020, ADV NUTR, V11, P1150, DOI 10.1093/advances/nmaa041
   Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244
   FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416
   Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x
   Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010
   Gibbs J, 2021, J HYPERTENS, V39, P23, DOI 10.1097/HJH.0000000000002604
   Grandner MA, 2010, SLEEP MED REV, V14, P191, DOI 10.1016/j.smrv.2009.07.006
   Gunta SS, 2013, NAT REV NEPHROL, V9, P337, DOI 10.1038/nrneph.2013.74
   Hales Craig M, 2020, NCHS Data Brief, P1
   Hall KD, 2017, EUR J CLIN NUTR, V71, P323, DOI 10.1038/ejcn.2016.260
   Harber MP, 2017, PROG CARDIOVASC DIS, V60, P11, DOI 10.1016/j.pcad.2017.03.001
   Harris WS, 2006, CURR OPIN LIPIDOL, V17, P387, DOI 10.1097/01.mol.0000236363.63840.16
   Harvey A, 2016, CAN J CARDIOL, V32, P659, DOI 10.1016/j.cjca.2016.02.070
   Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009
   HIRAI A, 1980, LANCET, V2, P1132
   Hoevenaar-Blom MP, 2014, EUR J NUTR, V53, P1209, DOI 10.1007/s00394-013-0621-8
   Hu FB, 1998, BMJ-BRIT MED J, V317, P1341, DOI 10.1136/bmj.317.7169.1341
   Islam MA, 2019, DIABETES METAB SYND, V13, P1643, DOI 10.1016/j.dsx.2019.03.033
   Jain AP, 2015, EUR REV MED PHARMACO, V19, P441
   Jenkins DJA, 2018, J AM COLL CARDIOL, V71, P2570, DOI 10.1016/j.jacc.2018.04.020
   Jing LL, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.864600
   Joris PJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050530
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372
   Katcher HI, 2008, AM J CLIN NUTR, V87, P79, DOI 10.1093/ajcn/87.1.79
   Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355
   Kelly JH, 2006, BRIT J NUTR, V96, pS61, DOI 10.1017/BJN20061865
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Konstantinidi Melina, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6030094
   Kris-Etherton P, 2001, CIRCULATION, V103, P1823, DOI 10.1161/01.CIR.103.13.1823
   Kris-Etherton PN, 2008, J NUTR, V138, p1746S
   Lavie CJ, 2019, CIRC RES, V124, P799, DOI 10.1161/CIRCRESAHA.118.312669
   Levitan EB, 2009, ARCH INTERN MED, V169, P851, DOI 10.1001/archinternmed.2009.56
   Li J, 2022, SLEEP BREATH, V26, P1479, DOI 10.1007/s11325-021-02458-1
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Llorente-Cortés V, 2010, ATHEROSCLEROSIS, V208, P442, DOI 10.1016/j.atherosclerosis.2009.08.004
   Lloyd-Jones DM, 2022, CIRCULATION, V146, pE18, DOI 10.1161/CIR.0000000000001078
   Ludwig DS, 2018, JAMA INTERN MED, V178, P1098, DOI 10.1001/jamainternmed.2018.2933
   Lutsey PL, 2015, JACC-HEART FAIL, V3, P347, DOI 10.1016/j.jchf.2014.11.013
   d'Almeida KSM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010058
   Macready AL, 2014, AM J CLIN NUTR, V99, P479, DOI 10.3945/ajcn.113.074237
   Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]
   Marketou ME, 2019, J CLIN HYPERTENS, V21, P749, DOI 10.1111/jch.13535
   Martín-Peláez S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082236
   Martínez-González MA, 2015, PROG CARDIOVASC DIS, V58, P50, DOI 10.1016/j.pcad.2015.04.003
   Mayer-Davis EJ, 2017, NEW ENGL J MED, V377, P301, DOI 10.1056/NEJMc1706291
   Menotti A, 1999, EUR J EPIDEMIOL, V15, P507, DOI 10.1023/A:1007529206050
   Michos ED, 2021, J AM COLL CARDIOL, V77, P437, DOI 10.1016/j.jacc.2020.09.617
   Miller CA, 2014, AM J CLIN NUTR, V100, P778, DOI 10.3945/ajcn.114.087692
   Miller V, 2017, LANCET, V390, P2037, DOI [10.1016/S0140-6736(17)32253-5, 10.1016/s0140-6736(17)32253-5]
   Mutungi G, 2008, J NUTR, V138, P272, DOI 10.1093/jn/138.2.272
   Nani A, 2021, MOLECULES, V26, DOI 10.3390/molecules26040985
   Neale RE, 2022, LANCET DIABETES ENDO, V10, P120, DOI 10.1016/S2213-8587(21)00345-4
   Neufeld L. M., 2023, Science and Innovations for Food Systems Transformation, P21, DOI [DOI 10.1007/978-3-031-15703-53, 10.1007/978-3-031-15703-53]
   Nguyen HT, 2012, J AM COLL NUTR, V31, P401, DOI 10.1080/07315724.2012.10720466
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Oellgaard J, 2017, CURR PHARM DESIGN, V23, P3699, DOI 10.2174/1381612823666170622095324
   Onyszkiewicz M, 2020, EXP BIOL MED, V245, P166, DOI 10.1177/1535370219900898
   Parto P, 2017, CURR PROB CARDIOLOGY, V42, P376, DOI [10.1016/j.cpcardio1.2017.04.004, 10.1016/j.cpcardiol.2017.04.004]
   Pearson H, 2006, NATURE, V443, P261, DOI 10.1038/443261a
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854
   Rechner AR, 2002, FREE RADICAL RES, V36, P1127, DOI 10.1080/1071576021000006707
   Reid IR, 2011, OSTEOPOROSIS INT, V22, P1649, DOI 10.1007/s00198-011-1599-9
   RICHARD JL, 1987, ARCH MAL COEUR VAISS, V80, P17
   Rizzo M, 2023, PHARMACOL RES, V189, DOI 10.1016/j.phrs.2023.106679
   Robinson JG, 2006, AM J CARDIOL, V98, p39I, DOI 10.1016/j.amjcard.2005.12.026
   Robinson-Cohen C, 2013, JAMA-J AM MED ASSOC, V310, P179, DOI 10.1001/jama.2013.7228
   Ros E, 2006, BRIT J NUTR, V96, pS29, DOI 10.1017/BJN20061861
   Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/S0140-6736(18)32203-7
   Sabaté J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79
   Sabouret PF, 2023, ARCH MED SCI, V19, P1901, DOI 10.5114/aoms/173511
   Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510
   Salas-Salvadó J, 2008, EUR J CLIN NUTR, V62, P651, DOI 10.1038/sj.ejcn.1602762
   Santos-Parker JR, 2014, ADV PHYSIOL EDUC, V38, P296, DOI 10.1152/advan.00088.2014
   Satija A, 2018, TRENDS CARDIOVAS MED, V28, P437, DOI 10.1016/j.tcm.2018.02.004
   Seidelmann SB, 2018, LANCET PUBLIC HEALTH, V3, pE419, DOI 10.1016/S2468-2667(18)30135-X
   Sievenpiper JL, 2020, NUTR REV, V78, P69, DOI 10.1093/nutrit/nuz082
   Sikand G, 2021, AM J PREVENT CARDIOL, V6, DOI 10.1016/j.ajpc.2021.100174
   Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285
   Soliman GA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051155
   Stevens LM, 2021, CIRC-HEART FAIL, V14, DOI 10.1161/CIRCHEARTFAILURE.119.006799
   Stewart LK, 2007, MED SCI SPORT EXER, V39, P1714, DOI 10.1249/mss.0b013e31811ece1c
   Swift DL, 2018, PROG CARDIOVASC DIS, V61, P206, DOI 10.1016/j.pcad.2018.07.014
   Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008
   Thompson B, 2023, BMJ-BRIT MED J, V381, DOI 10.1136/bmj-2023-075230
   Threapleton DE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6879
   Tice JA
   Tognon G, 2014, BRIT J NUTR, V111, P151, DOI 10.1017/S0007114513001931
   Tognon G, 2012, J NUTR, V142, P1547, DOI 10.3945/jn.112.160499
   Tong TYN, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0677-4
   Turnbull D, 2017, REGUL TOXICOL PHARM, V89, P165, DOI 10.1016/j.yrtph.2017.07.025
   van Dam RM, 2020, NEW ENGL J MED, V383, P369, DOI 10.1056/NEJMra1816604
   Visseren FLJ, 2021, EUR HEART J, V42, P3227, DOI 10.1093/eurheartj/ehab484
   Voskoboinik A, 2019, TRENDS CARDIOVAS MED, V29, P345, DOI 10.1016/j.tcm.2018.09.019
   Voskoboinik A, 2018, JACC-CLIN ELECTROPHY, V4, P425, DOI 10.1016/j.jacep.2018.01.012
   Watanabe Y, 2020, J ATHEROSCLER THROMB, V27, P183, DOI 10.5551/jat.50658
   Whelton SP, 2005, J HYPERTENS, V23, P475, DOI 10.1097/01.hjh.0000160199.51158.cf
   WHO, 2003, WHO TECH REP SER, V916, P1
   WRIGHT RS, 1990, P SOC EXP BIOL MED, V195, P26, DOI 10.3181/00379727-195-43113
   Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283
   Xiao YJ, 2018, CLIN NUTR, V37, P831, DOI 10.1016/j.clnu.2017.04.011
   Yang C, 2020, J AM COLL NUTR, V39, P352, DOI 10.1080/07315724.2019.1649219
   Zuo Xuezhi, 2014, BMC Res Notes, V7, P120, DOI 10.1186/1756-0500-7-120
NR 141
TC 2
Z9 2
U1 2
U2 2
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA KLEEBERGA 2, POZNAN, 61-615, POLAND
SN 1734-1922
EI 1896-9151
J9 ARCH MED SCI
JI Arch. Med. Sci.
PY 2024
VL 20
IS 5
BP 1385
EP 1399
DI 10.5114/aoms/187841
PG 15
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA N7A4W
UT WOS:001365820600001
PM 39649275
OA gold
DA 2025-04-28
ER

PT J
AU Yang, CS
   Wang, H
   Sheridan, ZP
AF Yang, Chung Shu
   Wang, Hong
   Sheridan, Zachary Paul
TI Studies on prevention of obesity, metabolic syndrome, diabetes,
   cardiovascular diseases and cancer by tea
SO JOURNAL OF FOOD AND DRUG ANALYSIS
LA English
DT Review
DE Cancer; Diabetes; Metabolic syndrome; Obesity; Polyphenols
ID ACTIVATED PROTEIN-KINASE; GREEN TEA; EPIGALLOCATECHIN GALLATE; COFFEE
   CONSUMPTION; INSULIN-RESISTANCE; POLYPHENON-E; ENERGY-EXPENDITURE;
   PROSPECTIVE COHORT; LIPID-METABOLISM; CONTROLLED-TRIAL
AB Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been studied extensively in recent decades for its beneficial health effects in the prevention of obesity, metabolic syndrome, diabetes, cancer, and other diseases. Whereas these beneficial effects have been convincingly demonstrated in most laboratory studies, results from human studies have not been consistent. Some studies demonstrated that weight reduction, alleviation of metabolic syndrome and risk reduction in diabetes were only observed in individuals who consume 3-4 cups of tea (600-900 mg tea catechins) or more daily. This chapter reviews some of these studies, the possible mechanisms of actions of tea constituents, and the challenges in extrapolating laboratory studies to human situations. Copyright (C) 2017, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
C1 [Yang, Chung Shu; Wang, Hong; Sheridan, Zachary Paul] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, 164 Frelinghuysen Rd, Piscataway, NJ 08854 USA.
C3 Rutgers University System; Rutgers University New Brunswick
RP Yang, CS (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, 164 Frelinghuysen Rd, Piscataway, NJ 08854 USA.
EM csyang@pharmacy.rutgers.edu
FU NIH [CA120915, CA122474, CA133021]
FX This work was supported by NIH grants CA120915, CA122474, and CA133021.
   We thank Ms. Vi P. Dan for her assistance in the preparation of this
   manuscript.
CR Aggio A, 2013, EUR J NUTR, V52, P263, DOI 10.1007/s00394-012-0320-x
   Akiyama S, 2009, BIOSCI BIOTECH BIOCH, V73, P2779, DOI 10.1271/bbb.90576
   Arnaud MJ, HDB EXPT PHARM, V200
   Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005
   Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Byun JK, 2014, IMMUNOL LETT, V157, P51, DOI 10.1016/j.imlet.2013.11.006
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808
   Chen HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051001
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Chow HHS, 2011, PHARMACOL RES, V64, P105, DOI 10.1016/j.phrs.2011.05.007
   Chow HHS, 2003, CLIN CANCER RES, V9, P3312
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Crew KD, 2012, CANCER PREV RES, V5, P1144, DOI 10.1158/1940-6207.CAPR-12-0117
   Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009
   Di Castelnuovo A, 2012, EUR J INTERN MED, V23, P15, DOI 10.1016/j.ejim.2011.07.014
   Dostal AM, 2016, J NUTR, V146, P38, DOI 10.3945/jn.115.222414
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Everard A, 2014, MBIO, V5, DOI 10.1128/mBio.01011-14
   Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   Friedrich M, 2012, INT J OBESITY, V36, P735, DOI 10.1038/ijo.2011.136
   Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939
   GAO YT, 1994, JNCI-J NATL CANCER I, V86, P855, DOI 10.1093/jnci/86.11.855
   Grassi D., 2016, Nutrients, P8
   Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hartley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009934.pub2
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480
   Huang YQ, 2016, NUTRITION, V32, P3, DOI 10.1016/j.nut.2015.05.021
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   James KD, 2015, FOOD CHEM TOXICOL, V76, P103, DOI 10.1016/j.fct.2014.12.009
   Janssens PLHR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153134
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741
   Jensen GS, 2016, CLIN INTERV AGING, V11, P367, DOI 10.2147/CIA.S94881
   Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x
   Jochmann N, 2008, BRIT J NUTR, V99, P863, DOI 10.1017/S0007114507838992
   Joe AK, 2015, CANCER PREV RES, V8, P1131, DOI 10.1158/1940-6207.CAPR-14-0274-T
   Ju J, 2007, SEMIN CANCER BIOL, V17, P395, DOI 10.1016/j.semcancer.2007.06.013
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Kumar NB, 2015, CANCER PREV RES, V8, P879, DOI 10.1158/1940-6207.CAPR-14-0324
   Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255
   Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030
   Lee LS, 2015, MOL NUTR FOOD RES, V59, P784, DOI 10.1002/mnfr.201400470
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837
   Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039
   Li GW, 2015, J HYPERTENS, V33, P243, DOI 10.1097/HJH.0000000000000426
   Li M, 2016, CANCER EPIDEMIOL, V40, P73, DOI 10.1016/j.canep.2015.11.013
   Li X, 2017, HEART, V103, P783, DOI 10.1136/heartjnl-2016-310462
   Li YC, 2016, DIABETES-METAB RES, V32, P2, DOI 10.1002/dmrr.2641
   Li YR, 2009, J NUTR BIOCHEM, V20, P1021, DOI 10.1016/j.jnutbio.2008.12.001
   Liang WB, 2009, STROKE, V40, P2480, DOI 10.1161/STROKEAHA.109.548586
   Liu JX, 2016, EUR J EPIDEMIOL, V31, P853, DOI 10.1007/s10654-016-0173-3
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200
   Lu YP, 2011, CANCER PREV RES, V4, P1118, DOI 10.1158/1940-6207.CAPR-11-0116
   Makiuchi T, 2016, CANCER SCI, V107, P76, DOI 10.1111/cas.12843
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Miller PE, 2017, AM J MED, V130, P188, DOI 10.1016/j.amjmed.2016.08.038
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Most J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17896
   Muenzner M, 2016, INT J OBESITY, V40, P1850, DOI 10.1038/ijo.2016.172
   Mukamal KJ, 2006, J AM COLL NUTR, V25, P472, DOI 10.1080/07315724.2006.10719561
   Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7
   Munir KM, 2013, AM J PHYSIOL-ENDOC M, V305, pE679, DOI 10.1152/ajpendo.00377.2013
   Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021
   Ng HLH, 2017, J NUTR BIOCHEM, V40, P23, DOI 10.1016/j.jnutbio.2016.10.005
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Ogunleye AA, 2010, BREAST CANCER RES TR, V119, P477, DOI 10.1007/s10549-009-0415-0
   Okuda MH, 2014, J NUTR BIOCHEM, V25, P1084, DOI 10.1016/j.jnutbio.2014.05.012
   Ortsäter H, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-11
   Pae MY, 2012, J NUTR BIOCHEM, V23, P526, DOI 10.1016/j.jnutbio.2011.02.006
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Pullikotil P, 2012, J NUTR BIOCHEM, V23, P1134, DOI 10.1016/j.jnutbio.2011.06.007
   Qin BL, 2010, MOL NUTR FOOD RES, V54, pS14, DOI 10.1002/mnfr.200900306
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Sasazuki S, 2012, JPN J CLIN ONCOL, V42, P335, DOI 10.1093/jjco/hys009
   Schönthal AH, 2011, MOL NUTR FOOD RES, V55, P874, DOI 10.1002/mnfr.201000644
   Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386
   Serrano JCE, 2013, MOL NUTR FOOD RES, V57, P459, DOI 10.1002/mnfr.201200513
   Sesso HD, 2003, AM J CLIN NUTR, V77, P1400, DOI 10.1093/ajcn/77.6.1400
   Shen GX, 2005, PHARM RES-DORDR, V22, P1805, DOI 10.1007/s11095-005-7546-8
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Shin CM., 2017, Clin Nutr
   Song YQ, 2005, J AM COLL NUTR, V24, P376, DOI 10.1080/07315724.2005.10719488
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427
   Tian C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24353
   Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014
   van der Pijl PC, 2010, J FUNCT FOODS, V2, P239, DOI 10.1016/j.jff.2010.08.001
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Vuong QV, 2011, J SCI FOOD AGR, V91, P1931, DOI 10.1002/jsfa.4373
   Wang DX, 2015, TOXICOL APPL PHARM, V283, P65, DOI 10.1016/j.taap.2014.12.018
   Wang J, 2012, CANCER EPIDEMIOL, V36, pE354, DOI 10.1016/j.canep.2012.08.004
   Wang L, 2016, FOOD FUNCT, V7, P4956, DOI [10.1039/c6fo01150k, 10.1039/C6FO01150K]
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI [10.1039/c4fo00095a, 10.1039/C4FO00095A]
   Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717
   Yang CS, 2011, PHARMACOL RES, V64, P113, DOI 10.1016/j.phrs.2011.03.001
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234
   Yang CS, 2016, MOLECULES, P21
   Yarmolinsky J, 2015, NUTR REV, V73, P236, DOI 10.1093/nutrit/nuv001
   Yuan JM, 2011, PHARMACOL RES, V64, P123, DOI 10.1016/j.phrs.2011.03.002
   Zhao LG, 2017, J EPIDEMIOL, V27, P36, DOI 10.1016/j.je.2016.08.004
   Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087008
   Zhou Q, 2016, ARCH GYNECOL OBSTET, V293, P143, DOI 10.1007/s00404-015-3811-1
NR 124
TC 98
Z9 108
U1 1
U2 74
PU DIGITAL COMMONS BEPRESS
PI BERKELEY
PA 2100 MILVIA ST, STE 300, BERKELEY, CA 94704 USA
SN 1021-9498
J9 J FOOD DRUG ANAL
JI J. Food Drug Anal.
PD JAN
PY 2018
VL 26
IS 1
BP 1
EP 13
DI 10.1016/j.jfda.2017.10.010
PG 13
WC Food Science & Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Pharmacology & Pharmacy
GA GD1FN
UT WOS:000430245600001
PM 29389543
OA hybrid, Green Published
DA 2025-04-28
ER

PT J
AU Brigas, D
AF Brigas, Diana
TI Gastro-oesophageal Reflux Disease in an Obese Patient
SO CLINICAL DRUG INVESTIGATION
LA English
DT Article
AB A 45-year-old woman, with a body mass index of 41.8 kg/m(2) and a medical history of anxiety-depression syndrome, had iatrogenic hypothyroidism and degenerative osteoarticular pathology of the spinal column and complained of a burning sensation behind the sternum associated with ail acidic taste in her mouth. Symptoms had appeared 3 months previously and were especially prevalent when lying down, following large meals or after drinking coffee. The patient had started to experience symptoms on most days approximately 1 month earlier. Upper digestive endoscopy (UDE) revealed isolated erosions of the distal third of the oesophagus, compatible with a diagnosis of erosive reflux oesophagitis. Lifestyle changes were recommended and 8 weeks' treatment with pantoprazole 40 mg/day taken 15-30 Minutes before breakfast was prescribed. Follow-up UDE showed resolution of oesophageal lesions with no pathological changes of the mucosa. Mild regurgitation and pyrosis persisted; therefore the patient continued to receive pantoprazole 40 mg for a further 3 weeks.
C1 [Brigas, Diana] Ctr Saude Oliveira do Douro, Vila Nova De Gaia, Portugal.
RP Brigas, D (corresponding author), Rua Navegadores 145, P-4415040 Perosinho, Portugal.
EM dianabrigasmgf@hotmail.com
NR 0
TC 1
Z9 1
U1 0
U2 2
PU ADIS INT LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW
   ZEALAND
SN 1173-2563
J9 CLIN DRUG INVEST
JI Clin. Drug Invest.
PY 2009
VL 29
BP 17
EP 18
DI 10.2165/1153123-S0-000000000-00000
PG 2
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 534UB
UT WOS:000272921700004
PM 19938882
DA 2025-04-28
ER

PT J
AU Pang, J
   Choi, Y
   Park, T
AF Pang, Jisook
   Choi, Youngshim
   Park, Taesun
TI Ilex paraguariensis extract ameliorates obesity induced by
   high-fat diet:: Potential role of AMPK in the visceral adipose tissue
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Ilex paraguariensis; high-fat diet; anti-obesity effect; AMPK; ACC;
   UCP2; UCP3; epididymal adipose tissue; rat
ID GREEN TEA; BODY-WEIGHT; CAFFEINE; EXPRESSION; CHOLESTEROL; GENE; ACID;
   THERMOGENESIS; GAMMA; RATS
AB The aim of present study was to investigate the anti-obesity effect of Ilex paraguariensis extract and its molecular mechanism in rats rendered obese by a high-fat diet (HFD). T paraguariensis extract supplementation significantly lowered body weight, visceral fat-pad weights, blood and hepatic lipid, glucose, insulin, and leptin levels of rats administered HFD. Feeding I. paraguariensis extract reversed the HFD-induced downregulation of the epididymal adipose tissue genes implicated in adipogenesis or thermogenesis, such as peroxisome proliferators' activated receptor gamma 2, adipocyte fatty acid binding protein, sterol-regulatory-element-binding protein-1c, fatty acid synthase, HMG-CoA reductase, uncoupling protein 2, and uncoupling protein 3. Dietary supplementation with I. paraguariensis extract protected rats from the HFD-induced decreases in the phospho-AMP-activated protein kinase (AMPK)/AMPK and phospho-acetylCoA carboxylase (ACC)/ACC protein ratio related to fatty acid oxidation in the edipidymal adipose tissue. The present study reports that the I. paraguariensis extract can have a protective effect against a HFD-induced obesity in rats through an enhanced expression of uncoupling proteins and elevated AMPK phosphorylation in the visceral adipose tissue. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Pang, Jisook; Choi, Youngshim; Park, Taesun] Yonsei Univ, Dept Food & Nutr, Brain Korea Project 21, Seoul 120749, South Korea.
C3 Yonsei University
RP Park, T (corresponding author), Yonsei Univ, Dept Food & Nutr, Brain Korea Project 21, 134 Shinchon Dong, Seoul 120749, South Korea.
EM tspark@yonsei.ac.kr
OI Park, Taesun/0000-0002-9752-9407
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   BABA N, 1982, AM J CLIN NUTR, V35, P678, DOI 10.1093/ajcn/35.4.678
   Bixby M, 2005, LIFE SCI, V77, P345, DOI 10.1016/j.lfs.2004.11.030
   Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   Diraison F, 2002, AM J PHYSIOL-ENDOC M, V282, pE46, DOI 10.1152/ajpendo.2002.282.1.E46
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Emilsson V, 2000, METABOLISM, V49, P1610, DOI 10.1053/meta.2000.18692
   Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5
   Ferreira F, 1997, PHYTOTHER RES, V11, P79, DOI 10.1002/(SICI)1099-1573(199702)11:1<79::AID-PTR34>3.3.CO;2-I
   Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Han UK, 2002, J NUTR, V132, P2241, DOI 10.1093/jn/132.8.2241
   HETZLER RK, 1990, J APPL PHYSIOL, V68, P44, DOI 10.1152/jappl.1990.68.1.44
   HOSTTETMANN K, 1995, SAPONINS
   Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920
   Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Kraemer KH, 1996, PHYTOCHEMISTRY, V42, P1119, DOI 10.1016/0031-9422(96)00036-2
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Matsuda J, 1998, DIABETES, V47, P1809, DOI 10.2337/diabetes.47.11.1809
   Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106
   Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371
   OAKENFULL DG, 1984, NUTR REP INT, V29, P1039
   Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x
   Pomilio AB, 2002, PHYTOCHEM ANALYSIS, V13, P235, DOI 10.1002/pca.647
   Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004
   Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715
   Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055
   Stein FLP, 2005, BIOL RES NURS, V7, P146, DOI 10.1177/1099800405280521
   Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061
   Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045
   Tripathy D, 2003, DIABETES, V52, P2882, DOI 10.2337/diabetes.52.12.2882
   Unger RH, 2004, CELL, V117, P145, DOI 10.1016/S0092-8674(04)00339-3
   VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740
   Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081
   World Health Organisation, 2002, WORLD HLTH REPORT 20
   Zheng GD, 2004, IN VIVO, V18, P55
NR 40
TC 116
Z9 121
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2008
VL 476
IS 2
BP 178
EP 185
DI 10.1016/j.abb.2008.02.019
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 337GW
UT WOS:000258424500012
PM 18314006
DA 2025-04-28
ER

PT J
AU Feng, XY
   Qin, YC
   Ma, SC
   Ming, SJ
   Weng, ZH
   Xuan, YQ
   Gong, SY
   Fan, FY
   Chen, P
   Chu, Q
   Li, ZX
AF Feng, Xinyu
   Qin, Yuechao
   Ma, Shicheng
   Ming, Shengjin
   Weng, Zhihang
   Xuan, Yuqi
   Gong, Shuying
   Fan, Fangyuan
   Chen, Ping
   Chu, Qiang
   Li, Zhongxia
TI Liubao tea extract restrains obesity-related hyperlipidemia via
   regulation of AMPK/p38/NF-κB pathway and intestinal microbiota
SO FOOD CHEMISTRY
LA English
DT Article
DE Liubao tea; Obesity; Hyperlipidemia; Intestinal microbiota
ID METABOLISM; OXIDATION; CAFFEINE; LIVER; MICE
AB Liubao tea, a traditional dark tea, has gained widespread recognition for various health benefits. In this study, the effects of Liubao tea extract (LTE) on obesity-related hyperlipidemia and the potential mechanism involved were explored. Anti-obesity compounds such as tricetin, isovitexin, tiliroside, etc. in LTE were identified. In high-fat diet mouse models, LTE effectively reduced tissues, organs, and body weight growth, and restored abnormal serum lipid levels. LTE could reverse adipocyte enlargement, lipid accumulation, and hepatic microstructure abnormalities. Notably, LTE reshaped gut microbiota by boosting beneficial bacteria (e.g., Bacteroides, Akkermansia, Psychrobacter) and suppressing harmful bacteria (e.g., Dubosiella, Faecalibaculum). Spearman correlation analysis unveiled significant associations between serum lipid levels, weight gain, LTE dosage, and gut microbiota, underlining the modulatory effects of LTE on metabolic disorders via the regulation of intestinal microbiota. Collectively, LTE could serve as a potential therapy for obesity-related hyperlipidemia prevention.
C1 [Feng, Xinyu; Qin, Yuechao; Ming, Shengjin; Li, Zhongxia] Guangxi Med Univ, Wuzhou Gongren Hosp, Affiliated Hosp 7, Wuzhou, Peoples R China.
   [Feng, Xinyu; Weng, Zhihang; Gong, Shuying; Fan, Fangyuan; Chen, Ping; Chu, Qiang] Zhejiang Univ, Tea Res Inst, Hangzhou, Peoples R China.
   [Ma, Shicheng] Wuzhou Liubao Tea Res Assoc, Wuzhou, Peoples R China.
   [Xuan, Yuqi] Cangwu Cty Liuwang Forestry Ind Dev Co Ltd, Wuzhou, Peoples R China.
C3 Guangxi Medical University; Zhejiang University
RP Li, ZX (corresponding author), Guangxi Med Univ, Wuzhou Gongren Hosp, Affiliated Hosp 7, Wuzhou, Peoples R China.; Chu, Q (corresponding author), Zhejiang Univ, Tea Res Inst, Hangzhou, Peoples R China.
EM 0619363@zju.edu.cn
RI Li, Zhongxia/JNS-8893-2023; Chu, Qiang/HZJ-2044-2023
FU Special Subsidy Funds Program of the Central Government guide for local
   science and technology of Wuzhou Province [202301003]; Wuzhou Science
   and Technology Program [202202126]; Small Highland Construction of
   Scientific Talent Program for Guangxi Liubao tea industry [85]; China
   Association for Science and Technology Youth talent lifting project
   [YESS20230294]
FX This study was financially supported by the Special Subsidy Funds
   Program of the Central Government guide for local science and technology
   of Wuzhou Province (202301003) ; Wuzhou Science and Technology Program
   (202202126) ; Small Highland Construction of Scientific Talent Program
   for Guangxi Liubao tea industry (Gui Group Tongzi [2019] No. 85) ; China
   Association for Science and Technology Youth talent lifting project (NO.
   YESS20230294) .Thanks to Jingli Cheng for the help with instrument
   analysis.
CR Anachad Oumaima, 2023, Microbiol Insights, V16, p11786361231162720, DOI 10.1177/11786361231162720
   Anhê FF, 2016, GUT MICROBES, V7, P146, DOI 10.1080/19490976.2016.1142036
   Aziz CBA, 2014, N AM J MED SCI, V6, P377, DOI 10.4103/1947-2714.139286
   Azizishafa M, 2023, FOOD QUAL SAF-OXFORD, V7, DOI 10.1093/fqsafe/fyad028
   Boccellino M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165642
   Chaoyin Chen, 2011, Proceedings of the 2011 International Symposium on Information Technology in Medicine and Education (ITME 2011), P696, DOI 10.1109/ITiME.2011.6132095
   Chen L, 2023, FOOD FUNCT, V14, P2870, DOI [10.1039/d2fo02524h, 10.1039/D2FO02524H]
   Cheng LZ, 2021, LWT-FOOD SCI TECHNOL, V150, DOI 10.1016/j.lwt.2021.111875
   Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003
   Nitert MD, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00605
   Chu DT, 2018, DIAB MET SYND CLIN R, V12, P1095, DOI 10.1016/j.dsx.2018.05.004
   Duarte L, 2021, REV ENDOCR METAB DIS, V22, P367, DOI 10.1007/s11154-020-09622-0
   Ells L. J., 2018, Diet, genes, and obesity, V360
   Feng XY, 2023, COMPR REV FOOD SCI F, V22, P5063, DOI 10.1111/1541-4337.13254
   Gauffin Cano P., 2012, Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity
   Geng JF, 2022, BIOMED PHARMACOTHER, V147, DOI 10.1016/j.biopha.2022.112678
   Gong X, 2020, TRENDS FOOD SCI TECH, V103, P304, DOI 10.1016/j.tifs.2020.07.026
   Goto T, 2012, J NUTR BIOCHEM, V23, P768, DOI 10.1016/j.jnutbio.2011.04.001
   Guo M, 2019, FOOD FUNCT, V10, P6873, DOI 10.1039/c9fo00296k
   Hou DZ, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103687
   Hu S, 2021, FOOD RES INT, V147, DOI 10.1016/j.foodres.2021.110472
   Huang YY, 2023, FOOD RES INT, V174, DOI 10.1016/j.foodres.2023.113615
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033
   Khedr NF, 2020, ENDOCRINE, V67, P109, DOI 10.1007/s12020-019-02127-0
   Kim JH, 2020, MOLECULES, V25, DOI 10.3390/molecules25081920
   Lavie CJ, 2018, LANCET DIABETES ENDO, V6, P678, DOI 10.1016/S2213-8587(18)30143-8
   Lee H, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.858192
   Liang W, 2014, LAB INVEST, V94, P491, DOI 10.1038/labinvest.2014.11
   Liu XM, 2023, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.1065263
   Long JL, 2024, INT J BIOL MACROMOL, V272, DOI 10.1016/j.ijbiomac.2024.132860
   Malnick S., 2022, GastroHep, V2022
   Mohanty SK, 2012, J BACTERIOL, V194, P3872, DOI 10.1128/JB.00597-12
   Nagarthna P., 2020, J Adv Sci Res, V11, P1
   Nie QX, 2022, FOOD CHEM, V371, DOI 10.1016/j.foodchem.2021.131106
   Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309
   Prakash S, 2020, BIOCHIMIE, V168, P198, DOI 10.1016/j.biochi.2019.11.005
   Qiao SS, 2022, NAT METAB, V4, P1271, DOI 10.1038/s42255-022-00649-y
   Qiu XX, 2021, INT J OBESITY, V45, P143, DOI 10.1038/s41366-020-00712-2
   Ran HY, 2023, PROTEOMICS, V23, DOI 10.1002/pmic.202300043
   Repas Thomas, 2011, S D Med, V64, P241
   Roshanravan N, 2023, ARCH PHYSIOL BIOCHEM, V129, P741, DOI 10.1080/13813455.2021.1871760
   Ruscica M, 2022, CARDIOVASC RES, V118, P3288, DOI 10.1093/cvr/cvac020
   Scorletti E, 2022, J HEPATOL, V76, P934, DOI 10.1016/j.jhep.2021.11.009
   Seo YG, 2021, J OBES METAB SYNDR, V30, P12, DOI 10.7570/jomes20059
   Takeuchi T, 2023, NATURE, V621, P389, DOI 10.1038/s41586-023-06466-x
   Tang Y, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.1062323
   Tsiklauri L, 2018, OSTEOARTHR CARTILAGE, V26, P1225, DOI 10.1016/j.joca.2018.06.001
   Wang J, 2020, FOOD NUTR RES, V64, DOI 10.29219/fnr.v64.3672
   Waritu N. C., 2024, HIV AIDS-Research and Palliative Care, V17
   Wen JJ, 2023, FOOD CHEM, V404, DOI 10.1016/j.foodchem.2022.134591
   Wen X, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01149-x
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wu WL, 2021, RSC ADV, V11, P23791, DOI 10.1039/d1ra04438a
   Wu Y, 2021, J FOOD SCI, V86, P215, DOI 10.1111/1750-3841.15551
   Wu ZM, 2023, PHYTOMEDICINE, V110, DOI 10.1016/j.phymed.2022.154633
   Xu W, 2023, FOOD CHEM X, V19, DOI 10.1016/j.fochx.2023.100863
   Xu Y, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00219
   Yan C, 2023, J HAZARD MATER, V459, DOI 10.1016/j.jhazmat.2023.132057
   Yang SY, 2024, PHYTOMEDICINE, V132, DOI 10.1016/j.phymed.2024.155834
   Yao Y, 2022, CRIT REV FOOD SCI, V62, P1, DOI 10.1080/10408398.2020.1854675
   Ye J, 2021, FOOD RES INT, V144, DOI 10.1016/j.foodres.2021.110360
   Yoshida N, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103342
   Yu H, 2024, LUMINESCENCE, V39, DOI 10.1002/bio.4765
   Zeng HL, 2023, CARBOHYD POLYM, V314, DOI 10.1016/j.carbpol.2023.120939
   Zeng Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49462-w
   Zhang HX, 2024, NUTRIENTS, V16, DOI 10.3390/nu16111579
   Zhang Q, 2022, CURR RES FOOD SCI, V5, P775, DOI 10.1016/j.crfs.2022.04.009
   Zhou S, 2023, FOOD FUNCT, V14, P7400, DOI [10.1039/d3fo02277c, 10.1039/D3FO02277C]
   Zhou S, 2023, FOOD BIOSCI, V53, DOI 10.1016/j.fbio.2023.102750
   Zhou S, 2022, FOOD BIOSCI, V50, DOI 10.1016/j.fbio.2022.102172
   Zong X, 2023, J ADV RES, V52, P203, DOI 10.1016/j.jare.2023.08.003
NR 72
TC 1
Z9 1
U1 45
U2 45
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD FEB 1
PY 2025
VL 464
AR 141910
DI 10.1016/j.foodchem.2024.141910
EA NOV 2024
PN 3
PG 12
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA M1X1P
UT WOS:001355529100001
PM 39522375
DA 2025-04-28
ER

PT J
AU El Sebaei, M
   El-Bahr, SM
   Al-Nazawi, M
   Abdel-Raheem, S
AF El Sebaei, Mahmoud
   El-Bahr, Sabry Mohamed
   Al-Nazawi, Mohamed
   Abdel-Raheem, Sherief
TI Effects of Green Tea on Adipose Gene Expression, Hepatic Antioxidants
   and Lipid Profile in Obese Male Rats
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Green tea; catechins; polyphenols; adipose genes; malondialdehyde;
   obesity
ID CATECHINS; EXTRACT; LIVER
AB Background and Objective: Role of green tea constituents in enhancing adipose Mesoderm Specific Transcript (MEST) expression of obese rats has not investigated yet. Evaluation of their effects on lipid profile, MEST expression and oxidative biomarkers were main objective of the current study. Materials and Methods: About 60 rats used in the current experiment (32 weeks) and divided into two unequal groups. Rats of the first group (n = 10) was negative control and fed basal diet (C). Rats of the second group (n = 50) was positive control, fed high fat diet and divided into five equal treatments (T1, T2, T3, T4 and T5). Rats of T1 were positive control and fed high fat diet. Rats of T2-T5 fed high fat diet mixed with green tea, Epigallocatechin gallate (EGCG), polyphenol 60 and EGCG+caffeine, respectively. Results: High fat diet elevated total cholesterol (TC), triacylglycerol (TAG), low-density lipoprotein cholesterol (LDL-C), malondialdehyde (MDA) and MEST gene expression and reduced high-density lipoprotein cholesterol (HDL-C), glutathione (GSH), catalase (CAT) and glutathione-s-transferase (GST). Green tea or its constituents particularly EGCG restored the changed values towards the negative control. Conclusion:These results concluded that EGCG might be potential therapy against obesity over whole herb or other studied constituents.
C1 [El Sebaei, Mahmoud; El-Bahr, Sabry Mohamed; Al-Nazawi, Mohamed] King Faisal Univ, Coll Vet Med, Dept Physiol Biochem & Pharmacol, POB 400, Al Hasa 31982, Saudi Arabia.
   [El Sebaei, Mahmoud] Mansoura Univ, Fac Vet Med, Dept Biochem & Chem Nutr, Mansoura 35516, Egypt.
   [El-Bahr, Sabry Mohamed] Alexandria Univ, Fac Vet Med, Dept Biochem, Alexandria, Egypt.
   [Abdel-Raheem, Sherief] King Faisal Univ, Coll Vet Med, Dept Vet Publ Hlth & Anim Husb, Al Hasa 31982, Saudi Arabia.
   [Abdel-Raheem, Sherief] Assiut Univ, Fac Vet Med, Dept Anim Nutr & Clin Nutr, Assiut 71526, Egypt.
C3 King Faisal University; Egyptian Knowledge Bank (EKB); Mansoura
   University; Egyptian Knowledge Bank (EKB); Alexandria University; King
   Faisal University; Egyptian Knowledge Bank (EKB); Assiut University
RP El-Bahr, SM (corresponding author), King Faisal Univ, Coll Vet Med, Dept Physiol Biochem & Pharmacol, POB 400, Al Hasa 31982, Saudi Arabia.
RI El-Bahr, Sabry/D-6380-2015; Abdel-Raheem, Sherief/G-3424-2016; G. El
   Sebaei, Mahmoud/G-3552-2017
OI G. El Sebaei, Mahmoud/0000-0002-2807-8710
FU Deanship of Scientific Research, King Faisal University, Saudi Arabia
   [186026]
FX The authors thank Deanship of Scientific Research, King Faisal
   University, Saudi Arabia for financial support (Grant#186026).
CR Afrin S, 2016, J AGR FOOD CHEM, V64, P4435, DOI 10.1021/acs.jafc.6b00857
   Anunciado-Koza RP, 2016, BIOCHIMIE, V124, P134, DOI 10.1016/j.biochi.2015.05.007
   Bakr ESH, 2014, INT J PURE APPL SCI, V21, P53
   Bártíková H, 2015, ACTA PHARMACEUT, V65, P65, DOI 10.1515/acph-2015-0007
   Bhardwaj P, 2013, CHIN J NAT MEDICINES, V11, P345, DOI 10.1016/S1875-5364(13)60051-5
   Bhurosy Trishnee, 2014, ScientificWorldJournal, V2014, P964236, DOI 10.1155/2014/964236
   BRENT JA, 1993, J TOXICOL-CLIN TOXIC, V31, P173, DOI 10.3109/15563659309000384
   Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chen L, 2014, J SCI FOOD AGR, V94, P180, DOI 10.1002/jsfa.6216
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   Friedrich M, 2012, INT J OBESITY, V36, P735, DOI 10.1038/ijo.2011.136
   Gad S. B., 2013, Global Veterinaria, V11, P191
   Huang JB, 2015, J ANIM PHYSIOL AN N, V99, P719, DOI 10.1111/jpn.12276
   Jura M, 2016, BIOCHIMIE, V124, P124, DOI 10.1016/j.biochi.2015.05.006
   Khan Nazish Iqbal, 2006, Pak J Pharm Sci, V19, P62
   Kim SJ, 2007, J NUTR BIOCHEM, V18, P587, DOI 10.1016/j.jnutbio.2006.11.001
   Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004
   Lu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038332
   Murakami A, 2014, ARCH BIOCHEM BIOPHYS, V557, P3, DOI 10.1016/j.abb.2014.04.018
   Pang J, 2016, INT J CARDIOL, V202, P967, DOI 10.1016/j.ijcard.2014.12.176
   Park JP, 2011, BIOTECHNOL BIOPROC E, V16, P1065, DOI 10.1007/s12257-011-0215-3
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8
   Satoh E, 2005, INT J FOOD SCI NUTR, V56, P551, DOI 10.1080/09637480500398835
   Shishikura Y, 2005, J SCI FOOD AGR, V85, P2125, DOI 10.1002/jsfa.2206
   Snoussi C, 2014, J NUTR BIOCHEM, V25, P557, DOI 10.1016/j.jnutbio.2014.01.006
   SPSS, 2010, STAT WIND REL IBM VE
   Stoner L, 2014, AUSTRALAS MED J, V7, P462, DOI 10.4066/AMJ.2014.2281
   Suzuki T, 2016, MOLECULES, V21, DOI 10.3390/molecules21101305
   Szulinska M, 2017, FOOD NUTR RES, V61, DOI [10.1080/16546628.2017.1295525, 10.1080/16546628.2017]
   Voigt A, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0477-z
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu LY, 2004, J AGR FOOD CHEM, V52, P643, DOI 10.1021/jf030365d
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
NR 35
TC 1
Z9 1
U1 1
U2 6
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PY 2019
VL 15
IS 5
BP 542
EP 548
DI 10.3923/ijp.2019.542.548
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA IM1FB
UT WOS:000477732900003
OA Bronze
DA 2025-04-28
ER

PT J
AU Aragonès, G
   Ardid-Ruiz, A
   Ibars, M
   Suárez, M
   Bladé, C
AF Aragones, Gerard
   Ardid-Ruiz, Andrea
   Ibars, Maria
   Suarez, Manuel
   Blade, Cinta
TI Modulation of leptin resistance by food compounds
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Review
DE Agouti-related peptide; Megalin; Proopiomelanocortin; Protein tyrosine
   phosphatase 1B
ID HIGH-FAT-DIET; ENDOPLASMIC-RETICULUM STRESS; PHOSPHATASE 1B PTP1B;
   BETA/NF-KAPPA-B; INSULIN-RESISTANCE; LIPID-METABOLISM; GENE-EXPRESSION;
   WEIGHT-GAIN; SIGNAL-TRANSDUCTION; INHIBITORY-ACTIVITY
AB Leptin is mainly secreted by white adipose tissue and regulates energy homeostasis by inhibiting food intake and stimulating energy expenditure through its action in neuronal circuits in the brain, particularly in the hypothalamus. However, hyperleptinemia coexists with the loss of responsiveness to leptin in common obese conditions. This phenomenon has been defined as leptin resistance and the restoration of leptin sensitivity is considered to be a useful strategy to treat obesity. This review summarizes the existing literature on potentially valuable nutrients and food components to reverse leptin resistance. Notably, several food compounds, such as teasaponins, resveratrol, celastrol, caffeine, and taurine among others, are able to restore the leptin signaling in neurons by overexpressing anorexigenic peptides (proopiomelanocortin) and/or repressing orexigenic peptides (neuropeptide Y/agouti-related peptide), thus decreasing food intake. Additionally, some nutrients, such as vitamins A and D, can improve leptin transport through the blood-brain barrier. Therefore, food components can improve leptin resistance by acting at different levels of the leptin pathway; moreover, some compounds are able to target more than one feature of leptin resistance. However, systematic studies are necessary to define the actual effectiveness of each compound.
C1 [Aragones, Gerard; Ardid-Ruiz, Andrea; Ibars, Maria; Suarez, Manuel; Blade, Cinta] Univ Rovira & Virgili, Dept Biochem & Biotechnol, Nutrigen Res Grp, Tarragona, Spain.
C3 Universitat Rovira i Virgili
RP Bladé, C (corresponding author), Univ Rovira & Virgili, Dept Biochem & Biotechnol, Nutrigen Res Grp, Tarragona, Spain.
EM mariacinta.blade@urv.cat
RI Serra, Maria/O-7451-2019; Aragonès, Gerard/AAJ-9150-2021; Aragones,
   Gerard/F-9673-2016; Suarez Recio, Manuel/F-5039-2016
OI Aragones, Gerard/0000-0001-8657-5726; Ardid-Ruiz,
   Andrea/0000-0003-2786-0847; Suarez Recio, Manuel/0000-0003-0122-8253;
   Ibars, Maria/0000-0003-1208-390X
FU Spanish Government [AGL2013-40707-R]
FX This work was supported by grant number AGL2013-40707-R from the Spanish
   Government.
CR Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0
   Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200
   Andreassen KV, 2014, AM J PHYSIOL-ENDOC M, V307, pE24, DOI 10.1152/ajpendo.00121.2014
   Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3
   Belury MA, 2003, J NUTR, V133, p257S, DOI 10.1093/jn/133.1.257S
   Benzler J, 2015, DIABETES, V64, P2015, DOI 10.2337/db14-0093
   Bjorbæk C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059
   Bjorbæk C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305
   Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009
   Boado RJ, 1998, J NEUROCHEM, V71, P1761
   Boonloh K, 2015, NUTRIENTS, V7, P6313, DOI 10.3390/nu7085292
   Bornstein SR, 1998, J CLIN ENDOCR METAB, V83, P280, DOI 10.1210/jc.83.1.280
   Byun K, 2014, EMBO REP, V15, P801, DOI 10.15252/embr.201338317
   Cabezas F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016794
   Çakir I, 2013, J BIOL CHEM, V288, P17675, DOI 10.1074/jbc.M113.475343
   Camargo RL, 2015, AMINO ACIDS, V47, P2419, DOI 10.1007/s00726-015-2035-9
   Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X
   Choi HN, 2014, NUTR RES PRACT, V8, P544, DOI 10.4162/nrp.2014.8.5.544
   Clarke SD, 2001, J NUTR, V131, P1129, DOI 10.1093/jn/131.4.1129
   Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757
   Crujeiras A.B., 2015, Life Sci
   de Git KCG, 2015, OBES REV, V16, P207, DOI 10.1111/obr.12243
   Dhillon SS, 2011, ENDOCRINOLOGY, V152, P4138, DOI 10.1210/en.2011-0178
   Dietrich MO, 2008, NEUROBIOL AGING, V29, P902, DOI 10.1016/j.neurobiolaging.2007.01.008
   Domínguez-Avila JA, 2015, FOOD CHEM, V168, P529, DOI 10.1016/j.foodchem.2014.07.092
   Eo H, 2015, J AGR FOOD CHEM, V63, P349, DOI 10.1021/jf502830b
   Erranz B, 2004, J LIPID RES, V45, P2185, DOI 10.1194/jlr.M400235-JLR200
   EscobarMorreale HF, 1997, ENDOCRINOLOGY, V138, P4485, DOI 10.1210/en.138.10.4485
   Fang LL, 2014, J FUNCT FOODS, V9, P264, DOI 10.1016/j.jff.2014.04.017
   Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204
   Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y
   Franco JG, 2016, EUR J NUTR, V55, P601, DOI 10.1007/s00394-015-0880-7
   Häkansson ML, 1998, NEUROENDOCRINOLOGY, V68, P420, DOI 10.1159/000054392
   Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775
   Hoek-van den Hil EF, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0469-z
   Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070
   Hosoi T, 2015, J NEUROCHEM, V133, P343, DOI 10.1111/jnc.13057
   Hosoi T, 2014, NEUROSCI LETT, V569, P23, DOI 10.1016/j.neulet.2014.03.053
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Indra Mochamad Rasjad, 2013, BMC Res Notes, V6, P275, DOI 10.1186/1756-0500-6-275
   Jia S, 2015, FOOD FUNCT, V6, P878, DOI 10.1039/c4fo00993b
   Jiang CS, 2012, ACTA PHARMACOL SIN, V33, P1217, DOI 10.1038/aps.2012.90
   Kim KW, 2011, MOL CELL ENDOCRINOL, V336, P219, DOI 10.1016/j.mce.2010.11.019
   Kim SJ, 2010, ARCH PHARM RES, V33, P775, DOI 10.1007/s12272-010-0518-5
   Kim SW, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.10
   Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392
   Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000
   Kowalska K, 2015, FOOD CHEM, V185, P383, DOI 10.1016/j.foodchem.2015.03.152
   Liang YC, 2001, FEBS LETT, V496, P12, DOI 10.1016/S0014-5793(01)02393-6
   Lima ND, 2014, LIFE SCI, V115, P29, DOI 10.1016/j.lfs.2014.09.003
   Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011
   Liu W, 1998, EUR J CLIN INVEST, V28, P100
   Lynn RB, 1996, BIOCHEM BIOPH RES CO, V219, P884, DOI 10.1006/bbrc.1996.0328
   Maeda A, 2014, MOL NUTR FOOD RES, V58, P1177, DOI 10.1002/mnfr.201300675
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142
   Meli R, 2004, ENDOCRINOLOGY, V145, P3115, DOI 10.1210/en.2004-0129
   Luvizotto RDM, 2013, BRIT J NUTR, V110, P1803, DOI 10.1017/S0007114513001256
   Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009
   Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a
   Mnafgui K, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/620384
   Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071
   Muradian K, 2015, NUTR METAB CARDIOVAS, V25, P891, DOI 10.1016/j.numecd.2015.05.010
   Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002
   Myoung HJ, 2010, ARCH PHARM RES, V33, P1741, DOI 10.1007/s12272-010-1105-5
   Noratto G, 2015, J NUTR BIOCHEM, V26, P633, DOI 10.1016/j.jnutbio.2014.12.014
   Oh-I S, 2005, CELL METAB, V1, P331, DOI 10.1016/j.cmet.2005.04.004
   Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004
   Palou M, 2015, MOL NUTR FOOD RES, V59, P2022, DOI 10.1002/mnfr.201500292
   Pan HT, 2014, PHYSIOL BEHAV, V130, P157, DOI 10.1016/j.physbeh.2014.04.003
   Panariello F, 2012, J OBES, V2012, DOI 10.1155/2012/572848
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Park CH, 2015, ARCH PHARM RES, V38, P1270, DOI 10.1007/s12272-014-0457-7
   Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004
   Park Hyeong-Kyu, 2014, F1000Prime Rep, V6, P73, DOI 10.12703/P6-73
   Park YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109344
   Piper ML, 2008, MOL ENDOCRINOL, V22, P751, DOI 10.1210/me.2007-0389
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822
   Rao PS, 2012, BIOINFORMATION, V8, P834, DOI 10.6026/97320630008834
   Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9
   Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172
   SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0
   Saravanan G, 2014, J SCI FOOD AGR, V94, P2972, DOI 10.1002/jsfa.6642
   Saravanan S, 2015, EUR J PHARMACOL, V761, P279, DOI 10.1016/j.ejphar.2015.05.034
   Sasaki T, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00109
   Sasaki T, 2014, DIABETOLOGIA, V57, P819, DOI 10.1007/s00125-013-3140-5
   Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589
   Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025
   Suhitha S, 2012, BIOINFORMATION, V8, P1125, DOI 10.6026/97320630081125
   Susanti VY, 2014, OBESITY, V22, P2115, DOI 10.1002/oby.20838
   Takahashi N, 2011, MOL NUTR FOOD RES, V55, P1791, DOI 10.1002/mnfr.201100401
   Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002
   Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551
   Tang YC, 2009, ENDOCRINOLOGY, V150, P3011, DOI 10.1210/en.2008-1601
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Quang TH, 2015, MOLECULES, V20, P11173, DOI 10.3390/molecules200611173
   Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190
   Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279
   van der Stelt I, 2015, J FUNCT FOODS, V14, P702, DOI 10.1016/j.jff.2015.02.040
   Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546
   Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293
   Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679
   Whang WK, 2005, EXP MOL MED, V37, P436, DOI 10.1038/emm.2005.54
   White CL, 2009, AM J PHYSIOL-ENDOC M, V296, pE291, DOI 10.1152/ajpendo.90513.2008
   Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194
   Wu YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092618
   Xiong Y, 2010, DIABETES, V59, P2505, DOI 10.2337/db10-0315
   Xu Y, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2011.06248.x
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
   Yu YH, 2013, ENDOCRINOLOGY, V154, P3130, DOI 10.1210/en.2013-1218
   Yuan XW, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.27373
   Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X
   Zhang J, 2010, FOOD CHEM, V119, P1491, DOI 10.1016/j.foodchem.2009.09.031
   Zhang Q, 2015, MOL MED REP, V11, P603, DOI 10.3892/mmr.2014.2708
   Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885
   Zulet MA, 2014, PHYTOMEDICINE, V21, P1162, DOI 10.1016/j.phymed.2014.04.027
NR 119
TC 49
Z9 52
U1 0
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD AUG
PY 2016
VL 60
IS 8
SI SI
BP 1789
EP 1803
DI 10.1002/mnfr.201500964
PG 15
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA DV5JV
UT WOS:000382964200004
PM 26842874
DA 2025-04-28
ER

PT J
AU Ríos-Hoyo, A
   Gutiérrez-Salmeán, G
AF Rios-Hoyo, Alejandro
   Gutierrez-Salmean, Gabriela
TI New Dietary Supplements for Obesity: What We Currently Know
SO CURRENT OBESITY REPORTS
LA English
DT Article
DE Dietary supplements; Obesity; Weight loss
ID AURANTIUM BITTER ORANGE; BODY-WEIGHT REDUCTION; OAT BETA-GLUCAN;
   CITRUS-AURANTIUM; BLOOD-PRESSURE; DOUBLE-BLIND; RASPBERRY KETONE;
   HOODIA-GORDONII; SYNEPHRINE ALKALOIDS; HYDROXYCITRIC ACID
AB Obesity and its associated cardiometabolic alterations currently are considered an epidemic; thus, their treatment is of major importance. The cornerstone for such treatment involves therapeutic lifestyle changes; however, the vast majority of cases fail and/or significant weight loss is maintained only in the short term because of lack of compliance. The popularity of dietary supplements for weight management has increased, and a wide variety of these products are available over the counter. However, the existing scientific evidence is insufficient to recommend their safe use. Hence, the purpose of this article is to review the clinical effects, proposed mechanism of action, and safety profile of some of the new dietary supplements, including white bean extract, Garcinia cambogia, bitter orange, Hoodia gordonii, forskolin, green coffee, glucomannan, beta-glucans, chitosan, guar gum, and raspberry ketones.
C1 [Rios-Hoyo, Alejandro; Gutierrez-Salmean, Gabriela] Univ Anahuac Mexico Norte, Fac Ciencias Salud, Ave Univ Anahuac 46, Huixquilucan 52786, Estado De Mexic, Mexico.
C3 Universidad Anahuac
RP Gutiérrez-Salmeán, G (corresponding author), Univ Anahuac Mexico Norte, Fac Ciencias Salud, Ave Univ Anahuac 46, Huixquilucan 52786, Estado De Mexic, Mexico.
EM gabrielasalmean@yahoo.com
RI Ríos-Hoyo, Alejandro/KIC-5708-2024
OI Rios-Hoyo, Alejandro/0000-0001-5344-9168
CR Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x
   Allison DB, 2005, INT J OBESITY, V29, P443, DOI 10.1038/sj.ijo.0802879
   Alonso-Sande M, 2009, EUR J PHARM BIOPHARM, V72, P453, DOI 10.1016/j.ejpb.2008.02.005
   [Anonymous], 2006, BMC COMPLEM ALTERN M, DOI [DOI 10.1186/1472-6882-6-9, 10.1186/1472-6882-6-9]
   Arogba S. S., 2014, Nigerian Food Journal, V32, P62, DOI 10.1016/S0189-7241(15)30097-7
   Astell KJ, 2013, COMPLEMENT THER MED, V21, P407, DOI 10.1016/j.ctim.2013.05.007
   Bent S, 2004, AM J CARDIOL, V94, P1359, DOI 10.1016/j.amjcard.2004.07.137
   Beppu F, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-112
   Blom WAM, 2011, AM J CLIN NUTR, V94, P1171, DOI 10.3945/ajcn.111.020321
   Bradley J., 2015, NUTR BUS J
   Bredsdorff L, 2015, REGUL TOXICOL PHARM, V73, P196, DOI 10.1016/j.yrtph.2015.06.022
   Celleno Leonardo, 2007, Int J Med Sci, V4, P45
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Cloetens L, 2012, NUTR REV, V70, P444, DOI 10.1111/j.1753-4887.2012.00494.x
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   D'Orazio N, 2012, MAR DRUGS, V10, P604, DOI 10.3390/md10030604
   Dall'Alba V, 2013, BRIT J NUTR, V110, P1601, DOI 10.1017/S0007114513001025
   Dave V, 1997, J ENVIRON POLYM DEGR, V5, P237
   Davy BM, 2002, J NUTR, V132, P394, DOI 10.1093/jn/132.3.394
   de Lira-García Cynthia, 2008, Rev. salud pública, V10, P818
   El Khoury D, 2012, J NUTR METAB, V2012, DOI [10.1155/2012/703490, 10.1155/2012/851362]
   Ernst E, 1998, PERFUSION, V11, P461
   Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003
   Flanagan J, 2014, PHYTOTHER RES, V28, P946, DOI 10.1002/ptr.5085
   Food and Drug Administration, 2015, WHAT IS DIET SUPPL
   Fugh-Berman A, 2004, EXP BIOL MED, V229, P698, DOI 10.1177/153537020422900802
   Gammone MA, 2015, MAR DRUGS, V13, P2196, DOI 10.3390/md13042196
   Geller AI, 2015, NEW ENGL J MED, V373, P1531, DOI 10.1056/NEJMsa1504267
   Godard MP, 2005, OBES RES, V13, P1335, DOI 10.1038/oby.2005.162
   Guerciolini R, 2001, OBES RES, V9, P364, DOI 10.1038/oby.2001.47
   Haaz S, 2006, OBES REV, V7, P79, DOI 10.1111/j.1467-789X.2006.00195.x
   Henderson Shonteh, 2005, J Int Soc Sports Nutr, V2, P54, DOI 10.1186/1550-2783-2-2-54
   Heymsfield SB, 1998, JAMA-J AM MED ASSOC, V280, P1596, DOI 10.1001/jama.280.18.1596
   Hu XJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P59, DOI 10.1016/j.abb.2012.01.011
   Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883
   Kaats GR, 2013, FOOD CHEM TOXICOL, V55, P358, DOI 10.1016/j.fct.2013.01.013
   Kabir M, 2002, METABOLISM, V51, P819, DOI 10.1053/meta.2002.33345
   Kalman DS, 2000, CURR THER RES CLIN E, V61, P199, DOI 10.1016/S0011-393X(00)89034-7
   Kang SI, 2011, BIOCHEM BIOPH RES CO, V409, P769, DOI 10.1016/j.bbrc.2011.05.086
   Kavitha C, 2010, J MED PLANTS RES, V4, P278
   Keithley J, 2005, ALTERN THER HEALTH M, V11, P30
   Keithley JK, 2013, J OBES, V2013, DOI 10.1155/2013/610908
   Kim GS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-31
   Kim H, 2006, CEREAL FOOD WORLD, V51, P29, DOI 10.1094/CFW-51-0029
   Kim KY, 2008, BIOSCI BIOTECH BIOCH, V72, P1772, DOI 10.1271/bbb.80072
   Kim YJ, 2013, WORLD J GASTROENTERO, V19, P4689, DOI 10.3748/wjg.v19.i29.4689
   Le Nevé B, 2010, AM J PHYSIOL-GASTR L, V299, pG1368, DOI 10.1152/ajpgi.00135.2010
   Lobb A, 2009, WORLD J GASTROENTERO, V15, P1786, DOI 10.3748/wjg.15.1786
   Lyly M, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.2149
   Lyly M, 2009, EUR J NUTR, V48, P251, DOI 10.1007/s00394-009-0009-y
   MacLean DB, 2004, BRAIN RES, V1020, P1, DOI 10.1016/j.brainres.2004.04.041
   Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002
   Maki KC, 2007, EUR J CLIN NUTR, V61, P786, DOI 10.1038/sj.ejcn.1602562
   Márquez F, 2012, CRIT REV FOOD SCI, V52, P585, DOI 10.1080/10408398.2010.500551
   Mattes RD, 2007, PHYSIOL BEHAV, V90, P705, DOI 10.1016/j.physbeh.2006.12.009
   Mhurchu CN, 2004, INT J OBESITY, V28, P1149, DOI 10.1038/sj.ijo.0802693
   Morimoto C, 2005, LIFE SCI, V77, P194, DOI 10.1016/j.lfs.2004.12.029
   Mudgil D, 2014, J FOOD SCI TECH MYS, V51, P409, DOI 10.1007/s13197-011-0522-x
   Mullin GE, 2015, NUTR CLIN PRACT, V30, P311, DOI 10.1177/0884533615572655
   Ngondi Judith L, 2005, Lipids Health Dis, V4, P12, DOI 10.1186/1476-511X-4-12
   Oben JE, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-12
   Oben JE, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-44
   Onakpoya I, 2014, J AM COLL NUTR, V33, P70, DOI 10.1080/07315724.2014.870013
   Onakpoya Igho, 2013, Journal of Dietary Supplements, V10, P29, DOI 10.3109/19390211.2012.760508
   Onakpoya I, 2011, BRIT J NUTR, V106, P196, DOI 10.1017/S0007114511001516
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/382852
   Park KS, 2015, PHARM BIOL, V53, P870, DOI 10.3109/13880209.2014.946059
   Park KS, 2010, PLANTA MED, V76, P1654, DOI 10.1055/s-0030-1249860
   Pasman WJ, 1997, INT J OBESITY, V21, P548, DOI 10.1038/sj.ijo.0800439
   Peng J, 2011, MAR DRUGS, V9, P1806, DOI 10.3390/md9101806
   Pereira A, 2009, ARQ BRAS CARDIOL, V93, P253, DOI 10.1590/S0066-782X2009000900009
   Peters HPF, 2009, AM J CLIN NUTR, V89, P58, DOI 10.3945/ajcn.2008.26701
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Pittler MH, 2001, AM J MED, V110, P724, DOI 10.1016/S0002-9343(01)00702-1
   Queenan KM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-6
   Ribeiro SMR, 2008, FOOD CHEM, V110, P620, DOI 10.1016/j.foodchem.2008.02.067
   Russell PJ, 2012, FOOD CHEM TOXICOL, V50, pS6, DOI 10.1016/j.fct.2011.02.020
   Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731
   Schiller R.N., 2001, J AM NUTRACEUT ASS, V4, P42
   Semwal RB, 2015, FITOTERAPIA, V102, P134, DOI 10.1016/j.fitote.2015.02.012
   Smith C, 2014, J ETHNOPHARMACOL, V155, P987, DOI 10.1016/j.jep.2014.06.033
   Sood N, 2008, AM J CLIN NUTR, V88, P1167, DOI 10.1093/ajcn/88.4.1167
   Stohs SJ, 2011, PHYTOTHER RES, V25, P1421, DOI 10.1002/ptr.3490
   Stohs SJ, 2011, INT J MED SCI, V8, P295, DOI 10.7150/ijms.8.295
   Stohs SJ, 2010, J FUNCT FOODS, V2, P235, DOI 10.1016/j.jff.2010.10.003
   Synytsya A, 2009, CARBOHYD POLYM, V76, P548, DOI 10.1016/j.carbpol.2008.11.021
   Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231
   van Bennekum AM, 2005, BRIT J NUTR, V94, P331, DOI 10.1079/BJN20051498
   van Heerden FR, 2008, J ETHNOPHARMACOL, V119, P434, DOI 10.1016/j.jep.2008.08.023
   Vinson J.A., 2009, The Open Nutraceuticals Journal, V2, P88, DOI [10.2174/1876396000902010088, DOI 10.2174/1876396000902010088]
   Willis HJ, 2009, NUTR RES, V29, P100, DOI 10.1016/j.nutres.2009.01.004
   Wu M, 2011, P NATL ACAD SCI USA, V108, P5378, DOI 10.1073/pnas.1002588108
   Yamoneka J, 2015, LWT-FOOD SCI TECHNOL, V64, P989, DOI 10.1016/j.lwt.2015.06.035
NR 94
TC 81
Z9 85
U1 3
U2 99
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2162-4968
J9 CURR OBES REP
JI Curr. Obes. Rep.
PD JUN
PY 2016
VL 5
IS 2
BP 262
EP 270
DI 10.1007/s13679-016-0214-y
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA EB0ST
UT WOS:000387056600012
PM 27053066
DA 2025-04-28
ER

PT J
AU Zaklos-Szyda, M
   Pawlik, N
   Polka, D
   Nowak, A
   Koziolkiewicz, M
   Podsedek, A
AF Zaklos-Szyda, Malgorzata
   Pawlik, Nina
   Polka, Dominika
   Nowak, Adriana
   Koziolkiewicz, Maria
   Podsedek, Anna
TI Viburnum opulus Fruit Phenolic Compounds as Cytoprotective Agents
   Able to Decrease Free Fatty Acids and Glucose Uptake by Caco-2 Cells
SO ANTIOXIDANTS
LA English
DT Article
DE Viburnum opulus; phenolic compounds; free fatty acids uptake; glucose
   uptake; cytoprotection
ID INDUCED OXIDATIVE STRESS; CHLOROGENIC ACID; POLYPHENOLS; ABSORPTION;
   TRANSPORT; EXTRACT; PROTEIN; GREEN; GLUT2; CD36
AB In recent years, there has been increasing interest in studying food-originated phytocompounds with beneficial influences for humans. Amongst the most active natural substances are polyphenols, for which high content has been identified in the Viburnum opulus berry, and which are unused in Western Europe. Due to its strong antioxidant activity we explored the potential of V. opulus as a preventive agent against diet-related chronic diseases, such as obesity and type 2 diabetes. Among the causes of these ailments is oxidative stress, as well as impaired glucose and free fatty acids (FFA) uptake. Thus, the purpose of this study was to determine biological activity of V. opulus phenolic extracts as cytoprotective agents able to decrease induced oxidative stress, lower lipid accumulation and attenuate glucose and FFA uptake by Caco-2 cells via GLUT2 and CD36/FAT transporters. To determine the source of the most biologically active phenolic compounds, we obtained four phenolic compounds extracts as crude juice, phenolics isolated from juice and two preparations of phenolics obtained with different extraction agents from fruit pomace. Among the studied extracts, the phenolic rich fraction obtained from fruit juice revealed the strongest activity to decrease uptake of glucose, FFA and accumulation of lipid droplets in Caco-2 cells without affecting their viability (IC0 50 mu g/mL). Observed uptake attenuation was followed by decrease of the CD36/FAT gene expression, without influence on the GLUT2 and PPAR alpha levels. We suspect that V. opulus phenolics were able to modulate the cellular membrane dynamic, although that hypothesis requires further, more detailed studies. Extracts revealed strong chemo-preventive activity against oxidative stress induced chemically by tert-butylhydroperoxide (t-BOOH), as well as against DNA damage through the induction of DNA repair after cell exposition to methylnitronitrosoguanidine (MNNG) and H2O2. Our findings suggest Viburnum opulus fruit as a dietary source of phytocompounds, which could be considered as a tailored design food supplement components for the prevention and treatment of postprandial elevation of glucose and fatty acids through delaying the rate of glucose and fatty acid absorption by intestinal cells.
C1 [Zaklos-Szyda, Malgorzata; Pawlik, Nina; Polka, Dominika; Koziolkiewicz, Maria; Podsedek, Anna] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Tech Biochem, Stefanowskiego 4-10, PL-90924 Lodz, Poland.
   [Nowak, Adriana] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Fermentat Technol & Microbiol, Wolczanska 171-173, PL-90924 Lodz, Poland.
C3 Lodz University of Technology; Lodz University of Technology
RP Zaklos-Szyda, M (corresponding author), Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Tech Biochem, Stefanowskiego 4-10, PL-90924 Lodz, Poland.
EM malgorzata.zaklos-szyda@p.lodz.pl
RI Podsędek, Anna/M-4197-2018; Pietrzyk, Nina/AAD-5480-2019; Kajszczak,
   Dominika/KQU-5772-2024; NOWAK, ADRIANA/M-2927-2018; Zaklos-Szyda,
   Malgorzata/M-5229-2019
OI Kajszczak, Dominika/0000-0002-3122-0685; NOWAK,
   ADRIANA/0000-0002-1865-4833; Zaklos-Szyda,
   Malgorzata/0000-0001-8341-1654; Pietrzyk, Nina/0000-0002-3279-0612
FU National Science Centre, Poland [2016/23/B/NZ9/03629]
FX This research was supported by grant nr 2016/23/B/NZ9/03629 from The
   National Science Centre, Poland.
CR Amararathna M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081352
   [Anonymous], 2015, CURR TOP MED CHEM
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Budryn G, 2017, EUR FOOD RES TECHNOL, V243, P1323, DOI 10.1007/s00217-017-2843-0
   Ceylan D, 2018, J CANCER RES THER, V14, P314, DOI 10.4103/0973-1482.181173
   Cheah KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098921
   Cifarelli V, 2018, COMPR PHYSIOL, V8, P493, DOI 10.1002/cphy.c170026
   Cory H, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00087
   De C., 2013, BBA-BIOMEMBRANES, V1828, P357
   Dhuriya YK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1235-0
   Drahota Z, 2010, BIOCHEM BIOPH RES CO, V391, P1348, DOI 10.1016/j.bbrc.2009.12.050
   Ekbatan SS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030723
   Eken A, 2017, KAFKAS UNIV VET FAK, V23, P437, DOI 10.9775/kvfd.2016.16964
   Fam TK, 2018, MATERIALS, V11, DOI 10.3390/ma11091768
   Faria A, 2009, MOL NUTR FOOD RES, V53, P1430, DOI 10.1002/mnfr.200900007
   Farrell TL, 2013, BIOFACTORS, V39, P448, DOI 10.1002/biof.1090
   Glatz JFC, 2017, BIOCHIMIE, V136, P21, DOI 10.1016/j.biochi.2016.12.007
   Gonçalves P, 2013, EUR J PHARMACOL, V699, P88, DOI 10.1016/j.ejphar.2012.11.029
   Gorlach S, 2011, NUTR CANCER, V63, P1348, DOI 10.1080/01635581.2011.608480
   Goszcz K, 2017, BRIT J PHARMACOL, V174, P1209, DOI 10.1111/bph.13708
   Hajiaghaalipour F, 2015, INT J BIOL SCI, V11, P508, DOI 10.7150/ijbs.11241
   Hemmersbach S, 2013, J AGR FOOD CHEM, V61, P7932, DOI 10.1021/jf402019f
   Hogan AM, 2016, INT J SPECTROSC, DOI 10.1155/2016/5215086
   Hresko RC, 2016, J BIOL CHEM, V291, P17271, DOI 10.1074/jbc.M116.730168
   Karaçelik AA, 2015, FOOD CHEM, V175, P106, DOI 10.1016/j.foodchem.2014.11.085
   Kozlowska W, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00295
   Kraujalyte V, 2013, FOOD CHEM, V141, P3695, DOI 10.1016/j.foodchem.2013.06.054
   Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com
   Kzlay O.N., 2019, TURK J UROL, DOI [10.5152/tud.2019.23463, DOI 10.5152/TUD.2019.23463]
   Liang NJ, 2019, MOL CELL BIOCHEM, V457, P105, DOI 10.1007/s11010-019-03516-9
   Liang NJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123873
   Lin WP, 2014, TUMOR BIOL, V35, P8065, DOI 10.1007/s13277-014-2064-0
   Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019
   Margina D, 2013, FOOD CHEM TOXICOL, V61, P86, DOI 10.1016/j.fct.2013.02.046
   Mihaylova D., 2018, The Open Biotechnology Journal, V12, P219, DOI DOI 10.2174/1874070701812010219
   Moldovan B, 2012, MOLECULES, V17, P11655, DOI 10.3390/molecules171011655
   Nowak A, 2017, J AGR FOOD CHEM, V65, P2947, DOI 10.1021/acs.jafc.6b05387
   Pandey MK, 2017, SEMIN CANCER BIOL, V46, P158, DOI 10.1016/j.semcancer.2017.07.002
   Peng BJ, 2015, BIOMED ENVIRON SCI, V28, P894, DOI 10.3967/bes2015.123
   Peng SG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8594767
   Perona JS, 2017, BBA-BIOMEMBRANES, V1859, P1690, DOI 10.1016/j.bbamem.2017.04.015
   Perova IB, 2014, PHARM CHEM J+, V48, P332, DOI 10.1007/s11094-014-1105-8
   Phan HTT, 2014, BBA-BIOMEMBRANES, V1838, P2670, DOI 10.1016/j.bbamem.2014.07.001
   Podsedek A, 2014, J AGR FOOD CHEM, V62, P4610, DOI 10.1021/jf5008264
   Pruchnik H, 2014, J THERM ANAL CALORIM, V118, P943, DOI 10.1007/s10973-014-3841-0
   Rodríguez-Ramiro I, 2011, J NUTR BIOCHEM, V22, P1186, DOI 10.1016/j.jnutbio.2010.10.005
   Rohm B, 2015, FOOD FUNCT, V6, P173, DOI 10.1039/c4fo00435c
   Schneider H, 2014, ARCH BIOCHEM BIOPHYS, V546, P8, DOI 10.1016/j.abb.2014.01.025
   Schreck K, 2018, MOLECULES, V23, DOI 10.3390/molecules23102544
   Stremmel W, 2017, BBA-MOL CELL BIOL L, V1862, P917, DOI 10.1016/j.bbalip.2017.05.013
   Tsuchiya H, 2015, MOLECULES, V20, P18923, DOI 10.3390/molecules201018923
   Velioglu YS, 2006, INT J FOOD SCI TECH, V41, P1011, DOI [10.1111/j.1365-2621.2006.01142.x, 10.1111/j.1365-2621.2005.01142.x]
   Wang JS, 2016, MOL MED REP, V14, P4063, DOI 10.3892/mmr.2016.5743
   Zaklos-Szyda M, 2018, ACTA BIOCHIM POL, V65, P67, DOI 10.18388/abp.2017_1604
   Zhang DD, 2018, GENE, V659, P155, DOI 10.1016/j.gene.2018.03.060
   Zou TB, 2014, NUTRIENTS, V6, P4165, DOI 10.3390/nu6104165
NR 56
TC 55
Z9 59
U1 5
U2 26
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD AUG
PY 2019
VL 8
IS 8
AR 262
DI 10.3390/antiox8080262
PG 25
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA IT6CX
UT WOS:000482958900055
PM 31374918
OA Green Submitted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Ramirez, G
   Zamilpa, A
   Zavala, M
   Perez, J
   Morales, D
   Tortoriello, J
AF Ramirez, Guillermo
   Zamilpa, Alejandro
   Zavala, Miguel
   Perez, Julia
   Morales, Dulce
   Tortoriello, Jaime
TI Chrysoeriol and other polyphenols from Tecoma stuns with lipase
   inhibitory activity
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Tecoma stuns; Diabetes; Obesity; Chrysoeriol; Luteolin; Verbascoside;
   Chlorogenic acid
ID PLANTS; ETHNOBOTANY; EXTRACT; FAT
AB Ethnopharmacological relevance: Tecoma stans is traditionally used by several ethnical groups in Mexico and Central America to treat diabetes. This species is mentioned in the majority of the ethnopharmacological studies compiled in Mexico focused in medicinal plants used as anti-diabetic treatment. Aim of the study: Recently, this plant was found to display a high level of pancreatic lipase inhibitory activity, in addition to the several action mechanisms already described. Here we show the phytochemical and in vitro pharmacological characterization of some of the compounds responsible for the antilipase activity.
   Materials and methods: Starting with a hydroalcoholic extract, fractions were obtained by liquid-liquid separation and successive processes of column chromatography purifications. Lipase inhibitory activity was measured employing a spectrophotometric analysis. For structural elucidation H-1 and C-13 NMR experiments were used. HPLC was used to quantify and confirm the identity of the bioactive compounds.
   Results: Bio-guided chemical purification of the hydroalcoholic extract produced an organic fraction (ethyl acetate, TsEA), flavone fractions (TsC1F13), (TsC1F15), (TsC1F16) and isolated compounds (chrysoeriol, apigenin, luteolin, and verbascoside) with the capability to inhibit the activity of pancreatic lipase. The most active fraction (TsC2F6B) was constituted by a mixture of Chrysoeriol (5,7-dihydroxy-2-[4-hydroxy-3-methoxyphenyl]chromen-4-one, 96%) and Apigenin (4%). This flavone mixture displayed a percentage of inhibition of 85% when it was eavaluated at 0.25 mg/mL. Luteolin and chrysoeriol produced a noncompetitive and mixed inhibition with values of IC50 = 63 and 158 mu M respectively. The content of chrysoeriol was also quantified in the hydroalcoholic extract (TsHAE) and organic fraction (TsEA) as 1% and 7% respectively. All of this confirms that high proportion of both flavones produce an increase of the biological activity due to they show the highest inhibition of lipase enzyme in a concentration dependant way.
   Conclusions: These results evidence that the medicinal use of T. stans could be in part because of its lipase inhibitory activity allowing to adapt the administration of this plant before meals. Also this data could help to develop a novel phytopharmaceutical drug (standardized in luteolin, chrysoeriol, and apigenin) auxiliary for the Type 2 Diabetes mellitus. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Ramirez, Guillermo; Zamilpa, Alejandro; Morales, Dulce; Tortoriello, Jaime] IMSS, Ctr Invest Biomed Sur, Argentina 1, Xochitepec 62790, Morelos, Mexico.
   [Zavala, Miguel; Perez, Julia] UAM Xochimilco, Dept Syst Biol, Calzada Hueso 1100, Mexico City 04960, DF, Mexico.
C3 Universidad Autonoma Metropolitana - Mexico; University Autonoma
   Metropolitana Xochimilco
RP Zamilpa, A (corresponding author), Mexican Inst Social Secur, Southern Biomed Res, Argentina 1, Xochitepec 62790, Morelos, Mexico.
EM azamilpa_2000@yahoo.com.mx
RI zavala, miguel angel/AAO-6851-2020; Zamilpa, Alejandro/AAC-2241-2019;
   Ramirez, Guillermo/I-5429-2013
OI TORTORIELLO, JAIME/0000-0002-1597-7645; Morales,
   Dulce/0000-0001-8095-7694
CR Abdel-Mageed WM, 2012, FITOTERAPIA, V83, P500, DOI 10.1016/j.fitote.2011.12.025
   Aguilar-Santamaría L, 2009, J ETHNOPHARMACOL, V124, P284, DOI 10.1016/j.jep.2009.04.033
   Al-Azzawi A. M., 2012, Canadian Journal of Pure & Applied Sciences, V6, P1809
   Alarcon-Aguilara FJ, 1998, J ETHNOPHARMACOL, V61, P101, DOI 10.1016/S0378-8741(98)00020-8
   Andrade-Cetto A, 2005, J ETHNOPHARMACOL, V99, P325, DOI 10.1016/j.jep.2005.04.019
   Andrade-Cetto A, 2006, J ETHNOPHARMACOL, V107, P199, DOI 10.1016/j.jep.2006.03.005
   ANDRADECETTO A, 1995, THESIS UNAM MEXICO, P93
   [Anonymous], REV COLOMB CIENC QUI
   [Anonymous], ATLAS PLANTAS MED TR
   BIANCO A, 1981, PHYTOCHEMISTRY, V20, P1871, DOI 10.1016/0031-9422(81)84024-1
   Cruz EC, 2015, J ETHNOPHARMACOL, V159, P238, DOI 10.1016/j.jep.2014.11.021
   Cheng N, 2014, CHINESE CHEM LETT, V25, P1094, DOI 10.1016/j.cclet.2014.05.021
   Choi JS, 2014, FOOD CHEM TOXICOL, V64, P27, DOI 10.1016/j.fct.2013.11.020
   Choi SJ, 2003, J BIOCHEM MOL BIOL, V36, P417
   Costantino Luca, 2003, Farmaco, V58, P781
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   De la Paz J., 2003, REV CUB MED MILITAR, V32, P13
   Juárez-Vázquez MD, 2013, J ETHNOPHARMACOL, V148, P521, DOI 10.1016/j.jep.2013.04.048
   Ding L, 2010, J NUTR BIOCHEM, V21, P941, DOI 10.1016/j.jnutbio.2009.07.009
   Frei B, 1998, J ETHNOPHARMACOL, V62, P149, DOI 10.1016/S0378-8741(98)00051-8
   Ganapaty S, 2008, ASIAN J CHEM, V20, P4493
   Garcia Mesa M., 2014, PHARM ONLINE ARCH, V1, P52
   Hernandez-Galicia E, 2002, P W PHARMACOL SOC, V45, P118
   Hu B, 2015, INT J BIOL MACROMOL, V80, P529, DOI 10.1016/j.ijbiomac.2015.07.031
   Johnson L, 2006, PHYTOTHER RES, V20, P250, DOI 10.1002/ptr.1820
   Alonso-Castro AJ, 2010, J ETHNOPHARMACOL, V127, P1, DOI 10.1016/j.jep.2009.09.060
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026
   Liu Y, 2014, BEHAV BRAIN RES, V267, P178, DOI 10.1016/j.bbr.2014.02.040
   Liu Y, 2013, BRAIN RES BULL, V94, P23, DOI 10.1016/j.brainresbull.2013.02.001
   LOZOYAMECKES M, 1985, J ETHNOPHARMACOL, V14, P1, DOI 10.1016/0378-8741(85)90022-4
   Mabry T.J., 2012, SYSTEMATIC IDENTIFIC
   Nickavar B, 2013, IRAN J PHARM RES, V12, P57
   Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736
   Park Y, 2007, MAGN RESON CHEM, V45, P1072, DOI 10.1002/mrc.2063
   Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023
   Ramírez G, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/701261
   Rauter AP, 2010, PHYTOTHER RES, V24, pS133, DOI 10.1002/ptr.3017
   Rivellese AA, 2008, CLIN NUTR, V27, P133, DOI 10.1016/j.clnu.2007.07.005
   Roman-Ramos R, 1991, Arch Invest Med (Mex), V22, P87
   Scheen AJ, 2007, DIABETES METAB, V33, P3, DOI 10.1016/j.diabet.2006.11.005
   Singh L.K. Vijay., 2011, JAPHR, V1, P75
   SRIVASTAVA BK, 1995, ASIAN J CHEM, V7, P679
   VANLOO P, 1986, MAGN RESON CHEM, V24, P879, DOI 10.1002/mrc.1260241007
   Wagner H., 2001, PLANT DRUG ANAL THIN, P349, DOI [10.1016/s0031-9422(97)80771-6, DOI 10.1016/S0031-9422(97)80771-6]
   Winkelman M, 1989, Med Anthropol, V11, P255
   Wu XL, 2014, FOOD CHEM, V142, P306, DOI 10.1016/j.foodchem.2013.07.071
   Yan JK, 2014, INT J BIOL MACROMOL, V64, P213, DOI 10.1016/j.ijbiomac.2013.12.007
   Yang RM, 2015, J ETHNOPHARMACOL, V169, P459, DOI 10.1016/j.jep.2014.12.066
NR 49
TC 42
Z9 45
U1 1
U2 43
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JUN 5
PY 2016
VL 185
BP 1
EP 8
DI 10.1016/j.jep.2016.03.014
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA DM9OV
UT WOS:000376696500001
PM 26970570
DA 2025-04-28
ER

PT J
AU Sung, JH
   Chon, JW
   Lee, MA
   Park, JK
   Woo, JT
   Park, YK
AF Sung, Ju-Hyun
   Chon, Jeong-Woo
   Lee, Mi-Ae
   Park, Jin-Kyung
   Woo, Jeong-Taek
   Park, Yoo Kyoung
TI The anti-obesity effect of Lethariella cladonioides in 3T3-L1
   cells and obese mice
SO NUTRITION RESEARCH AND PRACTICE
LA English
DT Article
DE Lethariella cladonioides; obesity; 3T3-L1 cells; obese mice
ID HIGH-FAT DIET; BODY-WEIGHT REGULATION; GREEN TEA; IN-VITRO; CAFFEINE;
   RATS; ANTIOXIDANT; EXTRACT; PROTEIN; DIFFERENTIATION
AB The aim of this study was to investigate whether a water extract of L. cladonioides (LC) has an anti-obesity effect in 3T3-L1 cells and obese mice. Treatment of differentiated 3T3-L1 adipocytes with LC caused a significant increase in glycerol release and reduced the protein expression of the adipogenic transcription factors, PPAR gamma and C/EBPa. In an animal model, obese mice were artificially induced by a high fat diet for 10 weeks. Experimental groups were treated with LC (100 mg/kg/day) by gavage for the next 10 weeks. At the end of experiment, the body weight of the LC group mice was reduced by 14.2% compared to the high fat diet (HFD) group. The treatment also decreased liver (31.0%), epididymal (18.0%) and retroperitoneal (19.3%) adipose tissue, and kidney (6.7%) weights, respectively, compared with those of the RFD group. LC prevented diet-induced increases in the serum level of TC (22.6%), TG (11.6%), and glucose (35.0%), respectively, compared with the HFD group. However, the HDL-C level was higher in the LC group (26.1%) than the HFD group. The results of this study thus suggest that LC suppressed lipid accumulation and expression of adipogenic transcription factors, and increased the amount of glycerol release. LC also indicated an anti-obese and anti-hyperlipidemic effect.
C1 [Sung, Ju-Hyun; Chon, Jeong-Woo; Lee, Mi-Ae; Park, Jin-Kyung; Park, Yoo Kyoung] Kyung Hee Univ, Grad Sch EW Med Sci, Dept Med Nutr, Yongin 446701, Gyeonggi, South Korea.
   [Woo, Jeong-Taek] Kyung Hee Univ, Sch Med, Dept Endocrinol & Metab, Seoul 130701, South Korea.
   [Park, Yoo Kyoung] Kyung Hee Univ, Res Inst Med Nutr, Seoul 130701, South Korea.
C3 Kyung Hee University; Kyung Hee University; Kyung Hee University
RP Park, YK (corresponding author), Kyung Hee Univ, Grad Sch EW Med Sci, Dept Med Nutr, 1 Seocheon Dong, Yongin 446701, Gyeonggi, South Korea.
EM ypark@khu.ac.kr
RI Park, Jinkyung/JPK-6016-2023; Woo, Jean/K-2625-2014; Park, Yoo
   Kyoung/F-1735-2013
OI Woo, Jeong-Taek/0000-0001-9201-0713; Park, Yoo
   Kyoung/0000-0002-8536-0835
FU Kyung Hee University [KHU-20071517]
FX The research was supported by the Kyung Hee University Research Fund
   (KHU-20071517).
CR Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chumark P, 2008, J ETHNOPHARMACOL, V116, P439, DOI 10.1016/j.jep.2007.12.010
   Chun MR, 2010, J KOREAN MED SCI, V25, P1053, DOI 10.3346/jkms.2010.25.7.1053
   Cowherd RM, 1999, SEMIN CELL DEV BIOL, V10, P3, DOI 10.1006/scdb.1998.0276
   Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5
   Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FRAYN KN, 1980, J LIPID RES, V21, P139
   Hauck M, 2009, ANN BOT-LONDON, V103, P13, DOI 10.1093/aob/mcn202
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Jiang B, 2001, FITOTERAPIA, V72, P832, DOI 10.1016/S0367-326X(01)00287-8
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071
   Kinoshita K, 2010, J NAT MED-TOKYO, V64, P85, DOI 10.1007/s11418-009-0364-2
   Lee WJ, 2005, INT J BIOCHEM CELL B, V37, P2254, DOI 10.1016/j.biocel.2005.06.019
   Meier U, 2004, CLIN CHEM, V50, P1511, DOI 10.1373/clinchem.2004.032482
   Mori S, 2009, INT J BIOL SCI, V5, P311
   MOUSSALLI C, 1986, DIABETES, V35, P759, DOI 10.2337/diabetes.35.7.759
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Naik GH, 2003, PHYTOCHEMISTRY, V63, P97, DOI 10.1016/S0031-9422(02)00754-9
   Niu DL, 2011, LICHENOLOGIST, V43, P213, DOI 10.1017/S0024282911000119
   OBENNAYER W, 2001, BIBL LICHENOL, V78, P321
   Park YS, 2007, WORLD J GASTROENTERO, V13, P3493, DOI 10.3748/wjg.v13.i25.3493
   Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x
   Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063
   Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540
   RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069
   Saito M, 2005, FOOD CHEM TOXICOL, V43, P411, DOI 10.1016/j.fct.2004.11.008
   Shehzad A, 2011, EUR J NUTR, V50, P151, DOI 10.1007/s00394-011-0188-1
   Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469
   Slanc P, 2009, PHYTOTHER RES, V23, P874, DOI 10.1002/ptr.2718
   Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203
   Wei AH, 2012, J SCI FOOD AGR, V92, P373, DOI 10.1002/jsfa.4601
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yun JW, 2008, EXP ANIM TOKYO, V57, P461, DOI 10.1538/expanim.57.461
   Zheng GD, 2004, IN VIVO, V18, P55
NR 37
TC 14
Z9 17
U1 0
U2 17
PU KOREAN NUTRITION SOC
PI SEOUL
PA 804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-1457
EI 2005-6168
J9 NUTR RES PRACT
JI Nutr. Res. Pract.
PD DEC
PY 2011
VL 5
IS 6
BP 503
EP 510
DI 10.4162/nrp.2011.5.6.503
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 874DQ
UT WOS:000298936000002
PM 22259674
OA Green Submitted, Green Published
DA 2025-04-28
ER

PT J
AU Franzini, L
   Ardigò, D
   Zavaroni, I
AF Franzini, Laura
   Ardigo, Diego
   Zavaroni, Ivana
TI Dietary antioxidants and glucose metabolism
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Article
DE antioxidant; diet; inflammation; insulin resistance; type 2 diabetes
ID CORONARY-HEART-DISEASE; CONJUGATED LINOLEIC-ACID; INSULIN-RESISTANCE;
   OXIDATIVE STRESS; VITAMIN-E; CARDIOVASCULAR-DISEASE; VEGETABLE INTAKE;
   TOCOPHEROL SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; COFFEE CONSUMPTION
AB Purpose of review
   Oxidative stress seems to play a pathogenic role in the vicious circle linking obesity, insulin resistance and type 2 diabetes. Hypothetically, dietary antioxidants should decrease oxidative stress and therefore improve glucose metabolism. However, many interventional trials evaluating the effect of antioxidant supplementation on insulin resistance, plasma glucose levels and risk of type 2 diabetes gave inconsistent results.
   Recent findings
   Many studies have recently demonstrated a positive effect of vitamin supplementation and of food enriched in antioxidants (seafood, whole nut, etc.) on markers of oxidative stress, insulin resistance, fasting plasma glucose and incidence of diabetes. The present paper critically reviews the consolidated notions on dietary antioxidants in view of the recent evidence.
   Summary
   Although a definitive estimation of the impact of dietary antioxidants on glucose metabolism is still lacking, food with high antioxidant concentrations seems to have a protective effect, improving oxidative stress-mediated detrimental effects on the vicious circle linking obesity, insulin resistance and redox imbalance.
C1 [Franzini, Laura; Ardigo, Diego; Zavaroni, Ivana] Univ Parma, Dept Internal Med & Biomed Sci, I-43100 Parma, Italy.
C3 University of Parma
RP Zavaroni, I (corresponding author), Via Gramsci 14, I-43100 Parma, Italy.
EM ivana.zavaroni@unipr.it
RI ARDIGO, DIEGO/AAD-5928-2022
OI Ardigo, Diego/0000-0003-1127-7999
CR Antoniades C, 2003, HERZ, V28, P628, DOI 10.1007/s00059-003-2417-8
   Azadbakht L, 2007, DIABETES CARE, V30, P967, DOI 10.2337/dc06-2126
   Bose K. S. C., 2007, SMJ Singapore Medical Journal, V48, P415
   Brownlee M, 2003, J CLIN INVEST, V112, P1788, DOI 10.1172/JCI200320501
   Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x
   Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78
   Chen H, 2006, AM J PHYSIOL-HEART C, V290, pH137, DOI 10.1152/ajpheart.00768.2005
   Choi JS, 2007, BRIT J NUTR, V98, P264, DOI 10.1017/S000711450770497X
   Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5
   Czernichow S, 2006, AM J CLIN NUTR, V84, P395
   Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588
   De Caterina R, 2002, CIRCULATION, V106, P2543, DOI 10.1161/01.CIR.0000038500.43292.D7
   DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Devaraj S, 2007, AM J CLIN NUTR, V86, P1392
   Esmaillzadeh A, 2006, AM J CLIN NUTR, V84, P1489, DOI 10.1093/ajcn/84.6.1489
   Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1
   Ford ES, 1999, AM J EPIDEMIOL, V149, P168, DOI 10.1093/oxfordjournals.aje.a009783
   Garg N, 2006, J PERIODONTAL RES, V41, P405, DOI 10.1111/j.1600-0765.2006.00889.x
   Gökkusu C, 2001, ENDOCR RES, V27, P377, DOI 10.1081/ERC-100106015
   Grassi D, 2005, AM J CLIN NUTR, V81, P611
   Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB
   Haber CA, 2003, AM J PHYSIOL-ENDOC M, V285, pE744, DOI 10.1152/ajpendo.00355.2002
   Hamer M, 2007, J HYPERTENS, V25, P2361, DOI 10.1097/HJH.0b013e3282efc214
   Hodge AM, 2007, AM J EPIDEMIOL, V165, P603, DOI 10.1093/aje/kwk061
   Houseknecht KL, 1998, BIOCHEM BIOPH RES CO, V244, P678, DOI 10.1006/bbrc.1998.8303
   Hozawa A, 2007, CLIN CHEM, V53, P447, DOI 10.1373/clinchem.2006.074930
   Inami S, 2007, INT HEART J, V48, P725, DOI 10.1536/ihj.48.725
   Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0
   KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035
   Korish AA, 2008, ARCH GERONTOL GERIAT, V46, P25, DOI 10.1016/j.archger.2007.02.006
   Kris-Etherton Penny M., 2002, American Journal of Medicine, V113, p71S, DOI 10.1016/S0002-9343(01)00995-0
   Kushi LH, 1996, NEW ENGL J MED, V334, P1156, DOI 10.1056/NEJM199605023341803
   Li N, 2007, J NUTR, V137, P2717, DOI 10.1093/jn/137.12.2717
   Liu S, 2000, AM J CLIN NUTR, V72, P922
   Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.2993
   Manning PJ, 2004, DIABETES CARE, V27, P2166, DOI 10.2337/diacare.27.9.2166
   McSorley PT, 2005, DIABETIC MED, V22, P703, DOI 10.1111/j.1464-5491.2005.01506.x
   Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094
   Nakaya Y, 2000, AM J CLIN NUTR, V71, P54
   Parra D., 2007, EUR J NUTR, V46, P460
   Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323
   Reaven G, 2004, RECENT PROG HORM RES, V59, P207, DOI 10.1210/rp.59.1.207
   Reaven GM, 2005, ENDOCRIN METAB CLIN, V34, P49, DOI 10.1016/j.ecl.2004.12.001
   REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473
   Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447
   RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004
   Roberts CK, 2006, DIABETES RES CLIN PR, V73, P249, DOI 10.1016/j.diabres.2006.02.013
   SanchezLugo L, 1997, AM J CLIN NUTR, V66, P1224, DOI 10.1093/ajcn/66.5.1224
   Saremi A, 2003, DIABETES CARE, V26, P2211, DOI 10.2337/diacare.26.7.2211
   Sargeant LA, 2001, EUR J CLIN NUTR, V55, P342, DOI 10.1038/sj.ejcn.1601162
   Schulze MB, 2005, ANNU REV PUBL HEALTH, V26, P445, DOI 10.1146/annurev.publhealth.26.021304.144532
   Shih CK, 2008, BRIT J NUTR, V99, P59, DOI 10.1017/S0007114507781497
   Singh U, 2005, ANNU REV NUTR, V25, P151, DOI 10.1146/annurev.nutr.24.012003.132446
   Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323
   Sugiura M, 2006, J EPIDEMIOL, V16, P71, DOI 10.2188/jea.16.71
   Syvertsen C, 2007, INT J OBESITY, V31, P1148, DOI 10.1038/sj.ijo.0803482
   Trevisan M, 2001, AM J EPIDEMIOL, V154, P348, DOI 10.1093/aje/154.4.348
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5
   Valtueña S, 2007, EUR J CLIN NUTR, V61, P69, DOI 10.1038/sj.ejcn.1602485
   Valtuena S, 2008, AM J CLIN NUTR, V87, P1290, DOI 10.1093/ajcn/87.5.1290
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Weinberg RB, 2001, ARTERIOSCL THROM VAS, V21, P1029, DOI 10.1161/01.ATV.21.6.1029
   Wu JHY, 2007, CLIN CHEM, V53, P511, DOI 10.1373/clinchem.2006.076992
   Xiao C, 2008, DIABETOLOGIA, V51, P139, DOI 10.1007/s00125-007-0859-x
   Ylönen K, 2003, AM J CLIN NUTR, V77, P1434
   Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302
   ZAVARONI I, 1989, NEW ENGL J MED, V320, P702, DOI 10.1056/NEJM198903163201105
   Zhou JF, 2000, BIOMED ENVIRON SCI, V13, P44
NR 70
TC 34
Z9 37
U1 0
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD JUL
PY 2008
VL 11
IS 4
BP 471
EP 476
DI 10.1097/MCO.0b013e328303be79
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 354TR
UT WOS:000259662400018
PM 18542009
DA 2025-04-28
ER

PT J
AU Di Pietro, G
   Cardoso, DS
   da Silva, HMBS
   Santos, JC
   dos Santos, JR
   Simoes, RA
AF Di Pietro, Giuliano
   Cardoso, Damaris Santana
   Bernini Soares da Silva, Heloisa Mendonca
   Santos, Jessyca Costa
   dos Santos, Jordana Rosa
   Simoes, Rodrigo Almeida
TI Profile Development of Noncommunicable Chronic Diseases in a Brazilian
   Rural Town
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE nutritional epidemiological transition; lifestyle; chronic diseases
ID BODY-MASS INDEX; RISK-FACTORS; NUTRITION TRANSITION; WOMEN; CANCER;
   DIET; HYPERTENSION; OBESITY; HEALTH
AB Objective: To assess the relationship between socioeconomic and anthropometric data, frequency of food consumption, and the development of noncommunicable diseases (NCDs) in patients from a small rural town in northeastern Brazil.
   Methods: A cross-sectional questionnaire study was performed on patients from the Lagarto City Hospital (n = 50) and from family health units (n = 370).
   Results: The 420patients in the study had one or more NCDs such as hypertension, type 2 diabetes mellitus, and dyslipidemia. The mean age was 63.1 +/- 8.7years for both sexes. The typical patient was of mixed or black descent (66%), a farmer, and of low socioeconomic status and education; 100% of men and 84% of women were illiterate or had less than 4years of schooling. Approximately 50% of women and 89% of men were married and most had never used tobacco or were ex-smokers. The body mass index (BMI) of the study population was 29.4 +/- 5.5 kg/m(2), where 70% of the patients were type 2 diabetic with waist circumferences of 99.8 +/- 21.2 cm for men and 98.1 +/- 13.9 cm for women. The correlation between BMI and waist circumference was r = 0.88. Even with the use of medication, total cholesterol levels of above 240mg/dL were recorded in 10% of women and about 5% of men. Likewise, 10% of women and 100% of men had triglyceride levels above 200mg/dL; glucose levels were 133.6 +/- 47.4mg/dL in men and 110.8 +/- 38.8mg/dL in women. Blood pressure values were high, even in patients using one or more antihypertensive drugs for at least 2years (systolic pressure = 128.5 +/- 18.2; diastolic pressure = 86.3 +/- 8.9mmHg). Indices considered above the limit recommended by the World Health Organization (WHO) were obtained for 60% of women and 100% of men. Our research revealed that this population is characterized by a relatively low intake of fats and oils. Nevertheless, 100% of patients consumed meat every day, 57.6% never consumed processed foods such as candy or soft drinks, and 89% consumed coffee daily. Furthermore, the consumption of fruits was very low: 46.6% of respondents never ate fruit and 7.8% rarely consumed fruit. Likewise, 68.2% reported never eating milk and dairy products. Vegetables were consumed by only 51.4% of the population and 38.5% rarely or never consumed green vegetables. Products made from wheat, maize, cassava, beans, and rice were often consumed by 59.2% of the population.
   Conclusions: Our results indicate that the studied population is affected by nutritional transition, in which the greater access to carbohydrates and animal proteins is associated with high BMI, with the vast majority overweight and suffering from uncontrolled hypertension despite the use of medications. The high consumption of carbohydrates and animal protein, rapid urbanization, and sedentary lifestyle are the main factors responsible for the epidemic of noncommunicable diseases, especially among people with low income and education. Men are particularly affected, with increased visceral fat characterized by an increased waist circumference.
C1 [Di Pietro, Giuliano; Cardoso, Damaris Santana; Simoes, Rodrigo Almeida] Univ Fed Sergipe, Dept Farm, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Bernini Soares da Silva, Heloisa Mendonca] Univ Fed Sergipe, Dept Nutr, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Santos, Jessyca Costa; dos Santos, Jordana Rosa] Univ Fed Sergipe, Dept Nursing, BR-49100000 Sao Cristovao, Sergipe, Brazil.
C3 Universidade Federal de Sergipe; Universidade Federal de Sergipe;
   Universidade Federal de Sergipe
RP Di Pietro, G (corresponding author), Univ Fed Sergipe, Dept Farm, Ave Marechal Rondon,S-N Jardim Roza Elze, BR-49100000 Sao Cristovao, Sergipe, Brazil.
EM dipietrobr@yahoo.com.br
RI Santos, Joao R. L./G-9705-2012
OI Di Pietro, Giuliano/0000-0001-9753-222X
FU National Council for Research (Conselho Nacional de Pesquisa-CNPq,
   Brazil)
FX The authors acknowledge the relevant research grants from the National
   Council for Research (Conselho Nacional de Pesquisa-CNPq, Brazil).
CR [Anonymous], Global Status Report on Noncommunicable Diseases 2010
   Batista Filho Malaquias, 2003, Cad. Saúde Pública, V19, pS181, DOI 10.1590/S0102-311X2003000700019
   Belahsen R, 2006, PUBLIC HEALTH NUTR, V9, P1130, DOI 10.1017/S1368980007668517
   Bertrand KA, 2013, CANCER PREV RES, V6, P864, DOI [10.1158/1940-6207.CAPR-3-0132, 10.1158/1940-6207.CAPR-13-0132]
   Bolormaa Norov, 2008, Asia Pac J Public Health, V20 Suppl, P23
   BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725
   Brazilian Ministry of Health, 2010, VIGITEL TEL SURV SUR
   Brazilian Ministry of Planning Budget and Management, 2011, CENS 2010 CHAR POP H
   Burr JF, 2010, PHYSICIAN SPORTSMED, V38, P72, DOI 10.3810/psm.2010.04.1764
   Carvalho GQ, 2008, REV NUTR, V21, P577, DOI 10.1590/S1415-52732008000500010
   Cervato AM, 1999, THESIS USP SAO PAULO
   Cortez-Dias N, 2013, J HYPERTENS, V31, P1991, DOI 10.1097/HJH.0b013e32836342f7
   Castro Simone Henriques de, 2006, Arq Bras Endocrinol Metab, V50, P450, DOI 10.1590/S0004-27302006000300007
   Decker SL, 2013, JAMA-J AM MED ASSOC, V309, P2579, DOI 10.1001/jama.2013.7106
   Di Pietro RF, 2007, NUTR HOSP, V22, P565
   Duarte ACG, 2007, AV NUTR ASP CLIN LAB
   Goon D, 2013, IRAN J PUBLIC HEALTH, V42, P489
   Jaime PC, 2011, J URBAN HEALTH, V88, P567, DOI 10.1007/s11524-010-9537-2
   Kitsantas P, 2013, J OBSTET GYNAECOL RE, V39, P1330, DOI 10.1111/jog.12065
   Kruger HS, 2001, BRIT J NUTR, V86, P733, DOI 10.1079/BJN2001469
   Laamiri FZ, 2013, INT J GEN MED, V6, P439, DOI 10.2147/IJGM.S40826
   Lee Hye Ah, 2013, J Prev Med Public Health, V46, P173, DOI 10.3961/jpmph.2013.46.4.173
   Magno LAV, 2009, PHARMACOLOGY, V83, P231, DOI 10.1159/000205823
   Meetoo Danny, 2008, Br J Nurs, V17, P1320
   Miller ER, 2005, ATHEROSCLEROSIS, V183, P175, DOI 10.1016/j.atherosclerosis.2005.04.001
   Millett C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001459
   Misra A, 2011, J DIABETES, V3, P278, DOI 10.1111/j.1753-0407.2011.00139.x
   Musaiger AO, 2012, INT J GEN MED, V5, P199, DOI 10.2147/IJGM.S29663
   Nagao H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-88
   Navarro A. M., 2001, Revista de Nutricao, V14, P37, DOI 10.1590/S1415-52732001000100006
   Niinikoski H, 2012, NUTR METAB CARDIOVAS, V22, P770, DOI 10.1016/j.numecd.2012.05.002
   Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
   Popkin BM, 2009, NESTLE NUTR WORKS SE, V63, P1, DOI 10.1159/000209967
   Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]
   Sarno F, 2007, REV SAUDE PUBL, V41, P788, DOI 10.1590/S0034-89102007000500013
   Thawornchaisit P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002826
NR 36
TC 4
Z9 4
U1 0
U2 22
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD MAY 4
PY 2015
VL 34
IS 3
BP 191
EP 198
DI 10.1080/07315724.2014.926162
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CI1ZE
UT WOS:000354543100002
PM 25751416
DA 2025-04-28
ER

PT J
AU Vogel, RM
   Joy, JM
   Falcone, PH
   Mosman, MM
   Kim, MP
   Moon, JR
AF Vogel, Roxanne M.
   Joy, Jordan M.
   Falcone, Paul H.
   Mosman, Matt M.
   Kim, Michael P.
   Moon, Jordan R.
TI Consuming a multi-ingredient thermogenic supplement for 28 days is
   apparently safe in healthy adults
SO FOOD & NUTRITION RESEARCH
LA English
DT Article
DE weight loss supplement; safety; clinical; hematology; nutrition; fat
   burner
ID WEIGHT-LOSS; GREEN TEA; DIETARY-SUPPLEMENTS; ENERGY-EXPENDITURE;
   DOUBLE-BLIND; US ADULTS; EFFICACY; OBESITY; CAPSAICIN; CAFFEINE
AB Background: Thermogenic (TRM) supplements are often used by people seeking to decrease body weight. Many TRM supplements are formulated with multiple ingredients purported to increase energy expenditure and maximize fat loss. However, in the past some TRM ingredients have been deemed unsafe and removed from the market. Therefore, it is important to verify the safety of multi-ingredient TRM supplements with chronic consumption.
   Objective: To assess the safety of daily consumption of a multi-ingredient TRM supplement over a 28-day period in healthy adults.
   Design: Twenty-three recreationally active adults (11M, 12F; 27.1 +/- 5.4 years, 171.6 +/- 9.6 cm, 76.8 +/- 16.1 kg, 26 +/- 5 BMI) were randomly assigned either to consume a multi-ingredient TRM supplement (SUP; n = 9) or remain unsupplemented (CRL; n = 14) for 28 days. Participants maintained their habitual dietary and exercise routines for the duration of the study. Fasting blood samples, resting blood pressure, and heart rate were taken before and after the supplementation period. Samples were analyzed for complete blood counts, comprehensive metabolic, and lipid panels.
   Results: Significant (p<0.05) group by time interactions were present for diastolic BP, creatinine, estimated glomerular filtration rate (eGFR), chloride, CO2, globulin, albumin: globulin (A/G), and high-density lipoprotein (HDL). Dependent t-tests conducted on significant variables revealed significant (p<0.05) within-group differences in SUP for diastolic BP (+6.2 +/- 5.3 mmHG), creatinine (+0.09 +/- 0.05 mg/dL), eGFR (-11.2 +/- 5.8 mL/min/1.73), globulin (-0.29 +/- 0.24 g/dL), A/G (+0.27 +/- 0.23), and HDL (-5.0 +/- 5.5 mg/dL), and in CRL for CO2 (-1.9 +/- 1.5 mmol/L) between time points. Each variable remained within the accepted physiological range.
   Conclusion: Results of the present study support the clinical safety of a multi-ingredient TRM containing caffeine, green tea extract, and cayenne powder. Although there were statistically significant (p<0.05) intragroup differences in SUP from pre-to postsupplementation for diastolic BP, creatinine, eGFR, globulin, A/G, and HDL, all remained within accepted physiological ranges and were not clinically significant. In sum, it appears as though daily supplementation with a multi-ingredient TRM is safe for consumption by healthy adults for a 28-day period.
C1 [Vogel, Roxanne M.; Joy, Jordan M.; Falcone, Paul H.; Mosman, Matt M.; Kim, Michael P.; Moon, Jordan R.] MusclePharm Sports Sci Inst, Denver, CO USA.
   [Vogel, Roxanne M.; Joy, Jordan M.] Concordia Univ Chicago, Dept Human Performance, River Forest, IL USA.
   [Moon, Jordan R.] US Sports Acad, Dept Sports Exercise Sci, Daphne, AL USA.
RP Moon, JR (corresponding author), 4721 Ironton St,Bldg A, Denver, CO 80239 USA.
EM jordan@musclepharm.com
FU MusclePharm Corporation
FX We thank all the participants as well as MusclePharm Corporation for
   supplying product and funding the investigation.
CR ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Farney TM, 2012, NUTR METAB INSIGHTS, V5, DOI 10.4137/NMI.S8568
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kruger J, 2004, AM J PREV MED, V26, P402, DOI 10.1016/j.ampere.2004.02.001
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Pillitteri JL, 2008, OBESITY, V16, P790, DOI 10.1038/oby.2007.136
   Reinbach HC, 2009, CLIN NUTR, V28, P260, DOI 10.1016/j.clnu.2009.01.010
   Roberts MD, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-19
   Saper RB, 2004, AM FAM PHYSICIAN, V70, P1731
   Smeets AJ, 2013, J NUTR, V143, P442, DOI 10.3945/jn.112.170613
   *US FDA, 2004, FDA ISS REG PROH SAL
   US Food and Drug Administration, 2013, STIM POT DANG HLTH F
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
NR 18
TC 11
Z9 12
U1 0
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1654-6628
EI 1654-661X
J9 FOOD NUTR RES
JI Food Nutr. Res.
PY 2015
VL 59
AR 27999
DI 10.3402/fnr.v59.27999
PG 6
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA CN3DC
UT WOS:000358303100001
PM 26205229
OA Green Submitted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Park, S
   McGuire, LC
   Galuska, DA
AF Park, Sohyun
   McGuire, Lisa C.
   Galuska, Deborah A.
TI Regional Differences in Sugar-Sweetened Beverage Intake among US Adults
SO JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS
LA English
DT Article
DE Sugar-sweetened beverages; Soda; Fruit-flavored drinks; Sports and
   energy drinks; Geographic region
ID UNITED-STATES; CONSUMPTION; RISK; QUESTIONNAIRE; OBESITY; WEIGHT
AB Background Higher consumption of sugar-sweetened beverages (SSBs) is associated with obesity and type 2 diabetes, and the prevalence of obesity varies by geographic region. Although information on whether SSB intake differs geographically could be valuable for designing targeted interventions, this information is limited.
   Objective This cross-sectional study examined associations between living in specific census regions and frequency of SSB consumption among US adults using 2010 National Health Interview Survey data (n=25,431).
   Methods SSB consumption was defined as the consumption of four types of beverages (regular sugar-sweetened carbonated beverages, fruit drinks, sports/energy drinks, and sweetened coffee/tea drinks). The exposure variable was census region of residence (Northeast, Midwest, South, and West). We used multivariable logistic regression to estimate adjusted odds ratios (aORs) and 95% CIs for drinking SSBs after controlling for sociodemographic characteristics.
   Results Approximately 64% of adults consumed SSBs >= 1 time/day. The odds of drinking SSBs >= 1 time/day were significantly higher among adults living in the Northeast (aOR=1.13; 95% CI=1.01, 1.26) but lower among adults living in the Midwest (aOR=0.70; 95% CI=0.64, 0.78) or West (aOR=0.78; 95% CI=0.71, 0.87) compared with those living in the South. By type of SSB, the odds of drinking regular soda >= 1 time/day was significantly lower among adults living in the Northeast (aOR=0.51; 95% CI=0.45, 0.57), Midwest (aOR=0.86; 95% CI=0.78, 0.96), or West (aOR=0.56; 95% CI=0.51, 0.62) than those living in the South. The odds of drinking sports/energy drinks >= 1 time/day were significantly lower among adults living in the West (aOR=0.77; 95% CI=0.64, 0.93) than those living in the South. The odds of drinking a sweetened coffee/tea drink >= 1 time/day were significantly higher among adults living in the Northeast (aOR=1.60; 95% CI=1.43, 1.78) but lower among adults living in the Midwest (aOR=0.70; 95% CI=0.62, 0.78) than those living in the South.
   Conclusions Total frequency of SSB consumption and types of SSB consumption differed by geographic region. Interventions to reduce SSB intake could consider regional variations in SSB intake, particularly when more local data are not available.
C1 [Park, Sohyun; McGuire, Lisa C.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
   [Galuska, Deborah A.] Ctr Dis Control & Prevent, Sci, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
C3 Centers for Disease Control & Prevention - USA; Centers for Disease
   Control & Prevention - USA
RP Park, S (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop F77, Atlanta, GA 30341 USA.
EM spark3@cdc.gov
OI Park, Sohyun/0000-0002-8192-7048
FU Intramural CDC HHS [CC999999] Funding Source: Medline
CR 2015 Dietary Guidelines Advisory Committee. Scientific report of the 2015 Dietary Guidelines Advisory Committee, SCI REP 2015 DIET GU
   [Anonymous], AD OB FACTS
   [Anonymous], OB PREV MAPS
   [Anonymous], 2014, National diabetes statistics report
   [Anonymous], CENS REG DIV US
   [Anonymous], 2019, DAT STAT
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Centers for Disease Control and Prevention, Division of Nutrition. Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion. Adult obesity facts
   Centers for Disease Control and Prevention US Department of Health and Human Services, 2011, 2010 NAT HLTH INT SU
   de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Hedrick VE, 2012, J ACAD NUTR DIET, V112, P840, DOI 10.1016/j.jand.2012.01.023
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Kumar GS, 2014, MMWR-MORBID MORTAL W, V63, P686
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Martin-Biggers J, 2013, APPETITE, V62, P160, DOI 10.1016/j.appet.2012.12.001
   Ogden Cynthia L, 2011, NCHS Data Brief, P1
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Park S, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130304
   Park S, 2014, J ACAD NUTR DIET, V114, P1059, DOI 10.1016/j.jand.2013.11.003
   Park S, 2013, J ACAD NUTR DIET, V113, P112, DOI 10.1016/j.jand.2012.09.019
   Pomeranz JL, 2012, J PUBLIC HEALTH POL, V33, P75, DOI 10.1057/jphp.2011.46
   Stanhope KL, 2011, J CLIN ENDOCR METAB, V96, pE1596, DOI 10.1210/jc.2011-1251
   Starbucks Coffee Company, EXPL OUR MEN BOTTL D
   Tucker KL, 2005, PUBLIC HEALTH NUTR, V8, P87, DOI 10.1079/PHN2005663
   United States Department of Agriculture Agricultural Research Service, USDA NAT NUTR DAT ST
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
NR 33
TC 43
Z9 49
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 2212-2672
EI 2212-2680
J9 J ACAD NUTR DIET
JI J. Acad. Nutr. Diet.
PD DEC
PY 2015
VL 115
IS 12
BP 1996
EP 2002
DI 10.1016/j.jand.2015.06.010
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CX9DF
UT WOS:000366004400011
PM 26231057
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Kovacs, EMR
   Mela, DJ
AF Kovacs, EMR
   Mela, DJ
TI Metabolically active functional food ingredients for weight control
SO OBESITY REVIEWS
LA English
DT Review
DE energy expenditure; fat oxidation; metabolism; thermogenesis
ID CONJUGATED LINOLEIC-ACID; MEDIUM-CHAIN TRIGLYCERIDES; REDUCES BODY-FAT;
   24-H ENERGY-EXPENDITURE; EPHEDRINE METHYLXANTHINE MIXTURES; LONG-CHAIN;
   DOUBLE-BLIND; RED-PEPPER; GREEN TEA; DIETARY DIACYLGLYCEROL
AB The scale of the obesity epidemic creates a pressing consumer need as well as an enormous business opportunity for successful development and marketing of food products with added benefits for weight control. A number of proposed functional food ingredients have been shown to act post-absorptively to influence substrate utilization or thermogenesis. Characteristics and supporting data on conjugated linoleic acid, diglycerides, medium-chain triglycerides, green tea, ephedrine, caffeine, capsaicin and calcium, are reviewed here, giving examples of how these could act to alter energy expenditure or appetite control. Consideration is also given to other factors, in addition to efficacy, which must be satisfied to get such ingredients into foods. We conclude that, for each of the safe, putatively metabolically active agents, there remain gaps in clinical evidence or knowledge of mechanisms, which need to be addressed in order to specify the dietary conditions and food product compositions where these ingredients could be of most benefit for weight control.
C1 Unilever Res Labs, Unilever Hlth Inst, NL-3130 AC Vlaardingen, Netherlands.
C3 Unilever
RP Unilever Res Labs, Unilever Hlth Inst, POB 114, NL-3130 AC Vlaardingen, Netherlands.
EM eva.kovacs@unilever.com
RI Mela, David/LKJ-1837-2024
OI Mela, David/0000-0003-1824-4305
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   AMELSVOORT JM, 2001, XENOBIOTICA, V31, P891
   [Anonymous], 2001, J OLEO SCI, DOI DOI 10.5650/JOS.50.677
   ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F
   ASTRUP A, 1992, INT J OBESITY, V16, P269
   ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S
   ASTRUP A, 1985, AM J CLIN NUTR, V42, P83, DOI 10.1093/ajcn/42.1.83
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Astrup A, 1999, AM J CLIN NUTR, V69, P1117
   BABA N, 1982, AM J CLIN NUTR, V35, P678, DOI 10.1093/ajcn/35.4.678
   BABAYAN VK, 1987, LIPIDS, V22, P417, DOI 10.1007/BF02537271
   Bach AC, 1996, J LIPID RES, V37, P708
   Barbera R, 2000, GUT, V46, P32, DOI 10.1136/gut.46.1.32
   Barr SI, 2003, J NUTR, V133, p245S
   BELL DG, J APPL PHYSL, V93, P1227
   Berven G, 2000, EUR J LIPID SCI TECH, V102, P455, DOI 10.1002/1438-9312(200008)102:7<455::AID-EJLT455>3.0.CO;2-V
   BIERBACH H, 1983, DIGESTION, V28, P138, DOI 10.1159/000198977
   Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943
   BLUMENTHAL M, 1998, MONOGRAPHS THERAPEUT, P125
   Boon N, 2005, AM J CLIN NUTR, V82, P1244, DOI 10.1093/ajcn/82.6.1244
   Boozer CN, 2001, INT J OBESITY, V25, P316, DOI 10.1038/sj.ijo.0801539
   Boozer CN, 2002, INT J OBESITY, V26, P593, DOI 10.1038/sj.ijo.0802023
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Bowen J, 2005, INT J OBESITY, V29, P957, DOI 10.1038/sj.ijo.0802895
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BRAY GA, 1995, OBES RES, V3, P491, DOI 10.1002/j.1550-8528.1995.tb00180.x
   BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420
   BREUM L, 1994, INT J OBESITY, V18, P99
   Brodie AE, 1999, J NUTR, V129, P602
   BUIATTI E, 1989, INT J CANCER, V44, P611, DOI 10.1002/ijc.2910440409
   Bursey R., 1989, The Journal of the Federation of American Societies for Experimental Biology, V3, pA265
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Cheng S, 2005, AM J CLIN NUTR, V82, P1115, DOI 10.1093/ajcn/82.5.1115
   Clément L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200
   CROZIER G, 1987, METABOLISM, V36, P807, DOI 10.1016/0026-0495(87)90122-3
   DALY PA, 1993, INT J OBESITY, V17, pS73
   Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635
   Delany JP, 1999, AM J PHYSIOL-REG I, V276, pR1172, DOI 10.1152/ajpregu.1999.276.4.R1172
   DENKE MA, 1993, J NUTR, V123, P1047
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   Dulloo AG, 1996, EUR J CLIN NUTR, V50, P152
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   DULLOO AG, 1987, AM J PHYSIOL, V252, pR507, DOI 10.1152/ajpregu.1987.252.3.R507
   DULLOO AG, 1987, J NUTR, V117, P383, DOI 10.1093/jn/117.2.383
   DULLOO AG, 1986, AM J CLIN NUTR, V43, P388, DOI 10.1093/ajcn/43.3.388
   DULLOO AG, 1989, NUTRITION, V5, P7
   ELDERSHAW TPD, 1992, INT J OBESITY, V16, P755
   FLATT JP, 1995, AM J CLIN NUTR, V62, P820, DOI 10.1093/ajcn/62.4.820
   Flickinger BD, 2003, LIPIDS, V38, P129, DOI 10.1007/s11745-003-1042-8
   FREED WJ, 1979, SCIENCE, V206, P850, DOI 10.1126/science.493987
   FRIRTSCHE J, 1998, Z LEBENSM UNTERS F A, V206, P77
   FURUSE M, 1992, PHYSIOL BEHAV, V52, P815, DOI 10.1016/0031-9384(92)90419-3
   Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118
   GELIEBTER A, 1983, AM J CLIN NUTR, V37, P1
   Graham TE, 2000, J PHYSIOL-LONDON, V529, P837, DOI 10.1111/j.1469-7793.2000.00837.x
   Gunther CW, 2005, AM J CLIN NUTR, V81, P751, DOI 10.1093/ajcn/81.4.751
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   HARA K, 1993, ANN NUTR METAB, V37, P185, DOI 10.1159/000177767
   Harvey-Berino J, 2005, OBES RES, V13, P1720, DOI 10.1038/oby.2005.210
   Hase T., 2001, Journal of Oleo Science, V50, P599, DOI [10.5650/jos.50.599, DOI 10.5650/JOS.50.599]
   HASHIM SA, 1960, LANCET, V1, P1105
   Heaney RP, 2002, FOOD CHEM TOXICOL, V40, P1263, DOI 10.1016/S0278-6915(02)00094-7
   HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165
   HETZLER RK, 1990, J APPL PHYSIOL, V68, P44, DOI 10.1152/jappl.1990.68.1.44
   HILL JO, 1990, J LIPID RES, V31, P407
   HILL JO, 1989, METABOLISM, V38, P641, DOI 10.1016/0026-0495(89)90101-7
   HOLLANDS MA, 1981, AM J CLIN NUTR, V34, P2291, DOI 10.1093/ajcn/34.10.2291
   HOLT PR, 1967, GASTROENTEROLOGY, V53, P961
   Ivy JL., 1980, Int J Sports Med, V1, P15, DOI [10.1055/s-2008-1034624, DOI 10.1055/S-2008-1034624]
   Jacqmain M, 2003, AM J CLIN NUTR, V77, P1448, DOI 10.1093/ajcn/77.6.1448
   JEBB SA, 1995, WEIGHT CONTROL CURRE
   JONDERKO K, 1991, ALIMENT PHARM THERAP, V5, P413
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Kamphuis MMJW, 2003, INT J OBESITY, V27, P840, DOI 10.1038/sj.ijo.0802304
   Kamphuis MMJW, 2003, AM J CLIN NUTR, V77, P1133, DOI 10.1093/ajcn/77.5.1133
   Kang WS, 1999, THROMB RES, V96, P229, DOI 10.1016/S0049-3848(99)00104-8
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   KAWADA T, 1988, P SOC EXP BIOL MED, V188, P229, DOI 10.3181/00379727-188-2-RC1
   KAWADA T, 1986, J NUTR, V116, P1272, DOI 10.1093/jn/116.7.1272
   KAWADA T, 1986, P SOC EXP BIOL MED, V183, P250
   Kim KM, 1998, J NUTR, V128, P1978, DOI 10.1093/jn/128.11.1978
   Kim SJ, 2000, J AGR FOOD CHEM, V48, P3922, DOI 10.1021/jf991215z
   KOBAYASHI A, 2001, AM J PHYSIOL, V275, pR92
   KONO S, 1992, PREV MED, V21, P526, DOI 10.1016/0091-7435(92)90060-U
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Kreider RB, 2002, J STRENGTH COND RES, V16, P325
   Krotkiewski M, 2001, INT J OBESITY, V25, P1393, DOI 10.1038/sj.ijo.0801682
   LASEKAN JB, 1992, J NUTR, V122, P1483, DOI 10.1093/jn/122.7.1483
   LAVAU MM, 1978, J NUTR, V108, P613, DOI 10.1093/jn/108.4.613
   LEBLANC J, 1985, J APPL PHYSIOL, V59, P832, DOI 10.1152/jappl.1985.59.3.832
   Ledeboer M, 1999, JPEN-PARENTER ENTER, V23, P203, DOI 10.1177/0148607199023004203
   Lejeune MPGM, 2003, BRIT J NUTR, V90, P651, DOI 10.1079/BJN2003938
   Lim K, 1997, MED SCI SPORT EXER, V29, P355, DOI 10.1097/00005768-199703000-00010
   Lin YC, 2000, J AM COLL NUTR, V19, P754, DOI 10.1080/07315724.2000.10718075
   Lin YG, 2001, J NUTR BIOCHEM, V12, P183, DOI 10.1016/S0955-2863(00)00155-8
   LIU YL, 1995, INT J OBESITY, V19, P678
   LOPEZCARRILLO L, 1994, AM J EPIDEMIOL, V139, P263, DOI 10.1093/oxfordjournals.aje.a116993
   Lorenzen JK, 2004, INT J OBESITY, V28, pS34
   LOWERY LM, 1998, MED SCI SPORTS EXERC, V30, P182
   Maas MIM, 1998, EUR J CLIN INVEST, V28, P123, DOI 10.1046/j.1365-2362.1998.00255.x
   Maki KC, 2002, AM J CLIN NUTR, V76, P1230, DOI 10.1093/ajcn/76.6.1230
   Malpuech-Brugère C, 2004, OBES RES, V12, P591, DOI 10.1038/oby.2004.68
   MASSOUDI M, 1983, ANN NUTR METAB, V27, P26, DOI 10.1159/000176621
   Matsuo T, 1996, J NUTR SCI VITAMINOL, V42, P249, DOI 10.3177/jnsv.42.249
   MCCARRON DA, 1984, SCIENCE, V224, P1392, DOI 10.1126/science.6729459
   McLaughlin J, 1999, GASTROENTEROLOGY, V116, P46, DOI 10.1016/S0016-5085(99)70227-1
   Meguro S, 2001, J OLEO SCI, V50, P593, DOI DOI 10.5650/JOS.50.593
   Melanson EL, 2004, FASEB J, V18, pA846
   Melanson EL, 2003, INT J OBESITY, V27, P196, DOI 10.1038/sj.ijo.802202
   Meng XH, 2004, LIPIDS, V39, P37, DOI 10.1007/s11745-004-1199-1
   METZ JA, 1988, AM J HYPERTENS, V1, P58, DOI 10.1093/ajh/1.1.58
   Mougios V, 2001, J NUTR BIOCHEM, V12, P585, DOI 10.1016/S0955-2863(01)00177-2
   Moya-Camarena SY, 1999, J LIPID RES, V40, P1426
   Mukhtar H, 1999, TOXICOL SCI, V52, P111, DOI 10.1093/toxsci/52.suppl_1.111
   Murase T, 2002, J LIPID RES, V43, P1312, DOI 10.1194/jlr.M200094-JLR200
   Murase T, 2002, J NUTR, V132, P3018, DOI 10.1093/jn/131.10.3018
   Murase T, 2001, J LIPID RES, V42, P372
   MURATA M, 1994, BIOSCI BIOTECH BIOCH, V58, P1416, DOI 10.1271/bbb.58.1416
   Murata M, 1997, BRIT J NUTR, V77, P107, DOI 10.1079/BJN19970013
   Nagao T, 2000, J NUTR, V130, P792, DOI 10.1093/jn/130.4.792
   Nagao T., 2001, Journal of Oleo Science, V50, P717
   Nagasawa A, 2001, J OLEO SCI, V50, P711, DOI [10.5650/jos.50.711, DOI 10.5650/JOS.50.711]
   Noone EJ, 2002, BRIT J NUTR, V88, P243, DOI 10.1079/BJN2002615
   Ohnuki K, 2001, BIOSCI BIOTECH BIOCH, V65, P2033, DOI 10.1271/bbb.65.2033
   Ohnuki K, 2001, BIOSCI BIOTECH BIOCH, V65, P2735, DOI 10.1271/bbb.65.2735
   Papakonstantinou E, 2003, OBES RES, V11, P387, DOI 10.1038/oby.2003.52
   Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398
   Pariza M, 1997, FASEB J, V11, P813
   Park Y, 1999, LIPIDS, V34, P243, DOI 10.1007/s11745-999-0359-7
   Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x
   Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8
   PASQUALI R, 1985, INT J OBESITY, V9, P93
   PASQUALI R, 1987, INT J OBESITY, V11, P163
   PASQUALI R, 1992, CLIN SCI, V82, P85, DOI 10.1042/cs0820085
   PERLOW MJ, 1980, PHARMACOL BIOCHEM BE, V12, P609, DOI 10.1016/0091-3057(80)90196-3
   POEHLMAN ET, 1985, MED SCI SPORT EXER, V17, P689, DOI 10.1249/00005768-198512000-00012
   Rados Carol, 2004, FDA Consum, V38, P6
   Ramsey JJ, 1998, AM J CLIN NUTR, V68, P42, DOI 10.1093/ajcn/68.1.42
   Rasheed A, 1998, ARCH PHARM RES, V21, P348, DOI 10.1007/BF02975300
   RAVUSSIN E, 1985, AM J PHYSIOL, V249, pE470, DOI 10.1152/ajpendo.1985.249.5.E470
   RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802
   Reid IR, 2005, J CLIN ENDOCR METAB, V90, P3824, DOI 10.1210/jc.2004-2205
   Risérus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516
   Risérus U, 2002, CIRCULATION, V106, P1925, DOI 10.1161/01.CIR.0000033589.15413.48
   Risérus U, 2001, INT J OBESITY, V25, P1129, DOI 10.1038/sj.ijo.0801659
   ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403
   ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124
   Roche HM, 2002, DIABETES, V51, P2037, DOI 10.2337/diabetes.51.7.2037
   ROLLS BJ, 1988, AM J CLIN NUTR, V48, P66, DOI 10.1093/ajcn/48.1.66
   ROTHWELL NJ, 1987, METABOLISM, V36, P128, DOI 10.1016/0026-0495(87)90005-9
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Satory DL, 1999, J NUTR, V129, P92, DOI 10.1093/jn/129.1.92
   SCALFI L, 1991, AM J CLIN NUTR, V53, P1130, DOI 10.1093/ajcn/53.5.1130
   SEATON TB, 1986, AM J CLIN NUTR, V44, P630, DOI 10.1093/ajcn/44.5.630
   Serafini M, 1996, EUR J CLIN NUTR, V50, P28
   Shannon JR, 1999, CLIN SCI, V96, P483, DOI 10.1042/CS19980206
   Shapses SA, 2004, J CLIN ENDOCR METAB, V89, P632, DOI 10.1210/jc.2002-021136
   Skinner JD, 2003, J AM DIET ASSOC, V103, P1626, DOI [10.1016/j.jada.2003.09.018, 10.1016/j.jada.2003.09.020]
   Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7
   St-Onge MP, 2003, INT J OBESITY, V27, P1565, DOI 10.1038/sj.ijo.0802467
   St-Onge MP, 2003, OBES RES, V11, P395, DOI 10.1038/oby.2003.53
   St-Onge MP, 2003, INT J OBESITY, V27, P95, DOI 10.1038/sj.ijo.0802169
   Stubbs RJ, 1996, INT J OBESITY, V20, P435
   Summerbell CD, 1998, BRIT MED J, V317, P1487, DOI 10.1136/bmj.317.7171.1487
   Sung H, 2000, EUR J CLIN NUTR, V54, P527, DOI 10.1038/sj.ejcn.1600994
   Surh YJ, 1996, FOOD CHEM TOXICOL, V34, P313, DOI 10.1016/0278-6915(95)00108-5
   Taguchi H, 2000, J AM COLL NUTR, V19, P789, DOI 10.1080/07315724.2000.10718079
   Taguchi H, 2001, LIPIDS, V36, P379, DOI 10.1007/s11745-001-0731-7
   Terpstra AHM, 2003, J NUTR, V133, P3181, DOI 10.1093/jn/133.10.3181
   Thom E, 2001, J INT MED RES, V29, P392, DOI 10.1177/147323000102900503
   Thompson WG, 2005, OBES RES, V13, P1344, DOI 10.1038/oby.2005.163
   TOUBRO S, 1993, INT J OBESITY, V17, pS73
   Toubro S., 2003, International Journal of Obesity, V27, pS124
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   TSCHIDA T, 2002, PROG MED, V22, P2189
   Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534
   Tsuji H, 2001, J NUTR, V131, P2853, DOI 10.1093/jn/131.11.2853
   TULP OL, 1986, COMP BIOCHEM PHYS C, V85, P17
   TURKENKOPF IJ, 1982, J NUTR, V112, P1254, DOI 10.1093/jn/112.7.1254
   Van Wymelbeke V, 1998, AM J CLIN NUTR, V68, P226, DOI 10.1093/ajcn/68.2.226
   Van Wymelbeke V, 2001, AM J CLIN NUTR, V74, P620
   Warden BA, 2001, J NUTR, V131, P1731, DOI 10.1093/jn/131.6.1731
   Watanabe H., 1997, Journal of the Japan Oil Chemists' Society, V46, P309
   Watanabe H., 1997, J JPN OIL CHEM SOC, V46, P301
   WATANABE T, 1987, BIOCHEM BIOPH RES CO, V142, P259, DOI 10.1016/0006-291X(87)90479-7
   WATANABE T, 1988, P SOC EXP BIOL MED, V187, P370
   WATANABE T, 1988, AM J PHYSIOL, V255, pE23, DOI 10.1152/ajpendo.1988.255.1.E23
   WATANABE T, 1994, LIFE SCI, V54, P369, DOI 10.1016/0024-3205(94)00793-4
   WELBERG JWM, 1994, ANN NUTR METAB, V38, P185, DOI 10.1159/000177810
   West DB, 1998, AM J PHYSIOL-REG I, V275, pR667
   West DB, 2000, J NUTR, V130, P2471, DOI 10.1093/jn/130.10.2471
   Westerterp-Plantenga MS, 2004, INT J OBESITY, V28, pS35
   White MD, 1999, AM J CLIN NUTR, V69, P883
   Yang L, 2000, J AGR FOOD CHEM, V48, P3072, DOI 10.1021/jf0003404
   Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534
   Yoshioka M, 1995, J NUTR SCI VITAMINOL, V41, P647, DOI 10.3177/jnsv.41.647
   Yoshioka M, 1999, BRIT J NUTR, V82, P115, DOI 10.1017/S0007114599001269
   Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597
   Yoshioka M, 2004, BRIT J NUTR, V91, P991, DOI 10.1079/BJN20041148
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
   YOST TJ, 1989, AM J CLIN NUTR, V49, P326, DOI 10.1093/ajcn/49.2.326
   Zambell KL, 2000, LIPIDS, V35, P777, DOI 10.1007/s11745-000-0585-z
   Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132
   Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67
   Zemel MB, 2001, J AM COLL NUTR, V20, p428S, DOI 10.1080/07315724.2001.10719180
   Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212
   Zhang QM, 2004, AM J PHYSIOL-REG I, V286, pR669, DOI 10.1152/ajpregu.00655.2003
NR 212
TC 84
Z9 96
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7881
EI 1467-789X
J9 OBES REV
JI Obes. Rev.
PD FEB
PY 2006
VL 7
IS 1
BP 59
EP 78
DI 10.1111/j.1467-789X.2006.00203.x
PG 20
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 007QC
UT WOS:000234983400007
PM 16436103
DA 2025-04-28
ER

PT J
AU Zhang, YZ
   Gu, MX
   Wang, RR
   Li, MW
   Li, DX
   Xie, ZW
AF Zhang, Yanzhong
   Gu, Mingxing
   Wang, Ruru
   Li, Menwan
   Li, Daxiang
   Xie, Zhongwen
TI Dietary supplement of Yunkang 10 green tea and treadmill exercise
   ameliorate high fat diet induced metabolic syndrome of C57BL/6 J mice
SO NUTRITION & METABOLISM
LA English
DT Article
DE Yunkang 10 green tea; Exercise; Metabolic syndrome; Skeletal muscle;
   inflammation; RNAseq
ID NF-KAPPA-B; INSULIN-RESISTANCE; GENE-EXPRESSION; RISK-FACTORS; SEDENTARY
   BEHAVIOR; REGULATORY ELEMENT; VOLUNTARY EXERCISE; PHYSICAL-ACTIVITY;
   BLOOD-PRESSURE; WEIGHT-GAIN
AB Background Diet and exercise play important roles in ameliorating metabolic syndrome. Yunkang 10 (Camellia sinensis var. assamica) is a most cultivated tea variety for making tea in the Southwestern China. Currently, there is no report of healthy effects of Yunkang 10 green tea (YKGT) and treadmill exercise (Ex) on high fat diet induced metabolic syndrome (MetS). We aimed to investigate the beneficial effects and molecular mechanism of YKGT and Ex using high fat diet induced MetS of C57BL/6 mice. Methods Catechins and caffeine in water extract of YKGT were measured via high performance liquid chromatography (HPLC). 10-week old mice were fed with high fat diet (HFD) for 10 weeks to induce obese mice. Then the obese mice were fed with continuous high fat diet (HFD), HFD with YKGT, HFD with Ex, and HFD with both YKGT and Ex for 8 weeks, respectively. The another group of 10-week old mice fed with low fat diet (LFD) were used as control. Results HPLC data revealed that YKGT has abundantly high concentration of epigallocatechin gallate (EGCG) and caffeine compared to Longjing 43 (Camellia sinensis var. sinensis) green tea. YKGT and Ex significantly decreased the level of blood glucose, serum total cholesterol (TC), triglyceride (TG), insulin, and alanine aminotransferase activity (ALT) when compared to HFD group. The fatty liver and hepatic pro-inflammatory gene expression in the YKGT, Ex and YKGT+Ex groups was mitigated significantly compared with HFD group, respectively. The phosphorylation of inhibitor of nuclear factor kappa-B kinase alpha/beta (IKK alpha/beta) and inhibitor of nuclear factor kappa-B alpha (IkB alpha) protein in the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) signaling pathway was also decreased in YKGT or YKGT+Ex groups. The combination of YKGT and Ex prevented gene expression for lipid synthesis in the liver tissue, and significantly upregulated mRNA level of glucose transport genes in the skeletal muscles, when compared to the HFD group. Conclusions This study demonstrated that YKGT supplement or exercise appeared to reverse preexisting metabolic syndrome, and effectively relieved the fatty liver and hepatic inflammatory response induced by high fat diet. YKGT supplement and treadmill exercise together had better beneficial effects than only one intervention.
C1 [Zhang, Yanzhong] Anhui Agr Univ, Dept Sports Sci, Hefei, Anhui, Peoples R China.
   [Zhang, Yanzhong; Gu, Mingxing; Wang, Ruru; Li, Menwan; Li, Daxiang; Xie, Zhongwen] Anhui Agr Univ, Sch Tea & Food Sci & Technol, State Key Lab Tea Plant Biol & Utilizat, 130 West Changjiang Rd, Hefei 230036, Anhui, Peoples R China.
C3 Anhui Agricultural University; Anhui Agricultural University
RP Xie, ZW (corresponding author), Anhui Agr Univ, Sch Tea & Food Sci & Technol, State Key Lab Tea Plant Biol & Utilizat, 130 West Changjiang Rd, Hefei 230036, Anhui, Peoples R China.
EM zhongwenxie@ahau.edu.cn
RI Xie, Zhongwen/I-7705-2019; li, daxiang/H-6815-2017
OI RURU, WANG/0000-0002-7743-2296; Xie, Zhongwen/0000-0002-3080-4881
FU key grant for innovative province from the Department of Sciences and
   Technology of Anhui Province [11080001]; National Sciences Foundation of
   China [31571207]; grant for Nutrition and Quality & Safety of
   Agricultural Products from the Anhui Province Talent Team Program; open
   grant from State Key Laboratory of Tea Plant Biology and Utilization;
   grant for supporting animal core facility in Anhui Agricultural
   University from the Department of Sciences and Technology of Anhui
   Province
FX This research was funded by a key grant for innovative province from the
   Department of Sciences and Technology of Anhui Province to Z. X (Grant
   Number 11080001), the National Sciences Foundation of China to Z.X.
   (Grant Number 31571207), a grant for Nutrition and Quality & Safety of
   Agricultural Products from the Anhui Province Talent Team Program to Z.
   X, a open grant from State Key Laboratory of Tea Plant Biology and
   Utilization to Y. Z, and a grant for supporting animal core facility in
   Anhui Agricultural University from the Department of Sciences and
   Technology of Anhui Province.
CR Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005
   Ahmad RS, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0436-x
   Amozadeh H, 2018, INT J ENDOCRINOL MET, V16, DOI 10.5812/ijem.60738
   Argmann CA, 2017, BBA-MOL BASIS DIS, V1863, P3277, DOI 10.1016/j.bbadis.2017.09.021
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Beals JW, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00087
   Beals JW, 2018, J PHYSIOL-LONDON, V596, P5119, DOI 10.1113/JP276210
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Cialdella-Kam L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070773
   Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6
   Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728
   Cooper AJM, 2014, DIABETOLOGIA, V57, P73, DOI 10.1007/s00125-013-3069-8
   Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521
   Fritschi C, 2016, BIOL RES NURS, V18, P160, DOI 10.1177/1099800415600065
   Gahreman D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080510
   Guruvaiah P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091276
   Haramizu S, 2013, MED SCI SPORT EXER, V45, P1694, DOI 10.1249/MSS.0b013e31828de99f
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177
   Inge TH, 2016, NEW ENGL J MED, V374, P113, DOI 10.1056/NEJMoa1506699
   Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853
   King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246
   Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001
   Lee LS, 2015, MOL NUTR FOOD RES, V59, P784, DOI 10.1002/mnfr.201400470
   Li XM, 2020, CLIN NUTR, V39, P1049, DOI 10.1016/j.clnu.2019.05.019
   Liu DD, 2016, ANIMAL, V10, P1319, DOI 10.1017/S1751731116000380
   Ma SH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111696
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Martin BJ, 2016, J APPL PHYSIOL, V121, P1282, DOI 10.1152/japplphysiol.00657.2016
   Minihane AM, 2015, BRIT J NUTR, V114, P999, DOI 10.1017/S0007114515002093
   Moon JY, 2017, DIABETES, V66, P3001, DOI 10.2337/db17-0573
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2008, AM J PHYSIOL-REG I, V295, pR281, DOI 10.1152/ajpregu.00880.2007
   Pan HT, 2014, PHYSIOL BEHAV, V130, P157, DOI 10.1016/j.physbeh.2014.04.003
   Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Sae-Tan S, 2015, J FUNCT FOODS, V14, P210, DOI 10.1016/j.jff.2015.01.036
   Sae-tan S, 2014, MOL NUTR FOOD RES, V58, P1156, DOI 10.1002/mnfr.201300621
   Santana A, 2015, J NUTR BIOCHEM, V26, P893, DOI 10.1016/j.jnutbio.2015.03.001
   Schiavon CA, 2018, CIRCULATION, V137, P1132, DOI 10.1161/CIRCULATIONAHA.117.032130
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   Snoussi C, 2014, J NUTR BIOCHEM, V25, P557, DOI 10.1016/j.jnutbio.2014.01.006
   Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317
   Stuart CA, 2001, METABOLISM, V50, P771, DOI 10.1053/meta.2001.24202
   Su W, 2012, AM J PHYSIOL-HEART C, V302, pH621, DOI 10.1152/ajpheart.00825.2011
   Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x
   Suzuki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02749
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Teng Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010075
   Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014
   Tsai TW, 2017, BRIT J NUTR, V117, P1343, DOI 10.1017/S0007114517001374
   Ueno T, 2009, INT J MOL MED, V24, P17, DOI 10.3892/ijmm_00000200
   Wang C, 2017, FOOD RES INT, V100, P267, DOI 10.1016/j.foodres.2017.07.013
   Wang RR, 2019, J AGR FOOD CHEM, V67, P5413, DOI 10.1021/acs.jafc.8b05057
   Wang SM, 2017, EUR J NUTR, V56, P2037, DOI 10.1007/s00394-016-1241-x
   Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006
   Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528
   Wu EK, 2020, EUR J NUTR, V59, P1937, DOI 10.1007/s00394-019-02044-y
   Xia EH, 2017, MOL PLANT, V10, P866, DOI 10.1016/j.molp.2017.04.002
   Xie ZW, 2015, J CLIN INVEST, V125, P324, DOI 10.1172/JCI76881
   Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462
   Yan XM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01848
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Zhu MZ, 2017, FOOD RES INT, V94, P36, DOI 10.1016/j.foodres.2017.01.026
NR 68
TC 17
Z9 18
U1 1
U2 25
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD FEB 4
PY 2020
VL 17
IS 1
AR 14
DI 10.1186/s12986-020-0433-9
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA KM2CQ
UT WOS:000513929300002
PM 32042300
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Li, MY
   Liu, HY
   Wu, DT
   Kenaan, A
   Geng, F
   Li, HB
   Gunaratne, A
   Li, H
   Gan, RY
AF Li, Ming-Yue
   Liu, Hong-Yan
   Wu, Ding-Tao
   Kenaan, Ahmad
   Geng, Fang
   Li, Hua-Bin
   Gunaratne, Anil
   Li, Hang
   Gan, Ren-You
TI L-Theanine: A Unique Functional Amino Acid in Tea (Camellia
   sinensis L.) With Multiple Health Benefits and Food Applications
SO FRONTIERS IN NUTRITION
LA English
DT Review
DE L-theanine; tea; health benefits; mechanisms of action; food
   applications
ID KAPPA-B; INDUCED NEUROTOXICITY; ANTIOXIDANT ACTIVITY; UP-REGULATION;
   YELLOW TEA; GREEN TEA; CAFFEINE; GROWTH; TOXICITY; STRESS
AB Tea (Camellia sinensis L.) is a very popular health drink and has attracted increasing attention in recent years due to its various bioactive substances. Among them, L-theanine, a unique free amino acid, is one of the most important substances in tea and endows tea with a special flavor. Moreover, L-theanine is also a bioactive compound with plenty of health benefits, including antioxidant, anti-inflammatory, neuroprotective, anticancer, metabolic regulatory, cardiovascular protective, liver and kidney protective, immune regulatory, and anti-obesity effects. Due to the unique characteristics and beneficial functions, L-theanine has potential applications in the development of functional foods. This review summarized the influencing factors of L-theanine content in teas, the main health benefits and related molecular mechanisms of L-theanine, and its applications in food, understanding of which can provide updated information for the further research of L-theanine.
C1 [Li, Ming-Yue; Wu, Ding-Tao; Geng, Fang; Gan, Ren-You] Chengdu Univ, Sichuan Engn & Technol Res Ctr Coarse Cereal Indus, Sch Food & Biol Engn, Key Lab Coarse Cereal Proc, Chengdu, Peoples R China.
   [Li, Ming-Yue; Liu, Hong-Yan; Li, Hang; Gan, Ren-You] Chinese Acad Agr Sci, Inst Urban Agr, Res Ctr Plants & Human Hlth, Chengdu Natl Agr Sci & Technol Ctr, Chengdu, Peoples R China.
   [Kenaan, Ahmad] Univ Manchester, Natl Graphene Inst, Manchester, Lancashire, England.
   [Li, Hua-Bin] Sun Yat sen Univ, Sch Publ Hlth, Dept Nutr, Guangdong Prov Key Lab Food, Guangzhou, Peoples R China.
   [Gunaratne, Anil] Sabaragamuwa Univ Sri Lanka, Fac Agr Sci, Belihuloya, Sri Lanka.
C3 Chengdu University; Chinese Academy of Agricultural Sciences; Institute
   of Urban Agriculture, CAAS; University of Manchester; Sun Yat Sen
   University; Sabaragamuwa University of Sri Lanka
RP Wu, DT; Gan, RY (corresponding author), Chengdu Univ, Sichuan Engn & Technol Res Ctr Coarse Cereal Indus, Sch Food & Biol Engn, Key Lab Coarse Cereal Proc, Chengdu, Peoples R China.; Gan, RY (corresponding author), Chinese Acad Agr Sci, Inst Urban Agr, Res Ctr Plants & Human Hlth, Chengdu Natl Agr Sci & Technol Ctr, Chengdu, Peoples R China.
EM wudingtao@cdu.edu.cn; ganrenyou@163.com
RI Wu, Ding-Tao/G-2553-2014; Mingyue, Li/GPX-8855-2022; Li,
   Hua-Bin/AEX-9846-2022; Gan, Renyou/C-9868-2009; Li, Hang/AAZ-8070-2021;
   Geng, Fang/W-9992-2019
OI Gan, Ren-You/0000-0002-4162-1511; Li, Hang/0000-0003-4681-8791
FU Opening Fund of the Key Laboratory of Coarse Cereal Processing, Ministry
   of Agriculture and Rural Affairs, Chengdu University [2021CC002];
   Scientific Research Foundation of Chengdu University [2081921047]
FX Funding This research was funded by the Opening Fund of the Key
   Laboratory of Coarse Cereal Processing, Ministry of Agriculture and
   Rural Affairs, Chengdu University (No. 2021CC002), and Scientific
   Research Foundation of Chengdu University (No. 2081921047).
CR Adhikary R, 2017, ASIAN PAC J TROP BIO, V7, P842, DOI 10.1016/j.apjtb.2017.08.005
   Altinkaynak Y, 2018, BIOMED PHARMACOTHER, V108, P1524, DOI 10.1016/j.biopha.2018.09.171
   Baba Y, 2021, J MED FOOD, V24, P333, DOI 10.1089/jmf.2020.4803
   Bai H, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071988
   Nguyen BT, 2019, FOOD FUNCT, V10, P325, DOI [10.1039/c8fo01577e, 10.1039/C8FO01577E]
   Ben PL, 2018, BIOL PHARM BULL, V41, P1678, DOI 10.1248/bpb.b18-00387
   Ben PL, 2016, NEUROTOXICOLOGY, V57, P95, DOI 10.1016/j.neuro.2016.09.010
   Bi AJ, 2020, J NUTR BIOCHEM, V82, DOI 10.1016/j.jnutbio.2020.108398
   Bi W, 2016, ACTA PHARM SIN B, V6, P170, DOI 10.1016/j.apsb.2015.11.003
   Boros K, 2016, PHARMACOGN MAG, V12, P75, DOI 10.4103/0973-1296.176061
   Chen CN, 2018, CHINESE J PHYSIOL, V61, P35, DOI 10.4077/CJP.2018.BAG529
   Chen L, 2020, ARCH PHARM RES, V43, P821, DOI 10.1007/s12272-020-01248-9
   Chen Y, 2020, BIOL PHARM BULL, V43, P938, DOI 10.1248/bpb.b19-00790
   Chen Z, 2021, J AGR FOOD CHEM, V69, P1187, DOI 10.1021/acs.jafc.0c06694
   Cheng SH, 2019, FOOD CHEM, V276, P93, DOI 10.1016/j.foodchem.2018.10.010
   Culetu A, 2016, FOOD CHEM, V197, P14, DOI 10.1016/j.foodchem.2015.10.097
   Culetu A, 2015, INT J FOOD SCI TECH, V50, P413, DOI 10.1111/ijfs.12625
   Dassanayake TL, 2022, NUTR NEUROSCI, V25, P698, DOI 10.1080/1028415X.2020.1804098
   De Felice M, 2021, J NEUROSCI, V41, P739, DOI 10.1523/JNEUROSCI.1050-20.2020
   Deng YL, 2016, J FUNCT FOODS, V24, P527, DOI 10.1016/j.jff.2016.04.029
   Dias TR, 2019, EUR J NUTR, V58, P2961, DOI 10.1007/s00394-019-01999-2
   Dias TR, 2016, FOOD FUNCT, V7, P1301, DOI [10.1039/C5FO01611H, 10.1039/c5fo01611h]
   Dong CX, 2020, PLANT J, V101, P57, DOI 10.1111/tpj.14517
   Dramard V, 2018, IRISH VET J, V71, DOI 10.1186/s13620-018-0130-4
   Eschenauer G, 2006, AM J HEALTH-SYST PH, V63, P26, DOI 10.2146/ajhp050148
   Fan XR, 2021, J NUTR BIOCHEM, V89, DOI 10.1016/j.jnutbio.2020.108556
   Gibson N, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040316
   Gong AD, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02443-y
   Gong ZH, 2019, J FUNCT FOODS, V54, P32, DOI 10.1016/j.jff.2019.01.011
   Gong ZH, 2018, EUR J PHARMACOL, V818, P184, DOI 10.1016/j.ejphar.2017.10.050
   Guo WL, 2019, BIOCHEM BIOPH RES CO, V508, P1126, DOI 10.1016/j.bbrc.2018.11.124
   Guo XY, 2019, FOOD CHEM, V280, P73, DOI 10.1016/j.foodchem.2018.12.066
   Guo YJ, 2017, FOOD CHEM, V237, P645, DOI 10.1016/j.foodchem.2017.05.024
   He J, 2021, J FUNCT FOODS, V81, DOI 10.1016/j.jff.2021.104476
   Hidese S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102362
   Hwang YP, 2017, FOOD CHEM TOXICOL, V99, P162, DOI 10.1016/j.fct.2016.11.032
   Jamwal S, 2017, EUR J PHARMACOL, V811, P171, DOI 10.1016/j.ejphar.2017.06.016
   Jamwal S, 2017, MOL NEUROBIOL, V54, P2327, DOI 10.1007/s12035-016-9822-5
   Jeon DB, 2017, FOOD CHEM, V219, P443, DOI 10.1016/j.foodchem.2016.09.184
   Juszkiewicz A, 2019, J INT SOC SPORT NUTR, V16, DOI 10.1186/s12970-019-0274-y
   Kahathuduwa CN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70037-7
   Kahathuduwa CN, 2018, NUTR RES, V49, P67, DOI 10.1016/j.nutres.2017.11.002
   Kahathuduwa CN, 2017, NUTR NEUROSCI, V20, P369, DOI [10.1080/1028415X.2016.1144845, 10.1080/1028415x.2016.1144845]
   Kakuda T, 2011, PHARMACOL RES, V64, P162, DOI 10.1016/j.phrs.2011.03.010
   Kawashiri T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69674-9
   Kim S, 2019, PHARM BIOL, V57, P65, DOI 10.1080/13880209.2018.1557698
   Kobayashi M, 2020, INT J CLIN ONCOL, V25, P1814, DOI 10.1007/s10147-020-01728-4
   Li CJ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1497097
   Li Chengjian, 2016, Med Sci Monit, V22, P662
   Li F, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01397
   Li X, 2020, J PLANT PHYSIOL, V253, DOI 10.1016/j.jplph.2020.153273
   Lin FJ, 2021, TRENDS FOOD SCI TECH, V109, P126, DOI 10.1016/j.tifs.2021.01.030
   Lin L, 2020, FOOD FUNCT, V11, P1798, DOI [10.1039/c9fo02451d, 10.1039/C9FO02451D]
   Liu A, 2021, FOOD FUNCT, V12, P5755, DOI [10.1039/D1FO00505G, 10.1039/d1fo00505g]
   Liu A, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103670
   Liu JN, 2016, EUR J PHARMACOL, V791, P297, DOI 10.1016/j.ejphar.2016.09.007
   Liu ZW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00498
   Ma H, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104279
   Malkoç M, 2020, LIFE SCI, V249, DOI 10.1016/j.lfs.2020.117502
   Matsuu-Matsuyama M, 2020, ENVIRON TOXICOL PHAR, V78, DOI 10.1016/j.etap.2020.103395
   Nagai K, 2018, PHARMACOLOGY, V101, P219, DOI 10.1159/000486625
   Ninomiya T, 2019, DIABETES CARE, V42, P1234, DOI 10.2337/dc18-2655
   Ogawa S, 2018, PSYCHOPHARMACOLOGY, V235, P37, DOI 10.1007/s00213-017-4743-1
   Park S, 2018, NUTR RES, V60, P116, DOI 10.1016/j.nutres.2018.09.010
   Pérez-Vargas JE, 2016, HUM EXP TOXICOL, V35, P135, DOI 10.1177/0960327115578864
   Qi ZP, 2020, J NANOMATER, V2020, DOI 10.1155/2020/3068173
   Ribeiro M, 2020, FOOD CHEM, V324, DOI 10.1016/j.foodchem.2020.126840
   Saeed M, 2020, POULTRY SCI, V99, P5625, DOI 10.1016/j.psj.2020.07.016
   Saeed M, 2019, POULTRY SCI, V98, P842, DOI 10.3382/ps/pey394
   Saha A, 2018, PHARMACOGN MAG, V14, pS36, DOI 10.4103/pm.pm_595_17
   Sharma E, 2018, FOOD CHEM, V242, P601, DOI 10.1016/j.foodchem.2017.09.046
   Shen MJ, 2019, PHYTOTHER RES, V33, P412, DOI 10.1002/ptr.6237
   Shojaei-Zarghani S, 2021, BIOMED PHARMACOTHER, V134, DOI 10.1016/j.biopha.2020.111140
   Soung HS, 2018, NEUROTOX RES, V34, P375, DOI 10.1007/s12640-018-9897-z
   Sumathi T, 2016, ENVIRON TOXICOL PHAR, V42, P99, DOI 10.1016/j.etap.2016.01.008
   Takarada T, 2016, NEUROCHEM RES, V41, P5, DOI 10.1007/s11064-015-1591-4
   Takeshima M, 2016, J CLIN BIOCHEM NUTR, V59, P93, DOI 10.3164/jcbn.16-15
   Tan JF, 2017, J FOOD COMPOS ANAL, V57, P8, DOI 10.1016/j.jfca.2016.12.011
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Tsai CC, 2019, CHINESE J PHYSIOL, V62, P17, DOI 10.4103/CJP.CJP_8_19
   Tsai WH, 2017, NEUROUROL URODYNAM, V36, P297, DOI 10.1002/nau.22965
   Tsuchiya T, 2016, INT J CLIN ONCOL, V21, P1085, DOI 10.1007/s10147-016-0996-7
   Unno K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010193
   Unno K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010174
   Unno K, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01653
   Unno K, 2016, PHYTOMEDICINE, V23, P1365, DOI 10.1016/j.phymed.2016.07.006
   Wang DX, 2020, FOOD RES INT, V137, DOI 10.1016/j.foodres.2020.109409
   Wang DX, 2018, J AGR FOOD CHEM, V66, P7674, DOI 10.1021/acs.jafc.8b02293
   Wang DX, 2018, J FUNCT FOODS, V45, P181, DOI 10.1016/j.jff.2018.04.001
   Wang RR, 2019, J AGR FOOD CHEM, V67, P5413, DOI 10.1021/acs.jafc.8b05057
   White DJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010053
   Williams J, 2020, FOODS, V9, DOI 10.3390/foods9030371
   Xin YQ, 2018, MOL MED REP, V18, P4535, DOI 10.3892/mmr.2018.9459
   Xu W, 2020, FOOD FUNCT, V11, P8369, DOI [10.1039/D0FO01069C, 10.1039/d0fo01069c]
   Xu XY, 2020, CRIT REV FOOD SCI, V60, P1693, DOI 10.1080/10408398.2019.1588223
   Yan QX, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9747256
   Yang CC, 2020, J FORMOS MED ASSOC, V119, P1405, DOI 10.1016/j.jfma.2019.11.009
   Yu XC, 2016, DRUG CHEM TOXICOL, V39, P217, DOI 10.3109/01480545.2015.1080264
   Zaragoza J, 2019, J INT SOC SPORT NUTR, V16, DOI 10.1186/s12970-019-0326-3
   Zeng L, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110823
   Zeng WJ, 2018, CHEM-BIOL INTERACT, V284, P69, DOI 10.1016/j.cbi.2018.02.019
   Zhang C, 2020, J SCI FOOD AGR, V100, P1718, DOI 10.1002/jsfa.10192
   Zhang GY, 2016, J AGR FOOD CHEM, V64, P7002, DOI 10.1021/acs.jafc.6b02509
   Zhang MM, 2020, LWT-FOOD SCI TECHNOL, V129, DOI 10.1016/j.lwt.2020.109512
   Zhang Y, 2021, ANN PALLIAT MED, V10, P4572, DOI 10.21037/apm-21-663
   Zhao J, 2020, LIFE SCI, V241, DOI 10.1016/j.lfs.2019.117160
   Zhu GQ, 2018, NEUROPHARMACOLOGY, V138, P331, DOI 10.1016/j.neuropharm.2018.06.030
   Zhu YM, 2021, FOOD CHEM, V353, DOI 10.1016/j.foodchem.2021.129428
NR 108
TC 54
Z9 55
U1 34
U2 203
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD APR 4
PY 2022
VL 9
AR 853846
DI 10.3389/fnut.2022.853846
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 0W9WN
UT WOS:000789368800001
PM 35445053
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Gurley, BJ
   Miousse, IR
   Nookaew, I
   Ewing, LE
   Skinner, CM
   Jenjaroenpun, P
   Wongsurawat, T
   Kennon-McGill, S
   Avula, B
   Bae, JY
   McGill, MR
   Ussery, D
   Khan, IA
   Koturbash, I
AF Gurley, Bill J.
   Miousse, Isabelle R.
   Nookaew, Intawat
   Ewing, Laura E.
   Skinner, Charles M.
   Jenjaroenpun, Piroon
   Wongsurawat, Thidathip
   Kennon-McGill, Stefanie
   Avula, Bharathi
   Bae, Ji-Yeong
   McGill, Mitchell R.
   Ussery, David
   Khan, Ikhlas A.
   Koturbash, Igor
TI Decaffeinated Green Tea Extract Does Not Elicit Hepatotoxic Effects and
   Modulates the Gut Microbiome in Lean B6C3F1 Mice
SO NUTRIENTS
LA English
DT Article
DE catechins; green tea extract; herbal dietary supplements;
   hepatotoxicity; microbiome
ID ENERGY-EXPENDITURE; EPIGALLOCATECHIN GALLATE; METABOLIC-FATE; SAFETY
   ASSESSMENT; POLYPHENOLS; CATECHINS; ABSORPTION; EXPRESSION; CAFFEINE;
   SUPPLEMENTATION
AB The main purpose of this study was to investigate the hepatotoxic potential and effects on the gut microbiome of decaffeinated green tea extract (dGTE) in lean B6C3F(1) mice. Gavaging dGTE over a range of 1X-10X mouse equivalent doses (MED) for up to two weeks did not elicit significant histomorphological, physiological, biochemical or molecular alterations in mouse livers. At the same time, administration of dGTE at MED comparable to those consumed by humans resulted in significant modulation of gut microflora, with increases in Akkermansia sp. being most pronounced. Results of this study demonstrate that administration of relevant-to-human-consumption MED of dGTE to non-fasting mice does not lead to hepatotoxicity. Furthermore, dGTE administered to lean mice, caused changes in gut microflora comparable to those observed in obese mice. This study provides further insight into the previously reported weight management properties of dGTE; however, future studies are needed to fully evaluate and understand this effect.
C1 [Gurley, Bill J.] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA.
   [Gurley, Bill J.; Skinner, Charles M.; McGill, Mitchell R.; Koturbash, Igor] Univ Arkansas Med Sci, Ctr Dietary Supplements Res, Little Rock, AR 72205 USA.
   [Miousse, Isabelle R.; Ewing, Laura E.; Skinner, Charles M.; Kennon-McGill, Stefanie; McGill, Mitchell R.; Koturbash, Igor] Univ Arkansas Med Sci, Dept Environm & Occupat Hlth, Little Rock, AR 72205 USA.
   [Miousse, Isabelle R.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.
   [Nookaew, Intawat; Jenjaroenpun, Piroon; Wongsurawat, Thidathip; Ussery, David] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA.
   [Ewing, Laura E.; McGill, Mitchell R.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.
   [Avula, Bharathi; Bae, Ji-Yeong; Khan, Ikhlas A.] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA.
C3 University of Arkansas System; University of Arkansas Medical Sciences;
   University of Arkansas System; University of Arkansas Medical Sciences;
   University of Arkansas System; University of Arkansas Medical Sciences;
   University of Arkansas System; University of Arkansas Medical Sciences;
   University of Arkansas System; University of Arkansas Medical Sciences;
   University of Arkansas System; University of Arkansas Medical Sciences;
   University of Mississippi
RP Koturbash, I (corresponding author), Univ Arkansas Med Sci, Ctr Dietary Supplements Res, Little Rock, AR 72205 USA.; Koturbash, I (corresponding author), Univ Arkansas Med Sci, Dept Environm & Occupat Hlth, Little Rock, AR 72205 USA.
EM GurleyBillyJ@uams.edu; IRacinemiousse@uams.edu; INookaew@uams.edu;
   LEEwing@uams.edu; CMSkinner@uams.edu; PJenjaroenpun@uams.edu;
   TWongsurawat@uams.edu; SKennonmcgill@uams.edu; bavula@olemiss.edu;
   jbae7@olemiss.edu; MMcgill@uams.edu; DWUssery@uams.edu;
   ikhan@olemiss.edu; IKoturbash@uams.edu
RI Gurley, Bill/GQP-7738-2022; Khan, Ikhlas/AAA-1829-2020; Miousse,
   Isabelle/K-3512-2013; Bae, Ji-Yeong/AAD-5985-2019; McGill,
   Mitchell/AFL-8840-2022; Ussery, David/J-2026-2019; Khan,
   Ikhlas/AAA-1490-2020; Kennon-McGill, Stefanie/IAN-7416-2023; Ewing,
   Laura/AAG-3877-2021
OI Wongsurawat, Thidathip/0000-0002-3659-2074; Miousse, Isabelle
   R./0000-0001-6543-3219; Ussery, David/0000-0003-3632-5512; McGill,
   Mitchell/0000-0002-0401-0463; Ewing, Laura/0000-0001-8496-8518
FU National Institute of General Medical Sciences [P20 GM109005,
   P20GM125503]; Arkansas Biosciences Institute; Helen Adams & Arkansas
   Research Alliance Endowment
FX This work was supported by the National Institute of General Medical
   Sciences (P20 GM109005 and P20GM125503) and Arkansas Biosciences
   Institute. DWU, IN, PJ and TW are supported by the Helen Adams &
   Arkansas Research Alliance Endowment.
CR Auger C, 2008, J NUTR, V138, P1535
   Bajzer M, 2006, NATURE, V444, P1009, DOI 10.1038/4441009a
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brown AC, 2017, FOOD CHEM TOXICOL, V107, P472, DOI 10.1016/j.fct.2016.07.001
   Chen LS, 1997, DRUG METAB DISPOS, V25, P1045
   Cheng M, 2017, FOOD RES INT, V92, P9, DOI 10.1016/j.foodres.2016.12.008
   Church RJ, 2015, FOOD CHEM TOXICOL, V76, P19, DOI 10.1016/j.fct.2014.11.008
   Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521
   Coyle CH, 2008, LIFE SCI, V83, P12, DOI 10.1016/j.lfs.2008.04.010
   de Boer YS, 2017, CLIN LIVER DIS, V21, P135, DOI 10.1016/j.cld.2016.08.010
   Dekant W, 2017, TOXICOL LETT, V277, P104, DOI 10.1016/j.toxlet.2017.06.008
   Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0
   Donovan JL, 2002, BRIT J NUTR, V87, P299, DOI 10.1079/BJN2001517
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Foong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139656
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   García-Cortés M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040537
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Gurley BJ, 2018, CLIN PHARMACOL THER, V104, P470, DOI 10.1002/cpt.1131
   Gurley BJ, 2015, CLIN THER, V37, P275, DOI 10.1016/j.clinthera.2014.08.012
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004
   Ikarashi N, 2017, EUR J PHARM SCI, V100, P211, DOI 10.1016/j.ejps.2017.01.022
   Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P636, DOI 10.1016/j.fct.2005.11.003
   Isomura T, 2016, EUR J CLIN NUTR, V70, P1340, DOI 10.1038/ejcn.2016.165
   Janssens PLHR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153134
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jenner AM, 2005, FREE RADICAL BIO MED, V38, P763, DOI 10.1016/j.freeradbiomed.2004.11.020
   Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006
   Kapetanovic IM, 2009, TOXICOLOGY, V260, P28, DOI 10.1016/j.tox.2009.03.007
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Kohri T, 2003, J AGR FOOD CHEM, V51, P5561, DOI 10.1021/jf034450x
   Kohri T, 2001, J AGR FOOD CHEM, V49, P4102, DOI 10.1021/jf001491+
   Lambert JD, 2005, AM J CLIN NUTR, V81, p284S, DOI 10.1093/ajcn/81.1.284S
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mazzanti G, 2015, ARCH TOXICOL, V89, P1175, DOI 10.1007/s00204-015-1521-x
   Mcgill MR, 2015, TOXICOL MECH METHOD, V25, P589, DOI 10.3109/15376516.2015.1094844
   Miousse IR, 2017, FOOD CHEM TOXICOL, V109, P194, DOI 10.1016/j.fct.2017.08.025
   Miousse IR, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0576-0
   Most J, 2014, INT J OBESITY, V38, P698, DOI 10.1038/ijo.2013.231
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Navarro VJ, 2017, HEPATOLOGY, V65, P363, DOI 10.1002/hep.28813
   Okushio K, 1999, DRUG METAB DISPOS, V27, P309
   Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Roytman MM, 2018, CLIN PHARMACOL THER, V104, P458, DOI 10.1002/cpt.1097
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Skinner CM, 2018, FOOD CHEM TOXICOL, V122, P21, DOI 10.1016/j.fct.2018.09.067
   Stalmach A, 2009, MOL NUTR FOOD RES, V53, pS44, DOI 10.1002/mnfr.200800169
   Surapaneni BK, 2018, CLIN MED INSIGHTS-GA, V11, DOI 10.1177/1179552218779970
   Tan XL, 2010, J NUTR, V140, P1404, DOI 10.3945/jn.110.121905
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Väremo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111
   Wang L, 2016, FOOD FUNCT, V7, P4956, DOI [10.1039/c6fo01150k, 10.1039/C6FO01150K]
   Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI 10.1093/ajcn/81.1.243S
   Wojcikowski K, 2014, PHYTOTHER RES, V28, P22, DOI 10.1002/ptr.4966
   Wu KM, 2011, INT J TOXICOL, V30, P19, DOI 10.1177/1091581810387445
   Xue B, 2016, FOOD FUNCT, V7, P1501, DOI 10.1039/c5fo01438g
   Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351
   Yuan XJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800178
   Zhang X, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800274
NR 67
TC 16
Z9 16
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD APR
PY 2019
VL 11
IS 4
AR 776
DI 10.3390/nu11040776
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HX9SX
UT WOS:000467749800069
PM 30987244
OA Green Submitted, gold, Green Published
DA 2025-04-28
ER

PT J
AU Choi, M
   Mukherjee, S
   Yun, JW
AF Choi, Minji
   Mukherjee, Sulagna
   Yun, Jong Won
TI Trigonelline induces browning in3T3-L1white adipocytes
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE anti-obesity; beige adipocyte; fat browning; obesity; trigonelline
ID NICOTINIC-ACID; WHITE FAT; LIPID-ACCUMULATION; NATURAL-PRODUCTS; NIACIN;
   COFFEE; DIFFERENTIATION; ENERGY; ASSAY
AB Trigonelline, a major alkaloid component of fenugreek, has been demonstrated to have several biological activities, including antidiabetic and anticancer effects. This study aimed to examine the possible application of trigonelline as an anti-obesity compound based on an investigation of its enhancement of lipid catabolism and induction of browning in white adipocytes. Trigonelline induces browning of 3T3-L1 white adipocytes by enhancing the expressions of brown-fat signature proteins and genes as well as beige-specific genes, includingCd137,Cited1,Tbx1, andTmem26. Trigonelline also improves lipid metabolism in white adipocytes by decreasing adipogenesis and lipogenesis as well as promotes lipolysis and fatty acid oxidation. Moreover, trigonelline increases the expression ofCox4,Nrf1, andTfamgenes that are responsible for mitochondrial biogenesis. Mechanistic studies revealed that the browning effect of trigonelline in 3T3-L1 white adipocytes is mediated by activating beta 3-AR and inhibiting PDE4, thereby stimulating the p38 MAPK/ATF-2 signaling pathway. Considering its high bioavailability in humans and the results of this study, trigonelline may have potential as an anti-obesity compound.
C1 [Choi, Minji; Mukherjee, Sulagna; Yun, Jong Won] Daegu Univ, Dept Biotechnol, Gyongsan 38453, Gyeongbuk, South Korea.
C3 Daegu University
RP Yun, JW (corresponding author), Daegu Univ, Dept Biotechnol, Gyongsan 38453, Gyeongbuk, South Korea.
EM jwyun@daegu.ac.kr
RI Mukherjee, Sulagna/AAJ-6217-2021
OI Yun, Jong Won/0000-0003-2453-2282; Mukherjee,
   Sulagna/0000-0001-6595-4137
FU National Research Foundation of Korea [2019R1A2C2002163]
FX National Research Foundation of Korea, Grant/Award Number:
   2019R1A2C2002163
CR Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Azhar Y, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0150-6
   Cheng ZX, 2013, CHIN J NAT MEDICINES, V11, P164, DOI [10.1016/S1875-5364(13)60044-8, 10.3724/SP.J.1009.2013.00164]
   Christian M., 2017, ENDOCRIONOLOGIST, V126, P15
   Concha F, 2019, REV ENDOCR METAB DIS, V20, P161, DOI 10.1007/s11154-019-09495-y
   Costa MC, 2020, J NUTR BIOCHEM, V76, DOI 10.1016/j.jnutbio.2019.108303
   de Jong JMA, 2017, AM J PHYSIOL-ENDOC M, V312, pE508, DOI 10.1152/ajpendo.00437.2016
   GRANNEMAN JG, 1995, CELL SIGNAL, V7, P9, DOI 10.1016/0898-6568(94)00066-K
   Heinrich M, 2020, J ETHNOPHARMACOL, V246, DOI 10.1016/j.jep.2019.112230
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hirakawa N, 2005, BIOSCI BIOTECH BIOCH, V69, P653, DOI 10.1271/bbb.69.653
   Ilavenil S, 2014, PHYTOMEDICINE, V21, P758, DOI 10.1016/j.phymed.2013.11.007
   Izzo AA, 2020, BRIT J PHARMACOL, V177, P2169, DOI 10.1111/bph.15054
   Jang MH, 2020, EUR J NUTR, V59, P3503, DOI 10.1007/s00394-020-02184-6
   Jang MH, 2018, BIOTECHNOL BIOPROC E, V23, P617, DOI 10.1007/s12257-018-0434-y
   Jeremic N, 2017, J CELL PHYSIOL, V232, P61, DOI 10.1002/jcp.25450
   Jiang YW, 2017, ELIFE, V6, DOI 10.7554/eLife.30329
   Kang NH, 2020, PFLUG ARCH EUR J PHY, V472, P583, DOI 10.1007/s00424-020-02380-7
   Li D, 2010, WORLD J GASTROENTERO, V16, P2378, DOI 10.3748/wjg.v16.i19.2378
   Mele L, 2017, ADV NUTR, V8, P694, DOI 10.3945/an.117.015792
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mukherjee S, 2020, BIOTECHNOL BIOPROC E, V25, P29, DOI 10.1007/s12257-020-0023-8
   Mushtaq S, 2018, EXCLI J, V17, P420, DOI 10.17179/excli2018-1174
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Petropoulos GA, 2002, MED AROM PLANTS, V11, P1
   Sharma L, 2018, FOOD CHEM TOXICOL, V121, P283, DOI 10.1016/j.fct.2018.09.011
   Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362
   Silvester AJ, 2019, J NUTR BIOCHEM, V64, P1, DOI 10.1016/j.jnutbio.2018.09.028
   Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5
   Subramanian S.P., 2014, Biomed. Preven. Nutrit, V4, P475, DOI [10.1016/j.bionut.2014.07.001, DOI 10.1016/J.BIONUT.2014.07.001, 10.1016/J.BIONUT.2014.07.001]
   Trugo L C., 2003, Encyclopedia of Food Sciences and Nutrition, V3, P1498
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Wanders D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071285
   Ye LY, 2019, FASEB J, V33, P4765, DOI [10.1096/fj.201801951R, 10.1096/fj.201801951r]
   Yoshinari O, 2010, CURR MED CHEM, V17, P2196, DOI 10.2174/092986710791299902
   Yoshinari O, 2009, BIOSCI BIOTECH BIOCH, V73, P1033, DOI 10.1271/bbb.80805
   Zeman M, 2015, MED SCI MONITOR, V21, P2156, DOI 10.12659/MSM.893619
   Zhang DF, 2015, ASIAN PAC J TROP MED, V8, P639, DOI 10.1016/j.apjtm.2015.07.012
   Zhang JM, 2018, PHYSIOL RES, V67, P347, DOI 10.33549/physiolres.933650
   Zhang X, 2018, CELL REP, V24, P3180, DOI 10.1016/j.celrep.2018.08.055
   Zhou J, 2012, CURR MED CHEM, V19, P3523, DOI 10.2174/092986712801323171
   Zhou JY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/164219
   Zhou JY, 2013, FUND CLIN PHARMACOL, V27, P279, DOI 10.1111/j.1472-8206.2011.01022.x
NR 44
TC 39
Z9 42
U1 3
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD FEB
PY 2021
VL 35
IS 2
BP 1113
EP 1124
DI 10.1002/ptr.6892
EA OCT 2020
PG 12
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA QL6VR
UT WOS:000574896200001
PM 33015893
DA 2025-04-28
ER

PT J
AU Brown, L
   Poudyal, H
   Panchal, SK
AF Brown, L.
   Poudyal, H.
   Panchal, S. K.
TI Functional foods as potential therapeutic options for metabolic syndrome
SO OBESITY REVIEWS
LA English
DT Review
DE Flavonoids; functional food; obesity; prebiotics
ID HIGH-FAT-DIET; CONJUGATED LINOLEIC-ACID; BROWN ADIPOSE-TISSUE; HEPATIC
   LIPID-ACCUMULATION; MEDIUM-CHAIN TRIGLYCERIDE; PURIFIED EICOSAPENTAENOIC
   ACID; CARDIOVASCULAR RISK-FACTORS; INDUCED INSULIN-RESISTANCE; ACTIVATED
   PROTEIN-KINASE; REDUCES ADIPOCYTE SIZE
AB Obesity as part of metabolic syndrome is a major lifestyle disorder throughout the world. Current drug treatments for obesity produce small and usually unsustainable decreases in body weight with the risk of major adverse effects. Surgery has been the only treatment producing successful long-term weight loss. As a different but complementary approach, lifestyle modification including the use of functional foods could produce a reliable decrease in obesity with decreased comorbidities. Functional foods may include fruits such as berries, vegetables, fibre-enriched grains and beverages such as tea and coffee. Although health improvements continue to be reported for these functional foods in rodent studies, further evidence showing the translation of these results into humans is required. Thus, the concept that these fruits and vegetables will act as functional foods in humans to reduce obesity and thereby improve health remains intuitive and possible rather than proven.
C1 [Brown, L.; Panchal, S. K.] Univ So Queensland, Inst Agr & Environm, Toowoomba, Qld 4350, Australia.
   [Brown, L.] Univ So Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld 4350, Australia.
   [Poudyal, H.] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Hakubi Ctr Adv Res, Kyoto, Japan.
C3 University of Southern Queensland; University of Southern Queensland;
   Kyoto University
RP Panchal, SK (corresponding author), Univ So Queensland, Inst Agr & Environm, Toowoomba, Qld 4350, Australia.
EM Sunil.Panchal@usq.edu.au
RI Poudyal, Hemant/HOH-9324-2023
OI Panchal, Sunil K/0000-0001-5464-3376
CR Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362
   Abenavoli L, 2014, REV RECENT CLIN TRIA, V9, P134, DOI 10.2174/1574887109666141216102458
   Adan RAH, 2008, TRENDS PHARMACOL SCI, V29, P208, DOI 10.1016/j.tips.2008.01.008
   Adiels M, 2008, CURR DIABETES REP, V8, P60, DOI 10.1007/s11892-008-0011-4
   Agatston AS, 2005, CLEV CLIN J MED, V72, P946, DOI 10.3949/ccjm.72.10.946
   Aguilar F, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3145
   Aguirre L, 2014, MOLECULES, V19, P18632, DOI 10.3390/molecules191118632
   Al-Sheraji SH, 2013, J FUNCT FOODS, V5, P1542, DOI 10.1016/j.jff.2013.08.009
   Alberdi G, 2013, FOOD CHEM, V141, P1530, DOI 10.1016/j.foodchem.2013.03.085
   Alissa EM, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/569486
   Alligier M, 2014, OBESITY, V22, P1653, DOI 10.1002/oby.20733
   An HM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-116
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Arai T, 2009, J ATHEROSCLER THROMB, V16, P283, DOI 10.5551/jat.E463
   Arias N, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0361-7
   Arnaud Maurice J, 2011, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-642-13443-2_3
   Ascacio-Valdés JA, 2011, J MED PLANTS RES, V5, P4696
   Assunçao ML, 2009, LIPIDS, V44, P593, DOI 10.1007/s11745-009-3306-6
   Astell KJ, 2013, COMPLEMENT THER MED, V21, P180, DOI 10.1016/j.ctim.2013.01.004
   Aureli P, 2011, PHARMACOL RES, V63, P366, DOI 10.1016/j.phrs.2011.02.006
   Azizi-Soleiman F, 2013, INT J PREVENTIVE MED, V4, P922
   Bachmann K, 1996, ENVIRON HEALTH PERSP, V104, P400, DOI 10.2307/3432684
   Baek SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep03879
   Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003
   Baranowski M, 2012, CYTOKINE, V59, P382, DOI 10.1016/j.cyto.2012.04.004
   Barnes AS, 2012, TEX HEART I J, V39, P224
   Barre Douglas Edward, 2007, J Oleo Sci, V56, P319
   Bellesia A, 2015, INT J FOOD SCI NUTR, V66, P85, DOI 10.3109/09637486.2014.953455
   Ben Amara N, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0410-x
   Bender N, 2014, OBES REV, V15, P657, DOI 10.1111/obr.12189
   Bes-Rastrollo M, 2010, OLIVES AND OLIVE OIL IN HEALTH AND DISEASE PREVENTION, P895, DOI 10.1016/B978-0-12-374420-3.00096-6
   Beserra BTS, 2015, CLIN NUTR, V34, P845, DOI 10.1016/j.clnu.2014.10.004
   Binnendijk KH, 2013, BENEF MICROBES, V4, P223, DOI 10.3920/BM2013.0019
   Bjermo H, 2012, AM J CLIN NUTR, V95, P1003, DOI 10.3945/ajcn.111.030114
   Blankson H, 2000, J NUTR, V130, P2943, DOI 10.1093/jn/130.12.2943
   Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Borrelli RC, 2005, MOL NUTR FOOD RES, V49, P673, DOI 10.1002/mnfr.200500011
   Bray GA, 2002, J NUTR, V132, P2488, DOI 10.1093/jn/132.9.2488
   Bray GA, 2014, BEST PRACT RES CL GA, V28, P665, DOI 10.1016/j.bpg.2014.07.015
   Broeders E, 2015, ANN MED, V47, P123, DOI 10.3109/07853890.2013.874663
   Brunerova L, 2007, DIABETIC MED, V24, P533, DOI 10.1111/j.1464-5491.2007.02104.x
   Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Cao K, 2014, FREE RADICAL BIO MED, V67, P396, DOI 10.1016/j.freeradbiomed.2013.11.029
   Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001
   CARLOTTI M, 1993, ANN NY ACAD SCI, V683, P349
   Chachay VS, 2014, CLIN GASTROENTEROL H, V12, P2092, DOI 10.1016/j.cgh.2014.02.024
   Chajès V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118206
   Chan EW, 2013, OBES REV, V14, P383, DOI 10.1111/obr.12015
   Chandler PD, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2014.44
   Chechi K, 2010, BRIT J NUTR, V104, P1313, DOI 10.1017/S0007114510002187
   Chen JJ, 2011, EXP BIOL MED, V236, P823, DOI 10.1258/ebm.2011.010399
   Chen JJ, 2012, BRIT J NUTR, V107, P1429, DOI 10.1017/S0007114511004491
   Chen ZY, 2014, CAN J PHYSIOL PHARM, V92, P797, DOI 10.1139/cjpp-2014-0169
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cheung BMY, 2013, THER ADV DRUG SAF, V4, P171, DOI 10.1177/2042098613489721
   Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746
   Coelho MS, 2010, REGUL PEPTIDES, V162, P61, DOI 10.1016/j.regpep.2010.03.008
   Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341
   Covas MI, 2006, NUTR REV, V64, pS20, DOI 10.1111/j.1753-4887.2006.tb00260.x
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766
   Crescenzo R, 2014, EXP PHYSIOL, V99, P1203, DOI 10.1113/expphysiol.2014.079632
   da Costa CAS, 2013, HORM METAB RES, V45, P652, DOI 10.1055/s-0033-1345150
   da Silva ST, 2013, NUTR HOSP, V28, P1039, DOI 10.3305/nh.2013.28.4.6525
   Daniel D, 2015, J COMMUNITY HOSP INT, V5, DOI 10.3402/jchimp.v5.26069
   Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856
   de Ligt M, 2015, BBA-MOL BASIS DIS, V1852, P1137, DOI 10.1016/j.bbadis.2014.11.012
   de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028
   de Roos B, 1999, CURR OPIN LIPIDOL, V10, P41, DOI 10.1097/00041433-199902000-00008
   de Wit N, 2012, AM J PHYSIOL-GASTR L, V303, pG589, DOI 10.1152/ajpgi.00488.2011
   Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126
   desLuis DA, 2011, NUTR HOSP, V26, P827
   DeWeerdt S, 2014, NATURE, V508, pS61, DOI 10.1038/508S61a
   Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304
   Diaz MB, 2014, METABOLISM, V63, P1238, DOI 10.1016/j.metabol.2014.07.002
   DiBaise JK., 2012, AM J GASTROENTEROL, V1, P22, DOI DOI 10.1038/AJGSUP.2012.5
   Dilzer A, 2012, CRIT REV FOOD SCI, V52, P488, DOI 10.1080/10408398.2010.501409
   Do GM, 2012, MOL NUTR FOOD RES, V56, P1282, DOI 10.1002/mnfr.201200067
   Dombrowski S U, 2014, BMJ, V348, pg2646, DOI 10.1136/bmj.g2646
   DOUGLAS JG, 1982, PHARMACOL THERAPEUT, V18, P351, DOI 10.1016/0163-7258(82)90037-7
   Dulloo AG, 1996, EUR J CLIN NUTR, V50, P152
   Ebaid GMX, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-46
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Faintuch J, 2007, OBES SURG, V17, P341, DOI 10.1007/s11695-007-9062-x
   Feitoza AB, 2009, NUTR HOSP, V24, P422
   Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132
   Fiori JL, 2013, DIABETES, V62, P3500, DOI 10.2337/db13-0266
   Fleming JW, 2013, ANN PHARMACOTHER, V47, P1007, DOI [10.1345/aph.1R779, 10.1345/aph.1r779]
   Franco J. G., 2015, EUR J NUTR, DOI [10.1007/s00394-015-0880-7, DOI 10.1007/S00394-00015-00880-00397]
   Franco JG, 2013, J NUTR BIOCHEM, V24, P960, DOI 10.1016/j.jnutbio.2012.06.019
   Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1
   Gebauer SK, 2011, ADV NUTR, V2, P332, DOI 10.3945/an.111.000521
   Genta S, 2009, CLIN NUTR, V28, P182, DOI 10.1016/j.clnu.2009.01.013
   Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y
   Glade MJ, 2010, NUTRITION, V26, P932, DOI 10.1016/j.nut.2010.08.004
   Glanville J, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0004-5
   Gómez-Zorita S, 2012, BRIT J NUTR, V107, P202, DOI 10.1017/S0007114511002753
   Gómez-Zorita S, 2014, J AGR FOOD CHEM, V62, P8371, DOI 10.1021/jf501318b
   Gómez-Zorita S, 2013, NUTRITION, V29, P1374, DOI 10.1016/j.nut.2013.04.014
   Gong JA, 2011, AM J CLIN NUTR, V93, P186, DOI 10.3945/ajcn.110.006502
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Grimsgaard S, 1997, AM J CLIN NUTR, V66, P649, DOI 10.1093/ajcn/66.3.649
   Gulvady AA, 2013, J NUTR BIOCHEM, V24, P1625, DOI 10.1016/j.jnutbio.2013.02.003
   Guo HH, 2015, REV ENDOCR METAB DIS, V16, P1, DOI 10.1007/s11154-014-9302-z
   Guo HH, 2012, J NUTR BIOCHEM, V23, P349, DOI 10.1016/j.jnutbio.2010.12.013
   Halford JCG, 2006, APPETITE, V46, P6, DOI 10.1016/j.appet.2005.07.010
   Han JR, 2007, METABOLISM, V56, P985, DOI 10.1016/j.metabol.2007.03.005
   Han JR, 2003, OBES RES, V11, P734, DOI 10.1038/oby.2003.103
   Hartmann-Boyce J, 2014, OBES REV, V15, P920, DOI 10.1111/obr.12220
   Hartmann-Boyce J, 2014, OBES REV, V15, P598, DOI 10.1111/obr.12165
   Hassanali Z, 2010, DIABETES OBES METAB, V12, P139, DOI 10.1111/j.1463-1326.2009.01130.x
   Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007
   Hellmann J, 2013, J IMMUNOL, V191, P1383, DOI 10.4049/jimmunol.1203369
   Henagan TM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0451-1
   Fernandes AAH, 2010, BIOMED PHARMACOTHER, V64, P214, DOI 10.1016/j.biopha.2009.08.007
   HORROBIN DF, 1992, PROG LIPID RES, V31, P163, DOI 10.1016/0163-7827(92)90008-7
   Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r
   Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Hussein N, 2005, J LIPID RES, V46, P269, DOI 10.1194/jlr.M400225-JLR200
   Ibrügger S, 2012, APPETITE, V58, P490, DOI 10.1016/j.appet.2011.12.024
   Iepsen EW, 2014, EXPERT OPIN PHARMACO, V15, P2487, DOI 10.1517/14656566.2014.965678
   Ilich JZ, 2014, ARH HIG RADA TOKSIKO, V65, P139, DOI 10.2478/10004-1254-65-2014-2541
   Ivanova Z, 2014, EUR J NUTR, DOI [10.1007/s00394-00014-00782-00390, DOI 10.1007/S00394-00014-00782-00390]
   Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179
   Jacome-Sosa MM, 2014, J NUTR BIOCHEM, V25, P692, DOI 10.1016/j.jnutbio.2014.02.011
   Jakobsen MU, 2013, BRIT J NUTR, V109, P353, DOI 10.1017/S0007114512001079
   Jensen MG, 2013, OBES REV, V14, P129, DOI 10.1111/j.1467-789X.2012.01056.x
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004
   Jourdes M, 2011, ANAL BIOANAL CHEM, V401, P1531, DOI 10.1007/s00216-011-4949-8
   Jurgonski A, 2015, EUR J NUTR, V54, P991, DOI 10.1007/s00394-014-0775-z
   Juzwiak S, 2005, PHARMACOL REP, V57, P604
   Kam PCA, 2002, ANAESTHESIA, V57, P1083, DOI 10.1046/j.1365-2044.2002.02823.x
   Kang JH, 2010, J MICROBIOL, V48, P712, DOI 10.1007/s12275-010-0363-8
   Karlsen A, 2007, J NUTR, V137, P1951
   Katan MB, 2012, BENEF MICROBES, V3, P85, DOI 10.3920/BM2012.0008
   Kaume L, 2012, J FUNCT FOODS, V4, P480, DOI 10.1016/j.jff.2012.02.008
   Kechagia Maria, 2013, ISRN Nutr, V2013, P481651, DOI 10.5402/2013/481651
   Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003
   Kim HY, 2015, MOLECULES, V20, P3107, DOI 10.3390/molecules20023107
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713
   Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012
   Konings E, 2014, INT J OBESITY, V38, P470, DOI 10.1038/ijo.2013.155
   Krishna KM, 2005, CAN J PHYSIOL PHARM, V83, P343, DOI [10.1139/y05-009, 10.1139/Y05-009]
   Kunesová M, 2012, PHYSIOL RES, V61, P597, DOI 10.33549/physiolres.932414
   Kwon JY, 2012, J BIOL CHEM, V287, P11566, DOI 10.1074/jbc.M111.259721
   Lacroix É, 2012, AM J CLIN NUTR, V95, P318, DOI 10.3945/ajcn.111.023408
   Lai M, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.30
   Lai YHL, 2013, CLIN NUTR, V32, P966, DOI 10.1016/j.clnu.2013.05.002
   Larsen TM, 2003, J LIPID RES, V44, P2234, DOI 10.1194/jlr.R300011-JLR200
   Le NH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/834294
   Lee JH, 2009, NAT REV CARDIOL, V6, P753, DOI 10.1038/nrcardio.2009.188
   Lee K, 2007, J APPL MICROBIOL, V103, P1140, DOI 10.1111/j.1365-2672.2007.03336.x
   Lee LS, 2015, MOL NUTR FOOD RES, V59, P784, DOI 10.1002/mnfr.201400470
   Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82
   Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513
   Lei F, 2007, INT J OBESITY, V31, P1023, DOI 10.1038/sj.ijo.0803502
   Li SY, 2008, OBESITY, V16, P811, DOI 10.1038/oby.2007.116
   Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012
   Liberato MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036297
   Lim JX, 2013, FASEB J, V27, P4757, DOI 10.1096/fj.13-232702
   Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582
   Lin PH, 2012, OBESITY, V20, P571, DOI 10.1038/oby.2011.17
   Liu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091163
   Liu YX, 2009, INDIAN J MED RES, V129, P150
   López-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007
   Lorente-Cebrián S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4
   Lou-Bonafonte JM, 2012, CURR VASC PHARMACOL, V10, P392
   Luo J, 2000, J NUTR, V130, P1572, DOI 10.1093/jn/130.6.1572
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mahmoud AAA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106993
   Makino-Wakagi Y, 2012, BIOCHEM BIOPH RES CO, V417, P880, DOI 10.1016/j.bbrc.2011.12.067
   Malaguarnera M, 2012, DIGEST DIS SCI, V57, P545, DOI 10.1007/s10620-011-1887-4
   Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085
   Mamikutty N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/263897
   Maric G, 2014, ACTA PHYSIOL HUNG, V101, P395, DOI 10.1556/APhysiol.101.2014.4.1
   Marineli RD, 2015, NUTRITION, V31, P740, DOI 10.1016/j.nut.2014.11.009
   Marseglia L, 2015, INT J MOL SCI, V16, P378, DOI 10.3390/ijms16010378
   Martin CK, 2015, OBESITY, V23, P935, DOI 10.1002/oby.21063
   Martínez-Victoria E, 2012, BRIT J NUTR, V107, pS107, DOI 10.1017/S000711451200150X
   Mason C, 2014, AM J CLIN NUTR, V99, P1015, DOI 10.3945/ajcn.113.073734
   Masquio DCL, 2015, BRIT J NUTR, V113, P1920, DOI 10.1017/S0007114515001129
   McCrorie TA, 2011, NUTR RES REV, V24, P206, DOI 10.1017/S0954422411000114
   McGill AT, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-30
   Medjakovic S, 2013, FOOD FUNCT, V4, P19, DOI 10.1039/c2fo30034f
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007
   Mohankumar SK, 2013, BRIT J NUTR, V109, P1628, DOI 10.1017/S000711451200339X
   Moon J, 2013, FOOD CHEM TOXICOL, V58, P347, DOI 10.1016/j.fct.2013.05.006
   Morales FJ, 2012, AMINO ACIDS, V42, P1097, DOI 10.1007/s00726-010-0774-1
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Moreno MF, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-84
   Moreno-Luna R, 2012, AM J HYPERTENS, V25, P1299, DOI 10.1038/ajh.2012.128
   Mori Y, 1999, METABOLISM, V48, P1089, DOI 10.1016/S0026-0495(99)90120-8
   Moroti C, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-29
   Morrison Shaun F, 2012, Front Endocrinol (Lausanne), V3
   Motard-Bélanger A, 2008, AM J CLIN NUTR, V87, P593, DOI 10.1093/ajcn/87.3.593
   Moussavi N, 2008, OBESITY, V16, P7, DOI 10.1038/oby.2007.14
   Moy GA, 2013, PHYSIOL BEHAV, V109, P69, DOI 10.1016/j.physbeh.2012.11.008
   Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035
   Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Münzberg H, 2015, OBES REV, V16, P77, DOI 10.1111/obr.12258
   Mumme K, 2015, J ACAD NUTR DIET, V115, P249, DOI 10.1016/j.jand.2014.10.022
   Murkovic M, 2004, J BIOCHEM BIOPH METH, V61, P155, DOI 10.1016/j.jbbm.2004.04.002
   Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505
   Mykkänen OT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114790
   Nagao K, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-8
   Nagao K, 2010, PHARMACOL RES, V61, P208, DOI 10.1016/j.phrs.2009.11.007
   Nakamura K, 2011, J PHYSIOL-LONDON, V589, P3641, DOI 10.1113/jphysiol.2011.210047
   Nakamura YK, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-60
   Nedergaard J, 2010, ANN NY ACAD SCI, V1212, pE20, DOI 10.1111/j.1749-6632.2010.05905.x
   Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]
   Nimptsch K, 2010, PUBLIC HEALTH NUTR, V13, P1636, DOI 10.1017/S1368980009993041
   Norris LE, 2009, AM J CLIN NUTR, V90, P468, DOI 10.3945/ajcn.2008.27371
   Núñez IN, 2014, NUTRITION, V30, P1423, DOI 10.1016/j.nut.2014.03.025
   O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229
   O'Reilly GA, 2014, OBES REV, V15, P453, DOI 10.1111/obr.12156
   Okada T, 2005, AM J CLIN NUTR, V82, P747, DOI 10.1093/ajcn/82.4.747
   Oleszczuk J, 2012, POL J VET SCI, V15, P403, DOI 10.2478/v10181-012-0063-x
   Oliva ME, 2013, PROSTAG LEUKOTR ESS, V89, P279, DOI 10.1016/j.plefa.2013.09.010
   Andrade JMO, 2014, NUTRITION, V30, P915, DOI 10.1016/j.nut.2013.11.016
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ozen AE, 2012, NUTR REV, V70, P472, DOI 10.1111/j.1753-4887.2012.00492.x
   Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413
   Päivärinta E, 2006, NUTR CANCER, V54, P79, DOI 10.1207/s15327914nc5401_9
   Pala L, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/253428
   Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Panchal SK, 2011, J NUTR, V141, P1062, DOI 10.3945/jn.111.137877
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]
   Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982
   Pandey MM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/376327
   Panickar KS, 2013, MOL NUTR FOOD RES, V57, P34, DOI 10.1002/mnfr.201200431
   Parker-Barnes JM, 2000, P NATL ACAD SCI USA, V97, P8284, DOI 10.1073/pnas.97.15.8284
   Parkinson L, 2014, INT J MOL SCI, V15, P12323, DOI 10.3390/ijms150712323
   Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163
   Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465
   Passariello A, 2014, CURR MED RES OPIN, V30, P1055, DOI 10.1185/03007995.2014.898138
   Patel J, 2009, INDIAN J BIOCHEM BIO, V46, P66
   Patel S, 2012, 3 BIOTECH, V2, P115, DOI 10.1007/s13205-012-0044-x
   Peirson Leslea, 2014, CMAJ Open, V2, pE268, DOI 10.9778/cmajo.20140019
   Pena F., 2014, J Food Nutr Res, V2, P491, DOI DOI 10.12691/JFNR
   Pérez-Jiménez F, 2007, MOL NUTR FOOD RES, V51, P1199, DOI [10.1002/mnfr.200600273, 10.1002/mnfr.200790023]
   Pérez-Matute P, 2007, BRIT J NUTR, V97, P389, DOI 10.1017/S0007114507207627
   Perez-Vizcaino F, 2009, PHARMACOL REP, V61, P67, DOI 10.1016/S1734-1140(09)70008-8
   Pieterse Z, 2005, NUTRITION, V21, P67, DOI 10.1016/j.nut.2004.09.010
   PINDER RM, 1975, DRUGS, V10, P241, DOI 10.2165/00003495-197510040-00001
   Pojer E, 2013, COMPR REV FOOD SCI F, V12, P483, DOI 10.1111/1541-4337.12024
   Poudyal H, 2013, J NUTR BIOCHEM, V24, P1381, DOI 10.1016/j.jnutbio.2012.11.006
   Poudyal H, 2013, J NUTR BIOCHEM, V24, P1041, DOI 10.1016/j.jnutbio.2012.07.014
   Poudyal H, 2013, ENDOCR METAB IMMUNE, V13, P105, DOI 10.2174/1871530311313010013
   Poudyal H, 2012, AM J PHYSIOL-ENDOC M, V302, pE1472, DOI 10.1152/ajpendo.00102.2012
   Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011
   Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003
   Poudyal H, 2010, BRIT J NUTR, V104, P1322, DOI 10.1017/S0007114510002308
   Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812
   Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975
   Preuss HG, 2004, DIABETES OBES METAB, V6, P171, DOI 10.1111/j.1462-8902.2004.00328.x
   Prior RL, 2010, J AGR FOOD CHEM, V58, P3970, DOI 10.1021/jf902852d
   Qiao Y, 2014, FOOD FUNCT, V5, P1241, DOI 10.1039/c3fo60630a
   Qin BL, 2012, BRIT J NUTR, V108, P581, DOI 10.1017/S000711451100599X
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rhee EJ, 2011, AM J MED, V124, P69, DOI 10.1016/j.amjmed.2010.08.012
   Rivière C, 2012, NAT PROD REP, V29, P1317, DOI 10.1039/c2np20049j
   Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363
   Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621
   Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1
   Rusconi RE, 2015, INT J FOOD SCI NUTR, V66, P132, DOI 10.3109/09637486.2014.959902
   Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020
   Sae-tan S, 2014, MOL NUTR FOOD RES, V58, P1156, DOI 10.1002/mnfr.201300621
   Salazar N, 2015, CLIN NUTR, V34, P501, DOI 10.1016/j.clnu.2014.06.001
   Salehpour A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-78
   Samane S, 2009, METABOLISM, V58, P909, DOI 10.1016/j.metabol.2009.02.013
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Santos S, 2013, NUTR RES, V33, P687, DOI 10.1016/j.nutres.2013.07.002
   Santuré M, 2002, BRIT J PHARMACOL, V137, P185, DOI 10.1038/sj.bjp.0704864
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Schwingshackl L, 2011, ANN NUTR METAB, V59, P176, DOI 10.1159/000334071
   Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003
   Seeley RJ, 2015, CELL METAB, V21, P369, DOI 10.1016/j.cmet.2015.01.001
   Segula D, 2014, MALAWI MED J, V26, P20
   Sharma N, 2008, J HYPERTENS, V26, P1402, DOI 10.1097/HJH.0b013e3283007dda
   Shen Y, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/971890
   Silveira MB, 2007, PUBLIC HEALTH NUTR, V10, P1181, DOI 10.1017/S1368980007000687
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Sioen I, 2009, LIPIDS, V44, P603, DOI 10.1007/s11745-009-3307-5
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/718379
   Speakman J, 2008, LAB ANIM-UK, V42, P413, DOI 10.1258/la.2007.006067
   St-Onge MP, 2008, J AM COLL NUTR, V27, P547, DOI 10.1080/07315724.2008.10719737
   St-Onge MP, 2008, AM J CLIN NUTR, V87, P621, DOI 10.1093/ajcn/87.3.621
   St-Onge MP, 2003, INT J OBESITY, V27, P1565, DOI 10.1038/sj.ijo.0802467
   St-Onge MP, 2003, INT J OBESITY, V27, P95, DOI 10.1038/sj.ijo.0802169
   Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tan HW, 2008, ACTA PHARMACOL SIN, V29, P1051, DOI 10.1111/j.1745-7254.2008.00843.x
   Thavanesan N, 2011, BRIT J NUTR, V106, P1297, DOI 10.1017/S0007114511003849
   Thirunavukkarasu V, 2004, NUTR METAB CARDIOVAS, V14, P351, DOI 10.1016/S0939-4753(04)80025-5
   Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002
   Tong XL, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-98
   Tsuji H, 2001, J NUTR, V131, P2853, DOI 10.1093/jn/131.11.2853
   Uchiyama-Tanaka Y, 2014, J ALTERN COMPLEM MED, V20, P800, DOI 10.1089/acm.2013.0245
   Valenti L, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/145421
   van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993
   Vandenplas Y, 2015, J PEDIAT-BRAZIL, V91, P6, DOI 10.1016/j.jped.2014.08.005
   Vijay-Kumar M, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-2
   Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885
   Voigt JP, 2015, BEHAV BRAIN RES, V277, P14, DOI 10.1016/j.bbr.2014.08.065
   Vyas U, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/872716
   Wach A, 2007, FOOD CHEM, V100, P699, DOI 10.1016/j.foodchem.2005.10.028
   Wadikar DD, 2012, CRIT REV FOOD SCI, V52, P949, DOI 10.1080/10408398.2010.514757
   Wang B, 2014, FOOD FUNCT, V5, P1452, DOI 10.1039/c3fo60714c
   Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075
   Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23
   Wang X, 2014, J HUM NUTR DIET, V27, P501, DOI 10.1111/jhn.12181
   Wein S, 2009, DIABETES-METAB RES, V25, P185, DOI 10.1002/dmrr.925
   WEINTRAUB M, 1991, CLIN PHARMACOL THER, V50, P330, DOI 10.1038/clpt.1991.144
   Wendland E, 2006, HEART, V92, P166, DOI 10.1136/hrt.2004.053538
   Whigham LD, 2007, AM J CLIN NUTR, V85, P1203
   Williams CM, 1999, PSYCHOPHARMACOLOGY, V143, P315, DOI 10.1007/s002130050953
   Williams LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106159
   Woodman RJ, 2002, AM J CLIN NUTR, V76, P1007, DOI 10.1093/ajcn/76.5.1007
   Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690
   Wright ORL, 2013, CAN J PHYSIOL PHARM, V91, P480, DOI 10.1139/cjpp-2012-0349
   Wu J, 2015, TRENDS GENET, V31, P232, DOI 10.1016/j.tig.2015.03.003
   Wu T, 2013, FOOD FUNCT, V4, P1654, DOI 10.1039/c3fo60251f
   Wu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077585
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Xue C, 2009, EUR J CLIN NUTR, V63, P879, DOI 10.1038/ejcn.2008.76
   Xue CY, 2009, BIOSCI BIOTECH BIOCH, V73, P1711, DOI 10.1271/bbb.80827
   Yamamoto Y, 2006, BIOSCI BIOTECH BIOCH, V70, P933, DOI 10.1271/bbb.70.933
   Yang ZH, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-120
   Yin YN, 2010, WORLD J GASTROENTERO, V16, P3394, DOI 10.3748/wjg.v16.i27.3394
   Yoshimura Y, 2013, BIOCHEM BIOPH RES CO, V434, P486, DOI 10.1016/j.bbrc.2013.03.100
   Yu W, 2012, J CELL BIOCHEM, V113, P752, DOI 10.1002/jcb.23431
   Yuliana ND, 2014, CRIT REV FOOD SCI, V54, P373, DOI 10.1080/10408398.2011.586739
   Zarfeshany Aida, 2014, Adv Biomed Res, V3, P100, DOI 10.4103/2277-9175.129371
   Zhang Y, 2011, NUTR METAB CARDIOVAS, V21, P418, DOI 10.1016/j.numecd.2009.10.020
   Zhang YH, 2010, LIPIDS, V45, P501, DOI 10.1007/s11745-010-3418-z
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zhu Y, 2013, NUTR METAB CARDIOVAS, V23, P843, DOI 10.1016/j.numecd.2012.06.005
   Zhu YN, 2014, J CLIN ENDOCR METAB, V99, P561, DOI 10.1210/jc.2013-2845
   Zhu YN, 2011, CLIN CHEM, V57, P1524, DOI 10.1373/clinchem.2011.167361
   Ziaee A, 2009, BASIC CLIN PHARMACOL, V104, P253, DOI 10.1111/j.1742-7843.2008.00368.x
NR 361
TC 127
Z9 129
U1 0
U2 103
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7881
EI 1467-789X
J9 OBES REV
JI Obes. Rev.
PD NOV
PY 2015
VL 16
IS 11
BP 914
EP 941
DI 10.1111/obr.12313
PG 28
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA CU3KQ
UT WOS:000363424300002
PM 26345360
DA 2025-04-28
ER

PT J
AU Kiszko, K
   Cantor, J
   Abrams, C
   Ruddock, C
   Moltzen, K
   Devia, C
   McFarline, B
   Singh, H
   Elbel, B
AF Kiszko, Kamila
   Cantor, Jonathan
   Abrams, Courtney
   Ruddock, Charmaine
   Moltzen, Kelly
   Devia, Carlos
   McFarline, Bernice
   Singh, Hardeep
   Elbel, Brian
TI Corner Store Purchases in a Low-Income Urban Community in NYC
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Choice behavior; Diet; Food; Obesity; New York City
ID FOOD STORES; HEALTHY FOODS; AVAILABILITY; ACCESS; ENVIRONMENTS
AB We assessed purchases made, motivations for shopping, and frequency of shopping at four New York City corner stores (bodegas). Surveys and purchase inventories (n = 779) were collected from consumers at four bodegas in Bronx, NY. We use Chi square tests to compare types of consumers, items purchased and characteristics of purchases based on how frequently the consumer shops at the specific store and the time of day the purchase was made. Most consumers shopped at the bodega because it was close to their home (52 %). The majority (68 %) reported shopping at the bodega at least once per day. The five most commonly purchased items were sugary beverages, (29.27 %), sugary snacks (22.34 %), coffee, (13.99 %), sandwiches, (13.09 %) and non-baked potato chips (12.2 %). Nearly 60 % of bodega customers reported their purchase to be healthy. Most of the participants shopped at the bodega frequently, valued its convenient location, and purchased unhealthy items. Work is needed to discover ways to encourage healthier choices at these stores.
C1 [Kiszko, Kamila; Cantor, Jonathan; Abrams, Courtney; Elbel, Brian] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA.
   [Cantor, Jonathan; Elbel, Brian] NYU, Robert F Wagner Sch Publ Serv, New York, NY 10012 USA.
   [Ruddock, Charmaine; Moltzen, Kelly; Devia, Carlos; McFarline, Bernice; Singh, Hardeep] Inst Family Hlth, Bronx Hlth REACH, New York, NY 10003 USA.
C3 New York University; New York University
RP Elbel, B (corresponding author), NYU, Sch Med, Dept Populat Hlth, 550 First Ave,VZ30 6th Floor, New York, NY 10016 USA.
EM Kamila.Kiszko@nyumc.org; Jonathan.Cantor@nyumc.org;
   Courtney.Abrams@nyumc.org; cruddock@institute.org;
   kmoltzen@institute.org; carlos.devia@gmail.com; andawiber@yahoo.com;
   hardeep.s.hunjan@gmail.com; brian.elbel@nyumc.org
RI Devia, Carlos/AAN-2255-2021
OI Elbel, Brian/0000-0003-1615-9430; Devia, Carlos/0000-0003-1230-2498
FU Centers for Disease Control and Prevention [1U48DP001904-01]
FX This study was funded by the Centers for Disease Control and Prevention
   (Supplement to 1U48DP001904-01).
CR Bodor JN, 2008, PUBLIC HEALTH NUTR, V11, P413, DOI 10.1017/S1368980007000493
   Borradaile KE, 2009, PEDIATRICS, V124, P1293, DOI 10.1542/peds.2009-0964
   Cannuscio CC, 2013, AM J PREV MED, V45, P606, DOI 10.1016/j.amepre.2013.06.021
   Cavanaugh E, 2013, PREV MED, V56, P149, DOI 10.1016/j.ypmed.2012.12.007
   D'Angelo H, 2011, PUBLIC HEALTH NUTR, V14, P1632, DOI 10.1017/S1368980011000498
   Dannefer R., 2009, UNPUB
   Dannefer R, 2012, AM J PUBLIC HEALTH, V102, pE27, DOI 10.2105/AJPH.2011.300615
   Farley T., UNPUB
   Galvez MP, 2009, ACAD PEDIATR, V9, P339, DOI 10.1016/j.acap.2009.05.003
   Gibson DM, 2011, AM J PUBLIC HEALTH, V101, P71, DOI 10.2105/AJPH.2009.187567
   Gittelsohn J, 2008, J HUNGER ENVIRON NUT, V2, P33, DOI 10.1080/19320240801891438
   Gordon C., 2007, Eating Well in Harlem: How Availabile Is Healthy Food?
   Graham R., 2006, EATING EATING OUT EA
   Kaufman L, 2007, SOC SCI MED, V64, P2177, DOI 10.1016/j.socscimed.2007.02.019
   Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025
   Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1031, DOI 10.1017/S1368980009992771
   Lent MR, 2015, PUBLIC HEALTH NUTR, V18, P1706, DOI 10.1017/S1368980014001670
   Lucan SC, 2010, J URBAN HEALTH, V87, P394, DOI 10.1007/s11524-010-9453-5
   New York City Department of Health and Mental Hygiene, 2014, EPI DATA BRIEF, V44, P1
   New York City Department of Health and Mental Hygiene, 2012, EPI DATA BRIEF, V17, P1
   New York City Department of Health and Mental Hygiene, HLTH FOOD LIST PICT
   O'Malley K, 2013, J COMMUN HEALTH, V38, P741, DOI 10.1007/s10900-013-9673-1
   Powell LM, 2007, AM J PREV MED, V33, pS301, DOI 10.1016/j.amepre.2007.07.007
   Ruff R. R., 2015, AM J HLTH PROMOTION
   Song HJ, 2009, PUBLIC HEALTH NUTR, V12, P2060, DOI 10.1017/S1368980009005242
NR 25
TC 39
Z9 44
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD DEC
PY 2015
VL 40
IS 6
BP 1084
EP 1090
DI 10.1007/s10900-015-0033-1
PG 7
WC Health Policy & Services; Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA CV0XU
UT WOS:000363978000005
PM 25910485
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Ding, QZ
   Zheng, W
   Zhang, BW
   Chen, XJ
   Zhang, J
   Pang, X
   Zhang, Y
   Jia, DX
   Pei, SR
   Dong, YS
   Ma, BP
AF Ding, Qianzhi
   Zheng, Wei
   Zhang, Bowei
   Chen, Xiaojuan
   Zhang, Jie
   Pang, Xu
   Zhang, Yong
   Jia, Dexian
   Pei, Surui
   Dong, Yuesheng
   Ma, Baiping
TI Comparison of hypoglycemic effects of ripened pu-erh tea and raw pu-erh
   tea in streptozotocin-induced diabetic rats
SO RSC ADVANCES
LA English
DT Article
ID GUT MICROBIOTA; CHEMICAL-CONSTITUENTS; IN-VITRO; HYPERGLYCEMIA;
   POLYPHENOLS; FLAVANOLS; EXTRACT; OBESITY; KIDNEY
AB Pu-erh tea is produced from the leaves of large-leaf tea species (Camellia sinensis var. assamica) in the Yunnan province of China and divided into ripened pu-erh tea (RIPT, with pile-fermentation) and raw pu-erh tea (RAPT) according to processing methods. RIPT extract showed more potent anti-diabetic effects on two-hour postprandial blood glucose (2h-PBG) and fasting blood glucose (FBG) than RAPT extract. UHPLC-Q-TOF/MS and UHPLC-PDA analyses found that 17 newly formed components and the increased components after fermentation, such as quinic acid, gallic acid, caffeine, puerin I and so on, might be the main contributors to the enhanced activities of RIPT. In addition, the probiotic role of RIPT to some beneficial gut bacteria, such as lactobacillus, Prevotellaceae NK3B31 group, Alloprevotella and Prevotella, was observed in our study. These results might provide a clue to anti-diabetic mechanism and active components of pu-erh tea, and use as a functional beverage worth to be further studied.
C1 [Ding, Qianzhi; Zheng, Wei; Chen, Xiaojuan; Zhang, Jie; Pang, Xu; Ma, Baiping] Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.
   [Zhang, Bowei; Dong, Yuesheng] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Liaoning, Peoples R China.
   [Zhang, Yong; Jia, Dexian] Beijing Univ Chinese Med, Beijing 100029, Peoples R China.
   [Pei, Surui] Annord Gene Technol Co Ltd, Beijing 100176, Peoples R China.
C3 Academy of Military Medical Sciences - China; Dalian University of
   Technology; Beijing University of Chinese Medicine
RP Ma, BP (corresponding author), Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.
EM mabaiping@sina.com
RI Dong, yuesheng/ABA-7029-2020; Ma, Baiping/GWM-6284-2022
OI dong, yuesheng/0000-0001-5010-6426
FU National Natural Science Foundation of China [81773867]
FX The authors thank Annoroad Gene Tech. (Beijing) Co., Ltd for their
   excellent technical assistance. This study was supported by the National
   Natural Science Foundation of China (No. 81773867).
CR [Anonymous], 2010, J SCI FOOD AGR
   Arya A, 2014, FOOD CHEM TOXICOL, V71, P183, DOI 10.1016/j.fct.2014.06.010
   Blandino G, 2016, DIABETES METAB, V42, P303, DOI 10.1016/j.diabet.2016.04.004
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023
   Crusell MKW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0472-x
   Danda RS, 2005, KIDNEY INT, V68, P2562, DOI 10.1111/j.1523-1755.2005.00727.x
   Deng YT, 2015, FOOD FUNCT, V6, P1539, DOI [10.1039/C4FO01025F, 10.1039/c4fo01025f]
   Du WH, 2012, J AGR FOOD CHEM, V60, P10126, DOI 10.1021/jf302426w
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Gu Xiao-Pan, 2018, Zhongguo Zhong Yao Za Zhi, V43, P2339, DOI 10.19540/j.cnki.cjcmm.20180323.001
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Hollman PCH, 2000, J SCI FOOD AGR, V80, P1081, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1081::AID-JSFA566>3.0.CO;2-G
   Huang QF, 2013, FOOD CHEM TOXICOL, V53, P75, DOI 10.1016/j.fct.2012.11.039
   Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001
   Lee LK, 2013, FOOD RES INT, V53, P619, DOI 10.1016/j.foodres.2013.02.036
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Lv HP, 2013, FOOD RES INT, V53, P608, DOI 10.1016/j.foodres.2013.02.043
   Mukwevho E, 2008, AM J PHYSIOL-ENDOC M, V294, pE582, DOI 10.1152/ajpendo.00312.2007
   Nie QX, 2019, FOOD HYDROCOLLOID, V86, P34, DOI 10.1016/j.foodhyd.2017.12.026
   Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916
   Simon MC, 2015, DIABETES CARE, V38, P1827, DOI 10.2337/dc14-2690
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Wang WN, 2014, FOOD CHEM, V152, P539, DOI 10.1016/j.foodchem.2013.10.117
   Wang X, 2017, ACTA PHARM SIN B, V7, P342, DOI 10.1016/j.apsb.2016.12.007
   Wei XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22094-2
   World Health Organization, 2016, GLOB REP DIAB
   Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345
   Zhang BW, 2018, J FUNCT FOODS, V46, P256, DOI 10.1016/j.jff.2018.04.070
   Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593
   Zhang L, 2011, J AGR FOOD CHEM, V59, P8754, DOI 10.1021/jf2015733
   Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089
   Zhu YF, 2015, FOOD CHEM, V170, P110, DOI 10.1016/j.foodchem.2014.08.075
NR 33
TC 38
Z9 42
U1 3
U2 58
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PD JAN 24
PY 2019
VL 9
IS 6
BP 2967
EP 2977
DI 10.1039/c8ra09259a
PG 11
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA HK4GQ
UT WOS:000457880900009
PM 35518948
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Kao, CC
   Wu, BT
   Tsuei, YW
   Shih, LJ
   Kuo, YL
   Kao, YH
AF Kao, Chung-Cheng
   Wu, Bo-Tsung
   Tsuei, Yi-Wei
   Shih, Li-Jane
   Kuo, Yu-Liang
   Kao, Yung-Hsi
TI Green Tea Catechins: Inhibitors of Glycerol-3-Phosphate Dehydrogenase
SO PLANTA MEDICA
LA English
DT Article
DE green tea; Camellia sinensis; Theaceae; epigallocatechin-3-gallate
ID EPIGALLOCATECHIN GALLATE; POLYPHENOLS; (-)-EPIGALLOCATECHIN-3-GALLATE;
   ACCUMULATION; MECHANISMS; CAFFEINE
AB Green tea catechins, especially (-)-epigallocatechin-3-gallate (EGCG), are known to regulate obesity and fat accumulation. We performed a kinetic analysis in a cell-free system to determine the mode of inhibition of glycerol-3-phosphate dehydrogenase (GPDH; EC 1.1.1.8) by EGCG. GPDH catalyzes the beta-nicotinamide adenine dinucleotide (NADH)-dependent reduction of dihydroxyacetone phosphate (DHAP) to yield glycerol-3-phosphate, which serves as one of the major precursors of triacylglycerols. We found that EGCG dose-dependently inhibited GPDH activity at a concentration of approximately 20 mu M for 50% inhibition. The IC50 values of other green tea catechins, such as (-)-epicatechin, (-)-epicatechin-3-gallate, and (-)-epigallocatechin, were all above 100 mu M. This suggests a catechin type-dependent effect. Based on double-reciprocal plots of the kinetic data, EGCG was a noncompetitive inhibitor of the GPDH substrates, NADH and DHAP, with respective inhibition constants (Ki) of 18 and 31 mu M. Results of this study possibly support previous studies that EGCG mediates fat content.
C1 [Wu, Bo-Tsung; Kao, Yung-Hsi] Natl Cent Univ, Dept Life Sci, Jhongli 32001, Taoyuan County, Taiwan.
   [Kao, Chung-Cheng; Tsuei, Yi-Wei] Armed Forces Taoyuan Gen Hosp, Dept Emergency, Tao Yuan, Taiwan.
   [Shih, Li-Jane] Armed Forces Taoyuan Gen Hosp, Dept Joint Lab, Tao Yuan, Taiwan.
   [Kuo, Yu-Liang] Armed Forces Taoyuan Gen Hosp, Dept Obstet & Gynecol, Natl Def Med Ctr, Tao Yuan, Taiwan.
C3 National Central University; National Defense Medical Center
RP Kao, YH (corresponding author), Natl Cent Univ, Dept Life Sci, 300 Jhongda Rd, Jhongli 32001, Taoyuan County, Taiwan.
EM ykao@cc.ncu.edu.tw
OI Shih, Li-Jane/0000-0001-7195-7676
FU National Science Council, Taiwan
   [NSC95-2311-B-008-008-MY3/NSC98-2311-B-008-001-MY3]; Taoyuan Armed
   Forces General Hospital; CGH-NCU Joint Research Foundation
   [CNJRF-98CGH-NCU-B3]
FX This work was supported by the National Science Council, Taiwan
   (NSC95-2311-B-008-008-MY3/NSC98-2311-B-008-001-MY3); the Taoyuan Armed
   Forces General Hospital; and the CGH-NCU Joint Research Foundation
   funding (CNJRF-98CGH-NCU-B3) to Y.-H.K.
CR Abe I, 2000, BIOCHEM BIOPH RES CO, V268, P767, DOI 10.1006/bbrc.2000.2217
   Abe I, 2000, FEBS LETT, V483, P131, DOI 10.1016/S0014-5793(00)02100-1
   Calixto Joao B., 2004, Planta Medica, V70, P93
   Chen D, 2005, BIOCHEM PHARMACOL, V69, P1523, DOI 10.1016/j.bcp.2005.01.024
   CHOSH KS, 2004, BIOCHEM BIOPH RES CO, V325, P807
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+
   Hiipakka RA, 2002, BIOCHEM PHARMACOL, V63, P1165, DOI 10.1016/S0006-2952(02)00848-1
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   IRELAND RC, 1986, J BIOL CHEM, V261, P1779
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Koyama Y, 2004, PLANTA MED, V70, P1100, DOI 10.1055/s-2004-832659
   Ku HC, 2009, AM J PHYSIOL-CELL PH, V297, pC121, DOI 10.1152/ajpcell.00272.2008
   Lambert JD, 2003, J NUTR, V133, p3262S, DOI 10.1093/jn/133.10.3262S
   LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393
   Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367
   Liao SS, 2001, VITAM HORM, V62, P1, DOI 10.1016/S0083-6729(01)62001-6
   Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138
   Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x
   Mochizuki M, 2004, PHYTOTHER RES, V18, P449, DOI 10.1002/ptr.1437
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   Rejman J, 2004, J AGR FOOD CHEM, V52, P246, DOI 10.1021/jf034745a
   ROBERTS EAH, 1952, J SCI FOOD AGR, V3, P193, DOI 10.1002/jsfa.2740030501
   Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205
   Wang CT, 2009, MOL NUTR FOOD RES, V53, P349, DOI 10.1002/mnfr.200800013
   Wang X, 2001, BIOCHEM BIOPH RES CO, V288, P1200, DOI 10.1006/bbrc.2001.5923
   WISE LS, 1979, J BIOL CHEM, V254, P273
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038
NR 31
TC 13
Z9 16
U1 0
U2 3
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0032-0943
EI 1439-0221
J9 PLANTA MED
JI Planta Med.
PD MAY
PY 2010
VL 76
IS 7
BP 694
EP 696
DI 10.1055/s-0029-1240623
PG 3
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 596BT
UT WOS:000277659000008
PM 19937554
DA 2025-04-28
ER

PT J
AU Lee, H
   Kim, H
   Byun, S
AF Lee, Hyeonji
   Kim, Heeju
   Byun, Sanguine
TI A review on the effect of green tea extract against obesity
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Review
DE Obesity; Body weight; Green tea extract; Epigallocatechin gallate
ID DIET-INDUCED OBESITY; FATTY LIVER-DISEASE; BODY-WEIGHT; METABOLIC
   SYNDROME; ADIPOSE-TISSUE; ABDOMINAL FAT; CATECHINS;
   (-)-EPIGALLOCATECHIN-3-GALLATE; REDUCTION; CAFFEINE
AB Obesity is a public health crisis that has reached epidemic proportions worldwide, demanding urgent attention. To combat obesity, people endeavor to follow a healthy diet and regularly engage in physical activities. However, maintaining a healthy diet and physical activity is challenging, highlighting the need for novel effective therapies. This review aims to evaluate the therapeutic efficacy and safety of a well-researched functional food ingredient, green tea extract, for combating obesity. To assess the effectiveness of green tea extract, the review systematically examines various obesity indicators. It focuses on markers for body fat reduction in rodent models and humans, including weight, BMI, body fat percentage, and waist circumference. Furthermore, it explores the potential for suppressing and preventing obesity-related metabolic disorders. By thoroughly examining the effectiveness and mechanism of green tea extract, the study seeks to understand the potential of green tea extract as a nutraceutical/functional food for obesity management and prevention.
C1 [Lee, Hyeonji; Kim, Heeju; Byun, Sanguine] Yonsei Univ, Dept Biotechnol, Seoul 03722, South Korea.
C3 Yonsei University
RP Byun, S (corresponding author), Yonsei Univ, Dept Biotechnol, Seoul 03722, South Korea.
EM sanguine@yonsei.ac.kr
RI Byun, Sanguine/AAR-5451-2021
FU National Research Foundation of Korea [2023R1A2C1006827,
   RS-2023-00222997]; National Research Foundation of Korea (NRF) - Korea
   government (MSIT)
FX This work was supported by National Research Foundation of Korea (NRF)
   grant funded by the Korea government (MSIT) (No. 2023R1A2C1006827 and
   RS-2023-00222997)
CR Albuquerque D, 2017, BRIT MED BULL, V123, P159, DOI 10.1093/bmb/ldx022
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bagheri R, 2020, BRIT J CLIN PHARMACO, V86, P753, DOI 10.1111/bcp.14176
   Barazzoni R, 2019, CLIN NUTR, V38, P1171, DOI 10.1016/j.clnu.2018.04.014
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Biro R, 2021, ARCH GYNECOL OBSTET, V303, P1235, DOI 10.1007/s00404-020-05907-6
   Annette B, 2017, BBA-MOL BASIS DIS, V1863, P1026, DOI 10.1016/j.bbadis.2017.01.016
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Braicu C, 2013, FOOD CHEM, V141, P3282, DOI 10.1016/j.foodchem.2013.05.122
   Bruno RS, 2008, J NUTR, V138, P323, DOI 10.1093/jn/138.2.323
   Burns RJ, 2018, CAN J DIABETES, V42, P626, DOI 10.1016/j.jcjd.2018.05.005
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chen H, 2003, AM J PHYSIOL-ENDOC M, V284, pE804, DOI 10.1152/ajpendo.00330.2002
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Cho BO, 2020, EXP THER MED, V19, P2783, DOI 10.3892/etm.2020.8493
   Cho BO, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13105
   De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546
   Erba D, 2005, J NUTR BIOCHEM, V16, P144, DOI 10.1016/j.jnutbio.2004.11.006
   Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040
   Ferrannini E, 2007, J CLIN ENDOCR METAB, V92, P2885, DOI 10.1210/jc.2007-0334
   Ferreira MA, 2017, CLIN NUTR ESPEN, V22, P1, DOI 10.1016/j.clnesp.2017.08.008
   Frühbeck G, 2018, ADIPOCYTE, V7, P57, DOI 10.1080/21623945.2017.1402151
   Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Herrera BM, 2010, CURR DIABETES REP, V10, P498, DOI 10.1007/s11892-010-0153-z
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Im H, 2022, NUTR METAB, V19, DOI 10.1186/s12986-022-00648-6
   Jovanovski E, 2021, EUR J NUTR, V60, P101, DOI 10.1007/s00394-020-02224-1
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Loos RJF, 2022, NAT REV GENET, V23, P120, DOI 10.1038/s41576-021-00414-z
   Lu C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034833, 10.1371/journal.pone.0038332]
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Mamrot P, 2019, NEUROSCI BIOBEHAV R, V107, P59, DOI 10.1016/j.neubiorev.2019.08.021
   Mandviwala T, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0575-4
   Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399
   Martinez JA, 2000, P NUTR SOC, V59, P337, DOI 10.1017/S0029665100000380
   Minatti J, 2012, NUTR RES, V32, P684, DOI 10.1016/j.nutres.2012.08.003
   Mokdad A. H., 2003, JAMA, Journal of the American Medical Association, V289, P76, DOI 10.1001/jama.289.1.76
   Molinari M, 2006, LIVER TRANSPLANT, V12, P1892, DOI 10.1002/lt.21021
   Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nicolaidis S, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.006
   Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Park HJ, 2011, J NUTR BIOCHEM, V22, P393, DOI 10.1016/j.jnutbio.2010.03.009
   Pasrija D, 2015, FOOD BIOPROCESS TECH, V8, P935, DOI 10.1007/s11947-015-1479-y
   Patel SS, 2013, WORLD J GASTROENTERO, V19, P5174, DOI 10.3748/wjg.v19.i31.5174
   Phelps NH, 2024, LANCET, V403, P1027, DOI 10.1016/S0140-6736(23)02750-2
   Quezada-Fernández P, 2019, INT J FOOD SCI NUTR, V70, P977, DOI 10.1080/09637486.2019.1589430
   Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002
   Scherer PE, 2016, AM HEART ASS, P1703
   Senanayake SPJN, 2013, J FUNCT FOODS, V5, P1529, DOI 10.1016/j.jff.2013.08.011
   Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75
   Tadayon Mitra, 2018, J Tradit Complement Med, V8, P391, DOI 10.1016/j.jtcme.2017.07.005
   Weisell RC, 2003, ASIA PAC J CLIN NUTR, V11
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wolin KY, 2010, ONCOLOGIST, V15, P556, DOI 10.1634/theoncologist.2009-0285
   Wright SM., 2012, RADIOLOGY, V37, P730
   Xi J, 2011, INT J PHARMACEUT, V408, P97, DOI 10.1016/j.ijpharm.2011.02.002
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Zhao HX, 2019, RADIOTHER ONCOL, V137, P186, DOI 10.1016/j.radonc.2019.02.022
NR 69
TC 0
Z9 0
U1 13
U2 13
PU KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST
PI SEOUL
PA #605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL,
   135-703, SOUTH KOREA
SN 1226-7708
EI 2092-6456
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD APR
PY 2025
VL 34
IS 8
SI SI
BP 1661
EP 1678
DI 10.1007/s10068-024-01778-8
EA DEC 2024
PG 18
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 0OB5K
UT WOS:001378354200001
PM 40151607
DA 2025-04-28
ER

PT J
AU Hamilton, D
   Beall, C
   Jeromson, S
   Chevtzoff, C
   Cuthbertson, D
   Ashford, M
AF Hamilton, D. Lee
   Beall, Craig
   Jeromson, Stewart
   Chevtzoff, Cyrille
   Cuthbertson, Daniel J.
   Ashford, Michael L. J.
TI Kv1.3 inhibitors have differential effects on glucose uptake and AMPK
   activity in skeletal muscle cell lines and mouse ex vivo skeletal muscle
SO JOURNAL OF PHYSIOLOGICAL SCIENCES
LA English
DT Article
DE AMPK; Kv1.3; Skeletal muscle; Glucose uptake
ID GLUT4 TRANSLOCATION; HEXOSE-TRANSPORT; INSULIN; CHANNEL; STIMULATION;
   CONTRACTION; ACTIVATION; PHOSPHORYLATION; HOMEOSTASIS; CAFFEINE
AB Knockout of Kv1.3 improves glucose homeostasis and confers resistance to obesity. Additionally, Kv1.3 inhibition enhances glucose uptake. This is thought to occur through calcium release. Kv1.3 inhibition in T-lymphocytes alters mitochondrial membrane potential, and, as many agents that induce Ca2+ release or inhibit mitochondrial function activate AMPK, we hypothesised that Kv1.3 inhibition would activate AMPK and increase glucose uptake. We screened cultured muscle with a range of Kv1.3 inhibitors for their ability to alter glucose uptake. Only Psora4 increased glucose uptake in C2C12 myotubes. None of the inhibitors had any impact on L6 myotubes. Magratoxin activated AMPK in C2C12 myotubes and only Pap1 activated AMPK in the SOL. Kv1.3 inhibitors did not alter cellular respiration, indicating a lack of effect on mitochondrial function. In conclusion, AMPK does not mediate the effects of Kv1.3 inhibitors and they display differential effects in different skeletal muscle cell lines without impairing mitochondrial function.
C1 [Hamilton, D. Lee; Beall, Craig; Ashford, Michael L. J.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland.
   [Beall, Craig; Cuthbertson, Daniel J.] Aintree Univ Hosp NHS Fdn Trust, Obes & Endocrinol Clin Res Unit, Liverpool L9 7AL, Merseyside, England.
   [Jeromson, Stewart] Univ Stirling, Sch Sport, Hlth & Exercise Sci Res Grp, Stirling FK9 4LA, Scotland.
   [Chevtzoff, Cyrille] Univ Dundee, Coll Life Sci, Div Cell Sci & Immunol, Dundee DD1 5EH, Scotland.
C3 University of Dundee; Aintree University Hospitals NHS Foundation Trust;
   University of Stirling; University of Dundee
RP Ashford, M (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland.
EM d.l.hamilton@stir.ac.uk; m.l.j.ashford@dundee.ac.uk
RI cuthbertson, Daniel/LWZ-8202-2024; Beall, Craig/O-3804-2018
OI Hamilton, David/0000-0002-5620-4788; Ashford,
   Michael/0000-0002-0861-7676; Cuthbertson, Daniel/0000-0002-6128-0822;
   Beall, Craig/0000-0002-4263-0866
FU Tenovous Tayside (award); Diabetes UK; Anonymous Trust
FX This work was supported by Tenovous Tayside (award to M.L.J.A. and D.
   C.), Diabetes UK (award to M.L.J.A.) and The Anonymous Trust (award to
   D. L. H.). We also gratefully acknowledge expert technical assistance
   from Laura Burgess, and Dr Keith Baar for the kind gift of
   C<INF>2</INF>C<INF>12</INF> cell line.
CR Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782
   Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x
   Cook KK, 2002, J BIOL CHEM, V277, P13268, DOI 10.1074/jbc.M108898200
   Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x
   Fadool DA, 2000, J NEUROPHYSIOL, V83, P2332, DOI 10.1152/jn.2000.83.4.2332
   Freymond D, 2002, ACTA PHYSIOL SCAND, V176, P283, DOI 10.1046/j.1365-201X.2002.01039.x
   Gulbins E, 2012, BIOCHIM BIOPHYS ACTA, V1797, P1251
   Hamilton DL, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-37
   JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0
   Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, pE286, DOI 10.1152/ajpendo.00693.2006
   Jensen TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002102
   Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65
   Khayat ZA, 1998, AM J PHYSIOL-CELL PH, V275, pC1487, DOI 10.1152/ajpcell.1998.275.6.C1487
   KLIP A, 1984, AM J PHYSIOL, V247, pE297, DOI 10.1152/ajpendo.1984.247.3.E297
   KLIP A, 1992, ENDOCRINOLOGY, V130, P2535, DOI 10.1210/en.130.5.2535
   Klip A, 2009, APPL PHYSIOL NUTR ME, V34, P481, DOI 10.1139/H09-047
   Li YY, 2006, AM J PHYSIOL-CELL PH, V290, pC345, DOI 10.1152/ajpcell.00091.2005
   Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685
   Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, pE1058, DOI 10.1152/ajpendo.00773.2009
   Philp A, 2010, AM J PHYSIOL-CELL PH, V299, pC240, DOI 10.1152/ajpcell.00438.2009
   Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006
   Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008
   Santos JM, 2008, INT J SPORTS MED, V29, P785, DOI 10.1055/s-2008-1038404
   SARABIA V, 1990, BIOCHEM CELL BIOL, V68, P536, DOI 10.1139/o90-076
   Straub SV, 2013, AM J PHYSL IN PRESS
   Szabó I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]
   Tschritter O, 2006, J CLIN ENDOCR METAB, V91, P654, DOI 10.1210/jc.2005-0725
   Tucker K, 2008, INT J OBESITY, V32, P1222, DOI 10.1038/ijo.2008.77
   Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2
   Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005
   Xu JC, 2004, P NATL ACAD SCI USA, V101, P3112, DOI 10.1073/pnas.0308450100
   Xu JC, 2003, HUM MOL GENET, V12, P551, DOI 10.1093/hmg/ddg049
   YOUN JH, 1991, AM J PHYSIOL, V260, pC555, DOI 10.1152/ajpcell.1991.260.3.C555
NR 33
TC 7
Z9 8
U1 1
U2 5
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1880-6546
EI 1880-6562
J9 J PHYSIOL SCI
JI J. Physiol. Sci.
PD JAN
PY 2014
VL 64
IS 1
BP 13
EP 20
DI 10.1007/s12576-013-0285-4
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 280XN
UT WOS:000329064200002
PM 24043354
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Yakubo, S
   Ueda, Y
   Tanekura, N
   Okudaira, T
   Namiki, T
   Shimabukuro, H
   Arashima, Y
AF Yakubo, Shuji
   Ueda, Yukiko
   Tanekura, Naomichi
   Okudaira, Tomoyuki
   Namiki, Takao
   Shimabukuro, Hiroaki
   Arashima, Yasutomo
TI Thermogenic Effect of Bofu-Tsusho-San on Human Interscapular Adipose
   Tissue
SO INTERNATIONAL MEDICAL JOURNAL
LA English
DT Article
DE Bofu-tsusho-San; Kampo medicine; obesity; thermogenesis; addipose tissue
ID METABOLIC-SYNDROME; UNCOUPLING PROTEINS; EPHEDRINE; OBESE; MICE;
   CAFFEINE; RATS; UCP1
AB Purpose of the study: Bofu-tsusho-San (Fang-feng-tong-sheng-san) has been used to treat obesity for about 700 years in China and Japan. In mice, the anti-obesity actions of Tsumura Bofu-tsusho-San extract granules (Tokyo, Japan)(TJ-62) have been shown to include promotion in brown adipose tissue (BAT) thermogenesis via l-ephedrine and d-pseudoephedrine, as well as inhibition of phosphodiesterase activity. And it was reported that TJ-62 has actions to decrease the weight and size gains of white adipose tissue (WAT) along with up-regulating uncoupling protein (UCP)1 mRNA in WAT of high-fat mice. We investigated in human activating thermogenesis of adipose tissue by TJ-62.
   Material and methods: We studied 6 healthy subjects. As control, we administered 150 ml of hot water (60 degrees C). On another day, we administered TJ-62 (5.0 g) and 150 ml of hot water (60 degrees C). We investigated the thermogenic effect of TJ-62 on human interscapular adipose tissue including BAT and WAT with a CM-210 (Terumo Co. Ltd., Tokyo, Japan).
   Results: We found that the interscapular area of the back showed a higher temperature from 10 minutes after oral administration of TJ-62, and it was higher than after administration of the control. No significant changes of chest temperature occurred, an area where little adipose tissue exists.
   Conclusion: We think that the anti-obesity action of TJ-62 is based on activating thermogenesis of adipose tissue in human.
C1 [Yakubo, Shuji; Ueda, Yukiko; Tanekura, Naomichi; Okudaira, Tomoyuki] Nihon Univ, Sch Med, Dept Med, Div Integrated Herbal Med,Itabashi Ku, Tokyo 1738610, Japan.
   [Namiki, Takao] Chiba Univ, Grad Sch Med, Dept Japanese Oriental Kampo Med, Chuo Ku, Chiba 2608670, Japan.
   [Shimabukuro, Hiroaki] Nihon Univ, Itabashi Hosp, Clin Lab, Itabashi Ku, Tokyo 1738610, Japan.
   [Arashima, Yasutomo] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Lab Med,Itabashi Ku, Tokyo 1738610, Japan.
C3 Nihon University; Chiba University; Nihon University; Nihon University
RP Arashima, Y (corresponding author), Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Lab Med,Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.
EM ara1145145@gmail.com
CR Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022
   ARCH JRS, 1982, LIFE SCI, V30, P1817, DOI 10.1016/0024-3205(82)90319-8
   Argilés JM, 2002, BIOCHEM BIOPH RES CO, V293, P1145, DOI 10.1016/S0006-291X(02)00355-8
   Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001
   DULLOO AG, 1991, INT J OBESITY, V15, P317
   DULLOO AG, 1989, NUTRITION, V5, P7
   EVANS E, 1977, P NUTR SOC, V36, pA136
   Hioki C, 2004, CLIN EXP PHARMACOL P, V31, P614, DOI 10.1111/j.1440-1681.2004.04056.x
   HOTON TJ, 1990, P NUTR SOC, V49, pA120
   Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005
   Kampo Terasawa K., 1993, JAPANESE ORIENTAL ME, P248
   Liu YC, 2006, BIOSCI BIOTECH BIOCH, V70, P2733, DOI 10.1271/bbb.60349
   Matsukawa T, 1996, EUR J ANAESTH, V13, P340, DOI 10.1046/j.1365-2346.1996.00974.x
   Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751
   Narita O, 1983, SANKA TO FUJINKA, V2, P123
   Ordovas JM, 2008, KIDNEY INT, V74, pS10, DOI 10.1038/ki.2008.517
   Tchernof A, 2007, NUTR REV, V65, pS24, DOI 10.1301/nr.2007.jun.S24-S29
   Ueda Y, 2012, INT MED J, V19, P314
   Yamakawa K, 1993, KAMPO MED, V17, P424
   YOSHIDA T, 1995, INT J OBESITY, V19, P717
NR 20
TC 0
Z9 0
U1 0
U2 5
PU JAPAN INT CULTURAL EXCHANGE FOUNDATION
PI TOKYO
PA 2-15-5-207, SHOTO, SHIBUYA-KU, TOKYO, 150-0046, JAPAN
SN 1341-2051
J9 INT MED J
JI Int. Med. J.
PD DEC
PY 2012
VL 19
IS 4
BP 378
EP 381
PG 4
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 078WY
UT WOS:000314132300029
DA 2025-04-28
ER

PT J
AU Aksoy, IS
   Otles, S
AF Selek Aksoy, Ilknur
   Otles, Semih
TI Effects of Green Apple (Golden Delicious) and Its Three Major Flavonols
   Consumption on Obesity, Lipids, and Oxidative Stress in Obese Rats
SO MOLECULES
LA English
DT Article
DE Golden Delicious; flavonol; lipid; obesity; oxidative stress; quercetin
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; BODY-WEIGHT; ELEMENT CONTENTS;
   QUERCETIN; FAT; CAFFEINE; GLUCOSE; POMACE; FRUITS; PULP
AB Obesity is becoming increasingly common all over the world and global strategies are accordingly being developed to prevent it. In order to support the strategies, the effects of green apple (Golden Delicious) and the consumption of its three major flavonols (quercetin-3-glucoside, quercetin-3-D-galactoside, and quercetin-3-rhamnoside) on body weight; the weight of liver, kidney, and spleen; some lipid parameters in serum; and total lipid ratios of liver and kidney and oxidative stress parameters of obese rats were studied. This study was conducted on two experimental groups: one of which was given an apple, and the other was given flavonols, in addition to their high-energy diet; along with a sham and a control rat group, for 4 weeks. According to results, there was no difference in body and organ weights between groups. The liver and kidney weights increased in obese rats, but there was no difference between the total lipid ratios in these organs. The addition of green apple and selected flavonols to the high-energy diet of rats was not sufficient to prevent the increase in body and organ weights, but it supported the reduction in some lipid fractions and in oxidative stress parameters of obese rats. Moreover, this study supported the argument that obesity causes most of the lipid fractions increase in serum and induces oxidative stress.
C1 [Selek Aksoy, Ilknur; Otles, Semih] Ege Univ, Food Engn Dept, TR-35040 Izmir, Turkey.
C3 Ege University
RP Aksoy, IS (corresponding author), Ege Univ, Food Engn Dept, TR-35040 Izmir, Turkey.
EM selekilknur87@gmail.com; semih.otles@gmail.com
RI Otles, Semih/AAE-8407-2019
OI SELEK AKSOY, ILKNUR/0000-0002-7106-1674
CR Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077
   Albuali Waleed H, 2014, World J Clin Pediatr, V3, P6, DOI 10.5409/wjcp.v3.i1.6
   Amirkhizi F, 2014, OBES RES CLIN PRACT, V8, pE26, DOI 10.1016/j.orcp.2012.07.004
   Amirkhizi F, 2007, ARYA ATHEROSCLER, V2, P189
   Arfat Y, 2014, TOXICOL REP, V1, P554, DOI 10.1016/j.toxrep.2014.08.004
   Aslan M., 2010, MISED, V23, P91
   BERUTER J, 1985, J PLANT PHYSIOL, V121, P331, DOI 10.1016/S0176-1617(85)80026-2
   Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007
   Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5
   Busetto L, 2002, OBES RES, V10, P408, DOI 10.1038/oby.2002.56
   Chinnici F, 2004, J AGR FOOD CHEM, V52, P4684, DOI 10.1021/jf049770a
   Cho KD, 2013, J MED FOOD, V16, P823, DOI [10.1089/jmf.2013.2784, 10.1095/jmf.2013.2784]
   Durust N, 1997, J AGR FOOD CHEM, V45, P2085, DOI 10.1021/jf9606159
   Ebrahimpour S, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101095
   Ekholm P, 2007, J FOOD COMPOS ANAL, V20, P487, DOI 10.1016/j.jfca.2007.02.007
   Escarpa A, 1998, J CHROMATOGR A, V823, P331, DOI 10.1016/S0021-9673(98)00294-5
   Fernández-Jalao I, 2019, INNOV FOOD SCI EMERG, V51, P20, DOI 10.1016/j.ifset.2018.06.002
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   González-Castejón M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004
   González-Sarrías A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070746
   Griffin LE, 2021, J NUTR BIOCHEM, V87, DOI 10.1016/j.jnutbio.2020.108521
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   Han LK, 2001, INT J OBESITY, V25, P1459, DOI 10.1038/sj.ijo.0801747
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211
   Imessaoudene A, 2016, J NUTR BIOCHEM, V29, P107, DOI 10.1016/j.jnutbio.2015.11.011
   JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997
   Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425
   Laight DW, 1999, EUR J PHARMACOL, V377, P89, DOI 10.1016/S0014-2999(99)00407-0
   Leontowicz M, 2003, J AGR FOOD CHEM, V51, P5780, DOI 10.1021/jf030137j
   Leontowicz M, 2001, FOOD CHEM, V72, P73, DOI 10.1016/S0308-8146(00)00207-7
   Liu YD, 2006, J AGR FOOD CHEM, V54, P2810, DOI 10.1021/jf052889e
   Lu YR, 1997, FOOD CHEM, V59, P187, DOI 10.1016/S0308-8146(96)00287-7
   Ma CM, 2014, FOOD CHEM, V145, P784, DOI 10.1016/j.foodchem.2013.08.135
   MARSHALL NB, 1957, AM J PHYSIOL, V189, P343, DOI 10.1152/ajplegacy.1957.189.2.343
   Martin AA, 2016, PHYSIOL BEHAV, V162, P120, DOI 10.1016/j.physbeh.2016.04.010
   Mermel VL, 2004, TRENDS FOOD SCI TECH, V15, P532, DOI 10.1016/j.tifs.2004.03.0054
   Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128
   Moloney M, 2000, P NUTR SOC, V59, P601, DOI 10.1017/S0029665100000859
   Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858
   Nagasako-Akazome Yoko, 2007, J Oleo Sci, V56, P417
   Nakazato K, 2006, EXP ANIM TOKYO, V55, P383, DOI 10.1538/expanim.55.383
   Nour V, 2010, NOT BOT HORTI AGROBO, V38, P228
   Novelli ELB, 2007, LAB ANIM-UK, V41, P111, DOI 10.1258/002367707779399518
   Oguz C., 2009, TABAD, Tarim Bilimleri Aras<tail>tirma Dergisi, V2, P41
   Ono Y, 2006, J ETHNOPHARMACOL, V106, P238, DOI 10.1016/j.jep.2005.12.036
   Özcan M, 2004, FOOD CHEM, V84, P437, DOI 10.1016/S0308-8146(03)00263-2
   Page KA, 2016, CURR OPIN BEHAV SCI, V9, P111, DOI 10.1016/j.cobeha.2016.03.002
   Pellicer F, 1996, PHYSIOL BEHAV, V60, P435, DOI 10.1016/S0031-9384(96)80016-3
   Samout N, 2016, BIOMED PHARMACOTHER, V83, P1233, DOI 10.1016/j.biopha.2016.08.038
   Sato S, 2020, J INFLAMM RES, V13, P421, DOI 10.2147/JIR.S228361
   Schieber A, 2002, J SEP SCI, V25, P361, DOI 10.1002/1615-9314(20020401)25:5/6<361::AID-JSSC361>3.0.CO;2-D
   Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455
   Tsao R, 2003, J AGR FOOD CHEM, V51, P6347, DOI 10.1021/jf0346298
   van Steenbergen W., 1995, INT J OBES RELAT MET, V19, P27
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   World Health Organisation, 2024, Obesity
   Zheng GD, 2004, IN VIVO, V18, P55
NR 59
TC 6
Z9 6
U1 0
U2 16
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD FEB
PY 2022
VL 27
IS 4
AR 1243
DI 10.3390/molecules27041243
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA ZM3UY
UT WOS:000764288000001
PM 35209038
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Matsuyama, T
   Tanaka, Y
   Kamimaki, I
   Nagao, T
   Tokimitsu, I
AF Matsuyama, Takeshi
   Tanaka, Yuriko
   Kamimaki, Isamu
   Nagao, Tomonori
   Tokimitsu, Ichiro
TI Catechin safely improved higher levels of fatness, blood pressure, and
   cholesterol in children
SO OBESITY
LA English
DT Article
ID GREEN TEA; BODY-FAT; ENERGY-EXPENDITURE; METABOLIC SYNDROME; VISCERAL
   FAT; POLYPHENOLS; OBESITY; CHILDHOOD; OXIDATION; CAFFEINE
AB Objective: The purpose of this study was to evaluate the effects of a catechin-rich beverage on body fat and cardiovascular disease risk factors in obese children and to verify the safety of its use.
   Methods and Procedures: Obese or near-obese Japanese children were recruited for this study. A double-blind, randomized, controlled study was performed with a 4-week lead-in, a 24-week beverage ingestion period and a 12-week follow-up. Subjects ingested green tea containing 576 mg catechins ( catechin group) or 75 mg catechins ( control group) once per day for 24 weeks. Randomization was stratified by gender, age, and BMI. Subjects were instructed to maintain their usual lifestyles during the study period.
   Results: Data were analyzed using samples from 40 subjects ( catechin group; n = 21, control group; n = 19). There were no significant differences in major outcome variables, such as body fat mass, between the catechin and the control groups. When, however, the analysis was stratified using the median of the week-0 values, the decrease at week 24 in waist circumference, systolic blood pressure, and low-density lipoprotein cholesterol in the catechin group was significantly greater than that in the control group for the above-median category. Ingestion of the catechin-rich beverage was not associated with any adverse effects.
   Discussion: These findings suggest that ingestion of a catechin-rich beverage ameliorates serious obesity and cardiovascular disease risk factors without raising any safety concerns in Japanese children.
C1 [Nagao, Tomonori; Tokimitsu, Ichiro] Kao Corp, Hlth Care Food Res Labs, Sumida Ku, Tokyo, Japan.
   [Kamimaki, Isamu] Natl Hosp Org Saitama Natl Hosp, Dept Pediat, Wako, Saitama, Japan.
   [Matsuyama, Takeshi; Tanaka, Yuriko] Fussa Hosp, Dept Pediat, Tokyo, Japan.
C3 KAO Corporation
RP Nagao, T (corresponding author), Kao Corp, Hlth Care Food Res Labs, Sumida Ku, Tokyo, Japan.
EM nagao.tomonori@kao.co.jp
CR Abe I, 2000, BIOCHEM BIOPH RES CO, V268, P767, DOI 10.1006/bbrc.2000.2217
   Asayama K, 2002, INT J OBESITY, V26, P208, DOI 10.1038/sj.ijo.0801865
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Chen W, 2005, DIABETES CARE, V28, P126, DOI 10.2337/diacare.28.1.126
   Cole TJ, 2008, BIOSTATISTICS, V9, P159, DOI 10.1093/biostatistics/kxm020
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Huang TTK, 2001, OBES RES, V9, P283, DOI 10.1038/oby.2001.35
   ISHIWATARI N, 1990, CLIN ENDOCRINOL, V38, P601
   KIMIE Y, 1994, J JPN PEDIAT SOC, V98, P99
   Kitagawa T, 1998, CLIN PEDIATR, V37, P111, DOI 10.1177/000992289803700208
   Lin JK, 1998, J AGR FOOD CHEM, V46, P3635, DOI 10.1021/jf980223x
   Ma ZM, 1996, CLIN CHEM, V42, P942
   Matsushita Y, 2004, OBES RES, V12, P205, DOI 10.1038/oby.2004.27
   Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   SOGABE M, 1995, J CLIN EXP MED, V173, P997
   Terasawa F, 1999, ZOO BIOL, V18, P153, DOI 10.1002/(SICI)1098-2361(1999)18:2<153::AID-ZOO7>3.0.CO;2-F
   TOKUNAGA K, 1983, INT J OBESITY, V7, P437
   Tonari Y, 2001, Rinsho Byori, V49, P178
   Yoshinaga M, 2005, OBES RES, V13, P1135, DOI 10.1038/oby.2005.134
NR 23
TC 86
Z9 91
U1 2
U2 32
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 1930-7381
J9 OBESITY
JI Obesity
PD JUN
PY 2008
VL 16
IS 6
BP 1338
EP 1348
DI 10.1038/oby.2008.60
PG 11
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 307XU
UT WOS:000256353700027
PM 18356827
OA Bronze
DA 2025-04-28
ER

PT J
AU Lee, SJ
   Cho, KH
   Kim, JC
   Choo, HJ
   Hwang, JY
   Cho, HC
   Hah, YS
AF Lee, Seung-Jun
   Cho, Kyoung Hwan
   Kim, Jong Cheol
   Choo, Ho Jin
   Hwang, Jeong-Yun
   Cho, Hyun Chin
   Hah, Young-Sool
TI Comparative analysis of anti-obesity effects of green, fermented, and
   γ-aminobutyric acid teas in a high-fat diet-induced mouse model
SO APPLIED BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Anti-obesity effects; Green tea; Fermented tea; GABA tea; High-fat
   diet-induced obesity
ID HEALTH; OBESITY; POLYPHENOLS; CONSUMPTION; BIOMARKERS
AB Obesity, a prevalent disease associated with numerous chronic conditions, including hyperlipidemia, hyperglycemia, diabetes, and metabolic syndrome, remains a major global health challenge. This study investigated the potential of green tea (GT), fermented tea (FT), and gamma-aminobutyric acid (GABA) tea (GBT), which are rich in phytonutrients and polyphenols, for the management of obesity. Using a high-fat diet-induced obese mouse model (C57BL/6N), we explored the effect of these teas on various obesity-related parameters. The mice were categorized into five groups: normal diet with water, high-fat diet with water, and high-fat diet supplemented with GT, FT, or GBT. Over 13 weeks, we monitored body weight, perirenal and liver fat, adipocyte lipid accumulation, and key metabolic indicators, such as serum cholesterol, leptin, insulin, and fasting blood glucose. These teas contain beneficial phytochemicals such as GABA, theanine, and caffeine, and have demonstrated an enhanced antioxidant capacity, which increases the scavenging of free radicals and may reduce oxidative stress. The animal study indicated a decrease in feeding efficiency and significant reductions in body weight liver fat, epididymal fat, and perirenal fat, as well as in adipocyte lipid accumulation. Additionally, notable improvements were observed in metabolic health indicators, including reductions in serum cholesterol, leptin, insulin, and fasting blood glucose levels. Our findings revealed that GT, FT, or GBT significantly counteracted the negative effects of a high-fat diet, suggesting their potential in combating obesity and related metabolic disorders.
C1 [Lee, Seung-Jun; Hwang, Jeong-Yun] Gyeongsang Natl Univ, Dept Convergence Med Sci, Jinju 52727, South Korea.
   [Cho, Kyoung Hwan; Kim, Jong Cheol] Inst Hadong Green Tea, Hadong 52304, South Korea.
   [Choo, Ho Jin] Jeongok Co Ltd, Jinkyo 52343, South Korea.
   [Cho, Hyun Chin] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Jinju 52727, South Korea.
   [Cho, Hyun Chin] Gyeongsang Natl Univ Hosp, Jinju 52727, South Korea.
   [Hah, Young-Sool] Gyeongsang Natl Univ, Gyoengsang Natl Univ Hosp, Biomed Res Inst, Inst Med Sci,Sch Med, Jinju 52727, South Korea.
C3 Gyeongsang National University; Gyeongsang National University;
   Gyeongsang National University; Gyeongsang National University Hospital;
   Gyeongsang National University
RP Cho, HC (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Jinju 52727, South Korea.; Cho, HC (corresponding author), Gyeongsang Natl Univ Hosp, Jinju 52727, South Korea.; Hah, YS (corresponding author), Gyeongsang Natl Univ, Gyoengsang Natl Univ Hosp, Biomed Res Inst, Inst Med Sci,Sch Med, Jinju 52727, South Korea.
EM hccholuck@gmail.com; yshah@gnu.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea [NRF-2021R1F1A1057920]
FX This work was supported by the Basic Science Research Program through
   the National Research Foundation of Korea (NRF-2021R1F1A1057920).
CR Aleksandrova K, 2018, CLIN CHEM, V64, P142, DOI 10.1373/clinchem.2017.275172
   Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005
   Ciraj A M, 2001, Indian J Med Sci, V55, P376
   De Lorenzo A, 2016, WORLD J GASTROENTERO, V22, P681, DOI 10.3748/wjg.v22.i2.681
   Endalifer ML, 2020, J OBES, V2020, DOI 10.1155/2020/6134362
   Gaur S, 2014, GERIATR GERONTOL INT, V14, P238, DOI 10.1111/ggi.12194
   Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Green M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082890
   Hayat K, 2015, CRIT REV FOOD SCI, V55, P939, DOI 10.1080/10408398.2012.678949
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hwang I, 2019, P NATL ACAD SCI USA, V116, P11936, DOI 10.1073/pnas.1822067116
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Koch W, 2019, MOLECULES, V24, DOI 10.3390/molecules24234277
   Kolb H, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01688-6
   Lee MK, 2019, EUR FOOD RES TECHNOL, V245, DOI 10.1007/s00217-018-3201-6
   Li Y, 2016, EUR REV MED PHARMACO, V20, P3863
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005
   Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002
   Nagasawa T, 2020, FOOD FUNCT, V11, P10534, DOI [10.1039/d0fo02442b, 10.1039/D0FO02442B]
   Payet B, 2005, J AGR FOOD CHEM, V53, P10074, DOI 10.1021/jf0517703
   Pérez M, 2023, J AGR FOOD CHEM, V71, P17543, DOI 10.1021/acs.jafc.3c04022
   Ren TY, 2021, PLANT PHYSIOL BIOCH, V159, P363, DOI 10.1016/j.plaphy.2021.01.003
   Schwingshackl L, 2018, J LIPID RES, V59, P1771, DOI 10.1194/jlr.P085522
   Shatenstein B, 2003, J NUTR, V133, P2384
   Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174
   Sivamaruthi BS, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3291367
   Studentsova V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27634-4
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Tang Li-Li, 2014, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V36, P614, DOI 10.3881/j.issn.1000-503X.2014.06.010
   Tian J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025338
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P1681, DOI 10.1080/10408398.2015.1016141
   Untereiner A, 2019, FASEB J, V33, P3968, DOI 10.1096/fj.201801397R
   Weerawatanakorn M, 2023, ACS OMEGA, V8, P33997, DOI 10.1021/acsomega.3c04874
   Xing LJ, 2019, J AGR FOOD CHEM, V67, P1029, DOI 10.1021/acs.jafc.8b06146
   Yan ZM, 2020, ANIM NUTR, V6, P115, DOI 10.1016/j.aninu.2020.01.001
   Yang CS, 1999, P SOC EXP BIOL MED, V220, P213, DOI 10.1046/j.1525-1373.1999.d01-36.x
NR 38
TC 4
Z9 4
U1 4
U2 9
PU SPRINGER SINGAPORE PTE LTD
PI SINGAPORE
PA 152 Beach Road, #21-01 Gateway East, SINGAPORE, SINGAPORE
SN 2468-0834
EI 2468-0842
J9 APPL BIOL CHEM
JI Appl. Biol. Chem.
PD MAR 26
PY 2024
VL 67
IS 1
AR 36
DI 10.1186/s13765-024-00888-5
PG 12
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA MB8Z8
UT WOS:001191272000001
OA gold
DA 2025-04-28
ER

PT J
AU Zheng, J
   DiLorenzo, DJ
   McLaughlin, L
   Roberts, AT
   Greenway, FL
AF Zheng, Jolene
   DiLorenzo, Daniel J.
   McLaughlin, Leslie
   Roberts, Andrew T.
   Greenway, Frank L.
TI Stimulation of sympathetic innervation in the upper gastrointestinal
   tract as a treatment for obesity
SO MEDICAL HYPOTHESES
LA English
DT Article
AB Sympathetic activity and obesity have a reciprocal relationship. Firstly, hypothalamic obesity is associated with decreased sympathetic activity. Caffeine and ephedrine increase sympathetic activity and induce weight loss, of which 25% is due to increased metabolic rate and 75% is due to a reciprocally decreased food intake. Secondly, hormones and drugs that affect body weight have an inverse relationship between food intake and metabolic rate. Neuropepticle Y decreases sympathetic activity and increases food intake and body weight. Thirdly, a gastric pacemaker Transcend (R) and vagotorny increase the ratio of sympathetic to parasympathetic activation, decrease food intake, and block gut satiety hormones. Weight loss with the pacemaker or vagotomy is variable. Significant weight reduction is seen only in a small group of those treated. This suggests that activation of the sympathetic arm of the autonomic nervous system may be most important for weight loss. Systemic sympathetic activation causes weight loss in obese patients, but side effects limited its use. We hypothesize that selective local electrical sympathetic stimulation of the upper gastrointestinal tract may induce weight loss and offer a safer, yet effective, obesity treatment. Celiac ganglia delivers sympathetic innervation to the upper gastrointestinal tract. Voltage regulated electrical simulation of the rat celiac ganglia increased metabolic rate in a dose-dependent manner. Stimulation of 6, 3, or 1.5 V increased metabolic rate 15.6%, 6.2%, and 5%, respectively in a single rat. These responses support our hypothesis that selective sympathetic stimulation of the upper GI tract may treat obesity while avoiding side effects of systemic sympathetic activation. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Zheng, Jolene] Louisiana State Univ, Dept Vet Sci, AgCtr, Baton Rouge, LA 70803 USA.
   [DiLorenzo, Daniel J.] Methodist Hosp, Dept Neurosurg, Houston, TX 77030 USA.
   [DiLorenzo, Daniel J.] DiLorenzo Biomed LLC, Houston, TX USA.
   [McLaughlin, Leslie] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
   [DiLorenzo, Daniel J.] Biogen Idec Inc, Cambridge, MA USA.
   [Greenway, Frank L.] LSU Syst, Pennington Biomed Res Ctr, Clin Unit, Baton Rouge, LA 70803 USA.
   [Greenway, Frank L.] Louisiana State Univ, Humman Ecol Dept, AgCtr, Baton Rouge, LA 70803 USA.
C3 Louisiana State University System; Louisiana State University; Houston
   Methodist; Louisiana State University System; Louisiana State
   University; Louisiana State University School of Veterinary Medicine;
   Biogen; Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Louisiana State University
   System; Louisiana State University
RP Zheng, J (corresponding author), Louisiana State Univ, Dept Vet Sci, AgCtr, HD Wilson Bldg,Room 110,S Stadium Dr, Baton Rouge, LA 70803 USA.
EM zhengz@lsu.edu
RI Greenway, Frank/N-1966-2017
FU NIDDK NIH HHS [P30 DK072476-04, P30 DK072476] Funding Source: Medline
CR ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S
   ASTRUP A, 1992, AM J CLIN NUTR, V55, P246
   ASTRUP A, 1992, INT J OBESITY, P269
   BABINSKI M, 1900, REV NEUROL, P531
   BERTHOUD HR, 1983, J AUTONOM NERV SYST, V7, P97, DOI 10.1016/0165-1838(83)90039-5
   BRAY GA, 1991, J NUTR, V121, P1146, DOI 10.1093/jn/121.8.1146
   BRAY GA, 1992, PROG BRAIN RES, V93, P333
   BRAY GA, 1989, VITAM HORM, P1
   BRAY GA, 2000, INT J OBESITY, pS8
   BRAY GA, 1975, MED BALTIMORE, P301
   BRUCH H, 1939, OBES, P329
   Camilleri M, 2008, SURGERY, V143, P723, DOI 10.1016/j.surg.2008.03.015
   Cigaina V, 2003, OBES RES, V11, P1456, DOI 10.1038/oby.2003.195
   Cigaina V, 1996, OBES SURG, V6, P250, DOI 10.1381/096089296765556854
   COCKEY CD, 2004, AWHONN LIFELINES, P19
   DULLOO AG, 1993, INT J OBESITY, V17, pS35
   ERDHEIM J, 1904, SITZUNGSB AKAD WISSE, P537
   Flaa A, 2008, AM J CLIN NUTR, V87, P1596, DOI 10.1093/ajcn/87.6.1596
   Frohlich A., 1901, Wien Klin Rundsch, V15, P883
   GREENWAY FL, 2001, OBES REV, P199
   GREENWAY FL, 2008, ENDOCR PRACT
   GREENWAY FL, 2007, J DIABETES SCI TECHN, P251
   INOUE S, 1977, ENDOCRINOLOGY, V100, P108, DOI 10.1210/endo-100-1-108
   INOUE S, 1978, AM J PHYSIOL, V235, pE266, DOI 10.1152/ajpendo.1978.235.3.E266
   JEANRENAUD B, 1983, EXPERIENTIA S, P57
   KING BM, 1982, NEUROSCI BIOBEHAV R, V6, P205, DOI 10.1016/0149-7634(82)90056-2
   KING BM, 2006, PHYSIOL BEHAV, P221
   KRAL JG, 1979, SURG CLIN N AM, V59, P1131
   NIIJIMA A, 1984, AM J PHYSIOL, V247, pR650, DOI 10.1152/ajpregu.1984.247.4.R650
   PASQUALI R, 1992, CLIN SSCI LOND, P85
   PERKINS MN, 1981, NATURE, V289, P401, DOI 10.1038/289401a0
   PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011
   REEVES AG, 1969, ARCH NEUROL-CHICAGO, P616
   SAKAGUCHI T, 1988, BRAIN RES BULL, V20, P461, DOI 10.1016/0361-9230(88)90135-9
   SAUTER JF, 1983, PFLUGERS ARCH, P68
   SEYDOUX J, 1982, ENDOCRINOLOGY, V110, P432, DOI 10.1210/endo-110-2-432
   SHIMIZU H, 1989, AM J PHYSIOL, V256, pR494, DOI 10.1152/ajpregu.1989.256.2.R494
   SMITH DK, 1983, LANCET, V1, P1330
   TOKUNAGA K, 1986, ENDOCRINOLOGY, V119, P1708, DOI 10.1210/endo-119-4-1708
   VANDERTUIG JG, 1982, LIFE SCI, V30, P913, DOI 10.1016/0024-3205(82)90619-1
   YORK DA, 1972, ENDOCRINOLOGY, V90, P885, DOI 10.1210/endo-90-4-885
   YOSHIDA T, 1984, AM J PHYSIOL, V246, pR558, DOI 10.1152/ajpregu.1984.246.4.R558
NR 42
TC 8
Z9 9
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD JUN
PY 2009
VL 72
IS 6
BP 706
EP 710
DI 10.1016/j.mehy.2008.12.046
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 437GF
UT WOS:000265474100023
PM 19246162
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Bustanji, Y
   Issa, A
   Mohammad, M
   Hudaib, M
   Tawah, K
   Alkhatib, H
   Almasri, I
   Al-Khalidi, B
AF Bustanji, Yasser
   Issa, Ala
   Mohammad, Mohammad
   Hudaib, Mohammad
   Tawah, Khalid
   Alkhatib, Hatim
   Almasri, Ihab
   Al-Khalidi, Bashar
TI Inhibition of hormone sensitive lipase and pancreatic lipase by
   Rosmarinus officinalis extract and selected phenolic constituents
SO JOURNAL OF MEDICINAL PLANTS RESEARCH
LA English
DT Article
DE Rosmarinus officinalis; Rosemary; obesity; diabetes mellitus; pancreatic
   lipase; hormone sensitive lipase; phenolic compounds; rosmarinic acid
ID ANTIOXIDANT ACTIVITIES; FAT-CELLS; IN-VITRO; ROSEMARY; ACID; DISCOVERY;
   LIPOLYSIS; THERAPY; OBESITY; ASSAYS
AB Rosmarinus officinalis L. (Rosemary) has been long claimed to have hypogylcemic-hypolipidemic dual effects in folkloric medicine. In an effort to explain rosemary's claimed benefits, numerous published studies have investigated an array of pharmacologic activities of the plant including anti-inflammatory, anticarcinogenic and metabolic effects. The question remained, however, as how rosemary would target both plasma lipids and glucose levels simultaneously. A newer mechanism has been suggested, in which targeting the hormone sensitive lipase (HSL) would be the common link between the two metabolic effects. In fact, HSL has been extensively studied for its effects on the metabolic switch between glucose and free fatty acids (FFAs) as an energy source. The current manuscript summarizes a significant amount of work that was undertaken to identify plant species native to Jordan with potential HSL and pancreatic lipase (PL) inhibitory activities. Our results demonstrated in vitro inhibitory effects of R. officnalis on both HSL and PL in a dose dependent manner. Interestingly, the rosemary extract had an IC50 for PL that was several fold lower than the IC50 for HSL, indicating a higher affinity to the former enzyme (13.8 and 95.2 mu g/mL for PL and HSL, respectively). In addition, we have compared the inhibitory activities of purified constituents found in rosemary to the parent plant [ rosmarinic acid (RA), chlorogenic acid (CA), caffeic acid (CaA) and gallic acid (GA)]. Our results showed that all the tested compounds (RA, CA, CaA, and GA) were able to inhibit the PL and HSL activities in a dose dependent manner, but with different potencies. PL and HSL IC50 values were calculated for each compound and GA was found to be the most potent (IC50 10.1 and 14.5 for PL and HSL, respectively). Further work is necessary to determine whether our in vitro findings would correlate with the in vivo effects. Nonetheless, our results are a first step in fully understanding the long claimed hypoglycemic-hypolipidemic dual effects of rosemary. Simultaneous targeting of both HSL and PL is likely to open the door for a new era in our continuous battle against DM type 2 and its cardiovascular complications. Currently we are working on identifying the most active constituents of the plant to evaluate a structure-activity relationship which would pave the road for future therapeutic use.
C1 [Bustanji, Yasser; Issa, Ala; Mohammad, Mohammad; Hudaib, Mohammad; Tawah, Khalid; Alkhatib, Hatim; Al-Khalidi, Bashar] Univ Jordan, Dept Clin Pharm & Biopharmaceut, Fac Pharm, Amman 11942, Jordan.
   [Almasri, Ihab] Al Azhar Univ, Fac Pharm, Gaza, Gaza Strip, Israel.
C3 University of Jordan; Al Azhar University Gaza
RP Bustanji, Y (corresponding author), Univ Jordan, Dept Clin Pharm & Biopharmaceut, Fac Pharm, Amman 11942, Jordan.
EM bustanji@ju.edu.jo
RI Issa, Ala/AAW-7065-2020; Alkhalidi, Bashar/S-3425-2017; Hudaib,
   Mohammad/HRA-3247-2023; Almasri, Ihab/AAK-5245-2021; AlKhatib,
   Hatim/G-6170-2016; Hudaib, Mohammad/L-2745-2015; Bustanji,
   Yasser/C-2626-2015
OI AlKhatib, Hatim/0000-0001-7037-2764; Hudaib,
   Mohammad/0000-0002-3807-7236; Hudaib, Mohammad/0000-0003-1400-462X;
   alkhalidi, bashar/0000-0003-4207-3956; Almasri,
   ihab/0000-0001-5988-5059; Bustanji, Yasser/0000-0003-1315-0609
FU Deanship of Scientific Research at the University of Jordan
FX This project was sponsored by the Deanship of Scientific Research at the
   University of Jordan. The authors wish to thank the Deanship of
   Scientific Research for their generous funds.
CR Al-Sereiti M. R., 1999, Indian Journal of Experimental Biology, V37, P124
   Anthonsen MW, 1999, PROG OBES R, P89
   Bai NS, 2010, J AGR FOOD CHEM, V58, P5363, DOI 10.1021/jf100332w
   Bakirel T, 2008, J ETHNOPHARMACOL, V116, P64, DOI 10.1016/j.jep.2007.10.039
   BASSANI V, 1990, INT J PHARMACEUT, V63, P57, DOI 10.1016/0378-5173(90)90101-9
   Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   BUSTANJI Y, 2010, JORDAN J PH IN PRESS
   Bustanji Y, 2010, J MED PLANT IN PRESS
   Cicero AFG, 2004, ACTA DIABETOL, V41, P91, DOI 10.1007/s00592-004-0150-2
   Dearlove RP, 2008, J MED FOOD, V11, P275, DOI 10.1089/jmf.2007.536
   Dipiro JT, 2007, PHARMACOTHERAPY PATH
   Dubois M, 2008, J MED CHEM, V51, P2575, DOI 10.1021/jm7011134
   El Deeb KS, 1993, B FAC PHARM, V31, P237
   Erenmemisoglu A, 1997, PHARMAZIE, V52, P645
   Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400
   Fabio A, 2007, PHYTOTHER RES, V21, P374, DOI 10.1002/ptr.1968
   Fazio G, 2010, CURR PHARM DESIGN, V16, P463, DOI 10.2174/138161210790232167
   Flex M, 2008, BIOCHEM SOC T, V36, P885, DOI 10.1042/BST0360885
   Furtado RA, 2010, J APPL TOXICOL, V30, P254, DOI 10.1002/jat.1491
   Gutiérrez R, 2010, PHYTOTHER RES, V24, P595, DOI 10.1002/ptr.2997
   Hadafi A, 1998, RIV ITAL EPPOS, P325
   Harach T, 2010, PLANTA MED, V76, P566, DOI 10.1055/s-0029-1240612
   Hasani-Ranjbar Shirin, 2009, Inflammation & Allergy Drug Targets, V8, P2
   Herrero M, 2010, J CHROMATOGR A, V1217, P2512, DOI 10.1016/j.chroma.2009.11.032
   HOLM C, 1994, PROTEIN ENG, V7, P537, DOI 10.1093/protein/7.4.537
   Koga K, 2006, J FOOD SCI, V71, pS507, DOI 10.1111/j.1750-3841.2006.00125.x
   Lean MEJ, 2004, J DRUG EVAL, V2, P179
   LEE YP, 1993, BIOCHIM BIOPHYS ACTA, V1169, P156
   LOWE ME, 1989, J BIOL CHEM, V264, P20042
   McCue PP, 2004, ASIA PAC J CLIN NUTR, V13, P101
   Mohammad M., 2010, Jordan Journal of Pharmaceutical Sciences, V3, P69
   Mohammad MK, 2010, PHARM BIOL IN PRESS
   Moon DO, 2010, CANCER LETT, V288, P183, DOI 10.1016/j.canlet.2009.06.033
   Morimoto C, 1999, J BIOCHEM-TOKYO, V125, P976, DOI 10.1093/oxfordjournals.jbchem.a022377
   Nabekura T, 2010, PHARMACOL RES, V61, P259, DOI 10.1016/j.phrs.2009.11.010
   Nawroth PP, 2010, EXP CLIN ENDOCR DIAB, V118, P1, DOI 10.1055/s-0029-1246117
   Osterlund T, 2001, EUR J BIOCHEM, V268, P1899, DOI 10.1046/j.1432-1327.2001.02097.x
   Park SU, 2008, AFR J BIOTECHNOL, V7, P4959
   Petry S, 2005, J LIPID RES, V46, P603, DOI 10.1194/jlr.D400021-JLR200
   Pfeiffer AFH, 2007, HORM METAB RES, V39, P734, DOI 10.1055/s-2007-990271
   Rababah TM, 2004, J AGR FOOD CHEM, V52, P5183, DOI 10.1021/jf049645z
   Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713
   RODBELL M, 1964, J BIOL CHEM, V239, P375
   Sanjust E, 2008, NAT PROD RES, V22, P689, DOI 10.1080/14786410801997125
   Scarpati M., 1958, Ric. Sci, V28, P2329
   Shetty K., 2007, Food Science and Technology, P187
   Sjöström L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4
   Slanc P, 2009, PHYTOTHER RES, V23, P874, DOI 10.1002/ptr.2718
   Smith GM, 1996, FEBS LETT, V396, P90, DOI 10.1016/0014-5793(96)01076-9
   Sotelo-Félix JI, 2002, EUR J GASTROEN HEPAT, V14, P1001, DOI 10.1097/00042737-200209000-00011
   Taha MO, 2008, J MED CHEM, V51, P6478, DOI 10.1021/jm800718k
   Takaki I, 2008, J MED FOOD, V11, P741, DOI 10.1089/jmf.2007.0524
   Vanithadevi B., 2008, INT J DIABETES METAB, V16, P35, DOI DOI 10.1159/000497651
   Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0
   Wang HF, 2004, FOOD CHEM, V87, P307, DOI 10.1016/j.foodchem.2003.12.029
   Wheatley D, 2004, HDB EXP PHARM, V157, P325
   Yamamoto H, 2005, LIPASE INHIBITOR CON, P10
NR 58
TC 94
Z9 99
U1 1
U2 23
PU ACADEMIC JOURNALS
PI VICTORIA ISLAND
PA P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA
SN 1996-0875
J9 J MED PLANTS RES
JI J. Med. Plants Res.
PD NOV 4
PY 2010
VL 4
IS 21
BP 2235
EP 2242
PG 8
WC Chemistry, Medicinal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 699UY
UT WOS:000285689600011
DA 2025-04-28
ER

PT J
AU Wu, ZM
   Yu, WX
   Ni, WJ
   Teng, CQ
   Ye, WL
   Yu, CP
   Zeng, Y
AF Wu, Zhimin
   Yu, Wenxin
   Ni, Weiju
   Teng, Cuiqin
   Ye, Weile
   Yu, Cuiping
   Zeng, Yu
TI Improvement of obesity by Liupao tea is through the IRS-1/PI3K/AKT/GLUT4
   signaling pathway according to network pharmacology and experimental
   verification
SO PHYTOMEDICINE
LA English
DT Article
DE Obesity; Insulin resistance; Network pharmacology; 3T3-L1 preadipocytes
ID (-)-EPIGALLOCATECHIN GALLATE; ADIPOCYTE DIFFERENTIATION;
   INSULIN-RESISTANCE; GLUCOSE-UPTAKE; MODULATION; MECHANISMS; RECEPTOR;
   DISEASE; 2-NBDG; GLUT4
AB Background: Obesity is a state of accumulating excessive body fat, charactering by a high blood lipid and associating with various metabolic diseases. As a kind of dark tea, many studies revealed that long-term drinking Liupao tea (LT) can reduce weight (Liu et al., 2014). However, the anti-obesity mechanism and active ingredients of LT are not known.
   Methods: Liquid chromatography-mass spectrometry (LC-MS) combined with network pharmacology was used to screen the active components and related targets of Liupao tea water extract (LTWE). The key anti-obesity targets and pathways of LTWE were predicted by protein-protein interaction (PPI) networks, and enrichment analyses using Kyoto Encyclopedia of Genes and Genomes and Gene Ontology databases. Then, the active components selected by high-performance liquid chromatography (HPLC) fingerprinting were used together with LTWE in an adipogenic model and insulin resistance (IR) model in vitro.
   Results: Most of the compounds identified from LTWE were flavonofids, esters, and amides. Key targets such as RAC-alpha serine/threonine-protein kinase, insulin, and tumor necrosis factor (TNF) were involved in the phosphatidylinositol-3-kinase-protein kinase B (PI3K-AKT) signaling pathway, pathways in cancer, and other pathways. Four active components were screened by network pharmacology combined with HPLC fingerprinting. The in vitro experiment of LTWE and its four active components showed that in insulin-resistant 3T3-L1 cells, LTWE, (-)-epigallocatechin gallate (EGCG) and gallic acid (GA) inhibited adipocyte differentiation. Three factors could inhibit the differentiation of 3T3-L1 cells by decreasing gene expression of peroxisome proliferators-activated receptor gamma (PPAR gamma), fatty acid synthase (FAS), CCAAT/enhancer binding proteins-alpha (C/EBP alpha) and interleukin-6 (IL-6). Caffeine and ellagic acid (EA) showed opposite results, but their effects on promoting adipose differentiation diminished with increasing concentrations of drug. In dexamethasone-induced insulin-resistant 3T3-L1 cells, the fluorescence intensity of 2-Deoxy-2-[(7-nitro-2,1,3-Benzoxadiazol-4-yl)amino]-D-glucose revealed that LTWE, GA, EGCG, caffeine, and EA significantly promoted glucose consumption. LTWE, GA, and EA improved insulin resistance in adipocytes by upregulating gene expression of insulin receptor substrate-1 (IRS-1), PI3K, AKT, and glucose transporter 4 (GLUT4).
   Conclusion: LC-MS combined with network pharmacology preliminarianized that LTWE acts mainly on the PI3K-AKT signaling pathway. Cell experiments revealed that the anti-obesity effect of LTWE is the result of multicomponent action, which inhibits the proliferation and differentiation of preadipocytes by regulating gene expression of adipogenic transcription factors and proinflammatory factors, and improves IR by activating the IRS-1/PI3K/AKT/GLUT4 pathway.
C1 [Wu, Zhimin; Yu, Wenxin; Ni, Weiju; Ye, Weile; Zeng, Yu] Guangdong Pharmaceut Univ, Sch Chinese Mat Med, Guangzhou 510006, Peoples R China.
   [Teng, Cuiqin; Yu, Cuiping] Wuzhou Inst Agr Sci, Wuzhou Liupao Tea Res Inst, Wuzhou 543002, Guangxi Zhuang, Peoples R China.
   [Zeng, Yu] Guangzhou Univ Chinese Med, Affiliated Hosp 2, State Key Lab Dampness Syndrome Chinese Med, Guangzhou 510006, Peoples R China.
   [Yu, Cuiping] Wuzhou Inst Agr Sci, 139-3 Xinxing Second Rd, Wuzhou 543000, Guangxi, Peoples R China.
C3 Guangdong Pharmaceutical University; Guangzhou University of Chinese
   Medicine
RP Zeng, Y (corresponding author), Guangdong Pharmaceut Univ, Sch Chinese Mat Med, Guangzhou 510006, Peoples R China.; Zeng, Y (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, State Key Lab Dampness Syndrome Chinese Med, Guangzhou 510006, Peoples R China.; Yu, CP (corresponding author), Wuzhou Inst Agr Sci, 139-3 Xinxing Second Rd, Wuzhou 543000, Guangxi, Peoples R China.
RI wu, zhimin/IXD-5020-2023
FU Special funds for Guangxi Major Science and Technology Special Project
   [Gui AA20302018-17]; State Key Laboratory of Dampness Syndrome of
   Chinese Medicine of the Second Affiliated Hospital of Guangzhou
   University of Chinese Medicine [SZ2022KF04]
FX Funding This work was supported by the Special funds for Guangxi Major
   Science and Technology Special Project (Gui AA20302018-17) and the State
   Key Laboratory of Dampness Syndrome of Chinese Medicine of the Second
   Affiliated Hospital of Guangzhou University of Chinese Medicine
   (SZ2022KF04) .
CR Cao SY, 2020, FOODS, V9, DOI 10.3390/foods9030262
   Cao YS, 2019, PHARM BIOL, V57, P660, DOI 10.1080/13880209.2019.1659831
   Chen Y, 2015, J MOL NEUROSCI, V55, P126, DOI 10.1007/s12031-014-0385-5
   Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350
   Ding QZ, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109262
   Dludla PV, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010023
   Feng C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00298
   Ghadimi M, 2021, PHYTOTHER RES, V35, P1023, DOI 10.1002/ptr.6867
   Giovanni T., 2016, NAT REV GASTRO HEPAT, V13
   [顾宇虹 Gu Yuhong], 2021, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V38, P244
   Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327
   Hickman RA, 2021, NEUROPATH APPL NEURO, V47, P415, DOI 10.1111/nan.12675
   Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118
   Huang JB, 2020, FOOD FUNCT, V11, P9924, DOI [10.1039/d0fo02152k, 10.1039/D0FO02152K]
   Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006
   Huang XJ, 2018, INT J BIOL SCI, V14, P1483, DOI 10.7150/ijbs.27173
   Ifa P.D.M, 2019, NUTR RES, V68
   Ismail BS, 2021, J PHARM RES INT, V33, P378, DOI 10.9734/JPRI/2021/v33i44B32689
   Jaynthi B, 2012, RES J PHARM TECHNOL, V5
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235
   Kotsis V, 2015, J HYPERTENS, V33, P1499, DOI 10.1097/HJH.0000000000000645
   Ku HC, 2012, MOL NUTR FOOD RES, V56, P580, DOI 10.1002/mnfr.201100438
   Lair B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176358
   Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10
   Li T, 2020, BIOMED PHARMACOTHER, V131
   Li XM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41289
   Ling HY, 2011, CLIN EXP PHARMACOL P, V38, P239, DOI 10.1111/j.1440-1681.2011.05493.x
   Liu AB, 2018, BIOFACTORS, V44, P348, DOI 10.1002/biof.1430
   Liu JiaQi Liu JiaQi, 2014, China Journal of Traditional Chinese Medicine and Pharmacy, V29, P108
   Ma Wan-jun, 2020, Journal of Tea Science, V40, P289
   Manaharan T, 2013, FOOD CHEM, V136, P354, DOI 10.1016/j.foodchem.2012.08.056
   Mao LM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205081
   Mao Y, 2018, INT J FOOD SCI TECH, V53, P599, DOI 10.1111/ijfs.13633
   Mi L, 2015, J CELL BIOCHEM, V116, P1195, DOI 10.1002/jcb.25065
   Mohammadinejad A, 2022, BIOTECHNOL APPL BIOC, V69, P2323, DOI 10.1002/bab.2288
   Organization W. H., 2021, OB OV
   Pahlavani M, 2017, J INVEST MED, V65, P1021, DOI 10.1136/jim-2017-000535
   Pan YN, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091280
   Pang BY, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/3837270
   Pedersen BK, 2007, BIOCHEM SOC T, V35, P1295, DOI 10.1042/BST0351295
   Perry R.J., 2015, CELL, P160
   Polce SA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050531
   Qian Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23112848
   Ramachandran V, 2015, HUM EXP TOXICOL, V34, P884, DOI 10.1177/0960327114561663
   Rong SX, 2017, ELIFE, V6, DOI [10.7554/eLife.25015.001, 10.7554/eLife.25015]
   Shan B., 2017, NAT IMMUNOL, P18
   Shimizu M, 2011, CANCER PREV RES, V4, P396, DOI 10.1158/1940-6207.CAPR-10-0331
   Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Sudeep G., 2014, APPL BIOCHEM BIOTECH, V174
   T.M A., 1995, ENDOCRINOLOGY, V136
   Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879
   Wang LF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/287534
   Wu Y, 2021, J FOOD SCI, V86, P215, DOI 10.1111/1750-3841.15551
   Xu M, 2019, FOOD FUNCT, V10, P7489, DOI 10.1039/c9fo00502a
   Yang Z, 2019, PHYTOTHER RES, V33, P1019, DOI 10.1002/ptr.6295
   Zhang R, 2021, LIFE SCI, V278, DOI 10.1016/j.lfs.2021.119630
   Zhang RZ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00123
   Zhang ZC, 2021, MOLECULES, V26, DOI 10.3390/molecules26123692
   Zhu MZ, 2021, FOOD FUNCT, V12, P4105, DOI [10.1039/d0fo01768j, 10.1039/D0FO01768J]
   Zhu ZJ, 2017, FOOD FUNCT, V8, P1680, DOI 10.1039/c7fo00089h
NR 62
TC 23
Z9 27
U1 9
U2 89
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
EI 1618-095X
J9 PHYTOMEDICINE
JI Phytomedicine
PD FEB
PY 2023
VL 110
AR 154633
DI 10.1016/j.phymed.2022.154633
EA JAN 2023
PG 19
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 8K5AI
UT WOS:000923114100001
PM 36628832
DA 2025-04-28
ER

PT J
AU Pan, A
   Malik, VS
   Hao, T
   Willett, WC
   Mozaffarian, D
   Hu, FB
AF Pan, A.
   Malik, V. S.
   Hao, T.
   Willett, W. C.
   Mozaffarian, D.
   Hu, F. B.
TI Changes in water and beverage intake and long-term weight changes:
   results from three prospective cohort studies
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE water; beverage; body weight; prospective cohort study
ID SUGAR-SWEETENED BEVERAGES; BODY-WEIGHT; ENERGY-INTAKE; FOOD-INTAKE;
   INDUCED THERMOGENESIS; CALORIC BEVERAGES; DRINKING-WATER; OLDER-ADULTS;
   US ADULTS; CONSUMPTION
AB OBJECTIVE: To examine the long-term relationship between changes in water and beverage intake and weight change.
   SUBJECTS: Prospective cohort studies of 50 013 women aged 40-64 years in the Nurses' Health Study (NHS, 1986-2006), 52 987 women aged 27-44 years in the NHS II (1991-2007) and 21 988 men aged 40-64 years in the Health Professionals Follow-up Study (1986-2006) without obesity and chronic diseases at baseline.
   MEASURES: We assessed the association of weight change within each 4-year interval, with changes in beverage intakes and other lifestyle behaviors during the same period. Multivariate linear regression with robust variance and accounting for within-person repeated measures were used to evaluate the association. Results across the three cohorts were pooled by an inverse-variance-weighted meta-analysis.
   RESULTS: Participants gained an average of 1.45 kg (5th to 95th percentile: -1.87 to 5.46) within each 4-year period. After controlling for age, baseline body mass index and changes in other lifestyle behaviors (diet, smoking habits, exercise, alcohol, sleep duration, TV watching), each 1 cup per day increment of water intake was inversely associated with weight gain within each 4-year period (-0.13 kg; 95% confidence interval (CI): -0.17 to -0.08). The associations for other beverages were: sugar-sweetened beverages (SSBs) (0.36 kg; 95% CI: 0.24-0.48), fruit juice (0.22 kg; 95% CI: 0.15-0.28), coffee (-0.14 kg; 95% CI: -0.19 to -0.09), tea (-0.03 kg; 95% CI: -0.05 to -0.01), diet beverages (-0.10 kg; 95% CI: -0.14 to -0.06), low-fat milk (0.02 kg; 95% CI: -0.04 to 0.09) and whole milk (0.02 kg; 95% CI: -0.06 to 0.10). We estimated that replacement of 1 serving per day of SSBs by 1 cup per day of water was associated with 0.49 kg (95% CI: 0.32-0.65) less weight gain over each 4-year period, and the replacement estimate of fruit juices by water was 0.35 kg (95% CI: 0.23-0.46). Substitution of SSBs or fruit juices by other beverages (coffee, tea, diet beverages, low-fat and whole milk) were all significantly and inversely associated with weight gain.
   CONCLUSION: Our results suggest that increasing water intake in place of SSBs or fruit juices is associated with lower long-term weight gain.
C1 [Pan, A.; Malik, V. S.; Willett, W. C.; Mozaffarian, D.; Hu, F. B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Pan, A.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore.
   [Pan, A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore.
   [Pan, A.] Natl Univ Hlth Syst, Singapore, Singapore.
   [Hao, T.; Willett, W. C.; Mozaffarian, D.; Hu, F. B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Willett, W. C.; Mozaffarian, D.; Hu, F. B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA.
   [Willett, W. C.; Mozaffarian, D.; Hu, F. B.] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Mozaffarian, D.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA.
C3 Harvard University; Harvard T.H. Chan School of Public Health; National
   University of Singapore; National University of Singapore; National
   University of Singapore; Harvard University; Harvard T.H. Chan School of
   Public Health; Harvard University; Harvard University Medical
   Affiliates; Brigham & Women's Hospital; Harvard University; Harvard
   Medical School; Harvard University; Harvard University Medical
   Affiliates; Brigham & Women's Hospital
RP Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave,Bldg 2,Floor 3, Boston, MA 02115 USA.
EM ephanp@nus.edu.sg; frank.hu@channing.harvard.edu
RI Hu, Frank/C-1919-2013; Willett, Walter/E-2352-2013; Pan, An/C-5572-2011
OI Pan, An/0000-0002-1089-7945
FU National Institutes of Health [P01CA087969, R01CA050385, U19CA055075,
   R01DK058845, P30DK046200, U54CA155626]
FX We are indebted to the participants in the Nurses' Health Study, Nurses'
   Health Study II and HPFS for their continuing outstanding support and
   colleagues working in these studies for their valuable help. The study
   was supported by the National Institutes of Health Grants (P01CA087969,
   R01CA050385, U19CA055075, R01DK058845, P30DK046200 and U54CA155626). The
   study sponsors were not involved in the study design and the collection,
   analysis and interpretation of data, nor the writing of the article or
   the decision to submit it for publication. The authors were independent
   from the study sponsors.
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Boschmann M, 2003, J CLIN ENDOCR METAB, V88, P6015, DOI 10.1210/jc.2003-030780
   Boschmann M, 2007, J CLIN ENDOCR METAB, V92, P3334, DOI 10.1210/jc.2006-1438
   Brown CM, 2006, J CLIN ENDOCR METAB, V91, P3598, DOI 10.1210/jc.2006-0407
   Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240
   Chen M, 2012, AM J CLIN NUTR, V96, P735, DOI 10.3945/ajcn.112.037119
   Daniels MC, 2010, NUTR REV, V68, P505, DOI 10.1111/j.1753-4887.2010.00311.x
   Davy BM, 2008, J AM DIET ASSOC, V108, P1236, DOI 10.1016/j.jada.2008.04.013
   DellaValle DM, 2005, APPETITE, V44, P187, DOI 10.1016/j.appet.2004.11.003
   Dennis EA, 2010, OBESITY, V18, P300, DOI 10.1038/oby.2009.235
   DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229
   FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Libuda L, 2008, BRIT J NUTR, V99, P1370, DOI 10.1017/S0007114507862362
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101
   Mattes RD, 2011, OBES REV, V12, P346, DOI 10.1111/j.1467-789X.2010.00755.x
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Olsen NJ, 2009, OBES REV, V10, P68, DOI 10.1111/j.1467-789X.2008.00523.x
   Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698
   Pepino MY, 2011, CURR OPIN CLIN NUTR, V14, P391, DOI 10.1097/MCO.0b013e3283468e7e
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721
   Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559
   ROLLS BJ, 1990, PHYSIOL BEHAV, V48, P19, DOI 10.1016/0031-9384(90)90254-2
   SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858
   Stookey JD, 2008, OBESITY, V16, P2481, DOI 10.1038/oby.2008.409
   Stookey JD, 2007, OBESITY, V15, P3013, DOI 10.1038/oby.2007.359
   Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278
   TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963
   Van Walleghen EL, 2007, OBESITY, V15, P93, DOI 10.1038/oby.2007.506
   Wolf A, 2008, OBES REV, V9, P151, DOI 10.1111/j.1467-789X.2007.00389.x
NR 39
TC 168
Z9 185
U1 0
U2 66
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD OCT
PY 2013
VL 37
IS 10
BP 1378
EP 1385
DI 10.1038/ijo.2012.225
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 233CG
UT WOS:000325542200013
PM 23318721
OA Green Accepted, Green Submitted
DA 2025-04-28
ER

PT J
AU Gondoin, A
   Grussu, D
   Stewart, D
   McDougall, GJ
AF Gondoin, Anais
   Grussu, Dominic
   Stewart, Derek
   McDougall, Gordon J.
TI White and green tea polyphenols inhibit pancreatic lipase in
   vitro
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Tea; Polyphenols; Lipase; Fat digestion; Obesity; Health; Tannins
ID EPIGALLOCATECHIN GALLATE; INTESTINAL-ABSORPTION; PURINE ALKALOIDS;
   GALLIC ACID; CATECHINS; EXTRACT; CAFFEINE; IDENTIFICATION;
   CHROMATOGRAPHY; CHOLESTEROL
AB Green, white and black teas were assayed for inhibition of pancreatic lipase activity in vitro. White tea proved to be more effective than green tea with black tea showing little inhibition even at 200 mu g GAE/ml. The EC50 values for inhibition were 22 mu g/ml for white tea and 35 mu g/ml for green tea: both easily achievable from normal infusions of tea. Liquid chromatography-mass spectroscopy analysis showed that white and green teas had essentially equal amounts of flavan-3-ols but green tea had higher levels of flavonols. White tea had higher levels of 5-galloyl quinic acid, digalloyl glucose, trigalloyl glucose and the tannin, strictinin.
   After chromatography on Sephadex LH-20, the main inhibitory fraction was enriched in strictinin and fractions enriched in other components were ineffective. This suggests that strictinin content may be crucial for inhibition of pancreatic lipase. However, the possibility of synergies between the polyphenols cannot be disregarded. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.
C1 [Gondoin, Anais; Grussu, Dominic; Stewart, Derek; McDougall, Gordon J.] Scottish Crop Res Inst Mylnefield, Plant Prod & Food Qual Programme, Dundee DD2 5DA, Scotland.
C3 James Hutton Institute
RP McDougall, GJ (corresponding author), Scottish Crop Res Inst Mylnefield, Plant Prod & Food Qual Programme, Dundee DD2 5DA, Scotland.
EM Gordon.mcdougall@scri.ac.uk
RI McDougall, Gordon/HKO-7201-2023
FU Rural and Environment Research and Analysis Directorate, Scottish
   Government
FX We acknowledge the gift of white tea from Honeybush & Butterbum Ltd, via
   Dr Ed Okello, University of Newcastle. We also thank the Ecole Nationale
   Superieure d'Agronomie et des Industries Alimentaires, Nancy, France for
   allowing Anais Gondoin to spend her internship training period at SCRI.
   We also thank the Rural and Environment Research and Analysis
   Directorate, Scottish Government for support.
CR [Anonymous], 2003, OBESITY OVERWEIGHT F
   BALENTINE DA, 1992, ACS SYM SER, V506, P102
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   de Mejia EG, 2009, BRAIN BEHAV IMMUN, V23, P721, DOI 10.1016/j.bbi.2009.02.013
   Deighton N, 2000, J SCI FOOD AGR, V80, P1307, DOI 10.1002/1097-0010(200007)80:9<1307::AID-JSFA638>3.0.CO;2-P
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   Dou J, 2008, PHYTOCHEM ANALYSIS, V19, P251, DOI 10.1002/pca.1044
   Engelhardt UH, 2004, ACS SYM SER, V871, P254
   FINGER A, 1992, J CHROMATOGR, V624, P293, DOI 10.1016/0021-9673(92)85685-M
   Frazier RA, 2010, J PHARMACEUT BIOMED, V51, P490, DOI 10.1016/j.jpba.2009.05.035
   Friedman M, 2006, J FOOD SCI, V71, pC328, DOI 10.1111/j.1750-3841.2006.00090.x
   Grassi D, 2008, J NUTR, V138, P1554
   Henning SA, 2005, J NUTR BIOCHEM, V16, P610, DOI 10.1016/j.jnutbio.2005.03.003
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hilal Y, 2007, J VERBRAUCH LEBENSM, V2, P414, DOI 10.1007/s00003-007-0250-3
   Hsu CL, 2008, MOL NUTR FOOD RES, V52, P53, DOI [10.1002/mnfr.200890019, 10.1002/mnfr.200700393]
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kim HJ, 2009, PHYTOTHER RES, V23, P467, DOI 10.1002/ptr.2647
   Komes D, 2010, FOOD RES INT, V43, P167, DOI 10.1016/j.foodres.2009.09.022
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Koo SI, 2008, FASEB J, V22
   Lin YS, 2003, J AGR FOOD CHEM, V51, P1864, DOI 10.1021/jf021066b
   Mämmelä P, 2000, J CHROMATOGR A, V891, P75, DOI 10.1016/S0021-9673(00)00624-5
   McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926
   McDougall GJ, 2009, FOOD CHEM, V115, P193, DOI 10.1016/j.foodchem.2008.11.093
   Mizukami Y, 2007, J AGR FOOD CHEM, V55, P4957, DOI 10.1021/jf070323f
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Price KR, 1998, J AGR FOOD CHEM, V46, P2517, DOI 10.1021/jf9800211
   Record IR, 2001, FOOD CHEM, V73, P481, DOI 10.1016/S0308-8146(01)00131-5
   ROBERTS HR, 1983, FOOD TECHNOL-CHICAGO, V37, P32
   Rusak G, 2008, FOOD CHEM, V110, P852, DOI 10.1016/j.foodchem.2008.02.072
   Serafini M, 1996, EUR J CLIN NUTR, V50, P28
   Seto R, 1997, BIOSCI BIOTECH BIOCH, V61, P1434, DOI 10.1271/bbb.61.1434
   Stalmach A, 2010, MOL NUTR FOOD RES, V54, P323, DOI 10.1002/mnfr.200900194
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309
   Yang DJ, 2007, J CHROMATOGR A, V1156, P312, DOI 10.1016/j.chroma.2006.11.088
   Zeeb DJ, 2000, ANAL CHEM, V72, P5020, DOI 10.1021/ac000418f
NR 43
TC 99
Z9 113
U1 7
U2 138
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD JUN
PY 2010
VL 43
IS 5
BP 1537
EP 1544
DI 10.1016/j.foodres.2010.04.029
PG 8
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 645CO
UT WOS:000281428700045
DA 2025-04-28
ER

PT J
AU Riachi, LG
   De Maria, CAB
AF Riachi, Liza Ghassan
   Bastos De Maria, Carlos Alberto
TI Yerba mate: An overview of physiological effects in humans
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Ilex paraguariensis; Human; Oxidative stress; Antioxidant enzymes;
   Lipidaemic and glycaemic control; Weight loss
ID TEA ILEX-PARAGUARIENSIS; OXIDATIVE STRESS BIOMARKERS;
   LOW-DENSITY-LIPOPROTEIN; CHLOROGENIC ACIDS; DOUBLE-BLIND; AMELIORATES
   OBESITY; ANTIOXIDANT STATUS; GLUCOSE-UPTAKE; GREEN COFFEE; CONSUMPTION
AB This review aims to make an outline of the existing clinical studies from the past twenty years concerning to mate effects in human health. Physiological effects have been attributed to phenolics, methylxanthines and saponins. Antilipemic activity was more consistent than glycaemic control. Mate seems to protect low-density lipoprotein cholesterol (LDL-c) from oxidation in whole plasma. Results from isolated LDL-c particles are contradictory. The antioxidant enzymatic complex was positively modulated, indicating that mate might help in the redox homeostasis maintenance. Most clinical trials did not find a significant positive effect of mate consumption on glycaemia. However, it seems that mate hypoglycaemic effect is more evident in type-2 diabetes mellitus subjects. Mate had no effect on anti-glycation in vivo. It has shown potential to increase energy expenditure and weight loss. Carcinogenicity is related to consumption temperature, not mate itself. Long-term randomized double-blind placebo-controlled studies are essential to provide more consistent data. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Riachi, Liza Ghassan; Bastos De Maria, Carlos Alberto] PPGENFBIO UNIRIO, Nursing Sch, Nursing & Biosci Postgrad Program, Av Pasteur 296, BR-22290240 Rio De Janeiro, Brazil.
   [Bastos De Maria, Carlos Alberto] Univ Fed Estado Rio de Janeiro, Biomed Inst, Collect Hlth Dept, Rio de Janeiro, Brazil.
C3 Universidade Federal do Estado do Rio de Janeiro
RP De Maria, CAB (corresponding author), Fed Univ Rio de Janeiro State UNIRIO, Collect Hlth Dept, Biomed Inst, Rua Frei Caneca 94,Sala A-411, BR-20211040 Rio De Janeiro, Brazil.
EM lizagr00@gmail.com; carreb@uol.com.br
RI de maria, carlos/B-8585-2013
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX This work was supported by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (Capes) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq).
CR Alkhatib A, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-42
   Amigo-Benavent M, 2017, FOOD CHEM TOXICOL, V106, P125, DOI 10.1016/j.fct.2017.05.019
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Arçari DP, 2011, J FUNCT FOODS, V3, P190, DOI 10.1016/j.jff.2011.04.001
   Bains Y, 2017, FITOTERAPIA, V117, P6, DOI 10.1016/j.fitote.2016.12.006
   Bastos DHM, 2006, BRAZ ARCH BIOL TECHN, V49, P399, DOI 10.1590/S1516-89132006000400007
   Bastos Deborah H. Markowicz, 2005, Acta Farmaceutica Bonaerense, V24, P91
   Bastos DHM., 2007, Med Aromat Plant Sci Biotechnol, V1, P37
   Bixby M, 2005, LIFE SCI, V77, P345, DOI 10.1016/j.lfs.2004.11.030
   Bloomer RJ, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-32
   Bloomer RJ, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-4
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Branco CD, 2013, BRAIN RES BULL, V92, P60, DOI 10.1016/j.brainresbull.2012.11.008
   Bravo L, 2014, FITOTERAPIA, V92, P219, DOI 10.1016/j.fitote.2013.11.007
   Boaventura BCB, 2015, LWT-FOOD SCI TECHNOL, V62, P948, DOI 10.1016/j.lwt.2015.02.028
   Boaventura BCB, 2013, J FUNCT FOODS, V5, P1057, DOI 10.1016/j.jff.2013.03.001
   Boaventura BCB, 2012, NUTRITION, V28, P657, DOI 10.1016/j.nut.2011.10.017
   BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253
   Bruckbauer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089166
   Campbell BI, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0123-1
   Coelho GC, 2007, BIOCHEM SYST ECOL, V35, P75, DOI 10.1016/j.bse.2006.09.001
   Conforti AS, 2012, BONE, V50, P9, DOI 10.1016/j.bone.2011.08.029
   da Silva EL, 2008, FOOD RES INT, V41, P973, DOI 10.1016/j.foodres.2008.08.004
   Danhelova H, 2012, ANAL BIOANAL CHEM, V403, P2883, DOI 10.1007/s00216-012-5820-2
   De Maria C. A. B., 2011, QUIM NOVA
   de Morais EC, 2009, J AGR FOOD CHEM, V57, P8316, DOI 10.1021/jf901660g
   de Oliveira EP, 2016, RBONE-REV BRAS OBES, V10, P242
   de Resende PE, 2015, J FUNCT FOODS, V15, P440, DOI 10.1016/j.jff.2015.03.040
   DeChristopher LR, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.7
   DeChristopher LR, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0097-x
   Deneo-Pellegrini H, 2013, HEAD NECK-J SCI SPEC, V35, P1091, DOI 10.1002/hed.23080
   Farah A, 2005, J AGR FOOD CHEM, V53, P1505, DOI 10.1021/jf048701t
   Fernandes ES, 2012, NUTRITION, V28, P1157, DOI 10.1016/j.nut.2012.04.011
   da Silveira TFF, 2016, FOOD RES INT, V82, P165, DOI 10.1016/j.foodres.2015.12.033
   da Silveira TFF, 2014, FOOD RES INT, V60, P241, DOI 10.1016/j.foodres.2013.09.024
   Ferreira F, 1997, PHYTOTHER RES, V11, P79, DOI 10.1002/(SICI)1099-1573(199702)11:1<79::AID-PTR34>3.3.CO;2-I
   Gnoatto SCB, 2005, J BRAZIL CHEM SOC, V16, P723, DOI 10.1590/S0103-50532005000500007
   GUGLIUCCI A, 1995, BIOCHEM MOL BIOL INT, V35, P47
   Gugliucci A, 1996, BIOCHEM BIOPH RES CO, V224, P338, DOI 10.1006/bbrc.1996.1030
   Gugliucci A, 2009, FITOTERAPIA, V80, P339, DOI 10.1016/j.fitote.2009.04.007
   Harrold JA, 2013, APPETITE, V62, P84, DOI 10.1016/j.appet.2012.11.018
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Heck CI, 2008, J AGR FOOD CHEM, V56, P8394, DOI 10.1021/jf801748s
   Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-1
   Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x
   IARC, 1991, IARC MONOGR EVAL CAR, V51, P1
   Isolabella S, 2010, FOOD CHEM, V122, P695, DOI 10.1016/j.foodchem.2010.03.039
   Jitomir J, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-23
   정지혜, 2016, Journal of Obesity & Metabolic Syndrome, V25, P197
   Kahale KH, 2015, NUTR FOOD SCI, V45, P433, DOI 10.1108/NFS-12-2014-0097
   Kamanna VS, 2008, AM J CARDIOL, V101, p20B, DOI 10.1016/j.amjcard.2008.02.029
   Khan S, 2016, DRUG DEV IND PHARM, V42, P209, DOI 10.3109/03639045.2015.1040414
   Kim HJ, 2012, J FUNCT FOODS, V4, P287, DOI 10.1016/j.jff.2011.12.005
   Kim SY, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0859-1
   Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604
   Kita T., 2006, Ann. N. Y. Acad. Sci, V947, P199
   Klein GA, 2011, J AM COLL NUTR, V30, P320, DOI 10.1080/07315724.2011.10719975
   Liao CC, 2013, J AGR FOOD CHEM, V61, P11082, DOI 10.1021/jf4026647
   Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Lunceford N, 2005, FITOTERAPIA, V76, P419, DOI 10.1016/j.fitote.2005.03.021
   Gatto EM, 2015, J NEUROL SCI, V356, P163, DOI 10.1016/j.jns.2015.06.043
   Marques V, 2009, FOOD CHEM, V113, P1370, DOI 10.1016/j.foodchem.2008.08.086
   Márquez V, 2013, FOOD RES INT, V53, P808, DOI 10.1016/j.foodres.2013.02.016
   Martinet A, 1999, PHYTOMEDICINE, V6, P231, DOI 10.1016/S0944-7113(99)80014-2
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Matsumoto RLT, 2009, NUTRIENTS, V1, P18, DOI 10.3390/nu1010018
   Meinhart AD, 2010, J AGR FOOD CHEM, V58, P2188, DOI 10.1021/jf903781w
   Menini T, 2007, PLANTA MED, V73, P1141, DOI 10.1055/s-2007-981585
   Messina D, 2015, NUTR HOSP, V31, P2131, DOI 10.3305/nh.2015.31.5.8386
   Narita Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2329, DOI 10.1271/bbb.120518
   Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718
   Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016
   Outlaw J, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-25
   Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019
   Panza VP, 2016, BRIT J NUTR, V115, P1370, DOI 10.1017/S000711451600043X
   Pereira DF, 2012, PHYTOMEDICINE, V19, P868, DOI 10.1016/j.phymed.2012.05.008
   Peres RG, 2013, MOLECULES, V18, P3859, DOI 10.3390/molecules18043859
   Petrilli AA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050132
   Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092
   Rashti SL, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-57
   Ribeiro MC, 2017, J FUNCT FOODS, V28, P240, DOI 10.1016/j.jff.2016.11.024
   Ronco Alvaro L, 2016, Asian Pac J Cancer Prev, V17, P2923
   Ronco Alvaro L, 2016, Asian Pac J Cancer Prev, V17, P1453
   Ruxton CHS, 2005, NUTR FOOD SCI, V35, P303, DOI 10.1108/00346650510625494
   Ruxton CHS, 2007, BRIT FOOD J, V109, P416, DOI 10.1108/00070700710753481
   Ruxton C. H. S., 2004, Nutrition & Food Science, V34, P25, DOI 10.1108/00346650410516199
   Santos IS, 2005, J NUTR, V135, P1120, DOI 10.1093/jn/135.5.1120
   Serra F, 1999, INT J OBESITY, V23, P650, DOI 10.1038/sj.ijo.0800897
   Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697
   Stohs SJ, 2016, PHYTOTHER RES, V30, P732, DOI 10.1002/ptr.5583
   Szymanska K, 2010, CANCER CAUSE CONTROL, V21, P1799, DOI 10.1007/s10552-010-9606-6
   Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI [10.1139/H11-072, 10.1139/h11-072]
   VASSALLO A, 1985, JNCI-J NATL CANCER I, V75, P1005
   Yu SH, 2015, EXP GERONTOL, V62, P14, DOI 10.1016/j.exger.2014.12.016
   Yuan XX, 2017, FASEB J, V31, P333, DOI [10.1096/fj.201600459rr, 10.1096/fj.201600459RR]
NR 97
TC 44
Z9 47
U1 2
U2 38
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD NOV
PY 2017
VL 38
BP 308
EP 320
DI 10.1016/j.jff.2017.09.020
PN A
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA FM3FU
UT WOS:000414890500031
DA 2025-04-28
ER

PT J
AU Domínguez-Avila, JA
   González-Aguilar, GA
   Alvarez-Parrilla, E
   de la Rosa, LA
AF Abraham Dominguez-Avila, J.
   Gonzalez-Aguilar, Gustavo A.
   Alvarez-Parrilla, Emilio
   de la Rosa, Laura A.
TI Modulation of PPAR Expression and Activity in Response to Polyphenolic
   Compounds in High Fat Diets
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE PPAR; polyphenols; high fat; gene expression
ID PROLIFERATOR-ACTIVATED RECEPTORS; LIPID-METABOLISM; GENE-EXPRESSION;
   GREEN TEA; OLIVE OIL; GAMMA; ACCUMULATION; ALPHA; ACID; LIPOGENESIS
AB Peroxisome proliferator-activated receptors (PPAR) are transcription factors that modulate energy metabolism in liver, adipose tissue and muscle. High fat diets (HFD) can negatively impact PPAR expression or activity, favoring obesity, dyslipidemia, insulin resistance and other conditions. However, polyphenols (PP) found in vegetable foodstuffs are capable of positively modulating this pathway. We therefore focused this review on the possible effects that PP can have on PPAR when administered together with HFD. We found that PP from diverse sources, such as coffee, olives, rice, berries and others, are capable of inducing the expression of genes involved in a decrease of adipose mass, liver and serum lipids and lipid biosynthesis in animal and cell models of HFD. Since cells or gut bacteria can transform PP into different metabolites, it is possible that a synergistic or antagonistic effect ultimately occurs. PP molecules from vegetable sources are an interesting option to maintain or return to a state of energy homeostasis, possibly due to an adequate PPAR expression and activity.
C1 [Abraham Dominguez-Avila, J.; Gonzalez-Aguilar, Gustavo A.] Ctr Invest Alimentac & Desarrollo AC, Coordinac Tecnol Alimentos Origen Vegetal, Carretera La Victoria Km 0-6,AP 1735, Hermosillo 83304, Sonora, Mexico.
   [Alvarez-Parrilla, Emilio; de la Rosa, Laura A.] Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Dept Ciencias Quim Biol, Anillo Envolvente PRONAF & Estocolmo S-N, Ciudad Juarez 32310, Chihuahua, Mexico.
C3 CIAD - Centro de Investigacion en Alimentacion y Desarrollo; Universidad
   Autonoma de Ciudad Juarez
RP de la Rosa, LA (corresponding author), Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Dept Ciencias Quim Biol, Anillo Envolvente PRONAF & Estocolmo S-N, Ciudad Juarez 32310, Chihuahua, Mexico.
EM abrahamdominguez9@yahoo.com; gustavo@ciad.mx; ealvarez@uacj.mx;
   ldelaros@uacj.mx
RI de la Rosa, Laura/AFS-1811-2022; Alvarez, Emilio/K-7277-2019;
   Dominguez-Avila, J. Abraham/D-8365-2017
OI Dominguez-Avila, J. Abraham/0000-0001-6220-1623; de la Rosa, Laura
   A./0000-0003-2082-873X; Alvarez-Parrilla, Emilio/0000-0002-6162-8139
FU National Council for Science and Technology (CONACYT); CONACYT
   [CB-2011-01-167164]
FX Dominguez-Avila thanks the National Council for Science and Technology
   (CONACYT) for his postdoctoral fellowship received during the writing of
   this article. Financial support from CONACYT through Project
   CB-2011-01-167164 is also acknowledged.
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Amritpal Singh Amritpal Singh, 2010, Journal of Natural Products (India), V3, P64
   Arabshahi-Delouee S, 2007, FOOD CHEM, V102, P1233, DOI 10.1016/j.foodchem.2006.07.013
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Awika JM, 2004, PHYTOCHEMISTRY, V65, P1199, DOI 10.1016/j.phytochem.2004.04.001
   Azuma K, 1999, J AGR FOOD CHEM, V47, P3963, DOI 10.1021/jf990347p
   Bogacka I, 2007, DIABETES CARE, V30, P1179, DOI 10.2337/dc06-1962
   Bozan B, 2008, BIORESOURCE TECHNOL, V99, P6354, DOI 10.1016/j.biortech.2007.12.009
   Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354
   Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2
   Caponio F, 1999, FOOD CHEM, V64, P203, DOI 10.1016/S0308-8146(98)00146-0
   Chang CJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/787152
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Cheng H. S., 2016, NUTRITION, DOI [10.1016/j.nut.2016.02.002, DOI 10.1016/J.NUT.2016.02.00227130470]
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Collins B, 2016, J NUTR BIOCHEM, V31, P150, DOI 10.1016/j.jnutbio.2015.12.021
   Erlund I, 2004, NUTR RES, V24, P851, DOI 10.1016/j.nutres.2004.07.005
   Falcao SI, 2010, ANAL BIOANAL CHEM, V396, P887, DOI 10.1007/s00216-009-3232-8
   Fernández-Mar MI, 2012, FOOD CHEM, V130, P797, DOI 10.1016/j.foodchem.2011.08.023
   Frazier-Wood AC, 2013, PHARMACOGENOMICS J, V13, P312, DOI 10.1038/tpj.2012.9
   Fuentes E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/136584
   Fukumitsu S, 2008, BRIT J NUTR, V100, P669, DOI 10.1017/S0007114508911570
   Grygiel-Górniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17
   Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392
   Hassen I, 2015, J FUNCT FOODS, V18, P926, DOI 10.1016/j.jff.2014.09.001
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Herranz-López M, 2015, PHYTOMEDICINE, V22, P605, DOI 10.1016/j.phymed.2015.03.015
   Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x
   Hillebrand S, 2004, J AGR FOOD CHEM, V52, P7331, DOI 10.1021/jf0487957
   Honda K, 2009, ANIM SCI J, V80, P562, DOI 10.1111/j.1740-0929.2009.00670.x
   Hu C, 2003, J AGR FOOD CHEM, V51, P5271, DOI 10.1021/jf034466n
   Hu Y, 2013, P NATL ACAD SCI USA, V110, P15401, DOI 10.1073/pnas.1307211110
   Ichi I, 2009, J FOOD SCI, V74, pH127, DOI 10.1111/j.1750-3841.2009.01147.x
   Ikarashi N., 2011, EVID-BASED COMPL ALT, V2011, DOI [10.1093/ecam/nep24121799697, DOI 10.1093/ECAM/NEP24121799697]
   Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015
   Jang HH, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-27
   Jia YY, 2013, BBA-MOL CELL BIOL L, V1831, P698, DOI 10.1016/j.bbalip.2012.11.012
   Kalt W, 2008, J AGR FOOD CHEM, V56, P705, DOI 10.1021/jf071998l
   Kim H, 2010, J AGR FOOD CHEM, V58, P3984, DOI 10.1021/jf903230s
   Kim MS, 2014, TROP J PHARM RES, V13, P31, DOI 10.4314/tjpr.v13i1.5
   Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392
   Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779
   Kuem N, 2014, MOL NUTR FOOD RES, V58, P2166, DOI 10.1002/mnfr.201400159
   Kumazawa S, 2007, J AGR FOOD CHEM, V55, P7722, DOI 10.1021/jf071187h
   Kuo DH, 2009, J ETHNOPHARMACOL, V124, P544, DOI 10.1016/j.jep.2009.05.005
   Lin YL, 2012, PLANT FOOD HUM NUTR, V67, P294, DOI 10.1007/s11130-012-0309-x
   Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Andrade JMO, 2014, NUTRITION, V30, P915, DOI 10.1016/j.nut.2013.11.016
   Ou TT, 2011, J SCI FOOD AGR, V91, P2740, DOI 10.1002/jsfa.4489
   Park JH, 2012, NUTR RES PRACT, V6, P322, DOI 10.4162/nrp.2012.6.4.322
   Pascual ME, 2001, J ETHNOPHARMACOL, V76, P201, DOI 10.1016/S0378-8741(01)00234-3
   Ragab SMM, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0087-1
   Rasouli N, 2012, PHARMACOGENET GENOM, V22, P484, DOI 10.1097/FPC.0b013e328352a72e
   Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.3862
   Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321
   Sugden M C, 2012, Curr Mol Pharmacol, V5, P224
   Tian C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053796
   Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231
   Vissers MN, 2004, EUR J CLIN NUTR, V58, P955, DOI 10.1038/sj.ejcn.1601917
   Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001
   Wall MM, 2006, J FOOD COMPOS ANAL, V19, P655, DOI 10.1016/j.jfca.2005.12.001
   Wang L, 2011, EUR J NUTR, V50, P127, DOI 10.1007/s00394-010-0122-y
   Wang LQ, 2000, CHEM PHARM BULL, V48, P1606, DOI 10.1248/cpb.48.1606
   Wein S, 2010, EUR J PHARM SCI, V41, P16, DOI 10.1016/j.ejps.2010.05.004
   Wu LN, 2016, SCI REP-UK, V6, DOI 10.1038/srep26072
   Yang DJ, 2010, FOOD CHEM, V119, P1457, DOI 10.1016/j.foodchem.2009.09.027
   Yang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068035
   Yang X. R., 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/783860, DOI 10.1155/2013/78386023935682]
   Youssef J.A., 2013, Peroxisome Proliferator-Activated Receptors: Discovery and Recent Advances, P33
   Zadernowski R, 2005, J AGR FOOD CHEM, V53, P2118, DOI 10.1021/jf040411p
   Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006
   Zhang QY, 2009, J CHROMATOGR A, V1216, P1954, DOI 10.1016/j.chroma.2008.07.072
   Zhang ZS, 2001, J NUTR BIOCHEM, V12, P144, DOI 10.1016/S0955-2863(00)00137-6
   Zheng XK, 2011, J ETHNOPHARMACOL, V137, P662, DOI 10.1016/j.jep.2011.06.018
NR 76
TC 59
Z9 60
U1 2
U2 39
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL
PY 2016
VL 17
IS 7
AR 1002
DI 10.3390/ijms17071002
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA DT5DK
UT WOS:000381500900017
PM 27367676
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU AlAmmar, WA
   Albeesh, FH
   Khattab, RY
AF AlAmmar, Welayah A.
   Albeesh, Fatima H.
   Khattab, Rabie Y.
TI Food and Mood: the Corresponsive Effect
SO CURRENT NUTRITION REPORTS
LA English
DT Article
DE Food - Mood; Diseases; Healthy choices
ID QUALITY-OF-LIFE; DEPRESSED MOOD; CONTROLLED-TRIAL; POSITIVE MOOD;
   YOUNG-PEOPLE; CONSUMPTION; CHOCOLATE; OBESITY; CAFFEINE;
   OMEGA-3-FATTY-ACIDS
AB Purpose of Review The question whether food choice and eating behavior influence the mood or are influenced by the mood has been inquisitive to scientists and researchers. The purpose of this review is to support or refuse the argument that mood is affected by food or vice versa.
   Recent Findings The association between food and mood has been comprehensively elucidated in this review based on several studies that include participants from different ages, cultural backgrounds, and health status. The correlation among food, mood, and diseases such as diabetes mellitus, obesity, and depression was thoroughly investigated. The effect of different foods and nutrients on the mood was further explained. It is concluded that the mood significantly affects food intake and food choices. On the other hand, food also influences the mood, which affects the diseases either positively or negatively.
   Summary Appropriate food choices play a significant role in mood enhancement. Advertisement is another crucial factor that negatively affects food choices and mood and contributes to many diseases. Understanding the interaction between food and mood can help to prevent or alleviate undesired health issues.
C1 [AlAmmar, Welayah A.; Albeesh, Fatima H.; Khattab, Rabie Y.] Imam Abdulrahman Bin Faisal Univ, Clin Nutr Dept, Dammam, Saudi Arabia.
C3 Imam Abdulrahman Bin Faisal University
RP Khattab, RY (corresponding author), Imam Abdulrahman Bin Faisal Univ, Clin Nutr Dept, Dammam, Saudi Arabia.
EM rykhattab@iau.edu.sa
RI Khattab, Rabie/C-4990-2017
OI Khattab, Rabie/0000-0002-1715-970X
CR Alfonso-Rosa RM, 2013, J NUTR HEALTH AGING, V17, P315, DOI 10.1007/s12603-013-0028-5
   Alpert JE, 1997, NUTR REV, V55, P145, DOI 10.1111/j.1753-4887.1997.tb06468.x
   Andreyeva T, 2011, ECON HUM BIOL, V9, P221, DOI 10.1016/j.ehb.2011.02.004
   Appleton KM, 2011, P NUTR SOC, V70, pE106, DOI 10.1017/S0029665111001467
   Armstrong LE, 2012, J NUTR, V142, P382, DOI 10.3945/jn.111.142000
   Baines S, 2007, PUBLIC HEALTH NUTR, V10, P436, DOI 10.1017/S1368980007217938
   Beezhold BL, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-9
   BENTON D, 1995, NEUROPSYCHOBIOLOGY, V32, P98, DOI 10.1159/000119220
   Benton D, 1997, PSYCHOPHARMACOLOGY, V129, P66, DOI 10.1007/s002130050163
   Benton D, 1999, PUBLIC HEALTH NUTR, V2, P403, DOI 10.1017/S1368980099000555
   Blanchflower DG, 2013, SOC INDIC RES, V114, P785, DOI 10.1007/s11205-012-0173-y
   Boddy LM, 2014, J HUM NUTR DIET, V27, P236, DOI 10.1111/jhn.12129
   Bongers P, 2013, APPETITE, V67, P74, DOI 10.1016/j.appet.2013.03.017
   Brice CF, 2002, PSYCHOPHARMACOLOGY, V164, P188, DOI 10.1007/s00213-002-1175-2
   Brookie KL, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00487
   Cartwright F, 2007, APPETITE, V48, P87, DOI 10.1016/j.appet.2006.07.081
   Chapman K, 2006, HEALTH PROMOT INT, V21, P172, DOI 10.1093/heapro/dal021
   Chou SY, 2008, J LAW ECON, V51, P599, DOI 10.1086/590132
   Christensen L, 2001, CLIN NUTR, V20, P161, DOI 10.1054/clnu.2001.0420
   Collins R, 2015, APPETITE, V84, P107, DOI 10.1016/j.appet.2014.09.021
   Conklin SM, 2007, PSYCHIAT RES, V152, P1, DOI 10.1016/j.psychres.2006.10.006
   Conner TS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171206
   Conner TS, 2015, BRIT J HEALTH PSYCH, V20, P413, DOI 10.1111/bjhp.12113
   de la Fuente-Arrillaga C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2739-0
   Duarte CS, 2010, J PEDIATR-US, V156, P93, DOI 10.1016/j.jpeds.2009.06.066
   El Ansari W, 2015, INT J PUBLIC HEALTH, V60, P707, DOI 10.1007/s00038-015-0717-4
   England CY, 2017, PUBLIC HEALTH NUTR, V20, P191, DOI [10.1017/S1368980016002275, 10.1017/s1368980016002275]
   Evers C, 2010, PERS SOC PSYCHOL B, V36, P792, DOI 10.1177/0146167210371383
   Federal Trade Commission, 2008, MARK FOOD CHILDR AD
   Federal Trade Commission, 2007, CHILDR EXP TV ADV 19
   Fletcher BC, 2007, APPETITE, V48, P211, DOI 10.1016/j.appet.2006.09.002
   Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030
   Fraser LK, 2012, AM J PREV MED, V42, pE77, DOI 10.1016/j.amepre.2012.02.007
   Ganio MS, 2011, BRIT J NUTR, V106, P1535, DOI 10.1017/S0007114511002005
   Gibson-Smith D, 2018, SOC PSYCH PSYCH EPID, V53, P629, DOI 10.1007/s00127-018-1512-3
   Grosso G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/313570
   Hamer M, 2012, MOL PSYCHIATR, V17, P940, DOI 10.1038/mp.2012.30
   Harris J., 2008, THESIS
   Harris JL, 2012, AM J PUBLIC HEALTH, V102, P214, DOI 10.2105/AJPH.2011.300328
   Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399
   Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304
   Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3
   Hendy HM, 2012, APPETITE, V58, P771, DOI 10.1016/j.appet.2011.11.014
   Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122
   Hood MM, 2014, APPETITE, V79, P91, DOI 10.1016/j.appet.2014.04.009
   Institute of Medicine, 2005, DIETARY REFERENCE IN
   Iyer K., 2012, RES J RECENT SCI, V1, P79
   Jacka FN, 2012, PSYCHOTHER PSYCHOSOM, V81, P196, DOI 10.1159/000334910
   James JE, 2004, HUM PSYCHOPHARM CLIN, V19, P333, DOI 10.1002/hup.589
   James P, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0537-4
   Kampov-Polevoy Alexey B, 2006, Eat Behav, V7, P181, DOI 10.1016/j.eatbeh.2005.09.005
   Kang JX, 2013, CNS NEUROL DISORD-DR, V12, P460, DOI 10.2174/1871527311312040004
   Kato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066681
   Khalid S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020158
   Kloiber S, 2007, BIOL PSYCHIAT, V62, P321, DOI 10.1016/j.biopsych.2006.10.001
   Konttinen H, 2010, APPETITE, V54, P473, DOI 10.1016/j.appet.2010.01.014
   Kotchen TA, 2010, AM J HYPERTENS, V23, P1170, DOI 10.1038/ajh.2010.172
   Kroes MCW, 2014, NEUROIMAGE, V84, P825, DOI 10.1016/j.neuroimage.2013.09.041
   Ladwig KH, 2006, INT J OBESITY, V30, P1408, DOI 10.1038/sj.ijo.0803285
   Larrieu T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01047
   Larsson CL, 2002, J ADOLESCENT HEALTH, V31, P190, DOI 10.1016/S1054-139X(02)00344-0
   Leidy HJ, 2015, J NUTR, V145, P1614, DOI 10.3945/jn.115.212092
   Li YF, 2011, PSYCHIAT RES, V190, P103, DOI 10.1016/j.psychres.2011.05.012
   Liu XQ, 2016, NUTRITION, V32, P296, DOI 10.1016/j.nut.2015.09.009
   Lucas M, 2011, ARCH INTERN MED, V171, P1571, DOI 10.1001/archinternmed.2011.393
   Lustig R., 2012, Fat chance: Beating the odds against sugar, processed food, obesity, and disease
   Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002
   Maddock S, 2016, BRIT FOOD J, V118, P327, DOI 10.1108/BFJ-04-2015-0136
   Malone RM, 2015, P NUTR SOC, V74, pE135, DOI 10.1017/S0029665115001500
   Meier BP, 2017, APPETITE, V108, P21, DOI 10.1016/j.appet.2016.09.018
   Moreno-Dominguez S, 2012, APPETITE, V58, P111, DOI 10.1016/j.appet.2011.09.013
   Mujcic R, 2016, AM J PUBLIC HEALTH, V106, P1504, DOI 10.2105/AJPH.2016.303260
   Muñoz CX, 2015, APPETITE, V92, P81, DOI 10.1016/j.appet.2015.05.002
   Mutanen M., 2011, Vegetables, whole grains, and their derivatives in cancer prevention
   Ness AR, 2003, NUTR NEUROSCI, V6, P63, DOI 10.1080/1028415021000056069
   Nestler EJ, 2012, NATURE, V490, P171, DOI 10.1038/490171a
   Ottley C, 2000, Nurs Stand, V15, P46
   Pan LA, 2017, AM J PSYCHIAT, V174, P42, DOI 10.1176/appi.ajp.2016.15111500
   Parker G, 2006, J AFFECT DISORDERS, V92, P149, DOI 10.1016/j.jad.2006.02.007
   Parker G, 2011, ACTA PSYCHIAT SCAND, V124, P417, DOI 10.1111/j.1600-0447.2011.01706.x
   Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969
   Pauwels EKJ, 2008, DRUG NEWS PERSPECT, V21, P446, DOI 10.1358/dnp.2008.21.8.1272136
   Pribis P, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110668
   Prinz N, 2017, J AFFECT DISORDERS, V208, P384, DOI 10.1016/j.jad.2016.08.077
   Privitera GJ, 2019, J HEALTH PSYCHOL, V24, P199, DOI 10.1177/1359105316650508
   Privitera GJ, 2018, J HEALTH PSYCHOL, V23, P598, DOI 10.1177/1359105316681861
   Pross N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094754
   Pross N, 2013, BRIT J NUTR, V109, P313, DOI 10.1017/S0007114512001080
   Raaijmakers I, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124771
   Radin D, 2007, EXPLORE-NY, V3, P485, DOI 10.1016/j.explore.2007.06.004
   Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170
   Raymond KL, 2015, APPETITE, V95, P383, DOI 10.1016/j.appet.2015.07.030
   Reynolds EH, 2002, BMJ-BRIT MED J, V324, P1512, DOI 10.1136/bmj.324.7352.1512
   Rogers PJ, 2007, NUTR BULL, V32, P84, DOI 10.1111/j.1467-3010.2007.00607.x
   Rogers PJ, NUTR RES REV, V95, P243
   Rooney C, 2013, P NUTR SOC, V72, P420, DOI 10.1017/S0029665113003388
   Rose MH, 2018, J PEDIATR PSYCHOL, V43, P443, DOI 10.1093/jpepsy/jsx127
   Schüz B, 2015, APPETITE, V87, P310, DOI 10.1016/j.appet.2015.01.002
   Singh M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00925
   Souissi Makram, 2012, Asian J Sports Med, V3, P161
   Sproesser G, 2014, PSYCHOL SCI, V25, P58, DOI 10.1177/0956797613494849
   Stahl LA, 2008, CURR OPIN INVEST DR, V9, P57
   Taut D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00359
   Tomita Andrea Gomes Santiago., 2015, Encyclopedia of Latin American Religions, P1, DOI DOI 10.1002/9781118900772.ETRDS0324
   Turner SA, 2010, APPETITE, V54, P143, DOI 10.1016/j.appet.2009.09.020
   Wagner HS, 2014, HEALTH PSYCHOL, V33, P1552, DOI 10.1037/hea0000068
   Wahl DR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17262-9
   Wang RT, 2018, AGRIC RESOUR ECON RE, V47, P1, DOI 10.1017/age.2018.1
   Wansink B, 2003, PHYSIOL BEHAV, V79, P739, DOI 10.1016/S0031-9384(03)00203-8
   White BA, 2013, BRIT J HEALTH PSYCH, V18, P782, DOI 10.1111/bjhp.12021
   WHO, 2019, COMM END CHILDH OB F
   Wilfley D, 2011, DIABETES CARE, V34, P858, DOI 10.2337/dc10-1704
   Wolfe AR, 2011, PROG NEURO-PSYCHOPH, V35, P232, DOI 10.1016/j.pnpbp.2010.11.011
   Yeum TS, 2019, PSYCHIAT ANN, V49, P21, DOI 10.3928/00485713-20181205-02
   Young H, 2015, NUTRIENTS, V7, P887, DOI 10.3390/nu7020887
   Young SN, 2007, J PSYCHIATR NEUROSCI, V32, P80
   Zhao Guixiang, 2011, BMC Psychiatry, V11, P130, DOI 10.1186/1471-244X-11-130
NR 117
TC 28
Z9 32
U1 9
U2 97
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2161-3311
J9 CURR NUTR REP
JI Curr. Nutr. Rep.
PD SEP
PY 2020
VL 9
IS 3
BP 296
EP 308
DI 10.1007/s13668-020-00331-3
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA SD3QQ
UT WOS:000651290100019
PM 32623655
DA 2025-04-28
ER

PT J
AU Liu, JY
   He, D
   Xing, YF
   Zeng, W
   Ren, K
   Zhang, C
   Lu, Y
   Yang, S
   Ou, SJ
   Wang, Y
   Xing, XH
AF Liu, Jun-Yu
   He, Dong
   Xing, Yi-Fan
   Zeng, Wen
   Ren, Kai
   Zhang, Chong
   Lu, Yuan
   Yang, Song
   Ou, Shu-Jian
   Wang, Yi
   Xing, Xin-Hui
TI Effects of bioactive components of Pu-erh tea on gut microbiomes and
   health: A review
SO FOOD CHEMISTRY
LA English
DT Review
DE Pu-erh tea; Bioactive components; Gut microbiomes; Intestinal
   environment; Quality indicators
ID BUTYRATE-PRODUCING BACTERIA; DIET-INDUCED OBESITY; CHAIN FATTY-ACIDS;
   METABOLIC SYNDROME; BLACK TEA; FERMENTATION; THEABROWNIN; CAFFEINE;
   MODULATION; PATHWAY
AB Pu-erh tea is a post-fermentation tea with unique flavor and multiple health benefits. Due to the various microorganisms involved in the post-fermentation process, Pu-erh tea contains highly complex components, which have rich interactions with the gut microbiomes (GMs). Because the structure and homeostasis of GMs are closely related to human wellness and the various diseases progress, the beneficial effects of Pu-erh tea on GMs have a great potential for application in health care. However, there is no systematic summary of the bioactive components of Pu-erh tea, and their effects on the GMs. Here, we review the current studies on the effects of Pu-erh tea and its bioactive components on the structure of GMs as well as on health improvement, and further discuss the relevant quality indicators. This "components - function - indicators" clue will hopefully stimulate the standardization of Pu-erh tea fermentation process and the development of its functional products.
C1 [Liu, Jun-Yu; Xing, Yi-Fan; Zeng, Wen; Ren, Kai; Zhang, Chong; Lu, Yuan; Wang, Yi; Xing, Xin-Hui] Tsinghua Univ, Dept Chem Engn, Key Lab Ind Biocatalysis, Minist Educ China, Beijing 100084, Peoples R China.
   [Zhang, Chong; Xing, Xin-Hui] Tsinghua Univ, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China.
   [Xing, Xin-Hui] Tsinghua Shenzhen Int Grad Sch, Inst Biopharmaceut & Hlth Engn, Shenzhen 518055, Peoples R China.
   [Xing, Xin-Hui] Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518055, Peoples R China.
   [He, Dong] Guangdong Univ Technol, Sch Chem Engn & Light Ind, Guangzhou 510006, Peoples R China.
   [Yang, Song] Qingdao Agr Univ, Sch Life Sci, Shandong Prov Key Lab Appl Mycol, Qingdao 266109, Shandong, Peoples R China.
   [Yang, Song] Qingdao Agr Univ, Qingdao Int Ctr Microbes Utilizing Biogas, Qingdao 266109, Shandong, Peoples R China.
   [Ou, Shu-Jian] Yunnan Shujian Tea Co Ltd, Kunming 650000, Yunnan, Peoples R China.
C3 Tsinghua University; Tsinghua University; Tsinghua Shenzhen
   International Graduate School; Shenzhen Bay Laboratory; Guangdong
   University of Technology; Qingdao Agricultural University; Qingdao
   Agricultural University
RP Wang, Y; Xing, XH (corresponding author), Tsinghua Univ, Dept Chem Engn, Key Lab Ind Biocatalysis, Minist Educ China, Beijing 100084, Peoples R China.
EM liujunyu0306@163.com; hedong86284116@163.com;
   xingyf18@mails.tsinghua.edu.cn; zengw17@mails.tsinghua.edu.cn;
   kairenshanxi@126.com; chongzhang@tsinghua.edu.cn;
   yuanlu@tsinghua.edu.cn; yangsong1209@163.com; oushujian2020@163.com;
   wangyi671@mail.tsinghua.edu.cn; xhxing@tsinghua.edu.cn
RI Wang, Jianmei/HHZ-0585-2022; Zhang, Chong/A-2007-2011; Lu,
   Yuan/H-6500-2011
OI Lu, Yuan/0000-0003-4500-6230; Wang, Yi/0000-0003-4028-2471; Zhang,
   Chong/0000-0001-9609-8855
FU Key-Area Research and Development Program of Guangdong Province, China
   [2019B020210001]; National Key Research Project of Hebei Province, China
   [20375502D]
FX This work was supported by funding from Key-Area Research and
   Development Program of Guangdong Province, China (No. 2019B020210001)
   and National Key Research Project of Hebei Province, China (No.
   20375502D).
CR Ahmed S, 2010, J ETHNOPHARMACOL, V132, P176, DOI 10.1016/j.jep.2010.08.016
   Ananingsih VK, 2013, FOOD RES INT, V50, P469, DOI 10.1016/j.foodres.2011.03.004
   Autenrieth DM, 2017, DEUT MED WOCHENSCHR, V142, P261, DOI 10.1055/s-0042-111608
   Bibbò S, 2016, EUR REV MED PHARMACO, V20, P4742
   BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933
   BLANCHARD J, 1983, J PHARMACOKINET BIOP, V11, P109, DOI 10.1007/BF01061844
   Bond T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102364
   Chen GJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700485
   Chen GJ, 2018, J AGR FOOD CHEM, V66, P2783, DOI 10.1021/acs.jafc.8b00296
   Chen TT, 2020, CRIT REV FOOD SCI, V60, P2691, DOI 10.1080/10408398.2019.1654430
   Clemente JC, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5145
   CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221
   Deng YT, 2015, FOOD FUNCT, V6, P1539, DOI [10.1039/C4FO01025F, 10.1039/c4fo01025f]
   Ding QZ, 2019, RSC ADV, V9, P2967, DOI 10.1039/c8ra09259a
   Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661
   Dong Fang, 2008, Journal of Chinese Institute of Food Science and Technology, V8, P133
   Du WH, 2012, J AGR FOOD CHEM, V60, P10126, DOI 10.1021/jf302426w
   Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002
   Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817
   Fraga CG, 2019, FOOD FUNCT, V10, P514, DOI [10.1039/C8FO01997E, 10.1039/c8fo01997e]
   Gai S., 2005, ACTA BOT YUNN, V27, P572
   Gao XY, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00601-17
   Gong JS, 2010, J FOOD SCI, V75, pH182, DOI 10.1111/j.1750-3841.2010.01675.x
   Gu Xiao-Pan, 2018, Zhongguo Zhong Yao Za Zhi, V43, P2339, DOI 10.19540/j.cnki.cjcmm.20180323.001
   Haas D, 2013, INT J FOOD MICROBIOL, V166, P316, DOI 10.1016/j.ijfoodmicro.2013.07.024
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x
   Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259
   Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x
   [蒋慧颖 Jiang Huiying], 2018, [食品工业科技, Science & Technology of Food Industry], V39, P274
   Jobu K, 2013, FOOD RES INT, V54, P324, DOI 10.1016/j.foodres.2013.07.037
   Kanegae A, 2013, J NAT MED-TOKYO, V67, P652, DOI 10.1007/s11418-012-0704-5
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746
   Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001
   [李晨晨 Li ChenChen], 2012, [北京化工大学学报. 自然科学版, Journal of Beijing University of Chemical Technology. Natural Science Edition], V39, P74
   Li XSM, 2017, EUR HEART J, V38, P814, DOI 10.1093/eurheartj/ehw582
   Liang YR, 2005, J SCI FOOD AGR, V85, P381, DOI 10.1002/jsfa.1857
   Liu Y, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900943
   Liu YC, 2020, APPL MICROBIOL BIOT, V104, P981, DOI 10.1007/s00253-019-10306-2
   Liu ZB, 2016, FOOD FUNCT, V7, P4869, DOI 10.1039/c6fo01439a
   Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004
   Lu XJ, 2019, J AGR FOOD CHEM, V67, P6978, DOI 10.1021/acs.jafc.8b04909
   Lv HP, 2013, FOOD RES INT, V53, P608, DOI 10.1016/j.foodres.2013.02.043
   Macedo JA, 2012, FOOD CHEM, V133, P358, DOI 10.1016/j.foodchem.2012.01.041
   Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane
   MACFARLANE GT, 1986, J APPL BACTERIOL, V60, P195, DOI 10.1111/j.1365-2672.1986.tb01073.x
   Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106
   Maukonen J, 2006, FEMS MICROBIOL ECOL, V58, P517, DOI 10.1111/j.1574-6941.2006.00179.x
   Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003
   Mohan KVPC, 2007, CELL BIOL INT, V31, P599, DOI 10.1016/j.cellbi.2006.11.034
   Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e
   Morrison M, 2000, FEMS MICROBIOL LETT, V185, P109
   Mosele JI, 2015, MOL NUTR FOOD RES, V59, P1942, DOI 10.1002/mnfr.201500227
   Mukherjee G, 2004, J BASIC MICROB, V44, P42, DOI 10.1002/jobm.200310317
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Oi Y, 2012, PHYTOTHER RES, V26, P475, DOI 10.1002/ptr.3602
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646
   Peng CX, 2013, J ANAL APPL PYROL, V104, P226, DOI 10.1016/j.jaap.2013.07.011
   Peng CX, 2013, INT J BIOL MACROMOL, V54, P197, DOI 10.1016/j.ijbiomac.2012.12.021
   Piaopiao L., 2020, FOOD CHEM, V311
   Qin JH, 2012, J AGR FOOD CHEM, V60, P1213, DOI 10.1021/jf204844g
   Quan LH, 2020, GUT, V69, P1239, DOI 10.1136/gutjnl-2019-319114
   Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012
   Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005
   Roda G, 2019, MOLECULES, V24, DOI 10.3390/molecules24030473
   Rothenberg DO, 2018, MOLECULES, V23, DOI 10.3390/molecules23051176
   Sandhu KV, 2017, TRANSL RES, V179, P223, DOI 10.1016/j.trsl.2016.10.002
   Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06
   Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342
   Singh R, 2010, LIFE SCI, V86, P907, DOI 10.1016/j.lfs.2010.04.013
   Soni R.P., 2015, INT J FOOD FERMENT T, V5, P95, DOI [10.5958/2277-9396.2016.00002.7, DOI 10.5958/2277-9396.2016.00002.7]
   Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413
   Sridharan GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6492
   Sung MM, 2017, DIABETES, V66, P418, DOI 10.2337/db16-0680
   Tanaka T, 2012, FOOD CHEM, V134, P276, DOI 10.1016/j.foodchem.2012.02.136
   Tao MK, 2014, NAT PROD COMMUN, V9, P1167
   Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510
   [田洋 Tian Yang], 2010, [食品科学, Food Science], V31, P20
   Wang JH, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060555
   Wang K, 2019, CELL REP, V26, P222, DOI 10.1016/j.celrep.2018.12.028
   Wang Q., 2010, T CHINESE SOC AGR EN, V26, P394, DOI [10.3969/j.issn.1002-6819.2010.z1.070, DOI 10.3969/J.ISSN.1002-6819.2010.Z1.070]
   Wang QP, 2018, LWT-FOOD SCI TECHNOL, V90, P598, DOI 10.1016/j.lwt.2018.01.021
   Wang QP, 2016, J BIOTECHNOL, V231, P250, DOI 10.1016/j.jbiotec.2016.06.010
   Wang QP, 2011, J SCI FOOD AGR, V91, P2412, DOI 10.1002/jsfa.4480
   Wang WN, 2014, FOOD CHEM, V152, P539, DOI 10.1016/j.foodchem.2013.10.117
   Wang XG, 2008, FOOD CHEM, V107, P1086, DOI 10.1016/j.foodchem.2007.09.023
   Wei XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22094-2
   Wulandari RA, 2011, J NAT MED-TOKYO, V65, P594, DOI 10.1007/s11418-011-0515-0
   Xiang L., 2018, MODERN FOOD SCI TECH, V34, P56, DOI [10.13982/j.mfst.1673-9078.2018.04.010, DOI 10.13982/J.MFST.1673-9078.2018.04.010]
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2018, J FOOD DRUG ANAL, V26, P1, DOI 10.1016/j.jfda.2017.10.010
   Yang DJ, 2006, J CHROMATOGR A, V1119, P277, DOI 10.1016/j.chroma.2005.12.031
   Yang JY, 2017, MUCOSAL IMMUNOL, V10, P104, DOI 10.1038/mi.2016.42
   Yue SJ, 2019, FOOD FUNCT, V10, P7063, DOI 10.1039/c9fo01334b
   Zhang CH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205150
   Zhang L, 2019, COMPR REV FOOD SCI F, V18, P1474, DOI 10.1111/1541-4337.12479
   Zhang L, 2013, FOOD RES INT, V53, P600, DOI 10.1016/j.foodres.2013.01.016
   Zhang L, 2011, J AGR FOOD CHEM, V59, P8754, DOI 10.1021/jf2015733
   Zhang T, 2016, INT C APPL BIOT SING
   Zhang YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157847
   Zhao M, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00680-19
   Zhao M, 2013, WORLD J MICROB BIOT, V29, P1877, DOI 10.1007/s11274-013-1351-z
   Zhao ZJ, 2015, INT FOOD RES J, V22, P1240
   Zhao ZJ, 2013, INT J FOOD MICROBIOL, V164, P26, DOI 10.1016/j.ijfoodmicro.2013.03.018
   [赵振军 Zhao Zhenjun], 2012, [食品科学, Food Science], V33, P173
   Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z
   Zhu MZ, 2020, FOOD CHEM, V312, DOI 10.1016/j.foodchem.2019.126043
NR 111
TC 43
Z9 46
U1 17
U2 186
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD AUG 15
PY 2021
VL 353
AR 129439
DI 10.1016/j.foodchem.2021.129439
EA MAR 2021
PG 13
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA SJ4ZA
UT WOS:000655543300007
PM 33743430
DA 2025-04-28
ER

PT J
AU Ma, H
   Zhang, BW
   Hu, YZ
   Li, X
   Wang, J
   Yang, FE
   Ji, XM
   Wang, S
AF Ma, Hui
   Zhang, Bowei
   Hu, Yaozhong
   Li, Xiang
   Wang, Jin
   Yang, Feier
   Ji, Xuemeng
   Wang, Shuo
TI The novel intervention effect of cold green tea beverage on high-fat
   diet induced obesity in mice
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Low-calorie beverage; Cold-water brewed green tea (CWB-GT); Active
   ingredients; Obesity; Specific bacteria; PYY
ID DIFFERENT BREWING METHODS; GUT MICROBIOTA; BLACK TEA; HEALTH;
   EPIGALLOCATECHIN; BUTYRATE; CAFFEINE; THEANINE; BRAIN; ACID
AB This study was designed to explore the anti-obesity effects of cold-water brewed green tea (CWB-GT) on high-fat diet (HFD)-fed mice. CWB-GT was prepared by brewing tea leaves with 30 degrees C cold water, which contained considerable active ingredients including catechins, gallic acid and theanine. Our data demonstrated that CWB-GT could significantly ameliorate obesity and modulate gut micmbiota composition of HFD-fed mice by affecting some specific bacteria. Besides, the expression of lipogenesis-related genes including FAS, HMGR and SREBP-1c in liver was inhibited and the expression of fatty acid oxidation-related genes including PPAR alpha and PGC-1 alpha in adipose tissue was enhanced. These benefits might be attributed to the stimulation of serum peptide YY (PYY) secretion. In particular, specific bacteria modulated by CWB-GT including Lachnospiraceae bacterium DW67, Blautia coccoides, Parabacteroides merdae and Bacteroides_vulgatus might be key mediators in exerting anti-obesity effects. This study suggested that CWB-GT could represent a novel functional low-calorie beverage.
C1 [Ma, Hui; Zhang, Bowei; Hu, Yaozhong; Li, Xiang; Wang, Jin; Yang, Feier; Ji, Xuemeng; Wang, Shuo] Nankai Univ, Sch Med, Tianjin Key Lab Food Sci & Hlth, Tianjin 300071, Peoples R China.
C3 Nankai University
RP Wang, S (corresponding author), Nankai Univ, Sch Med, Tianjin Key Lab Food Sci & Hlth, Tianjin 300071, Peoples R China.
EM wangshuo@nankai.edu.cn
RI ji, xm/KYQ-7196-2024; Wang, Shuai/HZJ-7466-2023
OI Ma, Hui/0009-0009-9704-2605
FU National Key R&D Program of China [2019YFC1606202]; Fundamental Research
   Funds for the Central Universities, Nankai University [63201218,
   63201222]; Shanxi Province Key RD Plan [201903D211006]
FX This research was funded by National Key R&D Program of China
   (2019YFC1606202), the Fundamental Research Funds for the Central
   Universities, Nankai University (63201222), the Fundamental Research
   Funds for the Central Universities, Nankai University (63201218) and
   Shanxi Province Key R&D Plan (201903D211006).
CR Akinyemiju T, 2018, OBESITY, V26, P193, DOI 10.1002/oby.22067
   Barraj LM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020314
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Cani PD, 2019, NAT METAB, V1, P34, DOI 10.1038/s42255-018-0017-4
   Cao SY, 2019, TRENDS FOOD SCI TECH, V92, P194, DOI 10.1016/j.tifs.2019.08.004
   Caron A, 2018, NAT REV NEUROSCI, V19, P153, DOI 10.1038/nrn.2018.7
   Chassaing B, 2014, TOXICOL PATHOL, V42, P49, DOI 10.1177/0192623313508481
   Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chen TT, 2020, CRIT REV FOOD SCI, V60, P2691, DOI 10.1080/10408398.2019.1654430
   Damiani E, 2014, J FOOD COMPOS ANAL, V33, P59, DOI 10.1016/j.jfca.2013.09.010
   Drouin-Chartier JP, 2019, DIABETES CARE, V42, P2181, DOI 10.2337/dc19-0734
   Gunathilake KDPP, 2013, J FUNCT FOODS, V5, P1392, DOI 10.1016/j.jff.2013.05.007
   Huang JB, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700696
   Jayarathne S, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900149
   Jiang JY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201970042
   Kim KS, 2018, NAT REV NEUROSCI, V19, P185, DOI 10.1038/nrn.2018.8
   Lai X., 2019, FOOD FUNCT, DOI DOI 10.1039/c8fo02334d
   Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050
   Lin SD, 2008, LWT-FOOD SCI TECHNOL, V41, P1616, DOI 10.1016/j.lwt.2007.10.009
   Lin SD, 2014, J FOOD PROCESS PRES, V38, P1234, DOI 10.1111/jfpp.12084
   Liu H, 2018, ADV NUTR, V9, P21, DOI 10.1093/advances/nmx009
   Liu JH, 2020, J AGR FOOD CHEM, V68, P33, DOI 10.1021/acs.jafc.9b06817
   Liu JH, 2019, FOOD FUNCT, V10, P2847, DOI 10.1039/c8fo02051e
   Liu ZB, 2016, FOOD FUNCT, V7, P4869, DOI 10.1039/c6fo01439a
   López-García G, 2020, J FUNCT FOODS, V65, DOI 10.1016/j.jff.2019.103747
   Ma H, 2019, J AGR FOOD CHEM, V67, P7325, DOI 10.1021/acs.jafc.9b02211
   Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050
   Monobe M, 2018, JARQ-JPN AGR RES Q, V52, P1, DOI 10.6090/jarq.52.1
   Norton M, 2017, CURR OPIN PHARMACOL, V37, P16, DOI 10.1016/j.coph.2017.07.005
   Panahi Y, 2018, J CELL PHYSIOL, V233, P141, DOI 10.1002/jcp.25756
   Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004
   Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90
   Rufino AT, 2021, MED RES REV, V41, P556, DOI 10.1002/med.21740
   Shang AO, 2021, CRIT REV FOOD SCI, V61, P2061, DOI 10.1080/10408398.2020.1769548
   Shiba T, 2003, MICROBIOL IMMUNOL, V47, P371, DOI 10.1111/j.1348-0421.2003.tb03368.x
   Tanaka S, 2016, APPL ENVIRON MICROB, V82, P2693, DOI 10.1128/AEM.03343-15
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P1681, DOI 10.1080/10408398.2015.1016141
   Unno K, 2016, PHYTOMEDICINE, V23, P1365, DOI 10.1016/j.phymed.2016.07.006
   Vacca M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040573
   van Duynhoven J, 2013, AM J CLIN NUTR, V98, p1631S, DOI 10.3945/ajcn.113.058263
   Xie LH, 2018, TRENDS FOOD SCI TECH, V72, P13, DOI 10.1016/j.tifs.2017.12.002
   Yan QL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00381
   Yang DJ, 2007, J CHROMATOGR A, V1156, P312, DOI 10.1016/j.chroma.2006.11.088
   Zhang HH, 2017, J SCI FOOD AGR, V97, P2826, DOI 10.1002/jsfa.8111
NR 45
TC 14
Z9 15
U1 4
U2 48
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD DEC
PY 2020
VL 75
AR 104279
DI 10.1016/j.jff.2020.104279
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA QQ5NP
UT WOS:000624570700005
OA gold
DA 2025-04-28
ER

PT J
AU Rocha, A
   Bolin, AP
   Cardoso, CAL
   Otton, R
AF Rocha, Andrea
   Bolin, Anaysa Paola
   Lima Cardoso, Claudia Andrea
   Otton, Rosemari
TI Green tea extract activates AMPK and ameliorates white adipose tissue
   metabolic dysfunction induced by obesity
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Obesity; Flavonoids; Metabolism; Gene expression; Polyphenols
ID PROTEIN-KINASE; ANTIOXIDANT CAPACITY; ADIPONECTIN; THERMOGENESIS;
   POLYPHENOLS; INHIBITION; MECHANISMS; CAFFEINE; CATECHIN; SYNTHASE
AB Beneficial effects of green tea (GT) polyphenols against obesity have been reported. However, until this moment the molecular mechanisms of how green tea can modulate obesity and regulates fat metabolism, particularly in adipose tissue, remain poorly understood. The aim of this study was to evaluate the role of GT extract in the adipose tissue of obese animals and its effect on weight gain, metabolism and function (de novo lipogenesis and lipolysis), and the involvement of AMP-activated protein kinase (AMPK).
   Male Wistar rats were treated with GT by gavage (12 weeks/5 days/week; 500 mg/kg of body weight), and obesity was induced by cafeteria diet (8 weeks). Here, we show that obese rats treated with GT showed a significant reduction in indicators of obesity such as hyperlipidemia, fat synthesis, body weight, and fat depots as compared to those treated with standard control diet. AMPK was induced in adipose tissue in rats that were treated with GT and likely restored insulin sensitivity, increased mRNA expression of GLUT4, reducing the concentrations of plasma and liver lipid content, also stimulating fatty acid oxidation in the same tissue. Importantly, repression of de novo lipogenesis in the adipose tissue, reduced lipid droplets in the liver, and the development of insulin resistance in diet-induced obese rats were accompanied by AMPK activation.
   Our study identified that metabolic changes caused by GT intake induced AMPK activation and modulate the expression of genes involved in metabolism, particularly in adipose tissue, thus offering a therapeutic strategy to combat insulin resistance, dyslipidemia, and obesity in rats.
C1 [Rocha, Andrea; Bolin, Anaysa Paola; Otton, Rosemari] Cruzeiro do Sul Univ, Sci Inst Phys Act & Sports, Human Movement Sci, Ave Regente Feijo 1295, BR-03342000 Sao Paulo, SP, Brazil.
   [Bolin, Anaysa Paola; Otton, Rosemari] Univ Sao Paulo, Postgrad Program Pharmacol, Sao Paulo, SP, Brazil.
   [Lima Cardoso, Claudia Andrea] Mato Grosso do Sul Univ, Rodovia Ithaum,Km 12 Cidade Univ, BR-79804970 Dourados, MS, Brazil.
C3 Universidade de Sao Paulo
RP Otton, R (corresponding author), Cruzeiro do Sul Univ, Sci Inst Phys Act & Sports, Human Movement Sci, Ave Regente Feijo 1295, BR-03342000 Sao Paulo, SP, Brazil.; Otton, R (corresponding author), Univ Sao Paulo, Postgrad Program Pharmacol, Sao Paulo, SP, Brazil.
EM rosemari.otton@cruzeirodosul.edu.br
RI Cardoso, Claudia/AAK-5578-2020; Bolin, Anaysa/AAG-2808-2019; Otton,
   Rosemari/C-6531-2012; Bolin, Anaysa/L-1199-2018
OI Rocha, Andrea/0000-0002-9044-980X; Otton, Rosemari/0000-0001-5503-3967;
   Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Bolin,
   Anaysa/0000-0003-0956-5801
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP
   2011/19216-8]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico CNPq [139307/2012-5]; Universidade Cruzeiro do Sul; Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/19216-8]
   Funding Source: FAPESP
FX The authors are grateful to the technical assistance of R. C. Macedo, B.
   A. Guerra, A. C. Morandi, R. G. Cruz, Marinovic M. P., Maia, O. F. Mori
   M, and R. Holanda. This research was supported by Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP 2011/19216-8), Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico CNPq (139307/2012-5), and
   Universidade Cruzeiro do Sul.
CR Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002
   Anesini C, 2008, J AGR FOOD CHEM, V56, P9225, DOI 10.1021/jf8022782
   Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x
   Hong MH, 2007, LIFE SCI, V80, P1957, DOI 10.1016/j.lfs.2007.02.024
   Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a
   IJzerman RG, 2003, CIRCULATION, V108, P566, DOI 10.1161/01.CIR.0000081778.35370.1B
   Kadowaki T, 2011, CELL METAB, V13, P123, DOI 10.1016/j.cmet.2011.01.012
   Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   Lee H, 2013, J NUTR BIOCHEM, V24, P1232, DOI 10.1016/j.jnutbio.2012.09.007
   Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465
   Park HJ, 2011, J NUTR BIOCHEM, V22, P393, DOI 10.1016/j.jnutbio.2010.03.009
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499
   Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x
   Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357
NR 27
TC 73
Z9 78
U1 4
U2 68
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD OCT
PY 2016
VL 55
IS 7
BP 2231
EP 2244
DI 10.1007/s00394-015-1033-8
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DX7EV
UT WOS:000384550300005
PM 26361764
DA 2025-04-28
ER

PT J
AU Michimi, A
   Wimberly, MC
AF Michimi, Akihiko
   Wimberly, Michael C.
TI The food environment and adult obesity in US metropolitan areas
SO GEOSPATIAL HEALTH
LA English
DT Article
DE Food environments; Obesity; Urban; USA
ID DIETARY ENERGY DENSITY; BODY-MASS INDEX; UNITED-STATES; WEIGHT STATUS;
   RISK; NEIGHBORHOOD; CONSUMPTION; AVAILABILITY; ASSOCIATIONS; PREVALENCE
AB This research examines the larger-scale associations between obesity and food environments in metropolitan areas in the United States (US). The US Census County Business Patterns dataset for 2011 was used to construct various indices of food environments for selected metropolitan areas. The numbers of employees engaged in supermarkets, convenience stores, full service restaurants, fast food restaurants, and snack/coffee shops were standardised using the location quotients, and factor analysis was used to produce two uncorrelated factors measuring food environments. Data on obesity were obtained from the 2011 Behavioral Risk Factor Surveillance System. Individual level obesity measures were linked to the metropolitan area level food environment factors. Models were fitted using generalised estimating equations to control for metropolitan area level intra-correlation and individual level sociodemographic characteristics. It was found that adults residing in cities with a large share of supermarket and full-service restaurant workers were less likely to be obese, while adults residing in cities with a large share of convenience store and fast food restaurant workers were more likely to be obese. Supermarkets and full-service restaurant workers are concentrated in the Northeast and West of the US, where obesity prevalence is relatively lower, while convenience stores and fast-food restaurant workers are concentrated in the South and Midwest, where obesity prevalence is relatively higher. The food environment landscapes measured at the metropolitan area level explain the continental-scale patterns of obesity prevalence. The types of food that are readily available and widely served may translate into obesity disparities across metropolitan areas.
C1 [Michimi, Akihiko; Wimberly, Michael C.] S Dakota State Univ, Geospatial Sci Ctr Excellence, 1021 Medary Ave,Wecota Hall 115,506B, Brookings, SD 57007 USA.
C3 South Dakota State University
RP Michimi, A (corresponding author), S Dakota State Univ, Geospatial Sci Ctr Excellence, 1021 Medary Ave,Wecota Hall 115,506B, Brookings, SD 57007 USA.
EM akihiko.michimi@gmail.com
CR [Anonymous], SAS STAT 9 3 US GUID
   [Anonymous], 2014, Behavioral Risk Factor Surveillance System Survey Data
   [Anonymous], 2013, Guidance on Exhibits 53 and 300-Information Technology and E-Government
   Bleich SN, 2010, J EPIDEMIOL COMMUN H, V64, P465, DOI 10.1136/jech.2009.096297
   Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244
   Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007
   Broda C, 2009, J ECON PERSPECT, V23, P77, DOI 10.1257/jep.23.2.77
   Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464
   CDC, 2014, 2011 SMART BRFSS MMS
   Chaix B, 2012, PLOS ONE, V7
   Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082
   Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31
   Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276
   Currie J, 2010, EFFECT FAST FOOD RES
   DiStefano C., 2009, Practical Assessment, Research and Evaluation, V14, P20, DOI [DOI 10.7275/DA8T-4G52, 10.7275/da8t-4g52]
   Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011
   Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S
   Drewnowski Adam, 2012, Am J Public Health, V102, pe74, DOI 10.2105/AJPH.2012.300660
   Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201
   Duncan DT, 2014, AM J EPIDEMIOL, V179, P373, DOI 10.1093/aje/kwt251
   Garcia G, 2012, OBES SURG, V22, P810, DOI 10.1007/s11695-012-0601-8
   Gase LN, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00229
   Glanz K, 2007, AM J PREV MED, V32, P383, DOI 10.1016/j.amepre.2007.01.003
   Hattori A, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120123
   Hill JL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1051
   Jekanowski MD, 2001, J AGR RESOUR ECON, V26, P58
   Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025
   Larsen K, 2015, INT J PUBLIC HEALTH, V60, P69, DOI 10.1007/s00038-014-0620-4
   Larson N, 2011, J AM DIET ASSOC, V111, P1696, DOI 10.1016/j.jada.2011.08.007
   Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025
   Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1031, DOI 10.1017/S1368980009992771
   Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085
   McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001
   Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031
   Michimi A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-49
   Michimi A, 2010, AM J PREV MED, V39, pE1, DOI 10.1016/j.amepre.2010.04.008
   Monsivais P, 2014, AM J PREV MED, V47, P796, DOI 10.1016/j.amepre.2014.07.033
   Moore LV, 2009, AM J EPIDEMIOL, V170, P29, DOI 10.1093/aje/kwp090
   Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003
   Morland KB, 2009, HEALTH PLACE, V15, P491, DOI 10.1016/j.healthplace.2008.09.004
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Ogden Cynthia L, 2010, NCHS Data Brief, P1
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Ogden Cynthia L, 2013, NCHS Data Brief, P1
   OMB, 2010, 2010 Standards for Delineating Metropolitan and Micropolitan Statistical Areas
   Pitts SBJ, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120319
   Powell LA, 2007, AM J PREV MED, V33, pS240, DOI 10.1016/j.amepre.2007.07.005
   Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008
   Prentice A M, 2003, Obes Rev, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x
   Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590
   Shortridge BG, 2003, GEOGR REV, V93, P507, DOI 10.1111/j.1931-0846.2003.tb00045.x
   Smith LP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-45
   SOBAL J., 2001, Social and Cultural Influences on Obesity. International Textbook of Obesity
   Stewart H., 2004, DEMAND FOOD AWAY HOM
   Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585
   Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x
   US Census Bureau, 2011, COUNT BUS PATT
   US Census Bureau, 2015, N AM IND CLASS SYST
   Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007
   Wong David W. S., 2004, WorldMinds: Geographical Perspectives on 100 Problems, P571, DOI [10.4135/9780857020130.n7, DOI 10.1007/978-1-4020-2352-1_93, 10.1007/978-1-4020-2352-193]
   Yun S, 2006, INT J OBESITY, V30, P164, DOI 10.1038/sj.ijo.0803125
   Zenk SN, 2009, AM J NURS, V109, P61, DOI 10.1097/01.NAJ.0000357175.86507.c8
   Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202
NR 63
TC 12
Z9 16
U1 1
U2 16
PU UNIV NAPLES FEDERICO II
PI NAPLES
PA FAC VET MED, DEP PATHOLOGY & ANIMAL HEALTH, VET PARASITOLOGY, VIA DELLA
   VETERINARIA 1, NAPLES, 80137, ITALY
SN 1827-1987
EI 1970-7096
J9 GEOSPATIAL HEALTH
JI Geospatial Health
PY 2015
VL 10
IS 2
BP 223
EP 231
DI 10.4081/gh.2015.368
PG 9
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA DG3YF
UT WOS:000372006400016
PM 26618317
OA Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Mori, S
   Satou, M
   Kanazawa, S
   Yoshizuka, N
   Hase, T
   Tokimitsu, I
   Takema, Y
   Nishizawa, Y
   Yada, T
AF Mori, Shinobu
   Satou, Mayumi
   Kanazawa, Satoshi
   Yoshizuka, Naonobu
   Hase, Tadashi
   Tokimitsu, Ichiro
   Takema, Yoshinori
   Nishizawa, Yoshinori
   Yada, Toshihiko
TI Body fat mass reduction and up-regulation of uncoupling protein by novel
   lipolysis-promoting plant extract
SO INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE beta adrenergic receptor; lipolysis; fat reduction; uncoupling protein;
   plant extract
ID BROWN ADIPOSE-TISSUE; OBESE WOMEN; WHITE FAT; BETA-3-ADRENERGIC
   RECEPTOR; METABOLIC-RATE; WEIGHT-LOSS; EXPRESSION; CELLS; ADIPOCYTES;
   MECHANISMS
AB We have found natural products exhibiting lipolysis-promoting activity in subcutaneous adipocytes, which are less sensitive to hormones than visceral adipocytes. The activities and a action mechanisms of a novel plant extract of Cirsium oligophyllum (CE) were investigated in isolated adipocytes from rat subcutaneous fat, and its fat-reducing effects by peroral administration and topical application were evaluated in vivo. CE-induced lipolysis was synergistically enhanced by caffeine, a phosphodiesterase inhibitor, and was reduced by propranolol, a beta adrenergic antagonist. The peroral administration of 10% CE solution to Wistar rats for 32 days reduced body weight gain, subcutaneous, and visceral fat weights by 6.6, 26.2, and 3.0%, respectively, as compared to the control group. By the topical application of 2% of this extract to rats for 7 days, weight of subcutaneous fat in the treated skin was reduced by 23.2%. This fat mass reduction was accompanied by the up-regulation of uncoupling protein 1 (UCP), a principal thermogenic mitochondrial molecule related to energy dissipating, in subcutaneous fat and UCP3 in skin except for the fat layer. These results indicate that CE promotes lipolysis via a mechanism involving the beta adrenergic receptor, and affects the body fat mass. This fat reduction may be partially due to UCP up-regulation in the skin including subcutaneous fat. This is the first report showing that repeated lipolysis promotion through CE administration may be beneficial for the systematic suppression of body fat accumulation or the control of fat distribution in obesity.
C1 [Mori, Shinobu; Satou, Mayumi; Kanazawa, Satoshi; Yoshizuka, Naonobu; Hase, Tadashi; Tokimitsu, Ichiro; Takema, Yoshinori; Nishizawa, Yoshinori] Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan.
   [Mori, Shinobu; Yada, Toshihiko] Jichi Med Univ, Sch Med, Div Integrat Physiol, Dept Physiol, Shimotsuke, Tochigi 3290498, Japan.
C3 KAO Corporation; Jichi Medical University
RP Mori, S (corresponding author), Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
EM mori.shinobu@kao.co.jp
OI Mori, Shinobu/0000-0003-0374-979X; HASE, TADASHI/0009-0003-3657-5332;
   Ohtsuka, Mayumi/0000-0001-5366-321X
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Arner P., 1996, Diabetes Reviews, V4, P450
   Atgié C, 1998, COMP BIOCHEM PHYS A, V119, P629, DOI 10.1016/S1095-6433(97)00476-5
   Bairras C, 2007, J PHYSIOL BIOCHEM, V63, P287, DOI 10.1007/BF03165760
   Baumruk F, 1999, FEBS LETT, V444, P206, DOI 10.1016/S0014-5793(99)00053-8
   Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0
   Bottcher H, 1997, INT J OBESITY, V21, P439, DOI 10.1038/sj.ijo.0800425
   CANNON B, 1982, FEBS LETT, V150, P129, DOI 10.1016/0014-5793(82)81319-7
   Doucet E, 2002, EUR J CLIN NUTR, V56, P297, DOI 10.1038/sj.ejcn.1601334
   EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461
   Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269
   GREENWAY FL, 1987, CLIN THER, V9, P663
   HELLMER J, 1992, J CLIN ENDOCR METAB, V75, P15, DOI 10.1210/jc.75.1.15
   Hoffstedt J, 1997, J LIPID RES, V38, P795
   Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005
   Jezek P, 1999, J BIOENERG BIOMEMBR, V31, P457, DOI 10.1023/A:1005496306893
   KAWANOTAKAHASHI Y, 1984, INT J OBESITY, V8, P655
   Klaus S, 1998, AM J PHYSIOL-REG I, V274, pR287, DOI 10.1152/ajpregu.1998.274.2.R287
   LANGIN D, 1995, FUND CLIN PHARMACOL, V9, P97, DOI 10.1111/j.1472-8206.1995.tb00268.x
   Lupi Omar, 2007, J Cosmet Dermatol, V6, P102
   MAURIEGE P, 1995, AM J PHYSIOL-ENDOC M, V269, pE341, DOI 10.1152/ajpendo.1995.269.2.E341
   Mori S, 2008, J INVEST DERMATOL, V128, P1894, DOI 10.1038/jid.2008.20
   Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748
   Nagase I, 2001, FEBS LETT, V494, P175, DOI 10.1016/S0014-5793(01)02341-9
   NEDERGAARD J, 1985, AM J PHYSIOL, V248, pC365, DOI 10.1152/ajpcell.1985.248.3.C365
   RODBELL M, 1964, J BIOL CHEM, V239, P375
   Shen J, 2007, NEUROSCI LETT, V416, P241, DOI 10.1016/j.neulet.2006.12.063
   SHIMIZU Y, 1991, AM J PHYSIOL, V261, pR301, DOI 10.1152/ajpregu.1991.261.2.R301
   Solanes G, 1997, J BIOL CHEM, V272, P25433, DOI 10.1074/jbc.272.41.25433
   TAVERNIER G, 1995, AM J PHYSIOL-ENDOC M, V268, pE1135, DOI 10.1152/ajpendo.1995.268.6.E1135
   THOMAS RF, 1992, P NATL ACAD SCI USA, V89, P4490, DOI 10.1073/pnas.89.10.4490
   Vidal H, 2001, ANN MED, V33, P547, DOI 10.3109/07853890108995965
   Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012
   YOSHIDA T, 1994, INT J OBESITY, V18, P345
   Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747
NR 35
TC 11
Z9 13
U1 0
U2 6
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-2288
J9 INT J BIOL SCI
JI Int. J. Biol. Sci.
PY 2009
VL 5
IS 4
BP 311
EP 318
PG 8
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 468TF
UT WOS:000267843900003
PM 19421341
DA 2025-04-28
ER

PT J
AU Jones, AC
   Kirkpatrick, SI
   Hammond, D
AF Jones, Amanda C.
   Kirkpatrick, Sharon I.
   Hammond, David
TI Beverage consumption and energy intake among Canadians: analyses of 2004
   and 2015 national dietary intake data
SO NUTRITION JOURNAL
LA English
DT Article
DE Beverage intake; Fluid intake; Nutrition surveillance; Sugar-sweetened
   beverages; Sugary drinks; Alcohol
ID SUGAR-SWEETENED BEVERAGES; FRUIT JUICE CONSUMPTION; BODY-MASS INDEX; US
   ADULTS; SOCIOECONOMIC-STATUS; PATTERNS; CHILDREN; TRENDS; RISK;
   OVERWEIGHT
AB Background Among adults and children consuming Western diets, beverages are significant sources of free sugars, saturated fats, excess calories, and alcohol, with relevance to chronic disease risk. The impact of recent healthy eating policies and beverage market evolutions on population-level consumption patterns in Canada is unknown. The current study examined trends in intake of a range of beverage types among a nationally-representative sample of Canadians, with stratification by socio-demographic characteristics. Methods The 2004 (n = 34,775) and 2015 (n = 20,176) nutrition-focused cycles of the Canadian Community Health Surveys are cross-sectional surveys representative of the population of the 10 Canadian provinces. Based on a single multiple-pass 24-h dietary recall for each participant, fluids consumed as beverages were grouped into seven categories. Using linear regression, reported intake (volume, ml and energy, kcal) of each category was characterized over time and in relation to sex, age, ethnicity, income, body mass index (BMI), and province of residence. Results In 2015, Canadians reported consuming an average of 1806 ml (275 kcal) fluids as beverages per day, including: plain water 867 ml (0 kcal); other unsweetened beverages, e.g. coffee, 364 ml (6 kcal); sugar-sweetened beverages (SSBs) 204 ml (99 kcal); plain milk 132 ml (64 kcal); alcoholic drinks 120 ml (71 kcal); 100% juice 74 ml (34 kcal); and diet or low calorie beverages 44 ml (2 kcal). Differential consumption was observed across socio-demographic groups, with high consumption of sugary drinks (i.e., SSBs and 100% juice) and alcohol across groups. From 2004 to 2015, the reported volumes of beverages consumed decreased by 10% (energy: - 24%). With adjustment for socio-demographic characteristics, there were significant changes (p < 0.001) over time in intake of: 100% juice - 40% (- 38%); plain milk - 37% (- 35%); SSBs - 26% (- 20%); diet or low calorie beverages (- 46%); and other unsweetened beverages - 11% (- 42%). The volume of plain water consumed increased by 10% (p < 0.0001). Intake of alcoholic (volume and energy) and diet or light beverages did not change significantly. Conclusions Lower intake of beverages was reported by Canadians in 2015 versus 2004, with a shift towards plain water. Consumption of sugary drinks decreased, but these beverages continue to contribute substantially to Canadians' overall energy intake. The findings underscore the need for policies to further reduce the consumption of sugary and alcoholic beverages, as well as calories from beverages.
C1 [Jones, Amanda C.] Univ Otago Wellington, Dept Publ Hlth, POB 7343, Wellington 6242, Newtown, New Zealand.
   [Kirkpatrick, Sharon I.; Hammond, David] Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
C3 University of Otago; University of Waterloo
RP Jones, AC (corresponding author), Univ Otago Wellington, Dept Publ Hlth, POB 7343, Wellington 6242, Newtown, New Zealand.
EM amanda.jones@otago.ac.nz
RI Kirkpatrick, Sharon/AEX-6257-2022; Hammond, David/JPW-9267-2023
OI Kirkpatrick, Sharon/0000-0001-9896-5975; Jones, Amanda
   C/0000-0001-8426-8407
FU CIHR [NAS-151550]; Ontario Graduate Scholarship; University of Waterloo
   President's Graduate Scholarship; CIHR PHAC Chair in Applied Public
   Health
FX Funding for this study was provided by a CIHR Project Grant
   (NAS-151550). Additional support was provided by Ontario Graduate
   Scholarship (ACJ), University of Waterloo President's Graduate
   Scholarship (ACJ), CIHR PHAC Chair in Applied Public Health (DH). The
   funders had no role in the study design; data collection, analysis, and
   interpretation; or preparation of the manuscript.
CR [Anonymous], 2014, AUSTR HLTH SURV US G
   [Anonymous], 2018, LANCET
   [Anonymous], 2012, CARB NUTR FOOD
   [Anonymous], 2009, WHAT AR EQ SCAL
   [Anonymous], PASS DAT
   [Anonymous], 2019, Canada's Dietary Guidelines
   [Anonymous], 2008, CANADIAN COMMUNITY H
   [Anonymous], 2017, 2015 Canadian Community Health Survey
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bernstein JT, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090582
   Bleich SN, 2014, AM J PUBLIC HEALTH, V104, pE72, DOI 10.2105/AJPH.2013.301556
   Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879
   Butler L, 2016, J ACAD NUTR DIET, V116, P1087, DOI 10.1016/j.jand.2016.03.008
   Butt P., 2011, Alcohol and health in Canada: A summary of evidence and guidelines for low risk drinking
   Centers for Disease Control and Prevention, 2013, KEY CONC UND MEAS ER
   Centers for Disease Control and Prevention, 2013, KEY CONC ID AN IMPL
   Danyliw AD, 2012, APPL PHYSIOL NUTR ME, V37, P900, DOI [10.1139/h2012-074, 10.1139/H2012-074]
   Danyliw AD, 2011, PUBLIC HEALTH NUTR, V14, P1961, DOI 10.1017/S1368980011001091
   de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978
   Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1
   Dunford EK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020257
   Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8
   Garriguet D, 2018, HEALTH REP, V29, P3
   Garriguet Didier, 2008, Health Rep, V19, P23
   Garriguet Didier, 2008, Health Rep, V19, P17
   Garriguet Didier, 2008, Health Rep, V19, P37
   Gibson S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-9
   Giesbrecht N, 2016, INT J ALCOHOL DRUG R, V5, P33, DOI 10.7895/ijadr.v5i2.221
   Grant M, 2016, CANADIAN BEVERAGE AS
   Health Canada, 2019, CAN FOOD GUID HLTH E
   Health Canada, 2017, CANUCS CANADIAN NIRI
   Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576
   Jones A.C., 2017, The health and economic impact of a tax on sugary drinks in Canada
   Kim Y, 2016, ARCH CARDIOVASC DIS, V109, P242, DOI 10.1016/j.acvd.2015.10.005
   Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091
   Kirkpatrick SI, 2019, APPL PHYSIOL NUTR ME, V44, P650, DOI 10.1139/apnm-2018-0532
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Malik AH, 2014, AM J CARDIOL, V113, P1574, DOI 10.1016/j.amjcard.2014.01.437
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Mark S, 2012, CAN J PUBLIC HEALTH, V103, P94, DOI 10.1007/BF03404210
   McElligott JT, 2012, SOUTH MED J, V105, P364, DOI 10.1097/SMJ.0b013e31825c0252
   Mesirow MSC, 2015, J ACAD NUTR DIET, V115, P559, DOI 10.1016/j.jand.2014.09.004
   Miller G, 2017, MMWR-MORBID MORTAL W, V66, P112, DOI 10.15585/mmwr.mm6604a5
   Ministry of Education, 2010, 150 MIN ED GOV ONT
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.E7492
   Moubarac JC, 2014, CAN J DIET PRACT RES, V75, P15, DOI 10.3148/75.1.2014.15
   Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954
   Murakami K, 2016, BRIT J NUTR, V115, P294, DOI 10.1017/S0007114515004304
   Murakami K, 2015, BRIT J NUTR, V114, P1294, DOI 10.1017/S0007114515002706
   Murphy Brian., 2010, REVISING STAT CANADA
   Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465
   Nieto C, 2019, OBES REV, V20, P67, DOI 10.1111/obr.12814
   Nikpartow N, 2012, PUBLIC HEALTH NUTR, V15, P2175, DOI 10.1017/S1368980012003898
   Nikpartow N, 2012, CAN J PUBLIC HEALTH, V103, P178, DOI 10.1007/BF03403809
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x
   *PUBL HLTH AG CAN, 2016, CAN CHRON DIS SURV S
   Rehm J, 2016, LANCET GASTROENTEROL, V1, P78, DOI 10.1016/S2468-1253(16)30013-9
   Rippin HL, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1362
   Shupler M, 2017, CAN J PUBLIC HEALTH, V108, pE145, DOI [10.17269/cjph.108.5664, 10.17269/CJPH.108.5664]
   Stockwell T, 2012, DRUG ALCOHOL REV, V31, P126, DOI 10.1111/j.1465-3362.2011.00342.x
   Sylvetsky AC, 2012, AM J CLIN NUTR, V96, P640, DOI 10.3945/ajcn.112.034751
   Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521
   Twells Laurie K, 2014, CMAJ Open, V2, pE18, DOI 10.9778/cmajo.20130016
   Vandevijvere S, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0278-0
   WCRF, 2018, NOURISHING DAT WORLD
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
   White C, 2017, INT SOC BEH NUTR PHY
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
   WHO, 2019, BMI FOR AG CHILD GRO
   WHO EURO, 2019, BOD MASS IND BMI
   World Cancer Research Fund International, 2018, MEAT FISH DAIR PROD
   World Health Organization, 2016, GUID SUG INT AD CHIL
   World Health Organization, 2019, BMI FOR AG 5 19 YEAR
   Wymond BS, 2016, PUBLIC HEALTH NUTR, V19, P2592, DOI 10.1017/S136898001600063X
NR 75
TC 56
Z9 57
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD OCT 18
PY 2019
VL 18
IS 1
AR 60
DI 10.1186/s12937-019-0488-5
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA JF0AY
UT WOS:000491051400001
PM 31627756
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Tognolli, K
   Silva, V
   Sousa, CPB
   Cardoso, CAL
   Gorjao, R
   Otton, R
AF Tognolli, Kaue
   Silva, Victoria
   Batista Sousa-Filho, Celso Pereira
   Lima Cardoso, Claudia Andrea
   Gorjao, Renata
   Otton, Rosemari
TI Green tea beneficial effects involve changes in the profile of immune
   cells in the adipose tissue of obese mice
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Immune cells; Obesity; Polyphenols; Metabolism; Inflammation;
   Thermoneutrality
ID NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; BODY-WEIGHT; INFLAMMATION;
   IL-6; RICH; POLARIZATION; POLYPHENOLS; MECHANISMS; CAFFEINE
AB Purpose During obesity, the adipose tissue is usually infiltrated by immune cells which are related to hallmarks of obesity such as systemic inflammation and insulin resistance (IR). Green tea (GT) has been widely studied for its anti-inflammatory actions, including the modulation in the proliferation and activity of immune cells, in addition to preventing cardiovascular and metabolic diseases. Methods The aim of the present study was to analyze the population of immune cells present in the subcutaneous and epididymal white adipose tissue (WAT) of mice kept at thermoneutrality (TN) and fed with a high-fat diet (HFD) for 16 weeks, supplemented or not with GT extract (500 mg/kg/12 weeks). Results The HFD in association with TN has induced chronic inflammation, and IR in parallel with changes in the profile of immune cells in the subcutaneous and epidydimal WAT, increasing pro-inflammatory cytokines release, inflammatory cells infiltration, and fibrotic aspects in WAT. On the other hand, GT prevented body weight gain, in addition to avoiding IR and inflammation, and the consequent tissue fibrosis, maintaining a lower concentration of cytokines and a profile of immune cells similar to the control mice, preventing the harmful modulations induced by both HFD and TN. Conclusions GT beneficial effects in WAT abrogated the deleterious effects triggered by HFD and TN, maintaining all immune cells and fibrotic markers at the same level as in lean mice. These results place WAT immune cells population as a potential target of GT action, also highlighting the positive effects of GT in obese mice housed at TN.
C1 [Tognolli, Kaue; Silva, Victoria; Batista Sousa-Filho, Celso Pereira; Gorjao, Renata; Otton, Rosemari] Cruzeiro do Sul Univ, Interdisciplinary Postgrad Program Hlth Sci, Regente Feijo Ave 1295, BR-03342000 Sao Paulo, SP, Brazil.
   [Lima Cardoso, Claudia Andrea] Mato Grosso do Sul State Univ, Dourados, MS, Brazil.
C3 Universidade Estadual de Mato Grosso do Sul
RP Otton, R (corresponding author), Cruzeiro do Sul Univ, Interdisciplinary Postgrad Program Hlth Sci, Regente Feijo Ave 1295, BR-03342000 Sao Paulo, SP, Brazil.
EM rosemariotton@hotmail.com
RI Sousa-Filho, Celso/AAE-4155-2020; Cardoso, Claudia/AAK-5578-2020; Silva,
   Victória/MQE-6214-2025; Otton, Rosemari/C-6531-2012; Gorjao,
   Renata/D-4130-2013
OI Otton, Rosemari/0000-0001-5503-3967; Sousa-Filho, Celso Pereira
   Batista/0000-0002-9349-2731; Tognolli, Kaue/0000-0002-9897-0472; Gorjao,
   Renata/0000-0002-9655-1477
FU SAo Paulo Research Foundation (FAPESP) [2019/10616-5]; CoordenacAo de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; Cruzeiro do
   Sul University
FX The authors are indebted to the assistance of Dr. Alexandre Steiner and
   Dr. Eduardo H. Moretti, for indirect calorimeter machine utilization and
   support, and to all Otton's Lab members for helping in mice care. The
   authors are grateful to Alembert Eistein Lino Alvarado for technical
   assistance in picrosirius staining analyses. This research was supported
   by the SAo Paulo Research Foundation (FAPESP, process no. 2019/10616-5),
   CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)-Finance Code 001 and Cruzeiro do Sul University.
CR Sousa CPB, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104956
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Bolin AP, 2020, J NUTR BIOCHEM, V83, DOI 10.1016/j.jnutbio.2020.108429
   Bolin AP, 2020, J NUTR BIOCHEM, V78, DOI 10.1016/j.jnutbio.2019.108322
   Braune J, 2017, J IMMUNOL, V198, P2927, DOI 10.4049/jimmunol.1600476
   Catrysse L, 2018, CELL IMMUNOL, V330, P114, DOI 10.1016/j.cellimm.2018.03.001
   Chen D, 2005, BIOCHEM PHARMACOL, V69, P1523, DOI 10.1016/j.bcp.2005.01.024
   Clayton ZS, 2018, AM J PHYSIOL-REG I, V315, pR627, DOI 10.1152/ajpregu.00364.2017
   Cox AR, 2019, ENDOCRINOLOGY, V160, P1645, DOI 10.1210/en.2019-00266
   Daniele G, 2014, ACTA DIABETOL, V51, P123, DOI 10.1007/s00592-013-0543-1
   Davanzo GG, 2021, CURR OPIN PHARMACOL, V58, P44, DOI 10.1016/j.coph.2021.03.004
   Djeridane A, 2006, FOOD CHEM, V97, P654, DOI 10.1016/j.foodchem.2005.04.028
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Ellulu MS, 2017, ARCH MED SCI, V13, P851, DOI 10.5114/aoms.2016.58928
   Fischer AW, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.568682
   Fischer AW, 2019, MOL METAB, V26, P1, DOI 10.1016/j.molmet.2019.05.006
   Flehmig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099785
   Francisco V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00640
   Haghighatdoost F, 2017, J AM COLL NUTR, V36, P541, DOI 10.1080/07315724.2017.1333470
   Henninger AMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105262
   HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074
   Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396
   Hwang I, 2019, DIABETES METAB J, V43, P752
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kane H, 2019, TRENDS IMMUNOL, V40, P857, DOI 10.1016/j.it.2019.07.006
   Keijer J, 2019, MOL METAB, V25, P168, DOI 10.1016/j.molmet.2019.04.001
   Kim J, 2020, INT J OBESITY, V44, P1541, DOI 10.1038/s41366-020-0602-y
   Konstantinidi Melina, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6030094
   Kwon EY, 2015, DIABETES, V64, P1658, DOI 10.2337/db14-0631
   Lang P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55987-x
   Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358
   Misumi I, 2019, CELL REP, V27, P514, DOI 10.1016/j.celrep.2019.03.030
   Neff EP, 2020, LAB ANIMAL, V49, P169, DOI 10.1038/s41684-020-0560-y
   Otton R, 2018, J NUTR BIOCHEM, V57, P170, DOI 10.1016/j.jnutbio.2018.03.024
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012
   Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200
   Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002
   Samanta S, 2022, J AM NUTR ASSOC, V41, P65, DOI 10.1080/07315724.2020.1827082
   Singer K, 2017, J CLIN INVEST, V127, P65, DOI [10.1172/jci88882, 10.1172/JCI88882]
   Skop V, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.065
   Stemmer K, 2015, INT J OBESITY, V39, P791, DOI 10.1038/ijo.2014.187
   Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Torres LF, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4168380
   Vialard F, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.588387
   Vieira-Potter VJ, 2014, CELL MICROBIOL, V16, P1484, DOI 10.1111/cmi.12336
   Villarroya F, 2018, CELL METAB, V27, P954, DOI 10.1016/j.cmet.2018.04.006
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wensveen FM, 2015, SEMIN IMMUNOL, V27, P322, DOI 10.1016/j.smim.2015.10.006
   Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001
   Xing LJ, 2019, J AGR FOOD CHEM, V67, P1029, DOI 10.1021/acs.jafc.8b06146
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717
   Yang D, 2016, OBES REV, V17, P485, DOI 10.1111/obr.12397
   Zheng C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.54
   Zhi XH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00085
NR 60
TC 3
Z9 3
U1 1
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD FEB
PY 2023
VL 62
IS 1
BP 321
EP 336
DI 10.1007/s00394-022-02963-3
EA AUG 2022
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 8P5VC
UT WOS:000842856000001
PM 35994086
DA 2025-04-28
ER

PT J
AU Hashimoto, T
   Sato, K
   Iemitsu, M
AF Hashimoto, Takeshi
   Sato, Koji
   Iemitsu, Motoyuki
TI Exercise-inducible factors to activate lipolysis in adipocytes
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE obesity; lipid droplet; lipid droplet-associated protein; mitochondria
ID HUMAN ADIPOSE-TISSUE; DROPLET-ASSOCIATED PROTEINS; MITOCHONDRIAL
   BIOGENESIS; LIPID DROPLETS; NITRIC-OXIDE; PERILIPIN; EXPRESSION;
   PGC-1-ALPHA; MICE; DIET
AB We examined the effects of exercise training on the levels of lipid droplet (LD)-associated and mitochondria-related proteins in diet-induced obese (DIO) rats. Furthermore, we assessed putative factors induced by exercise to activate lipolysis in differentiated 3T3-L1 adipocytes. DIO Wistar male rats (age 20 wk) were divided into sedentary control (SED, n = 7) and exercise training (EX, n = 7) groups. EX animals were subjected to treadmill running (25 m/min, 1 h/day, 5 days/wk) for 6 wk. Epididymal fat was dissected and used for protein analyses. 3T3-L1 adipocytes were incubated with media containing hydrogen peroxide (H2O2), sodium-lactate, caffeine, AICAR, or SNAP (NO donor) for 6 h, or 1 mM H2O2 for 15 min, followed by incubation with normal media for up to 24 h total. Protein expression levels and lipolytic activities were biochemically assayed. Epididymal fat significantly decreased in EX animals compared with SED animals. Levels of cytochrome c oxidase (COx), perilipin, hormone sensitive lipase (HSL), and adipose triglyceride lipase (ATGL) proteins in epididymal fat pads of EX animals were significantly increased compared with those in SED animals. In 3T3-L1 cells, glycerol or fatty acid release was significantly increased by all treatments. Lactate or SNAP significantly increased PGC-1 alpha expression, and H2O2 significantly increased COx protein levels compared with controls. Expression of perilipin, HSL, ATGL, or comparative gene identification (CGI)-58 was significantly increased by all treatments. By increasing lipolytic activity in adipocytes, the exercise-inducible factors are attractive therapeutic effectors against LD-associated metabolic diseases.
C1 [Hashimoto, Takeshi; Sato, Koji; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan.
C3 Ritsumeikan University
RP Hashimoto, T (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan.
EM thashimo@fc.ritsumei.ac.jp
RI Iemitsu, Motoyuki/LOQ-9172-2024
FU Japan Society for Promotion of Science; Yamaha Motor Foundation for
   Sports; Nakatomi Foundation; Suzuken Memorial Foundation; Grants-in-Aid
   for Scientific Research [23700849, 25560378, 25560344, 22700652,
   23680071] Funding Source: KAKEN
FX This work was supported in part by a Grant-in-Aid for Young Scientists
   (B) to T.H. and K.S., and by a Grant-in-Aid for Young Scientists (A) to
   M.I. from the Japan Society for Promotion of Science. Partial support
   was provided by the Yamaha Motor Foundation for Sports to T.H., the
   Nakatomi Foundation to T.H., and the Suzuken Memorial Foundation to T.H.
CR Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200
   Campbell JE, 2009, METABOLISM, V58, P651, DOI 10.1016/j.metabol.2009.01.002
   Chabi B, 2005, MED SCI SPORT EXER, V37, P2102, DOI 10.1249/01.mss.0000177426.68149.83
   Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2
   de Glisezinski I, 2003, AM J PHYSIOL-ENDOC M, V285, pE984, DOI 10.1152/ajpendo.00152.2003
   De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155
   Enevoldsen LH, 2000, AM J PHYSIOL-ENDOC M, V279, pE585, DOI 10.1152/ajpendo.2000.279.3.E585
   Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003
   Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200
   Gaudiot N, 1998, J BIOL CHEM, V273, P13475, DOI 10.1074/jbc.273.22.13475
   Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200
   GIUDICELLI Y, 1977, BIOCHIM BIOPHYS ACTA, V486, P385, DOI 10.1016/0005-2760(77)90035-2
   Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006
   Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478
   Gustafsson J, 2007, SCAND J CLIN LAB INV, V67, P155, DOI 10.1080/00365510600995259
   Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com
   Hashimoto T, 2012, J CELL SCI, V125, P6127, DOI 10.1242/jcs.113084
   JANSSON PA, 1990, DIABETOLOGIA, V33, P253, DOI 10.1007/BF00404805
   Kawanami H, 2002, JPN J PHYSIOL, V52, P343, DOI 10.2170/jjphysiol.52.343
   Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910
   Leroyer SN, 2006, J BIOL CHEM, V281, P13141, DOI 10.1074/jbc.M512943200
   Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200
   McConell GK, 2010, J APPL PHYSIOL, V108, P589, DOI 10.1152/japplphysiol.00377.2009
   Miyoshi H, 2010, J LIPID RES, V51, P975, DOI 10.1194/jlr.M002352
   Moro C, 2009, J CLIN ENDOCR METAB, V94, P2579, DOI 10.1210/jc.2009-0051
   Mottagui-Tabar S, 2003, DIABETOLOGIA, V46, P789, DOI 10.1007/s00125-003-1112-x
   Ogasawara J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040876
   Ojuka EO, 2004, P NUTR SOC, V63, P275, DOI 10.1079/PNS2004339
   Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200
   Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x
   Sato K, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-47
   Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, pE274, DOI 10.1152/ajpendo.00564.2010
   Satoor SN, 2011, SCI REP-UK, V1, DOI 10.1038/srep00081
   Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464
   Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998
   Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003
   Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004
   Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752
   Wohlers LM, 2011, J CELL BIOCHEM, V112, P3675, DOI 10.1002/jcb.23302
   Wohlers LM, 2010, J CELL BIOCHEM, V110, P420, DOI 10.1002/jcb.22553
   Yamaguchi T, 2010, BIOL PHARM BULL, V33, P342, DOI 10.1248/bpb.33.342
   You TJ, 2004, J CLIN ENDOCR METAB, V89, P1739, DOI 10.1210/jc.2003-031310
   Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200
NR 45
TC 28
Z9 35
U1 0
U2 20
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD JUL
PY 2013
VL 115
IS 2
BP 260
EP 267
DI 10.1152/japplphysiol.00427.2013
PG 8
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA 183MH
UT WOS:000321819000015
PM 23681914
DA 2025-04-28
ER

PT J
AU Bombak, AE
   Colotti, T
   Riediger, ND
   Raji, D
   Eckhart, N
AF Bombak, Andrea E.
   Colotti, Taylor
   Riediger, Natalie D.
   Raji, Dolapo
   Eckhart, Nicholas
TI Fizzy foibles: examining attitudes toward sugar-sweetened beverages in
   Michigan
SO CRITICAL PUBLIC HEALTH
LA English
DT Article
DE Sugar-sweetened beverage; stigma; food; shame; weight
ID PERCEIVED DISCRIMINATION; OBESITY; FAT; ASSOCIATION; DISPARITIES;
   CAMPAIGNS; AMERICAN; CHILDREN; TOBACCO; POLICY
AB Health educators are increasingly publicizing the noxious health effects of sugar-sweetened beverages (SSB). American counties are implementing SSB taxes, as modeled after the 'success' of tobacco policies, to address the 'obesity crisis'. Under-explored is how the linking of SSB to a stigmatized condition, 'obesity', has affected attitudes toward the purchasing and consumption of SSB and those individuals who purchase and consume SSB. This study sought to explore individuals' attitudes and experiences with SSB in rural Michigan. Three themes emerged: Negativity, Egregious beverages and Implicated imbibers. These attitudes were situated within a context of increased exposure to SSB health discourses, particularly among younger participants. Additional themes arose regarding which SSB were labelled especially problematic, who should or should not be drinking SSB, as well as the consequences of drinking SSB. Pop/soda, energy drinks, and diet pop/soda were identified as particularly harmful, albeit for different reasons - sugar, caffeine, and unnatural additives. Many participants reported reacting negatively when they saw children of higher weights drinking SSB, though judgement was reserved for parents. Ultimately, SSB and their consumers appear increasingly stigmatized in ways that carry important equity implications for already marginalized groups.
C1 [Bombak, Andrea E.] Univ New Brunswick, Dept Sociol, Fredericton, NB, Canada.
   [Colotti, Taylor; Raji, Dolapo] Cent Michigan Univ, Sch Hlth Sci, Community Hlth Div, Mt Pleasant, MI 48859 USA.
   [Riediger, Natalie D.] Univ Manitoba, Fac Agr & Food Sci, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada.
   [Riediger, Natalie D.] Univ Manitoba, Rady Fac Hlth Sci, Dept Community Hlth Sci, Winnipeg, MB, Canada.
   [Eckhart, Nicholas] Univ Alabama, Coll Commun & Informat Sci, Tuscaloosa, AL USA.
   [Colotti, Taylor] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA.
   [Raji, Dolapo] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA.
C3 University of New Brunswick; Central Michigan University; University of
   Manitoba; University of Manitoba; University of Alabama System;
   University of Alabama Tuscaloosa; Utah System of Higher Education;
   University of Utah; University of Michigan System; University of
   Michigan
RP Bombak, AE (corresponding author), Univ New Brunswick, Dept Sociol, Fredericton, NB, Canada.
EM andrea.bombak@unb.ca
OI Riediger, Natalie/0000-0002-8736-9446
FU Central Michigan University; CIHR Early Career Investigator Award for
   NDR [155435]
FX This work was supported by Central Michigan University [Start-up funds];
   CIHR Early Career Investigator Award for NDR [155435].
CR [Anonymous], 2014, RED CONS SUG SWEET B
   Bacon L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-9
   Bell K., 2009, Critical Public Health, V19, P155, DOI 10.1080/09581590802385664
   Bell K, 2011, CRIT PUBLIC HEALTH, V21, P49, DOI [10.1080/09581596.2010.529419, 10.1080/09581596.2010.530642]
   Blecher E, 2015, SOC SCI MED, V136, P175, DOI 10.1016/j.socscimed.2015.05.022
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   Bombak AE, 2015, FOOD CULT SOC, V18, P681, DOI 10.1080/15528014.2015.1088196
   Burris S, 2008, SOC SCI MED, V67, P473, DOI 10.1016/j.socscimed.2008.03.020
   Creswell J. W., 2003, Research design: Qualitative, quantitative, and mixed methods approaches, DOI DOI 10.3109/08941939.2012.723954
   Dwyer-Lindgren L, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-5
   Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x
   Emerson RobertM., 1995, WRITING ETHNOGRAPHIC
   Fee M, 2006, SOC SCI MED, V62, P2988, DOI 10.1016/j.socscimed.2005.11.062
   Gallegos D, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040561
   Gard Michael., 2005, OBESITY EPIDEMIC SCI
   Goffman E., 1963, STIGMA NOTES MANAGEM, DOI DOI 10.1093/SF/43.1.127
   Greenebaum J, 2018, FOOD CULT SOC, V21, P680, DOI 10.1080/15528014.2018.1512285
   Guthman Julie., 2011, Weighing In: Obesity, Food Justice, and the Limits of Capitalism, DOI DOI 10.1525/J.CTT1PP061
   Hayes S, 2015, OBES SURG, V25, P191, DOI 10.1007/s11695-014-1478-5
   Hayward LE, 2019, OBES SCI PRACT, V5, P333, DOI 10.1002/osp4.353
   Herndon A.M., 2005, Social Semiotics, V15, P127, DOI DOI 10.1080/10350330500154634
   Herndon AM, 2010, FOOD CULT SOC, V13, P331, DOI 10.2752/175174410X12699432700863
   Jutel A., 2005, SOC SEMIOT, V15, P113, DOI DOI 10.1080/10350330500154717
   Kuo LE, 2016, SURG OBES RELAT DIS, V12, P144, DOI 10.1016/j.soard.2015.05.007
   Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822
   Kwan Samantha., 2013, FRAMING FAT COMPETIN
   Kwarteng JL, 2016, J BIOSOC SCI, V48, P709, DOI 10.1017/S0021932016000225
   Lauridsen DS, 2018, HEALTH EXPECT, V21, P878, DOI 10.1111/hex.12681
   LeBesco Kathleen., 2004, Revolting Bodies? The Struggle to Redefine Fat Identity
   Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941
   Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004
   Lucan SC, 2017, J URBAN HEALTH, V94, P220, DOI 10.1007/s11524-016-0127-9
   LUPTON D., 2016, Food, the Body and the Self
   Lupton D, 2015, CRIT PUBLIC HEALTH, V25, P4, DOI 10.1080/09581596.2014.885115
   *MCLAREN HLTH CAR, 2017, COMM HLTH NEEDS ASS
   McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001
   McPhail D, 2015, CRIT PUBLIC HEALTH, V25, P539, DOI 10.1080/09581596.2014.992391
   McPhail D, 2013, HEALTH PLACE, V22, P132, DOI 10.1016/j.healthplace.2013.03.009
   MECHLING EW, 1983, CENT STATES SPEECH J, V34, P19, DOI 10.1080/10510978309368111
   MEEUF R, 2016, CELEBRITY STUDIES, V7, P1
   Mintz S., 1997, MORALITY HLTH, P173
   Mintz SidneyWilfred., 1986, SWEETNESS POWER PLAC
   Monaghan LF, 2018, CRIT PUBLIC HEALTH, V28, P498, DOI 10.1080/09581596.2017.1371278
   Myers AM, 2017, FOOD SECUR, V9, P1419, DOI 10.1007/s12571-017-0733-8
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI [10.1001/jama.2012.39, 10.1001/jama.2012.40]
   PACKER M, 2016, BERKELEY J SOCIOLOGY
   Park S, 2016, AM J HEALTH PROMOT, V30, P357, DOI 10.1177/0890117116646343
   Park S, 2015, J ACAD NUTR DIET, V115, P1996, DOI 10.1016/j.jand.2015.06.010
   Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491
   Raisborough Jayne., 2016, Fat Bodies, Health, and the Media
   RIEDIGER N, 2018, CMAJ CANADIAN MED AS, V190, P11
   *RUR HLTH INF HUB, 2018, AM I RUR
   Saldaa J., 2009, CODING MANUAL QUALIT
   Slobe T, 2018, LANG SOC, V47, P541, DOI 10.1017/S004740451800060X
   Stepanikova I, 2017, AM J PREV MED, V52, pS77, DOI 10.1016/j.amepre.2016.07.034
   Stroehla BC, 2005, J AM DIET ASSOC, V105, P1908, DOI 10.1016/j.jada.2005.09.002
   Tait CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195962
   Thompson LE, 2009, HEALTH RISK SOC, V11, P181, DOI 10.1080/13698570902784281
   Thompson L, 2011, CRIT PUBLIC HEALTH, V21, P105, DOI 10.1080/09581591003797129
   Trivedi T, 2015, RURAL REMOTE HEALTH, V15
   *US BUR CENS, 2016, IS COUNT FAST FACTS
   Wallace AE, 2010, OBES SURG, V20, P1354, DOI 10.1007/s11695-009-0054-x
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Warin M, 2008, SOCIOL HEALTH ILL, V30, P97, DOI 10.1111/j.1467-9566.2007.01029.x
   Warin M, 2011, SOC THEOR HEALTH, V9, P24, DOI 10.1057/sth.2010.2
   Warin Megan., 2011, Fatness and the maternal body: women's experiences of corporeality and the shaping of social policy, P22
   Wong MS, 2015, PATIENT EDUC COUNS, V98, P492, DOI 10.1016/j.pec.2014.12.007
   Zhang XC, 2011, COMP AM STUD, V9, P68, DOI 10.1179/147757011X12983070064953
   Zivkovic T., 2015, Careful eating: Bodies, food and care, P109
NR 69
TC 7
Z9 7
U1 0
U2 12
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0958-1596
EI 1469-3682
J9 CRIT PUBLIC HEALTH
JI Crit. Public Heath
PD JAN 1
PY 2021
VL 31
IS 1
SI SI
BP 113
EP 124
DI 10.1080/09581596.2019.1680804
EA OCT 2019
PG 12
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA PN8IE
UT WOS:000492116100001
DA 2025-04-28
ER

PT J
AU Zhang, Y
   Yu, YJ
   Li, X
   Meguro, S
   Hayashi, S
   Katashima, M
   Yasumasu, T
   Wang, JZ
   Li, KJ
AF Zhang, Ying
   Yu, Yingjie
   Li, Xu
   Meguro, Shinichi
   Hayashi, Satoshi
   Katashima, Mitsuhiro
   Yasumasu, Takeshi
   Wang, Jingzhong
   Li, Keji
TI Effects of catechin-enriched green tea beverage on visceral fat loss in
   adults with a high proportion of visceral fat: A double-blind,
   placebo-controlled, randomized trial
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Body weight; Body fat mass; Catechins; Green tea; Visceral fat;
   Functional beverage
ID DIET-INDUCED OBESITY; ABDOMINAL FAT; BODY-FAT; EXTRACT; RICH;
   SUPPLEMENTATION; CONSUMPTION; REDUCTION; OXIDATION; HUMANS
AB The effects of catechin-enriched green tea on Chinese adults with a high proportion of abdominal visceral fat were evaluated. Subjects (118) were randomly assigned to consume daily a beverage containing 609.3 mg catechins and 68.7 mg caffeine or a control beverage for 12 weeks. Abdominal fat area, body weight and composition were measured at week 0, week 8, and week 12. One hundred and four subjects completed the trial. Average visceral fat area, body weight, and body fat were reduced significantly by catechin-enriched green tea treatment but these effects were not seen in the control group with per-protocol sets analysis. The decrease at week 12 in the visceral fat area in the catechin group was greater than that in the control group (P = 0.04). Thus, consumption of the catechin-enriched green tea beverage for 12 weeks induced visceral fat loss in Chinese adults with a high proportion of abdominal visceral fat. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Zhang, Ying; Li, Xu; Li, Keji] Peking Univ, Sch Publ Hlth, Dept Food Hyg & Nutr, Beijing, Peoples R China.
   [Yu, Yingjie] Beijing Ctr Dis Control & Prevent, Inst Nutr & Food Safety, Beijing, Peoples R China.
   [Wang, Jingzhong] Chinese Ctr Dis Control & Prevent, Inst Nutr & Food Safety, Beijing, Peoples R China.
C3 Peking University; Chinese Center for Disease Control & Prevention
RP Li, KJ (corresponding author), Peking Univ, Sch Publ Hlth, Dept Food Hyg & Nutr, Beijing, Peoples R China.
EM ying1985love0905@yahoo.com.cn; yyj.jane.1982@163.com; xuli998@gmail.com;
   meguro.shinichi@kao.co.jp; hayashi.satoshi@kao.co.jp;
   katashima.mitsuhiro@kao.co.jp; Yasumasu.Takeshi@kao.co.jp;
   jingzhong.wang@yahoo.com.cn; li.keji@163.com
CR Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Hasegawa N, 2003, PHYTOTHER RES, V17, P477, DOI 10.1002/ptr.1177
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049
   Jingzhong W., 2003, J HYGIENE RES, V32, P386
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Trautwein EA, 2010, EUR J NUTR, V49, P27, DOI 10.1007/s00394-009-0045-7
   WANG H, 2009, OBESITY SILVER SPRIN, V18, P773
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Yoneda T, 2009, METAB SYNDR RELAT D, V7, P349, DOI 10.1089/met.2008.0061
NR 25
TC 43
Z9 46
U1 0
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN
PY 2012
VL 4
IS 1
BP 315
EP 322
DI 10.1016/j.jff.2011.12.010
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 913NN
UT WOS:000301884800036
OA hybrid
DA 2025-04-28
ER

PT J
AU Wang, J
   Engler-Stringer, R
   Muhajarine, N
AF Wang, Jin
   Engler-Stringer, Rachel
   Muhajarine, Nazeem
TI Assessing the Consumer Food Environment in Restaurants by Neighbourhood
   Distress Level across Saskatoon, Saskatchewan
SO CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH
LA English
DT Article
ID NUTRITION INFORMATION; PUBLIC-HEALTH; DEPRIVATION; DISPARITIES; OBESITY;
   ACCESS; INDEX
AB Purpose: To assess the consumer food environment in restaurants in Saskatoon, using the Nutrition Environment Measures Survey for Restaurants (NEMS-R), to examine differences by neighbourhood distress level and to reflect on the need for further refinement of the assessment of restaurant consumer food environments.
   Methods: Neighbourhoods were classified as low, middle, or high distress level based on the socioeconomic indicators (income, employment, and education) in the Material Deprivation Index. Differences in restaurant consumer food environments, indicated by mean NEMS-R total and sub-scores, were examined by various restaurant categories and by varying neighbourhood distress levels.
   Results: Chain coffee shops and pita and sandwich restaurants had higher NEMS-R totals and "Healthy Entrees" sub-scores; however, burger and chicken restaurants and pizza restaurants had more barriers to healthful eating. Although restaurants in lower distress level neighbourhoods generally rated healthier (higher NEMS-R scores), only a few measures (such as "Facilitators" and "Barriers") significantly differed by neighbourhood distress level.
   Conclusions: The findings highlight the importance of developing interventions to improve restaurant consumer food environments, especially in neighbourhoods with higher distress levels. The results suggest that reliable measures of the consumer food environment could be developed beginning with what can be measured by NEMS-R.
C1 [Wang, Jin; Engler-Stringer, Rachel; Muhajarine, Nazeem] Univ Saskatchewan, Coll Med, Dept Community Hlth & Epidemiol, Saskatoon, SK S7N 0W0, Canada.
C3 University of Saskatchewan
RP Wang, J (corresponding author), Univ Saskatchewan, Coll Med, Dept Community Hlth & Epidemiol, Saskatoon, SK S7N 0W0, Canada.
RI Muhajarine, Nazeem/D-7360-2012
FU Canadian Institutes for Health Research [106643]
FX This research was funded by the Canadian Institutes for Health Research
   ( grant #106643).
CR [Anonymous], 2008, Reducing Gaps in Health: A focus on Socioeconomic Status in Urban Canada
   [Anonymous], 2013, MEAS FOOD ENV CAN
   Auchincloss AH, 2013, PUBLIC HEALTH NUTR, V16, P2138, DOI 10.1017/S1368980013000104
   Azagba S, 2012, J PRIM CARE COMMUNIT, V3, P57, DOI 10.1177/2150131911417445
   Bader MDM, 2010, ECON GEOGR, V86, P409, DOI 10.1111/j.1944-8287.2010.01084.x
   Black C, 2014, HEALTH PLACE, V27, P229, DOI 10.1016/j.healthplace.2013.09.015
   Buckeridge DL, 2014, ANN NY ACAD SCI, V1331, P270, DOI 10.1111/nyas.12332
   Burton S, 2006, AM J PUBLIC HEALTH, V96, P1669, DOI 10.2105/AJPH.2004.054973
   Cerin E, 2011, APPETITE, V56, P693, DOI 10.1016/j.appet.2011.02.006
   City of Saskatoon, 2012, CIT SASK NEIGHB PROF
   De Vogli R, 2014, B WORLD HEALTH ORGAN, V92, P99, DOI 10.2471/BLT.13.120287
   Drouin S, 2009, CAN J PUBLIC HEALTH, V100, P361, DOI 10.1007/BF03405271
   Duffey KJ, 2009, J NUTR, V139, P2113, DOI 10.3945/jn.109.109520
   Engler-Stringer R, 2014, CHARACTERIZATION FOO
   Engler-Stringer R, 2014, SPAT SPATIO-TEMPORAL, V11, P23, DOI 10.1016/j.sste.2014.07.001
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Hobin E, 2015, CAN J DIET PRACT RES, V76, P44, DOI 10.3148/cjdpr-2014-026
   Hollands S, 2014, CAN J PUBLIC HEALTH, V105, pE172, DOI 10.17269/cjph.105.4287
   Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267
   Institut national de santei publique du Queibec, 2008, IND CAN DEIF
   Janssen I, 2013, CAN J DIABETES, V37, P90, DOI 10.1016/j.jcjd.2013.02.059
   Jones J, 2009, CAN J PUBLIC HEALTH, V100, P32, DOI 10.1007/BF03405489
   Kershaw T, 2010, FOOD ACCESS SASKATOO
   Krieger JW, 2013, AM J PREV MED, V44, P595, DOI 10.1016/j.amepre.2013.01.031
   Larsen K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-16
   Longacre MR, 2012, AM J PREV MED, V42, P579, DOI 10.1016/j.amepre.2012.02.017
   Lytle LA, 2009, AM J PREV MED, V36, pS134, DOI 10.1016/j.amepre.2009.01.018
   McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012
   Minaker LM, 2009, CAN J PUBLIC HEALTH, V100, P421, DOI 10.1007/BF03404337
   Pampalon R, 2014, CHRON DIS INJ CAN, V34, P12
   Peters E.J., 2008, Canadian Journal of Urban Research, V71, P78
   Rehm CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103543
   Robitaille E, 2010, 1092 I NAT SANT PUBL
   Saelens BE, 2007, AM J PREV MED, V32, P273, DOI 10.1016/j.amepre.2006.12.022
   Saelens BE, 2012, AM J PREV MED, V43, P505, DOI 10.1016/j.amepre.2012.07.025
   Sallis JF, 2009, SOC SCI MED, V68, P1285, DOI 10.1016/j.socscimed.2009.01.017
   Statistics Canada, 2010, CAN HLTH MEAS SURV
   Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
NR 39
TC 5
Z9 7
U1 0
U2 7
PU DIETITIANS CANADA
PI TORONTO
PA 480 UNIV AVE, SUITE 604, TORONTO, ONTARIO M5G 1V2, CANADA
SN 1486-3847
EI 2292-9592
J9 CAN J DIET PRACT RES
JI Can. J. Diet. Pract. Res.
PD MAR
PY 2016
VL 77
IS 1
BP 9
EP 16
DI 10.3148/cjdpr-2015-031
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA DN0QI
UT WOS:000376768100004
PM 26450080
DA 2025-04-28
ER

PT J
AU Shen, Y
   Xiao, XJ
   Wu, KL
   Wang, YP
   Yuan, YJ
   Liu, JW
   Sun, SM
   Liu, J
AF Shen, Yu
   Xiao, Xiaojuan
   Wu, Kunlu
   Wang, Yanpeng
   Yuan, Yijun
   Liu, Jianwei
   Sun, Shuming
   Liu, Jing
TI Effects and molecular mechanisms of Ninghong black tea extract in
   nonalcoholic fatty liver disease of rats
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE microsomal triglyceride transfer protein; Ninghong black tea;
   nonalcoholic fatty liver disease; peroxisome proliferator-activated
   receptor alpha
ID PU-ERH TEA; TRIGLYCERIDE TRANSFER PROTEIN; GREEN TEA; CAFFEINE
   CONSUMPTION; INFLAMMATORY RESPONSES; INSULIN-RESISTANCE; HEPATIC
   STEATOSIS; STEATOHEPATITIS; METABOLISM; OBESE
AB The aim of this study is to observe the effects of Ninghong black tea extract on fat deposition and high-fat diet-induced nonalcoholic fatty liver disease (NAFLD) and to explore the potential mechanisms of these effect. Under 2% Ninghong black tea extract diet feeding in rat model, the results showed that Ninghong black tea extract decreased the body fat ratio and the number of lipid droplets in the liver and significantly alleviated NAFLD in the rat model. The real-time fluorescence quantitative polymerase chain reaction results showed that Ninghong black tea extract significantly upregulated the expression of peroxisome proliferator-activated receptor alpha (PPAR alpha), which is important in fatty acid beta-oxidation, and microsomal triglyceride transfer protein (MTP), which plays an important role in the synthesis of very low density lipoprotein (VLDL). By promoting the expression of PPAR alpha and MTP in liver tissue and thereby promoting fatty acid beta-oxidation and VLDL synthesis, Ninghong black tea extract relieves high-fat diet-induced NAFLD.
C1 [Shen, Yu; Xiao, Xiaojuan; Wu, Kunlu; Wang, Yanpeng; Yuan, Yijun; Liu, Jianwei; Sun, Shuming; Liu, Jing] Cent South Univ, Mol Biol Res Ctr, Sch Life Sci, Changsha 410078, Peoples R China.
C3 Central South University
RP Sun, SM; Liu, J (corresponding author), Cent South Univ, Mol Biol Res Ctr, Sch Life Sci, Changsha 410078, Peoples R China.
EM sunshuming203@163.com; jingliucsu@hotmail.com
FU Jiangxi Zhenxian Tea Industry Co., Ltd., Jiangxi, China
   [H201610130250001]; Science and Technology Program of Hunan Province of
   China [2013NK3127]
FX This work was supported by grants from Jiangxi Zhenxian Tea Industry
   Co., Ltd., Jiangxi, China (H201610130250001) and the Science and
   Technology Program of Hunan Province of China (2013NK3127).
CR Birerdinc A, 2012, ALIMENT PHARM THER, V35, P76, DOI 10.1111/j.1365-2036.2011.04916.x
   Bruno RS, 2008, J NUTR, V138, P323, DOI 10.1093/jn/138.2.323
   Cai XB, 2016, J GASTROENTEROL, V51, P819, DOI 10.1007/s00535-015-1154-0
   Chen C, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700483
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Chung MY, 2012, J NUTR BIOCHEM, V23, P361, DOI 10.1016/j.jnutbio.2011.01.001
   Ehara T, 2015, DIABETES, V64, P775, DOI 10.2337/db14-0158
   Fiorini R. N., 2005, J GASTROINTESTINAL S, V9, P536
   Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200
   Foster MT, 2016, MOL NUTR FOOD RES, V60, P1213, DOI 10.1002/mnfr.201500654
   Gan L, 2015, ACTA PHARMACOL SIN, V36, P597, DOI 10.1038/aps.2015.11
   [高斌 Gao Bin], 2010, [营养学报, Acta Nutrimenta Sinica], V32, P362
   Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059
   GIBBONS GF, 1990, BIOCHEM J, V268, P1
   Gong JS, 2010, J FOOD SCI, V75, pH182, DOI 10.1111/j.1750-3841.2010.01675.x
   Grygiel-Górniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Hu WY, 2017, FOOD FUNCT, V8, P1105, DOI 10.1039/c6fo01591c
   Hussain M, 2017, PAK J MED SCI, V33, P931, DOI 10.12669/pjms.334.12571
   Jung Y, 2019, FOOD SCI BIOTECHNOL, V28, P261, DOI 10.1007/s10068-018-0433-y
   Kochi T, 2014, CANCER LETT, V342, P60, DOI 10.1016/j.canlet.2013.08.031
   Lee C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092369
   Li JH, 2016, MOL NUTR FOOD RES, V60, P858, DOI 10.1002/mnfr.201500814
   Liu ZH, 2015, ELECTROPHORESIS, V36, P2002, DOI 10.1002/elps.201500076
   Luo XY, 2012, BIOCHEM BIOPH RES CO, V417, P287, DOI 10.1016/j.bbrc.2011.11.102
   Mansour-Ghanaei F, 2018, PHYTOTHER RES, V32, P1876, DOI 10.1002/ptr.6130
   Masterjohn C, 2012, NUTR REV, V70, P41, DOI 10.1111/j.1753-4887.2011.00440.x
   Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279
   Molloy JW, 2012, HEPATOLOGY, V55, P429, DOI 10.1002/hep.24731
   Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001
   Neyrinck AM, 2017, J NUTR BIOCHEM, V49, P15, DOI 10.1016/j.jnutbio.2017.07.008
   Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8
   Park HJ, 2012, J NUTR, V142, P57, DOI 10.3945/jn.111.148544
   Park HJ, 2011, J NUTR BIOCHEM, V22, P393, DOI 10.1016/j.jnutbio.2010.03.009
   Pezeshki A, 2016, INT J PREVENTIVE MED, V7, DOI 10.4103/2008-7802.173051
   Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576
   Rutledge AC, 2010, BIOCHEM CELL BIOL, V88, P251, DOI [10.1139/O09-168, 10.1139/o09-168]
   Santamarina AB, 2015, J NUTR BIOCHEM, V26, P1348, DOI 10.1016/j.jnutbio.2015.07.002
   Shen Huafeng, 2016, Therap Adv Gastroenterol, V9, P113, DOI 10.1177/1756283X15593700
   Tan Y, 2017, WORLD J GASTROENTERO, V23, P3805, DOI 10.3748/wjg.v23.i21.3805
   Wang QiuPing Wang QiuPing, 2012, Journal of Tea Science, V32, P87
   Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793
   Wu T, 2016, FOOD FUNCT, V7, P2469, DOI 10.1039/c6fo00401f
   Yan H., 2009, J CHINESE I FOOD SCI, V9, P80
   Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013
   YOSHINO K, 1994, BIOL PHARM BULL, V17, P146, DOI 10.1248/bpb.17.146
   Yuan HuaBing Yuan HuaBing, 2009, Acta Nutrimenta Sinica, V31, P167
   Yuan RS, 2011, ACS CATAL, V1, P200, DOI 10.1021/cs100122v
   Zeng L, 2015, FOOD FUNCT, V6, P2008, DOI 10.1039/c5fo00362h
   Zhang L, 2019, FOOD RES INT, V125, DOI 10.1016/j.foodres.2019.108516
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/c5fo00247h, 10.1039/C5FO00247H]
   Zhou J, 2019, J AGR FOOD CHEM, V67, P5306, DOI 10.1021/acs.jafc.8b05032
   Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649
   Zhou YJ, 2016, RSC ADV, V6, P40010, DOI 10.1039/c6ra04150g
NR 54
TC 10
Z9 12
U1 0
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD MAR
PY 2020
VL 85
IS 3
BP 800
EP 807
DI 10.1111/1750-3841.14846
EA FEB 2020
PG 8
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA KT9MT
UT WOS:000515108100001
PM 32090345
DA 2025-04-28
ER

PT J
AU He, YF
   Liu, FY
   Zhang, WX
AF He, Y. F.
   Liu, F. Y.
   Zhang, W. X.
TI Tangeritin inhibits adipogenesis by down-regulating C/EBPα, C/EBPβ, and
   PPARγ expression in 3T3-L1 fat cells
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE Tangeritin; 3T3-L1; C/EBP alpha; C/EBP beta; PPAR gamma; Adipogenesis
ID NF-KAPPA-B; INDUCED INFLAMMATION; DIFFERENTIATION; PHOSPHORYLATION;
   ADIPOCYTES; ACTIVATION; PROMOTER; COFFEE; NRF2; MICE
AB The treatment of obese patients is a topic investigated by an increasing number of researchers. This study aimed to elucidate the possible inhibitory effect of tangeritin on the development and function of fat cells. 3T3-L1 fat cells were grown to confluence and subjected to different concentrations of tangeritin. The most effective tangeritin inhibition concentration was determined by the MTT assay. The treated cells were subjected to real-time reverse transcriptase FOR and western blot analysis, to detect changes in the CCAAT/enhancer binding protein (C/EBP)a, C/EBPI3, and peroxisome proliferator activated receptor (PPAR) y expression levels. The MTT assay revealed that the fat cell growth was inhibited at a 20 ng/mL concentration of tangeritin. The results of realtime FOR revealed a significant decrease in the expression of C/EBP alpha, C/ EBP beta, and PPAR gamma mRNA, following the treatment with tangeritin. Western blot analysis also presented similar results at a protein level. Therefore, we concluded that tangeritin inhibits adipogenesis via the down-regulation of C/EBP alpha, C/EBP beta, and PPAR gamma mRNA and protein expression in 3T3-L1 cells.
C1 [He, Y. F.; Liu, F. Y.; Zhang, W. X.] Cent Hosp Xinxiang City, Dept Pediat 1, Xinxiang, Henan, Peoples R China.
RP Zhang, WX (corresponding author), Cent Hosp Xinxiang City, Dept Pediat 1, Xinxiang, Henan, Peoples R China.
EM weixingty@126.com
CR Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3
   Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077
   Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198
   Esteves CL, 2014, J CLIN ENDOCR METAB, V99, pE160, DOI 10.1210/jc.2013-1708
   Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014
   Harmon AW, 2002, BIOCHEM J, V367, P203, DOI 10.1042/BJ20020300
   Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010
   Huang JQ, 2012, J PHARM PHARMACOL, V64, P1119, DOI 10.1111/j.2042-7158.2012.01504.x
   Kim EK, 2012, J CELL PHYSIOL, V227, P1680, DOI 10.1002/jcp.22892
   Maier PJ, 2014, J BIOL CHEM, V289, P12896, DOI 10.1074/jbc.M114.550517
   Paur I, 2010, CANCER PREV RES, V3, P653, DOI 10.1158/1940-6207.CAPR-09-0089
   Paur I, 2010, FREE RADICAL BIO MED, V48, P1218, DOI 10.1016/j.freeradbiomed.2010.02.005
   Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613
   Rosati M, 2001, J IMMUNOL, V167, P1654, DOI 10.4049/jimmunol.167.3.1654
   Staikos C, 2013, RHEUMATOLOGY, V52, P1077, DOI 10.1093/rheumatology/kes422
   WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370
   White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023
   Yang MH, 2014, J ENZYM INHIB MED CH, V29, P1, DOI 10.3109/14756366.2012.742517
   Yasmeen R, 2012, BBA-MOL CELL BIOL L, V1821, P190, DOI 10.1016/j.bbalip.2011.06.004
   Zhan LJ, 2012, FREE RADICAL BIO MED, V53, P758, DOI 10.1016/j.freeradbiomed.2012.05.041
   Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200
NR 21
TC 14
Z9 22
U1 0
U2 15
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000,
   BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2015
VL 14
IS 4
BP 13642
EP 13648
DI 10.4238/2015.October.28.26
PG 7
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CV9BJ
UT WOS:000364582000062
PM 26535679
OA Bronze
DA 2025-04-28
ER

PT J
AU Nasir, NF
   Mohamad, NE
   Alitheen, NB
AF Nasir, Nurul Farhana
   Mohamad, Nurul Elyani
   Alitheen, Noorjahan Banu
TI Fermented Black Tea and Its Relationship with Gut Microbiota and
   Obesity: A Mini Review
SO FERMENTATION-BASEL
LA English
DT Review
DE fermentation; fermented black tea; gut microbiota; obesity
ID HEALTH-BENEFITS; OXIDATIVE STRESS; BACILLUS-SUBTILIS; KOMBUCHA;
   ANTIOXIDANT; CAFFEINE; BACTERIA; ACID; FOOD; CONSUMPTION
AB Fermentation is one of the world's oldest techniques for food preservation, nutrient enhancement, and alcohol manufacturing. During fermentation, carbohydrates such as glucose and starch are converted into other molecules, such as alcohol and acid, anaerobically through enzymatic action while generating energy for the microorganism or cells involved. Black tea is among the most popular fermented beverages; it is made from the dried tea leaves of the evergreen shrub plant known as Camellia sinensis. The adequate consumption of black tea is beneficial to health as it contains high levels of flavanols, also known as catechins, which act as effective antioxidants and are responsible for protecting the body against the development of illnesses, such as inflammation, diabetes, hypertension, cancer, and obesity. The prevalence of obesity is a severe public health concern associated with the incidence of various serious diseases and is now increasing, including in Malaysia. Advances in 'omic' research have allowed researchers to identify the pivotal role of the gut microbiota in the development of obesity. This review explores fermented black tea and its correlation with the regulation of the gut microbiota and obesity.
C1 [Nasir, Nurul Farhana; Mohamad, Nurul Elyani] Univ Malaysia Sabah, Biotechnol Res Inst, Kota Kinabalu 88400, Sabah, Malaysia.
   [Alitheen, Noorjahan Banu] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang 43400, Selangor, Malaysia.
C3 Universiti Malaysia Sabah; Universiti Putra Malaysia
RP Mohamad, NE (corresponding author), Univ Malaysia Sabah, Biotechnol Res Inst, Kota Kinabalu 88400, Sabah, Malaysia.
EM elyani.mohamad@ums.edu.my
RI Alitheen, Noorjahan/AAL-3713-2020; Mohamad, Nurul/AAK-5307-2020
OI Nasir, Nurul Farhana/0000-0001-7002-1892; Alitheen, Noorjahan
   Banu/0000-0003-1966-8580; Mohamad, Nurul Elyani/0000-0003-3461-8602
FU Universiti Malaysia Sabah (UMS) through Skim Pensyarah Lantikan Baru
   grant [SLB2116]
FX This research was supported by Universiti Malaysia Sabah (UMS) through
   Skim Pensyarah Lantikan Baru (SLB2116) grant.
CR Abaci N, 2022, FOOD CHEM X, V14, DOI 10.1016/j.fochx.2022.100302
   Abdullah Z, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-021-12480-3
   Adebiyi JA, 2017, FOOD CHEM, V232, P210, DOI 10.1016/j.foodchem.2017.04.020
   Agostoni C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4102
   Ahmed RF, 2020, ANN AGR SCI-CAIRO, V65, P35, DOI 10.1016/j.aoas.2020.04.001
   Ahmed SMU, 2017, BBA-MOL BASIS DIS, V1863, P585, DOI 10.1016/j.bbadis.2016.11.005
   Al-Mohammadi AR, 2021, MOLECULES, V26, DOI 10.3390/molecules26165026
   Calderón-Ospina CA, 2020, CNS NEUROSCI THER, V26, P5, DOI 10.1111/cns.13207
   Alstadhaug KB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01275
   Anagnostopoulos DA, 2019, INNOVATIONS IN TRADITIONAL FOODS, P257, DOI 10.1016/B978-0-12-814887-7.00010-1
   Anal AK, 2019, FERMENTATION-BASEL, V5, DOI 10.3390/fermentation5010008
   Aoun Antoine, 2020, Prev Nutr Food Sci, V25, P113, DOI 10.3746/pnf.2020.25.2.113
   Ashaolu TJ, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8081176
   Assohoun M. C. N., 2013, Food and Nutrition Sciences, V4, P1120, DOI 10.4236/fns.2013.411146
   Badwaik LS, 2014, FOOD SCI TECHNOL RES, V20, P255, DOI 10.3136/fstr.20.255
   Bauer-Petrovska B, 2000, INT J FOOD SCI TECH, V35, P201, DOI 10.1046/j.1365-2621.2000.00342.x
   Bäumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849
   Beresniak A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000648
   Besky S, 2020, SOC STUD SCI, V50, P398, DOI 10.1177/0306312720915780
   Bhattacharya D, 2016, CURR MICROBIOL, V73, P885, DOI 10.1007/s00284-016-1136-3
   Binda C, 2018, DIGEST LIVER DIS, V50, P421, DOI 10.1016/j.dld.2018.02.012
   Bule M, 2020, RECENT ADVANCES IN NATURAL PRODUCTS ANALYSIS, P132
   Chilton SN, 2015, NUTRIENTS, V7, P390, DOI 10.3390/nu7010390
   Choi J, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040953
   Chupeerach C, 2021, FOODS, V10, DOI 10.3390/foods10010117
   Copetti MV, 2019, CURR OPIN FOOD SCI, V25, P57, DOI 10.1016/j.cofs.2019.02.014
   Costa MAD, 2023, CRIT REV FOOD SCI, V63, P3851, DOI 10.1080/10408398.2021.1995321
   Coelho RMD, 2020, INT J GASTRON FOOD S, V22, DOI 10.1016/j.ijgfs.2020.100272
   de Miranda JF, 2022, J FOOD SCI, V87, P503, DOI 10.1111/1750-3841.16029
   de Noronha MC, 2022, FOOD CHEM, V384, DOI 10.1016/j.foodchem.2022.132515
   del Castillo MD, 2019, COFFEE: CONSUMPTION AND HEALTH IMPLICATIONS, P20
   DePaula J, 2019, BEVERAGES, V5, DOI 10.3390/beverages5020037
   Devi PB, 2021, LWT-FOOD SCI TECHNOL, V149, DOI 10.1016/j.lwt.2021.111818
   Devi SM, 2018, J FUNCT FOODS, V47, P19, DOI 10.1016/j.jff.2018.05.036
   Di Cesare M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1449-8
   Dimidi E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081806
   Dufresne C, 2000, FOOD RES INT, V33, P409, DOI 10.1016/S0963-9969(00)00067-3
   Dwiputri Maria Christiani, 2019, Journal of Physics: Conference Series, V1241, DOI 10.1088/1742-6596/1241/1/012014
   Ellermann C, 2022, J CARDIOVASC ELECTR, V33, P1290, DOI 10.1111/jce.15458
   Engwa G.A., 2018, Phytochemicals: Source of Antioxidants and Role in Disease Prevention, P49, DOI DOI 10.5772/INTECHOPEN.76719
   Estrada M.A.R., 2019, SSRN ELECT J, DOI [10.2139/ssrn.3455108, DOI 10.2139/SSRN.3455108]
   Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192
   Fredholm Bertil B., 2003, Neurology, V61, pS5
   Fried NT, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7030030
   Gan RY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111682
   Gargi S., 2020, Arch Food Nutr Sci,, V4, P001, DOI [10.29328/journal.afns.1001020, DOI 10.29328/JOURNAL.AFNS.1001020]
   Gasbarrini G, 2016, J CLIN GASTROENTEROL, V50, pS116, DOI 10.1097/MCG.0000000000000697
   Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378
   Gentile CL, 2018, SCIENCE, V362, P776, DOI 10.1126/science.aau5812
   Giri SS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00473
   Giuberti G, 2020, CURR OPIN FOOD SCI, V31, P102, DOI 10.1016/j.cofs.2020.04.003
   Goh W. N., 2012, International Food Research Journal, V19, P109
   Gomaa EZ, 2020, ANTON LEEUW INT J G, V113, P2019, DOI 10.1007/s10482-020-01474-7
   Guo JD, 2018, INT J MOL MED, V41, P1817, DOI 10.3892/ijmm.2018.3406
   Haile M, 2019, FERMENTATION-BASEL, V5, DOI 10.3390/fermentation5010029
   Harrison K, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9051060
   He HF, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1344521
   Jaenicke L, 2007, ANGEW CHEM INT EDIT, V46, P6776, DOI 10.1002/anie.200700390
   Jakubczyk Karolina, 2020, Pol Merkur Lekarski, V48, P124
   Jayabalan R, 2007, FOOD CHEM, V102, P392, DOI 10.1016/j.foodchem.2006.05.032
   Jayabalan R, 2017, REF SER PHYTOCHEM, DOI 10.1007/978-3-319-19456-1_12-1
   Jayabalan R, 2014, COMPR REV FOOD SCI F, V13, P538, DOI 10.1111/1541-4337.12073
   Jee HJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103080
   Jhoo JW, 2005, J AGR FOOD CHEM, V53, P6146, DOI 10.1021/jf050662d
   John GK, 2016, CURR ONCOL REP, V18, DOI 10.1007/s11912-016-0528-7
   Jung Y, 2019, FOOD SCI BIOTECHNOL, V28, P261, DOI 10.1007/s10068-018-0433-y
   Kaewkod T, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120700
   Kaleem M, 2018, THERAPEUTIC, PROBIOTIC, AND UNCONVENTIONAL FOODS, P137, DOI 10.1016/B978-0-12-814625-5.00008-X
   Karademir E, 2019, QUAL ASSUR SAF CROP, V11, P127, DOI 10.3920/QAS2018.1389
   Kasron N., 2021, MALAYSIAN J SOC SCI, V6, P306, DOI [10.47405/mjssh.v6i11.1163, DOI 10.47405/MJSSH.V6I11.1163]
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Kharaba Z, 2022, J NUTR METAB, V2022, DOI 10.1155/2022/5762299
   Koch W., 2020, Handbook of dietary phytochemicals, V1, P975
   Koech K.R., 2013, POLYPHENOLS, DOI [10.13140/2.1.1274.6241, DOI 10.13140/2.1.1274.6241]
   Kumar V., 2016, International Journal of Food and Fermentation Technology, V6, P13, DOI [DOI 10.5958/2277-9396.2016.00022.2, 10.5958/2277-9396.2016.00022, DOI 10.5958/2277-9396.2016.00022]
   Kyrou I., 2018, Clinical Problems Caused by Obesity, in Endotext Internet
   La Sala L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218178
   Laureys D, 2020, J AM SOC BREW CHEM, V78, P165, DOI 10.1080/03610470.2020.1734150
   Lazarus M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00740
   Lee C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092369
   Lee KR, 2022, FOOD SCI TECH-BRAZIL, V42, DOI 10.1590/fst.70020
   Li C, 2014, FOOD FUNCT, V5, P3216, DOI 10.1039/c4fo00549j
   Li SL, 2020, LWT-FOOD SCI TECHNOL, V125, DOI 10.1016/j.lwt.2020.109264
   Li SL, 2018, J CEREAL SCI, V84, P83, DOI 10.1016/j.jcs.2018.10.008
   Li Y, 2016, J APPL MICROBIOL, V120, P195, DOI 10.1111/jam.12972
   Li ZY, 2021, BIOMED PHARMACOTHER, V134, DOI 10.1016/j.biopha.2020.111097
   Lieberman HR, 2020, MAYO CLIN PROC, V95, P1562, DOI 10.1016/j.mayocp.2020.06.032
   Liu WJ, 2019, J FOOD PROCESS PRES, V43, DOI 10.1111/jfpp.14022
   Liu ZB, 2018, J AGR FOOD CHEM, V66, P8469, DOI 10.1021/acs.jafc.8b02233
   Loos RJF, 2022, NAT REV GENET, V23, P120, DOI 10.1038/s41576-021-00414-z
   Lu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18955
   Lukic J, 2017, WOUND REPAIR REGEN, V25, P912, DOI 10.1111/wrr.12607
   Lynch KM, 2019, COMPR REV FOOD SCI F, V18, P587, DOI 10.1111/1541-4337.12440
   Galdeano CM, 2019, ANN NUTR METAB, V74, P115, DOI 10.1159/000496426
   Manalo RVM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00137
   Mani A., 2018, International Journal of Academic Research Development, V1, P51
   Marco ML, 2017, CURR OPIN BIOTECH, V44, P94, DOI 10.1016/j.copbio.2016.11.010
   Marsh AJ, 2014, FOOD MICROBIOL, V38, P171, DOI 10.1016/j.fm.2013.09.003
   Leal JM, 2018, CYTA-J FOOD, V16, P390, DOI 10.1080/19476337.2017.1410499
   Maruvada P, 2020, AM J CLIN NUTR, V112, P1390, DOI 10.1093/ajcn/nqaa259
   Mataragas M, 2018, FOOD MICROBIOL, V76, P279, DOI 10.1016/j.fm.2018.05.009
   Matijasic M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082668
   McGovern P, 2017, P NATL ACAD SCI USA, V114, pE10309, DOI 10.1073/pnas.1714728114
   McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102
   McNulty H, 2019, P NUTR SOC, V78, P449, DOI [10.1017/S0029665119000661, 10.1017/s0029665119000661]
   Mo HZ, 2013, FOOD CHEM, V141, P2418, DOI 10.1016/j.foodchem.2013.05.017
   Mohd-Sidik S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030868
   Mousavi SM, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/4397543
   Narzary Yutika, 2016, Journal of Ethnic Foods, V3, P284
   Neffe-Skocinska K, 2017, CYTA-J FOOD, V15, P601, DOI 10.1080/19476337.2017.1321588
   Nimse SB, 2015, RSC ADV, V5, P27986, DOI 10.1039/c4ra13315c
   Nowaczewska M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082259
   Nwokoro O, 2012, REV CHIL NUTR, V39, P180
   Nyhan L. M., 2022, Applied Microbiology, 2673-8007, V2, P73, DOI 10.3390/applmicrobiol2010005
   Okubo H, 2018, CURR MED CHEM, V25, P984, DOI 10.2174/0929867324666171009121702
   Osman MA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00767
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Park J, 2022, NUTRIENTS, V14, DOI 10.3390/nu14102078
   Park KY, 2014, J MED FOOD, V17, P6, DOI 10.1089/jmf.2013.3083
   Park S, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0204-7
   Pasha C, 2005, FOOD CHEM, V89, P449, DOI 10.1016/j.foodchem.2004.02.054
   Patel Naveen, 2019, Recent Pat Biotechnol, V13, P45, DOI 10.2174/1872208312666181029093333
   Phetxumphou K, 2023, J AM SOC BREW CHEM, V81, P99, DOI 10.1080/03610470.2021.2022879
   Plasek B, 2019, APPETITE, V143, DOI 10.1016/j.appet.2019.104398
   Pou K. R. Jolvis, 2016, Journal of Biosystems Engineering, V41, P85
   Pranoto Y., 2013, Food Biosci., V2, P46, DOI [DOI 10.1016/J.FBIO.2013.04.001, 10.1016/j.fbio.2013.04.001]
   Pretorius IS, 2005, AUST J GRAPE WINE R, V11, P83, DOI 10.1111/j.1755-0238.2005.tb00281.x
   Prior R.L, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI [10.1016/J.PBI.2005.03.005, DOI 10.1016/J.PBI.2005.03.005]
   Rahmawati IS, 2016, PROCEDIA CHEM, V18, P53, DOI 10.1016/j.proche.2016.01.010
   Rai P., 2014, Polyphenols in human health and disease, P715, DOI [10.1016/B978-0-12-398456-2.00055-4, DOI 10.1016/B978-0-12-398456-2.00055-4]
   Rasheed Z, 2019, INT J HEALTH SCI-IJH, V13, P1
   Reilly JJ, 2018, LANCET, V391, P1773, DOI 10.1016/S0140-6736(18)30794-3
   Richards G, 2015, J PSYCHOPHARMACOL, V29, P1236, DOI 10.1177/0269881115612404
   Rohimah Azizah, 2021, Polish Journal of Natural Sciences, V36, P59
   Rubio-Almanza M, 2019, ENDOCRINOL DIAB NUTR, V66, P140, DOI 10.1016/j.endinu.2018.08.003
   Ryu JA, 2021, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.620478
   Samaha A, 2020, DATA BRIEF, V28, DOI 10.1016/j.dib.2019.104845
   Santosh O., 2021, J. Pharmacogn. Phytochem, V10, P330
   Sarkar S, 2019, NUTR FOOD SCI, V49, P182, DOI [10.1108/NFS-05-2018-0139, 10.1108/nfs-05-2018-0139]
   Shan ZG, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6256618
   Sharma N, 2020, J SCI FOOD AGR, V100, P3126, DOI 10.1002/jsfa.10347
   Sharma R, 2020, FERMENTATION-BASEL, V6, DOI 10.3390/fermentation6040106
   Sharma V, 2009, CRIT REV FOOD SCI, V49, P379, DOI 10.1080/10408390802068066
   Shen N, 2022, FOOD CHEM, V383, DOI 10.1016/j.foodchem.2022.132531
   Shivashankara A.R., 2019, Dietary interventions in liver disease, P183, DOI DOI 10.1016/B978-0-12-814466-4.00015-X
   Silva SI, 2012, ACTA ALIMENT HUNG, V41, P443, DOI 10.1556/AAlim.41.2012.4.6
   Singla RK, 2019, J AOAC INT, V102, P1397, DOI [10.1093/jaoac/102.5.1397, 10.5740/jaoacint.19-0133]
   Sinir G.O., 2019, Fermented Beverages str, P401, DOI [10.1016/B978-0-12-815271-3.00010-5, DOI 10.1016/B978-0-12-815271-3.00010-5, 10.1016/b978-0-12-815271-3.00010-5]
   Song Hong Ji, 2014, Journal of Ethnic Foods, V1, P8
   Stodt UW, 2014, J AGR FOOD CHEM, V62, P7854, DOI 10.1021/jf501591j
   Stojanov S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111715
   Suwannasom N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030950
   Swain Manas Ranjan, 2014, Biotechnol Res Int, V2014, P250424, DOI 10.1155/2014/250424
   Tamang JP, 2020, COMPR REV FOOD SCI F, V19, P184, DOI 10.1111/1541-4337.12520
   Tan PL, 2021, PROBIOTIC BEVERAGES, P175, DOI [DOI 10.1016/B978-0-12-818588-9.00002-4, DOI 10.1016/B978-0-12-818588-9.00008-5]
   Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715
   Teng D, 2012, BIOCATAL AGR BIOTECH, V1, P32, DOI 10.1016/j.bcab.2011.08.005
   Teoh AL, 2004, INT J FOOD MICROBIOL, V95, P119, DOI 10.1016/j.ijfoodmicro.2003.12.020
   The Academy of Medical Sciences, 2017, ADDR GLOB HLTH CHALL
   Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510
   Tran T, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.836617
   Tran T, 2020, FOODS, V9, DOI 10.3390/foods9070963
   Tran T, 2020, COMPR REV FOOD SCI F, V19, P2050, DOI 10.1111/1541-4337.12574
   Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0
   Ullah A, 2020, MOLECULES, V25, DOI 10.3390/molecules25225243
   Unban K, 2019, J FOOD SCI TECH MYS, V56, P2687, DOI 10.1007/s13197-019-03758-x
   Vieira CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139910
   Villarreal-Soto SA, 2018, J FOOD SCI, V83, P580, DOI 10.1111/1750-3841.14068
   Vohra BM, 2019, MALAYS J FUNDAM APPL, V15, P298
   Volkow ND, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.46
   Wan MLY, 2019, CRIT REV FOOD SCI, V59, P1927, DOI 10.1080/10408398.2018.1433629
   Wang Ni., 2011, Asian Culture and History, V3, P13, DOI [10.5539/ach.v3n2p13, DOI 10.5539/ACH.V3N2P13, https://doi.org/10.5539/ach.v3n2p13]
   Wang TY, 2018, ASIAN J PHARM SCI, V13, P12, DOI 10.1016/j.ajps.2017.08.004
   Watson EJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080479
   Wilkins LJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49452-y
   Willson C, 2018, TOXICOL REP, V5, P1140, DOI 10.1016/j.toxrep.2018.11.002
   Wong CB, 2019, J FUNCT FOODS, V54, P506, DOI 10.1016/j.jff.2019.02.002
   Woting A, 2014, MBIO, V5, DOI 10.1128/mBio.01530-14
   Yale Global Online, US
   Yang JP, 2022, NUTRIENTS, V14, DOI 10.3390/nu14030670
   Zhang L, 2019, COMPR REV FOOD SCI F, V18, P1474, DOI 10.1111/1541-4337.12479
   Zhang LF, 2022, TRANSPORTMETRICA B, V10, P1206, DOI 10.1080/21680566.2022.2034550
   Zhang YD, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18030077
   Zhao CR, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.704893
   Zou C, 2021, FOOD CHEM, V363, DOI 10.1016/j.foodchem.2021.130322
   Zubaidah E, 2019, BIOCATAL AGR BIOTECH, V17, P465, DOI 10.1016/j.bcab.2018.12.026
NR 186
TC 3
Z9 3
U1 1
U2 44
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2311-5637
J9 FERMENTATION-BASEL
JI FERMENTATION
PD NOV
PY 2022
VL 8
IS 11
AR 603
DI 10.3390/fermentation8110603
PG 16
WC Biotechnology & Applied Microbiology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 6B4FX
UT WOS:000881291800001
OA gold
DA 2025-04-28
ER

PT J
AU Mayén, AL
   Stringhini, S
   Ford, ND
   Martorell, R
   Stein, AD
   Paccaud, F
   Marques-Vidal, P
AF Mayen, Ana-Lucia
   Stringhini, Silvia
   Ford, Nicole D.
   Martorell, Reynaldo
   Stein, Aryeh D.
   Paccaud, Fred
   Marques-Vidal, Pedro
TI Socioeconomic predictors of dietary patterns among Guatemalan adults
SO INTERNATIONAL JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Socioeconomic; Diet patterns; Guatemala; Expenditures
ID NUTRITION TRANSITION; INCOME; ASSOCIATIONS; REDUCTION; ADHERENCE;
   EDUCATION; OBESITY; FOODS; WOMEN
AB We aimed to assess the associations of socioeconomic factors with dietary patterns in a Guatemalan population.
   Cross-sectional data of 1076 participants (42 % men, mean age 32.6 +/- A 4.2 years) collected between 2002 and 2004 in four rural villages in Guatemala. Dietary patterns were derived using principal component analysis. Chi-square and Poisson regression models were used to assess associations between socioeconomic factors and dietary patterns.
   Three dietary patterns were identified: "Western" (high in processed foods), "traditional" (high in traditional foods) and "coffee and sugar", explaining 11, 7 and 6 % of the variance, respectively. Annual expenditures were associated with a higher adherence to the "Western" pattern: prevalence ratios [(PR) (95 % confidence interval)] 1.92 (1.17-3.15) for the highest vs. lowest expenditure group in men and 8.99 (3.57-22.64) in women. A borderline significant (p = 0.06) negative association was found between the "traditional" pattern and higher household expenditures [0.71 (0.49-1.02) in men] and with schooling [0.23 (0.05-1.02)] in women (p = 0.05).
   Dietary patterns in Guatemala are predicted by socioeconomic factors. In particular, high annual expenditures are associated with a more westernized, less traditional diet.
C1 [Mayen, Ana-Lucia; Stringhini, Silvia; Paccaud, Fred] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.
   [Ford, Nicole D.] Emory Univ, Laney Grad Sch, Nutr & Hlth Sci, Atlanta, GA 30322 USA.
   [Martorell, Reynaldo; Stein, Aryeh D.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.
   [Marques-Vidal, Pedro] Univ Lausanne Hosp, Dept Med, Internal Med, Lausanne, Switzerland.
C3 University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV);
   Emory University; Emory University; Rollins School Public Health;
   University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)
RP Marques-Vidal, P (corresponding author), Univ Lausanne Hosp, Dept Med, Internal Med, Lausanne, Switzerland.
EM Ana-Lucia.Mayen-Chacon@chuv.ch; Silvia.Stringhini@chuv.ch;
   ndionne@emory.edu; rmart77@emory.edu; aryeh.stein@emory.edu;
   Fred.Paccaud@chuv.ch; Pedro-Manuel.Marques-Vidal@chuv.ch
RI Mayen, Ana/R-6521-2017; Stein, Airton/E-3333-2010; Martorell,
   Reynaldo/I-2539-2012; Stringhini, Silvia/B-4899-2013; paccaud,
   fred/M-7516-2019; Marques-Vidal, Pedro/C-9449-2009; Mayen,
   Ana-Lucia/K-1387-2013
OI Martorell, Reynaldo/0000-0001-8862-7243; Marques-Vidal,
   Pedro/0000-0002-4548-8500; Stein, Aryeh/0000-0003-1138-6458; Ford,
   Nicole/0000-0002-6463-5094; Mayen, Ana-Lucia/0000-0001-9635-0416;
   Stringhini, Silvia/0000-0002-4387-8943
FU US National Institutes of Health [R01 TW-05598]; Swiss Excellence
   Government scholarship; Swiss National Science Foundation (SNSF)
   [PZ00P3_147998]
FX Data were collected using funding provided by the US National Institutes
   of Health (R01 TW-05598: PI Martorell). Ana-Lucia Mayen-Chacon is a
   recipient of a Swiss Excellence Government scholarship. Silvia
   Stringhini is supported by an Ambizione Grant (No. PZ00P3_147998) from
   the Swiss National Science Foundation (SNSF). Funders had no role in the
   design, analysis or writing of this article.
CR Araujo MC, 2014, PUBLIC HEALTH NUTR, V17, P2740, DOI 10.1017/S1368980013003005
   Barquera S, 2013, OBES REV, V14, P69, DOI 10.1111/obr.12096
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Blouin C, 2009, LANCET, V373, P502, DOI 10.1016/S0140-6736(08)61777-8
   Campos-Ortiz F., 2013, Study on the Competitiveness of the Mexican Sugar Industry
   Cardoso I, 2013, EUR J CLIN NUTR, V67, P135, DOI 10.1038/ejcn.2012.199
   Central Bank of Guatemala, 2014, CENTR BANK GUAT MONT
   Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107
   Dekker LH, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.26317
   Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0
   Fernández-Alvira JM, 2014, EUR J CLIN NUTR, V68, P811, DOI 10.1038/ejcn.2014.78
   Ferrante D, 2011, REV PANAM SALUD PUBL, V29, P69, DOI 10.1590/S1020-49892011000200001
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003
   Grajeda Ruben, 2005, Food and Nutrition Bulletin, V26, pS15
   Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3
   Kesse-Guyot E, 2009, EUR J CLIN NUTR, V63, P521, DOI 10.1038/sj.ejcn.1602978
   Kline R.B., 1994, EASY GUIDE FACTOR AN
   Lako JV, 2001, ASIA PAC J CLIN NUTR, V10, P188, DOI 10.1046/j.1440-6047.2001.00255.x
   Luger E, 2016, PUBLIC HEALTH NUTR, V19, P1211, DOI 10.1017/S1368980015002852
   Arruda SPM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-654
   Maluccio John A., 2005, Food and Nutrition Bulletin, V26, pS110
   Maluccio John A., 2005, Food and Nutrition Bulletin, V26, pS120
   Mayén AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029
   Menchu M.T., 2012, Tabla de composicion de alimentos de Centroamerica
   Ministerio de Salud Publica y Asistencia Social Instituto Nacional de Estadistica Universidad del Valle de Guatemala, 2011, 5 ENC NAC SAL MAT IN
   Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940
   Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127
   Ni Mhurchu C, 2010, AM J CLIN NUTR, V91, P736, DOI 10.3945/ajcn.2009.28742
   Noel SE, 2009, J NUTR, V139, P1360, DOI 10.3945/jn.109.105874
   Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X
   Perez-Grovas Victor., 2001, Case Study of the Coffee Sector in Mexico
   Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Public Health Ministry, 2009, GUAT REPR HLTH SURV
   Sofianou A, 2011, J AM DIET ASSOC, V111, P1563, DOI 10.1016/j.jada.2011.07.005
   de Castro MBT, 2016, PUBLIC HEALTH NUTR, V19, P1245, DOI 10.1017/S1368980015002700
   USDA Foreign Agricultural Service GAIN, 2013, GUAT MY 2012 2013 SU
   Waterlander WE, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-59
   Winham DM, 2009, AM J LIFESTYLE MED, V3, p64S, DOI 10.1177/1559827609335552
NR 39
TC 14
Z9 16
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1661-8556
EI 1661-8564
J9 INT J PUBLIC HEALTH
JI Int. J. Public Health
PD DEC
PY 2016
VL 61
IS 9
BP 1069
EP 1077
DI 10.1007/s00038-016-0863-3
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA ED3HA
UT WOS:000388739000010
PM 27421467
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Xu, XY
   Zhao, CN
   Cao, SY
   Tang, GY
   Gan, RY
   Li, HB
AF Xu, Xiao-Yu
   Zhao, Cai-Ning
   Cao, Shi-Yu
   Tang, Guo-Yi
   Gan, Ren-You
   Li, Hua-Bin
TI Effects and mechanisms of tea for the prevention and management of
   cancers: An updated review
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Tea; anticancer; mechanism of action; gut microbiota; adjuvant therapy
ID GREEN TEA; PROSTATE-CANCER; BREAST-CANCER; STEM-CELLS; DOWN-REGULATION;
   BLACK TEA; IN-VITRO; INHIBITS PROLIFERATION; LIVER CARCINOGENESIS;
   DECAFFEINATED COFFEE
AB Tea is a traditional and popular beverage worldwide, and the consumption of tea has been demonstrated to possess many health benefits, such as cardiovascular protection, anti-obesity, anti-diabetes, and anticancer. Epidemiological studies have shown that the consumption of tea is inversely associated with the risk of several cancers. In addition, experimental studies have revealed that the anticancer actions of tea are mainly attributed to tea polyphenols, such as epigallocatechin-3-gallate and theaflavins. Both in vitro and in vivo studies have demonstrated that the possible anticancer mechanisms are the inhibition on proliferation, anti-angiogenesis, induction of apoptosis, suppression on metastasis, inhibition on cancer stem cells, and modulation on gut microbiota. Its synergetic anticancer effects with drugs or other compounds could promote anticancer therapies. Furthermore, clinical trials have elucidated that intervention of tea phytochemicals is effective in the prevention of several cancers. This paper is an updated review for the prevention and management of cancers by tea based on the findings from epidemiological, experimental and clinical studies, and special attention is paid on the mechanisms of action.
C1 [Xu, Xiao-Yu; Zhao, Cai-Ning; Cao, Shi-Yu; Tang, Guo-Yi; Li, Hua-Bin] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Peoples R China.
   [Gan, Ren-You] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Food Sci & Technol, Shanghai, Peoples R China.
C3 Sun Yat Sen University; Shanghai Jiao Tong University
RP Gan, RY; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Food Sci & Technol, Shanghai, Peoples R China.
EM renyougan@sjtu.edu.cn; lihuabin@mail.sysu.edu.cn
RI Gan, Renyou/C-9868-2009; Li, Hua-Bin/AEX-9846-2022
OI Gan, Ren-You/0000-0002-4162-1511
CR Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Almajano MP, 2008, FOOD CHEM, V108, P55, DOI 10.1016/j.foodchem.2007.10.040
   Bray Freddie, 2018, CA Cancer J Clin, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
   Bäckhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Bamia C, 2015, INT J CANCER, V136, P1899, DOI 10.1002/ijc.29214
   Bonuccelli G, 2018, AGING-US, V10, P1867, DOI 10.18632/aging.101483
   Caini S, 2017, INT J CANCER, V140, P2246, DOI 10.1002/ijc.30659
   Cao SY, 2019, J FUNCT FOODS, V52, P316, DOI 10.1016/j.jff.2018.11.004
   Chung JE, 2014, NAT NANOTECHNOL, V9, P907, DOI [10.1038/nnano.2014.208, 10.1038/NNANO.2014.208]
   Clark J, 2006, MOL NUTR FOOD RES, V50, P144, DOI 10.1002/mnfr.200500135
   Conde VR, 2015, ANTI-CANCER AGENT ME, V15, P26
   D'Angelo L, 2014, CARCINOGENESIS, V35, P2314, DOI 10.1093/carcin/bgu173
   Deb G, 2015, MOL CARCINOGEN, V54, P485, DOI 10.1002/mc.22121
   Fang CY, 2015, INT J MOL SCI, V16, P2530, DOI 10.3390/ijms16022530
   Fujiki H, 2018, MOL CELLS, V41, P73, DOI 10.14348/molcells.2018.2227
   Fujiki H, 2017, J CANCER RES CLIN, V143, P2401, DOI 10.1007/s00432-017-2515-2
   Gan RY, 2018, CRIT REV FOOD SCI, V58, P924, DOI 10.1080/10408398.2016.1231168
   Gao Y, 2016, INT J ONCOL, V48, P281, DOI 10.3892/ijo.2015.3257
   Gee JR, 2017, CANCER PREV RES, V10, P298, DOI 10.1158/1940-6207.CAPR-16-0167
   Granja A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050307
   Hajiaghaalipour F, 2015, FOOD CHEM, V169, P401, DOI 10.1016/j.foodchem.2014.07.005
   Haratifar S, 2014, FOOD FUNCT, V5, P1160, DOI 10.1039/c3fo60343a
   Henning SM, 2015, PROSTATE, V75, P550, DOI 10.1002/pros.22943
   Huang YQ, 2016, NUTRITION, V32, P3, DOI 10.1016/j.nut.2015.05.021
   Hudlikar RR, 2017, MOL CARCINOGEN, V56, P625, DOI 10.1002/mc.22521
   Islam SN, 2018, INT J FOOD SCI TECH, V53, P182, DOI 10.1111/ijfs.13572
   Jian L, 2004, INT J CANCER, V108, P130, DOI 10.1002/ijc.11550
   Jin G, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.84
   Khan N, 2014, CARCINOGENESIS, V35, P415, DOI 10.1093/carcin/bgt321
   Kumar NB, 2015, CANCER PREV RES, V8, P879, DOI 10.1158/1940-6207.CAPR-14-0324
   Lazzeroni M, 2017, CANCER PREV RES, V10, P363, DOI 10.1158/1940-6207.CAPR-16-0298
   Lee JC, 2015, CANCER LETT, V360, P310, DOI 10.1016/j.canlet.2015.02.034
   Li F, 2013, J FUNCT FOODS, V5, P1298, DOI 10.1016/j.jff.2013.04.016
   Li F, 2013, FOOD FUNCT, V4, P530, DOI 10.1039/c2fo30252g
   Li Y., 2017, NUTRIENTS, V9, P728, DOI [DOI 10.3390/nu9070728, 10.3390/nu9070728]
   Liang K, 2018, ADV MATER, V30, DOI 10.1002/adma.201706963
   Liu JX, 2016, EUR J EPIDEMIOL, V31, P853, DOI 10.1007/s10654-016-0173-3
   Liu LQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020506
   Luo KW, 2017, J NUTR BIOCHEM, V41, P56, DOI 10.1016/j.jnutbio.2016.12.004
   Luo KW, 2014, J NUTR BIOCHEM, V25, P395, DOI 10.1016/j.jnutbio.2013.11.013
   Mayr C, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0721-5
   Meng X, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101457
   Monobe M, 2008, J AGR FOOD CHEM, V56, P1423, DOI 10.1021/jf073127h
   Mukherjee S, 2015, J NUTR BIOCHEM, V26, P1283, DOI 10.1016/j.jnutbio.2015.06.003
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731
   Ogawa T, 2016, INT J CANCER, V139, P2714, DOI 10.1002/ijc.30405
   Oh JK, 2015, INT J CANCER, V137, P1979, DOI 10.1002/ijc.29569
   Oya Y, 2017, J NUTR BIOCHEM, V42, P7, DOI 10.1016/j.jnutbio.2016.12.015
   Oze I, 2014, INT J CANCER, V135, P391, DOI 10.1002/ijc.28653
   Pan HB, 2018, J FUNCT FOODS, V46, P1, DOI 10.1016/j.jff.2018.04.037
   Pan HB, 2017, INT J ONCOL, V51, P1508, DOI 10.3892/ijo.2017.4145
   Pan J, 2014, MOL CARCINOGEN, V53, P19, DOI 10.1002/mc.21941
   Peluso I, 2017, BRIT J PHARMACOL, V174, P1195, DOI 10.1111/bph.13649
   Posadino AM, 2017, TOXICOL IN VITRO, V42, P255, DOI 10.1016/j.tiv.2017.05.005
   Ramadass SK, 2015, COLLOID SURFACE B, V125, P65, DOI 10.1016/j.colsurfb.2014.11.005
   Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167
   Rizzi F, 2014, CARCINOGENESIS, V35, P828, DOI 10.1093/carcin/bgt481
   Samavat H, 2017, CANCER PREV RES, V10, P710, DOI 10.1158/1940-6207.CAPR-17-0187
   Sanikini H, 2015, INT J CANCER, V136, pE720, DOI 10.1002/ijc.29223
   Seo EJ, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00398
   Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215
   Singh M, 2015, INT J NANOMED, V10, P6789, DOI 10.2147/IJN.S79489
   Suganuma M, 2016, MOLECULES, V21, DOI 10.3390/molecules21111566
   Sur S, 2016, TOXICOL APPL PHARM, V300, P34, DOI 10.1016/j.taap.2016.03.016
   Sur S, 2016, J NUTR BIOCHEM, V27, P32, DOI 10.1016/j.jnutbio.2015.08.016
   Tao J, 2020, CRIT REV FOOD SCI, V60, P1025, DOI 10.1080/10408398.2018.1555789
   Tao J, 2018, J FUNCT FOODS, V42, P95, DOI 10.1016/j.jff.2017.12.064
   Tao L, 2015, MOL NUTR FOOD RES, V59, P203, DOI 10.1002/mnfr.201400485
   Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263
   Tsai YJ, 2016, INT J NANOMED, V11, P1907, DOI 10.2147/IJN.S103759
   Tu YY, 2016, INT J ONCOL, V48, P2657, DOI 10.3892/ijo.2016.3472
   Tyagi N, 2017, INT J PHARMACEUT, V518, P220, DOI 10.1016/j.ijpharm.2016.12.030
   Tyagi T, 2015, BREAST CANCER RES TR, V149, P655, DOI 10.1007/s10549-015-3295-5
   Wang JZ, 2018, CANCER LETT, V412, P10, DOI 10.1016/j.canlet.2017.09.054
   Wang PW, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0351-x
   Wang PW, 2015, J NUTR BIOCHEM, V26, P408, DOI 10.1016/j.jnutbio.2014.11.017
   Wang WC, 2014, ORAL ONCOL, V50, P276, DOI 10.1016/j.oraloncology.2013.12.014
   Wubetu GY, 2016, J GASTROEN HEPATOL, V31, P256, DOI 10.1111/jgh.13069
   Xie J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00190
   Yang CS, 2009, ARCH TOXICOL, V83, P11, DOI 10.1007/s00204-008-0372-0
   Yang G, 2007, CANCER EPIDEM BIOMAR, V16, P1219, DOI 10.1158/1055-9965.EPI-07-0097
   Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836
   Yi Z, 2018, J MATER CHEM B, V6, P1373, DOI 10.1039/c7tb03293e
   Yuan XJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800178
   Zapf MAC, 2015, SURGERY, V158, P1039, DOI 10.1016/j.surg.2015.06.011
   Zhang DY, 2018, CARCINOGENESIS, V39, P808, DOI 10.1093/carcin/bgy048
   Zhang M, 2002, CANCER EPIDEM BIOMAR, V11, P713
   Zhang XB, 2018, RSC ADV, V8, P11305, DOI 10.1039/c8ra00151k
   Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493
   Zhao CN, 2018, CANCER LETT, V431, P161, DOI 10.1016/j.canlet.2018.05.039
   Zhao HX, 2015, RADIOTHER ONCOL, V114, P351, DOI 10.1016/j.radonc.2015.02.014
   Zheng J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080495
   Zhou Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030156
   Zhou Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080515
NR 96
TC 92
Z9 98
U1 3
U2 314
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD MAY 30
PY 2020
VL 60
IS 10
BP 1693
EP 1705
DI 10.1080/10408398.2019.1588223
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA LL7BT
UT WOS:000531711300008
PM 30869995
DA 2025-04-28
ER

PT J
AU Egger, G
   Dixon, J
AF Egger, G.
   Dixon, J.
TI Inflammatory effects of nutritional stimuli: further support for the
   need for a big picture approach to tackling obesity and chronic disease
SO OBESITY REVIEWS
LA English
DT Review
DE Environment; inflammation; nutrition; obesity
ID C-REACTIVE PROTEIN; FATTY-ACID-COMPOSITION; NECROSIS-FACTOR-ALPHA;
   MODERATE ALCOHOL-CONSUMPTION; FACTOR-KAPPA-B; SYSTEMIC INFLAMMATION;
   COFFEE CONSUMPTION; DIETARY PATTERNS; ENDOTHELIAL DYSFUNCTION;
   CARDIOVASCULAR-DISEASE
AB The discovery of a form of low-grade systemic inflammation (called 'metaflammation'), and the close evolutionary link between the immune and metabolic systems, poses questions about the supposed antigens (inducers) of such an immune reaction. Initially, this was thought to be mediated through obesity. However, we have identified a number of lifestyle or environmentally related inducers that may cause metaflammation, even in the absence of obesity. In this paper, the third of a series linking obesity with broad environmental and evolutionary factors, we identify nutritional stimuli with evidence of an involvement in metaflammation. From this we propose that components of certain foods and beverages with which humans have not evolved, are more often the inducers of an inflammatory effect in the body than those with which humans have become more familiar, and to which a neutral, or anti-inflammatory response may be expected to have developed. The implications of such a finding are considered in relation to broader aspects of the environment, economic growth, policy change and current global financial issues.
C1 [Egger, G.] So Cross Univ, Lismore, NSW 2480, Australia.
   [Egger, G.] Ctr Hlth Promot & Res, Sydney, NSW, Australia.
   [Dixon, J.] Monash Univ, Dept Primary Hlth Care, Obes Res Unit, Melbourne, Vic 3004, Australia.
C3 Southern Cross University; Monash University
RP Egger, G (corresponding author), POB 313 Fairlight, Fairlight, NSW 2093, Australia.
EM eggergj@ozemail.com.au
RI Dixon, John/A-5318-2011
OI Dixon, John/0000-0001-6399-7010
CR Ajani UA, 2004, J NUTR, V134, P1181, DOI 10.1093/jn/134.5.1181
   Aljada A, 2004, AM J CLIN NUTR, V79, P682
   ARYA F, 2009, DIFFERENCES AC UNPUB
   Azadbakht L, 2007, DIABETES CARE, V30, P967, DOI 10.2337/dc06-2126
   Baer DJ, 2004, AM J CLIN NUTR, V79, P969
   Beulens JWJ, 2008, DIABETES CARE, V31, P2050, DOI 10.2337/dc08-0814
   BIANCOCOLIO LM, 2000, CIRCULATION, V102, P1020
   Blum S, 2006, ANN NUTR METAB, V50, P20, DOI 10.1159/000089560
   Bogani P, 2007, ATHEROSCLEROSIS, V190, P181, DOI 10.1016/j.atherosclerosis.2006.01.011
   Brand-Miller JC, 2007, AM J CLIN NUTR, V85, P1545, DOI 10.1093/ajcn/85.6.1545
   Buescher ES, 2001, ADV EXP MED BIOL, V501, P207
   Bulló M, 2007, PUBLIC HEALTH NUTR, V10, P1164, DOI 10.1017/S1368980007000663
   Campos H, 2007, NUTR REV, V65, P173, DOI [10.1301/nr.2007.apr.173-179, 10.1111/j.1753-4887.2007.tb00297.x]
   Cao Heping, 2007, J Inflamm (Lond), V4, P1, DOI 10.1186/1476-9255-4-1
   Castilla P, 2006, AM J CLIN NUTR, V84, P252, DOI 10.1093/ajcn/84.1.252
   Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105
   Chacko BK, 2005, AM J PHYSIOL-HEART C, V289, pH908, DOI 10.1152/ajpheart.00781.2004
   Chen L, 2007, MOLECULES, V12, P946, DOI 10.3390/12050946
   Chun OK, 2008, J NUTR, V138, P753
   Cooper KA, 2008, BRIT J NUTR, V99, P1, DOI 10.1017/S0007114507795296
   Cordain L, 2002, EUR J CLIN NUTR, V56, pS42, DOI 10.1038/sj.ejcn.1601353
   Cornelis MC, 2007, CURR OPIN CLIN NUTR, V10, P745, DOI 10.1097/MCO.0b013e3282f05d81
   Dalgard C., 2008, BR J NUTR, V28, P1
   De Bacquer D, 2006, ATHEROSCLEROSIS, V189, P428, DOI 10.1016/j.atherosclerosis.2005.12.028
   de Roos B, 2008, PROTEOMICS, V8, P1965, DOI 10.1002/pmic.200700457
   Delgado-Lista J, 2008, AM J CLIN NUTR, V87, P317, DOI 10.1093/ajcn/87.2.317
   Devaraj S, 2008, METABOLISM, V57, P867, DOI 10.1016/j.metabol.2008.02.016
   Devaraj S, 2006, AM J CLIN NUTR, V84, P756, DOI 10.1093/ajcn/84.4.756
   di Giuseppe R, 2008, J NUTR, V138, P1939, DOI 10.1093/jn/138.10.1939
   Dickinson S, 2008, AM J CLIN NUTR, V87, P1188
   Dixon Andrew F, 2003, Aust Fam Physician, V32, P649
   DROKE EA, 2007, J INFLAMM-LOND, V7, P17
   Egger G, 2008, OBES REV, V9, P456, DOI 10.1111/j.1467-789X.2008.00469.x
   Egger G, 2009, OBES REV, V10, P237, DOI 10.1111/j.1467-789X.2008.00542.x
   EGGER G, 2009, NUTR REV, V18, P1
   Egger G, 2009, AM J PREV MED, V37, P78, DOI 10.1016/j.amepre.2009.03.004
   ENGLUND OL, 2006, DIABETES CARE, V29, P908
   Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286
   Esmaillzadeh A, 2008, AM J CLIN NUTR, V88, P913, DOI 10.1093/ajcn/88.4.913
   Esmaillzadeh A, 2007, J NUTR, V137, P992, DOI 10.1093/jn/137.4.992
   Esposito Katherine, 2007, Metabolic Syndrome and Related Disorders, V5, P291, DOI 10.1089/met.2007.0018
   Estruch R, 2004, ATHEROSCLEROSIS, V175, P117, DOI 10.1016/j.atherosclerosis.2004.03.006
   Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004
   Fargnoli JL, 2008, AM J CLIN NUTR, V88, P1213, DOI 10.3945/ajcn.2008.26480
   Faridi Z, 2008, AM J CLIN NUTR, V88, P58, DOI 10.1093/ajcn/88.1.58
   Fitó M, 2008, EUR J CLIN NUTR, V62, P570, DOI 10.1038/sj.ejcn.1602724
   Fontana L, 2008, EUR J CARDIOV PREV R, V15, P3, DOI 10.1097/HJR.0b013e3282f17bd4
   FRENK J, 1989, HLTH POLICY PLAN, V41, P29
   Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   Fung TT, 2005, AM J CLIN NUTR, V82, P163
   Galgani J, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-22
   Gao X, 2004, J NUTR, V134, P913, DOI 10.1093/jn/134.4.913
   Garg ML, 2007, LIPIDS, V42, P583, DOI 10.1007/s11745-007-3042-8
   Greany KA, 2008, EUR J CLIN NUTR, V62, P1419, DOI 10.1038/sj.ejcn.1602885
   HALPEN GM, 2008, INFLAMMOPHARMACOLOGY, V16, P1
   Hamed MS, 2008, SOUTH MED J, V101, P1203, DOI 10.1097/SMJ.0b013e31818859eb
   Han SN, 2002, J LIPID RES, V43, P445
   Harvey KA, 2008, BRIT J NUTR, V99, P723, DOI 10.1017/S0007114507842772
   Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1111/j.1753-4887.2005.tb00132.x, 10.1301/nr.2005.may.133-157]
   Hayes DP, 2008, AM J CLIN NUTR, V88, p578S, DOI 10.1093/ajcn/88.2.578S
   Hickling S, 2008, PREV MED, V47, P71, DOI 10.1016/j.ypmed.2008.02.007
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hijmering ML, 2007, NETH J MED, V65, P29
   Hodgson JM, 2007, J NUTR, V137, P363, DOI 10.1093/jn/137.2.363
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449
   Hu FB, 2008, CIRCULATION, V118, P1913, DOI 10.1161/CIRCULATIONAHA.108.808493
   Hyun YJ, 2008, OBESITY, V16, P784, DOI 10.1038/oby.2007.127
   Imhof A, 2004, EUR HEART J, V25, P2092, DOI 10.1016/j.ehj.2004.09.032
   Inadera Hidekuni, 2008, Int J Med Sci, V5, P248
   Inoue T, 2008, J CARDIOL, V52, P127, DOI 10.1016/j.jjcc.2008.06.004
   Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716
   Jacob K, 2008, BRIT J NUTR, V99, P137, DOI 10.1017/S0007114507791894
   Jenkins DJA, 2008, EUR J CLIN NUTR, V62, P781, DOI 10.1038/sj.ejcn.1602768
   Jenkins DJA, 2008, J NUTR, V138, p1752S, DOI 10.1093/jn/138.9.1752S
   Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033
   Jimenez-Gomez Yolanda, 2009, Atherosclerosis, V204, pe70, DOI 10.1016/j.atherosclerosis.2008.09.011
   Josse AR, 2007, METABOLISM, V56, P400, DOI 10.1016/j.metabol.2006.10.024
   Kallio P, 2008, AM J CLIN NUTR, V87, P1497, DOI 10.1093/ajcn/87.5.1497
   Kashyap Sangeeta R, 2008, J Cardiometab Syndr, V3, P141, DOI 10.1111/j.1559-4572.2008.00013.x
   Kechagias S, 2008, GUT, V57, P649, DOI 10.1136/gut.2007.131797
   Kim Jeong-A., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P82, DOI 10.2174/187153008784534349
   King DE, 2008, ANN FAM MED, V6, P100, DOI 10.1370/afm.819
   King DE, 2007, ARCH INTERN MED, V167, P502, DOI 10.1001/archinte.167.5.502
   King DE, 2005, MOL NUTR FOOD RES, V49, P594, DOI 10.1002/mnfr.200400112
   King DE, 2003, AM J CARDIOL, V92, P1335, DOI 10.1016/j.amjcard.2003.08.020
   King JC, 2008, J NUTR, V138, p1734S, DOI 10.1093/jn/138.9.1734S
   Kotani K, 2008, CLIN CHEM LAB MED, V46, P1434, DOI 10.1515/CCLM.2008.286
   Kris-Etherton PN, 2008, J NUTR, V138, p1746S
   Krishnaswamy K, 2008, ASIA PAC J CLIN NUTR, V17, P265
   Lamon BD, 2008, AM J PATHOL, V173, P1253, DOI 10.2353/ajpath.2008.080442
   Lansky EP, 2007, J ETHNOPHARMACOL, V109, P177, DOI 10.1016/j.jep.2006.09.006
   Laugesen M, 2003, NZ MED J, V116, P1
   Li HL, 2006, FREE RADICAL BIO MED, V40, P1756, DOI 10.1016/j.freeradbiomed.2006.01.005
   Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158
   Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888
   Luu NT, 2007, J NUTR, V137, P2769, DOI 10.1093/jn/137.12.2769
   Ma YS, 2006, AM J CLIN NUTR, V83, P760, DOI 10.1093/ajcn/83.4.760
   Ma YS, 2008, NUTRITION, V24, P941, DOI 10.1016/j.nut.2008.04.005
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   Alvarez JRM, 2009, NUTRITION, V25, P182, DOI 10.1016/j.nut.2008.08.005
   MATSUZAWA Y, 2005, BEST PRACT RES CLIN, V19, P969
   Mayer-Davis EJ, 2008, DIABETES CARE, V31, P470, DOI 10.2337/dc07-1321
   Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201
   Miller A, 2008, CURR OPIN GASTROEN, V24, P204, DOI 10.1097/MOG.0b013e3282f3f4c4
   Mourente G, 2006, COMP BIOCHEM PHYS B, V145, P389, DOI 10.1016/j.cbpb.2006.08.012
   Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035
   Mukamal KJ, 2004, ATHEROSCLEROSIS, V173, P79, DOI 10.1016/j.atherosclerosis.2003.10.011
   Nakamura Y, 2007, METABOLISM, V56, P1060, DOI 10.1016/j.metabol.2007.03.014
   Nanri A, 2008, AM J CLIN NUTR, V87, P1488, DOI 10.1093/ajcn/87.5.1488
   Nasca MM, 2008, AM J CARDIOL, V102, P84, DOI 10.1016/j.amjcard.2008.02.100
   Nettleton JA, 2006, AM J CLIN NUTR, V83, P1369, DOI 10.1093/ajcn/83.6.1369
   O'Keefe JH, 2008, J AM COLL CARDIOL, V51, P249, DOI 10.1016/j.jacc.2007.10.016
   O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089
   Pai JK, 2006, ATHEROSCLEROSIS, V186, P113, DOI 10.1016/j.atherosclerosis.2005.06.037
   Papoutsi Z, 2008, BRIT J NUTR, V99, P715, DOI 10.1017/S0007114507837421
   Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Petersson H, 2009, ATHEROSCLEROSIS, V203, P298, DOI 10.1016/j.atherosclerosis.2008.06.020
   Pischon T, 2003, CIRCULATION, V108, P155, DOI 10.1161/01.CIR.0000079224.46084.C2
   Plat J, 2007, J NUTR, V137, P2635, DOI 10.1093/jn/137.12.2635
   Pollan M., 2006, The omnivore's dilemma; a history of four meals
   Poppitt SD, 2008, NUTRITION, V24, P322, DOI 10.1016/j.nut.2007.12.012
   Qi L, 2007, CURR OPIN LIPIDOL, V18, P3, DOI 10.1097/MOL.0b013e328011c6e0
   Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109
   Retterstol L, 2005, ALCOHOL ALCOHOLISM, V40, P102, DOI 10.1093/alcalc/agh132
   Riley J. C., 2001, Rising Life Expectancy: A Global History
   Rimm EB, 2002, CIRCULATION, V105, P2806, DOI 10.1161/01.CIR.0000022344.79651.CC
   Rodrigues C, 2006, HYPERTENS PREGNANCY, V25, P69
   Ros E, 2006, BRIT J NUTR, V96, pS29, DOI 10.1017/BJN20061861
   Rosenblum M., 2005, Chocolate: a bittersweet saga of dark and light
   Rutledge AC, 2007, NUTR REV, V65, pS13, DOI 10.1301/nr.2007.jun.S13-S23
   Sacanella E, 2007, AM J CLIN NUTR, V86, P1463, DOI 10.1093/ajcn/86.5.1463
   Salas-Salvadó J, 2008, ASIA PAC J CLIN NUTR, V17, P333
   Sartorelli DS, 2009, NUTR METAB CARDIOVAS, V19, P77, DOI 10.1016/j.numecd.2008.04.004
   Seierstad SL, 2005, EUR J CLIN INVEST, V35, P52, DOI 10.1111/j.1365-2362.2005.01443.x
   Seimi C, 2008, MOL NUTR FOOD RES, V52, P1340, DOI 10.1002/mnfr.200700435
   Shai I, 2004, DIABETOLOGIA, V47, P1760, DOI 10.1007/s00125-004-1526-0
   Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s
   Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011
   Sorensen LB, 2005, AM J CLIN NUTR, V82, P421, DOI 10.1093/ajcn/82.2.421
   STANHOPE KL, 2008, AM DIAB ANN M SAN FR
   Steptoe A, 2007, ATHEROSCLEROSIS, V193, P277, DOI 10.1016/j.atherosclerosis.2006.08.054
   Surh YJ, 2002, FOOD CHEM TOXICOL, V40, P1091, DOI 10.1016/S0278-6915(02)00037-6
   Swarbrick MM, 2008, BRIT J NUTR, V100, P947, DOI 10.1017/S0007114508968252
   Swinburn B., 2004, BETA CASEIN A1 A2 MI
   Tannahill Reay., 1988, FOOD HIST
   Tapsell LC, 2006, MED J AUSTRALIA, V185, pS4
   Togashi N, 2000, J HYPERTENS, V18, P1605, DOI 10.1097/00004872-200018110-00011
   Valtuena S, 2008, AM J CLIN NUTR, V87, P1290, DOI 10.1093/ajcn/87.5.1290
   van der Crabben SN, 2008, J CLIN ENDOCR METAB, V93, P638, DOI 10.1210/jc.2006-2491
   Velayutham P, 2008, CURR MED CHEM, V15, P1840
   Volpato S, 2004, CIRCULATION, V109, P607, DOI 10.1161/01.CIR.0000109503.13955.00
   Vos Miriam B, 2008, Medscape J Med, V10, P160
   Waldschmidt TJ, 2008, ALCOHOL, V42, P137, DOI 10.1016/j.alcohol.2007.11.003
   Wandler A, 2008, MOL CELL ENDOCRINOL, V296, P26, DOI 10.1016/j.mce.2008.09.006
   Wang JJ, 2008, ACTA CARDIOL, V63, P65, DOI 10.2143/AC.63.1.2025334
   Wannamethee SG, 2006, AM J CLIN NUTR, V83, P567, DOI 10.1093/ajcn.83.3.567
   Warden BA, 2001, J NUTR, V131, P1731, DOI 10.1093/jn/131.6.1731
   Waterhouse AL, 1996, LANCET, V348, P834, DOI 10.1016/S0140-6736(05)65262-2
   Watzl B, 2005, AM J CLIN NUTR, V82, P1052, DOI 10.1093/ajcn/82.5.1052
   White JS, 2008, AM J CLIN NUTR, V88, p1716S, DOI 10.3945/ajcn.2008.25825B
   Willett W.C., 2001, EAT DRINK BE HLTH
   Willett WC, 2008, ASIA PAC J CLIN NUTR, V17, P1
   Willett WC, 2007, J CARDIOVASC MED, V8, pS42, DOI 10.2459/01.JCM.0000289275.72556.13
   Wolf A, 2008, OBES REV, V9, P151, DOI 10.1111/j.1467-789X.2007.00389.x
   Yamaguchi K, 2005, HYPERTENS RES, V28, P773, DOI 10.1291/hypres.28.773
   Yoneyama S, 2007, J EPIDEMIOL, V17, P86, DOI 10.2188/jea.17.86
   Yoon JH, 2005, YONSEI MED J, V46, P585, DOI 10.3349/ymj.2005.46.5.585
   Yung L. M., 2008, Inflammopharmacology, V16, P230, DOI 10.1007/s10787-008-8022-y
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   Zemel MB, 2008, J NUTR, V138, P1047, DOI 10.1093/jn/138.6.1047
   Zhao GX, 2007, AM J CLIN NUTR, V85, P385, DOI 10.1093/ajcn/85.2.385
   Zielinska-Przyjemska M, 2009, PHYTOTHER RES, V23, P49, DOI 10.1002/ptr.2535
NR 176
TC 39
Z9 42
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7881
EI 1467-789X
J9 OBES REV
JI Obes. Rev.
PD FEB
PY 2010
VL 11
IS 2
BP 137
EP 149
DI 10.1111/j.1467-789X.2009.00644.x
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 545LD
UT WOS:000273732700006
PM 19656309
DA 2025-04-28
ER

PT J
AU Deliens, T
   Clarys, P
   De Bourdeaudhuij, I
   Deforche, B
AF Deliens, Tom
   Clarys, Peter
   De Bourdeaudhuij, Ilse
   Deforche, Benedicte
TI Correlates of University Students' Soft and Energy Drink Consumption
   According to Gender and Residency
SO NUTRIENTS
LA English
DT Article
ID SUGAR-SWEETENED BEVERAGE; TYPE-2 DIABETES-MELLITUS; WEIGHT-GAIN;
   DETERMINANTS; OBESITY; METAANALYSIS; PATTERNS; CAFFEINE; FRUCTOSE;
   BEHAVIOR
AB This study assessed personal and environmental correlates of Belgian university students' soft and energy drink consumption and investigated whether these associations were moderated by gender or residency. Four hundred twenty-five university students completed a self-reported on-line questionnaire assessing socio-demographics, health status, soft and energy drink consumption, as well as personal and environmental factors related to soft and energy drink consumption. Multiple linear regression analyses were conducted. Students believing soft drink intake should be minimized (individual subjective norm), finding it less difficult to avoid soft drinks (perceived behavioral control), being convinced they could avoid soft drinks in different situations (self-efficacy), having family and friends who rarely consume soft drinks (modelling), and having stricter family rules about soft drink intake were less likely to consume soft drinks. Students showing stronger behavioral control, having stricter family rules about energy drink intake, and reporting lower energy drink availability were less likely to consume energy drinks. Gender and residency moderated several associations between psychosocial constructs and consumption. Future research should investigate whether interventions focusing on the above personal and environmental correlates can indeed improve university students' beverage choices.
C1 [Deliens, Tom; Clarys, Peter; Deforche, Benedicte] Vrije Univ Brussel, Dept Human Biometry & Biomech, B-1050 Brussels, Belgium.
   [De Bourdeaudhuij, Ilse; Deforche, Benedicte] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium.
C3 Vrije Universiteit Brussel; Ghent University
RP Deliens, T (corresponding author), Vrije Univ Brussel, Dept Human Biometry & Biomech, Pl Laan 2, B-1050 Brussels, Belgium.
EM Tom.Deliens@vub.ac.be; pclarys@vub.ac.be; ilse.debourdeaudhuij@ugent.be;
   Benedicte.Deforche@vub.ac.be
RI De+Bourdeaudhuij, Ilse/AAC-5528-2019; Deliens, Tom/KEH-7822-2024
OI Deliens, Tom/0000-0002-8165-4617; De Bourdeaudhuij,
   Ilse/0000-0001-9969-7597
CR Aguinis H, 2005, J APPL PSYCHOL, V90, P94, DOI 10.1037/0021-9010.90.1.94
   Aiken L. S., 1991, Multiple regression: testing and interpreting interactions
   Ajzen I., 1985, ACTION CONTROL COGNI, P11, DOI [DOI 10.1007/978-3-642-69746-32, 10.1007/978-3-642-69746-32, DOI 10.1007/978-3-642-69746-3_2]
   [Anonymous], 1986, Social Foundations of Thought and Action, DOI DOI 10.5465/AMR.1987.4306538
   Aranda M, 2006, J CHROMATOGR A, V1131, P253, DOI 10.1016/j.chroma.2006.07.018
   Attila S, 2011, NUTRITION, V27, P316, DOI 10.1016/j.nut.2010.02.008
   Bere E, 2008, PUBLIC HEALTH NUTR, V11, P49, DOI 10.1017/S1368980007000122
   Block JP, 2013, J ADOLESCENT HEALTH, V52, P702, DOI 10.1016/j.jadohealth.2012.11.017
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Brunt AR, 2008, APPETITE, V51, P615, DOI 10.1016/j.appet.2008.04.019
   Burrows T, 2013, NUTR REV, V71, P135, DOI 10.1111/nure.12005
   Campbell B, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-1
   Crombie AP, 2009, NUTR REV, V67, P83, DOI 10.1111/j.1753-4887.2008.00143.x
   Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53
   Deliens T, 2013, APPETITE, V65, P111, DOI 10.1016/j.appet.2013.01.024
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   El Ansari W, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-28
   Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911
   Ezendam NPM, 2010, BRIT J NUTR, V103, P768, DOI 10.1017/S0007114509992297
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Hattersley L, 2009, PUBLIC HEALTH NUTR, V12, P1816, DOI 10.1017/S136898000800462X
   Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x
   Hoge Gezondheidsraad, 2021, Stand van 'omics'-technologieen en hun klinische toepassing (Advies van de Hoge Gezondheidsraad No. 9477)
   Kelly NR, 2013, J NUTR EDUC BEHAV, V45, P304, DOI 10.1016/j.jneb.2012.10.012
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35
   Mullie P, 2009, MIL MED, V174, P852, DOI 10.7205/MILMED-D-00-1409
   Nelson MC, 2009, J NUTR EDUC BEHAV, V41, P287, DOI 10.1016/j.jneb.2008.05.005
   Pereira MA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0375-z
   Pettit ML, 2011, J AM COLL HEALTH, V59, P335, DOI 10.1080/07448481.2010.510163
   Prestwich A, 2014, HEALTH PSYCHOL REV, V8, P270, DOI 10.1080/17437199.2013.813729
   Reid SD, 2015, J EPIDEMIOL GLOB HEA, V5, P103, DOI 10.1016/j.jegh.2014.05.004
   Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001
   Renner B, 2012, HEALTH PSYCHOL, V31, P306, DOI 10.1037/a0025302
   Rush E, 2006, ASIA PAC J CLIN NUTR, V15, P242
   Sakurai M, 2014, EUR J NUTR, V53, P251, DOI 10.1007/s00394-013-0523-9
   Sallis JF., 2002, Ecological Models of Health Behavior, V3rd
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Tak NI, 2011, APPETITE, V56, P503, DOI 10.1016/j.appet.2011.01.013
   Vandelanotte C, 2004, HEALTH PROMOT INT, V19, P463, DOI 10.1093/heapro/dah408
   Vella-Zarb RA, 2009, J AM COLL HEALTH, V58, P161, DOI 10.1080/07448480903221392
   Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x
   West DS, 2006, OBESITY, V14, P1825, DOI 10.1038/oby.2006.210
   Yang CC, 2010, APPETITE, V54, P512, DOI 10.1016/j.appet.2010.02.004
NR 44
TC 16
Z9 23
U1 1
U2 42
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2015
VL 7
IS 8
BP 6550
EP 6566
DI 10.3390/nu7085298
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA CQ4PQ
UT WOS:000360587500030
PM 26258790
OA Green Published, gold, Green Submitted
DA 2025-04-28
ER

PT J
AU Kang, JS
   Lee, WK
   Yoon, WK
   Kim, N
   Park, SK
   Park, HK
   Ly, SY
   Han, SB
   Yun, J
   Lee, CW
   Lee, K
   Lee, KH
   Park, SK
   Kim, HM
AF Kang, Jong Soon
   Lee, Won Kyung
   Yoon, Won Kee
   Kim, Nayang
   Park, Sang-Ki
   Park, Hyoung Kook
   Ly, Sun Yung
   Han, Sang-Bae
   Yun, Jieun
   Lee, Chang Woo
   Lee, Kiho
   Lee, Ki Hoon
   Park, Song-Kyu
   Kim, Hwan Mook
TI A Combination of Grape Extract, Green Tea Extract and L-Carnitine
   Improves High-fat Diet-induced Obesity, Hyperlipidemia and Non-alcoholic
   Fatty Liver Disease in Mice
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE grape extract; green tea extract; L-carnitine; high-fat diet;
   hyperlipidemia; fatty liver disease
ID 3T3-L1 ADIPOCYTES; METABOLIC SYNDROME; GENE-EXPRESSION; RESVERATROL;
   CATECHINS; CAFFEINE; ADIPOGENESIS; POLYPHENOLS; INHIBITION; QUERCETIN
AB To develop a therapeutic agent for obesity-related metabolic disorders, a mixture of dietary components was prepared, including grape extract, green tea extract and L-carnitine (RGTC), and its effects on obesity, hyperlipidemia and non-alcoholic fatty liver disease examined. The RGTC dramatically inhibited the high-fat diet (HFD)-induced increase in body weight and fat in C57BL/6 mice, whereas food consumption was not affected by RGTC treatment. The RGTC also concentration-dependently suppressed the HFD-induced increase in plasma lipids, such as low-density lipoprotein cholesterol and triglycerides. In addition, increases in liver weight and liver steatosis were returned to normal by RGTC treatment in HFD-fed C57BL/6 mice. The plasma levels of glutamic-oxaloacetic transaminase and glutamic-pyruvic transaminase were also significantly down-regulated by RGTC treatment. These results suggest that RGTC suppressed HFD-induced obesity, hyperlipidemia and non-alcoholic fatty liver disease, suggesting that RGTC supplementation might be a promising adjuvant therapy for the treatment of these metabolic disorders. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Park, Song-Kyu] Korea Univ, Coll Pharm, Jochiwon, Chungnam, South Korea.
   [Kang, Jong Soon; Yun, Jieun; Lee, Chang Woo; Lee, Kiho; Lee, Ki Hoon; Kim, Hwan Mook] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongwon, Chungbuk, South Korea.
   [Lee, Won Kyung; Kim, Nayang; Park, Sang-Ki; Park, Hyoung Kook] LG Household & Healthcare R&D Ctr, Taejon, South Korea.
   [Yoon, Won Kee] Korea Res Inst Biosci & Biotechnol, Biomed Mouse Resource Ctr, Cheongwon, Chungbuk, South Korea.
   [Ly, Sun Yung] Chungnam Natl Univ, Coll Human Ecol, Dept Food Nutr, Taejon, South Korea.
   [Han, Sang-Bae] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea.
C3 Korea University; Korea Research Institute of Bioscience & Biotechnology
   (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB);
   Chungnam National University; Chungbuk National University
RP Park, SK (corresponding author), Korea Univ, Coll Pharm, Jochiwon, Chungnam, South Korea.
EM spark123@korea.ac.kr; hwanmook@kribb.re.kr
RI Lee, Chang-Woo/L-5093-2015; Lee, Jongyeol/F-8932-2015
OI Ly, Sun Yung/0000-0001-6813-8573; Kang, Jong Soon/0000-0001-7698-0162
FU Cooperation of Industry, Research Institute and Government; Ministry for
   Health, Welfare and Family Affairs, Republic of Korea [A101836]; KRIBB
FX This study was supported by a grant from the Chungbuk Bioinfrastructure
   Project supporting Cooperation of Industry, Research Institute and
   Government, the Korean Health Technology R&D Project, Ministry for
   Health, Welfare and Family Affairs, Republic of Korea (no. A101836) and
   the KRIBB Research Initiative Program.
CR Amin KA, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-17
   [Anonymous], COCHRANE DATABASE SY
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196
   Brisdelli F, 2009, CURR DRUG METAB, V10, P530, DOI 10.2174/138920009789375423
   Bruno RS, 2008, J NUTR, V138, P323, DOI 10.1093/jn/138.2.323
   Bujanda L, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-40
   Couillard C, 2000, INT J OBESITY, V24, P782, DOI 10.1038/sj.ijo.0801227
   Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Ewald N, 2009, CURR OPIN LIPIDOL, V20, P497, DOI 10.1097/MOL.0b013e3283319a1d
   Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737
   Kohjima M, 2007, INT J MOL MED, V20, P351
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lee MS, 2006, J MED FOOD, V9, P468, DOI 10.1089/jmf.2006.9.468
   LeRoith D, 2008, EXP CLIN ENDOCR DIAB, V116, pS4, DOI 10.1055/s-2008-1081488
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   Mitscher LA, 1997, MED RES REV, V17, P327, DOI 10.1002/(SICI)1098-1128(199707)17:4<327::AID-MED2>3.0.CO;2-Y
   Murosaki S, 2007, J NUTR, V137, P2252, DOI 10.1093/jn/137.10.2252
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Orgaard A, 2008, EXP BIOL MED, V233, P1066, DOI 10.3181/0712-MR-347
   Park HJ, 2008, J MED FOOD, V11, P773, DOI 10.1089/jmf.2008.0077
   Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503
   Shang J, 2008, ACTA PHARMACOL SIN, V29, P698, DOI 10.1111/j.1745-7254.2008.00807.x
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Staiger H, 2005, EXP CLIN ENDOCR DIAB, V113, P67, DOI 10.1055/s-2004-830555
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Tian WX, 2006, CURR MED CHEM, V13, P967, DOI 10.2174/092986706776361012
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003
   Yang JY, 2006, J MED FOOD, V9, P459, DOI 10.1089/jmf.2006.9.459
   Zheng GD, 2004, IN VIVO, V18, P55
NR 35
TC 16
Z9 18
U1 0
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD DEC
PY 2011
VL 25
IS 12
BP 1789
EP 1795
DI 10.1002/ptr.3476
PG 7
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 864ZB
UT WOS:000298277900009
PM 21480410
DA 2025-04-28
ER

PT J
AU Francini-Pesenti, F
   Spinella, P
   Calò, LA
AF Francini-Pesenti, Francesco
   Spinella, Paolo
   Calo, Lorenzo A.
TI Potential role of phytochemicals in metabolic syndrome prevention and
   therapy
SO DIABETES METABOLIC SYNDROME AND OBESITY
LA English
DT Review
DE metabolic syndrome; bioactive substances; nutrition; cardiovascular risk
ID CARDIOVASCULAR RISK-FACTORS; GREEN TEA SUPPLEMENTATION; LOWER
   PLASMA-CHOLESTEROL; LOW-DENSITY-LIPOPROTEIN; SUGAR-CANE POLICOSANOL;
   PLANT STEROLS; INSULIN-RESISTANCE; DOUBLE-BLIND; DARK CHOCOLATE; LIPID
   PROFILE
AB Metabolic syndrome (MetS) is a set of cardiovascular risk factors which severely increases the risk of type II diabetes, renal disease and cardiovascular disease. Over the last decades, the role of dietary bioactive substances in features of MetS has been extensively investigated. Due to their multiple properties, these plant-derived natural compounds have demonstrated to provide positive effects in obesity, diabetes, renal and in cardiovascular disease. Catechins of green tea and caffeine reduce body mass index and waist circumference. Catechins, anthocyanins and proanthocyanidins of cocoa reduce blood pressure and blood glucose. Curcumin and silymarin exert hepatoprotective effects. Monacolins of red yeast rice are effective cholesterol-lowering agents. However, inconsistent or conflicting results have been found in clinical trials when other promising compounds in vitro or in animal studies, such as policosanol, curcumin or silymarin, were used. Low oral bioavailability of substances, ineffective dosages, inadequate treatment duration and insufficient statistical approach may explain the lack of effectiveness observed in some human studies. Further clinical studies are needed to better understand the role of bioactive compounds in the prevention and management of MetS.
C1 [Francini-Pesenti, Francesco; Spinella, Paolo] Univ Padua, Azienda Osped, Nutr Unit, Dept Med DIMED, Padua, Italy.
   [Calo, Lorenzo A.] Univ Padua, Azienda Osped, Nephrol Dialysis & Transplantat Unit, Dept Med DIMED, Padua, Italy.
C3 University of Padua; Azienda Ospedaliera - Universita di Padova;
   University of Padua; Azienda Ospedaliera - Universita di Padova
RP Calò, LA (corresponding author), Univ Padua, Azienda Osped, Nephrol Dialysis & Transplantat Unit, Dept Med, Via Giustiniani 2, I-35128 Padua, Italy.
RI Spinella, Philip/GNW-3633-2022; FRANCINI, FRANCESCO/AAX-4258-2021; Calò,
   Lorenzo/AAC-9123-2019
OI SPINELLA, PAOLO/0000-0002-5979-9203
CR Abourashed E A., 2017, J. Nat. Prod, V80, P577, DOI DOI 10.1021/ACS.JNATPROD.7B00089
   Actis-Goretta L, 2006, J AGR FOOD CHEM, V54, P229, DOI 10.1021/jf052263o
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Alwi Idrus, 2008, Acta Med Indones, V40, P201
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   [Anonymous], 1995, FOOD PHENOLICS SOURC
   [Anonymous], 2013, EVID-BASED COMPL ALT
   [Anonymous], DISEASES
   [Anonymous], MOLECULES
   [Anonymous], INT J ENV RES PUBLIC
   [Anonymous], MOLECULES
   Assmann G, 2006, NUTR METAB CARDIOVAS, V16, P13, DOI 10.1016/j.numecd.2005.04.001
   Babio N, 2009, PUBLIC HEALTH NUTR, V12, P1607, DOI 10.1017/S1368980009990449
   Bahmani M, 2015, J EVID-BASED INTEGR, V20, P292, DOI 10.1177/2156587215571116
   Basu A, 2010, NUTR RES, V30, P462, DOI 10.1016/j.nutres.2010.06.016
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Baumgartner S, 2017, EUR J NUTR, V56, P909, DOI 10.1007/s00394-016-1289-7
   Berthold HK, 2006, JAMA-J AM MED ASSOC, V295, P2262, DOI 10.1001/jama.295.19.2262
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Beukes N, 2014, J PHARM PHARMACOL, V66, P1505, DOI 10.1111/jphp.12267
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Calo LA, 2014, CLIN NUTR, V33, P437, DOI 10.1016/j.clnu.2013.06.010
   Castaño G, 1999, INT J CLIN PHARM RES, V19, P105
   Castaño G, 2003, DRUG AGING, V20, P153, DOI 10.2165/00002512-200320020-00006
   Castaño G, 2002, INT J CLIN PHARM RES, V22, P55
   Castro-Acosta ML, 2017, J NUTR BIOCHEM, V49, P53, DOI 10.1016/j.jnutbio.2017.07.013
   Chu SL, 2011, CHIN J INTEGR MED, V17, P492, DOI 10.1007/s11655-011-0781-4
   Cicero AFG, 2020, EUR J NUTR, V59, P477, DOI 10.1007/s00394-019-01916-7
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.0.CO;2-Q]
   COLLINS LC, 1994, INT J OBESITY, V18, P551
   Covas MI, 2006, ANN INTERN MED, V145, P333, DOI 10.7326/0003-4819-145-5-200609050-00006
   de Avelar CR, 2017, WORLD J GASTROENTERO, V23, P5004, DOI 10.3748/wjg.v23.i27.5004
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Desideri G, 2012, HYPERTENSION, V60, P794, DOI 10.1161/HYPERTENSIONAHA.112.193060
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Dorenkott MR, 2014, J AGR FOOD CHEM, V62, P2216, DOI 10.1021/jf500333y
   Dulin MF, 2006, AM J CLIN NUTR, V84, P1543, DOI 10.1093/ajcn/84.6.1543
   Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667
   Ervin R Bethene, 2009, Natl Health Stat Report, P1
   Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004
   Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x
   Fallahzadeh MK, 2012, AM J KIDNEY DIS, V60, P896, DOI 10.1053/j.ajkd.2012.06.005
   Faridi Z, 2008, AM J CLIN NUTR, V88, P58, DOI 10.1093/ajcn/88.1.58
   Farrell GC, 2018, ADV EXP MED BIOL, V1061, P19, DOI 10.1007/978-981-10-8684-7_3
   Fehér J, 2012, CURR PHARM BIOTECHNO, V13, P210, DOI 10.2174/138920112798868818
   Fernández JC, 2001, CLIN DRUG INVEST, V21, P103, DOI 10.2165/00044011-200121020-00003
   Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/00004872-200312000-00016
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   Francini-Pesenti F, 2008, COMPLEMENT THER MED, V16, P61, DOI 10.1016/j.ctim.2007.08.003
   Francini-Pesenti F, 2008, PHYTOTHER RES, V22, P318, DOI 10.1002/ptr.2315
   Genser B, 2012, EUR HEART J, V33, P444, DOI 10.1093/eurheartj/ehr441
   Grassi D, 2005, AM J CLIN NUTR, V81, P611
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Greyling A, 2006, BRIT J NUTR, V95, P968, DOI 10.1079/BJN20061715
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI [10.1161/01.CIR.0000111245.75752.C6, 10.1161/01.CIR.0000112379.88385.67]
   Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8
   Haghighat N., 2013, Razi Journal of Medical Sciences, V20, P78
   Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Huang WY, 2014, MOLECULES, V19, P12827, DOI 10.3390/molecules190812827
   IKEDA I, 1988, J LIPID RES, V29, P1573
   Kalea AZ, 2009, J MED FOOD, V12, P21, DOI 10.1089/jmf.2008.0078
   Karalis DG, 2014, ATHEROSCLEROSIS, V237, P191, DOI 10.1016/j.atherosclerosis.2014.07.039
   Kassis AN, 2009, LIPIDS, V44, P391, DOI 10.1007/s11745-009-3295-5
   Kim H, 2018, FOOD FUNCT, V9, P3097, DOI 10.1039/c8fo00595h
   Kim JJ, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/212563
   Kunnumakkara AB, 2017, BRIT J PHARMACOL, V174, P1325, DOI 10.1111/bph.13621
   Lau FC, 2007, J NEUROSCI RES, V85, P1010, DOI 10.1002/jnr.21205
   Lau LHS, 2018, ADV EXP MED BIOL, V1061, P111, DOI 10.1007/978-981-10-8684-7_9
   Lin YG, 2004, METABOLISM, V53, P1309, DOI 10.1016/j.metabol.2004.05.006
   Liu WD, 2016, J DRUG TARGET, V24, P694, DOI 10.3109/1061186X.2016.1157883
   Macready AL, 2014, AM J CLIN NUTR, V99, P479, DOI 10.3945/ajcn.113.074237
   Magrone T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00677
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Mandel Silvia A, 2012, Front Biosci (Schol Ed), V4, P581
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Marinangeli CPF, 2007, BRIT J NUTR, V97, P381, DOI 10.1017/S0007114507336763
   Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005
   Martínez-González MA, 2015, PROG CARDIOVASC DIS, V58, P50, DOI 10.1016/j.pcad.2015.04.003
   Medjakovic S, 2013, FOOD FUNCT, V4, P19, DOI 10.1039/c2fo30034f
   Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367
   Mellor DD, 2010, DIABETIC MED, V27, P1318, DOI 10.1111/j.1464-5491.2010.03108.x
   Menéndez R, 2000, BRIT J CLIN PHARMACO, V50, P255, DOI 10.1046/j.1365-2125.2000.00250.x
   Milani A, 2017, BRIT J PHARMACOL, V174, P1290, DOI 10.1111/bph.13625
   Moazzen H, 2017, PLANT FOOD HUM NUTR, V72, P126, DOI 10.1007/s11130-017-0605-6
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Napoli C, 2009, ARCH PHARM RES, V32, P1103, DOI 10.1007/s12272-009-1801-1
   Ng CH, 2005, J AGR FOOD CHEM, V53, P6289, DOI 10.1021/jf051269a
   Ostlund RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE911, DOI 10.1152/ajpendo.00328.2001
   Ostlund RE, 2007, LIPIDS, V42, P41, DOI 10.1007/s11745-006-3001-9
   Panahi Y, 2018, DRUG RES, V68, P403, DOI 10.1055/s-0044-101752
   Patel MD, 2006, ATHEROSCLEROSIS, V186, P12, DOI 10.1016/j.atherosclerosis.2005.10.026
   POLLAK OJ, 1953, CIRCULATION, V7, P702, DOI 10.1161/01.CIR.7.5.702
   PONS P, 1994, INT J CLIN PHARM RES, V14, P27
   PROPST A, 1995, GASTROENTEROLOGY, V108, P1607, DOI 10.1016/0016-5085(95)90724-6
   Racette SB, 2015, J AOAC INT, V98, P679, DOI 10.5740/jaoacint.SGERacette
   Ramirez-Sanchez I, 2013, INT J CARDIOL, V168, P3982, DOI 10.1016/j.ijcard.2013.06.089
   Ranasinghe P, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4041-1
   Ras RT, 2015, EUR J PREV CARDIOL, V22, P1067, DOI 10.1177/2047487314554864
   Ras RT, 2015, AM J CLIN NUTR, V101, P733, DOI 10.3945/ajcn.114.102053
   Rideout TC, 2015, J AOAC INT, V98, P707, DOI 10.5740/jaoacint.SGERideout
   Rocha VZ, 2016, ATHEROSCLEROSIS, V248, P76, DOI 10.1016/j.atherosclerosis.2016.01.035
   Romer S, 2006, COLLOID SURFACE A, V282, P435, DOI 10.1016/j.colsurfa.2005.12.032
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Ruiz-Canela M, 2011, MATURITAS, V68, P245, DOI 10.1016/j.maturitas.2010.12.002
   Sayin FK, 2016, POL J FOOD NUTR SCI, V66, P43, DOI 10.1515/pjfns-2015-0014
   Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096
   Seymour EM, 2008, J MED FOOD, V11, P252, DOI 10.1089/jmf.2007.658
   Shaghaghi MA, 2013, J ACAD NUTR DIET, V113, P1494, DOI 10.1016/j.jand.2013.07.006
   Shakeri Abolfazl, 2016, Recent Pat Drug Deliv Formul, V10, P7
   Shiina Y, 2009, INT J CARDIOL, V131, P424, DOI 10.1016/j.ijcard.2007.07.131
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Silbernagel G, 2010, J LIPID RES, V51, P2384, DOI 10.1194/jlr.P002899
   Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055
   Soleimani M, 2015, KIDNEY INT, V87, P497, DOI 10.1038/ki.2014.392
   Strat KM, 2016, J NUTR BIOCHEM, V35, P1, DOI 10.1016/j.jnutbio.2015.12.008
   Sudhop T, 2002, METABOLISM, V51, P1519, DOI 10.1053/meta.2002.36298
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Tajmohammadi A, 2018, PHYTOTHER RES, V32, P1933, DOI 10.1002/ptr.6153
   Tao C, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0245-x
   THOMPSON LU, 1991, NUTR CANCER, V16, P43, DOI 10.1080/01635589109514139
   TORRES O, 1995, DIABETES CARE, V18, P393, DOI 10.2337/diacare.18.3.393
   Tsartsou E, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00006
   Tuck KL, 2002, J NUTR BIOCHEM, V13, P636, DOI 10.1016/S0955-2863(02)00229-2
   VANHANEN HT, 1992, CLIN CHIM ACTA, V205, P97, DOI 10.1016/S0009-8981(05)80004-X
   Vendrame S, 2013, J NUTR BIOCHEM, V24, P1508, DOI 10.1016/j.jnutbio.2012.12.010
   de Melo ISV, 2018, PHARMACOL RES, V128, P137, DOI 10.1016/j.phrs.2017.09.010
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885
   Wang HB, 1999, J NAT PROD, V62, P294, DOI 10.1021/np980501m
   Wang TH, 2007, ADV FOOD NUTR RES, V53, P123, DOI 10.1016/S1043-4526(07)53004-4
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Windler E, 2009, ATHEROSCLEROSIS, V203, P284, DOI 10.1016/j.atherosclerosis.2008.06.014
   Yang L, 2015, JAMA INTERN MED, V175, P1412, DOI 10.1001/jamainternmed.2015.2405
   Yang LP, 2017, ADV NUTR, V8, P684, DOI 10.3945/an.116.014852
   Yang TY, 2014, PHYTOTHER RES, V28, P1096, DOI 10.1002/ptr.5111
   Yang YS, 2014, PHYTOTHER RES, V28, P1770, DOI 10.1002/ptr.5197
   Zarvandi M, 2017, BIOMED PHARMACOTHER, V89, P69, DOI 10.1016/j.biopha.2017.02.016
   Zhong S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009061
   ,, 2011, EFSA Journal, V9, P2255
NR 143
TC 42
Z9 43
U1 1
U2 19
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2019
VL 12
BP 1987
EP 2002
DI 10.2147/DMSO.S214550
PG 16
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA JC9WF
UT WOS:000489626600001
PM 31632110
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Muñoz, MD
   Fernández, MD
   Román-Carmena, M
   de la Cruz, MDI
   Amor, S
   Martorell, P
   Enrique-López, M
   García-Villalón, AL
   Inarejos-García, AM
   Granado, M
AF de la Fuente Munoz, Mario
   de la Fuente Fernandez, Maria
   Roman-Carmena, Marta
   Iglesias de la Cruz, Maria del Carmen
   Amor, Sara
   Martorell, Patricia
   Enrique-Lopez, Maria
   Luis Garcia-Villalon, Angel
   Manuel Inarejos-Garcia, Antonio
   Granado, Miriam
TI Supplementation with Two New Standardized Tea Extracts Prevents the
   Development of Hypertension in Mice with Metabolic Syndrome
SO ANTIOXIDANTS
LA English
DT Article
DE hypertension; obesity; metabolic syndrome; white tea; green tea; black
   tea; extract; antioxidant
ID IMPROVES ENDOTHELIAL FUNCTION; GREEN TEA; BLOOD-PRESSURE;
   INSULIN-RESISTANCE; BODY-WEIGHT; PROTECTS; EGCG;
   (-)-EPIGALLOCATECHIN-3-GALLATE; CONTRACTILITY; DYSFUNCTION
AB Hypertension is considered to be both a cardiovascular disease and a risk factor for other cardiovascular diseases, such as coronary ischemia or stroke. In many cases, hypertension occurs in the context of metabolic syndrome (MetS), a condition in which other circumstances such as abdominal obesity, dyslipidemia, and insulin resistance are also present. The high incidence of MetS makes necessary the search for new strategies, ideally of natural origin and with fewer side effects than conventional pharmacological treatments. Among them, the tea plant is a good candidate, as it contains several bioactive compounds such as caffeine, volatile terpenes, organic acids, and polyphenols with positive biological effects. The aim of this study was to assess whether two new standardized tea extracts, one of white tea (WTE) and the other of black and green tea (CTE), exert beneficial effects on the cardiovascular alterations associated with MetS. For this purpose, male C57/BL6J mice were fed a standard diet (Controls), a diet high in fats and sugars (HFHS), HFHS supplemented with 1.6% WTE, or HFHS supplemented with 1.6% CTE for 20 weeks. The chromatography results showed that CTE is more concentrated on gallic acid, xanthines and flavan-3-ols than WTE. In vivo, supplementation with WTE and CTE prevented the development of MetS-associated hypertension through improved endothelial function. This improvement was associated with a lower expression of proinflammatory and prooxidant markers, and-in the case of CTE supplementation-also with a higher expression of antioxidant enzymes in arterial tissue. In conclusion, supplementation with WTE and CTE prevents the development of hypertension in obese mice; as such, they could be an interesting strategy to prevent the cardiovascular disorders associated with MetS.
C1 [de la Fuente Munoz, Mario; de la Fuente Fernandez, Maria; Roman-Carmena, Marta; Iglesias de la Cruz, Maria del Carmen; Amor, Sara; Luis Garcia-Villalon, Angel; Granado, Miriam] Univ Autonoma Madrid, Fac Med, Physiol Dept, Madrid 28029, Spain.
   [Martorell, Patricia; Enrique-Lopez, Maria] R&D Dept Biopolis, Paterna 46980, Spain.
   [Manuel Inarejos-Garcia, Antonio] ADM, R&D Dept Funct Extracts, Valencia 46740, Spain.
   [Granado, Miriam] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid 28029, Spain.
C3 Autonomous University of Madrid; Instituto de Salud Carlos III; CIBER -
   Centro de Investigacion Biomedica en Red; CIBEROBN
RP Granado, M (corresponding author), Univ Autonoma Madrid, Fac Med, Physiol Dept, Madrid 28029, Spain.; Granado, M (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid 28029, Spain.
EM miriam.granado@uam.es
RI Martorell, Patricia/ABC-8717-2021; Iglesias-de la Cruz, Maria
   Carmen/A-6630-2010; Granado, Miriam/B-8978-2017
OI Martorell, Patricia/0000-0001-5689-8399; Iglesias-de la Cruz, Maria
   Carmen/0000-0003-0596-1284; Granado, Miriam/0000-0001-9178-8822; Roman
   Carmena, Marta/0000-0001-9104-2959
FU company ADM Wild; Universidad Autonoma de Madrid through the second call
   of "Programa de Fomento de la Transferencia del Conocimiento UAM";
   Community of Madrid [PEJ-2020-AI/BMD-19155, PEJ-2018AI/SAL-11315]
FX This work was funded by the company ADM Wild, and by Universidad
   Autonoma de Madrid through the second call of "Programa de Fomento de la
   Transferencia del Conocimiento UAM". Community of Madrid funded the
   contracts of Maria de la Fuente-Fernandez (PEJ-2018AI/SAL-11315) and
   Mario de la Fuente Munoz (PEJ-2020-AI/BMD-19155) through the Youth
   Employment Program.
CR Antonello M, 2007, AM J HYPERTENS, V20, P1321, DOI 10.1016/j.amjhyper.2007.08.006
   Auger C, 2010, BIOCHEM BIOPH RES CO, V393, P162, DOI 10.1016/j.bbrc.2010.01.112
   Bai JR, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.110985
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bruno RS, 2008, J NUTR, V138, P323, DOI 10.1093/jn/138.2.323
   Carvalheira JBC, 2008, ARQ BRAS ENDOCRINOL, V52, P6, DOI 10.1590/S0004-27302008000100003
   Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329
   Chatree S, 2021, EXP BIOL MED, V246, P163, DOI 10.1177/1535370220962708
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chen ZM, 2015, J ZHEJIANG UNIV-SC B, V16, P87, DOI 10.1631/jzus.B1500001
   Chupeerach C, 2021, FOODS, V10, DOI 10.3390/foods10010117
   Daiber A, 2017, BRIT J PHARMACOL, V174, P1591, DOI 10.1111/bph.13517
   Dange RB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0242-7
   de la Fuente-Fernández M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040339
   Dong Hua-Jin, 2016, Nan Fang Yi Ke Da Xue Xue Bao, V36, P604
   Feng W, 2012, MOL PHARMACOL, V82, P993, DOI 10.1124/mol.112.079707
   Fuchs FD, 2020, HYPERTENSION, V75, P285, DOI 10.1161/HYPERTENSIONAHA.119.14240
   Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697
   Hirai M, 2007, LIFE SCI, V80, P1020, DOI 10.1016/j.lfs.2006.11.032
   Ihm SH, 2012, ATHEROSCLEROSIS, V224, P377, DOI 10.1016/j.atherosclerosis.2012.07.006
   Inarejos-García AM, 2021, ACS FOOD SCI TECHNOL, V1, P596, DOI 10.1021/acsfoodscitech.1c00003
   Kang JS, 2010, J PHARMACOL EXP THER, V334, P619, DOI 10.1124/jpet.110.169391
   Kendall DM, 2002, AM J MANAG CARE, V8, pS635
   Khalesi S, 2014, EUR J NUTR, V53, P1299, DOI 10.1007/s00394-014-0720-1
   Kishi T, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00335
   Kizhakekuttu TJ, 2010, CARDIOVASC THER, V28, pe20, DOI 10.1111/j.1755-5922.2010.00137.x
   Krzeminska J, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11010172
   Lee BL, 2000, J CHROMATOGR A, V881, P439, DOI 10.1016/S0021-9673(00)00215-6
   LEMBO G, 1992, J CLIN INVEST, V90, P24, DOI 10.1172/JCI115842
   Leung FP, 2016, EUR J NUTR, V55, P1963, DOI 10.1007/s00394-015-1012-0
   Li GW, 2015, J HYPERTENS, V33, P243, DOI 10.1097/HJH.0000000000000426
   Li WJ, 2010, J AGR FOOD CHEM, V58, P8977, DOI 10.1021/jf101277t
   Liou YM, 2010, PFLUG ARCH EUR J PHY, V460, P1003, DOI 10.1007/s00424-010-0881-6
   Liu JH, 2019, FOOD FUNCT, V10, P2847, DOI 10.1039/c8fo02051e
   Mancusi C, 2020, HIGH BLOOD PRESS CAR, V27, P515, DOI 10.1007/s40292-020-00408-8
   Mena P, 2014, IUBMB LIFE, V66, P745, DOI 10.1002/iub.1332
   Meng Q, 2019, J AGR FOOD CHEM, V67, P5379, DOI 10.1021/acs.jafc.8b05917
   Modesto PN, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/8898919
   Mozaffari-Khosravi Hassan, 2013, Journal of Dietary Supplements, V10, P105, DOI 10.3109/19390211.2013.790333
   Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1
   Nacera H, 2017, ACTA POL PHARM, V74, P277
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Nantz MP, 2009, NUTRITION, V25, P147, DOI 10.1016/j.nut.2008.07.018
   Pagnotta E, 2006, J AGR FOOD CHEM, V54, P10159, DOI 10.1021/jf062859r
   Peng XL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06251
   Pinto G, 2020, FOODS, V9, DOI 10.3390/foods9060835
   Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006
   Qi YY, 2019, J PHARMACOL EXP THER, V371, P663, DOI 10.1124/jpet.119.260117
   Razavi BM, 2017, BIOMED PHARMACOTHER, V92, P726, DOI 10.1016/j.biopha.2017.05.113
   Rocha NG, 2014, METABOLISM, V63, P951, DOI 10.1016/j.metabol.2014.04.007
   Salameh A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020628
   Shibu MA, 2018, ENVIRON TOXICOL, V33, P220, DOI 10.1002/tox.22510
   Siamwala JH, 2013, J NUTR BIOCHEM, V24, P595, DOI 10.1016/j.jnutbio.2012.02.016
   Singh N, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00829
   Sorriento D, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00258
   Tong XL, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-98
   Turtle JR, 2000, INT J CLIN PRACT, P23
   Underwood PC, 2013, CURR HYPERTENS REP, V15, P59, DOI 10.1007/s11906-012-0323-2
   WHO, 2021, HLTH TOP CARD DIS TA
   Yanagi S, 2011, J THORAC CARDIOV SUR, V141, P511, DOI 10.1016/j.jtcvs.2010.04.016
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8152, DOI 10.1002/jcp.27603
   Younes M, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5239
   Zagula G, 2017, MOLECULES, V22, DOI 10.3390/molecules22101656
   Zhang YZ, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-0433-9
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 66
TC 8
Z9 8
U1 3
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD AUG
PY 2022
VL 11
IS 8
AR 1573
DI 10.3390/antiox11081573
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 4C4DW
UT WOS:000846407300001
PM 36009292
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Wang, S
   Sparks, LM
   Xie, H
   Greenway, FL
   de Jonge, L
   Smith, SR
AF Wang, S.
   Sparks, L. M.
   Xie, H.
   Greenway, F. L.
   de Jonge, L.
   Smith, S. R.
TI Subtyping obesity with microarrays: implications for the diagnosis and
   treatment of obesity
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
DE subtyping obesity; microarray; cluster analysis; clinical
   characteristics; weight loss
ID VISCERAL ADIPOSE-TISSUE; FAT OXIDATION; EXPRESSION; MUSCLE; GENES; FOOD
AB Objective: Obese patients respond differently to weight loss interventions. No efficient diagnostic tool exists to separate obese patients into subtypes as a means to improve prediction of response to interventions. We aimed to separate obese subjects into distinct subgroups using microarray technology to identify gene expression-based subgroups to predict weight loss.
   Design: A total of 72 obese men and women without family history of diabetes were enrolled in the study; 52 were treated with ephedra and caffeine (E+C) and 20 with placebo for 8 weeks. Adipose and skeletal muscle tissue biopsies were performed at baseline. RNA sample pairs were labeled and hybridized to oligonucleotide microarrays. Quantile normalization and gene shaving were performed, and a clustering algorithm was then applied to cluster subjects based on their gene expression profile. Clusters were visualized using heat maps and related to weight changes.
   Results: Cluster analysis of gene expression data revealed two distinct subgroups of obesity and predicted weight loss in response to the treatment with E+C. One cluster ('red') decreased to 96.87 +/- 2.35% body weight, and the second cluster ('green') decreased to 95.59 +/- 2.75% body weight (P<0.05). 'Red' cluster had less visceral adipose tissue mass ( 2.77 +/- 1.08 vs 3.43 +/- 1.49 kg; P<0.05) and decreased size of the very large fat cells (1.45 +/- 0.61 vs 2.16 +/- 1.74 mu l; P<0.05) compared to 'green' cluster. Gene expression for both skeletal muscle and adipose tissue was also different between clusters.
   Conclusions: Our study provides the first evidence that the combined approach of gene expression profiling and cluster analysis can identify discrete subtypes of obesity, these subtypes have different physiological characteristics and respond differently to an adrenergic weight loss therapy. This brings us that into an era of personalized treatment in the obesity
C1 [Wang, S.; Sparks, L. M.; Xie, H.; Greenway, F. L.; de Jonge, L.; Smith, S. R.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center
RP Smith, SR (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
EM smithsr@pbrc.edu
RI Greenway, Frank/N-1966-2017
OI de Jonge, Lilian/0000-0001-5900-0695; Smith, Steven/0000-0002-5098-8147
FU Community Foundation of Southeast Michigan; PBRC CNRU NIH [P30-DK072476]
FX This work was supported by Community Foundation of Southeast Michigan
   and the PBRC CNRU NIH P30-DK072476. We thank David Hymel for the RNA
   extractions. We are grateful to the volunteers who participated in this
   study and the staff of the clinic at Pennington Biomedical Research
   Center for their assistance.
CR Alizadeh AA, 2001, J PATHOL, V195, P41, DOI 10.1002/path.889
   BJORNTORP P, 1991, INT J OBESITY, V15, P67
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   DEJONGE L, 1991, AM J PHYSIOL, V260, pE238, DOI 10.1152/ajpendo.1991.260.2.E238
   ELIA M, 1988, AM J CLIN NUTR, V47, P591, DOI 10.1093/ajcn/47.4.591
   Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200
   Gastaldelli A, 2005, DIABETOLOGIA, V48, P2090, DOI 10.1007/s00125-005-1891-3
   GUYGRAND B, 1989, LANCET, V2, P1142
   Harris RBS, 1996, J CLIN INVEST, V97, P2020, DOI 10.1172/JCI118637
   Hastie T, 2001, GENOME BIOL, V2
   Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200
   KROTKIEWSKI M, 1977, INT J OBESITY, V1, P395
   LEFEVRE M, 1998, INT J OBESITY S3, V22, pP61
   Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212
   Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   REBUFFESCRIVE M, 1987, INT J OBESITY, V11, P347
   Smith SR, 1999, INT J OBESITY, V23, P329, DOI 10.1038/sj.ijo.0800834
   Smith SR, 2003, DIABETES, V52, P2914, DOI 10.2337/diabetes.52.12.2914
   Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693
   Smith SR., 2006, ADIPOCYTES, V2, P11
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098
   Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926
   Stunkard A, 2000, APPETITE, V34, P333, DOI 10.1006/appe.1999.0337
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Torgerson JS, 1999, J CLIN ENDOCR METAB, V84, P4197, DOI 10.1210/jc.84.11.4197
   Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332
   Vague J, 1996, OBES RES, V4, P201, DOI 10.1002/j.1550-8528.1996.tb00535.x
   Verdich C, 2001, OBES RES, V9, P452, DOI 10.1038/oby.2001.59
   West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998
   White MA, 2002, OBES RES, V10, P107, DOI 10.1038/oby.2002.17
NR 31
TC 15
Z9 16
U1 0
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD APR
PY 2009
VL 33
IS 4
BP 481
EP 489
DI 10.1038/ijo.2008.277
PG 9
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 432AW
UT WOS:000265106900011
PM 19188926
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Park, JS
   Kwon, J
   Choi, HJ
   Lee, C
AF Park, Joon Seok
   Kwon, Jieun
   Choi, Hyung Jin
   Lee, Changhyun
TI Clinical effectiveness of liraglutide on weight loss in South Koreans
   First real-world retrospective data on Saxenda in Asia
SO MEDICINE
LA English
DT Article
DE liraglutide; obesity; weight loss; body mass index; treatment outcome
ID BODY-COMPOSITION; GLP-1 ANALOG; 3.0 MG; MANAGEMENT; OBESE; MAINTENANCE;
   APPETITE
AB Among Asian countries, South Korea was the first to approve liraglutide as a treatment for obesity. Thus, the clinical effectiveness of liraglutide has not been studied in Asian populations. In this study, we retrospectively analyzed obese patients [body mass index (BMI) >27 kg/m(2)] who were treated with liraglutide between March 2018 and March 2019 in a single clinic. Weight, BMI, HbA1c, and clinical data were collected before liraglutide treatment. Changes in body weight and composition and their relationships with clinical variables were examined at re-prescription dates within 30, 60, 90, and 180 days. A total of 169 subjects were studied. The average age was 41.5 years, and 42% of the subjects were male. The average weight was 85.2 kg, and the average BMI was 30.8 kg/m(2). Weight reduction was significant (-5.5 +/- 3.4 kg, 30 days: -3.2 +/- 1.8 kg, 60 days: -4.5 +/- 2.3 kg, 90 days: -6.3 +/- 2.6 kg, 180 days: -7.8 +/- 3.5 kg) during the follow-up period and increased with longer treatment time (P < .001). The percentages of subjects that showed >= 5% and >= 10% body weight reduction were 62.1% and 17.2%, respectively. In the body composition analysis, skeletal muscle weight loss was -3.56 +/- 29.7%, which was significantly smaller than fat weight loss of -11.06 +/- 10.4% (P = .03). Weight loss was not significantly related to age, sex, baseline BMI, baseline HbA1c, smoking status, alcohol consumption, coffee intake. In conclusion, Liraglutide treatment led to meaningful weight loss in South Korean patients, and fat mass reduction was prominent during treatment. Furthermore, liraglutide showed greater clinical effectiveness with longer treatment time.
C1 [Park, Joon Seok; Choi, Hyung Jin] Seoul Natl Univ, Coll Med, Seoul, South Korea.
   [Park, Joon Seok; Kwon, Jieun; Lee, Changhyun] Seoul Happiness Clin Internal Med, 88 Jungjaro, Sungnam Si 13612, South Korea.
C3 Seoul National University (SNU)
RP Lee, C (corresponding author), Seoul Happiness Clin Internal Med, 88 Jungjaro, Sungnam Si 13612, South Korea.
EM mdchlee@gmail.com
OI Kwon, Ji Eun/0000-0001-6615-8319; Park, Joon Seok/0000-0002-1901-8097
FU National Research Foundation of Korea (NRF) - Korean Government [MIST]
   [NRF-2018R1A5A2025964]; Creative-Pioneering Researchers Program through
   Seoul National University (SNU) The Seoul National University Hospital
   Medical Research Collaborating Center (SNUH MRCC)
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grant funded by the Korean Government [MIST]
   (No.NRF-2018R1A5A2025964) This work was supported by Creative-Pioneering
   Researchers Program through Seoul National University (SNU) The Seoul
   National University Hospital Medical Research Collaborating Center (SNUH
   MRCC) contributed to the review of statistical analysis.
CR Bray GA, 2013, OBESITY, V21, P893, DOI 10.1002/oby.20394
   Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726
   Dombrowski S U, 2014, BMJ, V348, pg2646, DOI 10.1136/bmj.g2646
   Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]
   Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003
   Fujioka K, 2016, OBESITY, V24, P2278, DOI 10.1002/oby.21629
   Gorgojo-Martínez JJ, 2019, INT J CLIN PRACT, V73, DOI 10.1111/ijcp.13399
   Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009
   Ishii Satoshi, 2019, J Clin Med Res, V11, P219, DOI 10.14740/jocmr3647
   Jerlhag E, 2018, NEUROPHARMACOLOGY, V136, P343, DOI 10.1016/j.neuropharm.2018.01.013
   Lin KJ, 2016, CLIN PHARMACOL THER, V100, P147, DOI 10.1002/cpt.359
   Lykkegaard K, 2008, SCHIZOPHR RES, V103, P94, DOI 10.1016/j.schres.2008.05.011
   Mancini MC, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0242-0
   Oh TJ, 2019, J OBES METAB SYNDR, V28, P158
   Pasto R, 2019, CURR PHARM DESIGN, V25, P1783, DOI 10.2174/1381612825666190701155737
   Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892
   Poobalan AS, 2007, OBES REV, V8, P503, DOI 10.1111/j.1467-789X.2007.00393.x
   Rondanelli M, 2016, PATIENT PREFER ADHER, V10, P407, DOI 10.2147/PPA.S97383
   Saltiel AR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad1811
   Scott LJ, 2015, DRUGS, V75, P899, DOI 10.1007/s40265-015-0408-8
   van Can J, 2014, INT J OBESITY, V38, P784, DOI 10.1038/ijo.2013.162
   Wadden TA, 2013, INT J OBESITY, V37, pS1, DOI [10.1038/ijo.2013.89, 10.1038/ijo.2013.120]
   Wharton S, 2019, OBESITY, V27, P917, DOI 10.1002/oby.22462
   WHO, 2004, LANCET, V363, P902, DOI 10.1016/S0140-6736(03)15268-3
   Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S
   Wright F, 2013, J HEALTH PSYCHOL, V18, P574, DOI 10.1177/1359105312451865
   Yang SW, 2018, J EXERC REHABIL, V14, P621, DOI 10.12965/jer.1836284.142
NR 27
TC 18
Z9 19
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JAN 15
PY 2021
VL 100
IS 2
AR e23780
DI 10.1097/MD.0000000000023780
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA PZ5VL
UT WOS:000612807900010
PM 33466127
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Akyildiz, K
   Yilmaz, A
   Avci, U
   Toraman, MN
   Yazici, ZA
AF Akyildiz, Kerimali
   Yilmaz, Adnan
   Avci, Ugur
   Toraman, Merve Nur
   Yazici, Zihni Acar
TI White Tea Consumption Alleviates Anthropometric and Metabolic Parameters
   in Obese Patients
SO MEDICINA-LITHUANIA
LA English
DT Article
DE obesity; weight loss; inflammation; lipid profile; oxidative stress
ID OXIDATIVE STRESS; GREEN
AB Background and Objectives: Obesity and related disorders are an increasing global health problem. Achieving and maintaining long-term weight loss through lifestyle changes and/or pharmacological interventions have not met expectations. Dietary supplements and alternative treatments have also shown limited effectiveness in this regard. The consumption of green tea in general has been shown to benefit obese patients, with effects attributed to caffeine, catechins, polyphenols and other components. However, the potential of white tea to prevent and treat the negative effects of obesity has not been addressed so far. In this study, the effect of white tea (WT) consumption in obese individuals was anthropometrically and biochemically investigated. Materials and Methods: Based on anthropometric and biochemical assessments, the patients were assigned to the control, orlistat, metformin and WT groups. Patients were given a diet and exercise program and one of either orlistat, metformin or WT for 12 weeks. At the end of the 12th week, the anthropometric and biochemical measurements were reassessed. Results: Body weight, waist circumference and BMI parameters decreased significantly in all groups. TNF-alpha, IL-6, IL-1 beta and MMP-9 levels decreased significantly in the WT group. In addition, contrary to a significant elevation in HDL-C, the serum cholesterol, LDL-C and TG levels decreased significantly. Furthermore, leptin, ghrelin and asprosin levels decreased significantly. Serum glucose levels decreased significantly in all groups except for the control. In the WT group, while there was a significant decrease in the levels of serum PL MDA and 8-OHdG, the opposite was true for GSH. Conclusions: The oral consumption of WT, its availability and its potency in obesity treatment and prevention pave the way for further delineation of the mechanisms of actions of its bioactive compounds at the cellular and endocrinological levels.
C1 [Akyildiz, Kerimali] Recep Tayyip Erdogan Univ, Sch Vocat Healh Care Serv, Dept Med Serv & Tech, TR-53100 Rize, Turkiye.
   [Yilmaz, Adnan] Recep Tayyip Erdogan Univ, Dept Biochem, TR-53100 Rize, Turkiye.
   [Avci, Ugur] Recep Tayyip Erdogan Univ, Dept Endocrinol & Metab Dis, TR-53100 Rize, Turkiye.
   [Toraman, Merve Nur] Recep Tayyip Erdogan Univ, Dept Nutr & Diet, TR-53100 Rize, Turkiye.
   [Yazici, Zihni Acar] Recep Tayyip Erdogan Univ, Dept Microbiol, TR-53100 Rize, Turkiye.
C3 Recep Tayyip Erdogan University; Recep Tayyip Erdogan University; Recep
   Tayyip Erdogan University; Recep Tayyip Erdogan University; Recep Tayyip
   Erdogan University
RP Yilmaz, A (corresponding author), Recep Tayyip Erdogan Univ, Dept Biochem, TR-53100 Rize, Turkiye.
EM kerimali.akyildiz@erdogan.edu.tr; adnan.yilmaz@erdogan.edu.tr;
   ugur.avci@erdogan.edu.tr; mervenur_toraman19@erdogan.edu.tr
RI Akyildiz, Kerimali/O-1225-2019; yilmaz, adnan/ABB-9340-2020; Yazici,
   Zihni A/AAT-5678-2021
OI yilmaz, adnan/0000-0003-4842-1173; Yazici, Zihni A/0000-0003-1603-6545
FU Recep Tayyip Erdogan University Development Foundation [02024007031029]
FX This study has been supported by the Recep Tayyip Erdogan University
   Development Foundation (Grant number: 02024007031029).
CR Akbulut Atilla, 2020, Akademik Ziraat Dergisi, V9, P279, DOI 10.29278/azd.720699
   Boardman NT, 2020, AM J PHYSIOL-HEART C, V319, pH682, DOI 10.1152/ajpheart.00284.2020
   Büyükuslu N, 2015, CLIN EXP HEALTH SCI, V5, P197, DOI 10.5455/musbed.20150604061607
   Castro-Barquero S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101523
   Chatatikun M, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/6769726
   Chedea VS, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050588
   Cheung BMY, 2013, THER ADV DRUG SAF, V4, P171, DOI 10.1177/2042098613489721
   Doganay S., 2022, Kocatepe Med. J, V23, P244
   DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
   Duraiyarasan Shrimahitha, 2022, Cureus, V14, pe27589, DOI 10.7759/cureus.27589
   Eid AM, 2023, BMC COMPLEMENT MED, V23, DOI 10.1186/s12906-022-03830-8
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029
   Heck AM, 2000, PHARMACOTHERAPY, V20, P270, DOI 10.1592/phco.20.4.270.34882
   Huang LH, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2355-x
   Kajarabille N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194968
   Jovanovic GK, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113583
   Khati WH, 2023, GEN COMP ENDOCR, V331, DOI 10.1016/j.ygcen.2022.114161
   Knez M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010093
   Kumar M, 2012, NUTR CANCER, V64, P300, DOI 10.1080/01635581.2012.648300
   Lai XF, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.848918
   Li N, 2022, GENE, V833, DOI 10.1016/j.gene.2022.146553
   Ludwig DS, 2021, AM J CLIN NUTR, V114, P1873, DOI 10.1093/ajcn/nqab270
   Nahra R, 2021, DIABETES CARE, V44, P1433, DOI 10.2337/dc20-2151
   Nakadate K, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24087054
   Pérez-Torres I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041786
   Phengpol N, 2023, J PHYSIOL BIOCHEM, V79, P1, DOI 10.1007/s13105-022-00927-z
   pour ED, 2021, CLIN NUTR ESPEN, V45, P134, DOI 10.1016/j.clnesp.2021.08.025
   Raynor HA, 2018, CURR OBES REP, V7, P68, DOI 10.1007/s13679-018-0298-7
   Sagkan Ozturk A, 2018, MED J MUSTAFA KEMAL, V9, P136, DOI [10.17944/mkutfd.328412, DOI 10.17944/MKUTFD.328412]
   Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]
   Sari I.K., 2022, J. Health Sci. Med, V5, P755
   Shen CL, 2012, NUTR RES, V32, P448, DOI 10.1016/j.nutres.2012.05.001
   Taylor EB, 2021, CLIN SCI, V135, P731, DOI 10.1042/CS20200895
   Teixeira LG, 2012, CIENCIA TECNOL ALIME, V32, P733, DOI 10.1590/S0101-20612012005000099
   Triggle CR, 2022, METABOLISM, V133, DOI 10.1016/j.metabol.2022.155223
   Weyer C, 2000, J CLIN ENDOCR METAB, V85, P1087, DOI 10.1210/jc.85.3.1087
   Xia XY, 2021, J SCI FOOD AGR, V101, P2500, DOI 10.1002/jsfa.10876
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yilmaz A, 2017, J MATERN-FETAL NEO M, V30, P1355, DOI 10.1080/14767058.2016.1214124
   Yilmaz A, 2024, LIFE-BASEL, V14, DOI 10.3390/life14091077
   Yilmaz F., 2016, J. Contemp. Med, V6, P137
   Zhou F, 2022, FOOD RES INT, V161, DOI 10.1016/j.foodres.2022.111788
   Zorena K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103570
   Zou J, 2022, J TRANSL MED, V20, DOI 10.1186/s12967-022-03542-0
NR 45
TC 1
Z9 1
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1010-660X
EI 1648-9144
J9 MEDICINA-LITHUANIA
JI Med. Lith.
PD OCT
PY 2024
VL 60
IS 10
AR 1568
DI 10.3390/medicina60101568
PG 11
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA K3E8S
UT WOS:001342751800001
PM 39459354
OA gold
DA 2025-04-28
ER

PT J
AU Perez, LC
   Perez, LT
   Nene, Y
   Umpierrez, GE
   Davis, GM
   Pasquel, FJ
AF Perez, Luis. C. C.
   Perez, Laura. T. T.
   Nene, Yash
   Umpierrez, Guillermo. E. E.
   Davis, Georgia. M. M.
   Pasquel, Francisco. J. J.
TI Interventions associated with brown adipose tissue activation and the
   impact on energy expenditure and weight loss: A systematic review
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Review
DE brown adipose tissue; beta agonist; cold exposure; sildenafil;
   capsinoids; browning of white adipose tissue; energy expenditure and
   brown adipose tissue; weight loss and brown adipose tissue
ID BETA(3)-ADRENERGIC RECEPTOR AGONIST; GLP-1 ANALOG LIRAGLUTIDE; GREEN
   TEA; BETA(2)-ADRENERGIC STIMULATION; ADAPTIVE THERMOGENESIS;
   CONTROLLED-TRIAL; FAT OXIDATION; DOUBLE-BLIND; MILD COLD; OBESE
AB Background: Brown adipose tissue (BAT) plays a role in modulating energy expenditure. People with obesity have been shown to have reduced activation of BAT. Agents such as beta-agonists, capsinoids, thyroid hormone, sildenafil, caffeine, or cold exposure may lead to activation of BAT in humans, potentially modulating metabolism to promote weight loss. Methods: We systematically searched electronic databases for clinical trials testing the effect of these agents and cold exposure on energy expenditure/thermogenesis and the extent to which they may impact weight loss in adults. Results : A total of 695 studies from PubMed, Web of Science, and Medline electronic databases were identified. After the removal of duplicates and further evaluation, 47 clinical trials were analyzed. We observed significant heterogeneity in the duration of interventions and the metrics utilized to estimate thermogenesis/energy expenditure. Changes observed in energy expenditure do not correlate with major weight changes with different interventions commonly known to stimulate thermogenesis. Even though cold exposure appears to consistently activate BAT and induce thermogenesis, studies are small, and it appears to be an unlikely sustainable therapy to combat obesity. Most studies were small and potential risks associated with known side effects of some agents such as beta-agonists (tachycardia), sibutramine (hypertension, tachycardia), thyroid hormone (arrhythmias) cannot be fully evaluated from these small trials. Conclusion: Though the impact of BAT activation and associated increases in energy expenditure on clinically meaningful weight loss is a topic of great interest, further data is needed to determine long-term feasibility and efficacy.
C1 [Perez, Luis. C. C.; Perez, Laura. T. T.] Ponce Hlth Sci Univ, Sch Med, Ponce, PR USA.
   [Nene, Yash] SUNY Upstate Med Univ, Neurol Residency Program, Syracuse, NY USA.
   [Umpierrez, Guillermo. E. E.; Davis, Georgia. M. M.; Pasquel, Francisco. J. J.] Emory Univ, Sch Med, Dept Endocrinol, Atlanta, GA 30307 USA.
C3 Ponce Health Sciences University; State University of New York (SUNY)
   System; State University of New York (SUNY) Upstate Medical Center;
   Emory University
RP Pasquel, FJ (corresponding author), Emory Univ, Sch Med, Dept Endocrinol, Atlanta, GA 30307 USA.
EM fpasque@emory.edu
RI MEZQUITA, LAURA/AAH-8859-2020
FU National Institute of General Medical Sciences [K23GM128221] Funding
   Source: NIH RePORTER
CR Acosta FM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196543
   Baskin AS, 2018, DIABETES, V67, P2113, DOI 10.2337/db18-0462
   Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038/sj.ijo.0803351
   Bergmann NC, 2019, DIABETOLOGIA, V62, P665, DOI 10.1007/s00125-018-4810-0
   Blondin DP, 2014, J CLIN ENDOCR METAB, V99, pE438, DOI 10.1210/jc.2013-3901
   Bordicchia M, 2014, J HYPERTENS, V32, P389, DOI 10.1097/HJH.0000000000000024
   Bradley DP, 2012, APPL PHYSIOL NUTR ME, V37, P893, DOI [10.1139/H2012-068, 10.1139/h2012-068]
   Broeders EPM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145049
   Carpentier AC, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00447
   Celi FS, 2010, EUR J ENDOCRINOL, V163, P863, DOI 10.1530/EJE-10-0627
   Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213
   Chondronikola M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00129
   Connoley IP, 1999, BRIT J PHARMACOL, V126, P1487, DOI 10.1038/sj.bjp.0702446
   Coskun T, 2018, MOL METAB, V18, P3, DOI 10.1016/j.molmet.2018.09.009
   Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009
   Cypess AM, 2010, CURR OPIN PEDIATR, V22, P478, DOI 10.1097/MOP.0b013e32833a8d6e
   Din MU, 2016, EUR J NUCL MED MOL I, V43, P1878, DOI 10.1007/s00259-016-3364-y
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dushay J, 2012, DIABETES CARE, V35, P4, DOI 10.2337/dc11-0931
   Engelking L., 2015, TXB VET PHYSIOLOGICA, V3 ed, P444
   Finlin BS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121510
   Florido R., 2011, Handbook of the Biology of Aging, P119
   Gosselin C, 2013, BRIT J NUTR, V110, P282, DOI 10.1017/S0007114512005089
   Hanssen MJW, 2016, DIABETES, V65, P1179, DOI 10.2337/db15-1372
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Heinen CA, 2018, EUR J ENDOCRINOL, V179, P31, DOI 10.1530/EJE-17-0966
   Hoeks J, 2003, AM J PHYSIOL-ENDOC M, V285, pE775, DOI 10.1152/ajpendo.00175.2003
   Horowitz M, 2012, DIABETES RES CLIN PR, V97, P258, DOI 10.1016/j.diabres.2012.02.016
   Inoue N, 2007, BIOSCI BIOTECH BIOCH, V71, P380, DOI 10.1271/bbb.60341
   Jessen S, 2018, SCAND J MED SCI SPOR, V28, P2114, DOI 10.1111/sms.13221
   Josse AR, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-65
   Kim JY, 2021, J OBES METAB SYNDR, V30, P20, DOI 10.7570/jomes20065
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Larsen TM, 2002, AM J CLIN NUTR, V76, P780, DOI 10.1093/ajcn/76.4.780
   Lee P, 2013, INT J OBESITY, V37, P593, DOI 10.1038/ijo.2012.90
   Li SG, 2018, METABOLISM, V78, P106, DOI 10.1016/j.metabol.2017.09.008
   Loh RKC, 2018, DIABETOLOGIA, V61, P220, DOI 10.1007/s00125-017-4479-9
   MacDonald JA, 1998, J COMP PHYSIOL B, V168, P513, DOI 10.1007/s003600050172
   McDonald R.B, 2009, Encyclopedia of Neuroscience, P977, DOI [DOI 10.1016/B978-008045046-9.00118-2, 10.1016/B978-008045046-9.00118-2]
   Mehta NM., 2011, PEDIAT CRITICAL CARE, V4th ed, P1073
   Montell C, 2007, CURR BIOL, V17, pR885, DOI 10.1016/j.cub.2007.08.016
   Moonen MPB, 2019, BBA-MOL CELL BIOL L, V1864, P104, DOI 10.1016/j.bbalip.2018.05.012
   Nahon KJ, 2020, DIABETES OBES METAB, V22, P2032, DOI 10.1111/dom.14120
   Ndahimana Didace, 2017, Clin Nutr Res, V6, P68, DOI 10.7762/cnr.2017.6.2.68
   Nedergaard J., 2017, FETAL NEONATAL PHYSL, V1, P354, DOI [10.1016/B978-0-323-35214-7.00035-4, DOI 10.1016/B978-0-323-35214-7.00035-4]
   O'Mara AE, 2020, J CLIN INVEST, V130, P2209, DOI 10.1172/JCI131126
   Onslev J, 2017, EUR J APPL PHYSIOL, V117, P1907, DOI 10.1007/s00421-017-3679-9
   Peterson CM, 2016, OBESITY, V24, P96, DOI 10.1002/oby.21233
   Pontzer H, 2021, SCIENCE, V373, P808, DOI 10.1126/science.abe5017
   Ang QY, 2017, J PHYSIOL SCI, V67, P395, DOI 10.1007/s12576-016-0472-1
   Redman LM, 2007, J CLIN ENDOCR METAB, V92, P527, DOI 10.1210/jc.2006-1740
   Redman LM, 2014, AM J CLIN NUTR, V99, P71, DOI 10.3945/ajcn.113.065631
   Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184
   Rotstein A, 2008, ANN NUTR METAB, V52, P17, DOI 10.1159/000114290
   Saraç F, 2006, ADV THER, V23, P1016, DOI 10.1007/BF02850222
   Schiffelers SLH, 2000, CLIN PHARMACOL THER, V67, P558, DOI 10.1067/mcp.2000.106794
   Schlögl M, 2013, J CLIN ENDOCR METAB, V98, pE1956, DOI 10.1210/jc.2013-2387
   Senn JR, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01184
   Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561
   Sun LJ, 2018, AM J CLIN NUTR, V107, P62, DOI 10.1093/ajcn/nqx025
   van Baak MA, 2002, CLIN PHARMACOL THER, V71, P272, DOI 10.1067/mcp.2002.122527
   van Can J, 2014, INT J OBESITY, V38, P784, DOI 10.1038/ijo.2013.162
   van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247
   Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288
   Wang QD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123795
   Westerterp K.R., 2000, Endotext
   Whiting S, 2012, APPETITE, V59, P341, DOI 10.1016/j.appet.2012.05.015
   Whittle A, 2013, TRENDS PHARMACOL SCI, V34, P347, DOI 10.1016/j.tips.2013.04.004
   Wijers SLJ, 2007, J CLIN ENDOCR METAB, V92, P4299, DOI 10.1210/jc.2007-1065
   Wijers SLJ, 2011, J CLIN ENDOCR METAB, V96, pE598, DOI 10.1210/jc.2010-1957
   Wijers SLJ, 2010, OBESITY, V18, P1092, DOI 10.1038/oby.2010.74
   Yoneshiro T, 2017, AM J CLIN NUTR, V105, P873, DOI 10.3945/ajcn.116.144972
   Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
   Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105
   Zemel MB, 2019, OBESITY, V27, P59, DOI 10.1002/oby.22346
NR 78
TC 6
Z9 6
U1 0
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD DEC 9
PY 2022
VL 13
AR 1037458
DI 10.3389/fendo.2022.1037458
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 7G3VO
UT WOS:000902456600001
PM 36568070
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Gruber, A
   Nasser, K
   Smith, R
   Sharma, JC
   Thomson, GA
AF Gruber, A
   Nasser, K
   Smith, R
   Sharma, JC
   Thomson, GA
TI Diabetes prevention: is there more to it than lifestyle changes?
SO INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
LA English
DT Review
DE diabetes; prevention; exercise; lifestyle
ID CARDIOVASCULAR RISK-FACTORS; IMPAIRED GLUCOSE-TOLERANCE;
   WEIGHT-REDUCTION; TYPE-2; MELLITUS; OBESITY; HYPERTENSION; PRAVASTATIN;
   RIMONABANT; EXENDIN-4
AB Over the past years, there has been an explosive increase in the prevalence of type 2 diabetes (T2DM) and this is expected to continue, entailing associated morbidity and mortality. An increasing number of studies explore the different ways T2DM could be prevented. On-going lifestyle modifications need to be addressed. High-risk patients should be given counselling on weight loss, possibly using a low glycaemic index diet, with a target of around 7-10% over 6-12 months, as well as instruction for increasing physical activity to around 150 min of physical exercise weekly (NNT = 4-8). Moderate alcohol consumption and coffee consumption may also be of benefit (NNT = 89 and 66, respectively). Metformin (NNT = 14), acarbose (NNT = 11) and troglitazone (NNT = 6) have been shown to prevent/delay T2DM and angiotensin-converting enzyme (ACE) inhibitors and statins appear to have an adjunctive role (NNT = 42 and 112, respectively). Trials with orlistat and bariatric surgery have also prevented T2DM (NNT = 36 and 6, respectively), and forthcoming treatment with GLP1 mimetics appears promising. Diabetes prevention studies should help create well-defined strategies for screening and treating high-risk populations in the real world, as prevention is our only chance to alleviate the ever growing burden of diabetes mellitus in the world.
C1 Kings Mill Hosp, Sherwood Forest Hosp NHS Trust, Sutton In Ashfield NG18 4JL, Notts, England.
RP Kings Mill Hosp, Diabet Unit, Sutton In Ashfield NG18 4JL, Notts, England.
EM agruber@doctors.org.uk
RI Thomson, George/K-8882-2019
CR Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796
   Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628
   Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486
   Conigrave Katherine M, 2003, Treat Endocrinol, V2, P145, DOI 10.2165/00024677-200302030-00001
   Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390
   Dahlöf B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1
   Deedwania PC, 2005, CARDIOL CLIN, V23, P165, DOI 10.1016/j.ccl.2004.11.003
   Freeman DJ, 2001, CIRCULATION, V103, P357
   GESLER WM, 2005, HLTH PLACE      0704
   Gill JMR, 2003, J NUTR BIOCHEM, V14, P122, DOI 10.1016/S0955-2863(02)00275-9
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   *INT DIAB FOR, PREV DIAB
   James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/nejmoa012512
   Lee WJ, 2004, ARCH SURG-CHICAGO, V139, P1088, DOI 10.1001/archsurg.139.10.1088
   Masuzaki Hiroaki, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P255
   NAUCK MA, 2005, PRACT DIABETES INT, V22, P171
   Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537
   Pi-Sunyer FX, 2005, CIRCULATION, V111, P1727
   Pontiroli AE, 2005, DIABETES CARE, V28, P2703, DOI 10.2337/diacare.28.11.2703
   Prisant LM, 2004, J CLIN PHARMACOL, V44, P406, DOI 10.1177/0091270004263018
   Scheen AJ, 2004, DRUGS, V64, P2537, DOI 10.2165/00003495-200464220-00004
   SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
   Sjöström L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622
   Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155
   Trento M, 2001, DIABETES CARE, V24, P995, DOI 10.2337/diacare.24.6.995
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X
   Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270
NR 30
TC 12
Z9 14
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1368-5031
EI 1742-1241
J9 INT J CLIN PRACT
JI Int. J. Clin. Pract.
PD MAY
PY 2006
VL 60
IS 5
BP 590
EP 594
DI 10.1111/j.1368-5031.2006.00929.x
PG 5
WC Medicine, General & Internal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Pharmacology & Pharmacy
GA 038VV
UT WOS:000237258500020
PM 16700860
OA gold
DA 2025-04-28
ER

PT J
AU Lee, CG
   Koo, JH
   Kim, SG
AF Lee, Chan Gyu
   Koo, Ja Hyun
   Kim, Sang Geon
TI Phytochemical regulation of Fyn and AMPK signaling circuitry
SO ARCHIVES OF PHARMACAL RESEARCH
LA English
DT Review
DE Fyn; AMPK; Phytochemical; Antioxidant; Metabolic disease
ID ACTIVATED PROTEIN-KINASE; TYROSINE KINASE; COFFEE CONSUMPTION;
   EPIGALLOCATECHIN-3-GALLATE EGCG; ENERGY-EXPENDITURE; OXIDATIVE-STRESS;
   NUCLEAR EXPORT; ACTS UPSTREAM; SIRT1; INHIBITION
AB During the past decades, phytochemical terpenoids, polyphenols, lignans, flavonoids, and alkaloids have been identified as antioxidative and cytoprotective agents. Adenosine monophosphate-activated protein kinase (AMPK) is a kinase that controls redox-state and oxidative stress in the cell, and serves as a key molecule regulating energy metabolism. Many phytochemicals directly or indirectly alter the AMPK pathway in distinct manners, exerting catabolic metabolism. Some of them are considered promising in the treatment of metabolic diseases such as type II diabetes, obesity, and hyperlipidemia. Another important kinase that regulates energy metabolism is Fyn kinase, a member of the Src family kinases that plays a role in various cellular responses such as insulin signaling, cell growth, oxidative stress and apoptosis. Phytochemical inhibition of Fyn leads to AMPK-mediated protection of the cell in association with increased antioxidative capacity and mitochondrial biogenesis. The kinases may work together to form a signaling circuitry for the homeostasis of energy conservation and expenditure, and may serve as targets of phytochemicals. This review is intended as a compilation of recent advancements in the pharmacological research of phytochemicals targeting Fyn and AMPK circuitry, providing information for the prevention and treatment of metabolic diseases and the accompanying tissue injuries.
C1 [Lee, Chan Gyu; Koo, Ja Hyun; Kim, Sang Geon] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea.
C3 Seoul National University (SNU)
RP Kim, SG (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 151742, South Korea.
EM leeck7@snu.ac.kr; jhkoo@snu.ac.kr; sgk@snu.ac.kr
RI Kim, Tae/AAG-9722-2020; Koo, Ja Hyun/GQP-5440-2022
OI Koo, Ja Hyun/0000-0001-5738-1105
FU Ministry of Health Welfare [A111641]; National Research Foundation of
   Korea grant - Korea government (MSIP) [2007-0056817]
FX This work was supported by the Ministry of Health & Welfare (No.
   A111641) and in part by the National Research Foundation of Korea grant
   funded by the Korea government (MSIP) (No. 2007-0056817).
CR Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003
   Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004
   Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010
   AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
   Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702
   Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008
   [Anonymous], 2008, The Federal Register / FIND, V73, P47828
   Ascherio A, 2004, AM J EPIDEMIOL, V160, P977, DOI 10.1093/aje/kwh312
   Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292
   Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081
   Boney CM, 2001, CELL GROWTH DIFFER, V12, P379
   Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241
   Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079
   Bulzomi P, 2012, J CELL PHYSIOL, V227, P1891, DOI 10.1002/jcp.22917
   Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   CHEADLE C, 1994, J BIOL CHEM, V269, P24034
   Choi SH, 2010, BIOCHEM PHARMACOL, V79, P1352, DOI 10.1016/j.bcp.2009.12.011
   Choi SH, 2010, EXPERT OPIN DRUG MET, V6, P213, DOI 10.1517/17425250903427972
   Choudhury GG, 2006, CELL SIGNAL, V18, P1854, DOI 10.1016/j.cellsig.2006.02.003
   Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667
   Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012
   Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45
   Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104
   Eberl G, 1999, J IMMUNOL, V163, P4091
   Fujiwara H, 2008, DIABETES RES CLIN PR, V80, P185, DOI 10.1016/j.diabres.2007.12.004
   Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004
   Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164
   Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189
   Gan RY, 2014, INT J MOL SCI, V15, P16698, DOI 10.3390/ijms150916698
   Han CY, 2011, ANTIOXID REDOX SIGN, V14, P187, DOI 10.1089/ars.2010.3190
   Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb
   Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879
   Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527
   He ZW, 2008, MOL CARCINOGEN, V47, P172, DOI 10.1002/mc.20299
   HIRANO T, 1989, LIFE SCI, V45, P1111, DOI 10.1016/0024-3205(89)90168-9
   Hou DX, 2010, ANTIOXID REDOX SIGN, V13, P691, DOI 10.1089/ars.2009.2816
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Hwang JT, 2009, PHYTOTHER RES, V23, P262, DOI 10.1002/ptr.2606
   Hwang MK, 2009, BIOCHEM PHARMACOL, V77, P1213, DOI 10.1016/j.bcp.2008.12.021
   Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200
   Janssen PLTMK, 1998, AM J CLIN NUTR, V67, P255, DOI 10.1093/ajcn/67.2.255
   Jelic D, 2007, J MED CHEM, V50, P1090, DOI 10.1021/jm0607202
   Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2
   Joo MS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.427
   Jung SK, 2008, CANCER RES, V68, P6021, DOI 10.1158/0008-5472.CAN-08-0899
   Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282
   Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553
   Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009
   Kim AY, 2012, FREE RADICAL BIO MED, V53, P1198, DOI 10.1016/j.freeradbiomed.2012.06.039
   Kim HS, 2013, J BIOL CHEM, V288, P22693, DOI 10.1074/jbc.M113.477505
   Kim YW, 2009, FREE RADICAL BIO MED, V47, P1082, DOI 10.1016/j.freeradbiomed.2009.07.018
   Ko HH, 1999, J NAT PROD, V62, P164, DOI 10.1021/np980281c
   Koo JH, 2012, MOL PHARMACOL, V82, P27, DOI 10.1124/mol.111.077149
   Kook D, 2008, INVEST OPHTH VIS SCI, V49, P1712, DOI 10.1167/iovs.07-0477
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200
   Landete JM, 2012, CRIT REV FOOD SCI, V52, P936, DOI 10.1080/10408398.2010.513779
   LANG DR, 1974, BIOCHIM BIOPHYS ACTA, V333, P180, DOI 10.1016/0005-2728(74)90002-4
   Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007
   Lee DY, 2010, BIOORG MED CHEM LETT, V20, P3764, DOI 10.1016/j.bmcl.2010.04.064
   Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006
   Li B, 2011, BIOL PHARM BULL, V34, P1566, DOI 10.1248/bpb.34.1566
   Li CY, 2010, CURR OPIN PHARMACOL, V10, P111, DOI 10.1016/j.coph.2009.11.009
   Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074
   Liu G, 2007, J ENDOCRINOL, V194, P569, DOI 10.1677/joe-07-0200
   LIU YL, 1988, TOXICOL APPL PHARM, V93, P442, DOI 10.1016/0041-008X(88)90047-6
   Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664
   Lu J, 2010, J PATHOL, V222, P199, DOI 10.1002/path.2754
   Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162
   Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706
   McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394
   McKenna E, 1996, J BIOL CHEM, V271, P24517, DOI 10.1074/jbc.271.40.24517
   Mokhber-Dezfuli Najmeh, 2014, Pharmacogn Rev, V8, P8, DOI 10.4103/0973-7847.125517
   Niture SK, 2011, J BIOL CHEM, V286, P28821, DOI 10.1074/jbc.M111.255042
   Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1
   Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209
   Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Roebuck BD, 2003, CARCINOGENESIS, V24, P1919, DOI 10.1093/carcin/bgg173
   Rosenzweig T, 2004, CELL SIGNAL, V16, P1299, DOI 10.1016/j.cellsig.2004.03.015
   Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957
   Sánchez-Wandelmer J, 2009, BBA-BIOMEMBRANES, V1788, P1731, DOI 10.1016/j.bbamem.2009.05.002
   Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336
   Serrano JCE, 2013, MOL NUTR FOOD RES, V57, P459, DOI 10.1002/mnfr.201200513
   Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479
   Shin SM, 2009, MOL PHARMACOL, V75, P242, DOI 10.1124/mol.108.051128
   Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093
   SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0
   Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611
   Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583
   Sung SH, 2000, J NAT PROD, V63, P1019, DOI 10.1021/np990499e
   Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022
   Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013
   Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005
   Tse MCL, 2013, MOL CELL BIOL, V33, P1797, DOI 10.1128/MCB.01410-12
   Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552
   Umemori H, 1999, J NEUROSCI, V19, P1393
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vatish Manu, 2009, Archives of Physiology and Biochemistry, V115, P191, DOI 10.1080/13813450903164348
   Wang TTY, 1996, CARCINOGENESIS, V17, P271, DOI 10.1093/carcin/17.2.271
   Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031
   Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005
   Wu LX, 2006, ACTA PHARMACOL SIN, V27, P694, DOI 10.1111/j.1745-7254.2006.00326.x
   Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103
   Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028
   Yamada E, 2010, CELL METAB, V11, P113, DOI 10.1016/j.cmet.2009.12.010
   Yan GR, 2010, PROTEOMICS, V10, P976, DOI 10.1002/pmic.200900662
   Yang YM, 2010, WORLD J GASTROENTERO, V16, P3731, DOI 10.3748/wjg.v16.i30.3731
   Zhang Q, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/924851
   Zhang YS, 2008, MOL CANCER THER, V7, P3470, DOI 10.1158/1535-7163.MCT-08-0625
   Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087161
   ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E
   Zhu H, 2009, EXP BIOL MED, V234, P418, DOI 10.3181/0811-RM-340
NR 120
TC 10
Z9 12
U1 0
U2 16
PU PHARMACEUTICAL SOC KOREA
PI SEOUL
PA 1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA
SN 0253-6269
EI 1976-3786
J9 ARCH PHARM RES
JI Arch. Pharm. Res.
PD DEC
PY 2015
VL 38
IS 12
BP 2093
EP 2105
DI 10.1007/s12272-015-0611-x
PG 13
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CX5RX
UT WOS:000365761300001
PM 25951818
DA 2025-04-28
ER

PT J
AU Jang, YJ
   Koo, HJ
   Sohn, EH
   Kang, SC
   Rhee, DK
   Pyo, S
AF Jang, Yeon Jeong
   Koo, Hyun Jung
   Sohn, Eun-Hwa
   Kang, Se Chan
   Rhee, Dong-Kwon
   Pyo, Suhkneung
TI Theobromine inhibits differentiation of 3T3-L1 cells during the early
   stage of adipogenesis via AMPK and MAPK signaling pathways
SO FOOD & FUNCTION
LA English
DT Article
ID MITOTIC CLONAL EXPANSION; ACTIVATED PROTEIN-KINASE; ADIPOCYTE
   DIFFERENTIATION; RECEPTOR-GAMMA; INSULIN-RESISTANCE; CYCLE ARREST;
   PPAR-GAMMA; EXPRESSION; CAFFEINE; OBESITY
AB Obesity is characterized by hypertrophy and/or by the differentiation or adipogenesis of pre-existing adipocytes. In this study, we investigated the inhibitory effects of theobromine, a type of alkaloid in cocoa, on adipocyte differentiation of 3T3-L1 preadipocytes and its mechanisms of action. Theobromine inhibited the accumulation of lipid droplets, the expression of PPAR gamma and C/EBP alpha, and the mRNA expression of aP2 and leptin. The inhibition of adipogenic differentiation by theobromine occurred primarily in the early stages of differentiation. In addition, theobromine arrested the cell cycle at the G(0)/G(1) phase and regulated the expressions of CDK2, p27, and p21. Theobromine treatment increased AMPK phosphorylation and knockdown of AMPK alpha 1/alpha 2 prevented the ability of theobromine to inhibit PPAR. expression in the differentiating 3T3-L1 cells. Theobromine reduced the phosphorylation of ERK and JNK. Moreover, the secretion and the mRNA level of TNF-alpha and IL-6 were inhibited by theobromine treatment. These data suggest that theobromine inhibits adipocyte differentiation during the early stages of adipogenesis by regulating the expression of PPAR. and C/EBP alpha through the AMPK and ERK/JNK signaling pathways in 3T3-L1 preadipocytes.
C1 [Jang, Yeon Jeong; Rhee, Dong-Kwon; Pyo, Suhkneung] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, Gyeonggi Do, South Korea.
   [Koo, Hyun Jung] Korea Natl Coll Agr & Fisheries, Dept Med & Ind Crops, Jeonju 560500, Jeollabuk Do, South Korea.
   [Sohn, Eun-Hwa] Kangwon Natl Univ, Dept Herbal Med Resources, Samcheok 245710, Gangwon Do, South Korea.
   [Kang, Se Chan] Gachon Univ, Dept Life Sci, Songnam 461701, Gyeonggi Do, South Korea.
C3 Sungkyunkwan University (SKKU); Kangwon National University; Gachon
   University
RP Jang, YJ (corresponding author), Sungkyunkwan Univ, Sch Pharm, Suwon 440746, Gyeonggi Do, South Korea.
EM snpyo@skku.edu
CR Akiba T, 2004, BIOCHEM PHARMACOL, V68, P1929, DOI 10.1016/j.bcp.2004.07.036
   Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022
   Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018
   Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/NCHEMBIO.610, 10.1038/nchembio.610]
   Choi KM, 2012, OBESITY, V20, P1365, DOI 10.1038/oby.2011.388
   Do H, 2013, CELL BIOL TOXICOL, V29, P365, DOI 10.1007/s10565-013-9260-3
   Dorenkott MR, 2014, J AGR FOOD CHEM, V62, P2216, DOI 10.1021/jf500333y
   Fajas L, 1999, MOL CELL BIOL, V19, P5495
   Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907
   Franco R, 2013, NUTRIENTS, V5, P4159, DOI 10.3390/nu5104159
   Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17
   Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783
   Gwon SY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-207
   Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324
   Kim SH, 2008, BIOCHEM BIOPH RES CO, V372, P108, DOI 10.1016/j.bbrc.2008.04.188
   LARSSON B, 1984, BMJ-BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401
   Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001
   Madsen MS, 2014, MOL CELL BIOL, V34, P939, DOI 10.1128/MCB.01344-13
   Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Nasri H, 2014, INT J PREVENTIVE MED, V5, P1487
   Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749
   Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S
   Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005
   Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005
   Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473
   SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149
   Shimba S, 2001, J CELL SCI, V114, P2809
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI [10.1152/physrev.00011.2008, 10.15252/embj.201488104]
   STEINFELDER HJ, 1990, BIOCHEM PHARMACOL, V40, P1154, DOI 10.1016/0006-2952(90)90508-I
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Sugimoto N, 2014, NUTR CANCER, V66, P419, DOI 10.1080/01635581.2013.877497
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231
   Tarantino G, 2011, WORLD J GASTROENTERO, V17, P3785, DOI 10.3748/wjg.v17.i33.3785
   Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242
   Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143
   Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21
   Zhang WY, 2012, DIABETES, V61, P3114, DOI 10.2337/db11-1373
NR 44
TC 63
Z9 68
U1 0
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PY 2015
VL 6
IS 7
BP 2365
EP 2374
DI 10.1039/c5fo00397k
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA CM7TT
UT WOS:000357900100028
PM 26085110
DA 2025-04-28
ER

PT J
AU Miller, PE
   McKinnon, RA
   Krebs-Smith, SM
   Subar, AF
   Chriqui, J
   Kahle, L
   Reedy, J
AF Miller, Paige E.
   McKinnon, Robin A.
   Krebs-Smith, Susan M.
   Subar, Amy F.
   Chriqui, Jamie
   Kahle, Lisa
   Reedy, Jill
TI Sugar-Sweetened Beverage Consumption in the US Novel Assessment
   Methodology
SO AMERICAN JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Article
ID SOFT DRINK CONSUMPTION; METABOLIC SYNDROME; RISK-FACTORS; WEIGHT-GAIN;
   CHILDREN; ADOLESCENTS; ADULTS; YOUNG; OBESITY; TRIAL
AB Background: Sugar-sweetened beverage (SSB) consumption has been linked with poor diet quality, weight gain, and increased risk for obesity, diabetes, and cardiovascular disease. Previous studies have been hampered by inconsistent definitions and a failure to capture all types of SSBs.
   Purpose: To comprehensively examine total SSB consumption in the U.S. using an all-encompassing definition that includes beverages calorically sweetened after purchase in addition to presweetened beverages.
   Methods: Data from the 2005-2008 National Health and Nutrition Examination Survey (N=17,078) were analyzed in September 2012 and used to estimate calories (kilocalories) of added sugars from SSBs and to identify top sources of SSBs.
   Results: On average, Americans aged >= 2 years consumed 171 kcal (8% of total kcal) per day from added sugars in SSBs; the top sources were soda, fruit drinks, tea, coffee, energy/sports drinks, and flavored milks. Male adolescents (aged 12-19 years) had the highest mean intakes (293 kcal/day; 12% of total kcal).
   Conclusions: Americans consume more calories from added sugars in beverages than previously reported. The methodology presented in this paper allows for more-comprehensive estimates than those previously used regarding the extent to which SSBs provide calories from added sugars. (C) 2013 American Journal of Preventive Medicine. All rights reserved.
C1 [Miller, Paige E.] NCI, Canc Prevent Fellowship Program, Rockville, MD USA.
   [McKinnon, Robin A.; Krebs-Smith, Susan M.; Subar, Amy F.; Reedy, Jill] NCI, Div Canc Control & Populat Sci, Rockville, MD USA.
   [Kahle, Lisa] Informat Management Serv Inc, Calverton, MD USA.
   [Miller, Paige E.] Exponent Inc, Ctr Epidemiol Biostat & Computat Biol, Chicago, IL 60661 USA.
   [Chriqui, Jamie] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer
   Institute (NCI); NIH Division of Cancer Control & Population Sciences;
   Information Management Services, Inc.; Exponent; University of Illinois
   System; University of Illinois Chicago; University of Illinois Chicago
   Hospital
RP Miller, PE (corresponding author), Exponent Inc, 525 West Monroe St,Suite 1050, Chicago, IL 60661 USA.
EM pmiller@exponent.com
RI Chriqui, Jamie/LNR-7938-2024
FU Cancer Prevention Fellowship Program of the National Cancer Institute
FX This research was supported by the Cancer Prevention Fellowship Program
   of the National Cancer Institute.
CR [Anonymous], 2010, Dietary Guidelines for Americans, 2010, DOI 10.1177/21650799211026980
   [Anonymous], 2012, NHANES QUEST DAT REL
   [Anonymous], FLUID MILK CONS US W
   Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873
   Bleich SN, 2011, DIABETES CARE, V34, P551, DOI 10.2337/dc10-1687
   Bowman SA, 2008, MYPYRAMID EQUIAVALNE
   Chen LW, 2009, DIABETES CARE, V32, P2236, DOI 10.2337/dc09-0866
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3
   Harris JL, 2011, SUGAR DRINK FACTS EV
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Kirkpatrick SI, 2012, J ACAD NUTR DIET, V112, P624, DOI 10.1016/j.jand.2011.11.012
   Koegel KL, 2011, CTR NUTR POLICY PROM
   KREBSSMITH SM, 1989, J AM DIET ASSOC, V89, P671
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Marshall TA, 2005, J AM COLL NUTR, V24, P65, DOI 10.1080/07315724.2005.10719445
   Mathias KC, 2013, AM J PREV MED, V44, P351, DOI 10.1016/j.amepre.2012.11.036
   O'Neil CE, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-17
   Ogden Cynthia L, 2012, NCHS Data Brief, P1
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI [10.1001/jama.2012.39, 10.1001/jama.2012.40]
   Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013
   Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010
   Rodríguez-Artalejo F, 2003, BRIT J NUTR, V89, P419, DOI 10.1079/BJN2002787
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166
   Yoo S, 2004, AM J CLIN NUTR, V80, P841, DOI 10.1093/ajcn/80.4.841
NR 36
TC 53
Z9 61
U1 0
U2 39
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0749-3797
EI 1873-2607
J9 AM J PREV MED
JI Am. J. Prev. Med.
PD OCT
PY 2013
VL 45
IS 4
BP 416
EP 421
DI 10.1016/j.amepre.2013.05.014
PG 6
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA 228NQ
UT WOS:000325193900006
PM 24050417
DA 2025-04-28
ER

PT J
AU Walton, CM
   Saito, ER
   Warren, CE
   Larsen, JG
   Remund, NP
   Reynolds, PR
   Hansen, JM
   Bikman, BT
AF Walton, Chase M.
   Saito, Erin R.
   Warren, Cali E.
   Larsen, John G.
   Remund, Nicole P.
   Reynolds, Paul R.
   Hansen, Jason M.
   Bikman, Benjamin T.
TI Yerba Mate (Ilex paraguariensis) Supplement Exerts Beneficial,
   Tissue-Specific Effects on Mitochondrial Efficiency and Redox Status in
   Healthy Adult Mice
SO NUTRIENTS
LA English
DT Article
DE yerba mate; metabolism; obesity; nutraceuticals; mitochondria
ID OXIDATIVE STRESS; WEIGHT-LOSS; FAT; PHYTONUTRIENTS; GLUTATHIONE;
   METABOLISM; CAFFEINE; EXTRACT; PLANTS
AB Yerba mate, a herbal tea derived from Ilex paraguariensis, has previously been reported to be protective against obesity-related and other cardiometabolic disorders. Using high-resolution respirometry and reverse-phase high-performance liquid chromatography, the effects of four weeks of yerba mate consumption on mitochondrial efficiency and cellular redox status in skeletal muscle, adipose, and liver, tissues highly relevant to whole-body metabolism, were explored in healthy adult mice. Yerba mate treatment increased the mitochondrial oxygen consumption in adipose but not in the other examined tissues. Yerba mate increased the ATP concentration in skeletal muscle and decreased the ATP concentration in adipose. Combined with the observed changes in oxygen consumption, these data yielded a significantly higher ATP:O-2, a measure of mitochondrial efficiency, in muscle and a significantly lower ATP:O-2 in adipose, which was consistent with yerba mate-induced weight loss. Yerba mate treatment also altered the hepatic glutathione (GSH)/glutathione disulfide (GSSG) redox potential to a more reduced redox state, suggesting the treatment's potential protective effects against oxidative stress and for the preservation of cellular function. Together, these data indicate the beneficial, tissue-specific effects of yerba mate supplementation on mitochondrial bioenergetics and redox states in healthy mice that are protective against obesity.
C1 [Walton, Chase M.; Saito, Erin R.; Warren, Cali E.; Larsen, John G.; Remund, Nicole P.; Reynolds, Paul R.; Hansen, Jason M.; Bikman, Benjamin T.] Brigham Young Univ, Dept Cell Biol & Physiol, Provo, UT 84602 USA.
C3 Brigham Young University
RP Bikman, BT (corresponding author), Brigham Young Univ, Dept Cell Biol & Physiol, Provo, UT 84602 USA.
EM bikman@byu.edu
RI Bikman, Benjamin/AAT-9606-2021; Walton, Chase/JCE-8552-2023
OI Reynolds, Paul/0000-0002-0931-3025
FU Unicity International [R0602556]
FX This work was funded by Unicity International (award number R0602556).
CR Alkhatib A, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-42
   Andersen T, 2001, J HUM NUTR DIET, V14, P243, DOI 10.1046/j.1365-277X.2001.00290.x
   Andrade VMD, 2023, MOL CELL ENDOCRINOL, V564, DOI 10.1016/j.mce.2023.111881
   Arçari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033
   Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204
   Beecher GR, 1999, NUTR REV, V57, pS3
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   de Morais EC, 2009, J AGR FOOD CHEM, V57, P8316, DOI 10.1021/jf901660g
   Drasar PB, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10030576
   Galli RL, 2002, ANN NY ACAD SCI, V959, P128, DOI 10.1111/j.1749-6632.2002.tb02089.x
   Gao HL, 2013, EXP GERONTOL, V48, P572, DOI 10.1016/j.exger.2013.03.008
   Gawron-Gzella A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113706
   Hansen ME, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/765784
   Harris Craig, 2012, Methods Mol Biol, V889, P325, DOI 10.1007/978-1-61779-867-2_21
   Harrold JA, 2013, APPETITE, V62, P84, DOI 10.1016/j.appet.2012.11.018
   Hutchison AT, 2016, BIOCHIMIE, V124, P187, DOI 10.1016/j.biochi.2015.07.025
   Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001
   Jo E, 2016, J STRENGTH COND RES, V30, P1871, DOI 10.1519/JSC.0000000000001277
   Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2
   Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0
   Kim HJ, 2012, J FUNCT FOODS, V4, P287, DOI 10.1016/j.jff.2011.12.005
   Kim SY, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0859-1
   Krolikowski TC, 2022, SPORTS MED-OPEN, V8, DOI 10.1186/s40798-022-00482-3
   Kungel PTAN, 2018, INT J BIOL MACROMOL, V114, P1161, DOI 10.1016/j.ijbiomac.2018.04.020
   Lobo PCB, 2022, NUTRIENTS, V14, DOI 10.3390/nu14132619
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu SC., 2020, Liver Res, V4, P64, DOI [:https://doi.org/10.1016/j.livres.2020.05.003, DOI 10.1016/J.LIVRES.2020.05.003, 10.1016/j.livres.2020.05.003]
   Maleki SJ, 2019, FOOD CHEM, V299, DOI 10.1016/j.foodchem.2019.125124
   Meinhart AD, 2017, FOOD RES INT, V99, P522, DOI 10.1016/j.foodres.2017.06.017
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Miao M, 2014, FOOD CHEM, V145, P205, DOI 10.1016/j.foodchem.2013.08.056
   Lima MTNS, 2022, FOODS, V11, DOI 10.3390/foods11121676
   Panza VP, 2016, BRIT J NUTR, V115, P1370, DOI 10.1017/S000711451600043X
   Piorczynski TB, 2022, NEUROTOXICOL TERATOL, V89, DOI 10.1016/j.ntt.2021.107039
   Plotnick GD, 2003, J AM COLL CARDIOL, V41, P1744, DOI 10.1016/S0735-1097(03)00302-4
   Rani V, 2016, LIFE SCI, V148, P183, DOI 10.1016/j.lfs.2016.02.002
   Rotariu D, 2022, BIOMED PHARMACOTHER, V152, DOI 10.1016/j.biopha.2022.113238
   Rowley TJ, 2017, J NUTR BIOCHEM, V49, P30, DOI 10.1016/j.jnutbio.2017.07.015
   Ruíz-Moreno C, 2020, BRIT J CLIN PHARMACO, V86, P861, DOI 10.1111/bcp.14189
   Saito ER, 2022, METABOLITES, V12, DOI 10.3390/metabo12111019
   Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681
   Silva RD, 2011, FITOTERAPIA, V82, P818, DOI 10.1016/j.fitote.2011.04.011
   Smith ME, 2013, BIOCHEM J, V456, P427, DOI 10.1042/BJ20130807
   Tippetts TS, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-165
   Vasanthi HR, 2012, CURR MED CHEM, V19, P2242
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Walton CM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176255
   Weigel HJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03233
NR 52
TC 4
Z9 4
U1 3
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2023
VL 15
IS 20
AR 4454
DI 10.3390/nu15204454
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA W8VM3
UT WOS:001094351100001
PM 37892529
OA Green Submitted, gold, Green Published
DA 2025-04-28
ER

PT J
AU El Oirdi, M
AF El Oirdi, Mohamed
TI Harnessing the Power of Polyphenols: A New Frontier in Disease
   Prevention and Therapy
SO PHARMACEUTICALS
LA English
DT Review
DE polyphenols; flavonoids; non-flavonoids; action mechanisms; therapeutic
   uses
ID IMPROVES INSULIN SENSITIVITY; BREAST-CANCER CELLS; GREEN TEA EXTRACT;
   RHEUMATOID-ARTHRITIS; HIGH-FAT; DIETARY POLYPHENOLS; OXIDATIVE STRESS;
   ADIPOSE-TISSUE; IN-VITRO; RESVERATROL SUPPLEMENTATION
AB There are a wide variety of phytochemicals collectively known as polyphenols. Their structural diversity results in a broad range of characteristics and biological effects. Polyphenols can be found in a variety of foods and drinks, including fruits, cereals, tea, and coffee. Studies both in vitro and in vivo, as well as clinical trials, have shown that they possess potent antioxidant activities, numerous therapeutic effects, and health advantages. Dietary polyphenols have demonstrated the potential to prevent many health problems, including obesity, atherosclerosis, high blood sugar, diabetes, hypertension, cancer, and neurological diseases. In this paper, the protective effects of polyphenols and the mechanisms behind them are investigated in detail, citing the most recent available literature. This review aims to provide a comprehensive overview of the current knowledge on the role of polyphenols in preventing and managing chronic diseases. The cited publications are derived from in vitro, in vivo, and human-based studies and clinical trials. A more complete understanding of these naturally occurring metabolites will pave the way for the development of novel polyphenol-rich diet and drug development programs. This, in turn, provides further evidence of their health benefits.
C1 [El Oirdi, Mohamed] King Faisal Univ, Coll Sci, Dept Life Sci, Al Hasa 31982, Saudi Arabia.
   [El Oirdi, Mohamed] King Faisal Univ, Dept Basic Sci, Al Hasa 31982, Saudi Arabia.
C3 King Faisal University; King Faisal University
RP El Oirdi, M (corresponding author), King Faisal Univ, Coll Sci, Dept Life Sci, Al Hasa 31982, Saudi Arabia.; El Oirdi, M (corresponding author), King Faisal Univ, Dept Basic Sci, Al Hasa 31982, Saudi Arabia.
EM meloirdi@kfu.edu.sa
RI El Oirdi, Mohamed/HKE-6630-2023; El Oirdi, Mohamed/B-5826-2017
OI El Oirdi, Mohamed/0000-0001-5193-0759
FU Deanship of Scientific Research, Vice Presidency, King Faisal
   University, Saudi Arabia [A461]
FX The Deanship of Scientific Research, Vice Presidency supported this work
   for Graduate Studies and Scientific Research, King Faisal University,
   Saudi Arabia [Grant No. Grant A461].
CR Aatif M, 2023, BIOMEDICINES, V11, DOI 10.3390/biomedicines11072078
   Abarova S, 2024, BIOMOLECULES, V14, DOI 10.3390/biom14010130
   Abarova S, 2020, SCI PHARM, V88, DOI 10.3390/scipharm88040045
   Motaal AA, 2020, MOLECULES, V25, DOI 10.3390/molecules25245864
   Satar NA, 2021, MOLECULES, V26, DOI 10.3390/molecules26041056
   Aghababaei F, 2023, PHARMACEUTICALS-BASE, V16, DOI 10.3390/ph16071020
   Ahangarpour A, 2016, J PHYSIOL PHARMACOL, V67, P243
   Ahangarpour A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7496936
   Ahire V, 2017, NUTR CANCER, V69, P904, DOI 10.1080/01635581.2017.1339811
   Ahmed S, 2024, FRONT PHARMACOL, V15, DOI 10.3389/fphar.2024.1344123
   Al-Khayri JM, 2022, MOLECULES, V27, DOI 10.3390/molecules27092901
   Alam MA, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00121
   Alam W, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101643
   Alexova R, 2023, MOLECULES, V28, DOI 10.3390/molecules28093772
   Amato B, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S87609
   Amawi H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080911
   Amri J, 2022, BIOTECHNOL APPL BIOC, V69, P2112, DOI 10.1002/bab.2272
   Anand S, 2022, LIFE-BASEL, V12, DOI 10.3390/life12101639
   [Anonymous], 2022, Curr. Trends Pharm. Pharm. Chem, V4, P13, DOI [10.18231/j.ctppc.2022.004, DOI 10.18231/J.CTPPC.2022.004]
   Ansari MY, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110452
   Arabshomali A, 2023, MOLECULES, V28, DOI 10.3390/molecules28207209
   Arias-Sánchez RA, 2023, MOLECULES, V28, DOI 10.3390/molecules28145415
   AronPharma Sp. z o. o, 2023, Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy
   AronPharma Sp. z o. o, 2023, Investigation of a Polyphenol-Rich Preparation as Support for Oncology Patients Undergoing Gastrointestinal Tumor Resection
   Attia W Y, 2008, Egypt J Immunol, V15, P169
   Awan FT, 2016, ANN HEMATOL, V95, P1137, DOI 10.1007/s00277-016-2683-1
   Badolato M, 2017, EUR J MED CHEM, V142, P290, DOI 10.1016/j.ejmech.2017.07.064
   Bae JH, 2010, J IMMUNOTHER, V33, P391, DOI 10.1097/CJI.0b013e3181d32f22
   Bagang N, 2023, CHEM-BIOL INTERACT, V377, DOI 10.1016/j.cbi.2023.110470
   Bahman AA, 2018, INT J MOL MED, V42, P1695, DOI 10.3892/ijmm.2018.3725
   Bakour M, 2022, MOLECULES, V27, DOI 10.3390/molecules27185777
   Banach Maciej, 2004, Przegl Epidemiol, V58, P663
   Bari A, 2022, MOLECULES, V27, DOI 10.3390/molecules27082399
   Basak S, 2024, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1323233
   Bathina S, 2015, ARCH MED SCI, V11, P1164, DOI 10.5114/aoms.2015.56342
   Ben Lagha A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244805
   Betts JW, 2019, J MED MICROBIOL, V68, P1552, DOI 10.1099/jmm.0.001060
   Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003
   Bhosale PB, 2020, TRANSL CANCER RES, V9, P7619, DOI 10.21037/tcr-20-2359
   Bie JQ, 2023, COMPOUNDS-BASEL, V3, P40, DOI 10.3390/compounds3010005
   Biesinger S, 2016, EUR J CLIN NUTR, V70, P10, DOI 10.1038/ejcn.2015.88
   Bobrysheva T. N., 2023, Voprosy Pitaniya, V92, P92, DOI 10.33029/0042-8833-2023-92-1-92-107
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Bouloumpasi E, 2024, PROCESSES, V12, DOI 10.3390/pr12010140
   Bouymajane A, 2024, MOLECULES, V29, DOI 10.3390/molecules29030596
   Brückner M, 2012, J CROHNS COLITIS, V6, P226, DOI 10.1016/j.crohns.2011.08.012
   Burkard M, 2017, J NUTR BIOCHEM, V46, P1, DOI 10.1016/j.jnutbio.2017.01.006
   Caponio GR, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11071274
   Carecho R, 2022, MOL NUTR FOOD RES, V66, DOI 10.1002/mnfr.202100959
   Cásedas G, 2017, FOOD FUNCT, V8, P4187, DOI [10.1039/c7fo01205e, 10.1039/C7FO01205E]
   Cetinalp P., 2022, Association of Different Doses of Curcumin with Preadipocyte-Adipocyte Differentiation and Inflammatory Statu
   Charalambous A, 2017, EUR J ONCOL NURS, V27, P1, DOI 10.1016/j.ejon.2017.01.001
   Chen C, 2021, INT IMMUNOPHARMACOL, V96, DOI 10.1016/j.intimp.2021.107805
   Chen DL, 2022, FRONT PLANT SCI, V13, DOI 10.3389/fpls.2022.881032
   Chen MX, 2021, IRAN RED CRESCENT ME, V23, DOI 10.32592/ircmj.2021.23.4.350
   Chen ZQ, 2024, PHYSIOL RES, V73, P91, DOI 10.33549/physiolres.935172
   Chesworth R, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.699329
   Chico L, 2018, CNS NEUROL DISORD-DR, V17, P767, DOI 10.2174/1871527317666180720162029
   Chlif N, 2022, J PHARMACEUT BIOMED, V213, DOI 10.1016/j.jpba.2022.114695
   Choy KW, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01295
   Chuang CC, 2012, J AGR FOOD CHEM, V60, P12458, DOI 10.1021/jf3028107
   Cimmino G, 2023, J CARDIOVASC MED, V24, pE156, DOI 10.2459/JCM.0000000000001450
   Cipolletti M, 2019, J CELL PHYSIOL, V234, P3147, DOI 10.1002/jcp.27309
   Cisár P, 2008, PHYTOTHER RES, V22, P1087, DOI 10.1002/ptr.2461
   Ciumarnean L, 2020, MOLECULES, V25, DOI 10.3390/molecules25184320
   Collins B, 2016, J NUTR BIOCHEM, V31, P150, DOI 10.1016/j.jnutbio.2015.12.021
   Constantin RP, 2010, CELL BIOCHEM FUNCT, V28, P149, DOI 10.1002/cbf.1635
   COSPITE M, 1994, ANGIOLOGY, V45, P566, DOI 10.1177/000331979404500612
   Czerkas K, 2024, MOLECULES, V29, DOI 10.3390/molecules29040879
   Di Lorenzo C, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010273
   Di Meo F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072564
   Dias MC, 2021, MOLECULES, V26, DOI 10.3390/molecules26175377
   Dinu M, 2022, NUTRIENTS, V14, DOI 10.3390/nu14102073
   Donati MB, 2021, SUPPLEMENTATION DIET
   Doss HM, 2018, LIFE SCI, V207, P284, DOI 10.1016/j.lfs.2018.06.013
   Draganescu D, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10010043
   Duda-Chodak A, 2023, MOLECULES, V28, DOI 10.3390/molecules28062536
   Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013
   Dugo L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6293740
   Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje
   Elíes J, 2011, MOL NUTR FOOD RES, V55, P1237, DOI 10.1002/mnfr.201100240
   Erdogan MK, 2022, NUTR CANCER, V74, P660, DOI 10.1080/01635581.2021.1900301
   Eseberri I, 2022, NUTRIENTS, V14, DOI 10.3390/nu14091925
   Esteves F, 2021, J XENOBIOTICS, V11, P94, DOI 10.3390/jox11030007
   Farhan M, 2024, MOLECULES, V29, DOI 10.3390/molecules29040865
   Farhan M, 2023, NUTRIENTS, V15, DOI 10.3390/nu15204486
   Farid R, 2007, NUTR RES, V27, P692, DOI 10.1016/j.nutres.2007.09.007
   Feragalli B, 2019, MINERVA ENDOCRINOL, V44, P97, DOI 10.23736/S0391-1977.18.02820-1
   Ferrara LA, 2000, ARCH INTERN MED, V160, P837, DOI 10.1001/archinte.160.6.837
   Ferraz CR, 2020, MOLECULES, V25, DOI 10.3390/molecules25030762
   Figueira I, 2017, CURR NEUROPHARMACOL, V15, P562, DOI 10.2174/1570159X14666161026151545
   Foti MC, 2007, J PHARM PHARMACOL, V59, P1673, DOI 10.1211/jpp.59.12.0010
   Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008
   Fukami T, 2022, ANNU REV PHARMACOL, V62, P405, DOI 10.1146/annurev-pharmtox-052220-105907
   Gadacha W, 2009, REDOX REP, V14, P154, DOI 10.1179/135100009X466131
   Gallelli G, 2020, INT WOUND J, V17, P485, DOI 10.1111/iwj.13299
   Ranilla LG, 2010, BIORESOURCE TECHNOL, V101, P4676, DOI 10.1016/j.biortech.2010.01.093
   Garbetta A, 2018, FOOD RES INT, V106, P878, DOI 10.1016/j.foodres.2018.01.072
   Gessner DK, 2012, J ANIM PHYSIOL AN N, V96, P1074, DOI 10.1111/j.1439-0396.2011.01222.x
   Gonzales GB, 2015, DRUG METAB REV, V47, P175, DOI 10.3109/03602532.2014.1003649
   Graziani G, 2005, GUT, V54, P193, DOI 10.1136/gut.2004.046292
   Grgic J, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100923
   Guo QP, 2020, SCI CHINA LIFE SCI, V63, P866, DOI 10.1007/s11427-019-9591-5
   Hachimura S, 2018, BIOSCI BIOTECH BIOCH, V82, P584, DOI 10.1080/09168451.2018.1433017
   Han X, 2018, INT J MOL MED, V42, P1460, DOI 10.3892/ijmm.2018.3710
   Has IM, 2023, NUTRIENTS, V15, DOI 10.3390/nu15102281
   Hasima N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.467
   He YZ, 2022, CANCER BIOMARK, V34, P297, DOI 10.3233/CBM-210282
   Herrera-Martínez AD, 2022, OBESITY, V30, P2351, DOI 10.1002/oby.23581
   Horie K, 2019, MOLECULES, V24, DOI 10.3390/molecules24071259
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Hu XP, 2023, MOLECULES, V28, DOI 10.3390/molecules28031444
   Hu Y, 2019, FREE RADICAL BIO MED, V145, P146, DOI 10.1016/j.freeradbiomed.2019.09.024
   Hyun HB, 2018, MOLECULES, V23, DOI 10.3390/molecules23020209
   Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005
   Iqbal I, 2023, MOLECULES, V28, DOI 10.3390/molecules28176403
   Islam T, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202100274
   Jain PG, 2020, FUTUR J PHARM SCI, V6, DOI 10.1186/s43094-020-00071-9
   Javadi F, 2017, J AM COLL NUTR, V36, P9, DOI 10.1080/07315724.2016.1140093
   Alvarez-Martínez FJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80003-y
   Ji XY, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109338
   Jiao XY, 2019, J NUTR BIOCHEM, V64, P88, DOI 10.1016/j.jnutbio.2018.07.008
   Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004
   Jyoti MA, 2024, FRONT CHEM, V12, DOI 10.3389/fchem.2024.1341308
   Kabir ER, 2023, CURR NEUROPHARMACOL, V21, P787, DOI 10.2174/1570159X20666221010113812
   Kalai FZ, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020704
   Kang JH, 2007, FEBS LETT, V581, P4389, DOI 10.1016/j.febslet.2007.07.082
   Kardum Nevena, 2018, Adv Food Nutr Res, V84, P103, DOI 10.1016/bs.afnr.2017.12.001
   Kasprzak-Drozd K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073715
   Kelishadi R, 2005, ARYA ATHEROSCLER, V1, P28
   Kenny TP, 2004, EXP BIOL MED, V229, P765, DOI 10.1177/153537020422900808
   Kenny TP, 2004, EXP BIOL MED, V229, P255, DOI 10.1177/153537020422900306
   Kesse-Guyot E, 2012, J NUTR, V142, P76, DOI 10.3945/jn.111.144428
   Khan D, 2020, CURR PHARM BIOTECHNO, V21, P1059, DOI 10.2174/1389201021666200217112244
   Khan R, 2009, MOLECULES, V14, P586, DOI 10.3390/molecules14020586
   Kiran S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.680944
   Kitson TM, 2004, BIOSCI BIOTECH BIOCH, V68, P2165, DOI 10.1271/bbb.68.2165
   Krauth V, 2023, BIOCHEM PHARMACOL, V208, DOI 10.1016/j.bcp.2022.115385
   Kumar V, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/6852276
   Kurgvietiene L, 2016, MEDICINA-LITHUANIA, V52, P148, DOI 10.1016/j.medici.2016.03.003
   Kwak SC, 2013, BIOL PHARM BULL, V36, P1779
   Laaroussi H, 2020, FOOD RES INT, V138, DOI 10.1016/j.foodres.2020.109802
   Lalitha N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231543
   Lamport Daniel Joseph, 2021, Brain Plast, V6, P139, DOI 10.3233/BPL-200111
   Lee BK, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090843
   Lee HE, 2019, MOLECULES, V24, DOI 10.3390/molecules24112138
   Lee JY, 2011, J AGR FOOD CHEM, V59, P857, DOI 10.1021/jf1033587
   Lee Y, 2021, J INNATE IMMUN, V13, P94, DOI 10.1159/000510315
   Les F, 2021, J PHYSIOL BIOCHEM, V77, P109, DOI 10.1007/s13105-020-00739-z
   Lessard-Lord J, 2024, NPJ BIOFILMS MICROBI, V10, DOI 10.1038/s41522-024-00493-w
   Li JY, 2023, PHYTOMEDICINE, V116, DOI 10.1016/j.phymed.2023.154867
   Li SZ, 2018, BIOMED PHARMACOTHER, V100, P441, DOI 10.1016/j.biopha.2018.02.055
   Li WJ, 2021, J INFLAMM RES, V14, P3393, DOI 10.2147/JIR.S311924
   Li Y., 2012, FOOD SCI HUM WELL, V1, P19, DOI [DOI 10.1016/J.FSHW.2012.08.002, 10.1016/j.fshw.2012.08.002]
   Li Y, 2017, FASEB J, V31, P2603, DOI 10.1096/fj.201601339R
   Liao HF, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.110917
   Liu J, 2023, INT J OBESITY, V47, P100, DOI 10.1038/s41366-022-01245-6
   Liu K, 2010, BIOCHIMIE, V92, P789, DOI 10.1016/j.biochi.2010.02.024
   Long ZY, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/9931957
   Lopes G, 2022, MOLECULES, V27, DOI 10.3390/molecules27227707
   Lossi L, 2022, BIOCHEM J, V479, P357, DOI 10.1042/BCJ20210854
   Lu HY, 2015, BANGL J PHARMACOL, V10, P251, DOI 10.3329/bjp.v10i2.20387
   Luca SV, 2020, CRIT REV FOOD SCI, V60, P626, DOI 10.1080/10408398.2018.1546669
   Luo ZH, 2021, FOOD FUNCT, V12, P10676, DOI [10.1039/d1fo01630j, 10.1039/D1FO01630J]
   Luo ZH, 2021, J AGR FOOD CHEM, V69, P2444, DOI 10.1021/acs.jafc.0c07630
   Lv JW, 2020, DIABET METAB SYND OB, V13, P3313, DOI 10.2147/DMSO.S272147
   Mahajan R, 2018, MINI-REV MED CHEM, V18, P1253, DOI 10.2174/1389557516666161024145216
   Majidinia M, 2019, DNA REPAIR, V82, DOI 10.1016/j.dnarep.2019.102679
   Malekmohammad K, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080301
   Mamun MAA, 2024, BIOMOLECULES, V14, DOI 10.3390/biom14020221
   Manso T, 2022, ANTIBIOTICS-BASEL, V11, DOI 10.3390/antibiotics11010046
   Marinas Ioana Cristina, 2014, Roum Arch Microbiol Immunol, V73, P35
   Marouf BH, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/3668568
   de Toda IM, 2023, MECH AGEING DEV, V211, DOI 10.1016/j.mad.2023.111797
   Martinez J, 2000, BIOCHEM PHARMACOL, V59, P865, DOI 10.1016/S0006-2952(99)00380-9
   McKenna E, 1996, J BIOL CHEM, V271, P24517, DOI 10.1074/jbc.271.40.24517
   Melrose J, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12030663
   Meng QH, 2020, J ETHNOPHARMACOL, V248, DOI 10.1016/j.jep.2019.112326
   Micek A, 2022, J BERRY RES, V12, P551, DOI 10.3233/JBR-220054
   Miklasinska-Majdanik M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102321
   Mohammadi A, 2019, J NUTR BIOCHEM, V66, P1, DOI 10.1016/j.jnutbio.2018.12.005
   Montes  O, 2019, PHYTON-INT J EXP BOT, V88, P1, DOI 10.32604/phyton.2019.04525
   Morris G, 2021, FREE RADICAL BIO MED, V172, P101, DOI 10.1016/j.freeradbiomed.2021.05.036
   Mou X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149513
   Moussa C, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0779-0
   Murakami A, 2024, CURR OPIN BIOTECH, V86, DOI 10.1016/j.copbio.2024.103074
   Ortíz BM, 2016, WORLD J DIABETES, V7, P615, DOI 10.4239/wjd.v7.i20.615
   Nájera-Maldonado JM, 2024, J XENOBIOTICS, V14, P227, DOI 10.3390/jox14010014
   Nakagawa Y, 2020, CLIN MED INSIGHTS-AR, V13, DOI 10.1177/1179544120948471
   Nasrabadi MH, 2022, J AYURVEDA INTEGR ME, V13, DOI 10.1016/j.jaim.2021.10.001
   Neamatallah T, 2018, FOOD FUNCT, V9, P3743, DOI [10.1039/c8fo00653a, 10.1039/C8FO00653A]
   Negrati M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103482
   Neog MK, 2017, BIOFACTORS, V43, P698, DOI 10.1002/biof.1377
   Nunes C, 2013, FOOD FUNCT, V4, P373, DOI 10.1039/c2fo30233k
   Nyakundi BB, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24076846
   Oliviero F, 2019, FOODS, V8, DOI 10.3390/foods8110560
   Orchard T., 2023, Protecting the Brain From Toxic Side Effects of Chemotherapy: A Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer
   Oz HS, 2005, J NUTR BIOCHEM, V16, P297, DOI 10.1016/j.jnutbio.2004.09.007
   Oza MJ, 2018, BIOMED PHARMACOTHER, V107, P1119, DOI 10.1016/j.biopha.2018.08.073
   Oza MJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00739
   Ozkan E, 2020, AN ACAD BRAS CIENC, V92, DOI 10.1590/0001-3765202020200548
   Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906, 10.1136/bmj.n160]
   Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41
   Pandareesh MD, 2015, NEUROCHEM INT, V89, P198, DOI 10.1016/j.neuint.2015.07.003
   Patel Harsh, 2024, Med Rev (2021), V4, P5, DOI 10.1515/mr-2023-0058
   Patra S, 2021, PHYTOMEDICINE, V90, DOI 10.1016/j.phymed.2021.153554
   Paul BM, 2024, FOOD CHEM, V435, DOI 10.1016/j.foodchem.2023.137577
   Pereira L, 2023, MAR DRUGS, V21, DOI 10.3390/md21060323
   Pey AL, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20180459
   Pinent M, 2005, INT J OBESITY, V29, P934, DOI 10.1038/sj.ijo.0802988
   Pintea A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9070562
   Pop OL, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12040865
   Prasath GS, 2014, EUR J PHARMACOL, V740, P248, DOI 10.1016/j.ejphar.2014.06.065
   Purgatorio R, 2024, ANTIOXIDANTS-BASEL, V13, DOI 10.3390/antiox13010133
   Qin SH, 2020, CANCERS, V12, DOI 10.3390/cancers12040974
   Raeessi MA, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-293
   Rahman SU, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02448-7
   Rajput A, 2023, N-S ARCH PHARMACOL, V396, P901, DOI 10.1007/s00210-023-02410-y
   Ram C, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12051052
   Rangkadilok N, 2012, FITOTERAPIA, V83, P545, DOI 10.1016/j.fitote.2011.12.023
   Rasheed Z, 2018, EUR J NUTR, V57, P917, DOI 10.1007/s00394-016-1375-x
   Rasmi Y., 2022, Dietary Polyphenols in Human Diseases, P27, DOI [DOI 10.1201/9781003251538-2, 10.1201/9781003251538-2]
   Rathod NB, 2023, PLANTS-BASEL, V12, DOI 10.3390/plants12061217
   Rizza S, 2011, J CLIN ENDOCR METAB, V96, pE782, DOI 10.1210/jc.2010-2879
   Rojas-García A, 2023, NUTRIENTS, V15, DOI 10.3390/nu15020449
   Rolnik A, 2020, IND CROP PROD, V152, DOI 10.1016/j.indcrop.2020.112536
   Campos-Esparza MR, 2009, CELL CALCIUM, V45, P358, DOI 10.1016/j.ceca.2008.12.007
   Sadri H, 2017, BRAZ ARCH BIOL TECHN, V60, DOI 10.1590/1678-4324-2017160741
   Sahadevan R, 2023, CRIT REV FOOD SCI, V63, P10382, DOI 10.1080/10408398.2022.2068500
   Sahebkar A, 2014, PHYTOTHER RES, V28, P633, DOI 10.1002/ptr.5045
   Sanches-Silva A, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2019.104626
   Sang SM, 2022, J NUTR SCI VITAMINOL, V68, pS124, DOI 10.3177/jnsv.68.S124
   Santhakumar AB, 2018, FOOD CHEM TOXICOL, V113, P49, DOI 10.1016/j.fct.2018.01.022
   Saxena P, 2022, BIOTECHNOL LETT, V44, P1, DOI 10.1007/s10529-021-03200-3
   Schaefer S, 2006, MOL NUTR FOOD RES, V50, P24, DOI 10.1002/mnfr.200500136
   Schewe T, 2001, BIOL CHEM, V382, P1687, DOI 10.1515/BC.2001.204
   Seeram NP, 2005, J NUTR BIOCHEM, V16, P360, DOI 10.1016/j.jnutbio.2005.01.006
   Shahwan AJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211131
   Shamsudin NF, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232012605
   Shavandi M, 2017, IRAN J ALLERGY ASTHM, V16, P99
   Sheikhshabani SH, 2021, LIFE SCI, V278, DOI 10.1016/j.lfs.2021.119525
   Shep D, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019723
   Simoes R, 2024, NUTRIENTS, V16, DOI 10.3390/nu16040551
   Sirca TB, 2024, INT J MOL SCI, V25, DOI 10.3390/ijms25052962
   Sirse M, 2022, LIFE-BASEL, V12, DOI 10.3390/life12030436
   Soeng S., 2015, J Exp Integr Med, V5, P55, DOI [10.5455/JEIM.200115.OR.120, DOI 10.5455/JEIM.200115.OR.120]
   Solnier J, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24108663
   Song X, 2024, MOLECULES, V29, DOI 10.3390/molecules29040825
   Song YJ, 2023, MOL NUTR FOOD RES, V67, DOI 10.1002/mnfr.202200768
   Stein JH, 1999, CIRCULATION, V100, P1050, DOI 10.1161/01.CIR.100.10.1050
   Su CY, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11010239
   Sung S, 2019, MOLECULES, V24, DOI 10.3390/molecules24081589
   Sychrová A, 2022, MOLECULES, V27, DOI 10.3390/molecules27144491
   Symonds EL, 2013, BRIT J NUTR, V109, P2117, DOI 10.1017/S0007114512004333
   Szczepanska P, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24087167
   Takruri H. R., 2017, Journal of Agricultural Science (Toronto), V9, P196, DOI 10.5539/jas.v9n2p196
   Tay KC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00820
   Teng H, 2019, CRIT REV FOOD SCI, V59, P2040, DOI 10.1080/10408398.2018.1437023
   Thaipitakwong T, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2019.102292
   Thaipitakwong T, 2018, PHARM BIOL, V56, P109, DOI 10.1080/13880209.2018.1424210
   Tian Y, 2020, CELL MOL LIFE SCI, V77, P665, DOI 10.1007/s00018-019-03298-9
   Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002
   Tsai MH, 2017, INT J BIOCHEM CELL B, V88, P113, DOI 10.1016/j.biocel.2017.05.015
   Uchiyama Y, 2013, J AGR FOOD CHEM, V61, P11410, DOI 10.1021/jf401635w
   van der Zande HJP, 2021, INT J OBESITY, V45, P2016, DOI 10.1038/s41366-021-00870-x
   Venturelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073097
   Vinayagam R, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0057-7
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
   Wahba MGF, 2016, PHARM BIOL, V54, P1705, DOI 10.3109/13880209.2015.1125931
   Walle T, 2009, INT J MOL SCI, V10, P5002, DOI 10.3390/ijms10115002
   Wang B, 2014, FOOD FUNCT, V5, P1452, DOI 10.1039/c3fo60714c
   Wang J, 2021, LETT APPL MICROBIOL, V72, P688, DOI 10.1111/lam.13458
   Wang LM, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619871359
   Wang Q, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.948889
   Wang SH, 2022, FOOD FUNCT, V13, P9734, DOI [10.1039/d2fo01552h, 10.1039/D2FO01552H]
   Wang Tong, 2025, Comb Chem High Throughput Screen, DOI 10.2174/1386207326666230412084201
   Wang XP, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9899
   Wen LH, 2022, NUTRIENTS, V14, DOI 10.3390/nu14214681
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Xie Y, 2022, J AGR FOOD CHEM, V70, P7683, DOI 10.1021/acs.jafc.2c01784
   Xu L, 2023, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.1131074
   Xu MJ, 2023, MOLECULES, V28, DOI 10.3390/molecules28083424
   Xu T, 2020, J CANCER, V11, P3955, DOI 10.7150/jca.41783
   Xu XL, 2020, DRUG DES DEV THER, V14, P2079, DOI 10.2147/DDDT.S244059
   Xue D., 2020, Espacenet, Patent No. 111447940
   Yamagata K, 2019, CURR PHARM DESIGN, V25, P2443, DOI 10.2174/1381612825666190722100504
   Yan XH, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0179-x
   Yang MD, 2021, MOLECULES, V26, DOI 10.3390/molecules26082204
   Yi JJ, 2019, BIOMED PHARMACOTHER, V113, DOI 10.1016/j.biopha.2019.108703
   Yin JH, 2019, ONCOTARGETS THER, V12, P3893, DOI 10.2147/OTT.S199601
   Yu RR, 2023, MOLECULES, V28, DOI 10.3390/molecules28217321
   Zargaran A, 2018, NEUROL SCI, V39, P1345, DOI 10.1007/s10072-018-3415-1
   Zatterale F, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01607
   Zeng P, 2021, AGING-US, V13, P18993, DOI 10.18632/aging.203348
   Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014
   Zhang PW, 2022, PHYTOTHER RES, V36, P551, DOI 10.1002/ptr.7342
   Zhang W, 2019, J CELL BIOCHEM, V120, P16283, DOI 10.1002/jcb.28910
   Zhang WW, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.671150
   Zhang XF, 2022, FOOD FUNCT, V13, P437, DOI [10.1039/d1fo02974f, 10.1039/D1FO02974F]
   Zhang Y, 2022, NUTRIENTS, V14, DOI 10.3390/nu14245373
   Zhao ZQ, 2022, BIOMED PHARMACOTHER, V153, DOI 10.1016/j.biopha.2022.113530
   Zhou F, 2020, J NUTR, V150, P2131, DOI 10.1093/jn/nxaa163
   Zhou YY, 2020, EUR J PHARMACOL, V881, DOI 10.1016/j.ejphar.2020.173185
   Zhou Z, 2019, MOL MED REP, V20, P2893, DOI 10.3892/mmr.2019.10512
   Zhu CL, 2022, CHEMOTHERAPY, V67, P211, DOI 10.1159/000518121
NR 305
TC 14
Z9 14
U1 10
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1424-8247
J9 PHARMACEUTICALS-BASE
JI Pharmaceuticals
PD JUN
PY 2024
VL 17
IS 6
AR 692
DI 10.3390/ph17060692
PG 45
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA WS0C7
UT WOS:001256735200001
PM 38931359
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Baltar, VT
   Cunha, DB
   Santos, RD
   Marchioni, DM
   Sichieri, R
AF Baltar, Valeria Troncoso
   Cunha, Diana Barbosa
   Santos, Roberta de Oliveira
   Marchioni, Dirce Maria
   Sichieri, Rosely
TI Breakfast patterns and their association with body mass index in
   Brazilian adults
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Breakfast; Feeding Behavior; Body Mass Index; Statistical Factor
   Analysis
ID DIETARY PATTERNS; WAIST CIRCUMFERENCE; NATIONAL-HEALTH; METABOLIC
   SYNDROME; FOOD PATTERNS; ENERGY-INTAKE; OBESITY; QUALITY; DENSITY; MEALS
AB The objective was to investigate the relationships between body mass index (BMI), skipping breakfast, and breakfast patterns in Brazilian adults. We analyzed data of 21,003 individuals aged between 20 to 59 from the Brazilian National Dietary Survey 2008-2009. Breakfast was defined as the eating occasion between 5 and 10a.m. with the highest usual food consumption (exceeding 50Kcal/209.2kJ). Dietary patterns were derived by the factor analysis of 18 food groups (usual intake). Controlling for confounders linear regressions of BMI were used to verify the associations considering the survey design. Skipping breakfast was not associated with BMI. Three breakfast patterns were observed (48% variability): Brazilian Northern (positive loading for meats, preparations with corn, eggs, tubers/roots/potatoes, dairy products, savory snacks/crackers, fruit juices/fruit drinks/soy-based drinks); Western (positive for fruit juices/fruit drinks/soy-based drinks, sandwiches/ pizza, baked/deep-fried snacks, chocolate/desserts, cakes/cookies) and Brazilian Southeastern (cold cut meat, milk, cheese, coffee/tea, bread). The Brazilian Southeastern pattern was inversely associated with BMI, while the Brazilian Northern pattern was directly associated with it. Therefore, the results suggest a role for breakfast quality in the association with BMI. Thus, a Brazilian Southeastern breakfast usual intake may be inversely associated with BMI.
C1 [Baltar, Valeria Troncoso] Univ Fed Fluminense, Dept Epidemiol & Bioestat, Travessa Marques Parana 303,32 Andar, BR-24030210 Niteroi, RJ, Brazil.
   [Cunha, Diana Barbosa; Sichieri, Rosely] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Santos, Roberta de Oliveira; Marchioni, Dirce Maria] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, Brazil.
C3 Universidade Federal Fluminense; Universidade do Estado do Rio de
   Janeiro; Universidade de Sao Paulo
RP Baltar, VT (corresponding author), Univ Fed Fluminense, Dept Epidemiol & Bioestat, Travessa Marques Parana 303,32 Andar, BR-24030210 Niteroi, RJ, Brazil.
EM vtbaltar@id.uff.br
RI Brito, Flavia/ADC-5052-2022; Baltar, Valeria/AFM-7189-2022; de Oliveira
   Santos, Roberta/AAN-2098-2020; Marchioni, Dirce Maria/C-6053-2012;
   Santos, Roberta de Oliveira/P-3433-2015
OI Barbosa Cunha, Diana/0000-0003-0900-5628; Marchioni, Dirce
   Maria/0000-0002-6810-5779; Santos, Roberta de
   Oliveira/0000-0001-5598-1350
FU Carlos Chagas Filho Foundation for Research Support in the State of Rio
   de Janeiro (FAPERJ)
FX To Carlos Chagas Filho Foundation for Research Support in the State of
   Rio de Janeiro (FAPERJ) for the financial support.
CR Andersson J, 2003, APPETITE, V41, P149, DOI 10.1016/S0195-6663(03)00052-7
   [Anonymous], 2011, COORD TRAB REND PESQ
   Brown AW, 2013, AM J CLIN NUTR, V98, P1298, DOI 10.3945/ajcn.113.064410
   Casazza K, 2013, NEW ENGL J MED, V368, P2236, DOI [10.1056/NEJMsa1208051, 10.1056/NEJMc1303009]
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/s0140-6736(16)30054-x
   Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Gosby AK, 2014, OBES REV, V15, P183, DOI 10.1111/obr.12131
   Hair J. F., 2010, Multivariate data analysis with readings, V7th Edition, DOI DOI 10.1016/J.IJPHARM.2011.02.019
   Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Huang CJ, 2010, INT J OBESITY, V34, P720, DOI 10.1038/ijo.2009.285
   Instituto Brasileiro de Geografia e Estatistica, 2011, PESQ ORC FAM 2008 20
   Johnson RA., 1992, Applied multivariate statistical analysis, V3rd edn
   Kant AK, 2008, AM J CLIN NUTR, V88, P1396, DOI 10.3945/ajcn.2008.26171
   LeCheminant GM, 2017, APPETITE, V112, P44, DOI 10.1016/j.appet.2016.12.041
   Lee JS, 2016, EAT BEHAV, V21, P84, DOI 10.1016/j.eatbeh.2016.01.009
   Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262
   Martínez-González MA, 2013, REV ENDOCR METAB DIS, V14, P265, DOI 10.1007/s11154-013-9264-6
   Maskarinec G, 2000, J NUTR, V130, P3068, DOI 10.1093/jn/130.12.3068
   Min C, 2012, NUTR RES PRACT, V6, P61, DOI 10.4162/nrp.2012.6.1.61
   Mu M, 2014, J AM COLL NUTR, V33, P120, DOI 10.1080/07315724.2013.874897
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504
   Ocké MC, 2013, P NUTR SOC, V72, P191, DOI 10.1017/S0029665113000013
   Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X
   Pannu Poonam K, 2016, Adv Food Nutr Res, V77, P57, DOI 10.1016/bs.afnr.2015.11.001
   Pasiakos SM, 2015, J NUTR, V145, P605, DOI 10.3945/jn.114.205203
   Santos RD, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4582-3
   Santos RD, 2015, BRIT J NUTR, V114, P822, DOI 10.1017/S0007114515002445
   SCHLUNDT DG, 1992, AM J CLIN NUTR, V55, P645, DOI 10.1093/ajcn/55.3.645
   Schulze MB, 2006, OBESITY, V14, P1444, DOI 10.1038/oby.2006.164
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Siega-Riz AM, 2000, PREV MED, V30, P415, DOI 10.1006/pmed.2000.0651
   Song WO, 2005, J AM DIET ASSOC, V105, P1373, DOI 10.1016/j.jada.2005.06.002
   Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005
   Timlin MT, 2007, NUTR REV, V65, P268, DOI [10.1301/nr.2007.jun.268-281, 10.1111/j.1753-4887.2007.tb00304.x]
   Tooze JA, 2006, J AM DIET ASSOC, V106, P1575, DOI 10.1016/j.jada.2006.07.003
   Verly E, 2017, EUR J CLIN NUTR, V71, P1418, DOI 10.1038/ejcn.2017.120
   Verly E, 2017, CAD SAUDE PUBLICA, V33, DOI 10.1590/0102-311X00173216
   WHO, 2003, WHO TECH REP SER, V916, P1
   Willett WC, 2008, ASIA PAC J CLIN NUTR, V17, P75
   Yoo KB, 2014, ASIA PAC J CLIN NUTR, V23, P128, DOI 10.6133/apjcn.2014.23.1.08
NR 45
TC 21
Z9 23
U1 0
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2018
VL 34
IS 6
AR e00111917
DI 10.1590/0102-311X00111917
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA GL0JY
UT WOS:000436773800001
PM 29952402
OA gold, Green Submitted, Green Published
DA 2025-04-28
ER

PT J
AU Salas, S
   Cottet, V
   Dossus, L
   Fassier, P
   Ginhac, J
   Latino-Martel, P
   Romieu, I
   Schneider, S
   Srour, B
   Touillaud, M
   Touvier, M
   Ancellin, R
AF Salas, Sebastien
   Cottet, Vanessa
   Dossus, Laure
   Fassier, Philippine
   Ginhac, Julie
   Latino-Martel, Paule
   Romieu, Isabelle
   Schneider, Stephane
   Srour, Bernard
   Touillaud, Marina
   Touvier, Mathilde
   Ancellin, Raphaelle
TI Nutritional Factors during and after Cancer: Impacts on Survival and
   Quality of Life
SO NUTRIENTS
LA English
DT Review
DE cancer; diet; dietary supplements; obesity; alcohol
ID BODY-MASS INDEX; BREAST-CANCER; COLORECTAL-CANCER; PROSTATE-CANCER;
   POOLED ANALYSIS; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC VALUE;
   CLINICAL-TRIALS; GASTRIC-CANCER; COFFEE INTAKE
AB The French National Cancer Institute conducted a collective expertise study with researchers and clinical experts from the French Network for Nutrition And Cancer Research (NACRe Network). The objective was to update the state of knowledge on the impacts of nutritional factors on clinical endpoints during or after cancer. Data from 150 meta-analyses, pooled analyses or intervention trials and 93 cohort studies were examined; they concerned 8 nutritional factors, 6 clinical events and 20 cancer locations. This report shows that some nutritional factors have impacts on mortality and on the risks of recurrence or second primary cancer in cancer patients. Therefore, high-risk nutritional conditions can be encountered for certain cancer sites: from the diagnosis and throughout the health care pathways, weight loss (lung and esophageal cancers), malnutrition (lung, esophageal, colorectal, pancreatic, gastric and liver cancers), weight gain (colorectal, breast and kidney cancers) and alcohol consumption (upper aerodigestive cancers) should be monitored; and after cancer treatments, excess weight should be detected (colorectal, breast and kidney cancers). These situations require nutritional assessments, and even support or management by health care professionals, in the context of tertiary prevention. This report also highlights some limitations regarding the existing literature and some needs for future research.
C1 [Salas, Sebastien] Aix Marseille Univ, Timone Hosp, AP HM, F-13000 Marseille, France.
   [Salas, Sebastien; Cottet, Vanessa; Dossus, Laure; Fassier, Philippine; Ginhac, Julie; Latino-Martel, Paule; Romieu, Isabelle; Schneider, Stephane; Srour, Bernard; Touillaud, Marina; Touvier, Mathilde] French Network Nutr & Canc Res NACRe Network, F-78350 Jouy En Josas, France.
   [Cottet, Vanessa] Univ Burgundy Franche Comte, INSERM UMR1231, CIC 1432, LabEx LipSTIC ANR LABX 0021 11, F-21000 Dijon, France.
   [Dossus, Laure; Romieu, Isabelle] Int Agcy Res Canc, F-69000 Lyon, France.
   [Fassier, Philippine] Gustave Roussy Inst, F-94800 Villejuif, France.
   [Ginhac, Julie; Latino-Martel, Paule; Srour, Bernard; Touvier, Mathilde] Univ Paris, Sorbonne Paris Nord Univ, Epidemiol & Stat Res Ctr CRESS, INSERM,INRAE,CNAM,Nutr Epidemiol Res Team EREN, F-93022 Bobigny, France.
   [Schneider, Stephane] Univ Cote Azur, Univ Hosp, F-06000 Nice, France.
   [Touillaud, Marina] Leon Berard Canc Ctr, UA8 Inserm, F-69000 Lyon, France.
   [Ancellin, Raphaelle] French Natl Canc Inst INCa, F-92012 Boulogne, France.
C3 Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Institut Agro; AgroSup Dijon; Universite Bourgogne Europe; World Health
   Organization; International Agency for Research on Cancer (IARC);
   UNICANCER; Gustave Roussy; INRAE; heSam Universite; Conservatoire
   National Arts & Metiers (CNAM); Universite Paris Cite; Institut National
   de la Sante et de la Recherche Medicale (Inserm); CHU Nice; Universite
   Cote d'Azur; UNICANCER; Centre Leon Berard; Institut National du Cancer
   (INCA) France
RP Cottet, V (corresponding author), French Network Nutr & Canc Res NACRe Network, F-78350 Jouy En Josas, France.; Cottet, V (corresponding author), Univ Burgundy Franche Comte, INSERM UMR1231, CIC 1432, LabEx LipSTIC ANR LABX 0021 11, F-21000 Dijon, France.
EM sebastien.salas@ap-hm.fr; vanessa.cottet@u-bourgogne.fr;
   dossusl@iarc.fr; p.fassier@eren.smbh.univ-paris13.fr;
   julie.ginhac@inrae.fr; paule.latino-martel@inrae.fr; iromieu@gmail.com;
   schneider.s@chu-nice.fr; b.srour@eren.smbh.univ-paris13.fr;
   marina.touillaud@lyon.unicancer.fr; m.touvier@eren.smbh.univ-paris13.fr;
   rancellin@institutcancer.fr
RI Cottet, Vanessa/ABE-3236-2020; Fassier, Philippine/F-5918-2018; Dossus,
   Laure/AAW-9097-2021; Latino-Martel, Paule/F-2706-2017; Srour,
   Bernard/X-8652-2019; Touvier, Mathilde/E-8817-2017; Touvier,
   Mathilde/GLT-6939-2022; Schneider, Stephane/G-9511-2011
OI Touvier, Mathilde/0000-0002-8322-8857; Dossus,
   Laure/0000-0003-2716-5748; Schneider, Stephane/0000-0001-6256-8169;
   Srour, Bernard/0000-0002-1277-3380
CR [AFSSA] Agence Fran?aise de S?curit? Sanitaire des Aliments, 2005, SEC BEN PHYT ESTR AP
   Angot Christine, 2018, Un Tournant de la Vie
   ANSES, Complements Alimentaires a Base de Plantes: Vers Une Meilleure Information Des Consommateurs
   Aparicio T, 2018, EUR J CANCER, V98, P1, DOI 10.1016/j.ejca.2018.03.031
   Arends J, 2017, CLIN NUTR, V36, P11, DOI 10.1016/j.clnu.2016.07.015
   Asher GN, 2017, AM FAM PHYSICIAN, V96, P101
   Boshier PR, 2018, DIS ESOPHAGUS, V31, DOI 10.1093/dote/doy047
   Chan DSM, 2014, ANN ONCOL, V25, P1901, DOI 10.1093/annonc/mdu042
   Chang KV, 2018, LIVER CANCER, V7, P90, DOI 10.1159/000484950
   Chen L, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0056-6
   Chi F, 2013, ASIAN PAC J CANCER P, V14, P2407, DOI 10.7314/APJCP.2013.14.4.2407
   Chlebowski RT, 2017, J CLIN ONCOL, V35, P2919, DOI [10.1200/JCO.2016.72.0326, 10.1200/jco.2016.72.0326]
   Clark LH, 2016, GYNECOL ONCOL, V141, P497, DOI 10.1016/j.ygyno.2016.03.035
   Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230
   Druesne-Pecollo N, 2014, CANCER EPIDEM BIOMAR, V23, P324, DOI 10.1158/1055-9965.EPI-13-0779
   Druesne-Pecollo N, 2012, BREAST CANCER RES TR, V135, P647, DOI 10.1007/s10549-012-2187-1
   Eliza WLY, 2012, RECENT PATENTS INFLA, V6, P78, DOI [10.2174/187221312798889275, 10.2174/187221312798889310]
   Fasinu PS, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01356
   Fontanella C, 2015, BREAST CANCER RES TR, V150, P127, DOI 10.1007/s10549-015-3287-5
   Guercio BJ, 2015, J CLIN ONCOL, V33, P3598, DOI 10.1200/JCO.2015.61.5062
   Harris HR, 2014, EUR J CANCER, V50, P1223, DOI 10.1016/j.ejca.2014.02.013
   Hong L, 2013, DIS ESOPHAGUS, V26, P623, DOI 10.1111/dote.12016
   Hu Y, 2018, GASTROENTEROLOGY, V154, P916, DOI 10.1053/j.gastro.2017.11.010
   INCa, 2017, CONNAISSANCES SCIENT
   Institut National du Cancer, 2015, NUTR PREV PRIM CANC
   Institut National du Cancer, 2016, SURV NETT COND CHEZ
   Institut national du cancer, 2019, EC LAIT CHIFFR
   Kamarajah SK, 2019, GASTRIC CANCER, V22, P10, DOI 10.1007/s10120-018-0882-2
   Kizer NT, 2011, CANCER-AM CANCER SOC, V117, P948, DOI 10.1002/cncr.25544
   Lee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120706
   Mintziras I, 2018, INT J SURG, V59, P19, DOI 10.1016/j.ijsu.2018.09.014
   Nechuta S, 2016, INT J CANCER, V138, P2088, DOI 10.1002/ijc.29940
   Nojiri S, 2017, NUTRITION, V33, P20, DOI 10.1016/j.nut.2016.07.013
   Oei RW, 2018, ONCOTARGETS THER, V11, P4857, DOI 10.2147/OTT.S165133
   Pai PC, 2012, INT J RADIAT ONCOL, V83, pE93, DOI 10.1016/j.ijrobp.2011.11.071
   Pajares B, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3572
   Patel JD, 2016, ANN ONCOL, V27, P1612, DOI 10.1093/annonc/mdw211
   Pettersson A, 2012, CANCER EPIDEM BIOMAR, V21, P428, DOI 10.1158/1055-9965.EPI-11-1004
   Poole EM, 2013, BREAST CANCER RES TR, V139, P529, DOI 10.1007/s10549-013-2548-4
   Ravasco P, 2012, AM J CLIN NUTR, V96, P1346, DOI 10.3945/ajcn.111.018838
   Ren GX, 2018, BONE MARROW TRANSPL, V53, P708, DOI 10.1038/s41409-018-0234-1
   Renfro LA, 2016, J CLIN ONCOL, V34, P144, DOI 10.1200/JCO.2015.61.6441
   Richman EL, 2013, JAMA INTERN MED, V173, P1318, DOI 10.1001/jamainternmed.2013.6536
   Rock Cheryl L, 2012, CA Cancer J Clin, V62, P243, DOI 10.3322/caac.21142
   Shachar SS, 2016, EUR J CANCER, V57, P58, DOI 10.1016/j.ejca.2015.12.030
   Shi Q, 2016, COMPUT INTEL NEUROSC, P1, DOI [10.1007/s11655-015-2437-2, DOI 10.1007/S11655-015-2437-2]
   Sinicrope FA, 2013, CANCER-AM CANCER SOC, V119, P1528, DOI 10.1002/cncr.27938
   Sinicrope FA, 2012, J CLIN ONCOL, V30, P406, DOI 10.1200/JCO.2011.39.2563
   Van Blarigan EL, 2015, CANCER CAUSE CONTROL, V26, P1117, DOI 10.1007/s10552-015-0606-4
   Vrieling A, 2018, EUR UROL FOCUS, V4, P420, DOI 10.1016/j.euf.2016.11.009
   Wang J, 2018, EUR J CLIN NUTR, V72, P4, DOI 10.1038/ejcn.2017.70
   World Cancer Research Fund International/American Institute for Cancer Research, 2014, WORLD CANC RES FUND
   Wu SJ, 2014, CANCER CAUSE CONTROL, V25, P1489, DOI 10.1007/s10552-014-0450-y
   Wu XS, 2013, WORLD J GASTROENTERO, V19, P4596, DOI 10.3748/wjg.v19.i27.4596
   Xing MY, 2014, ASIAN PAC J CANCER P, V15, P1141, DOI 10.7314/APJCP.2014.15.3.1141
   Yang M, 2015, INT J CANCER, V137, P2462, DOI 10.1002/ijc.29608
   Yetley EA, 2007, AM J CLIN NUTR, V85, p269S, DOI 10.1093/ajcn/85.1.269S
   Zeng Q, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2214-4
   Zhang Jiao, 2018, Oncotarget, V9, P13959, DOI 10.18632/oncotarget.24210
   Zhang SF, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/6180810
   Zhao BC, 2018, NUTR CANCER, V70, P1254, DOI 10.1080/01635581.2018.1559937
NR 61
TC 46
Z9 48
U1 2
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUL
PY 2022
VL 14
IS 14
AR 2958
DI 10.3390/nu14142958
PG 18
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 3H8YK
UT WOS:000832315900001
PM 35889914
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Baret, P
   Septembre-Malaterre, A
   Rigoulet, M
   d'Hellencourt, CL
   Priault, M
   Gonthier, MP
   Devin, A
AF Baret, Pascal
   Septembre-Malaterre, Axelle
   Rigoulet, Michel
   d'Hellencourt, Christian Lefebvre
   Priault, Muriel
   Gonthier, Marie-Paule
   Devin, Anne
TI Dietary polyphenols preconditioning protects 3T3-L1 preadipocytes from
   mitochondrial alterations induced by oxidative stress
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Mitochondria biogenesis; Polyphenols; Oxidative stress; 3T3-L1
   pre-adipocytes
ID INDUCED INSULIN-RESISTANCE; HYDROGEN-PEROXIDE; ADIPOCYTE
   DIFFERENTIATION; ADIPOSE-TISSUE; OBESITY; METABOLISM; ADIPOGENESIS;
   FIBROBLASTS; DYSFUNCTION; BIOGENESIS
AB Numerous studies indicate that an increase in reactive oxygen species (ROS) significantly affects white adipose tissue biology and leads to an inflammatory profile and insulin resistance, which could contribute to obesity-associated diabetes and cardiovascular diseases. Mitochondria play a key role in adipose tissue energy metabolism and constitute the main source of cellular ROS such as H2O2. Polyphenols constitute the most abundant antioxidants provided by the human diet. Indeed, they are widely distributed in fruits, vegetables and some plant-derived beverages such as coffee and tea. Thus, the biological effects of dietary polyphenols that may increase the antioxidant capacity of the body against obesity-induced oxidative stress are of high interest. Here, we studied the capacity of polyphenols to modulate the impact of oxidative stress on the mitochondria of preadipocytes, which are important cells governing the adipose tissue development for energy homeostasis. Whereas H2O2 treatment induces a proliferation arrest associated with an increase in mitochondrial content in 3T3-L1 preadipocytes, preconditioning with some major dietary polyphenols totally or partially protects the cells against oxidative stress consequences.
   This article is part of a Directed Issue entitled: Bioenergetic dysfunction, adaptation and therapy. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Baret, Pascal; Septembre-Malaterre, Axelle; d'Hellencourt, Christian Lefebvre; Gonthier, Marie-Paule] Univ La Reunion, Grp Etud Inflammat Chron & Obesite EA 4516, F-97715 St Denis Messag 9, France.
   [Baret, Pascal; Rigoulet, Michel; Priault, Muriel; Devin, Anne] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France.
   [Baret, Pascal; Rigoulet, Michel; Priault, Muriel; Devin, Anne] Univ Bordeaux, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France.
C3 University of La Reunion; Universite de Bordeaux; Centre National de la
   Recherche Scientifique (CNRS); CNRS - National Institute for Biology
   (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS -
   National Institute for Biology (INSB); Universite de Bordeaux
RP Devin, A (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France.
EM anne.devin@ibgc.u-bordeaux2.fr
RI Priault, Muriel/HHT-0658-2022
OI Priault, Muriel/0000-0001-8193-0389
FU Agence Nationale de la Recherche ANR; Conseil Regional d'Aquitaine;
   European Union; French Ministere de la recherche; La Region Reunion
FX This work was supported in part by the Agence Nationale de la Recherche
   ANR, and the Conseil Regional d'Aquitaine, the European Union, the
   French Ministere de la recherche and La Region Reunion. The authors wish
   to thank Dr. C. Schwimmer for English proofreading.
CR Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005
   Ailhaud G, 2006, CR BIOL, V329, P570, DOI 10.1016/j.crvi.2005.12.012
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   Barnouin K, 2002, J BIOL CHEM, V277, P13761, DOI 10.1074/jbc.M111123200
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936
   Carrasco-Pozo C, 2012, CHEM-BIOL INTERACT, V195, P199, DOI 10.1016/j.cbi.2011.12.007
   Carrière A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200
   Carrière A, 2003, FEBS LETT, V550, P163, DOI 10.1016/S0014-5793(03)00862-7
   Casteilla L, 2001, IUBMB LIFE, V52, P181, DOI 10.1080/15216540152845984
   Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570
   de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708
   Ducluzeau PH, 2011, J PHYSIOL BIOCHEM, V67, P285, DOI 10.1007/s13105-011-0074-6
   FALOONA GR, 1969, BIOCHEMISTRY-US, V8, P4497, DOI 10.1021/bi00839a041
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Gonthier MP, 2003, FREE RADICAL BIO MED, V35, P837, DOI 10.1016/S0891-5849(03)00394-0
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Guo HH, 2008, BIOCHEM PHARMACOL, V75, P1393, DOI 10.1016/j.bcp.2007.11.016
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Hsu CL, 2007, J AGR FOOD CHEM, V55, P7359, DOI 10.1021/jf071223c
   Imhoff BR, 2010, DIFFERENTIATION, V80, P31, DOI 10.1016/j.diff.2010.04.005
   Kim JR, 2006, EXP MOL MED, V38, P162, DOI 10.1038/emm.2006.20
   Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200
   Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200
   Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200
   Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010
   MICHIELS C, 1990, J CELL PHYSIOL, V144, P295, DOI 10.1002/jcp.1041440216
   Newton BW, 2011, J PROTEOME RES, V10, P4692, DOI 10.1021/pr200491h
   Nishikawa T, 2007, DIABETES RES CLIN PR, V77, pS41, DOI 10.1016/j.diabres.2007.01.031
   Nogueira V, 2001, J BIOL CHEM, V276, P46104, DOI 10.1074/jbc.M107425200
   Panickar KS, 2011, INT J MOL SCI, V12, P8181, DOI 10.3390/ijms12118181
   Park HS, 2009, BIOFACTORS, V35, P373, DOI 10.1002/biof.38
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363
   Roche M, 2009, CELL BIOL TOXICOL, V25, P635, DOI 10.1007/s10565-008-9118-2
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Schönfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243
   Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456
   Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752
   Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003
   Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829
   Yen GC, 2011, J AGR FOOD CHEM, V59, P546, DOI 10.1021/jf1036992
NR 52
TC 33
Z9 33
U1 0
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD JAN
PY 2013
VL 45
IS 1
BP 167
EP 174
DI 10.1016/j.biocel.2012.10.007
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 078BP
UT WOS:000314073400024
PM 23103716
DA 2025-04-28
ER

PT J
AU Liu, W
   Wan, CP
   Huang, YJ
   Li, MX
AF Liu, Wei
   Wan, Chunpeng
   Huang, Yingjie
   Li, Mingxi
TI Effects of tea consumption on metabolic syndrome: A systematic review
   andmeta-analysisof randomized clinical trials
SO PHYTOTHERAPY RESEARCH
LA English
DT Review
DE BMI; diabetes; hyperlipidemia; hypertension; tea
ID BLACK TEA; INSULIN-RESISTANCE; BLOOD-PRESSURE; EXTRACT; OBESITY;
   METAANALYSES; INDIVIDUALS; ASSOCIATION; QUALITY; COFFEE
AB The metabolic syndrome (MetS) is one of the major health hazards and an epidemic worldwide. There is no known best remedy has been defined yet. In the current investigation, we designed a meta-analysis of randomized clinical trials (RCTs) to evaluate the beneficial effects of tea consumption in alleviating metabolic syndromes. Herein, we accumulated the relevant literature available on PubMed and EMBASE databases from January, 2000 to August, 2019. RCTs bearing impact factor of at least 1 or more were studied for the effect of tea consumption on MetS. This meta-analysis suggested that tea consumption has beneficial effects on diastolic blood pressure (DBP), and this finding was characterized of all types of tea in the current study and also for body mass index (BMI) value. Furthermore, this analysis also found that black tea consumption has protective effects on systolic SBP, green tea reduces the incidence of diabetes and lower the level of low-density lipoprotein (LDL) cholesterol. These functions required BMI value at least 28 or higher. The meta data led us to conclude that tea consumption have protective effects on MetS, however, different types of tea might have different protective mechanisms on MetS, but, exact mechanisms are not yet clear and needs to be explored.
C1 [Liu, Wei] Yili Normal Univ, Key Lab Univ Educ, Dept Xinjiang Uygur Autonomous Reg, Xinjiang, Peoples R China.
   [Wan, Chunpeng; Huang, Yingjie; Li, Mingxi] Jiangxi Agr Univ, Coll Agron, Res Ctr Tea & Tea Culture, Nanchang 330045, Jiangxi, Peoples R China.
C3 Yili Normal University; Jiangxi Agricultural University
RP Li, MX (corresponding author), Jiangxi Agr Univ, Coll Agron, Res Ctr Tea & Tea Culture, Nanchang 330045, Jiangxi, Peoples R China.
EM liming.xi@hotmail.com
RI wan, chunpeng/T-8707-2019; Li, Yong-Qiang/E-4298-2019; Wan,
   Chunpeng/H-1423-2011
OI Wan, Chunpeng/0000-0001-6892-016X; liu, wei/0000-0002-4404-6348
FU Education Department project of Jiangxi province [GJJ160360]; Key
   Laboratory of Natural Product Chemistry and Application [2019YSHXZD01];
   Natural Science Foundation in Jiangxi Province [20181BBF60025]
FX Education Department project of Jiangxi province, Grant/Award Number:
   GJJ160360; Key Laboratory of Natural Product Chemistry and Application,
   Grant/Award Number: 2019YSHXZD01; Natural Science Foundation in Jiangxi
   Province, Grant/Award Number: 20181BBF60025
CR Amiot MJ, 2016, OBES REV, V17, P573, DOI 10.1111/obr.12409
   Basu A, 2011, NUTRITION, V27, P206, DOI 10.1016/j.nut.2010.01.015
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Bohn SK, 2014, FOOD FUNCT, V5, P1613, DOI 10.1039/c4fo00209a
   Brown L, 2015, OBES REV, V16, P914, DOI 10.1111/obr.12313
   CAO SY, 2019, ANTIOXIDANTS BASEL, V8
   Costa-Vieira D, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051141
   Engin A, 2017, ADV EXP MED BIOL, V960, P1, DOI 10.1007/978-3-319-48382-5_1
   Fukino Y, 2005, J NUTR SCI VITAMINOL, V51, P335, DOI 10.3177/jnsv.51.335
   Gao WQ, 2018, BIOMED PHARMACOTHER, V103, P637, DOI 10.1016/j.biopha.2018.04.043
   Grassi D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110727
   Grassi D, 2015, NUTRIENTS, V7, P1037, DOI 10.3390/nu7021037
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Hibi M, 2018, NUTR RES, V55, P1, DOI 10.1016/j.nutres.2018.03.012
   Huang JB, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700696
   Huh JH, 2019, DIABETES METAB J, V43, P530, DOI 10.4093/dmj.2018.0111
   Kim Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010017
   Kuriyan R, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-27
   Li XM, 2020, CLIN NUTR, V39, P1049, DOI 10.1016/j.clnu.2019.05.019
   Liu CJ, 2014, ACS SUSTAIN CHEM ENG, V2, P3, DOI 10.1021/sc400376m
   Meng J M., 2019, Antioxidants (Basel), V8
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   Moher D, 2000, ONKOLOGIE, V23, P597, DOI 10.1159/000055014
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287
   Mukamal KJ, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.07.008
   Payab M, 2020, PHYTOTHER RES, V34, P526, DOI 10.1002/ptr.6547
   Pei RS, 2020, CURR OPIN BIOTECH, V61, P153, DOI 10.1016/j.copbio.2019.12.018
   Prasanth MI, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020474
   Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379
   Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z
   Samavat H, 2016, AM J CLIN NUTR, V104, P1671, DOI 10.3945/ajcn.116.137075
   Sherling DH, 2017, J CARDIOVASC PHARM T, V22, P365, DOI 10.1177/1074248416686187
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Troup R, 2015, J ACAD NUTR DIET, V115, P264, DOI 10.1016/j.jand.2014.07.021
   Tsai CH, 2009, INT J FOOD SCI NUTR, V60, P151, DOI 10.1080/09637480903136667
   Yamagata K, 2020, J CARDIOVASC PHARM, V75, P292, DOI 10.1097/FJC.0000000000000792
   Yang CS, 2019, J AGR FOOD CHEM, V67, P5446, DOI 10.1021/acs.jafc.8b05242
   Yang CS, 2018, J FOOD DRUG ANAL, V26, P1, DOI 10.1016/j.jfda.2017.10.010
   Zheng YY, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010224
   Zhou J, 2019, J AGR FOOD CHEM, V67, P5306, DOI 10.1021/acs.jafc.8b05032
NR 41
TC 23
Z9 23
U1 3
U2 73
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD NOV
PY 2020
VL 34
IS 11
BP 2857
EP 2866
DI 10.1002/ptr.6731
EA JUN 2020
PG 10
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA OS7SL
UT WOS:000542163600001
PM 32578328
DA 2025-04-28
ER

PT J
AU Settle, PJ
   Cameron, AJ
   Thornton, LE
AF Settle, Philippa J.
   Cameron, Adrian J.
   Thornton, Lukar E.
TI Socioeconomic differences in outdoor food advertising at public transit
   stops across Melbourne suburbs
SO AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE food advertising; area-level disadvantage; public transport
ID OBESITY; DISADVANTAGE; ENVIRONMENTS; CONSUMPTION; EXTENT; AUDIT; FAT
AB Objective: To assess and compare the number and type of outdoor food advertisements at public transit stops within suburbs of varying levels of socioeconomic disadvantage.
   Method: An observational audit tool was developed and implemented to assess the number and type of food advertisements at public transit stops within Melbourne, Victoria. A total of 20 Melbourne neighbourhoods (suburbs) from across the least and the most socioeconomically disadvantaged areas were selected. All public transit stops, including train stations and bus and tram stops with a shelter were audited.
   Results: A similar proportion of transit stops in the least and most-disadvantaged suburbs displayed food advertisements (total n= 203). However, some differences in the type of advertisements across suburbs were noted with advertisements for fast food restaurants, flavoured milk and fruit juice more common in the most-disadvantaged neighbourhoods (all p< 0.05) and advertisements for diet soft drink, tea, coffee and convenience stores more common in the least-disadvantaged neighbourhoods (all p< 0.05).
   Conclusion: This exploration of outdoor food advertising at Melbourne transit stops found 30% displayed food advertisements, with those in more disadvantaged suburbs more frequently promoting chain-brand fast food and less frequently promoting diet varieties of soft drinks. These findings may help raise awareness of unhealthy environmental exposures.
C1 [Settle, Philippa J.; Thornton, Lukar E.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Burwood, Vic 3125, Australia.
   [Cameron, Adrian J.] World Hlth Org Collaborating Ctr Obes Prevent, Deakin Populat Hlth, Melbourne, Vic, Australia.
C3 Deakin University; World Health Organization; World Health Organization
   (WHO) Australia
RP Thornton, LE (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.
EM lukar.thornton@deakin.edu.au
RI Cameron, Adrian/AAF-2277-2020
OI Cameron, Adrian/0000-0002-0568-5497; Thornton, Lukar/0000-0001-8759-8671
FU Deakin University; Deakin University Alfred Deakin Postdoctoral Research
   Fellowship; National Health and Medical Research Council [1013313]
FX The collection of data within Melbourne was supported by funding through
   Deakin University. LET is supported by a Deakin University Alfred Deakin
   Postdoctoral Research Fellowship. AJC is supported by a National Health
   and Medical Research Council Fellowship (#1013313).
CR Adams J, 2011, PUBLIC HEALTH NUTR, V14, P945, DOI 10.1017/S1368980010003332
   [Anonymous], 2012, 4364 0 055 001 AUSTR
   Australian Bureau of Statistics, 2013, CENS POP HOUS 2011
   Australian Bureau of Statistics, 2013, WHAT IS SEIFA
   Cairns G, 2013, APPETITE, V62, P209, DOI 10.1016/j.appet.2012.04.017
   Cameron AJ, 2013, PUBLIC HEALTH NUTR, V16, P1178, DOI 10.1017/S1368980012002649
   Chandon P, 2012, NUTR REV, V70, P571, DOI 10.1111/j.1753-4887.2012.00518.x
   Fraser LK, 2010, INT J ENV RES PUB HE, V7, P2290, DOI 10.3390/ijerph7052290
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399
   Henderson VR, 2005, J NUTR EDUC BEHAV, V37, P191, DOI 10.1016/S1499-4046(06)60245-5
   Hillier A, 2009, HEALTH PLACE, V15, P935, DOI 10.1016/j.healthplace.2009.02.014
   House of Representatives Standing Committee on Social Policy and Legal Affairs, 2011, RECL PUBL SPAC INQ R
   Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149
   Kelly B, 2008, AUST NZ J PUBL HEAL, V32, P522, DOI 10.1111/j.1753-6405.2008.00303.x
   Kelly B, 2012, HEALTH PROMOT J AUST, V23, P73, DOI 10.1071/HE12073
   King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176
   Kwate NOA, 2007, J URBAN HEALTH, V84, P21, DOI 10.1007/s11524-006-9127-5
   Lesser LI, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-20
   Lobstein T, 2005, OBES REV, V6, P203, DOI 10.1111/j.1467-789X.2005.00191.x
   Maher A., 2005, New Zealand Medical Journal, V118, P1556
   Melway, 2012, GREATER MELBOURNE ST
   Mhurchu CN, 2013, OBES REV, V14, P108, DOI 10.1111/obr.12080
   Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009
   Pierce HL, 2013, MED J AUSTRALIA, V198, P478, DOI 10.5694/mja13.10317
   STATA, 2013, STATA STAT SOFTW COM
   Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926
   Thornton LE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-194
   Village Well, 2006, TRAIN STAT PLAC COMM
   Walton M, 2009, HEALTH PLACE, V15, P841, DOI 10.1016/j.healthplace.2009.02.003
   WHO, 2003, WHO TECHN REP SER
   Yancey AK, 2009, MILBANK Q, V87, P155, DOI 10.1111/j.1468-0009.2009.00551.x
   Zimmerman FJ, 2011, ANNU REV PUBL HEALTH, V32, P285, DOI 10.1146/annurev-publhealth-090810-182502
NR 33
TC 26
Z9 27
U1 3
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1326-0200
EI 1753-6405
J9 AUST NZ J PUBL HEAL
JI Aust. N. Z. Publ. Health
PD OCT
PY 2014
VL 38
IS 5
SI SI
BP 414
EP 418
DI 10.1111/1753-6405.12257
PG 5
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA AQ4KL
UT WOS:000342765100006
PM 25269979
OA Bronze
DA 2025-04-28
ER

PT J
AU Yang, CS
   Zhang, JS
   Zhang, L
   Huang, JB
   Wang, YJ
AF Yang, Chung S.
   Zhang, Jinsong
   Zhang, Le
   Huang, Jinbao
   Wang, Yijun
TI Mechanisms of body weight reduction and metabolic syndrome alleviation
   by tea
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Review
DE AMPK; Diabetes; EGCG; Obesity; Tea
ID ACTIVATED PROTEIN-KINASE; GREEN TEA; EPIGALLOCATECHIN-GALLATE;
   INSULIN-RESISTANCE; BLACK-TEA; COFFEE CONSUMPTION; LIPID-METABOLISM;
   POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; DIETARY SUPPLEMENTATION;
   CARDIOVASCULAR-DISEASE
AB Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been shown to reduce body weight, alleviate metabolic syndrome, and prevent diabetes and cardiovascular diseases in animal models and humans. Such beneficial effects have generally been observed in most human studies when the level of tea consumption was three to four cups (600-900 mg tea catechins) or more per day. Green tea is more effective than black tea. In spite of numerous studies, the fundamental mechanisms for these actions still remain unclear. From a review of the literature, we propose that the two major mechanisms are: (i) decreasing absorption of lipids and proteins by tea constituents in the intestine, thus reducing calorie intake; and (ii) activating AMP-activated protein kinase by tea polyphenols that are bioavailable in the liver, skeletal muscle, and adipose tissues. The relative importance of these two mechanisms depends on the types of tea and diet consumed by individuals. The activated AMP-activated protein kinase would decrease gluconeogenesis and fatty acid synthesis and increase catabolism, leading to body weight reduction and metabolic syndrome alleviation. Other mechanisms and the health relevance of these beneficial effects of tea consumption remain to be further investigated.
C1 [Yang, Chung S.; Zhang, Le] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ USA.
   [Yang, Chung S.; Zhang, Jinsong; Zhang, Le; Huang, Jinbao; Wang, Yijun] Anhui Agr Univ, Int Joint Res Lab Tea Chem & Hlth Effects, Hefei, Anhui, Peoples R China.
   [Zhang, Jinsong; Huang, Jinbao; Wang, Yijun] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei, Anhui, Peoples R China.
C3 Rutgers University System; Rutgers University New Brunswick; Anhui
   Agricultural University; Anhui Agricultural University
RP Yang, CS (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ USA.
EM csyang@pharmacy.rutgers.edu
RI Huang, Jinbao/N-3391-2018; Wang, Yijun/X-2674-2018
OI Wang, Yijun/0000-0001-5815-7172; Huang, Jinbao/0000-0003-2272-933X;
   Zhang, Jinsong/0000-0001-9366-9819
FU US NIH [CA122474, CA133021]; Anhui Major Demonstration Project for
   Leading Talent Team on Tea Chemistry and Health; Tea Project of Anhui
   Provincial Agriculture Committee
FX This work was supported by US NIH grants CA122474 and CA133021, Anhui
   Major Demonstration Project for Leading Talent Team on Tea Chemistry and
   Health, and Tea Project of Anhui Provincial Agriculture Committee. We
   thank Ms. Dorothy Wong for her capable assistance in the preparation of
   this manuscript.
CR Aggio A, 2013, EUR J NUTR, V52, P263, DOI 10.1007/s00394-012-0320-x
   Akiyama S, 2009, BIOSCI BIOTECH BIOCH, V73, P2779, DOI 10.1271/bbb.90576
   Alves MG, 2015, J FUNCT FOODS, V14, P102, DOI 10.1016/j.jff.2015.01.019
   Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470
   Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005
   Bao SQ, 2014, MOL NUTR FOOD RES, V58, P677, DOI 10.1002/mnfr.201300335
   Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Byun JK, 2014, IMMUNOL LETT, V157, P51, DOI 10.1016/j.imlet.2013.11.006
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Cao H, 2007, J AGR FOOD CHEM, V55, P6372, DOI 10.1021/jf070695o
   Chang CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038874
   Chen D, 2005, BIOCHEM PHARMACOL, V69, P1523, DOI 10.1016/j.bcp.2005.01.024
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Chow HHS, 2011, PHARMACOL RES, V64, P105, DOI 10.1016/j.phrs.2011.05.007
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613
   Cunha CA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/635470
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009
   Di Castelnuovo A, 2012, EUR J INTERN MED, V23, P15, DOI 10.1016/j.ejim.2011.07.014
   Du WH, 2012, J AGR FOOD CHEM, V60, P10126, DOI 10.1021/jf302426w
   Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Egawa T, 2011, ACTA PHYSIOL, V201, P227, DOI 10.1111/j.1748-1716.2010.02169.x
   Ellinger S, 2011, PHYTOMEDICINE, V18, P903, DOI 10.1016/j.phymed.2011.06.006
   Everard A, 2014, MBIO, V5, DOI 10.1128/mBio.01011-14
   Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   Forester SC, 2012, MOL NUTR FOOD RES, V56, P1647, DOI 10.1002/mnfr.201200206
   Friedrich M, 2012, INT J OBESITY, V36, P735, DOI 10.1038/ijo.2011.136
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hartley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009934.pub2
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480
   Hsu Chung-Hua, 2011, Altern Med Rev, V16, P157
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ikeda I, 2010, J AGR FOOD CHEM, V58, P8591, DOI 10.1021/jf1015285
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   James KD, 2015, FOOD CHEM TOXICOL, V76, P103, DOI 10.1016/j.fct.2014.12.009
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x
   Jochmann N, 2008, BRIT J NUTR, V99, P863, DOI 10.1017/S0007114507838992
   Josic J, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-63
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kim SB, 2000, NUTR CANCER, V37, P41, DOI 10.1207/S15327914NC3701_5
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Ku HC, 2012, MOL NUTR FOOD RES, V56, P580, DOI 10.1002/mnfr.201100438
   Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837
   Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039
   Li YR, 2009, J NUTR BIOCHEM, V20, P1021, DOI 10.1016/j.jnutbio.2008.12.001
   Liang WB, 2009, STROKE, V40, P2480, DOI 10.1161/STROKEAHA.109.548586
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Mukamal KJ, 2006, J AM COLL NUTR, V25, P472, DOI 10.1080/07315724.2006.10719561
   Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7
   Munir KM, 2013, AM J PHYSIOL-ENDOC M, V305, pE679, DOI 10.1152/ajpendo.00377.2013
   Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Okuda MH, 2014, J NUTR BIOCHEM, V25, P1084, DOI 10.1016/j.jnutbio.2014.05.012
   Ortsäter H, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-11
   Pae MY, 2012, J NUTR BIOCHEM, V23, P526, DOI 10.1016/j.jnutbio.2011.02.006
   Park JH, 2009, J PHYSIOL PHARMACOL, V60, P101
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Pullikotil P, 2012, J NUTR BIOCHEM, V23, P1134, DOI 10.1016/j.jnutbio.2011.06.007
   Qin BL, 2010, MOL NUTR FOOD RES, V54, pS14, DOI 10.1002/mnfr.200900306
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386
   Serrano JCE, 2013, MOL NUTR FOOD RES, V57, P459, DOI 10.1002/mnfr.201200513
   Sesso HD, 2003, AM J CLIN NUTR, V77, P1400, DOI 10.1093/ajcn/77.6.1400
   Shen GX, 2005, PHARM RES-DORDR, V22, P1805, DOI 10.1007/s11095-005-7546-8
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341
   Song YQ, 2005, J AM COLL NUTR, V24, P376, DOI 10.1080/07315724.2005.10719488
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tang WP, 2013, J FUNCT FOODS, V5, P1784, DOI 10.1016/j.jff.2013.08.007
   Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427
   Tian C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053796
   Ueda M, 2012, J AGR FOOD CHEM, V60, P8917, DOI 10.1021/jf2053788
   Urusova DV, 2011, CANCER PREV RES, V4, P1366, DOI 10.1158/1940-6207.CAPR-11-0301
   Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Wang DX, 2015, TOXICOL APPL PHARM, V283, P65, DOI 10.1016/j.taap.2014.12.018
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407
   Wu JJ, 2014, EUR J PHARMACOL, V745, P59, DOI 10.1016/j.ejphar.2014.09.046
   Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI [10.1039/c4fo00095a, 10.1039/C4FO00095A]
   Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c
   Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234
   Yang TY, 2014, PHYTOTHER RES, V28, P1096, DOI 10.1002/ptr.5111
   Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087008
NR 119
TC 276
Z9 305
U1 19
U2 424
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD JAN
PY 2016
VL 60
IS 1
SI SI
BP 160
EP 174
DI 10.1002/mnfr.201500428
PG 15
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA DA3WK
UT WOS:000367730800015
PM 26577614
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Chen, RH
   Lai, XF
   Xiang, LM
   Li, QH
   Sun, LL
   Lai, ZX
   Li, ZG
   Zhang, WJ
   Wen, S
   Cao, JX
   Sun, SL
AF Chen, Ruohong
   Lai, Xingfei
   Xiang, Limin
   Li, Qiuhua
   Sun, Lingli
   Lai, Zhaoxiang
   Li, Zhigang
   Zhang, Wenji
   Wen, Shuai
   Cao, Junxi
   Sun, Shili
TI Aged green tea reduces high-fat diet-induced fat accumulation and
   inflammation via activating the AMP-activated protein kinase signaling
   pathway
SO FOOD & NUTRITION RESEARCH
LA English
DT Article
DE anti-obesity; anti-inflammation; AMPK; aged green tea; metabolism
ID INDUCED-OBESITY; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE;
   MECHANISMS; MODULATION; CAFFEINE
AB Background: Obesity is a global public health concern and increases the risk of metabolic syndrome and other diseases. The anti-obesity effects of various plant-derived bioactive compounds, such as tea extracts, are well-established. The mechanisms underlying the anti-obesity activity of Jinxuan green tea (JXGT) from different storage years are still unclear.
   Objective: The aim of this study was to evaluate the effects of JXGTs from three different years on the high fat diet (HFD)-fed mouse model.
   Design: The mice were divided into six groups, the control group received normal diet and the obese model group received HFD. We analyzed the effects of JXGTs from 2005, 2008, and 2016 on HFD-fed obese mice over a period of 7 weeks.
   Results: The JXGTs reduced the body weight of the obese mice, and also alleviated fat accumulation and hepatic steatosis. Mechanistically, JXGTs increased the plosplorylation of AMP-activated protein kinase (p-AMPK)/AMP-activated protein kinase (AMPK) ratio, up-regulated carnitine acyl transferase 1A (CPT-1A), and down-regulated fatty acid synthase (FAS), Glycogen synthase kinase-3beta (GSK-3 beta), Peroxisome proliferator-activated receptor-gamma co-activator-lalpha (PGC-1 alpha), Interleukin 6 (IL-6), and Tumour necrosis factor alpha (TNF alpha). Thus, JXGTs can alleviate HFD-induced obesity by inhibiting lipid biosynthesis and inflammation, thereby promoting fatty acid oxidation via the AMPK pathway.
   Discussion: The anti-obesity effect of three aged JXGTs were similar. However, JXGT2016 exhibited a more potent activation of AMPK, and JXGT2005 and JXGT2008 exhibited a more potent inhibiting glycogen synthase and inflammation effect. Furthermore, the polyphenol (-)-epicatechin (EC) showed the strongest positive correlation with the anti-obesity effect of JXGT.
   Conclusions: These findings demonstrate that JXGT treatment has a potential protection on HFD-induced obesity mice via activating the AMPK/CPT-1A and down-regulating FAS/GSK-3 beta/PGC-1 alpha and IL-6/TNF alpha. Our study results also revealed that different storage time would not affect the anti-obesity and anti-inflammation effect of JXGT.
C1 [Chen, Ruohong; Lai, Xingfei; Xiang, Limin; Li, Qiuhua; Sun, Lingli; Lai, Zhaoxiang; Li, Zhigang; Zhang, Wenji; Wen, Shuai; Cao, Junxi; Sun, Shili] Guangdong Acad Agr Sci, Tea Res Inst, Guangdong Prov Key Lab Tea Plant Resources Innova, Guangzhou, Peoples R China.
C3 Guangdong Academy of Agricultural Sciences
RP Cao, JX; Sun, SL (corresponding author), Guangdong Acad Agr Sci, Tea Res Inst, 20 Jinying Rd, Guangzhou 510640, Peoples R China.
EM junxic@126.com; sunshili@zju.edu.cn
RI Li, Haoyu/ACR-0968-2022; Xiang, Limin/B-9206-2015; Li,
   Zhigang/AAC-2901-2022; lai, xingfei/IYJ-6251-2023
OI Xingfei, Lai/0000-0003-3736-605X
FU "14th Five-Year Plan" team-building projects of Guangdong Academy of
   Agricultural Sciences [202126TD]; Guangdong Basic and Applied Basic
   Research Foundation [2020A1515011266, 2021A1515010958]; Guangzhou
   Science and Technology Plan Projects [202102020047, 202002030202];
   Key-Area Research and Development Program of Guangdong Province
   [2020B0202080003]; Maoming Science and Technology Program [mmkj2020045];
   Zhanjiang Science and Technology Program [2020A03014]; Innovation Fund
   projects of Guangdong Academy of Agricultural Sciences [202115, 202035];
   Special fund for scientific innovation strategy-construction of high
   level Academy of Agriculture Science [R2019PY-JX004]; Innovation Fund
   projects of Guangdong Key Laboratory of Tea Plant Resources Innovation
   and Utilization [2021CX02]; Academy of Finland (AKA) [202115] Funding
   Source: Academy of Finland (AKA)
FX The authors declare no conflict of interest. This study was funded by
   the "14th Five-Year Plan" team-building projects of Guangdong Academy of
   Agricultural Sciences [Grant Nos. 202126TD]; Guangdong Basic and Applied
   Basic Research Foundation [Grant Nos. 2020A1515011266, 2021A1515010958];
   Guangzhou Science and Technology Plan Projects [Grant Nos. 202102020047,
   202002030202]; Key-Area Research and Development Program of Guangdong
   Province [Grant Nos. 2020B0202080003]; Maoming Science and Technology
   Program (Grant Nos. mmkj2020045); Zhanjiang Science and Technology
   Program (Grant Nos. 2020A03014); Innovation Fund projects of Guangdong
   Academy of Agricultural Sciences (Grant Nos. 202115, 202035); Special
   fund for scientific innovation strategy-construction of high level
   Academy of Agriculture Science (Grant Nos. R2019PY-JX004); the
   Innovation Fund projects of Guangdong Key Laboratory of Tea Plant
   Resources Innovation and Utilization (Grant Nos. 2021CX02). Funders did
   not have any role in study design, data collection, and data analysis.
CR Abbas NAT, 2017, N-S ARCH PHARMACOL, V390, P1145, DOI 10.1007/s00210-017-1414-z
   An R, 2020, J MED FOOD, V23, P943, DOI 10.1089/jmf.2020.4706
   Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005
   Beh BK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06235-7
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4
   Chen GL, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900602
   Chen GJ, 2019, J AGR FOOD CHEM, V67, P5350, DOI 10.1021/acs.jafc.8b05338
   Choi EO, 2015, MOL MED REP, V12, P1314, DOI 10.3892/mmr.2015.3463
   Chung KW, 2017, AUTOPHAGY, V13, P1113, DOI 10.1080/15548627.2017.1319040
   Dorresteijn JAN, 2012, OBES REV, V13, P17, DOI 10.1111/j.1467-789X.2011.00914.x
   Du HP, 2019, J AGR FOOD CHEM, V67, P2839, DOI 10.1021/acs.jafc.8b06927
   Fang K, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2671-9
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Garcia D, 2019, CELL REP, V26, P192, DOI 10.1016/j.celrep.2018.12.036
   Grundy SM, 2016, TRENDS CARDIOVAS MED, V26, P364, DOI 10.1016/j.tcm.2015.10.004
   Hocayen PDS, 2016, PHARM BIOL, V54, P1263, DOI 10.3109/13880209.2015.1067232
   Hu SW, 2019, MAR DRUGS, V17, DOI 10.3390/md17080455
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Jing NN, 2020, FOOD FUNCT, V11, P6971, DOI [10.1039/d0fo01282c, 10.1039/D0FO01282C]
   Jochmann N, 2008, CURR OPIN CLIN NUTR, V11, P758, DOI 10.1097/MCO.0b013e328314b68b
   Juneja LR, 2013, GREEN TEA POLYPHENOL, pxiii
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Khan N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010039
   Kogawa AC, 2019, J AOAC INT, V102, P801, DOI 10.5740/jaoacint.18-0200
   Kuang WH, 2018, ARCH PHARM RES, V41, P1190, DOI 10.1007/s12272-017-0941-y
   Lally JSV, 2019, CELL METAB, V29, P174, DOI 10.1016/j.cmet.2018.08.020
   Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a
   Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200
   Li F, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01366
   Li QH, 2020, FOOD NUTR RES, V64, DOI 10.29219/fnr.v64.1681
   Ling W, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040099
   Liou CJ, 2019, FASEB J, V33, P11791, DOI 10.1096/fj.201900413RRR
   Liu C, 2019, FOOD FUNCT, V10, P2061, DOI 10.1039/c8fo02334d
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Luo Y, 2018, OBES REV, V19, P786, DOI 10.1111/obr.12671
   Lyu CY, 2013, J SCI FOOD AGR, V93, P3165, DOI 10.1002/jsfa.6149
   Misawa K, 2015, J NUTR BIOCHEM, V26, P1058, DOI 10.1016/j.jnutbio.2015.04.014
   Okuda MH, 2014, J NUTR BIOCHEM, V25, P1084, DOI 10.1016/j.jnutbio.2014.05.012
   Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6
   Pichard C, 2008, MATURITAS, V60, P19, DOI 10.1016/j.maturitas.2008.03.002
   Prasanth MI, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020474
   Roh E, 2017, CRIT REV FOOD SCI, V57, P1631, DOI 10.1080/10408398.2014.1003365
   Ronnett Gabriele V, 2006, Obesity (Silver Spring), V14 Suppl 5, p201S, DOI 10.1038/oby.2006.309
   Seravalle G, 2017, PHARMACOL RES, V122, P1, DOI 10.1016/j.phrs.2017.05.013
   Sheng Y, 2019, FOOD FUNCT, V10, P4771, DOI [10.1039/C9FO00883G, 10.1039/c9fo00883g]
   Suzuki T, 2016, MOLECULES, V21, DOI 10.3390/molecules21101305
   Tanaka M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051479
   Thatiparthi J, 2019, J ETHNOPHARMACOL, V238, DOI 10.1016/j.jep.2019.111843
   Tiegs G, 2007, Z GASTROENTEROL, V45, P63, DOI 10.1055/s-2006-927397
   Timm KN, 2020, CARDIOVASC DRUG THER, V34, P255, DOI 10.1007/s10557-020-06941-x
   Vecchié A, 2018, EUR J INTERN MED, V48, P6, DOI 10.1016/j.ejim.2017.10.020
   Wang SY, 2017, FOOD FUNCT, V8, P3831, DOI [10.1039/C7FO01094J, 10.1039/c7fo01094j]
   Weikel KA, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160174
   Xing LJ, 2019, J AGR FOOD CHEM, V67, P1029, DOI 10.1021/acs.jafc.8b06146
   Yuan ED, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020187
   Zang LQ, 2019, MOLECULES, V24, DOI 10.3390/molecules24183256
   Zhang WL, 2014, OBES REV, V15, P957, DOI 10.1111/obr.12228
   Zhang XB, 2015, FOOD TECHNOL BIOTECH, V53, P180
NR 59
TC 9
Z9 10
U1 1
U2 17
PU SWEDISH NUTRITION FOUNDATION-SNF
PI LUND
PA IDEON SCIENCE PARK, BESOK SCHEELEV 17 BETA 5, 3V, LUND, 223 70, SWEDEN
SN 1654-6628
EI 1654-661X
J9 FOOD NUTR RES
JI Food Nutr. Res.
PD MAR 10
PY 2022
VL 66
AR 7923
DI 10.29219/fnr.v66.7923
PG 12
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA ZU7JE
UT WOS:000770015500001
PM 35382381
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Tallis, J
   Hill, C
   James, RS
   Cox, VM
   Seebacher, F
AF Tallis, Jason
   Hill, Cameron
   James, Rob S.
   Cox, Val M.
   Seebacher, Frank
TI The effect of obesity on the contractile performance of isolated mouse
   soleus, EDL, and diaphragm muscles
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE muscle quality; muscular lipid, lipid accumulation; force; power
ID SKELETAL-MUSCLE; POWER OUTPUT; FIBER-TYPE; PHYSICAL-ACTIVITY; SEVERELY
   OBESE; ELDERLY-WOMEN; LIPID-CONTENT; STRENGTH; CAFFEINE; IMPACT
AB Obesity affects the major metabolic and cellular processes involved in skeletal muscle contractility. Surprisingly, the effect of obesity on isolated skeletal muscle performance remains unresolved. The present study is the first to examine the muscle-specific changes in contractility following dietary-induced obesity using an isolated muscle work-loop (WL) model that more closely represents in vivo muscle performance. Following 16-wk high-calorific feeding, soleus (SOL), extensor digitorum longus (EDL), and diaphragm (DIA) were isolated from female (CD-1) mice, and contractile performance was compared against a lean control group. Obese SOL produced greater isometric force; however, isometric stress (force per unit muscle area), absolute WL power, and normalized WL power (watts per kilogram muscle mass) were unaffected. Maximal isometric force and absolute WL power of the EDL were similar between groups. For both EDL and DIA, isometric stress and normalized WL power were reduced in the obese groups. Obesity caused a significant reduction in fatigue resistance in all cases. Our findings demonstrate a muscle-specific reduction in contractile performance and muscle quality that is likely related to in vivo mechanical role, fiber type, and metabolic profile, which may in part be related to changes in myosin heavy chain expression and AMP-activated protein kinase activity. These results infer that, beyond the additional requirement of moving a larger body mass, functional performance and quality of life may be further limited by poor muscle function in obese individuals. As such, a reduction in muscle performance may be a substantial contributor to the negative cycle of obesity.
   NEW & NOTEWORTHY The effect of obesity on isolated muscle function is surprisingly underresearched. The present study is the first to examine the effects of obesity on isolated muscle performance using a method that more closely represents real-world muscle function. This work uniquely establishes a muscle-specific profile of mechanical changes in relation to underpinning mechanisms. These findings may be important to understanding the negative cycle of obesity and in designing interventions for improving weight status.
C1 [Tallis, Jason; Hill, Cameron; James, Rob S.; Cox, Val M.] Coventry Univ, Fac Hlth & Life Sci, Ctr Appl Biol & Exercise Sci, Coventry, W Midlands, England.
   [Seebacher, Frank] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.
C3 Coventry University; University of Sydney
RP Tallis, J (corresponding author), Coventry Univ, Fac Hlth & Life Sci, James Starley Bldg,Priory St, Coventry CV1 5FB, W Midlands, England.
EM tallisj2@uni.coventry.ac.uk
RI Hill, Cameron/M-1378-2019
OI Hill, Cameron/0000-0002-0815-5109; Seebacher, Frank/0000-0002-2281-9311;
   James, Rob S./0000-0002-3969-8261; Cox, Valerie/0000-0002-7836-6120;
   Tallis, Jason/0000-0001-8904-2693
FU TANITA Healthy Weight Community Trust
FX This project was supported by funding from the TANITA Healthy Weight
   Community Trust.
CR Abdelmoula A, 2012, APPL PHYSIOL NUTR ME, V37, P269, DOI [10.1139/h2012-010, 10.1139/H2012-010]
   Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643
   Addison O, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/309570
   Akhmedov D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00371
   Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007
   ALTRINGHAM JD, 1991, J EXP BIOL, V157, P381
   Aucouturier J, 2007, APPL PHYSIOL NUTR ME, V32, P367, DOI 10.1139/h06-114
   Bruton JD, 2002, PFLUG ARCH EUR J PHY, V444, P692, DOI 10.1007/s00424-002-0882-1
   Capodaglio P, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-47
   Ciapaite J, 2015, J NUTR BIOCHEM, V26, P155, DOI 10.1016/j.jnutbio.2014.09.014
   Cosper PF, 2012, INT J CANCER, V130, P2722, DOI 10.1002/ijc.26298
   D'Souza DM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12506
   de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007
   DeNies MS, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.204
   Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100
   Ekman MJ, 2013, OBESITY, V21, pE236, DOI 10.1002/oby.20046
   Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581
   Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x
   Funai K, 2013, J CLIN INVEST, V123, P1229, DOI 10.1172/JCI65726
   Garcia-Vicencio S, 2016, INT J OBESITY, V40, P245, DOI 10.1038/ijo.2015.158
   Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755
   Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI [10.2147/DMSO.S7384, 10.2147/DMSOTT.S7384]
   Higgins MF, 2013, J SPORT SCI, V31, P972, DOI 10.1080/02640414.2012.758868
   Hofmann M, 2016, EUR J APPL PHYSIOL, V116, P885, DOI 10.1007/s00421-016-3344-8
   Houmard JA, 2011, J OBES, V2011, DOI 10.1155/2011/250496
   Ivey FM, 2000, J GERONTOL A-BIOL, V55, pB152, DOI 10.1093/gerona/55.3.B152
   James RS, 2013, J COMP PHYSIOL B, V183, P723, DOI 10.1007/s00360-013-0748-1
   James RS, 2005, EUR J APPL PHYSIOL, V95, P74, DOI 10.1007/s00421-005-1396-2
   James RS, 1996, PFLUG ARCH EUR J PHY, V432, P767, DOI 10.1007/s004240050197
   James RS, 2004, J APPL PHYSIOL, V96, P545, DOI 10.1152/japplphysiol.00696.2003
   JAMES RS, 1995, J EXP BIOL, V198, P491
   JOSEPHSON RK, 1985, J EXP BIOL, V114, P493
   Kemp JG, 2009, INT J OBESITY, V33, P831, DOI 10.1038/ijo.2009.100
   Kriketos AD, 1997, INT J OBESITY, V21, P796, DOI 10.1038/sj.ijo.0800476
   Lee I, 2012, J PHYSIOL-LONDON, V590, P5231, DOI 10.1113/jphysiol.2012.239707
   Machann J, 2003, J MAGN RESON IMAGING, V17, P350, DOI 10.1002/jmri.10255
   Maffiuletti NA, 2008, EUR J APPL PHYSIOL, V103, P481, DOI 10.1007/s00421-008-0737-3
   Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2
   Maffiuletti NA, 2013, CURR OBES REP, V2, P251, DOI 10.1007/s13679-013-0066-7
   Mayer JM, 2012, J OBES, V2012, DOI 10.1155/2012/729283
   MENDEZ J, 1960, METABOLISM, V9, P184
   Minetto MA, 2013, J ELECTROMYOGR KINES, V23, P285, DOI 10.1016/j.jelekin.2012.09.008
   Miyatake N, 2000, DIABETES RES CLIN PR, V48, P15, DOI 10.1016/S0168-8227(99)00132-1
   Moffat C, 2010, IUBMB LIFE, V62, P739, DOI 10.1002/iub.387
   Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014
   O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019
   Paolillo FR, 2012, MENOPAUSE, V19, P556, DOI 10.1097/gme.0b013e3182364e80
   Pataky Z, 2014, OBESITY, V22, P56, DOI 10.1002/oby.20514
   Pinto RS, 2014, AGE, V36, P365, DOI 10.1007/s11357-013-9567-2
   Rolland Y, 2004, AM J CLIN NUTR, V79, P552
   Schilder RJ, 2011, J EXP BIOL, V214, P1523, DOI 10.1242/jeb.051763
   Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293
   STEPHENS DN, 1980, PHYSIOL BEHAV, V25, P313, DOI 10.1016/0031-9384(80)90222-X
   Tallis J, 2015, BRIT J PHARMACOL, V172, P3703, DOI 10.1111/bph.13187
   Tallis J, 2014, AM J PHYSIOL-REG I, V307, pR670, DOI 10.1152/ajpregu.00115.2014
   Tallis J, 2014, CAN J PHYSIOL PHARM, V92, P42, DOI 10.1139/cjpp-2013-0195
   Tallis J, 2013, J PHYSIOL SCI, V63, P125, DOI 10.1007/s12576-012-0247-2
   Tallis J, 2012, J APPL PHYSIOL, V112, P64, DOI 10.1152/japplphysiol.00801.2011
   Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001
   Trajcevski KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071747
   WADE AJ, 1990, LANCET, V335, P805, DOI 10.1016/0140-6736(90)90933-V
   Wakeling JM, 2005, ANIM BIOL, V55, P41, DOI 10.1163/1570756053276880
   Walter I, 2010, J EXP BIOL, V213, P3167, DOI 10.1242/jeb.043349
   Ward DS, 1997, OBES RES, V5, P572, DOI 10.1002/j.1550-8528.1997.tb00578.x
   Warmington SA, 2000, INT J OBESITY, V24, P1040, DOI 10.1038/sj.ijo.0801357
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yoshida Y, 2012, MUSCLE NERVE, V46, P813, DOI 10.1002/mus.23506
NR 67
TC 48
Z9 53
U1 0
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD JAN
PY 2017
VL 122
IS 1
BP 170
EP 181
DI 10.1152/japplphysiol.00836.2016
PG 12
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA EK1PN
UT WOS:000393698000021
PM 27856719
OA Green Submitted, Bronze
DA 2025-04-28
ER

PT J
AU Moudon, AV
   Drewnowski, A
   Duncan, GE
   Hurvitz, PM
   Saelens, BE
   Scharnhorst, E
AF Moudon, Anne Vernez
   Drewnowski, Adam
   Duncan, Glen E.
   Hurvitz, Philip M.
   Saelens, Brian E.
   Scharnhorst, Eric
TI Characterizing the food environment: pitfalls and future directions
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Census of food sources; Health value; Exposure
ID NEIGHBORHOOD CHARACTERISTICS; STORE AVAILABILITY; RACIAL COMPOSITION;
   PHYSICAL-ACTIVITY; WEIGHT STATUS; RESTAURANTS; ASSOCIATION; PROXIMITY;
   OBESITY; ACCESS
AB Objective: To assess a county population's exposure to different types of food sources reported to affect both diet quality and obesity rates.
   Design: Food permit records obtained from the local health department served to establish the full census of food stores and restaurants. Employing prior categorization schemes which classified the relative healthfulness of food sources based on establishment type (i.e. supermarkets v. convenience stores, or full-service v. fast-food restaurants), food establishments were assigned to the healthy, unhealthy or undetermined groups.
   Setting: King County, WA, USA.
   Subjects: Full census of food sources.
   Results: According to all categorization schemes, most food establishments in King County fell into the unhealthy and undetermined groups. Use of the food permit data showed that large stores, which included supermarkets as healthy food establishments, contained a sizeable number of bakery/delis, fish/meat, ethnic and standard quick-service restaurants and coffee shops, all food sources that, when housed in a separate venue or owned by a different business establishment, were classified as either unhealthy or of undetermined value to health.
   Conclusions: To fully assess the potential health effects of exposure to the extant food environment, future research would need to establish the health value of foods in many such common establishments as individually owned grocery stores and ethnic food stores and restaurants. Within-venue exposure to foods should also be investigated.
C1 [Moudon, Anne Vernez] Univ Washington, Dept Urban Design & Planning, Seattle, WA 98195 USA.
   [Drewnowski, Adam; Duncan, Glen E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Hurvitz, Philip M.] Univ Washington, Urban Form Lab, Seattle, WA 98195 USA.
   [Saelens, Brian E.] Univ Washington, Div Gen Pediat, Seattle Childrens Res Inst, Seattle, WA 98195 USA.
   [Scharnhorst, Eric] Royal Danish Acad Fine Arts, Sch Architecture, Copenhagen, Denmark.
C3 University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle; University of
   Washington; University of Washington Seattle; Seattle Children's
   Hospital; University of Washington; University of Washington Seattle
RP Moudon, AV (corresponding author), Univ Washington, Dept Urban Design & Planning, Box 3548002, Seattle, WA 98195 USA.
EM moudon@uw.edu
RI Duncan, Glen/A-3771-2008; Drewnowski, Adam/HCI-4117-2022
OI Duncan, Glen/0000-0001-6909-1869; Saelens, Brian/0000-0001-6998-6339
FU TWINStudy of environment, lifestyle behaviors, and health [R01AG042176];
   Food environment, diet quality, and disparities in obesity
   [R01DK076608]; The effect of light rail transit on physical activity: a
   natural experiment [R01HL091881]
FX Sources of funding: This work was carried out under grants R01AG042176,
   TWINStudy of environment, lifestyle behaviors, and health; R01DK076608,
   Food environment, diet quality, and disparities in obesity; and
   R01HL091881, The effect of light rail transit on physical activity: a
   natural experiment. Conflicts of interest: The authors have no conflicts
   of interest in the presented research. Ethics: Ethical approval was not
   required. Authors' contributions: All authors contributed to the
   conceptual structure and the writing of the manuscript. A. V. M. led the
   research design and the development of the manuscript. A. D., G. E. D.,
   P. M. H. and B. E. S. contributed to the research method. E. S. carried
   out the classification of the food permits and establishments.
CR Andrews M., 2001, FoodReview, V24, P45
   [Anonymous], SUP FACTS IND OV 201
   Apparicio P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-4
   Ayala GX, 2005, J AM DIET ASSOC, V105, P38, DOI 10.1016/j.jada.2004.10.023
   Bodor JN, 2010, J URBAN HEALTH, V87, P771, DOI 10.1007/s11524-010-9460-6
   Boone-Heinonen J, 2011, ARCH INTERN MED, V171, P1162, DOI 10.1001/archinternmed.2011.283
   Brown AF, 2008, J GEN INTERN MED, V23, P1137, DOI 10.1007/s11606-008-0601-5
   Casey AA, 2008, PREV MED, V47, P600, DOI 10.1016/j.ypmed.2008.10.001
   Chung CJ, 1999, J CONSUM AFF, V33, P276, DOI 10.1111/j.1745-6606.1999.tb00071.x
   Cummins SCJ, 2005, AM J PREV MED, V29, P308, DOI 10.1016/j.amepre.2005.06.011
   Dennisuk LA, 2011, AM J PREV MED, V40, P625, DOI 10.1016/j.amepre.2011.02.015
   Duerksen SC, 2007, J AM DIET ASSOC, V107, P849, DOI 10.1016/j.jada.2007.02.012
   Economic Research Service, 2011, BRIEF ROOMS FOOD CON
   Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x
   Forsyth Ann, 2010, J Transp Land Use, V3, P43
   Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003
   Frank L, 2009, BRIT J SPORT MED, V43, P124, DOI 10.1136/bjsm.2008.055533
   Galvez MP, 2008, PUBLIC HEALTH NUTR, V11, P624, DOI 10.1017/S1368980007001097
   Gibson DM, 2011, AM J PUBLIC HEALTH, V101, P71, DOI 10.2105/AJPH.2009.187567
   GiskeS K, 2007, PREV MED, V45, P41, DOI 10.1016/j.ypmed.2007.04.007
   Glanz K, 2007, AM J PREV MED, V32, P282, DOI 10.1016/j.amepre.2006.12.019
   Glanz K, 2009, AM J PREV MED, V36, pS93, DOI 10.1016/j.amepre.2009.01.010
   Hackett A, 2008, J HUM NUTR DIET, V21, P428, DOI 10.1111/j.1365-277X.2008.00894.x
   Han E, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-46
   He MZ, 2012, PUBLIC HEALTH NUTR, V15, P2331, DOI 10.1017/S1368980012000584
   Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267
   Jetter KM, 2006, AM J PREV MED, V30, P38, DOI 10.1016/j.amepre.2005.08.039
   Kelly B, 2011, HEALTH PLACE, V17, P1284, DOI 10.1016/j.healthplace.2011.08.014
   Kipke MD, 2007, J ADOLESCENT HEALTH, V40, P325, DOI 10.1016/j.jadohealth.2006.10.021
   Laraia BA, 2004, PREV MED, V39, P869, DOI 10.1016/j.ypmed.2004.03.018
   Larson N, 2009, ANN BEHAV MED, V38, pS56, DOI 10.1007/s12160-009-9120-9
   Latham J, 2007, HEALTH PLACE, V13, P273, DOI 10.1016/j.healthplace.2006.01.006
   Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005
   Lytle LA, 2009, AM J PREV MED, V36, pS134, DOI 10.1016/j.amepre.2009.01.018
   McKinnon RA, 2009, AM J PREV MED, V36, pS124, DOI 10.1016/j.amepre.2009.01.012
   Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040
   Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2
   Ohri-Vachaspati P, 2011, AM J HEALTH PROMOT, V26, P116, DOI 10.4278/ajhp.100120-QUAN-21
   Powell LM, 2011, HEALTH PLACE, V17, P1122, DOI 10.1016/j.healthplace.2011.05.010
   Raja S, 2008, J PLAN EDUC RES, V27, P469, DOI 10.1177/0739456X08317461
   Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590
   Saelens BE, 2007, AM J PREV MED, V32, P273, DOI 10.1016/j.amepre.2006.12.022
   Sharkey JR, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-37
   Sharkey JR, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-9
   Simon PA, 2008, PREV MED, V47, P284, DOI 10.1016/j.ypmed.2008.02.021
   Sturm R, 2008, PUBLIC HEALTH, V122, P681, DOI 10.1016/j.puhe.2007.09.004
   US Census Bureau, 2007, N AM IND CLASS SYST
   US Department of Agriculture, 2010, FOOD MARK SYST US FO
   VerPloeg M., 2009, ACCESS AFFORDABLE NU
   Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013
   Wang MC, 2008, PUBLIC HEALTH NUTR, V11, P963, DOI 10.1017/S136898000700105X
   Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680
   Wrigley N, 2003, ENVIRON PLANN A, V35, P151, DOI 10.1068/a35150
   Zenk SN, 2006, ETHNIC DIS, V16, P275
   Zenk SN, 2005, AM J PREV MED, V29, P1, DOI 10.1016/j.amepre.2005.03.002
   Zenk SN, 2005, AM J PUBLIC HEALTH, V95, P660, DOI 10.2105/AJPH.2004.042150
NR 56
TC 39
Z9 45
U1 0
U2 28
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JUL
PY 2013
VL 16
IS 7
BP 1238
EP 1243
DI 10.1017/S1368980013000773
PG 6
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 153PO
UT WOS:000319614800011
PM 23570695
OA Bronze, Green Accepted, Green Published
DA 2025-04-28
ER

PT J
AU Epperlein, S
   Gebhardt, C
   Rohde, K
   Chakaroun, R
   Patt, M
   Schamarek, I
   Kralisch, S
   Heiker, JT
   Scholz, M
   Stumvoll, M
   Kovacs, P
   Breitfeld, J
   Tönjes, A
AF Epperlein, Sarah
   Gebhardt, Claudia
   Rohde, Kerstin
   Chakaroun, Rima
   Patt, Marie
   Schamarek, Imke
   Kralisch, Susan
   Heiker, John T.
   Scholz, Markus
   Stumvoll, Michael
   Kovacs, Peter
   Breitfeld, Jana
   Toenjes, Anke
TI The Effect of FGF21 and Its Genetic Variants on Food and Drug Cravings,
   Adipokines and Metabolic Traits
SO BIOMEDICINES
LA English
DT Article
DE fibroblast growth factor 21; eating behavior; addictive behavior;
   adipokines; genetic variation in FGF21
ID GROWTH-FACTOR 21; GENOME-WIDE ASSOCIATION; SELF-CONTAINED POPULATION;
   SERUM CONCENTRATIONS; INSULIN SENSITIVITY; BODY-WEIGHT; GLUCOSE;
   ADIPONECTIN; FGF-21; LIVER
AB Fibroblast growth factor 21 (FGF21) is a regulator of addictive behavior. Increasing evidence suggests an impact of FGF21 on eating behavior, food and drug cravings and on other adipokines like insulin-like growth factor 1 (IGF-1) or adiponectin. We investigated the association of serum FGF21 and genetic variants with aspects of food and drug craving and obesity related metabolic parameters including serum adipokine levels. Standardized questionnaires, blood samples and anthropometric data of the Sorbs cohort (n = 1046) were analyzed using SPSS. For genetic analyses, the FGF21-locus +/- 10 kb was genotyped and analyzed using PLINK. Validation was conducted in a second independent cohort (n = 704). FGF21 was significantly associated with alcohol and coffee consumption, smoking and eating behavior (disinhibition). We confirmed correlations of FGF21 serum levels with IGF-1, adiponectin, pro-enkephalin, adipocyte fatty-acid-binding protein, chemerin and progranulin. FGF21 genetic variants were associated with anthropometric and metabolic parameters, adipokines, food and drug craving while strongest evidence was seen with low-density lipoprotein cholesterol (LDL-C). We highlight the potential role of FGF21 in food and drug cravings and provide new insights regarding the link of FGF21 with other adipokines as well as with metabolic traits, in particular those related to lipid metabolism (LDL-C).
C1 [Epperlein, Sarah; Chakaroun, Rima; Patt, Marie; Schamarek, Imke; Kralisch, Susan; Stumvoll, Michael; Kovacs, Peter; Breitfeld, Jana; Toenjes, Anke] Univ Leipzig, Med Dept Endocrinol Nephrol Rheumatol 3, Med Ctr, D-04103 Leipzig, Germany.
   [Gebhardt, Claudia; Rohde, Kerstin; Heiker, John T.] Univ Leipzig, Helmholtz Inst Metab Obes & Vasc Res HI MAG, Helmholtz Ctr Munich, D-04103 Leipzig, Germany.
   [Gebhardt, Claudia; Rohde, Kerstin; Heiker, John T.] Univ Leipzig, Med Ctr, D-04103 Leipzig, Germany.
   [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Fac Med, D-04107 Leipzig, Germany.
   [Stumvoll, Michael] Deutsch Zentrum Diabetesforsch, D-85764 Neuherberg, Germany.
C3 Leipzig University; Leipzig University; Helmholtz Association;
   Helmholtz-Center Munich - German Research Center for Environmental
   Health; Leipzig University; Leipzig University
RP Breitfeld, J; Tönjes, A (corresponding author), Univ Leipzig, Med Dept Endocrinol Nephrol Rheumatol 3, Med Ctr, D-04103 Leipzig, Germany.
EM sarah.epperlein@medizin.uni-leipzig.de;
   claudia.gebhardt@helmholtz-muenchen.de;
   kerstin.rohde@helmholtz-muenchen.de;
   rima.chakaroun@medizin.uni-leipzig.de;
   marie.patt@medizin.uni-leipzig.de;
   imke.schamarek@medizin.uni-leipzig.de;
   susan.kralisch@medizin.uni-leipzig.de;
   john.heiker@helmholtz-muenchen.de; markus.scholz@imise.uni-leipzig.de;
   michael.stumvoll@medizin.uni-leipzig.de;
   peter.kovacs@medizin.uni-leipzig.de;
   jana.breitfeld@medizin.uni-leipzig.de;
   anke.toenjes@medizin.uni-leipzig.de
RI Heiker, John/O-9728-2019; Stumvoll, Michael/ABE-1121-2021; Chakaroun,
   Rima/AAU-3660-2020; Chakaroun, Rima/LGY-8314-2024
OI Kovacs, Peter/0000-0002-0290-5423; Heiker, John/0000-0003-2822-3006;
   Stumvoll, Michael/0000-0001-6225-8240; Chakaroun,
   Rima/0000-0001-9901-1815; Tonjes, Anke/0009-0005-1944-1812
FU Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
   [209933838-SFB 1052]; DFG Priority Program "Thyroid Transact" [SPP1629,
   TO 718/2-1]; Deutsches Zentrum fur Diabetesforschung [82DZD06D03]
FX This research was funded by grants from the Deutsche
   Forschungsgemeinschaft (DFG, German Research Foundation-Projektnummer
   209933838-SFB 1052 "Obesity mechanisms"; B03, C06, C07); DFG Priority
   Program "Thyroid Transact" SPP1629 (TO 718/2-1) and from Deutsches
   Zentrum fur Diabetesforschung (82DZD06D03).
CR Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   Baruch A, 2020, P NATL ACAD SCI USA, V117, P28992, DOI 10.1073/pnas.2012073117
   Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970
   Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684
   Chen C, 2011, DIABETES CARE, V34, P2113, DOI 10.2337/dc11-0294
   Cheng XB, 2011, ENDOCR RES, V36, P142, DOI 10.3109/07435800.2011.558550
   Chu AY, 2013, HUM MOL GENET, V22, P1895, DOI 10.1093/hmg/ddt032
   Clarke TK, 2017, MOL PSYCHIATR, V22, P1376, DOI 10.1038/mp.2017.153
   Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816
   Desai BN, 2017, MOL METAB, V6, P1395, DOI 10.1016/j.molmet.2017.08.004
   Ding RY, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0666-z
   Ebert T, 2018, J CLIN ENDOCR METAB, V103, P1015, DOI 10.1210/jc.2017-02085
   Evangelou E, 2019, NAT HUM BEHAV, V3, P950, DOI 10.1038/s41562-019-0653-z
   Fazeli PK, 2015, J CLIN INVEST, V125, P4601, DOI 10.1172/JCI83349
   Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197
   Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193
   Frayling TM, 2018, CELL REP, V23, P327, DOI 10.1016/j.celrep.2018.03.070
   Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200
   Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005
   Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591
   Heianza Y, 2016, DIABETES CARE, V39, P1909, DOI 10.2337/dc16-1111
   Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006
   Kamizono Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011947
   Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606
   Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168
   Kim AM, 2017, DIABETES OBES METAB, V19, P1762, DOI 10.1111/dom.13023
   Kralisch S, 2013, J ENDOCRINOL, V216, P135, DOI 10.1530/JOE-12-0367
   Lee Y, 2014, CLIN ENDOCRINOL, V80, P57, DOI 10.1111/cen.12134
   Li G, 2018, EUR NEUROPSYCHOPHARM, V28, P892, DOI 10.1016/j.euroneuro.2018.05.015
   Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018
   Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005
   Löffler A, 2017, PUBLIC HEALTH NUTR, V20, P2706, DOI 10.1017/S1368980017001653
   Löffler A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133977
   Lundsgaard AM, 2017, MOL METAB, V6, P22, DOI 10.1016/j.molmet.2016.11.001
   Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Minard AY, 2016, CELL REP, V17, P29, DOI 10.1016/j.celrep.2016.08.086
   Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x
   National Center for Biotechnology Information (NCBI), 2020, US ROCKVILLE PIKE
   Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975
   Samms RJ, 2017, J CLIN ENDOCR METAB, V102, P3806, DOI 10.1210/jc.2017-01257
   Santoso P, 2017, SCI REP-UK, V7, DOI 10.1038/srep45819
   Schumann G, 2016, P NATL ACAD SCI USA, V113, P14372, DOI 10.1073/pnas.1611243113
   Seberg S, 2018, MOL METAB, V11, P96, DOI 10.1016/j.molmet.2018.03.010
   Soberg S, 2017, CELL METAB, V25, P1045, DOI 10.1016/j.cmet.2017.04.009
   Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   Talukdar S, 2016, CELL METAB, V23, P427, DOI 10.1016/j.cmet.2016.02.001
   Talukdar S, 2016, CELL METAB, V23, P344, DOI 10.1016/j.cmet.2015.12.008
   Tanaka T, 2013, AM J CLIN NUTR, V97, P1395, DOI 10.3945/ajcn.112.052183
   Tanimura Y, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12828
   Tönjes A, 2012, INT J OBESITY, V36, P766, DOI 10.1038/ijo.2011.162
   Tönjes A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004854
   Tönjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107
   Tönjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423
   Verger EO, 2017, J ACAD NUTR DIET, V117, P878, DOI 10.1016/j.jand.2016.10.030
   Wang N, 2018, INFLAMMATION, V41, P73, DOI 10.1007/s10753-017-0665-7
   Wannamethee SG, 2007, INT J OBESITY, V31, P1089, DOI 10.1038/sj.ijo.0803544
   Westhofer J., 1989, FRAGEBOGEN ZUM E VER
   Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797
   Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009
   Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476
NR 64
TC 10
Z9 10
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD APR
PY 2021
VL 9
IS 4
AR 345
DI 10.3390/biomedicines9040345
PG 18
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA RQ9ZT
UT WOS:000642770200001
PM 33805553
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Yuda, N
   Tanaka, M
   Suzuki, M
   Asano, Y
   Ochi, H
   Iwatsuki, K
AF Yuda, Naoki
   Tanaka, Miyuki
   Suzuki, Manabu
   Asano, Yuzo
   Ochi, Hiroshi
   Iwatsuki, Keiji
TI Polyphenols Extracted from Black Tea (Camellia sinensis) Residue
   by Hot-Compressed Water and Their Inhibitory Effect on Pancreatic Lipase
   in vitro
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE black tea; high-performance liquid chromatography-mass spectrometry;
   hot-compressed water; pancreatic lipase; residue; theaflavin
ID PRODUCTS; WEIGHT; WASTES; GREEN; FAT
AB Polyphenols, retained in black tea wastes following the commercial production of tea beverages, represent an underutilized resource. The purpose of this study was to investigate the potential use of hot-compressed water (HCW) for the extraction of pancreatic lipase-inhibiting polyphenols from black tea residues. Black tea residues were treated with HCW at 10 degrees C intervals, from 100 to 200 degrees C. The resulting extracts were analyzed using high-performance liquid chromatography-mass spectrometry and assayed to determine their inhibitory effect on pancreatic lipase activity in vitro. Four theaflavins (TF), 5 catechins, 2 quercetin glycosides, quinic acid, gallic acid, and caffeine were identified. The total polyphenol content of extracts increased with increasing temperature but lipase inhibitors (TF, theaflavin 3-O-gallate, theaflavin 3'-O-gallate, theaflavin 3,3'-O-gallate, epigallocatechin gallate, and epicatechin gallate) decreased over 150 degrees C. All extracts inhibited pancreatic lipase but extracts obtained at 100 to 140 degrees C showed the greatest lipase inhibition (IC(50)s of 0.9 to 1.3 mu g/mL), consistent with the optimal extraction of TFs and catechins except catechin by HCW between 130 and 150 degrees C. HCW can be used to extract pancreatic lipase-inhibiting polyphenols from black tea waste. These extracts have potential uses, as dietary supplements and medications, for the prevention and treatment of obesity.
C1 [Yuda, Naoki; Tanaka, Miyuki; Suzuki, Manabu; Asano, Yuzo; Ochi, Hiroshi; Iwatsuki, Keiji] Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, Zama, Kanagawa 2528583, Japan.
C3 Morinaga Milk Industry Company, Ltd
RP Yuda, N (corresponding author), Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, 1-83,5 Chome, Zama, Kanagawa 2528583, Japan.
EM n-yuda@morinagamilk.co.jp
OI Yuda, Naoki/0000-0003-2737-2077
CR Arvanitoyannis IS, 2008, CRIT REV FOOD SCI, V48, P205, DOI 10.1080/10408390701279798
   Baysal T, 2000, J AGR FOOD CHEM, V48, P5507, DOI 10.1021/jf000311t
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   Drynan JW, 2010, NAT PROD REP, V27, P417, DOI 10.1039/b912523j
   Duran C, 2011, ANAL CHIM ACTA, V688, P75, DOI 10.1016/j.aca.2010.12.029
   Etoh H, 2010, BIOSCI BIOTECH BIOCH, V74, P858, DOI 10.1271/bbb.90800
   Farhoosh R, 2007, FOOD CHEM, V100, P231, DOI 10.1016/j.foodchem.2005.09.046
   Folin O, 1915, J BIOL CHEM, V22, P305
   Gu YY, 2011, J AGR FOOD CHEM, V59, P5305, DOI 10.1021/jf200180n
   Herrero M, 2006, FOOD CHEM, V98, P136, DOI 10.1016/j.foodchem.2005.05.058
   Hill JO, 1999, AM J CLIN NUTR, V69, P1108
   Jin FM, 2001, J SUPERCRIT FLUID, V19, P251, DOI 10.1016/S0896-8446(00)00094-2
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kante K, 2012, J HAZARD MATER, V201, P141, DOI 10.1016/j.jhazmat.2011.11.053
   Kurihara H, 2003, BIOL PHARM BULL, V26, P383, DOI 10.1248/bpb.26.383
   Kusano R, 2008, CHEM PHARM BULL, V56, P266, DOI 10.1248/cpb.56.266
   LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2
   MARSHALL WL, 1981, J PHYS CHEM REF DATA, V10, P295, DOI 10.1063/1.555643
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Sharma V, 2009, CRIT REV FOOD SCI, V49, P379, DOI 10.1080/10408390802068066
   Tsubaki S, 2008, J AGR FOOD CHEM, V56, P11293, DOI 10.1021/jf802253s
   van der Burg-Koorevaar MCD, 2011, J AGR FOOD CHEM, V59, P7752, DOI 10.1021/jf2015232
   Wiboonsirikul J, 2008, FOOD SCI TECHNOL RES, V14, P319, DOI 10.3136/fstr.14.319
NR 23
TC 64
Z9 68
U1 2
U2 100
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
J9 J FOOD SCI
JI J. Food Sci.
PD DEC
PY 2012
VL 77
IS 12
BP H254
EP H261
DI 10.1111/j.1750-3841.2012.02967.x
PG 8
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 057HK
UT WOS:000312553600009
PM 23106349
DA 2025-04-28
ER

PT J
AU Xie, LY
   Tang, QY
   Yao, D
   Gu, QY
   Zheng, H
   Wang, XD
   Yu, ZP
   Shen, XH
AF Xie, Luyao
   Tang, Qingya
   Yao, Die
   Gu, Qiuyun
   Zheng, Hao
   Wang, Xiaodi
   Yu, Zhiping
   Shen, Xiuhua
TI Effect of Decaffeinated Green Tea Polyphenols on Body Fat and Precocious
   Puberty in Obese Girls: A Randomized Controlled Trial
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE obesity; precocious puberty; decaffeinated green tea polyphenol; girls;
   randomized controlled trial
ID XANTHINE-OXIDASE; BLOOD-PRESSURE; MASS INDEX; BLACK TEA; EXTRACT;
   CAFFEINE; MENARCHE; CONSUMPTION; MATURATION; REDUCTION
AB Background
   Obesity has been reported to be an important contributing factor for precocious puberty, especially in girls. The effect of green tea polyphenols on weight reduction in adult population has been shown, but few related studies have been conducted in children. This study was performed to examine the effectiveness and safety of decaffeinated green tea polyphenols (DGTP) on ameliorating obesity and early sexual development in girls with obesity.
   Design
   This is a double-blinded randomized controlled trial. Girls with obesity aged 6-10 years old were randomly assigned to receive 400 mg/day DGTP or isodose placebo orally for 12 weeks. During this period, all participants received the same instruction on diet and exercise from trained dietitians. Anthropometric measurements, secondary sexual characteristics, B-scan ultrasonography of uterus, ovaries and breast tissues, and related biochemical parameters were examined and assessed pre- and post-treatment.
   Results
   Between August 2018 and January 2020, 62 girls with obesity (DGTP group n = 31, control group n = 31) completed the intervention and were included in analysis. After the intervention, body mass index, waist circumference, and waist-to-hip ratio significantly decreased in both groups, but the percentage of body fat (PBF), serum uric acid (UA), and the volumes of ovaries decreased significantly only within the DGTP group. After controlling confounders, DGTP showed a significantly decreased effect on the change of PBF (beta = 2.932, 95% CI: 0.214 to 5.650), serum UA (beta = 52.601, 95% CI: 2.520 to 102.681), and ovarian volumes (right: beta = 1.881, 95% CI: 0.062 to 3.699, left: beta = 0.971, 95% CI: 0.019 to 1.923) in girls with obesity. No side effect was reported in both groups during the whole period.
   Conclusion
   DGTP have shown beneficial effects of ameliorated obesity and postponed early sexual development in girls with obesity without any adverse effects.
C1 [Xie, Luyao; Tang, Qingya; Zheng, Hao] Shanghai Jiao Tong Univ, Dept Clin Nutr, Sch Med, Xinhua Hosp, Shanghai, Peoples R China.
   [Xie, Luyao; Yao, Die; Gu, Qiuyun; Wang, Xiaodi] Shanghai Jiao Tong Univ, Sch Publ Hlth, Sch Med, Shanghai, Peoples R China.
   [Xie, Luyao; Yao, Die; Gu, Qiuyun; Wang, Xiaodi; Shen, Xiuhua] Shanghai Jiao Tong Univ, Dept Nutr, Sch Med, Shanghai, Peoples R China.
   [Yu, Zhiping] Univ North Florida, Dept Nutr & Dietet, Jacksonville, FL USA.
   [Shen, Xiuhua] Shanghai Jiao Tong Univ, Shanghai Key Lab Pediat Gastroenterol & Nutr, Sch Med, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai
   Jiao Tong University; State University System of Florida; University of
   North Florida; Shanghai Jiao Tong University
RP Shen, XH (corresponding author), Shanghai Jiao Tong Univ, Dept Nutr, Sch Med, Shanghai, Peoples R China.; Shen, XH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Pediat Gastroenterol & Nutr, Sch Med, Shanghai, Peoples R China.
EM srachel@126.com
RI Xie, Luyao/HSD-1878-2023; shen, Rachel/LCL-2708-2024
FU National Natural Science Foundation of China; National Natural Science
   Foundation of China [81773407]
FX This work is supported by the National Natural Science Foundation of
   China (No. 81773407).
CR Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144
   Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476
   Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Cesario SK, 2007, JOGNN-J OBST GYN NEO, V36, P263, DOI 10.1111/J.1552-6909.2007.00145.x
   Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318
   Chen G, 2015, J ETHNOPHARMACOL, V175, P14, DOI 10.1016/j.jep.2015.08.043
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chinese Preventive Medicine Association Adolescent health care group of women health care society, 2018, CHIN J WOMAN CHILD H, V29, P135, DOI [10.3969/j.issn.1673-5293.2018.02.001, DOI 10.3969/J.ISSN.1673-5293.2018.02.001]
   Clarkson J, 2010, MOL CELL ENDOCRINOL, V324, P45, DOI 10.1016/j.mce.2010.01.026
   Denham M, 2005, PEDIATRICS, V115, pE127, DOI 10.1542/peds.2004-1161
   Gavela-Pérez T, 2015, PEDIATR OBES, V10, P410, DOI 10.1111/ijpo.277
   Glisan SL, 2017, FOOD CHEM, V216, P296, DOI 10.1016/j.foodchem.2016.08.052
   Golub MS, 2008, PEDIATRICS, V121, pS218, DOI 10.1542/peds.2007-1813G
   Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Jaruratanasirikul S, 2014, WORLD J PEDIATR, V10, P256, DOI 10.1007/s12519-014-0472-2
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Li F, 2020, ANN PALLIAT MED, V9, P331, DOI 10.21037/apm.2019.11.28
   Li WY, 2018, AM J HUM BIOL, V30, DOI 10.1002/ajhb.23195
   Ma HM, 2009, PEDIATRICS, V124, pE269, DOI 10.1542/peds.2008-2638
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Pubertal Study Group of the Subspecialty Group of Endocrinologic Hereditary and Metabolic Diseases Society of Pediatrics Chinese Medical Association, 2010, ZHONG HUA NEI FEN MI, V26, P669, DOI [DOI 10.3760/CMA.J.ISSN.1000-6699.2010.08.011, 10.3760/cma.j.issn.1000-6699.2010.08.011]
   Richards G, 2015, J PSYCHOPHARMACOL, V29, P1236, DOI 10.1177/0269881115612404
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Rosenfield RL, 2009, PEDIATRICS, V123, P84, DOI 10.1542/peds.2008-0146
   Rubin C, 2009, PAEDIATR PERINAT EP, V23, P492, DOI 10.1111/j.1365-3016.2009.01055.x
   Satoh T, 2015, J ETHNOPHARMACOL, V161, P147, DOI 10.1016/j.jep.2014.12.009
   Shen CL, 2012, NUTR RES, V32, P448, DOI 10.1016/j.nutres.2012.05.001
   Tehrani FR, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.16130
   Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012
   tsuchida t., 2002, Prog med, V9, P2189
   Turley KR, 2007, PEDIATR EXERC SCI, V19, P481, DOI 10.1123/pes.19.4.481
   Wang SM, 2017, EUR J NUTR, V56, P2037, DOI 10.1007/s00394-016-1241-x
   Watson EJ, 2017, J CLIN SLEEP MED, V13, P533, DOI 10.5664/jcsm.6536
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu YM, 2016, MED HYPOTHESES, V95, P24, DOI 10.1016/j.mehy.2016.07.017
   Zhai LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134656
   Zhu Mingqiang, 2013, Zhejiang Da Xue Xue Bao Yi Xue Ban, V42, P396
NR 46
TC 13
Z9 14
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD OCT 12
PY 2021
VL 12
AR 736724
DI 10.3389/fendo.2021.736724
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA WP6XG
UT WOS:000713271300001
PM 34712203
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Bailey, RL
   Fulgoni, VL
   Cowan, AE
   Gaine, PC
AF Bailey, Regan L.
   Fulgoni, Victor L., III
   Cowan, Alexandra E.
   Gaine, P. Courtney
TI Sources of Added Sugars in Young Children, Adolescents, and Adults with
   Low and High Intakes of Added Sugars
SO NUTRIENTS
LA English
DT Article
DE NHANES; added sugars; obesity; sweetened beverages; Dietary Guidelines
ID SWEETENED BEVERAGE CONSUMPTION; UNITED-STATES; SOFT DRINKS; US CHILDREN;
   SOLID FATS; METAANALYSIS; PREVALENCE; NUTRIENTS; HEALTH; TRENDS
AB High intake of added sugars is associated with excess energy intake and poorer diet quality. The objective of this cross-sectional study (n = 16,806) was to estimate usual intakes and the primary food sources of added sugars across the range of intakes (i.e., deciles) among U.S. children (2-8 years), adolescents and teens (9-18 years), and adults (19 years) using the National Health and Nutrition Examination (NHANES) data from 2009-2012. The percent energy contributed by added sugars was 14.3 +/- 0.2% (2-8 years), 16.2 +/- 0.2% (9-18 years), and 13.1 +/- 0.2% (19 years), suggesting the highest intakes are among adolescents and teens. However, the primary foods/beverages that contribute to added sugars were remarkably consistent across the range of intakes, with the exception of the lowest decile, and include sweetened beverages and sweet bakery products. Interestingly across all age groups, even those in the lowest decile of added sugars exceed the 10% guidelines. Additional foods contributing to high intakes were candy and other desserts (e.g., ice cream) in children and adolescents, and coffee and teas in adults. Tailoring public health messaging to reduce intakes of these identified food groups may be of utility in designing effective strategies to reduce added sugar intake in the U.S.
C1 [Bailey, Regan L.] Purdue Univ, Dept Nutr Sci, Stone Hall,Room 143A,700 West State St, W Lafayette, IN 47906 USA.
   [Fulgoni, Victor L., III] Nutr Impact LLC, 9725 D Dr North, Battle Creek, MI 49014 USA.
   [Cowan, Alexandra E.] Purdue Univ, Dept Nutr Sci, Room 143,700 West State St, W Lafayette, IN 47906 USA.
   [Gaine, P. Courtney] Sugar Assoc Inc, 1300 L St NW,Suite 1001, Washington, DC 20005 USA.
C3 Purdue University System; Purdue University; Nutrition Impact, LLC;
   Purdue University System; Purdue University
RP Bailey, RL (corresponding author), Purdue Univ, Dept Nutr Sci, Stone Hall,Room 143A,700 West State St, W Lafayette, IN 47906 USA.
EM reganbailey@purdue.edu; vic3rd@aol.com; cowan9@purdue.edu;
   gaine@sugar.org
RI Bailey, Regan/KHC-5106-2024
OI Bailey, Regan/0000-0003-0181-6223
FU Sugar Association
FX Nutrition Impact LLC (Battle Creek, MI, USA) received financial support
   from the Sugar Association for the research presented here. Nutrition
   Impact LLC will cover the publication costs.
CR [Anonymous], DIET REF INT
   Bailey R.L., 2017, Nutrition Today, V52, pS3, DOI DOI 10.1097/NT.0000000000000210
   BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064
   Clemens RA, 2016, COMPR REV FOOD SCI F, V15, P433, DOI 10.1111/1541-4337.12194
   Dietary Guidelines Advisory Committee, ADV REP SECR HLTH HU, P421
   Ervin R.B., 2013, NCHS DATA BRIEF, P1
   Ervin RB, 2012, NCHS DATA BRIEF, P1
   Freedman LS, 2015, AM J EPIDEMIOL, V181, P473, DOI 10.1093/aje/kwu325
   Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Kaartinen NE, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.3
   Khan TA, 2016, EUR J NUTR, V55, pS25, DOI 10.1007/s00394-016-1345-3
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Marriott BP, 2010, CRIT REV FOOD SCI, V50, P228, DOI 10.1080/10408391003626223
   Micha R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175149
   Miller G, 2017, MMWR-MORBID MORTAL W, V66, P112, DOI 10.15585/mmwr.mm6604a5
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Narain A, 2016, INT J CLIN PRACT, V70, P791, DOI 10.1111/ijcp.12841
   National Cancer Institute, TOP FOOD SOURC SAT F
   Ogden CL, 2015, NCHS DATA BRIEF, P1, DOI DOI 10.1017/S1368980017000088
   Park S, 2016, MMWR-MORBID MORTAL W, V65, P169, DOI 10.15585/mmwr.mm6507a1
   Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010
   Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8
   Rosinger A., 2017, NCHS DATA BRIEF, P1
   Sievenpiper JL, 2013, AM J CLIN NUTR, V98, P261, DOI 10.3945/ajcn.113.067215
   Sigman-Grant M, 2003, AM J CLIN NUTR, V78, p815S, DOI 10.1093/ajcn/78.4.815S
   Slining MM, 2013, PEDIATR OBES, V8, P307, DOI 10.1111/j.2047-6310.2013.00156.x
   Tasevska N, 2015, NUTRIENTS, V7, P5816, DOI 10.3390/nu7075255
   The National Academies of Sciences Engineering and Medicine, 2017, P WORKSH NAT AC SCI
   Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063
   US Department of Agriculture, FOOD PATT EQ DAT
   US Department of Health and Human Services, NUTR WEIGHT STAT AV
   US Department of Health and Human Services, DIET GUID AM 2015 20, P122
   Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834
   Welsh J. A., 2017, Nutrition Today, V52, pS60, DOI [10.1097/nt.0000000000000193, 10.1097/NT.0000000000000193]
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
   World Health Organization (WHO), 2015, Guideline: Sugars Intake for Adults and Children
NR 39
TC 146
Z9 170
U1 0
U2 61
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JAN
PY 2018
VL 10
IS 1
AR 102
DI 10.3390/nu10010102
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FU8FF
UT WOS:000424088000101
PM 29342109
OA Green Published, Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Tarantino, G
   Balsano, C
AF Tarantino, Giovanni
   Balsano, Clara
TI Gastrointestinal peptides and nonalcoholic fatty liver disease
SO CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY
LA English
DT Review
DE cholecystokinin; GIP; glucagon-like peptide 1; nesfatin; peptide YY
ID BODY-WEIGHT; LIRAGLUTIDE; YY
AB Purpose of review In this review, authors have selected from literature the most recent and suggestive studies on therapy of nonalcoholic fatty liver disease (NAFLD). The selected interventions regulate the action of gastrointestinal peptides, such as gastric inhibitory polypeptide (GIP), nesfatin, peptide YY, cholecystokinin, and glucagon-like peptide 1 (GLP-1). These hormones have been found frequently modified in obesity and/or type 2 diabetes mellitus, morbidities mostly associated with NAFLD. This disease has a very high prevalence worldwide and could evolve in a more severe form, that is, nonalcoholic steatohepatitis, characterized by inflammation and fibrosis. The findings shown by this article describe the metabolic effects of new drugs, mainly but not only, as well of some old substances. Recent findings Recent approaches, in animal models or in humans, use synthetic GLP-1 receptor agonists, a centrally administered antibody neutralizing GIP receptor, curcumin, compound being active on nesfatin, resveratrol (antiinflammatory agent), and Ginseg, both of them acting on nesfatin, a cholecystokinin receptor analogue, and finally coffee functioning on YY peptide. The implications of the presented findings, if they are confirmed in larger clinical trials, likely open the door to future application in clinical practice. In fact, nowadays, patients have only diet and article (incl abstract and keywords) exercise as well accepted recommendations. Thus, there are unmet needs to find substances that could really improve the progression of nonalcoholic steatohepatitis toward liver cirrhosis and hepatocellular carcinoma.
C1 [Tarantino, Giovanni] Univ Naples Federico II, Med Sch Naples, Dept Clin Med & Surg, Naples, Italy.
   [Balsano, Clara] Univ Aquila, Dept Clin Med Life Hlth & Environm Sci MESVA, Laquila, Italy.
C3 University of Naples Federico II; University of L'Aquila
RP Tarantino, G (corresponding author), Univ Naples Federico II, Med Sch Naples, Dept Clin Med & Surg, Naples, Italy.
EM tarantin@unina.it
RI Tarantino, Giovanni/AAW-2007-2021; Balsano, Clara/MCY-5404-2025
OI Balsano, Clara/0000-0002-9615-7031
CR Abegg K, 2017, DIABETES OBES METAB, V19, P1740, DOI 10.1111/dom.13020
   Cervantes A, 2018, GASTROENTEROL RES, V11, P280, DOI 10.14740/gr1042w
   Chen XX, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00434
   Christoffersen BO, 2019, INT J OBES LOND
   Elvert R, 2018, DIABETES OBES METAB, V20, P1836, DOI 10.1111/dom.13212
   Emmerzaal TL, 2013, CURR PHARM DESIGN, V19, P6941, DOI 10.2174/138161281939131127125042
   Feng WH, 2019, J DIABETES INVEST, V10, P399, DOI 10.1111/jdi.12888
   Finn PD, 2019, AM J PHYSIOL-GASTR L, V316, pG412, DOI 10.1152/ajpgi.00300.2018
   Frossing S, 2018, DIABETES OBES METAB, V20, P215, DOI 10.1111/dom.13053
   Guillory B, 2018, AGING CELL, V17, DOI 10.1111/acel.12688
   Ipsen DH, 2018, BASIC CLIN PHARMACOL, V123, P704, DOI 10.1111/bcpt.13082
   Jazayeri-Tehrani SA, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0331-1
   Kaneko K, 2019, J CLIN INVEST, V129, P3786, DOI 10.1172/JCI126107
   Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269
   Kim KH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00485
   Lafferty RA, 2018, PEPTIDES, V100, P269, DOI 10.1016/j.peptides.2017.11.005
   Moreira GV, 2018, J NUTR BIOCHEM, V62, P143, DOI 10.1016/j.jnutbio.2018.07.009
   Norregaard PK, 2018, DIABETES OBES METAB, V20, P60, DOI 10.1111/dom.13034
   Park HJ, 2019, CHIN J INTEGR MED, V25, P895, DOI 10.1007/s11655-019-3200-x
   Patel V, 2018, CAN J PHYSIOL PHARM, V96, P587, DOI 10.1139/cjpp-2017-0683
   Sánchez-Garrido MA, 2017, DIABETOLOGIA, V60, P1851, DOI 10.1007/s00125-017-4354-8
   Valdecantos MP, 2017, HEPATOLOGY, V65, P950, DOI 10.1002/hep.28962
   Vitaglione P, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.10
   Witjaksono F, 2019, ROM J INTERN MED, V57, P15, DOI 10.2478/rjim-2018-0027
   Wu Y, 2019, CURR PROTEIN PEPT SC, V20, P750, DOI 10.2174/1389203720666190125105401
   Younossi ZM, 2019, J HEPATOL, V71, P793, DOI 10.1016/j.jhep.2019.06.021
NR 26
TC 8
Z9 8
U1 4
U2 18
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1752-296X
EI 1752-2978
J9 CURR OPIN ENDOCRINOL
JI Curr. Opin. Endocrinol. Diabetes Obes.
PD FEB
PY 2020
VL 27
IS 1
BP 11
EP 15
DI 10.1097/MED.0000000000000514
PG 5
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA NG6TB
UT WOS:000564112900003
PM 31815784
DA 2025-04-28
ER

PT J
AU Kakuta, Y
   Nakaya, N
   Nagase, S
   Fujita, M
   Koizumi, T
   Okamura, C
   Niikura, H
   Ohmori, K
   Kuriyama, S
   Tase, T
   Ito, K
   Minami, Y
   Yaegashi, N
   Tsuji, I
AF Kakuta, Yukika
   Nakaya, Naoki
   Nagase, Satoru
   Fujita, Megumi
   Koizumi, Toshimitsu
   Okamura, Chikako
   Niikura, Hitoshi
   Ohmori, Kaori
   Kuriyama, Shinichi
   Tase, Toru
   Ito, Kiyoshi
   Minami, Yuko
   Yaegashi, Nobuo
   Tsuji, Ichiro
TI Case-control study of green tea consumption and the risk of endometrial
   endometrioid adenocarcinoma
SO CANCER CAUSES & CONTROL
LA English
DT Article
DE Green tea; Endometrial cancer; Endometrial endometrioid adenocarcinoma;
   Japanese
ID FOOD-FREQUENCY QUESTIONNAIRE; COFFEE CONSUMPTION; POOLED ANALYSIS;
   GASTRIC-CANCER; NO ASSOCIATION; COHORT; JAPAN
AB To investigate the association between green tea consumption and the risk of endometrial cancer restricted to endometrial endometrioid adenocarcinoma (EEA) using a case-control design in Japan.
   The cases were 152 patients with histopathologically diagnosed EEA, and the controls were 285 healthy women who were matched for age and area of residence with individual cases. The subjects completed a questionnaire regarding health-related lifestyle and reproductive history, and a food frequency questionnaire. Odds ratios (ORs) of EEA for frequency of green tea consumption were calculated by conditional logistic regression analysis.
   We observed a significant inverse association between green tea consumption and the risk of EEA with a dose-response relationship. The multivariate-adjusted OR of EEA was 0.77 (95% CI: 0.37-1.58) for those in the second quartile of green tea consumption (5-6 cups/week-1 cup/day), 0.61 (0.30-1.23) in the third quartile (2-3 cups/day), and 0.33 (0.15-0.75) in the highest quartile (a parts per thousand yen4 cups/day), as referenced with those in the lowest quartile (a parts per thousand currency sign4 cups/week; p for trend = 0.007). This inverse association was consistently observed regardless of the presence or absence of factors such as obesity and menopause.
   Green tea consumption may be associated with a lower risk of EEA.
C1 [Kakuta, Yukika; Nagase, Satoru; Fujita, Megumi; Koizumi, Toshimitsu; Niikura, Hitoshi; Ito, Kiyoshi; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Div Gynecol, Dept Reprod & Dev Med,Aoba Ku, Sendai, Miyagi 9808574, Japan.
   [Kakuta, Yukika; Nakaya, Naoki; Ohmori, Kaori; Kuriyama, Shinichi; Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Div Epidemiol, Dept Publ Hlth & Forens Med, Sendai, Miyagi 9808574, Japan.
   [Okamura, Chikako] Sendai City Hosp, Dept Gynecol, Sendai, Miyagi, Japan.
   [Tase, Toru] Miyagi Canc Ctr, Dept Gynecol, Sendai, Miyagi, Japan.
   [Minami, Yuko] Tohoku Univ, Sch Hlth Sci, Div Community Hlth, Sendai, Miyagi 9808574, Japan.
C3 Tohoku University; Tohoku University; Miyagi Cancer Center; Tohoku
   University
RP Kakuta, Y (corresponding author), Tohoku Univ, Grad Sch Med, Div Gynecol, Dept Reprod & Dev Med,Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.
EM qyp06776@nifty.com
RI Kuriyama, Shinichi/ABC-2104-2020
OI Nagase, Satoru/0000-0001-5212-1128; Shinichi,
   Kuriyama/0000-0002-6445-0911
FU Ministry of Education, Science, Sports and Culture, Japan; Ministry of
   Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research
   [21592119] Funding Source: KAKEN
FX We deeply thank for Dr. Y. Tsubono's permission to use the FFQ for this
   study. This study was supported in part by a Grant-in-Aid for Scientific
   Research on Priority Areas, a Grant-in-Aid for Scientific Research (B)
   and (C), a Grant-in-Aid for Young Scientists (B), a Grant-in-Aid for
   Exploratory Research, from the Ministry of Education, Science, Sports
   and Culture, Japan; a Grant-in-Aid from the Ministry of Health, Labor
   and Welfare, Japan; the 21st Century COE Program Special Research Grant
   (Tohoku University) from the Ministry of Education Science, Sports and
   Culture, Japan; a Grant-in-aid from the Kurokawa Cancer Research
   Foundation, the Uehara Memorial Foundation, All Japan Coffee
   Association, and the Third Term Comprehensive 10-year Strategy for
   Cancer Control from the Ministry of Health, Labour and Welfare, Japan.
   All the authors of this article have directly participated in the
   planning, execution, or analysis of this study. There are no financial
   or other relations that could lead to conflict of interest.
CR Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8
   BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7
   CHRISTOPHER P, 2006, DIAGNOSTIC GYNECOLOG, P546
   Cooper R, 2005, J ALTERN COMPLEM MED, V11, P639, DOI 10.1089/acm.2005.11.639
   DELIGDISCH L, 1987, CANCER DETECT PREV, V10, P237
   Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S
   Hirose K, 2007, CANCER SCI, V98, P411, DOI 10.1111/j.1349-7006.2007.00391.x
   Inoue M, 1998, CANCER CAUSE CONTROL, V9, P209, DOI 10.1023/A:1008890529261
   Ishikawa A, 2006, J EPIDEMIOL, V16, P185, DOI 10.2188/jea.16.185
   Kikuchi N, 2006, BRIT J CANCER, V95, P371, DOI 10.1038/sj.bjc.6603230
   Koizumi T, 2008, EUR J CANCER PREV, V17, P358, DOI 10.1097/CEJ.0b013e3282f0c02c
   Koizumi Y, 2003, CANCER EPIDEM BIOMAR, V12, P472
   Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255
   Liao CK, 2003, CANCER CAUSE CONTROL, V14, P357, DOI 10.1023/A:1023925010837
   Luo JH, 2007, EUR J CANCER PREV, V16, P542, DOI 10.1097/CEJ.0b013e32809b4d30
   Nagano J, 2001, CANCER CAUSE CONTROL, V12, P501, DOI 10.1023/A:1011297326696
   *NAT CANC I, 2008, SNAPSH END CANC
   Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411
   OHTA H, 2000, SANFUJINKA JISSAI, V49, P1669
   *SAS I INC, 2004, SAS STAT GUID US GUI
   Sasazuki S, 2004, CANCER CAUSE CONTROL, V15, P483, DOI 10.1023/B:CACO.0000036449.68454.42
   SHIMAZU T, 2008, INT J CANC      0818
   Suzuki Y, 2005, J EPIDEMIOL, V15, P118, DOI 10.2188/jea.15.118
   Suzuki Y, 2004, BRIT J CANCER, V90, P1361, DOI 10.1038/sj.bjc.6601652
   Tsubono Y, 2001, NUTR CANCER, V39, P78, DOI 10.1207/S15327914nc391_11
   Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903
   Xu WH, 2007, AM J EPIDEMIOL, V166, P1420, DOI 10.1093/aje/kwm242
   Yang CS, 2007, TOXICOL APPL PHARM, V224, P265, DOI 10.1016/j.taap.2006.11.024
   Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006
   Zhang M, 2002, CANCER EPIDEM BIOMAR, V11, P713
NR 30
TC 23
Z9 24
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-5243
EI 1573-7225
J9 CANCER CAUSE CONTROL
JI Cancer Causes Control
PD JUL
PY 2009
VL 20
IS 5
BP 617
EP 624
DI 10.1007/s10552-008-9272-0
PG 8
WC Oncology; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Public, Environmental & Occupational Health
GA 449OP
UT WOS:000266340200013
PM 19067194
DA 2025-04-28
ER

PT J
AU Lima, ND
   Numata, ED
   Mesquita, LMD
   Dias, PH
   Vilegas, W
   Gambero, A
   Ribeiro, ML
AF Lima, Natalia da Silva
   Numata, Erica de Paula
   de Souza Mesquita, Leonardo Mendes
   Dias, Pollyana Hammoud
   Vilegas, Wagner
   Gambero, Alessandra
   Ribeiro, Marcelo Lima
TI Modulatory Effects of Guarana (Paullinia cupana) on Adipogenesis
SO NUTRIENTS
LA English
DT Article
DE adipogenesis; guarana (Paullinia cupana); obesity; 3T3L1; Wnt pathway;
   miRNA
ID EXTRACT FORMULATION; YERBA-MATE; IN-VITRO; DIFFERENTIATION; OXIDATION;
   CAFFEINE; OBESITY
AB Guarana (Paullinia cupana) is a plant originated in Brazil that presents a beneficial effect on body weight control and metabolic alterations. The aim of this study was to evaluate the effects of guarana on genes and miRNAs related to adipogenesis in 3T3L1 cells. The anti-adipogenic effect of guarana was evaluated by Oil Red-O staining. Gene and miRNA expression levels were determined by real time PCR. The Cebp alpha and beta-catenin nuclear translocation were evaluated using immunocytochemistry. Our data indicated that the triglyceride-reducing effect of guarana was dose-dependent from 100 to 300 mu g/mL (-12%, -20%, -24% and -40%, respectively, p < 0.0001). An up-regulation of the anti-adipogenic genes Wnt10b, Wnt3a, Wnt1, Gata3 and Dlk1 and a down-regulation of pro-adipogenic genes Cebp alpha, Ppar gamma and Creb1 were also observed. Furthermore, guarana repressed mmu-miR-27b-3p, mmu-miR-34b-5p and mmu-miR-760-5p, that contributed for up-regulation of their molecular targets Wnt3a, Wnt1 and Wnt10b. Additionally, cells treated with guarana presented an increase on beta-catenin nuclear translocation (p < 0.0018). In summary, our data indicate that guarana has an anti-adipogenic potential due to its ability to modulate miRNAs and genes related to this process. Together our data demonstrate the important role of guarana as a putative therapeutic agent.
C1 [Lima, Natalia da Silva; Numata, Erica de Paula; Gambero, Alessandra; Ribeiro, Marcelo Lima] Sao Francisco Univ, Med Sch, Clin Pharmacol & Gastroenterol Unit, Lab Immunopharmacol & Mol Biol, BR-12916900 Braganca Paulista, SP, Brazil.
   [de Souza Mesquita, Leonardo Mendes; Dias, Pollyana Hammoud; Vilegas, Wagner] UNESP Sao Paulo State Univ, Lab Bioprospect & Nat Prod LBPN, Coastal Campus Sao Vicente, BR-11330900 Sao Vicente, SP, Brazil.
C3 Universidade Estadual Paulista
RP Lima, ND; Ribeiro, ML (corresponding author), Sao Francisco Univ, Med Sch, Clin Pharmacol & Gastroenterol Unit, Lab Immunopharmacol & Mol Biol, BR-12916900 Braganca Paulista, SP, Brazil.
EM lima.nat@gmail.com; aykime@hotmail.com; mesquitalms@gmail.com;
   pollyhdias@gmail.com; vilegasw@gmail.com; alessandra.gambero@usf.edu.br;
   marcelo.ribeiro@usf.edu.br
RI LIMA, NATALIA/K-5674-2015; Ribeiro, Marcelo/H-8856-2013; de Souza
   Mesquita, Leonardo/AAA-5697-2020; Vilegas, Wagner/S-3209-2019; Gambero,
   Alessandra/G-5792-2013; Vilegas, Wagner/D-3170-2012
OI Gambero, Alessandra/0000-0002-4862-4328; DA SILVA LIMA,
   NATALIA/0000-0001-9448-4090; Mendes de Souza Mesquita,
   Leonardo/0000-0002-7602-7731; /0000-0003-4529-7832; Vilegas,
   Wagner/0000-0003-3032-2556
FU National Council for Scientific and Technological Development (CNPq);
   Coordination for the Enhancement of Higher Education Personnel (CAPES)
FX This work was supported by National Council for Scientific and
   Technological Development (CNPq) and Coordination for the Enhancement of
   Higher Education Personnel (CAPES).
CR Angelo PCSA, 2008, PLANT CELL REP, V27, P117, DOI 10.1007/s00299-007-0456-y
   [Anonymous], 2014, Overweight and obesity
   Arçari DP, 2013, FOOD CHEM, V141, P809, DOI 10.1016/j.foodchem.2013.04.062
   Colquitt J.L., 2016, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD012105
   Cunha CA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/635470
   Finelli C, 2012, WORLD J GASTROENTERO, V18, P6790, DOI 10.3748/wjg.v18.i46.6790
   Gu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep38491
   Hansen L., 2017, J CLIN ENDOCR METAB, P7
   Harrold JA, 2013, APPETITE, V62, P84, DOI 10.1016/j.appet.2012.11.018
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009
   Krewer CD, 2011, PHYTOTHER RES, V25, P1367, DOI 10.1002/ptr.3437
   da Silva LAL, 2015, PHARMACOGN MAG, V11, P96, DOI 10.4103/0973-1296.149721
   Nakabayashi H, 2008, BIOFACTORS, V34, P293, DOI [10.3233/BIO-2009-1083, 10.1002/biof.5520340405]
   Phillips CM, 2017, ANN NY ACAD SCI, V1391, P85, DOI 10.1111/nyas.13230
   Portella RD, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-12
   Raynor HA, 2016, J ACAD NUTR DIET, V116, P129, DOI 10.1016/j.jand.2015.10.031
   Rosen ED, 2000, GENE DEV, V14, P1293
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950
   Santos JC, 2014, MOLECULES, V19, P16909, DOI 10.3390/molecules191016909
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Tian C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053796
   Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259
   Velayutham P, 2008, CURR MED CHEM, V15, P1840
   Williams CL, 2002, CIRCULATION, V106, P143, DOI 10.1161/01.CIR.0000019555.61092.9E
NR 27
TC 28
Z9 30
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2017
VL 9
IS 6
AR 635
DI 10.3390/nu9060635
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EY7NA
UT WOS:000404177100106
PM 28632199
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Ko, JH
   Jang, EH
   Park, CS
   Kim, HK
   Cho, SG
   Shin, DW
   Yi, HG
   Kang, JH
AF Ko, Jeong-Hyeon
   Jang, Eun-Hee
   Park, Chang-Shin
   Kim, Hyoung-Kwang
   Cho, Soon Gu
   Shin, Dong Wun
   Yi, Hyeon Gyu
   Kang, Ju-Hee
TI Pharmacokinetic and Pharmacodynamic Interaction between Metformin and
   (-)-Epigallocatechin-3-gallate
SO MOLECULAR & CELLULAR TOXICOLOGY
LA English
DT Article
DE (-)-Epigallocatechin-3-gallate; Metformin; Pharmacokinetics;
   AMP-activated protein kinase
ID GREEN TEA; EPIGALLOCATECHIN GALLATE; PROTEIN-KINASE; CANCER CELLS; EGCG;
   MODULATION; POLYPHENOL; CAFFEINE; CATECHIN; AMPK
AB (-)-Epigallocatechin-3-gallate (EGCG), a major flavonoid in green tea has multiple health benefits including chemoprevention, anti-inflammatory, anti-diabetic and anti-obesity effects. In connection with these effects, EGCG can be a candidate to help the treatment of metabolic diseases. Metformin is a widely used anti-diabetic drug regulating cellular energy homeostasis via AMP-activated protein kinase (AMPK) activation. Therefore, the combination of metformin with EGCG may have additive or synergistic effects on treatment of type 2 diabetes. Nevertheless, there is no report for the pharmacokinetic and/or pharmacodynamic interaction of EGCG with metformin. Here, we evaluated the pharmacokinetic and pharmacodynamic interaction between metformin and EGCG in rats. Pharmacokinetics parameters of metformin were measured after oral administration of metformin in rats pre-treated with EGCG (10 mg/kg) or saline for 7 days. The results showed that there is no significant difference in pharmacokinetic parameters between saline control and EGCG-treated group. In addition, the hepatic AMPK activation by metformin in EGCG-treated rats was also similar to the control. The lack of additive effects of EGCG on AMPK activation or intrarcellular uptake of metformin was also evaluated in cells in the presence or absence of EGCG. Treatment of HepG2 cells with EGCG inhibited the metformin-induced AMPK activation. Combined results suggested that EGCG has no effect on the pharmarcokinetics of metformin but may contribute to metformin action.
C1 [Ko, Jeong-Hyeon; Jang, Eun-Hee; Park, Chang-Shin; Kim, Hyoung-Kwang; Kang, Ju-Hee] Inha Univ, Coll Med, Ctr Adv Med Educ, Dept Pharmacol,Project BK 21, Inchon 400712, South Korea.
   [Ko, Jeong-Hyeon; Jang, Eun-Hee; Park, Chang-Shin; Kim, Hyoung-Kwang; Kang, Ju-Hee] Inha Univ, Coll Med, Ctr Adv Med Educ, Med Toxicol Res Ctr,Project BK 21, Inchon 400712, South Korea.
   [Jang, Eun-Hee; Kang, Ju-Hee] Inha Univ, Hosp Clin Trial Ctr, Inchon 400712, South Korea.
   [Cho, Soon Gu] Inha Univ Hosp, Dept Radiol, Inchon 400700, South Korea.
   [Shin, Dong Wun] Inje Univ, Ilsan Paik Hosp, Dept Emergency Med, Gyeonggi Do 411706, South Korea.
   [Yi, Hyeon Gyu] Inha Univ Hosp, Dept Internal Med, Inchon 400700, South Korea.
C3 Inha University; Inha University; Inha University; Inha University; Inha
   University Hospital; Inje University; Inha University; Inha University
   Hospital
RP Kang, JH (corresponding author), Inha Univ, Coll Med, Ctr Adv Med Educ, Dept Pharmacol,Project BK 21, Jungseok Bldg 6FL,3 Ga, Inchon 400712, South Korea.
EM johykang@inha.ac.kr
FU Inha University
FX This work was supported by an Intramural Grant from Inha University.
CR Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   Choi YB, 2004, BRAIN RES, V1019, P47, DOI 10.1016/j.brainres.2004.05.079
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   Hwang JT, 2007, CANCER LETT, V247, P115, DOI 10.1016/j.canlet.2006.03.030
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kao Y, 2000, AM J CLIN NUTR, V72, P1232
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Lambert JD, 2003, J NUTR, V133, p3262S, DOI 10.1093/jn/133.10.3262S
   Lee CH, 2000, J IMAGING SCI TECHN, V44, P308
   Liao SS, 2001, VITAM HORM, V62, P1, DOI 10.1016/S0083-6729(01)62001-6
   Lin CL, 2008, MOL NUTR FOOD RES, V52, P930, DOI 10.1002/mnfr.200700437
   Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200
   Monteiro R, 2005, N-S ARCH PHARMACOL, V372, P147, DOI 10.1007/s00210-005-0012-7
   Qanungo S, 2005, CARCINOGENESIS, V26, P958, DOI 10.1093/carcin/bgi040
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558
   Song EK, 2003, ARCH PHARM RES, V26, P559, DOI 10.1007/BF02976881
   Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200
   Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140
NR 22
TC 0
Z9 1
U1 0
U2 13
PU KOREAN SOCIETY TOXICOGENOMICS & TOXICOPROTEOMICS-KSTT
PI GYEONGGI-DO
PA HANYANG UNIV, SCI & TECHNOL BLDG 1, RM 423, SA-DONG, SANGROK-GU, ANSAN,
   GYEONGGI-DO, 426 791, SOUTH KOREA
SN 1738-642X
EI 2092-8467
J9 MOL CELL TOXICOL
JI Mol. Cell. Toxicol.
PD DEC 31
PY 2009
VL 5
IS 4
BP 298
EP 303
PG 6
WC Biochemistry & Molecular Biology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Toxicology
GA 540FG
UT WOS:000273316100004
DA 2025-04-28
ER

PT J
AU Rajan, L
   Palaniswamy, D
   Mohankumar, SK
AF Rajan, Logesh
   Palaniswamy, Dhanabal
   Mohankumar, Suresh Kumar
TI Targeting obesity with plant-derived pancreatic lipase inhibitors: A
   comprehensive review
SO PHARMACOLOGICAL RESEARCH
LA English
DT Review
DE Obesity; Pancreatic lipase; Phyto-molecules; Enzyme inhibitors; Natural
   products; Orlistat
ID HIGH-FAT-DIET; GREEN TEA EXTRACT; AESCULUS-TURBINATA BLUME; KEY
   DIGESTIVE ENZYMES; METABOLIC SYNDROME; COFFEE CONSUMPTION; BODY-WEIGHT;
   IN-VITRO; TRITERPENOID SAPONINS; ALPHA-GLUCOSIDASE
AB The prevalence of obesity is alarmingly increasing in the last few decades and leading to many serious public health concerns worldwide. The dysregulated lipid homeostasis due to various genetic, environmental and lifestyle factors is considered one of the critical putative pathways mediating obesity. Nonetheless, the scientific advancements unleashing the molecular dynamics of lipid metabolism have provided deeper insights on the emerging roles of lipid hydrolysing enzymes, including pancreatic lipase. It is hypothesized that inhibiting pancreatic lipase would prevent the breakdown of triglyceride and delays the absorption of fatty acids into the systemic circulation and adipocytes. Whilst, orlistat is the only conventional pancreatic lipase enzyme inhibitor available in clinics, identifying the safe clinical alternatives from plants to inhibit pancreatic lipase has been considered a significant advancement. Consequently, plants which have shown significant potential to combat obesity are now revisited for its abilities to inhibit pancreatic lipase. In this regard, our review surveyed the potential of medicinal plants and its phytoconstituents to inhibit pancreatic lipase and to elicit anti-obesity effects. Thus, the review collate and critically appraise the potential of medicinal plants and phyto-molecules inhibiting pancreatic lipase enzyme and consequently modulating triglyceride absorption in gut, and discuss its implications in the development of novel therapeutic strategies to combat obesity.
C1 [Rajan, Logesh; Palaniswamy, Dhanabal; Mohankumar, Suresh Kumar] JSS Acad Higher Educ & Res, JSS Coll Pharm, TIFAC CORE Herbal Drugs, Dept Pharmacognosy, Ooty 643001, Tamil Nadu, India.
C3 JSS Academy of Higher Education & Research; JSS College of Pharmacy,
   Ooty
RP Mohankumar, SK (corresponding author), JSS Acad Higher Educ & Res, JSS Coll Pharm, TIFAC CORE Herbal Drugs, Nilgiris 643001, Tamil Nadu, India.
EM suresh.jsscpo@jssuni.edu.in
RI Rajan, Dr. Logesh/HPH-7500-2023; Mohankumar, Suresh/G-5201-2011
OI Rajan, Dr. Logesh/0000-0001-6853-3565; Mohankumar,
   Suresh/0000-0001-8862-2979
FU Indian Council of Medical Research (ICMR) [45/43/2018/MP/BMS]
FX We highly acknowledge the TIFAC CORE in Herbal Drugs, JSS College of
   Pharmacy, Ooty and JSS Academy of Higher Education and Research for
   providing us the infra-structure. This work was funded by the Indian
   Council of Medical Research (ICMR) as a senior research fellow with
   reference no. 45/43/2018/MP/BMS/dt. 05.12.2018. We would also like to
   thank Dr. Kannan Rengasamy and Dr. Mohamad Fawzi Mahomoodally for their
   constructive guidance for the manuscript. We acknowledge the help
   rendered by Mr. Deeparaj Paul for proof reading and suggestions for
   editing and formatting the manuscript.
CR Ahn JH, 2013, NAT PROD RES, V27, P1132, DOI 10.1080/14786419.2012.711328
   Al-Suwailem AK., 2006, Journal of Applied Sciences Research, V2, P205
   Andersson L, 1996, BBA-LIPID LIPID MET, V1302, P236, DOI 10.1016/0005-2760(96)00068-9
   [Anonymous], 2003, Middle East Pharmacy
   Armand M, 1996, AM J PHYSIOL-GASTR L, V271, pG172, DOI 10.1152/ajpgi.1996.271.1.G172
   ARMAND M, 1994, AM J PHYSIOL, V266, pG372, DOI 10.1152/ajpgi.1994.266.3.G372
   Ashigai H, 2016, BIOL PHARM BULL, V39, P699, DOI 10.1248/bpb.b15-00662
   Assini JM, 2013, CURR OPIN LIPIDOL, V24, P34, DOI 10.1097/MOL.0b013e32835c07fd
   Avci G, 2010, PHARM BIOL, V48, P247, DOI 10.3109/13880200903085466
   Bajerska J, 2015, J MED FOOD, V18, P698, DOI 10.1089/jmf.2014.0032
   Balagalle S., 1997, EFFECT GROUND CURRY
   Balk L, 2009, EUR J EPIDEMIOL, V24, P203, DOI 10.1007/s10654-009-9323-1
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Batubara I, 2014, J WOOD SCI, V60, P169, DOI 10.1007/s10086-013-1388-5
   BEGLINGER C, 1985, J CLIN INVEST, V75, P1471, DOI 10.1172/JCI111850
   Ben Khedher MR, 2018, PEERJ, V6, DOI 10.7717/peerj.4166
   Bhagwat S., 2014, USDA DATABASE FLAVON
   Birari R, 2010, FITOTERAPIA, V81, P1129, DOI 10.1016/j.fitote.2010.07.013
   Birari R, 2009, NAT PROD COMMUN, V4, P1089
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Bladé C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476
   BOIVIN M, 1990, GASTROENTEROLOGY, V99, P1763, DOI 10.1016/0016-5085(90)90485-J
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   BOZKURT T, 1988, DIGESTION, V41, P108, DOI 10.1159/000199739
   BRAGANZA JM, 1978, GUT, V19, P358, DOI 10.1136/gut.19.5.358
   Bray G.A., 2007, OVERWEIGHT METABOLIC, V26
   Bray GA, 2007, GASTROENTEROLOGY, V132, P2239, DOI 10.1053/j.gastro.2007.03.053
   Brockerhoff H., 1974, LIPOLYTIC ENZYMES, P34
   Brockman H.L., 1984, P3
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Brown AL, 2011, BRIT J NUTR, V106, P1880, DOI 10.1017/S0007114511002376
   BRUNNER H, 1974, MAYO CLIN PROC, V49, P851
   Bustanji Y, 2011, J ENZYM INHIB MED CH, V26, P453, DOI 10.3109/14756366.2010.525509
   CANTOR P, 1992, GASTROENTEROLOGY, V102, P1742, DOI 10.1016/0016-5085(92)91738-P
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251
   Carrière F, 2000, GASTROENTEROLOGY, V119, P949, DOI 10.1053/gast.2000.18140
   CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876, DOI 10.1016/0016-5085(93)90908-U
   Casacchia T, 2019, EUR J NUTR, V58, P965, DOI 10.1007/s00394-018-1609-1
   Casuso RA, 2014, BIOL SPORT, V31, P63, DOI 10.5604/20831862.1086734
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Cha YS, 2004, J MED FOOD, V7, P422, DOI 10.1089/jmf.2004.7.422
   Chanoine JP, 2005, JAMA-J AM MED ASSOC, V293, P2873, DOI 10.1001/jama.293.23.2873
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Cheung BMY, 2013, THER ADV DRUG SAF, V4, P171, DOI 10.1177/2042098613489721
   Cho S, 2012, J NUTR BIOCHEM, V23, P192, DOI 10.1016/j.jnutbio.2010.11.016
   Cho SY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/974313
   Choi I, 2006, BIOFACTORS, V26, P273, DOI 10.1002/biof.5520260405
   D'Agostino D, 2002, J BIOL CHEM, V277, P7170, DOI 10.1074/jbc.M108328200
   Dalar A, 2014, PLANT FOOD HUM NUTR, V69, P30, DOI 10.1007/s11130-013-0393-6
   DIMAGNO EP, 1977, NEW ENGL J MED, V296, P1318, DOI 10.1056/NEJM197706092962304
   Dimmito MP, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090492
   Djeziri FZ, 2018, BIOCHIMIE, V152, P110, DOI 10.1016/j.biochi.2018.06.025
   Dostal AM, 2016, J NUTR, V146, P256, DOI 10.3945/jn.115.219238
   Dostal AM, 2016, J NUTR, V146, P38, DOI 10.3945/jn.115.222414
   DUKEHART MR, 1989, AM J CLIN NUTR, V50, P1023, DOI 10.1093/ajcn/50.5.1023
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A
   ENTRESSANGLES B, 1968, BIOCHIM BIOPHYS ACTA, V159, P285, DOI 10.1016/0005-2744(68)90077-6
   Eteng MU, 2000, NUTR RES, V20, P1513, DOI 10.1016/S0271-5317(00)80032-9
   Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581
   FRIED M, 1991, GASTROENTEROLOGY, V101, P503, DOI 10.1016/0016-5085(91)90031-F
   FRIED M, 1988, GASTROENTEROLOGY, V95, P1344, DOI 10.1016/0016-5085(88)90371-X
   GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456
   GERBER PR, 1988, HELV CHIM ACTA, V71, P1429, DOI 10.1002/hlca.19880710607
   GIBON V, 1984, B SOC CHIM BELG, V93, P27
   Gourineni V, 2012, J AGR FOOD CHEM, V60, P7674, DOI 10.1021/jf3013663
   Gras J, 2013, DRUG TODAY, V49, P15, DOI 10.1358/dot.2013.49.1.1910723
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   GRIFFITHS DW, 1979, J SCI FOOD AGR, V30, P458, DOI 10.1002/jsfa.2740300503
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Gu YY, 2014, EUR J NUTR, V53, P149, DOI 10.1007/s00394-013-0510-1
   Gu YY, 2011, J AGR FOOD CHEM, V59, P5305, DOI 10.1021/jf200180n
   Gubenator K., 1990, STRUCTURE HUMAN PANC, P9
   GUBERNATOR K, 1993, MOL SIMULAT, V10, P211, DOI 10.1080/08927029308022165
   Han Li-Kun, 2005, BMC Complement Altern Med, V5, P9, DOI 10.1186/1472-6882-5-9
   Han LK, 2000, J NUTR, V130, P2760, DOI 10.1093/jn/130.11.2760
   Han LK, 1999, INT J OBESITY, V23, P98, DOI 10.1038/sj.ijo.0800766
   Han LK, 2001, INT J OBESITY, V25, P1459, DOI 10.1038/sj.ijo.0801747
   Han UK, 2002, J NUTR, V132, P2241, DOI 10.1093/jn/132.8.2241
   Haslam E., 1989, Plant polyphenols: vegetable tannins revisited.
   Hazman Ö, 2016, TURK J MED SCI, V46, P1593, DOI 10.3906/sag-1506-108
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hirata B.K., 2019, FRONT ENDOCRINOL, P10
   HOLT PR, 1972, ARCH INTERN MED, V130, P574, DOI 10.1001/archinte.130.4.574
   HOWARD AN, 1981, INT J OBESITY, V5, P195
   Hu JN, 2008, CHEM PHARM BULL, V56, P12, DOI 10.1248/cpb.56.12
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Ilavenil S, 2014, PHYTOMEDICINE, V21, P758, DOI 10.1016/j.phymed.2013.11.007
   Im JY, 2015, BIOSCI BIOTECH BIOCH, V79, P1133, DOI 10.1080/09168451.2015.1006567
   Jang DS, 2008, ARCH PHARM RES, V31, P666, DOI 10.1007/s12272-001-1210-9
   Jaradat Nidal, 2017, Medicines (Basel), V4, DOI 10.3390/medicines4040089
   Jeong JY, 2014, BIOORG MED CHEM LETT, V24, P2329, DOI 10.1016/j.bmcl.2014.03.067
   Jia HJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0389-3
   Jin DY, 2013, J FUNCT FOODS, V5, P1142, DOI 10.1016/j.jff.2013.03.011
   Jung CH, 2012, J MED FOOD, V15, P959, DOI 10.1089/jmf.2012.2286
   Kamel H.I., 2019, MIDDLE E J APPL SCI, V9, P117
   Karu N, 2007, J AGR FOOD CHEM, V55, P2824, DOI 10.1021/jf0628025
   Kato E, 2012, BIOORG MED CHEM LETT, V22, P6410, DOI 10.1016/j.bmcl.2012.08.055
   KATSCHINSKI M, 1992, CLIN INVESTIGATOR, V70, P902
   Kawaguchi K, 1997, BIOSCI BIOTECH BIOCH, V61, P102, DOI 10.1271/bbb.61.102
   Keller J, 1997, AM J PHYSIOL-GASTR L, V272, pG632, DOI 10.1152/ajpgi.1997.272.3.G632
   Keller J, 2001, AM J PHYSIOL-GASTR L, V280, pG273, DOI 10.1152/ajpgi.2001.280.2.G273
   Keller J., 1996, POSTPRANDIALE REGULA
   Kim JH, 2017, NUTR RES, V41, P97, DOI 10.1016/j.nutres.2017.04.004
   Kim KD, 2019, NUTR METAB CARDIOVAS, V29, P409, DOI 10.1016/j.numecd.2018.12.001
   Kim NH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111734
   Kimura H, 2006, J PHARMACEUT BIOMED, V41, P1657, DOI 10.1016/j.jpba.2006.02.031
   Kimura H, 2011, FOOD RES INT, V44, P121, DOI 10.1016/j.foodres.2010.10.052
   Kishida T, 2008, OBESITY, V16, P290, DOI 10.1038/oby.2007.68
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kobori M, 2009, MOL NUTR FOOD RES, V53, P859, DOI 10.1002/mnfr.200800310
   Koh YM, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2669-3
   Kuem N, 2014, MOL NUTR FOOD RES, V58, P2166, DOI 10.1002/mnfr.201400159
   Kumar S, 2013, PHARM BIOL, V51, P607, DOI 10.3109/13880209.2012.757327
   Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332
   Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020
   Kurihara H, 2003, BIOL PHARM BULL, V26, P383, DOI 10.1248/bpb.26.383
   Kwon CS, 2003, BIOSCI BIOTECH BIOCH, V67, P1451, DOI 10.1271/bbb.67.1451
   Kwon EY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101415
   Larsen SC, 2018, INT J OBESITY, V42, P880, DOI 10.1038/ijo.2017.310
   de la Garza AL, 2011, PLANTA MED, V77, P773, DOI 10.1055/s-0030-1270924
   LAWS BM, 1963, BIOCHEM J, V87, P632, DOI 10.1042/bj0870632
   Lee EJ, 2012, PLANTA MED, V78, P1536, DOI 10.1055/s-0032-1315147
   Lee EM, 2010, MOLECULES, V15, P8251, DOI 10.3390/molecules15118251
   Lee IA, 2005, BIOL PHARM BULL, V28, P2106, DOI 10.1248/bpb.28.2106
   Lee J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121340
   Lee YM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101089
   Li F, 2007, CHEM PHARM BULL, V55, P1087, DOI 10.1248/cpb.55.1087
   Li ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086724
   Liou CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050447
   Liu W, 2008, PHYTOMEDICINE, V15, P1140, DOI 10.1016/j.phymed.2008.07.002
   [刘颜香 Liu Yanxiang], 2013, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V28, P264
   Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lunagariya NA, 2014, EXCLI J, V13, P897
   Lunder M, 2005, J LIPID RES, V46, P1512, DOI 10.1194/jlr.M500048-JLR200
   Luo LL, 2017, RSC ADV, V7, P37858, DOI 10.1039/c7ra05621d
   LUTHIPENG QQ, 1992, FEBS LETT, V299, P111, DOI 10.1016/0014-5793(92)80112-T
   Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   MALAGELADA JR, 1973, J CLIN INVEST, V52, P2160, DOI 10.1172/JCI107400
   MALAGELADA JR, 1979, DIGEST DIS SCI, V24, P101, DOI 10.1007/BF01324736
   Malloy M.J., 2015, ROSENBERGS MOL GENET, P577
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Marrelli M, 2019, S AFR J BOT, V120, P104, DOI 10.1016/j.sajb.2018.01.006
   Marrelli M, 2014, J SCI FOOD AGR, V94, P2217, DOI 10.1002/jsfa.6544
   McClendon KS, 2009, EXPERT OPIN DRUG SAF, V8, P727, DOI 10.1517/14740330903321485
   McNeely W, 1998, DRUGS, V56, P241, DOI 10.2165/00003495-199856020-00007
   Medeiros-Neto G., 2003, P 9 INT C OB J LIBB, V9
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Miled N, 2000, BIOCHIMIE, V82, P973, DOI 10.1016/S0300-9084(00)01179-2
   MILLER LJ, 1979, DIGEST DIS SCI, V24, P150, DOI 10.1007/BF01324743
   Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595
   Miyoshi N., 2015, Bot. Targets Ther, V5, P85, DOI [DOI 10.2147/BTAT.S91784, 10.2147/BTAT.S91784]
   MOLE S, 1987, PHYTOCHEMISTRY, V26, P99
   Molly J, 2017, INT J PHARM SCI RES, V8, P1858, DOI 10.13040/IJPSR.0975-8232.8(4).1858-64
   Moreno DA, 2003, NUTRITION, V19, P876, DOI 10.1016/S0899-9007(03)00167-9
   Morikawa T, 2009, PHYTOCHEMISTRY, V70, P1166, DOI 10.1016/j.phytochem.2009.06.015
   Moro CO, 2000, FITOTERAPIA, V71, pS73, DOI 10.1016/S0367-326X(00)00177-5
   Mosqueda-Solís A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32875-4
   Mu HL, 2004, PROG LIPID RES, V43, P105, DOI 10.1016/S0163-7827(03)00050-X
   MUELLER K, 1988, B SOC CHIM BELG, V97, P655
   Mukherjee A., 2013, INDIAN MED PLANTS KN
   Mukherjee M, 2003, J MOL CATAL B-ENZYM, V22, P369, DOI 10.1016/S1381-1177(03)00052-3
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Luyen NT, 2013, PHYTOCHEM LETT, V6, P322, DOI 10.1016/j.phytol.2013.03.015
   Ninomiya K, 2004, BIOORG MED CHEM LETT, V14, P1943, DOI 10.1016/j.bmcl.2004.01.091
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   O'Keefe SJD, 2003, AM J PHYSIOL-GASTR L, V284, pG27, DOI 10.1152/ajpgi.00155.2002
   OLSEN O, 1989, SCAND J GASTROENTERO, V24, P74, DOI 10.3109/00365528909092242
   OWYANG C, 1986, J CLIN INVEST, V77, P2042, DOI 10.1172/JCI112534
   PACKTER NM., 1994, Biochemical Education, V22, P216
   Padwal R, 2008, CURR OPIN INVEST DR, V9, P414
   Palatty Princy Louis, 2012, J Assoc Physicians India, V60, P34
   Papadopoulou E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018895
   Park HS, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/2719794
   Porsgaard T, 2003, LIPIDS, V38, P1039, DOI 10.1007/s11745-006-1158-x
   Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007
   Quesada H, 2009, INT J OBESITY, V33, P1007, DOI 10.1038/ijo.2009.136
   Rameshreddy P, 2018, MOL CELL BIOCHEM, V442, P143, DOI 10.1007/s11010-017-3199-2
   Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315
   Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x
   Sakulnarmrat K, 2014, LWT-FOOD SCI TECHNOL, V57, P366, DOI 10.1016/j.lwt.2014.01.002
   Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005
   Sayari A, 2000, BIOCHIMIE, V82, P153, DOI 10.1016/S0300-9084(00)00379-5
   SCHONHEYDER F, 1946, ACTA PHYSIOL SCAND, V11, P349, DOI 10.1111/j.1748-1716.1946.tb00356.x
   Seetaloo AD, 2019, S AFR J BOT, V120, P3, DOI 10.1016/j.sajb.2018.05.015
   Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42
   Sergent T, 2012, FOOD CHEM, V135, P68, DOI 10.1016/j.foodchem.2012.04.074
   Sharma T., 2018, J Biochem Cell Biol, V1, P1, DOI DOI 10.4172/JBCB
   Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469
   Shimoda Hiroshi, 2015, Int J Biomed Sci, V11, P67
   SHIMURA S, 1994, J JPN SOC FOOD SCI, V41, P847
   Shin H, 2017, KOREAN J FAM MED, V38, P346, DOI 10.4082/kjfm.2017.38.6.346
   Singh G., 2015, International Journal of Pharmacy and Pharmaceutical Sciences, V7, P1
   Singh Sukhdev, 2013, Int. Res. J. Med. Sci, V1, P15, DOI DOI 10.1016/J.APJTB.2015.09.012
   Spencer JPE, 2008, BRIT J NUTR, V99, pES60, DOI 10.1017/S0007114508965776
   Stefanucci A, 2019, NEW J CHEM, V43, P3208, DOI 10.1039/c8nj05884a
   Stewart LK, 2008, METABOLISM, V57, pS39, DOI 10.1016/j.metabol.2008.03.003
   Su HM, 2016, J ZHEJIANG UNIV-SC B, V17, P437, DOI 10.1631/jzus.B1600074
   Sugimoto S, 2009, CHEM PHARM BULL, V57, P257, DOI 10.1248/cpb.57.257
   Sumantran VN, 2007, PHYTOTHER RES, V21, P210, DOI 10.1002/ptr.2055
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tao Y, 2013, ANAL CHIM ACTA, V785, P75, DOI 10.1016/j.aca.2013.04.058
   Thomas E., 2014, Journal of Food Research, V3, P71
   tsuchida t., 2002, Prog med, V9, P2189
   Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213
   Uddandrao VVS, 2020, ARCH PHYSIOL BIOCHEM, V126, P453, DOI 10.1080/13813455.2018.1555668
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   van Dam RM, 2004, DIABETOLOGIA, V47, P2152, DOI 10.1007/s00125-004-1573-6
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   VANTILBEURGH H, 1992, NATURE, V359, P159, DOI 10.1038/359159a0
   Varshney R, 2019, J FUNCT FOODS, V59, P194, DOI 10.1016/j.jff.2019.05.004
   Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0
   Verger R., 1984, P83
   VIDON N, 1988, AM J CLIN NUTR, V47, P400, DOI 10.1093/ajcn/47.3.400
   Viner RM, 2010, OBES REV, V11, P593, DOI 10.1111/j.1467-789X.2009.00651.x
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   WEIBEL EK, 1987, J ANTIBIOT, V40, P1081, DOI 10.7164/antibiotics.40.1081
   WEINER PK, 1981, J COMPUT CHEM, V2, P287, DOI 10.1002/jcc.540020311
   Wickham M, 1998, J LIPID RES, V39, P623
   Wikiera A, 2012, POL J FOOD NUTR SCI, V62, P109, DOI 10.2478/v10222-011-0043-3
   Wilding John P. H., 2008, P47
   WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0
   WISEN O, 1993, SCAND J GASTROENTERO, V28, P737, DOI 10.3109/00365529309098283
   Wollgast J, 2000, FOOD RES INT, V33, P423, DOI 10.1016/S0963-9969(00)00068-5
   Wu YHS, 2013, J FUNCT FOODS, V5, P923, DOI 10.1016/j.jff.2013.02.002
   Xiao WP, 2017, J FOOD DRUG ANAL, V25, P43, DOI 10.1016/j.jfda.2016.11.005
   Xu BJ, 2005, ARCH PHARM RES, V28, P180, DOI 10.1007/BF02977712
   Xu G., 2017, ALTERN MED
   Yadav R.P., 2016, MGM J MEDI SCI, V3, P34, DOI [10.5005/jp-journals-10036-1084, DOI 10.5005/JP-JOURNALS-10036-1084]
   Yamada K, 2010, PHYTOCHEMISTRY, V71, P1884, DOI 10.1016/j.phytochem.2010.08.009
   Yamada K, 2008, BIOL PHARM BULL, V31, P651, DOI 10.1248/bpb.31.651
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yao X., 2015, CAN J PHYSL PHARM, P1
   Yoshikawa M, 2002, J NUTR, V132, P1819, DOI 10.1093/jn/132.7.1819
   Yoshikawa M, 2009, CHEM BIODIVERS, V6, P903, DOI 10.1002/cbdv.200800153
   Yoshizumi K, 2006, J AGR FOOD CHEM, V54, P335, DOI 10.1021/jf052047f
   Yoshizumi K, 2008, BIOSCI BIOTECH BIOCH, V72, P1126, DOI 10.1271/bbb.70761
   You Q, 2012, LWT-FOOD SCI TECHNOL, V46, P164, DOI 10.1016/j.lwt.2011.10.011
   You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v
   You YL, 2018, J FUNCT FOODS, V41, P62, DOI 10.1016/j.jff.2017.12.025
   Yuda N, 2012, J FOOD SCI, V77, pH254, DOI 10.1111/j.1750-3841.2012.02967.x
   Zhang HongMei Zhang HongMei, 2014, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V3, P184
   Zhang RL, 2019, MOLECULES, V24, DOI 10.3390/molecules24193527
   Zhao HL, 2005, INT J OBESITY, V29, P983, DOI 10.1038/sj.ijo.0802948
   Zhao HL, 2004, ARCH PHARM RES, V27, P968, DOI [10.1007/BF02975852, 10.1007/BF02975430]
   Zhao YT, 2015, J AGR FOOD CHEM, V63, P4843, DOI 10.1021/acs.jafc.5b01246
   Zheng Q, 2004, J NAT PROD, V67, P604, DOI 10.1021/np0304722
   Zheng Q, 2007, CHEM PHARM BULL, V55, P646, DOI 10.1248/cpb.55.646
NR 258
TC 128
Z9 131
U1 14
U2 124
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD MAY
PY 2020
VL 155
AR 104681
DI 10.1016/j.phrs.2020.104681
PG 34
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA LF8YV
UT WOS:000527701100041
PM 32045666
DA 2025-04-28
ER

PT J
AU Jalil, AMM
   Ismail, A
   Pei, CP
   Hamid, M
   Kamaruddin, SHS
AF Jalil, Abbe Maleyki Mhd
   Ismail, Amin
   Pei, Chong Pei
   Hamid, Muhajir
   Kamaruddin, Syed Hasbullah Syed
TI Effects of cocoa extract on glucometabolism, oxidative stress, and
   antioxidant enzymes in obese-diabetic (Ob-db) rats
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE caffeine; catalase; catechin; cocoa; epicatechin; superoxide dismutase;
   theobromine
ID 2ND-PHASE INSULIN-SECRETION; CACAO LIQUOR; GLUCOSE-LEVELS;
   THEOBROMA-CACAO; LIPID PROFILES; POWDER; DIET; CHOCOLATE; HUMANS;
   ATHEROSCLEROSIS
AB In this present study, we investigated the effects of cocoa extract containing polyphenols and methylxanthines prepared from cocoa powder on the biochemical parameters of obese-diabetic (Ob-db) rats. Obese-diabetic (Ob-db) rats were developed using a high-fat diet (49% fat, 32% carbohydrate, and 19% protein from total energy, kcal) for 3 months, followed by a low dose (35 mg/kg body weight) streptozotocin (STZ) injection. Cocoa extract (600 mg/kg body weight/day) was given to the rats for 4 weeks. The results indicated that there were no significant differences in fasting plasma glucose and insulin level after 4 weeks of cocoa extract administration. Oral glucose tolerance test revealed that cocoa supplementation in Ob-db rats significantly (p < 0.05) reduced plasma glucose at 60 and 90 min compared to unsupplemented Ob-db rats. Plasma free fatty acid and oxidative stress biomarker (8-isoprostane) were significantly (p < 0.05) reduced after cocoa supplementation. Superoxide dismutase activity was enhanced in Ob-db compared to that in nonsupplemented rats. However, no change was observed in catalase activity. The results showed that cocoa supplementation had an effect on postprandial glucose control but not for long term (4 weeks). Moreover, cocoa supplementation could reduce circulating plasma free fatty acid and 8-isoprostane and may enhance the antioxidant defense system.
C1 [Jalil, Abbe Maleyki Mhd; Ismail, Amin; Kamaruddin, Syed Hasbullah Syed] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Malaysia.
   [Pei, Chong Pei] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Malaysia.
   [Hamid, Muhajir] Univ Putra Malaysia, Dept Microbiol, Fac Biotechnol & Biomol Sci, Serdang 43400, Malaysia.
C3 Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra
   Malaysia
RP Ismail, A (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang 43400, Malaysia.
EM amin@medic.upm.edu.my
RI Chong, Pei/AAP-4227-2021; Ismail, Amin/J-8725-2015; Mhd Jalil, Abbe
   Maleyki/Y-3659-2018; Chong, Pei Pei/G-1367-2018
OI Ismail, Amin/0000-0002-9427-2028; Mhd Jalil, Abbe
   Maleyki/0000-0002-0051-4533; Chong, Pei Pei/0000-0002-8229-3593; Hamid,
   Muhajir/0000-0002-2475-7628
CR Amin I., 2004, Nutrition & Food Science, V34, P116, DOI 10.1108/00346650410536737
   Amin I, 2004, J MED FOOD, V7, P7, DOI 10.1089/109662004322984635
   Baba S, 2007, J NUTR, V137, P1436, DOI 10.1093/jn/137.6.1436
   Bisson JF, 2008, EUR J CANCER PREV, V17, P54, DOI 10.1097/CEJ.0b013e3280145b33
   Brand-Miller J, 2003, J NUTR, V133, P3149, DOI 10.1093/jn/133.10.3149
   *CMA, 2008, COC CHOC RES
   Colak E, 2008, BIOCHEM MEDICA, V18, P42
   Dillinger TL, 2000, J NUTR, V130, p2057S, DOI 10.1093/jn/130.8.2057S
   Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093
   Joo Soon-Jae, 1995, Journal of Applied Nutrition, V47, P67
   Kanaya Y, 2004, DIABETES RES CLIN PR, V66, pS157, DOI 10.1016/j.diabres.2003.09.021
   Kelm MA, 2006, J AGR FOOD CHEM, V54, P1571, DOI 10.1021/jf0525941
   Kumari K, 2007, J ETHNOPHARMACOL, V109, P367, DOI 10.1016/j.jep.2006.07.045
   Kurosawa T, 2005, J ATHEROSCLER THROMB, V12, P20, DOI 10.5551/jat.12.20
   Lecumberri E, 2007, NUTRITION, V23, P332, DOI 10.1016/j.nut.2007.01.013
   Malstrom B., 1975, ENZYMES B, VXIIB, P533
   Natsume M, 2000, BIOSCI BIOTECH BIOCH, V64, P2581, DOI 10.1271/bbb.64.2581
   Osakabe N, 1998, J NUTR SCI VITAMINOL, V44, P313, DOI 10.3177/jnsv.44.313
   Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77
   PETERSON J, 1990, P NATL ACAD SCI USA, V87, P909, DOI 10.1073/pnas.87.3.909
   Quddusi S, 2003, DIABETES CARE, V26, P791, DOI 10.2337/diacare.26.3.791
   Ramiro-Puig E, 2007, J AGR FOOD CHEM, V55, P6431, DOI 10.1021/jf070487w
   Ruzaidi A, 2005, J ETHNOPHARMACOL, V98, P55, DOI 10.1016/j.jep.2004.12.018
   Ruzaidi AMM, 2008, J SCI FOOD AGR, V88, P1442, DOI 10.1002/jsfa.3236
   Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323
   Srinivasan K, 2007, INDIAN J MED RES, V125, P451
   Tomaru M, 2007, NUTRITION, V23, P351, DOI 10.1016/j.nut.2007.01.007
   Tomas-Barberán FA, 2007, J AGR FOOD CHEM, V55, P3926, DOI 10.1021/jf070121j
   Vinson JA, 1999, J AGR FOOD CHEM, V47, P4821, DOI 10.1021/jf990312p
   Yamagishi M, 2001, LIPIDS, V36, P67, DOI 10.1007/s11745-001-0669-9
NR 30
TC 72
Z9 79
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD SEP 10
PY 2008
VL 56
IS 17
BP 7877
EP 7884
DI 10.1021/jf8015915
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 344OU
UT WOS:000258938000044
PM 18702467
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Murase, T
   Haramizu, S
   Shimotoyodome, A
   Nagasawa, A
   Tokimitsu, I
AF Murase, T
   Haramizu, S
   Shimotoyodome, A
   Nagasawa, A
   Tokimitsu, I
TI Green tea extract improves endurance capacity and increases muscle lipid
   oxidation in mice
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE catechins; epigallocatechin gallate; lipid metabolism; swimming
ID CHAIN FATTY-ACIDS; SKELETAL-MUSCLE; INSULIN SENSITIVITY; CAFFEINE
   INGESTION; N-ACETYLCYSTEINE; FREE-RADICALS; EXERCISE; METABOLISM;
   FATIGUE; OBESITY
AB Green tea contains a high level of polyphenolic compounds known as catechins. We investigated the effects of green tea extract (GTE), which is rich in catechins, on endurance capacity, energy metabolism, and fat oxidation in BALB/c mice over a 10-wk period. Swimming times to exhaustion for mice fed 0.2-0.5% (wt/wt) GTE were prolonged by 8-24%. The effects were dose dependent and accompanied by lower respiratory quotients and higher rates of fat oxidation as determined by indirect calorimetry. In addition, feeding with GTE increased the level of beta-oxidation activity in skeletal muscle. Plasma lactate concentrations in mice fed GTE were significantly decreased after exercise, concomitant with increases in free fatty acid concentrations in plasma, suggesting an increased lipid use as an energy source in GTE-fed mice. Epigallocatechin gallate (EGCG), a major component of tea catechins, also enhanced endurance capacity, suggesting that the endurance-improving effects of GTE were mediated, at least in part, by EGCG. The beta-oxidation activity and the level of fatty acid translocase/CD36 mRNA in the muscle was higher in GTE-fed mice compared with control mice. These results indicate that GTE are beneficial for improving endurance capacity and support the hypothesis that the stimulation of fatty acid use is a promising strategy for improving endurance capacity.
C1 Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan.
C3 KAO Corporation
RP Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
EM murase.takatoshi@kao.co.jp
OI shimotoyodome, akira/0000-0001-7567-8316
CR ALESSIO HM, 1993, MED SCI SPORT EXER, V25, P218, DOI 10.1249/00005768-199302000-00010
   BARCLAY JK, 1991, CAN J PHYSIOL PHARM, V69, P279, DOI 10.1139/y91-043
   Chyu KY, 2004, CIRCULATION, V109, P2448, DOI 10.1161/01.CIR.0000128034.70732.C2
   Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200
   COLLOMP K, 1991, INT J SPORTS MED, V12, P439, DOI 10.1055/s-2007-1024710
   Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577
   COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   GRAHAM TE, 1995, J APPL PHYSIOL, V78, P867, DOI 10.1152/jappl.1995.78.3.867
   Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638
   Hawley JA, 1998, SPORTS MED, V25, P241, DOI 10.2165/00007256-199825040-00003
   Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S
   Howlett RA, 2003, J APPL PHYSIOL, V94, P1682, DOI 10.1152/japplphysiol.00556.2002
   Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004
   Ishihara K, 2000, J NUTR, V130, P2990, DOI 10.1093/jn/130.12.2990
   IVY JL, 1979, MED SCI SPORT EXER, V11, P6
   Jeukendrup AE, 1998, INT J SPORTS MED, V19, P371, DOI 10.1055/s-2007-971932
   Jeukendrup AE, 1998, INT J SPORTS MED, V19, P293, DOI 10.1055/s-2007-971921
   Kim KM, 1998, J NUTR, V128, P1978, DOI 10.1093/jn/128.11.1978
   Kim KM, 1997, BIOSCI BIOTECH BIOCH, V61, P1718, DOI 10.1271/bbb.61.1718
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Lee HJ, 2002, BIOCHEM BIOPH RES CO, V296, P293, DOI 10.1016/S0006-291X(02)00822-7
   LEIJTEN PAA, 1984, J PHYSIOL-LONDON, V357, P327, DOI 10.1113/jphysiol.1984.sp015502
   LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X
   Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843
   Mikami Y, 2002, J NEUROSURG, V97, P142, DOI 10.3171/spi.2002.97.1.0142
   Miller Y D, 2004, J Sci Med Sport, V7, P52, DOI 10.1016/S1440-2440(04)80278-0
   Miura Y, 2001, J NUTR, V131, P27, DOI 10.1093/jn/131.1.27
   Mizunoya W, 2002, BIOSCI BIOTECH BIOCH, V66, P1133, DOI 10.1271/bbb.66.1133
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   NAGAO T, IN PRESS AM J CLIN N
   NOVELLI GP, 1990, FREE RADICAL BIO MED, V8, P9, DOI 10.1016/0891-5849(90)90138-9
   REID MB, 1994, J CLIN INVEST, V94, P2468, DOI 10.1172/JCI117615
   REID MB, 1992, J APPL PHYSIOL, V73, P1797, DOI 10.1152/jappl.1992.73.5.1797
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Ryan DH, 2003, INT J CLIN PRACT, P28
   Schoonjans K, 1996, J LIPID RES, V37, P907
   SHINDOH C, 1990, J APPL PHYSIOL, V68, P2107, DOI 10.1152/jappl.1990.68.5.2107
   Shiota S, 1999, BIOL PHARM BULL, V22, P1388, DOI 10.1248/bpb.22.1388
   SINGH H, 1994, J BIOL CHEM, V269, P9514
   Stremmel W, 2001, LIPIDS, V36, P981, DOI 10.1007/s11745-001-0809-2
   Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1
   Tunstall RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66, DOI 10.1152/ajpendo.00475.2001
   Valet P, 2002, J LIPID RES, V43, P835
   Viña J, 2000, IUBMB LIFE, V50, P271, DOI 10.1080/15216540051080994
   Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294
   Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607
   YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038
   ZHANG Y, 1990, J PHARMACOL EXP THER, V254, P757
NR 49
TC 176
Z9 188
U1 1
U2 34
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD MAR
PY 2005
VL 288
IS 3
BP R708
EP R715
DI 10.1152/ajpregu.00693.2004
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 895AJ
UT WOS:000226832800023
PM 15563575
DA 2025-04-28
ER

PT J
AU Chen, D
   Chen, GJ
   Sun, Y
   Zeng, XX
   Ye, H
AF Chen, Dan
   Chen, Guijie
   Sun, Yi
   Zeng, Xiaoxiong
   Ye, Hong
TI Physiological genetics, chemical composition, health benefits and
   toxicology of tea (Camellia sinensis L.) flower: A review
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Review
DE Tea flower; Physiological genetics; Catechins; Polysaccharide; Saponins;
   Health benefits; Safety
ID WATER-SOLUBLE POLYSACCHARIDE; CHAKASAPONINS I-III;
   QUANTITATIVE-ANALYSIS; TRITERPENE OLIGOGLYCOSIDES; ANTIOXIDANT
   ACTIVITIES; L-PHENYLALANINE; DEVELOPMENTAL-STAGES; VOLATILE COMPONENTS;
   MEDICINAL FLOWERS; DIFFERENT REGIONS
AB The flower of tea (Camellia sinensis L.) plant has been paid an increasing attention in the last twenty years, since it was found that tea flowers contained representative constituents similar to those of tea leaves, such as catechins, caffeine and amino acids. Tea flower is theoretically valuable although it has been considered as an industrial waste over a long period of time. This review summarizes the research findings conducted until now on physiological genetics, chemical composition, health benefits and toxicology of tea flowers, aiming to foresee their future applications. A lot of genes are involved in flower development and the synthesis and transmission of various chemicals in tea flowers. The chemical composition of tea flower consists mainly of catechins, polysaccharides, proteins, amino acids and saponins and thus tea flower possesses various health benefits such as antioxidant, anti-inflammatory, immunostimulating, antitumor, hypoglycemic, anti-obesity and anti-allergic activities. Moreover, tea flower contains a protease that can elevate the free amino acids content in the tea infusion by almost two folds. More importantly, the enzymatic activity of the protease is much higher than that of the commercially available proteases. Additionally, aqueous extracts of tea flower are demonstrated to safe to animals. Thus, the potential uses of tea flowers in food and medical fields are warranted.
C1 [Chen, Dan; Chen, Guijie; Sun, Yi; Zeng, Xiaoxiong; Ye, Hong] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Peoples R China.
C3 Nanjing Agricultural University
RP Zeng, XX; Ye, H (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Peoples R China.
EM zengxx@njau.edu.cn; yehong@njau.edu.cn
RI Zeng, Xiaoxiong/LYP-2646-2024; Chen, Guijie/J-7325-2019
OI Chen, Guijie/0000-0002-6870-5360; Zeng, Xiaoxiong/0000-0003-2954-3896;
   Chen, Dan/0000-0003-1289-1077
FU National Natural Science Foundation of China [31201454]; Priority
   Academic Program Development of Jiangsu Higher Education Institutions
FX This work was financially supported by National Natural Science
   Foundation of China (31201454) and a project funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions.
CR Baldermann S, 2013, J SCI FOOD AGR, V93, P1660, DOI 10.1002/jsfa.5944
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Brumos J, 2018, DEV CELL, V47, P306, DOI 10.1016/j.devcel.2018.09.022
   Cai Xuan Cai Xuan, 2011, Modern Food Science and Technology, V27, P262
   Cao H, 2013, INT J BIOL MACROMOL, V62, P76, DOI 10.1016/j.ijbiomac.2013.08.033
   Chen BT, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/537923
   Chen D, 2020, INT J BIOL MACROMOL, V158, P968, DOI 10.1016/j.ijbiomac.2020.04.248
   Chen D, 2020, J FOOD SCI, V85, P1948, DOI 10.1111/1750-3841.15155
   Chen D, 2020, FOOD RES INT, V132, DOI 10.1016/j.foodres.2020.109100
   Chen D, 2019, J FUNCT FOODS, V61, DOI 10.1016/j.jff.2019.103470
   Chen D, 2017, FOOD FUNCT, V8, P4619, DOI [10.1039/c7fo01024a, 10.1039/C7FO01024A]
   Chen GJ, 2016, CARBOHYD POLYM, V153, P663, DOI 10.1016/j.carbpol.2016.08.022
   Chen LB, 2019, HEREDITAS, V156, DOI 10.1186/s41065-019-0090-z
   Chen Xuan Chen Xuan, 2009, Journal of Tea Science, V29, P47
   Chen YY, 2018, MOLECULES, V23, DOI 10.3390/molecules23040790
   Chen YY, 2016, J FUNCT FOODS, V25, P149, DOI 10.1016/j.jff.2016.05.017
   Chen ZC, 2014, J SCI FOOD AGR, V94, P316, DOI 10.1002/jsfa.6260
   Dissanayake C. Y., 2018, Korean Journal of Veterinary Research, V58, P65, DOI 10.14405/kjvr.2018.58.2.65
   Dong F, 2017, MOLECULES, V22, DOI 10.3390/molecules22010131
   Dong F, 2016, MOLECULES, V21, DOI 10.3390/molecules21091106
   Dong F, 2012, J PLANT PHYSIOL, V169, P217, DOI 10.1016/j.jplph.2011.12.003
   Facchini PJ, 2002, CAN J BOT, V80, P577, DOI [10.1139/B02-065, 10.1139/b02-065]
   Fan K, 2019, J PLANT PHYSIOL, V232, P200, DOI 10.1016/j.jplph.2018.11.007
   Fang WP, 2006, ACTA BIOCH BIOPH SIN, V38, P653, DOI 10.1111/j.1745-7270.2006.00202.x
   Feng ZH, 2019, FOOD CHEM, V285, P347, DOI 10.1016/j.foodchem.2019.01.174
   FORREST GI, 1969, BIOCHEM J, V113, P741, DOI 10.1042/bj1130741
   FUJIMORI N, 1993, ANN BOT-LONDON, V71, P279, DOI 10.1006/anbo.1993.1034
   González-Rábade N, 2011, BIOTECHNOL ADV, V29, P983, DOI 10.1016/j.biotechadv.2011.08.017
   Hamao M, 2011, BIOORGAN MED CHEM, V19, P6033, DOI 10.1016/j.bmc.2011.08.042
   Han Q, 2012, J FOOD BIOCHEM, V36, P46, DOI 10.1111/j.1745-4514.2010.00512.x
   Han Q, 2011, CARBOHYD POLYM, V86, P797, DOI 10.1016/j.carbpol.2011.05.039
   Han QA, 2011, J FOOD SCI, V76, pC462, DOI 10.1111/j.1750-3841.2011.02063.x
   Han QA, 2010, PROG BIOCHEM BIOPHYS, V37, P646, DOI 10.3724/SP.J.1206.2009.00656
   Hayashi S, 2004, TETRAHEDRON, V60, P7005, DOI 10.1016/j.tet.2003.10.130
   Jia SS, 2016, PLANT PHYSIOL BIOCH, V106, P316, DOI 10.1016/j.plaphy.2016.06.013
   Joshi R, 2011, SCI HORTIC-AMSTERDAM, V130, P266, DOI 10.1016/j.scienta.2011.06.007
   Joshi R, 2011, NAT PROD COMMUN, V6, P1155
   Kroyer G., 2001, Innovative Food Science & Emerging Technologies, V2, P171, DOI 10.1016/S1466-8564(01)00039-X
   Li B, 2011, J ETHNOPHARMACOL, V133, P583, DOI 10.1016/j.jep.2010.02.030
   Li JK, 2008, J AGR FOOD CHEM, V56, P7535, DOI 10.1021/jf800885z
   Lin YS, 2003, J AGR FOOD CHEM, V51, P975, DOI 10.1021/jf020870v
   Liu D., 2019, J TEA COMMUNICATION, V46, P23
   Liu F, 2017, GENE, V631, P39, DOI 10.1016/j.gene.2017.08.013
   Liu SA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-228
   Liu Y, 2020, GENOMICS, V112, P2318, DOI 10.1016/j.ygeno.2020.01.003
   Ma C, 2001, CHEM PHARM BULL, V49, P915, DOI 10.1248/cpb.49.915
   Ma QP, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4674-1
   MAHANTA PK, 1988, J SCI FOOD AGR, V45, P317, DOI 10.1002/jsfa.2740450405
   Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
   Masclaux-Daubresse C, 2017, CURR OPIN PLANT BIOL, V39, P8, DOI 10.1016/j.pbi.2017.05.001
   Matsuda H, 2016, J NAT MED-TOKYO, V70, P689, DOI 10.1007/s11418-016-1021-1
   Matsuda H, 2016, CHEM PHARM BULL, V64, P96, DOI 10.1248/cpb.c15-00781
   Matsuda H, 2012, CHEM PHARM BULL, V60, P674, DOI 10.1248/cpb.60.674
   Morikawa T, 2013, NAT PROD COMMUN, V8, P1553
   Morikawa T, 2013, FOOD CHEM, V140, P353, DOI 10.1016/j.foodchem.2013.02.079
   Morikawa T, 2012, J NAT MED-TOKYO, V66, P608, DOI 10.1007/s11418-012-0627-1
   Ohta T, 2017, NAT PROD COMMUN, V12, P1193
   Ohta T, 2015, TETRAHEDRON, V71, P846, DOI 10.1016/j.tet.2014.12.049
   Pan JT, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3158-4
   Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510
   Rawat R, 2007, FOOD CHEM, V105, P229, DOI 10.1016/j.foodchem.2007.03.071
   Rothenberg DO, 2019, MOLECULES, V24, DOI 10.3390/molecules24061064
   Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x
   Shen X, 2017, IND CROP PROD, V95, P140, DOI 10.1016/j.indcrop.2016.10.008
   Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131
   [施雁飞 Shi Yanfei], 2015, [陕西师范大学学报. 自然科学版, Journal of Shaanxi Normal University. Natural Science Edition], V43, P70
   Sood S, 2006, SCI HORTIC-AMSTERDAM, V108, P390, DOI 10.1016/j.scienta.2006.02.012
   Sugimoto S, 2009, HETEROCYCLES, V78, P1023, DOI 10.3987/COM-08-11568
   Sun LT, 2019, ACTA PHYSIOL PLANT, V41, DOI 10.1007/s11738-019-2822-0
   Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196
   Terahara N, 2001, PHYTOCHEMISTRY, V56, P359, DOI 10.1016/S0031-9422(00)00359-9
   Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103
   Wang H, 2015, J ESSENT OIL BEAR PL, V18, P320, DOI 10.1080/0972060X.2014.961036
   Wang L, 2010, FOOD CHEM, V123, P1259, DOI 10.1016/j.foodchem.2010.05.063
   Wang XQ, 2019, FOOD CHEM, V270, P17, DOI 10.1016/j.foodchem.2018.07.056
   Wang YM, 2017, J FUNCT FOODS, V37, P310, DOI 10.1016/j.jff.2017.08.001
   Wang YF, 2012, CARBOHYD POLYM, V88, P146, DOI 10.1016/j.carbpol.2011.11.083
   Wang YF, 2012, CYTA-J FOOD, V10, P1, DOI 10.1080/19476337.2010.523901
   Wang YF, 2010, INT J BIOL MACROMOL, V47, P534, DOI 10.1016/j.ijbiomac.2010.07.007
   Wang YF, 2010, INT J BIOL MACROMOL, V47, P266, DOI 10.1016/j.ijbiomac.2010.04.011
   WATANABE N, 1993, BIOSCI BIOTECH BIOCH, V57, P1101, DOI 10.1271/bbb.57.1101
   Way TD, 2009, FOOD CHEM, V114, P1231, DOI 10.1016/j.foodchem.2008.10.084
   Wei XL, 2010, CARBOHYD POLYM, V79, P418, DOI 10.1016/j.carbpol.2009.08.030
   Weng W., 2004, THESIS
   Xin ZJ, 2019, PLANT PHYSIOL BIOCH, V135, P132, DOI 10.1016/j.plaphy.2018.11.035
   Xu RJ, 2012, FOOD CHEM TOXICOL, V50, P2473, DOI 10.1016/j.fct.2011.10.047
   Xu YQ, 2013, J FOOD SCI TECH MYS, V50, P171, DOI 10.1007/s13197-011-0239-x
   Yang O, 2007, YAKUGAKU ZASSHI, V127, P10
   Yang ZY, 2012, J SCI FOOD AGR, V92, P2128, DOI 10.1002/jsfa.5596
   Yang ZY, 2009, LWT-FOOD SCI TECHNOL, V42, P1439, DOI 10.1016/j.lwt.2009.03.017
   Yang ZY, 2007, ASIA PAC J CLIN NUTR, V16, P148
   [Ye Aihua 叶爱华], 2008, [激光生物学报, Acta Laser Biology Sinica], V17, P733
   Yoshikawa M, 2005, J NAT PROD, V68, P1360, DOI 10.1021/np0580614
   Yoshikawa M, 2008, CHEM PHARM BULL, V56, P1297, DOI 10.1248/cpb.56.1297
   Yoshikawa M, 2008, YAKUGAKU ZASSHI, V128, P141, DOI 10.1248/yakushi.128.141
   Yoshikawa M, 2007, CHEM PHARM BULL, V55, P598, DOI 10.1248/cpb.55.598
   Yoshikawa M, 2009, CHEM BIODIVERS, V6, P903, DOI 10.1002/cbdv.200800153
   Yu F., 1986, J TEA SCI, V6, P1
   Yu XL, 2018, FOOD SCI NUTR, V6, P1734, DOI 10.1002/fsn3.724
   Zhang L, 2019, COMPR REV FOOD SCI F, V18, P1474, DOI 10.1111/1541-4337.12479
   Zhou CB, 2020, MOLECULES, V25, DOI 10.3390/molecules25010190
   Zhou Y, 2019, FOOD CHEM, V280, P27, DOI 10.1016/j.foodchem.2018.12.035
   Zhou Y, 2018, FOOD CHEM, V258, P352, DOI 10.1016/j.foodchem.2018.03.095
   Zhou Y, 2017, RSC ADV, V7, P32336, DOI 10.1039/c7ra03219f
   Zhou Y, 2014, J AGR FOOD CHEM, V62, P8042, DOI 10.1021/jf5022658
NR 105
TC 68
Z9 72
U1 10
U2 134
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS
SN 0963-9969
EI 1873-7145
J9 FOOD RES INT
JI Food Res. Int.
PD NOV
PY 2020
VL 137
AR 109584
DI 10.1016/j.foodres.2020.109584
PG 17
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA OY0PP
UT WOS:000593956500009
PM 33233193
DA 2025-04-28
ER

PT J
AU Celi, FS
   Brychta, RJ
   Linderman, JD
   Butler, PW
   Alberobello, AT
   Smith, S
   Courville, AB
   Lai, EW
   Costello, R
   Skarulis, MC
   Csako, G
   Remaley, A
   Pacak, K
   Chen, KY
AF Celi, Francesco S.
   Brychta, Robert J.
   Linderman, Joyce D.
   Butler, Peter W.
   Alberobello, Anna Teresa
   Smith, Sheila
   Courville, Amber B.
   Lai, Edwin W.
   Costello, Rene
   Skarulis, Monica C.
   Csako, Gyorgy
   Remaley, Alan
   Pacak, Karel
   Chen, Kong Y.
TI Minimal changes in environmental temperature result in a significant
   increase in energy expenditure and changes in the hormonal homeostasis
   in healthy adults
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID BROWN ADIPOSE-TISSUE; MILD COLD; OBESITY; DEIODINASE; METABOLISM;
   CAFFEINE; PROTEIN; PLASMA; DIET; FAT
AB Objective: Resting energy expenditure (EE) is a major contributor to the total EE and thus plays an important role in body weight regulation. Adaptive thermogenesis is a major component of EE in rodents, but little is known on the effects of exposure of humans to mild and sustainable reduction in environmental temperature.
   Design: To characterize the dynamic changes in continuously measured resting EE, substrate utilization, and hormonal axes simultaneously in response to mild reduction in environmental temperature, we performed a cross-over intervention.
   Methods: Twenty-five volunteers underwent two 12-h recordings of EE in whole room indirect calorimeters at 24 and 19 degrees C with simultaneous measurement of spontaneous movements and hormonal axes.
   Results: Exposure to 19 degrees C resulted in an increase in plasma and urine norepinephrine levels (P < 0.0001), and a 5.96% (P < 0.001) increase in EE without significant changes in spontaneous physical activity. Exposure to the lower temperature resulted in a significant increase in free fatty acid levels (P < 0.01), fasting insulin levels (P < 0.05), and a marginal decrease in postprandial glucose levels. A small but significant (P < 0.002) increase in serum free thyroxine and urinary free cortisol (P < 0.05) was observed at 19 degrees C.
   Conclusions: Our observations indicate that exposure to 19 degrees C, a mild and tolerable cold temperature, results in a predictable increase in EE driven by a sustained rise in catecholamine and the activation of counter-regulatory mechanisms.
C1 [Celi, Francesco S.; Brychta, Robert J.; Linderman, Joyce D.; Butler, Peter W.; Alberobello, Anna Teresa; Smith, Sheila; Skarulis, Monica C.; Chen, Kong Y.] NIDDK, Clin Endocrinol Branch, Bethesda, MD 20892 USA.
   [Butler, Peter W.; Lai, Edwin W.; Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Reprod & Adult Endocrinol Branch, Bethesda, MD 20892 USA.
   [Courville, Amber B.; Costello, Rene; Csako, Gyorgy; Remaley, Alan] NIH, Dept Lab Med, Ctr Clin, CRC, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute of
   Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of
   Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of
   Child Health & Human Development (NICHD); National Institutes of Health
   (NIH) - USA; NIH Clinical Center (CC)
RP Celi, FS (corresponding author), NIDDK, Clin Endocrinol Branch, Bldg 10,RM 6-3940,10 Ctr Dr,MSC 1613, Bethesda, MD 20892 USA.
EM fc93a@nih.gov
RI Celi, Francesco S./LTF-7731-2024; Chen, Kong/L-6972-2017
OI Butler, Peter/0000-0002-4735-1954; Chen, Kong/0000-0002-0306-1904
FU NIDDK [Z01-DK047057-02, Z01-DK071013-02]; Clinical Center, NIH
FX This work was supported by the Intramural Research Program of the NIDDK
   programs Z01-DK047057-02, Z01-DK071013-02, and the Clinical Center, NIH.
CR [Anonymous], 2000, NIH PUBL
   Astrup A, 2000, ENDOCRINE, V13, P207, DOI 10.1385/ENDO:13:2:207
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Camm AJ, 1996, CIRCULATION, V93, P1043
   Canettieri G, 2000, ENDOCRINOLOGY, V141, P1804, DOI 10.1210/en.141.5.1804
   CSAKO G, 1990, CLIN CHEM, V36, P645
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   DAUNCEY MJ, 1981, BRIT J NUTR, V45, P257, DOI 10.1079/BJN19810102
   de Jonge L, 2001, INT J OBESITY, V25, P929, DOI 10.1038/sj.ijo.0801656
   EISENHOFER G, 1986, CLIN CHEM, V32, P2030
   FAGIUS J, 1991, ACTA PHYSIOL SCAND, V142, P201, DOI 10.1111/j.1748-1716.1991.tb09148.x
   Hansen DL, 1998, AM J CLIN NUTR, V68, P1180, DOI 10.1093/ajcn/68.6.1180
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   Hull H, 2009, J CLIN DENSITOM, V12, P95, DOI 10.1016/j.jocd.2008.09.004
   HUTTUNEN P, 1981, EUR J APPL PHYSIOL, V46, P339, DOI 10.1007/BF00422121
   JENNIFER JPH, 2006, DIETARY REFERENCE IN, P84
   Kinugasa H, 1999, EXP PHYSIOL, V84, P369, DOI 10.1111/j.1469-445X.1999.01839.x
   Lichtenbelt WDV, 2002, AM J PHYSIOL-ENDOC M, V282, pE1077, DOI 10.1152/ajpendo.00020.2001
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   Magnus-Levy A., 1895, Berlin klin. Wochschr, V32, P650
   Maia AL, 2005, J CLIN INVEST, V115, P2524, DOI 10.1172/JCI25083
   McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599
   MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241
   Popkin BM, 2006, OBES REV, V7, P271, DOI 10.1111/j.1467-789X.2006.00230.x
   RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749
   RIZZA RA, 1980, J CLIN INVEST, V65, P682, DOI 10.1172/JCI109714
   Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748
   SCHEIDEGGER K, 1984, J CLIN ENDOCR METAB, V58, P895, DOI 10.1210/jcem-58-5-895
   Schrauwen P, 2002, INT J OBESITY, V26, P450, DOI 10.1038/sj.ijo.0801943
   Shannon JR, 1999, CLIN SCI, V96, P483, DOI 10.1042/CS19980206
   Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543
   Smith SR, 2000, AM J CLIN NUTR, V71, P450
   VANDER A, 1998, HUMAN PHYSL MECH BOD, P625
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Westerterp KR, 2002, CURR OPIN CLIN NUTR, V5, P489, DOI 10.1097/00075197-200209000-00006
   WESTERTERPPLANT.M, 2002, CLIN NUTR, V56, P288, DOI DOI 10.1038/SJ.EJCN.1601308)
   Wijers SLJ, 2010, OBESITY, V18, P1092, DOI 10.1038/oby.2010.74
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
NR 38
TC 71
Z9 79
U1 0
U2 14
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD DEC
PY 2010
VL 163
IS 6
BP 863
EP 872
DI 10.1530/EJE-10-0627
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 678RR
UT WOS:000284098400003
PM 20826525
OA Bronze, Green Accepted
DA 2025-04-28
ER

PT J
AU Gil-Lespinard, M
   Castaneda, J
   Almanza-Aguilera, E
   Gomez, JH
   Tjonneland, A
   Kyro, C
   Overvad, K
   Katzke, V
   Schulze, MB
   Masala, G
   Agnoli, C
   de Magistris, MS
   Tumino, R
   Sacerdote, C
   Skeie, G
   Lasheras, C
   Molina-Montes, E
   Huerta, JM
   Barricarte, A
   Amiano, P
   Sonestedt, E
   da Silva, M
   Johansson, I
   Hultdin, J
   May, AM
   Forouhi, NG
   Heath, AK
   Freisling, H
   Weiderpass, E
   Scalbert, A
   Zamora-Ros, R
AF Gil-Lespinard, Mercedes
   Castaneda, Jazmin
   Almanza-Aguilera, Enrique
   Gomez, Jesus Humberto
   Tjonneland, Anne
   Kyro, Cecilie
   Overvad, Kim
   Katzke, Verena
   Schulze, Matthias B.
   Masala, Giovanna
   Agnoli, Claudia
   Santucci de Magistris, Maria
   Tumino, Rosario
   Sacerdote, Carlotta
   Skeie, Guri
   Lasheras, Cristina
   Molina-Montes, Esther
   Huerta, Jose Maria
   Barricarte, Aurelio
   Amiano, Pilar
   Sonestedt, Emily
   da Silva, Marisa
   Johansson, Ingegerd
   Hultdin, Johan
   May, Anne M.
   Forouhi, Nita G.
   Heath, Alicia K.
   Freisling, Heinz
   Weiderpass, Elisabete
   Scalbert, Augustin
   Zamora-Ros, Raul
TI Dietary Intake of 91 Individual Polyphenols and 5-Year Body Weight
   Change in the EPIC-PANACEA Cohort
SO ANTIOXIDANTS
LA English
DT Article
DE polyphenol; intake; body weight; obesity; cohort; EPIC
ID GREEN TEA; PHYSICAL-ACTIVITY; VALIDITY; OBESITY; CANCER; QUESTIONNAIRE;
   HEIGHT; WOMEN; INDEX; MASS
AB Polyphenols are bioactive compounds from plants with antioxidant properties that may have a protective role against body weight gain, with adipose tissue and systemic oxidative stress as potential targets. We aimed to investigate the dietary intake of individual polyphenols and their association with 5-year body weight change in a sub-cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). This study included 349,165 adult participants from nine European countries. Polyphenol intake was estimated through country-specific validated dietary questionnaires and the Phenol-Explorer database. Body weight was obtained at recruitment and after a mean follow-up time of 5 years. Associations were estimated using multilevel mixed linear regression models. From 91 polyphenols included, the majority (n = 67) were inversely associated with 5-year body weight change after FDR-correction (q < 0.05). The greatest inverse associations were observed for quercetin 3-O-rhamnoside (change in weight for doubling in intake: -0.071 (95% CI: -0.085; -0.056) kg/5 years). Only 13 polyphenols showed positive associations with body weight gain, mainly from the subclass hydroxycinnamic acids (HCAs) with coffee as the main dietary source, such as 4-caffeoylquinic acid (0.029 (95% CI: 0.021; 0.038) kg/5 years). Individual polyphenols with fruit, tea, cocoa and whole grain cereals as the main dietary sources may contribute to body weight maintenance in adults. Individual HCAs may have different roles in body weight change depending on their dietary source.
C1 [Gil-Lespinard, Mercedes; Castaneda, Jazmin; Almanza-Aguilera, Enrique; Zamora-Ros, Raul] Catalan Inst Oncol ICO, Bellvitge Biomed Res Inst IDIBELL, Canc Epidemiol Res Programme, Unit Nutr & Canc, Barcelona 08908, Spain.
   [Gomez, Jesus Humberto; Huerta, Jose Maria] IMIB Arrixaca, Reg Hlth Council, Dept Epidemiol, Murcia 30008, Spain.
   [Gomez, Jesus Humberto; Molina-Montes, Esther; Huerta, Jose Maria; Barricarte, Aurelio; Amiano, Pilar] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid 28029, Spain.
   [Tjonneland, Anne; Kyro, Cecilie] Danish Canc Soc Res Ctr, DK-2100 Copenhagen, Denmark.
   [Tjonneland, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Sect Environm Hlth, DK-1353 Copenhagen, Denmark.
   [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, DK-8000 Aarhus, Denmark.
   [Katzke, Verena] German Canc Res Ctr, Dept Canc Epidemiol, D-69120 Heidelberg, Germany.
   [Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, D-14558 Nuthetal, Germany.
   [Schulze, Matthias B.] Univ Potsdam, Inst Nutr Sci, D-14469 Potsdam, Germany.
   [Masala, Giovanna] Inst Canc Res Prevent & Clin Network ISPRO, Canc Risk Factors & Life Style Epidemiol Unit, I-50139 Florence, Italy.
   [Agnoli, Claudia] Fdn IRCCS Ist Nazl Tumori Via Venezian, Dept Res, Epidemiol & Prevent Unit, I-20133 Milan, Italy.
   [Santucci de Magistris, Maria] Univ Naples Federico II, Dept Clin & Expt Med, I-80131 Naples, Italy.
   [Tumino, Rosario] Hyblean Assoc Epidemiol Res AIRE ONLUS, I-97100 Ragusa, Italy.
   [Sacerdote, Carlotta] Citta Salute & Sci Univ Hosp, Unit Canc Epidemiol, I-10124 Turin, Italy.
   [Skeie, Guri] Univ Tromso, Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, N-9019 Tromso, Norway.
   [Lasheras, Cristina] Univ Oviedo, Dept Funct Biol, Oviedo 33007, Spain.
   [Molina-Montes, Esther] Univ Granada, Dept Nutr & Food Sci, Campus Cartuja, Granada 18071, Spain.
   [Molina-Montes, Esther] Inst Invest Biosanitaria ibs GRANADA, Granada 18012, Spain.
   [Molina-Montes, Esther] Univ Granada, Inst Nutr & Food Technol INYTA Jose Mataix, Biomed Res Ctr, Granada 18071, Spain.
   [Barricarte, Aurelio] Navarra Publ Hlth Inst, Pamplona 31003, Spain.
   [Barricarte, Aurelio] Navarra Inst Hlth Res IdiSNA, Pamplona 31008, Spain.
   [Amiano, Pilar] Minist Hlth Basque Govt, Subdirectorate Publ Hlth & Addict Gipuzkoa, San Sebastian 20013, Spain.
   [Amiano, Pilar] BioDonostia Res Inst, Publ Hlth Div Gipuzkoa, San Sebastian 20014, Spain.
   [Sonestedt, Emily] Lund Univ, Dept Clin Sci Malmo, Nutr Epidemiol, S-22184 Malmo, Sweden.
   [da Silva, Marisa] Lund Univ, Dept Clin Sci Lund, Register Based Epidemiol, S-22184 Lund, Sweden.
   [Johansson, Ingegerd] Umea Univ, Dept Odontol, S-90187 Umea, Sweden.
   [Hultdin, Johan] Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden.
   [May, Anne M.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands.
   [Forouhi, Nita G.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Sch Clin Med, Cambridge Biomed Campus, Cambridge CB2 0SL, Cambs, England.
   [Heath, Alicia K.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England.
   [Freisling, Heinz; Weiderpass, Elisabete; Scalbert, Augustin] Int Agcy Res Canc IARC WHO, F-69008 Lyon, France.
C3 Institut Catala d'Oncologia; Institut d'Investigacio Biomedica de
   Bellvitge (IDIBELL); Hospital Clinico Universitario Virgen de la
   Arrixaca; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP;
   Danish Cancer Society; University of Copenhagen; Aarhus University;
   Helmholtz Association; German Cancer Research Center (DKFZ); Leibniz
   Association; Deutsches Institut fur Ernahrungsforschung
   Potsdam-Rehbrucke (DIfE); University of Potsdam; Fondazione IRCCS
   Istituto Nazionale Tumori Milan; University of Naples Federico II;
   A.O.U. Citta della Salute e della Scienza di Torino; UiT The Arctic
   University of Tromso; University of Oviedo; University of Granada;
   Instituto de Investigacion Biosanitaria IBS Granada; University of
   Granada; Public Health Institute of Navarra; Basque Government; Lund
   University; Lund University; Umea University; Umea University; Utrecht
   University; Utrecht University Medical Center; University of Cambridge;
   Imperial College London; World Health Organization; International Agency
   for Research on Cancer (IARC)
RP Zamora-Ros, R (corresponding author), Catalan Inst Oncol ICO, Bellvitge Biomed Res Inst IDIBELL, Canc Epidemiol Res Programme, Unit Nutr & Canc, Barcelona 08908, Spain.
EM rzamora@idibell.cat
RI Agnoli, Claudia/K-5916-2016; Kyro, Cecilie/ACG-9913-2022; Hultdin,
   Johan/AAD-4623-2021; Gil-Lespinard, Mercedes/ACE-5171-2022; Sacerdote,
   Carlotta/K-3611-2018; Tjonneland, Anne/AGU-0320-2022; Masala,
   Giovanna/AAC-5474-2022; Almanza Aguilera, Enrique/AAA-2853-2020; Zamora,
   Raul/HNC-1515-2023; Forouhi, Nita/JAC-2361-2023; Sonestedt,
   Emily/I-3814-2016; Molina-Montes, Esther/AFS-7568-2022; Schulze,
   Matthias B./AAH-6906-2021; Huerta, Jose Maria/N-8654-2015; Heath,
   Alicia/AAO-4007-2020; Weiderpass, Elisabete/M-4029-2016
OI Johansson, Ingegerd/0000-0002-9227-8434; Sacerdote,
   Carlotta/0000-0002-8008-5096; tumino, rosario/0000-0003-2666-414X; Gomez
   Gomez, Jesus Humberto/0000-0001-8442-8327; Sonestedt,
   Emily/0000-0002-0747-4562; Overvad, Kim/0000-0001-6429-7921; Almanza
   Aguilera, Enrique/0000-0002-4805-0774; Tjonneland,
   Anne/0000-0003-4385-2097; Hultdin, Johan/0000-0002-9599-0961;
   Molina-Montes, Esther/0000-0002-0428-2426; Schulze, Matthias
   B./0000-0002-0830-5277; Huerta, Jose Maria/0000-0002-9637-3869; Heath,
   Alicia/0000-0001-6517-1300; Masala, Giovanna/0000-0002-5758-9069;
   Zamora-Ros, Raul/0000-0002-6236-6804; Weiderpass,
   Elisabete/0000-0003-2237-0128; Kyro, Cecilie/0000-0002-9083-8960;
   Lasheras-Mayo, Maria Cristina/0000-0003-0482-4229; da Silva,
   Marisa/0000-0003-1215-8625; Gil Lespinard, Mercedes/0000-0002-7387-2139;
   Skeie, Guri/0000-0003-2476-4251
FU Instituto De Salud Carlos III (European Regional Development Fund, ERDF,
   a way to build Europe); European Union [PI18/00191]; International
   Agency for Research on Cancer (IARC) [2005328]; Department of
   Epidemiology and Biostatistics, School of Public Health, Imperial
   College London; Danish Cancer Society (Denmark); Ligue Contre le Cancer
   (France); Institut Gustave Roussy (France); Mutuelle Generale de
   l'Education Nationale (France); Institut National de la Sante et de la
   Recherche Medicale (INSERM) (France); German Cancer Aid (Germany);
   German Cancer Research Center (DKFZ) (Germany); German Institute of
   Human Nutrition Potsdam-Rehbruecke (DIfE) (Germany); Federal Ministry of
   Education and Research (BMBF) (Germany); Associazione Italiana per la
   Ricerca sul Cancro-AIRC-Italy (Italy); Compagnia di San Paolo (Italy);
   National Research Council (Italy); Dutch Ministry of Public Health,
   Welfare and Sports (VWS) (The Netherlands); Netherlands Cancer Registry
   (NKR) (The Netherlands); LK Research Funds (The Netherlands); Dutch
   Prevention Funds (The Netherlands); Dutch ZON (Zorg Onderzoek Nederland)
   (The Netherlands); World Cancer Research Fund (WCRF) (The Netherlands);
   Statistics Netherlands (The Netherlands); Health Research Fund
   (FIS)-Instituto de Salud Carlos III (ISCIII) (Spain); Regional
   Government of Andalucia (Spain); Regional Government of Asturias
   (Spain); Regional Government of Basque Country (Spain); Regional
   Government of Murcia (Spain); Regional Government of Navarra (Spain);
   Catalan Institute of Oncology-ICO (Spain); Swedish Cancer Society
   (Sweden); Swedish Research Council (Sweden); County Council of Skane
   (Sweden); County Council of Vaesterbotten (Sweden); Cancer Research UK
   (United Kingdom); Medical Research Council (United Kingdom) [14136,
   C8221/A29017]; MRC Epidemiology Unit [1000143, MR/M012190/1]; NIHR
   Cambridge Biomedical Research Centre diet, nutrition and lifestyle theme
   [MC_UU_0006/3]; CONACYT [IS-BRC-1215-20014]; Instituto de Salud Carlos
   III (European Social Fund (ESF) investing in your future) [693636]; 
   [FI19/00185];  [CD20/00071];  [CPII20/00009]
FX This research has been funded by the Instituto De Salud Carlos III
   through the project PI18/00191 (Co-funded by European Regional
   Development Fund, ERDF, a way to build Europe). The PANACEA project was
   funded by the European Union, in the framework of the Public Health
   Programme (project number: 2005328). The coordination of EPIC is
   financially supported by International Agency for Research on Cancer
   (IARC) and also by the Department of Epidemiology and Biostatistics,
   School of Public Health, Imperial College London which has additional
   infrastructure support provided by the NIHR Imperial Biomedical Research
   Centre (BRC). The national cohorts are supported by: Danish Cancer
   Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy,
   Mutuelle Generale de l'Education Nationale, Institut National de la
   Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid,
   German Cancer Research Center (DKFZ), German Institute of Human
   Nutrition Potsdam-Rehbruecke (DIfE), Federal Ministry of Education and
   Research (BMBF) (Germany); Associazione Italiana per la Ricerca sul
   Cancro-AIRC-Italy, Compagnia di San Paolo and National Research Council
   (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS),
   Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention
   Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund
   (WCRF), Statistics Netherlands (The Netherlands); Health Research Fund
   (FIS)-Instituto de Salud Carlos III (ISCIII), Regional Governments of
   Andalucia, Asturias, Basque Country, Murcia and Navarra, and the Catalan
   Institute of Oncology-ICO (Spain); Swedish Cancer Society, Swedish
   Research Council and County Councils of Skane and Vaesterbotten
   (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C8221/A29017 to
   EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk;
   MR/M012190/1 to EPIC-Oxford). (United Kingdom). NGF acknowledges support
   from MRC Epidemiology Unit (MC_UU_0006/3) and from the NIHR Cambridge
   Biomedical Research Centre diet, nutrition and lifestyle theme
   (IS-BRC-1215-20014). She is an NIHR Senior Investigator. We thank the
   CERCA Program/Generalitat de Catalunya for the institutional support to
   IDIBELL. JC thanks the CONACYT predoctoral fellowship (ID 693636). MG-L,
   EA-A, and RZ-R were supported by the PFIS (FI19/00185), the "Sara
   Borrell" (CD20/00071), and the "Miguel Servet II" (CPII20/00009)
   programmes from the Instituto de Salud Carlos III (Co-funded by European
   Social Fund (ESF) investing in your future).
CR Adriouch S, 2018, INT J OBESITY, V42, P310, DOI 10.1038/ijo.2017.227
   Ambikairajah A, 2019, AM J OBSTET GYNECOL, V221, P393, DOI 10.1016/j.ajog.2019.04.023
   Asbaghi O, 2020, PHYTOTHER RES, V34, P239, DOI 10.1002/ptr.6518
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Castaneda J., 2023, OBESITY
   Castro-Barquero S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101523
   Chiriboga DE, 2008, OBESITY, V16, P137, DOI 10.1038/oby.2007.38
   Cohen AK, 2013, OBES REV, V14, P989, DOI 10.1111/obr.12062
   Corrêa TAF, 2019, NUTRITION, V59, P150, DOI 10.1016/j.nut.2018.08.010
   Di Lorenzo C, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010273
   Dmitruk Agnieszka, 2018, Rocz Panstw Zakl Hig, V69, P95
   Drake I, 2018, BRIT J NUTR, V119, P1168, DOI 10.1017/S000711451800079X
   Corrêa TAF, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00188
   Freisling H, 2018, EUR J NUTR, V57, P2399, DOI 10.1007/s00394-017-1513-0
   García-Montero C, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020699
   GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569
   Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x
   Guasch-Ferré M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6723931
   Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7
   Huang HH, 2019, DIABET METAB SYND OB, V12, P553, DOI 10.2147/DMSO.S199830
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kabat GC, 2017, AM J PREV MED, V52, pE77, DOI 10.1016/j.amepre.2016.10.020
   Kipnis V, 2002, PUBLIC HEALTH NUTR, V5, P915, DOI 10.1079/PHN2002383
   Knaze V, 2018, AM J CLIN NUTR, V108, P517, DOI 10.1093/ajcn/nqy098
   Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13
   Margetts BM, 1997, INT J EPIDEMIOL, V26, pS1, DOI 10.1093/ije/26.suppl_1.S1
   Marranzano M, 2018, INT J FOOD SCI NUTR, V69, P1020, DOI 10.1080/09637486.2018.1452900
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024
   Pérez-Torres I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041786
   Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y
   Poti JM, 2017, CURR OBES REP, V6, P420, DOI 10.1007/s13679-017-0285-4
   -project.org, LANG ENV STAT COMP
   Rakhra Varundeep, 2020, Mo Med, V117, P536
   Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394
   Slavin JL, 2005, NUTRITION, V21, P411, DOI 10.1016/j.nut.2004.08.018
   Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679
   Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322
   Tabrizi R, 2019, CRIT REV FOOD SCI, V59, P2688, DOI 10.1080/10408398.2018.1507996
   Tabrizi R, 2018, FOOD FUNCT, V9, P6117, DOI 10.1039/c8fo01259h
   van Baak MA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081916
   van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008
   Cisneros LCV, 2017, NUTR HOSP, V34, P731, DOI 10.20960/nh.753
   Vergnaud AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057300
   Vinke PC, 2020, J NUTR, V150, P560, DOI 10.1093/jn/nxz262
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zamora-Ros R, 2014, AM J CLIN NUTR, V100, P11, DOI 10.3945/ajcn.113.077743
   Zhao Y, 2020, J SCI FOOD AGR, V100, P897, DOI 10.1002/jsfa.10049
   Zielinska-Blizniewska H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184556
NR 52
TC 6
Z9 6
U1 2
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD DEC
PY 2022
VL 11
IS 12
AR 2425
DI 10.3390/antiox11122425
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 7G2GP
UT WOS:000902350000001
PM 36552633
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Hsu, CS
   Chang, ST
   Nfor, ON
   Lee, KJ
   Ho, CC
   Liu, CC
   Lee, SS
   Liaw, YP
AF Hsu, Chun-Sheng
   Chang, Shin-Tsu
   Nfor, Oswald Ndi
   Lee, Kuan-Jung
   Ho, Chien-Chang
   Liu, Chuan-Ching
   Lee, Shiuan-Shinn
   Liaw, Yung-Po
TI Association of Metabolic Syndrome with Aerobic Exercise and LPL
   rs3779788 Polymorphism in Taiwan Biobank Individuals
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE polymorphisms; variant; physical activity; metabolic disorders
ID LIPOPROTEIN-LIPASE GENE; HINDIII; EXPRESSION; RESISTANCE; DISEASE;
   HEALTH; S447X; RISK
AB Purpose: The Lipoprotein lipase (LPL) gene is a significant contributor to dyslipidemia. It has shown associations with several conditions including atherosclerosis, obesity, and metabolic syndrome (MetS). We assessed the interactive association between MetS and rs3779788 of the LPL gene based on aerobic exercise. Materials and Methods: Data were available for 7532 Taiwan Biobank (TWB) participants recruited between 2008 and 2016. We used multiple logistic regression to determine the odds ratios (OR) for MetS and their 95% confident intervals (C.I.). Potential variables included LPL rs3779788, aerobic exercise, sex, age, education, marital status, body mass index (BMI), smoking, alcohol consumption, midnight snacking, vegetarian diet, coffee, dietary fat, and tea drinking. Results: Aerobic exercise was protective against MetS (OR, 0.858; 95% C.I., 0.743-0.991). Compared to CC/CT genotype, the OR for developing MetS was 0.875, (95% C.I., 0.571- 1.341) in TT individuals. The test for interaction was significant for the rs3779788 variant and aerobic exercise (p = 0.0484). In our group analyses, the OR for MetS was 0.841 (95% C.I., 0.727-0.974) in CC/CT and 4.076 (95% C.I., 1.158-14.346) in TT individuals who did aerobic exercise compared to those who did not. Conclusion: Our study indicated that aerobic exercise improved metabolic syndrome in Taiwanese adults with rs3779788 CC/CT genotype relative to those with TT genotype.
C1 [Hsu, Chun-Sheng; Chang, Shin-Tsu; Liu, Chuan-Ching] Taichung Vet Gen Hosp, Dept Phys Med & Rehabil, Taichung 40201, Taiwan.
   [Hsu, Chun-Sheng; Nfor, Oswald Ndi; Lee, Kuan-Jung; Lee, Shiuan-Shinn; Liaw, Yung-Po] Chung Shan Med Univ, Dept Publ Hlth, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.
   [Hsu, Chun-Sheng; Nfor, Oswald Ndi; Lee, Kuan-Jung; Lee, Shiuan-Shinn; Liaw, Yung-Po] Chung Shan Med Univ, Inst Publ Hlth, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.
   [Hsu, Chun-Sheng] Natl Def Med Ctr, Sch Med, Taipei 11490, Taiwan.
   [Hsu, Chun-Sheng] Natl Chung Hsing Univ, Coll Med, Taichung 402, Taiwan.
   [Chang, Shin-Tsu] Natl Def Med Ctr, Triserv Gen Hosp, Sch Med, Dept Phys Med & Rehabil, Taipei 11490, Taiwan.
   [Chang, Shin-Tsu] Kaohsiung Vet Gen Hosp, Dept Phys Med & Rehabil, Kaohsiung 813414, Taiwan.
   [Ho, Chien-Chang] Fu Jen Catholic Univ, Dept Phys Educ, New Taipei 24205, Taiwan.
   [Ho, Chien-Chang] Fu Jen Catholic Univ, Res & Dev Ctr Phys Educ Hlth & Informat Technol, New Taipei 24205, Taiwan.
   [Liaw, Yung-Po] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung, Taiwan.
C3 Taichung Veterans General Hospital; Chung Shan Medical University; Chung
   Shan Medical University; National Defense Medical Center; National Chung
   Hsing University; National Defense Medical Center; Tri-Service General
   Hospital; Kaohsiung Veterans General Hospital; Fu Jen Catholic
   University; Fu Jen Catholic University; Chung Shan Medical University;
   Chung Shan Medical University Hospital
RP Lee, SS; Liaw, YP (corresponding author), Chung Shan Med Univ, Dept Publ Hlth, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.; Lee, SS; Liaw, YP (corresponding author), Chung Shan Med Univ, Inst Publ Hlth, 110 Sec 1 Jianguo N Rd, Taichung 40201, Taiwan.
EM shinn@csmu.edu.tw; Liawyp@csmu.edu.tw
RI Chang, Shin-Tsu/AAF-8506-2020; Liaw, Yung/AAV-6746-2021; Chen,
   Chao-Hsien/AAE-8065-2022
OI Liaw, Yung-Po/0000-0003-2046-4964; Chang, Shin-Tsu/0000-0003-4005-2094
FU Ministry of Science and Technology, Taiwan [MOST 107-2627-M-040-002,
   108-2621-M-040-001, 109-2121-M-040-002]
FX This study was supported by the Ministry of Science and Technology,
   Taiwan (MOST 107-2627-M-040-002, 108-2621-M-040-001, and
   109-2121-M-040-002) .
CR Alinaghian N, 2019, GENE, V706, P13, DOI 10.1016/j.gene.2019.04.069
   Cahua-Pablo JA, 2015, INT J MOL SCI, V16, P21539, DOI 10.3390/ijms160921539
   Bakker EA, 2017, MAYO CLIN PROC, V92, P1214, DOI 10.1016/j.mayocp.2017.02.018
   Castellano-Castillo D, 2018, CLIN CHEM, V64, P210, DOI 10.1373/clinchem.2017.277921
   Cheema AN, 2017, DATABASE-OXFORD, P1, DOI 10.1093/database/bax078
   Chen YF, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/6612447
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Earnest CP, 2013, AM J CARDIOL, V111, P1805, DOI 10.1016/j.amjcard.2013.02.037
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Fan AZ, 2006, EUR J EPIDEMIOL, V21, P129, DOI 10.1007/s10654-005-5457-y
   Fenwick PH, 2019, CRIT REV FOOD SCI, V59, P2028, DOI 10.1080/10408398.2018.1437022
   Gehrisch S, 1999, Curr Atheroscler Rep, V1, P70, DOI 10.1007/s11883-999-0052-4
   Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214
   Hölzl B, 2002, DIABETOLOGIA, V45, P378, DOI 10.1007/s00125-001-0771-8
   Information(NCBI) NCfB, 2020, LPL LIP LIP
   JEMAA R, 1995, INT J OBESITY, V19, P270
   Jeong Seok Won, 2014, Genomics & Informatics, V12, P187, DOI 10.5808/GI.2014.12.4.187
   Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48
   Kastelein JJP, 1999, CLIN GENET, V56, P297, DOI 10.1034/j.1399-0004.1999.560407.x
   Katzmarzyk PT, 2003, MED SCI SPORT EXER, V35, P1703, DOI 10.1249/01.MSS.0000089337.73244.9B
   김상훈, 2009, [Journal of the Korea Gerontological Society, 한국노년학], V29, P823
   Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9
   Lin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36830
   Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060
   Ma YQ, 2003, METABOLISM, V52, P338, DOI 10.1053/meta.2003.50053
   McMurray RG, 2010, AM J LIFESTYLE MED, V4, P176, DOI 10.1177/1559827609351234
   Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9
   Morales-Palomo F, 2019, MED SCI SPORT EXER, V51, P1876, DOI 10.1249/MSS.0000000000001983
   Muñoz-Barrios S, 2012, DIS MARKERS, V33, P313, DOI [10.1155/2012/673452, 10.3233/DMA-2012-00940]
   Myers J, 2003, CIRCULATION, V107, pE2, DOI 10.1161/01.CIR.0000048890.59383.8D
   Myers J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071652
   Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064
   Okura T, 2007, OBESITY, V15, P2478, DOI 10.1038/oby.2007.294
   Pattyn N, 2013, SPORTS MED, V43, P121, DOI 10.1007/s40279-012-0003-z
   Pourranjbar Mohammad, 2018, J Med Life, V11, P381, DOI 10.25122/jml-2018-0033
   Radha V, 2007, INT J OBESITY, V31, P913, DOI 10.1038/sj.ijo.0803547
   Rahalkar AR, 2009, CAN J PHYSIOL PHARM, V87, P151, DOI [10.1139/Y09-005, 10.1139/y09-005]
   Ranjith N, 2009, METAB SYNDR RELAT D, V7, P571, DOI 10.1089/met.2009.0015
   Riddell Michael, 2009, J Diabetes Sci Technol, V3, P914
   SEIP RL, 1995, AM J PHYSIOL-ENDOC M, V268, pE229, DOI 10.1152/ajpendo.1995.268.2.E229
   Stancáková A, 2014, REV ENDOCR METAB DIS, V15, P243, DOI 10.1007/s11154-014-9293-9
   Ukkola O, 2001, ANN MED, V33, P79, DOI 10.3109/07853890109002062
   Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008
   Welfare MoHa, 2018, STAT CAUS DEATH
   Welfare MoHa, 2017, STAT CAUS DEATH
   Wung SF, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-19
   Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035
   Yoo Yong-Kwon, 2013, J Exerc Nutrition Biochem, V17, P133, DOI 10.5717/jenb.2013.17.4.133
   Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461
NR 49
TC 4
Z9 5
U1 0
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2021
VL 14
BP 3997
EP 4004
DI 10.2147/DMSO.S328308
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA UR8ZI
UT WOS:000697029700004
PM 34548800
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Lin, BH
   Dong, DS
   Carlson, A
   Rahkovsky, I
AF Lin, Biing-Hwan
   Dong, Diansheng
   Carlson, Andrea
   Rahkovsky, Ilya
TI Potential dietary outcomes of changing relative prices of healthy and
   less healthy foods: The case of ready-to-eat breakfast cereals
SO FOOD POLICY
LA English
DT Article
DE Food demand; Subsidy and taxation; Breakfast cereals; Pricing strategy;
   Dietary outcomes
ID OBESITY; DEMAND
AB Many prevalent and costly health disorders in the U.S. can be attributed in part to poor diets, overconsumption of calories, and physical inactivity. Taxing less healthy foods and subsidizing healthy foods as a strategy to improve diet and health has attracted growing interest among policy makers and researchers. We test this strategy by using national household purchase data to estimate a censored, price and expenditure endogenous demand system for 12 food groups that are commonly consumed at breakfast: low- and high-nutrition ready-to-eat breakfast cereals, eggs, breads, hot cereals, breakfast bars, juice, whole and reduced-fat milk, yogurt, meats, and coffee. The estimated demand elasticities are applied to nationally representative food intake data to simulate under the assumption of perfectly price elastic supply the potential dietary improvement from taxing low-nutrition and subsidizing high nutrition ready-to-eat breakfast cereals. We find that the demand for both types of cereals is own price inelastic, suggesting that consumers are not likely to make large shifts in consumption of cereals if the price changes. Thus only limited dietary improvement can be expected from taxes and subsidies. Furthermore, when the healthfulness of breakfast foods is evaluated using a comprehensive list of nutrients and food components, a price intervention strategy may result in unintended, adverse impacts. Our simulation results suggest that the hypothetical price intervention actually increases the calorie content of foods consumed at breakfast. Published by Elsevier Ltd.
C1 [Lin, Biing-Hwan; Dong, Diansheng; Carlson, Andrea; Rahkovsky, Ilya] Econ Res Serv, USDA, Washington, DC USA.
C3 United States Department of Agriculture (USDA)
RP Lin, BH (corresponding author), 355 E St SW, Washington, DC 20024 USA.
EM blin@ers.usda.gov
RI Carlson, Andrea/KFT-3502-2024
CR Agricultural Research Service U.S. Department of Agriculture, 2015, FOOD NUTR DATABASE D
   Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   [Anonymous], 2008, 69 US DEP AGR EC RES
   [Anonymous], 2015, RAPP ACT 2015 REP PE
   [Anonymous], NUTR REV
   [Anonymous], LAB NUTR
   Bartlett S., 2014, EVALUATION HLTH INCE
   Buse A., 2000, Empir. Econ., V25, P519, DOI 10.1007/s001810000031
   Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x
   Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003
   Centers for Disease Control and Prevention, CHRON DIS HLTH PROM
   Centers for Disease Control and Prevention National Center for Health Statistics (CDC/NCHS), NAT HLTH NUTR EXAM S
   Chidmi B, 2007, AM J AGR ECON, V89, P324, DOI 10.1111/j.1467-8276.2007.00994.x
   Committee DGA HHS Prevention OoD Promotion H USDA Promotion CfNP, 2015, Dietary Guidelines for Americans 2015-2020
   Cornelsen L, 2015, HEALTH ECON, V24, P1548, DOI 10.1002/hec.3107
   DEATON A, 1980, AM ECON REV, V70, P312
   Dhar T, 2003, AM J AGR ECON, V85, P605, DOI 10.1111/1467-8276.00459
   Dharmasena S, 2014, J AGR RESOUR ECON, V39, P157
   Dharmasena S, 2012, HEALTH ECON, V21, P669, DOI 10.1002/hec.1738
   Dong DS, 2007, AGR ECON, V36, P313, DOI 10.1111/j.1574-0862.2007.00209.x
   Duffey KJ, 2010, ARCH INTERN MED, V170, P420, DOI 10.1001/archinternmed.2009.545
   Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449
   Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822
   Fischer LM., 2011, Am J Health Promot, V26, pe55, DOI [10.4278/ajhp.100709-QUAL-238, DOI 10.4278/AJHP.100709-QUAL-238]
   Fletcher JM, 2010, CONTEMP ECON POLICY, V28, P23, DOI 10.1111/j.1465-7287.2009.00182.x
   Food and Nutrition Service U.S, HLTH INC PIL
   French SA, 2003, AM J PUBLIC HEALTH, V93, P1161, DOI 10.2105/AJPH.93.7.1161
   French SA, 2001, AM J PUBLIC HEALTH, V91, P112, DOI 10.2105/AJPH.91.1.112
   Gladson, GLADS NUTR DAT
   Golub A., 2005, 2005 AAEA M JUL 24 2
   Guthrie J, 2016, LINKING FEDERAL FOOD
   Hamrick K.S., 2014, ROLE TIME FAST FOOD
   Ishdorj A., 2010, 1 JOINT EAAE AAEA SE
   Kuchler F, 2005, REV AGR ECON, V27, P4, DOI 10.1111/j.1467-9353.2004.00204.x
   Lin BH, 2014, INT FOOD AGRIBUS MAN, V17, P7
   Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007
   Lin BH, 2010, CONTEMP ECON POLICY, V28, P524, DOI 10.1111/j.1465-7287.2009.00193.x
   Mancino L, 2008, FOOD POLICY, V33, P489, DOI 10.1016/j.foodpol.2008.05.005
   McCloskey D. N., 1982, APPL THEORY PRICE
   Meyerhoefer CD, 2010, AM J AGR ECON, V92, P1271, DOI 10.1093/ajae/aaq064
   Mytton O., 2012, BMJ-BRIT MED J, P29
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Oliveira V., 2014, EC INFORM B, V120
   Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002
   Rahkovsky I, 2013, FOOD POLICY, V43, P100, DOI 10.1016/j.foodpol.2013.08.013
   Rahkovsky I, 2013, ECON HUM BIOL, V11, P95, DOI 10.1016/j.ehb.2012.01.004
   Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070
   Smith TA, 2009, RENEW AGR FOOD SYST, V24, P197, DOI 10.1017/S1742170509002579
   Thow A.M., 2010, B WORLD HEALTH ORGAN, P1
   Tiffin R., 2014, HLTH EC
   Todd J.E., 2014, 161 US DEP AGR EC RE
   U.S. Department of Agriculture U.S. Department of Health and Human Services, 2010, DIET GUID AM 2010, P2010
   Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049
   Zhen C, 2011, AM J AGR ECON, V93, P175, DOI 10.1093/ajae/aaq155
NR 54
TC 7
Z9 11
U1 2
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-9192
EI 1873-5657
J9 FOOD POLICY
JI Food Policy
PD APR
PY 2017
VL 68
BP 77
EP 88
DI 10.1016/j.foodpol.2017.01.004
PG 12
WC Agricultural Economics & Policy; Economics; Food Science & Technology;
   Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Agriculture; Business & Economics; Food Science & Technology; Nutrition
   & Dietetics
GA ES9DS
UT WOS:000399856900008
OA Bronze
DA 2025-04-28
ER

PT J
AU Storey, ML
   Forshee, RA
   Anderson, PA
AF Storey, Maureen L.
   Forshee, Richard A.
   Anderson, Patricia A.
TI Beverage consumption in the US population
SO JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
LA English
DT Article
ID BODY-MASS INDEX; CHILDHOOD OBESITY; SECULAR TRENDS; CHILDREN; CALCIUM;
   WEIGHT; ASSOCIATIONS; DEMOGRAPHICS; ADOLESCENTS; CHOICES
AB Objective The purpose of this study was to examine beverage consumption across age, sex, and race/ethnicity categories using the most current data available, the National Health and Nutrition Examination Survey 1999-2002.
   Design Beverage consumption that included fluid milk, fruit juices, regular and diet carbonated soft drinks, regular and diet fruit drinks/ades, coffee, and tea was examined among white, African-American, and Mexican-American persons in age groups 6 to 11 years, 12 to 19 years, 20 to 39 years, 40 to 59 years, and >60 years. Data from the National Health and Nutrition Examination Survey 1999-2002 were used in this study.
   Statistical analysis Group means were estimated for the age group, sex, and race/ethnicity subgroups. The probability that any of these group means were equal to one another was tested using statistical software.
   Results The data,showed marked differences in beverage consumption depending on age, sex, and race/ethnicity. In general, males consumed more beverages than did females. Specifically, white and Mexican-American persons of all ages consumed more milk than did African-American persons. On average, African-American males and females of all ages consumed significantly more fruit drinks/ades than did other race/ethnicity groups. In contrast, white persons consumed more carbonated soft drinks than did other race/ethnicity groups.
   Conclusion Average beverage consumption varied depending on age, sex, and race/ethnicity. Knowledge of differences in beverage consumption patterns is important for food and nutrition professionals and nutrition policymakers. Better understanding of the many factors that influence beverage consumption levels is needed.
C1 Univ Maryland, Ctr Food Nutr & Agr Policy, Special Res Initiat, College Pk, MD 20742 USA.
C3 University System of Maryland; University of Maryland College Park
RP Storey, ML (corresponding author), Univ Maryland, Ctr Food Nutr & Agr Policy, Special Res Initiat, 1122 Patapsco, College Pk, MD 20742 USA.
EM storey@umd.edu
CR [Anonymous], DIET REF INT EN CARB
   [Anonymous], 2006, NAT HLTH NUTR EX SUR
   Barr SI, 2005, J NUTR, V135, P1336, DOI 10.1093/jn/135.5.1336
   Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94
   Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349
   CARRIQUIRY AL, 1992, J14654 IOW AGR HOM E
   Centers for Disease Control and Prevention, NHANES 1999 2000 DAT
   Centers for Disease Control and Prevention NCfHS, 1999 2000 NAT HLTH N
   Field AE, 2004, INT J OBESITY, V28, P1210, DOI 10.1038/sj.ijo.0802762
   Fisher JO, 2004, AM J CLIN NUTR, V79, P698
   Forshee RA, 2006, J AM COLL NUTR, V25, P108, DOI 10.1080/07315724.2006.10719520
   Forshee RA, 2005, RISK ANAL, V25, P1121, DOI 10.1111/j.1539-6924.2005.00667.x
   Forshee RA, 2005, J NUTR, V135, P1337, DOI 10.1093/jn/135.5.1337
   Forshee RA, 2004, INT J FOOD SCI NUTR, V55, P463, DOI 10.1080/09637480400015729
   Forshee RA, 2004, J NUTR, V134, P2733, DOI 10.1093/jn/134.10.2733
   Forshee RA, 2003, INT J FOOD SCI NUTR, V54, P297, DOI [10.1080/09637480120092143, 10.1080/096374803766666175]
   French SA, 2003, J AM DIET ASSOC, V103, P1326, DOI 10.1016/S0002-8223(03)01076-9
   French Simone A, 2004, BMJ, V329, pE315, DOI 10.1136/bmj.329.7462.E315
   Hanson NI, 2005, PUBLIC HEALTH NUTR, V8, P77, DOI [10.1079/PHN2005661, 10.1079/PHN2004661]
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   James J, 2004, BRIT MED J, V328, P1236
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Murphy SP, 2003, J NUTR, V133, p585S, DOI 10.1093/jn/133.2.585S
   Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020
   Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005
   Nielsen SJ, 2002, PREV MED, V35, P107, DOI 10.1006/pmed.2002.1037
   Nielsen SJ, 2002, OBES RES, V10, P370, DOI 10.1038/oby.2002.51
   *NIH NAT I DIAB DI, LACT INT
   Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570
   Popkin BM, 2005, OBES RES, V13, P2146, DOI 10.1038/oby.2005.266
   Rajeshwari R, 2005, J AM DIET ASSOC, V105, P208, DOI 10.1016/j.jada.2004.11.026
   Storey ML, 2004, J AM COLL NUTR, V23, P18, DOI 10.1080/07315724.2004.10719339
   Storey ML, 2003, INT J FOOD SCI NUTR, V54, P491, DOI 10.1080/09637480310001622350
   Tran NL, 2004, RISK ANAL, V24, P19, DOI 10.1111/j.0272-4332.2004.00408.x
   *USDA, FOOD AV DAT CARB SOF
   *USDA, 1998, 1994 96 CONT SURV FO
   Wooten WJ, 2004, J NATL MED ASSOC, V96, p5S
   Woteki CE, 2003, J NUTR, V133, p582S, DOI 10.1093/jn/133.2.582S
NR 38
TC 134
Z9 172
U1 0
U2 13
PU AMER DIETETIC ASSOC
PI CHICAGO
PA 120 S RIVERSIDE PLZ, STE 2000, CHICAGO, IL 60606-6995 USA
SN 0002-8223
J9 J AM DIET ASSOC
JI J. Am. Diet. Assoc.
PD DEC
PY 2006
VL 106
IS 12
BP 1992
EP 2000
DI 10.1016/j.jada.2006.09.009
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 112YH
UT WOS:000242563600016
PM 17126630
DA 2025-04-28
ER

PT J
AU Kent, LM
   Worsley, A
AF Kent, Lillian M.
   Worsley, Anthony
TI Breakfast size is related to body mass index for men, but not women
SO NUTRITION RESEARCH
LA English
DT Article
DE Breakfast; Survey; Dietary practice; BMI; Men; Prudent lifestyle;
   "Affluent lifestyle"
ID NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; WEIGHT-GAIN;
   CONSUMPTION; PATTERNS; ADOLESCENTS; ADEQUACY; CHILDREN; ENERGY; ADULTS
AB The objective of this study was to examine the effect of self-reported breakfast size, daily eating, and other health habits on body mass index (BMI). We hypothesized that a consumption of a substantial breakfast compared with skipping or small breakfasts would be associated with lower BMI. Three independent, cross-sectional, screening surveys were conducted by Sydney Adventist Hospital in 1976, 1986, and 2005 in the surrounding community. The archived survey forms of 384 men and 338 women in 1976, 244 men and 229 women in 1986, and 270 men and 62 women in 2005 were randomly selected. Body mass index was determined from height and weight measured by hospital staff. The reported amount consumed at breakfast was one of several eating habits that predicted BMI for men but not women. It explained 5% to 6% of the variance in male BMI in all 3 years examined. As the reported breakfast amount increased, men's BMI decreased. Lifestyle confounders including vegetarianism and physical activity did not affect this relationship. However, the consumption of breakfast was significantly positively associated with consumption of cereals, bread, fruit, and spreads, while coffee consumption was significantly associated with smaller breakfasts or breakfast skipping. The consumption of relatively large breakfasts may influence BMI in men, and its promotion may help reduce the prevalence of obesity in Australia and elsewhere. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Kent, Lillian M.] Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.
   [Worsley, Anthony] Univ Wollongong, Sch Hlth Sci, Wollongong, NSW 2522, Australia.
C3 Australian National University; University of Wollongong
RP Kent, LM (corresponding author), Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.
EM u4783787@anu.edu.au
OI Worsley, Anthony/0000-0002-4635-6059; Kent, Lillian/0000-0001-9518-7303
FU Deakin University, Melbourne, Australia; Sanitarium Health Food Company;
   Australian Research Council
FX Financial support was provided by Deakin University, Melbourne,
   Australia; the Sanitarium Health Food Company and Australian Research
   Council grants were awarded to A. W. Thanks are also due to Kai Lo Sing
   for statistical advice. The authors report no conflicts of interest.
CR Albertson AM, 2009, J AM DIET ASSOC, V109, P1557, DOI 10.1016/j.jada.2009.06.363
   Bazzano LA, 2005, OBES RES, V13, P1952, DOI 10.1038/oby.2005.240
   Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008
   Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Dubois L, 2009, PUBLIC HEALTH NUTR, V12, P19, DOI 10.1017/S1368980008001894
   EGGER G, 1996, FAT LOSS HDB GUIDE P
   Erlichman J, 2002, Obes Rev, V3, P273, DOI 10.1046/j.1467-789X.2002.00078.x
   Fiore H, 2006, J AM DIET ASSOC, V106, P55, DOI 10.1016/j.jada.2005.09.046
   Fulton JE, 2009, ARCH INTERN MED, V169, P2124, DOI 10.1001/archinternmed.2009.413
   Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2
   Haines PS, 2003, OBES RES, V11, P945, DOI 10.1038/oby.2003.130
   Isaksson Hanna, 2008, Food Nutr Res, V52, DOI 10.3402/fnr.v52i0.1809
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kent LM, 2009, ASIA PAC J CLIN NUTR, V18, P453
   Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618
   Louie JCY, 2008, ASIA PAC J CLIN NUTR, V17, P657
   MARMOT M, 2001, B WORLD HEALTH ORGAN, V79, P906
   Nicklas TA, 1998, J AM DIET ASSOC, V98, P1432, DOI 10.1016/S0002-8223(98)00325-3
   Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007
   Ravussin E, 2002, J CLIN INVEST, V109, P1537, DOI 10.1172/JCI200216045
   Song WO, 2005, J AM DIET ASSOC, V105, P1373, DOI 10.1016/j.jada.2005.06.002
   Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585
   Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514
   van der Heijden AAWA, 2007, OBESITY, V15, P2463, DOI 10.1038/oby.2007.292
   Willett WC, 1999, AM J CLIN NUTR, V70, p434S, DOI 10.1093/ajcn/70.3.434s
   Williams BM, 2009, PUBLIC HEALTH NUTR, V12, P489, DOI 10.1017/S1368980008002760
   Williams P., 2002, Nutrition & Dietetics, V59, P103
   Williams P, 2005, INT J FOOD SCI NUTR, V56, P65, DOI 10.1080/09637480500082108
   Wilson DM, 2010, OBESITY, V18, P402, DOI 10.1038/oby.2009.261
   Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S
   Worsley A, 2004, PUBLIC HEALTH NUTR, V7, P649, DOI 10.1079/PHN2003577
NR 32
TC 18
Z9 20
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
J9 NUTR RES
JI Nutr. Res.
PD APR
PY 2010
VL 30
IS 4
BP 240
EP 245
DI 10.1016/j.nutres.2010.03.006
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 610CD
UT WOS:000278706400003
PM 20534326
DA 2025-04-28
ER

PT J
AU Essman, M
   Popkin, BM
   Corvalán, C
   Reyes, M
   Taillie, LS
AF Essman, Michael
   Popkin, Barry M.
   Corvalan, Camila
   Reyes, Marcela
   Taillie, Lindsey Smith
TI Sugar-Sweetened Beverage Intake among Chilean Preschoolers and
   Adolescents in 2016: A Cross-Sectional Analysis
SO NUTRIENTS
LA English
DT Article
DE beverage intake; children; adolescents; sugar-sweetened beverages;
   juice; milk
ID FRONT-OF-PACK; BODY-MASS; CHILDREN; OBESITY; ADULTS; BMI
AB Background: Chile has the highest sugar-sweetened beverage (SSB) sales of any country and a growing burden of childhood obesity. This study examines SSB intake in Chilean children after a 5% SSB tax increase in 2014 but prior to marketing, labeling, and school policies implemented in 2016. Methods: 24-h recalls were collected in 2016 from two cohorts comprised of preschoolers 3-5 years of age (n = 961) and adolescents 12-14 years of age (n = 770) from low-moderate income neighborhoods. Beverages were categorized as regulated or unregulated according to whether they exceeded nutrient thresholds established by the 2016 policies. Results: Preschoolers consumed mainly beverage calories from regulated dairy beverages and substitutes (109 kcal, SD 30), unregulated dairy beverages (102 kcal, SD 24), and regulated fruit and vegetables drinks (44 kcal, SD 20). For adolescents, the greatest contributions came from regulated sodas (77 kcal, SD 47), regulated dairy beverages and substitutes (41 kcal, SD 16), and unregulated coffee and tea (41 kcal, SD 11). Overall, regulated beverages provided a greater proportion of calories than unregulated for preschoolers (15.0% vs. 11.8%) and for adolescents (9.1% vs. 5.0%). Conclusions: Before major policy implementation, regulated beverages accounted for a higher percentage of energy intake than unregulated beverages among both age groups. Future research will be needed to evaluate the impact of Chile's new policies on sugary beverage intake in children.
C1 [Essman, Michael; Popkin, Barry M.; Taillie, Lindsey Smith] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.
   [Popkin, Barry M.; Taillie, Lindsey Smith] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA.
   [Corvalan, Camila; Reyes, Marcela] Univ Chile, Inst Nutr & Food Technol INTA, Santiago 7830490, Chile.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   Universidad de Chile
RP Taillie, LS (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.; Taillie, LS (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA.
EM essmanm@live.unc.edu; popkin@unc.edu; ccorvalan@inta.uchile.cl;
   mreyes@inta.uchile.cl; taillie@unc.edu
RI Popkin, Barry/T-6633-2019; Corvalan, Camila/B-2914-2011; Reyes,
   Marcela/A-6247-2013
OI Essman, Michael/0000-0001-5017-3880; Corvalan,
   Camila/0000-0003-3766-7709; popkin, barry/0000-0001-9495-9324; Reyes,
   Marcela/0000-0002-4601-7663
FU Bloomberg Philanthropies; IDRC Grant [108180]; CONICYT Fondecyt
   [1161436]
FX This support comes from Bloomberg Philanthropies with additional support
   from IDRC Grant 108180 (INTA-UNC) and CONICYT Fondecyt #1161436.
CR Agriculture Research Service USDA, NAT NUTR DAT STAND R
   Agriculture Research Service USDA, AUT MULT METH
   Araneda J, 2015, SALUD PUBLICA MEXICO, V57, P128
   Caro JC, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002597
   Cerda R., 2010, Photographic Atlas of Chilean Food and Typical Preparations: National survey of Food Consumption, V1st
   Corvalan C, 2017, OBES REV, V18, P7, DOI 10.1111/obr.12571
   FAO and PAHO, 2017, PAN FOOD NUTR SEC LA
   Feunekes GI, 2008, APPETITE, V50, P57, DOI 10.1016/j.appet.2007.05.009
   Garmendia ML, 2013, EUR J CLIN NUTR, V67, P513, DOI 10.1038/ejcn.2012.190
   Grunert KG, 2010, APPETITE, V55, P177, DOI 10.1016/j.appet.2010.05.045
   JUNAEB, 2015, SIT NUTR PREESC ESC
   Kain J, 2002, EUR J CLIN NUTR, V56, P200, DOI 10.1038/sj.ejcn.1601301
   Kain J, 2009, OBESITY, V17, P1603, DOI 10.1038/oby.2009.37
   Kelly B, 2009, HEALTH PROMOT INT, V24, P120, DOI 10.1093/heapro/dap012
   Luger M, 2017, OBESITY FACTS, V10, P674, DOI 10.1159/000484566
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nissinen K, 2009, PUBLIC HEALTH NUTR, V12, P2018, DOI 10.1017/S1368980009005849
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652
   UNDP, HUM DEV REP CHIL
   Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183
   Vyth EL, 2010, PUBLIC HEALTH NUTR, V13, P1882, DOI 10.1017/S1368980010000637
NR 24
TC 17
Z9 19
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV
PY 2018
VL 10
IS 11
AR 1767
DI 10.3390/nu10111767
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HC1GH
UT WOS:000451547700205
PM 30445671
OA Green Published, Green Submitted, gold
DA 2025-04-28
ER

PT J
AU Kollia, N
   Panagiotakos, DB
   Chrysohoou, C
   Georgousopoulou, E
   Tousoulis, D
   Stefanadis, C
   Papageorgiou, C
   Pitsavos, C
AF Kollia, Natasa
   Panagiotakos, Demosthenes B.
   Chrysohoou, Christina
   Georgousopoulou, Ekavi
   Tousoulis, Dimitrios
   Stefanadis, Christodoulos
   Papageorgiou, Charalabos
   Pitsavos, Christos
TI DETERMINANTS OF HEALTHY AGEING AND ITS RELATION TO 10-YEAR
   CARDIOVASCULAR DISEASE INCIDENCE: THE ATTICA STUDY
SO CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE ageing; cardiovascular disease; risk factors; psychological
ID RISK-FACTOR; MARKERS; INFLAMMATION; OBESITY; POPULATION; MORTALITY;
   EUROPE; SCORE
AB Objectives: The aim of the study was to understand determinants of ageing in relation to future cardiovascular disease (CVD) events at population level, and to explore determinants of healthy ageing and its relation to 10-year CVD incidence among apparently healthy individuals.
   Methods: In the context of the ATTICA study 453 apparently healthy men (45 +/- 13 years) and 400 women (44 +/- 18 years) with complete psychological evaluation were studied and followed during 2002-2012. Healthy Ageing Index (HAI) (range 0-7) was calculated based on socioeconomical, bio-clinical, psychological, and lifestyle characteristics (i.e. dietary habits and physical activity) of the participants during the baseline examination. CVD incidence during the follow-up period was defined according to ICD-10 criteria.
   Results: Healthy Ageing Index was inversely associated with higher 10-year CVD risk (OR per 1/7 (95% CI): 0.47 (0.28, 0.80). Age and sex-adjusted determinants of healthy ageing were abnormal waist to hip ratio (p <0.001), increased coffee consumption (p = 0.04), reduced basic metabolic rhythm (p <0.001), increased triglycerides (p = 0.003), and C-reactive protein levels (p = 0.02), as aggravating factors, while moderate alcohol consumption (p =0.002) was identified as a positive influential parameter.
   Conclusions: Understanding healthy ageing, as a dominant factor of CVD development, provides a new direction for better prevention efforts focused on healthy ageing at both population and individual level.
C1 [Kollia, Natasa; Panagiotakos, Demosthenes B.; Georgousopoulou, Ekavi] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece.
   [Chrysohoou, Christina; Tousoulis, Dimitrios; Stefanadis, Christodoulos; Pitsavos, Christos] Univ Athens, Sch Med, Cardiol Clin 1, Athens, Greece.
   [Papageorgiou, Charalabos] Univ Athens, Sch Med, Dept Psychiat, Athens, Greece.
C3 Harokopio University Athens; National & Kapodistrian University of
   Athens; Athens Medical School; Athens Medical School; National &
   Kapodistrian University of Athens
RP Panagiotakos, DB (corresponding author), 46 Paleon Polemiston St, Attica 16674, Greece.
EM d.b.panagiotakos@usa.net
RI Panagiotakos, Demosthenes/K-8294-2019; Georgousopoulou,
   Ekavi/AAC-2563-2019; Stefanadis, Christodoulos/ABH-2232-2020
OI Chrysohoou, Christina/0000-0002-6340-3996; Papageorgiou,
   Charalabos/0000-0001-7635-1956; Georgousopoulou,
   Ekavi/0000-0002-0592-3838; Stefanadis, Christodoulos/0000-0001-5974-6454
FU Coca-Cola Company; Hellenic Cardiology Society [HCS2002]; Hellenic
   Atherosclerosis Society [HAS2003]; Aging Trajectories of Health:
   Longitudinal Opportunities and Synergies (ATHLOS) project (European
   Union's Horizon research and innovation program) [635316]
FX Demosthenes Panagiotakos and Ekavi Georgousopoulou received research
   grants by the Coca-Cola Company. The ATTICA study is supported by
   research grants from the Hellenic Cardiology Society (HCS2002) and the
   Hellenic Atherosclerosis Society (HAS2003). DBP and NK are funded within
   the Aging Trajectories of Health: Longitudinal Opportunities and
   Synergies (ATHLOS) project (European Union's Horizon 2020 research and
   innovation program) under grant agreement No 635316.
CR [Anonymous], 2006, COM/2006/0571
   Atzmon G, 2002, J GERONTOL A-BIOL, V57, pM712, DOI 10.1093/gerona/57.11.M712
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
   Dokic B, 2015, CENT EUR J PUBL HEAL, V23, P195
   Fountoulakis KN, 2006, ANN GEN PSYCHIAT, V5, DOI [10.1186/1744-859X-5-2, DOI 10.1186/1744-859X-5-2]
   Fountoulakis KN, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-6
   Genchev G D, 2001, Cent Eur J Public Health, V9, P83
   Gorenoi V, 2015, CENT EUR J PUBL HEAL, V23, P91
   Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545
   Kamphuis Carlijn B M, 2012, BMC Public Health, V12, P1045, DOI 10.1186/1471-2458-12-1045
   Katsouyanni Klea, 1997, International Journal of Epidemiology, V26, pS118, DOI 10.1093/ije/26.suppl_1.S118
   Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96
   Lira FS, 2014, CURR DIABETES REV, V10, P391, DOI 10.2174/1573399810666141122210135
   Panagiotakos Demosthenes B, 2007, Hellenic J Cardiol, V48, P55
   Panagiotakos DB, 2006, NUTR METAB CARDIOVAS, V16, P559, DOI 10.1016/j.numecd.2005.08.006
   Panagiotakos DB, 2015, INT J CARDIOL, V180, P178, DOI 10.1016/j.ijcard.2014.11.206
   Papathanasiou George, 2009, Hellenic J Cardiol, V50, P283
   Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5
   Pikhart Hynek, 2007, Central European Journal of Public Health, V15, P140
   Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001
   Pitsavos C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-32
   Raber J, 1998, MOL NEUROBIOL, V18, P1, DOI 10.1007/BF02741457
   Ruggiero C, 2008, J GERONTOL A-BIOL, V63, P698, DOI 10.1093/gerona/63.7.698
   Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5
   Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3
   Tyrovolas S, 2014, EXP GERONTOL, V60, P57, DOI 10.1016/j.exger.2014.09.010
   World Health Organization, 2018, WORLD REP AG HLTH, DOI DOI 10.1007/S13398-014-0173-7.2
   Zubko A., 1998, TREASURY SPIRITUAL W, V3rd
NR 28
TC 5
Z9 6
U1 1
U2 9
PU NATL INST PUBLIC HEALTH
PI PRAGUE 10
PA DEPT SCIENTIFIC INFORMATION, SROBAROVA 48, PRAGUE 10, 100 42, CZECH
   REPUBLIC
SN 1210-7778
EI 1803-1048
J9 CENT EUR J PUBL HEAL
JI Cent. Eur. J. Public Health
PD MAR
PY 2018
VL 26
IS 1
BP 3
EP 9
DI 10.21101/cejph.a5165
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA GG7AM
UT WOS:000432850200001
PM 29684290
OA Bronze
DA 2025-04-28
ER

PT J
AU Amarra, MSV
   Khor, GL
   Chan, P
AF Amarra, Maria Sofia V.
   Khor, Geok Lin
   Chan, Pauline
TI Intake of added sugar in Malaysia: a review
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Review
DE sugar; intake; added sugars; sources; Malaysia
ID RISK-FACTORS; FRUCTOSE; NUTRITION; OBESITY; ENERGY
AB The term 'added sugars' refers to sugars and syrup added to foods during processing or preparation, and sugars and syrups added at the table. Calls to limit the daily intakes of added sugars and its sources arose from evidence analysed by WHO, the American Heart Association and other organizations. The present review examined the best available evidence regarding levels of added sugar consumption among different age and sex groups in Malaysia and sources of added sugars. Information was extracted from food balance sheets, household expenditure surveys, nutrition surveys and published studies. Varying results emerged, as nationwide information on intake of sugar and foods with added sugar were obtained at different times and used different assessment methods. Data from the 2003 Malaysian Adult Nutrition Survey (MANS) using food frequency questionnaires suggested that on average, Malaysian adults consumed 30 grams of sweetened condensed milk (equivalent to 16 grams sugar) and 21 grams of table sugar per day, which together are below the WHO recommendation of 50 grams sugar for every 2000 kcal/day to reduce risk of chronic disease. Published studies suggested that, for both adults and the elderly, frequently consumed sweetened foods were beverages (tea or coffee) with sweetened condensed milk and added sugar. More accurate data should be obtained by conducting population-wide studies using biomarkers of sugar intake (e.g. 24-hour urinary sucrose and fructose excretion or serum abundance of the stable isotope C-13) to determine intake levels, and multiple 24 hour recalls to identify major food sources of added sugar.
C1 [Amarra, Maria Sofia V.; Chan, Pauline] Int Life Sci Inst Southeast Asia Reg ILSI SEA, Sci Programs, 9 Mohamed Sultan Rd 02-01, Singapore 238959, Singapore.
   [Khor, Geok Lin] Int Med Univ, Sch Hlth Sci, Kuala Lumpur 57000, Malaysia.
C3 International Medical University Malaysia
RP Amarra, MSV (corresponding author), Int Life Sci Inst Southeast Asia Reg ILSI SEA, Sci Programs, 9 Mohamed Sultan Rd 02-01, Singapore 238959, Singapore.
EM sofiaamarra@ilsisea.org.sg
OI Khor, Geok Lin/0000-0002-4691-6319
FU International Life Sciences Institute Southeast Asia Region
FX None declared. Funding for the research was provided by International
   Life Sciences Institute Southeast Asia Region. The funding organization
   had no role in study design, collection, analysis and interpretation of
   data.
CR [Anonymous], 1997, NUTR COMPOSITION MAL
   [Anonymous], CARB HUM NUTR
   [Anonymous], WHAT AR ADD SUG
   [Anonymous], 2013, World health statistics 2013: A wealth of information on global public health
   [Anonymous], USE HOUSEHOLD EXPEND
   [Anonymous], USDA NAT NUTR DAT ST
   [Anonymous], 2005, DIET REF INT EN CARB
   [Anonymous], IIUM J EC MANAGEMENT
   [Anonymous], ASEAN FOOD COMP TABL
   [Anonymous], NHANES DIET WEB TUT
   [Anonymous], HAB FOOD INT AD AG 1
   [Anonymous], DIET INT AD AG 18 59
   [Anonymous], STUDY DIETARY INTAKE
   [Anonymous], REP HOUS EXP SURV MA
   [Anonymous], 2010, Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans
   [Anonymous], IEJSME
   [Anonymous], MAL DIET GUID
   [Anonymous], ESSENTIALS HUMAN NUT
   Bellisle F, 2012, J NUTR, V142, p1149S, DOI 10.3945/jn.111.149583
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866
   Boo NY, 2010, SINGAP MED J, V51, P126
   Boon TeoYee Boon TeoYee, 2012, American Journal of Food and Nutrition, V2, P69, DOI 10.5251/ajfn.2012.2.3.69.77
   Bray GA, 2013, ADV NUTR, V4, P220, DOI 10.3945/an.112.002816
   Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726
   Chan TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082004
   Gan W Y, 2011, Malays J Nutr, V17, P213
   Hedrick VE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-109
   Huat F L., 2006, Malays J Nutr, V12, P11
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814
   Khitan Z, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/682673
   Manaf ZA, 2012, MALAYS J MED SCI, V19, P56
   Mann J, 2007, EUR J CLIN NUTR, V61, pS132, DOI 10.1038/sj.ejcn.1602943
   Mirnalini K Jr, 2008, Malays J Nutr, V14, P1
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700]
   Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492
   Moynihan P, 2004, PUBLIC HEALTH NUTR, V7, P201, DOI 10.1079/PHN2003589
   Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954
   Nash SH, 2014, EUR J CLIN NUTR, V68, P91, DOI 10.1038/ejcn.2013.230
   Nurul-Fadhilah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059297
   Saw W. S., 2012, Pakistan Journal of Nutrition, V11, P1066
   Shahar S, 2000, ASIA PAC J CLIN NUTR, V9, P122, DOI 10.1046/j.1440-6047.2000.00147.x
   Shahril MR, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/658642
   Shanita Nik S, 2012, Malays J Nutr, V18, P283
   Sigman-Grant M, 2003, AM J CLIN NUTR, V78, p815S, DOI 10.1093/ajcn/78.4.815S
   Smith LC., 2007, Measuring food security using household expenditure surveys, DOI DOI 10.2499/0896297675
   Tappy L, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-42
   Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009
   Tasevska N, 2005, CANCER EPIDEM BIOMAR, V14, P1287, DOI 10.1158/1055-9965.EPI-04-0827
   Van Horn Linda, 2010, Circulation, V122, P2470, DOI 10.1161/CIR.0b013e3181ffdcb0
   WHO, 2003, WHO TECHN REP SER
   World Health Organization (WHO), 2015, Guideline: Sugars Intake for Adults and Children
   Zahara A M Jr, 2010, Malays J Nutr, V16, P83
   Zaini M Z Anuar, 2005, Asia Pac J Public Health, V17, P71, DOI 10.1177/101053950501700203
NR 55
TC 40
Z9 43
U1 2
U2 13
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI MCKINNON
PA PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA
SN 0964-7058
EI 1440-6047
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PY 2016
VL 25
IS 2
BP 227
EP 240
DI 10.6133/apjcn.2016.25.2.13
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DN4PZ
UT WOS:000377051000002
PM 27222405
DA 2025-04-28
ER

PT J
AU Yim, HR
   Yun, HJ
   Lee, JH
AF Yim, Hui-Rang
   Yun, Hyun Ju
   Lee, Jee Hye
TI An Investigation on Korean Adolescents' Dietary Consumption: Focused on
   Sociodemographic Characteristics, Physical Health, and Mental Health
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE adolescents; dietary intake; sociodemographic characteristics; physical
   health; mental health
ID FAST-FOOD CONSUMPTION; SOCIOECONOMIC-STATUS; UNIVERSITY-STUDENTS;
   SEDENTARY BEHAVIORS; VEGETABLE INTAKE; EATING HABITS; SUGAR INTAKE;
   WEIGHT-GAIN; CHILDREN; OBESITY
AB The promotion of healthful dietary intake in adolescents is an important public health concern, as obesity is on the rise among adolescents. The current study aimed to determine the association between sociodemographic characteristics and dietary intake (breakfast, vegetables, milk, fruits, fast food, carbohydrate beverages, and caffeine beverages) and to examine the influences of physical and mental health on dietary intake. A nationally representative sample of 187,622 adolescents who attended middle and high schools and participated in the Korean Youth Risk Behavior Survey (2015, 2017, and 2019) was used. The results showed a decrease in breakfast, vegetable, milk, and fruit consumption and an increase in the obesity rate from 2015 to 2019. There was a significant association between dietary intake and gender, economic status, BMI, and academic achievement. Multiple logistic regression analysis results revealed that the consumption of breakfast, vegetables, milk, and fruit were associated with greater odds of having enough sleep. Fast food intake was shown to be a significant risk factor for depression with an odds ratio of 1.204 (95% CI = 1.169-1.239), and carbonated beverage consumption was shown to be a significant risk factor for stress with an odds ratio of 1.042 (95% CI = 1.030-1.054). These results provide fundamental data that can be used to develop an effective nutrition intervention program or nutrition policy for adolescents or school food service programs.
C1 [Yim, Hui-Rang] Kyungsung Univ, Dept Food & Nutr, Coll Life & Hlth Sci, 309 Suyeong Ro, Busan 48434, South Korea.
   [Yun, Hyun Ju; Lee, Jee Hye] Univ Ulsan, Coll Human Ecol, Dept Food & Nutr, 93 Daehak Ro, Ulsan 44610, South Korea.
C3 Kyungsung University; University of Ulsan
RP Lee, JH (corresponding author), Univ Ulsan, Coll Human Ecol, Dept Food & Nutr, 93 Daehak Ro, Ulsan 44610, South Korea.
EM hrlim@ks.ac.kr; goidcat@ulsan.ac.kr; lljh2000@ulsan.ac.kr
FU University of Ulsan
FX This work was supported by the 2020 Research Fund of the University of
   Ulsan.
CR Amahmid O, 2020, INT J HEALTH PROMOT, V58, P242, DOI 10.1080/14635240.2019.1685399
   Arganini C, 2012, PUBLIC HEALTH - SOCIAL AND BEHAVIORAL HEALTH, P83
   Arria AM, 2014, NUTR REV, V72, P87, DOI 10.1111/nure.12129
   Baldasso JG, 2016, REV NUTR, V29, P65, DOI 10.1590/1678-98652016000100007
   Barbosa VC, 2014, CIENC SAUDE COLETIVA, V19, P173, DOI 10.1590/1413-81232014191.0446
   Blundell JE, 2003, P NUTR SOC, V62, P651, DOI 10.1079/PNS2003286
   Burrows T, 2017, J HUM NUTR DIET, V30, P117, DOI 10.1111/jhn.12407
   Burton-Freeman B, 2000, J NUTR, V130, p272S, DOI 10.1093/jn/130.2.272S
   Cartwright M, 2003, HEALTH PSYCHOL, V22, P362, DOI 10.1037/0278-6133.22.4.362
   Das JK, 2017, ANN NY ACAD SCI, V1393, P21, DOI 10.1111/nyas.13330
   Drewnowski A, 2004, AM J CLIN NUTR, V79, P6
   Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326
   Epstein LH, 2001, OBES RES, V9, P171, DOI 10.1038/oby.2001.18
   Errisuriz VL, 2016, EAT BEHAV, V22, P211, DOI 10.1016/j.eatbeh.2016.06.008
   Finlayson G, 2009, PHYSIOL BEHAV, V97, P62, DOI 10.1016/j.physbeh.2009.02.002
   Gillman MW, 2001, PREV MED, V32, P295, DOI 10.1006/pmed.2000.0812
   Ha K, 2016, NUTR RES PRACT, V10, P537, DOI 10.4162/nrp.2016.10.5.537
   Harada Tetsuo, 2007, Journal of Physiological Anthropology, V26, P201, DOI 10.2114/jpa2.26.201
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   Hong SA, 2017, CHILD ADOL PSYCH MEN, V11, DOI 10.1186/s13034-017-0194-z
   Huang CJ, 2010, INT J OBESITY, V34, P720, DOI 10.1038/ijo.2009.285
   양영모, 2014, [YAKHAK HOEJI, 약 학 회 지], V58, P387
   Hwang JiYun Hwang JiYun, 2009, Korean Journal of Nutrition, V42, P171, DOI 10.4163/kjn.2009.42.2.171
   Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488
   Inglis V, 2005, APPETITE, V45, P334, DOI 10.1016/j.appet.2005.05.003
   Jääskeläinen A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-321
   Jang HanByul Jang HanByul, 2011, Korean Journal of Nutrition, V44, P416, DOI 10.4163/kjn.2011.44.5.416
   Jeffery RW, 2009, APPETITE, V52, P238, DOI 10.1016/j.appet.2008.08.008
   Jeong J.H., 2001, J KOREAN HOME EC ASS, V39, P111
   Jung BokMi Jung BokMi, 2003, Korean Journal of Community Nutrition, V8, P129
   Kaushik JS, 2011, INDIAN PEDIATR, V48, P97, DOI 10.1007/s13312-011-0035-8
   KHIDI (Korea Health Industry Development Institute), 2015, SUG DAT COMP COMM CO
   Kim HyeSoo Kim HyeSoo, 2014, Journal of Nutrition and Health, V47, P134, DOI 10.4163/jnh.2014.47.2.134
   김재구, 2012, [Journal of Coaching Development, 코칭능력개발지], V14, P115
   Kim SeolA Kim SeolA, 2008, Korean Journal of Nutrition, V41, P786
   Kinard BR, 2012, INT J CONSUM STUD, V36, P23, DOI 10.1111/j.1470-6431.2011.01005.x
   Korea Consumer Agency, 2013, SURV SAF EN DRINK CO
   Korea Consumer Agency, 2013, EN DRINK CAFF CONT M
   Kwon YS, 2018, ASIA PAC J CLIN NUTR, V27, P217, DOI 10.6133/apjcn.032017.09
   Lambert J, 2004, BRIT J NUTR, V92, pS147, DOI 10.1079/BJN20041160
   Lee CY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090567
   Lee MyoungSook Lee MyoungSook, 2018, Journal of Nutrition and Health, V51, P455
   Lien L, 2007, PUBLIC HEALTH NUTR, V10, P422, DOI 10.1017/S1368980007258550
   Lim HJ, 2018, J ACAD NUTR DIET, V118, P1228, DOI 10.1016/j.jand.2017.08.001
   Lluch A, 1998, EUR J CLIN NUTR, V52, P300, DOI 10.1038/sj.ejcn.1600555
   Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x
   Loprinzi PD, 2014, MAYO CLIN PROC, V89, P190, DOI 10.1016/j.mayocp.2013.09.018
   Marques-Vidal P, 2006, INT J OBESITY, V30, P88, DOI 10.1038/sj.ijo.0803045
   Marshall TA, 2013, J AM DENT ASSOC, V144, P1148, DOI 10.14219/jada.archive.2013.0033
   MFDS (Ministry of Food and Drug Safety), 2017, CHECK OUT PHRAS CONT
   Michael SL, 2020, PREV MED REP, V19, DOI 10.1016/j.pmedr.2020.101153
   Moreno-Gómez C, 2012, PUBLIC HEALTH NUTR, V15, P2131, DOI 10.1017/S1368980012000080
   Mullie P, 2010, EUR J CLIN NUTR, V64, P231, DOI 10.1038/ejcn.2009.145
   Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001
   Noonan RJ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061224
   Ock S.M., 2002, J KOREAN ACAD FAM ME, V23, P905
   Oddy WH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5268
   OECD, 2017, RES PROGR INT STUD A
   Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016
   Paans NPG, 2019, APPETITE, V134, P103, DOI 10.1016/j.appet.2018.12.030
   Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x
   Patrick K, 2004, ARCH PEDIAT ADOL MED, V158, P385, DOI 10.1001/archpedi.158.4.385
   Rhew I, 2007, CONTEMP CLIN TRIALS, V28, P472, DOI 10.1016/j.cct.2007.01.002
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Schutz Y., 2000, ENERGY SUBSTRATE BAL, V10, P137
   Shahar D, 2005, NUTRITION, V21, P559, DOI 10.1016/j.nut.2004.09.018
   Shim JS, 2019, NUTR RES PRACT, V13, P134, DOI 10.4162/nrp.2019.13.2.134
   Steptoe A, 2002, PREV MED, V35, P97, DOI 10.1006/pmed.2002.1048
   Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9
   Teegarden SL, 2008, PHYSIOL BEHAV, V93, P713, DOI 10.1016/j.physbeh.2007.11.030
   Wardle J, 2001, J EPIDEMIOL COMMUN H, V55, P185, DOI 10.1136/jech.55.3.185
   WesterterpPlantenga MS, 1997, PHYSIOL BEHAV, V62, P1345, DOI 10.1016/S0031-9384(97)00353-3
   Whitaker KM, 2014, NUTR RES, V34, P294, DOI 10.1016/j.nutres.2014.01.007
   Wijnhoven TMA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-806
   WURTMAN JJ, 1993, J AFFECT DISORDERS, V29, P183, DOI 10.1016/0165-0327(93)90032-F
   Yoo J.S., 2008, J NUTR HLTH, V41, P818
   Yoo JiYeon Yoo JiYeon, 2009, Korean Journal of Community Nutrition, V14, P147
NR 77
TC 9
Z9 9
U1 1
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD SEP
PY 2021
VL 18
IS 18
AR 9773
DI 10.3390/ijerph18189773
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA UX2HV
UT WOS:000700667600001
PM 34574695
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Balasubramanian, GV
   Chuah, KA
   Khor, BH
   Sualeheen, A
   Yeak, ZW
   Chinna, K
   Sundram, K
   Karupaiah, T
AF Balasubramanian, Gaiyal Viliy
   Chuah, Khun-Aik
   Khor, Ban-Hock
   Sualeheen, Ayesha
   Yeak, Zu-Wei
   Chinna, Karuthan
   Sundram, Kalyana
   Karupaiah, Tilakavati
TI Associations of Eating Mode Defined by Dietary Patterns with
   Cardiometabolic Risk Factors in the Malaysia Lipid Study Population
SO NUTRIENTS
LA English
DT Article
DE dietary pattern; sugar-sweetened beverages; home meal; atherogenicity;
   metabolic syndrome
ID HEART-DISEASE; MORTALITY; OBESITY
AB Cardiometabolic risk is scarcely explored related to dietary patterns (DPs) in Asian populations. Dietary data (n= 562) from the cross-sectional Malaysia Lipid Study were used to derive DPs through principal component analysis. Associations of DPs were examined with metabolic syndrome (MetS), atherogenic, inflammation and insulinemic status. Four DPs with distinctive eating modes were Home meal (HM), Chinese traditional (CT), Plant foods (PF) and Sugar-sweetened beverages (SSB). Within DP tertiles (T3 vs. T1), the significantly lowest risk was associated with CT for hsCRP (AOR = 0.44, 95% CI 0.28, 0.70,p< 0.001) levels. However, SSB was associated with the significantly highest risks for BMI (AOR = 2.01, 95% CI 1.28, 3.17,p= 0.003), waist circumference (AOR = 1.81, 95% CI 1.14, 2.87,p= 0.013), small LDL-C particles (AOR= 1.69, 95% CI 1.02, 2.79,p= 0.043), HOMA2-IR (AOR = 2.63, 95% CI 1.25, 5.57,p= 0.011), hsCRP (AOR = 2.21, 95% CI 1.40, 3.50,p= 0.001), and MetS (AOR = 2.78, 95% CI 1.49, 5.22,p= 0.001). Adherence behaviors to SSBs (T3) included consuming coffee/tea with condensed milk (29%) or plain with sugar (20.7%) and eating out (12 +/- 8 times/week,p< 0.001). Overall, the SSB pattern with a highest frequency of eating out was detrimentally associated with cardiometabolic risks.
C1 [Balasubramanian, Gaiyal Viliy; Sualeheen, Ayesha] Univ Kebangsaan Malaysia, Fac Hlth Sci, Dietet Program, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
   [Chuah, Khun-Aik; Yeak, Zu-Wei] Univ Kebangsaan Malaysia, Fac Hlth Sci, Nutr Program, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
   [Khor, Ban-Hock] Univ Kebangsaan Malaysia, Fac Med, Dept Med, Kuala Lumpur 56000, Malaysia.
   [Chinna, Karuthan] Taylors Univ, Fac Hlth & Med Sci, Sch Med, Subang Jaya 47500, Selangor, Malaysia.
   [Sundram, Kalyana] Malaysian Palm Oil Council, Petaling Jaya 46100, Selangor, Malaysia.
   [Karupaiah, Tilakavati] Taylors Univ, Fac Hlth & Med Sci, Sch BioSci, Subang Jaya 47500, Selangor, Malaysia.
C3 Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia;
   Universiti Kebangsaan Malaysia; Taylor's University; Taylor's University
RP Karupaiah, T (corresponding author), Taylors Univ, Fac Hlth & Med Sci, Sch BioSci, Subang Jaya 47500, Selangor, Malaysia.
EM gaiyalviliy@gmail.com; cruise_chuah@hotmail.com; khorbanhock@gmail.com;
   aishaltaf@ymail.com; yeak_wei@hotmail.com; karuthan@gmail.com;
   kalyana@mpoc.org.my; tilly_karu@yahoo.co.uk
RI Karupaiah, Tilakavati/C-9868-2013; Khor, Ban/AAK-1925-2020
OI KARUPAIAH, TILAKAVATI/0000-0001-5808-8074; Sualeheen,
   Ayesha/0000-0002-1391-9644; Khor, Ban Hock/0000-0003-1359-9342
FU Universiti Kebangsaan Malaysia [DLP-2014-017, GUP-2014-057,
   GSP-2013-020]; Malaysian Palm Oil Council [NN-047-2012]
FX This study was funded through the Research University Grants
   (DLP-2014-017, GUP-2014-057, GSP-2013-020) of the Universiti Kebangsaan
   Malaysia and the Malaysian Palm Oil Council (NN-047-2012).
CR Aekplakorn W, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/468759
   Akter S, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-30
   Al Thani M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060698
   Al-Lahou B, 2020, J ACAD NUTR DIET, V120, P424, DOI 10.1016/j.jand.2019.09.012
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Martínez-González MA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111226
   [Anonymous], 2008, MAL COUNTR STUD GUID
   [Anonymous], 2016, NHANES TASK 2 KEY CO
   [Anonymous], 2015, NAT HLTH MORB SURV 2
   [Anonymous], 2005, 1 DATABANK NUTR PRON
   [Anonymous], 2011, Population Distribution by Local Authority Areas and Mukims, 2010: Tables of Local Authority Areas in Selangor
   [Anonymous], 2016, 2015-2020 Dietary Guidelines for Americans. Dietary Guidelines for Americans
   Barbaresko J, 2013, NUTR REV, V71, P511, DOI 10.1111/nure.12035
   BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546
   Chen Y, 2013, INT J CARDIOL, V167, P1495, DOI 10.1016/j.ijcard.2012.04.041
   Collin LJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3121
   Daniel CR, 2014, BRIT J NUTR, V111, P160, DOI 10.1017/S0007114513001864
   Dietary Guidelines Advisory Committee, 2015, REP 2015 DIET GUID A
   Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]
   Eng JY, 2018, J ACAD NUTR DIET, V118, P1249, DOI 10.1016/j.jand.2018.01.014
   Fabiani R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092056
   Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020
   Institute for Health Metrics and Evaluation, 2017, GBD COMP DAT VIS RIS
   Jamal R, 2015, INT J EPIDEMIOL, V44, P423, DOI 10.1093/ije/dyu089
   Kapoor D, 2018, ASIA PAC J CLIN NUTR, V27, P1332, DOI 10.6133/apjcn.201811_27(6).0021
   Karupaiah T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49911-6
   Malik VS, 2019, CIRCULATION, V139, P2113, DOI 10.1161/CIRCULATIONAHA.118.037401
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Mayén AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029
   Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585
   Naja F, 2013, EUR J NUTR, V52, P97, DOI 10.1007/s00394-011-0291-3
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Ocké MC, 2013, P NUTR SOC, V72, P191, DOI 10.1017/S0029665113000013
   Odegaard AO, 2014, AM J CLIN NUTR, V100, P877, DOI 10.3945/ajcn.114.086124
   Rebello SA, 2014, AM J CLIN NUTR, V100, P53, DOI 10.3945/ajcn.113.076273
   Rezagholizadeh F, 2017, NUTR RES, V41, P1, DOI 10.1016/j.nutres.2017.01.006
   Schulze MB, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2396
   Shikany JM, 2015, CIRCULATION, V132, P804, DOI 10.1161/CIRCULATIONAHA.114.014421
   Suliga E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121366
   Syauqy A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020143
   Tharrey M, 2018, INT J EPIDEMIOL, V47, P1603, DOI 10.1093/ije/dyy030
   Wei ZY, 2018, PUBLIC HEALTH NUTR, V21, P2409, DOI [10.1017/S1368980018001088, 10.1017/s1368980018001088]
   Woo HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111593
   World Health Organization (WHO), 2014, Uganda 2014 Report
   Xu SH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040180
   Zuñiga YLM, 2014, BRIT J NUTR, V111, P1118, DOI 10.1017/S0007114513003486
NR 46
TC 11
Z9 11
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUL
PY 2020
VL 12
IS 7
AR 2080
DI 10.3390/nu12072080
PG 21
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA MS4QC
UT WOS:000554261700001
PM 32674327
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Godin, KM
   Chacón, V
   Barnoya, J
   Leatherdale, ST
AF Godin, Katelyn M.
   Chacon, Violeta
   Barnoya, Joaquin
   Leatherdale, Scott T.
TI The school environment and sugar-sweetened beverage consumption among
   Guatemalan adolescents
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Sugar-sweetened beverages; School health; Nutrition policy; Latin
   America
ID DISCONTINUING COFFEE INTAKE; SOFT DRINK CONSUMPTION; DENTAL-CARIES; FOOD
   ENVIRONMENT; CHRONIC DISEASE; RISK; CHILDREN; OBESITY; ASSOCIATION;
   NUTRITION
AB Objective: The current study sought to examine Guatemalan adolescents' consumption of sugar-sweetened beverages (SSB), identify which individuallevel characteristics are associated with SSB consumption and describe school characteristics that may influence students' SSB consumption.
   Design: Within this observational pilot study, a questionnaire was used to assess students' consumption of three varieties of SSB (soft drinks, energy drinks, sweetened coffees/teas), as well as a variety of sociodemographic and behavioural characteristics. We collected built environment data to examine aspects of the school food environment. We developed Poisson regression models for each SSB variety and used descriptive analyses to characterize the sample.
   Setting: Guatemala City, Guatemala.
   Subjects: Guatemalan adolescents (n 1042) from four (two public, two private) secondary schools.
   Results: Built environment data revealed that students from the two public schools lacked access to water fountains/coolers. The SSB industry had a presence in the schools through advertisements, sponsored food kiosks and products available for sale. Common correlates of SSB consumption included school type, sedentary behaviour, frequency of purchasing lunch in the cafeteria, and frequency of purchasing snacks from vending machines in school and off school property.
   Conclusions: Guatemalan adolescents frequently consume SSB, which may be encouraged by aspects of the school environment. Schools represent a viable setting for equitable population health interventions designed to reduce SSB consumption, including increasing access to clean drinking-water, reducing access to SSB, restricting SSB marketing and greater enforcement of existing food policies.
C1 [Godin, Katelyn M.; Leatherdale, Scott T.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
   [Chacon, Violeta; Barnoya, Joaquin] Cardiovasc Surg Unit Guatemala, Guatemala City, Guatemala.
   [Barnoya, Joaquin] Washington Univ, Dept Surg, Div Publ Hlth Sci, St Louis, MO USA.
C3 University of Waterloo; Washington University (WUSTL)
RP Godin, KM (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
EM kmgodin@uwaterloo.ca
RI Leatherdale, Scott/AAE-4515-2022
OI Barnoya, Joaquin/0000-0002-1731-479X; Alcaraz Valencia, Pablo
   Armando/0000-0003-2994-2395; Chacon, Violeta/0000-0003-0529-512X
FU Canadian Institutes of Health Research (CIHR) Institute of Nutrition,
   Metabolism and Diabetes through the 'Obesity - Interventions to Prevent
   or Treat' priority funding awards [OOP-110788]; CIHR Institute of
   Population and Public Health [MOP-114875]; Small Grants for Innovative
   Research and Knowledge-sharing from the International Development
   Research Centre [107467-027]; Public Health Agency of Canada; CIHR;
   Foundation for Barnes-Jewish Hospital
FX The development of the COMPASS system was supported by a bridge grant
   from the Canadian Institutes of Health Research (CIHR) Institute of
   Nutrition, Metabolism and Diabetes through the 'Obesity - Interventions
   to Prevent or Treat' priority funding awards (S.T.L., grant number
   OOP-110788) and an operating grant from the CIHR Institute of Population
   and Public Health (S.T.L., grant number MOP-114875). The COMPASS
   Guatemala Study was funded by the Small Grants for Innovative Research
   and Knowledge-sharing from the International Development Research Centre
   (S.T.L., grant number 107467-027). S.T.L. is a Chair in Applied Public
   Health Research funded by the Public Health Agency of Canada in
   partnership with CIHR. J.B. receives additional support from The
   Foundation for Barnes-Jewish Hospital. These funders had no role in the
   design, analysis or writing of this article.
CR Rivera JA, 2014, LANCET DIABETES ENDO, V2, P321, DOI 10.1016/S2213-8587(13)70173-6
   [Anonymous], GROWTH REF 5 19 YEAR
   Bermudez O.I., 2010, NUTR J, V9, P1
   Bredin C, 2015, 3 COMPASS
   Bredin C, 2014, 2 COMPASS
   Chacon V, 2015, CRIT PUBLIC HEALTH, V25, P291, DOI 10.1080/09581596.2014.953035
   Comision Nacional de Escuelas Saludables Ministerio de Educacion de Guatemala, 2014, ESC SAL DIR GEN FORT
   Dewey KG, 1997, J NUTR, V127, P306, DOI 10.1093/jn/127.2.306
   Engle PL, 1999, EARLY HUM DEV, V53, P251, DOI 10.1016/S0378-3782(98)00080-2
   Fiorito LM, 2010, J AM DIET ASSOC, V110, P543, DOI 10.1016/j.jada.2009.12.027
   Frary CD, 2004, J ADOLESCENT HEALTH, V34, P56, DOI 10.1016/S1054-139X(03)00248-9
   Grimm GC, 2004, J AM DIET ASSOC, V104, P1244, DOI 10.1016/j.jada.2004.05.206
   Harrington S, 2008, J SCH NURS, V24, P3, DOI 10.1622/1059-8405(2008)024[0003:TROSBC]2.0.CO;2
   Heller KE, 2001, J DENT RES, V80, P1949, DOI 10.1177/00220345010800101701
   Herciu AC, 2014, J ALCOHOL DRUG DEPEN, V2, P1
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Johnson DB, 2009, J ADOLESCENT HEALTH, V45, pS30, DOI 10.1016/j.jadohealth.2009.03.008
   Kain J, 2014, CURR OBES REP, V3, P150, DOI 10.1007/s13679-014-0097-8
   Leatherdale ST, 2015, PREV MED, V74, P74, DOI 10.1016/j.ypmed.2015.02.005
   Leatherdale ST, 2015, CANCER CAUSE CONTROL, V26, P519, DOI 10.1007/s10552-015-0529-0
   Leatherdale ST, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-331
   Leatherdale ST, 2014, MEASUREMENT, V50, P331, DOI 10.1016/j.measurement.2014.01.008
   Letona P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-101
   Libuda L, 2009, BRIT J NUTR, V101, P1549, DOI 10.1017/S0007114508094671
   Makkes S, 2011, MATERN CHILD NUTR, V7, P410, DOI 10.1111/j.1740-8709.2010.00249.x
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2009, AM J CLIN NUTR, V89, P438, DOI 10.3945/ajcn.2008.26980
   Mâsse LC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-29
   Mbowe O, 2014, MATERN CHILD HLTH J, V18, P1619, DOI 10.1007/s10995-013-1402-y
   Minaker LM, 2016, AM J HEALTH BEHAV, V40, P21, DOI 10.5993/AJHB.40.1.3
   Montenegro-Bethancourt G, 2010, MATERN CHILD NUTR, V6, P174, DOI 10.1111/j.1740-8709.2009.00193.x
   Montenegro-Bethancourt G, 2009, REV PANAM SALUD PUBL, V25, P146, DOI 10.1590/S1020-49892009000200008
   Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492
   Nagata JM, 2011, ECOL FOOD NUTR, V50, P297, DOI 10.1080/03670244.2011.568911
   Park S, 2010, J AM DIET ASSOC, V110, P1532, DOI 10.1016/j.jada.2010.07.003
   Patte KA, 2017, J PUBLIC HEALTH-UK, V39, P321, DOI 10.1093/pubmed/fdw034
   Pehlke EL, 2016, HEALTH PROMOT INT, V31, P542, DOI 10.1093/heapro/dav011
   Pehlke EL, 2016, ECOL FOOD NUTR, V55, P324, DOI 10.1080/03670244.2016.1161618
   Ramirez-Zea M, 2014, AM J CLIN NUTR, V100, p1644S, DOI 10.3945/ajcn.114.083857
   Rideout K, 2007, CAN J PUBLIC HEALTH, V98, P246, DOI 10.1007/BF03405396
   Secretaria de Seguridad Alimentaria y Nutricional, 2012, PLAN PACT HAMB CER G
   Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845
   Sohn W, 2006, J DENT RES, V85, P262, DOI 10.1177/154405910608500311
   Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S
   Uauy Ricardo, 2004, Food and Nutrition Bulletin, V25, P175
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Warren JJ, 2009, COMMUNITY DENT ORAL, V37, P116, DOI 10.1111/j.1600-0528.2008.00447.x
   WHO, 2003, WHO TECHN REP SER
   Wiecha JL, 2006, J AM DIET ASSOC, V106, P1624, DOI 10.1016/j.jada.2006.07.007
NR 51
TC 30
Z9 32
U1 1
U2 26
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD NOV
PY 2017
VL 20
IS 16
BP 2980
EP 2987
DI 10.1017/S1368980017001926
PG 8
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA FN5IH
UT WOS:000416040100015
PM 28803573
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Maghsoudi, Z
   Ghiasvand, R
   Salehi-Abargouei, A
AF Maghsoudi, Zahra
   Ghiasvand, Reza
   Salehi-Abargouei, Amin
TI Empirically derived dietary patterns and incident type 2 diabetes
   mellitus: a systematic review and meta-analysis on prospective
   observational studies
SO PUBLIC HEALTH NUTRITION
LA English
DT Review
DE Dietary patterns; Type 2 diabetes mellitus; Systematic review;
   Meta-analysis
ID COFFEE CONSUMPTION; RISK; WOMEN; MEN; ASSOCIATION; OBESITY; INDEX; FRUIT
AB Objective To systematically review prospective cohort studies about the association between dietary patterns and type 2 diabetes mellitus (T2DM) incidence, and to quantify the effects using a meta-analysis.
   Design Databases such as PubMed, ISI Web of Science, SCOPUS and Google Scholar were searched up to 15 January 2015. Cohort studies which tried to examine the association between empirically derived dietary patterns and incident T2DM were selected. The relative risks (RR) and their 95 % confidence intervals for diabetes among participants with highest v. lowest adherence to derived dietary patterns were incorporated into meta-analysis using random-effects models.
   Results Ten studies (n 404 528) were enrolled in the systematic review and meta-analysis; our analysis revealed that adherence to the healthy' dietary patterns significantly reduced the risk of T2DM (RR=086; 95 % CI 082, 090), while the unhealthy' dietary patterns adversely affected diabetes risk (RR=130; 95 % CI 118, 143). Subgroup analysis showed that unhealthy dietary patterns in which foods with high phytochemical content were also loaded did not significantly increase T2DM risk (RR=106; 95 % CI 087, 130).
   Conclusions Healthy' dietary patterns containing vegetables, fruits and whole grains can lower diabetes risk by 14 %. Consuming higher amounts of red and processed meats, high-fat dairy and refined grains in the context of unhealthy' dietary patterns will increase diabetes risk by 30 %; while including foods with high phytochemical content in these patterns can modify this effect.
C1 [Maghsoudi, Zahra; Ghiasvand, Reza] Isfahan Univ Med Sci, Food Secur Res Ctr, Esfahan, Iran.
   [Maghsoudi, Zahra; Ghiasvand, Reza] Isfahan Univ Med Sci, Sch Food & Nutr Sci, Dept Community Nutr, Esfahan, Iran.
   [Salehi-Abargouei, Amin] Shahid Sadoughi Univ Med Sci, Nutr & Food Secur Res Ctr, Yazd, Iran.
   [Salehi-Abargouei, Amin] Shahid Sadoughi Univ Med Sci, Fac Hlth, Dept Nutr, POB 887-89165, Yazd, Iran.
C3 Isfahan University of Medical Sciences; Isfahan University of Medical
   Sciences
RP Salehi-Abargouei, A (corresponding author), Shahid Sadoughi Univ Med Sci, Nutr & Food Secur Res Ctr, Yazd, Iran.; Salehi-Abargouei, A (corresponding author), Shahid Sadoughi Univ Med Sci, Fac Hlth, Dept Nutr, POB 887-89165, Yazd, Iran.
EM abargouei@hlth.mui.ac.ir
RI ghiasvand, reza/U-7750-2018; Shirani, Fatemeh/D-7442-2016;
   Salehi-Abargouei, Amin/C-9039-2011
OI ghiasvand, Reza/0000-0002-0755-2575; Salehi-Abargouei,
   Amin/0000-0002-7580-6717
CR Alhazmi A, 2014, J HUM NUTR DIET, V27, P251, DOI 10.1111/jhn.12139
   [Anonymous], 2008, SYSTEMATIC REV HLTH
   Bauer F, 2013, EUR J NUTR, V52, P1127, DOI 10.1007/s00394-012-0423-4
   Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Erber E, 2010, DIABETES CARE, V33, P532, DOI 10.2337/dc09-1621
   Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235
   Halton TL, 2006, AM J CLIN NUTR, V83, P284
   Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hodge AM, 2007, AM J EPIDEMIOL, V165, P603, DOI 10.1093/aje/kwk061
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Jacobs DR, 2003, AM J CLIN NUTR, V78, p508S, DOI 10.1093/ajcn/78.3.508S
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Kuhad A, 2008, LIFE SCI, V83, P128, DOI 10.1016/j.lfs.2008.05.013
   Kuhad A, 2008, EUR J PAIN, V12, P624, DOI 10.1016/j.ejpain.2007.10.008
   Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528
   Montonen J, 2005, AM J EPIDEMIOL, V161, P219, DOI 10.1093/aje/kwi039
   Morimoto A, 2012, ASIA PAC J CLIN NUTR, V21, P601
   Nanri A, 2013, EUR J CLIN NUTR, V67, P18, DOI 10.1038/ejcn.2012.171
   Nettleton JA, 2008, DIABETES CARE, V31, P1777, DOI 10.2337/dc08-0760
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Odegaard AO, 2011, DIABETES CARE, V34, P880, DOI 10.2337/dc10-2350
   Palli D, 2013, DIABETOLOGIA, V56, P47, DOI 10.1007/s00125-012-2718-7
   Sahyoun NR, 2008, AM J CLIN NUTR, V87, P126, DOI 10.1093/ajcn/87.1.126
   Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X
   Sluijs I, 2010, DIABETES CARE, V33, P43, DOI 10.2337/dc09-1321
   Smith B, 2006, DIABETES CARE, V29, P2385, DOI 10.2337/dc06-1084
   Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109
   Thompson S., 2011, THESIS ARIZONA STATE
   Thompson SV, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-23
   van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003
   van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008
   Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.574
   Villegas R, 2010, INT J EPIDEMIOL, V39, P889, DOI 10.1093/ije/dyq008
   Wells GA, 2016, Borrero v. Wells
   Winham D., 2008, Nutrition Today, V43, P201, DOI 10.1097/01.NT.0000303354.21347.45
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
   Zhang Y, 2011, NUTR METAB CARDIOVAS, V21, P418, DOI 10.1016/j.numecd.2009.10.020
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 41
TC 46
Z9 54
U1 2
U2 26
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD FEB
PY 2016
VL 19
IS 2
BP 230
EP 241
DI 10.1017/S1368980015001251
PG 12
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA DH2TR
UT WOS:000372639900005
PM 25917191
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Mwafi, NR
   Al-Rawashdeh, IM
   Al-Kubaisy, WAQ
   Ezzat, WR
   Al-Qazaqi, RA
   Salameh, MH
AF Mwafi, Nesrin Riad
   Al-Rawashdeh, Israa Mohammad
   Al-Kubaisy, Waqar Abdul-Qahar
   Ezzat, Waleed Rifaat
   Al-Qazaqi, Raghad Abdelqader
   Salameh, Mohamed Hashem
TI Prevalence and factors related to obesity and fast food consumption
   among Mutah University students, Jordan
SO JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
LA English
DT Article
DE Fast food; Physical exercise; University students; Body mass index;
   Cross-sectional study
ID RISK
AB Objective:To identify the prevalence and factors related to obesity and fast food consumption among university students.
   Methods: The cross-sectional study was conducted at Mutah University, Al-Karak governorate in southern Jordan, from January to April, 2019, and comprised students recruited from different faculties. Data was collected using a structured, validated questionnaire. Height and weight were measured for body mass index calculation. Data was analysed using SPSS 23.
   Results: Of the 503 students, 278(55.3%) were females. The overall mean age of the sample was 21.62 +/- 2.22 years (range: 19-39 years). Fast food consumption was >= 2 times/week for 299(59.4%) students. The prevalence was significantly higher among students spending >= 21 Jordanian dinar per week (p=0.020) and those who were not performing physical exercise (p=0.025). Significant correlations were found between fast food consumption and fried potato (p<0.001), processed meat products (p<0.001), coffee (p=0.006) and candies (p=0.039). No significant relation was found between fast food consumption and body mass index, religion, gender, field of study or living away from family (p>0.05). The most common reason for consumption was shortage of time 115(38.5%); lunch time was the most preferred time 210(70.2%); 97(32.4%) students were willing to read the nutrient information; and 211(70.5%) were interested in choosing healthy meals.
   Conclusion: The prevalence of fast food consumption among university students was found to be high.
C1 [Mwafi, Nesrin Riad] Mutah Univ, Dept Biochem & Mol Biol, Al Karak, Jordan.
   [Al-Rawashdeh, Israa Mohammad; Al-Kubaisy, Waqar Abdul-Qahar] Mutah Univ, Dept Publ Hlth & Community Med, Al Karak, Jordan.
   [Ezzat, Waleed Rifaat] Mutah Univ, Dept Physiol & Pathol, Al Karak, Jordan.
   [Al-Qazaqi, Raghad Abdelqader; Salameh, Mohamed Hashem] Mutah Univ, Al Karak, Jordan.
C3 Mutah University; Mutah University; Mutah University; Mutah University
RP Mwafi, NR (corresponding author), Mutah Univ, Dept Biochem & Mol Biol, Al Karak, Jordan.
EM drnesrin@mutah.edu.jo
OI Al-Rawashdeh, Israa/0000-0002-5236-1372
CR al-Jadid R., 2018, The Jordan Times
   Al-Otaibi H. H., 2015, Pakistan Journal of Nutrition, V14, P511
   Alfawaz H. A., 2012, Pakistan Journal of Nutrition, V11, P406
   Alsabieh M, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01566
   Anderson B, 2011, PREV CHRONIC DIS, V8
   Bipasha M. S., 2014, South East Asia J. Public Health, V3, P61, DOI DOI 10.3329/SEAJPH.V3I1.17713
   Deivanai DP, 2016, IOSR J BUSINESS MANA, V18, P20
   Department of StatisticsJordan, 2019, EMPL COMP EMPL SURV
   Department of StatisticsJordan, STAT YB JORD 2018
   El-Gilany A. H. A. F., 2016, TAF Preventive Medicine Bulletin, V15, P440
   El-Qudah J. M., 2014, World Applied Sciences Journal, V29, P1213
   Fryar Cheryl D, 2018, NCHS Data Brief, P1
   Goon S., 2014, European Journal of Preventative Medicine, V2, P99, DOI DOI 10.11648/J.EJPM.20140206.14
   Gosliner W, 2011, J SCHOOL HEALTH, V81, P146, DOI 10.1111/j.1746-1561.2010.00573.x
   Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329
   Health Promotion Administration, 2020, body mass index as assessed using effect size
   Jaworowska A, 2013, NUTR REV, V71, P310, DOI 10.1111/nure.12031
   Kayisoglu S, 2014, ACTA ALIMENT HUNG, V43, P53, DOI 10.1556/AAlim.43.2014.1.6
   Salameh P, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00185
   Shaban L, 2019, INT J PREVENTIVE MED, V10, DOI 10.4103/ijpvm.IJPVM_480_18
   Shah T, 2014, J CLIN DIAGN RES, V8, pCC5, DOI 10.7860/JCDR/2014/7908.4351
   Sharifirad G, 2013, J OBES, V2013, DOI 10.1155/2013/147589
   Tayyem Reema F, 2018, Asian Pac J Cancer Prev, V19, P261, DOI 10.22034/APJCP.2018.19.1.261
   WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1
   Xi B, 2015, BRIT J NUTR, V113, P709, DOI 10.1017/S0007114514004383
   Younis F.H., 2019, Journal of Regenerative Biology Medicine, V1, P1, DOI [10.37191/Mapsci-2582-385X-1(1)-005, DOI 10.37191/MAPSCI-2582-385X-1(1)-005]
NR 26
TC 10
Z9 11
U1 1
U2 8
PU PAKISTAN MEDICAL ASSOC
PI KARACHI
PA PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN
SN 0030-9982
J9 J PAK MED ASSOC
JI J. Pak. Med. Assoc.
PD JUN
PY 2021
VL 71
IS 6
BP 1608
EP 1612
DI 10.47391/JPMA.274
PG 5
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA SS5DR
UT WOS:000661775200005
PM 34111082
OA gold
DA 2025-04-28
ER

PT J
AU Iqbal, R
   Iqbal, SP
   Yakub, M
   Tareen, AK
   Iqbal, MP
AF Iqbal, Romaina
   Iqbal, Saleem Perwaiz
   Yakub, Mohsin
   Tareen, Asa Khan
   Iqbal, Mohammad Perwaiz
TI Major dietary patterns and risk of acute myocardial infarction in young,
   urban Pakistani population
SO PAKISTAN JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Acute myocardial infarction; Dietary patterns; Dietary records;
   Pakistani population
ID CORONARY-HEART-DISEASE; RED MEAT; ASSOCIATION; CONSUMPTION; OBESITY
AB Objective: To investigate the role of dietary intake in the development of premature acute myocardial infarction (AMI) in a hospital-based Pakistani population in Karachi.
   Methods: In a case control study, 203 consecutive patients (146 males and 57 females) with their first AMI and age below 45 years were enrolled with informed consent. Similarly, 205 gender and age matched (within 3 years) healthy adults were also included as controls. Dietary intake of both cases and controls was assessed by using a simple 14-item food frequency questionnaire. Using factor analysis, 3 major dietary patterns- prudent dietary pattern, combination dietary pattern and western dietary pattern were identified. Fasting plasma/serum of both cases and controls were analyzed for homocysteine, folate, vitamin B12, blood Pb, ferritin, cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides. ANOVA and conditional logistic regression were used to predict the association of dietary patterns with AMI.
   Results: Consumption of prudent diet, characterized by high consumption of legumes, vegetables, wheat, chicken and fruits, is protective against the risk of premature AMI. Moderate to high consumption of combination diet, characterized by high intake of eggs, fish, fruits, juices and coffee was associated with decreased risk of AMI. No association was observed between western diet, characterized by high intake of meat, fish and tea with milk and risk of AMI.
   Conclusions: Consumption of a prudent dietary pattern and a combination dietary pattern is protective against the risk of AMI in a Pakistani population.
C1 [Iqbal, Romaina; Iqbal, Saleem Perwaiz] New York Inst Technol, Coll Osteopath Med, Dept Community Hlth Sci, Old Westbury, NY 11568 USA.
   [Yakub, Mohsin] New York Inst Technol, Coll Osteopath Med, Dept Biol & Biomed Sci, Old Westbury, NY 11568 USA.
   [Tareen, Asa Khan] Natl Inst Cardiovasc Dis, Karachi, Pakistan.
   [Iqbal, Romaina; Yakub, Mohsin; Iqbal, Mohammad Perwaiz] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi 74800, Pakistan.
C3 New York Institute Technology; New York Institute Technology; Aga Khan
   University
RP Iqbal, MP (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Stadium Rd, Karachi 74800, Pakistan.
EM perwaiz.iqbal@aku.edu
RI Iqbal, Mohammad/I-6763-2015
OI Iqbal, Romaina/0000-0002-5364-4366
FU Pakistan Academy of Sciences/Higher Education Commission
FX Pakistan Academy of Sciences/Higher Education Commission.
CR Ahmed J, 2013, E MEDITERR HEALTH J, V19, P242, DOI 10.26719/2013.19.3.242
   Butt MS, 2009, J AOAC INT, V92, P1277
   Field A, 2012, Discovering Statistics Using SPSS
   Fung TT, 2001, AM J CLIN NUTR, V73, P61
   Grieger JA, 2012, J HUM NUTR DIET, V25, P75, DOI 10.1111/j.1365-277X.2011.01195.x
   Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029
   Holmboe-Ottesen G, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.18891
   Hu FB, 2000, AM J CLIN NUTR, V72, P912
   Hunt JR, 2003, AM J CLIN NUTR, V78, p633S, DOI 10.1093/ajcn/78.3.633S
   Iqbal Mohammad Perwaiz, 2013, PLoS One, V8, pe67981, DOI 10.1371/journal.pone.0067981
   Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716
   Jafary MH, 2007, PAK J MED SCI, V23, P485
   Javed I, 2012, PAK J MED SCI, V28, P143
   Kamath SK, 1999, AM J CLIN NUTR, V69, P621
   Lim JH, 2011, J KOREAN MED SCI, V26, P1201, DOI 10.3346/jkms.2011.26.9.1201
   Moshe G, 2013, J PEDIATR GASTR NUTR, V57, P722, DOI 10.1097/MPG.0b013e3182a80c42
   Olaya GA, 2013, AM J CLIN NUTR, V98, P983, DOI 10.3945/ajcn.112.053595
   Panwar RB, 2011, INDIAN J MED RES, V134, P26
   QUADROS E, 2000, CHEM ANAL SERIES, P311
   Vyas A, 2003, J HUM NUTR DIET, V16, P327, DOI 10.1046/j.1365-277X.2003.00461.x
   Willet W., 1998, NUTR EPIDEMIOLOGY, VSecond
   Yakub M, 2010, J NUTR, V140, P1261, DOI 10.3945/jn.109.120477
   Zobairi SE, 1998, AUST NZ J OBSTET GYN, V38, P188, DOI 10.1111/j.1479-828X.1998.tb02999.x
NR 23
TC 6
Z9 7
U1 0
U2 11
PU PROFESSIONAL MEDICAL PUBLICATIONS
PI SADDAR
PA PANORAMA CENTRE, RM 522, 5TH FLOOR, BLDG 2, RAJA GHAZANFAR ALI RD, PO
   BOX 8766, SADDAR, KARACHI 00000, PAKISTAN
SN 1682-024X
EI 1681-715X
J9 PAK J MED SCI
JI Pak. J. Med. Sci.
PD SEP-OCT
PY 2015
VL 31
IS 5
BP 1213
EP 1218
DI 10.12669/pjms.315.7690
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA CX1KU
UT WOS:000365455900038
PM 26649016
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Zhang, Q
   Jones, S
   Ruhm, CJ
   Andrews, M
AF Zhang, Qi
   Jones, Sonya
   Ruhm, Christopher J.
   Andrews, Margaret
TI Higher Food Prices May Threaten Food Security Status among American
   Low-Income Households with Children
SO JOURNAL OF NUTRITION
LA English
DT Article
ID PHYSICAL-ACTIVITY; HEALTH OUTCOMES; US ADULTS; INSECURITY; CONSUMPTION;
   OBESITY; ECONOMICS; DIETARY; TAX
AB Children in food-insecure households are more likely to experience poorer health function and worse academic achievement. To investigate the relation between economic environmental factors and food insecurity among children, we examined the relation between general and specific food prices (fast food, fruits and vegetables, beverages) and risk of low (LFS) and very low food security (VLFS) status among low-income American households with children. Using information for 27,900 child-year observations from the Early Childhood Longitudinal Study-Kindergarten Class of 1998 1999 linked with food prices obtained from the Cost of Living Data of the Council for Community and Economic Research, formerly known as the American Chamber of Commerce Researchers' Association, fixed effects models were estimated within stratified income groups. Higher overall food prices were associated with increased risk of LFS and VLFS (coefficient = 0.617; P < 0.05). Higher fast food and fruit and vegetable prices also contributed to higher risk of food insecurity (coefficient = 0.632, P < 0.01 for fast food; coefficient = 0.879, P < 0.01 for fruits and vegetables). However, increasing beverage prices, including the prices of soft drinks, orange juice, and coffee, had a protective effect on food security status, even when controlling for general food prices. Thus, although food price changes were strongly related to food security status among low-income American households with children, the effects were not uniform across types of food. These relations should be accounted for when implementing policies that change specific food prices.
C1 [Zhang, Qi] Old Dominion Univ, Sch Community & Environm Hlth, Norfolk, VA 23529 USA.
   [Jones, Sonya] Univ S Carolina, Ctr Res Nutr & Hlth Dispar, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.
   [Ruhm, Christopher J.] Univ Virginia, Frank Batten Sch Leadership & Publ Policy, Charlottesville, VA USA.
   [Andrews, Margaret] USDA, Econ Res Serv, Washington, DC USA.
C3 Old Dominion University; University of South Carolina System; University
   of South Carolina Columbia; University of Virginia; United States
   Department of Agriculture (USDA)
RP Zhang, Q (corresponding author), Old Dominion Univ, Sch Community & Environm Hlth, Norfolk, VA 23529 USA.
EM qzhang@odu.edu
FU USDA/Economic Research Service, Food Assistance and Nutrition Research
   Program [58-5000-0-0089]
FX Supported by the USDA/Economic Research Service, Food Assistance and
   Nutrition Research Program (58-5000-0-0089). All opinions are the
   authors' and do not reflect the official policy of the USDA.
CR Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415
   [Anonymous], 118 USDA EC RES SERV
   [Anonymous], EC INFORM B
   [Anonymous], HLTH PEOPL 2020
   [Anonymous], 2000, Guide to Measuring Household Food Insecurity
   [Anonymous], 2007, HLTH SUST FOOD SYST
   [Anonymous], ERR83 USDA EC RES SE
   [Anonymous], 2002, The state of food insecurity in the world 2001
   Bartfield J, 2006, J POLICY ANAL MANAG, V25, P921, DOI 10.1002/pam.20214
   Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687
   Bureau of Labor and Statistics, 2013, CONS EXP SURV
   Cawley J, 2010, HEALTH AFFAIR, V29, P364, DOI 10.1377/hlthaff.2009.0721
   Census Bureau, 2013, HIST POV TABL
   Cook JT, 2004, J NUTR, V134, P1432
   Dharmasena S, 2012, HEALTH ECON, V21, P669, DOI 10.1002/hec.1738
   DHHS, 2012 HHS POV GUID
   Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S
   Duffey KJ, 2010, ARCH INTERN MED, V170, P420, DOI 10.1001/archinternmed.2009.545
   Fram MS, 2011, J NUTR, V141, P1114, DOI 10.3945/jn.110.135988
   Gregory C, DO FOOD PRICES AFFEC
   Gundersen C, 2011, APPL ECON PERSPECT P, V33, P281, DOI 10.1093/aepp/ppr022
   Jyoti DF, 2005, J NUTR, V135, P2831, DOI 10.1093/jn/135.12.2831
   Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826
   Kuchler F, 2008, Price Trends Are Similar for Fruits, Vegetables, and Snack Foods, V55
   Lakdawalla D, 2009, ECON HUM BIOL, V7, P283, DOI 10.1016/j.ehb.2009.08.001
   Lin BH., 2007, EC INFORM B
   Lipsky LM, 2009, AM J CLIN NUTR, V90, P1397, DOI 10.3945/ajcn.2008.27384
   Liu JH, 2012, CHILD OBES, V8, P440, DOI [10.1089/chi.2011.0090, 10.1089/chi.2012.0090]
   Monsivais P, 2007, J AM DIET ASSOC, V107, P2071, DOI 10.1016/j.jada.2007.09.009
   Monsivais P, 2009, J AM DIET ASSOC, V109, P814, DOI 10.1016/j.jada.2009.02.002
   National Center for Education Statistics, 2013, EARL CHILDH LONG STU
   NORD M, 2004, 42 USDA EC RES SERV
   Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1
   Powell LM, 2009, J HEALTH ECON, V28, P963, DOI 10.1016/j.jhealeco.2009.06.009
   Powell LM, 2009, HEALTH PLACE, V15, P1064, DOI 10.1016/j.healthplace.2009.05.002
   Rickard BJ, 2013, HEALTH ECON, V22, P316, DOI 10.1002/hec.2799
   StataCorp, 2012, STAT SOFTW REL 12 0
   Todd JE, 2010, USDA EC RES SERVICE, V1926
   Yaniv G, 2009, J PUBLIC ECON, V93, P823, DOI 10.1016/j.jpubeco.2009.02.004
   Yen S. T., 2004, Agribusiness (New York), V20, P309, DOI 10.1002/agr.20015
   Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202
   Zhang Q, 2007, INT J EPIDEMIOL, V36, P916, DOI 10.1093/ije/dym064
NR 42
TC 16
Z9 25
U1 0
U2 23
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD OCT
PY 2013
VL 143
IS 10
BP 1659
EP 1665
DI 10.3945/jn.112.170506
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA 298NW
UT WOS:000330331700018
PM 23946342
OA Bronze
DA 2025-04-28
ER

PT J
AU Symonds, ME
   Pope, M
   Bloor, I
   Law, J
   Alagal, R
   Budge, H
AF Symonds, Michael E.
   Pope, Mark
   Bloor, Ian
   Law, James
   Alagal, Reham
   Budge, Helen
TI Adipose tissue growth and development:the modulating role of ambient
   temperature
SO JOURNAL OF ENDOCRINOLOGY
LA English
DT Review
DE adipose tissue; development; nutrition; lipid
ID BROWN FAT; NONSHIVERING THERMOGENESIS; ENERGY-METABOLISM; CAFFEINE;
   THERMOREGULATION; EXPRESSION; MICRORNAS; OBESITY; TRPV1; HOMEOSTASIS
AB Adipose tissue is usually laid down in small amounts in the foetus and is characterised as possessing small amounts of the brown adipose tissue-specific mitochondrial uncoupling protein (UCP)1. In adults, a primary factor determining the abundance and function of UCP1 is ambient temperature. Cold exposure causes activation and the rapid generation of heat through the free flow of protons across the mitochondria with no requirement to convert ADP to ATP. In rodents, housing at an ambient temperature below thermoneutrality promotes the appearance of beige like adipocytes. These arise as discrete regions of UCP1 containing cells in white fat depots. There is increasing evidence to show that to gain credible translational results on brown and beige fat function in rodent models that they should be housed at thermoneutrality. This not only reflects the type of environment in which humans spend a majority of their time, but is in accord with the rise of global temperature caused by industrialisation and the uncontrolled burning of fossil fuels. There is now good evidence in adult humans, that stimulating brown fat can improve glucose homeostasis which can be achieved either by nutritional or pharmacological interventions. The challenge, therefore, is to establish credible developmental models in animals maintained at thermoneutrality which will elucidate the true impact of nutrition. The primary focus should fall specifically on the components of breast milk and how these modulate long term effects on brown or beige fat development and function.
C1 [Symonds, Michael E.; Pope, Mark; Bloor, Ian; Law, James; Budge, Helen] Univ Nottingham, Div Child Hlth Obstet & Gynaecol, Early Life Res Unit, Nottingham, England.
   [Symonds, Michael E.] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England.
   [Symonds, Michael E.] Univ Nottingham, Biomed Res Ctr, Sch Med, Nottingham, England.
   [Alagal, Reham] Princess Nourah Bint AbdulRahman Univ, Dept Phys Sport Sci, Riyadh, Saudi Arabia.
C3 University of Nottingham; University of Nottingham; University of
   Nottingham; Princess Nourah bint Abdulrahman University
RP Symonds, ME (corresponding author), Univ Nottingham, Div Child Hlth Obstet & Gynaecol, Early Life Res Unit, Nottingham, England.; Symonds, ME (corresponding author), Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England.; Symonds, ME (corresponding author), Univ Nottingham, Biomed Res Ctr, Sch Med, Nottingham, England.
EM michael.Symonds@nottingham.ac.uk
RI Alagal, Reham/AAA-1983-2022; Law, James/M-8888-2018
OI Alagal, Reham/0000-0002-8515-1574; Pope, Mark/0000-0003-4576-7814
FU Deanship of Scientific Research at Princess Nourah Bint Abdulrahman
   University through the Fast-track Research Funding Program
FX The research was funded by the Deanship of Scientific Research at
   Princess Nourah Bint Abdulrahman University through the Fast-track
   Research Funding Program.
CR Albustanji L, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00209
   Arany Z, 2019, NEW ENGL J MED, V381, P2270, DOI 10.1056/NEJMcibr1911353
   ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759
   Barreca A, 2020, NAT CLIM CHANGE, V10, P77, DOI 10.1038/s41558-019-0632-4
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671
   BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Cannon B, 2020, EXP PHYSIOL, V105, P1191, DOI 10.1113/EP087875
   Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989
   Clarke L, 1998, EXP PHYSIOL, V83, P651, DOI 10.1113/expphysiol.1998.sp004146
   Cypess AM, 2014, CELL METAB, V20, P408, DOI 10.1016/j.cmet.2014.07.025
   Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f
   Darré L, 2015, MOL PHARMACEUT, V12, P4454, DOI 10.1021/acs.molpharmaceut.5b00641
   de Jong JMA, 2019, NAT METAB, V1, P830, DOI 10.1038/s42255-019-0101-4
   Derbenev AV, 2016, SEMIN IMMUNOPATHOL, V38, P397, DOI 10.1007/s00281-015-0529-x
   Deshmukh AS, 2019, CELL METAB, V30, P963, DOI 10.1016/j.cmet.2019.10.001
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Fainberg HP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27376-3
   Finlin BS, 2020, J CLIN INVEST, V130, P2319, DOI 10.1172/JCI134892
   GIRALT M, 1990, EUR J BIOCHEM, V193, P297, DOI 10.1111/j.1432-1033.1990.tb19336.x
   Gliniak CM, 2019, J CLIN INVEST, V129, P2198, DOI 10.1172/JCI128830
   Ha M, 2008, BBA-GENE REGUL MECH, V1779, P735, DOI 10.1016/j.bbagrm.2008.03.004
   Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889
   Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001
   Icli B, 2017, CARDIOVASC RES, V113, P1024, DOI 10.1093/cvr/cvx098
   Jimenez-Pavon D, 2019, OBESITY, V27, P1932, DOI 10.1002/oby.22635
   Kahn CR, 2019, J CLIN INVEST, V129, P3990, DOI 10.1172/JCI129187
   Kalinovich AV, 2017, BIOCHIMIE, V134, P127, DOI 10.1016/j.biochi.2017.01.007
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843
   Law J, 2019, HANDB EXP PHARMACOL, V251, P259, DOI 10.1007/164_2018_137
   Law J, 2018, J NUCL MED, V59, P516, DOI 10.2967/jnumed.117.190546
   Law JM, 2019, J ENDOCR SOC, V3, P2411, DOI 10.1210/js.2019-00342
   Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010
   Luo ZD, 2012, CELL RES, V22, P551, DOI 10.1038/cr.2011.205
   MELLOR DJ, 1986, Q J EXP PHYSIOL CMS, V71, P361, DOI 10.1113/expphysiol.1986.sp002995
   Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501
   Mostyn A, 2002, FASEB J, V16, P1438, DOI 10.1096/fj.02-0077fje
   Nedergaard J., 1986, BROWN ADIPOSE TISSUE, P152
   O'Mara AE, 2020, J CLIN INVEST, V130, P2209, DOI 10.1172/JCI131126
   Ojha S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87460
   Okamatsu-Ogura Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49754-1
   Protsiv M, 2020, ELIFE, V9, DOI 10.7554/eLife.49555
   Robinson L, 2014, J PEDIATR-US, V164, P318, DOI 10.1016/j.jpeds.2013.10.005
   Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430
   Scotney H, 2017, METABOLISM, V70, P125, DOI 10.1016/j.metabol.2017.01.024
   Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622
   Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362
   Solomon CG, 2019, NEW ENGL J MED, V380, P209, DOI 10.1056/NEJMp1817067
   Song AY, 2020, J CLIN INVEST, V130, P247, DOI 10.1172/JCI129167
   Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8
   Symonds ME, 2012, DIABETOLOGIA, V55, P1597, DOI 10.1007/s00125-012-2505-5
   SYMONDS ME, 1992, P NUTR SOC, V51, P165, DOI 10.1079/PNS19920026
   SYMONDS ME, 1995, EXP PHYSIOL, V80, P907, DOI 10.1113/expphysiol.1995.sp003905
   Symonds ME, 2007, REPROD FERT DEVELOP, V19, P53, DOI 10.1071/RD06130
   Symonds Michael E, 2018, F1000Res, V7, DOI 10.12688/f1000research.14585.1
   Symonds ME, 2018, J ENDOCRINOL, V238, pR53, DOI 10.1530/JOE-18-0084
   Symonds ME, 2015, ANNU REV NUTR, V35, P295, DOI 10.1146/annurev-nutr-071813-105330
   Symonds ME, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/305763
   Symonds ME, 2012, J PEDIATR-US, V161, P892, DOI 10.1016/j.jpeds.2012.04.056
   Velickovic K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45540-1
   Velickovic K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23267-9
   Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136
   Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022
   Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621
   Yu HD, 2019, J CLIN INVEST, V129, P2485, DOI 10.1172/JCI125646
NR 67
TC 6
Z9 7
U1 1
U2 11
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0022-0795
EI 1479-6805
J9 J ENDOCRINOL
JI J. Endocrinol.
PD JAN
PY 2021
VL 248
IS 1
BP R19
EP R28
DI 10.1530/JOE-20-0075
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA PQ1QK
UT WOS:000606323100002
PM 33232264
DA 2025-04-28
ER

PT J
AU Ezoe, M
   Wakamatsu, JI
   Takahata, Y
   Hasegawa, T
   Morimatsu, F
   Nishimura, T
AF Ezoe, Misako
   Wakamatsu, Jun-ichi
   Takahata, Yoshihisa
   Hasegawa, Takanori
   Morimatsu, Fumiki
   Nishimura, Takanori
TI Diet-Induced Thermogenesis and Expression Levels of Thyroid Hormone
   Target Genes and Their Products in Rats Differ between Meat Proteins
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE meat protein; diet-induced thermogenesis; brown adipose tissue; thyroid
   hormone target gene; UCP1
ID BROWN ADIPOSE-TISSUE; BIOACTIVE PEPTIDES; FAT THERMOGENESIS;
   MOLECULAR-BASIS; GREEN TEA; CAFFEINE; OBESITY
AB We compared the effects of purified meat proteins on postprandial thermogenesis and on the secretion of and responsiveness to thyroid hormones (THs) in rats. Body temperatures at 2 h after feeding were significantly higher in the chicken and mutton protein groups than in the other groups, and these proteins seem to have a strong thermogenic effect. There were no significant differences in plasma TH concentrations among the groups, but levels of TH-responsive Spot 14 protein in the liver and brown adipose tissue were significantly higher in the chicken and mutton protein groups than in the other groups. Levels of malic enzyme 1 protein in the liver and brown adipose tissue were significantly higher in the chicken protein group than in the other groups except for the mutton protein group. Furthermore, levels of uncoupling protein 1 were higher in the chicken and mutton protein groups than in the other groups. The results suggest that the difference in postprandial thermogenesis of meat is strongly dependent on meat proteins; chicken and mutton proteins are strong promoters of postprandial thermogenesis, and THs may contribute to this effect. Since strong postprandial thermogenesis and high expression levels of TH target genes and their products were not observed in the amino acid group, chicken and mutton proteins or their digested peptides might contribute to these effects.
C1 [Ezoe, Misako; Wakamatsu, Jun-ichi; Nishimura, Takanori] Hokkaido Univ, Grad Sch Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.
   [Ezoe, Misako; Takahata, Yoshihisa; Hasegawa, Takanori; Morimatsu, Fumiki] Nippon Meat Packer Inc, R&D Ctr, 3-3 Midorigahara, Tsukuba, Ibaraki 3002646, Japan.
C3 Hokkaido University; NH Foods Ltd.
RP Wakamatsu, JI (corresponding author), Hokkaido Univ, Grad Sch Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.
EM jwaka@anim.agr.hokudai.ac.jp
RI Wakamatsu, Jun-ichi/F-6931-2012
OI Wakamatsu, Jun-ichi/0000-0002-3104-3404
CR BLENNEMANN B, 1995, MOL CELL ENDOCRINOL, V110, P1, DOI 10.1016/0303-7207(95)03509-6
   Branco M, 1999, AM J PHYSIOL-ENDOC M, V276, pE179, DOI 10.1152/ajpendo.1999.276.1.E179
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Carlson GL, 1997, BAILLIERE CLIN ENDOC, V11, P603, DOI 10.1016/S0950-351X(97)80878-6
   Collin A, 2005, DOMEST ANIM ENDOCRIN, V29, P78, DOI 10.1016/j.domaniend.2005.02.007
   Cunningham BA, 1998, THYROID, V8, P815, DOI 10.1089/thy.1998.8.815
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947
   Fitzgerald RJ, 2006, INT J DAIRY TECHNOL, V59, P118, DOI 10.1111/j.1471-0307.2006.00250.x
   Gabarrou JF, 1997, BRIT J NUTR, V78, P963, DOI 10.1079/BJN19970212
   GALTON VA, 1991, ENDOCRINOLOGY, V128, P1717, DOI 10.1210/endo-128-4-1717
   Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   GLICK Z, 1989, PHYSIOL BEHAV, V45, P243, DOI 10.1016/0031-9384(89)90125-X
   Jequier E, 1983, Experientia Suppl, V44, P26
   Kagawa Y., 2011, STANDARD TABLES FOOD
   KARST H, 1984, ANN NUTR METAB, V28, P245, DOI 10.1159/000176811
   Kastner J., 2009, Chinese Nutrition Therapy: Dietetics in Traditional Chinese Medicine (TCM), Vsecond
   Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266
   Kodera T, 2006, J FOOD SCI, V71, pC164, DOI 10.1111/j.1365-2621.2006.tb15612.x
   Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012
   LIAW CW, 1984, J BIOL CHEM, V259, P7253
   Nihon chui shokuyo gakkai, 2009, YAK ZEN HDB
   OBREGON MJ, 1989, AM J PHYSIOL, V257, pE625, DOI 10.1152/ajpendo.1989.257.5.E625
   Obregon MJ, 1996, ENDOCRINOLOGY, V137, P4721, DOI 10.1210/en.137.11.4721
   RABELO R, 1995, ENDOCRINOLOGY, V136, P1003, DOI 10.1210/en.136.3.1003
   Rizzello CG, 2005, J DAIRY SCI, V88, P2348, DOI 10.3168/jds.S0022-0302(05)72913-1
   ROTHWELL NJ, 1983, HORM METAB RES, V15, P394, DOI 10.1055/s-2007-1018733
   Saito M, 2013, CURR OPIN LIPIDOL, V24, P71, DOI 10.1097/MOL.0b013e32835a4f40
   Scott CB, 2005, NUTRITION, V21, P874, DOI 10.1016/j.nut.2004.12.010
   Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005
   SILVA JE, 1988, MOL ENDOCRINOL, V2, P706, DOI 10.1210/mend-2-8-706
   Wakamatsu J, 2013, J NUTR SCI VITAMINOL, V59, P516, DOI 10.3177/jnsv.59.516
   Wakamatsu J, 2013, ANIM SCI J, V84, P416, DOI 10.1111/asj.12013
   Wang WY, 2005, COMPR REV FOOD SCI F, V4, P63, DOI 10.1111/j.1541-4337.2005.tb00075.x
   Westerterp Klaas R, 2004, Nutr Metab (Lond), V1, P5
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097
NR 39
TC 6
Z9 7
U1 0
U2 7
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD APR
PY 2016
VL 62
IS 2
BP 93
EP 100
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DL1AE
UT WOS:000375363500004
PM 27264093
OA gold
DA 2025-04-28
ER

PT J
AU Rohde, K
   Keller, M
   Poulsen, LL
   Ronningen, T
   Stumvoll, M
   Tönjes, A
   Kovacs, P
   Horstmann, A
   Villringer, A
   Blüher, M
   Böttcher, Y
AF Rohde, Kerstin
   Keller, Maria
   Poulsen, Lars la Cour
   Ronningen, Torunn
   Stumvoll, Michael
   Toenjes, Anke
   Kovacs, Peter
   Horstmann, Annette
   Villringer, Arno
   Blueher, Matthias
   Boettcher, Yvonne
TI (Epi)genetic regulation of CRTC1 in human eating behaviour and
   fat distribution
SO EBIOMEDICINE
LA English
DT Article
DE CRTC1; rs7256986; DNA methylation; Fat distribution; Eating behaviour
ID TRANSCRIPTIONAL COACTIVATOR 1; GENE-BODY METHYLATION; ADIPOSE-TISSUE;
   CREB; POLYMORPHISMS; ASSOCIATION
AB Background: In brain, CREB-regulated transcription co-activator 1 (CRTC1) is involved in metabolic dysregulation. In humans a SNP in CRTC1 was associated to body fat percentage and two SNPs affected RNA Pol II binding and chromatin structure, implying epigenetic regulation of CRTC1. We sought to understand the relevance of CRTC1 SNPs, DNA methylation and expression in human eating behaviour and its relationship to clinical variables of obesity in blood and adipose tissue.
   Methods: 13 CRTC1 SNPs were included to analyze eating behaviour. For rs7256986, follow up association analyses were applied on DNA methylation, CRTC1 expression and clinical parameters. Linear regression was used throughout the study adjusted for age, sex and BMI. Besides data extraction from previous work, rs7256986 was de-novo genotyped and DNA methylation was evaluated by using pyrosequencing.
   Findings: We found several SNPs in the CRTC1 locus nominally associated with human eating behaviour or 2hr postprandial insulin levels and observed a correlation with alcohol and coffee intake (all P< 0.05). G-allele carriers of rs7256986 showed slightly increased hip circumference. We showed that rs7256986 represents a methylation quantitative trait locus (meQTL) in whole blood and adipose tissue. The presence of the SNP and/or DNA methylation correlated with CRTCI gene expression which in turn, related to BMI and fat distribution.
   Interpretation: Our data support the known role of CRCT1 regulating energy metabolism in brain. Here, we highlight relevance of CRTC1 regulation in blood and adipose tissue. (C) 2019 Published by Elsevier B.V.
C1 [Rohde, Kerstin; Boettcher, Yvonne] Univ Oslo, Inst Clin Med, Oslo, Norway.
   [Rohde, Kerstin; Poulsen, Lars la Cour; Ronningen, Torunn; Boettcher, Yvonne] Akershus Univ Sykehus, Dept Clin Mol Biol, Postboks 1000, N-1478 Lorenskog, Norway.
   [Rohde, Kerstin; Keller, Maria; Kovacs, Peter; Blueher, Matthias; Boettcher, Yvonne] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany.
   [Stumvoll, Michael; Toenjes, Anke; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany.
   [Horstmann, Annette; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.
   [Villringer, Arno] Univ Leipzig, Clin Cognit Neurol, Leipzig, Germany.
C3 University of Oslo; Leipzig University; Leipzig University; Max Planck
   Society; Leipzig University
RP Böttcher, Y (corresponding author), Akershus Univ Sykehus, Dept Clin Mol Biol, Postboks 1000, N-1478 Lorenskog, Norway.
EM Kerstin.Rohde@medizin.uni-leipzig.de;
   Maria.Keller@medizin.uni-leipzig.de; l.l.c.poulsen@medisin.uio.no;
   torunn.ronningen@medisin.uio.no;
   Michael.Stumvoll@medizin.uni-leipzig.de;
   Anke.Toenjes@medizin.uni-leipzig.de;
   Peter.Kovacs@medizin.uni-leipzig.de;
   Annette.Horstmann@medizin.uni-leipzig.de;
   Arno.Villringer@medizin.uni-leipzig.de;
   Matthias.Blueher@medizin.uni-leipzig.de; yvonne.bottcher@medisin.uio.no
RI Keller, Maria/AAD-4877-2020; Stumvoll, Michael/ABE-1121-2021; Horstmann,
   Annette/C-9083-2011
OI Kovacs, Peter/0000-0002-0290-5423; Ronningen,
   Torunn/0009-0002-2452-0871; la Cour Poulsen, Lars/0000-0001-5406-3945;
   Tonjes, Anke/0009-0005-1944-1812; Villringer, Arno/0000-0003-2604-2404;
   Stumvoll, Michael/0000-0001-6225-8240; Horstmann,
   Annette/0000-0001-6184-8484
FU IFB AdiposityDiseases [ADI-K50D, ADI K6e-97, K403, K737, AD2-7123,
   AD2-060E, AD2-06E95]; Federal Ministry of Education and Research (BMBF),
   Germany [FKZ: 01EO1501]; EU-Scientia Fellowship (Marie Sklodowska-Curie
   action from the University of Oslo, Norway (FP7-PEOPLE-2013-COFUND));
   European Union Seventh Framework Programme (FP7-PEOPLE-2013-COFUND)
   [n609020]; Helse-SorOst, Norway grant; Kompetenznetz Adipositas -
   Federal Ministry of Education and Research (BMBF, Germany: German
   Obesity Biomaterial Bank) [FKZ 01GI1128]; Deutsche
   Forschungsgemeinschaft for a Collaborative Research Center, Germany [CRC
   1052/1, CRC 1052/2]; German Diabetes Association
FX This work was supported by research grants from the IFB
   AdiposityDiseases: ADI-K50D and ADI K6e-97 to YB; K403, K737 and
   AD2-7123 to AT and AD2-060E and AD2-06E95 to PK. The IFB
   AdiposityDiseases is supported by the Federal Ministry of Education and
   Research (BMBF), Germany, FKZ: 01EO1501. KR received a personal
   EU-Scientia Fellowship (Marie Sklodowska-Curie action from the
   University of Oslo, Norway (FP7-PEOPLE-2013-COFUND)). The research
   leading to the results has received funding from the European Union
   Seventh Framework Programme (FP7-PEOPLE-2013-COFUND) under agreement
   n609020-Scientia Fellows. LlCP was funded by a Helse-SorOst, Norway
   grant to YB. Further support leading to the results of this work came
   from the Kompetenznetz Adipositas to MB (Competence network for Obesity)
   funded by the Federal Ministry of Education and Research (BMBF, Germany:
   German Obesity Biomaterial Bank; FKZ 01GI1128). A grant by the Deutsche
   Forschungsgemeinschaft for a Collaborative Research Center, Germany (CRC
   1052/1 and/2) further supported this work: "Obesity mechanisms" (A1 to
   AT and MS; B1 to MB and B3 to PK). Further support was given by the
   German Diabetes Association (to AT). The funders had no role in any
   aspect pertinent to the study.
CR Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866
   Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533
   Breuillaud L, 2012, BIOL PSYCHIAT, V72, P528, DOI 10.1016/j.biopsych.2012.04.011
   Castellano JM, 2010, BRAIN RES, V1364, P129, DOI 10.1016/j.brainres.2010.08.057
   Ch'ng TH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00048
   Choong E, 2013, JAMA PSYCHIAT, V70, P1011, DOI 10.1001/jamapsychiatry.2013.187
   de Lauzon B, 2004, J NUTR, V134, P2372
   Escoubas CC, 2017, TRENDS GENET, V33, P303, DOI 10.1016/j.tig.2017.03.002
   Gao WW, 2018, BBA-GENE REGUL MECH, V1861, P211, DOI 10.1016/j.bbagrm.2018.01.021
   Gast MT, 2013, BRAIN BEHAV, V3, P495, DOI 10.1002/brb3.151
   Hill MJ, 2016, MOL ENDOCRINOL, V30, P104, DOI 10.1210/me.2015-1237
   Jagannath A, 2013, CELL, V154, P1100, DOI 10.1016/j.cell.2013.08.004
   Keller M, 2018, FASEB J, V32, P6898, DOI 10.1096/fj.201800528R
   Keller M, 2017, MOL METAB, V6, P86, DOI 10.1016/j.molmet.2016.11.003
   Kim GH, 2015, MOL METAB, V4, P227, DOI 10.1016/j.molmet.2014.12.006
   Kim H, 2016, SCI REP, V6, P84
   Klöting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009
   Lu Y, 2016, NAT COMMUN, V7, P889
   Malm HA, 2016, MOL CELL ENDOCRINOL, V424, P23, DOI 10.1016/j.mce.2016.01.010
   Parra-Damas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18215-y
   Prats-Puig A, 2016, CLIN CHEM, V62, P476, DOI 10.1373/clinchem.2015.249136
   Pudel V, 1989, FRAGEBOGEN ZUM ESSVE
   Quteineh L, 2016, J AFFECT DISORDERS, V198, P43, DOI 10.1016/j.jad.2016.03.031
   Rossetti C, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0023-4
   STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8
   Tönjes A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004854
   Uchida S, 2017, TRENDS GENET, V33, P303
   Uchida S, 2017, CELL REP, V18, P352, DOI 10.1016/j.celrep.2016.12.052
   Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65
   Watts AG, 2011, J NEUROENDOCRINOL, V23, P754, DOI 10.1111/j.1365-2826.2011.02178.x
   Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340
   Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028
   Zhou SS, 2017, ONCOTARGET, V8, P34652, DOI 10.18632/oncotarget.16147
NR 33
TC 14
Z9 14
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUN
PY 2019
VL 44
BP 476
EP 488
DI 10.1016/j.ebiom.2019.05.050
PG 13
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA IF0LQ
UT WOS:000472768900050
PM 31153815
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Cherniack, EP
AF Cherniack, E. Paul
TI Polyphenols: Planting the seeds of treatment for the metabolic syndrome
SO NUTRITION
LA English
DT Review
DE Polyphenol; Metabolic syndrome
ID GREEN TEA POLYPHENOL; PULP PREPARATION RICH; MEDIATED OXIDATIVE STRESS;
   INSOLUBLE DIETARY FIBER; REDUCES BLOOD-PRESSURE; INSULIN-RESISTANCE;
   CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; PROINFLAMMATORY CYTOKINES;
   ADIPOCYTE DIFFERENTIATION
AB Greater understanding about the pathogenesis of metabolic syndrome and potential causes suggests that plant polyphenols might be useful as a treatment. Dietary excess energy can be stored in adipocytes, leading to the release of proinflammatory cytokines and adipose-related hormones that cause vascular injury. Plant polyphenols, organic compounds found in numerous plant species and their fruits, are being actively studied as potential treatments for components of the metabolic syndrome. Individual polyphenols that have been examined include resveratrol, quercetin, epigallocathechin-3-gallate, and curcumin. Resveratrol lowers weight, blood pressure, glucose, and insulin resistance in rodents, and a human trial is currently underway. Quercetin decreases lipid and glucose levels in obese rats, and in a human investigation of subjects with the metabolic syndrome has lowered blood pressure without significant alteration of lipids. Epigallocathechin-3-gallate-induced weight loss has attenuated glucose levels and insulin resistance in rodents and improved hemoglobin A(1c) and lipid in human studies. Plant extracts also can be used. Grape seed and chokeberry extracts have decreased blood pressure and lipid levels in small human trials. Other human investigations have shown the beneficial effects of cocoa, coffee, carob, and Momordica charantia. Thus far, most studies have involved a small number of subjects and have been of short duration. Future studies should be designed to account for a disease process in which the pathogenic factors may take place for years before disease manifestations take place, the possibly limited bioavailability of polyphenols, and the potential need to provide combinations or modifications of polyphenols. Published by Elsevier Inc.
C1 [Cherniack, E. Paul] Univ Miami, Miller Sch Med, Dept Med, Geriatr Inst,Div Gerontol & Geriatr Med, Miami, FL 33136 USA.
   [Cherniack, E. Paul] Bruce W Carter Vet Affairs Med Ctr, Miami, FL USA.
C3 University of Miami
RP Cherniack, EP (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Geriatr Inst,Div Gerontol & Geriatr Med, Miami, FL 33136 USA.
EM evan.cherniack@va.gov
CR Ahn J, 2008, J HEPATOL, V49, P1019, DOI 10.1016/j.jhep.2008.08.012
   Alexopoulos N, 2008, EUR J CARDIOV PREV R, V15, P300, DOI 10.1097/HJR.0b013e3282f4832f
   Altschuler JA, 2007, DIABETES CARE, V30, P813, DOI 10.2337/dc06-1871
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   Anderson RA, 2008, P NUTR SOC, V67, P48, DOI 10.1017/S0029665108006010
   [Anonymous], P EXP BIOL AN CA
   [Anonymous], PRESENTED AT THE 90T
   [Anonymous], NUTRITION
   [Anonymous], MOL CELL ENDOCRINOL
   [Anonymous], ARTERIOSCLER THROMB
   [Anonymous], NUTRITION
   Baiges I, 2010, MOL CELL PROTEOMICS, V9, P1499, DOI 10.1074/mcp.M000055-MCP201
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007
   Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x
   Berrougui H, 2009, ATHEROSCLEROSIS, V207, P420, DOI 10.1016/j.atherosclerosis.2009.05.017
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Boots AW, 2008, NUTRITION, V24, P703, DOI 10.1016/j.nut.2008.03.023
   Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
   Broncel M, 2010, MED SCI MONITOR, V16, pCR28
   Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727
   Campia U, 2008, J AM COLL CARDIOL, V51, P2150, DOI 10.1016/j.jacc.2008.02.058
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chou E, 2002, CIRCULATION, V105, P373, DOI 10.1161/hc0302.102143
   Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437
   Dans AML, 2007, J CLIN EPIDEMIOL, V60, P554, DOI 10.1016/j.jclinepi.2006.07.009
   Desch S, 2010, AM J HYPERTENS, V23, P97, DOI 10.1038/ajh.2009.213
   Djousse L., 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P124
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Egert S, 2010, J NUTR, V140, P278, DOI 10.3945/jn.109.117655
   Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   Fischer-Posovszky P, 2010, AM J CLIN NUTR, V92, P5, DOI 10.3945/ajcn.2009.28435
   Floyd ZE, 2008, METABOLISM, V57, pS32, DOI 10.1016/j.metabol.2008.04.006
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u
   Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17
   Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862
   Gruendel S, 2006, J NUTR, V136, P1533, DOI 10.1093/jn/136.6.1533
   Gruendel S, 2007, BRIT J NUTR, V98, P1170, DOI 10.1017/S0007114507777127
   Gruendel S, 2007, BRIT J NUTR, V98, P101, DOI 10.1017/S0007114507701642
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Heiss C, 2010, J AM COLL CARDIOL, V56, P218, DOI 10.1016/j.jacc.2010.03.039
   Hininger-Favier I, 2009, J AM COLL NUTR, V28, P355, DOI 10.1080/07315724.2009.10718097
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Huang KC, 2008, OBESITY, V16, P684, DOI 10.1038/oby.2007.112
   Jia L, 2010, AM J CLIN NUTR, V92, P218, DOI 10.3945/ajcn.2009.28202
   Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215
   Kim HY, 2010, BRIT J NUTR, V103, P502, DOI 10.1017/S0007114509991978
   Kim NH, 2008, PFLUG ARCH EUR J PHY, V457, P293, DOI 10.1007/s00424-008-0537-y
   Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x
   Kovacs P, 2007, DIABETES, V56, P3095, DOI 10.2337/db06-1647
   Lee DH, 2007, PANCREAS, V35, P53, DOI 10.1097/01.mpa.0000278676.58491.ef
   Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200
   Li HL, 2006, FREE RADICAL BIO MED, V40, P1756, DOI 10.1016/j.freeradbiomed.2006.01.005
   Li RW, 2006, J ETHNOPHARMACOL, V104, P24, DOI 10.1016/j.jep.2005.08.045
   Lin J, 2005, OBES RES, V13, P982, DOI 10.1038/oby.2005.115
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Marshall Stephen, 2006, Sci STKE, V2006, pre7
   Martínez-Flórez S, 2005, J NUTR, V135, P1359, DOI 10.1093/jn/135.6.1359
   Morishita R, 1998, J Atheroscler Thromb, V4, P128
   Muthusamy VS, 2010, BRIT J NUTR, P1
   Nerurkar PV, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-34
   Palsamy P, 2008, BIOMED PHARMACOTHER, V62, P598, DOI 10.1016/j.biopha.2008.06.037
   Palsamy P, 2010, CHEM-BIOL INTERACT, V186, P200, DOI 10.1016/j.cbi.2010.03.028
   Palsamy P, 2010, J CELL PHYSIOL, V224, P423, DOI 10.1002/jcp.22138
   Peng N, 2009, J AGR FOOD CHEM, V57, P7268, DOI 10.1021/jf901169y
   Pérez YY, 2007, AM J CHINESE MED, V35, P1037, DOI 10.1142/S0192415X07005491
   Pinent M, 2005, INT J OBESITY, V29, P934, DOI 10.1038/sj.ijo.0802988
   Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006
   Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812
   Ramadan G, 2009, BRIT J NUTR, V102, P1611, DOI 10.1017/S000711450999208X
   Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315
   Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027
   Robich MP, 2010, SURGERY, V148, P453, DOI 10.1016/j.surg.2010.04.013
   Rocha KKR, 2009, FOOD CHEM TOXICOL, V47, P1362, DOI 10.1016/j.fct.2009.03.010
   Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208
   Scalbert Augustin, 2000, Journal of Nutrition, V130, p2073S
   Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987
   Sivaprakasapillai B, 2009, METABOLISM, V58, P1743, DOI 10.1016/j.metabol.2009.05.030
   Skoczynska A, 2007, PHARMACOL REP, V59, P177
   Solà R, 2010, ATHEROSCLEROSIS, V211, P630, DOI 10.1016/j.atherosclerosis.2010.03.010
   Szkudelska K, 2009, J STEROID BIOCHEM, V113, P17, DOI 10.1016/j.jsbmb.2008.11.001
   Tongia Abhishek, 2004, Indian Journal of Physiology and Pharmacology, V48, P241
   Vachharajani V, 2009, IUBMB LIFE, V61, P424, DOI 10.1002/iub.169
   Valcheva-Kuzmanova S, 2007, PLANT FOOD HUM NUTR, V62, P19, DOI 10.1007/s11130-006-0036-2
   Vanschoonbeek K, 2006, J NUTR, V136, P977, DOI 10.1093/jn/136.4.977
   Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003
   Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711
   Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330
   Yu SW, 2008, MOL CANCER THER, V7, P2609, DOI 10.1158/1535-7163.MCT-07-2400
   Zern TL, 2005, J NUTR, V135, P1911, DOI 10.1093/jn/135.8.1911
   Ziegenfuss TN, 2006, J INT SOC SPORT NUTR, V3, DOI 10.1186/1550-2783-3-2-45
NR 97
TC 93
Z9 110
U1 2
U2 30
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD JUN
PY 2011
VL 27
IS 6
BP 617
EP 623
DI 10.1016/j.nut.2010.10.013
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA V44LJ
UT WOS:000209750200001
PM 21367579
DA 2025-04-28
ER

PT J
AU Hodgson, AB
   Randell, RK
   Jeukendrup, AE
AF Hodgson, Adrian B.
   Randell, Rebecca K.
   Jeukendrup, Asker E.
TI The Effect of Green Tea Extract on Fat Oxidation at Rest and during
   Exercise: Evidence of Efficacy and Proposed Mechanisms
SO ADVANCES IN NUTRITION
LA English
DT Review
ID CATECHOL-O-METHYLTRANSFERASE; 24-H ENERGY-EXPENDITURE; DIET-INDUCED
   OBESITY; SKELETAL-MUSCLE; BODY-WEIGHT; INSULIN SENSITIVITY; ENDURANCE
   EXERCISE; GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; LIPID UTILIZATION
AB Green tea is made from the leaves of the Camellia sinensis L plant, which is rich in polyphenol catechins and caffeine. There is increasing interest in the potential role of green tea extract (GTE) in fat metabolism and its influence on health and exercise performance. A number of studies have observed positive effects of GTE on fat metabolism at rest and during exercise, following both shorter and longer term intake. However, overall, the literature is inconclusive. The fact that not all studies observed effects may be related to differences in study designs, GTE bioavailability, and variation of the measurement (fat oxidation). In addition, the precise mechanisms of GTE in the human body that increase fat oxidation are unclear. The often-cited in vitro catechol-O-methyltransferase mechanism is used to explain the changes in substrate metabolism with little in vivo evidence to support it. Also, changes in expression of fat metabolism genes with longer term GTE intake have been implicated at rest and with exercise training, including the upregulation of fat metabolism enzyme gene expression in the skeletal muscle and downregulation of adipogenic genes in the liver. The exact molecular signaling that activates changes to fat metabolism gene expression is unclear but may be driven by PPAR-gamma coactivator 1-alpha and PPARs. However, to date, evidence from human studies to support these adaptations is lacking. Clearly, more studies have to be performed to elucidate the effects of GTE on fat metabolism as well as improve our understanding of the underlying mechanisms. Adv. Nutr. 4: 129-140, 2013.
C1 [Hodgson, Adrian B.; Randell, Rebecca K.; Jeukendrup, Asker E.] Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Edgbaston, England.
C3 University of Birmingham
RP Jeukendrup, AE (corresponding author), Univ Birmingham, Human Performance Lab, Sch Sport & Exercise Sci, Edgbaston, England.
EM a.e.jeukendrup@bham.ac.uk
RI Jeukendrup, Asker/D-1770-2010
FU Unilever
FX A. B. Hodgson, R. K. Randell, and A. E. Jeukendrup, no conflicts of
   interest. ABH and RKR work is funded by Unilever. AEJ is currently
   employed at PepsiCo (at the University of Birmingham at the time of the
   study) and the views in this paper do not necessarily reflect those of
   PepsiCo.
CR Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005
   Achten J, 2003, INT J SPORTS MED, V24, P603, DOI 10.1055/s-2003-43265
   Astill C, 2001, J AGR FOOD CHEM, V49, P5340, DOI 10.1021/jf010759+
   Astrup A, 2011, OBES REV, V12, P859, DOI 10.1111/j.1467-789X.2011.00894.x
   Astrup A, 1999, AM J CLIN NUTR, V69, P1117
   Aura Anna-Marja, 2008, Phytochemistry Reviews, V7, P407, DOI 10.1007/s11101-008-9095-3
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Carter J, 2002, EUR J APPL PHYSIOL, V86, P435, DOI 10.1007/s00421-001-0572-2
   Chen D, 2005, BIOCHEM PHARMACOL, V69, P1523, DOI 10.1016/j.bcp.2005.01.024
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chow HHS, 2011, PHARMACOL RES, V64, P105, DOI 10.1016/j.phrs.2011.05.007
   Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001
   Danesi F, 2009, BRIT J NUTR, V101, P1736, DOI 10.1017/S0007114508145871
   Dean S, 2009, INT J SPORT NUTR EXE, V19, P624, DOI 10.1123/ijsnem.19.6.624
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eichenberger P, 2009, INT J VITAM NUTR RES, V79, P24, DOI 10.1024/0300-9831.79.1.24
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Friedrich M, 2011, INT J OBES LOND, V36, P735
   Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270
   Gonzalez JT, 2012, BRIT J NUTR, V107, P339, DOI 10.1017/S0007114511006684
   Goodpaster BH, 2003, DIABETES, V52, P2191, DOI 10.2337/diabetes.52.9.2191
   Goodpaster Bret H, 2002, Curr Diab Rep, V2, P216, DOI 10.1007/s11892-002-0086-2
   Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002
   Graham TE, 2008, APPL PHYSIOL NUTR ME, V33, P1311, DOI 10.1139/H08-129
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Harada U, 2004, J HEALTH SCI, V51, P7
   Haramizu S, 2011, J APPL PHYSIOL, V111, P1654, DOI 10.1152/japplphysiol.01434.2010
   Hawley JA, 2011, J APPL PHYSIOL, V110, P834, DOI 10.1152/japplphysiol.00949.2010
   Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003
   Horowitz JF, 1997, AM J PHYSIOL-ENDOC M, V273, pE768, DOI 10.1152/ajpendo.1997.273.4.E768
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Ichinose T, 2011, SCAND J MED SCI SPOR, V21, P598, DOI 10.1111/j.1600-0838.2009.01077.x
   Jeukendrup AE, 2011, OBES REV, V12, P841, DOI 10.1111/j.1467-789X.2011.00908.x
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004
   Kim HJ, 2009, PHYTOTHER RES, V23, P467, DOI 10.1002/ptr.2647
   KLEMETSDAL B, 1994, EUR J CLIN PHARMACOL, V46, P231
   Kroon PA, 2004, AM J CLIN NUTR, V80, P15
   Lee Kookkyung, 2004, J Vet Sci, V5, P325
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   LEIJTEN PAA, 1984, J PHYSIOL-LONDON, V357, P327, DOI 10.1113/jphysiol.1984.sp015502
   Li RW, 2006, J ETHNOPHARMACOL, V104, P24, DOI 10.1016/j.jep.2005.08.045
   Lonac MC, 2011, OBESITY, V19, P298, DOI 10.1038/oby.2010.181
   Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Männistö PT, 1999, PHARMACOL REV, V51, P593
   MCLEOD HL, 1994, J PHARMACOL EXP THER, V270, P26
   Meyer T, 2009, SCAND J MED SCI SPOR, V19, P213, DOI 10.1111/j.1600-0838.2008.00775.x
   Mora-Rodriguez R, 2000, AM J PHYSIOL-ENDOC M, V278, pE669, DOI 10.1152/ajpendo.2000.278.4.E669
   Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Murase T, 2008, AM J PHYSIOL-REG I, V295, pR281, DOI 10.1152/ajpregu.00880.2007
   Nagai M, 2004, DRUG METAB DISPOS, V32, P497, DOI 10.1124/dmd.32.5.497
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Ota N, 2005, J HEALTH SCI, V51, P233, DOI 10.1248/jhs.51.233
   Qin BL, 2010, MOL NUTR FOOD RES, V54, pS14, DOI 10.1002/mnfr.200900306
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Randell R, 2012, MED SCI SPO IN PRESS
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Sale C, 2006, INT J OBESITY, V30, P764, DOI 10.1038/sj.ijo.0803209
   Schneider K, 2004, REGUL TOXICOL PHARM, V39, P334, DOI 10.1016/j.yrtph.2004.03.001
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   STRALFORS P, 1983, J BIOL CHEM, V258, P5146
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   TOUBRO S, 1995, INT J OBESITY, V19, P544
   van Loon LJC, 2004, J APPL PHYSIOL, V97, P1170, DOI 10.1152/japplphysiol.00368.2004
   Venables MC, 2005, J APPL PHYSIOL, V98, P160, DOI 10.1152/japplphysiol.00662.2003
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Weltan SM, 1998, AM J PHYSIOL-ENDOC M, V274, pE83, DOI 10.1152/ajpendo.1998.274.1.E83
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   White MD, 1996, J APPL PHYSIOL, V80, P133, DOI 10.1152/jappl.1996.80.1.133
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Yeo WK, 2011, APPL PHYSIOL NUTR ME, V36, P12, DOI 10.1139/H10-089
   Zhu BT, 2001, XENOBIOTICA, V31, P879, DOI 10.1080/00498250110079798
   Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586
   ZURLO F, 1990, AM J PHYSIOL, V259, pE650
NR 93
TC 64
Z9 67
U1 0
U2 71
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2161-8313
EI 2156-5376
J9 ADV NUTR
JI Adv. Nutr.
PD MAR
PY 2013
VL 4
IS 2
BP 129
EP 140
DI 10.3945/an.112.003269
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 120HJ
UT WOS:000317161100001
PM 23493529
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Trevenzoli, IH
   Valle, MMR
   Machado, FB
   Garcia, RMG
   Passos, MCF
   Lisboa, PC
   Moura, EG
AF Trevenzoli, I. H.
   Valle, M. M. R.
   Machado, F. B.
   Garcia, R. M. G.
   Passos, M. C. F.
   Lisboa, P. C.
   Moura, E. G.
TI Neonatal hyperleptinaemia programmes adrenal medullary function in adult
   rats: effects on cardiovascular parameters
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
ID BODY-WEIGHT; LEPTIN TREATMENT; ADIPOSE-TISSUE; FOOD-INTAKE;
   CATECHOLAMINE SYNTHESIS; TYROSINE-HYDROXYLASE; METABOLIC SYNDROME;
   THYROID-FUNCTION; OBESITY; RECEPTOR
AB Epidemiological studies have shown a strong correlation between stressful events (nutritional, hormonal or environmental) in early life and development of adult diseases such as obesity, diabetes and cardiovascular failure. It is known that gestation and lactation are crucial periods for healthy growth in mammals and that the sympathoadrenal system is markedly influenced by environmental conditions during these periods. We previously demonstrated that neonatal hyperleptinaemia in rats programmes higher body weight, higher food intake and hypothalamic leptin resistance in adulthood. Using this model of programming, we investigated adrenal medullary function and effects on cardiovascular parameters in male rats in adulthood. Leptin treatment during the first 10 days of lactation (8 mu g 100 g(-1) day(-1), S.C.) resulted in lower body weight (6.5%, P < 0.05), hyperleptinaemia (10-fold, P < 0.05) and higher catecholamine content in adrenal glands (18.5%, P < 0.05) on the last day of treatment. In adulthood (150 days), the rats presented higher body weight (5%, P < 0.05), adrenal catecholamine content (3-fold, P < 0.05), tyrosine hydroxylase expression (35%, P < 0.05) and basal and caffeine-stimulated catecholamine release (53% and 100%, respectively, P < 0.05). Systolic blood pressure and heart rate were also higher in adult rats (7% and 6%, respectively, P < 0.05). Our results show that hyperleptinaemia in early life increases adrenal medullary function in adulthood and that this may alter cardiovascular parameters. Thus, we suggest that imprinting factors which increase leptin and catecholamine levels during the neonatal period could be involved in development of adult chronic diseases.
C1 Univ Fed Rio de Janeiro, Dept Physiol, Roberto Alcantara Gomes Biol Inst, Rio De Janeiro, Brazil.
   Univ Fed Juiz de Fora, Inst Biol Sci, Dept Biol, Juiz De Fora, MG, Brazil.
   Univ Fed Rio de Janeiro, Inst Nutr, Appl Nutr Dept, Rio De Janeiro, Brazil.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal de Juiz de
   Fora; Universidade Federal do Rio de Janeiro
RP Lisboa, PC (corresponding author), Univ Estado Rio de Janeiro, Inst Biol, Dept Ciencias Fisiol, 5 Andar,Av 28 Setembro 87, BR-20551030 Rio De Janeiro, RJ, Brazil.
EM pclisboa@uerj.br
RI Machado, Filipe/G-5497-2012; Hara, Isis/AEI-2086-2022; Lisboa,
   Patricia/H-8336-2015; Moura, Egberto/H-1270-2012
OI Lisboa, Patricia/0000-0002-2477-4364; Moura,
   Egberto/0000-0002-1159-7549; Mello Rezende Valle,
   Maira/0000-0002-1470-7280
CR Almeida JR, 2005, LIFE SCI, V77, P1307, DOI 10.1016/j.lfs.2004.12.043
   Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009
   Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428
   BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x
   Bates SH, 2004, J MOL MED, V82, P12, DOI 10.1007/s00109-003-0494-z
   Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003
   BAYNE K, 1996, PHYSIOLOGIST, V38, P208
   Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004
   Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cao GY, 1997, AM J PHYSIOL-ENDOC M, V273, pE448, DOI 10.1152/ajpendo.1997.273.2.E448
   Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0
   Cravo CD, 2002, HORM METAB RES, V34, P400, DOI 10.1055/s-2002-33473
   FISCHBECK KL, 1987, J NUTR, V117, P1967, DOI 10.1093/jn/117.11.1967
   FLATT JP, 1995, AM J CLIN NUTR, V62, P820, DOI 10.1093/ajcn/62.4.820
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861
   Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376
   Gallardo N, 2005, ENDOCRINOLOGY, V146, P4934, DOI 10.1210/en.2005-0220
   Glasow A, 1998, J CLIN ENDOCR METAB, V83, P4459, DOI 10.1210/jc.83.12.4459
   Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3
   Inoue M, 2003, CELL CALCIUM, V33, P19, DOI 10.1016/S0143-4160(02)00178-1
   KELNER KL, 1985, NEUROCHEM INT, V7, P373, DOI 10.1016/0197-0186(85)90128-7
   Kim J, 2004, SOLID STATE ELECTRON, V48, P175, DOI 10.1016/S0038-1101(03)00113-8
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   LAFONTAN M, 1993, J LIPID RES, V34, P1057
   Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3
   Lisboa PC, 2006, HORM METAB RES, V38, P295, DOI 10.1055/s-2006-925390
   Lisboa PC, 2003, AM J PHYSIOL-ENDOC M, V284, pE1172, DOI 10.1152/ajpendo.00513.2002
   Malendowicz LK, 2004, INT J MOL MED, V13, P829
   Martins ACP, 2004, LIFE SCI, V74, P3211, DOI 10.1016/j.lfs.2003.10.034
   McKenzie S, 2002, EUR J NEUROSCI, V15, P1485, DOI 10.1046/j.1460-9568.2002.01990.x
   Molendi-Coste O, 2006, ENDOCRINOLOGY, V147, P3050, DOI 10.1210/en.2005-1331
   Nowak KW, 2002, INT J MOL MED, V9, P31
   Passos MCF, 2004, HORM METAB RES, V36, P625, DOI 10.1055/s-2004-825927
   Passos MCF, 2000, NUTR RES, V20, P1603, DOI 10.1016/S0271-5317(00)00246-3
   Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4
   RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701
   Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002
   Sahu A, 2004, ENDOCRINOLOGY, V145, P2613, DOI 10.1210/en.2004-0032
   Sanchez A, 2003, PHARMACOL RES, V48, P607, DOI 10.1016/S1043-6618(03)00241-X
   Satoh N, 1999, DIABETES, V48, P1787, DOI 10.2337/diabetes.48.9.1787
   Savoia C, 2004, MED CLIN N AM, V88, P39, DOI 10.1016/S0025-7125(03)00122-6
   Stallknecht B, 2004, DAN MED BULL, V51, P1
   Steinberg GR, 2004, AM J PHYSIOL-ENDOC M, V286, pE57, DOI 10.1152/ajpendo.00302.2003
   Takekoshi K, 2001, ENDOCRINOLOGY, V142, P290, DOI 10.1210/en.142.1.290
   Takekoshi K, 2001, ENDOCRINOLOGY, V142, P4861, DOI 10.1210/en.142.11.4861
   Teixeira CV, 2003, HORM METAB RES, V35, P367, DOI 10.1055/s-2003-41359
   Teixeira CV, 2002, J NUTR BIOCHEM, V13, P493, DOI 10.1016/S0955-2863(02)00197-3
   Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726
   Utsunomiya K, 2001, J NEUROCHEM, V76, P926, DOI 10.1046/j.1471-4159.2001.00123.x
   VANDERTUIG JG, 1985, AM J PHYSIOL, V248, pE607, DOI 10.1152/ajpendo.1985.248.5.E607
   Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581
   Waterland RA, 1999, AM J CLIN NUTR, V69, P179
   Yanagihara N, 2000, BIOCHEM PHARMACOL, V59, P1141, DOI 10.1016/S0006-2952(00)00240-9
   Young JB, 2002, TRENDS ENDOCRIN MET, V13, P381, DOI 10.1016/S1043-2760(02)00661-6
   Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005
   Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313
NR 57
TC 43
Z9 45
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD APR 15
PY 2007
VL 580
IS 2
BP 629
EP 637
DI 10.1113/jphysiol.2006.126151
PG 9
WC Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Physiology
GA 156KN
UT WOS:000245646900025
PM 17218354
OA Green Published
DA 2025-04-28
ER

PT J
AU Khoo, WY
   Chrisfield, BJ
   Sae-Tan, S
   Lambert, JD
AF Khoo, Weslie Y.
   Chrisfield, Benjamin J.
   Sae-tan, Sudathip
   Lambert, Joshua D.
TI Mitigation of nonalcoholic fatty liver disease in high-fat-fed mice by
   the combination of decaffeinated green tea extract and voluntary
   exercise
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
ID BILE-ACID; METABOLIC SYNDROME; LIPID-METABOLISM; CAFFEINE; CONSUMPTION;
   INFLAMMATION; ASSOCIATION; POLYPHENOLS; CANCER; COHORT
AB We have shown that combination treatment with decaffeinated green tea extract (GTE) and voluntary exercise (Ex) reduces obesity and insulin resistance in high-fat (HF)-fed mice to a greater extent than either treatment alone. Here, we investigated the effects of GTE-, Ex- or the combination on the development of obesity-related NAFLD. Male C57BL/6 J mice were treated for 16 weeks with HF diet (60% energy from fat), HF supplemented with 7.7 g GTE/kg, HF plus access to a voluntary running wheel, or the combination. We found that treatment of mice with the combination mitigated the development of HF-induced NAFLD to a greater extent than either treatment alone. Combination-treated mice had lower plasma alanine aminotransferase (92% lower) and hepatic lipid accumulation (80% lower) than HF-fed controls: the effect of the single treatments was less significant. Mitigation of NAFLD was associated with higher fecal lipid and nitrogen levels. Combination treated, but not singly treated mice, had higher hepatic expression of genes related to mitochondrial biogenesis (sirtuin 1[59%]; peroxisome proliferator-activated receptor gamma coactivator 1 alpha [42%]; nuclear respiratory factor 1[38%]; and transcription factor B1, mitochondrial [89%]) compared to the HF-fed controls. GTE-, Ex-, and the combination-treatment groups also had higher hepatic expression of genes related to cholesterol synthesis and uptake, but the combination was not better than the single treatments. Our results suggest the combination of GTE and Ex can effectively mitigate NAFLD. Future studies should determine if the combination is additive or synergistic compared to the single treatments. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Khoo, Weslie Y.; Chrisfield, Benjamin J.; Sae-tan, Sudathip; Lambert, Joshua D.] Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA.
   [Lambert, Joshua D.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA.
   [Sae-tan, Sudathip] Kasetsart Univ, Dept Food Sci & Technol, Bangkok, Thailand.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Penn State Behrend; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); Pennsylvania State University; Penn State
   Behrend; Pennsylvania State University - University Park; Kasetsart
   University
RP Lambert, JD (corresponding author), Penn State Univ, Dept Food Sci, Ctr Mol Toxicol & Carcinogenesis, 332 Food Sci Bldg, University Pk, PA 16802 USA.
EM jdl134@psu.edu
RI Khoo, Weslie/AAM-1185-2020; Lambert, Joshua/M-1788-2014
OI Khoo, Weslie/0000-0002-1317-1293
FU National Institutes of Health [NIH AT004678]; United States Department
   of Agriculture (USDA) [4565]
FX We thank the staff at PSU Genomics Core Facility for their support and
   patience during gene expression analysis. This work was supported by
   funding from the National Institutes of Health (NIH AT004678 to JDL) and
   the United States Department of Agriculture (USDA Hatch Project No. 4565
   to JDL). The NIH and USDA had no role in the study design and execution.
CR Annaba F, 2010, AM J PHYSIOL-GASTR L, V298, pG467, DOI 10.1152/ajpgi.00360.2009
   [Anonymous], TEA FACT SHEET 2018
   Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010
   Birerdinc A, 2012, ALIMENT PHARM THER, V35, P76, DOI 10.1111/j.1365-2036.2011.04916.x
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Chen C, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700483
   Cho Jinkyung, 2014, J Exerc Nutrition Biochem, V18, P339, DOI 10.5717/jenb.2014.18.4.339
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Federico A, 2014, WORLD J GASTROENTERO, V20, P16841, DOI 10.3748/wjg.v20.i45.16841
   Foretz M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092826
   Glisan SL, 2016, J NUTR BIOCHEM, V37, P60, DOI 10.1016/j.jnutbio.2016.07.009
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Gu YY, 2014, J NUTR BIOCHEM, V25, P439, DOI 10.1016/j.jnutbio.2013.12.004
   Haase TN, 2011, AM J PHYSIOL-REG I, V301, pR1501, DOI 10.1152/ajpregu.00775.2010
   Helal MG, 2018, HUM EXP TOXICOL, V37, P983, DOI 10.1177/0960327117747026
   Huang JB, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700696
   Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI 10.1158/1055-9965.EPI-08-0923
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/bse0470069, 10.1042/BSE0470069]
   Kenneally S, 2017, BMJ OPEN GASTROENTER, V4, DOI 10.1136/bmjgast-2017-000139
   Liu JX, 2016, EUR J EPIDEMIOL, V31, P853, DOI 10.1007/s10654-016-0173-3
   Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712
   Masterjohn C, 2012, NUTR REV, V70, P41, DOI 10.1111/j.1753-4887.2011.00440.x
   Meissner M, 2011, ATHEROSCLEROSIS, V218, P323, DOI 10.1016/j.atherosclerosis.2011.06.040
   Meissner M, 2010, MED SCI SPORT EXER, V42, P1460, DOI 10.1249/MSS.0b013e3181cfcb02
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Ogawa K, 2016, J AGR FOOD CHEM, V64, P204, DOI 10.1021/acs.jafc.5b05088
   Papadopoulou A, 2004, TRENDS FOOD SCI TECH, V15, P186, DOI 10.1016/j.tifs.2003.09.017
   Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200
   Petridou A., 2018, Metabolism
   Pezeshki A, 2016, INT J PREVENTIVE MED, V7, DOI 10.4103/2008-7802.173051
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Sae-Tan S, 2015, J FUNCT FOODS, V14, P210, DOI 10.1016/j.jff.2015.01.036
   Sae-tan S, 2014, MOL NUTR FOOD RES, V58, P1156, DOI 10.1002/mnfr.201300621
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Sakata R, 2013, INT J MOL MED, V32, P989, DOI 10.3892/ijmm.2013.1503
   Santamarina AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141227
   Schneider K, 2004, REGUL TOXICOL PHARM, V39, P334, DOI 10.1016/j.yrtph.2004.03.001
   Schon HT, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00283
   Shen Huafeng, 2016, Therap Adv Gastroenterol, V9, P113, DOI 10.1177/1756283X15593700
   Shen Q, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111633
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Tolman Keith G, 2007, Ther Clin Risk Manag, V3, P1153
   Van Buiten CB, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700879
   Yang Z, 2019, PHYTOTHER RES, V33, P1019, DOI 10.1002/ptr.6295
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang GY, 2002, BIOSCI BIOTECH BIOCH, V66, P711, DOI 10.1271/bbb.66.711
   Zhang L, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/2157451
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI [10.1039/c5fo00247h, 10.1039/C5FO00247H]
NR 50
TC 21
Z9 21
U1 3
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD FEB
PY 2020
VL 76
AR 108262
DI 10.1016/j.jnutbio.2019.108262
PG 7
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA KJ7AS
UT WOS:000512211200003
PM 31759197
OA Green Accepted, Bronze
DA 2025-04-28
ER

PT J
AU Hsieh, CF
   Tsuei, YW
   Liu, CW
   Kao, CC
   Shih, LJ
   Ho, LT
   Wu, LY
   Wu, CP
   Tsai, PH
   Chang, HH
   Ku, HC
   Kao, YH
AF Hsieh, Chi-Fen
   Tsuei, Yi-Wei
   Liu, Chi-Wei
   Kao, Chung-Cheng
   Shih, Li-Jane
   Ho, Low-Tone
   Wu, Liang-Yi
   Wu, Chi-Peng
   Tsai, Pei-Hua
   Chang, Hsin-Huei
   Ku, Hui-Chen
   Kao, Yung-Hsi
TI Green Tea Epigallocatechin Gallate Inhibits Insulin Stimulation of
   Adipocyte Glucose Uptake via the 67-Kilodalton Laminin Receptor and
   AMP-Activated Protein Kinase Pathways
SO PLANTA MEDICA
LA English
DT Article
DE green tea; Camellia sinensis; Theaceae; epigallocatechin 3-gallate;
   insulin; glucose uptake
ID CATECHIN-POLYPHENOLS; TRANSPORTER; EGCG; MODULATION; MECHANISMS;
   CAFFEINE; RESISTIN
AB Insulin and (-)-epigallocatechin gallate (EGCG) are reported to regulate obesity and fat accumulation, respectively. This study investigated the pathways involved in EGCG modulation of insulin-stimulated glucose uptake in 3T3-L1 and C3H10T1/2 adipocytes. EGCG inhibited insulin stimulation of adipocyte glucose uptake in a dose- and time-dependent manner. The concentration of EGCG that decreased insulin-stimulated glucose uptake by 50-60% was approximately 5-10 mu M for a period of 2h. At 10 mu M, EGCG and gallic acid were more effective than (-)-epicatechin, (-)-epigallocatechin, and (-)-epicatechin 3-gallate. We identified the EGCG receptor [also known as the 67-kDa laminin receptor (67LR)] in fat cells and extended the findings for this study to clarify whether EGCG-induced changes in insulin-stimulated glucose uptake in adipocytes could be mediated through the 67LR. Pretreatment of adipocytes with a 67LR antibody, but not normal rabbit immunoglobulin, prevented the effects of EGCG on insulin-increased glucose uptake. This suggests that the 67LR mediates the effect of EGCG on insulin-stimulated glucose uptake in adipocytes. Moreover, pretreatment with an AMP-activated protein kinase (AMPK) inhibitor, such as compound C, but not with a glutathione (GSH) activator, such as N-acetyl-L-cysteine (NAC), blocked the antiinsulin effect of EGCG on adipocyte glucose uptake. These data suggest that EGCG exerts its anti-insulin action on adipocyte glucose uptake via the AMPK, but not the GSH, pathway. The results of this study possibly support that EGCG mediates fat content.
C1 [Hsieh, Chi-Fen; Liu, Chi-Wei; Wu, Chi-Peng; Tsai, Pei-Hua; Chang, Hsin-Huei; Ku, Hui-Chen; Kao, Yung-Hsi] Natl Cent Univ, Dept Life Sci, Jhongli 32001, Taoyuan County, Taiwan.
   [Wu, Liang-Yi] Chung Yuan Christian Univ, Dept Biosci Biotechnol, Jhongli, Taiwan.
   [Ho, Low-Tone] Vet Gen Hosp, Dept Internal Med, Taipei, Taiwan.
   [Shih, Li-Jane] Armed Forces Taoyuan Gen Hosp, Dept Joint Lab, Tao Yuan, Taiwan.
   [Tsuei, Yi-Wei; Kao, Chung-Cheng] Armed Forces Taoyuan Gen Hosp, Dept Emergency, Tao Yuan, Taiwan.
C3 National Central University; Chung Yuan Christian University
RP Kao, YH (corresponding author), Natl Cent Univ, Dept Life Sci, 300 Jhongda Rd, Jhongli 32001, Taoyuan County, Taiwan.
EM ykao@cc.ncu.edu.tw
RI Hen Hong, Chang/ITT-2813-2023
OI Shih, Li-Jane/0000-0001-7195-7676; Ku, Hui-Chen/0000-0001-5169-1292
FU National Science Council, Taiwan [NSC98-2311-B-008-001-MY3]; Taoyuan
   Armed Forces General Hospital; Veterans General Hospital-UST; Tsou's
   Foundation [VGHUST97-P3-09/VGHUST98-P3-10]; CGH-NCU Joint Research
   Foundation [CNJRF-98CGH-NCU-B3]
FX This work was supported by the National Science Council, Taiwan
   (NSC98-2311-B-008-001-MY3); the Taoyuan Armed Forces General Hospital;
   the Veterans General Hospital-UST Joint Research Program and Tsou's
   Foundation (VGHUST97-P3-09/VGHUST98-P3-10); and the CGH-NCU Joint
   Research Foundation (CNJRF-98CGH-NCU-B3) to Y.-H.K.
CR Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   Calixto Joao B., 2004, Planta Medica, V70, P93
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Fong JC, 2001, CELL SIGNAL, V13, P491, DOI 10.1016/S0898-6568(01)00174-7
   Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   KAO CC, 2009, PLANTA MED, V75, P1
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832
   Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008
   Koyama Y, 2004, PLANTA MED, V70, P1100, DOI 10.1055/s-2004-832659
   Ku HC, 2009, AM J PHYSIOL-CELL PH, V297, pC121, DOI 10.1152/ajpcell.00272.2008
   Liao SS, 2001, VITAM HORM, V62, P1, DOI 10.1016/S0083-6729(01)62001-6
   Lin CL, 2008, MOL NUTR FOOD RES, V52, P930, DOI 10.1002/mnfr.200700437
   Lin JK, 2006, MOL NUTR FOOD RES, V50, P211, DOI 10.1002/mnfr.200500138
   Liu F, 2008, ACTA PHARMACOL SIN, V29, P98, DOI 10.1111/j.1745-7254.2008.00709.x
   Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x
   Mochizuki M, 2004, PHYTOTHER RES, V18, P449, DOI 10.1002/ptr.1437
   Naftalin RJ, 2003, BRIT J PHARMACOL, V140, P487, DOI 10.1038/sj.bjp.0705460
   Nomura M, 2008, BIOL PHARM BULL, V31, P1403, DOI 10.1248/bpb.31.1403
   Reiter CEN, 2010, ENDOCRINOLOGY, V151, P103, DOI 10.1210/en.2009-0997
   ROBERTS EAH, 1952, J SCI FOOD AGR, V3, P193, DOI 10.1002/jsfa.2740030501
   Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743
   Ueda M, 2008, BIOCHEM BIOPH RES CO, V377, P286, DOI 10.1016/j.bbrc.2008.09.128
   Wang CT, 2009, MOL NUTR FOOD RES, V53, P349, DOI 10.1002/mnfr.200800013
   WISE LS, 1979, J BIOL CHEM, V254, P273
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wolfram S, 2006, J NUTR, V136, P2512, DOI 10.1093/jn/136.10.2512
   YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038
NR 32
TC 26
Z9 28
U1 0
U2 16
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0032-0943
EI 1439-0221
J9 PLANTA MED
JI Planta Med.
PD OCT
PY 2010
VL 76
IS 15
BP 1694
EP 1698
DI 10.1055/s-0030-1249877
PG 5
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 676MY
UT WOS:000283917300011
PM 20455202
DA 2025-04-28
ER

PT J
AU Wiggers, D
   Vanderlee, L
   White, CM
   Reid, JL
   Minaker, L
   Hammond, D
AF Wiggers, Danielle
   Vanderlee, Lana
   White, Christine M.
   Reid, Jessica L.
   Minaker, Leia
   Hammond, David
TI Food sources among young people in five major Canadian cities
SO CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE
LA English
DT Article
DE Diet, food and nutrition; Fast foods; Cooking; Nutrition policy
ID ULTRA-PROCESSED FOODS; LIKELY IMPACT; CONSUMPTION; WEIGHT; DIET;
   ASSOCIATIONS; PRODUCTS; QUALITY; COOKING; ENERGY
AB Objective To examine food sources among young people in five major Canadian cities.
   Methods As part of the 2016 Canada Food Study, respondents aged 16-30 were recruited from five Canadian cities (Toronto, Montreal, Halifax, Edmonton, and Vancouver) using in-person intercept sampling and completed an online survey (n = 2840 retained for analysis). Descriptive statistics were used to summarize food preparation and purchase locations. A linear regression model was fitted to examine correlates of the proportion of meals that were ready-to-eat or prepared outside the home.
   Results In total, 80% of meals were prepared at home and 20% were prepared outside the home. More than 25% of meals prepared at home were ready-to-eat/box food. Of all meals consumed, 42% were either ready-to-eat/box food prepared at home or prepared outside the home. Food for meals prepared at home was purchased predominantly at grocery stores/supercentres while meals prepared outside the home were purchased predominantly at fast food/quick service/coffee shop outlets. Respondents who were younger, identified as Aboriginal, had obesity, had no children, lived in residence at school, university, or college, and reported poorer cooking skills reported more meals that were ready-to-eat or prepared outside the home.
   Conclusions The current findings indicate that a substantial proportion of meals consumed by young people consist of meals either prepared outside the home or ready-to-eat/box food prepared at home. Dietary recommendations should highlight basic patterns of food preparation and eating, such as limiting ultra-processed food and food prepared outside the home.
C1 [Wiggers, Danielle; White, Christine M.; Reid, Jessica L.; Hammond, David] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.
   [Vanderlee, Lana] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada.
   [Minaker, Leia] Univ Waterloo, Sch Planning, Waterloo, ON, Canada.
C3 University of Waterloo; University of Toronto; University of Waterloo
RP Hammond, D (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.
EM dhammond@uwaterloo.ca
RI Hammond, David/JPW-9267-2023
OI Vanderlee, Lana/0000-0001-5384-1821; Reid, Jessica/0000-0001-9909-6265
FU Public Health Agency of Canada; Public Health Agency of Canada -
   Canadian Institutes of Health Research Chair in Applied Public Health;
   Canadian Institutes of Health Research Banting Postdoctoral Fellowship;
   Canadian Cancer Society [704744]
FX This project has been made possible through funding from the Public
   Health Agency of Canada. The views expressed herein do not necessarily
   represent the view of the Public Health Agency of Canada. Additional
   funding for this project has been provided by a Public Health Agency of
   Canada - Canadian Institutes of Health Research Chair in Applied Public
   Health, which supports Professor Hammond, staff, and students at the
   University of Waterloo. LV is supported by a Canadian Institutes of
   Health Research Banting Postdoctoral Fellowship. LM is supported by the
   Canadian Cancer Society (award #704744).
CR An R, 2016, EUR J CLIN NUTR, V70, P97, DOI 10.1038/ejcn.2015.104
   [Anonymous], CENS PROF
   Bauer KW, 2009, PREV MED, V48, P284, DOI 10.1016/j.ypmed.2008.12.021
   Binkley JK, 2008, REV AGR ECON, V30, P750, DOI 10.1111/j.1467-9353.2008.00444.x
   Canadian Restaurant and Foodservices Association, 2010, CAN REST IND PUTT JO
   Garriguet D., 2004, OVERVIEW CANADIANS E
   Government of Canada, 2017, CAN FOOD GUID CONS
   Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3
   Hammond D., 2017, 2016 Canada Food Study: Technical report - Wave 2
   Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004
   Larson NI, 2006, J AM DIET ASSOC, V106, P2001, DOI 10.1016/j.jada.2006.09.008
   Mills S, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0567-y
   Minaker LM, 2016, PUBLIC HEALTH NUTR, V19, P2268, DOI 10.1017/S1368980016000355
   Minaker LM, 2014, J HUNGER ENVIRON NUT, V9, P485, DOI 10.1080/19320248.2014.898175
   Ministry of Health of Brazil, 2015, DIET GUID BRAZ POP
   Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Moubarac J-C, 2017, ULTRAPROCESSED FOODS
   Moubarac JC, 2017, APPETITE, V108, P512, DOI 10.1016/j.appet.2016.11.006
   Moubarac JC, 2014, CAN J DIET PRACT RES, V75, P15, DOI 10.3148/75.1.2014.15
   Moubarac JC, 2013, PUBLIC HEALTH NUTR, V16, P2240, DOI 10.1017/S1368980012005009
   Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365
   ONeill M, 2017, INT SOC BEH NUTR PHY
   Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0
   Poti JM, 2011, J AM DIET ASSOC, V111, P1156, DOI 10.1016/j.jada.2011.05.007
   Public Health Agency of Canada, 2011, OB IN CAN
   Seguin RA, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/3074241
   Shields M., 2006, REGIONAL DIFFERENCES
   Smith LP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-45
   Steele EM, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0119-3
   Stern D, 2016, AM J PREV MED, V50, P180, DOI 10.1016/j.amepre.2015.07.025
   Tiwari A, 2017, AM J PREV MED, V52, P616, DOI 10.1016/j.amepre.2017.01.017
   van der Horst KD, 2011, PUBLIC HEALTH NUTR, V14, P239, DOI 10.1017/S1368980010002624
   WHO, 2017, GLOB DAT BOD MASS IN
NR 34
TC 12
Z9 14
U1 0
U2 36
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0008-4263
EI 1920-7476
J9 CAN J PUBLIC HEALTH
JI Can. J. Public Health-Rev. Can. Sante Publ.
PD AUG
PY 2018
VL 109
IS 4
BP 506
EP 515
DI 10.17269/s41997-018-0083-0
PG 10
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA GW5LV
UT WOS:000446977300010
PM 29981100
OA Green Published
DA 2025-04-28
ER

PT J
AU Li, LJ
   Yang, PT
   Duan, YL
   Xie, JF
   Liu, M
   Zhou, Y
   Luo, XF
   Zhang, C
   Li, Y
   Wang, JA
   Chen, ZH
   Zhang, XH
   Cheng, ASK
AF Li, Lijun
   Yang, Pingting
   Duan, Yinglong
   Xie, Jianfei
   Liu, Min
   Zhou, Yi
   Luo, Xiaofei
   Zhang, Chun
   Li, Ying
   Wang, Jiangang
   Chen, Zhiheng
   Zhang, Xiaohong
   Cheng, Andy S. K.
TI Association between dietary diversity, sedentary time outside of work
   and depressive symptoms among knowledge workers: a multi-center
   cross-sectional study
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Dietary diversity; Sedentary; Depressive symptoms; Knowledge workers;
   Cross sectional
ID PHYSICAL-ACTIVITY; LIFE-STYLE; BEHAVIOR; OBESITY; HEALTH; SEVERITY;
   METAANALYSIS; PREVALENCE; PATTERNS; VITAMIN
AB Background Low-diversity diets and sedentary status are risk factors for depressive symptoms, while knowledge workers were ignored before. The purpose of this current study was to examine the relationship between dietary diversity, sedentary time spent outside of work, and depressive symptoms among knowledge workers.Study design and methods This was a multicenter and cross-sectional design that included 118,723 knowledge workers. Participants self-reported online between January 2018 and December 2020. Demographic information, the Dietary Diversity Scale, the Patient Health Questionnaire-9, dietary habits (which included eating three meals on time, midnight snacking, overeating, social engagement, coffee consumption, sugary drink consumption, smoking and alcohol use), sedentary time spent outside of work and physical activity were investigated.Results The relationships between demographic information, dietary habits and dietary diversity, and depressive symptoms were estimated. Compared with the first and second levels of dietary diversity, the third level of dietary diversity (OR: 0.91; 95% CI: 0.84-0.98) reduced the risk of depressive symptoms. Knowledge workers with different degrees of sedentary status (2-4 h (OR: 1.11; 95% CI: 1.07-1.14), 4-6 h (OR: 1.21; 95% CI: 1.17-1.26), and > 6 h (OR: 1.49; 95% CI: 1.43-1.56), presented a progressively higher risk of depressive symptoms.Conclusion High amounts of sedentary time spent after work and low levels of dietary diversity are risk factors for depressive symptoms. In addition, an irregular diet and overeating are also major risk factors for knowledge workers.
C1 [Li, Lijun; Yang, Pingting; Li, Ying; Wang, Jiangang; Chen, Zhiheng] Cent South Univ, Xiangya Hosp 3, Hlth Management Ctr, Changsha, Peoples R China.
   [Li, Lijun; Duan, Yinglong; Xie, Jianfei; Liu, Min; Zhang, Xiaohong] Cent South Univ, Xiangya Hosp 3, Nursing Dept, Changsha, Peoples R China.
   [Zhou, Yi; Luo, Xiaofei; Zhang, Chun] Cent South Univ, Xiangya Nursing Sch, Changsha, Peoples R China.
   [Cheng, Andy S. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Peoples R China.
C3 Central South University; Central South University; Central South
   University; Hong Kong Polytechnic University
RP Xie, JF; Zhang, XH (corresponding author), Cent South Univ, Xiangya Hosp 3, Nursing Dept, Changsha, Peoples R China.
EM xiejianfei@csu.edu.cn; 19942490@qq.com
RI Luo, Xiaofei/JJC-6737-2023; Liu, Min/MSW-7837-2025; Li,
   Lijun/AAG-9407-2019; Cheng, Andy/AAW-1120-2020; Wang, Wen/HKV-9621-2023
OI Li, Lijun/0000-0003-2166-6429
FU Special Funding for the Construction of Innovative Provinces in Hunan
FX We would like thanks to four hospitals' managers and 118723 knowledge
   workers for their voluntary participation.
CR Albaladejo-Blázquez N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081569
   Andersen LL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2340
   [Anonymous], 2016, DIETARY GUIDELINES C
   Appelhans BM, 2012, J ACAD NUTR DIET, V112, P693, DOI 10.1016/j.jand.2012.02.006
   Arnetz BB, 2014, J OCCUP ENVIRON MED, V56, P79, DOI 10.1097/JOM.0000000000000029
   Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7
   BENDER MM, 1992, J AM DIET ASSOC, V92, P1096
   Blümel JE, 2015, MATURITAS, V80, P100, DOI 10.1016/j.maturitas.2014.10.007
   Bojsen-Moller E, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234721
   Brunet J, 2014, PREV MED, V60, P16, DOI 10.1016/j.ypmed.2013.12.003
   Chocano-Bedoya PO, 2013, AM J CLIN NUTR, V98, P813, DOI 10.3945/ajcn.112.052761
   Derakhshanrad N, 2021, EUR SPINE J, V30, P461, DOI 10.1007/s00586-020-06640-z
   Dimitriadis D, 2016, ISR J PSYCHIATR REL, V53, P17
   Drucker PF, 1999, CALIF MANAGE REV, V41, P79, DOI 10.2307/41165987
   Endrighi R, 2016, BRIT J PSYCHIAT, V208, P245, DOI 10.1192/bjp.bp.114.150755
   Field JC, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02414
   Florida R, 2004, HARVARD BUS REV, V82, P122
   Gallardo-Alfaro L, 2021, NUTR METAB CARDIOVAS, V31, P2870, DOI 10.1016/j.numecd.2021.06.015
   Gibbs BB, 2015, MED SCI SPORT EXER, V47, P1295, DOI 10.1249/MSS.0000000000000517
   Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662
   Hayward J, 2016, AUST NZ J PSYCHIAT, V50, P1064, DOI 10.1177/0004867416671596
   Heiman ML, 2016, MOL METAB, V5, P317, DOI 10.1016/j.molmet.2016.02.005
   Herbert J, 2013, PSYCHOL MED, V43, P449, DOI 10.1017/S0033291712000955
   Hills RD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071613
   Huang YQ, 2019, LANCET PSYCHIAT, V6, P211, DOI 10.1016/S2215-0366(18)30511-X
   Kang W, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0134-z
   Konttinen H, 2020, P NUTR SOC, V79, P283, DOI 10.1017/S0029665120000166
   Korkalo L, 2017, EUR J NUTR, V56, P1179, DOI 10.1007/s00394-016-1167-3
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lee JY, 2018, PSYCHOL ADDICT BEHAV, V32, P466, DOI 10.1037/adb0000373
   Li R, Annals of Palliative Medicine
   Li R, 2022, ANN PALLIAT MED, V11, P1278, DOI 10.21037/apm-21-1449
   Lin HL, 2022, HEALTHCARE-BASEL, V10, DOI 10.3390/healthcare10010137
   Maitiniyazi GSH, 2022, NUTRIENTS, V14, DOI 10.3390/nu14061186
   Michael SL, 2020, PREV MED REP, V19, DOI 10.1016/j.pmedr.2020.101153
   Mitchell AJ, 2016, BJPSYCH OPEN, V2, P127, DOI 10.1192/bjpo.bp.115.001685
   Nelson SB, 2017, INT J INFORM MANAGE, V37, P54, DOI 10.1016/j.ijinfomgt.2016.11.008
   Ogasawara K, 2011, J AFFECT DISORDERS, V128, P33, DOI 10.1016/j.jad.2010.06.015
   Ojo SO, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162903
   Oldewage-Theron W, 2011, NUTRITION, V27, P420, DOI 10.1016/j.nut.2010.05.013
   Oliván-Blázquez B, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082724
   Parry S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-296
   Patrick K, 2016, AM J PREV MED, V51, P816, DOI 10.1016/j.amepre.2016.05.001
   Pengpid S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081413
   Poorrezaeian M, 2017, ANN GEN PSYCHIATR, V16, DOI 10.1186/s12991-017-0162-2
   Poorrezaeian M, 2015, PSYCHIAT RES, V230, P622, DOI 10.1016/j.psychres.2015.10.016
   Radavelli-Bagatini S, 2021, EUR J NUTR, V60, P3743, DOI 10.1007/s00394-021-02532-0
   Raudsepp L, 2008, PEDIATR EXERC SCI, V20, P251, DOI 10.1123/pes.20.3.251
   Raudsepp L, 2019, J PHYS ACT HEALTH, V16, P191, DOI 10.1123/jpah.2018-0123
   Raudsepp L, 2016, EUR J SPORT SCI, V16, P1153, DOI 10.1080/17461391.2016.1174312
   Reis DJ, 2020, MED HYPOTHESES, V134, DOI 10.1016/j.mehy.2019.109421
   Ren XL, 2018, PROC EUR TEST SYMP, DOI 10.1145/3274415
   Rodman AM, 2019, BIOL PSYCHIAT, V86, P464, DOI 10.1016/j.biopsych.2019.04.033
   Saidj M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1711-8
   Salehi-Abargouei A, 2016, EUR J CLIN NUTR, V70, P1, DOI 10.1038/ejcn.2015.118
   Schrempft S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6424-y
   Silva-Alves LM, 2017, NEUROSCIENCE, V349, P239, DOI 10.1016/j.neuroscience.2017.03.001
   Simons D, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10003
   Sinopoli A, 2022, NUTRIENTS, V14, DOI 10.3390/nu14194081
   Soons JPM, 2009, J MARRIAGE FAM, V71, P1141, DOI 10.1111/j.1741-3737.2009.00660.x
   Steiger DM, 2008, KNOWL MAN RES PRACT, V6, P312, DOI 10.1057/kmrp.2008.19
   Tsehay M, 2021, J PUBLIC MENT HEALTH, V20, P229, DOI 10.1108/JPMH-11-2020-0149
   Tsutsumimoto K, 2017, INT J GERIATR PSYCH, V32, P193, DOI 10.1002/gps.4461
   Vandevijvere S, 2010, PUBLIC HEALTH NUTR, V13, P1965, DOI 10.1017/S1368980010001606
   Wali RM, 2021, ANN MED HEALTH SCI R, V11, P1
   Wang J, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0358-6
   Wang PeiCheng Wang PeiCheng, 2016, Modern Preventive Medicine, V43, P1409
   Waxman Amalia, 2004, Food and Nutrition Bulletin, V25, P292
   Weiner LS, 2019, J CANCER SURVIV, V13, P468, DOI 10.1007/s11764-019-00768-8
   Weng TT, 2012, PUBLIC HEALTH NUTR, V15, P673, DOI 10.1017/S1368980011003077
   Whitaker KM, 2014, NUTR RES, V34, P294, DOI 10.1016/j.nutres.2014.01.007
   Won MH, Eur J Cardiovasc Nurs.
   Yan SJ, 2016, INT J DIABETES DEV C, V36, P158, DOI 10.1007/s13410-015-0373-5
   Zhang MY, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8380151
   Zhang Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172406
NR 75
TC 2
Z9 2
U1 6
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 2
PY 2024
VL 24
IS 1
AR 53
DI 10.1186/s12889-023-17567-7
PG 12
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA DX5J7
UT WOS:001135394000021
PM 38166945
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Nelson, MC
   Story, M
AF Nelson, Melissa C.
   Story, Mary
TI Food Environments in University Dorms 20,000 Calories per Dorm Room and
   Counting
SO AMERICAN JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Article
ID AVAILABILITY; OBESITY
AB Background: Few young adults meet national dietary recommendations. Although home food availability likely has important influences on dietary intake, little research has examined thiS issue among young adults. The objective of this research was to conduct a detailed, observational assessment of food and beverages available in college-student dormitory rooms.
   Methods: Dormitory-residing students (n=100) were recruited from a large, public university. Research staff completed a detailed inventory of food and beverages in the clorin rooms, including nutrient contents and purchasing Sources. Data were collected and analyzed in 2008.
   Results: The mean number of food and beverage items per participant was 47 (range: 0-208), with 4% of participants not having any food or beverages. More than 70% Of Students had each of the following types of items: salty snacks, cereal or granola bars, main dishes, desserts or candy, and sugar-sweetened beverages. Fewer students had low-calorie beverages, fruits and vegetables, dairy products, tea/coffee, and 100% fruit/vegetable juice. The average number of calories per dorm room was 22,888. Items purchased by parents had a higher calorie and fat content than items purchased by students.
   Conclusions: Findings indicate that students maintain a wide array of food and beverages in their dormitory rooms. Parents purchased a Substantial amount of food for their children's dormitory rooms, and these food items were less healthful than the food that students purchased. The foods observed in college students' living spaces may have air important impact on eating habits. Overall, young adult-oriented obesity prevention efforts are needed, and improving the various facets of campus food environments may mark an important component of such strategies. (Am J Prev Med 2009;36(6):523-526) (C) 2009 American Journal of Preventive Medicine
C1 [Nelson, Melissa C.; Story, Mary] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities
RP Nelson, MC (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, 1300 S 2nd St,WBOB Suite 300, Minneapolis, MN 55454 USA.
EM nels5024@umn.edu
OI Laska, Melissa/0000-0002-3836-0269
FU Maternal and Child Health Bureau, Health Resources Services
   Administration [T79 MC00007-13]
FX Data collection for this work was supported by a Public Health Nutrition
   Grant (T79 MC00007-13) from the Maternal and Child Health Bureau, Health
   Resources Services Administration. The authors would like to acknowledge
   and thank Meg Bruening, Lacey Arneson, Beth Reisdorf, and Rachel Bowers
   (Division of Epidemiology and Community Health, University of Minnesota)
   for their efforts in collecting these data as part of their
   graduate-fellowship training.
CR [Anonymous], 2007, J Am Coll Health, V55, P195, DOI DOI 10.3200/JACH.55.4.195-206
   Brown LB, 2005, J AM DIET ASSOC, V105, P445, DOI 10.1016/j.jada.2004.12.030
   Campbell KJ, 2007, OBESITY, V15, P719, DOI 10.1038/oby.2007.553
   Cullen KW, 2003, HEALTH EDUC BEHAV, V30, P615, DOI 10.1177/1090198103257254
   NELSON MC, 2009, J AM DIET A IN PRESS
   NELSON MC, 2009, J NUTR ED B IN PRESS
   Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Raynor HA, 2004, OBES RES, V12, P816, DOI 10.1038/oby.2004.98
   US Department of Agriculture, National nutrient database for standard reference release 17
NR 10
TC 47
Z9 79
U1 0
U2 30
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0749-3797
EI 1873-2607
J9 AM J PREV MED
JI Am. J. Prev. Med.
PD JUN
PY 2009
VL 36
IS 6
BP 523
EP 526
DI 10.1016/j.amepre.2009.01.030
PG 4
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA 446PD
UT WOS:000266132700009
PM 19356889
DA 2025-04-28
ER

PT J
AU Lanfer, A
   Bammann, K
   Knof, K
   Buchecker, K
   Russo, P
   Veidebaum, T
   Kourides, Y
   de Henauw, S
   Molnar, D
   Bel-Serrat, S
   Lissner, L
   Ahrens, W
AF Lanfer, Anne
   Bammann, Karin
   Knof, Kolja
   Buchecker, Kirsten
   Russo, Paola
   Veidebaum, Toomas
   Kourides, Yiannis
   de Henauw, Stefaan
   Molnar, Denes
   Bel-Serrat, Silvia
   Lissner, Lauren
   Ahrens, Wolfgang
TI Predictors and correlates of taste preferences in European children: The
   IDEFICS study
SO FOOD QUALITY AND PREFERENCE
LA English
DT Article
DE Taste preference; Cross-cultural comparison; Age; Children; Europe
ID CONSUMPTION FREQUENCIES; FOOD-CONSUMPTION; BODY-COMPOSITION; SWEET; AGE;
   PERCEPTION; OBESITY; HABITS; HUMANS; FAT
AB The present study investigated taste preferences in a sample of 1705 children aged 6 to 9 years from survey centres in Italy, Estonia, Cyprus, Belgium, Sweden, Germany, Hungary, and Spain and aimed to identify factors correlated with taste preference. Children's preferences for varying levels of sucrose (sweet) in apple juice and fat, sodium chloride (salt) and monosodium glutamate (umami) in crackers were assessed using paired-comparison tests. Socio-demographics (age, sex, parental education), early feeding practises (breastfeeding, introduction of fruits), parenting behaviour (TV viewing, using food as a reward) and taste threshold sensitivity for sucrose (sweet), sodium chloride (salt), caffeine (bitter) and monosodium glutamate (umami) were investigated as possible correlates of taste preferences. Parents reported on socio-demographics, early feeding and parenting behaviour. Taste thresholds were determined via a paired-comparison staircase method. Country of residence was the strongest factor related to preferences for all four tastes. Taste preferences also differed by age. Preference for sugar and salt increased between 6 and 9 years of age while preference for monosodium glutamate decreased. The age differences remained significant even after adjustment for sex, country of residence, parental education and early feeding habits. Sex, parental education, early feeding habits, TV viewing, using food as a reward and taste thresholds were not consistently related to taste preferences among the survey centres. In summary, the results highlight the importance of culture and age in taste preferences in children younger than 10 years of age. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Lanfer, Anne; Bammann, Karin; Ahrens, Wolfgang] BIPS Inst Epidemiol & Prevent Res, D-28359 Bremen, Germany.
   [Bammann, Karin] Univ Bremen, Inst Publ Hlth & Nursing Sci IPP, D-28359 Bremen, Germany.
   [Knof, Kolja; Buchecker, Kirsten] Ttz Bremerhaven, Dept Food Sci, D-27572 Bremerhaven, Germany.
   [Russo, Paola] CNR, Inst Food Sci, I-83100 Avellino, Italy.
   [Veidebaum, Toomas] Natl Inst Hlth Dev, EE-11619 Tallinn, Estonia.
   [Kourides, Yiannis] Child Hlth Res & Educ Inst, CY-2035 Strovolos, Cyprus.
   [de Henauw, Stefaan] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium.
   [de Henauw, Stefaan] Univ Coll Ghent, Fac Hlth Care Vesalius, Dept Nutr & Dietet, B-9000 Ghent, Belgium.
   [Molnar, Denes] Univ Pecs, Dept Pediat, H-7623 Pecs, Hungary.
   [Bel-Serrat, Silvia] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, E-50009 Zaragoza, Spain.
   [Lissner, Lauren] Univ Gothenburg, Dept Publ Hlth & Community Med, S-40530 Gothenburg, Sweden.
C3 Leibniz Association; Leibniz Institute for Prevention Research &
   Epidemiology (BIPS); University of Bremen; Consiglio Nazionale delle
   Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR);
   National Institute for Health Development - Estonia; Ghent University;
   HOGENT University College of Applied Sciences & Arts; University of
   Pecs; University of Zaragoza; University of Gothenburg
RP Ahrens, W (corresponding author), BIPS Inst Epidemiol & Prevent Res, Achterstr 30, D-28359 Bremen, Germany.
EM ahrens@bips.uni-bremen.de
RI RUSSO, Paola/A-3931-2011; Molnár, Dénes/AAB-6820-2022; Bel-Serrat,
   Silvia/K-9019-2019; Ahrens, Wolfgang/A-2740-2012
OI Bammann, Karin/0000-0002-5623-8160; Ahrens, Wolfgang/0000-0003-3777-570X
FU European Community [016181 (FOOD)]; Hans-Bockler-Stiftung
FX This work was done as part of the IDEFICS Study (www.idefics.eu). We
   gratefully acknowledge the financial support of the European Community
   within the Sixth RTD Framework Programme Contract No. 016181 (FOOD).
   Additionally, the first author acknowledges the financial contribution
   from the Hans-Bockler-Stiftung. The funding sources were not involved in
   collection, analysis and interpretation of the data, the writing of the
   report, and in the decision to submit the article for publication.
   Finally, we want to thank Monica Hunsberger for her language editing and
   valuable comments to the manuscript.
CR Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30
   [Anonymous], 1998, J AM DIET ASSOC
   [Anonymous], 2006, INT STAND CLASS ED I
   Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853
   Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41
   Brug J, 2008, BRIT J NUTR, V99, pS7, DOI 10.1017/S0007114508892458
   Cervellon MC, 2005, FOOD QUAL PREFER, V16, P455, DOI 10.1016/j.foodqual.2004.09.002
   Coldwell S. E., 2009, PHYSIOL BEHAV, V96, P574
   Cooke LJ, 2005, BRIT J NUTR, V93, P741, DOI 10.1079/BJN20051389
   Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527
   Cornwell TB, 2011, APPETITE, V56, P428, DOI 10.1016/j.appet.2011.01.010
   De Graaf C, 1999, PHYSIOL BEHAV, V67, P513, DOI 10.1016/S0031-9384(99)00090-6
   DESOR JA, 1975, SCIENCE, V190, P686, DOI 10.1126/science.1188365
   DESOR JA, 1987, PHYSIOL BEHAV, V39, P639, DOI 10.1016/0031-9384(87)90166-1
   DREWNOWSKI A, 1985, PHYSIOL BEHAV, V35, P617, DOI 10.1016/0031-9384(85)90150-7
   ENNS MP, 1979, PHYSIOL BEHAV, V22, P999, DOI 10.1016/0031-9384(79)90346-9
   Harris J, 2009, DANCING TIMES, V99, P11
   Huybrechts I, 2011, INT J OBESITY, V35, pS69, DOI 10.1038/ijo.2011.37
   KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121
   KLOEHN NW, 1948, AM J PSYCHOL, V61, P90, DOI 10.2307/1417296
   Knof K, 2011, INT J OBESITY, V35, pS131, DOI 10.1038/ijo.2011.45
   Lanfer A, 2012, INT J OBESITY, V36, P27, DOI 10.1038/ijo.2011.164
   Lanfer A, 2011, INT J OBESITY, V35, pS61, DOI 10.1038/ijo.2011.36
   Lawless HT, 2004, CHEM SENSES, V29, P25, DOI 10.1093/chemse/bjh003
   MELA DJ, 1991, AM J CLIN NUTR, V53, P908, DOI 10.1093/ajcn/53.4.908
   Mojet J, 2005, FOOD QUAL PREFER, V16, P413, DOI 10.1016/j.foodqual.2004.08.001
   MONNEUSE MO, 1991, PHYSIOL BEHAV, V50, P1111, DOI 10.1016/0031-9384(91)90569-A
   Prescott J, 2002, FOOD QUAL PREFER, V13, P489, DOI 10.1016/S0950-3293(02)00010-1
   PRESCOTT J, 1995, TRENDS FOOD SCI TECH, V6, P201, DOI 10.1016/S0924-2244(00)89055-X
   Ricketts CD, 1997, EUR J CLIN NUTR, V51, P778, DOI 10.1038/sj.ejcn.1600487
   ROZIN P, 1986, ANNU REV NUTR, V6, P433, DOI 10.1146/annurev.nu.06.070186.002245
   Skinner JD, 2002, J NUTR EDUC BEHAV, V34, P310, DOI 10.1016/S1499-4046(06)60113-9
   Suling M, 2011, INT J OBESITY, V35, pS30, DOI 10.1038/ijo.2011.33
   SULLIVAN SA, 1994, PEDIATRICS, V93, P271
   Tabacchi G, 2007, NUTR RES, V27, P587, DOI 10.1016/j.nutres.2007.06.001
   Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458
   Wright L.T., 2001, BRIT FOOD J, V103, P348, DOI DOI 10.1108/00070700110396321
NR 37
TC 20
Z9 23
U1 2
U2 117
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0950-3293
J9 FOOD QUAL PREFER
JI Food. Qual. Prefer.
PD MAR
PY 2013
VL 27
IS 2
SI SI
BP 128
EP 136
DI 10.1016/j.foodqual.2012.09.006
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 054OL
UT WOS:000312353000004
OA Green Submitted, Green Published
DA 2025-04-28
ER

PT J
AU Venables, MC
   Hulston, CJ
   Cox, HR
   Jeukendrup, AE
AF Venables, Michelle C.
   Hulston, Carl J.
   Cox, Hannah R.
   Jeukendrup, Asker E.
TI Green tea extract ingestion, fat oxidation, and glucose tolerance in
   healthy humans
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE tea catechins; substrate metabolism; oralglucose-tolerance test;
   moderate-intensity exercise; men
ID INSULIN SENSITIVITY; EXERCISE INTENSITY; METABOLISM; MUSCLE;
   PERFORMANCE; ENDURANCE; CAFFEINE; MICE; SUPPLEMENTATION; RESISTANCE
AB Background: Green tea consumption is reportedly associated with various health-promoting properties. For example, it has been shown to promote fat oxidation in humans at rest and to prevent obesity and improve insulin sensitivity in mice.
   Objective: We investigated the effects of acute ingestion of green tea extract (GTE) on glucose tolerance and fat oxidation during moderate-intensity exercise in humans.
   Design: Two studies were performed, both with a counter-balanced crossover design. In study A, 12 healthy men performed a 30-min cycling exercise at 60% of maximal oxygen consumption (<(V)over dot>O(2)max) before and after supplementation. In study B, 11 healthy men took an oral-glucose-tolerance test before and after supplementation. In the 24-h period before the experimental trials, participants ingested 3 capsules containing either GTE (total: 890 +/- 13 mg polyphenols and 366 +/- 5 mg EGCG) or a corn-flour placebo (total: 1729 +/- 22 mg).
   Results: Average fat oxidation rates were 17% higher after ingestion of GTE than after ingestion of placebo (0.41 +/- 0.03 and 0.35 +/- 0.03 g/min, respectively; P < 0.05). Moreover, the contribution of fat oxidation to total energy expenditure was also significantly higher, by a similar percentage, after GTE supplementation. The insulin area under the curve decreased in both the GTE and placebo trials (3612 +/- 301 and 4280 +/- 309 mu IU/dL (.) 120 min, respectively; P < 0.01), and there was a concomitant increase of 13% in insulin sensitivity.
   Conclusions: Acute GTE ingestion can increase fat oxidation during moderate-intensity exercise and can improve insulin sensitivity and glucose tolerance in healthy young men.
C1 [Venables, Michelle C.; Hulston, Carl J.; Cox, Hannah R.; Jeukendrup, Asker E.] Univ Birmingham, Sch Sport & Exercise Sci, Human Performance Lab, Birmingham B15 2TT, W Midlands, England.
C3 University of Birmingham
RP Jeukendrup, AE (corresponding author), Univ Birmingham, Sch Sport & Exercise Sci, Human Performance Lab, Birmingham B15 2TT, W Midlands, England.
EM a.e.jeukendrup@bham.ac.uk
RI Jeukendrup, Asker/D-1770-2010; Hulston, Carl/K-8605-2012
OI Hulston, Carl/0000-0002-5375-1161; Venables,
   Michelle/0000-0002-9380-0060
CR ARNER P, 1990, J CLIN INVEST, V85, P893, DOI 10.1172/JCI114516
   Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313
   CAMPBELL PJ, 1992, AM J PHYSIOL, V263, pE1063
   COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Horowitz JF, 1997, AM J PHYSIOL-ENDOC M, V273, pE768, DOI 10.1152/ajpendo.1997.273.4.E768
   Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005
   IVY JL, 1979, MED SCI SPORT EXER, V11, P6
   Jeukendrup AE, 1998, INT J SPORTS MED, V19, P293, DOI 10.1055/s-2007-971921
   Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512
   KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839
   Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   McArdle W.D., 2000, ESSENTIALS EXERCISE, V2nd
   Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006
   ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x
   Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200
   Watanabe J, 1998, BIOSCI BIOTECH BIOCH, V62, P532, DOI 10.1271/bbb.62.532
   WOLFE RR, 1990, AM J PHYSIOL, V258, pE382, DOI 10.1152/ajpendo.1990.258.2.E382
   Wu LY, 2004, J AGR FOOD CHEM, V52, P643, DOI 10.1021/jf030365d
   Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x
   Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200
NR 27
TC 212
Z9 238
U1 0
U2 47
PU AMER SOC CLINICAL NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, SUBSCRIPTIONS, RM L-3300, BETHESDA, MD 20814-3998
   USA
SN 0002-9165
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD MAR
PY 2008
VL 87
IS 3
BP 778
EP 784
DI 10.1093/ajcn/87.3.778
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 273KA
UT WOS:000253927700032
PM 18326618
OA Bronze
DA 2025-04-28
ER

PT J
AU Souza, RAG
   Yokoo, EM
   Sichieri, R
   Pereira, RA
AF Souza, Rita A. G.
   Yokoo, Edna M.
   Sichieri, Rosely
   Pereira, Rosangela A.
TI Energy and macronutrient intakes in Brazil: results of the first
   nationwide individual dietary survey
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Food consumption; Dietary survey; Food records; Energy intake
ID FATTY-ACIDS; MEAT CONSUMPTION; NUTRITION; FOOD; CHOLESTEROL; ADULTS;
   LIPIDS
AB Objective: To characterize energy and macronutrient intakes in Brazil and to describe the top food items contributing to energy and macronutrient intakes.
   Design: Two non-consecutive 24 h dietary records were collected and energy and macronutrient data were adjusted for usual intake distribution. Descriptive statistics and ANOVA with the Bonferroni post hoc test were analysed using SAS version 9.1. Means and standard deviations were estimated for sex, age and income strata.
   Setting: Nationwide cross-sectional survey, 2008-2009.
   Subjects: Nationally representative sample of individuals 10 years old (n32 749), excluding pregnant and lactating women (n 1254).
   Results: The average energy intake was 7958 kJ/d (1902 kcal/d) and mean energy density was 6.82 kJ/g (1.63 kcal/g). Added sugar represented 13 % of total energy intake and animal protein represented 10 %. The mean contribution of total fat to energy intake was 27 %, while the mean saturated fat contribution was 9 %. Compared with the lowest quartile of income, individuals in the highest income quartile had greater mean intakes of energy, added sugar, alcohol, animal protein, total fat, saturated fat, monounsaturated fat and trans fat. Rice, beans, beef, bread and coffee were among the top five foods contributing most to the intakes of energy, carbohydrates, protein, fat and fibre.
   Conclusions: In general, Brazilians' dietary intake is compatible with a high risk of obesity and non-communicable chronic diseases, being characterized by high intakes of added sugar and saturated fat. Income may be a major determinant of diet nutritional characteristics.
C1 [Souza, Rita A. G.] Univ Fed Mato Grosso, Inst Community Hlth, Cuiaba, MT, Brazil.
   [Yokoo, Edna M.] Univ Fed Fluminense, Dept Epidemiol & Biostat, Niteroi, RJ, Brazil.
   [Sichieri, Rosely] Univ Estado Rio De Janeiro, Dept Epidemiol, Rio De Janeiro, Brazil.
   [Pereira, Rosangela A.] Univ Fed Rio de Janeiro, Dept Social & Appl Nutr, BR-21941902 Rio De Janeiro, RJ, Brazil.
C3 Universidade Federal de Mato Grosso; Universidade Federal Fluminense;
   Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de
   Janeiro
RP Pereira, RA (corresponding author), Univ Fed Rio de Janeiro, Dept Social & Appl Nutr, Ave Carlos Chagas Filho 373,CCS Bloco J-2 Andar, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM roapereira@gmail.com
RI Pereira, Rosangela/D-8830-2013; Brito, Flavia/ADC-5052-2022
FU Brazilian Federal Agency for the Support and Evaluation of Graduate
   Education (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior,
   CAPES) [23038.008544/2010-78]; Brazilian National Council for Scientific
   and Technological Development (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, CNPq)
FX R.A.G.S. received a post-doc scholarship from the Brazilian Federal
   Agency for the Support and Evaluation of Graduate Education (Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior, CAPES; grant number
   23038.008544/2010-78). R.S. and R.A.P. received research productivity
   scholarships from the Brazilian National Council for Scientific and
   Technological Development (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, CNPq).
CR [Anonymous], 2004, PESQ ORC FAM 2002 20
   [Anonymous], NUTR DAT SYST RES ND
   [Anonymous], JOINT WHO FAO EXP CO
   [Anonymous], 2011, TAB BRAS COMP AL TAC
   [Anonymous], 2012, VIG BRAS 2011 VIG FA
   [Anonymous], PUBLIC HEALTH NUTRIT
   Azevedo MR, 2007, REV SAUDE PUBL, V41, P69, DOI 10.1590/S0034-89102007000100010
   Brasil. Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, Pesquisa de Orgamentos Familiares 2008-2009: Andlise do consumo alimentar pessoal no Brasil
   Drewnowski A, 2003, LIPIDS, V38, P109, DOI 10.1007/s11745-003-1039-3
   Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625
   Elmadfa I, 2009, FORUM NUTR, V62, P1, DOI [10.1159/000244607, 10.1159/000242367]
   Gharib N, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-62
   Gupta N, 2010, J AM COLL NUTR, V29, P81, DOI 10.1080/07315724.2010.10719820
   Haubrock J, 2011, J NUTR, V141, P914, DOI 10.3945/jn.109.120394
   Instituto Brasileiro de Geografia e Estatistica Diretoria de Pesquisas Coordenacao de Trabalho e Rendimento, 2010, PESQ ORC FAM 2008 20
   Jebb SA, 2005, P NUTR SOC, V64, P217, DOI 10.1079/PNS2005429
   Kumar V, 2012, CRIT REV FOOD SCI, V52, P899, DOI 10.1080/10408398.2010.512671
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Martin Clayton Antunes, 2006, Rev. Nutr., V19, P761, DOI 10.1590/S1415-52732006000600011
   MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703
   Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146
   Montonen J, 2013, EUR J NUTR, V52, P337, DOI 10.1007/s00394-012-0340-6
   Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164
   Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287
   Pietinen P, 2010, PUBLIC HEALTH NUTR, V13, P920, DOI 10.1017/S1368980010001102
   Pot GK, 2012, BRIT J NUTR, V107, P405, DOI 10.1017/S0007114511002911
   Salter AM, 2013, ANIMAL, V7, P163, DOI 10.1017/S1751731111002023
   Santos RD, 2013, Arq Bras Cardiol, V100, pS1
   Sarkadi Nagy Eszter, 2012, Orvosi Hetilap, V153, P1057, DOI 10.1556/OH.2012.29376
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   Temme E, 2010, BRIT J NUTR, V103, P1823, DOI 10.1017/S0007114510000085
   Tessier S, 2005, PUBLIC HEALTH NUTR, V8, P1286, DOI 10.1079/PHN2005747
   Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923
   World Cancer Research Fund, 2007, FOOD NUTR PHYS ACT P
   World Health Organization, 2007, PREV CARD DIS POCK G
NR 35
TC 29
Z9 30
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD DEC
PY 2015
VL 18
IS 17
BP 3086
EP 3095
DI 10.1017/S1368980015000750
PG 10
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA CW5IS
UT WOS:000365029500004
PM 25905449
OA Green Published
DA 2025-04-28
ER

PT J
AU Munsell, CR
   Harris, JL
   Sarda, V
   Schwartz, MB
AF Munsell, Christina R.
   Harris, Jennifer L.
   Sarda, Vishnudas
   Schwartz, Marlene B.
TI Parents' beliefs about the healthfulness of sugary drink options:
   opportunities to address misperceptions
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Sugary beverages; Food beliefs; Parents; Children
ID SWEETENED BEVERAGES; CHILDHOOD OBESITY; METABOLIC SYNDROME; CONSUMPTION;
   RISK; NUTRITION
AB Objective: To assess potential misperceptions among parents regarding the healthfulness of sugary drinks for their children.
   Design: Online survey of parents. Participants identified the categories and specific brands of sugary drinks they provided for their children. They also indicated their perceptions of sugary drink categories and brands as healthy options for children, perceived importance of on-package claims in purchase decisions and their concerns about common sugary drink ingredients.
   Setting: Online market research panel.
   Subjects: Parents (n 982) of 2- to 17-year-olds, 46 % non-white or Hispanic.
   Results: Ninety-six per cent of parents provided on average 2.9 different categories of sugary drinks for their children in the past month. Flavoured waters, fruit drinks and sports drinks were rated as the healthiest sugary drink categories. Across all categories and brands, parents who purchased specific products rated them as significantly healthier than those who did not (P < 0.05). Over half of parents reported concern about caffeine, sugar and artificial sweeteners in sugary drinks that their children consume and approximately one-third reported that on-package ingredient claims were important in their purchase decisions.
   Conclusions: Nearly all parents provide sugary drinks for their children and many believe that some sugary drinks are healthy options for children, particularly flavoured waters, fruit drinks and sports drinks. Furthermore, many parents rely upon on-package claims in their purchase decisions. Given excessive consumption of added sugar by children in the home, there is a continuing need to address parents' misperceptions about the healthfulness of many sugary drink products.
C1 [Munsell, Christina R.; Harris, Jennifer L.; Sarda, Vishnudas; Schwartz, Marlene B.] Yale Univ, Rudd Ctr Food Policy & Obes, 309 Edwards St, New Haven, CT 06511 USA.
   [Sarda, Vishnudas] Boston Childrens Hosp, Boston, MA USA.
C3 Yale University; Harvard University; Harvard University Medical
   Affiliates; Boston Children's Hospital
RP Harris, JL (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, 309 Edwards St, New Haven, CT 06511 USA.
EM jennifer.harris@yale.edu
OI Schwartz, Marlene/0000-0002-8939-1954
FU Robert Wood Johnson Foundation; Rudd Foundation
FX This research was supported by the Robert Wood Johnson Foundation and
   the Rudd Foundation. The Robert Wood Johnson Foundation and the Rudd
   Foundation had no role in the design, analysis or writing of this
   article.
CR Aaker D A., 2012, Marketing research, V11th
   American Academy of Pediatrics Committee on School Health, 2014, PEDIATRICS, V113, P152
   Andreyeva T, 2011, ECON HUM BIOL, V9, P221, DOI 10.1016/j.ehb.2011.02.004
   [Anonymous], 2010, DIET GUID AM 2010
   [Anonymous], 2004, GLOB STRAT DIET PHYS
   Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C
   Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94
   Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B
   Center for Science in the Public Interest, LIF SWEET CAMP
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1
   Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Harris JL, 2011, PUBLIC HEALTH NUTR, V14, P2207, DOI 10.1017/S1368980011001741
   Harris JL., 2011, Sugary Drink Facts: Evaluating Sugary Drink Nutrition and Marketing to Youth
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Jordan A, 2012, ANN AM ACAD POLIT SS, V640, P118, DOI 10.1177/0002716211425656
   Leibowitz J., 2012, A Review of Food Marketing to Children and Adolescents: Follow-Up Report
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   National Diabetes Information Clearinghouse, 2011, NAT DIAB STAT 2011
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI [10.1001/jama.2012.39, 10.1001/jama.2012.40]
   Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536
   Pollock NK, 2012, J NUTR, V142, P251, DOI 10.3945/jn.111.150219
   Robert Wood Johnson Foundation, 2012, RES REV
   Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965
   Simmons K, 2013, FASEB J, V27
   Stallings VA., 2007, NUTR STANDARDS FOODS
   Stevens RE, 2011, ESSENTIALS MARKETING
   Sun SS, 2008, J PEDIATR-US, V152, P191, DOI 10.1016/j.jpeds.2007.07.055
   US Department of Agriculture, CAL MAN CAN I HAV
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
NR 33
TC 79
Z9 89
U1 0
U2 27
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JAN
PY 2016
VL 19
IS 1
BP 46
EP 54
DI 10.1017/S1368980015000397
PG 9
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA DH2UH
UT WOS:000372641600006
PM 25757372
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Ruzzin, J
   Lai, YC
   Jensen, J
AF Ruzzin, J
   Lai, YC
   Jensen, J
TI Consumption of carbohydrate solutions enhances energy intake without
   increased body weight and impaired insulin action in rat skeletal
   muscles
SO DIABETES & METABOLISM
LA English
DT Article
DE diet; soft drinks; beverages; obesity; catecholamines; fructose; sucrose
ID SYMPATHETIC-NERVOUS-SYSTEM; PROTEIN-KINASE B; GLYCOGEN-SYNTHESIS;
   ADIPOSE-TISSUE; FRUCTOSE; SUCROSE; RESISTANCE; GLUCOSE; DIET; CAFFEINE
AB Objectives: In the present study, we investigated whether replacement of tap water by fructose or sucrose solutions affect rat body weight and insulin action in skeletal muscles.
   Methods: Rats were fed standard rodent chow ad libitum with water, or water containing fructose (10.5% or 35%) or sucrose (10,5% or 35%) for 11 weeks. Body weight and energy intake from chow and drinking solutions were measured. Urinary catecholamines secretion was determined after 50-60 days. At the end of the feeding period, soleus and epitrochlearis were removed for in vitro measurements of glucose uptake (with tracer amount of 2- [H-3]-deoxy-D-glucose) and PKB Ser(473) phosphorylation (assessed by Western Blot) with or without insulin.
   Results: Fructose and sucrose solutions enhanced daily energy intake by about 15% without increasing rat body weight. Secretion of urinary noradrenaline was higher in rats drinking a 35% sucrose solution than in rats drinking water. In the other groups, urinary noradrenaline secretion was similar to rats consuming water. Urinary adrenaline secretion was similar in all groups. Insulin-stimulated glucose uptake and insulin-stimulated PKB phosphorylation were not reduced by intake of fructose or sucrose solution.
   Conclusions: Fructose and sucrose solutions enhanced energy intake but did not increase body weight. Although noradrenaline may regulate body weight in rats drinking 35% sucrose solution, body weight seems to be regulated by other mechanisms. Intake of fructose or sucrose solution did not impair insulin-stimulated glucose uptake or signaling in skeletal muscles.
C1 Natl Inst Occupat Hlth, Dept Physiol, N-0033 Oslo, Norway.
RP Natl Inst Occupat Hlth, Dept Physiol, POB 8149 Dep, N-0033 Oslo, Norway.
EM jorgen.jensen@stami.no
RI Lai, Yu-Chiang/AAR-8005-2021; Jensen, Jørgen/O-2245-2013; Ruzzin,
   Jerome/AAA-5826-2020; Ruzzin, Jerome/U-1688-2017
OI Ruzzin, Jerome/0000-0003-3676-8145; Lai, Yu-Chiang/0000-0002-8254-3732
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   APUVIAN CM, 2004, JAMA-J AM MED ASSOC, V292, P978
   Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001
   Aslesen R, 1998, AM J PHYSIOL-ENDOC M, V275, pE448, DOI 10.1152/ajpendo.1998.275.3.E448
   Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160
   BECKNIELSEN H, 1980, AM J CLIN NUTR, V33, P273, DOI 10.1093/ajcn/33.2.273
   BELLET S, 1969, METABOLIS, V18, P288, DOI 10.1016/0026-0495(69)90049-3
   Bezerra RMN, 2000, J NUTR, V130, P1531, DOI 10.1093/jn/130.6.1531
   Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   BUKOWIECKI LJ, 1983, AM J PHYSIOL, V244, pR500, DOI 10.1152/ajpregu.1983.244.4.R500
   Choi SB, 2002, J NUTR BIOCHEM, V13, P727, DOI 10.1016/S0955-2863(02)00216-4
   CHOU T, 1992, WESTERN J MED, V157, P544
   Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082
   COTTETEMARD JM, 1980, J NEURAL TRANSM, V48, P189, DOI 10.1007/BF01243503
   DAI S, 1995, J PHARMACOL TOX MET, V33, P101, DOI 10.1016/1056-8719(94)00063-A
   Dulloo AG, 2002, SCIENCE, V297, P780, DOI 10.1126/science.1074923
   EIFFERT KC, 1993, J GERONTOL, V48, pB206, DOI 10.1093/geronj/48.6.B206
   El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170
   French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309
   Gross LS, 2004, AM J CLIN NUTR, V79, P774
   Hay M, 2000, J ANIM SCI, V78, P420
   HILL R, 1954, J BIOL CHEM, V209, P705
   HOLMES C, 1994, J CHROMATOGR B, V653, P131, DOI 10.1016/0378-4347(93)E0430-X
   HOWRD BV, 2002, AM J MED S9B, V113, pS38
   Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547
   Jensen J, 2002, PFLUG ARCH EUR J PHY, V444, P213, DOI 10.1007/s00424-002-0793-1
   Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANDSBERG L, 1978, NEW ENGL J MED, V298, P1295, DOI 10.1056/NEJM197806082982306
   LANDSBERG L, 1983, AM J CLIN NUTR, V38, P1018, DOI 10.1093/ajcn/38.6.1018
   Lentner C., 1981, GEIGY SCI TABLES, V8th
   Levi B, 1998, J NUTR, V128, P1442, DOI 10.1093/jn/128.9.1442
   LEVI L, 1967, ACTA MED SCAND, V181, P431
   Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212
   Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527
   Lowry OH., 1972, FLEXIBLE SYSTEM ENZY, P1
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   MAEGAWA H, 1986, AM J PHYSIOL, V251, pE616, DOI 10.1152/ajpendo.1986.251.5.E616
   Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020
   Pagliassotti MJ, 1996, AM J PHYSIOL-REG I, V271, pR1319, DOI 10.1152/ajpregu.1996.271.5.R1319
   Pagliassotti MJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE170, DOI 10.1152/ajpendo.2002.282.1.E170
   PAGLIASSOTTI MJ, 1994, AM J PHYSIOL, V266, pR1637, DOI 10.1152/ajpregu.1994.266.5.R1637
   PAGLIASSOTTI MJ, 1995, AM J PHYSIOL-REG I, V269, pR641, DOI 10.1152/ajpregu.1995.269.3.R641
   Qin B, 2004, HORM METAB RES, V36, P119, DOI 10.1055/s-2004-814223
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276
   Stark AH, 2000, EUR J NUTR, V39, P229, DOI 10.1007/s003940070016
   Strack AM, 1997, AM J PHYSIOL-REG I, V272, pR840, DOI 10.1152/ajpregu.1997.272.3.R840
   THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155
   Thresher JS, 2000, AM J PHYSIOL-REG I, V279, pR1334, DOI 10.1152/ajpregu.2000.279.4.R1334
   TOPPING DL, 1971, NUTR METAB, V13, P331
   Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315
   VRANA A, 1978, METABOLISM, V27, P885, DOI 10.1016/0026-0495(78)90131-2
   VRANA A, 1978, NUTR METAB, V22, P313
   WALGREN MC, 1987, METABOLISM, V36, P585, DOI 10.1016/0026-0495(87)90172-7
   Wang QH, 1999, MOL CELL BIOL, V19, P4008
   Webber J, 2003, P NUTR SOC, V62, P539, DOI 10.1079/PNS2003256
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763
   YOUNG JB, 1977, NATURE, V269, P615, DOI 10.1038/269615a0
   YOUNG JB, 1977, CLIN RES, V25, pA404
   YOUNG JB, 1981, AM J PHYSIOL, V240, pE314, DOI 10.1152/ajpendo.1981.240.3.E314
NR 63
TC 7
Z9 8
U1 0
U2 5
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
EI 1878-1780
J9 DIABETES METAB
JI Diabetes Metab.
PD APR
PY 2005
VL 31
IS 2
BP 178
EP 188
DI 10.1016/S1262-3636(07)70184-2
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 921FG
UT WOS:000228749000011
PM 15959424
DA 2025-04-28
ER

PT J
AU Kubo, K
   Kiyose, C
   Ogino, S
   Saito, M
AF Kubo, K
   Kiyose, C
   Ogino, S
   Saito, M
TI Suppressive effect of Citrus aurantium against body fat
   accumulation and its safety
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE Citrus aurantium; synephrine; dietary supplement; body fat accumulation;
   safety
ID HUMAN BETA-3-ADRENERGIC RECEPTOR; MOLECULAR-CLONING; DOWN-REGULATION;
   ADIPOSE-TISSUE; SYNEPHRINE; OCTOPAMINE; EXTRACTS; OBESITY; PLANTS; WHITE
AB A large number of so-called diet foods containing Citrus aurantium (CA) and its active constituent, synephrine, for suppressing body fat accumulation are currently on the market. However, only one human study has demonstrated the efficacy of CA, and its potential cardiotoxicity has been reported in a rat study. Therefore, we investigated the safety of CA and its suppressive effect against body fat accumulation in rats. High-fat (20% (w/w)) diets containing CA (synephrine content, 6.4%) at 0, 40, 200, 1,000, and 5,000 mg/kg diet were fed to rats ad libitum for 79 days. For dieting, the recommended daily intake of CA in many dietary supplements ranges from 100 to 1,000 mg/day, and the amount used in this experiment was approximately equivalent to 40 and/or 200 mg/kg diet. In the 5,000 mg/kg CA group, the adrenaline and dopamine concentrations in plasma were significantly higher, perirenal fat pad weight was significantly lower, and body weight tended to be lower than in the control group. Although no abnormalities of serum clinical and biochemical parameters were observed except for adrenaline and dopamine, and also no histopathological abnormalities were evident in the heart, heart weight in the 5,000 mg/kg CA group was significantly lower than in the control group. Therefore, it is necessary to examine more precisely the potential cardiotoxicity caused by excess intake of CA. Particularly, the elucidation of influences of the simultaneous intake of CA and some stimulants, such as caffeine, awaits further characterization.
C1 Natl Inst Hlth & Nutr, Div Food Sci, Inc Adm Agcy, Shinjuku Ku, Tokyo 1628636, Japan.
C3 National Institute of Health & Nutrition - Japan
RP Saito, M (corresponding author), Natl Inst Hlth & Nutr, Div Food Sci, Inc Adm Agcy, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.
EM msaito@nih.go.jp
CR ATWATER WO, 1910, USDA FARMERS B, V142, P48
   BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297
   Calapai G, 1999, FITOTERAPIA, V70, P586, DOI 10.1016/S0367-326X(99)00093-3
   Carpéné C, 1999, N-S ARCH PHARMACOL, V359, P310, DOI 10.1007/PL00005357
   Carpéné C, 1998, ANN NY ACAD SCI, V839, P186, DOI 10.1111/j.1749-6632.1998.tb10756.x
   Colker CM, 1999, CURR THER RES CLIN E, V60, P145, DOI 10.1016/S0011-393X(00)88523-9
   DUNCAN DB, 1957, BIOMETRICS, V13, P164, DOI 10.2307/2527799
   EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461
   GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895
   IBRAHIM KE, 1985, J NEUROCHEM, V44, P1862, DOI 10.1111/j.1471-4159.1985.tb07180.x
   KUSU F, 1995, CHEM PHARM BULL, V43, P1158, DOI 10.1248/cpb.43.1158
   LAFONTAN M, 1993, J LIPID RES, V34, P1057
   LELIAS JM, 1993, FEBS LETT, V324, P127, DOI 10.1016/0014-5793(93)81377-C
   Marcus DM, 2003, SCIENCE, V301, P1669
   Moro CO, 2000, FITOTERAPIA, V71, pS73, DOI 10.1016/S0367-326X(00)00177-5
   MUZZIN P, 1991, J BIOL CHEM, V266, P24053
   NAHMIAS C, 1991, EMBO J, V10, P3721, DOI 10.1002/j.1460-2075.1991.tb04940.x
   Nykamp DL, 2004, ANN PHARMACOTHER, V38, P812, DOI 10.1345/aph.1D473
   Park JH, 1998, GEN COMP ENDOCR, V110, P88, DOI 10.1006/gcen.1997.7053
   Parra AL, 2001, PHYTOMEDICINE, V8, P395, DOI 10.1078/0944-7113-00044
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Shirai Y, 2003, J CLIN BIOCHEM NUTR, V33, P53
   STEWART I, 1964, J BIOL CHEM, V239, P930
   WHEATLEY AM, 1985, J MOL CELL CARDIOL, V17, P349, DOI 10.1016/S0022-2828(85)80134-6
   WHEATON TA, 1970, LLOYD, V33, P244
NR 25
TC 9
Z9 9
U1 0
U2 4
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PY 2005
VL 36
IS 1
BP 11
EP 17
DI 10.3164/jcbn.36.11
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 916QV
UT WOS:000228401600002
OA Bronze
DA 2025-04-28
ER

PT J
AU Park, S
   Blanck, HM
   Dooyema, CA
   Ayala, GX
AF Park, Sohyun
   Blanck, Heidi M.
   Dooyema, Carrie A.
   Ayala, Guadalupe X.
TI Association Between Sugar-Sweetened Beverage Intake and Proxies of
   Acculturation Among US Hispanic and Non-Hispanic White Adults
SO AMERICAN JOURNAL OF HEALTH PROMOTION
LA English
DT Article
DE sugar-sweetened beverages; hispanic; acculturation; language;
   birthplace; prevention research
ID CORONARY-HEART-DISEASE; CALORIC BEVERAGES; UNITED-STATES; CONSUMPTION;
   RISK; OBESITY; QUESTIONNAIRE; CHILDREN; WEIGHT; ENERGY
AB Purpose: This study examined associations between sugar-sweetened beverage (SSB) intake and acculturation among a sample representing civilian noninstitutionalized U.S. adults.
   Design: Quantitative, cross-sectional study.
   Setting: National.
   Subjects: The 2010 National Health Interview Survey data for 17,142 Hispanics and U.S.-born non-Hispanic whites (>= 18 years).
   Measures: The outcome variable was daily SSB intake (nondiet soda, fruit drinks, sports drinks, energy drinks, and sweetened coffee/tea drinks). Exposure variables were Hispanic ethnicity and proxies of acculturation (language of interview, birthplace, and years living in the United States).
   Analysis: We used multivariate logistic regression to estimate adjusted odds ratios (ORs) for the exposure variables associated with drinking SSB >= 1 time/d after controlling for covariates.
   Results: The adjusted odds of drinking SSB >= 1 time/d was significantly higher among Hispanics who completed the interview in Spanish (OR = 1.65) than U.S.-born non-Hispanic whites. Compared with those who lived in the United States for < 5 years, the adjusted odds of drinking SSB >= 1 time/d was higher among adults who lived in the United States for 5 to < 10 years (OR = 2.72), those who lived in the United States for 10 to < 15 years (OR = 2.90), and those who lived in the United States for >= 15 years (OR = 2.41). However, birthplace was not associated with daily SSB intake.
   Conclusion: The acculturation process is complex and these findings contribute to identifying important subpopulations that may benefit from targeted intervention to reduce SSB intake.
C1 [Park, Sohyun; Blanck, Heidi M.; Dooyema, Carrie A.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy,NE,Mailstop F77, Atlanta, GA 30341 USA.
   [Ayala, Guadalupe X.] San Diego State Univ, Div Hlth Promot & Behav Sci, Inst Behav & Community Hlth, San Diego, CA 92182 USA.
   [Ayala, Guadalupe X.] San Diego Prevent Res Ctr, San Diego, CA USA.
C3 Centers for Disease Control & Prevention - USA; California State
   University System; San Diego State University
RP Park, S (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy,NE,Mailstop F77, Atlanta, GA 30341 USA.
EM spark3@cdc.gov
OI Park, Sohyun/0000-0002-8192-7048
FU Intramural CDC HHS [CC999999] Funding Source: Medline
CR [Anonymous], 2010, DIET GUID AM 2010
   [Anonymous], NIH PUBLICATION
   Ayala GX, 2008, J AM DIET ASSOC, V108, P1330, DOI 10.1016/j.jada.2008.05.009
   Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974
   Bernstein AM, 2012, AM J CLIN NUTR, V95, P1190, DOI 10.3945/ajcn.111.030205
   Brener N, 2011, MMWR-MORBID MORTAL W, V60, P778
   Centers for Disease Control and Prevention US Department of Health and Human Services, 2011, 2010 NAT HLTH INT SU
   Clark SE, 2012, INT J OCCUP ENV HEAL, V18, P53, DOI 10.1179/1077352512Z.0000000007
   de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Hedrick VE, 2012, J ACAD NUTR DIET, V112, P840, DOI 10.1016/j.jand.2012.01.023
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Himmelgreen DA, 2005, ECOL FOOD NUTR, V44, P105, DOI 10.1080/03670240590923514
   Kim H, 2010, WATER CONDITIONING P, V52, P42
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Kumar GS, 2014, MMWR-MORBID MORTAL W, V63, P686
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Marin G, 1996, HISPANIC J BEHAV SCI, V18, P297, DOI 10.1177/07399863960183002
   Novotny R, 2009, J AM DIET ASSOC, V109, P1712, DOI 10.1016/j.jada.2009.07.013
   rodwan John g., 2012, Bottled water 2011: the recovery continues
   Satia-Abouta J, 2002, J AM DIET ASSOC, V102, P1105, DOI 10.1016/S0002-8223(02)90247-6
   Sharkey JR, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.5819
   Sharkey JR, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-101
   Stanhope KL, 2011, J CLIN ENDOCR METAB, V96, pE1596, DOI 10.1210/jc.2011-1251
   Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652
   Sukalakamala S, 2006, J AM DIET ASSOC, V106, P103, DOI 10.1016/j.jada.2005.09.050
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
NR 34
TC 28
Z9 39
U1 0
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0890-1171
EI 2168-6602
J9 AM J HEALTH PROMOT
JI Am. J. Health Promot.
PD MAY-JUN
PY 2016
VL 30
IS 5
BP 357
EP 364
DI 10.1177/0890117116646343
PG 8
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA DM4GG
UT WOS:000376304300007
PM 27404644
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Kobayashi, S
   Asakura, K
   Suga, H
   Sasaki, S
AF Kobayashi, S.
   Asakura, K.
   Suga, H.
   Sasaki, S.
CA Three Generation Study Women Diets
TI Inverse association between dietary habits with high total antioxidant
   capacity and prevalence of frailty among elderly Japanese women: A
   multicenter cross-sectional study
SO JOURNAL OF NUTRITION HEALTH & AGING
LA English
DT Article
DE Frailty; dietary total antioxidant capacity; brief-type
   self-administered diet history questionnaire; elderly Japanese women
ID FOOD-FREQUENCY QUESTIONNAIRE; SF-36 HEALTH SURVEY; C-REACTIVE PROTEIN;
   OLDER-ADULTS; HISTORY QUESTIONNAIRES; ABDOMINAL OBESITY; OXIDATIVE
   STRESS; PREDICT FRAILTY; REDOX STATUS; AGED 65
AB To examine the association of dietary habits with high total antioxidant capacity (TAC) with frailty among elderly Japanese women.
   Cross-sectional multicenter study.
   Thirty-five of 47 prefectures in Japan.
   2121 grandmothers or acquaintances of dietetic students aged 65 and older.
   Dietary TAC and food intakes were calculated using a validated brief-type self-administered diet history questionnaire. The TAC value of each food was assigned using four different assays, ferric reducing ability of plasma (FRAP), oxygen radical absorbance capacity (ORAC), Trolox equivalent antioxidant capacity (TEAC), and total radical-trapping antioxidant parameter (TRAP). Frailty was defined as the presence three or more of the following four components: slowness and weakness (two points), exhaustion, low physical activity, and unintentional weight loss.
   The number of subjects with frailty was 486 (23%). Multivariate adjusted ORs (95% CI) for frailty in the highest compared to the lowest quintile were 0.35 (0.24, 0.53) for FRAP, 0.35 (0.23, 0.52) for ORAC, 0.40 (0.27, 0.60) for TEAC, and 0.41 (0.28, 0.62) for TRAP. The intakes of green tea, coffee, vegetables, and fruits which contribute to dietary TAC were also associated with lower odds of frailty (the range of multivariate adjusted OR: 0.47 for vegetables to 0.77 for green tea), although the odds ratios were less marked than those of dietary TAC.
   Dietary habits with high TAC showed a stronger inverse association with frailty in elderly Japanese women than the individual foods examined.
C1 [Kobayashi, S.; Suga, H.; Sasaki, S.] Univ Tokyo, Dept Social & Prevent Epidemiol, Grad Sch Med, Tokyo 1130033, Japan.
   [Asakura, K.; Sasaki, S.] Univ Tokyo, Dept Social & Prevent Epidemiol, Sch Publ Hlth, Tokyo 1130033, Japan.
   [Asakura, K.] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan.
C3 University of Tokyo; University of Tokyo; University of Tokyo
RP Sasaki, S (corresponding author), Univ Tokyo, Dept Social & Prevent Epidemiol, Sch Publ Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
EM stssasak@m.u-tokyo.ac.jp
RI Asakura, Keiko/HLG-5315-2023
OI Kobayashi, Satomi/0000-0001-8798-8549; Asakura,
   Keiko/0000-0002-2323-1640
FU JSPS KAKENHI Grant from the Japan Society for the Promotion of Science
   [22240077]; Grants-in-Aid for Scientific Research [24500837, 26305027,
   22240077] Funding Source: KAKEN
FX This study was funded by JSPS KAKENHI Grant Number 22240077 from the
   Japan Society for the Promotion of Science. We thank the members of the
   Three-generation Study of Women on Diets and Health Study Group (in
   addition to the authors; Supplementary Material 3).
CR Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12
   Bartali B, 2006, J GERONTOL A-BIOL, V61, P589, DOI 10.1093/gerona/61.6.589
   Ble A, 2006, J GERONTOL A-BIOL, V61, P278, DOI 10.1093/gerona/61.3.278
   Bollwein J, 2013, J GERONTOL A-BIOL, V68, P483, DOI 10.1093/gerona/gls204
   Brighenti F, 2005, BRIT J NUTR, V93, P619, DOI 10.1079/BJN20051400
   Carlsen MH, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-3
   Chan DCD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-58
   Chen XL, 2010, J CLIN ONCOL, V28, P991, DOI 10.1200/JCO.2009.23.0565
   Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x
   Dent E, 2012, J NUTR HEALTH AGING, V16, P764, DOI 10.1007/s12603-012-0405-5
   Detopoulou P, 2010, EUR J CLIN NUTR, V64, P161, DOI 10.1038/ejcn.2009.130
   Devore EE, 2010, AM J CLIN NUTR, V92, P1157, DOI 10.3945/ajcn.2010.29634
   Doba N, 2012, EXP GERONTOL, V47, P638, DOI 10.1016/j.exger.2012.05.016
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X
   Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1
   Fukuhara S., 2004, MANUAL SF 36V2 JAPAN
   Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4
   Hermsdorff HHM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-42
   Hsiao PY, 2013, J NUTR HEALTH AGING, V17, P19, DOI 10.1007/s12603-012-0082-4
   Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186
   Kaiser MJ, 2009, AGING MALE, V12, P87, DOI 10.3109/13685530903296706
   Kobayashi S, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-91
   Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075
   Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504
   Kolomvotsou AI, 2013, EUR J NUTR, V52, P37, DOI 10.1007/s00394-011-0283-3
   La Vecchia C, 2013, INT J CANCER, V133, P1447, DOI 10.1002/ijc.28133
   Lakey SL, 2012, J AM GERIATR SOC, V60, P854, DOI 10.1111/j.1532-5415.2012.03940.x
   Lee PH, 2012, J CLIN GERONTOL GERI, V3, P47, DOI 10.1016/j.jcgg.2012.04.001
   Michelon E, 2006, J GERONTOL A-BIOL, V61, P600, DOI 10.1093/gerona/61.6.600
   Ministry of Education Culture Sports and Technology, 2012, GEN SURV SCH
   Ministry of Health Labour and Welfare, 2009, DIET REF INT JAP 201
   Mulero J, 2011, J NUTR HEALTH AGING, V15, P756, DOI 10.1007/s12603-011-0130-5
   Murayama H, 2012, J EPIDEMIOL, V22, P551, DOI 10.2188/jea.JE20120015
   Nemoto M, 2012, ARCH GERONTOL GERIAT, V55, P385, DOI 10.1016/j.archger.2011.10.004
   Niu KJ, 2009, AM J CLIN NUTR, V90, P1615, DOI 10.3945/ajcn.2009.28216
   Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812
   Pellegrini N, 2007, J NUTR, V137, P93, DOI 10.1093/jn/137.1.93
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Raji MA, 2010, J GERONTOL A-BIOL, V65, P1228, DOI 10.1093/gerona/glq121
   Rautiainen S, 2008, AM J CLIN NUTR, V87, P1247, DOI 10.1093/ajcn/87.5.1247
   Science and Technology Agency, 2010, STAND TABL FOOD COMP
   Semba RD, 2006, J GERONTOL A-BIOL, V61, P594, DOI 10.1093/gerona/61.6.594
   Serafini M, 2004, REDOX REP, V9, P145, DOI 10.1179/135100004225004814
   Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543
   Takebayashi J, 2010, BIOSCI BIOTECH BIOCH, V74, P2137, DOI 10.1271/bbb.100430
   Talegawkar SA, 2012, J NUTR, V142, P2161, DOI 10.3945/jn.112.165498
   Valtuena S, 2008, AM J CLIN NUTR, V87, P1290, DOI 10.1093/ajcn/87.5.1290
   Wada K, 2007, AM J IND MED, V50, P8, DOI 10.1002/ajim.20403
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
   Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x
NR 51
TC 60
Z9 62
U1 0
U2 27
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 1279-7707
EI 1760-4788
J9 J NUTR HEALTH AGING
JI J. Nutr. Health Aging
PD DEC
PY 2014
VL 18
IS 9
BP 827
EP 836
DI 10.1007/s12603-014-0556-7
PG 10
WC Geriatrics & Gerontology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology; Nutrition & Dietetics
GA AW3LE
UT WOS:000346187400008
PM 25389961
OA hybrid
DA 2025-04-28
ER

PT J
AU Vernarelli, JA
   Lambert, JD
AF Vernarelli, Jacqueline A.
   Lambert, Joshua D.
TI Tea consumption is inversely associated with weight status and other
   markers for metabolic syndrome in US adults
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE NHANES; Tea; Obesity; Waist circumference; BMI; Metabolic syndrome
ID SUGAR-SWEETENED BEVERAGES; GREEN TEA; ENERGY-EXPENDITURE; BODY-WEIGHT;
   RISK; INHIBITION; PREVENTION; OBESITY; COFFEE; FAT
AB Tea (Camellia sinensis) is a widely consumed beverage, and laboratory and some intervention studies have indicated the potential health benefits of hot tea. The present study examines the association between tea consumption (evaluating hot and iced tea independently) and markers for metabolic syndrome adults in a sample of 6,472 who participated in the 2003-2006 National Health and Nutrition Examination surveys.
   Tea consumption was evaluated using food frequency questionnaires and 24-h dietary recalls. Seventy percent of the sample reported any consumption of iced tea and 16 % were daily consumers, whereas approximately 56 % of this sample reported hot tea consumption and 9 % were daily consumers.
   Hot tea consumption was inversely associated with obesity: tea consumers had lower mean waist circumference and lower BMI (25 vs. 28 kg/m(2) in men; 26 vs. 29 kg/m(2) in women; both P < 0.01) than non-consumers after controlling for age, physical activity, total energy intake, and other confounders. For iced tea consumption, the association was reversed: increased iced tea consumption was associated with higher BMI, greater waist circumference, and greater subcutaneous skinfold thickness after controlling for age, physical activity, energy intake, sugar intake, and other confounders. Hot tea consumption was associated with beneficial biomarkers of cardiovascular disease risk and inflammation (increased high-density lipoprotein-associated cholesterol and decreased C-reactive protein in both sexes, and reduced triglycerides in women), whereas the association with iced tea consumption was again reversed.
   These cross-sectional results support growing laboratory data, which demonstrate the negative association of hot tea intake with markers of MetS.
C1 [Vernarelli, Jacqueline A.] Penn State Univ, Dept Nutr Sci, Chandlee Lab 110, University Pk, PA 16802 USA.
   [Vernarelli, Jacqueline A.; Lambert, Joshua D.] Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Penn State Behrend; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); Pennsylvania State University; Pennsylvania
   State University - University Park; Penn State Behrend
RP Vernarelli, JA (corresponding author), Penn State Univ, Dept Nutr Sci, Chandlee Lab 110, University Pk, PA 16802 USA.
EM jvern@psu.edu; jdl134@psu.edu
RI Lambert, Joshua/M-1788-2014
FU National Institutes of Health [AT 004678]
FX JAV performed the analysis and wrote the first draft of the manuscript,
   JDL provided critical revisions to the manuscript prior to submission.
   Both authors read, reviewed, and approved the final version of this
   manuscript. The authors thank Dr. Terry J. Hartman for her careful
   critique of this manuscript. This study was supported by National
   Institutes of Health Grant AT 004678 (to JDL).
CR Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Brewer HB, 2011, J CLIN ENDOCR METAB, V96, P1246, DOI 10.1210/jc.2010-0163
   de Couto G, 2010, NAT REV CARDIOL, V7, P334, DOI 10.1038/nrcardio.2010.51
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Goris AHC, 2000, AM J CLIN NUTR, V71, P130
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Grove KA, 2010, J NUTR, V140, P446, DOI 10.3945/jn.109.115972
   HOLLANDS MA, 1981, AM J CLIN NUTR, V34, P2291, DOI 10.1093/ajcn/34.10.2291
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Kim MK, 2011, DIABETES RES CLIN PR, V93, P174, DOI 10.1016/j.diabres.2011.04.009
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Liang YC, 2002, NUTR CANCER, V42, P217, DOI 10.1207/S15327914NC422_11
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966
   Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025
   Richard D, 2009, PHARMACOL RES, V59, P351, DOI 10.1016/j.phrs.2009.01.015
   Seeram NP, 2008, J AGR FOOD CHEM, V56, P1415, DOI 10.1021/jf073035s
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Tooze JA, 2004, AM J CLIN NUTR, V79, P795
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Ukil A, 2006, BRIT J PHARMACOL, V149, P121, DOI 10.1038/sj.bjp.0706847
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Weisburger JH, 1997, CANCER LETT, V114, P315, DOI 10.1016/S0304-3835(97)04691-0
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
   Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008
NR 35
TC 73
Z9 80
U1 0
U2 64
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD APR
PY 2013
VL 52
IS 3
BP 1039
EP 1048
DI 10.1007/s00394-012-0410-9
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 119DY
UT WOS:000317078900018
PM 22777108
OA Green Accepted
DA 2025-04-28
ER

PT J
AU Fogelholm, M
   Kanerva, N
   Männistö, S
AF Fogelholm, M.
   Kanerva, N.
   Mannisto, S.
TI Association between red and processed meat consumption and chronic
   diseases: the confounding role of other dietary factors
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
ID ENERGY-INTAKE; WEIGHT-GAIN; CARDIOVASCULAR RISK; UNPROCESSED RED;
   CANCER; WOMEN; CARBOHYDRATE; MORTALITY; PATTERNS; CUTOFF
AB BACKGROUND/OBJECTIVES: High consumption of meat has been linked with the risk for obesity and chronic diseases. This could partly be explained by the association between meat and lower-quality diet. We studied whether high intake of red and processed meat was associated with lower-quality dietary habits, assessed against selected nutrients, other food groups and total diet. Moreover, we studied whether meat consumption was associated with obesity, after adjustment for all identified associations between meat and food consumption.
   SUBJECTS/METHODS: The nationally representative cross-sectional study population consisted of 2190 Finnish men and 2530 women, aged 25-74 years. Food consumption over the previous 12 months was assessed using a validated 131-item Food Frequency Questionnaire. Associations between nutrients, foods, a modified Baltic Sea Diet Score and meat consumption (quintile classification) were analysed using linear regression. The models were adjusted for age and energy intake and additionally for education, physical activity and smoking.
   RESULTS: High consumption of red and processed meat was inversely associated with fruits, whole grain and nuts, and positively with potatoes, oil and coffee in both sexes. Results separately for the two types of meat were essentially similar. In a linear regression analysis, high consumption of meat was positively associated with body mass index in both men and women, even when using a model adjusted for all foods with a significant association with meat consumption in both sexes identified in this study.
   CONCLUSIONS: The association between meat consumption and a lower-quality diet may complicate studies on meat and health.
C1 [Fogelholm, M.] Univ Helsinki, Dept Food & Environm Sci, FI-00014 Helsinki, Finland.
   [Kanerva, N.] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.
   [Kanerva, N.; Mannisto, S.] Natl Inst Hlth & Welf, Helsinki, Finland.
C3 University of Helsinki; University of Helsinki; Finland National
   Institute for Health & Welfare
RP Fogelholm, M (corresponding author), Univ Helsinki, Dept Food & Environm Sci, POB 99, FI-00014 Helsinki, Finland.
EM mikael.fogelholm@helsinki.fi
OI Mannisto, Satu/0000-0002-8668-3046; Kanerva, Noora/0000-0001-6776-9357;
   Fogelholm, Mikael/0000-0001-8110-102X
FU Academy of Finland [136895, 263836]; Academy of Finland (AKA) [136895,
   263836] Funding Source: Academy of Finland (AKA); European Research
   Council (ERC) [263836] Funding Source: European Research Council (ERC)
FX The study was supported by the Academy of Finland (grants 136895 and
   263836).
CR [Anonymous], BR J NUTR
   Aston LM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001072
   Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376
   Brennan IM, 2012, AM J PHYSIOL-GASTR L, V303, pG129, DOI 10.1152/ajpgi.00478.2011
   Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]
   FAO/WHO/UNU, 1985, EN PROT REQ
   Fogelholm M, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.19103
   Fretts AM, 2012, AM J CLIN NUTR, V95, P752, DOI 10.3945/ajcn.111.029942
   Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235
   GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569
   Halkjer J, 2009, J AM DIET ASSOC, V109, P1356, DOI 10.1016/j.jada.2009.05.015
   Kaartinen NE, 2012, BRIT J NUTR, V107, P1367, DOI 10.1017/S0007114511004296
   Kappeler R, 2013, EUR J CLIN NUTR, V67, P598, DOI 10.1038/ejcn.2013.59
   Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149
   Larsson SC, 2012, BRIT J CANCER, V106, P603, DOI 10.1038/bjc.2011.585
   Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X
   Männistö S, 2010, BRIT J NUTR, V103, P1817, DOI 10.1017/S0007114510000073
   Meltzer HM, 2008, MATERN CHILD NUTR, V4, P14, DOI 10.1111/j.1740-8709.2007.00104.x
   Micha R, 2012, CURR ATHEROSCLER REP, V14, P515, DOI 10.1007/s11883-012-0282-8
   Mikkilä V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978
   R Development Core Team, R: A language and enviroment for statistical computing
   Reinivuo H, 2010, PUBLIC HEALTH NUTR, V13, P915, DOI 10.1017/S1368980010001096
   Rohrmann S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-63
   Romaguera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023384
   Rosell M, 2006, INT J OBESITY, V30, P1389, DOI 10.1038/sj.ijo.0803305
   Sánchez-Villegas A, 2006, INT J OBESITY, V30, P350, DOI 10.1038/sj.ijo.0803118
   Tolonen H., 2008, Recommendations for the Health Examination Surveys in Europe
   Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330
   Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713
   WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366
NR 32
TC 41
Z9 44
U1 0
U2 41
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD SEP
PY 2015
VL 69
IS 9
BP 1060
EP 1065
DI 10.1038/ejcn.2015.63
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CQ7SX
UT WOS:000360805600011
PM 25969395
DA 2025-04-28
ER

PT J
AU Kourouniotis, S
   Keast, RSJ
   Riddell, LJ
   Lacy, K
   Thorpe, MG
   Cicerale, S
AF Kourouniotis, S.
   Keast, R. S. J.
   Riddell, L. J.
   Lacy, K.
   Thorpe, M. G.
   Cicerale, S.
TI The importance of taste on dietary choice, behaviour and intake in a
   group of young adults
SO APPETITE
LA English
DT Article
DE Taste importance; Taste; Food choice; Influences; Nutrition; Young
   adults
ID ENERGY DENSITY; FOOD; STUDENTS; OBESITY; HABITS; HEALTH; CONSUMPTION;
   PREFERENCES; ATTITUDES; NUTRITION
AB The 'taste of food' plays an important role in food choice. Furthermore, foods high in fat, sugar and salt are highly palatable and associated with increased food consumption. Research exploring taste importance on dietary choice, behaviour and intake is limited, particularly in young adults. Therefore, in this study a total of 1306 Australian university students completed questionnaires assessing dietary behaviors (such as how important taste was on food choice) and frequency of food consumption over the prior month. Diet quality was also assessed using a dietary guideline index. Participants had a mean age of 20 +/- 5 years, Body Mass Index (BMI) of 22 +/- 3 kg/m(2), 79% were female and 84% Australian. Taste was rated as being a very or extremely important factor for food choice by 82% of participants. Participants who rated taste as highly important, had a poorer diet quality (p = 0.001) and were more likely to consume less fruit (p = 0.03) and vegetables (p = 0.05). Furthermore, they were significantly more likely to consume foods high in fat, sugar and salt, including chocolate and confectionary, cakes and puddings, sweet pastries, biscuits, meat pies, pizza, hot chips, potato chips, takeaway meals, soft drink, cordial and fruit juice (p = 0.001-0.02). They were also more likely to consider avoiding adding salt to cooking (p = 0.02) and adding sugar to tea or coffee (p = 0.01) as less important for health. These findings suggest that the importance individuals place on taste plays an important role in influencing food choice, dietary behaviors and intake. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Kourouniotis, S.; Keast, R. S. J.; Cicerale, S.] Deakin Univ, Ctr Adv Sensory Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.
   [Riddell, L. J.; Lacy, K.; Thorpe, M. G.] Deakin Univ, Ctr Phys Act & Nutr Res, 221 Burwood Highway, Burwood, Vic 3125, Australia.
C3 Deakin University; Deakin University
RP Cicerale, S (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, 221 Burwood Highway, Burwood, Vic 3125, Australia.
EM sara.cicerale@deakin.edu.au
RI Mead, Maree/AAH-3587-2021; Lacy, Kathleen/B-4179-2017; Riddell,
   Lynn/P-4950-2016; Keast, Russell/P-1899-2017
OI Riddell, Lynn/0000-0002-0688-2134; Lacy, Kathleen
   Erin/0000-0002-2982-4455; Mead, Maree G/0000-0001-6101-6709; Keast,
   Russell/0000-0003-2147-7687; Cicerale, Sara/0000-0002-1100-0423
CR Anderson Drew A, 2003, Eat Behav, V4, P363, DOI 10.1016/S1471-0153(03)00030-8
   [Anonymous], 2013, AUSTR DIET GUID
   [Anonymous], 2013, NUTR 1 RES FOODS NUT
   [Anonymous], 2013, 4364 0 55 003 AUSTR
   [Anonymous], P 4 INT C COMP CREAT
   [Anonymous], 1998, J AM DIET ASSOC
   Ansari W. E., 2012, NUTR J, V11, P1
   Bagordo F, 2013, J FOOD NUTR RES-SLOV, V52, P164
   Barclay AW, 2011, NUTRIENTS, V3, P491, DOI 10.3390/nu3040491
   BEAUCHAMP GK, 1987, AM SCI, V75, P27
   BERTINO M, 1986, PHYSIOL BEHAV, V38, P203, DOI 10.1016/0031-9384(86)90155-1
   Biloukha OO, 2001, PUBLIC HEALTH NUTR, V4, P207, DOI 10.1079/PHN200059
   BIRCH LL, 1992, NUTR REV, V50, P249, DOI 10.1111/j.1753-4887.1992.tb01341.x
   DeBate RD, 2001, ADOLESCENCE, V36, P819
   Deliens T, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-162
   Drewnowski A, 1997, J AM DIET ASSOC, V97, P266, DOI 10.1016/S0002-8223(97)00070-9
   Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S
   DREWNOWSKI A, 1983, PHYSIOL BEHAV, V30, P629, DOI 10.1016/0031-9384(83)90232-9
   Drewnowski A, 2004, AM J CLIN NUTR, V79, P6
   DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P1081, DOI 10.1093/ajcn/62.5.1081S
   Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019
   Garcia-Bailo B, 2009, OMICS, V13, P69, DOI 10.1089/omi.2008.0031
   Garnweidner LM, 2012, J NUTR EDUC BEHAV, V44, P335, DOI 10.1016/j.jneb.2011.08.005
   Georgiou CC, 1997, J AM DIET ASSOC, V97, P754, DOI 10.1016/S0002-8223(97)00187-9
   Gokhan I., 2014, Online International Interdisciplinary Research Journal, V4, P341
   Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628
   Hennekens C.H., 1987, EPIDEMIOLOGY MED
   Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19
   Lennernas M, 1997, EUR J CLIN NUTR, V51, pS8
   McCrory MA, 2006, PHYSIOL BEHAV, V87, P451, DOI 10.1016/j.physbeh.2004.10.025
   McNaughton SA, 2008, J NUTR, V138, P86, DOI 10.1093/jn/138.1.86
   National Health and Medical Research Council, 2005, FOOD FOR HLTH
   Noble AC, 1996, TRENDS FOOD SCI TECH, V7, P439, DOI 10.1016/S0924-2244(96)10044-3
   Olsen NV, 2012, FOOD QUAL PREFER, V24, P171, DOI 10.1016/j.foodqual.2011.11.001
   Papadaki A, 2007, APPETITE, V49, P169, DOI 10.1016/j.appet.2007.01.008
   Riddell LJ, 2011, APPETITE, V56, P726, DOI 10.1016/j.appet.2011.02.010
   SHEPHERD R, 1986, APPETITE, V7, P343, DOI 10.1016/S0195-6663(86)80003-4
   Silliman K., 2004, Californian Journal of Health Promotion, V2, P10
   Soriano JM, 2000, NUTR RES, V20, P1249, DOI 10.1016/S0271-5317(00)00217-7
   Vadiveloo M, 2013, APPETITE, V71, P349, DOI 10.1016/j.appet.2013.09.005
   WARDLE J, 1991, SOC SCI MED, V33, P925, DOI 10.1016/0277-9536(91)90263-C
NR 41
TC 106
Z9 120
U1 3
U2 113
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6663
EI 1095-8304
J9 APPETITE
JI Appetite
PD AUG 1
PY 2016
VL 103
BP 1
EP 7
DI 10.1016/j.appet.2016.03.015
PG 7
WC Behavioral Sciences; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Nutrition & Dietetics
GA DP7GF
UT WOS:000378666500001
PM 26972352
DA 2025-04-28
ER

PT J
AU Carlsson, S
AF Carlsson, Sofia
TI Lifestyle or Environmental Influences and Their Interaction With Genetic
   Susceptibility on the Risk of LADA
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Review
DE lifestyle; gene*environment; obesity; smoking; HLA; latent autoimmune
   diabetes
ID MODERATE ALCOHOL-CONSUMPTION; LOW-BIRTH-WEIGHT; ADULTS LADA;
   INSULIN-RESISTANCE; FOLLOW-UP; ISLET AUTOIMMUNITY; DIABETES-MELLITUS;
   FAMILY-HISTORY; GAD ANTIBODY; FATTY-ACIDS
AB BackgroundLADA is a common form of diabetes described as a mix between type 1 and type 2 diabetes. Understanding of how genes and environmental factors interact in the development of LADA is central for future efforts to prevent the disease. This review aims to synthesize the literature on lifestyle factors linked to LADA risk and discuss their potential interaction with genetic susceptibility. FindingsCurrent knowledge on environmental risk factors for LADA is primarily based on observational data from Scandinavian populations. Increasing evidence suggest that lifestyle factors promoting type 2 diabetes such as obesity, sedentariness, low birth weight and smoking, is implicated in the risk of LADA. Data from mendelian randomization studies support that the link between LADA and obesity, low birth weight and smoking is causal. Limited evidence indicates that dietary factors including consumption of red meat, coffee and sweetened beverages may increase the risk while consumption of alcohol and omega-3 fatty acids may reduce the risk. Several lifestyle factors, including smoking and obesity, seem to interact with human leukocyte antigen genes associated with autoimmunity, conferring much stronger effects on disease risk among those exposed to both factors. Available studies suggest that lifestyle modification has the potential for prevention of LADA, particularly for individuals with high risk of disease such as those with genetic susceptibility. Research into risk factors of LADA is however limited, confirmations are warranted, many factors remain to be explored, and there is a need for intervention studies to assess causality
C1 [Carlsson, Sofia] Karolinska Inst, Inst Environm Med, Stockholm, Sweden.
C3 Karolinska Institutet
RP Carlsson, S (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.
EM sofia.carlsson@ki.se
FU Swedish Research Council [2018-03035]; Research Council for Health,
   Working Life and Welfare (FORTE) [2018-00337]; Novo Nordisk Foundation
   [NNF19OC0057274]; Swedish Research Council [2018-03035] Funding Source:
   Swedish Research Council; Forte [2018-00337] Funding Source: Forte
FX SC was supported by grants from the Swedish Research Council
   (2018-03035), the Research Council for Health, Working Life and Welfare
   (FORTE, 2018-00337), and the Novo Nordisk Foundation (NNF19OC0057274).
CR Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2
   Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002
   Andersen MK, 2020, CURR DIABETES REP, V20, DOI 10.1007/s11892-020-01330-y
   Bajaj M, 2012, DIABETES, V61, P3078, DOI 10.2337/db12-1100
   Bellou V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194127
   Burgess S, 2015, EUR J EPIDEMIOL, V30, P543, DOI 10.1007/s10654-015-0011-z
   Buzzetti R, 2007, DIABETES CARE, V30, P932, DOI 10.2337/dc06-1696
   Calder PC, 2013, P NUTR SOC, V72, P326, DOI 10.1017/S0029665113001031
   Cardwell CR, 2010, DIABETOLOGIA, V53, P641, DOI 10.1007/s00125-009-1648-5
   Carlsson A, 2012, INT J OBESITY, V36, P718, DOI 10.1038/ijo.2011.122
   Carlsson S, 2017, J INTERN MED, V281, P398, DOI 10.1111/joim.12592
   Carlsson S, 2007, DIABETES CARE, V30, P3040, DOI 10.2337/dc07-0718
   Carlsson S, 2019, CURR DIABETES REV, V15, P178, DOI 10.2174/1573399814666180716150253
   Censin JC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002362
   Chen WJ, 2021, GENE, V767, DOI 10.1016/j.gene.2020.145177
   Chiu HK, 2007, DIABETES RES CLIN PR, V77, P237, DOI 10.1016/j.diabres.2006.12.013
   Cousminer DL, 2018, DIABETES CARE, V41, P2396, DOI 10.2337/dc18-1032
   Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Edstorp J., 2022, DIABETOLOGIA
   Edstorp J, 2022, DIABETIC MED, V39, DOI 10.1111/dme.14830
   Ferrara-Cook C, 2020, DIABETES CARE, V43, P580, DOI 10.2337/dc19-1167
   Fourlanos S, 2005, DIABETOLOGIA, V48, P2206, DOI 10.1007/s00125-005-1960-7
   Gale EAM, 2005, DIABETOLOGIA, V48, P2195, DOI 10.1007/s00125-005-1954-5
   Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329
   HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1093/ije/dyt133
   Hawa MI, 2013, DIABETES CARE, V36, P908, DOI 10.2337/dc12-0931
   Hawa MI, 2014, DIABETES CARE, V37, P1643, DOI 10.2337/dc13-2383
   Hemmingsen B, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub4
   Herzog K, 2021, DIABETES RES CLIN PR, V174, DOI 10.1016/j.diabres.2021.108760
   Hjort R, 2017, DIABETES METAB, V43, P536, DOI 10.1016/j.diabet.2017.05.010
   Hjort R, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa549
   Hjort R, 2019, J CLIN ENDOCR METAB, V104, P4815, DOI 10.1210/jc.2019-00183
   Hjort R, 2018, DIABETOLOGIA, V61, P1333, DOI 10.1007/s00125-018-4596-0
   Hjort R, 2015, DIABETOLOGIA, V58, P2525, DOI 10.1007/s00125-015-3711-8
   Huang T, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10915
   Iliadou A, 2004, INT J EPIDEMIOL, V33, P948, DOI 10.1093/ije/dyh117
   IRVINE WJ, 1977, LANCET, V1, P1025
   Jones AG, 2021, DIABETES CARE, V44, P1243, DOI 10.2337/dc20-2834
   Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y
   Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095
   Lamb MM, 2015, DIABETOLOGIA, V58, P2027, DOI 10.1007/s00125-015-3657-x
   Lampousi AM, 2021, EBIOMEDICINE, V72, DOI 10.1016/j.ebiom.2021.103633
   Lana A, 2014, J NUTR, V144, P1099, DOI 10.3945/jn.114.195230
   Li J, 2021, DIABET METAB SYND OB, V14, P885, DOI 10.2147/DMSO.S298068
   Liu BW, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3205
   Löfvenborg JE, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.36
   Löfvenborg JE, 2021, DIABETES CARE, V44, P416, DOI 10.2337/dc20-1463
   Löfvenborg JE, 2021, EUR J NUTR, V60, P769, DOI 10.1007/s00394-020-02285-2
   Löfvenborg JE, 2020, EUR J NUTR, V59, P127, DOI 10.1007/s00394-019-01893-x
   Löfvenborg JE, 2016, EUR J ENDOCRINOL, V175, P605, DOI 10.1530/EJE-16-0376
   Lundgren VM, 2010, DIABETES, V59, P416, DOI 10.2337/db09-0747
   Maddaloni E, 2020, MATURITAS, V137, P37, DOI 10.1016/j.maturitas.2020.04.014
   Maddaloni E, 2020, LANCET DIABETES ENDO, V8, P206, DOI 10.1016/S2213-8587(20)30003-6
   Maddaloni E, 2019, DIABETES OBES METAB, V21, P2115, DOI 10.1111/dom.13788
   Mishra R, 2018, TRENDS ENDOCRIN MET, V29, P638, DOI 10.1016/j.tem.2018.07.001
   Mishra R, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0846-0
   Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120
   Neuenschwander M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l2368
   Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x
   Norris JM, 2020, LANCET DIABETES ENDO, V8, P226, DOI 10.1016/S2213-8587(19)30412-7
   Olsson L, 2013, DIABETES CARE, V36, P3971, DOI 10.2337/dc13-0564
   Osterdahl BG, 2004, J AGR FOOD CHEM, V52, P5085, DOI 10.1021/jf049931a
   Pai JK, 2006, ATHEROSCLEROSIS, V186, P113, DOI 10.1016/j.atherosclerosis.2005.06.037
   Pan A, 2015, LANCET DIABETES ENDO, V3, P958, DOI 10.1016/S2213-8587(15)00316-2
   Pieralice S, 2018, DIABETES METAB J, V42, P451, DOI 10.4093/dmj.2018.0190
   Rasouli B, 2018, DIABETES METAB, V44, P354, DOI 10.1016/j.diabet.2018.05.002
   Rasouli B, 2017, DIABETIC MED, V34, P1259, DOI 10.1111/dme.13410
   Rasouli B, 2013, DIABETIC MED, V30, P56, DOI 10.1111/j.1464-5491.2012.03713.x
   Rasouli B, 2014, EUR J ENDOCRINOL, V171, P535, DOI 10.1530/EJE-14-0403
   Rasouli B, 2013, DIABETES CARE, V36, P604, DOI 10.2337/dc12-0913
   Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4
   Rolandsson O, 2010, DIABETOLOGIA, V53, P1250, DOI 10.1007/s00125-010-1713-0
   Rolandsson O, 2020, DIABETOLOGIA, V63, P266, DOI 10.1007/s00125-019-05016-3
   ROTHMAN KJ, 1980, AM J EPIDEMIOL, V112, P467, DOI 10.1093/oxfordjournals.aje.a113015
   Sharif K, 2017, AUTOIMMUN REV, V16, P712, DOI 10.1016/j.autrev.2017.05.007
   Smith AD, 2016, DIABETOLOGIA, V59, P2527, DOI 10.1007/s00125-016-4079-0
   Sorgjerd EP, 2012, DIABETOLOGIA, V55, P1310, DOI 10.1007/s00125-012-2463-y
   Tuomi T, 1999, DIABETES, V48, P150, DOI 10.2337/diabetes.48.1.150
   TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359
   Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9
   Verbeeten KC, 2011, DIABETIC MED, V28, P10, DOI 10.1111/j.1464-5491.2010.03160.x
   Virtanen SM, 2010, EUR J CLIN NUTR, V64, P792, DOI 10.1038/ejcn.2010.75
   VIRTANEN SM, 1994, EUR J CLIN NUTR, V48, P279
   Wei YX, 2022, DIABETOLOGIA, V65, P1510, DOI 10.1007/s00125-022-05725-2
   Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886
   Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548
   Wolk A, 2017, J INTERN MED, V281, P106, DOI 10.1111/joim.12543
   World Health Organization, 2019, Classification of diabetes mellitus
   Yang L, 2019, ACTA DIABETOL, V56, P1217, DOI 10.1007/s00592-019-01387-6
   Yuan S, 2020, DIABETOLOGIA, V63, P116, DOI 10.1007/s00125-019-05019-0
   Zampetti S, 2014, EUR J ENDOCRINOL, V171, P697, DOI 10.1530/EJE-14-0342
   Zhang YB, 2020, DIABETOLOGIA, V63, P21, DOI 10.1007/s00125-019-04985-9
   Zhou ZG, 2013, DIABETES, V62, P543, DOI 10.2337/db12-0207
NR 94
TC 8
Z9 9
U1 1
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD JUN 29
PY 2022
VL 13
AR 917850
DI 10.3389/fendo.2022.917850
PG 12
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 2X3LA
UT WOS:000825107900001
PM 35846274
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Riediger, N
   Dhalla, A
   Cooper, M
   Bombak, A
   Sreeramaiah, H
AF Riediger, Natalie
   Dhalla, Anika
   Cooper, Maureen
   Bombak, Andrea
   Sreeramaiah, Hemalatha
TI A qualitative analysis of the perceived socio-cultural contexts and
   health concerns of sugar-sweetened beverages among adults studying or
   working at a post-secondary institution in Dharwad, India
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Sugar-sweetened beverages; Diabetes; India; Health; Nutrition; Health
   policy; Global health; Stigma
ID RISK; TRANSITION; NUTRITION; OBESITY; STIGMA; FOOD
AB BackgroundWe sought to explore the perceptions of the socio-cultural contexts and health concerns of consuming sugar-sweetened beverages (SSB) among Indian adults working or studying at a post-secondary institution in Karnataka, India.MethodsWe completed a qualitative study, including 24 semi-structured interviews between 2017 and 2018 at the University of Agricultural Sciences, Dharwad, Karnataka, India. Data were analyzed using thematic content analysis.ResultsOne over-arching theme emerged, westernization and changing perceptions of food, sugar, and health. Participants discussed SSB and associated health concerns in the broad context of westernization and overall economic development in India. Three sub-themes regarding the health perceptions of consuming SSB were: healthy drinks are clean and natural; hydration and energy; and moderation and body weight. Hygienically-prepared beverages were a consistent concern among participants. Juices and beverages, such as tea or coffee, sweetened with jaggery were viewed positively due to their naturalness and lack of processed sugar. Participants perceived SSB as providing hydration and energy, particularly in hot weather. Lastly, if consumed in moderation, SSB were thought to have no direct adverse health consequences. Though some participants noted excessive, 'addictive' consumption would contribute to weight gain and diabetes.ConclusionPerceived health concerns of SSB reflect dominant health issues in India, namely, food insecurity, food safety, and increasingly, diabetes. Policymakers tend to prioritize acute challenges over long-term concerns. As such, the capacity of any policy to address chronic nutritional concerns related to SSB are likely to be muted in the absence of improvements to food safety and security.
C1 [Riediger, Natalie; Dhalla, Anika; Cooper, Maureen] Univ Manitoba, Fac Agr & Food Sci, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada.
   [Riediger, Natalie] Univ Manitoba, Rady Fac Hlth Sci, Dept Community Hlth Sci, Winnipeg, MB, Canada.
   [Bombak, Andrea] Univ New Brunswick, Dept Sociol, Fredericton, NB, Canada.
   [Sreeramaiah, Hemalatha] Univ Agr Sci Dharwad, Food Sci & Technol Dept, Dharwad, Karnataka, India.
C3 University of Manitoba; University of Manitoba; University of New
   Brunswick
RP Riediger, N (corresponding author), Univ Manitoba, Fac Agr & Food Sci, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada.; Riediger, N (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Community Hlth Sci, Winnipeg, MB, Canada.
EM Natalie.riediger@umanitoba.ca
OI Riediger, Natalie/0000-0002-8736-9446
FU Queen Elizabeth II Diamond Jubilee Scholarship; Mitacs Globalink
   Research Award in 2018; Queen Elizabeth Scholarship Program; University
   of Manitoba; CIHR Early Career Investigator Award [155435]
FX AD and MC each received a Queen Elizabeth II Diamond Jubilee Scholarship
   and a Mitacs Globalink Research Award in 2018. Data collection in 2017
   was also supported through the Queen Elizabeth Scholarship Program with
   awards to Vineet Sidhu and Helen Tieu, whom we also acknowledge for
   their role in data collection. The study was also supported through
   start-up funds from the University of Manitoba to NR. NR is the
   recipient of a CIHR Early Career Investigator Award (#155435).
CR Aliferis L., 2014, HERES WHAT WOULD BE
   American Heart Association, FRUITS VEG SERV SIZ
   [Anonymous], 2019, LANCET PUBLIC HEALTH, V4, pE168, DOI 10.1016/S2468-2667(19)30045-3
   [Anonymous], 2021, Sugary drink taxes around the world
   [Anonymous], 2015, Fiscal Policies for Diet and Prevention of Noncommunicable Diseases
   [Anonymous], Sugar Sweetened Beverage Tax
   Arifin B, 2020, QUAL LIFE RES, V29, P109, DOI 10.1007/s11136-019-02299-2
   Bailey C, 2018, J NUTR EDUC BEHAV, V50, P675, DOI 10.1016/j.jneb.2018.03.013
   Basu M., 2020, ENVIRON DEV SUSTAIN, V10, P1, DOI [10.5296/emsd.v10i1.17820, DOI 10.5296/EMSD.V10I1.17820]
   Birbeck GL, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1282-0
   Biswas S., 2019, BBC News
   Bragg MA, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0303-z
   Brewis A., 2019, LAZY CRAZY DISGUSTIN
   Creswell J.W., 2014, Fourth Edition. Research design: Qualitative, quantitative
   Diabetes Canada, 2020, SUG DIAB
   Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x
   Finkler K, 2004, SOC SCI MED, V59, P2037, DOI 10.1016/j.socscimed.2004.03.008
   Fletcher J, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120195
   Food and Agriculture Organization of the United Nations, 2021, FOOD BAS DIET GUID I
   Gard M., 2005, OBESITY EPIDEMIC SCI, DOI [10.4324/9780203619308, DOI 10.4324/9780203619308]
   Government of Karnataka, DHARW DISTR GLANC 20
   Government of UK: HM Revenue & Custom, 2018, CHECK YOUR DRINK IS
   Gulati S, 2014, NUTRIENTS, V6, P5955, DOI 10.3390/nu6125955
   Gulati S, 2013, ANN NUTR METAB, V62, P279, DOI 10.1159/000346554
   Gupta Setu, 2017, Indian J Community Med, V42, P43, DOI 10.4103/0970-0218.199800
   International Diabetes Foundation,, 2019, IDF DIABETES ATLAS
   International Sugar Organization, 2020, SUG SUG MARK
   John S, 2002, TOBACCO POVERTY OBSE
   Kapoor N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237974
   Kato A, 2020, DIABETOL INT, V11, P73, DOI 10.1007/s13340-019-00421-w
   Kuperstein Anna., 2008, J HLTH CARE LAW POLI, V11, P103
   Law C, 2020, J AGR ECON, V71, P118, DOI 10.1111/1477-9552.12322
   Lencucha R, 2019, INT J HEALTH POLICY, V8, P514, DOI 10.15171/ijhpm.2019.56
   LUPTON D., 2016, Food, the Body and the Self
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Marini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083543
   Maru Ami M, 2012, J Contemp Dent Pract, V13, P382
   McCarthy M, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5940
   Mccoy D, 2017, HEALTH ECON POLICY L, V12, P179, DOI [10.1017/S174413311600044X, 10.1017/s174413311600044x]
   Mendenhall E, 2019, LANCET, V393, P741, DOI 10.1016/S0140-6736(19)30310-1
   Miglani Sanjay, 2020, Int J Clin Pediatr Dent, V13, P155, DOI 10.5005/jp-journals-10005-1733
   Ministry of Health and Family Welfare, 2011, FOOD SAF STAND PACK
   Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018
   Myers A, 2017, GLOB PUBLIC HEALTH, V12, P98, DOI 10.1080/17441692.2015.1071419
   Pande R, 2020, LANCET PUBLIC HEALTH, V5, pE195, DOI 10.1016/S2468-2667(20)30031-1
   Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491
   Quint B., 2020, TOBACCO FARMERS BODY
   Salda~na J, 2015, The Coding Manual for Qualitative Researchers
   Salmona M, 2015, AUST J MANAGE, V40, P403, DOI 10.1177/0312896214536204
   Saxena N.C., 2018, Poverty, Chronic Poverty and Poverty Dynamics: Policy Imperatives, P55, DOI [10.1007/978-981-13-0677-8_4, DOI 10.1007/978-981-13-0677-8_4]
   Shetty P, 2012, NATURE, V485, pS14, DOI 10.1038/485S14a
   SHRIVASTAVA A. K., 2020, Sugar and Sugar Derivatives: Changing Consumer Preferences, P1, DOI [10.1007/9789811566639_1, DOI 10.1007/978]
   Singh RB, 1999, INT J CARDIOL, V69, P139, DOI 10.1016/S0167-5273(99)00010-8
   Surendran S, 2020, GLOB FOOD SECUR-AGR, V24, DOI 10.1016/j.gfs.2019.100343
   University of Agricultural Sciences Dharwad, WELC UAS DHARW
   Valenzuela MJ, 2021, EUR J PUBLIC HEALTH, V31, P122, DOI 10.1093/eurpub/ckaa147
   Vandana K, 2018, Indian J Dent Res, V29, P428, DOI 10.4103/ijdr.IJDR_75_17
   Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860
   Walls H, 2019, GLOB FOOD SECUR-AGR, V21, P69, DOI 10.1016/j.gfs.2019.05.005
   Walls HL, 2012, J PUBLIC HEALTH POL, V33, P89, DOI 10.1057/jphp.2011.50
   Wojcicki JM, 2010, PEDIATRICS, V126, pE1617, DOI 10.1542/peds.2010-0461
   Wutich A, 2014, CURR ANTHROPOL, V55, P444, DOI 10.1086/677311
NR 63
TC 2
Z9 2
U1 2
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 29
PY 2021
VL 21
IS 1
AR 1016
DI 10.1186/s12889-021-11033-y
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA SO6VM
UT WOS:000659112400008
PM 34051790
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Zhang, N
   Jia, ZH
   Gu, TS
   Zheng, Y
   Zhang, YP
   Song, WH
   Chen, ZL
   Li, GP
   Tse, G
   Liu, T
AF Zhang, Nan
   Jia, Ziheng
   Gu, Tianshu
   Zheng, Yi
   Zhang, Yunpeng
   Song, Wenhua
   Chen, Ziliang
   Li, Guangping
   Tse, Gary
   Liu, Tong
TI Associations between modifiable risk factors and frailty: a Mendelian
   randomisation study
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Article
DE prevention; aging; cardiovascular diseases; epidemiology; genetics
ID BODY-MASS INDEX; OLDER-ADULTS; ALCOHOL-CONSUMPTION; DISEASE;
   TESTOSTERONE; INFLAMMATION; METAANALYSIS; MANAGEMENT; OBESITY; POWER
AB BackgroundEarly identification of modifiable risk factors is essential for the prevention of frailty. This study aimed to explore the causal relationships between a spectrum of genetically predicted risk factors and frailty. MethodsUnivariable and multivariable Mendelian randomisation (MR) analyses were performed to explore the relationships between 22 potential risk factors and frailty, using summary genome-wide association statistics. Frailty was accessed by the frailty index. ResultsGenetic liability to coronary artery disease (CAD), type 2 diabetes mellitus (T2DM), ischaemic stroke, atrial fibrillation and regular smoking history, as well as genetically predicted 1-SD increase in body mass index, systolic blood pressure, diastolic blood pressure, low-density lipoprotein cholesterol, triglycerides, alcohol intake frequency and sleeplessness were significantly associated with increased risk of frailty (all p<0.001). In addition, there was a significant inverse association between genetically predicted college or university degree with risk of frailty (beta -0.474; 95% CI (-0.561 to -0.388); p<0.001), and a suggestive inverse association between high-density lipoprotein cholesterol level with risk of frailty (beta -0.032; 95% CI (-0.055 to -0.010); p=0.004). However, no significant causal associations were observed between coffee consumption, tea consumption, serum level of total testosterone, oestradiol, 25-hydroxyvitamin D, C reactive protein or moderate to vigorous physical activity level with frailty (all p>0.05). Results of the reverse directional MR suggested bidirectional causal associations between T2DM and CAD with frailty. ConclusionsThis study provided genetic evidence for the causal associations between several modifiable risk factors with lifetime frailty risk. A multidimensional approach targeting these factors may hold a promising prospect for prevention frailty.
C1 [Tse, Gary; Liu, Tong] Tianjin Med Univ, Tianjin Inst Cardiol, Dept Cardiol, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis,Hosp, 23 Pingjiang Rd, Tianjin 300211, Peoples R China.
   [Zhang, Nan; Jia, Ziheng; Gu, Tianshu; Zheng, Yi; Zhang, Yunpeng; Song, Wenhua; Chen, Ziliang; Li, Guangping; Tse, Gary; Liu, Tong] Tianjin Med Univ, Tianjin Inst Cardiol, Dept Cardiol, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis,Hosp, Tianjin 300211, Peoples R China.
   [Tse, Gary] Univ Kent, Kent & Medway Med Sch, Canterbury, Kent, England.
   [Tse, Gary] Canterbury Christ Church Univ, Canterbury, Kent, England.
   [Tse, Gary] Metropolitan Univ, Sch Nursing & Hlth Studies, Hong Kong, Peoples R China.
C3 Tianjin Medical University; Tianjin Medical University; University of
   Kent; Canterbury Christ Church University
RP Tse, G; Liu, T (corresponding author), Tianjin Med Univ, Tianjin Inst Cardiol, Dept Cardiol, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis,Hosp, 23 Pingjiang Rd, Tianjin 300211, Peoples R China.; Tse, G (corresponding author), Univ Kent, Kent & Medway Med Sch, Canterbury, Kent, England.; Tse, G (corresponding author), Metropolitan Univ, Sch Nursing & Hlth Studies, Hong Kong, Peoples R China.
EM gary.tse@kmms.ac.uk; liutongdoc@126.com
RI Tse, Gary/P-1171-2015
OI Tse, Gary/0000-0001-5510-1253
FU National Natural Science Foundation of China [81970270, 82170327];
   Natural Science Foundation~ [20JCZDJC00340, 20JCZXJC00130]; Tianjin Key
   Medical Discipline (Specialty) Construction Project [TJYXZDXK-029A]
FX This work was funded by the National Natural Science Foundation of China
   (81970270, 82170327 to TL), Natural Science Foundation &
   nbsp;(20JCZDJC00340, 20JCZXJC00130 to TL) and Tianjin Key Medical
   Discipline (Specialty) Construction Project (TJYXZDXK-029A).
CR Aguayo GA, 2019, DIABETES CARE, V42, P1903, DOI 10.2337/dc19-0497
   Atkins JL, 2021, AGING CELL, V20, DOI 10.1111/acel.13459
   Benetos A, 2019, CIRC RES, V124, P1045, DOI 10.1161/CIRCRESAHA.118.313236
   Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179
   Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998
   Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325
   Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601
   Dent E, 2019, LANCET, V394, P1376, DOI 10.1016/S0140-6736(19)31785-4
   Dzau VJ, 2019, NEW ENGL J MED, V381, P1699, DOI 10.1056/NEJMp1912298
   Ensrud KE, 2011, J AM GERIATR SOC, V59, P101, DOI 10.1111/j.1532-5415.2010.03201.x
   Evangelou E, 2018, NAT GENET, V50, P1412, DOI 10.1038/s41588-018-0205-x
   Guo YT, 2014, EXP GERONTOL, V50, P1, DOI 10.1016/j.exger.2013.11.005
   Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408
   Hemani G, 2017, PLOS GENET, V13, DOI [10.1371/journal.pgen.1007081, 10.1371/journal.pgen.1007149]
   Hoogendijk EO, 2014, ANN EPIDEMIOL, V24, P538, DOI 10.1016/j.annepidem.2014.05.002
   Huibregtse BM, 2021, J GERONTOL B-PSYCHOL, V76, P173, DOI 10.1093/geronb/gbz092
   Klimentidis YC, 2018, INT J OBESITY, V42, P1161, DOI 10.1038/s41366-018-0120-3
   Kojima G, 2018, AGE AGEING, V47, P126, DOI 10.1093/ageing/afx136
   Kojima G, 2018, AGE AGEING, V47, P26, DOI 10.1093/ageing/afx086
   Kojima G, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0134-9
   Larsson SC, 2017, JAMA-J AM MED ASSOC, V318, P371, DOI 10.1001/jama.2017.8981
   Levin MG, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.34461
   Li SJ, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.987911
   Ligthart S, 2018, AM J HUM GENET, V103, P691, DOI 10.1016/j.ajhg.2018.09.009
   Liu MZ, 2019, NAT GENET, V51, P237, DOI 10.1038/s41588-018-0307-5
   Liu WS, 2022, EUR J NEUROL, V29, P1913, DOI 10.1111/ene.15332
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Malik R, 2018, NAT GENET, V50, P524, DOI 10.1038/s41588-018-0058-3
   McKechnie DGJ, 2021, AGE AGEING, V50, P1979, DOI 10.1093/ageing/afab143
   Mohr BA, 2007, J AM GERIATR SOC, V55, P548, DOI 10.1111/j.1532-5415.2007.01121.x
   Moreno-Tamayo K, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02272-0
   Moreno-Tamayo K, 2020, MATURITAS, V136, P7, DOI 10.1016/j.maturitas.2020.03.005
   Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158
   Nielsen JB, 2018, NAT GENET, V50, P1234, DOI 10.1038/s41588-018-0171-3
   Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396
   Palmer K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01255
   Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151
   Revez JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15421-7
   Richard G, 2022, AGE AGEING, V51, DOI 10.1093/ageing/afab273
   Richter D, 2022, EUR J PREV CARDIOL, V29, P216, DOI 10.1093/eurjpc/zwaa167
   Ruth KS, 2020, NAT MED, V26, P252, DOI 10.1038/s41591-020-0751-5
   Skrivankova VW, 2021, JAMA-J AM MED ASSOC, V326, P1614, DOI 10.1001/jama.2021.18236
   Strandberg AY, 2018, AGE AGEING, V47, P248, DOI 10.1093/ageing/afx165
   Trombetti A, 2018, ANN INTERN MED, V168, P309, DOI 10.7326/M16-2011
   Velissaris Dimitrios, 2017, J Clin Med Res, V9, P461, DOI 10.14740/jocmr2959w
   Veronese N, 2016, J AM MED DIR ASSOC, V17, P902, DOI 10.1016/j.jamda.2016.04.021
   Wang Q, 2019, EBIOMEDICINE, V45, P487, DOI 10.1016/j.ebiom.2019.07.007
   Wilhelm-Leen ER, 2010, J INTERN MED, V268, P171, DOI 10.1111/j.1365-2796.2010.02248.x
   Willer Cristen J, 2013, Nat Genet, V45, P1274, DOI 10.1038/ng.2797
   Wong TY, 2018, AGE AGEING, V47, P714, DOI 10.1093/ageing/afy080
   Xue A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04951-w
   Yuan LL, 2021, AGE AGEING, V50, P1118, DOI 10.1093/ageing/afab039
   Zhu JH, 2022, AGE AGEING, V51, DOI 10.1093/ageing/afac256
NR 53
TC 15
Z9 15
U1 3
U2 26
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
EI 1470-2738
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD DEC
PY 2023
VL 77
IS 12
BP 782
EP 790
DI 10.1136/jech-2023-220882
EA AUG 2023
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA Y4DC0
UT WOS:001052656700001
PM 37604674
DA 2025-04-28
ER

PT J
AU Sótoudeh, G
   Abshirini, M
   Bagheri, F
   Siassi, F
   Koohdani, F
   Aslany, Z
AF Sotoudeh, Gity
   Abshirini, Maryam
   Bagheri, Fariba
   Siassi, Fereydoun
   Koohdani, Fariba
   Aslany, Zahra
TI Higher dietary total antioxidant capacity is inversely related to
   prediabetes: A case-control study
SO NUTRITION
LA English
DT Article
DE Dietary total antioxidant capacity; Oxidative stress; Fasting blood
   sugar; Prediabetes
ID OXIDATIVE STRESS; METABOLIC SYNDROME; GLUCOSE; OBESITY; COHORT; ADULTS;
   ADOLESCENTS; CHILDREN; HEALTHY; CANCER
AB Objectives: Dietary total antioxidant capacity (DTAC) has been proposed as a tool for assessing the intake of antioxidants. The relationship between DTAC and blood glucose levels has been investigated mostly in healthy people. The aim of this study was to evaluate the association between DTAC and prediabetes morbidity in a case-control study.
   Methods: We examined 300 individuals with and without prediabetes (n = 150/group) who attended a Diabetes Screening Center in Shahreza, Iran. The anthropometric measures, physical activity, and blood glucose levels of all participants were measured. Food intake over the previous year was determined using a semiquantitative food frequency questionnaire, and sex-specific, energy-adjusted DTAC was calculated using the U.S. Department of Agriculture's database. Logistic reg/ression was used to model the relationship between DTAC and prediabetes morbidity.
   Results: The mean DTAC was significantly lower in individuals with prediabetes than in the control group (P < 0.001). Across increasing DTAC quartiles, the participants had lower fasting blood glucose and 2-h postchallenge plasma glucose (P-trend < 0.02). After adjustment for body mass index; physical activity; education; dietary intake of fiber, fat, energy, and coffee; participants in the fourth quartile of DTAC were less likely to experience prediabetes compared with those in the first quartile (odds ratio, 0.18; 95% confidence interval, 0.07-0.49).
   Conclusion: The DTAC score appears useful when assessing the antioxidant capacity of diet and to better understand the relationship between diet and prediabetes morbidity. Future studies are needed to confirm the findings from the present study in other populations. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Sotoudeh, Gity; Abshirini, Maryam; Bagheri, Fariba; Siassi, Fereydoun; Aslany, Zahra] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
   [Koohdani, Fariba] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Cellular, Mol Nutr, Tehran, Iran.
C3 Tehran University of Medical Sciences; Tehran University of Medical
   Sciences
RP Sótoudeh, G (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
EM Gsotodeh@tums.ac.ir
RI Abshirini, Maryam/V-1065-2019; Sotoudeh, Gity/E-3973-2018; Koohdani,
   Fariba/D-1298-2018; Siassi, Fereydoun/D-4991-2018
OI Sotoudeh, Gity/0000-0001-6541-2581; Koohdani,
   Fariba/0000-0002-7108-5350; Siassi, Fereydoun/0000-0002-2591-9406
FU Tehran University of Medical Sciences
FX This research was supported by Tehran University of Medical Sciences.
CR Agudo A, 2007, AM J CLIN NUTR, V85, P1634, DOI 10.1093/ajcn/85.6.1634
   [Anonymous], 2010, US DEP AGR
   Avignon A, 2012, NUTRITION, V28, P715, DOI 10.1016/j.nut.2012.01.001
   Azadbakht L, 2009, J NUTR, V139, P335, DOI 10.3945/jn.108.096297
   Azizi F, 2015, IJEM, V17, P1
   Bagheri F, 2016, BRIT J NUTR, V116, P874, DOI 10.1017/S0007114516002634
   Bahadoran Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-70
   Barnard ND, 2005, AM J MED, V118, P991, DOI 10.1016/j.amjmed.2005.03.039
   Bhagwat S, 2007, USDA DATABASE OXYGEN, P1
   Coskun O, 2005, PHARMACOL RES, V51, P117, DOI 10.1016/j.phrs.2004.06.002
   Craig ME, 2009, PEDIATR DIABETES, V10, P3, DOI 10.1111/j.1399-5448.2009.00568.x
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563
   Ford ES, 2001, PREV MED, V32, P33, DOI 10.1006/pmed.2000.0772
   Franzini L, 2012, NUTR METAB CARDIOVAS, V22, P50, DOI 10.1016/j.numecd.2010.04.001
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Hadaegh F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-176
   Hermsdorff HHM, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-59
   Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398
   Kataja-Tuomola MK, 2011, EUR J CLIN NUTR, V65, P590, DOI 10.1038/ejcn.2010.283
   Kavanaugh CJ, 2007, JNCI-J NATL CANCER I, V99, P1074, DOI 10.1093/jnci/djm037
   Li CY, 2009, DIABETES CARE, V32, P342, DOI 10.2337/dc08-1128
   Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058
   Moghaddam M.B., 2012, WORLD APPL SCI J, V18, P1073, DOI [DOI 10.5829/idosi.wasj.2012.18.08.754, 10.5829/idosi.wasj.2012.18.08]
   Morris DH, 2013, DIABETOLOGIA, V56, P1489, DOI 10.1007/s00125-013-2902-4
   Okubo H, 2014, NUTR METAB CARDIOVAS, V24, P301, DOI 10.1016/j.numecd.2013.08.001
   Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812
   Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89
   Psaltopoulou T, 2011, NUTR METAB CARDIOVAS, V21, P561, DOI 10.1016/j.numecd.2009.11.005
   Puchau B, 2010, INT J FOOD SCI NUTR, V61, P713, DOI 10.3109/09637481003757860
   Puchau B, 2009, J AM COLL NUTR, V28, P648, DOI 10.1080/07315724.2009.10719797
   Puchau B, 2010, NUTRITION, V26, P534, DOI 10.1016/j.nut.2009.06.017
   Shen XH, 2009, INT J VITAM NUTR RES, V79, P255, DOI 10.1024/0300-9831.79.4.255
   Tabák AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Wu XL, 2004, J FOOD COMPOS ANAL, V17, P407, DOI 10.1016/j.jfca.2004.03.001
   Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7
NR 38
TC 24
Z9 25
U1 1
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD FEB
PY 2018
VL 46
BP 20
EP 25
DI 10.1016/j.nut.2017.08.005
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FT2XT
UT WOS:000423010000004
PM 29290350
DA 2025-04-28
ER

PT J
AU Yang, YX
   Yu, DM
   Piao, W
   Huang, K
   Zhao, LY
AF Yang, Yuxiang
   Yu, Dongmei
   Piao, Wei
   Huang, Kun
   Zhao, Liyun
TI Association between Habitual Tea Consumption and Metabolic Syndrome and
   Its Components among Chinese Adults Aged 18-59 Years: Based on China
   Nutrition and Health Surveillance 2015-2017
SO NUTRIENTS
LA English
DT Article
DE tea consumption; metabolic syndrome; Chinese adult; nutrition
   surveillance
ID GREEN TEA; CARDIOVASCULAR-DISEASES; POLISH ARM; COFFEE; METAANALYSIS;
   MECHANISMS; POLYPHENOLS; PREVENTION; DISORDERS; OBESITY
AB Background: Tea consumption is widely reported to have beneficial effects on metabolic functions. The current study is to evaluate the association between habitual tea consumption and risk for metabolic syndrome and its components among Chinese adults aged 18 similar to 59 years. Methods: 43,757 participants aged 18 similar to 59 years from China Nutrition and Health Surveillance 2015-2017 were included and divided into four groups based on the amount of daily tea consumption in the current study. Using multiple-adjustment logistic regression to explore the relationship between habitual tea consumption and metabolic syndrome-related health outcomes. Results: Compared with those who did not consume tea habitually, participants who drank over 5 cups of tea per day showed a significantly lower risk of metabolic syndrome (OR = 0.836, 95% CI = 0.771-0.905), blood pressure elevated (OR = 0.906, 95% CI = 0.845-0.972), triglyceride elevated (OR = 0.797, 95% CI = 0.741-0.857), and fasting plasma glucose elevated (OR = 0.772, 95% CI = 0.715-0.833), but higher risk for central obesity (OR = 1.354, 95% CI = 1.236-1.484). Regardless of gender, higher tea consumption was related to lower risk of triglyceride and fasting blood glucose elevated but higher risk for central obesity. While for protective effect on metabolic syndrome, blood pressure elevated, and HDL-C reduction only showed in females. Conclusions: Results from current study support that habitual tea consumption would benefit metabolic syndrome and its related components, especially among females.
C1 [Yang, Yuxiang; Yu, Dongmei; Piao, Wei; Huang, Kun; Zhao, Liyun] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, NHC Key Lab Trace Element Nutr, Beijing 100050, Peoples R China.
C3 Chinese Center for Disease Control & Prevention; National Institute for
   Nutrition & Health, Chinese Center for Disease Control & Prevention
RP Zhao, LY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, NHC Key Lab Trace Element Nutr, Beijing 100050, Peoples R China.
EM zhaoly@ninh.chinacdc.cn
RI yang, xiao/HJI-7815-2023; Huang, Kun/KIA-6654-2024
OI Yang, Yuxiang/0000-0001-5491-4789; Huang, Kun/0000-0001-5340-1535
FU National Health Commission of the People's Republic of China Medical
   Reform Major Program: China National Chronic Diseases and Nutrition
   Surveillance of Adults
FX This research was funded by National Health Commission of the People's
   Republic of China Medical Reform Major Program: China National Chronic
   Diseases and Nutrition Surveillance of Adults (2015-2017).
CR Buscemi S, 2014, EAT WEIGHT DISORD-ST, V19, P225, DOI 10.1007/s40519-014-0117-4
   Castro-Barquero S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12102983
   Cicero AFG, 2016, PHYTOMEDICINE, V23, P1134, DOI 10.1016/j.phymed.2015.11.009
   Cornelis MC, 2020, J NUTR, V150, P2772, DOI 10.1093/jn/nxaa212
   Dong XX, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02707-8
   Ervin R Bethene, 2009, Natl Health Stat Report, P1
   Fan Mengyu, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P961
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, NUTRITION, V30, P1398, DOI 10.1016/j.nut.2014.04.012
   Hibi M, 2018, NUTR RES, V55, P1, DOI 10.1016/j.nutres.2018.03.012
   Hui WS, 2010, EUR J EPIDEMIOL, V25, P375, DOI 10.1007/s10654-010-9459-z
   Islam Mohammed A, 2012, Recent Pat Cardiovasc Drug Discov, V7, P88
   Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x
   Koziarska-Rosciszewska M, 2021, LIFE-BASEL, V11, DOI 10.3390/life11080742
   Li XM, 2020, CLIN NUTR, V39, P1049, DOI 10.1016/j.clnu.2019.05.019
   Liu Dan, 2018, Wei Sheng Yan Jiu, V47, P744
   Liu W, 2020, PHYTOTHER RES, V34, P2857, DOI 10.1002/ptr.6731
   Lu JL, 2017, J CLIN ENDOCR METAB, V102, P507, DOI 10.1210/jc.2016-2477
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/801457, 10.1155/2013/702196]
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   Miller PE, 2013, AM J CLIN NUTR, V98, P794, DOI 10.3945/ajcn.113.063602
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Munir KM, 2013, AM J PHYSIOL-ENDOC M, V305, pE679, DOI 10.1152/ajpendo.00377.2013
   Psaltopoulou Theodora, 2010, Rev Diabet Stud, V7, P26, DOI 10.1900/RDS.2010.7.26
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Schönthal AH, 2011, MOL NUTR FOOD RES, V55, P874, DOI 10.1002/mnfr.201000644
   Sirotkin AV, 2021, PHYSIOL RES, V70, P161, DOI 10.33549/physiolres.934674
   Dinh TC, 2019, DIAB MET SYND CLIN R, V13, P1667, DOI 10.1016/j.dsx.2019.03.021
   van den Brandt PA, 2018, EUR J EPIDEMIOL, V33, P183, DOI 10.1007/s10654-018-0359-y
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Voskoboinik A, 2019, TRENDS CARDIOVAS MED, V29, P345, DOI 10.1016/j.tcm.2018.09.019
   Wang XY, 2020, EUR J PREV CARDIOL, V27, P1956, DOI 10.1177/2047487319894685
   Xiao ML, 2020, PUBLIC HEALTH NUTR, V23, P674, DOI 10.1017/S1368980019002568
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717
   Yang CS, 2018, J FOOD DRUG ANAL, V26, P1, DOI 10.1016/j.jfda.2017.10.010
   Yang Y., 2009, China Food Composition Table, V42, P795
   Yang Y.X., 2018, CHINA FOOD CONSUMPTI
   Yang YX, 2022, NUTRIENTS, V14, DOI 10.3390/nu14040844
   Yao F, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124475
   Yu DM, 2021, CHINA CDC WEEKLY, V3, P193, DOI 10.46234/ccdcw2021.058
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
NR 44
TC 0
Z9 1
U1 0
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2022
VL 14
IS 17
AR 3502
DI 10.3390/nu14173502
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 4K0JR
UT WOS:000851648000001
PM 36079760
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Rothenberg, DO
   Zhou, CB
   Zhang, LY
AF Rothenberg, Dylan O'Neill
   Zhou, Caibi
   Zhang, Lingyun
TI A Review on the Weight-Loss Effects of Oxidized Tea Polyphenols
SO MOLECULES
LA English
DT Review
DE Camellia sinensis; tea catechins; obesity; weight-loss; lipid metabolism
ID GUT MICROBIOTA COMPOSITION; PANCREATIC ALPHA-AMYLASE; FERMENTATION
   IN-VITRO; DIET-INDUCED OBESITY; GREEN TEA; OOLONG TEA; BLACK TEA;
   HIGH-FAT; BODY-FAT; INTESTINAL MICROBIOTA
AB The mechanistic systems in the body through which tea causes weight loss are complex and multi-dimensional. Additionally, the bioactive components in tea such as catechins, caffeine, and products of tea polyphenol oxidation vary greatly from one major tea type to the next. Green tea has been the primary subject of consideration for investigation into the preventative health effects of tea because it contains the highest levels of phenolic compounds and retains the highest antioxidant capabilities of any major tea type. However, recent research suggests decreasing body fat accumulation has little to do with antioxidant activity and more to do with enzyme inhibition, and gut microbiota interactions. This paper reviews several different tea polyphenol-induced weight-loss mechanisms, and purposes a way in which these mechanisms may be interrelated. Our original short-chain fatty acid (SCFA) hypothesis' suggests that the weight-loss efficacy of a given tea is determined by a combination of carbohydrate digestive enzyme inhibition and subsequent reactions of undigested carbohydrates with gut microbiota. These reactions among residual carbohydrates, tea polyphenols, and gut microbiota within the colon produce short-chain fatty acids, which enhance lipid metabolism through AMP-activated protein kinase (AMPK) activation. Some evidence suggests the mechanisms involved in SCFA generation may be triggered more strongly by teas that have undergone fermentation (black, oolong, and dark) than by non-fermented (green) teas. We discussed the mechanistic differences among fermented and non-fermented teas in terms of enzyme inhibition, interactions with gut microbiota, SCFA generation, and lipid metabolism. The inconsistent results and possible causes behind them are also discussed.
C1 [Rothenberg, Dylan O'Neill; Zhang, Lingyun] South China Agr Univ, Coll Hort Sci, Guangzhou 510640, Guangdong, Peoples R China.
   [Zhou, Caibi] Qiannan Normal Univ Nationalities, Dept Tea Sci, Duyun 558000, Peoples R China.
C3 South China Agricultural University; Qiannan Normal University of
   Nationalities
RP Zhang, LY (corresponding author), South China Agr Univ, Coll Hort Sci, Guangzhou 510640, Guangdong, Peoples R China.
EM Dylan.Rothenberg@colorado.edu; teasky@foxmail.com;
   Zhanglingyun@scau.edu.cn
RI zhang, lingyun/GVS-8606-2022; Rothenberg, Dylan/Q-4243-2019
OI Rothenberg, Dylan O'Neill/0000-0003-2463-0317; zhou,
   caibi/0000-0003-4218-6408; Zhang, Lingyun/0000-0001-5733-1810
FU Research and innovation team Foundation of Guizhou Province Education
   Department
FX This work was financially supported by the Research and innovation team
   Foundation of Guizhou Province Education Department.
CR Bäckhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Balaji M, 2016, OBES RES CLIN PRACT, V10, P363, DOI 10.1016/j.orcp.2015.12.004
   Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005
   Bessesen DH., 2007, YB ENDOCRINOL, V2007, P163, DOI DOI 10.1016/S0084-3741(08)70093-3
   Besten GD, 2014, PLOS ONE, V9
   Bradlow HL, 2014, HORM MOL BIOL CLIN I, V17, P53, DOI 10.1515/hmbci-2013-0063
   Candela M, 2010, INT J FOOD MICROBIOL, V140, P93, DOI 10.1016/j.ijfoodmicro.2010.04.017
   Cao ZH, 2013, PHYTOTHER RES, V27, P1193, DOI 10.1002/ptr.4831
   Espín JC, 2017, BIOCHEM PHARMACOL, V139, P82, DOI 10.1016/j.bcp.2017.04.033
   Chaput JP, 2007, MINI-REV MED CHEM, V7, P3, DOI 10.2174/138955707779317849
   Cheng M, 2017, FOOD RES INT, V92, P9, DOI 10.1016/j.foodres.2016.12.008
   den Besten G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136364
   den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Dostal AM, 2016, J NUTR, V146, P38, DOI 10.3945/jn.115.222414
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Glisan SL, 2017, FOOD CHEM, V216, P296, DOI 10.1016/j.foodchem.2016.08.052
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Hamdaoui M. H., 2016, Journal of Nutrition & Intermediary Metabolism, V6, P33, DOI 10.1016/j.jnim.2016.07.002
   Han ZX, 2016, FOOD CHEM, V212, P739, DOI 10.1016/j.foodchem.2016.06.049
   Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Hodgson JM, 2006, BRIT J NUTR, V95, P14, DOI 10.1079/BJN20051621
   Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464
   Hu CJ, 2016, FOOD CHEM, V194, P312, DOI 10.1016/j.foodchem.2015.08.029
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R., 2009, APPETITE, V52, P838
   Janssens PLHR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153134
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jobu K, 2013, FOOD RES INT, V54, P324, DOI 10.1016/j.foodres.2013.07.037
   Katuna-Czaplinska J, 2017, TRENDS FOOD SCI TECH, V70, P105, DOI 10.1016/j.tifs.2017.10.010
   Karamadoukis L, 2009, CLIN NEPHROL, V71, P430
   Kayashima Yasunari, 2015, Biochem Biophys Rep, V4, P417, DOI 10.1016/j.bbrep.2015.10.013
   Koh LW, 2010, J AGR FOOD CHEM, V58, P148, DOI 10.1021/jf903011g
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Korpela K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090702
   Kwon YI, 2008, J FOOD BIOCHEM, V32, P15, DOI 10.1111/j.1745-4514.2007.00165.x
   Lee LS, 2016, FOOD SCI BIOTECHNOL, V25, P1523, DOI 10.1007/s10068-016-0236-y
   Lee MS, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1325307
   Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005
   [李府 Li Fu], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P3061
   Liu SY, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1361-0
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Lu SY, 2016, J FUNCT FOODS, V20, P506, DOI 10.1016/j.jff.2015.11.017
   Mahmood N., 2016, Comparative Clinical Pathology, V25, P1253, DOI 10.1007/s00580-014-1967-x
   Miao M, 2013, J FUNCT FOODS, V5, P2024, DOI 10.1016/j.jff.2013.09.021
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172
   Moreno-Indias I, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/970375
   Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Nam M, 2018, J NUTR BIOCHEM, V51, P1, DOI 10.1016/j.jnutbio.2017.09.002
   Nyambe-Silavwe H, 2016, BRIT J NUTR, V116, P443, DOI 10.1017/S0007114516002221
   Ozdal T, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020078
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Raso RA, 2017, ACTA CIR BRAS, V32, P342, DOI 10.1590/s0102-865020170050000003
   Remely M, 2015, BENEF MICROBES, V6, P431, DOI 10.3920/BM2014.0104
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Satoh T, 2015, J ETHNOPHARMACOL, V161, P147, DOI 10.1016/j.jep.2014.12.009
   Serrano JCE, 2013, MOL NUTR FOOD RES, V57, P459, DOI 10.1002/mnfr.201200513
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Spiegelman BM, 2010, RES PERSPECT END INT, P89, DOI 10.1007/978-3-642-13517-0_8
   Striegel Lisa, 2015, Front Nutr, V2, P3, DOI 10.3389/fnut.2015.00003
   Sun HY, 2018, J FOOD SCI TECH MYS, V55, P399, DOI 10.1007/s13197-017-2951-7
   Sun LJ, 2016, J FUNCT FOODS, V26, P144, DOI 10.1016/j.jff.2016.07.012
   Thurairajah PH, 2005, EUR J GASTROEN HEPAT, V17, P1437, DOI 10.1097/01.meg.0000187680.53389.88
   Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Unno T, 2009, J NUTR SCI VITAMINOL, V55, P447, DOI 10.3177/jnsv.55.447
   Walle T, 2009, INT J MOL SCI, V10, P5002, DOI 10.3390/ijms10115002
   Wang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111143
   Wang SM, 2017, EUR J NUTR, V56, P2037, DOI 10.1007/s00394-016-1241-x
   Welker TL, 2017, AQUACULT INT, V25, P1073, DOI 10.1007/s10499-016-0099-5
   Wen X, 2006, DRUG METAB DISPOS, V34, P1786, DOI 10.1124/dmd.106.011122
   Wilson T., 2016, Beverage impacts on health and nutrition, V2
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI [10.1039/c4fo00095a, 10.1039/C4FO00095A]
   Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2018, J FOOD DRUG ANAL, V26, P1, DOI 10.1016/j.jfda.2017.10.010
   Yang XP, 2016, LWT-FOOD SCI TECHNOL, V66, P232, DOI 10.1016/j.lwt.2015.10.035
   Yang Y, 2015, FITOTERAPIA, V104, P45, DOI 10.1016/j.fitote.2015.05.007
   Yi Juan Yi Juan, 2007, Acta Nutrimenta Sinica, V29, P582
   Zhang X, 2016, J AGR FOOD CHEM, V64, P2582, DOI 10.1021/acs.jafc.6b00586
   Zhang X, 2014, J AGR FOOD CHEM, V62, P10046, DOI 10.1021/jf5016335
   Zhang X, 2013, FOOD RES INT, V54, P1589, DOI 10.1016/j.foodres.2013.10.005
   Zhong YD, 2015, MOL NUTR FOOD RES, V59, P2066, DOI 10.1002/mnfr.201500187
   Zhou H, 2017, FOOD CHEM, V235, P227, DOI 10.1016/j.foodchem.2017.05.034
   Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087161
   Zhou L, 2016, FOOD FUNCT, V7, P1959, DOI [10.1039/c6fo00032k, 10.1039/C6FO00032K]
   Zhu XL, 2013, J AGR FOOD CHEM, V61, P1868, DOI 10.1021/jf304643k
NR 94
TC 70
Z9 74
U1 7
U2 122
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD MAY
PY 2018
VL 23
IS 5
AR 1176
DI 10.3390/molecules23051176
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA GJ3NX
UT WOS:000435204000191
PM 29758009
OA Green Submitted, Green Published, gold
DA 2025-04-28
ER

PT J
AU Nicanor-Carreón, JG
   Rowitz, B
   Pepino, MY
AF Nicanor-Carreon, Jessica G.
   Rowitz, Blair
   Pepino, Marta Yanina
TI Taste and odor interactions after metabolic surgery
SO CHEMICAL SENSES
LA English
DT Article
DE bariatric surgery; flavor; gustation; olfaction; retronasal; sleeve
   gastrectomy
ID Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; BARIATRIC SURGERY; FAT PERCEPTION;
   WEIGHT-LOSS; SMELL; SENSITIVITY; APPETITE; SATIETY; OBESITY
AB Most patients report "taste" changes after undergoing metabolic surgeries. Yet, most studies that used validated sensory evaluation techniques, including ours, found no changes in perceived taste intensity from before to after surgery. However, we assessed participants with pure gustatory stimuli and after an overnight fast, which raises questions about whether patients' self-reported "taste" changes are due to conflating changes in retronasal smell/"flavor" with taste changes or whether they only manifest during the fed state. To investigate this, we conducted a cross-sectional study comparing sensory responses in women who underwent metabolic surgery 2 to 6 yr ago (n = 15) with 2 nonoperated control groups: one with a body mass index (BMI) equivalent (n = 15) and one with a healthy BMI (n = 15). Participants attended 2 sessions, one fed and one fasted. Using a sip-and-spit method, women tasted liquid samples containing gustatory and olfactory stimuli and puddings with varying fat content with and without nose clips. They used separate general labeled magnitude scales to rate their perceived intensity of taste, smell, flavor, and liking. Mixed ANOVAs indicated that the surgery and BMI equivalent groups rated retronasal smell intensity of coffee stronger than the healthy BMI group (P <= 0.015). However, there were no differences in taste/flavor intensity or liking ratings among groups. Additionally, feeding conditions did not significantly affect perceived intensity ratings. Our findings suggest that changes in the sensory-discriminatory component of taste or taste-odor interactions are not significant contributors to dietary modifications following metabolic surgery.
C1 [Nicanor-Carreon, Jessica G.; Rowitz, Blair; Pepino, Marta Yanina] Univ Illinois, Div Nutr Sci, Urbana, IL USA.
   [Rowitz, Blair; Pepino, Marta Yanina] Univ Illinois, Carle Illinois Coll Med, Urbana, IL USA.
   [Rowitz, Blair] Carle Fdn Hosp, Dept Surg, Urbana, IL USA.
   [Pepino, Marta Yanina] Univ Illinois, Food Sci & Human Nutr, Urbana, IL USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign
RP Pepino, MY (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, Bevier Hall 437,905 South Goodwin Ave, Urbana, IL 61801 USA.
EM ypepino@illinois.edu
OI Rowitz, Blair/0000-0002-7058-6145; Nicanor-Carreon, Jessica
   G./0000-0002-5340-9016; Pepino, M. Yanina/0000-0003-2381-1095
FU United States Department of Agriculture National Institute of Food and
   Agriculture Hatch Project [698-991]; National Council of Humanities,
   Sciences, and Technologies of Mexico (CONAHCYT) Fellowship
FX This work was supported, in part, by the United States Department of
   Agriculture National Institute of Food and Agriculture Hatch Project
   number 698-991 (MYP). Jessica G. Nicanor-Carreon was supported, in part,
   by The National Council of Humanities, Sciences, and Technologies of
   Mexico (CONAHCYT) Fellowship.
CR Al-Alsheikh AS, 2022, NUTRIENTS, V14, DOI 10.3390/nu14040866
   Alfaro R, 2021, CHEM SENSES, V46, DOI 10.1093/chemse/bjab026
   Alfaro R, 2023, CHEM SENSES, V48, DOI 10.1093/chemse/bjad004
   Althukair NK, 2024, OBES SURG, V34, P1168, DOI 10.1007/s11695-023-07035-x
   Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853
   Bartoshuk LM, 2013, CURR BIOL, V23, pR374, DOI 10.1016/j.cub.2013.03.038
   Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Besser G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020366
   Bradley D, 2014, OBESITY, V22, P2026, DOI 10.1002/oby.20803
   Bradley D, 2012, J CLIN INVEST, V122, P4667, DOI 10.1172/JCI64895
   Clapp B, 2022, SURG OBES RELAT DIS, V18, P1134, DOI 10.1016/j.soard.2022.06.284
   Coldwell SE., 2013, Chem Senses, V38, pe1, DOI [10.1093/chemse/bjt036, DOI 10.1093/CHEMSE/BJT036]
   Coldwell SE, 2013, NEUROLOGY, V80, pS20, DOI 10.1212/WNL.0b013e3182872e38
   Doty R., 2013, The Smell Identification Test Administration Manual
   DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5
   Eisenberg D, 2023, OBES SURG, V33, P3, DOI 10.1007/s11695-022-06332-1
   Fadool DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024921
   Fryar CDCM, 2024, Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960-1962 through 2017-2018
   Fuchs HF, 2015, J LAPAROENDOSC ADV S, V25, P196, DOI 10.1089/lap.2014.0639
   Fujimaru T, 2013, CHEMOSENS PERCEPT, V6, P1, DOI 10.1007/s12078-013-9140-5
   Goldstone AP, 2016, J CLIN ENDOCR METAB, V101, P599, DOI 10.1210/jc.2015-2665
   Graham L, 2014, OBES SURG, V24, P1463, DOI 10.1007/s11695-014-1221-2
   Green BG, 2012, CHEM SENSES, V37, P77, DOI 10.1093/chemse/bjr068
   Hanci D, 2016, OBES SURG, V26, P558, DOI 10.1007/s11695-015-1784-6
   Hubert PA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040804
   King WC, 2018, JAMA-J AM MED ASSOC, V320, P1560, DOI 10.1001/jama.2018.14433
   Kittrell H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199508
   Lopes KG, 2022, EAT WEIGHT DISORD-ST, V27, P1679, DOI 10.1007/s40519-021-01304-3
   López-Dávalos PC, 2023, FOOD RES INT, V167, DOI 10.1016/j.foodres.2023.112660
   Makaronidis JM, 2016, APPETITE, V107, P93, DOI 10.1016/j.appet.2016.07.029
   Matiashova L, 2024, METABOLITES, V14, DOI 10.3390/metabo14010016
   MATTES RD, 1993, AM J CLIN NUTR, V57, P373, DOI 10.1093/ajcn/57.3.373
   MEISELMAN HL, 1967, PERCEPT PSYCHOPHYS, V2, P496, DOI 10.3758/BF03210253
   Melis M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010250
   MURPHY C, 1977, SENS PROCESS, V1, P204
   Nance K, 2020, APPETITE, V146, DOI 10.1016/j.appet.2019.104423
   Nance K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010018
   Nettore IC, 2020, NUTR METAB CARDIOVAS, V30, P1299, DOI 10.1016/j.numecd.2020.04.005
   Nicanor Carren J., 2021, Sensory science and chronic diseases: clinical implications and disease management, P125
   Nicanor-Carreón JG, 2023, NUTRIENTS, V15, DOI 10.3390/nu15173670
   Parma V, 2020, CHEM SENSES, V45, P609, DOI 10.1093/chemse/bjaa041
   Peng M, 2019, OBES REV, V20, P325, DOI 10.1111/obr.12800
   Pepino MY, 2014, OBESITY, V22, pE13, DOI 10.1002/oby.20649
   Pepino MY, 2014, OBESITY, V22, P1050, DOI 10.1002/oby.20697
   ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3
   Stevenson RJ, 1999, CHEM SENSES, V24, P627, DOI 10.1093/chemse/24.6.627
   Thanarajah SE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43693-7
NR 48
TC 0
Z9 0
U1 1
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0379-864X
EI 1464-3553
J9 CHEM SENSES
JI Chem. Senses
PD OCT 3
PY 2024
VL 49
AR bjae034
DI 10.1093/chemse/bjae034
PG 11
WC Behavioral Sciences; Food Science & Technology; Neurosciences;
   Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Behavioral Sciences; Food Science & Technology; Neurosciences &
   Neurology; Physiology
GA H6J2E
UT WOS:001324473700001
PM 39292252
DA 2025-04-28
ER

PT J
AU Martinez-Perez, N
   Torheim, LE
   Castro-Díaz, N
   Arroyo-Izaga, M
AF Martinez-Perez, Naiara
   Torheim, Liv Elin
   Castro-Diaz, Nerea
   Arroyo-Izaga, Marta
TI On-campus food environment, purchase behaviours, preferences and
   opinions in a Norwegian university community
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Food environment; Food-purchasing determinants; Nutrient profiling
   model; Adults; University food
ID DIET QUALITY; NUTRIENT PROFILE; BEVERAGES SOLD; HEALTHY FOOD;
   YOUNG-ADULTS; COLLEGE; OBESITY; INTERVENTIONS; STRATEGIES; DISEASE
AB Objective: To assess the food environment at OsloMet, through the nutritional profile and processing level of available commercial foods and drinks, as well as to determine food-purchasing behaviours, preferences and opinions on the food environment, in order to identify whether interventions on campus need to be conducted. Design: Cross-sectional descriptive study. Setting: Pilestredet and Kjeller campus of OsloMet (Norway). Participants: To analyse the nutritional profile of products offered at all food outlets (seven canteens, three coffee shops and two vending machines) at the main campuses three criteria were applied: those proposed by the Spanish Agency for Food Safety and Nutrition, the UK nutrient profiling model and those of the Food and Drink Industry Professional Practices Committee Norway. In addition, products were classified by processing level, using the NOVA system. Food purchasing, food choice behaviours and opinions were analysed through a survey online, in which 129 subjects participated. Results: With regard to the first of the objectives, the combination of the above-mentioned criteria showed that 39 center dot 8 % of the products were 'unhealthy' and 85 center dot 9 % were 'ultra-processed'. Regarding the second objective, the most important determinants of food choice were taste, convenience, and cost and nutrition/health value. The most common improvements suggested were lowering the cost, improving the allergen information on labelling and increasing the variety of fresh and healthy foods. Conclusions: A high proportion of the products offered were considered 'unhealthy' and highly processed. Interventions that improve food prices, availability and information on labelling would be well-received in this community.
C1 [Martinez-Perez, Naiara] Univ Basque Country UPV EHU, Fac Med & Nursing, Dept Nursing, Leioa, Spain.
   [Torheim, Liv Elin] OsloMet Oslo Metropolitan Univ, Fac Hlth Sci, Dept Nursing & Hlth Promot, Oslo, Norway.
   [Castro-Diaz, Nerea; Arroyo-Izaga, Marta] Univ Basque Country UPV EHU, Fac Pharm, Dept Pharm & Food Sci, Paseo Univ 7, Vitoria 01006, Spain.
C3 University of Basque Country; Oslo Metropolitan University (OsloMet);
   University of Basque Country
RP Arroyo-Izaga, M (corresponding author), Univ Basque Country UPV EHU, Fac Pharm, Dept Pharm & Food Sci, Paseo Univ 7, Vitoria 01006, Spain.
EM marta.arroyo@ehu.eus
RI Martinez, Naiara/ACJ-7499-2022; Arroyo-Izaga, Marta/F-2139-2013
OI Arroyo-Izaga, Marta/0000-0001-5592-4241; Martinez Perez,
   Naiara/0000-0001-7271-3657
FU UPV/EHU [EHU12/24]; Vice Rector for Innovation, Social Outreach and
   Cultural Activities of the UPV/EHU; Basque Government [19ARRO]; Erasmus
   Doctoral Program
FX This project was supported by the UPV/EHU (EHU12/24), the Vice Rector
   for Innovation, Social Outreach and Cultural Activities of the UPV/EHU,
   funding by the contract-program formalised with the Basque Government
   (code of the Campus Bizia Lab project: 19ARRO) and by the Department of
   Nursing and Health Promotion of the OsloMet. The authors also
   acknowledge the support provided by the Erasmus Doctoral Program
   (2019-2020) for the fellowship grant. Open Access funding provided by
   the UPV/EHU.
CR Agencia Espauola de Consumo Seguridad Alimentaria y NutriciuEn (AECOSAN), 2010, DOC CONS AL CENTR ED
   Al Sabbah H, 2020, J NUTR SCI, V9, DOI 10.1017/jns.2020.23
   Alagiyawanna AMAAP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2201-8
   An RP, 2013, PUBLIC HEALTH NUTR, V16, P1215, DOI 10.1017/S1368980012004715
   [Anonymous], INT J QUALITY SERVIC, DOI 10.1108/17566690910945903
   Baum CL II, 2017, DEMOGRAPHY, V54, P311, DOI 10.1007/s13524-016-0530-6
   Byrd-Bredbenner C, 2012, APPETITE, V58, P1143, DOI 10.1016/j.appet.2012.02.055
   Chen SE, 2013, HEALTH ECON, V22, P835, DOI 10.1002/hec.2863
   Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027
   Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53
   den Braver NR, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0997-z
   Downs JS, 2009, AM ECON REV, V99, P159, DOI 10.1257/aer.99.2.159
   Emory University of Sustainable Initiatives, 2016, FOOD DIN SUPP HLTH L
   Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380
   Freedman MR, 2011, J AM COLL HEALTH, V59, P205, DOI 10.1080/07448481.2010.502203
   Gamba RJ, 2015, J COMMUN HEALTH, V40, P464, DOI 10.1007/s10900-014-9958-z
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Gores SE, 2008, J AM ACAD NURSE PRAC, V20, P5, DOI 10.1111/j.1745-7599.2007.00273.x
   He MZ, 2012, INT J ENV RES PUB HE, V9, P1458, DOI 10.3390/ijerph9041458
   Hebden L, 2015, J HUM NUTR DIET, V28, P401, DOI 10.1111/jhn.12312
   Hervada X., 2006, EPIDAT 3 1 ANALISIS
   Horacek TM, 2013, PUBLIC HEALTH NUTR, V16, P1186, DOI 10.1017/S1368980012004454
   Horacek TM, 2013, AM J HEALTH PROMOT, V27, pE81, DOI 10.4278/ajhp.120425-QUAN-220
   Januszewska R, 2011, APPETITE, V57, P94, DOI 10.1016/j.appet.2011.03.014
   Jiang YH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061071
   Jun JinHyun Jun JinHyun, 2016, Journal of Foodservice Business Research, V19, P197
   Kelly NR, 2013, J NUTR EDUC BEHAV, V45, P304, DOI 10.1016/j.jneb.2012.10.012
   Kjær IGH, 2015, CLIN OBES, V5, P211, DOI 10.1111/cob.12100
   Labonté MÉ, 2018, ADV NUTR, V9, P741, DOI 10.1093/advances/nmy045
   Lachat CK, 2009, BRIT J NUTR, V102, P1030, DOI 10.1017/S000711450930389X
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Levi A, 2006, J AM COLL HEALTH, V55, P91, DOI 10.3200/JACH.55.2.91-98
   Lobstein T, 2009, PUBLIC HEALTH NUTR, V12, P331, DOI 10.1017/S1368980008002541
   Luiten CM, 2016, PUBLIC HEALTH NUTR, V19, P530, DOI 10.1017/S1368980015002177
   Matbransjens Fagligle Utvalg (MFU), 2013, FOOD DRINK IND PROF
   Milosevic J, 2012, APPETITE, V58, P205, DOI 10.1016/j.appet.2011.09.012
   Monteiro C.A., 2016, J WORLD PUBLIC HLTH, V7, P3
   Muhammad Andrew, 2017, BMJ Glob Health, V2, pe000184, DOI 10.1136/bmjgh-2016-000184
   Norwegian Directorate of Health & Norwegian Food Safety Authority, KOSTH
   OrganizaciuEn Panamericana de la Salud (OPS) OrganizaciuEn Mundial de la Salud (OMS), 2005, AL BEB ULTR AM LAT T
   Oslo Metropolitan University, 2019, OSL METR U ARSR 2019
   Pacheco AF, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018701
   Pelletier JE, 2013, AM J HEALTH PROMOT, V28, P80, DOI 10.4278/ajhp.120705-QUAN-326
   Phipps EJ, 2015, AM J PUBLIC HEALTH, V105, P166, DOI 10.2105/AJPH.2013.301752
   Popping R., 2015, Bull Sociol Methodol/Bull Mthodol Sociol, V128, P23, DOI [DOI 10.1177/0759106315597389, https://doi.org/10.1177/0759106315597389]
   Roy R, 2016, BRIT J NUTR, V115, P1598, DOI 10.1017/S0007114516000568
   Roy R, 2019, J NUTR EDUC BEHAV, V51, P865, DOI 10.1016/j.jneb.2019.03.003
   Roy R, 2017, NUTRITION, V34, P118, DOI 10.1016/j.nut.2016.09.013
   Roy R, 2015, J ACAD NUTR DIET, V115, P1647, DOI 10.1016/j.jand.2015.06.380
   Sharkey JR, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-32
   Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926
   Tam R, 2017, NUTRITION, V37, P7, DOI 10.1016/j.nut.2016.07.007
   Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987
   Turner Christopher, 2017, Innovative Methods and Metrics for Agriculture and Nutrition Actions (M)
   UK Department of Health, 2011, Nutrient Profiling Technical Guidance'
   Vadeboncoeur Claudia, 2016, BMC Obes, V3, P45
   Vadeboncoeur Claudia, 2015, BMC Obes, V2, P22, DOI 10.1186/s40608-015-0051-7
   Wilkins E, 2019, HEALTH PLACE, V57, P186, DOI 10.1016/j.healthplace.2019.02.007
   Yale University Guides, 2011, SUST PROC STAND GUID
NR 59
TC 14
Z9 14
U1 0
U2 21
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD JUN
PY 2022
VL 25
IS 6
BP 1619
EP 1630
AR PII S136898002100272X
DI 10.1017/S136898002100272X
EA JUN 2021
PG 12
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA 1G6GI
UT WOS:000781644600001
PM 34176546
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Hostmark, AT
AF Hostmark, Arne Torbjorn
TI The Oslo Health Study: A Dietary Index estimating high intake of soft
   drinks and low intake of fruits and vegetables was positively associated
   with components of the metabolic syndrome
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM-PHYSIOLOGIE APPLIQUEE
   NUTRITION ET METABOLISME
LA English
DT Article
DE metabolic syndrome; dietary acid load; men; women; cross-sectional study
ID STEAROYL-COA DESATURASE; INSULIN-RESISTANCE; ACID LOAD; URINE PH;
   CONSUMPTION; POPULATION; RISK; TRIGLYCERIDES; CHOLESTEROL; SUCROSE
AB A previous finding that soft drink intake is associated with increased serum triglycerides and decreased highdensity-lipoprotein (HDL) cholesterol, both components of the metabolic syndrome (MetS), raises the question of whether other aspects of an unhealthy diet might be associated with MetS. Main MetS requirements are central obesity and 2 of the following: increased triglycerides, low HDL, increased systolic or diastolic blood pressure, and elevated fasting blood glucose. Of the 18 770 participants in the Oslo Health Study, there were 13 170 respondents (5997 men and 7173 women) with data on MetS factors (except fasting glucose) and on the components used to determine the Dietary Index score (calculated as the intake estimate of soft drinks divided by the sum of intake estimates of fruits and vegetables). MetSRisk was calculated as the sum of arbitrarily weighted factors positively associated with MetS divided by HDL cholesterol. Using regression analyses, the association of the Dietary Index with MetSRisk, with the number of MetS requirements present, and with the complete MetS was studied. In young, middle-aged, and senior men and women, there was, in general, a positive association (p < 0.001) between the Dietary Index and the MetS estimates, which persisted in regression models adjusted for sex, age, time since the last meal, intake of cheese, intake of fatty fish, intake of coffee, intake of alcohol, smoking, physical activity, education, and birthplace. Thus, an index reflecting a high intake of soft drinks and a low intake of fruit and vegetables was positively and independently associated with aspects of MetS.
C1 Univ Oslo, Sect Prevent Med & Epidemiol, N-0318 Oslo, Norway.
C3 University of Oslo
RP Hostmark, AT (corresponding author), Univ Oslo, Sect Prevent Med & Epidemiol, Box 1130 Blindern, N-0318 Oslo, Norway.
EM a.t.hostmark@medisin.uio.no
CR Archer SL, 1998, ANN EPIDEMIOL, V8, P433, DOI 10.1016/S1047-2797(98)00007-6
   BARZEL US, 1995, J BONE MINER RES, V10, P1431, DOI 10.1002/jbmr.5650101002
   Brenner RR, 2003, LIPIDS, V38, P733, DOI 10.1007/s11745-003-1121-x
   Dargent-Molina P, 2008, J BONE MINER RES, V23, P1915, DOI 10.1359/JBMR.080712
   Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935
   Dobrzyn A, 2005, PROSTAG LEUKOTR ESS, V73, P35, DOI 10.1016/j.plefa.2005.04.011
   Dobrzyn A, 2005, OBES REV, V6, P169, DOI 10.1111/j.1467-789X.2005.00177.x
   Dobrzyn P, 2008, EUR J LIPID SCI TECH, V110, P93, DOI 10.1002/ejlt.200700249
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Heaney RP, 2008, AM J CLIN NUTR, V87, p1567S, DOI 10.1093/ajcn/87.5.1567S
   Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220
   Hostmark A. T., 2010, CLIN REV OPINIONS, V2, P8
   Hostmark AT, 2009, APPL PHYSIOL NUTR ME, V34, P901, DOI 10.1139/H09-094
   HOSTMARK AT, 1985, ACTA PHYSIOL SCAND, V125, P553, DOI 10.1111/j.1748-1716.1985.tb07755.x
   *INT DIAB FED, 2009, IDF CONS WORLDW DEF
   JENSDOTTIR T, 2006, PMID, V85, P226, DOI DOI 10.1177/154405910608500304.PMID:16498068
   Kapicioglu S, 2000, DIS ESOPHAGUS, V13, P69, DOI 10.1046/j.1442-2050.2000.00082.x
   Merchant AT, 2007, AM J CLIN NUTR, V85, P225
   MOSTOL A, 2004, DIETARY ASSESSMENT W
   MURRAY RK, 2000, HARPERS BIOCH, P281
   Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211
   NEWSHOLME EA, 1983, BIOCH MED SCI, P509
   REMER T, 1995, J AM DIET ASSOC, V95, P791, DOI 10.1016/S0002-8223(95)00219-7
   SCHLIERF G, 1973, J CLIN INVEST, V52, P732, DOI 10.1172/JCI107235
   Sidorenkov O, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-23
   Sogaard AJ., 2004, International Journal for Equity in Health, V3, P3, DOI [10.1186/1475-9276-3-3, DOI 10.1186/1475-9276-3-3]
   Taylor EN, 2008, KIDNEY INT, V73, P207, DOI 10.1038/sj.ki.5002588
   van Hees AMJ, 2008, J NUTR, V138, P2399, DOI 10.3945/jn.108.094516
   Warensjö E, 2008, AM J CLIN NUTR, V88, P203, DOI 10.1093/ajcn/88.1.203
   Welch AA, 2008, BRIT J NUTR, V99, P1335, DOI 10.1017/S0007114507862350
NR 30
TC 14
Z9 18
U1 1
U2 7
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 1200 MONTREAL ROAD, BUILDING M-55, OTTAWA, ON K1A 0R6, CANADA
SN 1715-5312
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD DEC
PY 2010
VL 35
IS 6
BP 816
EP 825
DI 10.1139/H10-080
PG 10
WC Nutrition & Dietetics; Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA 697YJ
UT WOS:000285555400011
PM 21164553
DA 2025-04-28
ER

PT J
AU Alkanad, M
   Hani, U
   Annegowda, H
   Ghazwani, M
   Haider, N
   Osmani, RAM
   Pandareesh, MD
   Hamsalakshmi
   Bhat, R
AF Alkanad, Maged
   Hani, Umme
   Annegowda, H., V
   Ghazwani, Mohammed
   Haider, Nazima
   Osmani, Riyaz Ali M.
   Pandareesh, M. D.
   Hamsalakshmi
   Bhat, Rajeev
TI Bitter yet beneficial: The dual role of dietary alkaloids in managing
   diabetes and enhancing cognitive function
SO BIOFACTORS
LA English
DT Review
DE cognition improvement; cognitive function; diabetic cognitive
   dysfunction; diabetic disorders; dietary alkaloids
ID BRAIN INSULIN-RESISTANCE; INDUCED OXIDATIVE STRESS; WHITE
   ADIPOSE-TISSUE; NF-KAPPA-B; ALZHEIMERS-DISEASE; IN-VITRO;
   ALPHA-GLUCOSIDASE; NELUMBO-NUCIFERA; ANTI-ALZHEIMER;
   PHARMACOLOGICAL-ACTIVITIES
AB With the rising prevalence of diabetes and its association with cognitive impairment, interest in the use of dietary alkaloids and other natural products has grown significantly. Understanding how these compounds manage diabetic cognitive dysfunction (DCD) is crucial. This comprehensive review explores the etiology of DCD and the effects of alkaloids in foods and dietary supplements that have been investigated as DCD therapies. Data on how dietary alkaloids like berberine, trigonelline, caffeine, capsaicin, 1-deoxynojirimycin, nuciferine, neferine, aegeline, tetramethylpyrazine, piperine, and others regulate cognition in diabetic disorders were collected from PubMed, Research Gate, Web of Science, Science Direct, and other relevant databases. Dietary alkaloids could improve memory in behavioral models and modulate the mechanisms underlying the cognitive benefits of these compounds, including their effects on glucose metabolism, gut microbiota, vasculopathy, neuroinflammation, and oxidative stress. Evidence suggests that dietary alkaloids hold promise for improving cognition in diabetic patients and could open exciting avenues for future research in diabetes management.
   Diabetic cognitive dysfunction (DCD), a cognitive impairment associated with diabetes, stems from disturbances in glucose metabolism, including insulin resistance, abnormal blood sugar levels, and obesity. These disruptions lead to mitochondrial dysfunction, vascular injury, and altered gut microbiota. As a result, metabolic imbalances, increased oxidative stress, and inflammation contribute to NDD-like neuropathy, affecting cognitive function. Alkaloids found in food and dietary supplements offer potential for managing these underlying causes and supporting DCD treatment.image
C1 [Alkanad, Maged; Annegowda, H., V] Adichunchanagiri Univ, Sri Adichunchanagiri Coll Pharm, Dept Pharmacognosy, Mandya, India.
   [Hani, Umme; Ghazwani, Mohammed] King Khalid Univ, Coll Pharm, Dept Pharmaceut, Abha 62529, Saudi Arabia.
   [Haider, Nazima] King Khalid Univ, Coll Med, Dept Pathol, Abha, Saudi Arabia.
   [Osmani, Riyaz Ali M.] JSS Acad Higher Educ & Res, JSS Coll Pharm, Dept Pharmaceut, Mysuru, India.
   [Pandareesh, M. D.] Adichunchanagiri Univ, Ctr Res & Innovat, BGSIT, Mandya, India.
   [Hamsalakshmi] Cauvery Grp Inst, Cauvery Coll Pharm, Dept Pharmacognosy, Mysuru, India.
   [Bhat, Rajeev] Estonian Univ Life Sci, ERA Chair Food By Prod Valorisat Technol VALORTEC, Tartu, Estonia.
C3 Adichunchanagiri University; Sri Adichunchanagiri College of Pharmacy;
   King Khalid University; King Khalid University; JSS Academy of Higher
   Education & Research; JSS College of Pharmacy, Mysuru; Adichunchanagiri
   University; Adichunchanagiri University Centre for Research &
   Innovation; BGS Institute of Technology; Estonian University of Life
   Sciences
RP Hani, U (corresponding author), King Khalid Univ, Coll Pharm, Dept Pharmaceut, Abha 62529, Saudi Arabia.; Annegowda, H (corresponding author), Adichunchanagiri Univ, Sri Adichunchanagiri Coll Pharm, Mandya 571448, Karnataka, India.
EM uahmed@kku.edu.sa
RI hani, umme/CAJ-4228-2022; Bhat, Rajeev/G-4863-2010; H V,
   Annegowda/N-7448-2013; Ghazwani, Mohammed/AAL-5572-2020; ,
   Hamsalakshmi/AAE-7586-2022; Osmani, Riyaz Ali/B-7455-2017; MIRAZKAR,
   PANDAREESH/J-2235-2019; Alkanad, Maged/GPG-3072-2022
OI Bhat, Rajeev/0000-0003-3391-6624; Alkanad, Maged/0000-0003-1598-5482;
   Ghazwani, Mohammed/0000-0003-3555-4268; Haider,
   Nazima/0000-0003-4712-2622; Osmani, Riyaz Ali/0000-0002-2333-0817;
   Mirazkar, Pandareesh/0000-0003-4988-5180; H V,
   Annegowda/0000-0003-1542-6154; , Hamsalakshmi/0000-0002-1655-0344
FU Deanship of Scientific Research, King Khalid University [RGP.1/433/44]
FX Deanship of Scientific Research, King Khalid University, Grant/Award
   Number:RGP.1/433/44
CR Adamse P, 2014, QUAL ASSUR SAF CROP, V6, P15, DOI 10.3920/QAS2013.0314
   Adefegha Stephen A., 2022, Journal of Basic and Clinical Physiology and Pharmacology, V33, P389, DOI 10.1515/jbcpp-2020-0173
   Ahmad W, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0379-z
   Ahmed T, 2015, PHARMACOL REP, V67, P970, DOI 10.1016/j.pharep.2015.03.002
   Al-Baghdadi OB, 2012, BIOORG MED CHEM LETT, V22, P7183, DOI 10.1016/j.bmcl.2012.09.056
   Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS168, DOI 10.2337/dc21-S012
   Amin FM, 2023, LIFE SCI, V314, DOI 10.1016/j.lfs.2022.121275
   Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233
   An Y, 2018, ALZHEIMERS DEMENT, V14, P318, DOI 10.1016/j.jalz.2017.09.011
   Arnaud M J, 1987, Prog Drug Res, V31, P273
   Arnoriaga-Rodríguez M, 2019, REV ENDOCR METAB DIS, V20, P473, DOI 10.1007/s11154-019-09537-5
   Aryal B, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/7299778
   Asai A, 2011, J DIABETES INVEST, V2, P318, DOI 10.1111/j.2040-1124.2011.00101.x
   Aski ML, 2018, IRAN J BASIC MED SCI, V21, P53, DOI 10.22038/IJBMS.2017.23195.5865
   Asokan SM, 2018, LIFE SCI, V199, P60, DOI 10.1016/j.lfs.2018.02.032
   Atal S, 2012, ACTA POL PHARM, V69, P965
   Ballestero JA, 2005, MOL PHARMACOL, V68, P822, DOI 10.1124/mol.105.014431
   Balleza-Tapia H, 2018, ELIFE, V7, DOI 10.7554/eLife.37703
   Banks WA, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10111695
   Bartolucci C, 2001, PROTEINS, V42, P182, DOI 10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1
   Baskaran P, 2016, BRIT J PHARMACOL, V173, P2369, DOI 10.1111/bph.13514
   Batiha Gaber El-Saber., 2020, Journal of Drug Delivery and Therapeutics, V10, P187, DOI [10.22270/jddt.v10i1-s.3866, DOI 10.22270/JDDT.V10I1-S.3866]
   Behl T, 2022, MOLECULES, V27, DOI 10.3390/molecules27185851
   Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005
   Bhanukiran K, 2023, ACS CHEM NEUROSCI, V14, P2743, DOI 10.1021/acschemneuro.3c00269
   Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8
   Biessels GJ, 2020, LANCET NEUROL, V19, P699, DOI 10.1016/S1474-4422(20)30139-3
   Biessels GJ, 2018, NAT REV ENDOCRINOL, V14, P591, DOI 10.1038/s41574-018-0048-7
   Biessels GJ, 2010, J ALZHEIMERS DIS, V20, pS143, DOI 10.3233/JAD-2010-091228
   Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2
   Borshchev YY, 2019, LIFE SCI, V237, DOI 10.1016/j.lfs.2019.116932
   Brown AC, 2017, FOOD CHEM TOXICOL, V107, P449, DOI 10.1016/j.fct.2016.11.001
   Bukhari SNA, 2022, LETT DRUG DES DISCOV, V19, P565, DOI 10.2174/1570180819666220405232333
   Cahlíková L, 2021, MOLECULES, V26, DOI 10.3390/molecules26175240
   Cely-Veloza W, 2023, ACS OMEGA, V8, P27862, DOI 10.1021/acsomega.3c02179
   Chan KC, 2013, J AGR FOOD CHEM, V61, P9867, DOI 10.1021/jf403636z
   Chen C, 2022, BRAIN SCI, V12, DOI 10.3390/brainsci12050572
   Chen CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108021
   Chen C, 2022, DIABETOL METAB SYNDR, V14, DOI 10.1186/s13098-022-00798-w
   Chen G, 2011, DIABETES CARE, V34, P2586, DOI 10.2337/dc11-0958
   Chen GH, 2015, AGE, V37, DOI 10.1007/s11357-015-9839-0
   Chen QJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00334
   Chen WS, 2017, INT IMMUNOPHARMACOL, V42, P44, DOI 10.1016/j.intimp.2016.11.001
   Chen WK, 2018, BIOMED PHARMACOTHER, V106, P92, DOI 10.1016/j.biopha.2018.06.106
   Chlebek J, 2016, FITOTERAPIA, V109, P241, DOI 10.1016/j.fitote.2016.01.008
   Choi M, 2021, PHYTOTHER RES, V35, P1113, DOI 10.1002/ptr.6892
   Chonpathompikunlert P, 2010, FOOD CHEM TOXICOL, V48, P798, DOI 10.1016/j.fct.2009.12.009
   Chowdhury AA, 2018, PHARMACOL REP, V70, P372, DOI 10.1016/j.pharep.2017.09.006
   Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183
   Combs CK, 2001, J NEUROSCI, V21, P1179
   Cui HQ, 2020, EXP THER MED, V20, P3878, DOI 10.3892/etm.2020.9110
   da Silva LA, 2018, CURR NUTR FOOD SCI, V14, P293, DOI 10.2174/1573401313666170724114054
   Dai RH, 2022, BIOMED PHARMACOTHER, V154, DOI 10.1016/j.biopha.2022.113576
   Davis C, 2014, NEUROBIOL DIS, V72, P61, DOI 10.1016/j.nbd.2014.04.012
   De Boer D, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11040580
   de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35
   de la Monte SM, 2012, DRUGS, V72, P49, DOI 10.2165/11597760-000000000-00000
   de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101
   Reyes-Escogido MD, 2011, MOLECULES, V16, P1253, DOI 10.3390/molecules16021253
   Deng CJ, 2023, J CHEM NEUROANAT, V127, DOI 10.1016/j.jchemneu.2022.102207
   Deshmukh R, 2009, EUR J PHARMACOL, V620, P49, DOI 10.1016/j.ejphar.2009.08.027
   Dhaliwal J, 2022, NEUROCHEM RES, V47, P2431, DOI 10.1007/s11064-022-03640-x
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dray C, 2007, J PHYSIOL BIOCHEM, V63, P329, DOI 10.1007/BF03165764
   Duarte JMN, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01015
   Duarte JMN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0021899
   Dunno K, 2022, J FUNCT FOODS, V89, DOI 10.1016/j.jff.2022.104937
   Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016
   Durmaz L, 2022, MOLECULES, V27, DOI 10.3390/molecules27185902
   Edgar JA, 2011, FOOD ADDIT CONTAM A, V28, P308, DOI 10.1080/19440049.2010.547520
   Ehteshamfar SM, 2020, J CELL MOL MED, V24, P13573, DOI 10.1111/jcmm.16049
   Ehtewish H, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23116144
   El-Kabbani O, 1999, MOL VIS, V5, pU1
   Emami MR, 2019, COMPLEMENT THER MED, V44, P282, DOI 10.1016/j.ctim.2019.05.003
   Eruygur N, 2019, PHYTOMEDICINE, V53, P234, DOI 10.1016/j.phymed.2018.09.016
   Evangelista TCS, 2022, J ENZYM INHIB MED CH, V37, P2395, DOI 10.1080/14756366.2022.2117912
   Fahanik-Babaei J, 2019, METAB BRAIN DIS, V34, P191, DOI 10.1007/s11011-018-0338-8
   Fan DH, 2019, CURR NEUROPHARMACOL, V17, P563, DOI 10.2174/1570159X16666180419141613
   Fan X, 2017, INFLAMMATION, V40, P1012, DOI 10.1007/s10753-017-0546-0
   Fang Chong-Ye, 2015, Chin J Nat Med, V13, P595, DOI 10.1016/S1875-5364(15)30055-8
   Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100
   Favrod-Coune T., 2021, TXB ADDICTION TREATM, P215, DOI [DOI 10.1007/978-3-030-36391-816, 10.1007/978-3-030-36391-816]
   Ferreira MJU, 2022, MOLECULES, V27, DOI 10.3390/molecules27041347
   Ferreira S, 2021, NEURAL REGEN RES, V16, P1127, DOI 10.4103/1673-5374.300323
   Freude S, 2009, CURR ALZHEIMER RES, V6, P213, DOI 10.2174/156720509788486527
   Friedman M, 1996, J NUTR, V126, P989, DOI 10.1093/jn/126.4.989
   Gan L, 2014, BBA-MOL BASIS DIS, V1842, P1208, DOI 10.1016/j.bbadis.2013.12.011
   Gasecka A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092807
   Gautam S, 2015, EUR J PHARMACOL, V762, P419, DOI 10.1016/j.ejphar.2015.05.021
   Ge YC, 2022, BIOCHIMIE, V195, P100, DOI 10.1016/j.biochi.2021.11.008
   Gomaa AA, 2022, EUR J PHARMACOL, V921, DOI 10.1016/j.ejphar.2022.174873
   Grabowska I, 2010, CURR ALZHEIMER RES, V7, P165, DOI 10.2174/156720510790691290
   Grover P, 2023, CURR TOP MED CHEM, V23, P1221, DOI 10.2174/1568026623666230406084315
   Guan GY, 2014, ENDOCRINE, V47, P764, DOI 10.1007/s12020-014-0186-1
   Guo S, 2021, PHYTOMEDICINE, V84, DOI 10.1016/j.phymed.2021.153507
   Hamid HA, 2015, J FUNCT FOODS, V16, P74, DOI 10.1016/j.jff.2015.04.011
   Iahtisham-Ul Haq, 2021, PHYTOTHER RES, V35, P680, DOI 10.1002/ptr.6855
   Hayat Z, 2022, SCI SPORT, V37, P333, DOI 10.1016/j.scispo.2021.07.011
   He Q, 2022, J FUNCT FOODS, V88, DOI 10.1016/j.jff.2021.104890
   Heckman PRA, 2015, CURR PHARM DESIGN, V21, P317
   Heidari H, 2023, PHYTOTHER RES, V37, P1462, DOI 10.1002/ptr.7737
   Herraiz T, 2004, FOOD ADDIT CONTAM, V21, P1041, DOI 10.1080/02652030400019844
   Hira T, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126623
   Hou W, 2023, EUR J MED CHEM, V258, DOI 10.1016/j.ejmech.2023.115544
   Hu TG, 2019, J NAT PROD, V82, P2189, DOI 10.1021/acs.jnatprod.9b00205
   Hu ZX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60682-3
   Huang GZ, 2014, EUR J MED CHEM, V81, P15, DOI 10.1016/j.ejmech.2014.05.002
   Huang M, 2017, EXP GERONTOL, V91, P25, DOI 10.1016/j.exger.2017.02.004
   Huang XB, 2022, IND CROP PROD, V179, DOI 10.1016/j.indcrop.2022.114694
   Huang YP, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/3912173
   Hui HX, 2005, DIABETES-METAB RES, V21, P313, DOI 10.1002/dmrr.553
   Hui SC, 2020, FASEB J, V34, P8558, DOI 10.1096/fj.201902618RR
   Hui SC, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900608
   Ibrahim NA, 2018, TOXICOL REP, V5, P1161, DOI 10.1016/j.toxrep.2018.09.005
   Ionescu-Tucker A, 2021, NEUROBIOL AGING, V107, P86, DOI 10.1016/j.neurobiolaging.2021.07.014
   Jash K, 2020, DRUG DEVELOP RES, V81, P144, DOI 10.1002/ddr.21579
   Jing M, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.680336
   Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4
   Jung HA, 2015, ARCH PHARM RES, V38, P1178, DOI 10.1007/s12272-014-0492-4
   Jung HA, 2010, LIFE SCI, V87, P420, DOI 10.1016/j.lfs.2010.08.005
   Jung HA, 2009, BIOL PHARM BULL, V32, P1433, DOI 10.1248/bpb.32.1433
   Kahya MC, 2017, MOL NEUROBIOL, V54, P2345, DOI 10.1007/s12035-016-9727-3
   Kaur Ginpreet, 2016, J Complement Integr Med, V13, P247, DOI 10.1515/jcim-2016-0016
   Khalil NY, 2022, PROF DRUG SUB EXCIP, V47, P1, DOI 10.1016/bs.podrm.2021.10.001
   Khalili-Fomeshi M, 2018, BEHAV BRAIN RES, V337, P131, DOI 10.1016/j.bbr.2017.09.031
   Khan RMM, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55090546
   Khan S, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15101205
   Kharbanda C, 2016, CHEM BIOL DRUG DES, V88, P354, DOI 10.1111/cbdd.12760
   Khazrai YM, 2014, DIABETES-METAB RES, V30, P24, DOI 10.1002/dmrr.2515
   Kim DK, 2004, ARCH PHARM RES, V27, P1127, DOI 10.1007/BF02975117
   Kim Nam-Jun, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-018-0198-7
   Kim SH, 2013, BIOCHEM BIOPH RES CO, V439, P66, DOI 10.1016/j.bbrc.2013.08.027
   Kim SM, 2022, INFLAMMOPHARMACOLOGY, V30, P2373, DOI 10.1007/s10787-022-01075-y
   Kim YJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22060925
   Knight CA, 2004, FOOD CHEM TOXICOL, V42, P1923, DOI 10.1016/j.fct.2004.05.002
   Kodumuri Praveen K., 2019, Journal of Basic and Clinical Physiology and Pharmacology, V30, P20180140, DOI 10.1515/jbcpp-2018-0140
   Kolahdouzan M, 2017, CNS NEUROSCI THER, V23, P272, DOI 10.1111/cns.12684
   Kolb H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041144
   Koleva II, 2012, MOL NUTR FOOD RES, V56, P30, DOI 10.1002/mnfr.201100165
   Kong YR, 2021, MOLECULES, V26, DOI 10.3390/molecules26030728
   Konrath EL, 2013, J PHARM PHARMACOL, V65, P1701, DOI 10.1111/jphp.12090
   Kooshki L, 2023, PHYTOMEDICINE, V112, DOI 10.1016/j.phymed.2023.154686
   Kousaxidis A, 2020, EUR J MED CHEM, V207, DOI 10.1016/j.ejmech.2020.112742
   Kukula-Koch W, 2015, ANAL BIOANAL CHEM, V407, P2581, DOI 10.1007/s00216-015-8468-x
   Kumar S, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.595471
   Labad J, 2012, NEUROBIOL AGING, V33, P2938, DOI 10.1016/j.neurobiolaging.2012.02.026
   Lan X, 2020, PHARMACOL RES, V151, DOI 10.1016/j.phrs.2019.104541
   Lee CW, 2013, CURR ALZHEIMER RES, V10, P298, DOI 10.2174/1567205011310030009
   Lee LM, 2002, AM J CHINESE MED, V30, P601, DOI 10.1142/S0192415X02000594
   Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006
   Li GM, 2020, INT J MOL MED, V45, P1711, DOI 10.3892/ijmm.2020.4548
   Li HY, 2018, REJUV RES, V21, P200, DOI 10.1089/rej.2017.1972
   Li RZ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8165707
   Lima JA, 2018, STUD NAT PROD CHEM, V61, P301, DOI 10.1016/B978-0-444-64183-0.00008-7
   Lin H, 2019, J NANOMATER, V2019, DOI 10.1155/2019/8491269
   Lin JG, 2022, BIOMED PHARMACOTHER, V150, DOI 10.1016/j.biopha.2022.113005
   Lin XR, 2018, PHYTOTHER RES, V32, P1501, DOI 10.1002/ptr.6107
   Liu D, 2018, EXP CLIN ENDOCR DIAB, V126, P513, DOI 10.1055/s-0043-125066
   Liu QP, 2015, MOLECULES, V20, P21700, DOI 10.3390/molecules201219794
   Liu X, 2016, ONCOTARGET, V7, P61703, DOI 10.18632/oncotarget.11225
   Liu YP, 2020, LIFE SCI, V248, DOI 10.1016/j.lfs.2020.117459
   Liu YT, 2018, J INT MED RES, V46, P3318, DOI 10.1177/0300060518781705
   Londzin P, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020537
   Lu F, 2017, ACTA BIOCH BIOPH SIN, V49, P722, DOI 10.1093/abbs/gmx059
   Lu MW, 2020, FOOD FUNCT, V11, P2848, DOI [10.1039/d0fo00351d, 10.1039/D0FO00351D]
   Lu Y., 2015, CHIN J CLINICIANS CH, V24, P4585
   Luo AL, 2022, NEUROSCI BIOBEHAV R, V137, DOI 10.1016/j.neubiorev.2022.104642
   Lyu F, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2020.117771
   Ma CJ, 2015, LIFE SCI, V136, P120, DOI 10.1016/j.lfs.2015.07.001
   Ma DY., 2012, TRADITIONAL CHIN DRU, V28, P39, DOI DOI 10.13412/J.CNKI.ZYYL.2012.05.018
   Ma WX, 2019, EUR J PHARMACOL, V865, DOI 10.1016/j.ejphar.2019.172746
   Ma XQ, 2007, J ETHNOPHARMACOL, V113, P15, DOI 10.1016/j.jep.2007.05.030
   Maeda A, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800086
   Makowska J, 2014, J CHROMATOGR B, V968, P101, DOI 10.1016/j.jchromb.2013.12.001
   Man B, 2022, BIOCHEM BIOPH RES CO, V624, P59, DOI 10.1016/j.bbrc.2022.07.072
   Mao XY, 2016, CELL MOL NEUROBIOL, V36, P915, DOI 10.1007/s10571-015-0276-5
   Mao XY, 2014, INT J MOL SCI, V15, P7667, DOI 10.3390/ijms15057667
   Michailidis M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23052687
   Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019
   Mohamadi Neda, 2018, Journal of Dietary Supplements, V15, P207, DOI 10.1080/19390211.2017.1329244
   Moini-Nodeh S, 2021, DRUG RES, V71, P438, DOI 10.1055/a-1381-6625
   Moodie LWK, 2019, NAT PROD REP, V36, P1053, DOI 10.1039/c9np00010k
   Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143
   Nakagawa K, 2013, BIOSCI BIOTECH BIOCH, V77, P900, DOI 10.1271/bbb.120908
   Navaratna D, 2011, DIABETES, V60, P1789, DOI 10.2337/db10-1371
   Nguyen KH, 2012, J ETHNOPHARMACOL, V142, P488, DOI 10.1016/j.jep.2012.05.024
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Oboh G, 2017, METAB BRAIN DIS, V32, P629, DOI 10.1007/s11011-017-9951-1
   Och A, 2020, TOXINS, V12, DOI 10.3390/toxins12110713
   Omar F, 2021, MOLECULES, V26, DOI 10.3390/molecules26082297
   Othman MA, 2023, CELL TISSUE RES, V392, P443, DOI 10.1007/s00441-022-03735-5
   Ouyang MQ, 2022, FRONT CELL NEUROSCI, V16, DOI 10.3389/fncel.2022.822702
   Panahi Y, 2017, CURR CLIN PHARMACOL, V12, P253, DOI 10.2174/1574884713666180104095641
   Panchal SK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050630
   Park S, 2022, J FUNCT FOODS, V95, DOI 10.1016/j.jff.2022.105180
   Pasierski M, 2022, MOLECULES, V27, DOI 10.3390/molecules27082484
   Patel DK., 2020, NANOMEDICINE BIOACTI, P383, DOI DOI 10.1007/978-981-15
   Patel MB, 2011, PHYTOMEDICINE, V18, P1045, DOI 10.1016/j.phymed.2011.05.006
   Dionísio AP, 2012, WOODHEAD PUBL FOOD S, P231
   Pelimanni E, 2019, J INT NEUROPSYCH SOC, V25, P215, DOI 10.1017/S1355617718001042
   Pérez-Rubio KG, 2013, METAB SYNDR RELAT D, V11, P366, DOI 10.1089/met.2012.0183
   Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002
   Piechowska P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040814
   Pirillo A, 2015, ATHEROSCLEROSIS, V243, P449, DOI 10.1016/j.atherosclerosis.2015.09.032
   Pohanka M, 2015, BRATISL MED J, V116, P520, DOI 10.4149/BLL_2015_106
   Priya LB, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13986
   Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017
   Rafii MS, 2011, NEUROLOGY, V76, P1389, DOI 10.1212/WNL.0b013e318216eb7b
   Raheja S, 2019, LIFE SCI, V221, P196, DOI 10.1016/j.lfs.2019.02.032
   Rai U, 2019, LIFE SCI, V236, DOI 10.1016/j.lfs.2019.116836
   Rajan S, 2018, METABOLISM, V85, P1, DOI 10.1016/j.metabol.2018.03.001
   Rajput A, 2022, MATER TODAY-PROC, V48, P1407, DOI 10.1016/j.matpr.2021.09.189
   Ramappa VK, 2020, J HORTIC SCI BIOTECH, V95, P679, DOI 10.1080/14620316.2020.1760738
   Rammohan A., 2023, RECENT DEV SYNTHESIS, P411, DOI DOI 10.1016/B978-0-323-91221-1.00009-9
   Rasouli H, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104723
   Ravera A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060363
   Regen F, 2017, CURR ALZHEIMER RES, V14, P1140, DOI 10.2174/1567205014666170203141717
   Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247
   Rojas-Vera JD, 2021, S AFR J BOT, V136, P126, DOI 10.1016/j.sajb.2020.03.001
   Rosca AE, 2020, MOLECULES, V25, DOI 10.3390/molecules25235681
   Sadeghnia HR, 2017, IRAN J BASIC MED SCI, V20, P594, DOI 10.22038/IJBMS.2017.8847
   Sahoo AK, 2018, J ETHNOPHARMACOL, V215, P42, DOI 10.1016/j.jep.2017.12.015
   Samra YA, 2016, LIFE SCI, V157, P187, DOI 10.1016/j.lfs.2016.06.002
   Sanati S, 2018, IRAN J BASIC MED SCI, V21, P439, DOI 10.22038/IJBMS.2018.25200.6238
   Sandeep MS, 2017, BIOMED PHARMACOTHER, V94, P605, DOI 10.1016/j.biopha.2017.07.142
   Sarkar S, 2014, EUR J MED CHEM, V80, P135, DOI 10.1016/j.ejmech.2014.04.020
   SatheeshKumar N, 2010, PHYTOMEDICINE, V17, P292, DOI 10.1016/j.phymed.2009.06.006
   Sato N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00143
   Schreiner TG, 2022, LIFE-BASEL, V12, DOI 10.3390/life12030330
   Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065
   Serasanambati M., 2016, South Indian J. Biol. Sci, V2, P368, DOI DOI 10.22205/SIJBS/2016/V2/I4/103443
   Seth E., 2018, NEUROPROTECTIVE EFFE
   Shalimova A, 2019, J CLIN ENDOCR METAB, V104, P2239, DOI 10.1210/jc.2018-01315
   Shehadeh MB, 2021, MOLECULES, V26, DOI 10.3390/molecules26144333
   Siatka T, 2017, MOLECULES, V22, DOI 10.3390/molecules22071181
   Siddiqui S, 2023, CURR PHARMACOL REP, V9, P117, DOI 10.1007/s40495-023-00314-2
   Siegmund B, 1999, J AGR FOOD CHEM, V47, P3113, DOI 10.1021/jf990089w
   Silva Iordanny X., 2017, Current Bioactive Compounds, V13, P152, DOI 10.2174/1573407212666160607094049
   Silver M, 2012, NEUROIMAGE, V63, P1681, DOI 10.1016/j.neuroimage.2012.08.002
   Singh N, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00021
   Srikanth V, 2020, LANCET DIABETES ENDO, V8, P535, DOI 10.1016/S2213-8587(20)30118-2
   Stefanello N, 2014, MOL CELL BIOCHEM, V388, P277, DOI 10.1007/s11010-013-1919-9
   Strachan MWJ, 2011, NAT REV ENDOCRINOL, V7, P108, DOI 10.1038/nrendo.2010.228
   Subramanian S.P., 2014, Biomed. Preven. Nutrit, V4, P475, DOI [10.1016/j.bionut.2014.07.001, DOI 10.1016/J.BIONUT.2014.07.001, 10.1016/J.BIONUT.2014.07.001]
   Sun WL, 2021, ISR J PLANT SCI, V68, P61, DOI 10.1163/22238980-bja10019
   Sun X, 2022, FRONT CHEM, V10, DOI 10.3389/fchem.2022.1040435
   Sun Y., 2022, FRONT NEUROSCI, V16
   Szallasi A, 2005, TRENDS PHARMACOL SCI, V26, P437, DOI 10.1016/j.tips.2005.07.001
   Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903
   Thakur K, 2019, TRENDS FOOD SCI TECH, V89, P88, DOI 10.1016/j.tifs.2019.05.010
   Tharaheswari M, 2014, MOL CELL BIOCHEM, V396, P161, DOI 10.1007/s11010-014-2152-x
   Tian Y, 2022, CNS NEUROL DISORD-DR, V21, P869, DOI 10.2174/1871527321666220124140323
   Tohda C, 1999, BIOL PHARM BULL, V22, P679, DOI 10.1248/bpb.22.679
   Tong MM., 2019, LIAONING J TRADITION, V46, P839, DOI DOI 10.13192/J.ISSN.1000-1719.2019.04.050
   Tsuda S, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12592
   Tundis R, 2010, MINI-REV MED CHEM, V10, P315, DOI 10.2174/138955710791331007
   Tyroller S, 2002, J AGR FOOD CHEM, V50, P4909, DOI 10.1021/jf020281p
   Van Gerven L, 2014, J ALLERGY CLIN IMMUN, V133, P1332, DOI 10.1016/j.jaci.2013.08.026
   van Sloten TT, 2020, LANCET DIABETES ENDO, V8, P325, DOI 10.1016/S2213-8587(19)30405-X
   Veer B., 2023, RECENT DEV SYNTHESIS, P189
   Venkatesan S, 2022, DIABETES RES CLIN PR, V186, DOI 10.1016/j.diabres.2022.109633
   Vrabec R, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24054399
   Wan Y, 2022, PHARMACOL RES, V175, DOI 10.1016/j.phrs.2021.106002
   Wang AM, 2017, EXP THER MED, V14, P2392, DOI 10.3892/etm.2017.4754
   Wang C, 2020, J NUTR BIOCHEM, V75, DOI 10.1016/j.jnutbio.2019.108261
   Wang C, 2019, J NUTR BIOCHEM, V70, P147, DOI 10.1016/j.jnutbio.2019.05.009
   Wang CF, 2022, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.763866
   Wang DM, 2018, COGN NEURODYNAMICS, V12, P303, DOI 10.1007/s11571-017-9471-z
   Wang H., 2018, Oncotarget, V9, P10135, DOI DOI 10.18632/ONCOTARGET.20807
   Wang HY, 2020, ACTA PHARMACOL SIN, V41, P145, DOI 10.1038/s41401-019-0257-1
   Wang J, 2012, NEUROSCIENCE, V202, P58, DOI 10.1016/j.neuroscience.2011.11.062
   Wang J, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00918-y
   Wang KF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01003
   Wang NQ, 2022, J CHEM NEUROANAT, V123, DOI 10.1016/j.jchemneu.2022.102119
   Wang SS, 2022, MOLECULES, V27, DOI 10.3390/molecules27134175
   Wang SS, 2018, J ALZHEIMERS DIS, V65, P1385, DOI [10.3233/JAD-180497, 10.3233/jad-180497]
   Wang SB, 2014, ACTA PHARMACOL SIN, V35, P331, DOI 10.1038/aps.2013.158
   Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083264
   Wang Y, 2020, EXP MOL MED, V52, P1959, DOI 10.1038/s12276-020-00534-2
   Wang Y, 2016, CURR NEUROPHARMACOL, V14, P364, DOI 10.2174/1570159X14666160119094820
   Wang ZY, 2023, CRIT REV FOOD SCI, V63, P4867, DOI 10.1080/10408398.2021.2009436
   Wang ZY, 2021, TRENDS FOOD SCI TECH, V112, P631, DOI 10.1016/j.tifs.2021.04.033
   Wen AY, 2020, J FOOD SCI TECH MYS, V57, P4092, DOI 10.1007/s13197-020-04443-0
   West RK, 2019, J GERONTOL A-BIOL, V74, P683, DOI 10.1093/gerona/gly090
   Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b
   Wu NH, 2021, BIOFACTORS, V47, P587, DOI 10.1002/biof.1725
   Wu W, 2013, BEHAV BRAIN RES, V253, P212, DOI 10.1016/j.bbr.2013.07.052
   Wu XL, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106559
   Xia T, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103681
   Xiang ML, 2022, NAT PRODUCT BIOPROSP, V12, DOI 10.1007/s13659-022-00345-0
   Xiang QR, 2022, FOODS, V11, DOI 10.3390/foods11050686
   Xiang YY, 2020, BIOCHEM BIOPH RES CO, V532, P605, DOI 10.1016/j.bbrc.2020.08.099
   Xiao PJ, 2022, MOLECULES, V27, DOI 10.3390/molecules27217583
   Xiao SJ, 2023, NAT PRODUCT BIOPROSP, V13, DOI 10.1007/s13659-023-00369-0
   Xiao XQ, 2000, NEUROSCI LETT, V286, P155, DOI 10.1016/S0304-3940(00)01088-0
   Xie WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024520
   Xie WT, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.1015045
   Xu HY, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.632236
   Xu WJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172477
   Xuan WT, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-02354-7
   Xue M, 2019, AGEING RES REV, V55, DOI 10.1016/j.arr.2019.100944
   Yadav A, 2021, J ETHNOPHARMACOL, V267, DOI 10.1016/j.jep.2020.113510
   Yan YP, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232315238
   Yang HJ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0005-6
   Yang W, 2015, INT J MOL MED, V36, P1369, DOI 10.3892/ijmm.2015.2356
   Yang ZD, 2012, NAT PROD RES, V26, P387, DOI 10.1080/14786419.2010.487188
   Yang ZD, 2014, MED CHEM RES, V23, P3178, DOI 10.1007/s00044-013-0905-9
   Yelanchezian YMM, 2022, MOLECULES, V27, DOI 10.3390/molecules27123737
   Yin QS, 2022, PHYTOMEDICINE, V99, DOI 10.1016/j.phymed.2022.154000
   Yin S, 2019, CLIN EXP HYPERTENS, V41, P708, DOI 10.1080/10641963.2018.1545846
   Yu YJ, 2022, FOOD FUNCT, V13, P6623, DOI [10.1039/d1fo04396j, 10.1039/D1FO04396J]
   Yu YL, 2010, BIOCHEM PHARMACOL, V79, P1000, DOI 10.1016/j.bcp.2009.11.017
   Yuan SM, 2011, ACTA PHARMACOL SIN, V32, P295, DOI 10.1038/aps.2010.230
   Yuan T, 2014, J NAT PROD, V77, P2316, DOI 10.1021/np500398m
   Yue SJ, 2019, AM J PHYSIOL-ENDOC M, V316, pE73, DOI 10.1152/ajpendo.00256.2018
   Zaccardi F, 2016, POSTGRAD MED J, V92, P63, DOI 10.1136/postgradmedj-2015-133281
   Zarrinpar A, 2012, ALIMENT PHARM THER, V36, P909, DOI 10.1111/apt.12084
   Zeng WY, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/7656834
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhang HY, 2008, CHEM-BIOL INTERACT, V175, P396, DOI 10.1016/j.cbi.2008.04.049
   Zhang JH, 2021, AM J CHINESE MED, V49, P1399, DOI 10.1142/S0192415X21500658
   Zhang Q, 2021, CURR MED SCI, V41, P548, DOI 10.1007/s11596-021-2379-1
   Zhang RY, 2022, NEUROCHEM INT, V154, DOI 10.1016/j.neuint.2022.105289
   Zhang YF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18414-8
   Zhao JJ, 2022, STARCH-STARKE, V74, DOI 10.1002/star.202100231
   Zhao MM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25952-2
   Zhao TF, 2018, IUBMB LIFE, V70, P60, DOI 10.1002/iub.1704
   Zhong M, 2016, MED SCI MONITOR, V22, P5082, DOI 10.12659/MSM.898921
   Zhou JY, 2016, EUR J PHARMACOL, V774, P87, DOI 10.1016/j.ejphar.2016.02.007
   Zhou JY, 2013, FUND CLIN PHARMACOL, V27, P279, DOI 10.1111/j.1472-8206.2011.01022.x
   Zhu FQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-125
   Zhu JJ, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6654954
NR 332
TC 2
Z9 2
U1 11
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-6433
EI 1872-8081
J9 BIOFACTORS
JI Biofactors
PD JUL
PY 2024
VL 50
IS 4
BP 634
EP 673
DI 10.1002/biof.2034
EA JAN 2024
PG 40
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA D0T0S
UT WOS:001134999200001
PM 38169069
DA 2025-04-28
ER

PT J
AU Kobayashi, M
   Kawano, T
   Ukawa, Y
   Sagesaka, YM
   Fukuhara, I
AF Kobayashi, Makoto
   Kawano, Takanori
   Ukawa, Yuuichi
   Sagesaka, Yuko M.
   Fukuhara, Ikuo
TI Green tea beverages enriched with catechins with a galloyl moiety reduce
   body fat in moderately obese adults: a randomized double-blind
   placebo-controlled trial
SO FOOD & FUNCTION
LA English
DT Article
ID MICELLAR SOLUBILITY; LIPID-PEROXIDATION; ENERGY-EXPENDITURE;
   POSTPRANDIAL FAT; DIETARY-FAT; CHOLESTEROL; WEIGHT; ABSORPTION;
   OXIDATION; CAFFEINE
AB Objective To determine whether ingesting a green tea beverage enriched with catechins with a galloyl moiety during a meal reduces body fat in moderately obese adults. Design Randomized double-blind placebo-controlled study. Subjects A total of 126 obese subjects (25 <= body mass index < 30 kg m(-2)) were randomly assigned to a group receiving green tea beverages without catechins (placebo), or a group receiving green tea beverages with a low or high content of catechins with a galloyl moiety. Each subject ingested 500 mL bottled green tea beverages containing 25, 180, or 279.5 mg green tea catechins (0, 149.5, or 246.5 mg catechins with a galloyl moiety, respectively), at mealtimes for 12 weeks; the subjects were instructed to ingest the beverage during the meal that had the highest fat content on that day. Methods Anthropometric measurements and blood chemistry analysis were performed during the run-in period; at weeks 0, 4, 8, and 12 of the intake period; and at the end of the withdrawal period. Abdominal fat area was measured by computed tomography at weeks 0, 8, and 12 of the intake period and at the end of the withdrawal period. Results Both the low-and high-dose groups exhibited significant reductions in visceral and subcutaneous fat areas compared to the control group at 12 weeks post-intervention. Conclusion Ingestion of a green tea beverage enriched with catechins with a galloyl moiety during a high-fat meal reduces body fat in moderately obese adults.
C1 [Kobayashi, Makoto; Kawano, Takanori; Ukawa, Yuuichi; Sagesaka, Yuko M.] ITO EN Ltd, Cent Res Inst, Shizuoka 4210516, Japan.
   [Fukuhara, Ikuo] Fukuhara Hosp, Fukuhara, Hokkaido 0611351, Japan.
RP Kobayashi, M (corresponding author), ITO EN Ltd, Cent Res Inst, Shizuoka 4210516, Japan.
EM m-kobayasi@itoen.co.jp
CR Asaka M, 2000, J JPN SOC FOOD SCI, V47, P708, DOI 10.3136/nskkk.47.708
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Chan PT, 1999, J NUTR, V129, P1094, DOI 10.1093/jn/129.6.1094
   Chen ZY, 2001, J AGR FOOD CHEM, V49, P477, DOI 10.1021/jf000877h
   Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549
   Cohn JS, 2010, NUTRIENTS, V2, P116, DOI 10.3390/nu2020116
   Després JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Fujiki H, 1998, MUTAT RES-FUND MOL M, V402, P307, DOI 10.1016/S0027-5107(97)00310-2
   GORDON DJ, 1988, J CLIN EPIDEMIOL, V41, P679, DOI 10.1016/0895-4356(88)90120-5
   Goto T, 1996, J CHROMATOGR A, V749, P295, DOI 10.1016/0021-9673(96)00456-6
   Gutiérrez-Salmeán G, 2014, FOOD FUNCT, V5, P521, DOI 10.1039/c3fo60416k
   Harada U, 2005, J HEALTH SCI, V51, P248, DOI 10.1248/jhs.51.248
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hursel R, 2011, OBES REV, V12, pE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Ikeda I, 2005, BIOSCI BIOTECH BIOCH, V69, P1049, DOI 10.1271/bbb.69.1049
   IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   Ikeda I, 2003, J AGR FOOD CHEM, V51, P7303, DOI 10.1021/jf034728l
   Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016/S0955-2863(99)00070-4
   KADA T, 1985, MUTAT RES, V150, P127, DOI 10.1016/0027-5107(85)90109-5
   Kajimoto O, 2005, J HEALTH SCI, V51, P161, DOI 10.1248/jhs.51.161
   Kajimoto O, 2003, J CLIN BIOCHEM NUTR, V33, P101
   Kajimoto O., 2006, HLTH SCI, V22, P60
   Kobayashi M, 2014, J AGR FOOD CHEM, V62, P2881, DOI 10.1021/jf405591g
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Miura Y, 2001, J NUTR, V131, P27, DOI 10.1093/jn/131.1.27
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981, DOI 10.1271/bbb.61.1981
   Nakagawa K, 2009, BIOSCI BIOTECH BIOCH, V73, P2014, DOI 10.1271/bbb.90195
   OKUDA T, 1983, CHEM PHARM BULL, V31, P1625
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Seto R, 1997, BIOSCI BIOTECH BIOCH, V61, P1434, DOI 10.1271/bbb.61.1434
   SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   TOKUNAGA K, 1983, INT J OBESITY, V7, P437
   Ukawa Y., 2013, JPN PHARM THER, V41, P919
   Unno T, 2005, BRIT J NUTR, V93, P543, DOI 10.1079/BJN20041379
   Unno T., 2005, JPN J NUTR ASSESS, V22, P207
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wu CD, 2002, NUTRITION, V18, P443, DOI 10.1016/S0899-9007(02)00763-3
   YOSHINO K, 1994, AGE, V17, P79, DOI 10.1007/BF02435010
NR 47
TC 26
Z9 27
U1 0
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PY 2016
VL 7
IS 1
BP 498
EP 507
DI 10.1039/c5fo00750j
PG 10
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA DB9TO
UT WOS:000368860000050
PM 26569165
DA 2025-04-28
ER

PT J
AU Shaikh, NI
   Patil, SS
   Halli, S
   Ramakrishnan, U
   Cunningham, SA
AF Shaikh, Nida I.
   Patil, Shailaja S.
   Halli, Shiva
   Ramakrishnan, Usha
   Cunningham, Solveig A.
TI Going global: Indian adolescents' eating patterns
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Adolescents; Food; Nutrition transition; Globalization; India
ID NUTRITION TRANSITION; DIETARY-INTAKE; CHILDREN; BURDEN; SCHOOLCHILDREN;
   OVERNUTRITION; COUNTRIES; DISEASES; OBESITY; TRENDS
AB Objective: To describe adolescents' eating patterns of traditional, global/non-local and mixed foods, and the factors that may influence food consumption, access and preferences, in a globalizing city.
   Design: A representative sample of school-going adolescents completed a cross-sectional survey including an FFQ designed to identify traditional and global foods. Student's t test and ordinal logistic regression were used to examine weekly food intake, including differences between boys and girls and between adolescents attending private and public schools.
   Setting: Vijayapura city, Karnataka State, India.
   Subjects: Adolescents (n 399) aged 13-16 years.
   Results: Compared with dietary guidelines, adolescents consumed fruit, green leafy vegetables, non-green leafy vegetables and dairy less frequently than recommended and consumed energy-dense foods more frequently than recommended. Traditional but expensive foods (fruits, dairy, homemade sweets and added fat) were more frequently consumed by private-school students, generally from wealthier, more connected families, than by public-school students; the latter more frequently consumed both traditional (tea, coffee, eggs) and mixed foods (snack and street foods; P <= 0.05). Girls reported more frequent consumption of global/non-local packaged and ready-to-eat foods, non-green leafy vegetables and added fat than boys (P <= 0.05). Boys reported more frequent consumption of eggs and street foods than girls (P <= 0.05).
   Conclusions: Adolescents' eating patterns in a globalizing city reflect a combination of global/non-local and traditional foods, access and preferences. As global foods continue to appear in low-and middle-income countries, understanding dietary patterns and preferences can inform efforts to promote diversity and healthfulness of foods.
C1 [Shaikh, Nida I.; Ramakrishnan, Usha; Cunningham, Solveig A.] Emory Univ, Laney Grad Sch, Doctoral Program Nutr & Hlth Sci, 1518 Clifton Rd NE,7040-J, Atlanta, GA 30322 USA.
   [Patil, Shailaja S.] BLDE Univ, Shri BM Patil Med Coll Hosp & Res Ctr, Dept Community Med, Vijayapura, Karnataka, India.
   [Halli, Shiva] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.
   [Ramakrishnan, Usha; Cunningham, Solveig A.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, 1518 Clifton Rd NE,7040-J, Atlanta, GA 30322 USA.
   [Cunningham, Solveig A.] Emory Univ, Dept Sociol, 1518 Clifton Rd NE,7040-J, Atlanta, GA 30322 USA.
C3 Emory University; BLDE (Deemed to be University); University of
   Manitoba; Emory University; Rollins School Public Health; Emory
   University
RP Shaikh, NI (corresponding author), Emory Univ, Laney Grad Sch, Doctoral Program Nutr & Hlth Sci, 1518 Clifton Rd NE,7040-J, Atlanta, GA 30322 USA.
EM nida.shaikh@emory.edu
RI Patil, Shailaja/AAX-9436-2020; Cunningham, Solveig/K-6760-2012; PATIL,
   SHAILAJA S/HLW-4450-2023
OI PATIL, SHAILAJA S/0000-0002-6071-8028; Shaikh, Nida
   I/0000-0002-3684-2651; Argeseanu Cunningham, Solveig/0000-0002-2354-1526
FU Eunice Kennedy Shriver National Institute of Child Health & Human
   Development [3D43HD065249-03S1]; Fogarty International Center at the
   National Institutes of Health [1-R25 TW009337-01]
FX The study described was supported by the Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (award number
   3D43HD065249-03S1). N.S. was supported by the Fogarty International
   Center at the National Institutes of Health (award number 1-R25
   TW009337-01). The Eunice Kennedy Shriver National Institute of Child
   Health & Human Development had no role in the design, analysis or
   writing of this article.
CR AGARWAL B, 1994, J PEASANT STUD, V22, P81, DOI 10.1080/03066159408438567
   Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5
   [Anonymous], 1990, J AM DIET ASSOC
   [Anonymous], BRIEF IND PROF BIJ D
   [Anonymous], DIET GUID IND
   [Anonymous], 2006 ANN M POP ASS A
   [Anonymous], 2007, EUR J CLIN NUTR
   Baker P, 2014, OBES REV, V15, P564, DOI 10.1111/obr.12174
   Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952
   Dasen PR., 2000, INT J GROUP TENS, V29, P17, DOI DOI 10.1023/A:1005126629553
   Davidson JA., 2003, Journal of the Adventist Theological Society, V14, P114
   Eckhardt GM, 2012, J MACROMARKETING, V32, P280, DOI 10.1177/0276146712440708
   Griffiths PL, 2001, J NUTR, V131, P2692, DOI 10.1093/jn/131.10.2692
   Gulati S, 2013, ANN NUTR METAB, V62, P279, DOI 10.1159/000346554
   Gupta N, 2010, J AM COLL NUTR, V29, P81, DOI 10.1080/07315724.2010.10719820
   Gupta R, 2003, J Assoc Physicians India, V51, P470
   Hannerz Ulf., 2000, Transnational Connections: Culture, People, Places
   Hoefling A, 2010, APPETITE, V54, P603, DOI 10.1016/j.appet.2010.02.016
   Jatrana S., 2003, Explaining Gender Disparity in Child Health in Haryana State of India
   Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168
   Kapil Umesh, 2012, Indian J Community Med, V37, P207, DOI 10.4103/0970-0218.103465
   Kotecha PV, 2013, J HEALTH POPUL NUTR, V31, P490
   Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169
   Misra A, 2011, J DIABETES, V3, P278, DOI 10.1111/j.1753-0407.2011.00139.x
   Misra A, 2011, ANN NUTR METAB, V58, P203, DOI 10.1159/000329431
   Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433
   Patel SA, 2015, ANN EPIDEMIOL, V25, P336, DOI 10.1016/j.annepidem.2015.02.009
   Pingali P., 2004, ESA Working Paper No. 04-05
   Plüss C, 2005, INT SOCIOL, V20, P201, DOI 10.1177/0268580905052369
   Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289
   Popkin BM, 2001, NUTR REV, V59, P379, DOI 10.1111/j.1753-4887.2001.tb06967.x
   Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P93, DOI 10.1079/PHN200180
   Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7
   Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022
   Shaw A., 1993, Indian Food Packer, V47, P29
   Shetty P, 2013, INDIAN J PEDIATR, V80, pS21, DOI 10.1007/s12098-013-0971-5
   Singh PN, 2014, AM J CLIN NUTR, V100, p359S, DOI 10.3945/ajcn.113.071571
   Spear BA, 2002, J AM DIET ASSOC, V102, pS23, DOI 10.1016/S0002-8223(02)90418-9
   Stigler MH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-9
   Swaminathan S, 2007, INDIAN PEDIATR, V44, P593
   THIMMAYAMMA BV, 1973, INDIAN J NUTR DIET, V10, P8
   Tzioumis E, 2014, FOOD NUTR BULL, V35, P230, DOI 10.1177/156482651403500210
   UNICEF, 2011, STAT WORLDS CHILDR 2
   Vaz M., 2005, SAJCN - South African Journal of Clinical Nutrition, V18, P198
   Venkaiah K, 2002, EUR J CLIN NUTR, V56, P1119, DOI 10.1038/sj.ejcn.1601457
   Vereecken CA, 2005, BRIT J NUTR, V94, P423, DOI 10.1079/BJN20051513
   Vijayapushpam T, 2003, PUBLIC HEALTH NUTR, V6, P683, DOI 10.1079/PHN2003478
   WHO, 2003, WHO TECHN REP SER
   WOODWARD DR, 1986, HUM NUTR-APPL NUTR, V40A, P185
   Zollo Peter., 1995, American Demographics, V17, P22
NR 50
TC 21
Z9 22
U1 3
U2 8
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD OCT
PY 2016
VL 19
IS 15
BP 2799
EP 2807
DI 10.1017/S1368980016001087
PG 9
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA FH5ZG
UT WOS:000411250600014
PM 27170203
OA Green Published, Bronze
DA 2025-04-28
ER

PT J
AU Deng, XJ
   Hou, Y
   Zhou, HJ
   Li, YL
   Xue, ZQ
   Xue, XT
   Huang, GH
   Huang, KL
   He, XY
   Xu, WT
AF Deng, Xiujuan
   Hou, Yan
   Zhou, Hongjie
   Li, Yali
   Xue, Zhiqiang
   Xue, Xiaoting
   Huang, Ganghua
   Huang, Kunlun
   He, Xiaoyun
   Xu, Wentao
TI Hypolipidemic, anti-inflammatory, and anti-atherosclerotic effects of
   tea before and after microbial fermentation
SO FOOD SCIENCE & NUTRITION
LA English
DT Article
DE anti-atherosclerotic; anti-inflammatory; hypolipidemic; microbial
   fermentation; tea
ID PU-ERH TEA; NF-KAPPA-B; THEABROWNIN; INHIBITION; ACTIVATION; EXTRACTS;
   CAFFEINE; OBESITY; RATS
AB Background Microbial fermentation significantly affects the flavor and efficacy of tea. It is generally believed that fermented tea is more effective in lowering lipids, while unfermented tea can more effectively inhibit inflammation. However, there is not sufficient evidence to support this claim. To systematically compare the hypolipidemic, anti-inflammatory, and anti-atherosclerotic effects of tea before and after microbial fermentation, hyperlipidemic rats and inflammatory injury cells were treated with Monascus purpureus-fermented pu-erh tea water extract (MPT) and sun-dried green tea water extract (SGT), respectively.
   Results MPT, with higher levels of theabrownins, flavonoids, gallic acid (GA), and lovastatin, was more effective in reducing serum triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and inflammatory cytokines (TNF-alpha, IL-1 beta, and IL-6), while SGT, with higher levels of tea polyphenols, amino acids, (-)-epigallocatechin gallate (EGCG), and theaflavins, was more effective in increasing serum high-density lipoprotein cholesterol (HDL-C) in hyperlipidemic rats. The foam cells on the arterial wall of the rats in the MPT group were visibly less, and the thrombosis time was longer than that in the SGT group. Cell experiments showed that MPT was more effective in protecting endothelial cells from damage than SGT.
   Conclusion Surprisingly, Monascus purpureus-fermented pu-erh tea not only had better hypolipidemic and anti-atherosclerotic effects than its raw material (sun-dried green tea), but also was superior in anti-inflammatory effects to the latter, which was possibly attributable to the great changes in functional ingredients during microbial fermentation.
C1 [Deng, Xiujuan] Yunnan Agr Univ, Coll Food Sci & Technol, Kunming, Yunnan, Peoples R China.
   [Hou, Yan; Zhou, Hongjie; Li, Yali; Xue, Zhiqiang; Xue, Xiaoting; Huang, Ganghua] Yunnan Agr Univ, Coll Long Run Pu Erh Tea, Kunming 650201, Yunnan, Peoples R China.
   [Huang, Kunlun; He, Xiaoyun; Xu, Wentao] China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, Beijing 100083, Peoples R China.
C3 Yunnan Agricultural University; Yunnan Agricultural University; China
   Agricultural University
RP Zhou, HJ (corresponding author), Yunnan Agr Univ, Coll Long Run Pu Erh Tea, Kunming 650201, Yunnan, Peoples R China.; Xu, WT (corresponding author), China Agr Univ, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual, Beijing 100083, Peoples R China.
EM 1984020@ynau.edu.cn; xuwentao@cau.edu.cn
RI Xu, Wentao/AAF-3955-2020; Zhou, Hongjie/KIG-7468-2024; huang,
   kun/MXJ-7845-2025
OI Hou, Yan/0000-0001-8398-5498; he, xiaoyun/0000-0002-9503-8532
FU National Natural Science Foundation of China [31260197]
FX National Natural Science Foundation of China, Grant/Award Number:
   31260197
CR Badshah H, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110719
   Cai XB, 2017, J GASTROENTEROL, V52, P1240, DOI 10.1007/s00535-017-1332-3
   Chen LC, 2016, J FUNCT FOODS, V22, P132, DOI [10.1016/j.jff.2016.01, 10.1016/j.jff.2016.01.021]
   Cheng MJ, 2011, PHYTOCHEM LETT, V4, P372, DOI 10.1016/j.phytol.2011.08.003
   Choi HW, 2018, INT J MOL MED, V41, P1103, DOI 10.3892/ijmm.2017.3309
   Chu SL, 2011, CHIN J INTEGR MED, V17, P492, DOI 10.1007/s11655-011-0781-4
   Mota MAD, 2015, ACTA CIR BRAS, V30, P242, DOI 10.1590/S0102-865020150040000002
   Gong JS, 2010, J FOOD SCI, V75, pH182, DOI 10.1111/j.1750-3841.2010.01675.x
   Grégoire É, 2018, INT J ARTIF INTELL T, V27, DOI 10.1142/S0218213018400043
   Hou Y, 2009, EXP GERONTOL, V44, P434, DOI 10.1016/j.exger.2009.03.007
   Huang FJ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00063
   Indra Mochamad Rasjad, 2013, BMC Res Notes, V6, P275, DOI 10.1186/1756-0500-6-275
   Jiang X. F., 2011, FOOD SCI, V32, P3
   Li Chun-lei, 2011, Chinese Journal of Biologicals, V24, P1293
   [李晓飞 Li Xiaofei], 2017, [食品工业科技, Science & Technology of Food Industry], V38, P67
   Li Y., 2013, Food and Fermentation Technology, V49, P34, DOI [10.3969/j.issn.1674-506X.2013.02-009, DOI 10.3969/J.ISSN.1674-506X.2013.02-009]
   Liu LT, 2017, BIOSCI BIOTECH BIOCH, V81, P1948, DOI 10.1080/09168451.2017.1364618
   Liu YL, 2020, MOL NEUROBIOL, V57, P96, DOI 10.1007/s12035-019-01759-7
   Lu JP, 2019, ANN INTERN MED, V170, P298, DOI 10.7326/M18-1932
   Manning S, 2014, THER ADV CHRONIC DIS, V5, P135, DOI 10.1177/2040622314522848
   Nakamura M, 2017, INT J FOOD SCI NUTR, V68, P321, DOI 10.1080/09637486.2016.1232376
   Sugiura C, 2020, J FOOD SCI, V85, P192, DOI 10.1111/1750-3841.14811
   Sun Q, 2014, PAK J PHARM SCI, V27, P1015
   Sun Y, 2019, FOOD FUNCT, V10, P3502, DOI [10.1039/C9FO00162J, 10.1039/c9fo00162j]
   Tang NN, 2016, MOL CELL BIOCHEM, V422, P11, DOI 10.1007/s11010-016-2799-6
   Ueda P, 2017, LANCET DIABETES ENDO, V5, P196, DOI 10.1016/S2213-8587(17)30015-3
   Wang QP, 2011, J SCI FOOD AGR, V91, P2412, DOI 10.1002/jsfa.4480
   Wang TF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00433
   Wu YT, 2017, EUR J PHARMACOL, V794, P52, DOI 10.1016/j.ejphar.2016.11.027
   [肖懿慧 Xiao Yihui], 2019, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V40, P847
   Xiong C., 2019, J BIOSCI MED, V7, P120, DOI [10.4236/jbm.2019.72010, DOI 10.4236/JBM.2019.72010]
   Xiong ZX, 2019, FOOD CHEM TOXICOL, V131, DOI 10.1016/j.fct.2019.110585
   Yang DF, 2020, J CELL MOL MED, V24, P5911, DOI 10.1111/jcmm.15278
   Yao Min, 2020, Journal of Tea Science, V40, P1
   Zeng XQ, 2019, J SCI FOOD AGR, V99, P6882, DOI 10.1002/jsfa.9974
   Zhang L, 2012, FOOD CHEM, V135, P2222, DOI 10.1016/j.foodchem.2012.07.033
   Zhang ShuPing Zhang ShuPing, 2019, Journal of Tea Science, V39, P231
   Zhao F, 2014, J AGR FOOD CHEM, V62, P2772, DOI 10.1021/jf4056314
   Zhong L, 2020, AQUAC RES, V51, DOI 10.1111/are.14403
   Zhu MZ, 2020, FOOD CHEM, V312, DOI 10.1016/j.foodchem.2019.126043
NR 40
TC 41
Z9 43
U1 5
U2 100
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD FEB
PY 2021
VL 9
IS 2
BP 1160
EP 1170
DI 10.1002/fsn3.2096
EA JAN 2021
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA QD2RF
UT WOS:000604394900001
PM 33598200
OA Green Published, hybrid
DA 2025-04-28
ER

PT J
AU Soares, IF
   Vasconcellos, F
   Cunha, FA
AF Soares, Isabela F.
   Vasconcellos, Fabricio
   Cunha, Felipe A.
TI Time to achieve steady state for an accurate assessment of resting
   energy expenditure in adolescents with healthy weight and obesity: A
   cross-sectional study
SO ARCHIVES OF ENDOCRINOLOGY METABOLISM
LA English
DT Article
DE Resting metabolic rate; kilocalories; oxygen uptake; reliability; CPX
   Ultima CardiO2; indirect calorimetry
ID METABOLIC-RATE; PREDICTIVE EQUATIONS; CHILDREN; NONOBESE; AGE
AB Objective: The present study investigated the time needed to achieve a steady state for an accurate assessment of resting energy expenditure (REE) in adolescents with healthy weight and obesity. Materials and methods: Thirty adolescents aged 12-17 years were assigned to a group with healthy weight (GHW; n = 12, body mass index [BMI] 22.5 +/- 3.6 kg/m(2)) and another group with obesity (GO; n = 18, BMI 34.1 +/- 5.2 kg/m(2)). Participants underwent test-retest reliability of REE assessment as follows: a) 24 h of abstention from physical exercise, soft drinks, or caffeine; b) fasting for similar to 12 h; c) acclimation period of 10 min; d) 30-min assessment in a supine position. Results and discussion: A significant change occurred during the 30 min in REE. Significant differences existed between consecutive means until the 20th and 25th min for the GHW and GO, respectively. Although significant differences between trials 1 and 2 were detected during the first 5-10 min of assessment, the REE for each 5-min time point exhibited high test-retest reliability across trials in both groups (intraclass correlation coefficients range 0.79-0.99). Conclusion: The following recommendations are provided to promote accurate assessment of REE among adolescents: a) initiate the REE assessment with 10 min of acclimation to decrease restlessness; b) determine REE for a minimum of 20 min if healthy weight and 25 min if obesity; c) determine REE for a further 5 min, with the average of this last 5 min of REE data being regarded as the REE.
C1 [Soares, Isabela F.; Vasconcellos, Fabricio; Cunha, Felipe A.] Univ Estado Rio de Janeiro, Programa Posgrad Ciencias Exercicio & Esportes, Rio De Janeiro, RJ, Brazil.
   [Vasconcellos, Fabricio; Cunha, Felipe A.] Univ Estado Rio de Janeiro, Lab Atividade Fis & Promocao Saude, Rua Sao Francisco Xavier 524,Sala 8121F, BR-20550013 Rio De Janeiro, RJ, Brazil.
C3 Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio
   de Janeiro
RP Cunha, FA (corresponding author), Univ Estado Rio de Janeiro, Lab Atividade Fis & Promocao Saude, Rua Sao Francisco Xavier 524,Sala 8121F, BR-20550013 Rio De Janeiro, RJ, Brazil.
EM felipe.cunha@uerj.br
RI Cunha, Felipe/H-4372-2012; Vasconcellos, Fabricio/L-1321-2016
OI Cunha, Felipe/0000-0002-8912-5656; Vasconcellos,
   Fabricio/0000-0002-4522-4425; Soares, Isabela/0000-0002-6544-3772
FU Carlos Chagas Filho Foundation for the Research Support in Rio de
   Janeiro (FAPERJ) [E-26/202.705/2019]
FX this study was partially supported by the Carlos Chagas Filho Foundation
   for the Research Support in Rio de Janeiro (FAPERJ, E-26/202.705/2019,
   recipient FC). The funder had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   Alberga AS, 2017, APPL PHYSIOL NUTR ME, V42, P15, DOI 10.1139/apnm-2016-0244
   Alcantara JMA, 2018, NUTR METAB CARDIOVAS, V28, P929, DOI 10.1016/j.numecd.2018.03.010
   Borges JH, 2019, NUTRITION, V59, P44, DOI 10.1016/j.nut.2018.07.015
   Cheng HL, 2016, AM J CLIN NUTR, V104, P1061, DOI 10.3945/ajcn.115.129205
   Cohen Jacob, 1988, Statistical Power Analysis for the Behavioral Sciences
   Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009
   Cunha FA, 2013, EUR J APPL PHYSIOL, V113, P1441, DOI 10.1007/s00421-012-2571-x
   Herrmann SD, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22944
   Hohenadel MG, 2019, METABOLISM, V93, P68, DOI 10.1016/j.metabol.2018.12.008
   Horner NK, 2001, J NUTR, V131, P2215, DOI 10.1093/jn/131.8.2215
   Irving CJ, 2017, NUTR CLIN PRACT, V32, P77, DOI 10.1177/0884533616672064
   Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941
   Kansra AR, 2021, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.581461
   Kim MH, 2012, NUTR RES PRACT, V6, P51, DOI 10.4162/nrp.2012.6.1.51
   Kuczmarski RJ, 2000, VITAL HLTH STAT, P1, DOI [DOI 10.1016/J.BBRC.2015.06.114, DOI 10.1590/S1516-35982002000600018]
   Lindberg L, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003078
   Marra M, 2015, J PEDIATR-US, V166, P1390, DOI 10.1016/j.jpeds.2015.03.013
   Mellecker RR, 2009, JPEN-PARENTER ENTER, V33, P640, DOI 10.1177/0148607109336603
   Ohlsson C, 2016, LANCET DIABETES ENDO, V4, P1017, DOI 10.1016/S2213-8587(16)30273-X
   RAVUSSIN E, 1989, AM J CLIN NUTR, V49, P968, DOI 10.1093/ajcn/49.5.968
   Rodríguez G, 2002, J PHYSIOL BIOCHEM, V58, P9, DOI 10.1007/BF03179833
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Tang QY, 2014, ASIA PAC J CLIN NUTR, V23, P459, DOI 10.6133/apjcn.2014.23.3.02
   Ventham JC, 1999, BRIT J NUTR, V81, P435, DOI 10.1017/S0007114599000781
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
NR 26
TC 3
Z9 3
U1 0
U2 5
PU SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
PI RIO DE JANEIRO, RJ
PA RUA HUMAITA, 85 CJ 501, RIO DE JANEIRO, RJ, 22261-000, BRAZIL
SN 2359-3997
EI 2359-4292
J9 ARCH ENDOCRIN METAB
JI Arch. Endocrinol. Metab.
PD MAR-APR
PY 2022
VL 66
IS 2
DI 10.20945/2359-3997000000450
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 1L0OA
UT WOS:000798991100019
PM 35315987
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Leme, AC
   Baranowski, T
   Thompson, D
   Philippi, S
   O'Neil, C
   Fulgoni, V
   Nicklasz, T
AF Leme, Ana Carolina
   Baranowski, Tom
   Thompson, Debbe
   Philippi, Sonia
   O'Neil, Carol
   Fulgoni, Victor, III
   Nicklasz, Theresa
TI Top food sources of percentage of energy, nutrients to limit and total
   gram amount consumed among US adolescents: National Health and Nutrition
   Examination Survey 2011-2014
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Energy; Grams; Sodium; SFA; Added sugars; Adolescents; Food sources;
   NHANES
ID CHILDREN; OBESITY; SUGARS; TRENDS; STATES
AB Objective: To identify most commonly consumed foods by adolescents contributing to percentage of total energy, added sugars, SFA, Na and total gram intake per day.
   Design: Data from the National Health and Nutrition Examination Survey (NHANES) 2011-2014.
   Setting: NHANES is a cross-sectional study nationally representative of the US population.
   Participants: One 24 h dietary recall was used to assess dietary intake of 3156 adolescents aged 10-19 years. What We Eat in America food category classification system was used for all foods consumed. Food sources of energy, added sugars, SFA, Na and total gram amount consumed were sample-weighted and ranked based on percentage contribution to intake of total amount.
   Results: Three-highest ranked food subgroup sources of total energy consumed were: sugar-sweetened beverages (SSB; 7.8 %); sweet bakery products (6.9 %); mixed dishes - pizza (6.6%). Highest ranked food sources of total gram amount consumed were: plain water (33.1 %); SSB (15.8 %); milk (7.2 %). Three highest ranked food sources of total Na were: mixed dishes - pizza (8.7 %); mixed dishes - Mexican (6.7 %); cured meats/poultry (6.6 %). Three highest ranked food sources of SFA were: mixed dishes - pizza (9.1 %); sweet bakery products (8.3 %); mixed dishes - Mexican (7.9%). Three highest ranked food sources of added sugars were: SSB (42.1 %); sweet bakery products (12.1 %); coffee and tea (7.6%).
   Conclusions: Identifying current food sources of percentage energy, nutrients to limit and total gram amount consumed among US adolescents is critical for designing strategies to help them meet nutrient recommendations within energy needs.
C1 [Leme, Ana Carolina; Philippi, Sonia] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil.
   [Leme, Ana Carolina; Baranowski, Tom; Thompson, Debbe; Nicklasz, Theresa] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, 100 Bates Ave, Houston, TX 77030 USA.
   [O'Neil, Carol] Louisiana State Univ, Agr Ctr, Sch Nutr & Food Sci, Baton Rouge, LA 70803 USA.
   [Fulgoni, Victor, III] Nutr Impact LLC, Battle Creek, MI USA.
C3 Universidade de Sao Paulo; United States Department of Agriculture
   (USDA); Baylor College of Medicine; Louisiana State University System;
   Louisiana State University; Nutrition Impact, LLC
RP Nicklasz, T (corresponding author), Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, 100 Bates Ave, Houston, TX 77030 USA.
EM tnicklas@bcm.edu
RI Philippi, Sonia/C-4895-2013; Thompson, Debbe/GOV-5741-2022; Barco Leme,
   Ana Carolina/H-3619-2015
OI Barco Leme, Ana Carolina/0000-0003-2782-4301; Thompson,
   Debbe/0000-0002-5491-8816; Baranowski, Tom/0000-0002-0653-2222
CR Ahluwalia N, 2016, ADV NUTR, V7, P121, DOI 10.3945/an.115.009258
   [Anonymous], 2003, Paediatr Child Health, V8, P577
   [Anonymous], 2015, RAPP ACT 2015 REP PE
   [Anonymous], 2007, NAT HLTH NUTR EX SUR
   [Anonymous], 2005, Dietary Reference intakes for energy, carbohydrate, fiber, Fat, fatty acids, cholesterol, protein, and amino acids
   [Anonymous], 2013, VITAL HLTH STAT SERI
   [Anonymous], UNW RESP RAT NHANES
   [Anonymous], Nutrition and National Health
   [Anonymous], 2015, National Health and Nutrition Examination Survey
   Avelino GF, 2014, CAD SAUDE PUBLICA, V30, P663, DOI 10.1590/0102-311X00073713
   Bailey RL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010102
   Blanton CA, 2006, J NUTR, V136, P2594, DOI 10.1093/jn/136.10.2594
   Celermajer DS, 2006, HEART, V92, P1701, DOI 10.1136/hrt.2005.081760
   Centers for Disease Control and Prevention, 2016, CDC GROWTH CHARTS
   Centers for Disease Control and Prevention (2015), 2015, UNW RESP RAT NHANES
   Centers for Disease Control and Prevention National Center for Health Statistics, 2013, NHANES I WEB TUT SUR
   Collins CE, 2010, INT J OBESITY, V34, P1103, DOI 10.1038/ijo.2009.241
   Collins CE, 2014, APPETITE, V73, P147, DOI 10.1016/j.appet.2013.11.003
   Committee DGA HHS Prevention OoD Promotion H USDA Promotion CfNP, 2015, Dietary Guidelines for Americans 2015-2020
   Deierlein AL, 2014, PUBLIC HEALTH NUTR, V17, P2194, DOI 10.1017/S1368980014000639
   Dunford EK, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060610
   Huth PJ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-116
   Keast DR, 2013, NUTRIENTS, V5, P283, DOI 10.3390/nu5010283
   Lipsky LM, 2017, AM J CLIN NUTR, V105, P1424, DOI [10.3945/ajcn.116150029, 10.3945/ajcn.116.150029]
   Naska Androniki, 2017, F1000Res, V6, P926, DOI 10.12688/f1000research.10703.1
   *NAT I HLTH NAT HE, 2002, 3 REP NAT CHOL ED PR
   National Health and Nutrition Examination Survey, 2002, MEC IN PERS DIET INT
   O'Connor EA, 2017, JAMA-J AM MED ASSOC, V317, P2427, DOI 10.1001/jama.2017.0332
   O'Neil CE, 2012, NUTRIENTS, V4, P2097, DOI 10.3390/nu4122097
   Papanikolaou Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020160
   Previdelli AN, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100593
   Quader ZS, 2017, J ACAD NUTR DIET, V117, P39, DOI 10.1016/j.jand.2016.09.010
   Rangan A, 2014, J HUM NUTR DIET, V27, P450, DOI 10.1111/jhn.12182
   Rangan AM, 2011, NUTRIENTS, V3, P186, DOI 10.3390/nu3020186
   Rehm CD, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120804
   Rodríguez LA, 2016, PUBLIC HEALTH NUTR, V19, P2424, DOI 10.1017/S1368980016000057
   Scagliusi FB, 2008, J AM DIET ASSOC, V108, P2031, DOI 10.1016/j.jada.2008.09.012
   Skinner AC, 2016, OBESITY, V24, P1116, DOI 10.1002/oby.21497
   Slining MM, 2013, PEDIATR OBES, V8, P307, DOI 10.1111/j.2047-6310.2013.00156.x
   Slining MM, 2013, J ACAD NUTR DIET, V113, P1683, DOI 10.1016/j.jand.2013.06.001
   Taber DR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/1479-5868-12-S1-S7
   Taber DR, 2012, PEDIATRICS, V130, P437, DOI 10.1542/peds.2011-3353
   Thorpe MG, 2014, PUBLIC HEALTH NUTR, V17, P1767, DOI 10.1017/S1368980013001924
   United States Department of Agriculture Agricultural Research Service, 2018, WHAT WE EAT AM DAT T
   US Department of Agriculture Agriculture Research Service, OV FOOD PATT EQ DAT
   Utley JM, 2016, CLIN OBES, V6, P296, DOI 10.1111/cob.12163
   Vedovato GM, 2015, APPETITE, V87, P296, DOI 10.1016/j.appet.2014.12.229
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
NR 48
TC 24
Z9 25
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD MAR
PY 2019
VL 22
IS 4
BP 661
EP 671
DI 10.1017/S1368980018002884
PG 11
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA HQ8LZ
UT WOS:000462677500008
PM 30468140
OA Bronze
DA 2025-04-28
ER

PT J
AU Kelly, B
   Cretikos, M
   Rogers, K
   King, L
AF Kelly, Bridget
   Cretikos, Michelle
   Rogers, Kris
   King, Lesley
TI The commercial food landscape: outdoor food advertising around primary
   schools in Australia
SO AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE public health; marketing; food; child; advertisements
ID TELEVISION; CHILDREN; ALCOHOL; EXTENT
AB Objective: Food marketing is linked to childhood obesity through its influence on children's food preferences, purchase requests and food consumption. We aimed to describe the volume and nature of outdoor food advertisements and factors associated with outdoor food advertising in the area surrounding Australian primary schools.
   Methods: Forty primary schools in Sydney and Wollongong were selected using random sampling within population density and socio-economic strata. The area within a 500m radius of each school was scanned and advertisements coded according to pre-defined criteria, including: food or non-food product advertisement, distance from the school, size and location. Food advertisements were further categorised as core foods, non-core foods and miscellaneous drinks (tea and coffee).
   Results: The number of advertisements identified was 9,151, of which 2,286 (25%) were for food. The number of non-core food advertisements was 1,834, this accounted for 80% of food advertisements. Soft drinks and alcoholic beverages were the food products most commonly advertised around primary schools (24% and 22% of food advertisements, respectively). Non-core food products were twice as likely to be advertised close to a primary school (95 non-core food advertisements per km(2) within 250 m vs. 46 advertisements per km(2) within 250-500 m).
   Conclusions: The density of non-core food advertisements within 500 m of primary schools, and the potential for repeated exposure of children to soft drink and alcoholic beverage advertisements in particular, highlights the need for outdoor food marketing policy intervention.
   Implications: Outdoor advertising is an important food marketing tool that should be considered in future debates on regulation of food marketing to children.
C1 [Kelly, Bridget; Cretikos, Michelle; Rogers, Kris; King, Lesley] Univ Sydney, Sch Publ Hlth, NSW Ctr Overweight & Obes, Sydney, NSW 2006, Australia.
   [Cretikos, Michelle] Ctr Epidemiol & Res, NSW Dept Hlth, Sydney, NSW, Australia.
C3 University of Sydney
RP Kelly, B (corresponding author), Univ Sydney, Sch Publ Hlth, NSW Ctr Overweight & Obes, Level 2 K25,Med Fdn Bldg, Sydney, NSW 2006, Australia.
EM Bridgetk@health.usyd.edu.au
RI Kelly, Bridget/AAW-9549-2021
OI Kelly`, Bridget/0000-0003-3111-6279
CR Andrieu E, 2006, EUR J CLIN NUTR, V60, P434, DOI 10.1038/sj.ejcn.1602331
   [Anonymous], 2004, JUNK FOOD GENERATION
   *ASUTR BUR STAT, 2006, HOUS EXP SURV 2003 2
   *AUST, 2004, RISK FACT MON RIS EP
   *AUSTR ASS NAT ADV, 2006, FOOD BEV ADV MARK CO
   *AUSTR BUR STAT, 2006, AUSTR SCH DIR
   Australian Bureau of Statistics, 2007, CENS POP HOUS SOC IN
   BOOTH ML, 2004, SCH PHYS ACTIVITY NU, P2006
   Chapman K, 2006, HEALTH PROMOT INT, V21, P172, DOI 10.1093/heapro/dal021
   *CIT SYDN, 2005, CIT SYDN SIGN ADV ST
   *CONS INT, 2007, REC INT COD MARK FOO
   Dalmeny K., 2003, Broadcasting bad health: Why food advertising needs to be controlled
   *DEP ED TRAIN, 2005, PUBL SCH NSW
   *DEP HLTH HUM SERV, 1996, EX SUMM REG RESTR SA
   *DEP LOC GOV, 2006, COMP INF NSW LOC GOV
   Department of Health and Ageing, 2001, AUSTR GUID HLTH EAT
   Hackbarth DP, 2001, PUBLIC HEALTH REP, V116, P558, DOI 10.1093/phr/116.6.558
   Hastings G., 2003, REV RES EFFECTS FOOD
   Kelly B, 2008, PUBLIC HEALTH NUTR, V11, P1180, DOI 10.1017/S1368980008001778
   Kelly B, 2007, PUBLIC HEALTH NUTR, V10, P1234, DOI 10.1017/S1368980007687126
   Kelly B, 2007, HEALTH PROMOT INT, V22, P284, DOI 10.1093/heapro/dam026
   LUKE D, 2000, TOB CONTROL, V16, P23
   McGinnis M.J., 2006, FOOD MARKETING CHILD, DOI 10.17226/11514
   Neville L, 2005, HEALTH PROMOT INT, V20, P105, DOI 10.1093/heapro/dah601
   *NSW GOV DEP PLANN, 2007, TRANSP CORR OUTD ADV
   Pasch KE, 2007, J STUD ALCOHOL DRUGS, V68, P587, DOI 10.15288/jsad.2007.68.587
   Pucci LG, 1998, AM J PREV MED, V15, P155, DOI 10.1016/S0749-3797(98)00034-8
   Schor JB, 2007, J LAW MED ETHICS, V35, P10, DOI 10.1111/j.1748-720X.2007.00110.x
   SISOO P, KOREA TIMES      MAR
   Thorburn AW, 2005, OBES REV, V6, P187, DOI 10.1111/j.1467-789X.2005.00187.x
   WACHTLER S, 2007, BOSTON YOUTH SPEAK C
NR 31
TC 77
Z9 82
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1326-0200
EI 1753-6405
J9 AUST NZ J PUBL HEAL
JI Aust. N. Z. Publ. Health
PD DEC
PY 2008
VL 32
IS 6
BP 522
EP 528
DI 10.1111/j.1753-6405.2008.00303.x
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA 382WP
UT WOS:000261636400006
PM 19076742
OA Green Submitted, hybrid
DA 2025-04-28
ER

PT J
AU Xiao, Y
   Wu, YP
   Zhong, K
   Gao, H
AF Xiao, Yue
   Wu, Yanping
   Zhong, Kai
   Gao, Hong
TI Comprehensive evaluation of the composition of Mingshan Laochuancha
   green tea and demonstration of hypolipidemic activity in a zebrafish
   obesity model
SO RSC ADVANCES
LA English
DT Article
ID CAMELLIA-SINENSIS L.; PU-ERH TEAS; GAS CHROMATOGRAPHY-OLFACTOMETRY; FREE
   AMINO-ACIDS; CHEMICAL-COMPONENTS; KEY ODORANTS; BLACK; QUALITY; OOLONG;
   DIFFERENTIATION
AB Laochuancha is an ancient tea plant originating from the Mingshan district of Ya'an city, Sichuan province, China, which is used to produce tea products with excellent quality. Mingshan Laochuancha green tea (MLGT) is a type of green tea manufactured from Laochuancha tea leaves. Currently, not much is known regarding the chemical compositions of MLGT and its bioactivity. Herein, the present study explores, for the first time, the chemical compositions and hypolipidemic activity of MLGT. It was observed that K was the most abundant element of 26.58 mg g(-1), and contents of toxic As, Cd, Cr and Pb elements were all below concentration limits. Alcohols (55.65%) were the main volatiles, and numerous volatiles with chestnut-like aroma were detected. Total content of 21 amino acids was 28.61 mg g(-1), and amino acids with velvety-like and umami taste totally accounted for 65.39%. The high content of amino acids and low ratio of polyphenols to total amino acids were attributed to strong umami and mellow taste of MLGT. Moreover, catechins and alkaloids were abundant in MLGT, where EGCG (85.82 mg g(-1)) and caffeine (33.78 mg g(-1)) were at highest content. Analyses of chemical compositions revealed excellent quality of MLGT. Correspondingly, MLGT showed potent hypolipidemic activity, and water extract of MLGT at 200 mu g mL(-1) significantly reduced lipid level to 43.06% of high-fat zebrafish. Results firstly revealed the quality characteristics of MLGT and provided further insights into bioactivity of Laochuancha.
C1 [Xiao, Yue; Wu, Yanping; Zhong, Kai; Gao, Hong] Sichuan Univ, Coll Biomass Sci & Engn, Hlth Food Evaluat Res Ctr, Chengdu 610065, Peoples R China.
   [Xiao, Yue; Wu, Yanping; Zhong, Kai; Gao, Hong] Sichuan Univ, Key Lab Food Sci & Technol, Minist Educ Sichuan Prov, Chengdu 610065, Peoples R China.
C3 Sichuan University; Sichuan University
RP Zhong, K (corresponding author), Sichuan Univ, Coll Biomass Sci & Engn, Hlth Food Evaluat Res Ctr, Chengdu 610065, Peoples R China.; Zhong, K (corresponding author), Sichuan Univ, Key Lab Food Sci & Technol, Minist Educ Sichuan Prov, Chengdu 610065, Peoples R China.
EM eric211@163.com
RI yanping, wu/AAR-4840-2021
OI Zhong, Kai/0000-0002-7515-1386; Xiao, Yue/0000-0002-3328-3516
FU National Natural Science Foundation of China [31701574]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 31701574).
CR Alcazar A, 2007, J AGR FOOD CHEM, V55, P5960, DOI 10.1021/jf070601a
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Brzezicha-Cirocka J, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5157-y
   Chen GJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700485
   Chen L, 2007, EUPHYTICA, V154, P239, DOI 10.1007/s10681-006-9292-3
   Cooper R, 2012, INT J FOOD SCI NUTR, V63, P90, DOI 10.3109/09637486.2011.629180
   den Broeder MJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040894
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1038/168167a0
   Feng ZH, 2019, FOOD CHEM, V285, P347, DOI 10.1016/j.foodchem.2019.01.174
   Fernández-Cáceres PL, 2001, J AGR FOOD CHEM, V49, P4775, DOI 10.1021/jf0106143
   Gong XW, 2017, INT J FOOD PROP, V20, pS1107, DOI 10.1080/10942912.2017.1336719
   He W, 2009, FOOD RES INT, V42, P1462, DOI 10.1016/j.foodres.2009.08.008
   Horanni R, 2013, J FOOD COMPOS ANAL, V31, P94, DOI 10.1016/j.jfca.2013.03.005
   Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a
   Jiang H, 2019, J FOOD COMPOS ANAL, V77, P28, DOI 10.1016/j.jfca.2019.01.005
   Kottawa-Arachchi JD, 2019, GENET RESOUR CROP EV, V66, P259, DOI 10.1007/s10722-018-0698-2
   Kumar A, 2005, FOOD CHEM, V89, P441, DOI 10.1016/j.foodchem.2004.03.003
   Li MY, 2019, INT J FOOD PROP, V22, P878, DOI 10.1080/10942912.2019.1614951
   Liu LT, 2018, J FUNCT FOODS, V47, P156, DOI 10.1016/j.jff.2018.05.030
   Luo X.-p., 2017, W CHINA, V7, P12
   Lv SD, 2014, J AGR FOOD CHEM, V62, P1810, DOI 10.1021/jf405237u
   Meguro S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120142
   Ordoñez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024
   Raederstorff DG, 2003, J NUTR BIOCHEM, V14, P326, DOI 10.1016/S0955-2863(03)00054-8
   Ros E, 2000, ATHEROSCLEROSIS, V151, P357, DOI 10.1016/S0021-9150(00)00456-1
   Scharbert S, 2005, J AGR FOOD CHEM, V53, P5377, DOI 10.1021/jf050294d
   SOLMS J, 1969, J AGR FOOD CHEM, V17, P686, DOI 10.1021/jf60164a016
   Su H, 2019, FOOD SCI NUTR, V7, P2167, DOI 10.1002/fsn3.1062
   Syu KY, 2008, J AGR FOOD CHEM, V56, P7637, DOI 10.1021/jf801795m
   Tainaka T., 2012, NUTR METAB, V9, P73
   Tainaka T, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-88
   Tan HR, 2019, LWT-FOOD SCI TECHNOL, V108, P221, DOI 10.1016/j.lwt.2019.03.054
   Troisi J, 2019, FOOD CHEM, V288, P193, DOI 10.1016/j.foodchem.2019.02.115
   Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973
   Wang KB, 2009, INT J FOOD SCI TECH, V44, P2476, DOI 10.1111/j.1365-2621.2009.02040.x
   Wei H, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10050492
   Williams J, 2019, PHYTOTHER RES, V33, P571, DOI 10.1002/ptr.6277
   Wu XY, 2016, ENVIRON SCI POLLUT R, V23, P8244, DOI 10.1007/s11356-016-6333-x
   Xiao ZB, 2017, FLAVOUR FRAG J, V32, P265, DOI 10.1002/ffj.3378
   Xin ZQ, 2018, FOOD CHEM, V266, P534, DOI 10.1016/j.foodchem.2018.06.056
   Xu M, 2019, FOOD CHEM, V289, P482, DOI 10.1016/j.foodchem.2019.03.080
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yang ZY, 2013, FOOD RES INT, V53, P585, DOI 10.1016/j.foodres.2013.02.011
   Yemane M, 2008, FOOD CHEM, V107, P1236, DOI 10.1016/j.foodchem.2007.09.058
   Yi T, 2015, LWT-FOOD SCI TECHNOL, V62, P194, DOI 10.1016/j.lwt.2015.01.003
   Zhang J, 2018, MOLECULES, V23, DOI 10.3390/molecules23113013
   Zhang L, 2011, J AGR FOOD CHEM, V59, P8754, DOI 10.1021/jf2015733
   Zhao M, 2011, J AGR FOOD CHEM, V59, P3641, DOI 10.1021/jf104601v
   Zhou J, 2015, J PHARMACOL TOX MET, V72, P47, DOI 10.1016/j.vascn.2014.12.002
   Zhu Y, 2018, FOOD RES INT, V108, P74, DOI 10.1016/j.foodres.2018.03.026
   Zhu YC, 2016, FOOD CHEM, V194, P643, DOI 10.1016/j.foodchem.2015.08.054
NR 51
TC 11
Z9 12
U1 2
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
EI 2046-2069
J9 RSC ADV
JI RSC Adv.
PD DEC 12
PY 2019
VL 9
IS 70
BP 41269
EP 41279
DI 10.1039/c9ra07655g
PG 11
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA KG9CH
UT WOS:000510247900053
PM 35540089
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Li, XY
   Zeng, JJ
   Chen, B
   Yan, QJ
   Cui, YZ
   Xu, WL
   Zhang, XT
   Xu, SY
AF Li, Xiaying
   Zeng, Jingjing
   Chen, Bo
   Yan, Qiongjie
   Cui, Yuze
   Xu, Wenlei
   Zhang, Xiaotong
   Xu, Shaoyong
TI Daily higher tea consumption is associated with a reduced risk of type 2
   diabetes: A cohort study and updated systematic review and meta-analysis
SO NUTRITION RESEARCH
LA English
DT Review
DE Tea consumption; Type 2 diabetes mellitus; Cohort study; Meta-analysis;
   China Health and Nutrition Survey
ID GREEN TEA; COFFEE CONSUMPTION; METABOLIC SYNDROME; CHINA HEALTH;
   JAPANESE MEN; MELLITUS; DIETARY; OBESITY; WOMEN
AB Tea is abundant in phytochemicals (such as polyphenols and theaflavins), which have a hypoglycemic effect. Previous studies investigating the relationship between tea consumption and the risk of type 2 diabetes mellitus (T2DM) have yielded inconsistent results. We hypothesized that tea consumption would be associated with a reduced risk of T2DM. This cohort study used data from the China Health and Nutrition Survey, involving a total of 5199 participants initially recruited in 1997 and subsequently followed until 2009. Consumption of any variety of tea was tracked using structured questionnaires, and T2DM was diagnosed according to the American Diabetes Association's criteria. We also performed a systematic literature search of PubMed, Web of Science, and EMBASE for publications through September 2021, including 19 cohort studies comprising 1,076,311 participants. In our cohort study, the logistic regression model showed a relative risk (RR) of T2DM among tea drinkers of 1.02 (95% confidence interval [CI], 0.82-1.28) compared with non-tea drinkers. Although our updated meta-analysis showed no significant association between tea consumption and T2DM on the whole (pooled RR of 0.96 [0.91-1.00]), compared with the non-tea-drinking group, participants consuming 4 or more cups of tea per day had a 17% reduced risk of T2DM, with an RR of 0.83 (95% CI, 0.76-0.90). These data support our hypothesis that tea consumption at higher doses (e.g., >= 4 cups/day) is associated with a reduced risk of T2DM.(c) 2023 Elsevier Inc. All rights reserved.
C1 [Li, Xiaying] Wuhan Univ Sci & Technol, Coll Med, Wuhan, Hubei, Peoples R China.
   [Zeng, Jingjing; Chen, Bo; Yan, Qiongjie; Cui, Yuze; Xu, Wenlei; Xu, Shaoyong] Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Cent Hosp, Ctr Clin Evidence Based & Translat Med, Xiangyang, Hubei, Peoples R China.
   [Zhang, Xiaotong] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Affiliated Hosp, Dept Nephrol, Xiangyang, Hubei, Peoples R China.
   [Xu, Shaoyong] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Affiliated Hosp, Dept Endocrinol, Xiangyang, Hubei, Peoples R China.
   [Xu, Shaoyong] Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Cent Hosp, Dept Endocrinol, 136 Jingzhou St, Xiangyang 441021, Hubei, Peoples R China.
C3 Wuhan University of Science & Technology; Hubei University of Arts &
   Science; Hubei University of Arts & Science; Hubei University of Arts &
   Science; Hubei University of Arts & Science
RP Xu, SY (corresponding author), Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Cent Hosp, Dept Endocrinol, 136 Jingzhou St, Xiangyang 441021, Hubei, Peoples R China.
EM yoji_xu@hotmail.com
RI xiaying, li/ADT-9333-2022
OI xu, shaoyong/0000-0002-8260-2456
FU Young Talents Project of Hubei Provincial Health Commission, China
   [WJ2021Q012]; Science and Technology Research Key Project of Education
   Department of Hubei Province, China [D20212602]; Sanuo Diabetes Charity
   Foundation, China; Xiangyang Science and Technology Plan Project, China
   [2019ZD12]
FX The study was supported by the Young Talents Project of Hubei Provincial
   Health Commission, China (Grant number WJ2021Q012) ; Science and
   Technology Research Key Project of Education Department of Hubei
   Province, China (Grant num- ber D20212602) ; Sanuo Diabetes Charity
   Foundation, China; and Xiangyang Science and Technology Plan Project,
   China (Grant number 2019ZD12) .
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002
   Aravind SM, 2021, FOOD RES INT, V142, DOI 10.1016/j.foodres.2021.110189
   Bag S, 2022, FOOD CHEM, V371, DOI 10.1016/j.foodchem.2021.131098
   Bhupathiraju SN, 2013, AM J CLIN NUTR, V97, P155, DOI 10.3945/ajcn.112.048603
   Boggs DA, 2010, AM J CLIN NUTR, V92, P960, DOI 10.3945/ajcn.2010.29598
   Gao SJ, 2009, PUBLIC HEALTH NUTR, V12, P2371, DOI 10.1017/S1368980009005102
   Gao WQ, 2018, BIOMED PHARMACOTHER, V103, P637, DOI 10.1016/j.biopha.2018.04.043
   Greenberg JA, 2005, INT J OBESITY, V29, P1121, DOI 10.1038/sj.ijo.0802999
   Hamer M, 2008, BRIT J NUTR, V100, P1046, DOI 10.1017/S0007114508944135
   Han LL, 2014, MOL NUTR FOOD RES, V58, P2189, DOI 10.1002/mnfr.201400088
   Hayashino Y, 2011, DIABETIC MED, V28, P805, DOI 10.1111/j.1464-5491.2011.03239.x
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hirata A, 2017, ASIA PAC J CLIN NUTR, V26, P545, DOI 10.6133/apjcn.042016.04
   Hu G, 2006, INT J OBESITY, V30, P1742, DOI 10.1038/sj.ijo.0803341
   International Diabetes Federation, IDF DIABETES ATLAS, V9th ed.
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Jing YL, 2009, J GEN INTERN MED, V24, P557, DOI 10.1007/s11606-009-0929-5
   Khan MAB, 2020, J EPIDEMIOL GLOB HEA, V10, P107, DOI 10.2991/jegh.k.191028.001
   Liu XN, 2018, INT J EPIDEMIOL, V47, P1887, DOI 10.1093/ije/dyy173
   Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585
   Nie J, 2021, AM J CLIN NUTR, V114, P194, DOI 10.1093/ajcn/nqab006
   North Carolina at Chapel Hill National Institute for Nutrition and Health at the Chinese Center for Disease Control and Prevention, China Health and Nutrition Survey
   Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Oh J, 2015, INT J MOL SCI, V16, P8811, DOI 10.3390/ijms16048811
   Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311
   Qiu L, 2012, BRIT J NUTR, V108, P1686, DOI 10.1017/S0007114511007173
   Sartorelli DS, 2010, AM J CLIN NUTR, V91, P1002, DOI 10.3945/ajcn.2009.28741
   Shimizu M, 1999, NAHRUNG, V43, P154, DOI 10.1002/(SICI)1521-3803(19990601)43:3<154::AID-FOOD154>3.0.CO;2-A
   Song YQ, 2005, J AM COLL NUTR, V24, P376, DOI 10.1080/07315724.2005.10719488
   STROBE, Strengthening the Reporting of Observational Studies in Epidemiology
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   van Woudenbergh GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036910
   Wang SZ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218029
   Wells GA, 2014, NEWCASTLE OTTAWA SCA, DOI DOI 10.1007/S10654-010-9491-Z
   Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654
   World Health Organization, Diabetes
   Yang J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005632
   Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836
   Yang WS, 2014, BRIT J NUTR, V111, P1329, DOI 10.1017/S0007114513003887
   Yasui K, 2011, BIOMED RES-TOKYO, V32, P119, DOI 10.2220/biomedres.32.119
   Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119
   Zhang HY, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2911
   Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83
NR 45
TC 8
Z9 9
U1 9
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
EI 1879-0739
J9 NUTR RES
JI Nutr. Res.
PD OCT
PY 2023
VL 118
BP 116
EP 127
DI 10.1016/j.nutres.2023.08.002
EA AUG 2023
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA T1JQ6
UT WOS:001075622600001
PM 37647847
OA Bronze
DA 2025-04-28
ER

PT J
AU Han, E
   Powell, LM
   Kim, TH
AF Han, Euna
   Powell, Lisa M.
   Kim, Tae Hyun
TI Trends in exposure to television food advertisements in South Korea
SO APPETITE
LA English
DT Article
DE TV food advertising; Targeted ratings data; South Korea
ID BODY-MASS INDEX; UNITED-STATES; NUTRITION TRANSITION; US ADULTS;
   CHILDREN; DIETARY; ADOLESCENTS; OBESITY; CONSUMPTION; PATTERNS
AB Given the increased concern about the impact of TV food advertisements (ads) on individual food choices, we provide important evidence on TV food ad exposure between 2004 and 2009 in South Korea. We used monthly targeted ratings data by age group as the number of ads seen daily from Korean Nielsen Media Research. We generated six food groups: beverages (milk, soda, fruit drinks, sports/energy drinks, water, coffee/tea products, and other); snacks/sweets (cookies/chips, candy, and chewing gum); fast food (Domino's pizza, Lotteria, McDonald's, Mr. Pizza, Pizza Hut, local chicken and pizza franchises, and other); instant noodle; full-service restaurants; and other. From 2004 to 2009, overall exposure to television food ads fell by 19.0% (from 6.8 to 5.5 ads daily), although exposure to full-service restaurant ads increased over that time period by 45.7%. While fast-food ad exposure fell overall, exposure to ads for local fried chicken franchises nearly doubled, making them the most commonly seen fast-food ads by 2009. Fast-food and instant noodle ads made up larger proportions of total ad exposure in 2009 than in 2004 in all age groups, with the largest increase among adolescents. Beverage ads continue to be the most prevalent food ads seen in South Korea. Differential trends found in exposure across and within food product categories and differences by age groups highlight the need for continued monitoring to help inform the regulatory policy debate on food advertising, particularly with regards to ads directed at children and adolescents. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Han, Euna] Gachon Univ, Gachon Inst Pharmaceut Sci, Coll Pharm, Inchon 406799, South Korea.
   [Powell, Lisa M.] Univ Illinois, Inst Hlth Res & Policy, Sch Publ Hlth, Hlth Policy & Adm, Chicago, IL 60608 USA.
   [Kim, Tae Hyun] Yonsei Univ, Inst Hlth Serv Res, Grad Sch Publ Hlth, Seoul 120752, South Korea.
C3 Gachon University; University of Illinois System; University of Illinois
   Chicago; University of Illinois Chicago Hospital; Yonsei University;
   Yonsei University Health System
RP Kim, TH (corresponding author), Yonsei Univ, Inst Hlth Serv Res, Grad Sch Publ Hlth, 50 Yonsei Ro, Seoul 120752, South Korea.
EM thkim@yuhs.ac
RI Han, Euna/KFA-2394-2024; Kim, Juewon/ABH-3314-2020
OI Kim, Tae Hyun/0000-0003-1053-8958; Han, Euna/0000-0003-2656-7059
FU Korea National Research Foundation [NRF-2012007096]
FX We gratefully acknowledge research support from the Korea National
   Research Foundation (NRF-2012007096). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official view of the Korea National Research Foundation.
CR Advertising Information Center, 2008, SUMM ADV EXP QUART M
   [Anonymous], 2006, MMWR - Morbidity Mortality Weekly Report
   [Anonymous], 2001, SURG GEN CALL ACT PR
   [Anonymous], 2005, Youth Opportunity Monthly Data and Rate Analysis Report, DOI [10.17226/11514, DOI 10.17226/11514]
   Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356
   Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007
   Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357
   Brunello G., 2009, RISE OBESITY ATLANTT
   Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012
   Cho K. Y., 2009, KOREAN J PEDIAT GAST, V11, P150
   CONDRY J, 1988, J BROADCAST ELECTRON, V32, P255
   Connor SM, 2006, PEDIATRICS, V118, P1478, DOI 10.1542/peds.2005-2837
   COTUGNA N, 1988, J NUTR EDUC, V20, P125
   Emery S, 2005, ARCH PEDIAT ADOL MED, V159, P639, DOI 10.1001/archpedi.159.7.639
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Fox MK, 2010, J AM DIET ASSOC, V110, pS52, DOI 10.1016/j.jada.2010.09.002
   French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429
   Gamble M, 1999, AM J HEALTH BEHAV, V23, P261, DOI 10.5993/AJHB.23.4.3
   Gantz W., 2007, FOOD THOUGHT TELEVIS
   Harris J.L., 2010, Fast food F.A.C.T.S.: Evaluating fast food nutrition and marketing to youth
   Harris JL, 2012, CEREAL FACTS LTD PRO
   Harris JL, 2009, CEREAL FACTS NUTR MA
   Harrison K, 2005, AM J PUBLIC HEALTH, V95, P1568, DOI 10.2105/AJPH.2004.048058
   Hastings G., 2003, REV RES EFFECTS FOOD, pi
   Holt D., 2007, CHILDRENS EXPOSURE T
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017
   Kim S, 2000, AM J CLIN NUTR, V71, P44
   Korea Center for Disease Control and Prevention, 2010, PUBLIC HLTH WKLY REP, V3, P597
   Korea Food and Drug Administration, 2010, BAN HIGH CAL LOW NUT
   Korea Food Consumption Information, 2011, HDB FOOD CONSUMPTION
   Korean Nutrition Society, 2005, NUTR DAT CD
   KOTZ K, 1994, J AM DIET ASSOC, V94, P1296, DOI 10.1016/0002-8223(94)92463-5
   Kunkel D., 2009, The impact of industry self-regulation on the nutritional quality of foods advertised on television to children
   Lee JungSug Lee JungSug, 2009, Korean Journal of Nutrition, V42, P723
   Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Ministry of Health and Welfare, 2006, NAT HLTH NUTR EX SUR
   Ministry of Health and Welfare, 2009, HLTH EAT GUID KOR
   Moon Y. S., 2009, KOR ADV ASS SPRING C, P52
   Park W. I., 2008, 0804 KOR BROADC I
   Powell LM, 2007, ARCH PEDIAT ADOL MED, V161, P553, DOI 10.1001/archpedi.161.6.553
   Powell LM, 2011, ARCH PEDIAT ADOL MED, V165, P1078, DOI 10.1001/archpediatrics.2011.131
   Powell LM, 2010, ARCH PEDIAT ADOL MED, V164, P794, DOI 10.1001/archpediatrics.2010.139
   서정완, 2008, Clinical and Experimental Pediatrics, V51, P576
   Song Y, 2005, BRIT J NUTR, V93, P943, DOI 10.1079/BJN20051435
   Southwell BG, 2002, J HEALTH COMMUN, V7, P445, DOI 10.1080/10810730290001800
   TARAS HL, 1995, ARCH PEDIAT ADOL MED, V149, P649, DOI 10.1001/archpedi.1995.02170190059010
   The Third Korea National Health and Nutrition Examination Survey (KNHANES III), 2005, HLTH EX KOR CTR DIS, P38
   TNS Media Korea, 2011, EXP TV ADV GEN TARG
   Wakefield M, 2005, ADDICTION, V100, P1875, DOI 10.1111/j.1360-0443.2005.01298.x
   Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971
   Wells JCK, 2008, INT J OBESITY, V32, P152, DOI 10.1038/sj.ijo.0803685
   World Instant Noodle Association, 2012, NAT TRENDS INST NOOD
   Youngah Ah, 2010, [Journal of School Social Work, 학교사회복지], V18, P29
NR 54
TC 18
Z9 19
U1 1
U2 56
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6663
EI 1095-8304
J9 APPETITE
JI Appetite
PD MAR 1
PY 2013
VL 62
BP 225
EP 231
DI 10.1016/j.appet.2012.10.015
PG 7
WC Behavioral Sciences; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Behavioral Sciences; Nutrition & Dietetics
GA 091SO
UT WOS:000315070300032
PM 23108149
DA 2025-04-28
ER

PT J
AU Grove, KA
   Lambert, JD
AF Grove, Kimberly A.
   Lambert, Joshua D.
TI Laboratory, Epidemiological, and Human Intervention Studies Show That
   Tea (Camellia sinensis) May Be Useful in the Prevention of
   Obesity
SO JOURNAL OF NUTRITION
LA English
DT Review
ID DIET-INDUCED OBESITY; GREEN TEA; EPIGALLOCATECHIN GALLATE; BODY-FAT;
   (-)-EPIGALLOCATECHIN GALLATE; WEIGHT-LOSS; 3T3-L1 PREADIPOCYTES;
   METABOLIC SYNDROME; GALLOYL MOIETY; GLUCOSE-UPTAKE
AB Tea (Camellia sinensis, Theaceae) and tea polyphenols have been studied for the prevention of chronic diseases, including obesity. Obesity currently affects >20% of adults in the United States and is a risk factor for chronic diseases such as type II diabetes, cardiovascular disease, and cancer. Given this increasing public health concern, the use of dietary agents for the prevention of obesity would be of tremendous benefit. Whereas many laboratory studies have demonstrated the potential efficacy of green or black tea for the prevention of obesity, the underlying mechanisms remain unclear. The results of human intervention studies are mixed and the role of caffeine has not been clearly established. Finally, there is emerging evidence that high doses of tea polyphenols may have adverse side effects. Given that the results of scientific studies on dietary components, including tea polyphenols, are often translated into dietary supplements, understanding the potential toxicities of the tea polyphenols is critical to understanding their potential usefulness in preventing obesity. In this review, we will critically evaluate the evidence for the prevention of obesity by tea, discuss the relevance of proposed mechanisms in light of tea polyphenol bioavailability, and review the reports concerning the toxic effects of high doses of tea polyphenols and the implication that this has for the potential use of tea for the prevention of obesity. We hope that this review will expose areas for further study and encourage research on this important public health issue. J. Nutr. 140: 446-453,2010.
C1 [Grove, Kimberly A.; Lambert, Joshua D.] Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Pennsylvania State University -
   University Park; Penn State Behrend
RP Lambert, JD (corresponding author), Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA.
EM jdl134@psu.edu
RI Lambert, Joshua/M-1788-2014
FU NIH [AT004678]
FX Supported in part by NIH AT004678.
CR [Anonymous], 2008, State-Specific Prevalence and Trends in Adult Cigarette Smoking --- United States, 1998--2007
   Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Bernert CP, 2007, DIABETES METAB, V33, P13, DOI 10.1016/j.diabet.2006.11.004
   Blumenthal T.C., 2006, HERB GRAM, P64
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Bruno RS, 2008, J NUTR, V138, P323, DOI 10.1093/jn/138.2.323
   Cao H, 2007, J AGR FOOD CHEM, V55, P6372, DOI 10.1021/jf070695o
   Cho SY, 2007, AM J PHYSIOL-ENDOC M, V292, pE1166, DOI 10.1152/ajpendo.00436.2006
   Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549
   Chow HHS, 2003, CLIN CANCER RES, V9, P3312
   Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Du YT, 2005, J ENZYM INHIB MED CH, V20, P349, DOI 10.1080/14756360500148841
   Filippatos TD, 2008, DRUG SAFETY, V31, P53, DOI 10.2165/00002018-200831010-00005
   Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822
   Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014
   Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hossain SJ, 2002, J AGR FOOD CHEM, V50, P5215, DOI 10.1021/jf020252e
   Hughes LAE, 2008, AM J CLIN NUTR, V88, P1341, DOI 10.3945/ajcn.2008.26058
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Ikeda I, 2005, J NUTR, V135, P155, DOI 10.1093/jn/135.2.155
   Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P636, DOI 10.1016/j.fct.2005.11.003
   Ito Y, 2008, BIOMED RES-TOKYO, V29, P27, DOI 10.2220/biomedres.29.27
   Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109
   Kim HJ, 2009, PHYTOTHER RES, V23, P467, DOI 10.1002/ptr.2647
   Kohri T, 2001, J AGR FOOD CHEM, V49, P1042, DOI 10.1021/jf0011236
   Ku HC, 2009, AM J PHYSIOL-CELL PH, V297, pC121, DOI 10.1152/ajpcell.00272.2008
   Lambert JD, 2005, AM J CLIN NUTR, V81, p284S, DOI 10.1093/ajcn/81.1.284S
   Lambert JD, 2006, DRUG METAB DISPOS, V34, P8, DOI 10.1124/dmd.104.003434
   Lambert JD, 2003, MUTAT RES-FUND MOL M, V523, P201, DOI 10.1016/S0027-5107(02)00336-6
   Lambert JD, 2007, MOL PHARMACEUT, V4, P819, DOI 10.1021/mp700075m
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Liu HS, 2006, AM J PHYSIOL-ENDOC M, V290, pE273, DOI 10.1152/ajpendo.00325.2005
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7
   Menet MC, 2004, J AGR FOOD CHEM, V52, P2455, DOI 10.1021/jf035427e
   Moon HS, 2007, CHEM-BIOL INTERACT, V167, P85, DOI 10.1016/j.cbi.2007.02.008
   Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004
   Nagao T, 2005, AM J CLIN NUTR, V81, P122
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Newmark HL, 2001, CARCINOGENESIS, V22, P1871, DOI 10.1093/carcin/22.11.1871
   Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246
   Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3
   Pories WJ, 2008, J CLIN ENDOCR METAB, V93, pS89, DOI 10.1210/jc.2008-1641
   Sang SM, 2004, BIOORGAN MED CHEM, V12, P3009, DOI 10.1016/j.bmc.2004.03.027
   Sang SM, 2002, TETRAHEDRON LETT, V43, P7129, DOI 10.1016/S0040-4039(02)01707-0
   Shimizu M, 2000, BIOFACTORS, V13, P61, DOI 10.1002/biof.5520130111
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Wang CT, 2009, MOL NUTR FOOD RES, V53, P349, DOI 10.1002/mnfr.200800013
   Wang S, 2006, J NUTR BIOCHEM, V17, P492, DOI 10.1016/j.jnutbio.2006.03.004
   Wang X, 2003, BIOCHEM PHARMACOL, V66, P2039, DOI 10.1016/S0006-2952(03)00585-9
   Wang X, 2001, BIOCHEM BIOPH RES CO, V288, P1200, DOI 10.1006/bbrc.2001.5923
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wolfram S, 2006, MOL NUTR FOOD RES, V50, P176, DOI 10.1002/mnfr.200500102
   Wu BT, 2005, J AGR FOOD CHEM, V53, P5695, DOI 10.1021/jf050045p
   Wu CH, 2003, OBES RES, V11, P1088, DOI 10.1038/oby.2003.149
   Yang CS, 2007, TOXICOL APPL PHARM, V224, P265, DOI 10.1016/j.taap.2006.11.024
   Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309
   Yang MH, 2001, J NUTR BIOCHEM, V12, P14, DOI 10.1016/S0955-2863(00)00140-6
   Yang TTC, 1999, LIFE SCI, V66, P411, DOI 10.1016/S0024-3205(99)00607-4
NR 69
TC 127
Z9 144
U1 0
U2 48
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD MAR
PY 2010
VL 140
IS 3
BP 446
EP 453
DI 10.3945/jn.109.115972
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 559FJ
UT WOS:000274807800002
PM 20089791
OA Bronze, Green Published
DA 2025-04-28
ER

PT J
AU Sugiyama, T
   Xie, DW
   Graham-Maar, RC
   Inoue, K
   Kobayashi, Y
   Stettler, N
AF Sugiyama, Takehiro
   Xie, Dawei
   Graham-Maar, Rose C.
   Inoue, Kazuo
   Kobayashi, Yasuki
   Stettler, Nicolas
TI Dietary and lifestyle factors associated with blood pressure among US
   adolescents
SO JOURNAL OF ADOLESCENT HEALTH
LA English
DT Article; Proceedings Paper
CT 46th Annual Conference on Cardiovascular Disease Epidemiology and
   Prevention
CY MAR 02-05, 2006
CL Phoenix, AZ
SP Amer Heart Assoc, Natl Heart, Lung & Blood Inst
DE adolescent; blood pressure; body mass index; cross-sectional studies;
   exercise; life style; nutrition; nutrition surveys; obesity; television
ID CARDIOVASCULAR MORTALITY; SEDENTARY BEHAVIOR; PULSE PRESSURE;
   METAANALYSIS; HYPERTENSION; CHILDHOOD; OBESITY; SODIUM; SUPPLEMENTATION;
   POTASSIUM
AB Purpose: To identify modifiable lifestyle factors associated with blood pressure among U.S. adolescents.
   Methods: A cross-sectional study was conducted of 4508 12-19-year-old respondents of the 1999-2002 National Health and Nutrition Examination Survey. Systolic and diastolic blood pressure (SBP and DBP) were measured and adjusted for gender, age, and height using z-scores (SBPZ and DBPZ). Body mass index (BMI) was adjusted for gender and age (BMIZ). Questionnaires were used to measure nutrient intake (carbohydrate, protein, saturated and unsaturated fat, sodium, potassium, calcium, magnesium, fiber, and caffeine) and activities (physical activities and sedentary activities, including television watching).
   Results: In the adjusted model (R-2 = .115), SBPZ was higher by .022 standard deviation (SD) (95% confidence interval [CI]:.007-038, equivalent to similar to .2 mmHg) per 1-hour increments in sedentary activities; higher by .244 SD (.198 - .289, similar to 2.6 mmHg) per 1 SD of BMIZ; and lower by .099 SD (-.192 to -.006, similar to 1.1 mmHg) per 100 g of carbohydrate intake. Unexpectedly, BMIZ was negatively associated with DBPZ (-.078 per 1 SD, -.114 to -.043, similar to.9 mmHg).
   Conclusions: Among U.S. adolescents, sedentary activities and BMI are positively associated with SBP after adjustment for confounding factors and mediators, while BMI is negatively associated with DBP. If confirmed by further studies, population-based interventions aimed at sedentary activities may be practical approaches to decrease SBP and the risk of obesity among adolescents.) 2007 Society for Adolescent Medicine. All rights reserved.
C1 Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.
   Univ Tokyo, Fac Med, Tokyo 113, Japan.
   Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.
   Univ Tokyo, Dept Publ Hlth, Tokyo, Japan.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Tokyo; University of Pennsylvania;
   University of Tokyo
RP Stettler, N (corresponding author), Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, N 1559,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM nstettle@cceb.med.upenn.edu
RI Sugiyama, Takehiro/I-8309-2019
OI Kobayashi, Yasuki/0000-0002-9616-0687
CR [Anonymous], 1996, APPL LINEAR STAT MOD
   Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6
   APPEL LJ, 1993, ARCH INTERN MED, V153, P1429, DOI 10.1001/archinte.153.12.1429
   Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601
   Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455
   BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7
   Beilin LJ, 2001, BLOOD PRESSURE, V10, P352, DOI 10.1080/080370501753400656
   Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410
   Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302
   CAPPUCCIO FP, 1995, AM J EPIDEMIOL, V142, P935, DOI 10.1093/oxfordjournals.aje.a117741
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   ELLIOTT P, 1988, BRIT MED J, V297, P319
   Epstein LH, 2002, J PEDIATR-US, V140, P334, DOI 10.1067/mpd.2002.122395
   EPSTEIN LH, 1995, HEALTH PSYCHOL, V14, P109, DOI 10.1037/0278-6133.14.2.109
   Falkner Bonita, 1997, American Journal of Clinical Nutrition, V65, p618S, DOI 10.1093/ajcn/65.2.618S
   Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354
   Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111
   Kelley George A, 2003, Prev Cardiol, V6, P8, DOI 10.1111/j.1520-037X.2003.01224.x
   Kuczmarski RJ, 2000, VITAL HLTH STAT, P1, DOI [DOI 10.1016/J.BBRC.2015.06.114, DOI 10.1590/S1516-35982002000600018]
   Liu LJ, 2002, HYPERTENS RES, V25, P689
   Midgley JP, 1996, JAMA-J AM MED ASSOC, V275, P1590, DOI 10.1001/jama.275.20.1590
   Moore LL, 2005, EPIDEMIOLOGY, V16, P4, DOI 10.1097/01.ede.0000147106.32027.3e
   MOTOYAMA T, 1989, HYPERTENSION, V13, P227, DOI 10.1161/01.HYP.13.3.227
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
   PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460
   Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561
   ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905
   ROCCHINI AP, 1988, PEDIATRICS, V82, P16
   Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101
   SimonsMorton DG, 1997, HYPERTENSION, V29, P930, DOI 10.1161/01.HYP.29.4.930
   Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12
   Sorof JM, 2004, PEDIATRICS, V113, P475, DOI 10.1542/peds.113.3.475
   Streppel MT, 2005, ARCH INTERN MED, V165, P150, DOI 10.1001/archinte.165.2.150
   VanLeer EM, 1995, INT J EPIDEMIOL, V24, P1117, DOI 10.1093/ije/24.6.1117
   Weisberg S., 2005, Applied Linear Regression, V3rd, DOI DOI 10.1002/0471704091
   Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624
   Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006
   WILLET W, 1998, NUTR EPIDEMIOLOGY, P30
   2004, NHANES ANAL GUIDELIN
NR 39
TC 58
Z9 71
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1054-139X
EI 1879-1972
J9 J ADOLESCENT HEALTH
JI J. Adolesc. Health
PD FEB
PY 2007
VL 40
IS 2
BP 166
EP 172
DI 10.1016/j.jadohealth.2006.09.006
PG 7
WC Psychology, Developmental; Public, Environmental & Occupational Health;
   Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)
SC Psychology; Public, Environmental & Occupational Health; Pediatrics
GA 131SF
UT WOS:000243889500011
PM 17259057
DA 2025-04-28
ER

PT J
AU Poortvliet, PC
   Bérubé-Parent, S
   Drapeau, V
   Lamarche, B
   Blundell, JE
   Tremblay, A
AF Poortvliet, Peter C.
   Berube-Parent, Sonia
   Drapeau, Vicky
   Lamarche, Benoit
   Blundell, John E.
   Tremblay, Angelo
TI Effects of a healthy meal course on spontaneous energy intake, satiety
   and palatability
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE appetite control; palatability; energy intake; macronutrients;
   functional food
ID HIGH-FAT DIET; WEIGHT-LOSS; GREEN TEA; FOOD-INTAKE; CAFFEINE
   CONSUMPTION; METABOLIC-RATE; OXIDATION; EXPENDITURE; DENSITY;
   MAINTENANCE
AB Many food components can influence satiety or energy intake. Combined together, these food components could represent an interesting dietary strategy in the prevention and treatment of obesity. The aims of this study were: 1) to determine the effect of a functional food in the form of a healthy meal course on subsequent energy intake and satiety; 2) to verify if it is possible to maintain palatability while preserving the satiating effects of the test meal. Thirteen subjects were invited to eat two lunch sessions: healthy and control meal courses (2090 kJ/meal). Anthropometric and ad libitum food intake measurements, and visual analogue scales (VAS) were performed during the two lunch sessions. The healthy main course acutely decreased energy intake during the rest of the meal (-744 kJ, P <= 0.0001) and lipid (-6%, P <= 0.0001) compared with the control meal. VAS ratings during the course of the testing showed a meal effect for hunger, desire to eat and prospective food consumption (P <= 0.05) and a time effect for all appetite sensations (P: <= 0.0001). VAS scores on hunger ratings were lower for the healthy meal (P <= 0.05), whereas fullness ratings were higher shortly after the healthy main course (P <= 0.05). The healthy meal produced a slightly higher palatability rating but this effect was not statistically significant. These results suggest that it is possible to design a healthy meal that decreases spontaneous energy intake and hunger without compromising palatability.
C1 Univ Laval, Dept Social & Prevent Med, Div Kinesiol, Ste Foy, PQ G1K 7P4, Canada.
   Univ Laval, Inst Nutraceut & Funct Foods, Ste Foy, PQ G1K 7P4, Canada.
   Univ Leeds, Inst Psychol & Sci, Psychobiol Grp, Leeds, W Yorkshire, England.
C3 Laval University; Laval University; University of Leeds
RP Tremblay, A (corresponding author), Univ Laval, Dept Social & Prevent Med, Div Kinesiol, Ste Foy, PQ G1K 7P4, Canada.
EM angelo.tremblay@kin.msp.ulaval.ca
RI Lamarche, Benoit/ABA-4785-2021
OI Drapeau, Vicky/0000-0002-3061-691X; Lamarche,
   Benoit/0000-0002-4443-5378; Blundell, John/0000-0002-7085-9596
CR Anderson JW, 2001, AM J CLIN NUTR, V74, P579
   Bell EA, 1998, AM J CLIN NUTR, V67, P412
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Diepvens K, 2005, BRIT J NUTR, V94, P1026, DOI 10.1079/BJN20051580
   Doucet E., 2000, International Journal of Obesity, V24, pS157
   Drapeau V, 2000, HANDB EXP PHARM, V149, P237
   DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P1081, DOI 10.1093/ajcn/62.5.1081S
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Eisenstein J, 2002, NUTR REV, V60, P189, DOI 10.1301/00296640260184264
   Esch T, 2004, NEUROENDOCRINOL LETT, V25, P235
   HILL A J, 1986, Nutrition and Behavior, V3, P133
   *HLTH WELF CAN, 1997, CAN NUTR FIL
   Horgen KB, 2002, HEALTH PSYCHOL, V21, P505, DOI 10.1037/0278-6133.21.5.505
   Howarth NC, 2001, NUTR REV, V59, P129, DOI 10.1111/j.1753-4887.2001.tb07001.x
   Jacqmain M, 2003, AM J CLIN NUTR, V77, P1448, DOI 10.1093/ajcn/77.6.1448
   Johnston CS, 2005, J AM COLL NUTR, V24, P158, DOI 10.1080/07315724.2005.10719460
   Koh-Banerjee P, 2003, P NUTR SOC, V62, P25, DOI 10.1079/PNS2002232
   LISSNER L, 1987, AM J CLIN NUTR, V46, P886, DOI 10.1093/ajcn/46.6.886
   Ludwig DS, 2000, J NUTR, V130, p280S, DOI 10.1093/jn/130.2.280S
   Pereira MA, 2001, PEDIATR CLIN N AM, V48, P969, DOI 10.1016/S0031-3955(05)70351-5
   Pi-Sunyer FX, 1998, OBES RES, V6, p51S
   POEHLMAN ET, 1985, MED SCI SPORT EXER, V17, P689, DOI 10.1249/00005768-198512000-00012
   Roberts Susan B, 2003, Nutr Clin Care, V6, P20
   Rolls BJ, 1999, AM J CLIN NUTR, V70, P448
   Rolls BJ, 2005, OBES RES, V13, P1052, DOI 10.1038/oby.2005.123
   Rolls BJ, 1999, AM J CLIN NUTR, V69, P863
   Rolls BJ, 1998, AM J CLIN NUTR, V67, P1170, DOI 10.1093/ajcn/67.6.1170
   Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012
   Rumpler W, 2001, J NUTR, V131, P2848, DOI 10.1093/jn/131.11.2848
   Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867
   Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391
   STUBBS RJ, 1995, AM J CLIN NUTR, V62, P316
   TREMBLAY A, 1989, AM J CLIN NUTR, V49, P799, DOI 10.1093/ajcn/49.5.799
   TREMBLAY A, 1995, AM J CLIN NUTR, V62, P639, DOI 10.1093/ajcn/62.3.639
   Tremblay A, 1996, AM J CLIN NUTR, V63, P479, DOI 10.1093/ajcn/63.4.479
   TREMBLAY A, 1988, NUTR RES, V8, P553, DOI 10.1016/S0271-5317(88)80077-0
   TREMBLAY A, 1991, AM J CLIN NUTR, V53, P1134, DOI 10.1093/ajcn/53.5.1134
   WADDEN TA, 1993, ANN INTERN MED, V119, P688, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00012
   WADDEN TA, 1989, INT J OBESITY, V13, P39
   Warren JM, 2003, PEDIATRICS, V112, pE414, DOI 10.1542/peds.112.5.e414
   Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142
   Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224
   Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132
NR 44
TC 25
Z9 29
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD MAR
PY 2007
VL 97
IS 3
BP 584
EP 590
DI 10.1017/S000711450738135X
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 148MQ
UT WOS:000245079700023
PM 17313722
OA Bronze
DA 2025-04-28
ER

PT J
AU Saldiva, SRDM
   Venancio, SI
   de Santana, AC
   Castro, ALD
   Escuder, MML
   Giugliani, ERJ
AF Dias Medici Saldiva, Silvia Regina
   Venancio, Sonia Isoyama
   de Santana, Andreia Cardoso
   da Silva Castro, Ana Lucia
   Loureiro Escuder, Maria Mercedes
   Justo Giugliani, Elsa Regina
TI The consumption of unhealthy foods by Brazilian children is influenced
   by their mother's educational level
SO NUTRITION JOURNAL
LA English
DT Article
DE Supplementary feeding; Food habits; Infant; Cross-sectional study
ID SUGAR-SWEETENED BEVERAGES; CHILDHOOD OBESITY; FEEDING PRACTICES;
   WEIGHT-GAIN; IMPACT; DIET; ASSOCIATION; DISPARITIES; VARIETY; INFANCY
AB Objective: To evaluate the association between the consumption of unhealthy foods in children under one year and the education level of the mothers, data obtained from participants of the II Survey on the prevalence of breastfeeding in the Brazilian capitals and the Federal District in 2008 was analyzed.
   Methods: During the second stage of the campaign for multi-vaccination, a questionnaire on food consumption in the last 24 hours was given to mothers or guardians of children under one year old. We analyzed the consumption of unhealthy foods according to age group, maternal education, region of residence and breastfeeding status. The state capitals and the Federal District were grouped according to the five macro-regions of the country (North, Northeast, Southeast, South and West). Processed juice, soda, coffee, cookies/salted snacks and sugar and/or honey were defined as unhealthy foods. Prevalence ratios (RP) for the association between the consumption of unhealthy foods and maternal education were estimated using Poisson regression models. Results: The study included 34,366 children. The consumption of sweet foods started early and was predominant until the age of six months; after this age, the consumption of biscuits and/or snacks became more prevalent. The consumption of these foods also differs in relation to the macro-region of residence.
   Consumption of unhealthy foods was higher among mothers with lower education levels. Conclusions: The consumption of unhealthy foods by Brazilian children under one year old was high, indicating a need for developing effective strategies to combat the consumption of unhealthy foods in Brazilian children as a way of preventing obesity and other future disorders.
C1 [Dias Medici Saldiva, Silvia Regina; Venancio, Sonia Isoyama; de Santana, Andreia Cardoso; da Silva Castro, Ana Lucia; Loureiro Escuder, Maria Mercedes] Secretaria Estado Saude Sao Paulo, Inst Saude, BR-01314000 Sao Paulo, Brazil.
   [Justo Giugliani, Elsa Regina] Univ Fed Rio Grande do Sul, Fac Med, Dept Pediat & Puericultura, BR-90035003 Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul
RP Saldiva, SRDM (corresponding author), Secretaria Estado Saude Sao Paulo, Inst Saude, Rua Santo Antonio,590,Bela Vista, BR-01314000 Sao Paulo, Brazil.
EM smsaldiva@isaude.sp.gov.br
RI Venancio, Sonia/O-2588-2013; Giugliani, Elsa/Y-9236-2019; Saldiva,
   Silvia/ABC-4205-2021
OI Saldiva, Silvia/0000-0002-0641-834X
FU Brazilian Ministry of Health - Brazil
FX This article is based on data from the Second National Survey of
   Prevalence of Breastfeeding, which was conducted in state capitals and
   the Federal District during the second stage of the multi-vaccination
   campaign in 2008 and supported by the Brazilian Ministry of Health -
   Brazil.
CR Agostoni C, 2005, ACTA PAEDIATR, V94, P523, DOI 10.1080/08035320510031054
   [Anonymous], SERIE A NORMAS C MAN
   [Anonymous], ESTR NAC AL COMP
   [Anonymous], POP BAS PREV STRAT C
   [Anonymous], UNDERNUTRITION POOR
   [Anonymous], 2 PESQ PREV AL MAT N
   [Anonymous], PUBLIC HLTH NUTR
   [Anonymous], DEZ PASS PAR UM ALIM
   [Anonymous], 2011, PESQ ORC FAM 2008 20
   [Anonymous], 2009, INF YOUNG CHILD FEED
   [Anonymous], PREV AL MAT NAS CAPT
   [Anonymous], PUBLIC HLTH NUTR
   [Anonymous], PESQ NAC DEM SAUD CR
   Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Bernardi JR, 2011, CAD SAUDE PUBLICA, V27, P1213, DOI 10.1590/S0102-311X2011000600018
   Birch LL, 2009, INT J OBESITY, V33, pS74, DOI 10.1038/ijo.2009.22
   Buyken AE, 2008, AM J CLIN NUTR, V88, P755, DOI 10.1093/ajcn/88.3.755
   Caldeira Antônio Prates, 2008, Rev. Saúde Pública, V42, P1027, DOI 10.1590/S0034-89102008005000057
   Carvalhaes MABL, 1998, REV SAUDE PUBL, V32, P430, DOI 10.1590/S0034-89101998000500005
   de Aquino RD, 2002, REV SAUDE PUBL, V36, P655, DOI 10.1590/S0034-89102002000700001
   Bernardi JLD, 2009, REV PANAM SALUD PUBL, V26, P405, DOI 10.1590/S1020-49892009001100004
   Saldiva SRDM, 2010, REV NUTR, V23, P221, DOI 10.1590/S1415-52732010000200005
   Dixon B, 2012, ADV NUTR, V3, P73, DOI 10.3945/an.111.000919
   Erkkola M, 2009, BRIT J NUTR, V101, P1209, DOI 10.1017/S0007114508057619
   Feldens CA, 2010, CARIES RES, V44, P445, DOI 10.1159/000319898
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Fox MK, 2006, J AM DIET ASSOC, V106, pS77, DOI 10.1016/j.jada.2005.09.039
   Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913
   Gibson S, 2009, BRIT J NUTR, V101, P100, DOI 10.1017/S0007114508981484
   HOFMAN A, 1983, JAMA-J AM MED ASSOC, V250, P370, DOI 10.1001/jama.250.3.370
   Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25
   Instituto Brasileiro de Geografia e Estatistica, 2010, Pesquisa de Orcamentos Familiares 2008-2009: antropometria e estado nutricional de criancas, adolescentes e adultos no Brasil
   Kim J, 2008, ARCH PEDIAT ADOL MED, V162, P627, DOI 10.1001/archpedi.162.7.627
   Kranz S, 2005, J PEDIATR-US, V146, P105, DOI 10.1016/j.jpeds.2004.08.077
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Fernandez-Alvira JM, 2013, PUBLIC HEALTH NUTR, V16, P487, DOI 10.1017/S136898001200290X
   Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005
   Moorcroft KE, 2011, MATERN CHILD NUTR, V7, P3, DOI 10.1111/j.1740-8709.2010.00284.x
   Nicklaus S, 2005, APPETITE, V44, P289, DOI 10.1016/j.appet.2005.01.006
   Pearce J, 2013, INT J OBESITY, V37, P477, DOI 10.1038/ijo.2013.8
   Pereira MA, 2006, INT J OBESITY, V30, pS28, DOI 10.1038/sj.ijo.0803489
   Ruottinen S, 2008, PEDIATRICS, V121, pE1676, DOI 10.1542/peds.2007-1642
   Saldiva SRDM, 2007, J PEDIAT-BRAZIL, V83, P53, DOI 10.2223/JPED.1588
   Skinner JD, 2002, J NUTR EDUC BEHAV, V34, P310, DOI 10.1016/S1499-4046(06)60113-9
   Thompson AL, 2013, SOC SCI MED, V97, P288, DOI 10.1016/j.socscimed.2012.12.007
   VICTORA CG, 1992, SOC SCI MED, V34, P899, DOI 10.1016/0277-9536(92)90258-R
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA
   Wilson TA, 2009, J AM DIET ASSOC, V109, P1012, DOI 10.1016/j.jada.2009.03.007
   World Health Organization, 2008, GUID DRINK WAT QUAL, DOI DOI 10.1007/S12403-018-0288-8
NR 50
TC 42
Z9 48
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD APR 3
PY 2014
VL 13
AR 33
DI 10.1186/1475-2891-13-33
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA AG4QD
UT WOS:000335404300001
PM 24708610
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Lee, HA
   Son, N
   Lee, WK
   Park, H
AF Lee, Hye Ah
   Son, NaYeong
   Lee, Won Kyung
   Park, Hyesook
TI A Diabetes-Related Dietary Pattern Is Associated with Incident Diabetes
   in Obese Men in the Korean Genome Epidemiology Study
SO JOURNAL OF NUTRITION
LA English
DT Article
DE diabetes; dietary patterns; prospective cohort study; reduced rank
   regression
ID REDUCED RANK REGRESSION; JAPANESE MEN; RISK; DISEASE; SODIUM
AB Background: Diet plays an important role in both the development and management of diabetes.
   Objective: Using data from the Korean Genome Epidemiology Study, we assessed dietary patterns associated with the clinical indicators of diabetes.
   Methods: This study included 7255 subjects aged 40-69 y. Individuals with chronic diseases were excluded. The daily intakes of specific food items were assessed using a dish-based semiquantitative food-frequency questionnaire comprising 103 items; the food items were then grouped into 26 food groups. Dietary patterns were analyzed by the reduced rank regression method using glycated hemoglobin, the homeostasis model of insulin resistance, and fasting glucose concentrations as dependent variables. We investigated the associations between dietary patterns and incident diabetes using the Cox proportional hazards model.
   Results: During an 11.5-y follow-up, the incidence of diabetes was 11.8/1000 person-years. The dietary pattern related to selected biomarkers of diabetes was characterized by a relatively high intake of kimchi, beef, other meat, fish, and coffee in men and a high intake of rice, kimchi, and fruit in women. In men, the association of dietary patterns with incident diabetes was significant only in the obese group, and those in the top quartile of the dietary pattern score had a 1.72 times (95% CI: 1.15, 2.56 times) greater risk of incident diabetes than those in the bottom quartile. Conversely, dietary patterns in women were not associated with incident diabetes.
   Conclusion: Using reduced rank regression, we identified dietary patterns related to selected biomarkers of diabetes in a long-term study with follow-up data in Korea.
C1 [Lee, Hye Ah] Mokdong Hosp, Clin Trial Ctr, Seoul, South Korea.
   [Son, NaYeong] Ewha Womans Univ, Sch Med, Dept Stat, Seoul, South Korea.
   [Park, Hyesook] Ewha Womans Univ, Sch Med, Dept Prevent Med, Seoul, South Korea.
   [Son, NaYeong] Korea Inst Drug Safety & Risk Management, Off Pharmacoepidemiol, Anyang Si, South Korea.
   [Lee, Won Kyung] Inha Univ, Sch Med, Dept Social & Prevent Med, Incheon, South Korea.
C3 Ewha Womans University; Ewha Womans University; Inha University
RP Lee, HA (corresponding author), Mokdong Hosp, Clin Trial Ctr, Seoul, South Korea.; Park, H (corresponding author), Ewha Womans Univ, Sch Med, Dept Prevent Med, Seoul, South Korea.
EM khyeah@naver.com; hpark@ewha.ac.kr
RI Lee, Hye Ah/ABC-8131-2021; Park, Haekyun/JWF-7949-2024
OI Park, Hyesook/0000-0002-9359-6522
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [NRF-2017 R1D1A1B03028719]
FX Supported by the Basic Science Research Program through the National
   Research Foundation of Korea (NRF) funded by the Ministry of Education
   (NRF-2017 R1D1A1B03028719), which had no role in the design, analysis,
   or writing of this manuscript.
CR Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657
   [Anonymous], ALC HEART HLTH
   Asif Mohammad, 2014, J Educ Health Promot, V3, P1, DOI 10.4103/2277-9531.127541
   Batis C, 2016, PUBLIC HEALTH NUTR, V19, P195, DOI 10.1017/S1368980014003103
   Costanzo S, 2010, J AM COLL CARDIOL, V55, P1339, DOI 10.1016/j.jacc.2010.01.006
   Cunha DB, 2010, CAD SAUDE PUBLICA, V26, P2138, DOI 10.1590/S0102-311X2010001100015
   Erber E, 2010, DIABETES CARE, V33, P532, DOI 10.2337/dc09-1621
   Heidemann C, 2005, DIABETOLOGIA, V48, P1126, DOI 10.1007/s00125-005-1743-1
   Hoffmann K, 2004, AM J CLIN NUTR, V80, P633
   Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134
   Horikawa C, 2014, J CLIN ENDOCR METAB, V99, P3635, DOI 10.1210/jc.2013-4315
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Hu G, 2005, DIABETOLOGIA, V48, P1477, DOI 10.1007/s00125-005-1824-1
   Imamura F, 2009, AM J CLIN NUTR, V90, P1075, DOI 10.3945/ajcn.2009.28009
   Jacobs S, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.000620
   Jannasch F, 2017, J NUTR, V147, P1174, DOI 10.3945/jn.116.242552
   Jeon J., 2013, Academic research on task, final report
   Kim J, 2011, J AM DIET ASSOC, V111, P1141, DOI 10.1016/j.jada.2011.05.001
   Kim Y, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv316
   Livingstone KM, 2017, BRIT J NUTR, V117, P248, DOI 10.1017/S0007114516004505
   McNaughton SA, 2008, DIABETES CARE, V31, P1343, DOI 10.2337/dc07-1946
   Nanri A, 2013, EUR J CLIN NUTR, V67, P18, DOI 10.1038/ejcn.2012.171
   Nanri A, 2008, DIABETES CARE, V31, P1568, DOI 10.2337/dc08-0297
   National Research Institute of Health, KOR GEN EP STUD
   Noh J, 2016, ENDOCRINOL METAB, V31, P349, DOI 10.3803/EnM.2016.31.3.349
   Sauvageot N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161298
   Shen XH, 2016, ENDOCR PRACT, V22, P1119, DOI 10.4158/EP161199.RA
   Song SJ, 2012, NUTR RES PRACT, V6, P349, DOI 10.4162/nrp.2012.6.4.349
   Song Y, 2012, NUTR METAB CARDIOVAS, V22, P456, DOI 10.1016/j.numecd.2010.09.002
   Vermeulen E, 2017, EUR J CLIN NUTR, V71, P987, DOI 10.1038/ejcn.2017.61
   Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068
   Woo HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111593
   Yoon J, 2016, J KOREAN MED SCI, V31, pS158, DOI 10.3346/jkms.2016.31.S2.S158
NR 33
TC 8
Z9 11
U1 1
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3166
EI 1541-6100
J9 J NUTR
JI J. Nutr.
PD FEB
PY 2019
VL 149
IS 2
BP 323
EP 329
DI 10.1093/jn/nxy274
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HL3QX
UT WOS:000458632000018
PM 30590687
OA Bronze
DA 2025-04-28
ER

PT J
AU Sharma, S
   De Roose, E
   Cao, X
   Pokiak, A
   Gittelsohn, J
   Corriveau, A
AF Sharma, Sangita
   De Roose, Elsie
   Cao, Xia
   Pokiak, Anita
   Gittelsohn, Joel
   Corriveau, Andre
TI Dietary Intake in a Population Undergoing a Rapid Transition in Diet and
   Lifestyle: The Inuvialuit in the Northwest Territories of Arctic Canada
SO CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE
LA English
DT Article
DE Nutrition transition; food and nutrient intake; Quantitative Food
   Frequency Questionnaire (QFFQ); Inuvialuit; nutritional intervention;
   Northwest Territories (NWT)
ID FOOD-FREQUENCY QUESTIONNAIRES; INTERVENTION; OBESITY; NATIONS; INUIT
AB Objectives: To: 1) characterize diet in Inuvialuit; 2) determine the foods and nutrients to be targeted for a nutritional intervention program; and 3) develop a Quantitative Food Frequency Questionnaire (QFFQ) to evaluate the program and monitor nutrition transition for Inuvialuit in the Northwest Territories (NWT), Canada.
   Methods: Twenty-four-hour dietary recalls were collected among 101 Inuvialuit aged 19 years and over in two communities in the NWT. All foods reported in the recall were tabulated for inclusion in the QFFQ.
   Results: Forty-eight men and 53 women (mean age 49 and 45 yrs, respectively) completed the recalls. Mean energy intake was 2,352 kcal and 1,739 kcal for men and women, respectively. Mean daily intakes of many nutrients including dietary fibre, calcium, and vitamins A, C and E, and total folate were much lower than recommended. The most frequently reported foods were non-nutrient-dense store-bought foods. Most traditional foods (TF) were reported one time by one person. The top two contributors to energy intake, 'sugar added to tea and coffee' and 'sweetened juices and drinks', were targeted by the intervention program. A 145-item QFFQ was developed including 41 TF and 8 categories of consumption frequency.
   Conclusions: This study has provided dietary intake data previously unavailable for Inuvialuit and highlighted nutrients and foods to be targeted for the intervention program. The QFFQ is up-to-date, culturally appropriate, and currently being used to evaluate the intervention program, Healthy Foods North, which aims to reduce dietary- and lifestyle-related risk factors for chronic disease in Inuvialuit.
C1 [Sharma, Sangita; Cao, Xia] Univ N Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA.
   [Sharma, Sangita; Cao, Xia] Univ Hawaii, Canc Etiol Program, Canc Res Ctr, Honolulu, HI 96822 USA.
   [Gittelsohn, Joel] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Human Nutr, Baltimore, MD 21218 USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   Cancer Research Center of Hawaii; University of Hawaii System; Johns
   Hopkins University; Johns Hopkins Bloomberg School of Public Health
RP Sharma, S (corresponding author), Univ N Carolina Chapel Hill, Inst Nutr Res, 500 Laureate Way,Rm 4201, Kannapolis, NC 28081 USA.
EM sangita_sharma@unc.edu
OI Sharma, Sangita/0000-0002-4995-0010
CR [Anonymous], 2005, DIET REF INT EN CARB
   [Anonymous], SAS VERS 9 1
   [Anonymous], CAR FOR OUR HER OUR
   [Anonymous], FACT SHEET TIM TUNDR
   [Anonymous], 2004, IMP WARM ARCT
   [Anonymous], 2 DIAGN HLTH 1 NAT I
   [Anonymous], NUTR CLIN NUTR MAN V
   [Anonymous], DIABETES PREVENTION
   Batal Malek, 2005, Int J Circumpolar Health, V64, P46
   Bélanger-Ducharme F, 2005, OBES REV, V6, P183, DOI 10.1111/j.1467-789X.2005.00179.x
   Bjerregaard P, 2002, INT J OBESITY, V26, P1503, DOI 10.1038/sj.ijo.0802082
   Blanchet C, 2000, CAN J DIET PRACT RES, V61, P50
   Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318
   Campbell ML, 1997, CAN J PUBLIC HEALTH, V88, P105, DOI 10.1007/BF03403871
   Collings P, 1998, ARCTIC, V51, P301
   Ebbesson SOK, 1998, DIABETES CARE, V21, P563, DOI 10.2337/diacare.21.4.563
   Katzmarzyk PT, 2008, OBESITY, V16, P184, DOI 10.1038/oby.2007.51
   Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
   Kuhnlein HV, 2007, J NUTR, V137, P1110, DOI 10.1093/jn/137.4.1110
   Kuhnlein HV, 2004, J NUTR, V134, P1447, DOI 10.1093/jn/134.6.1447
   Lawn J., 2001, CHANGE NUTR FOOD SEC
   LEBRUN JB, 1993, CAN J PUBLIC HEALTH, V84, P394
   Nakano Tomoko, 2005, Int J Circumpolar Health, V64, P137
   Receveur O, 1997, J NUTR, V127, P2179, DOI 10.1093/jn/127.11.2179
   Sharma S, 2008, PUBLIC HEALTH NUTR, V11, P831, DOI 10.1017/S1368980007001218
   Sharma S, 2007, PUBLIC HEALTH NUTR, V10, P464, DOI 10.1017/S1368980007220531
   Sharma S, 2007, PUBLIC HEALTH NUTR, V10, P948, DOI 10.1017/S1368980007662302
   Smith T., 1989, POLAR REC, V25, P93, DOI DOI 10.1017/S003224740001038X
   Stark A, 2002, ECOL FOOD NUTR, V41, P35, DOI 10.1080/03670240212531
   Statistics Canada, 2007, 2006 COMM PROF 2006
   Vastine A, 2005, AM J HEALTH BEHAV, V29, P57, DOI 10.5993/AJHB.29.1.5
   Whiting SJ, 1998, NUTR REV, V56, P248, DOI 10.1111/j.1753-4887.1998.tb01757.x
   Willett WC, 1998, NUTR EPIDEMIOLOGY
   Young TK, 2000, CAN MED ASSOC J, V163, P561
NR 34
TC 39
Z9 41
U1 0
U2 7
PU SPRINGER INT PUBL AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0008-4263
EI 1920-7476
J9 CAN J PUBLIC HEALTH
JI Can. J. Public Health-Rev. Can. Sante Publ.
PD NOV-DEC
PY 2009
VL 100
IS 6
BP 442
EP 448
DI 10.1007/BF03404341
PG 7
WC Public, Environmental & Occupational Health
WE Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA V16JB
UT WOS:000207864800009
PM 20209738
OA Green Published
DA 2025-04-28
ER

PT J
AU Barboza, BP
   Bricarello, LP
   Alves, MD
   Tureck, C
   Retondario, A
   Longo, GZ
   Souza, AD
   de Vasconcelos, FDG
AF Barboza, Bernardo Paz
   Bricarello, Liliana Paula
   Alves, Mariane de Almeida
   Tureck, Camila
   Retondario, Anabelle
   Longo, Giana Zarbato
   Souza, Amanda de Moura
   de Vasconcelos, Francisco de Assis Guedes
TI Dietary patterns and biochemical markers related to diabetes mellitus:
   an association analysis based on data from the Study of Cardiovascular
   Risk in Adolescents (ERICA)
SO NUTRITION
LA English
DT Article
DE Diabetes; Adolescent; Factor analysis; Feeding behavior; Food; diet and;
   nutrition; Nutritional epidemiology
ID METABOLIC SYNDROME; CHILDHOOD OBESITY; FOOD GROUPS; METAANALYSIS;
   DISEASE; ADULTS; HEALTH
AB Objective: The aim of this study was to investigate the association between dietary patterns and biochemical markers related to diabetes mellitus (DM): glucose, insulin, glycated hemoglobin (HbA1c), and homeostasis model assessment of insulin resistance index from 35 454 Brazilian adolescents 12 to 17 y of age.Methods: Dietary patterns were derived using factor analysis by the principal components method. The data originated from the school-based study ERICA (Study of Cardiovascular Risk in Adolescents) carried out between 2013 and 2014. Linear regression models analyzed the associations.Results: Three dietary patterns were found: traditional Brazilian, bread and coffee, and Western. An inverse association was found in young girls between the traditional Brazilian pattern and fasting glucose (beta = -0.76; P = 0.005) and HbA1c in the second and third tertiles (beta = -0.04; P = 0.002; beta = -0 .06; P < 0.001), and the Western pattern with HbA1c (beta = -0.02; P = 0.035). In boys, a positive association was found between the second tertile of the dietary pattern and insulin (beta = 0.48; P = 0.009) and homeostasis model assessment of insulin resistance index (beta = 0.11; P = 0.012).Conclusions: This study showed that the traditional Brazilian pattern was inversely associated with blood glucose and HbA1c values in girls. Furthermore, the data suggest that there is an important difference between boys and girls in the association of dietary patterns and the markers used.(c) 2023 Elsevier Inc. All rights reserved.
C1 [Barboza, Bernardo Paz; Bricarello, Liliana Paula; Tureck, Camila; Longo, Giana Zarbato; de Vasconcelos, Francisco de Assis Guedes] Fed Univ Santa Catarina UFSC, Postgrad Program Nutr, Florianopolis, SC, Brazil.
   [Alves, Mariane de Almeida] Univ Sao Paulo, Sch Publ Hlth, Postgrad Program Nutr Publ Hlth, Sao Paulo, Brazil.
   [Retondario, Anabelle] Fed Univ Parana UFPR, Nutr Dept, Curitiba, Parana, Brazil.
   [Souza, Amanda de Moura] Fed Univ Rio De Janeiro UFRJ, Inst Studies Collect Hlth, Rio De Janeiro, Brazil.
C3 Universidade Federal de Santa Catarina (UFSC); Universidade de Sao
   Paulo; Universidade Federal do Parana; Universidade Federal do Rio de
   Janeiro
RP Barboza, BP (corresponding author), Fed Univ Santa Catarina UFSC, Postgrad Program Nutr, Florianopolis, SC, Brazil.
EM bernardo.paz@posgrad.ufsc.br
RI Retondario, Anabelle/HSH-3866-2023; Alves, Mariane/G-7344-2019
OI /0000-0001-7666-5007; Alves, Mariane/0000-0002-9628-7522; Retondario,
   Anabelle/0000-0002-8809-5627; Paz Barboza, Bernardo/0000-0002-0080-1452
FU Fundacao de Amparo a Pesquisa e Inovacao de Santa Catarina (FAPESC);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX BPB received a scholarship from Fundacao de Amparo a Pesquisa e Inovacao
   de Santa Catarina (FAPESC) . CT received a scholarship from Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) . MAA received a
   grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   . The authors declare that CAPES, FAPESC, and FAPESP had no action in
   the design, data collection, decision to publish the manuscript, or
   preparation of this original article. All authors participated in the
   writing of this manuscript. All authors read and approved the final
   manuscript.
CR Alves MD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00153818, 10.1590/0102-311x00153818]
   Ambrosini GL, 2010, NUTR METAB CARDIOVAS, V20, P274, DOI 10.1016/j.numecd.2009.03.024
   Andrade Maria Izabel Siqueira de, 2016, Rev. paul. pediatr., V34, P234, DOI 10.1016/j.rpped.2015.08.006
   Barboza BP, 2023, NUTR METAB CARDIOVAS, V33, P685, DOI 10.1016/j.numecd.2022.12.005
   Barros NERP, 2021, CHILD OBES, V17, P400, DOI 10.1089/chi.2020.0265
   Barufaldi Laura Augusta, 2016, Rev. bras. epidemiol., V19, P464, DOI 10.1590/1980-5497201600020020
   Bielefeld D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072123
   Bloch KV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1442-x
   Bodega P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102297
   Buttermore E, 2021, DIABETES METAB SYND, V15, DOI 10.1016/j.dsx.2021.102253
   Cao YT, 2022, NUTRIENTS, V14, DOI 10.3390/nu14030662
   Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183
   Chen L, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz117
   Conway JM, 2003, AM J CLIN NUTR, V77, P1171, DOI 10.1093/ajcn/77.5.1171
   Cureau FV, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006683, 10.1590/s01518-8787.2016050006683]
   da Silva GM, 2021, CIENC SAUDE COLETIVA, V26, P3865, DOI 10.1590/1413-81232021269.2.28252019
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   dos Santos EA, 2020, ARCH ENDOCRIN METAB, V64, P436, DOI 10.20945/2359-3997000000230
   Giovannucci E, 2019, EUR J EPIDEMIOL, V34, P319, DOI 10.1007/s10654-019-00488-4
   Gorgulho B, 2021, PUBLIC HEALTH NUTR, V24, P5006, DOI 10.1017/S1368980020005340
   Hu EA, 2019, CLIN J AM SOC NEPHRO, V14, P1419, DOI 10.2215/CJN.09440819
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   IBGE, 2010, POFPesquisa de Orcamentos Familiares
   IDF, 2017, IDF Diabetes Atlas
   International Diabetes Federation, 2015, IDF diabetes atlas, V7th
   Kafyra M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010198
   Khayyatzadeh SS, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12897
   Kuschnir MCC, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006701, 10.1590/s01518-8787.2016050006701]
   Lascar N, 2018, LANCET DIABETES ENDO, V6, P69, DOI 10.1016/S2213-8587(17)30186-9
   de Vasconcellos MTL, 2015, CAD SAUDE PUBLICA, V31, P921, DOI 10.1590/0102-311X00043214
   Carvalho SDL, 2021, J PEDIAT-BRAZIL, V97, P66, DOI 10.1016/j.jped.2019.11.007
   Liu JL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09502-x
   Luo GQ, 2022, ASIA PAC J CLIN NUTR, V31, P660, DOI 10.6133/apjcn.202212_31(4).0009
   Magliano DJ, 2020, NAT REV ENDOCRINOL, V16, P321, DOI 10.1038/s41574-020-0334-z
   Studart EPM, 2018, REV NUTR, V31, P1, DOI 10.1590/1678-98652018000100001
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Oliveira RS, 2021, AM HEART J, V235, P65, DOI 10.1016/j.ahj.2021.01.014
   Palma D, 2011, Revista de Nutricao, V24, P17
   Powers MA, 2018, DIABETES RES CLIN PR, V141, P217, DOI 10.1016/j.diabres.2018.05.011
   Ramírez-López G, 2019, SALUD PUBLICA MEXICO, V61, P619, DOI 10.21149/9541
   Rupp K, 2021, Int J Adolesc Med Health, P33
   Sallis JF, 1996, MED SCI SPORT EXER, V28, P840, DOI 10.1097/00005768-199607000-00011
   Santos Roberta de Oliveira, 2019, Rev. bras. epidemiol., V22, pe190041
   Schulz CA, 2021, EUR J NUTR, V60, P4115, DOI 10.1007/s00394-021-02545-9
   Schwingshackl L, 2018, AM J CLIN NUTR, V108, P576, DOI 10.1093/ajcn/nqy151
   Schwingshackl L, 2017, EUR J EPIDEMIOL, V32, P363, DOI 10.1007/s10654-017-0246-y
   Souza Amanda de Moura, 2016, Rev. Saúde Pública, V50, p5s, DOI [10.1590/S01518-8787.2016050006698, 10.1590/s01518-8787.2016050006698]
   Silveira BKS, 2018, CARDIOL RES PRACT, V2018, DOI 10.1155/2018/4585412
   Telo GH, 2019, PEDIATR DIABETES, V20, P389, DOI 10.1111/pedi.12828
   Vittinghoff E, 2005, STAT BIOL HEALTH, pVII
   Wang PL, 2023, NAT MED, V29, P719, DOI 10.1038/s41591-023-02235-5
   Weihrauch-Blüher S, 2019, METABOLISM, V92, P147, DOI 10.1016/j.metabol.2018.12.001
   Zhang JG, 2015, BRIT J NUTR, V113, P1978, DOI 10.1017/S0007114515001154
NR 53
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD FEB
PY 2024
VL 118
AR 112283
DI 10.1016/j.nut.2023.112283
EA DEC 2023
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA DU6Z9
UT WOS:001134647100001
PM 38071935
DA 2025-04-28
ER

PT J
AU Hostmark, AT
   Tomten, SE
AF Hostmark, Arne T.
   Tomten, Sissel E.
TI The Oslo Health Study: Cheese Intake Was Negatively Associated with the
   Metabolic Syndrome
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE metabolic syndrome; cheese intake; men; women; cross-sectional study
ID ISCHEMIC-HEART-DISEASE; HIGH-FIBER DIET; BLOOD-LIPIDS; DAIRY
   CONSUMPTION; FATTY-ACIDS; MILK-FAT; RISK; CHOLESTEROL; SERUM; BUTTER
AB Objective: We previously reported that the frequency of cheese intake (FCI) was negatively associated with serum triglycerides and positively associated with high-density lipoprotein cholesterol (HDL), both components of the metabolic syndrome (MetS). We therefore wanted to study whether FCI is associated with MetS.
   Methods: The Oslo Health Study (18,770 subjects), obtained data from 7815 men and 9685 women on cheese intake and risk factors for MetS, except for fasting glucose. MetS requires central obesity and at least 2 of the following: increased triglycerides, low HDL cholesterol, increased systolic or diastolic blood pressure, and elevated fasting blood glucose. We calculated the index SumRisk, providing the number of MetS factors present, and MetSRisk to reflect the combined levels of many MetS factors. The association between FCI and MetSRisk (SumRisk) was studied using regression analyses.
   Results: In young (30 years), middle-aged (40 and 45 years), seniors (59-60), and old (75-76 years) subjects, there was an inverse association between FCI and MetSRisk (p <= 0.005, except in old men). Using regression, we found a consistent negative association (p < 0.001) between FCI and MetSRisk, SumRisk, single MetS components, and the complete MetS, prevailing after controlling for sex, age, time since last meal, intake of fruit/berries, fruit juice, fatty fish, coffee, alcohol, smoking, leisure time physical activity, years at school, and birthplace. FCI was also negatively associated with body mass index (p < 0.02), except in old women.
   Conclusion: Cheese intake can be negatively and independently associated with (1) an index including the level of many risk factors for MetS, (2) the number of MetS requirements present, (3) single MetS components, and (4) the complete MetS.
C1 [Hostmark, Arne T.] Univ Oslo, Sect Prevent Med & Epidemiol, N-0318 Oslo, Norway.
   [Tomten, Sissel E.] Norwegian Sch Sport Sci, Oslo, Norway.
C3 University of Oslo; Norwegian School of Sport Sciences
RP Hostmark, AT (corresponding author), Univ Oslo, Sect Prevent Med & Epidemiol, 1130 Blindern, N-0318 Oslo, Norway.
EM a.t.hostmark@medisin.uio.no
CR Andersen LF, 2002, EUR J PUBLIC HEALTH, V12, P208, DOI 10.1093/eurpub/12.3.208
   [Anonymous], THESIS U OSLO OSLO
   [Anonymous], 2005, DIET GUID AM 2005
   Azadbakht L, 2005, AM J CLIN NUTR, V82, P523, DOI 10.1093/ajcn/82.3.523
   Beydoun MA, 2008, AM J CLIN NUTR, V87, P1914, DOI 10.1093/ajcn/87.6.1914
   Biong AS, 2004, BRIT J NUTR, V92, P791, DOI 10.1079/BJN20041257
   Biong AS, 2007, THESIS U OSLO OSLO
   Chi D., 2004, Central European Journal of Public Health, V12, P84
   COLQUHOUN DM, 2003, ASIA PAC J CLIN NU S, V12, pS65
   EICHHOLZER M, 1993, INT J VITAM NUTR RES, V63, P159
   El-Salam MHA, 2009, DAIRY SCI TECHNOL, V89, P437, DOI 10.1051/dst/2009022
   Elwood PC, 2004, EUR J CLIN NUTR, V58, P718, DOI 10.1038/sj.ejcn.1601869
   Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157
   Engberink MF, 2009, AM J CLIN NUTR, V89, P1877, DOI 10.3945/ajcn.2008.27064
   FEHILY AM, 1993, BRIT J NUTR, V69, P303, DOI 10.1079/BJN19930035
   Gulseth HL, 2010, BRIT J NUTR, V104, P160, DOI 10.1017/S0007114510000565
   HEGSTED DM, 1965, AM J CLIN NUTR, V17, P281
   Higurashi S, 2007, INT DAIRY J, V17, P1224, DOI 10.1016/j.idairyj.2007.03.012
   Hostmark AT, 2009, J FOOD LIPIDS, V16, P89, DOI 10.1111/j.1745-4522.2009.01134.x
   Insel Paul., 2004, NUTRITION
   *INT DIAB FED, 2009, IDF CONS WORLDW DEF
   Katan MB, 2010, AM J CLIN NUTR, V92, P459, DOI 10.3945/ajcn.2010.29692
   Lamarche B, 1999, DIABETES METAB, V25, P199
   MARCKMANN P, 1994, AM J CLIN NUTR, V59, P935, DOI 10.1093/ajcn/59.4.935
   Moebus S, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-22
   Ness AR, 2001, J EPIDEMIOL COMMUN H, V55, P379, DOI 10.1136/jech.55.6.379
   Nestel PJ, 2005, EUR J CLIN NUTR, V59, P1059, DOI 10.1038/sj.ejcn.1602211
   O'Callaghan D, 1996, J Cardiovasc Risk, V3, P441
   PICARD S, 1995, DIABETES METAB, V21, P89
   SANDSTROM B, 1992, EUR J CLIN NUTR, V46, P95
   SCHLIERF G, 1979, EUR J CLIN INVEST, V9, P319, DOI 10.1111/j.1365-2362.1979.tb00891.x
   Schuster G S, 1980, Pharmacol Ther Dent, V5, P25
   Seidel C, 2005, ANN NUTR METAB, V49, P42, DOI 10.1159/000084176
   Sjogren P, 2004, J NUTR, V134, P1729, DOI 10.1093/jn/134.7.1729
   Smedman AEM, 1999, AM J CLIN NUTR, V69, P22
   Sogaard Anne Johanne, 2004, Int J Equity Health, V3, P3
   St-Pierre AC, 2005, ARTERIOSCL THROM VAS, V25, P553, DOI 10.1161/01.ATV.0000154144.73236.f4
   STAHELIN HB, 1992, BIBL NUTR DIET, V49, P24
   Tholstrup T, 2004, J AM COLL NUTR, V23, P169, DOI 10.1080/07315724.2004.10719358
   Tonstad S, 2003, J CARDIOVASC RISK, V10, P129, DOI 10.1097/00043798-200304000-00008
   van Hees AMJ, 2008, J NUTR, V138, P2399, DOI 10.3945/jn.108.094516
   Warensjö E, 2004, BRIT J NUTR, V91, P635, DOI 10.1079/BJN20041080
   WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P
NR 43
TC 18
Z9 18
U1 0
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUN
PY 2011
VL 30
IS 3
BP 182
EP 190
DI 10.1080/07315724.2011.10719959
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA V28MQ
UT WOS:000208685300004
PM 21896876
DA 2025-04-28
ER

PT S
AU Belpoggi, F
   Soffritti, M
   Tibaldi, E
   Falcioni, L
   Bua, L
   Trabucco, F
AF Belpoggi, Fiorella
   Soffritti, Morando
   Tibaldi, Eva
   Falcioni, Laura
   Bua, Luciano
   Trabucco, Francesca
BE Mehlman, MA
   Soffritti, M
   Landrigan, P
   Bingham, E
   Belpoggi, F
TI Results of long-term carcinogenicity bioassays on Coca-Cola administered
   to Sprague-Dawley rats
SO LIVING IN A CHEMICAL WORLD: FRAMING THE FUTURE IN LIGHT OF THE PAST
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT Conference on Framing the Future in Light of the Past - Living in a
   Chemical World
CY SEP 18-21, 2005
CL Bologna, ITALY
SP Comuni Carpi, European Ramazzini Fdn, Natl Ramazzini Inst, Collegium Ramazzini
DE Coca-Cola; carcinogenicity; long-term bioassay; rat
ID CANCER; OBESITY; COHORT; ADULTS
AB Coca-Cola was invented in May 1886 in Atlanta, Georgia by a pharmacist who, by accident or design, mixed carbonated water with the syrup of sugar, phosphoric acid, caffeine, and other natural flavors to create what is known as "the world's favorite soft drink." Coca-Cola is currently sold in more than 200 countries and in early 2000, the company sold its 10 billionth unit case of Coca-Cola branded products. Given the worldwide consumption of Coca-Cola, a project of experimental bioassays to study its long-term effects when administered as substitute for drinking water on male and female Sprague-Dawley rats was planned and executed. The objective of the project was to study whether and how long-term consumption of Coca-Cola affects the basic tumorigram of test animals. The bioassays were performed on rats beginning at different ages, namely: (a) on males and females exposed since embryonic life or from 7 weeks of age; and (b) on males and females exposed from 30, 39, or 55 weeks of age. Overall, the project included 1999 rats. During the biophase, data were collected on fluid and feed consumption, body weight, and survival. Animals were kept under observation until spontaneous death and underwent complete necropsy. The results indicate: (a) an increase in body weight in all treated animals; (b) a statistically significant increase of the incidence in females, both breeders and offspring, bearing malignant mammary tumors; (c) a statistically significant increase in the incidence of exocrine ademonas of the pancreas in both male and female breeders and offspring; and (d) an increased incidence, albeit not statistically significant, of pancreatic islet cell carcinomas in females, a malignant tumor which occurs very rarely in our historical controls. On the basis of the results of this study, excessive consumption of regular soft-drinks should be generally discouraged, in particular for children and adolescents.
C1 European Ramazzini Fdn, Cesare Maltoni Canc Res Ctr, I-40010 Bentivoglio, BO, Italy.
RP Soffritti, M (corresponding author), European Ramazzini Fdn, Cesare Maltoni Canc Res Ctr, I-40010 Bentivoglio, BO, Italy.
EM crcfr@ramazzini.it
CR Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Rapp K, 2005, BRIT J CANCER, V93, P1062, DOI 10.1038/sj.bjc.6602819
   Soffritti M, 1996, INT CONGR SER, V1120, P241
   SOFFRITTI M, 1999, ANN NY ACAD SCI, V895, P43
   Tannebaum A., 1940, American Journal of Cancer, V38, P335
   TANNENBAUM A, 1953, ADV CANCER RES, V1, P451, DOI 10.1016/S0065-230X(08)60009-3
NR 6
TC 17
Z9 18
U1 0
U2 19
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA
SN 0077-8923
BN 1-57331-653-9
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2006
VL 1076
BP 736
EP 752
DI 10.1196/annals.1371.078
PG 17
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Multidisciplinary Sciences; Toxicology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Science & Technology - Other Topics; Toxicology
GA BFH91
UT WOS:000241943500062
PM 17119251
DA 2025-04-28
ER

PT J
AU Lima, TP
   Nicoletti, CF
   Marchini, JS
   Salgado, W
   Nonino, CB
AF Lima, Tatiana Pereira
   Nicoletti, Carolina Ferreira
   Marchini, Julio Sergio
   Salgado Junior, Wilson
   Nonino, Carla Barbosa
TI Effect of Weight Loss on Bone Mineral Density Determined by Ultrasound
   of Phalanges in Obese Women After Roux-en-y Gastric Bypass: Conflicting
   Results With Dual-Energy X-ray Absorptiometry
SO JOURNAL OF CLINICAL DENSITOMETRY
LA English
DT Article
DE Bariatric surgery; bone mass; DXA; obesity; utrasonography
ID BARIATRIC SURGERY; BODY-COMPOSITION; CALCIUM-METABOLISM; LIFE-STYLE;
   TURNOVER; DISEASE; MARKERS
AB The rapid weight loss that occurs in obese patients submitted to Roux-en-y gastric bypass (RYGB) as well as the changes in dietary pattern and the intestinal malabsorption result in changes in bone mineral density (BMD). The objective of the present study was to assess the changes in BMD after the weight loss induced by RYGB using ultrasound of the phalanges and compare the results with those obtained by dual-energy X-ray absorptiometry (DXA). We conducted a 1-yr prospective longitudinal study on women with grade III obesity submitted to RYGB. Anthropometric (weight, height, body mass index, and abdominal circumference) and body composition measurements by electrical bioimpedance, assessment of food consumption by 24-h recall, biochemical evaluation, and assessment of BMD by ultrasonography of the phalanges and DXA (BMD values are from the 33% radius site) were performed during the preoperative period and 3, 6, and 12 mo after surgery. The mixed-effects linear regression model was used to analyze the effect of postoperative time on the variable of interest, and the kappa coefficient (p < 0.05) was used to compare the concordance of the methods used for BMD evaluation. Twenty-nine patients were included in the study. During the 1-yr follow-up, a reduction of 39 +/- 8 kg (71 +/- 15% of excess weight) and -29 +/- 7 kg of fat mass was observed. Calcium and zinc concentrations were reduced after 12 mo. No difference in caffeine, calcium, or sodium consumption was observed between the preoperative and postoperative periods. Analysis of BMD by ultrasonography of the phalanges 1 yr after surgery showed increased values of amplitude-dependent speed of sound (2064.6 +/- 59.4 vs 2154.7 +/- 63 m/s; p < 0.001) and ultrasound bone profile index (0.73 +/- 0.13 vs 0.76 +/- 0.14; p < 0.001). Analysis of BMD by DXA showed a reduction of BMD values (0.6 +/- 0.04 vs 0.57 +/- 0.05 g/cm(3); p < 0.001) in the sixth month and maintenance of the values from the sixth to the 12th month. At the end of the study, there was no concordance between the methods for BMD analysis. This study showed improvement in bone quality and quantity assessed by ultrasonography. However, the MCA results showed a reduction in BMD after 12 mo of RYGB. Thus, the BMD measurement methods were discordant.
C1 [Lima, Tatiana Pereira; Nicoletti, Carolina Ferreira; Marchini, Julio Sergio; Nonino, Carla Barbosa] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Salgado Junior, Wilson] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surgely & Anat, BR-14049900 Ribeirao Preto, SP, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo
RP Nonino, CB (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM carla@fmrp.usp.br
RI Salgado, Wilson/L-1470-2016; Marchini, Julio Sergio/K-1992-2016; Nonino,
   Carla Barbosa/D-4637-2012
OI Marchini, Julio Sergio/0000-0001-9999-9149; Nonino, Carla
   Barbosa/0000-0001-8559-0772; Salgado Jr., Wilson/0000-0001-9796-0339
CR Binkley N, 2003, J CLIN DENSITOM, V6, P199, DOI 10.1385/JCD:6:3:199
   Bruno C, 2010, J CLIN ENDOCR METAB, V95, P159, DOI 10.1210/jc.2009-0265
   Brzozowska MM, 2013, OBES REV, V14, P52, DOI 10.1111/j.1467-789X.2012.01050.x
   Carrasco F, 2009, OBES SURG, V19, P41, DOI 10.1007/s11695-008-9638-0
   Casagrande DS, 2012, OBES SURG, V22, P1287, DOI 10.1007/s11695-012-0687-z
   Coates PS, 2004, J CLIN ENDOCR METAB, V89, P1061, DOI 10.1210/jc.2003-031756
   Cohen HJ, 2000, FOOD CHEM TOXICOL, V38, P237, DOI 10.1016/S0278-6915(99)00145-3
   De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y
   De Prisco C, 2005, AM J MED SCI, V329, P57, DOI 10.1097/00000441-200502000-00001
   Dib L, 2005, BONE, V36, P736, DOI 10.1016/j.bone.2005.01.009
   Drozdzowska B, 2005, J CLIN DENSITOM, V8, P216, DOI 10.1385/JCD:8:2:216
   El-Kadre LJ, 2004, OBES SURG, V14, P1062, DOI 10.1381/0960892041975505
   Fleischer J, 2008, J CLIN ENDOCR METAB, V93, P3735, DOI 10.1210/jc.2008-0481
   De Carvalho FG, 2012, NUTR HOSP, V27, P612, DOI [10.3305/nh.2012.27.2.5625, 10.1590/S0212-16112012000200039]
   Hyppönen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860
   Iannetta O, 2006, OSTEOPOROSE EXENFERM, P237
   Jakicic JM, 1998, INT J OBESITY, V22, P243, DOI 10.1038/sj.ijo.0800576
   Mahdy T, 2008, OBES SURG, V18, P1526, DOI 10.1007/s11695-008-9653-1
   Mann Tandip S, 2008, Mcgill J Med, V11, P132
   *MLF, 1983, HEIGHT WEIGHT TABL M
   Nicoletti CF, 2013, SURG OBES RELAT DIS, V9, P1008, DOI 10.1016/j.soard.2013.07.004
   Ricci TA, 2001, AM J CLIN NUTR, V73, P347
   Rico H, 2002, NUTRITION, V18, P189, DOI 10.1016/S0899-9007(01)00718-3
   Schweitzer DH, 2007, OBES SURG, V17, P1510, DOI 10.1007/s11695-008-9431-0
   Scibora LM, 2012, OBES SURG, V22, P654, DOI 10.1007/s11695-012-0596-1
   Sinha N, 2011, OBESITY, V19, P2388, DOI 10.1038/oby.2011.133
   Slater GH, 2004, J GASTROINTEST SURG, V8, P48, DOI 10.1016/j.gassur.2003.09.020
   Soleymani T, 2011, CURR OPIN RHEUMATOL, V23, P396, DOI 10.1097/BOR.0b013e328346f832
   Tsukiyama K, 2006, MOL ENDOCRINOL, V20, P1644, DOI 10.1210/me.2005-0187
   Viegas M, 2010, ARQ BRAS ENDOCRINOL, V54, P158, DOI 10.1590/S0004-27302010000200011
   Vilarrasa N, 2011, OBES SURG, V21, P465, DOI 10.1007/s11695-010-0338-1
   Wucher H, 2008, OBES SURG, V18, P58, DOI 10.1007/s11695-007-9258-0
   Yu EW, 2014, J BONE MINER RES, V29, P542, DOI 10.1002/jbmr.2063
NR 33
TC 9
Z9 10
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1094-6950
EI 1559-0747
J9 J CLIN DENSITOM
JI J. Clin. Densitom.
PD OCT-DEC
PY 2014
VL 17
IS 4
BP 473
EP 478
DI 10.1016/j.jocd.2014.08.002
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AT3MS
UT WOS:000344839500006
PM 25443227
DA 2025-04-28
ER

PT J
AU Kashino, I
   Serafini, M
   Kurotani, K
   Akter, S
   Mizoue, T
   Ishihara, J
   Kotemori, A
   Sawada, N
   Inoue, M
   Iwasaki, M
   Noda, M
   Tsugane, S
   Tsugane, S
   Sawada, N
   Iwasaki, M
   Sasazuki, S
   Yamaji, T
   Shimazu, T
   Hanaoka, T
   Ogata, J
   Baba, S
   Mannami, T
   Okayama, A
   Kokubo, Y
   Miyakawa, K
   Saito, F
   Koizumi, A
   Sano, Y
   Hashimoto, I
   Ikuta, T
   Tanaba, Y
   Sato, H
   Roppongi, Y
   Takashima, T
   Suzuki, H
   Miyajima, Y
   Suzuki, N
   Nagasawa, S
   Furusugi, Y
   Nagai, N
   Ito, Y
   Komatsu, S
   Minamizono, T
   Sanada, H
   Hatayama, Y
   Kobayashi, F
   Uchino, H
   Shirai, Y
   Kondo, T
   Sasaki, R
   Watanabe, Y
   Miyagawa, Y
   Kobayashi, Y
   Machida, M
   Kobayashi, K
   Tsukada, M
   Kishimoto, Y
   Takara, E
   Fukuyama, T
   Kinjo, M
   Irei, M
   Sakiyama, H
   Imoto, K
   Yazawa, H
   Seo, T
   Seiko, A
   Ito, F
   Shoji, F
   Saito, R
   Murata, A
   Minato, K
   Motegi, K
   Fujieda, T
   Yamato, S
   Matsui, K
   Abe, T
   Katagiri, M
   Suzuki, M
   Niigata, KM
   Doi, M
   Terao, A
   Ishikawa, Y
   Tagami, T
   Sueta, H
   Doi, H
   Urata, M
   Okamoto, N
   Ide, F
   Goto, H
   Fujita, R
   Onga, N
   Takaesu, H
   Uehara, M
   Nakasone, T
   Yamakawa, M
   Horii, F
   Asano, I
   Yamaguchi, H
   Aoki, K
   Maruyama, S
   Ichii, M
   Takano, M
   Tsubono, Y
   Suzuki, K
   Honda, Y
   Yamagishi, K
   Sakurai, S
   Tsuchiya, N
   Kabuto, M
   Yamaguchi, M
   Matsumura, Y
   Sasaki, S
   Watanabe, S
   Akabane, M
   Kadowaki, T
   Inoue, M
   Noda, M
   Mizoue, T
   Kawaguchi, Y
   Takashima, Y
   Yoshida, Y
   Nakamura, K
   Takachi, R
   Ishihara, J
   Matsushima, S
   Natsukawa, S
   Shimizu, H
   Sugimura, H
   Tominaga, S
   Hamajima, N
   Iso, H
   Sobue, T
   Iida, M
   Ajiki, W
   Ioka, A
   Sato, S
   Maruyama, E
   Konishi, M
   Okada, K
   Saito, I
   Yasuda, N
   Kono, S
   Akiba, S
   Isobe, T
   Sato, Y
AF Kashino, Ikuko
   Serafini, Mauro
   Kurotani, Kayo
   Akter, Shamima
   Mizoue, Tetsuya
   Ishihara, Junko
   Kotemori, Ayaka
   Sawada, Norie
   Inoue, Manami
   Iwasaki, Motoki
   Noda, Mitsushiko
   Tsugane, Shoichiro
   Tsugane, S.
   Sawada, N.
   Iwasaki, M.
   Sasazuki, S.
   Yamaji, T.
   Shimazu, T.
   Hanaoka, T.
   Ogata, J.
   Baba, S.
   Mannami, T.
   Okayama, A.
   Kokubo, Y.
   Miyakawa, K.
   Saito, F.
   Koizumi, A.
   Sano, Y.
   Hashimoto, I
   Ikuta, T.
   Tanaba, Y.
   Sato, H.
   Roppongi, Y.
   Takashima, T.
   Suzuki, H.
   Miyajima, Y.
   Suzuki, N.
   Nagasawa, S.
   Furusugi, Y.
   Nagai, N.
   Ito, Y.
   Komatsu, S.
   Minamizono, T.
   Sanada, H.
   Hatayama, Y.
   Kobayashi, F.
   Uchino, H.
   Shirai, Y.
   Kondo, T.
   Sasaki, R.
   Watanabe, Y.
   Miyagawa, Y.
   Kobayashi, Y.
   Machida, M.
   Kobayashi, K.
   Tsukada, M.
   Kishimoto, Y.
   Takara, E.
   Fukuyama, T.
   Kinjo, M.
   Irei, M.
   Sakiyama, H.
   Imoto, K.
   Yazawa, H.
   Seo, T.
   Seiko, A.
   Ito, F.
   Shoji, F.
   Saito, R.
   Murata, A.
   Minato, K.
   Motegi, K.
   Fujieda, T.
   Yamato, S.
   Matsui, K.
   Abe, T.
   Katagiri, M.
   Suzuki, M.
   Matsui Niigata, K.
   Doi, M.
   Terao, A.
   Ishikawa, Y.
   Tagami, T.
   Sueta, H.
   Doi, H.
   Urata, M.
   Okamoto, N.
   Ide, F.
   Goto, H.
   Fujita, R.
   Onga, N.
   Takaesu, H.
   Uehara, M.
   Nakasone, T.
   Yamakawa, M.
   Horii, F.
   Asano, I
   Yamaguchi, H.
   Aoki, K.
   Maruyama, S.
   Ichii, M.
   Takano, M.
   Tsubono, Y.
   Suzuki, K.
   Honda, Y.
   Yamagishi, K.
   Sakurai, S.
   Tsuchiya, N.
   Kabuto, M.
   Yamaguchi, M.
   Matsumura, Y.
   Sasaki, S.
   Watanabe, S.
   Akabane, M.
   Kadowaki, T.
   Inoue, M.
   Noda, M.
   Mizoue, T.
   Kawaguchi, Y.
   Takashima, Y.
   Yoshida, Y.
   Nakamura, K.
   Takachi, R.
   Ishihara, J.
   Matsushima, S.
   Natsukawa, S.
   Shimizu, H.
   Sugimura, H.
   Tominaga, S.
   Hamajima, N.
   Iso, H.
   Sobue, T.
   Iida, M.
   Ajiki, W.
   Ioka, A.
   Sato, S.
   Maruyama, E.
   Konishi, M.
   Okada, K.
   Saito, I
   Yasuda, N.
   Kono, S.
   Akiba, S.
   Isobe, T.
   Sato, Y.
CA Japan Public Hlth Center-based Pro
TI Relationship between dietary non-enzymatic antioxidant capacity and type
   2 diabetes risk in the Japan Public Health Center-based Prospective
   Study
SO NUTRITION
LA English
DT Article
DE NEAC; TAC; Antioxidant capacity; Antioxidant; Cohort study; Diabetes
ID FOOD FREQUENCY QUESTIONNAIRE; GREEN TEA; OXIDATIVE STRESS; CANCER RISK;
   JPHC; MEN; ASSOCIATION; COHORT; COFFEE; FRUIT
AB Objective: Intake of antioxidants may reduce the risk for type 2 diabetes (T2D) by reducing oxidative stress. However, it is unclear whether dietary non-enzymatic antioxidant capacity (NEAC), which represents the cumulative action of dietary antioxidants and their synergistic effects in foods, is associated with decreased T2D risk. The aim of this study was to investigate the associations between dietary NEAC and T2D.
   Methods: The study included 64 660 adults (27 809 men and 36 851 women), 44 to 76 y of age without history of T2D in the Japan Public Health Center-based Prospective Study. Dietary NEAC was estimated using databases of NEAC measurements compiled from results for three different assays: ferric reducing-antioxidant power (FRAP), oxygen radical absorbance capacity (ORAC), and total radical-trapping antioxidant parameter (TRAP). A multiple logistic regression model was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of self-reported physician-diagnosed T2D over 5 y with adjustment for potential confounders.
   Results: In all, 1191 cases of newly diagnosed T2D were reported. Dietary NEACs were not significantly associated with T2D. The multivariate-adjusted ORs were 1.04 (95% CI, 0.88-1.23; P-trend = 0.56) for FRAP, 1.11 (95% CI, 0.93-1.32; P-trend = 0.26) for ORAC, and 0.99 (95% CI, 0.84-1.18; P-trend = 0.84) for TRAP. Similar associations were observed in men and women (P-interaction = 0.46 for FRAP, 0.35 for ORAC, and 0.63 for TRAP). In stratified analyses of major prooxidant factors, no notable associations with smoking and obesity status were observed.
   Conclusions: This finding suggests that dietary NEAC may not be appreciably associated with T2D in Japanese adults. (C) 2019 Published by Elsevier Inc.
C1 [Kashino, Ikuko; Kurotani, Kayo; Akter, Shamima; Mizoue, Tetsuya; Iwasaki, M.] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.
   [Serafini, Mauro; Sasazuki, S.] Univ Teramo, Biosci & Technol Food Agr & Environm, Funct Foods & Metab Stress Prevent Lab, Teramo, Italy.
   [Kurotani, Kayo; Yamaji, T.] Natl Inst Biomed Innovat, Natl Inst Hlth & Nutr, Dept Nutr Epidemiol & Shokuiku, Tokyo, Japan.
   [Ishihara, Junko] Azabu Univ, Sch Life & Environm Sci, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan.
   [Kotemori, Ayaka; Sawada, Norie; Inoue, Manami; Iwasaki, Motoki; Tsugane, Shoichiro; Hanaoka, T.] Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan.
   [Noda, Mitsushiko; Ogata, J.] Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan.
   [Sawada, Norie; Iwasaki, Motoki; Tsugane, S.; Sawada, N.; Iwasaki, M.; Sasazuki, S.; Yamaji, T.; Shimazu, T.; Hanaoka, T.] Natl Canc Ctr, Tokyo, Japan.
   [Ogata, J.; Baba, S.; Mannami, T.; Okayama, A.; Kokubo, Y.] Natl Cerebral & Cardiovasc Ctr, Osaka, Japan.
   [Miyakawa, K.; Saito, F.; Koizumi, A.; Sano, Y.; Hashimoto, I; Ikuta, T.; Tanaba, Y.; Sato, H.; Roppongi, Y.; Takashima, T.; Suzuki, H.] Iwate Prefectural Ninohe Publ Hlth Ctr, Ninohe, Iwate, Japan.
   [Miyajima, Y.; Suzuki, N.; Nagasawa, S.; Furusugi, Y.; Nagai, N.; Ito, Y.; Komatsu, S.; Minamizono, T.] Akita Prefectural Yokote Publ Hlth Ctr, Akita, Japan.
   [Sanada, H.; Hatayama, Y.; Kobayashi, F.; Uchino, H.; Shirai, Y.; Kondo, T.; Sasaki, R.; Watanabe, Y.; Miyagawa, Y.; Kobayashi, Y.; Machida, M.; Kobayashi, K.; Tsukada, M.] Nagano Prefectural Saku Publ Hlth Ctr, Nagano, Japan.
   [Kishimoto, Y.; Takara, E.; Fukuyama, T.; Kinjo, M.; Irei, M.; Sakiyama, H.] Okinawa Prefectural Chubu Publ Hlth Ctr, Uruma, Okinawa, Japan.
   [Imoto, K.; Yazawa, H.; Seo, T.; Seiko, A.; Ito, F.; Shoji, F.; Saito, R.] Katsushika Publ Hlth Ctr, Tokyo, Japan.
   [Murata, A.; Minato, K.; Motegi, K.; Fujieda, T.; Yamato, S.] Ibaraki Prefectural Mito Publ Hlth Ctr, Ibaraki, Japan.
   [Matsui, K.; Abe, T.; Katagiri, M.; Suzuki, M.; Matsui Niigata, K.] Niigata Prefectural Kashiwazaki & Nagaoka Publ Hl, Niigata, Japan.
   [Doi, M.; Terao, A.; Ishikawa, Y.; Tagami, T.] Kochi Prefectural Chuo Higashi Publ Hlth Ctr, Kochi, Japan.
   [Sueta, H.; Doi, H.; Urata, M.; Okamoto, N.; Ide, F.; Goto, H.; Fujita, R.] Nagasaki Prefectural Kamigoto Publ Hlth Ctr, Nagasaki, Japan.
   [Sakiyama, H.; Onga, N.; Takaesu, H.; Uehara, M.; Nakasone, T.; Yamakawa, M.] Okinawa Prefectural Miyako Pub Lic Hlth Ctr, Uruma, Okinawa, Japan.
   [Horii, F.; Asano, I; Yamaguchi, H.; Aoki, K.; Maruyama, S.; Ichii, M.; Takano, M.] Osaka Prefectural Suita Publ Hlth Ctr, Osaka, Japan.
   [Tsubono, Y.] Tohoku Univ, Sendai, Miyagi, Japan.
   [Suzuki, K.] Res Inst Brain & Blood Vessels, Akita, Japan.
   [Honda, Y.; Yamagishi, K.; Sakurai, S.; Tsuchiya, N.] Univ Tsukuba, Ibaraki, Japan.
   [Kabuto, M.] Natl Inst Environm Studies, Ibaraki, Japan.
   [Yamaguchi, M.; Matsumura, Y.; Sasaki, S.; Watanabe, S.] Natl Inst Hlth & Nutr, Tokyo, Japan.
   [Akabane, M.] Tokyo Univ Agr, Tokyo, Japan.
   [Kadowaki, T.; Inoue, M.] Univ Tokyo, Tokyo, Japan.
   [Mizoue, Tetsuya; Noda, M.; Mizoue, T.] Natl Ctr Global Hlth & Med, Tokyo, Japan.
   [Kawaguchi, Y.] Tokyo Med & Dent Univ, Tokyo, Japan.
   [Takashima, T.; Takashima, Y.; Yoshida, Y.] Kyorin Univ, Tokyo, Japan.
   [Nakamura, K.; Takachi, R.] Niigata Univ, Niigata, Japan.
   [Ishihara, J.] Sagami Womens Univ, Sagamihara, Kanagawa, Japan.
   [Matsushima, S.; Natsukawa, S.] Saku Gen Hosp, Nagano, Japan.
   [Shimizu, H.] Sakihae Inst, Gifu, Japan.
   [Sugimura, H.] Hamamatsu Univ Sch Med, Shizuoka, Japan.
   [Tominaga, S.] Aichi Canc Ctr, Nagoya, Aichi, Japan.
   [Hamajima, N.] Nagoya Univ, Nagoya, Aichi, Japan.
   [Iso, H.; Sobue, T.] Osaka Univ, Osaka, Japan.
   [Iida, M.; Ajiki, W.; Ioka, A.] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan.
   [Sato, S.] Chiba Prefectural Inst Publ Hlth, Chiba, Japan.
   [Maruyama, E.] Kobe Univ, Kobe, Hyogo, Japan.
   [Konishi, M.; Okada, K.; Saito, I] Ehime Univ, Matsuyama, Ehime, Japan.
   [Yasuda, N.] Kochi Univ, Kochi, Japan.
   [Kono, S.] Kyushu Univ, Fukuoka, Fukuoka, Japan.
   [Akiba, S.] Kagoshima Univ, Kagoshima, Japan.
   [Isobe, T.] Keio Univ, Tokyo, Japan.
   [Sato, Y.] Tokyo Gakugei Univ, Tokyo, Japan.
C3 Japan Institute for Health Security (JIHS); National Center for Global
   Health & Medicine - Japan; University of Teramo; National Institute of
   Health Sciences - Japan; National Institute of Health & Nutrition -
   Japan; Azabu University; National Cancer Center - Japan; Saitama Medical
   University; National Cancer Center - Japan; National Cerebral &
   Cardiovascular Center - Japan; Tohoku University; University of Tsukuba;
   National Institute for Environmental Studies - Japan; National Institute
   of Health & Nutrition - Japan; Tokyo University of Agriculture;
   University of Tokyo; Japan Institute for Health Security (JIHS);
   National Center for Global Health & Medicine - Japan; Institute of
   Science Tokyo; Tokyo Medical & Dental University (TMDU); Kyorin
   University; Niigata University; Hamamatsu University School of Medicine;
   Aichi Cancer Center; Nagoya University; The University of Osaka; Osaka
   Medical Center for Cancer & Cardiovascular Diseases; Kobe University;
   Ehime University; Kochi University; Kyushu University; Kagoshima
   University; Keio University; Tokyo Gakugei University
RP Kashino, I (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.
EM ikukokashino@gmail.com
RI KASHINO, IKUKO/AAS-4008-2020; Shimazu, Taichi/A-4470-2015; Noda,
   Mitsuhiko/W-3905-2019; Akter Swapna, Shamima/AAA-5921-2022; Sobue,
   Tomotaka/ABE-4739-2021; Ishihara, Jun/Y-7468-2019; Tsugane,
   Shoichiro/A-2424-2015; Yamagishi, Kazumasa/ABD-6320-2021; tsuchiya,
   naoyuki/CAA-4545-2022; Hamajima, Nobuyuki/I-7237-2014; matsushima,
   shouji/IUO-9529-2023; Iwasaki, Motoki/A-2409-2015; Kurotani,
   Kayo/LBI-1517-2024; Serafini, Mauro/K-6498-2018
OI Iwasaki, Motoki/0000-0003-3319-4131; Kurotani, Kayo/0000-0002-0109-6046;
   KOTEMORI, Ayaka/0000-0003-3954-8615; Serafini,
   Mauro/0000-0003-0913-936X; NODA, Mitsuhiko/0000-0003-0413-4631
FU National Cancer Center Research and Development Fund; Ministry of
   Health, Labour and Welfare of Japan; Japan Agency for Medical Research
   [15 ek0210021 h0002]
FX This study was supported by National Cancer Center Research and
   Development Fund (since 2011), Grant-in-Aid for Cancer Research from the
   Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010),
   Practical Research Project for Life-Style related Diseases including
   Cardiovascular Diseases and Diabetes Mellitus (15 ek0210021 h0002) from
   the Japan Agency for Medical Research. ST was involved in the design of
   the study as the principal investigator. NS and ST conducted the
   surveys. IK, MS, KK, SA, TM, AS, MI (M Inoue), MI (M Iwasaki), and MN
   drafted the plan for data analyses. IK conducted the data analyses and
   drafted the manuscript. TM provided statistical expertise. and IK and TM
   had primary responsibility for the final content. All authors were
   involved in the interpretation of the results and revision of the
   manuscript and approved the final version of the manuscript. The authors
   have no conflicts of interest to declare.
CR Ashor AW, 2017, EUR J CLIN NUTR, V71, P1371, DOI 10.1038/ejcn.2017.24
   Bastide N, 2017, EUR J NUTR, V56, P1233, DOI 10.1007/s00394-016-1172-6
   Colarusso L, 2017, NUTRITION, V33, P234, DOI 10.1016/j.nut.2016.07.009
   Czernichow S, 2006, AM J CLIN NUTR, V84, P395
   Dávalos A, 2004, J AGR FOOD CHEM, V52, P48, DOI 10.1021/jf0305231
   Delgado-Andrade C, 2005, J AGR FOOD CHEM, V53, P1403, DOI 10.1021/jf048500p
   Eshak ES, 2013, CLIN NUTR, V32, P300, DOI 10.1016/j.clnu.2012.08.003
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Hamer M, 2007, J HYPERTENS, V25, P2361, DOI 10.1097/HJH.0b013e3282efc214
   Hermsdorff HHM, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-59
   Hirata A, 2017, ASIA PAC J CLIN NUTR, V26, P545, DOI 10.6133/apjcn.042016.04
   Ishihara J, 2003, J EPIDEMIOL, V13, pS134
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kashino I, 2018, J EPIDEMIOL, V28, P428, DOI 10.2188/jea.JE20170063
   Kataja-Tuomola MK, 2011, EUR J CLIN NUTR, V65, P590, DOI 10.1038/ejcn.2010.283
   Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003
   Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11
   Kurotani K, 2013, BRIT J NUTR, V109, P709, DOI 10.1017/S0007114512001705
   Liu SM, 2006, DIABETES, V55, P2856, DOI 10.2337/db06-0456
   Mancini FR, 2018, DIABETOLOGIA, V61, P308, DOI 10.1007/s00125-017-4489-7
   Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058
   Mekary RA, 2010, CANCER CAUSE CONTROL, V21, P1315, DOI 10.1007/s10552-010-9559-9
   Morales FJ, 2012, AMINO ACIDS, V42, P1097, DOI 10.1007/s00726-010-0774-1
   Oba S, 2010, BRIT J NUTR, V103, P453, DOI 10.1017/S0007114509991966
   Okubo H, 2014, NUTR METAB CARDIOVAS, V24, P301, DOI 10.1016/j.numecd.2013.08.001
   Pan A, 2015, LANCET DIABETES ENDO, V3, P958, DOI 10.1016/S2213-8587(15)00316-2
   Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812
   Pellegrini N, 2006, MOL NUTR FOOD RES, V50, P1030, DOI 10.1002/mnfr.200600067
   Psaltopoulou T, 2011, NUTR METAB CARDIOVAS, V21, P561, DOI 10.1016/j.numecd.2009.11.005
   Sasaki S, 2003, J EPIDEMIOL, V13, pS13
   Science and Technology Agency, 2005, STAND TABL FOOD COMP
   Seeram NP, 2008, J AGR FOOD CHEM, V56, P1415, DOI 10.1021/jf073035s
   Serafini M, 2004, REDOX REP, V9, P145, DOI 10.1179/135100004225004814
   Serafini M, 2012, INT J CANCER, V131, pE544, DOI 10.1002/ijc.27347
   Takebayashi J, 2013, J FOOD COMPOS ANAL, V29, P25, DOI 10.1016/j.jfca.2012.10.006
   Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096
   Vece MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142995
   Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w
   Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
   Zielinski H, 2009, J AGR FOOD CHEM, V57, P4771, DOI 10.1021/jf900313e
NR 41
TC 9
Z9 9
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD OCT
PY 2019
VL 66
BP 62
EP 69
DI 10.1016/j.nut.2019.03.011
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IW6KV
UT WOS:000485087400011
PM 31212252
DA 2025-04-28
ER

PT J
AU Li, DZ
   Jia, Y
   Yu, J
   Liu, Y
   Li, FH
   Liu, YM
   Wu, QQ
   Liao, XY
   Zeng, Z
   Wan, Z
   Zeng, R
AF Li, Dongze
   Jia, Yu
   Yu, Jing
   Liu, Yi
   Li, Fanghui
   Liu, Yanmei
   Wu, Qinqin
   Liao, Xiaoyang
   Zeng, Zhi
   Wan, Zhi
   Zeng, Rui
TI Adherence to a Healthy Lifestyle and the Risk of All-Cause Mortality and
   Cardiovascular Events in Individuals With Diabetes: The ARIC Study
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE diabetes; healthy lifestyle; mortality; cardiovascular events and
   mortality; cohort study
ID BODY-MASS INDEX; ATHEROSCLEROSIS RISK; PHYSICAL-ACTIVITY; FOLLOW-UP;
   METAANALYSIS; MELLITUS; DISEASE; ADULTS; ASSOCIATION; OBESITY
AB Objective: The relationship between combined healthy lifestyle and cardiovascular (CV) events in diabetes is unclear. We aim to investigate the association between a healthy lifestyle score (HLS) and the risk of mortality and CV events in diabetes.
   Methods: We examined the associations of six lifestyle factors scores (including healthy diet, moderate alcohol and regular coffee intakes, never smoking, physical activity, and normal weight) with diabetes in the Atherosclerosis Risk in Communities (ARIC) study of 3,804 participants with diabetes from the United States at baseline. Primary outcomes included all-cause mortality, CV mortality, and composite CV events (heart failure hospitalizations, myocardial infarction, fatal coronary heart disease, and stroke).
   Results: Among these diabetic participants, 1,881 (49.4%), 683 (18.0%), and 1,600 (42.0%) cases of all-cause mortality, CV mortality, and CV events were documented, respectively, during the 26 years of follow-up. Further, the prevalence of these adverse events became lower with the increase of HLS (all P < 0.001). In the risk-factors adjusted Cox regression model, compared to participants with HLS of 0, participants with HLS of 2 had significant lower risk of all-cause mortality (HR = 0.811, 95% CI: 0.687-0.957, P = 0.013), CV mortality (HR = 0.744, 95% CI: 0.576-0.962, P = 0.024), and CV events (HR = 0.789, 95% CI: 0.661-0.943, P = 0.009). The association of HLS with CV events was stronger for women than men (P for interaction <0.05).
   Conclusion: Adherence to a healthy lifestyle was associated with a lower risk of CV events and mortality in diabetics. Our findings suggest that the promotion of a healthy lifestyle would help reduce the increasing healthcare burden of diabetes.
C1 [Li, Dongze; Jia, Yu; Liu, Yi; Zeng, Zhi; Wan, Zhi; Zeng, Rui] Sichuan Univ, West China Hosp, Dept Emergency Med, Chengdu, Peoples R China.
   [Li, Dongze; Jia, Yu; Liu, Yi; Zeng, Zhi; Wan, Zhi; Zeng, Rui] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Res Lab Emergency Med,Disaster Med, Chengdu, Peoples R China.
   [Yu, Jing] Sichuan Univ, West China Sch Nursing, West China Hosp, Chengdu, Peoples R China.
   [Li, Fanghui; Zeng, Rui] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China.
   [Liu, Yanmei] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Peoples R China.
   [Wu, Qinqin] Sichuan Univ, West China Hosp, Hlth Management Ctr, Chengdu, Peoples R China.
   [Liao, Xiaoyang] Sichuan Univ, West China Hosp, Dept Gen Practice, Chengdu, Peoples R China.
   [Liao, Xiaoyang] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China.
C3 Sichuan University; Sichuan University; Sichuan University; Sichuan
   University; Sichuan University; Sichuan University; Sichuan University;
   Sichuan University
RP Zeng, R (corresponding author), Sichuan Univ, West China Hosp, Dept Emergency Med, Chengdu, Peoples R China.; Zeng, R (corresponding author), Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Res Lab Emergency Med,Disaster Med, Chengdu, Peoples R China.; Zeng, R (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China.
EM zengrui_0524@126.com
RI jia, yu/HHR-9047-2022; Zeng, Rui/GRY-0646-2022; 刘, 艳枚/HLQ-3584-2023; Li,
   Dongze/X-5873-2019; Li, Dongze/H-4710-2017; wu, qinqin/N-4348-2017
OI Li, Dongze/0000-0002-7548-7007; wu, qinqin/0000-0002-2430-4493
FU Sichuan Science and Technology Program [2020YFS0154, 2020YFSY0014];
   Sichuan University West China Hospital [2018HXFH001, 2018HXFH027,
   2020HXFH050]; Sichuan University West China Nursing Discipline
   Development Special Fund Project [HXHL20046, HXHL19023]; Chengdu Science
   and Technology Bureau [2019-YF05-00322-SN]; National Clinical Research
   Center for Geriatrics, West China Hospital, Sichuan University
   [Z20191009]
FX This work was supported financially by grants from the Sichuan Science
   and Technology Program (Nos. 2020YFS0154, 2020YFSY0014), 1 center dot 3
   center dot 5 Project for Disciplines of Excellence-Clinical Research
   Incubation Project, Sichuan University West China Hospital (Nos.
   2018HXFH001, 2018HXFH027, and 2020HXFH050), Sichuan University West
   China Nursing Discipline Development Special Fund Project (HXHL20046,
   HXHL19023), Chengdu Science and Technology Bureau (2019-YF05-00322-SN),
   National Clinical Research Center for Geriatrics, West China Hospital,
   Sichuan University (Z20191009).
CR Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.010]
   Barazzoni R, 2018, EAT WEIGHT DISORD-ST, V23, P149, DOI 10.1007/s40519-018-0481-6
   Barba C, 2004, LANCET, V363, P157, DOI 10.1016/s0140-6736(03)15268-3
   Becerra-Tomas N, 2020, CRIT REV FOOD SCI, V60, P1207, DOI 10.1080/10408398.2019.1565281
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282
   Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062
   Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222
   Chomistek AK, 2015, J AM COLL CARDIOL, V65, P43, DOI 10.1016/j.jacc.2014.10.024
   Cosentino F, 2020, EUR HEART J, V41, P255, DOI 10.1093/eurheartj/ehz486
   Costanzo P, 2015, ANN INTERN MED, V162, P610, DOI 10.7326/M14-1551
   da Silva RC, 2016, ARQ BRAS CARDIOL, V107, P10, DOI 10.5935/abc.20160091
   Das SR, 2020, J AM COLL CARDIOL, V76, P1117, DOI 10.1016/j.jacc.2020.05.037
   Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
   Haj Mouhamed D, 2016, Ann Cardiol Angeiol (Paris), V65, P21, DOI 10.1016/j.ancard.2014.12.001
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Hu G, 2005, DIABETES CARE, V28, P799, DOI 10.2337/diacare.28.4.799
   Hussain A, 2021, J AM COLL CARDIOL, V77, P559, DOI 10.1016/j.jacc.2020.11.063
   Jacobs S, 2017, BRIT J NUTR, V118, P312, DOI [10.1017/S0007114517002033, 10.1017/s0007114517002033]
   Komorita Y, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001252
   Li YP, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6669
   Li YP, 2018, CIRCULATION, V138, P345, DOI [10.1161/CIRCULATIONAHA.117.032047, 10.1161/circulationaha.117.032047]
   Lin CC, 2012, DIABETES CARE, V35, P105, DOI 10.2337/dc11-0930
   Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017
   Long GH, 2014, DIABETES CARE, V37, P1712, DOI 10.2337/dc13-1731
   Lv J, 2017, INT J EPIDEMIOL, V46, P1410, DOI 10.1093/ije/dyx074
   Lv J, 2017, J AM COLL CARDIOL, V69, P1116, DOI 10.1016/j.jacc.2016.11.076
   Morse SA, 2010, CURR HYPERTENS REP, V12, P120, DOI 10.1007/s11906-010-0099-1
   Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21
   Napoli R, 2020, NUTR METAB CARDIOVAS, V30, P1926, DOI 10.1016/j.numecd.2020.07.012
   Nöthlings U, 2010, J DIABETES, V2, P112, DOI 10.1111/j.1753-0407.2010.00069.x
   Nyberg ST, 2018, LANCET PUBLIC HEALTH, V3, pE490, DOI 10.1016/S2468-2667(18)30139-7
   O'Doherty MG, 2016, EUR J EPIDEMIOL, V31, P455, DOI 10.1007/s10654-015-0112-8
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Pan A, 2015, CIRCULATION, V132, P1795, DOI 10.1161/CIRCULATIONAHA.115.017926
   Patel YR, 2018, CLIN NUTR, V37, P139, DOI 10.1016/j.clnu.2016.11.003
   Paterson AD, 2007, DIABETES CARE, V30, P2107, DOI 10.2337/dc06-1441
   Petersen M, 2003, DIABETES CARE, V26, P917
   Polsky S, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0950-8
   RICHARDSON MT, 1995, INT J EPIDEMIOL, V24, P685, DOI 10.1093/ije/24.4.685
   Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523
   Loureiro LMR, 2018, INT J SPORT NUTR EXE, V28, P284, DOI 10.1123/ijsnem.2017-0342
   Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736
   Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/s0140-6736(10)60484-9
   SASAKI A, 1989, DIABETES RES CLIN PR, V7, P33, DOI 10.1016/0168-8227(89)90042-9
   Schrieks IC, 2015, DIABETES CARE, V38, P723, DOI 10.2337/dc14-1556
   Stenholm S, 2016, INT J EPIDEMIOL, V45, P1260, DOI 10.1093/ije/dyw126
   Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039
   van Dam RM, 2008, BMJ-BRIT MED J, V337, DOI [10.1136/bmj.a1440, DOI 10.1136/bmj.a1440]
   Vetter C, 2019, NAT REV ENDOCRINOL, V15, P194, DOI 10.1038/s41574-019-0164-z
   WHO Guidelines Approved by the Guidelines Review Committee, 2020, WHO GUID PHYS ACT SE
   WILLETT W, 1983, AM HEART J, V105, P417, DOI 10.1016/0002-8703(83)90358-7
   WILLETT WC, 1987, J AM DIET ASSOC, V87, P43
   Zaccardi F, 2017, DIABETOLOGIA, V60, P240, DOI 10.1007/s00125-016-4162-6
   Zhang DD, 2017, METABOLISM, V75, P36, DOI 10.1016/j.metabol.2017.08.001
NR 56
TC 9
Z9 9
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD JUL 5
PY 2021
VL 8
AR 698608
DI 10.3389/fnut.2021.698608
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA TK6LL
UT WOS:000674267500001
PM 34291073
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Eshima, H
   Tamura, Y
   Kakehi, S
   Kakigi, R
   Hashimoto, R
   Funai, K
   Kawamori, R
   Watada, H
AF Eshima, Hiroaki
   Tamura, Yoshifumi
   Kakehi, Saori
   Kakigi, Ryo
   Hashimoto, Ryota
   Funai, Katsuhiko
   Kawamori, Ryuzo
   Watada, Hirotaka
TI A chronic high-fat diet exacerbates contractile dysfunction with
   impaired intracellular Ca<SUP>2+</SUP> release capacity in the skeletal
   muscle of aged mice
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE aging; calcium; high-fat diet; muscle contraction; obesity
ID INSULIN SENSITIVITY; SARCALUMENIN; POPULATION; RESISTANCE; STRENGTH;
   FATIGUE; OBESITY; FIBERS; SOLEUS; HEALTH
AB Obesity and aging reduce skeletal muscle contractile function. However, it remains unclear whether obesity additively promotes muscle contractile dysfunction in the setting of aging. In this study. we investigated skeletal muscle contractile function ex vivo and intracellular Ca2+ release in male C57BL/6J mice fed a low-fat diet (LFD) or a high-fat diet (HFD) for 4 or 20 mo. Tetanic force production in the extensor digitorum longus muscle was decreased by aging or HFD feeding, and the further reduction was observed in aged HFD mice. The 20-mo HFD-fed mice, not the 20-mo LFD-fed mice or 4-mo HFD-fed mice, showed reduced intracellular Ca2+ peak levels by high concentration of caffeine (25 mM) compared with 4-mo LFD mice. Aging and HFD feeding additively increased intramyocellular lipid (IMCL) levels and were associated with the degree of impaired muscle contractile force and peak Ca2+ level. These data suggest that impairment in the contractile force in aged muscle is aggravated by HFD, which may be due, at least in part, to dysfunction in intracellular Ca2+ release. The IMCL, level may be a marker for impaired muscle contractile force caused by aging and HFD.
   NEW & NOTEWORTHY The aim of this study was to examine the effect of high-fat diet (HFD)-induced obesity on contractile function and Ca2+ release capacity in aged skeletal muscle. Not only were the force production and peak Ca2+ levels decreased by aging and HFD feeding, respectively, but also, these interventions had an additive effect in aged HFD-fed mice. These data suggest that the impairment in the contractile force in aged muscle is aggravated by a HFD, which may be due to synergistic dysfunction in intracellular Ca2+ release.
C1 [Eshima, Hiroaki; Tamura, Yoshifumi; Kakehi, Saori; Kawamori, Ryuzo; Watada, Hirotaka] Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan.
   [Eshima, Hiroaki; Tamura, Yoshifumi; Kakehi, Saori; Kawamori, Ryuzo; Watada, Hirotaka] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan.
   [Eshima, Hiroaki; Funai, Katsuhiko] Univ Utah, Diabet & Metab Res Ctr, Salt Lake City, UT USA.
   [Kakigi, Ryo; Hashimoto, Ryota] Juntendo Univ, Dept Physiol, Fac Med, Tokyo, Japan.
   [Watada, Hirotaka] Juntendo Univ, Ctr Therapeut Innovat Diabet, Grad Sch Med, Tokyo, Japan.
   [Watada, Hirotaka] Juntendo Univ, Ctr Mol Diabetol, Grad Sch Med, Tokyo, Japan.
C3 Juntendo University; Juntendo University; Utah System of Higher
   Education; University of Utah; Juntendo University; Juntendo University;
   Juntendo University
RP Tamura, Y (corresponding author), Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan.; Tamura, Y (corresponding author), Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan.
EM ys-tamur@juntendo.ac.jp
RI Hashimoto, Ryota/AAE-3200-2019; Tamura, Yoshifumi/AFK-2430-2022
OI Tamura, Yoshifumi/0000-0002-1685-7821
FU Strategic Research Foundation at Private Universities from the Ministry
   of Education, Culture, Sports, Science and Technology of Japan; KAKENHI
   from the Ministry of Education, Culture, Sports, Science and Technology
   of Japan [16J11193, 15H06597]; Suzuken Memorial Foundation;
   Grants-in-Aid for Scientific Research [16J11193, 15H06597] Funding
   Source: KAKEN
FX This work was supported, in part, by the Strategic Research Foundation
   at Private Universities and KAKENHI (Grants 16J11193 and 15H06597) from
   the Ministry of Education, Culture, Sports, Science and Technology of
   Japan and Suzuken Memorial Foundation.
CR Abrigo J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9047821
   Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007
   Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014
   Andrich DE, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01327
   Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4
   BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279
   Bruton JD, 2002, PFLUG ARCH EUR J PHY, V444, P692, DOI 10.1007/s00424-002-0882-1
   Chan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012345
   Choi SJ, 2016, J GERONTOL A-BIOL, V71, P557, DOI 10.1093/gerona/glv169
   Ciapaite J, 2015, J NUTR BIOCHEM, V26, P155, DOI 10.1016/j.jnutbio.2014.09.014
   des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075
   Eshima H, 2019, J APPL PHYSIOL, V126, P170, DOI 10.1152/japplphysiol.00048.2018
   Eshima H, 2017, AM J PHYSIOL-REG I, V312, pR1017, DOI 10.1152/ajpregu.00032.2017
   Eshima H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13250
   Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758
   Funai K, 2016, DIABETES, V65, P358, DOI 10.2337/db15-0659
   Funai K, 2013, J CLIN INVEST, V123, P1229, DOI 10.1172/JCI65726
   González E, 2000, J MEMBRANE BIOL, V178, P175, DOI 10.1007/s002320010025
   Graber TG, 2015, AGE, V37, DOI 10.1007/s11357-015-9773-1
   Gueugneau M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1165
   Hill C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030505
   Hurst J, 2019, EUR J APPL PHYSIOL, V119, P213, DOI 10.1007/s00421-018-4017-6
   Jiao QB, 2009, AM J PHYSIOL-HEART C, V297, pH576, DOI 10.1152/ajpheart.00946.2008
   Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933
   Kelley RC, 2018, EXP GERONTOL, V103, P69, DOI 10.1016/j.exger.2017.12.017
   Krause MP, 2009, J APPL PHYSIOL, V106, P1650, DOI 10.1152/japplphysiol.91565.2008
   Lamboley CR, 2015, J PHYSIOL-LONDON, V593, P2499, DOI 10.1113/JP270179
   Lan W, 2009, CELL CALCIUM, V45, P474, DOI 10.1016/j.ceca.2009.03.006
   Laver DR, 1997, J MEMBRANE BIOL, V156, P213, DOI 10.1007/s002329900202
   Lee SR, 2015, AGING CLIN EXP RES, V27, P403, DOI 10.1007/s40520-015-0316-5
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mosole S, 2018, GERONTOL GERIATR MED, V4, DOI 10.1177/2333721418768998
   Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72
   Nikolova-Karakashian MN, 2011, ANTIOXID REDOX SIGN, V15, P2501, DOI 10.1089/ars.2011.3940
   O'Connell K, 2008, EXP GERONTOL, V43, P958, DOI 10.1016/j.exger.2008.07.006
   Oláh T, 2016, J PHYSIOL-LONDON, V594, P7381, DOI 10.1113/JP272449
   Payne AM, 2004, J PHYSIOL-LONDON, V560, P137, DOI 10.1113/jphysiol.2004.067322
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Russ DW, 2011, ACTA PHYSIOL, V201, P391, DOI 10.1111/j.1748-1716.2010.02191.x
   Sabbadini RA, 1999, ITAL J NEUROL SCI, V20, P423
   Sackmann-Sala L, 2012, OBESITY, V20, P101, DOI 10.1038/oby.2011.235
   Shrestha LB, 2000, HEALTH AFFAIR, V19, P204, DOI 10.1377/hlthaff.19.3.204
   Sorrentino V, 1995, Adv Pharmacol, V33, P67, DOI 10.1016/S1054-3589(08)60666-3
   Tallis J, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.163840
   Tallis J, 2017, J APPL PHYSIOL, V122, P170, DOI 10.1152/japplphysiol.00836.2016
   Tang W, 2004, FASEB J, V18, P1597, DOI 10.1096/fj.04-1587fje
   Wilborn C, 2005, J INT SOC SPORT NUTR, V2, DOI 10.1186/1550-2783-2-2-4
   Yoshida M, 2005, J BIOL CHEM, V280, P3500, DOI 10.1074/jbc.M406618200
   Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005
NR 50
TC 31
Z9 31
U1 2
U2 13
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD MAY
PY 2020
VL 128
IS 5
BP 1153
EP 1162
DI 10.1152/japplphysiol.00530.2019
PG 10
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA LT0QJ
UT WOS:000536781200006
PM 32213111
OA Green Published
DA 2025-04-28
ER

PT J
AU Tan, SB
   Arcaya, M
AF Tan, Shin Bin
   Arcaya, Mariana
TI Where we eat is who we are: a survey of food-related travel patterns to
   Singapore's hawker centers, food courts and coffee shops
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE Food environments; Food related travel; Travel mode
ID ENVIRONMENT; OBESITY; NEIGHBORHOOD; DESERTS; HEALTH; BEHAVIORS; LEVEL;
   SEOUL; DIET
AB Background The development of empirically-grounded policies to change the obesogenic nature of urban environment has been impeded by limited, inconclusive evidence of the link between food environments, dietary behaviors, and health-related outcomes, in part due to inconsistent methods of classifying and analyzing food environments. This study explores how individual and built environment characteristics may be associated with how far and long people travel to food venues,that can serve as a starting point for further policy-oriented research to develop a more nuanced, context-specific delineations of 'food environments' in an urban Asian context. Methods Five hundred twenty nine diners in eight different neighborhoods in Singapore were surveyed about how far and long they travelled to their meal venues, and by what mode. We then examined how respondents' food-related travel differed by socioeconomic characteristics, as well as objectively-measured built environment characteristics at travel origin and destination, using linear regression models. Results Low-income individuals expended more time traveling to meal destinations than high-income individuals, largely because they utilized slower modes like walking rather than driving. Those travelling from areas with high food outlet density travelled shorter distances and times than those from food-sparse areas, while those seeking meals away from their home and work anchor points had lower thresholds for travel. Respondents also travelled longer distances to food-dense locations, compared to food-sparse locations. Conclusion Those seeking to improve food environments of poor individuals should consider studying an intervention radius pegged to typical walking distances, or ways to improve their transport options as a starting point. Policy-focused research on food environments should also be sensitive to locational characteristics, such as food outlet densities and land use.
C1 [Tan, Shin Bin; Arcaya, Mariana] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Tan, Shin Bin] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, 469C Bukit Timah Rd, Singapore 259772, Singapore.
C3 Massachusetts Institute of Technology (MIT); National University of
   Singapore
RP Tan, SB (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tan, SB (corresponding author), Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, 469C Bukit Timah Rd, Singapore 259772, Singapore.
EM shinbin@mit.edu
OI /0000-0002-4432-7860
FU MIT Horowitz Fund
FX This research received funding from the MIT Horowitz Fund. The funders
   played no role in designing the study, or collecting, analyzing, and
   interpreting the data, or writing the manuscript.
CR Abadie A., 2017, When Should You Adjust Standard Errors for Clustering, DOI [DOI 10.3386/W24003, 10.3386/w24003]
   Agency N, 2019, HIGH MAJ PATR SAT HA
   [Anonymous], 2016, What's in our food and on our mind (Issue Agosto 2016)
   Authority U, MAST PLAN 2014 SUBZ
   Baddeley A, 2016, CHAP HALL CRC INTERD, P1
   Bae Sang Geun, 2012, J Prev Med Public Health, V45, P47, DOI 10.3961/jpmph.2012.45.1.47
   Bhat CR, 1999, TRANSPORTATION, V26, P119, DOI 10.1023/A:1005196331393
   Block J, 2018, NEIGHBORHOODS HLTH
   Board H. National Nutrition Survey 2010 Singapore., 2013, TECHN REP HPB
   Cao XY, 2009, TRANSPORT RES A-POL, V43, P548, DOI 10.1016/j.tra.2009.02.001
   Caspi CE, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0531-x
   Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006
   Chaix B, 2013, HEALTH PLACE, V21, P46, DOI 10.1016/j.healthplace.2013.01.003
   Cheadle A, 2010, AM J PUBLIC HEALTH, V100, P2129, DOI 10.2105/AJPH.2010.300002
   Choi Y, 2013, APPL GEOGR, V43, P87, DOI 10.1016/j.apgeog.2013.05.009
   Cobb LK, 2015, OBESITY, V23, P1331, DOI 10.1002/oby.21118
   Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276
   Cummins S, 2005, J EPIDEMIOL COMMUN H, V59, P1035, DOI 10.1136/jech.2004.029843
   Dijst M, 2000, TRANSPORTATION, V27, P179, DOI 10.1023/A:1005293330869
   Duncan DT, 2014, AM J EPIDEMIOL, V179, P373, DOI 10.1093/aje/kwt251
   Ewing R, 2001, TRANSPORT RES REC, P87, DOI 10.3141/1780-10
   Gamba RJ, 2015, J COMMUN HEALTH, V40, P464, DOI 10.1007/s10900-014-9958-z
   Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330
   Hanibuchi T, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-43
   Hirsch JA, 2013, INT J ENV RES PUB HE, V10, P295, DOI 10.3390/ijerph10010295
   Hughey SM, 2019, HEALTH PLACE, V56, P174, DOI 10.1016/j.healthplace.2019.01.011
   Jiao JF, 2011, TRANSPORT RES REC, P85, DOI 10.3141/2230-10
   Jones-Smith JC, 2013, DIABETES CARE, V36, P2697, DOI 10.2337/dc12-2190
   Kelly B, 2011, HEALTH PLACE, V17, P1284, DOI 10.1016/j.healthplace.2011.08.014
   Kerr J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-58
   Kim D, 2016, NUTR RES PRACT, V10, P530, DOI 10.4162/nrp.2016.10.5.530
   King TL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008878
   Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349
   Li J, 2017, J NANOMATER, V2017, P1, DOI DOI 10.1155/2017/8785121
   Liu JQ, 2019, FRONT LIFE SCI, V12, P1, DOI 10.1080/21553769.2019.1670739
   Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005
   Lytle LA, 2017, HEALTH PLACE, V44, P18, DOI 10.1016/j.healthplace.2016.12.007
   Ortega AN, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3074-1
   Park S, 2013, J ADOLESCENT HEALTH, V53, P655, DOI 10.1016/j.jadohealth.2013.06.002
   Raja S, 2008, J PLAN EDUC RES, V27, P469, DOI 10.1177/0739456X08317461
   Ramachandran A, 2010, J OBES, V2010, DOI 10.1155/2010/868573
   Rasouli S, 2014, INT J URBAN SCI, V18, P31, DOI 10.1080/12265934.2013.835118
   Roux AVD, 2016, AM J PUBLIC HEALTH, V106, P430, DOI 10.2105/AJPH.2016.303064
   Rustin S, 2017, GUARDIAN
   Sallis J, 2008, ECOLOGICAL MODELS HL, P467
   Scheiner J, 2014, J TRANSP GEOGR, V37, P47, DOI 10.1016/j.jtrangeo.2014.04.007
   Statistics Do, GEN HOUS SURV 2015 T
   Su SL, 2017, HABITAT INT, V64, P22, DOI 10.1016/j.habitatint.2017.04.007
   Susilo YO, 2010, TRANSPORT PLAN TECHN, V33, P19, DOI 10.1080/03081060903429280
   Thornton LE, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0082-z
   United Nations, 2019, Report ST/ESA/SER.A/420
   Webb Matthew D., 2013, 1315 QUEENS EC DEP
   Wei QJ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030405
   Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1
   Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001
NR 55
TC 6
Z9 6
U1 2
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5868
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD OCT 20
PY 2020
VL 17
IS 1
AR 132
DI 10.1186/s12966-020-01031-5
PG 14
WC Nutrition & Dietetics; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics; Physiology
GA OD4CD
UT WOS:000579799500001
PM 33081793
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Hjelmesæth, J
   Åsberg, A
   Andersson, S
   Sandbu, R
   Robertsen, I
   Johnson, LK
   Angeles, PC
   Hertel, JK
   Skovlund, E
   Heijer, M
   Ek, AL
   Krogstad, V
   Karlsen, TI
   Christensen, H
   Andersson, TB
   Karlsson, C
AF Hjelmesaeth, Joran
   Asberg, Anders
   Andersson, Shalini
   Sandbu, Rune
   Robertsen, Ida
   Johnson, Line Kristin
   Angeles, Philip Carlo
   Hertel, Jens Kristoffer
   Skovlund, Eva
   Heijer, Maria
   Ek, Anna-Lena
   Krogstad, Veronica
   Karlsen, Tor-Ivar
   Christensen, Hege
   Andersson, Tommy B.
   Karlsson, Cecilia
TI Impact of body weight, low energy diet and gastric bypass on drug
   bioavailability, cardiovascular risk factors and metabolic biomarkers:
   protocol for an open, non-randomised, three-armed single centre study
   (COCKTAIL)
SO BMJ OPEN
LA English
DT Article
ID BETA-CELL FUNCTION; QUALITY-OF-LIFE; BARIATRIC SURGERY; SYSTEMIC
   EXPOSURE; OBESITY; PHARMACOKINETICS; INFLAMMATION; ATORVASTATIN;
   DISPOSITION; ENZYMES
AB Introduction Roux-en-Y gastric bypass (GBP) is associated with changes in cardiometabolic risk factors and bioavailability of drugs, but whether these changes are induced by calorie restriction, the weight loss or surgery per se, remains uncertain. The COCKTAIL study was designed to disentangle the short-term (6 weeks) metabolic and pharmacokinetic effects of GBP and a very low energy diet (VLED) by inducing a similar weight loss in the two groups.
   Methods and analysis This open, non-randomised, three-armed, single-centre study is performed at a tertiary care centre in Norway. It aims to compare the short-term (6 weeks) and long-term (2 years) effects of GBP and VLED on, first, bioavailability and pharmacokinetics (24 hours) of probe drugs and biomarkers and, second, their effects on metabolism, cardiometabolic risk factors and biomarkers. The primary outcomes will be measured as changes in: (1) all six probe drugs by absolute bioavailability area under the curve (AUC(oral)/AUC(iv)) of midazolam (CYP3A4 probe), systemic exposure (AUC(oral)) of digoxin and rosuvastatin and drug:metabolite ratios for omeprazole, losartan and caffeine, levels of endogenous CYP3A biomarkers and genotypic variation, changes in the expression and activity data of the drug-metabolising, drug transport and drug regulatory proteins in biopsies from various organs and (2) body composition, cardiometabolic risk factors and metabolic biomarkers.
   Ethics and dissemination The COCKTAIL protocol was reviewed and approved by the Regional Committee for Medical and Health Research Ethics (Ref: 2013/2379/REK serest A). The results will be disseminated to academic and health professional audiences and the public via presentations at conferences, publications in peer-reviewed journals and press releases and provided to all participants.
C1 [Hjelmesaeth, Joran; Sandbu, Rune; Johnson, Line Kristin; Angeles, Philip Carlo; Hertel, Jens Kristoffer; Karlsen, Tor-Ivar] Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway.
   [Hjelmesaeth, Joran] Univ Oslo, Inst Clin Med, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway.
   [Asberg, Anders; Robertsen, Ida; Krogstad, Veronica; Christensen, Hege] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway.
   [Asberg, Anders] Oslo Univ Hosp, Rikshosp, Dept Transplantat Med, Oslo, Norway.
   [Andersson, Shalini; Andersson, Tommy B.] AstraZeneca Gothenburg, IMED Biotech Unit, Drug Metab & Pharmacokinet, Cardiovasc Renal & Metab, Gothenburg, Sweden.
   [Skovlund, Eva] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway.
   [Heijer, Maria; Ek, Anna-Lena] AstraZeneca Gothenburg, IMED Biotech Unit, Early Clin Dev, Study Operat, Gothenburg, Sweden.
   [Karlsen, Tor-Ivar] Univ Agder, Fac Hlth & Sports Sci, Kristiansand, Norway.
   [Andersson, Tommy B.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Pharmacogenet, Stockholm, Sweden.
   [Karlsson, Cecilia] AstraZeneca Gothenburg, IMED Biotech Unit, Cardiovasc Renal & Metab Translat Med Unit, Early Clin Dev, Gothenburg, Sweden.
   [Karlsson, Cecilia] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.
C3 University of Oslo; University of Oslo; University of Oslo; National
   Hospital Norway; AstraZeneca; Norwegian University of Science &
   Technology (NTNU); AstraZeneca; University of Agder; Karolinska
   Institutet; AstraZeneca; University of Gothenburg
RP Hjelmesæth, J (corresponding author), Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway.; Hjelmesæth, J (corresponding author), Univ Oslo, Inst Clin Med, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway.
EM joran.hjelmeseth@siv.no
RI Karlsen, Tor-Ivar/ABA-6914-2021
OI Asberg, Anders/0000-0002-0628-1769
FU Vestfold Hospital Trust, Tonsberg, Norway; School of Pharmacy,
   University of Oslo, Oslo, Norway; AstraZeneca Gothenburg, Sweden;
   Vestfold Hospital Trust
FX This research is funded by the three collaborators: (1) Vestfold
   Hospital Trust, Tonsberg, Norway; (2) School of Pharmacy, University of
   Oslo, Oslo, Norway; and (3) AstraZeneca Gothenburg, Sweden. The sponsor
   of the trial is Vestfold Hospital Trust. The results of the study will
   be published on completion following appropriate review by the steering
   committee.
CR Abdelaal M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.107
   Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x
   Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285
   Bock KW, 2014, BIOCHEM PHARMACOL, V90, P1, DOI 10.1016/j.bcp.2014.04.009
   Boullata JI, 2010, P NUTR SOC, V69, P543, DOI 10.1017/S0029665110001990
   Bradley D, 2014, OBESITY, V22, P2026, DOI 10.1002/oby.20803
   Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3
   Brethauer SA, 2011, SURG ENDOSC, V25, P2650, DOI 10.1007/s00464-011-1620-6
   Brill MJE, 2014, CLIN PHARMACOKINET, V53, P931, DOI 10.1007/s40262-014-0166-x
   Brill MJE, 2012, CLIN PHARMACOKINET, V51, P277, DOI 10.2165/11599410-000000000-00000
   Brunes A, 2013, SOC PSYCH PSYCH EPID, V48, P745, DOI 10.1007/s00127-012-0594-6
   Buechler C, 2011, CURR DRUG METAB, V12, P24, DOI 10.2174/138920011794520035
   Cappelleri JC, 2009, INT J OBESITY, V33, P611, DOI 10.1038/ijo.2009.74
   Chan LN, 2015, PHARMACOTHERAPY, V35, P361, DOI 10.1002/phar.1560
   Cheng PY, 2001, CURR DRUG METAB, V2, P165, DOI 10.2174/1389200013338676
   Christensen M, 2003, CLIN PHARMACOL THER, V73, P517, DOI 10.1016/S0009-9236(03)00050-X
   Clarke JD, 2012, EXPERT OPIN DRUG MET, V8, P349, DOI 10.1517/17425255.2012.656087
   Darwich AS, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.23
   Darwich AS, 2012, BRIT J CLIN PHARMACO, V74, P774, DOI 10.1111/j.1365-2125.2012.04284.x
   DeFronzo RA, 2011, DIABETES CARE, V34, P789, DOI 10.2337/dc11-0064
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/s0140-6736(16)30054-x
   Edwards A, 2012, ANN PHARMACOTHER, V46, P130, DOI 10.1345/aph.1Q414
   Ferrannini E, 2009, DIABETES CARE, V32, P514, DOI 10.2337/dc08-1762
   Foo J, 2011, OBES SURG, V21, P1914, DOI 10.1007/s11695-011-0527-6
   Gandhi A, 2012, CURR DRUG METAB, V13, P1327, DOI 10.2174/138920012803341302
   Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229
   Arno AG, 2017, OBES SURG, V27, P3194, DOI 10.1007/s11695-017-2745-z
   GREENBLATT DJ, 1984, ANESTHESIOLOGY, V61, P27, DOI 10.1097/00000542-198461010-00006
   Hachon L, 2017, OBES SURG, V27, P1076, DOI 10.1007/s11695-016-2535-z
   Hamad GG, 2012, AM J PSYCHIAT, V169, P256, DOI 10.1176/appi.ajp.2011.11050719
   Hamilton R, 2013, J ANTIMICROB CHEMOTH, V68, P666, DOI 10.1093/jac/dks431
   Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000
   Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4
   Illán-Gómez F, 2012, OBES SURG, V22, P950, DOI 10.1007/s11695-012-0643-y
   Jackness C, 2013, DIABETES, V62, P3027, DOI 10.2337/db12-1762
   Jakobsen GS, 2013, SURG ENDOSC, V27, P2094, DOI 10.1007/s00464-012-2716-3
   Jiao J, 2013, DIABETES, V62, P1074, DOI 10.2337/db12-0681
   Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442
   Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109
   Kissane NA, 2011, BEST PRACT RES-CLIN, V25, P11, DOI 10.1016/j.bpa.2011.01.001
   Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13
   Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8
   Lingvay I, 2013, DIABETES CARE, V36, P2741, DOI 10.2337/dc12-2316
   Lloret-Linares C, 2017, EXPERT OPIN DRUG MET, V13, P493, DOI 10.1080/17425255.2017.1290796
   Lloret-Linares C, 2014, CLIN PHARMACOKINET, V53, P919, DOI 10.1007/s40262-014-0163-0
   Münzberg H, 2015, OBES REV, V16, P77, DOI 10.1111/obr.12258
   Nguyen NT, 2017, NAT REV GASTRO HEPAT, V14, P160, DOI 10.1038/nrgastro.2016.170
   Niero M, 2002, CLIN THER, V24, P690, DOI 10.1016/S0149-2918(02)85144-X
   Padwal RS, 2012, J ANTIMICROB CHEMOTH, V67, P2203, DOI 10.1093/jac/dks177
   Padwal RS, 2011, DIABETES CARE, V34, P1295, DOI 10.2337/dc10-2140
   Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552
   Patrick DL, 2004, OBES RES, V12, P48, DOI 10.1038/oby.2004.8
   Rendic S, 2010, CURR DRUG METAB, V11, P4, DOI 10.2174/138920010791110917
   Rogers CC, 2008, CLIN TRANSPLANT, V22, P281, DOI 10.1111/j.1399-0012.2007.00783.x
   Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b
   Shah RR, 2015, DRUG METAB DISPOS, V43, P400, DOI 10.1124/dmd.114.061093
   Skottheim IB, 2010, CLIN PHARMACOL THER, V87, P699, DOI 10.1038/clpt.2010.32
   Skottheim IB, 2009, CLIN PHARMACOL THER, V86, P311, DOI 10.1038/clpt.2009.82
   Spaggiari D, 2016, TOXICOL APPL PHARM, V302, P41, DOI 10.1016/j.taap.2016.04.013
   Stein J, 2014, ALIMENT PHARM THER, V40, P582, DOI 10.1111/apt.12872
   Summa KC, 2014, ADV NUTR, V5, p312S, DOI 10.3945/an.113.005132
   Tandra S, 2013, ANN SURG, V258, P262, DOI 10.1097/SLA.0b013e31827a0e82
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
   Ulvestad M, 2013, CLIN PHARMACOL THER, V93, P275, DOI 10.1038/clpt.2012.261
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008
   Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664
NR 67
TC 19
Z9 19
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD MAY
PY 2018
VL 8
IS 5
AR e021878
DI 10.1136/bmjopen-2018-021878
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA GJ7KZ
UT WOS:000435567200177
PM 29844102
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Lonac, MC
   Richards, JC
   Schweder, MM
   Johnson, TK
   Bell, C
AF Lonac, Mark C.
   Richards, Jennifer C.
   Schweder, Melani M.
   Johnson, Tyler K.
   Bell, Christopher
TI Influence of Short-Term Consumption of the Caffeine-Free,
   Epigallocatechin-3-Gallate Supplement, Teavigo, on Resting Metabolism
   and the Thermic Effect of Feeding
SO OBESITY
LA English
DT Article
ID CATECHOL-O-METHYLTRANSFERASE; TONIC SYMPATHETIC SUPPORT; GREEN TEA
   CATECHINS; FAT OXIDATION; BODY-WEIGHT; ENERGY-EXPENDITURE;
   ADIPOSE-TISSUE; OBESE SUBJECTS; ABDOMINAL FAT; ASCORBIC-ACID
AB Green tea is purported to promote weight loss. Resting metabolic rate (RMR) and the thermic effect of feeding (TEF) are significant components of total daily energy expenditure and are partially determined by the sympathetic nervous system via catecholamine-mediated stimulation of beta-adrenergic receptors. Epigallocatechin-3-gallate (EGCG: the most bioactive catechin in green tea) inhibits catechol-O-methyltransferase, an enzyme contributing to the degradation of catecholamines. Accordingly, we hypothesized that short-term consumption of a commercially available EGCG supplement (Teavigo) augments RMR and TEF. On two separate occasions, seven placebo or seven EGCG capsules (135 mg/capsule) were administered to 16 adults (9 males, 7 females, age 25 +/- 2 years, BMI 24.6 +/- 1.2 kg/m(2) (mean +/- s.e.)). Capsules (three/day) were consumed over 48 h; the final capsule was consumed 2 h prior to visiting the laboratory. Energy expenditure (ventilated hood technique) was determined at rest and for 5 h following ingestion of a liquid meal (caloric content: 40% RMR). Contrary to our hypothesis, RMR was not greater (P = 0.10) following consumption of EGCG (6,740 +/- 373 kJ/day) compared with placebo (6,971 +/- 352). Similarly, the area under the TEF response curve (Delta energy expenditure) was also unaffected by EGCG (246,808 +/- 23,748 vs. 243,270 +/- 22,177 kJ; P = 0.88). EGCG had no effect on respiratory exchange ratio at rest (P = 0.29) or throughout the TEF measurement (P = 0.56). In summary, together RMR and TEF may account for up to 85% of total daily energy expenditure; we report that short-term consumption of a commercially available EGCG supplement did not increase RMR or TEF.
C1 [Lonac, Mark C.; Richards, Jennifer C.; Schweder, Melani M.; Johnson, Tyler K.; Bell, Christopher] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA.
C3 Colorado State University System; Colorado State University Fort Collins
RP Bell, C (corresponding author), Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA.
EM cbell@cahs.colostate.edu
OI Bell, Christopher/0000-0002-7706-0912
FU National Institute on Aging [NIA AG022053]; American Diabetes
   Association [ADA 1-09-RA-09]; Colorado Agricultural Experiment Station
   at Colorado State University
FX This study was supported, in part, by grants from National Institute on
   Aging (NIA AG022053), American Diabetes Association (ADA 1-09-RA-09),
   the American Diabetes Association's Amaranth Diabetes Fund, and Colorado
   Agricultural Experiment Station at Colorado State University. We are
   grateful to William Hanneman and Greg Dooley at the Center for
   Environmental Medicine at Colorado State University for analysis of
   Teavigo.
CR Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160
   Bell C, 2005, J APPL PHYSIOL, V98, P845, DOI 10.1152/japplphysiol.00790.2004
   Bell C, 2004, J CLIN ENDOCR METAB, V89, P3573, DOI 10.1210/jc.2003-032146
   Bell C, 2001, J CLIN ENDOCR METAB, V86, P4440, DOI 10.1210/jc.86.9.4440
   BORCHARDT RT, 1975, J MED CHEM, V18, P120, DOI 10.1021/jm00235a030
   BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
   Boschmann M, 2007, J AM COLL NUTR, V26, p389S, DOI 10.1080/07315724.2007.10719627
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chesley A, 1998, AM J PHYSIOL-REG I, V275, pR596, DOI 10.1152/ajpregu.1998.275.2.R596
   Chow HHS, 2003, CLIN CANCER RES, V9, P3312
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Franklin BA., 2000, ACSM's Guidelines for Exercise Training and Prescription, V7th
   Granata GP, 2002, NUTR REV, V60, P223, DOI 10.1301/002966402320289359
   Gregersen NT, 2009, BRIT J NUTR, V102, P1187, DOI 10.1017/S0007114509371779
   Hill AM, 2007, J AM COLL NUTR, V26, p396S, DOI 10.1080/07315724.2007.10719628
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Jones PP, 2004, J CLIN ENDOCR METAB, V89, P5138, DOI 10.1210/jc.2004-0101
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Lee MS, 2009, BIOSCI BIOTECH BIOCH, V73, P434, DOI 10.1271/bbb.80563
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293
   Monroe MB, 2001, AM J PHYSIOL-ENDOC M, V280, pE740, DOI 10.1152/ajpendo.2001.280.5.E740
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Newsom SA, 2008, OBESITY, V16, P1749, DOI 10.1038/oby.2008.304
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   RAVUSSIN E, 1992, AM J CLIN NUTR, V55, P242
   RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802
   Reed GW, 1996, AM J CLIN NUTR, V63, P164, DOI 10.1093/ajcn/63.2.164
   Richards JC, 2010, MED SCI SPORT EXER, V42, P739, DOI 10.1249/MSS.0b013e3181bcab6c
   SCHWARTZ RS, 1988, AM J PHYSIOL, V254, pR90, DOI 10.1152/ajpregu.1988.254.1.R90
   SCHWARTZ RS, 1990, METABOLISM, V39, P733, DOI 10.1016/0026-0495(90)90109-P
   Seeram NP, 2006, J AGR FOOD CHEM, V54, P1599, DOI 10.1021/jf052857r
   Shixian Q, 2006, J MED FOOD, V9, P451, DOI 10.1089/jmf.2006.9.451
   Stob NR, 2007, J APPL PHYSIOL, V103, P616, DOI 10.1152/japplphysiol.01434.2006
   Straznicky NE, 2009, DIABETES, V58, P1126, DOI 10.2337/db08-1595
   Straznicky NE, 2009, AM J CLIN NUTR, V89, P27, DOI 10.3945/ajcn.2008.26299
   Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8
   TAPPY L, 1986, AM J PHYSIOL, V250, pE718, DOI 10.1152/ajpendo.1986.250.6.E718
   Tappy L, 1996, REPROD NUTR DEV, V36, P391, DOI 10.1051/rnd:19960405
   Thielecke F, 2010, EUR J CLIN NUTR, V64, P704, DOI 10.1038/ejcn.2010.47
   Thielecke F, 2009, PHYTOCHEMISTRY, V70, P11, DOI 10.1016/j.phytochem.2008.11.011
   Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205
   Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wolfram S, 2007, J AM COLL NUTR, V26, p373S, DOI 10.1080/07315724.2007.10719626
   Zhu BT, 2008, XENOBIOTICA, V38, P130, DOI [10.1080/00498250701744641, 10.1080/00498250701744641 ]
NR 56
TC 35
Z9 40
U1 2
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1930-7381
EI 1930-739X
J9 OBESITY
JI Obesity
PD FEB
PY 2011
VL 19
IS 2
BP 298
EP 304
DI 10.1038/oby.2010.181
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 712FW
UT WOS:000286651400011
PM 20725062
DA 2025-04-28
ER

PT J
AU Ohishi, W
   Fujiwara, S
   Cologne, JB
   Suzuki, G
   Akahoshi, M
   Nishi, N
   Takahashi, I
   Chayama, K
AF Ohishi, Waka
   Fujiwara, Saeko
   Cologne, John B.
   Suzuki, Gen
   Akahoshi, Masazurni
   Nishi, Nobuo
   Takahashi, Ikuno
   Chayama, Kazuaki
TI Risk factors for hepatocellular carcinoma in a Japanese population: A
   nested case-control study
SO CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
LA English
DT Article
ID CHRONIC HEPATITIS-C; LIVER-CANCER; INSULIN-RESISTANCE; SELECTING
   CONTROLS; VIRUS-INFECTIONS; VIRAL-HEPATITIS; ALCOHOL; OBESITY; COHORT;
   FIBROSIS
AB Background: Epidemiologic studies have shown effects of lifestyle-related factors on risk for hepatocellular carcinoma. However, few cohort studies have incorporated, in a strict and in-depth manner, hepatitis B virus (HBV) and hepatitis C virus (HCV) infections or investigated synergism between such factors.
   Methods: We conducted a nested case-control study using sera stored before hepatocellular carcinoma diagnosis in the longitudinal cohort of atomic bomb survivors. The study included 224 hepatocellular carcinoma cases and 644 controls that were matched to the cases on gender, age, city, time of serum storage, and method of serum storage, and countermatched on radiation dose.
   Results: Univariate analysis showed that HBV and HCV infections, alcohol consumption, smoking habit, body mass index (BMI), and diabetes mellitus were associated with increased hepatocellular carcinoma risk, whereas coffee drinking was associated with decreased hepatocellular carcinoma risk. Multivariate relative risks of hepatocellular carcinoma (95% confidence interval) were 45.8 (15.2-138), 101 (38.7-263), 70.7 (8.3-601), 4.36 (1.48-13.0), and 4.57 (1.85-11.3), for HBV infection alone, HCV infection alone, both HBV and HCV infections, alcohol consumption of >= 40 g of ethanol per day, and BMI of >25.0 kg/m(2) 10 years before diagnosis, respectively. HBV and HCV infection and BMI of >25.0 kg/m(2) remained independent risk factors even after adjusting for severity of liver fibrosis. Among HCV-infected individuals, the relative risk of hepatocellular carcinoma for a 1 kg/m(2) increase in BMI was 1.39 (P = 0.003).
   Conclusions: To limit the risk for hepatocellular carcinoma, control of excess weight may be crucial for individuals with chronic liver disease, especially those with chronic hepatitis C.
C1 [Ohishi, Waka; Fujiwara, Saeko; Suzuki, Gen; Akahoshi, Masazurni; Takahashi, Ikuno] Radiat Effects Res Fdn, Dept Clin Studies, Minami Ku, Hiroshima 7320815, Japan.
   [Cologne, John B.] Radiat Effects Res Fdn, Dept Stat, Hiroshima 7320815, Japan.
   [Nishi, Nobuo] Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima 7320815, Japan.
   [Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Div Frontier Med Sci,Programs Biomed Res, Hiroshima, Japan.
   [Suzuki, Gen] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama, Japan.
C3 Radiation Effects Research Foundation - Japan; Radiation Effects
   Research Foundation - Japan; Radiation Effects Research Foundation -
   Japan; Hiroshima University; National Institute of Public Health - Japan
RP Ohishi, W (corresponding author), Radiat Effects Res Fdn, Dept Clin Studies, Minami Ku, 5-2 Hijiyama Pk, Hiroshima 7320815, Japan.
EM nwaka@rerf.or.jp
RI NISHI, NOBUO/S-6195-2019; Takahashi, Hiromitsu/T-2713-2017; Chayama,
   Kazuaki/B-2493-2016
OI Chayama, Kazuaki/0000-0002-5530-5341
CR Aizawa Y, 2000, CANCER, V89, P53, DOI 10.1002/1097-0142(20000701)89:1<53::AID-CNCR8>3.0.CO;2-6
   [Anonymous], 2000, ASIA PACIFIC PERSPEC
   [Anonymous], 1980, CLASSICAL METHODS AN
   Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920
   Bullock RE, 2004, J HEPATOL, V41, P685, DOI 10.1016/j.jhep.2004.05.008
   Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Cologne J, 2003, J EPIDEMIOL, V13, P193, DOI 10.2188/jea.13.193
   Cologne JB, 2004, INT J EPIDEMIOL, V33, P485, DOI 10.1093/ije/dyh097
   COLOGNE JB, 1995, EPIDEMIOLOGY, V6, P271, DOI 10.1097/00001648-199505000-00014
   Cologne JE, 1999, RADIAT RES, V152, P364, DOI 10.2307/3580221
   Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2
   Donato F, 2002, AM J EPIDEMIOL, V155, P323, DOI 10.1093/aje/155.4.323
   El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065
   Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639
   Ferrannini E, 2000, LANCET, V355, P2181, DOI 10.1016/S0140-6736(00)02397-7
   Fukuhara T, 2001, J RADIAT RES, V42, P117, DOI 10.1269/jrr.42.117
   Gupta K, 2002, AM J MED SCI, V323, P140, DOI 10.1097/00000441-200203000-00004
   Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780
   Hu KQ, 2004, J HEPATOL, V40, P147, DOI 10.1016/S0168-8278(03)00479-3
   *IARC, 2004, IARC MON EC CARC RIS, V83
   Inoue M, 2005, JNCI-J NATL CANCER I, V97, P293, DOI 10.1093/jnci/dji040
   Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871
   Ioannou GN, 2007, CLIN GASTROENTEROL H, V5, P938, DOI 10.1016/j.cgh.2007.02.039
   IWAHASHI K, 1995, ALCOHOL CLIN EXP RES, V19, P564, DOI 10.1111/j.1530-0277.1995.tb01549.x
   Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027
   Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012
   LANGHOLZ B, 1995, BIOMETRIKA, V82, P69
   Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005
   Monto A, 2004, HEPATOLOGY, V39, P826, DOI 10.1002/hep.20127
   Moriya K, 2001, CANCER RES, V61, P4365
   Nair S, 2002, HEPATOLOGY, V36, P150, DOI 10.1053/jhep.2002.33713
   Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726
   Ohishi W, 2003, SCAND J GASTROENTERO, V38, P894, DOI 10.1080/00365520310004434
   Ohishi W, 2007, RES ADV MICROBIOLOGY, V7, P1
   Ohishi W, 2006, J CLIN MICROBIOL, V44, P4593, DOI 10.1128/JCM.00621-06
   Perumalswami P, 2006, HEPATOLOGY, V43, P780, DOI 10.1002/hep.21078
   Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x
   Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075
   Sharp GB, 2005, INT J CANCER, V115, P290, DOI 10.1002/ijc.20897
   Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056
   TANAKA T, 1990, BASIC LIFE SCI, V52, P429
   Wang LY, 1998, AM J EPIDEMIOL, V147, P315
   YAGINUMA K, 1987, J VIROL, V61, P1808, DOI 10.1128/JVI.61.6.1808-1813.1987
   Young RW., 2005, REASSESSMENT ATOMIC
   Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018
   Yuan JM, 2004, CANCER, V101, P1009, DOI 10.1002/cncr.20427
NR 47
TC 85
Z9 91
U1 0
U2 14
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1055-9965
EI 1538-7755
J9 CANCER EPIDEM BIOMAR
JI Cancer Epidemiol. Biomarkers Prev.
PD APR
PY 2008
VL 17
IS 4
BP 846
EP 854
DI 10.1158/1055-9965.EPI-07-2806
PG 9
WC Oncology; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Public, Environmental & Occupational Health
GA 288EM
UT WOS:000254969000016
PM 18398026
OA Bronze
DA 2025-04-28
ER

PT J
AU Alzaben, AS
   Alnashwan, NI
   Alatr, AA
   Alneghamshi, NA
   Alhashem, AM
AF Alzaben, Abeer Salman
   Alnashwan, Noha Ibrahim
   Alatr, Afnan Abdullah
   Alneghamshi, Nourah Abdullah
   Alhashem, Anwar Mohammed
TI Effectiveness of a nutrition education and intervention programme on
   nutrition knowledge and dietary practice among Princess Nourah Bint
   Abdulrahman University's population
SO PUBLIC HEALTH NUTRITION
LA English
DT Article
DE Nutrition; Knowledge; Practice; Intervention nutrition education;
   Nutritional knowledge; Dietary practices; Nutritional intervention
   programmes
ID VEGETABLE CONSUMPTION; NONMEDICAL STUDENTS; SAUDI-ARABIA; OBESITY;
   HABITS; FRUIT
AB Objective:
   The study sought to assess the influence of nutrition education and intervention programmes on nutrition knowledge and dietary practice among both students and staff (including faculty) of Princess Nourah Bint Abdulrahman University in Saudi Arabia.
   Design:
   A pretest-posttest, non-randomised experimental study design was implemented at Princess Nourah Bint Abdulrahman University in Riyadh City between September 2019 and February 2020.
   Setting:
   Princess Nourah Bint Abdulrahman University is the largest women's university in the world and has eighteen colleges and institutions and around ninety academic programmes.
   Participants:
   The survey was completed by 1824 participants (1350 students and 474 staff/faculty) before the intervention and by a different cohort of 1731 participants (1317 students and 414 staff/faculty) after the intervention. In total, an independent sample of 3555 staff and students participated. Participants were asked about dietary knowledge and practices. Dietary knowledge entailed food variety and nutrients, fast food and its poor nutritional value, and the influence of cooking style on the nutritional quality of food. Dietary practices involved eating breakfast; consuming salt/sugar, eating high-salt food; eating pre-packaged food and consumption of vegetables, fruits, supplements, water and caffeine.
   Results:
   The majority of the sample consisted of students (75 center dot 1 %) and had not been diagnosed with any disease (73 center dot 7 %). The result of the current study showed that nutrition knowledge improved after completion of the nutrition programme.
   Conclusions:
   The nutrition awareness programme improved students' nutritional knowledge; however, there was no significant effect on their dietary practices. Future nutrition awareness programmes should separate activities for students and staff, focusing on one target population at a time.
C1 [Alzaben, Abeer Salman] Princess Nourah Bint Abdulrahman Univ, Dept Hlth Sci, Coll Hlth & Rehabil Sci, Clin Nutr Program, Riyadh, Saudi Arabia.
   [Alnashwan, Noha Ibrahim; Alatr, Afnan Abdullah; Alneghamshi, Nourah Abdullah] Princess Nourah Bint Abdulrahman Univ, Nutr Dept Deanship Students Affairs, Riyadh, Saudi Arabia.
   [Alhashem, Anwar Mohammed] Princess Nourah Bint Abdulrahman Univ, Hlth Educ Program, Dept Hlth Sci, Coll Hlth & Rehabil Sci, POB 84428, Riyadh 11671, Saudi Arabia.
C3 Princess Nourah bint Abdulrahman University; Princess Nourah bint
   Abdulrahman University; Princess Nourah bint Abdulrahman University
RP Alhashem, AM (corresponding author), Princess Nourah Bint Abdulrahman Univ, Hlth Educ Program, Dept Hlth Sci, Coll Hlth & Rehabil Sci, POB 84428, Riyadh 11671, Saudi Arabia.
EM amalhashem@pnu.edu.sa
RI Alhashem, Anwar/HKO-0742-2023
OI Alzaben, Abeer/0000-0001-9813-1524; Alatr, Afnan/0000-0002-1958-5075
FU Deanship of Scientific Research at Princess Nourah Bint Abdulrahman
   University through the Fasttrack Research Funding Program
FX This research was funded by the Deanship of Scientific Research at
   Princess Nourah Bint Abdulrahman University through the Fasttrack
   Research Funding Program. No grant number provided.
CR Abood DA, 2004, J NUTR EDUC BEHAV, V36, P135, DOI 10.1016/S1499-4046(06)60150-4
   Al-Rethaiaa AS, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-39
   Alnader HM., 2019, Univ Jordan, V46, P17
   Alqarni S., 2016, Journal of Obesity Eat Disorder, V2, DOI [DOI 10.21767/2471-8203.100025, 10.21767/2471-8203.100025]
   Alrashedi W., 2018, J FOOD MICROBIOLOGY, V3
   Althumiri NA, 2018, Food Drug Regul Sci J, V1, P1, DOI [10.32868/rsj.v1i1.21, DOI 10.32868/RSJ.V1I1.21]
   Bakhotmah BA, 2012, ECOL FOOD NUTR, V51, P313, DOI 10.1080/03670244.2012.691388
   Bano R., 2013, IOSR Journal of Nursing and Health Science, V2, P29
   Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458
   Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x
   Epuru S., 2014, Journal of Dental and Medical Sciences, V13, P68, DOI DOI 10.9790/0853-13156874
   Gardner B, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0135-7
   Ha EJ, 2011, J NUTR EDUC BEHAV, V43, P263, DOI 10.1016/j.jneb.2010.02.008
   Ha EJ, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-50
   Ha EJ, 2009, J NUTR EDUC BEHAV, V41, P103, DOI 10.1016/j.jneb.2008.07.001
   Liu HC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111810
   Monga Shaveta, 2008, STUD HOME COMM SCI, V2, P99
   Moradi-Lakeh M, 2017, PUBLIC HEALTH NUTR, V20, P1075, DOI [10.1017/S1368980016003141, 10.1017/s1368980016003141]
   Organization WH, 2020, OB OV
   Pearson N, 2010, PUBLIC HEALTH NUTR, V13, P876, DOI 10.1017/S1368980010000121
   Phagava H, 2019, Georgian Med News, P118
   Poddar KH, 2010, J AM DIET ASSOC, V110, P1723, DOI 10.1016/j.jada.2010.08.008
   Saeidlou Sakineh Nouri, 2016, Maedica (Bucur), V11, P286
   Sajwani Rubina A., 2009, JPMA Journal of the Pakistan Medical Association, V59, P650
   Saudi Food and Drug Authority, 2018, SFDA LAUNCH HLTH FOO
   Spronk I, 2014, BRIT J NUTR, V111, P1713, DOI 10.1017/S0007114514000087
   World Health Organization, 2020, HLTH DIET
   Worsley A, 2002, ASIA PAC J CLIN NUTR, V11, pS579, DOI 10.1046/j.1440-6047.11.supp3.7.x
   Zulfiqar F, 2019, PAK HEART J, V52, P41
NR 29
TC 10
Z9 11
U1 2
U2 27
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1368-9800
EI 1475-2727
J9 PUBLIC HEALTH NUTR
JI Public Health Nutr.
PD MAY
PY 2021
VL 24
IS 7
BP 1854
EP 1860
AR PII S1368980021000604
DI 10.1017/S1368980021000604
PG 7
WC Public, Environmental & Occupational Health; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Nutrition & Dietetics
GA RW1FH
UT WOS:000646268400029
PM 33563363
OA Green Published
DA 2025-04-28
ER

PT J
AU Leider, J
   Powell, LM
AF Leider, Julien
   Powell, Lisa M.
TI Sugar-sweetened beverage prices: Variations by beverage, food store, and
   neighborhood characteristics, 2017
SO PREVENTIVE MEDICINE REPORTS
LA English
DT Article
DE Sugar-sweetened beverages; Price; Sugar-sweetened beverage tax
ID UNITED-STATES; SOCIOECONOMIC-STATUS; OBESITY PREVENTION; PORTION SIZES;
   CONSUMPTION; DISPARITIES; ADULTS; PREVALENCE; RISK; NUTRITION
AB Sugar-sweetened beverage (SSB) consumption is associated with obesity, type 2 diabetes, and cardiovascular disease. A number of U.S. jurisdictions have levied volume-based specific SSB taxes. This study estimated baseline mean SSB prices across categories and sizes as this will help to determine the percentage increase in price resulting from the imposition of specific taxes.
   Data on food store SSB prices were collected in 2017 in Cook County, IL, St. Louis City/County, MO, Oakland, CA, and Sacramento, CA (N = 11,767 product-level observations from 581 stores). Data were weighted to represent volume sold by category and size. Mean prices per ounce were computed across categories and sizes. Linear regression models, clustered on store, were run to estimate associations between price per ounce and product characteristics, neighborhood (linked by census tract) characteristics, store type, and site.
   Weighted summary statistics show that the mean price of SSBs was 4.8 cents/oz. Soda was least expensive (3.4 cents/oz), followed by sports drinks (4.8 cents/oz), juice drinks (5.2 cents/oz), ready-to-drink tea/coffee (7.8 cents/oz), and energy drinks (19.9 cents/oz). Prices were higher for individual-sized (9.6 cents/oz) compared to family-sized drinks (> 1 L/multi-pack; 3.5 cents/oz). Regression results revealed that prices were lower in stores in majority non-Hispanic black tracts and varied by beverage characteristics and store type but not tract-level socioeconomic status.
   Given substantial variation in prices by SSB category, a penny-per-ounce SSB tax, if fully passed through, would increase soda prices by 29% versus 5% for energy drinks, highlighting the potential importance of different specific tax rates across beverage categories.
C1 [Leider, Julien; Powell, Lisa M.] Univ Illinois, Inst Hlth Res & Policy, 1747 W Roosevelt Rd,M-C 275, Chicago, IL 60608 USA.
   [Powell, Lisa M.] Univ Illinois, Div Hlth Policy & Adm, Sch Publ Hlth, 1603 W Taylor St,M-C 923, Chicago, IL 60612 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital
RP Leider, J (corresponding author), Univ Illinois, Inst Hlth Res & Policy, 1747 W Roosevelt Rd,M-C 275, Chicago, IL 60608 USA.
EM jleide2@uic.edu; powelll@uic.edu
FU Bloomberg Philanthropies' Obesity Prevention Initiative [49255];
   University of Illinois at Chicago Center for Clinical and Translational
   Science [UL1TR002003]
FX This work was supported by the Bloomberg Philanthropies' Obesity
   Prevention Initiative (www.bloomberg.org) [grant number 49255]. The
   contents of this publication do not necessarily reflect the view or
   policies of Bloomberg Philanthropies. Access to the REDCap data system
   (used to record store audit data) was provided by the University of
   Illinois at Chicago Center for Clinical and Translational Science [grant
   number UL1TR002003]. The study sponsor had no role in study design;
   collection, analysis, and interpretation of data; writing the
   manuscript; or the decision to submit the manuscript for publication.
CR [Anonymous], 2013, Stata 13 Base Reference Manual
   [Anonymous], 2015, Fiscal Policies for Diet and Prevention of Noncommunicable Diseases
   [Anonymous], 2014, Sugar stock, ex-factory prices
   [Anonymous], 2018, DEV RELIABILITY TEST
   Colchero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144408
   Beckles GL, 2016, MMWR-MORBID MORTAL W, V65, P1265, DOI 10.15585/mmwr.mm6545a4
   Bernabé E, 2014, J DENT, V42, P952, DOI 10.1016/j.jdent.2014.04.011
   Bleich SN, 2018, OBESITY, V26, P432, DOI 10.1002/oby.22056
   Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392
   Carroll S., 2011, NCHS DATA BRIEF
   Cawley J, 2018, JAMA-J AM MED ASSOC, V319, P305, DOI 10.1001/jama.2017.16903
   *CDCP, 2017, NAT DIAB STAT REP
   Center for Science in the Public Interest, 2018, LOC SUG DRINK TAX VO
   Chaloupka FJ, 2011, J POLICY ANAL MANAG, V30, P662, DOI 10.1002/pam.20588
   Chriqui JF, 2013, J PUBLIC HEALTH POL, V34, P403, DOI 10.1057/jphp.2013.17
   Committee DGA HHS Prevention OoD Promotion H USDA Promotion CfNP, 2015, Dietary Guidelines for Americans 2015-2020
   Esri, 2016, EUCL ALL
   Falbe J, 2015, AM J PUBLIC HEALTH, V105, P2194, DOI 10.2105/AJPH.2015.302881
   Fiscella K, 2009, AM HEART J, V157, P988, DOI 10.1016/j.ahj.2009.03.019
   Graham G, 2015, CURR CARDIOL REV, V11, P238, DOI 10.2174/1573403X11666141122220003
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Harris J., 2014, Sugary Drink FACTS 2014: Some Progress but Much Room for Improvement in Marketing to Youth
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Kern DM, 2016, PUBLIC HEALTH NUTR, V19, P3386, DOI 10.1017/S1368980016001579
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Kumar G, 2015, PUBLIC HEALTH NUTR, V18, P1173, DOI 10.1017/S1368980014001785
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   McGuire S, 2012, ADV NUTR, V3, P708, DOI 10.3945/an.112.002733
   Moran AJ, 2018, AM J PREV MED, V55, P55, DOI 10.1016/j.amepre.2018.03.012
   Ogden CL, 2017, MMWR-MORBID MORTAL W, V66, P1369, DOI 10.15585/mmwr.mm6650a1
   Ogden Cynthia L, 2015, NCHS Data Brief, P1
   Powell LM, 2016, PREV MED, V86, P106, DOI 10.1016/j.ypmed.2016.01.011
   Powell LM, 2014, HEALTH PLACE, V29, P124, DOI 10.1016/j.healthplace.2014.06.006
   Rimkus L, 2013, J NUTR EDUC BEHAV, V45, P540, DOI 10.1016/j.jneb.2013.02.005
   Roberto CA, 2015, AM J PUBLIC HEALTH, V105, P2183, DOI 10.2105/AJPH.2015.302862
   Rosinger A., 2017, Sugar-sweetened beverage consumption among U.S. adults, 2011-2014
   Schwartz J, 2012, HEALTH AFFAIR, V31, P399, DOI 10.1377/hlthaff.2011.0224
   Singleton CR, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101242
   U.S. Census Bureau, 2020, American community survey, 5-Year estimates
   UIC Center for Clinical Translational Science, 2018, REDCAP RES EL DAT CA
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
NR 44
TC 10
Z9 12
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2211-3355
J9 PREV MED REP
JI Prev. Med. Rep.
PD SEP
PY 2019
VL 15
AR 100883
DI 10.1016/j.pmedr.2019.100883
PG 7
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA VJ9EF
UT WOS:000645518700011
PM 31193242
OA gold, Green Published
DA 2025-04-28
ER

PT J
AU Collins, RA
   Ashton, LM
   Burrows, TL
   Hutchesson, M
   Adam, MTP
   Clarke, ED
   Collins, CE
AF Collins, Rebecca A.
   Ashton, Lee M.
   Burrows, Tracy L.
   Hutchesson, Melinda
   Adam, Marc T. P.
   Clarke, Erin D.
   Collins, Clare E.
TI No Money No Time Culinary Nutrition Website eHealth Challenge: A
   Pre-Post Evaluation of Impact on Diet Quality, Food Expenditure, and
   Engagement
SO NUTRIENTS
LA English
DT Article
DE nutrition; diet quality; eHealth
ID PHYSICAL-ACTIVITY; INTERVENTIONS; ADULTS; BEHAVIOR; OBESITY; HEALTH;
   INDEX
AB No Money No Time (NMNT) is a culinary nutrition website designed to optimize diet quality. The primary aim was to evaluate the impact of an online targeted nutrition challenge email campaign that encouraged engagement with NMNT and goal setting to improve diet quality and weekly food expenditure. A secondary aim was to assess NMNT engagement. Australian adults >= 18 years were recruited to the eHealth nutrition challenge delivered via weekly emails. Diet quality was assessed using the Healthy Eating Quiz (HEQ) diet quality tool. Engagement was assessed using email open and click-through rates. Intention-to-treat (ITT) analysis was conducted using mixed effects linear regression. Of 481 adults (49.7 +/- 13.9 years, 84% female) who enrolled 79 (16%) completed the challenge. ITT results indicated statistically significant 6-week increases in diet quality score (+3.8 points p <= 0.001, d = 0.58) with sub-scale improvements in vegetables (+0.9 points, p = 0.01, d = 0.32), fruit (+1.2 points, p <= 0.001, d = 0.55), and dairy (+0.9 points, p <= 0.001, d = 0.58). There were significant post-challenge reductions in household spending on takeaway/snacks/coffee of AUD 8.9 per week (p = 0.01, d = 0.29), body weight reduction (-0.6 kg, p = 0.03, d = 0.26), and BMI (-0.2 kg/m2 p = 0.02, d = 0.28). The email open rate remained constant at around 67% (56% to 75%), with an average click-through rate of 18% (7.1% to 37.9%). The eHealth nutrition challenge significantly improved diet quality while reducing BMI and money spent on discretionary foods. Strategies to scale the challenge should be tested as an innovative population strategy for improving diet quality, health indicators, and managing household food budgets.
C1 [Collins, Rebecca A.; Ashton, Lee M.; Burrows, Tracy L.; Hutchesson, Melinda; Clarke, Erin D.; Collins, Clare E.] Univ Newcastle, Coll Hlth Med & Wellbeing, Sch Hlth Sci, Callaghan, NSW 2308, Australia.
   [Collins, Rebecca A.; Burrows, Tracy L.; Hutchesson, Melinda; Clarke, Erin D.; Collins, Clare E.] Hunter Med Res Inst, Food & Nutr Res Grp, New Lambton Hts, NSW 2305, Australia.
   [Ashton, Lee M.] Univ Newcastle, Coll Human & Social Futures, Sch Educ, Callaghan, NSW 2308, Australia.
   [Ashton, Lee M.] Hunter Med Res Inst, Act Living Res Program, New Lambton Hts, NSW 2305, Australia.
   [Adam, Marc T. P.] Univ Newcastle, Coll Engn Sci & Environm, Sch Informat & Phys Sci, New Lambton Hts, NSW 2305, Australia.
C3 University of Newcastle; Hunter Medical Research Institute; University
   of Newcastle; University of Newcastle; Hunter Medical Research
   Institute; University of Newcastle; University of Newcastle
RP Collins, RA; Collins, CE (corresponding author), Univ Newcastle, Coll Hlth Med & Wellbeing, Sch Hlth Sci, Callaghan, NSW 2308, Australia.; Collins, RA; Collins, CE (corresponding author), Hunter Med Res Inst, Food & Nutr Res Grp, New Lambton Hts, NSW 2305, Australia.
EM rebecca.collins10@newcastle.edu.au; lee.ashton@newcastle.edu.au;
   tracy.burrows@newcastle.edu.au; melinda.hutchesson@newcastle.edu.au;
   marc.adam@newcastle.edu.au; erin.clarke@newcastle.edu.au;
   clare.collins@newcastle.edu.au
RI Ashton, Lee/AAA-8485-2019; Clarke, Erin/KUF-4263-2024; COLLINS,
   CLARE/AAO-9933-2020; Hutchesson, Melinda/G-7737-2013; Burrows,
   Tracy/G-7802-2013
OI Collins, Rebecca/0000-0003-3594-8486; Burrows, Tracy/0000-0002-1431-7864
FU Nib Foundation [G2301186]
FX This research was funded by the nib Foundation, grant number G2301186.
CR Active Campaign, 2023, About us
   [Anonymous], Socio-Economic Indexes for Areas, from
   Ashton L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080888
   Australian Bureau of Statistics, 2023, Monthly Household Spending Indicator.
   Australian Institute of Health and Welfare, 2018, Australia's health 2018
   Baldwin JN, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082829
   Beleigoli A, 2020, J MED INTERNET RES, V22, DOI 10.2196/17494
   Beleigoli AM, 2019, J MED INTERNET RES, V21, DOI 10.2196/jmir.9609
   Beydoun MA, 2008, EUR J CLIN NUTR, V62, P303, DOI 10.1038/sj.ejcn.1602700
   Broadbent P, 2023, LANCET REG HEALTH-EU, V27, DOI 10.1016/j.lanepe.2023.100585
   campaignmonitor, 2023, Campaign Monitor by Marigold Ultimate Email Marketing Benchmarks for 2022: By Industry and Day
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Collins CE, 2015, NUTRIENTS, V7, P785, DOI 10.3390/nu7020785
   Collins CE, 2014, CLIN NUTR, V33, P906, DOI 10.1016/j.clnu.2013.09.015
   Crosland P, 2019, AUST NZ J PUBL HEAL, V43, P163, DOI 10.1111/1753-6405.12882
   Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027
   Herman PM, 2022, PUBLIC HEALTH NUTR, V25, P1265, DOI 10.1017/S136898002100015X
   Hutchesson MJ, 2015, OBES REV, V16, P376, DOI 10.1111/obr.12268
   Hutchesson MJ, 2021, OBES REV, V22, DOI 10.1111/obr.13295
   Kothe EJ, 2014, APPETITE, V78, P68, DOI 10.1016/j.appet.2014.03.006
   Kupila SKE, 2023, CURR OBES REP, V12, P371, DOI 10.1007/s13679-023-00515-2
   Myers CA, 2023, CURR DIABETES REP, V23, P371, DOI 10.1007/s11892-023-01529-9
   Nair MK, 2016, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00277
   Norman GJ, 2007, AM J PREV MED, V33, P336, DOI 10.1016/j.amepre.2007.05.007
   O'Brien KM, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-82
   Oosterveen E, 2017, PREV MED, V99, P197, DOI 10.1016/j.ypmed.2017.01.009
   Petersen KS, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124305
   Petretto Donatella Rita, 2024, Clin Pract Epidemiol Ment Health, V20, pe17450179279732, DOI 10.2174/0117450179279732231211110248
   Qiao J, 2022, J HUM NUTR DIET, V35, P202, DOI 10.1111/jhn.12904
   Saha S, 2023, J AM COLL HEALTH, V71, P1270, DOI 10.1080/07448481.2021.1926267
   Scarry A, 2022, NUTRIENTS, V14, DOI 10.3390/nu14122437
   Schwingshackl L, 2018, J ACAD NUTR DIET, V118, P74, DOI 10.1016/j.jand.2017.08.024
   Sun MR, 2021, HEALTH SOC CARE COMM, V29, P464, DOI 10.1111/hsc.13107
   Tanaka N, 2022, NUTRIENTS, V14, DOI 10.3390/nu14030506
   Taylor RM, 2024, NUTR DIET, V81, P35, DOI 10.1111/1747-0080.12860
   Tiwari A, 2017, AM J PREV MED, V52, P616, DOI 10.1016/j.amepre.2017.01.017
   Turner GM, 2018, J CLEAN PROD, V195, P1581, DOI 10.1016/j.jclepro.2017.07.072
   Wellard-Cole L, 2022, CRIT REV FOOD SCI, V62, P5511, DOI 10.1080/10408398.2021.1887075
   Whatnall M, 2022, NUTRIENTS, V14, DOI 10.3390/nu14194072
   Whatnall MC, 2018, APPETITE, V120, P335, DOI 10.1016/j.appet.2017.09.017
   Williams RL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080880
NR 41
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2024
VL 16
IS 17
AR 2950
DI 10.3390/nu16172950
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA F6O8L
UT WOS:001311000900001
PM 39275264
OA Green Published, gold
DA 2025-04-28
ER

PT J
AU Nassif, E
   Davies, A
   Bente, KB
   Wellard-Cole, L
   Jung, JS
   Kay, J
   Hughes, C
   Koprinska, I
   Watson, WL
   Yacef, K
   Chapman, K
   Rangan, A
   Bauman, A
   Mhurchu, CN
   Allman-Farinelli, M
AF Nassif, Emma
   Davies, Alyse
   Bente, Kim B.
   Wellard-Cole, Lyndal
   Jung, Jisu
   Kay, Judy
   Hughes, Clare
   Koprinska, Irena
   Watson, Wendy L.
   Yacef, Kalina
   Chapman, Kathy
   Rangan, Anna
   Bauman, Adrian
   Mhurchu, Cliona Ni
   Allman-Farinelli, Margaret
TI The Contribution of Nutrients of Concern to the Diets of
   18-to-30-Year-Old Australians from Food Prepared Outside Home Differs by
   Food Outlet Types: The MYMeals Cross-Sectional Study
SO NUTRIENTS
LA English
DT Article
DE young adults; nutrition; restaurant; fast food; food prepared outside
   home; menu labelling; saturated fat; sodium; energy
ID BELIEFS; OBESITY; ADULTS; FRUIT
AB Young adults are frequent consumers of food prepared outside the home (FOH). In a cross-sectional survey, the MYMeals study, we showed FOH provided one-third of meals and snacks for young Australian adults, yet it contributed higher proportions of energy and nutrients of concern, such as saturated fat and sodium. This study aimed to determine the detailed proportional contribution of nutrients of concern from the nine food outlet types captured in the MYMeals study. Young adults residing in New South Wales (NSW), Australia, (n = 1001) used a validated smartphone app to report all types and amounts of food and beverages consumed for three consecutive days, as well as their preparation location. The proportions of daily energy, macronutrients, sodium, total sugars, and saturated fat were calculated for each of the nine following outlet types: bakeries or patisseries, coffee chains, cold-drink chains, fast-food chains, ice creamery or frozen yoghurt outlets, independent cafes or restaurants, pubs (hotels) and clubs, service stations or convenience stores, and others not fitting the above categories. Of all FOH outlet types, independent cafes or restaurants contributed the most energy (17.5%), sodium (20.0%) and saturated fat (17.8%) to the total diet, followed by fast-food chains (12.0% energy, 15.8% sodium, and 12.0% saturated fat) and other outlets, with smaller proportions. For males, the proportion of energy and nutrients contributed by fast-food outlets was higher than for females (14.8% versus 9.8% energy). Menu labelling at independent cafes and restaurants is recommended, comprising, in addition to the energy labels already in use in fast-food restaurants, the labelling of nutrients of concern. The feasibility of this recommendation warrants further exploration.
C1 [Nassif, Emma; Davies, Alyse; Wellard-Cole, Lyndal; Rangan, Anna; Allman-Farinelli, Margaret] Univ Sydney, Fac Med & Hlth, Susan Wakil Sch Nursing & Midwifery, Discipline Nutr & Dietet, Sydney, NSW 2006, Australia.
   [Nassif, Emma; Davies, Alyse; Rangan, Anna; Bauman, Adrian; Allman-Farinelli, Margaret] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Bente, Kim B.; Jung, Jisu; Kay, Judy; Koprinska, Irena; Yacef, Kalina] Univ Sydney, Sch Comp Sci, Sydney, NSW 2006, Australia.
   [Wellard-Cole, Lyndal; Hughes, Clare; Watson, Wendy L.] Canc Council NSW, Canc Prevent & Advocacy Div, Sydney, NSW 2011, Australia.
   [Chapman, Kathy] Macular Dis Fdn Australia, Sydney, NSW 2000, Australia.
   [Bauman, Adrian] Univ Sydney, Prevent Res Ctr, Sch Publ Hlth, Sydney, NSW 2006, Australia.
   [Mhurchu, Cliona Ni] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1023, New Zealand.
C3 University of Sydney; University of Sydney; University of Sydney; Cancer
   Council New South Wales; Macular Disease Foundation Australia;
   University of Sydney; University of Auckland
RP Allman-Farinelli, M (corresponding author), Univ Sydney, Fac Med & Hlth, Susan Wakil Sch Nursing & Midwifery, Discipline Nutr & Dietet, Sydney, NSW 2006, Australia.; Allman-Farinelli, M (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
EM margaret.allman-farinelli@sydney.edu.au
RI Rangan, Anna/AFS-4449-2022; allman-farinelli, m/AEI-0052-2022; Kay,
   Judy/AAU-8701-2020; Bauman, Adrian/K-8988-2015; Davies,
   Alyse/AAK-8917-2020
OI Wellard-Cole, Lyndal/0000-0003-1514-2135; Watson,
   Wendy/0000-0002-8906-4064; Yacef, Kalina/0000-0001-7521-6429; Ni
   Mhurchu, Cliona/0000-0002-1144-9167; Davies, Alyse/0000-0002-9448-7539;
   Bente, Kim/0000-0002-7126-7736; Allman-Farinelli,
   Margaret/0000-0002-6478-1374; Rangan, Anna/0000-0003-1815-844X
FU Australian Research Council [LP150100831]; Cancer Council NSW;
   Australian Government Research Training Program (RTP) Scholarship;
   Australian Research Council [LP150100831] Funding Source: Australian
   Research Council
FX This research was funded by a Linkage Grant from the Australian Research
   Council (LP150100831) and Cancer Council NSW. KB was supported by an
   Australian Government Research Training Program (RTP) Scholarship.
CR Allen WMK, 2020, J PAEDIATR CHILD H, V56, P8, DOI 10.1111/jpc.14666
   Allman-Farinelli M, 2016, CURR OBES REP, V5, P23, DOI 10.1007/s13679-016-0189-8
   [Anonymous], ONL FOOD DEL WORLDW
   [Anonymous], 033055001 CENS POP H
   Australian Bureau of Statistics, CPI ROS 18 JUN 2022
   Australian Bureau of Statistics, NAT HLTH SURV 1 RES
   Australian Bureau of Statistics National Health Survey, NAT HLTH SURV 1 RES
   Chan V, 2022, EUR J NUTR, V61, P3407, DOI 10.1007/s00394-022-02891-2
   Chapman K, 2017, APPETITE, V113, P310, DOI 10.1016/j.appet.2017.02.043
   Chung LMY, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020333
   Davies A, 2021, EUR J NUTR, V60, P1875, DOI 10.1007/s00394-020-02380-4
   Duncan A., 2022, Dietetics, V1, P105, DOI 10.3390/dietetics1020011
   Dunford E, 2010, APPETITE, V55, P484, DOI 10.1016/j.appet.2010.08.015
   Dunn KI, 2008, APPETITE, V51, P331, DOI 10.1016/j.appet.2008.03.003
   Food Standards Australia New Zealand, FOOD NUTR DAT
   Food Standards Australia New Zealand, DEV ADD NUTR PROF FO
   Food Standards Australia New Zealand, AUSNUT 2011-13
   Galea LM, 2017, PUBLIC HEALTH NUTR, V20, P2166, DOI 10.1017/S1368980017001082
   Hoare E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101075
   Jaques DA, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093177
   Jung JS, 2020, PROC ACM INTERACT MO, V4, DOI 10.1145/3397327
   Kim EJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249355
   Kris-Etherton Penny M, 2018, BMJ Nutr Prev Health, V1, P23, DOI 10.1136/bmjnph-2018-000009
   Liang S, 2019, NUTR DIET, V76, P284, DOI 10.1111/1747-0080.12544
   Liu JX, 2020, J NUTR, V150, P873, DOI 10.1093/jn/nxz299
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   McNaughton S.A., 2018, FASEB J, V31, DOI [10.1096/fasebj.31.1_supplement.136.5, DOI 10.1096/FASEBJ.31.1_SUPPLEMENT.136.5]
   Mills S, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0567-y
   National Health and Medical Research Council, REC RED CHRON DIS RI
   National Health & Medical Research Council, AUSTR DIET GUID
   Nour M, 2017, PUBLIC HEALTH NUTR, V20, P2499, DOI [10.1017/S1368980017001124, 10.1017/s1368980017001124]
   Nour MM, 2018, APPETITE, V120, P547, DOI 10.1016/j.appet.2017.10.016
   NSW Government Food Authority, KJ LAB NUTR INF
   NSW Government Food Authority, EV KIL MEN LAB
   Partridge SR, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103107
   Rangan AM, 2015, JMIR MHEALTH UHEALTH, V3, P3, DOI 10.2196/mhealth.4613
   Roy Morgan Research Meal Delivery Services, DOUBL US ONL 18 MONT
   Santos JA, 2017, PUBLIC HEALTH NUTR, V20, P1887, DOI 10.1017/S1368980017000799
   Vinyard M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082717
   Vreman RA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013543
   Wang CLN, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030905
   Watson WL, 2016, NUTR DIET, V73, P81, DOI 10.1111/1747-0080.12226
   Wellard-Cole L, 2021, NUTRIENTS, V13, DOI 10.3390/nu13061761
   Wellard-Cole L, 2022, CRIT REV FOOD SCI, V62, P5511, DOI 10.1080/10408398.2021.1887075
   Wellard-Cole L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030621
   Wellard-Cole L, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/12136
   Wellard-Cole L, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.9038
   Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4
   World Health Organization, SALT INT
   World Health Organization, Obesity and overweight
NR 50
TC 0
Z9 0
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD SEP
PY 2022
VL 14
IS 18
AR 3751
DI 10.3390/nu14183751
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 4U7KI
UT WOS:000858968000001
PM 36145127
OA gold, Green Published
DA 2025-04-28
ER

EF